From 354fea9a3d87fe62903363cd4f4e86fc1104c90d Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Tue, 31 Jan 2017 17:42:47 -0300 Subject: [PATCH 01/23] Building orgs clusters and suggesting normalized entries --- processors/base/helpers/__init__.py | 68 +- .../data/organisation_training_data.csv | 11470 ++++++++++++++++ processors/base/processors/trial.py | 14 +- requirements.txt | 2 + 4 files changed, 11549 insertions(+), 5 deletions(-) create mode 100644 processors/base/helpers/data/organisation_training_data.csv diff --git a/processors/base/helpers/__init__.py b/processors/base/helpers/__init__.py index aea5d61..cad4ba7 100644 --- a/processors/base/helpers/__init__.py +++ b/processors/base/helpers/__init__.py @@ -13,9 +13,11 @@ import datetime import urlparse import csv +import unidecode import fuzzywuzzy.fuzz import fuzzywuzzy.process import iso3166 +import dedupe from . import pybossa_tasks_updater @@ -25,8 +27,6 @@ # Module API -EDIT_DISTANCE_THRESHOLD = 75 - def get_variables(object, filter=None): """Exract variables from object to dict using name filter. @@ -301,6 +301,7 @@ def get_canonical_location_name(location): # Extracted from: https://github.com/datasets/country-codes/blob/master/data/country-codes.csv CSV_PATH = os.path.join(os.path.dirname(__file__), 'data/countries.csv') DISTANCE_SCORER = fuzzywuzzy.fuzz.token_sort_ratio + EDIT_DISTANCE_THRESHOLD = 75 cleaned_location = remove_string_punctuation(location) current_match = location @@ -329,3 +330,66 @@ def get_canonical_location_name(location): logger.debug('Location "%s" normalized as "%s"', cleaned_location, current_match) return current_match + +def _dedup_cluster(cluster_entries): + """Sample, train and build organisation clusters + + Args: + cluster_entries (str): a list of candidates to + be grouped in equivalent sets + """ + + MATCH_THRESHOLD = 0.5 + TRAINING_FILE = os.path.join(os.path.dirname(__file__), 'data/organisation_training_data.csv') + + fields = [{'field' : 'name', 'type': 'String'}] + deduper = dedupe.Dedupe(fields) + deduper.sample(cluster_entries, 15000) + + with open(TRAINING_FILE) as training_file: + deduper.readTraining(training_file) + + deduper.train() + + return deduper.match(cluster_entries, MATCH_THRESHOLD) + +def get_organisation_clusters(org_list): + """Build an usable list of clusters to be used + when normalizing new entries + + Args: + org_list (str): list of all organisations + stored on database + """ + + logger.debug('Generating organisations cluster data') + + cluster_members = {entry['id']: {'name': unidecode.unidecode(entry['name'])} + for entry in org_list} + clustered_dupes = _dedup_cluster(cluster_members) + + extended_clusters = [] + for (_, cluster) in enumerate(clustered_dupes): + id_set, _ = cluster + cluster_d = [cluster_members[c]['name'] for c in id_set] + extended_clusters.append(cluster_d) + + return extended_clusters + +def normalize_organisation_name(organisation, org_clusters): + """Find a canonical organisation name according to + a pre-built set of clusters + + Args: + location (str): the organisation to be normalized + """ + + normalized_organisation = organisation + # Try to find the organisation into any of the clusters + for cluster in org_clusters: + if organisation in cluster: + normalized_organisation = max(cluster, key=len) + break + logger.debug('Organisation "%s" normalized as "%s"', organisation, normalized_organisation) + # Return itself if there's no cluster containing that org (org is unique) + return normalized_organisation diff --git a/processors/base/helpers/data/organisation_training_data.csv b/processors/base/helpers/data/organisation_training_data.csv new file mode 100644 index 0000000..2e4a493 --- /dev/null +++ b/processors/base/helpers/data/organisation_training_data.csv @@ -0,0 +1,11470 @@ +Cluster ID,confidence_score,id,name,slug,,,canonical_,canonical_id,canonical_slug,canonical_name +1082,,0bcc726f-6130-4d98-b550-7de1761bda43,Justus Liebig Universität Gießen,justus_liebig_universit_t_gie_en,,,,,, +1083,,685b050c-ed03-45df-b7ed-8f914b10114f,"Department of Obstetrics and Gynecolog, Randers Centralsygehusy",department_of_obstetrics_and_gynecolog_randers_centralsygehusy,,,,,, +236,0.94672501087188721,773e090f-d432-4405-870d-7cc6cc5ee44e,"Pfizer Ltd. Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK",pfizer_ltd_ramsgate_road_sandwich_kent_ct13_9nj_uk,,,,36e40cab-06cf-41e0-bef3-04e11a49311d,pfizer_ltd_ramsgate_road_sandwich_kent,"Pfizer Ltd, Ramsgate Road, Sandwich, Kent" +1084,,341cc510-7158-11e6-a0cd-0242ac12000b,CIPLA,cipla,,,,,, +1085,,a3402450-cde4-4e28-8477-fee965743a62,Alfact Innovation,alfact_innovation,,,,,, +459,0.95726326107978821,fa56fa20-0cae-4922-8edb-783fd6898a45,"Janssen-Cilag International N.V., Turnhoutseweg 30, 2340 Beerse, Belgium",janssen_cilag_international_n_v_turnhoutseweg_30_2340_beerse_belgium,,,,caa9eeff-a0fe-407d-8a39-097924dbd94c,janssen_cilag_international_n_v_turnhoutseweg_30_2340_beerse_belgium,"Janssen-Cilag International N.V., Turnhoutseweg 30, 2340 Beerse, Belgium" +1086,,a7f32198-0a3e-4944-9e0a-687a9adcef24,Universitätsklinikum Essen - Zentrum für Innere Medizin - Klinik für Endokrinologie,universit_tsklinikum_essen_zentrum_f_r_innere_medizin_klinik_f_r_endokrinologie,,,,,, +1087,,fae4fcf2-9a6d-425b-ab65-1b9e6f3aa25c,Digna Biotech S.L,digna_biotech_s_l,,,,,, +900,0.955805,578a311e-a483-4d9f-906e-cd1723e08711,Chiesi Farmaceutici S.p.A,chiesi_farmaceutici_s_p_a,,,,578a311e-a483-4d9f-906e-cd1723e08711,chiesi_farmaceutici_s_p_a,Chiesi Farmaceutici S.p.A +1088,,93620f8f-105f-433c-94e0-860b7f3bf880,Belgian Society of Medical Oncology,belgian_society_of_medical_oncology,,,,,, +1089,,01d24c67-0656-4b41-b0d3-4e021e6f474d,"Nycomed Danmark ApS, International Medical Affairs",nycomed_danmark_aps_international_medical_affairs,,,,,, +1090,,a121f538-9a44-4514-b2dc-eb693b1e50d3,AXXONIS PHARMA GMBH,axxonis_pharma_gmbh,,,,,, +1091,,d9525d1e-b581-4145-8cc2-5776d2639c45,TxCell,txcell,,,,,, +1092,,d00926f9-c59d-4035-b6ce-ed0b58fa5a5a,Kitov Pharmaceuticals Ltd,kitov_pharmaceuticals_ltd,,,,,, +1093,,cb2f077b-f1f1-4532-b11a-08dc14984a21,"Delcath Systems, Inc",delcath_systems_inc,,,,,, +1094,,5b0c28bc-306c-4acd-9c6a-39bc9300ba95,"Nile Therapeutics, Inc",nile_therapeutics_inc,,,,,, +1095,,bd312691-a403-45d9-a2d7-132751eea0f5,TOPIVERT Pharma Limited,topivert_pharma_limited,,,,,, +493,0.98653608560562134,d264e962-7141-11e6-a0cd-0242ac12000b,AMNEAL PHARM,amneal_pharm,,,,d264e962-7141-11e6-a0cd-0242ac12000b,amneal_pharms,AMNEAL PHARMS +1096,,7c9b2132-b2f6-4392-88b9-69cf11dc9075,Danish University of Pharmaceutical Sciences,danish_university_of_pharmaceutical_sciences,,,,,, +1097,,206b7df2-2e79-4123-97f1-5c2590f319c3,Inventiva SAS,inventiva_sas,,,,,, +1098,,1dae84f9-4277-453d-91ad-f375a7889f4a,Dept. of Infectious diseases / virology University of Gothenburg,dept_of_infectious_diseases_virology_university_of_gothenburg,,,,,, +1099,,3ebd7cbe-6f04-4bfe-8e34-9272aa8449aa,Swiss Group for Clinical Cancer Reaserch (SAKK),swiss_group_for_clinical_cancer_reaserch_sakk,,,,,, +1100,,74c9ea7a-0b5a-474d-8016-eba5358c71cd,"Coloplast A/S, Consumer Products",coloplast_a_s_consumer_products,,,,,, +1101,,87df94e1-8c6e-4914-acc6-a2e6daadde1b,"LUMC, Department Infection Disease",lumc_department_infection_disease,,,,,, +783,0.988564,7e086a89-ce6e-4201-a20f-f377b113a14a,Friedrich Schiller University Jena,friedrich_schiller_university_jena,,,,7e086a89-ce6e-4201-a20f-f377b113a14a,friedrich_schiller_university_jena,Friedrich Schiller University Jena +925,0.96910750865936279,844eaa65-2406-4ab1-9c51-75be91cc2736,LUMC,lumc,,,,844eaa65-2406-4ab1-9c51-75be91cc2736,lumc,LUMC +1102,,43f54556-29fe-4aff-8541-4798a7b00184,"Ark Therapeutics, Ltd",ark_therapeutics_ltd,,,,,, +1103,,1be23313-1080-4009-bdb4-41cf53132903,Vectura Limited,vectura_limited,,,,,, +1104,,5b410d48-f53c-461b-a9ef-9228e7d16eb8,Rodrigo Aguilera,rodrigo_aguilera,,,,,, +947,0.98283,3d9cc66f-e29e-4146-9f7e-6baf8b6a7b2e,Hospital Clínic,hospital_cl_nic,,,,3d9cc66f-e29e-4146-9f7e-6baf8b6a7b2e,hospital_cl_nic,Hospital Clínic +1105,,5e7e8fa3-07af-4c0e-bde5-05bed4ed177d,AZIENDA OSPEDALIERA UNIVERSITARIA SAN MARTINO GENOVA,azienda_ospedaliera_universitaria_san_martino_genova,,,,,, +1106,,da34504e-153b-4cd3-8ed6-1e24ecb96abd,Medizinische Universität Innsbruck / Allg. u. chirug. Intensivmedizin,medizinische_universit_t_innsbruck_allg_u_chirug_intensivmedizin,,,,,, +1107,,b5919966-d90d-42f3-ba77-7b50b2f3f8bf,SFJ Pharma Ltd. II,sfj_pharma_ltd_ii,,,,,, +1108,,085fad23-7eb6-4a25-bd05-9518cd77a48e,ALEXION PHARMACEUTICALS INCORPORATED,alexion_pharmaceuticals_incorporated,,,,,, +1109,,102808f8-9c78-4560-9fc5-8a62863aa81b,SAKK Swiss Group for Clinical Cancer Research,sakk_swiss_group_for_clinical_cancer_research,,,,,, +1110,,66449089-8b55-4739-ae2c-e5dafe79ec6d,"Protherics Salt Lake City, Inc",protherics_salt_lake_city_inc,,,,,, +1111,,eb3df69f-4546-4938-b7a3-64b5ce006a5a,Valletta Health BV,valletta_health_bv,,,,,, +1112,,dd6a0d1c-faf9-40e4-b5b6-1359f7412edc,Jorge Alonso Zafra,jorge_alonso_zafra,,,,,, +1113,,e38a8829-3b07-4403-91c8-57c61c331d1e,Bombastus-Werke AG,bombastus_werke_ag,,,,,, +1114,,1de2254b-38b4-4ec4-bdcd-0cec65691870,Asociación Instituto Biodonostia,asociaci_n_instituto_biodonostia,,,,,, +1115,,6b0b04dc-f900-4b57-9764-eb8a7ec5acf6,South Manchester University Hospital NHS Trust,south_manchester_university_hospital_nhs_trust,,,,,, +1116,,e78cf862-14ba-4a09-a057-f1e296fa7a70,University of New South Wales,university_of_new_south_wales,,,,,, +1117,,c532e84d-37ae-47e1-8d59-1fe9b7b85f84,Uniklinikum Tuebingen,uniklinikum_tuebingen,,,,,, +1118,,48fc7a5a-a19f-4635-bc54-53ff1b721914,"Department of Anesthesiology and Operative Intensive Care Medicine, Charité (CBF)",department_of_anesthesiology_and_operative_intensive_care_medicine_charit_cbf,,,,,, +1119,,c015bcd2-0131-47b0-8c25-da262e82688f,Dr. Martin Pinsger & Univ.-Prof. Dr. Rupert Prokesch,dr_martin_pinsger_univ_prof_dr_rupert_prokesch,,,,,, +1120,,945770d2-8bd0-11e6-a449-0242ac12000b,Flamel Ireland Limited,flamel_ireland_limited,,,,,, +1121,,8b724bde-0581-449c-a20a-a59a7e9ed470,Stanmore Clinical Research Facility Ltd,stanmore_clinical_research_facility_ltd,,,,,, +677,0.981509,22accd65-c14d-4d5b-acab-c1bb9180b01d,"Christian Geisler, Righospitalet, dept. Haematology 4042",christian_geisler_righospitalet_dept_haematology_4042,,,,22accd65-c14d-4d5b-acab-c1bb9180b01d,christian_geisler_righospitalet_dept_haematology_4042,"Christian Geisler, Righospitalet, dept. Haematology 4042" +1122,,d41fa9dd-13f0-48aa-9efd-efc87b4186f0,Cruz Bartolome Moreno,cruz_bartolome_moreno,,,,,, +1123,,f185757e-5452-4936-ac54-6a6b96c6a00a,Avexa Limited,avexa_limited,,,,,, +1124,,9f2c6bce-7164-11e6-a0cd-0242ac12000b,IDENTI PHARMS INC,identi_pharms_inc,,,,,, +393,0.941004,b8f2d360-526a-43ca-87db-757c93078a81,Pantec Biosolution AG,pantec_biosolution_ag,,,,6cd8a498-2fe7-40c6-b305-fa69e84aa23d,pantec_biosolutions_ag,Pantec Biosolutions AG +1125,,a98ec312-d088-4c03-bcfa-9564b67d9ff4,Gasthuisberg Leuven,gasthuisberg_leuven,,,,,, +1126,,5bab5133-43b0-453b-8dd3-250fddc47961,Greenpark Healthcare Trust,greenpark_healthcare_trust,,,,,, +368,0.95132752259572351,554078a3-61dd-4b6c-ac18-7ca2d6b7f6eb,"Bayer HealthCare AG, D-51368 Leverkusen Germany",bayer_healthcare_ag_d_51368_leverkusen_germany,,,,0f2245d6-1eb2-4a26-ba28-2ddd66aada58,bayer_healthcare_ag_51368_leverkusen,"Bayer HealthCare AG, 51368 Leverkusen" +1127,,4c9fbb8b-a98b-44c5-ae26-c024e61fdaed,HARRAS-PHARMA-CURARINA GmbH,harras_pharma_curarina_gmbh,,,,,, +1128,,9f1e82ad-baff-445a-b5a8-c33415868459,Gedeon Richter Ltd,gedeon_richter_ltd,,,,,, +1129,,23bcda38-5e3a-4536-9e52-31d508fbbbbc,KYS,kys,,,,,, +1130,,7b811b3f-ceb9-4d0f-8401-6a5744a31032,"BHR PHARMA, LLC",bhr_pharma_llc,,,,,, +1131,,bfb0a553-12ce-48c9-955a-eed9dc534ffa,Renal Clinic Heidelberg,renal_clinic_heidelberg,,,,,, +1132,,1f069a1f-6273-4ffa-973a-59db06dfd60b,Associació Catalana per a la Recerca Oncológica i les seves implicacions Sanitáries i Socials,associaci_catalana_per_a_la_recerca_oncol_gica_i_les_seves_implicacions_sanit_ries_i_socials,,,,,, +1133,,2a2e0f46-3bab-4f08-a5e6-c89ed6cb06ab,Augenklinik Universitaetsallee,augenklinik_universitaetsallee,,,,,, +1134,,02707a4d-90f9-40d4-b5e5-e1a6c6d80718,Academic MS Center Limburg,academic_ms_center_limburg,,,,,, +1135,,bf9e4b8e-2e0b-476c-a7be-c36b7b50f24e,Institut d'Anesthésiologie des Alpes Maritimes,institut_d_anesth_siologie_des_alpes_maritimes,,,,,, +1136,,56e143d4-eed3-4b7b-b97e-7ed9a4fd3d2d,"Medicinsk Afd. M, Århus Sygehus, Nørrebrogade",medicinsk_afd_m_rhus_sygehus_n_rrebrogade,,,,,, +1137,,453a2e1d-8382-49c5-89ea-788dde31dd55,Kungälv Hospital,kung_lv_hospital,,,,,, +248,0.981904,101cc2b8-71b8-11e6-a0cd-0242ac12000b,HILL DERMAC,hill_dermac,,,,101cc2b8-71b8-11e6-a0cd-0242ac12000b,hill_dermac,HILL DERMAC +1138,,997acf9c-739c-11e6-a0cd-0242ac12000b,GASTROENTERO,gastroentero,,,,,, +1139,,b649833c-76bd-4a9b-b7ba-b6618aa8f368,MediGene AG,medigene_ag,,,,,, +1140,,7239deff-df7d-4838-9ee0-a4a2b153b4a2,PEPTONIC medical AB,peptonic_medical_ab,,,,,, +1141,,c029a266-ac32-4a07-9bed-84d734711102,"ERASMUS MC, Dept Anesthesiology",erasmus_mc_dept_anesthesiology,,,,,, +1142,,d02bffb2-5a4f-4182-82a7-88cba3b0cf5c,Prof Vassilis Georgoulias,prof_vassilis_georgoulias,,,,,, +1143,,262bf37c-6dc1-4b63-b609-ce8a1769dc2f,Julio A Virseda Rodriguez,julio_a_virseda_rodriguez,,,,,, +1144,,1e4335b0-7164-11e6-a0cd-0242ac12000b,CHINA RESOURCES,china_resources,,,,,, +1145,,5000330c-715d-11e6-a0cd-0242ac12000b,AUSTARPHARMA LLC,austarpharma_llc,,,,,, +1146,,9b1c6698-a41f-4c3e-adc7-9d81f73ed568,Bayer HealthCare Aktiengesellschaft,bayer_healthcare_aktiengesellschaft,,,,,, +1147,,f5104ada-7495-4088-bb35-2fe6539a5ae2,Dr. Christian Domingo,dr_christian_domingo,,,,,, +1148,,86cdb35c-95e5-4bb7-8493-01bc4e87d1b2,HSK Research GmbH,hsk_research_gmbh,,,,,, +562,0.979163,2618aeee-2b40-46b0-83e0-69a85a4447c6,Glaxo SmithKine Research and Development Limited,glaxo_smithkine_research_and_development_limited,,,,2618aeee-2b40-46b0-83e0-69a85a4447c6,glaxo_smithkine_research_and_development_limited,Glaxo SmithKine Research and Development Limited +1149,,5c4c0109-e5c9-4d12-9699-392fef444445,Provexis Plc,provexis_plc,,,,,, +574,0.96224385499954224,fe7a9983-1939-4f96-adc3-8176dcaae168,Queen Mary University of London,queen_mary_university_of_london,,,,8567fa14-efb0-4bb0-9c97-bf093f58ba24,queen_mary_university_of_london_qmul,"Queen Mary, University of London (QMUL)" +1150,,16230cf5-b7a9-4308-a324-bdf5830582f0,Alliance Pharmaceuticals,alliance_pharmaceuticals,,,,,, +1151,,18dd6240-fd14-435d-9848-fb6c6f1f5a9b,"Kémia, Inc",k_mia_inc,,,,,, +1152,,819d165e-40be-4ef3-b85f-03a6b1bbca0c,Aventis Pharma Recherche De ve loppement,aventis_pharma_recherche_de_ve_loppement,,,,,, +1153,,8c474d43-c5f5-43c2-af49-da46918b5d4b,ikfe – Institute for Clinical Research and Development,ikfe_institute_for_clinical_research_and_development,,,,,, +257,0.943406,62b269c4-7163-11e6-a0cd-0242ac12000b,MACLEODS PHARMA,macleods_pharma,,,,62b269c4-7163-11e6-a0cd-0242ac12000b,macleods_pharma,MACLEODS PHARMA +1154,,99ebe893-62a6-41ed-821a-188b78e041da,Daiichi Medical Research Inc,daiichi_medical_research_inc,,,,,, +503,0.9617990255355835,1e7e8025-6216-4754-a0a3-b1cf72ba2a3d,Sanofi-Synthelabo Research,sanofi_synthelabo_research,,,,1e7e8025-6216-4754-a0a3-b1cf72ba2a3d,sanofi_synthelabo_research,Sanofi-Synthelabo Research +1155,,cffe7e9c-f52f-489f-9d32-0cdf00536513,Forum Pharmaceuticals Inc,forum_pharmaceuticals_inc,,,,,, +349,0.956416,a845a11a-fa6e-4bb7-9057-a36a08b6b773,GITMO (GRUPPO ITALIANO DI MIDOLLLO OSSEO),gitmo_gruppo_italiano_di_midolllo_osseo,,,,81b272b1-dc41-4ac6-b169-23e9c0bb81d7,gitmo,GITMO +1156,,7c245b5f-814a-4ce9-8516-b8c71e9169b1,IRCCS CASA SOLLIEVO DELLA SOFFERENZA,irccs_casa_sollievo_della_sofferenza,,,,,, +1157,,acda27d0-accc-4027-b69d-fd2536b2a068,Mónica Saldaña Valderas,m_nica_salda_a_valderas,,,,,, +740,0.91375583410263062,5e33332a-5eab-46e0-84d6-df15c6f32cd7,"ICORG, all-Ireland Cooperative Oncology Research Group",icorg_all_ireland_cooperative_oncology_research_group,,,,a915c184-a118-4ca9-8fb4-2b38760107dc,icorg_the_all_ireland_cooperative_oncology_research_group,"ICORG, the all-Ireland Co-operative Oncology Research Group" +1158,,dbd9c17b-e41d-4de0-9c41-7a60bbf57f58,az turnhout,az_turnhout,,,,,, +42,0.97669962048530579,cabd6cbe-fd00-4d66-b275-8a313d21ba84,"Universitätsklinik für Augenheilkunde und Optometrie, AKH Wien",universit_tsklinik_f_r_augenheilkunde_und_optometrie_akh_wien,,,,e3a4dbed-6085-4f4f-a871-0b11b6bed573,universit_tsklinik_f_r_augenheilkunde_und_optometrie,Universitätsklinik für Augenheilkunde und Optometrie +703,0.95236596465110779,221122f6-31e0-4da1-94ad-8d33b5a25cd7,University Hospitals Leicester,university_hospitals_leicester,,,,09b03690-5970-415f-b749-e56be3b9df7b,university_hospitals_leicester_nhs_trust,University Hospitals Leicester NHS Trust +1159,,0103709a-6fbc-11e6-abe8-0242ac12000b,Roche Bulgaria EOOD,roche_bulgaria_eood,,,,,, +1160,,d38ce76c-7363-11e6-a0cd-0242ac12000b,MANNKIND,mannkind,,,,,, +1161,,8b5c3d5e-7d91-4606-bc87-73317a6d0c2c,Cortendo AB,cortendo_ab,,,,,, +1162,,b80e8d76-71a9-11e6-a0cd-0242ac12000b,NORWICH-EATON PHARMA,norwich_eaton_pharma,,,,,, +1163,,998c59d7-4ff2-4972-909d-7ddde956fb0a,Vicente Estrada Pérez,vicente_estrada_p_rez,,,,,, +1164,,a5f02f86-73ee-11e6-a0cd-0242ac12000b,AIR LIQUID INDUSTRIAL US LP,air_liquid_industrial_us_lp,,,,,, +272,0.98419728875160217,c26dcdfa-7158-11e6-a0cd-0242ac12000b,LEK PHARMS DD,lek_pharms_dd,,,,5ab1cb72-7148-11e6-a0cd-0242ac12000b,lek_pharms,LEK PHARMS +1165,,6ef4f3be-72ee-11e6-a0cd-0242ac12000b,RELIANT PHARMS,reliant_pharms,,,,,, +1166,,bdafa1c6-c40e-4b85-a59e-33133882512e,J.W. Goethe University Hospital,j_w_goethe_university_hospital,,,,,, +1167,,ebe1f4ff-4d9b-47ff-8d94-25967f98c51e,"Med. Klinik II, Klinikum der Universität München Grosshadern",med_klinik_ii_klinikum_der_universit_t_m_nchen_grosshadern,,,,,, +1168,,7713923f-838a-41a7-85e4-d95e2f41373f,Medinova AG,medinova_ag,,,,,, +1169,,b6941fca-b583-48a3-839b-6e603d6316ce,University Hospitals Coventry and Warwickshire NHS Trust,university_hospitals_coventry_and_warwickshire_nhs_trust,,,,,, +163,0.94221,2e1d8af2-76ea-4f16-98e7-156c78aa3581,"Iho-ja allergiasairaala, HYKS",iho_ja_allergiasairaala_hyks,,,,2e1d8af2-76ea-4f16-98e7-156c78aa3581,iho_ja_allergiasairaala_hyks,"Iho-ja allergiasairaala, HYKS" +145,0.938045,c4a9bf5d-eebd-42f0-a384-39801bffce72,Menarini Benelux SA/NV,menarini_benelux_sa_nv,,,,c4a9bf5d-eebd-42f0-a384-39801bffce72,menarini_benelux_sa_nv,Menarini Benelux SA/NV +1170,,abf53551-61c0-42bb-b281-119b9d4fa14d,Liverpool Heart and Chest Hospital NHS Trust,liverpool_heart_and_chest_hospital_nhs_trust,,,,,, +1171,,47ce6de3-9443-4502-ae52-a5334f96682f,Air Liquide Santé International,air_liquide_sant_international,,,,,, +916,0.986414,6370e13d-5a9e-49dc-a468-3b76aad11206,University of Edinburgh,university_of_edinburgh,,,,6370e13d-5a9e-49dc-a468-3b76aad11206,university_of_edinburgh,University of Edinburgh +1172,,d4f45a5a-dc88-4cce-9136-282a962a60a8,"Relevare Pharmaceuticals, Ltd",relevare_pharmaceuticals_ltd,,,,,, +1173,,3eff6b54-1ba5-48e2-a3eb-3b83099affe2,Mona Ring Gätke,mona_ring_g_tke,,,,,, +1174,,744ad1ba-2269-4c03-b95a-d92205530669,South Warwickshire NHS Foundation Trust,south_warwickshire_nhs_foundation_trust,,,,,, +558,0.984864,2d701be4-7168-11e6-a0cd-0242ac12000b,FERA PHARMS LLC,fera_pharms_llc,,,,19dd85ae-7144-11e6-a0cd-0242ac12000b,fera_pharms,FERA PHARMS +1175,,415de809-0a79-429e-a577-e54b5a6f6646,Innotech international,innotech_international,,,,,, +1176,,7e1922b6-7168-11e6-a0cd-0242ac12000b,DEVA HOLDING A.S,deva_holding_a_s,,,,,, +1177,,28391b70-145c-4ba0-9704-e16dfe2484cf,sanofi-aventis Belgium,sanofi_aventis_belgium,,,,,, +1178,,45c5f0b0-7366-11e6-a0cd-0242ac12000b,EDGEMONT PHARMS LLC,edgemont_pharms_llc,,,,,, +1179,,c00965ea-9b79-4883-a6f5-d48ee6ac0bc7,"Department of Otolaryngology, Head and Neck Surgery Johannes Gutenberg-Universität Mainz",department_of_otolaryngology_head_and_neck_surgery_johannes_gutenberg_universit_t_mainz,,,,,, +922,0.98430114984512329,41a3f51d-cc79-4d85-ad20-dd3ecef8b74f,Pfizer bv CR,pfizer_bv_cr,,,,41a3f51d-cc79-4d85-ad20-dd3ecef8b74f,pfizer_bv_cr,Pfizer bv CR +1180,,7976fecc-73fc-11e6-a0cd-0242ac12000b,PEARL THERAPS INC,pearl_theraps_inc,,,,,, +1181,,5ece2eb4-716e-11e6-a0cd-0242ac12000b,VIDARA THERAPEUTICS RESEARCH LTD,vidara_therapeutics_research_ltd,,,,,, +1182,,a1c8b8c2-712a-11e6-a89e-0242ac12000b,MYLAN PHARMS INC,mylan_pharms_inc,,,,,, +1183,,4cebd297-a8ff-46b4-935c-be6b2b0f60ae,Wilhelminenspital der Stadt Wien,wilhelminenspital_der_stadt_wien,,,,,, +1184,,7041d3f0-a02c-46e6-9544-56b882632a04,"Targacept, Inc",targacept_inc,,,,,, +943,0.910995,ded3dbf8-f0ef-458f-8c5f-53b5c2f16584,"PDL BioPharm, Inc",pdl_biopharm_inc,,,,d64fbb64-ace2-40d6-b379-d8f2f6277ac6,pdl_biopharma_inc,"PDL BioPharma, Inc" +1185,,13dccfb2-2cc2-44d8-b220-81db7034de45,John Vissing,john_vissing,,,,,, +1186,,deaf6e3f-0604-450e-b413-d2d7583697a2,Sheffield Health and Social Research Consortium,sheffield_health_and_social_research_consortium,,,,,, +1187,,076f76fa-71a5-11e6-a0cd-0242ac12000b,JDS PHARMS,jds_pharms,,,,,, +1188,,ce0dd53e-946d-43ac-b1a1-db83722ed791,The Newcastle upon Tyne NHS Hospitals Foundation Trust,the_newcastle_upon_tyne_nhs_hospitals_foundation_trust,,,,,, +441,0.985292,38fa42f7-b481-47f1-ad59-ebc7650a6a92,"Dept. of Anaesthesia, Center of Head and Orthopaedics, Copenhagen University Hospital Rigshospitalet",dept_of_anaesthesia_center_of_head_and_orthopaedics_copenhagen_university_hospital_rigshospitalet,,,,38fa42f7-b481-47f1-ad59-ebc7650a6a92,dept_of_anaesthesia_center_of_head_and_orthopaedics_copenhagen_university_hospital_rigshospitalet,"Dept. of Anaesthesia, Center of Head and Orthopaedics, Copenhagen University Hospital Rigshospitalet" +745,0.974187,0b393cda-95af-44e2-87c2-0f3e708c0eea,"Medical School Hannover, Department of Psychiatry, Socialpsychiatry and Psychotherapy",medical_school_hannover_department_of_psychiatry_socialpsychiatry_and_psychotherapy,,,,0b393cda-95af-44e2-87c2-0f3e708c0eea,medical_school_hannover_department_of_psychiatry_socialpsychiatry_and_psychotherapy,"Medical School Hannover, Department of Psychiatry, Socialpsychiatry and Psychotherapy" +1189,,4283d691-73d0-4d24-be84-a765960a5330,"Medizinische Universität Wien, Klinik für Innere Medizin II, Abteilung für Kardiologie",medizinische_universit_t_wien_klinik_f_r_innere_medizin_ii_abteilung_f_r_kardiologie,,,,,, +1190,,c14cce6d-f942-4397-8dd3-b566ed15c495,University Medical Center Eppendorf,university_medical_center_eppendorf,,,,,, +1191,,cc6ec836-7167-11e6-a0cd-0242ac12000b,SECAN PHARMS,secan_pharms,,,,,, +1192,,2b782fd4-9243-4f68-afcf-82917bc1795a,AGI Therapeutics Research Ltd,agi_therapeutics_research_ltd,,,,,, +524,0.985088,211ecc7f-a65d-460f-803c-c95a4e47e245,Sanofi Pasteur Incorporated,sanofi_pasteur_incorporated,,,,211ecc7f-a65d-460f-803c-c95a4e47e245,sanofi_pasteur_incorporated,Sanofi Pasteur Incorporated +1193,,829e75aa-e69d-48a9-9b58-6cb72601a614,Luis Miguel Ruilope Urioste,luis_miguel_ruilope_urioste,,,,,, +1194,,f67de3b3-f274-4c62-a988-8645600dfe47,KeyNeurotek Pharma GmbH,keyneurotek_pharma_gmbh,,,,,, +206,0.97898,82b82cf4-7168-11e6-a0cd-0242ac12000b,MIKART INC,mikart_inc,,,,050afe2e-7129-11e6-a89e-0242ac12000b,mikart,MIKART +1195,,e51e7b3d-34a2-4fc9-b50b-37a2e9001358,Laboratoire IASON,laboratoire_iason,,,,,, +1196,,2ae93f86-afc2-4c33-a9ab-4cf5557b9a75,Myron D. Ginsberg,myron_d_ginsberg,,,,,, +1197,,16cfada7-4af0-4d8c-84e9-0a3f8b2c2d5d,BioAlliance Pharma,bioalliance_pharma,,,,,, +1198,,bf696e0b-e343-4271-a3f2-fafb8d61ed83,"OxThera, Inc",oxthera_inc,,,,,, +1199,,c66e3903-6167-4581-8b0f-2d9de6da40f8,Synosia Therapeutics AG,synosia_therapeutics_ag,,,,,, +1200,,00268eb1-4ad8-4d4d-952d-d7e469c1fddd,ALTUS PHARMACEUTICALS INC,altus_pharmaceuticals_inc,,,,,, +1201,,6d14b98a-719b-46a3-96ac-8a2c093adb5a,university medical centre utrecht,university_medical_centre_utrecht,,,,,, +1202,,10962173-23c6-4151-812d-ef214f40e09d,Centre Hospitalier Universiaire de Nantes,centre_hospitalier_universiaire_de_nantes,,,,,, +370,0.951764,09b4c65d-3052-471d-a9c2-a2a03f06e86f,"HUS, HYKS, Diabetesklinikka",hus_hyks_diabetesklinikka,,,,09b4c65d-3052-471d-a9c2-a2a03f06e86f,hus_hyks_diabetesklinikka,"HUS, HYKS, Diabetesklinikka" +1203,,fe21c370-bc93-4280-a053-3ef14214bb21,CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS,centro_nacional_de_investigaciones_oncologicas,,,,,, +857,0.97087401151657104,b76bef22-6cac-475a-a7cd-1b5b6d7ad7e4,Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,,,,0213f530-437f-430a-b936-0bfa94166165,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau +266,0.96782034635543823,07e8ff92-7129-11e6-a89e-0242ac12000b,TEVA PHARMS,teva_pharms,,,,07e8ff92-7129-11e6-a89e-0242ac12000b,teva_pharms,TEVA PHARMS +1204,,3f6f99ac-7391-11e6-a0cd-0242ac12000b,ORAPHARMA,orapharma,,,,,, +350,0.980777,3e83bd20-82b9-4762-84e9-fe87fe651346,Pharmacyclics LLC,pharmacyclics_llc,,,,3e83bd20-82b9-4762-84e9-fe87fe651346,pharmacyclics_llc,Pharmacyclics LLC +569,0.952896,25abd45e-c724-4c38-a7f4-5b17f2b4e77f,Pharming Tecnologies B.V,pharming_tecnologies_b_v,,,,25abd45e-c724-4c38-a7f4-5b17f2b4e77f,pharming_tecnologies_b_v,Pharming Tecnologies B.V +1205,,e438054c-c5ad-460e-8be2-ff24f3b3aad4,Department of Anesthesiology University Hospital Center,department_of_anesthesiology_university_hospital_center,,,,,, +1206,,117d1943-7183-40ed-b028-5b3ebdad2d13,Miguel Ángel Zapata. Oftalmología. Hospital vall d'Hebron,miguel_ngel_zapata_oftalmolog_a_hospital_vall_d_hebron,,,,,, +651,0.98270362615585327,4501c601-be00-4be3-8378-bb49eca4c7fb,"Boehringer Ingelheim bv, Medical department",boehringer_ingelheim_bv_medical_department,,,,4501c601-be00-4be3-8378-bb49eca4c7fb,boehringer_ingelheim_bv_medical_department,"Boehringer Ingelheim bv, Medical department" +1207,,dfc220fb-8d70-405e-afa6-812fc02e5326,PROMEFARM,promefarm,,,,,, +1208,,4f6bf09f-c2c3-46f4-89c4-dc72ff5fa330,Hillbom Matti OYS/neurologian klinikka,hillbom_matti_oys_neurologian_klinikka,,,,,, +1209,,899fde21-40d2-4d43-b11c-98a136355e54,St Bartholomew's and The London NHS Trust,st_bartholomew_s_and_the_london_nhs_trust,,,,,, +381,0.93488822877407074,367caed2-fccd-479f-a0e1-c0d0a6d66c2b,"Merck Sharp & Dohme Copr., a subsidary of Merck & Co",merck_sharp_dohme_copr_a_subsidary_of_merck_co,,,,70a76c95-9bc5-4453-ace1-7d9c98a92a7d,merck_sharp_dohme_o,"Merck Sharp & Dohme Copr., a subsidary of Merck & Co" +1210,,0e175f4e-7142-11e6-a0cd-0242ac12000b,SEPTODONT INC,septodont_inc,,,,,, +434,0.98384493589401245,3051319e-81c1-4e75-84ee-7e6002bdcc03,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017",pfizer_inc_235_east_42nd_street_new_york_ny_10017,,,,0068e377-8873-41b9-baad-e3768b77d0b1,pfizer_inc_235_east_42nd_street_new_york_ny_10017,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017" +1211,,aafbcbb6-7146-11e6-a0cd-0242ac12000b,RADIUS PHARMS,radius_pharms,,,,,, +1212,,40068bda-2666-491d-b985-f801f3acab11,SIGMA-TAU,sigma_tau,,,,,, +1213,,0f4e418a-e1c4-4244-9de6-33bf1e3a7799,Liverpool Heart and Chest Hospital NHS Foundation Trust,liverpool_heart_and_chest_hospital_nhs_foundation_trust,,,,,, +1214,,12d1c16d-ee00-4890-a9bb-6f2f7433cbe1,"Karolinska Institute, Södersjukhuset AB",karolinska_institute_s_dersjukhuset_ab,,,,,, +1215,,2f89dcfc-7d79-4636-8993-7fb63ea3e9ca,University Medical Centre St Radboud,university_medical_centre_st_radboud,,,,,, +1216,,726cbfdb-d95c-497d-a78c-2313d0ddfabf,Aventis Pharma Ltd,aventis_pharma_ltd,,,,,, +1217,,39f984ce-7355-11e6-a0cd-0242ac12000b,JAVELIN PHARMS INC,javelin_pharms_inc,,,,,, +1218,,f9ac003e-11a3-403a-8dc5-0f8901bbe172,Kari Leino,kari_leino,,,,,, +1219,,378ff01d-7b5f-465e-9fc4-f387bc31b542,"IFS gGmbH, Universitätsmedizin Göttingen",ifs_ggmbh_universit_tsmedizin_g_ttingen,,,,,, +1220,,65ad650c-31e4-4814-80f3-bb339b187afb,"Erasmus MC, University Medical Center Rotterdam",erasmus_mc_university_medical_center_rotterdam,,,,,, +1221,,a0af921d-d62a-4417-a7ba-982c1d5ed9f3,Ipsen Ltd,ipsen_ltd,,,,,, +973,0.987557,9333210d-087c-420a-b3c2-e6d678ea9766,Cutanea Life Sciences,cutanea_life_sciences,,,,9333210d-087c-420a-b3c2-e6d678ea9766,cutanea_life_sciences,Cutanea Life Sciences +1222,,c6c4db92-3b4e-4600-85f1-bbdfff9cece8,Gesellschaft für Wissens- und Technologietransfer der TU Dresden mbH,gesellschaft_f_r_wissens_und_technologietransfer_der_tu_dresden_mbh,,,,,, +1223,,ec057b58-7163-11e6-a0cd-0242ac12000b,ALCON RES,alcon_res,,,,,, +661,0.988375,e59de0b4-d987-4c5d-b0a1-b8b0f8293749,BioCryst Pharmaceuticals,biocryst_pharmaceuticals,,,,e15edbf4-2f93-4ee5-b9aa-da446c1209d0,biocryst_pharmaceuticals_inc,BioCryst Pharmaceuticals Inc +516,0.984713,8a7efac8-7148-11e6-a0cd-0242ac12000b,UPSHER SMITH LABS,upsher_smith_labs,,,,05ba4e48-7141-11e6-a0cd-0242ac12000b,upsher_smith,UPSHER SMITH +1224,,c3d23f08-f480-4164-aa1a-ec570830426c,Psykiatrisk Center Gentofte,psykiatrisk_center_gentofte,,,,,, +1225,,75e1cdda-7219-11e6-a0cd-0242ac12000b,SANKYO,sankyo,,,,,, +1226,,5098b1b0-da1c-4f5c-bb76-369738b13561,Jon Perez Barcena,jon_perez_barcena,,,,,, +299,0.98712396621704102,7aebdff6-717d-11e6-a0cd-0242ac12000b,NOVARTIS PHARMS,novartis_pharms,,,,7aebdff6-717d-11e6-a0cd-0242ac12000b,novartis_pharms,NOVARTIS PHARMS +659,0.989406,94a3c5e1-819b-42db-8dbd-f3f70a0d7fb3,Swedish Institute for Infectious Disease Control,swedish_institute_for_infectious_disease_control,,,,3b17812c-fdb5-4544-97fd-496a11299fc7,swedish_institute_for_infectious_disease_control_smi,Swedish Institute for Infectious Disease Control (SMI) +1227,,328c75a7-c099-4c26-9e44-2d9caf50497b,BioMarin Nederland B.V,biomarin_nederland_b_v,,,,,, +73,0.983343,a9d0f101-5d13-4345-bc0c-7527c110c176,AM-Pharma B.V,am_pharma_b_v,,,,a9d0f101-5d13-4345-bc0c-7527c110c176,am_pharma_b_v,AM-Pharma B.V +1228,,1ecfd5cb-9273-4fed-9f2d-b6b8c38c4a9c,"Department of Haematology, Aalborg University Hospital",department_of_haematology_aalborg_university_hospital,,,,,, +1229,,5c7ae09f-eaf9-4e44-93d2-6f15a40ad30c,Clinical Research International Ltd,clinical_research_international_ltd,,,,,, +1230,,7a5daf4e-cc3d-4164-8a8b-4af3e56fd609,CHU de GRENOBLE,chu_de_grenoble,,,,,, +1231,,7db992ce-6fe6-426c-a407-e5a90c7abec6,Bracco ALTANA Pharma GmbH,bracco_altana_pharma_gmbh,,,,,, +1232,,36466c64-9623-46fd-b9de-cf5b9e59e3c8,"Arginox Pharmaceuticals, Inc",arginox_pharmaceuticals_inc,,,,,, +1233,,dfbcd008-74a3-48cf-8f24-b0abdd1766c4,AIBILI - Associação para Investigação Biomédica e Inovação em Luz e Imagem,aibili_associa_o_para_investiga_o_biom_dica_e_inova_o_em_luz_e_imagem,,,,,, +1234,,ef200286-e83a-472d-8e19-977af55a1244,Sligo General Hospital,sligo_general_hospital,,,,,, +1235,,27997317-9d15-4cab-8c0f-073337199cbc,Hospital Universitario Dr. Negrin,hospital_universitario_dr_negrin,,,,,, +1236,,3d134f04-7167-11e6-a0cd-0242ac12000b,WUSM CYCLOTRON,wusm_cyclotron,,,,,, +1237,,eb85db05-d1c4-479a-9e01-7d7e736adc24,OSIRIS,osiris,,,,,, +1238,,356224f2-995c-4570-a710-4fd38eb8fffb,NHS Lothian - University Hospitals Division,nhs_lothian_university_hospitals_division,,,,,, +1239,,08276e09-df40-4bc3-9ca1-45711bb2c9e7,UNI-PHARMA SA,uni_pharma_sa,,,,,, +1240,,4b44c27f-ce85-4c74-bb66-c07e55c30fd2,UROLOGY ASSOCIATES S.L,urology_associates_s_l,,,,,, +1241,,aca8d1f1-889a-490e-8b62-d01cb792f6a0,Stichting Toegepast Caridologisch Onderzoek,stichting_toegepast_caridologisch_onderzoek,,,,,, +1242,,3c8fd31a-0f79-4d65-b32a-971f8c95c928,"Charite CBF, Endokrinologie",charite_cbf_endokrinologie,,,,,, +1243,,1113831e-76cd-4d09-9b5d-3468e9e1b54b,Merck Sharp & Dohme Ireland (Human Healthcare) Ltd,merck_sharp_dohme_ireland_human_healthcare_ltd,,,,,, +1244,,c926f160-7150-11e6-a0cd-0242ac12000b,AESGEN,aesgen,,,,,, +1245,,6a37befd-b572-4ce2-81fd-f085675ee7c8,Lourdes Lozano-Bailen,lourdes_lozano_bailen,,,,,, +1246,,2a1b11c4-71bd-11e6-a0cd-0242ac12000b,VIIV HLTHCARE,viiv_hlthcare,,,,,, +874,0.982418,7980a7c5-e0b0-4bbe-8695-41376036421e,"InterMune, Inc",intermune_inc,,,,7980a7c5-e0b0-4bbe-8695-41376036421e,intermune_inc,"InterMune, Inc" +1247,,0641d599-f0a1-4cd7-908c-cc63891f2069,"Medivation, Inc",medivation_inc,,,,,, +1248,,b092997b-2f65-43f5-b4b0-2348a659a084,"Faculty of Medicine at the Georg-August University, Göttingen",faculty_of_medicine_at_the_georg_august_university_g_ttingen,,,,,, +704,0.963353,0fbda7a2-0e8a-489e-b902-fd13c5dec4c2,Profil Institut fuer Stoffwechselforschung GmbH,profil_institut_fuer_stoffwechselforschung_gmbh,,,,0fbda7a2-0e8a-489e-b902-fd13c5dec4c2,profil_institut_fuer_stoffwechselforschung_gmbh,Profil Institut fuer Stoffwechselforschung GmbH +1249,,7804867f-3211-4307-afba-0700a845785e,EPIFARMA SRL,epifarma_srl,,,,,, +1250,,35cf3908-9a3b-4b13-b70f-d06112a25f1a,ErasmusMC,erasmusmc,,,,,, +1251,,43f68c68-6399-4f80-a396-aad424759a45,"Astellas Pharma China, Inc",astellas_pharma_china_inc,,,,,, +1252,,7636f895-0833-4de4-8c2e-e6a0af308523,Infociencia Clinical Research,infociencia_clinical_research,,,,,, +345,0.96143,8e80d144-7163-11e6-a0cd-0242ac12000b,BARR LABS DIV TEVA,barr_labs_div_teva,,,,66393a08-7129-11e6-a89e-0242ac12000b,barr,BARR +1253,,93e49948-591c-4d71-8fe2-d97520f7a10b,"Department of Psychiatry and Psychotherapy, University of Mainz",department_of_psychiatry_and_psychotherapy_university_of_mainz,,,,,, +1254,,f2bb3f22-717d-11e6-a0cd-0242ac12000b,CREALTA PHARMS LLC,crealta_pharms_llc,,,,,, +1255,,dd601c23-dc02-4b12-b16d-7b0f9d25288f,KU Leuven - UZ Leuven,ku_leuven_uz_leuven,,,,,, +1256,,371233f8-471d-4d81-8c3f-d6b6fe86375b,Bausch & Lomb Incorporated,bausch_lomb_incorporated,,,,,, +1257,,4c345b8f-6902-4757-b3d7-4d0b8c47f008,Hôpital Universitaire de Münster,h_pital_universitaire_de_m_nster,,,,,, +1258,,0247ceda-d4d8-45ec-bc65-3ff100ccfa9c,"Biovail Laboratories International SRL, c/o Biovail Technologies Ltd",biovail_laboratories_international_srl_c_o_biovail_technologies_ltd,,,,,, +486,0.98096510767936707,fdb032b4-26cd-4d32-b895-bdd7cc97e99d,Sahlgrenska Universitetssjukhuset/Sahlgrenska,sahlgrenska_universitetssjukhuset_sahlgrenska,,,,e6237908-6daa-4272-adad-f5434c004df0,sahlgrenska_universitetssjukhuset,Sahlgrenska Universitetssjukhus +1259,,e8073246-fd76-4ef0-8a92-f6f62d65bc27,Javier García Campayo,javier_garc_a_campayo,,,,,, +1260,,8d7e91cd-98eb-4872-a576-4bd40522d649,Div KIR AMC,div_kir_amc,,,,,, +1261,,ab8a8c88-7129-11e6-a89e-0242ac12000b,WE PHARMS,we_pharms,,,,,, +1262,,df03d0e3-1345-473c-8400-e5dc3e505b99,"Dainippon Sumitomo Pharma America, Inc",dainippon_sumitomo_pharma_america_inc,,,,,, +946,0.987167,6deffe28-ea22-44c2-b710-cb272fb32a14,"Universität Leipzig, HNO",universit_t_leipzig_hno,,,,4cc8b53a-0566-477c-a16e-fcd4919e14fe,universit_t_leipzig,Universität Leipzig +1263,,ff2036ac-d8c7-4190-b08f-1b1f6542b249,"Allergan, Ltd",allergan_ltd,,,,,, +1264,,feff2cba-5c95-4b98-ab8c-c15c28b2e188,"Klinikum der Universität München Innenstadt, I. Frauenklinik",klinikum_der_universit_t_m_nchen_innenstadt_i_frauenklinik,,,,,, +1265,,5749b408-606b-4473-b58e-a865dbf85b80,Department of Endocrinology and Internal Medicine,department_of_endocrinology_and_internal_medicine,,,,,, +1266,,bad58c7b-4a11-44d0-9bbd-c25ebde5bcf3,Gerencia de Atención Primaria de Mallorca,gerencia_de_atenci_n_primaria_de_mallorca,,,,,, +1267,,0c328717-8c58-4563-ab5c-a4764d340fc0,Deventer Ziekenhuis,deventer_ziekenhuis,,,,,, +1268,,9cdf4fbc-7164-11e6-a0cd-0242ac12000b,L PERRIGO CO,l_perrigo_co,,,,,, +1269,,245a4584-8bd0-11e6-a449-0242ac12000b,KAS Glostrup,kas_glostrup,,,,,, +1270,,db042233-9011-4acd-a517-aeb1b02e65fc,Nice University Hospital,nice_university_hospital,,,,,, +1271,,754065c6-2e87-4529-a2ac-dc3ecffdd4d1,Celimmune LLC,celimmune_llc,,,,,, +1272,,0e3da904-8efa-4371-a1a0-90f40cad50ef,University Hospitals Coventry & Warwickshire NHS Trust,university_hospitals_coventry_warwickshire_nhs_trust,,,,,, +435,0.9795151948928833,e70ee262-6f9a-11e6-9663-0242ac12000b,Pfizer Inc. New York,pfizer_inc_new_york,,,,aad2d334-ecaa-4920-9328-b23c18f3711d,pfizer_inc,Pfizer Inc +1273,,42fbc6d5-4c28-4359-854c-40adab089495,ILTOO PHARMA,iltoo_pharma,,,,,, +1274,,72135ff6-7166-11e6-a0cd-0242ac12000b,PHARMS,pharms,,,,,, +963,0.97782692313194275,3b5eea67-90c9-473c-aaaf-488b308a2999,"Helsinki University Hospital, Department of Gastroenterology",helsinki_university_hospital_department_of_gastroenterology,,,,65248d8e-5a22-48b5-a66d-dc1d1f751700,helsinki_university_hospital,Helsinki University Hospital +1275,,75e71b2d-a150-4f4e-bbcd-67ccaba6c96d,Stragen France,stragen_france,,,,,, +93,0.942231,c24247a8-c2ed-48ff-b1d5-e3d498354044,LABORATORIOS CASEN FLEET S.L.U,laboratorios_casen_fleet_s_l_u,,,,bab1dcfc-4751-41db-9ee8-b9ec54e63541,laboratorios_casen_fleet_s_l,"LABORATORIOS CASEN-FLEET,S.L" +1276,,400a9f82-df6b-4911-bf7c-0d2f733e2a27,IRCCS Ospedale Pediatrico Bambino Gesù,irccs_ospedale_pediatrico_bambino_ges,,,,,, +122,0.9800211489200592,89ecf617-74e0-496c-8ac4-d4eae3b54d8c,F. Hoffmann-La Roche Ltd,f_hoffmann_la_roche_ltd,,,,89ecf617-74e0-496c-8ac4-d4eae3b54d8c,f_hoffmann_la_roche_ltd_pharmaceuticals_divison_pdr,"F. Hoffmann-La Roche Ltd, Pharmaceuticals Divison, PDR" +725,0.989909,1ad9c652-f097-480c-b6e9-4e1f4c988f0c,"National Institute of Allergy and Infectious Diseases (NIAID), NIH",national_institute_of_allergy_and_infectious_diseases_niaid_nih,,,,1ad9c652-f097-480c-b6e9-4e1f4c988f0c,national_institute_of_allergy_and_infectious_diseases_niaid_nih,"National Institute of Allergy and Infectious Diseases (NIAID), NIH" +21,0.98614925146102905,f1937510-b48e-43cb-91ce-4fc479e24205,STALLERGENES SA,stallergenes_sa,,,,31fe54e5-0be3-4070-88f1-464180a02a89,stallergenes,STALLERGENES +754,0.974038,2605a116-7400-44c9-9e20-fd5eac2e111d,Eisai Limited,eisai_limited,,,,2605a116-7400-44c9-9e20-fd5eac2e111d,eisai_limited,Eisai Limited +1014,0.98753157258033752,967576bf-31fd-4f9d-8be3-ae18ae1a40bc,Institut de Recherches Internationales,institut_de_recherches_internationales,,,,9b368f8e-02db-4935-a1a6-f2a417efa7ee,institut_de_recherches_internationales_servier,Institut de Recherches Internationales Servier +888,0.9590187668800354,04e5cd56-5cd4-4f97-85cf-5ecb9b22479a,"Schering-Plough Research Institute, a Divison of Schering Corporation",schering_plough_research_institute_a_divison_of_schering_corporation,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" +1277,,6e661e44-f968-4e47-9a37-b42988cba83a,Ferrosan A/S,ferrosan_a_s,,,,,, +1278,,506f2494-54fc-49bc-9e54-a320ba46de24,St Mary's NHS Trust,st_mary_s_nhs_trust,,,,,, +1279,,9cc4c3bc-ff15-41e9-ab5c-eddd9065fb9c,"Danderyds Hospital, Department of Clinical Sciences, Division of Orthopaedics",danderyds_hospital_department_of_clinical_sciences_division_of_orthopaedics,,,,,, +1280,,0f0cc48e-799b-4e1e-94dd-718c3a3e0252,University of Florida Board of Trustees,university_of_florida_board_of_trustees,,,,,, +1281,,fd4dd3bf-1d29-43d3-902d-8cf6e551d5b0,"Medizinische Universität Wien, Univ.Klinik für Zahn-,Mund-u.Kieferheilkunde,Klin.Abt.f.orale Chirurg",medizinische_universit_t_wien_univ_klinik_f_r_zahn_mund_u_kieferheilkunde_klin_abt_f_orale_chirurg,,,,,, +1282,,c154965f-4fa1-4b98-882d-7196fa457f0a,ACCORD (Academic and Clinical Central Office for Research & Development),accord_academic_and_clinical_central_office_for_research_development,,,,,, +1283,,db460c34-ec4d-4e9c-87ae-a3d51fd23383,"Medizinische Universität Wien; Univ.Klin.f.Innere Med. III, Abt.f.Gastroenterologie u. Hepatologie",medizinische_universit_t_wien_univ_klin_f_innere_med_iii_abt_f_gastroenterologie_u_hepatologie,,,,,, +1284,,df64c454-a703-4e1d-aa31-27cc25c79f2e,"Rigshospitalet, Hjertemedicinsk afd. B",rigshospitalet_hjertemedicinsk_afd_b,,,,,, +1285,,aefbd9ae-afa9-4e75-8359-4cee55269ea2,"Göteborgs Universitet, Göteborg Sweden",g_teborgs_universitet_g_teborg_sweden,,,,,, +1286,,60916fd0-7165-11e6-a0cd-0242ac12000b,FOUGERA PHARMS INC,fougera_pharms_inc,,,,,, +643,0.96428561210632324,1a23c45f-2c11-4e5d-a222-082def03ebc8,Boehringer Ingelheim Noway KS,boehringer_ingelheim_noway_ks,,,,1a23c45f-2c11-4e5d-a222-082def03ebc8,boehringer_ingelheim_noway_ks,Boehringer Ingelheim Noway KS +110,0.97392818331718445,6139ccae-9a9d-4de8-9b9c-753da3579d62,Department of Oncology Karolinska,department_of_oncology_karolinska,,,,7ab0aad4-ccd7-43a6-abf8-e331125b5500,department_of_oncology_karolinska,Department of Oncology +1287,,a71c8328-44d5-4d94-821b-9cce743d4f69,"ONO Pharmaceutical Co., Ltd",ono_pharmaceutical_co_ltd,,,,,, +1288,,e70f6aa9-a3df-45ca-a108-4a0d7c527692,Iniciativa Andaluza en Terapias Avanzadas-Fundación Pública Andaluza Progreso y Salud,iniciativa_andaluza_en_terapias_avanzadas_fundaci_n_p_blica_andaluza_progreso_y_salud,,,,,, +160,0.95195136070251463,ed3f0617-2793-45bc-9ade-1aa72282e214,Fundación para la Investigación biomédica del Hopsital Gregorio Marañón,fundaci_n_para_la_investigaci_n_biom_dica_del_hopsital_gregorio_mara_n,,,,ce27e24e-62ac-42de-a596-4ceed67e634f,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón +870,0.98664483428001404,deb12ae0-1752-4e26-a0e5-920c56f9b1a0,Astellas Pharma Europe BV (APEB),astellas_pharma_europe_bv_apeb,,,,483064d3-f8fd-47e0-a0a2-b17b8d5df7d6,astellas_pharma_europe_bv,Astellas Pharma Europe BV +1289,,6c77ca9a-07a8-4911-ac40-1277ff47800a,Itziar Astigarraga Aguirre,itziar_astigarraga_aguirre,,,,,, +1290,,40650bc0-7167-11e6-a0cd-0242ac12000b,ORIENT PHARMA CO LTD,orient_pharma_co_ltd,,,,,, +1291,,d152d84a-aeec-429e-a1f0-48d42cc4ca80,Decan of Medical Faculty of Goethe University Frankfurt,decan_of_medical_faculty_of_goethe_university_frankfurt,,,,,, +1292,,11f8db8a-1255-4b7a-b94e-b274f35bfe5b,Fundació Privada Institut d´Investigació Biomèdica de Girona Dr. Josep Trueta,fundaci_privada_institut_d_investigaci_biom_dica_de_girona_dr_josep_trueta,,,,,, +1293,,e9c24602-6521-44da-9b74-03d3a5c1086d,St Radboud UMC,st_radboud_umc,,,,,, +1294,,3005c2a7-dd62-43f8-9ac0-db3413793875,Basque Health System,basque_health_system,,,,,, +1295,,de694b65-acca-43dd-950e-b2712707c8df,"Department of Palliative Medicine, RWTH Aachen",department_of_palliative_medicine_rwth_aachen,,,,,, +1296,,07248b3f-7d4c-4163-abd0-52b782a3ec3a,Academical Medical Center,academical_medical_center,,,,,, +1297,,ae5a53c5-4819-48f4-9410-d46efabbae26,TransTech Pharma,transtech_pharma,,,,,, +9,0.96687185764312744,af35cb5f-b8db-41b8-88b2-0af8194a43d2,Centre Hospitalier Universitaire de Rennes,centre_hospitalier_universitaire_de_rennes,,,,2f45bfe9-0b5a-450f-abb3-c7aa18916ff8,centre_hospitalier_universitaire,Centre Hospitalier Universitaire +1298,,5879f511-a09c-4a24-9e78-d4c158b7b8fd,Sanofi S.p.A,sanofi_s_p_a,,,,,, +1299,,aafee193-eb1b-4aaa-bf0d-5eedacdea2c4,"Artisan Pharma, Inc",artisan_pharma_inc,,,,,, +1300,,2df0a54c-4610-4b0d-8483-2cca8b3ddc42,West Middlesex University Hospital,west_middlesex_university_hospital,,,,,, +1301,,7995ee55-2bfc-4211-bc73-5a445f081322,"Department of Anaesthesia, Tampere University Hospital",department_of_anaesthesia_tampere_university_hospital,,,,,, +484,0.969424,3ee3992f-cbe0-49c2-8456-39b7a3c82ed9,"Department of Anesthesiology, University Hospital Erlangen",department_of_anesthesiology_university_hospital_erlangen,,,,3ee3992f-cbe0-49c2-8456-39b7a3c82ed9,department_of_anesthesiology_university_hospital_erlangen,"Department of Anesthesiology, University Hospital Erlangen" +1302,,1f39b7b7-12af-4e6e-b7ba-520c0c95dd78,Dr. Antonio Mari Roig,dr_antonio_mari_roig,,,,,, +1303,,e9f49fe2-8bd0-11e6-a449-0242ac12000b,Aquinox Pharmaceuticals (Canada) Inc,aquinox_pharmaceuticals_canada_inc,,,,,, +1304,,63d403d2-66ef-47ef-92e7-6078233d6b95,CARLOS SANTOS VILLAR,carlos_santos_villar,,,,,, +1305,,9ce91350-73f6-11e6-a0cd-0242ac12000b,BIOCRYST,biocryst,,,,,, +431,0.984484,b88016be-c592-4cca-86cb-908f8cedcd26,Central Manchester and Manchester Children's University Hospitals NHS Trust,central_manchester_and_manchester_children_s_university_hospitals_nhs_trust,,,,14c37603-26cd-4e70-aef6-639320d368b6,central_manchester_and_manchester_children_s_university_hospital_nhs_trust,Central Manchester and Manchester Children's University Hospital NHS Trust +821,0.979768,3655f927-01ad-48d8-9cb0-516379501a0a,Dipartimento di Pediatria Università Federico II di Napoli,dipartimento_di_pediatria_universit_federico_ii_di_napoli,,,,3655f927-01ad-48d8-9cb0-516379501a0a,dipartimento_di_pediatria_universit_federico_ii_di_napoli,Dipartimento di Pediatria Università Federico II di Napoli +1306,,e5c9cbe7-2ba5-42a1-b838-a1fa87d53683,María de los Ángeles Álvarez López,mar_a_de_los_ngeles_lvarez_l_pez,,,,,, +1307,,3506063a-276a-458d-98fe-9803035607aa,FUNDACIÓN CANARIA DE INVESTIGACIÓN Y SALUD (FUNCIS),fundaci_n_canaria_de_investigaci_n_y_salud_funcis,,,,,, +1308,,4127e50a-715d-11e6-a0cd-0242ac12000b,PHARMAFORCE,pharmaforce,,,,,, +1309,,9bfbe25f-f46f-4428-b7ee-da295694b3d6,Vanda Pharmaceuticals Inc,vanda_pharmaceuticals_inc,,,,,, +1310,,c275e09b-494a-47ef-961e-29346c49d5aa,Enrique Rey Díaz-Rubio,enrique_rey_d_az_rubio,,,,,, +1311,,ea563ddc-7155-11e6-a0cd-0242ac12000b,DOUGLAS PHARMS,douglas_pharms,,,,,, +351,0.97875547409057617,490436c4-c1f2-4859-b7ae-69b121dd48d9,Deutsches Herzzentrum München,deutsches_herzzentrum_m_nchen,,,,490436c4-c1f2-4859-b7ae-69b121dd48d9,deutsches_herzzentrum_m_nchen,Deutsches Herzzentrum München +1312,,b96a163d-86ee-4ad2-a98e-31d110f1fd10,Cancer International Research Group,cancer_international_research_group,,,,,, +1313,,64d247a6-67a7-4370-b1d9-4c1046516e7d,"Foreseeacer Pharmaceuticals, Inc",foreseeacer_pharmaceuticals_inc,,,,,, +1314,,4a70e5bd-95b9-4e8f-9fec-4c20747cc75d,London School of Hygiene & Tropical Medicine,london_school_of_hygiene_tropical_medicine,,,,,, +1315,,5a59446c-d930-4066-a6dc-302821edaceb,Foundation for Liverdisease,foundation_for_liverdisease,,,,,, +1316,,1140f0c8-d8e3-469c-a6f7-a506f9444a31,IVI Sevilla,ivi_sevilla,,,,,, +1317,,adba483a-0dd8-42da-88ac-1122655b7148,Avillion Development 1 Limited,avillion_development_1_limited,,,,,, +1318,,bf3614b9-00a9-4d30-9320-f9b8f09483fb,Auxilium UK Limited,auxilium_uk_limited,,,,,, +930,0.97669827938079834,108222e4-8b5a-4716-a3aa-cd9eb69305b4,"Pierre Fabre Ibérica, S.A. en representación de Pierre Fabre Mèdicament",pierre_fabre_ib_rica_s_a_en_representaci_n_de_pierre_fabre_m_dicament,,,,108222e4-8b5a-4716-a3aa-cd9eb69305b4,pierre_fabre_ib_rica_s_a_en_representaci_n_de_pierre_fabre_m_dicament,"Pierre Fabre Ibérica, S.A. en representación de Pierre Fabre Mèdicament" +1319,,444dd439-1cfc-48d3-ac07-900559c6ae26,RespiVert Ltd,respivert_ltd,,,,,, +1320,,c509a1de-49f5-46c9-a673-acc3749ddd96,Jesper Hastrup Svendsen,jesper_hastrup_svendsen,,,,,, +1321,,ff0f7664-715d-11e6-a0cd-0242ac12000b,EMCURE PHARMS LTD,emcure_pharms_ltd,,,,,, +440,0.985233,52bf7852-7313-11e6-a0cd-0242ac12000b,PERNIX THERAPS LLC,pernix_theraps_llc,,,,52bf7852-7313-11e6-a0cd-0242ac12000b,pernix_theraps_llc,PERNIX THERAPS LLC +1322,,dc1c972c-880f-11e6-a998-0242ac12000b,Fondazione Michelangelo Onlus - Avanzamento dello studio e cura dei tumori,fondazione_michelangelo_onlus_avanzamento_dello_studio_e_cura_dei_tumori,,,,,, +1323,,cedc06c2-d733-4583-bcf4-3d91df337647,ACS Biomarker,acs_biomarker,,,,,, +1324,,aa77b200-6c34-45d6-a0e4-3d2387f939cc,Aptalis Pharma US Inc,aptalis_pharma_us_inc,,,,,, +1063,0.968193,72f46314-5a65-467f-abea-944dcfd78d17,PENTA,penta,,,,72f46314-5a65-467f-abea-944dcfd78d17,penta,PENTA +1325,,c50b252d-0280-4507-9b7a-c729819baa31,PIERRE FABRE MEDICAMENT -IRPF- PIERRE FABRE INNOVATION,pierre_fabre_medicament_irpf_pierre_fabre_innovation,,,,,, +1326,,c5b1aabf-0979-44dd-8e10-b0cd7e545a5d,Helperby Therapeutics Limited,helperby_therapeutics_limited,,,,,, +1327,,4793b6a4-c834-4f4f-ae81-e40aba26b7f3,Fundacion para la investigación biomédica del hospital Ramón y Cajal de Madrid,fundacion_para_la_investigaci_n_biom_dica_del_hospital_ram_n_y_cajal_de_madrid,,,,,, +1328,,9cee827b-9190-44d4-ac80-a1c8cad26a9d,"Fertility Clinic, dept. of Obstetrics and gynecology, OUH",fertility_clinic_dept_of_obstetrics_and_gynecology_ouh,,,,,, +1329,,9e64a8b8-71fb-11e6-a0cd-0242ac12000b,RARE DIS THERAP,rare_dis_therap,,,,,, +1330,,1b200d87-c053-4490-b327-abd985efa50c,Instituto Científico Tecnológico de Navarra (ICTN),instituto_cient_fico_tecnol_gico_de_navarra_ictn,,,,,, +1331,,0617c8a8-dd7c-4827-86ca-a55b718a9739,CUB - Hôpital Erasme,cub_h_pital_erasme,,,,,, +1332,,ff5023a4-4e9c-4bb6-a016-1acda8a2924a,"Hologic, Inc",hologic_inc,,,,,, +1333,,a90b09a8-83d5-4a76-b0d0-22f2c62436a8,Pfizer Global Pharmaceutical Group,pfizer_global_pharmaceutical_group,,,,,, +1334,,73ce4878-8dfd-450b-8255-d08e44518dc5,"Medical University of Vienna, Department of Internal Med. I, Division of Infectious Diseases",medical_university_of_vienna_department_of_internal_med_i_division_of_infectious_diseases,,,,,, +1335,,175675e9-f134-48e5-8d06-98c21032a516,"Transplant Institute, Sahlgrenska University Hospital",transplant_institute_sahlgrenska_university_hospital,,,,,, +414,0.952896,99f9452a-8bde-11e6-a449-0242ac12000b,Medical Univerity Vienna,medical_univerity_vienna,,,,5f666fad-c0f0-4e6a-8a52-a4806a60a3ee,medical_university_vienna,Medical University Vienna +1336,,2d698705-1d23-4c83-99c8-148d581a7385,IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli,irccs_istituto_centro_san_giovanni_di_dio_fatebenefratelli,,,,,, +1337,,ab9f3024-f39d-4c09-a76f-13d6dd6cc840,"Charles University in Prague, Faculty of Medicine in Hradec Králové",charles_university_in_prague_faculty_of_medicine_in_hradec_kr_lov,,,,,, +1338,,1d3a7a8d-d7fa-4569-8a9d-cfffac59ffe2,University of Helsinki - Erkki Isometsä,university_of_helsinki_erkki_isomets,,,,,, +1339,,bc3e68b9-fe0e-4452-8516-728273975d81,Gateshead Health NHS Trust Research & Development,gateshead_health_nhs_trust_research_development,,,,,, +1340,,b740e1ac-73a0-11e6-a0cd-0242ac12000b,CEREXA,cerexa,,,,,, +1341,,04a1a60a-6f98-11e6-9663-0242ac12000b,Romark Laboratories L.C,romark_laboratories_l_c,,,,,, +1342,,3055f710-52b7-4b47-8a70-6620d56718f4,Klinik für Anästhesiologie Universitätsklinikum Aachen,klinik_f_r_an_sthesiologie_universit_tsklinikum_aachen,,,,,, +1343,,297f20ef-81b9-4ef1-bb6b-977b12cead35,APTALIS PHARMA CANADA INC,aptalis_pharma_canada_inc,,,,,, +1344,,54aff514-9644-43ca-8e7f-ece5a1aa7683,University of Duisburg-Essen,university_of_duisburg_essen,,,,,, +419,0.97916126251220703,7b859cd9-f38a-4202-ab4e-7ce3650f0ea2,National and Kapodistrial University of Athens,national_and_kapodistrial_university_of_athens,,,,24418820-0b75-41e2-993c-2f2c0b00efb6,national_and_kapodistrian_university_of_athens,National and Kapodistrian University of Athens +1345,,c340fdbb-b3e1-4555-b499-428874e46b64,Academic hospital Maastricht,academic_hospital_maastricht,,,,,, +1071,0.96678978204727173,a1ac5ed3-48d6-4b25-be01-f8fe60a9d1d6,University College Dublin CRC,university_college_dublin_crc,,,,a1ac5ed3-48d6-4b25-be01-f8fe60a9d1d6,university_college_dublin,University College Dublin +1346,,ac85ad89-1ff8-4003-9c2a-bf3f68760ea0,Karl Emil Kristensen,karl_emil_kristensen,,,,,, +1347,,b0722950-7399-11e6-a0cd-0242ac12000b,VERNALIS R AND D LTD,vernalis_r_and_d_ltd,,,,,, +1348,,26e46186-1c42-4561-acf2-c54a9df90ea4,"Adelaide & Meath Hospital, incorporating The National Children's Hospital",adelaide_meath_hospital_incorporating_the_national_children_s_hospital,,,,,, +1349,,f4eef681-9e4a-4ca1-8714-2835fa8cdbec,medac GmbH,medac_gmbh,,,,,, +1350,,3957ba6e-0328-4b23-84c8-a2e310c56dd8,Forest Laboratories UK Ltd,forest_laboratories_uk_ltd,,,,,, +1351,,795c094c-1932-4f68-89fe-f603c9e61be6,The Finnish Breast Cancer Group,the_finnish_breast_cancer_group,,,,,, +1352,,6d1568c1-b968-487b-b8b0-3fd7751c7a7a,"H-PHAR,sa",h_phar_sa,,,,,, +1353,,a741a9fb-b3b9-4fdc-a19b-f7cc627b7e3d,PharmaMar S.A,pharmamar_s_a,,,,,, +1354,,ef78504a-8b08-4d66-a3b8-5dd780420f99,AZIENDA OSPEDALIERA PISANA,azienda_ospedaliera_pisana,,,,,, +738,0.96910750865936279,0223cc5a-d770-406a-9db1-a0c4325ff12b,Fundació Clinic per la Recerca Biomédica,fundaci_clinic_per_la_recerca_biom_dica,,,,0223cc5a-d770-406a-9db1-a0c4325ff12b,fundaci_clinic_per_la_recerca_biom_dica,Fundació Clinic per la Recerca Biomédica +1355,,95617726-751f-4a37-bfe7-e5703dd27bd5,Verein für Tumorforschung,verein_f_r_tumorforschung,,,,,, +35,0.977622,1b03f797-4154-432f-973b-87560cdf6cc4,"Landstinget Västmanland, Division Kirurgi, Operationskliniken",landstinget_v_stmanland_division_kirurgi_operationskliniken,,,,1b03f797-4154-432f-973b-87560cdf6cc4,landstinget_v_stmanland_division_kirurgi_operationskliniken,"Landstinget Västmanland, Division Kirurgi, Operationskliniken" +1356,,55bce374-05a5-42de-8b38-32940937cb3b,Helsingin Yliopistollinen keskussairaala,helsingin_yliopistollinen_keskussairaala,,,,,, +1357,,dc076014-19dc-4081-8fa9-9e22f663ba9e,Sahlgrenska Academy-Gothenburg University Institute,sahlgrenska_academy_gothenburg_university_institute,,,,,, +1358,,7460bacb-ee89-436d-836c-cd1a43d8aa58,"The Kirby Institute (formerly National Centre in HIV Epidemiology and Clinical Research (NCHECR)), University of New Sou",the_kirby_institute_formerly_national_centre_in_hiv_epidemiology_and_clinical_research_nchecr_university_of_new_sou,,,,,, +1359,,5ff4ad07-11b6-491d-9896-b0fb229d7c89,Mª Victoria Gil Navarro,m_victoria_gil_navarro,,,,,, +1360,,7938f48e-ed8f-4f3e-9cf8-cb17b754fadb,Eisai GmbH,eisai_gmbh,,,,,, +1361,,793e04e8-bae1-4d6d-8c8e-204cd525d4ae,Merrion Pharmaceuticals plc,merrion_pharmaceuticals_plc,,,,,, +1362,,5bd8282a-ce40-4ac1-91ec-bde67a69784d,Associació Per a la Recerca Oncològica (APRO),associaci_per_a_la_recerca_oncol_gica_apro,,,,,, +1363,,b99bf3be-ef5e-4f9d-a988-eaaf8a005957,Niuvanniemen sairaala,niuvanniemen_sairaala,,,,,, +1364,,8f2448c8-5cb8-4018-b225-07ce2e5dbdd4,Nottingham University Hospital,nottingham_university_hospital,,,,,, +1365,,50fc18ba-7145-11e6-a0cd-0242ac12000b,OMAN PHARM PRODUCTS,oman_pharm_products,,,,,, +253,0.97890456517537439,4a176b41-c873-44ad-8442-a2e57b0b4289,Instituto Científico y Tecnológico de Navarra,instituto_cient_fico_y_tecnol_gico_de_navarra,,,,4a176b41-c873-44ad-8442-a2e57b0b4289,instituto_cient_fico_y_tecnol_gico_de_navarra,Instituto Científico y Tecnológico de Navarra +1366,,c0626f0e-98a2-47d4-895a-42abe9031e25,MAASTRO clinic,maastro_clinic,,,,,, +1367,,f7852934-48be-4a4e-aa3d-8a1558a1493f,"Clinical research lab for neurodegeneration, Dept. of Neurology, St. Josef-Hospital, Ruhr-University",clinical_research_lab_for_neurodegeneration_dept_of_neurology_st_josef_hospital_ruhr_university,,,,,, +1368,,5aafd783-c512-4c83-a2ee-89134cbfdcd0,"Department of Clinical Science, Intervention and Technology, Karolinska Institute",department_of_clinical_science_intervention_and_technology_karolinska_institute,,,,,, +1369,,37e72344-3a44-45f2-97f2-256b5daaca19,"ORtopædkirurgisk Forskningsenhed, Aarhus Universitetshospital",ortop_dkirurgisk_forskningsenhed_aarhus_universitetshospital,,,,,, +1370,,18cd5783-0ff7-4483-aa32-e5499a043c34,Centro sociale oncologico,centro_sociale_oncologico,,,,,, +1032,0.98019236326217651,62b186bb-cb30-4ebd-9462-a1bd321e2179,Kvinnokliniken i Östergötland,kvinnokliniken_i_sterg_tland,,,,62b186bb-cb30-4ebd-9462-a1bd321e2179,kvinnokliniken_i_sterg_tland,Kvinnokliniken i Östergötland +1371,,8a673c86-71ec-11e6-a0cd-0242ac12000b,OAK PHARMS INC,oak_pharms_inc,,,,,, +295,0.988084,4fe3be9a-b05b-4bc8-b2c3-37b02726367b,Centre for Human Drug Research (CHDR),centre_for_human_drug_research_chdr,,,,4fe3be9a-b05b-4bc8-b2c3-37b02726367b,centre_for_human_drug_research_chdr,Centre for Human Drug Research (CHDR) +1372,,28751337-c075-4102-87b9-28542c4c14d3,"SFJ LungCancer, Ltd",sfj_lungcancer_ltd,,,,,, +275,0.972986,a3ebb60b-9170-4a8f-b88f-443598d1fa3d,Universitätsmedizin der Johannes Gutenberg-University Mainz,universit_tsmedizin_der_johannes_gutenberg_university_mainz,,,,61dc1432-2742-471c-9dcc-67fb304ce278,universit_tsmedizin_der_johannes_gutenberg_universit_t_mainz,Universitätsmedizin der Johannes Gutenberg-Universität Mainz +1373,,cfe702d4-719f-11e6-a0cd-0242ac12000b,INSIGHT PHARMS,insight_pharms,,,,,, +1374,,6b834ff0-73e8-11e6-a0cd-0242ac12000b,EXELTIS SUISSE,exeltis_suisse,,,,,, +1375,,00233aa2-0675-475b-a4d4-87fdcd93d49f,UNIVERSITA' DEGLI STUDI DI UDINE,universita_degli_studi_di_udine,,,,,, +1376,,91aebdab-5521-47f6-88d9-925051980c75,EM-kliniken,em_kliniken,,,,,, +1377,,8077b0ef-e6c9-40b3-8891-a58806a13639,Dra Maria Luz Couce,dra_maria_luz_couce,,,,,, +1378,,a0f50340-6fbf-11e6-abe8-0242ac12000b,NV AstraZeneca SA,nv_astrazeneca_sa,,,,,, +1042,0.989009,ab743a24-721d-11e6-a0cd-0242ac12000b,GLAXOSMITHKLINE CONS,glaxosmithkline_cons,,,,ab743a24-721d-11e6-a0cd-0242ac12000b,glaxosmithkline_cons,GLAXOSMITHKLINE CONS +312,0.973688,61d96cf8-a5e6-47f3-8422-68006b928dbb,"Stockholms Läns Landsting, Karolinska Universitetssjukhuset Huddinge, Anestesikliniken",stockholms_l_ns_landsting_karolinska_universitetssjukhuset_huddinge_anestesikliniken,,,,16c13ad3-319c-4580-9561-26254cba7ca2,stockholms_l_ns_landsting,Stockholms Läns Landsting +1379,,fceaf78e-9c35-44aa-b13b-0de86d8bd15d,"Research and Development Directorate, University Hospitals of Leicester NHS Trust",research_and_development_directorate_university_hospitals_of_leicester_nhs_trust,,,,,, +1380,,d990823b-6a01-44c8-8360-523885f6e3a3,Innocoll Technologies,innocoll_technologies,,,,,, +377,0.97151175141334534,a995503b-132d-44dc-a6b0-648b85bc0828,Merck,merck,,,,a995503b-132d-44dc-a6b0-648b85bc0828,merck_co,Merck & Co +1381,,f9e5c9e1-83fa-46e2-9871-c5a4eec992e9,Lothian Health Board,lothian_health_board,,,,,, +1382,,1f0395ae-d667-4820-bac1-3df7801d3365,All-Ireland Co-operative Oncology Research Group (ICORG),all_ireland_co_operative_oncology_research_group_icorg,,,,,, +1383,,89aa0ad7-c72a-4284-86ae-28210e87ed80,TauRx Therapeutics PTE Ltd,taurx_therapeutics_pte_ltd,,,,,, +92,0.967029,c3e873ff-4ae6-499b-8ac6-5d8e2203e040,Diakonhjemmet Hospital AS,diakonhjemmet_hospital_as,,,,c3e873ff-4ae6-499b-8ac6-5d8e2203e040,diakonhjemmet_hospital_as,Diakonhjemmet Hospital AS +1384,,2657234a-44ed-4486-b15a-2c6f9a7b0d7f,"DEPARTMENT OF DERMATOLOGY, UNIVERSITY OF MODENA AND REGGIO EMILIA",department_of_dermatology_university_of_modena_and_reggio_emilia,,,,,, +1385,,c7b73c84-7166-11e6-a0cd-0242ac12000b,USV NORTH AMERICA,usv_north_america,,,,,, +1386,,8a6f1056-878d-42a0-8ef8-0c18b2f0e50c,Summit Corporation plc,summit_corporation_plc,,,,,, +884,0.96910750865936279,e644919e-8d5c-4749-8862-167280abf364,AGMT,agmt,,,,0535053a-70a1-4184-85fb-a82d42918846,agmt_ggmbh,AGMT gGmbH +1387,,4e06497e-0a90-466e-bea2-8f59ec41cc45,Johan Hellgren,johan_hellgren,,,,,, +1025,0.96489724516868591,349202d3-c159-4eb0-a563-61bee70e783e,"Eli Lilly and Company Limited, UK",eli_lilly_and_company_limited_uk,,,,2f59f764-513a-43d8-ba41-bc314f18f59b,eli_lilly_and_company_limited,Eli Lilly and Company limited +1388,,734b565a-e22b-4f30-87f0-9b8290707887,Royal Marsden Hospital NHS Foundation Trust,royal_marsden_hospital_nhs_foundation_trust,,,,,, +1389,,fe0eba9a-5709-4982-a02c-d29273db52a7,"Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, endvertreten durch den Dekan",martin_luther_universit_t_halle_wittenberg_medizinische_fakult_t_endvertreten_durch_den_dekan,,,,,, +1390,,2941475f-a7c6-11e6-94cb-5656d04fc2b5,ORASIS Pharmaceuticals Ltd,orasis_pharmaceuticals_ltd,,,,,, +1391,,5c9bcb81-736e-4e3c-b214-73b440a80c9a,OSE Pharma,ose_pharma,,,,,, +1079,0.956865,0d9451d0-cac1-41f0-a202-5d895bc08f17,The Institute of Cancer Research / The Royal Marsden NHS Foundation Trust,the_institute_of_cancer_research_the_royal_marsden_nhs_foundation_trust,,,,0d9451d0-cac1-41f0-a202-5d895bc08f17,the_institute_of_cancer_research_the_royal_marsden_nhs_foundation_trust,The Institute of Cancer Research / The Royal Marsden NHS Foundation Trust +1392,,49f32fb4-1bf0-4326-9a39-730a3a685bfa,CHU DE POITIERS,chu_de_poitiers,,,,,, +1393,,d896be42-7a8c-4cd1-8d53-c6b9ea656ad2,"Charité Berlin, department of rheumatology",charit_berlin_department_of_rheumatology,,,,,, +1394,,40715934-32ad-4ce5-8290-4519a533b123,HUS - Naistentautien ja synnytysten tulosyksikkö,hus_naistentautien_ja_synnytysten_tulosyksikk,,,,,, +1395,,b926bfa2-949b-4111-985e-d80ecaf4eb64,University College of London,university_college_of_london,,,,,, +1396,,d83dd198-390e-42e0-b38a-37b4e427e621,YM Biosciences Inc,ym_biosciences_inc,,,,,, +1397,,5d2489f2-0a5f-4380-967d-08f588f2f7dc,Luis López Cortes - FISEVI,luis_l_pez_cortes_fisevi,,,,,, +1398,,f068903f-7a20-4b87-995b-1721976d94f6,MERCK SHARP & DOHME CORP. UNA SUSSIDIARIA DI MERCK & CO. INC,merck_sharp_dohme_corp_una_sussidiaria_di_merck_co_inc,,,,,, +1399,,1b97ddb4-8818-11e6-a998-0242ac12000b,"Octapharma Pharmazeutika Produktionsges.m.b.H, Oberlaaer Strasse 235, A-1100 Vienna, Austria",octapharma_pharmazeutika_produktionsges_m_b_h_oberlaaer_strasse_235_a_1100_vienna_austria,,,,,, +1048,0.98716670274734497,92cf0698-f0a3-49e3-b16c-ece2bebd1173,University Hospital,university_hospital,,,,92cf0698-f0a3-49e3-b16c-ece2bebd1173,university_hospital,University Hospital +90,0.988251,51f2f135-0aa9-4e39-b934-2ebfce55549a,Bio Products Laboratory,bio_products_laboratory,,,,51f2f135-0aa9-4e39-b934-2ebfce55549a,bio_products_laboratory,Bio Products Laboratory +1400,,698dd981-0168-4ee1-bae9-b34e09bc800f,Hellenic Cardiovascular Research Society,hellenic_cardiovascular_research_society,,,,,, +1401,,03904747-32fd-4bf8-926f-34dde2c1f4b3,Dr. Lluis Mont-Girbau,dr_lluis_mont_girbau,,,,,, +1402,,262e70eb-f592-4b5f-8e06-12a5152ab7c9,Servicio de Cirugía General y Digestiva Hospital Universitario de Bellvitge,servicio_de_cirug_a_general_y_digestiva_hospital_universitario_de_bellvitge,,,,,, +1403,,afdbaef4-28d2-4308-a7c1-92368f97cf04,Henogen s.a,henogen_s_a,,,,,, +664,0.97318911552429199,56238a57-b5e3-44be-840b-09e7fea2a5aa,Charité,charit,,,,56238a57-b5e3-44be-840b-09e7fea2a5aa,charit,Charité +1404,,a1b25ca1-bdb2-49ab-8b6e-b5eca5abc4f2,Sylentis,sylentis,,,,,, +1405,,a7b475cc-c7ca-4146-a636-f429612178fd,NIH-National Institut of Health - NINDS-National Institut of Neurogical Disorders and Stroke,nih_national_institut_of_health_ninds_national_institut_of_neurogical_disorders_and_stroke,,,,,, +986,0.97420722246170044,67902b25-58c1-419c-918d-42f6cc022a27,Imperial College Healthcare NHS Trust and Imperial College London,imperial_college_healthcare_nhs_trust_and_imperial_college_london,,,,67902b25-58c1-419c-918d-42f6cc022a27,imperial_college_healthcare_nhs_trust,Imperial College Healthcare NHS Trust +1406,,d83916f1-ec43-4919-b86c-5947d959fe54,West Yorkshire Primary Care R&D Unit,west_yorkshire_primary_care_r_d_unit,,,,,, +1407,,44ce2536-2ee2-4791-a112-63a909ff90f0,Lipopeptide AB,lipopeptide_ab,,,,,, +1408,,42f742c6-81c4-4087-b01e-ee9df8b92fb7,San Joan de Déu. Serveis de Salut Mental,san_joan_de_d_u_serveis_de_salut_mental,,,,,, +745,0.974187,aabefd85-885a-4e88-a6ef-3b820f53dd2f,"Medical School Hannover. Department of Psychiatry, Social Psychiatry and Psychotherapy",medical_school_hannover_department_of_psychiatry_social_psychiatry_and_psychotherapy,,,,0b393cda-95af-44e2-87c2-0f3e708c0eea,medical_school_hannover_department_of_psychiatry_socialpsychiatry_and_psychotherapy,"Medical School Hannover, Department of Psychiatry, Socialpsychiatry and Psychotherapy" +1409,,0820973f-28ec-41ec-bb94-ae1c25bc04ba,Viiv Healthcare,viiv_healthcare,,,,,, +1410,,75da775c-73bc-11e6-a0cd-0242ac12000b,NAPO PHARMS INC,napo_pharms_inc,,,,,, +485,0.985716,d4d3b8e8-ff21-4f29-9209-678e5c00d01b,IRCCS CENTRO SAN GIOVANNI DI DIO,irccs_centro_san_giovanni_di_dio,,,,d4d3b8e8-ff21-4f29-9209-678e5c00d01b,irccs_centro_san_giovanni_di_dio,IRCCS CENTRO SAN GIOVANNI DI DIO +1411,,bf792251-bceb-4b48-a9b5-0095df9039d6,"Institute of Psychiatry, Kings College London & South London and Maudsley NHS Trust",institute_of_psychiatry_kings_college_london_south_london_and_maudsley_nhs_trust,,,,,, +1412,,4fc12d4d-bcac-4fc0-9289-3b6604851788,"BIAL - PORTELA & C�, S.A",bial_portela_amp_c_s_a,,,,,, +943,0.910995,d64fbb64-ace2-40d6-b379-d8f2f6277ac6,"PDL BioPharma, Inc",pdl_biopharma_inc,,,,d64fbb64-ace2-40d6-b379-d8f2f6277ac6,pdl_biopharma_inc,"PDL BioPharma, Inc" +1413,,60c98481-6711-4ad4-8cc2-81556a33e22b,ErasmusMC - Sophia,erasmusmc_sophia,,,,,, +1414,,c09f4926-0cff-4e77-865f-6e7389b8c889,Fundació Institut Català de Farmacologia,fundaci_institut_catal_de_farmacologia,,,,,, +733,0.982275,ea39e7dd-e998-4569-9284-4040ea4aacc2,"Technical University Munich, Klinikum rechts der Isar",technical_university_munich_klinikum_rechts_der_isar,,,,7e09558a-ee7d-474c-9101-17cf9741e4d6,technical_university_munich,Technical University Munich +1415,,532bc2b4-484f-42ed-a498-1d54d98e029e,Bangor University,bangor_university,,,,,, +1416,,cef09098-71b8-11e6-a0cd-0242ac12000b,PARNELL,parnell,,,,,, +1417,,739c3383-ddae-44d9-92df-228547007126,Dra. Mª Dolores Arenas,dra_m_dolores_arenas,,,,,, +1418,,1a498868-20c3-4742-9f0c-1df7cc3f50c4,"ZAMBON, S.A",zambon_s_a,,,,,, +1419,,83d5d329-00bf-4d68-89d4-a1435edf1569,NIDDK TYPE 1 DIABETES TRIALNET,niddk_type_1_diabetes_trialnet,,,,,, +1420,,32c044fa-73a4-11e6-a0cd-0242ac12000b,NEW HAVEN PHARMS,new_haven_pharms,,,,,, +1421,,c19146a3-ed0a-4139-8857-988e978a8062,"TRACON Pharmaceuticals, Inc",tracon_pharmaceuticals_inc,,,,,, +186,0.987464,2cec47b8-3bd6-4f10-8180-b9e29e1ccf01,ISTITUTO GIANNINA GASLINI-PRINTO,istituto_giannina_gaslini_printo,,,,2cec47b8-3bd6-4f10-8180-b9e29e1ccf01,istituto_giannina_gaslini_printo,ISTITUTO GIANNINA GASLINI-PRINTO +1422,,a13ad6c4-c1ec-4eda-91c8-3924d72aac10,"Algeta ASA, Oslo, Norway",algeta_asa_oslo_norway,,,,,, +1423,,515c1e7a-2d34-4c32-a95f-710511d1d5bd,Birmingham Community Healthcare NHS Trust,birmingham_community_healthcare_nhs_trust,,,,,, +1424,,804eb04b-e153-47c9-8087-3a4de9ab227b,Friedrich-Alexander-Universitaet Erlangen-Nuernberg,friedrich_alexander_universitaet_erlangen_nuernberg,,,,,, +1425,,dc2ae94b-8024-4df2-bba4-52c0549b8247,"Johnson&Johnson Pharmaceutical Research and Development, Division de Janssen-Cilag",johnson_johnson_pharmaceutical_research_and_development_division_de_janssen_cilag,,,,,, +1426,,4c921685-e48a-4f5c-af8b-ffc894bd48d1,IRCCS Ospedale San Raffaele,irccs_ospedale_san_raffaele,,,,,, +792,0.980742,97fbdb53-1d5f-4818-9d3f-51409c6494bc,LEO Pharmaceuticals Products Ltd. A/S (LEO Pharma A/S),leo_pharmaceuticals_products_ltd_a_s_leo_pharma_a_s,,,,3eeb7409-fc6a-4e35-b3ca-369fcd621d64,leo_pharmaceutical_products_ltd_a_s_leo_pharma_a_s,LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S) +1427,,358578aa-72cc-11e6-a0cd-0242ac12000b,ABRAXIS BIOSCIENCE,abraxis_bioscience,,,,,, +1428,,4528833d-9c09-48ae-91ac-cfb24aa38723,FUNDACIÓN SANT JOAN DE DEU,fundaci_n_sant_joan_de_deu,,,,,, +1429,,f3d2f69a-209e-4213-85a9-ebe9ff8f07c4,Ethik-Kommission der Medizinischen Fakultät der Martin-Luther-Universität Halle Wittenberg,ethik_kommission_der_medizinischen_fakult_t_der_martin_luther_universit_t_halle_wittenberg,,,,,, +1430,,0ccb32cd-d2c7-43a6-ab56-1fb2dc2759ee,"Theracos, Inc",theracos_inc,,,,,, +1431,,1ce4ac5a-642a-4b3e-80f1-ee916d1bde47,Royal Free Hampstead NHS Trust,royal_free_hampstead_nhs_trust,,,,,, +1432,,43551469-90e0-4915-94e2-2a99467bbf52,Sahlgrenska Academy,sahlgrenska_academy,,,,,, +1433,,c1163915-da66-4df9-89ca-0c6d5e53601f,"Forest Research Institute, Inc., a wholly owned subsidiary of Forest Laboratories, Inc",forest_research_institute_inc_a_wholly_owned_subsidiary_of_forest_laboratories_inc,,,,,, +1434,,ee6e8018-08a9-49f4-b383-6e8139348029,"Salix Pharmaceuticals, Inc",salix_pharmaceuticals_inc,,,,,, +139,0.949534,2b57b25f-7999-42a9-bc73-ba293507ad94,AWD.pharma GmbH & Co KG,awd_pharma_gmbh_co_kg,,,,2b57b25f-7999-42a9-bc73-ba293507ad94,awd_pharma_gmbh_co_kg,AWD.pharma GmbH & Co KG +1435,,e30e8125-aee1-4c14-94be-fa06b2051035,Hepatology UZ Gasthuisberg,hepatology_uz_gasthuisberg,,,,,, +1436,,a581a6e3-f8df-400c-83d0-76e0bf4d7086,Herlev Gentofte Hospital,herlev_gentofte_hospital,,,,,, +1437,,2d707abc-46d7-433c-99ba-8a9788241279,Joint UCLH/UCH Biomedical Research Unit,joint_uclh_uch_biomedical_research_unit,,,,,, +1438,,7596c937-9782-4dc5-8265-7e01001d7aed,"Pharmanord, UK, LTD",pharmanord_uk_ltd,,,,,, +1439,,7fe00a20-9ef0-4c86-9368-0be5c00a34d2,Department of Nuclear Medicine,department_of_nuclear_medicine,,,,,, +1440,,72390df7-09f9-41f5-afc8-7ddf26173a3a,Mundipharma Pharmaceuticals B.V,mundipharma_pharmaceuticals_b_v,,,,,, +1441,,f29ad6dc-8be9-45d6-b1c7-762e7bca12d7,Kansanterveyslaitos,kansanterveyslaitos,,,,,, +1442,,7baf301c-71a2-11e6-a0cd-0242ac12000b,JUBILANT DRAXIMAGE,jubilant_draximage,,,,,, +149,0.98663,196b721b-cf1f-48fb-9325-0abb1def7a34,Array BioPharma,array_biopharma,,,,196b721b-cf1f-48fb-9325-0abb1def7a34,array_biopharma,Array BioPharma +1443,,90b1b931-4335-4914-a8b7-154e9a2ec266,University of Turku,university_of_turku,,,,,, +1444,,0b2dd014-9d2e-4ad5-b22a-eb9b89518eee,Rheoscience A/S,rheoscience_a_s,,,,,, +62,0.98616591095924377,8776dd79-3ee8-4ef0-a9ce-fb6aef833e21,"Talecris Biotherapeutics, Incorporated",talecris_biotherapeutics_incorporated,,,,8776dd79-3ee8-4ef0-a9ce-fb6aef833e21,talecris_biotherapeutics_inc,"Talecris Biotherapeutics, Inc" +1445,,d4bdd8da-7129-11e6-a89e-0242ac12000b,ACTAVIS LABS FL INC,actavis_labs_fl_inc,,,,,, +1446,,ee7e787e-4ce7-4eeb-92a0-a83ad5ba812f,"Universitätsklinik für Augenheilkunden und Optometrie, Medizinische Universität Wien",universit_tsklinik_f_r_augenheilkunden_und_optometrie_medizinische_universit_t_wien,,,,,, +449,0.98227512836456299,c0ddef62-c8b9-4735-824a-6c81d6d62508,ALLERGAN INC,allergan_inc,,,,17a7cd12-2e89-4b00-832e-bc19b8172771,allergan,ALLERGAN +315,0.97933,f9936692-71d9-11e6-a0cd-0242ac12000b,CEPHALON,cephalon,,,,859cee6f-b91c-4dae-a958-dcbf3458bbb4,cephalon_france,CEPHALON FRANCE +1447,,ea516ab6-bee6-4b2d-b9a3-563299c429e7,Laboratorio Reig Jofré S.A,laboratorio_reig_jofr_s_a,,,,,, +1448,,36c257ab-810c-4e10-b428-89ca5d00438b,USV Private Limited,usv_private_limited,,,,,, +1449,,67d6f15e-d5f9-454c-821f-513efa46dcda,IOBA - Instituto Universitario de Oftalmobiología Aplicada,ioba_instituto_universitario_de_oftalmobiolog_a_aplicada,,,,,, +196,0.981008,9324d427-ccb6-48fe-912d-ec2b4be0fbec,"CHRU Montpellier - Direction de la Recherche, Partenariats et Réseaux, Relations avec l'Université",chru_montpellier_direction_de_la_recherche_partenariats_et_r_seaux_relations_avec_l_universit,,,,9324d427-ccb6-48fe-912d-ec2b4be0fbec,chru_montpellier_direction_de_la_recherche_partenariats_et_r_seaux_relations_avec_l_universit,"CHRU Montpellier - Direction de la Recherche, Partenariats et Réseaux, Relations avec l'Université" +1450,,da1cb51a-715d-11e6-a0cd-0242ac12000b,BIO PHARM INC,bio_pharm_inc,,,,,, +1451,,e330911b-10c6-4d8d-a0c1-4cdfa0f4e4d1,Pharma Stulln GmbH,pharma_stulln_gmbh,,,,,, +1452,,49212f89-dc17-4cd7-8001-26cfda5cac5d,Fondazione P E N T A,fondazione_p_e_n_t_a,,,,,, +1453,,b69016aa-600d-49a1-875f-24396565a303,"Department of Psychiatry and Psychotherapy, Friedrich-Schiller-University Jena",department_of_psychiatry_and_psychotherapy_friedrich_schiller_university_jena,,,,,, +1454,,59af4fe7-0f53-47ad-97eb-3ece87f0af88,Biogen Idec Italia S.r.l,biogen_idec_italia_s_r_l,,,,,, +1455,,f800ee2c-5b6c-45bb-beaf-90dbc5da300e,Cell Medica Ltd,cell_medica_ltd,,,,,, +1456,,fd078e39-b430-433d-849c-221660a8222a,Alize Pharma,alize_pharma,,,,,, +1457,,b1247a9c-5011-4603-ac8a-aa4a64cb8c1a,CHU Liège - Physical Medicine Service,chu_li_ge_physical_medicine_service,,,,,, +1458,,4bd4a4ab-4259-4802-942f-31f7e0a89933,AZIENDA OSPEDALIERA OSPEDALE S. SALVATORE,azienda_ospedaliera_ospedale_s_salvatore,,,,,, +1459,,75cbd4ee-8dc7-40a3-b8d5-9190cb7b3a15,"Intec Pharma, Ltd",intec_pharma_ltd,,,,,, +1460,,1d5c4f06-73ad-11e6-a0cd-0242ac12000b,SUPERNUS PHARMS,supernus_pharms,,,,,, +1051,0.981904,bbf2cf53-53f8-4b29-80dd-79c7bfc9befa,Bioenvision,bioenvision,,,,4bcc1755-5dc6-434d-aed0-d5fa3a830bf2,bioenvision_limited,Bioenvision Limited +1461,,e64e6b78-417c-4d21-8468-7d060598f6eb,Foreest Medical School,foreest_medical_school,,,,,, +1039,0.97356534004211426,9baf045c-89f9-4085-b743-41b82541dc46,Celgene International II Sàrl,celgene_international_ii_s_rl,,,,34050438-2ab9-4f3c-ad8e-1d5dea845aa7,celgene_international_ii_sarl_cis_ii,Celgene International II Sarl (CIS II) +1462,,7bd7b020-b4f0-47be-a2f1-2b8b2ee724c5,Bayer HealhCare AG,bayer_healhcare_ag,,,,,, +1463,,8bb92342-f000-48a4-ada4-8648a394328a,"Synthetic Biologics, Inc",synthetic_biologics_inc,,,,,, +1464,,3198db4b-fabe-4e97-abae-a75cec98f54e,"A.P. Pharma, Inc",a_p_pharma_inc,,,,,, +1465,,01c8844e-dfc1-446e-88ee-52c7a90e5fa9,Universitätsklinik Mainz Pneumologie,universit_tsklinik_mainz_pneumologie,,,,,, +277,0.97426038980484009,71fa3658-cdd0-4248-b428-53aae9afea66,"Teva Branded Pharmaceutical Producs R&D, Inc",teva_branded_pharmaceutical_producs_r_d_inc,,,,71fa3658-cdd0-4248-b428-53aae9afea66,teva_branded_pharmaceutical_products_r_d_inc,"Teva Branded Pharmaceutical Products R&D, Inc" +1466,,c601d4c3-823b-4cea-ad46-98cdbf346316,Weill Medical College of Cornell University,weill_medical_college_of_cornell_university,,,,,, +1467,,532d637b-e540-43c5-98f0-cfb4c90cb11f,SESP,sesp,,,,,, +1468,,d4b2f361-12f5-4a10-92c0-f26403a083bb,Addmedica S.A.S,addmedica_s_a_s,,,,,, +1469,,81805d97-01b8-452a-9b16-bc6b9e775265,Klinik und Poliklinik für Augenheilkunde der Universität Regensburg,klinik_und_poliklinik_f_r_augenheilkunde_der_universit_t_regensburg,,,,,, +1470,,2617f388-734f-11e6-a0cd-0242ac12000b,AR HOLDING CO INC,ar_holding_co_inc,,,,,, +1471,,6716d59e-4937-4e77-9dbe-ff9576b83787,Markku Kupari,markku_kupari,,,,,, +805,0.97709846496582031,677d2804-ad3e-4bab-95aa-43e72db6366f,"Otsuka Pharmaceutical Development & Commercialization, Inc",otsuka_pharmaceutical_development_commercialization_inc,,,,8e240a49-6e4c-46a0-8366-15b78371ff26,otsuka_pharmaceutical_development_commercialization_inc,"Otsuka Pharmaceutical Development & Commercialization, Inc" +1472,,d9cdc79d-283e-48b3-8508-14217f6c8d33,OrbusNeich Medical BV,orbusneich_medical_bv,,,,,, +845,0.984184,c064f018-7141-11e6-a0cd-0242ac12000b,ELITE LABS INC,elite_labs_inc,,,,c064f018-7141-11e6-a0cd-0242ac12000b,elite_labs_inc,ELITE LABS INC +1473,,ef19f09d-8fae-492e-bd7b-fd984cedeadf,Kedrion SpA,kedrion_spa,,,,,, +807,0.968782,420745a1-a57e-4545-a9b6-170be97fb467,"Medical University of Vienna, Dept. of Clinical Pharmacology",medical_university_of_vienna_dept_of_clinical_pharmacology,,,,420745a1-a57e-4545-a9b6-170be97fb467,medical_university_of_vienna_dept_of_clinical_pharmacology,"Medical University of Vienna, Dept. of Clinical Pharmacology" +1474,,14df6efe-b457-49ec-b6df-53eed1bf03e8,Heart- and Diabetescenter NRW,heart_and_diabetescenter_nrw,,,,,, +1475,,23395044-73f9-11e6-a0cd-0242ac12000b,RELIANT HOLDINGS LTD,reliant_holdings_ltd,,,,,, +1476,,4d2c701b-d2d6-4a65-9ece-1c8450dda308,Fundación para la investigación biomedica del hospital clinico san carlos de madrid,fundaci_n_para_la_investigaci_n_biomedica_del_hospital_clinico_san_carlos_de_madrid,,,,,, +1477,,b2af178c-9d62-47fe-87df-a91fa6a2b933,Grupo Español de Tumores Neuroendocrinos,grupo_espa_ol_de_tumores_neuroendocrinos,,,,,, +233,0.980434,bc0bdbc9-5679-4ff2-b014-d9efcc38f706,"Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre",department_of_infectious_diseases_copenhagen_university_hospital_hvidovre,,,,321f06bc-9aaf-4f20-b50b-fec99e946a29,department_of_infectious_diseases,Department of Infectious Diseases +1478,,fcd43351-6043-472a-9cac-6dd580562714,Agustín Albillos Martinez,agust_n_albillos_martinez,,,,,, +85,0.979515,43e9673c-7162-11e6-a0cd-0242ac12000b,PERRIGO CO,perrigo_co,,,,32d4a4cc-7142-11e6-a0cd-0242ac12000b,perrigo_co_tennessee,PERRIGO CO TENNESSEE +1479,,040a1a3b-306a-4a08-be78-b178e1d033da,Laboratoires IPRAD,laboratoires_iprad,,,,,, +1480,,da523855-2a61-4a14-84b1-9ddef039cf04,"Medical clinic, University Hospital of North Norway",medical_clinic_university_hospital_of_north_norway,,,,,, +1481,,5139ffa3-35c0-4406-80a1-d0a48e765722,Dr. José Ignacio Chacón López-Muñiz,dr_jos_ignacio_chac_n_l_pez_mu_iz,,,,,, +1482,,5bea85f2-f1a8-46b8-b8ef-77c4e865b4e7,Miguel Giovanni Uriol Rivera,miguel_giovanni_uriol_rivera,,,,,, +1483,,69fb388d-6ce6-4caa-9916-a556e042fd77,NOVARTIS FARMA S.p.A,novartis_farma_s_p_a,,,,,, +1484,,83d147af-380c-48c4-b34c-ab3cdac326e9,University Eye Hospital,university_eye_hospital,,,,,, +981,0.97865206003189087,b57930d5-608d-413d-80c5-1204dbea3b2c,Bispebjerg Hospital,bispebjerg_hospital,,,,7924c511-76dd-4819-aff7-6958da1692ce,bispebjerg_hospital_department_of_dermatology,"Bispebjerg Hospital, Department of Dermatology" +1485,,b5f04647-9329-4c71-8269-935f945cb669,"Seattle Genetics, Inc",seattle_genetics_inc,,,,,, +1486,,5fa823ff-ef6a-4a2c-886e-fe9231b0f54b,Creabilis Limited,creabilis_limited,,,,,, +1487,,01f90b45-7fd1-40c5-9555-167560599dd9,Dr. Javier Pérez Gisbert,dr_javier_p_rez_gisbert,,,,,, +1488,,0cebf120-71ec-4157-9bc0-e339de7de377,Institut für Spezifische Prophylaxe und Tropenmedizin,institut_f_r_spezifische_prophylaxe_und_tropenmedizin,,,,,, +1489,,23c78d7a-aabf-4d5e-8fca-07431edb9679,Cardeas Pharma,cardeas_pharma,,,,,, +1490,,0e5e513b-a71c-40c0-8d0a-adc390b2cccf,United Bristol Healthcare Trust,united_bristol_healthcare_trust,,,,,, +1491,,fb34a78f-fa50-4f3f-9a94-f2795baed313,Zsolt Lohinai DMD PhD,zsolt_lohinai_dmd_phd,,,,,, +1492,,3ff39c76-7165-11e6-a0cd-0242ac12000b,UNITED BIOMEDCL,united_biomedcl,,,,,, +1493,,a17e8112-715c-11e6-a0cd-0242ac12000b,STRIDES ACROLAB,strides_acrolab,,,,,, +796,0.98663,26536bce-72ec-11e6-a0cd-0242ac12000b,STRIDES ARCOLAB,strides_arcolab,,,,26536bce-72ec-11e6-a0cd-0242ac12000b,strides_arcolab,STRIDES ARCOLAB +1494,,db5ba9cc-352d-4c06-9546-f4e59542096e,Mid Cheshire Hospitals NHS Trust,mid_cheshire_hospitals_nhs_trust,,,,,, +1495,,8a187e2e-43f7-4dd5-8083-62a2d7241cdd,"Department of Neurosurgery, PMU",department_of_neurosurgery_pmu,,,,,, +1496,,64945698-7a05-4058-a61e-47d1323a211c,BGP Kranj,bgp_kranj,,,,,, +688,0.98544374108314514,4f99f7a3-6aa3-48d1-bbd6-5bfbc38e7e8d,"Ruprecht-Karls-University Heidelberg, Medical Faculty",ruprecht_karls_university_heidelberg_medical_faculty,,,,4f99f7a3-6aa3-48d1-bbd6-5bfbc38e7e8d,ruprecht_karls_university_heidelberg_medical_faculty,"Ruprecht-Karls-University Heidelberg, Medical Faculty" +1497,,601e88fa-2e81-40a3-94c7-92870e050004,University Hospital of Tübingen,university_hospital_of_t_bingen,,,,,, +1498,,7215cc6b-f2e3-4632-bcca-af68390883f2,"Med. Univ. Wien, Klinik Innere Medizin I, Intensivstation",med_univ_wien_klinik_innere_medizin_i_intensivstation,,,,,, +1499,,1ecd9df1-ff07-4652-9df0-6c3dcba4d72e,ISTITUTO CLINICO HUMANITAS,istituto_clinico_humanitas,,,,,, +1500,,fd94f628-42b0-4de2-a7c1-3d00e3d2947c,CSL Behring GmbH,csl_behring_gmbh,,,,,, +1501,,61673059-674d-47da-9b5c-45145cc60749,"Supernus Pharmaceuticals, Inc",supernus_pharmaceuticals_inc,,,,,, +1502,,dab39b79-16d3-463f-896f-ea1b399bc782,Department of gastroenterology. University Hospital of Santiago,department_of_gastroenterology_university_hospital_of_santiago,,,,,, +1503,,285b7f85-63be-4da0-afc9-06b4e3ade1fc,Cerus Corporation,cerus_corporation,,,,,, +1504,,2cec0c2c-c84a-4b81-a31d-49ef52e44c98,CeQur Corp,cequr_corp,,,,,, +1505,,757340bd-15f9-4d36-b7c4-b0f6b5d86cfe,Christine Bengtsson,christine_bengtsson,,,,,, +1506,,d7ae7b9a-611e-4a82-8acb-b3f1c25f7470,Astellas Pharma Canada Inc,astellas_pharma_canada_inc,,,,,, +1507,,902f7b8b-e4ee-431b-9282-f01aab4e6ee0,Barnsley Hospital NHS Foundation Trust,barnsley_hospital_nhs_foundation_trust,,,,,, +1508,,fac53175-bd7c-4994-9451-9dff1b050ec5,"Merckle GmbH, a member of the ratiopharm group, a subsidiary of Teva Pharmaceutical Industries Ltd. Germany",merckle_gmbh_a_member_of_the_ratiopharm_group_a_subsidiary_of_teva_pharmaceutical_industries_ltd_germany,,,,,, +1509,,45f116ea-8811-11e6-a998-0242ac12000b,"Vertex Pharamceuticals, Inc",vertex_pharamceuticals_inc,,,,,, +1510,,bdc7af5e-7235-11e6-a0cd-0242ac12000b,NOVEN PHARMS INC,noven_pharms_inc,,,,,, +1511,,228f01cd-d116-4c2e-921b-3c582313be4a,Belfast HSC Trust,belfast_hsc_trust,,,,,, +911,0.955326,e90dccc5-87bf-45ae-9fd1-a29dda792f2e,"DIATER, Laboratorio de Diagnóstico y Aplicaciones Terapéuticas, S.A",diater_laboratorio_de_diagn_stico_y_aplicaciones_terap_uticas_s_a,,,,6fe95abc-39e9-4d47-999a-8959adcc1009,diater_laboratorio_de_diagnostico_y_aplicaciones_terap_uticas_s_a,DIATER Laboratorio de Diagnostico y Aplicaciones Terapéuticas S.A +1512,,0fb1babe-72af-470f-9091-5811e9f34ab4,Philips,philips,,,,,, +123,0.93060654401779175,acb87f8a-df4a-4496-9d3a-83c2f7389db1,"F. Hoffmann-La Roche Ltd (representado en España por Roche Farma, S.A)",f_hoffmann_la_roche_ltd_representado_en_espa_a_por_roche_farma_s_a,,,,6f6fa7c2-4fab-461f-9b80-d0b26f4f354e,f_hoffmann_la_roche_ag,F. Hoffmann-La Roche AG +1513,,9a531394-71b6-11e6-a0cd-0242ac12000b,QOL MEDCL,qol_medcl,,,,,, +453,0.900843,9b07a8e6-7165-11e6-a0cd-0242ac12000b,ANTIBIOTICS SA,antibiotics_sa,,,,7b861ad6-7163-11e6-a0cd-0242ac12000b,antibiotice,ANTIBIOTICE +1514,,fd354bb8-3bb8-427b-acf8-21b94cc4a3e9,"Regensburg University Medical Center, Department of Surgery",regensburg_university_medical_center_department_of_surgery,,,,,, +1515,,c649aa3d-25ff-4070-843e-284bd79f0564,Policlinico Gemelli-CIC- UCSC,policlinico_gemelli_cic_ucsc,,,,,, +739,0.95527833700180054,44219b72-858c-4e54-8209-9aba06a32318,ICORG,icorg,,,,44219b72-858c-4e54-8209-9aba06a32318,icorg,ICORG +1516,,1f3c8195-0880-49f8-8d63-e8ea86ca4ec1,Universiteit Leiden,universiteit_leiden,,,,,, +1517,,01e6b8a7-46b9-4314-84bb-2ad8895a1281,Hopitaux Universitaires de Strasbourg,hopitaux_universitaires_de_strasbourg,,,,,, +1518,,8f1b855a-7151-4848-8275-b56c98da6e32,"investigator-driven research: Erasmus MC, Neurovascular Section",investigator_driven_research_erasmus_mc_neurovascular_section,,,,,, +325,0.97939214110374451,44cc3539-0a28-4a7b-820a-41115f05ad15,"Ferrer Internacional, SA",ferrer_internacional_sa,,,,199a1dd6-828f-4e0b-b783-d712bad32b9e,ferrer_internacional,Ferrer Internacional +1519,,5f009d76-8f37-430c-8faf-b5a320d52956,"Medizinische Universität Wien, Bernhard Gottlieb Universitätszahnklinik",medizinische_universit_t_wien_bernhard_gottlieb_universit_tszahnklinik,,,,,, +971,0.981633,e38d28dc-8bbb-11e6-a449-0242ac12000b,"Department of Anaesthesiology, University Hospital of Skejby",department_of_anaesthesiology_university_hospital_of_skejby,,,,7c6e82f0-9a46-47cd-89bb-39837da65876,department_of_anaesthesiology,Department of Anaesthesiology +1520,,d08c73bf-b7e9-410f-a6c0-3b7faaad10ad,PROGEN PHARMACEUTICALS LIMITED,progen_pharmaceuticals_limited,,,,,, +366,0.98152613639831543,834ddc5d-8e84-46be-ae7c-139ec547ee6b,"Bayer Health Care AG, D-51368 Leverkusen",bayer_health_care_ag_d_51368_leverkusen,,,,17a7c9c8-3636-4a11-a0b2-a237ca2e374e,bayer_health_care_ag,Bayer Health Care AG +1521,,8e74251a-e929-4ba1-9486-29ac1c9c2e24,DR. ALEJANDRO SOUSA ESCANDÓN,dr_alejandro_sousa_escand_n,,,,,, +1522,,2c8bf6e0-73f1-11e6-a0cd-0242ac12000b,AIRGAS USA LLC,airgas_usa_llc,,,,,, +1523,,886bc173-799f-4d33-9b19-de0e457ed309,Servicio de Neumología del Hospital Valle Hebrón,servicio_de_neumolog_a_del_hospital_valle_hebr_n,,,,,, +1524,,46aaf2de-36b2-4ae2-9e02-ee306174509a,"CombinatoRx, Inc",combinatorx_inc,,,,,, +1525,,9104d4ac-7167-11e6-a0cd-0242ac12000b,KETTERING MEDCTR,kettering_medctr,,,,,, +1526,,c25e1332-76a6-4008-859d-429b935d50c5,Orphan Europe SARL,orphan_europe_sarl,,,,,, +1527,,efaf9895-b6ac-4dc5-b4a2-6a5999c07ddf,Pharmaxis Ltd,pharmaxis_ltd,,,,,, +1528,,006b7c4d-12d3-4ab4-88a9-c3414a852b6f,Elan Pharma Ltd,elan_pharma_ltd,,,,,, +143,0.98837488889694214,bc945ca3-8945-4a29-9bb6-08e3e6715f24,Västra Götalandsregionen,v_stra_g_talandsregionen,,,,a370f60e-0db0-41b7-9f59-748ac05359ac,v_stra_g_talandsregionen_n_l,Västra Götalandsregionen/NÄL +1529,,6f73b6c8-1f90-492f-a899-fa04a1d6534c,Rehabilitation Department. Hospital mútua de Terrassa,rehabilitation_department_hospital_m_tua_de_terrassa,,,,,, +1530,,11768859-d442-4ceb-87b0-a64bfe7eb53a,Ethicare GmbH,ethicare_gmbh,,,,,, +1531,,2eec58fc-7145-11e6-a0cd-0242ac12000b,FRESENIUS KABI ONCOL,fresenius_kabi_oncol,,,,,, +1532,,ada37f66-1a9c-4303-ba1e-95ddc778ec8e,TweeSteden hospital,tweesteden_hospital,,,,,, +1533,,e87ea879-501c-4481-a87b-8f6ee3b06e45,Stage Pharmaceuticals GmbH,stage_pharmaceuticals_gmbh,,,,,, +1078,0.95581340789794922,1242e11a-4288-492d-8023-e4ffe5a4e9bd,IBSA,ibsa,,,,1242e11a-4288-492d-8023-e4ffe5a4e9bd,ibsa_institute_biochimique_sa,IBSA Institute Biochimique SA +1534,,ddb510fa-819f-4f49-8777-67856e06385e,daniel pacha vicente,daniel_pacha_vicente,,,,,, +1535,,5a3985a4-56e5-4d1c-bbe6-37e1332baca8,Sanochemia Pharmazeutika AG,sanochemia_pharmazeutika_ag,,,,,, +1536,,2ea806c8-96db-11e6-becf-0242ac110008,SAREPTA THERAPS INC,sarepta_theraps_inc,,,,,, +1537,,089c4c13-07bc-4a84-9288-a8cbaf427192,Assistance Publique Hopitaux de marseille,assistance_publique_hopitaux_de_marseille,,,,,, +595,0.985826,e5db50b4-cb54-4e0c-9a29-3f1f6726af8f,Erasmus Medical Centre Rotterdam,erasmus_medical_centre_rotterdam,,,,6548489f-2430-4636-90c0-4f63a9939b5c,erasmus_medical_centre,Erasmus Medical Centre +1538,,8bd89508-afb6-4e5d-9ad4-6182fae033df,Baxter R&D Europe SCRL,baxter_r_d_europe_scrl,,,,,, +1539,,2834a2b4-add1-4c2c-afe9-c27f6dd26c42,"Merck Serono Geneva- an affiliate of Merck KGaA, Darmstadt Germany",merck_serono_geneva_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,,, +1540,,4cbed40c-e7c6-4447-a081-64f21ed8e450,Tekonivelsairaala Coxa,tekonivelsairaala_coxa,,,,,, +219,0.980666,dee7f909-005a-4a98-9eaf-2ea27e22763d,Bioprojet,bioprojet,,,,bb0251f2-2efa-42a2-8d24-fa858e7ba0cc,bioprojet_pharma,Bioprojet Pharma +1541,,436da1ec-a0f0-4c1f-bfa5-22ea0f9d44ce,"Department of Anesthesia, Div. of Cardiothoracic and Vascular Anesthesia, Medical University Vienna",department_of_anesthesia_div_of_cardiothoracic_and_vascular_anesthesia_medical_university_vienna,,,,,, +1542,,7191688c-6fa1-11e6-9663-0242ac12000b,Boehringer Ingelheim Ireland Ltd,boehringer_ingelheim_ireland_ltd,,,,,, +964,0.97516081730524695,16556fb5-6653-4d5b-bd94-fc6343fa4fd8,Helsinki University Central Hospital,helsinki_university_central_hospital,,,,16556fb5-6653-4d5b-bd94-fc6343fa4fd8,helsinki_university_central_hospital,Helsinki University Central Hospital +1543,,5bb0d033-224f-47fd-a89d-64ec445cdf84,Isotechnika Inc,isotechnika_inc,,,,,, +1544,,56e739be-f1b4-4a08-b086-b583ad195524,Landspítali Háskólasjúkrahús,landsp_tali_h_sk_lasj_krah_s,,,,,, +1545,,6090d518-a585-4e72-bb21-cfedec294a49,Queen Mary University London,queen_mary_university_london,,,,,, +1546,,c0cdf8fb-41a3-40e8-be6a-a7dd255d9758,A.U.S.L. RIMINI,a_u_s_l_rimini,,,,,, +1547,,087d7412-cdc9-4e3d-b53b-2b2d75bf41c4,FIDIA,fidia,,,,,, +1548,,53c07b47-e690-4ee7-ac41-e62fb0bfdbcb,"Fertility Clinic, Copenhagen University Hospital, Rigshospitalet",fertility_clinic_copenhagen_university_hospital_rigshospitalet,,,,,, +1549,,74756ce4-898b-4928-9d75-1a64d5ece247,AZIENDA OSPEDALIERA S. LUIGI GONZAGA,azienda_ospedaliera_s_luigi_gonzaga,,,,,, +1550,,7773cfd2-de1f-4fe4-9f72-cfe4679d0e86,CHX Technologies Inc,chx_technologies_inc,,,,,, +318,0.98787707090377808,bf5310ea-463d-4046-9a2e-499966b7d909,Department of Neurology UMCG,department_of_neurology_umcg,,,,215a6fe0-4912-4052-b609-f99824db28f0,department_of_neurology,Department of Neurology +1551,,00749640-ca53-481e-8804-6edece705cd5,Dr. Guillermo Reyes Copa,dr_guillermo_reyes_copa,,,,,, +1552,,9f4eb914-73f2-11e6-a0cd-0242ac12000b,VERTEX PHARMS INC,vertex_pharms_inc,,,,,, +1553,,c2ad3284-fde5-4a3d-9d80-b7f9d91d83f2,Fovea Pharmaceuticals SA,fovea_pharmaceuticals_sa,,,,,, +473,0.986317,a65c196b-462c-42a6-84d1-8d84e1c940d6,Algeta AS,algeta_as,,,,a65c196b-462c-42a6-84d1-8d84e1c940d6,algeta_as,Algeta AS +926,0.985988,634e757f-8ba8-4364-ad56-f51636b9ab94,Haukeland University Hospital,haukeland_university_hospital,,,,634e757f-8ba8-4364-ad56-f51636b9ab94,haukeland_university_hospital,Haukeland University Hospital +1554,,974c189a-0be0-471d-ba1a-2f314ef32416,Teva Pharmaceutical Works Private Limited Company,teva_pharmaceutical_works_private_limited_company,,,,,, +608,0.97275575002034509,3a5bee20-b6ec-4b84-b5a5-a5049252c6e4,RWTH Aachen University,rwth_aachen_university,,,,8cf07097-1668-4840-99e4-5f3861195629,rwth_aachen_university_for_the_medical_faculty_represented_by_clinical_trial_center_aachen_ctc_a,"RWTH Aachen University for the Medical Faculty, represented by Clinical Trial Center Aachen (CTC-A)" +1555,,3e33b769-58d1-4072-bd25-fd514e693cd2,"Ruprecht-Karls-University Heidelberg, Medical Faculty represented by University Hospital Heidelberg",ruprecht_karls_university_heidelberg_medical_faculty_represented_by_university_hospital_heidelberg,,,,,, +1556,,9b5f3163-46f8-4083-945b-0d16683a8ac7,"Wyeth Korea, Inc",wyeth_korea_inc,,,,,, +1557,,6bd837e6-7124-48ef-8ff5-bbf2e2eb1032,PIERRE FABRE Ltd,pierre_fabre_ltd,,,,,, +1558,,bd434e5a-7e49-4d2f-8622-ca621aa7d770,TOGA Thoracic Oncology Group Antwerp,toga_thoracic_oncology_group_antwerp,,,,,, +1559,,b3404fa6-47c0-4392-b74e-3bf22e792af1,"Klinikum der Ludwig-Maximilians-Univ. Münch , Klinikum Großhadern (vertreten durch die kaufmännische Direktion)",klinikum_der_ludwig_maximilians_univ_m_nch_klinikum_gro_hadern_vertreten_durch_die_kaufm_nnische_direktion,,,,,, +1560,,48e403e0-7168-11e6-a0cd-0242ac12000b,GAVIS PHARMS LLC,gavis_pharms_llc,,,,,, +1561,,122d843f-01c8-4c70-9ddf-f4a8bde1cbec,ImClone Systems Corporation,imclone_systems_corporation,,,,,, +1562,,b80cf9a0-880d-11e6-a998-0242ac12000b,"CymaBay Therapeutics, Inc",cymabay_therapeutics_inc,,,,,, +829,0.980992,644211ae-bb15-4824-abbb-0de942c913a7,OSPEDALE G.PASQUINUCCI-FONDAZIONE TOSCANA GABRIELE MONASTERIO,ospedale_g_pasquinucci_fondazione_toscana_gabriele_monasterio,,,,49311101-9fd1-4902-b91d-e36e1f2e30c2,ospedale_g_pasquinucci_fondazione_toscana_gabriele_monasterio_cnr,OSPEDALE G.PASQUINUCCI-FONDAZIONE TOSCANA GABRIELE MONASTERIO/CNR +532,0.967052,4c49fb26-4e7e-409c-ab8a-627200080dc0,East and North Hertfordshire NHS Trust,east_and_north_hertfordshire_nhs_trust,,,,4c49fb26-4e7e-409c-ab8a-627200080dc0,east_and_north_hertfordshire_nhs_trust,East and North Hertfordshire NHS Trust +1563,,b69cc18f-8bff-45df-9513-02d9936f98ee,GlaxoSmithKline Consumer Healthcare (GSKCH),glaxosmithkline_consumer_healthcare_gskch,,,,,, +1564,,01e8b7a5-bd9b-4441-be04-c6159556bf7d,FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA,fondazione_irccs_istituto_neurologico_carlo_besta,,,,,, +1565,,4477b526-bee3-4698-aaf0-852cfc746ba6,Onkološki inštitut Ljubljana,onkolo_ki_in_titut_ljubljana,,,,,, +1566,,a0e726f7-f3b6-4556-bf7b-e335fd54f1fe,University Hospital Münster,university_hospital_m_nster,,,,,, +1567,,eed1b1db-3dc4-4794-a661-0689a54a13e0,Roche (Hungary) Ltd,roche_hungary_ltd,,,,,, +816,0.989949,efc24352-69e0-4fbf-bcfd-b7fe922c0213,The Kompetenznetz Vorhofflimmern e.V. [German Atrial Fibrillation Competence Network association (AFNET e.V.)],the_kompetenznetz_vorhofflimmern_e_v_german_atrial_fibrillation_competence_network_association_afnet_e_v,,,,d89406de-85c4-474e-a03e-9516d6463bf7,the_kompetenznetz_vorhofflimmern_e_v_german_atrial_fibrillation_competence_network_association_af,The Kompetenznetz Vorhofflimmern e.V. [German Atrial Fibrillation Competence Network association (AF +1568,,ee6b5a81-2904-4718-b3e4-7f54f0c758c6,EVER Neuro Pharma GmbH,ever_neuro_pharma_gmbh,,,,,, +878,0.986926,d508d70a-7141-11e6-a0cd-0242ac12000b,ZYDUS PHARMS USA INC,zydus_pharms_usa_inc,,,,c04f7850-7141-11e6-a0cd-0242ac12000b,zydus_pharms_usa,ZYDUS PHARMS USA +1569,,4fc015ec-fb78-4a16-8fd5-d66b59fd9ef0,MERCK SHARP DOHME,merck_sharp_dohme,,,,,, +891,0.978652,9818edbf-d627-4f19-971a-74599a393266,Australasian Gastro−Intestinal Trials Group,australasian_gastro_intestinal_trials_group,,,,0aaff566-edcf-48b0-acb4-a30bb9fe5405,australasian_gastro_intestinal_trials_group_sydney_university,"Australasian Gastro-Intestinal Trials Group, Sydney University" +1570,,d23d611f-e279-49de-9730-28e105fd78f9,"Istituto di ricerche farmacologiche ""Mario Negri",istituto_di_ricerche_farmacologiche_mario_negri,,,,,, +1571,,d4e07fc7-8de2-433d-ad17-23988f6eeb2e,"ACCESS Pharmaceuticals, Inc",access_pharmaceuticals_inc,,,,,, +1572,,682c2d39-7ffb-469b-8c72-18cd6b550b46,H. Lundbeck A/S,h_lundbeck_a_s,,,,,, +1573,,b3b89a8c-efc0-4652-be27-4f90152c852f,"Merck, S.L",merck_s_l,,,,,, +608,0.96548187732696533,8cf07097-1668-4840-99e4-5f3861195629,RWTH Aachen,rwth_aachen,,,,8cf07097-1668-4840-99e4-5f3861195629,rwth_aachen_university_for_the_medical_faculty_represented_by_clinical_trial_center_aachen_ctc_a,"RWTH Aachen University for the Medical Faculty, represented by Clinical Trial Center Aachen (CTC-A)" +1574,,f3f53758-fac6-40d7-9ed1-b98513ad4123,Laboratoires MSD-Chibret,laboratoires_msd_chibret,,,,,, +1575,,afdbb1a4-323f-4e43-bdbb-0a5962d67a60,Otonomy Inc,otonomy_inc,,,,,, +1576,,1346b5bf-e37a-4250-85a0-9f8f243d4ddf,"Krka, d.d., Novo mesto",krka_d_d_novo_mesto,,,,,, +621,0.956445,52d997a2-9f49-426b-bfc6-c251dadcce43,"Universitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie",universit_tsklinik_f_r_innere_medizin_iii_klinische_abteilung_f_r_gastroenterologie_und_hepatologie,,,,52d997a2-9f49-426b-bfc6-c251dadcce43,universit_tsklinik_f_r_innere_medizin_iii_klinische_abteilung_f_r_gastroenterologie_und_hepatologie,"Universitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie" +1577,,6ab6983d-1d4f-46f7-886d-53fd3f1458a5,The Symbio Herborn Group GmbH,the_symbio_herborn_group_gmbh,,,,,, +1578,,3bc10be7-b012-44c3-96cf-95a4790a51be,"NPS Pharmaceuticals, Inc",nps_pharmaceuticals_inc,,,,,, +820,0.98334300518035889,88ff59be-7129-11e6-a89e-0242ac12000b,WOCKHARDT,wockhardt,,,,5febc4b8-715b-11e6-a0cd-0242ac12000b,wockhardt_ltd,WOCKHARDT LTD +1579,,aba45409-1cc0-45e7-9b2d-cf16b3247f16,AISF - ASSOCIAZIONE ITALIANA PER LO STUDIO DEL FEGATO,aisf_associazione_italiana_per_lo_studio_del_fegato,,,,,, +1580,,f131a850-d979-4cc9-b5ed-49278a139b00,INSTITUT DE CANCEROLOGIE DE L'OUEST,institut_de_cancerologie_de_l_ouest,,,,,, +1581,,6183093c-34c7-45dc-9229-711bfff2d642,Medicines for Malaria Venture,medicines_for_malaria_venture,,,,,, +330,0.925303,786ccf58-7b82-4056-b49c-f3946952c95d,Unidad de Trasplantes y Terapia Celular del Hospital General Universitario Central de Asturias,unidad_de_trasplantes_y_terapia_celular_del_hospital_general_universitario_central_de_asturias,,,,786ccf58-7b82-4056-b49c-f3946952c95d,unidad_de_trasplantes_y_terapia_celular_del_hospital_general_universitario_central_de_asturias,Unidad de Trasplantes y Terapia Celular del Hospital General Universitario Central de Asturias +1582,,cc41e1e0-67b8-4d3d-a981-4d8ede206bc4,Royal Bournemouth & Christchurch Hospitals NHS Foundation Trust,royal_bournemouth_christchurch_hospitals_nhs_foundation_trust,,,,,, +1583,,71bec098-1947-45d7-87dd-03625236d470,"Department of Gynecological Oncology, University Hospital, Örebro",department_of_gynecological_oncology_university_hospital_rebro,,,,,, +1584,,ed38c280-1080-4834-895f-f14256bb34c2,Policlinico A. Gemelli,policlinico_a_gemelli,,,,,, +1585,,16e9b460-1963-4b72-b2a5-0a7273293783,"Sepracor, Inc",sepracor_inc,,,,,, +1586,,b562174b-953b-40c7-8982-5e24d964dfd2,"Axovant Sciences, Inc",axovant_sciences_inc,,,,,, +1587,,3f10c263-8eaf-4a76-8caa-e981e4d4cf40,"Committee of Management, Common Services Agency T/A Scottish National Blood Transfusion Service",committee_of_management_common_services_agency_t_a_scottish_national_blood_transfusion_service,,,,,, +614,0.96949491898218787,1f4b6569-9247-4094-9c36-e11efb0201df,Fundación para la Investigación Biomédica del Hospital Universitario La Paz,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz,,,,1f4b6569-9247-4094-9c36-e11efb0201df,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz,Fundación para la Investigación Biomédica del Hospital Universitario La Paz +1588,,7fd4b91f-1e1f-4e0a-a595-bb6a4c836b9e,Ole Hamberg,ole_hamberg,,,,,, +1589,,23524721-6797-4e6a-93ce-19951837d9d5,Boris Modrau,boris_modrau,,,,,, +1590,,df320978-87b9-45d3-887b-40b034c72218,Herlev and Gentofte Hospital,herlev_and_gentofte_hospital,,,,,, +136,0.958341,a83d7e8b-aa57-4e44-a6e7-9a0f7bd40eaf,Medisch Centrum Leeuwarden,medisch_centrum_leeuwarden,,,,3e746564-6364-4770-b1d4-841842beb7c7,medisch_centrum_leeuwaarden,Medisch Centrum Leeuwaarden +1591,,54cda435-d7e8-446e-a726-cb97a68c0f1f,Medisch Spectrum Twente,medisch_spectrum_twente,,,,,, +990,0.988915,d87f9c09-9858-4188-959a-3ed4d92d4f51,INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG),international_extranodal_lymphoma_study_group_ielsg,,,,7729c4f5-04ed-489e-a85c-cd0279e1c490,international_extranodal_lymphoma_study_group,INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP +60,0.94956863777978084,67020723-1387-4f57-9a26-42f7744d3492,"Wyeth Research Division of Wyeth Pharmceuticals Inc. A Pfizer Company, Philadelphia, PA-19101, USA",wyeth_research_division_of_wyeth_pharmceuticals_inc_a_pfizer_company_philadelphia_pa_19101_usa,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc +447,0.952846,0000011d-452f-4fe6-9214-3df63d041f46,ETOP (European Thoracic Oncology Platform),etop_european_thoracic_oncology_platform,,,,0000011d-452f-4fe6-9214-3df63d041f46,etop_european_thoracic_oncology_platform,ETOP (European Thoracic Oncology Platform) +1592,,ccd7e06a-db5d-45f8-bf45-74f71a94c10c,MUKOVISZIDOSE E.V,mukoviszidose_e_v,,,,,, +757,0.984269,af82f758-66a1-4c9c-ab35-f3ad4f8b4833,"The Netherlands Cancer Institute Amsterdam, Netherlands",the_netherlands_cancer_institute_amsterdam_netherlands,,,,4fdd63b2-11be-4586-9f81-b4e4a2263768,the_netherlands_cancer_institute,The Netherlands Cancer Institute +969,0.98663,44eb1394-7142-11e6-a0cd-0242ac12000b,WARNER CHILCOTT,warner_chilcott,,,,44eb1394-7142-11e6-a0cd-0242ac12000b,warner_chilcott,WARNER CHILCOTT +245,0.975108,8cc13716-154a-455e-8604-397805d40f97,"Karyopharm Therapeutic, Inc",karyopharm_therapeutic_inc,,,,8cc13716-154a-455e-8604-397805d40f97,karyopharm_therapeutic_inc,"Karyopharm Therapeutic, Inc" +1593,,0b0ab072-2600-4bff-9deb-1ca8288d40c7,Green Cross Corporation,green_cross_corporation,,,,,, +771,0.989275,f6b59c9f-cc32-4099-ac21-33f7074e532e,Swiss Group for Clinical Cancer Research SAKK,swiss_group_for_clinical_cancer_research_sakk,,,,ae4da2c3-6d27-4362-b182-669f879ac3d4,swiss_group_for_clinical_cancer_research,Swiss Group for Clinical Cancer Research +1594,,be60110f-117e-4cba-b551-095f0d652bb0,University College Cork,university_college_cork,,,,,, +1595,,54e79886-7d44-4353-8fa0-e53b467d37b1,"Ardea Biosciences, Inc",ardea_biosciences_inc,,,,,, +1596,,a418dee3-0eb7-40fe-92b8-b075de6a39ef,UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA,universita_degli_studi_di_milano_bicocca,,,,,, +1597,,b2baebe3-7c37-4773-a470-728b5b870360,GETNE (Grupo Español de Tumores Neuroendocrinos),getne_grupo_espa_ol_de_tumores_neuroendocrinos,,,,,, +1598,,d5a5f4f2-a4ec-4d08-af7f-0baa4e548a16,"Aarhus University Hospital, Department of Neurology",aarhus_university_hospital_department_of_neurology,,,,,, +311,0.94804,d24a8fcd-b259-45c2-8a36-5604474c370e,VU University Medical Centre,vu_university_medical_centre,,,,b1e7a97f-3f72-43f4-a8f1-ab6902f55179,vu_univeristy_medical_centre,VU Univeristy Medical Centre +1599,,659d408c-d92d-47bd-8292-9aef6e77463f,"R+ D department, Hull and East Yorkshire NHS Hospital Trust",r_d_department_hull_and_east_yorkshire_nhs_hospital_trust,,,,,, +158,0.98881235718727112,8465bae2-df61-4d12-b842-02ea11ba6546,Medizinische Universität Wien, Univ.Klin.f. Chirurgie,,,,5b2fbdce-d691-41c6-9a74-e06608d419f4,medizinische_universit_t_wien_hno_klinik,Medizinische Universität Wien +230,0.95899969339370728,e36533aa-a267-461b-b595-a7c0d4d12b23,Medical Department I,medical_department_i,,,,e36533aa-a267-461b-b595-a7c0d4d12b23,medical_department_i,Medical Department I +1600,,90ba5602-6ba9-40f1-87be-fd32a5b64ef2,"University Children´s Hospital Tübingen,",university_children_s_hospital_t_bingen,,,,,, +1601,,f3518218-7144-11e6-a0cd-0242ac12000b,ORCHID HLTHCARE,orchid_hlthcare, Klin. Abtlg. f. Transplantation,medizinische_universit_t_wien_univ_klin_f_chirurgie_klin_abtlg_f_transplantation,,,, +1602,,be36baff-f263-458b-9f87-d9dac7eab87b,Association of Dutch Burn Centres,association_of_dutch_burn_centres,,,,,, +1603,,b58f2578-6fa2-11e6-9663-0242ac12000b,UCL University College London,ucl_university_college_london,,,,,, +1604,,a325ab84-6ecd-4eeb-9eb8-bb5f04cf44ba,Ville Artto,ville_artto,,,,,, +1605,,69eb576e-2178-493f-aafa-03daf8222e0f,University of York,university_of_york,,,,,, +203,0.986562,3429eb3c-72ca-11e6-a0cd-0242ac12000b,GALDERMA LABS,galderma_labs,,,,16d65dd4-7146-11e6-a0cd-0242ac12000b,galderma_labs_lp,GALDERMA LABS LP +1606,,ee1c97e2-1acf-4735-bf58-395919bea552,"Biosense Webster, Inc",biosense_webster_inc,,,,,, +1607,,88e985d3-f19f-4159-8c3b-7ae6df33922c,Erasmus MC Rotterdam,erasmus_mc_rotterdam,,,,,, +1608,,9b867e7c-af9b-40d8-a57e-106d4f94acd1,"FAES FARMA, S.A",faes_farma_s_a,,,,,, +1609,,d40a5f19-3207-4257-a90c-f50353baac8b,FARMIGEA,farmigea,,,,,, +1610,,f2c32a60-3f90-4b7d-bc0b-e61692bb72bc,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,sidney_kimmel_comprehensive_cancer_center_at_johns_hopkins,,,,,, +1611,,526ae032-cfcd-471f-b9fd-b0bc5fa0662b,United Lincolnshire Hospitals NHS Trust,united_lincolnshire_hospitals_nhs_trust,,,,,, +208,0.98087829351425171,ceab788a-7142-11e6-a0cd-0242ac12000b,ALVOGEN INC,alvogen_inc,,,,2237cc76-7146-11e6-a0cd-0242ac12000b,alvogen,ALVOGEN +1612,,5c8a09b2-d68a-4222-8595-b965ae09415f,"University Hospital, Catholic University of Leuven",university_hospital_catholic_university_of_leuven,,,,,, +1613,,1a4f2ec9-6c8f-4fca-ab54-7852054d2b93,"Onconova Therapeutics, Inc",onconova_therapeutics_inc,,,,,, +1614,,2b4c095f-7b47-48f0-9795-389fc378f080,Province of Gelderland & Overijssel,province_of_gelderland_overijssel,,,,,, +1615,,9e8c84f9-6aac-471d-ace9-50fdfc1ed61f,IBCSG,ibcsg,,,,,, +1616,,c6009f30-e444-4d38-bf07-12a868189f0b,Anxiofit Ltd,anxiofit_ltd,,,,,, +1617,,278dd113-f7a4-4e1d-ac1a-fdb25b62ce77,Dexcel Pharma Technologies Ltd,dexcel_pharma_technologies_ltd,,,,,, +1068,0.97769945859909058,24095e02-bf25-4c7e-bbc3-925378eaba6e,Serono,serono,,,,24095e02-bf25-4c7e-bbc3-925378eaba6e,serono,Serono +72,0.93533533811569214,0d580b3a-6f99-11e6-9663-0242ac12000b,Takeda Global Research and Development Centre (Europe) Ltd,takeda_global_research_and_development_centre_europe_ltd,,,,a359d331-932d-4716-9cec-7901baf5cc1b,takeda_global_research_development_centre_europe_ltd,Takeda Global Research & Development Centre (Europe) Ltd +1618,,7cd1e697-3021-4773-9734-2d91a38de5f2,Auris Medical AG,auris_medical_ag,,,,,, +1619,,f8fbde9c-09fa-4ce9-adfe-ad8da7100ab0,Valeant Research & Development,valeant_research_development,,,,,, +1620,,a53a68f3-ad61-4aa4-a231-814cb599822a,"Institute of pharmacology, Aarhus university",institute_of_pharmacology_aarhus_university,,,,,, +1621,,98302d76-b607-4427-b5bc-e4979ede67e3,"Millennium Pharmaceuticals, Inc. (Takeda)",millennium_pharmaceuticals_inc_takeda,,,,,, +1622,,aca9813e-715e-11e6-a0cd-0242ac12000b,AUXILIUM PHARMS INC,auxilium_pharms_inc,,,,,, +1623,,143a1669-a9a6-4102-ac73-c5c06638e63d,WELEDA AG DEUTSCHLAND,weleda_ag_deutschland,,,,,, +1624,,0930be78-5711-4511-9c03-7f83d3a085c7,The Newcastle upon Tyne Hospitals NHS Trust,the_newcastle_upon_tyne_hospitals_nhs_trust,,,,,, +1625,,83a28b95-0c92-41cb-afb9-c8c098c4a4c0,Axcan Pharma S.A,axcan_pharma_s_a,,,,,, +1626,,7e5f82b7-ef52-4a88-9906-c39e998c209b,Centro Hospitalar de São João E.P.E,centro_hospitalar_de_s_o_jo_o_e_p_e,,,,,, +1627,,12968904-5538-447f-b655-73dee6ab764a,GUNA SPA,guna_spa,,,,,, +1628,,d756dec8-9f5c-4ce4-b786-bc0f7da3e5b9,Stichting Hemato-Oncologie voor Volwassenen Nederland (Hovon),stichting_hemato_oncologie_voor_volwassenen_nederland_hovon,,,,,, +1629,,d0c2db43-284f-46b1-a90b-7ca259e69b2c,Novartis Vaccines and Diagnostics GmbH & Co. KG,novartis_vaccines_and_diagnostics_gmbh_co_kg,,,,,, +1630,,0b692ff4-b080-46a5-b50d-af300521aeed,"Medical University Vienna, Dept. of surgery",medical_university_vienna_dept_of_surgery,,,,,, +1631,,192e9de8-e440-408e-958e-cdda6b201e24,Lipid Therapeutics GmbH,lipid_therapeutics_gmbh,,,,,, +1632,,a6f1d600-487c-4231-b320-7120d184d44f,SANGART,sangart,,,,,, +268,0.982988,ed76101e-8eb2-463e-a1df-1cd0cb269b63,CELL THERAPEUTICS INC. SEDE SECONDARIA,cell_therapeutics_inc_sede_secondaria,,,,ad6dc0d9-13c5-492c-a7c3-cdf65dee7f25,cell_therapeutics_inc,CELL THERAPEUTICS INC +1633,,6947cb1a-7003-43d6-994c-448f47107eca,University Medical Centre Hamburg - Eppendorf,university_medical_centre_hamburg_eppendorf,,,,,, +1634,,e7e8ce4a-c520-474b-8d88-5a2978d2fcb4,Örebro University Hospital,rebro_university_hospital,,,,,, +459,0.9483584463596344,caa9eeff-a0fe-407d-8a39-097924dbd94c,Janssen-Cilag Intrenational N.V,janssen_cilag_intrenational_n_v,,,,caa9eeff-a0fe-407d-8a39-097924dbd94c,janssen_cilag_international_n_v_turnhoutseweg_30_2340_beerse_belgium,"Janssen-Cilag International N.V., Turnhoutseweg 30, 2340 Beerse, Belgium" +777,0.97387266159057617,51713059-523f-4247-b288-a682d6d8e72b,MEDA AB,meda_ab,,,,51713059-523f-4247-b288-a682d6d8e72b,meda_ab,MEDA AB +773,0.958103,af8b6727-2812-4d69-b998-869a14637308,The Institute of Cancer Reseacrh,the_institute_of_cancer_reseacrh,,,,3ebee54d-bab5-4063-88aa-8fc3ffe15712,the_institute_of_cancer_research,The Institute of Cancer Research +365,0.98037067055702209,b39065c5-dce3-4082-9a6a-c7dd7f684319,Bayer HealthCare Pharmaceuticals Inc,bayer_healthcare_pharmaceuticals_inc,,,,17d529dc-dc91-4ddb-8f15-7de6d2fa75e3,bayer_healthcare_pharmaceuticals,Bayer HealthCare Pharmaceuticals +1635,,df40d7b6-117b-4112-95e7-b6adf853413f,Vall de Hebron Hospital,vall_de_hebron_hospital,,,,,, +1636,,9259e736-bfbb-4a8c-ab8c-041209e5bcac,AZIENDA OSPEDALIERA CARDINALE G.PANICO-TRICASE (LECCE),azienda_ospedaliera_cardinale_g_panico_tricase_lecce,,,,,, +896,0.983343,b50175fc-719b-11e6-a0cd-0242ac12000b,WYETH PHARMS,wyeth_pharms,,,,a1bb1c18-7336-11e6-a0cd-0242ac12000b,wyeth_pharms_pfizer,WYETH PHARMS PFIZER +1637,,815b6fce-f606-4c76-9b9e-31c7defa1798,Prof Bart Neyns,prof_bart_neyns,,,,,, +779,0.988892,da801118-83b2-438f-93fd-ced9cd672ee1,"The Centre for Child and Adolescent Mental Health, Eastern and Southern Norway (R.BUP)",the_centre_for_child_and_adolescent_mental_health_eastern_and_southern_norway_r_bup,,,,bf76ac82-c2cb-490f-8a4b-46603ab679e7,the_centre_for_child_and_adolescent_mental_health_eastern_and_southern,"The Centre for Child and Adolescent Mental Health, Eastern and Southern" +1638,,7829610e-8f71-4210-9039-b18234ed0950,The Mater Foundation/HRB Grant,the_mater_foundation_hrb_grant,,,,,, +1639,,4120a4b2-2541-4f6c-a3ca-7772fcb6a323,"Department of Pediatrics, Medical and Health Science Center, University of Debrecen",department_of_pediatrics_medical_and_health_science_center_university_of_debrecen,,,,,, +1640,,34e9e154-9386-44ef-98c5-e2485283fc5e,ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS/ DE`LE`GATION A` LA RECHERCHE CLINIQUE ET AU DE`VELOPPEMENT,assistance_publique_h_pitaux_de_paris_de_le_gation_a_la_recherche_clinique_et_au_de_veloppement,,,,,, +1641,,c3c8fe98-4082-4e95-bf4b-f145535f63de,Nemours Children's Clinic,nemours_children_s_clinic,,,,,, +1642,,fa9d137c-aec8-48c1-9c64-b7b8d9cee42e,Ernesto Pérez Persona,ernesto_p_rez_persona,,,,,, +1643,,afbfd242-0191-4289-89f7-0781650cba24,Pfizer AB,pfizer_ab,,,,,, +1644,,ef1f9f7a-79fc-4441-977c-744c6935df09,"Deutsche Homöopathie-Union, DHU-Arzneimittel GmbH & Co. KG",deutsche_hom_opathie_union_dhu_arzneimittel_gmbh_co_kg,,,,,, +1645,,f11f4975-4d67-431a-b1f3-bb36abc4ea57,Francophone de Cancérologie Digestive (FFCD),francophone_de_canc_rologie_digestive_ffcd,,,,,, +1646,,44f30cbb-de86-4c04-9c35-2dd6abc62c95,SHIRE PHARMACEUTICALS LTD,shire_pharmaceuticals_ltd,,,,,, +1647,,8f173b68-252a-49ff-8aa3-b62c2a6a5766,Omeros Corporation,omeros_corporation,,,,,, +192,0.98893731832504272,6a1d3bdf-f164-4e56-bf8f-d628a1663ffa,Teva Pharmaceutical Industries,teva_pharmaceutical_industries,,,,7621f0c9-df30-4cbd-95c1-d0d5719d2751,teva_pharmaceutical_industries,Teva Pharmaceutical Industries +1648,,49363b5c-d12f-4e43-b96d-a5a08ea52a86,Johannes Gutenberg-Universität,johannes_gutenberg_universit_t,,,,,, +1649,,1dfc8fac-6d74-4b9c-a668-0281d2df3eeb,Greater Glasgow & Clyde NHS,greater_glasgow_clyde_nhs,,,,,, +1650,,4f0b7009-702e-408a-89de-f94dbc1563cc,Novartis Pharrna Services AG,novartis_pharrna_services_ag,,,,,, +19,0.95549,28cd44d5-abe5-4c05-bd83-bc9462e97d2d,"IOBA, Universidad de Valladolid",ioba_universidad_de_valladolid,,,,28cd44d5-abe5-4c05-bd83-bc9462e97d2d,ioba_universidad_de_valladolid,"IOBA, Universidad de Valladolid" +1651,,05393a8b-d197-4778-9983-b26814fd6c89,CRESIB-Barcelona Centre for International Health Research,cresib_barcelona_centre_for_international_health_research,,,,,, +1652,,eebe2596-8be1-11e6-a449-0242ac12000b,Grifols Inc,grifols_inc,,,,,, +1653,,04009859-31b5-4136-8c4b-606333489add,"Palliativ medicinsk afdeling, Bispebjerg Hospital",palliativ_medicinsk_afdeling_bispebjerg_hospital,,,,,, +1654,,da95101f-f89e-4c97-8eb5-ff5f63598438,Lourdes Grande Santamaria,lourdes_grande_santamaria,,,,,, +1655,,22a15d2f-f7be-48f1-9e75-494449f9e9aa,"Deutsches Herzzentrum München, Klinik an der Technischen Universität München",deutsches_herzzentrum_m_nchen_klinik_an_der_technischen_universit_t_m_nchen,,,,,, +1656,,8d1a9e4c-3870-466e-a3d9-03b1b967673d,Allergan Pharmaceuticals Ireland,allergan_pharmaceuticals_ireland,,,,,, +1657,,614772e9-d59f-4923-926e-c626f4bb31e7,"Klinikum rechts der Isar, Technical University of Munich",klinikum_rechts_der_isar_technical_university_of_munich,,,,,, +1658,,7e8ba40a-585b-4bb9-8973-019fb0ee24e8,"Pfizer Consumer Healthcare, Pfizer Health AB",pfizer_consumer_healthcare_pfizer_health_ab,,,,,, +339,0.980344,1a9c7667-0a16-4463-a38f-f3fc2f60143b,Adocia SA,adocia_sa,,,,1a9c7667-0a16-4463-a38f-f3fc2f60143b,adocia_sa,Adocia SA +1659,,c624779a-2041-41b5-956e-08a2a8c4cd35,Dresden Technical University,dresden_technical_university,,,,,, +327,0.962536,74acbba7-8bef-4cf6-a584-3c8b328a6a63,ISTITUTO EUROPEO DI ONCOLOGIA,istituto_europeo_di_oncologia,,,,74acbba7-8bef-4cf6-a584-3c8b328a6a63,istituto_europeo_di_oncologia,ISTITUTO EUROPEO DI ONCOLOGIA +1660,,c8b13afe-0ae4-4f06-a8ce-be3e2b016d73,Salford Royal Hospitals NHS Trust,salford_royal_hospitals_nhs_trust,,,,,, +1661,,9b4d2b38-1769-4087-ab6f-972cddb23c5e,Augenklinik der LMU München,augenklinik_der_lmu_m_nchen,,,,,, +1662,,b008b71f-37fe-443a-b932-36fb4b9f54cc,Professor Thomas John Kiernan,professor_thomas_john_kiernan,,,,,, +143,0.98837488889694214,a370f60e-0db0-41b7-9f59-748ac05359ac,Västra Götalandsregionen/NÄL,v_stra_g_talandsregionen_n_l,,,,a370f60e-0db0-41b7-9f59-748ac05359ac,v_stra_g_talandsregionen_n_l,Västra Götalandsregionen/NÄL +1663,,93b0fab7-ec29-4ebf-a24e-32ba2dc54eff,ribosepharm GmbH,ribosepharm_gmbh,,,,,, +1664,,09c92d79-167f-4246-aa45-5b385f05a1d5,Merk KGaA,merk_kgaa,,,,,, +1665,,6dd215c9-5ebc-42ca-9978-999e99bcabb7,"Laboratorios Andrómaco, S.A (compañía perteneciente al Grupo Grünenthal España)",laboratorios_andr_maco_s_a_compa_a_perteneciente_al_grupo_gr_nenthal_espa_a,,,,,, +1666,,f8828c26-3852-4bfe-b0be-e4c68bdfb5c9,Dr August Wolff GmbH & Co KG Arzneimittel,dr_august_wolff_gmbh_co_kg_arzneimittel,,,,,, +1667,,3e407ece-4df3-4703-93f5-bc7e3b7103a4,Antares Pharma AG,antares_pharma_ag,,,,,, +861,0.95123109221458435,346f1a70-efcd-43d4-abdf-e7492786e3d6,"Academic Medical Center, Department of dermatology",academic_medical_center_department_of_dermatology,,,,7cef3d29-cecb-442c-acdb-b0a10dec2da0,academic_medical_center_department_of_dermatology,"Academic Medical Center, Department of dermatology" +1668,,d2c5b6d1-8a56-41e8-a060-b27872ba6548,Zentralklinikum St. Pölten,zentralklinikum_st_p_lten,,,,,, +1669,,e0b85ca7-6fde-43dc-a2c7-576293766b1c,GlaxoSmithKline LLC,glaxosmithkline_llc,,,,,, +1670,,f518ddbd-3a6e-4a89-a239-8a7be21e46d1,"AstraZeneca AB, European Regulatory Affairs",astrazeneca_ab_european_regulatory_affairs,,,,,, +890,0.91218763589859009,eb27cc54-248e-4cdc-a8d8-2286ca709082,University Medical Center of Johannes -Gutenberg University Mainz,university_medical_center_of_johannes_gutenberg_university_mainz,,,,6e8ed001-5c25-4c82-8b82-365ae91ee2c8,university_medical_center_johannes_gutenberg_university_mainz,"University Medical Center, Johannes Gutenberg-University Mainz" +1671,,74d73ad7-77e6-4e29-bc5a-d8edfd837005,Fundación Investigación Biomédica Hospital La Paz,fundaci_n_investigaci_n_biom_dica_hospital_la_paz,,,,,, +1672,,eb525940-71f6-11e6-a0cd-0242ac12000b,STAND HOMEOPATH,stand_homeopath,,,,,, +443,0.976266,93ee88e4-8723-494d-86b5-c1f43bbd66c8,"Klinikum Grosshadern Medical Center, University of Munich",klinikum_grosshadern_medical_center_university_of_munich,,,,93ee88e4-8723-494d-86b5-c1f43bbd66c8,klinikum_grosshadern_medical_center_university_of_munich,"Klinikum Grosshadern Medical Center, University of Munich" +1673,,9571aa0c-7547-4821-97fb-a60352590e0b,Barcelona Macula Foundation Research for Vision,barcelona_macula_foundation_research_for_vision,,,,,, +1674,,13d37a6e-a22f-454d-8c96-519556903e54,CNIC,cnic,,,,,, +1675,,17480022-554b-463c-a681-9de2928fab7d,Academic Medical Centrum,academic_medical_centrum,,,,,, +377,0.97536033391952515,c5239cb2-1657-4f7a-9ab8-3c78cb0f26d4,"Merck & Co., Inc",merck_co_inc,,,,a995503b-132d-44dc-a6b0-648b85bc0828,merck_co,Merck & Co +1676,,fdc476c9-f757-42b3-9fe9-b53df3a0e5fe,"Janssen-Cilag, Johnson & Johnson spol. s.r.o",janssen_cilag_johnson_johnson_spol_s_r_o,,,,,, +1677,,10d7685c-6893-45be-a7f1-34a3256a4de5,Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts,deutsches_krebsforschungszentrum_stiftung_des_ffentlichen_rechts,,,,,, +1678,,6f46cfd2-1e66-4915-9163-9129aa08f437,"Klinik für Physikalische Medizin und Rehabilitation, Medizinische Universität Wien",klinik_f_r_physikalische_medizin_und_rehabilitation_medizinische_universit_t_wien,,,,,, +1679,,7458bddc-c71b-4a97-9c05-60aa7fee135e,Fundació Hospital Vall Hebron Institut de Recerca,fundaci_hospital_vall_hebron_institut_de_recerca,,,,,, +1680,,3e13f467-a230-492d-a2ad-bf53f3643dae,"University of California, San Francisco, Immune Tolerance Network",university_of_california_san_francisco_immune_tolerance_network,,,,,, +903,0.978271,d862f39f-cfbc-4498-a1ce-645fdd08bd34,Besancon University Hospitaö,besancon_university_hospita,,,,03392dcb-ef6c-4051-ad43-dad84dc61463,besancon_university_hospital,Besancon University Hospital +1059,0.982418,a6c5c084-7190-11e6-a0cd-0242ac12000b,RECORDATI RARE,recordati_rare,,,,6dce2ae5-2f18-4049-bbc1-1d01299ee637,recordati,RECORDATI +951,0.98241811990737915,d8eabef5-6cfe-4ff7-90ab-73a88f7b1905,MedImmune,medimmune,,,,2e8e4fb4-3915-4ead-8787-31c5f3981781,medimmune_llc,"MedImmune, LLC" +1681,,33fbc167-b9f9-4c28-a5cb-e041d9855c57,DR. REDDY'S LABORATORIES LIMITED,dr_reddy_s_laboratories_limited,,,,,, +1682,,062d6d72-ff95-4af5-85e0-404fff16b5af,Piramal Imaging SA,piramal_imaging_sa,,,,,, +1683,,ecc38fbc-9d67-4dcc-b201-407b9e58231c,"Versartis, Inc",versartis_inc,,,,,, +1684,,79ed562e-523d-4391-9046-60359932153d,MedQuality Forschung GmbH,medquality_forschung_gmbh,,,,,, +1685,,9a913b45-fd3b-4b6f-aaaf-05ee836596f8,CHU de Montpellier,chu_de_montpellier,,,,,, +617,0.98493295907974243,667dc3b3-c538-4b51-a2ab-8386933ed203,Grupo Español de Investigación en Sarcomas (GEIS),grupo_espa_ol_de_investigaci_n_en_sarcomas_geis,,,,0359d070-d59d-4dab-8d3e-cdb60bbcff96,grupo_espa_ol_de_investigaci_n_en_sarcomas,Grupo Español de Investigación en Sarcomas +1686,,f6f5a328-7166-11e6-a0cd-0242ac12000b,UNIV TX MD ANDERSON,univ_tx_md_anderson,,,,,, +1687,,c8643d05-f1ec-4ea3-8bb0-f4ca43872b1e,EURAND SPA,eurand_spa,,,,,, +1688,,57d08e82-d0aa-4362-b310-5ee9d82fa714,Annadalstichting,annadalstichting,,,,,, +1689,,bf86a27a-c318-4762-9d95-b3157aa44e38,"Peninsula Pharmaceuticals, Inc",peninsula_pharmaceuticals_inc,,,,,, +1690,,ef3ee494-7c3e-40e4-95a6-5d6df7d1592a,World Health Organization,world_health_organization,,,,,, +1691,,8f9bf5c6-f57d-4362-a53c-251a4fde6303,ST. ANNA KINDERKREBSFORSCHUNG e.V,st_anna_kinderkrebsforschung_e_v,,,,,, +1692,,2a31f017-0e0f-4e9f-b5ef-762d94edab22,Natural Pharma International Npi AB,natural_pharma_international_npi_ab,,,,,, +541,0.98826968669891357,fe3bcde9-71bd-4309-b7ec-09a0bd998c85,Fournier Laboratories Ireland,fournier_laboratories_ireland,,,,06598f56-3fa1-48ed-824d-b88b0bafc1ab,fournier_laboratories_ireland_fli,Fournier Laboratories Ireland (FLI) +1693,,e6569a11-9394-47ad-b4fe-4127a0fdc037,Medical University of Graz - Division of Endocrinology and Metabolism,medical_university_of_graz_division_of_endocrinology_and_metabolism,,,,,, +1694,,65790c05-fea4-413c-b6d7-8a988c7de18a,Novartis PharmaServices AG,novartis_pharmaservices_ag,,,,,, +1695,,70ab1f98-66dc-4bca-9412-68352a646048,Sebastiano Biondo Aglio,sebastiano_biondo_aglio,,,,,, +1696,,a180e828-2504-487f-9b6c-7013280e0462,"National Heart, Lung, and Blood Institute / National Institutes of Health",national_heart_lung_and_blood_institute_national_institutes_of_health,,,,,, +1697,,ceea2b69-369e-4fa1-bdd4-fcc09e4a6b08,University Hospital of North Norway,university_hospital_of_north_norway,,,,,, +1698,,64c7bcfc-5512-42c9-b184-ca30a2c2e148,CYTHERIS,cytheris,,,,,, +1699,,235385bb-94be-465d-b4cd-a76c1a6f50e8,Litaphar S.L,litaphar_s_l,,,,,, +1700,,9e582489-8e87-4b80-be4c-28c3494ec9e6,"Free State of Bavaria rep. by the Univ. of Regensburg, rep. by the Regensburg Univ. Hospital",free_state_of_bavaria_rep_by_the_univ_of_regensburg_rep_by_the_regensburg_univ_hospital,,,,,, +142,0.985676,3467328a-7167-11e6-a0cd-0242ac12000b,BRIGHAM WOMENS,brigham_womens,,,,32a060d4-7167-11e6-a0cd-0242ac12000b,brigham_womens_hosp,BRIGHAM WOMENS HOSP +229,0.985968,458254a2-d310-4f72-a0ef-d961ef0c56e4,The National Institute of Allergy and Infectious Diseases (NIAID) And The Eunice Kennedy Shriver NICHD,the_national_institute_of_allergy_and_infectious_diseases_niaid_and_the_eunice_kennedy_shriver_nichd,,,,458254a2-d310-4f72-a0ef-d961ef0c56e4,the_national_institute_of_allergy_and_infectious_diseases_niaid_and_the_eunice_kennedy_shriver_nichd,The National Institute of Allergy and Infectious Diseases (NIAID) And The Eunice Kennedy Shriver NICHD +1701,,98ff4a8d-9011-429f-9c2f-4eef1084cbc6,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (referred to as Merck)",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_referred_to_as_merck,,,,,, +1702,,396417d0-94f6-41de-a34a-5bfff20b7c78,MedImmune Ltd,medimmune_ltd,,,,,, +1703,,2b7e9abb-f2a5-4163-92f3-d3d7201291e5,Laboratorios Biomendi S.A.U,laboratorios_biomendi_s_a_u,,,,,, +1704,,32d3b0b3-13de-42b8-b6bf-2e84d43173f6,Universiteit Utrecht,universiteit_utrecht,,,,,, +1705,,f483e308-a1e7-4d2a-88d7-ba84bc289e56,Autifony Therapeutics Limited,autifony_therapeutics_limited,,,,,, +1706,,f9d6fd22-e7e1-4989-81d2-16bb01719f36,"Medical University Vienna, Dept. of Medicine I, Clinical Division of Oncology",medical_university_vienna_dept_of_medicine_i_clinical_division_of_oncology,,,,,, +1707,,e944e7a9-f50b-4f25-bcf5-7daefb39030b,ANRS,anrs,,,,,, +1708,,5dad3781-0f5e-40fd-9a16-4d563082836d,CHRU Montpellier,chru_montpellier,,,,,, +1709,,daf54d0c-2a4a-4361-bb58-4f3fee918b18,sanna kivivuori,sanna_kivivuori,,,,,, +1710,,db914e93-2026-47c2-9577-0af29a025a9a,Dept. of Clinical Pharmacology,dept_of_clinical_pharmacology,,,,,, +329,0.977699,00c3e472-71cc-11e6-a0cd-0242ac12000b,ABBOTT LABS,abbott_labs,,,,00c3e472-71cc-11e6-a0cd-0242ac12000b,abbott_labs,ABBOTT LABS +1711,,649854a8-56ee-48be-9952-b733b90511b4,SANT JOAN DE DEU - SSM,sant_joan_de_deu_ssm,,,,,, +1712,,a04a830a-2b43-4ba9-a020-65fb0fe9f467,University of the Saarland,university_of_the_saarland,,,,,, +1713,,dd81105c-6cd9-4432-a592-4af8a76ed18c,"Charité Campus Mitte, Klinik für Psychiatrie und Psychotherapie",charit_campus_mitte_klinik_f_r_psychiatrie_und_psychotherapie,,,,,, +1714,,2615ed6f-d98a-484b-938b-5a51b2f4907e,Marc Miratvilles,marc_miratvilles,,,,,, +1715,,b53fc831-1e38-4416-a745-c2b1022d0235,Birmingham Heartlands Hospital,birmingham_heartlands_hospital,,,,,, +1716,,667dc7a0-a439-4dd1-af99-e4163a661a09,Archemix Corp,archemix_corp,,,,,, +679,0.967014,73f44df3-f258-476a-8ae7-6cb143e4cbb3,CHU Angers,chu_angers,,,,73f44df3-f258-476a-8ae7-6cb143e4cbb3,chu_angers,CHU Angers +160,0.97712674140930178,ce27e24e-62ac-42de-a596-4ceed67e634f,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,,,,ce27e24e-62ac-42de-a596-4ceed67e634f,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón +1717,,f9ecaf09-8531-4b39-8ac4-1f039af9e443,Allergie-Centrum-Charité,allergie_centrum_charit,,,,,, +1718,,b766804d-0b81-4efe-a697-d4395724a2f5,ISTITUTO DERMOPATICO IMMACOLATA,istituto_dermopatico_immacolata,,,,,, +1719,,f69169d5-449c-41a9-bbb1-553e75402c43,Paediatric European Network for Treatment of AIDS (PENTA) Foundation,paediatric_european_network_for_treatment_of_aids_penta_foundation,,,,,, +217,0.983343,32ba4b51-aea2-4074-88ac-a23bc5b63b1d,TRANSGENE S.A,transgene_s_a,,,,32ba4b51-aea2-4074-88ac-a23bc5b63b1d,transgene_s_a,TRANSGENE S.A +1720,,6f9b737c-a23d-4ff4-8adf-4eb2e8ff9eb9,Institute of Hematology and Blood Transfusion,institute_of_hematology_and_blood_transfusion,,,,,, +1721,,037c0b04-6a0f-4522-9217-2403bfaab5d5,"Luitpold Pharmaceuticals, Inc",luitpold_pharmaceuticals_inc,,,,,, +1722,,370cd0ae-73f0-11e6-a0cd-0242ac12000b,LINDE GAS PUERTO RICO INC,linde_gas_puerto_rico_inc,,,,,, +435,0.9795151948928833,aad2d334-ecaa-4920-9328-b23c18f3711d,Pfizer Inc,pfizer_inc,,,,aad2d334-ecaa-4920-9328-b23c18f3711d,pfizer_inc,Pfizer Inc +1723,,ef07bfbc-7a26-4343-843d-50dfaa8b19cc,fonds NutsOhra,fonds_nutsohra,,,,,, +1724,,c417e40d-e9f5-49da-a1df-920becf3d586,UNIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II,universita_degli_studi_di_napoli_federico_ii,,,,,, +1725,,aa2cd280-2abb-4f9c-b363-4a13d742e2a6,Engelhard Arzneimittel GmbH & Co.KG,engelhard_arzneimittel_gmbh_co_kg,,,,,, +1726,,4bb79ea4-7192-11e6-a0cd-0242ac12000b,TURING PHARMS AG,turing_pharms_ag,,,,,, +1727,,cfcd7a65-345b-4278-a665-81a0a651b897,ISTITUTO NAZIONALE DI RICOVERO E CURA PER ANZIANI IRCCS,istituto_nazionale_di_ricovero_e_cura_per_anziani_irccs,,,,,, +1728,,5f4bf1c9-4d42-4361-9c61-65c56aeb9dc7,Ferring Pharmaceuticals Ltd,ferring_pharmaceuticals_ltd,,,,,, +1729,,d239e02e-e325-4c51-afd8-355f68b1ffd0,The Nordic Colorectal Cancer Biomodulation Group,the_nordic_colorectal_cancer_biomodulation_group,,,,,, +1006,0.9811970591545105,76940d77-7350-4137-8034-dc7c3c7289ad,Folktandvården Östergötland,folktandv_rden_sterg_tland,,,,76940d77-7350-4137-8034-dc7c3c7289ad,folktandv_rden_sterg_tland,Folktandvården Östergötland +859,0.9885413646697998,2030c40f-9eb7-4a24-af68-69c831c5fc3c,Deutsches Krebsforschungszentrum (DKFZ,deutsches_krebsforschungszentrum_dkfz,,,,2030c40f-9eb7-4a24-af68-69c831c5fc3c,deutsches_krebsforschungszentrum_dkfz,Deutsches Krebsforschungszentrum (DKFZ +1730,,14b1b853-d25d-41fe-aa32-f210b92deb6f,IGENEON,igeneon,,,,,, +1731,,4fcb48c0-1222-46c1-af12-63b27308177a,"Center of Pediatrics and Neonatology, Asklepios Clinic Sankt Augustin",center_of_pediatrics_and_neonatology_asklepios_clinic_sankt_augustin,,,,,, +1060,0.98586,3430485d-03ef-4333-85f5-fa9ef76f501b,FONDAZIONE PENTA ONLUS,fondazione_penta_onlus,,,,0b2aae39-94a4-4319-927d-68470e818403,fondazione_penta,FONDAZIONE PENTA +1732,,2c8410c0-d199-43a4-8886-a62b1a98e841,Lone Baandrup,lone_baandrup,,,,,, +1733,,caad583f-6a89-410d-aa0f-9603961e6e5a,TAP Pharmaceutical Products Inc,tap_pharmaceutical_products_inc,,,,,, +1734,,41be5dd3-4eec-4b3f-a84f-c91a6ac92606,Anestesikliniken,anestesikliniken,,,,,, +277,0.97426038980484009,cbb2332f-d8b9-460f-9726-3b2352f5f93e,"Teva Branded Pharmaceutical Product R&D, Inc",teva_branded_pharmaceutical_product_r_d_inc,,,,71fa3658-cdd0-4248-b428-53aae9afea66,teva_branded_pharmaceutical_products_r_d_inc,"Teva Branded Pharmaceutical Products R&D, Inc" +267,0.989332,9e2eb0ad-e2df-43f2-bc5d-f12af02311cf,Grupo de Tratamiento de los Tumores Digestivos,grupo_de_tratamiento_de_los_tumores_digestivos,,,,9e2eb0ad-e2df-43f2-bc5d-f12af02311cf,grupo_de_tratamiento_de_los_tumores_digestivos,Grupo de Tratamiento de los Tumores Digestivos +1735,,ce5ef201-e345-4079-9735-896e1b9b1701,Independent Pharmaceutica AB,independent_pharmaceutica_ab,,,,,, +1736,,d9bdf04d-d0d3-441b-ae5f-b1cbca412121,Wyeth Vaccines Research,wyeth_vaccines_research,,,,,, +1737,,1dc91b7b-7f14-4aa2-970a-9a1d94667f7f,Cork Cancer Research Centre,cork_cancer_research_centre,,,,,, +1738,,c5e1865f-c691-4402-9cc2-6124df926dcb,"Pfizer Limited, Ramsgate Road, Sandwich, CT13 9NJ Kent, UK",pfizer_limited_ramsgate_road_sandwich_ct13_9nj_kent_uk,,,,,, +1739,,702a8968-ef6c-4193-ad42-6ac7c0367054,Christos N. Papandreou,christos_n_papandreou,,,,,, +1740,,dc2d0d37-aaf7-408e-a12e-6e4bcf7bc1a8,Dutch Diabetes Research Foundation,dutch_diabetes_research_foundation,,,,,, +1741,,031b01e6-f574-433c-ad39-f7c2d89a0f42,Ipsen Scandinavia,ipsen_scandinavia,,,,,, +1742,,c10d0e68-b5a2-46f5-bc61-3c1af46f2b9a,MSD ITALIA S.R.L,msd_italia_s_r_l,,,,,, +725,0.989909,a3c58291-967d-4ff8-998b-c8bf14553b5d,National Institute of Allergy and Infectious Diseases (NIAID),national_institute_of_allergy_and_infectious_diseases_niaid,,,,1ad9c652-f097-480c-b6e9-4e1f4c988f0c,national_institute_of_allergy_and_infectious_diseases_niaid_nih,"National Institute of Allergy and Infectious Diseases (NIAID), NIH" +1743,,2403ecb9-6f93-4822-a9a1-9202fd1bced8,"Civitas Therapeutics, a wholly owned subsidiary of Acorda",civitas_therapeutics_a_wholly_owned_subsidiary_of_acorda,,,,,, +1744,,0b362f6f-7355-4737-bfcf-98e319528352,NephroGenex,nephrogenex,,,,,, +1745,,a5eeab32-1bce-4baf-9a64-542f1697780c,Alcon d.o.o,alcon_d_o_o,,,,,, +601,0.969108,0cbd210d-2ea8-4bc2-85dc-5959ed1c55ad,CHU de Saint-Étienne,chu_de_saint_tienne,,,,0cbd210d-2ea8-4bc2-85dc-5959ed1c55ad,chu_de_saint_tienne,CHU de Saint-Étienne +1746,,34d88fb6-73f1-11e6-a0cd-0242ac12000b,AIRGAS CARBONIC INC,airgas_carbonic_inc,,,,,, +1747,,4223cf2b-388b-4e3a-9765-c5c16c557d31,Regents of the University of Minnesota,regents_of_the_university_of_minnesota,,,,,, +1748,,4c1d2586-d9c6-4d2d-80fb-d19fcc24a793,Orphazyme ApS,orphazyme_aps,,,,,, +950,0.97788405418395996,389af5e7-be5f-4143-aff1-2c121f2ec673,"MedImmune LLC (a wholly owned subsidiary of AstraZeneca PLC, One MedImmune Way, Gaithersburg, Maryland, 20878, USA)",medimmune_llc_a_wholly_owned_subsidiary_of_astrazeneca_plc_one_medimmune_way_gaithersburg_maryland_20878_usa,,,,389af5e7-be5f-4143-aff1-2c121f2ec673,medimmune_llc_a_wholly_owned_subsidiary_of_astrazeneca_plc_one_medimmune_way_gaithersburg_maryland_20878_usa,"MedImmune LLC (a wholly owned subsidiary of AstraZeneca PLC, One MedImmune Way, Gaithersburg, Maryland, 20878, USA)" +1749,,61a66732-9a2d-4643-b0b2-fd474ff0bca8,"Kliniken för onkologi, Karolinska Universitetssjukhuset, Solna",kliniken_f_r_onkologi_karolinska_universitetssjukhuset_solna,,,,,, +1750,,4e443485-3308-4c89-8a73-35e50e9f1312,"Paracelsus Mediznische Privatuniversität, Universitätsklinik für Anästhesiologie, perioperative Medizin und Intensiv",paracelsus_mediznische_privatuniversit_t_universit_tsklinik_f_r_an_sthesiologie_perioperative_medizin_und_intensiv,,,,,, +1751,,bf0a3bad-54b6-494d-b385-b694a0fa2c95,"Amersham Health, S.A. (filial de GE Healthcare Ltd)",amersham_health_s_a_filial_de_ge_healthcare_ltd,,,,,, +1752,,e129b142-79f0-41ac-96c1-4ff2569f42f2,Antonio Pérez Martínez,antonio_p_rez_mart_nez,,,,,, +1753,,fa98cfd2-73fa-11e6-a0cd-0242ac12000b,ARDEA BIOSCIENCES,ardea_biosciences,,,,,, +798,0.98433560132980347,1725fbdf-53a4-4e4e-bb56-b7af6038a3c4,Technische Universität München,technische_universit_t_m_nchen,,,,1466a25b-707c-4fd6-8cf9-33dfd10f0436,technische_universit_t_m_nchen_fakult_t_f_r_medizin,Technische Universität München Fakultät für Medizin +1754,,924a5f66-730c-4206-a311-ffdd56f4df4b,Sheffield Teaching Hospitals NHS Foundation Trust,sheffield_teaching_hospitals_nhs_foundation_trust,,,,,, +1755,,60001aea-a91a-4e99-89a3-37ed16f6ea17,ProFibrix Inc,profibrix_inc,,,,,, +809,0.98034405708312988,bd7e81dd-23da-4ec0-b236-7fde1685bf76,Biogen MA,biogen_ma,,,,9aa84ae0-f050-4e53-93f9-888fa0e9a08e,biogen,Biogen +1756,,f681405c-906f-4c1b-8c3b-073a5951dd7d,"Enturia, Inc",enturia_inc,,,,,, +1757,,2ed6045a-73f0-11e6-a0cd-0242ac12000b,LINDE MERCHANT PRODUCTIONS INC,linde_merchant_productions_inc,,,,,, +382,0.98027,37341944-6d19-4843-a80d-f568e4d60ef1,BIOMARIN,biomarin,,,,37341944-6d19-4843-a80d-f568e4d60ef1,biomarin,BIOMARIN +770,0.984713,1a3a35f8-7142-11e6-a0cd-0242ac12000b,DELCOR ASSET CORP,delcor_asset_corp,,,,1a3a35f8-7142-11e6-a0cd-0242ac12000b,delcor_asset_corp,DELCOR ASSET CORP +107,0.950967,63b03e43-7f22-494c-8b54-c8682235d858,FONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI,fondazione_michelangelo_avanzamento_dello_studio_e_cura_dei_tumori,,,,63b03e43-7f22-494c-8b54-c8682235d858,fondazione_michelangelo_avanzamento_dello_studio_e_cura_dei_tumori,FONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI +1758,,3ed6a762-6b3a-400c-913f-544f41f1354b,University Clinic Essen,university_clinic_essen,,,,,, +1018,0.97652915120124817,ccd67b13-6ac6-4275-ad27-b525f9e3df71,Southampton University Hospitals NHS Trust R&D department,southampton_university_hospitals_nhs_trust_r_d_department,,,,4be171c0-8ae0-4db6-b193-567f4e972c15,southampton_university_hospitals_nhs_trust,Southampton University Hospitals NHS Trust +491,0.9828302264213562,280c153e-a191-46ae-8ddc-97dc33b90bb5,GlaxoSmithKline SIA Latvia,glaxosmithkline_sia_latvia,,,,280c153e-a191-46ae-8ddc-97dc33b90bb5,glaxosmithkline_sia_latvia,GlaxoSmithKline SIA Latvia +1759,,55387cc9-fc58-49ea-8651-ff616923eb32,University Hospital of North Tees and Hartlepool,university_hospital_of_north_tees_and_hartlepool,,,,,, +1760,,b9ae01f7-4e1a-497a-b1f3-efbe526bfe09,Winthrop Arzneimittel GmbH,winthrop_arzneimittel_gmbh,,,,,, +1761,,92001494-73f5-11e6-a0cd-0242ac12000b,ROCKWELL MEDICAL INC,rockwell_medical_inc,,,,,, +389,0.989307,be278fc2-12cf-407f-ae31-824dbfaec721,Ludwig Institute for Cancer Research Ltd,ludwig_institute_for_cancer_research_ltd,,,,b0142515-efdf-489a-bd08-d53f5508a4ba,ludwig_institute_for_cancer_research,Ludwig Institute for Cancer Research +1762,,0772d669-b445-412f-a1d5-4d8bf9922567,"Faculty of Odontology, University of Iceland",faculty_of_odontology_university_of_iceland,,,,,, +1763,,ee29af86-739c-11e6-a0cd-0242ac12000b,AYTU PHARMS,aytu_pharms,,,,,, +1052,0.92084199190139771,4ff0ee50-4cfc-45a7-a15d-7a978e624e6a,University of Oxford Clinical Trials & Research Governance,university_of_oxford_clinical_trials_research_governance,,,,574a16cb-eb53-4e25-95a2-a07455968d04,university_of_oxford_clinical_trials_and_research_governance,"University of Oxford, Clinical Trials and Research Governance Office" +1764,,52a4f6db-b249-4be0-84ba-aeefbc97a970,Christian Westergaard,christian_westergaard,,,,,, +172,0.96958163380622864,6fbfcc91-00e1-4cd8-990a-361431274d3f,"Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt",merck_serono_international_a_branch_of_laboratoires_serono_sa_an_affiliate_of_merck_kgaa_darmstadt,,,,4d103db0-46f8-458b-804a-442a7728fad2,merck_serono_international_a_branch_of_laboratoires_serono_sa_an_affiliate_of_merck_kgaa,"Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA" +1765,,91e678cd-83cd-4810-bebe-99dec4bfa1a4,InflaRx GmbH,inflarx_gmbh,,,,,, +1766,,a57aed91-f1a7-49f6-b421-459da2900d25,Gebro Pharma,gebro_pharma,,,,,, +1767,,fd272b94-06e5-44bf-849e-0af05fa45af9,Center for Neuropsychiatric Schizophrenia Research,center_for_neuropsychiatric_schizophrenia_research,,,,,, +650,0.95941996574401855,2c7b1b3b-323c-4045-ae75-4712a0ece886,Boehringer Ingelheim Austria GmbH,boehringer_ingelheim_austria_gmbh,,,,2c7b1b3b-323c-4045-ae75-4712a0ece886,boehringer_ingelheim_ab,Boehringer Ingelheim AB +1768,,9930a4cb-eaba-490f-b1da-d6e709c10f8e,"Grifols Therapeutics, Incorporated",grifols_therapeutics_incorporated,,,,,, +1769,,c4ff97f3-bd70-465c-9e83-370777fb28b4,Francisco Muñoz Negrete,francisco_mu_oz_negrete,,,,,, +1770,,dc7ced28-7164-11e6-a0cd-0242ac12000b,STANDARD CHEM PHARM,standard_chem_pharm,,,,,, +1771,,794987f2-7187-11e6-a0cd-0242ac12000b,AMYLIN PHARMS LLC,amylin_pharms_llc,,,,,, +1772,,0843cdbb-a3fc-42b2-96f9-304b57c4408b,"Strahlenklinik, Universitätsklinikum Erlangen, insoweit handelnd für den Freistaat Bayern",strahlenklinik_universit_tsklinikum_erlangen_insoweit_handelnd_f_r_den_freistaat_bayern,,,,,, +659,0.989406,3b17812c-fdb5-4544-97fd-496a11299fc7,Swedish Institute for Infectious Disease Control (SMI),swedish_institute_for_infectious_disease_control_smi,,,,3b17812c-fdb5-4544-97fd-496a11299fc7,swedish_institute_for_infectious_disease_control_smi,Swedish Institute for Infectious Disease Control (SMI) +1773,,3ad28e3a-7162-11e6-a0cd-0242ac12000b,MAYRAND,mayrand,,,,,, +1774,,6f97c3cf-38f6-4898-9dbf-8c6b7eb2e4b5,Delta Crystallon B.V,delta_crystallon_b_v,,,,,, +1775,,13d09747-bdbf-4dbc-a32a-7ce744cc6935,Landstinget i Värmland,landstinget_i_v_rmland,,,,,, +1776,,fb686767-51f3-470c-9ec1-1596beeb4f76,Juha Hartikainen,juha_hartikainen,,,,,, +1045,0.98760741949081421,fa200595-3ec2-4548-b852-3a8525fbfc68,Synta Pharmaceuticals Corp,synta_pharmaceuticals_corp,,,,558c49d6-0383-4c86-9ba7-9561b98f7845,synta_pharmaceuticals_corporation,Synta Pharmaceuticals Corporation +1777,,4d37bd41-f850-4a78-ba68-2cd5698f421e,Norfolk and Norwich University Hospitals NHS Trust,norfolk_and_norwich_university_hospitals_nhs_trust,,,,,, +1778,,aaf924b5-9379-4589-95f4-f8b9c539d14d,GP-Pharm s.a,gp_pharm_s_a,,,,,, +1779,,7631b99e-7372-4b6c-97be-8a017639d08e,Oriel Therapeutics Inc,oriel_therapeutics_inc,,,,,, +1780,,b04e3b85-0c34-4859-a85f-96dec575bfeb,CHU of Rennes,chu_of_rennes,,,,,, +1781,,0c304dd2-6fa6-11e6-9663-0242ac12000b,GRIFOLS S.A,grifols_s_a,,,,,, +1782,,a790a4f6-71a0-11e6-a0cd-0242ac12000b,GEN ELECTRIC,gen_electric,,,,,, +1783,,63f0dd0a-7165-11e6-a0cd-0242ac12000b,ENDO PHARMS INC,endo_pharms_inc,,,,,, +258,0.98775,64f7d7d9-e504-4ff5-a540-55635d4c61d0,Karolinska Universitetssjukhuset Huddinge,karolinska_universitetssjukhuset_huddinge,,,,64f7d7d9-e504-4ff5-a540-55635d4c61d0,karolinska_universitetssjukhuset_huddinge,Karolinska Universitetssjukhuset Huddinge +1784,,0051517f-62c3-4d9b-bed2-8725a1f613f0,Haga Hospital,haga_hospital,,,,,, +1785,,4b48463b-084b-419a-9ec5-957998cde2d9,Eli Lilly Nederland,eli_lilly_nederland,,,,,, +469,0.985292,55158cf1-cd99-4f28-8043-743b9a161005,OSPEDALE S. RAFFAELE,ospedale_s_raffaele,,,,55158cf1-cd99-4f28-8043-743b9a161005,ospedale_s_raffaele,OSPEDALE S. RAFFAELE +1786,,7eca731c-f233-4aa8-b95e-b86da832638f,CELSION CORPORATION,celsion_corporation,,,,,, +1787,,45498b8d-ca2e-4466-87dc-296da43d3b5c,Portsmouth Hospitals Trust,portsmouth_hospitals_trust,,,,,, +548,0.98087829351425171,0ea42022-8be2-11e6-a449-0242ac12000b,FERRING SPA,ferring_spa,,,,0ea42022-8be2-11e6-a449-0242ac12000b,ferring_spa,FERRING SPA +1788,,82ffe76d-d02d-4d6d-b6c4-e90ee665add6,Westpfalz-Klinikum GmbH,westpfalz_klinikum_gmbh,,,,,, +893,0.9773980975151062,2f028fcc-7872-4732-95a8-d0e74e80f7ae,"Aarhus Universitetshospital, Aarhus Sygehus THG",aarhus_universitetshospital_aarhus_sygehus_thg,,,,2f028fcc-7872-4732-95a8-d0e74e80f7ae,aarhus_universitetshospital_aarhus_sygehus_thg,"Aarhus Universitetshospital, Aarhus Sygehus THG" +1789,,57cc8305-046c-4feb-a838-b1f1b94e5746,University Of Tuebingen,university_of_tuebingen,,,,,, +45,0.90533584356307983,7c8f44a5-f228-4272-a17a-08c93ebdc8bd,"Medicinsk Forskning, Regionshospitalet Holstebro",medicinsk_forskning_regionshospitalet_holstebro,,,,7c8f44a5-f228-4272-a17a-08c93ebdc8bd,medicinsk_forskning_regionshospitalet_holstebro,"Medicinsk Forskning, Regionshospitalet Holstebro" +1790,,01e2370c-7148-11e6-a0cd-0242ac12000b,MYLAN TECHNOLOGIES,mylan_technologies,,,,,, +1791,,9e5c0088-720e-11e6-a0cd-0242ac12000b,MYLAN BERTEK,mylan_bertek,,,,,, +1792,,ea2ff3d2-6fcd-4354-9862-2fdc61d725ed,Infirst+ HEALTHCARE Ltd,infirst_healthcare_ltd,,,,,, +1793,,3064beba-c138-40ae-bc49-a3cbd7434374,Univ. Prof. Dr. Markus Peck-Radosavljevic,univ_prof_dr_markus_peck_radosavljevic,,,,,, +63,0.983835,e11289fe-0824-4834-8ad2-2124b9651048,Clínica Universidad de Navarra/Universidad de Navarra,cl_nica_universidad_de_navarra_universidad_de_navarra,,,,01a1f7f6-8bc3-11e6-a449-0242ac12000b,cl_nica_universidad_de_navarra,Clínica Universidad de Navarra +1794,,429ebcd5-1315-4722-9ae8-f88f6da5623d,Merck Serono The Netherlands - a division of Merck B.V,merck_serono_the_netherlands_a_division_of_merck_b_v,,,,,, +1795,,bdbe7941-f515-48fa-9501-28cd26f1d3bc,ECUPHARMA S.R.L,ecupharma_s_r_l,,,,,, +1018,0.97911614179611206,4be171c0-8ae0-4db6-b193-567f4e972c15,Southampton University Hospitals NHS Trust,southampton_university_hospitals_nhs_trust,,,,4be171c0-8ae0-4db6-b193-567f4e972c15,southampton_university_hospitals_nhs_trust,Southampton University Hospitals NHS Trust +917,0.986946,5cdbde15-83c4-4b59-a418-8452d890ac4e,Bristol Myers Squibb,bristol_myers_squibb,,,,5cdbde15-83c4-4b59-a418-8452d890ac4e,bristol_myers_squibb,Bristol Myers Squibb +1796,,94a38a2b-7b09-4362-af09-40f00f3651eb,AZIENDA USL 4 PRATO,azienda_usl_4_prato,,,,,, +1071,0.9851963222026825,27a87295-855d-4f98-b9d7-56d99260317a,University College Dublin,university_college_dublin,,,,a1ac5ed3-48d6-4b25-be01-f8fe60a9d1d6,university_college_dublin,University College Dublin +1797,,c4d552c3-5287-46af-b360-ca25ed645657,Nordic Society for Gynecologic Oncology,nordic_society_for_gynecologic_oncology,,,,,, +1798,,114eebc4-6abb-4948-8ad7-126e70506078,Fundacion General Universidad de Valladolid,fundacion_general_universidad_de_valladolid,,,,,, +1799,,c15ada7f-d95f-4de2-b339-07138afe75d4,"GeneCare Research Institute Co., Ltd",genecare_research_institute_co_ltd,,,,,, +1800,,65c4723b-4e35-4351-a268-5667b99dfbb5,Nicanor Vega Diaz. Hospital Universitario de Gran Canaria Dr Negrin,nicanor_vega_diaz_hospital_universitario_de_gran_canaria_dr_negrin,,,,,, +1801,,2bec3268-7167-11e6-a0cd-0242ac12000b,WI MEDCL CYCLOTRON,wi_medcl_cyclotron,,,,,, +1802,,d24ca47f-7ab5-4a3b-a34f-ecca8632cb38,Alcon Pharma GmbH,alcon_pharma_gmbh,,,,,, +1803,,d271a623-8816-4bb9-8781-5031005ca930,NeuroVive Pharmaceutical AB,neurovive_pharmaceutical_ab,,,,,, +490,0.98192024230957031,024a3a7c-59ae-4694-93a8-645207bf73b5,Radboud University Medical Center Nijmegen,radboud_university_medical_center_nijmegen,,,,3fd47231-c0e0-48e2-9df1-24e6ff72daf7,radboud_university_medical_center,Radboud University Medical Center +1804,,19e97c24-288c-4077-bbe8-0bdb9d6240f5,Kamada Limited,kamada_limited,,,,,, +1805,,510c9ba3-a208-425c-9dba-54134fe07c98,Centre d'Etude des Cellules Souches (CECS),centre_d_etude_des_cellules_souches_cecs,,,,,, +1806,,4797a425-aabd-4e5d-a3ae-a5325e9b9194,Bonaventura Clotet/Ramón Planas/Ricard Solá,bonaventura_clotet_ram_n_planas_ricard_sol,,,,,, +1807,,21238b73-c8d7-4838-bbb0-dea892858a45,GEMCAD (Grupo Español Multidisciplinar en Cáncer Digestivo),gemcad_grupo_espa_ol_multidisciplinar_en_c_ncer_digestivo,,,,,, +1808,,6542cb0a-e35e-4aea-9fda-aa75d5627098,Laboratoires Menarini France,laboratoires_menarini_france,,,,,, +1809,,74a8c146-a754-11e6-94cb-5656d04fc2b5,FUNDACIÓN INVESTIGACIÓN BIOMÉDICA HOSPITAL PUERTA DE HIERRO,fundaci_n_investigaci_n_biom_dica_hospital_puerta_de_hierro,,,,,, +1810,,c614bf11-a9e1-4a7f-ad61-00bba7225e26,Uppsala Clinical Research Center,uppsala_clinical_research_center,,,,,, +240,0.987416,61f718c1-8bf2-4352-81a1-859abc44901a,MEDIMMUNE ONCOLOGY INC,medimmune_oncology_inc,,,,61f718c1-8bf2-4352-81a1-859abc44901a,medimmune_oncology_inc,MEDIMMUNE ONCOLOGY INC +1811,,8da9f322-bdad-43fb-8a5c-368cf7b951cc,Swansea NHS Trust,swansea_nhs_trust,,,,,, +1812,,3bb71aae-35fa-404b-9e79-2bd8f474163e,"Universitätsklinikum Schleswig-Holstein, Campus Lübeck: Klinik für Strahlentherapie",universit_tsklinikum_schleswig_holstein_campus_l_beck_klinik_f_r_strahlentherapie,,,,,, +1813,,8fc520eb-d559-4c92-baf2-e5382511cbe4,"Div. of Cardiology, Innsbruck Medical University",div_of_cardiology_innsbruck_medical_university,,,,,, +1814,,b8335c71-bdb8-4660-a641-4dc3e6179948,zna middelheim,zna_middelheim,,,,,, +1815,,7e718175-17e5-485c-b25d-62abc5193d2c,"Universitätsklinikum Mannheim, Klinik für Anästhesiologie",universit_tsklinikum_mannheim_klinik_f_r_an_sthesiologie,,,,,, +1816,,9f400bdb-ee02-446a-b67d-2ef8ffc4ce7c,GEMCAD,gemcad,,,,,, +64,0.986698,fbd4d1d9-2f52-4351-ba24-4bdbabfea4ac,Wilhelmina Children's Hospital,wilhelmina_children_s_hospital,,,,ccc2695d-93a7-4900-a3b6-e4bb0c11c688,wilhelmina_children_s_hospital_umc_utrecht,Wilhelmina Children's Hospital/UMC Utrecht +1817,,bd335916-72db-11e6-a0cd-0242ac12000b,DEPOMED INC,depomed_inc,,,,,, +1818,,e4d1bbe3-6a2a-412d-b236-8a6c0f1acdf6,"Dept. of Pediatrics, The Childrens Hospital, Denver",dept_of_pediatrics_the_childrens_hospital_denver,,,,,, +1819,,96379a55-56a6-4583-ba69-a8873b750d51,"Rhythm Pharmaceuticals, Inc",rhythm_pharmaceuticals_inc,,,,,, +1820,,7c259332-716c-11e6-a0cd-0242ac12000b,SERONO INC,serono_inc,,,,,, +1821,,7d5d838d-d2cf-446f-b244-45fc710503d6,"Department of hospital Pharmacy, Medical Centre Haaglanden",department_of_hospital_pharmacy_medical_centre_haaglanden,,,,,, +1822,,619f7fb2-fe0d-45bb-b553-766565755af4,PIERRE FABRE PHARMA,pierre_fabre_pharma,,,,,, +1823,,d3fcb59f-91bf-430b-97f8-14e4417f9b49,Fundació de Recerca de L?Institut de Microcirurgia Ocular,fundaci_de_recerca_de_l_institut_de_microcirurgia_ocular,,,,,, +1824,,c15a785e-49ec-4983-b92b-bbc35d48dc21,"Schering Corporation, a Subsidiary of Merck & Co., Inc",schering_corporation_a_subsidiary_of_merck_co_inc,,,,,, +1825,,4d1a6e85-c2ea-4a2d-872f-f5d66e239268,Maria Fernanda Pedrero Escalas,maria_fernanda_pedrero_escalas,,,,,, +1826,,5f69f22a-67ff-43c9-81d5-2e8b33def10e,Elena Rubio. Consorcio Hospital General Universitario de Valencia,elena_rubio_consorcio_hospital_general_universitario_de_valencia,,,,,, +1827,,7f6a3cfb-2038-4c78-8594-550b890bc919,Glostrup University Hospital,glostrup_university_hospital,,,,,, +1828,,67530744-edeb-4c0d-b358-79de01dae181,TRICHOLOG GmbH,tricholog_gmbh,,,,,, +1829,,4f3819aa-18bb-4a39-9225-746aae6321ea,Baxter Healthcare S.A,baxter_healthcare_s_a,,,,,, +734,0.980666,b0fb7e3c-715d-11e6-a0cd-0242ac12000b,WEST WARD PHARMS,west_ward_pharms,,,,78a71c0c-715e-11e6-a0cd-0242ac12000b,west_ward,WEST WARD +1830,,14701813-d545-43ba-a0a3-cb4643c4a5e1,FUNDACIÓN IBEROAMERICANA ITACA,fundaci_n_iberoamericana_itaca,,,,,, +1831,,382624dd-3b9e-44b4-a37b-eb76e303ca8b,Transition Therapeutics Ireland Ltd,transition_therapeutics_ireland_ltd,,,,,, +1832,,ca6ea810-a6a7-11e6-94cb-5656d04fc2b5,CHC-Clinique Espérance,chc_clinique_esp_rance,,,,,, +1833,,8440d1e6-1a42-45a5-ad1c-013ad2988a09,XAVIER CARBONELL ESTRANY,xavier_carbonell_estrany,,,,,, +731,0.97176811099052429,55b1cd8b-93b6-4262-9f20-ab35fbdc2476,Bristol-Myers Squibb Internaltional Corporation,bristol_myers_squibb_internaltional_corporation,,,,55b1cd8b-93b6-4262-9f20-ab35fbdc2476,bristol_myers_squibb_international_corporation,Bristol-Myers Squibb International Corporation +1834,,f0258197-cf49-49fa-afd1-144834d722bc,BIOGEN-DOMPE` SRL,biogen_dompe_srl,,,,,, +1835,,e5d60aee-71cd-11e6-a0cd-0242ac12000b,XANODYNE PHARMS INC,xanodyne_pharms_inc,,,,,, +1836,,919a088c-0940-4457-8340-edf7b4192215,Xavier Pintó Sala,xavier_pint_sala,,,,,, +653,0.95209956169128418,e091f4a8-4358-4d9d-b90c-5f77fef3e3a6,Boehringer Ingelheim RCV GmbH & CoKG,boehringer_ingelheim_rcv_gmbh_cokg,,,,5c99ca16-39a1-4b89-bbde-8627966f253d,boehringer_ingelheim_rcv_gmbh,Boehringer Ingelheim RCV GmbH +1837,,ebe87f1f-7bf4-46df-bfa7-e7822d7f8b61,The Medicines Company UK Ltd,the_medicines_company_uk_ltd,,,,,, +1838,,89856702-7165-11e6-a0cd-0242ac12000b,HETERO LABS UNIT III,hetero_labs_unit_iii,,,,,, +1839,,eb190fce-7191-11e6-a0cd-0242ac12000b,PANRAY,panray,,,,,, +888,0.92826088837214882,76734339-1c16-4d19-ae19-293d00e7cd32,"Schering-Plough Research Institution, A Division of Schering Corporation",schering_plough_research_institution_a_division_of_schering_corporation,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" +1840,,b8bd986c-7144-11e6-a0cd-0242ac12000b,LUPIN PHARMS,lupin_pharms,,,,,, +1841,,6a5ce6bd-3b97-461e-b2b8-10953851d872,Sint Antonius Hospital,sint_antonius_hospital,,,,,, +1842,,f3443565-6688-49cb-b6e9-f6d17af8aca7,KAI Pharmaceuticals Incorporated,kai_pharmaceuticals_incorporated,,,,,, +1843,,e2f7ab95-9af5-4e45-82c5-51512fda4379,GELA-Recherche Clinique,gela_recherche_clinique,,,,,, +822,0.986019,7ea15226-d1e9-49e7-8712-7ea0bb120819,Heinrich-Heine-Universität Duesseldorf,heinrich_heine_universit_t_duesseldorf,,,,7ea15226-d1e9-49e7-8712-7ea0bb120819,heinrich_heine_universit_t_duesseldorf,Heinrich-Heine-Universität Duesseldorf +1844,,639a9148-164d-4f77-bb09-4411fb260b6e,Anne Vakkuri,anne_vakkuri,,,,,, +10,0.984827,6b476606-7236-11e6-a0cd-0242ac12000b,THE MEDICINES CO,the_medicines_co,,,,6b476606-7236-11e6-a0cd-0242ac12000b,the_medicines_co,THE MEDICINES CO +1845,,d71775f1-d1ac-4e1c-82f0-93beb26a4014,Philogen S.p.A,philogen_s_p_a,,,,,, +1846,,36ad4f56-651c-4e05-bcbe-715ece380c2f,BIOCODEX,biocodex,,,,,, +1029,0.935805,9a6febf5-845f-4a3f-9335-26042f8acfc9,EORTC - European Organisation for Research and Treatment of Cancer,eortc_european_organisation_for_research_and_treatment_of_cancer,,,,5107d29f-cc09-411e-b173-d701ced714e6,eortc_european_organization_for_research_and_treatment_of_cancer,EORTC (European Organization for Research and Treatment of Cancer) +565,0.984012,405d1fa4-2b8c-4b5a-97c9-ad8bfa9c2763,University Hospitals of Leicester - Research & Development,university_hospitals_of_leicester_research_development,,,,3bf7860d-fdab-4edb-a9b9-646110448c48,university_hospitals_of_leicester,University Hospitals of Leicester +137,0.964969,bb5a7f2b-82c6-41c8-b7b4-dd8d75806e35,University Hospitals Birmingham NHS Foundation Trust,university_hospitals_birmingham_nhs_foundation_trust,,,,0e091d56-1af6-42d9-8d7c-b1eab6a90b8a,university_hospitals_of_birmingham_nhs_foundation_trust,University Hospitals of Birmingham NHS Foundation Trust +1847,,9a42440d-102d-4b39-b424-b19051635e7e,Daiichi SankyoGmbH,daiichi_sankyogmbh,,,,,, +1848,,6d716724-7196-11e6-a0cd-0242ac12000b,VALIDUS PHARMS INC,validus_pharms_inc,,,,,, +992,0.98193579912185669,dc954dd6-f123-41b9-af61-c0fc69aba77c,Medizinische Universität Innsbruck / Univ.-Klinik für Allg. u. Chirurg. Intensivmedizin,medizinische_universit_t_innsbruck_univ_klinik_f_r_allg_u_chirurg_intensivmedizin,,,,85bd52ce-4912-412b-98e5-33039d390569,medizinische_universit_t_innsbruck_univ_klinik_f_r_allg_u_chirurg_intensivmedizin,Medizinische Universität Innsbruck / Univ.-Klinik für Allg. u. Chirurg. Intensivmedizin +1058,0.94924008846282959,aca25ae9-a1c2-40c1-8516-239ddf48a9e1,Pfizer Hellas A.E,pfizer_hellas_a_e,,,,9f433fc9-52ae-42c8-afcf-a91a3762e82b,pfizer_hellas_ae,Pfizer Hellas AE +1849,,752c674e-6fba-11e6-abe8-0242ac12000b,Universitätspital Zürich Anästhesie,universit_tspital_z_rich_an_sthesie,,,,,, +1850,,196fbd9b-c49b-49fd-ae99-d67714f173ae,Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis,stichting_het_nederlands_kanker_instituut_antoni_van_leeuwenhoek_ziekenhuis,,,,,, +1851,,049c4e58-7191-11e6-a0cd-0242ac12000b,EDISON THERAPS LLC,edison_theraps_llc,,,,,, +1852,,5d1e35b5-20c0-464c-aa24-13d71743734d,IST. DI RICERCHE FARMACOLOG. M. NEGRI,ist_di_ricerche_farmacolog_m_negri,,,,,, +1853,,40bac149-23af-4640-a2f8-624c65ab970d,Association pour la promotion de la réanimation médicale à Tours,association_pour_la_promotion_de_la_r_animation_m_dicale_tours,,,,,, +1854,,89db32ce-b526-435a-8697-b192540bc792,Lucia Galan Hospital Clinico San Carlos,lucia_galan_hospital_clinico_san_carlos,,,,,, +1855,,b601f3ec-0223-428b-aa7b-5e75b707f1a7,GEICAM (Fundación Grupo Español de Investigación en Cáncer de Mama),geicam_fundaci_n_grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama,,,,,, +1856,,6a75b276-6b29-42b9-aad0-2fb631b72ebc,Bayer SpA,bayer_spa,,,,,, +1857,,a2ec763e-9978-4e92-ba6f-0758845b03b7,Isidre Vilacosta,isidre_vilacosta,,,,,, +827,0.98924979567527771,a76f8a47-a17c-42bc-b482-cc7b236a1fb3,INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE,instituto_de_investigaci_n_sanitaria_la_fe_de,,,,975869a5-d12b-4f5f-9a3d-d76a15c61a6a,instituto_de_investigaci_n_sanitaria_la_fe_de,INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE +1858,,b2a110f2-404c-4d7e-8b21-d807e3f60c00,West Hertfordshire Hospitals NHS Trust,west_hertfordshire_hospitals_nhs_trust,,,,,, +902,0.975661,c4639166-c014-47d0-bd0d-48ac262c02d3,Klaus Olkkola,klaus_olkkola,,,,107fc324-9e45-4afc-8ead-3498cf036471,klaus_olkkola_university_of_helsinki,Klaus Olkkola/University of Helsinki +1859,,f734d888-7141-11e6-a0cd-0242ac12000b,SUN PHARM INDS LTD,sun_pharm_inds_ltd,,,,,, +1860,,4dfa808b-96d0-403e-a1f9-5a144c2ea6e2,ANSR,ansr,,,,,, +328,0.932685,5809dce0-1c57-445d-9068-5b5bffdd2080,Aziende Chimiche Riunite Angelini Francesco - ACRAF S.p.A,aziende_chimiche_riunite_angelini_francesco_acraf_s_p_a,,,,5809dce0-1c57-445d-9068-5b5bffdd2080,aziende_chimiche_riunite_angelini_francesco_acraf_s_p_a,Aziende Chimiche Riunite Angelini Francesco - ACRAF S.p.A +1861,,808d7ccc-54b2-4df1-9848-c773d5df49a6,Novartis Vaccines Institute for Global Health (NVGH),novartis_vaccines_institute_for_global_health_nvgh,,,,,, +360,0.986646,3f73d507-49f7-4bba-847d-11619261c4ae,Academisch Medisch Centrum,academisch_medisch_centrum,,,,3f73d507-49f7-4bba-847d-11619261c4ae,academisch_medisch_centrum,Academisch Medisch Centrum +1862,,9c5fe7fc-6a53-41b4-945e-56bf154b6295,"Department of Occupational and Environmental Dermatology, Malmö University Hospital",department_of_occupational_and_environmental_dermatology_malm_university_hospital,,,,,, +1863,,da3aad48-3bb1-4bf9-b3fd-7942b74efc97,"HOC, Rigshospitalet",hoc_rigshospitalet,,,,,, +1864,,6c5359ad-18d4-4218-b384-074d2e107e2b,AZIENDA SANITARIA LOCALE DI BARI,azienda_sanitaria_locale_di_bari,,,,,, +1865,,c3afe20e-81a8-4027-a6d1-71d729beb2f7,National Centre in HIV Epidemiology and Clinical Research,national_centre_in_hiv_epidemiology_and_clinical_research,,,,,, +1866,,11b64365-95ca-4a59-ad34-2aefd9072f7c,MERCK SHARP DOHME ITALIA S.P.A,merck_sharp_dohme_italia_s_p_a,,,,,, +1867,,a8508f68-4869-450f-833b-3a077309c6b7,Medizinische Universität Wien Univ.Klinik f.Innere Medizin I/Hämatologie,medizinische_universit_t_wien_univ_klinik_f_innere_medizin_i_h_matologie,,,,,, +1868,,c7eef3e9-63dd-4653-b1cf-c43564270770,"MAP Pharmaceuticals, Inc",map_pharmaceuticals_inc,,,,,, +1869,,14c3a8cf-9a5f-48f2-bcd4-664210f2abe9,Fa.Elexxion,fa_elexxion,,,,,, +1870,,f16b6afb-6cbe-4b1c-bd26-9dad17fb6e33,Sun Pharma Global FZE,sun_pharma_global_fze,,,,,, +858,0.94989776611328125,5ce030ba-f524-45f7-b154-b5509cfe5e6d,Institut de Recerca Hospital de la Sant Creu i Sant Pau,institut_de_recerca_hospital_de_la_sant_creu_i_sant_pau,,,,5ce030ba-f524-45f7-b154-b5509cfe5e6d,institut_de_recerca_hospital_de_la_sant_creu_i_sant_pau,Institut de Recerca Hospital de la Sant Creu i Sant Pau +606,0.98722973465919495,c3706f14-715d-11e6-a0cd-0242ac12000b,AUROBINDO PHARM,aurobindo_pharm,,,,f36837b0-7144-11e6-a0cd-0242ac12000b,aurobindo_pharma,AUROBINDO PHARMA +1871,,a6a4658f-22ac-41e2-a8b5-5cbdb95f6545,Pharmacosmos A/S,pharmacosmos_a_s,,,,,, +1872,,2a6cec66-883e-471c-a287-80b342b4c2ae,"Med Uni Graz, Univ. Klinik für Anästhesiologie und Intensivmedizin",med_uni_graz_univ_klinik_f_r_an_sthesiologie_und_intensivmedizin,,,,,, +1873,,c8293bb4-7165-11e6-a0cd-0242ac12000b,SPEAR PHARMS INC,spear_pharms_inc,,,,,, +985,0.98482728004455566,ede51c8a-35c0-466b-a6aa-e9e49c4956b3,"Imperial College, London",imperial_college_london,,,,275d9cef-debb-4aaf-8234-93691b0c3e94,imperial_college,Imperial College +1874,,8ffe068c-73f1-11e6-a0cd-0242ac12000b,PRAXAIR DISTRIBUTION MID-ATLANTIC LLC,praxair_distribution_mid_atlantic_llc,,,,,, +1875,,1af40566-664d-4bc7-b85d-d257aca57df4,"Merck Serono Int, a branch of Laboratoires Seron SA an affiliate of Merck KGaA, Darmstadt, Germany",merck_serono_int_a_branch_of_laboratoires_seron_sa_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,,, +1876,,ffc0110e-0caf-4e4f-a523-a1b548cadf7d,Omninvest Ltd,omninvest_ltd,,,,,, +1877,,48ea0d59-c895-4668-b3b3-986a15bc25b0,PROMIX Trial Group,promix_trial_group,,,,,, +1878,,a4103634-1e22-4ebf-9782-fb0104c05ae1,PASCOE pharmazeutische Präparate GmbH,pascoe_pharmazeutische_pr_parate_gmbh,,,,,, +1879,,796063a8-7148-11e6-a0cd-0242ac12000b,CUMBERLAND PHARMS,cumberland_pharms,,,,,, +1880,,ca9c1bf6-ca6a-4dd7-83c4-dcd1ae62a4eb,"Department of Ophthalmology, Aarhus University Hospital",department_of_ophthalmology_aarhus_university_hospital,,,,,, +736,0.9846251209576925,eda88abe-5243-41c5-924e-0698f02867ba,European Organization for the Research and Treatment of Cancer,european_organization_for_the_research_and_treatment_of_cancer,,,,86b7934b-bd40-4e41-90e2-f2b10e4f66c8,european_organization_for_the_research_and_treatment_of_cancer_eortc,European Organization for the Research and Treatment of Cancer (EORTC) +1066,0.919718,36b27479-ba79-4094-93f3-0a7496de4aec,Universitätsklinikum Tübingen,universit_tsklinikum_t_bingen,,,,36b27479-ba79-4094-93f3-0a7496de4aec,universit_tsklinikum_t_bingen,Universitätsklinikum Tübingen +1881,,1e94876e-beee-449e-940f-d326eae2f5ad,Research and Development NHS Lothian,research_and_development_nhs_lothian,,,,,, +1882,,f6f35f13-e9ae-4403-bacd-3f344aae47ae,Center for Stroke Research Berlin - Charité Universitätsmedizin Berlin,center_for_stroke_research_berlin_charit_universit_tsmedizin_berlin,,,,,, +1883,,5f926f8d-f8b4-4e93-a71b-dae72d61daff,Virttu Biologics Limited,virttu_biologics_limited,,,,,, +1884,,4b19cffa-894d-487f-af60-846dea5ca443,ACROSS:Associació Catalana per a la Recerca Oncològica i les seves implicacions sanitàries i Socials,across_associaci_catalana_per_a_la_recerca_oncol_gica_i_les_seves_implicacions_sanit_ries_i_socials,,,,,, +1885,,8f282e06-9f89-425f-b2c1-f6adb6c40780,Guy's and St Thomas Foundation NHS Trust,guy_s_and_st_thomas_foundation_nhs_trust,,,,,, +1886,,244b727a-1df7-433c-9a23-380add963d83,"Charles University in Prague, Third Faculty of Medicine",charles_university_in_prague_third_faculty_of_medicine,,,,,, +1887,,993bfe4f-a811-4b7e-a8b1-f243cf2beea7,HEXAL BIOTECH,hexal_biotech,,,,,, +1888,,11ac98e6-1a9e-4906-857f-a537b80d8725,Ersi Voskaridou-Dimoula,ersi_voskaridou_dimoula,,,,,, +1889,,8b690a1b-e529-4162-ad62-186251ac03e4,Institut für Klinische Forschung und Entwicklung (ikfe) GmbH,institut_f_r_klinische_forschung_und_entwicklung_ikfe_gmbh,,,,,, +1890,,35af0f6e-7144-11e6-a0cd-0242ac12000b,HIKMA FARMACEUTICA,hikma_farmaceutica,,,,,, +1891,,5ea673fe-5829-41d3-8e80-509fabf7cf70,"Medizinische Universität Innsbruck, vertreten durch Univ. Prof. Dr. Martin Krismer",medizinische_universit_t_innsbruck_vertreten_durch_univ_prof_dr_martin_krismer,,,,,, +1892,,89480dc7-5193-4857-b71b-1f7930d02813,"Samsung Bioepis Co., Ltd",samsung_bioepis_co_ltd,,,,,, +1893,,b03d6394-c28d-458c-99ce-aac61f6b1d73,DiaMedica Inc,diamedica_inc,,,,,, +1894,,2c0b3176-5a46-4d9f-99b4-ed1b390aa6d3,Fundación Fernández-Cruz,fundaci_n_fern_ndez_cruz,,,,,, +1895,,704538ab-c289-41f8-b44d-2d80857611ff,PD Dr. Gerhard Treiber,pd_dr_gerhard_treiber,,,,,, +202,0.9779740571975708,e1159672-2a52-43b2-9e5e-38398d43b8d6,"Helse Bergen HF, Haukeland Unversity Hospital",helse_bergen_hf_haukeland_unversity_hospital,,,,0ca95325-5fdb-4264-9a4d-da0285235e77,helse_bergen_hf_haukeland_university_hospital,"Helse Bergen HF, Haukeland University Hospital" +1896,,bfbfc0c4-841d-4393-b2da-0c2f0c2c3d06,"Institutt for nevromedisin, NTNU",institutt_for_nevromedisin_ntnu,,,,,, +1897,,510ed425-0435-4d52-a19e-6a9bb112b0cf,"Sequel Pharmaceuticals, Inc",sequel_pharmaceuticals_inc,,,,,, +546,0.912289,066b98e8-5ec4-4f5b-9b43-91f546ee98d1,University Hospital of Regensburg,university_hospital_of_regensburg,,,,066b98e8-5ec4-4f5b-9b43-91f546ee98d1,university_hospital_of_regensburg,University Hospital of Regensburg +1898,,a9252def-bfbd-434a-8554-7e88e70c34f2,CRINOS S.p.A,crinos_s_p_a,,,,,, +1899,,c1054dcf-ea5a-4611-a920-a9a0e63c0399,Hoffmann- La Roche Ltd,hoffmann_la_roche_ltd,,,,,, +1900,,d20931f4-7159-11e6-a0cd-0242ac12000b,SPEAR PHARMS,spear_pharms,,,,,, +1901,,e304e7c2-eaf6-47cb-a34d-ea0d3ab066e9,"Aarhus University Hospital, Dept of Endocrinology and Internel Medicine (MEA)",aarhus_university_hospital_dept_of_endocrinology_and_internel_medicine_mea,,,,,, +1902,,f8461567-196a-40ec-b87c-808e2d1bc1f9,Italian Drug Agency,italian_drug_agency,,,,,, +1903,,b2e4d3a8-7160-11e6-a0cd-0242ac12000b,BI-COASTAL PHARMA,bi_coastal_pharma,,,,,, +1904,,42b9d5c5-f81b-4b7a-887c-2cf2a1c91593,Uriach Pharma,uriach_pharma,,,,,, +1905,,9f0d9abb-85c9-46cf-a721-900295acccd5,"Zeria Pharmaceutical Co., Ltd",zeria_pharmaceutical_co_ltd,,,,,, +1906,,110d4190-904c-4e60-a365-5b86db8adbed,Dept. of Neurology Vienna,dept_of_neurology_vienna,,,,,, +1907,,1466ef63-ccce-413c-8e4a-f73b929fdaba,"AOU di Bologna, Policlinico S.Orsola-Malpighi",aou_di_bologna_policlinico_s_orsola_malpighi,,,,,, +1908,,ee502fc0-fe87-4b55-8e63-0b9ea88880a8,Thrombotech Ltd,thrombotech_ltd,,,,,, +777,0.97387266159057617,c45a1a04-da40-42ec-92c8-78c633bc032a,MEDA,meda,,,,51713059-523f-4247-b288-a682d6d8e72b,meda_ab,MEDA AB +1909,,fb30bd82-96d8-11e6-becf-0242ac110008,ARALEZ PHARMS,aralez_pharms,,,,,, +1910,,f37ae7b6-227b-4a6a-b97f-a3164b993d8a,Orfagen,orfagen,,,,,, +1911,,7df88942-4e70-47bc-b8c1-cdd08636fd14,"Infinity Pharmaceuticals, Inc",infinity_pharmaceuticals_inc,,,,,, +1912,,adec9e83-b4b4-4ae3-8eb4-5d52fb8cd372,Laboratorios Inibsa S.A,laboratorios_inibsa_s_a,,,,,, +1913,,9a7b9c89-5f33-4863-a657-93d264aabe62,"GlaxoSmithKline, S.A",glaxosmithkline_s_a,,,,,, +1914,,4a755366-9790-4edd-9c31-9a352079b987,Olympus Biotech Europe SAS,olympus_biotech_europe_sas,,,,,, +1915,,2dcec354-bb69-4b28-94b1-9967178b790f,VIATRIS GmbH & Co. KG,viatris_gmbh_co_kg,,,,,, +1916,,94c1163b-d748-4754-a1c3-5e3e4a844f60,José Miguel Cisneros Herreros,jos_miguel_cisneros_herreros,,,,,, +1917,,dc6fd2c4-8ef0-4c7f-a74e-6754d7b6a09f,Lexicon Pharmaceuticals Incorporated,lexicon_pharmaceuticals_incorporated,,,,,, +988,0.960341,a43af95c-8bc5-11e6-a449-0242ac12000b,"Department of Cardio-Thoracic and Vascular Surgery, Aarhus University Hospital",department_of_cardio_thoracic_and_vascular_surgery_aarhus_university_hospital,,,,2cbebc88-9b76-4642-b406-d5374c2aabfa,department_of_cardiothoracic_and_vascular_surgery,Department of Cardiothoracic and Vascular Surgery +1041,0.97318911552429199,64e4c2d9-005c-4577-8791-92439d12eda2,Celgene Corporation,celgene_corporation,,,,64e4c2d9-005c-4577-8791-92439d12eda2,celgene_corporation,Celgene Corporation +1918,,11bd403b-5873-4ed2-acac-f32ad9acadf8,"Rigshospitalet, Onkologisk Klinik",rigshospitalet_onkologisk_klinik,,,,,, +1919,,7007cbac-648f-4051-a251-e13b3e4ee9bb,Asklepios Fachkliniken München Gauting,asklepios_fachkliniken_m_nchen_gauting,,,,,, +1920,,f68ccefc-0477-49e6-96fe-bbcb2eb0f4ca,"Rigshospitalet, 2032",rigshospitalet_2032,,,,,, +1921,,d1e895c8-73e0-11e6-a0cd-0242ac12000b,KNIGHT THERAPS,knight_theraps,,,,,, +433,0.98984676599502563,bbb58274-b96a-4b86-89c9-899c1d1a7717,"Pfizer Inc, 235 East 42nd Street, New York, New York 10017",pfizer_inc_235_east_42nd_street_new_york_new_york_10017,,,,83f77026-9bf3-42d7-bdf1-59a5d35a6b9b,pfizer_inc_235_east_42nd_street_new_york_new_york_10017_usa,"Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA" +1922,,744bfc1c-92ff-4d05-8676-8f6f6a08dc8d,"University Hospital Schleswig-Holstein, UKSH Campus Kiel",university_hospital_schleswig_holstein_uksh_campus_kiel,,,,,, +1923,,21cdbfce-1cf5-4009-8c12-73a5f39f267b,Dr. Felipe Villacampa,dr_felipe_villacampa,,,,,, +1924,,3e84b70a-7168-11e6-a0cd-0242ac12000b,LUPIN ATLANTIS,lupin_atlantis,,,,,, +1925,,90a5c0bf-691c-4412-8f3b-e081397858df,An-Institut für Qualitätssicherung in der operativen Medizin gGmbH,an_institut_f_r_qualit_tssicherung_in_der_operativen_medizin_ggmbh,,,,,, +1926,,2fd0eb36-dc1c-4ecc-af2c-130e38f46861,AISAR ASSOCIAZIONE ITALIANA PER LO STUDIO DEGLI ANTIMICROBICI E DELLE RESISTENZE,aisar_associazione_italiana_per_lo_studio_degli_antimicrobici_e_delle_resistenze,,,,,, +1927,,425bfa44-bb31-4354-80d9-926a3bc0e072,"Med. Uni. Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie",med_uni_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,,,,,, +228,0.908956,67f8d943-3794-4830-beba-23b1e4232b8d,"St. George's, University of London",st_george_s_university_of_london,,,,67f8d943-3794-4830-beba-23b1e4232b8d,st_george_s_university_of_london,"St. George's, University of London" +1928,,6c153c37-f4f6-4ca4-a344-63fbf7ccde92,Max-Planck-Institute of Experimental Medicine,max_planck_institute_of_experimental_medicine,,,,,, +1929,,10836e5d-ffbd-4f29-8936-372197b27709,BioXell S.p.A,bioxell_s_p_a,,,,,, +1046,0.98746395111083984,d8ba59ca-6fa0-11e6-9663-0242ac12000b,Synta Pharmaceutical Corporation,synta_pharmaceutical_corporation,,,,6de197b9-6b4f-41ef-b8a0-fbee9c50e584,synta_pharmaceutical_corp,Synta Pharmaceutical Corp +1930,,ee8ed160-0651-4154-aecc-ac31d1a27088,"Medizinische Fakultät Mannheim, Ruprecht-Karls-Universität Heidelberg",medizinische_fakult_t_mannheim_ruprecht_karls_universit_t_heidelberg,,,,,, +1931,,be62cca5-051c-4cce-bfd1-c23de90375e1,Novartis Farma SpA,novartis_farma_spa,,,,,, +1932,,125a08d9-9be9-4eaf-8f23-e86959d90c9a,Lund University Hospital,lund_university_hospital,,,,,, +1933,,58e27496-72dc-11e6-a0cd-0242ac12000b,DISCOVERY LABS,discovery_labs,,,,,, +4,0.980166,9cfc2818-f38d-4019-a76a-f0b7b7a2fd91,University of Dundee (Research & Innovation),university_of_dundee_research_innovation,,,,32b2141c-7602-42db-a25b-43a2694f5d75,university_of_dundee,University of Dundee +1934,,f10ce5b4-a290-4403-ad1c-2aa1ec9bfdb1,Institut de Cancérologie de l'Ouest,institut_de_canc_rologie_de_l_ouest,,,,,, +1935,,3d60d834-998c-4660-ad6f-2c0bdec9d285,Catholic University Leuven,catholic_university_leuven,,,,,, +1936,,9efff0b1-e76f-415b-a2b8-67d8ba11e965,Pfizer Worldwide Research and Development,pfizer_worldwide_research_and_development,,,,,, +1937,,c6c9c1b5-4620-407f-86e8-7dff8c0a257b,"Technical University Dresden, Department of Dermatology",technical_university_dresden_department_of_dermatology,,,,,, +520,0.97626614570617676,fe98ef06-797b-44b9-9bcd-e65c4505295f,ROCHE SPA,roche_spa,,,,da2c7cf7-0913-42b9-90fb-cdba8baae892,roche,ROCHE +938,0.977852,4e50d7b3-8213-4621-928b-ca4731a41e10,FUNDACIÓN ESPAÑOLA DE REUMATOLOGIA,fundaci_n_espa_ola_de_reumatologia,,,,41fdac3b-97bb-4404-84a8-1a8ece5e5818,fundaci_n_espa_ola_de_reumatolog_a_fer,FUNDACIÓN ESPAÑOLA DE REUMATOLOGÍA (FER) +1938,,b07c5cdb-2480-4498-b9d6-37480a85330f,Centus Biotherapeutics Limited,centus_biotherapeutics_limited,,,,,, +1939,,9e2e0e17-79fc-4606-8473-65d37fb49240,Dr.ssa Marina Aiello-Universit� degli studi di Parma,dr_ssa_marina_aiello_universit_degli_studi_di_parma,,,,,, +646,0.96602542698383331,56a22be9-52b5-48ab-b2d7-2ba199f18928,Boehringer Ingelheim Ellas S.A,boehringer_ingelheim_ellas_s_a,,,,237ec247-b474-4bd6-9041-c2ffb0213c0e,boehringer_ingelheim_ellas,Boehringer Ingelheim Ellas +1940,,55d06447-7653-44f0-8c39-f2240e489d80,HERMAL Kurt Herrmann GmbH & Co OHG,hermal_kurt_herrmann_gmbh_co_ohg,,,,,, +1941,,7ceac940-5715-446b-8259-a5cae4bf56bd,Novo Nordisk Farma Oy,novo_nordisk_farma_oy,,,,,, +1942,,e53b24b8-db89-4abc-b485-78a3ab37f678,Janssen Cilag Limited,janssen_cilag_limited,,,,,, +681,0.98222681879997253,8256073c-6fbe-11e6-abe8-0242ac12000b,"Aarhus University Hospital, Department M",aarhus_university_hospital_department_m,,,,e9e3f1a5-d19d-4eea-b83e-62046558fbb3,aarhus_university_hospital,Aarhus University Hospital +1943,,54ed7fd2-71bf-4a1d-859f-9ae065bcc8ef,MOLOGEN AG,mologen_ag,,,,,, +1944,,5723e517-88a9-40d4-9dbe-0bd1df935cfe,Boehringer Ingelheim RCV GmbH and Co KG,boehringer_ingelheim_rcv_gmbh_and_co_kg,,,,,, +116,0.98872168858846032,63ca73d2-fd68-4693-872c-2121b000d68c,Shire Pharmaceutical Development,shire_pharmaceutical_development,,,,63ca73d2-fd68-4693-872c-2121b000d68c,shire_pharmaceutical_development,Shire Pharmaceutical Development +1945,,0edbcc88-c701-42dc-929e-b21d1b58f67a,Asociación de Investigación Hepatológica y Transplante Hepático Infantil,asociaci_n_de_investigaci_n_hepatol_gica_y_transplante_hep_tico_infantil,,,,,, +1946,,80565886-6fc0-11e6-abe8-0242ac12000b,Sophiahemmet,sophiahemmet,,,,,, +1947,,3cc0b9a1-b883-4616-b5ef-56938f7c5a51,Sheffield Children's NHS Foundation Trust,sheffield_children_s_nhs_foundation_trust,,,,,, +1948,,67b07524-715e-11e6-a0cd-0242ac12000b,MK LABS,mk_labs,,,,,, +1949,,d0ccbfb2-7146-11e6-a0cd-0242ac12000b,AMEDRA PHARMS LLC,amedra_pharms_llc,,,,,, +262,0.9615,c9af08d3-4d1a-4228-918e-15dd207e2f26,"SCHWARZ BIOSCIENCES, INC A member of the UCB Group of Companies",schwarz_biosciences_inc_a_member_of_the_ucb_group_of_companies,,,,9d682749-f368-4251-b8c0-9399d1ecd77d,schwarz_biosciences_inc_a_member_of_ucb_group_of_companies,"SCHWARZ BIOSCIENCES, INC A member of UCB Group of Companies" +1950,,0daa6722-6df3-4b2e-ad38-a833e00c0e1b,"Marinus Pharmaceuticals, Inc",marinus_pharmaceuticals_inc,,,,,, +684,0.98852276802062988,07e5285a-7e7c-4b06-8e27-29dfa99a2153,University Medical Center Groningen (UMCG),university_medical_center_groningen_umcg,,,,07e5285a-7e7c-4b06-8e27-29dfa99a2153,university_medical_center_groningen_umcg,University Medical Center Groningen (UMCG) +1951,,69bc3a21-c486-47b1-8a47-088e78964c8e,DuPont Nutrition and Health Active Nutrition,dupont_nutrition_and_health_active_nutrition,,,,,, +1952,,1d889ba9-5692-4e42-bc60-0964592b469c,Geistlich Pharma AG,geistlich_pharma_ag,,,,,, +1953,,0ad6484f-fde5-44ca-89de-44224fced468,CONSORCIO DE APOYO A LA INVESTIGACION BIOMEDICA EN RED (CAIBER),consorcio_de_apoyo_a_la_investigacion_biomedica_en_red_caiber,,,,,, +1954,,e72e68d1-6aef-44a5-86f2-bd543f0af803,Christie Hospital,christie_hospital,,,,,, +1955,,9e8cd390-e0d4-4841-831a-4fb2e048a336,OSI-prosidion Ltd,osi_prosidion_ltd,,,,,, +1956,,fae4585f-3c0c-476d-9c20-49f4bb464c6a,Stiefel Laboratories Maidenhead Ltd (commonly known as Stiefel Laboratories International Division),stiefel_laboratories_maidenhead_ltd_commonly_known_as_stiefel_laboratories_international_division,,,,,, +1957,,f314b8aa-ea93-4949-b306-7bb2d7a4ea6a,Schering AG,schering_ag,,,,,, +1958,,b57df435-22d9-42ef-9c38-b59e5dd520ca,The Central Remedial Clinic and The Children's University Hospital,the_central_remedial_clinic_and_the_children_s_university_hospital,,,,,, +156,0.9854559600353241,2fb9a49d-c309-4c13-bb15-835da6973955,"Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin",medizinische_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin,,,,93c5f8d2-c2d8-4c9b-abde-962e31e9c1a5,medizinische_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,"Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie" +1959,,83aa6b17-1756-46f1-9bc5-45e407811b41,Sociedad Española de Cirugía Pediátrica,sociedad_espa_ola_de_cirug_a_pedi_trica,,,,,, +1960,,7396d607-3567-4810-80ba-8ea58d5650d5,elbion AG,elbion_ag,,,,,, +1961,,ec1468d5-219b-4bbe-8600-ebfad8f1b066,ReceptoPharm Inc,receptopharm_inc,,,,,, +1962,,28a0f9d0-7145-11e6-a0cd-0242ac12000b,APOTEX CORP,apotex_corp,,,,,, +1963,,23c2555d-9622-4bed-ae5c-2f204388ea56,Spinal Cord Injury Centre of Western Denmark,spinal_cord_injury_centre_of_western_denmark,,,,,, +1964,,88a3e6fd-7ba3-47b1-9eb0-a434f2421c9d,Pantarhei Bioscience B.V,pantarhei_bioscience_b_v,,,,,, +1965,,b7dffe0e-0362-4d41-858b-0a94f2d0dab3,Greater Glasgow Health Board (North Glasgow University Hospitals Division),greater_glasgow_health_board_north_glasgow_university_hospitals_division,,,,,, +1966,,a6544968-ea5e-46a4-af6a-88b32be8c722,"ImmunoGen, Inc",immunogen_inc,,,,,, +1004,0.975197,7c89af62-71b6-11e6-a0cd-0242ac12000b,SOMERSET,somerset,,,,5dffa2d8-7164-11e6-a0cd-0242ac12000b,somerset_theraps_llc,SOMERSET THERAPS LLC +572,0.97600215673446655,e3bdd826-4b43-4d33-8f70-20154485e250,"Human Genome Sciences, Inc",human_genome_sciences_inc,,,,e3bdd826-4b43-4d33-8f70-20154485e250,human_genome_sciences_inc_a_wholy_owned_subsidiary_of_glaxosmithkline_plc,"Human Genome Sciences, Inc. (a wholy owned subsidiary of GlaxoSmithKline PLC)" +1967,,8739f99e-fa04-4a92-9b99-da076933b4ee,Javier Pascual Ramírez,javier_pascual_ram_rez,,,,,, +1968,,e4d968ac-e48b-461b-a99c-82c47c4851fe,"University Hospital Lund, Thoracic Oncology Unit, Dept of Respiratory Medicine",university_hospital_lund_thoracic_oncology_unit_dept_of_respiratory_medicine,,,,,, +1969,,2f60d09e-3050-4eca-868e-7503833a0f5f,"Herlev Hospital, Onkologisk Afd. R",herlev_hospital_onkologisk_afd_r,,,,,, +676,0.987472,683d790a-7146-11e6-a0cd-0242ac12000b,BECTON DICKINSON,becton_dickinson,,,,683d790a-7146-11e6-a0cd-0242ac12000b,becton_dickinson,BECTON DICKINSON +1970,,aaae6f52-741a-4d82-8ac9-efd5eb95661a,BIOTRONIK France,biotronik_france,,,,,, +411,0.965652,2684f500-be7b-4cc1-b06c-5ea5752af978,Region Skåne,region_sk_ne,,,,2684f500-be7b-4cc1-b06c-5ea5752af978,region_sk_ne,Region Skåne +1971,,e166a2c0-9c7f-4663-9452-09e40f9a806f,Instituto de Investigaciones del Sueño,instituto_de_investigaciones_del_sue_o,,,,,, +709,0.9641061623891195,4fa44469-c2ba-4abb-a4ab-cecbbeb9cad2,Reckitt Benckiser Healthcare (UK) Limited,reckitt_benckiser_healthcare_uk_limited,,,,62dccd7b-325f-4731-b158-229a0c9ea429,reckitt_benckiser_healthcare_uk_ltd,Reckitt Benckiser Healthcare (UK) Ltd +1972,,a65f5e8c-71fb-11e6-a0cd-0242ac12000b,LUKARE MEDICAL LLC,lukare_medical_llc,,,,,, +119,0.98682153224945068,767dc014-93a9-40fb-90be-df7dd774d593,Rheinische Friedrich-Wilhelms-University of Bonn,rheinische_friedrich_wilhelms_university_of_bonn,,,,2d92428c-71e3-498b-80e5-8358645cf21c,rheinische_friedrich_wilhelms_university_of_bonn_university_hospital,"Rheinische Friedrich-Wilhelms-University of Bonn, University Hospital" +1973,,628c1f69-e951-4be6-b931-2a796ba4f658,Health Ministry,health_ministry,,,,,, +352,0.98674958944320679,3c65321f-86b5-4caf-b891-98518f69b348,Deutsches Herzzentrum,deutsches_herzzentrum,,,,3c65321f-86b5-4caf-b891-98518f69b348,deutsches_herzzentrum,Deutsches Herzzentrum +75,0.984093,e1bb69a2-a85c-4beb-a383-f554c4c5fdcf,GALENpharma,galenpharma,,,,d1b481d9-2e7a-4149-86cf-32b5b57a8168,galenpharma_gmbh,GALENpharma GmbH +1974,,0dc7b60b-d774-4787-958c-6a9ec6b3aab8,Trimel Biopharma SRL,trimel_biopharma_srl,,,,,, +586,0.912289,cac457a1-2330-4708-971c-e042de05e51c,Fundació de Lluita contra la Sida,fundaci_de_lluita_contra_la_sida,,,,2d4e8bd8-17d2-4b35-a93e-d9f401ce497b,fundaci_lluita_contra_la_sida,Fundació Lluita contra la Sida +967,0.97196,996732ad-052b-4476-9f85-11c636f30f69,Skånes universitetssjukhus,sk_nes_universitetssjukhus,,,,55950bfd-6b69-499d-a3b6-2dd8b514c97d,sk_nes_universitetssjukhus_lund,Skånes Universitetssjukhus Lund +1975,,3d35f00c-5c3f-417f-9417-1e67e0a3421c,Bone Therapeutics S.A,bone_therapeutics_s_a,,,,,, +1976,,85248f47-1006-4fbe-9e69-1230c6e5a545,Skaraborg Hospital,skaraborg_hospital,,,,,, +1977,,afd4368c-fbc3-496c-af02-77fd0434fde7,"Department of Medicine I, Clinical Dep. f. Oncology, University Hospital,",department_of_medicine_i_clinical_dep_f_oncology_university_hospital,,,,,, +1978,,0cbca6c8-bfc9-472b-820a-2a9a3236b2b0,"Universitätsklinik für Innere Medizin, Klinische Abteilung für Endokrinologie und Nuklearmedizin",universit_tsklinik_f_r_innere_medizin_klinische_abteilung_f_r_endokrinologie_und_nuklearmedizin,,,,,, +1979,,1f9cf02f-b074-476a-bae0-e71e3d6bef51,Zambon SA,zambon_sa,,,,,, +1980,,84196f62-7164-11e6-a0cd-0242ac12000b,AGILA SPECLTS,agila_speclts,,,,,, +148,0.977699,c343e70c-8f15-4acd-8007-f7e64cc0f975,Nuvelo,nuvelo,,,,a3c7b078-642d-4dfa-bfc9-34dd103124ed,nuvelo_inc,"Nuvelo, Inc" +847,0.970712,5f00d410-ca22-4e53-ace6-3a13d122ff34,Janssen-Cilag Medical Affairs EMEA,janssen_cilag_medical_affairs_emea,,,,2cd6ae2e-14d4-42b4-bac7-96f94b86a23b,janssen_cilag_medical_affaires_emea,Janssen-Cilag Medical Affaires EMEA +1981,,6794697c-2209-472e-8b9a-c8ef82a38a02,"Catalyst Pharmaceutical Partners, Inc",catalyst_pharmaceutical_partners_inc,,,,,, +1982,,8ec409aa-73f2-11e6-a0cd-0242ac12000b,UNITED STATES WELDING INC,united_states_welding_inc,,,,,, +1983,,b2c6a9a3-1add-47c0-bf39-ce008b23d626,Janssen Cilag Pharma GmbH,janssen_cilag_pharma_gmbh,,,,,, +1984,,43e27a24-baa2-46fa-90cc-cffa1c27276c,Equipo de doctores: Dr. Amado Andrés y Dr. Manuel Praga,equipo_de_doctores_dr_amado_andr_s_y_dr_manuel_praga,,,,,, +1985,,e526b28a-72e3-11e6-a0cd-0242ac12000b,OTSUKA PHARM CO LTD,otsuka_pharm_co_ltd,,,,,, +1986,,41ee6189-0831-4567-8fe4-52531c7f7241,Dr. Ortega: Hospital General de Valencia,dr_ortega_hospital_general_de_valencia,,,,,, +1987,,18ceda50-4dae-4271-af71-da1834b82b95,Lumena Pharmaceuticals Inc,lumena_pharmaceuticals_inc,,,,,, +1988,,71e5412a-72e2-11e6-a0cd-0242ac12000b,MIST PHARMS LLC,mist_pharms_llc,,,,,, +765,0.98034405708312988,59b7be85-48d9-4a80-8f5f-ff23404f5da2,AbbVie,abbvie,,,,59b7be85-48d9-4a80-8f5f-ff23404f5da2,abbvie,AbbVie +1005,0.955584,d0a19ea5-f2be-4d51-860e-d7e13528d3d9,"Population Health Research Institute, McMaster University/Hamilton Health Sciences",population_health_research_institute_mcmaster_university_hamilton_health_sciences,,,,4e5f77d3-9cb8-4aca-96ce-cb524d785be9,population_health_research_institute_phri_mcmaster_university_hamilton_health_sciences,"Population Health Research Institute (PHRI), McMaster University/Hamilton Health Sciences" +1989,,53a20fb6-7145-11e6-a0cd-0242ac12000b,GLAND PHARMA LTD,gland_pharma_ltd,,,,,, +810,0.98486357927322388,f716737f-65ba-4748-b6e7-4d024cf10d3e,Biogen Idec,biogen_idec,,,,43a1c732-1624-42d6-96fa-66ffa3a8fc4e,biogen_idec_a_s,Biogen Idec A/S +1990,,3239cce7-4ab1-40ea-9f5a-0e7b75a91696,GW Research Ltd,gw_research_ltd,,,,,, +1991,,1077a33f-5b3d-4671-b7c9-b644328302f5,GW PHARMA LTD,gw_pharma_ltd,,,,,, +1992,,d26c4676-7141-11e6-a0cd-0242ac12000b,FRONTIDA BIOPHARM,frontida_biopharm,,,,,, +1993,,eed01fc2-7141-11e6-a0cd-0242ac12000b,PHARMAX,pharmax,,,,,, +1994,,652563ad-46b7-4803-8c6a-e852f1aaf757,Regulon AE,regulon_ae,,,,,, +1995,,a0302b12-67b3-417e-8d99-c6e7cb5d8d89,"OA Dr. Philipp Becker c/o Abteilung für Wirbelsäulenchirurgie, Orthopädisches Spital Speising GmbH",oa_dr_philipp_becker_c_o_abteilung_f_r_wirbels_ulenchirurgie_orthop_disches_spital_speising_gmbh,,,,,, +1996,,ccf7d0a4-73d0-4404-be80-d1a73c6495d6,Neuro-Consil GmbH,neuro_consil_gmbh,,,,,, +1997,,cb787574-8bbd-11e6-a449-0242ac12000b,"Dept. of Pharmacology, Aarhus University",dept_of_pharmacology_aarhus_university,,,,,, +1998,,f7391db4-7144-11e6-a0cd-0242ac12000b,CEPHAZONE PHARMA,cephazone_pharma,,,,,, +1999,,f521fbd1-c9b3-406d-b377-bd29ff42c246,GlaxoSmithKline S.A. España,glaxosmithkline_s_a_espa_a,,,,,, +2000,,dc9f0e65-4404-4eec-9ba7-942c41f74e2e,UK Children’s Cancer Study Group,uk_children_s_cancer_study_group,,,,,, +302,0.977381,974eb300-9713-4e49-855f-c4eefd403abb,Janssen Biologics B.V,janssen_biologics_b_v,,,,02f80d08-964f-4144-817a-07dd524f56fc,janssen_biologics_b_v_formerly_known_as_centocor_b_v,Janssen Biologics B.V. (formerly known as Centocor B.V.) +2001,,a8504196-1df7-41ed-958d-3ee21d2ef65a,"IMPAX Pharmaceuticals a Division of IMPAX Laboratories, Inc",impax_pharmaceuticals_a_division_of_impax_laboratories_inc,,,,,, +695,0.987167,dfe7b6c1-3e71-4357-9f75-c1315a5a0501,Abbott Laboratories,abbott_laboratories,,,,193a42c8-a09d-4028-9be8-16ebcda41920,abbott_laboratories_gmbh,Abbott Laboratories GmbH +2002,,2680c860-841d-442f-ac1c-9b6d8d966b89,Aventis Pasteur MSD SNC,aventis_pasteur_msd_snc,,,,,, +2003,,c6028f93-7b0f-44f3-9f43-3a76ea00a644,Institut Produits Synthèse (IPSEN) AB,institut_produits_synth_se_ipsen_ab,,,,,, +2004,,1e12b620-3abc-4b78-bbe0-a13acccf6240,IBI,ibi,,,,,, +2005,,84bca50b-3032-4611-83cb-14f89d60da2a,"Omthera Pharmaceuticals, Inc",omthera_pharmaceuticals_inc,,,,,, +2006,,84cbfa5c-118f-4b00-995e-b5a98161cf8f,"Hospital Virgen de la Salud, Toledo (Spain)",hospital_virgen_de_la_salud_toledo_spain,,,,,, +2007,,ba57541e-3ca6-420f-8802-aaf91e0d3a47,SCS Boehringer Ingelheim Ingelheim Comm.V,scs_boehringer_ingelheim_ingelheim_comm_v,,,,,, +479,0.98417377471923828,6fe604f9-fd34-437e-abeb-8db781496639,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. f. Endokrinologie und Stoffwechsel",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klin_abt_f_endokrinologie_und_stoffwechsel,,,,6550973d-6d3a-4fa8-a3d5-17c7365cb8cb,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klin_abt_f_r_endokrinologie_und_stoffwechsel,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Endokrinologie und Stoffwechsel" +2008,,337ca848-3273-4e2a-adad-fa745f3da0f0,National Medical Center (Országos Gyógyintézeti Központ),national_medical_center_orsz_gos_gy_gyint_zeti_k_zpont,,,,,, +2009,,a3ec0ec6-9b11-4191-a822-109bc4205362,Clinical Trial Center Aachen,clinical_trial_center_aachen,,,,,, +2010,,2b7f7bd5-ea06-4ac3-b5be-fc172e9720c2,Panin S.r.l,panin_s_r_l,,,,,, +2011,,085769da-eea3-4cd4-a170-366c6f536f33,LFB SA,lfb_sa,,,,,, +2012,,55dc3af9-da50-4614-bdeb-59aef351101b,University Hospital Grenoble,university_hospital_grenoble,,,,,, +2013,,ce950aff-f2c7-4755-9c0a-7d4820970062,Pertti Suominen,pertti_suominen,,,,,, +2014,,057406c9-7df8-4397-8a37-52c7c73e2524,Universitätsklinikum Ulm / University Clinical Center Ulm,universit_tsklinikum_ulm_university_clinical_center_ulm,,,,,, +2015,,23bb1ae7-4142-43be-9526-71260ab15542,"University of Oslo, Institute of General Practice and Community Medicine",university_of_oslo_institute_of_general_practice_and_community_medicine,,,,,, +2016,,10058590-49b3-476e-ad76-701508a1cf34,Heart Center Co. Tampere University Hospital,heart_center_co_tampere_university_hospital,,,,,, +2017,,0b7140de-7142-11e6-a0cd-0242ac12000b,SAGENT PHARMS,sagent_pharms,,,,,, +590,0.986737,28581ffa-a0e9-4a5d-8765-aa97b1847c37,Asociación Andaluza de Hematología y Hemoterapia,asociaci_n_andaluza_de_hematolog_a_y_hemoterapia,,,,28581ffa-a0e9-4a5d-8765-aa97b1847c37,asociaci_n_andaluza_de_hematolog_a_y_hemoterapia,Asociación Andaluza de Hematología y Hemoterapia +2018,,320879dc-8bc4-11e6-a449-0242ac12000b,Edmond Pharma,edmond_pharma,,,,,, +304,0.953319,f0f73489-144a-4a97-a09d-29fff716b352,"Medical university Graz, Department of Plastic Surgery",medical_university_graz_department_of_plastic_surgery,,,,8700379b-5f4a-4dc7-82aa-ea7910222ff1,medical_university_graz_department_for_plastic_surgery,"Medical University Graz, Department for Plastic Surgery" +336,0.98143,1fd64b02-1ed5-4f02-a826-80abb2b33e23,"Universitätsklinikum Essen, Westdeutsches Tumorzentrum",universit_tsklinikum_essen_westdeutsches_tumorzentrum,,,,1fd64b02-1ed5-4f02-a826-80abb2b33e23,universit_tsklinikum_essen_westdeutsches_tumorzentrum,"Universitätsklinikum Essen, Westdeutsches Tumorzentrum" +242,0.985891,a3937fbe-7163-11e6-a0cd-0242ac12000b,CYPRESS PHARM INC,cypress_pharm_inc,,,,a3937fbe-7163-11e6-a0cd-0242ac12000b,cypress_pharm_inc,CYPRESS PHARM INC +2019,,d5c32eb2-2923-4a6d-a274-fa1a135604a3,Sanquin Blood Supply Foundation,sanquin_blood_supply_foundation,,,,,, +2020,,9408abf9-a1b4-4b08-b082-de998045b629,Dr. Luis Escribano,dr_luis_escribano,,,,,, +2021,,42c535cd-c99b-4b6c-ae90-dbea220573ce,CHU Caen,chu_caen,,,,,, +2022,,38356b55-34c8-4af0-80d8-7949da6bebab,"University Hospital Geneva, Switzerland",university_hospital_geneva_switzerland,,,,,, +2023,,3654fd2b-400d-471e-931c-6003e894b222,Thrombotargets Europe,thrombotargets_europe,,,,,, +2024,,b11952b8-72f7-11e6-a0cd-0242ac12000b,ALKERMES,alkermes,,,,,, +2025,,708d8c9c-1538-40ba-8c40-97d47507a519,"McNeil AB (Johnson & Johnson Consumer and Personal Products Worldwide, J&J CPPW)",mcneil_ab_johnson_johnson_consumer_and_personal_products_worldwide_j_j_cppw,,,,,, +2026,,bcc0a2d6-14c6-48a5-8e4b-ba5e2e01213c,Aires Pharmaceuticals Inc,aires_pharmaceuticals_inc,,,,,, +2027,,0b509829-d125-4528-bb24-3625fdf232ec,"Catalan Society of Family Medicine, represented by Dr Mariano de la Figuera Von Wichman and Gabriel",catalan_society_of_family_medicine_represented_by_dr_mariano_de_la_figuera_von_wichman_and_gabriel,,,,,, +2028,,b4299aaf-97f6-41e3-a197-852e884e1706,Prof. Dr. Peter Eickholz,prof_dr_peter_eickholz,,,,,, +585,0.909143,95fd4687-5482-4ec2-ac1e-01aa97e3591a,"MUW, Klinik für Innere Medizin I, Onkologie",muw_klinik_f_r_innere_medizin_i_onkologie,,,,73005770-61f7-451a-a1d5-6cb043330409,muw_klinik_f_r_innere_med_i_onkologie,"MUW, Klinik für Innere Med. I, Onkologie" +2029,,e441777e-998d-4ac7-9cdd-7ab506f7ed33,"Universitätsklinik für Innere Medizin III, Medizinische Universität Wien",universit_tsklinik_f_r_innere_medizin_iii_medizinische_universit_t_wien,,,,,, +2030,,cfa82bb6-a7bf-45c7-88d2-6bb1b02661d6,Radboudumc,radboudumc,,,,,, +2031,,d279bdab-f489-4486-ac7e-143bca7a82a0,"QUIMICA FARMACEUTICA BAYER, S.A",quimica_farmaceutica_bayer_s_a,,,,,, +16,0.934144,51d90f84-9fff-4086-b7af-47e96a6585d1,VERTEX PHARMACEUTICALS INCOPORATED,vertex_pharmaceuticals_incoporated,,,,349884c4-73b1-11e6-a0cd-0242ac12000b,vertex_pharms,VERTEX PHARMS +2032,,5d3f54cf-dbc6-4c60-b55a-69c77ffd815e,"ViiV Healthcare, S.L",viiv_healthcare_s_l,,,,,, +2033,,2315a5d1-30d5-4d15-94a9-94460a3eb3e4,Guy's & St Thomas's NHS Foundation Trust,guy_s_st_thomas_s_nhs_foundation_trust,,,,,, +2034,,bd37af47-0cdb-4c45-a391-02a501c112a2,MCM Klosterfrau Vertriebs GmbH,mcm_klosterfrau_vertriebs_gmbh,,,,,, +2035,,c0df8070-9b5c-4d8b-8818-358fc77f8fcb,Eduardo García Díaz,eduardo_garc_a_d_az,,,,,, +2036,,d1a1fc54-0a8a-4d83-b66b-e12242b85552,MRC Health Services Research Collaboration,mrc_health_services_research_collaboration,,,,,, +2037,,7765414e-a95c-4222-bb57-748a2c2a74ec,FUNDACIÓN PÚBLICA ANDALUZA PROGRESO Y SALUD,fundaci_n_p_blica_andaluza_progreso_y_salud,,,,,, +2038,,90682075-f156-462a-b61c-6b879b34aa05,"Hvidovre Hospital, Anæstesiologisk afdeling 532",hvidovre_hospital_an_stesiologisk_afdeling_532,,,,,, +2039,,020919a1-8973-40e5-a795-ca5b91f4093d,Tayside Medical Science Centre,tayside_medical_science_centre,,,,,, +2040,,7ddce62c-8f59-477e-af1d-c396a7e7cf1f,"TiGenix, S.A. Unipersonal",tigenix_s_a_unipersonal,,,,,, +2041,,1994eb95-766a-4c1d-b9d8-2ae645b7b780,"Charité CBF, Endokrinologie",charit_cbf_endokrinologie,,,,,, +336,0.98143,48435603-2c2a-4b5c-bb17-b3b96be841f9,Universitätsklinikum Essen,universit_tsklinikum_essen,,,,1fd64b02-1ed5-4f02-a826-80abb2b33e23,universit_tsklinikum_essen_westdeutsches_tumorzentrum,"Universitätsklinikum Essen, Westdeutsches Tumorzentrum" +2042,,31fa220c-347d-4fc6-bee2-f2185eb3c634,FERROKIN BIOSCIENCES INC,ferrokin_biosciences_inc,,,,,, +2043,,124e72e6-7160-11e6-a0cd-0242ac12000b,ANABOLIC,anabolic,,,,,, +2044,,6dea90c2-5b52-4c3a-82e6-185f8f4e3deb,Fundación ACE,fundaci_n_ace,,,,,, +2045,,d017d445-cdca-445f-bbc7-5d08a2c2f665,University of Dundee and NHS Tayside,university_of_dundee_and_nhs_tayside,,,,,, +39,0.981087,277efbbe-0659-4d05-bc5a-4b600b2919e3,Innovacell Biotechnologie AG - Life Science Center Innsbruck,innovacell_biotechnologie_ag_life_science_center_innsbruck,,,,277efbbe-0659-4d05-bc5a-4b600b2919e3,innovacell_biotechnologie_ag_life_science_center_innsbruck,Innovacell Biotechnologie AG - Life Science Center Innsbruck +2046,,ff698371-4731-433c-b119-91485a9e8d61,"Department of Anesthesiology and Intensive Care, University Hospital Muenster",department_of_anesthesiology_and_intensive_care_university_hospital_muenster,,,,,, +497,0.976266,6f4fd964-7168-11e6-a0cd-0242ac12000b,ABHAI INC,abhai_inc,,,,6f4fd964-7168-11e6-a0cd-0242ac12000b,abhai_inc,ABHAI INC +2047,,5325958a-1305-4a1d-8ad4-5e378ca954ed,Hansa Medical AB,hansa_medical_ab,,,,,, +398,0.988564,e073b711-5d38-461b-98fa-4232f3e10c6e,St. Anna Kinderkrebsforschung,st_anna_kinderkrebsforschung,,,,40763009-de94-4c2e-a686-9a5a36e5ac86,st_anna_kinderkrebsforschung_ccri,St. Anna Kinderkrebsforschung/CCRI +2048,,656dc747-865b-4012-aa29-b29da4363b9b,Vrinnevi Hospital,vrinnevi_hospital,,,,,, +2049,,cbce6418-0d78-438e-a3c4-658855f1a778,JADO Technologies GmbH,jado_technologies_gmbh,,,,,, +2050,,a8058945-0305-4e32-bc4b-4350f29a3fae,InfaCare Pharmaceutical Corporation,infacare_pharmaceutical_corporation,,,,,, +953,0.97483021020889282,7366e944-7126-11e6-8a77-0242ac12000b,MYLAN,mylan,,,,7366e944-7126-11e6-8a77-0242ac12000b,mylan,MYLAN +2051,,b42c49a7-6486-45f0-a6f7-54de39002752,Eisai Manufacturing Limited,eisai_manufacturing_limited,,,,,, +384,0.94804,d4769d8c-3e0e-4c98-9b81-51f13b95b5e1,The University of Nottingham,the_university_of_nottingham,,,,8aa216f5-6b16-4908-9de4-6ff33dd6be69,the_univeristy_of_nottingham,The Univeristy of Nottingham +2052,,cbe2b26f-9c2d-4efb-ab5f-d3032b84a9d4,Polichem SA,polichem_sa,,,,,, +2053,,95821a01-207b-4eb8-9565-c683b3e3e281,Hospital General Universitario Gregorio Marañón de Madrid,hospital_general_universitario_gregorio_mara_n_de_madrid,,,,,, +2054,,dad20bdb-270b-4a5f-a5d6-26ba33b0a63f,Universitätsklinikum Hamburg-Eppendorf,universit_tsklinikum_hamburg_eppendorf,,,,,, +2055,,78cb3373-c013-4bf9-a7c3-bf09db61254a,Mª Luz Couce,m_luz_couce,,,,,, +2056,,21ccfe4a-6bf4-4ee1-9023-32eeb74771c5,Basilea Pharmaceutica International Ltd,basilea_pharmaceutica_international_ltd,,,,,, +482,0.9060404896736145,2023e16d-080b-4eeb-8515-b467f748a454,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Nephrologie",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klinische_abteilung_f_r_nephrologie,,,,2023e16d-080b-4eeb-8515-b467f748a454,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klinische_abteilung_f_r_nephrologie,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Nephrologie" +2057,,6d8dc8b9-a735-11e6-94cb-5656d04fc2b5,Axovant Sciences Limited,axovant_sciences_limited,,,,,, +2058,,b8bbf07c-8c48-4f7e-933b-6310189fd22c,"The Pediatric Clinics, The Juliane Marie Center, The Danish National Hospital ""Rigshospitalet",the_pediatric_clinics_the_juliane_marie_center_the_danish_national_hospital_rigshospitalet,,,,,, +321,0.97670942544937134,a5224f59-d528-4599-8b9c-3b2815dbb909,All Ireland Cooperative Oncology Research Group,all_ireland_cooperative_oncology_research_group,,,,12641096-e1dd-46f5-9635-3bd405807ce5,all_ireland_cooperative_oncology_research_group,All Ireland Cooperative Oncology Research Group +2059,,9c56f2d7-a613-4cef-9684-3547817c1a6d,Phytopharm plc,phytopharm_plc,,,,,, +2060,,981b5a27-1c14-4f69-98f8-49192b4b6c8c,University of Mainz,university_of_mainz,,,,,, +2061,,c49817d2-620c-4242-bab0-14c95d6cd3a1,Medical University of Graz,medical_university_of_graz,,,,,, +2062,,8fb79d72-f583-4732-b077-89d4de96aefe,Actavis Group PTC ehf,actavis_group_ptc_ehf,,,,,, +2063,,1a9dd09a-7142-11e6-a0cd-0242ac12000b,MONARCH PHARMS,monarch_pharms,,,,,, +2064,,0186bc10-7161-11e6-a0cd-0242ac12000b,WENDT,wendt,,,,,, +881,0.98713856935501099,1c3d56fb-b1f2-4c6a-9f11-76a16c719843,PIERRE FABRE MEDICAMENT,pierre_fabre_medicament,,,,d9486864-e255-4256-b088-49f706c79293,pierre_fabre_medicament,PIERRE FABRE MEDICAMENT +2065,,3305d1cd-b69a-47d4-b047-e07da0fa8520,CNRS: VAN DER REST Michel,cnrs_van_der_rest_michel,,,,,, +2066,,9c8e3e87-fcf2-4d31-af20-50c0ddeb082f,JDRF Danielle Alberti Memorial Centre For Diabetes Complications Baker Heart Research Institute,jdrf_danielle_alberti_memorial_centre_for_diabetes_complications_baker_heart_research_institute,,,,,, +2067,,22779437-fb38-4b35-a4b6-e7baffdee94f,Chiron Behring GmbH & Co KG,chiron_behring_gmbh_co_kg,,,,,, +2068,,485f94f6-2273-4a83-9a0b-c8dd9e3c6679,"GenVec, Inc",genvec_inc,,,,,, +2069,,aff5735e-2d89-40af-8f8a-d1d6f9ead7ad,University Medical Centre Utrech,university_medical_centre_utrech,,,,,, +2070,,19f9db20-58f4-48fb-8c1f-4311fff09e5f,Birthe Pedersen,birthe_pedersen,,,,,, +2071,,407f43e6-eee8-4e81-8530-48c0a1749021,Teijo Saari,teijo_saari,,,,,, +2072,,21fe2617-59e4-4a5f-b512-30ba2aa65cf6,The George Institute for Global Health Australia,the_george_institute_for_global_health_australia,,,,,, +2073,,608fb9af-780e-46a5-9b59-f4816641a292,University of Heidelberg,university_of_heidelberg,,,,,, +2074,,19fb0068-7142-11e6-a0cd-0242ac12000b,ELORAC,elorac,,,,,, +2075,,236d144e-6fba-11e6-abe8-0242ac12000b,Neovacs S.A,neovacs_s_a,,,,,, +2076,,833d0c69-8200-4fce-8d57-06e36c4612cc,"Helsinki University Central Hospital, Skin and Allergy Hospital",helsinki_university_central_hospital_skin_and_allergy_hospital,,,,,, +2077,,1cd340ba-ae3f-4a06-9b39-b804bdd5d291,Abbvie Deutschland GmbH & Co. K.G,abbvie_deutschland_gmbh_co_k_g,,,,,, +877,0.943406,06cdfc3c-1180-4e50-a488-39de382fbc30,"Department of Dermatology D92, Bispebjerg Hospital",department_of_dermatology_d92_bispebjerg_hospital,,,,06cdfc3c-1180-4e50-a488-39de382fbc30,department_of_dermatology_d92_bispebjerg_hospital,"Department of Dermatology D92, Bispebjerg Hospital" +2078,,f88d7e6b-d5dc-46d9-9563-92408ebd7b1a,Helsingin reumakeskus,helsingin_reumakeskus,,,,,, +2079,,59b1a3a4-73d8-11e6-a0cd-0242ac12000b,NEOS THERAPS,neos_theraps,,,,,, +2080,,78b0a3fc-8765-437f-8ca3-af6c3e16a3bf,"Medical University of Graz, Department of Internal Medicine, Div. Endocrinology and Nuclear Medicine",medical_university_of_graz_department_of_internal_medicine_div_endocrinology_and_nuclear_medicine,,,,,, +2081,,52f56d5a-162b-40e3-ae03-5aea52e61203,"The Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital",the_department_of_cardiothoracic_and_vascular_surgery_aarhus_university_hospital,,,,,, +2082,,d6247337-6ad2-4ae7-be40-c521d144f629,Princess Alexandra Hospital,princess_alexandra_hospital,,,,,, +2083,,3dd88550-d36e-43eb-ac1f-77785d757c08,Slotervaart Hospital,slotervaart_hospital,,,,,, +2084,,6c87f2b4-31c1-4f24-bd66-3a862b3cd0ff,"Scleroseklinikken, Rigshospitalet",scleroseklinikken_rigshospitalet,,,,,, +2085,,230e12b4-558c-464d-a0ef-b8d76b7f1398,FUNDACIÓN GREGORIO MARAÑÓN,fundaci_n_gregorio_mara_n,,,,,, +261,0.938998,e6b8a267-0ac8-4cbd-b8ab-ac657d43c126,Servicio de Nefrologia-Hospital Universitario Vall d'Hebron,servicio_de_nefrologia_hospital_universitario_vall_d_hebron,,,,d226d28e-bcc2-49e5-b106-505094f7139d,servicio_de_neumologia_hospital_universitario_vall_d_hebron,Servicio de Neumologia. Hospital Universitario Vall d'Hebron +2086,,1d68ed36-25ae-47ab-9d1f-e0ad418a20ad,Brighton and Sussex University Hospitals NHS Trust,brighton_and_sussex_university_hospitals_nhs_trust,,,,,, +2087,,252fecd0-6fbe-11e6-abe8-0242ac12000b,UniversitätsSpital Zürich,universit_tsspital_z_rich,,,,,, +2088,,f5d76b18-6fa2-11e6-9663-0242ac12000b,Daiichi Asubio Pharmaceuticals Inc,daiichi_asubio_pharmaceuticals_inc,,,,,, +2089,,615b6d7d-9319-477f-8afd-c1f2c02cb238,Robugen GmbH,robugen_gmbh,,,,,, +2090,,d9afd4bd-f7c7-4288-9575-0d72aeaa5963,"Novartis Healthcare Pvt. Ltd., Vaccines Division",novartis_healthcare_pvt_ltd_vaccines_division,,,,,, +2091,,cfac284e-201a-4d22-80c5-8cca53027bdb,Infant Bacterial Therapeutics AB,infant_bacterial_therapeutics_ab,,,,,, +436,0.95875248312950134,5279e7a0-be2f-4951-aef4-b57bc1e52779,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017, United states",pfizer_inc_235_east_42nd_street_new_york_ny_10017_united_states,,,,25203332-c6eb-4eda-87c7-a780f5142133,pfizer_inc_235_east_42nd_street_new_york_ny10017_united_states,"Pfizer Inc., 235 East 42nd Street, New York, 10017, United States" +2092,,4831bf48-0ae1-4b9b-ab97-401c87f8b711,Laboratoires Mayoly Spindler SA,laboratoires_mayoly_spindler_sa,,,,,, +2093,,cf1cea5f-413c-40a2-be9d-75eb4e338315,ZooBiotic Limited,zoobiotic_limited,,,,,, +2094,,c66ff36f-6390-4b56-8ec3-2e0247fd4281,University of Exeter,university_of_exeter,,,,,, +2095,,bff9ce9d-a726-4391-bf1c-151c1e503c5e,JOSE MANUEL GARCIA DOMINGUEZ,jose_manuel_garcia_dominguez,,,,,, +864,0.973341,e718e1af-e57d-457c-9e97-8ef88faf2a76,"NHS Grampian, Aberdeen Royal Infirmary",nhs_grampian_aberdeen_royal_infirmary,,,,a333a82a-36dd-4629-8cf3-573aaa584a38,nhs_grampian,NHS Grampian +2096,,29b43190-7143-11e6-a0cd-0242ac12000b,LEDERLE,lederle,,,,,, +2097,,2f1a9a2c-e70d-4b3d-b578-1c836f136542,CHU de Fort-de-France,chu_de_fort_de_france,,,,,, +2098,,77efc05a-5498-438b-b258-e135cf55a017,ReNeuron Ltd,reneuron_ltd,,,,,, +2099,,dc88850b-ef07-4373-9efd-54ac50a07689,Prof. Giampiero CAMPANELLI,prof_giampiero_campanelli,,,,,, +2100,,fae59fe0-1161-4a21-b5ed-d0d5febbcc0f,PD Dr. Maria De Santis,pd_dr_maria_de_santis,,,,,, +571,0.977622,cfa63376-7140-11e6-a0cd-0242ac12000b,FOUGERA PHARMS,fougera_pharms,,,,8a1a7572-7142-11e6-a0cd-0242ac12000b,fougera,FOUGERA +2101,,87b57f12-7150-11e6-a0cd-0242ac12000b,TRACE LIFE,trace_life,,,,,, +2102,,2338ecd4-ce50-4bc5-ba5c-49357907de94,Dr. Antonio Javier Trujillo Santos,dr_antonio_javier_trujillo_santos,,,,,, +2103,,60997ba9-33ae-4017-af70-5a2ac599563f,Fundación GEL/TAMO (Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea),fundaci_n_gel_tamo_grupo_espa_ol_de_linfomas_y_trasplante_aut_logo_de_m_dula_sea,,,,,, +2104,,1484b435-1ec8-4d94-b273-c880c03aef84,Laboratoire BAILLY-CREAT,laboratoire_bailly_creat,,,,,, +905,0.98715120553970337,18d9ea5c-b3a8-49aa-a224-39aa5d2a425d,King's College London,king_s_college_london,,,,18d9ea5c-b3a8-49aa-a224-39aa5d2a425d,king_s_college_london,King's College London +2105,,81dec2f7-f060-4107-845b-492cdd310239,UZBrussel Department of Anesthesiology and Perioperative Medicine, Acute and Chronic Pain Therapy,,,,,, +2106,,2673e6bd-5f04-41ef-b346-197a6ad5f2c2,Laboratoire HRA Pharma,laboratoire_hra_pharma,,,,,, +2107,,91e5f262-25f4-416c-ae86-7744e58723d6,TRASTEC,trastec,,,,,, +2108,,f276eb8e-2628-4655-bb2a-80b8f529206b,Poissy Hospital,poissy_hospital,uzbrussel_department_of_anesthesiology_and_perioperative_medicine_acute_and_chronic_pain_therapy,,,,, +2109,,83e346d5-b775-47ec-b8db-8c2ee78ea192,"NOVAG S.A., FERRER GRUPO",novag_s_a_ferrer_grupo,,,,,, +2110,,d3a40b34-1d85-4d0a-b8c4-7a5397513e97,Fundación SEIMC-GESIDA,fundaci_n_seimc_gesida,,,,,, +147,0.989212,d1b2f592-a4c6-4429-904f-202000c36a22,Sociedad Andaluza de Trasplante de Órganos y Tejidos,sociedad_andaluza_de_trasplante_de_rganos_y_tejidos,,,,552c8b5e-6e4d-462c-97e1-a56f192796b2,sociedad_andaluza_de_trasplante_de_rganos_y_tejidos_satot,Sociedad Andaluza de Trasplante de Órganos y Tejidos (SATOT) +2111,,8da3b094-7167-11e6-a0cd-0242ac12000b,IBA MOLECULAR N AM,iba_molecular_n_am,,,,,, +2112,,5f5bcf5a-ea89-4d77-ab09-6d1993494765,University Hospital Ostrava,university_hospital_ostrava,,,,,, +2113,,c944a8de-c381-41f0-9752-5a2d3c343612,"Department of Psychiatry, Ludwig-Maximilians-University Munich",department_of_psychiatry_ludwig_maximilians_university_munich,,,,,, +2114,,1242ab36-1c75-445d-87ee-977c5fba7d9e,"REPLIDYNE, INC",replidyne_inc,,,,,, +2115,,26be1bcc-8416-48d1-8e87-824ea9ccdd34,"Lexicon Pharmaceuticals, Inc",lexicon_pharmaceuticals_inc,,,,,, +748,0.952392,e18b3cc7-abc6-4eaf-8f2f-60b271d0cb75,North Bristol NHS Trust Research and Development Office,north_bristol_nhs_trust_research_and_development_office,,,,e18b3cc7-abc6-4eaf-8f2f-60b271d0cb75,north_bristol_nhs_trust_research_and_development_office,North Bristol NHS Trust Research and Development Office +2116,,9e5f378d-7876-4fc9-8d83-54dfa6ab7b5d,AZIENDA USL 8 AREZZO,azienda_usl_8_arezzo,,,,,, +280,0.978312,acbce76f-4566-4480-b1d9-e6b09b7c9c66,Vejle Hospital,vejle_hospital,,,,038ffc9a-cc49-4155-9812-d242dccadca0,vejle_hospital_dept_of_oncology,"Vejle Hospital, Dept. of Oncology" +2117,,d1a40e6c-7142-11e6-a0cd-0242ac12000b,ACTAVIS MID ATLANTIC,actavis_mid_atlantic,,,,,, +2118,,e53665fc-b628-4c78-a135-fabd370fe8ef,"Department of Neuroscience, NTNU",department_of_neuroscience_ntnu,,,,,, +2119,,964b3564-718a-11e6-a0cd-0242ac12000b,JANSSEN BIOTECH,janssen_biotech,,,,,, +2120,,2af2e3b5-7c80-417b-9769-27cecf532d4a,CHU Rennes,chu_rennes,,,,,, +2121,,6245ae80-4d89-4bc3-9452-7bddbe128931,Charité Universitaetsmedizin,charit_universitaetsmedizin,,,,,, +2122,,69fd2257-0edd-41e9-87ce-db4a5c3e5144,University of Hertfordshire,university_of_hertfordshire,,,,,, +2123,,15d0febc-7146-11e6-a0cd-0242ac12000b,SOAPCO,soapco,,,,,, +2124,,649fce6c-508f-43bd-934c-eaf1be18b025,"University of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy",university_of_debrecen_medical_and_health_science_center_department_of_anaesthesiology_and_intensive_therapy,,,,,, +2125,,871917c4-bb39-4e79-aff8-5d359ee839aa,MARIA TERESA PARRAS MALDONADO,maria_teresa_parras_maldonado,,,,,, +2126,,bd0fadf1-f344-4524-ab73-ca7e11604659,Hospital General de Ciudad Real,hospital_general_de_ciudad_real,,,,,, +388,0.969459,8b0575a1-8376-4915-a366-981ce5a80282,"Uppsala University Hospital, Dept of Medical Scienses",uppsala_university_hospital_dept_of_medical_scienses,,,,8b0575a1-8376-4915-a366-981ce5a80282,uppsala_university_hospital_dept_of_medical_scienses,"Uppsala University Hospital, Dept of Medical Scienses" +2127,,2c4c9532-ebd2-41b0-994a-1344b2fd65f7,FUNDACIÓN PARA LA FORMACIÓN E INVESTIGACIÓN SANITARIAS DE LA REGIÓN DE MURCIA,fundaci_n_para_la_formaci_n_e_investigaci_n_sanitarias_de_la_regi_n_de_murcia,,,,,, +305,0.974081,5bc4c1d9-6cde-4851-827c-0b196ea4da36,Erasmus MC - Sophia Children's Hospital,erasmus_mc_sophia_children_s_hospital,,,,1d4eea22-5d60-4df5-ad75-599835189ec4,erasmusmc_sophia_children_s_hospital,ErasmusMC - Sophia Children's Hospital +2128,,bfef700e-29b7-420d-84d0-ff462bafa759,INDUSTRIA FARMACEUTICA SERONO,industria_farmaceutica_serono,,,,,, +964,0.94218007723490393,13d0aa47-c66c-42d9-a5e4-2336faccc2e1,Helsinki Uniersity Central Hospital,helsinki_uniersity_central_hospital,,,,16556fb5-6653-4d5b-bd94-fc6343fa4fd8,helsinki_university_central_hospital,Helsinki University Central Hospital +2129,,2e3cf633-e757-455f-a606-af2225efab0a,Northumbria Healthcare NHS Foundation Trust,northumbria_healthcare_nhs_foundation_trust,,,,,, +992,0.97264575958251953,85bd52ce-4912-412b-98e5-33039d390569,Medizinische Universität Innsbruck / Univ.-Klinik für Allg. und Chirurg. Intensivmedizin,medizinische_universit_t_innsbruck_univ_klinik_f_r_allg_und_chirurg_intensivmedizin,,,,85bd52ce-4912-412b-98e5-33039d390569,medizinische_universit_t_innsbruck_univ_klinik_f_r_allg_u_chirurg_intensivmedizin,Medizinische Universität Innsbruck / Univ.-Klinik für Allg. u. Chirurg. Intensivmedizin +665,0.98648929595947266,f6d48103-0f0c-4464-8cd2-7589fc1def08,"Charité-Universitätsmedizin Berlin, Germany",charit_universit_tsmedizin_berlin_germany,,,,f6d48103-0f0c-4464-8cd2-7589fc1def08,charit_universit_tsmedizin,Charité-Universitätsmedizin Berlin +2130,,c042069e-7373-4465-8085-e3eb24461c90,"Takeda Development Centre Europe, Ltd",takeda_development_centre_europe_ltd,,,,,, +2131,,13af24c5-ea11-4333-a6b1-f771aa334ff3,Chugai Pharmaceutical Co. Ltd,chugai_pharmaceutical_co_ltd,,,,,, +2132,,54e13cb9-b49e-48a8-b214-7d357dd5cd12,Centre hospitalier universitaire d'Amiens,centre_hospitalier_universitaire_d_amiens,,,,,, +813,0.94623455405235291,45261051-f8a9-4d4c-a48e-fb89c9492d92,ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS,istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori_irst_s_r_l_irccs,,,,d8bfcede-efc3-4714-b642-f79fb12833f5,istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori,ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI +2133,,de740ddc-442d-45d9-958e-3daac063ff56,Takeda Pharma A/S,takeda_pharma_a_s,,,,,, +2134,,827411e6-05aa-46ab-ad11-ff1a58d190ff,AOP ORPHAN PHARMACEUTICALS,aop_orphan_pharmaceuticals,,,,,, +2135,,f9d27789-0ec3-444c-ba71-d19a98d31c84,Dr. J.A. Barberà. Servicio de Neumología. Hospital Clínic de Barcelona,dr_j_a_barber_servicio_de_neumolog_a_hospital_cl_nic_de_barcelona,,,,,, +2136,,6c9eb135-e639-4e17-958d-b6e670a783a5,GlaxoSmithKline Centre of Excellence,glaxosmithkline_centre_of_excellence,,,,,, +2137,,37de4dbf-48d1-4c8d-9b5a-0514d1a2c8c9,NPS PHARMACEUTICALS,nps_pharmaceuticals,,,,,, +2138,,35928660-8648-463d-9110-15df4545d158,GBG Forchungs GmBH,gbg_forchungs_gmbh,,,,,, +2139,,58004e38-0908-454f-a112-b9c397610d63,Institut für Frauengesundheit GmbH,institut_f_r_frauengesundheit_gmbh,,,,,, +2140,,7ce18070-9c5b-4724-baef-1d8b11444d11,Boehringer Ingelheim Pharmaceuticals (Pty) Ltd,boehringer_ingelheim_pharmaceuticals_pty_ltd,,,,,, +2141,,bcb2c601-7dba-46c3-a25d-a7438b30948c,"SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU",salk_gemeinn_tzige_salzburger_landeskliniken_betriebsges_m_b_h_christian_doppler_klinik_uk_f_r_neurologie_der_pmu,,,,,, +826,0.9834962785243988,ff19d072-54b8-4632-a1ae-bbc176010b8a,Department of Nephrology and Renal Transplantation,department_of_nephrology_and_renal_transplantation,,,,e662831f-0d28-42b9-a406-77cb46fe2d36,department_of_nephrology_and_renal_transplantation,Department of Nephrology and Renal Transplantation +2142,,f2a0eb8b-00ee-4171-9718-12df7e22f5e4,Medi-Flex,medi_flex,,,,,, +2143,,8d9e5530-98ef-4383-a46d-bd121b9d1dd7,Common Services Agency,common_services_agency,,,,,, +2144,,b633b7e9-814c-4254-be35-19abcae9a9e3,Oncology Institute of Southern Switzerland,oncology_institute_of_southern_switzerland,,,,,, +2145,,fdfc99b8-6f97-11e6-9663-0242ac12000b,"Autoimmune Technologies, LLC",autoimmune_technologies_llc,,,,,, +2146,,c8fe3779-277e-42b2-b642-49f742f7f2be,"Novelos Therapeutics, Inc",novelos_therapeutics_inc,,,,,, +2147,,dc52f3a7-6e0a-4a89-a57e-931fbbbf598c,José Manuel Porcel Pérez Hospital Arnau de Vilanova de Lleida Servicio Medicina Interna,jos_manuel_porcel_p_rez_hospital_arnau_de_vilanova_de_lleida_servicio_medicina_interna,,,,,, +2148,,48be98fa-8f26-4eb0-acea-948916f7a5cc,Duke University,duke_university,,,,,, +2149,,b8fb9790-5523-4faa-8817-65b561b4598c,Sørlandet Sykehus HF,s_rlandet_sykehus_hf,,,,,, +2150,,382eba7c-bb3d-44db-ba74-080a093bf828,"Elevation Pharmaceuticals, Inc",elevation_pharmaceuticals_inc,,,,,, +753,0.987206,665866e6-cb85-4777-9b73-c87834f2d95c,Sun Pharma Advanced Research Company Ltd. (SPARC),sun_pharma_advanced_research_company_ltd_sparc,,,,29241c8d-7ad8-4877-83dd-b4d1b01b5563,sun_pharma_advanced_research_company,Sun Pharma Advanced Research Company +2151,,fc698f2b-42e8-46bd-9b15-e90f2760c91c,The Austrian Society of Surgical Oncology (ACO-ASSO),the_austrian_society_of_surgical_oncology_aco_asso,,,,,, +2152,,214e5c86-fbe4-4a2d-810e-ba2f1c9b3ef1,The Nordic CML Study Group,the_nordic_cml_study_group,,,,,, +2153,,87dc63ba-431d-4ceb-9cbd-cc0221708670,Antisense Pharma GmbH,antisense_pharma_gmbh,,,,,, +2154,,35eae5fe-c310-4194-b4d3-c4b749e8a004,Aegerion Pharmaceuticals Inc,aegerion_pharmaceuticals_inc,,,,,, +2155,,b2a07469-9752-4517-9f14-ec7ec88e4d00,Katholieke Universiteit Leuven - Pharmacotechnology and Biopharmacy,katholieke_universiteit_leuven_pharmacotechnology_and_biopharmacy,,,,,, +2156,,ccbfaa50-9c5b-4e56-aa07-97fa87cebef4,St. Elisabeth Ziekenhuis,st_elisabeth_ziekenhuis,,,,,, +646,0.96602542698383331,9911d666-737a-45f5-9c81-144d773d7ea2,Boehringer Ingelheim Ellas A.E,boehringer_ingelheim_ellas_a_e,,,,237ec247-b474-4bd6-9041-c2ffb0213c0e,boehringer_ingelheim_ellas,Boehringer Ingelheim Ellas +2157,,50ae8a9d-17cb-432b-8df6-ae512497054a,"The Cardiovascular MR Group, Dept. 2011, Rigshospitalet",the_cardiovascular_mr_group_dept_2011_rigshospitalet,,,,,, +966,0.963804,77f76197-601c-4f7d-a484-16ca18daeb6c,Isala,isala,,,,77f76197-601c-4f7d-a484-16ca18daeb6c,isala,Isala +2158,,109ce233-d0ba-4a2a-941f-7b6ce95e9b67,SAKK - GRUPPO SVIZZERO DI RICERCA CLINICA SUL CANCRO,sakk_gruppo_svizzero_di_ricerca_clinica_sul_cancro,,,,,, +2159,,8f97f4a9-acf0-4e66-9e95-6d96c4236c7f,"Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin",allergie_centrum_charit_charit_universit_tsmedizin_berlin,,,,,, +2160,,925a0b6f-8808-41de-a8fe-ba66fe766f1f,Activaero GmbH,activaero_gmbh,,,,,, +2161,,b356e087-d991-4284-86ea-5a9934ea422a,Servicio de Anestesia Infantil. Hospital Universitario La Paz,servicio_de_anestesia_infantil_hospital_universitario_la_paz,,,,,, +2162,,6d4c6a3a-73c8-11e6-a0cd-0242ac12000b,PARAGON BIOTECK,paragon_bioteck,,,,,, +2163,,b351474c-387b-4c87-b88b-723a995d302d,TÜ Kardioloogiakliinik,t_kardioloogiakliinik,,,,,, +806,0.9831,8c3e61bc-f8b8-4391-8314-26161be485ab,The Royal Liverpool and Broadgreen University Hospitals NHS Trust,the_royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,,,,8c3e61bc-f8b8-4391-8314-26161be485ab,the_royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,The Royal Liverpool and Broadgreen University Hospitals NHS Trust +1051,0.981904,4bcc1755-5dc6-434d-aed0-d5fa3a830bf2,Bioenvision Limited,bioenvision_limited,,,,4bcc1755-5dc6-434d-aed0-d5fa3a830bf2,bioenvision_limited,Bioenvision Limited +2164,,7ad4887a-3617-4bce-b02b-0f3fbc221154,ProstaLundOperations AB,prostalundoperations_ab,,,,,, +2165,,19756812-6953-4790-afc4-16c005d6e5bf,Novartis Pharma Belgium,novartis_pharma_belgium,,,,,, +2166,,daa67e84-7159-11e6-a0cd-0242ac12000b,IVAX PHARMS,ivax_pharms,,,,,, +2167,,3ac25975-df07-469f-8709-c2746d249da7,University Hospital Antwerp,university_hospital_antwerp,,,,,, +2168,,927fe419-74ea-41f1-8959-4cf0bd2632da,"Medizinische Universität Wien, Klinik für Innere Medizin III, Klin. Abteilung für Nephrologie und Dialyse",medizinische_universit_t_wien_klinik_f_r_innere_medizin_iii_klin_abteilung_f_r_nephrologie_und_dialyse,,,,,, +176,0.96485203504562378,bfd7331d-6d18-4faa-8fd6-fe957061def6,Novartis Vaccines and Diagnostics Srl,novartis_vaccines_and_diagnostics_srl,,,,fbdb10c1-6146-4761-86bf-a8541dc3b4fa,novartis_vaccines_and_diagnostics,Novartis Vaccines and Diagnostics +2169,,00adeeda-de6e-4a6d-b301-74009057b83d,JOAQUIN PORTILLA,joaquin_portilla,,,,,, +2170,,057c238f-12c1-441f-ae09-021ba6782283,Christoffer Hedetoft,christoffer_hedetoft,,,,,, +5,0.90053069591522217,d883794e-fe54-4fc1-bf84-4e58dd7b2648,Centre Hospitalier Universitaire de La Réunion,centre_hospitalier_universitaire_de_la_r_union,,,,dd5747ea-816f-45f7-b207-0763f720a969,centre_hospitalier_universitaire_de_li_ge,Centre Hospitalier Universitaire de Liège +2171,,11277c1c-898e-4e13-8fe6-347fe1f28c4b,"EnVivo Pharmaceuticals, Inc",envivo_pharmaceuticals_inc,,,,,, +2172,,cb253c7a-6fba-11e6-abe8-0242ac12000b,Napp Pharmaceuticals Limited,napp_pharmaceuticals_limited,,,,,, +2173,,8d00d89e-586d-4d10-ac69-d403474e3813,"Watson Laboratories, Inc. - A subsidiary of Actavis, Inc",watson_laboratories_inc_a_subsidiary_of_actavis_inc,,,,,, +2174,,e954c38a-556f-4e14-b048-5f2586ca6ef0,PROF. TIZIANO GHERLI,prof_tiziano_gherli,,,,,, +621,0.956445,9655af03-762e-4bf2-ab8b-bd82fb1ed0a5,"Universitätsklinik für Innere Medizin IV, Klinische Abteilung Gastroenterologie und Hepatologie",universit_tsklinik_f_r_innere_medizin_iv_klinische_abteilung_gastroenterologie_und_hepatologie,,,,52d997a2-9f49-426b-bfc6-c251dadcce43,universit_tsklinik_f_r_innere_medizin_iii_klinische_abteilung_f_r_gastroenterologie_und_hepatologie,"Universitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie" +2175,,e684f99c-0f0f-4155-9fc1-26ab82eefd73,GeneMedix plc,genemedix_plc,,,,,, +733,0.982275,7e09558a-ee7d-474c-9101-17cf9741e4d6,Technical University Munich,technical_university_munich,,,,7e09558a-ee7d-474c-9101-17cf9741e4d6,technical_university_munich,Technical University Munich +2176,,2b0695ed-65f3-4e32-a688-ccfc49d6ed39,masimo,masimo,,,,,, +2177,,ee60a64b-ed90-4582-84b7-ea2799b249bf,ABScience,abscience,,,,,, +2178,,85292d75-9d48-444e-8d9c-7d67642159ba,"ORTHO BIOTECH, Division of JANSSEN-CILAG GmbH",ortho_biotech_division_of_janssen_cilag_gmbh,,,,,, +2179,,a04034e0-a727-11e6-94cb-5656d04fc2b5,"Herlev & Gentofte Hospital, Oncology Dept",herlev_gentofte_hospital_oncology_dept,,,,,, +2180,,f026f13f-a5ac-4bf8-be20-8909ce0470ca,"Visterra, Inc",visterra_inc,,,,,, +2181,,e3e5aae2-715e-11e6-a0cd-0242ac12000b,TABLICAPS,tablicaps,,,,,, +827,0.98834410309791565,975869a5-d12b-4f5f-9a3d-d76a15c61a6a,INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE VALENCIA,instituto_de_investigaci_n_sanitaria_la_fe_de_valencia,,,,975869a5-d12b-4f5f-9a3d-d76a15c61a6a,instituto_de_investigaci_n_sanitaria_la_fe_de,INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE +2182,,cb750f0b-0900-40eb-a2d3-3488710b76ad,"University of Trondheim, NTNU, Norway",university_of_trondheim_ntnu_norway,,,,,, +987,0.985423,66dfa91e-7193-11e6-a0cd-0242ac12000b,ASPEN GLOBAL,aspen_global,,,,497e2c7a-7165-11e6-a0cd-0242ac12000b,aspen_global_inc,ASPEN GLOBAL INC +2183,,fa3939e5-9232-4a98-abc5-742b7910fba9,United Bristol Healthcare NHS Trust,united_bristol_healthcare_nhs_trust,,,,,, +2184,,954240e4-7140-11e6-a0cd-0242ac12000b,EPIC PHARMA,epic_pharma,,,,,, +2185,,4935c0a6-8ba6-47b9-a351-01796928a100,Nutrinia Ltd,nutrinia_ltd,,,,,, +2186,,15ecdbb6-60d8-4e72-8613-1ae2204f881b,Liisa Elomaa,liisa_elomaa,,,,,, +104,0.987186,b7f24e50-8445-4a02-9bbf-c06da892f699,Merck Lipha Santé,merck_lipha_sant,,,,75e8ee69-62d3-42ee-992e-eee1cd45ffb8,merck_lipha_sant_sas,Merck Lipha Santé SAS +758,0.919169,e029c264-bd4f-4753-a984-31fcff699b06,Especialidades Farmaceúticas Centrum S.A,especialidades_farmace_ticas_centrum_s_a,,,,b7570d88-35b2-48c8-bf49-66ed83edbe35,especialidades_farmac_uticas_centrum_s_a,"Especialidades Farmacéuticas Centrum, S.A" +2187,,8db0c2ca-7167-11e6-a0cd-0242ac12000b,GROUPE PARIMA INC,groupe_parima_inc,,,,,, +2188,,4cb6c19d-d7ee-439c-9940-90a2aa9023e3,Institut de Recerca Hospital Sta. Creu i St. Pau,institut_de_recerca_hospital_sta_creu_i_st_pau,,,,,, +2189,,db876a6e-f5ff-4308-b0c9-465e345f6f51,County council of Ostergotland,county_council_of_ostergotland,,,,,, +1062,0.98627,68e001f6-0acf-4ba6-831c-dae305950d6b,Sint Franciscus Gasthuis,sint_franciscus_gasthuis,,,,68e001f6-0acf-4ba6-831c-dae305950d6b,sint_franciscus_gasthuis,Sint Franciscus Gasthuis +2190,,4b5089f1-894c-49fa-881b-5bdb604d0c45,Clínica Plató Fundació Privada,cl_nica_plat_fundaci_privada,,,,,, +2191,,1761ac72-7cbf-434e-a924-6ac0a11dbaba,Biomet NL,biomet_nl,,,,,, +2192,,f1ff7a6e-421a-4bd4-9299-3d66eb82649a,ITALFARMACO S.A,italfarmaco_s_a,,,,,, +525,0.98547,254a684e-a281-4ecf-989d-ea9a018d8552,University Hospital of Wuerzburg,university_hospital_of_wuerzburg,,,,254a684e-a281-4ecf-989d-ea9a018d8552,university_hospital_of_wuerzburg,University Hospital of Wuerzburg +2193,,8b2758d3-4dfa-45b1-8492-00a716b31afe,University Medical Centre Ljubljana,university_medical_centre_ljubljana,,,,,, +2194,,09858a78-729b-11e6-a0cd-0242ac12000b,EXELTIS USA INC,exeltis_usa_inc,,,,,, +2195,,dadb465a-6fa1-11e6-9663-0242ac12000b,Novartis Sweden AB,novartis_sweden_ab,,,,,, +2196,,8f9ebfec-8be8-11e6-a449-0242ac12000b,GlaxoSmithKline Research anda Development,glaxosmithkline_research_anda_development,,,,,, +2197,,4594b4d2-a124-49ba-96d2-6e15da9f27f0,"Capnia, Inc",capnia_inc,,,,,, +2198,,5fbbd71b-bd74-4bcf-a2d7-56ef620b2296,Rheumazentrum Ruhrgebiet,rheumazentrum_ruhrgebiet,,,,,, +2199,,a8eea728-cf24-49d6-bd52-5ea8f2ff20bf,"National Institute of Allergy and Infectious Diseases, National Institutes of Health",national_institute_of_allergy_and_infectious_diseases_national_institutes_of_health,,,,,, +2200,,1ee1056c-80bf-4e3e-8c90-f7ca377c5398,Alfacell Corporation,alfacell_corporation,,,,,, +2201,,c80f0c7e-715d-11e6-a0cd-0242ac12000b,HOSPIRA WORLDWIDE,hospira_worldwide,,,,,, +2202,,26a0a310-360f-4de8-98dd-9a8144e6f11a,KV Pharmaceutical Co,kv_pharmaceutical_co,,,,,, +2203,,899912bf-be0c-4787-8ede-ee02f88fda18,OSPEDALE G.PASQUINUCCI-FONDAZIONE G.MONASTERIO,ospedale_g_pasquinucci_fondazione_g_monasterio,,,,,, +2204,,4d9dee60-32b5-452c-8328-6ed126a2e7ea,IDIBAPS,idibaps,,,,,, +2205,,4bc8802c-5b07-4c6d-a4db-f2edd0f68d85,Service Desk,service_desk,,,,,, +2206,,afae719e-274c-4a4e-a7f2-e42c0bced641,GISCAD,giscad,,,,,, +2207,,ecab9994-9e4f-4439-8c65-bafbe9c73ac4,"Activus Pharma Co., Ltd",activus_pharma_co_ltd,,,,,, +2208,,474d9400-914f-44a2-9690-f78b557689cb,Jagiellonian University Medical College,jagiellonian_university_medical_college,,,,,, +2209,,a736c09b-fbd8-4a27-94ce-76402b12f39f,Department of Ophthalmology,department_of_ophthalmology,,,,,, +2210,,63f74f04-ae70-41f1-baf0-24c57f55c691,"Afdeling V, Aarhus Sygehus",afdeling_v_aarhus_sygehus,,,,,, +2211,,a6717cb0-46f0-4ef5-9778-8b8484069cff,"Medizinische Universität Wien, Abteilung für Anästhesie und Intensivmedizin",medizinische_universit_t_wien_abteilung_f_r_an_sthesie_und_intensivmedizin,,,,,, +2212,,fd921e86-279c-4e96-b83b-3324836b9d36,North Estonia Medical Centre Foundation,north_estonia_medical_centre_foundation,,,,,, +2213,,380c43b5-2c4a-4a1b-8e48-0e7040d6a17b,University Clinic of Dermatology Division of Special and Enviromental Dermatology,university_clinic_of_dermatology_division_of_special_and_enviromental_dermatology,,,,,, +724,0.981953,c0f9399c-2b0a-4f97-bddd-c3658b4892b6,University of Iceland,university_of_iceland,,,,52dd1d55-52d2-42d6-b026-3416877c1096,university_of_iceland_dept_pharmacology,"University of Iceland, Dept. Pharmacology" +2214,,e7ea91ca-6fa1-11e6-9663-0242ac12000b,IKP,ikp,,,,,, +2215,,2e4c8442-e989-4737-8e94-ebf545016560,University hospital Brussel,university_hospital_brussel,,,,,, +2216,,fcb11d96-c211-44f5-ace6-c8d672f8192f,Universitaetsklinikum Wuerzburg,universitaetsklinikum_wuerzburg,,,,,, +243,0.982397,84165c73-a712-4209-9005-cccca1ac46d9,Oxford BioMedica,oxford_biomedica,,,,84165c73-a712-4209-9005-cccca1ac46d9,oxford_biomedica,Oxford BioMedica +2217,,623390b5-5644-45fe-8f5d-9eb142632001,Cristália Produtos Químicos Farmacêuticos Ltda,crist_lia_produtos_qu_micos_farmac_uticos_ltda,,,,,, +2218,,3ca60fbd-f2cc-412a-b63f-1082f29ff6a8,INNOVACELL BIOTECNOLOGIE,innovacell_biotecnologie,,,,,, +2219,,0efe8610-715d-11e6-a0cd-0242ac12000b,NAVINTA LLC,navinta_llc,,,,,, +2220,,530ddc0c-a274-47be-bb1c-19b58b7ba7f4,Corimmun GmbH,corimmun_gmbh,,,,,, +554,0.98628848791122437,a0731512-712a-11e6-a89e-0242ac12000b,VINTAGE PHARMS LLC,vintage_pharms_llc,,,,5a0d7e38-7129-11e6-a89e-0242ac12000b,vintage_pharms,VINTAGE PHARMS +2221,,90a15d23-27ae-4e52-be99-fc5f7027b6a6,Servicio Nefrología Hospital Universitario de Bellvitge,servicio_nefrolog_a_hospital_universitario_de_bellvitge,,,,,, +2222,,5dd338aa-7129-11e6-a89e-0242ac12000b,HIKMA INTL PHARMS,hikma_intl_pharms,,,,,, +2223,,cbb845f4-7142-11e6-a0cd-0242ac12000b,HANFORD GC,hanford_gc,,,,,, +2224,,2ea111cc-840b-4585-9ae0-f08d90745c19,Statens Serum Institut,statens_serum_institut,,,,,, +570,0.967052,deea0724-71ac-11e6-a0cd-0242ac12000b,CARDINAL HEALTH 418,cardinal_health_418,,,,c7f9a7b2-715d-11e6-a0cd-0242ac12000b,cardinal_health_414,CARDINAL HEALTH 414 +2225,,aa653360-cb96-4c40-9bd3-7e573d1a3fa9,Ainara Aguirre Caballero,ainara_aguirre_caballero,,,,,, +2226,,7ae09bc5-806a-408b-a472-985481c91bd7,"Santarus, Inc",santarus_inc,,,,,, +2227,,40749946-d7d1-4793-bcd1-39d4cbf4ece4,"Dept of Rheumatology, Lund University Hospital, Lund, Sweden",dept_of_rheumatology_lund_university_hospital_lund_sweden,,,,,, +2228,,8167f1de-d4e1-43d4-99e5-15d1a11db9d2,VUMC,vumc,,,,,, +2229,,6122c576-2811-40a9-9141-ac1940821644,PurGenesis Techonologies Inc,purgenesis_techonologies_inc,,,,,, +2230,,45a64f2e-7bb2-4967-855c-0d6dfe7bb864,Prim. Univ.-Prof. Dr. Günter Janetschek c/o Universitätsklinik für Urologie und Andrologie,prim_univ_prof_dr_g_nter_janetschek_c_o_universit_tsklinik_f_r_urologie_und_andrologie,,,,,, +2231,,7440c839-89bb-49ae-8831-21d28d8fbae2,Fundación Castellano-Leonesa de Cardiología (FUCALEC),fundaci_n_castellano_leonesa_de_cardiolog_a_fucalec,,,,,, +2232,,ad7fe08e-7141-11e6-a0cd-0242ac12000b,PERRIGO NEW YORK,perrigo_new_york,,,,,, +2233,,9982c037-dd15-4a28-ac2b-bbb8290e7746,Interuniversity Cardiology Institute Netherlands,interuniversity_cardiology_institute_netherlands,,,,,, +2234,,58f89827-ef02-4bad-8f19-655d8c0ed16f,Lluís Cabero Roura,llu_s_cabero_roura,,,,,, +2235,,6c3b8362-4519-4a00-bf8e-e3791c243319,Clinical Research Center for Hair and Skin Science,clinical_research_center_for_hair_and_skin_science,,,,,, +2236,,50c27c8a-72c7-11e6-a0cd-0242ac12000b,HEYL CHEMISCH,heyl_chemisch,,,,,, +2237,,602f5b92-54b4-4f72-a608-a83e3fad6b6d,"University Hospital Basel, Dept. of Angiology",university_hospital_basel_dept_of_angiology,,,,,, +610,0.98603665828704834,939de536-b8b8-4a22-98b4-c84303a056ca,Fédération Nationale des Centres de Lutte Contre le Cancer,f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer,,,,4b5b75aa-a963-452e-848e-256ac41c5d72,f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer,Fédération Nationale des Centres de Lutte Contre le Cancer +2238,,cdafd400-a784-11e6-94cb-5656d04fc2b5,"AVIZOREX PHARMA, S.L",avizorex_pharma_s_l,,,,,, +2239,,76bd52f2-72ef-11e6-a0cd-0242ac12000b,HALOZYME THERAP,halozyme_therap,,,,,, +2240,,749b7ac3-f1a3-4c40-978a-a3ff80b54967,Sanol GmbH,sanol_gmbh,,,,,, +918,0.94804,7e1a91a4-5515-4186-84f8-e0dba33780e4,AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE),azienda_ospedaliera_l_sacco_a_o_di_rilievo_nazionale,,,,7e1a91a4-5515-4186-84f8-e0dba33780e4,azienda_ospedaliera_l_sacco_a_o_di_rilievo_nazionale,AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) +1065,0.91470474004745483,5f66ac18-d357-4f69-abc8-effab180e9c2,Cambridge University Hospitals NHS Trust,cambridge_university_hospitals_nhs_trust,,,,21aba99b-7de3-432e-87cd-3af4301e3cdb,cambridge_university_hospitals_nhs_foundation_trust_jointly_with_university_of_cambridge,"Cambridge University Hospitals NHS Foundation Trust, jointly with University of Cambridge" +2241,,d7520087-4ce0-411c-98a9-59658e1ab215,RJAH Orthopaedic Hospital,rjah_orthopaedic_hospital,,,,,, +2242,,cde28245-354e-4765-b477-9cf0b021e1bf,"ProFibrix, A wholly owned subsidary of the Medicines Company",profibrix_a_wholly_owned_subsidary_of_the_medicines_company,,,,,, +2243,,8410235c-2d22-43c5-bc5a-0ae07c2c7c2a,Galapagos NV,galapagos_nv,,,,,, +581,0.94542974233627319,a55c2c48-10fa-4304-9426-defee4a9c8f4,Wyeth Pharmaceuticals Inc. Philadelphia (A Pfizer Company),wyeth_pharmaceuticals_inc_philadelphia_a_pfizer_company,,,,8ad98169-689d-44f5-943d-55c909d71e4d,wyeth_parmaceuticals_inc,Wyeth Parmaceuticals Inc +2244,,ab0a8214-4081-473c-ad2f-1d84ea420e8a,Laboratoires Thea,laboratoires_thea,,,,,, +2245,,cf869a09-cfce-4ab0-a727-7f345d8b00ed,FONDAZIONE SANDRO PITIGLIANI PER LA LOTTA CONTRO I TUMORI-ONLUS,fondazione_sandro_pitigliani_per_la_lotta_contro_i_tumori_onlus,,,,,, +2246,,09be7a33-28de-4d7b-96c5-0f23e10bf4a1,Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie,christelijke_vereniging_voor_de_verpleging_van_lijders_aan_epilepsie,,,,,, +2247,,025587da-d17d-4813-904a-849e77b5d4a4,MENARINI Benelux NV/SA,menarini_benelux_nv_sa,,,,,, +2248,,9627033f-cdc1-48e6-928a-0bcaf3890e69,Policlinico Universitario Agustino Gemelli,policlinico_universitario_agustino_gemelli,,,,,, +2249,,7757d914-9d76-4f46-a879-71c49001cd03,UNIVERSITA' DEGLI STUDI DI FERRARA,universita_degli_studi_di_ferrara,,,,,, +685,0.98814409971237183,6215f084-4978-4b33-9f3e-b048c59d9d5d,University Medical Center UMCU,university_medical_center_umcu,,,,6215f084-4978-4b33-9f3e-b048c59d9d5d,university_medical_center_umcu,University Medical Center UMCU +2250,,c3b506ac-7152-11e6-a0cd-0242ac12000b,SYNTHON PHARMS,synthon_pharms,,,,,, +2251,,4ea69b82-81b1-44bb-9553-d000ddebe390,Sint Antonius Ziekenhuis,sint_antonius_ziekenhuis,,,,,, +2252,,e1bfb19a-c1ba-44ed-bb7f-5589e60c8c33,"Göteborgs Universitet, Institutionen för Invärtesmedicin",g_teborgs_universitet_institutionen_f_r_inv_rtesmedicin,,,,,, +895,0.985938,04f887b5-910f-4837-bcdf-e290b18c94c3,FUNDACION DE INVESTIGACION EN RED EN ENFERMEDADES CARDIOVASCULARES (FIRCAVA),fundacion_de_investigacion_en_red_en_enfermedades_cardiovasculares_fircava,,,,03e90e85-40a8-444e-8bc5-373590743e16,fundacion_de_investigacion_en_red_en_enfermedades,FUNDACION DE INVESTIGACION EN RED EN ENFERMEDADES +2253,,2c03430a-718e-11e6-a0cd-0242ac12000b,ELUSYS THERAPEUTICS INC,elusys_therapeutics_inc,,,,,, +760,0.987506,e22edd85-a19f-43f8-8906-119a7c84b332,Västra Götalandregionen (VGR),v_stra_g_talandregionen_vgr,,,,db892fbd-e5f0-40a8-8d13-447693b60e04,v_stra_g_talandregionen,Västra Götalandregionen +2254,,37fa388c-b65d-4a5c-8cd4-ad3adfef0434,Medway NHS Trust,medway_nhs_trust,,,,,, +2255,,61fbbb24-c9ef-4ba8-9b73-fc9efefc2fb1,Hammersmith Hospitals NHS Trust,hammersmith_hospitals_nhs_trust,,,,,, +203,0.986562,16d65dd4-7146-11e6-a0cd-0242ac12000b,GALDERMA LABS LP,galderma_labs_lp,,,,16d65dd4-7146-11e6-a0cd-0242ac12000b,galderma_labs_lp,GALDERMA LABS LP +2256,,e36eb139-8e54-4f7b-8ca5-3c9f00962518,Pluristem Ltd,pluristem_ltd,,,,,, +2257,,55add0fa-7169-11e6-a0cd-0242ac12000b,INTERFERON SCIENCES,interferon_sciences,,,,,, +2258,,eccca97e-715b-11e6-a0cd-0242ac12000b,HARRIS PHARM,harris_pharm,,,,,, +2259,,4d362410-72b6-11e6-a0cd-0242ac12000b,AXCAN SCANDIPHARM,axcan_scandipharm,,,,,, +2260,,e02aabff-a175-4afe-ad0e-f51ef9b58d2f,"Univ.-Klinik für Augenheilkunde und Optometrie, Medizinische Universität Wien",univ_klinik_f_r_augenheilkunde_und_optometrie_medizinische_universit_t_wien,,,,,, +2261,,d00094d8-44aa-47fc-9e31-55ecb94b6141,CHU Limoges,chu_limoges,,,,,, +2262,,af7175c7-ab7c-44b1-a4f6-99f630603df2,"BIAL Portela & Companhia, S.A",bial_portela_companhia_s_a,,,,,, +2263,,4c9ed818-9095-4845-b6d2-d8c8e2ef1666,"Department of Neurology, Odense University Hospital",department_of_neurology_odense_university_hospital,,,,,, +647,0.96851974725723267,de5efac3-9523-44b0-b815-56de9863e1ba,"Boehringer Ingelheim Esapaña, S.A",boehringer_ingelheim_esapa_a_s_a,,,,7f6e75e2-17dd-48cc-93b5-ed854fcfc0e1,boehringer_ingelheim_espa_a_s_a,"Boehringer Ingelheim España, S.A" +421,0.98666298389434814,ff0c702a-29b6-4638-ac4a-a462b6024ae7,Rigshospitalet,rigshospitalet,,,,91fae256-199c-4920-9cd2-0437b5db434d,rigshospitalet,Rigshospitalet +2264,,ba88ec34-ec92-4583-ba0f-ba3ffb6b769e,The University of Birmingham,the_university_of_birmingham,,,,,, +2265,,5df82d1b-0e41-47f1-92d3-163d93d2217f,Bayer plc,bayer_plc,,,,,, +78,0.988885,d39e8360-7141-11e6-a0cd-0242ac12000b,BRECKENRIDGE PHARM,breckenridge_pharm,,,,5e1c611c-7163-11e6-a0cd-0242ac12000b,breckenridge_pharms,BRECKENRIDGE PHARMS +2266,,c0f82336-cdce-47f7-bb5b-3f09ebe1d3ad,Plymouth Hospitals NHS Trust,plymouth_hospitals_nhs_trust,,,,,, +377,0.97867879271507263,cd77b786-db5e-445f-849f-1e0166f4f885,Merck & Co,merck_co,,,,a995503b-132d-44dc-a6b0-648b85bc0828,merck_co,Merck & Co +2267,,5121d025-9eb3-4959-a089-8aacf11b9ad9,The Sahlgrenska Center for Pediatric Ophtalmology Research,the_sahlgrenska_center_for_pediatric_ophtalmology_research,,,,,, +434,0.9664912223815918,0068e377-8873-41b9-baad-e3768b77d0b1,"Pfizer Inc., 235 East 42nd Streeet, New York, NY 10017",pfizer_inc_235_east_42nd_streeet_new_york_ny_10017,,,,0068e377-8873-41b9-baad-e3768b77d0b1,pfizer_inc_235_east_42nd_street_new_york_ny_10017,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017" +2268,,ca492921-5461-44bb-aa24-b22ffeb23cc6,Meda Pharmaceuticals,meda_pharmaceuticals,,,,,, +2269,,60e9b817-724e-4174-a9a0-e1a456b273e9,CASA DI CURA PRIVATA S.RAFFAELE - PISANA,casa_di_cura_privata_s_raffaele_pisana,,,,,, +2270,,8378f648-93ea-4dae-abf9-15461937efa2,"AKH Wien, Universitätsklinik für Physikalische Medizin und Rehabilitation",akh_wien_universit_tsklinik_f_r_physikalische_medizin_und_rehabilitation,,,,,, +31,0.98087829351425171,b37c4348-71a9-11e6-a0cd-0242ac12000b,DURAMED RES,duramed_res,,,,5b1b823c-72c5-11e6-a0cd-0242ac12000b,duramed,DURAMED +2271,,7286dd01-efcb-4a7f-bf3c-15565302e683,FinnBladder,finnbladder,,,,,, +2272,,dca9eafc-7165-11e6-a0cd-0242ac12000b,ACI HEALTHCARE LTD,aci_healthcare_ltd,,,,,, +2273,,40b1b5b3-e916-4b31-8fcf-45d7f90e7e4f,Novartis Farmacéuitica S.A,novartis_farmac_uitica_s_a,,,,,, +2274,,c6f7a259-b7bc-4174-b445-f25c3b8cb31b,"Prof. Gustav Dobos, Kliniken Essen Mitte",prof_gustav_dobos_kliniken_essen_mitte,,,,,, +2275,,279ef50e-2ae8-491e-a369-9f50826e4b9d,Medizinische Universität Innsbruck - Univ.-Klinik für Anästhesie und Allgemeine Intensivmedizin,medizinische_universit_t_innsbruck_univ_klinik_f_r_an_sthesie_und_allgemeine_intensivmedizin,,,,,, +2276,,77303051-6789-4c16-862d-ead8a9ab763a,Ipsen Pharma GmbH,ipsen_pharma_gmbh,,,,,, +2277,,39b29521-a5ff-4a5c-ac2a-6a63c6d6fa06,FONDAZIONE FRANCO E PIERA CUTINO,fondazione_franco_e_piera_cutino,,,,,, +2278,,f2abbbb2-66f7-4913-9682-64ee52957f5f,South Eastern Health & Social Care Trust,south_eastern_health_social_care_trust,,,,,, +2279,,a93f7512-0650-410e-86e4-c7ee710f15da,"Wrightington, Wigan and Leigh NHS Trust",wrightington_wigan_and_leigh_nhs_trust,,,,,, +2280,,e0c85370-7198-11e6-a0cd-0242ac12000b,STANLABS PHARM,stanlabs_pharm,,,,,, +517,0.97254005074501038,3c6426fc-228f-4f52-bcda-4e8faabc90a8,GELTAMO (Grupo Español de Linfoma y Transplante Autólogo de Médula Ósea),geltamo_grupo_espa_ol_de_linfoma_y_transplante_aut_logo_de_m_dula_sea,,,,be21c811-4df1-4aa6-8fd6-8b4eb1416f21,geltamo_grupo_espa_ol_de_linfomas_y_transplante_aut_logo_de_m_dula_sea,GELTAMO (Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea) +2281,,23588938-71a0-11e6-a0cd-0242ac12000b,VALEANT BERMUDA,valeant_bermuda,,,,,, +2282,,c012b8b3-9230-47b7-9b68-c101fab2f76e,SBL Vaccin AB,sbl_vaccin_ab,,,,,, +2283,,a4c544cc-c590-4d88-a055-b3e7d32dffe8,BTI BIOTECHNOLOGY INSTITUTE IMASD,bti_biotechnology_institute_imasd,,,,,, +2284,,570f1380-7364-11e6-a0cd-0242ac12000b,LAB HRA PHARMA,lab_hra_pharma,,,,,, +2285,,482b174a-b55a-436f-b74f-a752ca84fd52,SCIOTEC DIAGNOSTIC TECHNOLOGIES GMBH,sciotec_diagnostic_technologies_gmbh,,,,,, +1028,0.91099542379379272,b27185ae-0ca5-4391-a009-a1a74ae54832,Eli Lilly & Company - Indianapolis,eli_lilly_company_indianapolis,,,,5cd4a39f-21fd-403d-abbe-561ea83b270d,eli_lilly_and_company_indianapolis,Eli Lilly and Company - Indianapolis +2286,,b940d4fa-85e5-4d35-a31d-d4937de1a388,"NTNU, Norwegian University of Science and Technology",ntnu_norwegian_university_of_science_and_technology,,,,,, +432,0.948456,a8f25ee1-e008-4b22-8471-b1f44d51a5fe,Daiichi Sankyo Development Ltd,daiichi_sankyo_development_ltd,,,,1f71611f-b1a0-468a-826f-555058e87660,daiichi_sankyo_development_limited,Daiichi Sankyo Development Limited +2287,,752a6686-779f-4fc8-bce2-8f1ef63312a9,"Merck Sharp & Dohme, Lda",merck_sharp_dohme_lda,,,,,, +850,0.919718,591012c8-60e7-45be-a309-770fa9ece008,University Hospital of Leuven,university_hospital_of_leuven,,,,25d4b3ea-5908-4ea6-af45-ca4271adfcb9,university_hospitals_of_leuven,University hospitals of Leuven +2288,,18b69059-6d82-463f-81cd-cbded3c28082,OSPEDALE ONCOLOGICO DI BARI,ospedale_oncologico_di_bari,,,,,, +2289,,3e398afa-2123-43dc-959f-d731c6d453bb,VISIOTACT PHARMA,visiotact_pharma,,,,,, +2290,,595dba80-ce38-4c8c-9226-fbbd775db77e,Pharmaxis UK Limited,pharmaxis_uk_limited,,,,,, +2291,,d3eb0135-a3c5-4691-8fa1-ee7feca33887,Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie Onlus (GIMURELL),gruppo_italiano_multiregionale_per_lo_studio_dei_linfomi_e_delle_leucemie_onlus_gimurell,,,,,, +2292,,0671c9eb-9ce2-4896-ab47-65bc202d91de,School of Human Development,school_of_human_development,,,,,, +1064,0.97092048823833466,f6222fd2-ba80-4ae3-b1c5-8d83031ed9a8,Cambridge University Hospitals NHS Foundation Trust and University of,cambridge_university_hospitals_nhs_foundation_trust_and_university_of,,,,5832b652-f280-4dd6-850d-477a81887563,cambridge_university_hospitals_nhs_foundation_trust,Cambridge University Hospitals NHS Foundation Trust +2293,,d99cf07a-72f5-11e6-a0cd-0242ac12000b,INSMED,insmed,,,,,, +2294,,eb422b42-71f6-11e6-a0cd-0242ac12000b,IOMED,iomed,,,,,, +472,0.983628,77d74083-7ff5-4dec-88ac-be73492f43ab,"Rigshospitalet, Copenhagen",rigshospitalet_copenhagen,,,,77d74083-7ff5-4dec-88ac-be73492f43ab,rigshospitalet_copenhagen,"Rigshospitalet, Copenhagen" +1059,0.982418,6dce2ae5-2f18-4049-bbc1-1d01299ee637,RECORDATI,recordati,,,,6dce2ae5-2f18-4049-bbc1-1d01299ee637,recordati,RECORDATI +2295,,f6d95481-5cd6-49db-aab6-a25a7fbd9a63,Stichting Pediatrisch Onderzoek Enschede,stichting_pediatrisch_onderzoek_enschede,,,,,, +2296,,cfbdaf88-f1ac-41ab-a485-206f99be8e1d,"Delcath Systems, Ltd",delcath_systems_ltd,,,,,, +2297,,19ec8d6c-cbc1-42e8-abcb-095b4569a2f7,"Institut for Sundhedstjenesteforskning, Klinisk Farmakologi, Syddansk Universitet",institut_for_sundhedstjenesteforskning_klinisk_farmakologi_syddansk_universitet,,,,,, +974,0.98890119791030884,cc5ae5a1-d580-4f2e-a312-171b4fee0406,Universitätsklinikum Schleswig-Holstein,universit_tsklinikum_schleswig_holstein,,,,4cbb7e37-feeb-4dcf-a21f-ec40d4959c01,universit_tsklinikum_schleswig_holstein,Universitätsklinikum Schleswig-Holstein +2298,,597dc04e-799a-4bfc-bd88-1327e04d5391,Helena Isoniemi,helena_isoniemi,,,,,, +862,0.97933542728424072,2d106fa3-c940-42d6-a28f-8db21de52b04,"Academic Medical Center Amsterdam, department of Internal Medicine",academic_medical_center_amsterdam_department_of_internal_medicine,,,,2d106fa3-c940-42d6-a28f-8db21de52b04,academic_medical_center_amsterdam,Academic Medical Center Amsterdam +906,0.98112761974334717,842c3098-ea3e-4d46-b13c-da88e6deacb0,Kings College London (IOP),kings_college_london_iop,,,,fb29808d-7985-4804-b8d4-5620bbba60e6,kings_college_london_iop,Kings College London (IOP) +454,0.987768,c6a06456-3663-448c-8c5d-27a447b6849a,Hôpital Universitaire Des Enfants Reine Fabiola (H.U.D.E.R.F.),h_pital_universitaire_des_enfants_reine_fabiola_h_u_d_e_r_f,,,,c6a06456-3663-448c-8c5d-27a447b6849a,h_pital_universitaire_des_enfants_reine_fabiola_h_u_d_e_r_f,Hôpital Universitaire Des Enfants Reine Fabiola (H.U.D.E.R.F.) +2299,,e3a87d3c-2b97-4dfd-a91d-0107e0dba15f,"Department of Pharmacy, Uppsala University",department_of_pharmacy_uppsala_university,,,,,, +2300,,2fb8f371-a475-4ee7-8290-f348b4c7ac7c,"Research and Development Office, Royal Infirmary of Edinburgh",research_and_development_office_royal_infirmary_of_edinburgh,,,,,, +2301,,20f08d9c-38ef-4dc0-bbba-624944735a51,"Städtische Kliniken Neuss, Lukaskrankenhaus GmbH",st_dtische_kliniken_neuss_lukaskrankenhaus_gmbh,,,,,, +2302,,b855edc6-715c-11e6-a0cd-0242ac12000b,PEDIATRX,pediatrx,,,,,, +141,0.954454,eb54e67a-810b-4d63-87af-4e099ccc7a97,GRUPO ESPAÑOL DE INVESTIGACIÓN EN NEUROONCOLOGGÍA (GEINO),grupo_espa_ol_de_investigaci_n_en_neurooncologg_a_geino,,,,a50426da-ce4e-4ecd-b491-397a2aadb68f,grupo_espa_ol_de_investigacion_en_neurooncologia,GRUPO ESPAÑOL DE INVESTIGACION EN NEUROONCOLOGIA +2303,,6cb464a8-697d-4c01-b806-20d93dd290dd,Medical University Graz,medical_university_graz,,,,,, +2304,,722146b5-2da3-46f0-8d5f-43570fc37b50,Clinic for Psychiatry and Psychotherapy of the Ludwig Maximilian University,clinic_for_psychiatry_and_psychotherapy_of_the_ludwig_maximilian_university,,,,,, +2305,,ed72e27a-6f9f-11e6-9663-0242ac12000b,Pulmagen Therapeutics LLP,pulmagen_therapeutics_llp,,,,,, +2306,,bf0fcd6a-7375-11e6-a0cd-0242ac12000b,ALLERQUEST,allerquest,,,,,, +2307,,ac2ea195-ee57-4135-95ab-234e81c19d49,"Charité Universitätsmedizin, Campus Charité Mitte",charit_universit_tsmedizin_campus_charit_mitte,,,,,, +2308,,2bf2bcb4-7167-11e6-a0cd-0242ac12000b,BIOMEDCL RES FDN,biomedcl_res_fdn,,,,,, +2309,,7af728a6-7138-46ba-bb53-adb4c41e10fe,University Heidelberg,university_heidelberg,,,,,, +507,0.986912,2d581c28-7141-11e6-a0cd-0242ac12000b,HI TECH PHARMA CO,hi_tech_pharma_co,,,,2d581c28-7141-11e6-a0cd-0242ac12000b,hi_tech_pharma_co,HI TECH PHARMA CO +2310,,f07b3004-e6e4-4f9a-937a-bb2dcfee8930,Netherlands Vaccine Institute,netherlands_vaccine_institute,,,,,, +2311,,0b32183d-cc2a-4c2a-8825-b58312c6c1da,SYGNIS Bioscience GmbH & Co. KG,sygnis_bioscience_gmbh_co_kg,,,,,, +2312,,25f9fb4e-a3f5-49d8-a78e-b3a23cd18fdb,JOSÉ ANTONIO SERRANO TRENAS,jos_antonio_serrano_trenas,,,,,, +942,0.985052,9eb06cf2-3062-4b75-9c69-530ebc8ce5f7,BioGeneriX,biogenerix,,,,02c56274-3bd4-4bfe-bfe8-b2385f2eef41,biogenerix_ag,BioGeneriX AG +842,0.97305294871330261,19e6b110-6043-450d-8ef8-6a798742be5d,University Hospital of South Manchester Nhs Foundation Trust,university_hospital_of_south_manchester_nhs_foundation_trust,,,,19e6b110-6043-450d-8ef8-6a798742be5d,university_hospital_of_south_manchester_nhs_foundation_trust,University Hospital of South Manchester +2313,,55a4dcf6-2c3e-4bf7-a386-5aa6a73809e8,Bioeq GmbH,bioeq_gmbh,,,,,, +2314,,154840da-73ec-45bd-9331-b3e37be4aa1c,Janssen-Cliag International N.V,janssen_cliag_international_n_v,,,,,, +2315,,e9ab2ec9-94da-47eb-82e3-b317e653b2d6,UNITED THERAPEUTICS,united_therapeutics,,,,,, +390,0.95186018943786621,b5653343-db85-468f-9ea0-a6d1b957afa2,Galderma Research & Development SNC,galderma_research_development_snc,,,,b5653343-db85-468f-9ea0-a6d1b957afa2,galderma_research_development,Galderma research & Development +2316,,162a9cb7-075e-4fae-b3cc-2886170ed6a6,Fundación de Investigación Biomédica Hospital Universitario de la Princesa,fundaci_n_de_investigaci_n_biom_dica_hospital_universitario_de_la_princesa,,,,,, +2317,,01563330-44ab-4593-9b40-118bdf8a757b,Prague Psychiatric Centre,prague_psychiatric_centre,,,,,, +2318,,5244ebc7-d220-4f2a-b22e-e70d474d9697,"Folktandvården, Landstinget Dalarna",folktandv_rden_landstinget_dalarna,,,,,, +2319,,6f4b09b0-32d1-4b50-b57f-bd61cd1e27e8,GIOGer (Gruppo Italiano di Oncologia Geriatrica),gioger_gruppo_italiano_di_oncologia_geriatrica,,,,,, +2320,,dc5e6725-e192-41a6-bb07-1423babdc79a,"F.HOFFMANN-LA ROCHE representado en España por Roche Farma,S.A",f_hoffmann_la_roche_representado_en_espa_a_por_roche_farma_s_a,,,,,, +2321,,87d28190-82e9-41e9-a1ca-999e32ca24ca,Pharmachemie B.V,pharmachemie_b_v,,,,,, +2322,,9ada1253-cf77-4e6a-976d-0de2fd7458ab,"Medizinische Universität Graz, Universitätsklinik für Dermatologie",medizinische_universit_t_graz_universit_tsklinik_f_r_dermatologie,,,,,, +2323,,85e9070d-7c5e-41f2-8c28-cdceb70cf350,Wolfson Medical Center,wolfson_medical_center,,,,,, +2324,,44f36e04-ca02-419d-88bc-aef4bcef3d6c,Procter & Gamble Technical Centres Limited,procter_gamble_technical_centres_limited,,,,,, +2325,,af2c0cde-b064-40c7-8081-1ddedda2b204,GENZYME,genzyme,,,,,, +2326,,2e56f5b2-c7c5-4a2f-9a36-4e9362e90705,Convergence Pharmaceuticals Ltd,convergence_pharmaceuticals_ltd,,,,,, +2327,,67ddf20c-6404-46b6-ad4f-aa32333da94a,SBG (Scandinivian Breast Cancer Group),sbg_scandinivian_breast_cancer_group,,,,,, +2328,,3dc5e010-78ea-4398-903a-525f90641adc,Boehringer Ingelheim Italia S.p.A,boehringer_ingelheim_italia_s_p_a,,,,,, +2329,,281021cf-91a9-4327-8a29-0695fc86c10f,"Boehringer Ingelheim, Canada Ltd",boehringer_ingelheim_canada_ltd,,,,,, +2330,,3d2540a6-8e97-45b0-9061-4b209eba949f,"Nitric BioTherapeutics, Inc",nitric_biotherapeutics_inc,,,,,, +2331,,ce90c327-34f7-44d4-9551-b1e6d6bbfad5,Novartis Services AG,novartis_services_ag,,,,,, +956,0.980878,fafa09f0-8e27-4d83-a6c3-85c9a05e3eab,OBEcure,obecure,,,,b1885f5c-880d-11e6-a998-0242ac12000b,obecure_ltd,OBEcure Ltd +2332,,b29394f8-9c97-4692-904c-2bbe181e84c4,University of South Manchester NHS Foundation Trust,university_of_south_manchester_nhs_foundation_trust,,,,,, +2333,,7199e323-c428-4892-832a-426a35b39661,Klaus Tapio Olkkola,klaus_tapio_olkkola,,,,,, +2334,,7efe0612-da12-414e-b1b1-f433e0c0faa1,"Head, EU/ROW Regulatory Affairs",head_eu_row_regulatory_affairs,,,,,, +2335,,a2e40cda-7129-11e6-a89e-0242ac12000b,JUBILANT CADISTA,jubilant_cadista,,,,,, +587,0.95549,f3580246-7144-11e6-a0cd-0242ac12000b,IDT AUSTRALIA LTD,idt_australia_ltd,,,,12d4a6e2-73f7-11e6-a0cd-0242ac12000b,idt,IDT +2336,,b7c87029-e0ee-4232-873f-76e62fe18fd5,Dr. Theiss Naturwaren GmbH,dr_theiss_naturwaren_gmbh,,,,,, +334,0.969856,30daea08-31b9-44eb-b245-a0bfc280fc21,Boiron,boiron,,,,30daea08-31b9-44eb-b245-a0bfc280fc21,boiron,Boiron +996,0.977047,334999d1-9ed1-4d92-a66a-e05623d343a8,Kings College Hospital NHS Foundation Trust,kings_college_hospital_nhs_foundation_trust,,,,334999d1-9ed1-4d92-a66a-e05623d343a8,kings_college_hospital_nhs_foundation_trust,Kings College Hospital NHS Foundation Trust +465,0.98048589626948035,2e4a0d21-5259-4b26-b5dd-ed587c02073f,Leiden University,leiden_university,,,,2e4a0d21-5259-4b26-b5dd-ed587c02073f,leiden_university,Leiden University +2337,,54714d86-73f1-11e6-a0cd-0242ac12000b,ASPEN AIR,aspen_air,,,,,, +687,0.96910750865936279,98459814-11f4-4cc9-a742-4a4619828373,"Ruprecht-Karls-University Heidelberg, Med Faculty represented by Universitätsklinikum Heidelberg and its Commercial D",ruprecht_karls_university_heidelberg_med_faculty_represented_by_universit_tsklinikum_heidelberg_and_its_commercial_d,,,,197d4369-9301-4bac-b737-20a72c9e0d7b,ruprecht_karls_university_heidelberg_medical_faculty_represented_by_universit_tsklinikum_heidelberg_and_its_commercial,"Ruprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg and its Commercial" +2338,,ba65a115-02e1-4e57-9f98-e90a45792f6c,"Merck Serona S.A., Geneva, Switzerland",merck_serona_s_a_geneva_switzerland,,,,,, +2339,,04eae760-7142-11e6-a0cd-0242ac12000b,RANBAXY,ranbaxy,,,,,, +2340,,8ce1a506-6fbb-11e6-abe8-0242ac12000b,Organon Hungary Ltd,organon_hungary_ltd,,,,,, +2341,,43b31e9b-5c86-4f61-a788-a3e7f71c04ef,"Promedior, Inc",promedior_inc,,,,,, +2342,,ce11fc95-3d22-4c28-94dc-35be2d9f6091,AKH Linz,akh_linz,,,,,, +2343,,21db6c72-5da2-4c64-b673-432321c1b314,Sanofi-Aventis AG,sanofi_aventis_ag,,,,,, +2344,,4bfffa88-7146-11e6-a0cd-0242ac12000b,MILEX,milex,,,,,, +2345,,922f3fb6-9042-4a10-bacb-5fe5aa04ee75,AXON Neuroscience SE,axon_neuroscience_se,,,,,, +2346,,0b133984-de0d-4428-ae13-995f8d0e324f,ULB ERASME HOSPITAL,ulb_erasme_hospital,,,,,, +2347,,e4459b4e-955f-4dad-8ebf-0b5b2baf5021,"Protein Design Labs, Inc",protein_design_labs_inc,,,,,, +2348,,59396a22-71eb-11e6-a0cd-0242ac12000b,AMAG PHARMS INC,amag_pharms_inc,,,,,, +2349,,385e20a3-1fd3-4339-ac11-9f77cf17c728,Innate Pharma S.A,innate_pharma_s_a,,,,,, +2350,,2e3d3d1e-7194-11e6-a0cd-0242ac12000b,TARGACEPT,targacept,,,,,, +2351,,cc896b62-f942-4e86-b3f5-79a548aef3b1,Hannu Kokki,hannu_kokki,,,,,, +2352,,ef4a9ee5-bbf6-4943-9402-640d6e4a3889,"Tranzyme, Inc",tranzyme_inc,,,,,, +2353,,8cc1878a-7164-11e6-a0cd-0242ac12000b,AIPING PHARM INC,aiping_pharm_inc,,,,,, +2354,,874b524c-7158-11e6-a0cd-0242ac12000b,EXELA PHARMA SCIENCE,exela_pharma_science,,,,,, +2355,,5adfaf27-bb17-4d7c-a8f5-ce3cb257c8d6,"Lithuanian University of Health Sciences, Endocrinology Department",lithuanian_university_of_health_sciences_endocrinology_department,,,,,, +2356,,d5b4154c-bda4-4f3f-ab31-55e12d9afb89,"Verksamhetsområde Geriatrik, Lungmedicin och Allergologi vid Sahlgrenska Universitetssjukhuset",verksamhetsomr_de_geriatrik_lungmedicin_och_allergologi_vid_sahlgrenska_universitetssjukhuset,,,,,, +904,0.943406,eafe4f37-4f5a-4128-8d0f-96b207ab9cfd,Novo Nordisk A/S,novo_nordisk_a_s,,,,a017bdc5-4a8a-48c3-ab48-5b1db4f8ed6e,novo_nordisk_as,Novo Nordisk AS +2357,,1822b285-c272-4571-9ec8-0e4840818a65,"Medizinische Universität Innsbruck, AGO Studienzentrale",medizinische_universit_t_innsbruck_ago_studienzentrale,,,,,, +2358,,ae68b0d5-a42a-4ada-9d3a-5a4721eb9a1c,"Oslo University Hospital, Dept of Urology",oslo_university_hospital_dept_of_urology,,,,,, +2359,,c1560782-435e-4bc1-8423-76f62dac3062,"Medizinische Hochschule Hannover, Klinik für Pneumologie",medizinische_hochschule_hannover_klinik_f_r_pneumologie,,,,,, +2360,,e54d8ea2-d343-4530-9052-776fba203207,Helena Elding Larsson,helena_elding_larsson,,,,,, +2361,,9bfa0753-3bc3-453a-bc32-854f9ba19cc2,Västra Götalandsregionen (VGR),v_stra_g_talandsregionen_vgr,,,,,, +2362,,89fbd6cd-cd2b-429c-a491-e5cffff12002,UAB “Eli Lilly Lietuva”,uab_eli_lilly_lietuva,,,,,, +2363,,fa7840ff-3106-4665-b4a3-aac3b29efdc7,ICT de Navarra S.A,ict_de_navarra_s_a,,,,,, +2364,,e36597c2-20d6-406c-82f1-e834c7315473,St Helens & Knowsley Hospitals NHS Trust,st_helens_knowsley_hospitals_nhs_trust,,,,,, +2365,,1edbaa2c-9d94-4796-9c0b-ccd52f669a82,Klinikum der Otto-von-Guericke Universität Magdeburg,klinikum_der_otto_von_guericke_universit_t_magdeburg,,,,,, +2366,,b88aedad-b843-4c93-b4c5-7c7b85dacb0d,Chr. Hansen A/S,chr_hansen_a_s,,,,,, +2367,,468a4598-0f63-4c9e-a9fe-9e53d5416109,University of Plymouth,university_of_plymouth,,,,,, +918,0.94804,efd6c1e0-c374-4f00-99d0-088b90b5d95a,AZIENDA OSPEDALIERA S. PAOLO (A.O. DI RILIEVO NAZIONALE),azienda_ospedaliera_s_paolo_a_o_di_rilievo_nazionale,,,,7e1a91a4-5515-4186-84f8-e0dba33780e4,azienda_ospedaliera_l_sacco_a_o_di_rilievo_nazionale,AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) +57,0.9411388635635376,1d53dcae-9b86-416e-9d92-a62412245dcc,"Wyeth Research Division of Wyeth Pharmaceuticals, Inc. Clinical Research & Development",wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_development,,,,1d53dcae-9b86-416e-9d92-a62412245dcc,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_development,"Wyeth Research Division of Wyeth Pharmaceuticals, Inc. Clinical Research & Development" +2368,,1e287424-b298-42dd-88ef-189d71e1062e,SERMAS (Hospital la Paz),sermas_hospital_la_paz,,,,,, +2369,,8e6088f3-ba69-4e61-9835-e8602dd25077,NovartisPharma Services AG,novartispharma_services_ag,,,,,, +2370,,be8b441e-dde8-4eca-a72a-d672113ea9b8,Philogen S.pA,philogen_s_pa,,,,,, +252,0.97271484136581421,571002ec-617e-4005-8cd5-1585b09674f0,"Martin Luther University of Halle/Wittenberg, Medizinische Fakultät, Prodekanat Forschung",martin_luther_university_of_halle_wittenberg_medizinische_fakult_t_prodekanat_forschung,,,,0f0d8991-097b-4737-a496-fd2e4d5aa3ff,martin_luther_university_of_halle_wittenberg,Martin Luther University of Halle/Wittenberg +2371,,ecae3491-b7e8-4a29-8c5d-e233e6fe362c,"DSC Services, s.r.o",dsc_services_s_r_o,,,,,, +2372,,b24d61a0-545a-4fe1-b5de-549e6f8b2dd7,Johann-Wolfgang Goethe-Universität,johann_wolfgang_goethe_universit_t,,,,,, +2373,,f8a2e7f4-1e58-4471-89a0-30d512e770f7,BUDAI HEPATOLÓGIAI CENTRUM,budai_hepatol_giai_centrum,,,,,, +2374,,1f7129e9-528d-452e-bf42-1edfaab3ebf0,"Bert Mueller, Dep. Ophthalmology",bert_mueller_dep_ophthalmology,,,,,, +2375,,29c35e6c-a3b8-479f-ad8d-7ac1aefa3dde,SSG,ssg,,,,,, +2376,,94359441-f797-4dd6-af5c-8c133dae8607,Minster Pharmaceuticals Ltd,minster_pharmaceuticals_ltd,,,,,, +2377,,e0eb00f5-1be5-45eb-864b-95f0335c4087,Hospital Sant Joan de Deu,hospital_sant_joan_de_deu,,,,,, +2378,,742e983d-bc19-454a-b98a-c13d50e41dc0,FUNDACIÓN GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA,fundaci_n_grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama,,,,,, +2379,,e6e5460c-ce48-4956-bdcf-a284df896b2d,Dr. Antonio Llombart Cussac,dr_antonio_llombart_cussac,,,,,, +2380,,ab1f3606-36a1-4f89-bae4-6efe4263d555,JANSSEN-CILAG EMEA,janssen_cilag_emea,,,,,, +416,0.968388,da6ce2e0-306e-4461-9ae3-5767282527c6,Fraunhofer Gesellschaft,fraunhofer_gesellschaft,,,,da6ce2e0-306e-4461-9ae3-5767282527c6,fraunhofer_gesellschaft,Fraunhofer Gesellschaft +225,0.98610919713973999,20e12445-21a7-4273-8a0c-39079af8786b,Fertilitetsklinikken Nordica,fertilitetsklinikken_nordica,,,,090da71e-b718-413e-ba77-0e109a22d5d5,fertilitetsklinikken,Fertilitetsklinikken +2381,,c89fa10e-528e-4d1b-83e1-0796a07eb21e,Solvay Biologicals BV,solvay_biologicals_bv,,,,,, +277,0.9798356294631958,742e5b04-42fe-442b-af30-e1ceda614670,"Teva Branded Pharmaceutical Products R&D, Inc",teva_branded_pharmaceutical_products_r_d_inc,,,,71fa3658-cdd0-4248-b428-53aae9afea66,teva_branded_pharmaceutical_products_r_d_inc,"Teva Branded Pharmaceutical Products R&D, Inc" +2382,,e9744b7b-0112-469c-aa5e-953bac68c05b,AZIENDA OSPEDALIERA DI CASERTA,azienda_ospedaliera_di_caserta,,,,,, +2383,,25eeb652-93f2-45eb-998d-b2d355f1f2cc,Novartis Faarmacéutica S.A,novartis_faarmac_utica_s_a,,,,,, +2384,,dda0a005-872b-4f86-bf68-a84830d3b423,Division of Special and Environmental Dermatology,division_of_special_and_environmental_dermatology,,,,,, +708,0.984864,d9cb587c-7163-11e6-a0cd-0242ac12000b,NOVAST LABS LTD,novast_labs_ltd,,,,3e40eb72-7165-11e6-a0cd-0242ac12000b,novast_labs,NOVAST LABS +2385,,e09260af-d202-4e00-a253-062655806647,SCHERING-PLOUGH,schering_plough,,,,,, +2386,,3f0ebe02-536a-4e48-b0e7-21e0dd29b7b2,ALK-Abelló Arzneimittel GmbH,alk_abell_arzneimittel_gmbh,,,,,, +2387,,3a76c118-dc5c-4280-a287-bbc242d98d6b,Calixa Therapeutics Inc,calixa_therapeutics_inc,,,,,, +2388,,de8ab3be-a75f-11e6-94cb-5656d04fc2b5,"University of Southern Denmark, Clinical Pharmacology",university_of_southern_denmark_clinical_pharmacology,,,,,, +2389,,358073be-0290-4c51-96bd-de9abe2e9d3d,Mika J. Mäkelä,mika_j_m_kel,,,,,, +2390,,399faf0c-52c9-4ee0-9025-873e502aab24,futurum,futurum,,,,,, +2391,,50ff4dec-7167-11e6-a0cd-0242ac12000b,CFT PHARMS LLC,cft_pharms_llc,,,,,, +3,0.975901,759e5476-0767-445f-9373-05a555bd1be8,Klinik für Anästhesiologie, Johannes Gutenberg Universität,,,,759e5476-0767-445f-9373-05a555bd1be8, Johannes Gutenberg Universität,Klinik für Anästhesiologie +2392,,d60f9494-7142-11e6-a0cd-0242ac12000b,LOCH,loch,,,,,, +2393,,4a41eb18-7149-11e6-a0cd-0242ac12000b,GENSIA SICOR PHARMS,gensia_sicor_pharms,,,,,, +2394,,5c9378e2-971a-40be-bc39-fe3591d97f9b,University of Chicago,university_of_chicago,klinik_f_r_an_sthesiologie_johannes_gutenberg_universit_t,,,,, +466,0.91411077976226807,62011efa-04e1-422d-bc6f-ad2b4e216ef5,Leiden Universtity Medical Center,leiden_universtity_medical_center,,,,0c30b492-594c-4ddd-8d03-fa24bfa5bbd3,leiden_university_medical_center_department_of_rheumatology,"Leiden University Medical Center, department of rheumatology" +2395,,1e50d85c-7167-11e6-a0cd-0242ac12000b,CENTAUR PHARMA,centaur_pharma,,,,,, +676,0.987472,7c9c2246-722e-11e6-a0cd-0242ac12000b,BECTON DICKINSON CO,becton_dickinson_co,,,,683d790a-7146-11e6-a0cd-0242ac12000b,becton_dickinson,BECTON DICKINSON +2396,,4ba6550d-29ae-4c7d-b10e-9ecd75913aad,AZIENDA OSPEDALIERA MEYER,azienda_ospedaliera_meyer,,,,,, +2397,,5bcd533d-7146-4199-b912-e2c4bde26cab,"insaf, Institut für Atemwegsforschung GmbH",insaf_institut_f_r_atemwegsforschung_gmbh,,,,,, +2398,,66e71556-9553-4f75-be5f-e5537a0f4251,"Med. Universität Wien, Universitätsklinik für Innere Medizin II",med_universit_t_wien_universit_tsklinik_f_r_innere_medizin_ii,,,,,, +862,0.98416075110435486,c678152f-1832-493f-a30b-931d5d31d950,Academic Medical Center Amsterdam,academic_medical_center_amsterdam,,,,2d106fa3-c940-42d6-a28f-8db21de52b04,academic_medical_center_amsterdam,Academic Medical Center Amsterdam +861,0.92882567644119263,814a6fa8-6b39-4d4a-90b5-c93d021a2e48,"Academic Medical Center, Department of Haematology, University of Amsterdam",academic_medical_center_department_of_haematology_university_of_amsterdam,,,,7cef3d29-cecb-442c-acdb-b0a10dec2da0,academic_medical_center_department_of_dermatology,"Academic Medical Center, Department of dermatology" +2399,,c6fc68b4-a6f1-11e6-94cb-5656d04fc2b5,Herlev og Gentofte Hospital,herlev_og_gentofte_hospital,,,,,, +2400,,6650279a-1220-4ca8-a74e-c81137cafa9b,Pharmacia and Upjohn,pharmacia_and_upjohn,,,,,, +2401,,2d23cfb6-420f-4982-9940-f15a12b3c86a,FONDAZIONE EVIDENCE,fondazione_evidence,,,,,, +2402,,3a2e9aee-a8c3-434c-838e-0d0f6ec84ae4,"Synergia Pharma, Inc",synergia_pharma_inc,,,,,, +2403,,75e278c8-a86a-467a-b01d-5bec92edb7d2,Santhera Pharmaceuticals (Switzerland) Ltd,santhera_pharmaceuticals_switzerland_ltd,,,,,, +2404,,adb0d488-71b8-11e6-a0cd-0242ac12000b,CHIESI USA INC,chiesi_usa_inc,,,,,, +2405,,60d0103d-4609-4947-89a6-f5e4e4c3824a,University Hospital Birmingham NHS Foundation Trust,university_hospital_birmingham_nhs_foundation_trust,,,,,, +2406,,e56ce7fa-a556-4321-b0df-1096c2c2810b,Norrlands university hospital,norrlands_university_hospital,,,,,, +2407,,7df69bd4-d2c1-4298-a8e4-3a07edb87e98,"Kingston General Hospital, Queen's University of Kingston",kingston_general_hospital_queen_s_university_of_kingston,,,,,, +2408,,ce7f0c3c-7142-11e6-a0cd-0242ac12000b,VITARINE,vitarine,,,,,, +2409,,b172a37e-2b18-43b5-ad71-6ae19c246354,Novartis Healthcare A/S,novartis_healthcare_a_s,,,,,, +2410,,1da8f1ba-e9cd-447e-b4aa-27d11d6da7c4,LifeCycle Pharma A/S,lifecycle_pharma_a_s,,,,,, +2411,,d7312e52-4192-4983-920d-0634cb7e2bda,"University Hospital Sjaelland, Roskilde,Palliative Unit",university_hospital_sjaelland_roskilde_palliative_unit,,,,,, +2412,,b5cf1970-7165-11e6-a0cd-0242ac12000b,HQ SPCLT PHARMA,hq_spclt_pharma,,,,,, +2413,,6d4d113f-881e-4722-9d58-515ce6e76915,Centre Hospitalier Universitaire Brugmann,centre_hospitalier_universitaire_brugmann,,,,,, +364,0.985698,87d09c6e-75c9-457a-a75f-98fe01c68879,Linköping University Hospital,link_ping_university_hospital,,,,3c37c02e-cf63-439c-9fbf-de047eae2685,link_ping_university,Linköping University +271,0.936507,a53a0518-14bd-43f6-a865-5dbca410808b,AstraZeneca NV/SA,astrazeneca_nv_sa,,,,1f1910ef-d8fc-404c-af9b-dd7bc5fd4d42,astrazeneca_bv,AstraZeneca BV +776,0.931044,cda596b1-95e9-44c2-ae59-cc4ef1c1e9a4,Thomas Fichnter Bendtsen,thomas_fichnter_bendtsen,,,,5cb4c7b4-22d3-4d2e-baa3-ec6641e8024b,thomas_fichtner_bendtsen,Thomas Fichtner Bendtsen +2414,,ec3405e6-f0a2-4b01-a22d-c578e8d30372,Dilafor AB,dilafor_ab,,,,,, +91,0.9638105034828186,1152e981-0c70-498b-86c9-697b85b3f5c7,Actelion Pharmaceuticals Nederland bv,actelion_pharmaceuticals_nederland_bv,,,,773f50b2-9db9-4907-b659-e4a90dab71f6,actelion_pharmaceuticals,Actelion Pharmaceuticals +220,0.987246,881bb9ba-33dc-4a2c-8dc8-686f26ee9973,Sanofi-Aventis Recherche & Dev,sanofi_aventis_recherche_dev,,,,28a6a997-3c3d-4bd8-8c3e-e02946553a33,sanofi_aventis_recherche_dev_loppement,Sanofi-Aventis Recherche & Devéloppement +2415,,0a9fc54e-e627-4f82-a9ee-276d889a2263,GTC BIOTHERAPEUTICS,gtc_biotherapeutics,,,,,, +2416,,5fb63deb-1a1b-47fe-a012-d04e6e31735d,GETAID - Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives,getaid_groupe_d_etude_th_rapeutique_des_affections_inflammatoires_digestives,,,,,, +2417,,7f00ac82-8ef1-4616-9992-1e0ee9059383,"Royal Hospital For Sick Children, Yorkhill Division",royal_hospital_for_sick_children_yorkhill_division,,,,,, +2418,,51513e5a-a71b-4452-aa2b-d87d10ec4d67,CMIV,cmiv,,,,,, +1012,0.9465501606464386,3a155d92-5624-4478-adee-a0b9485e9d1a,"Shire Human Genetic Therapies, Inc. (Shire HGT)",shire_human_genetic_therapies_inc_shire_hgt,,,,c06cb74b-1c77-4c28-9c14-a6b870a4012a,shire_human_genetic_therapies_inc,"Shire Human Genetic Therapies, Inc. (Shire HGT)" +512,0.976744,57316fb9-869d-4e0f-830d-b7178467cef3,"Novartis Farmacéutica, S.A",novartis_farmac_utica_s_a,,,,0d23d029-d573-4d0e-aaab-1b66e6a0fd64,novartis_farmac_utuca_s_a,"Novartis Farmacéutuca, S.A" +2419,,2e5a8d74-72f2-11e6-a0cd-0242ac12000b,FEINSTEIN,feinstein,,,,,, +1011,0.982558,19f3330e-027c-4344-a82b-28a25bade93e,German Breast Group,german_breast_group,,,,19f3330e-027c-4344-a82b-28a25bade93e,german_breast_group,German Breast Group +2420,,cfd3ba86-f12c-4e7c-a6e2-a27283b6f0c4,Inst of Ophtalmology Lund University hospital,inst_of_ophtalmology_lund_university_hospital,,,,,, +2421,,7c682222-f2fd-4c0b-8c03-29bdf8ff63f5,PRESURGY S.L,presurgy_s_l,,,,,, +2422,,6f8d0fd0-71fb-11e6-a0cd-0242ac12000b,HORIZON PHARMA INC,horizon_pharma_inc,,,,,, +428,0.984324,02faf8af-e6fd-4c07-aca4-71ef06427271,Ghent University,ghent_university,,,,02faf8af-e6fd-4c07-aca4-71ef06427271,ghent_university,Ghent University +772,0.985698,fcf4391d-2abf-4988-9179-57f9b75037e1,Abbott GmbH & Co. KG (Abbott),abbott_gmbh_co_kg_abbott,,,,6faaed46-35f6-404d-9128-03b55daaae47,abbott_gmbh_co_kg,Abbott GmbH & Co. KG +2423,,3770529b-6b59-45f6-adf4-93d4dccdbd66,Institut für klinische Forschung und Entwicklung Berlin GmbH am St. Hedwig Krankenhaus,institut_f_r_klinische_forschung_und_entwicklung_berlin_gmbh_am_st_hedwig_krankenhaus,,,,,, +2424,,195e0710-5fa1-4564-a11c-dd188182e535,silvia sanchez ramon,silvia_sanchez_ramon,,,,,, +2425,,22df266d-8f91-4c00-8e4b-a8f3a1e57306,Queen Victoria Hospital,queen_victoria_hospital,,,,,, +2426,,585eb738-9f4a-42a8-b468-0b0e9f3eb77c,NVALT,nvalt,,,,,, +2427,,919851f1-e5b4-4cc8-a6b6-ab9115e2ad2b,University of Leicester,university_of_leicester,,,,,, +2428,,ce32a653-6127-4f5f-b254-8eeb4266b010,Buckinghamshire Healthcare NHS Trust,buckinghamshire_healthcare_nhs_trust,,,,,, +197,0.986644,3f5bfa23-183e-4eb2-b25e-ef95e03935f7,Medizinische Fakultät der Technischen Universität München,medizinische_fakult_t_der_technischen_universit_t_m_nchen,,,,0a2316b0-4362-41ed-8199-5421a077abe7,medizinische_fakult_t_der_technischen_universit_t_m_nchen_vertreten_durch_den_dekan,"Medizinische Fakultät der Technischen Universität München, Vertreten durch den Dekan" +2429,,9dd75915-f5cb-4915-9901-8ace578d6fed,NeuroCode AG,neurocode_ag,,,,,, +56,0.98165720701217651,abc1c336-a76f-11e6-94cb-5656d04fc2b5,Radboud University Nijmegen,radboud_university_nijmegen,,,,9078130e-eeb6-4d4a-9b3b-bf9f3a7082c5,radboud_university_nijmegen_medical_centre,Radboud University Nijmegen Medical Centre +2430,,e128cde4-9390-41d7-a36f-13b4dac850b5,"Prof Flora Peyvandi, MD",prof_flora_peyvandi_md,,,,,, +7,0.95328104496002197,e37ff462-7351-402c-828d-d17f23d6fa72,Centre Hospitalier Universitaire de Nancy,centre_hospitalier_universitaire_de_nancy,,,,e37ff462-7351-402c-828d-d17f23d6fa72,centre_hospitalier_universitaire_de_nantes,Centre Hospitalier Universitaire de Nantes +800,0.972677,6c1b4883-f94c-4db9-a252-6308442f5577,Institut Català d’Oncologia (ICO),institut_catal_d_oncologia_ico,,,,15671013-8a1c-41eb-b118-71cf71e315ed,institut_catal_d_oncologia,Institut Català d’Oncologia +2431,,5baf3ecb-fc11-4150-a708-78f71b17ca63,Orphan Europe Recordati,orphan_europe_recordati,,,,,, +2432,,74b89c37-3b8b-49d6-ba0d-2da31d436263,G.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI,g_i_s_l_gruppo_italiano_studio_linfomi,,,,,, +2433,,445d59cf-d65f-4372-8f1f-10c3ab6bf05d,"Department of research & development, TheLeeds teaching hospitals NHS trust",department_of_research_development_theleeds_teaching_hospitals_nhs_trust,,,,,, +2434,,60ff77b8-c176-480b-ae13-f417775472f5,"Department of Oncology, University Hospital Herlev",department_of_oncology_university_hospital_herlev,,,,,, +364,0.985698,3c37c02e-cf63-439c-9fbf-de047eae2685,Linköping University,link_ping_university,,,,3c37c02e-cf63-439c-9fbf-de047eae2685,link_ping_university,Linköping University +2435,,613afa86-c07a-4505-be8c-ae6c73b2b3a2,Southampton Universities Hospital Trust,southampton_universities_hospital_trust,,,,,, +2436,,2e47032a-8e02-405a-807d-1dbb97afeabc,SLA Pharma,sla_pharma,,,,,, +2437,,787d3bf7-892f-4231-b179-4aca27639e68,Scheper Ziekenhuis,scheper_ziekenhuis,,,,,, +2438,,1a9bb52c-715f-11e6-a0cd-0242ac12000b,AMARIN PHARMS,amarin_pharms,,,,,, +2439,,b55dc79f-1890-4369-a860-e363d6f349d2,FONDAZIONE RICERCA TRAPIANTO DI MIDOLLO OSSEO,fondazione_ricerca_trapianto_di_midollo_osseo,,,,,, +2440,,045b350f-863f-410d-8cb6-94d5b0f67fd3,"Universitätsklinik für Anästhesie,Intesivmedizin und Schmerztherapie,Mediniz.Universität Wien",universit_tsklinik_f_r_an_sthesie_intesivmedizin_und_schmerztherapie_mediniz_universit_t_wien,,,,,, +2441,,ecadce0a-7179-4f1f-9b8a-20e25d3eb02c,King’s College London & King’s College Hospital,king_s_college_london_king_s_college_hospital,,,,,, +2442,,bcde285f-399f-446c-8cf9-1360fd53f80f,Bo Lennernäs,bo_lennern_s,,,,,, +2443,,7531d453-bb5a-4ba2-bb6e-989f48e86acd,"Regado Biosciences, Inc",regado_biosciences_inc,,,,,, +2444,,71c9f4f4-79c4-4c5b-a60b-0a49aa869e8a,Abbvie previously known as Abbott,abbvie_previously_known_as_abbott,,,,,, +2445,,f2ddedcc-2a57-4f83-a916-bb0b6c953eab,LABORATOIRES EXPANSCIENCE,laboratoires_expanscience,,,,,, +2446,,116fd721-d776-4a1a-b004-7ff07aec5911,"Klinisk Farmakologisk Center og Med. Afd. M, Århus Sygehus, NBG",klinisk_farmakologisk_center_og_med_afd_m_rhus_sygehus_nbg,,,,,, +2447,,36ea61a4-3037-4fd4-bf23-53cc86929db7,A.O PAPA GIOVANNI XXIII- BERGAMO,a_o_papa_giovanni_xxiii_bergamo,,,,,, +2448,,7d1868cc-5361-43fc-955a-c30933bf6a25,Fundació Privada EUGIn,fundaci_privada_eugin,,,,,, +2449,,41d80070-7167-11e6-a0cd-0242ac12000b,ANTRIM PHARMS LLC,antrim_pharms_llc,,,,,, +2450,,1c707bbd-c1aa-4415-af2f-d5823d6f40e4,Joint Research & Development Office (QMUL),joint_research_development_office_qmul,,,,,, +2451,,5cc6a55d-e6eb-41e5-9b09-02effa296e43,Prostrakan Pharmaceuticals Ltd,prostrakan_pharmaceuticals_ltd,,,,,, +2452,,1349e18e-7319-11e6-a0cd-0242ac12000b,R-PHARM US LLC,r_pharm_us_llc,,,,,, +2453,,b09bcc7d-9ac1-4ae5-973a-4d482165514f,TB Investigation Unit of Barcelona,tb_investigation_unit_of_barcelona,,,,,, +2454,,bcd975f9-6912-418c-9768-7e8fd6c92553,Philipps-University of Marburg,philipps_university_of_marburg,,,,,, +2455,,41d5ed63-71fa-4c67-b385-026d76a0dd59,"Cardiology, J. W. Goethe University Frankfurt",cardiology_j_w_goethe_university_frankfurt,,,,,, +2456,,3ab1fc3a-8abe-44b2-ac4f-f0964f61250c,"Gilead Colorado, Inc",gilead_colorado_inc,,,,,, +2457,,61f440c8-7197-11e6-a0cd-0242ac12000b,AH ROBINS INC,ah_robins_inc,,,,,, +2458,,50e925f9-7a46-4555-bcf1-60066163ffda,UCL - The Joint UCLH/UCL Comprehensive Biomedical Research Unit,ucl_the_joint_uclh_ucl_comprehensive_biomedical_research_unit,,,,,, +2459,,ed2e0303-b14f-45ed-8a32-1718b3719e35,"Halozyme, Inc",halozyme_inc,,,,,, +2460,,daa65295-9161-41af-a5c8-db8d50482397,"Abteilung Klinische Chemie, UKL Freiburg",abteilung_klinische_chemie_ukl_freiburg,,,,,, +2461,,c835cbfc-5dae-4efa-afe3-d7272e699203,Janssen Korea Ltd,janssen_korea_ltd,,,,,, +481,0.98966941237449646,b5aab8dc-9d99-478f-8852-3de6e3070b50,Medizinische Universität Graz, Universitätsklinik für Innere Medizin,,,,48f0d5ed-174c-4ce4-98d7-cc34770f5107, Universitätsklinik für Innere Medizin,Medizinische Universität Graz +2462,,102e0c2a-9e51-450a-b4a5-c2240a99a8be,Prothena Therapeutics Limited,prothena_therapeutics_limited,,,,,, +2463,,01d88d1e-81d8-4fc8-ad99-cb5557995908,OPERA SRL,opera_srl,,,,,, +2464,,6f669f89-3bd6-4f84-817a-6dc301b67598,BarcelonaBeta Brain Research Center,barcelonabeta_brain_research_center, Abteilung für Endokrinologie und Stoffwechsel,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_abteilung_f_r_endokrinologie_und_stoffwechsel,,,, +2465,,5cc62c92-7129-11e6-a89e-0242ac12000b,ACTAVIS ELIZABETH,actavis_elizabeth,,,,,, +2466,,edee8a99-d220-4560-bfd4-b99a544acb42,Valderm ApS,valderm_aps,,,,,, +2467,,0967bee3-9253-47d0-a8ab-0e88b0423c10,"Anesthesiological dep., Hospital of Frederikssund",anesthesiological_dep_hospital_of_frederikssund,,,,,, +255,0.988054,fba9d4ba-f942-4323-8150-ae1a4789f6c7,Antwerp University Hospital,antwerp_university_hospital,,,,ab2495df-affb-476e-8780-84d610f1930d,antwerp_university_hospital_uza,Antwerp University Hospital (UZA) +418,0.977699,d47bf620-73ba-11e6-a0cd-0242ac12000b,INCYTE CORP,incyte_corp,,,,3a88d7e1-4064-447e-a62a-a9900c4f088e,incyte,INCYTE +2468,,86d59069-c11c-4735-b747-da68b48c46cd,TKT INC,tkt_inc,,,,,, +2469,,3f75d270-9e38-4a16-8f24-40051983c50c,CIB/RIVM,cib_rivm,,,,,, +2470,,b1d37205-6c46-481c-be05-9ab4c408cf88,Klinikum Augsburg,klinikum_augsburg,,,,,, +2471,,cd9ef4c6-4f43-4d85-be96-315a4177f459,MERCK SERONO s.a.s,merck_serono_s_a_s,,,,,, +2472,,4cfbf9ac-8ace-4672-a618-1718147fea97,Ageo,ageo,,,,,, +289,0.97350454330444336,b9338179-52f4-4b2b-8310-e1de13af8922,BAYER,bayer,,,,444ae102-9372-40dc-a56f-84e8d39e27c0,bayer_sante,BAYER SANTE +2473,,8a84149c-2f38-46a7-9c55-fc8fe14906ed,DURECT Corporation,durect_corporation,,,,,, +2474,,4417bb6b-c20a-43de-91ce-e16e4b435a02,Medizinische Universität Innsbruck - Institut für gerichtliche Medizin,medizinische_universit_t_innsbruck_institut_f_r_gerichtliche_medizin,,,,,, +2475,,bb030478-626f-47e6-9c9e-09455e3e2248,Ferring BV,ferring_bv,,,,,, +2476,,a61d3d42-71a9-11e6-a0cd-0242ac12000b,INDIVIOR INC,indivior_inc,,,,,, +2477,,cce3286a-ea5c-40e3-9644-962df6345c7e,Odense University Hostital,odense_university_hostital,,,,,, +2478,,7af2aef8-8bd6-11e6-a449-0242ac12000b,"Medical Department, Kolding Hospital",medical_department_kolding_hospital,,,,,, +985,0.98482728004455566,275d9cef-debb-4aaf-8234-93691b0c3e94,Imperial College,imperial_college,,,,275d9cef-debb-4aaf-8234-93691b0c3e94,imperial_college,Imperial College +32,0.97160464525222778,c243e6ab-0061-456d-9240-32ae88fba7d5,Technische Universität Dresen,technische_universit_t_dresen,,,,8013f413-0613-4f61-a0a5-e7241cff8548,technische_universit_t_dreden,Technische Universität Dreden +657,0.988592,adefb4c0-1527-4dcd-8c16-d38cccb425d2,sanofi-aventis Netherlands B.V,sanofi_aventis_netherlands_b_v,,,,94fe56aa-5dec-4b9e-95e5-c23b1585d045,sanofi_aventis_netherlands,sanofi-aventis Netherlands +2479,,f591d25a-cab3-4916-8617-2e9d66aeed44,Grupo Español para el Tratamiento y Estudio de los Linfomas (GOTEL),grupo_espa_ol_para_el_tratamiento_y_estudio_de_los_linfomas_gotel,,,,,, +2480,,3d7e4244-29b2-4e18-b020-a8bd71e70c83,AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA,azienda_ospedaliera_arcispedale_s_maria_nuova,,,,,, +278,0.97598719596862793,ee928994-e797-4b93-87d0-4ac65936de69,GlaxoSmithKline Research & Devlopment Ltd,glaxosmithkline_research_devlopment_ltd,,,,e86cb604-6399-4605-9a60-17154f1ecb73,glaxosmithkline_research_devleopment_ltd,GlaxoSmithKline Research & Devleopment Ltd +2481,,25cd62ad-312a-4f83-812a-e20817ce3507,Heli Sätilä,heli_s_til,,,,,, +2482,,3154456c-daf6-411c-9fa2-812ea8e3c1ae,GGz Nijmegen,ggz_nijmegen,,,,,, +2483,,1024edd0-9f40-462b-b9d5-eaa74a8a2c0f,University Antwerp,university_antwerp,,,,,, +390,0.95186018943786621,65bfdb33-6e94-44cb-98e5-4ec4d0ef60a9,Galderma Research & Development Inc,galderma_research_development_inc,,,,b5653343-db85-468f-9ea0-a6d1b957afa2,galderma_research_development,Galderma research & Development +260,0.985178,aac14393-408b-4045-b7ea-8cfc88f89eec,National Cancer Institute,national_cancer_institute,,,,91b42753-22b3-40cf-91c4-a74d2a2ada1b,national_cancer_institute_naples_italy,"National Cancer Institute Naples, Italy" +481,0.98544037342071533,77e5f2eb-c368-46a0-928b-5d9465a6166f,"Medizinische Universität Graz, Innere Medizin",medizinische_universit_t_graz_innere_medizin,,,,48f0d5ed-174c-4ce4-98d7-cc34770f5107, Universitätsklinik für Innere Medizin,Medizinische Universität Graz +2484,,0899ec3d-a121-4250-abe3-84255c8974d1,Anna Karlberg,anna_karlberg,,,,,, +2485,,3be3a072-a23d-45c2-a997-0038395e4689,Celyad SA,celyad_sa,,,,,, +2486,,096420dd-8981-41e2-a3be-f0bc2ff5d7a6,Washington University in St. Louis,washington_university_in_st_louis,,,,,, +2487,,a6951379-2e48-4cb1-b70b-1968bfda28f5,LETI Pharma GmbH,leti_pharma_gmbh,,,,,, +2488,,b30f5f14-d7b7-424f-87c4-8c4335d912cc,Stichting Longgeneeskunde Fryslan,stichting_longgeneeskunde_fryslan,,,,,, +67,0.960694,e44ea607-2c3b-495f-ad1d-b97fc34b7012,Servier Research and Development Limited,servier_research_and_development_limited,,,,8fbbc81e-1516-4d7f-b54e-79f6a0aef8e0,servier_research_and_development_ltd,Servier Research and Development Ltd +933,0.98634018500645959,8728530f-6b1a-45be-8dd9-ea62e4e4d9b3,Pierre Fabre Médicament,pierre_fabre_m_dicament,,,,e26f58e7-f0e7-4ad4-9432-e13ea279b291,pierre_fabre,Pierre Fabre Médicament +2489,,18397458-8fe9-4393-86b1-47c89b52ed98,TrialNet Coordinating Center,trialnet_coordinating_center,,,,,, +2490,,f2ae8ac8-6413-4c5c-bfe2-0d4e65e3adc1,Helsingin ja uudenmaan sairaanhoitopiiri,helsingin_ja_uudenmaan_sairaanhoitopiiri,,,,,, +2491,,b9cf4de5-a08f-485e-b137-5ee4acfede18,Laboratoires Théa,laboratoires_th_a,,,,,, +1012,0.90563303232192993,60da3cea-6fa0-11e6-9663-0242ac12000b,Shire Human Genetics Therapies Inc,shire_human_genetics_therapies_inc,,,,c06cb74b-1c77-4c28-9c14-a6b870a4012a,shire_human_genetic_therapies_inc,"Shire Human Genetic Therapies, Inc. (Shire HGT)" +2492,,75bd6ca6-1cd0-449d-b2ee-2c5c83df2d75,Dekan des Fachbereichs Medizin der Johann Wolfgang Goethe-Universität Frankfurt/M,dekan_des_fachbereichs_medizin_der_johann_wolfgang_goethe_universit_t_frankfurt_m,,,,,, +2493,,f31d6004-0186-4e56-b3f6-194e4e15b02b,Anthera Pharmaceuticals Incorporated,anthera_pharmaceuticals_incorporated,,,,,, +2494,,0cb2bb19-99d8-4231-b0af-a95af7282c28,"Department of Nuclear Medicine and Endocrinology, Paracelsus Medical University Salzburg",department_of_nuclear_medicine_and_endocrinology_paracelsus_medical_university_salzburg,,,,,, +2495,,9dd132e3-7f60-42d6-b5ed-33394636d73b,Fertin Pharma A/S,fertin_pharma_a_s,,,,,, +2496,,8c2e6288-6fbc-11e6-abe8-0242ac12000b,Research Institute for the prevention of allergy and airway diseases in childhood,research_institute_for_the_prevention_of_allergy_and_airway_diseases_in_childhood,,,,,, +60,0.95962155716759823,267a3e5c-87bd-4f2a-b839-71e2bf32b251,Wyeth Research Division of Wyeth Pharmaeuticals Inc. (A Pfizer Company),wyeth_research_division_of_wyeth_pharmaeuticals_inc_a_pfizer_company,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc +2497,,30d020aa-7167-11e6-a0cd-0242ac12000b,MIDWEST MEDCL,midwest_medcl,,,,,, +2498,,d2ef22f3-26d8-4d88-b226-511e8ddc04c6,"University Hospital, Limoges",university_hospital_limoges,,,,,, +59,0.96049280961354577,f4c6a588-0b61-41c0-8d2f-ce159443b414,"Wyeth Research Division, Wyeth Pharmeceuticals Inc",wyeth_research_division_wyeth_pharmeceuticals_inc,,,,96e5ebae-c6a3-41db-ae14-3ec5437c35f2,wyeth_research_division,Wyeth Research Division +2499,,40d9b1a6-5414-42d9-85c6-9c46343da071,Dr. Josep Brugada Terradellas- Hospital Clínic,dr_josep_brugada_terradellas_hospital_cl_nic,,,,,, +2500,,224f0a77-83d9-40a8-8e81-ead3edf4967b,"Patara Pharma, LLC",patara_pharma_llc,,,,,, +2501,,6a828d30-7160-11e6-a0cd-0242ac12000b,MERICON,mericon,,,,,, +2502,,849838dc-7129-11e6-a89e-0242ac12000b,IVAX SUB TEVA PHARMS,ivax_sub_teva_pharms,,,,,, +2503,,2344e167-a5ad-40f9-98f5-efcffd676091,GSO Global Clinical Research B.V,gso_global_clinical_research_b_v,,,,,, +2504,,53d5c287-401a-4ec5-a733-db80d8c368b3,E. Merck AB,e_merck_ab,,,,,, +1072,0.959984,d943ec30-97c3-4f8b-96df-4c65aab4025e,Danish Breast Cancer Group (BDCG),danish_breast_cancer_group_bdcg,,,,0e59fcb8-db64-490f-b629-84fe6f12827e,danish_breast_cancer_group_dbcg,Danish Breast Cancer Group (DBCG) +2505,,a73639bf-1432-43fb-90c3-800051cd1d48,Guys and St Thomas NHS Foundation Trust,guys_and_st_thomas_nhs_foundation_trust,,,,,, +151,0.968867,f875fece-bc54-4d3d-b6d3-a15de3894a92,Institute of Cancer research and molecular medicine,institute_of_cancer_research_and_molecular_medicine,,,,17459e96-4beb-4a3a-bba1-71e183697af9,institute_of_cancer_research,Institute of Cancer Research +910,0.9759957492351532,b7983b78-cf39-48ab-8d1d-be637a853547,Laboratorios Servier SL,laboratorios_servier_sl,,,,32161af5-1f02-447e-a38b-e0f0858697d7,laboratorios_servier,Laboratorios Servier +2506,,e210b1dd-76ef-4af7-a96a-8812beb53ca5,Servier Research and Development Ltd (for UK only),servier_research_and_development_ltd_for_uk_only,,,,,, +2507,,a58751fd-470c-400d-aacb-4e1822dfdccf,E.M.N. - EUROPEAN MYELOMA NETWORK,e_m_n_european_myeloma_network,,,,,, +2508,,073f0d4b-fd1d-49f7-98e3-ae03670d93b3,"MRC Clinical Trials Unit, Cancer Division",mrc_clinical_trials_unit_cancer_division,,,,,, +2509,,c45bcf64-7166-11e6-a0cd-0242ac12000b,WILSHIRE PHARMS INC,wilshire_pharms_inc,,,,,, +2510,,2316b8ad-ce99-4a60-a8db-fc7e952b0834,TAYS Sydänkeskus Oy,tays_syd_nkeskus_oy,,,,,, +2511,,a8a16462-259b-4913-96ab-2082154ab070,New Medical Enzymes AG,new_medical_enzymes_ag,,,,,, +2512,,69c107a6-e7ab-4707-89db-44c34c69471b,Per H. Rosenberg,per_h_rosenberg,,,,,, +2513,,d5c1d888-6c32-4065-b7f1-9b7857947a08,"SBI Pharmaceuticals Co., Ltd",sbi_pharmaceuticals_co_ltd,,,,,, +2514,,22725360-5e5f-48e7-96ba-ff3ca81cd759,Logical Therapeutics Inc,logical_therapeutics_inc,,,,,, +2515,,f847057d-154a-4436-8b6c-bae3ea8b9ceb,"Ethicon Inc., a Johnson & Johnson Co",ethicon_inc_a_johnson_johnson_co,,,,,, +57,0.9411388635635376,a64aa1b6-6fbe-11e6-abe8-0242ac12000b,Wyeth Research Division of Wyeth Pharmaceuticals Inc.Clinical Research & Development Department,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_development_department,,,,1d53dcae-9b86-416e-9d92-a62412245dcc,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_development,"Wyeth Research Division of Wyeth Pharmaceuticals, Inc. Clinical Research & Development" +2516,,696f7623-9220-4025-9662-796e0328e438,OPi,opi,,,,,, +2517,,8a2fd13d-592b-4717-93f3-dd801d1eaccd,DIPAK Consortium,dipak_consortium,,,,,, +2518,,c2512063-8e43-4610-b09a-614da94fff75,Verisfield (UK) Ltd,verisfield_uk_ltd,,,,,, +2519,,b59de1f0-6f9b-11e6-9663-0242ac12000b,Stiefel Laboratories Inc,stiefel_laboratories_inc,,,,,, +2520,,b9501075-0d16-4e96-97ea-27066331f5c7,SOCIETA` ITALIANA DI ANDROLOGIA,societa_italiana_di_andrologia,,,,,, +819,0.912088,ec01752b-56f3-496e-9ff4-7c90ad1666dc,UNIVERSITA DEGLI STUDI DI PAVIA,universita_degli_studi_di_pavia,,,,bf66c8e7-dc46-4d4b-a5d0-60ce8486fef9,universita_degli_studi_di_parma,UNIVERSITA` DEGLI STUDI DI PARMA +579,0.98861104249954224,4f145c09-2deb-446d-b29d-1c733e1a550e,"Wyeth Pharmaceuticals Inc., acting through its division of Wyeth Research",wyeth_pharmaceuticals_inc_acting_through_its_division_of_wyeth_research,,,,2087c696-3203-4dfa-967f-2d9749dedb6f,wyeth_pharmaceuticals_inc_acting_through_its_division_of_wyeth_research_a_pfizer_company,"Wyeth Pharmaceuticals Inc., acting through its division of Wyeth Research, a Pfizer company" +2521,,a5592bcf-b2a9-4eef-87b4-32f428e1cd67,Universitätsklinikum Heidelberg,universit_tsklinikum_heidelberg,,,,,, +846,0.94804,8e57a7f2-6f76-49f9-afae-1f3f5c9f50b4,"Eyetech Pharamceuticals, Inc",eyetech_pharamceuticals_inc,,,,8e57a7f2-6f76-49f9-afae-1f3f5c9f50b4,eyetech_pharamceuticals_inc,"Eyetech Pharamceuticals, Inc" +2522,,7b55278e-8358-4717-8e71-d41b21058f00,"SCHWARZ BIOSCIENCES, GmbH, Miembro del Grupo UCB",schwarz_biosciences_gmbh_miembro_del_grupo_ucb,,,,,, +2523,,08a36ab5-a610-40b0-94df-d3cd9c2aab40,Polichem S.A,polichem_s_a,,,,,, +2524,,a08b493b-1115-44ee-91f2-eb85a7aa2d08,"CoMentis, Inc., USA",comentis_inc_usa,,,,,, +2525,,e268185a-6d94-4087-83c8-3be004288014,Central Manchester and Manchester Children's University NHS trust,central_manchester_and_manchester_children_s_university_nhs_trust,,,,,, +2526,,dd9a4d86-cf13-4dce-81c9-54423e3b27c6,Jose Carlos Flores González,jose_carlos_flores_gonz_lez,,,,,, +2527,,060718e6-72fd-11e6-a0cd-0242ac12000b,INSTITUT BIOCHIMIQUE,institut_biochimique,,,,,, +210,0.944644,7fb393d1-3662-49ec-8f79-16654d5ad677,Finnish Braest Cancer Group,finnish_braest_cancer_group,,,,0b4f5fcf-dbeb-40d7-9a94-9cb3a8d69d76,finnish_breast_cancer_group,Finnish Breast Cancer Group +2528,,a47cae2f-c087-4a4e-87c8-9fa94556d4dc,Inserm-ISP Pole Recherches cliniques et thérapeutiques,inserm_isp_pole_recherches_cliniques_et_th_rapeutiques,,,,,, +2529,,df50c7b2-f49f-4a07-9225-d5914fceca52,Dept anaesthesiology and intensive care,dept_anaesthesiology_and_intensive_care,,,,,, +2530,,64553f92-f0c1-41ae-ac91-ebc7bf5ab5ec,The Royal Liverpool University Hospital NHS Trust,the_royal_liverpool_university_hospital_nhs_trust,,,,,, +2531,,c0d5e646-7255-11e6-a0cd-0242ac12000b,PACIRA PHARMS INC,pacira_pharms_inc,,,,,, +2532,,8d24c35d-f2af-4a15-b998-c3c54bc6ffa3,"Unilfarma - União Internacional de Lab. Farmacêuticos, Lda",unilfarma_uni_o_internacional_de_lab_farmac_uticos_lda,,,,,, +2533,,3b3963bc-7167-11e6-a0cd-0242ac12000b,UCSF RODIOPHARM,ucsf_rodiopharm,,,,,, +2534,,bbaea4a6-8fc9-4523-83eb-1195c557c829,EBEWE Pharma Ges.m.b.H Nfg.KG,ebewe_pharma_ges_m_b_h_nfg_kg,,,,,, +2535,,ee041bb3-e14b-4de3-abd4-74873e97791e,TECHNI-PHARMA,techni_pharma,,,,,, +2536,,aa559ac5-ca14-4fa8-b33b-a41ae73d2bc2,"Barrier Therapeutics, Inc",barrier_therapeutics_inc,,,,,, +2537,,ac9f4ccc-8acd-451b-aa16-124bff24eccd,Laboratoire Innotech International,laboratoire_innotech_international,,,,,, +2538,,cd4203cf-aba0-43b0-af98-daf0e5767501,York Pharma GmbH,york_pharma_gmbh,,,,,, +2539,,43b74e40-95d5-11e6-becf-0242ac110008,WEST-WARD PHARMS INT,west_ward_pharms_int,,,,,, +2540,,869c3698-7191-11e6-a0cd-0242ac12000b,CONSOLIDATED MIDLAND,consolidated_midland,,,,,, +14,0.95796602964401245,f569f240-7fd2-4fc3-b7f2-3c2a20010671,Menarini International Operations Luxembourg SA,menarini_international_operations_luxembourg_sa,,,,41be544c-1f46-41e5-bb1b-0bb3baefda2e,menarini_international_operation_luxembourg_sa,Menarini International Operation Luxembourg S.A +2541,,2a18e5e0-c196-4861-a862-efb4afde6259,"Department of Pulmonology, Rijnstate Hospital",department_of_pulmonology_rijnstate_hospital,,,,,, +2542,,66a728ee-abd0-49ce-96cd-cb1a7020bdc0,Hospital General de Granollers,hospital_general_de_granollers,,,,,, +325,0.9791768491268158,0292d041-5c8d-4dee-ba50-01c0869a5672,"Ferrer Internacional, S.A",ferrer_internacional_s_a,,,,199a1dd6-828f-4e0b-b783-d712bad32b9e,ferrer_internacional,Ferrer Internacional +2543,,265c309e-d8ee-41d0-90a2-a012daf5692d,Merck Generics UK Ltd,merck_generics_uk_ltd,,,,,, +534,0.974154,c768dbb0-8719-4eac-87b7-85a4bd69abf0,"R&D Department,",r_d_department,,,,26b8ea41-7b0c-465a-88f2-0c4f81b680ce,r_d_department_box_146_addenbrooke_s_hospital,"R&D Department, Box 146, Addenbrooke's Hospital" +340,0.98418444395065308,c2050242-2845-4f5c-bc40-956b4ae6c60d,Intercytex,intercytex,,,,02763460-e885-4cb3-a951-4a777203fe35,intercytex_ltd,Intercytex Ltd +2544,,bd324332-a52e-4288-a7e5-2181703fb46d,University of Regensburg,university_of_regensburg,,,,,, +2545,,ca0ae959-94c5-4ef0-b1f3-c9a0a676dfb0,Pfizer ApS,pfizer_aps,,,,,, +1021,0.97737881541252136,8ba0704e-f5bd-4a63-ab3d-b93274d707ee,"Impax Laboratories, Inc. acting through its Impax Pharmaceuticals Division",impax_laboratories_inc_acting_through_its_impax_pharmaceuticals_division,,,,2e27f2ec-dcc5-4828-b31a-e2eca3930c17,impax_laboratories_inc_acting_through_its_impax_pharmaceuticals_division_impax,"Impax Laboratories, Inc., acting through its Impax Pharmaceuticals Division (Impax)" +2546,,a692601e-c115-4d7a-9ce9-f47382f2f4a7,THERABEL PHARMACEUTICAL Ltd,therabel_pharmaceutical_ltd,,,,,, +2547,,6992edc5-f356-416c-b38c-413873f64761,AMGEN S.P.A,amgen_s_p_a,,,,,, +547,0.96279633045196533,8f1a10a0-5c3a-45de-a1fa-2ff0f80316bf,G.O.N.O,g_o_n_o,,,,8f1a10a0-5c3a-45de-a1fa-2ff0f80316bf,g_o_n_o,G.O.N.O +2548,,0ab50354-ae03-4fe3-9397-f7de7f9fc374,MIPHARM,mipharm,,,,,, +198,0.96630248427391052,59af07b2-8bdc-4113-8ce3-1b459956f500,Agence nationale de recherches sur le sida et les hépatites virales (National Agency for AIDS-ANRS),agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales_national_agency_for_aids_anrs,,,,59af07b2-8bdc-4113-8ce3-1b459956f500,agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales,Agence nationale de recherches sur le sida et les hépatites virales +2549,,f9214ef8-7167-11e6-a0cd-0242ac12000b,SANJA PHARMS CO,sanja_pharms_co,,,,,, +2550,,61bd0d18-7167-11e6-a0cd-0242ac12000b,SHERTECH LABS LLC,shertech_labs_llc,,,,,, +2551,,273125b7-6fc5-444e-81aa-580abfad0acf,Investigator Trondheim Hudlegesenter AS,investigator_trondheim_hudlegesenter_as,,,,,, +2552,,a37cb91c-a24c-4183-91dd-d9ee6e699ce3,Laboratories León Farma S.A,laboratories_le_n_farma_s_a,,,,,, +2553,,b2ec6574-3b70-4903-891b-3c514a6140ea,The Back Research center,the_back_research_center,,,,,, +2554,,59f328b2-fe43-4649-b8b1-c55777b2848a,Erempharma SAS,erempharma_sas,,,,,, +2555,,b5c912a2-3fb2-4f35-b29f-d55defaa9696,JOSEP ORDI-ROS,josep_ordi_ros,,,,,, +2556,,d5a733c6-7161-11e6-a0cd-0242ac12000b,UDL,udl,,,,,, +2557,,0712daf2-6f70-469e-9158-797040198dae,Lightlake Sinclair Oy,lightlake_sinclair_oy,,,,,, +840,0.98523330688476562,9d9eb480-bf21-4092-839f-09f898baa735,JANSSEN-CILAG,janssen_cilag,,,,3db31bd4-ebf3-4e55-8979-0617fa1fc589,janssen_cilag_gmbh,JANSSEN-CILAG GmbH +2558,,42afcaae-2e6e-4428-a256-ae07d9645abd,Nordic Bioscience A/S,nordic_bioscience_a_s,,,,,, +43,0.978791,38b6ac83-2901-4af7-b81e-62ce14bad7cc,Nordic Society of Gynaecological Oncology (NSGO),nordic_society_of_gynaecological_oncology_nsgo,,,,38b6ac83-2901-4af7-b81e-62ce14bad7cc,nordic_society_of_gynaecological_oncology_nsgo,Nordic Society of Gynaecological Oncology (NSGO) +363,0.953188,e6c54f15-e683-4ea1-9a75-6d49165a6ff5,AZIENDA OSPEDALIERA S. GERARDO DI MONZA,azienda_ospedaliera_s_gerardo_di_monza,,,,6d5782a7-67e2-4374-a6a3-c1e2c79b8eb4,azienda_ospedaliera_san_gerardo_di_monza,AZIENDA OSPEDALIERA SAN GERARDO DI MONZA +2559,,eede47d6-7197-11e6-a0cd-0242ac12000b,HRA PHARMA,hra_pharma,,,,,, +2560,,33dae41b-85a1-48cf-a750-795711775339,Medicis Pharmaceutical Corporation,medicis_pharmaceutical_corporation,,,,,, +2561,,024b7fd9-9fbc-4854-88e1-acaedd822508,"Nippon Shinyaku Co., Ltd",nippon_shinyaku_co_ltd,,,,,, +2562,,57e68227-ef30-4396-9070-835860ac80de,Novartis Hungária Kft,novartis_hung_ria_kft,,,,,, +436,0.95831960439682007,70a57a39-1462-4239-a163-1968d0d1a9d3,"Pfizer Inc, 235 East 42nd Street, New York, NY10017, United States",pfizer_inc_235_east_42nd_street_new_york_ny10017_united_states,,,,25203332-c6eb-4eda-87c7-a780f5142133,pfizer_inc_235_east_42nd_street_new_york_ny10017_united_states,"Pfizer Inc., 235 East 42nd Street, New York, 10017, United States" +2563,,9cee772c-7168-11e6-a0cd-0242ac12000b,ADVANCE BIOFACTURES,advance_biofactures,,,,,, +2564,,21d2bedb-b9ab-4871-ba3e-2f73706d0c7e,Roche Slovensko s.r.o,roche_slovensko_s_r_o,,,,,, +901,0.952896,ffeff90c-563b-439c-969c-9d5ba8527f28,Fundació Privada Clinic per la Recerca Biomèdica,fundaci_privada_clinic_per_la_recerca_biom_dica,,,,465a5556-c902-495a-8a94-7999cb29da09,fundaci_privada_cl_nic_per_a_la_recerca_biom_dica,Fundació Privada Clínic per a la Recerca Biomèdica +2565,,c2a7c909-20f0-474d-bd90-c76772fe0bf3,INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS),instituto_de_investigaciones_biomedicas_august_pi_i_sunyer_idibaps,,,,,, +2566,,9b0efc58-6487-48cc-b571-7c9725f6fc67,Institut Bergonié - Centre Régional de Lutte Contre le Cancer de Bordeaux et du Sud-ouest,institut_bergoni_centre_r_gional_de_lutte_contre_le_cancer_de_bordeaux_et_du_sud_ouest,,,,,, +2567,,cb08ba3c-7311-11e6-a0cd-0242ac12000b,HISAMITSU PHARM CO,hisamitsu_pharm_co,,,,,, +216,0.972547,eb525a5a-b41f-456c-a3fc-544e7cf55e70,Universitätsklinik für Kinder-und Jugendheilkunde,universit_tsklinik_f_r_kinder_und_jugendheilkunde,,,,797c01ee-1dfa-4820-a53e-5dcb99477f68,universit_tsklinik_f_r_kinder_und_jugendheilkunde_medizinsiche_universit_t_wien,"Universitätsklinik für Kinder- und Jugendheilkunde, Medizinsiche Universität Wien" +2568,,37451c20-e607-4b7c-b15a-dfe4e86383ee,Erasme hospital,erasme_hospital,,,,,, +2569,,50a18d5b-e8ef-44aa-8907-4762b639b67b,"Bente Langdahl, consultant, ass. professor, PhD, DMSc",bente_langdahl_consultant_ass_professor_phd_dmsc,,,,,, +2570,,b3032470-0645-4179-861f-0f9bef551c6e,"Helsingin Yliopisto, Kemian laitos",helsingin_yliopisto_kemian_laitos,,,,,, +2571,,cc68c5cc-fdbb-4373-94c1-5ca552d98650,Instituto Oftalmológico de Alicante (VISSUM),instituto_oftalmol_gico_de_alicante_vissum,,,,,, +2572,,e61c4852-6fba-11e6-abe8-0242ac12000b,Life Recovery Systems,life_recovery_systems,,,,,, +2573,,71ed3db2-80df-4d61-95aa-7d3b77fd29ee,Biopure Corporation,biopure_corporation,,,,,, +2574,,f5e7e24a-7141-11e6-a0cd-0242ac12000b,TEDOR PHARM,tedor_pharm,,,,,, +2575,,da4e4290-8bb8-11e6-a449-0242ac12000b,Hospitalsenheden Horsens,hospitalsenheden_horsens,,,,,, +2576,,d992d79e-35f6-4ee4-9584-5ae8fbb2057d,Pfizer Inc. 235 East 42nd street – New York – 10017 NY - USA,pfizer_inc_235_east_42nd_street_new_york_10017_ny_usa,,,,,, +2577,,6a4a0eba-1959-4494-9e58-bdb7da7ada01,GlaxoSmithKline Research & Development Limited,glaxosmithkline_research_development_limited,,,,,, +2578,,25a60d16-71a8-11e6-a0cd-0242ac12000b,PRAGMA PHARMS LLC,pragma_pharms_llc,,,,,, +2579,,3bbe38b9-b3f4-4d58-811e-8dba91c20f92,"University Medical Centre St. Radboud, Department of Dermatology",university_medical_centre_st_radboud_department_of_dermatology,,,,,, +2580,,5fb82390-a41b-4a84-bc3e-70e50d1b3f13,"GETAID, Jean Minjoz Hospital",getaid_jean_minjoz_hospital,,,,,, +2581,,5de3af86-01b2-411e-9170-4c2ec5449fd0,ThromboGenics Ltd,thrombogenics_ltd,,,,,, +946,0.987167,4cc8b53a-0566-477c-a16e-fcd4919e14fe,Universität Leipzig,universit_t_leipzig,,,,4cc8b53a-0566-477c-a16e-fcd4919e14fe,universit_t_leipzig,Universität Leipzig +2582,,21cbeb95-1682-4a22-b1c7-10bd3d31f344,University Hospital of Zurich and City Hospital Waid,university_hospital_of_zurich_and_city_hospital_waid,,,,,, +2583,,25cf526b-16f4-4daa-b8e5-95c76af72eac,"KaloBios Pharmaceuticals, Inc",kalobios_pharmaceuticals_inc,,,,,, +389,0.989307,b0142515-efdf-489a-bd08-d53f5508a4ba,Ludwig Institute for Cancer Research,ludwig_institute_for_cancer_research,,,,b0142515-efdf-489a-bd08-d53f5508a4ba,ludwig_institute_for_cancer_research,Ludwig Institute for Cancer Research +2584,,e4a07adb-d315-4c0b-a729-ae7a905dd171,CKF at Västmanlands hospital Västerås,ckf_at_v_stmanlands_hospital_v_ster_s,,,,,, +2585,,0150ae11-2d58-41c8-89c9-91e7a8b52b42,Alimera Science Inc,alimera_science_inc,,,,,, +2586,,7c29e3db-7764-4c57-83c7-c7ce51e36422,Dekan des FB Medizin der Johann-Wolfgang Goethe-Universität,dekan_des_fb_medizin_der_johann_wolfgang_goethe_universit_t,,,,,, +2587,,49699c3a-715e-11e6-a0cd-0242ac12000b,UNICHEM LABS LTD,unichem_labs_ltd,,,,,, +2588,,3caddc74-7161-11e6-a0cd-0242ac12000b,OLTA PHARMS,olta_pharms,,,,,, +2589,,10e077a6-80ef-404a-8239-766b4e475635,"Saniona, A/S",saniona_a_s,,,,,, +2590,,5ead929b-bc15-4457-a6be-e163543c68b9,CUB Erasme Hospital,cub_erasme_hospital,,,,,, +2591,,a1c8d7c5-930d-4de9-95e6-efb2eb0b3542,Artu Biologicals Europe BV,artu_biologicals_europe_bv,,,,,, +2592,,19371419-7ff8-4a2a-a319-40135b928879,"Department of experimental and clinical medicine ""F. Magrassi",department_of_experimental_and_clinical_medicine_f_magrassi,,,,,, +2593,,4a057ad0-0954-440e-be12-6707eb1c7413,Grupo Oncológico para el Tratamiento y Estudio de los Linfomas (GOTEL),grupo_oncol_gico_para_el_tratamiento_y_estudio_de_los_linfomas_gotel,,,,,, +652,0.95031802356243134,241bd917-a30c-4145-b0b2-d1232db3c592,Boehringer Ingelheim KS,boehringer_ingelheim_ks,,,,756fbf26-6aec-45b4-9273-9afca275034e,boehringer,Boehringer +2594,,2d5b4b82-c4d6-4905-84e0-f71dae9ac4b4,"dept of endocrinology J 106, herlev Hosptial",dept_of_endocrinology_j_106_herlev_hosptial,,,,,, +2595,,7c015004-73e1-11e6-a0cd-0242ac12000b,SHIRE DEV LLC,shire_dev_llc,,,,,, +2596,,d65dcd42-453e-46d7-854b-400ec51ec742,"Respiratory Research Unit, Bispebjerg Hospital",respiratory_research_unit_bispebjerg_hospital,,,,,, +2597,,3e19cd09-3d60-4afa-87fb-0faf41d6d41a,University Hospital Innsbruck,university_hospital_innsbruck,,,,,, +2598,,afbcef29-1495-49da-96d6-2c4493294ccd,Sager Pharma Ltd,sager_pharma_ltd,,,,,, +2599,,5515bd50-49b2-4503-8732-1a26ab7b1d39,Azienda Ospedaliera Universitaria Integrata Verona,azienda_ospedaliera_universitaria_integrata_verona,,,,,, +2600,,b14ca4dd-82c2-492b-a2a5-5bf27c0bca1b,FONDAZIONE ANGELO BIANCHI BONOMI,fondazione_angelo_bianchi_bonomi,,,,,, +2601,,8c4a4e9b-08a9-4d26-b2f3-d4cdfea5b812,"Medizinische Universiätsklinik Graz, Abteilung für Endokrinologie und Nuklearmedizin",medizinische_universi_tsklinik_graz_abteilung_f_r_endokrinologie_und_nuklearmedizin,,,,,, +2602,,f48bd0ef-b570-4f57-8d0a-9708d05641cd,Janssen Pharmaceutica NV,janssen_pharmaceutica_nv,,,,,, +2603,,bfadd40a-f174-4e44-9310-44bf1ec99b6e,Velindre NHS Trust,velindre_nhs_trust,,,,,, +2604,,47ee3d3a-ab8c-47a1-ae04-4fb13b562ba4,UCB Biosciences GmbH,ucb_biosciences_gmbh,,,,,, +558,0.984864,19dd85ae-7144-11e6-a0cd-0242ac12000b,FERA PHARMS,fera_pharms,,,,19dd85ae-7144-11e6-a0cd-0242ac12000b,fera_pharms,FERA PHARMS +2605,,633e647c-abd3-4880-835d-793b0f66949d,Westfriesgasthuis,westfriesgasthuis,,,,,, +2606,,53384ef2-e877-487f-be83-6ef76ea3b9a6,Grupo Español de Tratamiento de Tumores Digestivos-TTD,grupo_espa_ol_de_tratamiento_de_tumores_digestivos_ttd,,,,,, +2607,,89cea462-7142-11e6-a0cd-0242ac12000b,MERZ PHARMS,merz_pharms,,,,,, +2608,,7dc45f4e-b825-4016-ac2d-87df73231e9a,Department of Endocrine Oncology,department_of_endocrine_oncology,,,,,, +71,0.95618447661399841,b67e60ae-e98f-4e54-abdb-b3347456bc5c,Takeda Europe R&D Centre Ltd,takeda_europe_r_d_centre_ltd,,,,a50a5323-eb43-4b40-8b80-cb222451e80b,takeda,Takeda +83,0.96475303173065186,82a6c5b2-dbb3-4ec5-851e-95e3fe015b13,"Medizinische Universität Wien, Universitätsklinik für Psychiatrie und Psychotherapie",medizinische_universit_t_wien_universit_tsklinik_f_r_psychiatrie_und_psychotherapie,,,,2e778965-4803-4c24-80eb-b2a9fc5651e6,medizinische_universit_t_wien_universit_tsklinik_f_r_psychiatrie_u_psychotherapie_abteil_f_r_biologische_psychiatrie,"Medizinische Universität Wien, Universitätsklinik für Psychiatrie u. Psychotherapie, Abteil. für biologische Psychiatrie" +2609,,1fadb2ef-b28e-4b35-8344-8ca9336c1150,"Center for Digestive Diseases, Karolinska University Hospital",center_for_digestive_diseases_karolinska_university_hospital,,,,,, +2610,,8b11de34-7165-11e6-a0cd-0242ac12000b,CHEM WERTH INC,chem_werth_inc,,,,,, +2611,,fd580de4-44be-4021-87b7-27de7e433a28,Abiogen Pharma SpA,abiogen_pharma_spa,,,,,, +912,0.988197,5ab6cc31-5c5f-48d7-b051-b6fa3cd71433,"Aarhus University Hospital, Skejby",aarhus_university_hospital_skejby,,,,3603d959-b219-470b-be2c-d1bcd4a7c148,aarhus_university_hospital_skejby_sygehus,"Aarhus University Hospital, Skejby sygehus" +2612,,e81faa5e-c3e4-4993-bae0-2a43cfee5d00,"The Police Rehabilitation Centre, Flint House",the_police_rehabilitation_centre_flint_house,,,,,, +2613,,d53179e8-6654-43cf-93f9-9bb6a698a35f,Janssen Cliag Ltd. C/O Johnson & Johnson PRD,janssen_cliag_ltd_c_o_johnson_johnson_prd,,,,,, +2614,,8778dead-c85f-42df-8040-c13c5e603b61,Czech Lymphoma Research Organization s.r.o. (CLRO),czech_lymphoma_research_organization_s_r_o_clro,,,,,, +2615,,7213434e-7167-11e6-a0cd-0242ac12000b,SIDMAK LABS INDIA,sidmak_labs_india,,,,,, +2616,,15f39481-07e8-4829-aaa8-99818f811c78,Johan Styrke,johan_styrke,,,,,, +2617,,e2a92b6e-4bbc-46e5-8bc1-4f3483345d9b,"Dept. of Anaesthesia and Intensive Care, Haukeland University Hospital",dept_of_anaesthesia_and_intensive_care_haukeland_university_hospital,,,,,, +2618,,1450cbd2-c282-4758-be96-96a452d58b96,Dr John Berth-Jones,dr_john_berth_jones,,,,,, +682,0.982418,23ad1ae6-2f3f-4ff6-98ef-777036a904b2,"Genentech, Inc",genentech_inc,,,,23ad1ae6-2f3f-4ff6-98ef-777036a904b2,genentech_inc,"Genentech, Inc" +2619,,82fb066b-8762-49a7-9276-27c739d32bf6,Fertility clinic Odense University Hospital,fertility_clinic_odense_university_hospital,,,,,, +2620,,5690ee55-e932-4c92-9823-ee21e2adef49,"Gilead Sciences, S.L",gilead_sciences_s_l,,,,,, +2621,,dc38435a-b194-4bad-bb30-57eafa38cfcb,"R&D Dept Raigmore Hospital, Inverness",r_d_dept_raigmore_hospital_inverness,,,,,, +636,0.988732,d340f3f9-d2dc-4928-902a-5b85cded2bdf,La Jolla Pharmaceutical Company,la_jolla_pharmaceutical_company,,,,0a4a7604-18d1-4751-9003-e209b313dd54,la_jolla_pharmaceutical_company_inc,"La Jolla Pharmaceutical Company, Inc" +2622,,2e8fabf6-ac68-432a-b849-e39b6bbd876e,Merck Sharp and Dohme Ltd,merck_sharp_and_dohme_ltd,,,,,, +2623,,5e8901d8-7144-11e6-a0cd-0242ac12000b,TORRENT PHARMA INC,torrent_pharma_inc,,,,,, +2624,,cf1b1338-f436-485e-87e7-71984d4023ad,Nordic MDS study group,nordic_mds_study_group,,,,,, +2625,,f4f652ac-6f9f-11e6-9663-0242ac12000b,"Ludwig-Maximilian-University of Munich, Department of Psychiatry",ludwig_maximilian_university_of_munich_department_of_psychiatry,,,,,, +2626,,4916ced7-e8fa-45a5-be46-09e714b462a7,CHU de Brest,chu_de_brest,,,,,, +2627,,fda5b1a3-f073-4f8f-ba74-b07e5914c58d,King's College London (Institute of Pyschiatry),king_s_college_london_institute_of_pyschiatry,,,,,, +2628,,e8f71fcc-b0b3-4c24-a766-259f47e88db5,"Astellas Global Pharma Development, Inc",astellas_global_pharma_development_inc,,,,,, +2629,,f0c91420-fa22-4165-8abd-76181b86384e,Pharmarama International Limited,pharmarama_international_limited,,,,,, +2630,,4833be49-1581-4533-a64b-ca081b6ab458,"University Hospital Schleswig-Holstein, Campus Luebeck",university_hospital_schleswig_holstein_campus_luebeck,,,,,, +974,0.97215098142623901,4cbb7e37-feeb-4dcf-a21f-ec40d4959c01,Universitätsklinikum Schleswig-Holstein UKSH,universit_tsklinikum_schleswig_holstein_uksh,,,,4cbb7e37-feeb-4dcf-a21f-ec40d4959c01,universit_tsklinikum_schleswig_holstein,Universitätsklinikum Schleswig-Holstein +2631,,61786956-9d2e-4ef9-bc65-e09f9689909a,"Semmelweis University, 2nd Department of Pediatrics",semmelweis_university_2nd_department_of_pediatrics,,,,,, +2632,,4fc5a22b-dc4e-4a7d-af36-1858f6ab4efe,ITALFARMACO,italfarmaco,,,,,, +2633,,39d265c7-8e4f-4288-8596-f25b54271d95,GRUPO DE TERAPIA CELULAR Y CARDIOVASCULAR DEL HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS,grupo_de_terapia_celular_y_cardiovascular_del_hospital_universitario_central_de_asturias,,,,,, +2634,,4ae05081-0b62-437f-9ac6-e91200cb4b8d,Leeds Teaching Hospitals R and D department,leeds_teaching_hospitals_r_and_d_department,,,,,, +2635,,4393a359-d6f4-4323-8bac-8e6bf8a0038a,Institute of Medicinal Molecular Design Inc,institute_of_medicinal_molecular_design_inc,,,,,, +2636,,59a594c9-8a23-4f96-b3e1-ad6f416b0438,Neurobiological Technologies Inc,neurobiological_technologies_inc,,,,,, +2637,,03c2824a-197d-480d-a59f-07ede9518797,"Department of Anesthesiology, Næstved Hospital",department_of_anesthesiology_n_stved_hospital,,,,,, +2638,,d6eb1925-c8da-499e-83e9-9b56d833cd87,Asahi Kasei Pharma America Corporation,asahi_kasei_pharma_america_corporation,,,,,, +2639,,c57efd66-5424-4bae-a1b5-c6f6282cb2b2,"CTSU, University of Oxford",ctsu_university_of_oxford,,,,,, +2640,,8a188e3f-fe75-4d7d-884e-8d92d646787e,University of Oxford- Research Services,university_of_oxford_research_services,,,,,, +2641,,8944751d-52f3-4a66-9d27-6594f8ee5021,"Katedra za biofarmacijo in farmakokinetiko, Fakulteta za farmacijo",katedra_za_biofarmacijo_in_farmakokinetiko_fakulteta_za_farmacijo,,,,,, +2642,,7f366c5b-9b4e-4b62-bb96-780b3c389fb1,"Liver Unit, ICMD, Hospital Clinic Barcelona",liver_unit_icmd_hospital_clinic_barcelona,,,,,, +2643,,e11298fd-7e82-4d3a-a2ed-5b898594fca7,NeuroNova AB,neuronova_ab,,,,,, +2644,,ed0805e1-babe-4ef2-b436-187d6a1ef3ac,RICARDO MORENO OTERO/MARIA CHAPARRO SANCHEZ,ricardo_moreno_otero_maria_chaparro_sanchez,,,,,, +2645,,4e663cf5-0d65-4e67-85cd-5bbe2e1c7f91,Dudley Group of Hospitals NHS Trust,dudley_group_of_hospitals_nhs_trust,,,,,, +2646,,7567410b-cd75-40a5-96fd-91c865d75368,Akron Molecules GmbH,akron_molecules_gmbh,,,,,, +2647,,16d69809-6da2-4ac3-a611-6632602c676b,"Medizinische Universitätsklinik II , Abteilung Hämatologie, Onkologie, Immunologie und Rheumatologie",medizinische_universit_tsklinik_ii_abteilung_h_matologie_onkologie_immunologie_und_rheumatologie,,,,,, +2648,,8ad7471f-2e88-4fb5-8d8b-4840a20c0820,"HY, HUS",hy_hus,,,,,, +2649,,b52dd2f8-c4c6-4146-84f3-93bee29751ca,Targid University Leuven,targid_university_leuven,,,,,, +212,0.976266,0a79ad16-61bb-4290-895a-ee60dfc583b0,POXEL,poxel,,,,0a79ad16-61bb-4290-895a-ee60dfc583b0,poxel,POXEL +232,0.98418444395065308,50e4806a-7145-11e6-a0cd-0242ac12000b,ACS DOBFAR SPA,acs_dobfar_spa,,,,455b5028-7142-11e6-a0cd-0242ac12000b,acs_dobfar,ACS DOBFAR +2650,,f1191cdb-a43d-455c-a5aa-42898eb770aa,"HUS, Korvaklinikka",hus_korvaklinikka,,,,,, +2651,,09c8066b-8845-43f7-bea1-b3769d623747,"Sahlgrenska Acadademy, GU",sahlgrenska_acadademy_gu,,,,,, +2652,,218069e4-e1de-4079-9e41-017fa4c1aa0a,Università degli Studi di Torino e Azienda Ospedaliera Città della Salute e della Scienza di Torino,universit_degli_studi_di_torino_e_azienda_ospedaliera_citt_della_salute_e_della_scienza_di_torino,,,,,, +247,0.98111611604690552,5796905e-d697-4a3c-a2d1-98d6d9104b0c,Hoffmann-La Roche,hoffmann_la_roche,,,,5796905e-d697-4a3c-a2d1-98d6d9104b0c,hoffmann_la_roche,Hoffmann-La Roche +2653,,67f9b628-7161-11e6-a0cd-0242ac12000b,ROSEDALE THERAPEUTIC,rosedale_therapeutic,,,,,, +2654,,7fc672e3-6724-4321-88a0-21adb585ec7b,Ullevål University Hospital,ullev_l_university_hospital,,,,,, +2655,,25aae276-8e00-4681-a3f1-eb556395eb28,Gebro Pharma GmbH,gebro_pharma_gmbh,,,,,, +184,0.973246,33152a86-6668-4582-ab39-412be4051a25,"Stockholm County Council, Karolinska University Hospital Huddinge, Dept of Anesthesiology and Intensive Care",stockholm_county_council_karolinska_university_hospital_huddinge_dept_of_anesthesiology_and_intensive_care,,,,035cad6f-a78e-4045-bb2b-51fc73fd33c1,stockholm_county_council_karolinska_university_hospital_huddinge_department_of_anesthesiology_and_intensive_care,"Stockholm County Council, Karolinska University Hospital Huddinge, Department of Anesthesiology and Intensive Care" +2656,,d5c9e23d-3d33-4aad-bd15-48f79cdc9896,"Medical Faculty, University Magdeburg",medical_faculty_university_magdeburg,,,,,, +2657,,67305436-8e27-4e48-b21e-9b8651145cf8,Enric Pedrol Clotet. Unidad Enfermedades Infecciosas.Hospital de Granollers,enric_pedrol_clotet_unidad_enfermedades_infecciosas_hospital_de_granollers,,,,,, +2658,,e8356348-a1c9-4eae-b38f-d865a9e13e84,"CoLucid Pharmaceuticals, Inc",colucid_pharmaceuticals_inc,,,,,, +2659,,b30441c5-5506-4dec-a574-0fae240fb145,AMO Pharma Ltd,amo_pharma_ltd,,,,,, +998,0.987967,c5d79443-102d-4059-8c81-6eb489fc8ac7,Lipid Pharmaceuticals,lipid_pharmaceuticals,,,,43136b72-9ea5-4280-955b-222830e86bf5,lipid_pharmaceuticals_ehf,Lipid Pharmaceuticals ehf +2660,,e28f1c52-aed1-4448-8ec2-8b0e3aa44143,"Dance Biopharm, Inc",dance_biopharm_inc,,,,,, +2661,,804172f4-5831-45ac-b009-5e1f9a81fef6,"Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari-Università di Padova",dipartimento_di_scienze_cardiologiche_toraciche_e_vascolari_universit_di_padova,,,,,, +2662,,aac77ddf-0802-4398-bfb7-5a0425c7dfcf,Novalon S.A,novalon_s_a,,,,,, +2663,,2a67d829-08ae-4fa5-811a-71f0d84087ee,Dilaforette AB,dilaforette_ab,,,,,, +2664,,9facda36-0d75-44fa-8de1-efdfe3c28fb6,Zdravstveni dom dr. Adolfa Drolca Maribor,zdravstveni_dom_dr_adolfa_drolca_maribor,,,,,, +2665,,d43a2a4e-daad-4209-b655-334aa981bb26,Cebix Incorporated,cebix_incorporated,,,,,, +2666,,af59b0a0-1037-496e-a3a8-dc6a725ceff3,AZIENDA SANITARIA LOCALE 9 DI GROSSETO,azienda_sanitaria_locale_9_di_grosseto,,,,,, +2667,,04de951e-7142-11e6-a0cd-0242ac12000b,RANBAXY LABS LTD,ranbaxy_labs_ltd,,,,,, +2668,,e52c6a7e-0ed3-4dcf-bd86-2cc1eebba4b4,"UZ KULeuven, service of Rheumatology",uz_kuleuven_service_of_rheumatology,,,,,, +2669,,d4796132-6235-4b6c-bf05-fc8288d63964,Amersham Buchler GmbH & Co KG an affiliate of GE Healthcare Bio-Sciences,amersham_buchler_gmbh_co_kg_an_affiliate_of_ge_healthcare_bio_sciences,,,,,, +2670,,05f919e2-c901-48de-aa21-4ea0bb08a61c,"Medizinische Universität Wien,Univ.Klinik f.Anästhesie, Intensivmedizin und Schmerztherapie",medizinische_universit_t_wien_univ_klinik_f_an_sthesie_intensivmedizin_und_schmerztherapie,,,,,, +2671,,1a3fbdc8-37cd-42ab-91f4-dd662a1007e4,"Senior Contracts Manager,Research and Enterprise,University of Glasgow",senior_contracts_manager_research_and_enterprise_university_of_glasgow,,,,,, +110,0.98208984732627869,7ab0aad4-ccd7-43a6-abf8-e331125b5500,Department of Oncology,department_of_oncology,,,,7ab0aad4-ccd7-43a6-abf8-e331125b5500,department_of_oncology_karolinska,Department of Oncology +2672,,09fbcaa5-2fe8-4d02-8138-b22aad4d43fd,"CLINICA DERMATOLOGICA POLICLINICO UMBERTO I ""SAPIENZA",clinica_dermatologica_policlinico_umberto_i_sapienza,,,,,, +2673,,55745818-7388-11e6-a0cd-0242ac12000b,ALKOPHARMA USA,alkopharma_usa,,,,,, +2674,,1443c1cd-b1a6-4bf3-9bb7-e123bac00e18,Steen Stender,steen_stender,,,,,, +2675,,6bd22256-cc46-46db-bdb8-d42e44fe4537,Dr. Willmar Schwabe GmbH &Co. KG,dr_willmar_schwabe_gmbh_co_kg,,,,,, +2676,,15ab5dbd-0764-4252-81f5-094ac9475d1b,ApaTech Limited,apatech_limited,,,,,, +1022,0.980344,9a9bdaa0-eda9-4f70-8e28-20f065d644e8,Ablynx,ablynx,,,,3d644372-21da-4da7-aba7-c8d44092d796,ablynx_nv,Ablynx NV +2677,,b11d61a7-2134-4b34-93cb-2493660dad4e,European Institute for Cystic Fibrosis Research (IERFC),european_institute_for_cystic_fibrosis_research_ierfc,,,,,, +2678,,e5767df2-ddc9-436a-b69a-ff765766fcde,"Univ. of Iceland, Dept. Pharmacol",univ_of_iceland_dept_pharmacol,,,,,, +2679,,feaae066-f638-4f32-854a-35d783c8df1c,Oscient Pharmaceuticals,oscient_pharmaceuticals,,,,,, +2680,,4aeb6ac4-08d4-4c41-8f9a-32574152f22f,Novartis Hungária Ltd,novartis_hung_ria_ltd,,,,,, +2681,,bb5c16ae-6b80-46fd-ae42-f0085f905393,Cambridge University Hospital (Addenbrookes Hospital),cambridge_university_hospital_addenbrookes_hospital,,,,,, +2682,,b885a74d-1d22-425c-a3ca-201e2136b823,Royal Wolverhampton Hospitals NHS Trust,royal_wolverhampton_hospitals_nhs_trust,,,,,, +2683,,3abdb564-73fb-11e6-a0cd-0242ac12000b,ST RENATUS,st_renatus,,,,,, +936,0.97166144847869873,15c72f9b-2bb4-403d-a772-1a67f29b1055,Royal Liverpool and Broadgreen University Hospitals Trust,royal_liverpool_and_broadgreen_university_hospitals_trust,,,,33e84b15-e25f-402d-bf4e-0f564d9c0255,royal_liverpool_and_broadgreen_university_hospitals_trust,Royal Liverpool and Broadgreen University Hospitals Trust +2684,,0d8682b6-d91d-4612-977d-c09a4f7aeca7,Northern Health and Social Care Trust,northern_health_and_social_care_trust,,,,,, +2685,,1bd76448-bf04-4d3f-9f36-a5accec8d01d,Silence Therapeutics GmbH,silence_therapeutics_gmbh,,,,,, +2686,,6a91c86e-d594-43c6-9e93-7870038691c5,"Handkirurgiska kliniken, Universitetssjukhuset Örebro",handkirurgiska_kliniken_universitetssjukhuset_rebro,,,,,, +628,0.980402,f7c53dd5-3744-4975-bd9a-6bc7e4e45dcc,"Queen's University Belfast, Research and Regional Services",queen_s_university_belfast_research_and_regional_services,,,,637afab2-e42f-4094-b3b3-6cf50354727c,queen_s_university_belfast,Queen's University Belfast +2687,,64d7a847-03b2-46d8-8e4f-75220d8cf6bf,"Freistaat Bayern, represented by the University of Regensburg",freistaat_bayern_represented_by_the_university_of_regensburg,,,,,, +2688,,5639eefe-7142-11e6-a0cd-0242ac12000b,ALPHARMA US PHARMS,alpharma_us_pharms,,,,,, +2689,,d005e72f-ef66-4e89-bda8-58b2206077d2,University Hospital Bristol NHS Foundation Trust,university_hospital_bristol_nhs_foundation_trust,,,,,, +2690,,5ad1051d-fbee-46ff-8d52-32244753b6a5,"Wyeth, a Pfizer Company",wyeth_a_pfizer_company,,,,,, +2691,,3e1cca1e-1f12-42b3-8de1-af6541e28783,AVI BioPharma Inc,avi_biopharma_inc,,,,,, +2692,,3fb43616-3d50-43cc-95ee-186113a2a462,Neocutis,neocutis,,,,,, +755,0.952513,773f19f3-a520-49fc-8b74-adda697fc76d,Sanofi Pasteur Korea Ltd,sanofi_pasteur_korea_ltd,,,,0c07c031-3aa4-42bd-a466-16b7d6794b5f,sanofi_pasteur_kk,Sanofi Pasteur KK +2693,,92a35101-d4fd-4d0c-b202-621d7ffe2cc8,Juan Pedro Barret Nerín,juan_pedro_barret_ner_n,,,,,, +2694,,23e32f33-64c2-48d7-98ad-bda4e558f1cc,"GCLLSG - Dept. of Internal Medicine I, University Hospital Cologne",gcllsg_dept_of_internal_medicine_i_university_hospital_cologne,,,,,, +2695,,63acf510-7168-11e6-a0cd-0242ac12000b,WATSON PHARMS INC,watson_pharms_inc,,,,,, +722,0.971833,d849df4a-222c-4517-b78c-1f8d3369f7eb,"Sven Olaf Skouby, Professor, MD, DMSc. Unit of Reproductive Medicine, Herlev/Gentofte Hospital",sven_olaf_skouby_professor_md_dmsc_unit_of_reproductive_medicine_herlev_gentofte_hospital,,,,d849df4a-222c-4517-b78c-1f8d3369f7eb,sven_olaf_skouby_professor_md_dmsc_unit_of_reproductive_medicine_herlev_gentofte_hospital,"Sven Olaf Skouby, Professor, MD, DMSc. Unit of Reproductive Medicine, Herlev/Gentofte Hospital" +2696,,f7d95af9-8ee9-4d1d-8052-1ad60e6e0a18,Oy Eli Lilly Finland Ab,oy_eli_lilly_finland_ab,,,,,, +2697,,d4686322-3206-4d52-8c13-30229e1d5dc5,Cardiff University,cardiff_university,,,,,, +2698,,49fe3f1c-7167-11e6-a0cd-0242ac12000b,NUVO PHARM INC,nuvo_pharm_inc,,,,,, +2699,,9cc0f535-af23-4d76-9c08-c5c5567eaee6,MUCOS Pharma GmbH & Co. KG,mucos_pharma_gmbh_co_kg,,,,,, +2700,,230820e6-d92a-4233-a40f-4b36227c2593,Bent Gymoese Jørgensen,bent_gymoese_j_rgensen,,,,,, +654,0.90361690521240234,ff8f8803-c00f-472d-8ccb-cf578ecbf270,Boehringer Ingelheim RCV GesmbH + CoKG,boehringer_ingelheim_rcv_gesmbh_cokg,,,,3849b74a-6dc1-4f1b-a6c5-a146b4d05357,boehringer_ingelheim_rcv_ges_mbh_co_kg,Boehringer Ingelheim RCV Ges mbH & Co KG +2701,,e2709602-3f09-4b29-9181-ad669b216e69,No Sponsor,no_sponsor,,,,,, +2702,,55f1363c-6435-45e6-bf60-d58e6b865c22,Lone Elisabeth Forner,lone_elisabeth_forner,,,,,, +2703,,7d3404cf-8ef0-4b64-bc82-fd53bbd8fc28,"Aragon Pharmaceuticals, Inc",aragon_pharmaceuticals_inc,,,,,, +2704,,0bcfec0e-63db-42ff-b226-0981ba72bd37,Janssen Cilag N.V./S.A,janssen_cilag_n_v_s_a,,,,,, +2705,,045a733f-3074-4d0f-9297-36c01e97db6c,Sociedad Madrileña de Nefrología (SOMANE),sociedad_madrile_a_de_nefrolog_a_somane,,,,,, +299,0.98556643724441528,d5f0471a-718d-11e6-a0cd-0242ac12000b,NOVARTIS PHARMS CORP,novartis_pharms_corp,,,,7aebdff6-717d-11e6-a0cd-0242ac12000b,novartis_pharms,NOVARTIS PHARMS +2706,,2503b4f8-df66-4e72-877c-dbbe6da8866d,GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa),geteccu_grupo_espa_ol_para_el_estudio_de_la_enfermedad_de_crohn_y_la_colitis_ulcerosa,,,,,, +2707,,07674ea8-1348-426d-b444-5594468aed74,BioInvent International AB,bioinvent_international_ab,,,,,, +2708,,2733bf84-71cb-11e6-a0cd-0242ac12000b,BLAIREX,blairex,,,,,, +509,0.940753,63424d17-e643-47cd-9c30-cf03acd4ee8c,UHL NHL Trust,uhl_nhl_trust,,,,27cde204-b342-4946-975c-01f75b78dc91,uhl_nhs_trust,UHL NHS Trust +494,0.95775824785232544,5796b890-7142-11e6-a0cd-0242ac12000b,DR REDDYS LABS INC,dr_reddys_labs_inc,,,,5796b890-7142-11e6-a0cd-0242ac12000b,dr_reddys_labs_inc,DR REDDYS LABS INC +2709,,24124a88-93a2-453c-8b27-ed488d0b06ee,Hevert-Arzneimittel GmbH & Co. KG,hevert_arzneimittel_gmbh_co_kg,,,,,, +2710,,fc240cf8-205c-4894-bbe1-22f4740fa0bb,N/A,n_a,,,,,, +2711,,73655ca5-ab6d-4cea-8621-f0375bc63425,"Ambulance Service, Stockholm City Council",ambulance_service_stockholm_city_council,,,,,, +2712,,dc8980f6-720e-472c-b255-2d862bac09b0,NIBIT (NETWORK ITALIANO PER LA BIO-IMMUNOTERAPIA DEI TUMORI),nibit_network_italiano_per_la_bio_immunoterapia_dei_tumori,,,,,, +2713,,d640b325-8f06-4e51-8ff8-afa09be8326f,Galderma R&D,galderma_r_d,,,,,, +2714,,f8a79c6c-17c0-4bfd-9653-199f4aaf8480,"Cubist Pharmaceuticals LLC, an indirect wholly-owned subsidary of Merck Sharp & Dohme Corp",cubist_pharmaceuticals_llc_an_indirect_wholly_owned_subsidary_of_merck_sharp_dohme_corp,,,,,, +2715,,de7287d8-6a2a-4f80-81cf-ff778474a221,Cefak KG,cefak_kg,,,,,, +999,0.984336,d9ffcf6b-92ba-40b8-9458-e7486475913d,Birmingham Children's Hospital,birmingham_children_s_hospital,,,,2851af76-cc6a-41a0-a263-399d40b7eb15,birmingham_children_s_hospital_nhs_foundation_trust,Birmingham Children's Hospital NHS Foundation Trust +2716,,6a9497ee-8dfe-4a80-9c2a-bfb91308d2ad,Healthcare & Pharma Consulting AG (Europe),healthcare_pharma_consulting_ag_europe,,,,,, +2717,,e6714ac6-d3b4-4cca-8559-02dbe4f5958d,"Stomatološka klinika UKC, Ljubljana",stomatolo_ka_klinika_ukc_ljubljana,,,,,, +2718,,6072f6d1-a7d0-11e6-94cb-5656d04fc2b5,MEDDAY PHARMACEUTICALS,medday_pharmaceuticals,,,,,, +2719,,622b3044-ddde-4da1-a123-1f4b4a17383b,Clinuvel Pharmaceuticals Limited,clinuvel_pharmaceuticals_limited,,,,,, +978,0.97898,01a7b83a-7129-11e6-a89e-0242ac12000b,SANDOZ,sandoz,,,,01a7b83a-7129-11e6-a89e-0242ac12000b,sandoz,SANDOZ +2720,,6c20ca36-7231-11e6-a0cd-0242ac12000b,PHARMOS,pharmos,,,,,, +2721,,12893c58-6511-4859-aadf-cbd4ced3f516,INEOS Healthcare Limited,ineos_healthcare_limited,,,,,, +2722,,6fb0cf66-7b59-4a05-83c0-46091995a487,"Casen Fleet, S.L.U",casen_fleet_s_l_u,,,,,, +2723,,f266daf5-aa1e-4a6a-8f23-3aa2e7b98403,bioskin GmbH,bioskin_gmbh,,,,,, +2724,,406a1c3a-735d-11e6-a0cd-0242ac12000b,QUESTCOR PHARMA,questcor_pharma,,,,,, +2725,,a2277f61-3420-4883-95c7-c94187a717a3,Loxo Oncology Inc,loxo_oncology_inc,,,,,, +2726,,29e0836b-e8fe-4d36-8daf-b749a82a6019,Aerovance Inc,aerovance_inc,,,,,, +2727,,5b56c10c-7244-11e6-a0cd-0242ac12000b,DUSA,dusa,,,,,, +912,0.988197,3603d959-b219-470b-be2c-d1bcd4a7c148,"Aarhus University Hospital, Skejby sygehus",aarhus_university_hospital_skejby_sygehus,,,,3603d959-b219-470b-be2c-d1bcd4a7c148,aarhus_university_hospital_skejby_sygehus,"Aarhus University Hospital, Skejby sygehus" +2728,,6daaf0aa-7161-11e6-a0cd-0242ac12000b,STAR PHARMS FL,star_pharms_fl,,,,,, +2729,,f7962f4b-9840-4e58-8e5c-0b7753adf86c,Dr Jose Sanchez de Toledo Codina,dr_jose_sanchez_de_toledo_codina,,,,,, +2730,,0af081f6-97e3-4a0f-9c45-4094cecdee83,Centre of Thrombosis and Haemostasis,centre_of_thrombosis_and_haemostasis,,,,,, +2731,,858507be-145c-48b5-8267-3fbb21c49033,"Department of Dermatology, University of Kiel",department_of_dermatology_university_of_kiel,,,,,, +322,0.98791098594665527,27185c1d-6e99-48fc-9d68-1530f804e15d,Tibotec Pharmaceuticals Limited Ireland,tibotec_pharmaceuticals_limited_ireland,,,,27185c1d-6e99-48fc-9d68-1530f804e15d,tibotec_pharmaceuticals_limited_ireland,Tibotec Pharmaceuticals Limited Ireland +692,0.987725,3896cef1-0043-4ce9-83b5-3668a99dacee,"Furiex Pharmaceuticals, Inc",furiex_pharmaceuticals_inc,,,,3896cef1-0043-4ce9-83b5-3668a99dacee,furiex_pharmaceuticals_inc,"Furiex Pharmaceuticals, Inc" +2732,,91da3f1b-96c4-4adb-b643-953272138eb3,Netherlands Asthma Foundation (NAF),netherlands_asthma_foundation_naf,,,,,, +2733,,a1861264-4fe3-460e-9d56-4204b1e1575d,Norgine International Limited,norgine_international_limited,,,,,, +2734,,a61e717e-535b-4f01-801d-92bf7abffa9a,CureVac AG,curevac_ag,,,,,, +2735,,85d84673-b22c-452b-9471-a230ed7c7411,Hospital Universitari Mutua Terrassa,hospital_universitari_mutua_terrassa,,,,,, +2736,,0a3f17e1-f771-4a14-acfb-d7368f406fd6,"Merck Sharp & Dohme de España, S.A",merck_sharp_dohme_de_espa_a_s_a,,,,,, +159,0.93876934051513672,f520785f-8956-4a25-b64b-588e23b207cb,"Medizinische Universität Wien, Univ.Klinik f.Innere Medizin I, Abt.f.Hämatologie u.Hämostaseologie",medizinische_universit_t_wien_univ_klinik_f_innere_medizin_i_abt_f_h_matologie_u_h_mostaseologie,,,,f520785f-8956-4a25-b64b-588e23b207cb,medizinische_universit_t_wien_univ_klink_f_innere_medizin_i,"Medizinische Universität Wien, Univ.Klink f. Innere Medizin I" +2737,,4242f4c1-9760-4311-a372-6a0638480701,AZIENDA OSPEDALIERA S. FILIPPO NERI,azienda_ospedaliera_s_filippo_neri,,,,,, +2738,,54c4ac85-8eb8-434e-a842-a48e60d2bc85,"TARGID, KU Leuven",targid_ku_leuven,,,,,, +2739,,018b7d39-3b8c-41b4-8cf4-ce1b0b339a02,AZIENDA UNITA' SANITARIA LOCALE DI PARMA,azienda_unita_sanitaria_locale_di_parma,,,,,, +2740,,a9d7ce76-7194-11e6-a0cd-0242ac12000b,ORGANICS LAGRANGE,organics_lagrange,,,,,, +2741,,64748d92-ba7b-44e6-b9d6-8cb5920ec185,Ospedale San Raffaele di Milano,ospedale_san_raffaele_di_milano,,,,,, +2742,,38d68618-4182-4b9c-91df-d043e874ea66,Neovas SA,neovas_sa,,,,,, +2743,,a895ca68-4505-4766-b319-251ad3678e4a,CUSL,cusl,,,,,, +2744,,ef9e4b56-61e1-44f5-b725-54b908980d05,Taunton & Somerset NHS Trust,taunton_somerset_nhs_trust,,,,,, +166,0.989139,8f3341d7-6e0f-42cf-8d93-6bad6582a5f2,Galderma Research and Development SNC,galderma_research_and_development_snc,,,,7eeea4e4-efc7-45bf-bac7-82d54c1ae894,galderma_research_and_development,Galderma Research and Development +2745,,4f5b0181-87cf-4dd6-a56c-1ff9d3fbf947,"University of Leeds, Division of Musculoskeletal Disease, Leeds Institute of Molecular Medicine",university_of_leeds_division_of_musculoskeletal_disease_leeds_institute_of_molecular_medicine,,,,,, +438,0.96206339200337732,9f27856c-6362-4966-b129-808cb11ba1b0,"Pfizer Inc. 235 East 42nd Street, New York, NY10017,USA",pfizer_inc_235_east_42nd_street_new_york_ny10017_usa,,,,09d833e6-81f6-4d84-ab0d-6d38c6152081,pfizer_inc_235_east_42nd_street_new_york_ny10017_usa,"Pfizer Inc 235 East 42nd Street, New York, NY10017" +603,0.98583465814590454,6eb8c187-922d-4265-a290-1d2eaf8c0f5f,Fundación para la Investigación y Desarrollo en el Área Cardiovascular (FIC),fundaci_n_para_la_investigaci_n_y_desarrollo_en_el_rea_cardiovascular_fic,,,,6eb8c187-922d-4265-a290-1d2eaf8c0f5f,fundaci_n_para_la_investigaci_n_y_desarrollo_en_el_rea_cardiovascular_fic,Fundación para la Investigación y Desarrollo en el Área Cardiovascular (FIC) +2746,,37fb50c5-d54a-4ca4-82fb-048bffb7d227,Laboratorio de Aplicaciones Farmacodinámicas S.A,laboratorio_de_aplicaciones_farmacodin_micas_s_a,,,,,, +2747,,95c433b9-c79b-4731-a6b7-c145b2bc42fa,PROBELTE PHARMA S.A,probelte_pharma_s_a,,,,,, +2748,,3028f354-ec8c-426d-82f8-48c3dec7599a,Merck Frosst Canada Ltd,merck_frosst_canada_ltd,,,,,, +2749,,52fb0c90-4d7d-49b6-b66e-ddcd5729c927,"The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark",the_parker_institute_bispebjerg_and_frederiksberg_hospital_the_capital_region_of_denmark,,,,,, +2750,,32603322-dde3-4d9e-ae78-e579f11daf77,"LABORATORIOS GRIFOLS, S.A",laboratorios_grifols_s_a,,,,,, +2751,,77f80472-6676-4f95-b658-7641175af1ce,"Department of Nephrology, OUH, Odense, DK",department_of_nephrology_ouh_odense_dk,,,,,, +2752,,93471e4b-a3c5-4a7c-9368-8ec937b0f5a6,Novartis Pharmaceuticals UK Ltd,novartis_pharmaceuticals_uk_ltd,,,,,, +121,0.98132741451263428,2929b798-0440-49f3-ab5b-122a578e01ba,"F. Hoffmann-La Roche Limited, Pharmaceuticals Division, PDR",f_hoffmann_la_roche_limited_pharmaceuticals_division_pdr,,,,2929b798-0440-49f3-ab5b-122a578e01ba,f_hoffmann_la_roche_limited_pharmaceuticals_division_pdr,"F. Hoffmann-La Roche Limited, Pharmaceuticals Division, PDR" +2753,,2677656f-af0f-466e-a073-e144706a2f80,STRAGEN FRANCE SAS,stragen_france_sas,,,,,, +2754,,6b813f4b-4738-4e90-bc17-11bf1832d79b,BioVex Inc,biovex_inc,,,,,, +2755,,4e153cc6-881f-11e6-a998-0242ac12000b,Great Ormond Street Hospital NHS Trust / University College London - Institute of Child Health,great_ormond_street_hospital_nhs_trust_university_college_london_institute_of_child_health,,,,,, +2756,,041c0139-5b23-48e3-9ccf-9f6d0227ce5b,Dr. Gerhard Franz Kieselbach,dr_gerhard_franz_kieselbach,,,,,, +967,0.97196,55950bfd-6b69-499d-a3b6-2dd8b514c97d,Skånes Universitetssjukhus Lund,sk_nes_universitetssjukhus_lund,,,,55950bfd-6b69-499d-a3b6-2dd8b514c97d,sk_nes_universitetssjukhus_lund,Skånes Universitetssjukhus Lund +840,0.98523330688476562,3db31bd4-ebf3-4e55-8979-0617fa1fc589,JANSSEN-CILAG GmbH,janssen_cilag_gmbh,,,,3db31bd4-ebf3-4e55-8979-0617fa1fc589,janssen_cilag_gmbh,JANSSEN-CILAG GmbH +2757,,8c7a4b78-dc33-4841-be01-806ef1c18e93,AFFiRiS AG,affiris_ag,,,,,, +2758,,bd817d4d-e257-4075-bac7-d2a9761f7ef9,GALDERMA R&D SNC,galderma_r_d_snc,,,,,, +2759,,f3bc27eb-6f96-49da-8d9a-52983c2a82a5,Central Manchester Foundation Hospitals Trust,central_manchester_foundation_hospitals_trust,,,,,, +574,0.96224385499954224,8567fa14-efb0-4bb0-9c97-bf093f58ba24,"Queen Mary, University of London (QMUL)",queen_mary_university_of_london_qmul,,,,8567fa14-efb0-4bb0-9c97-bf093f58ba24,queen_mary_university_of_london_qmul,"Queen Mary, University of London (QMUL)" +2760,,b1b2c096-75da-4642-bced-b420c68f34bc,Marjo Renko,marjo_renko,,,,,, +2761,,603c1f5a-38fa-4ebd-a4a3-34994a98c4bb,"Abteilung für Anästhesie, Intensiv- und Schmerzmedizin, Wilhelminenspital der Stadt Wien",abteilung_f_r_an_sthesie_intensiv_und_schmerzmedizin_wilhelminenspital_der_stadt_wien,,,,,, +2762,,cdf476a8-c681-4cd6-83a0-fddf35b601c7,service de santé des armées,service_de_sant_des_arm_es,,,,,, +2763,,1fa79654-316b-4828-a391-c4d85be21554,Servicio de Oncología. Hospital Vall d'Hebron,servicio_de_oncolog_a_hospital_vall_d_hebron,,,,,, +2764,,b144e1f1-e2a5-43cf-8dff-fe2de18cde12,Wuerzburg University Hospital,wuerzburg_university_hospital,,,,,, +2765,,2a58b07c-3759-4847-95f1-728a557d31ed,Dra. Carmen Ispa Callén,dra_carmen_ispa_call_n,,,,,, +424,0.976266,88cf624a-7129-11e6-a89e-0242ac12000b,AKORN,akorn,,,,824bf19e-712a-11e6-a89e-0242ac12000b,akorn_inc,AKORN INC +301,0.977974,fc5a931a-83ff-43ec-80af-5890cc425b2f,German High Grade Non-Hodgkins Lymphoma group,german_high_grade_non_hodgkins_lymphoma_group,,,,023ff627-407b-44a9-b5eb-1ea1e5f216c2,german_high_grade_non_hodgkin_s_lymphoma_group,German High Grade Non-Hodgkin's Lymphoma group +2766,,6c8fbaa8-ab49-488d-b782-1721703ac55a,"Xcovery Holding Company, LLC",xcovery_holding_company_llc,,,,,, +2767,,37845326-534a-46d3-abea-59405b1a3161,The Liverpool Heart & Chest Hospital NHS Trust,the_liverpool_heart_chest_hospital_nhs_trust,,,,,, +2768,,01cdc8ae-0a73-4c9d-a4f6-751760d485a3,Swedish Orphan International AB,swedish_orphan_international_ab,,,,,, +2769,,f72913a7-ad37-4539-9ffc-c4d10fff590f,Department of Anesthesiology and Perioperative Medicine,department_of_anesthesiology_and_perioperative_medicine,,,,,, +585,0.909143,73005770-61f7-451a-a1d5-6cb043330409,"MUW, Klinik für Innere Med. I, Onkologie",muw_klinik_f_r_innere_med_i_onkologie,,,,73005770-61f7-451a-a1d5-6cb043330409,muw_klinik_f_r_innere_med_i_onkologie,"MUW, Klinik für Innere Med. I, Onkologie" +2770,,85bcb124-dd93-49c8-af08-aaa7e6f60d90,NHS Greater Glasgow and Clyde Health Board,nhs_greater_glasgow_and_clyde_health_board,,,,,, +897,0.963506,8f278d90-7145-11e6-a0cd-0242ac12000b,OHM LABS,ohm_labs,,,,8f278d90-7145-11e6-a0cd-0242ac12000b,ohm_labs,OHM LABS +2771,,bf6e4136-979f-4d24-a1aa-edf859e4c73c,Hospital Universitario de Valme,hospital_universitario_de_valme,,,,,, +492,0.973505,a251aab2-cb01-4345-81c1-540a7deb2d88,"Rottapharm Madaus, Madaus GmbH",rottapharm_madaus_madaus_gmbh,,,,81977950-118e-45c5-b00b-ff958a1914c1,rottapharm,Rottapharm +945,0.916222,7dd3aa00-7164-11e6-a0cd-0242ac12000b,ZACH SYSTEMS,zach_systems,,,,7dd3aa00-7164-11e6-a0cd-0242ac12000b,zach_systems,ZACH SYSTEMS +2772,,d6688f5f-6de6-4039-8b49-bcbb85b43140,University Medical Centre Nijmegen St Radboud,university_medical_centre_nijmegen_st_radboud,,,,,, +2773,,56b75ccb-06f1-4a82-a74b-cf20cecd4cdf,Abbott GmbH & Co. K.G,abbott_gmbh_co_k_g,,,,,, +2774,,7fa12b2a-7a6c-4134-8791-737ec94d6c12,SUBSTIPHARM Développement,substipharm_d_veloppement,,,,,, +2775,,124baa17-7ecf-45cd-b1bf-185b2520a9d1,Xenome Ltd,xenome_ltd,,,,,, +2776,,2bc40bbe-a076-4a4f-b310-cf0d6ba87a75,Timo Iirola,timo_iirola,,,,,, +769,0.9661862850189209,78815b47-7b5c-468f-bbda-7577df93402c,GELTAMO (Grupo Cooperativo Español de Llinfoma/Trasplante Autólogo de Médula Ósea),geltamo_grupo_cooperativo_espa_ol_de_llinfoma_trasplante_aut_logo_de_m_dula_sea,,,,06287ea9-1e30-49c5-af4a-558dc91625a2,geltamo_grupo_cooperativo_espa_ol_de_linfoma_trasplante_aut_logo_de_m_dula_sea,GELTAMO (Grupo Cooperativo Español de Linfoma/Trasplante Autólogo de Médula Ósea) +2777,,39e0e85e-fee2-4c27-81dc-a39e1ccffb0b,Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol,fundaci_institut_d_investigaci_en_ci_ncies_de_la_salut_germans_trias_i_pujol,,,,,, +2778,,ff306cb3-1b4b-4c56-8eef-6d1db0213a4d,Dr. JOSE LUIS GONZALEZ LARRIBA,dr_jose_luis_gonzalez_larriba,,,,,, +2779,,1769fdb6-7167-11e6-a0cd-0242ac12000b,HOUSTON CYCLOTRON,houston_cyclotron,,,,,, +2780,,1b073c25-363c-4dcf-bc67-0a06520179f7,"UCB Biosciences, Inc. A Member of the UCB Group of Companies",ucb_biosciences_inc_a_member_of_the_ucb_group_of_companies,,,,,, +2781,,6b58315f-1c5e-40bd-9c27-fa49185274f7,Prosensa Therapeutics B.V,prosensa_therapeutics_b_v,,,,,, +200,0.97189050912857056,ce046c53-60a5-4a54-bb94-914d5bc33caa,"National Institute for Public Health and the Environment (RIVM, the Netherlands)",national_institute_for_public_health_and_the_environment_rivm_the_netherlands,,,,ce046c53-60a5-4a54-bb94-914d5bc33caa,national_institute_for_public_health_and_the_environment_rivm_the_netherlands,"National Institute for Public Health and the Environment (RIVM, the Netherlands)" +495,0.98471283912658691,42346020-7164-11e6-a0cd-0242ac12000b,DR REDDYS LABS SA,dr_reddys_labs_sa,,,,27140480-7146-11e6-a0cd-0242ac12000b,dr_reddys_la,DR REDDYS LA +2782,,cb38ee53-75dd-48c7-ac94-808b67d172a5,St Elisabeth Hospital,st_elisabeth_hospital,,,,,, +2783,,03063c92-952b-49f9-a79f-292bbf3e0fe3,Academic Psychiatric Center - AMC-UvA,academic_psychiatric_center_amc_uva,,,,,, +2784,,b09c5a76-4f18-40f2-8d29-ff594c214905,Fundación Hospital de Madrid,fundaci_n_hospital_de_madrid,,,,,, +2785,,e830f7a8-73cc-11e6-a0cd-0242ac12000b,EXELIXIS,exelixis,,,,,, +2786,,b2567e41-3aa8-4cbc-8649-dc676b8e3d6e,"MAGGOT 2006 Egészségügyi, Kereskedelmi és Szolgáltató Ltd",maggot_2006_eg_szs_g_gyi_kereskedelmi_s_szolg_ltat_ltd,,,,,, +2787,,253500cf-8743-4261-87e1-450d2c444539,INDEX PHARMACEUTICALS,index_pharmaceuticals,,,,,, +2788,,038960fd-ee43-483d-9820-048b96e50b00,Hospital Trebic,hospital_trebic,,,,,, +2789,,f73188ff-9c35-4458-8c13-f04e944a3fcc,Diurnal Limited,diurnal_limited,,,,,, +2790,,9e39fc1c-8bdc-11e6-a449-0242ac12000b,Special Account for Research Funds-University of Patras,special_account_for_research_funds_university_of_patras,,,,,, +71,0.96432900428771973,e066106c-fbac-4279-84ae-0946c0383093,Takeda,takeda,,,,a50a5323-eb43-4b40-8b80-cb222451e80b,takeda,Takeda +2791,,757adeb8-f7af-4d81-93dd-c86a4a180277,Grupo GICOR,grupo_gicor,,,,,, +2792,,1f7d4c33-745b-41df-a0bb-8ec975c7be7f,University Hospitals Birmingham NHS Trust,university_hospitals_birmingham_nhs_trust,,,,,, +51,0.98173725605010986,8fed167b-385c-411d-871f-ace18064604b,Pfizer Ltd (PGRD),pfizer_ltd_pgrd,,,,8b6c5421-c89a-418f-8c10-e2badcce65ee,pfizer_ltd,Pfizer Ltd +2793,,999e748f-b5c1-4297-8cf5-c90d69228836,Lundbeck SA,lundbeck_sa,,,,,, +991,0.94304704666137695,cbc32f6f-5625-4833-a40a-1a4645e7edda,Great Ormond Street Hospital For Children NHS Foundation Trust,great_ormond_street_hospital_for_children_nhs_foundation_trust,,,,136feb9a-ae28-4c13-afe3-e135660d48aa,great_ormond_street_hospital,Great Ormond Street Hospital +2794,,4cc06a61-c0b8-4109-aa50-edcc9d691a0e,"Poniard Pharmaceuticals, Inc",poniard_pharmaceuticals_inc,,,,,, +2795,,3a90cbaf-467b-451f-8858-ab908a78f8a5,Fondazione GISCAD,fondazione_giscad,,,,,, +508,0.980232,be0c7d14-2d93-4807-b3a6-5c835e640c1e,Pfizer S.A. Belgium,pfizer_s_a_belgium,,,,3f98bb64-87e2-43ad-bc25-60a24eb40e13,pfizer_s_a,Pfizer S.A +2796,,71db27fe-f727-47f2-bf0b-3cb3938c6cba,"University College London, Joint Research Office",university_college_london_joint_research_office,,,,,, +2797,,b359d0b0-6644-4b81-8079-5ff7f2375314,Deutsche Krebsgesellschaft e.V,deutsche_krebsgesellschaft_e_v,,,,,, +93,0.942231,bab1dcfc-4751-41db-9ee8-b9ec54e63541,"LABORATORIOS CASEN-FLEET,S.L",laboratorios_casen_fleet_s_l,,,,bab1dcfc-4751-41db-9ee8-b9ec54e63541,laboratorios_casen_fleet_s_l,"LABORATORIOS CASEN-FLEET,S.L" +787,0.98334300518035889,38be2188-71f1-46e1-9477-04ee58b8b8b0,"Intercell USA, Inc",intercell_usa_inc,,,,08982651-8665-4f48-91ab-412b9c9c69a9,intercell_usa_inc_intercell,"Intercell USA, Inc. (Intercell)" +2798,,c557c2aa-ed5e-4144-9145-cfbd76d33acc,"Aarhus University Hospital, Department of Respiratory Medicine",aarhus_university_hospital_department_of_respiratory_medicine,,,,,, +2799,,2a9b6c5c-6aa8-4f4b-9d25-c9b34c6dae98,"Research Programs' Unit, Diabetes & Obesity, University of Helsinki",research_programs_unit_diabetes_obesity_university_of_helsinki,,,,,, +561,0.981251,89f1114d-3553-4ac3-a66f-02effd57921a,"Bioheart, Inc",bioheart_inc,,,,89f1114d-3553-4ac3-a66f-02effd57921a,bioheart_inc,"Bioheart, Inc" +2800,,c1d642c7-c39a-4eea-b9c2-047d3215a0b7,MANUEL ÁNGEL GÓMEZ RÍOS,manuel_ngel_g_mez_r_os,,,,,, +637,0.987943,2629fa8a-7163-11e6-a0cd-0242ac12000b,TORRENT PHARM,torrent_pharm,,,,2629fa8a-7163-11e6-a0cd-0242ac12000b,torrent_pharm,TORRENT PHARM +2801,,2fa98d26-f43e-48ca-a229-2e7d11723593,Antipodean Pharmaceuticals,antipodean_pharmaceuticals,,,,,, +2802,,b7f3ddf8-7ea2-4825-9345-2c8f3654f1cd,fUNDACIÓN iNVESTIGACIÓN HOSPITAL RAMÓN Y CAJAL,fundaci_n_investigaci_n_hospital_ram_n_y_cajal,,,,,, +2803,,ce63b5b0-5778-4872-9b2c-802290b5703d,Hôpital FOCH,h_pital_foch,,,,,, +2804,,27b95ff4-afa5-4730-89b3-49816bbdfce1,Charité-University Berlin,charit_university_berlin,,,,,, +2805,,501b5de6-7232-11e6-a0cd-0242ac12000b,MALLINCKRODT HOSP,mallinckrodt_hosp,,,,,, +2806,,22bdd0f0-5125-4999-af88-90a943d6cf4e,ApoPharma Inc,apopharma_inc,,,,,, +2807,,7f5d7d9b-2b6e-4edc-a223-88fd5f0cb1f5,Dept of Urology Aarhus Universityhospital,dept_of_urology_aarhus_universityhospital,,,,,, +730,0.922323,ed32d3f4-275a-41ef-9dd9-7a713a6f2d48,Hellenic Oncology Research Group (HORG),hellenic_oncology_research_group_horg,,,,ed32d3f4-275a-41ef-9dd9-7a713a6f2d48,hellenic_oncology_research_group_horg,Hellenic Oncology Research Group (HORG) +2808,,1abe069c-cdae-4393-8bfe-0f7306deee71,"Maruho Co, Ltd. Kyoto R&D Center",maruho_co_ltd_kyoto_r_d_center,,,,,, +2809,,1a72bb13-a7c0-11e6-94cb-5656d04fc2b5,Dr. Manuel Rodríguez Yáñez,dr_manuel_rodr_guez_y_ez,,,,,, +2810,,b2db95b6-2d1f-44b8-86b2-2a04f7d9e9da,Company: Dr. Franz Köhler Chemie GmbH,company_dr_franz_k_hler_chemie_gmbh,,,,,, +2811,,08f49f72-bbc1-4e2e-8784-117c6b0a98fb,"Cliniques Universitaires Saint-Luc, Neurologie",cliniques_universitaires_saint_luc_neurologie,,,,,, +2812,,92c36334-73f2-11e6-a0cd-0242ac12000b,ACETYLENE OXYGENE CO,acetylene_oxygene_co,,,,,, +879,0.971226,bc449ec2-1390-4c75-ab67-e86f7d769a31,"RWTH Aachen University, represented by the Rector, himself represented by the CTC-A",rwth_aachen_university_represented_by_the_rector_himself_represented_by_the_ctc_a,,,,bc449ec2-1390-4c75-ab67-e86f7d769a31,rwth_aachen_university_represented_by_the_rector_himself_represented_by_the_ctc_a,"RWTH Aachen University, represented by the Rector, himself represented by the CTC-A" +2813,,7ca9c5e5-aa94-42cb-99c0-b75e83e21357,CHRU de TOURS,chru_de_tours,,,,,, +59,0.95637212196985877,77e6ca17-28b0-48f2-a375-f49a36571367,Wyeth Research Division of Wyeth Pharmaceuticals Inc Global Medical Affairs,wyeth_research_division_of_wyeth_pharmaceuticals_inc_global_medical_affairs,,,,96e5ebae-c6a3-41db-ae14-3ec5437c35f2,wyeth_research_division,Wyeth Research Division +2814,,9960f36a-6609-43da-a46e-5a208a8bb38b,Reanal Pte. Ltd,reanal_pte_ltd,,,,,, +2815,,811dc228-7186-11e6-a0cd-0242ac12000b,SEATTLE GENETICS,seattle_genetics,,,,,, +2816,,a0c69bd0-5044-488d-8447-43816777c75b,"Vtesse, Inc",vtesse_inc,,,,,, +2817,,b815fb8d-4bdc-42be-a0ef-ae2390d1140e,Oryzon Genomics S.A,oryzon_genomics_s_a,,,,,, +2818,,1cbd9156-5028-474c-a9bc-f8d24af2d087,NeuroBiotec Pharma AG,neurobiotec_pharma_ag,,,,,, +2819,,ac304799-c9b8-4c5e-bd28-980253f7e026,TransPharma Medical,transpharma_medical,,,,,, +2820,,535daab3-95a7-4af7-877e-28d24871837e,The Children's Memorial Health Institute,the_children_s_memorial_health_institute,,,,,, +2821,,18ea43e3-5e22-4608-bbf5-64b6a234ccf9,FONDAZIONE DEL PIEMONTE PER L'ONCOLOGIA - IRCCS,fondazione_del_piemonte_per_l_oncologia_irccs,,,,,, +2822,,de36c4ae-0e8b-4ddd-afe2-357efa856a24,vasopharm GmbH,vasopharm_gmbh,,,,,, +2823,,0c88bf36-2685-437b-87b6-ae5c27fe3727,A.O. SAN GERARDO,a_o_san_gerardo,,,,,, +797,0.985088,580874fd-bb2f-479f-bdf2-0da9df07a980,Sint Lucas Andreas,sint_lucas_andreas,,,,1030c221-004c-4496-88f4-1a34a95916e7,sint_lucas_andreas_hospital,Sint Lucas Andreas Hospital +2824,,9922424f-0067-4261-a280-0356577c6f05,"AHSC Joint Research Office, Imperial College",ahsc_joint_research_office_imperial_college,,,,,, +2825,,23c41ea8-7274-11e6-a0cd-0242ac12000b,CHEMISCH FBRK KRSSLR,chemisch_fbrk_krsslr,,,,,, +723,0.980428,0d4e58c8-3d68-4fc8-a668-ed2e49340828,"Department of Hematology, Aalborg University Hospital",department_of_hematology_aalborg_university_hospital,,,,0d4e58c8-3d68-4fc8-a668-ed2e49340828,department_of_hematology_aalborg_university_hospital,"Department of Hematology, Aalborg University Hospital" +775,0.929435,a4c79c45-e412-4fc9-8de9-7ac69b0e8cf5,"Ferring International PharmaScience Center U.S., Inc",ferring_international_pharmascience_center_u_s_inc,,,,3994ddd6-d614-47eb-80a8-773f166f17da,ferring_international_pharmascience_center_us_inc,"Ferring International Pharmascience Center US, Inc" +274,0.985423,025f7b50-7129-11e6-a89e-0242ac12000b,G AND W LABS INC,g_and_w_labs_inc,,,,025f7b50-7129-11e6-a89e-0242ac12000b,g_and_w_labs_inc,G AND W LABS INC +2826,,e40cdf74-cb8b-499d-9fad-dd22a9e23170,Anæstesisektor Nordjylland,an_stesisektor_nordjylland,,,,,, +2827,,a54bf322-da8a-443f-9ee8-dfacb7bd952f,UZ Gent,uz_gent,,,,,, +2828,,638fdb91-f6fe-4986-86c1-d4af3d4f31df,Sten Walther,sten_walther,,,,,, +488,0.98622655868530273,91023abe-f124-48ee-a18d-1e83054aa17e,STEBA BIOTECH,steba_biotech,,,,5d77fa00-9417-4d15-807e-607c459d6842,steba_biotech,STEBA BIOTECH +2829,,a4148467-9d20-4812-ad01-292070a9e6f7,Nordic Bone and Marrow Transplantation Group,nordic_bone_and_marrow_transplantation_group,,,,,, +2830,,a07df71f-3741-47c3-bc07-086f26e67b26,Aurinia Pharmaceuticals Inc,aurinia_pharmaceuticals_inc,,,,,, +2831,,48ea33fe-ae63-4aa6-b360-f9ff950caa3c,"Aarhus University Hospital, Dept of Endocrinology and Metabolism C",aarhus_university_hospital_dept_of_endocrinology_and_metabolism_c,,,,,, +2832,,f6db875a-7147-11e6-a0cd-0242ac12000b,CYCLE PHARMS LTD,cycle_pharms_ltd,,,,,, +2833,,b427989c-3990-4822-af42-0df4f6ad36fa,St Vincents University Hospital,st_vincents_university_hospital,,,,,, +222,0.955709,1cd31001-2166-4db7-b391-c4c12d25d9ea,SOGUG,sogug,,,,1cd31001-2166-4db7-b391-c4c12d25d9ea,sogug,SOGUG +2834,,44dc6c63-cf49-41cf-9dae-0a1efd9abea2,"Fundación de Investigación Biomédica del Hospital Universitario La Paz, Madrid",fundaci_n_de_investigaci_n_biom_dica_del_hospital_universitario_la_paz_madrid,,,,,, +2835,,5676374c-7165-11e6-a0cd-0242ac12000b,SVADS HOLDINGS SA,svads_holdings_sa,,,,,, +1009,0.98486357927322388,85199c3a-719f-11e6-a0cd-0242ac12000b,MCNEIL CONSUMER,mcneil_consumer,,,,85199c3a-719f-11e6-a0cd-0242ac12000b,mcneil_consumer,MCNEIL CONSUMER +2836,,aaf3e303-90be-4f39-b763-440962366ea3,BIAL Industrial Farmaceutica S.A,bial_industrial_farmaceutica_s_a,,,,,, +2837,,6d9aa4c0-cff5-40c7-a114-09e94ec8ed46,Fundación Investigación Biomédica Hospital Príncipe de Asturias,fundaci_n_investigaci_n_biom_dica_hospital_pr_ncipe_de_asturias,,,,,, +2838,,c74e3f66-ae65-44dd-8ef3-edce2f4a6ed8,Department of anesthesiology,department_of_anesthesiology,,,,,, +2839,,99281dc5-e2ab-4a9b-bd4a-f74d7a3c3c24,"Fertilitetsklinikken 4071, Rigshospitalet",fertilitetsklinikken_4071_rigshospitalet,,,,,, +2840,,6d82c8c1-8bb4-49cb-8288-8fb61f66a8a4,ActoGeniX NV,actogenix_nv,,,,,, +2841,,f9c91961-57df-4456-b9b4-1b4ad3400caf,Orexo AB,orexo_ab,,,,,, +2842,,2319e883-f3a0-4e05-af79-9235b8b28655,LFB Biomédicaments,lfb_biom_dicaments,,,,,, +2843,,3809dc04-7148-11e6-a0cd-0242ac12000b,AVEVA,aveva,,,,,, +2844,,0f7dfe76-5418-448b-a697-3f74075f9ee8,Bradford Teaching Hospitals NHS Foundation Trust,bradford_teaching_hospitals_nhs_foundation_trust,,,,,, +2845,,6ef34ade-0e44-4c99-bf05-7503eb19ee83,Dr. Javier Domínguez Ortega,dr_javier_dom_nguez_ortega,,,,,, +2846,,add26e78-c881-453b-b070-ef28a60f71e3,"Aldagen, Inc",aldagen_inc,,,,,, +2847,,d361aeb1-73da-4689-8af0-2db6593db9a9,Cristina Gómez Oliva,cristina_g_mez_oliva,,,,,, +2848,,19a7ac07-ca17-4b09-89a9-ad15dc968010,Birmingham Women's Hospital,birmingham_women_s_hospital,,,,,, +2849,,af29262a-fbdb-49a8-bd52-2cbba2222604,EBEWE Pharma GesmbH Nfg.KG,ebewe_pharma_gesmbh_nfg_kg,,,,,, +2850,,e0cfbe57-daa5-4221-b9de-b69d4816dfc6,Gentofte Hospital,gentofte_hospital,,,,,, +526,0.986058,73bd77f0-7126-11e6-8a77-0242ac12000b,BAXTER HLTHCARE,baxter_hlthcare,,,,73bd77f0-7126-11e6-8a77-0242ac12000b,baxter_hlthcare,BAXTER HLTHCARE +380,0.9613567590713501,fee3d059-f4b7-4cb6-b41f-9a5455c55791,"Merck Sharpe & Dohme Corp., a subsidiary of Merck & Co., Inc",merck_sharpe_dohme_corp_a_subsidiary_of_merck_co_inc,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" +2851,,14edb64b-826a-4d7e-baad-842ff3d95ec3,"University Hospital Virgen del Rocío, Andalousian Health Service",university_hospital_virgen_del_roc_o_andalousian_health_service,,,,,, +2852,,b0cb1886-af74-408b-acd9-cb458017900c,"Charité-Universitätsmedizin Berlin, Department of Dermatology, Clinical Research Center for Hair and Skin Science",charit_universit_tsmedizin_berlin_department_of_dermatology_clinical_research_center_for_hair_and_skin_science,,,,,, +2853,,cca038b3-6ee9-4b79-a840-5f0eb1a54e1a,Société Française de Cardiologie,soci_t_fran_aise_de_cardiologie,,,,,, +2854,,7f04a570-16ac-4b3a-a749-27b12968c96c,Erasmus MC - Department of Pediatrics,erasmus_mc_department_of_pediatrics,,,,,, +1020,0.97864839434623718,c0aa9218-7fe2-43e7-af57-645b438a7503,"Orion Corporation Orion Pharma, FI-02200 Espoo, Finland",orion_corporation_orion_pharma_fi_02200_espoo_finland,,,,b56a3044-dedf-4773-b7a5-e6cd18764bcd,orion_corporation_orion_pharma,Orion Corporation Orion Pharma +2855,,4c5f8fd3-23c6-4e26-a9b0-33fae35721f0,Raul de la Fuente-Fernandez,raul_de_la_fuente_fernandez,,,,,, +2856,,232363ec-0d32-4ffc-a561-f9497ada52ba,Queens University Belfast,queens_university_belfast,,,,,, +1040,0.97674435377120972,2296dd74-6817-4f30-819d-48b0af75055c,Celgene International Sàrl,celgene_international_s_rl,,,,2296dd74-6817-4f30-819d-48b0af75055c,celgene_international_s_rl,Celgene International Sàrl +2857,,34c98f69-a170-48e6-96e7-df08da23128a,UNIVERSITY HOSPITALS ST LUC,university_hospitals_st_luc,,,,,, +709,0.95942862828572595,d6befa2c-95fd-45a5-927e-52a8ac78b836,Reckitt Benckiser Healthcare (UK),reckitt_benckiser_healthcare_uk,,,,62dccd7b-325f-4731-b158-229a0c9ea429,reckitt_benckiser_healthcare_uk_ltd,Reckitt Benckiser Healthcare (UK) Ltd +2858,,297e26d8-12f4-4afb-b5be-2303c3385da1,Onyvax Limited,onyvax_limited,,,,,, +2859,,eb7e4744-7223-11e6-a0cd-0242ac12000b,AGOURON,agouron,,,,,, +2860,,f5f5df89-f5d2-4922-a2b8-cfaa3ea9b605,Zymenex A/S,zymenex_a_s,,,,,, +2861,,477519f3-7edd-498c-959f-154f358844da,"HUS, Leikkaus- ja anestesiaosasto",hus_leikkaus_ja_anestesiaosasto,,,,,, +612,0.98845240473747253,ddd27261-385f-46d8-a040-1cad84ab8d5e,Erasmus Medical Center,erasmus_medical_center,,,,f3ebaba1-aead-4675-858a-6f4e2a4f28d1,erasmus_medical_center,Erasmus Medical Center +2862,,ac58a232-92e0-4551-86b1-c8433a7a2944,The University of Nottingham-Research innovation services,the_university_of_nottingham_research_innovation_services,,,,,, +2863,,2bd8b157-1fa6-4c0e-b1b4-7f4d79704af7,Diagnostic Centre of Pécs,diagnostic_centre_of_p_cs,,,,,, +2864,,98ee2c30-dc68-4582-b80e-b8a84eb8517b,Schering-Plough Levant,schering_plough_levant,,,,,, +2865,,708dc135-af1d-44c3-a9f1-7b66886dedb5,"Merck Sharp & Dohme Corporation, a subsidiary of Merck & Co, Inc",merck_sharp_dohme_corporation_a_subsidiary_of_merck_co_inc,,,,,, +2866,,a965d6f4-7194-11e6-a0cd-0242ac12000b,WYETH CONS,wyeth_cons,,,,,, +2867,,bfaa1e0a-367c-4616-b0b5-d4423fb7c650,"HovedOrtoCentret, Rigshospitalet",hovedortocentret_rigshospitalet,,,,,, +2868,,5a874696-49c2-4d94-b5cb-76bd76939b5e,Novartis Vaccines & Diagnostic S.r.l,novartis_vaccines_diagnostic_s_r_l,,,,,, +2869,,4703e1e0-7158-11e6-a0cd-0242ac12000b,LAVIPHARM LABS,lavipharm_labs,,,,,, +2870,,334c0097-564e-4fe2-8836-8902c739c7ac,biosyn Arzneimittel GmbH,biosyn_arzneimittel_gmbh,,,,,, +2871,,70635bd7-0f42-4ef4-a2a3-ab4dc9c65e15,"CLARUS THERAPEUTICS, INC",clarus_therapeutics_inc,,,,,, +2872,,9d7737a2-71bc-11e6-a0cd-0242ac12000b,UT SW MEDCTR,ut_sw_medctr,,,,,, +2873,,7aaed050-6b0b-4278-a7c8-fae23b83f01b,Manuel Praga Terente,manuel_praga_terente,,,,,, +2874,,d66cacab-55a9-4596-8872-4b540dd0d054,Amgen Development Europe,amgen_development_europe,,,,,, +826,0.98002481460571289,e662831f-0d28-42b9-a406-77cb46fe2d36,"Department of Nephrology and Renal Transplantation, University Hospitals Leuven",department_of_nephrology_and_renal_transplantation_university_hospitals_leuven,,,,e662831f-0d28-42b9-a406-77cb46fe2d36,department_of_nephrology_and_renal_transplantation,Department of Nephrology and Renal Transplantation +2875,,214a81fd-5961-4f7b-9dec-ba60ba110bfc,LABOpoint GmbH,labopoint_gmbh,,,,,, +2876,,844e032e-dbe7-4ca5-b582-9316a92eef62,"Encore Clinical, Inc",encore_clinical_inc,,,,,, +2877,,a7e6dfc6-4712-4488-a0ff-5a9b2c926c66,FORMENTI,formenti,,,,,, +2878,,7744d03c-714c-11e6-a0cd-0242ac12000b,TORPHARM,torpharm,,,,,, +2879,,2a916110-ae87-4571-a128-6423ee9dcf38,Itziar Fernandez Gonzalez,itziar_fernandez_gonzalez,,,,,, +2880,,ed4360a6-8bbd-11e6-a449-0242ac12000b,"Medical University of Vienna, ISPTM",medical_university_of_vienna_isptm,,,,,, +2881,,b35fbd7f-11bc-4c5a-a130-367c8f70dbb6,GOF pancreatic cancer collaborative group,gof_pancreatic_cancer_collaborative_group,,,,,, +2882,,1a169708-7145-11e6-a0cd-0242ac12000b,MUSTAFA NEVZAT ILAC,mustafa_nevzat_ilac,,,,,, +2883,,df012d30-c960-4e5e-bf42-aaa079e65d41,"Astelleas Pharma US, Inc",astelleas_pharma_us_inc,,,,,, +2884,,7f3bd928-2181-44aa-a46c-478c38f5ae42,"Soligenix, Inc",soligenix_inc,,,,,, +2885,,c44a96f5-33f0-4a36-bfc3-d87aded1ecc9,Clinique Mutualiste Chirurgicale,clinique_mutualiste_chirurgicale,,,,,, +2886,,52513bbf-8a94-46d3-9f25-041823a0c955,"Department of Ophthalmology, Semmelweis University",department_of_ophthalmology_semmelweis_university,,,,,, +2887,,52959d08-ff18-48d7-b3bd-e54533d4910e,Medical Faculty Magdeburg,medical_faculty_magdeburg,,,,,, +2888,,28581a31-d025-41f2-ba4e-2f7a558362d6,Fred Hutchinson Cancer Research Center,fred_hutchinson_cancer_research_center,,,,,, +2889,,23e36dc6-881d-11e6-a998-0242ac12000b,Respicopea Limited,respicopea_limited,,,,,, +2890,,b8f2aeb4-247c-4f08-a6ac-fcb4cdead6dd,"Osiris Therapeutics, Inc",osiris_therapeutics_inc,,,,,, +79,0.98557180166244507,18921777-f15d-49c4-8f68-7695c0b2af40,Karolinska Institutet/ Hospital,karolinska_institutet_hospital,,,,18921777-f15d-49c4-8f68-7695c0b2af40,karolinska_institutet_hospital,Karolinska Institutet/ Hospital +158,0.9865456223487854,5b2fbdce-d691-41c6-9a74-e06608d419f4,"Medizinische Universität Wien, HNO Klinik",medizinische_universit_t_wien_hno_klinik,,,,5b2fbdce-d691-41c6-9a74-e06608d419f4,medizinische_universit_t_wien_hno_klinik,Medizinische Universität Wien +715,0.989009,84a2a3e7-1448-4643-904b-c2956829c048,Thoracale Oncologie Groep Antwerpen TOGA,thoracale_oncologie_groep_antwerpen_toga,,,,70c3cd85-d7da-4e83-91f1-0c2abad141d5,thoracale_oncologie_groep_antwerpen,Thoracale Oncologie Groep Antwerpen +2891,,4057a67b-679f-41ad-bbdf-fe0b775860c6,NV ROCHE SA,nv_roche_sa,,,,,, +2892,,22fe652d-2dbd-45d4-bb0b-a8cf0b1a8b8e,Institut Claudius Regaud,institut_claudius_regaud,,,,,, +2893,,7e791d01-4f46-4ceb-abb6-a5863262e615,"Professor Hans Erik Johnsen, MD, DMSc, Department of Haematology, Aalborg Hospital",professor_hans_erik_johnsen_md_dmsc_department_of_haematology_aalborg_hospital,,,,,, +2894,,295b0688-13be-47c9-a4fa-d161d8de40cb,Institut d?Investigació en Atenció Primaria IDIAP Jordi Gol,institut_d_investigaci_en_atenci_primaria_idiap_jordi_gol,,,,,, +2895,,b936af78-6f50-4f42-bdab-1dc0267cdfda,Dr. Daniel Podzamczer Palter. Hospital Univesitari de Bellvitge. Unidad de VIH,dr_daniel_podzamczer_palter_hospital_univesitari_de_bellvitge_unidad_de_vih,,,,,, +473,0.986317,ae601fc8-205d-4cfe-8db5-ee6f905fa76a,Algeta ASA,algeta_asa,,,,a65c196b-462c-42a6-84d1-8d84e1c940d6,algeta_as,Algeta AS +2896,,d3fae27b-4776-42e6-87e8-579af143da53,Västerbottens läns landsting,v_sterbottens_l_ns_landsting,,,,,, +2897,,5cce6401-a191-478a-b5e2-50891230330a,LUSOFARMACO,lusofarmaco,,,,,, +2898,,31f92e94-7190-11e6-a0cd-0242ac12000b,ISO TEX,iso_tex,,,,,, +170,0.98542284965515137,74fb15bb-fdfd-41cc-8c91-bce5a34274e0,Merck Serono,merck_serono,,,,6b07fdf4-4955-45ab-999a-be365a194900,merck_serono_ltd,Merck Serono Ltd +2899,,020f2595-befa-4806-8471-be14375250b2,"Dpt. of Internal Medicine, Medical University of Innsbruck",dpt_of_internal_medicine_medical_university_of_innsbruck,,,,,, +2900,,5429d412-d78a-49a5-a059-8ace6fbb8935,Royal Marsden Foundation Hospital,royal_marsden_foundation_hospital,,,,,, +2901,,63d826a4-7168-11e6-a0cd-0242ac12000b,APPCO PHARMA LLC,appco_pharma_llc,,,,,, +2902,,ac09b497-24e7-4ef3-bdc8-76aaedafcb14,Walton Centre Foundation Trust,walton_centre_foundation_trust,,,,,, +2903,,6c09427e-7328-11e6-a0cd-0242ac12000b,SEPTODONT HOLDING,septodont_holding,,,,,, +986,0.97833722829818726,c62786c4-a39e-4b4e-91b9-31a6cb58454a,Imperial College Healthcare NHS Trust,imperial_college_healthcare_nhs_trust,,,,67902b25-58c1-419c-918d-42f6cc022a27,imperial_college_healthcare_nhs_trust,Imperial College Healthcare NHS Trust +2904,,a876810d-efec-4159-a6d7-793205a1da0e,Gilead Sciences Limited,gilead_sciences_limited,,,,,, +2905,,0b9014b1-f14f-48ca-86a8-7876f37e5915,Procter & Gamble Ltd,procter_gamble_ltd,,,,,, +935,0.987803,7988f024-a631-4924-bf0e-e2ca70acbe43,Institute of Tropical Medicine Antwerp,institute_of_tropical_medicine_antwerp,,,,61fc895f-7aff-4a8e-951c-f9fb4acdbb1f,institute_of_tropical_medicine,Institute of Tropical Medicine +2906,,47f85708-304f-4c1c-997b-461db8ffa755,"VERISFIELD (UK) LTD, GREEK BRANCH",verisfield_uk_ltd_greek_branch,,,,,, +346,0.9722786545753479,b58b5e0c-7141-11e6-a0cd-0242ac12000b,HIKMA PHARMS,hikma_pharms,,,,6f98f000-7144-11e6-a0cd-0242ac12000b,hikma,HIKMA +2907,,c4a952a2-117b-479f-8aec-44d334aadf68,IIL INTERGRUPPO ITALIANO LINFOMI ONLUS,iil_intergruppo_italiano_linfomi_onlus,,,,,, +396,0.958444,df6e5f78-616d-4a12-bbfb-8e53e8e5382f,Maastricht University Medical Centre,maastricht_university_medical_centre,,,,1a94c234-91dd-4ddb-8ee3-62df600fe4df,maastricht_universitary_medical_centre,Maastricht Universitary Medical Centre +2908,,b89f373b-bf96-49af-8cba-12aeff424866,Dr. Antonio Arroyo Sebastián,dr_antonio_arroyo_sebasti_n,,,,,, +2909,,6f5c2bbe-d305-4bba-9586-654d16a2070e,"Anders Nyboe Andersen, klinikchef dr.med., Fertilitetsklinikken 4071, Rigshospitalet",anders_nyboe_andersen_klinikchef_dr_med_fertilitetsklinikken_4071_rigshospitalet,,,,,, +2910,,18ce2571-8b6c-4d9f-b51e-b3c9bbe990b7,Groupe d'Oncologie Radiothérapie Tête Et Cou (GORTEC),groupe_d_oncologie_radioth_rapie_t_te_et_cou_gortec,,,,,, +2911,,35079f3f-db55-4475-9b7f-ac2cbadd1b73,Ritva Nissi,ritva_nissi,,,,,, +2912,,0ad41d1c-cf32-4f7e-8fc0-32d602412c2f,Alder Hey Children's Hospital NHS Trust,alder_hey_children_s_hospital_nhs_trust,,,,,, +2913,,892580c7-eb94-4c62-a2d4-1a56718d3d68,EBMT Trial Office,ebmt_trial_office,,,,,, +788,0.918711,77da9f8d-af27-42f4-9848-1b383dc686c1,"The Royal Group of Hospitals, Belfast Health and Social Care Trust",the_royal_group_of_hospitals_belfast_health_and_social_care_trust,,,,77da9f8d-af27-42f4-9848-1b383dc686c1,the_royal_group_of_hospitals_belfast_health_and_social_care_trust,"The Royal Group of Hospitals, Belfast Health and Social Care Trust" +2914,,406aeb0a-73b8-11e6-a0cd-0242ac12000b,CORCEPT THERAP,corcept_therap,,,,,, +2915,,3f2296bf-8ae6-4ff4-a9fd-a359dfb597af,"Klinik for håndkirurgi, Gentofte hospital",klinik_for_h_ndkirurgi_gentofte_hospital,,,,,, +2916,,61b57488-2c04-4d5a-a64d-59f6652bf623,Jeppe Hagstrup Christensen,jeppe_hagstrup_christensen,,,,,, +834,0.9859306812286377,af140e43-272f-40c9-b6fb-fa0d99d028a8,Novartis Pharmaceuticals UK Limited,novartis_pharmaceuticals_uk_limited,,,,34a46c06-df18-492f-b4ff-39c0c77ef62f,novartis_pharmaceuticals,Novartis Pharmaceuticals +231,0.975369,8ae37762-7370-11e6-a0cd-0242ac12000b,ORPHAN EUROPE,orphan_europe,,,,6590967f-139c-4cf2-a3f2-b668fb314794,orphan,ORPHAN +2917,,065c7592-80b2-451e-ad53-5e610bcc68e5,Maruho Europe Limited,maruho_europe_limited,,,,,, +780,0.923509,86773771-1b6b-4904-92bb-68ad633f1348,Royal Liverpool and Broadgreen University Hospital,royal_liverpool_and_broadgreen_university_hospital,,,,233d48d7-e293-4935-96da-8421fde4be1f,royal_liverpool_broadgreen_university_hospital,Royal Liverpool & Broadgreen University hospital +2918,,032a4887-425c-4333-8937-1854f102d7f1,"GlaxoSmithKline R & D Ltd., 980 Great West Road, Brendford, Middlesex, TW8 9GS, UK",glaxosmithkline_r_d_ltd_980_great_west_road_brendford_middlesex_tw8_9gs_uk,,,,,, +2919,,a71eeb6a-649e-4f43-a739-a0462e766bb9,MIKEL URRETAVIZCAYA SARACHAGA,mikel_urretavizcaya_sarachaga,,,,,, +2920,,fcc8b307-fbe5-4c7a-a428-d7e7d0e0f0a3,Gemma Rialp,gemma_rialp,,,,,, +61,0.970142,6e54f3b2-7165-11e6-a0cd-0242ac12000b,PAR FORM,par_form,,,,6e54f3b2-7165-11e6-a0cd-0242ac12000b,par_form,PAR FORM +2921,,7a3650e8-73fb-11e6-a0cd-0242ac12000b,STRATA MEDICAL INNOVATIONS,strata_medical_innovations,,,,,, +2922,,8f84d8e1-9173-4c17-be44-e39caa184ef1,VITAL THERAPIES INCORPORATED,vital_therapies_incorporated,,,,,, +2923,,8c41f0e7-9d2e-4443-98ca-076bda43716a,ASPREVA PHARMACEUTICALS CORPORATION,aspreva_pharmaceuticals_corporation,,,,,, +644,0.97071176767349243,ed718528-e6c7-48e9-9179-f757c9f510f6,Boehringer Ingelheim Pharma Ges mbH,boehringer_ingelheim_pharma_ges_mbh,,,,2e1c5817-912c-4f5e-bd24-7888fb2cc9f1,boehringer_ingelheim_pharma_gesmbh,Boehringer Ingelheim Pharma GesmbH +2924,,7c72cc00-71b3-11e6-a0cd-0242ac12000b,PURDUE PHARM PRODS,purdue_pharm_prods,,,,,, +2925,,70f620db-7e01-4f0f-a21f-a97a1e7afd7e,ALEXION PHARMACEUTICALS,alexion_pharmaceuticals,,,,,, +2926,,de20f742-73fc-11e6-a0cd-0242ac12000b,ADVANCED ACCELERATOR APPLICATIONS USA INC,advanced_accelerator_applications_usa_inc,,,,,, +205,0.98037469387054443,d53282f0-0864-40b0-8142-29a74ab39198,Glostrup Hospital,glostrup_hospital,,,,9b893499-55e3-4437-bc95-7a74dbcfefa5,glostrup_hospital_dep_of_neurology,"Glostrup Hospital, Dep. of Neurology" +346,0.9722786545753479,6f98f000-7144-11e6-a0cd-0242ac12000b,HIKMA,hikma,,,,6f98f000-7144-11e6-a0cd-0242ac12000b,hikma,HIKMA +153,0.980878,18f855d3-a347-4059-9f52-8c87407690f3,Lung Rx Inc,lung_rx_inc,,,,18f855d3-a347-4059-9f52-8c87407690f3,lung_rx_inc,Lung Rx Inc +2927,,afab0dd3-a402-4b7f-91d4-47e66eabf33f,Dept of Oncology. Haukeland University Hospital,dept_of_oncology_haukeland_university_hospital,,,,,, +86,0.95734971761703491,7b7c4eb7-0b01-479a-b331-98f2d90174df,AMC,amc,,,,7b7c4eb7-0b01-479a-b331-98f2d90174df,amc,AMC +2928,,e1741fcb-8289-4b51-b3f0-cb2c2ff9fc6f,"VIROSTATICS, SRL",virostatics_srl,,,,,, +2929,,2efec91a-c418-44e5-ad56-e89f22aeabb1,Skanes University Hospital,skanes_university_hospital,,,,,, +2930,,1ae0685f-53b1-441a-ab61-803ca1e4bce2,XBiotech Germany GmbH,xbiotech_germany_gmbh,,,,,, +2931,,a21e7a1e-7518-4c0e-9fe2-60bc67a95c8a,Sankt Lukas Hospice,sankt_lukas_hospice,,,,,, +211,0.95665790637334192,f22b2279-303f-4edc-b9ec-12c13e4b17ec,"Rigshospitalet, Department of Clinical Physiology, Nucelar Medicine and PET",rigshospitalet_department_of_clinical_physiology_nucelar_medicine_and_pet,,,,6d416153-a74f-11e6-94cb-5656d04fc2b5,rigshospitalet_department_of_clinical_physiology_nuclear_medicine_and_pet,"Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET" +2932,,431ef4cb-cc4d-4368-a5ef-f00cf85bbed6,Hull & East Yorkhire NHS Hospitals Trust,hull_east_yorkhire_nhs_hospitals_trust,,,,,, +445,0.97700804471969604,c2269e9d-6da5-4ede-8536-a48d9a0414d8,Royal Brompton,royal_brompton,,,,349b447a-a3b8-4b62-9bd7-18319a9a48b8,royal_brompton_harefield_nhs_trust,Royal Brompton & Harefield NHS Trust +2933,,d437c474-385a-43dc-9413-21687a1b7e0c,"Universitäres Herzzentrum, Klinik für Kardiologie und Angiologie",universit_res_herzzentrum_klinik_f_r_kardiologie_und_angiologie,,,,,, +2934,,b3812a99-ac4c-48b4-a4cf-e64f0b810b14,Grupo Catalán de Estudio de enfermedades glomerulares. Sociedad Catalana de nefrología,grupo_catal_n_de_estudio_de_enfermedades_glomerulares_sociedad_catalana_de_nefrolog_a,,,,,, +256,0.988946,f658ce54-ef9a-4134-9575-436d4d551eb4,"Otsuka Maryland Research Institute, Inc",otsuka_maryland_research_institute_inc,,,,dee9d357-375e-48a1-b857-489f6be6b00c,otsuka_maryland_research_institute,Otsuka Maryland Research Institute +2935,,61660ef2-504d-4d1f-902c-a290aeb244a5,Andres Iñiguez Romo,andres_i_iguez_romo,,,,,, +2936,,498c303c-28e1-41b4-b96d-1c8ccd901a77,Fundació Privada Hospital Asil de Granollers,fundaci_privada_hospital_asil_de_granollers,,,,,, +2937,,e68b4f8e-8d31-49c1-a100-6f4895929241,FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL GREGORIO MARAÑON,fundacion_para_la_investigacion_biomedica_hospital_gregorio_mara_on,,,,,, +2938,,1efa9e61-6090-40bb-8daa-1ea7310830f4,"Pfizer Inc, East 42nd street, New York, NY10017, USA",pfizer_inc_east_42nd_street_new_york_ny10017_usa,,,,,, +2939,,44d3fd53-b8d1-487c-99b9-80f81b222c64,Atopix Therapeutics Limited,atopix_therapeutics_limited,,,,,, +2940,,f83c083b-5b89-4f83-8070-33d15e5166da,HEALTH RICERCAE SVILUPPO SRL,health_ricercae_sviluppo_srl,,,,,, +2941,,17f2c3d0-8bc0-11e6-a449-0242ac12000b,Ortopædkirurgisk Afdeling Århus Universitetshospital,ortop_dkirurgisk_afdeling_rhus_universitetshospital,,,,,, +2942,,6d9e4776-266c-4dd2-993b-814bc4551ac8,Ferrer Grupo S.A,ferrer_grupo_s_a,,,,,, +2943,,aecd588b-ff66-491f-9107-8021ebe51853,Sophiris Bio Corp,sophiris_bio_corp,,,,,, +546,0.912289,1c5f86c3-3a9e-42e5-909c-e661552eaa17,University Hospital Regensburg,university_hospital_regensburg,,,,066b98e8-5ec4-4f5b-9b43-91f546ee98d1,university_hospital_of_regensburg,University Hospital of Regensburg +2944,,9a276f06-67f7-45ea-a93a-2feafb3fb539,"Dr. med. Bernd Salzer, Private Praxis",dr_med_bernd_salzer_private_praxis,,,,,, +2945,,34123d8f-e998-43b0-baf9-0fa8093e0da9,"TAYS, Hematologian yksikkö",tays_hematologian_yksikk,,,,,, +857,0.949193075299263,68ee455c-bacf-486f-9146-38bccb330df1,Institut de Recerca del Hopsital de la Santa Creu i Sant Pau,institut_de_recerca_del_hopsital_de_la_santa_creu_i_sant_pau,,,,0213f530-437f-430a-b936-0bfa94166165,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau +2946,,b52b33b0-a84c-4ae7-b049-9076a067abe3,Tartu University Hospital,tartu_university_hospital,,,,,, +444,0.96833282709121704,3c8eeed9-b500-4ecf-a409-f59b86b21db3,Royal Brompton and Harefield NHS Foundation Trust (RB&HFT),royal_brompton_and_harefield_nhs_foundation_trust_rb_hft,,,,3c8eeed9-b500-4ecf-a409-f59b86b21db3,royal_brompton_and_harefield_nhs_foundation_trust,Royal Brompton and Harefield NHS Foundation Trust +2947,,7475ddbf-3223-463e-a320-778f4e4c411e,"Department of Clinical Microbiology, Hvidovre Hospital",department_of_clinical_microbiology_hvidovre_hospital,,,,,, +851,0.982275,b71ebe88-2670-41c6-bc97-75d073b40c14,Lung LLC Inc,lung_llc_inc,,,,9e0d93e9-f8e2-452d-9570-4897fca51742,lung_llc,Lung LLC +2948,,aabe2da6-16fc-436d-a5ec-f6edf70e4167,Boehringer Ingelheim Netherlands B.V,boehringer_ingelheim_netherlands_b_v,,,,,, +2949,,9198e9a2-34b3-4814-9aa2-6523b020006f,"PTC THERAPEUTICS, INC",ptc_therapeutics_inc,,,,,, +2950,,237a7d9a-4da0-4db7-9fff-e6caf2e5a8fd,Victoria Castel Sánchez,victoria_castel_s_nchez,,,,,, +58,0.96342335641384125,4ee22869-e1f2-4fe4-b839-8e304a477801,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical resaearch and Development,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_resaearch_and_development,,,,2ed1b6f4-e137-4ee3-a218-9e5c2d04039a,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_and_development,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development +2951,,9239d4c8-02f9-44d4-9e14-f156c77f7da2,PALUPA Medical Ltd,palupa_medical_ltd,,,,,, +2952,,5a62beb5-7ff9-4a17-8c6e-49cdceb0cfe3,José Hernández-Quero. Hospital Clínico San Cecilio,jos_hern_ndez_quero_hospital_cl_nico_san_cecilio,,,,,, +2953,,7be6451e-d4fe-4141-aed2-305b0420b2bb,"Università di Milano, Dipartimento di Scienze Chirurgiche, Ospedale Maggiore Policlinico, Padiglione",universit_di_milano_dipartimento_di_scienze_chirurgiche_ospedale_maggiore_policlinico_padiglione,,,,,, +2954,,60329e0a-8bba-11e6-a449-0242ac12000b,Convergence Pharmaceuticals Limited,convergence_pharmaceuticals_limited,,,,,, +2955,,96ea390c-59c8-41e0-90b3-1788779b74c3,University Hospital Hradec Kralove,university_hospital_hradec_kralove,,,,,, +2956,,1e2432a8-9a26-4684-bf67-f071896277ad,ANTONIO PEREZ MARTINEZ,antonio_perez_martinez,,,,,, +2957,,8af3a0ee-4d52-4444-afa2-33b3b4428ea3,Lactest S.L,lactest_s_l,,,,,, +213,0.979896,559fe1ec-2be1-4b2f-a03a-a510b2d4cf93,Bioforce AG,bioforce_ag,,,,559fe1ec-2be1-4b2f-a03a-a510b2d4cf93,bioforce_ag,Bioforce AG +2958,,71d50e54-faa1-4caa-9cca-1aca4a1a5898,Österreichische Gesellschaft zur Erforschung komplementär – alternativer Therapien in der Onkologie,sterreichische_gesellschaft_zur_erforschung_komplement_r_alternativer_therapien_in_der_onkologie,,,,,, +2959,,df432042-a752-4243-9e4e-80ed1e42f5fb,TORAY,toray,,,,,, +2960,,eac3acb4-01b7-4c19-bc2c-fc903c093803,DeveloGen Autoimmune GmbH,develogen_autoimmune_gmbh,,,,,, +2961,,9564bf36-c532-4665-946a-e36ca78f815e,Hospira UK Ltd,hospira_uk_ltd,,,,,, +2962,,27fd85ad-4ca9-4ff7-b565-bf3f65a73af2,Fundación PETHEMA para el tratamiento de la leucemia y el linfoma,fundaci_n_pethema_para_el_tratamiento_de_la_leucemia_y_el_linfoma,,,,,, +2963,,2593097e-3eb8-4ebc-85aa-77c394fd9348,Advanced BioHealing Inc,advanced_biohealing_inc,,,,,, +2964,,f171532a-28b8-4cf3-85a8-a42810690411,Køge Hospital,k_ge_hospital,,,,,, +2965,,ae23d8a6-8c5d-4f33-9086-d7aca7823858,"AZ. OSPEDALIERA GARIBALDI, S.LUIGI CURRO , ASCOLI TOMASELLI",az_ospedaliera_garibaldi_s_luigi_curro_ascoli_tomaselli,,,,,, +2966,,2ef2bea4-eeea-43d1-87be-3cfb8ab7c479,DEBIOPHARM S.A,debiopharm_s_a,,,,,, +2967,,9f35ce3c-1396-4a0f-9212-589f173e0ac4,Isofol Medical AB,isofol_medical_ab,,,,,, +2968,,ff20459b-c755-453a-be20-f6e2e0475c79,ImClone Systems Incorporated,imclone_systems_incorporated,,,,,, +608,0.97127266724904382,0b4ab157-794b-487d-82ae-2120741beadf,"RWTH Aachen University for the Medical Falculty, represented by Clinical Trial Center Aachen (CTC-A)",rwth_aachen_university_for_the_medical_falculty_represented_by_clinical_trial_center_aachen_ctc_a,,,,8cf07097-1668-4840-99e4-5f3861195629,rwth_aachen_university_for_the_medical_faculty_represented_by_clinical_trial_center_aachen_ctc_a,"RWTH Aachen University for the Medical Faculty, represented by Clinical Trial Center Aachen (CTC-A)" +2969,,6aedf804-7151-11e6-a0cd-0242ac12000b,RITEDOSE CORP,ritedose_corp,,,,,, +658,0.988286,664414da-3a46-4707-80ab-612f81e1142f,Liverpool Women's NHS Foundation Trust,liverpool_women_s_nhs_foundation_trust,,,,4423b650-5a4e-43b4-81a3-c06729eeaafc,liverpool_women_s_nhs_foundation_trust_hospital,Liverpool Women's NHS Foundation Trust Hospital +2970,,d03d9fbd-a6e0-11e6-94cb-5656d04fc2b5,MC Slotervaart,mc_slotervaart,,,,,, +2971,,c3b15e84-8c58-407d-a425-88860d2e1f5a,Funxional Therapeutics Ltd,funxional_therapeutics_ltd,,,,,, +2972,,27fbab2f-8e5f-4aba-8229-37d3039006b6,Pierre Fabre Dermo-Cosmétique,pierre_fabre_dermo_cosm_tique,,,,,, +274,0.985423,04d25e84-7129-11e6-a89e-0242ac12000b,G AND W LABS,g_and_w_labs,,,,025f7b50-7129-11e6-a89e-0242ac12000b,g_and_w_labs_inc,G AND W LABS INC +2973,,8f620a3c-82b8-42ee-8300-7655bb1567b5,Karo Bio AB,karo_bio_ab,,,,,, +2974,,2937a777-7b3d-41d1-8c8c-ec1d06626dd7,SmithKline Beecham Corporation (doing business as GlaxoSmithKline),smithkline_beecham_corporation_doing_business_as_glaxosmithkline,,,,,, +211,0.97447748978932702,634e604f-a542-4409-963c-b1a72c89e7da,"Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET",rigshospitalet_department_of_clinical_physiology_nuclear_medicine_and_pet,,,,6d416153-a74f-11e6-94cb-5656d04fc2b5,rigshospitalet_department_of_clinical_physiology_nuclear_medicine_and_pet,"Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET" +2975,,c161eda1-f27c-4f48-ab01-c4a59c9d196e,"ZymoGenetics, Inc",zymogenetics_inc,,,,,, +2976,,8e671ff4-90da-4713-bd31-73071c708913,Daniel Sanabria Lucena,daniel_sanabria_lucena,,,,,, +2977,,cf21ec0c-4b60-4bd9-8127-282eb543d87a,Enrique de Madaria Pascual,enrique_de_madaria_pascual,,,,,, +1010,0.97897982597351074,90b35626-7145-11e6-a0cd-0242ac12000b,MCNEIL,mcneil,,,,1ea84c68-71d5-11e6-a0cd-0242ac12000b,mcneil_ped,MCNEIL PED +2978,,411bf2c0-7c0e-4d67-9119-d3ddcac759db,Medizin Universität Wien,medizin_universit_t_wien,,,,,, +2979,,57fcbd9c-4f3b-4997-9365-a6d9256fa5b8,Retinaklinikken Omnia,retinaklinikken_omnia,,,,,, +1054,0.97196,88936054-83c4-44a0-9f56-8aea1c3f4534,Fundacion para La Investigación Biomédica Hospital Universitario La Paz (FIBHULP),fundacion_para_la_investigaci_n_biom_dica_hospital_universitario_la_paz_fibhulp,,,,88936054-83c4-44a0-9f56-8aea1c3f4534,fundacion_para_la_investigaci_n_biom_dica_hospital_universitario_la_paz_fibhulp,Fundacion para La Investigación Biomédica Hospital Universitario La Paz (FIBHULP) +2980,,d9b39f75-1a2f-4344-acc9-7269c6b48552,Apotex Inc,apotex_inc,,,,,, +176,0.96301039059956872,4785c12c-a8bf-4198-a32e-aaa4708f48a5,Novartis Vaccines and Diagnostics S.r.l,novartis_vaccines_and_diagnostics_s_r_l,,,,fbdb10c1-6146-4761-86bf-a8541dc3b4fa,novartis_vaccines_and_diagnostics,Novartis Vaccines and Diagnostics +2981,,1902b82c-7142-11e6-a0cd-0242ac12000b,APOTHECON,apothecon,,,,,, +818,0.972258,f3acf8e7-1669-4bce-8a09-1b81d95d57ed,UNIVERSITA` DEGLI STUDI DI FIRENZE - DIPARTIMENTO DI PSICOLOGIA,universita_degli_studi_di_firenze_dipartimento_di_psicologia,,,,87f0f612-d1e5-4f3f-9bcd-69b8c3e8fd9a,universita_degli_studi_di_firenze,UNIVERSITA' DEGLI STUDI DI FIRENZE +2982,,c7f994e3-21b6-403e-a747-1e5c3809dd6f,ALMIRALL PRODESFARMA,almirall_prodesfarma,,,,,, +2983,,8d9168e8-5656-4e06-bad2-8308e8d8e0f0,CTI BioPharma Corp,cti_biopharma_corp,,,,,, +2984,,076699e9-90c8-4697-9aa7-d73e6950ea78,Laboratoires ELERTE,laboratoires_elerte,,,,,, +2985,,3cd39890-7163-11e6-a0cd-0242ac12000b,MAYNE PHARMA INC,mayne_pharma_inc,,,,,, +191,0.9870394766330719,5325f171-c07b-408c-b066-827a1d919e30,CESAR Central European Society for Anticancer Drug Research,cesar_central_european_society_for_anticancer_drug_research,,,,4042f330-66f0-40ec-8288-db80eef6363c,cesar_central_european_society_for_anticancer_drug_research,CESAR Central European Society for Anticancer Drug Research +2986,,9afcd47a-7142-11e6-a0cd-0242ac12000b,CHARTWELL CIENCA,chartwell_cienca,,,,,, +2987,,8f1e05db-4d1d-4d8f-919f-8484d0258dff,Oxford Racliffe NHS Trust,oxford_racliffe_nhs_trust,,,,,, +2988,,3fa69f5f-6985-40ac-8249-cb1fc1c322c7,Unidad de Cirugia Artroscópica,unidad_de_cirugia_artrosc_pica,,,,,, +965,0.981266,b75dc5c8-3735-4c68-a632-699239b52e79,"Göteborg University, Sect. Psyhiatry and Neurochemistry",g_teborg_university_sect_psyhiatry_and_neurochemistry,,,,b75dc5c8-3735-4c68-a632-699239b52e79,g_teborg_university_sect_psyhiatry_and_neurochemistry,"Göteborg University, Sect. Psyhiatry and Neurochemistry" +2989,,18c925c4-213f-4e7b-81a6-efab2ce2fae8,sanofi Belgium,sanofi_belgium,,,,,, +2990,,18b70f62-7ff7-4f45-8ab5-bd5d65bd7b76,Karolinska Institutet/Södersjukhuset,karolinska_institutet_s_dersjukhuset,,,,,, +852,0.986862,105c8b52-7238-11e6-a0cd-0242ac12000b,ENDO PHARM,endo_pharm,,,,105c8b52-7238-11e6-a0cd-0242ac12000b,endo_pharm,ENDO PHARM +2991,,315b149b-dc2c-4e15-be14-3ca3a6b4981a,"University of Heidelberg, Klinikum Mannheim, Dep Surgery/Thoracical Oncology",university_of_heidelberg_klinikum_mannheim_dep_surgery_thoracical_oncology,,,,,, +2992,,f071a034-74de-4455-b903-812ae57bfa3e,Universitätsklinik für Psychiatrie - Spezialambulanz für Abhangigkeitserkrankungen,universit_tsklinik_f_r_psychiatrie_spezialambulanz_f_r_abhangigkeitserkrankungen,,,,,, +481,0.98966941237449646,d42b3939-6ec8-482a-b3b2-f71da478382e,Medizinische Universität Graz, Universitätsklinik fürInnere Medizin,,,,48f0d5ed-174c-4ce4-98d7-cc34770f5107, Universitätsklinik für Innere Medizin,Medizinische Universität Graz +2993,,b42d5d33-5c69-434f-ad3a-1532e7998e5f,"Roche Polska, Sp.z.o",roche_polska_sp_z_o,,,,,, +2994,,29ae8e58-6b6f-41ed-88c8-6f4fc9ff26bc,University of Modena and Reggio Emilia,university_of_modena_and_reggio_emilia,,,,,, +2995,,9c606ca1-40dc-40d6-a830-c2a2203929a2,"Klinikum der Universität München, Anstalt des öffentlichen Rechts vertreten durch den Vorstand",klinikum_der_universit_t_m_nchen_anstalt_des_ffentlichen_rechts_vertreten_durch_den_vorstand, Abteilung für Endokrinologie und Stoffwechsel,medizinische_universit_t_graz_universit_tsklinik_f_rinnere_medizin_abteilung_f_r_endokrinologie_und_stoffwechsel,,,, +2996,,d3ebaa39-fec8-413f-9559-fa83565e9e5e,Laboratoires Auris SAS,laboratoires_auris_sas,,,,,, +2997,,9d2f2b54-f66a-4fb2-8cdf-18b38f94f9e1,Farmak International Holding GmbH,farmak_international_holding_gmbh,,,,,, +2998,,62b88203-984e-495b-b122-f3e38e1a3401,Pfizer Pharmaceutical Group,pfizer_pharmaceutical_group,,,,,, +2999,,f4dc51aa-62db-4236-b5c0-aa174e830a5c,Iron Therapeutics (UK) Ltd,iron_therapeutics_uk_ltd,,,,,, +776,0.931044,5cb4c7b4-22d3-4d2e-baa3-ec6641e8024b,Thomas Fichtner Bendtsen,thomas_fichtner_bendtsen,,,,5cb4c7b4-22d3-4d2e-baa3-ec6641e8024b,thomas_fichtner_bendtsen,Thomas Fichtner Bendtsen +3000,,bd073614-9235-4c6b-a87e-53acfe659c37,Sigrun Kjotrod,sigrun_kjotrod,,,,,, +292,0.987186,577003d4-ce61-4acf-92c9-2f42061c86fc,Motif BioSciences Inc,motif_biosciences_inc,,,,577003d4-ce61-4acf-92c9-2f42061c86fc,motif_biosciences_inc,Motif BioSciences Inc +3001,,32ad65af-e5d4-4923-a4e8-48aa55f6d352,Neurochem Inc,neurochem_inc,,,,,, +3002,,35de09e7-5761-4a6a-bfd9-e11b0a41f0d6,"Johan Wolfgang Goethe Universität - Department of Internal medicine I, Division Endocrinology",johan_wolfgang_goethe_universit_t_department_of_internal_medicine_i_division_endocrinology,,,,,, +3003,,cd0aff71-dccc-4c98-add8-ed0e56fe00a3,"Division of Cardiology, Robert-Bosch-Krankenhaus",division_of_cardiology_robert_bosch_krankenhaus,,,,,, +3004,,a2b02b48-e518-40b7-91fb-e5fb16986d77,Klinikum der Universität München - AöR vertreten durch den Vorstand des Bereiches umanmedizinH,klinikum_der_universit_t_m_nchen_a_r_vertreten_durch_den_vorstand_des_bereiches_umanmedizinh,,,,,, +3005,,d23b8f13-ba40-46ce-b7fa-a1303d972064,Ziekenhuis Oost-Limburg,ziekenhuis_oost_limburg,,,,,, +561,0.981251,d85aa782-9e49-4348-aef6-da814a075e7e,Bioheart,bioheart,,,,89f1114d-3553-4ac3-a66f-02effd57921a,bioheart_inc,"Bioheart, Inc" +3006,,cad83b40-6fc0-11e6-abe8-0242ac12000b,"Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University",department_of_experimental_and_clinical_pharmacology_and_toxicology_friedrich_alexander_university,,,,,, +3007,,59f7deac-832e-44a1-a893-4d2530183177,Meander MC,meander_mc,,,,,, +3008,,b34e7da5-017b-4ce4-911f-a3116806254c,"Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Aachen",klinik_f_r_psychiatrie_und_psychotherapie_universit_tsklinikum_aachen,,,,,, +3009,,434c909a-cb82-4647-b740-00411b6825b8,"Universität Mainz, I. Medizinische Klinik und Poliklinik",universit_t_mainz_i_medizinische_klinik_und_poliklinik,,,,,, +3010,,bcb69a19-f443-4a78-a4fc-5d7f251b9307,XTL Development Inc,xtl_development_inc,,,,,, +942,0.985052,02c56274-3bd4-4bfe-bfe8-b2385f2eef41,BioGeneriX AG,biogenerix_ag,,,,02c56274-3bd4-4bfe-bfe8-b2385f2eef41,biogenerix_ag,BioGeneriX AG +3011,,cdbde9e5-a842-438b-9f30-eac716d712c7,Roessingh Research&Development,roessingh_research_development,,,,,, +3012,,1f8a49c9-315b-48da-961a-a1c7c326fd7d,Bial Industrial Farmacéutica S.A,bial_industrial_farmac_utica_s_a,,,,,, +3013,,e0955966-3d56-4a65-b3bb-f95f89ea0129,"Rigshospitalet, 2121",rigshospitalet_2121,,,,,, +181,0.9797365665435791,d0a0c878-7149-11e6-a0cd-0242ac12000b,VALEANT,valeant,,,,7e7a02de-715e-11e6-a0cd-0242ac12000b,valeant_intl,VALEANT INTL +573,0.900909,5a6ea281-ca4c-46d4-8b7d-0e24f0d68167,ARTIC (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie),artic_association_pour_la_recherche_de_th_rapeutiques_innovantes_en_canc_rologie,,,,5a6ea281-ca4c-46d4-8b7d-0e24f0d68167,artic_association_pour_la_recherche_de_th_rapeutiques_innovantes_en_canc_rologie,ARTIC (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie) +3014,,9d394246-6a66-457a-b2e2-e218e23d7eb6,Fundacion Renal Iñigo Alvarez Toledo,fundacion_renal_i_igo_alvarez_toledo,,,,,, +3015,,df20d874-7154-11e6-a0cd-0242ac12000b,RECIP,recip,,,,,, +735,0.98468996584415436,6e92b00d-0791-4d8e-975c-0fbd5ce95861,European Organization for Research and Treatment of Cancer,european_organization_for_research_and_treatment_of_cancer,,,,6e92b00d-0791-4d8e-975c-0fbd5ce95861,european_organisation_for_research_and_treatment_of_cancer,European Organisation for Research and Treatment of Cancer +3016,,9da60900-d9d5-44b4-98da-a5a69f4f7e3c,University College Hospitals NHS Foundation Trust/ University College London,university_college_hospitals_nhs_foundation_trust_university_college_london,,,,,, +712,0.98029342293739319,22a73e59-42a9-4d35-bdb8-fda7d14ab400,Reckitt Benckiser Healthcare International Ltd,reckitt_benckiser_healthcare_international_ltd,,,,38c6b681-96aa-439b-8189-1ea1e741e51b,reckitt_benckiser_healthcare_international,Reckitt Benckiser Healthcare International +3017,,9a5f2f5c-9e49-46d0-ad0a-e9c38824dad5,Division of Rheumatology,division_of_rheumatology,,,,,, +3018,,07c597aa-7142-11e6-a0cd-0242ac12000b,NORTHSTAR HLTHCARE,northstar_hlthcare,,,,,, +3019,,2251e762-a7c7-4745-8c3e-1c0e91242941,Aintree University Hospital NHS Trust,aintree_university_hospital_nhs_trust,,,,,, +3020,,c6a62134-45e0-498a-b721-39eaca0b8fb1,Newcastle Upon Tyne NHS Foundation Trust,newcastle_upon_tyne_nhs_foundation_trust,,,,,, +3021,,e0f00d12-de12-495b-9c1c-d1fd478e5b38,Uppsala University/Uppsala County Council,uppsala_university_uppsala_county_council,,,,,, +3022,,a2618c1b-0784-4ab6-8ea6-3466d75cb988,CHU de Rennes (Rennes University Hospital Centre),chu_de_rennes_rennes_university_hospital_centre,,,,,, +3023,,0d9fcf1e-0c7b-4ba9-b99d-e095669bc5d7,Fernando Lago Deibe,fernando_lago_deibe,,,,,, +3024,,b258aaa0-e968-4010-8608-2ca87998e70e,Nordic Society for Gynecological Cancer,nordic_society_for_gynecological_cancer,,,,,, +3025,,52240df5-d096-4d24-914f-7c2d6e1febb3,Eija Kalso,eija_kalso,,,,,, +747,0.987246,c38c767e-3bab-4964-aa89-3148c5732dd6,Universitaetsklinikum Erlangen-Nuernberg,universitaetsklinikum_erlangen_nuernberg,,,,61d9cb36-84e8-4785-a622-4f2f20464069,universitaetsklinikum_erlangen,Universitaetsklinikum Erlangen +670,0.98121541738510132,003e8352-381a-4a71-b3e3-25cd5e67e274,NHS Lothian (ACCORD),nhs_lothian_accord,,,,003e8352-381a-4a71-b3e3-25cd5e67e274,nhs_lothian_accord,NHS Lothian (ACCORD) +3026,,48ff745c-9fc4-4314-8272-ade69ee188f7,Servicio de psiquiatria. Hospital Universitario La Paz,servicio_de_psiquiatria_hospital_universitario_la_paz,,,,,, +3027,,ca2b02cc-8821-4f3e-899e-69c84148e0c9,Dompé s.p.a,domp_s_p_a,,,,,, +3028,,7fe7c4ab-18f3-4ec1-ade8-51f460677e36,ERYTECH Pharma,erytech_pharma,,,,,, +618,0.987151,3c1aae28-1aa7-461b-ae60-fe064393d484,Belfast City Hospital Trust,belfast_city_hospital_trust,,,,3c1aae28-1aa7-461b-ae60-fe064393d484,belfast_city_hospital_trust,Belfast City Hospital Trust +3029,,66ef28cd-8a17-4485-848f-f0b0d9bf9103,ProStrakan Ltd,prostrakan_ltd,,,,,, +3030,,b45df1d1-b14e-42cc-b65d-3c5bf21dde99,"University Hospitals Leicester, Leicester General Hospital",university_hospitals_leicester_leicester_general_hospital,,,,,, +3031,,fb80c762-68d3-4689-a142-20a1ee41e6b9,Academisch Medisch Centrum bij de Universiteit van Amsterdam (AMC),academisch_medisch_centrum_bij_de_universiteit_van_amsterdam_amc,,,,,, +380,0.96973061561584473,60384d82-f20c-4bc4-8d63-da5bc1c92478,"Merck Sharp & Dohme Corp., a subsidary of Merck & Co",merck_sharp_dohme_corp_a_subsidary_of_merck_co,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" +3032,,5f1f775e-2c7c-4ab8-a3f9-faf2dc1b0f13,"Roche Farma, S.A. , en nombre de F. Hoffmann- La Roche",roche_farma_s_a_en_nombre_de_f_hoffmann_la_roche,,,,,, +3033,,21c73b9e-4142-403d-8a1a-5ae12c3a5778,Mylan Pharmaceuticals Inc,mylan_pharmaceuticals_inc,,,,,, +3034,,f82a1da8-881f-11e6-a998-0242ac12000b,Solvay Pharmaceuticals BV,solvay_pharmaceuticals_bv,,,,,, +3035,,a67550aa-2e95-48f9-8bb5-0d2127a15261,"Gilead Sciences Canada, Inc",gilead_sciences_canada_inc,,,,,, +3036,,fb864186-a1c3-43e4-96ea-f0ce8ba32356,Sahlgrenska Akademin vid Göteborgs Universitet,sahlgrenska_akademin_vid_g_teborgs_universitet,,,,,, +204,0.98671889305114746,f3d26e6b-906d-4f66-b5d8-5c97a760e0bc,Institut de Recerca,institut_de_recerca,,,,e77923f8-3c50-4c19-aba2-8104ed582c2e,institut_de_recerca_hscsp,Institut de Recerca HSCSP +3037,,cfd0e8e9-6781-4f87-8251-56845fce0157,no sponsor for this trial,no_sponsor_for_this_trial,,,,,, +3038,,5420448b-fd74-45e7-91f0-9f730b48c22d,Desitin Arzneimittel GmbH,desitin_arzneimittel_gmbh,,,,,, +3039,,01cd8925-944b-48dd-951d-8ffffd9e1d3f,Dept. of Rhematology UMAS,dept_of_rhematology_umas,,,,,, +3040,,5b9f1606-978a-4207-b973-1a46a233f923,Serodus ASA,serodus_asa,,,,,, +236,0.9629122416178385,36e40cab-06cf-41e0-bef3-04e11a49311d,"Pfizer Ltd, Ramsgate Road, Sandwich, Kent",pfizer_ltd_ramsgate_road_sandwich_kent,,,,36e40cab-06cf-41e0-bef3-04e11a49311d,pfizer_ltd_ramsgate_road_sandwich_kent,"Pfizer Ltd, Ramsgate Road, Sandwich, Kent" +838,0.98826968669891357,046d6658-d5b1-4caa-8e4b-a52c60c09ffd,NHS Greater Glasgow and Clyde,nhs_greater_glasgow_and_clyde,,,,046d6658-d5b1-4caa-8e4b-a52c60c09ffd,nhs_greater_glasgow_and_clyde,NHS Greater Glasgow and Clyde +3041,,4c3a33ed-0499-4611-95d9-d5d6f55e468d,Splošna bolnišnica Celje,splo_na_bolni_nica_celje,,,,,, +3042,,75d9c295-c39f-4ccd-9a19-c89fa61db938,mib Dienstleistungsgesellschaft mbH,mib_dienstleistungsgesellschaft_mbh,,,,,, +3043,,30c2a37e-7150-11e6-a0cd-0242ac12000b,DEXCEL LTD,dexcel_ltd,,,,,, +3044,,7970b926-db39-4bce-9547-3f573248cf1a,"Chimerix, Inc",chimerix_inc,,,,,, +3045,,7d798544-5e49-4b24-899f-fbc24edba20c,I.R.I.S. Institut de Recherches Internationales Servier,i_r_i_s_institut_de_recherches_internationales_servier,,,,,, +3046,,0f271e14-1dfa-430b-8f55-1d51b33dbe08,"Department of Anaesthesiology and Intensive Care, University of Tartu",department_of_anaesthesiology_and_intensive_care_university_of_tartu,,,,,, +3047,,ee6dbd3b-5385-4cea-bce9-7801dd077af5,Karolinska Institute,karolinska_institute,,,,,, +3048,,fc2cd1da-7149-11e6-a0cd-0242ac12000b,LEHIGH VALLEY,lehigh_valley,,,,,, +3049,,7c1744f3-d3d4-4a99-9dfb-4434171209e7,"ConjuChem, Inc",conjuchem_inc,,,,,, +3050,,8ba3cb95-58e2-4ed1-996e-2cc9883bc6d6,GBG Forschung GmbH,gbg_forschung_gmbh,,,,,, +3051,,c8c5428f-7f58-48b9-a923-8c54e9fbc313,Nycomed Sweden Holding 2 AB,nycomed_sweden_holding_2_ab,,,,,, +3052,,afcbb067-7a47-4ae0-be71-ce3070201f2b,Neolab Ltd,neolab_ltd,,,,,, +3053,,6dfa41fc-c2c8-4be4-b527-6dedb6b2b2a0,Dr. Miguel Blanca Gómez,dr_miguel_blanca_g_mez,,,,,, +3054,,47a42bef-f837-40e0-8db0-1d4d1593d4cb,IMETISA,imetisa,,,,,, +3055,,3600d234-4c50-4e4b-9bd4-1389ea95233d,Servicio de Enfermedades Infecciosas. Unidad VIH. Hospital Universitari de Bellvitge,servicio_de_enfermedades_infecciosas_unidad_vih_hospital_universitari_de_bellvitge,,,,,, +3056,,6e50ec4e-3289-4289-a102-d1658c72fabe,Betsi Cadwaladr University Health Board,betsi_cadwaladr_university_health_board,,,,,, +3057,,d3504b21-f4a7-49c7-a199-c03732b6465f,Xenova Ltd,xenova_ltd,,,,,, +3058,,60a31ce0-9da8-4fb3-a828-358c4ebcf10d,CytRx Corporation,cytrx_corporation,,,,,, +380,0.97038671705457902,f262b660-2330-429c-8af0-63e5c4fec4b0,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., N.J., USA",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_n_j_usa,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" +3059,,63bd7b38-7168-11e6-a0cd-0242ac12000b,PURACAP PHARMACEUTICAL LLC,puracap_pharmaceutical_llc,,,,,, +3060,,1fed9587-215f-48ec-bff3-6fa1d30fca57,Institute of oncology,institute_of_oncology,,,,,, +3061,,6219db2b-5159-4b5a-9fca-fef7ddf20cb1,"Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Medizinische Hochschule Hannover",klinik_f_r_allgemein_viszeral_und_transplantationschirurgie_medizinische_hochschule_hannover,,,,,, +3062,,c327f5b1-2d4c-4f8e-bc71-66756d22aa9f,"Technische Universitaet Muenchen, Medizinische Fakultaet",technische_universitaet_muenchen_medizinische_fakultaet,,,,,, +705,0.975954,dd27398c-7163-11e6-a0cd-0242ac12000b,LUITPOLD PHARMS INC,luitpold_pharms_inc,,,,666dd3bc-7129-11e6-a89e-0242ac12000b,luitpold,LUITPOLD +759,0.983343,24121f55-fb32-464a-8d7d-28948ed0eae7,Sektion Chirurgische Forschung,sektion_chirurgische_forschung,,,,24121f55-fb32-464a-8d7d-28948ed0eae7,sektion_chirurgische_forschung,Sektion Chirurgische Forschung +3063,,2bc78fb7-6051-428c-a7ce-351a2f7ff28c,FISM ONLUS,fism_onlus,,,,,, +413,0.98836642503738403,6703561f-7892-4741-9e93-df86d84b4cdc,Karolinska University Hospital Solna,karolinska_university_hospital_solna,,,,4a616e09-39b2-4537-bceb-96327b70319b,karolinska_university_hospital,Karolinska University Hospital +655,0.96628576517105103,a91f8817-005f-4251-808a-ee4efece990a,Boehringer Ingelheim Inc,boehringer_ingelheim_inc,,,,a91f8817-005f-4251-808a-ee4efece990a,boehringer_ingelheim_inc,Boehringer Ingelheim Inc +126,0.985655,6ca002d3-030a-446d-9fc5-74a04207c321,"Clinical Trials and Research Governance, University of Oxford",clinical_trials_and_research_governance_university_of_oxford,,,,5760d01f-a672-4d09-ab67-83a15c2d8903,clinical_trials_and_research_governance,Clinical Trials and Research Governance +3064,,70a82b07-e3c6-4262-91b8-92811acf53f4,Laboratorios Ordesa,laboratorios_ordesa,,,,,, +3065,,89a5dbb0-d46c-413e-b614-30ebd13b244a,FAZ - Floridsdorf Allergy Center,faz_floridsdorf_allergy_center,,,,,, +3066,,90966315-fc20-499a-94e1-ed6ea9f8cfee,Drossapharm AG,drossapharm_ag,,,,,, +869,0.97674435377120972,8c2f1018-ffda-46d2-836f-6bb8351d4443,Astellas,astellas,,,,8c2f1018-ffda-46d2-836f-6bb8351d4443,astellas,Astellas +3067,,b699d253-a746-11e6-94cb-5656d04fc2b5,Finn Sellebjerg,finn_sellebjerg,,,,,, +3068,,60cc0fe2-83b3-43f7-bc60-af261cf89079,SE Dept. of Psychiatry and Psychotherapy,se_dept_of_psychiatry_and_psychotherapy,,,,,, +3069,,dd277b94-7141-11e6-a0cd-0242ac12000b,ACCORD HLTHCARE,accord_hlthcare,,,,,, +3070,,a57d81e8-7141-11e6-a0cd-0242ac12000b,APP PHARMS,app_pharms,,,,,, +3071,,bb2c89f4-3720-436e-b400-fc6d3dd179de,"CBLAYA&HUGET, S.L",cblaya_huget_s_l,,,,,, +3072,,8eff3282-2893-4457-ad82-85af51af6e1a,"CIS bio international, member of IBA group",cis_bio_international_member_of_iba_group,,,,,, +3073,,cb7dcb4b-2b13-4565-85e0-d7d13ed17f55,Boehringer Ingelheim Hellas,boehringer_ingelheim_hellas,,,,,, +3074,,48720625-a749-4eeb-9023-c6a500917eda,Tapestry Pharmaceuticals Ltd,tapestry_pharmaceuticals_ltd,,,,,, +3075,,5a59e464-9623-431a-85b7-abc05a0adda3,"Angelini Farmaceutici, ACRAF S.p.A",angelini_farmaceutici_acraf_s_p_a,,,,,, +442,0.934557,a4633fdb-5ef0-4fc4-8c7b-a058097e6bf2,Laboratorios Andrómaco S.A. (Co-sponsor Spanien),laboratorios_andr_maco_s_a_co_sponsor_spanien,,,,25695572-6fa2-11e6-9663-0242ac12000b,laboratorios_andr_maco_s_a_co_sponsor_spain,Laboratorios Andrómaco S.A. (co-sponsor Spain) +3076,,bc7c071c-b4d0-49b1-985f-f03f6f3e6426,Hull and east Yorkshire Hospital NHS Trust,hull_and_east_yorkshire_hospital_nhs_trust,,,,,, +125,0.982275,a37dc1b8-8773-48d3-ac48-d88bec02bf91,CureTech Ltd,curetech_ltd,,,,11b07734-c458-4066-877a-5c26e559db7c,curetech,CureTech +3077,,9e572ed7-89d1-429f-85ef-0238031a8f96,"Radboud University Nijmegen Medical Centre, Donders Institute for Brain, Cognition and Behaviour",radboud_university_nijmegen_medical_centre_donders_institute_for_brain_cognition_and_behaviour,,,,,, +3078,,be58fe63-c437-444a-8819-31c8a3687d0e,GSK Biologicals,gsk_biologicals,,,,,, +273,0.98508751392364502,22571e3f-0745-4cea-b1ca-5cc32ff5e911,Uppsala University Hospital,uppsala_university_hospital,,,,22571e3f-0745-4cea-b1ca-5cc32ff5e911,uppsala_university_hospital,Uppsala University Hospital +3079,,a0be3e04-c52d-482e-b6bd-6d27b71f6fc6,"Nuon Therapeutics, Inc",nuon_therapeutics_inc,,,,,, +3080,,d2c3fa76-a3f7-4f64-a2d0-5b1ced8042a8,Göteborg University,g_teborg_university,,,,,, +503,0.9617990255355835,e4d6bbcf-51b5-4969-b9e5-99d8e4d10f9c,Sanofi-Synthelabo Rt,sanofi_synthelabo_rt,,,,1e7e8025-6216-4754-a0a3-b1cf72ba2a3d,sanofi_synthelabo_research,Sanofi-Synthelabo Research +3081,,c53bc5e0-f77b-4a7f-9f85-0bcd333724e4,Pfixer Inc,pfixer_inc,,,,,, +3082,,1f08f17e-cc2e-41f4-9b6c-15128244b907,"Dept of Endocrinology O106, Herlev Hospital",dept_of_endocrinology_o106_herlev_hospital,,,,,, +3083,,2a254123-29b6-434d-837a-af00e9988b4b,GOELAMS,goelams,,,,,, +3084,,a5a66260-cfb1-46be-b364-a73832fe330a,ErasmusMC-University Medical Center Rotterdam,erasmusmc_university_medical_center_rotterdam,,,,,, +376,0.95499825477600098,105bd662-3e0a-487f-94e5-81782ae2a384,"Merck Sharp & Dohme Corp., una filial de Merck & Co., Inc",merck_sharp_dohme_corp_una_filial_de_merck_co_inc,,,,105bd662-3e0a-487f-94e5-81782ae2a384,merck_sharp_dohme_corp_una_filial_de_merck_co_inc,"Merck Sharp & Dohme Corp., una filial de Merck & Co., Inc" +3085,,63e9368d-68f0-438a-966a-b7413a36b5a8,Alios BioPharma,alios_biopharma,,,,,, +3086,,292064b6-780a-4123-bbb2-f401259b845c,"Schering Plough Institute, A Division of Schering Corporation",schering_plough_institute_a_division_of_schering_corporation,,,,,, +973,0.987557,a5b646ac-af3e-4961-8e78-b8f46d68415c,"Cutanea Life Sciences, Inc",cutanea_life_sciences_inc,,,,9333210d-087c-420a-b3c2-e6d678ea9766,cutanea_life_sciences,Cutanea Life Sciences +3087,,01827836-7129-11e6-a89e-0242ac12000b,INWOOD LABS,inwood_labs,,,,,, +3088,,2a60ac96-f361-43f8-a53d-5477ced2e7de,AZIENDA USL DI FORLI`,azienda_usl_di_forli,,,,,, +3089,,a30cbc20-5e20-4cc1-b407-a7e4ac8c4a05,University Hospital Of North Staffordshire,university_hospital_of_north_staffordshire,,,,,, +3090,,20adcb50-ad37-4eb8-86d0-b05e40e48460,A.C.R.A.F. S.p.A,a_c_r_a_f_s_p_a,,,,,, +3091,,7d4f965b-dde1-4254-86b7-7bd25a753546,"Medizinische Universität Wien, Univ.Klinik für Notfallmedizin",medizinische_universit_t_wien_univ_klinik_f_r_notfallmedizin,,,,,, +3092,,4455070a-7142-11e6-a0cd-0242ac12000b,APOTHEKERNES,apothekernes,,,,,, +525,0.98547,92847265-b43d-4060-94ca-5cc75acad0a3,"University Hospital of Wuerzburg, Medical Director",university_hospital_of_wuerzburg_medical_director,,,,254a684e-a281-4ecf-989d-ea9a018d8552,university_hospital_of_wuerzburg,University Hospital of Wuerzburg +3093,,39455995-5ac9-469e-939a-4c807771318c,Fundacion para la Investigación Biomédica del Hospital Gregorio Marañón,fundacion_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,,,,,, +111,0.90460896492004395,a2735ed0-5aeb-43b7-932c-5c550bb60e38,"Department of Oncology, Lund University Hospital",department_of_oncology_lund_university_hospital,,,,305770d0-2dc9-4f31-ad46-773cf169b699,department_of_oncology_sk_ne_university_hospital_lund,"Department of Oncology, Skåne University Hospital Lund" +3094,,a756494f-8dcd-4d61-97fb-2ae45dc32e74,Klinik und Poliklinik für Neurologie der Universität Regensburg am Bezirksklinikum,klinik_und_poliklinik_f_r_neurologie_der_universit_t_regensburg_am_bezirksklinikum,,,,,, +3095,,b25d87dd-b6ce-4774-b85a-ca965c0ddc25,"Pfizer Inc., 235 42nd Street, New York, NY 10017, USA",pfizer_inc_235_42nd_street_new_york_ny_10017_usa,,,,,, +3096,,4dfbbcba-d32c-4d33-ac82-6ccfd1e885be,LIGHT SCIENCES ONCOLOGY,light_sciences_oncology,,,,,, +3097,,b58a63dc-67bf-4f04-a31b-a463815f7fa0,Pharmion Corporation,pharmion_corporation,,,,,, +3098,,c11ed538-72f3-11e6-a0cd-0242ac12000b,AVANIR PHARMS,avanir_pharms,,,,,, +3099,,e7db3ec5-e090-4aa0-ab2c-361f627eada6,Dermal Laboratories Ltd,dermal_laboratories_ltd,,,,,, +3100,,718dcfcc-27da-4f5c-92f9-260997b382aa,Panacea Biotec Ltd,panacea_biotec_ltd,,,,,, +3101,,835a99dc-a477-4f73-aa41-7882b2913a9d,"Biogen Idec Inc., 9 Fourth Avenue,Waltham, MA 02451, USA",biogen_idec_inc_9_fourth_avenue_waltham_ma_02451_usa,,,,,, +944,0.98510605096817017,d377a9a0-b92b-4a59-a766-34cb27160196,"Georg-August-Universität Göttingen, Universitätsmedizin",georg_august_universit_t_g_ttingen_universit_tsmedizin,,,,bc3fb171-d422-4044-ae7a-9a9bc31f9e22,georg_august_universit_t_g_ttingen,Georg-August-Universität Göttingen +782,0.985647,0b630147-5207-4370-96bb-646e858f6049,Pfizer Corporation Austria Ges.m.b.H,pfizer_corporation_austria_ges_m_b_h,,,,0b630147-5207-4370-96bb-646e858f6049,pfizer_corporation_austria_ges_m_b_h,Pfizer Corporation Austria Ges.m.b.H +3102,,99c97c7b-dbe4-433a-aab5-8ca916a438c2,University College London Comprehensive Clinical Trials Unit,university_college_london_comprehensive_clinical_trials_unit,,,,,, +3103,,1af9aca2-0d83-430d-a5c7-b7423ccacd2d,"Institute for Social Medicine, Epidemiology, and Health Economics, Charité Berlin",institute_for_social_medicine_epidemiology_and_health_economics_charit_berlin,,,,,, +3104,,1bb109b3-d204-4eda-914b-32cb64215481,AZIENDA OSPEDALIERA ISTITUTI CLINICI DI PERFEZIONAMENTO DI MILANO,azienda_ospedaliera_istituti_clinici_di_perfezionamento_di_milano,,,,,, +3105,,b49ec2fc-f646-4e22-948b-5c7f27600418,Liverpool Heart and Chest Hospital,liverpool_heart_and_chest_hospital,,,,,, +3106,,900bad2a-b594-4559-9101-dfc0c5c3e77e,Beaufour Ipsen Pharma S.A.S,beaufour_ipsen_pharma_s_a_s,,,,,, +3107,,cd88e3be-6ef2-4fc2-9026-74f68a76672a,University Hospital Ghent,university_hospital_ghent,,,,,, +3108,,18eebb1c-45a0-475a-9b9b-c3c37274bd01,Bonaventura Clotet Sala,bonaventura_clotet_sala,,,,,, +3109,,c43e0cf9-f34c-4d9c-a3f3-e1c5b91d52ee,Derby Hospitals NHS Foundation Trust,derby_hospitals_nhs_foundation_trust,,,,,, +3110,,3e199cf3-4de5-4ed4-a227-b892f4f34c48,"Laboratorios SOPHIA, S.A. de C.V",laboratorios_sophia_s_a_de_c_v,,,,,, +3111,,39c1e28e-93e4-4287-bdd3-b1b99883f69d,ARCHIMEDES,archimedes,,,,,, +601,0.969108,3c28acd6-a12e-4774-8da0-312d8e4ff6e8,CHU de Saint-Etienne,chu_de_saint_etienne,,,,0cbd210d-2ea8-4bc2-85dc-5959ed1c55ad,chu_de_saint_tienne,CHU de Saint-Étienne +3112,,c22e87f5-cc87-498c-b01e-3bf1be388591,"Med. Universitaetsklinik Graz, ao Univ. Professor Dr. med. Thomas C. Wascher",med_universitaetsklinik_graz_ao_univ_professor_dr_med_thomas_c_wascher,,,,,, +3113,,582b1df0-7bc7-4fd3-8abf-52e44509c37c,Abeona Therapeutics Inc,abeona_therapeutics_inc,,,,,, +3114,,d109f3e7-f096-42fc-b11a-ce2dc0c705ce,Professor Krzysztof Tadeusz Drzewiecki,professor_krzysztof_tadeusz_drzewiecki,,,,,, +3115,,d3bb7e20-7141-11e6-a0cd-0242ac12000b,AMEDRA PHARMS,amedra_pharms,,,,,, +3116,,779b0eb0-114c-42eb-b34e-f7338ced8024,NHS Greater Glasgow & Clyde and University of Glasgow,nhs_greater_glasgow_clyde_and_university_of_glasgow,,,,,, +1073,0.987562,a0dd21db-1c17-47e9-af2f-92349a9503ac,Akershus University Hospital,akershus_university_hospital,,,,a0dd21db-1c17-47e9-af2f-92349a9503ac,akershus_university_hospital,Akershus University Hospital +3117,,afec5f88-f508-4b2e-9ad8-d69dfc8e2316,FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS,fundacion_para_la_investigacion_biomedica_del_hospital_universitario_principe_de_asturias,,,,,, +3118,,5e5896b1-bb42-47d6-b852-1787775ff234,Fondazione Melanoma ONLUS,fondazione_melanoma_onlus,,,,,, +134,0.984688,61bbf47c-775e-4ef4-9782-861df4424a72,University Hospitals Bristol NHS Foundation Trust,university_hospitals_bristol_nhs_foundation_trust,,,,61bbf47c-775e-4ef4-9782-861df4424a72,university_hospitals_bristol_nhs_foundation_trust,University Hospitals Bristol NHS Foundation Trust +3119,,26305a38-7163-11e6-a0cd-0242ac12000b,HISUN PHARM HANGZHOU,hisun_pharm_hangzhou,,,,,, +3120,,66bb86e7-bb9c-4c05-9d23-2538b1fad491,"CRC, Medical Department IV, University Erlangen-Nuremberg",crc_medical_department_iv_university_erlangen_nuremberg,,,,,, +3121,,67fea2b2-715e-11e6-a0cd-0242ac12000b,WHITEWORTH TOWN PLSN,whiteworth_town_plsn,,,,,, +3122,,2518a70c-726e-11e6-a0cd-0242ac12000b,ASCEND THERAPS US,ascend_theraps_us,,,,,, +3123,,2f119216-7145-11e6-a0cd-0242ac12000b,WOCKHARDT EU OPERATN,wockhardt_eu_operatn,,,,,, +3124,,1ab1d5c1-2c05-4114-924b-f9432abf02dd,AZIENDA OSPEDALIERA OSPEDALI GALLIERA,azienda_ospedaliera_ospedali_galliera,,,,,, +3125,,c18e20f1-06e1-48cb-9fbc-cf44ae2b0a8f,Tecnical University of Munich,tecnical_university_of_munich,,,,,, +3126,,d9ca433c-85d2-441f-9d57-4e5720e6225a,Fundación Grupo Español de Investigación en Cáncer de Mama (Fundación GEICAM),fundaci_n_grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama_fundaci_n_geicam,,,,,, +3127,,c2904f7f-5609-4d6a-aa73-c25676315aae,Merck Sharp & Dohme Ireland (Human Health) Limited,merck_sharp_dohme_ireland_human_health_limited,,,,,, +3128,,020fbdb0-10e3-4964-ba6b-0af8ed387b6c,Elan Pharma International Ltd,elan_pharma_international_ltd,,,,,, +3129,,bace2f9e-adec-4f6a-9e55-32cbe088ffb9,Oryx GmbH & Co KG,oryx_gmbh_co_kg,,,,,, +3130,,fc377e76-7146-11e6-a0cd-0242ac12000b,DORADO PHARMA,dorado_pharma,,,,,, +3131,,f601e336-66cd-4130-8c58-d2e52fea1133,Prof Jes Olesen,prof_jes_olesen,,,,,, +712,0.98916232585906982,38c6b681-96aa-439b-8189-1ea1e741e51b,Reckitt Benckiser Healthcare International,reckitt_benckiser_healthcare_international,,,,38c6b681-96aa-439b-8189-1ea1e741e51b,reckitt_benckiser_healthcare_international,Reckitt Benckiser Healthcare International +3132,,1bda6118-5a6e-4a2e-b021-c4b71693772b,Aintree University Hospitals NHS Trust,aintree_university_hospitals_nhs_trust,,,,,, +3133,,f107ea59-ed85-4273-b768-0e2c3184e560,CYTAVIS BioPharma GmbH,cytavis_biopharma_gmbh,,,,,, +743,0.978585,cae36710-5446-4e30-a773-3bb7f409ba33,Population health Research Institute,population_health_research_institute,,,,a57f06eb-3ab3-4751-a94f-5b412b84bbb7,population_health_research_institute_phri,Population Health Research Institute (PHRI) +3134,,5da3c684-3ba0-4801-a5ed-56343bc5cc09,"Agile Therapeutics, Inc",agile_therapeutics_inc,,,,,, +3135,,eeb7827d-8399-43f7-8cc5-5d1bef4102a5,"Department of Anesthesiology and Intensive Care, University Hospital Münster",department_of_anesthesiology_and_intensive_care_university_hospital_m_nster,,,,,, +434,0.9664912223815918,828072f6-88b3-464e-b218-539be8854135,"Pfizer Inc., 235 East 42nd Street, New York, NY 110017",pfizer_inc_235_east_42nd_street_new_york_ny_110017,,,,0068e377-8873-41b9-baad-e3768b77d0b1,pfizer_inc_235_east_42nd_street_new_york_ny_10017,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017" +178,0.914111,6cb03c75-a5d8-4c11-999f-9a0d26e68ba1,Nottingham Univeristy Hospitals NHS Trust,nottingham_univeristy_hospitals_nhs_trust,,,,6cb03c75-a5d8-4c11-999f-9a0d26e68ba1,nottingham_univeristy_hospitals_nhs_trust,Nottingham Univeristy Hospitals NHS Trust +848,0.928667,c292a342-b266-4a04-9816-329eda28532a,Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis (NKI-AVL),nederlands_kanker_instituut_antoni_van_leeuwenhoek_ziekenhuis_nki_avl,,,,c292a342-b266-4a04-9816-329eda28532a,nederlands_kanker_instituut_antoni_van_leeuwenhoek_ziekenhuis_nki_avl,Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis (NKI-AVL) +3136,,98cd0fcf-9ab2-4e3a-abe3-635cbc7c588f,N-Gene Research & Development Ltd,n_gene_research_development_ltd,,,,,, +3137,,48ab550e-7168-11e6-a0cd-0242ac12000b,INTERGEL PHARMS INC,intergel_pharms_inc,,,,,, +3138,,31ebb532-07b5-41c5-9280-7dcf0af2e17b,CURALOGIC,curalogic,,,,,, +3139,,04f82d32-5373-4289-af2a-31c3b90184a4,KU Leuven - Drug Delivery & Disposition,ku_leuven_drug_delivery_disposition,,,,,, +3140,,8a5fa188-7142-11e6-a0cd-0242ac12000b,DOW PHARM,dow_pharm,,,,,, +3141,,502fb3bc-f8ac-4503-b8d0-e9e5d7080728,BTG International Ltd,btg_international_ltd,,,,,, +3142,,1c2ea71b-e6f2-4180-ae8f-b74b1ac410fd,Servicio de Endocrinologia y Nutricion. Hospital Universitari Bellvitge,servicio_de_endocrinologia_y_nutricion_hospital_universitari_bellvitge,,,,,, +505,0.977622,f74104ca-7144-11e6-a0cd-0242ac12000b,MEDICIS,medicis,,,,6555c8c6-714d-11e6-a0cd-0242ac12000b,medicis_pharms,MEDICIS PHARMS +3143,,de274e76-18dc-4899-8988-b9e17cafd61c,Medizinische Universität Innsbruck - Univ.-Klinik f. Anästhesie u. Intensivmedizin,medizinische_universit_t_innsbruck_univ_klinik_f_an_sthesie_u_intensivmedizin,,,,,, +3144,,eba81dab-b4b5-4442-b037-bd8524120ff4,"Theravance Biopharma Antibiotics, Inc",theravance_biopharma_antibiotics_inc,,,,,, +3145,,00f4158f-9935-4fce-be58-eab569fee32a,Savara ApS,savara_aps,,,,,, +3146,,bc355355-b121-45ef-b1fa-e091006fda95,FIBICO,fibico,,,,,, +3147,,4807f47a-e9c1-41c1-a3c0-533c07766d5c,Tuomo Nieminen,tuomo_nieminen,,,,,, +3148,,bc94c3ee-953a-4d45-b3e5-95739a297c8c,Christine Fromer Stiftung,christine_fromer_stiftung,,,,,, +3149,,37fcc26c-c3af-4fcf-b8f3-214072365418,University Witten/Herdecke,university_witten_herdecke,,,,,, +3150,,cfdad5f4-7280-11e6-a0cd-0242ac12000b,KING PHARMS LLC,king_pharms_llc,,,,,, +3151,,ab63d321-45a6-4065-b1f2-7438820736ad,Acerta Pharma BV,acerta_pharma_bv,,,,,, +3152,,ba1fecda-76c3-4a19-9459-b08dc5ecc3ea,Pierre Fabre Dermocosmetique,pierre_fabre_dermocosmetique,,,,,, +3153,,33608afa-ac35-4e14-90af-777da0d1793d,Dr. Enrique Martínez López,dr_enrique_mart_nez_l_pez,,,,,, +3154,,b01312eb-5361-49ed-8aea-c65e6acd5390,Cubist Pharmaceuticals LLC,cubist_pharmaceuticals_llc,,,,,, +159,0.96092963218688965,4086c805-4b50-420e-a0f0-bdfb20450ba3,"Medizinische Universität Wien, Univ.Klink f. Innere Medizin I",medizinische_universit_t_wien_univ_klink_f_innere_medizin_i,,,,f520785f-8956-4a25-b64b-588e23b207cb,medizinische_universit_t_wien_univ_klink_f_innere_medizin_i,"Medizinische Universität Wien, Univ.Klink f. Innere Medizin I" +3155,,33bea7e6-326a-4319-b6d7-2afa55ee1879,"Mikko Pitkänen, MD, PhD",mikko_pitk_nen_md_phd,,,,,, +3156,,9bd75d9f-6555-49d9-97e0-0f296b5efadd,Novo Nordisk Pharma S.A,novo_nordisk_pharma_s_a,,,,,, +154,0.927976,925f7b61-cc29-4ed2-a0bc-f6d351384148,"Solvay Pharmaceuticals, GmbH",solvay_pharmaceuticals_gmbh,,,,1bb3b634-770c-4449-a84e-96c6eb88fe69,solvay_pharmaceutical_gmbh,Solvay Pharmaceutical GmbH +3157,,84c9cbeb-6518-48c4-9d44-81c1cb1d03d4,Ferring SAS,ferring_sas,,,,,, +3158,,73f74d94-d9e7-4d64-8e48-55074a8640e9,DIATOS.SA,diatos_sa,,,,,, +3159,,01a34ece-4c10-432c-a459-7a2a04bd3fbd,Ludwig Boltzmann institute for COPD and Respiratory Epidemiology,ludwig_boltzmann_institute_for_copd_and_respiratory_epidemiology,,,,,, +5,0.94206222891807556,cd76c6f4-f2dd-4c7f-88b5-e2b6f2123209,Centre Hospitalier Universitaire de Liège,centre_hospitalier_universitaire_de_li_ge,,,,dd5747ea-816f-45f7-b207-0763f720a969,centre_hospitalier_universitaire_de_li_ge,Centre Hospitalier Universitaire de Liège +3160,,c50763e0-7159-11e6-a0cd-0242ac12000b,OHM LABS INC,ohm_labs_inc,,,,,, +3161,,eb38050b-872c-46f0-8a6f-60172f85827c,"Premacure AB, A member of the Shire Group of Companies",premacure_ab_a_member_of_the_shire_group_of_companies,,,,,, +3162,,2f12f54e-2efd-413c-bbc5-a8f3486d6517,VU University Medical,vu_university_medical,,,,,, +993,0.98589098453521729,97e04c3e-2469-47b3-aea0-8522c32303ca,GE Healthcare,ge_healthcare,,,,97e04c3e-2469-47b3-aea0-8522c32303ca,ge_healthcare,GE Healthcare +3163,,dbeb77c8-d261-4c5e-8337-33268c916b95,Agios Pharmaceuticals Inc,agios_pharmaceuticals_inc,,,,,, +3164,,60aa0446-b010-4c03-82dc-3bc2c09d9268,Fondazione Italiana Linfomi,fondazione_italiana_linfomi,,,,,, +3165,,66613ed0-3224-4f56-a356-06daf1f5e915,GlaxoSmithKline Latvia SIA,glaxosmithkline_latvia_sia,,,,,, +3166,,db61ab1b-e03d-41ea-a0e4-8853fb3d7caf,Avexxin AS,avexxin_as,,,,,, +3167,,5c563798-7147-11e6-a0cd-0242ac12000b,PIRAMAL CRITICAL,piramal_critical,,,,,, +467,0.948148,33f6d476-e36d-47d6-b355-d0aff833ee95,MERRIMACK PHARMACEUTICALS,merrimack_pharmaceuticals,,,,33f6d476-e36d-47d6-b355-d0aff833ee95,merrimack_pharmaceuticals,MERRIMACK PHARMACEUTICALS +3168,,71aab502-b29e-444e-9995-4a6410957992,LOFARMA,lofarma,,,,,, +3169,,50bd8d86-8fa1-4b4e-870a-9a1bdcb3cd30,ALFREDO TAGARRO GARCIA,alfredo_tagarro_garcia,,,,,, +3170,,ca16a151-9d97-4ede-bd89-10cfb91f4bc8,HOSPITAL UNIVERSITARIO SON DURETA. UNIDAD DE INVESTIGACIÓN,hospital_universitario_son_dureta_unidad_de_investigaci_n,,,,,, +82,0.9889298677444458,34927d7f-aaf7-4211-886e-d6c66ea9e027,"Medizinische Universität Wien, Universitätsklinik für Chirurgie",medizinische_universit_t_wien_universit_tsklinik_f_r_chirurgie,,,,34927d7f-aaf7-4211-886e-d6c66ea9e027,medizinische_universit_t_wien_universit_tsklinik_f_r_chirurgie,"Medizinische Universität Wien, Universitätsklinik für Chirurgie" +112,0.97132119536399841,cd164157-9cad-43a7-b033-7b4a8d7de932,Yamanouchi Europe B.V,yamanouchi_europe_b_v,,,,fd7c0ea8-c5da-47db-837d-9b59407dd291,yamanouchi_europe_b_v,Yamanouchi Europe B.V +153,0.980878,dbfc9a71-22be-491f-b043-91e600c1a3a9,Lung Rx,lung_rx,,,,18f855d3-a347-4059-9f52-8c87407690f3,lung_rx_inc,Lung Rx Inc +3171,,a691f011-7a5a-40a1-babf-b3657f5fd647,AC Immune SA,ac_immune_sa,,,,,, +3172,,d92f75de-af1d-4a08-ad18-a13279814f30,CREPATS,crepats,,,,,, +489,0.94924008846282959,f2f09bbb-e879-4f9f-b342-434a12824df1,STEBA BIOTECH SA,steba_biotech_sa,,,,556aa12c-fe7a-4155-adda-e25a9fdaf844,steba_biotech_s_a,STEBA BIOTECH S.A +3173,,66da3a92-3b54-467d-99fb-afe7a518ff17,Novartis Finland OY,novartis_finland_oy,,,,,, +3174,,2b5c9b2c-72ec-11e6-a0cd-0242ac12000b,IPSEN INC,ipsen_inc,,,,,, +3175,,04ee0b01-caa9-4d90-a0fe-64e33688a06b,GlaxoSmithKline AS,glaxosmithkline_as,,,,,, +3176,,434da454-aeec-469b-8ccf-a8a1cccda5b3,"(OSI) Eyetech, Inc",osi_eyetech_inc,,,,,, +3177,,0d03e9d2-ce6c-439a-bfc1-1234ffa506d8,OxThera Intellectual Property AB,oxthera_intellectual_property_ab,,,,,, +3178,,1f2f9631-9c70-499a-b140-9d50f3237752,"Erasmusm MC, Rotterdam, The Netherlands",erasmusm_mc_rotterdam_the_netherlands,,,,,, +3179,,1c3406b8-c992-4a56-b709-967ddc583159,Therakind Limited,therakind_limited,,,,,, +988,0.960341,2cbebc88-9b76-4642-b406-d5374c2aabfa,Department of Cardiothoracic and Vascular Surgery,department_of_cardiothoracic_and_vascular_surgery,,,,2cbebc88-9b76-4642-b406-d5374c2aabfa,department_of_cardiothoracic_and_vascular_surgery,Department of Cardiothoracic and Vascular Surgery +3180,,c927a4bc-7145-11e6-a0cd-0242ac12000b,NORBROOK,norbrook,,,,,, +3181,,5b7a24a3-9d09-45ac-bd9f-8cda0b4b21fe,Universitätslehrkrankenhaus Hall in Tirol,universit_tslehrkrankenhaus_hall_in_tirol,,,,,, +3182,,7893e559-898b-4248-b4de-975672a75de9,"Pharmasset, Inc",pharmasset_inc,,,,,, +3183,,c9f483d0-cff1-41d6-a567-d2bd52a74c3e,SANFILIPPO Therapeutics SAS,sanfilippo_therapeutics_sas,,,,,, +3184,,8b1b7aaf-8765-40f9-9937-ec1a8f0ad450,AUSL DI MODENA,ausl_di_modena,,,,,, +421,0.98224687576293945,91fae256-199c-4920-9cd2-0437b5db434d,"Rigshospitalet, afd. 2034",rigshospitalet_afd_2034,,,,91fae256-199c-4920-9cd2-0437b5db434d,rigshospitalet,Rigshospitalet +3185,,c3f8f83c-73da-11e6-a0cd-0242ac12000b,ANACOR PHARMS INC,anacor_pharms_inc,,,,,, +3186,,19b8f044-ece8-4f39-aa23-ef8a38339159,"OptiNose US, Inc",optinose_us_inc,,,,,, +3187,,423a5519-8e91-4c33-a2e5-24a3d1d0b7ef,CHIRON,chiron,,,,,, +611,0.98173725605010986,eec7a1a9-acc8-4f30-8310-18451b5c2334,Erasmus MC,erasmus_mc,,,,e38a4be1-bb34-4ac4-9394-24f70e28cd5a,erasmus_mc_sophia,Erasmus MC Sophia +3188,,5b87ed80-5396-42ab-9256-63893284d85a,Wilson Therapeutics AB,wilson_therapeutics_ab,,,,,, +665,0.98638424277305603,360f8005-b204-4f00-91ff-535dfce2bdaf,Charité-Universitätsmedizin,charit_universit_tsmedizin,,,,f6d48103-0f0c-4464-8cd2-7589fc1def08,charit_universit_tsmedizin,Charité-Universitätsmedizin Berlin +799,0.97013264894485474,a3666a53-f0b3-41b0-b2d4-ff9661179fe8,Technische Universitaet München Fakultaet fuer Medizin,technische_universitaet_m_nchen_fakultaet_fuer_medizin,,,,a138a709-186c-4945-a784-d6f9bf6980b4,technische_universitaet_muenchen_fakultaet_fuer_medizin,Technische Universitaet Muenchen Fakultaet fuer Medizin +3189,,89218290-906c-41e8-b1d4-ca0387fe7e39,Lékařská fakulta Univerzity Karlovy v Hradci Králové,l_ka_sk_fakulta_univerzity_karlovy_v_hradci_kr_lov,,,,,, +3190,,c93bba30-7157-11e6-a0cd-0242ac12000b,PARENTA PHARMS,parenta_pharms,,,,,, +568,0.971368,982f23cd-4b55-47cc-8aa1-f7a5c248cabf,Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,fondazione_irccs_ca_granda_ospedale_maggiore_policlinico,,,,2a99366d-c8b5-4d6b-a57e-00e956554937,fondazione_irccs_c_granda_ospedale_maggiore_policlinico,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico +3191,,d5e0fa17-34e2-4882-8864-a39e548adfff,CIBERES (Centro de Investigación Biomédica en Red Enfermedades Respiratorias),ciberes_centro_de_investigaci_n_biom_dica_en_red_enfermedades_respiratorias,,,,,, +3192,,f00c6663-8894-4381-b1e1-a569f155dd25,Marshall Edwards Pty Limited,marshall_edwards_pty_limited,,,,,, +3193,,b7e0fc84-aa3a-4e18-ba72-03380623b29f,ZS Pharma Inc,zs_pharma_inc,,,,,, +3194,,8ab5ee98-715c-11e6-a0cd-0242ac12000b,ALTAIRE PHARMS INC,altaire_pharms_inc,,,,,, +3195,,a07b3a8c-88dc-4a5c-84a1-c73212b21695,"ORTHO BIOTECH, Geschäftsbereich der JANSSEN-CILAG GmbH",ortho_biotech_gesch_ftsbereich_der_janssen_cilag_gmbh,,,,,, +3196,,985492e0-d2a5-48f1-b5c7-808f3984f037,Radboud University Medical Centre Nijmegen,radboud_university_medical_centre_nijmegen,,,,,, +3197,,490ea87e-ffab-4b60-80fc-c16fa302bee8,"University of Birmingham, Research & Enterprise Services",university_of_birmingham_research_enterprise_services,,,,,, +885,0.98101651668548584,90979692-2a94-4a4b-9c9c-f6c047edea3e,Pharma Mar SA Unipersonal,pharma_mar_sa_unipersonal,,,,5821cf6c-5e8a-481f-8ff8-3198a9183cea,pharma_mar_sa,Pharma Mar SA +3198,,e0a8e402-df7e-43d9-bc5c-871a46ad3ff6,Anders Troelsen,anders_troelsen,,,,,, +3199,,51dfa822-b7a8-433d-b8a6-aea95c0b0c63,Opsona Therapeutics Ltd,opsona_therapeutics_ltd,,,,,, +3200,,ddfc954d-13f8-4b36-9cb0-ca28ea3b58d6,Laboratoires Ethypharm,laboratoires_ethypharm,,,,,, +3201,,d86baf94-7141-11e6-a0cd-0242ac12000b,ORIT LABS LLC,orit_labs_llc,,,,,, +3202,,045f43dd-7e77-4f03-8618-c3474d27467b,"Bavarian Nordic, Inc",bavarian_nordic_inc,,,,,, +3203,,c2fa5f4e-2c85-49bf-9c31-f227601f53c5,Chiesi Pharmaceuticals Inc,chiesi_pharmaceuticals_inc,,,,,, +3204,,b11fc304-a5d6-4351-a375-a1117e9c2651,Agis Industries (1983) ltd,agis_industries_1983_ltd,,,,,, +3205,,2cfec5b9-f199-44c6-9604-2c64d14b0026,Dr Alberto Domínguez-Rodríguez,dr_alberto_dom_nguez_rodr_guez,,,,,, +3206,,737f539a-7189-11e6-a0cd-0242ac12000b,"THROMBOGENICS, INC",thrombogenics_inc,,,,,, +3207,,7291017e-bffe-407c-b3c7-4ef1e66901b2,Laboratoire LABCATAL,laboratoire_labcatal,,,,,, +3208,,8e491fde-3b05-4e78-8a9c-9675dfaddca7,"Johns Hopkins University (Prof. Daniel Daniel F. Hanley, MD)",johns_hopkins_university_prof_daniel_daniel_f_hanley_md,,,,,, +3209,,4842d03e-64f0-4a7c-b508-98c7000c06e2,Dr. Llombart Cussac,dr_llombart_cussac,,,,,, +3210,,cb4bd689-1eda-4415-932d-2961ebfb2d4c,FISEVI Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla,fisevi_fundaci_n_p_blica_andaluza_para_la_gesti_n_de_la_investigaci_n_en_salud_de_sevilla,,,,,, +3211,,3514c539-7c74-43e5-92ed-b8b93b67798b,"Telik, Inc",telik_inc,,,,,, +799,0.97013264894485474,a138a709-186c-4945-a784-d6f9bf6980b4,Technische Universitaet Muenchen Fakultaet fuer Medizin,technische_universitaet_muenchen_fakultaet_fuer_medizin,,,,a138a709-186c-4945-a784-d6f9bf6980b4,technische_universitaet_muenchen_fakultaet_fuer_medizin,Technische Universitaet Muenchen Fakultaet fuer Medizin +656,0.985689,1dc11f6f-51cc-4072-9340-b3162a901b0e,Daniel Podzamczer Palter,daniel_podzamczer_palter,,,,1dc11f6f-51cc-4072-9340-b3162a901b0e,daniel_podzamczer_palter,Daniel Podzamczer Palter +3212,,638f955f-98a5-4d48-ae50-b7cf082324d8,"Dept. of Ophthalmology, Medical University of Vienna",dept_of_ophthalmology_medical_university_of_vienna,,,,,, +911,0.955326,6fe95abc-39e9-4d47-999a-8959adcc1009,DIATER Laboratorio de Diagnostico y Aplicaciones Terapéuticas S.A,diater_laboratorio_de_diagnostico_y_aplicaciones_terap_uticas_s_a,,,,6fe95abc-39e9-4d47-999a-8959adcc1009,diater_laboratorio_de_diagnostico_y_aplicaciones_terap_uticas_s_a,DIATER Laboratorio de Diagnostico y Aplicaciones Terapéuticas S.A +3213,,373cece7-ad91-4802-9636-351d784a7129,"Meiji Seika Kaisha, Ltd",meiji_seika_kaisha_ltd,,,,,, +3214,,a7065a2d-76e0-4289-868d-f6da3bf177b6,Verona Pharma plc,verona_pharma_plc,,,,,, +3215,,a886aae6-7163-11e6-a0cd-0242ac12000b,HANDA PHARMS,handa_pharms,,,,,, +3216,,1c17552e-5a1a-49a0-9770-36a6738d8aa1,Diurnal Ltd,diurnal_ltd,,,,,, +3217,,e1a183f8-3553-4386-836a-ff901673438c,Heart Center Freiburg - Bad Krozingen,heart_center_freiburg_bad_krozingen,,,,,, +3218,,87c58ad5-58ec-48b8-b615-07a02328ed90,Universitair Ziekenhuis Brussel,universitair_ziekenhuis_brussel,,,,,, +502,0.955255,569a1285-cdde-46ac-ab93-f30a3f2406e3,Aalborg Universitetshospital,aalborg_universitetshospital,,,,569a1285-cdde-46ac-ab93-f30a3f2406e3,aalborg_universitetshospital,Aalborg Universitetshospital +3219,,d5475e48-7810-402e-bf81-94348a6dd7c3,Johnson&Johnson Pharmaceutical Research and Development,johnson_johnson_pharmaceutical_research_and_development,,,,,, +3220,,f91d3320-5415-4e50-8d68-0165e45c4ba6,to-BBB technologies B.V,to_bbb_technologies_b_v,,,,,, +3221,,c9143cd1-1c37-489a-b032-f30a40444853,PLIVA - ISTRAŽIVANJE I RAZVOJ d.o.o,pliva_istra_ivanje_i_razvoj_d_o_o,,,,,, +3222,,c683d897-21f7-4587-a80c-c7efb76f2dce,"Schwarz Biosciences GmbH, UCB Group",schwarz_biosciences_gmbh_ucb_group,,,,,, +3223,,6237398e-7145-11e6-a0cd-0242ac12000b,J AND J CONSUMER INC,j_and_j_consumer_inc,,,,,, +3224,,bfa3d191-c002-4610-b69d-1921444b0964,Mads Werner,mads_werner,,,,,, +191,0.98649922013282776,d99244bd-ec4a-4174-ad00-95de8ef6a5a2,CESAR Central European Society for Anticancer Drug Research-EWIV,cesar_central_european_society_for_anticancer_drug_research_ewiv,,,,4042f330-66f0-40ec-8288-db80eef6363c,cesar_central_european_society_for_anticancer_drug_research,CESAR Central European Society for Anticancer Drug Research +3225,,204f89a5-cb72-4ddf-b303-7cba8abc6958,AGMT: Arbeitsgemeinschaft Medikamentöse Tumortherapie,agmt_arbeitsgemeinschaft_medikament_se_tumortherapie,,,,,, +3226,,b62bc76b-b663-4f8b-b430-1aec092b1b89,"Barts and the London NHS Trust, Department of Cardiology",barts_and_the_london_nhs_trust_department_of_cardiology,,,,,, +3227,,400f291b-84c7-42c3-864c-87cbe3a58255,Novartis Pharma NV,novartis_pharma_nv,,,,,, +1067,0.987607,29f3e0c0-134d-4f9b-952a-e3adc9a976d6,Generex Biotechnology Corporation,generex_biotechnology_corporation,,,,10ff3385-cf4c-44ce-8eb9-d60620664cbb,generex_biotechnology_corp,Generex Biotechnology Corp +3228,,8be67cb6-0be1-4cd2-9c2f-aed7a772df7f,Minna Tallgren,minna_tallgren,,,,,, +3229,,247a94c6-427c-4137-b55f-c1c12f7d6bdc,Erasme Hostpital - ULB,erasme_hostpital_ulb,,,,,, +888,0.97912924630301335,396cf7e8-b821-4caf-9fc9-ab2366cd9a70,"Schering-Plough Research Institute, a Division of Schering Corporation",schering_plough_research_institute_a_division_of_schering_corporation,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" +3230,,b8629c10-73e1-11e6-a0cd-0242ac12000b,FSC THERAP,fsc_therap,,,,,, +3231,,9ab9f170-f805-4f3b-a2c6-200ffeef38e7,Dr. Miquel Gómez. Servicio de Cardiología. Hospital del Mar,dr_miquel_g_mez_servicio_de_cardiolog_a_hospital_del_mar,,,,,, +379,0.9485869208971659,ca9aff82-819f-4039-bd0c-6f8f4e8abebe,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as the SPONSOR or Merck)",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_hereafter_referred_to_as_the_sponsor_or_merck,,,,b80f486c-a6f1-447b-bad6-34ea6d49fec0,merck_sharp_dohm_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as the SPONSOR or Merck)" +3232,,1be2680f-aca4-4686-9a32-4f02d5fd5f1b,Finnish melanoma group,finnish_melanoma_group,,,,,, +3233,,7e3fe287-9b32-4c0d-8b82-3875986839aa,"Karolinska University Hospital, Department of Molecular medicine and Surgery Karolinska Institutet, Gastrocentrum",karolinska_university_hospital_department_of_molecular_medicine_and_surgery_karolinska_institutet_gastrocentrum,,,,,, +3234,,5e6801ff-9279-4103-bcd8-89b16d4a0f39,Suffolk Mental Health Partnerships Trust,suffolk_mental_health_partnerships_trust,,,,,, +3235,,b8f6c95a-7141-11e6-a0cd-0242ac12000b,MYLAN IRELAND LTD,mylan_ireland_ltd,,,,,, +3236,,7dfbd0d6-0af0-4487-a179-f602b5d014e1,Health Protection Agency,health_protection_agency,,,,,, +3237,,063ea64c-b4fe-4161-9b3e-8b54fc191541,"A.I.Virtanen Insitute, University of Kuopio",a_i_virtanen_insitute_university_of_kuopio,,,,,, +3238,,2a509302-7141-11e6-a0cd-0242ac12000b,COREPHARMA,corepharma,,,,,, +3239,,96a96688-af5d-4355-9d72-073f4dc3c065,CRESIB- International Research Center in Health of Barcelona,cresib_international_research_center_in_health_of_barcelona,,,,,, +3240,,b748c6cf-c6b8-453c-8044-7045286bebaf,Fundación Biomédica del CHUVI,fundaci_n_biom_dica_del_chuvi,,,,,, +3241,,1854a760-2df3-4aad-9440-c8bd8732230b,ABCSG GmbH,abcsg_gmbh,,,,,, +3242,,5903fda0-65d1-4220-a2c2-2534b1a96db0,"National Institute of Public Health and Environment (RIVM, the Netherlands)",national_institute_of_public_health_and_environment_rivm_the_netherlands,,,,,, +3243,,5cb07fbb-a36f-4615-9a1f-64ab4e7d8cb9,Merckle GmbH,merckle_gmbh,,,,,, +3244,,edacff64-dc0d-4e30-a23f-18422248a45f,Ecron Acunova GmbH,ecron_acunova_gmbh,,,,,, +3245,,5fd55442-9cec-44ee-9d26-bbf08fe3c7cd,"Med. Univ. Wien, Klinik für Dermatologie",med_univ_wien_klinik_f_r_dermatologie,,,,,, +3246,,25cdee70-c643-493d-9c32-6923ad38fb79,University of Texas Health Science Center,university_of_texas_health_science_center,,,,,, +3247,,cbb1af8d-0ee3-40f6-ba6e-8b9d66b66c35,Genethon,genethon,,,,,, +3248,,e26b082b-a3c8-4bce-972c-0d6f2dd16a13,University of Calgary,university_of_calgary,,,,,, +399,0.988953,33290af1-5e28-4e4a-85eb-2b145405dc27,Groupe Francophone des Myélodysplasies,groupe_francophone_des_my_lodysplasies,,,,33290af1-5e28-4e4a-85eb-2b145405dc27,groupe_francophone_des_my_lodysplasies,Groupe Francophone des Myélodysplasies +3249,,00719da6-204e-49df-b9f4-899b6e50d72f,Trio Medicines Ltd,trio_medicines_ltd,,,,,, +3250,,bad6f458-f12e-49f5-9051-412d81333d41,Guys & St. Thomas' NHS Foundation Trust,guys_st_thomas_nhs_foundation_trust,,,,,, +708,0.984864,3e40eb72-7165-11e6-a0cd-0242ac12000b,NOVAST LABS,novast_labs,,,,3e40eb72-7165-11e6-a0cd-0242ac12000b,novast_labs,NOVAST LABS +3251,,f3e092c8-9d99-4b98-90f6-7e4e1f85e7e1,Turku University Hospital,turku_university_hospital,,,,,, +3252,,3007e2fe-4fce-4a9b-9236-466c5b7e4345,Göteborgs universitet,g_teborgs_universitet,,,,,, +3253,,12058919-dcf3-49df-a3d7-909ea5da6f88,PALAU PHARMA SA,palau_pharma_sa,,,,,, +3254,,7712aec8-6345-474f-a9fa-eb8f84380ac2,Sandwell Medical Research Unit,sandwell_medical_research_unit,,,,,, +3255,,ce3d80a7-a107-405f-9546-bfebb13dab31,"Prof. Sechtem, Department of Cardiology, Robert Bosch Hospital",prof_sechtem_department_of_cardiology_robert_bosch_hospital,,,,,, +3256,,f6679532-83e6-468e-94a1-2a09e882f9b7,"IRCCS - Istituto di Ricerche Farmacologiche ""Mario Negri",irccs_istituto_di_ricerche_farmacologiche_mario_negri,,,,,, +3257,,aab6e0d2-6ce5-4bf7-9de9-3e300477886b,Prof V Lund,prof_v_lund,,,,,, +132,0.986058,6f18faf0-7147-11e6-a0cd-0242ac12000b,AMPHASTAR PHARMS INC,amphastar_pharms_inc,,,,6f18faf0-7147-11e6-a0cd-0242ac12000b,amphastar_pharms_inc,AMPHASTAR PHARMS INC +3258,,ad19ac1c-96ab-11e6-becf-0242ac110008,WINDTREE THERAP,windtree_therap,,,,,, +3259,,7525628c-3df2-4db4-824d-3c842794991b,Scandinavian Sarcoma Group,scandinavian_sarcoma_group,,,,,, +3260,,c6b6a71b-1a3b-4791-b3f9-8d2ad614f5cc,Tartu Ülikooli kardioloogiakliinik,tartu_likooli_kardioloogiakliinik,,,,,, +3261,,a28cf75f-8b5e-45d6-8a74-cbd575537b0c,SERVICIO NEFROLOGIA HOSPITAL BELLVITGE,servicio_nefrologia_hospital_bellvitge,,,,,, +3262,,1b926dc4-54d4-4fd2-8741-eba57291c769,dipartimento di neurologia e psichiatria,dipartimento_di_neurologia_e_psichiatria,,,,,, +3263,,40cbc10e-a56d-468c-a911-90f32d10b564,ROTTAPHARM / ROTTA RESEARCH LABORATORIUM,rottapharm_rotta_research_laboratorium,,,,,, +3264,,ec98ae30-73f9-11e6-a0cd-0242ac12000b,MSD MERCK CO,msd_merck_co,,,,,, +3265,,1eb5ceb1-46ec-440a-a1fc-7abaf2b2e929,Gastroenterology CHC Liege,gastroenterology_chc_liege,,,,,, +3266,,79e8cf98-3cc5-4e99-b63e-ce25c5612e8c,"Sapienza"" University of Rome",sapienza_university_of_rome,,,,,, +3267,,1e18652f-6415-439d-be91-f573e65a72dd,LABCATAL,labcatal,,,,,, +3268,,32dd8a0c-3f6e-47f2-94f2-82b905b171b7,BioArctic Neuroscience AB,bioarctic_neuroscience_ab,,,,,, +3269,,cf4f4678-73f8-11e6-a0cd-0242ac12000b,CEE KAY SUPPLY,cee_kay_supply,,,,,, +138,0.975844,5739df1e-d602-413b-9853-34dc83584168,"Takeda Global Research & Development Center, Inc.,",takeda_global_research_development_center_inc,,,,5739df1e-d602-413b-9853-34dc83584168,takeda_global_research_development_center_inc,"Takeda Global Research & Development Center, Inc.," +3270,,99c0e42d-8445-4f43-bf9a-3428bbca8bfc,CELL THERAPEUTICS EUROPE S.r.l,cell_therapeutics_europe_s_r_l,,,,,, +3271,,b9d8d9f0-727a-11e6-a0cd-0242ac12000b,INST BIOCHEM,inst_biochem,,,,,, +3272,,3f4da7a9-e745-4bc1-9384-dee2274a2ab8,Finox AG,finox_ag,,,,,, +3273,,3efff714-eecc-4b42-b83f-20da261041f0,Region Östergötland,region_sterg_tland,,,,,, +3274,,ca545cdd-25de-4707-96d3-4b980fd55a97,"Prof. Ola Winsö, Anesthesia and Intensive Care Medicine, Norrlands University Hospiatal",prof_ola_wins_anesthesia_and_intensive_care_medicine_norrlands_university_hospiatal,,,,,, +3275,,aec5e4f2-f68e-41e9-b231-36d5b68a84a5,KKRN Katholisches Klinikum Ruhrgebiet Nord GmbH,kkrn_katholisches_klinikum_ruhrgebiet_nord_gmbh,,,,,, +3276,,70fe456d-12bc-4a54-9e45-9ab090f44d39,AZIENDA OSPEDALIERO UNIVERSITARIA DI CAGLIARI,azienda_ospedaliero_universitaria_di_cagliari,,,,,, +269,0.961582,bde7e2be-3d67-4bf2-a58c-76bffc9beda6,Austrian Breast & Colorectal Cancer Study Group (ABCSG),austrian_breast_colorectal_cancer_study_group_abcsg,,,,4deecc23-1926-409e-858b-2b5b11828232,austrian_breast_and_colorectal_cancer_study_group_abcsg,Austrian Breast and Colorectal Cancer Study Group (ABCSG) +3277,,62abb67c-7142-11e6-a0cd-0242ac12000b,PHARM SPEC,pharm_spec,,,,,, +3278,,04117269-a99a-46ca-93a0-c1cdcb5872b2,Speedel Pharma Ltd,speedel_pharma_ltd,,,,,, +3279,,83c2846f-b6f7-4ec0-b44b-5922530139ee,"University Heidelberg, Department of General Surgery",university_heidelberg_department_of_general_surgery,,,,,, +3280,,6965f8d4-716e-11e6-a0cd-0242ac12000b,ORTHO BIOLOGICS,ortho_biologics,,,,,, +3281,,120af6d9-8a93-4c4e-80bb-f3f03f686c3a,OPKO HEALTH INC,opko_health_inc,,,,,, +3282,,7259ebaa-8819-11e6-a998-0242ac12000b,LG Life Sciences Ltd,lg_life_sciences_ltd,,,,,, +3283,,27d698a6-72e0-11e6-a0cd-0242ac12000b,WEILL MEDCL COLL,weill_medcl_coll,,,,,, +3284,,b75ea448-055f-4223-9603-9617a296d861,"Aarhus University Hospital, Department of Ophthalmology",aarhus_university_hospital_department_of_ophthalmology,,,,,, +3285,,51644326-7155-11e6-a0cd-0242ac12000b,AVEMA PHARMA,avema_pharma,,,,,, +533,0.981251,215a399e-635c-44e7-a8f5-032b68855c29,THERAKOS,therakos,,,,215a399e-635c-44e7-a8f5-032b68855c29,therakos,THERAKOS +3286,,a74c2f75-49d0-4a5e-9312-03705bf48221,Alfred Health,alfred_health,,,,,, +3287,,610cd14a-4187-43cb-bdb1-640c3ebba0a8,Peptimmune Inc,peptimmune_inc,,,,,, +3288,,956a2fec-36b3-4f54-9368-bfbbbf1cb20e,"Medizinische Universität Graz, Universitäts-Augenklinik",medizinische_universit_t_graz_universit_ts_augenklinik,,,,,, +3289,,05f4d9e3-edd8-43ee-bfc3-c2c5afcf6f4a,RadioMedic s.r.o,radiomedic_s_r_o,,,,,, +3290,,5d5428e9-2e63-486f-9331-187f7844875a,Vantia Ltd,vantia_ltd,,,,,, +3291,,c5f66cc2-dade-4882-96f1-618762524358,Uzsoki Utcai Kórház,uzsoki_utcai_k_rh_z,,,,,, +3292,,9a691efa-fb50-4c9c-a007-1ef296abf9c0,ALTANA Pharma Ltd,altana_pharma_ltd,,,,,, +3293,,865fb47e-185f-4991-8d88-c3978daeb532,M.S. Arbous,m_s_arbous,,,,,, +3294,,953d4442-e3af-4fc9-b14b-61bdb8b3c201,UCB Pharma Inc,ucb_pharma_inc,,,,,, +3295,,70891b8f-6380-44d3-9d67-ddb37ab44591,The Nordic Myeloproliferative Neoplasm Group,the_nordic_myeloproliferative_neoplasm_group,,,,,, +3296,,9279f543-d250-4b06-950f-7c032201c134,AGI Therapeutics Limited,agi_therapeutics_limited,,,,,, +728,0.97973480820655823,09df191c-9f38-4b3a-ab06-90044d8a5690,"UCB Celltech, UK",ucb_celltech_uk,,,,093988ab-1f2c-48ab-84d3-0b1dff68400e,ucb_celltech_uk,"UCB Celltech, UK" +3297,,80cb69a1-a893-4836-bcbc-d912381a2d20,Bellerophon Pulse Technologies LLC,bellerophon_pulse_technologies_llc,,,,,, +3298,,127fb198-4cb1-432e-963c-6cd95f2f263b,Institute for Neurodegenerative Disorders,institute_for_neurodegenerative_disorders,,,,,, +3299,,09014b73-b3a6-47b3-bc32-40e2dd0c1219,East Tallinn Central Hospital,east_tallinn_central_hospital,,,,,, +936,0.94267457723617554,33e84b15-e25f-402d-bf4e-0f564d9c0255,Royal Liverpool & Broadgreen University Hospitals Trust,royal_liverpool_broadgreen_university_hospitals_trust,,,,33e84b15-e25f-402d-bf4e-0f564d9c0255,royal_liverpool_and_broadgreen_university_hospitals_trust,Royal Liverpool and Broadgreen University Hospitals Trust +3300,,16fcb22f-67c2-467f-aa31-3f8ff9ae3434,Roche (HELLAS) SA,roche_hellas_sa,,,,,, +3301,,6836ad02-679a-409e-846d-03def2652329,Foro Andaluz para el Estudio de Tumores Torácicos (FAETT),foro_andaluz_para_el_estudio_de_tumores_tor_cicos_faett,,,,,, +3302,,2f53c884-73bb-11e6-a0cd-0242ac12000b,NAVIDEA BIOPHARMS,navidea_biopharms,,,,,, +3303,,4eafb198-12c6-44b4-b453-18b6465f277f,Neovacs SA,neovacs_sa,,,,,, +3304,,fd805ce0-dbe5-423d-ac13-51c1cb4c9d3f,Lovisenberg Diaconal Hospital,lovisenberg_diaconal_hospital,,,,,, +3305,,192b6b5d-3fc5-40bd-98c5-7087ba3caba4,Ninewells Hospital,ninewells_hospital,,,,,, +3306,,a7dc8c64-4f22-4893-a315-90897cc3a628,LWL University Hospital Bochum,lwl_university_hospital_bochum,,,,,, +3307,,75e73fe3-6429-4c79-a0e5-d635444c03d0,Onkologisk afdeling R and the Unit for Experimental Chemotherapy,onkologisk_afdeling_r_and_the_unit_for_experimental_chemotherapy,,,,,, +916,0.986414,c1cc8b83-e3cb-4df9-a228-a9493d3c1abf,University of Edinburgh (ACCORD),university_of_edinburgh_accord,,,,6370e13d-5a9e-49dc-a468-3b76aad11206,university_of_edinburgh,University of Edinburgh +3308,,c7342910-0870-4ebc-affb-f1ae701c39c6,"AZ St Augustinus, Wilrijk",az_st_augustinus_wilrijk,,,,,, +3309,,d1c5a5b1-b929-4715-80bb-49f15d48fbef,Cell Genesys Inc,cell_genesys_inc,,,,,, +683,0.987967,988d0aa4-106e-4070-9a97-ae295beaf13c,Landstinget i Uppsala län,landstinget_i_uppsala_l_n,,,,93d2770e-11ee-4c28-b378-003b4e28a161,landstinget_i_uppsala,Landstinget i Uppsala +42,0.97710627317428589,fde089ee-61a3-4a26-98a0-0ba8b48a962f,"Universitätsklinik für Augenheilkunde und Optometrie, MUW",universit_tsklinik_f_r_augenheilkunde_und_optometrie_muw,,,,e3a4dbed-6085-4f4f-a871-0b11b6bed573,universit_tsklinik_f_r_augenheilkunde_und_optometrie,Universitätsklinik für Augenheilkunde und Optometrie +3310,,91ec1efd-1a73-43d1-9490-edb72ba8da58,Neus Fabregas Julia - Hospital Clinic de Barcelona,neus_fabregas_julia_hospital_clinic_de_barcelona,,,,,, +662,0.97071176767349243,59b31da0-f1a7-4e16-acd2-6659f5326e5d,Charité Univeritaetsmedizin Berlin,charit_univeritaetsmedizin_berlin,,,,03be6dab-3c3b-45d4-999e-013062e4a92e,charit_universitaetsmedizin_berlin,Charité Universitaetsmedizin Berlin +858,0.94989776611328125,a4afe98f-2343-420b-ae98-50be658abbef,Institut de Recerca / Hospital de la Santa Creu i Sant Pau,institut_de_recerca_hospital_de_la_santa_creu_i_sant_pau,,,,5ce030ba-f524-45f7-b154-b5509cfe5e6d,institut_de_recerca_hospital_de_la_sant_creu_i_sant_pau,Institut de Recerca Hospital de la Sant Creu i Sant Pau +3311,,e743e67b-b02d-4c42-b8d5-9713c7c74938,Oxford Radcliffe Hospital NHS Trust,oxford_radcliffe_hospital_nhs_trust,,,,,, +3312,,ddcaa69f-5b26-4ba0-bd10-873ca1e154c1,Ursapharm Arzneimittel GmbH&Co. KG,ursapharm_arzneimittel_gmbh_co_kg,,,,,, +3313,,c1bfea02-d95a-40c7-a1bc-66abc5c46acd,Isala Klinieken Department Cardiology,isala_klinieken_department_cardiology,,,,,, +3314,,23c7367f-96c7-4f87-8952-24a1197e2460,"GALDERMA R&D, LLC",galderma_r_d_llc,,,,,, +3315,,e1901832-50ba-49df-b5e8-309204f75b91,DBCG,dbcg,,,,,, +3316,,48b9f85e-dfdb-4785-b6df-0a68207e1f6c,Grupo Espagnol de Cancer de Pulmon,grupo_espagnol_de_cancer_de_pulmon,,,,,, +3317,,4111ad13-ac96-4c23-9b27-16efe1db71ca,Gothenburg University,gothenburg_university,,,,,, +3318,,c2051d8a-715f-11e6-a0cd-0242ac12000b,BEECHAM,beecham,,,,,, +3319,,ad93456a-7232-11e6-a0cd-0242ac12000b,WOMEN FIRST HLTHCARE,women_first_hlthcare,,,,,, +3320,,f255ca83-3c62-45e6-aa29-52c550464ee7,"Research and Development Department, Addenbrookes NHS Foundation Trust",research_and_development_department_addenbrookes_nhs_foundation_trust,,,,,, +3321,,771eee8b-09c5-4a0e-a9f7-9f6c33f619f7,"Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen",department_of_biomedical_sciences_faculty_of_health_sciences_university_of_copenhagen,,,,,, +669,0.988702,6139d772-2e3a-4727-b99c-78b770114708,The Walton Centre for Neurology and Neurosurgery NHS Trust,the_walton_centre_for_neurology_and_neurosurgery_nhs_trust,,,,6139d772-2e3a-4727-b99c-78b770114708,the_walton_centre_for_neurology_and_neurosurgery_nhs_trust,The Walton Centre for Neurology and Neurosurgery NHS Trust +3322,,847870c2-964a-4674-8a57-f117891df6b7,Department of Ophthalmology at St. Franziskus Hospital,department_of_ophthalmology_at_st_franziskus_hospital,,,,,, +3323,,87422532-ac60-49f3-8c0c-263bb5bd9359,Servicio de Psiquiatría. Hospital Universitari Vall d’Hebron,servicio_de_psiquiatr_a_hospital_universitari_vall_d_hebron,,,,,, +3324,,b273f3f1-a2c4-4edf-9fb3-fe45e1804a7e,"Minerva Neurosciences, Inc",minerva_neurosciences_inc,,,,,, +3325,,bc8e3eb9-ef18-484c-b819-21d528129e11,Nordic Nanovector ASA,nordic_nanovector_asa,,,,,, +3326,,16fc4833-15dc-491e-b98f-a895546396e0,"Klinisk Biokemisk Afdeling, Aarhus Universitetshospital, Skejby",klinisk_biokemisk_afdeling_aarhus_universitetshospital_skejby,,,,,, +3327,,078c3222-bfb1-4586-9b4f-07eaae3a9cd6,Mondobiotech Laboratories Anstalt,mondobiotech_laboratories_anstalt,,,,,, +616,0.95730888843536377,7220ec7d-ef30-46ae-ab61-e65a1f133c11,Shire Development LLC,shire_development_llc,,,,f8cdc923-8f9e-4a86-b916-6b3f45c65971,shire_development_llc,Shire Development LLC +429,0.970982,71d8e8b6-4155-47a0-ad75-6f0f13598830,Addex Pharmaceuticals SA,addex_pharmaceuticals_sa,,,,71d8e8b6-4155-47a0-ad75-6f0f13598830,addex_pharmaceuticals_sa,Addex Pharmaceuticals SA +875,0.9714733362197876,f8421bef-4039-4853-934b-b934099a9939,FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO NIÑO JESUS,fundacion_para_la_investigacion_biomedica_hospital_universitario_ni_o_jesus,,,,8ca22c91-ec68-4c4d-b67e-9354f508b1d3,fundacion_para_la_investigacion_biomedica_del_hospital_universitario_ni_o_jesus,FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO NIÑO JESUS +3328,,727eb8e2-d251-4eb6-b531-c1950d19cd95,"Boston Biomedical, Inc",boston_biomedical_inc,,,,,, +3329,,c9713e75-fd9d-4d5f-9a52-c10f6b9f974d,Egalet a/s,egalet_a_s,,,,,, +3330,,e3cb8a70-a745-11e6-94cb-5656d04fc2b5,PPM SERVICES SA,ppm_services_sa,,,,,, +82,0.9889298677444458,be34fe0d-08b2-48ab-aa99-08ea293d229f,"Medizinische Universität Wien, Universitätsklinik für",medizinische_universit_t_wien_universit_tsklinik_f_r,,,,34927d7f-aaf7-4211-886e-d6c66ea9e027,medizinische_universit_t_wien_universit_tsklinik_f_r_chirurgie,"Medizinische Universität Wien, Universitätsklinik für Chirurgie" +3331,,265e66c1-6226-4428-bd8f-d6b8c392e69e,"Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited",millennium_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_takeda_pharmaceutical_company_limited,,,,,, +3332,,cfcac0ad-65b7-4197-800c-5cbaecc5c656,AOU SAN LUIGI GONZAGA - SCDU ONCOLOGIA MEDICA,aou_san_luigi_gonzaga_scdu_oncologia_medica,,,,,, +3333,,563f33db-d22e-45a9-a6ef-e2b3c2ee6667,MARSHALL EDWARDS PTY LTD,marshall_edwards_pty_ltd,,,,,, +3334,,82a72fd6-2986-4f4b-8f17-6b1a55c38ff7,Gruenenthal GmbH,gruenenthal_gmbh,,,,,, +3335,,60fe56fb-b4cb-470b-83a7-713aada0acf2,Cornwall College Camborne,cornwall_college_camborne,,,,,, +526,0.986058,dd756c58-7148-11e6-a0cd-0242ac12000b,BAXTER HLTHCARE CORP,baxter_hlthcare_corp,,,,73bd77f0-7126-11e6-8a77-0242ac12000b,baxter_hlthcare,BAXTER HLTHCARE +3336,,9baa74cf-2773-4662-b7d0-e9d260fcedf5,North Glasgow NHS Trust,north_glasgow_nhs_trust,,,,,, +835,0.905873,81899287-3fd5-4be2-923d-6c76cdc477ff,University of Erlangen-Nuremberg,university_of_erlangen_nuremberg,,,,81899287-3fd5-4be2-923d-6c76cdc477ff,university_of_erlangen_nuremberg,University of Erlangen-Nuremberg +3337,,51c1f868-7191-11e6-a0cd-0242ac12000b,ARBROOK,arbrook,,,,,, +3338,,543c65f6-d098-40f8-9101-1bb75b10621b,AKELA Pharma Inc,akela_pharma_inc,,,,,, +3339,,6c19565d-3ba8-4693-9146-98267cc2f8a3,Lijf en Leven,lijf_en_leven,,,,,, +576,0.98835551738739014,296373b5-8871-4062-ab94-c1936a5306c2,"Wyeth Pharmaceuticals, Global Medical Affairs Department",wyeth_pharmaceuticals_global_medical_affairs_department,,,,296373b5-8871-4062-ab94-c1936a5306c2,wyeth_pharmaceuticals_global_medical_affairs_department,"Wyeth Pharmaceuticals, Global Medical Affairs Department" +550,0.98918396234512329,e2e54dd4-4db8-431a-af23-bae89d56cad0,"Freistaat Bayern, vertreten durch die Universität Regensburg",freistaat_bayern_vertreten_durch_die_universit_t_regensburg,,,,c02e31f5-3712-4237-9dae-6bec40ffabb9,freistaat_bayern_vertreten_durch_die_universit_t_regensburg_klinikum,"Freistaat Bayern, vertreten durch die Universität Regensburg, Klinikum" +3340,,9120653c-1e15-4a34-a749-0b3f0735fb13,Radboud University Nijmegen Medical Center,radboud_university_nijmegen_medical_center,,,,,, +3341,,06ce027b-a373-41ff-8fd2-fdb09ce907ab,"AZIENDA OSPEDALIERA ""S. CROCE E CARLE",azienda_ospedaliera_s_croce_e_carle,,,,,, +834,0.9859306812286377,34a46c06-df18-492f-b4ff-39c0c77ef62f,Novartis Pharmaceuticals,novartis_pharmaceuticals,,,,34a46c06-df18-492f-b4ff-39c0c77ef62f,novartis_pharmaceuticals,Novartis Pharmaceuticals +3342,,921f328d-a010-42b3-9323-1c6319fc8462,Retinaklinikken Aleris,retinaklinikken_aleris,,,,,, +3343,,9b8275e5-79b7-4c39-a084-8dd310160919,Univ.-Prof. Dr. Volker Wenzel,univ_prof_dr_volker_wenzel,,,,,, +3344,,a53ccb8a-78c5-41c4-aed3-7a63ff38e6d6,Catalan Institute of Oncology,catalan_institute_of_oncology,,,,,, +3345,,3c183ff8-7165-11e6-a0cd-0242ac12000b,CADILA PHARMS LTD,cadila_pharms_ltd,,,,,, +444,0.94951000809669495,3ae873dd-f223-4909-81c9-fe44d56c96ae,Royal Brompton & Harefield NHS Foundation Trust,royal_brompton_harefield_nhs_foundation_trust,,,,3c8eeed9-b500-4ecf-a409-f59b86b21db3,royal_brompton_and_harefield_nhs_foundation_trust,Royal Brompton and Harefield NHS Foundation Trust +132,0.986058,97c7677c-7154-11e6-a0cd-0242ac12000b,AMPHASTAR PHARM,amphastar_pharm,,,,6f18faf0-7147-11e6-a0cd-0242ac12000b,amphastar_pharms_inc,AMPHASTAR PHARMS INC +3346,,3c6015f8-7165-11e6-a0cd-0242ac12000b,NEOS THERAP INC,neos_therap_inc,,,,,, +3347,,df1fe8fd-4353-458f-a9ab-a7c4bb764208,"Med. Univ. Wien, Univ. Klinik für Innere Med. III",med_univ_wien_univ_klinik_f_r_innere_med_iii,,,,,, +3348,,d083540f-b308-429e-8d67-d13529dedac1,MEDITOP Gyógyszeripari Kft,meditop_gy_gyszeripari_kft,,,,,, +45,0.90533584356307983,a724bf82-6dee-47cb-9eb5-9ddf9d0131aa,"Medicinsk Forskningsafsnit, Regionshospitalet Holstebro (Department of Medical Research, Regional Hospital Holstebro)",medicinsk_forskningsafsnit_regionshospitalet_holstebro_department_of_medical_research_regional_hospital_holstebro,,,,7c8f44a5-f228-4272-a17a-08c93ebdc8bd,medicinsk_forskning_regionshospitalet_holstebro,"Medicinsk Forskning, Regionshospitalet Holstebro" +3349,,35bcf285-8232-49b9-8bda-2b5778565a4c,"Nyremedicinsk afdeling, Aalborg Sygehus",nyremedicinsk_afdeling_aalborg_sygehus,,,,,, +3350,,1cae79b0-730a-4c6a-9807-43fa22c9c18c,ACRAF SpA,acraf_spa,,,,,, +3351,,91af06ad-bec0-4545-83dd-89b06299d925,KeyNeurotek Pharmaceuticals AG,keyneurotek_pharmaceuticals_ag,,,,,, +3352,,221765eb-087c-44b8-9311-ba348e70bf5e,Wyeth Lederle Nordiska AB,wyeth_lederle_nordiska_ab,,,,,, +3353,,5135dfb7-ae4f-4b93-b93f-020d895828fd,Anna-Liisa Kautio,anna_liisa_kautio,,,,,, +3354,,22a8f8ef-6fd5-420b-9496-abdf60f87705,AZIENDA OSPEDALIERA - CENTRO RICERCHE CLINICHE DI VERONA,azienda_ospedaliera_centro_ricerche_cliniche_di_verona,,,,,, +3355,,225f97b1-af44-41ab-bb64-654b89fe1e33,TetraLogic Pharmaceuticals,tetralogic_pharmaceuticals,,,,,, +3356,,bc05cc87-6b7e-4ef9-b65a-e09416b83dd2,"Endocrine Research Unit, Odense University Hospital",endocrine_research_unit_odense_university_hospital,,,,,, +3357,,95db6177-b882-4aa7-8f44-d56c146461cf,"TolerX, Inc",tolerx_inc,,,,,, +3358,,e80ac0df-f952-4230-b205-59f859a4f6fd,Zealand Pharma,zealand_pharma,,,,,, +3359,,b45e6787-1d19-4a29-ae54-9d6ca56a526b,Seqirus UK Limited,seqirus_uk_limited,,,,,, +432,0.948456,1f71611f-b1a0-468a-826f-555058e87660,Daiichi Sankyo Development Limited,daiichi_sankyo_development_limited,,,,1f71611f-b1a0-468a-826f-555058e87660,daiichi_sankyo_development_limited,Daiichi Sankyo Development Limited +3360,,e45facbb-85e6-492c-99ee-a9540504fd71,Southampton University Hospital NHS Trust,southampton_university_hospital_nhs_trust,,,,,, +3361,,496c056c-3d00-45de-9b43-e648abd63db5,Jari Halonen,jari_halonen,,,,,, +3362,,927cdda0-3b07-49b0-b6fd-47ddcf392e2e,Turku PET Centre,turku_pet_centre,,,,,, +735,0.98652654886245728,0e15ce2f-64e1-4032-b656-601cb9cc8b46,European Organisation for Research and Treatment of Cancer,european_organisation_for_research_and_treatment_of_cancer,,,,6e92b00d-0791-4d8e-975c-0fbd5ce95861,european_organisation_for_research_and_treatment_of_cancer,European Organisation for Research and Treatment of Cancer +3363,,1898488b-488f-4af2-b033-4163bf0cffab,Hospital General de L’Hospitalet,hospital_general_de_l_hospitalet,,,,,, +3364,,94df9e62-d28f-4f38-bccf-b8fd8ea88efc,"Medical University of Vienna, Department of Internal medicine I",medical_university_of_vienna_department_of_internal_medicine_i,,,,,, +3365,,c5a2a499-fce2-4e3a-b974-7ef9ad414685,"Institute of Clinical Medicine, Family Medicine, University of Turku",institute_of_clinical_medicine_family_medicine_university_of_turku,,,,,, +3366,,9e38ca8b-a3cd-4a2c-898a-bedea1a2db77,Tayside Medical Sciences Centre on behalf of University of Dundee & NHS Tayside,tayside_medical_sciences_centre_on_behalf_of_university_of_dundee_nhs_tayside,,,,,, +3367,,2119d1fe-8424-4f0f-a830-dfaf8cf05e8e,University of Southampton,university_of_southampton,,,,,, +3368,,a164433a-3d24-45d0-86f7-b1df53a417c9,LUNDBECK ITALIA,lundbeck_italia,,,,,, +3369,,1cd4a556-69f2-4f1b-a35e-2cd66370661d,"UNIVERSITA` DEGLI STUDI ""G. D`ANNUNZIO"" CHIETI",universita_degli_studi_g_d_annunzio_chieti,,,,,, +3370,,232d30c3-dd0e-4f92-900b-7ac40e2990b7,University of Dundee (Research & Innovation Services),university_of_dundee_research_innovation_services,,,,,, +3371,,a6de52bb-1492-4080-995c-b4aa586fdf6f,FISEVI,fisevi,,,,,, +367,0.95796058575312293,047a607c-fbe0-4e4d-b18e-9ecb5a985c9a,Bayer HealthCare A/S,bayer_healthcare_a_s,,,,e8216e75-b447-4252-bb49-7b895bcf4108,bayer_healthcare,Bayer HealthCare +3372,,4af88ea7-2a58-43c2-8d53-321d13141271,Astex Therapeutics Ltd,astex_therapeutics_ltd,,,,,, +3373,,ee33b25f-ee18-4078-8cd1-7ce0ff1200a1,Debiopharm SA,debiopharm_sa,,,,,, +3374,,0cead598-7d32-42f3-878e-0a3c649910b8,Chief Scientitst Office,chief_scientitst_office,,,,,, +3375,,e6763d33-9e67-4f83-aaa7-a84770084493,YALE UNIVERSITY,yale_university,,,,,, +3376,,94dbea1a-7997-4166-96c7-78c2a11f4fe7,Q-med AB,q_med_ab,,,,,, +3377,,4093eace-8871-4db8-87b9-91b3df02fa6e,Dr. Franz Köhler Chemie GmbH,dr_franz_k_hler_chemie_gmbh,,,,,, +3378,,0da1f7f1-5dd5-41e4-aa97-6ab8c1e0078c,Palle Toft,palle_toft,,,,,, +3379,,ec4d9639-f810-4d8e-86f7-0376bda9922f,Shire Development Inc,shire_development_inc,,,,,, +3380,,6e9cd0e8-716e-11e6-a0cd-0242ac12000b,PALATIN TECHNOLOGIES,palatin_technologies,,,,,, +3381,,4d368dd9-bbe7-4f0b-94ee-d4d3bada1018,University of Birmingham,university_of_birmingham,,,,,, +3382,,59c6bf20-7129-11e6-a89e-0242ac12000b,USL PHARMA,usl_pharma,,,,,, +66,0.96240752935409546,3a393eb3-48da-40b7-8350-c4006da9885c,AKH Wien,akh_wien,,,,1eec3f23-406c-471b-948a-24dcf52e62a1,akh_wien_klinik_f_r_innere_medizin_i_onkologie,"AKH Wien, Klinik für Innere Medizin I, Onkologie" +490,0.98204740881919861,3fd47231-c0e0-48e2-9df1-24e6ff72daf7,Radboud University Medical Center Njmegen,radboud_university_medical_center_njmegen,,,,3fd47231-c0e0-48e2-9df1-24e6ff72daf7,radboud_university_medical_center,Radboud University Medical Center +3383,,5e74dac9-7e8f-4d5f-8d35-29d77c01d39f,The Royal Group Hospitals Trust,the_royal_group_hospitals_trust,,,,,, +3384,,c64b4e66-14bd-447f-ab0c-1128bbe1b7fe,Oculis ehf,oculis_ehf,,,,,, +3385,,7e9cf81e-72cd-11e6-a0cd-0242ac12000b,SAGE PRODS,sage_prods,,,,,, +3386,,ae5114fc-f87f-4868-84fa-5a82714a72d2,Sandwell & West Birmingham Hospitals NHS Trust,sandwell_west_birmingham_hospitals_nhs_trust,,,,,, +778,0.982179,09db9c0d-772c-417a-b2dd-c0f3dd272e65,Medica Scientia Innovation Research (MedSIR ARO),medica_scientia_innovation_research_medsir_aro,,,,09db9c0d-772c-417a-b2dd-c0f3dd272e65,medica_scientia_innovation_research_medsir_aro,Medica Scientia Innovation Research (MedSIR ARO) +3387,,78d55b7c-711b-4703-a250-0733363368ff,Rosa Herrera Castro,rosa_herrera_castro,,,,,, +3388,,aa13b485-6306-4a33-8f23-22e97527ebd6,Diamyd Therapeutics AB,diamyd_therapeutics_ab,,,,,, +3389,,a746c680-9266-4c53-a941-f13712e6e663,Danish University Antidepressant Group (DUAG),danish_university_antidepressant_group_duag,,,,,, +3390,,e103ac26-91be-49a5-a0f8-408a068e05c4,"Diater Laboratorio de Diagnósticos y Aplicaciones Terapéuticas, S.A",diater_laboratorio_de_diagn_sticos_y_aplicaciones_terap_uticas_s_a,,,,,, +3391,,cd253630-5198-4122-a522-c9f82b752583,BODE Chemie GmbH,bode_chemie_gmbh,,,,,, +3392,,940674f6-881b-11e6-a998-0242ac12000b,Bayer Pharma AG,bayer_pharma_ag,,,,,, +3393,,280a4541-cf5e-436a-bbd1-c082498f9154,University of Liège- Dpt de Médecine Générale,university_of_li_ge_dpt_de_m_decine_g_n_rale,,,,,, +3394,,8f48d724-3de1-44a6-b5cd-2a280a3ffca1,A.O. San Gerardo di Monza,a_o_san_gerardo_di_monza,,,,,, +3395,,cda82f06-9dcb-43c8-a707-a0633111f14f,Lothian Health - University Hospitals Division,lothian_health_university_hospitals_division,,,,,, +3396,,539ac931-2c4d-4af0-82a0-f576e4ee2360,Laboratoire GlaxoSmithKline,laboratoire_glaxosmithkline,,,,,, +250,0.95617127418518066,5071919f-1373-4a28-b00e-8112a8b47ef4,NMDSG Nordic Myelodysplastic Syndrom Group,nmdsg_nordic_myelodysplastic_syndrom_group,,,,5071919f-1373-4a28-b00e-8112a8b47ef4,nmdsg_nordic_myelodysplastic_syndrom_group,NMDSG Nordic Myelodysplastic Syndrom Group +3397,,98ad618c-7d46-4a45-bd4b-e1c3288f12cd,"Med. Klinik II, Grosshadern, Klinikum der Universität München",med_klinik_ii_grosshadern_klinikum_der_universit_t_m_nchen,,,,,, +3398,,e339ddca-9a41-4e3d-b73c-479442219ded,Merja Kokki,merja_kokki,,,,,, +3399,,115dd074-7184-11e6-a0cd-0242ac12000b,JAZZ PHARMS INC,jazz_pharms_inc,,,,,, +3400,,e7b77e15-08ca-40df-9b8c-9ab699cd5791,Aalto-yliopiston Kylmälaboratorion Aivotutkimusyksikkö,aalto_yliopiston_kylm_laboratorion_aivotutkimusyksikk,,,,,, +3401,,3dc6292b-a4bc-4d57-9038-d0fe2cf074af,Healthcare Product Development,healthcare_product_development,,,,,, +3402,,6e47b9a6-a5de-4df4-80e5-e7e0e57d68eb,Roche Farma que representa en España a F. Hoffmann-La Roche Ltd,roche_farma_que_representa_en_espa_a_a_f_hoffmann_la_roche_ltd,,,,,, +1032,0.98019236326217651,9a3a8486-1cad-4e30-8596-fcf14f58cb7b,Kvinnokliniken,kvinnokliniken,,,,62b186bb-cb30-4ebd-9462-a1bd321e2179,kvinnokliniken_i_sterg_tland,Kvinnokliniken i Östergötland +3403,,85c4358a-d718-4cd3-a15e-c06483ff4246,Maternite Regionale Universitaire de Nancy,maternite_regionale_universitaire_de_nancy,,,,,, +3404,,432f1531-b11a-4c83-9581-05492fad458b,PARI Pharma GmbH,pari_pharma_gmbh,,,,,, +3405,,1c3dd6b4-7167-11e6-a0cd-0242ac12000b,MYLAN TEORANTA,mylan_teoranta,,,,,, +3406,,178c87de-c954-48e5-8d8b-89364b8e57af,Gilead Sciences GmbH,gilead_sciences_gmbh,,,,,, +3407,,94a69fcf-b94c-47f4-bed2-59b0de3acf4d,PD Dr. med. K-H. Konz,pd_dr_med_k_h_konz,,,,,, +3408,,6dec3a3a-73f8-11e6-a0cd-0242ac12000b,ALLERGAN HOLDINGS,allergan_holdings,,,,,, +3409,,3dfe2c00-364b-4900-8e42-0a5ffb997239,ZIOPHARM Oncology Inc,ziopharm_oncology_inc,,,,,, +3410,,8abbf943-d8b4-4656-ad98-408a4f847b57,Nayana Joshi Jubert,nayana_joshi_jubert,,,,,, +3411,,d4f1e8fb-4f4f-4f29-9b28-cab57f4dc68b,Oxford BioMedica (UK) Ltd,oxford_biomedica_uk_ltd,,,,,, +3412,,6ebd23af-bbad-4c29-850f-153badf27d3e,Mª Antònia Perelló Juan,m_ant_nia_perell_juan,,,,,, +3413,,d30a7eeb-0421-4f94-96dd-e72632a037d2,University of Dundee/NHS Tayside,university_of_dundee_nhs_tayside,,,,,, +3414,,84f2c161-ef4b-478e-bd10-f51ab2dea0a9,"Aarhus University Hospital, Aarhus Sygehus",aarhus_university_hospital_aarhus_sygehus,,,,,, +3415,,2ed82d8c-b9f8-4f2f-ba9b-01b8954bfb1a,Universität Wuerzburg,universit_t_wuerzburg,,,,,, +3416,,33454f8c-a769-4f4c-a2f2-8210c6bd686d,"3.Med. Department, Academic Hospital Bogenhausen",3_med_department_academic_hospital_bogenhausen,,,,,, +493,0.98710572719573975,0b4d241a-7142-11e6-a0cd-0242ac12000b,AMNEAL PHARMS,amneal_pharms,,,,d264e962-7141-11e6-a0cd-0242ac12000b,amneal_pharms,AMNEAL PHARMS +3417,,de8e97c9-b058-4b07-ab85-ce13fe5a8743,SLA Pharma (UK) Ltd,sla_pharma_uk_ltd,,,,,, +3418,,6bb68bd3-278c-4516-86ea-5ed2200b5b9f,Sankt Eriks Eye Hospital,sankt_eriks_eye_hospital,,,,,, +960,0.988812,bf8e1dfc-7e55-4f48-ab32-ba4f23a1d935,AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA,azienda_universitaria_policlinico_umberto_i_di_roma,,,,9e4d3fbc-0e9a-4bef-af84-596f0765706f,azienda_universitaria_policlinico_umberto_i,AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I +3419,,2b019a3b-30f8-4101-844b-c3120848a98b,Cardiff and Vale NHS Trust,cardiff_and_vale_nhs_trust,,,,,, +3420,,bdd7a1cf-4495-4b65-8385-b1f1488d6874,"Ardelyx, Inc",ardelyx_inc,,,,,, +3421,,a3f2c0cf-397f-446f-9c08-56acde4fcb35,GlaxSmithKline Research & Development Limited,glaxsmithkline_research_development_limited,,,,,, +3422,,77d21801-56b6-4b8e-b5d3-f1ffc39d7e7e,Victor Martínez Taboada,victor_mart_nez_taboada,,,,,, +3423,,fa1d0a36-715d-11e6-a0cd-0242ac12000b,ALEMBIC PHARMS LTD,alembic_pharms_ltd,,,,,, +3424,,6a3a2bf5-745f-4ef2-8f05-3ee9a23ca396,Royal National Hospital for Rheumatic Disease,royal_national_hospital_for_rheumatic_disease,,,,,, +3425,,95dcd5fe-ea33-4bd4-b980-3b8a52d2e083,Synphora AB,synphora_ab,,,,,, +705,0.975954,666dd3bc-7129-11e6-a89e-0242ac12000b,LUITPOLD,luitpold,,,,666dd3bc-7129-11e6-a89e-0242ac12000b,luitpold,LUITPOLD +3426,,2fd748d2-9c44-4a2a-bab7-2cd1b28dcde8,Department of Pharmacology-Toxicology,department_of_pharmacology_toxicology,,,,,, +3427,,9124899a-8bd5-11e6-a449-0242ac12000b,"Parion Sciences, Incorporated",parion_sciences_incorporated,,,,,, +3428,,12ef157d-3eb5-4c25-acad-2a231404ef7c,LG Life Science Ltd,lg_life_science_ltd,,,,,, +3429,,43e80408-ecc1-4ed8-b99e-6cb2ff322a1f,Eiger BioPharmaceuticals,eiger_biopharmaceuticals,,,,,, +223,0.985233,942bacad-d838-4c73-ae5e-fc8e758a272b,"Surface Logix, Inc",surface_logix_inc,,,,44108cfa-cc6c-4533-88aa-39d1732610f2,surface_logix,Surface Logix +697,0.98663,5f97fd26-7163-11e6-a0cd-0242ac12000b,BAUSCH AND LOMB INC,bausch_and_lomb_inc,,,,0521bb50-7129-11e6-a89e-0242ac12000b,bausch_and_lomb,BAUSCH AND LOMB +3430,,3595c72a-adbb-4444-902e-9a6d3d1f278c,"Protherics Medicines Development Ltd, a BTG plc company",protherics_medicines_development_ltd_a_btg_plc_company,,,,,, +3431,,a3680e89-7dd3-4d52-a8ba-ff9fdb0ccd95,Grupo de Investigación en Oncología Médica del Hospital de Navarra,grupo_de_investigaci_n_en_oncolog_a_m_dica_del_hospital_de_navarra,,,,,, +464,0.979231,d09c685b-4a05-4cb4-a977-130633e1d160,SCHWARZ PHARMA,schwarz_pharma,,,,12f90377-956c-4817-b4ad-64555adaf3a0,schwarz_pharma_deutschland_gmbh,SCHWARZ PHARMA Deutschland GmbH +3432,,a833c45e-4e2a-4760-bd39-d0258e8115a0,Tampere University Hospital,tampere_university_hospital,,,,,, +3433,,2a8aebd0-73c4-11e6-a0cd-0242ac12000b,AVEDRO INC,avedro_inc,,,,,, +3434,,1cf3f838-517f-4c6f-8599-020eb894daeb,Fundación Sanitaria para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO),fundaci_n_sanitaria_para_el_fomento_de_la_investigaci_n_sanitaria_y_biom_dica_de_la_comunidad_valenciana_fisabio,,,,,, +883,0.97897982597351074,cf448ad3-7ed9-4898-a76a-3fe63bd531cf,ALTANA Inc,altana_inc,,,,0ea5911a-7142-11e6-a0cd-0242ac12000b,altana,ALTANA +3435,,2550f3d3-bff7-44a5-a0a5-e849e191cb2a,Hospital Universitario Araba (Sede Santiago),hospital_universitario_araba_sede_santiago,,,,,, +3436,,2ea7929f-2300-46ea-bc29-aa2a76077fa6,GUERBET,guerbet,,,,,, +272,0.98482978343963623,5ab1cb72-7148-11e6-a0cd-0242ac12000b,LEK PHARM,lek_pharm,,,,5ab1cb72-7148-11e6-a0cd-0242ac12000b,lek_pharms,LEK PHARMS +3437,,e6b0f99a-2068-4cd4-8179-50b4409a4ee3,Schriners Hospitals for Children,schriners_hospitals_for_children,,,,,, +3438,,435d5507-7709-4cec-ae69-d385e48fa6d8,Silkeborg Hospital,silkeborg_hospital,,,,,, +3439,,918d7e2a-4d05-4a47-a629-776bb01eaece,"OSI Pharmaceuticals, LLC",osi_pharmaceuticals_llc,,,,,, +3440,,03df4e07-3955-48b7-ab42-d43eb866f32c,Norwegian University of Science and Technology,norwegian_university_of_science_and_technology,,,,,, +3441,,781a2884-dae1-4ab2-9569-22b9e6a5504b,Arpida AG,arpida_ag,,,,,, +3442,,215852b2-356e-492c-a873-837b4368915f,"AZIENDA OSPEDALIERA ""OSPEDALI RIUNITI DI BERGAMO"" (A.O. DI RILIEVO NAZIONALE)",azienda_ospedaliera_ospedali_riuniti_di_bergamo_a_o_di_rilievo_nazionale,,,,,, +3443,,805a7c1d-98c5-4042-b5f9-b3428f0d9cd1,FUNDACION PARA LA INVESTIGACIÓN LA FE,fundacion_para_la_investigaci_n_la_fe,,,,,, +549,0.989229,e36f0842-a3fe-4d92-8d80-2f683e2f092d,Fédération Francophone de Cancérologie Digestive,f_d_ration_francophone_de_canc_rologie_digestive,,,,4932b407-af0a-4966-9a44-59fa9ac09e80,f_d_ration_francophone_de_canc_rologie_digestive_ffcd,Fédération Francophone de Cancérologie Digestive (FFCD) +163,0.94221,48bfd2b5-83e1-417f-a6ba-9f7b2b0a98b6,"Iho-ja allergiasairaala, HUS",iho_ja_allergiasairaala_hus,,,,2e1d8af2-76ea-4f16-98e7-156c78aa3581,iho_ja_allergiasairaala_hyks,"Iho-ja allergiasairaala, HYKS" +3444,,2f9be4f9-3e95-434d-b65c-3e6be427f5e7,INSTITUT D'INVESTIGACIÓ BIOMÈDICA DE BELLVITGE(IDIBELL),institut_d_investigaci_biom_dica_de_bellvitge_idibell,,,,,, +3445,,4f88cd18-9d55-4d2e-82ae-02469979decb,SOM Innovation Biotech SL (SOM Biotech),som_innovation_biotech_sl_som_biotech,,,,,, +3446,,86728b78-6955-47b5-b189-17f58cd37b61,HOSPITAL 12 OCTUBRE,hospital_12_octubre,,,,,, +3447,,a91796f2-715c-11e6-a0cd-0242ac12000b,SVC PHARMA,svc_pharma,,,,,, +3448,,d074a971-5024-4a64-b6f3-1435df8ba62c,"Schering-Plough Research Institute,divisione di Schering Corporation, per conto di MSP Singapore Co",schering_plough_research_institute_divisione_di_schering_corporation_per_conto_di_msp_singapore_co,,,,,, +3449,,f69ab08a-d179-495e-a029-fbca0563c9fc,AVAX Technologies Inc,avax_technologies_inc,,,,,, +3450,,a97bd5aa-c0b4-4679-adc6-4a640047cb0b,Neuropsychiatric clinic,neuropsychiatric_clinic,,,,,, +3451,,c45de963-05fe-4ec7-a8e2-002b41c81b59,Arbeitskreis für urologische Onkologie der österr. Gesellschaft für Urologie und Andrologie (AUO),arbeitskreis_f_r_urologische_onkologie_der_sterr_gesellschaft_f_r_urologie_und_andrologie_auo,,,,,, +3452,,433948dd-1396-4f4d-96bd-d8204dfb6f70,Institute of Psychophysiology and Rehabilitation (IRP) of the Kaunas University of Medicine,institute_of_psychophysiology_and_rehabilitation_irp_of_the_kaunas_university_of_medicine,,,,,, +3453,,3223097f-797a-4223-8aeb-7a2e6eaf7b06,Royal Victoria Infirmary,royal_victoria_infirmary,,,,,, +3454,,ea65abe1-3017-49c6-833e-154037555c6e,Stellaris Pharmaceuticals ApS,stellaris_pharmaceuticals_aps,,,,,, +3455,,7e65ec86-715e-11e6-a0cd-0242ac12000b,VALEANT PHARM INTL,valeant_pharm_intl,,,,,, +3456,,327a2c06-715e-11e6-a0cd-0242ac12000b,PETNET,petnet,,,,,, +3457,,f0303483-f893-4504-afdc-859a8f327999,Fondazione Italiana Linfomi Onlus,fondazione_italiana_linfomi_onlus,,,,,, +3458,,61d8b5ba-1039-4cc6-88d5-81e72a30d3a1,Shire-Movetis NV,shire_movetis_nv,,,,,, +3459,,468a76bf-6ce4-4489-8f22-e17b886c8aba,"PALAU PHARMA, S.A",palau_pharma_s_a,,,,,, +3460,,1ce82ae8-146e-4b57-8eb2-b53c89f4b999,"Johannes-Gutenberg-Universität Mainz, I. Medizinische Klinik und Poliklinik",johannes_gutenberg_universit_t_mainz_i_medizinische_klinik_und_poliklinik,,,,,, +3461,,9ec87cab-f636-4a48-b8da-6914cf47c9dd,Intendis GmbH,intendis_gmbh,,,,,, +678,0.97478169202804565,ddf3632f-3a35-464c-8cf1-c8b6486c323c,AbbVie Deutschland GmbH & Co. KG (Abbott),abbvie_deutschland_gmbh_co_kg_abbott,,,,ddf3632f-3a35-464c-8cf1-c8b6486c323c,abbvie_deutschland_gmbh_co_kg,AbbVie Deutschland GmbH & Co. KG +3462,,fa520b74-e763-49e1-81f2-7a6336af0f0f,"Medical and Health Science Center, University of Debrecen Dept. of Otolaryngology",medical_and_health_science_center_university_of_debrecen_dept_of_otolaryngology,,,,,, +3463,,e3db381e-124b-4fe2-b17a-0544b110b8eb,Maria Nabal Vicuña (Paliative Care Supportive Team-Hospital Universitari Arnau de Vilanova de Lleida),maria_nabal_vicu_a_paliative_care_supportive_team_hospital_universitari_arnau_de_vilanova_de_lleida,,,,,, +3464,,46283c60-466f-4250-b6fa-27491beab358,"HUS, Hospital for Children and Adolescents",hus_hospital_for_children_and_adolescents,,,,,, +3465,,d711ec96-2b26-41fe-9122-e562e858dd18,"Columbia Laboratories, Inc",columbia_laboratories_inc,,,,,, +539,0.969856,33c18818-71cf-11e6-a0cd-0242ac12000b,APOTEX TECHNOLOGIES,apotex_technologies,,,,33c18818-71cf-11e6-a0cd-0242ac12000b,apotex_technologies,APOTEX TECHNOLOGIES +3466,,390f6c8e-c346-4fbc-a9ad-e61cf540571e,ALTANA Pharma bv,altana_pharma_bv,,,,,, +3467,,b05d9796-e55c-4aa5-b96c-267e16f71f5a,HolsboerMaschmeyer NeuroChemie (HMNC) GmbH,holsboermaschmeyer_neurochemie_hmnc_gmbh,,,,,, +3468,,2cc5088a-0a5c-4ccd-b2e9-0c226bba435a,Arcutis Pharmaceuticals,arcutis_pharmaceuticals,,,,,, +612,0.98845240473747253,8ee4e877-1d00-45cf-ad2d-2275466ff57d,Erasmus Medical Center, Department of general practice,,,,f3ebaba1-aead-4675-858a-6f4e2a4f28d1,erasmus_medical_center,Erasmus Medical Center +67,0.960694,8fbbc81e-1516-4d7f-b54e-79f6a0aef8e0,Servier Research and Development Ltd,servier_research_and_development_ltd,,,,8fbbc81e-1516-4d7f-b54e-79f6a0aef8e0,servier_research_and_development_ltd,Servier Research and Development Ltd +824,0.979265,aac889d6-2c6b-4e79-9438-37e8b55cc08d,BAUSCH&LOMB,bausch_lomb,,,,aac889d6-2c6b-4e79-9438-37e8b55cc08d,bausch_lomb,BAUSCH&LOMB +3469,,83357af4-6f9e-11e6-9663-0242ac12000b,UCL-INSTITUTE OF CHILD HEALTH,ucl_institute_of_child_health,erasmus_medical_center_department_of_general_practice,,,,, +3470,,56c0f59a-78f0-4700-a66f-ed806a5932ec,Dr. Antonio Osuna Ortega,dr_antonio_osuna_ortega,,,,,, +3471,,bc0d0040-e1a5-4016-8853-f51c9ef921fd,SPCG,spcg,,,,,, +1000,0.98663,90ab4dda-7129-11e6-a89e-0242ac12000b,TEVA PHARMS USA,teva_pharms_usa,,,,80265282-715d-11e6-a0cd-0242ac12000b,teva_pharms_usa_inc,TEVA PHARMS USA INC +3472,,0ce46fe9-af37-405b-a611-1aa75471553c,CRUCELL SWITZERLAND AG,crucell_switzerland_ag,,,,,, +3473,,80dc5bd8-83c5-4428-8302-2d9d2e481e3a,Dean of Medical Faculty of Goethe University Frankfurt,dean_of_medical_faculty_of_goethe_university_frankfurt,,,,,, +3474,,b9e825f7-1fe0-4fc7-bce2-9c6aa4c919e1,Jarmo Hietala,jarmo_hietala,,,,,, +3475,,d297c03a-7141-11e6-a0cd-0242ac12000b,WEST-WARD PHARM CORP,west_ward_pharm_corp,,,,,, +3476,,90d06d25-c8cc-403d-aed6-02b23f675129,NOVAGALI PHARMA SAS,novagali_pharma_sas,,,,,, +3477,,84bf1e98-73ef-11e6-a0cd-0242ac12000b,LINDE NORTH AMERICA INC,linde_north_america_inc,,,,,, +3478,,e10bf969-77e4-4f16-bdfb-e072778fed0c,Gesellschaft für Epilepsieforschung e.V,gesellschaft_f_r_epilepsieforschung_e_v,,,,,, +3479,,4483190e-4157-4d8d-a105-b65115cd4782,CHU Nantes,chu_nantes,,,,,, +3480,,ce17ef6d-d214-4bfa-a3da-8c946b3421fc,AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI,azienda_ospedaliera_universitaria_careggi,,,,,, +3481,,d8838b96-7141-11e6-a0cd-0242ac12000b,WRASER PHARMS LLC,wraser_pharms_llc,,,,,, +3482,,ddd45916-715c-11e6-a0cd-0242ac12000b,BEXIMCO USA,beximco_usa,,,,,, +3483,,e41d88dc-73ab-11e6-a0cd-0242ac12000b,HOPE PHARMS,hope_pharms,,,,,, +857,0.96982835233211517,8fcc7ea7-9d11-4e81-89e5-b4b85e29ebcb,Institut de Recerca de l'Hospital de la Santa Creu i Sant Paui,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_paui,,,,0213f530-437f-430a-b936-0bfa94166165,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau +3484,,dd7e17b9-f773-49b5-b851-8a9b7d0e94ea,FARMEX SA,farmex_sa,,,,,, +465,0.97226685285568237,3758cf3a-2cf3-4c07-ae42-3a9d8c7f57c7,"Leiden University Medical Center, division 3",leiden_university_medical_center_division_3,,,,2e4a0d21-5259-4b26-b5dd-ed587c02073f,leiden_university,Leiden University +3485,,ce9e08e9-8bf5-4940-aaa7-b3fb68beb7ff,OMRIX biopharmaceuticals Ltd,omrix_biopharmaceuticals_ltd,,,,,, +3486,,9f3e2c4e-eb16-45fa-9bdc-35fe3ab2c9b7,Gynecologic Oncology Group,gynecologic_oncology_group,,,,,, +3487,,e96e53e1-130b-4cf8-a812-6e88f5dd72a3,Dyax Corp,dyax_corp,,,,,, +3488,,1b29cfc4-755c-4da7-9ce7-15f331eb606b,South Manchester University NHS Trust,south_manchester_university_nhs_trust,,,,,, +824,0.979265,fbe54b64-faf4-45bb-b992-cf986f3ba11f,BAUSCH&LOMB - IOM S.P.A,bausch_lomb_iom_s_p_a,,,,aac889d6-2c6b-4e79-9438-37e8b55cc08d,bausch_lomb,BAUSCH&LOMB +3489,,0d0d1869-6d21-4632-87af-9e8a85c2b81a,Centre Henri Becquerel,centre_henri_becquerel,,,,,, +3490,,9542d009-55b6-4f9b-9951-3f92df79dce2,Technical University Carl-Gustav-Carus,technical_university_carl_gustav_carus,,,,,, +3491,,502a2cd8-e412-4f05-a060-426f18cfb47e,CHU Toulouse,chu_toulouse,,,,,, +3492,,e6fbcaaf-cbec-40bb-9029-91300bae9a6d,AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI,azienda_ospedaliera_universitaria_della_seconda_universita_degli_studi_di_napoli,,,,,, +3493,,d302350a-6fc0-11e6-abe8-0242ac12000b,"Irish Clinical Oncology Research Group CLG, trading as Cancer Trials Ireland",irish_clinical_oncology_research_group_clg_trading_as_cancer_trials_ireland,,,,,, +3494,,eb3ba1fe-9aae-4756-9280-013688bc092b,Centre Val d'Aurelle - Paul Lamarque,centre_val_d_aurelle_paul_lamarque,,,,,, +3495,,933f80ea-ca12-45e2-8c5e-4985697fcaeb,Tibotec BVBA,tibotec_bvba,,,,,, +3496,,566f2525-88ca-4ad9-a985-788e49f4240e,"Pr Giampiero CAMPANELLI Università di Milano, Dipartimento di Scienze Chirurgiche, Ospedale Maggior",pr_giampiero_campanelli_universit_di_milano_dipartimento_di_scienze_chirurgiche_ospedale_maggior,,,,,, +3497,,d4d27fdc-a791-11e6-94cb-5656d04fc2b5,ASLTO2-Maria Vittoria Hospital Cardiology,aslto2_maria_vittoria_hospital_cardiology,,,,,, +3498,,5d6870b7-d677-46ea-93d6-d6e95fa09a37,"ALK-Abelló, S.A",alk_abell_s_a,,,,,, +3499,,7c925a02-ea4b-49f1-b328-2c62dca2fd88,WALA Heilmittel GmbH,wala_heilmittel_gmbh,,,,,, +3500,,0ac85da3-613b-4b8c-a1e0-d81a4f51c017,Roche spol. s r.o,roche_spol_s_r_o,,,,,, +3501,,b2d9816c-1b2d-4b35-98c3-b5f510856737,Universitätshautklinik Kiel,universit_tshautklinik_kiel,,,,,, +3502,,480c5f71-9635-4fab-9914-812d826fee67,Dermal Laboratories Limited,dermal_laboratories_limited,,,,,, +391,0.988144,ee3259eb-215f-42ac-9ef8-8f6bb9956740,Threshold Pharmaceuticals,threshold_pharmaceuticals,,,,4d1c7b0c-14e8-4b45-86cf-b9594868a087,threshold_pharmaceuticals_inc,"Threshold Pharmaceuticals, Inc" +3503,,62bb9b6d-82ac-448f-b80e-c72eefdde827,Nitto Denko Corporation,nitto_denko_corporation,,,,,, +3504,,48859ff4-7158-11e6-a0cd-0242ac12000b,SUN PHARMA GLOBAL,sun_pharma_global,,,,,, +3505,,1e787aa3-1503-4c16-81ea-805d32cd84d3,Dr Antonio Gimeno,dr_antonio_gimeno,,,,,, +3506,,0ae25e71-a0dd-4d32-ae92-f2e14fb91cb3,"Amylin Pharmaceuticals, LCC",amylin_pharmaceuticals_lcc,,,,,, +60,0.977790721825191,9f78d043-b5fa-4672-b3b6-adeedcf3e30a,Wyeth Research Division of Wyeth Pharmceuticals Inc,wyeth_research_division_of_wyeth_pharmceuticals_inc,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc +3507,,31700e62-8bcf-11e6-a449-0242ac12000b,agentschap innoveren en ondernemen,agentschap_innoveren_en_ondernemen,,,,,, +3508,,c319b695-60ec-4d29-96cf-54293c865ef4,NORGINE LIMITED,norgine_limited,,,,,, +173,0.9838290810585022,8ca2b721-4e34-4006-b99d-2917cd2811a3,Merck Serono S.A,merck_serono_s_a,,,,25f19699-b1c9-46a8-8933-0a2bbd3c7357,merck_serono_s_a_geneva,Merck Serono S.A. - Geneva +872,0.938247,9e17fcf8-9dea-44e0-8a01-1de434e51049,Newcastle upon Tyne Hospitals NHS Trust,newcastle_upon_tyne_hospitals_nhs_trust,,,,62c0263c-d0e1-4e0b-8c35-ed6babb3051d,newcastle_u_tyne_hospitals_nhs_trust,Newcastle u Tyne Hospitals NHS Trust +3509,,f3f7f704-8495-4cf1-b4cd-e758d42e7b9f,The Dutch Working Group on Immunotherapy of Oncology (WIN-O),the_dutch_working_group_on_immunotherapy_of_oncology_win_o,,,,,, +3510,,1d7eb73f-1b95-46b1-aacc-2738d8eb6a10,Fondazione IRCCS Policlinico San Matteo,fondazione_irccs_policlinico_san_matteo,,,,,, +3511,,8e954bfa-6be3-4e36-891f-307e9b4cfe87,"Landstinget Sörmland Landstingskansliet, Hälso-och Sjukvårdsledningen",landstinget_s_rmland_landstingskansliet_h_lso_och_sjukv_rdsledningen,,,,,, +3512,,ac798d50-5b0c-488a-8cb7-cbd78a281b9b,Freistaat Bayer respresented by University of Regensburg represented by Kaufmännischer Direktor,freistaat_bayer_respresented_by_university_of_regensburg_represented_by_kaufm_nnischer_direktor,,,,,, +3513,,a3a84a18-77f2-49e2-97a1-a4b4b4b6fbfb,LWL Universitätsklinik für Psychiatrie Bochum,lwl_universit_tsklinik_f_r_psychiatrie_bochum,,,,,, +3514,,3c48e1ad-7807-4da0-8ee2-26810189d245,Unidade de Investigação em Saúde Mental e Psiquiatria do Centro Hospitalar Conde de Ferreira,unidade_de_investiga_o_em_sa_de_mental_e_psiquiatria_do_centro_hospitalar_conde_de_ferreira,,,,,, +3515,,0d682ab3-834b-4458-bcf6-ce2c66b069a1,Mukoviszidose Institut gGmbH i. G,mukoviszidose_institut_ggmbh_i_g,,,,,, +3516,,c6e8335e-52f1-46e0-956f-b2e255089cc4,Radiumhemmet,radiumhemmet,,,,,, +3517,,266e37f4-6cf0-4fce-a27b-7b8cacb09340,AFT Pharmaceuticals Ltd,aft_pharmaceuticals_ltd,,,,,, +3518,,f6fb1c08-9e52-48eb-841a-5b4e3a4d1305,Q-Develop AB/co Freddie Norberg,q_develop_ab_co_freddie_norberg,,,,,, +3519,,15055c8c-44cd-4d20-a26b-6ffe057c3928,"Julius Center for Health Sciences and Primary Care, UMC Utrecht",julius_center_for_health_sciences_and_primary_care_umc_utrecht,,,,,, +332,0.986085,7336f82e-6c71-4f40-80a6-4017116b5145,Instituto Valenciano de Infertilidad (IVI) de Valencia,instituto_valenciano_de_infertilidad_ivi_de_valencia,,,,7336f82e-6c71-4f40-80a6-4017116b5145,instituto_valenciano_de_infertilidad_ivi_de_valencia,Instituto Valenciano de Infertilidad (IVI) de Valencia +3520,,b07e39a8-a8e3-486b-b4eb-42502f459037,"Centre for Ophthalmology, University of Tuebingen",centre_for_ophthalmology_university_of_tuebingen,,,,,, +968,0.98292633891105652,3c6e93c3-b2a6-4f7b-9211-088c20073f84,Maatschap Cardiologie Isala klinieken,maatschap_cardiologie_isala_klinieken,,,,e5d4a9c1-e0e4-4ac7-8c88-785f0f8e3beb,maatschap_cardiologie_isala_klinieken,Maatschap Cardiologie Isala klinieken +862,0.98123219609260559,e146990e-b84f-4869-b500-797607ef3b45,Academic Medical Center,academic_medical_center,,,,2d106fa3-c940-42d6-a28f-8db21de52b04,academic_medical_center_amsterdam,Academic Medical Center Amsterdam +3521,,e38005c2-dd4a-4a05-a472-b1efd0235986,L’OREAL SA,l_oreal_sa,,,,,, +3522,,c595b78b-70ce-4390-9e0b-9fc6a3876b26,Biologiske Stasjon Drøbak,biologiske_stasjon_dr_bak,,,,,, +3523,,159d3681-0be5-4fe7-845d-7dea9b456f49,"Department of Endocrinology, Sahlgrenska University Hospital",department_of_endocrinology_sahlgrenska_university_hospital,,,,,, +1003,0.970735,9134f49c-0675-4fb8-9e30-403bf260e44d,Pfizer Limited,pfizer_limited,,,,9134f49c-0675-4fb8-9e30-403bf260e44d,pfizer_limited,Pfizer Limited +3524,,92f3e5d8-8435-4020-a6ad-27ed5a0a8522,GGZ Oost Brabant,ggz_oost_brabant,,,,,, +3525,,16896f82-7147-11e6-a0cd-0242ac12000b,SENTYNL THERAPS INC,sentynl_theraps_inc,,,,,, +455,0.958341,964ac62f-bdf9-4059-a3e2-964f54f87cdb,Solvay Pharmaceuticqals B.V,solvay_pharmaceuticqals_b_v,,,,792dba77-9941-4659-aa31-5f86a7b2ad5b,solvay_pharmaceuticals_b_v,Solvay Pharmaceuticals B.V +3526,,3a9f56c4-9fbb-4e10-8b10-a49e643dd61a,Revalesio Corporation,revalesio_corporation,,,,,, +3527,,66743fcb-b1b2-4731-ac02-d4145460352b,Odense University Hospital,odense_university_hospital,,,,,, +3528,,85b86a82-e503-4329-88c6-ffdf7328e582,"Pulmonary Department, Gentofte Hospital",pulmonary_department_gentofte_hospital,,,,,, +3529,,bda2f10b-0055-4ce9-8515-8a1bbe6abfad,OA Doz. Dr. Thomas Müller c/o B&S Zentrallabor Konventhospital Barmherzige Brüder Linz,oa_doz_dr_thomas_m_ller_c_o_b_s_zentrallabor_konventhospital_barmherzige_br_der_linz,,,,,, +384,0.94804,8aa216f5-6b16-4908-9de4-6ff33dd6be69,The Univeristy of Nottingham,the_univeristy_of_nottingham,,,,8aa216f5-6b16-4908-9de4-6ff33dd6be69,the_univeristy_of_nottingham,The Univeristy of Nottingham +3530,,f6c6284b-870a-4229-96d8-963990528198,University of Rochester,university_of_rochester,,,,,, +458,0.98385661840438843,d927af23-71f2-4fd9-95f3-8ba0fa0b7578,"Janssen-Cilag International NV,Turnhoutseweg 30, 2340 Beerse, Belgium",janssen_cilag_international_nv_turnhoutseweg_30_2340_beerse_belgium,,,,3baabec0-1bc8-4e64-b010-70f6fcb400f2,jassen_cilag_international_nv_turnhoutseweg_30_2340_beerse_belgium,"Jassen-Cilag International NV,Turnhoutseweg 30, 2340 Beerse, Belgium" +3531,,7b64fec4-ee09-428c-ae9d-4172d633d944,Certmedica International GmbH,certmedica_international_gmbh,,,,,, +60,0.96309179067611694,c5d2e92d-817f-494c-8e69-41dd6341a522,Wyeth Research Division of Wyeth Pharmaceuticals Inc (a Pfizer Company),wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc +3532,,4f47aa78-7142-11e6-a0cd-0242ac12000b,MAST MM,mast_mm,,,,,, +3533,,5039c5b0-7160-11e6-a0cd-0242ac12000b,FLEMING PHARMS,fleming_pharms,,,,,, +3534,,24659412-1453-4dc9-870a-e4e7a107b011,ACCORD University of Edinburgh,accord_university_of_edinburgh,,,,,, +3535,,26861c79-8704-4677-8cd7-f6754152b755,ikfe GmbH,ikfe_gmbh,,,,,, +1041,0.97318911552429199,f84e2ab7-3032-4234-ba0d-3020f0de6fde,Celgene,celgene,,,,64e4c2d9-005c-4577-8791-92439d12eda2,celgene_corporation,Celgene Corporation +3536,,d150e3cf-c998-429a-8ace-6dc6dc6afbbf,"Carbylan BioSurgery, Inc",carbylan_biosurgery_inc,,,,,, +3537,,da0b59f8-70a7-47a1-b459-a2af4036bbf5,University Medical Center Hamburg-Eppendorf,university_medical_center_hamburg_eppendorf,,,,,, +3538,,068ca669-db79-4420-9927-4555606e7c7c,Martin Luther University of Hallle/Wittenburg,martin_luther_university_of_hallle_wittenburg,,,,,, +3539,,cd91e44e-3561-449f-9e91-fed12d985d1a,"Pharmazam, S.A",pharmazam_s_a,,,,,, +1078,0.95782852172851562,ca983e11-79a7-4cbe-9340-f9e67b19e0cf,"IBSA, Institute Biochimique S.A",ibsa_institute_biochimique_s_a,,,,1242e11a-4288-492d-8023-e4ffe5a4e9bd,ibsa_institute_biochimique_sa,IBSA Institute Biochimique SA +162,0.96508872509002686,045ba97e-7848-45f2-b26b-86cc761804b6,Norfolk and Norwich University Hospitals NHS Foundation Trust,norfolk_and_norwich_university_hospitals_nhs_foundation_trust,,,,045ba97e-7848-45f2-b26b-86cc761804b6,norfolk_and_norwich_university_hospitals_nhs_foundation_trust,Norfolk and Norwich University Hospitals NHS Foundation Trust +3540,,b264048d-bd26-4c92-b45d-79b49badd343,Novagali Pharma SA,novagali_pharma_sa,,,,,, +836,0.98650866746902466,ae273ddc-9a36-42fc-9c53-b60041ff6a52,NHS Greater Glasgow & Clyde,nhs_greater_glasgow_clyde,,,,8b728024-8fd6-4d73-82c9-94fcbe26c730,nhs_greater_glasgow_clyde_r_d_office,NHS Greater Glasgow & Clyde R&D Office +3541,,f2e52de5-ff86-48f9-8cd7-d882190e2795,GlaxoSmithKline Research and Devlopment Ltd,glaxosmithkline_research_and_devlopment_ltd,,,,,, +3542,,c8eab104-b4aa-4301-ac96-889a23ca977b,POLICHEM,polichem,,,,,, +603,0.98583465814590454,a0ddc1d2-40ab-45fd-8ead-18f31c252ce2,Fundación para la Investigación y desarrollo en el Área Cardiovascular,fundaci_n_para_la_investigaci_n_y_desarrollo_en_el_rea_cardiovascular,,,,6eb8c187-922d-4265-a290-1d2eaf8c0f5f,fundaci_n_para_la_investigaci_n_y_desarrollo_en_el_rea_cardiovascular_fic,Fundación para la Investigación y Desarrollo en el Área Cardiovascular (FIC) +282,0.96157515048980713,672cc16b-a1f9-47a6-864e-1ffd1fbe267d,"Sahlgrenska University Hospital, Östra",sahlgrenska_university_hospital_stra,,,,2f33c154-cafb-40b1-8fdc-8c3e78823f79,sahlgrenska_university_hospital,Sahlgrenska University Hospital +3543,,3a649bcb-adf2-48e5-bd96-9a9520c32212,Jansen-Cilag International N.V,jansen_cilag_international_n_v,,,,,, +3544,,b3c0b3da-6eee-447b-ab71-586acf78ea7e,Medical Centre Leeuwarden,medical_centre_leeuwarden,,,,,, +3545,,df25741a-715e-11e6-a0cd-0242ac12000b,ESI,esi,,,,,, +3546,,fa931d6f-4497-4cf9-b305-c07eeb9a54a3,Portuguese Lung Cancer Study Group,portuguese_lung_cancer_study_group,,,,,, +97,0.988116,fe10a55d-dd0e-4ce1-b012-70158b48434c,Newron Pharmaceuticals SpA,newron_pharmaceuticals_spa,,,,9abd20d6-1c2a-4aeb-922e-ae371ab88700,newron_pharmaceuticals,Newron Pharmaceuticals +3547,,dc11babf-a704-11e6-94cb-5656d04fc2b5,Dainippon Sumitomo Pharma America Ltd,dainippon_sumitomo_pharma_america_ltd,,,,,, +3548,,6e021816-7a43-4054-8d70-97ba4c2127a3,Gastroenterology UZ Gasthuisberg,gastroenterology_uz_gasthuisberg,,,,,, +214,0.975452,1ad07c8c-d03b-4847-bbe9-1ac8e4b893aa,Innsbruck Medical University,innsbruck_medical_university,,,,1ad07c8c-d03b-4847-bbe9-1ac8e4b893aa,innsbruck_medical_university,Innsbruck Medical University +3549,,28a7f954-09e2-47c3-a10c-4f9d40864356,Buckinghamshire Hospitals NHS Trust,buckinghamshire_hospitals_nhs_trust,,,,,, +3550,,e058bc88-3323-4040-8188-37010595558d,Weleda AG,weleda_ag,,,,,, +3551,,97480860-986f-4d47-a021-9ae95c1de16b,Calthorpe Clinic,calthorpe_clinic,,,,,, +3552,,f26c7809-f7bf-483e-aada-f4ab399e2bc3,"Department of Anaesthesie, General Intensive Care and Pain Therapy",department_of_anaesthesie_general_intensive_care_and_pain_therapy,,,,,, +3553,,3cf68ae6-381a-4c2b-9536-b087f6087b46,Anæstesiologisk Afd. Herlev Hospital,an_stesiologisk_afd_herlev_hospital,,,,,, +3554,,2818281a-7160-11e6-a0cd-0242ac12000b,ABC HOLDING,abc_holding,,,,,, +592,0.98310869932174683,b254d686-8bcf-4d48-9680-768d5a970e5e,"Medical University of Innsbruck, Austrian AGO Trial Centre",medical_university_of_innsbruck_austrian_ago_trial_centre,,,,75cfe52c-155f-4652-b05d-d246407f7a2f,medical_university_of_innsbruck,Medical University of Innsbruck +3555,,fb79415e-71f8-4943-8fd3-2fbfbef4b697,Salsarulo Pharma,salsarulo_pharma,,,,,, +116,0.94879655043284095,890908c2-1257-446a-a1d5-1de688f7b6d2,Shire Pharmaceutical Development Inc,shire_pharmaceutical_development_inc,,,,63ca73d2-fd68-4693-872c-2121b000d68c,shire_pharmaceutical_development,Shire Pharmaceutical Development +3556,,527ff895-2eae-4b6d-b625-af84e3b8572d,Všeobecná fakultní nemocnice v Praze,v_eobecn_fakultn_nemocnice_v_praze,,,,,, +3557,,655b3afd-fabd-40db-ad30-8b394590ab26,Peterborough and Stamford Hospitals NHS Foundation Trust,peterborough_and_stamford_hospitals_nhs_foundation_trust,,,,,, +3558,,8c07e94c-8c2b-4cae-a84f-5901c9598b2f,"TESARO UK Limited, (c/o Sisec Limited)",tesaro_uk_limited_c_o_sisec_limited,,,,,, +3559,,dc40a8b5-8197-4d7d-a503-8c9068ca6544,Beroendcentrum Stockholm,beroendcentrum_stockholm,,,,,, +3560,,2b36ec6c-8536-4a43-ab91-dd2ae8a89856,PROF. ALFREDO CHETTA,prof_alfredo_chetta,,,,,, +3561,,e51bf8ab-ba0a-4ab2-8b3e-3803f8913ba4,"Urologische Klinik und Poliklinik, Klinikum Großhadern der LMU München",urologische_klinik_und_poliklinik_klinikum_gro_hadern_der_lmu_m_nchen,,,,,, +3562,,41992939-5d76-4653-98d6-1891297fc87c,Universitätsklinikum Ulm (AöR),universit_tsklinikum_ulm_a_r,,,,,, +3563,,6ce4a628-467d-4c32-9759-f3aafb183efe,Norgine Pharma,norgine_pharma,,,,,, +3564,,a321fd62-981d-4e0c-b83d-b56631628040,"RWTH Aachen, Medizinische Fakultät",rwth_aachen_medizinische_fakult_t,,,,,, +3565,,0c5b0ccd-8a8d-45e4-b3df-fca76eebab97,Laboratorios del Dr Esteve S.A,laboratorios_del_dr_esteve_s_a,,,,,, +3566,,9ff9f635-3037-45fe-84bb-83d844700175,Sandwell and West Birmingham Hospitals NHS Trust,sandwell_and_west_birmingham_hospitals_nhs_trust,,,,,, +3567,,003d51f8-70e0-411b-94fd-5281d56c5c9c,Univ. Klinik für Anästhesiologie,univ_klinik_f_r_an_sthesiologie,,,,,, +3568,,ded09bd4-3d9f-446e-ac0f-fd9eedc9edd7,Pierrel Research Europe GmbH,pierrel_research_europe_gmbh,,,,,, +3569,,5c4d14ec-fa70-48bc-b979-fa947dcd715a,co.don AG,co_don_ag,,,,,, +366,0.98152613639831543,17a7c9c8-3636-4a11-a0b2-a237ca2e374e,Bayer Health Care AG,bayer_health_care_ag,,,,17a7c9c8-3636-4a11-a0b2-a237ca2e374e,bayer_health_care_ag,Bayer Health Care AG +3570,,9f5fc2a3-e2fa-4c09-aea8-9e377f2d03a4,"Asubio Pharmaceuticals, Inc",asubio_pharmaceuticals_inc,,,,,, +3571,,08ac6409-e0a2-4fd0-ac08-be68e17f1732,Novartis Pharma Sevices AG,novartis_pharma_sevices_ag,,,,,, +772,0.985698,6faaed46-35f6-404d-9128-03b55daaae47,Abbott GmbH & Co. KG,abbott_gmbh_co_kg,,,,6faaed46-35f6-404d-9128-03b55daaae47,abbott_gmbh_co_kg,Abbott GmbH & Co. KG +3572,,56482c23-5635-489f-bf8b-1d00a2a39596,STZ 1172 Gesundheitsförderung und Stoffwechselforschung,stz_1172_gesundheitsf_rderung_und_stoffwechselforschung,,,,,, +3573,,b37ce0eb-7b4d-4aa4-9ae9-1e6b5d35a435,Dendreon Corporation,dendreon_corporation,,,,,, +3574,,b1ce44b7-22fd-46c0-9b5b-5fd9a515d486,"Ferrer International, SA",ferrer_international_sa,,,,,, +3575,,c8f10cd3-1675-4927-b263-8cc6d18ec8d2,"MUW, Innere Med III, Abt.für Endokrinologie & Stoffwechsel",muw_innere_med_iii_abt_f_r_endokrinologie_stoffwechsel,,,,,, +3576,,898e1916-aef6-4174-8433-fdb4c05e9c66,NV Organon,nv_organon,,,,,, +3577,,dcb296bd-58b9-4362-be48-f28622f1708f,NINDS,ninds,,,,,, +3578,,d3bc185a-ba63-4dc7-95de-d32ad001f80f,Fundacio Clinic per a la recerca biomedica,fundacio_clinic_per_a_la_recerca_biomedica,,,,,, +3579,,d7642547-797b-4a10-92b2-ca0afa0fe821,Neurologische Klinik Bad Neustadt,neurologische_klinik_bad_neustadt,,,,,, +3580,,4d583a06-a059-4dfa-acf3-36f4dda56342,Axovant Sciences Ltd,axovant_sciences_ltd,,,,,, +3581,,4d2b5282-0ddf-4c86-8cc6-29b845ae014f,AININCAR,ainincar,,,,,, +407,0.97863081097602844,a2239364-7b3d-4f3a-af6f-e5452d1b0cf6,"Trius Therapeutics, a Wholly Owned Subsidiary of Cubist Pharmaceuticals, Inc",trius_therapeutics_a_wholly_owned_subsidiary_of_cubist_pharmaceuticals_inc,,,,2313c489-596d-4d80-8c94-aa42d3a2f015,trius_therapeutics_a_wholly_owned_subsidiary_of_cubist,"Trius Therapeutics, a Wholly Owned Subsidiary of Cubist" +87,0.983343,37a68bfe-7148-11e6-a0cd-0242ac12000b,MORTON GROVE PHARMS,morton_grove_pharms,,,,37900e74-7148-11e6-a0cd-0242ac12000b,morton_grove,MORTON GROVE +3582,,91751ae7-d823-4a71-90d7-1a9305a67374,University Hospital of Erlangen,university_hospital_of_erlangen,,,,,, +3583,,117e8327-c077-4248-8024-526045ba8543,Robapharm AG,robapharm_ag,,,,,, +3584,,9071994c-6f5c-4100-9cf4-2cf412eab874,NORDIC BIOSCIENCE,nordic_bioscience,,,,,, +3585,,f8f2d310-73f7-11e6-a0cd-0242ac12000b,LINDE GAS NORTH AMERICA LLC,linde_gas_north_america_llc,,,,,, +686,0.94387978315353394,6a59a49b-a6f0-423a-b72f-c211ebd85c3d,University Medical Center Goettingen,university_medical_center_goettingen,,,,6a59a49b-a6f0-423a-b72f-c211ebd85c3d,university_medical_center_goettingen,University Medical Center Goettingen +3586,,8edc7236-7142-11e6-a0cd-0242ac12000b,PVT FORM,pvt_form,,,,,, +3587,,2298786c-556a-48d6-a94b-045e98dc24b1,"CUB Hôpital Erasme, Department of Anesthesiology",cub_h_pital_erasme_department_of_anesthesiology,,,,,, +3588,,390398d4-0b00-4861-852d-1b99e83bbe96,Queen's Medical centre,queen_s_medical_centre,,,,,, +3589,,c84100f1-f768-4d5c-8d22-7e962f242dc6,"The Multiple Sclerosis Research Group, Department of Clinical Neuroscience",the_multiple_sclerosis_research_group_department_of_clinical_neuroscience,,,,,, +470,0.97350867589314782,e6c53557-058c-4969-833a-fd74ba05abe2,European Group for Blood and Marrow Transplantation (EBMT),european_group_for_blood_and_marrow_transplantation_ebmt,,,,2a4e4a42-e5c4-4da8-8f1f-18343eeb1fbc,european_group_for_blood_and_marrow_transplantation,European Group for Blood and Marrow Transplantation (EMBT) +390,0.97664374113082886,413059c9-efe8-46ed-89b0-70745ccb57a6,Galderma research & Development,galderma_research_development,,,,b5653343-db85-468f-9ea0-a6d1b957afa2,galderma_research_development,Galderma research & Development +418,0.977699,3a88d7e1-4064-447e-a62a-a9900c4f088e,INCYTE,incyte,,,,3a88d7e1-4064-447e-a62a-a9900c4f088e,incyte,INCYTE +712,0.97988840937614441,b5efd841-9b97-4591-a757-2af84a394472,Reckitt Benckiser Healthcare International Limited,reckitt_benckiser_healthcare_international_limited,,,,38c6b681-96aa-439b-8189-1ea1e741e51b,reckitt_benckiser_healthcare_international,Reckitt Benckiser Healthcare International +965,0.981266,ebeb3cd3-dfb5-4770-b59c-1ee248474bce,"Göteborg University, Sect. Psychiatry and Neurochemistry",g_teborg_university_sect_psychiatry_and_neurochemistry,,,,b75dc5c8-3735-4c68-a632-699239b52e79,g_teborg_university_sect_psyhiatry_and_neurochemistry,"Göteborg University, Sect. Psyhiatry and Neurochemistry" +3590,,cf032205-b5f1-4ed8-872a-15c8729daec3,"Medizinische Universität Wien, Univ. Klinik f. Klinische Pharmakologie",medizinische_universit_t_wien_univ_klinik_f_klinische_pharmakologie,,,,,, +3591,,bae3310f-518f-4cde-9f72-3981c8a7bb22,Regensburg University Hospital,regensburg_university_hospital,,,,,, +3592,,0342fbd4-a0db-4f1a-b751-cd229eb9bb9b,"Hospital General ""Gregorio Marañón",hospital_general_gregorio_mara_n,,,,,, +3593,,b8695dd5-485c-422c-8f91-460057752ca2,Boehringer Ingelheim GmbH,boehringer_ingelheim_gmbh,,,,,, +583,0.96693354845046997,a72d6b04-e5e5-483f-9071-b0af00c0a0c2,MSD,msd,,,,a72d6b04-e5e5-483f-9071-b0af00c0a0c2,msd,MSD +981,0.97865206003189087,7924c511-76dd-4819-aff7-6958da1692ce,"Bispebjerg Hospital, Department of Dermatology",bispebjerg_hospital_department_of_dermatology,,,,7924c511-76dd-4819-aff7-6958da1692ce,bispebjerg_hospital_department_of_dermatology,"Bispebjerg Hospital, Department of Dermatology" +3594,,6a8da5f0-538d-4587-87b3-df32aee83389,"Pharmaceutical Research Network, LLC",pharmaceutical_research_network_llc,,,,,, +3595,,d3501790-a74a-4e14-aaf1-13cfe7ecdd53,Mona R Gätke,mona_r_g_tke,,,,,, +3596,,e18c792d-d960-4b09-b31d-aac321919600,Basilea Pharmaceutica Ltd,basilea_pharmaceutica_ltd,,,,,, +3597,,da2d1a59-644f-4cce-844b-4f0a45be1947,"Dept. Ob.Gyn, Univ Oulu",dept_ob_gyn_univ_oulu,,,,,, +3598,,346e223d-1a6a-4984-b186-1c551bc9b345,Ursapharm Arzneimittel GmbH,ursapharm_arzneimittel_gmbh,,,,,, +3599,,a895274e-73f6-49b4-9c4e-cfd03c07f1c9,University of Göttingen, Dep. of Clinical Pharmacology,,,,,, +721,0.98208,01b65e7e-316f-44bb-97c2-362060dad470,TROPHOS,trophos,,,,01b65e7e-316f-44bb-97c2-362060dad470,trophos,TROPHOS +3600,,6b34fbe8-b56f-47c6-a41f-5f1bd7812a70,Clinipace GLobal Ltd,clinipace_global_ltd,,,,,, +3601,,c60ff36b-1ab3-4bf3-959b-ba6ff632b9b5,Astra Zeneca AB,astra_zeneca_ab,university_of_g_ttingen_dep_of_clinical_pharmacology,,,,, +3602,,1ca72f6c-433a-4831-89fd-adeea28b43f0,"Orthopaedic Research Laboratory, Århus University Hospital",orthopaedic_research_laboratory_rhus_university_hospital,,,,,, +3603,,c7e41fa7-4d75-4607-9cdb-dcb1fe40dbf6,AZIENDA OSPEDALIERA ORDINE MAURIZIANO,azienda_ospedaliera_ordine_mauriziano,,,,,, +3604,,87e66e0c-3b29-437b-b867-c8d3de5bc3ba,Central Manchester and Manchester Children's Hospital University NHS Trust,central_manchester_and_manchester_children_s_hospital_university_nhs_trust,,,,,, +3605,,d4d8cdc6-4b0b-4bfc-ac78-7a8db0891c70,ISDIN,isdin,,,,,, +3606,,febd83e8-bc81-4831-88a7-584bbed25731,Alfa Wassermann SpA,alfa_wassermann_spa,,,,,, +3607,,bed52de6-453f-4bbe-903f-a40e8ca6861d,"MERIT MEDICAL SYSTEMS, INC",merit_medical_systems_inc,,,,,, +50,0.902909,b0114826-49b0-41da-9e10-6bec93417396,EUSA pharma SAS,eusa_pharma_sas,,,,098236a3-98ed-47c3-8dcd-a916a201d337,eusa_pharma,EUSA Pharma +3608,,b136b4ed-3af7-48ec-ad9d-c3f3ef41350f,Novartis Pharma B.V,novartis_pharma_b_v,,,,,, +3609,,497dedc6-7de3-4beb-84f8-53c86e9107f5,GERENCIA DE ATENCIÓN PRIMARIA,gerencia_de_atenci_n_primaria,,,,,, +3610,,9da8fcbc-733b-11e6-a0cd-0242ac12000b,BIODELIVERY SCI INTL,biodelivery_sci_intl,,,,,, +3611,,c9bea4e8-f92d-48e5-9618-7a4e24528135,Centre René Gauducheau,centre_ren_gauducheau,,,,,, +3612,,13ad6677-508e-481c-9204-9d6c6273fb0f,FONDAZIONE SANTA LUCIA,fondazione_santa_lucia,,,,,, +3613,,4cf6f811-6752-461e-8db1-e8486b48c280,Araim Pharmaceuticals,araim_pharmaceuticals,,,,,, +168,0.98042827844619751,64386d51-a811-451e-9352-45afeb68a88e,"Merck Serono SA - Geneva, an affiliate of Merck KGaA,",merck_serono_sa_geneva_an_affiliate_of_merck_kgaa,,,,248e9396-0a3f-4ee2-b65a-5844a00bc75e,merck_serono_sa_geneva,Merck Serono SA - Geneva +3614,,3bad19b9-809c-491f-93e9-b833b3f3ad3d,Walton Centre NHS Foundation Trust,walton_centre_nhs_foundation_trust,,,,,, +3615,,266f690e-eb59-4de5-8af5-c13cca34f768,Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud,fundaci_n_p_blica_andaluza_para_la_investigaci_n_de_m_laga_en_biomedicina_y_salud,,,,,, +3616,,8a88db86-5c84-4605-85a1-178cfbeb080e,Greenpark Health Care Trust,greenpark_health_care_trust,,,,,, +3617,,844cd926-3f5a-43c6-9ebc-ae104090ade0,"Uppsala University Hospital, MHT, Department of Nephrology",uppsala_university_hospital_mht_department_of_nephrology,,,,,, +520,0.97626614570617676,da2c7cf7-0913-42b9-90fb-cdba8baae892,ROCHE,roche,,,,da2c7cf7-0913-42b9-90fb-cdba8baae892,roche,ROCHE +3618,,4482db1c-719c-11e6-a0cd-0242ac12000b,AKRIMAX PHARMS,akrimax_pharms,,,,,, +3619,,be358614-a576-4abf-9271-ae913e1e11bb,University of Bristol,university_of_bristol,,,,,, +3620,,22d241f0-715c-11e6-a0cd-0242ac12000b,KUDCO IRELAND,kudco_ireland,,,,,, +3621,,8c85fd94-7161-11e6-a0cd-0242ac12000b,AUXILIUM PHARMS LLC,auxilium_pharms_llc,,,,,, +3622,,2574363f-e64d-4766-a5d6-6a8657dd1edc,Universitäres Herzzentrum Hamburg,universit_res_herzzentrum_hamburg,,,,,, +3623,,24e00e4d-e123-4ee1-a31a-476d4606fbc0,Shionogi Inc,shionogi_inc,,,,,, +3624,,44f6de76-03d9-480e-a29d-390e5eb68c0d,University of Saarland,university_of_saarland,,,,,, +3625,,6246d8b9-7f90-494b-b703-42ba2ae22d23,Charité University Medicine,charit_university_medicine,,,,,, +3626,,11d76cd6-a8ec-4e63-8df1-75115f5b5a14,Bayer Healthcare LLC,bayer_healthcare_llc,,,,,, +3627,,bb32ffb9-a803-4a8d-bdde-509bcb189da2,Centre Oscar Lambret,centre_oscar_lambret,,,,,, +3628,,0447e916-4e9a-4d71-b01a-429f4d463731,Cambridge University Hospital NHS Foundation Trust,cambridge_university_hospital_nhs_foundation_trust,,,,,, +3629,,9db80b71-14a2-4709-b7b5-d67b5c1ea73d,Dr. Juan Jesús Gómez-Reino Carnota,dr_juan_jes_s_g_mez_reino_carnota,,,,,, +3630,,cb35fff2-700c-4c06-bd17-5e27af3b69c1,JESUS GONZALEZ BARBOTEO,jesus_gonzalez_barboteo,,,,,, +602,0.988116,cf2f842c-f2cd-4905-96b8-12fcfaeb3ea9,Syndax Pharmaceuticals Inc,syndax_pharmaceuticals_inc,,,,cf2f842c-f2cd-4905-96b8-12fcfaeb3ea9,syndax_pharmaceuticals_inc,Syndax Pharmaceuticals Inc +3631,,c4b88c6e-7165-11e6-a0cd-0242ac12000b,INVENTIA HLTHCARE,inventia_hlthcare,,,,,, +3632,,2317b349-a864-4a49-bc5d-f971b5c7b2c0,Ergonex Pharma GmbH,ergonex_pharma_gmbh,,,,,, +3633,,de7a851e-6311-4424-bdb4-5cb9b0990115,Lunamed Operations AG,lunamed_operations_ag,,,,,, +3634,,afe64e7c-788a-4194-923e-66b108a54ced,Institut Sainte Catherine,institut_sainte_catherine,,,,,, +3635,,b347393d-46d2-4033-bb7c-2ea12cbd08f6,OraPharma Inc,orapharma_inc,,,,,, +8,0.90233862400054932,2522451a-1c66-4b28-bcf5-7bcf3f2f11b8,Centre Hospitalier Universitaire de Saint-Etienne,centre_hospitalier_universitaire_de_saint_etienne,,,,2522451a-1c66-4b28-bcf5-7bcf3f2f11b8,centre_hospitalier_universitaire_de_saint_etienne,Centre Hospitalier Universitaire de Saint-Etienne +437,0.99035966396331787,a9a77d6a-a71d-48c7-993a-d57932d81ec2,"Pfizer Inc. 235 East 42nd Street, New York, 10017 USA",pfizer_inc_235_east_42nd_street_new_york_10017_usa,,,,8f1c3548-7a20-4796-a59b-3b727921d4f1,pfizer_inc_235_east_42nd_street_new_york_10017_us,"Pfizer Inc. 235 East 42nd Street, New York, 10017 US" +3636,,26238b0a-a8aa-4f46-99f0-fe278fcb367b,IRCCS- Mario Negri Institute,irccs_mario_negri_institute,,,,,, +3637,,ad249728-f74c-4dd3-855a-ddf493a6ba0e,Oncology Institute of Vilnius University,oncology_institute_of_vilnius_university,,,,,, +144,0.938386,26bb805d-b0a7-4b5c-bcee-c5480afe6696,Joint UCLH & UCL Biomedical Research Unit,joint_uclh_ucl_biomedical_research_unit,,,,26bb805d-b0a7-4b5c-bcee-c5480afe6696,joint_uclh_ucl_biomedical_research_unit,Joint UCLH & UCL Biomedical Research Unit +3638,,8a0fe414-b8b9-4987-b3d9-4a2a59ec77d4,Jari Tiihonen,jari_tiihonen,,,,,, +932,0.98627001047134399,2bfd78d4-7d7c-4e8a-84f2-b5f057dd988e,Pierre Fabre Médicament/Institut de Recherche Pierre Fabre,pierre_fabre_m_dicament_institut_de_recherche_pierre_fabre,,,,11113f5a-7350-422c-bd14-c920aa2332af,pierre_fabre_medicament_institut_de_recherche_pierre_fabre,Pierre Fabre Medicament/Institut de Recherche Pierre Fabre +770,0.984713,ec667aae-71ca-11e6-a0cd-0242ac12000b,DELCOR ASSET,delcor_asset,,,,1a3a35f8-7142-11e6-a0cd-0242ac12000b,delcor_asset_corp,DELCOR ASSET CORP +3639,,381c0626-a816-4104-83a5-496ccaa1ca10,"AstraZeneca AB; Karlebyhus, Astraallén, Södertälje SE-151 85, Sweden",astrazeneca_ab_karlebyhus_astraall_n_s_dert_lje_se_151_85_sweden,,,,,, +3640,,811140e3-7421-4526-9c54-46992f382dc8,Máxima Medisch Centrum,m_xima_medisch_centrum,,,,,, +228,0.908956,71bfef34-9b92-45f4-b0bf-ace9ff180a19,St. George's University of London (SGUL),st_george_s_university_of_london_sgul,,,,67f8d943-3794-4830-beba-23b1e4232b8d,st_george_s_university_of_london,"St. George's, University of London" +3641,,13fcbae8-7157-11e6-a0cd-0242ac12000b,KV PHARM,kv_pharm,,,,,, +3642,,07665300-0a32-44f3-b4c4-ffc6dfddce12,The Royal Marsden Foundation Trust and The Institute of Cancer Research,the_royal_marsden_foundation_trust_and_the_institute_of_cancer_research,,,,,, +3643,,c113db7c-7197-11e6-a0cd-0242ac12000b,AQUA PHARMS,aqua_pharms,,,,,, +3644,,6f342e64-095a-4f8b-906d-5bdfdfde2f56,"Medizinische Universität Wien, Univ.Klinik KIM II, Abteilung für Kardiologie",medizinische_universit_t_wien_univ_klinik_kim_ii_abteilung_f_r_kardiologie,,,,,, +3645,,537d652f-ae82-4ad4-915d-2bb5462ca14b,Guillem Cuatrecasas Cambra,guillem_cuatrecasas_cambra,,,,,, +3646,,0efb46cc-5369-4941-9185-9c169b46876f,TRBChemedica,trbchemedica,,,,,, +3647,,60444226-7e5f-4583-bbc0-7aa0a84e7df5,Pilar Samper Ots,pilar_samper_ots,,,,,, +512,0.976744,0d23d029-d573-4d0e-aaab-1b66e6a0fd64,"Novartis Farmacéutuca, S.A",novartis_farmac_utuca_s_a,,,,0d23d029-d573-4d0e-aaab-1b66e6a0fd64,novartis_farmac_utuca_s_a,"Novartis Farmacéutuca, S.A" +13,0.97626614570617676,24b88c8e-7145-11e6-a0cd-0242ac12000b,LUPIN LTD,lupin_ltd,,,,24b88c8e-7145-11e6-a0cd-0242ac12000b,lupin_ltd,LUPIN LTD +3648,,b3a8938f-3a61-47c6-ad6e-f81cf9ddd2b3,"bluebird bio, Inc",bluebird_bio_inc,,,,,, +3649,,8853143a-7145-11e6-a0cd-0242ac12000b,QUANTUM PHARMICS,quantum_pharmics,,,,,, +843,0.970735,95284310-8707-4697-ae32-b0baf209234a,Rikshospitalet,rikshospitalet,,,,759e05f5-7472-4ddb-baa8-c26f62d421d9,rikshospitalet_university_hospital_university_of_oslo,"Rikshospitalet University Hospital, University of Oslo" +3650,,86e0dbc2-353a-4853-90df-f26a640c72ca,Fundación Centro Nacional de Investigaciones Oncológicas Carlos III (CNIO),fundaci_n_centro_nacional_de_investigaciones_oncol_gicas_carlos_iii_cnio,,,,,, +3651,,323fd28f-0379-4cd4-abea-90066fc67253,"Med. Uni. Wien, Klinik für Innere I",med_uni_wien_klinik_f_r_innere_i,,,,,, +3652,,6bd05c85-7e1e-4e34-8ef5-3ecc455755ca,FORIM GmbH,forim_gmbh,,,,,, +3653,,478a6472-af44-40c3-b140-def42b50028d,infirst HEALTHCARE,infirst_healthcare,,,,,, +238,0.95441973209381104,3438eb84-9448-480b-915c-1c1511546785,"Pfizer Limited, Ramsgate Road,Sandwich,Kent CT13 9NJ",pfizer_limited_ramsgate_road_sandwich_kent_ct13_9nj,,,,3438eb84-9448-480b-915c-1c1511546785,pfizer_limited_ramsgate_road_sandwich_kent_ct13_9nj,"Pfizer Limited, Ramsgate Road,Sandwich,Kent CT13 9NJ" +3654,,3bb91b23-23b2-4262-a95c-82f7c214cca6,OptiNose UK Ltd,optinose_uk_ltd,,,,,, +3655,,38d2f88c-e5be-4d6f-9900-947d51ad8c6f,Protherics Development Medicines Ltd,protherics_development_medicines_ltd,,,,,, +3656,,054d5114-4292-4f30-82de-52f705161eca,Dr. César Sánchez Sánchez,dr_c_sar_s_nchez_s_nchez,,,,,, +3657,,8ef2af5e-eae9-4f66-97f9-445130c27bfd,Nutrim,nutrim,,,,,, +3658,,3b4e1ce8-592c-4829-a834-8ffadcd23700,"R and D Department, Cardiff and the Vale NHS Trust",r_and_d_department_cardiff_and_the_vale_nhs_trust,,,,,, +3659,,8d1afdaa-b1e6-4d79-a74f-7033246b21d7,Respiratory and Allergy Research Unit,respiratory_and_allergy_research_unit,,,,,, +3660,,cf105247-9a58-417a-a14b-5cad311471a6,"Janssen Oncology, Inc",janssen_oncology_inc,,,,,, +71,0.95618447661399841,a50a5323-eb43-4b40-8b80-cb222451e80b,Takeda Europe R&D Center Ltd,takeda_europe_r_d_center_ltd,,,,a50a5323-eb43-4b40-8b80-cb222451e80b,takeda,Takeda +3661,,fa72803a-8812-11e6-a998-0242ac12000b,Nordion (Canada) Inc,nordion_canada_inc,,,,,, +3662,,cd52695e-2ffe-44bc-af6c-ecc5d5764c24,Fundación Universidad de Salamanca,fundaci_n_universidad_de_salamanca,,,,,, +3663,,bbb44c51-68bc-4c32-bafb-c06795cee0d8,Allergy Centre,allergy_centre,,,,,, +865,0.987308,98172a5d-4f63-4af5-97a8-b1a01d9344ff,United Therapeutics Corporation,united_therapeutics_corporation,,,,98172a5d-4f63-4af5-97a8-b1a01d9344ff,united_therapeutics_corporation,United Therapeutics Corporation +1043,0.987372,6441853c-c50a-4eeb-acbc-a29226d17b89,University of Oxford,university_of_oxford,,,,6441853c-c50a-4eeb-acbc-a29226d17b89,university_of_oxford,University of Oxford +703,0.96583342552185059,09b03690-5970-415f-b749-e56be3b9df7b,University Hospitals Leicester NHS Trust,university_hospitals_leicester_nhs_trust,,,,09b03690-5970-415f-b749-e56be3b9df7b,university_hospitals_leicester_nhs_trust,University Hospitals Leicester NHS Trust +3664,,ae95f75c-6fba-11e6-abe8-0242ac12000b,"Department of Obstetrics and Gynaecology, Karolinska Institutet, Stockholm",department_of_obstetrics_and_gynaecology_karolinska_institutet_stockholm,,,,,, +3665,,d8fcd4a1-3be3-440b-87f0-2252e0d4226e,"Medical Sciences, Akademiska sjukhuset",medical_sciences_akademiska_sjukhuset,,,,,, +3666,,1e687fb0-bf61-4974-bda7-502db084c8a7,NHS Greater Glasgow Health Board,nhs_greater_glasgow_health_board,,,,,, +767,0.9821459949016571,d8f5d26d-62e1-49bb-a07d-419a89e892b6,"Medizinische Universität Innsbruck, Innere Medizin VI",medizinische_universit_t_innsbruck_innere_medizin_vi,,,,da4cbdf9-e1bc-4412-95a2-1df2b8781a19,medizinische_universit_t_innsbruck_innere_medizin_v,Medizinische Universität Innsbruck +952,0.98418444395065308,037d47ba-7142-11e6-a0cd-0242ac12000b,MYLAN LABS LTD,mylan_labs_ltd,,,,037d47ba-7142-11e6-a0cd-0242ac12000b,mylan_labs_ltd,MYLAN LABS LTD +3667,,e285a91b-4e04-4750-acc8-d333c500d7c2,"Dept. of Pediatric hematology and oncology, Astrid Lindgren Children´s Hosp,Karolinska Univ Hospital",dept_of_pediatric_hematology_and_oncology_astrid_lindgren_children_s_hosp_karolinska_univ_hospital,,,,,, +3668,,66e86de4-0184-485d-841c-8ae5cd13d216,Meditop Pharmaceuticals Co. Ltd,meditop_pharmaceuticals_co_ltd,,,,,, +507,0.986912,ef8114da-7128-11e6-a89e-0242ac12000b,HI TECH PHARMA,hi_tech_pharma,,,,2d581c28-7141-11e6-a0cd-0242ac12000b,hi_tech_pharma_co,HI TECH PHARMA CO +3669,,81bfbdf3-9b56-44b2-a9c6-1cb3886af6e6,Maastriccht University,maastriccht_university,,,,,, +3670,,418a8e89-c203-4eda-ae9a-bdc8a3c6ecfa,GENERICS [UK] Ltd,generics_uk_ltd,,,,,, +3671,,dbaae7a6-3c03-4978-88c6-d514927dd8fa,"St. Vincents University Hospital, Department of Rheumatology",st_vincents_university_hospital_department_of_rheumatology,,,,,, +3672,,d1bb101c-6dac-41e4-9637-36bc6ef8c3a4,"Universitätsklinik für Augenheilkunde und Optometrie, Medizinische Universität Innsbruck",universit_tsklinik_f_r_augenheilkunde_und_optometrie_medizinische_universit_t_innsbruck,,,,,, +3673,,4db0c1be-5d3d-47a7-8b3a-29e0d7060374,TYKS,tyks,,,,,, +3674,,9e105726-ba7e-4291-8cc6-9b6767248ab4,Allerderm,allerderm,,,,,, +3675,,aa0e7014-a5c9-45dc-b3ad-03f9266b812b,DR. JOAQUIM BELLMUNT MOLINS,dr_joaquim_bellmunt_molins,,,,,, +3676,,a35deaa3-8451-4760-90e0-a5895f1461e8,Department of Health,department_of_health,,,,,, +3677,,0b509dff-6ec1-4725-ab2d-06527b434d0b,MedPointe Pharmaceuticals,medpointe_pharmaceuticals,,,,,, +279,0.98237490653991699,7fdce817-2c7a-48bf-9fea-ccc1bb736300,Royal Liverpool and Broadgreen University Hospitals NHS Trust,royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,,,,7fdce817-2c7a-48bf-9fea-ccc1bb736300,royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,Royal Liverpool and Broadgreen University Hospitals NHS Trust +3678,,f203b3f6-96db-11e6-becf-0242ac110008,IRONWOOD PHARMS INC,ironwood_pharms_inc,,,,,, +3679,,77a224a0-715e-11e6-a0cd-0242ac12000b,SPERTI,sperti,,,,,, +3680,,5e5ad6f7-91ab-4d5a-8b42-702576a77d3d,Martina Hansens Hospital,martina_hansens_hospital,,,,,, +3681,,4f630c3f-86f7-45c5-9c0b-3a54fede87cf,"Copenhagen University Hospital Rigshospitalet, The Heart Center - Department of Thoracic Surgery",copenhagen_university_hospital_rigshospitalet_the_heart_center_department_of_thoracic_surgery,,,,,, +3682,,856249df-0f6a-4f77-97f8-93801fe609db,"ISTITUTO NEUROLOGICO ""CARLO BESTA",istituto_neurologico_carlo_besta,,,,,, +3683,,a2fb9301-4a66-44a2-bec0-cd23c36480c5,GlaxoSmithKline Consumer Healthcare,glaxosmithkline_consumer_healthcare,,,,,, +3684,,490c7139-d418-44c6-9062-545879ab9a88,Greater Glasgow NHS Health Board / University of Glasgow co-sponsorship,greater_glasgow_nhs_health_board_university_of_glasgow_co_sponsorship,,,,,, +3685,,16f2055b-7dd5-4672-a859-471fd1ff8338,OxyPharma AB,oxypharma_ab,,,,,, +3686,,518256cb-1a70-4d94-bb20-ff3c587153ec,Berufsverband der niedergelassenen gynäkologischen Onkologen in Deutschland e.V., BNGO e.V,,,,,, +3687,,1781ac6a-5bea-4b74-b429-cabf29dfe593,Heli Leppikangas,heli_leppikangas,,,,,, +3688,,cee0a0ca-3864-41ab-b98e-c35513cf7540,Cirugía General II. Hospital General Universitario “Gregorio Marañón”,cirug_a_general_ii_hospital_general_universitario_gregorio_mara_n,,,,,, +3689,,91cd6e5e-71d9-11e6-a0cd-0242ac12000b,SYMPLMED PHARMS LLC,symplmed_pharms_llc,berufsverband_der_niedergelassenen_gyn_kologischen_onkologen_in_deutschland_e_v_bngo_e_v,,,,, +3690,,f5105f9b-de31-4357-9bdd-59a3a2b655fb,Dutch-Belgian Cooperative Trial Group for Hematology Oncology,dutch_belgian_cooperative_trial_group_for_hematology_oncology,,,,,, +3691,,a1252940-7167-11e6-a0cd-0242ac12000b,DAEWOONG PHARM CO,daewoong_pharm_co,,,,,, +3692,,ad68ce36-6f9c-11e6-9663-0242ac12000b,McMaster University,mcmaster_university,,,,,, +317,0.985423,bb5abdb4-7141-11e6-a0cd-0242ac12000b,X-GEN PHARMS,x_gen_pharms,,,,ab7dfa68-7165-11e6-a0cd-0242ac12000b,x_gen_pharms_inc,X-GEN PHARMS INC +3693,,511c3d3f-bfe5-4066-bd28-e5074b82db0b,Chelsea Therapeutics Inc,chelsea_therapeutics_inc,,,,,, +3694,,d7b30c4b-9dfd-4d80-9711-67d4fb72fe7f,Foundation for Liver Research,foundation_for_liver_research,,,,,, +3695,,e454af36-e2fb-4b09-b0ba-9cfd434d8cee,Instituto Universitario IVI Valencia,instituto_universitario_ivi_valencia,,,,,, +704,0.963353,1f3f3cc7-8eba-4207-b34d-93cf7f7e8099,Profil Institut für Stoffwechselforschung GmbH,profil_institut_f_r_stoffwechselforschung_gmbh,,,,0fbda7a2-0e8a-489e-b902-fd13c5dec4c2,profil_institut_fuer_stoffwechselforschung_gmbh,Profil Institut fuer Stoffwechselforschung GmbH +504,0.91995066404342651,122b0a51-3453-4c2b-9161-369319d68912,"Sanofi-Synthelabo Recherche, a subsidiary of sanofi-aventis group",sanofi_synthelabo_recherche_a_subsidiary_of_sanofi_aventis_group,,,,122b0a51-3453-4c2b-9161-369319d68912,sanofi_synthelabo_recherche_a_subsidiary_of_sanofi_aventis_group,"Sanofi-Synthelabo Recherche, a subsidiary of sanofi-aventis group" +3696,,09b056fd-8710-4acd-ba1a-7d1c351ecb1a,University Hospital of Montpellier,university_hospital_of_montpellier,,,,,, +3697,,b9464f4b-b64f-4a72-b066-89745be78215,FUNDACION PARA LA INVESTIGACION CV HOSPITAL DR. PESET,fundacion_para_la_investigacion_cv_hospital_dr_peset,,,,,, +3698,,af51a734-aee4-4d2f-85a5-0e0ba812f810,"Hospital of the University of Munich, Grosshadern",hospital_of_the_university_of_munich_grosshadern,,,,,, +3699,,805f4ca3-d740-4202-898a-7c2ed74dce40,NeuroSearch A/S,neurosearch_a_s,,,,,, +3700,,cc6f90aa-7292-11e6-a0cd-0242ac12000b,TOLMAR THERAP,tolmar_therap,,,,,, +3701,,52ead9c3-074c-48a8-b4fb-1502ac263979,"Herlev Hospital, Department of Anaesthesiology I65N9",herlev_hospital_department_of_anaesthesiology_i65n9,,,,,, +3702,,c2bc2e59-d055-45a9-8668-78d4fcd1c7c0,UCB PHARMA SA/NV,ucb_pharma_sa_nv,,,,,, +3703,,64b49f9e-08e1-4d4c-8012-8c6693493f60,Institut Pasteur,institut_pasteur,,,,,, +157,0.94729951024055481,070bfa42-6fbd-11e6-abe8-0242ac12000b,"Medizinische Universität Wien, Univ.Klinik fuer Dermatologie",medizinische_universit_t_wien_univ_klinik_fuer_dermatologie,,,,f215164e-8e75-4f48-b691-ea2bfd10d042,medizinische_universit_t_wien_univ_klinik_f_r_dermatologie,"Medizinische Universität Wien, Univ. Klinik für Dermatologie" +560,0.97196030616760254,b8fa6088-d9e1-440f-94ee-dcefdd7542f6,UZ Leuven,uz_leuven,,,,069a9622-502b-4a08-9b02-c54aa4d2410f,uz_leuven_orthopedic_research,UZ Leuven Orthopedic research +3704,,ce8e426a-c2df-4b95-82b0-fcef7314c84c,Beroendecentrum Stockholm,beroendecentrum_stockholm,,,,,, +3705,,fcdecd49-0d4a-4ed8-9af1-988acf33b3dc,Maasstad Hospital,maasstad_hospital,,,,,, +129,0.96335113048553467,9bdf307c-38db-4038-96d5-79c3a5a0ebd1,Cliniques Universitaire St Luc,cliniques_universitaire_st_luc,,,,4bc32527-accc-401e-81cd-afaacbe32d0c,cliniques_universitaires_st_luc,Cliniques Universitaires St Luc +3706,,7fb912ee-28f7-425e-a9be-af87838ce1ce,INSTITUT BERGONIE,institut_bergonie,,,,,, +3707,,444a911e-719f-11e6-a0cd-0242ac12000b,DAVIS AND GECK,davis_and_geck,,,,,, +3708,,c529bc17-67b9-43be-81b1-42a4f14efb95,University of Warwick,university_of_warwick,,,,,, +3709,,d0742ee3-b129-4fc6-827e-c978f8a95c1d,"Beaufour Ipsen Pharma - 24, rue Erlanger 75016 Paris FRANCE",beaufour_ipsen_pharma_24_rue_erlanger_75016_paris_france,,,,,, +3710,,23250fbb-c38b-4a66-a36c-23a5931e5b7d,"Hjertemedicinsk klinik B, 2142, Rigshospitalet",hjertemedicinsk_klinik_b_2142_rigshospitalet,,,,,, +628,0.980402,637afab2-e42f-4094-b3b3-6cf50354727c,Queen's University Belfast,queen_s_university_belfast,,,,637afab2-e42f-4094-b3b3-6cf50354727c,queen_s_university_belfast,Queen's University Belfast +3711,,07efb3b2-a6a0-11e6-b9d4-0242ac12000b,"Dep. Nuclear medicine, Odense university hospital",dep_nuclear_medicine_odense_university_hospital,,,,,, +423,0.97237,a1ffae4a-fb57-43b0-9da3-56acbdfdf439,Universita' di Firenze, Dipartimento di Farmacologia Preclinica e Clinica,,,,0879f869-1102-4898-99d9-8197e98473d7,universita_di_firenze,Universita di Firenze +372,0.969108,24923580-c2a6-4b1d-955c-8c39f4256096,GELA,gela,,,,24923580-c2a6-4b1d-955c-8c39f4256096,gela,GELA +3712,,2a2c633f-94e9-4b12-982b-73d9ec972852,GBG Forschungsgesellschaft mbH,gbg_forschungsgesellschaft_mbh,,,,,, +3713,,228871e8-3cfe-44a3-85ff-6bae485bc072,East Sussex NHS Trust,east_sussex_nhs_trust,universita_di_firenze_dipartimento_di_farmacologia_preclinica_e_clinica,,,,, +3714,,b9ac1258-7ccb-4996-9014-905fe54127a7,Septodont,septodont,,,,,, +3715,,0e409f02-8d4c-44d3-b092-5b684492c91d,AZIENDA OSPEDALIERA CARDARELLI,azienda_ospedaliera_cardarelli,,,,,, +3716,,ebc6d0bc-dc2b-463d-978a-fe7fbcd1cda9,GlaxoSmithKline Resaearch and Development Ltd,glaxosmithkline_resaearch_and_development_ltd,,,,,, +3717,,7442c6ac-7168-11e6-a0cd-0242ac12000b,TIGER PHARMS LLC,tiger_pharms_llc,,,,,, +812,0.970088,37aa2406-dfec-4b12-bbb7-09f94b8adbf5,Universitätsklinik für Psychiatrie und Psychotherapie I,universit_tsklinik_f_r_psychiatrie_und_psychotherapie_i,,,,37aa2406-dfec-4b12-bbb7-09f94b8adbf5,universit_tsklinik_f_r_psychiatrie_und_psychotherapie_i,Universitätsklinik für Psychiatrie und Psychotherapie I +3718,,08586545-0c1f-4747-ac5e-e99252b52296,Dr. Carlos Serra,dr_carlos_serra,,,,,, +3719,,168e5596-0295-4c9c-8b1c-61e7b6491975,Dutch Childhood Oncology Group,dutch_childhood_oncology_group,,,,,, +3720,,3a19c7d5-85db-47f3-a6fe-ed9d030bb394,Asociación de Oncología Médica del Hospital de Cruces (ASONMEC),asociaci_n_de_oncolog_a_m_dica_del_hospital_de_cruces_asonmec,,,,,, +204,0.98671889305114746,e77923f8-3c50-4c19-aba2-8104ed582c2e,Institut de Recerca HSCSP,institut_de_recerca_hscsp,,,,e77923f8-3c50-4c19-aba2-8104ed582c2e,institut_de_recerca_hscsp,Institut de Recerca HSCSP +3721,,4e1a9c38-3282-494f-94fc-7731028c7df8,"Cardiovascular laboratory 2014, Rigshospitalet",cardiovascular_laboratory_2014_rigshospitalet,,,,,, +625,0.96852,d89e6689-270a-4db7-8b4b-2d4dbdb3e6ad,Dresden Universtity of Technology,dresden_universtity_of_technology,,,,05cdfe1b-418a-44a0-bab7-0a07fc861fd4,dresden_university_of_technology,Dresden University of Technology +3722,,b69ae7ef-b9a8-457a-9988-25fc82e0490b,Fundación para el Progreso de la Oncología en Cantabria,fundaci_n_para_el_progreso_de_la_oncolog_a_en_cantabria,,,,,, +247,0.95151522755622864,a19c66db-634c-448b-94e4-f87b6c870ef2,Hoffmann-La Roche AG,hoffmann_la_roche_ag,,,,5796905e-d697-4a3c-a2d1-98d6d9104b0c,hoffmann_la_roche,Hoffmann-La Roche +126,0.985655,5760d01f-a672-4d09-ab67-83a15c2d8903,Clinical Trials and Research Governance,clinical_trials_and_research_governance,,,,5760d01f-a672-4d09-ab67-83a15c2d8903,clinical_trials_and_research_governance,Clinical Trials and Research Governance +3723,,5c441ce6-e855-47e7-ae83-96a01fcfbe3e,Carlos Fernandez Galvan,carlos_fernandez_galvan,,,,,, +993,0.98589098453521729,c9185e1d-9928-4fba-b5da-60e24c1d7520,GE Healthcare Srl,ge_healthcare_srl,,,,97e04c3e-2469-47b3-aea0-8522c32303ca,ge_healthcare,GE Healthcare +3724,,55ebc98a-6f9f-11e6-9663-0242ac12000b,Boehringer Ingelheim Pharma Ellas AE,boehringer_ingelheim_pharma_ellas_ae,,,,,, +3725,,8c016273-05a4-4697-9342-f6631f5b4195,Sociedad Española de retina y Vítreo,sociedad_espa_ola_de_retina_y_v_treo,,,,,, +3726,,6d27ba3a-dfde-4bd2-bcbd-bae9af25612e,Angion Biomedica Corp,angion_biomedica_corp,,,,,, +3727,,556e17c0-8e05-4b55-8f5c-3520d5c8fde1,MIGUEL CASARES FERNÁNDEZ-ALVÉS,miguel_casares_fern_ndez_alv_s,,,,,, +3728,,15f01007-ac72-4345-8150-f51f9072bb2b,Great Ormond Street Hospital Hospital for Children NHS Foundation Trust,great_ormond_street_hospital_hospital_for_children_nhs_foundation_trust,,,,,, +675,0.95572340488433838,0db50825-cbd9-4ba0-9b70-46c1d448c066,UCB Pharma SA,ucb_pharma_sa,,,,0db50825-cbd9-4ba0-9b70-46c1d448c066,ucb_pharma,UCB Pharma +3729,,94a9d7ca-00d5-4ae6-b8ca-44e74cd69519,Dr Moya Mur,dr_moya_mur,,,,,, +3730,,566cec73-8e06-4476-9174-3753aa7863a0,Maria Victoria Ruiz Arzalluz,maria_victoria_ruiz_arzalluz,,,,,, +3731,,fa49fbce-b1a9-4f72-a1e1-7674b559d82d,"Digestive Disease Center, Bispebjerg Hospital",digestive_disease_center_bispebjerg_hospital,,,,,, +3732,,cb676930-7600-4a09-b2df-5a7abbb8b53f,Servier S.L,servier_s_l,,,,,, +273,0.98508751392364502,c5ef1964-06f4-433a-9a38-37d97c703417,Uppsala University,uppsala_university,,,,22571e3f-0745-4cea-b1ca-5cc32ff5e911,uppsala_university_hospital,Uppsala University Hospital +3733,,3e451ca8-0fd6-42a5-9c21-6b541c81685a,"Sucampo Pharma Americas, LLC",sucampo_pharma_americas_llc,,,,,, +3734,,ce02a7fc-e5cb-4541-8543-efa0bf0a6e6a,"Theravance Biopharma R&D, Inc",theravance_biopharma_r_d_inc,,,,,, +3735,,55e355f2-34c8-482b-b291-c5f01b018e63,Richter Gedeon Vegyészeti Gyár Rt,richter_gedeon_vegy_szeti_gy_r_rt,,,,,, +3736,,24a49a37-dd66-4316-978b-c9bd178153c5,"Klinik für Dermatologie, Venerologie und Allergologie; Charité - Universitätsmedizin Berlin",klinik_f_r_dermatologie_venerologie_und_allergologie_charit_universit_tsmedizin_berlin,,,,,, +3737,,fadb627b-3941-45a4-96f1-00c0eb0a558d,Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung SAKK,schweizerische_arbeitsgemeinschaft_f_r_klinische_krebsforschung_sakk,,,,,, +3738,,e1d7f79d-4a8a-471f-b9b8-532cf50d50e1,Koningin Wilhelmina Fonds,koningin_wilhelmina_fonds,,,,,, +3739,,38379167-228f-4321-b7f2-1df09aa63e69,"Cubist Pharmaceuticals, a wholly owned subsidiary of Merck & Co., Inc",cubist_pharmaceuticals_a_wholly_owned_subsidiary_of_merck_co_inc,,,,,, +102,0.98334300518035889,a08b16f4-afc3-483a-9911-a1f8bd577fc9,KU Leuven,ku_leuven,,,,2eb3e3c9-b195-488e-a7df-a29b241b8d60,ku_leuven_lrd,KU Leuven LRD +3740,,fb1d8d42-5c8d-4ab9-aad1-bc2ebb6f9fc3,"University Medical Center Groningen, dept. of Cardiology",university_medical_center_groningen_dept_of_cardiology,,,,,, +3741,,444b21aa-09c6-4ba0-8f9c-df0162d7a32d,"Fujisawa Healthcare, Inc",fujisawa_healthcare_inc,,,,,, +3742,,c79544d8-ceb6-415c-b110-941cbac7061f,"Clinic for Thoracic and Cardiovascular Surgery, Heart Centre North Rhine-Westfalia",clinic_for_thoracic_and_cardiovascular_surgery_heart_centre_north_rhine_westfalia,,,,,, +3743,,a5efd050-714f-11e6-a0cd-0242ac12000b,PHARMASCIENCE INC,pharmascience_inc,,,,,, +3744,,31961bc2-a14f-4b66-b96c-f9fa77d1e967,Papworth Hospital NHS Foundation Trust - Research and Development Department,papworth_hospital_nhs_foundation_trust_research_and_development_department,,,,,, +60,0.96424932139260433,c8a30c78-c8e4-4118-918e-9c02cdd93d00,Wyeth Research Division on Wyeth Pharmaceuticals Inc,wyeth_research_division_on_wyeth_pharmaceuticals_inc,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc +3745,,049689d2-d11e-4313-9178-d8b2259430fa,Caprion Pharmaceuticals Inc,caprion_pharmaceuticals_inc,,,,,, +1049,0.97674435377120972,3abc546a-5bd3-4194-a602-f5d74f7521a8,University Hospital Zurich,university_hospital_zurich,,,,3abc546a-5bd3-4194-a602-f5d74f7521a8,university_hospital_zurich,University Hospital Zurich +3746,,83978724-7167-11e6-a0cd-0242ac12000b,LIAONING CHENGDA,liaoning_chengda,,,,,, +3747,,59c7588d-1945-478f-bdfc-4fa5fb0b42be,SOTIO a.s,sotio_a_s,,,,,, +313,0.97091636061668396,67dc8352-af91-4bf9-8f74-dd730e4e18fc,GlaxoSmithKline Biologicals SA,glaxosmithkline_biologicals_sa,,,,d94a5eb6-cc98-4004-a7a3-95cf39383b18,glaxosmithkline_biologicals,GlaxoSmithKline Biologicals +3748,,cf9bdda5-ee9b-4403-adee-0324db1d6cd8,gepepharm GmbH,gepepharm_gmbh,,,,,, +3749,,df52c7dc-9ade-4e7b-b88c-2b8fcc01a143,PSKS,psks,,,,,, +3750,,3882c844-62b2-4a40-84b8-8d05e4083fd0,Fibrex Medical Research & Development GmbH,fibrex_medical_research_development_gmbh,,,,,, +337,0.98108,a0104195-a7e1-11e6-94cb-5656d04fc2b5,Ortopædkirurgisk afdeling Odense Universitetshospital,ortop_dkirurgisk_afdeling_odense_universitetshospital,,,,16be4521-35a5-4873-a0cc-3401b5169c7e,ortop_dkirurgisk_afdeling,Ortopædkirurgisk afdeling +3751,,37e92e2e-747e-48c1-90fe-148c750c809a,Dr. José Luis Fernández Trisac,dr_jos_luis_fern_ndez_trisac,,,,,, +3752,,f7fd6bcb-50b8-4f67-99c2-5c4e1162616e,"Cytokinetics, Inc",cytokinetics_inc,,,,,, +3753,,3e38d6a1-d0f4-497b-bfa0-8553c50cf5ea,Merck Serono SA International,merck_serono_sa_international,,,,,, +3754,,321735bc-9709-4802-9a13-5266db2050eb,STELIC INSTITUTE & CO,stelic_institute_co,,,,,, +3755,,82a3957f-ca60-4c8b-8740-79cf85b97f70,Dutch Cancer Society,dutch_cancer_society,,,,,, +3756,,b62e22fd-c3c3-4a02-b5ad-fbff2384a61c,Mundipharma Comm VA,mundipharma_comm_va,,,,,, +3757,,894b8c2b-f5d9-44b7-afb3-c43489645ab8,Heidelberg Pharma GmbH,heidelberg_pharma_gmbh,,,,,, +3758,,bc7e33c4-7141-11e6-a0cd-0242ac12000b,ACCELRX LABS,accelrx_labs,,,,,, +3759,,18460daf-dcca-4f3c-944c-6702d4f040be,Cholnoky F. County Hospital Veszprém Department of Ophthalmology,cholnoky_f_county_hospital_veszpr_m_department_of_ophthalmology,,,,,, +3760,,697cfaa8-36ec-4dc5-84fa-7da85d079af3,Servicio Madrileño de Salud (SERMAS),servicio_madrile_o_de_salud_sermas,,,,,, +3761,,136c1be4-0d37-4d88-acc9-a879cb141978,"Freistaat Bayern, vertreten durch Klinikum der Universität Regensburg",freistaat_bayern_vertreten_durch_klinikum_der_universit_t_regensburg,,,,,, +689,0.980666,e886c430-708a-48fb-ac6d-e89e5b342883,Allergopharma Joachim Ganzer KG,allergopharma_joachim_ganzer_kg,,,,08598a05-faa8-4889-ba3e-5127ae10b806,allergopharma_joachim_ganzer_kg_an_afilliate_of_merck_kgaa_darmstadt,"Allergopharma Joachim Ganzer KG an afilliate of Merck KGaA, Darmstadt" +3762,,164af130-cdf1-440d-9963-b7fd395c60b9,Instituto Catalán de Oncología,instituto_catal_n_de_oncolog_a,,,,,, +3763,,c68d5b68-0a4d-44b8-988d-3c736063f9a1,The University of Manchester,the_university_of_manchester,,,,,, +3764,,96707a71-9fd9-42a6-a202-a01bee7a5593,"Schering AG, Global Medical Development",schering_ag_global_medical_development,,,,,, +3765,,4e218370-39ed-4a53-9edd-6eb57c83ac45,UMC Groningen,umc_groningen,,,,,, +3766,,ff9cb2a1-0a40-4af3-9add-5c4771acc522,department of Pharmacology-Toxicology RUNMC,department_of_pharmacology_toxicology_runmc,,,,,, +3767,,b5415eb0-477e-48e5-b972-0ecc7ca273f7,University Hospital Aintree NHS Trust,university_hospital_aintree_nhs_trust,,,,,, +3768,,fc15e9d8-8666-41d4-9ef4-d822b1c48654,AstraZeneca oy,astrazeneca_oy,,,,,, +3769,,dc2805c3-d3ae-4673-9f88-4d04125e5288,EDISON PHARMACEUTICALS INC,edison_pharmaceuticals_inc,,,,,, +3770,,7c19583c-71a4-11e6-a0cd-0242ac12000b,US PHARMS HOLDINGS I,us_pharms_holdings_i,,,,,, +3771,,511dcb4c-7161-11e6-a0cd-0242ac12000b,LIEBEL-FLARSHEIM,liebel_flarsheim,,,,,, +3772,,f186ea08-96e7-43c7-9686-94a13748564c,Vernalis (R&D) Limited,vernalis_r_d_limited,,,,,, +3773,,4e3e1a04-a29b-4397-9943-add7b5abc712,LILLY FRANCE,lilly_france,,,,,, +3774,,4774ea6b-15a6-45f0-bcd0-d72c8fa1ef6b,Aktion Bronchialkarzinom (ABC) e.V,aktion_bronchialkarzinom_abc_e_v,,,,,, +3775,,1e5c2e7e-dc6c-4342-a560-aeed544ab0c0,GRUPO ESPAÑOL MULTIDISCIPLINARIO DEL CANCER DIGESTIVO(GEMCAD),grupo_espa_ol_multidisciplinario_del_cancer_digestivo_gemcad,,,,,, +3776,,60227124-9c78-4b06-8960-b2027d6f3f4b,ALK-Abelló A/S,alk_abell_a_s,,,,,, +3777,,dc9d5d49-316a-41db-b3ab-e51b971dd8a0,Mitsubishi Pharma Corporation,mitsubishi_pharma_corporation,,,,,, +3778,,39651b1c-7167-11e6-a0cd-0242ac12000b,HAUPT PHARMA,haupt_pharma,,,,,, +3779,,8c353821-ab15-44bf-ac3e-cbeafedb0241,Meander Medical Centre,meander_medical_centre,,,,,, +3780,,c2f70698-7323-11e6-a0cd-0242ac12000b,INST BIOCHIMIQUE,inst_biochimique,,,,,, +3781,,dca409da-b870-4bb7-812d-f83fa4885f24,The Royal Marsden NHSF Trust,the_royal_marsden_nhsf_trust,,,,,, +3782,,ff99844a-4d70-4e3a-826b-40a67dd074fd,Hull and East Yorkshire Acute Hospitals NHS Trust,hull_and_east_yorkshire_acute_hospitals_nhs_trust,,,,,, +3783,,e50c956a-b859-4e2a-94b6-80ca4df4ef0d,"Schering Plough Research Institute (SPRI), A Division of Schering Corporation",schering_plough_research_institute_spri_a_division_of_schering_corporation,,,,,, +3784,,65c91553-a945-42e5-ba39-05b17151ce30,ALTANA PHARMA,altana_pharma,,,,,, +3785,,e82b15a4-863a-4c74-8129-54edef919ad9,Proteo Biotech AG,proteo_biotech_ag,,,,,, +3786,,820491fe-7167-11e6-a0cd-0242ac12000b,CPDC,cpdc,,,,,, +1034,0.914544,2656ed3b-7c3f-4317-935a-59c30cccc2bc,Centre du Cancer des Cliniques Universitaires Saint-Luc,centre_du_cancer_des_cliniques_universitaires_saint_luc,,,,2656ed3b-7c3f-4317-935a-59c30cccc2bc,centre_du_cancer_des_cliniques_universitaires_saint_luc,Centre du Cancer des Cliniques Universitaires Saint-Luc +470,0.97350867589314782,2a4e4a42-e5c4-4da8-8f1f-18343eeb1fbc,European Group for Blood and Marrow Transplantation (EMBT),european_group_for_blood_and_marrow_transplantation_embt,,,,2a4e4a42-e5c4-4da8-8f1f-18343eeb1fbc,european_group_for_blood_and_marrow_transplantation,European Group for Blood and Marrow Transplantation (EMBT) +3787,,6d383694-715e-11e6-a0cd-0242ac12000b,BELMORA LLC,belmora_llc,,,,,, +633,0.974308,c06c533e-ab04-44e7-a0f7-e1b3fb8173f8,BRACCO IMAGING,bracco_imaging,,,,c06c533e-ab04-44e7-a0f7-e1b3fb8173f8,bracco_imaging,BRACCO IMAGING +3788,,b600dbe1-c9e4-4026-a0d8-423f1595e815,Maria Antonia Saornil Alvarez,maria_antonia_saornil_alvarez,,,,,, +3789,,e2a17f9e-7154-11e6-a0cd-0242ac12000b,ADARE PHARMS INC,adare_pharms_inc,,,,,, +3790,,453ce8e3-a10e-49a1-9300-48140beef269,TopoTarget Germany AG,topotarget_germany_ag,,,,,, +3791,,64e8e932-f8d6-4f33-b994-aa628d0fade0,Royal Marsden NHS Trust,royal_marsden_nhs_trust,,,,,, +3792,,f9e455c8-7154-11e6-a0cd-0242ac12000b,PAR STERILE PRODUCTS,par_sterile_products,,,,,, +3793,,a346f83f-ad17-44c2-98e5-9266fce72700,Laboratorios Dr. Esteve S.A. (ESTEVE),laboratorios_dr_esteve_s_a_esteve,,,,,, +3794,,59f6fd80-8820-11e6-a998-0242ac12000b,Janssen Medical Affairs EMEA,janssen_medical_affairs_emea,,,,,, +3795,,5573f3e4-d6bb-4c5a-ac4d-007fb38d2e79,Grünenthal Pharma S.A,gr_nenthal_pharma_s_a,,,,,, +3796,,05d57d99-61e6-472b-b84b-1cbae0c8a09f,"VIA PHARMACEUTICALS, INC",via_pharmaceuticals_inc,,,,,, +3797,,7805009f-9b20-4c47-8f48-a541137582a6,"Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E",instituto_portugu_s_de_oncologia_de_lisboa_francisco_gentil_e_p_e,,,,,, +625,0.96852,05cdfe1b-418a-44a0-bab7-0a07fc861fd4,Dresden University of Technology,dresden_university_of_technology,,,,05cdfe1b-418a-44a0-bab7-0a07fc861fd4,dresden_university_of_technology,Dresden University of Technology +160,0.96059775352478027,de2e78fc-1477-4ad5-bd9d-2d289aaee414,Fundación para la Investigación biomedica del Hospital Gregorio Marañon,fundaci_n_para_la_investigaci_n_biomedica_del_hospital_gregorio_mara_on,,,,ce27e24e-62ac-42de-a596-4ceed67e634f,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón +3798,,0a091072-3610-41b2-84ab-91926a32376b,Actelion Pharmaceuticals Sverige AB,actelion_pharmaceuticals_sverige_ab,,,,,, +3799,,cbeeb474-9b9d-4710-887b-b8c6b022afaa,"Exelixis, Inc",exelixis_inc,,,,,, +1053,0.987186,3ca85ebb-ef77-4ffc-bc31-c0440e250e6a,BOOG Study Center B.V,boog_study_center_b_v,,,,3ca85ebb-ef77-4ffc-bc31-c0440e250e6a,boog_study_center_b_v,BOOG Study Center B.V +308,0.987895,e239b75f-2e94-4044-9542-866a0e8f231b,Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla,fundaci_n_p_blica_andaluza_para_la_gesti_n_de_la_investigaci_n_en_salud_de_sevilla,,,,86807203-e56e-49a6-bcc8-c3d0deca55f4,fundaci_n_p_blica_andaluza_para_la_gestion_de_la_investigaci_n_en_salud_de_sevilla,Fundación Pública Andaluza para la Gestion de la Investigación en Salud de Sevilla +3800,,906e3e1c-4334-41b1-92ff-9a83812b649f,PARI GmbH,pari_gmbh,,,,,, +3801,,21869e3d-a23c-435f-a06c-9bec41863636,Lilly ICOS LLC,lilly_icos_llc,,,,,, +3802,,25597202-c22a-4d69-a4fb-4443a3d67f96,7TM Pharma A/S,7tm_pharma_a_s,,,,,, +3803,,719e2052-7129-11e6-a89e-0242ac12000b,LANNETT HOLDINGS INC,lannett_holdings_inc,,,,,, +550,0.98918396234512329,c02e31f5-3712-4237-9dae-6bec40ffabb9,"Freistaat Bayern, vertreten durch die Universität Regensburg, Klinikum",freistaat_bayern_vertreten_durch_die_universit_t_regensburg_klinikum,,,,c02e31f5-3712-4237-9dae-6bec40ffabb9,freistaat_bayern_vertreten_durch_die_universit_t_regensburg_klinikum,"Freistaat Bayern, vertreten durch die Universität Regensburg, Klinikum" +145,0.938045,d57e06d7-f7fa-4a12-9066-20923b514e74,Menarini Benelux S.A/N.V,menarini_benelux_s_a_n_v,,,,c4a9bf5d-eebd-42f0-a384-39801bffce72,menarini_benelux_sa_nv,Menarini Benelux SA/NV +3804,,cc6b8034-ebcb-4c66-9821-e0dbb74f9f98,Pharma 2100 ApS,pharma_2100_aps,,,,,, +3805,,a6a086e4-71ee-11e6-a0cd-0242ac12000b,BLACKSMITH BRANDS,blacksmith_brands,,,,,, +3806,,cc6ac0f3-fc84-4db1-84b5-421d8c83530c,Clovis Oncology Inc,clovis_oncology_inc,,,,,, +3807,,3caad73b-371e-4101-a53f-a8f691ceaa64,Tuula Manner,tuula_manner,,,,,, +299,0.98663288354873657,1346da36-73d0-11e6-a0cd-0242ac12000b,NOVARTIS PHARM,novartis_pharm,,,,7aebdff6-717d-11e6-a0cd-0242ac12000b,novartis_pharms,NOVARTIS PHARMS +3808,,80524c59-ec59-4f88-af43-4c3ca176df0b,"Department of Dermatology, Bispebjerg University Hospital",department_of_dermatology_bispebjerg_university_hospital,,,,,, +3809,,27b0a01c-73bf-11e6-a0cd-0242ac12000b,APGDI,apgdi,,,,,, +3810,,5e172e20-73e5-11e6-a0cd-0242ac12000b,TRYGG,trygg,,,,,, +3811,,26e795cd-57eb-4921-b8ea-d5fad1e6c3de,"SYSTEMS MEDICINE, LLC",systems_medicine_llc,,,,,, +3812,,19e5d102-7142-11e6-a0cd-0242ac12000b,PARKEDALE,parkedale,,,,,, +3813,,8652f9ef-11dd-4716-b9dd-6284027ec56f,Bionorica AG,bionorica_ag,,,,,, +3814,,b77a78da-60ae-4d26-8620-75d6f1b5e018,RUH (Bath) NHS Trust,ruh_bath_nhs_trust,,,,,, +3815,,2715598b-6fc3-46be-ab4e-e3d0b8ee666c,"Department of Hematology, Aarhus University Hospital",department_of_hematology_aarhus_university_hospital,,,,,, +457,0.98836642503738403,b1956d94-fa1c-4c96-9cc6-cd0765e72415,Janssen-Cilag International NV (JCI),janssen_cilag_international_nv_jci,,,,b1956d94-fa1c-4c96-9cc6-cd0765e72415,janssen_cilag_international_nv_jci,Janssen-Cilag International NV (JCI) +3816,,0605f678-07b2-438b-8607-8cb93573f601,Philipps-Universität Marburg,philipps_universit_t_marburg,,,,,, +3817,,5bfe149e-578b-4acb-8352-7f6a4cb2bea6,Greater Glasgow Health Board(GGHB)/ University of Glasgow,greater_glasgow_health_board_gghb_university_of_glasgow,,,,,, +445,0.97700804471969604,349b447a-a3b8-4b62-9bd7-18319a9a48b8,Royal Brompton & Harefield NHS Trust,royal_brompton_harefield_nhs_trust,,,,349b447a-a3b8-4b62-9bd7-18319a9a48b8,royal_brompton_harefield_nhs_trust,Royal Brompton & Harefield NHS Trust +3818,,531424f0-f342-4778-9240-be49c5269f5a,Centre Hospitalier de Toulouse,centre_hospitalier_de_toulouse,,,,,, +3819,,a0986f1c-844e-456a-b897-d08faeca4967,Accelerator Advanced Application,accelerator_advanced_application,,,,,, +3820,,3c2eabe4-0c3d-4c2c-adac-1867c30f4eec,CHU de Caen,chu_de_caen,,,,,, +234,0.98197808861732483,28cbc40e-dff3-45c4-8b15-2bde4da6a415,Novartis Pharma CH,novartis_pharma_ch,,,,7a736c7a-e49d-4f6d-a8da-98014f1ac986,novartis_pharma,Novartis Pharma +3821,,951c79fc-109a-42a3-ab08-b5d1025419d4,SIRTEX Medical Europe,sirtex_medical_europe,,,,,, +3822,,029d7038-5188-436d-9cb3-752126c92fc6,"Inst of OPhthalmology, Lund University",inst_of_ophthalmology_lund_university,,,,,, +668,0.984093,93043c3a-9344-4423-9114-20048877dc2b,BioPartners GmbH,biopartners_gmbh,,,,93043c3a-9344-4423-9114-20048877dc2b,biopartners_gmbh,BioPartners GmbH +3823,,1d0de80a-099b-4e2d-9eee-adf5dbb15fe6,Gloucestershire Hospitals NHS Foundation Trust,gloucestershire_hospitals_nhs_foundation_trust,,,,,, +230,0.95899969339370728,f9ca3489-3092-4dfd-a243-6cee45a702f6,"Medical Department M, Aarhus Sygehus",medical_department_m_aarhus_sygehus,,,,e36533aa-a267-461b-b595-a7c0d4d12b23,medical_department_i,Medical Department I +3824,,4c93fdd4-8bcf-11e6-a449-0242ac12000b,OLYMPUS FRANCE,olympus_france,,,,,, +3825,,670b1a2a-96ce-43a2-b9de-d8f0b77652c2,Folktandvården Västra Götaland,folktandv_rden_v_stra_g_taland,,,,,, +3826,,3a95ef30-2c75-4a75-9dd4-1aa22dfc339f,Essex Pharma GmbH,essex_pharma_gmbh,,,,,, +3827,,8bd7aeca-7142-11e6-a0cd-0242ac12000b,ELKINS SINN,elkins_sinn,,,,,, +3828,,3a44e4d2-e3c3-4eb6-925c-a97652e4ffd4,Frederiksberg Hospital,frederiksberg_hospital,,,,,, +3829,,632d1aeb-699e-4a61-8a30-8e25e43d5061,ASOCIACION ANDALUZA DE HEMATOLOGIA Y HEMOTERAPIA,asociacion_andaluza_de_hematologia_y_hemoterapia,,,,,, +3830,,abe20538-e7fb-4a2d-ad4c-863a697259de,GSK Vaccines S.r.l,gsk_vaccines_s_r_l,,,,,, +3831,,1785e80e-7847-4e9d-b010-7ce06929aabc,"Krajská nemocnice Liberec, a.s",krajsk_nemocnice_liberec_a_s,,,,,, +3832,,bd724e61-d2d0-4f0c-b10f-2f2a69308f4d,Merck Sharp & Dohme (Europe) Inc,merck_sharp_dohme_europe_inc,,,,,, +3833,,1868d223-d287-4848-b448-26c25631f391,Joslin Diabetes Center,joslin_diabetes_center,,,,,, +3834,,2aec6de4-05d4-4907-8d21-78a6a82cbce5,"Albert-Ludwig University Freiburg, Laboratory for Biological and Personality Psychology",albert_ludwig_university_freiburg_laboratory_for_biological_and_personality_psychology,,,,,, +236,0.92619631687800086,6f4a6bcd-1427-46aa-836c-03f830233033,"Pfizer Ltd, Ramsgate Road Sandwich, UK",pfizer_ltd_ramsgate_road_sandwich_uk,,,,36e40cab-06cf-41e0-bef3-04e11a49311d,pfizer_ltd_ramsgate_road_sandwich_kent,"Pfizer Ltd, Ramsgate Road, Sandwich, Kent" +3835,,2acfbd28-22a2-4891-ae83-f635b83d7506,"Integrated Therapeutics Group, Inc. - A subsidiary of Schering-Plough Corp",integrated_therapeutics_group_inc_a_subsidiary_of_schering_plough_corp,,,,,, +693,0.96936577558517456,48601627-d189-4d07-b717-58fa6e8591d5,NovaCardia Inc (wholly owned subsidiary of Merck & Co. Inc),novacardia_inc_wholly_owned_subsidiary_of_merck_co_inc,,,,48601627-d189-4d07-b717-58fa6e8591d5,novacardia_inc_wholly_owned_subsidiary_of_merck_co_inc,NovaCardia Inc (wholly owned subsidiary of Merck & Co. Inc) +3836,,676bce60-6244-47e3-a3a5-d55b208f30be,ATVB Verein,atvb_verein,,,,,, +310,0.963604,09253f61-375e-4a27-869a-8e74c421b025,sanofi-aventis Groupe,sanofi_aventis_groupe,,,,09253f61-375e-4a27-869a-8e74c421b025,sanofi_aventis_groupe,sanofi-aventis Groupe +3837,,bd8d0cf1-0b82-4294-ae13-5d5d3b6d7ddc,"THERACLONE SCIENCES, INC",theraclone_sciences_inc,,,,,, +3838,,03aa197d-0362-4da8-8bb6-4b7d1030bca7,"Laboratorios Leti, S.L.Unipersonal",laboratorios_leti_s_l_unipersonal,,,,,, +3839,,d9679400-91a8-4271-90e8-c4cf9e7a9711,Medical School of Hannover,medical_school_of_hannover,,,,,, +3840,,bbb0104a-8606-4d82-9c3b-349c196f319d,Solvotrin Innovations Ltd,solvotrin_innovations_ltd,,,,,, +3841,,2d3c26c3-99a3-4023-849a-7028c3fd7701,Fundación Interhospitalaria de Investigación Cardiovascular,fundaci_n_interhospitalaria_de_investigaci_n_cardiovascular,,,,,, +3842,,198fca05-280c-4e7a-ab3b-c8478debfe12,Klinikum Fulda gAG,klinikum_fulda_gag,,,,,, +3843,,f0088a5f-49a6-43de-98e8-d2a93cda692b,"Istituto Auxologico Italiano, IRCCS",istituto_auxologico_italiano_irccs,,,,,, +3844,,717f4682-85e7-4535-a5d1-4451339e41da,Endo Pharmaceuticals Solutions Inc,endo_pharmaceuticals_solutions_inc,,,,,, +3845,,7ee980c5-2e75-4fe6-b8df-00416bc966ce,GETECCU,geteccu,,,,,, +3846,,83a60fc0-2190-42f9-8b68-05d2a1702861,Montreal Heart Institute,montreal_heart_institute,,,,,, +3847,,c45f6afb-a1e9-4765-9491-7331a23b6d3e,Dra. Cristina Avendaño Solá,dra_cristina_avenda_o_sol,,,,,, +3848,,5c63a205-7777-4aa9-ba4c-7a1c27490437,ARCAGY,arcagy,,,,,, +3849,,c3dce589-9e0c-4d7e-87ab-63ea11b55d62,Institute for International Health,institute_for_international_health,,,,,, +3850,,4520716c-7163-11e6-a0cd-0242ac12000b,SANDOZ CANADA INC,sandoz_canada_inc,,,,,, +3851,,e40dc5ec-56ac-4c85-b67b-1aca42022931,SELARL du Docteur Jacques Buvat,selarl_du_docteur_jacques_buvat,,,,,, +3852,,4f7a9414-3759-40f7-80ed-da48fc9d9cb0,UCLH/UCL Biomedical Research Unit,uclh_ucl_biomedical_research_unit,,,,,, +3853,,2b7a77ae-fffe-4816-baff-35362de6abff,Jassen-Cilag International NV,jassen_cilag_international_nv,,,,,, +3854,,a2519ad7-66c6-4fe5-a142-e3bd92cd1eb5,IRCCS FONDAZIONE STELLA MARIS,irccs_fondazione_stella_maris,,,,,, +3855,,318304b9-5192-4311-aa86-9a5c1a213381,"Jens Benn Sorensen, Dept. oncology, Finsen Centre/National University Hospital",jens_benn_sorensen_dept_oncology_finsen_centre_national_university_hospital,,,,,, +3856,,4019fe7e-0a18-4a9a-8d37-0a5c94ea7862,Institut de Recherches Internationales (for France),institut_de_recherches_internationales_for_france,,,,,, +756,0.973609,339b2067-d133-4013-927e-2033004bf532,"Johannes Gutenberg-Universität Mainz, II. Med. Klinik (ausführende Stelle), Prof. Dr. T. Münzel",johannes_gutenberg_universit_t_mainz_ii_med_klinik_ausf_hrende_stelle_prof_dr_t_m_nzel,,,,339b2067-d133-4013-927e-2033004bf532,johannes_gutenberg_universit_t_mainz_ii_med_klinik_ausf_hrende_stelle_prof_dr_t_m_nzel,"Johannes Gutenberg-Universität Mainz, II. Med. Klinik (ausführende Stelle), Prof. Dr. T. Münzel" +3857,,e4fa72ae-37d3-4c8a-b502-b13491ef48e6,"Medical Faculty, TU Dresden",medical_faculty_tu_dresden,,,,,, +3858,,c7170371-6d5d-4df1-aee6-52bbc5cef7d7,"Institution for Clinical Science, Karolinska Institutet",institution_for_clinical_science_karolinska_institutet,,,,,, +3859,,95955d93-8c94-4a18-9b74-2bcd7f5177e5,"The Newcastle Upon Tyne Hospital NHS Foundation Trust, Freeman Hospital",the_newcastle_upon_tyne_hospital_nhs_foundation_trust_freeman_hospital,,,,,, +3860,,8f67ded4-daf9-4c5a-946b-be66807eb55b,Matrixx Initiatives Inc,matrixx_initiatives_inc,,,,,, +1013,0.96733957529067993,927f0840-1482-4ee8-bec9-a1452525e28a,Institut de Recherche International Servier,institut_de_recherche_international_servier,,,,05fd0678-f53a-4b88-9656-dc6d78bcac36,institut_de_recherche_internationales_servier,Institut de Recherche Internationales Servier +3861,,16712bdc-d896-44e4-817a-7049ed823331,JUAN MACIAS SANCHEZ,juan_macias_sanchez,,,,,, +3862,,00d8a53f-a307-46dc-8148-df83b78f1cd0,Royal Victoria Eye and Ear hospital,royal_victoria_eye_and_ear_hospital,,,,,, +3863,,80c29875-9348-4792-b514-2039f30abd00,IDIAP Jordi Gol,idiap_jordi_gol,,,,,, +751,0.9637179970741272,ddce1384-7144-11e6-a0cd-0242ac12000b,TARO PHARM INDS,taro_pharm_inds,,,,019c34b0-7129-11e6-a89e-0242ac12000b,taro,TARO +3864,,33a455ca-12f0-412a-a133-08e5311a8f59,Alliance Pharmaceuticals Ltd,alliance_pharmaceuticals_ltd,,,,,, +3865,,ff049a50-715d-11e6-a0cd-0242ac12000b,SANTOS BIOTECH,santos_biotech,,,,,, +3866,,ac7fcf3a-78cc-478b-b2fd-a80fc2f3b960,FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR,fondazione_centro_s_raffaele_del_monte_tabor,,,,,, +3867,,f6542d99-e1c2-454c-9085-50b3f52f097c,VästraGötaland,v_strag_taland,,,,,, +814,0.985423,5a1fbd8a-7158-11e6-a0cd-0242ac12000b,NATCO PHARMA LTD,natco_pharma_ltd,,,,03bcbda2-715e-11e6-a0cd-0242ac12000b,natco_pharma,NATCO PHARMA +654,0.90361690521240234,3849b74a-6dc1-4f1b-a6c5-a146b4d05357,Boehringer Ingelheim RCV Ges mbH & Co KG,boehringer_ingelheim_rcv_ges_mbh_co_kg,,,,3849b74a-6dc1-4f1b-a6c5-a146b4d05357,boehringer_ingelheim_rcv_ges_mbh_co_kg,Boehringer Ingelheim RCV Ges mbH & Co KG +395,0.982614,5cabde38-2e50-4a9e-b161-b9d60f252062,ASTRAZENECA,astrazeneca,,,,3a926c58-71c4-11e6-a0cd-0242ac12000b,astrazeneca_pharms,ASTRAZENECA PHARMS +3868,,34f22e00-ad6c-4616-8b22-b1a6b9878e2c,The University of Dundee,the_university_of_dundee,,,,,, +3869,,ceb5dbcb-3eed-455c-933c-c5c34e28f796,GE Healthcare Finland Oy,ge_healthcare_finland_oy,,,,,, +518,0.973471,ae49cd9c-0341-4f5e-a25b-775aca5642ab,"Department of Infetious Diseases, Odense University Hospital",department_of_infetious_diseases_odense_university_hospital,,,,ae49cd9c-0341-4f5e-a25b-775aca5642ab,department_of_infetious_diseases_odense_university_hospital,"Department of Infetious Diseases, Odense University Hospital" +479,0.98417377471923828,6550973d-6d3a-4fa8-a3d5-17c7365cb8cb,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Endokrinologie und Stoffwechsel",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klin_abt_f_r_endokrinologie_und_stoffwechsel,,,,6550973d-6d3a-4fa8-a3d5-17c7365cb8cb,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klin_abt_f_r_endokrinologie_und_stoffwechsel,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Endokrinologie und Stoffwechsel" +3870,,5a94c966-09c3-437d-8b9a-0554fd5fe878,Instituto de Investigación La Fe,instituto_de_investigaci_n_la_fe,,,,,, +3871,,c046e1d5-a486-499c-9d6b-8bfc6fd1eeab,Schering-Plough France,schering_plough_france,,,,,, +3872,,56ec0cfc-2793-4bfe-96ed-76925e6cc551,MSD SHARP & DOHME GMBH,msd_sharp_dohme_gmbh,,,,,, +3873,,4f6f5230-7142-11e6-a0cd-0242ac12000b,FACTA FARMA,facta_farma,,,,,, +3874,,b61d91fe-39c0-4f9d-81ee-3bfeb477fcf7,Max-Planck-Institut für Psychiatrie,max_planck_institut_f_r_psychiatrie,,,,,, +3875,,60367d18-e7d9-46f0-8655-85bc58b751b5,Myeloproliferative Disease Research Consortium (MPD-RC),myeloproliferative_disease_research_consortium_mpd_rc,,,,,, +3876,,7012ce01-def4-47a6-9508-471148ac1823,OxThera IP AB,oxthera_ip_ab,,,,,, +3877,,49665045-cd17-4b4f-9461-30400ea52f84,Boegringer Ingelheim Finland Ky,boegringer_ingelheim_finland_ky,,,,,, +3878,,57a05dd2-cb59-415c-889a-f3fa73d0fcd0,Celgene Corporation Headquarters,celgene_corporation_headquarters,,,,,, +444,0.97010031342506409,4f4f6343-5016-41b6-a586-c53ba90ea215,Royal Brompton and Harefield NHS Foundation Trust,royal_brompton_and_harefield_nhs_foundation_trust,,,,3c8eeed9-b500-4ecf-a409-f59b86b21db3,royal_brompton_and_harefield_nhs_foundation_trust,Royal Brompton and Harefield NHS Foundation Trust +3879,,21ff77cc-b720-403a-a55f-4af4eaa91120,"EIP Pharma, LLC",eip_pharma_llc,,,,,, +3880,,b89ad977-ff57-48e7-8cd0-b976755bfc37,Instituto de Investigación del Hospital de la Santa Creu i Sant Pau,instituto_de_investigaci_n_del_hospital_de_la_santa_creu_i_sant_pau,,,,,, +3881,,b49294d2-f6db-49e8-9f3a-fc904ce0a505,"Medarex, Inc",medarex_inc,,,,,, +3882,,6f5e051b-fbf8-41ac-a07b-98ab5ca09918,Noora Kaartinen,noora_kaartinen,,,,,, +741,0.9617915153503418,791ed7a8-0e54-418b-b501-7f7c85f1211c,AstraZeneca R&D Södertälje,astrazeneca_r_d_s_dert_lje,,,,5b96ae2b-b1a8-4688-88cd-0fcea433e529,astrazeneca_r_d,AstraZeneca R&D +3883,,629bc702-f660-42d6-a652-c35f3dd88d83,Växjö Central Hospital,v_xj_central_hospital,,,,,, +3884,,e13111a4-5c0b-4e59-af2b-af203617723b,Lilly S.A,lilly_s_a,,,,,, +3885,,6a2a5b01-ca16-4dab-b008-7f0242712dc5,Cristina Fernandez Pérez,cristina_fernandez_p_rez,,,,,, +166,0.989139,7eeea4e4-efc7-45bf-bac7-82d54c1ae894,Galderma Research and Development,galderma_research_and_development,,,,7eeea4e4-efc7-45bf-bac7-82d54c1ae894,galderma_research_and_development,Galderma Research and Development +711,0.98289656639099121,76c0c0d6-9f7c-4fde-bea7-4dd56b4a4546,Reckitt Benckiser (UK) Limited,reckitt_benckiser_uk_limited,,,,76c0c0d6-9f7c-4fde-bea7-4dd56b4a4546,reckitt_benckiser_uk_limited,Reckitt Benckiser (UK) Limited +3886,,c6aebdb9-1a0c-4134-9f1a-e3829a6727a5,Aktion Bronchialkarzinom e.V,aktion_bronchialkarzinom_e_v,,,,,, +365,0.98333936929702759,dd9c18be-f4a4-44ea-8e70-9257902058dd,Bayer HealthCare Pharmaceuticals,bayer_healthcare_pharmaceuticals,,,,17d529dc-dc91-4ddb-8f15-7de6d2fa75e3,bayer_healthcare_pharmaceuticals,Bayer HealthCare Pharmaceuticals +3887,,0fd1b4f6-b0f8-49aa-86bd-f295d699aff6,Pierre Fabre Ibérica S.A. as legal representative of Pierr Fabre Mèdicament,pierre_fabre_ib_rica_s_a_as_legal_representative_of_pierr_fabre_m_dicament,,,,,, +3888,,8564ee6f-0eb5-4f0b-97ec-b4374c61a413,Daiichi-Sankyo,daiichi_sankyo,,,,,, +774,0.94804,854e11d2-791a-4ad3-8709-b1916907edf4,BIOIBÉRICA S.A,bioib_rica_s_a,,,,6af20df4-5eb9-402f-a439-234b9bbabba6,bioiberica_s_a,BIOIBERICA S.A +3889,,ea11e952-b27e-4256-b97f-e67348f6912e,Southwest Oncology Group (SWOG),southwest_oncology_group_swog,,,,,, +600,0.9319939215977987,6b4a9b2d-18ff-4441-b335-98517841d021,Fundació Institut de Recerca de l'Hospital de la Santa Creu i de Sant Pau,fundaci_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_de_sant_pau,,,,6b4a9b2d-18ff-4441-b335-98517841d021,fundaci_n_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Fundació Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau +175,0.938547,963178a4-e414-458d-affa-8c2fb06efeb5,"Med. Univ. Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie",med_univ_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,,,,35c21566-4df9-4b63-ab48-4cc2ede6089b,med_univ_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerzmedizin,"Med. Univ. Wien, Universitätsklinik für Anästhesie, allgemeine Intensivmedizin und Schmerzmedizin" +506,0.981904,49d9286e-7129-11e6-a89e-0242ac12000b,WATSON LABS,watson_labs,,,,49d9286e-7129-11e6-a89e-0242ac12000b,watson_labs,WATSON LABS +199,0.982247,9ea15bf7-df50-400a-88c4-415b3dc2eda2,Mälarsjukhuset,m_larsjukhuset,,,,9ea15bf7-df50-400a-88c4-415b3dc2eda2,m_larsjukhuset,Mälarsjukhuset +3890,,876d1435-50e2-4be0-948e-335bed451049,IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro,irccs_azienda_ospedaliera_universitaria_san_martino_ist_istituto_nazionale_per_la_ricerca_sul_cancro,,,,,, +410,0.960286,73bbc013-4e9f-4481-88b6-3063a265c63f,ABOCA,aboca,,,,273912e1-1b32-44bf-9119-1caf84670781,aboca_s_p_a_societ_agricola,ABOCA S.P.A. SOCIETà AGRICOLA +3891,,5697b189-3f87-4b77-bf24-dd1bcc1ba4f2,"Oliver Ploder MD, DDS, PhD",oliver_ploder_md_dds_phd,,,,,, +3892,,b26e19d7-e843-42c0-85c2-c26c9167993e,Swedish Herbal Institute,swedish_herbal_institute,,,,,, +3893,,722688d0-715f-11e6-a0cd-0242ac12000b,MEDPOINTE PHARM HLC,medpointe_pharm_hlc,,,,,, +3894,,7ba8b458-2c58-4b6f-9034-700008f6cbc9,"Ospedale San Raffaele, UO Chirurgia Vascolare",ospedale_san_raffaele_uo_chirurgia_vascolare,,,,,, +462,0.969668,e47fcd5f-048f-4287-91ec-1f3ae2187dad,GamidaCell-Teva Joint Venture Ltd,gamidacell_teva_joint_venture_ltd,,,,c2cf1092-6676-478b-b6bc-5980f53650f5,gamida_cell_teva_joint_venture_ltd,Gamida Cell-Teva Joint Venture Ltd +3895,,75e97c8c-69d6-4b5d-a4b6-7571690c387f,Regulon Α.Ε,regulon,,,,,, +3896,,17896b8d-24d9-4496-abcf-7da2f360f833,MAR ESPINO HERNANDEZ,mar_espino_hernandez,,,,,, +3897,,2a01c240-97d3-4040-9987-bcc113d26e5f,Pfizer Consumer Healthcare Comm. VA/SCA,pfizer_consumer_healthcare_comm_va_sca,,,,,, +3898,,316e8ffe-8bdb-11e6-a449-0242ac12000b,Instituto Gallego de Medicina Vascular (IGAMEVAS S.L.),instituto_gallego_de_medicina_vascular_igamevas_s_l,,,,,, +160,0.93437572717666628,fafbf14a-7edf-4f4d-a87f-703785475b5c,Fundación para la Investigación Biomédica Hospital Gregorio Marañón,fundaci_n_para_la_investigaci_n_biom_dica_hospital_gregorio_mara_n,,,,ce27e24e-62ac-42de-a596-4ceed67e634f,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón +3899,,8d705dcc-3022-4674-b397-c7f418bdd927,Kiadis Pharma Netherlands B.V,kiadis_pharma_netherlands_b_v,,,,,, +3900,,3b4f921f-ba8d-4090-89d0-a58bc8ce6529,Mari Salmivuori,mari_salmivuori,,,,,, +34,0.97933,c148d4ca-273c-4294-9d90-0174a4aba478,Sanofi-Synthélabo Recherche,sanofi_synth_labo_recherche,,,,55dfece4-1cf8-463c-896f-48fbbec903fc,sanofi_synth_labo_recherche_a_subsidiary_of_sanofi_aventis_group,"Sanofi-Synthélabo Recherche, a subsidiary of sanofi-aventis group" +3901,,c23a23c8-4ce4-4f2c-ba5e-d96eeae23a66,Barts Health NHS Trust,barts_health_nhs_trust,,,,,, +3902,,b1fcc4b8-dae4-4f04-9687-6e64e2395bb2,"PULEVA BIOTECH, S.A",puleva_biotech_s_a,,,,,, +3903,,bc9917b7-e8e3-42e0-90d2-0718c5559515,"Genexine, Inc",genexine_inc,,,,,, +3904,,f0bdcf97-fad8-428f-aa8f-1a7adbabd7f9,Eisai Ltd,eisai_ltd,,,,,, +3905,,765dba7a-7157-11e6-a0cd-0242ac12000b,NOSTRUM PHARMS LLC,nostrum_pharms_llc,,,,,, +141,0.954454,a50426da-ce4e-4ecd-b491-397a2aadb68f,GRUPO ESPAÑOL DE INVESTIGACION EN NEUROONCOLOGIA,grupo_espa_ol_de_investigacion_en_neurooncologia,,,,a50426da-ce4e-4ecd-b491-397a2aadb68f,grupo_espa_ol_de_investigacion_en_neurooncologia,GRUPO ESPAÑOL DE INVESTIGACION EN NEUROONCOLOGIA +3906,,134aaaa3-4030-4a0b-b862-da77616b6237,eduardo anitua aldecoa,eduardo_anitua_aldecoa,,,,,, +808,0.94340622425079346,9dd926b0-8d48-4d08-b638-2eb1c4764ba3,Biogen Idec International GmbH,biogen_idec_international_gmbh,,,,9dd926b0-8d48-4d08-b638-2eb1c4764ba3,biogen_idec_international_gmbh,Biogen Idec International GmbH +902,0.975661,107fc324-9e45-4afc-8ead-3498cf036471,Klaus Olkkola/University of Helsinki,klaus_olkkola_university_of_helsinki,,,,107fc324-9e45-4afc-8ead-3498cf036471,klaus_olkkola_university_of_helsinki,Klaus Olkkola/University of Helsinki +3907,,6ef1b1a0-e461-4699-a8c5-1c422a7086c2,UNIMED PHARMA spol. s r. o,unimed_pharma_spol_s_r_o,,,,,, +3908,,e956887e-501f-451b-beab-11deebcf5a18,Zealand Pharma A/S,zealand_pharma_a_s,,,,,, +3909,,38673970-8922-4d99-ae98-9e22414a6b23,Julius Maximilians Universität Würzburg,julius_maximilians_universit_t_w_rzburg,,,,,, +3910,,c3f51464-0b38-4069-95dc-3858ae5af3af,"Corbus Pharmaceuticals, Inc",corbus_pharmaceuticals_inc,,,,,, +3911,,552dcc5b-8ae6-4048-9638-78eb24ab9df6,"Laboratorios Almirall, S.A",laboratorios_almirall_s_a,,,,,, +3912,,56fd01ec-b8d5-4343-ad0f-f0b6507e5f46,Dignity Sciences Limited,dignity_sciences_limited,,,,,, +3913,,023e9a34-04f0-4b7e-ab2c-60f165ad7f1d,Hanna Pitkänen,hanna_pitk_nen,,,,,, +3914,,61cda268-25c6-4699-88d6-86b80b9091d3,"Dr. Reddy’s Laboratories, Ltd",dr_reddy_s_laboratories_ltd,,,,,, +490,0.98798045516014099,e0a9ebe2-090f-4317-bf41-30ea0e2e6a42,Radboud University Medical Center,radboud_university_medical_center,,,,3fd47231-c0e0-48e2-9df1-24e6ff72daf7,radboud_university_medical_center,Radboud University Medical Center +3915,,5e682ed9-e85c-47b5-b65f-f58b040e8cd4,Institut d'Investigació Sanitària Pere Virgili (IISPV),institut_d_investigaci_sanit_ria_pere_virgili_iispv,,,,,, +3916,,05a809c3-0721-4d01-bd9d-eedb13065f63,RICARDO MOUZO MIRCO,ricardo_mouzo_mirco,,,,,, +3917,,9f461db8-73f2-11e6-a0cd-0242ac12000b,AIR LIQUIDE HEALTHCARE AMERICA CORP,air_liquide_healthcare_america_corp,,,,,, +1043,0.987372,b195c37b-f8e9-4c96-a6ce-a8345d3e7c8e,"University of Oxford, NDM",university_of_oxford_ndm,,,,6441853c-c50a-4eeb-acbc-a29226d17b89,university_of_oxford,University of Oxford +3918,,40fea4eb-91d7-4b0a-bc7e-4042757b9285,"Mesoblast, Inc",mesoblast_inc,,,,,, +3919,,708143d9-e8c8-4e58-a896-e2ba0b9cee99,"Joint Research Compliance Office, Imperial College",joint_research_compliance_office_imperial_college,,,,,, +3920,,6901323d-ab1a-4450-9c2c-2e43ab7f6fa5,Pedro Villarejo Campos(Hospital Universitario Ciudad Real),pedro_villarejo_campos_hospital_universitario_ciudad_real,,,,,, +3921,,e6106d45-7d83-444c-b1d2-88910f30b40b,Prof. Dr. Istvan Racz,prof_dr_istvan_racz,,,,,, +3922,,8bb732b4-9a7f-4d4d-9abc-4f2c77cc9ec2,SOCIETA' ITALO BRITANNICA L. MANETTI - H.ROBERTS & C. PER AZIONI,societa_italo_britannica_l_manetti_h_roberts_c_per_azioni,,,,,, +3923,,04fc82ef-ceca-4a89-aa7d-ee3576ab0cfa,FNCLCC,fnclcc,,,,,, +3924,,1fa95d86-a7dc-11e6-94cb-5656d04fc2b5,"Ribapharm, Inc",ribapharm_inc,,,,,, +337,0.98108,16be4521-35a5-4873-a0cc-3401b5169c7e,Ortopædkirurgisk afdeling,ortop_dkirurgisk_afdeling,,,,16be4521-35a5-4873-a0cc-3401b5169c7e,ortop_dkirurgisk_afdeling,Ortopædkirurgisk afdeling +3925,,15d41467-43dc-4927-97d9-63947208250e,UCL Saint Luc 1200 Bruxelles,ucl_saint_luc_1200_bruxelles,,,,,, +3926,,df3f5d92-35ea-4841-b2d9-a1894a38e972,EspeRare,esperare,,,,,, +3927,,8a9d7bee-7164-11e6-a0cd-0242ac12000b,JIANGSU HANSOH PHARM,jiangsu_hansoh_pharm,,,,,, +3928,,5d43259b-43e0-4f8b-bef5-22eff7015401,Lennart Andren,lennart_andren,,,,,, +3929,,0756f17a-845a-44a8-95ea-cc76200afa3b,Gastroenterology MIDT,gastroenterology_midt,,,,,, +3930,,f7a6ddd8-4e03-41b7-ab43-f7269102d5dd,"University Hospital of Schleswig-Holstein (UKSH), Campus Lübeck",university_hospital_of_schleswig_holstein_uksh_campus_l_beck,,,,,, +3931,,5e254602-41e5-4355-9f98-3b87ccb941ff,Mediquest Therapeutics Inc,mediquest_therapeutics_inc,,,,,, +895,0.985938,03e90e85-40a8-444e-8bc5-373590743e16,FUNDACION DE INVESTIGACION EN RED EN ENFERMEDADES,fundacion_de_investigacion_en_red_en_enfermedades,,,,03e90e85-40a8-444e-8bc5-373590743e16,fundacion_de_investigacion_en_red_en_enfermedades,FUNDACION DE INVESTIGACION EN RED EN ENFERMEDADES +3932,,54bd06ec-90d6-4cdb-9766-96da7c24ff27,"Pfizer Inc. NYO-685-21-14,685 3rd Avenue, NEW YORK, NY 10017. US",pfizer_inc_nyo_685_21_14_685_3rd_avenue_new_york_ny_10017_us,,,,,, +983,0.945615,59c0ebeb-5f3a-4456-89ec-4ec59bcd4670,St Stephens Aids Trust,st_stephens_aids_trust,,,,59c0ebeb-5f3a-4456-89ec-4ec59bcd4670,st_stephens_aids_trust,St Stephens Aids Trust +447,0.952846,c26f8ffe-a3eb-4cb6-b78c-8b91798a8a08,ETOP,etop,,,,0000011d-452f-4fe6-9214-3df63d041f46,etop_european_thoracic_oncology_platform,ETOP (European Thoracic Oncology Platform) +3933,,84d78b33-1281-45b3-8d36-65c9512e4dc8,German Society of Pediatric Hematology and Oncology gGmbH (GPOH gGmbH),german_society_of_pediatric_hematology_and_oncology_ggmbh_gpoh_ggmbh,,,,,, +195,0.98517,4a830ce9-4d8d-4914-94f3-d34026b2d02d,"Becton, Dickinson and Company",becton_dickinson_and_company,,,,4a830ce9-4d8d-4914-94f3-d34026b2d02d,becton_dickinson_and_company,"Becton, Dickinson and Company" +3934,,c8754026-2594-43db-b012-0429c9907513,Pfizer Healthcare Ireland,pfizer_healthcare_ireland,,,,,, +3935,,1e76f041-4ad8-45b4-8f1c-03625c95b942,Fundación Interhospitalaria para la Investigación Cardiovascular,fundaci_n_interhospitalaria_para_la_investigaci_n_cardiovascular,,,,,, +3936,,574d346c-d4d4-4140-9384-dd43ec3fd074,Meda Pharmaceuticals Inc,meda_pharmaceuticals_inc,,,,,, +962,0.97408080101013184,2484bf94-1589-4af7-a881-77e0aae0ece2,Hull and East Yorkshire Hospitals Trust,hull_and_east_yorkshire_hospitals_trust,,,,0db9909a-d59f-42e0-9159-2ecff62910d4,hull_and_east_yorkshire_hospital_trust,Hull and East Yorkshire Hospital Trust +3937,,e8bc3ba2-e026-4a79-86a4-0131fd1399e3,ALMIRALL SA,almirall_sa,,,,,, +3938,,40764ce6-2b9d-45ab-92e0-576edefb1836,LABORATOIRE ALLERBIO,laboratoire_allerbio,,,,,, +3939,,c75fb5e0-7198-11e6-a0cd-0242ac12000b,PERSONAL PRODS,personal_prods,,,,,, +3940,,aba5eeb4-c458-49f1-99f2-13509f8fae05,"Kliniken der Stadt Koeln gGmbH, Klinikum Merheim",kliniken_der_stadt_koeln_ggmbh_klinikum_merheim,,,,,, +3941,,520ba148-738a-11e6-a0cd-0242ac12000b,COLLAGENEX,collagenex,,,,,, +3942,,62f40122-0e1c-41d4-8248-e933f3ba7e69,Dr. Valérie gangji,dr_val_rie_gangji,,,,,, +197,0.986644,0a2316b0-4362-41ed-8199-5421a077abe7,"Medizinische Fakultät der Technischen Universität München, Vertreten durch den Dekan",medizinische_fakult_t_der_technischen_universit_t_m_nchen_vertreten_durch_den_dekan,,,,0a2316b0-4362-41ed-8199-5421a077abe7,medizinische_fakult_t_der_technischen_universit_t_m_nchen_vertreten_durch_den_dekan,"Medizinische Fakultät der Technischen Universität München, Vertreten durch den Dekan" +3943,,ede7e67c-d16d-46ef-9584-86a5d4e2a54b,NHS Lothian Health Board,nhs_lothian_health_board,,,,,, +3944,,ba38fcd3-26f0-45ba-9efe-3e4bb3cdd94a,Kuopion yliopistollinen sairaala/silmätautien poliklinikka,kuopion_yliopistollinen_sairaala_silm_tautien_poliklinikka,,,,,, +3945,,16002c9c-1c5c-4677-befb-157a58ec411d,"Greater Glasgow NHS Board, Yorkhill Division",greater_glasgow_nhs_board_yorkhill_division,,,,,, +3946,,3d364894-b992-44b4-ae7f-0885a2b34584,Arthritis Alapítvány,arthritis_alap_tv_ny,,,,,, +853,0.983941,899ef89b-d4a2-471a-bb67-f455fcc4b775,"Malmö University Hospital, Dep of Radiology",malm_university_hospital_dep_of_radiology,,,,802313d9-1b0d-4889-acd7-6878108beebc,malm_university_hospital,Malmö University Hospital +3947,,14a8899d-cb4a-43c3-82a0-4587fd84bd25,Centre Hospitalier Universitaire de Besançon,centre_hospitalier_universitaire_de_besan_on,,,,,, +3948,,953d5eb1-3537-48c3-89b8-9ffcca04b31d,BCN Peptides S.A,bcn_peptides_s_a,,,,,, +3949,,e0538c80-0c8f-415a-a43f-f3466054daf1,"BIAL-Portela & Ca, SA",bial_portela_ca_sa,,,,,, +868,0.98876041173934937,376a2423-30e5-4963-9880-cf25de8913ff,"Astellas Pharma Global Development, Inc",astellas_pharma_global_development_inc,,,,d75f8fe0-80ce-4bb5-9e6e-ab63e91189dc,astellas_pharma_global_development_inc,"Astellas Pharma Global Development, Inc" +3950,,6f96bb1b-57de-4cde-a7dd-f6c3263295ac,Skånes University Hospital,sk_nes_university_hospital,,,,,, +478,0.97189050912857056,d64abf90-4d4e-45b9-a06a-2d5341662320,"Medizinische Universität Graz, Abteilung für Endokrinologie und Stoffwechsel",medizinische_universit_t_graz_abteilung_f_r_endokrinologie_und_stoffwechsel,,,,a6ef0ba5-d49e-411b-92ac-7bad93bbb394,medizinische_universit_t_graz_kl_abteilung_f_r_endokrinologie_und_stoffwechsel,"Medizinische Universität Graz, Kl. Abteilung für Endokrinologie und Stoffwechsel" +3951,,bd96100c-0a61-4856-a8c8-dd944d5571c9,Dr Miguel Santín Cerezales,dr_miguel_sant_n_cerezales,,,,,, +3952,,385c996e-80fd-40f5-b2e7-2aa27926ac73,"Allos Therapeutics, Inc",allos_therapeutics_inc,,,,,, +3953,,69f52f01-6ebe-4acc-81c1-38916eff8994,"Vl-Medi Oy, Väestöliitto",vl_medi_oy_v_est_liitto,,,,,, +3954,,6b3a4ebe-6fbe-11e6-abe8-0242ac12000b,Asociación para el Estudio de las Enfermedades Infecciosas,asociaci_n_para_el_estudio_de_las_enfermedades_infecciosas,,,,,, +3955,,ef00e74c-7141-11e6-a0cd-0242ac12000b,MURTY PHARMS,murty_pharms,,,,,, +3956,,2b2a3798-715e-11e6-a0cd-0242ac12000b,TRIS PHARMA INC,tris_pharma_inc,,,,,, +3957,,8337c933-f29d-41f5-85b7-49602e677ab7,University Hospital Leuven - Department of Haematology,university_hospital_leuven_department_of_haematology,,,,,, +3958,,562a8d7e-1e37-4260-b6cc-3884c09e8a24,National Institute of Oncology,national_institute_of_oncology,,,,,, +3959,,123fa4b8-16da-47d6-88a9-c617c2295a83,AstraZeneca SAS,astrazeneca_sas,,,,,, +3960,,f1ac5d0f-0d69-4fcc-9b75-a3a32481efea,"Pfizer LTD, Pfizer Global RD-Sandwich Laboratories-I.P.C. 582",pfizer_ltd_pfizer_global_rd_sandwich_laboratories_i_p_c_582,,,,,, +3961,,354b02c2-8274-4ef4-a6fa-257f1f8e6801,Medizinische Universität Wien/ Universitätsklinik für Innere Medizin II/ Angiologie und Kardiologie,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_ii_angiologie_und_kardiologie,,,,,, +843,0.970735,759e05f5-7472-4ddb-baa8-c26f62d421d9,"Rikshospitalet University Hospital, University of Oslo",rikshospitalet_university_hospital_university_of_oslo,,,,759e05f5-7472-4ddb-baa8-c26f62d421d9,rikshospitalet_university_hospital_university_of_oslo,"Rikshospitalet University Hospital, University of Oslo" +3962,,a1d3fe19-5c0f-42fc-9bda-f554bf678214,UZ BRUSSEL,uz_brussel,,,,,, +3963,,3bbeee9c-1f72-412b-b2b8-1cf841043771,The University of Leeds,the_university_of_leeds,,,,,, +652,0.9401266872882843,6a82526b-a3f0-4364-b600-bf5233259d47,"Boehringer Ingelheim Pharmaceuticals, España S.A",boehringer_ingelheim_pharmaceuticals_espa_a_s_a,,,,756fbf26-6aec-45b4-9273-9afca275034e,boehringer,Boehringer +3964,,6ba78436-5e9a-40c4-a768-3f6871113bd1,"John L. Berk, M.D",john_l_berk_m_d,,,,,, +3965,,616b9665-7701-4e88-8785-d6b4707ab3ac,Isabel Pinilla Lozano,isabel_pinilla_lozano,,,,,, +3966,,81e76ff2-7167-11e6-a0cd-0242ac12000b,JOHNS HOPKINS UNIV,johns_hopkins_univ,,,,,, +650,0.95911291241645813,4b44d76c-5934-41c9-b025-daff7771bb88,Boehringer Ingelheim Austria GesmbH,boehringer_ingelheim_austria_gesmbh,,,,2c7b1b3b-323c-4045-ae75-4712a0ece886,boehringer_ingelheim_ab,Boehringer Ingelheim AB +3967,,c5df0c8e-3a7d-4db9-9312-7f42f2498652,GlaxoSmithKline GmbH & Co. KG,glaxosmithkline_gmbh_co_kg,,,,,, +893,0.9773980975151062,db2b75a4-2dcd-4a05-bd1d-454a679e9e67,Aarhus Universitet,aarhus_universitet,,,,2f028fcc-7872-4732-95a8-d0e74e80f7ae,aarhus_universitetshospital_aarhus_sygehus_thg,"Aarhus Universitetshospital, Aarhus Sygehus THG" +624,0.925655,d55f688a-1796-4607-a12b-e0dea07ae9f4,Aventis Intercontinental - Sanofi-aventis,aventis_intercontinental_sanofi_aventis,,,,695b704d-00ae-4579-8869-ffa0844dbd29,aventis_inc,Aventis Inc +3968,,54afa730-0571-4657-924c-ce8d7c8ad7be,The Royal Marsden Hospital NHS Foundation Trust,the_royal_marsden_hospital_nhs_foundation_trust,,,,,, +1001,0.97408080101013184,e74d2865-0067-48d6-b4c3-98fe172e3b16,Fundación para la Formación e Investigación Sanitaria de la Región de Murcia,fundaci_n_para_la_formaci_n_e_investigaci_n_sanitaria_de_la_regi_n_de_murcia,,,,97bed447-fd0e-4484-9d78-5d7a7aa3b967,fundaci_n_para_la_formaci_n_en_investigaci_n_sanitarias_de_la_regi_n_de_murcia,Fundación para la Formación en Investigación Sanitarias de la Región de Murcia +3969,,9ebc9580-8b83-4fb8-91a3-5902c38e7784,"UMC Utrecht, Julius Center for Health Sciences and Primary Care",umc_utrecht_julius_center_for_health_sciences_and_primary_care,,,,,, +3970,,d9fa81da-ea14-4e7a-806f-4c7ad6ee8228,photonamic GmbH & Co. KG,photonamic_gmbh_co_kg,,,,,, +673,0.989076,9779b86f-f9d6-440c-b621-4e88837285aa,Procter & Gamble Pharmaceuticals Inc,procter_gamble_pharmaceuticals_inc,,,,9779b86f-f9d6-440c-b621-4e88837285aa,procter_gamble_pharmaceuticals_inc,Procter & Gamble Pharmaceuticals Inc +3971,,5aa7e116-7166-11e6-a0cd-0242ac12000b,ACTAVIS INC,actavis_inc,,,,,, +3972,,b3cec21e-32dc-4608-994f-53cda2949c18,Boehringer Ingelheim (Pty) Ltd,boehringer_ingelheim_pty_ltd,,,,,, +26,0.981552,166642d4-cecb-4060-8a23-a1a73c72bbae,"Johns Hopkins University, Department of Neurology",johns_hopkins_university_department_of_neurology,,,,166642d4-cecb-4060-8a23-a1a73c72bbae,johns_hopkins_university_department_of_neurology,"Johns Hopkins University, Department of Neurology" +3973,,1332aa67-4f7a-48f6-9cea-44aab8478ec2,Univar BV,univar_bv,,,,,, +3974,,35416aeb-b94c-4749-8a1c-e54b28b464fe,Steigerwald Arzneimittelwerk GmbH,steigerwald_arzneimittelwerk_gmbh,,,,,, +3975,,f1410e6e-c212-4eb2-b43d-1ddb83e1cc66,UZ Leuven / Belgian Gynaecological Oncology Group,uz_leuven_belgian_gynaecological_oncology_group,,,,,, +3976,,e5de336b-e84e-4be3-9cca-3790fe244b65,Nottingham University Hospital NHS Trust (Research & Development),nottingham_university_hospital_nhs_trust_research_development,,,,,, +3977,,ac04bffa-73f7-11e6-a0cd-0242ac12000b,ROSEMONT PHARMS LTD,rosemont_pharms_ltd,,,,,, +3978,,025f8ded-efa8-4454-b8de-20ad931c0261,"Med. Univ. Wien, Univ. Klinikum für Interne Medizin III",med_univ_wien_univ_klinikum_f_r_interne_medizin_iii,,,,,, +3979,,638b72c8-0ab7-45d1-aa45-add491b742bb,Apogepha Arzneimittel GmbH,apogepha_arzneimittel_gmbh,,,,,, +3980,,df61d578-a93f-4d4d-8f82-194ee97b68c6,SANKYO EUROPE,sankyo_europe,,,,,, +3981,,b2f6e6bb-4ded-4d31-b51c-a081cf03ed42,Hospital Clínic de Barcelona,hospital_cl_nic_de_barcelona,,,,,, +3982,,24336551-4562-4b87-9d14-022e25fad2d0,Medical Center Leeuwarden,medical_center_leeuwarden,,,,,, +3983,,6bafdf34-4811-484b-bae3-8f48b70d8c2d,SagaMedica ehf,sagamedica_ehf,,,,,, +3984,,47c7d188-d907-4b05-a397-3a7a0bc319c9,Baxter AG,baxter_ag,,,,,, +3985,,9df22c29-022e-400e-a5cc-18f6b0583aca,Meerkanten GGz,meerkanten_ggz,,,,,, +3986,,d3fe4dfe-1074-4117-a731-0e5b968569ae,Tengion Inc,tengion_inc,,,,,, +632,0.988363,0be8c403-9955-44a5-a91f-7f50c9773ce9,Grupo Gallego de Cáncer de Pulmón (GGCP),grupo_gallego_de_c_ncer_de_pulm_n_ggcp,,,,0be8c403-9955-44a5-a91f-7f50c9773ce9,grupo_gallego_de_c_ncer_de_pulm_n_ggcp,Grupo Gallego de Cáncer de Pulmón (GGCP) +3987,,cf6990bf-17d4-450a-971d-1535c5e6273e,uniQure biopharma B.V,uniqure_biopharma_b_v,,,,,, +3988,,8f04d90c-b624-4ced-a101-65484f2c2e0b,Laboratoire de la Mer,laboratoire_de_la_mer,,,,,, +3989,,b9a095d7-f513-4580-a6cf-4a43a63e3bd1,University Hospital Azienda Ospedaliero S.Luigi Gonzaga Orbassano,university_hospital_azienda_ospedaliero_s_luigi_gonzaga_orbassano,,,,,, +3990,,38c6b5fc-3253-404c-aa7a-7ea309cf65f7,University Hospital Essen,university_hospital_essen,,,,,, +3991,,75542920-7166-11e6-a0cd-0242ac12000b,PACK PHARMS LLC,pack_pharms_llc,,,,,, +3992,,c1e1cd59-359a-4a7a-a82e-df1ebcc9ab53,Prof. Stefano Gandolfi-Universita` degli studi di Parma,prof_stefano_gandolfi_universita_degli_studi_di_parma,,,,,, +3993,,88c11c85-e7a8-4875-b741-60d5d333b739,OMNINVEST Kft,omninvest_kft,,,,,, +3994,,96ec509c-9897-4847-af75-bb7606199251,Dow Pharmaceutical Sciences Inc,dow_pharmaceutical_sciences_inc,,,,,, +3995,,b7eeead9-df2a-4186-bfd5-fa7bf22de999,Karolinska Universitetssjukhuset Solna,karolinska_universitetssjukhuset_solna,,,,,, +3996,,c7e915be-715d-11e6-a0cd-0242ac12000b,DRAXIMAGE,draximage,,,,,, +3997,,8c3093cc-7161-11e6-a0cd-0242ac12000b,ACTIENT PHARMS,actient_pharms,,,,,, +3998,,381483be-73fc-11e6-a0cd-0242ac12000b,LABORATORIOS SALVAT,laboratorios_salvat,,,,,, +727,0.983703,67dc03a5-4946-452a-be3e-787d57740764,Maastricht University Medical Center,maastricht_university_medical_center,,,,67dc03a5-4946-452a-be3e-787d57740764,maastricht_university_medical_center,Maastricht University Medical Center +3999,,2fa34095-bed2-486c-b506-c0fd3c6bbc1b,Biothera,biothera,,,,,, +4000,,d82a1e9d-7356-44d3-ae34-aa21e234c7d9,"Aastrom Biosciences, Inc",aastrom_biosciences_inc,,,,,, +4001,,2480e7a6-b795-4ee0-af9c-25f5d96e9c0a,A. N. M. C. O. - FONDAZIONE ITALIANA LOTTA MALATTIE CARDIOVASCOLARI,a_n_m_c_o_fondazione_italiana_lotta_malattie_cardiovascolari,,,,,, +4002,,5e609464-7548-4015-920d-61d39b8f43da,Cardiac Reserch Unit,cardiac_reserch_unit,,,,,, +4003,,c88c7f01-6122-4774-bc34-e2fb83276c96,"Melinta Therapeutics, Inc",melinta_therapeutics_inc,,,,,, +403,0.96267104148864746,96771e3a-7163-11e6-a0cd-0242ac12000b,EMCURE PHARMS,emcure_pharms,,,,11645014-715e-11e6-a0cd-0242ac12000b,emcure_pharms,EMCURE PHARMS +4004,,bf8b88d3-bb9a-4465-9ffd-3d1e24441b01,Universitätsmedizin Charite,universit_tsmedizin_charite,,,,,, +4005,,1295b477-1255-4050-93f3-a3003cbdb0b3,Les Laboratoires CTRS,les_laboratoires_ctrs,,,,,, +4006,,e72bd20b-26e8-43e6-8ce3-c6936b581f26,Klinikum der LMU,klinikum_der_lmu,,,,,, +4007,,8fabfef9-09aa-4293-9ce6-8a871c688885,Kell Osterlind,kell_osterlind,,,,,, +1080,0.975398,4d169b05-ac41-460f-9a9b-dbaba35ab0e5,Medice Arzneimittel Pütter GmbH & Co. KG,medice_arzneimittel_p_tter_gmbh_co_kg,,,,4d169b05-ac41-460f-9a9b-dbaba35ab0e5,medice_arzneimittel_p_tter_gmbh_co_kg,Medice Arzneimittel Pütter GmbH & Co. KG +4008,,6697d163-44d2-4a64-80cd-1f224c9a08e1,Heart Center co,heart_center_co,,,,,, +66,0.96240752935409546,1eec3f23-406c-471b-948a-24dcf52e62a1,"AKH Wien, Klinik für Innere Medizin I, Onkologie",akh_wien_klinik_f_r_innere_medizin_i_onkologie,,,,1eec3f23-406c-471b-948a-24dcf52e62a1,akh_wien_klinik_f_r_innere_medizin_i_onkologie,"AKH Wien, Klinik für Innere Medizin I, Onkologie" +4009,,d0bb19a6-44d4-48fa-bff2-035d4845d9df,Hammersmith Hospital,hammersmith_hospital,,,,,, +4010,,44f1a01c-1a8f-4e7c-93c9-e6e6cec26e80,Mikko Hallman/ Oulun yliopisto,mikko_hallman_oulun_yliopisto,,,,,, +180,0.9720233678817749,3c2638d2-7378-11e6-a0cd-0242ac12000b,VALEANT PHARMS INC,valeant_pharms_inc,,,,0b232628-7206-11e6-a0cd-0242ac12000b,valeant_pharms,VALEANT PHARMS +345,0.96143,66393a08-7129-11e6-a89e-0242ac12000b,BARR,barr,,,,66393a08-7129-11e6-a89e-0242ac12000b,barr,BARR +4011,,55864b1b-008f-499e-8d7b-4c0678c18847,AZIENDA OSPEDALIERA VINCENZO MONALDI DI NAPOLI,azienda_ospedaliera_vincenzo_monaldi_di_napoli,,,,,, +4012,,7fafef2d-4c7d-4a30-a4b8-feb747f69c2c,"Department of Academic Endocrinology, Beaumont Hospital",department_of_academic_endocrinology_beaumont_hospital,,,,,, +4013,,e9671d16-ea97-4b05-8ede-92b33114394c,Valeas SpA,valeas_spa,,,,,, +4014,,d6b5e5ea-b108-4299-b6bf-811a98896021,"Azienda Ospedaliera Fatebenefratelli e Oftalmico - Milano, Italy",azienda_ospedaliera_fatebenefratelli_e_oftalmico_milano_italy,,,,,, +4015,,4a849d42-dc7e-4542-a76b-92df61ad08fd,"Forest Research Institute, Inc",forest_research_institute_inc,,,,,, +486,0.97645202279090881,e6237908-6daa-4272-adad-f5434c004df0,Sahlgrenska universitetssjukhuset,sahlgrenska_universitetssjukhuset,,,,e6237908-6daa-4272-adad-f5434c004df0,sahlgrenska_universitetssjukhuset,Sahlgrenska Universitetssjukhus +4016,,9840dfd4-63d6-4e87-ae5e-4791ff260b87,Grupo Oncológico Gallego (GOG),grupo_oncol_gico_gallego_gog,,,,,, +4017,,a71efc61-4a83-44ab-af42-91e86803ebec,Northwest Biotherapeutics Inc,northwest_biotherapeutics_inc,,,,,, +4018,,88089406-6fa0-11e6-9663-0242ac12000b,Boehringer Ingelheim Coordination Centre Belgium,boehringer_ingelheim_coordination_centre_belgium,,,,,, +666,0.969108,78549656-23df-4335-b73d-acbb817c4068,NOPHO NHL-group,nopho_nhl_group,,,,57164cff-6f3b-448f-a2a2-cb44b3def10b,nopho,NOPHO +4019,,69604877-f125-442c-bb0f-3ceb9e902a87,IELSG (INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP),ielsg_international_extranodal_lymphoma_study_group,,,,,, +789,0.986288,216d0aa8-7165-11e6-a0cd-0242ac12000b,GRANULES INDIA LTD,granules_india_ltd,,,,216d0aa8-7165-11e6-a0cd-0242ac12000b,granules_india_ltd,GRANULES INDIA LTD +4020,,36941be7-e418-419d-91ed-c01d57bbaa4a,Istituto Nazionale per lo Studio e la Cura dei Tumori di Napoli – Fondazione “G.Pascale”,istituto_nazionale_per_lo_studio_e_la_cura_dei_tumori_di_napoli_fondazione_g_pascale,,,,,, +4021,,2d2c2e3c-b756-4be0-a180-46ba8d4404d0,Women's and Children's Hospital,women_s_and_children_s_hospital,,,,,, +4022,,1b3f6a2a-749e-4fe0-aa6c-d00856ba27e4,"GITMO GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO,CELLULE STAMINALI EMOPOIETICHE E TERAPIA CELLULARE - ONLUS",gitmo_gruppo_italiano_trapianto_di_midollo_osseo_cellule_staminali_emopoietiche_e_terapia_cellulare_onlus,,,,,, +4023,,ca41f28a-abc3-4687-9072-efde36bc129f,UNIVERSITY OF MANCHESTER,university_of_manchester,,,,,, +4024,,32be8361-2542-4df9-a021-708dda25cfd9,L'OREAL,l_oreal,,,,,, +997,0.978108,abff6004-a106-40f9-b146-4c3f25a5ec03,University of Ulm,university_of_ulm,,,,5bbd7601-f97c-4166-b061-6c6d0f6ab946,university_of_ulm_university_hospital_ulm,"University of Ulm, University Hospital Ulm" +4025,,87a538f8-d4f5-4554-81c1-acee1770c26c,Dana Farber Cancer Institute,dana_farber_cancer_institute,,,,,, +4026,,f5f2ba0f-38e9-449d-a20f-ff69f40998b8,StiL Forschungs-GmbH,stil_forschungs_gmbh,,,,,, +599,0.93973445892333984,9cf56282-7e14-4a02-88e7-6e6425636a65,Fundació privada de l'Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,fundaci_privada_de_l_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,,,,53d727ca-f81e-4c5b-a9a5-c177cdd19cfc,fundaci_privada_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Fundació Privada Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau +4027,,225d6d5b-a3d3-4799-8bfe-3d715d619cca,The London Clinic,the_london_clinic,,,,,, +4028,,b2637178-7147-11e6-a0cd-0242ac12000b,ACTAVIS LABS NY INC,actavis_labs_ny_inc,,,,,, +211,0.94713729619979858,d0501fb4-8bc4-11e6-a449-0242ac12000b,"Rigshospitalet, Dapartment of of Clinical Physiology, Nuclear Medicine and PET",rigshospitalet_dapartment_of_of_clinical_physiology_nuclear_medicine_and_pet,,,,6d416153-a74f-11e6-94cb-5656d04fc2b5,rigshospitalet_department_of_clinical_physiology_nuclear_medicine_and_pet,"Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET" +4029,,5f69f891-42d0-45ba-bb62-ac34727868ae,HELP Pharmaceuticals S.A,help_pharmaceuticals_s_a,,,,,, +582,0.98565453290939331,6326b447-28a1-4e90-85c9-3120652dc39b,MSD Finland Oy,msd_finland_oy,,,,1b6900c3-4c54-432a-91f1-2da705f73cdd,msd_finland,MSD Finland +4030,,73dec8c6-10d9-4b11-aec5-eef20a2bffe3,Golden Jubilee National Hospital,golden_jubilee_national_hospital,,,,,, +483,0.933215,4c50d4d9-2093-41e3-ac48-f701d16f0acc,Groupe d'Etudes des Lymphomes de l'Adult,groupe_d_etudes_des_lymphomes_de_l_adult,,,,4c50d4d9-2093-41e3-ac48-f701d16f0acc,groupe_d_etudes_des_lymphomes_de_l_adult,Groupe d'Etudes des Lymphomes de l'Adult +4031,,f0f92c48-2d14-4e8d-9e16-2eba69cae5d3,Biogen GmbH,biogen_gmbh,,,,,, +4032,,f90d580d-4d16-40ff-ab5c-db9fbf5e156d,Hôpital de Jolimont,h_pital_de_jolimont,,,,,, +4033,,43c3dc52-24a3-4ec3-88dd-28a13a99612d,The Florey Institute of Neuroscience and Mental Health,the_florey_institute_of_neuroscience_and_mental_health,,,,,, +4034,,55c001f3-2873-4264-8099-5e4f417564c3,"Medizinische Universitaet Wien, AKH Wien, Innere Medizin III, klin.Abteilung fuer Nephrologie und Dialyse",medizinische_universitaet_wien_akh_wien_innere_medizin_iii_klin_abteilung_fuer_nephrologie_und_dialyse,,,,,, +4035,,c103add9-c7fd-4009-860f-f26802c44fac,University Heart Center Freiburg - Bad Krozingen,university_heart_center_freiburg_bad_krozingen,,,,,, +641,0.97742700576782227,82029ede-b089-4dbb-93ae-f48a58277a9c,Boehringer Ingelheim Danmark A/S,boehringer_ingelheim_danmark_a_s,,,,82029ede-b089-4dbb-93ae-f48a58277a9c,boehringer_ingelheim_denmark_a_s,Boehringer Ingelheim Denmark A/S +4036,,6849ee00-8665-407a-84d1-3326f26ce20e,Fresenius Biotech North America,fresenius_biotech_north_america,,,,,, +4037,,45bf51f4-a239-4afa-ac7b-bbf52da6a1e9,"Merck Sharp & Dhome Corp., a subsidiary of Merck & Co., Inc (hereafter referred to as Sopnsor or Merck)",merck_sharp_dhome_corp_a_subsidiary_of_merck_co_inc_hereafter_referred_to_as_sopnsor_or_merck,,,,,, +4038,,105d33f2-43bb-43dd-b87c-93a7d1c7891f,"Valeant Pharmaceuticals, North America",valeant_pharmaceuticals_north_america,,,,,, +4039,,5772038e-d258-454b-8865-167f6ef0ff92,"University of Kiel, Department of Dermatology",university_of_kiel_department_of_dermatology,,,,,, +4040,,b2f45ef4-7377-11e6-a0cd-0242ac12000b,REMPEX PHARMS INC,rempex_pharms_inc,,,,,, +4041,,64c1fac0-c2c5-444c-85bc-3a2a88a5e0c6,University Hospital Leuven. Dept Hemaetology,university_hospital_leuven_dept_hemaetology,,,,,, +4042,,d9c3aaab-d728-4b42-87a2-80791cc677ff,Dr. Daniel López Aguado. Servicio de Otorrinolaringología. Hospital Universitario de Canarias,dr_daniel_l_pez_aguado_servicio_de_otorrinolaringolog_a_hospital_universitario_de_canarias,,,,,, +297,0.971007,8c8ef9b5-43dd-4ca5-9f4c-348a000dce63,UCB S.A. Pharma Sector,ucb_s_a_pharma_sector,,,,8c8ef9b5-43dd-4ca5-9f4c-348a000dce63,ucb_s_a_pharma_sector,UCB S.A. Pharma Sector +4043,,9b5b5264-e909-4009-8dd8-f62f847ba24c,Santen,santen,,,,,, +374,0.9175071120262146,98ef0b13-ac5f-4431-8738-f853fbd0d57c,Merck Sharp & Dohme Limited,merck_sharp_dohme_limited,,,,98ef0b13-ac5f-4431-8738-f853fbd0d57c,merck_sharp_dohme_limited,Merck Sharp & Dohme Limited +4044,,19397b4e-cf27-4eca-86f6-3159f5ddc989,"Universitätsklinikum Tübingen, Medizinische Klinik I",universit_tsklinikum_t_bingen_medizinische_klinik_i,,,,,, +739,0.95527833700180054,cb0d17fd-3585-442e-a26f-d7c2688f5881,"ICORG, Irish Clinical Oncology Research Group",icorg_irish_clinical_oncology_research_group,,,,44219b72-858c-4e54-8209-9aba06a32318,icorg,ICORG +4045,,aff04017-826f-4cb7-89ab-cd026f645f2b,"FoldRx Pharmaceuticals, Ltd",foldrx_pharmaceuticals_ltd,,,,,, +4046,,86fb937b-ccc9-4bb6-a2ff-b15abec1dcb9,"Dekan des Fachbereichs Medizin der Goethe Universität, represented by the Coordinating Investigator",dekan_des_fachbereichs_medizin_der_goethe_universit_t_represented_by_the_coordinating_investigator,,,,,, +265,0.969508,1f93290f-c593-4d33-b455-91f1096af905,Institut Paoli Calmette,institut_paoli_calmette,,,,1f93290f-c593-4d33-b455-91f1096af905,institut_paoli_calmette,Institut Paoli Calmette +36,0.98114,f0aeca44-9ab7-48b0-b749-ff721b5dd430,"Medical Faculty, Otto-von-Guericke University",medical_faculty_otto_von_guericke_university,,,,d98745c2-011b-495b-a0b3-26372585a6ae,medical_faculty_otto_von_guericke_university_magdeburg,"Medical Faculty, Otto-von-Guericke-University Magdeburg" +4047,,3871ae99-ccf0-4433-b56f-2843fcf3aebb,Azienda Ospedaliero Universitaria ''San Luigi Gonzaga'',azienda_ospedaliero_universitaria_san_luigi_gonzaga,,,,,, +4048,,d210e8b8-73a7-11e6-a0cd-0242ac12000b,GRACEWAY,graceway,,,,,, +4049,,ce5f13e6-8c40-4b41-a95d-40e3790f87e2,NHS Greater Glasgow and Clyde (NHSGG&C)/University of Glasgow (GU),nhs_greater_glasgow_and_clyde_nhsgg_c_university_of_glasgow_gu,,,,,, +4050,,4d05bcf7-42e5-4d6a-bd9b-45de3583ef60,Centre du Cancer,centre_du_cancer,,,,,, +1058,0.94924008846282959,9f433fc9-52ae-42c8-afcf-a91a3762e82b,Pfizer Hellas AE,pfizer_hellas_ae,,,,9f433fc9-52ae-42c8-afcf-a91a3762e82b,pfizer_hellas_ae,Pfizer Hellas AE +4051,,1f7dbd3d-9625-4eb3-bec5-7c5dede55845,Neurologische Uniklinik Regensburg,neurologische_uniklinik_regensburg,,,,,, +4052,,7820cc96-1b18-4241-8887-150c3124f1e7,"Dept of Oncology, Karolinska Universitetssjukhuset",dept_of_oncology_karolinska_universitetssjukhuset,,,,,, +4053,,aae4569d-e938-4113-a3f8-6674ddae75f2,ALFRED E. TIEFENBACHER (GMBH & CO. KG),alfred_e_tiefenbacher_gmbh_co_kg,,,,,, +4054,,12c46acd-f645-43ab-bac6-f76792b84382,"Dept of Anaesthesia, University College Hospital, Galway",dept_of_anaesthesia_university_college_hospital_galway,,,,,, +4055,,0e5958c0-2e71-46ae-b4a5-d115ae6e2df2,Shrewsbury & Telford Hospital NHS Trust,shrewsbury_telford_hospital_nhs_trust,,,,,, +4056,,a444037e-09fe-431a-9ec3-25840628454b,Centre Hospitalier Universitaire de Grenoble,centre_hospitalier_universitaire_de_grenoble,,,,,, +4057,,69dfc873-f968-47e9-a7ee-449d5b784cec,MDS Pharma Services,mds_pharma_services,,,,,, +4058,,8150dd72-4c1c-4b87-8c4b-1efac155d4d7,SALUS Haus GmbH & Co. KG,salus_haus_gmbh_co_kg,,,,,, +226,0.97584396600723267,43372c1e-43ce-4dcb-b2e0-ae9f60081a96,FUNDACIÓ SANT JOAN DE DÉU,fundaci_sant_joan_de_d_u,,,,43372c1e-43ce-4dcb-b2e0-ae9f60081a96,fundaci_sant_joan_de_d_u,FUNDACIÓ SANT JOAN DE DÉU +4059,,80be8450-715b-11e6-a0cd-0242ac12000b,XTTRIUM,xttrium,,,,,, +4060,,8d890050-7158-11e6-a0cd-0242ac12000b,FDC LTD,fdc_ltd,,,,,, +4061,,73264ef4-bc22-4270-a5f3-dc0dc71b681c,Roche S.p.A,roche_s_p_a,,,,,, +4062,,16d6a377-25aa-4f4c-a7a6-d89f7ccf9278,Anergis SA,anergis_sa,,,,,, +4063,,7a55b283-be1c-453d-8387-96efae53cf0e,Myotec Therapeutics Limited,myotec_therapeutics_limited,,,,,, +4064,,160e7919-7ee5-47de-8dcd-c09e5ad55c7b,Aesculap AG,aesculap_ag,,,,,, +4065,,6d8b5e92-2ce9-4d6f-af6b-f1b182080c19,"Division of Clinically Immunology and Rheumatology, AMC",division_of_clinically_immunology_and_rheumatology_amc,,,,,, +4066,,69d07960-b529-47e2-baa7-6111a281aa92,International Committee for Contraception Research of the Population Council,international_committee_for_contraception_research_of_the_population_council,,,,,, +4067,,ee087cb8-0f46-447a-8e84-b37124cc3106,ZISOP Zentrum für interdisziplinäre Schmerztherapie Landeskrankenhaus Klagenfurt,zisop_zentrum_f_r_interdisziplin_re_schmerztherapie_landeskrankenhaus_klagenfurt,,,,,, +4068,,43dffc33-c352-4365-af4f-9022c06fc3e9,ErasmusmMC/ Sophia Children Hospital,erasmusmmc_sophia_children_hospital,,,,,, +4069,,90bf1956-dd0a-454a-aa42-e241656157e4,PARIPharma GmbH,paripharma_gmbh,,,,,, +4070,,7151c5f2-1d59-40f2-8985-2ba3ac659181,University of Aberdeen,university_of_aberdeen,,,,,, +4071,,03ef3575-4088-4db3-81e2-d1e973e30292,Nordic Society of Gynaecological Oncology,nordic_society_of_gynaecological_oncology,,,,,, +4072,,5ed18449-09ba-4fd7-9313-2ff405356443,Departamento de Microbiología. Hospital Clinico San Carlos,departamento_de_microbiolog_a_hospital_clinico_san_carlos,,,,,, +4073,,b1f4f495-75ad-49b0-98d7-6a6b34405f11,MedaPharma,medapharma,,,,,, +4074,,f937bc8c-a47f-4460-bebe-7677575d59cc,Ramón Tormo Carnicé,ram_n_tormo_carnic,,,,,, +231,0.975369,6590967f-139c-4cf2-a3f2-b668fb314794,ORPHAN,orphan,,,,6590967f-139c-4cf2-a3f2-b668fb314794,orphan,ORPHAN +774,0.94804,6af20df4-5eb9-402f-a439-234b9bbabba6,BIOIBERICA S.A,bioiberica_s_a,,,,6af20df4-5eb9-402f-a439-234b9bbabba6,bioiberica_s_a,BIOIBERICA S.A +4075,,9e66c5e1-82fe-44b2-b2e0-9323c176be98,SANTEN INCORPORATED,santen_incorporated,,,,,, +409,0.98716670274734497,ebcee18c-2575-4f77-8b58-639a0e33f007,SCHWARZ BIOSCIENCES,schwarz_biosciences,,,,bafd53c7-e832-4f6f-89c8-d8d0d9dcabe4,schwarz_biosciences,SCHWARZ BIOSCIENCES GmbH +1026,0.96045973896980286,cbf68b19-d5e4-4da2-8beb-843959d4fdbf,Eli Lilly and Company Ltd,eli_lilly_and_company_ltd,,,,d2379c06-dc10-47c7-9eb7-094b64f48366,eli_lilly_and_company,Eli Lilly and Company +4076,,78157c0b-3547-4e6b-bf48-22a93e9195af,C.T. Development Switzerland SARL,c_t_development_switzerland_sarl,,,,,, +4077,,e6659e50-4652-4293-8a6e-1a4733328c3d,The Foundation European Group for Research in Schizophrenia (EGRIS),the_foundation_european_group_for_research_in_schizophrenia_egris,,,,,, +4078,,6c820520-515f-4c85-a0d3-b0012298c287,Public Health Service Amsterdam,public_health_service_amsterdam,,,,,, +4079,,0e03f80a-7142-11e6-a0cd-0242ac12000b,UNICHEM,unichem,,,,,, +4080,,3f3c26ea-73f9-11e6-a0cd-0242ac12000b,ACADIA PHARMS INC,acadia_pharms_inc,,,,,, +4081,,f0ffde36-71d2-11e6-a0cd-0242ac12000b,ALLIANCE PHARM,alliance_pharm,,,,,, +4082,,e482b344-eb7f-4f65-a873-579e7bbf9358,"Fujifilm Kyowa Kirin Biologics Co., Ltd",fujifilm_kyowa_kirin_biologics_co_ltd,,,,,, +4083,,abfe8e02-4f8e-4bad-afe7-0ba1cde03d81,"CONRAD, Eastern Virgina Medical School",conrad_eastern_virgina_medical_school,,,,,, +4084,,720b9da6-7167-11e6-a0cd-0242ac12000b,CHILDRENS HOSP MI,childrens_hosp_mi,,,,,, +329,0.977699,6bb6873c-5a83-4160-9eaa-ca0de2760368,ABBOTT,abbott,,,,00c3e472-71cc-11e6-a0cd-0242ac12000b,abbott_labs,ABBOTT LABS +4085,,aa918d5a-7146-11e6-a0cd-0242ac12000b,VALIDUS PHARMS,validus_pharms,,,,,, +4086,,3eabea78-5e3c-4ca9-87a9-230e27418b44,Merck Sharp & Dohme (MSD),merck_sharp_dohme_msd,,,,,, +4087,,1790a30a-3252-4005-a82a-98753064553d,Luis Fernando López Cortés,luis_fernando_l_pez_cort_s,,,,,, +4088,,78b8579e-18ca-4777-81a2-c667f3636be8,Landspitali - The National University Hospital of Iceland,landspitali_the_national_university_hospital_of_iceland,,,,,, +4089,,8aaebfcb-2e09-4281-a217-e16bdd9e104b,Lek Pharmaceuticals d.d,lek_pharmaceuticals_d_d,,,,,, +4090,,04fa972a-cbc5-40cc-a014-8f51e11aac0e,Colonis Pharma Limited,colonis_pharma_limited,,,,,, +1000,0.98663,80265282-715d-11e6-a0cd-0242ac12000b,TEVA PHARMS USA INC,teva_pharms_usa_inc,,,,80265282-715d-11e6-a0cd-0242ac12000b,teva_pharms_usa_inc,TEVA PHARMS USA INC +4091,,5faf4ac0-542b-4602-9d61-aa40fa1034e8,University Clinic of Heidelberg,university_clinic_of_heidelberg,,,,,, +4092,,e208c3c4-9faa-4c00-adfc-180ae43a85cf,Prague Psychiatric Center,prague_psychiatric_center,,,,,, +4093,,520d0856-f302-47ec-a08b-bc470cbdfa4f,IKEM,ikem,,,,,, +863,0.921141,63ece514-1ecd-4555-8b78-f2736a1ee227,Immunicum AB,immunicum_ab,,,,63ece514-1ecd-4555-8b78-f2736a1ee227,immunicum_ab,Immunicum AB +4094,,0ee8eb9d-cabb-4067-80c9-615833f5bdbe,"MedImmune, Inc",medimmune_inc,,,,,, +4095,,b7b4cf7f-e595-412f-b8fb-bd9075084da7,"Rigshospitalet, Klinisk Farmakologisk Afd. Q7642",rigshospitalet_klinisk_farmakologisk_afd_q7642,,,,,, +4096,,b9e14a9a-cb5c-4961-813e-57ae0e4d7a2d,NovImmune SA,novimmune_sa,,,,,, +4097,,3c7e96b0-2aab-4027-91fb-76e317e71a82,"Children's Hospital, Helsinki University Hospital",children_s_hospital_helsinki_university_hospital,,,,,, +4098,,b7731032-8cb2-4b68-9490-51be91014b7c,Centre Régional de Lutte contre le Cancer Val d'Aurelle- Paul Lamarque,centre_r_gional_de_lutte_contre_le_cancer_val_d_aurelle_paul_lamarque,,,,,, +4099,,9f54d983-ec75-4422-99a9-6fe94e5ce480,CHU d'Angers,chu_d_angers,,,,,, +559,0.971528559923172,e78543a1-45be-413e-ae9a-522fb25ea6da,"Department of Clinical Pharmacology, University of Greifswald",department_of_clinical_pharmacology_university_of_greifswald,,,,e78543a1-45be-413e-ae9a-522fb25ea6da,department_of_clinical_pharmacology,Department of Clinical Pharmacology +4100,,48a51979-97cf-44e6-b5de-adcf5f681844,Noordwest Ziekenhuisgroep,noordwest_ziekenhuisgroep,,,,,, +4101,,5646c540-7145-11e6-a0cd-0242ac12000b,NOVEL LABS INC,novel_labs_inc,,,,,, +4102,,6f6aadea-eca2-4d66-a436-649c03a874f7,"Charité-Universitätsmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie, CRC",charit_universit_tsmedizin_berlin_klinik_f_r_dermatologie_venerologie_und_allergologie_crc,,,,,, +4103,,ea3deaa6-c453-4c70-8308-885a5feda69e,Vectura Group plc,vectura_group_plc,,,,,, +4104,,233033cf-a407-4f97-bd82-16ae439563ad,Bayer Pharmaceutical Corporation,bayer_pharmaceutical_corporation,,,,,, +4105,,9e6264c8-f007-4f79-9a1f-c3ee6f3d601b,Clavis Pharma ASA,clavis_pharma_asa,,,,,, +4106,,bbe561db-fcef-4ba0-a270-a2d3fdf03200,Echo Pharmaceuticals B.V,echo_pharmaceuticals_b_v,,,,,, +4107,,933fb6dc-85a5-46d3-8ea5-22ae5fd45f95,"Cardiothoracic Surgery, Mater Misericordiae University Hospital",cardiothoracic_surgery_mater_misericordiae_university_hospital,,,,,, +4108,,a0377bdc-989d-4d9c-aaa6-956a862fc51a,Moorfields Eye Hospital R&D Department,moorfields_eye_hospital_r_d_department,,,,,, +219,0.980666,bb0251f2-2efa-42a2-8d24-fa858e7ba0cc,Bioprojet Pharma,bioprojet_pharma,,,,bb0251f2-2efa-42a2-8d24-fa858e7ba0cc,bioprojet_pharma,Bioprojet Pharma +4109,,245e9d1e-479d-4abf-8a0f-de32531520a3,AstraZeneca Portugal,astrazeneca_portugal,,,,,, +4110,,c0b15a9c-0129-49c5-827c-3911b64d65d8,Acedemic Medical Center,acedemic_medical_center,,,,,, +828,0.96305406093597412,cb37ddee-92a7-49ef-923e-8c1c2fef3407,INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ,instituto_de_investigacion_sanitaria_fundacion_jimenez_diaz,,,,343d2886-981b-46cc-bdb2-741a4f343dda,instituto_de_investigacion_sanitaria_fjd,INSTITUTO DE INVESTIGACION SANITARIA FJD +4111,,e71cce3e-8bcb-11e6-a449-0242ac12000b,Aalborg Sygehus Syd,aalborg_sygehus_syd,,,,,, +4112,,2c71a2a6-721e-11e6-a0cd-0242ac12000b,COLUMBIA RES LABS,columbia_res_labs,,,,,, +510,0.987557,e9a42e37-401d-4868-87b7-1a8a996b651e,Joint Research Office- UCL,joint_research_office_ucl,,,,9a59c260-eca4-4f86-a0fa-fed650d1712a,joint_research_office,Joint Research Office +4113,,74bc3e6e-5505-49c4-9866-319ff7f0b5f0,German Breast Group GBG Forschungsgesellschaft mbH (Sponsor nach GCP),german_breast_group_gbg_forschungsgesellschaft_mbh_sponsor_nach_gcp,,,,,, +4114,,6c46704b-e2dc-4577-9197-22e07b64d6ac,OPHTHOTECH CORPORATION,ophthotech_corporation,,,,,, +4115,,a4b0c222-8dcb-4c44-87a0-f51876e01ba0,"Chelsea Therapeutics, Incorporated",chelsea_therapeutics_incorporated,,,,,, +4116,,9b8a1cd3-001d-4722-83ef-b3aa8394d486,"NGM Biopharmaceuticals, Inc",ngm_biopharmaceuticals_inc,,,,,, +833,0.975572,2a713a15-71e1-4a58-a888-238d8c875592,"Aalborg University Hospital, Aalborg Psychiatric Hospital, Centre for Schizophrenia",aalborg_university_hospital_aalborg_psychiatric_hospital_centre_for_schizophrenia,,,,2a713a15-71e1-4a58-a888-238d8c875592,aalborg_university_hospital_aalborg_psychiatric_hospital_centre_for_schizophrenia,"Aalborg University Hospital, Aalborg Psychiatric Hospital, Centre for Schizophrenia" +4117,,50efdb7e-7f87-4ace-b6c6-f7e6dbdc2b6f,ratiopharm GmbH,ratiopharm_gmbh,,,,,, +637,0.987943,9557c854-7151-11e6-a0cd-0242ac12000b,TORRENT PHARMS,torrent_pharms,,,,2629fa8a-7163-11e6-a0cd-0242ac12000b,torrent_pharm,TORRENT PHARM +4118,,051f156a-0a2e-4c31-bc47-2f50acb6e164,Mipharm SpA,mipharm_spa,,,,,, +4119,,c6312308-9f66-4622-8534-9a1692347ac8,Bioforce GmbH,bioforce_gmbh,,,,,, +4120,,70232fca-06aa-4647-93a2-621b8cf5774e,Christie Hospital NHS Foundation Trust,christie_hospital_nhs_foundation_trust,,,,,, +4121,,4ef30c02-3cb7-4e5e-84ce-9bbf99f9b510,Royal Liverpool Children’s NHS Trust,royal_liverpool_children_s_nhs_trust,,,,,, +582,0.98565453290939331,1b6900c3-4c54-432a-91f1-2da705f73cdd,MSD Finland,msd_finland,,,,1b6900c3-4c54-432a-91f1-2da705f73cdd,msd_finland,MSD Finland +4122,,bccd565a-7166-11e6-a0cd-0242ac12000b,UNIMARK REMEDIES LTD,unimark_remedies_ltd,,,,,, +4123,,a32e060e-715c-11e6-a0cd-0242ac12000b,MYLAN PHARMA,mylan_pharma,,,,,, +177,0.98774003982543945,e5e8a69e-4787-4a3a-9804-66149fdcdf95,Swedish Orphan Biovitrum AB (publ),swedish_orphan_biovitrum_ab_publ,,,,417b3184-7ddd-49f2-af9e-84fb79bab1fd,swedish_orphan_biovitrum_ab,Swedish Orphan Biovitrum AB +4124,,c6b09f34-f15a-485e-897a-67ac5a66f234,Thallion Pharmaceuticals Inc,thallion_pharmaceuticals_inc,,,,,, +4125,,c944e572-8eff-42e5-963b-1683757fc027,"Dr. Gerhard Mann, Chem-pharm. Fabrik GmbH",dr_gerhard_mann_chem_pharm_fabrik_gmbh,,,,,, +4126,,45f77a7a-a7ae-4656-ad97-afa970199d17,Strathmann GmbH & Co. KG,strathmann_gmbh_co_kg,,,,,, +4127,,3a1fb1a6-d0b1-4559-8b01-9413e51af31e,Hertfordshire Partnership University NHS Foundation Trust,hertfordshire_partnership_university_nhs_foundation_trust,,,,,, +4128,,2048993a-73ef-11e6-a0cd-0242ac12000b,AIR LIQUIDE LARGE INDUSTRIES US LP,air_liquide_large_industries_us_lp,,,,,, +521,0.965089,1a46a2d5-d4cb-4f3f-8731-ed0b10a5b6d9,Department of Anaesthesia & General Intensive Care Medicine,department_of_anaesthesia_general_intensive_care_medicine,,,,1a46a2d5-d4cb-4f3f-8731-ed0b10a5b6d9,department_of_anaesthesia_general_intensive_care_medicine,Department of Anaesthesia & General Intensive Care Medicine +4129,,9abff547-d206-4c53-bbe6-28ac624fa23b,María Isabel López Gálvez-Instituto Universitario de Oftalmobiología Aplicada-Universidad Valladolid,mar_a_isabel_l_pez_g_lvez_instituto_universitario_de_oftalmobiolog_a_aplicada_universidad_valladolid,,,,,, +4130,,8d739af8-7158-11e6-a0cd-0242ac12000b,GLENMARK GENERICS,glenmark_generics,,,,,, +4131,,cdba6620-fad5-49d1-9c62-79e4e6a97cf5,Lundbeck Inc,lundbeck_inc,,,,,, +4132,,dafc8059-92b6-4dee-aae5-a64555de0906,"Bayer AB, Bayer Health Care, Bayer Schering Pharma",bayer_ab_bayer_health_care_bayer_schering_pharma,,,,,, +4133,,ec18346c-8684-40e7-b9d5-446cfc9ffee9,"Akademische Eigenstudie, Sektion für Hygiene und Medizinische Mikrobiologie",akademische_eigenstudie_sektion_f_r_hygiene_und_medizinische_mikrobiologie,,,,,, +4134,,8b800524-6315-440f-bddf-eb308120655f,Barrier Therapeutics nv,barrier_therapeutics_nv,,,,,, +4135,,85629318-0b3f-4952-8ea4-9faa7f721ee5,BTI Biotechnology Institute I mas D,bti_biotechnology_institute_i_mas_d,,,,,, +367,0.98357802629470825,e8216e75-b447-4252-bb49-7b895bcf4108,Bayer HealthCare,bayer_healthcare,,,,e8216e75-b447-4252-bb49-7b895bcf4108,bayer_healthcare,Bayer HealthCare +4136,,60a990e3-7cff-41d7-b318-8e5b9142983e,"Univ.-Prof. Dr. Hans F. Merk, Dept. of Dermatology, University Hospital, RWTH Aachen University",univ_prof_dr_hans_f_merk_dept_of_dermatology_university_hospital_rwth_aachen_university,,,,,, +4137,,6fe3181b-0837-4ecc-85e9-86976c5b0a93,"Theravance, Inc",theravance_inc,,,,,, +4138,,3227eff6-7373-11e6-a0cd-0242ac12000b,SHIRE HUMAN GENETIC,shire_human_genetic,,,,,, +4139,,4c227b6c-229c-43dc-b2ed-b31d7f16f7b4,"Faculty of Medicine at Georg August University,Goettingen, Germany",faculty_of_medicine_at_georg_august_university_goettingen_germany,,,,,, +4140,,a90a94b6-09ed-41fe-8348-9cbc74262899,"TAIHO PHARMA USA, INC",taiho_pharma_usa_inc,,,,,, +4141,,b35fdc90-72de-11e6-a0cd-0242ac12000b,FUJISAWA HLTHCARE,fujisawa_hlthcare,,,,,, +4142,,971d0a5b-3536-4368-b43f-9b2ee78c9652,Hospital S. Joao,hospital_s_joao,,,,,, +4143,,3f010b23-9b5e-4ef5-ab92-b2beb739ee11,"Department of Medical Research, Odense University Hospital, Svendborg Hospital",department_of_medical_research_odense_university_hospital_svendborg_hospital,,,,,, +4144,,6cf48bc6-beb2-4193-82a8-69cee7b5abee,Biomet Nederland BV,biomet_nederland_bv,,,,,, +4145,,ed2bd3e9-3e6a-4d7f-8e52-218a8373deca,Tarja Heiskanen,tarja_heiskanen,,,,,, +4146,,fb22fcd9-6e10-46ca-8c5b-e91fa89c9ccc,COG,cog,,,,,, +4147,,401c6953-fe04-49f4-b016-8f35303d653d,Håkan Ledin (investigator initiated trial),h_kan_ledin_investigator_initiated_trial,,,,,, +4148,,25a2bb80-d09c-43c3-a97b-c965ec33b0b4,Association Hospitalière CHU Brugmann,association_hospitali_re_chu_brugmann,,,,,, +4149,,26564a88-73eb-11e6-a0cd-0242ac12000b,CELGENE CORP,celgene_corp,,,,,, +4150,,38bd47d3-098d-45b6-b696-7725c10d26da,Myogen Inc,myogen_inc,,,,,, +4151,,943a57a8-9ad2-4eef-bd91-4829bc8ef8e1,Friedrich-Schiller-University of Jena,friedrich_schiller_university_of_jena,,,,,, +4152,,5ff088eb-0498-452b-8023-e3f8c93bcb1e,"Cytori Therapeutics, Inc",cytori_therapeutics_inc,,,,,, +4153,,85c9444c-7158-11e6-a0cd-0242ac12000b,ARCO PHARMS LLC,arco_pharms_llc,,,,,, +4154,,f8c6f536-f98b-4634-a368-8e69b98b0f43,INNOVIVE Pharmaceuticals,innovive_pharmaceuticals,,,,,, +4155,,420f4a86-84a7-4f7e-b616-fc0664f4ba4e,"North West London Hospitals NHS Trust, R&D Office",north_west_london_hospitals_nhs_trust_r_d_office,,,,,, +461,0.97450399398803711,72ebe678-1bc7-497b-9e19-848ac5196416,Debiopharm International S.A,debiopharm_international_s_a,,,,006566e8-3afd-4507-99a0-43f66a5ab93a,debiopharm,Debiopharm +4156,,7153e2b6-0ed0-43b2-8afa-1b003b4ab4ca,Universitaetsklinikum Hamburg,universitaetsklinikum_hamburg,,,,,, +4157,,593ca5f8-6fbf-11e6-abe8-0242ac12000b,Shire Pharmaceuticals Development Ltd,shire_pharmaceuticals_development_ltd,,,,,, +4158,,04b11562-7129-11e6-a89e-0242ac12000b,EASTMAN KODAK,eastman_kodak,,,,,, +4159,,b54dbc0e-6fa3-11e6-9663-0242ac12000b,"Dept. of Clinical Pharmacy, Radboud UMC Nijmegen, The Netherlands",dept_of_clinical_pharmacy_radboud_umc_nijmegen_the_netherlands,,,,,, +4160,,d1b4fcc5-8260-418a-a50a-75e79bce4b41,"Sanofi-Synthelabo Produtos Farmaceuticos, S.A",sanofi_synthelabo_produtos_farmaceuticos_s_a,,,,,, +4161,,9c008c8a-8bc9-11e6-a449-0242ac12000b,Medizinische Universität Wien/Univ.klinik für Innere Medizin III/Abteilung für Nephrologie und Dialyse/Prof Josef Smolen,medizinische_universit_t_wien_univ_klinik_f_r_innere_medizin_iii_abteilung_f_r_nephrologie_und_dialyse_prof_josef_smolen,,,,,, +4162,,11ee5361-7798-40db-87bb-fd97b752b851,Keele University,keele_university,,,,,, +4163,,a549c2f9-1337-4689-ad3d-acb2fd93682c,Gamida Cell Ltd,gamida_cell_ltd,,,,,, +183,0.959379,5c17ba0c-11f6-4fbe-8689-f48af0fac056,"Cliniques Universitaires St Luc, Centre du Cancer",cliniques_universitaires_st_luc_centre_du_cancer,,,,5c17ba0c-11f6-4fbe-8689-f48af0fac056,cliniques_universitaires_st_luc_centre_du_cancer,"Cliniques Universitaires St Luc, Centre du Cancer" +4164,,6852269b-3e58-4f35-bfa6-775cd1828d6f,HOSPITAL DE LA SANTA CREU I SANT PAU,hospital_de_la_santa_creu_i_sant_pau,,,,,, +4165,,c2ef189c-b56f-47cd-80e9-fcb598bfcda0,"Meical University, Dpt. Internal Medicine, Div. of General Internal Medicine",meical_university_dpt_internal_medicine_div_of_general_internal_medicine,,,,,, +4166,,e47f5f30-2d96-48d0-b0d1-7cab24238bd1,University of Edinburgh and NHS Lothian Health Board,university_of_edinburgh_and_nhs_lothian_health_board,,,,,, +721,0.98208,661f25ef-f850-4a8a-a3eb-d86b4bb5d084,TROPHOS SA,trophos_sa,,,,01b65e7e-316f-44bb-97c2-362060dad470,trophos,TROPHOS +4167,,eb6a7352-9e14-479e-9488-952282f8f1d2,UHCW NHS Trust,uhcw_nhs_trust,,,,,, +4168,,98e6cf10-e11e-4da2-af1b-ccb1754cde15,"KRKA ČR, s.r.o",krka_r_s_r_o,,,,,, +4169,,f412fa48-be7f-49fa-955c-7afacf22ad4d,Søren Rittig,s_ren_rittig,,,,,, +4170,,bb7e586c-7805-4154-84dd-a101fc1eb3d7,"Department of experimental and clincial medicine ""F. Magrassi",department_of_experimental_and_clincial_medicine_f_magrassi,,,,,, +4171,,09f16d83-fe4a-4d51-babf-b546da393bc1,Bionor Immuno AS,bionor_immuno_as,,,,,, +4172,,510e1e01-3c6b-4beb-a646-bda21b3c8013,SERVIER Research and Development ICTR (For United Kingdom only),servier_research_and_development_ictr_for_united_kingdom_only,,,,,, +227,0.979411780834198,f73a4ba6-7178-11e6-a0cd-0242ac12000b,ALEXION PHARM,alexion_pharm,,,,bf1a9e59-98fa-461b-84a8-7740b1743049,alexion_pharmaceuticals_inc,"ALEXION PHARMACEUTICALS, INC" +4173,,3461cebc-065b-406d-9101-caa1e0d5364f,"Department of Nephrology, Rigshospitalet, University of Copenhagen",department_of_nephrology_rigshospitalet_university_of_copenhagen,,,,,, +4174,,7b9f5c43-0517-495e-9dcf-453918733c4e,Tommi Vimpeli,tommi_vimpeli,,,,,, +4175,,1b172587-0cc7-45f3-ae55-a1b8994bba9e,Polyphor Ltd,polyphor_ltd,,,,,, +4176,,95390feb-20be-4fc1-9998-ab583134bc75,Center for Biomedical Research of La Rioja (CIBIR),center_for_biomedical_research_of_la_rioja_cibir,,,,,, +4177,,fa5654fd-32d3-4ef3-b66e-5c457e32d715,HOV GmbH,hov_gmbh,,,,,, +4178,,a7a86a96-7376-11e6-a0cd-0242ac12000b,STORZ,storz,,,,,, +4179,,e71fb1f1-362a-4b8a-af8c-e7cd7ac4fabc,sa Novo Nordisk Pharma nv,sa_novo_nordisk_pharma_nv,,,,,, +4180,,8d359990-b7c0-474c-9baa-16399209fee5,"Käkkliniken, Universitetssjukhuset i Linköping",k_kkliniken_universitetssjukhuset_i_link_ping,,,,,, +4181,,a49d6e12-6972-4725-b6e9-bc17b3aa3d9c,Ortopædkirurgisk Forskning - Aarhus Universitetshospita,ortop_dkirurgisk_forskning_aarhus_universitetshospita,,,,,, +4182,,163cea00-129b-4c75-91e1-0b8a20d0d489,"University Medical Centre Ljubljana, Department of Gynaecology",university_medical_centre_ljubljana_department_of_gynaecology,,,,,, +4183,,194d5a2a-c4df-483e-8ecf-81b95b4b2316,RB Pharmaceuticals Inc,rb_pharmaceuticals_inc,,,,,, +4184,,e6d2bf79-88b5-4e40-aa2b-a36c8a77b81d,"Johnson and Johnson Pharmaceutical Research and Development, una división de Janssen-Cilag, S.A",johnson_and_johnson_pharmaceutical_research_and_development_una_divisi_n_de_janssen_cilag_s_a,,,,,, +622,0.984184,d9ad1860-71ec-11e6-a0cd-0242ac12000b,EMD SERONO INC,emd_serono_inc,,,,9262c2fe-71a9-11e6-a0cd-0242ac12000b,emd_serono,EMD SERONO +4185,,246801f4-41b4-4f24-b4b4-30f7b5d4da08,Praxis Pharmaceutical S.A,praxis_pharmaceutical_s_a,,,,,, +4186,,dfcfdacb-4424-43a9-966c-c668ba46def7,"CELLERIX, S.L",cellerix_s_l,,,,,, +913,0.9859306812286377,28a229c0-5d6e-4889-95a4-444fe02e5e3c,Department of Cardiology,department_of_cardiology,,,,28a229c0-5d6e-4889-95a4-444fe02e5e3c,department_of_cardiology,Department of Cardiology +4187,,a6666551-9aec-4601-bdf4-602aed6bff0a,"Merck Serono International, An affiliate of Merck KGaA, Darmstadt, Germany",merck_serono_international_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,,, +4188,,e9a1f765-09ac-4708-8f5f-2b436721c55f,Laboratories SMB S.A,laboratories_smb_s_a,,,,,, +4189,,68d714b6-d5f0-4c9c-a148-a31f16d57c82,Elan Regulatory Holdings Ltd,elan_regulatory_holdings_ltd,,,,,, +4190,,eeade63a-8bc9-11e6-a449-0242ac12000b,"The Fertility Clinic, Skive Regional Hospital",the_fertility_clinic_skive_regional_hospital,,,,,, +4191,,917063ef-0f92-4b31-a4a6-0c69fb8f7700,Roche Pharma AG,roche_pharma_ag,,,,,, +391,0.988144,4d1c7b0c-14e8-4b45-86cf-b9594868a087,"Threshold Pharmaceuticals, Inc",threshold_pharmaceuticals_inc,,,,4d1c7b0c-14e8-4b45-86cf-b9594868a087,threshold_pharmaceuticals_inc,"Threshold Pharmaceuticals, Inc" +591,0.981797,028fff30-1193-4fcf-bcc7-abb85c227761,"Genzyme Corporation, a Sanofi company",genzyme_corporation_a_sanofi_company,,,,028fff30-1193-4fcf-bcc7-abb85c227761,genzyme_corporation_a_sanofi_company,"Genzyme Corporation, a Sanofi company" +4192,,13afa8de-225f-4efd-b8dd-20ae4a5b97a3,Crucell Holland BV,crucell_holland_bv,,,,,, +4193,,5b3a0ba0-b24b-4730-b08a-8793d3ec72b1,"Stockholm Läns Landsting, Karolinska University Hospital",stockholm_l_ns_landsting_karolinska_university_hospital,,,,,, +4194,,59955049-cb3d-4db8-bff1-b9757be2d531,ÁREA DE ATENCIÓN INTEGRADA DE ALBACETE,rea_de_atenci_n_integrada_de_albacete,,,,,, +4195,,e7788878-40b1-4aff-963b-3adedeb020d9,University Childrens Hospital,university_childrens_hospital,,,,,, +785,0.9885413646697998,a896ae02-0ec3-47cc-8072-7cf79e6d3551,Medizinische Hochschule Hannover,medizinische_hochschule_hannover,,,,a896ae02-0ec3-47cc-8072-7cf79e6d3551,medizinische_hochschule_hannover,Medizinische Hochschule Hannover +4196,,e1d94d02-72ae-11e6-a0cd-0242ac12000b,EMPI,empi,,,,,, +4197,,d108e64a-71b4-11e6-a0cd-0242ac12000b,SETON PHARM,seton_pharm,,,,,, +613,0.97674435377120972,12caeba5-ed14-4baa-9bbd-829d8aa11d8a,"Erasmus Medical Centre, Department of Anesthesiology",erasmus_medical_centre_department_of_anesthesiology,,,,12caeba5-ed14-4baa-9bbd-829d8aa11d8a,erasmus_medical_centre_department_of_anesthesiology,"Erasmus Medical Centre, Department of Anesthesiology" +4198,,7aee779f-a14d-4ac4-8abe-f87c91de6c9c,FUNDACION C.V. HOSPITAL PROVINCIAL DE CASTELLON,fundacion_c_v_hospital_provincial_de_castellon,,,,,, +4199,,f44acb6a-7de3-48a7-ae7f-7e3e18a95822,Research Institute of Biological Psychiatry Sct. Hans,research_institute_of_biological_psychiatry_sct_hans,,,,,, +4200,,c76372d8-1a96-4a7c-8eee-6dae24086ebe,CHRU Rennes,chru_rennes,,,,,, +4201,,a508f8ee-f395-4c24-8193-a12a02c6d436,GLAXO SMITH KLINE,glaxo_smith_kline,,,,,, +4202,,d67be399-4755-4022-8464-228d4dc65edd,SPHERIUM BIOMED S.L,spherium_biomed_s_l,,,,,, +4203,,b134ac14-8681-4bbc-a87d-4c4a479265ce,University of Essen,university_of_essen,,,,,, +424,0.976266,824bf19e-712a-11e6-a89e-0242ac12000b,AKORN INC,akorn_inc,,,,824bf19e-712a-11e6-a89e-0242ac12000b,akorn_inc,AKORN INC +53,0.98087829351425171,216dbd0a-5b1d-497f-8573-82115e0c5c35,"Med. Univ. Wien, Innere Med. I",med_univ_wien_innere_med_i,,,,0409ac6d-4311-4f84-9569-7d15fbdc4ffc,med_univ_wien,Med. Univ. Wien +4204,,af190c82-883a-4962-ae77-ca71db7dc2cc,GMIHO mbH,gmiho_mbh,,,,,, +426,0.988445,5e11478f-4293-4f4b-84dd-d3dc2a540f03,Leids Universitair Medisch Centrum (LUMC),leids_universitair_medisch_centrum_lumc,,,,5e11478f-4293-4f4b-84dd-d3dc2a540f03,leids_universitair_medisch_centrum_lumc,Leids Universitair Medisch Centrum (LUMC) +4205,,a19aaa7f-6ccd-4793-8621-af68384b888d,ANGELA PUENTE,angela_puente,,,,,, +919,0.985423,6e3bc4ca-7140-11e6-a0cd-0242ac12000b,NOVO NORDISK INC,novo_nordisk_inc,,,,6e3bc4ca-7140-11e6-a0cd-0242ac12000b,novo_nordisk_inc,NOVO NORDISK INC +4206,,93d60d6a-6e96-4fec-ba95-5efc673f09ad,AB-BIOTICS S.A,ab_biotics_s_a,,,,,, +4207,,9edcd4c2-ffc8-47ea-a0e1-484dfa7095c1,HOMVIORA Arzneimittel - Dr. Hagedorn GmbH & Co,homviora_arzneimittel_dr_hagedorn_gmbh_co,,,,,, +4208,,40787b0f-5990-4348-817c-810b76257d16,"ACCORD, NHS Lothian",accord_nhs_lothian,,,,,, +172,0.96988421678543091,4d103db0-46f8-458b-804a-442a7728fad2,"Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA",merck_serono_international_a_branch_of_laboratoires_serono_sa_an_affiliate_of_merck_kgaa,,,,4d103db0-46f8-458b-804a-442a7728fad2,merck_serono_international_a_branch_of_laboratoires_serono_sa_an_affiliate_of_merck_kgaa,"Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA" +4209,,a0228317-cea0-4337-9960-190e3a6151fb,Dr. Francisco Bosa Ojeda,dr_francisco_bosa_ojeda,,,,,, +899,0.98596411943435669,4cfdad12-75d3-4d01-af84-8fd41eb1eaf2,Kuopion yliopistollinen sairaala/Ensihoitokeskus,kuopion_yliopistollinen_sairaala_ensihoitokeskus,,,,3d00d697-8faa-4e4b-bfd7-814eddaee9da,kuopion_yliopistollinen_sairaala,Kuopion yliopistollinen sairaala +1020,0.97842517495155334,44de7c0e-a85b-476f-9b4c-4bc56b21b0df,Orion Corporation,orion_corporation,,,,b56a3044-dedf-4773-b7a5-e6cd18764bcd,orion_corporation_orion_pharma,Orion Corporation Orion Pharma +4210,,a6c75313-8a80-4a69-a423-7183b5dcbbef,CH VERSAILLES,ch_versailles,,,,,, +4211,,031e1192-41bd-4732-abe8-d19cd24645cc,AZIENDA OSPEDALIERA DI PERUGIA,azienda_ospedaliera_di_perugia,,,,,, +433,0.98984676599502563,83f77026-9bf3-42d7-bdf1-59a5d35a6b9b,"Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA",pfizer_inc_235_east_42nd_street_new_york_new_york_10017_usa,,,,83f77026-9bf3-42d7-bdf1-59a5d35a6b9b,pfizer_inc_235_east_42nd_street_new_york_new_york_10017_usa,"Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA" +4212,,5251ccd7-2fac-4e89-9214-207adc5742e9,Hanmi Pharmaceutical Company Limited,hanmi_pharmaceutical_company_limited,,,,,, +4213,,1e5d63b4-3d79-4a36-8bfd-cff16a822d8b,Matti Välimäki,matti_v_lim_ki,,,,,, +1021,0.97921851277351379,23f78320-5daf-4570-8ce4-866b6d027cd6,"Impax Laboratories, Inc., acting through its Impax Pharmaceuticals Division (Impax)",impax_laboratories_inc_acting_through_its_impax_pharmaceuticals_division_impax,,,,2e27f2ec-dcc5-4828-b31a-e2eca3930c17,impax_laboratories_inc_acting_through_its_impax_pharmaceuticals_division_impax,"Impax Laboratories, Inc., acting through its Impax Pharmaceuticals Division (Impax)" +4214,,a271560d-44df-423b-b625-9f8a71d227ba,Universitätsklinikum Giessen und Marburg - Standort Giessen,universit_tsklinikum_giessen_und_marburg_standort_giessen,,,,,, +4215,,cd9bd8b1-1864-46a2-992a-1368a30d607b,Fakultní nemocnice Plzeň,fakultn_nemocnice_plze,,,,,, +4216,,1ce8c765-0b94-41a3-9d53-ab381874a270,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,fundaci_n_para_la_investigaci_n_biom_dica_hospital_ram_n_y_cajal,,,,,, +4217,,dbb89171-fc0d-484e-acdb-c6578d6b3c48,Guy's and St Thomas NHS Foundation Trust,guy_s_and_st_thomas_nhs_foundation_trust,,,,,, +4218,,9897fd43-a55a-4a69-8473-85670699df64,Nitec Pharma AG,nitec_pharma_ag,,,,,, +886,0.982434,6d20580f-c914-4da7-8a5e-22023506a872,ULB - Unité de Recherche en Lymphologie,ulb_unit_de_recherche_en_lymphologie,,,,2dab8489-6b0d-42e8-91ae-f96f843a7d75,ulb_unit_de_recherche_en_lymphologie_facult_des_sciences_de_la_motricit,ULB - Unité de Recherche en Lymphologie - Faculté des Sciences de la motricité +4219,,22ecffc9-18d6-40a2-bd03-6c7edcfe3ac0,"KH der Elisabethinen Linz GmbH, I. Interne Abteilung",kh_der_elisabethinen_linz_gmbh_i_interne_abteilung,,,,,, +4220,,6c755c92-2c58-41c2-a55a-5096f8919f08,Odense Universitetshospital/Syddansk Universitet,odense_universitetshospital_syddansk_universitet,,,,,, +4221,,eda3f5fb-f5f9-4e2c-8e8a-7b29b6bff95a,"Universität Magdeburg, Medizinische Fakultät",universit_t_magdeburg_medizinische_fakult_t,,,,,, +4222,,411981a9-5166-4805-9210-0860ced3f5c8,Justus Liebig University of Giessen,justus_liebig_university_of_giessen,,,,,, +4223,,3286478e-7190-11e6-a0cd-0242ac12000b,POYTHRESS,poythress,,,,,, +4224,,546e85c6-50a5-490b-b5b7-8cfe57cd5749,University Medical Centre Freiburg,university_medical_centre_freiburg,,,,,, +359,0.97782391309738159,fab0d24f-2629-463f-ba19-f4ddeb577cee,IPSEN,ipsen,,,,453b2e40-8c8e-4dab-8a75-c9364067b629,ipsen_nv,IPSEN NV +267,0.989332,ce97b6ea-53cd-4ff4-ac88-f6f156eafef5,Grupo de Tratamiento de los Tumores Digestivos (TTD),grupo_de_tratamiento_de_los_tumores_digestivos_ttd,,,,9e2eb0ad-e2df-43f2-bc5d-f12af02311cf,grupo_de_tratamiento_de_los_tumores_digestivos,Grupo de Tratamiento de los Tumores Digestivos +4225,,dbea36f3-71fe-4137-a041-3ae6abf2d34f,AstraZeneca LP,astrazeneca_lp,,,,,, +4226,,bda39b46-013a-44ee-bc77-cfbd209869d2,North Staffordshire Combined Healthcare Trust,north_staffordshire_combined_healthcare_trust,,,,,, +207,0.915531,5ac2130a-6fbe-11e6-abe8-0242ac12000b,"BIAL - Portela & Cª, SA",bial_portela_c_sa,,,,46fed310-ee3c-4cc4-8649-37bb315ed072,bial_portela_ca_s_a,"BIAL - Portela & Ca, S.A" +4227,,2c1acae3-0918-4e34-b8f7-3c49664478c9,"Section of Clinical Pain Research, Department of Molecular Medicine and Surgery Karolinska Institute",section_of_clinical_pain_research_department_of_molecular_medicine_and_surgery_karolinska_institute,,,,,, +58,0.97642512619495392,2ed1b6f4-e137-4ee3-a218-9e5c2d04039a,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_and_development,,,,2ed1b6f4-e137-4ee3-a218-9e5c2d04039a,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_and_development,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development +4228,,e91bd950-5eee-4fcf-9668-cce62e0beb4a,Fa. Dr. F. Köhler Chemie GmbH,fa_dr_f_k_hler_chemie_gmbh,,,,,, +4229,,1e09d068-2c48-4818-84b7-e213824b395b,Ardeypharm GmbH,ardeypharm_gmbh,,,,,, +4230,,61b6bc62-f657-4150-b0b1-196edefa6990,Janssen-Cilag AB,janssen_cilag_ab,,,,,, +4231,,c297ad6f-63db-4f3a-a227-836813e4e1d0,Århus Universitetshospital Afd for Eksp. Klinisk onkologi,rhus_universitetshospital_afd_for_eksp_klinisk_onkologi,,,,,, +4232,,3d8a1f00-074b-4775-b47b-03003e1f35bd,"Pfizer Global Research & Development Ltd, Clinical R & D, IPC 137",pfizer_global_research_development_ltd_clinical_r_d_ipc_137,,,,,, +4233,,8efbb4be-94ce-44a5-9469-7114968c5ee5,Cellectis S.A,cellectis_s_a,,,,,, +4234,,1ec971a3-fbdf-495a-99b1-a20ff23a49f6,"Penine Acute NHS Trust, North Manchester General Hospital",penine_acute_nhs_trust_north_manchester_general_hospital,,,,,, +793,0.912188,d6256386-5911-453d-9333-445b4c930805,Amersham Health S.A. (parte de GE Healthcare Ltd y sus filiales),amersham_health_s_a_parte_de_ge_healthcare_ltd_y_sus_filiales,,,,9012ebe0-cafc-4b9e-8d91-e304af97eab8,amersham_health_sa_parte_de_ge_healthcare_ltd_y_sus_filiales,Amersham Health SA (Parte de GE Healthcare Ltd. y sus filiales) +631,0.944644,b7d3a443-d135-4e6c-beeb-dd08968c1fd9,ISTITUTO ORTOPEDICO RIZZOLI,istituto_ortopedico_rizzoli,,,,6e37f726-18bd-47e5-8ffd-231a4eb18b5b,istituti_ortopedici_rizzoli,ISTITUTI ORTOPEDICI RIZZOLI +4235,,6caebb33-4450-4588-a66e-435c7ee46c54,Jukka Sairanen,jukka_sairanen,,,,,, +4236,,a984690e-7156-11e6-a0cd-0242ac12000b,UNIQUE PHARM LABS,unique_pharm_labs,,,,,, +4237,,7f33ccb4-715e-11e6-a0cd-0242ac12000b,GRAHAM CHEM,graham_chem,,,,,, +54,0.987705,22fb394f-9949-4253-b978-e945565c187d,AIBILI - Association for Innovation and Biomedical Research on Light and Image,aibili_association_for_innovation_and_biomedical_research_on_light_and_image,,,,22fb394f-9949-4253-b978-e945565c187d,aibili_association_for_innovation_and_biomedical_research_on_light_and_image,AIBILI - Association for Innovation and Biomedical Research on Light and Image +4238,,fa673582-0dca-4926-99dc-e3ecdfcb7628,Centre Hospitalier Régional Universitaire de Besançon,centre_hospitalier_r_gional_universitaire_de_besan_on,,,,,, +4239,,51af2e30-f5a5-4cbe-bbca-bb483a10e349,GlaxSmithKline Research & Development,glaxsmithkline_research_development,,,,,, +4240,,6ec5a0c5-07e5-43f0-8df1-394f276a682c,"Miravant Pharmaceuticals, Inc",miravant_pharmaceuticals_inc,,,,,, +380,0.97179288334316682,41459cfe-38cc-478e-9688-0c682f4c29ad,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., U.S.A",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_u_s_a,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" +4241,,cce20ff9-0be3-4d4d-b709-54561c103fd5,"Tecnimede, Sociedade Técnico-Medicinal S.A",tecnimede_sociedade_t_cnico_medicinal_s_a,,,,,, +4242,,3cc8985d-a386-4b94-800b-7f8a03f06e3d,AZIENDA ASL BRESCIA,azienda_asl_brescia,,,,,, +4243,,01cb29f9-e6fd-4794-b56f-eec918a63d26,"OSPEDALE CIVILE SAN SALVATORE, ASL 04, L'AQUILA",ospedale_civile_san_salvatore_asl_04_l_aquila,,,,,, +4244,,88d4c0e4-e691-4c9f-b1a8-825ab8e84295,"Prof. Herta Flor, Head of the Institute of Clinical and Cognitive Neuroscience",prof_herta_flor_head_of_the_institute_of_clinical_and_cognitive_neuroscience,,,,,, +343,0.945615,fd3c40c4-9ca3-4b68-8285-dddbe2304d1a,Institut Gustave Roussy,institut_gustave_roussy,,,,df233af1-76b7-4839-86bc-252076367896,institut_gustav_roussy,Institut Gustav Roussy +4245,,b7771802-e505-45fa-933a-1f46a724da4f,Baxter R and D Europe SCRL,baxter_r_and_d_europe_scrl,,,,,, +795,0.982732,a794f8fb-a13b-44b5-98ab-9945768f16df,Medical Research Council,medical_research_council,,,,a794f8fb-a13b-44b5-98ab-9945768f16df,medical_research_council,Medical Research Council +4246,,2f167d26-79b0-4362-b7c5-d4756e85f798,Almirall Hermal GmbH,almirall_hermal_gmbh,,,,,, +4247,,6a64cce1-da60-465f-b41e-fbf98e57f1e3,"Genetronics, Inc",genetronics_inc,,,,,, +4248,,d238a4ed-4918-41c7-8290-aedeb1e884d5,University of Oslo,university_of_oslo,,,,,, +4249,,f92eb1ed-3c9d-4feb-a02a-ded95cb2f00d,FoldRx Pharmaceuticals Limited,foldrx_pharmaceuticals_limited,,,,,, +4250,,3f1b7204-7162-11e6-a0cd-0242ac12000b,METRIC,metric,,,,,, +4251,,031d126c-3c98-4cf1-939c-00ea9d902dc7,"Wyeth Pharmaceutical Co., Ltd",wyeth_pharmaceutical_co_ltd,,,,,, +4252,,9590f45a-ee8e-431f-9e48-de7056af23f6,Laboratorios Gebro Pharma S.A,laboratorios_gebro_pharma_s_a,,,,,, +4253,,67387f3a-7161-11e6-a0cd-0242ac12000b,ASCHER,ascher,,,,,, +4254,,64fc4012-9fa2-4c0c-b45c-cc1aeaa8ba22,CELGENE EUROPE LIMITED,celgene_europe_limited,,,,,, +425,0.96910750865936279,a89061fe-7d3c-47c4-acdc-5ea8273f45e8,HOVON,hovon,,,,a89061fe-7d3c-47c4-acdc-5ea8273f45e8,hovon,HOVON +4255,,aeb1acbc-1f63-42b3-a143-d40a6ee192ae,Lýsi hf,l_si_hf,,,,,, +324,0.98178735375404358,395b5e6f-c249-4152-9918-7fe1c4f16a37,Stiefel Laboratories Maidenhead Ltd,stiefel_laboratories_maidenhead_ltd,,,,0a082bad-97ec-4e82-be7d-2731907614ac,stiefel_laboratories_maidenhead_ltd,Stiefel Laboratories Maidenhead Ltd +4256,,c4afb20c-7141-11e6-a0cd-0242ac12000b,INGENUS PHARMS NJ,ingenus_pharms_nj,,,,,, +4257,,303132ea-7146-11e6-a0cd-0242ac12000b,NEPHRON,nephron,,,,,, +4258,,6207085a-6fa0-11e6-9663-0242ac12000b,Alliance pour la recherche en cancérologie,alliance_pour_la_recherche_en_canc_rologie,,,,,, +4259,,8e1574db-d8e9-46f1-8e1a-1c8a99c39dd5,AZIENDA UNITA` SANITARIA LOCALE N 12 DI VIAREGGIO,azienda_unita_sanitaria_locale_n_12_di_viareggio,,,,,, +4260,,1503c2df-0687-4597-ac14-c6b78b986f0f,Klinikum der Ludwigs-Maximilians-Universität München,klinikum_der_ludwigs_maximilians_universit_t_m_nchen,,,,,, +4261,,b2647ee4-0834-40a2-b3a0-eaf7638f3f02,"Faculty of Medicine Carl Gustav Carus, University of Technology, Dresden",faculty_of_medicine_carl_gustav_carus_university_of_technology_dresden,,,,,, +4262,,ce89fd40-7160-11e6-a0cd-0242ac12000b,MARATHON PHARMS,marathon_pharms,,,,,, +4263,,9b20d422-73c9-11e6-a0cd-0242ac12000b,KASTLE THERAPS LLC,kastle_theraps_llc,,,,,, +4264,,7dc696b7-471e-4851-a98f-39194b4b92f1,Madaus GmbH,madaus_gmbh,,,,,, +4265,,daadce72-a859-499f-a065-aa002eec4e4c,Koege Hospital,koege_hospital,,,,,, +4266,,db88b7c0-8bc8-11e6-a449-0242ac12000b,River Vision Development Corporation,river_vision_development_corporation,,,,,, +4267,,bc2718de-8b27-4f5a-a75d-9c0d1763b834,ANTISOMA,antisoma,,,,,, +687,0.96910750865936279,197d4369-9301-4bac-b737-20a72c9e0d7b,"Ruprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg and its Commercial",ruprecht_karls_university_heidelberg_medical_faculty_represented_by_universit_tsklinikum_heidelberg_and_its_commercial,,,,197d4369-9301-4bac-b737-20a72c9e0d7b,ruprecht_karls_university_heidelberg_medical_faculty_represented_by_universit_tsklinikum_heidelberg_and_its_commercial,"Ruprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg and its Commercial" +4268,,93ab78f5-54d1-4e11-ba0e-cfe0efb74926,Endo Pharmaceuticals Solutions,endo_pharmaceuticals_solutions,,,,,, +4269,,a7d7d862-0cb2-4142-ba1d-ac1b7aa8f03a,Antonio Noda Cabrera,antonio_noda_cabrera,,,,,, +4270,,70031a6e-715f-11e6-a0cd-0242ac12000b,PHARMERAL,pharmeral,,,,,, +114,0.97253835201263428,c0e26a28-8145-497a-8f48-d935495cc957,Shire Pharmaceutical Ireland Limited,shire_pharmaceutical_ireland_limited,,,,c0e26a28-8145-497a-8f48-d935495cc957,shire_pharmaceutical_ireland_limited,Shire Pharmaceutical Ireland Limited +64,0.986698,ccc2695d-93a7-4900-a3b6-e4bb0c11c688,Wilhelmina Children's Hospital/UMC Utrecht,wilhelmina_children_s_hospital_umc_utrecht,,,,ccc2695d-93a7-4900-a3b6-e4bb0c11c688,wilhelmina_children_s_hospital_umc_utrecht,Wilhelmina Children's Hospital/UMC Utrecht +4271,,1d903e05-a70d-11e6-94cb-5656d04fc2b5,Dr. José Maria Ruiz Moreno,dr_jos_maria_ruiz_moreno,,,,,, +4272,,4589aa48-ef44-4cdc-9166-6f88cefc1a85,Nottingham University Hospital NHS Trust,nottingham_university_hospital_nhs_trust,,,,,, +4273,,04b1d427-b4e6-4b02-bc6e-08a6af2ad760,State University Hospital,state_university_hospital,,,,,, +4274,,5fbb2589-b48e-4396-959e-0734e5b8920c,Lofarma S.p.A,lofarma_s_p_a,,,,,, +4275,,63728a44-7157-11e6-a0cd-0242ac12000b,CORNERSTONE,cornerstone,,,,,, +4276,,9d0bf600-a04f-47cb-ba9d-ec1558a02a5d,CHU AMBROISE PARE,chu_ambroise_pare,,,,,, +939,0.9797365665435791,2c899cf4-2f23-4023-b9ab-f8d5356588d9,Hospira,hospira,,,,2c899cf4-2f23-4023-b9ab-f8d5356588d9,hospira,Hospira +4277,,0c8f9b0e-53c3-46c6-8426-358806ac4b5d,Moberg Derma,moberg_derma,,,,,, +4278,,3c9aa55a-2e8b-4802-972c-3df8e83b39d8,ONCOGENEX TECHNOLOGIES INC,oncogenex_technologies_inc,,,,,, +4279,,7ebdf960-6a78-4158-b661-b07ff7b72ebb,TESARO Inc,tesaro_inc,,,,,, +4280,,e4cb387e-7199-11e6-a0cd-0242ac12000b,ATON,aton,,,,,, +4281,,86b6de43-8f6d-4e2a-83e0-b6223c58af3a,Swiss Cardio Technologies AG,swiss_cardio_technologies_ag,,,,,, +4282,,4f44f707-d794-46ed-90f4-c6ecc0600ba1,Medical Institutions of the District Oberpfalz/Bayern (MedBO GmbH),medical_institutions_of_the_district_oberpfalz_bayern_medbo_gmbh,,,,,, +4283,,d1ba0e7a-71f0-11e6-a0cd-0242ac12000b,PROSTRAKAN INC,prostrakan_inc,,,,,, +4284,,2ceb150b-7539-453c-806a-13d2f29cab85,sanofi synthelabo recherche,sanofi_synthelabo_recherche,,,,,, +380,0.97164037492540145,a89c5de9-eac7-4005-9478-f0cb55dbc2ac,"Merck Sharp & Dohme Corp., a subsidary of Merck & Co., Inc",merck_sharp_dohme_corp_a_subsidary_of_merck_co_inc,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" +4285,,b081a381-f1b2-42bf-9eb4-98aa889debb0,Charité-Campus Mitte und Campus Virchow-Klinikum,charit_campus_mitte_und_campus_virchow_klinikum,,,,,, +4286,,53241b6f-40a8-466a-9b46-7fde5e91f151,"Medizinische Universität Graz, Universitätsklinik für Zahn-, Mund- und Kieferheilkunde",medizinische_universit_t_graz_universit_tsklinik_f_r_zahn_mund_und_kieferheilkunde,,,,,, +4287,,b97ba26a-d35e-49f4-a98a-ed3a51100c4e,"Hæmatologisk Afsnit, Vejle Sygehus",h_matologisk_afsnit_vejle_sygehus,,,,,, +399,0.988953,3d14aa9b-70db-4d32-a4ed-e782e954b0db,Groupe Francophone des Myélodysplasies (GFM),groupe_francophone_des_my_lodysplasies_gfm,,,,33290af1-5e28-4e4a-85eb-2b145405dc27,groupe_francophone_des_my_lodysplasies,Groupe Francophone des Myélodysplasies +4288,,7495cbd2-a273-4dda-987c-9a50db0d5ca0,"University Hospital of Antwerp, Department of Respiratory Medicine",university_hospital_of_antwerp_department_of_respiratory_medicine,,,,,, +4289,,e00b0475-322d-4705-8b3c-80d70b11480d,"Helsingin Lääkärikeskus Oy, Graviditas Lapsettomuusklinikka",helsingin_l_k_rikeskus_oy_graviditas_lapsettomuusklinikka,,,,,, +761,0.958103,931e7207-ea0c-4262-baf3-da49815f8901,"The Heart Centre, Rigshospitalet",the_heart_centre_rigshospitalet,,,,931e7207-ea0c-4262-baf3-da49815f8901,the_heart_centre_rigshospitalet,"The Heart Centre, Rigshospitalet" +4290,,5230a359-baf1-45b3-a9ab-f99306ed8e73,AESCA Pharma GmbH,aesca_pharma_gmbh,,,,,, +839,0.952896,9ac934a2-f363-48d8-8da4-a925d66bd5cc,Newcastle Hospital Trust,newcastle_hospital_trust,,,,9ac934a2-f363-48d8-8da4-a925d66bd5cc,newcastle_hospital_trust,Newcastle Hospital Trust +4291,,f98bb0b6-c402-41ef-803c-4c36575a5db7,"BioMimetic Therapeutics, Inc",biomimetic_therapeutics_inc,,,,,, +98,0.979094,76157ebc-7bea-4a83-a2ca-6c02e460c234,University of Leipzig,university_of_leipzig,,,,76157ebc-7bea-4a83-a2ca-6c02e460c234,university_of_leipzig,University of Leipzig +215,0.983343,138e388c-71e0-11e6-a0cd-0242ac12000b,LEO PHARMA AS,leo_pharma_as,,,,138e388c-71e0-11e6-a0cd-0242ac12000b,leo_pharma_as,LEO PHARMA AS +4292,,3388d6f8-7314-11e6-a0cd-0242ac12000b,SERB SA,serb_sa,,,,,, +4293,,5bd0da91-8f94-4e98-8b9b-ad3b9c0bfd7c,CHU de Rennes,chu_de_rennes,,,,,, +4294,,1e1d7ecc-460e-47e8-af08-4b0fe7b43dc2,"Department of Genitourinary medicine and Infectious Diseases, St James's Hospital, Dublin 8",department_of_genitourinary_medicine_and_infectious_diseases_st_james_s_hospital_dublin_8,,,,,, +4295,,1ef11de6-ed5a-41d0-915d-85f60590468d,Thoraxclinic at the University of Heidelberg,thoraxclinic_at_the_university_of_heidelberg,,,,,, +4296,,1d0850bb-a709-11e6-94cb-5656d04fc2b5,"Bente Lomholt Langdahl, Dept. of Endocrinology and Internal Medicine, Aarhus University Hospital",bente_lomholt_langdahl_dept_of_endocrinology_and_internal_medicine_aarhus_university_hospital,,,,,, +4297,,1be637e6-1957-4157-8056-a39e2b2f2182,Grupo Español de Tratamiento de Tumores Genitourinarios (SOGUG)-Spanish Genitourinary Oncologic Group,grupo_espa_ol_de_tratamiento_de_tumores_genitourinarios_sogug_spanish_genitourinary_oncologic_group,,,,,, +4298,,ca3ab57a-3b65-431d-86c5-621a31896748,Prosensa Holding B.V,prosensa_holding_b_v,,,,,, +4299,,82c3056b-8fd2-4b35-935f-621074ee1d40,Repha GmbH,repha_gmbh,,,,,, +4300,,6f094a41-e19a-4d0c-b76b-610d830d5922,"Azienda Ospedaliero Universitaria Careggi, Firenze",azienda_ospedaliero_universitaria_careggi_firenze,,,,,, +4301,,928f550b-a74e-11e6-94cb-5656d04fc2b5,Rockefeller University,rockefeller_university,,,,,, +4302,,14bd7782-2ecf-4ad0-853f-932e4720fd10,GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa),geteccu_grupo_espa_ol_de_trabajo_en_enfermedad_de_crohn_y_colitis_ulcerosa,,,,,, +4303,,b713bf29-a0fa-4ced-876b-002d682612e0,"Department of medical gastroenterology, Herlev Hospital",department_of_medical_gastroenterology_herlev_hospital,,,,,, +4304,,e3a4725b-522b-4e16-a5fc-c62428e099b8,"Rigshospitalet, Kardiologisk afd",rigshospitalet_kardiologisk_afd,,,,,, +4305,,5e06d300-7164-11e6-a0cd-0242ac12000b,GENERA PHARMS,genera_pharms,,,,,, +4306,,3adfa772-740d-4b9a-98cd-7e55cf33b091,Amersham Health AB,amersham_health_ab,,,,,, +416,0.968388,f1cda425-4d6d-4eb7-95bd-c4d3ae48a550,Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME),fraunhofer_gesellschaft_for_its_institute_fraunhofer_institute_for_molecular_biology_and_applied_ecology_ime,,,,da6ce2e0-306e-4461-9ae3-5767282527c6,fraunhofer_gesellschaft,Fraunhofer Gesellschaft +4307,,3bc42ea2-0f5f-475c-a4d9-876fd6653785,Pharmecosse,pharmecosse,,,,,, +1046,0.98746395111083984,6de197b9-6b4f-41ef-b8a0-fbee9c50e584,Synta Pharmaceutical Corp,synta_pharmaceutical_corp,,,,6de197b9-6b4f-41ef-b8a0-fbee9c50e584,synta_pharmaceutical_corp,Synta Pharmaceutical Corp +4308,,188ce049-5fc4-46bc-9520-a10ad3c5ce59,Ninewells Hospital and Medical School,ninewells_hospital_and_medical_school,,,,,, +4309,,9e2395ca-71c0-11e6-a0cd-0242ac12000b,HERITAGE LIFE,heritage_life,,,,,, +4310,,958701a9-46d7-44eb-8de5-483a1334139d,St George's Healthcare NHS Trust,st_george_s_healthcare_nhs_trust,,,,,, +4311,,913e7f10-1d4f-4c89-bd06-364c74b11f57,"Univerzita Karlova v Praze, Lékařská fakulta v Hradci Králové",univerzita_karlova_v_praze_l_ka_sk_fakulta_v_hradci_kr_lov,,,,,, +4312,,07cde2bc-0932-40f4-a70e-588ecb76af65,Santhera Pharmaceuticals (Switzerland) Limited,santhera_pharmaceuticals_switzerland_limited,,,,,, +4313,,409822e1-791d-4990-801f-94d60328b102,Central Manchester University Hospitals NHS Foundation Trust,central_manchester_university_hospitals_nhs_foundation_trust,,,,,, +4314,,62dcee78-0e64-417e-9494-24a08895268d,Sakari Simula,sakari_simula,,,,,, +4315,,de86f2ed-4dd8-406c-b5d8-26864a95746d,Klinik für Psychiatrie und Psychotherapie der Ludwig Maximilian Universität München,klinik_f_r_psychiatrie_und_psychotherapie_der_ludwig_maximilian_universit_t_m_nchen,,,,,, +4316,,266f1e7c-78ff-44c9-8607-87900aa1ec06,Arana Therapeutics Ltd,arana_therapeutics_ltd,,,,,, +4317,,cf0e6880-139b-4e22-99c7-e0d3a4350ebf,"Tallaght Hospital, Dublin 24, Ireland",tallaght_hospital_dublin_24_ireland,,,,,, +4318,,2288b24e-18b1-4587-a5bd-18fa5cef8311,"Faustus Forschung Compagnie, Translational Cancer Research GmbH",faustus_forschung_compagnie_translational_cancer_research_gmbh,,,,,, +4319,,ff4ec925-549f-4382-bab7-3b512b37e04e,Aker BioMarine Antarctic AS,aker_biomarine_antarctic_as,,,,,, +157,0.95453011989593506,8d3cf1b7-c472-4063-8fda-cf934f8ed3b1,"Medizinische Universität Wien, Univ. Klinik für Dermatologie",medizinische_universit_t_wien_univ_klinik_f_r_dermatologie,,,,f215164e-8e75-4f48-b691-ea2bfd10d042,medizinische_universit_t_wien_univ_klinik_f_r_dermatologie,"Medizinische Universität Wien, Univ. Klinik für Dermatologie" +4320,,9fdecd75-6697-4052-89df-739d808d7710,Purdue Pharma L.P,purdue_pharma_l_p,,,,,, +4321,,a7d45a7f-0718-481c-af1b-9b004c2b2a9f,Ingrid Ehrén,ingrid_ehr_n,,,,,, +465,0.96418339014053345,e833ee0f-dd63-4035-b57e-eb474fdbcfaf,Leiden University Medical Centre,leiden_university_medical_centre,,,,2e4a0d21-5259-4b26-b5dd-ed587c02073f,leiden_university,Leiden University +4322,,4d4532ea-71b0-11e6-a0cd-0242ac12000b,PROMIUS PHARMA,promius_pharma,,,,,, +4323,,fa8a93e3-50b6-4b14-a567-bccc5fe8bd3d,Boehringer Ingelheim Austia Gm.b.H,boehringer_ingelheim_austia_gm_b_h,,,,,, +4324,,c9719cf9-dde9-4484-917e-8a67a92dcce4,"Department of Psychiatry, LMU Munich",department_of_psychiatry_lmu_munich,,,,,, +4325,,ba3da241-1200-4961-97d8-647574abf1e8,Nordsjællands Hospital. Dept. of Anaesthesiology and Intensive Care,nordsj_llands_hospital_dept_of_anaesthesiology_and_intensive_care,,,,,, +4326,,7a7f7990-dd94-42e6-9f4c-fc02c76e6c59,Spherium Biomed,spherium_biomed,,,,,, +4327,,7cfe35e7-bb26-42d6-aec2-793366ebba2e,Jose Luis Ponce Díaz-Reixa,jose_luis_ponce_d_az_reixa,,,,,, +263,0.986,7f982261-1f38-4450-bed0-692a6746f7c6,PIERRE FABRE DERMATOLOGIE,pierre_fabre_dermatologie,,,,7f982261-1f38-4450-bed0-692a6746f7c6,pierre_fabre_dermatologie,PIERRE FABRE DERMATOLOGIE +411,0.965652,283aaa37-fcdb-477b-a3fa-610093576baa,"Region Skåne, Universitetssjukhuset i Lund, Urologiska kliniken",region_sk_ne_universitetssjukhuset_i_lund_urologiska_kliniken,,,,2684f500-be7b-4cc1-b06c-5ea5752af978,region_sk_ne,Region Skåne +0,0.982418,5f4adcd3-a8a4-4ad8-bcc3-14aa5dc4d3e0,Morphotek,morphotek,,,,5f4adcd3-a8a4-4ad8-bcc3-14aa5dc4d3e0,morphotek,Morphotek +4328,,81952c66-c488-4247-ad23-fc19d22ea4d4,Swedish Pituitary Study group,swedish_pituitary_study_group,,,,,, +1022,0.980344,3d644372-21da-4da7-aba7-c8d44092d796,Ablynx NV,ablynx_nv,,,,3d644372-21da-4da7-aba7-c8d44092d796,ablynx_nv,Ablynx NV +4329,,c0b102f2-3bf8-4d96-9784-49d22e284f9c,Prof. Dr. med. Margitta Worm,prof_dr_med_margitta_worm,,,,,, +1013,0.96733957529067993,05fd0678-f53a-4b88-9656-dc6d78bcac36,Institut de Recherche Internationales Servier,institut_de_recherche_internationales_servier,,,,05fd0678-f53a-4b88-9656-dc6d78bcac36,institut_de_recherche_internationales_servier,Institut de Recherche Internationales Servier +4330,,5a5a6de0-b525-41db-a4ff-9b7b067b798d,"Technische Universität München, Fakultät für Medizin, represented by Dean",technische_universit_t_m_nchen_fakult_t_f_r_medizin_represented_by_dean,,,,,, +4331,,0239e4a0-2056-4836-8c57-c124c700aa71,Oncozyme Pharma Inc,oncozyme_pharma_inc,,,,,, +4332,,bb923015-c01e-4ed7-8634-4bdefaf90ad7,SCIDERM GMBH,sciderm_gmbh,,,,,, +4333,,54856423-affd-4213-a084-a26d30b906bb,Euroscreen S.A,euroscreen_s_a,,,,,, +4334,,3cd03721-a436-4154-a3ca-057b17c8eaaf,National Institute of Allergy and Infectious Diseases,national_institute_of_allergy_and_infectious_diseases,,,,,, +4335,,7312f078-72f0-4e9b-b9d7-38095aa98bff,"MDVI, LLC",mdvi_llc,,,,,, +4336,,f75ef0d2-8bd6-11e6-a449-0242ac12000b,Proximagen Ltd,proximagen_ltd,,,,,, +4337,,6dc960ab-c554-4ea7-a928-944ecec8fcdc,MICROMET GMBH,micromet_gmbh,,,,,, +459,0.95724058151245117,347ebbdb-d7ca-4b86-86e4-66cae5ee0b3e,"Janssen-Cilag International N.V., Turnhoutseweg 30, B-2340 Beerse, Belgium",janssen_cilag_international_n_v_turnhoutseweg_30_b_2340_beerse_belgium,,,,caa9eeff-a0fe-407d-8a39-097924dbd94c,janssen_cilag_international_n_v_turnhoutseweg_30_2340_beerse_belgium,"Janssen-Cilag International N.V., Turnhoutseweg 30, 2340 Beerse, Belgium" +4338,,d2b138e0-3eb4-4a8f-9a7c-ff6c3ee2a3b5,CYRENAIC,cyrenaic,,,,,, +4339,,5970adb6-736a-4d3c-bdf6-9369d667763b,Verein zur Förderung der Pneumologie am Krankenhaus Großhansdorf e.V,verein_zur_f_rderung_der_pneumologie_am_krankenhaus_gro_hansdorf_e_v,,,,,, +4340,,7f316395-e1a0-45b4-8c67-5292d51e0419,Österreichisches Akromegalie Register,sterreichisches_akromegalie_register,,,,,, +4341,,3badab18-046e-42d4-9296-595a6a51633c,Grupo GENOM,grupo_genom,,,,,, +409,0.9891228973865509,f4abcdbe-4eb2-4750-86d2-f234f7f56d0d,SCHWARZ BIOSCIENCES GmbH,schwarz_biosciences_gmbh,,,,bafd53c7-e832-4f6f-89c8-d8d0d9dcabe4,schwarz_biosciences,SCHWARZ BIOSCIENCES GmbH +4342,,04fedc13-b096-4b89-bb6c-11c873fb28b3,Pharmos Corp,pharmos_corp,,,,,, +4343,,ac0880c4-715c-11e6-a0cd-0242ac12000b,MN PHARMS,mn_pharms,,,,,, +4344,,35c5d57b-e1ab-4c00-aa57-a75aac474eb3,"Odense University Hospital, Department of Neurology",odense_university_hospital_department_of_neurology,,,,,, +4345,,e33662f6-111c-484e-90c7-dd4c29665375,ARTBC,artbc,,,,,, +4346,,a4728b4e-a69a-4e76-9527-3ce5f823a440,Scandinavian Prostate Cancer Group/ P.O. Hedlund,scandinavian_prostate_cancer_group_p_o_hedlund,,,,,, +4347,,16caeaa2-7142-11e6-a0cd-0242ac12000b,ARBOR PHARMS INC,arbor_pharms_inc,,,,,, +805,0.96108248829841614,8e240a49-6e4c-46a0-8366-15b78371ff26,"Otsuka Pharmaceutical Development and Commercialization, Inc",otsuka_pharmaceutical_development_and_commercialization_inc,,,,8e240a49-6e4c-46a0-8366-15b78371ff26,otsuka_pharmaceutical_development_commercialization_inc,"Otsuka Pharmaceutical Development & Commercialization, Inc" +4348,,ee6c1494-ef20-494b-b358-f202135b5bb4,Axonyx Corporation,axonyx_corporation,,,,,, +4349,,22d56df0-2297-4f01-ab0b-c645a6c68f5d,VU medical center,vu_medical_center,,,,,, +4350,,dd8b5914-d9d4-40de-9534-0e86219e1006,Papworth Hospital NHS Foundation Trust,papworth_hospital_nhs_foundation_trust,,,,,, +4351,,7a35b500-76c4-45e8-b11e-eadc0a1f790c,"HUCH, Division of Cardiology",huch_division_of_cardiology,,,,,, +4352,,f30201b0-7316-11e6-a0cd-0242ac12000b,AQUA PHARMS LLC,aqua_pharms_llc,,,,,, +4353,,51d8fc46-24a2-47c5-adc0-d64dd04d0cbd,St. Jude Children’s Research Hospital,st_jude_children_s_research_hospital,,,,,, +556,0.95241346955299377,3361148d-134d-40eb-b1d7-9105a55174b4,Greater Glasgow and Clyde Health Board,greater_glasgow_and_clyde_health_board,,,,3361148d-134d-40eb-b1d7-9105a55174b4,greater_glasgow_and_clyde_health_board_ggchb_university_of_glasgow,Greater Glasgow and Clyde Health Board (GGCHB)/University of Glasgow +241,0.984184,2cc199a4-715c-11e6-a0cd-0242ac12000b,BLU CARIBE,blu_caribe,,,,2cc199a4-715c-11e6-a0cd-0242ac12000b,blu_caribe,BLU CARIBE +4354,,bd9e11b2-880b-11e6-a998-0242ac12000b,Canbex Therapeutics Ltd,canbex_therapeutics_ltd,,,,,, +4355,,7452b8c2-8575-48bb-91f5-c48429337d01,Lilly Deutschland GmbH,lilly_deutschland_gmbh,,,,,, +4356,,0ca29306-bf4f-4888-9be5-bd1888f25f58,Complejo Hospitalario Torrecárdenas,complejo_hospitalario_torrec_rdenas,,,,,, +4357,,abc96a5e-6bd7-451b-838d-1e1e3cee308f,Dandrit Biotech A/S,dandrit_biotech_a_s,,,,,, +4358,,ac483e62-87fe-48fd-a97d-a279fbb8c956,Scil Technology GmbH,scil_technology_gmbh,,,,,, +4359,,31665538-d682-4a8c-81fa-9206803ef9b3,CR UK and UCL Cancer Trials Centre,cr_uk_and_ucl_cancer_trials_centre,,,,,, +4360,,f1d49eb2-68ce-42c6-8d56-e3e10fe0b40f,Genzyme Europe BV,genzyme_europe_bv,,,,,, +4361,,be317658-17aa-42d5-b9a1-a5f08520289e,AMC- academisch psychiatrisch centrum,amc_academisch_psychiatrisch_centrum,,,,,, +4362,,c577de62-5425-40ef-8beb-22ae5fee4fb8,Saarland University,saarland_university,,,,,, +4363,,8e313c5c-573c-4075-b936-e45d4b0a0326,Innate Pharma,innate_pharma,,,,,, +4364,,eb9ac754-9578-4839-8e4a-69483bce2afb,Kowa Research Europe Ltd,kowa_research_europe_ltd,,,,,, +511,0.931409,69596232-b165-4d72-8a18-1e0bbdd636c6,PharmaMar SA unipersonal,pharmamar_sa_unipersonal,,,,69596232-b165-4d72-8a18-1e0bbdd636c6,pharmamar_sa_unipersonal,PharmaMar SA unipersonal +4365,,1f9cd31d-e4e9-4806-bf92-07b81f93ba36,Univerity of Bonn,univerity_of_bonn,,,,,, +4366,,c86fa310-e3d1-4bf7-be4a-c9fed815a879,FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO 12 DE OCTUBRE,fundacion_para_la_investigacion_biomedica_hospital_universitario_12_de_octubre,,,,,, +4367,,8f0c2088-b319-4e7a-a580-4238784c332f,"Trevi Therapeutics, Inc",trevi_therapeutics_inc,,,,,, +4368,,dcb64dc9-2b7e-4e50-b3c7-2c2a43da353e,"Taneli Raivio, Helsingin yliopistollinen keskussairaala",taneli_raivio_helsingin_yliopistollinen_keskussairaala,,,,,, +4369,,aaa8bbea-71a7-11e6-a0cd-0242ac12000b,IVAX RES,ivax_res,,,,,, +4370,,1c3ea363-e90a-4019-8e90-2a183b616f66,MAYOLY-SPINDLER,mayoly_spindler,,,,,, +4371,,a93d39e2-7194-11e6-a0cd-0242ac12000b,BEL MAR,bel_mar,,,,,, +4372,,dd946424-fcfb-4d87-80f3-575b6bc911c7,Department of Dermatology and Allergy Charité- Universitätsmedizin Berlin,department_of_dermatology_and_allergy_charit_universit_tsmedizin_berlin,,,,,, +4373,,08488d9d-fa50-4a6d-aeee-a2d4762c806f,Pharmion GmbH,pharmion_gmbh,,,,,, +4374,,89489d00-7146-11e6-a0cd-0242ac12000b,GENPHARM,genpharm,,,,,, +4375,,8ef2f084-6fbb-11e6-abe8-0242ac12000b,NatImmune A/S,natimmune_a_s,,,,,, +147,0.989212,552c8b5e-6e4d-462c-97e1-a56f192796b2,Sociedad Andaluza de Trasplante de Órganos y Tejidos (SATOT),sociedad_andaluza_de_trasplante_de_rganos_y_tejidos_satot,,,,552c8b5e-6e4d-462c-97e1-a56f192796b2,sociedad_andaluza_de_trasplante_de_rganos_y_tejidos_satot,Sociedad Andaluza de Trasplante de Órganos y Tejidos (SATOT) +4376,,fc79d85b-fd68-45ab-a48c-51eb5653ebbc,"Azur Pharma, Ltd",azur_pharma_ltd,,,,,, +4377,,2dfb5940-15a3-4c61-94f6-45cc30044e44,"Seinäjoen keskussairaala, Fysiatrian ja kuntoutuksen tulosyksikkö",sein_joen_keskussairaala_fysiatrian_ja_kuntoutuksen_tulosyksikk,,,,,, +4378,,deee21fe-7334-11e6-a0cd-0242ac12000b,ORGANON SUB MERCK,organon_sub_merck,,,,,, +4379,,01a20798-3d29-4250-90a2-ff68c6e15675,Enobia Canada Limited Partnership,enobia_canada_limited_partnership,,,,,, +4380,,0865538b-acc1-43ca-9a17-db8dca1234e6,Ultragenyx Pharmaceutical Inc,ultragenyx_pharmaceutical_inc,,,,,, +4381,,a98a835b-e043-4d3e-ae42-b7adfc3af1ac,"Psychiatric Research Unit, Frederiksborg General Hospital",psychiatric_research_unit_frederiksborg_general_hospital,,,,,, +954,0.984184,69569858-7141-11e6-a0cd-0242ac12000b,IMPAX LABS,impax_labs,,,,69569858-7141-11e6-a0cd-0242ac12000b,impax_labs,IMPAX LABS +4382,,e5e80f98-c705-4602-8740-d5066c1e6e63,Centre Georges François Leclerc,centre_georges_fran_ois_leclerc,,,,,, +4383,,46447f1b-f3a3-4452-aa5f-7dc3b0235d92,Májbetegekért Alapítvány,m_jbetegek_rt_alap_tv_ny,,,,,, +4384,,5a0cefb3-980c-43ad-af8a-4bea7a981de3,Fundación Canaria de Investigación y Salud,fundaci_n_canaria_de_investigaci_n_y_salud,,,,,, +4385,,05cd22b1-4e16-4c6b-811b-1deabe3f47c7,Iron Therapeutics (Switzerland) AG,iron_therapeutics_switzerland_ag,,,,,, +4386,,ef52ecdf-42b3-481a-804f-a3754a9107b5,Clovis Oncology Italy s.r.l,clovis_oncology_italy_s_r_l,,,,,, +640,0.96883571147918701,49d4949c-d209-4f98-8d5a-12154a3d6677,Boehringer Ingeheim RCV GmbH & Co KG,boehringer_ingeheim_rcv_gmbh_co_kg,,,,d2f4fdea-3f56-449f-b5b3-ab25da9fa8af,boehringer_ingelheim_rcv_gmbh_co_kg,Boehringer Ingelheim RCV GmbH & Co KG +982,0.94804,4f75b1b6-7160-11e6-a0cd-0242ac12000b,JANSSEN PHARMS,janssen_pharms,,,,4f75b1b6-7160-11e6-a0cd-0242ac12000b,janssen_pharms,JANSSEN PHARMS +4387,,4782a974-737b-11e6-a0cd-0242ac12000b,MAYNE PHARMA INTL,mayne_pharma_intl,,,,,, +4388,,5abd57b2-8ffd-4aba-80c2-2cb64a92fab7,FIBio Hospital Universitario Ramón y Cajal,fibio_hospital_universitario_ram_n_y_cajal,,,,,, +4389,,d48dc5f9-3c3e-4063-a88b-54288c53ca8c,"Karolinska Institutet, Institutionen för klinisik neurovetenskap, sektion för psykiatri",karolinska_institutet_institutionen_f_r_klinisik_neurovetenskap_sektion_f_r_psykiatri,,,,,, +4390,,6d4a5a12-a735-49ab-86de-543e4525493f,CHU DE NANCY - DIRECTION DE LA RECHERCHE CLINIQUE ET DE L'INNOVATION,chu_de_nancy_direction_de_la_recherche_clinique_et_de_l_innovation,,,,,, +4391,,adb5ac52-7171-11e6-a0cd-0242ac12000b,SMITHKLINE BEECHAM,smithkline_beecham,,,,,, +4392,,e4ef215d-0d12-48b0-9dba-b4de4330afcd,"Medizinische Universität Graz, Univ. Frauenklinik, Abteilung für Gynäkologie",medizinische_universit_t_graz_univ_frauenklinik_abteilung_f_r_gyn_kologie,,,,,, +4393,,3531f823-86f7-460f-bd9b-289d3bcef8e7,Kringle Pharma Europe AB,kringle_pharma_europe_ab,,,,,, +4394,,6c0c31a1-b1c8-468b-8947-cb97c1b693c5,"Arbor Pharmaceuticals, LLC",arbor_pharmaceuticals_llc,,,,,, +4395,,1980bbbf-5110-4148-8c5e-566f313cc818,DR. JAVIER ANIDO RUBIO,dr_javier_anido_rubio,,,,,, +286,0.933312,f088a553-ffed-4b6f-abb2-e84111d03762,Helperby Thearapeutics Ltd,helperby_thearapeutics_ltd,,,,aa2861dc-8843-45b3-8d61-af022e0ad7ab,helperby_therapeutics,Helperby Therapeutics +569,0.952896,5ac9ac8a-68c4-4d8a-b503-c40b8352bccf,Pharming Technologies B.V,pharming_technologies_b_v,,,,25abd45e-c724-4c38-a7f4-5b17f2b4e77f,pharming_tecnologies_b_v,Pharming Tecnologies B.V +1033,0.97907406091690063,ba5dbf11-c6cc-4623-b6c7-f5abb168415d,"Kvinnokliniken, Universitetessjukhuset i Linköping, landstinget i Östergötland",kvinnokliniken_universitetessjukhuset_i_link_ping_landstinget_i_sterg_tland,,,,6fb84541-28be-49a0-a789-a0b8bf04fae5,kvinnokliniken_universitetssjukhuset_i_link_ping_landstinget_i_sterg_tland,"Kvinnokliniken, Universitetssjukhuset i Linköping, Landstinget i Östergötland" +417,0.988695,bbe38879-d93a-419a-8151-28e4cef833e1,ISTITUTI FISIOTERAPICI OSPITALIERI - IRE,istituti_fisioterapici_ospitalieri_ire,,,,8da96a38-2d6c-4cbb-9351-628c3c92a1ed,istituti_fisioterapici_ospitalieri,ISTITUTI FISIOTERAPICI OSPITALIERI +4396,,5514c86d-8bf5-4036-b173-f8acace30715,"Bonkolab, Rigshospitalet",bonkolab_rigshospitalet,,,,,, +4397,,1603b04f-bef6-4e9e-a949-c01d179869c5,Institute od Rheumatology Prague,institute_od_rheumatology_prague,,,,,, +4398,,44173ab7-9bc8-45f6-8536-f5d2f2824cc5,Ritva Jokela,ritva_jokela,,,,,, +4399,,cb8d68dc-b0a7-4039-8129-9c3756ecb85b,TNO,tno,,,,,, +4400,,8cf7b2ea-e843-421e-8d1f-6af40a085327,The Netherlands Cancer Institute/ Antoni van Leeuwenhoek hospital,the_netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital,,,,,, +864,0.973341,a333a82a-36dd-4629-8cf3-573aaa584a38,NHS Grampian,nhs_grampian,,,,a333a82a-36dd-4629-8cf3-573aaa584a38,nhs_grampian,NHS Grampian +4401,,94c07a8b-a310-476d-ac55-04922bc5f62c,XOMA,xoma,,,,,, +766,0.979934,e573cdb7-8920-4b04-80e3-8c471bff8a89,"Sussex NHS Research Consortium, Research Department, Worthing Hospital",sussex_nhs_research_consortium_research_department_worthing_hospital,,,,8a4b641c-5fe6-4b6b-a131-423b64e7cd1b,sussex_nhs_research_consortium,Sussex NHS Research Consortium +4402,,0a88bc18-5392-479d-b0e8-83d3a723d232,Maternté Régionale Universitaire de Nancy,maternt_r_gionale_universitaire_de_nancy,,,,,, +4403,,b5e066c6-7e06-4b41-93f1-71b956cb55b8,Vifor (International) AG,vifor_international_ag,,,,,, +4404,,22ff2d1e-2d8b-4e27-aac7-534beb2d9330,FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL 12 DE OCTUBRE,fundacion_para_la_investigacion_biomedica_hospital_12_de_octubre,,,,,, +4405,,8fc920d2-51f2-4bda-9d3b-53e72ef7767a,Maastricht UMC,maastricht_umc,,,,,, +4406,,d9f407ee-7141-11e6-a0cd-0242ac12000b,KVK TECH,kvk_tech,,,,,, +4407,,a5d9d788-7167-11e6-a0cd-0242ac12000b,SOVEREIGN PHARMS,sovereign_pharms,,,,,, +4408,,d3bc30d2-72da-11e6-a0cd-0242ac12000b,NYCOMED US,nycomed_us,,,,,, +4409,,799eb93c-db00-4c48-9c91-99501df0b968,FONDAZIONE MALATTIE RARE MAURO BASCHIROTTO B.I.R.D. ONLUS,fondazione_malattie_rare_mauro_baschirotto_b_i_r_d_onlus,,,,,, +662,0.97071176767349243,03be6dab-3c3b-45d4-999e-013062e4a92e,Charité Universitaetsmedizin Berlin,charit_universitaetsmedizin_berlin,,,,03be6dab-3c3b-45d4-999e-013062e4a92e,charit_universitaetsmedizin_berlin,Charité Universitaetsmedizin Berlin +4410,,12657556-a10d-49f2-ad1f-fb3210578e20,GRIFOLS ITALIA,grifols_italia,,,,,, +4411,,217be9cc-ecdd-4bb2-beb8-2ebdea746bcb,St. Eriks Eye Hospital,st_eriks_eye_hospital,,,,,, +4412,,2a08ab3c-b5a9-448d-a781-4656654815d0,Childrens's Research Institute,childrens_s_research_institute,,,,,, +4413,,573cec7a-72cd-11e6-a0cd-0242ac12000b,EMMAUS MEDCL,emmaus_medcl,,,,,, +641,0.98466187715530396,80207a17-976c-4923-a075-b4c1fd0d1587,Boehringer Ingelheim Denmark A/S,boehringer_ingelheim_denmark_a_s,,,,82029ede-b089-4dbb-93ae-f48a58277a9c,boehringer_ingelheim_denmark_a_s,Boehringer Ingelheim Denmark A/S +4414,,943a1e8e-7144-11e6-a0cd-0242ac12000b,TOLMAR,tolmar,,,,,, +395,0.982614,3a926c58-71c4-11e6-a0cd-0242ac12000b,ASTRAZENECA PHARMS,astrazeneca_pharms,,,,3a926c58-71c4-11e6-a0cd-0242ac12000b,astrazeneca_pharms,ASTRAZENECA PHARMS +4415,,0b12d7b4-efff-4661-8ae9-d907563208fa,"Cubist Pharmaceuticals, Inc",cubist_pharmaceuticals_inc,,,,,, +4416,,b8457276-8633-4ecf-8513-389558ae2bd1,Dutch Pancreatitis Study Group,dutch_pancreatitis_study_group,,,,,, +4417,,bb605c38-df01-4bd0-9558-912b7f5da864,North Glasgow Trust,north_glasgow_trust,,,,,, +4418,,3ea12dcd-a6b7-11e6-94cb-5656d04fc2b5,"University of Aarhus, School of Dentistry",university_of_aarhus_school_of_dentistry,,,,,, +4419,,9443d79d-8f66-47e4-b15a-931398c7cd95,HOSPITAL DE GALDAKAO-USANSOLO,hospital_de_galdakao_usansolo,,,,,, +4420,,9cf19dbe-b929-4dd1-812b-dda7c065e780,Institut National de la Santé et de la Research Médicale,institut_national_de_la_sant_et_de_la_research_m_dicale,,,,,, +797,0.985088,1030c221-004c-4496-88f4-1a34a95916e7,Sint Lucas Andreas Hospital,sint_lucas_andreas_hospital,,,,1030c221-004c-4496-88f4-1a34a95916e7,sint_lucas_andreas_hospital,Sint Lucas Andreas Hospital +4421,,3a8ab09a-7146-11e6-a0cd-0242ac12000b,MALLINKRODT NUCLEAR,mallinkrodt_nuclear,,,,,, +888,0.94497775179999211,d8e5702c-5977-4d8c-a2c6-20c18f0a0645,"Schering-Plough Research Institute, division of Schering Corporation",schering_plough_research_institute_division_of_schering_corporation,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" +4422,,8f24e68a-a5b4-4078-b899-ae9ecb4c05b2,Aurora Pujol Onofre,aurora_pujol_onofre,,,,,, +4423,,c0f564aa-e017-4252-8c49-908bef37a1da,research office urology VUmc,research_office_urology_vumc,,,,,, +4424,,3c71c950-f441-4618-8de5-aaa340ddc929,Nycomed Canada Inc,nycomed_canada_inc,,,,,, +4425,,d4e0f402-3c0a-4188-abc9-82a78aff3cd5,"Department of Psychiatry, Ludwig-Maximilian University Munich",department_of_psychiatry_ludwig_maximilian_university_munich,,,,,, +4426,,18c91bdd-c584-4375-bb86-61223529f32c,STEBA FRANCE,steba_france,,,,,, +605,0.916683,2966963f-a998-4261-8d68-d4c45ba26c05,"Novartis Vaccines & Diagnostics, Inc",novartis_vaccines_diagnostics_inc,,,,2966963f-a998-4261-8d68-d4c45ba26c05,novartis_vaccines_diagnostics_inc,"Novartis Vaccines & Diagnostics, Inc" +4427,,5a53ff0d-794f-4574-b824-05831aa1ca11,Ardana Bioscience Ltd,ardana_bioscience_ltd,,,,,, +768,0.987661,620215a3-9912-41e5-bf75-56cb04e20f09,Bayer Schering Pharma AG (BSP),bayer_schering_pharma_ag_bsp,,,,611690f5-8173-4554-bcb7-1ecc6dba03cd,bayer_schering_pharma_ag,Bayer Schering Pharma AG +4428,,4dc1a57f-8db3-4002-9116-9161e54a5480,academisch ziekenhuis Maastricht,academisch_ziekenhuis_maastricht,,,,,, +4429,,d0c5b7d4-68b0-4ff2-8ae7-c694fe4f0307,Iniciativa Andaluza en Terapias Avanzadas a través de la Fundación Progreso y Salud,iniciativa_andaluza_en_terapias_avanzadas_a_trav_s_de_la_fundaci_n_progreso_y_salud,,,,,, +4430,,24cc8b00-7198-11e6-a0cd-0242ac12000b,PURDUE FREDERICK,purdue_frederick,,,,,, +4431,,5577246e-7372-11e6-a0cd-0242ac12000b,MOBIUS THERAP,mobius_therap,,,,,, +4432,,1f3d50f9-2f96-46fb-ad2e-7c5236d16773,"Recordati S.p.A.,",recordati_s_p_a,,,,,, +1005,0.955584,4e5f77d3-9cb8-4aca-96ce-cb524d785be9,"Population Health Research Institute (PHRI), McMaster University/Hamilton Health Sciences",population_health_research_institute_phri_mcmaster_university_hamilton_health_sciences,,,,4e5f77d3-9cb8-4aca-96ce-cb524d785be9,population_health_research_institute_phri_mcmaster_university_hamilton_health_sciences,"Population Health Research Institute (PHRI), McMaster University/Hamilton Health Sciences" +4433,,79636eb0-e4f1-4041-af62-1f84d1858cc1,Masarykův onkologický ústav,masaryk_v_onkologick_stav,,,,,, +4434,,ed2d088e-7140-11e6-a0cd-0242ac12000b,IMPAX PHARMS,impax_pharms,,,,,, +244,0.98628848791122437,30cd9264-712a-11e6-a89e-0242ac12000b,SUN PHARM INDS,sun_pharm_inds,,,,30cd9264-712a-11e6-a89e-0242ac12000b,sun_pharm_inds,SUN PHARM INDS +387,0.973636,9151744a-bb73-438c-895c-dd8f508cc732,Foundation of Liver Research (SLO),foundation_of_liver_research_slo,,,,9151744a-bb73-438c-895c-dd8f508cc732,foundation_of_liver_research_slo,Foundation of Liver Research (SLO) +4435,,ff57e707-62e6-4251-b6e9-7b144ce7e7aa,Evestra GmbH,evestra_gmbh,,,,,, +4436,,40abca95-1809-432e-aee9-565c32056c09,BIOSYNEXUS INC,biosynexus_inc,,,,,, +4437,,e2bcf588-7129-11e6-a89e-0242ac12000b,LANNETT,lannett,,,,,, +4438,,ddb1fa1e-a305-4d78-b472-d7faf62d33cf,Royal Surrey County Hospital,royal_surrey_county_hospital,,,,,, +1057,0.98656213283538818,0e402f08-6f9b-11e6-9663-0242ac12000b,Pfizer Hellas,pfizer_hellas,,,,080946bd-1123-4c27-9ea3-501e78d94d82,pfizer_hellas_sa,Pfizer Hellas SA +4439,,2044c186-59d8-423a-91bd-91abffcb20d2,"R & D, Cambridge University Hospitals",r_d_cambridge_university_hospitals,,,,,, +4440,,523aa21d-baab-4df3-8c4d-01d9d17ca2ab,Royal College of Surgeon's Ireland,royal_college_of_surgeon_s_ireland,,,,,, +87,0.983343,37900e74-7148-11e6-a0cd-0242ac12000b,MORTON GROVE,morton_grove,,,,37900e74-7148-11e6-a0cd-0242ac12000b,morton_grove,MORTON GROVE +4441,,bb25a626-7144-11e6-a0cd-0242ac12000b,SAMSON MEDCL,samson_medcl,,,,,, +4442,,49275ed1-5a3d-45c0-bd15-72b51c92d40e,Fundacion par la investigación biomédica del Hospital Universitario La Paz,fundacion_par_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz,,,,,, +4443,,0a2898af-00b4-4db1-bd0d-9d3f9868b084,Dept of Molecular Medicin and Surgery,dept_of_molecular_medicin_and_surgery,,,,,, +4444,,1611821c-6bbe-4b5a-b359-985822c7b24b,"Mundipharma Medical Company, Basel",mundipharma_medical_company_basel,,,,,, +4445,,6eaf8008-9410-460f-8a09-decb966d18d9,"Afd. A, OUH",afd_a_ouh,,,,,, +4446,,dc7703ae-7146-11e6-a0cd-0242ac12000b,FALCON PHARMS,falcon_pharms,,,,,, +4447,,8aeccb00-c5bc-4ba8-bcfd-dc40022b4890,Prof. Dr. R. Kreutz Leiter der Abteilung Klinische Pharmakologie der Charite Berlin,prof_dr_r_kreutz_leiter_der_abteilung_klinische_pharmakologie_der_charite_berlin,,,,,, +934,0.92117515206336975,0e1658fb-8e8d-4f84-b74e-e1b20cda7414,Pierre Fabre Médicament represented by the Institut de Recherche Pierre Fabre (IRPF),pierre_fabre_m_dicament_represented_by_the_institut_de_recherche_pierre_fabre_irpf,,,,ed0e7a9e-3ecf-499e-8589-05b770cd0c82,pierre_fabre_m_dicament_represented_by_irpf,Pierre Fabre Médicament represented by IRPF +577,0.95634430646896362,ed49c65f-5f00-412a-ba1b-25fa875fab59,Wyeth Pharmaceutricals France Wyeth Research Division,wyeth_pharmaceutricals_france_wyeth_research_division,,,,e9abaf6d-ebc5-432c-be97-f7a5c26bd3f9,wyeth_pharmaceuticals_france_wyeth_research_division,"Wyeth Pharmaceuticals France, Wyeth Research Division" +752,0.97367790341377258,dad40206-1da0-46e9-8bd7-432191ce3108,Grupo Español de Tratamiento de Tumores de Cabeza y Cuello,grupo_espa_ol_de_tratamiento_de_tumores_de_cabeza_y_cuello,,,,137320fb-fac2-4e31-99c7-7873aa7537cc,grupo_espa_ol_de_tratamiento_de_tumores_de_cabeza_y_cuello_ttcc,Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC) +4448,,2b7dcf4a-9251-42ca-a1b8-4e9e0604b687,Javier Olascoaga Urtaza,javier_olascoaga_urtaza,,,,,, +4449,,af67027a-429a-465d-bc38-795ef4c3421c,Medeca Pharma AB,medeca_pharma_ab,,,,,, +4450,,a427c93e-bf11-4139-8cef-cf96d9cf2500,Derby Hospitals NHS Foundations Trust,derby_hospitals_nhs_foundations_trust,,,,,, +729,0.98694062232971191,ca089cae-dbbf-4ef6-867b-9d74f288bfb4,Sanofi Pasteur MSD,sanofi_pasteur_msd,,,,cb560f4c-875f-44a3-bed5-c8039bd52ca8,sanofi_pasteur_msd,Sanofi Pasteur MSD +4451,,a18c23b9-299f-4ff6-a555-b3d36052084d,Dra. Irene Halperin Rabinovich. Servicio de Endocrinología. Hospital Clínic de Barcelona,dra_irene_halperin_rabinovich_servicio_de_endocrinolog_a_hospital_cl_nic_de_barcelona,,,,,, +806,0.9831,b35e3bbf-ebb4-4571-b730-73bbb9141684,The Royal Liverpool and Broadgreen University Hospital NHS Trust,the_royal_liverpool_and_broadgreen_university_hospital_nhs_trust,,,,8c3e61bc-f8b8-4391-8314-26161be485ab,the_royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,The Royal Liverpool and Broadgreen University Hospitals NHS Trust +4452,,958767b3-3618-448a-826a-8a24571300d6,"N-GENE Research Laboratories, Inc",n_gene_research_laboratories_inc,,,,,, +4453,,b36a2be0-2091-46f1-b17f-435abac00d43,Kompetenznetz Vorhofflimmern e.V. (AFNET) [Atrial Fibrillation NETwork],kompetenznetz_vorhofflimmern_e_v_afnet_atrial_fibrillation_network,,,,,, +4454,,1170301c-a7fb-4e7f-b1b7-144ebf415d0b,"Allergy Centre, University Hospital",allergy_centre_university_hospital,,,,,, +4455,,4f0f7b01-833b-44c3-8b7f-cdea3215fc12,"Servicio de Neurología, HU. Germans Trias i Pujol",servicio_de_neurolog_a_hu_germans_trias_i_pujol,,,,,, +4456,,e4997f72-f07d-4462-835e-f6941fecac8f,Emilio Garcia Garcia,emilio_garcia_garcia,,,,,, +4457,,6d3a8a1c-814a-465a-9cfe-714246d368fd,Evolva SA,evolva_sa,,,,,, +4458,,541cb3c2-723c-11e6-a0cd-0242ac12000b,MEDICURE,medicure,,,,,, +4459,,1c38c63c-0581-4365-8772-e29ee7d2691b,Dr. Félix Armadá,dr_f_lix_armad,,,,,, +4460,,eda8a45b-b8a6-42c1-b3b8-1a6147dd66eb,Anne Pesonen,anne_pesonen,,,,,, +4461,,8238f739-a312-4e6a-94b3-a3d76ad3bc85,"University Hospital Schleswig Holstein Kiel, Clinic of Neurology",university_hospital_schleswig_holstein_kiel_clinic_of_neurology,,,,,, +4462,,141480fb-54e6-470e-a377-fadf71889ca8,I.N.M. NEUROMED (I.R.C.C.S.) S.R.L. GIA' SANATRIX,i_n_m_neuromed_i_r_c_c_s_s_r_l_gia_sanatrix,,,,,, +4463,,1bc87e1e-fb73-42e1-b63c-f94be8b21163,"Klinikum der Universität München, Medizinische Klinik und Poliklinik III",klinikum_der_universit_t_m_nchen_medizinische_klinik_und_poliklinik_iii,,,,,, +4464,,5f3378a2-719e-11e6-a0cd-0242ac12000b,ISOTEX,isotex,,,,,, +4465,,6ad266c0-3a28-4f47-8aca-3140e2513e76,"Zalicus, Inc",zalicus_inc,,,,,, +4466,,1e105941-1e6c-423c-ada6-ee0f94f5893d,SENDO TECH,sendo_tech,,,,,, +4467,,0b3bca8b-765b-4fa5-968d-79c9f28ff141,National Institutes of Neurological Disorders: Stroke,national_institutes_of_neurological_disorders_stroke,,,,,, +4468,,e52c56ca-2bb1-4c8a-aaa7-42f203dad86c,ITALFARMACO S.p.A,italfarmaco_s_p_a,,,,,, +580,0.98565506935119629,6e90ff22-ae0c-4450-9eec-85eba70c3fda,Wyeth Pharmaceuticals Inc,wyeth_pharmaceuticals_inc,,,,6e90ff22-ae0c-4450-9eec-85eba70c3fda,wyeth_pharmaceuticals_inc,Wyeth Pharmaceuticals Inc +300,0.972939,81b5ea66-d557-4880-b29f-db73b2bdcdc7,"Rigshospital, Finsencenter, Afsnit 3994",rigshospital_finsencenter_afsnit_3994,,,,5715166a-8be0-11e6-a449-0242ac12000b,rigshospital,Rigshospital +4469,,cfa61597-ae3f-4345-977f-c116cab63f62,NCIC Clinical Trials Group,ncic_clinical_trials_group,,,,,, +4470,,d7c29fd0-a336-4079-b486-cc691b1aa334,Schwarz BioSciences Inc,schwarz_biosciences_inc,,,,,, +842,0.97700116038322449,266d63ac-b3de-4324-b4d9-3059a2dc2174,University Hospital of South Manchester,university_hospital_of_south_manchester,,,,19e6b110-6043-450d-8ef8-6a798742be5d,university_hospital_of_south_manchester_nhs_foundation_trust,University Hospital of South Manchester +527,0.95949012041091919,eaf298ff-f4fb-4c80-9c59-229523335a88,"Roche Farma, S.A en nombre de F. Hoffman-La Roche Ltd",roche_farma_s_a_en_nombre_de_f_hoffman_la_roche_ltd,,,,80833833-6173-4f1f-82da-31787a716bc2,roche_farma_s_a_en_nombre_de_f_hoffmann_la_roche_ltd,"Roche Farma, S.A. en nombre de F. Hoffmann-La Roche Ltd" +4471,,420bbe8e-8bce-11e6-a449-0242ac12000b,"Uppsala University, Department of Medical Sciences",uppsala_university_department_of_medical_sciences,,,,,, +4472,,610f7c7e-8e76-4f64-82e2-c5864ca74b5a,Radiotherapy UZ Gasthuisberg,radiotherapy_uz_gasthuisberg,,,,,, +4473,,68ecb8ff-9898-4e4f-8ce2-dee8c90b326b,Medizinische Einrichtungen des Bezirks Oberpfalz GmbH,medizinische_einrichtungen_des_bezirks_oberpfalz_gmbh,,,,,, +4474,,8a0e1f4c-7166-11e6-a0cd-0242ac12000b,HETERO USA INC,hetero_usa_inc,,,,,, +744,0.97866427898406982,a9ae713f-1518-4e09-ac21-b4785f5a60ab,Johann Wolfgang Goethe-Universität Frankfurt/M,johann_wolfgang_goethe_universit_t_frankfurt_m,,,,7c93ba08-6123-42f2-a902-d13e42cdd905,johann_wolfgang_goethe_universit_t_frankfurt,Johann Wolfgang Goethe-Universität Frankfurt +4475,,0fc2319f-6815-419a-a55a-86d7b824c611,Hywel Dda Health Board,hywel_dda_health_board,,,,,, +4476,,e24b1e24-d7db-418d-a772-af767a07488b,Jules Borde Institute,jules_borde_institute,,,,,, +4477,,0438f52c-904f-4d43-a5fd-b3992dd30af9,"Karolinska Universitetssjukhuset i Solna, Thoraxanestesi & intensivvård",karolinska_universitetssjukhuset_i_solna_thoraxanestesi_intensivv_rd,,,,,, +4478,,5dc40c3a-2b79-4a68-b518-a0bb90ccc5fe,Profil Mainz GmbH & Co KG,profil_mainz_gmbh_co_kg,,,,,, +16,0.934144,349884c4-73b1-11e6-a0cd-0242ac12000b,VERTEX PHARMS,vertex_pharms,,,,349884c4-73b1-11e6-a0cd-0242ac12000b,vertex_pharms,VERTEX PHARMS +4479,,4a986bca-7129-11e6-a89e-0242ac12000b,DAVA PHARMS INC,dava_pharms_inc,,,,,, +4480,,240a0ec5-3217-4758-b549-cc08da35dba5,"Charité Universitätsmedizin Berlin, Campus Benjamin Franklin",charit_universit_tsmedizin_berlin_campus_benjamin_franklin,,,,,, +256,0.988946,dee9d357-375e-48a1-b857-489f6be6b00c,Otsuka Maryland Research Institute,otsuka_maryland_research_institute,,,,dee9d357-375e-48a1-b857-489f6be6b00c,otsuka_maryland_research_institute,Otsuka Maryland Research Institute +4481,,fef77d8e-df7c-442c-bc75-45624d361fb2,Baxalta Innovations GmbH,baxalta_innovations_gmbh,,,,,, +964,0.94218007723490393,4c6f8fec-ba3f-4d80-8325-5deca49115f8,Helsinki Universiy Central Hospital,helsinki_universiy_central_hospital,,,,16556fb5-6653-4d5b-bd94-fc6343fa4fd8,helsinki_university_central_hospital,Helsinki University Central Hospital +284,0.98087829351425171,f4504f58-7128-11e6-a89e-0242ac12000b,PADDOCK LLC,paddock_llc,,,,bc84a43e-7141-11e6-a0cd-0242ac12000b,paddock,PADDOCK +224,0.92743,e657f5e2-2230-412a-8859-9d36843109c2,Royal College of Surgeons Ireland,royal_college_of_surgeons_ireland,,,,19f50830-c64c-41ab-95d1-83f7f3427687,royal_college_of_surgeons_in_ireland,Royal College of Surgeons in Ireland +4482,,471f252a-837a-4042-bc65-4bf0c393c3aa,"Dept of Neurology, Umeå University Hospital, Umeå, Sweden",dept_of_neurology_ume_university_hospital_ume_sweden,,,,,, +4483,,fdeaddfd-d3eb-4620-879e-c7a5ebe251c5,GECP(Grupo Español de cancer de Pulmón),gecp_grupo_espa_ol_de_cancer_de_pulm_n,,,,,, +887,0.97673827409744263,aefe5ab0-8813-11e6-a998-0242ac12000b,Schering-Plough Research Institute (SPRI),schering_plough_research_institute_spri,,,,44b33ab6-d74e-4fa5-aa8c-510964a3ac9f,schering_plough_research_institute,Schering-Plough Research Institute +381,0.92955939471721649,b07a37c1-b7ac-42e2-b286-fd9b67ce9719,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., (Merck)",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_merck,,,,70a76c95-9bc5-4453-ace1-7d9c98a92a7d,merck_sharp_dohme_o,"Merck Sharp & Dohme Copr., a subsidary of Merck & Co" +4484,,fe84d598-4524-446b-9bb3-57f3746365a1,AZIENDA OSPEDALIERA S. MARIA DELLA MISERICORDIA,azienda_ospedaliera_s_maria_della_misericordia,,,,,, +4485,,64e18700-f216-4cf3-be43-93fcc9605f8f,St Vincent's Hospital,st_vincent_s_hospital,,,,,, +4486,,bacee0ec-47a3-4ae0-9f12-9839d9e72d99,alberto forteza,alberto_forteza,,,,,, +4487,,2222d89a-986b-469b-bb50-612793fcc924,Cardio3 BioSciences,cardio3_biosciences,,,,,, +4488,,65125d50-94f9-450b-82cc-a44c9203dadd,Universitätsmedizin Mainz,universit_tsmedizin_mainz,,,,,, +917,0.986946,7c9fa84f-cb0d-4978-8633-1d3ea599d9ad,Bristol Myers Squibb S.r.L,bristol_myers_squibb_s_r_l,,,,5cdbde15-83c4-4b59-a418-8452d890ac4e,bristol_myers_squibb,Bristol Myers Squibb +4489,,96e48115-11f8-4c90-aa2b-e5f6efa9962e,HYKS Vatsakeskus,hyks_vatsakeskus,,,,,, +4490,,8c33a5cc-e128-437a-9489-d9c44d331900,GANYMED Pharmaceuticals AG,ganymed_pharmaceuticals_ag,,,,,, +4491,,f93e54a1-dd47-4c56-8850-361f42f847aa,Jaro Karppinen,jaro_karppinen,,,,,, +4492,,8c129d92-323f-4e7f-9d4d-33397e48b9f6,"Privatärztliche urologische Partnerschaft GbR, EuromedClinic",privat_rztliche_urologische_partnerschaft_gbr_euromedclinic,,,,,, +4493,,e9cda2e3-769b-49ca-b47c-353d546f36cb,UCL Cliniques Universitaires Saint Luc,ucl_cliniques_universitaires_saint_luc,,,,,, +4494,,62fa7cb6-b0c3-4ab1-b614-685089ae4180,Institut de Recerca Hospital de Sant Pau,institut_de_recerca_hospital_de_sant_pau,,,,,, +112,0.9566093385219574,fd7c0ea8-c5da-47db-837d-9b59407dd291,"Yamanouchi Europe B.V. (to be renamed Astellas Pharma Europe B.V., as of August 2005)",yamanouchi_europe_b_v_to_be_renamed_astellas_pharma_europe_b_v_as_of_august_2005,,,,fd7c0ea8-c5da-47db-837d-9b59407dd291,yamanouchi_europe_b_v,Yamanouchi Europe B.V +4495,,7bd769d4-7129-11e6-a89e-0242ac12000b,PHARM ASSOC,pharm_assoc,,,,,, +244,0.98628848791122437,74861b88-7126-11e6-8a77-0242ac12000b,SUN PHARM INDS INC,sun_pharm_inds_inc,,,,30cd9264-712a-11e6-a89e-0242ac12000b,sun_pharm_inds,SUN PHARM INDS +4496,,c0bd19c3-5388-4c62-b9ea-e0538c6350fd,Kirurgisen sairaalan munuaisensiirtoihin liittyvän kivun hoidon tutkimusryhmä,kirurgisen_sairaalan_munuaisensiirtoihin_liittyv_n_kivun_hoidon_tutkimusryhm,,,,,, +4497,,ffbe707f-00b7-4e3a-9cd9-5fbea073583d,Rouen University Hospital,rouen_university_hospital,,,,,, +4498,,3c12923b-eb29-4e14-ad7c-c3d7345e4efd,Institut für Röntgendiagnostik der Technischen Universität München,institut_f_r_r_ntgendiagnostik_der_technischen_universit_t_m_nchen,,,,,, +4499,,09294918-4a3d-406f-8c75-693c39ef12ee,Deutsches Herzzentrum Muenchen,deutsches_herzzentrum_muenchen,,,,,, +4500,,53d82302-302b-499f-a366-d192a9eec993,ChemGenex Pharmaceuticals Ltd,chemgenex_pharmaceuticals_ltd,,,,,, +794,0.98656213283538818,3bb5af7e-90aa-42de-87dd-3a09da828fda,Clavis Pharma,clavis_pharma,,,,3bb5af7e-90aa-42de-87dd-3a09da828fda,clavis_pharma,Clavis Pharma +34,0.97933,55dfece4-1cf8-463c-896f-48fbbec903fc,"Sanofi-Synthélabo Recherche, a subsidiary of sanofi-aventis group",sanofi_synth_labo_recherche_a_subsidiary_of_sanofi_aventis_group,,,,55dfece4-1cf8-463c-896f-48fbbec903fc,sanofi_synth_labo_recherche_a_subsidiary_of_sanofi_aventis_group,"Sanofi-Synthélabo Recherche, a subsidiary of sanofi-aventis group" +4501,,2cbc5456-c9d3-4c58-8630-c96568ff3464,"Rigshospitalet,Cardiology Laboratory 2013",rigshospitalet_cardiology_laboratory_2013,,,,,, +315,0.97933,859cee6f-b91c-4dae-a958-dcbf3458bbb4,CEPHALON FRANCE,cephalon_france,,,,859cee6f-b91c-4dae-a958-dcbf3458bbb4,cephalon_france,CEPHALON FRANCE +4502,,5c06bd54-c807-40a5-ac89-1e9db67bc54d,Innocoll Pharmaceuticals Limited,innocoll_pharmaceuticals_limited,,,,,, +4503,,37a63ff0-96c7-4c6c-bbf1-caa8d784053b,AGMT gemeinnützige GmbH,agmt_gemeinn_tzige_gmbh,,,,,, +4504,,815f7992-b484-4c09-913a-d09219bd395f,"ActivX Biosciences, Inc",activx_biosciences_inc,,,,,, +4505,,b0f54ff1-6f73-4e26-b5fd-dd4820c64522,"Hôpital Erasme, ULB",h_pital_erasme_ulb,,,,,, +842,0.96419870853424072,5b4a4a4b-1f6a-4937-84e3-8bd61c9a9528,University Hospitals of South Manchester NHS Foundation Trust,university_hospitals_of_south_manchester_nhs_foundation_trust,,,,19e6b110-6043-450d-8ef8-6a798742be5d,university_hospital_of_south_manchester_nhs_foundation_trust,University Hospital of South Manchester +899,0.98596411943435669,3d00d697-8faa-4e4b-bfd7-814eddaee9da,Kuopion yliopistollinen sairaala,kuopion_yliopistollinen_sairaala,,,,3d00d697-8faa-4e4b-bfd7-814eddaee9da,kuopion_yliopistollinen_sairaala,Kuopion yliopistollinen sairaala +4506,,a628a14c-0190-45b1-a6cd-189ec7c9ae7e,Heikki Koskela,heikki_koskela,,,,,, +718,0.970142,f3b541b9-f809-4a91-a629-3db8b4a71047,"Med. Univ. Wien, Klinik f. Innere Med. I, Onkologie",med_univ_wien_klinik_f_innere_med_i_onkologie,,,,7d140a5d-838e-4824-90c7-b17c12e4b7aa,med_uni_wien_klinik_f_innere_med_i,"Med. Uni. Wien, Klinik f. Innere Med. I" +4507,,9c8fe084-27e8-4be5-831e-4d17b204b33e,Dainippon Sumitomo Pharma Europe Ltd,dainippon_sumitomo_pharma_europe_ltd,,,,,, +4508,,f4ba016c-668c-45d5-9f8a-185e05fc3a98,Smerteklinikken,smerteklinikken,,,,,, +4509,,8e96b04a-7163-11e6-a0cd-0242ac12000b,MICRO LABS LTD,micro_labs_ltd,,,,,, +4510,,89bc1a08-73e6-11e6-a0cd-0242ac12000b,PROVENSIS,provensis,,,,,, +4511,,9910e4e4-21e2-43fc-ac1b-516baa42ba5c,Albert Schweitzer hospital,albert_schweitzer_hospital,,,,,, +4512,,d272cb36-7141-11e6-a0cd-0242ac12000b,THE PHARMA NETWORK,the_pharma_network,,,,,, +4513,,c35c1894-727e-11e6-a0cd-0242ac12000b,FOREST LABS LLC,forest_labs_llc,,,,,, +4514,,a2ab83d2-2933-430d-a77e-82ad77d50ff5,FONDAZIONE ISTITUTO SAN RAFFAELE-G.GIGLIO,fondazione_istituto_san_raffaele_g_giglio,,,,,, +4515,,ceecdbd1-b90f-4146-83b5-e987dcb62f70,Hamilton Health Sciences through the Population Health Research Institute,hamilton_health_sciences_through_the_population_health_research_institute,,,,,, +1061,0.97933,7c1b47ae-b782-4a27-b575-82096c2eccd0,A.S.L. 2 SAVONA,a_s_l_2_savona,,,,332fca8d-891e-464f-bf2f-a65f4ecc24d7,a_s_l_2,A.S.L. 2 +4516,,30613286-a82a-4209-aca9-dd383dbd4573,The Clatterbridge Cancer Centre NHS Foundation Trust,the_clatterbridge_cancer_centre_nhs_foundation_trust,,,,,, +4517,,409fb41a-c20b-4321-b9f8-aef7078a0895,"Department of Cardiology, Odense University Hospital",department_of_cardiology_odense_university_hospital,,,,,, +4518,,928eda3b-919d-48e1-aabd-c95e9583facf,"Medical School, Dept. of Cardiology and Angiology",medical_school_dept_of_cardiology_and_angiology,,,,,, +4519,,fb707884-96fb-4ebe-87c5-f92c143e5298,"Charité - Universitätsmedizin Berlin, CharitéCentrum 3 für Zahn-, Mund- und Kieferheilkunde",charit_universit_tsmedizin_berlin_charit_centrum_3_f_r_zahn_mund_und_kieferheilkunde,,,,,, +1055,0.98234379291534424,81df0d59-40ca-4ad2-8667-97ceb4c20bea,"Neurologisk afdeling F, Århus Sygehus, NBG",neurologisk_afdeling_f_rhus_sygehus_nbg,,,,81df0d59-40ca-4ad2-8667-97ceb4c20bea,neurologisk_afdeling_f_rhus_sygehus_nbg,"Neurologisk afdeling F, Århus Sygehus, NBG" +4520,,e9ca358b-823b-4159-80d0-b7a4a8b6a5b9,Aleksander Krag,aleksander_krag,,,,,, +4521,,4e19c260-3f5e-4d32-9d09-49bbe547471a,Ludwig Boltzmann Institut für Retinologie und biomikroskopische Laserchirurgie,ludwig_boltzmann_institut_f_r_retinologie_und_biomikroskopische_laserchirurgie,,,,,, +4522,,710fabbe-72fb-11e6-a0cd-0242ac12000b,WRASER PHARMS,wraser_pharms,,,,,, +4523,,69723627-6f25-4050-892b-176403ef72f0,FUNDACION GELTAMO,fundacion_geltamo,,,,,, +4524,,de750299-4ed6-496a-a9d5-f9f09288586f,Merck Sante France,merck_sante_france,,,,,, +4525,,cb376e4b-e8ea-47cd-b126-f14060484053,Mepha Ltd,mepha_ltd,,,,,, +4526,,44416a4a-65b4-49e1-9d11-b5185373f4d5,Aspreva International Ltd,aspreva_international_ltd,,,,,, +498,0.938435,2399538a-18b4-4f23-997c-ea2ceaf364fb,Central Institute of Mental Health,central_institute_of_mental_health,,,,2399538a-18b4-4f23-997c-ea2ceaf364fb,central_institute_of_mental_health,Central Institute of Mental Health +4527,,b304544d-58eb-45d0-961e-c21d59e68564,BGDO,bgdo,,,,,, +647,0.96851974725723267,7f6e75e2-17dd-48cc-93b5-ed854fcfc0e1,"Boehringer Ingelheim España, S.A",boehringer_ingelheim_espa_a_s_a,,,,7f6e75e2-17dd-48cc-93b5-ed854fcfc0e1,boehringer_ingelheim_espa_a_s_a,"Boehringer Ingelheim España, S.A" +4528,,85edd5f1-d499-4368-87e2-8850e0363dc3,AIR LIQUIDE SANTE INTERNATIONAL,air_liquide_sante_international,,,,,, +4529,,923de263-7126-4679-a285-5614e0ef36b4,Universitätsklinik Freiburg,universit_tsklinik_freiburg,,,,,, +4530,,bb4594b5-47ea-4d40-8a4b-3f85cac38eae,GEINO,geino,,,,,, +4531,,eb5dc947-3c65-4933-89b6-cffb4aae45dd,"Dept. of Ophthalmol, Semmelweis University",dept_of_ophthalmol_semmelweis_university,,,,,, +4532,,721fd1ad-8b41-4d81-b0a9-39aa6e043a72,"Univ. hospital, Dpt. of anaesthesia",univ_hospital_dpt_of_anaesthesia,,,,,, +4533,,412bfeac-0e8f-4b2b-ad8f-c59310a11fa0,University of Glasgow & Greater Glasgow Health Board,university_of_glasgow_greater_glasgow_health_board,,,,,, +4534,,0283ac06-fd7d-4b68-b737-770352f7e4d7,University of Nottingham,university_of_nottingham,,,,,, +4535,,c26bde81-e58b-4cf0-9f24-47c7dd3dc9b1,AMARIN PHARMA INC,amarin_pharma_inc,,,,,, +4536,,93af64e1-a7fa-4dba-b5a2-e7e0f67ad8d7,"Department of Ophthalmology, Medical University of Graz",department_of_ophthalmology_medical_university_of_graz,,,,,, +4537,,538cc183-0f89-4c68-8124-915c644bc10f,AstraZenenca AB,astrazenenca_ab,,,,,, +4538,,a47c261e-19a0-46e9-a361-b7aca63f4ed9,"Advancell Advanced In Vitro Cell Technologies, S.A",advancell_advanced_in_vitro_cell_technologies_s_a,,,,,, +4539,,f201f6b2-7d57-48b7-963c-6e79b17cf0b9,"Medizinische Universität Wien, Univ.Klinik für Innere Medizin III, Abt.f.Endokrinologie und Stoffwechsel",medizinische_universit_t_wien_univ_klinik_f_r_innere_medizin_iii_abt_f_endokrinologie_und_stoffwechsel,,,,,, +4540,,60632d09-1424-43fd-9d45-00e7d0865c6e,Merckle Recordati GmbH,merckle_recordati_gmbh,,,,,, +4541,,83dafb78-3b85-4327-a764-f21d909f63b1,"Prof John Yarnold, Institute of Cancer Research",prof_john_yarnold_institute_of_cancer_research,,,,,, +5,0.94206222891807556,dd5747ea-816f-45f7-b207-0763f720a969,Centre Hospitalier Universitaire de Liege,centre_hospitalier_universitaire_de_liege,,,,dd5747ea-816f-45f7-b207-0763f720a969,centre_hospitalier_universitaire_de_li_ge,Centre Hospitalier Universitaire de Liège +4542,,68bc515e-7145-11e6-a0cd-0242ac12000b,INTL MEDICATION,intl_medication,,,,,, +4543,,62915947-6a3d-48e4-b2fe-b0c3d3b48813,Biogen Idec GmbH,biogen_idec_gmbh,,,,,, +4544,,5805897c-0bd6-4104-959b-3a7b9378591e,Genzyme GmbH,genzyme_gmbh,,,,,, +84,0.960935,d9acbe70-7141-11e6-a0cd-0242ac12000b,ECR,ecr,,,,93bcfb98-7158-11e6-a0cd-0242ac12000b,ecr_pharma,ECR PHARMA +4545,,09ab4c6e-fec7-40ba-aa02-156ee2efe906,Royal Marsden Hospital,royal_marsden_hospital,,,,,, +4546,,e97155fb-37a7-4db0-afc8-522a3663197c,"Klinikum der Universität München, Klinikum Großhadern",klinikum_der_universit_t_m_nchen_klinikum_gro_hadern,,,,,, +4547,,4e0b3bc8-5a6a-4396-85d4-be9eddf5e68e,"UCB BIOSCIENCES, Inc",ucb_biosciences_inc,,,,,, +4548,,ea97d080-2773-4db0-b06f-7e05cd282e36,South Tees NHS Trust,south_tees_nhs_trust,,,,,, +246,0.9320218563079834,5087f699-7133-45f6-90c4-97f11a55ecf1,Guys and St Thomas' NHS Foudation Trust,guys_and_st_thomas_nhs_foudation_trust,,,,5087f699-7133-45f6-90c4-97f11a55ecf1,guys_and_st_thomas_nhs_foudation_trust,Guys and St Thomas' NHS Foudation Trust +4549,,c615f4f8-63f6-482e-bd7c-c95fe902c370,"KOMINOX USA, Inc",kominox_usa_inc,,,,,, +812,0.970088,3ab32bf7-811c-42fa-8337-eb49e15069f8,"Universitätsklinik für Psychiatrie und Psychotherapie, Klin. Abteilung f. Biologische Psychiatrie",universit_tsklinik_f_r_psychiatrie_und_psychotherapie_klin_abteilung_f_biologische_psychiatrie,,,,37aa2406-dfec-4b12-bbb7-09f94b8adbf5,universit_tsklinik_f_r_psychiatrie_und_psychotherapie_i,Universitätsklinik für Psychiatrie und Psychotherapie I +688,0.98254102468490601,e59cd9f1-a10e-4d35-9ad8-0bbcd34a16f9,Ruprecht-Karls-University Heidelberg,ruprecht_karls_university_heidelberg,,,,4f99f7a3-6aa3-48d1-bbd6-5bfbc38e7e8d,ruprecht_karls_university_heidelberg_medical_faculty,"Ruprecht-Karls-University Heidelberg, Medical Faculty" +4550,,9a97cdae-6a8d-47d4-bc96-4b9ba83cd0db,Gador S.A,gador_s_a,,,,,, +4551,,933f9768-3c83-472d-9786-b44b26cccb49,Cardoz AB,cardoz_ab,,,,,, +4552,,cd9d985d-3500-491c-b3c0-94abdf5130bb,University Hospital Sint Radboud,university_hospital_sint_radboud,,,,,, +4553,,f78ffc1e-4276-46f8-9f18-592868d400ad,AZIENDA SANITARIA LOCALE BI DI BIELLA,azienda_sanitaria_locale_bi_di_biella,,,,,, +4554,,c87b9140-ae74-4882-b7f4-3c3c74efb5da,Fundació per la Recerca i la Docència Sant Joan de Déu,fundaci_per_la_recerca_i_la_doc_ncia_sant_joan_de_d_u,,,,,, +321,0.95550477504730225,12641096-e1dd-46f5-9635-3bd405807ce5,All Ireland Cooperative Oncology Research Group (ICORG),all_ireland_cooperative_oncology_research_group_icorg,,,,12641096-e1dd-46f5-9635-3bd405807ce5,all_ireland_cooperative_oncology_research_group,All Ireland Cooperative Oncology Research Group +4555,,1d70a99d-c300-49ae-8427-810f445e1933,Maastricht University - CAPHRI School for Public Health and Primary Care,maastricht_university_caphri_school_for_public_health_and_primary_care,,,,,, +4556,,576376ff-fafd-4849-b99e-c90cc4db552d,Vrije Universiteit Medical Center,vrije_universiteit_medical_center,,,,,, +4557,,3cd6fbf8-2fe5-4697-93ea-b178ef8a9f17,STOP SIDA,stop_sida,,,,,, +4558,,f2d91d58-cc55-4e35-abc5-d3bd8166b67d,"Department of dermatology, Odense University Hospital",department_of_dermatology_odense_university_hospital,,,,,, +4559,,aca89280-7672-4d06-8c1b-26653cba201a,Royal Liverpool University Hospital,royal_liverpool_university_hospital,,,,,, +4560,,7d9c7620-f982-4a39-9775-f539a51c189f,Hutchison MediPharma Enterprises Limited,hutchison_medipharma_enterprises_limited,,,,,, +898,0.96782034635543823,485cfb56-5188-4c47-8ac4-caf3e84b5e2f,EBMT,ebmt,,,,485cfb56-5188-4c47-8ac4-caf3e84b5e2f,ebmt,EBMT +161,0.98681116104125977,9f385dc9-f8a0-482e-8c35-dd79a5919f66,Fundación para la Investigación Biomédica del Hospital 12 de Octubre,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_12_de_octubre,,,,393eab2d-fa2d-419a-8ecd-278e02b1ad5b,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_12_de_octubre,Fundación para la Investigación Biomédica del Hospital 12 de Octubre +4561,,a722c794-96b5-11e6-becf-0242ac110008,KYOWA KIRIN,kyowa_kirin,,,,,, +4562,,198c8a4e-7cb2-4496-9da6-87fe6e0cf60a,John L. Berk,john_l_berk,,,,,, +4563,,2750aee0-14ef-47f8-83a0-ff56bf12f305,"Alita Pharmaceuticals, Inc",alita_pharmaceuticals_inc,,,,,, +4564,,7d8d6f79-cd2d-4f47-a542-af28865d9fae,Omthera Pharmaceutical Inc,omthera_pharmaceutical_inc,,,,,, +4565,,ddcf6a9b-f35e-473f-9a80-d04c1f6ad714,"Steen W. Henneberg, Børnesmerteenheden, Anæstesi afd. 4013, Juliane Marie Centeret, Rigshospitalet",steen_w_henneberg_b_rnesmerteenheden_an_stesi_afd_4013_juliane_marie_centeret_rigshospitalet,,,,,, +4566,,ffcd68a4-22bd-48b7-b48b-e5bbb42c4c31,Universitätsklinkum Erlangen,universit_tsklinkum_erlangen,,,,,, +909,0.985676,8b650ee2-73e0-11e6-a0cd-0242ac12000b,OSMOTICA PHARM CORP,osmotica_pharm_corp,,,,575af654-7159-11e6-a0cd-0242ac12000b,osmotica_pharm,OSMOTICA PHARM +649,0.92396390438079834,04c96b54-04e3-4fc0-9394-ec1a0060bdcd,Boehringer Ingelheim Ltd,boehringer_ingelheim_ltd,,,,04c96b54-04e3-4fc0-9394-ec1a0060bdcd,boehringer_ingelheim_ltd,Boehringer Ingelheim Ltd +4567,,5ac76716-69e6-472d-9de7-b9f0008d4dce,BASICS Study Group,basics_study_group,,,,,, +4568,,71fc2417-ed05-4474-af8a-a064123563fa,Royal Wolverhampton NHS trust,royal_wolverhampton_nhs_trust,,,,,, +4569,,5e650d5e-715e-11e6-a0cd-0242ac12000b,TORRENT PHARMS LTD,torrent_pharms_ltd,,,,,, +4570,,18deada9-5412-4245-981b-70a55abf1010,Center Human Drug Research,center_human_drug_research,,,,,, +4571,,9683a961-aa1b-4195-80d2-a32b4431f685,Grupo Español de Tumores Neuroendocrinos. SECRETARÍA TÉCNICA GETNE (GETNE),grupo_espa_ol_de_tumores_neuroendocrinos_secretar_a_t_cnica_getne_getne,,,,,, +4572,,5a1cfc63-9a21-4db9-a032-f417843cde75,Schering-Plough CE AG Hungarian Commercial Representative Office,schering_plough_ce_ag_hungarian_commercial_representative_office,,,,,, +4573,,83b68d31-473c-45f6-acf2-8273453ca0ef,PerioC Ltd,perioc_ltd,,,,,, +4574,,14cacee3-2105-48fd-9484-0437acff6e34,Dept of Oncology,dept_of_oncology,,,,,, +4575,,c1e67dc4-e768-4651-8905-e3c06a1ba370,Trimed Biotech GmbH,trimed_biotech_gmbh,,,,,, +4576,,fc35d73d-73a0-47d9-bf78-c5fcfbd3c887,"Talon Therapeutics , Inc",talon_therapeutics_inc,,,,,, +4577,,75672ec9-4f1d-4f39-b0d6-1e3242c52b4f,Pulmonary dept. Gentofte Hospital,pulmonary_dept_gentofte_hospital,,,,,, +4578,,a3e93b22-732d-11e6-a0cd-0242ac12000b,VANDA PHARMS INC,vanda_pharms_inc,,,,,, +4579,,ce09f9e6-08ca-49eb-b5e4-9405a96d519d,Novo Nordisk Pharmaceutique S.A.S,novo_nordisk_pharmaceutique_s_a_s,,,,,, +4580,,bcc67748-b987-4321-b8df-dbc5fa6ffcf4,Laboratorios Almirall SA,laboratorios_almirall_sa,,,,,, +4581,,ebec2e63-637f-4475-9c7a-7e4f94415efe,Creabilis Sàrl,creabilis_s_rl,,,,,, +4582,,2f27470e-e242-4953-a59f-785813dc2697,German Breast GBG Forschungsgesellschaft mbH,german_breast_gbg_forschungsgesellschaft_mbh,,,,,, +4583,,c4c139e3-e159-4888-89cf-c44d76107ea9,"Medical Oncology, VUmc",medical_oncology_vumc,,,,,, +4584,,53feb5a6-df0e-4911-9851-e1ca01203659,FONDAZIONE PAOLO PROCACCI ONLUS,fondazione_paolo_procacci_onlus,,,,,, +4585,,6610c193-dc5d-4e6e-9306-512c3691a247,Dra Cristina Avendaño Sola,dra_cristina_avenda_o_sola,,,,,, +4586,,cb8e4960-7161-11e6-a0cd-0242ac12000b,PHARMAFAIR,pharmafair,,,,,, +30,0.903169,9bad6f97-3bca-43b7-8146-268bcca0c619,ACROSS (Associació catalana per la recerca oncològica i les seves implicacions sanitàries i socials),across_associaci_catalana_per_la_recerca_oncol_gica_i_les_seves_implicacions_sanit_ries_i_socials,,,,261630f5-cc3d-4976-b8b8-66f665f0285f,across_associaci_catalana_de_recerca_oncol_gica_i_les_seves_implicacions_sanit_ries_i_socials,ACROSS (Associació Catalana de Recerca Oncològica i les seves implicacions Sanitàries i Socials) +4587,,c6965b16-c727-4829-911b-60005db71a30,KEDRION,kedrion,,,,,, +4588,,ed1cb115-7077-4cd4-a970-e20608d25aa0,Medivir AB,medivir_ab,,,,,, +4589,,ab6837b3-5aa6-44bf-93e2-724d6396caca,Forward Pharma GmbH,forward_pharma_gmbh,,,,,, +4590,,9ff45d87-d917-4ba5-8837-f2fb222e7e3b,"Azienda Ospedaliera, Polo Universitario Luigi Sacco, Milano",azienda_ospedaliera_polo_universitario_luigi_sacco_milano,,,,,, +4591,,60777ea3-567a-4121-a34a-cd0c96987def,Dr Ken O'Byrne,dr_ken_o_byrne,,,,,, +4592,,990ba9b5-22aa-4ace-b797-05ebfde0bd22,"Medizinische Universität Innsbruck, Universitätsklinik für Neurologie",medizinische_universit_t_innsbruck_universit_tsklinik_f_r_neurologie,,,,,, +4593,,659d1ce5-0dbe-4d6c-a7f3-6c68c6d35f39,"Blodbanken, Rigshospitalet",blodbanken_rigshospitalet,,,,,, +4594,,3e969b78-72ad-11e6-a0cd-0242ac12000b,VIB,vib,,,,,, +4595,,35e46c3a-0f32-484d-9f71-6d06d9a3da15,Boneca Corporation,boneca_corporation,,,,,, +4596,,89b7ad4a-8359-43fe-a621-1e1451143abb,"Central Institute of Mental Health, Department of Psychiatry and Psychotherapy",central_institute_of_mental_health_department_of_psychiatry_and_psychotherapy,,,,,, +4597,,27e83e35-6397-4035-bf10-7f98c21b9cf8,Laboratoires 3M Santé,laboratoires_3m_sant,,,,,, +4598,,98ac7789-440f-49c8-8ead-d49b435b1647,Bristol-Meyers Squibb International Corporation,bristol_meyers_squibb_international_corporation,,,,,, +4599,,d9b4b51c-7141-11e6-a0cd-0242ac12000b,BOCA PHARMA LLC,boca_pharma_llc,,,,,, +4600,,e4f30928-714c-11e6-a0cd-0242ac12000b,AMERIGEN PHARMS LTD,amerigen_pharms_ltd,,,,,, +4601,,1e6a3b37-0863-4e5d-a4cb-f115fc38553f,University Hospital of Ulm,university_hospital_of_ulm,,,,,, +4602,,8944bb2a-7292-11e6-a0cd-0242ac12000b,ALARA PHARM,alara_pharm,,,,,, +4603,,11b617fc-8388-41df-8845-00907935f6b1,Ann Merete Møller,ann_merete_m_ller,,,,,, +4604,,9c1aeb9c-233c-47fb-ab41-82466f41da9a,"Cardiovascular laboratory 2014, The Heart Centre, Rigshospitalet",cardiovascular_laboratory_2014_the_heart_centre_rigshospitalet,,,,,, +4605,,8683c491-3da8-4630-ac72-3bb919ada6d0,Arakis Ltd,arakis_ltd,,,,,, +4606,,28af658d-50ed-465d-b353-f8b03a5b70a3,Hellenic Oncology Research Group,hellenic_oncology_research_group,,,,,, +4607,,3143c171-12e6-43c9-820b-c04f52a46721,F.Hoffmann-La Roche,f_hoffmann_la_roche,,,,,, +182,0.972538,d6726488-cb2a-4dc9-8697-82aba6b6943c,Durata Therapeutics International B.V,durata_therapeutics_international_b_v,,,,14a0b753-a57f-41c0-b017-ca7adb32f3da,durata_therapeutic_international_b_v,Durata Therapeutic International B.V +4608,,024ca824-9ec6-45bb-8516-1d7e69f842da,OM PHARMA,om_pharma,,,,,, +309,0.98614925146102905,53ec0bfe-735f-11e6-a0cd-0242ac12000b,MALLINCKRODT IP,mallinckrodt_ip,,,,02f63d38-7129-11e6-a89e-0242ac12000b,mallinckrodt,MALLINCKRODT +4609,,025af88b-9529-4444-90b5-86481ce363f0,Centre Hospitalier Universitaire d'Angers,centre_hospitalier_universitaire_d_angers,,,,,, +17,0.985533,c63a0355-3210-4a0d-9c79-6e414a13ec40,"German Heart Centre Munich, Department of Cardiovascular Diseases",german_heart_centre_munich_department_of_cardiovascular_diseases,,,,c63a0355-3210-4a0d-9c79-6e414a13ec40,german_heart_centre_munich_department_of_cardiovascular_diseases,"German Heart Centre Munich, Department of Cardiovascular Diseases" +4610,,78157b7e-a826-46f3-8aae-98b3491da362,GlaxoSmithKline R&D UK Ltd,glaxosmithkline_r_d_uk_ltd,,,,,, +4611,,effd088c-46ba-4617-90f0-b113086f4bef,"Acetylon Pharmaceuticals, Inc",acetylon_pharmaceuticals_inc,,,,,, +4612,,445103ff-d64d-461b-8830-e1d2f38e9417,Dr. Chris Thompson,dr_chris_thompson,,,,,, +4613,,e3723851-b7cf-44af-acc4-492cdc439dac,Vical Incorporated,vical_incorporated,,,,,, +4614,,d8dfaf76-046b-4964-9207-539bb36fa742,GlaxoSmithKline Research Ltd,glaxosmithkline_research_ltd,,,,,, +4615,,3d913a2e-f0cc-4410-8465-efe29051f72c,"Århus University Hospital, Department of Dermatology",rhus_university_hospital_department_of_dermatology,,,,,, +4616,,02811bfc-7a4a-480f-a46f-0ba4a432d9e1,Univ.Clinic of Dermatology,univ_clinic_of_dermatology,,,,,, +4617,,231fdf0a-73f0-11e6-a0cd-0242ac12000b,WESTAIR GASES & EQUIPMENT INC,westair_gases_equipment_inc,,,,,, +54,0.987705,4309c229-e3c1-4201-9d80-c9e59f301793,AIBILI - Association for Innovation and Biomedical Research ob Light and Image,aibili_association_for_innovation_and_biomedical_research_ob_light_and_image,,,,22fb394f-9949-4253-b978-e945565c187d,aibili_association_for_innovation_and_biomedical_research_on_light_and_image,AIBILI - Association for Innovation and Biomedical Research on Light and Image +4618,,5041311b-13ed-4575-aa8c-5d0f14575ec1,ZARI - Univeristätsmedizin Göttingen,zari_univerist_tsmedizin_g_ttingen,,,,,, +4619,,f2ed3f1d-a72c-11e6-94cb-5656d04fc2b5,Fertilitycenter Odense,fertilitycenter_odense,,,,,, +4620,,57da89eb-695a-4806-8fc2-4ff828dc6b33,"Academic Medical Center, University of Amsterdam",academic_medical_center_university_of_amsterdam,,,,,, +4621,,2c7eb2db-2ce1-4c84-962d-ec4098da80a7,Scandinavian Prostate Cancer Group (SPCG),scandinavian_prostate_cancer_group_spcg,,,,,, +4622,,24fde8c2-52fe-4bbb-8c10-e57d480e040c,Dutch Childhood Oncology Group (DCOG),dutch_childhood_oncology_group_dcog,,,,,, +4623,,6de73923-d5f5-4d8b-9795-9cebd0aac307,"IPSEN Research and Development, BEAUFOUR IPSEN PHARMA",ipsen_research_and_development_beaufour_ipsen_pharma,,,,,, +4624,,a9da6c28-d83e-4411-aea4-6a3f620d5927,"Lil Valentin, Region Skåne, Malmö University Hospital, Dpt Obstetrics and Gynecology",lil_valentin_region_sk_ne_malm_university_hospital_dpt_obstetrics_and_gynecology,,,,,, +4625,,d189f68a-ba9f-4328-83b7-e34720049e4e,CAROLINA IBAÑEZ LOPEZ,carolina_iba_ez_lopez,,,,,, +4626,,105c2714-3c7f-4c49-8292-5d5d874cf217,"Zavante Therapeutics, Inc",zavante_therapeutics_inc,,,,,, +4627,,3c16d888-57c7-4f64-a33a-ff5c282a69f8,Piramal Life Sciences Limited,piramal_life_sciences_limited,,,,,, +466,0.91411077976226807,0c30b492-594c-4ddd-8d03-fa24bfa5bbd3,"Leiden University Medical Center, department of rheumatology",leiden_university_medical_center_department_of_rheumatology,,,,0c30b492-594c-4ddd-8d03-fa24bfa5bbd3,leiden_university_medical_center_department_of_rheumatology,"Leiden University Medical Center, department of rheumatology" +4628,,02d25d93-07d8-4018-837f-77cc07857130,Klaus Krogh,klaus_krogh,,,,,, +4629,,058dd909-c936-4725-91ae-e66e55db74eb,SANOFI- AVENTIS RECHERCHE ET DÉVELOPPEMENT,sanofi_aventis_recherche_et_d_veloppement,,,,,, +4630,,97fd4cf8-fa74-43b4-b733-28214f2db140,Sørlandet Hospital,s_rlandet_hospital,,,,,, +4631,,681747cc-7145-11e6-a0cd-0242ac12000b,MATRIX MEDCL,matrix_medcl,,,,,, +4632,,540fed12-7166-11e6-a0cd-0242ac12000b,ACIC FINE CHEMS,acic_fine_chems,,,,,, +207,0.915531,46fed310-ee3c-4cc4-8649-37bb315ed072,"BIAL - Portela & Ca, S.A",bial_portela_ca_s_a,,,,46fed310-ee3c-4cc4-8649-37bb315ed072,bial_portela_ca_s_a,"BIAL - Portela & Ca, S.A" +4633,,1f89690a-9a9c-416c-b094-2f9d9f53ba41,"Intarcia Therapeutics, Inc",intarcia_therapeutics_inc,,,,,, +4634,,72aca9dd-2c38-4fec-b0dd-e3d607751422,GE Healthcare Ltd,ge_healthcare_ltd,,,,,, +4635,,facd512d-325c-41cc-98e5-a6da21edb988,Albireo AB,albireo_ab,,,,,, +4636,,2b6258a9-3e96-400c-b7fe-422aef06b7a5,Kalmar County Council,kalmar_county_council,,,,,, +4637,,1b86e1d4-732e-11e6-a0cd-0242ac12000b,AMHERST PHARMS LLC,amherst_pharms_llc,,,,,, +4638,,f816f266-67c3-47d5-916e-ff64d4d45998,"Center for Spiseforstyrrelse, Endokrinologisk Afdeling M, Odense Universitetshospital",center_for_spiseforstyrrelse_endokrinologisk_afdeling_m_odense_universitetshospital,,,,,, +4639,,465402d8-71a4-11e6-a0cd-0242ac12000b,FERRING PHARMS INC,ferring_pharms_inc,,,,,, +4640,,a4323d6f-80ea-4dda-9fb7-c86a00a536eb,Zentrum für Neuro-Onkologie,zentrum_f_r_neuro_onkologie,,,,,, +4641,,9eae5a22-73e9-11e6-a0cd-0242ac12000b,OMEROS,omeros,,,,,, +4642,,20beaa5c-7619-4736-8f78-c478240fdd48,Belgian Study Group for Pediatric Endocrinology,belgian_study_group_for_pediatric_endocrinology,,,,,, +4643,,67d47ff8-7bc0-418b-abc6-3bb9795c224b,"NovaCardia, Inc. (A wholly owned subsidiary of Merck & Co., Inc.)",novacardia_inc_a_wholly_owned_subsidiary_of_merck_co_inc,,,,,, +4644,,0c591de0-726a-11e6-a0cd-0242ac12000b,SKINMEDICA,skinmedica,,,,,, +4645,,92c13aa6-2116-47da-b4e9-aa1813065437,"Västra Götalandsregionen, Shalgrenska University Hospital Östra",v_stra_g_talandsregionen_shalgrenska_university_hospital_stra,,,,,, +4646,,ac93cced-1fa6-4ec7-b35b-83e09c68fb08,GOTEL (Grupo Oncológico para el Tratamiento de las Enfermedades Linfoides),gotel_grupo_oncol_gico_para_el_tratamiento_de_las_enfermedades_linfoides,,,,,, +4647,,26502d11-6d14-4f40-ad10-9dffee76c43a,"Endocrine Department, Sahlgrenska University Hospital",endocrine_department_sahlgrenska_university_hospital,,,,,, +717,0.958979,8e8615e6-4618-4d17-8910-cbd6dfde0637,Dept. Child & Adolescent Psychiatry Univ. Freiburg,dept_child_adolescent_psychiatry_univ_freiburg,,,,7517b680-5ab5-4e0c-8c77-e2e66cd5f935,dept_child_adolescent_psychiatrie,Dept. Child & Adolescent Psychiatrie +4648,,6e2ef557-1886-405f-add8-d4f0da06eb94,FARMAKA Srl,farmaka_srl,,,,,, +4649,,87b4e3d6-1aa6-4d5b-a059-a7b155521ec5,BOEHRINGER ING,boehringer_ing,,,,,, +4650,,fad954e1-8a1b-423d-9787-709e10ba2d31,"Barts and the London School of Medicine and Dentistry, Queen Mary University of London",barts_and_the_london_school_of_medicine_and_dentistry_queen_mary_university_of_london,,,,,, +4651,,abcc0dc0-5897-40f0-97eb-1c653d2b3172,Professor Joergen Berg Dahl,professor_joergen_berg_dahl,,,,,, +4652,,63da7f28-b01c-46eb-9af9-e494c2d43480,Lumena Pharmaceuticals LLC,lumena_pharmaceuticals_llc,,,,,, +4653,,e0a0a560-3254-4ff7-9a0f-884c04fb1e4a,Serumwerk Bernburg,serumwerk_bernburg,,,,,, +4654,,193187fc-7155-11e6-a0cd-0242ac12000b,AEGIS PHARMS,aegis_pharms,,,,,, +4655,,617b68d5-f850-4b63-a90c-8131e3928f3c,ASONMEC (Asociación de Oncología Medica del Hospital de Cruces),asonmec_asociaci_n_de_oncolog_a_medica_del_hospital_de_cruces,,,,,, +4656,,80b01c1b-ed37-4e5a-b0be-251dd90e0e43,Nordfjord Psychiatric Centre,nordfjord_psychiatric_centre,,,,,, +767,0.98237824440002441,da4cbdf9-e1bc-4412-95a2-1df2b8781a19,Medizinische Universität Innsbruck Innere Medizin V,medizinische_universit_t_innsbruck_innere_medizin_v,,,,da4cbdf9-e1bc-4412-95a2-1df2b8781a19,medizinische_universit_t_innsbruck_innere_medizin_v,Medizinische Universität Innsbruck +464,0.979231,12f90377-956c-4817-b4ad-64555adaf3a0,SCHWARZ PHARMA Deutschland GmbH,schwarz_pharma_deutschland_gmbh,,,,12f90377-956c-4817-b4ad-64555adaf3a0,schwarz_pharma_deutschland_gmbh,SCHWARZ PHARMA Deutschland GmbH +768,0.987661,611690f5-8173-4554-bcb7-1ecc6dba03cd,Bayer Schering Pharma AG,bayer_schering_pharma_ag,,,,611690f5-8173-4554-bcb7-1ecc6dba03cd,bayer_schering_pharma_ag,Bayer Schering Pharma AG +4657,,83b3820e-2221-4da4-b297-e417b9188f3b,Klinik Neuropädiatrie und Muskelkrankheiten,klinik_neurop_diatrie_und_muskelkrankheiten,,,,,, +4658,,93f935be-716b-11e6-a0cd-0242ac12000b,IDEC PHARMACEUTICALS CORP,idec_pharmaceuticals_corp,,,,,, +4659,,8d579fdc-aca4-4c8d-a1b0-617a4b57b83d,BRISTOL-M.SQUIBB,bristol_m_squibb,,,,,, +888,0.96565869024821693,f5ba0c0f-5dea-4005-9de6-28efb2d2755c,"Schering-Plough Research Institute, a division of Schering Corp",schering_plough_research_institute_a_division_of_schering_corp,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" +4660,,4b27728a-7164-11e6-a0cd-0242ac12000b,AMPOLGEN,ampolgen,,,,,, +4661,,0e4855a0-b62e-43b5-8072-c5ec6ea7aa16,Ventrus Biosciences,ventrus_biosciences,,,,,, +1081,0.98753979802131653,db4d0602-1e15-4ac9-8de2-88720d9bf753,Vertex Pharmaceuticals Inc,vertex_pharmaceuticals_inc,,,,48c9366f-f57d-45a5-b7c5-8b03cb153868,vertex_pharmaceuticals_inc,Vertex Pharmaceuticals Inc +4662,,29f881ec-bd4b-4e60-87c2-a71dbf8d304b,Eisai Medical Research Inc,eisai_medical_research_inc,,,,,, +4663,,2b56b800-6c6e-4ccd-919e-21dda4f8e68a,"Aarhus University Hospital, Department of Endocrinology and Internal Diseases",aarhus_university_hospital_department_of_endocrinology_and_internal_diseases,,,,,, +4664,,dc67c1f7-ec46-445d-81eb-53f4b5773a45,Aker universitetssykehus,aker_universitetssykehus,,,,,, +4665,,533e324a-fa22-4000-bd45-f8697c1bacdb,WOLFSON DIGESTIVE DISEASES CENTRE,wolfson_digestive_diseases_centre,,,,,, +4666,,282e016e-061e-4f60-982d-3bf795895030,Apoxis SA,apoxis_sa,,,,,, +4667,,c1f9d37e-29ca-4135-8221-1e871bf454df,"Multidisciplinary Pain Center 7612, Rigshospitalet",multidisciplinary_pain_center_7612_rigshospitalet,,,,,, +4668,,a90e99e4-712a-11e6-a89e-0242ac12000b,GAVIS PHARMS,gavis_pharms,,,,,, +4669,,bdcfeb84-4aa1-47db-8426-be1cb3b02e95,Hunter-Fleming Ltd,hunter_fleming_ltd,,,,,, +4670,,d8e4283f-2eb0-44f1-9ec8-aea794d04c99,"IPSEN Research and Development, IPSEN PHARMA SAS",ipsen_research_and_development_ipsen_pharma_sas,,,,,, +4671,,762bd1c8-0a34-4c38-a4cb-7717b0c9aa62,Ana Vallejo de la Cueva,ana_vallejo_de_la_cueva,,,,,, +4672,,e00b5130-2aae-4b06-ad18-7076a37aa1f5,POLICLINICO GEMELLI,policlinico_gemelli,,,,,, +104,0.987186,75e8ee69-62d3-42ee-992e-eee1cd45ffb8,Merck Lipha Santé SAS,merck_lipha_sant_sas,,,,75e8ee69-62d3-42ee-992e-eee1cd45ffb8,merck_lipha_sant_sas,Merck Lipha Santé SAS +4673,,30ef7f8d-4618-49a8-85d8-e90c32d01989,C. HOSPITALARIO VIRGEN DEL ROCIO,c_hospitalario_virgen_del_rocio,,,,,, +4674,,e07d9269-90cd-4569-9510-6ebca5a7774e,Sucampo Pharma Europe Ltd,sucampo_pharma_europe_ltd,,,,,, +4675,,7ad053f4-f46b-4d19-8c5d-1268eb1e0ec1,"Dept of Paediatric Anaesthesia, Karolinska University Hospital-Solna",dept_of_paediatric_anaesthesia_karolinska_university_hospital_solna,,,,,, +475,0.985423,ffa313ee-734f-11e6-a0cd-0242ac12000b,HETERO DRUGS LTD,hetero_drugs_ltd,,,,f3be3318-715d-11e6-a0cd-0242ac12000b,hetero_drugs,HETERO DRUGS +4676,,d84a09a2-7141-11e6-a0cd-0242ac12000b,HI-TECH PHARMACAL,hi_tech_pharmacal,,,,,, +4677,,ce38eb37-e2b4-4b9b-bdde-32f4caacf023,"Tobira Therapeutics, Inc",tobira_therapeutics_inc,,,,,, +4678,,1deb2f69-46ec-4ef0-986d-88bfa9c81706,"MUW, Klinik f. Mund-, Kiefer, und Gesichtschirurgie",muw_klinik_f_mund_kiefer_und_gesichtschirurgie,,,,,, +186,0.987464,7c8c188f-61a9-4ebc-a77d-3b56eea02989,ISTITUTO GIANNINA GASLINI,istituto_giannina_gaslini,,,,2cec47b8-3bd6-4f10-8180-b9e29e1ccf01,istituto_giannina_gaslini_printo,ISTITUTO GIANNINA GASLINI-PRINTO +4679,,4762dcae-952c-4a22-91c1-81a58bc7324e,"Klinikum der Ludwig-Maximilians-Universität München, Klinikum Großhadern",klinikum_der_ludwig_maximilians_universit_t_m_nchen_klinikum_gro_hadern,,,,,, +4680,,d0e40f16-25af-4459-937c-2e8b3e8260c8,IRCCS AOU SAN MARTINO- IST,irccs_aou_san_martino_ist,,,,,, +4681,,63f7d194-af57-4043-af49-0cecfb6cf49c,POLICLINICO SAN DONATO IRCSS,policlinico_san_donato_ircss,,,,,, +4682,,80a6033e-7d75-4f86-adf6-94304c39d755,"Specialisttandvården/Bettfysiologi, Folktandvården Södra Bohslän",specialisttandv_rden_bettfysiologi_folktandv_rden_s_dra_bohsl_n,,,,,, +4683,,b388fb70-85c2-4ce8-9427-21b59d9596ac,University of Aberdeen & NHS Grampian,university_of_aberdeen_nhs_grampian,,,,,, +984,0.96790230274200439,d845bc54-1b47-4eaa-9f16-1a723a24d9b4,Imperial College London and Imperial College Healthcare NHS Trust,imperial_college_london_and_imperial_college_healthcare_nhs_trust,,,,1c2355a5-8dc8-4952-839c-0af765b26555,imperial_college_london_imperial_college_healthcare_nhs_trust,Imperial College London & Imperial College Healthcare NHS Trust +4684,,2ff60eec-72fc-11e6-a0cd-0242ac12000b,AMYLIN,amylin,,,,,, +897,0.963506,e6207d0a-7145-11e6-a0cd-0242ac12000b,OHM,ohm,,,,8f278d90-7145-11e6-a0cd-0242ac12000b,ohm_labs,OHM LABS +519,0.97853121161460876,85e83b77-dd1e-42a1-b79f-e5cd5d499f1a,CSL Behring AG (casa madre),csl_behring_ag_casa_madre,,,,c15af267-15cc-42e5-be46-4a84bd3c6dca,csl_behring_ag,CSL Behring AG +4685,,644a7803-6144-47ea-abff-af36f84c13da,"Clinical Trials Center Aachen, University of Aachen",clinical_trials_center_aachen_university_of_aachen,,,,,, +415,0.958927,59386aed-ad97-4761-8066-9f33da6b317f,Aspreva Pharmaceuticals Corporation as part of the Roche-Aspreva Collaboration Agreement,aspreva_pharmaceuticals_corporation_as_part_of_the_roche_aspreva_collaboration_agreement,,,,1a38fc33-48c6-45d0-8a30-54ce6c217bac,aspreva_pharmaceutical_corporation,Aspreva Pharmaceutical Corporation +4686,,aa283f81-977f-4da3-8c06-170ea8e59d8d,AZIENDA OSPEDALIERA FONDAZIONE MACCHI (A.O. DI RILIEVO NAZIONALE),azienda_ospedaliera_fondazione_macchi_a_o_di_rilievo_nazionale,,,,,, +4687,,4e8d38c1-0cbf-4219-834d-80815f68f5f6,GlaxoSmithKline Reseacrh and Development Limited,glaxosmithkline_reseacrh_and_development_limited,,,,,, +4688,,aca7b449-00dd-454d-9490-afaee661da2b,LYSARC,lysarc,,,,,, +4689,,d23d7634-7358-11e6-a0cd-0242ac12000b,PARAPRO LLC,parapro_llc,,,,,, +594,0.970712,e892a01f-3ea1-4cd9-9870-18a0aae9256f,"The Karolinska Institutet, ClinTRID",the_karolinska_institutet_clintrid,,,,1768a5c2-6d78-474d-b8b9-24906dea2085,the_karolinska_institute_clintrid,"The Karolinska Institute, ClinTRID" +65,0.97933,85300b96-9316-43a9-b115-b61f3263249b,ANGELINI,angelini,,,,85300b96-9316-43a9-b115-b61f3263249b,angelini,ANGELINI +4690,,65e35f10-980a-45a1-9583-ea8c86e6fd47,Chiron Vaccines Limited,chiron_vaccines_limited,,,,,, +4691,,1fa31c42-0c9b-43ab-81e0-35dd0e4d9857,FERRING ARZNEIMITTEL Ges.m.b.h. CEE AUSTRIA,ferring_arzneimittel_ges_m_b_h_cee_austria,,,,,, +4692,,dfb8d068-426a-41a7-b455-0406ca3c1011,Linde Gas Therapeutics,linde_gas_therapeutics,,,,,, +4693,,33454394-7142-11e6-a0cd-0242ac12000b,ARMENPHARM,armenpharm,,,,,, +4694,,90780bf1-e327-4555-be89-d6df896637b5,GYN Research GmbH,gyn_research_gmbh,,,,,, +4695,,5848e4ad-8b6a-4616-8e07-7fb9d3747035,CLINICAL PHARMACOLOGY SPANISH SOCIETY,clinical_pharmacology_spanish_society,,,,,, +667,0.985709,1a3268a1-1f5d-4bc4-a2cd-ff168ce961fd,Consorci Parc de Salut Mar de Barcelona,consorci_parc_de_salut_mar_de_barcelona,,,,1a3268a1-1f5d-4bc4-a2cd-ff168ce961fd,consorci_parc_de_salut_mar_de_barcelona,Consorci Parc de Salut Mar de Barcelona +4696,,9251eb5c-15f6-44aa-a851-18e1d6097b86,Universitätsklinik für Anästhesie - Paracelsus Medizinische Universität Salzburg,universit_tsklinik_f_r_an_sthesie_paracelsus_medizinische_universit_t_salzburg,,,,,, +4697,,d41da4ae-fbbe-4423-9ac2-63610ddeaaf0,Cedars Sinai Medical Center,cedars_sinai_medical_center,,,,,, +4698,,421321c8-7167-11e6-a0cd-0242ac12000b,UNIV NORTH DAKOTA,univ_north_dakota,,,,,, +4699,,eb68071b-fbc9-4667-a486-2a23faf778f9,Epifarma S.r.l,epifarma_s_r_l,,,,,, +4700,,95996a8a-e911-4274-a63c-330c9efad587,"Medizinische Universität Graz, Klin. Abteilung für Gastroenterologie und Hepatologie",medizinische_universit_t_graz_klin_abteilung_f_r_gastroenterologie_und_hepatologie,,,,,, +4701,,6659a2bb-bd7a-4386-8c87-c199d5be2fc7,Sylentis S.A.U,sylentis_s_a_u,,,,,, +4702,,96a7c44f-920b-4558-81b2-15fe98a8daae,(OSI) Eyetech Pharamceuticals Inc,osi_eyetech_pharamceuticals_inc,,,,,, +532,0.967052,54f4c723-6489-4990-9197-43e7be9cca13,East and North Hertfordhsire NHS Trust,east_and_north_hertfordhsire_nhs_trust,,,,4c49fb26-4e7e-409c-ab8a-627200080dc0,east_and_north_hertfordshire_nhs_trust,East and North Hertfordshire NHS Trust +4703,,045f4d5e-992a-49f7-9745-333f2ff87d30,Dompé farmaceutici s.p.a,domp_farmaceutici_s_p_a,,,,,, +4704,,0802e8a7-2020-4d39-8d98-b51e4b7817f8,Zogenix International Limited,zogenix_international_limited,,,,,, +4705,,02c2f2e2-f26a-41a6-b887-f321e878a4d7,The Medicines Company,the_medicines_company,,,,,, +4706,,4bd73325-dc0a-4ddc-96a1-324c7795ccaf,Medtronic International Trading Sarl,medtronic_international_trading_sarl,,,,,, +70,0.98913925886154175,c009dd7a-8228-4d50-861f-056ef834bb4b,Takeda Global R&D Centre (Europe),takeda_global_r_d_centre_europe,,,,ac8a4c93-016d-49ef-adcf-dab8bb9bc5aa,takeda_global_r_d_centre_europe_ltd,Takeda Global R&D Centre (Europe) Ltd +994,0.94387978315353394,2e5a2501-0997-4b88-9260-ccb94b118ad0,GE Healthcare Ltd and its Affiliates,ge_healthcare_ltd_and_its_affiliates,,,,2e5a2501-0997-4b88-9260-ccb94b118ad0,ge_healthcare_ltd_and_its_affiliates,GE Healthcare Ltd and its Affiliates +4707,,8573dbf3-9555-4690-808b-1174cd449c1e,PLIVA Research and Development Ltd,pliva_research_and_development_ltd,,,,,, +4708,,36df679a-8bab-48e6-ab54-46c1f8c00fe7,Indevus Pharmaceuticals Incorporated,indevus_pharmaceuticals_incorporated,,,,,, +4709,,29ce9749-7d1d-4b76-9faa-f23407aa280f,Sörmlands läns landsting,s_rmlands_l_ns_landsting,,,,,, +4710,,3e4b4d84-41bc-4628-a620-f7201d09bfa2,"Sykehuset Østfold, Fredrikstad",sykehuset_stfold_fredrikstad,,,,,, +438,0.96242703994115197,7db1aec7-f10a-44e5-a315-0e3766e79d16,"Pfizer Inc 235 East 42nd Street, New York, NY10017 US",pfizer_inc_235_east_42nd_street_new_york_ny10017_us,,,,09d833e6-81f6-4d84-ab0d-6d38c6152081,pfizer_inc_235_east_42nd_street_new_york_ny10017_usa,"Pfizer Inc 235 East 42nd Street, New York, NY10017" +4711,,1926ce99-34bc-4fa0-b1eb-3482668cf70d,Verein fuer Krebsfoschung (Society for Cancer Research),verein_fuer_krebsfoschung_society_for_cancer_research,,,,,, +4712,,d870802d-d68c-4f56-8fc5-94d8f011ebf6,"Akebia Therapeutics, Inc",akebia_therapeutics_inc,,,,,, +4713,,be840516-61c8-4d0e-8d95-a124c47a8b93,FUNDACION PUBLICA ANDALUZA PARA LA GESTION DE LA INVESTIGACION EN SALUD DE SEVILLA,fundacion_publica_andaluza_para_la_gestion_de_la_investigacion_en_salud_de_sevilla,,,,,, +4714,,1a2efa33-4417-4558-86cb-1b4d32d59f8a,Sigma-Tau Industrie Farmaceutiche Riunite S.p.A,sigma_tau_industrie_farmaceutiche_riunite_s_p_a,,,,,, +997,0.978108,5bbd7601-f97c-4166-b061-6c6d0f6ab946,"University of Ulm, University Hospital Ulm",university_of_ulm_university_hospital_ulm,,,,5bbd7601-f97c-4166-b061-6c6d0f6ab946,university_of_ulm_university_hospital_ulm,"University of Ulm, University Hospital Ulm" +624,0.925655,695b704d-00ae-4579-8869-ffa0844dbd29,Aventis Inc,aventis_inc,,,,695b704d-00ae-4579-8869-ffa0844dbd29,aventis_inc,Aventis Inc +4715,,f89e4922-df37-44af-aa55-ddaa31943f41,Bayer Health Care AG (study performed by Bayer Schering Pharma AG),bayer_health_care_ag_study_performed_by_bayer_schering_pharma_ag,,,,,, +4716,,ff219d51-7182-4932-9a4a-7cc9a05eb209,Hywel DdA Health Borad,hywel_dda_health_borad,,,,,, +4717,,cf79948e-5398-4b71-aa5a-7448d9749c7c,Shire Pharmaceutical Ltd,shire_pharmaceutical_ltd,,,,,, +91,0.96536672115325928,3dedb773-37f2-4652-90d4-6504c0c1d1ad,Actelion Pharmaceuticals Ltd,actelion_pharmaceuticals_ltd,,,,773f50b2-9db9-4907-b659-e4a90dab71f6,actelion_pharmaceuticals,Actelion Pharmaceuticals +4718,,3c9df4c9-038b-4718-ba28-92004764b39a,JOSE LUIS MONTERO ALVAREZ,jose_luis_montero_alvarez,,,,,, +4719,,8a805381-fcbc-4c29-8cd8-e4ce3a95c16a,Covidien,covidien,,,,,, +4720,,048e677d-adfc-4090-9351-eac2d182cb79,University Hospitals of Leiceter NHS Trust,university_hospitals_of_leiceter_nhs_trust,,,,,, +167,0.980699,eff1598b-0ad4-4c54-bb3b-768ea14ed615,"Universität zu Köln, Qualitätsmanagement",universit_t_zu_k_ln_qualit_tsmanagement,,,,4f0d312c-f55c-48d0-9554-4b675d8c084f,universit_t_zu_k_ln,Universität zu Köln +589,0.9786,3a83eff6-b403-4ef3-9768-88bc041f3b42,"Abteilung für Anästhesie und Intensivmedizin, Medizinische Universität Wien",abteilung_f_r_an_sthesie_und_intensivmedizin_medizinische_universit_t_wien,,,,3a83eff6-b403-4ef3-9768-88bc041f3b42,abteilung_f_r_an_sthesie_und_intensivmedizin_medizinische_universit_t_wien,"Abteilung für Anästhesie und Intensivmedizin, Medizinische Universität Wien" +4721,,681334fe-c2ff-4d9f-9248-8b81b6a42948,Asociación Científica para la investigación Nefrológica (ACINEF),asociaci_n_cient_fica_para_la_investigaci_n_nefrol_gica_acinef,,,,,, +4722,,920d431d-c414-45f2-8905-745fe554b7f3,HOSPITAL SANT JOAN DE DÉU,hospital_sant_joan_de_d_u,,,,,, +4723,,06978180-73f0-11e6-a0cd-0242ac12000b,MACHINE & WELDING SUPPLY CO,machine_welding_supply_co,,,,,, +4724,,fd5d6e35-0e88-4ae4-8ce3-4cfae98aec27,Grupo Español de Neurooncología Médica (GENOM),grupo_espa_ol_de_neurooncolog_a_m_dica_genom,,,,,, +4725,,d99b8884-dc5f-4512-a316-a24329bfe9d0,Blood Transfusion Centre of Slovenia,blood_transfusion_centre_of_slovenia,,,,,, +4726,,a562b491-c92c-43ae-8813-a63888202f7b,"Søren H. Sindrup, Department of Neurology, Odense University Hospital",s_ren_h_sindrup_department_of_neurology_odense_university_hospital,,,,,, +4727,,181a3037-a1ba-4200-98d0-ee002f7db314,"ASKA Pharmaceutical.Co., Ltd",aska_pharmaceutical_co_ltd,,,,,, +4728,,77c6eb77-ab9a-4b52-a829-062a47744d40,AZIENDA UNITA` SANITARIA LOCALE LECCE,azienda_unita_sanitaria_locale_lecce,,,,,, +4729,,1c173e2e-d41b-4c99-a059-8e17515ebaec,Britt Skogseid,britt_skogseid,,,,,, +4730,,1bfd0915-f037-42aa-b56a-04a16790ec4a,NUMICO RESEARCH BV,numico_research_bv,,,,,, +4731,,c66fd511-bc26-4374-9333-306f86cfbfe1,Dr. Miguel Yebra Bango,dr_miguel_yebra_bango,,,,,, +165,0.985075,1e5b75f8-7164-11e6-a0cd-0242ac12000b,MISSION PHARMACAL CO,mission_pharmacal_co,,,,1e5b75f8-7164-11e6-a0cd-0242ac12000b,mission_pharmacal_co,MISSION PHARMACAL CO +282,0.98588120937347412,73ad64c3-1db0-4276-bfd3-847419dc1449,Sahlgrenska University Hospital,sahlgrenska_university_hospital,,,,2f33c154-cafb-40b1-8fdc-8c3e78823f79,sahlgrenska_university_hospital,Sahlgrenska University Hospital +4732,,faedc197-8201-4a16-8cfc-906bf62eedc3,PsiOxus Therapeutics Ltd,psioxus_therapeutics_ltd,,,,,, +4733,,0c278703-63d6-4d65-8990-f9f8f76b25e8,EBMT (European group for Blood and Marrow Transplantation),ebmt_european_group_for_blood_and_marrow_transplantation,,,,,, +4734,,264bfd29-50c4-417a-9c65-a774cfa8e14f,"OncoMed Pharmaceuticals, Inc",oncomed_pharmaceuticals_inc,,,,,, +4735,,3657234b-a927-4608-918d-75c5acb9a394,Insmed Inc,insmed_inc,,,,,, +4736,,e743be49-f88a-47bc-9055-c3ca3cd8f164,ESSEX ITALIA,essex_italia,,,,,, +4737,,9574ecc0-7149-11e6-a0cd-0242ac12000b,ALKERMES GAINESVILLE,alkermes_gainesville,,,,,, +4738,,abf9b4be-bb85-48ed-be03-8f6a3f9a54f4,Centre Léon Bérard,centre_l_on_b_rard,,,,,, +4739,,61f81a65-4b2d-424b-9235-7bd647587359,"Universitätsklinik für Innere Medizin IV, Medizinische Universität Innsbruck",universit_tsklinik_f_r_innere_medizin_iv_medizinische_universit_t_innsbruck,,,,,, +4740,,95dc52c3-4295-4405-bafb-ca621be910d9,Department of Pediatrics Aarhus University Hospital Skejby,department_of_pediatrics_aarhus_university_hospital_skejby,,,,,, +4741,,5b54ddc3-479a-4a55-9c99-01755ebb3e78,Charité - University Hospital of Berlin,charit_university_hospital_of_berlin,,,,,, +4742,,0b6159ee-7142-11e6-a0cd-0242ac12000b,NEXGEN PHARMA,nexgen_pharma,,,,,, +4743,,1249d4f6-4ab2-4301-9fd0-d63125ff16ae,HOVON Foundation,hovon_foundation,,,,,, +4744,,724a6480-715f-11e6-a0cd-0242ac12000b,TG UNITED LABS,tg_united_labs,,,,,, +4745,,918423a1-e0fb-4bfb-816c-3353775163d9,Royal Bournemouth Hospital,royal_bournemouth_hospital,,,,,, +4746,,b086d628-323e-4473-b59f-b0fd7fda0940,Karolinska Institutet at Danderyd University Hospital,karolinska_institutet_at_danderyd_university_hospital,,,,,, +310,0.963604,f56b8ab9-a6e2-4dd5-b43d-64d9a7bbee84,sanofi-aventis group,sanofi_aventis_group,,,,09253f61-375e-4a27-869a-8e74c421b025,sanofi_aventis_groupe,sanofi-aventis Groupe +4747,,c142d027-8d27-4b18-95a0-463a80a5be49,East Kent Hospital Trust,east_kent_hospital_trust,,,,,, +4748,,529237a0-4eb7-4b2b-b442-bb7838834a45,"Med. Univ. Wien, Univ. Klinik f. Kinder- u. Jugendheilkunde, Klin. Abt.f. Pädiatrische Kardiologie",med_univ_wien_univ_klinik_f_kinder_u_jugendheilkunde_klin_abt_f_p_diatrische_kardiologie,,,,,, +713,0.96870841085910797,59edc476-1513-491e-9fdc-d5296e3e70c1,"Wyeth Parmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA",wyeth_parmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,,,,d2f1d48d-c243-473b-9f47-208723250aa6,wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA" +4749,,932b0bf5-cc9c-4e12-bd14-de383c751c20,Universtiy Medical Center Utrecht,universtiy_medical_center_utrecht,,,,,, +934,0.95976868271827698,ed0e7a9e-3ecf-499e-8589-05b770cd0c82,Pierre Fabre Médicament represented by IRPF,pierre_fabre_m_dicament_represented_by_irpf,,,,ed0e7a9e-3ecf-499e-8589-05b770cd0c82,pierre_fabre_m_dicament_represented_by_irpf,Pierre Fabre Médicament represented by IRPF +4750,,25bec611-0646-498a-b7fe-fff4f5822e51,Mater Misericordiae University Hospital,mater_misericordiae_university_hospital,,,,,, +4751,,b12a1933-8e05-48ac-ac0a-0097f45671ac,LABORATOIRES BOIRON,laboratoires_boiron,,,,,, +804,0.9722786545753479,1105f30e-7166-11e6-a0cd-0242ac12000b,ALCON PHARMA,alcon_pharma,,,,1105f30e-7166-11e6-a0cd-0242ac12000b,alcon_pharma,ALCON PHARMA +1064,0.96846312284469604,68d612ea-eec9-4118-bbaa-4c1bf28eade2,Cambridge University Hospitals NHS Foundation Trust and University of Cambridge,cambridge_university_hospitals_nhs_foundation_trust_and_university_of_cambridge,,,,5832b652-f280-4dd6-850d-477a81887563,cambridge_university_hospitals_nhs_foundation_trust,Cambridge University Hospitals NHS Foundation Trust +4752,,bc173d6c-32eb-4dfe-92a4-41dc7710f428,Georg-August-University Göttingen,georg_august_university_g_ttingen,,,,,, +4753,,6fb4058b-86df-4659-954d-a85034b8b931,"University Medical Center Groningen, Department of Genetics",university_medical_center_groningen_department_of_genetics,,,,,, +4754,,c4e899a8-a2ae-4801-81be-d2f7c71e39ba,Sirtris Pharmaceuticals Inc,sirtris_pharmaceuticals_inc,,,,,, +4755,,a361fa0b-6b01-4417-9fa8-82f07b99424c,"Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie",med_uni_graz_univ_klinik_innere_medizin_abt_rheumatologie_und_immunologie,,,,,, +4756,,b3d5ed6a-d050-4255-832e-dfa2c25622c0,Respiratory research UNit,respiratory_research_unit,,,,,, +4757,,de7cbd55-99d3-4e22-a9aa-5f4422056f21,SECONDA UNIVERSITA' DEGLI STUDI DI NAPOLI,seconda_universita_degli_studi_di_napoli,,,,,, +4758,,7a27e2de-53a1-414c-acab-ddb3fa878b87,"Zakłady Farmaceutyczne ""UNIA"" Spółdzielnia Pracy",zak_ady_farmaceutyczne_unia_sp_dzielnia_pracy,,,,,, +580,0.98199012875556946,2766825d-c0d8-418e-9851-e5593ebd1105,Wyeth Pharmaceuticals Inc. (a Pfizer Company),wyeth_pharmaceuticals_inc_a_pfizer_company,,,,6e90ff22-ae0c-4450-9eec-85eba70c3fda,wyeth_pharmaceuticals_inc,Wyeth Pharmaceuticals Inc +4759,,96a3fc85-48a9-499e-8c84-070848295bc8,Fundació Hospital Universitari Vall Hebron-Institut de Recerca (VHIR),fundaci_hospital_universitari_vall_hebron_institut_de_recerca_vhir,,,,,, +4760,,62698225-db2c-4f81-a4c8-1e9bb3cd875c,Fundacio Sant Joan de Deu,fundacio_sant_joan_de_deu,,,,,, +4761,,7577b58f-4f10-4688-b19c-c25beed3c1da,Dolorgiet GmbH & Co. KG,dolorgiet_gmbh_co_kg,,,,,, +4762,,b37f295c-8809-11e6-a998-0242ac12000b,Janssen Vaccines & Prevention BV,janssen_vaccines_prevention_bv,,,,,, +4763,,52c26a8f-814f-4949-b133-48d0b9c673cb,"Medical University of Vienna, Department of Clinical Pharmacology",medical_university_of_vienna_department_of_clinical_pharmacology,,,,,, +301,0.977974,023ff627-407b-44a9-b5eb-1ea1e5f216c2,German High Grade Non-Hodgkin's Lymphoma group,german_high_grade_non_hodgkin_s_lymphoma_group,,,,023ff627-407b-44a9-b5eb-1ea1e5f216c2,german_high_grade_non_hodgkin_s_lymphoma_group,German High Grade Non-Hodgkin's Lymphoma group +4764,,35471212-880d-11e6-a998-0242ac12000b,"Bayer AG, D-51368 Leverkusen, Germany",bayer_ag_d_51368_leverkusen_germany,,,,,, +691,0.958341,23401987-1f18-4798-a823-501b1b0edbf5,Light Sciences Oncology Inc,light_sciences_oncology_inc,,,,23401987-1f18-4798-a823-501b1b0edbf5,light_sciences_oncology_inc,Light Sciences Oncology Inc +4765,,799baa77-1da0-4278-855e-81c0cfb3bf6f,"Galena Biopharma, Inc",galena_biopharma_inc,,,,,, +4766,,647ecd0f-ddbd-49eb-a89b-1bfb08f28a78,"Shire ViroPharma, Inc",shire_viropharma_inc,,,,,, +4767,,28e9beee-5518-43cf-a218-295512061b65,"Olomouc University Hospital and Palacký University School of Medicine, Internal Medicine Dept. I",olomouc_university_hospital_and_palack_university_school_of_medicine_internal_medicine_dept_i,,,,,, +529,0.94006639719009399,05387ec7-b7a5-4b59-bbbd-5029e53bbb00,"Roche Farma, S.A., que representa en España a F. Hoffmann-La Roche Ltd",roche_farma_s_a_que_representa_en_espa_a_a_f_hoffmann_la_roche_ltd,,,,05387ec7-b7a5-4b59-bbbd-5029e53bbb00,roche_farma_s_a_que_representa_en_espa_a_a_f_hoffmann_la_roche_ltd,"Roche Farma, S.A., que representa en España a F. Hoffmann-La Roche Ltd" +4768,,a982bf86-29a8-4043-96da-0a20807f6341,Institut de Terapia Regenerativa Tissular (ITRT),institut_de_terapia_regenerativa_tissular_itrt,,,,,, +4769,,2971d92f-8a50-482c-9de7-442d34a88a8a,"Cellerix, S.A",cellerix_s_a,,,,,, +4770,,ab9de24b-c47b-42a5-9071-ecbd8ccdd346,"Skåne University Hospital, Malmö",sk_ne_university_hospital_malm,,,,,, +4771,,412fd71c-b660-44df-ae27-0fe34d3038a3,Peregrine Pharmaceuticals Inc,peregrine_pharmaceuticals_inc,,,,,, +4772,,4381a977-6f00-4b5f-b67f-a9d07e31670d,Servicio Enfermedades Infecciosas,servicio_enfermedades_infecciosas,,,,,, +4773,,3a582763-eb13-4b6d-81f7-2651f880fa16,GELA(RC),gela_rc,,,,,, +4774,,bb9d7c96-eef7-4e10-9b84-608ae126a647,Harry Scheinin,harry_scheinin,,,,,, +4775,,063283ad-abb1-44d1-9a0f-d07d6b2866cf,Barcelona Macula Foundation,barcelona_macula_foundation,,,,,, +4776,,8215847f-7ec0-46e9-8e85-7d11d14bce5e,Nerviano Medical Sciences s.r.l,nerviano_medical_sciences_s_r_l,,,,,, +4777,,0a5cfb12-a7c6-11e6-94cb-5656d04fc2b5,"Dep. Anaesthesia and Intensive Care, Aarhus University Hospital",dep_anaesthesia_and_intensive_care_aarhus_university_hospital,,,,,, +4778,,d7539b54-77e0-4656-825d-bbb976924f4d,Delenex Therapeutics AG,delenex_therapeutics_ag,,,,,, +4779,,ec162c08-7151-11e6-a0cd-0242ac12000b,FRESENIUS MEDCL,fresenius_medcl,,,,,, +463,0.98401951789855957,85f43a44-7199-11e6-a0cd-0242ac12000b,ORTHO MCNEIL,ortho_mcneil,,,,2518a26c-7146-11e6-a0cd-0242ac12000b,ortho_mcneil_pharm,ORTHO MCNEIL PHARM +837,0.98498398065567017,5ebc13d0-6a14-420a-ad6f-45684baeb6fb,NHS Greater Glasgow,nhs_greater_glasgow,,,,09c00199-a473-4e2e-b6d9-ca5616af7b3d,nhs_greater_glasgow_yorkhill,"NHS Greater Glasgow, Yorkhill" +4780,,27a729eb-baf8-4714-9b82-e915766887a1,Neurologisk Afdeling Århus Universitetshospital,neurologisk_afdeling_rhus_universitetshospital,,,,,, +4781,,96114c88-95ba-4608-a46c-7154e538a078,Radboud University medical centre,radboud_university_medical_centre,,,,,, +4782,,897d8191-f600-4f88-b59c-c7e13620e0ac,Dipartimento di Scienze mediche Oncologia Medica Policlinico Gemelli,dipartimento_di_scienze_mediche_oncologia_medica_policlinico_gemelli,,,,,, +4783,,8fde9ea8-4580-42b4-9600-680e743bee8d,Axxonis Pharma AG,axxonis_pharma_ag,,,,,, +4784,,5c6d4213-8e5d-4857-af82-e3d63260b190,Plymouth Hospital NHS Trust,plymouth_hospital_nhs_trust,,,,,, +4785,,d18023df-9279-440b-960f-8e40e3709ab7,"Peter Wolf MD, Department of Dermatology, Medical University of Graz",peter_wolf_md_department_of_dermatology_medical_university_of_graz,,,,,, +4786,,8d70b4a5-1085-4428-8060-cb5576a8e91c,University Hospital Birmingham Foundation NHS Trust,university_hospital_birmingham_foundation_nhs_trust,,,,,, +4787,,04276214-0f4a-4057-9442-875f71976ac9,University Medical Centre Nijmegen,university_medical_centre_nijmegen,,,,,, +4788,,dfa88aec-7147-11e6-a0cd-0242ac12000b,LABS AF,labs_af,,,,,, +4789,,4c4fd778-27a7-4e76-a108-340de546f9e0,"Astellas Pharma US, Inc",astellas_pharma_us_inc,,,,,, +4790,,7f70d9b7-1de9-414d-8cda-86f5db0c1e89,The University of Liverpool,the_university_of_liverpool,,,,,, +4791,,6962eea1-088d-427f-853e-3847a8b3a877,"Prof. Heinz Ludwig, MD, Wilhelminenspital, First Department of Medicine and Medical Oncology",prof_heinz_ludwig_md_wilhelminenspital_first_department_of_medicine_and_medical_oncology,,,,,, +4792,,5980bae5-4c57-46b6-8cc2-7e390b74eede,Santeon,santeon,,,,,, +4793,,4a59df35-6270-489f-998e-e4e000bfcb2e,"Universität Mainz, Klinik und Poliklinik für Neurologie",universit_t_mainz_klinik_und_poliklinik_f_r_neurologie,,,,,, +4794,,aa2d4b37-0d3b-4f0f-b134-fb0d5658aa78,Hospital Clinic,hospital_clinic,,,,,, +131,0.98589164018630981,742cdcfb-349e-4dad-b5ba-f31a71a78dba,Department of Psychiatry,department_of_psychiatry,,,,1ead7ee3-0e7d-4381-a630-ec14aeb73c0e,department_of_psychiatry,Department of Psychiatry +460,0.917507,5371757a-5ffa-4a03-be27-6844161516c2,GlaxoSmithKline R&D Ltd,glaxosmithkline_r_d_ltd,,,,5371757a-5ffa-4a03-be27-6844161516c2,glaxosmithkline_r_d_ltd,GlaxoSmithKline R&D Ltd +4795,,fe36b93a-454f-4498-94f4-59f31b9a6668,EOS S.p.A,eos_s_p_a,,,,,, +4796,,c5cb1d05-7189-4a3a-bd62-73fa1fbaeebf,Hospital General Universitario de Alicante,hospital_general_universitario_de_alicante,,,,,, +522,0.97898,2bce399b-f655-4890-9a07-afe0a1f39d7f,Renovo Ltd,renovo_ltd,,,,2bce399b-f655-4890-9a07-afe0a1f39d7f,renovo_ltd,Renovo Ltd +4797,,8c1f1ee3-2fa7-4053-a51f-76197816b7fe,Crucell Holland B.V,crucell_holland_b_v,,,,,, +4798,,dc2c25e7-4de4-40fc-b825-91c2bc698686,"Alvine Pharmaceuticals, Inc",alvine_pharmaceuticals_inc,,,,,, +4799,,6234d03c-70a2-4b2e-b9b5-52bcf3b71065,Boehringer Ingelheim GmbH & Co KG,boehringer_ingelheim_gmbh_co_kg,,,,,, +4800,,11dfb2aa-a098-4683-9c5c-005f9a202c1b,OSSERVATORIO EPIDEMIOLOGICO GISEA,osservatorio_epidemiologico_gisea,,,,,, +4801,,ac848843-60ea-406a-aae2-efd8063af12d,Dr. Olaf Stanger,dr_olaf_stanger,,,,,, +4802,,6ab84500-f314-44f3-aa38-f86f0e0bfe46,Gruppo Italiano Mesotelioma (G.I.Me.),gruppo_italiano_mesotelioma_g_i_me,,,,,, +4803,,69435ce2-680a-4477-840b-60bc3aa9878c,Symphogen A/S,symphogen_a_s,,,,,, +4804,,e747e178-6fa1-11e6-9663-0242ac12000b,Imperial College London | Imperial College NHS Healthcare Trust,imperial_college_london_imperial_college_nhs_healthcare_trust,,,,,, +4805,,3c3f6b77-d9c3-4062-a1eb-171a45ce129b,Helix BioPharma Cooperation,helix_biopharma_cooperation,,,,,, +4806,,b5072c3a-d11e-4d37-b30d-a5ade153ed3a,Thessaloniki's Aristoteleio University,thessaloniki_s_aristoteleio_university,,,,,, +681,0.98368257284164429,b72b9f71-1252-40e3-8dd1-c73d396c3dd5,Aarhus University Hospital,aarhus_university_hospital,,,,e9e3f1a5-d19d-4eea-b83e-62046558fbb3,aarhus_university_hospital,Aarhus University Hospital +4807,,ac9c531f-b2f1-453a-827a-3e1808af233f,University of Münster,university_of_m_nster,,,,,, +130,0.9775693416595459,3515d8bf-edb3-4b5e-ba66-e5a15542aded,Cliniques Universitaires Saint-Luc (CUSL),cliniques_universitaires_saint_luc_cusl,,,,3515d8bf-edb3-4b5e-ba66-e5a15542aded,cliniques_universitaires_saint_luc_cusl,Cliniques Universitaires Saint-Luc (CUSL) +4808,,a184497f-e1ef-4cfa-b238-160bf168096a,Bayer Schering Pharma Oy,bayer_schering_pharma_oy,,,,,, +4809,,f4a93696-5c65-4930-806a-de8c243e32e0,Synthon BV,synthon_bv,,,,,, +176,0.98896640539169312,fbdb10c1-6146-4761-86bf-a8541dc3b4fa,Novartis Vaccines and Diagnostics,novartis_vaccines_and_diagnostics,,,,fbdb10c1-6146-4761-86bf-a8541dc3b4fa,novartis_vaccines_and_diagnostics,Novartis Vaccines and Diagnostics +4810,,44132e62-71cd-11e6-a0cd-0242ac12000b,CHAPTER 7 TRUSTEE,chapter_7_trustee,,,,,, +4811,,a8a29b13-bdf0-41e1-a1cf-1ea1285e99f6,Laboratoires SMB S.A,laboratoires_smb_s_a,,,,,, +4812,,627e8507-a386-46cf-abbb-461afa70e335,Shire Pharmaceuticals Group plc,shire_pharmaceuticals_group_plc,,,,,, +4813,,a283d7d8-4ab4-4363-a3ca-3d4ba7bce8ca,INFECTOPHARM Arzneimittel GmbH,infectopharm_arzneimittel_gmbh,,,,,, +4814,,e595c41d-0240-4df8-ad3e-45973a62f99a,Universidad de Granada,universidad_de_granada,,,,,, +4815,,11d58e68-9fad-4360-bf3e-dc72422d8ff2,"UAB ""Merck Sharp & Dohme",uab_merck_sharp_dohme,,,,,, +94,0.97429078817367554,be263a28-72c2-11e6-a0cd-0242ac12000b,JAZZ PHARMS III,jazz_pharms_iii,,,,49d3c978-7273-11e6-a0cd-0242ac12000b,jazz_pharms,JAZZ PHARMS +370,0.951764,d87e461f-d3a3-4191-b1ac-8ed84cf48ba3,HUS,hus,,,,09b4c65d-3052-471d-a9c2-a2a03f06e86f,hus_hyks_diabetesklinikka,"HUS, HYKS, Diabetesklinikka" +650,0.9659787118434906,ed893853-aaa3-4324-93a2-68212b678087,Boehringer Ingelheim AB,boehringer_ingelheim_ab,,,,2c7b1b3b-323c-4045-ae75-4712a0ece886,boehringer_ingelheim_ab,Boehringer Ingelheim AB +4816,,f22a8fc9-1e40-4251-bfb7-560d649e5dd9,Helsingin yliopisto,helsingin_yliopisto,,,,,, +616,0.93451941013336182,f8cdc923-8f9e-4a86-b916-6b3f45c65971,Shire Devlopment LLC,shire_devlopment_llc,,,,f8cdc923-8f9e-4a86-b916-6b3f45c65971,shire_development_llc,Shire Development LLC +616,0.95630460977554321,d7d749f6-69c1-495f-a78a-8b33078d988c,Shire Development LLC and International Affiliates,shire_development_llc_and_international_affiliates,,,,f8cdc923-8f9e-4a86-b916-6b3f45c65971,shire_development_llc,Shire Development LLC +4817,,4a92395b-7c55-431f-94c8-18145f4c9586,Stallergenes GmbH & Co.KG,stallergenes_gmbh_co_kg,,,,,, +4818,,3a67d994-4c48-4642-87fb-3a935945f54e,Danderyds sjukhus AB,danderyds_sjukhus_ab,,,,,, +4819,,0edfb0bd-6d3a-447f-947a-a0db2a4097f1,NEUROBIOTEC GMBH,neurobiotec_gmbh,,,,,, +4820,,f2df00cf-c676-4cf9-ade8-9e3e4f151ea4,the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AvL),the_netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital_nki_avl,,,,,, +4821,,c9d14a33-35f5-4243-b9c8-25db73f40202,Maija Kaukonen,maija_kaukonen,,,,,, +4822,,01933e0b-5a2b-4c96-bbd5-bbfa4cf6b1c9,"Dr. Angel Chamorro Sánchez. Servicio de Neurología, Hospital Clinic",dr_angel_chamorro_s_nchez_servicio_de_neurolog_a_hospital_clinic,,,,,, +83,0.96475303173065186,2e778965-4803-4c24-80eb-b2a9fc5651e6,"Medizinische Universität Wien, Universitätsklinik für Psychiatrie u. Psychotherapie, Abteil. für biologische Psychiatrie",medizinische_universit_t_wien_universit_tsklinik_f_r_psychiatrie_u_psychotherapie_abteil_f_r_biologische_psychiatrie,,,,2e778965-4803-4c24-80eb-b2a9fc5651e6,medizinische_universit_t_wien_universit_tsklinik_f_r_psychiatrie_u_psychotherapie_abteil_f_r_biologische_psychiatrie,"Medizinische Universität Wien, Universitätsklinik für Psychiatrie u. Psychotherapie, Abteil. für biologische Psychiatrie" +906,0.97884830832481384,fb29808d-7985-4804-b8d4-5620bbba60e6,Kings College London,kings_college_london,,,,fb29808d-7985-4804-b8d4-5620bbba60e6,kings_college_london_iop,Kings College London (IOP) +4823,,20bcb230-c694-41a3-ac33-78545595d713,S.A. Odyssea Pharma,s_a_odyssea_pharma,,,,,, +4824,,527dd166-cec2-489c-881b-b29aa4c7ac71,Cardiologia - Azienda Ospedaliero Universitaria di Modena,cardiologia_azienda_ospedaliero_universitaria_di_modena,,,,,, +868,0.98796150088310242,a13c1e76-68ce-41b8-ba66-e40e0db78efa,Astellas Pharma Global Development,astellas_pharma_global_development,,,,d75f8fe0-80ce-4bb5-9e6e-ab63e91189dc,astellas_pharma_global_development_inc,"Astellas Pharma Global Development, Inc" +4825,,210f3969-30f8-48dc-8d07-63d7556837a2,"Unilfarma, Lda",unilfarma_lda,,,,,, +4826,,0f710c5e-a355-48ba-bd7a-f295d07dc9bc,Azienda ULSS 12 veneziana,azienda_ulss_12_veneziana,,,,,, +412,0.98863863945007324,c392f440-194a-4970-99e9-218fccd3765c,"Karolinska University Hospital, Huddinge",karolinska_university_hospital_huddinge,,,,404bfbb4-d805-4edf-b568-5d60418c0c9b,karolinska_university_hospital_huddinge_sweden,"Karolinska University Hospital, Huddinge, Sweden" +4827,,80eda9ea-052e-471b-a896-6a98fd93875c,Organon Nederland BV,organon_nederland_bv,,,,,, +4828,,5b51c94b-a4d7-4aff-9161-0081b82b2763,St. Lucas Andreas Hospital,st_lucas_andreas_hospital,,,,,, +4829,,c4fd4744-0267-46d2-b729-f6c6a09670d6,universiteit Maastricht,universiteit_maastricht,,,,,, +4830,,f8e5f83d-a022-4c0b-a3fc-be1ad9b7ac66,European Lung Cancer Working Party,european_lung_cancer_working_party,,,,,, +630,0.953662,541c00fc-7166-11e6-a0cd-0242ac12000b,HETERO LABS LTD V,hetero_labs_ltd_v,,,,0390bcaa-7142-11e6-a0cd-0242ac12000b,hetero_labs_ltd_iii,HETERO LABS LTD III +4831,,036b72ea-718f-11e6-a0cd-0242ac12000b,UNITED THERAP,united_therap,,,,,, +4832,,09aee10b-a94d-430b-92f0-6503f4032729,Metabolism and Nutrition Group of the SEMICYUC,metabolism_and_nutrition_group_of_the_semicyuc,,,,,, +4833,,270900b0-7143-11e6-a0cd-0242ac12000b,STERI PHARMA,steri_pharma,,,,,, +841,0.95600730180740356,722b5f6e-362a-4c38-b731-55a9124a902d,JANSSEN-CILAG INTERNATIONAL N.V,janssen_cilag_international_n_v,,,,640d2f05-d82c-4fcf-8cf1-823f7c525359,janssen_cilag_international_bv,JANSSEN-CILAG INTERNATIONAL BV +4834,,f062afd3-b030-4d9f-af7e-fc47cdaad689,NHS Tayside,nhs_tayside,,,,,, +4835,,bbd397d1-902a-4bff-a063-b16ed3064c3b,King's College Hospital,king_s_college_hospital,,,,,, +4836,,dd4c68cc-1a5b-4357-9ead-56404b19f6aa,Institut für Atemwegsforschung GmbH,institut_f_r_atemwegsforschung_gmbh,,,,,, +4837,,89de19f7-0150-4fb5-923c-c8506ddc8956,Oncology Department,oncology_department,,,,,, +4838,,053fa23a-7167-11e6-a0cd-0242ac12000b,JUBILANT HOLLISTRSTR,jubilant_hollistrstr,,,,,, +4839,,927e5757-2bf8-4fd4-bd38-7881576075a9,"SCHWARZ BIOSCIENCES, GmbH, A Member of the UCB Group of Companies",schwarz_biosciences_gmbh_a_member_of_the_ucb_group_of_companies,,,,,, +4840,,187a8d58-7db7-4cbc-9970-b08499bd3758,Lallemand Pharma International AG,lallemand_pharma_international_ag,,,,,, +379,0.95514367024103797,ddb585ca-eb58-4665-9786-d17d427cf5e4,Merck Sharp & Dohm Corp,merck_sharp_dohm_corp,,,,b80f486c-a6f1-447b-bad6-34ea6d49fec0,merck_sharp_dohm_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as the SPONSOR or Merck)" +4841,,39837694-715c-11e6-a0cd-0242ac12000b,NORTEC DEV ASSOC,nortec_dev_assoc,,,,,, +343,0.945615,df233af1-76b7-4839-86bc-252076367896,Institut Gustav Roussy,institut_gustav_roussy,,,,df233af1-76b7-4839-86bc-252076367896,institut_gustav_roussy,Institut Gustav Roussy +4842,,e7abc0eb-0f22-41f8-9940-c3db083a4c12,Gilead Sciences International Ltd,gilead_sciences_international_ltd,,,,,, +4843,,bcc41730-74b0-4c00-9e1c-6d053fbc77c3,Fundación Penta,fundaci_n_penta,,,,,, +4844,,a0282e7a-71e9-11e6-a0cd-0242ac12000b,ACORDA,acorda,,,,,, +4845,,fceeecd0-1c03-47b3-9d71-8eec2c37d0eb,Celgene International II Sàrl (CIS II),celgene_international_ii_s_rl_cis_ii,,,,,, +4846,,de6a9a67-0e15-458c-9b39-e47b278e515e,U.O. Terapia Intensiva,u_o_terapia_intensiva,,,,,, +4847,,c8194b0b-d077-4ec6-bae6-5e27ea8ba8c4,OYS,oys,,,,,, +4848,,e0c49aa3-3cff-450a-af8b-f0bd38d632e9,Fondazione Mediolanum Onlus,fondazione_mediolanum_onlus,,,,,, +4849,,0abfc084-7a11-449c-a64f-b1853580307b,"Dept of medical sciences, Rheumatology",dept_of_medical_sciences_rheumatology,,,,,, +4850,,626703e9-8df3-408e-9d69-cf7f8d9a62cc,Janssen Infectious Dieseases-Diagnostic BVBA,janssen_infectious_dieseases_diagnostic_bvba,,,,,, +360,0.986646,974a5c1d-8651-4bb8-8b78-cce4a6850f9c,Academisch Medisch Centrum Amsterdam,academisch_medisch_centrum_amsterdam,,,,3f73d507-49f7-4bba-847d-11619261c4ae,academisch_medisch_centrum,Academisch Medisch Centrum +4851,,bed28358-73f5-11e6-a0cd-0242ac12000b,KYTHERA BIOPHARMS,kythera_biopharms,,,,,, +4852,,b108da94-5691-44ed-b88e-8094c87cb4ac,Vibeke Hjortdal,vibeke_hjortdal,,,,,, +4853,,16e7bc24-64f2-45c0-b03d-97a9bb5fc879,Mental Health Services North Holland North,mental_health_services_north_holland_north,,,,,, +4854,,07fe1a3b-7b6f-4eaf-8427-fc877d0045b1,Kedrion S.P.A,kedrion_s_p_a,,,,,, +4855,,8670d633-6785-445d-bd58-cfb5cbcb9962,CPS Research,cps_research,,,,,, +4856,,d15708c3-de0c-474c-bf5c-96f739dd3aa2,"Wyeth Research, Clinical Research and Development, Division of Wyeth Pharmaceuticals Inc",wyeth_research_clinical_research_and_development_division_of_wyeth_pharmaceuticals_inc,,,,,, +4857,,401a3804-9603-490b-a95c-ce592463d6c1,Starpharma Pty Ltd,starpharma_pty_ltd,,,,,, +4858,,07327823-7afc-43f5-a0ab-79082c3020f6,APRO,apro,,,,,, +23,0.98531901836395264,32433559-55be-43ec-8a0d-06197533759d,University Hospitals Leuven (Gasthuisberg),university_hospitals_leuven_gasthuisberg,,,,32433559-55be-43ec-8a0d-06197533759d,university_hospitals_leuven_gasthuisberg,University Hospitals Leuven (Gasthuisberg) +4859,,9a986912-eedc-4a3f-849b-3c81fdb862b3,"Medical University of Graz, Department of Internal Medicine, Division of Gastroenterology and Hepatology",medical_university_of_graz_department_of_internal_medicine_division_of_gastroenterology_and_hepatology,,,,,, +4860,,de12a35c-459e-4f22-a954-01f9ae63e368,Frederiksberg University Hospital,frederiksberg_university_hospital,,,,,, +4861,,56fabebe-bd11-417a-b38d-9194672ccfef,UCB Celletech,ucb_celletech,,,,,, +4862,,5418b417-3b5a-411e-ab64-ecded957a64a,U.O.PNEUMOLOGIA- AZ. USL1 DI MASSA E CARRARA,u_o_pneumologia_az_usl1_di_massa_e_carrara,,,,,, +4863,,4121bae3-1ea0-4da5-825d-d0d20ab4995c,DIMETHAID AG,dimethaid_ag,,,,,, +4864,,319b3b56-2ce2-4f03-a44e-0db031b04164,D.A.S.T. BIOTECH PHARM Ε.Π.Ε,d_a_s_t_biotech_pharm,,,,,, +4865,,ef6a3c4c-6ccc-4266-be98-771796f0c2ed,CHU de DIJON - Délégation à la recherche clinique et à l’innovation,chu_de_dijon_d_l_gation_la_recherche_clinique_et_l_innovation,,,,,, +4866,,ae8be576-fbeb-49a3-b26d-0d264bb868ba,Fundación para la Investigación Biomédica del Hospital Ramón y Cajal,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_ram_n_y_cajal,,,,,, +847,0.970712,2cd6ae2e-14d4-42b4-bac7-96f94b86a23b,Janssen-Cilag Medical Affaires EMEA,janssen_cilag_medical_affaires_emea,,,,2cd6ae2e-14d4-42b4-bac7-96f94b86a23b,janssen_cilag_medical_affaires_emea,Janssen-Cilag Medical Affaires EMEA +530,0.961626,db7a3a24-3df1-4803-a508-28b7e9f72da7,Erasmus University Medical Centre Rotterdam,erasmus_university_medical_centre_rotterdam,,,,72fda02d-b614-4eda-a1b0-e9c6c71f8251,erasmus_university_medical_center,Erasmus University Medical Center +4867,,14edc59e-9be0-40d4-a96d-041c0ab9b478,Mario Negri Institute,mario_negri_institute,,,,,, +4868,,89ee3c63-4e09-4b24-8f28-c75d46a14efe,"Receptos, Inc",receptos_inc,,,,,, +4869,,3f76e1d0-3617-4677-9cf9-fd12b80f940e,Hungarian Kidney Foundation,hungarian_kidney_foundation,,,,,, +983,0.945615,8aec01c9-3cd9-4738-baef-0201bdb56c7b,St Stephen's Aids Trust,st_stephen_s_aids_trust,,,,59c0ebeb-5f3a-4456-89ec-4ec59bcd4670,st_stephens_aids_trust,St Stephens Aids Trust +469,0.985292,76a393da-5b46-4f29-a7e7-a31575f47074,OSPEDALE S. RAFFAELE DI MILANO,ospedale_s_raffaele_di_milano,,,,55158cf1-cd99-4f28-8043-743b9a161005,ospedale_s_raffaele,OSPEDALE S. RAFFAELE +4870,,36efb71f-f052-4669-ac29-e36a68ba0a0d,WKZ / UMC Utrecht,wkz_umc_utrecht,,,,,, +4871,,f28855cb-d949-44f5-8cdb-8d84d1d4ae7f,MMerck KGaA,mmerck_kgaa,,,,,, +1024,0.902645,2c174554-737a-4729-99f3-4cc6843b2b31,Celtic Pharma Development Services Bermuda Limited,celtic_pharma_development_services_bermuda_limited,,,,2c174554-737a-4729-99f3-4cc6843b2b31,celtic_pharma_development_services_bermuda_limited,Celtic Pharma Development Services Bermuda Limited +4872,,7bfce2b4-bb61-43dd-913b-c52e6e575b85,"Dr. Albert Lecube, Ph.D., M.D",dr_albert_lecube_ph_d_m_d,,,,,, +154,0.927976,1bb3b634-770c-4449-a84e-96c6eb88fe69,Solvay Pharmaceutical GmbH,solvay_pharmaceutical_gmbh,,,,1bb3b634-770c-4449-a84e-96c6eb88fe69,solvay_pharmaceutical_gmbh,Solvay Pharmaceutical GmbH +296,0.983343,6cdcb5b5-13ca-4bc2-becd-834515b92e8e,iOMEDICO AG,iomedico_ag,,,,6cdcb5b5-13ca-4bc2-becd-834515b92e8e,iomedico_ag,iOMEDICO AG +4873,,e64028f6-db66-460b-a6c8-2fe041503736,Alkermes Inc,alkermes_inc,,,,,, +4874,,86b52e9b-0db2-4a91-bfe0-18fda2f1e603,"Kuopio University Hospital, Clinic of Internal Medicine/Center of Medicine",kuopio_university_hospital_clinic_of_internal_medicine_center_of_medicine,,,,,, +4875,,1a1428cb-2164-4814-9445-22e9beaea5ec,"Servier Slovensko, spol. s.r.o",servier_slovensko_spol_s_r_o,,,,,, +4876,,6c9935de-9c35-44f1-8554-80ce2085dd6d,Jessaziekenhuis Hasselt,jessaziekenhuis_hasselt,,,,,, +4877,,f5598b18-8bbc-11e6-a449-0242ac12000b,NBMI Science AB,nbmi_science_ab,,,,,, +4878,,86db37fd-7edb-4405-a5fe-c6505098683a,Hospital Universitario de Bellvitge,hospital_universitario_de_bellvitge,,,,,, +4879,,c9db2bfb-cef8-4f20-89b8-233b1a65c8f3,"Department of Clinical Sciences, Danderyd Hospital",department_of_clinical_sciences_danderyd_hospital,,,,,, +413,0.98836642503738403,4a616e09-39b2-4537-bceb-96327b70319b,Karolinska University Hospital,karolinska_university_hospital,,,,4a616e09-39b2-4537-bceb-96327b70319b,karolinska_university_hospital,Karolinska University Hospital +4880,,773346f7-2818-45b1-873f-cf3cbe745379,AZIENDA OSPEDALIERA UMBERTO I,azienda_ospedaliera_umberto_i,,,,,, +4881,,4283f243-275a-4d00-99df-a1a9d668bc13,Grupo Español de Tratamiento de Tumores Urológicos (SOGUG),grupo_espa_ol_de_tratamiento_de_tumores_urol_gicos_sogug,,,,,, +731,0.98280638456344604,32b95fda-7aef-4157-8c46-ef6f2c37677c,Bristol-Myers Squibb International Corporation,bristol_myers_squibb_international_corporation,,,,55b1cd8b-93b6-4262-9f20-ab35fbdc2476,bristol_myers_squibb_international_corporation,Bristol-Myers Squibb International Corporation +4882,,70ae5800-7161-11e6-a0cd-0242ac12000b,SPECTRUM PHARMS,spectrum_pharms,,,,,, +4883,,0c3c87d3-753a-4edc-9448-2ca33416e5de,Aventis Pharmaceuticals Inc,aventis_pharmaceuticals_inc,,,,,, +4884,,737e57c0-5ded-49c2-a04a-44b5114fcd65,ANA M,ana_m,,,,,, +4885,,7bea2c90-4756-48ea-8394-dd44b6450a06,"UNIVERSITAT MAGDEBURG, MEDIZINISCHE FAKULTAT",universitat_magdeburg_medizinische_fakultat,,,,,, +711,0.98289656639099121,e90b85cd-96f6-48a3-b6b2-c2d62c8345d9,Reckitt Benckiser,reckitt_benckiser,,,,76c0c0d6-9f7c-4fde-bea7-4dd56b4a4546,reckitt_benckiser_uk_limited,Reckitt Benckiser (UK) Limited +4886,,6a546f82-1beb-40b2-a252-8109da4e2cfd,Dr. Falk Pharma GmbH,dr_falk_pharma_gmbh,,,,,, +4887,,0eafade6-7235-11e6-a0cd-0242ac12000b,VEROSCIENCE,veroscience,,,,,, +4888,,60a6ec7b-4f75-426c-a967-13ddc28dabf0,Department of Internal Medicine of the University of Munich,department_of_internal_medicine_of_the_university_of_munich,,,,,, +4889,,47d30b56-50ad-4e68-92e5-0f2ba0bbeb91,Pia Österlund and Helena Isoniemi,pia_sterlund_and_helena_isoniemi,,,,,, +4890,,a354f5e4-80e1-4edb-8b7a-7041c783a02c,Anne Ristikankare,anne_ristikankare,,,,,, +4891,,1bf42ae8-ade3-4ea8-97c2-518358b671b5,Glycotope GmbH,glycotope_gmbh,,,,,, +62,0.98770728707313538,8e5a8528-8808-11e6-a998-0242ac12000b,"Talecris Biotherapeutics, Inc",talecris_biotherapeutics_inc,,,,8776dd79-3ee8-4ef0-a9ce-fb6aef833e21,talecris_biotherapeutics_inc,"Talecris Biotherapeutics, Inc" +4892,,84a847d0-2b98-46a9-83b0-1ce03b978629,Unidad de Gestión Clínica de Endocrinología y Nutrición,unidad_de_gesti_n_cl_nica_de_endocrinolog_a_y_nutrici_n,,,,,, +619,0.972198,6c1607c0-6c35-4de7-98be-f53af3f83989,Department of Urology,department_of_urology,,,,4c2e1783-76a6-4110-ab48-f807ec4d7f82,department_of_urology_and_pediatric_urology_justus_liebig_university_giessen,Department of Urology and Pediatric Urology - Justus-Liebig-University Giessen +4893,,dacd9ae4-a0f6-42d4-8bfe-d10a92bf8fd4,Marcelo L. Berthier Torres,marcelo_l_berthier_torres,,,,,, +460,0.917507,ba72e80d-4cab-4cfe-9590-92be512b7cb4,GlaxoSmithKline R&D Limited,glaxosmithkline_r_d_limited,,,,5371757a-5ffa-4a03-be27-6844161516c2,glaxosmithkline_r_d_ltd,GlaxoSmithKline R&D Ltd +4894,,3ac6ec66-8bce-11e6-a449-0242ac12000b,PHF SA,phf_sa,,,,,, +15,0.946972,589ff7a7-30e3-4063-a4c0-177e212878a0,AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA,azienda_ospedaliera_istituti_ospitalieri_di_verona,,,,4becd0cc-b39a-41ea-8a3e-45c64348e698,azienda_ospedaliera_istituti_ospitalieri_di_cremona,AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI CREMONA +4895,,3762da32-0817-43dc-ab64-f69cb72b24f4,Central Manchester University Hospitals Foundation Trust,central_manchester_university_hospitals_foundation_trust,,,,,, +4896,,901e13bc-6c20-457d-81da-8854954c6f9f,Genera Research Ltd,genera_research_ltd,,,,,, +4897,,0a4928f2-6852-4313-8c3e-6bde65e5c828,Austrian Forum against Cancer,austrian_forum_against_cancer,,,,,, +4898,,0edb952d-612e-4801-9faf-2ef111f99bc9,SANOFI-AVENTIS S.P.A,sanofi_aventis_s_p_a,,,,,, +4899,,67baf632-269b-4aa5-b025-b7ffabd5decb,PENTA Foundation (Fondazione Penta Onlus),penta_foundation_fondazione_penta_onlus,,,,,, +4900,,0cd1829b-08d0-4cc0-90f3-c8446f6601dc,Royal Surrey County Hospital NHS Trust,royal_surrey_county_hospital_nhs_trust,,,,,, +4901,,f84fa875-39e7-4e6c-a96e-c3b65c792506,Immunocore Limited,immunocore_limited,,,,,, +744,0.97502317031224572,b5021803-6477-4392-9737-42b9679fe2de,Johann Wolfgang Goethe-University,johann_wolfgang_goethe_university,,,,7c93ba08-6123-42f2-a902-d13e42cdd905,johann_wolfgang_goethe_universit_t_frankfurt,Johann Wolfgang Goethe-Universität Frankfurt +4902,,089d246a-f39c-4366-865f-000275f19904,Dr. Kade Pharmazeutische Fabrik GmbH,dr_kade_pharmazeutische_fabrik_gmbh,,,,,, +4903,,1fa88af7-fc6b-4213-83e4-97b03e34e3c6,Atopix Therapeutics Ltd,atopix_therapeutics_ltd,,,,,, +4904,,5db19cf3-e91d-4a12-a088-6b1fb66c2fd9,"Medizinische Universität Wien, Univ.Klinik für Chirurgie, Abt.für Allgemeinchirurgie",medizinische_universit_t_wien_univ_klinik_f_r_chirurgie_abt_f_r_allgemeinchirurgie,,,,,, +4905,,90023b35-6ad4-4bac-9152-ba63929ae039,HOSPICES CIVILS DELYON,hospices_civils_delyon,,,,,, +4906,,08b5cc5c-137a-4e25-a65b-9772aacec991,Pergamum AB,pergamum_ab,,,,,, +4907,,0d8b1b8b-fcb2-4368-aedf-cd2d3e07996e,EctoPharma Limited,ectopharma_limited,,,,,, +4908,,0e0f5b82-7142-11e6-a0cd-0242ac12000b,CITRUSPHRMA,citrusphrma,,,,,, +95,0.977549,54a10183-297d-43b4-8cb3-8ad19beec3c5,Artu Biologicals Europe B.V,artu_biologicals_europe_b_v,,,,54a10183-297d-43b4-8cb3-8ad19beec3c5,artu_biologicals_europe_b_v,Artu Biologicals Europe B.V +4909,,10580f72-4f43-4e19-b26c-f855bd3fa3fe,University of Wales Swansea,university_of_wales_swansea,,,,,, +4910,,c4f78c4f-23e2-4033-bb44-9b8bdb4c5ed9,Roche (Hellas) S.A,roche_hellas_s_a,,,,,, +4911,,8d448640-715e-11e6-a0cd-0242ac12000b,MIZA PHARMS USA,miza_pharms_usa,,,,,, +4912,,04e37c02-7190-11e6-a0cd-0242ac12000b,TEVA RESPIRATORY LLC,teva_respiratory_llc,,,,,, +4913,,bb5eddc3-2b1e-4867-98c4-be7ab666ee87,"Fast Forward Pharmaceuticals, B.V",fast_forward_pharmaceuticals_b_v,,,,,, +4914,,3c53f4a0-25b3-4d6e-ba17-cb76c7323a05,3M Health Care Limited,3m_health_care_limited,,,,,, +4915,,912134bb-7efd-405f-a8d5-666365cebeb9,Evangelisches Krankenhaus Lutherhaus gGmbH,evangelisches_krankenhaus_lutherhaus_ggmbh,,,,,, +4916,,8ff1c187-212e-4abf-9355-a2fcd8f98602,Fundacion Marques de Valdecilla,fundacion_marques_de_valdecilla,,,,,, +4917,,7ee61065-9564-4811-be23-5f569e7d1ac2,Vicente Soriano-Hospital Carlos III. Madrid,vicente_soriano_hospital_carlos_iii_madrid,,,,,, +4918,,51f72aba-d14e-428a-b4a7-9b21d1cce499,Andrés Poveda,andr_s_poveda,,,,,, +4919,,8514b254-da81-455c-95f5-682357b724bd,Goethe Universität Frankfurt,goethe_universit_t_frankfurt,,,,,, +4920,,9c90d9d5-41b1-4b5e-9831-8dc770a1d7fe,LABORATOIRE TOP PHARM,laboratoire_top_pharm,,,,,, +622,0.984184,9262c2fe-71a9-11e6-a0cd-0242ac12000b,EMD SERONO,emd_serono,,,,9262c2fe-71a9-11e6-a0cd-0242ac12000b,emd_serono,EMD SERONO +4921,,6f2ecd7f-fd12-4f1a-b745-e7c810241d20,S.A. Alcon-Couvreur N.V,s_a_alcon_couvreur_n_v,,,,,, +4922,,d62bf9eb-d021-437e-824a-218869493881,Fundació Institut Mar d'investigacions Mediques,fundaci_institut_mar_d_investigacions_mediques,,,,,, +766,0.979934,8a4b641c-5fe6-4b6b-a131-423b64e7cd1b,Sussex NHS Research Consortium,sussex_nhs_research_consortium,,,,8a4b641c-5fe6-4b6b-a131-423b64e7cd1b,sussex_nhs_research_consortium,Sussex NHS Research Consortium +4923,,788e95ae-a6eb-4d0d-a9cc-c720aeb75eb3,Universitätsklinikum des Saarlandes,universit_tsklinikum_des_saarlandes,,,,,, +4924,,a2b5dfac-ce83-4e25-a247-bcb6cd628b9d,Janssen-Cilag A/S,janssen_cilag_a_s,,,,,, +4925,,d44fb393-1311-4136-aaa2-f5f7a11b4777,"Rainer Rupprecht, Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum",rainer_rupprecht_klinik_und_poliklinik_f_r_psychiatrie_und_psychotherapie_der_universit_t_regensburg_am_bezirksklinikum,,,,,, +4926,,27e6ee28-7168-11e6-a0cd-0242ac12000b,CRANE PHARMS LLC,crane_pharms_llc,,,,,, +4927,,b21ec16a-cec3-4072-964b-9a5910a962fe,Biomedizinische Forschungsgesellschaft m.b.H,biomedizinische_forschungsgesellschaft_m_b_h,,,,,, +4928,,e519406d-5cf3-460f-8535-0c2facc6183e,University of Jena,university_of_jena,,,,,, +4929,,056a68c6-715d-11e6-a0cd-0242ac12000b,STRIDES INC,strides_inc,,,,,, +4930,,8c5e7ced-9459-4fb8-9cfc-96aad5dc57a4,"Military Medical Academy Hospital for Active Treatment, Sofia",military_medical_academy_hospital_for_active_treatment_sofia,,,,,, +4931,,b2ab1af5-b75c-4fb8-a7c0-9a7764b33dfa,XCell-Center GmbH,xcell_center_gmbh,,,,,, +4932,,c0fa24d0-bfb7-4299-9e45-643086575b38,Fundación General Universidad Autónoma de Madrid,fundaci_n_general_universidad_aut_noma_de_madrid,,,,,, +4933,,88734d54-4bf7-4b85-8890-61e4c6acea41,Marinomed Biotechnologie GmbH,marinomed_biotechnologie_gmbh,,,,,, +4934,,8ff5172d-1f27-434a-8546-dca7da5762c1,"Hospital General Universitario Alicante, Dpto Farmacologia Clinica",hospital_general_universitario_alicante_dpto_farmacologia_clinica,,,,,, +4935,,758df9e7-2422-4c07-831b-b380c64feeb5,GPC Biotech AG,gpc_biotech_ag,,,,,, +4936,,89858960-7764-42dc-b71b-717ee1f14ac6,Fundación FISEVI,fundaci_n_fisevi,,,,,, +4937,,0123ee94-93cd-4628-8ebc-23da6f23b5cf,"Medizinische Universität Graz, Univ. Klinik für Dermatologie",medizinische_universit_t_graz_univ_klinik_f_r_dermatologie,,,,,, +4938,,cb458639-ffb8-4c3c-ac58-d6071f620bb1,Generics [UK] Ltd trading as Merck Generics,generics_uk_ltd_trading_as_merck_generics,,,,,, +4939,,0c53f778-51b3-4187-9d94-1e1fc0f8ed47,South Devon Health Care NHS Foundation Trust,south_devon_health_care_nhs_foundation_trust,,,,,, +4940,,5a403538-3034-4fb7-a092-60c6c1733d2b,Deutsche Krebsgesellschaft Sponsor GmbH,deutsche_krebsgesellschaft_sponsor_gmbh,,,,,, +4941,,f4dd5654-aaf6-4066-95a5-0be792282a2b,HEXAL AG (a Sandoz company),hexal_ag_a_sandoz_company,,,,,, +4942,,c8b1fafa-8bcb-11e6-a449-0242ac12000b,Werkgroep Cardiologische centra Nederland,werkgroep_cardiologische_centra_nederland,,,,,, +4943,,f3dc2851-8bc5-4fa3-8825-a8cf16ad4f76,Dep. of Medical Cell Biology Uppsala University,dep_of_medical_cell_biology_uppsala_university,,,,,, +4944,,86b5a63e-893b-49ef-8da9-fcc73f60f69d,Proximagen Limited,proximagen_limited,,,,,, +4945,,782cb034-dc39-41ff-9d91-ea1c9778d688,"Medizinische Universität Wien, UniKlinik für Klinische Pharmakologie",medizinische_universit_t_wien_uniklinik_f_r_klinische_pharmakologie,,,,,, +4946,,1a42ee09-91a2-4ea6-b200-58bd9cb2a215,Roskilde Hospital,roskilde_hospital,,,,,, +528,0.97553372383117676,0df36129-756b-443b-b038-466e73715fa6,"Roche Farma S.A en nombre de Genentech, Inc",roche_farma_s_a_en_nombre_de_genentech_inc,,,,0df36129-756b-443b-b038-466e73715fa6,roche_farma_s_a_en_nombre_de_genentech_inc,"Roche Farma S.A en nombre de Genentech, Inc" +941,0.95605242252349854,64f0df3e-982c-439f-87f4-bc34795b8f53,UCL Mont Godinne,ucl_mont_godinne,,,,215afd5f-229c-4506-bcca-821996e7d1cf,ucl,UCL +4947,,f01052ee-e919-4640-9263-0e287a2ccdbc,"The Sahlgrenska Academy, University of Gothenburg",the_sahlgrenska_academy_university_of_gothenburg,,,,,, +4948,,3dc3bffc-8ec5-4ce6-9c8c-583dc74b715a,Biota Scientific Management Pty Ltd,biota_scientific_management_pty_ltd,,,,,, +4949,,a935e55e-be0e-40d6-a84b-6d0e74a97880,sanofi-aventis recherche & development,sanofi_aventis_recherche_development,,,,,, +684,0.98852276802062988,8e580d74-355f-4c96-963e-5f3654629ce9,University Medical Center Groningen,university_medical_center_groningen,,,,07e5285a-7e7c-4b06-8e27-29dfa99a2153,university_medical_center_groningen_umcg,University Medical Center Groningen (UMCG) +165,0.985075,7ae84fa4-715e-11e6-a0cd-0242ac12000b,MISSION PHARMA,mission_pharma,,,,1e5b75f8-7164-11e6-a0cd-0242ac12000b,mission_pharmacal_co,MISSION PHARMACAL CO +4950,,fc3966b5-5b7b-40b1-8e40-3531b4e08b4a,IRCCS FONDAZIONE ISTITUTO NEUROLOGICO C. MONDINO,irccs_fondazione_istituto_neurologico_c_mondino,,,,,, +168,0.98042827844619751,248e9396-0a3f-4ee2-b65a-5844a00bc75e,Merck Serono SA - Geneva,merck_serono_sa_geneva,,,,248e9396-0a3f-4ee2-b65a-5844a00bc75e,merck_serono_sa_geneva,Merck Serono SA - Geneva +856,0.98108509182929993,8cb8aab4-4b60-42b8-a495-ddeb6c44ddc3,Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL),netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital_nki_avl,,,,66b401ea-5009-4db7-8b18-6fe29a2c6186,netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital,Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL) +4951,,32722523-594b-43b8-983b-45c7c6152593,Incyte Corporation,incyte_corporation,,,,,, +4952,,b3c53e60-7350-11e6-a0cd-0242ac12000b,KOWA CO,kowa_co,,,,,, +4953,,20b1cc22-b60f-4877-999d-8aa57ad6ebc1,Dra. Carmen Gómez Vaquero (Servicio de Reumatología del Hospital Universiari de Bellvitge - Idibell),dra_carmen_g_mez_vaquero_servicio_de_reumatolog_a_del_hospital_universiari_de_bellvitge_idibell,,,,,, +4954,,7ad7b83a-c805-439e-8c2d-745ef606c438,Stockholms Läns Sjukvårdsområde (SLSO),stockholms_l_ns_sjukv_rdsomr_de_slso,,,,,, +4955,,116d93e0-8b35-47b4-8f56-b8b8312cc5d9,Radboud University,radboud_university,,,,,, +4956,,a3e9c038-6845-44df-8fa9-9e1429fb216a,"IFSgGmbH, Institute for clinical research",ifsggmbh_institute_for_clinical_research,,,,,, +4957,,20184258-b473-4c2e-a603-3f67d7e84888,Activartis Biotech GmbH,activartis_biotech_gmbh,,,,,, +4958,,424d4d41-2da5-416d-9902-9879037bd71e,Bente Lomholt Langdahl,bente_lomholt_langdahl,,,,,, +4959,,b22eb854-8bbc-11e6-a449-0242ac12000b,Betagenon AB,betagenon_ab,,,,,, +4960,,c1c995c3-1134-40ae-a353-0c22790df4c2,Centre Jean Perrin,centre_jean_perrin,,,,,, +4961,,ebd152f6-7140-11e6-a0cd-0242ac12000b,NESHER PHARMS,nesher_pharms,,,,,, +4962,,c3d8f851-83f8-4e96-ba81-059424801cf8,Medizinische Fakultaet der Technischen Universitaet Muenchen,medizinische_fakultaet_der_technischen_universitaet_muenchen,,,,,, +4963,,281cddb2-7168-11e6-a0cd-0242ac12000b,SAVIOR LIFETEC CORP,savior_lifetec_corp,,,,,, +4964,,fe0c7a83-341d-4d5d-a2c5-144fb9a857db,PharmaNeuroBoost N.V. (PNB),pharmaneuroboost_n_v_pnb,,,,,, +486,0.98180347681045532,f662f787-fab7-4f94-97a0-1a3b3bc462fc,Sahlgrenska Universitetssjukhus,sahlgrenska_universitetssjukhus,,,,e6237908-6daa-4272-adad-f5434c004df0,sahlgrenska_universitetssjukhuset,Sahlgrenska Universitetssjukhus +374,0.9175071120262146,a5b2a4d0-a874-4eed-875f-af0923d49ff3,Merck Sharp & Dohme Ltd,merck_sharp_dohme_ltd,,,,98ef0b13-ac5f-4431-8738-f853fbd0d57c,merck_sharp_dohme_limited,Merck Sharp & Dohme Limited +4965,,74c1cf75-d3d3-440c-abc8-19e26fbec6c8,BELFAST HEALTH & SOCIAL CARE TRUST - BELFAST CITY HOSPITAL,belfast_health_social_care_trust_belfast_city_hospital,,,,,, +454,0.987768,d54ee838-0793-4a08-8231-4d0111043fe5,Hôpital Universitaire Des Enfants Reine Fabiola,h_pital_universitaire_des_enfants_reine_fabiola,,,,c6a06456-3663-448c-8c5d-27a447b6849a,h_pital_universitaire_des_enfants_reine_fabiola_h_u_d_e_r_f,Hôpital Universitaire Des Enfants Reine Fabiola (H.U.D.E.R.F.) +4966,,09ebeb9b-c0ee-402b-a60a-7834bd87ca29,LAB Pharma Ltd,lab_pharma_ltd,,,,,, +1023,0.962602,873cee39-8b99-4c6d-a602-07fd49d9627b,"Dept. of Intensive Care 4131, Copenhagen University Hospital, Rigshospitalet",dept_of_intensive_care_4131_copenhagen_university_hospital_rigshospitalet,,,,3d6896c7-f9eb-43cb-9c4d-49b6ab960bde,dept_of_intensive_care_copenhagen_university_hospital_rigshospitalet,"Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet" +4967,,9716b993-36fd-4dc6-8c04-577b31bb54f4,"Medizinische Universität Wien, Klinik für Innere Medizin I, Abt. Onkologie",medizinische_universit_t_wien_klinik_f_r_innere_medizin_i_abt_onkologie,,,,,, +4968,,ac1c6e0c-36ac-4960-939b-2e6f819fd43b,Klinikum Leverkusen gGmbH,klinikum_leverkusen_ggmbh,,,,,, +4969,,e08b437b-dfa0-4978-bc67-ffad559f059d,"Institute of Anaesthesiology, German Heart Centre",institute_of_anaesthesiology_german_heart_centre,,,,,, +200,0.97189050912857056,fe1d891c-caab-44f5-bedc-82af0ec75615,"National Institute for Public Health and the Environment (RIVM, Netherlands)",national_institute_for_public_health_and_the_environment_rivm_netherlands,,,,ce046c53-60a5-4a54-bb94-914d5bc33caa,national_institute_for_public_health_and_the_environment_rivm_the_netherlands,"National Institute for Public Health and the Environment (RIVM, the Netherlands)" +4970,,e94c9911-9c9b-46cd-9b48-dc512bd5360f,The Cardiothoracic Centre Liverpool NHS Trust,the_cardiothoracic_centre_liverpool_nhs_trust,,,,,, +681,0.98050621151924133,e9e3f1a5-d19d-4eea-b83e-62046558fbb3,"Aarhus University Hospital, Department of Cardiology",aarhus_university_hospital_department_of_cardiology,,,,e9e3f1a5-d19d-4eea-b83e-62046558fbb3,aarhus_university_hospital,Aarhus University Hospital +4971,,16f0b570-62a8-4e5b-b277-d5692e61267b,Central Manchester and Manchester University Children's Hospital NHS Trust,central_manchester_and_manchester_university_children_s_hospital_nhs_trust,,,,,, +4972,,154dc416-7164-11e6-a0cd-0242ac12000b,ACCORD HLTHCARE INC,accord_hlthcare_inc,,,,,, +4973,,c3992ee5-3a90-49be-b60b-14fb064c2581,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc",wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc,,,,,, +4974,,72fd5b3a-7191-11e6-a0cd-0242ac12000b,BAYER HLTHCARE,bayer_hlthcare,,,,,, +4975,,518ae137-093f-45cc-8d29-7fbe58f87f11,The BONiFIN study group,the_bonifin_study_group,,,,,, +4976,,72912c5b-8151-498b-a241-025c462ca079,DAIICHI SANKIO DEVELOPMENT LIMITED,daiichi_sankio_development_limited,,,,,, +818,0.972258,87f0f612-d1e5-4f3f-9bcd-69b8c3e8fd9a,UNIVERSITA' DEGLI STUDI DI FIRENZE,universita_degli_studi_di_firenze,,,,87f0f612-d1e5-4f3f-9bcd-69b8c3e8fd9a,universita_degli_studi_di_firenze,UNIVERSITA' DEGLI STUDI DI FIRENZE +4977,,480de809-6a0b-4684-8c5b-abf76eee946a,North Bristol Trust,north_bristol_trust,,,,,, +4978,,296ec335-93fd-4ce1-a10d-f3394aac006e,Ilkogen Ilac San. ve Tic. A.S,ilkogen_ilac_san_ve_tic_a_s,,,,,, +4979,,11a65836-8bb9-11e6-a449-0242ac12000b,G1 Therapeutics,g1_therapeutics,,,,,, +4980,,071bdada-a655-4496-8a2f-1ab0465e8527,Allergy Therapeutics (UK) Ltd,allergy_therapeutics_uk_ltd,,,,,, +4981,,4672c056-496e-4858-a8f8-77cf864e56a6,Siemens Molecular Imaging,siemens_molecular_imaging,,,,,, +4982,,1f53add5-0a89-47a8-8a59-50c47c1e39fc,Klinik für Psychiatrie und Psychotherapie des Kindes- und Jugendalters am Zentralinstitut für Seelische Gesundheit,klinik_f_r_psychiatrie_und_psychotherapie_des_kindes_und_jugendalters_am_zentralinstitut_f_r_seelische_gesundheit,,,,,, +4983,,ed82862d-debc-42a3-8b93-b80fb7fdeb1c,SSL International plc,ssl_international_plc,,,,,, +4984,,679875ce-8aa2-4ab0-9d69-48b8c5a8a424,IRCCS San Raffaele di Roma,irccs_san_raffaele_di_roma,,,,,, +4985,,71d50a6e-af23-4ec1-b1b1-1245977913cd,Ceregene Inc,ceregene_inc,,,,,, +4986,,1304d370-e286-498c-8b41-431e01c2c6d8,"Shire Human Genetic Therapies (HGT), Inc",shire_human_genetic_therapies_hgt_inc,,,,,, +4987,,30a69f01-503f-49fb-a054-dd8d4ec9098b,Instituto Andaluz de Sexología,instituto_andaluz_de_sexolog_a,,,,,, +4988,,ae8fa2ef-8311-45e0-91ed-105b402a5fb7,"Idenix Pharmaceuticals, Inc",idenix_pharmaceuticals_inc,,,,,, +4989,,412560a1-3c3c-468e-86f3-25a24b16c8a7,National Institute on Drug Abuse (NIDA),national_institute_on_drug_abuse_nida,,,,,, +1008,0.951024,4b0b3c57-a10d-4d99-beef-0ed9a5c1b30f,AOP Oprhan Pharmaceuticals AG,aop_oprhan_pharmaceuticals_ag,,,,4614bd92-4210-4230-a954-64c1de5fddc0,aop_orphan_pharmaceuticals_ag,AOP Orphan Pharmaceuticals AG +4990,,532ccfc5-e3ca-4b54-a90e-013bb9182b03,"Med Uni Graz, Univ. Klinik Dermatologie,Abteilung für Allgemeine Dermatologie",med_uni_graz_univ_klinik_dermatologie_abteilung_f_r_allgemeine_dermatologie,,,,,, +4991,,03e4235f-192e-4cc4-adcf-ee5092a78f9c,King's College Hospital Foundtion NHS Trust,king_s_college_hospital_foundtion_nhs_trust,,,,,, +4992,,87650e1a-7164-11e6-a0cd-0242ac12000b,HITECH PHARMA,hitech_pharma,,,,,, +4993,,4d563778-ff63-4415-a286-103203e9a573,"Dance Pharmaceuticals, Inc",dance_pharmaceuticals_inc,,,,,, +4994,,f82c77ef-3470-4ec0-892e-51ca522549e4,J. Uriach & Compañía SA,j_uriach_compa_a_sa,,,,,, +976,0.986562,1819b794-72dc-11e6-a0cd-0242ac12000b,PURDUE PHARMA,purdue_pharma,,,,1819b794-72dc-11e6-a0cd-0242ac12000b,purdue_pharma,PURDUE PHARMA +4995,,dc1f02f1-76cd-4dae-955e-6a5a9409c5f5,CETPARP,cetparp,,,,,, +729,0.96225506067276001,49a5f431-66a8-4a47-ae4f-0a20eff4609d,Sanofi Pasteur MSD S.N.C,sanofi_pasteur_msd_s_n_c,,,,cb560f4c-875f-44a3-bed5-c8039bd52ca8,sanofi_pasteur_msd,Sanofi Pasteur MSD +4996,,422fdc32-d866-4455-b406-0288de07f64d,Hoffman La Roche Ltd,hoffman_la_roche_ltd,,,,,, +4997,,86549d8a-9960-4ec2-82b2-3c79b66b147c,Danish Myeloma Study Group,danish_myeloma_study_group,,,,,, +4998,,85f70234-2537-48b5-b582-a9fd6a5edc28,COMBAT MEDICAL LTD,combat_medical_ltd,,,,,, +4999,,5c6898a1-b6ea-4657-8254-a9eb9e0694c1,HYKS Psykiatrikeskus,hyks_psykiatrikeskus,,,,,, +5000,,b1838e97-e6e7-4940-96e7-cee551ab881f,Finnish Uro-Oncological Group,finnish_uro_oncological_group,,,,,, +5001,,5640c740-7158-11e6-a0cd-0242ac12000b,OSMOTICA PHARM US,osmotica_pharm_us,,,,,, +987,0.985423,497e2c7a-7165-11e6-a0cd-0242ac12000b,ASPEN GLOBAL INC,aspen_global_inc,,,,497e2c7a-7165-11e6-a0cd-0242ac12000b,aspen_global_inc,ASPEN GLOBAL INC +5002,,090f61ff-26ef-490a-b792-1569ced1298b,University Hospital Tuebingen,university_hospital_tuebingen,,,,,, +5003,,c751852d-6cda-42fd-af27-5e2afdfc5867,Asociación Terapeutica en Hematologia y Oncología Médicas,asociaci_n_terapeutica_en_hematologia_y_oncolog_a_m_dicas,,,,,, +5004,,444af652-e6b5-408d-b826-9ab24b72e580,Takeda Pharma GmbH,takeda_pharma_gmbh,,,,,, +5005,,f843ee57-e570-4103-8f35-53147204de68,Dr. Jordi Montero Homs- Unidad de Neuromuscular- Servicio de Neurología- Hospital Universitario de Bellvitge,dr_jordi_montero_homs_unidad_de_neuromuscular_servicio_de_neurolog_a_hospital_universitario_de_bellvitge,,,,,, +5006,,a078fcd5-4784-455c-8e42-59145d459b2e,Katholieke Universiteit Leuven,katholieke_universiteit_leuven,,,,,, +5007,,002a5263-1108-4341-835b-161049d098cc,Turku University Central Hospital,turku_university_central_hospital,,,,,, +5008,,9f44a945-da06-49ec-99fa-d061da02c5bd,Servicio de Neurología. Hospital Universitari de Bellvitge,servicio_de_neurolog_a_hospital_universitari_de_bellvitge,,,,,, +99,0.97086024284362793,07d428a0-cf4e-4f85-9961-fc028370360e,Novartis Farmaceutica,novartis_farmaceutica,,,,bcb0e637-6442-4916-88f9-8cd0d5df3534,novartis_farmaceutica,Novartis Farmaceutica +5009,,6c4c59f5-476a-44e1-bc1b-ba6f5d391cfc,HUS/ Neuropsykiatrian poliklinikka,hus_neuropsykiatrian_poliklinikka,,,,,, +5010,,b7904252-b621-4f37-8f2e-b811888f1391,"NanoCarrier Co., Ltd",nanocarrier_co_ltd,,,,,, +5011,,580f05f6-71c5-11e6-a0cd-0242ac12000b,STIEFEL LABS INC,stiefel_labs_inc,,,,,, +124,0.98570466041564941,6c8a5ed2-f731-4585-8a6f-d17e1fc2915a,"F. Hoffman-La Roche Ltd., Roche Oy",f_hoffman_la_roche_ltd_roche_oy,,,,6c8a5ed2-f731-4585-8a6f-d17e1fc2915a,f_hoffman_la_roche_ltd_roche_oy,"F. Hoffman-La Roche Ltd., Roche Oy" +756,0.973609,a3d07aa8-578f-4f72-b06a-682bbc119d08,"Johannes Gutenberg-Universität Mainz, II. Med. Klinik (ausführende Stelle), Prof. Dr. med. T. Münzel",johannes_gutenberg_universit_t_mainz_ii_med_klinik_ausf_hrende_stelle_prof_dr_med_t_m_nzel,,,,339b2067-d133-4013-927e-2033004bf532,johannes_gutenberg_universit_t_mainz_ii_med_klinik_ausf_hrende_stelle_prof_dr_t_m_nzel,"Johannes Gutenberg-Universität Mainz, II. Med. Klinik (ausführende Stelle), Prof. Dr. T. Münzel" +5012,,fc051158-7145-11e6-a0cd-0242ac12000b,CONTRACT PHARMACAL,contract_pharmacal,,,,,, +5013,,a15cfcb5-961b-441d-9ba5-bcb844eec0e5,JAVIER MARTÍN BROTO,javier_mart_n_broto,,,,,, +5014,,744e1686-6348-4c4d-868c-2370ed289ce7,St. Anna Kinderkrebsforchung Children's Cancer Research Institute,st_anna_kinderkrebsforchung_children_s_cancer_research_institute,,,,,, +5015,,fb2924ad-206f-404a-8dbf-f1f9471d05f1,Integrated Therapeutics Group Incorporated (ITGI),integrated_therapeutics_group_incorporated_itgi,,,,,, +5016,,1ed265c0-70ea-47cd-89f1-29efb678ea03,Research and Innovation Services,research_and_innovation_services,,,,,, +5017,,9c050f54-7160-11e6-a0cd-0242ac12000b,CAMALL,camall,,,,,, +5018,,08900929-4345-47e6-85ec-3c88baa033dd,GOIM GRUPPO ONCOLOGICO MERIDIONALE,goim_gruppo_oncologico_meridionale,,,,,, +5019,,549d274b-a2d5-43e7-935a-d41c6807f0ae,Division K Kärnsjukhuset,division_k_k_rnsjukhuset,,,,,, +5020,,b0663aab-3c37-47c0-bbf4-b52b6136acea,Almirall Prodesfarma S.A,almirall_prodesfarma_s_a,,,,,, +5021,,ce8bcf12-7165-11e6-a0cd-0242ac12000b,YAOPHARMA CO LTD,yaopharma_co_ltd,,,,,, +5022,,740b6c6a-ac4f-47e0-8863-6ae2158e498f,"Deutsche Herzzentrum Berlin, Kompetenznetz Angeborene Herzfehler",deutsche_herzzentrum_berlin_kompetenznetz_angeborene_herzfehler,,,,,, +5023,,25678bc4-5b07-4f86-856c-caba6ecb78c5,University of Liverpool/Liverpool Women's Hospital,university_of_liverpool_liverpool_women_s_hospital,,,,,, +5024,,5f15b7af-c60b-4c64-8c48-56a487eb9f52,Grupo de Estudos Oncológicos,grupo_de_estudos_oncol_gicos,,,,,, +614,0.95383979876836145,fc47e3cc-4170-4925-b135-e77f956fcdef,Fundación para la Investigación Biomédica del Hospital Universitario de La Paz,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_de_la_paz,,,,1f4b6569-9247-4094-9c36-e11efb0201df,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz,Fundación para la Investigación Biomédica del Hospital Universitario La Paz +5025,,43552246-537d-441d-a3b1-c6a6846cf838,Jens Rolighed Larsen,jens_rolighed_larsen,,,,,, +5026,,9e646641-9081-4b19-a93f-972c1a282f86,AbbVie Biotherapeutics Inc. (AbbVie),abbvie_biotherapeutics_inc_abbvie,,,,,, +5027,,ad4f131e-7367-11e6-a0cd-0242ac12000b,THERATECHNOLOGIES,theratechnologies,,,,,, +1011,0.982558,d2e7717a-7a42-474a-9d20-1e8ff7dae2f4,German Breast Group Forschungs GmbH,german_breast_group_forschungs_gmbh,,,,19f3330e-027c-4344-a82b-28a25bade93e,german_breast_group,German Breast Group +688,0.98167827725410461,efc402d8-6fed-43fa-b994-36de1c4b8651,"Ruprecht-Karls-University Heidelberg, Medical Faculty Mannheim represented by the chancellor",ruprecht_karls_university_heidelberg_medical_faculty_mannheim_represented_by_the_chancellor,,,,4f99f7a3-6aa3-48d1-bbd6-5bfbc38e7e8d,ruprecht_karls_university_heidelberg_medical_faculty,"Ruprecht-Karls-University Heidelberg, Medical Faculty" +5028,,5b9b0886-bdfe-43ef-a518-5b133571056b,GlaxoSmithKine Research & Development Limited,glaxosmithkine_research_development_limited,,,,,, +5029,,48862b0c-13ca-4e27-b124-37a6323a8a06,"Univ.-Prof. DDr. Norbert Jakse, Universitätszahnklinik Graz, Dep. f. Orale Chirurgie u. Röntgenologi",univ_prof_ddr_norbert_jakse_universit_tszahnklinik_graz_dep_f_orale_chirurgie_u_r_ntgenologi,,,,,, +5030,,a007855c-9e0b-4f06-b58e-d4cffd050ada,Heart of England NHS Foundation Trust,heart_of_england_nhs_foundation_trust,,,,,, +5031,,d2e60d1d-66f4-4a3f-b975-f2385f81019d,Jelfa SA,jelfa_sa,,,,,, +5032,,d658279e-1e4f-403e-8b9c-b5d36860f536,Abiogen Pharma S.p.A,abiogen_pharma_s_p_a,,,,,, +5033,,61785265-c6ed-46f8-88aa-6501dc53f182,"Apex Bioscience, Inc",apex_bioscience_inc,,,,,, +5034,,d1250700-cdfb-4bd6-b004-b8ee082e63da,Prosonix Limited,prosonix_limited,,,,,, +5035,,1c8e5581-4c53-451e-b183-112ad705d875,Danube Pharmaceuticals Inc,danube_pharmaceuticals_inc,,,,,, +5036,,4d9f849d-dd1d-4f21-a8f3-f153e2791f76,AIO-Studien-gGmbH,aio_studien_ggmbh,,,,,, +5037,,baf8fc24-3c16-4187-b4a0-bd161783c9f2,CHU de Nantes,chu_de_nantes,,,,,, +5038,,974008ae-73f2-11e6-a0cd-0242ac12000b,NITROUS OXIDE CORP,nitrous_oxide_corp,,,,,, +5039,,49a1e495-5503-4855-98c2-21a6f0d7a351,University hospital of Bonn,university_hospital_of_bonn,,,,,, +922,0.98430114984512329,a1324003-35e8-470e-953b-3b8bca84ef3a,Pfizer bv,pfizer_bv,,,,41a3f51d-cc79-4d85-ad20-dd3ecef8b74f,pfizer_bv_cr,Pfizer bv CR +553,0.97483,05a127e0-09ed-418a-bb52-d8310d3063dc,Centre François Baclesse,centre_fran_ois_baclesse,,,,02d042a3-dbd3-41ce-bd72-42a098676c11,centre_francois_baclesse,Centre Francois Baclesse +977,0.984073,84f4a215-8c1a-46ef-828a-05f77f6a3e72,KULeuven and University Hospitals Leuven,kuleuven_and_university_hospitals_leuven,,,,5c717b25-0b28-45e6-bff5-45d9320631af,kuleuven_and_university_hospitals_leuven_leuven_lung_transplant_group,KULeuven and University Hospitals Leuven (Leuven Lung Transplant Group) +5040,,d9e757c1-24f1-4a3c-b2cd-564d74426891,Servier Portugal - Especialidades Farmacêuticas Lda,servier_portugal_especialidades_farmac_uticas_lda,,,,,, +5041,,caeb6dc2-f9a0-49f2-842a-4daa1ecc6de7,CELL THERAPEUTICS INC. (EUROPE)-SEDE SECONDARIA,cell_therapeutics_inc_europe_sede_secondaria,,,,,, +5042,,9300406a-3e3f-4639-99d0-0bde0f212af8,JSW Lifesciences GmbH,jsw_lifesciences_gmbh,,,,,, +5043,,bf02b309-9893-4b29-a236-0e3140a78cc9,Royal Berkshire and Battle Hospitals NHS Trust,royal_berkshire_and_battle_hospitals_nhs_trust,,,,,, +5044,,0a0bbe5e-7142-11e6-a0cd-0242ac12000b,CLARIS,claris,,,,,, +5045,,b347a763-b742-40b2-8ee8-235599581292,Roskilde Amts Sygehus,roskilde_amts_sygehus,,,,,, +5046,,599df9b1-a67e-43ca-ad67-0e2f44736c8d,Fundación Cerebro y Mente,fundaci_n_cerebro_y_mente,,,,,, +5047,,a8f4b896-f806-4c8b-8e1e-46ae5d092f00,Mercedes Zumarraga Ortiz,mercedes_zumarraga_ortiz,,,,,, +1060,0.98586,0b2aae39-94a4-4319-927d-68470e818403,FONDAZIONE PENTA,fondazione_penta,,,,0b2aae39-94a4-4319-927d-68470e818403,fondazione_penta,FONDAZIONE PENTA +456,0.95666962862014771,e9ad54fa-7237-11e6-a0cd-0242ac12000b,CIS BIO INTL SA,cis_bio_intl_sa,,,,6704e020-719e-11e6-a0cd-0242ac12000b,cis,CIS +556,0.92243582010269165,c14f025d-e1fd-4178-9c21-651db3e987e3,Greater Glasgow & Clyde Health Board,greater_glasgow_clyde_health_board,,,,3361148d-134d-40eb-b1d7-9105a55174b4,greater_glasgow_and_clyde_health_board_ggchb_university_of_glasgow,Greater Glasgow and Clyde Health Board (GGCHB)/University of Glasgow +1077,0.97536885738372803,3fdba14d-9b0e-469d-bb19-93144e9882fd,IBSA Institut Biochimique S.A,ibsa_institut_biochimique_s_a,,,,3fdba14d-9b0e-469d-bb19-93144e9882fd,ibsa_institut_biochimique_s_a,IBSA Institut Biochimique S.A +5048,,9fca1dd6-6fbd-11e6-abe8-0242ac12000b,Accenture,accenture,,,,,, +589,0.9786,a9471b81-d20a-4ad8-aba3-b02c3fcc30c7,"Abteilung für Anaesthesie und Intensivmedizin, Medizinische Universität Wien",abteilung_f_r_anaesthesie_und_intensivmedizin_medizinische_universit_t_wien,,,,3a83eff6-b403-4ef3-9768-88bc041f3b42,abteilung_f_r_an_sthesie_und_intensivmedizin_medizinische_universit_t_wien,"Abteilung für Anästhesie und Intensivmedizin, Medizinische Universität Wien" +5049,,370c4d5e-61bc-4c92-969d-1ae85df70306,Hvidovre University Hospital,hvidovre_university_hospital,,,,,, +5050,,c6c8b1da-3780-44e5-83c3-37a3729bd9e7,Pantarhei Bioscience BV,pantarhei_bioscience_bv,,,,,, +5051,,e5014f76-2148-4677-9597-ea2ae8640993,Max Zeller Söhne AG,max_zeller_s_hne_ag,,,,,, +386,0.985292,60874b79-ee1e-4812-b6c9-460d6bce27cc,University of Leuven Hospitals,university_of_leuven_hospitals,,,,1075f8b7-6380-4891-9141-7a995969037d,university_of_leuven,University of Leuven +594,0.970712,1768a5c2-6d78-474d-b8b9-24906dea2085,"The Karolinska Institute, ClinTRID",the_karolinska_institute_clintrid,,,,1768a5c2-6d78-474d-b8b9-24906dea2085,the_karolinska_institute_clintrid,"The Karolinska Institute, ClinTRID" +5052,,9370cd3c-d252-4396-adb5-d0452f435066,"Aerogen, Inc",aerogen_inc,,,,,, +5053,,2df0fbc6-3b70-46ef-bfe4-035678c0f668,GlaxoSmithKline AB,glaxosmithkline_ab,,,,,, +5054,,d28fa68b-2fc2-42e9-8f87-42beb5e2a009,Center for neuropsykiatrisk Schrizofreniforskning,center_for_neuropsykiatrisk_schrizofreniforskning,,,,,, +5055,,e1533350-a59f-4a08-aef5-07e769943a59,"TRF Pharma, Inc",trf_pharma_inc,,,,,, +5056,,276b8af0-3185-470c-97eb-17d65ff8ca40,Lupin Limited,lupin_limited,,,,,, +278,0.97598719596862793,e86cb604-6399-4605-9a60-17154f1ecb73,GlaxoSmithKline Research & Devleopment Ltd,glaxosmithkline_research_devleopment_ltd,,,,e86cb604-6399-4605-9a60-17154f1ecb73,glaxosmithkline_research_devleopment_ltd,GlaxoSmithKline Research & Devleopment Ltd +519,0.98101389408111572,c15af267-15cc-42e5-be46-4a84bd3c6dca,CSL Behring,csl_behring,,,,c15af267-15cc-42e5-be46-4a84bd3c6dca,csl_behring_ag,CSL Behring AG +5057,,4fabf996-f3c2-4f01-b9e8-9592228c3d7b,Klin. Abtlg. für Thorax- & Hyperbare Chirurgi,klin_abtlg_f_r_thorax_hyperbare_chirurgi,,,,,, +989,0.964382,9dee1320-7e61-4373-a4a5-0601870627ce,G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO,g_i_m_e_m_a_gruppo_italiano_malattie_ematologiche_dell_adulto,,,,9dee1320-7e61-4373-a4a5-0601870627ce,g_i_m_e_m_a_gruppo_italiano_malattie_ematologiche_dell_adulto,G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO +5058,,66a84d59-ecce-4688-ae12-5dca48f5abc5,NovImmune S.A,novimmune_s_a,,,,,, +5059,,1c4f1cc9-bae0-49c1-9529-83526549f02b,Orion Pharma,orion_pharma,,,,,, +5060,,ca45ccad-e3f0-4b22-a560-dbfec00eec04,Uniwersytet Medyczny,uniwersytet_medyczny,,,,,, +5061,,36d48d72-7ec9-4564-ac0c-1c8a28d10c00,Hanns-Ulrich Marschall,hanns_ulrich_marschall,,,,,, +5062,,ff468cae-938b-4295-af18-d37a0b27012e,AGMT – Arbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH,agmt_arbeitsgemeinschaft_medikament_se_tumortherapie_gemeinn_tzige_gmbh,,,,,, +5063,,426f6906-ee06-4cc9-b4b8-4f8045e7c2e2,"Medizinische Unversität Wien, Abteilung für Kinder- und Jugendheilkunde",medizinische_unversit_t_wien_abteilung_f_r_kinder_und_jugendheilkunde,,,,,, +5064,,898f56dd-7a9f-450a-9ddf-b559ecb4777b,ASL 2 SAVONESE,asl_2_savonese,,,,,, +5065,,20cdf177-0f5b-4356-8901-be9899e06b2a,Genetic Immunity Kft,genetic_immunity_kft,,,,,, +5066,,2aecdc85-8e6b-442d-8074-77c096d19ac1,Department of Orthopaedic Surgery University Hospital Linköping,department_of_orthopaedic_surgery_university_hospital_link_ping,,,,,, +5067,,df24c9e9-f301-41e5-ba23-7b6ea93709d7,Fundación Investigación Biomédica Puerta de Hierro,fundaci_n_investigaci_n_biom_dica_puerta_de_hierro,,,,,, +882,0.957248,acee4b3e-08b2-4604-95a5-b5c1e12e7628,Hyks,hyks,,,,acee4b3e-08b2-4604-95a5-b5c1e12e7628,hyks,Hyks +5068,,e1bda8ea-6773-46d2-ac96-235d03ac6a48,Curatis Pharma GmbH,curatis_pharma_gmbh,,,,,, +555,0.98070001602172852,553abbb3-263c-4177-a2fa-a95d21db2fc2,Greater Glasgow and Clyde NHS Board and The University Of Glasgow,greater_glasgow_and_clyde_nhs_board_and_the_university_of_glasgow,,,,613c1a9b-76b3-42ee-8979-2c8d31737f57,greater_glasgow_and_clyde_nhs_board,Greater Glasgow and Clyde NHS Board +5069,,36dd585b-b0e7-4934-9576-eb3fbdbc96cf,"Sexological Clinic, Rigshospitalet",sexological_clinic_rigshospitalet,,,,,, +5070,,2bcfb1c8-7190-11e6-a0cd-0242ac12000b,PHARMICS,pharmics,,,,,, +5071,,3b537544-649e-4c97-b0b1-3c440cc9965b,FOURNIER LABORATORIES IRELAND Ltd,fournier_laboratories_ireland_ltd,,,,,, +5072,,2d40f677-5f63-42f1-ac30-36493cb68b19,"Millennium Pharmaceuticals, Inc",millennium_pharmaceuticals_inc,,,,,, +627,0.97483,78e77398-73ed-45b6-b470-74acc67e6db9,Institut Bergonié,institut_bergoni,,,,51090fb3-f2e6-4878-8ebd-94da6e3ed0df,institut_bergoni_d_partement_d_oncologie_m_dicale,Institut Bergonié - Département d’Oncologie Médicale +5073,,80cd9d70-e291-4e9f-915c-fbb04017a948,"Medizinische Universität Wien, Univ.-Klinik für Innere Medizin I, Klinische Abteilung für Infetionen und Tropenmedizin",medizinische_universit_t_wien_univ_klinik_f_r_innere_medizin_i_klinische_abteilung_f_r_infetionen_und_tropenmedizin,,,,,, +5074,,7c6170f1-01ff-45f1-ae01-cb60480b2ff1,FNCLCC (Fédération Nationale des Centres de Lutte Contre le Cancer),fnclcc_f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer,,,,,, +5075,,533e7ed8-715e-11e6-a0cd-0242ac12000b,TORRENT PHARMS LLC,torrent_pharms_llc,,,,,, +5076,,32ee473d-a724-4640-a615-119263fbeca1,Investigador del estudio: Dr. Agustín Alomar Muntañola,investigador_del_estudio_dr_agust_n_alomar_munta_ola,,,,,, +5077,,81915db4-9c35-49cc-a37c-fc45466da848,"Medizinische Universität Graz, Klinische Abteilung für allgemeine Pädiatrie",medizinische_universit_t_graz_klinische_abteilung_f_r_allgemeine_p_diatrie,,,,,, +285,0.9883,eb291706-2c5d-4ba0-be9b-3c5939ceef07,UK für Anästhesiologie und allgemeine Intensivmedizin,uk_f_r_an_sthesiologie_und_allgemeine_intensivmedizin,,,,7213388e-5096-443a-80ed-002100f22598,uk_f_r_an_sthesiologie_und_allgemeine_intensivmedizin_lkh_salzburg,"UK für Anästhesiologie und allgemeine Intensivmedizin, LKH Salzburg" +5078,,7b4fb93d-7586-4794-9f84-bddd68010d13,NightstaRx Ltd,nightstarx_ltd,,,,,, +5079,,bb8bb302-e59e-43b1-bf3d-ba22d1eda2b4,BASILEA PHARMACEUTICA,basilea_pharmaceutica,,,,,, +5080,,9f8fa8a7-204a-4f50-af2a-a09c6c3a9ccd,Locemia Solutions ULC,locemia_solutions_ulc,,,,,, +529,0.94006639719009399,c79e1bf1-e4a3-4d35-a28e-9b09f3073525,"Roche Farma S.A., que representa en España a F.Hoffmann-La Roche",roche_farma_s_a_que_representa_en_espa_a_a_f_hoffmann_la_roche,,,,05387ec7-b7a5-4b59-bbbd-5029e53bbb00,roche_farma_s_a_que_representa_en_espa_a_a_f_hoffmann_la_roche_ltd,"Roche Farma, S.A., que representa en España a F. Hoffmann-La Roche Ltd" +786,0.98430114984512329,36d7c90b-a751-4f8d-8ad8-5535b85ebea2,Intercell AG,intercell_ag,,,,36d7c90b-a751-4f8d-8ad8-5535b85ebea2,intercell_ag,Intercell AG +941,0.95605242252349854,215afd5f-229c-4506-bcca-821996e7d1cf,UCL,ucl,,,,215afd5f-229c-4506-bcca-821996e7d1cf,ucl,UCL +5081,,fe83c411-f0f5-4561-bc76-f2472773527e,"Universität Rostock, für diese handelnd Universitätsklinikum",universit_t_rostock_f_r_diese_handelnd_universit_tsklinikum,,,,,, +5082,,f041b92c-07ff-4431-bc55-486256622dad,MediWound Ltd,mediwound_ltd,,,,,, +5083,,7af0fb1c-8bd6-11e6-a449-0242ac12000b,"Gynecology Department,Herning Hospital",gynecology_department_herning_hospital,,,,,, +5084,,f3fc6282-a312-40cd-9e8e-ccbfee1a869a,"Department of Nephrology and Renal Transplantation, KU Leuven",department_of_nephrology_and_renal_transplantation_ku_leuven,,,,,, +5085,,406465dd-3f6f-4369-8bb9-97a00306b87c,Antonio Moreno Galdó,antonio_moreno_gald,,,,,, +5086,,49d1d460-2459-4916-a093-29ecb0eb58e0,Biomay AG,biomay_ag,,,,,, +5087,,230a36c5-6a4a-4010-9a9f-2eae431696d0,"Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto",department_of_physiology_and_cardiothoracic_surgery_faculty_of_medicine_university_of_porto,,,,,, +5088,,9e7561e1-5430-4126-a864-968e33d3403f,Hospital de Girona Dr Josep Trueta,hospital_de_girona_dr_josep_trueta,,,,,, +5089,,15a90554-6d80-4238-8e17-209372f5f4f0,Clinica Rotger,clinica_rotger,,,,,, +5090,,f60bb756-8f7c-4f97-bad2-dc49f6654232,Kenta Biotech,kenta_biotech,,,,,, +737,0.9838290810585022,abd7706c-73a6-4724-a75c-500b163844ce,Fundació Clínic per a la Recerca Biomèdica,fundaci_cl_nic_per_a_la_recerca_biom_dica,,,,9d24a637-ff9d-4f52-87fc-ca0f3956d972,fundaci_clinic_per_a_la_recerca_biom_dica,Fundació Clinic per a la Recerca Biomèdica +5091,,f8bd98c2-c407-4d2a-82eb-f36477a50938,Allon Therapeutics Inc,allon_therapeutics_inc,,,,,, +5092,,d3a3d995-fb9f-4cee-b50f-cf42b55be56c,Klaipeda hospital,klaipeda_hospital,,,,,, +5093,,55a9071e-cf02-41f1-b6b8-1521557b6443,Intituto Aragonés de Ciencias de la Salud,intituto_aragon_s_de_ciencias_de_la_salud,,,,,, +5094,,9c326f60-b3fa-4793-bafe-9d5dd0003f40,SkyePharma AG,skyepharma_ag,,,,,, +5095,,5d3b3bf6-a380-46c6-922d-01347d5f80a7,"Ipsen Group, SCRAS Institut Henri Beaufour",ipsen_group_scras_institut_henri_beaufour,,,,,, +474,0.914969,6c80401e-c0a6-481c-8234-44f428b1fd51,Royal Devon & Exeter Foundation Trust,royal_devon_exeter_foundation_trust,,,,0222076c-1a8f-4b87-a730-9ae61df48508,royal_devon_exeter_nhs_foundation_trust,Royal Devon & Exeter NHS Foundation Trust +617,0.98639386892318726,0b62757d-a156-4d40-9ede-7264daaa5209,Grupo Español de Investigación en Sarcomas,grupo_espa_ol_de_investigaci_n_en_sarcomas,,,,0359d070-d59d-4dab-8d3e-cdb60bbcff96,grupo_espa_ol_de_investigaci_n_en_sarcomas,Grupo Español de Investigación en Sarcomas +5096,,faf8d634-8aed-4757-b580-4417c391c30e,Venter Pharma S.L,venter_pharma_s_l,,,,,, +5097,,f346cc64-d564-4227-958d-bee2f79cae9f,National Institute of Mental Health,national_institute_of_mental_health,,,,,, +5098,,3c6a09c4-d44f-41b0-8d91-57656fe34a61,"Department of Rheumatology, Internal Medicine III, Medical University of Vienna",department_of_rheumatology_internal_medicine_iii_medical_university_of_vienna,,,,,, +5099,,f55e4c2c-c01e-460b-97e2-889659e1b806,T1D Exchange Clinic Network Coordinating Center,t1d_exchange_clinic_network_coordinating_center,,,,,, +5100,,c3d25b15-a782-4394-8bbe-967958c120f3,Universitetet i Bergen,universitetet_i_bergen,,,,,, +5101,,26ba747a-88d6-4bd8-9e73-a30afc73335d,Osteologix A/S,osteologix_a_s,,,,,, +5102,,dd54efdb-9652-461d-ab90-c8253d4c181d,"Retrophin, Inc",retrophin_inc,,,,,, +5103,,7d6a5342-73bd-11e6-a0cd-0242ac12000b,PFIZER LABS,pfizer_labs,,,,,, +5104,,7877c73f-edf1-4203-9a84-bdfe86fb219f,NOXXON Pharma AG,noxxon_pharma_ag,,,,,, +5105,,c20363ae-fbc0-4099-b18b-7a3fe82b2c6b,Corporation Schering-Plough K.K,corporation_schering_plough_k_k,,,,,, +42,0.98929455876350403,e3a4dbed-6085-4f4f-a871-0b11b6bed573,Universitätsklinik für Augenheilkunde und Optometrie,universit_tsklinik_f_r_augenheilkunde_und_optometrie,,,,e3a4dbed-6085-4f4f-a871-0b11b6bed573,universit_tsklinik_f_r_augenheilkunde_und_optometrie,Universitätsklinik für Augenheilkunde und Optometrie +405,0.96709239482879639,dee4490b-b25c-4c54-b909-635261eba55d,Gilead,gilead,,,,dee4490b-b25c-4c54-b909-635261eba55d,gilead,Gilead +5106,,2f2a2d67-28a4-4642-80dc-839f15afc352,Dr. Jose Vicente Torregrosa Prats (fundacio clinic),dr_jose_vicente_torregrosa_prats_fundacio_clinic,,,,,, +5107,,50970099-d34a-4139-bb56-5f46761cc9df,Universit� Cattolica del Sacro Cuore,universit_cattolica_del_sacro_cuore,,,,,, +5108,,4b7e57a0-5ce0-4447-bcee-a2ee9bb76b6b,NYCOMED (HEADQUARTER),nycomed_headquarter,,,,,, +5109,,8e8079f4-7142-11e6-a0cd-0242ac12000b,ODYSSEY PHARMS,odyssey_pharms,,,,,, +5110,,74c6493b-e4d9-4b8f-b0a8-da2a62d8e1c4,Fundacio Parc Taulí,fundacio_parc_taul,,,,,, +492,0.973505,81977950-118e-45c5-b00b-ff958a1914c1,Rottapharm,rottapharm,,,,81977950-118e-45c5-b00b-ff958a1914c1,rottapharm,Rottapharm +5111,,ba053778-7581-4058-931f-75a2ebaf54a0,XOMA (US) LLC,xoma_us_llc,,,,,, +5112,,07c65efc-10de-41d8-947c-0b714a7c2568,Prolor Biotech Ltd,prolor_biotech_ltd,,,,,, +5113,,2b7d30e8-bb62-4fe1-ab34-53ebed4ba50b,Krewel Meuselbach GmbH,krewel_meuselbach_gmbh,,,,,, +5114,,da45fde8-cb54-4a7a-84c3-927a3f7f7f9e,Abteilung für Anaesthesiologie und Intensivmedizin,abteilung_f_r_anaesthesiologie_und_intensivmedizin,,,,,, +320,0.97903996706008911,2cc9c0de-712a-11e6-a89e-0242ac12000b,FRESENIUS KABI USA,fresenius_kabi_usa,,,,2cc9c0de-712a-11e6-a89e-0242ac12000b,fresenius_kabi_usa,FRESENIUS KABI USA +5115,,6d61994c-8bb9-11e6-a449-0242ac12000b,"University of Nottingham, Research Innovation Services",university_of_nottingham_research_innovation_services,,,,,, +5116,,87e4e78d-b055-4acd-b499-387c82bb3adf,Merz Pharmaceuticals GmbH,merz_pharmaceuticals_gmbh,,,,,, +5117,,db8a7512-8d3a-4e52-8a0f-fe59acc3bc21,Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova,dipartimento_di_neuroscienze_oftalmologia_e_genetica_dinog_universita_di_genova,,,,,, +5118,,38e62f5d-cf73-4cf4-8e14-968ac12a1ef0,Takeda Global R&D (Europe) Ltd,takeda_global_r_d_europe_ltd,,,,,, +5119,,43a2fbe6-416d-4d74-9ba4-fc088c05eef1,Zafgen Inc,zafgen_inc,,,,,, +5120,,5f6266bf-8ee1-4efe-b189-4a179ee7bac0,Sykehuset Innlandet HF,sykehuset_innlandet_hf,,,,,, +5121,,644908aa-b1e2-4f98-967a-19757ae49a2e,Pirkanmaan sairaanhoitopiiri,pirkanmaan_sairaanhoitopiiri,,,,,, +5122,,f972279a-7141-11e6-a0cd-0242ac12000b,IPCA LABS LTD,ipca_labs_ltd,,,,,, +5123,,6db876b8-e058-4069-809f-84d708d7ece4,BioCis Pharma Oy,biocis_pharma_oy,,,,,, +5124,,6fde36a8-3346-4e62-8d40-02bb649fce67,Anne-Mette Hvas,anne_mette_hvas,,,,,, +5125,,eed58fe7-1916-4824-9bbf-0d0e7578f788,"MRL, Merck and Co., Inc",mrl_merck_and_co_inc,,,,,, +975,0.93739336729049683,5a90c345-0950-4b20-a685-09b583a6ae3f,"Universitätsklinikum Schleswig-Holstein, Campus Kiel",universit_tsklinikum_schleswig_holstein_campus_kiel,,,,5a90c345-0950-4b20-a685-09b583a6ae3f,universit_tsklinikum_schleswig_holstein_campus_kiel,"Universitätsklinikum Schleswig-Holstein, Campus Kiel" +5126,,34684af8-6c37-43cb-aed6-3f78d05fbc10,ALCON ITALIA,alcon_italia,,,,,, +5127,,f2210b19-50f1-44d9-b635-a34c34c962ad,"Bayer HealthCare AG, Leverkusen, D-51368 Germany",bayer_healthcare_ag_leverkusen_d_51368_germany,,,,,, +5128,,a065c1fa-4d78-4a0f-8da9-efc7a5ace1de,"Vejle Hospital, Department of Oncology",vejle_hospital_department_of_oncology,,,,,, +5129,,1b7e1740-58d7-40d5-a0a0-8b972de597b4,"Medizinische Universität Wien, Univ.Klinik f.Frauenheilkunde,Abt. f.Geburtshilfe und Feto-maternale Medizin",medizinische_universit_t_wien_univ_klinik_f_frauenheilkunde_abt_f_geburtshilfe_und_feto_maternale_medizin,,,,,, +5130,,e97bcdd0-8f15-4ec9-ab88-f1e20376e4ea,EISAI LTD UK,eisai_ltd_uk,,,,,, +5131,,98e2d176-7142-11e6-a0cd-0242ac12000b,BELCHER PHARMS,belcher_pharms,,,,,, +5132,,89753f92-6fbe-11e6-abe8-0242ac12000b,"Gerlinde Egerer (MD); Internal Medicine, Department V",gerlinde_egerer_md_internal_medicine_department_v,,,,,, +5133,,2821497d-7cae-45ff-aa6e-8d9b2e045410,Cancer Research UK,cancer_research_uk,,,,,, +5134,,c36aab32-068d-4335-bbb0-5d4aaf050397,Instituto de Medicina Molecular,instituto_de_medicina_molecular,,,,,, +5135,,273bcb6a-d784-4a93-b196-bda193110808,Barts & the London NHS Trust,barts_the_london_nhs_trust,,,,,, +5136,,8b2c2658-6172-4f3e-944e-1f252d2c1664,Therabron Therapeutics Inc,therabron_therapeutics_inc,,,,,, +5137,,32709256-95dd-11e6-becf-0242ac110008,ZYDUS WORLDWIDE,zydus_worldwide,,,,,, +5138,,6058b6c9-7260-43af-9f14-48144246ebff,"AZ. DI RILIEVO NAZ. E DI ALTA SPECIALIZZAZIONE OSP. CIVICO E BENFRATELLI, G.DI CRISTINA E M.ASCOLI",az_di_rilievo_naz_e_di_alta_specializzazione_osp_civico_e_benfratelli_g_di_cristina_e_m_ascoli,,,,,, +5139,,616764fa-f962-4d52-a250-d4551f438587,"Almirall, SAS",almirall_sas,,,,,, +5140,,ad7f2385-a08a-4e10-bf19-ec20ef787194,CONSORCI SANITARI TERRASSA,consorci_sanitari_terrassa,,,,,, +5141,,8aeb7b28-bea3-46e6-962f-2a2366699e5f,ISTITUTI OSPITALIERI DI CREMONA,istituti_ospitalieri_di_cremona,,,,,, +414,0.952896,5f666fad-c0f0-4e6a-8a52-a4806a60a3ee,Medical University Vienna,medical_university_vienna,,,,5f666fad-c0f0-4e6a-8a52-a4806a60a3ee,medical_university_vienna,Medical University Vienna +5142,,c9a5cd61-1aa2-4afd-9bde-ee8a00a03e71,LungRx,lungrx,,,,,, +5143,,c0e64976-7158-11e6-a0cd-0242ac12000b,EXELA PHARMA SCS LLC,exela_pharma_scs_llc,,,,,, +1015,0.97426080703735352,505a3f41-b816-4c26-965c-c1b406728577,Institut de Recherches Internatinales Servier,institut_de_recherches_internatinales_servier,,,,505a3f41-b816-4c26-965c-c1b406728577,institut_de_recherches_internatinales_servier,Institut de Recherches Internatinales Servier +5144,,4e07263c-3b8a-4cac-8ea4-a0f7f6239651,POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI,policlinico_universitario_agostino_gemelli,,,,,, +5145,,c8b52c7e-73b7-11e6-a0cd-0242ac12000b,NEXTWAVE PHARMS,nextwave_pharms,,,,,, +5146,,a43cb066-4e1c-4cc3-989c-b7711ac37cf4,"Wyeth Farma, S.A",wyeth_farma_s_a,,,,,, +5147,,48cca71e-8814-11e6-a998-0242ac12000b,Immodulon Therapeutics Limited,immodulon_therapeutics_limited,,,,,, +5148,,ccd5e1b8-db85-482b-ad3f-7edb13b813a7,Vall d'Hebron Institut de Recerca (VHIR),vall_d_hebron_institut_de_recerca_vhir,,,,,, +758,0.919169,b7570d88-35b2-48c8-bf49-66ed83edbe35,"Especialidades Farmacéuticas Centrum, S.A",especialidades_farmac_uticas_centrum_s_a,,,,b7570d88-35b2-48c8-bf49-66ed83edbe35,especialidades_farmac_uticas_centrum_s_a,"Especialidades Farmacéuticas Centrum, S.A" +5149,,6d4b75f2-defb-4278-8256-aac0d7584ca2,General Hospital Linz,general_hospital_linz,,,,,, +5150,,b74ebbdd-1060-4b8f-8de7-2413832d1e8b,Stavanger University Hospital,stavanger_university_hospital,,,,,, +58,0.97219407558441162,09724a53-939b-4574-93f9-68f878e08648,"Wyeth Research Division of Wyeth Pharmaceutical Inc., Clinical Research and Development",wyeth_research_division_of_wyeth_pharmaceutical_inc_clinical_research_and_development,,,,2ed1b6f4-e137-4ee3-a218-9e5c2d04039a,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_and_development,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development +5151,,b9fd8b26-07cb-4299-99e3-75e8cc27a428,"Institute of Oncology, Vilnius University",institute_of_oncology_vilnius_university,,,,,, +5152,,cbf768a0-15ab-4517-a27e-9b6dba98d462,University Hospital South Manchester NHS Foundation Trust,university_hospital_south_manchester_nhs_foundation_trust,,,,,, +5153,,10c1ef3c-29db-4168-bb93-b1d85d716a44,Amvac Kft,amvac_kft,,,,,, +5154,,58e7ecd3-4cba-45c8-8ef3-1e4dec7d4a75,Institut Català de la Salut,institut_catal_de_la_salut,,,,,, +5155,,ed39b3f7-16ee-410c-8df1-eeed44df4011,Dr. Miguel Ferrer. Servicio de Neumología. Hospital Clínic de Barcelona,dr_miguel_ferrer_servicio_de_neumolog_a_hospital_cl_nic_de_barcelona,,,,,, +5156,,a18f7de9-649e-4c49-baf6-27d1e8c103ca,FRANCISCO BORJA BARRACHINA LARRAZA,francisco_borja_barrachina_larraza,,,,,, +5157,,04fa97b7-3ad6-4cc1-b6d9-56939cd5eb71,"The Department of Molecular Medicin and Surgery, P9:03, Karolinska Institutet",the_department_of_molecular_medicin_and_surgery_p9_03_karolinska_institutet,,,,,, +175,0.938547,35c21566-4df9-4b63-ab48-4cc2ede6089b,"Med. Univ. Wien, Universitätsklinik für Anästhesie, allgemeine Intensivmedizin und Schmerzmedizin",med_univ_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerzmedizin,,,,35c21566-4df9-4b63-ab48-4cc2ede6089b,med_univ_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerzmedizin,"Med. Univ. Wien, Universitätsklinik für Anästhesie, allgemeine Intensivmedizin und Schmerzmedizin" +5158,,790b65ae-2d4d-4737-992b-a6375e178f9f,MSD (Norge) AS,msd_norge_as,,,,,, +5159,,7371cef6-2d6d-4d66-8ffa-9aafcbb9eb96,Unidad integral de investigación en oncologia,unidad_integral_de_investigaci_n_en_oncologia,,,,,, +5160,,495c82e9-1398-4aaa-9fb5-f94f9cf29489,"Malmö University, Faculty of Odontology",malm_university_faculty_of_odontology,,,,,, +717,0.958979,7517b680-5ab5-4e0c-8c77-e2e66cd5f935,Dept. Child & Adolescent Psychiatrie,dept_child_adolescent_psychiatrie,,,,7517b680-5ab5-4e0c-8c77-e2e66cd5f935,dept_child_adolescent_psychiatrie,Dept. Child & Adolescent Psychiatrie +5161,,269eb09a-b8e3-4b55-be5f-ac0b3baf3a0d,"Abteilung für Augenheilkunde, AKH Linz",abteilung_f_r_augenheilkunde_akh_linz,,,,,, +5162,,cc68155e-a5ee-43ee-b607-8bc92cd02e67,N.V. Roche S.A,n_v_roche_s_a,,,,,, +5163,,73a5c26a-6fc1-11e6-abe8-0242ac12000b,ARYx Therapeutics,aryx_therapeutics,,,,,, +867,0.974081,d6e5614f-d962-4d82-b492-870d6ddb0fe8,"Dept. of Intensive Care, Rigshopitalet",dept_of_intensive_care_rigshopitalet,,,,321d9f48-9a0a-471b-b553-56fdf09a41f7,dept_of_intensive_care_rigshospitalet,"Dept. of Intensive Care, Rigshospitalet" +5164,,0a040010-7142-11e6-a0cd-0242ac12000b,HERITAGE PHARMS INC,heritage_pharms_inc,,,,,, +5165,,526e7166-7145-11e6-a0cd-0242ac12000b,STRIDES PHARMA,strides_pharma,,,,,, +1050,0.97903996706008911,9b0915b5-74ad-4748-ae49-c7504c4d919e,Rijnstate,rijnstate,,,,9b0915b5-74ad-4748-ae49-c7504c4d919e,rijnstate,Rijnstate +5166,,4cf68b70-73f1-11e6-a0cd-0242ac12000b,NEXAIR,nexair,,,,,, +519,0.98317185044288635,424a130c-b3bb-4fae-a841-2d4ea926eea4,CSL Behring AG,csl_behring_ag,,,,c15af267-15cc-42e5-be46-4a84bd3c6dca,csl_behring_ag,CSL Behring AG +5167,,20bff534-6fe0-4bf9-9402-dddee30b4993,Staf Longziekten,staf_longziekten,,,,,, +367,0.95244354009628296,f71bc1b5-7a61-4995-9283-fd63cc4fb485,Bayer HealthCare AG/Bayer Schering Pharma AG,bayer_healthcare_ag_bayer_schering_pharma_ag,,,,e8216e75-b447-4252-bb49-7b895bcf4108,bayer_healthcare,Bayer HealthCare +5168,,00349092-e8c2-4f45-8f78-c73a919911aa,AiCuris GmbH & Co. KG,aicuris_gmbh_co_kg,,,,,, +5169,,0d05f4a1-2e23-4563-b30f-fffd5c78673f,"MADAUS, S.A",madaus_s_a,,,,,, +5170,,ca10d771-b3d8-459e-9777-bebb7ab75d0a,European Commission,european_commission,,,,,, +5171,,57ae0316-f80a-4526-8210-a67020f4d27f,Mater University Hospital,mater_university_hospital,,,,,, +665,0.98784509301185608,ed964919-ca2c-4007-9600-7f07a3680f32,Charité-Universitätsmedizin Berlin, Department of Rheumatology and Clinical Immunology,,,,f6d48103-0f0c-4464-8cd2-7589fc1def08,charit_universit_tsmedizin,Charité-Universitätsmedizin Berlin +5172,,92daac8a-9dee-42c0-a0b0-d772fc5c70a2,"Administration management, Ludwig-Maximilians-University of Munich",administration_management_ludwig_maximilians_university_of_munich,,,,,, +954,0.984184,addf70ca-715b-11e6-a0cd-0242ac12000b,IMPAX LABS INC,impax_labs_inc,,,,69569858-7141-11e6-a0cd-0242ac12000b,impax_labs,IMPAX LABS +5173,,6d7bfca8-7168-11e6-a0cd-0242ac12000b,JUBILANT LIFE,jubilant_life,charit_universit_tsmedizin_berlin_department_of_rheumatology_and_clinical_immunology,,,,, +5174,,f07f6376-2bc0-4ebe-a6aa-9e2e3e3bd703,Southend Hospital,southend_hospital,,,,,, +5175,,4afbd107-5221-4456-9cc1-8365a7e3279a,PharmaEngine Inc,pharmaengine_inc,,,,,, +5176,,f1d4ccf4-7128-11e6-a89e-0242ac12000b,APPLIED ANAL,applied_anal,,,,,, +5177,,28d3ccdf-4ba4-4f90-9544-20e9c2affb88,CytoVac A/S,cytovac_a_s,,,,,, +5178,,4c2d0d85-008e-4824-acce-9ab87341782f,Merck Serono Middle East FZ-LLC,merck_serono_middle_east_fz_llc,,,,,, +30,0.903169,261630f5-cc3d-4976-b8b8-66f665f0285f,ACROSS (Associació Catalana de Recerca Oncològica i les seves implicacions Sanitàries i Socials),across_associaci_catalana_de_recerca_oncol_gica_i_les_seves_implicacions_sanit_ries_i_socials,,,,261630f5-cc3d-4976-b8b8-66f665f0285f,across_associaci_catalana_de_recerca_oncol_gica_i_les_seves_implicacions_sanit_ries_i_socials,ACROSS (Associació Catalana de Recerca Oncològica i les seves implicacions Sanitàries i Socials) +5179,,87c6b3bd-4f8c-497b-ba94-8c08a6eef4a4,"Universitätsklinikum Freiburg, Abteilung klinische Chemie",universit_tsklinikum_freiburg_abteilung_klinische_chemie,,,,,, +5180,,7a638c92-73c0-11e6-a0cd-0242ac12000b,MEDEFIL INC,medefil_inc,,,,,, +709,0.9746039708455404,985b42ee-700e-479f-8636-0715f067b780,Reckitt Benckiser Healthcare (UK) Ltd,reckitt_benckiser_healthcare_uk_ltd,,,,62dccd7b-325f-4731-b158-229a0c9ea429,reckitt_benckiser_healthcare_uk_ltd,Reckitt Benckiser Healthcare (UK) Ltd +5181,,3f732f7e-b7e5-4167-96fb-da5897e6b3ef,"Dept. of Anaestesiology, University hospital in Glostrup",dept_of_anaestesiology_university_hospital_in_glostrup,,,,,, +380,0.97923370864656234,7e279d84-f8fd-4294-b6c0-d03a5606ebc0,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,",merck_sharp_dohme_corp_a_subsidiary_of_merck_co,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" +358,0.968122,bbd5cc65-8109-4d78-9466-0dae250cb154,Fresenius Medical Care Deutschland GmbH,fresenius_medical_care_deutschland_gmbh,,,,0267831e-60a5-4058-a9fc-094b1cd84b8e,fresenius_medcial_care_deutschland_gmbh,Fresenius Medcial Care Deutschland GmbH +5182,,e8a72884-7150-11e6-a0cd-0242ac12000b,AVACOR PRODS,avacor_prods,,,,,, +5183,,cf39e61b-56c3-45f2-a738-9176daebf4bb,Medical University Vienna- Dept. of Pediatric Hemostaselology,medical_university_vienna_dept_of_pediatric_hemostaselology,,,,,, +5184,,d169818c-7162-11e6-a0cd-0242ac12000b,HERCON PHARM,hercon_pharm,,,,,, +5185,,2cd20bb4-2062-4366-9998-3ee9c5bd6991,Fundación de la Universidad de Salamanca,fundaci_n_de_la_universidad_de_salamanca,,,,,, +5186,,b1620ee3-57fd-495a-a760-888ef81e52a2,ESTHER URIARTE ITZAZELAIA,esther_uriarte_itzazelaia,,,,,, +118,0.982527,e394aa30-7194-11e6-a0cd-0242ac12000b,OAK PHARMS AKORN,oak_pharms_akorn,,,,1b1c70ea-715f-11e6-a0cd-0242ac12000b,oak_pharms,OAK PHARMS +5187,,c1d20174-d085-4139-bb64-eea3dd35fca2,"Svettmottagningen Hidroskliniken, Stockholm",svettmottagningen_hidroskliniken_stockholm,,,,,, +5188,,22957f8f-2469-4d2f-bf40-b69767d2bb7f,HUCH Eye Hospital,huch_eye_hospital,,,,,, +5189,,722986dc-292d-4ccb-8eef-a39ce1c2ba9d,Schering-Plough A/S,schering_plough_a_s,,,,,, +5190,,bae583b9-03be-4cf7-a136-87fc7bb76ed1,Novo Nordisk Scandinavia AB,novo_nordisk_scandinavia_ab,,,,,, +5191,,b7f241b6-714f-11e6-a0cd-0242ac12000b,BEN VENUE,ben_venue,,,,,, +5192,,8973d67f-bcb3-4265-9ad6-03051acddd25,Apogenix GmbH,apogenix_gmbh,,,,,, +5193,,bdae29e7-fcf3-4a69-9423-c90f8f7fb496,Janssen-Cilag Internation N.V,janssen_cilag_internation_n_v,,,,,, +470,0.9518304864565531,c244a64b-434f-4cec-92d1-7700f3f23d2d,European Group for Blood and Marrow trasnplantation,european_group_for_blood_and_marrow_trasnplantation,,,,2a4e4a42-e5c4-4da8-8f1f-18343eeb1fbc,european_group_for_blood_and_marrow_transplantation,European Group for Blood and Marrow Transplantation (EMBT) +5194,,0713ea0f-590d-40f2-88c1-f2543af7b66f,"MedImmune, LLC, a wholly owned subsidiary of AstraZeneca",medimmune_llc_a_wholly_owned_subsidiary_of_astrazeneca,,,,,, +5195,,82ed9cb7-a7cc-11e6-94cb-5656d04fc2b5,Moberg Pharma AB (publ),moberg_pharma_ab_publ,,,,,, +5196,,7bcdc3e2-8097-46ef-a66d-9eba0b5a9f6c,Epsom & St Helier University Hospitals NHS Trust,epsom_st_helier_university_hospitals_nhs_trust,,,,,, +5197,,1aaa952c-73f0-11e6-a0cd-0242ac12000b,"PURITY CYLINDER GASES, INC",purity_cylinder_gases_inc,,,,,, +906,0.97302970290184021,fca3e979-5b66-49a6-9ef4-f41a73231b74,Kings College London (IOP) / South London and Maudsley NHS Trust (Co-sponsorship),kings_college_london_iop_south_london_and_maudsley_nhs_trust_co_sponsorship,,,,fb29808d-7985-4804-b8d4-5620bbba60e6,kings_college_london_iop,Kings College London (IOP) +284,0.98087829351425171,bc84a43e-7141-11e6-a0cd-0242ac12000b,PADDOCK,paddock,,,,bc84a43e-7141-11e6-a0cd-0242ac12000b,paddock,PADDOCK +5198,,c0fd6845-45d8-45b5-b132-0b4065e2a1e4,Chesi Farmaceutici SpA,chesi_farmaceutici_spa,,,,,, +5199,,79f4422e-e16e-40c3-a54d-9d1b4cee47df,"SOLTI (Grupo Español de Estudio, Tratamiento y Otras Estrategias Experimentales en Tumores Sólidos)",solti_grupo_espa_ol_de_estudio_tratamiento_y_otras_estrategias_experimentales_en_tumores_s_lidos,,,,,, +1035,0.968193,35768696-3c8d-4b10-b3d3-c9d161f53a97,"Department of Infectious Diseases, Aarhus University Hospital, Skejby",department_of_infectious_diseases_aarhus_university_hospital_skejby,,,,35768696-3c8d-4b10-b3d3-c9d161f53a97,department_of_infectious_diseases_aarhus_university_hospital_skejby,"Department of Infectious Diseases, Aarhus University Hospital, Skejby" +5200,,1373a00e-49b3-4e29-a522-c8881687f976,University of Medicine Greifswald,university_of_medicine_greifswald,,,,,, +5201,,1f6d4557-25c4-4fb2-b311-6dc3a2187361,OTH - Chief Medical Officer's Office,oth_chief_medical_officer_s_office,,,,,, +5202,,e05609d1-cdb8-432f-b8f0-859bc892158b,FONDAZIONE NADIR ONLUS,fondazione_nadir_onlus,,,,,, +5203,,cf89a0a7-0f33-44f5-8fc2-cb551ba179cf,Uni-Zentrum naturheilkunde,uni_zentrum_naturheilkunde,,,,,, +963,0.98324790596961975,67a8d720-6864-4b95-9669-fdb022547a7d,Helsinki University Hospital,helsinki_university_hospital,,,,65248d8e-5a22-48b5-a66d-dc1d1f751700,helsinki_university_hospital,Helsinki University Hospital +5204,,1823cbf0-62a4-4bce-9092-5e0b1ba00f73,Leeds Teaching Hospitals NHS Trust,leeds_teaching_hospitals_nhs_trust,,,,,, +5205,,27114afe-0b6e-4539-be13-36e475d363cb,AMC-UvA,amc_uva,,,,,, +5206,,1146eaee-b1d4-42a6-ac6c-65e0f5459c5e,"Research Innovation Services, University of Nottingham",research_innovation_services_university_of_nottingham,,,,,, +5207,,688eb3ab-ca11-49fa-8d08-e6482b696122,"Medizinische Universität Innsbruck, Abteilung für Hygiene und Medizinische Mikrobiologie",medizinische_universit_t_innsbruck_abteilung_f_r_hygiene_und_medizinische_mikrobiologie,,,,,, +5208,,892be7a2-e9a3-4132-ac3c-4155291cd3b6,Medical University of Vienna (MUW),medical_university_of_vienna_muw,,,,,, +5209,,95b0a6c0-73fb-11e6-a0cd-0242ac12000b,BIOFRONTERA,biofrontera,,,,,, +5210,,da40600e-5799-481b-9ff7-55fcbd786750,Prof. Ivana Zavaroni,prof_ivana_zavaroni,,,,,, +5211,,a402eb05-97ee-4a6e-a124-885d87b7d647,Laboratoris Sanifit,laboratoris_sanifit,,,,,, +49,0.975369,e6e76398-715e-11e6-a0cd-0242ac12000b,SOLVAY,solvay,,,,d8f0d873-4306-4828-b744-12f1d67a0438,solvay_pharma,SOLVAY PHARMA +901,0.952896,465a5556-c902-495a-8a94-7999cb29da09,Fundació Privada Clínic per a la Recerca Biomèdica,fundaci_privada_cl_nic_per_a_la_recerca_biom_dica,,,,465a5556-c902-495a-8a94-7999cb29da09,fundaci_privada_cl_nic_per_a_la_recerca_biom_dica,Fundació Privada Clínic per a la Recerca Biomèdica +5212,,aa6d6bd3-ba3e-4bec-aefa-62edf2165fb9,Bioven (Europe) Ltd,bioven_europe_ltd,,,,,, +5213,,e11e35a2-a454-4e87-a49a-35f0afde1759,EAU Research Foundation,eau_research_foundation,,,,,, +5214,,c2c56495-e832-43d8-8d45-578fc116d546,Vifor Pharma Inc,vifor_pharma_inc,,,,,, +5215,,c146b3e1-783c-4ae5-b8ef-4880bf82dd4d,Maastricht Universitair Medisch Centrum,maastricht_universitair_medisch_centrum,,,,,, +5216,,414c4cf0-7163-11e6-a0cd-0242ac12000b,THEPHARMANETWORK LLC,thepharmanetwork_llc,,,,,, +5217,,70ed6158-712a-11e6-a89e-0242ac12000b,EPIC PHARMA INC,epic_pharma_inc,,,,,, +5218,,eefa7dda-7141-11e6-a0cd-0242ac12000b,WOCKHARDT USA,wockhardt_usa,,,,,, +5219,,5b0c7589-c866-43bf-b65d-cc60d7e81df1,ST. ANNA KINDERSPITAL,st_anna_kinderspital,,,,,, +5220,,fae53d90-d0cb-43ad-bbc4-e4e0d363ce79,InDex Pharmaceuticals AB,index_pharmaceuticals_ab,,,,,, +5221,,71dc034a-f52a-48a5-a873-f6ef26d95500,Allergopharma GmbH & Co. KG,allergopharma_gmbh_co_kg,,,,,, +5222,,54c4f172-535c-4881-858e-ef6a4dd4750e,Fertilitetsklinikken Herlev Hospital,fertilitetsklinikken_herlev_hospital,,,,,, +5223,,d2a15f43-d22f-42d3-9392-fefbf6652765,R-Pharm,r_pharm,,,,,, +5224,,ab28e423-5d45-47db-bf67-5b0feb368138,Alexion Pharma GmbH,alexion_pharma_gmbh,,,,,, +5225,,597df9f7-3e97-4d31-8816-aee19d167f67,MEDESTEA RESEARCH & PRODUCTION,medestea_research_production,,,,,, +5226,,c328e1b8-4371-4893-b450-c6a10a14c01f,Prof. Dr. Kristian Reich,prof_dr_kristian_reich,,,,,, +106,0.972495,39443038-185d-4279-b9d1-588d493613db,"Amar Agha, Beaumont Hospital",amar_agha_beaumont_hospital,,,,39443038-185d-4279-b9d1-588d493613db,amar_agha_beaumont_hospital,"Amar Agha, Beaumont Hospital" +5227,,10c46c54-6dc8-46d3-b8d7-6edbfc8b688b,Cangene Europe Limited,cangene_europe_limited,,,,,, +5228,,0d658636-f2a1-450f-b067-657afa1ceb09,Associazione Malattie Sangue Onlus,associazione_malattie_sangue_onlus,,,,,, +5229,,fa646900-48fc-4458-aa6c-09e66ab58e4c,Xencor Inc,xencor_inc,,,,,, +5230,,eaaafae4-295f-40d3-8ea6-783b444d8dd1,"Ortopædkirurgisk forskningsenhed, Aalborg universitetshospital",ortop_dkirurgisk_forskningsenhed_aalborg_universitetshospital,,,,,, +5231,,099d963a-b59b-489e-bc18-022e1eaa16d7,Universität Marburg,universit_t_marburg,,,,,, +5232,,f848264c-de8c-42a6-bef8-0becc63ab9d5,Ulster Community & Hospitals Trust,ulster_community_hospitals_trust,,,,,, +5233,,abd21c48-c434-4fc8-9645-ca99764998d2,University Hospital of Birmingham Foundation Trust,university_hospital_of_birmingham_foundation_trust,,,,,, +5234,,bbe61798-6fa1-11e6-9663-0242ac12000b,Pfizer Corporation Austria GmbH,pfizer_corporation_austria_gmbh,,,,,, +5235,,d7091b0f-0c6a-4a8d-bc5f-13c5b00986ac,"Departement of Anesthesiology, Næstved Hospital",departement_of_anesthesiology_n_stved_hospital,,,,,, +5236,,f0dbbe82-02e2-4048-9659-c400e650e83c,"KAI Pharmaceuticals, Inc",kai_pharmaceuticals_inc,,,,,, +5237,,71ce2fac-48fd-4254-882d-e1c6bd6f604f,Univ. Prof. Dr. Manuela Schmidinger,univ_prof_dr_manuela_schmidinger,,,,,, +741,0.9828302264213562,5b96ae2b-b1a8-4688-88cd-0fcea433e529,AstraZeneca R&D,astrazeneca_r_d,,,,5b96ae2b-b1a8-4688-88cd-0fcea433e529,astrazeneca_r_d,AstraZeneca R&D +5238,,39393420-5600-4146-b000-84e8a58c9b0b,Medizinische Fakultät der technischen Universität Muenchen,medizinische_fakult_t_der_technischen_universit_t_muenchen,,,,,, +828,0.96305406093597412,343d2886-981b-46cc-bdb2-741a4f343dda,INSTITUTO DE INVESTIGACION SANITARIA FJD,instituto_de_investigacion_sanitaria_fjd,,,,343d2886-981b-46cc-bdb2-741a4f343dda,instituto_de_investigacion_sanitaria_fjd,INSTITUTO DE INVESTIGACION SANITARIA FJD +44,0.98179709911346436,035a6b1e-8bb9-11e6-a449-0242ac12000b,"Medicinsk Forskningsafsnit, Holstebro",medicinsk_forskningsafsnit_holstebro,,,,035a6b1e-8bb9-11e6-a449-0242ac12000b,medicinsk_forskningsafsnit_holstebro,"Medicinsk Forskningsafsnit, Holstebro" +5239,,dfb00ef1-3b87-4398-a3d7-f7a62bd20e6c,Centre Hospitalier Intercommunal de Créteil,centre_hospitalier_intercommunal_de_cr_teil,,,,,, +5240,,78176a18-b53b-4cf7-94a6-2fe4f1286f63,ABCSG (Austrian Breast & Colorectal Cancer Study Group),abcsg_austrian_breast_colorectal_cancer_study_group,,,,,, +5241,,f5bf4c53-10db-4553-9b5a-28780ab61562,CHU Mont-Godinne,chu_mont_godinne,,,,,, +5242,,dd764c9f-2d36-4c45-99e3-49ac1e619ba2,"Department of Respiratory Diseases, Aarhus University Hospital",department_of_respiratory_diseases_aarhus_university_hospital,,,,,, +5243,,f2bc532e-f4bc-427f-aff9-d4326a62e159,Biotest AG,biotest_ag,,,,,, +5244,,66ab75bc-56db-40b6-937d-2d2ba18f52a6,PREGLEM SA,preglem_sa,,,,,, +5245,,74cb2975-8fa6-4ec5-8bc8-7cd2a73e09e6,Laboratorios Galderma S.A,laboratorios_galderma_s_a,,,,,, +5246,,2ebc30fa-7145-11e6-a0cd-0242ac12000b,AMNEAL PHARMS CO,amneal_pharms_co,,,,,, +5247,,902aa51c-b1b7-4f35-a308-ddacb7267702,Hospital of the University of Munich,hospital_of_the_university_of_munich,,,,,, +5248,,6a5b7452-7142-11e6-a0cd-0242ac12000b,WESTWOOD SQUIBB,westwood_squibb,,,,,, +478,0.97189050912857056,a6ef0ba5-d49e-411b-92ac-7bad93bbb394,"Medizinische Universität Graz, Kl. Abteilung für Endokrinologie und Stoffwechsel",medizinische_universit_t_graz_kl_abteilung_f_r_endokrinologie_und_stoffwechsel,,,,a6ef0ba5-d49e-411b-92ac-7bad93bbb394,medizinische_universit_t_graz_kl_abteilung_f_r_endokrinologie_und_stoffwechsel,"Medizinische Universität Graz, Kl. Abteilung für Endokrinologie und Stoffwechsel" +5249,,b4196001-285e-4733-afad-002973776db7,S&K Pharma Schumann und Kohl GmbH,s_k_pharma_schumann_und_kohl_gmbh,,,,,, +5250,,b2c666a0-3deb-42b7-bd10-d3ed09598b24,ONCOLYTICS,oncolytics,,,,,, +5251,,452f58c6-63c6-4d4d-8171-4075221dd1bc,FEDERATION FRANCOPHONE DE CANCEROLOGIE DIGESTIVE,federation_francophone_de_cancerologie_digestive,,,,,, +5252,,67c047ed-e861-419d-8f0d-fed1a380275a,Department of Pediatrics Holbaek Hospital,department_of_pediatrics_holbaek_hospital,,,,,, +5253,,a3002563-2ca3-44e6-8182-8900412328b9,VALEAS,valeas,,,,,, +195,0.98517,f3dd08fd-7bfc-4330-9b94-4de4558d953e,"Becton, Dickinson and Company, BD Technologies",becton_dickinson_and_company_bd_technologies,,,,4a830ce9-4d8d-4914-94f3-d34026b2d02d,becton_dickinson_and_company,"Becton, Dickinson and Company" +5254,,21ed34fc-b9ac-4d1f-a0cf-b7956b84909e,Clinic for Nephrology,clinic_for_nephrology,,,,,, +5255,,2d08c230-493b-47d8-8eae-ee0600e7adb0,Laboratorios ViiV Healthcare SL,laboratorios_viiv_healthcare_sl,,,,,, +5256,,c26e48d5-2f23-4237-bdc2-0147f171c045,"Discovery Laboratoryies, INC",discovery_laboratoryies_inc,,,,,, +5257,,bd767d0d-db11-4083-bc80-43e7603f22c7,FONDAZIONE PROGETTO EMATOLOGIA,fondazione_progetto_ematologia,,,,,, +5258,,74e9f10c-a766-11e6-94cb-5656d04fc2b5,Orthopaedic Syrgery Unit Northern Jytland,orthopaedic_syrgery_unit_northern_jytland,,,,,, +5259,,147d6884-485a-4462-a87a-b6e02a10d90e,Clínica IVI Barcelona,cl_nica_ivi_barcelona,,,,,, +5260,,b82bda9c-c3da-47af-947b-a25037876023,Neuro3d,neuro3d,,,,,, +5261,,385546cc-20b2-43a0-8a4f-c66ae02a96bc,Febena Pharma GmbH,febena_pharma_gmbh,,,,,, +5262,,57a22e70-ac28-41f0-92a5-2ff733fb9f4b,"Amylin Pharmaceuticals, Inc",amylin_pharmaceuticals_inc,,,,,, +5263,,8ef57930-b393-4084-9396-1b14297249e1,Klinikum rechts der Isar der Technischen Universitaet Muenchen,klinikum_rechts_der_isar_der_technischen_universitaet_muenchen,,,,,, +5264,,065b6fb3-2a69-4144-b0c9-265ac6d2db51,"HUCH, ATEK, TÖÖLÖN SAIRAALA, NEUROKIRURGIAN KLINIKKA",huch_atek_t_l_n_sairaala_neurokirurgian_klinikka,,,,,, +5265,,d366c313-c9fd-4f10-a095-407a18decd60,Summit (Cambridge) Ltd,summit_cambridge_ltd,,,,,, +5266,,6afa752a-0124-4dba-a32d-a189bc7a74ff,Danube Pharmaceuticals,danube_pharmaceuticals,,,,,, +5267,,12bc87df-3c73-4833-b3fb-b7d197c0807a,ACOSOG,acosog,,,,,, +5268,,b4001976-49c7-4694-b084-510d1a346f42,ISA Therapeutics B.V,isa_therapeutics_b_v,,,,,, +5269,,30a2008a-7194-11e6-a0cd-0242ac12000b,KING PHARMS R AND D,king_pharms_r_and_d,,,,,, +5270,,5c2f85da-9dfb-4349-8435-664173f53ffa,University of Washington,university_of_washington,,,,,, +5271,,0d861272-8a65-461b-b73c-62527dfc5324,Brystkirurgisk afd. F Amtsygehuset i Herlev 18 sal,brystkirurgisk_afd_f_amtsygehuset_i_herlev_18_sal,,,,,, +5272,,5bf4bcf8-71aa-11e6-a0cd-0242ac12000b,MT ADAMS,mt_adams,,,,,, +5273,,7faa2d06-ebcc-4e6b-8578-f7df840b27cc,Fundación para la Investigación Biomédica del Hospital Clínico de San Carlos,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_cl_nico_de_san_carlos,,,,,, +5274,,18cf29c1-ea2c-462a-911b-98a16d3e3860,"Watson Laboratories, Inc",watson_laboratories_inc,,,,,, +5275,,af57bfce-9c17-43e9-8e20-71bba4cc121d,"Cardiokine Biopharma, LLC",cardiokine_biopharma_llc,,,,,, +5276,,aedb143a-6fa0-487e-a7c9-f7eaceb4fbaf,Universitätsklinik für Radiodiagnostik,universit_tsklinik_f_r_radiodiagnostik,,,,,, +5277,,3dacb84c-0954-4870-8bc2-a4776f957b32,Stealth BioTherapeutics Inc,stealth_biotherapeutics_inc,,,,,, +5278,,edece8d2-a437-4a27-8568-f0a0ef5c8431,"Lipidklinikken, Aalborg Sygehus",lipidklinikken_aalborg_sygehus,,,,,, +5279,,9490df96-f954-4727-9719-e3b3341585ef,"Ludwig Boltzmann Cluster für Rheumatologie, Balneologie und Rehabilitation",ludwig_boltzmann_cluster_f_r_rheumatologie_balneologie_und_rehabilitation,,,,,, +844,0.989439,1b189425-2b98-4982-b3b0-a63cc85c263e,"Queen Mary and Westfield College, University of London (QMUL)",queen_mary_and_westfield_college_university_of_london_qmul,,,,1b189425-2b98-4982-b3b0-a63cc85c263e,queen_mary_and_westfield_college_university_of_london_qmul,"Queen Mary and Westfield College, University of London (QMUL)" +5280,,d717b7d2-7141-11e6-a0cd-0242ac12000b,LYNE,lyne,,,,,, +480,0.98699730634689331,f1926de7-bf3f-4138-90ce-fdceca00d91c,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin,,,,f1926de7-bf3f-4138-90ce-fdceca00d91c,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin" +5281,,fbeb32cc-73ae-11e6-a0cd-0242ac12000b,CUBIST PHARMS LLC,cubist_pharms_llc,,,,,, +5282,,97189f36-d82e-4a73-97bf-a323d98a4885,"Orion Corporation, ORION PHARMA, Finland",orion_corporation_orion_pharma_finland,,,,,, +5283,,0c81498c-5364-4b90-8d48-9789c45cb09c,Forschungszentrum Jülich GmbH,forschungszentrum_j_lich_gmbh,,,,,, +5284,,44518cf0-6905-494b-8fcc-63f38042de09,Spanish Lung Cancer Group,spanish_lung_cancer_group,,,,,, +5285,,6e0cc37f-d04a-40b1-b731-9a7a495b1218,NHS Grampian Research and Development,nhs_grampian_research_and_development,,,,,, +5286,,b13670ea-afe4-49ea-8695-3d12dcf77b19,RSPR Pharma AB,rspr_pharma_ab,,,,,, +5287,,5b56f016-d15d-4946-b36d-835733bf6e8f,"Amylin Pharmaceuticals, LLC",amylin_pharmaceuticals_llc,,,,,, +5288,,60dc7035-20e5-4e1e-ba9b-16163a6c11d7,KUROS BIOSURGERY AG,kuros_biosurgery_ag,,,,,, +5289,,74996a96-d6b9-44fa-a07a-05a00f346257,"University Clinic Erlangen, Medical Clinic II",university_clinic_erlangen_medical_clinic_ii,,,,,, +5290,,155ce5e7-7d87-4a74-a86f-3393a056739d,Hospital Universitario Gregorio Marañón,hospital_universitario_gregorio_mara_n,,,,,, +5291,,db5c2693-9c08-4963-86c0-2cf60464881a,Roche Diagnostics GmbH,roche_diagnostics_gmbh,,,,,, +5292,,e2bc42da-3306-4c3d-bf75-22f41b9ebf75,Medizinische Fakultät der Otto-von-Guericke Universität Magdeburg Universitätsklinikum Magdeburg A.ö.R,medizinische_fakult_t_der_otto_von_guericke_universit_t_magdeburg_universit_tsklinikum_magdeburg_a_r,,,,,, +5293,,d894daf0-7145-11e6-a0cd-0242ac12000b,FUTURE PAK,future_pak,,,,,, +5294,,43d0926c-0ec4-4546-bb0f-1971bd59294b,Melchor Riera Jaume,melchor_riera_jaume,,,,,, +5295,,f8b09176-83af-4f9c-9463-4d4293e70da8,FUNDACIÓ PUIGVERT,fundaci_puigvert,,,,,, +5296,,abe7293a-715f-11e6-a0cd-0242ac12000b,IVC INDS,ivc_inds,,,,,, +5297,,bb99f3aa-af7f-4062-a204-dcd5d65b8fe9,Asklepios Krankenhaus Weißenfels,asklepios_krankenhaus_wei_enfels,,,,,, +5298,,dbb60575-5d57-4d56-b648-947afe372ec4,"Blood bank, Rigshospitalet, University Hospital of Copenhagen",blood_bank_rigshospitalet_university_hospital_of_copenhagen,,,,,, +5299,,a4ff19ce-d9af-424e-8598-abfc411d3ba9,"Celldex Therapeutics, Inc",celldex_therapeutics_inc,,,,,, +5300,,4fca335c-7218-488c-9bcc-4196a5b0a5d9,"MUW, Division of nephrology",muw_division_of_nephrology,,,,,, +5301,,85f7573c-7168-11e6-a0cd-0242ac12000b,PRINSTON PHARMA INC,prinston_pharma_inc,,,,,, +5302,,38ba56a2-450d-40dd-aec3-65ffb6c1b676,"sanofi-aventis, s.r.o",sanofi_aventis_s_r_o,,,,,, +5303,,e9a077dd-10b2-40f9-b371-2121f2cb6494,Dra Maria José Colomina Soler,dra_maria_jos_colomina_soler,,,,,, +968,0.97420650720596313,555482da-4b7d-45b2-97ab-84909436613d,Maatschap cardiologie Isala klinieken Zwolle,maatschap_cardiologie_isala_klinieken_zwolle,,,,e5d4a9c1-e0e4-4ac7-8c88-785f0f8e3beb,maatschap_cardiologie_isala_klinieken,Maatschap Cardiologie Isala klinieken +247,0.94493213295936584,faba70cf-b03c-4f06-8988-51f699154f02,Hoffmann-La Roche Ltd/Inc/AG/Roche Global Development,hoffmann_la_roche_ltd_inc_ag_roche_global_development,,,,5796905e-d697-4a3c-a2d1-98d6d9104b0c,hoffmann_la_roche,Hoffmann-La Roche +5304,,b3509b5e-6fa5-4e17-8b27-39ebd2a1a174,"DIPART. DI NEUROSCIENZE, SCIENZE RIPRODUTTIVE E ODONTOSTOMATOLOGICHE DELL’UNIVERSITà DEGLI STUDI DI NAPOLI “FEDERICO II",dipart_di_neuroscienze_scienze_riproduttive_e_odontostomatologiche_dell_universit_degli_studi_di_napoli_federico_ii,,,,,, +5305,,50e32767-29d2-44c2-9145-cd0af4137b86,"Children´s Hospital, University of Helsinki",children_s_hospital_university_of_helsinki,,,,,, +169,0.94997268915176392,3e1da10e-fb5d-4c01-94a2-f31c443bb1c2,"Merck Serono Int, a branch ofLaboratories Serono S.A. an affiliate of Merck KGaA, Darmstadt, Germany",merck_serono_int_a_branch_oflaboratories_serono_s_a_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,3e1da10e-fb5d-4c01-94a2-f31c443bb1c2,merck_serono_int_a_branch_oflaboratories_serono_s_a_an_affiliate_of_merck_kgaa_darmstadt_germany,"Merck Serono Int, a branch ofLaboratories Serono S.A. an affiliate of Merck KGaA, Darmstadt, Germany" +5306,,6c4766a7-e84b-41a0-aff6-864a1796124d,ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE,istituto_mediterraneo_per_i_trapianti_e_terapie_ad_alta_specializzazione,,,,,, +5307,,40effd58-c047-403b-8bcc-9e4ce5c9ff4a,"Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich",department_of_psychiatry_and_psychotherapy_ludwig_maximilians_university_munich,,,,,, +5308,,dc1b0941-86d2-4c47-97c5-fd9a1fe7a42f,SOCIETA PRODOTTI ANTIBIOTICI,societa_prodotti_antibiotici,,,,,, +5309,,aec36f1b-4d05-485b-8dba-96f010ce60b6,"H. Lundbeck A/S, Lundbeck Austria GmbH",h_lundbeck_a_s_lundbeck_austria_gmbh,,,,,, +5310,,ef765090-a1e7-45ed-ba91-4b2d97fa3899,Asahi Kasei Pharma Corporation,asahi_kasei_pharma_corporation,,,,,, +5311,,7883977d-eaba-4524-ae1d-6ec1fa72019e,Bio-Medisinsk Innovasjon AS,bio_medisinsk_innovasjon_as,,,,,, +5312,,03d5304e-7168-11e6-a0cd-0242ac12000b,PHARMACEUTICS INTL,pharmaceutics_intl,,,,,, +5313,,54c9b5d0-8557-44f1-b912-b076b2724414,Newcastle Primary Care Trust,newcastle_primary_care_trust,,,,,, +5314,,2319638f-cf7d-4ef9-9444-2effccd8847f,Lukaskrankenhaus GmbH,lukaskrankenhaus_gmbh,,,,,, +5315,,96d2d3cf-22e1-4807-8f21-b6cc95ea4dda,Thoraxklinik-Heidelberg gGmbH,thoraxklinik_heidelberg_ggmbh,,,,,, +5316,,d58dc913-c547-4180-96af-3595e859202f,Kliniken Kärnan Urology Centre,kliniken_k_rnan_urology_centre,,,,,, +455,0.958341,792dba77-9941-4659-aa31-5f86a7b2ad5b,Solvay Pharmaceuticals B.V,solvay_pharmaceuticals_b_v,,,,792dba77-9941-4659-aa31-5f86a7b2ad5b,solvay_pharmaceuticals_b_v,Solvay Pharmaceuticals B.V +5317,,767506cd-7e81-49a6-b01c-925f6cd97df1,Zentiva k.s. Prague,zentiva_k_s_prague,,,,,, +5318,,64c063bc-7166-11e6-a0cd-0242ac12000b,ROUSES POINT PHARMS,rouses_point_pharms,,,,,, +5319,,a75fb102-9435-4019-8a9c-1f80eaed3c9c,University Hospital Magdeburg,university_hospital_magdeburg,,,,,, +316,0.987803,17eacfff-6322-4900-ab4b-4476d90f6cb8,Jazz Pharmaceuticals Inc,jazz_pharmaceuticals_inc,,,,17eacfff-6322-4900-ab4b-4476d90f6cb8,jazz_pharmaceuticals_inc,Jazz Pharmaceuticals Inc +5320,,69391ab4-b219-4670-947c-75b1ce8dce8a,"Prof. Dr. med. Milos Opravil, Universitätsspital Zürich",prof_dr_med_milos_opravil_universit_tsspital_z_rich,,,,,, +5321,,9f7bd914-c2e0-49b4-8dd0-ea2538d8ac8c,Lux Biosciences GmbH,lux_biosciences_gmbh,,,,,, +5322,,28db6aff-7035-4045-86c5-3ff0c9751b80,"Helse Fonna, Haugesund Sykehus",helse_fonna_haugesund_sykehus,,,,,, +5323,,61679ef8-daa6-4ac1-9a3a-908f2d94be92,ARQULE,arqule,,,,,, +5324,,a493c202-eba5-438d-8ecf-2c4f294a1590,Oxford Radcliffe Hospitals Trust,oxford_radcliffe_hospitals_trust,,,,,, +5325,,7c548c51-ce55-4a45-ab8b-f819bafe184e,"Department of Oncology, Linköping University Hospital, Linköping, Sweden",department_of_oncology_link_ping_university_hospital_link_ping_sweden,,,,,, +5326,,63550b8b-6404-4534-b036-e86cf64fe152,Novagali Pharma S.A,novagali_pharma_s_a,,,,,, +5327,,2fd51c51-77e1-4392-815f-64f6f2d36772,Riemser Pharma GmbH,riemser_pharma_gmbh,,,,,, +5328,,8f699beb-dc88-473a-929e-ef9c75fc977b,Elena Santagostino,elena_santagostino,,,,,, +5329,,33afcc1a-7146-11e6-a0cd-0242ac12000b,GUARDIAN DRUG,guardian_drug,,,,,, +5330,,56362b64-7199-11e6-a0cd-0242ac12000b,MALLARD,mallard,,,,,, +563,0.973989,d2e15a44-a454-409f-91c0-cf787effc96f,PETHEMA Foundation,pethema_foundation,,,,d2e15a44-a454-409f-91c0-cf787effc96f,pethema_foundation,PETHEMA Foundation +5331,,93d90cb3-2794-4906-b295-3107b6e5ec29,St. Antonius Hospital,st_antonius_hospital,,,,,, +5332,,5e05714e-a55a-424e-9698-5d9368fcbde0,Axelar AB,axelar_ab,,,,,, +5333,,fa8db4e1-28a1-440d-8b0f-62c8e3f08c18,AZIENDA SANITARIA OSPEDALIERA O.I.R.M. - S. ANNA,azienda_sanitaria_ospedaliera_o_i_r_m_s_anna,,,,,, +5334,,a0b7492a-9dc4-4e5a-9365-2a22b68751e5,SuppreMol GmbH,suppremol_gmbh,,,,,, +103,0.968844,3da026c0-6fa2-11e6-9663-0242ac12000b,"Janssen Research & Development, LLC",janssen_research_development_llc,,,,3da026c0-6fa2-11e6-9663-0242ac12000b,janssen_research_development_llc,"Janssen Research & Development, LLC" +5335,,e9ac3152-714b-11e6-a0cd-0242ac12000b,CONCORDIA PHARMS INC,concordia_pharms_inc,,,,,, +5336,,be6d7bce-7144-11e6-a0cd-0242ac12000b,YUNG SHIN PHARM,yung_shin_pharm,,,,,, +882,0.957248,d146bf92-529f-465c-b45b-532b0f6bece7,Hyks Silmätautien klinikka,hyks_silm_tautien_klinikka,,,,acee4b3e-08b2-4604-95a5-b5c1e12e7628,hyks,Hyks +854,0.92247,f3c8fb50-1426-41cc-b57e-428fc65a1ffb,"Faculty of Medicine, Otto-von-Guericke-University, Magdeburg",faculty_of_medicine_otto_von_guericke_university_magdeburg,,,,14aef904-0883-4517-a200-b52214e41d54,faculty_for_medicine_otto_von_guericke_university_magdeburg,"Faculty For Medicine, Otto-von-Guericke University Magdeburg" +5337,,c21737cc-f91c-4d4b-a5cf-f3cbca7e1b81,ChronTech Pharma AB,chrontech_pharma_ab,,,,,, +5338,,474611dd-b10e-4a07-998b-1e30c10c4c0e,Hôpitaux Universitaires de strasbourg,h_pitaux_universitaires_de_strasbourg,,,,,, +5339,,3db33d44-7238-11e6-a0cd-0242ac12000b,PFIZER IRELAND,pfizer_ireland,,,,,, +5340,,0166c2dd-8c7e-4161-945d-2079e3c6e204,Centre de Recherche et Développement Pierre Fabre,centre_de_recherche_et_d_veloppement_pierre_fabre,,,,,, +5341,,b6f85df9-02bd-47d5-9abc-71a6b1bfe2d7,Hospital de Cruces,hospital_de_cruces,,,,,, +5342,,b00f5bfb-f36a-4daa-8c65-88a0b5b26b4e,4D Pharma,4d_pharma,,,,,, +5343,,dde7ad12-76bd-4639-be02-4d8984d4cffa,Hammersmith Medicines Research,hammersmith_medicines_research,,,,,, +5344,,06f51c5d-9466-40de-bbb7-c2ba8d5a80b2,"Enzon Pharmaceuticals, Inc",enzon_pharmaceuticals_inc,,,,,, +694,0.95973223447799683,a1b6c5f2-16df-4bac-b6d9-a19ab340e9dd,Krankenhaus Nordwest gGmbH - Institut für Klinisch-Onkologische Forschung,krankenhaus_nordwest_ggmbh_institut_f_r_klinisch_onkologische_forschung,,,,a1b6c5f2-16df-4bac-b6d9-a19ab340e9dd,krankenhaus_nordwest,Krankenhaus Nordwest +5345,,3a1bc562-a534-4e7d-9eb5-7e43f6d966a0,"Celica, Biomedical Center, d.o.o",celica_biomedical_center_d_o_o,,,,,, +5346,,4ea68866-7168-11e6-a0cd-0242ac12000b,Wockhardt Bio AG,wockhardt_bio_ag,,,,,, +781,0.96116987864176429,506098e8-930b-438b-b506-5e599d8535e8,GlaxoSmithKline Research and Development Ltd,glaxosmithkline_research_and_development_ltd,,,,201d9d4f-5cd0-46df-836e-da17fa2b43dd,glaxosmithkline_research_and_development,GlaxoSmithKline Research and Development +5347,,5aac3b6c-8809-11e6-a998-0242ac12000b,Janssen-Cilag B.V,janssen_cilag_b_v,,,,,, +5348,,e2dd5ba7-61da-46e1-8f2f-25d654efe5c6,Companion Diagnostics BV,companion_diagnostics_bv,,,,,, +5349,,48742ac4-735c-417c-8d53-68d74c7d4886,"AS ""GRINDEKS",as_grindeks,,,,,, +392,0.98723113536834717,089e5628-bb66-4808-818a-a79770a11d54,Klinikum der Universität München-Großhadern,klinikum_der_universit_t_m_nchen_gro_hadern,,,,089e5628-bb66-4808-818a-a79770a11d54,klinikum_der_universit_t_m_nchen_gro_hadern,Klinikum der Universität München-Großhadern +5350,,8f38d5de-ebc2-4a1f-a361-cac8eec174f4,Dr. José Ramón Mel Lorenzo,dr_jos_ram_n_mel_lorenzo,,,,,, +5351,,6eb15f35-e85b-40ba-889b-fe70e8b2e43d,"Chorus, a Division of Eli Lilly and Company",chorus_a_division_of_eli_lilly_and_company,,,,,, +5352,,5df342c6-42ac-424c-8a5d-52acc6941d3f,María José Linares Gil,mar_a_jos_linares_gil,,,,,, +5353,,145de322-71bb-11e6-a0cd-0242ac12000b,RECRO GAINESVILLE,recro_gainesville,,,,,, +1021,0.97385847568511963,2e27f2ec-dcc5-4828-b31a-e2eca3930c17,"Impax Laboratories, Inc. acting through its Impax Pharmaceutical Division (Impax)",impax_laboratories_inc_acting_through_its_impax_pharmaceutical_division_impax,,,,2e27f2ec-dcc5-4828-b31a-e2eca3930c17,impax_laboratories_inc_acting_through_its_impax_pharmaceuticals_division_impax,"Impax Laboratories, Inc., acting through its Impax Pharmaceuticals Division (Impax)" +5354,,bc877c34-d932-4b66-8d0b-1f9e46c1e48f,University of Cologne,university_of_cologne,,,,,, +5355,,66c2445a-b173-488e-9f47-6402de853c13,Fondazione per il Tuo cuore onlus-ANMCO,fondazione_per_il_tuo_cuore_onlus_anmco,,,,,, +5356,,a7b5f9b6-dea1-46ba-bb15-c3ff18201e45,Belgian Group of Digestive Oncology,belgian_group_of_digestive_oncology,,,,,, +5357,,11ed3f85-8cc5-4f39-a598-51f56f7e4e36,Merck Shap @ Dohme,merck_shap_dohme,,,,,, +5358,,3db6e35a-b1b9-42c2-af88-7044cba69829,Juan Francisco Navarro González,juan_francisco_navarro_gonz_lez,,,,,, +5359,,565a8ab6-6309-4358-a7e0-eac3cbeb2623,"Human Genome Sciences, a wholly owned subsidiary of GlaxoSmithKline, Plc",human_genome_sciences_a_wholly_owned_subsidiary_of_glaxosmithkline_plc,,,,,, +518,0.973471,c681a058-67c4-4596-ab67-6bb33a32ec89,"Department of infectious Diseases, Odense University Hospital",department_of_infectious_diseases_odense_university_hospital,,,,ae49cd9c-0341-4f5e-a25b-775aca5642ab,department_of_infetious_diseases_odense_university_hospital,"Department of Infetious Diseases, Odense University Hospital" +5360,,a5680aae-34ab-4419-afc8-b12816498364,The Department of Calcium- and Bone-metabolic Diseases,the_department_of_calcium_and_bone_metabolic_diseases,,,,,, +5361,,5b18d038-67b6-4811-8f0e-16ce6a47abda,The University Hospitals of Leicester NHS Trust,the_university_hospitals_of_leicester_nhs_trust,,,,,, +5362,,83f94f48-87d3-400f-b382-0a3d306cda25,CRLCC Alexis Vautrin,crlcc_alexis_vautrin,,,,,, +513,0.977852,4cab1fe6-1355-4704-bbea-7a3c03e27398,Intergroupe Francophone du Myélome,intergroupe_francophone_du_my_lome,,,,04cef99e-6fba-11e6-abe8-0242ac12000b,intergroupe_francophone_du_myelome_ifm,Intergroupe Francophone du Myelome (IFM) +5363,,cc886340-a9e0-4093-a443-841ae11d7bff,REATA PHARMACEUTICALS INC,reata_pharmaceuticals_inc,,,,,, +5364,,bc085607-4592-47d9-b52c-89049eeb7c33,MedUni Innsbruck Klinik für Strahlentherapie,meduni_innsbruck_klinik_f_r_strahlentherapie,,,,,, +5365,,c4b80966-7141-11e6-a0cd-0242ac12000b,CEDAR PHARMS,cedar_pharms,,,,,, +5366,,56bbfcf3-612e-4455-9074-ae7a21eee65f,RedHill Biopharma Ltd,redhill_biopharma_ltd,,,,,, +5367,,b0ebcb00-6179-4862-936c-51f808246028,ZAMBON GROUP,zambon_group,,,,,, +5368,,1a9e6c33-c395-4a9f-b759-c708b1a84b76,TIPharma,tipharma,,,,,, +5369,,a9832062-715b-11e6-a0cd-0242ac12000b,MIRROR PHARMS,mirror_pharms,,,,,, +5370,,0e953077-e06a-4b1f-85a5-4fd66e546dcb,Solveig Wållberg-Jonsson,solveig_w_llberg_jonsson,,,,,, +921,0.98046,ffe14227-33a6-406e-a9aa-f8ce7dfd8125,"National Institutes of Health, National Eye Institute",national_institutes_of_health_national_eye_institute,,,,e90b434e-23d4-448b-9e92-391d596fe17c,national_institute_of_health_national_eye_institute,"National Institute of Health, National Eye Institute" +5371,,deca2126-685f-4c4c-a555-a9388aba9e7a,"Department of Immunology, Genetics and Pathology (IGP), Rudbeck Laboratory, Uppsala University",department_of_immunology_genetics_and_pathology_igp_rudbeck_laboratory_uppsala_university,,,,,, +5372,,9dc7431c-d0aa-4d05-bee1-8101956d28e6,Centre Hospitalier de Lens,centre_hospitalier_de_lens,,,,,, +5373,,f168c5cf-8be1-4b32-82c7-734f4652fa58,Dekan des Fachbereichs Humanmedizin,dekan_des_fachbereichs_humanmedizin,,,,,, +5374,,dc982b00-7165-11e6-a0cd-0242ac12000b,RARITAN PHARMS INC,raritan_pharms_inc,,,,,, +5375,,beec5897-d1b6-4b56-8d18-5f56e9f65f71,Proveca Ltd,proveca_ltd,,,,,, +5376,,8731efd0-b20a-45e5-b6c5-5aaf38abde80,"F. Hoffman-La Roche Ltd., realizado en España por Roche Farma S.A",f_hoffman_la_roche_ltd_realizado_en_espa_a_por_roche_farma_s_a,,,,,, +5377,,92fed13d-1869-42c6-8a53-a1b8bc5aa0ea,"Integrated Therapeutics Group, Incorporated - a subsidiary of Schering-Plough",integrated_therapeutics_group_incorporated_a_subsidiary_of_schering_plough,,,,,, +5378,,07beeb5d-9dd8-4d57-9ac0-76620f7ab5ce,Laboratorios Pfizer S.A,laboratorios_pfizer_s_a,,,,,, +5379,,da6976be-f055-4162-89e7-87d1368dade1,"Pfizer Ltd, Sandwich, UK",pfizer_ltd_sandwich_uk,,,,,, +716,0.986058,b224eb63-4342-47e7-8cbf-799b488e62a3,Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar),consorci_mar_parc_de_salut_de_barcelona_parc_de_salut_mar,,,,35022515-9c52-4711-b51c-84b1e5d62adf,consorci_mar_parc_de_salut_de_barcelona,Consorci Mar Parc de Salut de Barcelona +5380,,c14f6463-3285-42f5-9d06-7ea893b1cb98,Charité Universitätsmedizin Berlin - CVK,charit_universit_tsmedizin_berlin_cvk,,,,,, +5381,,a1c66c22-73f3-11e6-a0cd-0242ac12000b,MEDICINES360,medicines360,,,,,, +648,0.92974448204040527,9744044a-acde-47ca-82d9-cce98024b24f,"Boehringer Ingeleim España, S.A",boehringer_ingeleim_espa_a_s_a,,,,400bd40c-fbde-4cec-8aeb-cb463c403ce5,boehringer_ingleheim_espa_a_s_a,"Boehringer Ingleheim España, S.A" +5382,,36dc1206-68b1-4b42-b667-f4ef6b64e688,Cardiorentis Ltd,cardiorentis_ltd,,,,,, +5383,,c1dee9e0-063b-450f-ba5f-96a5b4fb56b9,CHRU-Tours,chru_tours,,,,,, +5384,,d5aea122-46b6-433e-89d3-8da4daef168b,BørneklinikkenRanders,b_rneklinikkenranders,,,,,, +5385,,c9fa5aff-a7ea-48f7-a101-1bb16fe22693,Nordic Pharma SAS,nordic_pharma_sas,,,,,, +5386,,08184b11-ae0e-4b89-a2f7-f61d4117be0d,Càndid Villanueva,c_ndid_villanueva,,,,,, +5387,,fb31fe79-2680-4df2-a803-b78f9ceeae53,Helsinn Healthcare SA,helsinn_healthcare_sa,,,,,, +5388,,0acba83b-37e0-4ad2-8730-54c486be8371,"Maruho Co., Ltd",maruho_co_ltd,,,,,, +5389,,5c443a96-2016-4ff3-b558-2de4336dbc49,"Tigercat Pharma, Inc",tigercat_pharma_inc,,,,,, +5390,,db6796ba-ae2b-4a88-9fb2-be8939d06049,ActoGeniX N.V,actogenix_n_v,,,,,, +5391,,d901e822-aacd-465f-bfdd-fc88903ab522,YAMANOUCHI PHARMA,yamanouchi_pharma,,,,,, +5392,,e1c217ea-7164-11e6-a0cd-0242ac12000b,GLENMARK PHARMS INC,glenmark_pharms_inc,,,,,, +5393,,19c471b0-9a62-479b-a54f-bc3cb39e03df,Hexal Biotech ForschungsGmbH,hexal_biotech_forschungsgmbh,,,,,, +114,0.97253835201263428,f9c63488-b208-4cec-bb35-736ec99784f4,Shire Pharmaceuticals Ireland Limited,shire_pharmaceuticals_ireland_limited,,,,c0e26a28-8145-497a-8f48-d935495cc957,shire_pharmaceutical_ireland_limited,Shire Pharmaceutical Ireland Limited +5394,,2bda0c17-0184-4604-a093-9c9c5ba3233f,KULeuven,kuleuven,,,,,, +5395,,26c09d91-8718-4bdd-8c56-9d1a9b6703d2,Mereo BioPharma 2 Limited,mereo_biopharma_2_limited,,,,,, +5396,,657cae18-c54d-4094-b829-5f02e00aec58,Red Europea de Mieloma (European Myeloma Network),red_europea_de_mieloma_european_myeloma_network,,,,,, +5397,,168507da-bb63-4a52-9cb5-5a8bf4f1e68a,Ipsen Pharma S.A.S,ipsen_pharma_s_a_s,,,,,, +1047,0.985052,010d35da-5d47-4a0d-b01d-6b5b38df61c0,InnaVirVax,innavirvax,,,,010d35da-5d47-4a0d-b01d-6b5b38df61c0,innavirvax,InnaVirVax +5398,,0debcf3f-2c51-4cb4-bcf8-e0aa540a3740,"Lilly Deutschland GmbH, Teichweg 3, 35396 Gießen",lilly_deutschland_gmbh_teichweg_3_35396_gie_en,,,,,, +933,0.98374366760253906,8a975e77-bff3-468d-a2aa-195e43fc01ee,Pierre Fabre Médicament - IRPF,pierre_fabre_m_dicament_irpf,,,,e26f58e7-f0e7-4ad4-9432-e13ea279b291,pierre_fabre,Pierre Fabre Médicament +5399,,ad4ab05f-c294-4fba-9441-73a7e4bf4262,Institut de Recerca Hospital Sant Pau,institut_de_recerca_hospital_sant_pau,,,,,, +5400,,38559e27-97ef-4488-b94c-f6171f949a03,Biotech Tools sa,biotech_tools_sa,,,,,, +5401,,5209b5fa-c96c-43dc-a954-faf731dbf753,Suomen MSD Oy,suomen_msd_oy,,,,,, +1035,0.968193,6b6beb8f-b475-4ffe-9251-555c397c2420,"Department off Infectious Diseases, Aarhus University Hospital Skejby, Denmark",department_off_infectious_diseases_aarhus_university_hospital_skejby_denmark,,,,35768696-3c8d-4b10-b3d3-c9d161f53a97,department_of_infectious_diseases_aarhus_university_hospital_skejby,"Department of Infectious Diseases, Aarhus University Hospital, Skejby" +58,0.97575701773166656,26c8a4f6-dda7-4538-a3f6-214df3725d63,Wyeth Research Division of Wyeth Pharmaceutical Inc,wyeth_research_division_of_wyeth_pharmaceutical_inc,,,,2ed1b6f4-e137-4ee3-a218-9e5c2d04039a,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_and_development,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development +5402,,a59ec6de-2316-499c-83fe-5c89039a4585,DR. AUGUST WOLFF GMBH & CO. KG,dr_august_wolff_gmbh_co_kg,,,,,, +5403,,580046a1-1e7c-4046-8f2f-c52beab3beb1,Dr. Joan Ramon Masclans. Servicio de Medicina Intensiva. Hospital Universitario Vall d'Hebron,dr_joan_ramon_masclans_servicio_de_medicina_intensiva_hospital_universitario_vall_d_hebron,,,,,, +5404,,0460de08-075b-4857-9ecf-5e5d6aeb70bf,Ospedale L. Sacco - Azienda Ospedaliera-Polo Universitario,ospedale_l_sacco_azienda_ospedaliera_polo_universitario,,,,,, +728,0.97142621874809265,71c0daf2-cfe7-43e5-be3b-917837604cd4,"UCB Celltech, UK Registered Branch of UCB Pharma SA",ucb_celltech_uk_registered_branch_of_ucb_pharma_sa,,,,093988ab-1f2c-48ab-84d3-0b1dff68400e,ucb_celltech_uk,"UCB Celltech, UK" +5405,,94a58601-99ac-4e35-a359-f2295c71f769,Streeklaboratorium voor de volksgezondheid Kennemerland,streeklaboratorium_voor_de_volksgezondheid_kennemerland,,,,,, +5406,,216ca999-a2e2-43a1-90e2-04afeb12c18b,Ammerland-Klinik Westerstede,ammerland_klinik_westerstede,,,,,, +5407,,6436fe51-97b5-473f-a2d1-77084847aa14,Department of Vascular Medicine of the Academic Medical Center,department_of_vascular_medicine_of_the_academic_medical_center,,,,,, +5408,,fe91873e-b1be-4636-a99e-335eb8a162d3,Phönix Laboratorium GmbH,ph_nix_laboratorium_gmbh,,,,,, +933,0.98634018500645959,32e92a8c-9148-48c6-a968-59666d75b63b,Pierre Fabre Médicament, Represented by Institut de Recherche Pierre Fabre,,,,e26f58e7-f0e7-4ad4-9432-e13ea279b291,pierre_fabre,Pierre Fabre Médicament +5409,,05c39b86-e6e8-4f38-a131-fc49fd62e46b,Stichting Lever Onderzoek,stichting_lever_onderzoek,,,,,, +5410,,a69947a5-b82c-4d42-af4e-85bd5efc28d4,Aquinox Pharmaceuticals Inc,aquinox_pharmaceuticals_inc,,,,,, +5411,,a992da05-20a5-4d4f-9543-cacd1b19243a,"Dipartimento Integrato di Oncologia, Ematologia e Patologie dell'Apparato Respiratorio",dipartimento_integrato_di_oncologia_ematologia_e_patologie_dell_apparato_respiratorio,pierre_fabre_m_dicament_represented_by_institut_de_recherche_pierre_fabre,,,,, +5412,,3e3bbc58-8d3a-4ebf-99a9-9cb231db11e2,Departamento de Oftalmología. Hospital Clínico San Carlos,departamento_de_oftalmolog_a_hospital_cl_nico_san_carlos,,,,,, +5413,,d4a8fd12-e500-4aaa-a47f-0f89fa2fad86,Dutch Colorectal Cancer Group,dutch_colorectal_cancer_group,,,,,, +5414,,dd341ac5-b342-4151-993b-37c343a459c6,"CHU de Liège, Domaine Universitaire du Sart Tilman",chu_de_li_ge_domaine_universitaire_du_sart_tilman,,,,,, +5415,,169a7edd-0fea-4ff9-b017-5890aeefa892,GILEAD SCIENCES S.R.L,gilead_sciences_s_r_l,,,,,, +5416,,14b22eaf-0e23-49c3-b07e-0ee4eba18c5f,LFB BIOTECHNOLOGIES,lfb_biotechnologies,,,,,, +5417,,7064efd2-715f-11e6-a0cd-0242ac12000b,PHOENIX LABS NY,phoenix_labs_ny,,,,,, +5418,,55cf01e0-2831-4e5b-adaf-bf4a2ac2b341,PLETHORA SOLUTIONS LIMITED,plethora_solutions_limited,,,,,, +5419,,80acf1b6-803a-4f60-afd9-d91e7a997b0a,"Academic Medical Center, department of Gastroenterology and hepatology",academic_medical_center_department_of_gastroenterology_and_hepatology,,,,,, +5420,,140a4fb2-06bd-4830-804e-0e695a5df065,Hytönen Maija,hyt_nen_maija,,,,,, +5421,,5cefc031-6f93-4339-86de-d85b4785766b,"Janssen-Cilag International NV, Turnhoutsweg 30, 2340 BEERSE, Belgium",janssen_cilag_international_nv_turnhoutsweg_30_2340_beerse_belgium,,,,,, +5422,,f1816e21-2d63-426f-8a5d-bbc7525de5bf,"Academic Medical Center, Neurosurgery",academic_medical_center_neurosurgery,,,,,, +5423,,d269a09f-e217-4227-b29f-1bb7670d5714,Cardiome Pharma Corp,cardiome_pharma_corp,,,,,, +868,0.98777571320533752,d75f8fe0-80ce-4bb5-9e6e-ab63e91189dc,"Astellas Pharma Global Development, Inc. (APGD)",astellas_pharma_global_development_inc_apgd,,,,d75f8fe0-80ce-4bb5-9e6e-ab63e91189dc,astellas_pharma_global_development_inc,"Astellas Pharma Global Development, Inc" +5424,,f9538f53-a235-43ad-b8d6-c912c58a4d26,Austrian Prostate Study Group (AUPSG),austrian_prostate_study_group_aupsg,,,,,, +5425,,b9aa917a-1637-4492-ba12-9290d9deca7e,AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI,azienda_ospedaliera_san_camillo_forlanini,,,,,, +5426,,f606bf38-7998-4701-b46c-9d6ec13b9ada,Fundación Investigación Biomédica Hospital Universitario Puerta de Hierro,fundaci_n_investigaci_n_biom_dica_hospital_universitario_puerta_de_hierro,,,,,, +5427,,73a76a8f-26f1-4b7d-a2d3-02faf0415cad,Royal National Lifeboat Institution,royal_national_lifeboat_institution,,,,,, +5428,,501a4be8-773c-4765-854d-867b49df9b60,STADA Arzneimittel AG,stada_arzneimittel_ag,,,,,, +404,0.984546,26d3b205-826f-444a-a5e3-2e552a9d8a82,"Technical University of Dresden, faculty of medicine",technical_university_of_dresden_faculty_of_medicine,,,,26d3b205-826f-444a-a5e3-2e552a9d8a82,technical_university_of_dresden_faculty_of_medicine,"Technical University of Dresden, faculty of medicine" +5429,,b083630f-316f-4ed8-b713-ad1939c5149f,Osmotica Pharmaceutical Corp,osmotica_pharmaceutical_corp,,,,,, +5430,,3dd6d08a-8de4-4b54-83a8-931402cb0184,"OXiGENE, Inc",oxigene_inc,,,,,, +5431,,b9a1d6d5-c6df-42a5-987a-3a44fa74c4dc,Laboratoires Bouchara-Recordati,laboratoires_bouchara_recordati,,,,,, +5432,,47cd072a-716a-11e6-a0cd-0242ac12000b,BERLEX LABS,berlex_labs,,,,,, +5433,,38846f40-72cf-11e6-a0cd-0242ac12000b,MSD INTL,msd_intl,,,,,, +5434,,ca99fe50-7157-11e6-a0cd-0242ac12000b,VISTA PHARMS,vista_pharms,,,,,, +5435,,bf8fddda-e0ff-4d9c-a579-f9be2581d93d,A.N.M.C.O.-Fondazione Italiana lotta Malattie Cardiovasc,a_n_m_c_o_fondazione_italiana_lotta_malattie_cardiovasc,,,,,, +5436,,a0594702-e873-419b-8600-819fbd8d06bb,Umeå Universitet,ume_universitet,,,,,, +651,0.98270362615585327,dc7fe857-5b5c-4680-bf4a-93d56847b77c,Boehringer Ingelheim bv,boehringer_ingelheim_bv,,,,4501c601-be00-4be3-8378-bb49eca4c7fb,boehringer_ingelheim_bv_medical_department,"Boehringer Ingelheim bv, Medical department" +5437,,f40a7fc2-8c1f-4b0b-89be-6343299d7598,Novartis S.A,novartis_s_a,,,,,, +5438,,8705e96e-e03c-4f8d-8961-d3d394bfff12,Novartis Phama GmbH,novartis_phama_gmbh,,,,,, +5439,,02a45e3f-96b8-4e0c-9247-41d0c82b511f,Bexel Pharmaceuticals Inc,bexel_pharmaceuticals_inc,,,,,, +719,0.98507535457611084,b0adc94a-71fc-11e6-a0cd-0242ac12000b,OTSUKA AMERICA,otsuka_america,,,,8ec06b1a-733e-11e6-a0cd-0242ac12000b,otsuka_america_pharm,OTSUKA AMERICA PHARM +453,0.900843,7b861ad6-7163-11e6-a0cd-0242ac12000b,ANTIBIOTICE,antibiotice,,,,7b861ad6-7163-11e6-a0cd-0242ac12000b,antibiotice,ANTIBIOTICE +5440,,ab59a145-9558-47c6-8c6e-f1513bd4db80,FONDAZIONE NEOPLASIE SANGUE ONLUS,fondazione_neoplasie_sangue_onlus,,,,,, +5441,,de128766-5b71-4095-8cc3-7fc6ff54be71,GRUPO ESPAÑOL DE TRASPLANTE HEMATOPOYÉTICO Y TERAPIA CELULAR (GETH),grupo_espa_ol_de_trasplante_hematopoy_tico_y_terapia_celular_geth,,,,,, +5442,,377a52d0-2e5f-40f9-8656-7548b252bdce,Sanaria Inc,sanaria_inc,,,,,, +5443,,8d8bb690-b398-4a61-9bee-735eccc38151,INMUNO DESIGNED MOLECULES (IDM),inmuno_designed_molecules_idm,,,,,, +5444,,3ed003c8-069c-4ac5-bd42-c9c0d1cb5322,Gilead Sciences Europe Ltd,gilead_sciences_europe_ltd,,,,,, +5445,,4863224b-a366-4a2e-824c-7f4a1ab3f49a,Reinier de Graaf Groep,reinier_de_graaf_groep,,,,,, +222,0.955709,dbe23764-1ae1-4f02-91a8-45cdf5d7ec2c,SOGUG - Spanish Oncology Genitourinary Group,sogug_spanish_oncology_genitourinary_group,,,,1cd31001-2166-4db7-b391-c4c12d25d9ea,sogug,SOGUG +5446,,9fc7fbbf-6c76-4fff-8def-8c0429a15b7c,Grupo Español Multidisciplinar en Cáncer Digestivo (GEMCAD),grupo_espa_ol_multidisciplinar_en_c_ncer_digestivo_gemcad,,,,,, +5447,,edc92120-5f18-4507-8b8e-8badf11e5fbe,Unidad de investigación en Tuberculosis de Barcelona,unidad_de_investigaci_n_en_tuberculosis_de_barcelona,,,,,, +5448,,76312428-f3fd-495c-a759-69bd025030ab,Ilkka Pörsti ja tutkimusryhmä,ilkka_p_rsti_ja_tutkimusryhm,,,,,, +5449,,be4c8548-abcc-42c9-bea3-6704ebfe2673,Fundacio Clinic per a la Recerca Biomèdica,fundacio_clinic_per_a_la_recerca_biom_dica,,,,,, +5450,,5d4b9f47-43d1-4efd-839d-e88a80cab2c2,Wyeth K.K. Research and Development Department,wyeth_k_k_research_and_development_department,,,,,, +5451,,12358d7a-715c-11e6-a0cd-0242ac12000b,HH AND P,hh_and_p,,,,,, +5452,,8f19bff5-57cb-45b4-b127-eec44992ef93,Mª Carmen Fariñas Álvarez. Hospital Universitario Marques de Valdecilla,m_carmen_fari_as_lvarez_hospital_universitario_marques_de_valdecilla,,,,,, +5453,,ee40c945-2c2d-4356-87a7-59b47a870049,Oy Lundbeck,oy_lundbeck,,,,,, +5454,,edbdbd3a-f429-480f-b50c-c68978cdaece,HK Clinical Trials,hk_clinical_trials,,,,,, +5455,,6e562480-10d0-4977-b3ff-c506fbad3275,Summit (Oxford) Limited,summit_oxford_limited,,,,,, +5456,,6bcce27a-8bdd-11e6-a449-0242ac12000b,"National Heart, Lung, and Blood Institute (NHLBI)",national_heart_lung_and_blood_institute_nhlbi,,,,,, +5457,,6744716d-6685-4c3e-ac8f-1bfa10aaf6e8,Exalenz BioScience Ltd,exalenz_bioscience_ltd,,,,,, +5458,,f13c25bd-81ef-4b46-89f4-e9e5769476f8,Craigavon Area Hospital Group Trust,craigavon_area_hospital_group_trust,,,,,, +5459,,310c3146-199c-4396-a66c-6b3175ad7d4f,TopoTarget A/S,topotarget_a_s,,,,,, +856,0.98108509182929993,9f592f36-f2fd-4ddb-82ae-45342aa0b7ea,Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-ALV),netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital_nki_alv,,,,66b401ea-5009-4db7-8b18-6fe29a2c6186,netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital,Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL) +5460,,70ab9e50-c7b6-4d52-98bc-f3a67e594f7b,Encysive Pharmaceuticals Inc,encysive_pharmaceuticals_inc,,,,,, +5461,,62c047bc-9a88-4129-9990-72b60f474804,"Karyopharm Therapeutics, Inc",karyopharm_therapeutics_inc,,,,,, +5462,,ad020afa-0b23-46b2-b667-1f7c67e3a8a0,CHRU of Lille,chru_of_lille,,,,,, +5463,,2755bb5f-5f21-42d4-a889-d358a31c9c73,Lupin Atlantis Holdings S.A,lupin_atlantis_holdings_s_a,,,,,, +760,0.987506,db892fbd-e5f0-40a8-8d13-447693b60e04,Västra Götalandregionen,v_stra_g_talandregionen,,,,db892fbd-e5f0-40a8-8d13-447693b60e04,v_stra_g_talandregionen,Västra Götalandregionen +5464,,f26aa29d-32c7-4b6d-8e11-b89452c6e1ef,"Adj,Professor, Torsten Gordh",adj_professor_torsten_gordh,,,,,, +5465,,ac689a48-5279-4d6c-9063-5ef34296650a,"Myriad Pharmaceuticals, Inc",myriad_pharmaceuticals_inc,,,,,, +5466,,1562785b-9f0c-4e1b-865a-53c67e3f54ef,Per F. Jensen,per_f_jensen,,,,,, +5467,,8672907b-e24a-4288-8702-7a044e466ae6,Pfizer N.V./S.A,pfizer_n_v_s_a,,,,,, +5468,,61224168-df00-47f7-8bb0-37b61e924936,Ashford & St. Peter's Hospitals NHS Trust,ashford_st_peter_s_hospitals_nhs_trust,,,,,, +5469,,9ff4366c-103d-4b62-99c2-fabd75795896,CELSG (Central European Leukemia Study Group),celsg_central_european_leukemia_study_group,,,,,, +5470,,7db85e0e-b948-4c72-8d4e-57c963b6a503,Vienna Institute for Research in Ocular Surgery,vienna_institute_for_research_in_ocular_surgery,,,,,, +5471,,63b9fbd7-d245-4bd5-80ba-1307da35fc13,Napp Pharmaceuticals Research Limited,napp_pharmaceuticals_research_limited,,,,,, +5472,,dd0b7f7c-a710-11e6-94cb-5656d04fc2b5,Orthopädisches Spital Speising,orthop_disches_spital_speising,,,,,, +5473,,c114e30c-2cd9-4b5a-b083-33134e6e4024,"HagaZiekenhuis, pulmonary department",hagaziekenhuis_pulmonary_department,,,,,, +5474,,3c54bfc4-5661-427d-8891-a439fd7081db,"Med. Univ. Wien, Klinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie",med_univ_wien_klinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,,,,,, +5475,,2336601a-25bf-429f-b5ef-dec18af6fe7e,"Helse Bergen, Haukeland University Hospital",helse_bergen_haukeland_university_hospital,,,,,, +5476,,59a36efc-41c2-4a83-bba6-95d6283477c6,Joseba Andoni Santamaría Zuazua,joseba_andoni_santamar_a_zuazua,,,,,, +5477,,6ea93704-856a-4b0e-8493-bf5eaf104520,Miguel Santin Cerezales,miguel_santin_cerezales,,,,,, +742,0.964268,50350555-1ec9-4ba6-9bb5-53e28ef8341d,Charite,charite,,,,50350555-1ec9-4ba6-9bb5-53e28ef8341d,charite,Charite +793,0.912188,9012ebe0-cafc-4b9e-8d91-e304af97eab8,Amersham Health SA (Parte de GE Healthcare Ltd. y sus filiales),amersham_health_sa_parte_de_ge_healthcare_ltd_y_sus_filiales,,,,9012ebe0-cafc-4b9e-8d91-e304af97eab8,amersham_health_sa_parte_de_ge_healthcare_ltd_y_sus_filiales,Amersham Health SA (Parte de GE Healthcare Ltd. y sus filiales) +765,0.98034405708312988,b8d4c322-6db4-4e89-8f5b-b4aa64ab122b,AbbVie GK,abbvie_gk,,,,59b7be85-48d9-4a80-8f5f-ff23404f5da2,abbvie,AbbVie +5478,,e90cb3ec-7160-11e6-a0cd-0242ac12000b,BAKER NORTON,baker_norton,,,,,, +5479,,30b6dd11-f766-47fb-8dfc-90c9e9f37253,Alexion Pharmaceuitcals Inc,alexion_pharmaceuitcals_inc,,,,,, +68,0.933464,9ba1f3da-ec16-443c-baaf-efec93f1ac9e,Medtronic International Trading,medtronic_international_trading,,,,9ba1f3da-ec16-443c-baaf-efec93f1ac9e,medtronic_international_trading,Medtronic International Trading +5480,,19e8cc00-71b9-11e6-a0cd-0242ac12000b,CHESEBROUGH PONDS,chesebrough_ponds,,,,,, +5481,,7c61ca40-881f-11e6-a998-0242ac12000b,Martha-Maria Krankenhaus Halle-Dölau gGmbH,martha_maria_krankenhaus_halle_d_lau_ggmbh,,,,,, +537,0.92192,a1967c73-0590-46d4-9778-5b03b30b3867,Centocor B.V. (Janssen Biologics),centocor_b_v_janssen_biologics,,,,5acde854-4953-47c0-9987-89e6a451966b,centocor_bv,Centocor BV +122,0.98044869303703308,5d30f108-14de-47f2-b6d3-5237b8c59f60,"F. Hoffmann-La Roche Ltd, Pharmaceuticals Division, PDR",f_hoffmann_la_roche_ltd_pharmaceuticals_division_pdr,,,,89ecf617-74e0-496c-8ac4-d4eae3b54d8c,f_hoffmann_la_roche_ltd_pharmaceuticals_divison_pdr,"F. Hoffmann-La Roche Ltd, Pharmaceuticals Divison, PDR" +860,0.972948,c56eab54-901b-4b49-af9e-003413595588,"Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust",addenbrooke_s_hospital_cambridge_university_hospitals_nhs_foundation_trust,,,,1fd9be47-d214-4572-b318-1aa9dc588ded,addenbrookes_hospital_cambridge_university_hospitals_nhs_foundation_trust,Addenbrookes Hospital Cambridge University Hospitals NHS Foundation Trust +5482,,70312420-7057-4cef-9d5d-020a121fa811,"Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases",radboud_university_nijmegen_medical_centre_department_of_rheumatic_diseases,,,,,, +5483,,bcc43f7a-2279-4c6a-9de6-88cd0039f6f1,Immunocore Ltd,immunocore_ltd,,,,,, +615,0.90712672472000122,27b37686-1c0f-4738-ab0a-36c44f7ea9cc,"Fundación para la Investigación Biomédica del Hospital Universitario La Paz, Sección de Cirugía Colorrectal del Hospital",fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz_secci_n_de_cirug_a_colorrectal_del_hospital,,,,27b37686-1c0f-4738-ab0a-36c44f7ea9cc,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz_secci_n_de_cirug_a_colorrectal_del_hospital,"Fundación para la Investigación Biomédica del Hospital Universitario La Paz, Sección de Cirugía Colorrectal del Hospital" +531,0.979737,b547816e-7141-11e6-a0cd-0242ac12000b,BEDFORD LABS,bedford_labs,,,,50f04e40-7145-11e6-a0cd-0242ac12000b,bedford,BEDFORD +5484,,4934f79e-7160-11e6-a0cd-0242ac12000b,R AND S PHARMA,r_and_s_pharma,,,,,, +342,0.97989612817764282,748853e0-73f0-11e6-a0cd-0242ac12000b,AIR LIQUIDE AMERICA LP,air_liquide_america_lp,,,,748853e0-73f0-11e6-a0cd-0242ac12000b,air_liquide_america_lp,AIR LIQUIDE AMERICA LP +5485,,bd32656d-5585-46dc-b525-81a5fd24bb8a,"VU University Medical Center, Department of Medical Oncology",vu_university_medical_center_department_of_medical_oncology,,,,,, +5486,,45edd3dd-de44-428a-b5a0-4024e9311498,Grupo Español Multidisciplinar de Melanoma,grupo_espa_ol_multidisciplinar_de_melanoma,,,,,, +5487,,53e6a43c-73fc-11e6-a0cd-0242ac12000b,SALIX PHARMS INC,salix_pharms_inc,,,,,, +5488,,b567e4ef-72fe-4e57-9c8c-1f81be0e4e05,Inamed Research GmbH & Co. KG,inamed_research_gmbh_co_kg,,,,,, +5489,,aabc636a-089f-4116-9c1f-965afb4d5648,IPPMed – Institut für Pharmakologie und Präventive Medizin GmbH,ippmed_institut_f_r_pharmakologie_und_pr_ventive_medizin_gmbh,,,,,, +908,0.97244110703468323,e9e7b197-6597-4676-882e-bdcdcd1c67e4,sanofi-aventis Recherche & Développement,sanofi_aventis_recherche_d_veloppement,,,,9c45d693-515d-4149-92e4-d7272d06a7df,sanofi_aventis_recherche_d_veloppement,sanofi-aventis Recherche & Développement +5490,,34331a89-e540-4915-afbd-53e9943b3f71,BIOVOMED,biovomed,,,,,, +5491,,03dce284-7150-11e6-a0cd-0242ac12000b,NOVEX,novex,,,,,, +5492,,6c562268-2c72-4929-97fc-995ff2441e60,Qualissima,qualissima,,,,,, +789,0.986288,4cf10dca-715e-11e6-a0cd-0242ac12000b,GRANULES INDIA,granules_india,,,,216d0aa8-7165-11e6-a0cd-0242ac12000b,granules_india_ltd,GRANULES INDIA LTD +5493,,5fdf0294-73d3-11e6-a0cd-0242ac12000b,ECLAT PHARMS LLC,eclat_pharms_llc,,,,,, +5494,,fbaf1b83-5030-4b53-8a77-143242cefca1,RWTH Aachen vertreten durch das CTC-A,rwth_aachen_vertreten_durch_das_ctc_a,,,,,, +121,0.98132741451263428,e3879409-1e60-4b17-837b-77daafa719b8,F. Hoffmann-La Roche Limited,f_hoffmann_la_roche_limited,,,,2929b798-0440-49f3-ab5b-122a578e01ba,f_hoffmann_la_roche_limited_pharmaceuticals_division_pdr,"F. Hoffmann-La Roche Limited, Pharmaceuticals Division, PDR" +5495,,67d7d813-d44a-4e44-aa25-f6a725b3ed99,Krankenhaus Nordwest gGmbH,krankenhaus_nordwest_ggmbh,,,,,, +833,0.975572,df3797bd-ef16-44fb-a365-bf5b5811b6a7,Aalborg University Hospital,aalborg_university_hospital,,,,2a713a15-71e1-4a58-a888-238d8c875592,aalborg_university_hospital_aalborg_psychiatric_hospital_centre_for_schizophrenia,"Aalborg University Hospital, Aalborg Psychiatric Hospital, Centre for Schizophrenia" +5496,,cbe966d4-5da4-4336-813a-a70cb41a5627,TikoMed AB,tikomed_ab,,,,,, +5497,,5ed56589-1113-44a5-acec-62fb05efffe7,Salford Royal Hospital,salford_royal_hospital,,,,,, +5498,,29a8ed06-4cbe-42fd-9e2c-9f341d5a1fd5,"Molecular Insight Pharmaceuticals, Inc",molecular_insight_pharmaceuticals_inc,,,,,, +5499,,d68dbbd9-0bd3-40fc-ab25-d74e4b0a29c5,AISSM ONLUS,aissm_onlus,,,,,, +5500,,5bc7ad23-f947-4db5-9ba3-41a43c6f6810,"Millenium Pharmaceuticals, a wholly owned subsidiary of Takeda pharmaceutical Company Limited",millenium_pharmaceuticals_a_wholly_owned_subsidiary_of_takeda_pharmaceutical_company_limited,,,,,, +5501,,55342c52-eab2-4039-b096-b5d6ccb692e0,Universitätsklinikum Erlangen,universit_tsklinikum_erlangen,,,,,, +461,0.97477978467941284,006566e8-3afd-4507-99a0-43f66a5ab93a,Debiopharm International SA,debiopharm_international_sa,,,,006566e8-3afd-4507-99a0-43f66a5ab93a,debiopharm,Debiopharm +5502,,77d8f087-df88-4e97-90a1-b5949ff1b3b8,Penwest Pharmaceuticals Co,penwest_pharmaceuticals_co,,,,,, +5503,,8f38a794-93c0-4b03-b233-584b5c5fbeb3,"University of Cologne, Quality Assurance Unit of the Sponsor, Dean of research office",university_of_cologne_quality_assurance_unit_of_the_sponsor_dean_of_research_office,,,,,, +5504,,e0a96853-7375-49bd-8494-4c6fba11ecb8,Erasmus University Rotterdam,erasmus_university_rotterdam,,,,,, +5505,,7a1c72fd-e9c8-4e40-9e84-4e27090a8f5b,Miltenyi Biotec GmbH,miltenyi_biotec_gmbh,,,,,, +2,0.983866,7f8c8a75-8bf8-48df-b832-ab6dba5c9c9c,Västra Götaland,v_stra_g_taland,,,,7f8c8a75-8bf8-48df-b832-ab6dba5c9c9c,v_stra_g_taland,Västra Götaland +5506,,13d394a6-f234-4b2b-a81c-d580f20e64a1,"Orion Corporation, Orion Pharma, Orionintie,",orion_corporation_orion_pharma_orionintie,,,,,, +630,0.953662,0390bcaa-7142-11e6-a0cd-0242ac12000b,HETERO LABS LTD III,hetero_labs_ltd_iii,,,,0390bcaa-7142-11e6-a0cd-0242ac12000b,hetero_labs_ltd_iii,HETERO LABS LTD III +5507,,96a4346c-2008-4a30-8533-75a806b40a23,Novartis Farmaceuica S.A,novartis_farmaceuica_s_a,,,,,, +5508,,d7656961-30bb-4910-89f5-fafc13b8244e,Hospital Ramón y Cajal,hospital_ram_n_y_cajal,,,,,, +5509,,f6d708ab-9af6-4837-9c86-52629a447c4f,Colotech A/S,colotech_a_s,,,,,, +5510,,c203cacd-d1bb-468e-8dad-99912d5e8bd2,The National Eye Institute,the_national_eye_institute,,,,,, +604,0.96016567945480347,74f3207f-10fc-4bf9-acea-27c94f21b20d,Fundación Investigación y Desarrollo en el Area Cardiovascular,fundaci_n_investigaci_n_y_desarrollo_en_el_area_cardiovascular,,,,1a6a910e-9e16-4295-9c10-800391283d55,fundaci_n_investigaci_n_y_desarrollo_en_el_rea_cardiovascular,Fundación Investigación y Desarrollo en el Área Cardiovascular +5511,,c4938b10-ba57-4b37-9ad1-a331f192fc37,Karl Andersen,karl_andersen,,,,,, +5512,,9e338ad8-fcc3-4c87-9a6f-72ea2e0f789b,Trichocare Diagnostics Ltd,trichocare_diagnostics_ltd,,,,,, +686,0.94387978315353394,f5b9d3f9-0e23-4b05-b9e6-7e07f8c8de90,University Medical Center Göttingen,university_medical_center_g_ttingen,,,,6a59a49b-a6f0-423a-b72f-c211ebd85c3d,university_medical_center_goettingen,University Medical Center Goettingen +5513,,6fbc0649-31b4-44e7-8955-49446fbfd28d,Department of Endocrinology University of Debrecen Medical and Health Science Center,department_of_endocrinology_university_of_debrecen_medical_and_health_science_center,,,,,, +5514,,c869a7e3-a3e6-4eca-9b98-f4264436f127,FUNDACION SANTIAGO DEXEUS FONT,fundacion_santiago_dexeus_font,,,,,, +5515,,a2d6898e-7129-11e6-a89e-0242ac12000b,OXFORD PHARMS,oxford_pharms,,,,,, +872,0.938247,62c0263c-d0e1-4e0b-8c35-ed6babb3051d,Newcastle u Tyne Hospitals NHS Trust,newcastle_u_tyne_hospitals_nhs_trust,,,,62c0263c-d0e1-4e0b-8c35-ed6babb3051d,newcastle_u_tyne_hospitals_nhs_trust,Newcastle u Tyne Hospitals NHS Trust +5516,,ccfce69d-b982-41bb-9229-2d6f7976fe56,"Medizinische Fakultät der TU-München, vertreten durch den Dekan",medizinische_fakult_t_der_tu_m_nchen_vertreten_durch_den_dekan,,,,,, +527,0.95949012041091919,80833833-6173-4f1f-82da-31787a716bc2,"Roche Farma, S.A. en nombre de F. Hoffmann-La Roche Ltd",roche_farma_s_a_en_nombre_de_f_hoffmann_la_roche_ltd,,,,80833833-6173-4f1f-82da-31787a716bc2,roche_farma_s_a_en_nombre_de_f_hoffmann_la_roche_ltd,"Roche Farma, S.A. en nombre de F. Hoffmann-La Roche Ltd" +173,0.9838290810585022,25f19699-b1c9-46a8-8933-0a2bbd3c7357,Merck Serono S.A. - Geneva,merck_serono_s_a_geneva,,,,25f19699-b1c9-46a8-8933-0a2bbd3c7357,merck_serono_s_a_geneva,Merck Serono S.A. - Geneva +257,0.943406,e7efab32-7164-11e6-a0cd-0242ac12000b,MACLEODS PHARMS LTD,macleods_pharms_ltd,,,,62b269c4-7163-11e6-a0cd-0242ac12000b,macleods_pharma,MACLEODS PHARMA +5517,,969d0285-ae23-4e59-b6ff-c8d753cfe4d5,"CALISTOGA PHARMACEUTICALS, INC",calistoga_pharmaceuticals_inc,,,,,, +750,0.987601,c6c1fe4f-e832-4867-8cdc-abc79a0bfed0,Danish Head and Neck Cancer Group (DAHANCA),danish_head_and_neck_cancer_group_dahanca,,,,c6c1fe4f-e832-4867-8cdc-abc79a0bfed0,danish_head_and_neck_cancer_group_dahanca,Danish Head and Neck Cancer Group (DAHANCA) +5518,,d528d6c4-0041-4eed-a5e5-985e08aaede8,Laboratoire BIODERMA,laboratoire_bioderma,,,,,, +5519,,9d1b6173-6c10-4b8d-89aa-7f0433d3b024,Novo Nordisk Pharmaceuticals Ltd,novo_nordisk_pharmaceuticals_ltd,,,,,, +5520,,51929102-121b-4469-8287-56f1377d4f4a,IMM - Instituto de Medicina Molecular,imm_instituto_de_medicina_molecular,,,,,, +5521,,42f5b998-ad55-4220-a0e8-55df5cebc81e,"Klinikum der Universität München, Campus Großhadern",klinikum_der_universit_t_m_nchen_campus_gro_hadern,,,,,, +803,0.98581516742706299,fc2c3b7b-ad68-40c8-8512-c39fa5444d71,"University Hospital Basel, Cardiology",university_hospital_basel_cardiology,,,,3752ea3c-adc5-42dc-b691-67baaf7d0875, Neurology,University Hospital Basel +5522,,ca16e08d-21b9-4325-949c-7c08e1c314ca,"Opko Health, Incorporated",opko_health_incorporated,,,,,, +251,0.987649,c20847f8-7164-11e6-a0cd-0242ac12000b,VIRTUS PHARM,virtus_pharm,,,,5b28c378-71c3-11e6-a0cd-0242ac12000b,virtus_pharms,VIRTUS PHARMS +5523,,e2999557-ffd6-4cdd-afc6-73c86aeb4a63,Laboratorios León Farma S.A,laboratorios_le_n_farma_s_a,,,,,, +5524,,7a1d1d1b-e6e9-4dfe-ae52-b5115bbb85cc,"Neonatal intensive care unit, VU medical center Amsterdam",neonatal_intensive_care_unit_vu_medical_center_amsterdam,,,,,, +5525,,a3ac19b6-da46-4b7c-b198-5b799e254672,S.C.D.U. MEDICINA INTERNA 1 Ospedale San Luigi Orbassano,s_c_d_u_medicina_interna_1_ospedale_san_luigi_orbassano,,,,,, +5526,,8361c9fa-633e-4935-9107-006a6d8f224b,Medizinische Universität Graz - Abteilung für Thorax- und Hyperbare Chirurgie,medizinische_universit_t_graz_abteilung_f_r_thorax_und_hyperbare_chirurgie,,,,,, +5527,,0a76522c-8bd8-11e6-a449-0242ac12000b,Institute of Molecular Medicine and Biomedical Research- I.M.B.E,institute_of_molecular_medicine_and_biomedical_research_i_m_b_e,,,,,, +378,0.94561511278152466,b2c83dbc-4b82-4ee6-bf53-5f11e5381e48,Merck Sharpe & Dohme BV,merck_sharpe_dohme_bv,,,,796acf07-1766-4af0-8f88-ef836fc80a36,merck_sharp_dohme_bv,Merck Sharp & Dohme BV +5528,,3588b95f-7f47-4d6f-a00a-e5c301985d8d,"Canadian Cardiovascular Collaboration, Population Health Research Institute, McMaster University",canadian_cardiovascular_collaboration_population_health_research_institute_mcmaster_university,,,,,, +406,0.98668,f8bd009e-a088-4918-82f1-82567ee57796,Beaumont Hospital,beaumont_hospital,,,,6a695a29-050c-4d3f-8e0d-c6d6a3afc8f2,beaumont_hospital_rcsi,Beaumont Hospital/RCSI +5529,,824861f3-ceae-4355-8844-7460b74b4888,Institut für Klinisch-Onkologische Forschung Krankenhaus Nordwest GmbH,institut_f_r_klinisch_onkologische_forschung_krankenhaus_nordwest_gmbh,,,,,, +894,0.980283,25c1b375-42c4-46ab-a38f-021e8ab03a25,Ludwig Boltzmann Institute forRetinology and Biomicroscopic Laser Surgery,ludwig_boltzmann_institute_forretinology_and_biomicroscopic_laser_surgery,,,,25c1b375-42c4-46ab-a38f-021e8ab03a25,ludwig_boltzmann_institute_forretinology_and_biomicroscopic_laser_surgery,Ludwig Boltzmann Institute forRetinology and Biomicroscopic Laser Surgery +5530,,4b1c3ebb-afb9-40dc-ad3e-2aed3ccacbaa,Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS),fundaci_n_p_blica_andaluza_para_la_investigaci_n_de_m_laga_en_biomedicina_y_salud_fimabis,,,,,, +5531,,6d3070a3-f56b-45af-9365-fe697b357156,Xellia d.o.o,xellia_d_o_o,,,,,, +5532,,a372212d-6f1a-4607-aaf7-b1d218975bb7,The Rotterdam Eye Hospital,the_rotterdam_eye_hospital,,,,,, +5533,,cf2d67da-715d-11e6-a0cd-0242ac12000b,PERRIGO PHARMS CO,perrigo_pharms_co,,,,,, +5534,,1179f7fa-30fd-4b1a-853c-5e4fd4bd69bb,HAL Allergy,hal_allergy,,,,,, +5535,,0d8e2748-b1fe-4527-9105-14feb6a27f4f,DIATOS S.A,diatos_s_a,,,,,, +5536,,522e95f0-8411-4ea3-bf8c-3d9a6c131a15,Euopean Organisation of Research and Treatment of Cancer,euopean_organisation_of_research_and_treatment_of_cancer,,,,,, +583,0.96693354845046997,f23b93ea-629c-4e30-bc46-8154a8aed113,MSD BV,msd_bv,,,,a72d6b04-e5e5-483f-9071-b0af00c0a0c2,msd,MSD +5537,,112c5079-9c53-4180-ae4e-46cafa877641,CHUGAI PHARMA EUROPE LIMITED,chugai_pharma_europe_limited,,,,,, +5538,,738e32a5-c222-44e2-b03f-77105e371b1a,"NHS Lothian University, Research & Development",nhs_lothian_university_research_development,,,,,, +5539,,50a029f4-716a-11e6-a0cd-0242ac12000b,BAYER HEALTHCARE PHARMS,bayer_healthcare_pharms,,,,,, +5540,,408e57b3-786d-4f2a-99bf-489b5404f9d2,Fundación PETHEMA,fundaci_n_pethema,,,,,, +5541,,036aca0e-7142-11e6-a0cd-0242ac12000b,INVAGEN PHARMS,invagen_pharms,,,,,, +5542,,0bad96fd-475b-426f-b89c-9cb4ff34896f,Anders Heijl,anders_heijl,,,,,, +586,0.912289,2d4e8bd8-17d2-4b35-a93e-d9f401ce497b,Fundació Lluita contra la Sida,fundaci_lluita_contra_la_sida,,,,2d4e8bd8-17d2-4b35-a93e-d9f401ce497b,fundaci_lluita_contra_la_sida,Fundació Lluita contra la Sida +5543,,34695c46-123a-4926-98c6-6f86a3d23340,Universitätsklinik für Klinische Pharmakologie,universit_tsklinik_f_r_klinische_pharmakologie,,,,,, +5544,,3a6854ad-4d99-4b7d-8a8c-b1d7eb4b2563,"MUW, Department of Clinical Pharmacology",muw_department_of_clinical_pharmacology,,,,,, +844,0.989439,a22c5dfa-87d4-4be2-8e2e-bcfdbc6b7f86,"Queen Mary and Westfield College, University of London",queen_mary_and_westfield_college_university_of_london,,,,1b189425-2b98-4982-b3b0-a63cc85c263e,queen_mary_and_westfield_college_university_of_london_qmul,"Queen Mary and Westfield College, University of London (QMUL)" +5545,,93bb4b6e-4905-456e-b048-9f17b74239e8,"Medizinische Universität Wien, Uni. Klinik für Neurologie",medizinische_universit_t_wien_uni_klinik_f_r_neurologie,,,,,, +5546,,571c3d47-a38a-443e-803e-5b04c34fd359,Fundación para la Investigación biomédica del Hospital Universitario Ramón y Cajal. Madrid,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_ram_n_y_cajal_madrid,,,,,, +5547,,f3792afc-7144-11e6-a0cd-0242ac12000b,AUROBINDO,aurobindo,,,,,, +5548,,001265a8-cd82-44e8-a4b7-f2520f74664b,"Rib-X Pharmaceuticals, Inc",rib_x_pharmaceuticals_inc,,,,,, +5549,,44990392-9007-4109-8340-74bf3fe08f68,Niconovum AB,niconovum_ab,,,,,, +5550,,64df797c-8be8-4c04-bdc7-8eb7c0b432e7,"Universitätsklinik für klinische Pharmakologie, Medizinische Universität Wien",universit_tsklinik_f_r_klinische_pharmakologie_medizinische_universit_t_wien,,,,,, +804,0.9722786545753479,3e3b9a3c-7142-11e6-a0cd-0242ac12000b,ALCON,alcon,,,,1105f30e-7166-11e6-a0cd-0242ac12000b,alcon_pharma,ALCON PHARMA +701,0.967271,560f7696-eaf2-4bd2-a256-7befc8defd81,Synageva Biopharma Corp,synageva_biopharma_corp,,,,22012f51-f648-4da1-8b80-539b591bf168,synageva_biopharma_corporation,Synageva BioPharma Corporation +5551,,569e81c6-9314-4035-98ee-34dace765f06,CHU de DIJON,chu_de_dijon,,,,,, +5552,,89fedba1-61aa-45d9-8fe5-f53d2ce18a49,Ipsen Group,ipsen_group,,,,,, +5553,,b612d7b4-7160-11e6-a0cd-0242ac12000b,CLONMEL HLTHCARE,clonmel_hlthcare,,,,,, +5554,,0d5a2b55-d549-4433-8881-3dda5be5f12b,SIFI,sifi,,,,,, +5555,,d15653b9-5070-49a2-be87-3396f8204985,GermanBreastGroup,germanbreastgroup,,,,,, +5556,,5ebda041-7158-4f3d-95fd-7b811a35dc08,Nycomed Danmark ApS,nycomed_danmark_aps,,,,,, +5557,,f9e0fce3-f685-486d-b77e-7d863760763d,Inn-Salzach-Klinikum gGmbH,inn_salzach_klinikum_ggmbh,,,,,, +640,0.97514638304710388,d2f4fdea-3f56-449f-b5b3-ab25da9fa8af,Boehringer Ingelheim RCV GmbH & Co KG q,boehringer_ingelheim_rcv_gmbh_co_kg_q,,,,d2f4fdea-3f56-449f-b5b3-ab25da9fa8af,boehringer_ingelheim_rcv_gmbh_co_kg,Boehringer Ingelheim RCV GmbH & Co KG +5558,,525916ec-2db7-42e3-8507-574afacfead4,Biovitrum AB (publ.),biovitrum_ab_publ,,,,,, +813,0.94668000936508179,29704645-80db-4f53-b002-9c5e0e861f7c,ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI IRST - IRCCS,istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori_irst_irccs,,,,d8bfcede-efc3-4714-b642-f79fb12833f5,istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori,ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI +5559,,a2ba2a12-9044-422c-9790-eefa6eeb3df8,"Vaccine Research Center, University of Tampere",vaccine_research_center_university_of_tampere,,,,,, +5560,,e3f7fb91-973f-4c58-8613-b2fc81eff249,H. 12 de Octubre,h_12_de_octubre,,,,,, +5561,,daf847ac-432d-4bf6-a247-4298f0fa9e13,"Universitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie, Medizinische Universität Wien",universit_tsklinik_f_r_innere_medizin_iii_klinische_abteilung_f_r_rheumatologie_medizinische_universit_t_wien,,,,,, +5562,,48a58a3d-123a-408a-86f3-0533e41a485a,FONDAZIONE SALVATORE MAUGERI - CLINICA DEL LAVORO E DELLA RIABILITAZIONE,fondazione_salvatore_maugeri_clinica_del_lavoro_e_della_riabilitazione,,,,,, +5563,,f4d027b2-c3b1-4f0a-a0c9-964dfbe4298e,AKH Vienna,akh_vienna,,,,,, +5564,,fc21ea5c-d162-46f5-bd49-bedac7f5851d,Kompetenznetz Vorhofflimmern e.V. [Atrial Fibrillation Competence Network (AFNET) e.V.],kompetenznetz_vorhofflimmern_e_v_atrial_fibrillation_competence_network_afnet_e_v,,,,,, +5565,,ad3f48a2-71d3-11e6-a0cd-0242ac12000b,BAJAJ MEDICAL LLC,bajaj_medical_llc,,,,,, +5566,,aa67fc5f-884d-4ec5-b4da-5ef37cf26a38,Neurologisk Afdeling,neurologisk_afdeling,,,,,, +5567,,488c2413-1ee4-4357-a2be-147174e6ded8,FONDAZIONE MONZINO CENTRO CARDIOLOGICO,fondazione_monzino_centro_cardiologico,,,,,, +750,0.987601,e7f285a2-b1dc-4c78-84e3-b8608adc3a75,Danish Head and Neck Cancer Group,danish_head_and_neck_cancer_group,,,,c6c1fe4f-e832-4867-8cdc-abc79a0bfed0,danish_head_and_neck_cancer_group_dahanca,Danish Head and Neck Cancer Group (DAHANCA) +5568,,895f7b63-746c-46fa-a942-51613f5b5d7a,"Amicus Therapeutics, Inc",amicus_therapeutics_inc,,,,,, +5569,,351c2b3b-fca0-4364-9941-c2f0735ff736,"Medizinische Universität Wien, Univ. KlM III, Klinische Abt. f. Gastroenterologie/Hepatologie",medizinische_universit_t_wien_univ_klm_iii_klinische_abt_f_gastroenterologie_hepatologie,,,,,, +405,0.96135038137435913,f2c4f4a2-1001-47df-820d-b480dcde3473,Gilead Sciences Incorporated,gilead_sciences_incorporated,,,,dee4490b-b25c-4c54-b909-635261eba55d,gilead,Gilead +5570,,17cc70f7-5525-4193-91fe-2f91323e6b2d,"Idera Pharmaceuticals, Inc",idera_pharmaceuticals_inc,,,,,, +323,0.98768532276153564,4f87e303-257a-4217-8700-a7ae561c79ec,Tibotec Pharmaceuticals Ltd,tibotec_pharmaceuticals_ltd,,,,7c715eec-7632-4bad-85ac-60fea60f92d9,tibotec_pharmaceuticals_ltd,Tibotec Pharmaceuticals Ltd +5571,,98f93e96-89d9-436a-91d1-cf3abdc7f160,Alcon Research Ltd,alcon_research_ltd,,,,,, +5572,,877ab712-c839-473c-96fd-f718f3278fde,AVENTIS PASTEUR MSD S.P.A,aventis_pasteur_msd_s_p_a,,,,,, +5573,,cdc2178f-0d59-4878-b8bd-a29181ca5c8e,Neurophyxia B.V,neurophyxia_b_v,,,,,, +5574,,087086ea-b9e5-4f5d-bc2a-e6388cf4b3b9,Cephalon Inc,cephalon_inc,,,,,, +5575,,e7550f5b-9f4f-4b90-97d6-128a86a85c7d,NMDSG Nordics Myeloplastics Syndrom Study Group,nmdsg_nordics_myeloplastics_syndrom_study_group,,,,,, +5576,,dd4bdf55-2be6-41a5-a74b-75a203634eda,GETH,geth,,,,,, +5577,,9fbec508-715c-11e6-a0cd-0242ac12000b,ACS DOBFAR INFO SA,acs_dobfar_info_sa,,,,,, +213,0.979896,801ffc64-51e2-42b5-afbc-2a5a23da743b,Bioforce AG Roggwil TG,bioforce_ag_roggwil_tg,,,,559fe1ec-2be1-4b2f-a03a-a510b2d4cf93,bioforce_ag,Bioforce AG +5578,,c2b219c1-360c-4ad9-afee-d9ffbac13dde,Karin Blomgren,karin_blomgren,,,,,, +5579,,724d9b78-0cd0-48c7-a4c2-5b4c655ed89c,Consorci Sanitari de Terrassa,consorci_sanitari_de_terrassa,,,,,, +5580,,db253254-73b4-4800-ac88-78efad359f70,University of Hull,university_of_hull,,,,,, +5581,,b59a26d2-f4a1-4322-925d-ba042cd0946f,FORMAC Pharmaceuticals NV,formac_pharmaceuticals_nv,,,,,, +5582,,8a26307c-7167-11e6-a0cd-0242ac12000b,CALL INC,call_inc,,,,,, +5583,,0b2f272f-76ce-44ff-bfc9-51b8e287988d,Eastern Norway Regional Health Authority,eastern_norway_regional_health_authority,,,,,, +5584,,60c093b1-3df9-4d4f-946c-f91df6310dc9,"Derartment of Anaesthesiology and Intensive Care, Turku University Hospital",derartment_of_anaesthesiology_and_intensive_care_turku_university_hospital,,,,,, +382,0.98027,d49544f4-718a-11e6-a0cd-0242ac12000b,BIOMARIN PHARM,biomarin_pharm,,,,37341944-6d19-4843-a80d-f568e4d60ef1,biomarin,BIOMARIN +442,0.934557,25695572-6fa2-11e6-9663-0242ac12000b,Laboratorios Andrómaco S.A. (co-sponsor Spain),laboratorios_andr_maco_s_a_co_sponsor_spain,,,,25695572-6fa2-11e6-9663-0242ac12000b,laboratorios_andr_maco_s_a_co_sponsor_spain,Laboratorios Andrómaco S.A. (co-sponsor Spain) +5585,,1b5d1fa3-e2c3-4af2-b1f9-462733096c51,Astion Danmark A/S,astion_danmark_a_s,,,,,, +5586,,9747b34c-73f2-11e6-a0cd-0242ac12000b,NITROUS OXIDE OF CANADA,nitrous_oxide_of_canada,,,,,, +5587,,5785df13-ad33-46bd-86de-da2069bc539a,BIODEL Inc,biodel_inc,,,,,, +131,0.98070418834686279,1ead7ee3-0e7d-4381-a630-ec14aeb73c0e,Department of Psychiatry and Psychotherapy (Cologne),department_of_psychiatry_and_psychotherapy_cologne,,,,1ead7ee3-0e7d-4381-a630-ec14aeb73c0e,department_of_psychiatry,Department of Psychiatry +5588,,a761d9e2-9ccd-496f-a17d-daf310188568,UCB Inc,ucb_inc,,,,,, +5589,,f852328e-30da-494a-8eac-9c16b63e8bf4,A.T. Development Switzerland SARL,a_t_development_switzerland_sarl,,,,,, +865,0.987308,c749378e-006f-4127-9f29-18525f0578c9,United Therapeutics Corp,united_therapeutics_corp,,,,98172a5d-4f63-4af5-97a8-b1a01d9344ff,united_therapeutics_corporation,United Therapeutics Corporation +100,0.94407099485397339,6bce5266-4f70-4a55-a2f5-d6d6414543be,Department of Anesthesiology & Intensive Care,department_of_anesthesiology_intensive_care,,,,3f816051-0ebf-47a9-b4f1-e129cf8f1167,department_of_anesthesiology_and_intensive_care_medicine,Department of Anesthesiology and Intensive Care Medicine +5590,,28ea9b69-607b-4274-9145-3945d31fe86a,Birken AG,birken_ag,,,,,, +855,0.983343,f991b548-715e-11e6-a0cd-0242ac12000b,GD SEARLE LLC,gd_searle_llc,,,,9eeb4efa-71af-11e6-a0cd-0242ac12000b,gd_searle,GD SEARLE +966,0.963804,f354139f-be71-4a4f-9aba-83d8422841df,Isala klinieken Zwolle,isala_klinieken_zwolle,,,,77f76197-601c-4f7d-a484-16ca18daeb6c,isala,Isala +1028,0.91099542379379272,5cd4a39f-21fd-403d-abbe-561ea83b270d,Eli Lilly and Company - Indianapolis,eli_lilly_and_company_indianapolis,,,,5cd4a39f-21fd-403d-abbe-561ea83b270d,eli_lilly_and_company_indianapolis,Eli Lilly and Company - Indianapolis +5591,,9b39f3ad-6890-4c38-8ad9-e56636bc691e,Rottapharm S.p.A,rottapharm_s_p_a,,,,,, +381,0.92556309700012207,70a76c95-9bc5-4453-ace1-7d9c98a92a7d,Merck Sharp & Dohme AB,merck_sharp_dohme_ab,,,,70a76c95-9bc5-4453-ace1-7d9c98a92a7d,merck_sharp_dohme_o,"Merck Sharp & Dohme Copr., a subsidary of Merck & Co" +5592,,b5eb58dd-61c0-4fd6-bc52-e5cde9bd7760,"Department of Haematology, Herlev Hospital, University of Copenhagen",department_of_haematology_herlev_hospital_university_of_copenhagen,,,,,, +5593,,c0a964c6-6d5c-45d3-84e6-79f0a91d31c7,Galápagos NV,gal_pagos_nv,,,,,, +5594,,8cc9520b-12fe-4b45-ba1d-e908dc0fa38d,Clinical Data Care Spain S.L,clinical_data_care_spain_s_l,,,,,, +5595,,96e3650c-71a1-11e6-a0cd-0242ac12000b,XSPIRE,xspire,,,,,, +5596,,7df4d9a8-1963-4432-8a4c-c87268368bd1,sanofi-aventis Zrt,sanofi_aventis_zrt,,,,,, +5597,,75d02ed4-527a-4c3a-83a0-e15e97fc7866,"Amgen, Inc. One Amgen Center Drive Thousand Oaks, California 91320",amgen_inc_one_amgen_center_drive_thousand_oaks_california_91320,,,,,, +5598,,51f07de7-8d96-4222-bee8-a34c53c6b3f3,"Roche Farmacêutica Química, Lda",roche_farmac_utica_qu_mica_lda,,,,,, +5599,,655182c3-51a4-4f33-b443-bd734b48fa0a,Novartis Consumer Health,novartis_consumer_health,,,,,, +5600,,ebd2ef67-795f-4036-8bd6-71c40c201510,"aTyr Pharma, Inc",atyr_pharma_inc,,,,,, +5601,,09fd1793-e79a-4454-904f-7f6b1ebe1944,"Department of Obstetrics and Gynecology, Oulu University Hospital",department_of_obstetrics_and_gynecology_oulu_university_hospital,,,,,, +438,0.94114851951599121,09d833e6-81f6-4d84-ab0d-6d38c6152081,"Pfizer Inc, 235 East 42nd Street, New York, NY 10017, USA",pfizer_inc_235_east_42nd_street_new_york_ny_10017_usa,,,,09d833e6-81f6-4d84-ab0d-6d38c6152081,pfizer_inc_235_east_42nd_street_new_york_ny10017_usa,"Pfizer Inc 235 East 42nd Street, New York, NY10017" +5602,,3c158304-3e4e-45c4-bd69-de1f0dafe21b,Flemming Bendtsen,flemming_bendtsen,,,,,, +5603,,88f64b40-75c2-4d7e-849c-b04187899746,Dermal Laboratories,dermal_laboratories,,,,,, +5604,,4d8cc40e-de2d-4728-a9ed-3514b4ab7cc0,Johanna Hästbacka,johanna_h_stbacka,,,,,, +5605,,df0ef22c-7603-4178-bc34-c7a3f71cc4bf,Regent Medical,regent_medical,,,,,, +5606,,1412cd67-10ce-4589-9996-432af277840d,"University of Oxford, Nuffield Department of Medicine",university_of_oxford_nuffield_department_of_medicine,,,,,, +5607,,593b49e6-1313-41ac-b4d1-cec5c4d85a00,Mª Isabel Fernández García,m_isabel_fern_ndez_garc_a,,,,,, +5608,,9f4c1582-6fbb-11e6-abe8-0242ac12000b,University College Hospital,university_college_hospital,,,,,, +971,0.981633,7c6e82f0-9a46-47cd-89bb-39837da65876,Department of Anaesthesiology,department_of_anaesthesiology,,,,7c6e82f0-9a46-47cd-89bb-39837da65876,department_of_anaesthesiology,Department of Anaesthesiology +5609,,e97d0e5e-714b-11e6-a0cd-0242ac12000b,KREMERS URBAN PHARMS,kremers_urban_pharms,,,,,, +5610,,59061910-00fd-456b-a3b8-36d1749207e9,Hospital Regional Universitario. IBIMA,hospital_regional_universitario_ibima,,,,,, +5611,,06546d1b-0ca9-456d-ac77-85533031bf43,"Department of R & D, Central Manchester and Manchester Children's Hospital NHS Trust",department_of_r_d_central_manchester_and_manchester_children_s_hospital_nhs_trust,,,,,, +5612,,36e99bb6-6fb7-4fbc-9719-ea0f6d98c775,Schering Lusitana,schering_lusitana,,,,,, +5613,,01ac1e4c-7143-11e6-a0cd-0242ac12000b,CNTY LINE PHARMS,cnty_line_pharms,,,,,, +5614,,d22a0840-3c31-4335-99b9-3909a433cad1,RIEMSER Arzneimittel AG,riemser_arzneimittel_ag,,,,,, +5615,,9a9ea5a4-2f8c-42e8-b075-313146f79950,Lukács és Társa Gyógyszerkereskedelmi Betéti Társaság,luk_cs_s_t_rsa_gy_gyszerkereskedelmi_bet_ti_t_rsas_g,,,,,, +5616,,59b797a9-1858-4059-b40a-87a26bd01ce5,Centro de Investigación Biomédica en Red en el Área de Salud Mental (CIBERSAM),centro_de_investigaci_n_biom_dica_en_red_en_el_rea_de_salud_mental_cibersam,,,,,, +5617,,23b3381c-a8f2-49bd-b0ea-b0daf0cc5c8a,University of Sydney,university_of_sydney,,,,,, +5618,,0752e59e-8ee8-4c4d-87c3-26fcd616bc19,AZIENDA OSPEDALIERA G. BROTZU,azienda_ospedaliera_g_brotzu,,,,,, +5619,,0f9dfb85-95fd-4e26-aa80-b964e3ed8faf,Academic Medical Center/ Gastroenterology,academic_medical_center_gastroenterology,,,,,, +5620,,511eadb8-c44b-4148-af13-26d98f121b19,Camden Provider Services,camden_provider_services,,,,,, +5621,,c8c07891-559a-404c-adcd-e91a83cd0f04,Pfizer España,pfizer_espa_a,,,,,, +5622,,0a7a6446-ed13-4788-9d3f-93b6faea183d,THE TECHNICAL UNIVERSITY OF DRESDEN,the_technical_university_of_dresden,,,,,, +5623,,08adb0be-7154-11e6-a0cd-0242ac12000b,INTL MEDICATION SYS,intl_medication_sys,,,,,, +5624,,3d023a6e-2350-4d17-b437-1a4e11aa1962,Imperial College Joint Research Office,imperial_college_joint_research_office,,,,,, +5625,,57fe149d-c4a8-40f7-8771-0ada8bb3a330,OSPEDALE POLICLINICO S. MATTEO,ospedale_policlinico_s_matteo,,,,,, +5626,,e7e4f7f4-ef06-4c08-ac9e-4c655acdac11,ZLB BEHRING,zlb_behring,,,,,, +5627,,ff92b6c3-59c8-42fb-9591-3bec333e71c4,Martina Bachmann,martina_bachmann,,,,,, +5628,,7a2b0132-c5c5-4083-9041-965f6efd64cd,Biotec Pharmacon ASA,biotec_pharmacon_asa,,,,,, +5629,,f4908fe9-02ee-4e92-a151-d50486f095ca,Spaarne Hospital,spaarne_hospital,,,,,, +5630,,2e0a275e-98ca-4977-8baa-c64928b9ff0d,Roche Oy,roche_oy,,,,,, +5631,,42b27b65-ce3f-4710-b25f-846a3a3f72a6,Lothian Health Board University Hospitals Division,lothian_health_board_university_hospitals_division,,,,,, +5632,,affbbf96-f52e-4aae-8d23-4e4f3f6a296f,Dept. of Nephrology,dept_of_nephrology,,,,,, +764,0.98123,eca7bccc-59ef-4deb-bbac-862d21270313,Universitair Ziekenhuis Antwerpen (UZA) - Multidisciplinair Pijncentrum,universitair_ziekenhuis_antwerpen_uza_multidisciplinair_pijncentrum,,,,2917de45-e710-4da7-9b4b-c54d1dd1327d,universitair_ziekenhuis_antwerpen,Universitair Ziekenhuis Antwerpen +663,0.97166502475738525,ae7adb7b-c45f-4298-be68-d5dcaa36ea65,Charité - Unversitätsmedizin Berlin,charit_unversit_tsmedizin_berlin,,,,57ad1b5e-ca5a-4470-9b1b-36e6151b1c01,charit_universit_tsmedizin_berlin,Charité - Universitätsmedizin Berlin +5633,,90d86014-7141-11e6-a0cd-0242ac12000b,MYLAN INSTITUTIONAL,mylan_institutional,,,,,, +5634,,69be49e2-714d-11e6-a0cd-0242ac12000b,AAIPHARMA LLC,aaipharma_llc,,,,,, +5635,,62313be9-6619-46cc-b768-c59f92d10271,JERINI AG,jerini_ag,,,,,, +5636,,4a6fe51d-4d0f-4be1-b332-1d538903f763,Clementia Pharmaceuticals Inc,clementia_pharmaceuticals_inc,,,,,, +5637,,551fbb5c-33b5-4567-bc7d-ff9fbb6d386d,Dr. Wolfgang Jaksch,dr_wolfgang_jaksch,,,,,, +5638,,6aa73bf1-0b6a-4937-8894-27225cf56a7e,Nottingham University NHS Trust,nottingham_university_nhs_trust,,,,,, +81,0.988541,8a5eb366-780e-4aa5-8b20-c800908bad95,Université catholique de Louvain (UCL),universit_catholique_de_louvain_ucl,,,,8a5eb366-780e-4aa5-8b20-c800908bad95,universit_catholique_de_louvain_ucl,Université catholique de Louvain (UCL) +5639,,77688cf1-87bc-419e-8dee-667b70034603,Clinical Immunology and Rheumatology,clinical_immunology_and_rheumatology,,,,,, +5640,,df7f43d1-855c-4ed5-9f6a-8a39cd3a7d65,Speising Orthopaedic Hospital Vienna,speising_orthopaedic_hospital_vienna,,,,,, +5641,,3987b723-ec4a-4e26-8e94-5bab49919019,Salford Royal Foundation Trust,salford_royal_foundation_trust,,,,,, +5642,,628527b4-f033-4ccb-b91a-674231b9fe72,Apeptico Forschung und Entwicklung GmbH,apeptico_forschung_und_entwicklung_gmbh,,,,,, +5643,,57154e3d-9bf7-4648-b388-197dec730b98,BAXTER HEALTHCARE CORPORATION,baxter_healthcare_corporation,,,,,, +5644,,77bf763e-71b5-11e6-a0cd-0242ac12000b,ECOLAB,ecolab,,,,,, +5645,,d5e531d0-73fa-11e6-a0cd-0242ac12000b,ACTAVIS LLC,actavis_llc,,,,,, +5646,,0b6f602f-254d-44c9-a762-5192383006bb,"Biolex Therapeutics, Inc",biolex_therapeutics_inc,,,,,, +73,0.983343,fa82421c-fb0e-450c-abc2-af99fa053bc2,AM-Pharma,am_pharma,,,,a9d0f101-5d13-4345-bc0c-7527c110c176,am_pharma_b_v,AM-Pharma B.V +5647,,fb4d5d0e-5493-4871-8745-17da3cad85a4,"Tanabe Seiyaku Co., Ltd",tanabe_seiyaku_co_ltd,,,,,, +5648,,515bc82b-89b9-42c9-9cb1-dde79728f9bf,NOPHO-NHL GRUPP,nopho_nhl_grupp,,,,,, +5649,,4195da0e-57dd-410b-a5de-1b2cc06c42d8,Dr. DANIEL PODZAMCZER PALTER,dr_daniel_podzamczer_palter,,,,,, +25,0.97483,a0372a33-487c-42a4-b29b-60e3a4ffb844,"Abraxis BioScience, LLC, a wholly-owned subsidiary of Celgene Corporation",abraxis_bioscience_llc_a_wholly_owned_subsidiary_of_celgene_corporation,,,,575a893b-fb9f-4cff-b2fd-090f406fd398,abraxis_bioscience_llc,"Abraxis BioScience, LLC" +5650,,a62fa2c7-cf07-436f-b0f2-e79e97c3e7d6,"SANOFI AVENTIS, S.A.U",sanofi_aventis_s_a_u,,,,,, +5651,,d93e11b8-7165-11e6-a0cd-0242ac12000b,SUNSHINE LAKE,sunshine_lake,,,,,, +312,0.973688,16c13ad3-319c-4580-9561-26254cba7ca2,Stockholms Läns Landsting,stockholms_l_ns_landsting,,,,16c13ad3-319c-4580-9561-26254cba7ca2,stockholms_l_ns_landsting,Stockholms Läns Landsting +5652,,cd444774-a365-41bb-8f4b-df3a6c8efff8,the Dutch Colorectal Cancer Group,the_dutch_colorectal_cancer_group,,,,,, +5653,,227899b2-ca90-4520-8cfb-97885c865d35,Neolab td,neolab_td,,,,,, +5654,,aa8185cf-0f5f-4ba8-bc28-6824e5574de4,ParnassiaBavoGroup,parnassiabavogroup,,,,,, +1015,0.97426080703735352,8811d706-c986-44c5-bf01-3f0b35984b6c,Institut de Recherches Internationales Servier (I.R.I.S),institut_de_recherches_internationales_servier_i_r_i_s,,,,505a3f41-b816-4c26-965c-c1b406728577,institut_de_recherches_internatinales_servier,Institut de Recherches Internatinales Servier +5655,,bcd05a90-5b15-4920-9677-ea3e5200b1eb,EryDel S.p.A,erydel_s_p_a,,,,,, +5656,,fc36750a-f55f-4e56-b67d-8d058e9dce96,Dept Hematology SLB Vejle,dept_hematology_slb_vejle,,,,,, +5657,,eb915430-1f57-44c3-a9d5-49b2f0515c10,Apodemus AB,apodemus_ab,,,,,, +5658,,be33b612-4df4-4c9f-b5c1-76c3dd7ef29b,STRUCTURAL GENOMIX,structural_genomix,,,,,, +11,0.979515,55ec7b48-7321-11e6-a0cd-0242ac12000b,THERAVANCE BIOPHARMA,theravance_biopharma,,,,52e0d1ff-2215-49b4-99dd-e6e6ac83eb94,theravance,THERAVANCE +5659,,57776011-4a1f-4529-9ddc-acfeba01e3f1,MDS Finland Oy,mds_finland_oy,,,,,, +5660,,03d1085d-e8a3-4db0-9507-b18ac51c094b,Chelsea and Westminster Hospital,chelsea_and_westminster_hospital,,,,,, +5661,,875672d4-9306-4aa1-97fa-5feb1ad2ab85,Roskilde University Hospital,roskilde_university_hospital,,,,,, +5662,,fd1a89dc-8807-11e6-a998-0242ac12000b,Prana Biotechnology,prana_biotechnology,,,,,, +5663,,be4350f3-a703-4086-ada5-7e2eea56df0b,"GUIDE Clinic, St James's Hospital",guide_clinic_st_james_s_hospital,,,,,, +5664,,cfe3db66-7142-11e6-a0cd-0242ac12000b,B BRAUN,b_braun,,,,,, +5665,,ab129215-0e92-4d69-8642-874a93241fec,Humedics GmbH,humedics_gmbh,,,,,, +5666,,2a2c20de-072d-4a13-b797-f1df68e09a1b,Dutch Kidney Foundation,dutch_kidney_foundation,,,,,, +5667,,d1f172d9-3bae-4072-9901-6f28a6e7566d,GENMAB,genmab,,,,,, +5668,,0808899e-0133-4e34-8c1e-b8b4c6e9f737,Cambridge Hospitals NHS Foundation Trust and Cambridge University,cambridge_hospitals_nhs_foundation_trust_and_cambridge_university,,,,,, +5669,,41c4cbec-71a1-11e6-a0cd-0242ac12000b,ATNAHS PHARMA US,atnahs_pharma_us,,,,,, +5670,,01d4edfe-17bc-4f2b-95c1-20fa7a0c10a6,Jorge Matias-Guiu Guia,jorge_matias_guiu_guia,,,,,, +234,0.98327115178108215,8609a092-7ab5-4797-982f-b897d6c7826b,Novartis Pharma,novartis_pharma,,,,7a736c7a-e49d-4f6d-a8da-98014f1ac986,novartis_pharma,Novartis Pharma +5671,,575e0b5c-84ce-4a35-8cd8-9f15428dbfa6,Lybar a.s,lybar_a_s,,,,,, +528,0.97553372383117676,2e1170b4-5a8c-4423-9ccd-2a59a1cdfee7,Roche Farma S.A,roche_farma_s_a,,,,0df36129-756b-443b-b038-466e73715fa6,roche_farma_s_a_en_nombre_de_genentech_inc,"Roche Farma S.A en nombre de Genentech, Inc" +5672,,1f3e22f0-5933-4d74-9885-0e8703e98611,"Cerexa, Inc. (subsidiary of Forest Laboratories)",cerexa_inc_subsidiary_of_forest_laboratories,,,,,, +5673,,1f714897-9b27-4e56-878d-80e451572a85,CESAR MARGARIT FERRI,cesar_margarit_ferri,,,,,, +5674,,fea83567-5bf7-44fb-b02e-63f9306b04c0,Plethora Solutions Ltd,plethora_solutions_ltd,,,,,, +5675,,42d5a3e1-7e5e-4c36-95bb-17926ce1af2a,AZIENDA OSPEDALIERA POLICLINICO DI MODENA,azienda_ospedaliera_policlinico_di_modena,,,,,, +5676,,096e3856-ebfa-496a-8273-51b5c08aaa65,Shire Pharmaceutical Contracts Ltd,shire_pharmaceutical_contracts_ltd,,,,,, +5677,,201bddeb-f6ec-4dfd-93fc-25e6f1d24c4b,SOFAR SPA,sofar_spa,,,,,, +5678,,c7c87fd6-7192-11e6-a0cd-0242ac12000b,TEVA BRANDED PHARM,teva_branded_pharm,,,,,, +5679,,aa43b9da-17af-4d2d-ad36-2dc3c97575be,"A.I.L. (ASSOCIAZIONE ITALIANA CONTRO LE LEUCEMIE, LINFOMI E MIELOMI",a_i_l_associazione_italiana_contro_le_leucemie_linfomi_e_mielomi,,,,,, +5680,,7139cb87-7827-4e78-a281-aefce5ab1512,Targovax Oy,targovax_oy,,,,,, +5681,,e93e9750-71b8-4293-80a2-b09b52b55987,Asociación para el estudio de enfermedades infecciosas,asociaci_n_para_el_estudio_de_enfermedades_infecciosas,,,,,, +5682,,3657b98d-9a98-4378-ac81-3f6977c1a661,Univ.-Kl. f.Augenheilkunde und Optometrie Wien,univ_kl_f_augenheilkunde_und_optometrie_wien,,,,,, +5683,,aedb4332-71a1-11e6-a0cd-0242ac12000b,PELAGIUS,pelagius,,,,,, +5684,,e05eff00-7f87-418c-b603-023c04a66670,GlaxoSmithKline R & D,glaxosmithkline_r_d,,,,,, +5685,,a5830a7a-3e79-4733-868d-b40f2ec40f8b,"Karolinska Institutet, Institution CLINTEC, enheten för anestesi",karolinska_institutet_institution_clintec_enheten_f_r_anestesi,,,,,, +5686,,0fbac65a-a8bc-4562-9634-3a2d3cf67294,R&D Addenbrookes Hospital,r_d_addenbrookes_hospital,,,,,, +5687,,14f4c4a6-7164-11e6-a0cd-0242ac12000b,HAMELN RDS GMBH,hameln_rds_gmbh,,,,,, +5688,,00946820-0adf-4ae8-8776-0742c717b6ee,CRLC VAL D’AURELLE,crlc_val_d_aurelle,,,,,, +5689,,e87035b4-12c6-46bd-8989-e7ec462c91d9,KU Leuven - Centre for Pharmacotherapy,ku_leuven_centre_for_pharmacotherapy,,,,,, +5690,,6a20db2c-d001-48c7-baf4-866c74d59002,DAIDS,daids,,,,,, +5691,,4feb9e30-7165-11e6-a0cd-0242ac12000b,OC PHARMA,oc_pharma,,,,,, +5692,,8100cbc9-cab2-49dd-a881-c3c1df1b107c,"Oslo University Hospital, Cancer Research Un it",oslo_university_hospital_cancer_research_un_it,,,,,, +5693,,a1fc4956-7154-11e6-a0cd-0242ac12000b,EI INC,ei_inc,,,,,, +5694,,84277f48-4561-479c-bd80-e8feee00743f,H. La Paz,h_la_paz,,,,,, +5695,,dfdc8f1f-6576-49d6-bcbd-480b40cdbe61,AVIR Green Hills Biotechnology Research Development Trade AG,avir_green_hills_biotechnology_research_development_trade_ag,,,,,, +5696,,2fc83671-bf15-4612-a423-e79a014ff9c6,ANZIC RESEARCH CENTRE,anzic_research_centre,,,,,, +218,0.97293919324874878,1e6ddb3d-f0f4-4b4e-89ca-d0b431c769eb,"Vifor Pharma, Vifor (International) Ltd",vifor_pharma_vifor_international_ltd,,,,15cb26f8-fd0f-4c18-8afe-0d8c7f03ce9f,vifor_pharma,Vifor Pharma +5697,,0c720e9a-7193-11e6-a0cd-0242ac12000b,CASPER PHARMA LLC,casper_pharma_llc,,,,,, +5698,,6bc61f90-5301-4676-a48d-12e25b299b43,ISTITUTO PER L'INFANZIA BURLO GAROFOLO,istituto_per_l_infanzia_burlo_garofolo,,,,,, +5699,,582fc826-95be-4467-ac77-e4072b39a635,NCIC Clinical Trial Group (NCIC CTG),ncic_clinical_trial_group_ncic_ctg,,,,,, +5700,,3fb57537-712c-4215-9ca4-ca312f62de6f,Dr. Daniel Podzamczer Palter (Unidad de VIH. Servicio de Enfermedades Infecciosas. Hospital de Bellvitge),dr_daniel_podzamczer_palter_unidad_de_vih_servicio_de_enfermedades_infecciosas_hospital_de_bellvitge,,,,,, +848,0.928667,c887e4c4-6fbd-11e6-abe8-0242ac12000b,Nederlands Kanker Instutuut-Antonie van Leeuwenhoek Ziekenhuis,nederlands_kanker_instutuut_antonie_van_leeuwenhoek_ziekenhuis,,,,c292a342-b266-4a04-9816-329eda28532a,nederlands_kanker_instituut_antoni_van_leeuwenhoek_ziekenhuis_nki_avl,Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis (NKI-AVL) +991,0.98197799921035767,136feb9a-ae28-4c13-afe3-e135660d48aa,Great Ormond Street Hospital,great_ormond_street_hospital,,,,136feb9a-ae28-4c13-afe3-e135660d48aa,great_ormond_street_hospital,Great Ormond Street Hospital +5701,,6826d4ec-8b85-427c-bb25-f10de5f646b0,"Medical University of Vienna, Department of Anesthesiology",medical_university_of_vienna_department_of_anesthesiology,,,,,, +798,0.98433560132980347,1466a25b-707c-4fd6-8cf9-33dfd10f0436,Technische Universität München Fakultät für Medizin,technische_universit_t_m_nchen_fakult_t_f_r_medizin,,,,1466a25b-707c-4fd6-8cf9-33dfd10f0436,technische_universit_t_m_nchen_fakult_t_f_r_medizin,Technische Universität München Fakultät für Medizin +5702,,1e4d090a-7472-4ef5-94da-b182b5d36501,Whittington Hospital NHS Trust,whittington_hospital_nhs_trust,,,,,, +5703,,75f81409-c9ac-4d99-9bc5-eed7a54677d3,Sheffield Children's NHS Foundation Hospital,sheffield_children_s_nhs_foundation_hospital,,,,,, +5704,,5698e666-d2c0-44c7-aa29-d90890f229f5,Thoraxklinik Heidelberg,thoraxklinik_heidelberg,,,,,, +5705,,c1716282-71fc-11e6-a0cd-0242ac12000b,BRYAN,bryan,,,,,, +5706,,3b7ea694-813e-4659-b174-e70cb536bc8a,Drug Delivery Solutions ApS,drug_delivery_solutions_aps,,,,,, +5707,,ae64ae92-3a61-44a2-b834-16be745c3ac5,U.L.S.S. 9 DI TREVISO,u_l_s_s_9_di_treviso,,,,,, +14,0.96103086074193322,41be544c-1f46-41e5-bb1b-0bb3baefda2e,"Menarini International Operations Luxembourg S.A., Avenue de la Gare, 1611 Luxembourg, Luxembourg",menarini_international_operations_luxembourg_s_a_avenue_de_la_gare_1611_luxembourg_luxembourg,,,,41be544c-1f46-41e5-bb1b-0bb3baefda2e,menarini_international_operation_luxembourg_sa,Menarini International Operation Luxembourg S.A +5708,,6fa4690d-a9dd-4b88-aa32-9d53ca11e9fe,Voyager Pharmaceutical Corporation,voyager_pharmaceutical_corporation,,,,,, +234,0.97803741693496704,7a736c7a-e49d-4f6d-a8da-98014f1ac986,Novartis,novartis,,,,7a736c7a-e49d-4f6d-a8da-98014f1ac986,novartis_pharma,Novartis Pharma +5709,,c9fb9945-c35e-4303-ae06-a7de683f3e2c,"DEFIANTE FARMACEUTICA,LDA",defiante_farmaceutica_lda,,,,,, +5710,,c063dc87-a77f-4442-82e0-7ae251688515,"HOSPITAL UNIVERSITARIO LA PAZ, SERVICIO DE ANESTESIA",hospital_universitario_la_paz_servicio_de_anestesia,,,,,, +5711,,b511b845-0322-487d-9008-a8a2c6a236c5,Oncobiologics Limited,oncobiologics_limited,,,,,, +5712,,ea1af215-ed23-4a58-8cfc-1f997d43b585,Kris-och Traumacentrum,kris_och_traumacentrum,,,,,, +5713,,5ac6f551-525b-4fde-85d0-d7c9b37b4d66,"Medizinische Universität Wien, Univ.Klinik f.Neurologie",medizinische_universit_t_wien_univ_klinik_f_neurologie,,,,,, +5714,,2950b554-7141-11e6-a0cd-0242ac12000b,SEBELA IRELAND LTD,sebela_ireland_ltd,,,,,, +5715,,b8abd6be-8a45-474d-a4d0-239384f4bb0e,"Innocrin Pharmaceuticals, Inc",innocrin_pharmaceuticals_inc,,,,,, +5716,,56b00d6d-b9b2-4434-a428-48d8e14b7352,Schur Pharmazeutika GmbH & Co. KG,schur_pharmazeutika_gmbh_co_kg,,,,,, +5717,,54d2ff3b-8157-4a72-ad08-38205b54bda7,"Foresee Pharmaceuticals Co., Ltd",foresee_pharmaceuticals_co_ltd,,,,,, +397,0.967352,d7c452de-3104-4c8e-bd02-3c40e45e5101,Copenhagen University Hospital Rigshospitalet,copenhagen_university_hospital_rigshospitalet,,,,a9e2a6af-3a27-4b28-a5a9-8ffd6a2cebe1,copenhagen_university_hospital_rigshospitalet_juliane_marie_centre_department_of_anaesthesiology,"Copenhagen University Hospital, Rigshospitalet, Juliane Marie Centre, Department of Anaesthesiology" +5718,,dfdd538c-8bf6-4c8f-9b7e-00fd922bdcdc,"Biota Pharmaceuticals, Inc",biota_pharmaceuticals_inc,,,,,, +5719,,386c5398-7143-11e6-a0cd-0242ac12000b,RENAISSANCE PHARMA,renaissance_pharma,,,,,, +5720,,90c581f7-9397-4ddb-83e6-a14c5d4537a4,"Merck Serono International, 9 Chemin des Mines, 1202 Geneva, Switzerland",merck_serono_international_9_chemin_des_mines_1202_geneva_switzerland,,,,,, +383,0.97393083572387695,cf4f2be5-6c16-4774-80da-73c264a99c4c,DBV Technologies S.A,dbv_technologies_s_a,,,,cf4f2be5-6c16-4774-80da-73c264a99c4c,dbv_technologies,DBV Technologies +5721,,be4de1e7-17d4-4ce0-8e26-cfede340d38b,AZIENDA POLICLINICO UMBERTO I,azienda_policlinico_umberto_i,,,,,, +5722,,4feb5c48-b6cf-4faf-917a-478d58dd7f50,Flevoziekenhuis,flevoziekenhuis,,,,,, +5723,,435a329b-40e9-43eb-92dd-e4e6e04d993f,"University Department of General, Visceral and Transplant Surgery Tuebingen",university_department_of_general_visceral_and_transplant_surgery_tuebingen,,,,,, +5724,,3a28b04b-6dc7-4716-97c5-d0d0f2e93b75,St Olavs Hospital Trondheim University Hospital,st_olavs_hospital_trondheim_university_hospital,,,,,, +5725,,4aef118f-d054-4dfe-88bb-723e5e9b5bb2,CAMBRIDGE UNIVERSITY HOSPITALS FOUNDATION NHS TRUST,cambridge_university_hospitals_foundation_nhs_trust,,,,,, +5726,,2b72ec07-4540-49ac-8796-4660d71de077,"Ministery of Defense, Military Mental Health - Research Centre",ministery_of_defense_military_mental_health_research_centre,,,,,, +5727,,fe01c6e3-0cc6-45e7-a705-cb6034608482,KV Pharmaceutical,kv_pharmaceutical,,,,,, +5728,,fb5faea6-7141-11e6-a0cd-0242ac12000b,EBEWE PHARMA,ebewe_pharma,,,,,, +867,0.974081,321d9f48-9a0a-471b-b553-56fdf09a41f7,"Dept. of Intensive Care, Rigshospitalet",dept_of_intensive_care_rigshospitalet,,,,321d9f48-9a0a-471b-b553-56fdf09a41f7,dept_of_intensive_care_rigshospitalet,"Dept. of Intensive Care, Rigshospitalet" +5729,,a5904c81-d7dd-4683-969f-d5cc2214fb11,Monash University,monash_university,,,,,, +5730,,6f418776-73be-11e6-a0cd-0242ac12000b,TALON THERAP,talon_therap,,,,,, +5731,,7eb33d6a-b44c-48d4-8dcd-f18317ecdcc3,Centre Hospitalier Intercommunal de Toulon - La Seyne sur Mer,centre_hospitalier_intercommunal_de_toulon_la_seyne_sur_mer,,,,,, +5732,,4d59ac92-167b-4b46-85e6-d3fb1e231a1a,"Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam",department_of_gastroenterology_and_hepatology_erasmus_mc_rotterdam,,,,,, +5733,,16ac32fe-7158-11e6-a0cd-0242ac12000b,PERRIGO R AND D,perrigo_r_and_d,,,,,, +958,0.979515,f16aba98-7151-11e6-a0cd-0242ac12000b,ELAN PHARM,elan_pharm,,,,6388a82e-7157-11e6-a0cd-0242ac12000b,elan_pharma_intl_ltd,ELAN PHARMA INTL LTD +5734,,d2023fdc-07d2-4bb0-9367-08e6755755df,Department of Anaesethesia,department_of_anaesethesia,,,,,, +5735,,667a69d2-6549-498c-9838-28c2bb9c24d3,Translational Oncology Research International,translational_oncology_research_international,,,,,, +5736,,6074af23-cc0e-41fb-a53e-27b8c4047675,Sepsicure LLC,sepsicure_llc,,,,,, +5737,,8da85710-7154-11e6-a0cd-0242ac12000b,THREE RIVERS PHARMS,three_rivers_pharms,,,,,, +5738,,d76cbcd7-75b7-4dad-a66c-eb7e73c8a607,"Jennerex, Inc",jennerex_inc,,,,,, +5739,,687c8251-d912-4b15-903f-d0ec5ad3f925,Sandoz GmbH,sandoz_gmbh,,,,,, +5740,,74823312-7a82-4064-89ef-0e812f9d60d3,GEL/TAMO (Cooperative Spanish Group of Lymphoma/Autologous bone marrow transplant),gel_tamo_cooperative_spanish_group_of_lymphoma_autologous_bone_marrow_transplant,,,,,, +5741,,1a245251-50f0-415f-b0da-8eb0a46d2137,Gesellschaft für Studienmanagement und Onkologie mbH,gesellschaft_f_r_studienmanagement_und_onkologie_mbh,,,,,, +742,0.964268,9cc141c9-55dc-4b03-84cc-245b7d5f45e4,Charite Universitaetsmedizin Berlin,charite_universitaetsmedizin_berlin,,,,50350555-1ec9-4ba6-9bb5-53e28ef8341d,charite,Charite +5742,,f30a9636-d4fe-4d5b-8a4b-4a834b287ca9,SANOFI-SYNTHELABO,sanofi_synthelabo,,,,,, +5743,,b3f463cb-d158-4436-8c43-df23061d7800,Cardiovascular Centre Aalst,cardiovascular_centre_aalst,,,,,, +8,0.90233862400054932,2f76c773-c7d9-474d-8b40-14c16bf7796f,Centre Hospitalier Universitaire de Reims,centre_hospitalier_universitaire_de_reims,,,,2522451a-1c66-4b28-bcf5-7bcf3f2f11b8,centre_hospitalier_universitaire_de_saint_etienne,Centre Hospitalier Universitaire de Saint-Etienne +5744,,ea699df7-bbf2-4856-a21f-e3ada0f3054c,Dr. Francisco Marrero Rodríguez. Hospital Universitario de Canarias,dr_francisco_marrero_rodr_guez_hospital_universitario_de_canarias,,,,,, +99,0.9399416446685791,bcb0e637-6442-4916-88f9-8cd0d5df3534,Novartis Farmacéutica,novartis_farmac_utica,,,,bcb0e637-6442-4916-88f9-8cd0d5df3534,novartis_farmaceutica,Novartis Farmaceutica +44,0.98179709911346436,58b676d5-ffb0-437b-b207-8be9df7a578f,Medicinsk Forskning,medicinsk_forskning,,,,035a6b1e-8bb9-11e6-a449-0242ac12000b,medicinsk_forskningsafsnit_holstebro,"Medicinsk Forskningsafsnit, Holstebro" +984,0.96790230274200439,1c2355a5-8dc8-4952-839c-0af765b26555,Imperial College London & Imperial College Healthcare NHS Trust,imperial_college_london_imperial_college_healthcare_nhs_trust,,,,1c2355a5-8dc8-4952-839c-0af765b26555,imperial_college_london_imperial_college_healthcare_nhs_trust,Imperial College London & Imperial College Healthcare NHS Trust +5745,,ba9eb216-6373-4b24-9560-aeb55105617f,"Rigshospitalet, Department of Oncology",rigshospitalet_department_of_oncology,,,,,, +5746,,d69ddc70-73f1-11e6-a0cd-0242ac12000b,NOVA LABS LTD,nova_labs_ltd,,,,,, +5747,,bad4acce-86c1-418f-a0ba-5bbc84162799,ICORG-All Ireland Co-operative Oncology Research Group,icorg_all_ireland_co_operative_oncology_research_group,,,,,, +714,0.985233,eae4c2b2-715c-11e6-a0cd-0242ac12000b,EUROHLTH INTL,eurohlth_intl,,,,0354c2c2-7129-11e6-a89e-0242ac12000b,eurohlth_intl_sarl,EUROHLTH INTL SARL +5748,,83827bc9-2fcc-4bd4-9bbb-973756d2bcc3,GIOM - Gruppo Italiano Oncologia Nefrologica,giom_gruppo_italiano_oncologia_nefrologica,,,,,, +5749,,36649dc5-d166-4496-8102-43c7682f0c9d,Boerhinger Ingelheim Pharma GmbH & Co.KG,boerhinger_ingelheim_pharma_gmbh_co_kg,,,,,, +5750,,c20cd435-3adc-4a02-8621-1e24a420ce82,Ester Neuroscience Ltd,ester_neuroscience_ltd,,,,,, +5751,,96be75f1-6f42-4e23-a152-6fcabfd7eb8f,Dr. Jaime Sagrista Sauleda,dr_jaime_sagrista_sauleda,,,,,, +5752,,b4dc07c0-95d0-4512-b89d-e5276f41e28d,Lumavita AG,lumavita_ag,,,,,, +5753,,a40f1b88-a986-483d-a539-b6cb3886f97f,Unit for Psychiatric Research,unit_for_psychiatric_research,,,,,, +5754,,04f61777-7bb8-4a5b-b201-5ff7c7ca0ae6,Esteban Ribera Pascuet,esteban_ribera_pascuet,,,,,, +5755,,0c915eb7-bec3-489a-8cbb-82a1d24048ba,"Department of Psychiatry and Psychotherapy, Charity University Medicine",department_of_psychiatry_and_psychotherapy_charity_university_medicine,,,,,, +5756,,7ff80805-62e2-4470-b0b0-87440be5e547,AesRx,aesrx,,,,,, +5757,,c3ee37b5-f7df-432e-835e-2c9f41fa7aae,Dynavax Technologies Corporation,dynavax_technologies_corporation,,,,,, +75,0.984093,d1b481d9-2e7a-4149-86cf-32b5b57a8168,GALENpharma GmbH,galenpharma_gmbh,,,,d1b481d9-2e7a-4149-86cf-32b5b57a8168,galenpharma_gmbh,GALENpharma GmbH +190,0.985423,1f75a770-d643-44ba-b10f-91da8b571eaa,Prima BioMed Ltd,prima_biomed_ltd,,,,1f75a770-d643-44ba-b10f-91da8b571eaa,prima_biomed_ltd,Prima BioMed Ltd +115,0.97782391309738159,b28c49a1-c21b-407a-9fd2-2dbd3207b28b,Shire,shire,,,,b28c49a1-c21b-407a-9fd2-2dbd3207b28b,shire,Shire +5758,,4838252f-a7ab-11e6-94cb-5656d04fc2b5,Corcept Therapeutics Incorporated,corcept_therapeutics_incorporated,,,,,, +5759,,1e9c5a17-7c4b-44c8-be23-3f12ea555d32,"Universität Mainz, III. Medizinische Klinik",universit_t_mainz_iii_medizinische_klinik,,,,,, +5760,,8b5aa592-0b1c-4e62-b04d-5f080be47319,VUAB Pharma a.s,vuab_pharma_a_s,,,,,, +5761,,2dd700e1-5ebb-4d23-ade5-a84cd5bf2eca,"Hôpital Erasme, Cliniques Universitaires de Bruxelles",h_pital_erasme_cliniques_universitaires_de_bruxelles,,,,,, +876,0.90458685159683228,5cd5bf06-2291-4844-9da5-1660b3540deb,FUNDACION PARA LA INVESTIGACION LA FE,fundacion_para_la_investigacion_la_fe,,,,5cd5bf06-2291-4844-9da5-1660b3540deb,fundacion_para_la_investigacion_la_fe,FUNDACION PARA LA INVESTIGACION LA FE +5762,,e91c08b7-b787-4e12-b24b-b37f8bc57cdc,Sociedad Española de Cardiología,sociedad_espa_ola_de_cardiolog_a,,,,,, +5763,,bb62f128-6fc0-11e6-abe8-0242ac12000b,Johnson & Johnson Taiwan Ltd,johnson_johnson_taiwan_ltd,,,,,, +787,0.98334300518035889,08982651-8665-4f48-91ab-412b9c9c69a9,"Intercell USA, Inc. (Intercell)",intercell_usa_inc_intercell,,,,08982651-8665-4f48-91ab-412b9c9c69a9,intercell_usa_inc_intercell,"Intercell USA, Inc. (Intercell)" +5764,,8f4924d1-212a-4921-8c16-0c43a8e38a3f,CONSORZIO ONCOTECH,consorzio_oncotech,,,,,, +5765,,f07ec2e0-5176-4b6e-83a8-506b890c8b89,SINTETICA ITALIA S.R.L,sintetica_italia_s_r_l,,,,,, +5766,,1e4fd291-1d3f-4b28-94df-b497128a1b36,"Medical University, Dpt. Internal Medicine, Div. of General Internal Medicine",medical_university_dpt_internal_medicine_div_of_general_internal_medicine,,,,,, +129,0.97715285420417786,2089014e-7f36-4848-b094-a8d5070e2afb,Cliniques Universitaires St Luc,cliniques_universitaires_st_luc,,,,4bc32527-accc-401e-81cd-afaacbe32d0c,cliniques_universitaires_st_luc,Cliniques Universitaires St Luc +5767,,b0b25ef0-5d3c-4602-b2f5-e750672ab211,National Headache Institute,national_headache_institute,,,,,, +5768,,1f32198f-8f9f-499a-8459-4ea26085dc87,Alllergopharma Joachim Ganzer KG,alllergopharma_joachim_ganzer_kg,,,,,, +5769,,7ad534cf-5ac2-42a6-b9c7-27adff12e69d,"Helsinn Therapeutics (U.S.), Inc",helsinn_therapeutics_u_s_inc,,,,,, +5770,,c2b1b06c-7165-11e6-a0cd-0242ac12000b,ORION CORP ORION,orion_corp_orion,,,,,, +5771,,76119c3f-3523-417e-a553-ed9634ae8bb1,Dr. Ritsert Pharma,dr_ritsert_pharma,,,,,, +5772,,b0960a5d-4802-438f-a2e3-d7faf8cc34d7,CIS bio International,cis_bio_international,,,,,, +5773,,54e8c1b1-d992-44ff-abd2-28abb8115d75,"Dekan der medizinischen Fakultät, Universitätsklinikum Frankfurt, Goethe-Universität",dekan_der_medizinischen_fakult_t_universit_tsklinikum_frankfurt_goethe_universit_t,,,,,, +5774,,dd9cb800-54ff-44b3-a6cf-e11d27056dd4,Elisabethinen Hospital Linz,elisabethinen_hospital_linz,,,,,, +5775,,80e88be2-f1b6-4178-a889-646d0680ae4b,Dept of Neurology,dept_of_neurology,,,,,, +5776,,a1794bf1-44f1-4434-a091-96f689b5c409,"Universitätsklinikum Aachen, Klinik f. Psychiatrie und Psychotherapie",universit_tsklinikum_aachen_klinik_f_psychiatrie_und_psychotherapie,,,,,, +5777,,7f352824-f43c-47b8-b3eb-f47f9b8ca55f,Genetronics Biomedical Corporation,genetronics_biomedical_corporation,,,,,, +5778,,9804ca16-f3ae-482f-a4e3-8e7d33f52a02,Alcon Sverige AB,alcon_sverige_ab,,,,,, +5779,,e58d6e1f-7af1-4f47-9686-709d0c794566,The Swedish AML Group,the_swedish_aml_group,,,,,, +883,0.97897982597351074,0ea5911a-7142-11e6-a0cd-0242ac12000b,ALTANA,altana,,,,0ea5911a-7142-11e6-a0cd-0242ac12000b,altana,ALTANA +5780,,3bed5ffc-c126-4e18-974f-dd6cfd783095,Cardio3 BioSciences SA,cardio3_biosciences_sa,,,,,, +5781,,409f50f7-22fe-4909-9fcf-485f96c2e9f5,GUIDOTTI,guidotti,,,,,, +5782,,443db8b8-7145-11e6-a0cd-0242ac12000b,EPIC PHARMA LLC,epic_pharma_llc,,,,,, +5783,,aed1551a-a597-4f9b-83f2-f31d031fde86,CESAR AUGUSTO VALERO MARTINEZ,cesar_augusto_valero_martinez,,,,,, +5784,,b425f68a-7191-11e6-a0cd-0242ac12000b,TEVA WOMENS,teva_womens,,,,,, +5785,,d1b2a40c-56d4-4785-8ff9-994ff7ad88fb,Seikagaku Corporation,seikagaku_corporation,,,,,, +237,0.98591169714927673,a0e33e4c-faf3-44df-85c6-ebc94469b62e,"Pfizer Limited, Ramsgate Road, Sandwich, Kent, UK",pfizer_limited_ramsgate_road_sandwich_kent_uk,,,,a0e33e4c-faf3-44df-85c6-ebc94469b62e,pfizer_limited_ramsgate_road_sandwich_kent_uk,"Pfizer Limited, Ramsgate Road, Sandwich, Kent" +5786,,4e6dad98-4731-4c2d-9076-7b412f2ef646,USV Limited,usv_limited,,,,,, +5787,,c2912cd3-2337-4ff2-aaa5-613b0c7956b2,"Landeshauptstadt Stuttgart, represented by Prof. Dr. J. Graf, Leitender Aerztlicher Direktor Klinikum Stuttgart",landeshauptstadt_stuttgart_represented_by_prof_dr_j_graf_leitender_aerztlicher_direktor_klinikum_stuttgart,,,,,, +5788,,63c5003a-73f0-11e6-a0cd-0242ac12000b,SCOTT-GROSS COMPANY,scott_gross_company,,,,,, +5789,,00b74dce-36a4-43e2-a58d-c23d0a333d04,Nordic Lymphoma Group,nordic_lymphoma_group,,,,,, +5790,,410db730-71e3-11e6-a0cd-0242ac12000b,DOWNSTATE CLINCL,downstate_clincl,,,,,, +5791,,49b8a3f8-71ee-11e6-a0cd-0242ac12000b,CONCORDIA LABS INC,concordia_labs_inc,,,,,, +5792,,2f229595-c3dc-40eb-be1c-e592787d8ea0,Stepani Bendel,stepani_bendel,,,,,, +5793,,c179aab3-9347-4a50-aea8-fbe5a3e19dc4,Phafag AG,phafag_ag,,,,,, +568,0.971368,2a99366d-c8b5-4d6b-a57e-00e956554937,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico,fondazione_irccs_c_granda_ospedale_maggiore_policlinico,,,,2a99366d-c8b5-4d6b-a57e-00e956554937,fondazione_irccs_c_granda_ospedale_maggiore_policlinico,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico +5794,,a1634d25-50bb-479e-a796-3df303757e17,"Department of Medicine M, Aarhus University Hospital",department_of_medicine_m_aarhus_university_hospital,,,,,, +15,0.946972,4becd0cc-b39a-41ea-8a3e-45c64348e698,AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI CREMONA,azienda_ospedaliera_istituti_ospitalieri_di_cremona,,,,4becd0cc-b39a-41ea-8a3e-45c64348e698,azienda_ospedaliera_istituti_ospitalieri_di_cremona,AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI CREMONA +5795,,ead7b187-89a2-404b-9225-3a6bd3ffe168,Leila Niemi-Murola,leila_niemi_murola,,,,,, +5796,,cdf03669-e8a1-4948-9080-d1681d7788ae,"Medizinische Universität Wien, Univ.Klinik für Kinder-und Jugendheilkunde",medizinische_universit_t_wien_univ_klinik_f_r_kinder_und_jugendheilkunde,,,,,, +5797,,9cd9c697-b224-4e0f-885a-f7d08ae50ebc,Eero Kaasinen,eero_kaasinen,,,,,, +5798,,4b9efd0c-e025-4df0-8a68-3c20ef40fd69,FUJISAWA,fujisawa,,,,,, +5799,,42482d1e-b420-4968-b720-5e2b11f0bcf5,Boehrringer Ingelheim Finland Ky,boehrringer_ingelheim_finland_ky,,,,,, +5800,,4310b5bd-c53f-40f5-9f74-219e40789117,Trevena Inc,trevena_inc,,,,,, +5801,,e7613e9b-586d-4312-bf40-13fdef853c82,Alberto Capelastegui Sainz,alberto_capelastegui_sainz,,,,,, +5802,,1c347ef6-1a52-487a-b0da-9587436ce522,Genta Incorporated,genta_incorporated,,,,,, +5803,,a8abd90f-c34f-4ecd-8fcd-472d64e95c07,PIERRE FABRE MEDICAMENT represented by Institut de Recherche Pierre Fabre,pierre_fabre_medicament_represented_by_institut_de_recherche_pierre_fabre,,,,,, +998,0.987967,43136b72-9ea5-4280-955b-222830e86bf5,Lipid Pharmaceuticals ehf,lipid_pharmaceuticals_ehf,,,,43136b72-9ea5-4280-955b-222830e86bf5,lipid_pharmaceuticals_ehf,Lipid Pharmaceuticals ehf +5804,,614c7f8c-04ca-4949-b1b1-8f42748277c5,The Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery,the_ludwig_boltzmann_institute_for_retinology_and_biomicroscopic_lasersurgery,,,,,, +5805,,b1731873-b436-4844-8912-672937e556f7,Antoni van Leeuwenhoek ziekenhuis,antoni_van_leeuwenhoek_ziekenhuis,,,,,, +5806,,39c22725-f367-44dd-99d1-0abec487a4c5,Brighton & Sussex University Hospitals NHS Trust,brighton_sussex_university_hospitals_nhs_trust,,,,,, +5807,,266cecd5-1f21-4f17-8bf2-cebe94728d3b,Hans Christian Wulf,hans_christian_wulf,,,,,, +5808,,9cc08f85-c758-4743-83a6-2325d3ac9c04,Landeskrankenhaus Fedkirch,landeskrankenhaus_fedkirch,,,,,, +5809,,b62e7f75-261f-4503-bb23-89bde04c04c9,GRUPO GETNE,grupo_getne,,,,,, +5810,,b1f0b4a7-295b-496f-b8c8-91b9eeba6a9e,"Abbott Products, Inc (Abbott Products Inc. is part of the parent company, Abbott Laboratories)",abbott_products_inc_abbott_products_inc_is_part_of_the_parent_company_abbott_laboratories,,,,,, +5811,,4b63f5c0-d516-4d83-ac0e-780013884646,"University Medical Center Nijmegen, dept. of Pharmacology-Toxicology",university_medical_center_nijmegen_dept_of_pharmacology_toxicology,,,,,, +5812,,5b2cd722-4729-438e-b703-b9ffb5684c0a,MASTELLI SRL,mastelli_srl,,,,,, +5813,,a9d5fa09-8561-48ae-a22a-912d4760fe0a,Dott.ssa Elena Santagostino,dott_ssa_elena_santagostino,,,,,, +35,0.977622,366baf89-cad4-4cfd-9336-5896cd05adb2,Landstinget Västmanland,landstinget_v_stmanland,,,,1b03f797-4154-432f-973b-87560cdf6cc4,landstinget_v_stmanland_division_kirurgi_operationskliniken,"Landstinget Västmanland, Division Kirurgi, Operationskliniken" +5814,,b6096e43-c252-4ccd-ab01-04fc2d181309,CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE,centre_hospitalier_universitaire_de_lille,,,,,, +5815,,64534176-1e28-48bc-aa28-882696d200b6,Novartis Pharma GmbH,novartis_pharma_gmbh,,,,,, +5816,,400e7fb4-e457-4ab6-9885-01cc2e2cf624,The Walton Centre NHS Foundation Trust,the_walton_centre_nhs_foundation_trust,,,,,, +5817,,997a0432-8a20-46b0-b73b-049095c547d0,JJANSSEN-CILAG, JOHNSON & JOHNSON spol. s r.o,,,,,, +5818,,d4086914-728c-11e6-a0cd-0242ac12000b,EXALENZ BIOSCIENCE,exalenz_bioscience,,,,,, +5819,,127ddead-226d-41b9-9d40-eda4c09b4c7a,Professor Jørgen Berg Dahl,professor_j_rgen_berg_dahl,,,,,, +5820,,6b4624ec-73c3-11e6-a0cd-0242ac12000b,LUNDBECK NA LTD,lundbeck_na_ltd,jjanssen_cilag_johnson_johnson_spol_s_r_o,,,,, +5821,,63db7ef7-ebfa-4d50-890d-c0713ad9a688,"Genzyme Europe B.V, Netherlands",genzyme_europe_b_v_netherlands,,,,,, +5822,,66510292-57c1-43f3-b6f0-e70ab102d7db,"Dept. of Neurology, Odense University Hospital",dept_of_neurology_odense_university_hospital,,,,,, +5823,,fdfef672-e1b8-493b-bce6-1c9f94943d4c,Wockhardt UK Limited,wockhardt_uk_limited,,,,,, +5824,,3817c5cd-ea3b-4f4a-a4b3-79eb95e3e0f6,Pfizer Global Research and Development,pfizer_global_research_and_development,,,,,, +5825,,32e42ab1-2403-40ae-a793-d8859207c4c0,C4Pain ApS,c4pain_aps,,,,,, +5826,,f12d9d48-0032-4245-b405-eaffe7522a4b,Resverlogix Corp,resverlogix_corp,,,,,, +5827,,c86bd526-7180-11e6-a0cd-0242ac12000b,SICOR BIOTECH,sicor_biotech,,,,,, +5828,,2dc8a129-9009-4796-9308-079dac6aebe5,"Vassilis Georgoulias, Prof. of Internal Medicine-Oncology of Medical Dpt University of Crete",vassilis_georgoulias_prof_of_internal_medicine_oncology_of_medical_dpt_university_of_crete,,,,,, +5829,,fe9e74b6-bc1e-4f0e-924c-47d9d09d5b55,Juvantia Pharma Ltd,juvantia_pharma_ltd,,,,,, +5830,,b1662bea-7321-11e6-a0cd-0242ac12000b,POWDER PHARMS,powder_pharms,,,,,, +5831,,8497a86e-40bb-4b5e-9ff4-f2e4fd7144e2,AZIENDA SANITARIA LOCALE 4 DI TORINO,azienda_sanitaria_locale_4_di_torino,,,,,, +5832,,271ba7a6-6260-431b-8399-70d7a97fb402,Kyowa Hakko U.K. Limited,kyowa_hakko_u_k_limited,,,,,, +5833,,be18238d-cb8e-42e3-b15b-6ce0eb6a5efc,"Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin",allergie_centrum_charit_department_of_dermatology_and_allergy_charit_universit_tsmedizin_berlin,,,,,, +5834,,5d60a0c9-8761-47b0-af8e-0cda96d53862,"Dept. of Anaesthesia, Medical University of Vienna",dept_of_anaesthesia_medical_university_of_vienna,,,,,, +995,0.98229312896728516,9f829155-76f5-4952-b92c-64b02c2f74f8,GE Healthcare Limited and its affiliates,ge_healthcare_limited_and_its_affiliates,,,,3f41d035-5505-424a-9eba-1d3001157ba6,ge_healthcare_limited,GE Healthcare Limited +5835,,3b410f42-1863-4a79-895e-8ae40639a265,HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON,hospital_general_universitario_gregorio_mara_on,,,,,, +784,0.966541,8c460761-0f56-46e2-8808-c7288d449545,EORTC,eortc,,,,8c460761-0f56-46e2-8808-c7288d449545,eortc,EORTC +5836,,bd1ada88-7762-409f-b069-27f969f42822,Merck Santé s.a.s,merck_sant_s_a_s,,,,,, +5837,,22598306-ce1f-44d4-a20c-d541a41f6ec9,K.U. Leuven,k_u_leuven,,,,,, +5838,,43695ee0-efb5-40ef-8115-71fddcb080c1,OSPEDALE SACRO CUORE-DON CALABRIA,ospedale_sacro_cuore_don_calabria,,,,,, +795,0.982732,f3146d45-b80c-4479-bdfd-0aff428c6b73,Medical Research Council Clinical Trials Unit,medical_research_council_clinical_trials_unit,,,,a794f8fb-a13b-44b5-98ab-9945768f16df,medical_research_council,Medical Research Council +406,0.98668,6a695a29-050c-4d3f-8e0d-c6d6a3afc8f2,Beaumont Hospital/RCSI,beaumont_hospital_rcsi,,,,6a695a29-050c-4d3f-8e0d-c6d6a3afc8f2,beaumont_hospital_rcsi,Beaumont Hospital/RCSI +5839,,edd85721-72cf-4b8f-9f91-cc96f5dca1e0,Mikkel Østergaard,mikkel_stergaard,,,,,, +5840,,2e4d8d4b-5380-4126-9f90-9f29429309ed,"Gentofte Hospital, Dep. of Medicine",gentofte_hospital_dep_of_medicine,,,,,, +133,0.951362,71e1740c-dc4b-46d2-86ac-23909116857c,Vakgroep Huisartsgeneeskunde Vrije Universiteit Brussel,vakgroep_huisartsgeneeskunde_vrije_universiteit_brussel,,,,71e1740c-dc4b-46d2-86ac-23909116857c,vakgroep_huisartsgeneeskunde_vrije_universiteit_brussel,Vakgroep Huisartsgeneeskunde Vrije Universiteit Brussel +5841,,dddfafc5-124e-4706-91c9-05c38d1e2a97,Henning Beck-Nielsen,henning_beck_nielsen,,,,,, +316,0.987803,bb3763b5-ae54-4b86-8b38-ca48db63ae2c,Jazz Pharmaceuticals,jazz_pharmaceuticals,,,,17eacfff-6322-4900-ab4b-4476d90f6cb8,jazz_pharmaceuticals_inc,Jazz Pharmaceuticals Inc +5842,,220456f1-0c39-4482-88b5-b1cfc67acc5a,Queen Victoria Hospital NHS Foundation Trust,queen_victoria_hospital_nhs_foundation_trust,,,,,, +5843,,e230ea06-5bb6-4fb7-a2ac-d62e0b00b5d7,Lennart Svensson Linköping University Medical Faculty,lennart_svensson_link_ping_university_medical_faculty,,,,,, +5844,,ce0c5b75-a1d5-4e3c-aa25-84c497a4f1c3,Copenhagen University Hospital Bispebjerg,copenhagen_university_hospital_bispebjerg,,,,,, +5845,,bc60c7cd-57d1-44c4-8057-9fce538c1c26,*LOC to complete*,loc_to_complete,,,,,, +5846,,24f1168d-a543-4a5c-ad9b-004ec6cce3ee,ICM- VAL D’AURELLE,icm_val_d_aurelle,,,,,, +5847,,eb467faa-455a-497e-b0d3-ffda6bcc55f1,EORTC Lymphoma Group,eortc_lymphoma_group,,,,,, +5848,,4b41251d-229d-4b19-bf64-2fede9dd4814,Pfizer Inc. - Research & Development,pfizer_inc_research_development,,,,,, +5849,,5c506588-4a5c-4ff9-bea0-5bbf2746c3d8,"FARMALIDER, S.A",farmalider_s_a,,,,,, +5850,,ea6bc3c0-3c41-4a93-9e3d-5ab71e7cd62f,Janssen Pharmaceutical K.K,janssen_pharmaceutical_k_k,,,,,, +685,0.98814409971237183,f406cf6a-764a-4362-8451-5306e5f99cb4,University Medical Center,university_medical_center,,,,6215f084-4978-4b33-9f3e-b048c59d9d5d,university_medical_center_umcu,University Medical Center UMCU +5851,,28d163d3-ceb8-49a0-864c-116c633ba923,CLINUVEL PHARMACUETICALS LTD,clinuvel_pharmacueticals_ltd,,,,,, +5852,,714556b0-39ae-4ac0-a183-cff5df1d1737,David López Vaquero,david_l_pez_vaquero,,,,,, +5853,,07765d40-fc20-42bd-86d2-62ca6f5be6cf,Parnassia Bavo Groep - PsyQ,parnassia_bavo_groep_psyq,,,,,, +5854,,089b458d-5991-4f6b-838b-f064b6ae707e,"Psykiatri Nordväst, Karolinska Universitetssjukhuset Solna",psykiatri_nordv_st_karolinska_universitetssjukhuset_solna,,,,,, +5855,,8495c042-f307-4e10-85fc-3815dc48f39e,"Optimer Pharmaceutical, Inc. (a Cubist company)",optimer_pharmaceutical_inc_a_cubist_company,,,,,, +5856,,ae0de7e2-0663-4a72-aa1e-b1775ed3364a,G.O.N.O. Gruppo Oncologico del Nord Ovest,g_o_n_o_gruppo_oncologico_del_nord_ovest,,,,,, +5857,,15d9e073-ca55-477a-b642-9ea609d9189a,Centre Paul Papin,centre_paul_papin,,,,,, +5858,,3f3d7deb-5729-46b1-8280-ad251a220dd8,Allan Flyvbjerg,allan_flyvbjerg,,,,,, +25,0.97483,575a893b-fb9f-4cff-b2fd-090f406fd398,"Abraxis BioScience, LLC",abraxis_bioscience_llc,,,,575a893b-fb9f-4cff-b2fd-090f406fd398,abraxis_bioscience_llc,"Abraxis BioScience, LLC" +5859,,5acdcbe0-8a59-426c-aea5-cbfdc5345cfb,Andrés Ignacio Bodegas Cañas,andr_s_ignacio_bodegas_ca_as,,,,,, +236,0.96209257841110229,4bcd631b-11cb-4115-911b-11d44ed9d2aa,"Pfizer Ltd, Ramsgate Road, Sandwich, Kent, UK",pfizer_ltd_ramsgate_road_sandwich_kent_uk,,,,36e40cab-06cf-41e0-bef3-04e11a49311d,pfizer_ltd_ramsgate_road_sandwich_kent,"Pfizer Ltd, Ramsgate Road, Sandwich, Kent" +5860,,9211e76f-3bc6-404d-9142-549ffc69e67b,Circassia Limited,circassia_limited,,,,,, +5861,,595c77a7-2f05-4377-adde-008df650892c,"Siegfried KASPER, O.Univ.Prof.Dr.Dr.h.c., Medizinische Universität Wien",siegfried_kasper_o_univ_prof_dr_dr_h_c_medizinische_universit_t_wien,,,,,, +5862,,da1fd1f3-cbbf-4836-ba05-d50e95cf4035,Elro Pharma,elro_pharma,,,,,, +5863,,7e476a0a-fc5d-4e6c-88cb-02d0d506e0f5,A.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA,a_i_e_o_p_associazione_italiana_ematologia_oncologia_pediatrica,,,,,, +894,0.980283,4c60518a-9908-4d13-88be-256b0c110878,"Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery, Rudolf Foundation Clinic",ludwig_boltzmann_institute_for_retinology_and_biomicroscopic_laser_surgery_rudolf_foundation_clinic,,,,25c1b375-42c4-46ab-a38f-021e8ab03a25,ludwig_boltzmann_institute_forretinology_and_biomicroscopic_laser_surgery,Ludwig Boltzmann Institute forRetinology and Biomicroscopic Laser Surgery +5864,,6ac42bb6-1d64-4e87-95c7-ae666c914a29,"Academic Medical Center, department of infectious diseases",academic_medical_center_department_of_infectious_diseases,,,,,, +5865,,b0475f82-715e-11e6-a0cd-0242ac12000b,NOVOCOL,novocol,,,,,, +5866,,342e0dbe-1a55-486d-b13f-8c56f771faa5,SmartPractice,smartpractice,,,,,, +5867,,a6338e86-7211-11e6-a0cd-0242ac12000b,DANCO LABS LLC,danco_labs_llc,,,,,, +5868,,3a64b24e-a0df-4f1b-bb32-239ad7f5bc93,Takeda Global Development Centre Europe Ltd,takeda_global_development_centre_europe_ltd,,,,,, +5869,,e1f3bb60-7164-11e6-a0cd-0242ac12000b,SUVEN LIFE,suven_life,,,,,, +5870,,ccb4af1d-193a-4b86-82db-045ef52b094c,Coombe Women and Infants University Hospital,coombe_women_and_infants_university_hospital,,,,,, +144,0.938386,790c1c0e-21be-4522-8397-7082338e668c,Joint UCLH and UCL Biomedical Research Unit,joint_uclh_and_ucl_biomedical_research_unit,,,,26bb805d-b0a7-4b5c-bcee-c5480afe6696,joint_uclh_ucl_biomedical_research_unit,Joint UCLH & UCL Biomedical Research Unit +5871,,326a7600-effd-4649-978f-5e6f2f5093e5,Federico Diaz González,federico_diaz_gonz_lez,,,,,, +5872,,44e7dfec-c02e-4e36-85a1-b6d4bc8c2532,"Department of Medicine, Haugesund Hospital",department_of_medicine_haugesund_hospital,,,,,, +5873,,1a7590fe-0f87-48c8-b1bf-6937e9032bb6,Vectura GmbH,vectura_gmbh,,,,,, +5874,,8b46dac0-21e7-426b-a817-c080ab91ead9,Mesoestetic Pharma group S.L,mesoestetic_pharma_group_s_l,,,,,, +5875,,a6436686-8fd6-4e15-bb2a-40a0b46f6e47,Kings College London/South London and Maudsley NHS Foundation Trust,kings_college_london_south_london_and_maudsley_nhs_foundation_trust,,,,,, +5876,,56eedb7f-38ea-4581-8018-ef86d2294582,University of Wuerzburg,university_of_wuerzburg,,,,,, +254,0.941004,07cef69a-6d39-498c-b1f5-a59bab4b33b0,GLAXO SMITH KLINE RESEARCH & DEVELOPMENT LTD,glaxo_smith_kline_research_development_ltd,,,,07cef69a-6d39-498c-b1f5-a59bab4b33b0,glaxo_smith_kline_research_development_ltd,GLAXO SMITH KLINE RESEARCH & DEVELOPMENT LTD +314,0.98565453290939331,b010a3d1-2373-46a5-aa8a-b8434224a757,Mundipharma AB,mundipharma_ab,,,,0c6b6aec-6007-4be6-917b-e3ac534e2858,mundipharma,Mundipharma +5877,,040029dd-29c2-43a9-b1a9-64e256ce744d,"Department of Nuclear Medicine, Odense University Hospital",department_of_nuclear_medicine_odense_university_hospital,,,,,, +5878,,a81351d0-71a0-11e6-a0cd-0242ac12000b,ALZA,alza,,,,,, +5879,,2659d697-5a06-46e5-a639-05ffb9369c59,Mundipharma Research Limited,mundipharma_research_limited,,,,,, +23,0.98531901836395264,660421b1-e8b2-4a60-8830-ced19c7ed774,University Hospitals Leuven,university_hospitals_leuven,,,,32433559-55be-43ec-8a0d-06197533759d,university_hospitals_leuven_gasthuisberg,University Hospitals Leuven (Gasthuisberg) +5880,,4e2ba68e-735f-11e6-a0cd-0242ac12000b,HERON THERAPEUTICS,heron_therapeutics,,,,,, +5881,,302a9b55-bd60-4a57-9868-7f16a3e854a0,"Wyeth Pharmaceuticals Inc., Wyeth Research Div., Clinical research and Development",wyeth_pharmaceuticals_inc_wyeth_research_div_clinical_research_and_development,,,,,, +408,0.931044,5af16d72-9df2-4fc9-8608-fbc9eb8e988a,CHU de Liege,chu_de_liege,,,,5af16d72-9df2-4fc9-8608-fbc9eb8e988a,chu_de_liege,CHU de Liege +5882,,696260f3-c278-41e1-9671-40c38e7ffbf9,Gerolsteiner Brunnen GmbH & Co. KG,gerolsteiner_brunnen_gmbh_co_kg,,,,,, +5883,,24408c3f-d7e0-4317-85a0-da4ca4d490fd,The University of Oxford,the_university_of_oxford,,,,,, +5884,,1d52a33c-4029-464f-8acd-35b21b53eafc,Medisch Centrum Alkmaar,medisch_centrum_alkmaar,,,,,, +5885,,91bd7ef8-82ee-4e89-b04c-1c5318e3bf42,"Civitas Therapeutics, a wholly owned subsidiary of Acorda Therapeutics, Inc",civitas_therapeutics_a_wholly_owned_subsidiary_of_acorda_therapeutics_inc,,,,,, +5886,,4c5285e5-b2c5-4e42-b4a4-ca772a63943a,Institute for Biomedical Aging Research,institute_for_biomedical_aging_research,,,,,, +5887,,69e095a7-3550-464e-adc3-f8ce8749a974,Tillotts Pharma AG,tillotts_pharma_ag,,,,,, +41,0.951277,1dd460c9-f84b-4b97-8376-8660e0cef195,Dr. Gerhard Mann chem.-pharm. Fabrik GmbH/ Bausch & Lomb Incorporated,dr_gerhard_mann_chem_pharm_fabrik_gmbh_bausch_lomb_incorporated,,,,1dd460c9-f84b-4b97-8376-8660e0cef195,dr_gerhard_mann_chem_pharm_fabrik_gmbh_bausch_lomb_incorporated,Dr. Gerhard Mann chem.-pharm. Fabrik GmbH/ Bausch & Lomb Incorporated +986,0.96840834617614746,ea4dc71b-e8ef-4f8f-9f2e-ed6a308b18fd,Imperial College Heathcare NHS Trust,imperial_college_heathcare_nhs_trust,,,,67902b25-58c1-419c-918d-42f6cc022a27,imperial_college_healthcare_nhs_trust,Imperial College Healthcare NHS Trust +5888,,d8fc4885-3f13-46ff-a9a7-2bc1c2f67dd4,Minna Honkila,minna_honkila,,,,,, +5889,,02930f71-5db3-459d-b021-cedbb97cf43c,"Puolustusvoimat, Sotilaslääketieteen keskus",puolustusvoimat_sotilasl_ketieteen_keskus,,,,,, +5890,,2dde3636-ba4a-425f-8912-370d24369ec6,"Athersys, Inc",athersys_inc,,,,,, +5891,,6bef7db0-0226-4460-8311-440fe592550b,ASAC PHARMACEUTICAL INTERNATIONAL A.I.E,asac_pharmaceutical_international_a_i_e,,,,,, +5892,,d1a49d54-800b-41e4-a174-02981c955c01,Rexgenero Limited,rexgenero_limited,,,,,, +5893,,f0d8e439-ddc2-4af5-a8cf-b9325ac5cbdd,"Copenhagen University Hospital Rigshospitalet, Department of Cardiology B 2143",copenhagen_university_hospital_rigshospitalet_department_of_cardiology_b_2143,,,,,, +5894,,3beab8a3-c9e9-4d5b-a665-f7c298a935be,Danish Gynaecological Cancer Group,danish_gynaecological_cancer_group,,,,,, +5895,,cba7a933-c0b0-4076-9593-65aacceb1201,Profile Pharma Ltd,profile_pharma_ltd,,,,,, +5896,,85b952aa-ce6c-49b5-83ab-2d2beedda736,"Corthera, Inc",corthera_inc,,,,,, +5897,,c331bb30-8349-4948-bab0-239082584e97,Bayer B.V,bayer_b_v,,,,,, +638,0.972279,a8a9c27e-73fc-11e6-a0cd-0242ac12000b,ADAPT PHARMA,adapt_pharma,,,,a8a9c27e-73fc-11e6-a0cd-0242ac12000b,adapt_pharma,ADAPT PHARMA +5898,,e42882e1-03d4-4a65-8f6e-792bff0de04f,Onxeo,onxeo,,,,,, +5899,,e86849ca-8bbd-11e6-a449-0242ac12000b,Archigen Biotech Limited,archigen_biotech_limited,,,,,, +5900,,847e3d5c-8724-413c-88b1-4db229bd48da,"Department of Clinical Oncology, Leiden University Medical Center",department_of_clinical_oncology_leiden_university_medical_center,,,,,, +5901,,f51d84f4-716a-11e6-a0cd-0242ac12000b,OMJ PHARMACEUTICALS,omj_pharmaceuticals,,,,,, +5902,,11145a7d-a298-4cf6-ae4b-46d2af4892d4,GlaxoSmithKline A.E.B.E,glaxosmithkline_a_e_b_e,,,,,, +5903,,986bad3a-f30b-4f04-a014-4eca2b475c80,CHU de Clermont-Ferrand,chu_de_clermont_ferrand,,,,,, +5904,,3659feba-6f33-43e6-8f32-fa742da849eb,Research and Development Office Cardiff and Vale NHS Trust,research_and_development_office_cardiff_and_vale_nhs_trust,,,,,, +752,0.9619777500629425,2b94d422-3c7c-4235-96fe-8b11faab4b13,Grupo Español de Tratamiento de los Tumores de Cabeza y Cuello (TTCC),grupo_espa_ol_de_tratamiento_de_los_tumores_de_cabeza_y_cuello_ttcc,,,,137320fb-fac2-4e31-99c7-7873aa7537cc,grupo_espa_ol_de_tratamiento_de_tumores_de_cabeza_y_cuello_ttcc,Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC) +513,0.977852,04cef99e-6fba-11e6-abe8-0242ac12000b,Intergroupe Francophone du Myelome (IFM),intergroupe_francophone_du_myelome_ifm,,,,04cef99e-6fba-11e6-abe8-0242ac12000b,intergroupe_francophone_du_myelome_ifm,Intergroupe Francophone du Myelome (IFM) +5905,,7202e99b-db60-4e40-9a1b-6fd39844a617,Almac Discovery,almac_discovery,,,,,, +5906,,7f455022-eab2-4c93-84b8-187a3b6ada11,University of Aarhus,university_of_aarhus,,,,,, +5907,,cfcda495-1bde-4a24-803b-0bb4616bac3b,Boehringer Ingelheim Pharma RCV GmbH & Co. KG,boehringer_ingelheim_pharma_rcv_gmbh_co_kg,,,,,, +5908,,2ac0067d-7eb4-4188-a7fd-fd5c668bab8d,Competence Centre for Transcultural Psychiatry,competence_centre_for_transcultural_psychiatry,,,,,, +5909,,12b586a3-c1a7-4548-b988-7635c4135ca7,Martini Ziekenhuis Groningen,martini_ziekenhuis_groningen,,,,,, +5910,,401ae81b-071f-4db9-80f6-8db8167cefb5,Paratek Pharma LLC,paratek_pharma_llc,,,,,, +5911,,1ebc9349-a691-4c2b-b43e-fea4cf260cd3,Institut für anwendungsorientierte Forschung und klinische Studien gGmbH der UMG Göttingen,institut_f_r_anwendungsorientierte_forschung_und_klinische_studien_ggmbh_der_umg_g_ttingen,,,,,, +5912,,6fdc208d-a104-4d5d-a986-12e717feee8d,Dept of Dermatology,dept_of_dermatology,,,,,, +5913,,6b9ad646-7142-11e6-a0cd-0242ac12000b,SYOSSET,syosset,,,,,, +5914,,a36a9647-ed15-47a5-92f1-14413b4f40b8,Psyadon Pharmaceuticals Inc,psyadon_pharmaceuticals_inc,,,,,, +5915,,28fb92e0-dc39-4a2f-8937-2696ae495ff9,"Sarepta Therapeutics, Inc",sarepta_therapeutics_inc,,,,,, +5916,,31006ad6-f3d2-4890-a9e4-f3c71d65c544,"Kirurgisk Afdeling, Nordsjællands Hospital",kirurgisk_afdeling_nordsj_llands_hospital,,,,,, +5917,,697be877-526d-4f05-b3d4-1d042f97088e,GeNeuro SA,geneuro_sa,,,,,, +5918,,341f7456-a6a6-4306-b6d9-dd6c6d0e372a,HARRAS Pharma Curarina Arzneimittel GmbH,harras_pharma_curarina_arzneimittel_gmbh,,,,,, +5919,,6e9dbcfb-1faf-4234-990a-b86b17352ba6,Astellas Pharma B.V,astellas_pharma_b_v,,,,,, +5920,,0b923e7f-4914-4a75-9d9d-0c5e508f2eef,"Medizinische Universität Wien, Univ.Klinik f.Frauenheilkunde,Abt. f.Gynäkologie und Gyn.Onkologie",medizinische_universit_t_wien_univ_klinik_f_frauenheilkunde_abt_f_gyn_kologie_und_gyn_onkologie,,,,,, +5921,,3bf95fb9-2629-4b1d-8489-6c3d4eca5efe,Rotterdam Eye Hospital,rotterdam_eye_hospital,,,,,, +10,0.984827,8fb7f3b7-2446-4f4c-a966-306786c40825,THE MEDICINES COMPANY UK,the_medicines_company_uk,,,,6b476606-7236-11e6-a0cd-0242ac12000b,the_medicines_co,THE MEDICINES CO +931,0.95911741256713867,58377bdc-7996-4dfb-8952-3aaff2549a93,Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre,pierre_fabre_dermatologie_represented_by_institut_de_recherche_pierre_fabre,,,,ee1d91c1-0d9e-47fa-b4e7-22a6f46f9512,pierre_fabre_dermatologie_represented_by_institut_de_recherche_pierre_fabre,Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre +5922,,cc1d56f8-6fa1-11e6-9663-0242ac12000b,"Medical University Graz,Department of Internal Medicine, Division of Gastroenterology and Hepatology",medical_university_graz_department_of_internal_medicine_division_of_gastroenterology_and_hepatology,,,,,, +989,0.964382,fce12d07-f839-4a5a-b389-f613430fe221,G.I.M.E.M.A,g_i_m_e_m_a,,,,9dee1320-7e61-4373-a4a5-0601870627ce,g_i_m_e_m_a_gruppo_italiano_malattie_ematologiche_dell_adulto,G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO +514,0.979838,303dfd4c-ed7a-4e4a-8468-59f96531ea89,PHARMACIA UPJOHN,pharmacia_upjohn,,,,197c3c96-71cf-11e6-a0cd-0242ac12000b,pharmacia,PHARMACIA +5923,,5c593445-d09c-4ee2-92ac-b6e60e10d58f,NOVINTETHICAL PHARMA SAGL,novintethical_pharma_sagl,,,,,, +5924,,621ff595-ed5e-4630-9655-9e80e8b241ce,FluoroPharma Medical,fluoropharma_medical,,,,,, +5925,,70106b82-01e3-445a-8dce-1f56c59a7634,"Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt",merck_serono_sa_geneva_an_affiliate_of_merck_kgaa_darmstadt,,,,,, +5926,,1942b0e4-bbb7-44d3-b281-ecca2f2808b4,Myelo Therapeutics GmbH,myelo_therapeutics_gmbh,,,,,, +5927,,cb318260-0f3b-40ae-a42b-b872d40cc37d,Erasmus University Medical Centre,erasmus_university_medical_centre,,,,,, +5928,,b24f7eba-b945-4e17-81af-c7b3309201f9,"Merck & Co., Inc./Suomen MSD Oy",merck_co_inc_suomen_msd_oy,,,,,, +5929,,6b5264c9-9d0c-49cf-847e-56db0edcee62,Royal Marsden NHS Foundation Trust,royal_marsden_nhs_foundation_trust,,,,,, +5930,,cc8f4954-cab6-43fc-b72a-8d26a13ac323,University of Wales College of Medicine,university_of_wales_college_of_medicine,,,,,, +5931,,0db51d3c-c8f6-44d9-8df1-fbb9beda7f9b,Martin Maaroos,martin_maaroos,,,,,, +5932,,a961a692-86b9-4528-9453-d6450f432f2d,Fundación de Investigación Biomédica. Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa,fundaci_n_de_investigaci_n_biom_dica_instituto_de_investigaci_n_sanitaria_del_hospital_universitario_de_la_princesa,,,,,, +5933,,9fe189f9-acd1-4708-86af-3883483f153a,"St Vincent’s Hospital, Sydney, Australia",st_vincent_s_hospital_sydney_australia,,,,,, +5934,,4a8f7742-7e2c-4ed4-852c-ec03514e2399,Laboratoire Erempharma,laboratoire_erempharma,,,,,, +5935,,742ca738-e328-4ec5-be1c-8f8face78667,INFAI Institut für biomedizinische Analytik und NMR Imaging GmbH,infai_institut_f_r_biomedizinische_analytik_und_nmr_imaging_gmbh,,,,,, +5936,,994f9478-7142-11e6-a0cd-0242ac12000b,ISTITUTO BIO ITA SPA,istituto_bio_ita_spa,,,,,, +5937,,3a405407-7ad1-41b1-83eb-531b9e4f4b42,INSTITUTO BERNABEU,instituto_bernabeu,,,,,, +5938,,7531e5e0-769a-47fa-a9da-ce77400387bd,Therapeutic Advances in Childhood Leukemia & Lymphoma,therapeutic_advances_in_childhood_leukemia_lymphoma,,,,,, +5939,,2da8f7fc-b23f-4c58-a9c6-beefadb6c771,IMMUNOMEDICS,immunomedics,,,,,, +156,0.98749953508377075,f5e197c6-eb46-44ef-aa5d-247fb7280101,"Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie",medizinische_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,,,,93c5f8d2-c2d8-4c9b-abde-962e31e9c1a5,medizinische_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,"Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie" +379,0.94667601585388184,bb464dd5-4611-4d24-89d1-e672f490e048,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_hereafter_referred_to_as,,,,b80f486c-a6f1-447b-bad6-34ea6d49fec0,merck_sharp_dohm_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as the SPONSOR or Merck)" +5940,,096fecd3-b1f7-463a-b3ec-78ed6d5ae24a,pSivida Corporation,psivida_corporation,,,,,, +5941,,09fff795-2215-466c-8b91-68782cb2bce0,"University of Heidelberg, Frau I. Gürkan, Kaufmännische Direktorin",university_of_heidelberg_frau_i_g_rkan_kaufm_nnische_direktorin,,,,,, +5942,,5ca59d74-c2f4-4cf1-b719-25f7c084143b,ORGANON ITALIA,organon_italia,,,,,, +5943,,47ef291e-199c-4799-97f8-f9261fff6ed5,Royal Marsden Hospital NHS Trust,royal_marsden_hospital_nhs_trust,,,,,, +5944,,bf26adf2-9623-4ed5-9dd3-2b94fea3d82c,Ferring Pharmaceuticals A/S,ferring_pharmaceuticals_a_s,,,,,, +18,0.97483,f3cd2358-7146-11e6-a0cd-0242ac12000b,COLGATE,colgate,,,,5a94ce26-71db-11e6-a0cd-0242ac12000b,colgate_palmolive,COLGATE PALMOLIVE +5945,,8e278c23-e000-47bf-8848-a4551ce53725,"Pfizer Global Pharamceuticals, EuCAn, Pfizer Inc",pfizer_global_pharamceuticals_eucan_pfizer_inc,,,,,, +5946,,3e619b25-48e7-4afd-8b3c-12eb684e3616,"Anestesicentrum, Sundsvalls Sjukhus, Landstinget Västernorrland",anestesicentrum_sundsvalls_sjukhus_landstinget_v_sternorrland,,,,,, +5947,,1d4873de-7162-11e6-a0cd-0242ac12000b,DENTSPLY PHARM,dentsply_pharm,,,,,, +5948,,5db961e3-1ff4-4079-a7cb-543c68c9412a,ALK-SCHERAX Arzneimittel GmbH,alk_scherax_arzneimittel_gmbh,,,,,, +5949,,f9c6a466-0bd2-479f-a5d8-2bc7604baa9c,"APOPHARMA INC., TORONTO, ONTARIO",apopharma_inc_toronto_ontario,,,,,, +5950,,6d0cae43-eb99-4a55-9396-b230c5fcc460,Joan Xavier Fontdevila Font,joan_xavier_fontdevila_font,,,,,, +5951,,fa2fbd13-a782-11e6-94cb-5656d04fc2b5,Fundación Hospital Alcorcón,fundaci_n_hospital_alcorc_n,,,,,, +590,0.986737,3a62aee1-f6d5-4d0b-9d6b-f01157434792,Asociación Andaluza de Hematología,asociaci_n_andaluza_de_hematolog_a,,,,28581ffa-a0e9-4a5d-8765-aa97b1847c37,asociaci_n_andaluza_de_hematolog_a_y_hemoterapia,Asociación Andaluza de Hematología y Hemoterapia +1007,0.977549,45f21be7-1a6d-4718-891b-7f5f25a7206a,Laboratorios Farmalíder S.A,laboratorios_farmal_der_s_a,,,,31e6b140-0f0d-4d6f-950c-f719a9051d5d,laboratorios_farmalider_s_a,Laboratorios Farmalider S.A +5952,,217af141-1d9d-4ea0-89ec-1fc58a95d2f0,Medical School Hannover,medical_school_hannover,,,,,, +5953,,2abe8135-2a22-4483-84d3-a9bde460d72a,"AZIENDA DI RILIEVO NAZIONALE E DI ALTA SPECIALIZZAZIONE OSPEDALE CIVICO E BENFRATELLI, G.DI CRISTINA E M.ASCOLI",azienda_di_rilievo_nazionale_e_di_alta_specializzazione_ospedale_civico_e_benfratelli_g_di_cristina_e_m_ascoli,,,,,, +5954,,dc06b812-a059-4df9-bb42-b47ded1e6e31,Fundació Vall Hebron Institut de Recerca,fundaci_vall_hebron_institut_de_recerca,,,,,, +5955,,ae199aab-0829-4df9-b118-9b3477c6f883,"Technische Universität München, Fakultät für Medizin, Klinikum rechts der Isar",technische_universit_t_m_nchen_fakult_t_f_r_medizin_klinikum_rechts_der_isar,,,,,, +5956,,a2c036c5-5a36-4952-9145-a37aeb31f0f9,"Kythera Biopharmaceuticals, Inc",kythera_biopharmaceuticals_inc,,,,,, +28,0.98589098453521729,74cf9045-4511-4c50-8cd0-de621c838ff2,University Hospital Birmingham,university_hospital_birmingham,,,,74cf9045-4511-4c50-8cd0-de621c838ff2,university_hospital_birmingham,University Hospital Birmingham +823,0.98386585712432861,b13c33db-7665-44df-a9b8-f4c589cd3347,Umeå University Hospital,ume_university_hospital,,,,0507f1f4-65ef-4d12-af2a-e024c19ed1f0,ume_university,Umeå University +5957,,ea522788-420b-4537-8ea0-530a7c168dc3,Yolanda de Diego Otero,yolanda_de_diego_otero,,,,,, +5958,,0ea47f1c-5af3-4b35-98df-6afc47907dab,Cabrellis Pharmaceuticals Corporation,cabrellis_pharmaceuticals_corporation,,,,,, +259,0.985423,dafc66a2-715c-11e6-a0cd-0242ac12000b,US WORLDMEDS,us_worldmeds,,,,34f3a53c-71a6-11e6-a0cd-0242ac12000b,us_worldmeds_llc,US WORLDMEDS LLC +880,0.941049,2d4630db-6244-46e0-a68c-f156131d2f04,Central Manchester& Manchester Children's University Hospitals NHS Trust,central_manchester_manchester_children_s_university_hospitals_nhs_trust,,,,2d4630db-6244-46e0-a68c-f156131d2f04,central_manchester_manchester_children_s_university_hospitals_nhs_trust,Central Manchester& Manchester Children's University Hospitals NHS Trust +199,0.982247,b8a13f3d-9a9f-45df-801b-e587c1a372e5,Mälarsjukhuset Eskilstuna,m_larsjukhuset_eskilstuna,,,,9ea15bf7-df50-400a-88c4-415b3dc2eda2,m_larsjukhuset,Mälarsjukhuset +5959,,65dbec6b-f01c-4e39-ac07-d1e124462b34,MGI Pharma Inc,mgi_pharma_inc,,,,,, +1004,0.975197,5dffa2d8-7164-11e6-a0cd-0242ac12000b,SOMERSET THERAPS LLC,somerset_theraps_llc,,,,5dffa2d8-7164-11e6-a0cd-0242ac12000b,somerset_theraps_llc,SOMERSET THERAPS LLC +5960,,412530ee-7834-41ee-be3c-fa0bfbd60174,"Can-Fite BioPharma, Ltd",can_fite_biopharma_ltd,,,,,, +5961,,87542afd-6065-419a-9a01-9bbf32c951af,Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ Onkotrápiás Klinika,szegedi_tudom_nyegyetem_szent_gy_rgyi_albert_klinikai_k_zpont_onkotr_pi_s_klinika,,,,,, +131,0.98589164018630981,0e0f3ed5-9732-4b14-9d55-9f884d0d428a,Department of Psychiatry, Section of Sleep Research and Pharmacopsychiatry,,,,1ead7ee3-0e7d-4381-a630-ec14aeb73c0e,department_of_psychiatry,Department of Psychiatry +5962,,89ceabfd-b732-4bb1-8537-f278f8b3213a,Erasmus Hospital,erasmus_hospital,,,,,, +5963,,8ef955ca-a87a-4b5b-b787-93bbe7cc635b,Fundación de la Comunidad Valenciana Hospital Provincial de Castellón,fundaci_n_de_la_comunidad_valenciana_hospital_provincial_de_castell_n,,,,,, +921,0.98046,e90b434e-23d4-448b-9e92-391d596fe17c,"National Institute of Health, National Eye Institute",national_institute_of_health_national_eye_institute,department_of_psychiatry_section_of_sleep_research_and_pharmacopsychiatry,,,e90b434e-23d4-448b-9e92-391d596fe17c,national_institute_of_health_national_eye_institute,"National Institute of Health, National Eye Institute" +269,0.961582,4deecc23-1926-409e-858b-2b5b11828232,Austrian Breast and Colorectal Cancer Study Group (ABCSG),austrian_breast_and_colorectal_cancer_study_group_abcsg,,,,4deecc23-1926-409e-858b-2b5b11828232,austrian_breast_and_colorectal_cancer_study_group_abcsg,Austrian Breast and Colorectal Cancer Study Group (ABCSG) +5964,,595e80c5-ebc1-44d4-a496-00b180fea87e,Hull and East Yorkshire NHS Trust,hull_and_east_yorkshire_nhs_trust,,,,,, +5965,,d8058be6-7d76-4ce5-80b7-3de2a0ae8b6b,IRCCS Ospedale San Raffaele U.O. Oculistica,irccs_ospedale_san_raffaele_u_o_oculistica,,,,,, +5966,,b5bc358d-d724-45a6-9c34-ed07db49b682,Children's Cancer and Leukaemia Group,children_s_cancer_and_leukaemia_group,,,,,, +5967,,1bdee05a-6eb2-4ab2-99bc-2b6542ecd88c,Japanese Gynecologic Oncology Group (JGOG),japanese_gynecologic_oncology_group_jgog,,,,,, +5968,,be176c13-a4bf-4f83-ba11-9010b0bdca93,Univ. Prof. Dr. Christoph Zielinski,univ_prof_dr_christoph_zielinski,,,,,, +5969,,e8b50f5e-c456-44d4-8d87-147ca9442acc,"Karolinska Institutet, Center for Molecular medicine, L8:03 L8:03",karolinska_institutet_center_for_molecular_medicine_l8_03_l8_03,,,,,, +5970,,8d8cb946-adb8-4da9-85e9-df889afd7b7e,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A,uni_pharma_kleon_tsetis_pharmaceutical_laboratories_s_a,,,,,, +849,0.97769945859909058,373295c7-9ca2-499a-ae31-52733bea403b,"PFIZER, SLU",pfizer_slu,,,,373295c7-9ca2-499a-ae31-52733bea403b,pfizer_slu,"PFIZER, SLU" +5971,,6d7fcba6-80dc-43cd-8c0c-e876795e1e54,"Division of Paediatrics, Rikshospitalet University Hospital",division_of_paediatrics_rikshospitalet_university_hospital,,,,,, +5972,,5a069d6e-f676-44a6-a9b5-b40eee878818,CHU de Nancy,chu_de_nancy,,,,,, +553,0.97483,02d042a3-dbd3-41ce-bd72-42a098676c11,Centre Francois Baclesse,centre_francois_baclesse,,,,02d042a3-dbd3-41ce-bd72-42a098676c11,centre_francois_baclesse,Centre Francois Baclesse +5973,,b318bf54-8ff0-4c84-8d40-6702515017a5,"Viamet Pharmaceuticals, Inc",viamet_pharmaceuticals_inc,,,,,, +5974,,f52ea27c-29a8-46eb-8ebf-152d484172f7,The lymphoma Study Association (LYSA),the_lymphoma_study_association_lysa,,,,,, +1053,0.987186,ca82b704-5fb5-48ac-8d51-4cb524d86727,BOOG Study Center,boog_study_center,,,,3ca85ebb-ef77-4ffc-bc31-c0440e250e6a,boog_study_center_b_v,BOOG Study Center B.V +5975,,12ee068a-7156-11e6-a0cd-0242ac12000b,SUNEVA MEDCL,suneva_medcl,,,,,, +5976,,81e7b303-5ac4-4f06-afb7-9527d74ea3a2,PH&T SpA,ph_t_spa,,,,,, +5977,,34a27514-7155-11e6-a0cd-0242ac12000b,GEDEON RICHTER USA,gedeon_richter_usa,,,,,, +638,0.972279,a97a0d0c-719b-11e6-a0cd-0242ac12000b,ADAPT,adapt,,,,a8a9c27e-73fc-11e6-a0cd-0242ac12000b,adapt_pharma,ADAPT PHARMA +446,0.96705156564712524,d7b69ba9-8bcc-4886-832c-dde1ff8859e9,Royal Brompton and Harefield NHS Trust,royal_brompton_and_harefield_nhs_trust,,,,d503d81e-b381-4df8-afc1-0e37f91ed710,royal_brompton_and_harefield_nhs_trsut,Royal Brompton and Harefield NHS Trsut +1055,0.98234379291534424,a9da8714-8bd5-11e6-a449-0242ac12000b,Neurologisk afdeling F,neurologisk_afdeling_f,,,,81df0d59-40ca-4ad2-8667-97ceb4c20bea,neurologisk_afdeling_f_rhus_sygehus_nbg,"Neurologisk afdeling F, Århus Sygehus, NBG" +653,0.94520390033721924,af89a852-eb3f-4e28-8da4-7206c23499f0,Boehringer Ingelheim RCV Gmb & Co KG,boehringer_ingelheim_rcv_gmb_co_kg,,,,5c99ca16-39a1-4b89-bbde-8627966f253d,boehringer_ingelheim_rcv_gmbh,Boehringer Ingelheim RCV GmbH +235,0.9735388457775116,c74d56c5-c48b-4ce6-bc89-a5762656c8ab,Novartis Pharma Services AG,novartis_pharma_services_ag,,,,683ca9e5-af11-4524-9288-1bb0932a9588,novartis_pharma_services,Novartis Pharma Services +5978,,206b03f3-bfcc-44cd-a124-77fa4c5282d9,"Taxolog, Inc",taxolog_inc,,,,,, +5979,,a07d77e2-c8cd-4fef-b249-1212b42ebf93,"Joint Research Office, Barts and The London NHS Trust",joint_research_office_barts_and_the_london_nhs_trust,,,,,, +5980,,21e8ecf1-af1e-4742-9089-f87e420f541f,UNITHER Pharmaceuticals,unither_pharmaceuticals,,,,,, +5981,,5df7f2e4-1cff-4b68-b25b-fcf8636a75f9,Vrije Universiteit Brussel,vrije_universiteit_brussel,,,,,, +5982,,50f780a3-7fee-4782-a54f-a0dd08750489,LYOCENTRE,lyocentre,,,,,, +400,0.910995,e353a2ed-1885-4d0a-945d-a275cba1016b,Belfast Health and Social Care Trust,belfast_health_and_social_care_trust,,,,2ba1fe2b-dcfd-42df-a719-7dec8ad39de2,belfast_health_social_care_trust,Belfast Health & Social Care Trust +5983,,6235a18a-1978-412b-a74d-f5c2d687cb5d,"Abbott Japan Co., Ltd",abbott_japan_co_ltd,,,,,, +5984,,a13fb752-ded2-4c8d-bf99-3d7e691903b4,Boston University- The Amyloid Treatment and Research Program,boston_university_the_amyloid_treatment_and_research_program,,,,,, +5985,,b714ef42-1972-4df7-8602-b3691b7fda1c,DIAKO Ev. Diakonie-Krankenhaus Bremen gGmbH,diako_ev_diakonie_krankenhaus_bremen_ggmbh,,,,,, +155,0.982232,0f7ff838-13c3-4637-91f3-73d90e40ccf4,"Department of Rheumatology,University hospital,Lund",department_of_rheumatology_university_hospital_lund,,,,0f7ff838-13c3-4637-91f3-73d90e40ccf4,department_of_rheumatology_university_hospital_lund,"Department of Rheumatology,University hospital,Lund" +5986,,569b5856-7142-11e6-a0cd-0242ac12000b,CEPH INTL,ceph_intl,,,,,, +5987,,44e581f3-6fee-475b-a128-c298ed874260,Lundbeck Limited,lundbeck_limited,,,,,, +5988,,86c37ace-73f2-11e6-a0cd-0242ac12000b,PRAXAIR CANADA INC,praxair_canada_inc,,,,,, +5989,,571841e3-8212-4428-a7d7-ea0f55d3a9bf,Jansenn Cilag International N.V,jansenn_cilag_international_n_v,,,,,, +362,0.955916,eb90fc4a-37fb-456d-ae78-9064af08c9b9,GRUPO ESPAÑOL DE INVETIGACION EN CANCER DE MAMA (GEICAM),grupo_espa_ol_de_invetigacion_en_cancer_de_mama_geicam,,,,3ed7af3a-1ee9-4762-b37f-885a7628f2f5,grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama_geicam,GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA (GEICAM) +5990,,177bc727-d047-4bd8-ab9c-35a56d8e3516,"Pearl Therapeutics, Inc",pearl_therapeutics_inc,,,,,, +5991,,5c839e3d-714f-4b43-a299-d70d618e4894,Angelini Farmaceutici,angelini_farmaceutici,,,,,, +5992,,d404cc16-a5f5-4e19-9cfd-b408643ccb51,G.I.S.E. - SOCIETA'' ITALIANA CARDIOLOGIA INVASIVA,g_i_s_e_societa_italiana_cardiologia_invasiva,,,,,, +5993,,13d1023d-fea7-4766-9ac7-0dbd749b5bea,Azienda Ospedaliero-Universitaria Meyer,azienda_ospedaliero_universitaria_meyer,,,,,, +5994,,fc3911b1-dc06-4af6-aa55-c3b113f01cee,Sykehuset i Vestfold HF,sykehuset_i_vestfold_hf,,,,,, +497,0.976266,82c49c5a-7168-11e6-a0cd-0242ac12000b,ABHAI,abhai,,,,6f4fd964-7168-11e6-a0cd-0242ac12000b,abhai_inc,ABHAI INC +5995,,82a778f5-4b94-40ce-8e2e-94dc8171d62a,Novo Nordisk Limited,novo_nordisk_limited,,,,,, +177,0.98774003982543945,417b3184-7ddd-49f2-af9e-84fb79bab1fd,Swedish Orphan Biovitrum AB,swedish_orphan_biovitrum_ab,,,,417b3184-7ddd-49f2-af9e-84fb79bab1fd,swedish_orphan_biovitrum_ab,Swedish Orphan Biovitrum AB +221,0.987337,fc26488d-2f30-45aa-99b3-1c157134ffc2,Addenbrooke's Hospital Trust,addenbrooke_s_hospital_trust,,,,edf35dc5-4a96-4c7e-ab5e-7c3239568465,addenbrooke_s_hospital,Addenbrooke's Hospital +3,0.975901,cf64616d-fa61-4a63-be7a-53b63f0f3f76,Klinik für Anästhesiologie und Operative Intensivmedizin Klinikum Ludwigshafen,klinik_f_r_an_sthesiologie_und_operative_intensivmedizin_klinikum_ludwigshafen,,,,759e5476-0767-445f-9373-05a555bd1be8, Johannes Gutenberg Universität,Klinik für Anästhesiologie +5996,,40bf114a-9958-44aa-b71c-6348b4c9d121,Institut fuer Gesundheits- und Praxismanagement GmbH,institut_fuer_gesundheits_und_praxismanagement_gmbh,,,,,, +5997,,35da42d2-8bee-11e6-a449-0242ac12000b,Therapeutic Research Unit,therapeutic_research_unit,,,,,, +5998,,cf2dd1d5-c573-4566-afea-e110f3175a28,AstraZeneca Sweden,astrazeneca_sweden,,,,,, +5999,,97754feb-5883-48e1-9a3d-a45cf1088d18,Karolinska Institutet Danderyds Sjukhus,karolinska_institutet_danderyds_sjukhus,,,,,, +6000,,5917b3bf-fdff-4c74-8ee3-5df51cb31f96,UNIVERSITA' DEGLI STUDI DI MESSINA,universita_degli_studi_di_messina,,,,,, +6001,,6416b254-72dd-11e6-a0cd-0242ac12000b,HAMELN PHARMA PLUS,hameln_pharma_plus,,,,,, +6002,,cb0efbbe-cffd-4c61-bc0f-6e573f9a2398,Atrium Medisch Centrum Parkstad,atrium_medisch_centrum_parkstad,,,,,, +6003,,43e13e7d-8154-483c-9295-6ab84ee19589,"Department of Medical Sciences, Dermatology and venerology, Uppsala University, Uppsala Sweden",department_of_medical_sciences_dermatology_and_venerology_uppsala_university_uppsala_sweden,,,,,, +6004,,9aabdb25-2a59-491f-b841-f24f8a009904,medac Gesellschaft für klinische Spezialpräparate mbH,medac_gesellschaft_f_r_klinische_spezialpr_parate_mbh,,,,,, +6005,,cbed5048-fbba-481d-ab4c-fd418d83daf1,CHDR,chdr,,,,,, +262,0.9615,9d682749-f368-4251-b8c0-9399d1ecd77d,"SCHWARZ BIOSCIENCES, INC A member of UCB Group of Companies",schwarz_biosciences_inc_a_member_of_ucb_group_of_companies,,,,9d682749-f368-4251-b8c0-9399d1ecd77d,schwarz_biosciences_inc_a_member_of_ucb_group_of_companies,"SCHWARZ BIOSCIENCES, INC A member of UCB Group of Companies" +6006,,04a4d02c-37ac-443f-b4f6-c0de2247e8c7,Aker University Hospital,aker_university_hospital,,,,,, +6007,,6cf50657-a0e4-494b-80f0-7888b67057ae,"Dept. of Intensive Care Medicine, Copenhagen University Hospital, Rigshospitalet",dept_of_intensive_care_medicine_copenhagen_university_hospital_rigshospitalet,,,,,, +296,0.983343,af4b3ac9-fffa-4d2e-898b-36d2273fda9d,iOMEDICO,iomedico,,,,6cdcb5b5-13ca-4bc2-becd-834515b92e8e,iomedico_ag,iOMEDICO AG +6008,,849a6e8b-31ac-40ea-94f2-b63298652025,D&A PHARMA,d_a_pharma,,,,,, +6009,,f3ab7778-4ca5-4b74-9328-3058eed4faf9,Synairgen Research Ltd,synairgen_research_ltd,,,,,, +6010,,949d7b56-3e43-4a7b-b57e-b0a6713ade16,Regionshospital skive,regionshospital_skive,,,,,, +6011,,02efccb2-73fb-11e6-a0cd-0242ac12000b,INTERCEPT PHARMS INC,intercept_pharms_inc,,,,,, +6012,,b72d17c3-54fc-4ec6-903b-0b76889cfee6,Egyesített Szent István és Szent László Kórház - Rendelőintézet,egyes_tett_szent_istv_n_s_szent_l_szl_k_rh_z_rendel_int_zet,,,,,, +6013,,70562274-99f8-49cc-a1ea-fdb3e2d7d6e5,"Shionogi & Co., Ltd",shionogi_co_ltd,,,,,, +430,0.98551523685455322,7cf2383a-86f2-40ef-bc4b-7282cc398374,University of California San Francisco,university_of_california_san_francisco,,,,3bc57cf3-53a2-4c69-b7e4-a49ee753b7f7,university_of_california_san_francisco_stroke_sciences_group,University of California San Francisco Stroke Sciences Group +6014,,ce10198f-c838-42a1-8bb3-d6efac79a57a,"Department of Neuroscience, Uppsala University",department_of_neuroscience_uppsala_university,,,,,, +6015,,60607abf-3284-44e1-97c7-dad9f04ae05c,"Erasmus MC, more specifically for and on behalf of the department of Neurology/Neuro-Oncology",erasmus_mc_more_specifically_for_and_on_behalf_of_the_department_of_neurology_neuro_oncology,,,,,, +6016,,d16cb4cc-0062-4a6a-b25a-c6b3d010bed4,"Univ. Klinik f. Anästhesie, Intensivmedizin und Schmerztherapie",univ_klinik_f_an_sthesie_intensivmedizin_und_schmerztherapie,,,,,, +160,0.96293512582778928,46c85acb-eaeb-4d95-9686-df020e747041,Fundación para La Investigación Biomedica del Hospital Gregorio Marañón,fundaci_n_para_la_investigaci_n_biomedica_del_hospital_gregorio_mara_n,,,,ce27e24e-62ac-42de-a596-4ceed67e634f,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón +6017,,802fb4c6-5e6d-4510-ad2b-7d1e9280d1f4,University of Helsinki / CLUE Working Group,university_of_helsinki_clue_working_group,,,,,, +6018,,db4d4503-abe4-424d-97d6-df695e925e0c,PAION UK Limited,paion_uk_limited,,,,,, +6019,,23b00bdf-aea3-4cac-93f2-f6f28ec44e8d,University of Glasgow,university_of_glasgow,,,,,, +216,0.972547,797c01ee-1dfa-4820-a53e-5dcb99477f68,"Universitätsklinik für Kinder- und Jugendheilkunde, Medizinsiche Universität Wien",universit_tsklinik_f_r_kinder_und_jugendheilkunde_medizinsiche_universit_t_wien,,,,797c01ee-1dfa-4820-a53e-5dcb99477f68,universit_tsklinik_f_r_kinder_und_jugendheilkunde_medizinsiche_universit_t_wien,"Universitätsklinik für Kinder- und Jugendheilkunde, Medizinsiche Universität Wien" +6020,,d3bc6ec3-b993-46b3-ad56-43cd9f78a52c,FUNDACION HOSPITAL NACIONAL DE PARAPLEJICOS PARA LA INVESTIGACIÓN Y LA INTEGRACIÓN,fundacion_hospital_nacional_de_paraplejicos_para_la_investigaci_n_y_la_integraci_n,,,,,, +920,0.98836344480514526,d94f6c83-6e14-4b83-88fc-13e50ecbc634,AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA,azienda_ospedaliero_universitaria_pisana,,,,d94f6c83-6e14-4b83-88fc-13e50ecbc634,azienda_ospedaliero_universitaria_pisana,AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA +602,0.988116,fa86a9f7-a3f8-41d6-a5e3-0ebd13bd9609,Syndax Pharmaceuticals,syndax_pharmaceuticals,,,,cf2f842c-f2cd-4905-96b8-12fcfaeb3ea9,syndax_pharmaceuticals_inc,Syndax Pharmaceuticals Inc +6021,,d768404d-f697-4fac-a821-576d417a301b,St. Vincent's University Hospital,st_vincent_s_university_hospital,,,,,, +6022,,d3c363d2-7142-11e6-a0cd-0242ac12000b,STEVENS J,stevens_j,,,,,, +6023,,0fa90dba-ffec-401b-8721-07730092ea76,AstraZeneca Produtos Farmacêuticos Lda,astrazeneca_produtos_farmac_uticos_lda,,,,,, +949,0.987284,b136848d-fa3d-4c16-9b15-a9721eb2e067,Astellas Pharma Europe B.V. (APEB),astellas_pharma_europe_b_v_apeb,,,,300881f9-28ca-4aa4-b8d5-58ad7c2806f3,astellas_pharma_europe_b_v,Astellas Pharma Europe B.V +6024,,7984ebb2-cc5f-4696-9fb6-b6f3f930cdd2,Theratechnologies Inc,theratechnologies_inc,,,,,, +6025,,f613ae66-d603-452a-bbad-d3ec7b1e4d77,Fundación Huésped,fundaci_n_hu_sped,,,,,, +6026,,613948d3-3850-4244-8633-e21f5224b897,INSERM - Institut National de la Sant� et de la Recherche m�dicale,inserm_institut_national_de_la_sant_et_de_la_recherche_m_dicale,,,,,, +597,0.979394,0bfd17f2-ec27-44b6-9dcf-b6e90369486a,Semmelweis University Department of Ophthalmology,semmelweis_university_department_of_ophthalmology,,,,0bfd17f2-ec27-44b6-9dcf-b6e90369486a,semmelweis_university_department_of_ophthalmology,Semmelweis University Department of Ophthalmology +6027,,b5cfb9bc-cdf7-45b5-8d95-dbab24e6a0b6,e-Therapeutics plc,e_therapeutics_plc,,,,,, +396,0.958444,1a94c234-91dd-4ddb-8ee3-62df600fe4df,Maastricht Universitary Medical Centre,maastricht_universitary_medical_centre,,,,1a94c234-91dd-4ddb-8ee3-62df600fe4df,maastricht_universitary_medical_centre,Maastricht Universitary Medical Centre +6028,,40d072e0-9ca9-44de-b214-6cdcb89b199c,SIMIT sezione Regione Lombardia,simit_sezione_regione_lombardia,,,,,, +6029,,565f1247-6b9b-4f21-ace7-c97a6d3d39fc,German Competence network “Acute and Chronic Leukemias” sponsored by Federal Ministry of Education a,german_competence_network_acute_and_chronic_leukemias_sponsored_by_federal_ministry_of_education_a,,,,,, +475,0.985423,f3be3318-715d-11e6-a0cd-0242ac12000b,HETERO DRUGS,hetero_drugs,,,,f3be3318-715d-11e6-a0cd-0242ac12000b,hetero_drugs,HETERO DRUGS +6030,,7b193a40-149b-484a-b595-af3e8761a311,GlaxoSmithKline Pharma A/S,glaxosmithkline_pharma_a_s,,,,,, +6031,,1a58d6af-324d-41b2-abc8-3a74080a856a,Biota Pharma Europe Limited,biota_pharma_europe_limited,,,,,, +6032,,c26d1c31-0995-4d7a-b476-5ec8abd729cd,Smith & Nephew Inc,smith_nephew_inc,,,,,, +6033,,8d95f51b-f565-4bd1-9316-1bfbda333b1e,Timo Jahnukainen,timo_jahnukainen,,,,,, +6034,,5e8918fe-be09-479a-8917-e8dc82017a38,Lilly,lilly,,,,,, +6035,,c2e7d8ba-cdc9-4be6-bbb5-73a2d10ba6e6,"Laboratorios Dr. Esteve, S.A",laboratorios_dr_esteve_s_a,,,,,, +648,0.92974448204040527,400bd40c-fbde-4cec-8aeb-cb463c403ce5,"Boehringer Ingleheim España, S.A",boehringer_ingleheim_espa_a_s_a,,,,400bd40c-fbde-4cec-8aeb-cb463c403ce5,boehringer_ingleheim_espa_a_s_a,"Boehringer Ingleheim España, S.A" +6036,,2ddbef9f-ef25-4ec4-b409-19564f021fad,FUNDACION INVESTIGACION HOSPITAL CLINICO DE VALENCIA-INSTITUTO DE INVESTIGACION SANITARIA INCLIVA,fundacion_investigacion_hospital_clinico_de_valencia_instituto_de_investigacion_sanitaria_incliva,,,,,, +830,0.980344,223e6632-3388-4cba-ab58-ea9c133365de,GENFIT SA,genfit_sa,,,,223e6632-3388-4cba-ab58-ea9c133365de,genfit_sa,GENFIT SA +6037,,1da56aa1-8095-4ddc-8ad6-01f3f1ffba4f,ASSOCIAZIONE ITALIANA ENDOCRINOLOGIA-METABOLISMO-IPOFISI,associazione_italiana_endocrinologia_metabolismo_ipofisi,,,,,, +6038,,d9e7d895-3b8b-4e25-a28e-b961808d74a7,Wyeth Consumer Healthcare,wyeth_consumer_healthcare,,,,,, +6039,,fb837318-7141-11e6-a0cd-0242ac12000b,OUTLOOK PHARMS,outlook_pharms,,,,,, +6040,,f89dde22-8be0-11e6-a449-0242ac12000b,University of Düsseldorf,university_of_d_sseldorf,,,,,, +6041,,84e46590-235d-42db-bd9d-00cd0b25eac2,Bristol-Myers Squibb Company,bristol_myers_squibb_company,,,,,, +6042,,536e8995-c30f-4b7b-b95d-1779e80f2b94,Radiation Therapy Oncology Group,radiation_therapy_oncology_group,,,,,, +6043,,3974051f-4dc3-4a54-aa52-190f77084296,GIULIANI,giuliani,,,,,, +6044,,0812f6c3-97dd-4a1c-a325-63f66cdfff25,Oxford University,oxford_university,,,,,, +6045,,44a10b43-4617-4363-a0b2-03214525a48d,"Chorus, Eli Lilly and Company",chorus_eli_lilly_and_company,,,,,, +6046,,5d024805-4612-480f-a1c8-8bcba4fd4fc0,"Deptartment of Hematology, Karolinska University Hospital",deptartment_of_hematology_karolinska_university_hospital,,,,,, +6047,,2cdc9b13-ea59-48a1-9221-288911588ba0,"Joint Stock Company ""Grindeks",joint_stock_company_grindeks,,,,,, +6048,,eab00df6-0636-4e25-ba09-8803c76ebc72,"Neurological Department, Aarhus University Hospital",neurological_department_aarhus_university_hospital,,,,,, +6049,,4f94537a-c304-4216-9ab5-49243c92f069,Genetronics / inovio Biomedical,genetronics_inovio_biomedical,,,,,, +184,0.973246,035cad6f-a78e-4045-bb2b-51fc73fd33c1,"Stockholm County Council, Karolinska University Hospital Huddinge, Department of Anesthesiology and Intensive Care",stockholm_county_council_karolinska_university_hospital_huddinge_department_of_anesthesiology_and_intensive_care,,,,035cad6f-a78e-4045-bb2b-51fc73fd33c1,stockholm_county_council_karolinska_university_hospital_huddinge_department_of_anesthesiology_and_intensive_care,"Stockholm County Council, Karolinska University Hospital Huddinge, Department of Anesthesiology and Intensive Care" +6050,,4a4fbf75-bf1d-4a89-9a17-176112e72cd0,YL Biologics Ltd,yl_biologics_ltd,,,,,, +6051,,a02c8f1a-1178-4264-809f-596dbe9a902f,"Dieter Hoelzer, MD,PhD",dieter_hoelzer_md_phd,,,,,, +20,0.9795151948928833,7456382f-5a4e-4c63-89ad-5c531dbdb834,"Charité Campus Mitte, Instituts für Radiologie",charit_campus_mitte_instituts_f_r_radiologie,,,,1e74f773-7ad1-4d34-8164-f40da5329bf6,charit_campus_mitte,Charité Campus Mitte +161,0.98616876204808557,393eab2d-fa2d-419a-8ecd-278e02b1ad5b,Fundación para la Investigación Biomédica del Hospital,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital,,,,393eab2d-fa2d-419a-8ecd-278e02b1ad5b,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_12_de_octubre,Fundación para la Investigación Biomédica del Hospital 12 de Octubre +6052,,de11f73b-5555-463c-883b-8504d78011b9,FGK Representative Service GmbH,fgk_representative_service_gmbh,,,,,, +6053,,a33d5406-bc4e-4ef2-99bc-3764a31f9ded,Medical Center Alkmaar,medical_center_alkmaar,,,,,, +6054,,d23ba241-a679-4ebc-a4fa-3063d9295395,CASA DI CURA ABANO TERME POLISPECIALISTICA E TERMALE,casa_di_cura_abano_terme_polispecialistica_e_termale,,,,,, +6055,,ed8755c0-00ff-444e-a9e2-cf1214d15db9,Universitaetsklinikum Schleswig-Holstein,universitaetsklinikum_schleswig_holstein,,,,,, +6056,,1cd5cde3-9e3b-4b89-9624-307a7ca752f4,Swindon & Marlborough NHS Trust,swindon_marlborough_nhs_trust,,,,,, +205,0.98037469387054443,9b893499-55e3-4437-bc95-7a74dbcfefa5,"Glostrup Hospital, Dep. of Neurology",glostrup_hospital_dep_of_neurology,,,,9b893499-55e3-4437-bc95-7a74dbcfefa5,glostrup_hospital_dep_of_neurology,"Glostrup Hospital, Dep. of Neurology" +6057,,b78a8cd5-b058-47eb-a111-27ddf661960f,FONDAZIONE HUMANITAS PER LA RICERCA,fondazione_humanitas_per_la_ricerca,,,,,, +440,0.985233,aff3b302-7382-11e6-a0cd-0242ac12000b,PERNIX THERAP,pernix_therap,,,,52bf7852-7313-11e6-a0cd-0242ac12000b,pernix_theraps_llc,PERNIX THERAPS LLC +6058,,fdbeb531-6f5a-46b6-8ff7-4bca7acc967f,Dept. of Pharmacology,dept_of_pharmacology,,,,,, +6059,,82786b60-5762-48fe-b32b-e632545c037d,"J&J PRD, a division of Janssen-Cilag NV",j_j_prd_a_division_of_janssen_cilag_nv,,,,,, +6060,,98ccf311-746c-4643-80f5-6ae8892dc079,Ashford and St Peters Hospitals NHS Trust,ashford_and_st_peters_hospitals_nhs_trust,,,,,, +115,0.97782391309738159,f0e78dcd-924b-4b3a-b5dc-a19375a0e924,Shire UK,shire_uk,,,,b28c49a1-c21b-407a-9fd2-2dbd3207b28b,shire,Shire +6061,,c3fc43fc-7164-11e6-a0cd-0242ac12000b,XELLIA PHARMS APS,xellia_pharms_aps,,,,,, +400,0.910995,2ba1fe2b-dcfd-42df-a719-7dec8ad39de2,Belfast Health & Social Care Trust,belfast_health_social_care_trust,,,,2ba1fe2b-dcfd-42df-a719-7dec8ad39de2,belfast_health_social_care_trust,Belfast Health & Social Care Trust +6062,,92d6b198-7288-11e6-a0cd-0242ac12000b,ACTELION PHARMS LTD,actelion_pharms_ltd,,,,,, +6063,,75be64be-f69d-48a0-b46c-e9b23444f027,Steen Bendix Haugaard,steen_bendix_haugaard,,,,,, +6064,,3dc26ae1-cf31-419b-b864-e9dc07d1e33a,UNIVERSITY HOSPITAL SCHLESWIG-HOLSTEIN CAMPUS KIEL,university_hospital_schleswig_holstein_campus_kiel,,,,,, +1056,0.978876,269c3398-c5cb-4532-8146-3d371fd1fcef,"Hospital Clinico San Carlos, Unidad de Investigacion Cardiovascular",hospital_clinico_san_carlos_unidad_de_investigacion_cardiovascular,,,,269c3398-c5cb-4532-8146-3d371fd1fcef,hospital_clinico_san_carlos_unidad_de_investigacion_cardiovascular,"Hospital Clinico San Carlos, Unidad de Investigacion Cardiovascular" +6065,,29eded75-a6f7-11e6-94cb-5656d04fc2b5,"Orbus Therapeutics, Inc",orbus_therapeutics_inc,,,,,, +6066,,f96d21a1-6762-428d-ae85-42ae6c1dca8c,Berlin-Chemie AG (Menarini Group),berlin_chemie_ag_menarini_group,,,,,, +6067,,0761384b-3ea6-4161-8213-5cd060b5e43c,Koskela Heikki,koskela_heikki,,,,,, +6068,,f1f4e9d2-3a88-4477-a3e4-6153e118d64c,The SAVE trial group,the_save_trial_group,,,,,, +6069,,a6bbff65-119f-456e-a853-7677b268853d,Aston University,aston_university,,,,,, +6070,,b251cf72-0027-45ec-84f9-dd28cf199fd5,"Clinical Institute of Virology, Medical University of Vienna",clinical_institute_of_virology_medical_university_of_vienna,,,,,, +6071,,320e8814-5f99-41ca-9177-b0359bff9189,"Merck, Sharp & Dohme-Clinical Pharmacology,Europe",merck_sharp_dohme_clinical_pharmacology_europe,,,,,, +1026,0.98430219292640686,087c319f-e255-4079-8ec4-d6481f72b50e,Eli Lilly and Company,eli_lilly_and_company,,,,d2379c06-dc10-47c7-9eb7-094b64f48366,eli_lilly_and_company,Eli Lilly and Company +6072,,9bec9948-4662-436f-9fe4-9c3aef6c4ffc,ICIN,icin,,,,,, +6073,,54315f19-3b31-4de4-b7d2-62a358d3d7af,PHARMA MAR,pharma_mar,,,,,, +6074,,e5c91bfd-f4b9-43a2-8e91-5f633c3bcb57,Groupe d’étude sur le risque d’exposition des soignants aux agents infectieux (GERES),groupe_d_tude_sur_le_risque_d_exposition_des_soignants_aux_agents_infectieux_geres,,,,,, +6075,,c8228bc3-8d21-43f1-89d3-14cde56f2061,"Medizinische Universität Innsbruck, Univ.-Klinik für Neurologie",medizinische_universit_t_innsbruck_univ_klinik_f_r_neurologie,,,,,, +539,0.969856,fb6c9648-7141-11e6-a0cd-0242ac12000b,APOTEX,apotex,,,,33c18818-71cf-11e6-a0cd-0242ac12000b,apotex_technologies,APOTEX TECHNOLOGIES +6076,,430f673e-715e-11e6-a0cd-0242ac12000b,SIGMAPHARM LABS LLC,sigmapharm_labs_llc,,,,,, +6077,,b172f8e7-fa1f-45bb-9e1e-694410e1601e,SIOP,siop,,,,,, +6078,,35ed4d4b-52ef-4b8c-a7dc-5a3cf9502aa3,"Medizinische Universität Wien, Universitätsklinik für Augenheilkunde",medizinische_universit_t_wien_universit_tsklinik_f_r_augenheilkunde,,,,,, +6079,,391eb045-df7d-47d0-bc1c-5c764ec2ac63,"Edimer Pharmaceuticals, Inc",edimer_pharmaceuticals_inc,,,,,, +6080,,05fa800e-73f7-11e6-a0cd-0242ac12000b,SANOFI US SERVICES,sanofi_us_services,,,,,, +6081,,85543e15-df14-4bf5-b986-ade3ad2c4f3a,Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU),grupo_espa_ol_de_trabajo_en_enfermedad_de_crohn_y_colitis_ulcerosa_geteccu,,,,,, +6082,,576fadd6-2568-46e7-87c0-18517d7d7ab8,The Irish Clinical Oncology Research Group,the_irish_clinical_oncology_research_group,,,,,, +6083,,6b8c8120-42a0-42ec-8403-a25af16bd883,Gruppo Oncologico Italiano Ricerca Cancro (GOIRC),gruppo_oncologico_italiano_ricerca_cancro_goirc,,,,,, +572,0.98035663366317749,636b6962-391c-4308-8f43-ec1b5c65a66f,"Human Genome Sciences, Inc. (a wholly owned subsidiary of GlaxoSmithKline PLC)",human_genome_sciences_inc_a_wholly_owned_subsidiary_of_glaxosmithkline_plc,,,,e3bdd826-4b43-4d33-8f70-20154485e250,human_genome_sciences_inc_a_wholy_owned_subsidiary_of_glaxosmithkline_plc,"Human Genome Sciences, Inc. (a wholy owned subsidiary of GlaxoSmithKline PLC)" +6084,,e322085c-71fa-11e6-a0cd-0242ac12000b,LANTHEUS MEDICAL,lantheus_medical,,,,,, +6085,,b5fff5d3-f88e-4be2-b692-1ab9575ac026,Max-Planck-Institute of Psychiatry,max_planck_institute_of_psychiatry,,,,,, +297,0.971007,dd88ea6a-5b36-4292-b4cc-a6ad5c3d9619,UCB S.A,ucb_s_a,,,,8c8ef9b5-43dd-4ca5-9f4c-348a000dce63,ucb_s_a_pharma_sector,UCB S.A. Pharma Sector +6086,,bfd86081-70d2-45c2-ae30-64e2837ce009,"Acuity Pharmaceuticals, LLC",acuity_pharmaceuticals_llc,,,,,, +6087,,a3e099e1-0b9d-45fb-b3ad-762f6b6b963f,GETAID,getaid,,,,,, +6088,,5ea0f723-b86e-47c6-93d5-a58eb7d1f7ee,CHU Sart-Tilman,chu_sart_tilman,,,,,, +996,0.977047,97fe0562-c7c6-420a-8abd-fcdbeea536e5,King's College Hospital NHS Foundation Trust,king_s_college_hospital_nhs_foundation_trust,,,,334999d1-9ed1-4d92-a66a-e05623d343a8,kings_college_hospital_nhs_foundation_trust,Kings College Hospital NHS Foundation Trust +6089,,823bdf78-86c6-4029-9b66-a08caa4191a7,FOVEA PHARMACEUTICALS,fovea_pharmaceuticals,,,,,, +6090,,56e7d434-010b-47db-8bc3-73019dd37f6a,Maarit Valkealahti / University hospital of Oulu,maarit_valkealahti_university_hospital_of_oulu,,,,,, +6091,,48aea259-9881-4fb5-b872-467aef43e2dd,GALSOR S.R.L,galsor_s_r_l,,,,,, +6092,,e11cd3b7-7f13-4b57-b69e-f2451ef50517,Jan Engvall,jan_engvall,,,,,, +6093,,ef300dca-9641-45d1-a8eb-462801cba30e,Complejo Hospitalario Universitario de Albacete. Director Gerente Dr Jesús Martino Sánchez Martínez,complejo_hospitalario_universitario_de_albacete_director_gerente_dr_jes_s_martino_s_nchez_mart_nez,,,,,, +6094,,c266f358-9616-11e6-becf-0242ac110008,TERSERA THERAP,tersera_therap,,,,,, +347,0.98146516084671021,71cd8e41-b876-47b3-8b6f-d8c4063fa62c,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin III/Rheumatologie",medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_iii_rheumatologie,,,,71cd8e41-b876-47b3-8b6f-d8c4063fa62c,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_iii_rheumatologie,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin III/Rheumatologie" +6095,,d64b8313-12a5-4152-9485-8085941349ed,"Laboratorios Stiefel (España), S.A",laboratorios_stiefel_espa_a_s_a,,,,,, +6096,,588da700-9386-4e2d-ac7f-a2e05e84e700,"FibroGen, Inc",fibrogen_inc,,,,,, +6097,,183b394d-b36c-47bd-a5d8-cd1294aec108,AZ Groeninge,az_groeninge,,,,,, +6098,,0d57bf55-f5c4-4add-9d54-b5ebf8add9eb,Università di Modena e ReggioEmilia,universit_di_modena_e_reggioemilia,,,,,, +6099,,05c95e04-1d50-4c51-bc1f-b03e840ce20b,deCODE genetics ehf,decode_genetics_ehf,,,,,, +6100,,27c15ba3-7a07-423c-8156-cb49032f7075,"Hanmi Pharmaceutical Co., Ltd",hanmi_pharmaceutical_co_ltd,,,,,, +860,0.972948,1fd9be47-d214-4572-b318-1aa9dc588ded,Addenbrookes Hospital Cambridge University Hospitals NHS Foundation Trust,addenbrookes_hospital_cambridge_university_hospitals_nhs_foundation_trust,,,,1fd9be47-d214-4572-b318-1aa9dc588ded,addenbrookes_hospital_cambridge_university_hospitals_nhs_foundation_trust,Addenbrookes Hospital Cambridge University Hospitals NHS Foundation Trust +6101,,b7059ec0-7167-11e6-a0cd-0242ac12000b,KEN LIFESCIENCE,ken_lifescience,,,,,, +6102,,64ed7277-958d-4a46-9a60-6a9cbcb0055e,SOUTH EASTERN EUROPEAN RESEARCH ONCOLOGY GROUP,south_eastern_european_research_oncology_group,,,,,, +6103,,5a416250-7199-11e6-a0cd-0242ac12000b,CLOVER PHARMS,clover_pharms,,,,,, +6104,,ff965368-7865-4a01-bfbd-739d146d65f5,"J&JPRD, a division of Janssen-Cilag",j_jprd_a_division_of_janssen_cilag,,,,,, +6105,,8a684089-ae7a-4416-934c-9fcbeaee468c,"Mech-Sense, Aalborg University Hospital",mech_sense_aalborg_university_hospital,,,,,, +6106,,15416496-7164-11e6-a0cd-0242ac12000b,KREMERS URBAN DEV,kremers_urban_dev,,,,,, +6107,,86f4f916-5046-486b-ab71-ee340ecdae6e,Merc & Co. Inc,merc_co_inc,,,,,, +6108,,957a0c8a-e51d-4ec3-95a7-32496810b431,Amphia Hospital,amphia_hospital,,,,,, +6109,,2ee35076-f319-435f-aacf-be31909a7a8e,AUSL VITERBO,ausl_viterbo,,,,,, +6110,,e853f524-9e97-4579-b8a2-f8c29eca6e92,N V Organon,n_v_organon,,,,,, +6111,,bea76306-730a-4ede-a883-f9a58dea2b44,Grupo Español de Trasplante Hematopoyético (GETH),grupo_espa_ol_de_trasplante_hematopoy_tico_geth,,,,,, +6112,,cb85253c-9c88-45b2-a009-35b62e91c79b,"Karolinska Institute, Danderyds hospital",karolinska_institute_danderyds_hospital,,,,,, +6113,,35138b39-7307-4855-9b4e-048e1268f415,Jules Bordet Institute,jules_bordet_institute,,,,,, +426,0.988445,d2fffea4-4542-45dd-888c-2a7a4ffdc389,Leids Universitair Medisch Centrum,leids_universitair_medisch_centrum,,,,5e11478f-4293-4f4b-84dd-d3dc2a540f03,leids_universitair_medisch_centrum_lumc,Leids Universitair Medisch Centrum (LUMC) +6114,,68406649-eca4-4ca6-aab6-23f093aa485b,Children's Oncology Group (COG),children_s_oncology_group_cog,,,,,, +6115,,c92015c4-4716-4479-806d-7ea2b31a4d76,Medical Department M (Endocrinology & Diabetes),medical_department_m_endocrinology_diabetes,,,,,, +6116,,b2878c7b-2629-497e-bc57-6ab60afe1109,Hospital de Valme,hospital_de_valme,,,,,, +6117,,314fe8dd-0004-491c-9dbd-61bb52271fa2,"Pacira Pharmaceuticals, Inc",pacira_pharmaceuticals_inc,,,,,, +6118,,f1d7cb83-6a05-46a3-b6bc-98e6330b2e8c,GERCOR,gercor,,,,,, +805,0.97389534115791321,e2655437-d609-4fca-96c6-e41a3ce4b02d,"Otsuka Pharmaceutical Development & Commercialization,",otsuka_pharmaceutical_development_commercialization,,,,8e240a49-6e4c-46a0-8366-15b78371ff26,otsuka_pharmaceutical_development_commercialization_inc,"Otsuka Pharmaceutical Development & Commercialization, Inc" +6119,,b944c190-1ab6-4dcd-b81c-c0191ae67107,Ziekenhuisgroep Twente,ziekenhuisgroep_twente,,,,,, +6120,,4947f79a-7129-11e6-a89e-0242ac12000b,VISTAPHARM,vistapharm,,,,,, +6121,,a617b6c2-73ef-11e6-a0cd-0242ac12000b,MEDAC PHARMA INC,medac_pharma_inc,,,,,, +1050,0.97903996706008911,c4f1ee23-277c-427d-be77-550ded77bf06,Rijnstate hospital,rijnstate_hospital,,,,9b0915b5-74ad-4748-ae49-c7504c4d919e,rijnstate,Rijnstate +6122,,928f9799-a4d9-450c-a61c-6ff8936432a7,Prof. Dr.Christian Werner,prof_dr_christian_werner,,,,,, +6123,,9a5ed211-6e37-414a-989e-cdcda4932cd7,Oral and Maxillofacial Surgery Department of Vall d'Hebron Hospital,oral_and_maxillofacial_surgery_department_of_vall_d_hebron_hospital,,,,,, +6124,,df14e587-b82c-4a95-876d-7e22c6eaa0bd,Janssen Infectious Diseases BVBA,janssen_infectious_diseases_bvba,,,,,, +6125,,f00c5d1a-0586-42c6-a4f4-0c54bb13e305,Dipartimento di Oncologia-Università degli studi di Torino,dipartimento_di_oncologia_universit_degli_studi_di_torino,,,,,, +6126,,b1b58145-01ed-4e53-9b18-47671c54a89d,"FoldRx Pharmaceuticals, a Pfizer Company",foldrx_pharmaceuticals_a_pfizer_company,,,,,, +392,0.98723113536834717,f09d5b0c-8a57-42ac-be28-2e185ec2cdd5,Klinikum der Universität München,klinikum_der_universit_t_m_nchen,,,,089e5628-bb66-4808-818a-a79770a11d54,klinikum_der_universit_t_m_nchen_gro_hadern,Klinikum der Universität München-Großhadern +573,0.900909,7dfb4821-12ac-417d-9c56-0abf06762456,A.R.T.I.C. (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie ),a_r_t_i_c_association_pour_la_recherche_de_th_rapeutiques_innovantes_en_canc_rologie,,,,5a6ea281-ca4c-46d4-8b7d-0e24f0d68167,artic_association_pour_la_recherche_de_th_rapeutiques_innovantes_en_canc_rologie,ARTIC (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie) +823,0.98386585712432861,0507f1f4-65ef-4d12-af2a-e024c19ed1f0,Umeå University,ume_university,,,,0507f1f4-65ef-4d12-af2a-e024c19ed1f0,ume_university,Umeå University +6127,,2f6226af-b544-4044-9a5a-4bcb3d05efbe,The Hospital District of Southwest Finland,the_hospital_district_of_southwest_finland,,,,,, +6128,,bfbb03e2-eda3-4a05-8b30-d02f3296d800,"Free State of Bavaria, represented by the University of Regensburg, represented by the University Hospital Regensburg",free_state_of_bavaria_represented_by_the_university_of_regensburg_represented_by_the_university_hospital_regensburg,,,,,, +6129,,d5749447-085f-4ad2-9c0c-7b6f19b77c0a,FUNDACION INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO LA PRINCESA,fundacion_investigacion_biomedica_hospital_universitario_la_princesa,,,,,, +6130,,a69c9272-7f51-4fbb-af0a-91ee9bdad28c,Alizyme Therapeutics Limited,alizyme_therapeutics_limited,,,,,, +6131,,879e5bda-7168-11e6-a0cd-0242ac12000b,MSN LABORATORIES,msn_laboratories,,,,,, +6132,,2f0bdcda-733a-11e6-a0cd-0242ac12000b,CYPRESS BIOSCIENCE,cypress_bioscience,,,,,, +6133,,65a74622-52a5-44aa-b68a-4a0614c78010,Merck Serono S.p.A,merck_serono_s_p_a,,,,,, +327,0.962536,dc4489f6-106f-4779-ab50-6c69a5b625e6,ISTITUTO EUROPEO DI ONCOLGIA,istituto_europeo_di_oncolgia,,,,74acbba7-8bef-4cf6-a584-3c8b328a6a63,istituto_europeo_di_oncologia,ISTITUTO EUROPEO DI ONCOLOGIA +6134,,2483200c-7141-11e6-a0cd-0242ac12000b,ABLE,able,,,,,, +715,0.989009,70c3cd85-d7da-4e83-91f1-0c2abad141d5,Thoracale Oncologie Groep Antwerpen,thoracale_oncologie_groep_antwerpen,,,,70c3cd85-d7da-4e83-91f1-0c2abad141d5,thoracale_oncologie_groep_antwerpen,Thoracale Oncologie Groep Antwerpen +157,0.95408710837364197,f215164e-8e75-4f48-b691-ea2bfd10d042,"Medizinische Universität Wien, Univ.Klinik für Dermatologie, Abteilung für Immundermatologie",medizinische_universit_t_wien_univ_klinik_f_r_dermatologie_abteilung_f_r_immundermatologie,,,,f215164e-8e75-4f48-b691-ea2bfd10d042,medizinische_universit_t_wien_univ_klinik_f_r_dermatologie,"Medizinische Universität Wien, Univ. Klinik für Dermatologie" +610,0.98081560929616296,4b5b75aa-a963-452e-848e-256ac41c5d72,Fédération Nationale des Centres de Lutte,f_d_ration_nationale_des_centres_de_lutte,,,,4b5b75aa-a963-452e-848e-256ac41c5d72,f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer,Fédération Nationale des Centres de Lutte Contre le Cancer +1020,0.98311978578567505,b56a3044-dedf-4773-b7a5-e6cd18764bcd,Orion Corporation Orion Pharma,orion_corporation_orion_pharma,,,,b56a3044-dedf-4773-b7a5-e6cd18764bcd,orion_corporation_orion_pharma,Orion Corporation Orion Pharma +6135,,dc59460a-9d8e-4673-a8ba-8d46f83dde30,Archimedes Development Ltd,archimedes_development_ltd,,,,,, +640,0.97884902358055115,4d681c57-3f4f-4cb4-bfc1-8067121ab51d,Boehringer Ingelheim RCV GmbH & Co KG,boehringer_ingelheim_rcv_gmbh_co_kg,,,,d2f4fdea-3f56-449f-b5b3-ab25da9fa8af,boehringer_ingelheim_rcv_gmbh_co_kg,Boehringer Ingelheim RCV GmbH & Co KG +6136,,28e52cf9-0b11-4b20-9e9f-facfb52f4173,DR. ENRICO MONTANARI,dr_enrico_montanari,,,,,, +6137,,b9880d0f-4391-4646-978b-8784c9964d80,Servicio de Anestesiología y Reanimación,servicio_de_anestesiolog_a_y_reanimaci_n,,,,,, +482,0.9060404896736145,eee3d6a7-f9c0-4023-8976-5e4f0a8a21de,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Lungenkrankheiten",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klinische_abteilung_f_r_lungenkrankheiten,,,,2023e16d-080b-4eeb-8515-b467f748a454,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klinische_abteilung_f_r_nephrologie,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Nephrologie" +6138,,18f3b9ef-6bc1-48eb-808e-60a221ceda7b,"University Hospital/Inselspital Berne, Department for Medical Oncology",university_hospital_inselspital_berne_department_for_medical_oncology,,,,,, +96,0.9879,b29eb661-1920-4894-b0f1-fd365cb40e54,Mekos Laboratories,mekos_laboratories,,,,b29eb661-1920-4894-b0f1-fd365cb40e54,mekos_laboratories,Mekos Laboratories +6139,,4cefbb99-05cf-4bb7-a167-a37f1ff72774,"Allergie-Centrum-Charite, Department of Dermatology, Charite - Universitätsmedizin Berlin",allergie_centrum_charite_department_of_dermatology_charite_universit_tsmedizin_berlin,,,,,, +194,0.976498,6dafc817-47f5-4070-8f2f-83bb2660a10a,ACROSS Group,across_group,,,,6dafc817-47f5-4070-8f2f-83bb2660a10a,across_group,ACROSS Group +6140,,f0042380-cb8d-4008-8d1e-66f82fcc8e55,DIPARTIMENTO DI MEDICINA CLINICA - UNIVERSITA` DEGLI STUDI DELL`INSUBRIA,dipartimento_di_medicina_clinica_universita_degli_studi_dell_insubria,,,,,, +735,0.98142971098423004,9437a80f-1f01-4d11-a163-662513465c34,European Organisation for Research and Treatment on Cancer,european_organisation_for_research_and_treatment_on_cancer,,,,6e92b00d-0791-4d8e-975c-0fbd5ce95861,european_organisation_for_research_and_treatment_of_cancer,European Organisation for Research and Treatment of Cancer +6141,,b53b8cde-4474-4f93-b8d7-bcd924788313,Research and Enterprise Department,research_and_enterprise_department,,,,,, +6142,,e13586fa-8d4a-4088-b86c-154c65dd41ef,NHS Glasgow and Clyde / University of Glasgow,nhs_glasgow_and_clyde_university_of_glasgow,,,,,, +6143,,b94fd1b2-959c-4377-8f33-55001d211815,Enceladus Pharmaceuticals,enceladus_pharmaceuticals,,,,,, +111,0.90460896492004395,305770d0-2dc9-4f31-ad46-773cf169b699,"Department of Oncology, Skåne University Hospital Lund",department_of_oncology_sk_ne_university_hospital_lund,,,,305770d0-2dc9-4f31-ad46-773cf169b699,department_of_oncology_sk_ne_university_hospital_lund,"Department of Oncology, Skåne University Hospital Lund" +6144,,dd8ac388-cfe3-4acb-9b4c-c7804febea18,"AMC, divisie Psychiatrie",amc_divisie_psychiatrie,,,,,, +693,0.96936577558517456,a76c2366-c812-414d-8cf9-58d6fa36de67,NovaCardia Inc,novacardia_inc,,,,48601627-d189-4d07-b717-58fa6e8591d5,novacardia_inc_wholly_owned_subsidiary_of_merck_co_inc,NovaCardia Inc (wholly owned subsidiary of Merck & Co. Inc) +6145,,2d3a7e4e-2cc4-490d-852f-dcbdba6303cd,"University Hospital, Dept of Oncology, clinical trial unit",university_hospital_dept_of_oncology_clinical_trial_unit,,,,,, +6146,,994c7cb9-90a9-4e63-9d09-09b93429d692,Gentofte University Hospital,gentofte_university_hospital,,,,,, +6147,,d2ae0121-e302-4cab-be42-dc7305143c6f,Ullevaal University Hospital,ullevaal_university_hospital,,,,,, +6148,,1e2ffe24-836a-4b62-8a97-38d15a259fac,"Department of Orthopedic Surgery, Aarhus University",department_of_orthopedic_surgery_aarhus_university,,,,,, +6149,,b6cbdf1c-7141-11e6-a0cd-0242ac12000b,ECI PHARMS LLC,eci_pharms_llc,,,,,, +6150,,8de5e438-ee9c-4829-b441-1a6dd52e766f,Odense Universitets Hospital,odense_universitets_hospital,,,,,, +6151,,806d4d52-6d06-4fd7-9df6-8416e211d65e,Kompetenznetz TDM-KJP e.V,kompetenznetz_tdm_kjp_e_v,,,,,, +6152,,81dc8c8b-5b1e-40a3-b7be-d0c695f8718a,ZonMw zorg voor jeugd-effecten en kosten,zonmw_zorg_voor_jeugd_effecten_en_kosten,,,,,, +6153,,c6c20094-598d-4dd2-a212-ed281d8f365d,Hellenic Oncology Cooperative Group,hellenic_oncology_cooperative_group,,,,,, +6154,,c8246372-bd66-4838-8d1a-bc8376bbc2f6,Lungmedicinska kliniken,lungmedicinska_kliniken,,,,,, +6155,,1ae54218-553d-458d-9b2a-5350af45e87c,YMBiosciences INC,ymbiosciences_inc,,,,,, +6156,,8594ad17-f56b-44a0-afda-9b205c09d462,Alcon Hungary Ltd,alcon_hungary_ltd,,,,,, +6157,,3fa553ef-a554-45a9-9d58-be3f8a926626,Fundación Investigación Sanitaria en León,fundaci_n_investigaci_n_sanitaria_en_le_n,,,,,, +6158,,4bb8a940-6f74-4706-b573-fb1e8fc7c8e3,"Paediatric Pulmonary Service, Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark",paediatric_pulmonary_service_department_of_paediatrics_and_adolescent_medicine_rigshospitalet_copenhagen_denmark,,,,,, +6159,,cfc7168a-96a1-4bcc-a52d-cd3152f1a26c,"Curis, Inc",curis_inc,,,,,, +740,0.9299778938293457,a915c184-a118-4ca9-8fb4-2b38760107dc,"ICORG, the All-Ireland Cooperative Oncology Research Group",icorg_the_all_ireland_cooperative_oncology_research_group,,,,a915c184-a118-4ca9-8fb4-2b38760107dc,icorg_the_all_ireland_cooperative_oncology_research_group,"ICORG, the all-Ireland Co-operative Oncology Research Group" +6160,,92c4c0b4-9a42-4f78-9a1e-bd08e4b20c07,Baxter Vaccine AG,baxter_vaccine_ag,,,,,, +6161,,d09019a4-b225-4a88-ad7a-2a22d377acd1,"Rigel Pharmaceuticals, Inc",rigel_pharmaceuticals_inc,,,,,, +6162,,a1157d38-6359-4f15-bf41-9e98b09a800d,Ann Hellström,ann_hellstr_m,,,,,, +29,0.987472,4a85ef8b-1aa9-4a42-b446-1e9beb780e11,INO Therapeutics,ino_therapeutics,,,,27abc283-e5cd-4ac3-968b-19e1e91d0bcd,ino_therapeutics_ab,INO Therapeutics AB +6163,,8dfe26f2-9111-4131-a1e1-cf4c04decd02,"HUS, ATEK, Töölön sairaala, Neurokirurgian klinikka",hus_atek_t_l_n_sairaala_neurokirurgian_klinikka,,,,,, +6164,,55b4bb17-0216-455c-813a-610887dab7a3,Roche AB,roche_ab,,,,,, +6165,,cd744cf7-9819-4a63-baca-45f226f81424,MethylGene Inc,methylgene_inc,,,,,, +6166,,68f08d47-18e6-4ae1-abd4-070b533d3466,"Department of Clinical Biochemestry, Aarhus University Hospital",department_of_clinical_biochemestry_aarhus_university_hospital,,,,,, +6167,,650f4777-ad05-450c-bb12-567cb14675e4,scPharmaceuticals Inc,scpharmaceuticals_inc,,,,,, +6168,,5d03a09e-71a7-11e6-a0cd-0242ac12000b,HIKMA (MAPLE),hikma_maple,,,,,, +6169,,0fe70ae0-7156-11e6-a0cd-0242ac12000b,MEDA PHARMS,meda_pharms,,,,,, +6170,,0dd6f60e-7c23-4279-b459-59def57cfcff,MetrioPharm AG,metriopharm_ag,,,,,, +6171,,b96f670d-0bb6-4993-89db-1544f4247908,RECKITT BENCKISER HEALTHCARE,reckitt_benckiser_healthcare,,,,,, +522,0.97898,868cd64a-08f1-4dc3-b30b-abd7473fd49f,Renovo,renovo,,,,2bce399b-f655-4890-9a07-afe0a1f39d7f,renovo_ltd,Renovo Ltd +6172,,9ffd956b-a33f-4076-8911-bd5c8b363c75,Servicio de Anestesia-Reanimación,servicio_de_anestesia_reanimaci_n,,,,,, +6173,,dbe8b077-b0cf-45d4-94f5-6b7a04fecd70,Gwent Healthcare NHS Trust,gwent_healthcare_nhs_trust,,,,,, +6174,,56662071-5658-4e6b-a867-8c84125cc160,Cellseed France S.A.R.L,cellseed_france_s_a_r_l,,,,,, +6175,,c9d2cd4e-87d8-4c4c-9df0-1b0b28fe44c3,ECRI,ecri,,,,,, +6176,,2847033c-8be7-11e6-a449-0242ac12000b,Oslo universitetssykehus health trust,oslo_universitetssykehus_health_trust,,,,,, +6177,,cd406dc2-880b-11e6-a998-0242ac12000b,Braeburn Pharmaceuticals,braeburn_pharmaceuticals,,,,,, +925,0.96910750865936279,ce8f68a3-57b0-4821-ab13-61e00be1d29e,"LUMC, VRSP",lumc_vrsp,,,,844eaa65-2406-4ab1-9c51-75be91cc2736,lumc,LUMC +6178,,cdb12dba-7365-11e6-a0cd-0242ac12000b,NIH NCI DCTD,nih_nci_dctd,,,,,, +6179,,27771b7c-1664-4492-8347-83a184802408,Alicia Pareja Ríos,alicia_pareja_r_os,,,,,, +171,0.98875898122787476,e33b991e-aa77-4ba1-842e-d3959ab310c0,Merck Serono International,merck_serono_international,,,,e0ea9f26-8028-4605-8f3e-bec9a3e04275,merck_serono_international,Merck Serono International +6180,,48024dc3-3391-43e7-9f84-ffd02e53a977,"Institution of Paediatric Anaesthesia and intensiv care, Astrid Lindgren Childrens Hospital, Karolin",institution_of_paediatric_anaesthesia_and_intensiv_care_astrid_lindgren_childrens_hospital_karolin,,,,,, +6181,,cf397ab2-0f00-449d-93c6-def630eeb7a4,"Allan Vaag, Steno Diabetes Center",allan_vaag_steno_diabetes_center,,,,,, +666,0.969108,57164cff-6f3b-448f-a2a2-cb44b3def10b,NOPHO,nopho,,,,57164cff-6f3b-448f-a2a2-cb44b3def10b,nopho,NOPHO +1030,0.98681271076202393,525d2720-5b9f-47f1-b135-6c39bc8e2abf,"Medical University of Vienna, Department of Internal Medicine II",medical_university_of_vienna_department_of_internal_medicine_ii,,,,525d2720-5b9f-47f1-b135-6c39bc8e2abf,medical_university_of_vienna_department_of_internal_medicine_ii,"Medical University of Vienna, Department of Internal Medicine II" +6182,,4818b20e-b640-42db-b4c2-8151990a7397,Ovation Pharmaceuticals,ovation_pharmaceuticals,,,,,, +6183,,0b39fd7f-3593-43a6-bc1c-d5794e4475b6,José Such Ronda,jos_such_ronda,,,,,, +238,0.95441973209381104,f02ec012-bcd3-4f41-a9c8-9be79bec0377,"Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, UNITED KINGDOM",pfizer_limited_ramsgate_road_sandwich_kent_ct13_9nj_united_kingdom,,,,3438eb84-9448-480b-915c-1c1511546785,pfizer_limited_ramsgate_road_sandwich_kent_ct13_9nj,"Pfizer Limited, Ramsgate Road,Sandwich,Kent CT13 9NJ" +6184,,370a0892-7152-11e6-a0cd-0242ac12000b,CAROLINA MEDCL,carolina_medcl,,,,,, +6185,,0d33da14-ee52-4218-b941-fb81e8b08830,AstraZeneca A/S,astrazeneca_a_s,,,,,, +6186,,345663e2-7167-11e6-a0cd-0242ac12000b,UCLA BIOMEDICAL,ucla_biomedical,,,,,, +59,0.97367590665817261,96e5ebae-c6a3-41db-ae14-3ec5437c35f2,Wyeth Research,wyeth_research,,,,96e5ebae-c6a3-41db-ae14-3ec5437c35f2,wyeth_research_division,Wyeth Research Division +6187,,17032d7a-ceba-4764-88cb-3d476d4abb62,TEVA UK Ltd,teva_uk_ltd,,,,,, +6188,,45d4462a-2326-4deb-8f3b-4bbdb4cb84af,"Kyowa Kirin Pharmaceutical Development, Inc",kyowa_kirin_pharmaceutical_development_inc,,,,,, +6189,,b9015aac-8bd9-11e6-a449-0242ac12000b,"Oslo University Hospital HF, Ullevål Hospital, FORMI-Formidlingsenheten for muskel- og skjelettlidelser",oslo_university_hospital_hf_ullev_l_hospital_formi_formidlingsenheten_for_muskel_og_skjelettlidelser,,,,,, +6190,,120f86dc-0deb-4381-aa6d-33e7ff920fc1,Genkyotex Innovation SAS,genkyotex_innovation_sas,,,,,, +6191,,e075a481-fe46-4d20-8a22-3437faddd450,Radboud University Nijmegen Medical Centre - Department of Dermatology,radboud_university_nijmegen_medical_centre_department_of_dermatology,,,,,, +6192,,03b0f3f8-7142-11e6-a0cd-0242ac12000b,DIAGNOSTIC GREEN,diagnostic_green,,,,,, +6193,,b3cd88e0-506e-45d7-ba9f-474f41c4344d,AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA` GRANDA (A.O. DI RILIEVO NAZIONALE),azienda_ospedaliera_ospedale_niguarda_ca_granda_a_o_di_rilievo_nazionale,,,,,, +243,0.982397,feaf2687-794e-43cf-90f6-0e5457185be9,Oxford BioMedica (UK) Limited,oxford_biomedica_uk_limited,,,,84165c73-a712-4209-9005-cccca1ac46d9,oxford_biomedica,Oxford BioMedica +6194,,2b3cbd58-4b33-4ba0-add9-4e1e5c88b07d,Genaera Corporation,genaera_corporation,,,,,, +6195,,c3fea6ac-71d1-11e6-a0cd-0242ac12000b,CLINIGEN HLTHCARE,clinigen_hlthcare,,,,,, +6196,,2dcb3f76-7265-11e6-a0cd-0242ac12000b,LLOYD,lloyd,,,,,, +6197,,a6d5beb6-052b-48f5-8b40-8886d133b556,VU University Medical Center Amsterdam,vu_university_medical_center_amsterdam,,,,,, +6198,,392044d2-9bac-472e-aab6-4fc73aec99d7,"CCIT Center for Cancer ImmunTerapi, Herlev Hospital, Hæmatologisk afd 54P4",ccit_center_for_cancer_immunterapi_herlev_hospital_h_matologisk_afd_54p4,,,,,, +6199,,0d67f289-26af-4c76-a9f3-211762e719d0,ADRFARCP,adrfarcp,,,,,, +6200,,80416083-397a-433a-96db-a13e46d5f54a,Moorfields Eye Hospital Foundation Trust,moorfields_eye_hospital_foundation_trust,,,,,, +6201,,c2eb78ba-72e5-4273-9eb4-fb7bb317fd2b,AESCA Pharma GesmbH,aesca_pharma_gesmbh,,,,,, +861,0.92456701397895813,7cef3d29-cecb-442c-acdb-b0a10dec2da0,"Academic Medical Center, Department of Rheumatology",academic_medical_center_department_of_rheumatology,,,,7cef3d29-cecb-442c-acdb-b0a10dec2da0,academic_medical_center_department_of_dermatology,"Academic Medical Center, Department of dermatology" +419,0.98464131355285645,24418820-0b75-41e2-993c-2f2c0b00efb6,National and Kapodistrian University of Athens,national_and_kapodistrian_university_of_athens,,,,24418820-0b75-41e2-993c-2f2c0b00efb6,national_and_kapodistrian_university_of_athens,National and Kapodistrian University of Athens +6202,,4da3f16e-e1ab-4dd4-ab04-18ec73bd63f6,"Karolinska University Hospital, Division of Pediatrics/Astrid Lindgren Children´s Hospital",karolinska_university_hospital_division_of_pediatrics_astrid_lindgren_children_s_hospital,,,,,, +6203,,5a93dda7-d83b-4528-8149-ef62f247f834,"Department of Anaesthesia&Intensive Care B, Vienna Medical University",department_of_anaesthesia_intensive_care_b_vienna_medical_university,,,,,, +509,0.940753,27cde204-b342-4946-975c-01f75b78dc91,UHL NHS Trust,uhl_nhs_trust,,,,27cde204-b342-4946-975c-01f75b78dc91,uhl_nhs_trust,UHL NHS Trust +6204,,9dad7e44-8355-4bbe-906e-ba5a98cae9b5,FONDAZIONE IRCCS OSPEDALE MAGGIORE POLICLINICO MANGIAGALLI E REGINA ELENA,fondazione_irccs_ospedale_maggiore_policlinico_mangiagalli_e_regina_elena,,,,,, +6205,,7e46e64e-ee44-433d-ae94-6ea1226ae17f,Grethe Andersen,grethe_andersen,,,,,, +6206,,1e1630c2-6d5a-49b4-b77b-506edeb7f211,"Bayer HealthCare AG, Bayer Vital GmbH, D-51368 Leverkusen",bayer_healthcare_ag_bayer_vital_gmbh_d_51368_leverkusen,,,,,, +6207,,fa788a31-b0e0-448d-ba73-c091b73b93b7,AGENNIX INC,agennix_inc,,,,,, +6208,,97b49235-8fa5-4994-b75c-f2f0c3cf6d9b,ACO Hud Nordic AB,aco_hud_nordic_ab,,,,,, +6209,,cf029863-46b2-47a6-bbfc-78dbee13f7aa,NPS Allelix Corporation,nps_allelix_corporation,,,,,, +1063,0.968193,f4900410-286d-48e4-8c75-4fc02e713a10,PENTA Foundation,penta_foundation,,,,72f46314-5a65-467f-abea-944dcfd78d17,penta,PENTA +6210,,b41a58f6-0a1a-4bb1-a593-62d98054d07f,Xenon Pharmaceuticals Inc,xenon_pharmaceuticals_inc,,,,,, +6211,,cb68b687-1e3f-4491-93a1-47c6dcfbc6df,Fakultät für Medizin der Technischen Universität München,fakult_t_f_r_medizin_der_technischen_universit_t_m_nchen,,,,,, +6212,,f410b83b-ab39-4bd8-8fc2-4afb35ecb4b2,"Universitätsklinik f. Innere Medizin III, Medizinische Universität Wien",universit_tsklinik_f_innere_medizin_iii_medizinische_universit_t_wien,,,,,, +6213,,3e594ee5-c6b8-4e05-9b2c-cabab15b1769,Marianne Kiszka-Kanowitz,marianne_kiszka_kanowitz,,,,,, +6214,,f0449ff3-17b4-4e9b-b4e9-22e91c86d2f3,Helsinki University Hospital Comprehensive Cancer Center Hematology,helsinki_university_hospital_comprehensive_cancer_center_hematology,,,,,, +6215,,e35f2092-3b29-4dad-b641-6df7bf1da76d,"Boehringer Ingelheim, Lda",boehringer_ingelheim_lda,,,,,, +6216,,f10efca8-7165-11e6-a0cd-0242ac12000b,DEXCEL PHARMA,dexcel_pharma,,,,,, +636,0.988732,0a4a7604-18d1-4751-9003-e209b313dd54,"La Jolla Pharmaceutical Company, Inc",la_jolla_pharmaceutical_company_inc,,,,0a4a7604-18d1-4751-9003-e209b313dd54,la_jolla_pharmaceutical_company_inc,"La Jolla Pharmaceutical Company, Inc" +6217,,c98cdee3-5ee4-44ef-84af-0937cd00a613,EB House Austria,eb_house_austria,,,,,, +6218,,56835c13-0683-4734-91e6-558f48d542df,Cell Medica Inc,cell_medica_inc,,,,,, +6219,,dd6a9e02-7154-11e6-a0cd-0242ac12000b,PLIVA PHARM IND,pliva_pharm_ind,,,,,, +6220,,01ddae79-3849-47ba-949a-6c64fa858dc3,"Cancer Prevention Pharmaceuticals, Inc",cancer_prevention_pharmaceuticals_inc,,,,,, +6221,,755f8b27-b05d-423f-b8fa-1595e8cbb235,Radiopharmacy,radiopharmacy,,,,,, +6222,,a19d8b78-7145-11e6-a0cd-0242ac12000b,COPLEY PHARM,copley_pharm,,,,,, +176,0.95111942291259766,7d38a850-1226-4260-83b3-3434311401ac,Novartis Vaccines and Diagnostics Inc,novartis_vaccines_and_diagnostics_inc,,,,fbdb10c1-6146-4761-86bf-a8541dc3b4fa,novartis_vaccines_and_diagnostics,Novartis Vaccines and Diagnostics +6223,,e881c694-71d1-11e6-a0cd-0242ac12000b,SAOL THERAPS RES LTD,saol_theraps_res_ltd,,,,,, +771,0.989275,ae4da2c3-6d27-4362-b182-669f879ac3d4,Swiss Group for Clinical Cancer Research,swiss_group_for_clinical_cancer_research,,,,ae4da2c3-6d27-4362-b182-669f879ac3d4,swiss_group_for_clinical_cancer_research,Swiss Group for Clinical Cancer Research +6224,,482e1a11-041e-4951-b575-49b38eeba893,AZIENDA OSPEDALIERA PROVINCIALE DI LECCO,azienda_ospedaliera_provinciale_di_lecco,,,,,, +6225,,9a620168-9c2b-4970-86b3-9aaa82aaa0b9,Alexion Pharma International Sàrl,alexion_pharma_international_s_rl,,,,,, +6226,,0b3cfd28-1a3a-47e7-a77c-2f3233727d4a,ASL 5 di PISA-ZONA VALDERA,asl_5_di_pisa_zona_valdera,,,,,, +6227,,d3d10843-39c8-4139-bc1e-fc4efe03be52,Collaborative group for Adrenocortical Carcinoma Therapy (COAT),collaborative_group_for_adrenocortical_carcinoma_therapy_coat,,,,,, +6228,,5b3734a2-82e2-4c16-9c4d-66d561ed0d51,"University of Oslo, Faculty of medicine, Institute of Health and Society",university_of_oslo_faculty_of_medicine_institute_of_health_and_society,,,,,, +6229,,14c14159-03ef-4670-917f-491b988075e8,Heikki Swan,heikki_swan,,,,,, +192,0.97530868649482727,9178b769-ccd5-4b69-99d5-18e3e7de020e,Teva Pharmaceutical Industries Ltd,teva_pharmaceutical_industries_ltd,,,,7621f0c9-df30-4cbd-95c1-d0d5719d2751,teva_pharmaceutical_industries,Teva Pharmaceutical Industries +6230,,b48e5d5a-7179-11e6-a0cd-0242ac12000b,CENTOCOR ORTHO BIOTECH INC,centocor_ortho_biotech_inc,,,,,, +639,0.98662564158439636,99c8c026-a38d-4aa0-ac2d-e1703ec3bcfb,Greater Glasgow Health Board/University of Glasgow,greater_glasgow_health_board_university_of_glasgow,,,,c80f0f43-274e-40b5-9c79-e591ce33aa3a,greater_glasgow_health_board_university_of_glasgow,Greater Glasgow Health Board/University of Glasgow +635,0.92223775386810303,fbd61dac-95f7-49cb-a759-c06335f234f8,"Research and Development Department, University Hospital of South Manchester NHS Foundation Trust",research_and_development_department_university_hospital_of_south_manchester_nhs_foundation_trust,,,,e73c0583-9c8a-433e-9519-117f883c39d0,research_development_department,Research & Development Department +6231,,127c1ab2-f7bc-4a17-b7ac-df962a90c9bf,"Department of Dermatology, medical University of Graz",department_of_dermatology_medical_university_of_graz,,,,,, +6232,,606e8f07-edf4-4ecc-b7c6-490f4c10ed4f,"Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc",johnson_johnson_healthcare_products_division_of_mcneil_ppc_inc,,,,,, +679,0.967014,7ea66ab6-e6d3-4852-ac14-3cc45c40c829,"CHU Angers, directeur général, Yvonnick Morice",chu_angers_directeur_g_n_ral_yvonnick_morice,,,,73f44df3-f258-476a-8ae7-6cb143e4cbb3,chu_angers,CHU Angers +6233,,ed006eaa-d319-4e71-a249-2f5cfd31fef5,"Medizinische Universität Wien, KIMIII, Abteilung für Endokrinologie und Stoffwechsel",medizinische_universit_t_wien_kimiii_abteilung_f_r_endokrinologie_und_stoffwechsel,,,,,, +6234,,4ea3f604-7146-11e6-a0cd-0242ac12000b,J AND J,j_and_j,,,,,, +6235,,4ccfa855-0e8f-4df0-80d1-77aba652f600,Kirsten Rasmussen,kirsten_rasmussen,,,,,, +6236,,fd369c1b-b034-4637-847c-a569f17a1b52,"Deparment of pediatrics, Skejby Hospital, Denmark",deparment_of_pediatrics_skejby_hospital_denmark,,,,,, +6237,,a5f51dee-c5c4-4f37-97b0-368d237b4850,UNIDAD HEPATICA. CIBERehd. HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE,unidad_hepatica_ciberehd_hospital_general_universitario_de_alicante,,,,,, +6238,,895833eb-d7e4-4fc2-b76b-8d28e40392da,Biotie Therapies Inc,biotie_therapies_inc,,,,,, +6239,,2d63edd6-7142-11e6-a0cd-0242ac12000b,MEDIMETRIKS PHARMS,medimetriks_pharms,,,,,, +6240,,886bb340-97ee-4365-b9dc-932902cf338b,"Malmö Högskola, Odontologiska fakulteten",malm_h_gskola_odontologiska_fakulteten,,,,,, +6241,,517beec6-60fe-4594-ad28-0fa37789666e,"Janssen - Cilag , Johnson & Johnson s.r.o",janssen_cilag_johnson_johnson_s_r_o,,,,,, +6242,,fda244be-00ab-46dd-b54e-1b878fd8ba48,U.O.C. EMATOLOGIA - OSP. S. EUGENIO - ASL RM C,u_o_c_ematologia_osp_s_eugenio_asl_rm_c,,,,,, +6243,,e594c941-0e2b-40df-8fed-1953a48c36af,"Calibra Medical, Inc",calibra_medical_inc,,,,,, +6244,,fddfc979-7f90-42a3-a89d-0991502c43cd,TREND,trend,,,,,, +6245,,ee3a8e82-739c-11e6-a0cd-0242ac12000b,AYTU BIOSCIENCE INC,aytu_bioscience_inc,,,,,, +639,0.985979825258255,c80f0f43-274e-40b5-9c79-e591ce33aa3a,Greater Glasgow Health Board/University of Glasgow (GU),greater_glasgow_health_board_university_of_glasgow_gu,,,,c80f0f43-274e-40b5-9c79-e591ce33aa3a,greater_glasgow_health_board_university_of_glasgow,Greater Glasgow Health Board/University of Glasgow +735,0.98617294430732727,5fc30646-7d65-488f-8e5a-a6c4dcb915c5,European Organisation for Research and Treatment of Cancer (EORTC),european_organisation_for_research_and_treatment_of_cancer_eortc,,,,6e92b00d-0791-4d8e-975c-0fbd5ce95861,european_organisation_for_research_and_treatment_of_cancer,European Organisation for Research and Treatment of Cancer +6246,,7bdca9c2-7344-11e6-a0cd-0242ac12000b,ALTATHERA PHARMS LLC,altathera_pharms_llc,,,,,, +6247,,b7738ad1-6044-4110-9da1-d39d6a0afcff,"GlaxoSmithKline Research, European Medical Governance",glaxosmithkline_research_european_medical_governance,,,,,, +6248,,9b93e7f0-7261-11e6-a0cd-0242ac12000b,METABOLIC SOLUTIONS,metabolic_solutions,,,,,, +1065,0.91470474004745483,21aba99b-7de3-432e-87cd-3af4301e3cdb,"Cambridge University Hospitals NHS Foundation Trust, jointly with University of Cambridge",cambridge_university_hospitals_nhs_foundation_trust_jointly_with_university_of_cambridge,,,,21aba99b-7de3-432e-87cd-3af4301e3cdb,cambridge_university_hospitals_nhs_foundation_trust_jointly_with_university_of_cambridge,"Cambridge University Hospitals NHS Foundation Trust, jointly with University of Cambridge" +645,0.97129645943641663,a8589c66-fe86-4470-ba8f-ef79159c3cf8,"Boehringer Ingelheim Pharma GmbH & Co. KG, Medical Affairs Germany",boehringer_ingelheim_pharma_gmbh_co_kg_medical_affairs_germany,,,,5b57c8bd-158c-42a5-bfa1-3323c67e0dd4,boehringer_ingelheim_pharma_gmbh,Boehringer Ingelheim Pharma GmbH +6249,,b7ddb2ec-b3e9-4a20-a77f-0b33298feea9,ASSOCIAZIONE ITALIANA PNEUMOLOGI OSPEDALIERI,associazione_italiana_pneumologi_ospedalieri,,,,,, +741,0.9617915153503418,0e4b6223-68c5-42cb-9eef-06cfdcc860dd,AstraZeneca R&D Sodertalje,astrazeneca_r_d_sodertalje,,,,5b96ae2b-b1a8-4688-88cd-0fcea433e529,astrazeneca_r_d,AstraZeneca R&D +6250,,e8d1e095-f4c4-4980-9477-48607095e6b3,"Med Uni Graz, Abt. für NEURO- u. GESICHTSCHIRURGISCHE ANÄSTHESIE u. INTENSIVMEDIZIN",med_uni_graz_abt_f_r_neuro_u_gesichtschirurgische_an_sthesie_u_intensivmedizin,,,,,, +6251,,1d954080-8bdc-11e6-a449-0242ac12000b,BayerAG,bayerag,,,,,, +6252,,d16c916b-13d2-40a6-a35f-df47ab8d4483,"Plymouth Hospital NHS Trust, R&D dept",plymouth_hospital_nhs_trust_r_d_dept,,,,,, +6253,,d05ac90e-3b70-4249-a4db-96c18f832716,ardana LTD,ardana_ltd,,,,,, +675,0.98461800813674927,d0b7c9bb-f1c2-49e9-8ebe-37e911f49aff,UCB Pharma,ucb_pharma,,,,0db50825-cbd9-4ba0-9b70-46c1d448c066,ucb_pharma,UCB Pharma +6254,,d7afcd5b-0be6-4039-a08b-52e26e0f5e64,FUNDACION PETHEMA,fundacion_pethema,,,,,, +6255,,835cd70a-7149-11e6-a0cd-0242ac12000b,ALCON LABS INC,alcon_labs_inc,,,,,, +871,0.98728418350219727,8fb63732-f5d5-48d2-a1af-14fecf057351,Astellas Pharma Europe Ltd,astellas_pharma_europe_ltd,,,,0f0582d8-6951-40ea-8acc-9d010331c376,astellas_pharma_europe_ltd_apel,Astellas Pharma Europe Ltd. (APEL) +706,0.98155027627944946,450942a3-d351-4153-8f52-7394952e4a17,"Medical University, Dpt. Internal Medicin, Division of General Inteal Medicine",medical_university_dpt_internal_medicin_division_of_general_inteal_medicine,,,,450942a3-d351-4153-8f52-7394952e4a17,medical_university_dpt_internal_medicin_division_of_general_inteal_medicine,"Medical University, Dpt. Internal Medicin, Division of General Inteal Medicine" +6256,,f4885735-2908-46ed-b1a3-b40a86bca8ab,Interuniversity Cardiology Institute of the Netherlands (ICIN),interuniversity_cardiology_institute_of_the_netherlands_icin,,,,,, +6257,,95f204be-72c8-11e6-a0cd-0242ac12000b,VICURON,vicuron,,,,,, +6258,,0f4d8664-d605-4b71-9dba-8307251c0000,Immodulon Therapeutics Ltd,immodulon_therapeutics_ltd,,,,,, +6259,,a643a9a7-939a-4a67-8ed3-aed8fe6ebf06,"Mpex Pharmaceuticals, Inc",mpex_pharmaceuticals_inc,,,,,, +6260,,ddf19fff-a72e-42bf-a3a0-8ce35ea1c928,"Intensive Care Unit, The Adelaide and Meath Hospital Incorporating the National Children's Hospital",intensive_care_unit_the_adelaide_and_meath_hospital_incorporating_the_national_children_s_hospital,,,,,, +6261,,82160a42-7167-11e6-a0cd-0242ac12000b,UNIV MICHIGAN,univ_michigan,,,,,, +356,0.903306,d51c6143-681e-4142-a4aa-e1eb46d2e51a,Fundación de Investigación Biomédica Hospital La Paz,fundaci_n_de_investigaci_n_biom_dica_hospital_la_paz,,,,ada15e9f-a2ab-489f-bc3e-e972a93587fc,fundaci_n_de_investigaci_n_biom_dica_hospital_de_getafe,Fundación de Investigación Biomédica Hospital de Getafe +6262,,179b0540-ac7d-4d97-ab1b-2fccf929ac32,Luis Bujanda Fernández de Piérola,luis_bujanda_fern_ndez_de_pi_rola,,,,,, +6263,,5bf740ae-893e-4bc9-9701-928d8850fbfc,Medicure International Inc,medicure_international_inc,,,,,, +283,0.988674,ddf9e838-47ae-4e3b-a87e-63b1d7217d1e,Centre Hospitalier Régional et Universitaire,centre_hospitalier_r_gional_et_universitaire,,,,3ed277d7-e94c-44a1-b2b4-33de175d3556,centre_hospitalier_r_gional_et_universitaire_de_lille,Centre Hospitalier Régional et Universitaire de Lille +6264,,ee92e9dd-2f76-4c62-8818-e5af8983e8fb,Dr. Peter Sydow,dr_peter_sydow,,,,,, +6265,,24797330-6fa3-11e6-9663-0242ac12000b,University Medical Center Nijmegen,university_medical_center_nijmegen,,,,,, +6266,,e84bf6e1-c5b3-4fa8-84ba-006530961dc7,Antoni van Leeuwenhoek Hospital-Nuclear Medicine department,antoni_van_leeuwenhoek_hospital_nuclear_medicine_department,,,,,, +6267,,a7d54aa0-515c-4d1f-b687-bdefef959f04,"Serono España, S.A",serono_espa_a_s_a,,,,,, +6268,,bac62fd4-2560-461c-9e0f-f133b5131455,"Medizinische Universität Wien, Univ. Kinderklinik",medizinische_universit_t_wien_univ_kinderklinik,,,,,, +334,0.969856,38455422-c7ad-4eb2-9778-ac9991d3011f,Boiron Laboratoires,boiron_laboratoires,,,,30daea08-31b9-44eb-b245-a0bfc280fc21,boiron,Boiron +6269,,061b31a2-4530-43b3-b31f-e6b5cefbdefc,CHU Gabriel Montpied,chu_gabriel_montpied,,,,,, +6270,,39e41c5e-e924-427f-a229-3f3e031cd580,Spanish Cooperative Group for Gastrointestinal Tomour therapy,spanish_cooperative_group_for_gastrointestinal_tomour_therapy,,,,,, +6271,,04d7a4c0-b243-4331-bc6b-0a94953b9dad,Sahlgrenska Akademien Wallenberglaboratoriet,sahlgrenska_akademien_wallenberglaboratoriet,,,,,, +6272,,02df78f9-c454-4b33-930b-956a2c968ac2,"MacroGenics, Inc",macrogenics_inc,,,,,, +6273,,e247a15e-336a-4e33-9801-b68f40a0cd26,B. Braun Melsungen AG,b_braun_melsungen_ag,,,,,, +6274,,7a48dd83-0ab4-4561-83c0-d1b536df599d,onepharm Research & Development GmbH,onepharm_research_development_gmbh,,,,,, +6275,,5f3d99f9-c3cf-4529-9464-539664d02c51,"UO Divisione Nefrologia, Dialisi e Trapianto renale",uo_divisione_nefrologia_dialisi_e_trapianto_renale,,,,,, +249,0.988541,d91a189c-0325-406f-a6f4-a01cdd87f5d9,Novartis Pharma S.A.S,novartis_pharma_s_a_s,,,,2f1fb211-53ee-482a-b616-521b6469ae37,novartis_pharma_s_a,Novartis Pharma S.A +6276,,743347e7-dae9-4dc9-acfb-f05b9a7dad0a,Universidad de Leipzig,universidad_de_leipzig,,,,,, +88,0.985891,a92a2176-0791-4187-b212-74df344a9470,Photopharmica,photopharmica,,,,31023a1a-6fbc-11e6-abe8-0242ac12000b,photopharmica_ltd,Photopharmica Ltd +588,0.914544,19952d22-67c1-4b82-9279-54d9c48ca7a5,Hospital of the Ludwig Maximilians University Munich,hospital_of_the_ludwig_maximilians_university_munich,,,,19952d22-67c1-4b82-9279-54d9c48ca7a5,hospital_of_the_ludwig_maximilians_university_munich,Hospital of the Ludwig Maximilians University Munich +6277,,89a7b6b4-2578-4cac-a15c-202db7a5d8a9,"Medizinische Universiät Wien, Universitaetsklinik fuer Klinische Pharmakologie",medizinische_universi_t_wien_universitaetsklinik_fuer_klinische_pharmakologie,,,,,, +6278,,945e8f6d-6bdf-4866-9d32-40869da046d6,Jacobo Formigo Couceiro,jacobo_formigo_couceiro,,,,,, +6279,,2890a658-89f1-40f8-aed4-a66af932163f,Central and North West London NHS Foundation Trust,central_and_north_west_london_nhs_foundation_trust,,,,,, +6280,,e1f71b11-d0b3-43bc-9f89-53b628b45e3e,Universität Regensburg,universit_t_regensburg,,,,,, +6281,,63309dd6-7162-11e6-a0cd-0242ac12000b,PHARMACHEMIE USA,pharmachemie_usa,,,,,, +6282,,a9beb2e1-0850-465a-9009-7df515037861,Prof. Asbjørn Mohr Drewes,prof_asbj_rn_mohr_drewes,,,,,, +6283,,77815f0b-c2a7-4442-af26-f3a319d19ec0,"Klinik für Dermatologie und Allergologie der RUB, St. Josef Hospital",klinik_f_r_dermatologie_und_allergologie_der_rub_st_josef_hospital,,,,,, +567,0.985423,0b85e728-7142-11e6-a0cd-0242ac12000b,NOSTRUM LABS INC,nostrum_labs_inc,,,,0b85e728-7142-11e6-a0cd-0242ac12000b,nostrum_labs_inc,NOSTRUM LABS INC +6284,,d6898766-7202-4893-98b6-5545c1a69969,"Aarhus University Hospital, Dept. of anaesthesiology and intensive care",aarhus_university_hospital_dept_of_anaesthesiology_and_intensive_care,,,,,, +6285,,1479a804-f362-45aa-98a7-ebdafa4db265,Assistance publique hôpitaux de marseille,assistance_publique_h_pitaux_de_marseille,,,,,, +6286,,c5cdb516-7160-11e6-a0cd-0242ac12000b,VALEANT PHARMS LLC,valeant_pharms_llc,,,,,, +788,0.918711,8485fc27-40be-49dd-a754-563a52a0814b,"The Royal Group of Hospitals, Belfast Trust",the_royal_group_of_hospitals_belfast_trust,,,,77da9f8d-af27-42f4-9848-1b383dc686c1,the_royal_group_of_hospitals_belfast_health_and_social_care_trust,"The Royal Group of Hospitals, Belfast Health and Social Care Trust" +194,0.976498,9c0c3eb2-c14a-4b84-99a3-653c35ee77ae,ACROSS,across,,,,6dafc817-47f5-4070-8f2f-83bb2660a10a,across_group,ACROSS Group +6287,,4d4bd10a-f480-4be0-aae4-eb7936224cc9,Fundación Academia Española de Dermatología y Venereología,fundaci_n_academia_espa_ola_de_dermatolog_a_y_venereolog_a,,,,,, +6288,,8abcc9ea-7164-11e6-a0cd-0242ac12000b,TAMARANG,tamarang,,,,,, +6289,,1bc2a9f4-98ac-4531-ad6e-9fc83eba88fd,Cristina Peris Martínez,cristina_peris_mart_nez,,,,,, +6290,,a6ac3ddb-4262-4bc0-b724-41727d6e68a1,"Karolinska Institutet, Department of Laboratory Medicine, Clinical Physiology C1:82,Karolinska Univ. Hosp., Huddinge",karolinska_institutet_department_of_laboratory_medicine_clinical_physiology_c1_82_karolinska_univ_hosp_huddinge,,,,,, +835,0.905873,e362093c-5a37-4704-8604-709da1989bd4,University Erlangen-Nuremberg,university_erlangen_nuremberg,,,,81899287-3fd5-4be2-923d-6c76cdc477ff,university_of_erlangen_nuremberg,University of Erlangen-Nuremberg +6291,,3cd153ee-288f-4394-a288-626560f21523,Aalborg Universitets Hospital,aalborg_universitets_hospital,,,,,, +6292,,a3ce8b42-b41d-47a2-bb44-b16c0a32f4f2,Jose M Gatell - Hospital Clinic de Barcelona,jose_m_gatell_hospital_clinic_de_barcelona,,,,,, +339,0.980344,242d528e-2adc-4d28-a02f-034e05a0ca60,Adocia,adocia,,,,1a9c7667-0a16-4463-a38f-f3fc2f60143b,adocia_sa,Adocia SA +6293,,0e62301a-4949-4531-b9e5-62030e3d2f78,Grifols Therapeutics Inc,grifols_therapeutics_inc,,,,,, +832,0.987803,31a12f1b-6a3e-46d8-aa62-861a42167d92,Medical Centre Haaglanden,medical_centre_haaglanden,,,,31a12f1b-6a3e-46d8-aa62-861a42167d92,medical_centre_haaglanden,Medical Centre Haaglanden +6294,,3f98fabd-63be-4035-88c0-ae7618e1da55,"Pfizer Ltd, Ramsgate Rd, Sandwich, Kent, United Kingdom",pfizer_ltd_ramsgate_rd_sandwich_kent_united_kingdom,,,,,, +6295,,a8508300-c034-43d4-83b5-fe2de4ff5f9d,"Department of Medical Research, Regional Hospital Holstebro",department_of_medical_research_regional_hospital_holstebro,,,,,, +6296,,2913a75a-c992-4901-b21e-85602ebc5f98,The Royal Marsden Hospital NHS Trust,the_royal_marsden_hospital_nhs_trust,,,,,, +6297,,952dc112-6cb8-4dcb-9b5d-f9911aced677,"University of Szeged, First Department of Internal Medicine",university_of_szeged_first_department_of_internal_medicine,,,,,, +6298,,e2b5b596-7167-11e6-a0cd-0242ac12000b,CROSSMEDIKA SA,crossmedika_sa,,,,,, +6299,,02943722-6fc2-11e6-abe8-0242ac12000b,University Hospitals Southampton NHS Foundation Trust,university_hospitals_southampton_nhs_foundation_trust,,,,,, +6300,,d7dc3bdf-7309-4431-8cd1-b5feaa1149f6,Pfizer Ltd - Sandwich Laboratories,pfizer_ltd_sandwich_laboratories,,,,,, +617,0.98236817121505737,0359d070-d59d-4dab-8d3e-cdb60bbcff96,Grupo Español de Investigacion en Sarcomas,grupo_espa_ol_de_investigacion_en_sarcomas,,,,0359d070-d59d-4dab-8d3e-cdb60bbcff96,grupo_espa_ol_de_investigaci_n_en_sarcomas,Grupo Español de Investigación en Sarcomas +439,0.98637,df726c6d-1af2-487b-aeec-d62038c2a932,SciencePharma spółka z ograniczoną odpowiedzialnością sp. j,sciencepharma_sp_ka_z_ograniczon_odpowiedzialno_ci_sp_j,,,,80bfc25c-b233-4572-aece-f1e06f4d720e,sciencepharma_sp_ka_z_ograniczon_odpowiedzialno_ci_sp_k,SciencePharma spółka z ograniczoną odpowiedzialnością sp. k +6301,,35c1d0a7-daf9-43bf-aa21-8db98e0ef8a2,"A. MENARINI PHARMA U.K.,",a_menarini_pharma_u_k,,,,,, +18,0.97483,5a94ce26-71db-11e6-a0cd-0242ac12000b,COLGATE PALMOLIVE,colgate_palmolive,,,,5a94ce26-71db-11e6-a0cd-0242ac12000b,colgate_palmolive,COLGATE PALMOLIVE +6302,,69e2e904-451d-4cdb-beb9-21ba9f7756a2,Schering Oy,schering_oy,,,,,, +6303,,b3613164-c782-42db-8210-4959aca604c6,Hexal AG,hexal_ag,,,,,, +6304,,e627fc5b-8d68-4a48-bd2a-215799922a7a,Biosynexus Incorporated,biosynexus_incorporated,,,,,, +6305,,f6e26b13-e86a-4335-acdc-994d4a2a9015,"University of Bergen, Faculty of medicin and dentistry, Dep. of Clinical Dentistry",university_of_bergen_faculty_of_medicin_and_dentistry_dep_of_clinical_dentistry,,,,,, +6306,,e97287d2-3dca-4b2a-a910-3a00ac2eaa3c,CHU de Toulouse,chu_de_toulouse,,,,,, +6307,,612f66e0-8af9-4664-8076-1c51d5bcbba6,Národní ústav duševního zdraví,n_rodn_stav_du_evn_ho_zdrav,,,,,, +226,0.97584396600723267,d67f1fcd-9097-482d-9faf-b5d8f85a5883,FUNDACIÓ SANT JOAN DE DEU,fundaci_sant_joan_de_deu,,,,43372c1e-43ce-4dcb-b2e0-ae9f60081a96,fundaci_sant_joan_de_d_u,FUNDACIÓ SANT JOAN DE DÉU +907,0.94901684919993079,bc78737f-5607-4fe9-a4a6-eab005b383ca,sanofi-aventis recherche et development,sanofi_aventis_recherche_et_development,,,,f72ce0f5-27b8-42db-aeea-0faa55409a54,sanofi_aventis_recherche_et_developpement,sanofi-aventis recherche et developpement +6308,,cedf41cb-749c-43ae-8c37-0e263ec5c65c,"OSI Pharmaceuticals, Inc",osi_pharmaceuticals_inc,,,,,, +866,0.96000528335571289,777eeb1f-10b4-4c96-8d33-42be9c44ad2b,"Hvidovre Hospital, Dept. of Rheumatology",hvidovre_hospital_dept_of_rheumatology,,,,777eeb1f-10b4-4c96-8d33-42be9c44ad2b,hvidovre_hospital,Hvidovre Hospital +892,0.98520499467849731,16b9d8ec-4b48-4fe9-bcae-e854bddbc3d8,Aarhus Universityhospital,aarhus_universityhospital,,,,16b9d8ec-4b48-4fe9-bcae-e854bddbc3d8,aarhus_universityhospital,Aarhus Universityhospital +6309,,b45e4eac-74d4-48fa-9477-9f8a86462df1,bioCSL Pty Ltd,biocsl_pty_ltd,,,,,, +6310,,3256bb7c-5fd2-4306-a232-852bfb30ef10,"Kern Pharma, S.L",kern_pharma_s_l,,,,,, +6311,,71bda146-8bd9-11e6-a449-0242ac12000b,Dept of Anaesthesiology 530,dept_of_anaesthesiology_530,,,,,, +6312,,e0da56ac-185f-49b3-a4aa-81e93e977968,Hospital Vall d Hebron,hospital_vall_d_hebron,,,,,, +6313,,104f5d7a-d035-4817-891d-48226b2c9f9f,InterMune International AG,intermune_international_ag,,,,,, +6314,,397d1d41-e945-4b0a-87c0-6028fae1ffcf,Stiefel Laboratories International Division,stiefel_laboratories_international_division,,,,,, +6315,,1df7ad58-074e-4c00-a49c-4017fd6f7d0e,"Cardiology, University of Frankfurt",cardiology_university_of_frankfurt,,,,,, +332,0.986085,fedf47d3-8924-4b5d-86ee-4c4bba29445d,Instituto Valenciano de Infertilidad,instituto_valenciano_de_infertilidad,,,,7336f82e-6c71-4f40-80a6-4017116b5145,instituto_valenciano_de_infertilidad_ivi_de_valencia,Instituto Valenciano de Infertilidad (IVI) de Valencia +6316,,a9877e08-dc31-4cae-9a47-3090b8228308,PEDRO ACIEN ALVAREZ,pedro_acien_alvarez,,,,,, +6317,,a6e60a11-63cc-4f54-b63f-4fe9ba8fff4c,"Laboratorios Effik, S.A",laboratorios_effik_s_a,,,,,, +6318,,5bab3405-2cb8-4b15-abe3-f952b16c1d24,Marienkrankenhaus Soest,marienkrankenhaus_soest,,,,,, +6319,,8897a044-865d-4674-871c-61c6f79c0b23,"Medizinische Universität Graz, Klinische Abteilung für Geburtshilfe, Univ. Klinik für Frauenheilkunde und Geburtshilfe",medizinische_universit_t_graz_klinische_abteilung_f_r_geburtshilfe_univ_klinik_f_r_frauenheilkunde_und_geburtshilfe,,,,,, +361,0.988596,7d7d20e5-897b-403b-ba75-22e35574cc70,Mitsubishi Tanabe Pharma Corporation (MTPC),mitsubishi_tanabe_pharma_corporation_mtpc,,,,7d7d20e5-897b-403b-ba75-22e35574cc70,mitsubishi_tanabe_pharma_corporation_mtpc,Mitsubishi Tanabe Pharma Corporation (MTPC) +6320,,02b46a59-0678-44d4-a5df-de9f101df96c,Univ.-Prof. Dr. Karlheinz Tscheliessnigg,univ_prof_dr_karlheinz_tscheliessnigg,,,,,, +6321,,ab482af0-972d-4660-855c-6391b24567d4,"Clinic for General Anesthesiology, Intensive Care and Pain Management",clinic_for_general_anesthesiology_intensive_care_and_pain_management,,,,,, +6322,,953bf657-cd2e-4830-8c82-3ed116f878f7,"Department of Rheumatology, Skåne University Hospital",department_of_rheumatology_sk_ne_university_hospital,,,,,, +604,0.96866416931152344,1a6a910e-9e16-4295-9c10-800391283d55,Fundación Investigación y Desarrollo en el Área Cardiovascular,fundaci_n_investigaci_n_y_desarrollo_en_el_rea_cardiovascular,,,,1a6a910e-9e16-4295-9c10-800391283d55,fundaci_n_investigaci_n_y_desarrollo_en_el_rea_cardiovascular,Fundación Investigación y Desarrollo en el Área Cardiovascular +620,0.964286,6ff65a26-4d52-43ab-86e1-d923b4e7de50,Technical University of Munich,technical_university_of_munich,,,,1ea7f82f-9f53-484a-93fe-2e25f14ea8ee,technical_unversity_of_munich,Technical Unversity of Munich +6323,,83c3b9cf-8d56-48ca-aaf9-86a9c37f6be5,Paracelsus Medizinische Universität - Universitätsklinik für Anästhesie,paracelsus_medizinische_universit_t_universit_tsklinik_f_r_an_sthesie,,,,,, +6324,,bc6ec18d-0cb0-44d9-aedb-aa393841edf5,"Tokai Pharmaceuticals, Inc",tokai_pharmaceuticals_inc,,,,,, +6325,,a462e85f-a474-473f-8195-381fabae5a3b,CEL-SCI Corporation,cel_sci_corporation,,,,,, +6326,,b4257ccc-ccb0-4aeb-8b63-85577c103973,Herz- & Diabeteszentrum NRW,herz_diabeteszentrum_nrw,,,,,, +6327,,739f1215-8dd8-4a7e-9ec3-1d629f5e7c3f,"Carlos Alonso-Villaverde Lozano, Hospital Universitari Sant Joan de Reus",carlos_alonso_villaverde_lozano_hospital_universitari_sant_joan_de_reus,,,,,, +614,0.95815481742223108,9a31a764-2448-46f8-8312-32fbbf9b20d9,Fundación para la Investigación Biomédica del Hospital Universitario La Paz (FIBHULP),fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz_fibhulp,,,,1f4b6569-9247-4094-9c36-e11efb0201df,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz,Fundación para la Investigación Biomédica del Hospital Universitario La Paz +609,0.920179,dc09b10e-f654-4170-87dd-310398d1a8d1,Department of Pharmacy Unversitätsmedizin Mainz,department_of_pharmacy_unversit_tsmedizin_mainz,,,,7ccdbeba-54a9-43ed-8e5c-58592f516aa3,department_of_pharmacy_universitaetsmedizin_mainz,Department of Pharmacy Universitaetsmedizin Mainz +6328,,34629678-734d-473e-b92a-f025d507d10b,Shire ViroPharma Incorporated,shire_viropharma_incorporated,,,,,, +401,0.985931,860ad342-327d-4ce5-b645-a14c7f03a545,European Myeloma Network,european_myeloma_network,,,,4881a846-a728-4902-a39b-d18aa6ed8b14,european_myeloma_network_datacenter,European Myeloma Network Datacenter +6329,,32788fbe-7167-11e6-a0cd-0242ac12000b,QUEEN HAMAMATSU PET,queen_hamamatsu_pet,,,,,, +6330,,c096be31-51b3-48f7-a97a-8664ac6a9351,"Dept. Hematology, Hospital Clinic",dept_hematology_hospital_clinic,,,,,, +6331,,b45b8c88-eebd-4335-95a7-5ee1ffaf28b9,Ospedale Regionale di Lugano,ospedale_regionale_di_lugano,,,,,, +6332,,48f22a76-b3e8-4636-9b76-7cc9d090c4bb,Ulrik Grevstad,ulrik_grevstad,,,,,, +6333,,41f07cdc-e50f-480a-9767-02e57aed0239,"Medizinische Klinik B, Herzzentrum Ludwigshafen",medizinische_klinik_b_herzzentrum_ludwigshafen,,,,,, +6334,,fedfcac0-f4b2-4f35-968b-2a1c2e525fd0,"Professor Christina Eintrei,Institution of Medical & Health, Section of Anesthesiology",professor_christina_eintrei_institution_of_medical_health_section_of_anesthesiology,,,,,, +1017,0.98363004624843597,49cb16ab-28c5-470e-940e-1e210b66cb7d,Southampton University Hospitals Trust,southampton_university_hospitals_trust,,,,986ad2cd-cb4e-460c-acdc-a2b32a61de09,southampton_university_hospitals,Southampton University Hospitals +6335,,43cb6fe4-8be7-11e6-a449-0242ac12000b,Khondrion BV,khondrion_bv,,,,,, +6336,,756d9d21-2728-45de-9f04-def255a6a7c2,"ALMIRALL, S. A., Research and Development (R&D) Centre",almirall_s_a_research_and_development_r_d_centre,,,,,, +6337,,dd89afb0-093d-4fec-b020-65446d473ecb,Novartis Vaccines and Diagnostics GmbH,novartis_vaccines_and_diagnostics_gmbh,,,,,, +1070,0.979707,40ccc091-c821-4ebb-b881-5c3d26d57a77,Hopital Erasme,hopital_erasme,,,,40ccc091-c821-4ebb-b881-5c3d26d57a77,hopital_erasme,Hopital Erasme +6338,,de4c6326-86eb-4fd1-a3ef-e2f17f8f39a5,anofi-aventis recherche et développement,anofi_aventis_recherche_et_d_veloppement,,,,,, +6339,,b53fe332-7141-11e6-a0cd-0242ac12000b,METRICS PHARM,metrics_pharm,,,,,, +6340,,dcc20283-e3c3-44ff-9364-b575e6141412,"Dept of Transplantation Surgery B 56, Karolinska University Hospital, Huddinge",dept_of_transplantation_surgery_b_56_karolinska_university_hospital_huddinge,,,,,, +6341,,127c0158-0a73-4cd1-a58c-b9c37d1cb319,EBMT Clinical Trial Office,ebmt_clinical_trial_office,,,,,, +6342,,0869ee61-8877-4052-b8b4-580dc2585d48,Cristina Díaz de Heredia Rubio,cristina_d_az_de_heredia_rubio,,,,,, +6343,,6e8064be-517c-4863-95c0-3781aeec2394,Universitätsklinikum Münster,universit_tsklinikum_m_nster,,,,,, +6344,,cc398b6b-ceb6-421b-8b26-08d3f905f4a2,The Rotunda Maternity Hospital,the_rotunda_maternity_hospital,,,,,, +263,0.986,fcd8a2e2-73e9-11e6-a0cd-0242ac12000b,PIERRE FABRE DERMA,pierre_fabre_derma,,,,7f982261-1f38-4450-bed0-692a6746f7c6,pierre_fabre_dermatologie,PIERRE FABRE DERMATOLOGIE +6345,,01e15be7-e291-4c81-8bbe-6d4b38d20625,MondoGEN AG,mondogen_ag,,,,,, +6346,,f6aed56e-71b7-11e6-a0cd-0242ac12000b,IMP,imp,,,,,, +761,0.958103,efa51ecb-16a9-46cd-b1b7-8863c908fa51,"The Heart Center, Rigshospitalet",the_heart_center_rigshospitalet,,,,931e7207-ea0c-4262-baf3-da49815f8901,the_heart_centre_rigshospitalet,"The Heart Centre, Rigshospitalet" +604,0.94218403100967407,c58ff616-bca8-4343-94ef-a840a482730c,Fundación para Investigación y Desarrollo en el Área Cardiovascular del Hospital Clínico San Carlos,fundaci_n_para_investigaci_n_y_desarrollo_en_el_rea_cardiovascular_del_hospital_cl_nico_san_carlos,,,,1a6a910e-9e16-4295-9c10-800391283d55,fundaci_n_investigaci_n_y_desarrollo_en_el_rea_cardiovascular,Fundación Investigación y Desarrollo en el Área Cardiovascular +791,0.972677,4cca3114-a70f-4d6b-a08d-fae9d4599f44,Fundación para la Investigación Biomédica Hospital Universitario Ramón y Cajal,fundaci_n_para_la_investigaci_n_biom_dica_hospital_universitario_ram_n_y_cajal,,,,4cca3114-a70f-4d6b-a08d-fae9d4599f44,fundaci_n_para_la_investigaci_n_biom_dica_hospital_universitario_ram_n_y_cajal,Fundación para la Investigación Biomédica Hospital Universitario Ramón y Cajal +6347,,c6cdbe50-0036-4a2e-95a1-cb202f78626f,Serentis Limited,serentis_limited,,,,,, +813,0.98849943280220032,d8bfcede-efc3-4714-b642-f79fb12833f5,ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI,istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori,,,,d8bfcede-efc3-4714-b642-f79fb12833f5,istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori,ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI +6348,,190d0e80-73b2-4b87-906f-2a2a8510cef6,ISTITUTO ONCOLOGICO ROMAGNOLO,istituto_oncologico_romagnolo,,,,,, +161,0.98298531770706177,dc8a7f62-673d-444a-ba00-53c705d099d1,Fundación para la Investigación Biomédica,fundaci_n_para_la_investigaci_n_biom_dica,,,,393eab2d-fa2d-419a-8ecd-278e02b1ad5b,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_12_de_octubre,Fundación para la Investigación Biomédica del Hospital 12 de Octubre +6349,,5f912534-5726-480a-af42-4ce4d3a35e42,"Sanofi-Aventis US, Inc",sanofi_aventis_us_inc,,,,,, +6350,,5a9cb16c-701d-4d7f-8237-47216d835772,Cassella-med,cassella_med,,,,,, +6351,,4bbc6429-0c5a-4086-9ec5-e6fec0f3a855,Britannia Pharmaceuticals Limited,britannia_pharmaceuticals_limited,,,,,, +689,0.980666,08598a05-faa8-4889-ba3e-5127ae10b806,"Allergopharma Joachim Ganzer KG an afilliate of Merck KGaA, Darmstadt",allergopharma_joachim_ganzer_kg_an_afilliate_of_merck_kgaa_darmstadt,,,,08598a05-faa8-4889-ba3e-5127ae10b806,allergopharma_joachim_ganzer_kg_an_afilliate_of_merck_kgaa_darmstadt,"Allergopharma Joachim Ganzer KG an afilliate of Merck KGaA, Darmstadt" +6352,,7d1660b8-a212-41e5-ad9e-4bd55ae850e4,Pharma Mar S.A. Sociedad Unipersonal,pharma_mar_s_a_sociedad_unipersonal,,,,,, +6353,,d0b2e43c-8615-4194-aaf4-9f8fb196c85a,"Forsight Vision 4, Inc",forsight_vision_4_inc,,,,,, +6354,,97c54974-f929-4178-9e5a-28168af41cf1,José Castillo Sanchez,jos_castillo_sanchez,,,,,, +6355,,c4250442-7167-11e6-a0cd-0242ac12000b,LIBERTY PHARMA INC,liberty_pharma_inc,,,,,, +6356,,f230c5cd-b4ea-45e9-9286-0a6333a7597c,Laboratoires Grünenthal,laboratoires_gr_nenthal,,,,,, +6357,,9189ce6c-bb95-4144-a8a4-d32b24f6d03c,Hull and East Yorkshire NHS Hospitals Trust,hull_and_east_yorkshire_nhs_hospitals_trust,,,,,, +162,0.96508872509002686,970b586c-4a29-4881-8880-c2619af89db7,Norfolk & Norwich University Hospitals NHS Foundation Trust,norfolk_norwich_university_hospitals_nhs_foundation_trust,,,,045ba97e-7848-45f2-b26b-86cc761804b6,norfolk_and_norwich_university_hospitals_nhs_foundation_trust,Norfolk and Norwich University Hospitals NHS Foundation Trust +124,0.98570466041564941,84203ae0-acea-4ba0-95f8-f2d3dbddc28f,F. Hoffman-La Roche Ltd,f_hoffman_la_roche_ltd,,,,6c8a5ed2-f731-4585-8a6f-d17e1fc2915a,f_hoffman_la_roche_ltd_roche_oy,"F. Hoffman-La Roche Ltd., Roche Oy" +6358,,7ccc461a-12c4-4557-b9e8-045c41f64186,Rafael Esteban Mur,rafael_esteban_mur,,,,,, +6359,,55c18843-e8e8-4f45-95b2-a8eac5c78bb1,Ministry of Infrastructure and the Environment,ministry_of_infrastructure_and_the_environment,,,,,, +210,0.944644,0b4f5fcf-dbeb-40d7-9a94-9cb3a8d69d76,Finnish Breast Cancer Group,finnish_breast_cancer_group,,,,0b4f5fcf-dbeb-40d7-9a94-9cb3a8d69d76,finnish_breast_cancer_group,Finnish Breast Cancer Group +6360,,a2d7b024-6cbb-43fe-995d-88361695c6cd,Santen Oy,santen_oy,,,,,, +6361,,f81b66ae-540f-4b4b-880f-5c1650e96651,Warner Chilcott UK Limited,warner_chilcott_uk_limited,,,,,, +6362,,f4de3dff-85c1-4b41-990b-fdc97a84d600,POLARIS GROUP,polaris_group,,,,,, +6363,,716dbe40-715f-11e6-a0cd-0242ac12000b,ALLERGAN HERBERT,allergan_herbert,,,,,, +6364,,537faa80-73bf-11e6-a0cd-0242ac12000b,ONYX THERAP,onyx_therap,,,,,, +6365,,626ea69c-bdc4-480e-bc48-b66814c1342f,"Research and Innovation Services, University of Dundee",research_and_innovation_services_university_of_dundee,,,,,, +6366,,b70734c3-9291-49dd-a262-12a6ee578b31,Universitätsklinikum Greifswald der Ernst-Moritz-Arndt Universität Greifswald AöR,universit_tsklinikum_greifswald_der_ernst_moritz_arndt_universit_t_greifswald_a_r,,,,,, +6367,,35d6801a-e436-4d64-8e4e-c60ce4bf04b7,"Great Western Hospital, Swindon",great_western_hospital_swindon,,,,,, +6368,,91f57cc2-3fc6-4974-abce-2d95b92e125e,FONDAZIONE SENDO,fondazione_sendo,,,,,, +6369,,23e39e06-77a0-4618-bb58-035311880f3e,"Neuromuscular Research Unit, Rigshospitalet",neuromuscular_research_unit_rigshospitalet,,,,,, +6370,,5ca100ae-6f7c-4a3f-af42-a7a75e7bea60,AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO-VITTORIO EMANUELE,azienda_ospedaliero_universitaria_policlinico_vittorio_emanuele,,,,,, +6371,,b30c4796-7ea3-4179-94f6-b2c2f870acd7,Valneva Austria GmbH,valneva_austria_gmbh,,,,,, +6372,,27959229-aaba-4086-8dc5-5e81e81860c9,COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ON AIDS,community_programs_for_clinical_research_on_aids,,,,,, +891,0.978652,0aaff566-edcf-48b0-acb4-a30bb9fe5405,"Australasian Gastro-Intestinal Trials Group, Sydney University",australasian_gastro_intestinal_trials_group_sydney_university,,,,0aaff566-edcf-48b0-acb4-a30bb9fe5405,australasian_gastro_intestinal_trials_group_sydney_university,"Australasian Gastro-Intestinal Trials Group, Sydney University" +499,0.95183,0c43fa82-723d-4a38-822b-83d3cb20290b,"Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany",merck_serono_s_a_geneva_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,0c43fa82-723d-4a38-822b-83d3cb20290b,merck_serono_s_a_geneva_an_affiliate_of_merck_kgaa_darmstadt_germany,"Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany" +451,0.901039,0a4faedb-ecc0-4282-8a39-c4f5fdd6ab92,Antisoma Research Ltd,antisoma_research_ltd,,,,0a4faedb-ecc0-4282-8a39-c4f5fdd6ab92,antisoma_research_ltd,Antisoma Research Ltd +6373,,b4353633-2caf-4d7c-8fe3-0bc5f1669f47,AZIENDA PROVINCIALE PER I SERVIZI SANITARI DELLA PROVINCIA AUTONOMA DI TRENTO,azienda_provinciale_per_i_servizi_sanitari_della_provincia_autonoma_di_trento,,,,,, +6374,,7ff93d8a-3425-446d-b936-43a2471c3978,Landstinget Gävleborg,landstinget_g_vleborg,,,,,, +6375,,1fc33c7d-b7c9-4b11-a396-cf51bc651f7f,"Laboratorios Dr. Esteve, SA",laboratorios_dr_esteve_sa,,,,,, +6376,,71c5877f-a7f0-4da5-bed7-818c1c9c0cfa,Endo Pharmaceuticals Inc,endo_pharmaceuticals_inc,,,,,, +6377,,c61f38ee-d1a8-470a-b902-4e48a341cc0a,VUmc Dept Urology,vumc_dept_urology,,,,,, +6378,,2ff23f9d-9c4e-40b6-bd97-3beb8cf1cf9b,The National Cancer Institute (NCI),the_national_cancer_institute_nci,,,,,, +6379,,74110639-a8bd-4b22-b7ba-65b254415b5c,"German Sport University Cologne, Institute of CArdiology and Sports Medicine",german_sport_university_cologne_institute_of_cardiology_and_sports_medicine,,,,,, +6380,,843091b8-9f69-4818-b795-774a8d2e9205,IIT : University Hospital - Medical Clinic II (Director: Prof. Dr. med. J. Floege - Sponsor),iit_university_hospital_medical_clinic_ii_director_prof_dr_med_j_floege_sponsor,,,,,, +476,0.971143,4543c7ec-daec-4a10-bab1-cd53aacf4083,CMC Contrast AB,cmc_contrast_ab,,,,4543c7ec-daec-4a10-bab1-cd53aacf4083,cmc_contrast_ab,CMC Contrast AB +6381,,96d802bf-c719-4767-b498-d1c2b022d3be,"Fournier Laboratories Ireland Ltd, a member of the Solvay group",fournier_laboratories_ireland_ltd_a_member_of_the_solvay_group,,,,,, +6382,,c5ed3b11-f19f-4a99-bd68-c588901762f6,Merck AB,merck_ab,,,,,, +6383,,dbe8477a-7166-11e6-a0cd-0242ac12000b,SCIEGEN PHARMS INC,sciegen_pharms_inc,,,,,, +924,0.97933,7ced7946-7140-11e6-a0cd-0242ac12000b,ALPHARMA,alpharma,,,,7ced7946-7140-11e6-a0cd-0242ac12000b,alpharma,ALPHARMA +6384,,e53fa60d-b8b4-4bc1-b4ff-5a3c954f34a5,Azienda Ospedaliero-Universitaria di Parma,azienda_ospedaliero_universitaria_di_parma,,,,,, +6385,,6f328271-fa63-4b99-a74b-3e04465e7888,Clinical Technology Centre (International) Limited,clinical_technology_centre_international_limited,,,,,, +6386,,49328c54-51e8-4170-944e-276325a1dea2,FOREST RESEARCH INSTITUTE,forest_research_institute,,,,,, +6387,,d06c2aad-587d-4d94-a135-f900b3b9bfd2,Heart of England NHS Foundation Trust Birmingham Heartlands Hospital,heart_of_england_nhs_foundation_trust_birmingham_heartlands_hospital,,,,,, +6388,,5de7e1f8-1cb6-4dce-940e-fb424c143990,Nektar Therapeutics,nektar_therapeutics,,,,,, +6389,,19accbcf-7796-44a1-8010-3b566db2dcef,Sinikka Oksa,sinikka_oksa,,,,,, +541,0.98826968669891357,06598f56-3fa1-48ed-824d-b88b0bafc1ab,Fournier Laboratories Ireland (FLI),fournier_laboratories_ireland_fli,,,,06598f56-3fa1-48ed-824d-b88b0bafc1ab,fournier_laboratories_ireland_fli,Fournier Laboratories Ireland (FLI) +6390,,3b28ce8f-da7d-43e6-ac07-d3af022ee5c6,IRCCS Policlinico San Donato,irccs_policlinico_san_donato,,,,,, +6391,,d4e42130-4dfe-4ceb-89ee-7be99804b2a5,University of Glasgow / NHS Greater Glasgow and Clyde,university_of_glasgow_nhs_greater_glasgow_and_clyde,,,,,, +6392,,7555d4a5-8b3d-4db8-83d3-5482d0d01d4b,Accord Healthcare Ltd,accord_healthcare_ltd,,,,,, +807,0.968782,517185b0-8dd4-4271-b913-fcaefd671991,"Medical University Vienna, Dept. of Clinical Pharmacology",medical_university_vienna_dept_of_clinical_pharmacology,,,,420745a1-a57e-4545-a9b6-170be97fb467,medical_university_of_vienna_dept_of_clinical_pharmacology,"Medical University of Vienna, Dept. of Clinical Pharmacology" +6393,,5278d316-73cc-11e6-a0cd-0242ac12000b,PLX PHARMA,plx_pharma,,,,,, +6394,,0fea4a36-8eab-49f6-981f-7d2af598ab52,"Medizinische Universität Graz, Univ. Klinik für Anästhesiologie und Intensivmedizin, Abt. Anästhesie und Intensivmedizin",medizinische_universit_t_graz_univ_klinik_f_r_an_sthesiologie_und_intensivmedizin_abt_an_sthesie_und_intensivmedizin,,,,,, +6395,,775866a6-7165-11e6-a0cd-0242ac12000b,AJANTA PHARMA LTD,ajanta_pharma_ltd,,,,,, +1076,0.960954,3f80858e-8e18-4b61-80e5-d5867133b696,"Dep. Ophthalmology, Medical University of Vienna",dep_ophthalmology_medical_university_of_vienna,,,,045cfbfc-1ceb-4114-9b7b-c749009a8f56,dep_of_ophthalmology_medical_university_of_vienna,"Dep. of Ophthalmology, Medical University of Vienna" +6396,,0b792c36-7142-11e6-a0cd-0242ac12000b,ERGOJECT,ergoject,,,,,, +6397,,1d7da9c7-3809-404d-969d-f58cb1e18e25,CONSORCI MAR PARC DE SALUT BARCELONA,consorci_mar_parc_de_salut_barcelona,,,,,, +6398,,a974039b-2093-4133-9868-e9b2eb78a38b,Prof. Dr. Karl-Heinz Emmerich,prof_dr_karl_heinz_emmerich,,,,,, +6399,,416990a3-0233-4293-b4f6-96f043d52b43,Cardiovascular Research Foundation,cardiovascular_research_foundation,,,,,, +6400,,7576b0f9-aa10-487f-9f36-ff242b62b42d,NHS Greater Glasgow/Glasgow University,nhs_greater_glasgow_glasgow_university,,,,,, +6401,,c39386f1-4c62-4e6f-a6eb-cc2dc35b00c4,Comité Départemental d’Hygiène Social,comit_d_partemental_d_hygi_ne_social,,,,,, +6402,,f1137379-1944-4b90-823b-6039979af029,CV THERAPEUTICS INC,cv_therapeutics_inc,,,,,, +6403,,2319c062-b293-4a9c-9bb2-53af22432ccd,UCR Uppsala Clinical Research Center,ucr_uppsala_clinical_research_center,,,,,, +6404,,7e9086ea-5b53-4aa0-be5e-81a674331dd1,Dutch Growth Foundation,dutch_growth_foundation,,,,,, +6405,,027b441e-7207-11e6-a0cd-0242ac12000b,AVENT,avent,,,,,, +6406,,8e3d8130-3dac-4bcc-8fbb-9e5539103aa6,Neurim Pharmaceuticals Ltd,neurim_pharmaceuticals_ltd,,,,,, +6407,,d9c13812-735f-11e6-a0cd-0242ac12000b,GE HLTHCARE INC,ge_hlthcare_inc,,,,,, +6408,,5b8be427-d9db-443a-adb9-89b3bab14893,Prof. M.A. Dimopoulos,prof_m_a_dimopoulos,,,,,, +6409,,36ee0f2c-7a5c-4dec-bf84-87215e13f235,GBG Forschungs GmbH (German Breast Group),gbg_forschungs_gmbh_german_breast_group,,,,,, +6410,,6152be60-213c-4ed7-a17c-741c90058dea,"Canyon Pharmaceuticals, Inc",canyon_pharmaceuticals_inc,,,,,, +6411,,3b6e121a-7167-11e6-a0cd-0242ac12000b,TRIAD ISOTOPES INC,triad_isotopes_inc,,,,,, +6412,,642b1eb7-53cc-45cd-a62d-9c2c71c72094,"NV Organon, part of Schering-Plough Corporation",nv_organon_part_of_schering_plough_corporation,,,,,, +6413,,46666d5e-7142-11e6-a0cd-0242ac12000b,DISTA,dista,,,,,, +6414,,c9ca8096-56c2-4c06-8f1a-e2e9213e2d0a,Palobiofarma S.L,palobiofarma_s_l,,,,,, +6415,,b7d6ae30-7928-4b38-b0e8-550fa879496a,MUMC+,mumc,,,,,, +6416,,f855c4d2-a292-4edb-b53e-28286d885357,County Council of Östergötland,county_council_of_sterg_tland,,,,,, +6417,,d28b01e5-ecbf-493f-b27f-7da39c4fc4aa,Abbott GmBH Co,abbott_gmbh_co,,,,,, +6418,,5b1d5ce0-d81a-4eb2-8fa0-e9c4960ee9e9,AZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI,azienda_ospedaliero_universitaria_ospedali_riuniti_umberto_i_g_m_lancisi_g_salesi,,,,,, +6419,,396fdf3a-f677-47ff-9d51-b5ec09dc34ae,PeP-Tonic Medical AB,pep_tonic_medical_ab,,,,,, +6420,,7ea9674b-5ef7-4bb9-8e02-4687939ded2d,CSC Pharmaceuticals Handels GmbH,csc_pharmaceuticals_handels_gmbh,,,,,, +6421,,360fd588-7167-11e6-a0cd-0242ac12000b,INDCHEMIE HEALTH,indchemie_health,,,,,, +6422,,9a7e0ef5-78f0-4f36-bd7f-c2c4d1d4b7d2,University Hospital Southampton NHS Trust,university_hospital_southampton_nhs_trust,,,,,, +959,0.94367156426111853,7958b99a-88dd-469b-bfbf-d2e920abbffb,"Andromeda Biotech Ltd, 42 Hayarkon st, Yavne, 81227, Israel",andromeda_biotech_ltd_42_hayarkon_st_yavne_81227_israel,,,,8e1ef03a-b2a7-496e-83ef-ae87bf0b27e9,andromeda_biotech_ltd_42_hayarkon_st_yavne_81227_israel,Andromeda Biotech Ltd +6423,,9ca8257f-43d0-4fe4-a59e-77737464348c,Umecrine Mood AB,umecrine_mood_ab,,,,,, +6424,,dc9aab6f-92ff-4602-bf55-a34929773531,Julio Bobes,julio_bobes,,,,,, +463,0.98401951789855957,2518a26c-7146-11e6-a0cd-0242ac12000b,ORTHO MCNEIL PHARM,ortho_mcneil_pharm,,,,2518a26c-7146-11e6-a0cd-0242ac12000b,ortho_mcneil_pharm,ORTHO MCNEIL PHARM +6425,,9171e1a3-32cc-411a-8b2b-44e794b4e64a,Vifor (International) Inc,vifor_international_inc,,,,,, +6426,,acbd90c4-715f-11e6-a0cd-0242ac12000b,GLENWOOD,glenwood,,,,,, +6427,,fb178c65-30c8-4039-b57a-cc42ec2fe74d,SBG,sbg,,,,,, +6428,,3f45ee9c-f2d1-478a-b0d9-6d92e1363684,LABORATOIRES MAYOLY SPINDLER,laboratoires_mayoly_spindler,,,,,, +537,0.92192,5acde854-4953-47c0-9987-89e6a451966b,Centocor BV,centocor_bv,,,,5acde854-4953-47c0-9987-89e6a451966b,centocor_bv,Centocor BV +451,0.901039,636d1604-7383-4dd8-bd01-4f3176721b36,Antisoma Research Limited,antisoma_research_limited,,,,0a4faedb-ecc0-4282-8a39-c4f5fdd6ab92,antisoma_research_ltd,Antisoma Research Ltd +6429,,d1c571f7-3357-423d-8a08-c0d6a4e2fb0c,IVI Madrid,ivi_madrid,,,,,, +6430,,cf83ec0b-4120-4dc1-bb20-5e955043be2d,ULB Erasme,ulb_erasme,,,,,, +839,0.952896,cd634b4f-58d5-4151-9b65-7bcb4290e9d4,Newcastle Hospitals Trust,newcastle_hospitals_trust,,,,9ac934a2-f363-48d8-8da4-a925d66bd5cc,newcastle_hospital_trust,Newcastle Hospital Trust +6431,,32ce9784-714d-11e6-a0cd-0242ac12000b,NEXGEN PHARMA INC,nexgen_pharma_inc,,,,,, +6432,,b9f55d70-b848-463c-9b13-182c1b3fd005,AVENTIS PHARMA S.P.A,aventis_pharma_s_p_a,,,,,, +136,0.958341,3e746564-6364-4770-b1d4-841842beb7c7,Medisch Centrum Leeuwaarden,medisch_centrum_leeuwaarden,,,,3e746564-6364-4770-b1d4-841842beb7c7,medisch_centrum_leeuwaarden,Medisch Centrum Leeuwaarden +6433,,9097f9b3-18cf-412c-acf5-028d84483665,Pharmazeutische Fabrik Evers & Co. GmbH,pharmazeutische_fabrik_evers_co_gmbh,,,,,, +6434,,dc05e43a-4a7d-4856-aa2f-c12522c510f4,CHU Saint-Etienne,chu_saint_etienne,,,,,, +6435,,87fc86db-37f6-4af1-8b5a-a59ebf5a4178,"Acusphere, Inc",acusphere_inc,,,,,, +6436,,fb58e5df-f6b8-44f2-87d2-1a7791f74db0,"Dept. of Neurology, Atrium Medical Centre",dept_of_neurology_atrium_medical_centre,,,,,, +56,0.98503333330154419,9078130e-eeb6-4d4a-9b3b-bf9f3a7082c5,Radboud University Nijmegen Medical Centre,radboud_university_nijmegen_medical_centre,,,,9078130e-eeb6-4d4a-9b3b-bf9f3a7082c5,radboud_university_nijmegen_medical_centre,Radboud University Nijmegen Medical Centre +6437,,72df664c-a842-48f0-a84e-5607d0cdec38,Walton Centre for Neurology and Neurosurgery,walton_centre_for_neurology_and_neurosurgery,,,,,, +6438,,3da2c9fe-71a3-11e6-a0cd-0242ac12000b,JANSSEN RES AND DEV,janssen_res_and_dev,,,,,, +6439,,ab458087-8c3a-4f58-bd60-5396c128e80b,COPSAC,copsac,,,,,, +209,0.960275,96c9d60f-aaeb-4452-901a-dddf22084636,FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO MILANO,fondazione_irccs_ca_granda_ospedale_maggiore_policlinico_milano,,,,2b67170d-4f17-4648-9c58-deeb978a3eb3,fondazione_irccs_ca_granda_ospedale_maggiore_policlinico_di_milano,FONDAZIONE IRCCS CA` GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO +6440,,1e2b196e-0da4-4848-b0c7-54521b293aeb,"Ariston Pharmaceuticals, Inc",ariston_pharmaceuticals_inc,,,,,, +6441,,03ddae74-91b3-49a7-869d-85aca302df3c,National Children's Hospital & Trinity College Dublin,national_children_s_hospital_trinity_college_dublin,,,,,, +577,0.96858552098274231,e9abaf6d-ebc5-432c-be97-f7a5c26bd3f9,Wyeth Pharmaceuticals France,wyeth_pharmaceuticals_france,,,,e9abaf6d-ebc5-432c-be97-f7a5c26bd3f9,wyeth_pharmaceuticals_france_wyeth_research_division,"Wyeth Pharmaceuticals France, Wyeth Research Division" +811,0.92396390438079834,1d7a4c7b-13ee-4fa9-9984-684f337fead9,Biogen Idec Research Ltd,biogen_idec_research_ltd,,,,1d7a4c7b-13ee-4fa9-9984-684f337fead9,biogen_idec_research_ltd,Biogen Idec Research Ltd +6442,,9e408621-7bb2-4c5f-8f2c-e23914650d18,Patara Pharma,patara_pharma,,,,,, +6443,,b5afb546-7159-11e6-a0cd-0242ac12000b,AREVA PHARMS,areva_pharms,,,,,, +6444,,d4113d29-846f-4157-afab-657d75f9b7dc,A.I.E.O.P,a_i_e_o_p,,,,,, +6445,,8c1018a2-badb-423f-b94e-c7c8c2b0eb48,"FONDAZIONE ITALIANA ""LEONARDO GIAMBRONE""PER LA GUARIGIONE DALLA TALASSEMIA - ONLUS",fondazione_italiana_leonardo_giambrone_per_la_guarigione_dalla_talassemia_onlus,,,,,, +620,0.964286,1ea7f82f-9f53-484a-93fe-2e25f14ea8ee,Technical Unversity of Munich,technical_unversity_of_munich,,,,1ea7f82f-9f53-484a-93fe-2e25f14ea8ee,technical_unversity_of_munich,Technical Unversity of Munich +6446,,8e40ecab-19cb-4f1e-aab7-84df7fa0e2b1,GlaxoSmithKiline Research and Development,glaxosmithkiline_research_and_development,,,,,, +6447,,21d9a9e7-1f0f-4318-ae70-9bf575090bdf,PannonPharma Ltd,pannonpharma_ltd,,,,,, +6448,,4222702a-6ac9-401c-9e2a-0920a742de49,Rijnstate ziekenhuis,rijnstate_ziekenhuis,,,,,, +6449,,144c6cdc-71bb-11e6-a0cd-0242ac12000b,FRANKLIN PHARMS,franklin_pharms,,,,,, +185,0.907369,103d48aa-e045-481f-9c54-07b97fc6c2c2,St James Hospital,st_james_hospital,,,,103d48aa-e045-481f-9c54-07b97fc6c2c2,st_james_hospital,St James Hospital +417,0.988695,8da96a38-2d6c-4cbb-9351-628c3c92a1ed,ISTITUTI FISIOTERAPICI OSPITALIERI,istituti_fisioterapici_ospitalieri,,,,8da96a38-2d6c-4cbb-9351-628c3c92a1ed,istituti_fisioterapici_ospitalieri,ISTITUTI FISIOTERAPICI OSPITALIERI +6450,,8bcce464-6464-46a1-9253-77ebad22020c,Aventis Pharma Ltd trading as sanofi-aventis,aventis_pharma_ltd_trading_as_sanofi_aventis,,,,,, +6451,,9989681f-b82e-472a-94f6-57dcd3a42bb7,"St. Josef-Hospital, Ruhr University, Bochum",st_josef_hospital_ruhr_university_bochum,,,,,, +6452,,030e5d68-d634-40af-9287-77cff6deea58,"R&D department, Hull and East Yorkshire Hospitals NHS Trust",r_d_department_hull_and_east_yorkshire_hospitals_nhs_trust,,,,,, +6453,,6b5ca3e0-7d43-41b0-a97e-561080cf2193,ADENOBIO N.V,adenobio_n_v,,,,,, +6454,,1573e7cf-a7bd-11e6-94cb-5656d04fc2b5,HUS-The Hospital District of Helsinki and Uusimaa,hus_the_hospital_district_of_helsinki_and_uusimaa,,,,,, +6455,,f31847e3-873e-4ee3-8234-b6c5503d6a6d,"Coherus BioSciences, Inc",coherus_biosciences_inc,,,,,, +6456,,98e4a8e5-b48f-4946-ab0e-590ab4f35817,Inserm-ANRS,inserm_anrs,,,,,, +829,0.980992,49311101-9fd1-4902-b91d-e36e1f2e30c2,OSPEDALE G.PASQUINUCCI-FONDAZIONE TOSCANA GABRIELE MONASTERIO/CNR,ospedale_g_pasquinucci_fondazione_toscana_gabriele_monasterio_cnr,,,,49311101-9fd1-4902-b91d-e36e1f2e30c2,ospedale_g_pasquinucci_fondazione_toscana_gabriele_monasterio_cnr,OSPEDALE G.PASQUINUCCI-FONDAZIONE TOSCANA GABRIELE MONASTERIO/CNR +6457,,500beea0-e401-4087-a045-11ee15fd26a1,Lluita contra la Sida Foundation,lluita_contra_la_sida_foundation,,,,,, +6458,,66dd30dc-663b-437e-bfbc-8c87fcfb4915,"Universitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Wien",universit_tsklinik_f_r_kinder_und_jugendheilkunde_medizinische_universit_t_wien,,,,,, +6459,,0caf6105-6ad3-46a8-8508-569eeb81d41e,"University of Athens, Medical School",university_of_athens_medical_school,,,,,, +6460,,151686d6-7164-11e6-a0cd-0242ac12000b,JIANGSU HENGRUI MED,jiangsu_hengrui_med,,,,,, +6461,,f506c7de-46f1-4bf5-ac78-1ed9de2bf613,"MedImmune Limited, a wholly owned subsidiary of AstraZeneca",medimmune_limited_a_wholly_owned_subsidiary_of_astrazeneca,,,,,, +1009,0.98486357927322388,d1eb2280-7146-11e6-a0cd-0242ac12000b,MCNEIL CONS,mcneil_cons,,,,85199c3a-719f-11e6-a0cd-0242ac12000b,mcneil_consumer,MCNEIL CONSUMER +6462,,a78bfc12-7335-11e6-a0cd-0242ac12000b,ENDO VENTURES LTD,endo_ventures_ltd,,,,,, +6463,,e2034d8d-ffdc-4b86-831b-21298073a33c,Meletios Athanasios Dimopoulos,meletios_athanasios_dimopoulos,,,,,, +264,0.969108,4b85caa2-d172-4ab8-beaf-797c52a06782,University or Tromsø,university_or_troms,,,,4b85caa2-d172-4ab8-beaf-797c52a06782,university_or_troms,University or Tromsø +443,0.976266,b56ce5d8-01b1-4592-bda3-d1fb728cc085,Klinikum Grosshadern,klinikum_grosshadern,,,,93ee88e4-8723-494d-86b5-c1f43bbd66c8,klinikum_grosshadern_medical_center_university_of_munich,"Klinikum Grosshadern Medical Center, University of Munich" +6464,,02bb78e2-7129-11e6-a89e-0242ac12000b,NOVEN,noven,,,,,, +6465,,26c0788a-736f-11e6-a0cd-0242ac12000b,ALEXZA PHARMS,alexza_pharms,,,,,, +6466,,c39ff6ba-9bb8-4c4f-845b-29708a7a4093,Renapharma AB,renapharma_ab,,,,,, +6467,,fa9f78bf-d2da-4d4e-b16b-eadac78aaa99,Instituo de Investigacion Sanitaria La Fe,instituo_de_investigacion_sanitaria_la_fe,,,,,, +6468,,3cdb7f3e-73f1-11e6-a0cd-0242ac12000b,PRAXAIR INC,praxair_inc,,,,,, +866,0.97940826416015625,acd534d0-3800-4778-8b81-4a81d24d1012,Hvidovre Hospital,hvidovre_hospital,,,,777eeb1f-10b4-4c96-8d33-42be9c44ad2b,hvidovre_hospital,Hvidovre Hospital +746,0.97187739610671997,048a131a-7874-4cd2-8c53-2320f09741c8,"Johnson & Johnson Pharamceutical Resarch & Development, L.L.C",johnson_johnson_pharamceutical_resarch_development_l_l_c,,,,6067fed3-20a1-48ca-80df-3675d4109505,johnson_johnson_pharamceutical_research_development_l_l_c,"Johnson & Johnson Pharamceutical Research & Development, L.L.C" +6469,,44a783ac-73ce-11e6-a0cd-0242ac12000b,AEGERION,aegerion,,,,,, +6470,,cd2143c6-7158-11e6-a0cd-0242ac12000b,TARO PHARMS IRELAND,taro_pharms_ireland,,,,,, +6471,,be015440-45b9-4dd6-b213-2e1c4b755f00,"AVEO Pharmaceuticals, Inc",aveo_pharmaceuticals_inc,,,,,, +748,0.952392,f78cccd6-09d6-49f2-8b0a-d9e82bf49fe7,"North Bristol NHS Trust, Research and Development",north_bristol_nhs_trust_research_and_development,,,,e18b3cc7-abc6-4eaf-8f2f-60b271d0cb75,north_bristol_nhs_trust_research_and_development_office,North Bristol NHS Trust Research and Development Office +6472,,e55dcd47-fd1d-4904-8bce-41acd43273a8,Jesús Villar Hernández,jes_s_villar_hern_ndez,,,,,, +6473,,c7be4e39-24ec-4a1b-9934-a0bcff6429a9,"Research and Development, Barts and The London NHS Trust",research_and_development_barts_and_the_london_nhs_trust,,,,,, +555,0.98226124048233032,613c1a9b-76b3-42ee-8979-2c8d31737f57,Greater Glasgow and Clyde,greater_glasgow_and_clyde,,,,613c1a9b-76b3-42ee-8979-2c8d31737f57,greater_glasgow_and_clyde_nhs_board,Greater Glasgow and Clyde NHS Board +6474,,1eb2491c-6a4c-4a57-b409-0d66b5c2baba,Movetis NV,movetis_nv,,,,,, +6475,,2b987b17-7fc4-4604-9755-50af216f800d,Per Honore,per_honore,,,,,, +951,0.98241811990737915,2e8e4fb4-3915-4ead-8787-31c5f3981781,"MedImmune, LLC",medimmune_llc,,,,2e8e4fb4-3915-4ead-8787-31c5f3981781,medimmune_llc,"MedImmune, LLC" +6476,,f64f9924-a07c-4845-b1d9-7265eaa29cc0,Ewopharma AG,ewopharma_ag,,,,,, +6477,,1a0b54ee-3c90-4fb0-a495-d2c36bae4a70,Grupo Español de Cáncer de Pulmón,grupo_espa_ol_de_c_ncer_de_pulm_n,,,,,, +6478,,7fe07037-bc2f-422c-8fa0-755ff4ac98bf,"Department of Ophthalmology, Hietzing Hospital",department_of_ophthalmology_hietzing_hospital,,,,,, +710,0.98913925886154175,4c8adf00-5f9a-4177-9cd5-a40768a4ee60,Reckitt Benckiser Pharmaceuticals Inc,reckitt_benckiser_pharmaceuticals_inc,,,,4c8adf00-5f9a-4177-9cd5-a40768a4ee60,reckitt_benckiser_pharmaceuticals_inc,Reckitt Benckiser Pharmaceuticals Inc +6479,,1c4879cc-7142-11e6-a0cd-0242ac12000b,PURDUE GMP,purdue_gmp,,,,,, +6480,,19d36e06-94c8-43db-a390-13cc76749397,Takeda Nederland B.V,takeda_nederland_b_v,,,,,, +6481,,65afcc67-4f1e-403f-b341-5c94fced167f,Janssen L.P,janssen_l_p,,,,,, +326,0.985702,a6dd0849-5d39-4beb-a4dc-0ce8c4928cbe,Servicio de Infecciones. Hospital Clinic de Barcelona,servicio_de_infecciones_hospital_clinic_de_barcelona,,,,14fb99c7-19be-430d-a74a-57408f88725e,servicio_de_infecciones_hospital_cl_nic_de_barcelona,Servicio de Infecciones. Hospital Clínic de Barcelona +6482,,4e3deda9-1788-45b5-9985-2e165726e0b7,Imperial College NHS trust,imperial_college_nhs_trust,,,,,, +6483,,ba94239a-c85f-4b60-b336-92ffa7ddf732,"Department of Psychiatry and Psychotherapy, University of Erlangen-Nuremberg",department_of_psychiatry_and_psychotherapy_university_of_erlangen_nuremberg,,,,,, +6484,,727a78b8-85a6-4c80-858a-d48518eaa0c9,McNeil AB,mcneil_ab,,,,,, +6485,,931614cf-b733-4fb6-ba49-91174665bca0,Mukoviszidose Institute gGmbH,mukoviszidose_institute_ggmbh,,,,,, +6486,,0606e7f5-7ac0-4f5f-a55a-f7cf17dcc5bb,Queen Charlotte's and Chelsea Hospital,queen_charlotte_s_and_chelsea_hospital,,,,,, +106,0.972495,8059cb99-0f16-4274-a2d9-a68b49d57f9b,Amar Agha,amar_agha,,,,39443038-185d-4279-b9d1-588d493613db,amar_agha_beaumont_hospital,"Amar Agha, Beaumont Hospital" +6487,,ede2d7eb-c502-43ce-a0af-af23aed0c855,Hospital Errikos Dunant- Department of Hematology,hospital_errikos_dunant_department_of_hematology,,,,,, +6488,,53bea586-7145-11e6-a0cd-0242ac12000b,SAGENT STRIDES,sagent_strides,,,,,, +6489,,d8691dce-20fd-467c-b00b-45780592e51a,"Research & Development Department, Addenbrookes Hospital",research_development_department_addenbrookes_hospital,,,,,, +6490,,d6a5f690-f26c-4ca8-b846-8e440931d27b,Mette Astrup Madsen,mette_astrup_madsen,,,,,, +6491,,125a85e2-1fea-4cfa-a5fe-c8937f598c0f,UCL Biomedicine R&D Unit,ucl_biomedicine_r_d_unit,,,,,, +6492,,9db72ef2-b4d4-43ef-b404-77813fbae453,VAS VASCULAR INDEPENDENT RESEACH AND EDUCATION EUROPEAN ORGANIZATION. C/O UNIV MILANO. OSP. L. SACCO,vas_vascular_independent_reseach_and_education_european_organization_c_o_univ_milano_osp_l_sacco,,,,,, +265,0.969508,838b627a-58f2-439a-ad85-0aea14ef3815,Institut Paoli-Calmettes,institut_paoli_calmettes,,,,1f93290f-c593-4d33-b455-91f1096af905,institut_paoli_calmette,Institut Paoli Calmette +6493,,e866cdc8-7161-11e6-a0cd-0242ac12000b,DEPROCO,deproco,,,,,, +6494,,37373aac-73b8-11e6-a0cd-0242ac12000b,B BRAUN MEDICAL INC,b_braun_medical_inc,,,,,, +6495,,999211de-e9f2-44f5-a3b9-b9719ab28be9,"Genocea Biosciences, Inc",genocea_biosciences_inc,,,,,, +6496,,eaeaa850-d1f6-40f5-98f4-0e8e212612c9,IOULIA & IRENE TSETI PHARMACEUTICAL LABORATORIES S.A.-INTERMED S.A,ioulia_irene_tseti_pharmaceutical_laboratories_s_a_intermed_s_a,,,,,, +6497,,4866127f-9ab3-4479-ac03-78d082aa8318,Serono International S.A,serono_international_s_a,,,,,, +6498,,069e15a0-b4ad-4368-92bc-c1f9d7a242c5,"University of Leuven Hospitals, Division of Gastroenterology",university_of_leuven_hospitals_division_of_gastroenterology,,,,,, +6499,,aaee2c42-7e1b-40cf-b267-092fc2765751,"Department für Pädiatrie, Medizinische Universität Innsbruck",department_f_r_p_diatrie_medizinische_universit_t_innsbruck,,,,,, +642,0.98837128281593323,49403ff2-36d6-4dad-91ac-59fd2af60030,Boehringer Ingelheim France,boehringer_ingelheim_france,,,,1eaa3c0c-4ecd-4593-886b-6af263dd0c86,boehringer_ingelheim_france,Boehringer Ingelheim France +6500,,5e393d52-7161-11e6-a0cd-0242ac12000b,ASCOT,ascot,,,,,, +6501,,72477cdc-3014-43c0-aa9c-a3c11f678ba5,Debreceni Egyetem Klinikai Központ,debreceni_egyetem_klinikai_k_zpont,,,,,, +1061,0.97933,332fca8d-891e-464f-bf2f-a65f4ecc24d7,A.S.L. 2,a_s_l_2,,,,332fca8d-891e-464f-bf2f-a65f4ecc24d7,a_s_l_2,A.S.L. 2 +6502,,418ca16b-1548-417f-a83f-8c49952fb7f9,Pfizer Global Research & Development,pfizer_global_research_development,,,,,, +720,0.9764975905418396,83d8194e-71e2-11e6-a0cd-0242ac12000b,OTSUKA,otsuka,,,,83d8194e-71e2-11e6-a0cd-0242ac12000b,otsuka,OTSUKA +6503,,9a928883-62f4-40e8-bf1e-c36ca297350b,"Imperial College London, Joint Research Compliance Office",imperial_college_london_joint_research_compliance_office,,,,,, +335,0.9851,80f6c66c-796e-4832-a021-2b15e0df6ad8,Fakultní nemocnice Ostrava,fakultn_nemocnice_ostrava,,,,63ca855a-0f57-4a87-972b-5334fae84ddf,fakultn_nemocnice_ostrava_czech_republic,"Fakultní nemocnice Ostrava,Czech Republic" +402,0.981186,b864ee6b-f5d7-4f18-a0ed-6ad119ce7d88,"AGO Research GmbH, AGO Study Group",ago_research_gmbh_ago_study_group,,,,b864ee6b-f5d7-4f18-a0ed-6ad119ce7d88,ago_research_gmbh_ago_study_group,"AGO Research GmbH, AGO Study Group" +6504,,a1c04b90-142d-4657-a2be-640b684cc3a7,"Interní grantová agentura, Ministerstvo zdravotnictví ČR",intern_grantov_agentura_ministerstvo_zdravotnictv_r,,,,,, +6505,,d2928c4b-c347-4dea-a326-e261e2d799de,"AstraZeneca Farmacéutica Spain, S.A",astrazeneca_farmac_utica_spain_s_a,,,,,, +6506,,baebc3e0-933d-45f6-a990-2a40bd97e19f,REGENSBURG UNIVERSITY MEDICAL CENTRE,regensburg_university_medical_centre,,,,,, +6507,,0fac54ec-715e-11e6-a0cd-0242ac12000b,COBALT LABS INC,cobalt_labs_inc,,,,,, +496,0.98474764823913574,869f3466-39ec-465e-891d-ffce2dc10b2b,Martin-Luther-Universität Halle-Wittenberg,martin_luther_universit_t_halle_wittenberg,,,,5c05fa95-0c90-4777-be79-ea6ecfc023ea,martin_luther_universit_t_halle_wittenberg_vertreten_durch_den_kanzler,"Martin-Luther-Universität Halle-Wittenberg, vertreten durch den Kanzler" +6508,,6ae58c6e-2e65-4a82-a30e-555035c0881d,"Laboratórios Pfizer, Lda",laborat_rios_pfizer_lda,,,,,, +6509,,8b4343ec-fb2f-4fb9-aa9f-044d60e28926,"Hull and east Yorkshire Hospitals Trust, Research and Deveopment, admin porta cabin",hull_and_east_yorkshire_hospitals_trust_research_and_deveopment_admin_porta_cabin,,,,,, +1067,0.987607,10ff3385-cf4c-44ce-8eb9-d60620664cbb,Generex Biotechnology Corp,generex_biotechnology_corp,,,,10ff3385-cf4c-44ce-8eb9-d60620664cbb,generex_biotechnology_corp,Generex Biotechnology Corp +6510,,53feedaf-8530-4d67-b488-2f1cb3e60ef6,Endocrine Society of Czech Republic,endocrine_society_of_czech_republic,,,,,, +6511,,5329b052-c85a-430f-8bca-02d12395b28c,Pneumologia c/o Villa Pineta,pneumologia_c_o_villa_pineta,,,,,, +1057,0.98656213283538818,080946bd-1123-4c27-9ea3-501e78d94d82,Pfizer Hellas SA,pfizer_hellas_sa,,,,080946bd-1123-4c27-9ea3-501e78d94d82,pfizer_hellas_sa,Pfizer Hellas SA +6512,,af329b77-fe20-4101-a258-2b4d48edc2cf,BioMimetic Therapeutic Inc,biomimetic_therapeutic_inc,,,,,, +6513,,49b54fc1-62e5-4727-b7ec-d3582a6b856a,SIAK,siak,,,,,, +6514,,a87d8a02-a768-11e6-94cb-5656d04fc2b5,"Department of Oral Surgery Dental School Med. Univ. Graz, Austria",department_of_oral_surgery_dental_school_med_univ_graz_austria,,,,,, +6515,,119fa7fd-18c0-4631-abea-242c1ee67a1e,Cytheris S.A,cytheris_s_a,,,,,, +6516,,f2b1cda0-d544-4b0b-be3d-0fcf26685da9,Curalogic A/S,curalogic_a_s,,,,,, +6517,,b0720067-a732-11e6-94cb-5656d04fc2b5,"Center for Diabetes Research, Gentofte Hospital",center_for_diabetes_research_gentofte_hospital,,,,,, +253,0.94460948308308923,672dbadc-6cff-4f5d-8ce1-7dbea1dddc99,"Instituto Cientí­fico y Tecnológico de Navarra, S.A",instituto_cient_fico_y_tecnol_gico_de_navarra_s_a,,,,4a176b41-c873-44ad-8442-a2e57b0b4289,instituto_cient_fico_y_tecnol_gico_de_navarra,Instituto Científico y Tecnológico de Navarra +598,0.98780262470245361,112df4bf-757e-4212-a536-a3908a697c4b,University College London (UCL),university_college_london_ucl,,,,112df4bf-757e-4212-a536-a3908a697c4b,university_college_london_ucl,University College London (UCL) +885,0.98101651668548584,5821cf6c-5e8a-481f-8ff8-3198a9183cea,Pharma Mar SA,pharma_mar_sa,,,,5821cf6c-5e8a-481f-8ff8-3198a9183cea,pharma_mar_sa,Pharma Mar SA +914,0.96143,8dc209bc-546d-4999-86f7-43245f5c50ff,TAYS,tays,,,,8dc209bc-546d-4999-86f7-43245f5c50ff,tays,TAYS +6518,,0d9bc368-fb23-479f-bbeb-e8734ca7be53,Clínica del Dr. Lobatón,cl_nica_del_dr_lobat_n,,,,,, +6519,,7579525e-beab-4413-9457-f5af70db3e11,Geron Corporation,geron_corporation,,,,,, +338,0.944177,59161c21-f110-4f6b-bf67-f4d922ff5a94,Medizinische Fakultät der Universität Rostock,medizinische_fakult_t_der_universit_t_rostock,,,,59161c21-f110-4f6b-bf67-f4d922ff5a94,medizinische_fakult_t_der_universit_t_rostock,Medizinische Fakultät der Universität Rostock +6520,,6c7a0908-a1fc-4d80-8e4d-405dbf2e9463,Catharina Hospital Eindhoven,catharina_hospital_eindhoven,,,,,, +6521,,ccc4ef7f-92dc-414a-9505-a37729060983,Nycomed Austria GmbH,nycomed_austria_gmbh,,,,,, +6522,,e1b1c73c-7146-11e6-a0cd-0242ac12000b,SCS,scs,,,,,, +6523,,cfe05250-4c8a-44b5-b686-13135c69ec88,Laboratoires Merck Sharp & Dhome-Chibret,laboratoires_merck_sharp_dhome_chibret,,,,,, +6524,,bddd4072-b30d-46e0-9d43-a56f08fa47bc,CHU DIJON,chu_dijon,,,,,, +910,0.97229477763175964,2ff031e3-15e0-4408-84d2-974f9250a92c,Laboratorios Servier S.L. (For Spain only),laboratorios_servier_s_l_for_spain_only,,,,32161af5-1f02-447e-a38b-e0f0858697d7,laboratorios_servier,Laboratorios Servier +6525,,23b89241-887e-4d0d-9a53-3d77c667a500,University Medical Center Freiburg,university_medical_center_freiburg,,,,,, +6526,,983be2d6-8899-450f-861e-42a25a2ba013,"Celgene International II Sàrl (CIS II), a wholly owned subsidiary of Celgene Corporation",celgene_international_ii_s_rl_cis_ii_a_wholly_owned_subsidiary_of_celgene_corporation,,,,,, +575,0.946558,2848a4da-8be7-11e6-a449-0242ac12000b,Oslo University Hospital Health Trust,oslo_university_hospital_health_trust,,,,28440dc6-8be7-11e6-a449-0242ac12000b,oslo_university_hospital_healt_trust,Oslo University Hospital healt Trust +6527,,640071c9-fca9-4c44-9f2b-0631d984d9c9,"Emergent Product Development Seattle, LLC",emergent_product_development_seattle_llc,,,,,, +6528,,ddb4ffd4-cf05-4ad9-a1a8-2039792f0bf4,Ramón Cañete Estrada,ram_n_ca_ete_estrada,,,,,, +6529,,da3303a3-de9f-45f0-8e68-0f3f1d2e6e33,"Unigene Laboratories, Inc",unigene_laboratories_inc,,,,,, +253,0.95808978875478112,49f7eb37-f6bc-4ed0-a66b-da7d0aa9452e,Instituto Cientifico y Tecnologico de Navarra,instituto_cientifico_y_tecnologico_de_navarra,,,,4a176b41-c873-44ad-8442-a2e57b0b4289,instituto_cient_fico_y_tecnol_gico_de_navarra,Instituto Científico y Tecnológico de Navarra +6530,,a7bf81fa-e3c6-48f0-a1aa-931449fa9850,Universitätsklinikum der RWTH Aachen - Ärztlicher Direktor Univ.-Prof. Dr. H. Sass,universit_tsklinikum_der_rwth_aachen_rztlicher_direktor_univ_prof_dr_h_sass,,,,,, +6531,,599ee111-ca9a-4121-85ef-8dd459c45419,University of East Anglia,university_of_east_anglia,,,,,, +6532,,bc8794b0-754a-4f49-a01c-3020c6c60899,"Amersham Health, S.A. como filial de GE Healthcare Limited",amersham_health_s_a_como_filial_de_ge_healthcare_limited,,,,,, +6533,,b291492b-d6bc-48ca-be0c-8d2380f77a26,Fundación Hospital Clinic i Provincial,fundaci_n_hospital_clinic_i_provincial,,,,,, +0,0.982418,ae7401a6-5748-45c3-a5b1-4f5e93d0e171,"Morphotek, Inc",morphotek_inc,,,,5f4adcd3-a8a4-4ad8-bcc3-14aa5dc4d3e0,morphotek,Morphotek +575,0.946558,28440dc6-8be7-11e6-a449-0242ac12000b,Oslo University Hospital healt Trust,oslo_university_hospital_healt_trust,,,,28440dc6-8be7-11e6-a449-0242ac12000b,oslo_university_hospital_healt_trust,Oslo University Hospital healt Trust +6534,,37c4b226-a5cf-4dae-b111-998db7c54f34,"Epizyme, Inc",epizyme_inc,,,,,, +6535,,32727a2b-4240-447e-a435-4f278330c364,"Tetraphase Pharmaceuticals, Inc",tetraphase_pharmaceuticals_inc,,,,,, +551,0.9728655219078064,3ae4acff-8257-4636-ad28-752d276490e5,"Freistaat Bayern, represented by Universität Regensburg",freistaat_bayern_represented_by_universit_t_regensburg,,,,0aa6ecae-1a53-4cf9-8648-924415ffb218,freistaat_bayern,Freistaat Bayern +198,0.98829472064971924,a1f882cc-4aed-44a9-8d73-7258767372d7,Agence nationale de recherches sur le sida et les hépatites virales,agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales,,,,59af07b2-8bdc-4113-8ce3-1b459956f500,agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales,Agence nationale de recherches sur le sida et les hépatites virales +85,0.979515,32d4a4cc-7142-11e6-a0cd-0242ac12000b,PERRIGO CO TENNESSEE,perrigo_co_tennessee,,,,32d4a4cc-7142-11e6-a0cd-0242ac12000b,perrigo_co_tennessee,PERRIGO CO TENNESSEE +6536,,1a36c257-2e1b-4639-80fe-2f034cc4a8f1,"Herlev University Hospital, Oncology Dept",herlev_university_hospital_oncology_dept,,,,,, +6537,,2a8f39a4-7362-11e6-a0cd-0242ac12000b,PIERREL,pierrel,,,,,, +6538,,16100785-ef81-4f01-9402-c0eb960b73ec,Gentium S.p.A,gentium_s_p_a,,,,,, +545,0.987705,4f5eb84e-1410-49da-8e9d-2b096a9a7341,HOSPITAL UNIVERSITARI DE BELLVITGE,hospital_universitari_de_bellvitge,,,,302c2638-8bd6-11e6-a449-0242ac12000b,hospital_universitari_de_bellvitge_idibell,HOSPITAL UNIVERSITARI DE BELLVITGE - IDIBELL +6539,,b1a426c0-c9d0-47f6-8f86-ce31d7fcd033,GlaxoSmithKline Biologicals - GSK China Vaccines,glaxosmithkline_biologicals_gsk_china_vaccines,,,,,, +6540,,21b82789-d7e2-407f-886b-2a1cddca1c44,Frimley Park Hospital,frimley_park_hospital,,,,,, +6541,,b85f832e-b618-4b41-a8c5-b4316be5ab91,North Essex Partnership NHS Foundation Trust,north_essex_partnership_nhs_foundation_trust,,,,,, +6542,,65f21210-caf4-4c6c-8362-c88d39c27a14,Raimo Tuuminen,raimo_tuuminen,,,,,, +6543,,bdebe208-b148-4742-a5b3-5a01d04bd9b7,Multiplex Pharma Holdings LLC,multiplex_pharma_holdings_llc,,,,,, +6544,,22bc4a03-0152-4689-a444-4605087f69c5,"Department of women's and Children's health, Uppsala University",department_of_women_s_and_children_s_health_uppsala_university,,,,,, +6545,,ba28857c-2053-4532-b5d1-b9692500ee19,ORPHANETICS Pharma Entwicklungs- GmbH,orphanetics_pharma_entwicklungs_gmbh,,,,,, +314,0.98565453290939331,0c6b6aec-6007-4be6-917b-e3ac534e2858,Mundipharma,mundipharma,,,,0c6b6aec-6007-4be6-917b-e3ac534e2858,mundipharma,Mundipharma +6546,,987c907e-2553-4050-8e5e-022c906a96b2,"Medical Centre of Postgraduate Education, Poland",medical_centre_of_postgraduate_education_poland,,,,,, +6547,,6a3fe440-1f93-415d-af89-c3263a52ec2c,Univeristy of Milano-Bicocca,univeristy_of_milano_bicocca,,,,,, +134,0.984688,76fec111-82e4-485f-8b4f-67c48f13862f,University Hospitals Bristol NHS Foundation Trust Research and Innovation Department,university_hospitals_bristol_nhs_foundation_trust_research_and_innovation_department,,,,61bbf47c-775e-4ef4-9782-861df4424a72,university_hospitals_bristol_nhs_foundation_trust,University Hospitals Bristol NHS Foundation Trust +6548,,d31112d2-3dce-4a0a-be46-18af0f3b6d22,"Merck, Sharpe & Dohme Corp., a subsidiary of Merck & Co. Inc (hereafter referred to as Merck)",merck_sharpe_dohme_corp_a_subsidiary_of_merck_co_inc_hereafter_referred_to_as_merck,,,,,, +6549,,be403ff7-a864-4dcb-ad21-a089702dba5c,Merus B.V,merus_b_v,,,,,, +6550,,eca94eac-9e5a-49d3-a1a0-e24d853a75c0,Guy's & St. Thomas' NHS Foundation Trust,guy_s_st_thomas_nhs_foundation_trust,,,,,, +6551,,f60df364-714f-11e6-a0cd-0242ac12000b,VPNA,vpna,,,,,, +908,0.94523629546165466,6bd628da-1d32-4991-9bda-bc309b439e53,sanofi-aventis Recherche & Dévelopment,sanofi_aventis_recherche_d_velopment,,,,9c45d693-515d-4149-92e4-d7272d06a7df,sanofi_aventis_recherche_d_veloppement,sanofi-aventis Recherche & Développement +6552,,45052c66-7142-11e6-a0cd-0242ac12000b,PUREPAC PHARM,purepac_pharm,,,,,, +6553,,a2fa33c5-169a-4580-9797-d95360063225,Charité - University Hospital Berlin,charit_university_hospital_berlin,,,,,, +6554,,0278e061-53bd-49c3-8620-381a25a1811f,Universityhospital of Heidelberg,universityhospital_of_heidelberg,,,,,, +33,0.98417317867279053,a5f26061-0a6f-4fd1-83b7-6557b7c1b6d1,Department of Endocrinology,department_of_endocrinology,,,,a5f26061-0a6f-4fd1-83b7-6557b7c1b6d1,department_of_endocrinology,Department of Endocrinology +763,0.970018,20d8ecc2-872e-4d93-9419-6e3e20fea29f,Danish Multiple Sclerosis Research Centre,danish_multiple_sclerosis_research_centre,,,,20d8ecc2-872e-4d93-9419-6e3e20fea29f,danish_multiple_sclerosis_research_centre,Danish Multiple Sclerosis Research Centre +6555,,53835a58-7145-11e6-a0cd-0242ac12000b,ALKEM LABS LTD,alkem_labs_ltd,,,,,, +999,0.984336,2851af76-cc6a-41a0-a263-399d40b7eb15,Birmingham Children's Hospital NHS Foundation Trust,birmingham_children_s_hospital_nhs_foundation_trust,,,,2851af76-cc6a-41a0-a263-399d40b7eb15,birmingham_children_s_hospital_nhs_foundation_trust,Birmingham Children's Hospital NHS Foundation Trust +6556,,ddf1661e-73fa-11e6-a0cd-0242ac12000b,TAIHO ONCOLOGY,taiho_oncology,,,,,, +544,0.978652,3e5070ce-7142-11e6-a0cd-0242ac12000b,BRISTOL,bristol,,,,3e5070ce-7142-11e6-a0cd-0242ac12000b,bristol,BRISTOL +6557,,bc70263e-715b-11e6-a0cd-0242ac12000b,PROVIDENT PHARM,provident_pharm,,,,,, +69,0.989009,2bcb0c19-b4b9-4f7c-9d21-fb61445071f3,"Schering Corporation, división Schering-Plough Research Institute",schering_corporation_divisi_n_schering_plough_research_institute,,,,2bcb0c19-b4b9-4f7c-9d21-fb61445071f3,schering_corporation_divisi_n_schering_plough_research_institute,"Schering Corporation, división Schering-Plough Research Institute" +6558,,97736042-d099-44c1-bccd-316be636b5d3,University Medicine Goettingen,university_medicine_goettingen,,,,,, +6559,,c9cd6080-9e28-463c-aacf-48029351d207,"MedImmune, Ltd, a wholly owned subsidiary of AstraZeneca UK",medimmune_ltd_a_wholly_owned_subsidiary_of_astrazeneca_uk,,,,,, +6560,,ef709a83-9c9e-4352-9eff-550e8f00a388,"Medizinische Universitaet Wien, Universitaetsklinik für Radiologie und Nuklearmedizin",medizinische_universitaet_wien_universitaetsklinik_f_r_radiologie_und_nuklearmedizin,,,,,, +6561,,3b927722-55b1-4b6b-93f6-a7b096071b83,AZIENDA OSPEDALIERA S. CARLO,azienda_ospedaliera_s_carlo,,,,,, +6562,,0f02577c-7167-11e6-a0cd-0242ac12000b,HAINAN POLY PHARMA CO LTD,hainan_poly_pharma_co_ltd,,,,,, +6563,,585982bc-7165-11e6-a0cd-0242ac12000b,BAYSHORE PHARMS LLC,bayshore_pharms_llc,,,,,, +6564,,3363cb70-3bd5-4259-aa0f-ed52850556e8,A. MENARINI I.F.R,a_menarini_i_f_r,,,,,, +6565,,4208254f-fefa-437b-859f-0d63aae3154f,Dept of ped hem/onc,dept_of_ped_hem_onc,,,,,, +6566,,ec35d57e-8bc5-11e6-a449-0242ac12000b,"Department of Oncology, Herlev Hospital",department_of_oncology_herlev_hospital,,,,,, +6567,,68af1d11-232f-4917-887e-950c168c726d,TETEC AG,tetec_ag,,,,,, +6568,,1b0f3e62-72b2-11e6-a0cd-0242ac12000b,VYTERIS,vyteris,,,,,, +6569,,dbd49db9-d73c-4dba-b94f-9ac664dea5b2,Novartis Consumer Health S.A,novartis_consumer_health_s_a,,,,,, +313,0.97367525100708008,d94a5eb6-cc98-4004-a7a3-95cf39383b18,GlaxoSmithKline Biologicals,glaxosmithkline_biologicals,,,,d94a5eb6-cc98-4004-a7a3-95cf39383b18,glaxosmithkline_biologicals,GlaxoSmithKline Biologicals +6570,,5ad221ec-2777-48b2-b450-026a456ddf9c,Abbott GmbH &, Co. KG,,,,,, +6571,,1527feba-7192-11e6-a0cd-0242ac12000b,MALLINCKRODT ARD,mallinckrodt_ard,,,,,, +6572,,dfae6deb-1cd2-4420-98b2-7a65cfb8b482,"Five Prime Therapeutics, Inc",five_prime_therapeutics_inc,,,,,, +6573,,ea9aa16a-977c-430a-a3b9-2842ad9d53d3,Biolipox AB,biolipox_ab,abbott_gmbh_amp_co_kg,,,,, +6574,,e6647b1c-8003-43e4-9cc2-eb8734e8b420,"PREMACURE AB, A MEMBER OF SHIRE GROUP OF COMPANIES",premacure_ab_a_member_of_shire_group_of_companies,,,,,, +6575,,ee868835-c082-4942-9109-6800f4c67b2e,Pharmaxis Pharmaceuticals Limited,pharmaxis_pharmaceuticals_limited,,,,,, +6576,,cb2d0027-0145-449c-bbbd-1cc6bd097c6f,AS.T.R.O,as_t_r_o,,,,,, +6577,,e5a7a91e-8bc8-11e6-a449-0242ac12000b,"Anders Nyboe Andersen, klinikchef, dr. med., Fertilitetsklinikken afsnit 4071, Rigshospitalet",anders_nyboe_andersen_klinikchef_dr_med_fertilitetsklinikken_afsnit_4071_rigshospitalet,,,,,, +6578,,430e11cd-5054-4d80-b3d7-f645e3eff6a6,MEDAC RESEARCH,medac_research,,,,,, +6579,,449f4753-2c74-4a20-8b0b-15a8b29e5164,Astellas Pharma Europe Limited,astellas_pharma_europe_limited,,,,,, +6580,,4b82adb2-7344-11e6-a0cd-0242ac12000b,NIAGARA PHARMS,niagara_pharms,,,,,, +6581,,8ec25ab7-d009-4a0d-8011-9095f895cf3b,UMCU,umcu,,,,,, +6582,,ef6b5a01-3ea3-49eb-a2df-d9a84f81be5e,Aintree Hospitals NHS Trust and University of Liverpool,aintree_hospitals_nhs_trust_and_university_of_liverpool,,,,,, +6583,,e177d3d5-db33-496d-bf8b-e734b7f866dc,"Actelion Pharmaceuticals US, Inc",actelion_pharmaceuticals_us_inc,,,,,, +436,0.96070769429206848,25203332-c6eb-4eda-87c7-a780f5142133,"Pfizer Inc., 235 East 42nd Street, New York, 10017, United States",pfizer_inc_235_east_42nd_street_new_york_10017_united_states,,,,25203332-c6eb-4eda-87c7-a780f5142133,pfizer_inc_235_east_42nd_street_new_york_ny10017_united_states,"Pfizer Inc., 235 East 42nd Street, New York, 10017, United States" +6584,,20f359c6-0732-4d50-a3cf-68d2dda156aa,Azienda Ospedaliera Universitaria S.Martino - U.O. Oncologia Medica - Genova,azienda_ospedaliera_universitaria_s_martino_u_o_oncologia_medica_genova,,,,,, +6585,,c8dae27b-0837-44f4-acb9-4eb9ca010cdf,Hospital Comarcal de Laredo. Sección de Digestivo,hospital_comarcal_de_laredo_secci_n_de_digestivo,,,,,, +747,0.987246,61d9cb36-84e8-4785-a622-4f2f20464069,Universitaetsklinikum Erlangen,universitaetsklinikum_erlangen,,,,61d9cb36-84e8-4785-a622-4f2f20464069,universitaetsklinikum_erlangen,Universitaetsklinikum Erlangen +968,0.97809287905693054,e5d4a9c1-e0e4-4ac7-8c88-785f0f8e3beb,Maatschap Cardiologie Isala,maatschap_cardiologie_isala,,,,e5d4a9c1-e0e4-4ac7-8c88-785f0f8e3beb,maatschap_cardiologie_isala_klinieken,Maatschap Cardiologie Isala klinieken +6586,,d775ddf9-4eed-419c-a8ed-a98d3656098a,Immuno-Designed Molecules,immuno_designed_molecules,,,,,, +933,0.97951988379160559,e26f58e7-f0e7-4ad4-9432-e13ea279b291,Pierre Fabre,pierre_fabre,,,,e26f58e7-f0e7-4ad4-9432-e13ea279b291,pierre_fabre,Pierre Fabre Médicament +6587,,b03e3897-0094-499b-b171-ffe24a8315b1,Szpital im. Jana Pawla II,szpital_im_jana_pawla_ii,,,,,, +6588,,8734f99c-05ca-42b1-8be0-1e420f7a92fc,"Dept. of Psychiaty, University of Freiburg",dept_of_psychiaty_university_of_freiburg,,,,,, +6589,,d08a67f5-4903-4af4-a318-1a91971ad887,Mylan Pharma UK Ltd,mylan_pharma_uk_ltd,,,,,, +6590,,5f15f2ea-4aa7-4660-81d5-dc02c5199612,Grupo de Investigação do Cancro Digestivo,grupo_de_investiga_o_do_cancro_digestivo,,,,,, +6591,,9de26bd0-1822-43da-862b-19b9cd9a34a6,NAMED SRL,named_srl,,,,,, +661,0.988375,e15edbf4-2f93-4ee5-b9aa-da446c1209d0,BioCryst Pharmaceuticals Inc,biocryst_pharmaceuticals_inc,,,,e15edbf4-2f93-4ee5-b9aa-da446c1209d0,biocryst_pharmaceuticals_inc,BioCryst Pharmaceuticals Inc +6592,,af7720f4-15df-4ceb-a637-e9b9db8c3d46,Malmoe University Hospital,malmoe_university_hospital,,,,,, +6593,,5e5e4d8a-51df-4a8a-b216-71028c12a01a,Donesta Bioscience BV,donesta_bioscience_bv,,,,,, +6594,,0076cf1f-dff2-4386-8e41-ede0c2f76c04,"Medizinische Universität Innsbruck, Abteilung für Nuklearmedizin",medizinische_universit_t_innsbruck_abteilung_f_r_nuklearmedizin,,,,,, +940,0.988452,f6959636-eb34-484b-8514-f49f9e548af3,"Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunersches Kinderspital",klinikum_der_universit_t_m_nchen_kinderklinik_und_poliklinik_im_dr_von_haunersches_kinderspital,,,,7c1e9a67-0589-4d28-bf1e-a81d74f16a46,klinikum_der_universit_t_m_nchen_kinderklinik_und_poliklinik_im_dr_von_haunerschen_kinderspital,"Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunerschen Kinderspital" +50,0.902909,098236a3-98ed-47c3-8dcd-a916a201d337,EUSA Pharma,eusa_pharma,,,,098236a3-98ed-47c3-8dcd-a916a201d337,eusa_pharma,EUSA Pharma +6595,,934c4f44-8e43-4028-b671-4d9ba99f8e0c,BOC Ltd,boc_ltd,,,,,, +471,0.987664,3162896a-c44b-4bc5-ab15-a97eb8b7517e,South Manchester University Hospitals NHS Trust,south_manchester_university_hospitals_nhs_trust,,,,3162896a-c44b-4bc5-ab15-a97eb8b7517e,south_manchester_university_hospitals_nhs_trust,South Manchester University Hospitals NHS Trust +6596,,b817b3dc-a352-4658-99c9-6584a985f2a5,ImmuPharma SA,immupharma_sa,,,,,, +43,0.978791,d2de3704-c86b-4587-bc51-08837265b2da,Nordic Society of Gynecological Oncology (NSGO),nordic_society_of_gynecological_oncology_nsgo,,,,38b6ac83-2901-4af7-b81e-62ce14bad7cc,nordic_society_of_gynaecological_oncology_nsgo,Nordic Society of Gynaecological Oncology (NSGO) +235,0.96446388959884644,199932d6-c852-48b7-8263-cea5e21e83f6,Novartis Pharma Service AG,novartis_pharma_service_ag,,,,683ca9e5-af11-4524-9288-1bb0932a9588,novartis_pharma_services,Novartis Pharma Services +6597,,85bbc1fe-5278-443d-9dc8-962b70df9e21,GABA GmbH,gaba_gmbh,,,,,, +849,0.97769945859909058,7f715054-2995-4abe-94ad-dfa6443ca063,PFIZER,pfizer,,,,373295c7-9ca2-499a-ae31-52733bea403b,pfizer_slu,"PFIZER, SLU" +6598,,47a62182-dff1-406d-8834-f8e682de0164,"Nora Therapeutics, Inc",nora_therapeutics_inc,,,,,, +6599,,fb2b6360-7152-11e6-a0cd-0242ac12000b,BIO NUCLEONICS,bio_nucleonics,,,,,, +328,0.932685,6f406dab-5805-481d-943e-14127b65646b,Aziende Chimiche Riunite Angelini Francesco S.p.A,aziende_chimiche_riunite_angelini_francesco_s_p_a,,,,5809dce0-1c57-445d-9068-5b5bffdd2080,aziende_chimiche_riunite_angelini_francesco_acraf_s_p_a,Aziende Chimiche Riunite Angelini Francesco - ACRAF S.p.A +6600,,b07beca0-ce90-4b1c-b956-54ed9022766d,Rheinisch-Westfälisch Technische Hochschule Aachen,rheinisch_westf_lisch_technische_hochschule_aachen,,,,,, +6601,,260fa8ab-a4ca-4e96-a8bd-6278bd387dbb,"Lantheus Medical Imaging, Inc",lantheus_medical_imaging_inc,,,,,, +179,0.977461,7307791a-55cf-4462-a41c-9a905939b273,MUTUAL PHARMACEUTICAL COMPANY,mutual_pharmaceutical_company,,,,7307791a-55cf-4462-a41c-9a905939b273,mutual_pharmaceutical_company,MUTUAL PHARMACEUTICAL COMPANY +6602,,a8db3e9f-50b8-4b02-8225-c938898dca66,Sandwell and West Birmingham NHS Trust,sandwell_and_west_birmingham_nhs_trust,,,,,, +576,0.98835551738739014,cc21573f-300a-40f0-a4f8-08ffae6cf7ca,"Wyeth Pharmaceuticals, Global Medical Affairs",wyeth_pharmaceuticals_global_medical_affairs,,,,296373b5-8871-4062-ab94-c1936a5306c2,wyeth_pharmaceuticals_global_medical_affairs_department,"Wyeth Pharmaceuticals, Global Medical Affairs Department" +6603,,21a96078-b915-4b3e-bd5e-e7da607432e4,Ascendis Pharma A/S,ascendis_pharma_a_s,,,,,, +6604,,b378ae87-64e1-4a02-88cb-2a49bc35b776,"GlycoMimetics, Inc",glycomimetics_inc,,,,,, +6605,,1aa821a8-6fa3-11e6-9663-0242ac12000b,Eli Lilly Sweden AB,eli_lilly_sweden_ab,,,,,, +6606,,9247c09e-a4e2-4843-96db-02d93ce1c16f,ANTHERA PHARMACEUTICALS,anthera_pharmaceuticals,,,,,, +6607,,10b14c80-1fac-45a2-840a-fc551f446b88,Diego Caicedo Valdés,diego_caicedo_vald_s,,,,,, +825,0.979838,1bd8b575-4f6d-4564-aa9e-6ea528cb17bb,University of Surrey Clinical Research Centre,university_of_surrey_clinical_research_centre,,,,1bd8b575-4f6d-4564-aa9e-6ea528cb17bb,university_of_surrey_clinical_research_centre,University of Surrey Clinical Research Centre +928,0.975714,87f2de76-726c-11e6-a0cd-0242ac12000b,LG LIFE SCIENCES,lg_life_sciences,,,,87f2de76-726c-11e6-a0cd-0242ac12000b,lg_life_sciences,LG LIFE SCIENCES +888,0.96880727154867985,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,"Schering-Plough Research Institute, a Division of Schering Corporation - for Global trials",schering_plough_research_institute_a_division_of_schering_corporation_for_global_trials,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" +6608,,691cc6fc-c90c-4878-a345-8ecf3743f138,FUNDACION PARA LA INVESTIGACIÓN BIOSANITARIA DE ANDALUCIA ORIENTAL_ FPA,fundacion_para_la_investigaci_n_biosanitaria_de_andalucia_oriental_fpa,,,,,, +6609,,11c7b033-c5ac-465d-b11e-6fd0e48613fb,"Royal Hospital for Sick Children, Glasgow",royal_hospital_for_sick_children_glasgow,,,,,, +6610,,f8ab1c83-4e52-42a9-8758-1490ec255bc1,daacro - diagnostic assessment and clinical research organization,daacro_diagnostic_assessment_and_clinical_research_organization,,,,,, +6611,,de0d8141-1339-4c0b-9443-72b2421247ec,"KRKA, tovarna zdravil, d. d., Novo mesto",krka_tovarna_zdravil_d_d_novo_mesto,,,,,, +6612,,6008f4b9-db21-40c3-96d0-fa6512a77dae,"University Hospital of Frankfurt, Department of Cardiology",university_hospital_of_frankfurt_department_of_cardiology,,,,,, +6613,,2290097d-5a8a-4773-83ec-e7ba2565dd9f,Grupo Español de Oncología Genitourinaria (SOGUG),grupo_espa_ol_de_oncolog_a_genitourinaria_sogug,,,,,, +6614,,449b4f58-7165-11e6-a0cd-0242ac12000b,ACTAVIS PHARMA,actavis_pharma,,,,,, +6615,,105e9968-8061-4d4f-94a3-f1a4c5e28dce,Joaquim Bellmunt Molins,joaquim_bellmunt_molins,,,,,, +6616,,1c87f7f2-7154-11e6-a0cd-0242ac12000b,CR DOUBLE CRANE,cr_double_crane,,,,,, +610,0.97186114390691125,a1e67e69-7e29-4ce5-b94c-82eb0d5252c9,Fédérationa Nationale des Centres de Lutte Contre le Cancer,f_d_rationa_nationale_des_centres_de_lutte_contre_le_cancer,,,,4b5b75aa-a963-452e-848e-256ac41c5d72,f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer,Fédération Nationale des Centres de Lutte Contre le Cancer +6617,,cd6d8a5b-ab33-4fc8-a0f2-4ab2d41d0365,AS Kevelt,as_kevelt,,,,,, +6618,,c5885d39-8c12-4f9b-b3cf-c064a1403351,ALK-ABELLO',alk_abello,,,,,, +6619,,1375fc1e-72b6-11e6-a0cd-0242ac12000b,PROF DSPLS,prof_dspls,,,,,, +500,0.991079,0f951df0-e851-4fc3-9f85-c87f75143477,Hannover Medical School,hannover_medical_school,,,,0f951df0-e851-4fc3-9f85-c87f75143477,hannover_medical_school,Hannover Medical School +6620,,97011f6c-71af-11e6-a0cd-0242ac12000b,ROACO,roaco,,,,,, +6621,,92146c5e-cb7f-4882-a74d-d32e61bb3c79,1. Frauenklinik der LMU- Innenstadt,1_frauenklinik_der_lmu_innenstadt,,,,,, +6622,,d6ffa210-622f-461c-b489-a7c41c7bad5c,"FARMACUSI, S.A",farmacusi_s_a,,,,,, +468,0.987296,055d2f79-6382-44aa-9acf-84a8274892de,Targovax AS,targovax_as,,,,055d2f79-6382-44aa-9acf-84a8274892de,targovax_as,Targovax AS +1031,0.98682358860969543,35980991-cb27-4147-a7f5-46a59beed065,Medical University of Vienna,medical_university_of_vienna,,,,9f76459d-c1a5-4dfd-8ba3-7773bf3ebbce,medical_university_of_vienna_department_of_pediatrics,Medical University of Vienna +6623,,047fc717-1461-4340-af26-a54131404b2b,Servier,servier,,,,,, +6624,,674de28b-04b4-45cd-a3d1-a8dae3df9650,ONO PHARMA UK LTD,ono_pharma_uk_ltd,,,,,, +6625,,1d0b0158-99a1-4316-9672-47db59d82ad0,Institute Jules Bordet,institute_jules_bordet,,,,,, +6626,,646a18e5-6c4a-484a-aaa6-5320887878a8,NOVAGALI Pharma S.A.S,novagali_pharma_s_a_s,,,,,, +6627,,73b7c121-e223-4400-bc26-559bf075b116,LYSA (The Lymphoma Study Association),lysa_the_lymphoma_study_association,,,,,, +6628,,4da92a5f-30ca-43c6-8a4b-3f5e642b1202,"Takeda Vaccines (Montana), Inc",takeda_vaccines_montana_inc,,,,,, +6629,,05bb40e0-92ec-42c3-b636-e7484a15c1e4,Queen Mary Medical University of London,queen_mary_medical_university_of_london,,,,,, +6630,,ffecd170-a525-4c9a-a1fd-234ac834df33,"Med. Univ. Wien, Univ. Klinik für Innere Medizin III, Abt. Gastroenterologie und Hepatologie",med_univ_wien_univ_klinik_f_r_innere_medizin_iii_abt_gastroenterologie_und_hepatologie,,,,,, +259,0.985423,34f3a53c-71a6-11e6-a0cd-0242ac12000b,US WORLDMEDS LLC,us_worldmeds_llc,,,,34f3a53c-71a6-11e6-a0cd-0242ac12000b,us_worldmeds_llc,US WORLDMEDS LLC +6631,,68e6d328-f29e-4e84-8883-7f1799b8385a,Dr. Luis Serra Majem,dr_luis_serra_majem,,,,,, +700,0.931044,e94af6e9-e4f4-4318-93ce-a915794b2ab2,Juan Cordoba,juan_cordoba,,,,71bf9d51-f211-4fcd-b6d2-35dce8b4c292,juan_c_rdoba,Juan Córdoba +6632,,aad98ce5-4622-419e-81bf-f4326f128b64,Professor Anita Leys - Dienst Oftalmologie UZ St. Rafaël,professor_anita_leys_dienst_oftalmologie_uz_st_rafa_l,,,,,, +6633,,c5520d5f-9f5e-4b99-9d7a-48f827a30a92,Radiological dept. Aalborg Hospital,radiological_dept_aalborg_hospital,,,,,, +6634,,be82da70-714c-11e6-a0cd-0242ac12000b,CARLSBAD,carlsbad,,,,,, +6635,,ad47982d-82ab-4643-b749-a205cf585b6d,"Med. Univ. Wien, Univ. Klinik für Radiodiagnostik",med_univ_wien_univ_klinik_f_r_radiodiagnostik,,,,,, +6636,,3150da36-738f-11e6-a0cd-0242ac12000b,SUPERGEN,supergen,,,,,, +7,0.95330825448036194,0d2542d7-45c9-45b1-a384-6899a6c75428,Centre Hospitalier Universitaire de Nantes,centre_hospitalier_universitaire_de_nantes,,,,e37ff462-7351-402c-828d-d17f23d6fa72,centre_hospitalier_universitaire_de_nantes,Centre Hospitalier Universitaire de Nantes +6637,,8b237369-cccf-4299-9996-50fac040a990,Raptor Therapeutics Inc,raptor_therapeutics_inc,,,,,, +6638,,4c9eafe2-ad94-456c-a7d0-c70d0441acfc,"Medizinische Universität Graz, Univ. Klinik Dermatologie, Forschungseinheit für Photodermatologie",medizinische_universit_t_graz_univ_klinik_dermatologie_forschungseinheit_f_r_photodermatologie,,,,,, +6639,,9320d63f-d87f-4295-a074-16824dca10dc,"Karolinska Institutet, Inst för kliniska vetenskaper, Danderyds sjukhus",karolinska_institutet_inst_f_r_kliniska_vetenskaper_danderyds_sjukhus,,,,,, +6640,,f8908b74-33c5-459e-adc2-89dbf9a36847,"Med. Univ. Wien, Uk für Innere Medizin I",med_univ_wien_uk_f_r_innere_medizin_i,,,,,, +6641,,3605e1ff-fca8-4cc8-82a5-4c75dc3a6e40,Verein für Krebsforschung,verein_f_r_krebsforschung,,,,,, +6642,,9cf246bb-985a-4b79-bd5b-f8a11d444cd8,University of Bonn,university_of_bonn,,,,,, +706,0.98155027627944946,ad3a923c-36e2-42c3-8d1d-8e516c97e54a,"Medical University, Dpt. Internal Medicin, Division of General Internal Medicine",medical_university_dpt_internal_medicin_division_of_general_internal_medicine,,,,450942a3-d351-4153-8f52-7394952e4a17,medical_university_dpt_internal_medicin_division_of_general_inteal_medicine,"Medical University, Dpt. Internal Medicin, Division of General Inteal Medicine" +6643,,b32abb28-b1ba-44ec-b8fe-0b19451a3ba5,Hospital Universitario Virgen de las Nieves,hospital_universitario_virgen_de_las_nieves,,,,,, +6644,,8b6b2294-7153-11e6-a0cd-0242ac12000b,ATLAS PHARMS LLC,atlas_pharms_llc,,,,,, +6,0.98172008991241455,17ea9e87-8473-4174-a0be-01570daa58e8,Centre Hospitalier Universitaire de Montpellier,centre_hospitalier_universitaire_de_montpellier,,,,17ea9e87-8473-4174-a0be-01570daa58e8,centre_hospitalier_universitaire_de_montpellier,Centre Hospitalier Universitaire de Montpellier +6645,,7a8b0f93-2e02-4f75-96d0-bec9cb90b4d3,"Unità Malattie Neurodegenerative, Ospedale Cardinale Giovanni Panico, Tricase",unit_malattie_neurodegenerative_ospedale_cardinale_giovanni_panico_tricase,,,,,, +6646,,835bfe25-65fb-4156-b949-069b1dab394c,Turku Univeristy Hospital,turku_univeristy_hospital,,,,,, +6647,,06be709c-cef4-4e18-bc06-9933231a7e0b,José Luis Vázquez Martínez,jos_luis_v_zquez_mart_nez,,,,,, +629,0.973923,8bf894ff-dd31-480c-84ce-842ae83c6af2,"Aarhus Sygehus, Universityhospital of Aarhus",aarhus_sygehus_universityhospital_of_aarhus,,,,8bf894ff-dd31-480c-84ce-842ae83c6af2,aarhus_sygehus_universityhospital_of_aarhus,"Aarhus Sygehus, Universityhospital of Aarhus" +6648,,a685b7d5-bf0d-4701-9993-ba2f101e0fc6,University Hospital Brussels (UZ Brussel),university_hospital_brussels_uz_brussel,,,,,, +6649,,32e29970-715a-4c43-861e-b138d3517882,RUNMC,runmc,,,,,, +6650,,6d6b05fe-337f-4161-84b0-b0ed2b99349f,Mª ANGELES CALDERON,m_angeles_calderon,,,,,, +6651,,e347ca27-d40a-40d9-8672-7190053cbd13,ALLOS,allos,,,,,, +6652,,d9724382-7654-4ba8-baea-764670d9fe39,UniversityHospitalGrenoble,universityhospitalgrenoble,,,,,, +6653,,08220eba-fc16-4bee-8064-a7ca848e405c,MorphoSys AG,morphosys_ag,,,,,, +6654,,9a7e88cd-04fe-4fff-a9cd-df6eff58502c,"Astellas Pharma Korea, Inc",astellas_pharma_korea_inc,,,,,, +292,0.987186,aa9c6b2d-f98b-420e-9de2-c94fac56e8a4,Motif BioSciences,motif_biosciences,,,,577003d4-ce61-4acf-92c9-2f42061c86fc,motif_biosciences_inc,Motif BioSciences Inc +6655,,444e75b7-b885-4ecc-b281-4022dee19b5e,WYETH LEDERLE,wyeth_lederle,,,,,, +6656,,1f237bb2-2b33-408d-a717-dc86e2efaec9,Kaija Puhakka,kaija_puhakka,,,,,, +6657,,95d3949b-2d87-4a68-827e-a08fc3c39978,Azienda Ospedaliera di Reggio Emilia Arcispedale S.Maria Nuova/IRCCS,azienda_ospedaliera_di_reggio_emilia_arcispedale_s_maria_nuova_irccs,,,,,, +6658,,9e76f950-a31c-4da7-b43d-1bbefb037799,FUNDACION INVESTIGACION BIOMEDICA HOSPITAL NINO JESUS,fundacion_investigacion_biomedica_hospital_nino_jesus,,,,,, +31,0.98087829351425171,5b1b823c-72c5-11e6-a0cd-0242ac12000b,DURAMED,duramed,,,,5b1b823c-72c5-11e6-a0cd-0242ac12000b,duramed,DURAMED +6659,,0dc753f0-73ea-11e6-a0cd-0242ac12000b,PULMOFLOW INC,pulmoflow_inc,,,,,, +6660,,2509c46d-1555-476e-bc62-262d2397baf6,Hillerød Hospital,hiller_d_hospital,,,,,, +6661,,ae343f46-4f8d-4b98-b318-9a2a93bbe7ad,CHX Technologies Europe Ltd,chx_technologies_europe_ltd,,,,,, +6662,,89295a71-2d9b-4e12-8f5f-2d8b47a8033f,"Discovery Laboratories, Inc",discovery_laboratories_inc,,,,,, +6663,,9c6dd52b-911e-45b0-bb8f-a251114a4e37,Agennix Incorporated,agennix_incorporated,,,,,, +461,0.97483241558074951,ed67c79c-9145-459a-8001-449f57f04800,Debiopharm,debiopharm,,,,006566e8-3afd-4507-99a0-43f66a5ab93a,debiopharm,Debiopharm +6664,,fca7b97d-5e47-4406-945b-cafccd6e2424,Sofamor - Danek,sofamor_danek,,,,,, +6665,,3d1b40a6-7167-11e6-a0cd-0242ac12000b,KREITCHMAN PET CTR,kreitchman_pet_ctr,,,,,, +223,0.985233,44108cfa-cc6c-4533-88aa-39d1732610f2,Surface Logix,surface_logix,,,,44108cfa-cc6c-4533-88aa-39d1732610f2,surface_logix,Surface Logix +6666,,7a7d437c-8a45-456e-8a6d-b44e17ae0356,"Martin Luther Universität Halle-Wittenberg, Klinikum der Medizinischen Fakultät",martin_luther_universit_t_halle_wittenberg_klinikum_der_medizinischen_fakult_t,,,,,, +6667,,7532f45b-9ae9-440b-981e-96a1a7a67e64,"Cerimon Pharmaceuticals, Inc",cerimon_pharmaceuticals_inc,,,,,, +6668,,fcfcd434-4e15-4426-ba50-f50077893dd3,Lundbeck España S.A,lundbeck_espa_a_s_a,,,,,, +6669,,091332b4-8583-4abd-af21-38571503ca9a,Royal Group Hospitals Trust,royal_group_hospitals_trust,,,,,, +6670,,9138ce3f-198b-49ba-9ab0-f8c2fe957aaa,Laboratoire Expanscience,laboratoire_expanscience,,,,,, +6671,,6a88581f-a02c-4983-b5ee-364733814b8a,MSD Korea LTD,msd_korea_ltd,,,,,, +6672,,67c621d6-61da-45dd-9d01-12eda2830f2b,Spectrum Pharmaceuticals,spectrum_pharmaceuticals,,,,,, +6673,,9460247e-73e9-11e6-a0cd-0242ac12000b,INTERPHARMA PRAHA AS,interpharma_praha_as,,,,,, +6674,,af69b74f-53df-413d-b05c-8e132c67595e,Sanofi-Synthelabo Groupe,sanofi_synthelabo_groupe,,,,,, +6675,,6595588a-7353-11e6-a0cd-0242ac12000b,EGALET US INC,egalet_us_inc,,,,,, +6676,,e5bf536d-2465-42c2-855c-9fe56b6770b4,"Haukeland University Hospital, Division of Psychiatry",haukeland_university_hospital_division_of_psychiatry,,,,,, +1042,0.989009,de78cca2-71a3-11e6-a0cd-0242ac12000b,GLAXOSMITHKLINE CON,glaxosmithkline_con,,,,ab743a24-721d-11e6-a0cd-0242ac12000b,glaxosmithkline_cons,GLAXOSMITHKLINE CONS +6677,,81fceae0-880e-11e6-a998-0242ac12000b,"Motus Therapeutics, Inc",motus_therapeutics_inc,,,,,, +333,0.986197,f01ae6b1-2363-42e6-b88f-0af1a726bf35,Nordsjællands Hospital,nordsj_llands_hospital,,,,c0de4999-a6b3-11e6-94cb-5656d04fc2b5,nordsj_llands_hospital_hiller_d,Nordsjællands Hospital Hillerød +6678,,9a2d5eb8-7145-11e6-a0cd-0242ac12000b,DEY,dey,,,,,, +6679,,68c4bad5-4dee-4e95-93f9-8646dc5cb554,"Radius Health, Inc",radius_health_inc,,,,,, +6680,,e89e6678-fb20-49e0-be1f-64f5ae70cbba,Eisai s.r.l,eisai_s_r_l,,,,,, +536,0.978219,9921c788-bec5-470a-b081-facbdc704f78,Institut Jules Bordet,institut_jules_bordet,,,,9921c788-bec5-470a-b081-facbdc704f78,institut_jules_bordet,Institut Jules Bordet +6681,,e6b327de-d032-4de8-84ba-4d354d1df916,Universitetssjukhuset Örebro,universitetssjukhuset_rebro,,,,,, +1019,0.974081,620095ee-c9a2-4531-944d-4a25e6b235d1,GlaxoSmithKline Reasearch & Development,glaxosmithkline_reasearch_development,,,,620095ee-c9a2-4531-944d-4a25e6b235d1,glaxosmithkline_reasearch_development,GlaxoSmithKline Reasearch & Development +6682,,8e881699-6806-4546-8296-ded115b2b449,CHRU de Brest,chru_de_brest,,,,,, +6683,,340b4809-f67e-4e21-898e-c6478a6f946f,S.P.A. ITALIANA LABORATORI BOUTY,s_p_a_italiana_laboratori_bouty,,,,,, +6684,,745aaee5-085e-4fa4-8241-569c58028da2,Gastrocentrum kirurgi,gastrocentrum_kirurgi,,,,,, +6685,,5208cfa4-0460-4695-a27e-ffef0290a1b3,Orion Pharma GmbH,orion_pharma_gmbh,,,,,, +217,0.983343,cdb1a12b-06ee-4c0a-932a-9d236076f296,TRANSGENE,transgene,,,,32ba4b51-aea2-4074-88ac-a23bc5b63b1d,transgene_s_a,TRANSGENE S.A +6686,,cddceb45-3fa5-4cb6-bc87-d4be5d979259,"Merck KGaA and EMD Serono, Inc",merck_kgaa_and_emd_serono_inc,,,,,, +6687,,da486d74-b473-42a5-b62c-2738d2dd8a47,Joint UCLH/UCL/Royal Free Biomedical Research Unit,joint_uclh_ucl_royal_free_biomedical_research_unit,,,,,, +6688,,7f56c029-d961-4572-8db3-704e22d64215,"Obstetrisk afd., Hvidovre Hospital",obstetrisk_afd_hvidovre_hospital,,,,,, +6689,,a0946414-1cad-4607-a7f6-d7d09f4d64ac,"Medizinische Universität Wien, Universitätsklinik f. Innere Med. III, Abt. f. Nephrologie u. Dialyse",medizinische_universit_t_wien_universit_tsklinik_f_innere_med_iii_abt_f_nephrologie_u_dialyse,,,,,, +6690,,63b8da67-a9fa-4fe1-80e2-b4816b5ec6bd,CSL Limited,csl_limited,,,,,, +1036,0.97620874643325806,0e73d51d-18db-4aac-81b0-bb770932bfdc,University of Leeds,university_of_leeds,,,,0e73d51d-18db-4aac-81b0-bb770932bfdc,university_of_leeds,University of Leeds +6691,,eb6c4c36-00b8-423d-b828-5fb308304cb9,HELIXOR Heilmittel GmbH & Co.KG,helixor_heilmittel_gmbh_co_kg,,,,,, +6692,,443d6764-d30e-4199-97be-cc7a16e1c747,Kliniken Essen Mitte,kliniken_essen_mitte,,,,,, +6693,,61a140e0-3b14-4f8b-af92-e6559e4a842b,The John Hopkins University,the_john_hopkins_university,,,,,, +6694,,f99fb711-2fd3-4486-bd0d-e7a47e0c23aa,Moberg Derma AB,moberg_derma_ab,,,,,, +6695,,306061d7-9e9a-400b-a614-78d58c605946,"Bellicum Pharmaceuticals, Inc",bellicum_pharmaceuticals_inc,,,,,, +40,0.98917752504348755,7c9cf661-e45e-442f-8b26-67d651e2722d,"Procter & Gamble Technical Centres Ltd., UK",procter_gamble_technical_centres_ltd_uk,,,,7852b0e6-2f36-4ee0-90a6-404e745340b5,procter_gamble_technical_centres_ltd,Procter & Gamble Technical Centres Ltd +6696,,82c67ac8-b58c-44f3-8e33-5803b02d3067,CSL BEHRING S.P.A,csl_behring_s_p_a,,,,,, +6697,,2a7a8b84-d3ad-4076-8c5c-06f2f6361ba5,AMERSHAM HEALTH,amersham_health,,,,,, +6698,,820a8edd-df37-496a-a104-f0834d792fc6,ASOCIACIÓN GALLEGA DE ENFERMEDAD INFLAMATORIA INTESTITAL (E.I.G.A.),asociaci_n_gallega_de_enfermedad_inflamatoria_intestital_e_i_g_a,,,,,, +6699,,d56713e5-161d-49e0-8af9-3f38aba26fc1,Centre Hospitalier de Nancy,centre_hospitalier_de_nancy,,,,,, +6700,,38003542-37b8-4db5-9b2e-4cac6a9d1ff6,GRUPO ESPAÑOL MULTICISPLINAR DE MELANOMA,grupo_espa_ol_multicisplinar_de_melanoma,,,,,, +1040,0.97674435377120972,92791194-a8b3-428a-9d15-cc0e3d01b15a,Celgene International Sarl,celgene_international_sarl,,,,2296dd74-6817-4f30-819d-48b0af75055c,celgene_international_s_rl,Celgene International Sàrl +6701,,5cd9e6da-d469-4272-b872-4606cf30eb14,Conatus Pharmaceuticals Inc,conatus_pharmaceuticals_inc,,,,,, +6702,,768a0344-7276-11e6-a0cd-0242ac12000b,SUCAMPO PHARMA LLC,sucampo_pharma_llc,,,,,, +6703,,ff12aaa9-8393-412a-8fb7-f1d4615ad870,NKI/Antoni van Leeuwenhoek Ziekenhuis,nki_antoni_van_leeuwenhoek_ziekenhuis,,,,,, +6704,,a9f6757c-ce2f-42d5-91c3-e9047d7baad4,Fundación Española de Esclerosis Múltiple (FEDEM),fundaci_n_espa_ola_de_esclerosis_m_ltiple_fedem,,,,,, +6705,,f702a3d8-4cd8-40c1-8467-81db2aabf52f,Danmarks Farmaceutiske Universitet,danmarks_farmaceutiske_universitet,,,,,, +6706,,3c3e49c8-7165-11e6-a0cd-0242ac12000b,JAI PHARMA LTD,jai_pharma_ltd,,,,,, +6707,,af0b34fa-cdb2-4246-81a1-18a357165472,University Medical Center of Groningen,university_medical_center_of_groningen,,,,,, +6708,,039496d6-c5c9-4653-a93c-fb35a8ada18d,IBD Center LMU Munich,ibd_center_lmu_munich,,,,,, +6709,,731e28eb-1645-4031-8c53-c6e4ef823481,"Transplantationscntrum, Sahlgrenska Universitetssjukhuset",transplantationscntrum_sahlgrenska_universitetssjukhuset,,,,,, +6710,,ff6f5ec7-b025-499e-bc66-290349c94abf,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research &, Development,,,,,, +6711,,456dab76-8bd5-11e6-a449-0242ac12000b,"Dept. of Cardiothoracic & Vascular Surgery, Aarhus University Hospital, Skejby",dept_of_cardiothoracic_vascular_surgery_aarhus_university_hospital_skejby,,,,,, +6712,,90e73c64-2949-40a8-95d8-078dd85b470a,Laboratorios Servier S.L,laboratorios_servier_s_l,,,,,, +6713,,5d609149-5484-4073-990f-67fa474ae157,Universitätsklinikum Würzburg,universit_tsklinikum_w_rzburg,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_amp_development,,,,, +6714,,3d372208-7167-11e6-a0cd-0242ac12000b,ESSENTIAL ISOTOPES,essential_isotopes,,,,,, +696,0.987337,221108ee-7307-42f8-832d-e148617d109a,Banc de Sang i Teixits,banc_de_sang_i_teixits,,,,221108ee-7307-42f8-832d-e148617d109a,banc_de_sang_i_teixits,Banc de Sang i Teixits +6715,,5476d014-7129-11e6-a89e-0242ac12000b,ALLERGAN SALES LLC,allergan_sales_llc,,,,,, +6716,,d0660b6e-6c26-4efc-a497-5070ce42ed3d,"Section for Transfusion Medicine, Capitol Region Blood Bank",section_for_transfusion_medicine_capitol_region_blood_bank,,,,,, +6717,,d2277a8a-4cb0-4f6e-962a-d0b6e16aabb9,Daniel Schmidt,daniel_schmidt,,,,,, +6718,,58384182-25d9-414e-8817-b3450bdd9f86,University Hospital Erlangen,university_hospital_erlangen,,,,,, +6719,,69041762-905c-4c6c-af4e-d2f7babb9234,"Christel B. Lajer, Dep. of Otolaryngology head and neck surgery, Rigshospitalet",christel_b_lajer_dep_of_otolaryngology_head_and_neck_surgery_rigshospitalet,,,,,, +6720,,429142ac-c82e-4b72-8727-65946c6b5ec8,ApoPharma Incorporated,apopharma_incorporated,,,,,, +6721,,a0380f84-ee0a-46e8-9eaa-266541414b79,Hospital Universitario Vall D'Hebron. Departamento de Medicina Interna,hospital_universitario_vall_d_hebron_departamento_de_medicina_interna,,,,,, +6722,,04081ba9-6391-4bba-8c2d-0d84bfad3a99,Strekin AG,strekin_ag,,,,,, +6723,,d5e31621-716b-4d42-9b1c-8927c8d30a64,Lars Søndergaard,lars_s_ndergaard,,,,,, +6724,,5098d244-716a-11e6-a0cd-0242ac12000b,ORTHO BIOTECH,ortho_biotech,,,,,, +317,0.985423,ab7dfa68-7165-11e6-a0cd-0242ac12000b,X-GEN PHARMS INC,x_gen_pharms_inc,,,,ab7dfa68-7165-11e6-a0cd-0242ac12000b,x_gen_pharms_inc,X-GEN PHARMS INC +598,0.98780262470245361,a17f5ff7-bbd9-42b0-8762-aa32b21f61e3,University College London,university_college_london,,,,112df4bf-757e-4212-a536-a3908a697c4b,university_college_london_ucl,University College London (UCL) +155,0.982232,32da3906-4bb3-4220-b809-a95a116fec70,Department of Rheumatology,department_of_rheumatology,,,,0f7ff838-13c3-4637-91f3-73d90e40ccf4,department_of_rheumatology_university_hospital_lund,"Department of Rheumatology,University hospital,Lund" +6725,,93be9132-7b4a-4460-b230-ef2dd36d5f9d,CENTRE LEON BERARD,centre_leon_berard,,,,,, +6726,,69694d30-cced-4380-acf2-145a79b8fa7b,"Department of Neurology, Roskilde Hospital",department_of_neurology_roskilde_hospital,,,,,, +6727,,e6e77279-6432-48ce-bb8c-be947b21be22,Estonian Science Foundation,estonian_science_foundation,,,,,, +6728,,ec52f114-5282-477c-a4df-1e1df9382925,Consorci Mar Parc de Parc de Salut de Barcelona (Parc de Salut MAR),consorci_mar_parc_de_parc_de_salut_de_barcelona_parc_de_salut_mar,,,,,, +6729,,3eec4b51-44df-4c0c-b07d-5c4e83dfb544,sterna biologicals GmbH & Co. KG,sterna_biologicals_gmbh_co_kg,,,,,, +6730,,411197a3-3ddf-4076-891a-f64aff0ba10e,Havenziekenhuis/ErasmusMC,havenziekenhuis_erasmusmc,,,,,, +6731,,0118a599-f57c-412e-b55e-71fb8a779cc7,Yeovil District Hospital,yeovil_district_hospital,,,,,, +554,0.98628848791122437,5a0d7e38-7129-11e6-a89e-0242ac12000b,VINTAGE PHARMS,vintage_pharms,,,,5a0d7e38-7129-11e6-a89e-0242ac12000b,vintage_pharms,VINTAGE PHARMS +6732,,c20a8219-cd10-465d-9c3b-e4086a5a9018,IUCPQ,iucpq,,,,,, +6733,,152ba7fe-ff95-4b48-a2de-4aa97e447923,Niuvannniemi Hospital,niuvannniemi_hospital,,,,,, +6734,,443aa692-61bd-458e-ba69-971f8344c688,Arbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH,arbeitsgemeinschaft_medikament_se_tumortherapie_gemeinn_tzige_gmbh,,,,,, +408,0.931044,a45ec509-2eb2-4db5-8022-b27de831dd06,CHU de Liège,chu_de_li_ge,,,,5af16d72-9df2-4fc9-8608-fbc9eb8e988a,chu_de_liege,CHU de Liege +6735,,a365e49f-2d26-4cd0-9f84-a94f77082d40,"Laboratorios Pfizer, Lda",laboratorios_pfizer_lda,,,,,, +6736,,1e0cbab8-3ff5-40c9-b2ac-2acf462a43c3,FUNDACIÓ PRIVADA CLINIC PER A LA RECERCA BIOMÈDICA,fundaci_privada_clinic_per_a_la_recerca_biom_dica,,,,,, +6737,,ee32f640-ed62-48d4-b239-cfda7e8e15d2,Ambria Dermatology,ambria_dermatology,,,,,, +6738,,102507d8-7aa0-455d-b743-ad6c65303406,Hospital Universitario Vall d’Hebron. Barcelona. Spain,hospital_universitario_vall_d_hebron_barcelona_spain,,,,,, +963,0.97998803853988647,65248d8e-5a22-48b5-a66d-dc1d1f751700,Helsinki University,helsinki_university,,,,65248d8e-5a22-48b5-a66d-dc1d1f751700,helsinki_university_hospital,Helsinki University Hospital +6739,,3482c8c5-1d0d-40d7-9f18-e053503db27b,Dra. Beatriz Sanchez Sobrino,dra_beatriz_sanchez_sobrino,,,,,, +6740,,f987772a-cbbe-4c89-84c0-3f9963c3505c,GlaxoSmithKlineResearch & Developemnt Ltd,glaxosmithklineresearch_developemnt_ltd,,,,,, +6741,,d5937e6b-4932-47dd-9d71-ecf679efe927,"Medizinische Universität Wien, Univ. Klinik für Anästhesie, Allg. Intensivmedizin u Schmerztherapie",medizinische_universit_t_wien_univ_klinik_f_r_an_sthesie_allg_intensivmedizin_u_schmerztherapie,,,,,, +6742,,01553610-f2db-4dd4-94e6-4c215f8cc225,DUTCH BELGIAN COOPERATIVE GROUP FOR HEMATOLOGY ONCOLOGY - HOVON,dutch_belgian_cooperative_group_for_hematology_oncology_hovon,,,,,, +6743,,ca0fe8b7-a640-4456-89d6-48a3bc848594,"Department of Cardiology, Rigshospitalet",department_of_cardiology_rigshospitalet,,,,,, +6744,,5a10c43b-a005-4a19-9b26-d2f2222dba94,Laboratoire Kreussler Pharma,laboratoire_kreussler_pharma,,,,,, +6745,,ac3b301c-6eab-40a8-999d-ff305e999e0e,"Novartis Nordic Countries, Business Unit Transplantation",novartis_nordic_countries_business_unit_transplantation,,,,,, +995,0.98229312896728516,3f41d035-5505-424a-9eba-1d3001157ba6,GE Healthcare Limited,ge_healthcare_limited,,,,3f41d035-5505-424a-9eba-1d3001157ba6,ge_healthcare_limited,GE Healthcare Limited +6746,,5a1f3867-be65-4bfb-bc74-f2c4d45eee3c,"Med. Univ. Wien, Universitätsklinik für Kinder- und Jugendheilkunde",med_univ_wien_universit_tsklinik_f_r_kinder_und_jugendheilkunde,,,,,, +6747,,daeb7a68-25f6-4772-92ab-6ced3ab276c0,University of Cambridge,university_of_cambridge,,,,,, +170,0.98542284965515137,6b07fdf4-4955-45ab-999a-be365a194900,Merck Serono Ltd,merck_serono_ltd,,,,6b07fdf4-4955-45ab-999a-be365a194900,merck_serono_ltd,Merck Serono Ltd +6748,,49070c1f-2c42-417e-9c5e-585cfc553d30,"Wyeth Pharmaceuticals, a Pfizer Company",wyeth_pharmaceuticals_a_pfizer_company,,,,,, +726,0.987967,81a28eac-2d1e-4864-ac25-63a4b019a446,Steno Diabetes Center A/S,steno_diabetes_center_a_s,,,,1b7f80c2-b4fd-41cd-875f-9db8a4bf35a2,steno_diabetes_center,Steno Diabetes Center +6749,,73b66dcd-a7cc-11e6-94cb-5656d04fc2b5,Region Ostergotland,region_ostergotland,,,,,, +6750,,41ed1dec-9a49-42f9-bb9a-15d3e18b028f,Fundacio Privada Clinic per a la Recerca Biomedica,fundacio_privada_clinic_per_a_la_recerca_biomedica,,,,,, +6751,,595656b9-71a6-4eea-8602-b0af1383b13b,KRKA-FARMA d. o. o,krka_farma_d_o_o,,,,,, +970,0.987506,8781fe28-c7b9-4fda-8f96-3fa77012de6c,Academic Medical Centre (AMC),academic_medical_centre_amc,,,,2899c14b-e123-4b6f-9261-bca58e778c63,academic_medical_centre,Academic Medical Centre +6752,,56a3ee52-51fe-4d80-b187-43f0f51c7b83,ACTELION PHARMACEUTICALS ITALIA,actelion_pharmaceuticals_italia,,,,,, +578,0.97902655601501465,3b0c06b0-85fa-4afa-9e00-53d2e010c8e4,"Wyeth Pharmaceuticals, Inc. Acting through its devision Wyeth Research, a Pfizer Company",wyeth_pharmaceuticals_inc_acting_through_its_devision_wyeth_research_a_pfizer_company,,,,724d1bdc-e54a-4c73-b212-98071e708ad2,wyeth_pharmaceuticals_inc_acting_through_its_division_wyeth_research_a_pfizer_company,"Wyeth Pharmaceuticals Inc. Acting through its division Wyeth Research, a Pfizer Company" +6753,,c4cc404c-b06d-4fec-a661-abed3dc02695,Istituto Clinico Humanitas - Humanitas Cancer Center,istituto_clinico_humanitas_humanitas_cancer_center,,,,,, +6754,,63a5d215-372c-4e85-a8d4-5b5a7b7390ed,Volution Immuno Pharmaceuticals (UK) Ltd,volution_immuno_pharmaceuticals_uk_ltd,,,,,, +6755,,ff976832-fd16-43c6-bf0d-8d6175ce7770,ONCOSUR,oncosur,,,,,, +6756,,0ee1a230-73f0-11e6-a0cd-0242ac12000b,"WYNN L MADER, INDUSTRIAL GAS DISTRIBUTORS",wynn_l_mader_industrial_gas_distributors,,,,,, +6757,,dda25f51-edce-4ecd-8533-1410004e6dc4,Evotec NeurosciencesGmbH,evotec_neurosciencesgmbh,,,,,, +595,0.985826,6548489f-2430-4636-90c0-4f63a9939b5c,Erasmus Medical Centre,erasmus_medical_centre,,,,6548489f-2430-4636-90c0-4f63a9939b5c,erasmus_medical_centre,Erasmus Medical Centre +6758,,7af8a91b-f608-4e0f-a27c-d133ca544d30,Fundación para la Investigación en Enfermedades del Aparato Digestivo,fundaci_n_para_la_investigaci_n_en_enfermedades_del_aparato_digestivo,,,,,, +6759,,fabe3355-6dd8-4332-af71-06d029154855,Pulmonary Research Institute GmbH an der Asklepiosklinik Barmbek. Niederlassung Hamburg,pulmonary_research_institute_gmbh_an_der_asklepiosklinik_barmbek_niederlassung_hamburg,,,,,, +6760,,0f85e531-8ba1-4b33-8ac0-febe37dd3201,Peer Tfelt-Hansen,peer_tfelt_hansen,,,,,, +6761,,20ea2182-6923-4095-b9ec-048807ecd693,Firma Dr. F. Köhler Chemie GmbH,firma_dr_f_k_hler_chemie_gmbh,,,,,, +150,0.919718,b3733316-ccdd-4aab-ad57-807a9a476ca0,Universitätsmedizin Göttingen,universit_tsmedizin_g_ttingen,,,,b3733316-ccdd-4aab-ad57-807a9a476ca0,universit_tsmedizin_g_ttingen,Universitätsmedizin Göttingen +6762,,815f4ae4-8bc7-11e6-a449-0242ac12000b,"Anæstesiklinikken, Frederiksberg Hospital",an_stesiklinikken_frederiksberg_hospital,,,,,, +1006,0.9811970591545105,b2f9f536-edf3-40a9-ad29-80751e7a2239,Folktandvården,folktandv_rden,,,,76940d77-7350-4137-8034-dc7c3c7289ad,folktandv_rden_sterg_tland,Folktandvården Östergötland +304,0.953319,8700379b-5f4a-4dc7-82aa-ea7910222ff1,"Medical University Graz, Department for Plastic Surgery",medical_university_graz_department_for_plastic_surgery,,,,8700379b-5f4a-4dc7-82aa-ea7910222ff1,medical_university_graz_department_for_plastic_surgery,"Medical University Graz, Department for Plastic Surgery" +6763,,22537761-9db1-42ef-a636-7bee9447f40b,Hospital of South West Jutland,hospital_of_south_west_jutland,,,,,, +6764,,3a5f5ce2-9a13-4922-8e10-75279bd98759,Foot and Ankle Surgical center,foot_and_ankle_surgical_center,,,,,, +187,0.983343,9b7df138-7145-11e6-a0cd-0242ac12000b,PAR PHARM INC,par_pharm_inc,,,,9b7df138-7145-11e6-a0cd-0242ac12000b,par_pharm_inc,PAR PHARM INC +6765,,7b551f72-6537-49a7-9c39-687533fe737b,"Stryker Biotech, LLC",stryker_biotech_llc,,,,,, +6766,,51b98af7-2edc-4846-95f2-064293ec6da2,Ferring Arzneimittel GmbH,ferring_arzneimittel_gmbh,,,,,, +6767,,a3e86f77-ff98-4cf6-a544-dbce7123f78b,"Medizinische Universität Wien, Abteilung für Anästhesie und allgemeine Intensivmedizin",medizinische_universit_t_wien_abteilung_f_r_an_sthesie_und_allgemeine_intensivmedizin,,,,,, +6768,,e1c37185-e42f-4dff-8773-e47fb45203cc,Dr. Miguel Cervero,dr_miguel_cervero,,,,,, +6769,,c46e737d-1316-4e76-a389-cca7620adfe3,Promethera Biosciences,promethera_biosciences,,,,,, +6770,,6de0c6cb-924f-4fc4-a346-fc20330aa6e1,"BioNumerik Pharmaceuticals, Inc",bionumerik_pharmaceuticals_inc,,,,,, +6771,,da4e3d78-d513-41c2-afe1-83d507dce3bc,University Hospital Southampton NHS Foundation Trust,university_hospital_southampton_nhs_foundation_trust,,,,,, +6772,,f1eeb85e-8be9-11e6-a449-0242ac12000b,"Univerzita Karlova v Praze, 2. lékařská fakulta",univerzita_karlova_v_praze_2_l_ka_sk_fakulta,,,,,, +6773,,11d03ee9-874f-499f-ba9e-9908cbfbeaaa,Arno Therapeutics Inc,arno_therapeutics_inc,,,,,, +6774,,34777b0c-8d4b-47ce-8868-9378e684dbed,JUAN IGNACIO ARENAS RUIZ-TAPIADOR,juan_ignacio_arenas_ruiz_tapiador,,,,,, +609,0.920179,7ccdbeba-54a9-43ed-8e5c-58592f516aa3,Department of Pharmacy Universitaetsmedizin Mainz,department_of_pharmacy_universitaetsmedizin_mainz,,,,7ccdbeba-54a9-43ed-8e5c-58592f516aa3,department_of_pharmacy_universitaetsmedizin_mainz,Department of Pharmacy Universitaetsmedizin Mainz +6775,,95e77da3-94b1-4ccf-aa5a-3e51720bcc00,Menarini Ricerche S.p.A,menarini_ricerche_s_p_a,,,,,, +6776,,77e80479-1438-4a2d-8ca7-4c4ca41cc012,Knappschaftskrankenhaus Bochum,knappschaftskrankenhaus_bochum,,,,,, +425,0.96910750865936279,fff5c38e-aabc-4262-ba50-28cd20898d02,HOVON CLL Group,hovon_cll_group,,,,a89061fe-7d3c-47c4-acdc-5ea8273f45e8,hovon,HOVON +6777,,932dc323-e807-4979-86ed-fce9cd9d2383,Björn Holmberg,bj_rn_holmberg,,,,,, +6778,,f221f154-5a41-4ba4-a5c2-c27ee0ec287c,Merrimack Pharmaceuticals Inc,merrimack_pharmaceuticals_inc,,,,,, +714,0.985233,0354c2c2-7129-11e6-a89e-0242ac12000b,EUROHLTH INTL SARL,eurohlth_intl_sarl,,,,0354c2c2-7129-11e6-a89e-0242ac12000b,eurohlth_intl_sarl,EUROHLTH INTL SARL +6779,,2f7e5c06-8816-11e6-a998-0242ac12000b,"Hana Biosciences, Inc",hana_biosciences_inc,,,,,, +6780,,c1a7a10c-1f94-4457-b5c8-403de04af934,"Neuromuscular Research Unit, Copenhagen University Hospital Rigshopspitalet",neuromuscular_research_unit_copenhagen_university_hospital_rigshopspitalet,,,,,, +6781,,7f54ee9e-55f0-4563-9072-f47cd32920d9,Aventis Pharma Deutschland GmbH,aventis_pharma_deutschland_gmbh,,,,,, +6782,,502fb8c4-59f0-47bc-a1b3-5fc9f1c58797,NEAT-ID,neat_id,,,,,, +6783,,e7273471-1761-4226-9450-830f2d3c69bf,nabi biopharmaceuticals,nabi_biopharmaceuticals,,,,,, +17,0.985533,da80fecf-b532-4a56-8c0a-c95702dc2907,"German Heart Centre Munich, Department of",german_heart_centre_munich_department_of,,,,c63a0355-3210-4a0d-9c79-6e414a13ec40,german_heart_centre_munich_department_of_cardiovascular_diseases,"German Heart Centre Munich, Department of Cardiovascular Diseases" +6784,,5b634114-7142-11e6-a0cd-0242ac12000b,VALEANT LUXEMBOURG,valeant_luxembourg,,,,,, +6785,,97b929db-d826-4ed4-9507-faf0704b56ad,RIB-X THERAPEUTICS LIMITED,rib_x_therapeutics_limited,,,,,, +6786,,64c9f687-fd2a-4dda-8484-97e78d0d1bc6,James Cook University Hospital,james_cook_university_hospital,,,,,, +6787,,e0e0d46e-72ff-11e6-a0cd-0242ac12000b,CPPI CV,cppi_cv,,,,,, +6788,,94e5efbf-7b81-45c0-bfe1-19f8b40d4d67,"Kennemer Gasthuis, afdeling maag-, darm-, leverziekten",kennemer_gasthuis_afdeling_maag_darm_leverziekten,,,,,, +6789,,d03ba1fd-e79c-4d2c-8150-eb0368dbd28a,Grupo Gallego de Investigación en Tumores ,Digestivos - GITuD,,,,,, +6790,,d2d31f06-04d7-46ba-81c5-450815064f5b,KA Rudolfstiftung - 2. Medizinische Abteilung,ka_rudolfstiftung_2_medizinische_abteilung,,,,,, +6791,,846e82d4-5253-400e-a272-f04262976032,Área de Trasplante y Terapia Celular - Hospital Central de Asturias,rea_de_trasplante_y_terapia_celular_hospital_central_de_asturias,,,,,, +6792,,3501e261-9a8c-40c7-af15-53bf7b8a0653,UNIVERSITA' DEGLI STUDI DI PERUGIA,universita_degli_studi_di_perugia,grupo_gallego_de_investigaci_n_en_tumores_digestivos_gitud,,,,, +6793,,72ed95cc-60fa-4289-a634-577fd13a2eab,Amgen Research (Munich) GmbH,amgen_research_munich_gmbh,,,,,, +6794,,17e66346-cd7d-401c-93a5-62336595c32b,Med. Klinik / Kardiologie der Med. Fakultät Carl Gustav Carus an der Technischen Unversität Dresden,med_klinik_kardiologie_der_med_fakult_t_carl_gustav_carus_an_der_technischen_unversit_t_dresden,,,,,, +6795,,36799654-2212-49d6-8333-68f45e9f67e4,Charitè Universitätmeditin Berlin,charit_universit_tmeditin_berlin,,,,,, +785,0.9885413646697998,afc09a30-3b4a-4041-9919-78df2cc5e391,Medizinische Hochschule Hannover (MHH),medizinische_hochschule_hannover_mhh,,,,a896ae02-0ec3-47cc-8072-7cf79e6d3551,medizinische_hochschule_hannover,Medizinische Hochschule Hannover +6796,,2e33910b-6bd6-47e7-8f48-c6cf9347c82f,Hospital Universitari de Girona Dr. Josep Trueta,hospital_universitari_de_girona_dr_josep_trueta,,,,,, +6797,,c8009921-4e7f-4548-b907-f9fcd34f75a7,Servicio de Digetivo del Hospital Valle Hebrón del Instituto Catalán de Salud. NIF Q5855029D,servicio_de_digetivo_del_hospital_valle_hebr_n_del_instituto_catal_n_de_salud_nif_q5855029d,,,,,, +6798,,aa2fad91-2f6f-46ff-af39-6c1eab30218d,QUADRAMED,quadramed,,,,,, +6799,,46f8525a-e6fc-4495-b946-32a7e0608d81,Roche Austria GmbH,roche_austria_gmbh,,,,,, +6800,,593b8042-741b-4496-8b28-3d4bd2f950c9,Actelion Registration Ltd,actelion_registration_ltd,,,,,, +496,0.98474764823913574,5c05fa95-0c90-4777-be79-ea6ecfc023ea,"Martin-Luther-Universität Halle-Wittenberg, vertreten durch den Kanzler",martin_luther_universit_t_halle_wittenberg_vertreten_durch_den_kanzler,,,,5c05fa95-0c90-4777-be79-ea6ecfc023ea,martin_luther_universit_t_halle_wittenberg_vertreten_durch_den_kanzler,"Martin-Luther-Universität Halle-Wittenberg, vertreten durch den Kanzler" +6801,,c3dd4e66-3816-4f37-b374-fff7ebaa6db6,Associação para Desenvolvimento da Dermatologia do Hospital de Santa Maria,associa_o_para_desenvolvimento_da_dermatologia_do_hospital_de_santa_maria,,,,,, +6802,,58e9e60c-59ef-4a1b-88b6-4e2ba90c3fd0,University Cologne,university_cologne,,,,,, +786,0.98430114984512329,ae486c69-258b-44cb-b1df-a166ffd46985,Intercell,intercell,,,,36d7c90b-a751-4f8d-8ad8-5535b85ebea2,intercell_ag,Intercell AG +6803,,8c09e964-d566-44c2-9d41-a526d1fdc4fb,Xention Limited,xention_limited,,,,,, +6804,,aa6532c1-3ef1-460f-988a-81c85916e0b4,M's Science Corporation,m_s_science_corporation,,,,,, +6805,,c07bbca0-3d27-4ae2-a41f-2c2de08122fe,Larime company of the Mediscis group,larime_company_of_the_mediscis_group,,,,,, +887,0.97905653715133667,44b33ab6-d74e-4fa5-aa8c-510964a3ac9f,Schering-Plough Research Institute,schering_plough_research_institute,,,,44b33ab6-d74e-4fa5-aa8c-510964a3ac9f,schering_plough_research_institute,Schering-Plough Research Institute +446,0.96705156564712524,d503d81e-b381-4df8-afc1-0e37f91ed710,Royal Brompton and Harefield NHS Trsut,royal_brompton_and_harefield_nhs_trsut,,,,d503d81e-b381-4df8-afc1-0e37f91ed710,royal_brompton_and_harefield_nhs_trsut,Royal Brompton and Harefield NHS Trsut +6806,,6600055a-7195-11e6-a0cd-0242ac12000b,JANSSEN R AND D,janssen_r_and_d,,,,,, +6807,,ef1f41c7-5e20-4687-965d-109e0f5bd6a9,"Univ of Lund, Dept of Pediatrics",univ_of_lund_dept_of_pediatrics,,,,,, +6808,,28e2c773-800f-418c-98f5-f064721ba8f1,"Medizinische Universität Innsbruck, Innere Medizin I",medizinische_universit_t_innsbruck_innere_medizin_i,,,,,, +6809,,16f70329-dafd-4428-bec6-483f539f52fc,Hull and East Yorkshire NHS Hospital Trust,hull_and_east_yorkshire_nhs_hospital_trust,,,,,, +6810,,cdd169b2-ecef-44aa-8993-0152f82b496b,GlobiFer International bvba,globifer_international_bvba,,,,,, +6811,,da073ce9-9d72-4211-86a3-0e3ac9fd24ae,Magle AB,magle_ab,,,,,, +311,0.94804,b1e7a97f-3f72-43f4-a8f1-ab6902f55179,VU Univeristy Medical Centre,vu_univeristy_medical_centre,,,,b1e7a97f-3f72-43f4-a8f1-ab6902f55179,vu_univeristy_medical_centre,VU Univeristy Medical Centre +279,0.97373181581497192,9eaa8840-f902-4a96-b7ae-dd6a74426316,Royal Liverpool and Broagreen University Hospitals NHS Trust,royal_liverpool_and_broagreen_university_hospitals_nhs_trust,,,,7fdce817-2c7a-48bf-9fea-ccc1bb736300,royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,Royal Liverpool and Broadgreen University Hospitals NHS Trust +6812,,9d9dbc49-a4d1-4b22-bee3-fe92f760e26a,Praxis Prof. Koenig,praxis_prof_koenig,,,,,, +6813,,53757671-32f1-4b75-9fb9-b140f3b44abf,INSTITUT CURIE,institut_curie,,,,,, +947,0.98283,9d41c520-5775-47af-8ab9-46394267d759,Hospital Clínic-Maternitat,hospital_cl_nic_maternitat,,,,3d9cc66f-e29e-4146-9f7e-6baf8b6a7b2e,hospital_cl_nic,Hospital Clínic +6814,,faddcfb2-73bc-11e6-a0cd-0242ac12000b,HANMI PHARM CO LTD,hanmi_pharm_co_ltd,,,,,, +6815,,4d2378fa-8629-48df-88b9-8b4a26bbfcd5,"Laguna Pharmaceuticals, Inc",laguna_pharmaceuticals_inc,,,,,, +6816,,6e29d46e-fef6-4308-b00f-34243d2810ee,Fidia Farmaceutici SpA,fidia_farmaceutici_spa,,,,,, +6817,,d0ccef3c-2f56-4eb0-bfb8-deb749eaf167,GEICAM (Spanish Breast Cancer Research Group Foundation),geicam_spanish_breast_cancer_research_group_foundation,,,,,, +6818,,f52d8b16-8bc7-11e6-a449-0242ac12000b,"Medical Research Laboratory, Clinical institute of Medicine, Aarhus University Hospital",medical_research_laboratory_clinical_institute_of_medicine_aarhus_university_hospital,,,,,, +6819,,9e375d2d-5d9f-426a-b8b3-043fa784ddb3,University Hospital of Grenoble,university_hospital_of_grenoble,,,,,, +944,0.98510605096817017,bc3fb171-d422-4044-ae7a-9a9bc31f9e22,Georg-August-Universität Göttingen,georg_august_universit_t_g_ttingen,,,,bc3fb171-d422-4044-ae7a-9a9bc31f9e22,georg_august_universit_t_g_ttingen,Georg-August-Universität Göttingen +781,0.92631208896636963,61b142b2-df48-40f9-8b9c-29a48d372da8,GlaxoSmithKline Research & Development,glaxosmithkline_research_development,,,,201d9d4f-5cd0-46df-836e-da17fa2b43dd,glaxosmithkline_research_and_development,GlaxoSmithKline Research and Development +6820,,f0f09e8e-881c-11e6-a998-0242ac12000b,Pfizer Denmark,pfizer_denmark,,,,,, +6821,,35a0fa09-9bad-42d3-a2cd-cf832e39d7af,Associazione Progetto Oncologia UMAN.A,associazione_progetto_oncologia_uman_a,,,,,, +6822,,816bb5af-4c95-4bc2-a69a-45eb7291bf8c,Biologische Heilmittel Heel GmbH,biologische_heilmittel_heel_gmbh,,,,,, +6823,,67b87bdf-dff1-44a1-8916-dd205bbc39a5,Research in Real-Life Ltd,research_in_real_life_ltd,,,,,, +6824,,0478eefc-7314-11e6-a0cd-0242ac12000b,VERTICAL PHARMS LLC,vertical_pharms_llc,,,,,, +28,0.98589098453521729,9bf0ded2-498f-41e8-a33e-f8ef449d3812,University Hospital Birmingham NHS Foundation,university_hospital_birmingham_nhs_foundation,,,,74cf9045-4511-4c50-8cd0-de621c838ff2,university_hospital_birmingham,University Hospital Birmingham +48,0.979231,ad79d699-2379-4397-bd1d-3bc4a90f3635,Fresenius Kabi,fresenius_kabi,,,,ad79d699-2379-4397-bd1d-3bc4a90f3635,fresenius_kabi,Fresenius Kabi +6825,,dd3b101e-8506-4344-b7e1-21a2434d9ea3,"Ortopædkirurgisk Afd. E, Århus Universitetshospital",ortop_dkirurgisk_afd_e_rhus_universitetshospital,,,,,, +6826,,17199a4d-9847-4e64-8b14-1bf7e17ed6f1,Städtisches Klinikum München GmbH,st_dtisches_klinikum_m_nchen_gmbh,,,,,, +6827,,8da56adc-7389-11e6-a0cd-0242ac12000b,STIEFEL,stiefel,,,,,, +6828,,7480b8df-8923-494b-a531-a72be9f31601,BioMarin Pharmaceutical Inc,biomarin_pharmaceutical_inc,,,,,, +342,0.97989612817764282,c7660ab0-005c-4f36-ae8c-13deb3b21748,AIR LIQUIDE,air_liquide,,,,748853e0-73f0-11e6-a0cd-0242ac12000b,air_liquide_america_lp,AIR LIQUIDE AMERICA LP +6829,,85fdaeca-7168-11e6-a0cd-0242ac12000b,POLYGEN PHARMS,polygen_pharms,,,,,, +6830,,2a879f61-a737-11e6-94cb-5656d04fc2b5,Department of Medical Gastroenterology,department_of_medical_gastroenterology,,,,,, +6831,,558bc19c-7194-11e6-a0cd-0242ac12000b,ROERIG,roerig,,,,,, +6832,,e418c9f0-c55e-41f8-8cf0-ef5bd76e9a82,Per Rosenberg,per_rosenberg,,,,,, +6833,,5d863e50-4af8-4114-8977-0b31f9da055a,Acedemic Medical Centre Amsterdam,acedemic_medical_centre_amsterdam,,,,,, +6834,,7d79a774-2966-45ce-8f7d-f1c00a445225,Pfizer Consumer Healthcare cva/sca,pfizer_consumer_healthcare_cva_sca,,,,,, +6835,,278f59cc-c3da-4764-91cd-18af23e7f527,SANOFI-AVENTIS OTC,sanofi_aventis_otc,,,,,, +6836,,b29d8b1d-08de-401a-827f-c629da20682b,Novo Nordisk Ltd,novo_nordisk_ltd,,,,,, +6837,,df357e04-5f43-44e7-b1f1-c83aba71f01f,"Astex Pharmaceuticals, Inc",astex_pharmaceuticals_inc,,,,,, +6838,,c4af9586-2a49-4537-9356-4523f846377f,"Department of Oncology, Haukeland University Hospital",department_of_oncology_haukeland_university_hospital,,,,,, +6839,,008ef416-7f61-4504-9005-b053d9279d63,NHS Greater Glasgow & Clyde Hospitals & University of Glasgow,nhs_greater_glasgow_clyde_hospitals_university_of_glasgow,,,,,, +6840,,d74759fa-0c9d-4f05-a4d9-58a645c0ea80,UNIVERSITÄTSKLINIKUM DER MEDIZINISCHEN FAKULTÄT FREIBURG,universit_tsklinikum_der_medizinischen_fakult_t_freiburg,,,,,, +6841,,f46c383a-f5ba-4c69-8eb4-843fb02fa6c9,OSPEDALE FATEBENEFRATELLI E OFTALMICO DI MILANO,ospedale_fatebenefratelli_e_oftalmico_di_milano,,,,,, +6842,,ec2f3601-830d-4cb1-9fe3-8f07b038fc3f,CHU-ULg,chu_ulg,,,,,, +291,0.978606,4d5cf9e6-6dd7-40a5-a084-d00ec1569bcb,GEICAM (GRUPO ESPAÑOL DE INVESTIGACION EN CANCER DE MAMA),geicam_grupo_espa_ol_de_investigacion_en_cancer_de_mama,,,,320e8407-98ad-450a-9b12-470d02f981e1,geicam_grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama,GEICAM (GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA) +6843,,28706a14-73f1-11e6-a0cd-0242ac12000b,AIRGAS MERCHANTS GASES LLC,airgas_merchants_gases_llc,,,,,, +6844,,9eb2f016-ad1b-4856-96fe-b1092883a115,"ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE ""G. PASCALE",istituto_nazionale_per_lo_studio_e_la_cura_dei_tumori_fondazione_g_pascale,,,,,, +6845,,d40b9b08-03fb-4cdc-8fab-e3f4ebc5b421,LABORATORI BALDACCI SPA,laboratori_baldacci_spa,,,,,, +6846,,328cf174-7190-11e6-a0cd-0242ac12000b,US PHARM HOLDINGS,us_pharm_holdings,,,,,, +710,0.98913925886154175,a117fcf6-2e5e-4345-9871-80e2d58cc89a,Reckitt Benckiser Pharmaceuticals,reckitt_benckiser_pharmaceuticals,,,,4c8adf00-5f9a-4177-9cd5-a40768a4ee60,reckitt_benckiser_pharmaceuticals_inc,Reckitt Benckiser Pharmaceuticals Inc +6847,,6f32372c-df0a-4be0-a836-e153db746ee0,FONDAZIONE DON CARLO GNOCCHI ONLUS,fondazione_don_carlo_gnocchi_onlus,,,,,, +6848,,cb7f21dc-cf52-45f7-9a1b-a04128171420,Alchemia Oncology Pty Ltd,alchemia_oncology_pty_ltd,,,,,, +6849,,772a54d3-915f-43ce-997c-df76a5cedcde,Dr. Miguel Martín,dr_miguel_mart_n,,,,,, +6850,,a8855b43-437d-42d5-9975-07c28c63f590,Respitatory and Allergy Research Unit,respitatory_and_allergy_research_unit,,,,,, +6851,,da1933cd-5e2f-4ae2-ace7-a573f2e6e12b,Medizinische Universität Innsbruck / Univ.-Klinik für Allgemeine und Chirurgische Intensivmedizin,medizinische_universit_t_innsbruck_univ_klinik_f_r_allgemeine_und_chirurgische_intensivmedizin,,,,,, +6852,,6d53c738-29ea-4d75-8661-73df9ee689f4,"Klinisk Farmakologisk Afdeling, Bispebjerg",klinisk_farmakologisk_afdeling_bispebjerg,,,,,, +953,0.97483021020889282,b19844c2-0641-440f-b8c1-ecb7a2484a06,MYLAN GmbH,mylan_gmbh,,,,7366e944-7126-11e6-8a77-0242ac12000b,mylan,MYLAN +6853,,d368cfa4-a1e3-40a3-b42b-21104557c874,ALLEGRIA onlus,allegria_onlus,,,,,, +6854,,7fa7bb9e-a90f-4265-821c-1f82198ee64d,Fundación Renal Iñigo Álvarez de Toledo,fundaci_n_renal_i_igo_lvarez_de_toledo,,,,,, +6855,,cfbcd01c-3790-4ffb-b7db-9faea1bea908,Stiftung Institut für Herzinfarktforschung,stiftung_institut_f_r_herzinfarktforschung,,,,,, +6856,,ad07ee51-4637-471b-82ba-2328ae730560,SEVAPHARMA a.s,sevapharma_a_s,,,,,, +645,0.98503661155700684,5b57c8bd-158c-42a5-bfa1-3323c67e0dd4,Boehringer Ingelheim Pharma GmbH,boehringer_ingelheim_pharma_gmbh,,,,5b57c8bd-158c-42a5-bfa1-3323c67e0dd4,boehringer_ingelheim_pharma_gmbh,Boehringer Ingelheim Pharma GmbH +6857,,35a7da52-1f58-4b18-89b1-3aeda93e440b,Fakultní nemocnice u sv. Anny v Brně,fakultn_nemocnice_u_sv_anny_v_brn,,,,,, +707,0.989136,b7175460-6c36-4ac7-8b9c-0166ae45766a,Grupo Español de Investigación en Cáncer de Ovario,grupo_espa_ol_de_investigaci_n_en_c_ncer_de_ovario,,,,5c77e08b-5755-407d-a8b9-74bfb0127f85,grupo_espa_ol_de_investigaci_n_en_c_ncer_de_ovario_geico,Grupo Español de Investigación en Cáncer de Ovario (GEICO) +6858,,3cfbc1dd-30e2-4137-bb24-5456fd295ee0,"Skåne University Hospital, Department of Oncology",sk_ne_university_hospital_department_of_oncology,,,,,, +6859,,20ef7316-9911-423c-a298-d5cf4307bbe3,"University Hospitals Leuven, department of pediatrics",university_hospitals_leuven_department_of_pediatrics,,,,,, +6860,,e0d389c4-23fa-413c-99d7-ee36897d56a5,"Department of Internal Medicine, University Hospital Gasthuisberg",department_of_internal_medicine_university_hospital_gasthuisberg,,,,,, +6861,,c44953f1-7353-4ecf-924b-8ea267442d25,PharmaMar S.A. Sociedad Unipersonal,pharmamar_s_a_sociedad_unipersonal,,,,,, +6862,,3a48dafd-e5b6-400f-a0aa-a13b29660736,Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR),fundaci_hospital_universitari_vall_d_hebron_institut_de_recerca_vhir,,,,,, +6863,,843c9dce-3e49-4193-8245-acf1bcc6b6a7,KORPO S.R.L,korpo_s_r_l,,,,,, +6864,,31ec4d6f-332c-4d85-8680-1127f39a5781,Dermatologikum Hamburg,dermatologikum_hamburg,,,,,, +6865,,5a7b4dea-0c5e-4c50-b7f8-ee4d737a98f4,AXCAN PHARMA Inc,axcan_pharma_inc,,,,,, +6866,,909eb53a-4e4b-4c50-b0b5-2c9c5c792f58,TRB CHEMEDICA INTERNATIONAL SA,trb_chemedica_international_sa,,,,,, +6867,,1f2ff80a-6fc0-11e6-abe8-0242ac12000b,Department of Oncology University Hospital Uppsala,department_of_oncology_university_hospital_uppsala,,,,,, +6868,,8cd190dd-43f4-4bd5-bddb-f9b62b3fb445,"VG Region, Sahlgrenska sjukhuset, Hudkliniken, Göteborg",vg_region_sahlgrenska_sjukhuset_hudkliniken_g_teborg,,,,,, +6869,,90a77e8d-6b6a-4948-9708-58e231a1996e,Diabetes-Centre Quakenbrueck,diabetes_centre_quakenbrueck,,,,,, +6870,,0327e0a7-5302-4d0d-911f-e7d1537ddec7,sanofi-aventis France,sanofi_aventis_france,,,,,, +6871,,e96690f2-715f-11e6-a0cd-0242ac12000b,PFIZER PHARMS,pfizer_pharms,,,,,, +6872,,2d2b604e-72f3-11e6-a0cd-0242ac12000b,DUCHESNAY,duchesnay,,,,,, +6873,,8aba2a6c-838a-48e8-9fad-359763810771,Sanquin Plasma Products,sanquin_plasma_products,,,,,, +6874,,07e705fe-714f-11e6-a0cd-0242ac12000b,SWAN PHARMS LLC,swan_pharms_llc,,,,,, +6875,,eca84209-69fd-4034-838b-9d9e5d6dfa17,Pierre Fabre Me'dicament,pierre_fabre_me_dicament,,,,,, +6876,,f5e1aa3b-9e23-4fd0-b5ae-a0777492a566,"Vital Therapies, Inc",vital_therapies_inc,,,,,, +6877,,5dd62f17-74bf-4bc6-8d42-0ce652195731,Proctor and Gamble Technical Centres Ltd,proctor_and_gamble_technical_centres_ltd,,,,,, +6878,,0c22b991-3c31-4a16-9512-4a04438aa5ed,"Johannes Gutenberg-Universität Mainz, Urologische Klinik (ausführende Stelle), Prof. Dr. med. Thürof",johannes_gutenberg_universit_t_mainz_urologische_klinik_ausf_hrende_stelle_prof_dr_med_th_rof,,,,,, +6879,,11f4cfe7-1797-4259-bf04-3cd1d8902e29,Sanna Vilo,sanna_vilo,,,,,, +6880,,776bff1d-f653-427e-b6aa-d780857cacd7,AZIENDA OSPEDALIERA DI PARMA,azienda_ospedaliera_di_parma,,,,,, +380,0.97214979595608186,c433cb87-9264-40ab-a126-96183cdaaee4,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., USA",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_usa,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" +387,0.973636,ca687599-182d-4009-8f97-ed0bf46b35a7,Foundation of Liver research,foundation_of_liver_research,,,,9151744a-bb73-438c-895c-dd8f508cc732,foundation_of_liver_research_slo,Foundation of Liver Research (SLO) +535,0.944741,4b00100f-06dd-4f72-b6f2-eafde94f2ed0,National Institute of Health and the Environment (Dutch acronym: RIVM),national_institute_of_health_and_the_environment_dutch_acronym_rivm,,,,2a1b4dd7-b8f2-4ab2-be0a-7f9f70d3d524,national_institute_of_health_and_the_environment_rivm,National Institute of Health and the Environment (RIVM) +6881,,4b2093de-7164-11e6-a0cd-0242ac12000b,LOTUS PHARM CO LTD,lotus_pharm_co_ltd,,,,,, +6882,,1fd12ca4-7167-11e6-a0cd-0242ac12000b,ZEVACOR PHARMA INC,zevacor_pharma_inc,,,,,, +6883,,509d5d18-8b88-423a-91bd-f334ea4ce177,"Anders Gadegaard Jensen,Anesthesia and Intensive Care Unit, Odense University Hospital",anders_gadegaard_jensen_anesthesia_and_intensive_care_unit_odense_university_hospital,,,,,, +6884,,4abb61a0-73fb-11e6-a0cd-0242ac12000b,BLUE EARTH,blue_earth,,,,,, +584,0.984184,afd27f84-72ec-11e6-a0cd-0242ac12000b,PHARMACARE LTD,pharmacare_ltd,,,,4a85fe12-965a-11e6-becf-0242ac110008,pharmacare,PHARMACARE +6885,,75b6e8ee-7305-11e6-a0cd-0242ac12000b,SHIRE DEVELOPMENT,shire_development,,,,,, +6886,,4e9ea8df-3e94-48d0-8250-2219196b04c2,Christie Hospital NHS Trust,christie_hospital_nhs_trust,,,,,, +6887,,c17b24c3-f3fb-4662-b897-8302377ed7e3,Novartis Sverige AB,novartis_sverige_ab,,,,,, +341,0.984301,c51b05f7-a4e4-43e5-9a41-6ef18a985cef,Pfizer SA,pfizer_sa,,,,669b5851-2df0-4123-b6d8-74dd0d44fb69,pfizer_sa_nv,Pfizer SA/NV +607,0.989401,dfe33f9c-fc87-4176-a56a-52c1a7a26063,Advanced Accelerator Applications,advanced_accelerator_applications,,,,dfe33f9c-fc87-4176-a56a-52c1a7a26063,advanced_accelerator_applications,Advanced Accelerator Applications +6888,,c86f9c70-6cb7-4275-aea8-8ecdd7937ec2,Pfizer Luxembourg SARL Branch Office in Lithuania,pfizer_luxembourg_sarl_branch_office_in_lithuania,,,,,, +6889,,400cabdc-1fe0-4df9-9a65-04bfd96b22dd,"MicroDose Therapeutx, Inc., a wholly owned subsidiary of Teva Pharmaceuticals Industries, Ltd",microdose_therapeutx_inc_a_wholly_owned_subsidiary_of_teva_pharmaceuticals_industries_ltd,,,,,, +6890,,963b4c0f-d041-4a8b-b25e-6843a3f231d4,"Departement of orthopaedic surgery, Århus Sygehus",departement_of_orthopaedic_surgery_rhus_sygehus,,,,,, +6891,,73e6f7e1-f535-4e20-9c53-eb570f7cb5e3,University of Michigan,university_of_michigan,,,,,, +225,0.98610919713973999,090da71e-b718-413e-ba77-0e109a22d5d5,Fertilitetsklinikken,fertilitetsklinikken,,,,090da71e-b718-413e-ba77-0e109a22d5d5,fertilitetsklinikken,Fertilitetsklinikken +6892,,a2d0dab2-ba4d-4a87-8292-2141cc000b57,Fundación MD Ánderson Internacional España,fundaci_n_md_nderson_internacional_espa_a,,,,,, +6893,,0aeecb73-8369-48d4-a06a-f27790fa88aa,"Academisch Medisch Centrum bij de Universiteit van Amsterdam (AMC) Prof. dr. M. M. Levi, Dean & Chair",academisch_medisch_centrum_bij_de_universiteit_van_amsterdam_amc_prof_dr_m_m_levi_dean_chair,,,,,, +6894,,3d6dd7f6-71a5-11e6-a0cd-0242ac12000b,MALLINCKRODT LLC,mallinckrodt_llc,,,,,, +6895,,90ef524c-7243-45c3-83d6-006bdffb7b59,Hermo Pharma Ltd,hermo_pharma_ltd,,,,,, +6896,,2ea89bac-c6b8-48ef-ad8b-ab9b4fa32611,"Helsinki University Central Hospital, Pain Clinic",helsinki_university_central_hospital_pain_clinic,,,,,, +6897,,ed0f3d1f-3a9a-463a-926a-c972ed7d9fa6,"Gabinete Berthier y Martínez, S.L",gabinete_berthier_y_mart_nez_s_l,,,,,, +6898,,5a3ca9c6-3856-4d33-a44a-33eff126c686,ProFibrix BV,profibrix_bv,,,,,, +6899,,110f53eb-33d2-41e7-9558-234256fe9799,"Medizinische Universität Wien,KIM I,Klinische Abteilung für Infektionen u.Tropenmedizin",medizinische_universit_t_wien_kim_i_klinische_abteilung_f_r_infektionen_u_tropenmedizin,,,,,, +6900,,3a5eb9b1-2f3d-4f19-98e0-94ea80663d1a,MedImmune Limited,medimmune_limited,,,,,, +6901,,fbd9b068-715d-11e6-a0cd-0242ac12000b,ALKEM,alkem,,,,,, +6902,,a2c45252-d267-4bd1-bdbe-4c48d7fc4205,D-Pharm Ltd,d_pharm_ltd,,,,,, +6903,,128cbd4f-fc92-4cb9-b8da-47f2107d8a52,prof. dr. M.A.F.J. van de Laar,prof_dr_m_a_f_j_van_de_laar,,,,,, +6904,,aaa9eb4d-27eb-44ba-b463-19135b8ce376,Berufsgenossenschaftliche Unfallklinik,berufsgenossenschaftliche_unfallklinik,,,,,, +699,0.984107,ea74ab29-48fb-4575-b97e-5d8ea891bdcb,Bayer Pharmaceutical,bayer_pharmaceutical,,,,ea74ab29-48fb-4575-b97e-5d8ea891bdcb,bayer_pharmaceutical,Bayer Pharmaceutical +6905,,703313b3-4cef-4fe6-b727-9ac459ad1dc4,MUC Research GmbH,muc_research_gmbh,,,,,, +6906,,19e4e3ff-3cda-4591-be1a-6a8e301615c3,BioMS Technology Corp,bioms_technology_corp,,,,,, +6907,,b338664f-54c4-4f11-9619-331df2dc19bd,"Medizinische Universität Wien, Klin. Abt. für Endokrinologie & Stoffwechsel, Universitätsklinik für Innere Medizin III",medizinische_universit_t_wien_klin_abt_f_r_endokrinologie_stoffwechsel_universit_tsklinik_f_r_innere_medizin_iii,,,,,, +6908,,7f61b3a2-719c-11e6-a0cd-0242ac12000b,STERLING,sterling,,,,,, +6909,,1e9ea819-cfce-4c9a-9faf-435756e3e401,UNIVERSITY CLINIC GOLNIK,university_clinic_golnik,,,,,, +6910,,f846bba2-a52b-4ce6-a688-461cd9b2dbd3,UMCN department Pharm-Tox,umcn_department_pharm_tox,,,,,, +6911,,734ade7a-7028-46b4-b173-4942a0d94dc2,EANM Forschungs GmbH / EANM Research Ltd,eanm_forschungs_gmbh_eanm_research_ltd,,,,,, +294,0.980402,3f94f9c4-5b24-4215-96a7-f4fef896ec87,Dept. of Internal Medicine,dept_of_internal_medicine,,,,3f94f9c4-5b24-4215-96a7-f4fef896ec87,dept_of_internal_medicine,Dept. of Internal Medicine +6912,,3232c842-edb2-4ec1-b5fd-e6c38fa895b7,Pfizer Kft,pfizer_kft,,,,,, +814,0.985423,03bcbda2-715e-11e6-a0cd-0242ac12000b,NATCO PHARMA,natco_pharma,,,,03bcbda2-715e-11e6-a0cd-0242ac12000b,natco_pharma,NATCO PHARMA +6913,,1550e7ce-c223-4cdd-80b6-95e6c12f3972,"CLINICAL TRIAL SERVICE UNIT, UNIVERSITY OF OXFORD",clinical_trial_service_unit_university_of_oxford,,,,,, +514,0.979838,197c3c96-71cf-11e6-a0cd-0242ac12000b,PHARMACIA,pharmacia,,,,197c3c96-71cf-11e6-a0cd-0242ac12000b,pharmacia,PHARMACIA +6914,,5f62b2e4-7148-11e6-a0cd-0242ac12000b,SIEGFRIED,siegfried,,,,,, +6915,,bcd51dce-34ad-4f3a-99c4-efa1a4cb5122,Probiodrug AG,probiodrug_ag,,,,,, +6916,,950eebaf-f262-4077-a1d5-9eb1a499a2a5,Cangene Europe Ltd,cangene_europe_ltd,,,,,, +6917,,684e0795-4da4-4972-8e6f-8d285eafaf0e,Apocare Pharma GmbH,apocare_pharma_gmbh,,,,,, +6918,,87306dc7-18d0-481a-a97d-4c52e078a121,"Abbott A/S Laboratories , Denmark",abbott_a_s_laboratories_denmark,,,,,, +6919,,4f560186-7368-11e6-a0cd-0242ac12000b,HORIZON PHARMA USA,horizon_pharma_usa,,,,,, +957,0.957248,321c0173-119e-4164-9f51-ae2b1d03cb92,"UMCG, Van Buchem Stichting",umcg_van_buchem_stichting,,,,321c0173-119e-4164-9f51-ae2b1d03cb92,umcg_van_buchem_stichting,"UMCG, Van Buchem Stichting" +351,0.97875547409057617,71261df6-46ce-421c-babd-99f3e048421a,"Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen",deutsches_herzzentrum_m_nchen_klinik_f_r_herz_und_kreislauferkrankungen,,,,490436c4-c1f2-4859-b7ae-69b121dd48d9,deutsches_herzzentrum_m_nchen,Deutsches Herzzentrum München +531,0.979737,50f04e40-7145-11e6-a0cd-0242ac12000b,BEDFORD,bedford,,,,50f04e40-7145-11e6-a0cd-0242ac12000b,bedford,BEDFORD +6920,,d24d15a0-7239-11e6-a0cd-0242ac12000b,DXS DEVICES,dxs_devices,,,,,, +6921,,fd4c0b7f-c16d-4a4c-9ffc-4464fb8a2467,URIACH J. URIACH Y COMPANIA S.A,uriach_j_uriach_y_compania_s_a,,,,,, +6922,,cd360ce3-d5ff-4b7a-9dad-41442177f531,ASSOCIAZIONE S.N.O.- SCIENZE NEUROLOGICHE OSPEDALIERE,associazione_s_n_o_scienze_neurologiche_ospedaliere,,,,,, +6923,,7a11a164-6bcf-441b-aab7-28e2569ceda5,RDD Pharma Ltd,rdd_pharma_ltd,,,,,, +6924,,81e0b1bf-6776-4395-88e3-a8c3ca4fd7e9,"Klinikum der Universität München, Anstalt des öffentlichen Rechts",klinikum_der_universit_t_m_nchen_anstalt_des_ffentlichen_rechts,,,,,, +6925,,58825152-33a9-4a87-95e8-4a79f2898323,"CoTherix, Inc",cotherix_inc,,,,,, +6926,,3c20fb30-aca3-4676-a90b-d2d285dae5fe,Hospira UK limited,hospira_uk_limited,,,,,, +6927,,aa498aa7-8c7c-4f7f-b8c4-41b705f2394b,Olympus France SAS,olympus_france_sas,,,,,, +6928,,57940930-b2e7-4a03-81c9-f1af0205df60,Michael J. Fox Foundation for Parkinson’s Research,michael_j_fox_foundation_for_parkinson_s_research,,,,,, +6929,,1ce02581-7376-41a2-8e50-c3f1d2f545ad,Allergan Limited,allergan_limited,,,,,, +6930,,f6dbb2d6-7276-11e6-a0cd-0242ac12000b,VANSEN PHARMA,vansen_pharma,,,,,, +6931,,1a57e819-c3bb-41df-8043-889a4265b9f2,Dr. Jesús San Miguel Izquierdo,dr_jes_s_san_miguel_izquierdo,,,,,, +6932,,20435caa-c19a-47dd-b388-40743fad085b,"Medizinische Universität Wien, Univ.-Klinik für Spezielle Anästhesie und Schmerztherapie",medizinische_universit_t_wien_univ_klinik_f_r_spezielle_an_sthesie_und_schmerztherapie,,,,,, +6933,,57077b79-9f85-4f91-930e-50be947b7779,"Neurocrine Biosciences, INC",neurocrine_biosciences_inc,,,,,, +6934,,79b16dee-73d6-11e6-a0cd-0242ac12000b,OREXO US INC,orexo_us_inc,,,,,, +6935,,f6946944-72c6-11e6-a0cd-0242ac12000b,GALEN SPECIALTY,galen_specialty,,,,,, +913,0.9859306812286377,bdf11e2c-ae9f-4c1b-84d0-efe510206597,"Department of Cardiology, UK Aachen",department_of_cardiology_uk_aachen,,,,28a229c0-5d6e-4889-95a4-444fe02e5e3c,department_of_cardiology,Department of Cardiology +6936,,b193159c-7146-11e6-a0cd-0242ac12000b,SILARX,silarx,,,,,, +6937,,133cb43b-3026-4af3-aa06-ea4dbe81aa9a,UCB Japan Co. Ltd,ucb_japan_co_ltd,,,,,, +6938,,b5255a10-719d-11e6-a0cd-0242ac12000b,APIL,apil,,,,,, +744,0.97777305046717322,7c93ba08-6123-42f2-a902-d13e42cdd905,Johann Wolfgang Goethe-Universität Frankfurt am Main,johann_wolfgang_goethe_universit_t_frankfurt_am_main,,,,7c93ba08-6123-42f2-a902-d13e42cdd905,johann_wolfgang_goethe_universit_t_frankfurt,Johann Wolfgang Goethe-Universität Frankfurt +6939,,db8d61d4-71ac-11e6-a0cd-0242ac12000b,CHART MEDCL,chart_medcl,,,,,, +6940,,25da3dfe-920a-4086-8caf-8b2fc22bdaf2,Heart of England NHS Foundation Trust Radiology Department,heart_of_england_nhs_foundation_trust_radiology_department,,,,,, +6941,,039c0e09-b4d7-48b7-8347-03ec181e13ca,Dra. Nuria Mañes Bonet. Sección de Cirugía Torácica. Hospital Universitario de Canarias,dra_nuria_ma_es_bonet_secci_n_de_cirug_a_tor_cica_hospital_universitario_de_canarias,,,,,, +907,0.97142676512400306,eb9e8887-858d-4ff5-add8-ce95d14fca4d,sanofi-aventis recherche et developpement,sanofi_aventis_recherche_et_developpement,,,,f72ce0f5-27b8-42db-aeea-0faa55409a54,sanofi_aventis_recherche_et_developpement,sanofi-aventis recherche et developpement +6942,,2ced2f14-f283-4541-80f7-d6e788d81a65,UHB NHS Foundation Trust,uhb_nhs_foundation_trust,,,,,, +6943,,dd8e27f1-6993-4e6f-9cf9-f080b60fb259,"Bayer Healthcare AG, D-51368, Leverkusen",bayer_healthcare_ag_d_51368_leverkusen,,,,,, +6944,,e918cf88-7160-11e6-a0cd-0242ac12000b,SHIRE RICHWOOD,shire_richwood,,,,,, +6945,,87bf0701-682f-4de2-a5c3-a7d9fe2b740e,AZAD Pharma AG,azad_pharma_ag,,,,,, +511,0.931409,a81bbb65-9b77-48ec-9afc-97b008ea886e,PharmaMar SAU,pharmamar_sau,,,,69596232-b165-4d72-8a18-1e0bbdd636c6,pharmamar_sa_unipersonal,PharmaMar SA unipersonal +6946,,73179bed-bab8-4dea-a961-433ccc2a4b6d,ITALIAN SARCOMA GROUP,italian_sarcoma_group,,,,,, +6947,,ed4c3d1a-716a-11e6-a0cd-0242ac12000b,INTERMUNE PHARMS,intermune_pharms,,,,,, +344,0.980149,11e94b5f-d540-4085-bee2-a20da96129f1,"Otto-von-Guericke University, Medical Faculty, Dpt. of Neurology",otto_von_guericke_university_medical_faculty_dpt_of_neurology,,,,11e94b5f-d540-4085-bee2-a20da96129f1,otto_von_guericke_university_medical_faculty_dpt_of_neurology,"Otto-von-Guericke University, Medical Faculty, Dpt. of Neurology" +6948,,39b8cf46-a737-408d-83f3-cd2c4acc498e,3M,3m,,,,,, +1052,0.93933373689651489,d6d116ab-4473-4e23-8414-54f606138536,"University of Oxford, Clinical Trials and Research Governance",university_of_oxford_clinical_trials_and_research_governance,,,,574a16cb-eb53-4e25-95a2-a07455968d04,university_of_oxford_clinical_trials_and_research_governance,"University of Oxford, Clinical Trials and Research Governance Office" +495,0.98471283912658691,27140480-7146-11e6-a0cd-0242ac12000b,DR REDDYS LA,dr_reddys_la,,,,27140480-7146-11e6-a0cd-0242ac12000b,dr_reddys_la,DR REDDYS LA +6949,,450a07f9-f783-4cb2-b62f-68125899724c,Investigacion Independiente,investigacion_independiente,,,,,, +6950,,feeb0b39-1102-41e2-8009-23077e318056,Orthopaedic research unit. Odense University Hospital,orthopaedic_research_unit_odense_university_hospital,,,,,, +6951,,94778532-634a-4bf6-96bb-fff1fe96720c,Park-Klinikum,park_klinikum,,,,,, +6952,,77393691-7c54-4fb6-8a9c-3df293b9b198,Dansk Hovedpinecenter,dansk_hovedpinecenter,,,,,, +6953,,bc271298-7030-4016-b22d-31b16f696871,Avigen Inc,avigen_inc,,,,,, +6954,,3752bbd6-798c-430b-a5b0-0bf956aea171,European Cardiovascular Research Institute,european_cardiovascular_research_institute,,,,,, +6955,,846472a6-9208-4c43-b4b4-fc78cd5953a6,Rafael Selgas,rafael_selgas,,,,,, +6956,,642dfe6b-b574-4450-8740-88976623328e,"Cliniques Universitaires Saint-Luc, Université catholique de Louvain",cliniques_universitaires_saint_luc_universit_catholique_de_louvain,,,,,, +118,0.982527,1b1c70ea-715f-11e6-a0cd-0242ac12000b,OAK PHARMS,oak_pharms,,,,1b1c70ea-715f-11e6-a0cd-0242ac12000b,oak_pharms,OAK PHARMS +6957,,062547a5-76a9-4994-97ae-3199e9d82682,"UCB Korea Co.,Ltd",ucb_korea_co_ltd,,,,,, +6958,,6dc6f3fa-e891-4604-b1cc-f45bb9399401,"Department of Neuroscience, neurology",department_of_neuroscience_neurology,,,,,, +6959,,1669ed6e-e493-4d1c-9573-1c096ff6f134,"University School of Medicine Hannover (MHH), represented by the chairmanship",university_school_of_medicine_hannover_mhh_represented_by_the_chairmanship,,,,,, +6960,,d5122562-8bc2-11e6-a449-0242ac12000b,"Pediatric Unit, Hillerød Hospital",pediatric_unit_hiller_d_hospital,,,,,, +6961,,ade49b58-bb0f-4e98-bf95-4992cce2ce96,"University of Oxford, Research Governance & Clinical Trials Office",university_of_oxford_research_governance_clinical_trials_office,,,,,, +6962,,d55ce4c4-3461-48b4-8156-18fd5c7910c7,CONRAD EASTERN VIRGINIA MEDICAL SCHOOL,conrad_eastern_virginia_medical_school,,,,,, +6963,,1338cf53-ca45-4d97-b99a-d62a0cc9a3f7,Diana Molina Villaverde,diana_molina_villaverde,,,,,, +980,0.979352,1743b2fc-080c-4820-9527-15454fe27836,Gambro Lundia AB,gambro_lundia_ab,,,,1743b2fc-080c-4820-9527-15454fe27836,gambro_lundia_ab,Gambro Lundia AB +564,0.925101,0c57bc5a-dee4-4689-9938-6075f7ec9b69,Norfolk and Norwich University Hospital NHS Foundation Trust,norfolk_and_norwich_university_hospital_nhs_foundation_trust,,,,0c57bc5a-dee4-4689-9938-6075f7ec9b69,norfolk_and_norwich_university_hospital_nhs_foundation_trust,Norfolk and Norwich University Hospital NHS Foundation Trust +6964,,0ba12214-71e2-4c31-b645-49e36bbe9930,"Orthopaedic department, Karolinska Institutet, Danderyd's Hospital",orthopaedic_department_karolinska_institutet_danderyd_s_hospital,,,,,, +251,0.987649,5b28c378-71c3-11e6-a0cd-0242ac12000b,VIRTUS PHARMS,virtus_pharms,,,,5b28c378-71c3-11e6-a0cd-0242ac12000b,virtus_pharms,VIRTUS PHARMS +1003,0.970735,ffb25e01-d581-4ef1-bf34-52ee1773efa2,Pfizer Limited. Pfizer Global Research and Development,pfizer_limited_pfizer_global_research_and_development,,,,9134f49c-0675-4fb8-9e30-403bf260e44d,pfizer_limited,Pfizer Limited +72,0.9488164484500885,a359d331-932d-4716-9cec-7901baf5cc1b,Takeda Global Research & Development Centre (Europe) Ltd (TGRD),takeda_global_research_development_centre_europe_ltd_tgrd,,,,a359d331-932d-4716-9cec-7901baf5cc1b,takeda_global_research_development_centre_europe_ltd,Takeda Global Research & Development Centre (Europe) Ltd +6965,,21c4b576-71a3-11e6-a0cd-0242ac12000b,IROKO PHARMS,iroko_pharms,,,,,, +6966,,44455077-dece-4c0e-b056-751e8b843baa,Portsmouth Hospitals NHS trust,portsmouth_hospitals_nhs_trust,,,,,, +6967,,1535df1c-73db-11e6-a0cd-0242ac12000b,BRAEBURN PHARMS INC,braeburn_pharms_inc,,,,,, +6968,,3acc81ce-96c5-4498-b997-d7a174490242,Acadia Pharmaceuticals Inc,acadia_pharmaceuticals_inc,,,,,, +6969,,ed72a9ab-1053-4270-8ed0-8b83f62dc07b,"Aarhus University Hospital, Department of Rheumatology U",aarhus_university_hospital_department_of_rheumatology_u,,,,,, +6970,,3dbe3eba-22ce-42cc-80e5-e2aa5616cb6c,PolyMedix Inc,polymedix_inc,,,,,, +202,0.9779740571975708,0ca95325-5fdb-4264-9a4d-da0285235e77,"Helse Bergen HF, Haukeland University Hospital",helse_bergen_hf_haukeland_university_hospital,,,,0ca95325-5fdb-4264-9a4d-da0285235e77,helse_bergen_hf_haukeland_university_hospital,"Helse Bergen HF, Haukeland University Hospital" +6971,,e0eecc66-8b90-4a62-8484-6b7a55123e59,"RE&D VÚFB, s.r.o",re_d_v_fb_s_r_o,,,,,, +6972,,d400ed48-6133-4340-94ec-e93df8540486,"University of Oslo, institute for basic medical sciences, department of nutrition",university_of_oslo_institute_for_basic_medical_sciences_department_of_nutrition,,,,,, +6973,,6aeef86a-0f07-4f94-ae5c-1094f6d3ca79,Seahorse Scientific Services Ltd,seahorse_scientific_services_ltd,,,,,, +6974,,88e1a2f1-1aa0-49ed-9f67-3e25c391ef58,University Hospital Vienna,university_hospital_vienna,,,,,, +6975,,f3000250-adf1-4d58-bf3b-b9e73365bba4,Bernardino Clavo - Hospital Dr. Negrin,bernardino_clavo_hospital_dr_negrin,,,,,, +6976,,30fff4ff-c2aa-4674-bb0b-607c9e86ef71,VIVENTIA BIOETICH INC,viventia_bioetich_inc,,,,,, +6977,,d7015255-5027-4345-9944-a232554abd6c,Universitätskinderklinik Heidelberg,universit_tskinderklinik_heidelberg,,,,,, +6978,,4904c469-a354-448d-bfa5-7d2c44c85729,Center for Muscle and Bone Research of the Charité Universitaetsmedizin Berlin,center_for_muscle_and_bone_research_of_the_charit_universitaetsmedizin_berlin,,,,,, +6979,,b9331f6b-4839-4ef5-9b8f-aa313b8a4f6c,"Dept Medicine I, Paracelsus Med. Univ. Landeskrankenanstalten Salzburg / SALK",dept_medicine_i_paracelsus_med_univ_landeskrankenanstalten_salzburg_salk,,,,,, +6980,,b9703d66-a283-4c68-848c-3e45227edb6a,IDEA AG,idea_ag,,,,,, +6981,,06ac8661-9dff-4bce-b2b3-5fa3e0182119,"Wyeth Pharmaceuticals, Inc., acting through Wyeth Research, a Pfizer Company",wyeth_pharmaceuticals_inc_acting_through_wyeth_research_a_pfizer_company,,,,,, +6982,,c42d8476-2e66-4c3a-a823-502be6080311,Allergie-Centrum-Charité Universitätsmedizin Berlin,allergie_centrum_charit_universit_tsmedizin_berlin,,,,,, +6983,,221aaa33-6a49-4b74-b045-b4ce8b9023f1,Parnassia-BAVO groep,parnassia_bavo_groep,,,,,, +6984,,8d6e2c1a-c710-41bd-9822-c9dfbcd5e71b,Maxima Medical center,maxima_medical_center,,,,,, +6985,,3bd97a30-c96b-4d59-bc00-31495267928d,Janssen Biologics BV,janssen_biologics_bv,,,,,, +6986,,1149336c-0e7b-47f7-8f47-fccfb49fb50f,The Mentholatum Company Ltd,the_mentholatum_company_ltd,,,,,, +6987,,74868533-09e6-4764-b80c-8feb044e5e7c,Antigenics Inc,antigenics_inc,,,,,, +866,0.96057683229446411,ead26ef6-4f3c-4e33-8dc7-c5d3c9146e43,"Hvidovre Hospital, Dept. Rheumatology",hvidovre_hospital_dept_rheumatology,,,,777eeb1f-10b4-4c96-8d33-42be9c44ad2b,hvidovre_hospital,Hvidovre Hospital +6988,,2a36d878-6673-496e-a61d-42c7980b788b,Cliniques Hopitaux Universitaires NANTES,cliniques_hopitaux_universitaires_nantes,,,,,, +129,0.97465506196022034,4bc32527-accc-401e-81cd-afaacbe32d0c,Cliniques Universitaires St Luc - UCL,cliniques_universitaires_st_luc_ucl,,,,4bc32527-accc-401e-81cd-afaacbe32d0c,cliniques_universitaires_st_luc,Cliniques Universitaires St Luc +540,0.979562,77d53b33-f406-4819-9900-50d2cea07c42,"Dow Pharmaceutical Sciences, Inc on behalf of Coria Laboratories",dow_pharmaceutical_sciences_inc_on_behalf_of_coria_laboratories,,,,3817f8bc-4ff8-495a-9b3e-ba7bf5fb409b,dow_pharmaceutical_sciences,Dow Pharmaceutical Sciences +6989,,fc61e5ae-6f9c-11e6-9663-0242ac12000b,Astra ZenecaGmbH,astra_zenecagmbh,,,,,, +6990,,06c03e3c-bda4-46e1-b8ae-15fa2cebc8c7,Bo Söderpalm,bo_s_derpalm,,,,,, +6991,,71c4bb60-04df-46e5-8f3e-f83bea6cc2d4,Plazmaferezis Állomás Közhasznú Nonprofit Kft,plazmaferezis_llom_s_k_zhaszn_nonprofit_kft,,,,,, +6992,,e6c4fc4e-84a4-42e9-a7bd-89aa4ff0eb28,University Medical Center Ultrecht,university_medical_center_ultrecht,,,,,, +1024,0.902645,5cec190c-2967-479b-94a5-361445088c27,"Celtic Pharma Development Services Bermuda, Ltd",celtic_pharma_development_services_bermuda_ltd,,,,2c174554-737a-4729-99f3-4cc6843b2b31,celtic_pharma_development_services_bermuda_limited,Celtic Pharma Development Services Bermuda Limited +6993,,2ec4d43f-068f-4af8-a1b8-abeb55de7498,"Ignyta, Inc",ignyta_inc,,,,,, +56,0.98137152194976807,0406db2b-5dbf-4c1f-87bb-d6df0227905a,"Radboud University Nijmegen Medical Centre, Department of Endocrinology",radboud_university_nijmegen_medical_centre_department_of_endocrinology,,,,9078130e-eeb6-4d4a-9b3b-bf9f3a7082c5,radboud_university_nijmegen_medical_centre,Radboud University Nijmegen Medical Centre +6994,,ff4e23a1-1754-49e4-8340-60326b611676,Martini Hospital Groningen,martini_hospital_groningen,,,,,, +300,0.972939,5715166a-8be0-11e6-a449-0242ac12000b,Rigshospital,rigshospital,,,,5715166a-8be0-11e6-a449-0242ac12000b,rigshospital,Rigshospital +21,0.98614925146102905,31fe54e5-0be3-4070-88f1-464180a02a89,STALLERGENES,stallergenes,,,,31fe54e5-0be3-4070-88f1-464180a02a89,stallergenes,STALLERGENES +1014,0.98766794800758362,9b368f8e-02db-4935-a1a6-f2a417efa7ee,Institut de Recherches Internationales Servier ( IRIS ),institut_de_recherches_internationales_servier_iris,,,,9b368f8e-02db-4935-a1a6-f2a417efa7ee,institut_de_recherches_internationales_servier,Institut de Recherches Internationales Servier +6995,,168954da-a683-4e1a-9e85-c88bef002371,North Hampshire Hospital NHS Trust,north_hampshire_hospital_nhs_trust,,,,,, +6996,,df27dbe6-d85e-4fbf-b184-3b1a23c0b903,Fundación Interhospitalaria Investigación Cardiovascular,fundaci_n_interhospitalaria_investigaci_n_cardiovascular,,,,,, +6997,,9fe7536e-ce24-4a41-bf15-f03b1e234cb0,Università degli Studi di Torino-Dipartimento di Biotecnologie Molecolari e Scienze della Salute,universit_degli_studi_di_torino_dipartimento_di_biotecnologie_molecolari_e_scienze_della_salute,,,,,, +6998,,b17073e8-ff4a-4825-b099-c7ae2938ab99,Sonderforschungsbereich 656 (SFB 656),sonderforschungsbereich_656_sfb_656,,,,,, +523,0.983968,4d30a044-47ed-412a-947f-20d391297f9c,Martin-Luther-University Halle-Wittenberg,martin_luther_university_halle_wittenberg,,,,32be795e-a544-49ea-9655-1702405333a9,martin_luther_university,Martin-Luther-University +6999,,8dff3bd2-1d10-4abf-97be-da73b191cc51,Omega Pharma N.V,omega_pharma_n_v,,,,,, +7000,,8b0c37a4-299e-4aa0-a23f-672a21bba675,QUANTUM GENOMICS,quantum_genomics,,,,,, +7001,,3d220292-7167-11e6-a0cd-0242ac12000b,HOT SHOTS NM LLC,hot_shots_nm_llc,,,,,, +936,0.95275402069091797,914bfd3e-c75d-45fc-b52a-86eeefd78a2e,Royal Liverpool and Broardgreen University Hospitals Trust,royal_liverpool_and_broardgreen_university_hospitals_trust,,,,33e84b15-e25f-402d-bf4e-0f564d9c0255,royal_liverpool_and_broadgreen_university_hospitals_trust,Royal Liverpool and Broadgreen University Hospitals Trust +7002,,55be6232-7144-11e6-a0cd-0242ac12000b,WORLD GEN,world_gen,,,,,, +7003,,836aca18-d45c-4431-b4f8-0bf18b17c7c2,Janssen Research & Development,janssen_research_development,,,,,, +7004,,42352d65-fa40-4102-aa16-0d993434926d,Dr. Evaristo Varo Pérez,dr_evaristo_varo_p_rez,,,,,, +7005,,d9cdb95a-dc6a-463a-a032-05f75b644c33,South Tees Hospitals NHS Trust,south_tees_hospitals_nhs_trust,,,,,, +7006,,ec73256b-a086-4059-8549-63c5669a5181,"Medizinische Universität Wien, Univ.Klinik f.Innere Medizin I,Abt. f. Infektionen u.Tropenmedizin",medizinische_universit_t_wien_univ_klinik_f_innere_medizin_i_abt_f_infektionen_u_tropenmedizin,,,,,, +7007,,4c7c1dad-13ae-4c28-af21-9f270651ee8e,CASSIOPEA SpA,cassiopea_spa,,,,,, +7008,,4a2b7c74-befc-4577-9520-9417229b05c7,Nordic Pharma France,nordic_pharma_france,,,,,, +7009,,81db082a-7167-11e6-a0cd-0242ac12000b,NCM USA BRONX LLC,ncm_usa_bronx_llc,,,,,, +7010,,d74df514-73c0-11e6-a0cd-0242ac12000b,PERNIX IRELAND PAIN,pernix_ireland_pain,,,,,, +7011,,5e1f57b6-e7ae-4b2e-8b65-fc77bd35e92d,mibe GmbH Arzneimittel,mibe_gmbh_arzneimittel,,,,,, +7012,,c4628c57-060f-4c5d-8516-894b45362f0c,Sanofi-Synthelabo Co. Ltd,sanofi_synthelabo_co_ltd,,,,,, +7013,,d2236b94-d2dc-4f2f-8679-e50444b22ca4,"Overlæge, dr.med. Claus Zachariae",overl_ge_dr_med_claus_zachariae,,,,,, +7014,,c005c7a9-4eb8-4915-ad3a-b315222a9f97,"Johannes Förster, anest.lääkäri",johannes_f_rster_anest_l_k_ri,,,,,, +7015,,b901ba62-7129-11e6-a89e-0242ac12000b,BARR LABS INC,barr_labs_inc,,,,,, +7016,,071d9584-4c2a-4bb7-920e-c1239274750c,"HSK, Dr. Horst Schmidt Kliniken GmbH",hsk_dr_horst_schmidt_kliniken_gmbh,,,,,, +7017,,bc446b96-53fd-4967-81ba-05f546f05fa2,"HY, Kliinisen farmakologian yksikkö",hy_kliinisen_farmakologian_yksikk,,,,,, +7018,,1c8d9e5e-4d61-4c07-b2a9-0217a1fd52bf,St Georges Hospital,st_georges_hospital,,,,,, +7019,,1f691f97-6f5d-4c7d-a629-0915a4980779,Jeroen Bosch Hospital,jeroen_bosch_hospital,,,,,, +7020,,002ff34e-436d-48e5-be88-943d50af57a6,Erasmus MC-Daniël den Hoed,erasmus_mc_dani_l_den_hoed,,,,,, +7021,,977bed4b-17f6-4cde-9dcd-0d079305af46,Sanofi-aventis U.S. Inc,sanofi_aventis_u_s_inc,,,,,, +7022,,f6668148-57b0-4ee6-94a4-a8958f19c696,Unité de Recherches Thérapeutiques,unit_de_recherches_th_rapeutiques,,,,,, +7023,,20dd8898-a8ed-4a13-8b26-fa08ed466bca,Combustin Pharmazeutische Präparate GmbH,combustin_pharmazeutische_pr_parate_gmbh,,,,,, +646,0.96544918417930603,237ec247-b474-4bd6-9041-c2ffb0213c0e,Boehringer Ingelheim Ellas AE,boehringer_ingelheim_ellas_ae,,,,237ec247-b474-4bd6-9041-c2ffb0213c0e,boehringer_ingelheim_ellas,Boehringer Ingelheim Ellas +7024,,f9a24959-69bf-4d29-bc8b-4eae0afa24ae,Virgilio Hernando Requejo,virgilio_hernando_requejo,,,,,, +109,0.952012,8a1dc0a1-759d-435f-ad3b-c75c8ce910d4,GlaxoSmithKline Consumer Healthcare GmbH & Co. KG,glaxosmithkline_consumer_healthcare_gmbh_co_kg,,,,8a1dc0a1-759d-435f-ad3b-c75c8ce910d4,glaxosmithkline_consumer_healthcare_gmbh_co_kg,GlaxoSmithKline Consumer Healthcare GmbH & Co. KG +578,0.98133742809295654,5850c0a3-a743-4f17-90b7-904795acdc7a,"Wyeth Pharmaceutical Inc. Acting through its division Wyeth Research, a Pfizer Company",wyeth_pharmaceutical_inc_acting_through_its_division_wyeth_research_a_pfizer_company,,,,724d1bdc-e54a-4c73-b212-98071e708ad2,wyeth_pharmaceuticals_inc_acting_through_its_division_wyeth_research_a_pfizer_company,"Wyeth Pharmaceuticals Inc. Acting through its division Wyeth Research, a Pfizer Company" +450,0.982048,08302f5a-a69b-4857-95b3-096818568221,Instituto de Investigacion Sanitaria La e,instituto_de_investigacion_sanitaria_la_e,,,,08302f5a-a69b-4857-95b3-096818568221,instituto_de_investigacion_sanitaria_la_e,Instituto de Investigacion Sanitaria La e +7025,,337fbaf4-8bc0-11e6-a449-0242ac12000b,Cancer Trials Ireland,cancer_trials_ireland,,,,,, +133,0.951362,c231857e-6087-450a-b8b7-28c375a19c91,Vakgroep Huisartsgeneeskunde VUB,vakgroep_huisartsgeneeskunde_vub,,,,71e1740c-dc4b-46d2-86ac-23909116857c,vakgroep_huisartsgeneeskunde_vrije_universiteit_brussel,Vakgroep Huisartsgeneeskunde Vrije Universiteit Brussel +7026,,2191777b-8ebe-4205-8126-e955d425dacd,Marius Henriksen,marius_henriksen,,,,,, +7027,,08deeac2-73d8-11e6-a0cd-0242ac12000b,SILVERGATE PHARMS,silvergate_pharms,,,,,, +7028,,73b1c674-f175-4e72-943f-d6d297ed9896,"Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie",medizinische_universit_t_wien_universit_tsklinik_f_r_klinische_pharmakologie,,,,,, +7029,,d2628802-8bbd-11e6-a449-0242ac12000b,Lycera Corp,lycera_corp,,,,,, +7030,,2e57922d-289f-4892-ae6a-db94dc5949ae,"Department of Urology, Herlev Hospital",department_of_urology_herlev_hospital,,,,,, +7031,,67e0b776-b61c-44d6-9f01-18396965342e,Solvay Pharmaceuticals. Inc,solvay_pharmaceuticals_inc,,,,,, +7032,,85b83ce3-4878-4113-b99c-c11381065bf2,Laboratoires WELEDA,laboratoires_weleda,,,,,, +7033,,28c02e0f-c88a-401b-8a08-5f616aa33105,"Bayer AB, Bayer Schering Pharma",bayer_ab_bayer_schering_pharma,,,,,, +7034,,59803a6e-1d1d-4193-a6b3-804924f4749a,"INSTITUTO CIENTÍFICO Y TECNOLÓGICO (ICT )DE NAVARRA, S.A",instituto_cient_fico_y_tecnol_gico_ict_de_navarra_s_a,,,,,, +7035,,6529cd70-7157-11e6-a0cd-0242ac12000b,PERRIGO ISRAEL,perrigo_israel,,,,,, +7036,,9aa833c0-7142-11e6-a0cd-0242ac12000b,WYETH PHARMS INC,wyeth_pharms_inc,,,,,, +7037,,82054b55-dafc-4c68-8618-b4745d2425b9,Grupo Español de Linfomas y transplantes Autólogos de Médula Osea (GELTAMO),grupo_espa_ol_de_linfomas_y_transplantes_aut_logos_de_m_dula_osea_geltamo,,,,,, +7038,,f1fbd800-c353-4402-b6dc-46942a78ba4d,"Beijing Novartis Pharma Co., Ltd",beijing_novartis_pharma_co_ltd,,,,,, +7039,,c8e5a8c2-69b1-4e77-b8db-3d3f956c3092,AZIENDA OSPEDALIERA OSPEDALE DI CIRCOLO A.O. DI RILIEVO REGIONALE,azienda_ospedaliera_ospedale_di_circolo_a_o_di_rilievo_regionale,,,,,, +7040,,a86205ce-7163-11e6-a0cd-0242ac12000b,SILARX PHARMS INC,silarx_pharms_inc,,,,,, +7041,,a076d363-dc13-4674-a9df-c64c5383ae08,FUNDACION HOSPITAL DE MADRID,fundacion_hospital_de_madrid,,,,,, +450,0.982048,6cd336d3-1b0c-4854-b789-e0345e7fe423,Instituto de Investigacion Sanitaria La Fe,instituto_de_investigacion_sanitaria_la_fe,,,,08302f5a-a69b-4857-95b3-096818568221,instituto_de_investigacion_sanitaria_la_e,Instituto de Investigacion Sanitaria La e +7042,,af7a863b-ad14-419b-ae09-d87b4096adf1,Servier Research and Development Ltd. (S.R.D.L) (for UK only),servier_research_and_development_ltd_s_r_d_l_for_uk_only,,,,,, +149,0.98663,754cbf5a-a0d1-46dd-8be7-2a83aa37d6de,Array BioPharma Inc,array_biopharma_inc,,,,196b721b-cf1f-48fb-9325-0abb1def7a34,array_biopharma,Array BioPharma +7043,,cca1f39c-7221-44b7-8a13-315cd97f7e3c,Laboratoires BIORGA,laboratoires_biorga,,,,,, +358,0.968122,0267831e-60a5-4058-a9fc-094b1cd84b8e,Fresenius Medcial Care Deutschland GmbH,fresenius_medcial_care_deutschland_gmbh,,,,0267831e-60a5-4058-a9fc-094b1cd84b8e,fresenius_medcial_care_deutschland_gmbh,Fresenius Medcial Care Deutschland GmbH +7044,,c546ba57-152c-4416-ba46-0a5f908b7334,Universitätsfrauenklinik Innsbruck,universit_tsfrauenklinik_innsbruck,,,,,, +827,0.98886597156524658,ffdb95f1-a80d-4d79-9648-8ab140edbd56,INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE,instituto_de_investigaci_n_sanitaria_la_fe,,,,975869a5-d12b-4f5f-9a3d-d76a15c61a6a,instituto_de_investigaci_n_sanitaria_la_fe_de,INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE +7045,,6eadbe6a-717a-11e6-a0cd-0242ac12000b,IPSEN BIOPHARM LTD,ipsen_biopharm_ltd,,,,,, +837,0.98498398065567017,09c00199-a473-4e2e-b6d9-ca5616af7b3d,"NHS Greater Glasgow, Yorkhill",nhs_greater_glasgow_yorkhill,,,,09c00199-a473-4e2e-b6d9-ca5616af7b3d,nhs_greater_glasgow_yorkhill,"NHS Greater Glasgow, Yorkhill" +7046,,773a8488-7165-11e6-a0cd-0242ac12000b,RUBICON RES PVT LTD,rubicon_res_pvt_ltd,,,,,, +7047,,f020125a-068c-40c6-b5c5-4a16f4b31ff6,Ludwig Boltzmann Gesellschaft,ludwig_boltzmann_gesellschaft,,,,,, +160,0.97226891517639158,84621fbf-cedb-43f3-85f6-9201a3a323e0,Fundación para la Investigación Biomédica del Hospital Gregorio Marañon,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_on,,,,ce27e24e-62ac-42de-a596-4ceed67e634f,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón +7048,,e8f9de9b-4ff2-4a3e-94ac-3b3bfe5f32fb,Dean of the Medical Faculty (University of Bonn),dean_of_the_medical_faculty_university_of_bonn,,,,,, +7049,,0a99e6e6-ad6e-402f-86cb-bdc8bd104e11,Schering-Plough Research Institute - A division of Schering-Plough Corp,schering_plough_research_institute_a_division_of_schering_plough_corp,,,,,, +7050,,310da474-9c03-449c-9381-9e1f0019171b,"Ögonkliniken, Akademiska sjukhuset i Uppsala",gonkliniken_akademiska_sjukhuset_i_uppsala,,,,,, +324,0.97549104690551758,947a607a-e91b-4de5-bbb8-6547ba861362,Stiefel Laboratories Maidenhead Ltd (commonly known as Stiefel International R&D),stiefel_laboratories_maidenhead_ltd_commonly_known_as_stiefel_international_r_d,,,,0a082bad-97ec-4e82-be7d-2731907614ac,stiefel_laboratories_maidenhead_ltd,Stiefel Laboratories Maidenhead Ltd +7051,,a6175ca9-ac65-4d80-92ad-a57ae078a259,VU University medical center (VUmc),vu_university_medical_center_vumc,,,,,, +7052,,1dbd18a6-29a3-4f3d-8396-91868b5d6a7e,Universitatsklinikum Munster,universitatsklinikum_munster,,,,,, +7053,,7d960b31-740c-4ba1-aa11-b0bca908a241,Montse Palacio Riera - Hospital Clínic de Barcelona - Maternitat,montse_palacio_riera_hospital_cl_nic_de_barcelona_maternitat,,,,,, +7054,,6dc515ec-668a-43c4-842b-844bd083b6fe,Univar B.V,univar_b_v,,,,,, +7055,,64d7a966-8c71-4ac4-a9c1-1c9711142ab8,Liverpoool Womens NHS Foundation Trust,liverpoool_womens_nhs_foundation_trust,,,,,, +7056,,494c98e0-7183-11e6-a0cd-0242ac12000b,AUXILIUM PHARMS,auxilium_pharms,,,,,, +7057,,050d5331-e475-46fc-9860-a4017a6234bb,CureVac GmbH,curevac_gmbh,,,,,, +7058,,11a91ee0-ce39-48bf-aa91-f0311f489cc2,ADELAIDA LAMAS FERREIRO,adelaida_lamas_ferreiro,,,,,, +7059,,258f5812-60a7-474f-b52b-9df85b92ebed,"Med. Univ. Wien, Univ. Klinik für Psychiatrie und Psychotherapie",med_univ_wien_univ_klinik_f_r_psychiatrie_und_psychotherapie,,,,,, +7060,,ec8fa845-50e4-4e84-8d2e-f0c567c44294,Novartis Pharma Services A.G,novartis_pharma_services_a_g,,,,,, +7061,,9852fc55-dab5-411c-863b-2e64c85dc773,Biocon S.A,biocon_s_a,,,,,, +7062,,e5421385-9c1e-4d11-a320-75f6bc64e82a,RIBAPHARM,ribapharm,,,,,, +961,0.93838614225387573,a6d6aa67-5161-45ca-a1eb-794cebec0129,Hull and East Yorkshire Hospitals NHS Trust,hull_and_east_yorkshire_hospitals_nhs_trust,,,,a6d6aa67-5161-45ca-a1eb-794cebec0129,hull_and_east_yorkshire_hospitals_nhs_trust,Hull and East Yorkshire Hospitals NHS Trust +7063,,78506a4d-ad4e-4d62-8c8c-3b8eb6ab25ed,Rafael Martinez Sanz. Servicio de Cirugía Cardiovascular. Hospital Universitario de Canarias,rafael_martinez_sanz_servicio_de_cirug_a_cardiovascular_hospital_universitario_de_canarias,,,,,, +7064,,6a58ca70-0076-4875-9734-4bb2094b5437,Citospin,citospin,,,,,, +7065,,e58e66ac-6fc1-11e6-abe8-0242ac12000b,Janssen-Cilag NV/SA,janssen_cilag_nv_sa,,,,,, +196,0.981008,96074814-e17a-40ea-8694-60a12c5abc77,CHRU Montpellier - Direction de la Recherche,chru_montpellier_direction_de_la_recherche,,,,9324d427-ccb6-48fe-912d-ec2b4be0fbec,chru_montpellier_direction_de_la_recherche_partenariats_et_r_seaux_relations_avec_l_universit,"CHRU Montpellier - Direction de la Recherche, Partenariats et Réseaux, Relations avec l'Université" +164,0.982418,e84a8652-7352-11e6-a0cd-0242ac12000b,BRAINTREE LABS,braintree_labs,,,,14e0f940-71b3-11e6-a0cd-0242ac12000b,braintree,BRAINTREE +564,0.925101,9295d145-4808-436f-b10a-e0a7ae32fa9c,Norfolk & Norwich University Hospital,norfolk_norwich_university_hospital,,,,0c57bc5a-dee4-4689-9938-6075f7ec9b69,norfolk_and_norwich_university_hospital_nhs_foundation_trust,Norfolk and Norwich University Hospital NHS Foundation Trust +7066,,21dc2f1b-1478-497d-b148-1020f90b42f0,Nuclear Medicine UZ Gasthuisberg,nuclear_medicine_uz_gasthuisberg,,,,,, +7067,,88618fc8-8da8-4883-9e6b-805d210b464c,"Karolinska Institutet, Dept of Medicine, Clinical Pharmacology Unit",karolinska_institutet_dept_of_medicine_clinical_pharmacology_unit,,,,,, +646,0.96544918417930603,74ce42ef-b6a1-46d8-882a-8e571fbe2570,Boehringer Ingelheim Ellas SA,boehringer_ingelheim_ellas_sa,,,,237ec247-b474-4bd6-9041-c2ffb0213c0e,boehringer_ingelheim_ellas,Boehringer Ingelheim Ellas +7068,,0505a6cc-7142-11e6-a0cd-0242ac12000b,AVANTHI INC,avanthi_inc,,,,,, +7069,,2228d404-719c-11e6-a0cd-0242ac12000b,ORTHO MCNEIL JANSSEN,ortho_mcneil_janssen,,,,,, +7070,,7b1285fd-8b50-4325-b964-2c1a031be71f,Sana Klinikum Lichtenberg,sana_klinikum_lichtenberg,,,,,, +7071,,2de882c8-c95f-4c54-8eaa-fd028a7e57a0,"Centro Hospitalar de São João, EPE",centro_hospitalar_de_s_o_jo_o_epe,,,,,, +7072,,48f8782d-82ed-42a5-a973-c3d7cc7e5305,"Bioinova, s.r.o",bioinova_s_r_o,,,,,, +7073,,64f567f6-e28f-47b0-8e83-0289fd03593c,Pediatric Cardiology,pediatric_cardiology,,,,,, +117,0.965586,a3094a98-9387-4ac2-b5e3-1680c2eb55b0,UMCN,umcn,,,,66c99c0f-befb-4321-8842-bd1047513dac,umcn_farm_tox,UMCN farm-tox +283,0.988674,3ed277d7-e94c-44a1-b2b4-33de175d3556,Centre Hospitalier Régional et Universitaire de Lille,centre_hospitalier_r_gional_et_universitaire_de_lille,,,,3ed277d7-e94c-44a1-b2b4-33de175d3556,centre_hospitalier_r_gional_et_universitaire_de_lille,Centre Hospitalier Régional et Universitaire de Lille +7074,,466e5b78-6712-4deb-8f59-4a12be02ec87,Cerenis Therapeutics,cerenis_therapeutics,,,,,, +535,0.944741,2a1b4dd7-b8f2-4ab2-be0a-7f9f70d3d524,National Institute of Health and the Environment (RIVM),national_institute_of_health_and_the_environment_rivm,,,,2a1b4dd7-b8f2-4ab2-be0a-7f9f70d3d524,national_institute_of_health_and_the_environment_rivm,National Institute of Health and the Environment (RIVM) +879,0.971226,f0485568-db8c-4351-a14a-1b70750079c5,"RWTH Aachen University, represented by the Rector, himself represented by the Clinical Trial Center (CTC-A)",rwth_aachen_university_represented_by_the_rector_himself_represented_by_the_clinical_trial_center_ctc_a,,,,bc449ec2-1390-4c75-ab67-e86f7d769a31,rwth_aachen_university_represented_by_the_rector_himself_represented_by_the_ctc_a,"RWTH Aachen University, represented by the Rector, himself represented by the CTC-A" +7075,,b51b6263-549c-445c-8b4b-405c19e42070,ZAMBON France,zambon_france,,,,,, +7076,,a0538aa0-16b6-4813-a407-175540ee5998,Hear Center of Semmelweis University,hear_center_of_semmelweis_university,,,,,, +889,0.98770618438720703,36018056-4c5e-4f92-a44e-4cff410d57aa,University Medical Center of the Johannes Gutenberg-University Mainz,university_medical_center_of_the_johannes_gutenberg_university_mainz,,,,36018056-4c5e-4f92-a44e-4cff410d57aa,university_medical_center_of_the_johannes_gutenberg_university_mainz,University Medical Center of the Johannes Gutenberg-University Mainz +7077,,138524be-f840-4eb5-b4b5-8b3a518f8f88,"Department of Clinical Pharmacology, Medical University of Vienna",department_of_clinical_pharmacology_medical_university_of_vienna,,,,,, +7078,,784d3c56-6e55-44e6-8393-449b16a65562,Alysis Zorggroep,alysis_zorggroep,,,,,, +7079,,017ca1f4-3da1-46aa-85ab-ae144c06c6ff,IFCT,ifct,,,,,, +7080,,5c443a2c-9f7d-4dbf-a70d-e5e0d48a8c2e,GELA (Groupe d'Etude du Lymphome de l'Adulte),gela_groupe_d_etude_du_lymphome_de_l_adulte,,,,,, +7081,,b37e6fab-609c-4d24-930f-41ee507f7739,Philipps-University Marburg,philipps_university_marburg,,,,,, +7082,,28cab53a-127e-41f2-9451-d65401e80aa1,"University Heidelberg, University Hospital Mannheim",university_heidelberg_university_hospital_mannheim,,,,,, +7083,,efe8343b-0108-4528-b5e7-88a83a74ac4e,McNeil Ltd,mcneil_ltd,,,,,, +7084,,6cc4f202-9205-4016-b948-b9729ea12b50,Vifor Fresenius Medical Care Renal Pharma France,vifor_fresenius_medical_care_renal_pharma_france,,,,,, +53,0.98087829351425171,0409ac6d-4311-4f84-9569-7d15fbdc4ffc,Med. Univ. Wien,med_univ_wien,,,,0409ac6d-4311-4f84-9569-7d15fbdc4ffc,med_univ_wien,Med. Univ. Wien +7085,,b940cf47-d7c2-488e-ae2a-a1ae3008760c,PROCTER & GAMBLE,procter_gamble,,,,,, +1027,0.98343661427497864,6d36b52f-db46-44ca-93f4-353e20df63e4,Eli Lilly & Co,eli_lilly_co,,,,284c00a4-0148-4486-88e3-8a67925fd222,eli_lilly_company,Eli Lilly & Company +7086,,547cb0d1-d200-4c7f-8d87-c23e9dd86ab2,Grünenthal GmbH,gr_nenthal_gmbh,,,,,, +7087,,0f74af50-95a6-4468-a331-be2e6f3c2dfc,"Ruprecht-Karls-University Heidelberg, Med Faculty represented by University Clinic HD and its Comm. Director",ruprecht_karls_university_heidelberg_med_faculty_represented_by_university_clinic_hd_and_its_comm_director,,,,,, +7088,,62d56128-ac8c-48e5-9091-7a119432f3f1,Vinforce - Institut für Osteoporoseforschung,vinforce_institut_f_r_osteoporoseforschung,,,,,, +7089,,922a9d2c-8d9a-458f-9b34-a159bcc6bf46,"Sønderjylland Hospital, department of neurology",s_nderjylland_hospital_department_of_neurology,,,,,, +7090,,c94ddb8a-7142-11e6-a0cd-0242ac12000b,ALRA,alra,,,,,, +7091,,bdfe9df3-ae41-466d-9835-754ea89e6731,Leeds Teaching Hospital NHS Trust,leeds_teaching_hospital_nhs_trust,,,,,, +7092,,3e33cfe4-5b84-4eeb-a52a-3e968cea2ccb,Kožní ordinace,ko_n_ordinace,,,,,, +7093,,c26cbb05-e7a7-43a9-b3d2-74c73ed26915,Hospital Clinic Barcelona,hospital_clinic_barcelona,,,,,, +1031,0.98256808519363403,ac624ddd-686b-4be1-80a9-858db3c2c4fb,"Medical University of Vienna, Department of Pediatrics",medical_university_of_vienna_department_of_pediatrics,,,,9f76459d-c1a5-4dfd-8ba3-7773bf3ebbce,medical_university_of_vienna_department_of_pediatrics,Medical University of Vienna +7094,,b0cd7ca0-cfcf-4d2c-8e3c-55604b3184e6,Gedeon Richter Plc,gedeon_richter_plc,,,,,, +7095,,d6bfe67d-d730-42e5-a456-a02b3823def2,"Department of Rheumatology, Medical University of Vienna",department_of_rheumatology_medical_university_of_vienna,,,,,, +7096,,01b645bc-7183-11e6-a0cd-0242ac12000b,BTG INTERNATIONAL INC,btg_international_inc,,,,,, +477,0.96643507480621338,092654ab-7dbc-4b58-83c4-7c2f45b75f9a,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Gastroenterologie und Hepatologie",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_abteilung_f_r_gastroenterologie_und_hepatologie,,,,092654ab-7dbc-4b58-83c4-7c2f45b75f9a,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_abteilung_f_r_gastroenterologie_und_hepatologie,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Gastroenterologie und Hepatologie" +7097,,dc730e96-7161-11e6-a0cd-0242ac12000b,PHARM RES ASSOC,pharm_res_assoc,,,,,, +7098,,647a699d-1576-4007-87c2-08b369a1f2ad,RIVM,rivm,,,,,, +7099,,b6d8d15b-23e7-4b14-892e-83b4a37f79de,Affectis Pharmaceuticals AG,affectis_pharmaceuticals_ag,,,,,, +7100,,be6cc8ff-4c9f-4531-8429-1cc17e930269,Genzyme Corporation Inc,genzyme_corporation_inc,,,,,, +915,0.9809834361076355,6f1862f8-4971-4ef9-ad8e-6b92b745108b,Oulu University Hospital,oulu_university_hospital,,,,61f167e1-4240-4936-a86a-3eb617eeeb8b,oulu_university_hospital_department_of_anaesthesia,"Oulu University Hospital, Department of Anaesthesia" +7101,,3eca5644-728e-11e6-a0cd-0242ac12000b,SPECIALITY EUROPEAN,speciality_european,,,,,, +7102,,d627bcd1-d72b-46d4-9df6-7d8c0fc79220,Fundación Hospital Nacional de Parapléjicos,fundaci_n_hospital_nacional_de_parapl_jicos,,,,,, +7103,,661eaf75-3a97-4d8a-9434-8f2f18786955,COUGAR BIOTECHNOLOGY,cougar_biotechnology,,,,,, +430,0.98551523685455322,3bc57cf3-53a2-4c69-b7e4-a49ee753b7f7,University of California San Francisco Stroke Sciences Group,university_of_california_san_francisco_stroke_sciences_group,,,,3bc57cf3-53a2-4c69-b7e4-a49ee753b7f7,university_of_california_san_francisco_stroke_sciences_group,University of California San Francisco Stroke Sciences Group +7104,,8d953c89-fbe8-46f4-b3f3-d9d12ecdb325,"MUW, Univ.Klinik f. Innere Medizin II, Abteilung f. Angiologie",muw_univ_klinik_f_innere_medizin_ii_abteilung_f_angiologie,,,,,, +7105,,012d6a4e-56c6-4cc9-b0e7-09d1df1fea37,Kings College London University,kings_college_london_university,,,,,, +7106,,cc154c60-daea-486e-8ba7-47b198526041,AVERA PHARMACEUTICALS INC,avera_pharmaceuticals_inc,,,,,, +7107,,cbc62c3b-a7d1-48da-88cb-09181bc392f6,"Anaesthesiology Department. Universitary Hospital Vall d'Hebron, Barcelona",anaesthesiology_department_universitary_hospital_vall_d_hebron_barcelona,,,,,, +7108,,e51ccc54-83ac-49f5-8d64-aa3fd9e03404,Clinical Institute of Medical and Chemical Laboratory Diagnostics Graz,clinical_institute_of_medical_and_chemical_laboratory_diagnostics_graz,,,,,, +7109,,4427c92a-a860-46cc-8caa-c410f347c6e3,Association Bigorre Douleurs,association_bigorre_douleurs,,,,,, +7110,,e15e1754-44c4-40ba-b554-353283e670ef,PROMO INTERNATIONAL SRL,promo_international_srl,,,,,, +7111,,59568ef2-cdb8-4567-8d40-2f6d6c3633d6,STX Pharma,stx_pharma,,,,,, +481,0.98966941237449646,063430c2-5fa1-40bb-ab27-c58c6cccb45e,Medizinische Universität Graz, Universitätsklinik für InnereMedizin,,,,48f0d5ed-174c-4ce4-98d7-cc34770f5107, Universitätsklinik für Innere Medizin,Medizinische Universität Graz +7112,,477c940a-715d-11e6-a0cd-0242ac12000b,UNICHEM PHARMS (USA),unichem_pharms_usa,,,,,, +7113,,b1e01596-c6f1-46c1-bcb7-52cc572f211e,PHARM – Pharmaceutical Research Management srl,pharm_pharmaceutical_research_management_srl,,,,,, +7114,,59a921e3-b50a-4a12-ad97-e4c407fc88f6,Dept of Surgery,dept_of_surgery, Abteilung für Endokrinologie und Stoffwechsel,medizinische_universit_t_graz_universit_tsklinik_f_r_inneremedizin_abteilung_f_r_endokrinologie_und_stoffwechsel,,,, +7115,,147e31e6-0d9d-44c5-95af-0d11a602c727,Genzyme Europe B.V,genzyme_europe_b_v,,,,,, +556,0.95394155383110046,a86f7110-f6be-4761-91ec-1bb707f1db65,Greater Glasgow and Clyde Health Board (GGCHB)/University of Glasgow,greater_glasgow_and_clyde_health_board_ggchb_university_of_glasgow,,,,3361148d-134d-40eb-b1d7-9105a55174b4,greater_glasgow_and_clyde_health_board_ggchb_university_of_glasgow,Greater Glasgow and Clyde Health Board (GGCHB)/University of Glasgow +7116,,8c89b3f1-e56d-4ca9-863b-68e053c61d1e,University Clinical Center of Tuebingen,university_clinical_center_of_tuebingen,,,,,, +7117,,26692b04-8f5f-4727-8a54-01aac5136cd8,"S.G.O. Johansson, MD PhD Professor",s_g_o_johansson_md_phd_professor,,,,,, +1002,0.97624942660331726,a42efa53-fa42-404a-8796-cf0a86d035ab,Fundación para la Formación e Investigación Sanitaria,fundaci_n_para_la_formaci_n_e_investigaci_n_sanitaria,,,,8fbc1a40-90b3-491d-9c96-f5d311f67e2e,fundaci_n_para_la_formaci_n_e_investigaci_n_sanitaria,Fundación para la Formación e Investigación Sanitaria +7118,,4de4e820-7193-11e6-a0cd-0242ac12000b,BOWMAN PHARMS,bowman_pharms,,,,,, +7119,,cc2fb3db-803d-4781-91ea-c6750946e716,Dekan of the Medical Faculty of the University Erlangen-Nuremberg, Prof. Dr. Dr. h. c. Jürgen Schüttler,,,,,, +7120,,581d6d12-276c-4ad1-9465-2b9adb8afbad,AVAPO RICERCHE - VENEZIA,avapo_ricerche_venezia,,,,,, +7121,,e29de71a-7129-11e6-a89e-0242ac12000b,MIKAH PHARMA LLC,mikah_pharma_llc,,,,,, +7122,,321c5f1f-f803-4293-9d66-d344a462a3ed,GMIHO Gesellschaft für medizinische Innovation/Hämatologie und Onkologie mbH,gmiho_gesellschaft_f_r_medizinische_innovation_h_matologie_und_onkologie_mbh,dekan_of_the_medical_faculty_of_the_university_erlangen_nuremberg_prof_dr_dr_h_c_j_rgen_sch_ttler,,,,, +7123,,65093549-873d-4c04-9d69-7d575b21f6b6,Octapharma Pharmazeutika Produktionsges.m.b.H,octapharma_pharmazeutika_produktionsges_m_b_h,,,,,, +7124,,a91d8628-e2a4-4cd4-92c4-77cffae98487,MCM Klosterfrau GmbH,mcm_klosterfrau_gmbh,,,,,, +7125,,b1ca2159-1579-40e2-961f-520a7f2455d1,Tartu University Hospital Psychiatry Clinic,tartu_university_hospital_psychiatry_clinic,,,,,, +294,0.980402,8bc6009e-67ad-4b1c-be4c-b1ddc0e89df4,"Dept. of Internal Medicine II, University Hospital Giessen",dept_of_internal_medicine_ii_university_hospital_giessen,,,,3f94f9c4-5b24-4215-96a7-f4fef896ec87,dept_of_internal_medicine,Dept. of Internal Medicine +7126,,2eeb65f4-2aa7-4bdf-8ea9-9ca7d374c27d,Pohjois-Karjalan keskussairaala,pohjois_karjalan_keskussairaala,,,,,, +7127,,1323a5f2-38a3-4717-b38b-3f6c5a9f0f35,University of Sheffield,university_of_sheffield,,,,,, +7128,,9a3590f2-8688-4520-ab15-91b60dad0d55,"Yamanouchi Europe B.V. (en trámite de cambio de nombre a Astellas Pharma Europe, B.V.)",yamanouchi_europe_b_v_en_tr_mite_de_cambio_de_nombre_a_astellas_pharma_europe_b_v,,,,,, +810,0.98486357927322388,43a1c732-1624-42d6-96fa-66ffa3a8fc4e,Biogen Idec A/S,biogen_idec_a_s,,,,43a1c732-1624-42d6-96fa-66ffa3a8fc4e,biogen_idec_a_s,Biogen Idec A/S +736,0.97966154416402185,86b7934b-bd40-4e41-90e2-f2b10e4f66c8,European Organisation for the Research and Treatment of Cancer,european_organisation_for_the_research_and_treatment_of_cancer,,,,86b7934b-bd40-4e41-90e2-f2b10e4f66c8,european_organization_for_the_research_and_treatment_of_cancer_eortc,European Organization for the Research and Treatment of Cancer (EORTC) +7129,,14c93531-b1c6-46a5-8e1c-9b412a615abe,INFAI GmbH,infai_gmbh,,,,,, +7130,,d284234b-d826-4ce9-b6f8-43a996aac994,FERNADO PEREZ RUIZ,fernado_perez_ruiz,,,,,, +156,0.98401394486427307,93c5f8d2-c2d8-4c9b-abde-962e31e9c1a5,"Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intesnivmedizin und Schmerztherapie",medizinische_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intesnivmedizin_und_schmerztherapie,,,,93c5f8d2-c2d8-4c9b-abde-962e31e9c1a5,medizinische_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,"Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie" +7131,,53859063-a67d-4244-a3b3-b0bc49c37b37,"Department of Rheumatology, Hvidovre Hospital",department_of_rheumatology_hvidovre_hospital,,,,,, +7132,,65a935f8-09ec-4986-883b-a8f1fb636a2e,MSE Pharmazeutika GmbH,mse_pharmazeutika_gmbh,,,,,, +7133,,e7d32627-f9df-4aa0-b1d8-0c4a9ab33d9f,Epsom and St Helier University Hospitals NHS Trust R&D Dpt,epsom_and_st_helier_university_hospitals_nhs_trust_r_d_dpt,,,,,, +415,0.958927,1a38fc33-48c6-45d0-8a30-54ce6c217bac,Aspreva Pharmaceutical Corporation,aspreva_pharmaceutical_corporation,,,,1a38fc33-48c6-45d0-8a30-54ce6c217bac,aspreva_pharmaceutical_corporation,Aspreva Pharmaceutical Corporation +69,0.989009,e21ef556-9fd2-43c0-b259-7f0ef1414c92,"Schering Corporation, división Schering-Plough Research",schering_corporation_divisi_n_schering_plough_research,,,,2bcb0c19-b4b9-4f7c-9d21-fb61445071f3,schering_corporation_divisi_n_schering_plough_research_institute,"Schering Corporation, división Schering-Plough Research Institute" +7134,,88d3674c-e17b-4999-a33e-864e4818ab21,GE Healthcare Ltd e le sue filiali,ge_healthcare_ltd_e_le_sue_filiali,,,,,, +7135,,2e1e643e-7b32-43c7-92c4-109e2e2c2098,NOVARTIS PHARMA AG,novartis_pharma_ag,,,,,, +375,0.98873221874237061,c2aa66b4-25c1-48ef-8ead-9e3c02c6d412,Merck Sharp and Dohme de España,merck_sharp_and_dohme_de_espa_a,,,,7e87bc11-ff9c-4927-879f-5e83f9da3259,merck_sharp_and_dohme_de_espa_a_s_a,"Merck Sharp and Dohme de España, S.A" +146,0.987534,a090216a-e555-4b1c-b5d2-b624ee996480,University Hospital Hamburg-Eppendorf,university_hospital_hamburg_eppendorf,,,,a090216a-e555-4b1c-b5d2-b624ee996480,university_hospital_hamburg_eppendorf,University Hospital Hamburg-Eppendorf +7136,,e81faf5e-735c-11e6-a0cd-0242ac12000b,FERRING PHARMS AS,ferring_pharms_as,,,,,, +7137,,fa2ecbc4-a0aa-4628-b842-d191fde9f04d,Ziarco Pharma Ltd,ziarco_pharma_ltd,,,,,, +7138,,b397ad9c-90ec-4ba4-a931-fa64afb8d4eb,Fujisawa GmbH,fujisawa_gmbh,,,,,, +959,0.94367156426111853,d80d2419-d789-4eb0-84f3-571467cef750,"Andromeda Biotech Ltd,: 42 Hayarkon str,Yavne,81227, Israel",andromeda_biotech_ltd_42_hayarkon_str_yavne_81227_israel,,,,8e1ef03a-b2a7-496e-83ef-ae87bf0b27e9,andromeda_biotech_ltd_42_hayarkon_st_yavne_81227_israel,Andromeda Biotech Ltd +7139,,457c590a-1470-4212-bd13-277af57692bd,Consorcio de Apoyo a la Investigación Biomédica en red (CAIBER),consorcio_de_apoyo_a_la_investigaci_n_biom_dica_en_red_caiber,,,,,, +7140,,3442b7de-7167-11e6-a0cd-0242ac12000b,TRUSTEES UNIV PA,trustees_univ_pa,,,,,, +7141,,fce152ce-68e7-45db-bad6-90a563943360,Dr. Amalia Velasco,dr_amalia_velasco,,,,,, +7142,,80a7e484-715b-11e6-a0cd-0242ac12000b,RATIOPHARM,ratiopharm,,,,,, +60,0.96751341649464195,eb86f60c-e0c1-4388-bcff-6a4ece7f4d74,"Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company,Philadelphia,PA-19101,USA",wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company_philadelphia_pa_19101_usa,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc +7143,,8408c773-8ef0-48e0-a9bb-2d5ce0873efa,Pharmaneuroboost N.V,pharmaneuroboost_n_v,,,,,, +7144,,a1c0acfa-a471-4f55-9cee-8d07e71a003f,GORTEC,gortec,,,,,, +7145,,b3880e5a-71a2-11e6-a0cd-0242ac12000b,MOLNLYCKE HLTH,molnlycke_hlth,,,,,, +7146,,62eca5da-becb-40f8-91e8-374c7724afb2,Estetra SPRL,estetra_sprl,,,,,, +7147,,ba921889-c955-47f2-b171-891962537a6d,Sociedad Española de Hematología-Oncología Pediátrica,sociedad_espa_ola_de_hematolog_a_oncolog_a_pedi_trica,,,,,, +7148,,9f72d276-38d8-43dd-bf96-691880f542f7,Exponential Biotherapies Inc,exponential_biotherapies_inc,,,,,, +7149,,1e3ac5d2-b437-47f6-a5cd-78c8a27d264c,South Manchester University Healthcare Trust,south_manchester_university_healthcare_trust,,,,,, +7150,,7959d7b4-8578-45e8-9e99-62140bb0a1b0,Universidad de Salamanca,universidad_de_salamanca,,,,,, +958,0.979515,6388a82e-7157-11e6-a0cd-0242ac12000b,ELAN PHARMA INTL LTD,elan_pharma_intl_ltd,,,,6388a82e-7157-11e6-a0cd-0242ac12000b,elan_pharma_intl_ltd,ELAN PHARMA INTL LTD +7151,,1a3f155e-7193-11e6-a0cd-0242ac12000b,PFIZER GLOBAL,pfizer_global,,,,,, +7152,,beb65622-5bb0-4ef6-80de-c809aa40ccca,Anni Ravnbek Jensen,anni_ravnbek_jensen,,,,,, +7153,,bcb33d21-b979-4fbd-8657-abd096c96ec6,CeRePP,cerepp,,,,,, +7154,,399fce44-729b-11e6-a0cd-0242ac12000b,HELSINN HLTHCARE,helsinn_hlthcare,,,,,, +7155,,becdbf42-bd5e-4483-afb0-07ff5d81cc62,"Pfizer AB, Vetenskapsvagen 10, 191 90 Sollentuna, Sweden",pfizer_ab_vetenskapsvagen_10_191_90_sollentuna_sweden,,,,,, +7156,,63e2ed24-7162-11e6-a0cd-0242ac12000b,LEITNER PHARMS,leitner_pharms,,,,,, +7157,,695e880d-88cd-46f3-961b-9c2c832faa78,Hilkka Soininen/Kuopio University Hospital,hilkka_soininen_kuopio_university_hospital,,,,,, +700,0.931044,71bf9d51-f211-4fcd-b6d2-35dce8b4c292,Juan Córdoba,juan_c_rdoba,,,,71bf9d51-f211-4fcd-b6d2-35dce8b4c292,juan_c_rdoba,Juan Córdoba +7158,,ef45cb52-8e29-4764-98da-e47e45a35d6a,Helena Barrasa,helena_barrasa,,,,,, +7159,,74cd8ac3-aa1f-49b2-9ccc-bc7bf79ff513,Ensinger Mineral-Heilquellen GmbH,ensinger_mineral_heilquellen_gmbh,,,,,, +7160,,6169badd-af23-4afb-b5fa-7f0f90b57b23,FAST Consortium under EU 7. FWP,fast_consortium_under_eu_7_fwp,,,,,, +7161,,b75cf5b4-47b0-4c73-ae06-11b3c7d22a0c,IDIAP JORDI GOL I GURINA,idiap_jordi_gol_i_gurina,,,,,, +7162,,30dced4d-a05b-4bfa-ad44-9e3e326cb882,"Department of Psychiatry, Helsinki University Central Hospital",department_of_psychiatry_helsinki_university_central_hospital,,,,,, +7163,,79ee8886-a2f1-4ac4-a5f8-326c7d689a63,"Onyx Therapeutics, Inc",onyx_therapeutics_inc,,,,,, +7164,,4b22d533-921c-4105-94ef-0fbe69a95625,"Klinikum der Universität München, Standort Großhadern",klinikum_der_universit_t_m_nchen_standort_gro_hadern,,,,,, +7165,,86be5b81-2954-4279-bfab-a3efbefb6ec3,Mentis Cura ehf,mentis_cura_ehf,,,,,, +7166,,11e2ca36-7b00-42e7-abd7-dc7992097f68,"Ortho-McNeil Janssen Scientific Affairs, LLC",ortho_mcneil_janssen_scientific_affairs_llc,,,,,, +7167,,5c737caf-da3d-4ab5-9d58-144028d9c46f,Jeroen Bosch - Groot Ziekengasthuis,jeroen_bosch_groot_ziekengasthuis,,,,,, +613,0.97674435377120972,f73db246-b5f4-49be-ab84-42d9dfa56dfb,"Erasmus Medical Center, Department of Anesthesiology",erasmus_medical_center_department_of_anesthesiology,,,,12caeba5-ed14-4baa-9bbd-829d8aa11d8a,erasmus_medical_centre_department_of_anesthesiology,"Erasmus Medical Centre, Department of Anesthesiology" +359,0.97782391309738159,453b2e40-8c8e-4dab-8a75-c9364067b629,IPSEN NV,ipsen_nv,,,,453b2e40-8c8e-4dab-8a75-c9364067b629,ipsen_nv,IPSEN NV +979,0.919788,5beb59d6-f94c-4993-90c5-181d33404f39,"Johnson & Johnson Consumer & Personal Products Worldwide, Division of Johnson & Johnson Consumer Companies, Inc",johnson_johnson_consumer_personal_products_worldwide_division_of_johnson_johnson_consumer_companies_inc,,,,5beb59d6-f94c-4993-90c5-181d33404f39,johnson_johnson_consumer_personal_products_worldwide_division_of_johnson_johnson_consumer_companies_inc,"Johnson & Johnson Consumer & Personal Products Worldwide, Division of Johnson & Johnson Consumer Companies, Inc" +355,0.989009,a1adcba9-c31d-4582-ac69-c64b28d7d11d,Asociación Colaboración Cochrane Iberoamericana,asociaci_n_colaboraci_n_cochrane_iberoamericana,,,,9cb0b7ef-9196-4272-8e74-952d80c320c4,asociaci_n_colaboraci_n_cochrane_iberoamericana_accib,Asociación Colaboración Cochrane Iberoamericana (ACCIb) +7168,,f15111a5-df89-4d0c-a844-44ad1c3fed2a,"Puma Biotechnology, Inc",puma_biotechnology_inc,,,,,, +7169,,e9b293c6-bd60-4ec7-9f29-c3e91d98c846,Epsom & St Helier's University Hospital NHS Trust,epsom_st_helier_s_university_hospital_nhs_trust,,,,,, +420,0.949464,4ff92bf9-dd91-4af4-8f0b-df007e6ac363,SAKK,sakk,,,,4ff92bf9-dd91-4af4-8f0b-df007e6ac363,sakk,SAKK +801,0.96035,d11a498d-47fc-48b8-84af-65a7f6eff7cf,"ORVACS, Objectif Recherche Vaccin SIDA",orvacs_objectif_recherche_vaccin_sida,,,,afb22cce-e75c-4e05-ab78-210fb3ae8aa8,orvacs,ORVACS +290,0.985423,4526ca2e-a18d-4d92-8100-e8a0507a1f36,Mayne Pharma,mayne_pharma,,,,4526ca2e-a18d-4d92-8100-e8a0507a1f36,mayne_pharma,Mayne Pharma +55,0.95857,43cce800-7149-11e6-a0cd-0242ac12000b,EGIS,egis,,,,43cce800-7149-11e6-a0cd-0242ac12000b,egis,EGIS +7170,,b4a1ac2e-98af-475e-8f53-9cd475936928,Bayer AG,bayer_ag,,,,,, +7171,,4bd47120-cbc7-45f9-9327-e056a1eacd5e,Takeda Development Centre Europe Limited,takeda_development_centre_europe_limited,,,,,, +7172,,19f40c73-c1bc-4f3e-982d-eb644a77bee5,"LOTUS Pharma CO., LTD",lotus_pharma_co_ltd,,,,,, +7173,,fe90f24c-a9b8-4d2c-91ef-17e9cdc16158,Landspitali University Hospital,landspitali_university_hospital,,,,,, +7174,,13bf1f19-7572-4507-abe4-1d6d1029dedb,CHU AMIENS,chu_amiens,,,,,, +657,0.988592,94fe56aa-5dec-4b9e-95e5-c23b1585d045,sanofi-aventis Netherlands,sanofi_aventis_netherlands,,,,94fe56aa-5dec-4b9e-95e5-c23b1585d045,sanofi_aventis_netherlands,sanofi-aventis Netherlands +7175,,3f77286d-c495-486c-93d9-567d9b150473,"Keryx Biopharmaceuticals, Inc",keryx_biopharmaceuticals_inc,,,,,, +491,0.9828302264213562,e0d1f6b9-224f-42aa-a9f1-fc7fdf02f5e4,GlaxoSmithKline,glaxosmithkline,,,,280c153e-a191-46ae-8ddc-97dc33b90bb5,glaxosmithkline_sia_latvia,GlaxoSmithKline SIA Latvia +405,0.96411377191543579,001f0c1a-b3ca-426e-bb98-8fb8a819a482,"Gilead Science, Inc",gilead_science_inc,,,,dee4490b-b25c-4c54-b909-635261eba55d,gilead,Gilead +7176,,daeaf21a-b265-479b-9ca3-6bbf469557aa,Dr. Antonio Román Broto,dr_antonio_rom_n_broto,,,,,, +7177,,7875d8b5-a7de-4d60-9cd0-c3054a8bf883,Manuel García Medina,manuel_garc_a_medina,,,,,, +7178,,01e34a1e-71d1-11e6-a0cd-0242ac12000b,CADEMA,cadema,,,,,, +7179,,08acc369-9848-4a20-80be-b1ed5472c7c1,Central Manchester and Manchester Children's Hospitals NHS Trust,central_manchester_and_manchester_children_s_hospitals_nhs_trust,,,,,, +7180,,80726611-effd-49f6-a29a-9591f86e8171,Universityhospital Ulm,universityhospital_ulm,,,,,, +515,0.928618,0b864f9c-6a82-4657-9f94-14d0aa558320,"J. Uriach y Compañia, S. A",j_uriach_y_compa_ia_s_a,,,,0b864f9c-6a82-4657-9f94-14d0aa558320,j_uriach_y_compa_ia_s_a,"J. Uriach y Compañia, S. A" +801,0.96035,afb22cce-e75c-4e05-ab78-210fb3ae8aa8,ORVACS,orvacs,,,,afb22cce-e75c-4e05-ab78-210fb3ae8aa8,orvacs,ORVACS +7181,,fc125586-73c3-11e6-a0cd-0242ac12000b,HORIZON THERAPS INC,horizon_theraps_inc,,,,,, +7182,,847eaa2e-4115-402c-94fd-61c63e38ea88,"Department of Surgery, Herlev Hospital",department_of_surgery_herlev_hospital,,,,,, +7183,,1d6c13b8-72aa-11e6-a0cd-0242ac12000b,EISAI MEDCL RES,eisai_medcl_res,,,,,, +7184,,2e1c0808-7160-11e6-a0cd-0242ac12000b,POLYMEDICA,polymedica,,,,,, +7185,,fa59c5d7-4e7f-4003-b10d-559062922dcd,Antonio Antela López,antonio_antela_l_pez,,,,,, +7186,,4f2f08ec-6fa3-11e6-9663-0242ac12000b,AESCA Pharma Ges.m.b.H,aesca_pharma_ges_m_b_h,,,,,, +188,0.9797365665435791,c698abc0-6f9b-11e6-9663-0242ac12000b,Nycomed,nycomed,,,,c698abc0-6f9b-11e6-9663-0242ac12000b,nycomed,Nycomed +796,0.98663,a1ce2c38-7163-11e6-a0cd-0242ac12000b,STRIDES ARCOLAB LTD,strides_arcolab_ltd,,,,26536bce-72ec-11e6-a0cd-0242ac12000b,strides_arcolab,STRIDES ARCOLAB +7187,,eb490b38-71d3-11e6-a0cd-0242ac12000b,HQ SPECLT PHARMA,hq_speclt_pharma,,,,,, +816,0.989949,d89406de-85c4-474e-a03e-9516d6463bf7,The Kompetenznetz Vorhofflimmern e.V. [German Atrial Fibrillation Competence Network association (AF,the_kompetenznetz_vorhofflimmern_e_v_german_atrial_fibrillation_competence_network_association_af,,,,d89406de-85c4-474e-a03e-9516d6463bf7,the_kompetenznetz_vorhofflimmern_e_v_german_atrial_fibrillation_competence_network_association_af,The Kompetenznetz Vorhofflimmern e.V. [German Atrial Fibrillation Competence Network association (AF +7188,,bb013508-ec7d-4956-91b5-c8b7cdc178eb,"ALK-Abello, Group Clinical Development",alk_abello_group_clinical_development,,,,,, +7189,,70af62ca-9ca2-4aae-b12c-5a4f8ea1c57b,Nordmark Arzneimittel GmbH,nordmark_arzneimittel_gmbh,,,,,, +7190,,ef637a9d-e802-4bfa-8e48-a3eb7b2d05aa,"KONSTANTINAS POVILAS VALUCKAS, INSTITUTE OF ONCOLOGY OF VILNIUS UNIVERSITY",konstantinas_povilas_valuckas_institute_of_oncology_of_vilnius_university,,,,,, +7191,,d6002afa-8811-11e6-a998-0242ac12000b,North West London NHS Trust,north_west_london_nhs_trust,,,,,, +319,0.943406,b6c9f78d-3623-4c1b-b488-81bf230000fd,MERCK SERONO SPA,merck_serono_spa,,,,8fd294ea-aee1-4e2e-86ed-6265cb17d1af,merck_serono_sa,MERCK SERONO SA +7192,,32027923-42dd-4ab4-b26f-ab03457677e8,JSC Grindeks,jsc_grindeks,,,,,, +7193,,53a21880-6f13-484d-b836-5b24ac6efd1d,F.Schreuder,f_schreuder,,,,,, +7194,,e42f0bfd-b496-4732-a47b-8c14964c9df2,Vesa Pakanen,vesa_pakanen,,,,,, +7195,,94af10da-72fd-11e6-a0cd-0242ac12000b,PERNIX IRELAND LTD,pernix_ireland_ltd,,,,,, +7196,,0dc19032-a5b8-4124-9ac4-cbe5211124eb,Academisch ziekenhuis Leiden acting under the name of Leids Universitair Medisch Centrum,academisch_ziekenhuis_leiden_acting_under_the_name_of_leids_universitair_medisch_centrum,,,,,, +7197,,6d487914-16e0-4dbf-9c1e-fd44f1a555a2,"Isis Pharmaceuticals, Inc",isis_pharmaceuticals_inc,,,,,, +7198,,488640d2-715b-11e6-a0cd-0242ac12000b,NU PHARM,nu_pharm,,,,,, +9,0.96726498007774353,2f45bfe9-0b5a-450f-abb3-c7aa18916ff8,Centre Hospitalier Universitaire Rennes,centre_hospitalier_universitaire_rennes,,,,2f45bfe9-0b5a-450f-abb3-c7aa18916ff8,centre_hospitalier_universitaire,Centre Hospitalier Universitaire +7199,,35987db1-fa3a-4bcf-a4e7-c3c2f9cee57a,STRUTTURA SEMPLICE GESTIONE-ORG.-FUNZ. HUB EMOFILIA,struttura_semplice_gestione_org_funz_hub_emofilia,,,,,, +562,0.979163,788b20ed-9fc5-4bbe-8a89-5a73895f8c3e,Glaxo SmithKline Research and Development Limited,glaxo_smithkline_research_and_development_limited,,,,2618aeee-2b40-46b0-83e0-69a85a4447c6,glaxo_smithkine_research_and_development_limited,Glaxo SmithKine Research and Development Limited +7200,,7f26886a-715e-11e6-a0cd-0242ac12000b,MARSHALL PHARMA,marshall_pharma,,,,,, +1078,0.958152174949646,0d8956db-6782-46d2-8279-946b33f25bc5,IBSA Institute Biochimique SA,ibsa_institute_biochimique_sa,,,,1242e11a-4288-492d-8023-e4ffe5a4e9bd,ibsa_institute_biochimique_sa,IBSA Institute Biochimique SA +1017,0.98458112776279449,c5aa9e47-d56f-4f01-92f1-cb0bad609620,Southampton University Hospitals,southampton_university_hospitals,,,,986ad2cd-cb4e-460c-acdc-a2b32a61de09,southampton_university_hospitals,Southampton University Hospitals +7201,,a6b74179-73d1-454f-b546-3bdc5a71b028,BIO PRODUCTS LABORATORY LIMITED (BPL),bio_products_laboratory_limited_bpl,,,,,, +7202,,46e2966b-78e5-4fd3-b275-62627bad64a5,Dorset County Hospital NHS foundation trust,dorset_county_hospital_nhs_foundation_trust,,,,,, +7203,,f1e04d98-6f9f-11e6-9663-0242ac12000b,Lytix Biopharma AS,lytix_biopharma_as,,,,,, +201,0.982782,01c1da90-d188-4b3b-9a77-71c11c8ab042,Kuopio University Hospital,kuopio_university_hospital,,,,01c1da90-d188-4b3b-9a77-71c11c8ab042,kuopio_university_hospital,Kuopio University Hospital +929,0.964008,9a5d3906-eb62-4e28-bbd4-1747e100864c,Leeds teaching Hospitals,leeds_teaching_hospitals,,,,9a5d3906-eb62-4e28-bbd4-1747e100864c,leeds_teaching_hospitals,Leeds teaching Hospitals +65,0.97933,8a33d4f4-7359-11e6-a0cd-0242ac12000b,ANGELINI PHARMA,angelini_pharma,,,,85300b96-9316-43a9-b115-b61f3263249b,angelini,ANGELINI +7204,,d41076a5-77a0-4aad-a665-20dcefaa37b5,Esko Kemppainen,esko_kemppainen,,,,,, +318,0.98787707090377808,215a6fe0-4912-4052-b609-f99824db28f0,Department of Neurology,department_of_neurology,,,,215a6fe0-4912-4052-b609-f99824db28f0,department_of_neurology,Department of Neurology +7205,,52bc7d4f-2884-44c9-9534-8e4c35266822,Aintree University Hospital NHS Foundation Trust,aintree_university_hospital_nhs_foundation_trust,,,,,, +7206,,3d21fcd2-6fc0-11e6-abe8-0242ac12000b,"Dept. of Cardiology, Medical University of Vienna",dept_of_cardiology_medical_university_of_vienna,,,,,, +108,0.976464,d3014e9c-d04d-49df-8301-b6d581035e05,Instituto de Inmunología y Alergia INMUNAL S.A..U,instituto_de_inmunolog_a_y_alergia_inmunal_s_a_u,,,,b357c82c-483a-4d22-ba95-f043cc73dd9b,instituto_de_inmunolog_a_y_alergia_inmunal_sau,Instituto de Inmunología y Alergia INMUNAL SAU +7207,,0c9836cc-5d39-4834-9a2c-09b85f3812cc,Novartis Vaccines and Diagnostics Limited,novartis_vaccines_and_diagnostics_limited,,,,,, +7208,,3b414b68-7167-11e6-a0cd-0242ac12000b,METHODIST HOSP RES,methodist_hosp_res,,,,,, +7209,,6b7d2b4f-4aca-4487-b0ce-3fe8d9b2f9da,Astellas US Pharma US Inc.(APUS),astellas_us_pharma_us_inc_apus,,,,,, +7210,,02aeddcf-2df8-4c1a-b746-a3975dbd9320,"Boehringer Ingelheim Hellas, S.A",boehringer_ingelheim_hellas_s_a,,,,,, +7211,,76a79fee-7140-11e6-a0cd-0242ac12000b,KING PHARMS,king_pharms,,,,,, +7212,,458e8d6f-b099-44c7-8ec3-eb4a7ea934af,AMC Medical research BV,amc_medical_research_bv,,,,,, +7213,,42698966-0dbc-4168-81d4-7a9ac2cb40e4,Atrium Medical Centre,atrium_medical_centre,,,,,, +7214,,e40c9897-9273-4be4-87e5-1e3a2ba5a16b,University Hospital of Muenster,university_hospital_of_muenster,,,,,, +7215,,328a4feb-090c-46e5-a2b3-ade9594d0dc8,ViroLogik GmbH,virologik_gmbh,,,,,, +458,0.98385661840438843,3baabec0-1bc8-4e64-b010-70f6fcb400f2,"Jassen-Cilag International NV,Turnhoutseweg 30, 2340 Beerse, Belgium",jassen_cilag_international_nv_turnhoutseweg_30_2340_beerse_belgium,,,,3baabec0-1bc8-4e64-b010-70f6fcb400f2,jassen_cilag_international_nv_turnhoutseweg_30_2340_beerse_belgium,"Jassen-Cilag International NV,Turnhoutseweg 30, 2340 Beerse, Belgium" +7216,,e9e33638-b4e7-45af-8793-6e60ee2f6978,Sahlgrenska University hospital of gothenburg Department of dermatology,sahlgrenska_university_hospital_of_gothenburg_department_of_dermatology,,,,,, +7217,,dc5de270-5772-4dd0-891f-4dec9f50a379,"Department Integrative Medicine, Kliniken Essen Mitte",department_integrative_medicine_kliniken_essen_mitte,,,,,, +7218,,fd915d18-a3f2-4837-bd7e-1c06698794a9,Hellmuth Ulrici Kliniken,hellmuth_ulrici_kliniken,,,,,, +7219,,43d56b38-162c-4ee9-a6e7-0e89acde29da,FIT Biotech Oyj Plc,fit_biotech_oyj_plc,,,,,, +105,0.92743,d4f547b3-11c3-4fc5-9074-7d39f3b62c47,Aristotle University Thessaloniki,aristotle_university_thessaloniki,,,,87f12084-92d1-4b68-89c3-59450c51ce2e,aristotle_university_of_thessaloniki,Aristotle University of Thessaloniki +7220,,7f46d36d-b4f9-4b46-ae57-51554025201b,"Dr. Olivier F. Bertrand , Laval Hospital",dr_olivier_f_bertrand_laval_hospital,,,,,, +7221,,9f6a4ba9-6b2f-4985-b151-06ff0897c23f,Toray Industries Inc,toray_industries_inc,,,,,, +376,0.95499825477600098,bd6bee50-086c-45b4-9e8c-06da513d3e0f,"Merck Sharp & Dohme Corp., filial de Merck & Co., Inc",merck_sharp_dohme_corp_filial_de_merck_co_inc,,,,105bd662-3e0a-487f-94e5-81782ae2a384,merck_sharp_dohme_corp_una_filial_de_merck_co_inc,"Merck Sharp & Dohme Corp., una filial de Merck & Co., Inc" +871,0.98728418350219727,0f0582d8-6951-40ea-8acc-9d010331c376,Astellas Pharma Europe Ltd. (APEL),astellas_pharma_europe_ltd_apel,,,,0f0582d8-6951-40ea-8acc-9d010331c376,astellas_pharma_europe_ltd_apel,Astellas Pharma Europe Ltd. (APEL) +7222,,9d6716e7-326c-4842-a170-11ce5d984e1f,Alimera Sciences Inc,alimera_sciences_inc,,,,,, +7223,,37d887f2-7194-11e6-a0cd-0242ac12000b,NURO PHARMA,nuro_pharma,,,,,, +7224,,0789c22e-1447-4fda-8059-9e0602b02195,Sanofi-Aventis recherche de veloppement,sanofi_aventis_recherche_de_veloppement,,,,,, +7225,,f9b41ee0-777d-4776-acec-5d3b42670002,Dermapharm AG,dermapharm_ag,,,,,, +7226,,857d85f6-71b8-11e6-a0cd-0242ac12000b,UNITED GUARDIAN,united_guardian,,,,,, +7227,,00e570d9-c195-40a4-ac87-a4a91f82be2a,Fondazione Neureca Onlus,fondazione_neureca_onlus,,,,,, +29,0.987472,27abc283-e5cd-4ac3-968b-19e1e91d0bcd,INO Therapeutics AB,ino_therapeutics_ab,,,,27abc283-e5cd-4ac3-968b-19e1e91d0bcd,ino_therapeutics_ab,INO Therapeutics AB +7228,,87306cb6-b40b-4013-835b-63b57755824b,María Carmen Cabellos Mínguez,mar_a_carmen_cabellos_m_nguez,,,,,, +896,0.983343,a1bb1c18-7336-11e6-a0cd-0242ac12000b,WYETH PHARMS PFIZER,wyeth_pharms_pfizer,,,,a1bb1c18-7336-11e6-a0cd-0242ac12000b,wyeth_pharms_pfizer,WYETH PHARMS PFIZER +7229,,435d2956-e780-4b67-973c-b31c98d130a4,Cytonet GmbH & Co. KG,cytonet_gmbh_co_kg,,,,,, +1025,0.96337196230888367,2f59f764-513a-43d8-ba41-bc314f18f59b,"Eli Lilly and Company Limited, Indianapolis",eli_lilly_and_company_limited_indianapolis,,,,2f59f764-513a-43d8-ba41-bc314f18f59b,eli_lilly_and_company_limited,Eli Lilly and Company limited +7230,,bd8730de-09b5-4ada-9a50-28a213327b58,Michael Larsen,michael_larsen,,,,,, +7231,,be28ec0f-4150-4f1d-9c22-b010ce920913,"prof W.J. Fokkens, academic medical center",prof_w_j_fokkens_academic_medical_center,,,,,, +667,0.985709,2e06635b-2945-406f-8fe4-e9afcb19c015,Consorci Parc de Salut Mar,consorci_parc_de_salut_mar,,,,1a3268a1-1f5d-4bc4-a2cd-ff168ce961fd,consorci_parc_de_salut_mar_de_barcelona,Consorci Parc de Salut Mar de Barcelona +130,0.9775693416595459,96e696d3-f783-429f-922d-c183e3c81995,Cliniques universitaires Saint-Luc,cliniques_universitaires_saint_luc,,,,3515d8bf-edb3-4b5e-ba66-e5a15542aded,cliniques_universitaires_saint_luc_cusl,Cliniques Universitaires Saint-Luc (CUSL) +7232,,ba2c923c-5fcc-44d6-9e41-35af745e107f,University of Zurich,university_of_zurich,,,,,, +7233,,6c7a15e2-5b0e-4ca9-bae1-ba470fcaf9b4,CISbio International,cisbio_international,,,,,, +7234,,0ccfb2d4-8b49-44de-b46a-118191523187,"Exxentia Grupo Fitoterapéutico, S.A",exxentia_grupo_fitoterap_utico_s_a,,,,,, +7235,,30fc0f2a-8398-49ed-9312-80d6b03b06b2,"Department of Molecular and Clinical Medicine; ""Sapienza"" University of Rome",department_of_molecular_and_clinical_medicine_sapienza_university_of_rome,,,,,, +7236,,78b04fde-18a9-4a11-a46e-537b31f0899e,AZIENDA OSPEDALIERA DI PADOVA,azienda_ospedaliera_di_padova,,,,,, +7237,,5fc47834-8413-4c3c-8f13-e282c716a1d1,Fundación Progreso y Salud,fundaci_n_progreso_y_salud,,,,,, +570,0.967052,c7f9a7b2-715d-11e6-a0cd-0242ac12000b,CARDINAL HEALTH 414,cardinal_health_414,,,,c7f9a7b2-715d-11e6-a0cd-0242ac12000b,cardinal_health_414,CARDINAL HEALTH 414 +7238,,acbfd119-3ec8-4ed5-80f8-dba74434eb32,KRKA-POLSKA Sp. z o.o,krka_polska_sp_z_o_o,,,,,, +7239,,8c0c2630-73f1-11e6-a0cd-0242ac12000b,PRAXAIR DISTRIBUTION INC,praxair_distribution_inc,,,,,, +7240,,21bdb8c3-c488-4b3e-97fc-8856925e3213,Protherics Medicines Development Ltd,protherics_medicines_development_ltd,,,,,, +7241,,4fc0232b-5b31-4cfd-a58d-e69413076dfa,"University of Turin, Dept of Clinical & Biological Sciences",university_of_turin_dept_of_clinical_biological_sciences,,,,,, +7242,,f3c88626-6701-41a0-85bc-e982a9dcaa82,"Unidad Integral de Investigación en Oncología, S.L",unidad_integral_de_investigaci_n_en_oncolog_a_s_l,,,,,, +7243,,74512f41-925f-4942-9cbd-7a05f7baba54,sanofi pasteur SA,sanofi_pasteur_sa,,,,,, +543,0.930137,c802f14e-ff99-4093-8da7-863343646050,Abbott Laboratories LLC,abbott_laboratories_llc,,,,71738680-41ff-4751-88bc-8c484e8e9bc7,abbott_laboratories_limited_queenborough_kent_me11_5el_england,"Abbott Laboratories Limited (Queenborough, Kent, ME11 5EL, England)" +7244,,a78b7bcc-7167-11e6-a0cd-0242ac12000b,MSN LABS PVT LTD,msn_labs_pvt_ltd,,,,,, +7245,,c0576e2c-bd1d-49ab-a3ee-f89de65b3b42,Glasgow University,glasgow_university,,,,,, +338,0.944177,8d963edd-4feb-4306-95ff-812ad6aebbde,Medizinische Fakultät der Universität Bonn,medizinische_fakult_t_der_universit_t_bonn,,,,59161c21-f110-4f6b-bf67-f4d922ff5a94,medizinische_fakult_t_der_universit_t_rostock,Medizinische Fakultät der Universität Rostock +291,0.978606,320e8407-98ad-450a-9b12-470d02f981e1,GEICAM (GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA),geicam_grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama,,,,320e8407-98ad-450a-9b12-470d02f981e1,geicam_grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama,GEICAM (GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA) +7246,,24c14c11-4a28-4351-8872-590127aaac41,CENTRO PER LA PREVENZIONE E CURA DEL TABAGISMO,centro_per_la_prevenzione_e_cura_del_tabagismo,,,,,, +7247,,b772b33d-0a76-4ae6-9de6-f238be87e134,Justus-Liebig-University,justus_liebig_university,,,,,, +7248,,fbca3518-c742-48cc-af5f-e0709dc105b3,Phenomix Corporation,phenomix_corporation,,,,,, +7249,,240f84eb-3774-4d80-aa50-ebd275572350,ISTITUTO C. MONDINO,istituto_c_mondino,,,,,, +7250,,6cb16e83-bb9b-436f-a26b-c13e5f1d85b7,"Universitätsklinik für Radiodiagnostik, Abteilung für Neuroradiologie, Medizinische Universität Wien",universit_tsklinik_f_r_radiodiagnostik_abteilung_f_r_neuroradiologie_medizinische_universit_t_wien,,,,,, +7251,,ddfc4ff8-fd92-4c99-83c6-2535e8b30911,Sigrun Kjøtrød,sigrun_kj_tr_d,,,,,, +7252,,a3926a79-3c06-4e2a-8455-8266d56015f0,Rafael Bielza Galindo,rafael_bielza_galindo,,,,,, +7253,,6049b86f-095c-4972-b467-778b1207af96,"University of Szeged, Medical and Pharmaceutical Center, Department of Ophthalmology",university_of_szeged_medical_and_pharmaceutical_center_department_of_ophthalmology,,,,,, +7254,,1b28347f-f138-4c56-9a19-4b40b7fd59cf,EGRIS,egris,,,,,, +920,0.98836344480514526,f01871b1-36b4-4081-95b7-6ef328172aa7,AZIENDA OSPEDALIERO-UNIVERSITARIA,azienda_ospedaliero_universitaria,,,,d94f6c83-6e14-4b83-88fc-13e50ecbc634,azienda_ospedaliero_universitaria_pisana,AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA +7255,,84151828-4784-4458-97bf-d1fe1f88b6a8,"Psychosis Early Detection and Intervention Centre, Department for Psychiatry, UKE Hamburg",psychosis_early_detection_and_intervention_centre_department_for_psychiatry_uke_hamburg,,,,,, +252,0.96770843863487244,0f0d8991-097b-4737-a496-fd2e4d5aa3ff,Martin Luther University of Halle-Wittemberg,martin_luther_university_of_halle_wittemberg,,,,0f0d8991-097b-4737-a496-fd2e4d5aa3ff,martin_luther_university_of_halle_wittenberg,Martin Luther University of Halle/Wittenberg +7256,,6d424ef0-af3e-49bb-92a5-1e880f9a4e11,"Genzyme, a Sanofi Company",genzyme_a_sanofi_company,,,,,, +101,0.96975362300872803,795618d0-8fa3-476f-af53-917115d81263,"University Children's Hospital, Department of Neonatology",university_children_s_hospital_department_of_neonatology,,,,6cac1b04-1612-4a24-92aa-2b5234eb2596,university_childrin_s_hospital,University Childrin's Hospital +7257,,b12f961f-65f0-45b2-bb50-b17bc54604b1,TRIGEN,trigen,,,,,, +7258,,2345d8b7-c300-4d81-a29d-f473ed2970bd,EKOS Corporation,ekos_corporation,,,,,, +7259,,8152210c-7b0c-421e-bfd8-1f3684fbd81d,Democritus Universityof Thrace Medical School,democritus_universityof_thrace_medical_school,,,,,, +7260,,3e87d3b1-e8e3-4ff7-b508-90fb811856c5,CERENIS THERAPEUTICS SA,cerenis_therapeutics_sa,,,,,, +7261,,53c95df4-77bd-404c-9bd9-0e97874b82e0,Swedish Orphan Biovitrum (Sobi) AB (publ),swedish_orphan_biovitrum_sobi_ab_publ,,,,,, +7262,,66861f29-b8e5-40f8-b293-ec281ac77975,ISTITUTO AUXOLOGICO ITALIANO,istituto_auxologico_italiano,,,,,, +608,0.97136334578196204,74941600-ec13-4438-9c7c-d11859941da7,"RWTH Aachen University for the Medical Faculty, represented by Clinical Trial Center Aachen (CTC-A)",rwth_aachen_university_for_the_medical_faculty_represented_by_clinical_trial_center_aachen_ctc_a,,,,8cf07097-1668-4840-99e4-5f3861195629,rwth_aachen_university_for_the_medical_faculty_represented_by_clinical_trial_center_aachen_ctc_a,"RWTH Aachen University for the Medical Faculty, represented by Clinical Trial Center Aachen (CTC-A)" +7263,,a0d4d94b-329e-4064-a1af-2b43cbc1a34b,Beaufour Ipsen Pharma-Ipsen Biotech Department,beaufour_ipsen_pharma_ipsen_biotech_department,,,,,, +39,0.981087,81ade96c-402d-40b2-b4a1-a4b54a97c3f1,Innovacell Biotechnologie AG,innovacell_biotechnologie_ag,,,,277efbbe-0659-4d05-bc5a-4b600b2919e3,innovacell_biotechnologie_ag_life_science_center_innsbruck,Innovacell Biotechnologie AG - Life Science Center Innsbruck +7264,,cd454559-7cea-4fb2-9485-06cf8aabf8be,Nabriva Therapeutics AG,nabriva_therapeutics_ag,,,,,, +890,0.91218763589859009,6e8ed001-5c25-4c82-8b82-365ae91ee2c8,"University Medical Center, Johannes Gutenberg-University Mainz",university_medical_center_johannes_gutenberg_university_mainz,,,,6e8ed001-5c25-4c82-8b82-365ae91ee2c8,university_medical_center_johannes_gutenberg_university_mainz,"University Medical Center, Johannes Gutenberg-University Mainz" +7265,,002936cc-1796-4c16-a046-0236c411b989,"Fundació Institut de Recerca, Hospital Santa Creu i Sant Pau",fundaci_institut_de_recerca_hospital_santa_creu_i_sant_pau,,,,,, +7266,,8bb3ad09-cf68-494d-a1c6-6b953da36cfc,Derbyshire NHS Trust,derbyshire_nhs_trust,,,,,, +7267,,63f9c956-1077-4225-8217-63a677f9a4a2,Newron Pharmaceuticals S.p.A,newron_pharmaceuticals_s_p_a,,,,,, +7268,,e983e7c4-714b-11e6-a0cd-0242ac12000b,VALEANT PHARMS NORTH,valeant_pharms_north,,,,,, +1081,0.98642590641975403,409b84eb-a4eb-4d52-878e-1faec5f0397f,Vertex Pharmaceuticals,vertex_pharmaceuticals,,,,48c9366f-f57d-45a5-b7c5-8b03cb153868,vertex_pharmaceuticals_inc,Vertex Pharmaceuticals Inc +7269,,73cd5dbf-1b23-478d-830a-77865dd72673,ASSOCIAZIONE SALENTINA ANGELA SERRA ONLUS,associazione_salentina_angela_serra_onlus,,,,,, +487,0.989076,9b0dc634-cbf6-42d8-8ab7-f7378694b382,University Eye Clinic Maastricht UMC,university_eye_clinic_maastricht_umc,,,,614b7da9-01e8-45b1-a601-7f743ec0f288,university_eye_clinic_maastricht,University Eye Clinic Maastricht +7270,,b8cc461d-f4df-4e00-ad13-3ccf6cf6f7b8,Regensburg University Medical Center,regensburg_university_medical_center,,,,,, +7271,,496acb41-295a-43ee-9136-4d1fef65e2b7,"TolerRx, Inc",tolerrx_inc,,,,,, +7272,,f741a791-41e4-4a48-831e-e9270ec7c683,"Pr Giampiero CAMPANELLI - Ospedale Maggiore Policlinico, Padiglione Beretta Est",pr_giampiero_campanelli_ospedale_maggiore_policlinico_padiglione_beretta_est,,,,,, +7273,,1100cb45-aefd-43d1-abf7-a7a7c2a29071,Institute of Diabetes “Gerhardt Katsch”,institute_of_diabetes_gerhardt_katsch,,,,,, +7274,,66a1e8b5-17d5-45b5-97c8-76183db6666a,The Leeds Teaching Hospitals NHS Trust,the_leeds_teaching_hospitals_nhs_trust,,,,,, +7275,,3cee0add-756e-4c92-ac22-fd802d49f62e,"Franz Volhard Clinic, Charite Campus Buch",franz_volhard_clinic_charite_campus_buch,,,,,, +7276,,e57d8cb8-a963-4e24-b1af-244548590216,Andrés Íñiguez Romo,andr_s_iguez_romo,,,,,, +7277,,e1176698-f2fc-4c41-a1e3-351fcba3d504,"Aventis Pharma, S.A",aventis_pharma_s_a,,,,,, +7278,,95d2929e-a58a-4103-a7ad-7eff0549e50c,"Cogentus Pharmaceuticals, Inc",cogentus_pharmaceuticals_inc,,,,,, +7279,,22c767cd-30c5-407f-b017-9def5ee2271e,Institut for Pharmacology and Toxicology,institut_for_pharmacology_and_toxicology,,,,,, +7280,,217b103f-db57-4ad2-9c75-b814aa4c3b8f,F. Hoffmann-La Roche Ltd as part of the Aspreva Rare Disease Program,f_hoffmann_la_roche_ltd_as_part_of_the_aspreva_rare_disease_program,,,,,, +7281,,ef2aa4dd-53dc-4557-9fef-8e9e19f5c38b,Medical University Vienna Division of Anesthesie and Pain Management,medical_university_vienna_division_of_anesthesie_and_pain_management,,,,,, +7282,,7598b836-dbe5-4c2f-845b-64ca57b2a087,Carl Dahlöf,carl_dahl_f,,,,,, +7283,,9d57e13f-674b-48cd-9fd4-86a5c2ba7e70,German Cancer Research Center (DKFZ),german_cancer_research_center_dkfz,,,,,, +674,0.98227512836456299,e7897bf7-d8e3-4baf-a043-22a7475f28df,CENTOCOR,centocor,,,,9ebe2d66-716a-11e6-a0cd-0242ac12000b,centocor_inc,CENTOCOR INC +929,0.964008,caa7f728-f2b0-43f9-976b-86e1d2d9f227,Leeds Teaching Hospitals and University of Leeds,leeds_teaching_hospitals_and_university_of_leeds,,,,9a5d3906-eb62-4e28-bbd4-1747e100864c,leeds_teaching_hospitals,Leeds teaching Hospitals +7284,,ace5f454-7148-11e6-a0cd-0242ac12000b,SIGHT PHARMS,sight_pharms,,,,,, +7285,,32db7cda-f0f3-49de-b90e-0d463f53ae3a,Acino Supply AG,acino_supply_ag,,,,,, +7286,,ca0b3111-1dc9-4ef6-bb8f-f208f041c9ad,COSMO TECHNOLOGIES LTD,cosmo_technologies_ltd,,,,,, +439,0.98637,80bfc25c-b233-4572-aece-f1e06f4d720e,SciencePharma spółka z ograniczoną odpowiedzialnością sp. k,sciencepharma_sp_ka_z_ograniczon_odpowiedzialno_ci_sp_k,,,,80bfc25c-b233-4572-aece-f1e06f4d720e,sciencepharma_sp_ka_z_ograniczon_odpowiedzialno_ci_sp_k,SciencePharma spółka z ograniczoną odpowiedzialnością sp. k +7287,,9c067030-b7bf-4614-8e5b-e7ad7b8f10e4,Lilly SA,lilly_sa,,,,,, +7288,,7d76e9cc-5133-440a-a881-dd21fd60cfa6,"LKH-Universitätsklinikum Graz,Universitäre Palliativmedizinische Einrichtung",lkh_universit_tsklinikum_graz_universit_re_palliativmedizinische_einrichtung,,,,,, +773,0.958103,3ebee54d-bab5-4063-88aa-8fc3ffe15712,The Institute of Cancer Research,the_institute_of_cancer_research,,,,3ebee54d-bab5-4063-88aa-8fc3ffe15712,the_institute_of_cancer_research,The Institute of Cancer Research +7289,,791d5c1e-8c4f-41fd-9390-d50f50515b3e,Veloxis Pharmaceuticals A/S,veloxis_pharmaceuticals_a_s,,,,,, +7290,,7ce6676c-c4ba-411e-9add-f99f13d66812,Swansea University,swansea_university,,,,,, +7291,,d9670674-736b-11e6-a0cd-0242ac12000b,SPROUT PHARMS,sprout_pharms,,,,,, +7292,,d464e784-efa2-470c-94a0-f8046f6ee419,PET Diagnosztikai Kft,pet_diagnosztikai_kft,,,,,, +7293,,347835ba-f3c7-4a0c-a80d-241d25fb72aa,"Lux Biosciences, Inc",lux_biosciences_inc,,,,,, +260,0.985178,91b42753-22b3-40cf-91c4-a74d2a2ada1b,"National Cancer Institute Naples, Italy",national_cancer_institute_naples_italy,,,,91b42753-22b3-40cf-91c4-a74d2a2ada1b,national_cancer_institute_naples_italy,"National Cancer Institute Naples, Italy" +7294,,31eb4f92-718e-11e6-a0cd-0242ac12000b,NPS PHARMS INC,nps_pharms_inc,,,,,, +7295,,12b2ed8c-67f7-4cfa-ab5c-23410a9954bd,Medical Developments International Limited,medical_developments_international_limited,,,,,, +7296,,d705f084-7145-11e6-a0cd-0242ac12000b,MERRO PHARM,merro_pharm,,,,,, +7297,,7a25d496-8f4d-4bb8-88c1-beeff9b38fb3,"Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron",programa_de_medicina_molecular_y_gen_tica_hospital_vall_d_hebron,,,,,, +7298,,858768a0-bd33-47b8-b94b-1a7d1b18cd70,Kneipp-Werke,kneipp_werke,,,,,, +7299,,d8b63e76-0973-48e2-8c64-9471fddbfaf7,MolMed S.pA,molmed_s_pa,,,,,, +261,0.938998,d226d28e-bcc2-49e5-b106-505094f7139d,Servicio de Neumologia. Hospital Universitario Vall d'Hebron,servicio_de_neumologia_hospital_universitario_vall_d_hebron,,,,d226d28e-bcc2-49e5-b106-505094f7139d,servicio_de_neumologia_hospital_universitario_vall_d_hebron,Servicio de Neumologia. Hospital Universitario Vall d'Hebron +969,0.98663,627a1c48-7142-11e6-a0cd-0242ac12000b,WARNER CHILCOTT LLC,warner_chilcott_llc,,,,44eb1394-7142-11e6-a0cd-0242ac12000b,warner_chilcott,WARNER CHILCOTT +7300,,51035542-0eae-4847-b85e-7d29c7baa734,Máximo Bernabeu Wittel,m_ximo_bernabeu_wittel,,,,,, +7301,,48b3dd11-cca1-4c48-be24-ba42b9d2b587,"Vienna Medical University, Dept. of Ophthalmology",vienna_medical_university_dept_of_ophthalmology,,,,,, +7302,,c99cd2d2-5c75-4c44-9dfe-73d5feb7908a,International Extranodal Lymphoma Srudy Group IELSG,international_extranodal_lymphoma_srudy_group_ielsg,,,,,, +7303,,a008374b-494b-444e-9e9f-3b3ab24a26f2,"Medical University of Vienna, Department of Psychiatry and Psychotherapy",medical_university_of_vienna_department_of_psychiatry_and_psychotherapy,,,,,, +723,0.980428,c1b5c4ff-4c44-4ed2-b1cd-24290f52d232,Department of Hematology,department_of_hematology,,,,0d4e58c8-3d68-4fc8-a668-ed2e49340828,department_of_hematology_aalborg_university_hospital,"Department of Hematology, Aalborg University Hospital" +7304,,a7bf6b0c-2367-49c7-ae4b-7cc850909a14,VU University Medical Center,vu_university_medical_center,,,,,, +7305,,a9d3bf17-345d-4b97-956b-242b5e2c6bd1,Asklepios Klinik Sankt Augustin,asklepios_klinik_sankt_augustin,,,,,, +152,0.97483,bb0ec6d6-6629-4ef3-8650-4464fe4403fb,Novartis Farmaceutica SA,novartis_farmaceutica_sa,,,,88ecc254-b9db-4f96-8ef3-b7e21d00b20d,novartis_farmac_utica_sa,Novartis Farmacéutica SA +7306,,db065210-18ff-407a-aa3c-72ea0d79bffd,"CrystalGenomics, Inc",crystalgenomics_inc,,,,,, +407,0.9811650812625885,2313c489-596d-4d80-8c94-aa42d3a2f015,"Trius Therapeutics, a Wholly Owned Subsidiary of Cubist",trius_therapeutics_a_wholly_owned_subsidiary_of_cubist,,,,2313c489-596d-4d80-8c94-aa42d3a2f015,trius_therapeutics_a_wholly_owned_subsidiary_of_cubist,"Trius Therapeutics, a Wholly Owned Subsidiary of Cubist" +7307,,28796ff8-6f75-4397-98d3-f3c79325c3ba,Blockeel Christophe,blockeel_christophe,,,,,, +249,0.988541,2f1fb211-53ee-482a-b616-521b6469ae37,Novartis Pharma S.A,novartis_pharma_s_a,,,,2f1fb211-53ee-482a-b616-521b6469ae37,novartis_pharma_s_a,Novartis Pharma S.A +7308,,b4226f34-16c8-4afc-8ed8-900ff13d9d58,A. O. Istituti Ospitalieri di Cremona,a_o_istituti_ospitalieri_di_cremona,,,,,, +7309,,44c853ae-dbf0-48ea-a6ad-54663d381c94,"Cougar Biotechnology, Inc",cougar_biotechnology_inc,,,,,, +7310,,be128163-af6a-4376-87c0-3fa578efb28f,ICT (Instituto Científico y Técnológico de Navarra),ict_instituto_cient_fico_y_t_cnol_gico_de_navarra,,,,,, +7311,,22fec0aa-5d0d-4786-9af3-98f4ec33c1b3,ABLYNX N.V,ablynx_n_v,,,,,, +669,0.988702,61938087-3feb-4db9-87d0-5fff3fff06a4,The Walton Centre for Neurology and Neurosurgery,the_walton_centre_for_neurology_and_neurosurgery,,,,6139d772-2e3a-4727-b99c-78b770114708,the_walton_centre_for_neurology_and_neurosurgery_nhs_trust,The Walton Centre for Neurology and Neurosurgery NHS Trust +7312,,285793d7-1300-4148-91d5-4e7915056db4,IST - ISTITUTO NAZIONALE PER LA RICERCA SUL CANCRO,ist_istituto_nazionale_per_la_ricerca_sul_cancro,,,,,, +7313,,629bb665-a14e-4de6-80e9-75932a3defea,University Utrecht,university_utrecht,,,,,, +7314,,db11ad6c-7537-4d99-9423-d2257cdb6843,GTx Inc,gtx_inc,,,,,, +7315,,981f217b-6e61-463a-8ccb-f0eb8878e4a6,"The Alimentary Pharmabiotic Centre, University College Cork",the_alimentary_pharmabiotic_centre_university_college_cork,,,,,, +1054,0.97196,dc5ee059-568b-4dcb-b276-e9fab04fb724,Fundacion para la Investigacion Biomedica Hospital Universitario La Paz,fundacion_para_la_investigacion_biomedica_hospital_universitario_la_paz,,,,88936054-83c4-44a0-9f56-8aea1c3f4534,fundacion_para_la_investigaci_n_biom_dica_hospital_universitario_la_paz_fibhulp,Fundacion para La Investigación Biomédica Hospital Universitario La Paz (FIBHULP) +7316,,dab207e9-5e6f-45a9-908e-abdcfb43554b,GlaxoSmithKline Biologicals s.a,glaxosmithkline_biologicals_s_a,,,,,, +923,0.907369,263da2fa-df57-4577-a618-d84b06ad1594,"Pharmacyclics, Incorporated",pharmacyclics_incorporated,,,,263da2fa-df57-4577-a618-d84b06ad1594,pharmacyclics_incorporated,"Pharmacyclics, Incorporated" +671,0.954126,4623aa22-c038-4229-9e84-b303554a2292,NILG (Northern Italy Leukemia Group),nilg_northern_italy_leukemia_group,,,,4623aa22-c038-4229-9e84-b303554a2292,nilg_northern_italy_leukemia_group,NILG (Northern Italy Leukemia Group) +309,0.98614925146102905,02f63d38-7129-11e6-a89e-0242ac12000b,MALLINCKRODT,mallinckrodt,,,,02f63d38-7129-11e6-a89e-0242ac12000b,mallinckrodt,MALLINCKRODT +381,0.93236404657363892,58009ccb-7b96-4dcb-a306-956400b90d6e,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (de aquí en adelante se referenciará como Promotor o Merck)",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_de_aqu_en_adelante_se_referenciar_como_promotor_o_merck,,,,70a76c95-9bc5-4453-ace1-7d9c98a92a7d,merck_sharp_dohme_o,"Merck Sharp & Dohme Copr., a subsidary of Merck & Co" +7317,,82079764-4f82-4ba9-969f-65fd0bf493b9,"SciClone Pharmaceuticals, Inc",sciclone_pharmaceuticals_inc,,,,,, +7318,,bd5b8d3a-72b0-11e6-a0cd-0242ac12000b,ROMARK,romark,,,,,, +379,0.93384393056233728,b80f486c-a6f1-447b-bad6-34ea6d49fec0,"Merck Sharp & Dohm Corp, a subsidiary of Merck Co., Inc",merck_sharp_dohm_corp_a_subsidiary_of_merck_co_inc,,,,b80f486c-a6f1-447b-bad6-34ea6d49fec0,merck_sharp_dohm_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as the SPONSOR or Merck)" +914,0.96143,bb4c1c14-dfcd-4e64-9c5a-b0abe87388e6,TAYS Sydänsairaala,tays_syd_nsairaala,,,,8dc209bc-546d-4999-86f7-43245f5c50ff,tays,TAYS +7319,,f0239a7b-8f00-459b-bac8-a72deebbec8a,"Rigshospitalet, ITA 4131, Department of Intensive care",rigshospitalet_ita_4131_department_of_intensive_care,,,,,, +7320,,17df0de3-0386-4c53-92dc-d9e25140dc72,Francisco J. González Vílchez,francisco_j_gonz_lez_v_lchez,,,,,, +660,0.984864,1984b48c-7145-11e6-a0cd-0242ac12000b,LARKEN LABS,larken_labs,,,,1984b48c-7145-11e6-a0cd-0242ac12000b,larken_labs,LARKEN LABS +674,0.98227512836456299,9ebe2d66-716a-11e6-a0cd-0242ac12000b,CENTOCOR INC,centocor_inc,,,,9ebe2d66-716a-11e6-a0cd-0242ac12000b,centocor_inc,CENTOCOR INC +14,0.96426129341125488,c681ef82-c846-4321-80be-97f382aafdb3,Menarini International Operation Luxembourg S.A,menarini_international_operation_luxembourg_s_a,,,,41be544c-1f46-41e5-bb1b-0bb3baefda2e,menarini_international_operation_luxembourg_sa,Menarini International Operation Luxembourg S.A +7321,,6359d811-e58f-4485-bf6d-8875c5d948cd,"Universitätsklinik für Psychiatrie des Kindes- und Jugendalters, AKH Wien, Medizinische Universität",universit_tsklinik_f_r_psychiatrie_des_kindes_und_jugendalters_akh_wien_medizinische_universit_t,,,,,, +1,0.958633,e77552d5-ef04-4ac9-aabc-20f2efd5a01d,Johnson & Johnson Pharmaceutical Research & Development,johnson_johnson_pharmaceutical_research_development,,,,5e39e1cf-f761-4acc-bd2c-247647d86e60,johnson_johnson_pharmaceutical_research_and_development_l_l_c,"Johnson & Johnson Pharmaceutical Research and Development, L.L.C" +7322,,debc5091-1932-4723-956a-0104da77714c,"Rigshospitalet, Capital Region Bloodbank 2034, Section for Transfusion Medicine",rigshospitalet_capital_region_bloodbank_2034_section_for_transfusion_medicine,,,,,, +7323,,e3402ff0-fed2-4afe-924a-efed55e81a91,UCB Pharma Ltd,ucb_pharma_ltd,,,,,, +7324,,c66e8d5c-b456-485a-b87b-2629f61aefad,Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea (GEL/TAMO),grupo_espa_ol_de_linfomas_trasplante_aut_logo_de_m_dula_sea_gel_tamo,,,,,, +7325,,9933aec6-9626-11e6-becf-0242ac110008,CITRON PHARMA LLC,citron_pharma_llc,,,,,, +7326,,dcef5268-3915-4e99-b9d5-2145dd4d3b0b,"Klinik f. Innere Med., Fachabteilung Hämatologie",klinik_f_innere_med_fachabteilung_h_matologie,,,,,, +7327,,716df5ff-05ea-4867-acc2-42f61b740910,"ParinGenix, Inc",paringenix_inc,,,,,, +7328,,8c01a261-8b36-40ec-90b4-50a14d45a5e8,University College London / University College London Hospitals NHS Foundation Trust,university_college_london_university_college_london_hospitals_nhs_foundation_trust,,,,,, +702,0.98027750849723816,e0c7765b-d53d-4aaf-a804-e820ff6c72ee,University Hospitals of Leicester NHS Trust,university_hospitals_of_leicester_nhs_trust,,,,e83cea40-d34c-423f-9f95-62293d47cae2,university_hospitals_of_leicester_nhs_trust,University Hospitals of Leicester NHS Trust +7329,,367ad4af-204b-4d85-9b35-ee57bb197d6f,"Medizinische Klinik III, Kardiologie, Universität Frankfurt",medizinische_klinik_iii_kardiologie_universit_t_frankfurt,,,,,, +7330,,21c2727a-81ec-49d6-8e75-d0e97ee4b92a,Tripep AB,tripep_ab,,,,,, +7331,,70cc5b53-925f-4b76-afe4-5879022f1e5c,Julie Gehl,julie_gehl,,,,,, +7332,,5f0b3384-2542-47bd-9c21-4e9309d690a7,Torrent Pharmaceuticals Ltd,torrent_pharmaceuticals_ltd,,,,,, +7333,,ebf6d80d-b24d-42c1-bf1c-8495ee504eeb,Affibody AB,affibody_ab,,,,,, +237,0.98497751355171204,0ef4ae4f-e284-42c3-b72f-5c46cc59f3e2,"Pfizer Limited, Ramsgate Road, Sandwich, Kent. UK. CT13 9NJ",pfizer_limited_ramsgate_road_sandwich_kent_uk_ct13_9nj,,,,a0e33e4c-faf3-44df-85c6-ebc94469b62e,pfizer_limited_ramsgate_road_sandwich_kent_uk,"Pfizer Limited, Ramsgate Road, Sandwich, Kent" +7334,,aa769e43-3df8-4c27-8e72-b4a4cbc52412,Universitätskrankenhaus Schleswig-Holstein,universit_tskrankenhaus_schleswig_holstein,,,,,, +185,0.907369,951ea194-0b51-4d20-b8cf-f9697b2412fd,"St. James Hospital, Ireland",st_james_hospital_ireland,,,,103d48aa-e045-481f-9c54-07b97fc6c2c2,st_james_hospital,St James Hospital +7335,,2c940245-206d-483c-82cb-466703bbaf94,"department of OBstetrics, Sahlgrenska university hospital",department_of_obstetrics_sahlgrenska_university_hospital,,,,,, +7336,,73c7a72c-274e-4f2e-8fd6-76632279e480,EXONHIT,exonhit,,,,,, +7337,,785eb08a-71d0-11e6-a0cd-0242ac12000b,GENZYME CORP,genzyme_corp,,,,,, +7338,,504552a3-6249-4ef9-bc4c-bae20ac9fb49,Green Medicine AB,green_medicine_ab,,,,,, +7339,,aa84056f-f4e1-493b-9733-920f72f3d81d,AZIENDA SANITARIA LOCALE N 15 DI CUNEO,azienda_sanitaria_locale_n_15_di_cuneo,,,,,, +438,0.9734784563382467,dbdc03f8-f997-4242-91be-566d7f5870a5,"Pfizer Inc 235 East 42nd Street, New York, NY10017",pfizer_inc_235_east_42nd_street_new_york_ny10017,,,,09d833e6-81f6-4d84-ab0d-6d38c6152081,pfizer_inc_235_east_42nd_street_new_york_ny10017_usa,"Pfizer Inc 235 East 42nd Street, New York, NY10017" +7340,,fdee1223-eb99-4adf-9a49-7418364690b7,Group of Clinical Investigation in Radiotherapy Oncology (GICOR),group_of_clinical_investigation_in_radiotherapy_oncology_gicor,,,,,, +7341,,bdb36604-73be-11e6-a0cd-0242ac12000b,HQ SPECIALITY PHARMA,hq_speciality_pharma,,,,,, +7342,,f5d3c506-0954-483e-a22a-18b6f8377246,"Oxford Radcliffe Hospitals NHS Trust (Cancer Research UK Medical Oncology Unit, Churchill Hospital)",oxford_radcliffe_hospitals_nhs_trust_cancer_research_uk_medical_oncology_unit_churchill_hospital,,,,,, +171,0.98239380121231079,c4b555f7-4e1d-4625-928e-7035ee64c517,Merck Serono International S.A,merck_serono_international_s_a,,,,e0ea9f26-8028-4605-8f3e-bec9a3e04275,merck_serono_international,Merck Serono International +7343,,f6b37952-715d-11e6-a0cd-0242ac12000b,ALEMBIC LTD,alembic_ltd,,,,,, +730,0.922323,f8e9534d-6936-464d-8c31-4e208bcf130c,Hellenic Oncology Research Group (H.O.R.G.),hellenic_oncology_research_group_h_o_r_g,,,,ed32d3f4-275a-41ef-9dd9-7a713a6f2d48,hellenic_oncology_research_group_horg,Hellenic Oncology Research Group (HORG) +7344,,62b03820-1037-4f84-9fde-327ed000a088,Merck Selbstmedikation GmbH,merck_selbstmedikation_gmbh,,,,,, +47,0.913597,31bad48e-93ea-4c40-8057-5790bbe13494,Sintetica S.A,sintetica_s_a,,,,31bad48e-93ea-4c40-8057-5790bbe13494,sintetica_s_a,Sintetica S.A +7345,,75893bd4-72f5-11e6-a0cd-0242ac12000b,DURATA THERAPS INTL,durata_theraps_intl,,,,,, +7346,,c4fcfc18-38b9-4b03-91be-94218524917f,Raija Ristamäki,raija_ristam_ki,,,,,, +7347,,78eb2bb4-3678-4a3d-ba56-c67fbb9650b1,Schering Plough S.p.A,schering_plough_s_p_a,,,,,, +7348,,ed23218a-1b96-4ba7-9e1f-51073a0bb75e,"Optimer Pharmaceuticals, Inc",optimer_pharmaceuticals_inc,,,,,, +7349,,4d49b348-6b8e-4831-ba39-5f524f61d0d7,University Bonn,university_bonn,,,,,, +60,0.97776298012052265,59056bee-e28a-4009-9b7a-1fb5fc6f95aa,Wyeth Research Division of Wyeth Pharmaeuticals Inc,wyeth_research_division_of_wyeth_pharmaeuticals_inc,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc +7350,,ce7d696a-31f9-45b3-b171-3796df93af85,PCI Biotech AS,pci_biotech_as,,,,,, +7351,,d185bc60-7376-11e6-a0cd-0242ac12000b,TRIAX PHARMS,triax_pharms,,,,,, +7352,,4300da2d-073e-47e2-8247-aad8c3bca8c2,AESCULAPIUS FARMACEUTICI S.R.L,aesculapius_farmaceutici_s_r_l,,,,,, +7353,,a0837827-e81a-4f40-a2cf-d7afeb2d3738,AstraZeneca Sverige,astrazeneca_sverige,,,,,, +7354,,dd4cb229-f36b-47b9-951b-c0bf4eb722bd,Cyclacel Limited,cyclacel_limited,,,,,, +7355,,49d218f4-9484-4ca0-aa83-f21183ebf6e5,Wepa Apothekenbedarf GmbH & Co KG,wepa_apothekenbedarf_gmbh_co_kg,,,,,, +7356,,a865b3bf-464c-46d5-a2a5-c0fdfad7c207,TLT Medical Ltd,tlt_medical_ltd,,,,,, +7357,,02faf7c8-cda5-478a-878e-886090ee75f0,"Australian Kidney Trials Network, University of Queensland",australian_kidney_trials_network_university_of_queensland,,,,,, +7358,,6a3a3adc-7285-11e6-a0cd-0242ac12000b,TAKEDA PHARMS NA,takeda_pharms_na,,,,,, +7359,,e34e17fa-6d52-4a1d-a518-ecd91091c040,Cell Genesys Ltd,cell_genesys_ltd,,,,,, +7360,,1f59fdc3-9ed7-4a68-a118-f39a32e4da6d,Gemphire Therapeutics Inc,gemphire_therapeutics_inc,,,,,, +7361,,586e55de-7165-11e6-a0cd-0242ac12000b,INNOPHARMA LICENSING,innopharma_licensing,,,,,, +7362,,97e59c02-7771-4ef2-8f90-f1da8c4aabb0,Pfizer Inc. Laboratoires,pfizer_inc_laboratoires,,,,,, +7363,,f68eec95-c7ec-4bad-94ea-2cd821353c37,Lab Servier,lab_servier,,,,,, +7364,,12e2a808-1753-47e6-920b-91e744004e00,"Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin I",medizinische_universit_t_innsbruck_universit_tsklinik_f_r_innere_medizin_i,,,,,, +448,0.984608,a6dd2c28-7928-45f0-bda2-157de4bfe0f0,Oslo University Hospital,oslo_university_hospital,,,,a6dd2c28-7928-45f0-bda2-157de4bfe0f0,oslo_university_hospital,Oslo University Hospital +1027,0.98351848125457764,12e98f1e-6f9a-11e6-9663-0242ac12000b,Eli Lilly & Company Limited,eli_lilly_company_limited,,,,284c00a4-0148-4486-88e3-8a67925fd222,eli_lilly_company,Eli Lilly & Company +7365,,9a8e2886-8be1-11e6-a449-0242ac12000b,"Lyric Pharmaceuticals, Inc",lyric_pharmaceuticals_inc,,,,,, +7366,,598b7a72-f648-4922-b02f-c0c0bcb0c817,Addenbrooke's NHS Trust,addenbrooke_s_nhs_trust,,,,,, +7367,,2e54b909-e10d-4e1b-9113-a299d553b10d,"Endocyte, Inc",endocyte_inc,,,,,, +7368,,d2222e22-77cd-404a-984a-6357c21e7699,UH Montpellier,uh_montpellier,,,,,, +7369,,bc1d467b-ead1-4d5f-8c00-f96cf3b31968,Facet Biotech Corporation,facet_biotech_corporation,,,,,, +7370,,26a1e474-f461-4bab-bf75-9c2efaafbc69,Sandoz SAS,sandoz_sas,,,,,, +7371,,44b7199a-65ea-4540-b800-d0fe35bd28e7,AFFYMAX INC,affymax_inc,,,,,, +7372,,a6351e38-de33-4035-a544-4ff622a5b5ec,Pfizer Inc. - La Jolla laboratories,pfizer_inc_la_jolla_laboratories,,,,,, +7373,,a2491410-1b36-4a8c-98e1-6a6c75291eaf,Jørgen Jeppesen,j_rgen_jeppesen,,,,,, +187,0.983343,dc83129e-7140-11e6-a0cd-0242ac12000b,PAR PHARM,par_pharm,,,,9b7df138-7145-11e6-a0cd-0242ac12000b,par_pharm_inc,PAR PHARM INC +7374,,42e1c2c2-3df9-4387-95a6-12455bb57b3d,Verus Pharmaceuticals Inc,verus_pharmaceuticals_inc,,,,,, +7375,,98e977f8-2acc-4e82-919e-28b78d50e430,Novartis (Hellas) S.A.C.I,novartis_hellas_s_a_c_i,,,,,, +7376,,1a445912-def2-4314-b298-37cf0fa6d67b,SCIPHARM SáRL,scipharm_s_rl,,,,,, +7377,,c8e26961-aadb-4699-a97b-ab22d5d33df8,"Forest Laboratories, Inc",forest_laboratories_inc,,,,,, +7378,,28033d2c-ddcb-4971-9011-bc29da05e9b6,Bayer Oy,bayer_oy,,,,,, +7379,,efd1e8a4-1578-4e58-8525-34fc858a65f0,"Oulu University Hospital, Department of Internal Medicine",oulu_university_hospital_department_of_internal_medicine,,,,,, +7380,,936b8b13-032d-4875-9ce6-12681d73b7e3,pharmed holding GmbH,pharmed_holding_gmbh,,,,,, +7381,,a79c3571-d107-4734-9fdf-4a3b71a73f81,Kings College Hospital Trust R&D,kings_college_hospital_trust_r_d,,,,,, +7382,,7fa7620a-7168-11e6-a0cd-0242ac12000b,FLAMINGO PHARMS,flamingo_pharms,,,,,, +7383,,7dbc4c6f-c69b-46c9-9aad-f09879623208,S.L.A. Pharma (UK) Ltd,s_l_a_pharma_uk_ltd,,,,,, +7384,,c5aa5aa0-716d-11e6-a0cd-0242ac12000b,IMMUNEX,immunex,,,,,, +7385,,1473e5bc-acaa-4022-a585-5108484ec212,sanofi-aventis Oy,sanofi_aventis_oy,,,,,, +7386,,4eabb761-a53a-402a-b2e7-64111fc9164b,"Trius Therapeutics, Inc",trius_therapeutics_inc,,,,,, +7387,,80ff7039-a0b4-4cfc-8276-7ff301ec43d0,HYKS Marian sairaala,hyks_marian_sairaala,,,,,, +7388,,9a8ea7b2-30ca-46a8-a111-ef074cb19f1b,Strakan Pharmaceuticals Ltd,strakan_pharmaceuticals_ltd,,,,,, +7389,,ac2ea3de-0d9d-445a-8714-4e450467107a,Fondation Charcot Stichting,fondation_charcot_stichting,,,,,, +7390,,b45ea13e-72cb-11e6-a0cd-0242ac12000b,TAKEDA GMBH,takeda_gmbh,,,,,, +7391,,e938833a-831f-4bf6-8bce-b2c557d63acd,"Prof. Dr. R Marre, University Hospital Ulm",prof_dr_r_marre_university_hospital_ulm,,,,,, +7392,,e154810b-ddfa-4097-9dac-fce9a1dc82f6,GRUPO ONCOPAZ,grupo_oncopaz,,,,,, +355,0.989009,9cb0b7ef-9196-4272-8e74-952d80c320c4,Asociación Colaboración Cochrane Iberoamericana (ACCIb),asociaci_n_colaboraci_n_cochrane_iberoamericana_accib,,,,9cb0b7ef-9196-4272-8e74-952d80c320c4,asociaci_n_colaboraci_n_cochrane_iberoamericana_accib,Asociación Colaboración Cochrane Iberoamericana (ACCIb) +7393,,ee4c64e6-715c-11e6-a0cd-0242ac12000b,INSYS THERAP,insys_therap,,,,,, +7394,,56b8cafa-7b3b-4749-a384-6a1d2146755f,Teemu Luostarinen,teemu_luostarinen,,,,,, +826,0.97779467701911926,088d8036-1703-4c64-8781-39bd714c26a5,Department of Nephrology,department_of_nephrology,,,,e662831f-0d28-42b9-a406-77cb46fe2d36,department_of_nephrology_and_renal_transplantation,Department of Nephrology and Renal Transplantation +276,0.955365,cb17da13-e5f0-4069-a9dc-bf97b4fc3aae,Axcan Pharma Inc. (Axcan Pharma International B.V. is a subsidiary of Axcan Pharma Inc.),axcan_pharma_inc_axcan_pharma_international_b_v_is_a_subsidiary_of_axcan_pharma_inc,,,,93daac2d-3fd1-447f-98fc-f605f37148a3,axcan_pharma_inc_axcan_pharma_international_bv_is_subsidiary_of_axcan_pharma_inc,Axcan Pharma Inc. (Axcan Pharma International BV is subsidiary of Axcan Pharma Inc.) +7395,,c48b0956-7160-11e6-a0cd-0242ac12000b,BIOGLAN,bioglan,,,,,, +38,0.97483,4789b24e-71b6-11e6-a0cd-0242ac12000b,BIOVAIL LABS INTL,biovail_labs_intl,,,,4789b24e-71b6-11e6-a0cd-0242ac12000b,biovail_labs_intl,BIOVAIL LABS INTL +7396,,abe96fa1-5b3e-44e0-bee5-828296c308df,Ipsen Farmaceutica b.v,ipsen_farmaceutica_b_v,,,,,, +7397,,7897ffe7-42d0-43ba-bd1c-abd448f39b3c,University of Newcastle,university_of_newcastle,,,,,, +7398,,3621efc1-16d7-4288-87d3-75a821b31cbc,Spanish Oncology Genito-Urinary Group (SOGUG),spanish_oncology_genito_urinary_group_sogug,,,,,, +7399,,cc8e178a-739d-11e6-a0cd-0242ac12000b,OREXIGEN,orexigen,,,,,, +7400,,916955c8-86b3-462d-96be-dc1c3fff8d94,Wallenberg laboratory,wallenberg_laboratory,,,,,, +7401,,1c71e9c1-3045-4455-ac56-1f7c5df37f41,Fundación pública andaluza para la gestión de la investigación en salud de Sevilla (FISEVI),fundaci_n_p_blica_andaluza_para_la_gesti_n_de_la_investigaci_n_en_salud_de_sevilla_fisevi,,,,,, +7402,,482d2c61-d139-4213-8a29-0578c825799f,Dr. Lluis Arias,dr_lluis_arias,,,,,, +7403,,118aa065-5c70-42f8-8b63-cbad5d960cea,Bio-Gels Pharmaceuticals,bio_gels_pharmaceuticals,,,,,, +7404,,fd8ee05d-93e4-4b9d-adc0-62629de30aa4,HOSPITAL UNIVERSITARIO RAMON Y CAJAL,hospital_universitario_ramon_y_cajal,,,,,, +7405,,18767366-6652-4789-8a2c-5365f33c273d,Hospital Erasme,hospital_erasme,,,,,, +7406,,01e680c9-7041-41c4-bb12-caca86cf6a0e,EAU Foundation for Urological Research,eau_foundation_for_urological_research,,,,,, +293,0.98027,3c9f7dec-c696-4e53-bf14-5c014e7babdd,Janssen Cilag International,janssen_cilag_international,,,,3c9f7dec-c696-4e53-bf14-5c014e7babdd,janssen_cilag_international,Janssen Cilag International +7407,,13f8f9a1-3670-4e48-995a-2bd18c63fa12,Sanofi-aventis recherche and developpement,sanofi_aventis_recherche_and_developpement,,,,,, +7408,,9fd27f9d-d593-4345-b4dc-a2b6acf41c17,Only for Children Pharmaceuticals,only_for_children_pharmaceuticals,,,,,, +7409,,85d36f0c-5687-46f0-a6f5-3dd06d6490b3,Orbus International BV,orbus_international_bv,,,,,, +7410,,221f0916-8bcc-11e6-a449-0242ac12000b,Gedske Daugaard,gedske_daugaard,,,,,, +7411,,07f6b45a-3900-42e3-987d-360de8111f31,Bracco Imaging S.p.A,bracco_imaging_s_p_a,,,,,, +7412,,4b148440-7164-11e6-a0cd-0242ac12000b,PADDOCK LABS,paddock_labs,,,,,, +875,0.9714733362197876,8ca22c91-ec68-4c4d-b67e-9354f508b1d3,FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO NIÑO JESUS,fundacion_para_la_investigacion_biomedica_del_hospital_universitario_ni_o_jesus,,,,8ca22c91-ec68-4c4d-b67e-9354f508b1d3,fundacion_para_la_investigacion_biomedica_del_hospital_universitario_ni_o_jesus,FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO NIÑO JESUS +7413,,3268b91f-ea5c-4681-9c5e-09d08a71ed3b,SERVICIO NEFROLOGIA HOSPITAL UNIVERSITARIO DE BELLVITGE,servicio_nefrologia_hospital_universitario_de_bellvitge,,,,,, +105,0.92743,87f12084-92d1-4b68-89c3-59450c51ce2e,Aristotle University of Thessaloniki,aristotle_university_of_thessaloniki,,,,87f12084-92d1-4b68-89c3-59450c51ce2e,aristotle_university_of_thessaloniki,Aristotle University of Thessaloniki +7414,,2ce0e8e4-016c-40f1-89c9-fa28cc3dc4e0,MRN-Medical Research Network GmbH,mrn_medical_research_network_gmbh,,,,,, +7415,,15530b58-8d13-4f62-8ff3-c16d8f280f80,Regen Therapeutics PLC,regen_therapeutics_plc,,,,,, +7416,,c6a314cc-1d00-453e-9b92-f8a3e2604a41,"University Hospital Frankfurt, Goethe University",university_hospital_frankfurt_goethe_university,,,,,, +1017,0.97598165273666382,986ad2cd-cb4e-460c-acdc-a2b32a61de09,Southampton University Hospital Trust,southampton_university_hospital_trust,,,,986ad2cd-cb4e-460c-acdc-a2b32a61de09,southampton_university_hospitals,Southampton University Hospitals +7417,,ef215b37-0942-4833-9366-68baba471a3c,Universitair Medisch Centrum Groningen,universitair_medisch_centrum_groningen,,,,,, +7418,,6307a342-89e9-4514-8fec-9a70aec719bc,"Anticancer Informing ""Me Gnosi Nika",anticancer_informing_me_gnosi_nika,,,,,, +7419,,5cca604e-fde8-46f9-b69e-655232303e2d,Servicio de Gastroenterología del Hospital Universitario Mútua de Terrassa,servicio_de_gastroenterolog_a_del_hospital_universitario_m_tua_de_terrassa,,,,,, +7420,,9871265c-f324-4b3a-a841-245973c28fac,"ICHTHYOL-GESELLSCHAFT Cordes, Hermanni & Co. (GmbH & Co.) KG",ichthyol_gesellschaft_cordes_hermanni_co_gmbh_co_kg,,,,,, +7421,,81406490-7168-11e6-a0cd-0242ac12000b,ASCENT PHARMS INC,ascent_pharms_inc,,,,,, +7422,,5821b48b-dd3a-4555-be00-16140d2e86d5,"Afdeling heelkunde, Universitair Medisch Centrum Sint Radboud",afdeling_heelkunde_universitair_medisch_centrum_sint_radboud,,,,,, +1027,0.98575803637504578,284c00a4-0148-4486-88e3-8a67925fd222,Eli Lilly & Company,eli_lilly_company,,,,284c00a4-0148-4486-88e3-8a67925fd222,eli_lilly_company,Eli Lilly & Company +7423,,71ad91a6-a07a-4a9b-b33b-607bf24b95cd,Taina Sipponen,taina_sipponen,,,,,, +7424,,add98864-715f-11e6-a0cd-0242ac12000b,REED AND CARNRICK,reed_and_carnrick,,,,,, +7425,,0d3e0740-d797-4b83-a4f7-c90549b7ba60,Arrow Therapeutics Ltd,arrow_therapeutics_ltd,,,,,, +992,0.9735756516456604,e1d99ba0-e81e-47cb-9a76-e99d5770ff7f,Medizinische Universität Innsbruck / Univ.-Klinik für Allgem. u. Chirurg. Intensivmedizin,medizinische_universit_t_innsbruck_univ_klinik_f_r_allgem_u_chirurg_intensivmedizin,,,,85bd52ce-4912-412b-98e5-33039d390569,medizinische_universit_t_innsbruck_univ_klinik_f_r_allg_u_chirurg_intensivmedizin,Medizinische Universität Innsbruck / Univ.-Klinik für Allg. u. Chirurg. Intensivmedizin +754,0.974038,8ae9d885-6a3a-41b7-92ff-708f5fd36353,"Eisai Limited, European Knowledge Centre",eisai_limited_european_knowledge_centre,,,,2605a116-7400-44c9-9e20-fd5eac2e111d,eisai_limited,Eisai Limited +7426,,13131c9f-7e16-4b23-8b8f-3a11287c37e7,"Nuron Biotech, Inc",nuron_biotech_inc,,,,,, +7427,,92c18401-1544-4143-920d-38c7b22cc60a,Abbott Deutschland GmbH & Co. KG,abbott_deutschland_gmbh_co_kg,,,,,, +7428,,f54424fe-dc94-4520-b9f7-e6a4ee5e0784,Manchester Mental Health and Social Care Trust,manchester_mental_health_and_social_care_trust,,,,,, +7429,,a71b6fc2-af68-4fbc-a2a6-27adb582b392,Micromet AG,micromet_ag,,,,,, +7430,,f87e10d8-49ca-42fb-bc98-a05dffdfa7db,Allergiklinikken,allergiklinikken,,,,,, +7431,,6fe7595c-70cf-4ddc-aa48-b6bcdd1399ef,ARYx Therapeutics Limited,aryx_therapeutics_limited,,,,,, +7432,,0016caed-8be9-4412-bbb3-8f0cedada55e,Celtaxsys Inc,celtaxsys_inc,,,,,, +634,0.98439878225326538,46a45c2f-43ce-4875-94a9-b47c1c64e0a4,Research and Development Department,research_and_development_department,,,,46a45c2f-43ce-4875-94a9-b47c1c64e0a4,research_and_development_department,Research and Development Department +7433,,b5b02752-d416-4203-b239-e14c5245b5d2,Acucela Inc,acucela_inc,,,,,, +7434,,b3dcccd4-b7b6-459e-9c21-faa64ef2a355,Lapland Hospital District/ Lapland Central Hospital,lapland_hospital_district_lapland_central_hospital,,,,,, +749,0.982152,7b2e0c4c-d3a5-4991-85ad-b05ef3d7b13e,"LABORATORIOS FARMACÉUTICOS ROVI, S.A",laboratorios_farmac_uticos_rovi_s_a,,,,7b2e0c4c-d3a5-4991-85ad-b05ef3d7b13e,laboratorios_farmac_uticos_rovi_s_a,"LABORATORIOS FARMACÉUTICOS ROVI, S.A" +7435,,b251fc02-fb6d-4d55-b641-0d79def86d3b,AbbVie Inc,abbvie_inc,,,,,, +7436,,faff384f-891c-4b02-9a85-0961a87eaa99,"Tarsa Therapeutics, Inc",tarsa_therapeutics_inc,,,,,, +7437,,607bdf97-1429-4548-9740-7f6f106a8351,Mithra Pharmaceuticals SA,mithra_pharmaceuticals_sa,,,,,, +7438,,e322d44a-252b-46c8-9ba9-803d4c69b051,"ImunomedicA, a.s",imunomedica_a_s,,,,,, +7439,,df27b3f5-87a5-458d-897b-a41b223d3d2c,Onyx Therapeutics,onyx_therapeutics,,,,,, +7440,,0ee6be2f-080f-4a8a-a06a-2d04345286ff,"Medizinsche Universität Wien, Univ.Klinik f. Anästhesie u. Allgem. Intensivmedizin",medizinsche_universit_t_wien_univ_klinik_f_an_sthesie_u_allgem_intensivmedizin,,,,,, +80,0.975018,e998682c-caff-41db-a4d4-47f82505696f,UMC St Radboud University Hospital Center,umc_st_radboud_university_hospital_center,,,,0510fd6f-8916-4b89-89b5-93c49e7400bb,umc_st_radboud,UMC St Radboud +7441,,a052255e-6fbe-11e6-abe8-0242ac12000b,Cliniques Universitaires Saint Luc-Centre du Cancer,cliniques_universitaires_saint_luc_centre_du_cancer,,,,,, +7442,,5732a2f9-5a34-459d-ba31-6c38d8163260,Institute of Psychiatry,institute_of_psychiatry,,,,,, +7443,,3e634bbd-26f5-48ef-b12c-916955cfd384,JOSEP MARIA BOTARGUES BOTÉ,josep_maria_botargues_bot,,,,,, +7444,,2d868774-e141-4d4d-92b7-8edf67ca2756,Örebro Läns Landsting,rebro_l_ns_landsting,,,,,, +7445,,cf2239aa-715d-11e6-a0cd-0242ac12000b,CADISTA PHARMS,cadista_pharms,,,,,, +7446,,b1fa2776-8179-4d66-9477-3034a2d24eff,Friedrich- Alexander- Universität Erlangen Nürnberg,friedrich_alexander_universit_t_erlangen_n_rnberg,,,,,, +7447,,13fbd60a-0d4f-4e89-80e7-6ddc7b114123,Aprea AB,aprea_ab,,,,,, +462,0.969668,c2cf1092-6676-478b-b6bc-5980f53650f5,Gamida Cell-Teva Joint Venture Ltd,gamida_cell_teva_joint_venture_ltd,,,,c2cf1092-6676-478b-b6bc-5980f53650f5,gamida_cell_teva_joint_venture_ltd,Gamida Cell-Teva Joint Venture Ltd +321,0.94320505857467651,bb6e45e6-e1f4-4407-be5e-72adf5b79a0d,All Ireland co-operative Oncology Research Group,all_ireland_co_operative_oncology_research_group,,,,12641096-e1dd-46f5-9635-3bd405807ce5,all_ireland_cooperative_oncology_research_group,All Ireland Cooperative Oncology Research Group +7448,,a132b886-ceba-403f-8104-bbc93aee584d,Dr. W. Schwabe GmbH & Co. KG,dr_w_schwabe_gmbh_co_kg,,,,,, +7449,,29fd9dbf-3c32-4b45-994c-e02e3e1fa090,Uniwersytet Jagielloński – Collegium Medicum,uniwersytet_jagiello_ski_collegium_medicum,,,,,, +7450,,eb2b804b-b983-4ac3-9a38-dec10c0f5742,German Foundation for Chronically Ill,german_foundation_for_chronically_ill,,,,,, +7451,,dfbc0aeb-2b1f-4a83-9282-a0f9942e7e7c,InfectoPharm - Arzneimittel und Consilium GmbH,infectopharm_arzneimittel_und_consilium_gmbh,,,,,, +542,0.985178,6ac48511-e29b-45d9-a99a-d067f972f24e,Skåne University Hospital,sk_ne_university_hospital,,,,6ac48511-e29b-45d9-a99a-d067f972f24e,sk_ne_university_hospital,Skåne University Hospital +7452,,12c78f60-0ee2-4691-a77b-a1baab5a95e7,"Avid Radiopharmaceuticals, Inc",avid_radiopharmaceuticals_inc,,,,,, +22,0.98036062717437744,c86bec53-7f8e-4a90-a21e-3546f2f9dc56,University Hospital Heidelberg,university_hospital_heidelberg,,,,ae6ad20a-a5ac-4fda-adad-69b8ff220a6a,university_hospital_heidelberg,University Hospital Heidelberg +7453,,c69e3631-a210-4c54-934c-72f920895011,"Daiichi Pharmaceutical Co., Ltd",daiichi_pharmaceutical_co_ltd,,,,,, +7454,,9e9986da-a225-40d5-b1a8-bae492450b03,Vasculitis Clinical Trial Office,vasculitis_clinical_trial_office,,,,,, +7455,,689d5a47-b78f-4e00-954b-b90dbe401153,OLV-ziekenhuis,olv_ziekenhuis,,,,,, +7456,,b85f357c-4442-4b42-8c59-22f37483e8d0,Biogen Idec Limited,biogen_idec_limited,,,,,, +7457,,1c3b6a9a-718b-11e6-a0cd-0242ac12000b,ELI LILLY AND CO,eli_lilly_and_co,,,,,, +255,0.988054,ab2495df-affb-476e-8780-84d610f1930d,Antwerp University Hospital (UZA),antwerp_university_hospital_uza,,,,ab2495df-affb-476e-8780-84d610f1930d,antwerp_university_hospital_uza,Antwerp University Hospital (UZA) +112,0.95708638429641724,3fdc83cd-1894-4fc3-a873-6017c4a29e0a,Yamanouchi Europe B.V. (to be renamed Astellas Pharma Europe B.V by August 2005),yamanouchi_europe_b_v_to_be_renamed_astellas_pharma_europe_b_v_by_august_2005,,,,fd7c0ea8-c5da-47db-837d-9b59407dd291,yamanouchi_europe_b_v,Yamanouchi Europe B.V +7458,,93b11f1a-70d7-46f7-bece-6426625b40a0,ASTELLAS PHARMA,astellas_pharma,,,,,, +7459,,192904a1-1d6e-441d-b10e-83799a08c9ae,"ALK-Abello, S.A",alk_abello_s_a,,,,,, +7460,,21d0f977-e73b-4232-a7c2-e7692e2f85ab,Novosis AG,novosis_ag,,,,,, +884,0.96910750865936279,0535053a-70a1-4184-85fb-a82d42918846,AGMT gGmbH,agmt_ggmbh,,,,0535053a-70a1-4184-85fb-a82d42918846,agmt_ggmbh,AGMT gGmbH +501,0.941946,51817147-4fe9-46e4-8642-703081f3e636,Medizinische Fakultät. Otto von Guericke Universität,medizinische_fakult_t_otto_von_guericke_universit_t,,,,51817147-4fe9-46e4-8642-703081f3e636,medizinische_fakult_t_otto_von_guericke_universit_t,Medizinische Fakultät. Otto von Guericke Universität +7461,,81de02bf-96bd-457f-96af-034d6f2c20b1,Icagen Inc,icagen_inc,,,,,, +7462,,e00a69cd-19fb-4277-980d-9d7f65dd0772,South London and Maudsley NHS Foundation Trust,south_london_and_maudsley_nhs_foundation_trust,,,,,, +7463,,84b540c9-53ac-4bd7-844f-460afffe032c,Orygen Research Centre,orygen_research_centre,,,,,, +1016,0.986181,347471d1-8499-40a9-8240-38e355408069,LABORATORIOS LETI,laboratorios_leti,,,,347471d1-8499-40a9-8240-38e355408069,laboratorios_leti,LABORATORIOS LETI +7464,,e7322128-c6ad-4abb-9919-c301d3521cfa,Derma Sciencs Inc,derma_sciencs_inc,,,,,, +642,0.97617602348327637,1eaa3c0c-4ecd-4593-886b-6af263dd0c86,Boehringer Ingelheim France SAS,boehringer_ingelheim_france_sas,,,,1eaa3c0c-4ecd-4593-886b-6af263dd0c86,boehringer_ingelheim_france,Boehringer Ingelheim France +7465,,69bc095b-12a3-4e98-8132-932407b96e43,Blackpool Fylde & Wyre Healthcare NHS Trust,blackpool_fylde_wyre_healthcare_nhs_trust,,,,,, +7466,,71949305-a1a2-425f-8e27-8bc1da071a20,Kari T. Kivistö,kari_t_kivist,,,,,, +7467,,51be2949-81cd-4023-91ae-5652dd7d1919,Universitätsmedizin Greifswald,universit_tsmedizin_greifswald,,,,,, +7468,,56c4b4e2-0fb6-4ad6-ac8a-e9ddefc9d47a,Novo Nordisk Pharma GmbH,novo_nordisk_pharma_gmbh,,,,,, +7469,,5cee0783-576b-489a-a48f-f73e2aeec025,Hospital Ruber Internacional,hospital_ruber_internacional,,,,,, +123,0.93060654401779175,6f6fa7c2-4fab-461f-9b80-d0b26f4f354e,F. Hoffmann-La Roche AG,f_hoffmann_la_roche_ag,,,,6f6fa7c2-4fab-461f-9b80-d0b26f4f354e,f_hoffmann_la_roche_ag,F. Hoffmann-La Roche AG +7470,,59d62a39-b8e5-4aec-b03f-457e9ce84129,CECOG,cecog,,,,,, +7471,,ca8d45b0-631e-488b-b9b9-8f22dd82aac5,Centre René Huguenin,centre_ren_huguenin,,,,,, +7472,,84d6fc0c-af6e-433b-af47-1f0199323338,Solenne BV,solenne_bv,,,,,, +7473,,31e2d4d1-53b1-441a-96c8-ce8179266418,Boehringer Ingelheim Pharma GmbH&Co.KG,boehringer_ingelheim_pharma_gmbh_co_kg,,,,,, +7474,,8eaff211-20e8-4ae6-bfa4-059e282fa5d7,Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research),gesellschaft_fuer_klinische_forschung_e_v_society_for_clinical_research,,,,,, +7475,,6b9d4031-245b-45a4-9cc4-e5f62d3c0d2e,"Tayside Clinical Trials Unit, University of Dundee",tayside_clinical_trials_unit_university_of_dundee,,,,,, +7476,,e3dacde8-e502-4a42-8c0a-56bd84b8e956,Sanofi-Aventis Deutschland GmbH,sanofi_aventis_deutschland_gmbh,,,,,, +326,0.985702,14fb99c7-19be-430d-a74a-57408f88725e,Servicio de Infecciones. Hospital Clínic de Barcelona,servicio_de_infecciones_hospital_cl_nic_de_barcelona,,,,14fb99c7-19be-430d-a74a-57408f88725e,servicio_de_infecciones_hospital_cl_nic_de_barcelona,Servicio de Infecciones. Hospital Clínic de Barcelona +7477,,d53a01c6-6fc1-11e6-abe8-0242ac12000b,Klinik Loewenstein gGmbH,klinik_loewenstein_ggmbh,,,,,, +7478,,9d4dbc02-8d23-4d9b-8f0b-57c5b89637bc,Royal Marsden Hosptial Foundation Trust,royal_marsden_hosptial_foundation_trust,,,,,, +7479,,8289ac7f-98aa-46a6-9fa0-3f8a08b785b3,Næstved Hospital,n_stved_hospital,,,,,, +7480,,1fe2380a-a32f-4bdb-a73c-6de473ae0cee,Overlæge dr.med. Frederik Grønhøj,overl_ge_dr_med_frederik_gr_nh_j,,,,,, +7481,,4e0a8ec2-73cd-11e6-a0cd-0242ac12000b,CIPHER PHARMS US,cipher_pharms_us,,,,,, +7482,,101edc2f-4668-43a0-b291-605d047a36e7,Karolinska Institute/Hospital,karolinska_institute_hospital,,,,,, +7483,,e1599481-d933-4b91-9ad2-a63f47f86861,Aventis Pharma Finland,aventis_pharma_finland,,,,,, +74,0.972986,53160446-62a1-4898-b8c2-2d60eb490bf9,Faculdade de Ciências Médicas da Universidade Nova de Lisboa,faculdade_de_ci_ncias_m_dicas_da_universidade_nova_de_lisboa,,,,53160446-62a1-4898-b8c2-2d60eb490bf9,faculdade_de_ci_ncias_m_dicas_da_universidade_nova_de_lisboa,Faculdade de Ciências Médicas da Universidade Nova de Lisboa +7484,,a6cd51a2-5fc6-463c-8e71-3f7e1af326fc,Graz Medical University,graz_medical_university,,,,,, +7485,,e3cb6f14-0fab-47d0-8527-234632b5a6aa,"Dept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University",dept_of_medical_sciences_clinical_diabetes_and_metabolism_uppsala_university,,,,,, +7486,,6de187b0-4605-4e4d-8034-76304a2f845b,Imperial College London South Kensington London,imperial_college_london_south_kensington_london,,,,,, +7487,,37ee61cf-f11b-493e-8f5b-ea1302165c14,PIERRE FABRE MEDICAMENT-IRPF-IDPF,pierre_fabre_medicament_irpf_idpf,,,,,, +7488,,f0dd3165-4b1d-4607-894c-2bdd7a710827,University Hospital Tübingen,university_hospital_t_bingen,,,,,, +1016,0.986181,7aa3fc2d-a3c7-4871-b05e-41f848dab0ef,LABORATORIOS LETI S.L.U,laboratorios_leti_s_l_u,,,,347471d1-8499-40a9-8240-38e355408069,laboratorios_leti,LABORATORIOS LETI +159,0.93964588642120361,8e61b774-a021-4643-8648-1f65d385db6e,"Medizinische Universität Wien, Univ.Klinik f.Innere Medizin II, Abt.f.Angiologie",medizinische_universit_t_wien_univ_klinik_f_innere_medizin_ii_abt_f_angiologie,,,,f520785f-8956-4a25-b64b-588e23b207cb,medizinische_universit_t_wien_univ_klink_f_innere_medizin_i,"Medizinische Universität Wien, Univ.Klink f. Innere Medizin I" +670,0.98121541738510132,e4d075aa-4a2c-4c87-a24d-a2bf30ca4b0e,NHS Lothian,nhs_lothian,,,,003e8352-381a-4a71-b3e3-25cd5e67e274,nhs_lothian_accord,NHS Lothian (ACCORD) +7489,,2d85304a-7160-11e6-a0cd-0242ac12000b,BUNDY,bundy,,,,,, +7490,,b821106f-da12-41b2-9766-24ad2642b16a,Bracco Imaging SPA,bracco_imaging_spa,,,,,, +7491,,83afee81-68a5-4acf-bf7b-df7f579248fc,Cranley Clinic,cranley_clinic,,,,,, +7492,,8fed3f2f-bce6-4382-89b4-34fd577b8f34,"Dept of Internal Medicine IV, Med Uni Vienna",dept_of_internal_medicine_iv_med_uni_vienna,,,,,, +7493,,14da021a-cc3a-492e-9e3f-81ba285f19cb,Sportmedisch expertisecentrum,sportmedisch_expertisecentrum,,,,,, +7494,,f372e443-4306-4021-a049-968fd8fee5b7,DOMPE' BIOTEC,dompe_biotec,,,,,, +7495,,1d65764b-3039-4b56-911f-d78dbac404d4,INSTITUT DE RESERCA.HSCSP,institut_de_reserca_hscsp,,,,,, +7496,,00f5ac2c-8071-4048-9b16-4b9d5a8eee82,MicroCHIPS,microchips,,,,,, +7497,,4600ea89-871f-4971-ac28-83ff8ea7fdb7,GlaxoSmithKlin Research and Development Ltd,glaxosmithklin_research_and_development_ltd,,,,,, +7498,,7b8e8788-f942-46ab-a0a2-7099fdde6b4b,HOSPITAL GENERAL DE VIC,hospital_general_de_vic,,,,,, +7499,,ea34ff94-1d1f-49ad-931d-1e1dfefda5b2,Karolinska Institutet and University Hospital,karolinska_institutet_and_university_hospital,,,,,, +7500,,ad168a42-e801-4860-a362-c99fa884d809,Heidi Mäkinen,heidi_m_kinen,,,,,, +7501,,d0aa218f-7832-410f-9a64-5bc04f57d44b,"Dept of Pediatrics, University Hospital of North Norway",dept_of_pediatrics_university_hospital_of_north_norway,,,,,, +781,0.96902046600977576,5fabe06e-ac55-4f2e-a26d-513b4b1bdb92,GlaxoSmithKline Research and Development,glaxosmithkline_research_and_development,,,,201d9d4f-5cd0-46df-836e-da17fa2b43dd,glaxosmithkline_research_and_development,GlaxoSmithKline Research and Development +7502,,b597458f-a4cd-41aa-b326-c54957320348,Institut Diagnostic per la Imatge,institut_diagnostic_per_la_imatge,,,,,, +403,0.93504321575164795,3fae5114-715d-11e6-a0cd-0242ac12000b,EMCURE PHARMA,emcure_pharma,,,,11645014-715e-11e6-a0cd-0242ac12000b,emcure_pharms,EMCURE PHARMS +7503,,25ba5784-d2ad-4ecf-ad1b-4efdc95e9eb8,Athena Care/ Isala Klinieken,athena_care_isala_klinieken,,,,,, +7504,,bed9aa2d-ef02-4d17-8bbe-e5ed5413aac3,Fundación Institut de Recerca Hospital Sant Pau,fundaci_n_institut_de_recerca_hospital_sant_pau,,,,,, +7505,,58bce5c1-e96d-4885-a545-9277737a0f87,SerumWerk Bernburg AG,serumwerk_bernburg_ag,,,,,, +7506,,886deff3-bc54-4e3b-a123-e78b59b2aaba,"Karolinska University Hospital Huddinge, Department of Anaesthesiology and Intensive Care",karolinska_university_hospital_huddinge_department_of_anaesthesiology_and_intensive_care,,,,,, +7507,,eff62459-c9a3-41bd-8a91-6b1d9fa1e7b0,"Brain Center Rudolf Magnus, University Medical Center Utrecht, Department of Psychiatry, Utrecht , the Netherlands",brain_center_rudolf_magnus_university_medical_center_utrecht_department_of_psychiatry_utrecht_the_netherlands,,,,,, +119,0.98682153224945068,2d92428c-71e3-498b-80e5-8358645cf21c,"Rheinische Friedrich-Wilhelms-University of Bonn, University Hospital",rheinische_friedrich_wilhelms_university_of_bonn_university_hospital,,,,2d92428c-71e3-498b-80e5-8358645cf21c,rheinische_friedrich_wilhelms_university_of_bonn_university_hospital,"Rheinische Friedrich-Wilhelms-University of Bonn, University Hospital" +7508,,4f84ae53-a231-454f-aca0-8f11d666d043,"Anæstesiologisk Afd. I, Skejby Sygehus",an_stesiologisk_afd_i_skejby_sygehus,,,,,, +7509,,7735cc0f-68ac-4438-818f-4c8bf58745ec,University of Antwerp,university_of_antwerp,,,,,, +7510,,5e09b7c6-664e-4232-be3f-81e14df7322b,"CTMM, the Center for Translational Molecular Medicine",ctmm_the_center_for_translational_molecular_medicine,,,,,, +7511,,0fbaf30e-8819-11e6-a998-0242ac12000b,GlaxoSmithKline Ltd,glaxosmithkline_ltd,,,,,, +7512,,8ba868d5-0ffd-4a73-b7c4-b9d331b7712b,CuraGen Corporation,curagen_corporation,,,,,, +7513,,a72360d9-613c-4705-bca7-00d428a352af,Fundació Clínic,fundaci_cl_nic,,,,,, +634,0.98439878225326538,a74282e0-87f2-40f3-811b-2b2fdfca3941,"Research and Development Department, John Radcliffe Hospital",research_and_development_department_john_radcliffe_hospital,,,,46a45c2f-43ce-4875-94a9-b47c1c64e0a4,research_and_development_department,Research and Development Department +7514,,52425251-4793-48c5-b92f-bc8507d27b88,Thoraxkirurgisk afd. Rigshospitalet,thoraxkirurgisk_afd_rigshospitalet,,,,,, +7515,,b7fade20-f957-4ce1-978b-e1af17ea0f06,ARCO,arco,,,,,, +7516,,37d64bcf-4ea3-4f20-a3f7-d80786909ba3,GlaxoSmithKline Group of Companies,glaxosmithkline_group_of_companies,,,,,, +7517,,e87e43d3-1b41-4485-ba2a-55b37051834f,Medizinische Universität Innsbruck / UK für Anästhesie und Intensivmedizin & UK für Allgem. u. Chirurg. Intensivmedizin,medizinische_universit_t_innsbruck_uk_f_r_an_sthesie_und_intensivmedizin_uk_f_r_allgem_u_chirurg_intensivmedizin,,,,,, +7518,,3f3122db-eecd-4b09-9fd4-658093c126f5,Alba Therapeutics,alba_therapeutics,,,,,, +7519,,ff8af62e-7129-11e6-a89e-0242ac12000b,TEDOR PHARMA INC,tedor_pharma_inc,,,,,, +7520,,c332f3de-8d64-4925-b34d-1b9b93d3f7a8,ALIO MEDICA Sp. z o.o,alio_medica_sp_z_o_o,,,,,, +7521,,a809533d-c98f-413a-b1d2-52fdfd8de2fb,"University Medical Center Freiburg Dept. Klinikum Stuttgart, Stuttgart Cancer Center",university_medical_center_freiburg_dept_klinikum_stuttgart_stuttgart_cancer_center,,,,,, +881,0.98332688212394714,d9486864-e255-4256-b088-49f706c79293,PIERRE FABRE MEDICAMENT - IRPF,pierre_fabre_medicament_irpf,,,,d9486864-e255-4256-b088-49f706c79293,pierre_fabre_medicament,PIERRE FABRE MEDICAMENT +7522,,04e26f08-714d-11e6-a0cd-0242ac12000b,PERRIGO PHARMA INTL,perrigo_pharma_intl,,,,,, +7523,,7a9fc39a-8d85-4417-a9d7-0dbd2c1fb29e,Merck Sharp & Dohme (Sweden) AB,merck_sharp_dohme_sweden_ab,,,,,, +7524,,238817db-2c95-4d52-aa52-54c9c3dfdff7,Norlands University Hospital,norlands_university_hospital,,,,,, +1073,0.987562,c6e78645-5bdb-4ec2-a139-0d95cbbc2ce8,"Akershus University Hospital, Norway",akershus_university_hospital_norway,,,,a0dd21db-1c17-47e9-af2f-92349a9503ac,akershus_university_hospital,Akershus University Hospital +7525,,5a3725bd-7745-4082-a8a5-85e5eb9cef32,Solace Pharmaceuticals Inc,solace_pharmaceuticals_inc,,,,,, +7526,,fd29ca01-7d5c-47b6-975c-e2755a60f9e5,Cardioangiologisches Centrum Bethanien,cardioangiologisches_centrum_bethanien,,,,,, +7527,,0cd680ff-e703-45e8-b070-08cccb5ca2cd,University Hospital of Antwerp,university_hospital_of_antwerp,,,,,, +7528,,fcc430c0-8bc5-11e6-a449-0242ac12000b,"Ability Pharmaceuticals, SL",ability_pharmaceuticals_sl,,,,,, +7529,,5803d687-3a0d-4891-a03e-ac1e0b1d4465,"Daiichi Sankyo, Inc",daiichi_sankyo_inc,,,,,, +7530,,07975b5e-71ad-11e6-a0cd-0242ac12000b,MAYER LABS INC,mayer_labs_inc,,,,,, +7531,,5867d8f9-39ae-4476-aea1-b9589e8baf39,St. Joseph-Hospital g GmbH,st_joseph_hospital_g_gmbh,,,,,, +7532,,66168656-2321-4f51-98d7-261f20c4dce5,"Progenics Pharmaceuticals, Inc",progenics_pharmaceuticals_inc,,,,,, +7533,,6e4bd89e-e17b-4ff6-8245-6115bfb5bc35,Universitätsklinik für Neurologie Innsbruck,universit_tsklinik_f_r_neurologie_innsbruck,,,,,, +7534,,5117dfd3-ec28-4a0e-82ae-9618516b1660,Nuvo Research GmbH,nuvo_research_gmbh,,,,,, +7535,,1116308a-e2c7-42b6-895b-b257ea7d8bbf,AstraZeneca UK Limited,astrazeneca_uk_limited,,,,,, +113,0.971346,c9f9b495-efda-4f21-8505-bc308f92a89a,Radiumhemmet Karolinska University Hospital,radiumhemmet_karolinska_university_hospital,,,,5c913850-fa7a-4490-8a20-b21a3b24bb85,radiumhemmet_karolinska_university_hospital_stockholm_sweden,"Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden" +713,0.96302181482315063,8d39533d-717f-4f34-87ef-35d8a793ccc1,"Wyeth Pharmaceuticals Inc, a wholled owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA",wyeth_pharmaceuticals_inc_a_wholled_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,,,,d2f1d48d-c243-473b-9f47-208723250aa6,wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA" +746,0.98131093382835388,5b1eeabe-cc05-4f21-a026-146f9ab5ed29,"Johnson & Johnson Pharamceutical Research & Development, L.L.C",johnson_johnson_pharamceutical_research_development_l_l_c,,,,6067fed3-20a1-48ca-80df-3675d4109505,johnson_johnson_pharamceutical_research_development_l_l_c,"Johnson & Johnson Pharamceutical Research & Development, L.L.C" +7536,,81a2090e-7150-41a6-8543-246e5fd9740d,Pifzer Limited,pifzer_limited,,,,,, +7537,,ef93bbaf-5e35-4f13-a8c5-5c24fb30f3d2,Carlos Gómez Martín,carlos_g_mez_mart_n,,,,,, +7538,,f3cd39fd-1405-42c7-83fc-8d8598119991,Antoni van Leeuwenhoek - Netherlands Cancer Institute,antoni_van_leeuwenhoek_netherlands_cancer_institute,,,,,, +7539,,e0f4ab73-7aa4-4203-809c-c6a91f163209,"Pfizer Ltd,Ramsgate Road,Sandwich CT13 9NJ",pfizer_ltd_ramsgate_road_sandwich_ct13_9nj,,,,,, +7540,,a434d809-b02f-4bff-bcb3-2bf08937aa96,Calcium and Bone Metabolic Unit Copenhange University Hospital Hvidovre,calcium_and_bone_metabolic_unit_copenhange_university_hospital_hvidovre,,,,,, +515,0.928618,9e98b95e-5b2b-412f-bd88-d7d3dcb15715,"J. Uriach y Compañía, S.A",j_uriach_y_compa_a_s_a,,,,0b864f9c-6a82-4657-9f94-14d0aa558320,j_uriach_y_compa_ia_s_a,"J. Uriach y Compañia, S. A" +852,0.986862,a1d49384-7190-11e6-a0cd-0242ac12000b,ENDO PHARMS,endo_pharms,,,,105c8b52-7238-11e6-a0cd-0242ac12000b,endo_pharm,ENDO PHARM +7541,,862619d4-b00b-48b2-ab74-6f77b4526fbd,Per Lindner,per_lindner,,,,,, +7542,,39b17afb-f30d-4eb9-9a45-cabe0c4899f9,CEPHALON EUROPE,cephalon_europe,,,,,, +7543,,2f13cc44-b2b9-4116-933b-76eee62c418e,"NEUROTEC PHARMA, S.L",neurotec_pharma_s_l,,,,,, +500,0.991079,1e819b43-f206-47d8-a4b0-f6a029ef48dd,Hannover Medical School, Competence Network Viral Hepatitis (Hep-Net),,,,0f951df0-e851-4fc3-9f85-c87f75143477,hannover_medical_school,Hannover Medical School +7544,,8a36434c-7142-11e6-a0cd-0242ac12000b,SAVAGE LABS,savage_labs,,,,,, +7545,,4051a944-abd6-4438-aaa4-5eb025fa8556,GlaxoSmithKline Research & Developement Ltd,glaxosmithkline_research_developement_ltd,,,,,, +7546,,31ccf542-3a0b-4b7b-920c-439212767dd7,Klinik Löwenstein gGmbH,klinik_l_wenstein_ggmbh,hannover_medical_school_competence_network_viral_hepatitis_hep_net,,,,, +70,0.98913925886154175,ac8a4c93-016d-49ef-adcf-dab8bb9bc5aa,Takeda Global R&D Centre (Europe) Ltd,takeda_global_r_d_centre_europe_ltd,,,,ac8a4c93-016d-49ef-adcf-dab8bb9bc5aa,takeda_global_r_d_centre_europe_ltd,Takeda Global R&D Centre (Europe) Ltd +7547,,466902a6-4346-4b79-b7ca-5f383175b98f,Chiron S.r.l,chiron_s_r_l,,,,,, +7548,,f47d02df-17c5-43c4-8935-31eb0acea02a,"HUCH, Hospital for Children and Adolescents",huch_hospital_for_children_and_adolescents,,,,,, +330,0.925303,7f144f49-62c8-4b16-9149-74b909e542e7,Unidad de Trasplantes y Terapia Celular del Hospital Universitario Central de Asturias,unidad_de_trasplantes_y_terapia_celular_del_hospital_universitario_central_de_asturias,,,,786ccf58-7b82-4056-b49c-f3946952c95d,unidad_de_trasplantes_y_terapia_celular_del_hospital_general_universitario_central_de_asturias,Unidad de Trasplantes y Terapia Celular del Hospital General Universitario Central de Asturias +7549,,b2bc0b48-58c3-416f-aae3-eb124dcee8e8,"ISDIN, S.A",isdin_s_a,,,,,, +7550,,d4f1c47a-f69d-4ddf-b79a-71e055980785,IPPMed GmbH,ippmed_gmbh,,,,,, +7551,,6f7dbde5-1eea-4379-b680-05e3e241cec7,Bayer Consumer Care AG,bayer_consumer_care_ag,,,,,, +7552,,ea869bf7-f4ed-45dd-a12f-85845b2936b5,"Universität Heidelberg, Medizinische Fakultät Mannheim",universit_t_heidelberg_medizinische_fakult_t_mannheim,,,,,, +7553,,35ba6255-034f-4c59-8192-df9b68e78400,Auris ehf,auris_ehf,,,,,, +7554,,7253538e-d337-4f88-8864-38601dc092c5,Sankyo Pharma GmbH,sankyo_pharma_gmbh,,,,,, +7555,,1a3cda55-f587-464e-9d8e-42851a8f707a,Abnoba GmbH,abnoba_gmbh,,,,,, +7556,,629b224a-541a-4fe0-9fee-478045c7d11c,ASIT biotech S.A,asit_biotech_s_a,,,,,, +7557,,21aeab25-a88d-49c7-ad88-eea95d4db979,Direction Centrale du Service de Santé des Armées (DCSSA),direction_centrale_du_service_de_sant_des_arm_es_dcssa,,,,,, +775,0.929435,3994ddd6-d614-47eb-80a8-773f166f17da,"Ferring International Pharmascience Center US, Inc",ferring_international_pharmascience_center_us_inc,,,,3994ddd6-d614-47eb-80a8-773f166f17da,ferring_international_pharmascience_center_us_inc,"Ferring International Pharmascience Center US, Inc" +7558,,4c7419d9-6a28-4b01-a428-e93f6c523ed0,PHARNEXT,pharnext,,,,,, +7559,,8d9d31b0-def5-412d-a864-0120fd4bf484,Universitätskinderklinik Innsbruck,universit_tskinderklinik_innsbruck,,,,,, +7560,,a1421ab4-73fb-11e6-a0cd-0242ac12000b,COLLEGIUM PHARM INC,collegium_pharm_inc,,,,,, +7561,,faaf48f9-5baf-4152-8d3f-3ba71cfa4e77,University of Gothenburg,university_of_gothenburg,,,,,, +7562,,1c1df285-f323-4e3d-81a7-9542ca043088,"Medizinische Universität Wien, KIM III, Abteilung für Nephrologie",medizinische_universit_t_wien_kim_iii_abteilung_f_r_nephrologie,,,,,, +7563,,63e52d7c-ab77-4fa4-a225-9b5d8c413af2,Norgine Pharmaceuticals Ltd,norgine_pharmaceuticals_ltd,,,,,, +7564,,b20d9dcd-c724-430e-a98a-92260d4d5835,"Amersham plc and its Amersham Health affiliates, trading as GE Healthcare",amersham_plc_and_its_amersham_health_affiliates_trading_as_ge_healthcare,,,,,, +7565,,4508f7d1-63c2-42fe-9ac2-3a106f064748,"Dept of Plastic Surgery, Breast Surgery & Burns",dept_of_plastic_surgery_breast_surgery_burns,,,,,, +675,0.95528984069824219,3892c071-1607-48b5-94a4-5140950912c9,UCB Pharma S.A,ucb_pharma_s_a,,,,0db50825-cbd9-4ba0-9b70-46c1d448c066,ucb_pharma,UCB Pharma +7566,,35709bf1-2e34-449c-aa66-c0dbb84e31ef,Sunovion Pharmaceuticals Inc,sunovion_pharmaceuticals_inc,,,,,, +7567,,bbbfa0f1-7f59-4d16-a599-809484a879b6,Biocompatibles UK Ltd,biocompatibles_uk_ltd,,,,,, +7568,,02d8827c-c1d9-4123-98b1-b411e58d6bcd,Jorge Orduna Valls,jorge_orduna_valls,,,,,, +7569,,9697dfba-fbce-4a72-bfd4-88922154b5fa,"Schering-Plough HealthCare Products, Inc",schering_plough_healthcare_products_inc,,,,,, +7570,,646c4a23-afbc-4a9c-912f-b6fde2eb9744,"Teva Pharamceutical Industries, Ltd",teva_pharamceutical_industries_ltd,,,,,, +7571,,2e39292e-4ff1-4eb9-afc7-c9988bca2753,GELTAMO,geltamo,,,,,, +7572,,a44c816f-91b7-43ea-bd98-fb9f85b24f1c,Institut of Public Health,institut_of_public_health,,,,,, +253,0.96116367975870765,1c783fda-dd3b-43ce-8fdb-91e95f0e98cd,"Instituto Científico y Tecnológico de Navarra, SA. (ICT)",instituto_cient_fico_y_tecnol_gico_de_navarra_sa_ict,,,,4a176b41-c873-44ad-8442-a2e57b0b4289,instituto_cient_fico_y_tecnol_gico_de_navarra,Instituto Científico y Tecnológico de Navarra +24,0.98570942878723145,98380ed0-6709-41ea-a19e-81804abcd9ff,University Hospital Leuven,university_hospital_leuven,,,,98380ed0-6709-41ea-a19e-81804abcd9ff,university_hospital_leuven,University Hospital Leuven +716,0.986058,35022515-9c52-4711-b51c-84b1e5d62adf,Consorci Mar Parc de Salut de Barcelona,consorci_mar_parc_de_salut_de_barcelona,,,,35022515-9c52-4711-b51c-84b1e5d62adf,consorci_mar_parc_de_salut_de_barcelona,Consorci Mar Parc de Salut de Barcelona +7573,,f3cd1386-0998-4298-977d-99eafd678fee,CHu - Hôpitaux de Rouen,chu_h_pitaux_de_rouen,,,,,, +7574,,cf3fa0b4-deef-4f24-aae5-13cbe887fad1,General Medical Oncology UZ Gasthuisberg,general_medical_oncology_uz_gasthuisberg,,,,,, +7575,,928d1413-94e4-4328-a920-61b2553b8a97,Department of General Psychiatry,department_of_general_psychiatry,,,,,, +7576,,ee92b624-fbac-4c55-be3d-ebace05aa355,IPSEN FARMACEUTICA BV,ipsen_farmaceutica_bv,,,,,, +7577,,e3b51516-553a-410b-bbb2-93d48dbd39aa,"University of Nottingham, ResearchHead of research grants and contractsInnovation Services",university_of_nottingham_researchhead_of_research_grants_and_contractsinnovation_services,,,,,, +7578,,0adeb22e-ec65-4cb3-b5b9-ce777ba53b99,Dr Josep Ordi-Ros. Hospital Universitario Vall d'Hebron,dr_josep_ordi_ros_hospital_universitario_vall_d_hebron,,,,,, +7579,,4c547785-27d8-4900-9e4c-712e6e32465d,Federal Highway Research Institute / Bundesanstalt für Straßenwesen (BASt),federal_highway_research_institute_bundesanstalt_f_r_stra_enwesen_bast,,,,,, +7580,,812f91da-44b4-47de-ac38-0ef7539061b1,Minna Honkila / OYS,minna_honkila_oys,,,,,, +7581,,ae5489e9-fd0c-4950-b5c6-572dc4429a56,Servicio de Farmacia. Hospital Universitario de Bellvitge,servicio_de_farmacia_hospital_universitario_de_bellvitge,,,,,, +959,0.93498680988947547,2a8c6269-d997-4a31-a545-868ea8714d34,Andromeda Biotec Ltd,andromeda_biotec_ltd,,,,8e1ef03a-b2a7-496e-83ef-ae87bf0b27e9,andromeda_biotech_ltd_42_hayarkon_st_yavne_81227_israel,Andromeda Biotech Ltd +7582,,146eba55-658c-421e-8105-efef785a0045,TC BioPharm Ltd,tc_biopharm_ltd,,,,,, +7583,,9b7f2cfb-01c9-4c37-aeca-06ac6fd3a63b,Ste-Justine Hospital - Montréal in the name of Canadian Institute of Health Research (Canada),ste_justine_hospital_montr_al_in_the_name_of_canadian_institute_of_health_research_canada,,,,,, +7584,,71fd0cd6-8e07-4d4e-9d41-0b0616443144,"Mirati Therapeutics, Inc",mirati_therapeutics_inc,,,,,, +7585,,7c3372c5-9174-4604-8c9d-4df6b9503cfd,"University Health Network, Toronto General Hospital",university_health_network_toronto_general_hospital,,,,,, +341,0.984301,669b5851-2df0-4123-b6d8-74dd0d44fb69,Pfizer SA/NV,pfizer_sa_nv,,,,669b5851-2df0-4123-b6d8-74dd0d44fb69,pfizer_sa_nv,Pfizer SA/NV +7586,,91dba53a-0411-41cb-af86-9eb07dd9f045,Akademiska University Hospital,akademiska_university_hospital,,,,,, +7587,,b3e41ee3-fe81-4c51-865a-0ff629851886,Mundipharma Pharmaceuticals BV,mundipharma_pharmaceuticals_bv,,,,,, +719,0.98507535457611084,8ec06b1a-733e-11e6-a0cd-0242ac12000b,OTSUKA AMERICA PHARM,otsuka_america_pharm,,,,8ec06b1a-733e-11e6-a0cd-0242ac12000b,otsuka_america_pharm,OTSUKA AMERICA PHARM +7588,,4c6bfe1a-a08a-4582-bce0-fa4fb948d4b8,Southport and Ormskirk Hospital NHS Trust,southport_and_ormskirk_hospital_nhs_trust,,,,,, +7589,,f5914060-ce11-459f-9d8e-729b44d87025,Departments of Medical Research and Medicine,departments_of_medical_research_and_medicine,,,,,, +728,0.97711426019668579,093988ab-1f2c-48ab-84d3-0b1dff68400e,UCB Celltech,ucb_celltech,,,,093988ab-1f2c-48ab-84d3-0b1dff68400e,ucb_celltech_uk,"UCB Celltech, UK" +7590,,b91ff2d9-91df-4981-899c-d347e5b16c70,"Schwartz Biosciences, INC - UCB Group",schwartz_biosciences_inc_ucb_group,,,,,, +7591,,e4932ded-a042-45b6-a1a7-9d934fd9fb38,Active Biotech Research AB,active_biotech_research_ab,,,,,, +7592,,0bc6aa0e-564d-4422-b33a-6fccfefccc2a,ZLB Behring GmbH,zlb_behring_gmbh,,,,,, +7593,,4b66915a-356a-4ba4-8dfe-10c237db95c5,Paediatrisches Sekretariat fuer Klinische Studien,paediatrisches_sekretariat_fuer_klinische_studien,,,,,, +7594,,215c7a83-e8bb-4653-9d1c-5f0297300101,Middelfart Rygsektor,middelfart_rygsektor,,,,,, +7595,,90518e90-5ef7-4abd-b01e-4a4b2b9166e7,A. Menarini Farmaceutica Internazionale s.r.l,a_menarini_farmaceutica_internazionale_s_r_l,,,,,, +7596,,d37861e7-72e9-4532-9947-12a54900b82f,H.-Hartziekenhuis Roeselare-Menen vzw,h_hartziekenhuis_roeselare_menen_vzw,,,,,, +7597,,ab0d0693-8223-4d8f-8fd5-8ae1232145de,Emiliano Hernández Galilea,emiliano_hern_ndez_galilea,,,,,, +7598,,6da30198-71a1-11e6-a0cd-0242ac12000b,CORDEN PHARMA,corden_pharma,,,,,, +7599,,250ce2ef-6073-4d09-9e99-811427167e81,Moorfields Eye Hospital,moorfields_eye_hospital,,,,,, +7600,,b1e4f356-9614-11e6-becf-0242ac110008,MARNEL PHARMS,marnel_pharms,,,,,, +7601,,cb1fcbd7-70f1-45c9-b2de-5c789e2c6220,Oxford Radcliffe Hospitals NHS Trust,oxford_radcliffe_hospitals_nhs_trust,,,,,, +239,0.94886791706085205,bc50f609-752e-4417-a664-52c2b9126015,"Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK",pfizer_limited_ramsgate_road_sandwich_kent_ct13_9nj_uk,,,,8c508aab-3056-4b10-a446-a25708805795,pfizer_limited_ramsgate_road_sandwich_kent_ct13_uk,"Pfizer Limited, Ramsgate Road, Sandwich, Kent,CT13,UK" +7602,,54b22548-5361-4722-81d5-2c5c85fb6aef,Charite Universitaetsmedizin,charite_universitaetsmedizin,,,,,, +7603,,7dc890a4-7167-11e6-a0cd-0242ac12000b,MIPS CRF,mips_crf,,,,,, +7604,,0551c29a-64da-4181-9efe-4d28e70306d7,TBF,tbf,,,,,, +886,0.982434,2dab8489-6b0d-42e8-91ae-f96f843a7d75,ULB - Unité de Recherche en Lymphologie - Faculté des Sciences de la motricité,ulb_unit_de_recherche_en_lymphologie_facult_des_sciences_de_la_motricit,,,,2dab8489-6b0d-42e8-91ae-f96f843a7d75,ulb_unit_de_recherche_en_lymphologie_facult_des_sciences_de_la_motricit,ULB - Unité de Recherche en Lymphologie - Faculté des Sciences de la motricité +7605,,5c2229bc-72fa-11e6-a0cd-0242ac12000b,DIALYSIS SUPS,dialysis_sups,,,,,, +7606,,3aa12b2d-c17a-4858-8663-eb26ca1a9bca,"Klinik for Klinisk Fysiologi, Nuklearmedicin og PET, Rigshospitalet",klinik_for_klinisk_fysiologi_nuklearmedicin_og_pet_rigshospitalet,,,,,, +174,0.980699,d3d4a32b-9168-476d-9c12-82ebd51b34e5,"University of Tartu, Faculty of Medicine",university_of_tartu_faculty_of_medicine,,,,b6d07c42-8f99-487e-8dbb-3129112907b5,university_of_tartu,University of Tartu +7607,,e4ce7e52-43b4-4fa5-aa12-360d148945f1,Centro Nacional Investigaciones Oncológicas (CNIO),centro_nacional_investigaciones_oncol_gicas_cnio,,,,,, +7608,,2185fc71-a62d-4e77-b987-7ce251c29ee6,U.Z. Gasthuisberg,u_z_gasthuisberg,,,,,, +7609,,6fd0acde-5edf-4d69-a3d1-6c4f83d36a90,"Lehrstuhl für Klinisch-Experimentelle Medizin, Universitaet des Saarlandes",lehrstuhl_f_r_klinisch_experimentelle_medizin_universitaet_des_saarlandes,,,,,, +7610,,be28135c-7191-11e6-a0cd-0242ac12000b,CHATTEM,chattem,,,,,, +7611,,cf90e8ea-9c1d-44cf-93c1-6e2e6de31ae4,"Amersham Health, S.A",amersham_health_s_a,,,,,, +7612,,865d9b09-ab36-48a4-a684-c60b60af1295,"AZIENDA SANITARIA OSPEDALIERA ""S. GIOVANNI BATTISTA DI TORINO",azienda_sanitaria_ospedaliera_s_giovanni_battista_di_torino,,,,,, +7613,,e7c635b8-c909-46ab-b8a7-d6c9e0b5bd9c,Fundació de l'Institut de Recerca HSCSP,fundaci_de_l_institut_de_recerca_hscsp,,,,,, +208,0.98087829351425171,2237cc76-7146-11e6-a0cd-0242ac12000b,ALVOGEN,alvogen,,,,2237cc76-7146-11e6-a0cd-0242ac12000b,alvogen,ALVOGEN +7614,,f7228b96-68e8-4451-ad32-c8477b38853d,"Odense Universitetshospital, Nyremedicinsk Afd. Y",odense_universitetshospital_nyremedicinsk_afd_y,,,,,, +7615,,bf8fbd09-3f3f-424e-968e-ee2ffb53148a,Österreichische Nationalbank - Jubiläumsfonds,sterreichische_nationalbank_jubil_umsfonds,,,,,, +7616,,06bef760-8ec4-4d70-b0d2-1b0425892036,Sahlgrenska Universtitetssjukhuset/SUS,sahlgrenska_universtitetssjukhuset_sus,,,,,, +122,0.9805833101272583,30ba52d9-6b66-48ba-8e96-5fffed95a5ca,"F. Hoffmann-La Roche Ltd, Pharmaceuticals Divison, PDR",f_hoffmann_la_roche_ltd_pharmaceuticals_divison_pdr,,,,89ecf617-74e0-496c-8ac4-d4eae3b54d8c,f_hoffmann_la_roche_ltd_pharmaceuticals_divison_pdr,"F. Hoffmann-La Roche Ltd, Pharmaceuticals Divison, PDR" +802,0.989407,cd7233a2-6fa1-11e6-9663-0242ac12000b,Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF),consorzio_per_valutazioni_biologiche_e_farmacologiche_cvbf,,,,a02415a8-3cdf-4ded-89d7-b50b2f02f0bd,consorzio_per_valutazioni_biologiche_e_farmacologiche,Consorzio per Valutazioni Biologiche e Farmacologiche +394,0.97813,3962e63e-5246-49ec-a9ae-2803f127cfde,Unidad de Investigación en Tuberculosis de Barcelona (UITB),unidad_de_investigaci_n_en_tuberculosis_de_barcelona_uitb,,,,2a062c79-99fa-45ef-95f7-3bfbfa472661, Hospital Universitario de Canarias,Unidad de Investigación +7617,,ff995683-97a1-496d-aa8e-4be2c7b6077b,DuoCort Pharma AB,duocort_pharma_ab,,,,,, +7618,,9dcb859d-59d4-4771-9d13-2846f6db5090,Phenex Pharmaceuticals AG,phenex_pharmaceuticals_ag,,,,,, +183,0.959379,5e949122-96f1-4d01-ad56-70e70e854e38,Cliniques Universiatires St Luc- Centre du Cancer,cliniques_universiatires_st_luc_centre_du_cancer,,,,5c17ba0c-11f6-4fbe-8689-f48af0fac056,cliniques_universitaires_st_luc_centre_du_cancer,"Cliniques Universitaires St Luc, Centre du Cancer" +380,0.98268057902654016,e3acf622-0e1e-442c-86eb-aafa4489dda1,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" +652,0.95031802356243134,00579454-324d-40af-85d4-934e24af2e2b,Boehringer Ingelheim Ky,boehringer_ingelheim_ky,,,,756fbf26-6aec-45b4-9273-9afca275034e,boehringer,Boehringer +7619,,1703c128-7242-11e6-a0cd-0242ac12000b,NUVO RES INC,nuvo_res_inc,,,,,, +841,0.95600730180740356,640d2f05-d82c-4fcf-8cf1-823f7c525359,JANSSEN-CILAG INTERNATIONAL BV,janssen_cilag_international_bv,,,,640d2f05-d82c-4fcf-8cf1-823f7c525359,janssen_cilag_international_bv,JANSSEN-CILAG INTERNATIONAL BV +7620,,60c1bb4e-4159-4a95-9f37-82a64d1f527a,Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_12_de_octubre,,,,,, +7621,,9b626529-57b7-499f-9333-92a72929f0d4,Sanofi-aventis Research & Development,sanofi_aventis_research_development,,,,,, +7622,,8b9f8577-6b6d-4d48-b7e7-194aa4dc3cd0,"Istituto Fisiologia Clinica, CNR",istituto_fisiologia_clinica_cnr,,,,,, +7623,,54b74af7-da2a-4d51-aea5-591da869d740,Tandvården SU/Mölndal,tandv_rden_su_m_lndal,,,,,, +7624,,838f6ee7-46da-4c10-8265-6ba40a0a41b6,German High-Grade non- Hodgkin's Lynphoma Study Group,german_high_grade_non_hodgkin_s_lynphoma_study_group,,,,,, +7625,,feca5ef4-e4db-4608-a21c-d1cad2b0992c,St. Antonius Ziekenhuis,st_antonius_ziekenhuis,,,,,, +7626,,28d95ccb-32ff-4b67-9112-ec17076a97ad,ALEJANDRA GARCIA BOTELLA,alejandra_garcia_botella,,,,,, +7627,,9d134468-aa02-44c2-87de-c1bc72ec82bc,Axonyx Inc,axonyx_inc,,,,,, +7628,,5f9aa4ba-a44f-448c-b8b7-1a9368b28c5c,Manchester Mental Health &Social Care Trust,manchester_mental_health_social_care_trust,,,,,, +7629,,c3bacb84-fbc1-413d-92cc-1ed4defa0239,"Universität Innsbruck, Institut für Biomedizinische Alternsforschung",universit_t_innsbruck_institut_f_r_biomedizinische_alternsforschung,,,,,, +7630,,1fe4919a-2864-4a0d-b38b-bbffa53ffeda,Timo Laitio,timo_laitio,,,,,, +7631,,f8961dce-011a-4296-a469-f359df20f8c8,Sumitomo Pharmaceuticals Europe Limited,sumitomo_pharmaceuticals_europe_limited,,,,,, +7632,,02fbc65b-45fe-4d6c-9677-62564553943e,ANGEL LANAS,angel_lanas,,,,,, +7633,,038a5577-74de-4b90-bf49-e8cf48059bfc,"Merk & Co., Inc",merk_co_inc,,,,,, +7634,,bc7e5204-9e97-4e34-b76e-94ddd6c91873,Hull & East Yorkshire NHS Trust,hull_east_yorkshire_nhs_trust,,,,,, +12,0.988363,ed989b24-8bd7-11e6-a449-0242ac12000b,University Medical Center Utrecht (UMCU),university_medical_center_utrecht_umcu,,,,43a29514-7df4-4ef9-8c2e-fd420fdb7e20,university_medical_center_utrecht,University Medical Center Utrecht +7635,,186055fe-4fc1-4b0c-b29a-d44ece646ddb,Translational Research In Oncology,translational_research_in_oncology,,,,,, +7636,,c06a291e-93ba-40c3-bfff-a263c053c14e,Colgate Palmolive Co,colgate_palmolive_co,,,,,, +7637,,1524de89-ea1f-4085-a48d-67b06129ce8a,SLL,sll,,,,,, +7638,,6561d4a8-3282-458b-8156-878ded032e06,Dr. med. Tina Vilsbøll,dr_med_tina_vilsb_ll,,,,,, +7639,,888ecead-0afd-4451-a718-fb2526e6dcf0,Glaukos Corporation,glaukos_corporation,,,,,, +7640,,2c269c3f-049e-45f2-b9cf-db978a37a5e2,Psykiatrisk Center Ballerup,psykiatrisk_center_ballerup,,,,,, +7641,,b25fa8fd-688e-4aa4-b3da-1d7476d11c47,"Adyton, s.r.o",adyton_s_r_o,,,,,, +7642,,11077792-573f-4483-9aa1-625d83d1ee36,Clinical Center Ljubljana,clinical_center_ljubljana,,,,,, +88,0.985891,31023a1a-6fbc-11e6-abe8-0242ac12000b,Photopharmica Ltd,photopharmica_ltd,,,,31023a1a-6fbc-11e6-abe8-0242ac12000b,photopharmica_ltd,Photopharmica Ltd +7643,,53fd8f6b-902a-446b-9c91-86c7cdea4239,Laboratoire BOIRON,laboratoire_boiron,,,,,, +7644,,7609d379-3c41-479b-b625-178204d6c845,BG university hospital Bergmannsheil GmbH,bg_university_hospital_bergmannsheil_gmbh,,,,,, +7645,,67dae82a-7142-11e6-a0cd-0242ac12000b,TARO PHARMS NORTH,taro_pharms_north,,,,,, +7646,,0a02a3c6-86b4-43ef-b663-7342adb691d8,University of Crete,university_of_crete,,,,,, +7647,,3acbbff4-662c-4b8a-a1a5-57113c0adafd,I.R.I.S,i_r_i_s,,,,,, +7648,,28422b74-7160-11e6-a0cd-0242ac12000b,PHARMATON,pharmaton,,,,,, +7649,,b44de3d6-7d21-4f43-8d94-0029c37cef6b,"Med. Univ. Wien, Klinik für klinische Pharmakologie",med_univ_wien_klinik_f_r_klinische_pharmakologie,,,,,, +7650,,5ed4b3e0-66a0-4f37-a0ea-a8a968f24589,Merck Farma y Química S.L,merck_farma_y_qu_mica_s_l,,,,,, +7651,,c088787e-9811-4b5f-87c2-b0a85049c762,"Ove Bäck, Dept Dermatology, University Hospital, Lund, Sweden",ove_b_ck_dept_dermatology_university_hospital_lund_sweden,,,,,, +7652,,7c832cd0-9f82-4358-990a-8b596507cc5f,"Ipsen Biopharmaceuticals, Inc",ipsen_biopharmaceuticals_inc,,,,,, +7653,,d988cb65-987a-4b7d-bc5e-98d8f7a43501,GLAXOSMITHLINE RESEARCH AND DEVELOPMENT LIMITED,glaxosmithline_research_and_development_limited,,,,,, +7654,,2b921b7b-bfb5-4c0f-a615-bf6bb757c33b,HOSPITAL VALL DE HEBRON,hospital_vall_de_hebron,,,,,, +7655,,51fdbbe1-05cd-416b-9dde-12dd011559f5,"Medical University of Vienna, Dep. of Internal Medicine I, division of Hematology & Hemostaseology",medical_university_of_vienna_dep_of_internal_medicine_i_division_of_hematology_hemostaseology,,,,,, +702,0.97233712673187256,e83cea40-d34c-423f-9f95-62293d47cae2,University Hospital of Leicester NHS Trust,university_hospital_of_leicester_nhs_trust,,,,e83cea40-d34c-423f-9f95-62293d47cae2,university_hospitals_of_leicester_nhs_trust,University Hospitals of Leicester NHS Trust +629,0.973923,a2b23675-9895-4989-9406-32001c82a978,Aarhus Sygehus,aarhus_sygehus,,,,8bf894ff-dd31-480c-84ce-842ae83c6af2,aarhus_sygehus_universityhospital_of_aarhus,"Aarhus Sygehus, Universityhospital of Aarhus" +485,0.985716,f5ed546c-10fd-4c11-a82d-b2c4946cdba7,IRCCS CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI,irccs_centro_san_giovanni_di_dio_fatebenefratelli,,,,d4d3b8e8-ff21-4f29-9209-678e5c00d01b,irccs_centro_san_giovanni_di_dio,IRCCS CENTRO SAN GIOVANNI DI DIO +7656,,dcdbaa55-bf8e-4d6c-be35-1a12072b3b9e,MEDDAY SAS,medday_sas,,,,,, +7657,,20bcbccf-0911-41ec-b532-ded8ae67a245,OmniVision GmbH,omnivision_gmbh,,,,,, +7658,,c93ca877-71a7-413e-9156-e8546b2dd3a0,Cumberland Pharmaceuticals Inc,cumberland_pharmaceuticals_inc,,,,,, +7659,,ba1435d3-b1e8-45d9-8d7f-b0b298131a94,Prof.Dr.Hartmut ZWICK,prof_dr_hartmut_zwick,,,,,, +7660,,8b16650d-d80a-406e-8147-ab226c6a7d71,Georg Hagmüller Institute for Vascular Research,georg_hagm_ller_institute_for_vascular_research,,,,,, +7661,,1fd6926f-b078-4a5d-a67d-9c6e776ef4f6,St Georges Healthcare NHS trust,st_georges_healthcare_nhs_trust,,,,,, +7662,,28ed6e56-d7c3-4dff-a541-40118534ee9c,Dra Itxarone Bilbao. Servicio de Cirugía Hepatobiliopancreatica y Trasplantes. HUVH,dra_itxarone_bilbao_servicio_de_cirug_a_hepatobiliopancreatica_y_trasplantes_huvh,,,,,, +7663,,2e88ce04-e0d1-4886-ba3c-e30013343376,Chimerix UK Limited,chimerix_uk_limited,,,,,, +7664,,5e6c77d8-d52b-48af-b2e6-6dfd3e254265,RAFAEL GARCIA LOPEZ,rafael_garcia_lopez,,,,,, +7665,,f94760e8-e21f-4f6a-8fb0-d99d100931f5,Juan Pasquau Liñao,juan_pasquau_li_ao,,,,,, +266,0.96782034635543823,f5fb73ac-fe01-4343-a38f-65de710199e4,TEVA,teva,,,,07e8ff92-7129-11e6-a89e-0242ac12000b,teva_pharms,TEVA PHARMS +7666,,7dcfbcff-c703-47cd-9782-1e57db49fcbb,ELI LILLY,eli_lilly,,,,,, +7667,,ca0f061e-4dd5-4b12-853f-062cd3b0c150,"Lund University, Malmö University Hospital",lund_university_malm_university_hospital,,,,,, +7668,,3d25aa23-3066-4c23-8378-9ce3565b8ff0,"ChemoCentryx, Inc",chemocentryx_inc,,,,,, +7669,,a2d44ce2-dcdc-47e9-84e1-0249f74117e2,Nordic Myeloma Study Group,nordic_myeloma_study_group,,,,,, +502,0.955255,857fd478-88b2-4bb7-94b5-f76c9d81d5e1,Aalborg University,aalborg_university,,,,569a1285-cdde-46ac-ab93-f30a3f2406e3,aalborg_universitetshospital,Aalborg Universitetshospital +7670,,18989427-a40f-41ac-a71d-3539886da202,Teva Pharmaceuticals Industries LtD,teva_pharmaceuticals_industries_ltd,,,,,, +755,0.952513,0c07c031-3aa4-42bd-a466-16b7d6794b5f,Sanofi Pasteur KK,sanofi_pasteur_kk,,,,0c07c031-3aa4-42bd-a466-16b7d6794b5f,sanofi_pasteur_kk,Sanofi Pasteur KK +7671,,2c464efc-714d-11e6-a0cd-0242ac12000b,HALOCARBON PRODS,halocarbon_prods,,,,,, +7672,,a45f5df6-c17f-4e74-89c1-b28409070404,HOSPITAL DE PALAMÓS,hospital_de_palam_s,,,,,, +907,0.94030070304870605,f72ce0f5-27b8-42db-aeea-0faa55409a54,sanofi-aventis recherche et de`veloppement,sanofi_aventis_recherche_et_de_veloppement,,,,f72ce0f5-27b8-42db-aeea-0faa55409a54,sanofi_aventis_recherche_et_developpement,sanofi-aventis recherche et developpement +878,0.986926,c04f7850-7141-11e6-a0cd-0242ac12000b,ZYDUS PHARMS USA,zydus_pharms_usa,,,,c04f7850-7141-11e6-a0cd-0242ac12000b,zydus_pharms_usa,ZYDUS PHARMS USA +7673,,39fa0653-2173-4c4e-9c60-9e35689a623e,Copenhagen CF-centre,copenhagen_cf_centre,,,,,, +280,0.978312,038ffc9a-cc49-4155-9812-d242dccadca0,"Vejle Hospital, Dept. of Oncology",vejle_hospital_dept_of_oncology,,,,038ffc9a-cc49-4155-9812-d242dccadca0,vejle_hospital_dept_of_oncology,"Vejle Hospital, Dept. of Oncology" +7674,,db9b5ff9-4cd6-4a86-b5f5-4874a9db2b25,RIBOSEPHARM,ribosepharm,,,,,, +7675,,97dd88a5-215c-4290-8e9e-fa0abaff3a07,Servicio Hepatología. Hospital Vall d'Hebron,servicio_hepatolog_a_hospital_vall_d_hebron,,,,,, +7676,,2d21aed3-23a1-44f8-b382-933861d3b397,Inserm-ANRS (Agence nationale de recherches sur le sida et les hépatites virales),inserm_anrs_agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales,,,,,, +7677,,cbd6f72d-f490-4042-9733-1d5f57953f96,"Research & Development Unit, Queen Alexandra Hospital",research_development_unit_queen_alexandra_hospital,,,,,, +7678,,dd26aacd-6909-4312-871f-0b6b8d29d641,Balkanpharma-Razgrad AD,balkanpharma_razgrad_ad,,,,,, +7679,,39c13a12-f3e8-4485-b2fa-0a7b0d751d00,Kantonsspital St. Gallen,kantonsspital_st_gallen,,,,,, +7680,,8a378b01-d64f-40a7-9960-68d921310271,Department of Anaesthesia,department_of_anaesthesia,,,,,, +7681,,054cef65-deb6-4362-a651-f4d878edb702,"Cardiff University, Research & Development Commercial Department",cardiff_university_research_development_commercial_department,,,,,, +7682,,70120a3b-c639-4430-8743-086b481fc6b7,"Department of Dermatology and Allergology, University of Szeged",department_of_dermatology_and_allergology_university_of_szeged,,,,,, +7683,,adf99fba-05fa-4490-b40a-5bec9a71da62,"University Medical Center Groningen, UMCG-Department of Gynaecologic Oncology",university_medical_center_groningen_umcg_department_of_gynaecologic_oncology,,,,,, +7684,,031a2ce9-4219-4223-b1f0-bed8fc220de2,DAVID DALMAU,david_dalmau,,,,,, +7685,,a1d85146-2698-46ca-b55c-dd2093d4f90e,"Anadys Development, LTD",anadys_development_ltd,,,,,, +919,0.985423,a73e16e9-8647-4b62-9351-fa10656902fa,NOVO NORDISK,novo_nordisk,,,,6e3bc4ca-7140-11e6-a0cd-0242ac12000b,novo_nordisk_inc,NOVO NORDISK INC +271,0.936507,1f1910ef-d8fc-404c-af9b-dd7bc5fd4d42,AstraZeneca BV,astrazeneca_bv,,,,1f1910ef-d8fc-404c-af9b-dd7bc5fd4d42,astrazeneca_bv,AstraZeneca BV +62,0.98647499084472656,371bb74c-7ef8-447f-97d1-6ea91a3686f0,Talecris Biotherapeutics,talecris_biotherapeutics,,,,8776dd79-3ee8-4ef0-a9ce-fb6aef833e21,talecris_biotherapeutics_inc,"Talecris Biotherapeutics, Inc" +7686,,931e2c7c-72e1-11e6-a0cd-0242ac12000b,IVAX INTL,ivax_intl,,,,,, +7687,,6bef1f1f-67aa-4b42-bce5-7aae791f641e,Ludwig-Maximilians-Universitaet Muenchen,ludwig_maximilians_universitaet_muenchen,,,,,, +7688,,65664cf5-47f2-4fe4-8aee-cd4668389bbd,"Klinische Abteilung für Gastroenterologie und Hepatologie, Medizinische Universitätsklinik, MUG",klinische_abteilung_f_r_gastroenterologie_und_hepatologie_medizinische_universit_tsklinik_mug,,,,,, +78,0.988885,5e1c611c-7163-11e6-a0cd-0242ac12000b,BRECKENRIDGE PHARMS,breckenridge_pharms,,,,5e1c611c-7163-11e6-a0cd-0242ac12000b,breckenridge_pharms,BRECKENRIDGE PHARMS +7689,,fb5a4f7b-b084-4077-9eff-0c7b11aecc75,Universitary Hospital Hamburg,universitary_hospital_hamburg,,,,,, +7690,,0ee4af01-185d-4cf1-ac3a-38dbd4ceae26,Circassia Ltd,circassia_ltd,,,,,, +248,0.981904,d3994724-733a-11e6-a0cd-0242ac12000b,HILL DERMACEUTICALS,hill_dermaceuticals,,,,101cc2b8-71b8-11e6-a0cd-0242ac12000b,hill_dermac,HILL DERMAC +7691,,a7602d2d-4925-496b-a10f-ebbe6090c39e,GlaxoSmithKline Research &, Development Ltd,,,,,, +7692,,5a18236a-c80e-4d4c-9d76-a5a9abec073e,GRUPO ESPAÑOL DE INVESTIGACIÓN EN CANCER DE OVARIO (GEICO),grupo_espa_ol_de_investigaci_n_en_cancer_de_ovario_geico,,,,,, +975,0.93739336729049683,5cf8174e-62dd-46c6-8a1e-ec1d71fed23c,"Universitätsklinikum Schleswig-Holstein, Campus Lübeck",universit_tsklinikum_schleswig_holstein_campus_l_beck,,,,5a90c345-0950-4b20-a685-09b583a6ae3f,universit_tsklinikum_schleswig_holstein_campus_kiel,"Universitätsklinikum Schleswig-Holstein, Campus Kiel" +7693,,a15b44e4-814d-4ab9-819e-9703b9670639,"F. Hoffmann - La Roche Ltd - Pharmaceutical Division, PDR",f_hoffmann_la_roche_ltd_pharmaceutical_division_pdr,glaxosmithkline_research_amp_development_ltd,,,,, +7694,,2be1a793-74aa-4531-8494-d711cb936e4c,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),national_institute_of_arthritis_and_musculoskeletal_and_skin_diseases_niams,,,,,, +7695,,6d3f19ce-5313-4361-938d-2552df91eb62,Steiner & Co. Deutsche Arzneimittelgesellschaft mbH & Co. KG,steiner_co_deutsche_arzneimittelgesellschaft_mbh_co_kg,,,,,, +7696,,8c98d8cb-26a0-4383-a458-cf109e25e637,Guerbet Laboratories Ltd,guerbet_laboratories_ltd,,,,,, +7697,,cbd0c87e-1b36-4ef6-9134-7e98137518fa,Univ.-Kl.f.Nuklearmedizin Wien,univ_kl_f_nuklearmedizin_wien,,,,,, +7698,,f3e33bd1-b988-459e-ac96-fb368e004708,APREC,aprec,,,,,, +7699,,876a98df-aff9-4577-8210-09e14eecab5f,Siena Biotech SpA,siena_biotech_spa,,,,,, +7700,,81afadd8-7167-11e6-a0cd-0242ac12000b,UNIV UTAH CYCLOTRON,univ_utah_cyclotron,,,,,, +7701,,61743b56-719e-11e6-a0cd-0242ac12000b,LANTHEUS MEDCL,lantheus_medcl,,,,,, +7702,,ac19807e-8bef-11e6-a449-0242ac12000b,Antonis Valachis,antonis_valachis,,,,,, +7703,,e932f528-7144-11e6-a0cd-0242ac12000b,COASTAL PHARMS,coastal_pharms,,,,,, +7704,,a5d50545-8d0c-452c-be10-debd15181916,Matti Ristikankare,matti_ristikankare,,,,,, +7705,,202076fe-7164-11e6-a0cd-0242ac12000b,JUBILANT GENERICS,jubilant_generics,,,,,, +7706,,fbe222d8-d19c-4c6e-88d5-d6034dfe6695,"Merck Serono International SA, An affiliate of Merck KGaA, Darmstadt, Germany",merck_serono_international_sa_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,,, +7707,,cf14a86a-581c-4394-bfa3-5be9a908b843,Australian Sarcoma Group (ASSG),australian_sarcoma_group_assg,,,,,, +7708,,92e80fb0-7a0a-4a57-9f67-87cbe8dab53e,BAS Medical Inc,bas_medical_inc,,,,,, +627,0.97483,51090fb3-f2e6-4878-8ebd-94da6e3ed0df,Institut Bergonié - Département d’Oncologie Médicale,institut_bergoni_d_partement_d_oncologie_m_dicale,,,,51090fb3-f2e6-4878-8ebd-94da6e3ed0df,institut_bergoni_d_partement_d_oncologie_m_dicale,Institut Bergonié - Département d’Oncologie Médicale +7709,,c73b115c-c0ae-44f1-bbbf-6507e89f8968,Themis Bioscience GmbH,themis_bioscience_gmbh,,,,,, +7710,,1b59f5d9-fba6-4756-9c55-6ec18cc4e471,"Schering-Plough Research Institute on behalf of MSP Singapore Company, LLC",schering_plough_research_institute_on_behalf_of_msp_singapore_company_llc,,,,,, +7711,,27fd8fa2-73d9-11e6-a0cd-0242ac12000b,FOREST RES INST INC,forest_res_inst_inc,,,,,, +7712,,134b2ab0-99bd-498c-ac11-a8dce306ac5f,Free State of Bavaria represented by Regensburg University represented by Regensburg University Hospital represented by,free_state_of_bavaria_represented_by_regensburg_university_represented_by_regensburg_university_hospital_represented_by,,,,,, +632,0.988363,cac50b51-5326-4418-b63e-99dee23e93b8,Grupo Gallego de Cáncer de Pulmón,grupo_gallego_de_c_ncer_de_pulm_n,,,,0be8c403-9955-44a5-a91f-7f50c9773ce9,grupo_gallego_de_c_ncer_de_pulm_n_ggcp,Grupo Gallego de Cáncer de Pulmón (GGCP) +7713,,1706ffae-c772-4957-9756-cf424896aac9,Heidelberg Pharma,heidelberg_pharma,,,,,, +7714,,2431a9b8-01c4-4bdf-8952-e75621de272b,Department of Genito-Urinary Medicine and Infectious Diseases,department_of_genito_urinary_medicine_and_infectious_diseases,,,,,, +7715,,6bb028ca-5c9c-4295-8af6-b5b66f36c7de,Semmelweis Egyetem Transzplantációs és Sebészeti Klinika,semmelweis_egyetem_transzplant_ci_s_s_seb_szeti_klinika,,,,,, +7716,,7c9fc3fa-71ad-11e6-a0cd-0242ac12000b,POHL BOSKAMP,pohl_boskamp,,,,,, +7717,,26701740-ecf2-4eb3-8869-3368ebe479e1,Thornton & Ross Ltd,thornton_ross_ltd,,,,,, +7718,,06a61b58-9db7-49fa-8214-f7423106e7d9,CONCEPCION MORO SERRANO,concepcion_moro_serrano,,,,,, +368,0.97238914171854651,e3d5ccce-d023-44a3-9122-51b95f10329f,"Bayer HealthCare AG, 51368 Leverkusen",bayer_healthcare_ag_51368_leverkusen,,,,0f2245d6-1eb2-4a26-ba28-2ddd66aada58,bayer_healthcare_ag_51368_leverkusen,"Bayer HealthCare AG, 51368 Leverkusen" +7719,,0bd978ba-d3ef-4d30-b44e-a97201c4e2a9,ADVENTRX Pharmaceuticals Inc,adventrx_pharmaceuticals_inc,,,,,, +7720,,b18480c2-5f60-4243-9b70-f597579deeb8,"Ikaria, Inc",ikaria_inc,,,,,, +102,0.98334300518035889,2eb3e3c9-b195-488e-a7df-a29b241b8d60,KU Leuven LRD,ku_leuven_lrd,,,,2eb3e3c9-b195-488e-a7df-a29b241b8d60,ku_leuven_lrd,KU Leuven LRD +7721,,48a7131f-670a-4237-99dc-eb0eef3da355,Sosei R&D Ltd,sosei_r_d_ltd,,,,,, +7722,,df869e77-e5aa-40fb-a8b8-bbd5824e91df,ALK Abello A/S,alk_abello_a_s,,,,,, +7723,,3fdb33bf-7f5c-456f-a933-5b9620cf3b49,"Institute for the Study, Research and Education in Diabetes Mellitus and Metabolic Disorders",institute_for_the_study_research_and_education_in_diabetes_mellitus_and_metabolic_disorders,,,,,, +7724,,b7132602-7145-11e6-a0cd-0242ac12000b,MYLAN SPECLT,mylan_speclt,,,,,, +7725,,fef3c91f-9abc-4f38-973e-5e7ae16c0f50,Śląski Uniwersytet Medyczny w Katowicach,l_ski_uniwersytet_medyczny_w_katowicach,,,,,, +1080,0.975398,ebd4395d-f808-443f-be1d-ab4674258fc6,Medice Arnzneimittel Pütter GmbH & Co. KG,medice_arnzneimittel_p_tter_gmbh_co_kg,,,,4d169b05-ac41-460f-9a9b-dbaba35ab0e5,medice_arzneimittel_p_tter_gmbh_co_kg,Medice Arzneimittel Pütter GmbH & Co. KG +7726,,6f80fab6-a72e-484b-90de-7b65ef90da4a,Gilead Sciences Pty Ltd,gilead_sciences_pty_ltd,,,,,, +7727,,e1c9b838-886d-4b15-81c6-7ccbbf94c488,Schering-Plough AB Sweden,schering_plough_ab_sweden,,,,,, +7728,,6b1a826a-53a1-42f3-a851-2b7dcbec969c,Antonio Cubillo Gracián (Servicio de Oncología Médica - Hospital MD Anderson),antonio_cubillo_graci_n_servicio_de_oncolog_a_m_dica_hospital_md_anderson,,,,,, +7729,,88117330-bb65-4e3e-a89c-f1c9dc07036e,Abbott Healthcare Products B.V,abbott_healthcare_products_b_v,,,,,, +7730,,f2248e4b-cb74-471f-8db1-b07a0979ef51,"Geir Øystein Andersen, Department of Cardiology, Ulleval University Hospital",geir_ystein_andersen_department_of_cardiology_ulleval_university_hospital,,,,,, +915,0.9809834361076355,61f167e1-4240-4936-a86a-3eb617eeeb8b,"Oulu University Hospital, Department of Anaesthesia",oulu_university_hospital_department_of_anaesthesia,,,,61f167e1-4240-4936-a86a-3eb617eeeb8b,oulu_university_hospital_department_of_anaesthesia,"Oulu University Hospital, Department of Anaesthesia" +7731,,e4584d7b-19ed-4607-94e5-a1884d4fd8ac,Birken GmbH,birken_gmbh,,,,,, +7732,,21c38081-4daa-4dfa-bfe8-c57cbdb53b1d,AETERNA ZENTARIS GMBH,aeterna_zentaris_gmbh,,,,,, +7733,,1fc7f870-71ec-11e6-a0cd-0242ac12000b,LUNDBECK LLC,lundbeck_llc,,,,,, +7734,,110fbced-4d46-406e-b9ce-9d019ede74b5,Trafford NHS Trust,trafford_nhs_trust,,,,,, +7735,,b443a406-2335-4b59-a4b9-14bc0d70b1fa,Janssen-Cilag Polska Sp z o.o,janssen_cilag_polska_sp_z_o_o,,,,,, +7736,,479c6171-6fd7-4c1e-bdfa-ebe156b483e3,Ana Boto de los Bueis,ana_boto_de_los_bueis,,,,,, +7737,,1057c411-e420-4d95-9850-1e5efb94ea6d,Servicio de Farmacia. Hospital Universitari de Bellvitge,servicio_de_farmacia_hospital_universitari_de_bellvitge,,,,,, +7738,,245b3501-2046-4f9e-9b4b-07b7490ab52f,"Abteilung für Pulmologie, Landesklinikum Thermenregion Hochegg",abteilung_f_r_pulmologie_landesklinikum_thermenregion_hochegg,,,,,, +7739,,4eb6e9d1-9b11-4613-92b2-56ef7ffe2d91,"Medizinische Universität Graz, Klinische Abteilung für Endokrinologie und Nuklearmedizin",medizinische_universit_t_graz_klinische_abteilung_f_r_endokrinologie_und_nuklearmedizin,,,,,, +7740,,91396f77-4e1b-4e35-93a2-629b9ad94939,Hospital Universitari de Tarragona Joan XXIII,hospital_universitari_de_tarragona_joan_xxiii,,,,,, +7741,,3cfa4fb8-1b49-4d36-b0f9-7efb5595fe8d,Novartis Pharma N.V,novartis_pharma_n_v,,,,,, +7742,,4288e88f-63ed-4b89-bfcb-0280fdc50d5f,Spirig Pharma AG,spirig_pharma_ag,,,,,, +7743,,3020178e-4134-4394-b976-ef29a7864a86,MannKind Corporation,mannkind_corporation,,,,,, +7744,,e6ee308e-d4c5-4cb4-b112-4e6fb5a09ed8,University Hospitals of the KU Leuven,university_hospitals_of_the_ku_leuven,,,,,, +7745,,52579968-4d60-4514-ac54-9cfb15b3c115,Addenbrooke's Hospital NHS Foundation Trust,addenbrooke_s_hospital_nhs_foundation_trust,,,,,, +7746,,9ecb5c92-7513-40f9-b274-63a8b2171243,ENCELADUS Pharmaceuticals BV,enceladus_pharmaceuticals_bv,,,,,, +7747,,ac77a856-c9bd-44d6-9ad2-767d66f28537,"480 Biomedical, Inc",480_biomedical_inc,,,,,, +7748,,d7f8103d-5e8e-43b8-827e-b7a894c63edf,"University Hospitals of Leicester NHS Trust, Research and Development Directorate",university_hospitals_of_leicester_nhs_trust_research_and_development_directorate,,,,,, +7749,,6d93f03c-7146-11e6-a0cd-0242ac12000b,CLONMEL,clonmel,,,,,, +927,0.983072,acf46b8c-60b7-4671-b4bc-ad1703a5253c,The University of Edinburgh & Lothian Health Board,the_university_of_edinburgh_lothian_health_board,,,,61519487-23d4-417a-83c9-581008f2af7b,the_university_of_edinburgh,The University of Edinburgh +7750,,a48450c7-69fa-4ae7-b19b-264a204a418a,4SC AG,4sc_ag,,,,,, +421,0.98666298389434814,4fb64be1-7068-4347-b4e2-1452dd8cf46d,Rigshospitalet, Department of Anaesthesia,,,,91fae256-199c-4920-9cd2-0437b5db434d,rigshospitalet,Rigshospitalet +7751,,d18ef15f-c080-4dd4-a37d-45b53068b769,John F. Kennedy Institute,john_f_kennedy_institute,,,,,, +873,0.987212,356fb77d-2541-44d7-b831-9556b88820e3,Emotional Brain BV,emotional_brain_bv,,,,356fb77d-2541-44d7-b831-9556b88820e3,emotional_brain_bv,Emotional Brain BV +190,0.985423,b06dc366-da0a-4b59-9973-9cb31751ecbe,Prima BioMed,prima_biomed,rigshospitalet_department_of_anaesthesia,,,1f75a770-d643-44ba-b10f-91da8b571eaa,prima_biomed_ltd,Prima BioMed Ltd +7752,,ac293448-f146-458e-82dd-c713b0d38e4d,IATEC B.V,iatec_b_v,,,,,, +325,0.9875873327255249,199a1dd6-828f-4e0b-b783-d712bad32b9e,Ferrer Internacional,ferrer_internacional,,,,199a1dd6-828f-4e0b-b783-d712bad32b9e,ferrer_internacional,Ferrer Internacional +7753,,1705da07-6b38-4579-8653-f200b6c3b474,"St Raphael's Hospice, Surrey",st_raphael_s_hospice_surrey,,,,,, +641,0.98154276609420776,574b90d0-3e5f-45c1-862c-9770d5cf9ad6,Boehringer Ingelheim Denmark,boehringer_ingelheim_denmark,,,,82029ede-b089-4dbb-93ae-f48a58277a9c,boehringer_ingelheim_denmark_a_s,Boehringer Ingelheim Denmark A/S +189,0.989095,9bfb7a20-2bce-4c76-8f13-53216dbb6f59,Grupo Español de Tumores Huérfanos e Infrecuentes (GETHI),grupo_espa_ol_de_tumores_hu_rfanos_e_infrecuentes_gethi,,,,9bfb7a20-2bce-4c76-8f13-53216dbb6f59,grupo_espa_ol_de_tumores_hu_rfanos_e_infrecuentes_gethi,Grupo Español de Tumores Huérfanos e Infrecuentes (GETHI) +832,0.987803,d6016430-a125-43f7-aa43-2a6bedb2af9e,Medical Centre Haaglanden (MCH),medical_centre_haaglanden_mch,,,,31a12f1b-6a3e-46d8-aa62-861a42167d92,medical_centre_haaglanden,Medical Centre Haaglanden +7754,,d5cea18e-0394-4f1e-bfa6-f1f2d88442b5,Novartis Pharma Arzneimittel GmbH,novartis_pharma_arzneimittel_gmbh,,,,,, +7755,,b0ada048-9cde-4bc3-bf7d-dc37162a8a44,George Washington University Biostatistics Center,george_washington_university_biostatistics_center,,,,,, +7756,,09e0d90a-7142-11e6-a0cd-0242ac12000b,DR REDDYS LABS LTD,dr_reddys_labs_ltd,,,,,, +7757,,7a95c1b3-a5da-4ff8-adb6-d8e01ca6c39e,Justus-Liebig-University Giessen,justus_liebig_university_giessen,,,,,, +7758,,c7a57ddc-7157-11e6-a0cd-0242ac12000b,ALPHAPHARM,alphapharm,,,,,, +7759,,ed85ec10-7b68-4063-93ee-367e4172a8fe,"The Clinical Research Centre, RCSI Education and Research Centre",the_clinical_research_centre_rcsi_education_and_research_centre,,,,,, +7760,,18d7cfc7-aeda-4b65-879e-459e9825fa26,Schering Nordiska AB,schering_nordiska_ab,,,,,, +7761,,632925d8-69ec-419d-9c3e-9fcb9232d7aa,"Karolinska Institute, CLINTEC, div of orthopedics",karolinska_institute_clintec_div_of_orthopedics,,,,,, +732,0.96950775384902954,27eaea93-f151-4561-89c0-307b7907bf86,Bristol-Myers Squibb SL,bristol_myers_squibb_sl,,,,23bc27b4-07ca-4d74-9d53-97dbe811474f,bristol_myers_squibb_s_a,Bristol-Myers Squibb S.A +7762,,6d364f6e-719f-11e6-a0cd-0242ac12000b,MEDTECH PRODUCTS,medtech_products,,,,,, +7763,,88511a9c-2b8d-4d49-9ff2-87f3514d4d3a,Daiichi Sankyo Pharma GmbH,daiichi_sankyo_pharma_gmbh,,,,,, +7764,,b1735e58-ff47-45ff-a09c-e3a8a0570822,KRANKENHAUS SALEM DER EVANG. STADTMISSION HEIDELBERG GGMBH,krankenhaus_salem_der_evang_stadtmission_heidelberg_ggmbh,,,,,, +7765,,db47bee3-6674-4115-beb1-e03f8ccdbef2,Prof. Per Soelberg Sørensen,prof_per_soelberg_s_rensen,,,,,, +7766,,d6ef67aa-c847-414b-aaad-e69410f2ad7b,Sucampo AG,sucampo_ag,,,,,, +7767,,35a7010a-4c88-4367-a5b2-584e3fb10cea,Universitair Medisch Centrum Utrecht,universitair_medisch_centrum_utrecht,,,,,, +7768,,3f729048-e477-4261-9b53-c3a6622616fd,Seksjon for odontologisk farmakologi og farmakoterapi. UiO,seksjon_for_odontologisk_farmakologi_og_farmakoterapi_uio,,,,,, +7769,,3dd3ff3a-6fa3-11e6-9663-0242ac12000b,OSPEDALI CIVILI DI LIONE,ospedali_civili_di_lione,,,,,, +791,0.972677,fd9a44f2-46d8-4616-977e-bcc532a0ffe3,Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_ram_n_y_cajal,,,,4cca3114-a70f-4d6b-a08d-fae9d4599f44,fundaci_n_para_la_investigaci_n_biom_dica_hospital_universitario_ram_n_y_cajal,Fundación para la Investigación Biomédica Hospital Universitario Ramón y Cajal +7770,,74065f69-a061-4d11-a19d-8c5374c68464,ASSOCIAZIONE QOL-ONE,associazione_qol_one,,,,,, +7771,,f85a1198-a465-421d-800b-46772dd057f2,Hospital Universitario Virgen del Rocío,hospital_universitario_virgen_del_roc_o,,,,,, +385,0.984184,d8772306-7141-11e6-a0cd-0242ac12000b,VERSAPHARM,versapharm,,,,53a89408-7145-11e6-a0cd-0242ac12000b,versapharm_inc,VERSAPHARM INC +7772,,b659fbcc-0c71-4610-9bc8-e5741646a4a6,Oxford Brookes University,oxford_brookes_university,,,,,, +7773,,ffad50b0-6427-4964-9e2c-438ac78e9d0c,Joint Sponsor: University of Glasgow with NHS Greater Glasgow and Clyde,joint_sponsor_university_of_glasgow_with_nhs_greater_glasgow_and_clyde,,,,,, +7774,,056f3bbb-f0ce-4933-bcbe-2a5416cb6ad3,OPOCRIN S.P.A,opocrin_s_p_a,,,,,, +7775,,722bb747-5576-46ad-920f-667527f938da,"Fold RX Pharmaceuticals, a Pfizer Company",fold_rx_pharmaceuticals_a_pfizer_company,,,,,, +7776,,b750b22c-15c4-4fd9-a6ee-52e7afa48f4a,Hellenic Cooperative Oncology Group (HeCOG),hellenic_cooperative_oncology_group_hecog,,,,,, +7777,,6f769841-c39f-49f1-b400-06e1cb6887e9,Mundipharma GmbH,mundipharma_gmbh,,,,,, +7778,,1a8c66e3-c078-489b-b7af-fd8a753075ec,Università di Napoli Federico II,universit_di_napoli_federico_ii,,,,,, +7779,,1c394218-27d2-41ea-a19c-7d0ed2c26a0a,"ALMIRALL, S.A",almirall_s_a,,,,,, +7780,,b675eb50-8bba-11e6-a449-0242ac12000b,NeuroDerm Ltd,neuroderm_ltd,,,,,, +428,0.984324,915ffa95-5612-45a3-a8e6-e65a34a38fda,Ghent University Hospital,ghent_university_hospital,,,,02faf8af-e6fd-4c07-aca4-71ef06427271,ghent_university,Ghent University +7781,,cb8d048a-5fa6-45c0-bb18-4c88b32c29fd,"EMD Pharmaceuticals, Inc. (an affiliate of Merck KGaA, Darmstadt, Germany)",emd_pharmaceuticals_inc_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,,, +7782,,1cdf0d0e-0db2-4951-8425-da62ae653eff,LIDDS AB,lidds_ab,,,,,, +7783,,3725f524-7162-11e6-a0cd-0242ac12000b,CENT PHARMS,cent_pharms,,,,,, +7784,,7ad28516-0e5a-415d-a1a2-6090b093010f,hVIVO Services Limited,hvivo_services_limited,,,,,, +7785,,245af2e7-8842-4ede-9856-a03212e2f815,Pfizer S.L.U,pfizer_s_l_u,,,,,, +7786,,21739d1d-323f-41bf-a8c4-ce7d958f18fc,Stallergenes S.A,stallergenes_s_a,,,,,, +7787,,870aaaee-727a-11e6-a0cd-0242ac12000b,SWEDISH ORPHAN,swedish_orphan,,,,,, +422,0.98334300518035889,bc908184-86f2-4e04-bfba-5f69c27a2578,Dr. Enrique,dr_enrique,,,,ac7fb87c-0de4-401d-a07b-881b2d29e8ea,dr_enrique_alday,Dr. Enrique Alday +7788,,a0f7a972-93b5-4441-9635-a92a5502fb6b,BKH Schwaz,bkh_schwaz,,,,,, +7789,,0ab1bf44-8bc7-11e6-a449-0242ac12000b,"Sunovion, Inc",sunovion_inc,,,,,, +7790,,bc871c36-3d37-452c-8d7e-a6d2f0487787,Scottish National Blood Transfusion Service,scottish_national_blood_transfusion_service,,,,,, +7791,,f7cdf245-b11e-4c21-8fde-6456f02be9ce,Fondazione Toscana Gabriele Monasterio,fondazione_toscana_gabriele_monasterio,,,,,, +480,0.98699730634689331,fadc08cd-85d4-4372-9e5f-0a148e771ffc,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Endokrinologie",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_abteilung_f_r_endokrinologie,,,,f1926de7-bf3f-4138-90ce-fdceca00d91c,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin" +7792,,8f50cb49-1d13-43f2-8758-6951547453a9,"Shire Regenerative Medicine, Inc",shire_regenerative_medicine_inc,,,,,, +335,0.9851,63ca855a-0f57-4a87-972b-5334fae84ddf,"Fakultní nemocnice Ostrava,Czech Republic",fakultn_nemocnice_ostrava_czech_republic,,,,63ca855a-0f57-4a87-972b-5334fae84ddf,fakultn_nemocnice_ostrava_czech_republic,"Fakultní nemocnice Ostrava,Czech Republic" +7793,,4207c9d6-8bc5-11e6-a449-0242ac12000b,Afdeling for Traumatisk Hjerneskade,afdeling_for_traumatisk_hjerneskade,,,,,, +7794,,bd38c994-d6d9-41ce-9ef6-3393268aab87,"Medizinische Universität Wien,Univ.Klinik f.Hals-, Nasen- und Ohrenkrankheiten",medizinische_universit_t_wien_univ_klinik_f_hals_nasen_und_ohrenkrankheiten,,,,,, +7795,,96cb6dab-6206-4394-9b51-55888b85bd28,INSPIRATION BIOPHARMACEUTICALS,inspiration_biopharmaceuticals,,,,,, +671,0.954126,ed8fc75c-be7a-46e8-8e18-0428756f0822,NILG,nilg,,,,4623aa22-c038-4229-9e84-b303554a2292,nilg_northern_italy_leukemia_group,NILG (Northern Italy Leukemia Group) +7796,,71ca9f42-6fbc-11e6-abe8-0242ac12000b,Amicus Therapeutics,amicus_therapeutics,,,,,, +7797,,af4e0dc2-db07-4f08-9349-53a0ecc13f08,Neurocure Ltd,neurocure_ltd,,,,,, +1017,0.98381006717681885,1384eb1a-56c8-46c7-8312-5abfd0b11a99,Southampton University,southampton_university,,,,986ad2cd-cb4e-460c-acdc-a2b32a61de09,southampton_university_hospitals,Southampton University Hospitals +7798,,59257191-17f8-42ad-9f7f-829bb6a90522,AZIENDA OSPEDALIERA BIANCHI-MELACRINO-MORELLI,azienda_ospedaliera_bianchi_melacrino_morelli,,,,,, +7799,,923be742-7208-11e6-a0cd-0242ac12000b,DENCO ASSET,denco_asset,,,,,, +7800,,5ae8a78d-6b15-4cbc-be77-2ab219c14444,"Durata Therapeutics, Inc",durata_therapeutics_inc,,,,,, +7801,,4ece15f8-4aec-4f37-a3de-103fc4a636da,Mª Angeles Aguirre Zamorano,m_angeles_aguirre_zamorano,,,,,, +7802,,9559be98-7795-4a89-99c5-91e471ca09c8,University of Cincinnati - Academic Medical Center -Department of Neurology,university_of_cincinnati_academic_medical_center_department_of_neurology,,,,,, +7803,,f7ff8d03-6131-4224-a5a4-8766f372be94,Univ.-Prof. Dr. Oliver Findl Med. Univ. Wien,univ_prof_dr_oliver_findl_med_univ_wien,,,,,, +7804,,baad9084-72cd-11e6-a0cd-0242ac12000b,DORC,dorc,,,,,, +7805,,1f89d16f-a739-11e6-94cb-5656d04fc2b5,"Dept. of Anaesthesiology, Odense University Hospital",dept_of_anaesthesiology_odense_university_hospital,,,,,, +7806,,25903f0e-80d4-426f-bad4-653735936a58,UNICANCER,unicancer,,,,,, +7807,,1b2392d1-ec1e-4b35-8aa1-a17e48fba664,"sanofi-aventis, S.A",sanofi_aventis_s_a,,,,,, +7808,,96fbef7a-e55d-47ef-a41e-3410fc28e672,Rijksinstituut voor Volksgezondheid en Milieu (RIVM),rijksinstituut_voor_volksgezondheid_en_milieu_rivm,,,,,, +7809,,b5493599-bc09-4b90-824f-35bc4541a9a4,Sanofi- aventis R&D,sanofi_aventis_r_d,,,,,, +7810,,0c6f6642-7146-11e6-a0cd-0242ac12000b,ANI PHARMS,ani_pharms,,,,,, +7811,,a9d78cdc-71b6-11e6-a0cd-0242ac12000b,ETHITEK,ethitek,,,,,, +7812,,1dee3749-1c11-4555-89fe-30f49adf4621,"Nippon Suisan Kaisha, Ltd",nippon_suisan_kaisha_ltd,,,,,, +7813,,ff4ce94e-3109-4510-8c6e-0855f9bc8134,ASSOCIAZIONE ITALIANA PER LO STUDIO DEL DOLORE,associazione_italiana_per_lo_studio_del_dolore,,,,,, +7814,,b176c306-7182-11e6-a0cd-0242ac12000b,GLAXO GRP LTD,glaxo_grp_ltd,,,,,, +7815,,bb9691d1-28d7-4a98-873c-034f62eeb600,Vienna Medical University,vienna_medical_university,,,,,, +7816,,7a4a721b-13fd-479c-8534-5fbaae294229,"Dr. Harald Dobnig, Medizinische Univ. Klinik Graz, Abteilung für Endokrinologie und Nuklearmedizin",dr_harald_dobnig_medizinische_univ_klinik_graz_abteilung_f_r_endokrinologie_und_nuklearmedizin,,,,,, +7817,,082a3f40-715e-11e6-a0cd-0242ac12000b,GLENMARK PHARMS,glenmark_pharms,,,,,, +7818,,7c968d69-a2f7-428b-9013-e48cf277d31e,Chemische Fabrik Kreussler & Co. GmbH,chemische_fabrik_kreussler_co_gmbh,,,,,, +7819,,4516848c-efc1-472d-8167-472e823ea249,Elpen Pharmaceutical Co. Inc,elpen_pharmaceutical_co_inc,,,,,, +7820,,56d65603-0b4b-4fa1-a8c1-c4d344b9df1a,SELARL du Dr Jacques BUVAT,selarl_du_dr_jacques_buvat,,,,,, +7821,,3120d65a-c4b7-4a63-8e2d-7f152b9567c7,Bertek Pharmaceuticals International Limited,bertek_pharmaceuticals_international_limited,,,,,, +7822,,db0523c5-648f-4d07-8ed5-9df65688d4d0,Cephalon UK Limited,cephalon_uk_limited,,,,,, +404,0.984546,62857e4f-02c4-4cab-a18c-61d5a5016eb1,Technical University of Dresden,technical_university_of_dresden,,,,26d3b205-826f-444a-a5e3-2e552a9d8a82,technical_university_of_dresden_faculty_of_medicine,"Technical University of Dresden, faculty of medicine" +7823,,4a60c3fb-2dbc-4a4c-b106-6e5486fc0a51,AZIENDA SANITARIA DELL'ALTO ADIGE - COMPRENSORIO SANITARIO DI BOLZANO,azienda_sanitaria_dell_alto_adige_comprensorio_sanitario_di_bolzano,,,,,, +7824,,4fb6c558-4cd8-435b-9d31-cc7321eb541f,Hammersmith Hospital NHS Trust,hammersmith_hospital_nhs_trust,,,,,, +7825,,fdcc4bb1-9d40-4c54-9a28-dcbf48b0d91a,Actelion Pharamceuticals Ltd,actelion_pharamceuticals_ltd,,,,,, +736,0.98533761501312256,c4f731d6-66f7-4e9e-a7d7-8a55b3936fdf,European Organization for the Research and Treatment of Cancer (EORTC),european_organization_for_the_research_and_treatment_of_cancer_eortc,,,,86b7934b-bd40-4e41-90e2-f2b10e4f66c8,european_organization_for_the_research_and_treatment_of_cancer_eortc,European Organization for the Research and Treatment of Cancer (EORTC) +7826,,322260e4-a04f-406f-8c48-3f4ee0cdb42b,Oncopeptides AB,oncopeptides_ab,,,,,, +1002,0.96150079369544983,8fbc1a40-90b3-491d-9c96-f5d311f67e2e,Fundación para Formación e Investigación Sanitaria,fundaci_n_para_formaci_n_e_investigaci_n_sanitaria,,,,8fbc1a40-90b3-491d-9c96-f5d311f67e2e,fundaci_n_para_la_formaci_n_e_investigaci_n_sanitaria,Fundación para la Formación e Investigación Sanitaria +7827,,b39867f6-dac0-4d6a-b80f-8953e2682acf,Anestesi och Operationskliniken,anestesi_och_operationskliniken,,,,,, +7828,,47daabac-5939-4922-9184-efa52c381db1,Matti Ristola,matti_ristola,,,,,, +559,0.98696577548980713,2e6f13f4-76f0-47d8-9579-a808aa6aa2eb,Department of Clinical Pharmacology,department_of_clinical_pharmacology,,,,e78543a1-45be-413e-ae9a-522fb25ea6da,department_of_clinical_pharmacology,Department of Clinical Pharmacology +870,0.98716828227043152,483064d3-f8fd-47e0-a0a2-b17b8d5df7d6,Astellas Pharma Europe,astellas_pharma_europe,,,,483064d3-f8fd-47e0-a0a2-b17b8d5df7d6,astellas_pharma_europe_bv,Astellas Pharma Europe BV +7829,,2cb513d6-f157-45f9-82bf-03f19ba766ca,Psykiatrien i Region Syddanmark,psykiatrien_i_region_syddanmark,,,,,, +549,0.989229,4932b407-af0a-4966-9a44-59fa9ac09e80,Fédération Francophone de Cancérologie Digestive (FFCD),f_d_ration_francophone_de_canc_rologie_digestive_ffcd,,,,4932b407-af0a-4966-9a44-59fa9ac09e80,f_d_ration_francophone_de_canc_rologie_digestive_ffcd,Fédération Francophone de Cancérologie Digestive (FFCD) +7830,,4013fe82-7dca-40f0-b1a8-81ee4b0b43f3,not applicable,not_applicable,,,,,, +7831,,15b33825-2d2d-419f-b43b-dc2ecf15cd6b,GWT-TUD GmbH,gwt_tud_gmbh,,,,,, +7832,,658da72c-7162-11e6-a0cd-0242ac12000b,SUPERPHARM,superpharm,,,,,, +7833,,00364980-7147-11e6-a0cd-0242ac12000b,AMNEAL PHARMS LLC,amneal_pharms_llc,,,,,, +7834,,c314e776-9264-4349-bcb9-c00c91b51dd2,"MUW-Medical University of Vienna,Medizinische Universität Wien",muw_medical_university_of_vienna_medizinische_universit_t_wien,,,,,, +7835,,c2be6cd9-df4c-4018-8fbd-2ad58e183432,"Takeda Global Research & Development Centre (Europe) Limited,",takeda_global_research_development_centre_europe_limited,,,,,, +7836,,382a6dc5-0d89-4add-a86a-3f320c9289fd,MOLTENI,molteni,,,,,, +7837,,9173ddf2-f0b1-4237-9d97-47813c0ecfcf,University of Utah,university_of_utah,,,,,, +7838,,3a1c5526-43c0-43eb-96d2-5027f55150a2,OSPEDALE MAGGIORE DI MILANO (IRCCS),ospedale_maggiore_di_milano_irccs,,,,,, +7839,,5fa402ca-532c-45fa-9e76-4dfa50b35005,"GZA vzw, GZA Ziekenhuizen, Sint-Augustinus",gza_vzw_gza_ziekenhuizen_sint_augustinus,,,,,, +172,0.9528670608997345,1a03f05f-1e23-469f-adc4-6156f3bc81aa,"Merck Serono International, a branch of Laboratories Serono S.A",merck_serono_international_a_branch_of_laboratories_serono_s_a,,,,4d103db0-46f8-458b-804a-442a7728fad2,merck_serono_international_a_branch_of_laboratoires_serono_sa_an_affiliate_of_merck_kgaa,"Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA" +7840,,a0fd899e-663c-404c-ae95-b5beaf0cdbbe,Institut de Cancérologie de la Loire,institut_de_canc_rologie_de_la_loire,,,,,, +7841,,20a72e40-6412-4dfd-9c4b-1f6ed7d5c5ca,VIROPHARMA INCORPORATED,viropharma_incorporated,,,,,, +7842,,4cf4add8-a52b-4704-83b6-a1ef5efc3513,PKH-Pharmazeutische Kontroll- und Herstellungslabor GmbH,pkh_pharmazeutische_kontroll_und_herstellungslabor_gmbh,,,,,, +7843,,d2412746-0c04-49bb-865a-69f898f04381,"Skånes Onkologiska Klinik, Skåne University Hospital, Lund",sk_nes_onkologiska_klinik_sk_ne_university_hospital_lund,,,,,, +7844,,f6b295f6-4bdc-4a00-91a5-6e320feb6004,CENTRE PAUL PAPIN - IRCAM,centre_paul_papin_ircam,,,,,, +109,0.952012,f4efa697-04df-43fa-bbb7-94a3353fb313,"GlaxoSmithKline Consumer Healthcare GmbH & Co KG, 77815 Bühl",glaxosmithkline_consumer_healthcare_gmbh_co_kg_77815_b_hl,,,,8a1dc0a1-759d-435f-ad3b-c75c8ce910d4,glaxosmithkline_consumer_healthcare_gmbh_co_kg,GlaxoSmithKline Consumer Healthcare GmbH & Co. KG +923,0.907369,279a25e7-5963-4a57-b4bf-fcd9fd2d1ea3,Pharmacyclics Inc,pharmacyclics_inc,,,,263da2fa-df57-4577-a618-d84b06ad1594,pharmacyclics_incorporated,"Pharmacyclics, Incorporated" +7845,,8dc8bc99-f283-40cd-a296-198b73bc4d74,AZIENDA OSPEDALIERA S. MARIA DI TERNI,azienda_ospedaliera_s_maria_di_terni,,,,,, +7846,,53ac1b64-a9b6-4d42-b96e-c5e493f90e51,Cliniques Universitaires Saint Luc - UCL,cliniques_universitaires_saint_luc_ucl,,,,,, +7847,,9c9dbbb0-6f8d-4074-9b76-2a85dd0e437a,Centocor B.V,centocor_b_v,,,,,, +7848,,4894a4eb-694b-4a88-8531-ecbf620ff668,"SOD Medicina e Cardiologia Geriatrica, Centro per lo Studio della Sincope - Università degli Studi di Firenze-AOUCareggi",sod_medicina_e_cardiologia_geriatrica_centro_per_lo_studio_della_sincope_universit_degli_studi_di_firenze_aoucareggi,,,,,, +7849,,0956e7c9-a335-4e3d-9246-b092e2799c8d,AUO,auo,,,,,, +853,0.983941,802313d9-1b0d-4889-acd7-6878108beebc,Malmö University Hospital,malm_university_hospital,,,,802313d9-1b0d-4889-acd7-6878108beebc,malm_university_hospital,Malmö University Hospital +7850,,6605ce7b-fb8c-4fb4-9057-a0baca3fb9a7,Merck Sharp & Dohme (China) Ltd,merck_sharp_dohme_china_ltd,,,,,, +536,0.978219,e4b045a7-4870-4b15-ac72-389f39b6c812,Institut Jules Bordet - Université Libre de Bruxelles,institut_jules_bordet_universit_libre_de_bruxelles,,,,9921c788-bec5-470a-b081-facbdc704f78,institut_jules_bordet,Institut Jules Bordet +7851,,e87a9b98-91f0-4f28-b929-b2f260befd19,Tayside Academic Sciences Centre,tayside_academic_sciences_centre,,,,,, +7852,,8580e020-401b-4fb7-a7af-cc8f103744dd,CECOG (Central European Cooperative Oncology Group),cecog_central_european_cooperative_oncology_group,,,,,, +46,0.972279,286d0033-04c6-4cd9-8601-edb31d1bee9f,Alloksys Life Sciences BV,alloksys_life_sciences_bv,,,,286d0033-04c6-4cd9-8601-edb31d1bee9f,alloksys_life_sciences_bv,Alloksys Life Sciences BV +7853,,c0fecb30-714f-11e6-a0cd-0242ac12000b,LANDELA PHARM,landela_pharm,,,,,, +7854,,036e56af-cfca-4b5f-8898-44118ed5b337,Netherlands Heart Foundation,netherlands_heart_foundation,,,,,, +7855,,72ed1a8d-8418-411f-a197-be336f583de7,Glaxo Group Ltd,glaxo_group_ltd,,,,,, +7856,,8e72b417-a727-11e6-94cb-5656d04fc2b5,National Institute of Diabetes and Digestive and Kidney Diseases,national_institute_of_diabetes_and_digestive_and_kidney_diseases,,,,,, +7857,,8002ea67-a233-45ee-ac48-850ce7585639,Dr. Héctor Escobar Morreale,dr_h_ctor_escobar_morreale,,,,,, +7858,,d95843f4-22bd-471d-bf0e-5e8f52a0173c,"National Poisons Information Center, University Medical Center Utrecht",national_poisons_information_center_university_medical_center_utrecht,,,,,, +7859,,2ad54ddc-bc8c-4fd5-8f46-ff621d117f55,RER Saint Denis,rer_saint_denis,,,,,, +7860,,0951b668-f77a-455d-a80e-0d04e31cedf2,Institut Universitari de Neurorehabiltació Guttmann,institut_universitari_de_neurorehabiltaci_guttmann,,,,,, +7861,,c89d0e90-adc2-43fc-9479-5b10f95f52a5,Antti Aho,antti_aho,,,,,, +7862,,f85060e8-4846-4ec1-8708-a26b48ade634,ALIZYME,alizyme,,,,,, +7863,,9cff5f0a-bf19-4f05-b2b7-07071d828d8e,"Hi-Tech Pharmacal Co., Inc",hi_tech_pharmacal_co_inc,,,,,, +668,0.984093,d69e9c95-b978-4053-bb60-175d8d004951,BioPartners,biopartners,,,,93043c3a-9344-4423-9114-20048877dc2b,biopartners_gmbh,BioPartners GmbH +7864,,f50cefd1-5d6c-45ec-9cb0-4db80d773928,Aradigm Corporation,aradigm_corporation,,,,,, +7865,,dac168d2-d4ec-4305-84d9-d841453ff1fa,"Department of Woman and Child health, Karolinska University Hospital",department_of_woman_and_child_health_karolinska_university_hospital,,,,,, +7866,,b43ce4bb-78e2-4908-a33b-57a1134f4ac7,THERABEL LUCIEN PHARMA,therabel_lucien_pharma,,,,,, +7867,,2cfce64b-a610-4a68-a8e0-26abf21ce32a,THE IMMUNE RESPONSE CORPORATION,the_immune_response_corporation,,,,,, +7868,,bd62d937-ec4f-4695-910f-35451e921f36,Asklepios Kliniken Hamburg GmbH,asklepios_kliniken_hamburg_gmbh,,,,,, +581,0.94542974233627319,8ad98169-689d-44f5-943d-55c909d71e4d,Wyeth Parmaceuticals Inc,wyeth_parmaceuticals_inc,,,,8ad98169-689d-44f5-943d-55c909d71e4d,wyeth_parmaceuticals_inc,Wyeth Parmaceuticals Inc +7869,,be0f942d-540e-490f-8209-87ec4cd2b065,"Anthera Pharmaceuticals, Inc",anthera_pharmaceuticals_inc,,,,,, +7870,,e9667179-e77d-4842-a39e-d41530e2791c,Fundacion Progreso y Salud,fundacion_progreso_y_salud,,,,,, +7871,,877765ea-7198-11e6-a0cd-0242ac12000b,GEMINI LABS LLC,gemini_labs_llc,,,,,, +7872,,7fb87334-73f1-11e6-a0cd-0242ac12000b,MATHESON TRI-GAS INC,matheson_tri_gas_inc,,,,,, +7873,,a59fadfc-c429-452b-93cd-a432301f7dc9,CIMT group,cimt_group,,,,,, +137,0.964969,0e091d56-1af6-42d9-8d7c-b1eab6a90b8a,University Hospitals of Birmingham NHS Foundation Trust,university_hospitals_of_birmingham_nhs_foundation_trust,,,,0e091d56-1af6-42d9-8d7c-b1eab6a90b8a,university_hospitals_of_birmingham_nhs_foundation_trust,University Hospitals of Birmingham NHS Foundation Trust +7874,,74c9aa4d-f2c2-4b3b-b2fe-bff74b6bd654,Takeda Europe R&D Centre Limited,takeda_europe_r_d_centre_limited,,,,,, +7875,,a5fe7bdd-c37c-4308-b7bf-2ce120778577,Bispebjerg University Hospital,bispebjerg_university_hospital,,,,,, +7876,,97b5d70a-7154-11e6-a0cd-0242ac12000b,ROCKWELL MEDCL,rockwell_medcl,,,,,, +909,0.985676,575af654-7159-11e6-a0cd-0242ac12000b,OSMOTICA PHARM,osmotica_pharm,,,,575af654-7159-11e6-a0cd-0242ac12000b,osmotica_pharm,OSMOTICA PHARM +437,0.99035966396331787,8f1c3548-7a20-4796-a59b-3b727921d4f1,"Pfizer Inc. 235 East 42nd Street, New York, 10017 US",pfizer_inc_235_east_42nd_street_new_york_10017_us,,,,8f1c3548-7a20-4796-a59b-3b727921d4f1,pfizer_inc_235_east_42nd_street_new_york_10017_us,"Pfizer Inc. 235 East 42nd Street, New York, 10017 US" +367,0.96779388189315796,cdd72c71-e722-4511-8609-a9ef7b4d05b3,Bayer HealthCare AS,bayer_healthcare_as,,,,e8216e75-b447-4252-bb49-7b895bcf4108,bayer_healthcare,Bayer HealthCare +7877,,93458d57-7a99-4149-9fb5-09977d16c461,Swindon and Marlborough NHS Foundation Trust,swindon_and_marlborough_nhs_foundation_trust,,,,,, +7878,,d12a899e-50e3-49c3-b041-c0c7ed9856e2,NOVARTIS PHARMA SAS,novartis_pharma_sas,,,,,, +952,0.98418444395065308,d73a7512-715d-11e6-a0cd-0242ac12000b,MYLAN LABS,mylan_labs,,,,037d47ba-7142-11e6-a0cd-0242ac12000b,mylan_labs_ltd,MYLAN LABS LTD +7879,,c9adea3e-72e6-11e6-a0cd-0242ac12000b,MIDATECH PHARMA US,midatech_pharma_us,,,,,, +7880,,437498d7-8b01-4fe1-973b-353e55ac75eb,QLT Inc,qlt_inc,,,,,, +7881,,5c4bb461-35db-467a-8cd3-9ac6bc4a8b31,"Univ.Clinic of Internal Medicine II, Department of Cardiology, Medical University of Vienna, Austria",univ_clinic_of_internal_medicine_ii_department_of_cardiology_medical_university_of_vienna_austria,,,,,, +7882,,e688c31b-ae39-484a-b69f-637e48b656b8,ADIENNE SA,adienne_sa,,,,,, +7883,,c9e666dc-0c73-4c62-9345-c1a04cadc6e8,CVie Therapeutics Company Limited,cvie_therapeutics_company_limited,,,,,, +7884,,77c0b784-60ac-48bc-9d75-e2844fce6cdf,ISPPCC - CHU Chrarleroi - Hôpital Civil Marie Curie - Clinique du Sein,isppcc_chu_chrarleroi_h_pital_civil_marie_curie_clinique_du_sein,,,,,, +7885,,3a6a0823-d1c6-410d-9355-6c9fbacd230e,"UAB ""Roche Lietuva",uab_roche_lietuva,,,,,, +7886,,119351df-7506-4974-9e25-2fde58cce5a0,UNIVERSITà DEGLI STUDI MILANO BICOCCA,universit_degli_studi_milano_bicocca,,,,,, +353,0.983343,33018013-878a-4dd3-b923-de7bc09fb504,Institut de Recherche Pierre Fabre,institut_de_recherche_pierre_fabre,,,,33018013-878a-4dd3-b923-de7bc09fb504,institut_de_recherche_pierre_fabre,Institut de Recherche Pierre Fabre +7887,,42065272-7167-11e6-a0cd-0242ac12000b,UIHC PET IMAGING,uihc_pet_imaging,,,,,, +7888,,e9416ff6-7160-11e6-a0cd-0242ac12000b,HORIZON PHARMA,horizon_pharma,,,,,, +431,0.984484,14c37603-26cd-4e70-aef6-639320d368b6,Central Manchester and Manchester Children's University Hospital NHS Trust,central_manchester_and_manchester_children_s_university_hospital_nhs_trust,,,,14c37603-26cd-4e70-aef6-639320d368b6,central_manchester_and_manchester_children_s_university_hospital_nhs_trust,Central Manchester and Manchester Children's University Hospital NHS Trust +7889,,19462914-7155-11e6-a0cd-0242ac12000b,ACELLA PHARMS LLC,acella_pharms_llc,,,,,, +7890,,a5497b54-716a-11e6-a0cd-0242ac12000b,CYTOGEN,cytogen,,,,,, +7891,,ae0b9627-31dd-4a0a-a5b8-27a7be432c00,ONCONOVA THERAPEUTICS,onconova_therapeutics,,,,,, +7892,,1210ea21-aeaa-4896-868b-0da3219ce4f0,"KRKA Magyarország Kft., Budapest",krka_magyarorsz_g_kft_budapest,,,,,, +7893,,5b64b7c7-034c-4b6e-bc23-8e47b6a5dffb,Dept of Renal medicine,dept_of_renal_medicine,,,,,, +7894,,f53b3cba-19f7-45bd-84ee-45010c89591d,Andreas Kjær,andreas_kj_r,,,,,, +7895,,43f82a4d-d713-4d36-8192-c2ceff90b083,FRANCISCO JOSE MORALES PONCE,francisco_jose_morales_ponce,,,,,, +7896,,1f997454-45ca-4971-93c2-4796c1f4f141,West-ward Pharmaceutical Corporation,west_ward_pharmaceutical_corporation,,,,,, +7897,,d98c5759-5037-412d-a4b1-7a477c1c316c,Oncoscience AG,oncoscience_ag,,,,,, +7898,,98cdaee6-d954-4d30-a817-477398877718,EleosInc Limited,eleosinc_limited,,,,,, +7899,,82f04873-639c-4507-9dfc-9608550b0e18,Reata UK Limited,reata_uk_limited,,,,,, +7900,,02620d83-7bf1-4ec4-ac2e-65c5edcd5fb1,Chirurgische Gemeinschaftspraxis Südstadt,chirurgische_gemeinschaftspraxis_s_dstadt,,,,,, +7901,,a7874498-715e-11e6-a0cd-0242ac12000b,HALOCARBON,halocarbon,,,,,, +7902,,063b1a84-82bd-4302-bbf8-6ef27a0b85bb,University of Ottawa Heart Institute,university_of_ottawa_heart_institute,,,,,, +7903,,23f6950a-5554-47f1-8541-e06575fc65d8,"Med. Uni. Wien, UK für Neurologie",med_uni_wien_uk_f_r_neurologie,,,,,, +854,0.92247,14aef904-0883-4517-a200-b52214e41d54,"Faculty For Medicine, Otto-von-Guericke University Magdeburg",faculty_for_medicine_otto_von_guericke_university_magdeburg,,,,14aef904-0883-4517-a200-b52214e41d54,faculty_for_medicine_otto_von_guericke_university_magdeburg,"Faculty For Medicine, Otto-von-Guericke University Magdeburg" +579,0.98861104249954224,2087c696-3203-4dfa-967f-2d9749dedb6f,"Wyeth Pharmaceuticals Inc., acting through its division of Wyeth Research, a Pfizer company",wyeth_pharmaceuticals_inc_acting_through_its_division_of_wyeth_research_a_pfizer_company,,,,2087c696-3203-4dfa-967f-2d9749dedb6f,wyeth_pharmaceuticals_inc_acting_through_its_division_of_wyeth_research_a_pfizer_company,"Wyeth Pharmaceuticals Inc., acting through its division of Wyeth Research, a Pfizer company" +7904,,3a379778-c49d-449d-999e-7b4ba1a56095,AB2 Bio Ltd,ab2_bio_ltd,,,,,, +7905,,b0f40772-92f8-48db-b562-61542481fa56,Intercytex Limited,intercytex_limited,,,,,, +7906,,eebea9ba-fcad-40e5-84f6-ca31168c4afb,Grupo Español de Sindromes Mielodisplásicos (GESMD),grupo_espa_ol_de_sindromes_mielodispl_sicos_gesmd,,,,,, +530,0.961626,72fda02d-b614-4eda-a1b0-e9c6c71f8251,Erasmus University Medical Center,erasmus_university_medical_center,,,,72fda02d-b614-4eda-a1b0-e9c6c71f8251,erasmus_university_medical_center,Erasmus University Medical Center +7907,,37288259-4c7e-470e-a768-5e956fa277a1,EBMT Central Office,ebmt_central_office,,,,,, +7908,,3b945b96-8819-11e6-a998-0242ac12000b,North west London Hospital Trust,north_west_london_hospital_trust,,,,,, +7909,,7a1cccc6-7168-11e6-a0cd-0242ac12000b,AILEX PHARMS PVT LTD,ailex_pharms_pvt_ltd,,,,,, +7910,,e466eef2-8bb9-11e6-a449-0242ac12000b,Shield TX (UK) Ltd,shield_tx_uk_ltd,,,,,, +7911,,6b92ef6e-98ac-49a7-a2cb-9d986df4cb2b,The Princess Alexandra Hospital NHS Trust,the_princess_alexandra_hospital_nhs_trust,,,,,, +7912,,f775d081-cc4f-4cfd-a743-5c167e30bbc7,South Tees Hospitals NHS Foundation Trust,south_tees_hospitals_nhs_foundation_trust,,,,,, +7913,,16fbd275-0bcc-4321-871e-7c8edba244e1,COGENTUS PHARMACEUTICALS INTERNATIONAL LIMITED,cogentus_pharmaceuticals_international_limited,,,,,, +7914,,c72e3c11-d2fa-45b6-b2e2-e99d11609885,Society (institute) for clinical research,society_institute_for_clinical_research,,,,,, +7915,,722152ad-b4ca-4c63-81ab-cd86b8bab46b,LABORATORIES THEA,laboratories_thea,,,,,, +571,0.977622,8a1a7572-7142-11e6-a0cd-0242ac12000b,FOUGERA,fougera,,,,8a1a7572-7142-11e6-a0cd-0242ac12000b,fougera,FOUGERA +86,0.95734971761703491,8f7e4684-4a31-4266-aef0-963a6a62bb6b,"AMC, Amsterdam",amc_amsterdam,,,,7b7c4eb7-0b01-479a-b331-98f2d90174df,amc,AMC +89,0.984864,e65240e4-715c-11e6-a0cd-0242ac12000b,MATRIX LABS LTD,matrix_labs_ltd,,,,246b37c8-715d-11e6-a0cd-0242ac12000b,matrix_labs,MATRIX LABS +643,0.96428561210632324,2c7c42cf-b819-48d8-a9cb-2b2a871ffa6d,Boehringer Ingelheim Norway KS,boehringer_ingelheim_norway_ks,,,,1a23c45f-2c11-4e5d-a222-082def03ebc8,boehringer_ingelheim_noway_ks,Boehringer Ingelheim Noway KS +7916,,61e15d3f-c1c2-479c-bb5c-acdee3da1cb1,Cubist Pharmaceuticals,cubist_pharmaceuticals,,,,,, +7917,,0107c681-04b8-439e-978a-fef304886e31,AMARIN NEUROSCIENCE LTD,amarin_neuroscience_ltd,,,,,, +7918,,06bc1f6a-8cbb-4888-9df7-f371342bde83,Vakcina Kft,vakcina_kft,,,,,, +7919,,80d6f6da-5502-49e6-8225-2e2cab455b97,LABORATOIRE AVENTIS,laboratoire_aventis,,,,,, +7920,,ad3a0acf-b370-4a3f-90e9-40bdd8632087,Hospital of Goethe-Universitiy,hospital_of_goethe_universitiy,,,,,, +7921,,42587571-741a-4e64-b485-4deee66c414c,AZIENDA OSPEDALIERA SENESE,azienda_ospedaliera_senese,,,,,, +695,0.987167,193a42c8-a09d-4028-9be8-16ebcda41920,Abbott Laboratories GmbH,abbott_laboratories_gmbh,,,,193a42c8-a09d-4028-9be8-16ebcda41920,abbott_laboratories_gmbh,Abbott Laboratories GmbH +7922,,59e58f2d-a948-4192-856e-bb7442f09f9a,"Oncologisch Centrum, Academisch Ziekenhuis Vrije Universiteit Brussel",oncologisch_centrum_academisch_ziekenhuis_vrije_universiteit_brussel,,,,,, +7923,,22e19773-2f14-4f61-a4c5-7d20f613d4d3,"University of Pécs, Medical School, Department of Ophthalmology",university_of_p_cs_medical_school_department_of_ophthalmology,,,,,, +120,0.97839492559432983,5fe8d145-19e5-463d-a2e8-3da1f78f0002,Rheinische Friedrich-Wilhelms-Universität Bonn,rheinische_friedrich_wilhelms_universit_t_bonn,,,,0b9eb68a-ecbc-4706-a3c1-e52c658684d3,rheinische_friedrichs_wilhelms_universit_t_bonn,Rheinische Friedrichs-Wilhelms-Universität Bonn +7924,,087c42aa-c2c9-4cc0-8796-bb82fe1d3122,"BG-Kliniken Bergmannsheil, Dept. of Pain Management",bg_kliniken_bergmannsheil_dept_of_pain_management,,,,,, +7925,,328b5dc4-7167-11e6-a0cd-0242ac12000b,3D IMAGING DRUG,3d_imaging_drug,,,,,, +7926,,ec8681df-2e1e-4a83-a1ad-b0e38c34ce4d,Slidgigtinstituttet A/S,slidgigtinstituttet_a_s,,,,,, +452,0.97584396600723267,d1efdd69-467e-4581-827e-d1f912280c3e,Novartis Farmaceútica S.A,novartis_farmace_tica_s_a,,,,7dc31ed2-c888-4a81-8a21-860b006cc000,novartis_farmaceutica_s_a,Novartis Farmaceutica S.A +7927,,f3a8c9bc-25fe-4564-831e-7b9696883276,ACO-ASSO,aco_asso,,,,,, +7928,,aeaf3bdd-998f-4d2b-ba93-57576f1c73b8,Novexel S. A,novexel_s_a,,,,,, +7929,,38e464c8-7161-11e6-a0cd-0242ac12000b,SUMMERS,summers,,,,,, +7930,,5105136a-1583-4894-aab8-4daaf3f25ce4,TACL,tacl,,,,,, +7931,,8cb5fc96-bcb1-4b2c-a0b7-8bf086db8c34,Belgian Gynaecological Oncolgy Group,belgian_gynaecological_oncolgy_group,,,,,, +7932,,95d17c51-6ffd-4e9b-982f-47acf272092d,HOSPITAL SAN PEDRO,hospital_san_pedro,,,,,, +152,0.97483,88ecc254-b9db-4f96-8ef3-b7e21d00b20d,Novartis Farmacéutica SA,novartis_farmac_utica_sa,,,,88ecc254-b9db-4f96-8ef3-b7e21d00b20d,novartis_farmac_utica_sa,Novartis Farmacéutica SA +7933,,f598a493-062d-4924-a13f-c71d9d0b4277,"Aalborg Psychiatric Hospital, Centre for Skizophrenia",aalborg_psychiatric_hospital_centre_for_skizophrenia,,,,,, +960,0.988812,9e4d3fbc-0e9a-4bef-af84-596f0765706f,AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I,azienda_universitaria_policlinico_umberto_i,,,,9e4d3fbc-0e9a-4bef-af84-596f0765706f,azienda_universitaria_policlinico_umberto_i,AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I +7934,,fffc0ea7-c06f-456b-8d98-4faf99745081,NAICONS Srl,naicons_srl,,,,,, +7935,,366941f3-2ed3-4d5d-badb-5c9593f151c5,Ineos Healthcare Ltd,ineos_healthcare_ltd,,,,,, +7936,,e93bfc7d-f2fe-408d-858b-c66465398bb4,"Academical Medical Center, University of Amsterdam",academical_medical_center_university_of_amsterdam,,,,,, +593,0.9775586724281311,3969045a-4ef0-424f-8964-e4403b2aa66b,"Medical University Innsbruck, Dpt. Internal Medicine, Div. Internal Medicine",medical_university_innsbruck_dpt_internal_medicine_div_internal_medicine,,,,3969045a-4ef0-424f-8964-e4403b2aa66b,medical_university_innsbruck_dpt_internal_medicine_div_internal_medicine,"Medical University Innsbruck, Dpt. Internal Medicine, Div. Internal Medicine" +7937,,a72bb318-0d07-44e9-a9f3-03fb47db413c,Bayer HelathCare AG,bayer_helathcare_ag,,,,,, +7938,,9d98a754-18b6-45c4-9cf5-5626b3fe1093,Euro Nippon Kayaku GmbH,euro_nippon_kayaku_gmbh,,,,,, +140,0.985075,11f4634e-719e-11e6-a0cd-0242ac12000b,MERIDIAN MEDCL TECHN,meridian_medcl_techn,,,,11f4634e-719e-11e6-a0cd-0242ac12000b,meridian_medcl_techn,MERIDIAN MEDCL TECHN +7939,,cc9a4820-7d14-4ff2-a6d7-be27096f9de6,"Transave, Inc",transave_inc,,,,,, +7940,,7be22471-a6aa-4383-b6f7-383cb1bc9301,"Lund University, Clinical Coagulation Research Unit, Skane University Hospital",lund_university_clinical_coagulation_research_unit_skane_university_hospital,,,,,, +7941,,ebfb269c-8260-44f4-946f-002607cb6599,Dra. Almudena Zapatero Laborda,dra_almudena_zapatero_laborda,,,,,, +7942,,e49779b0-02f3-4f77-82cd-584392033b5d,"Karolinska University Hospital, Stockholms Läns Landsting",karolinska_university_hospital_stockholms_l_ns_landsting,,,,,, +7943,,ad292967-ca70-4794-a1aa-cde8228be911,Riitta Veijola,riitta_veijola,,,,,, +7944,,0491ec1b-9690-4c56-9c4a-2128cc78a624,"Göteborg University, Institute for Internal Medicine",g_teborg_university_institute_for_internal_medicine,,,,,, +7945,,47ce4cce-9a01-482c-9dca-4d3eab9747db,PepTcell Limited (trading as SEEK),peptcell_limited_trading_as_seek,,,,,, +7946,,420ac551-345e-498f-b241-41425f069d0e,Dr. Falk Pharma Portugal,dr_falk_pharma_portugal,,,,,, +7947,,9d2fb4a6-7afe-47c4-b5d8-b671e8ad6151,Northwestern University,northwestern_university,,,,,, +7948,,426b7b18-9933-4bab-9562-8dc112e9f5d2,University of Amsterdam,university_of_amsterdam,,,,,, +7949,,0c33e61d-254f-40a5-a5fe-d99f6e80b3dc,National Institute for Health and Welfare,national_institute_for_health_and_welfare,,,,,, +7950,,83303207-847c-4bf7-bb3c-476d139f86a5,Unita` Operativa di Endocrinologia e Malattie del Metabolismo,unita_operativa_di_endocrinologia_e_malattie_del_metabolismo,,,,,, +7951,,430c5ce8-c77c-46fe-a981-d58e85011c1e,Wilex AG,wilex_ag,,,,,, +7952,,d3b9d8f2-302f-4b6f-8cb5-d1d9f91c7268,"TIGENIX, S.A.U",tigenix_s_a_u,,,,,, +7953,,027cf44c-aeb2-403b-8fd6-4e7bf847eda5,Pfizer NV/SA,pfizer_nv_sa,,,,,, +7954,,1b46d324-040b-452a-a483-88ab49cd416f,SOUTHERN ITALY COOPERATIVE ONCOLOGY GROUP,southern_italy_cooperative_oncology_group,,,,,, +7955,,00a95f4f-cf11-4285-a41d-c689923eb7db,Mallinckrodt Inc,mallinckrodt_inc,,,,,, +7956,,9d1ba840-7164-11e6-a0cd-0242ac12000b,TWI PHARMS INC,twi_pharms_inc,,,,,, +7957,,44344d90-fb01-4f6b-a7f7-5875e18c9c2e,Janssen-Cilag Kft,janssen_cilag_kft,,,,,, +7958,,0a652b18-6cc3-476f-b393-b653f6d6a5b1,Centro Nacional de Investigaciones Cardiovasculares (CNIC),centro_nacional_de_investigaciones_cardiovasculares_cnic,,,,,, +876,0.90458685159683228,ebc2ce4d-831d-4b06-b3dc-d0e7578f7829,FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO INFANTIL NIÑO JESUS,fundacion_para_la_investigacion_biomedica_hospital_universitario_infantil_ni_o_jesus,,,,5cd5bf06-2291-4844-9da5-1660b3540deb,fundacion_para_la_investigacion_la_fe,FUNDACION PARA LA INVESTIGACION LA FE +7959,,c1029137-e63b-41cc-910f-0aff8bd6b6eb,"MSP Singapore Co., LLC c/o Merck & Co., Inc",msp_singapore_co_llc_c_o_merck_co_inc,,,,,, +227,0.979411780834198,bf1a9e59-98fa-461b-84a8-7740b1743049,"ALEXION PHARMACEUTICALS, INC",alexion_pharmaceuticals_inc,,,,bf1a9e59-98fa-461b-84a8-7740b1743049,alexion_pharmaceuticals_inc,"ALEXION PHARMACEUTICALS, INC" +757,0.984269,4fdd63b2-11be-4586-9f81-b4e4a2263768,The Netherlands Cancer Institute,the_netherlands_cancer_institute,,,,4fdd63b2-11be-4586-9f81-b4e4a2263768,the_netherlands_cancer_institute,The Netherlands Cancer Institute +7960,,58e50939-c688-4e69-b5cd-00b7b06a3dc1,CUB Hopital Erasme,cub_hopital_erasme,,,,,, +272,0.98568406701087952,1078e71c-7147-11e6-a0cd-0242ac12000b,LEK PHARMS,lek_pharms,,,,5ab1cb72-7148-11e6-a0cd-0242ac12000b,lek_pharms,LEK PHARMS +7961,,6ffa483e-71ba-11e6-a0cd-0242ac12000b,US ARMY WALTER REED,us_army_walter_reed,,,,,, +7962,,c2f7993c-bc03-4e5c-a05b-1c441edf2cb6,"Amarantus BioScience Holdings, Inc",amarantus_bioscience_holdings_inc,,,,,, +1012,0.94605967402458191,c06cb74b-1c77-4c28-9c14-a6b870a4012a,"Shire Human Genetic Therapies, Inc",shire_human_genetic_therapies_inc,,,,c06cb74b-1c77-4c28-9c14-a6b870a4012a,shire_human_genetic_therapies_inc,"Shire Human Genetic Therapies, Inc. (Shire HGT)" +7963,,bf2d90fd-1d07-48e2-8513-d931129a15fe,Service of Neurology CHU Liege,service_of_neurology_chu_liege,,,,,, +7964,,d7805dd3-9b5a-4694-9f98-d1477614973f,Institut fuer Frauengesundheit GmbH,institut_fuer_frauengesundheit_gmbh,,,,,, +7965,,e2363832-a1ac-4d83-8fc4-f8fea3d3fd88,University Medical Center of the University Ulm,university_medical_center_of_the_university_ulm,,,,,, +7966,,368962f0-4cf2-44af-9f3f-3fe0924f2ffc,Jens Hilligsø,jens_hilligs,,,,,, +287,0.982375,bcce1791-2699-42fa-b905-cdce25675fe5,"Department of Anesthesia, University College Hospital Galway",department_of_anesthesia_university_college_hospital_galway,,,,471980ba-fc4b-45dc-b7bc-7d5ed19764b7,department_of_anaesthesia_university_college_hospital_galway,"Department of Anaesthesia, University College Hospital Galway" +7967,,5ee22b98-c5ac-428a-b708-9ca5d1b147bd,Institute of Specific Prophylaxis and Tropical Medicine,institute_of_specific_prophylaxis_and_tropical_medicine,,,,,, +7968,,6ed5d8fc-72db-11e6-a0cd-0242ac12000b,OSI PHARMS,osi_pharms,,,,,, +7969,,16bb6874-d3f4-4e4c-897c-c4e6d5e22a4a,Mariefreds Vårdcentral,mariefreds_v_rdcentral,,,,,, +7970,,59eeb51b-dbd9-4cab-ad50-8f3aab8aaad5,"Hæmatologisk afdeling, Roskilde Sygehus, Region Sjælland",h_matologisk_afdeling_roskilde_sygehus_region_sj_lland,,,,,, +7971,,1bd730e6-f707-40a3-ad31-7b81d860582d,"The Finsen Center, Rigshospitalet",the_finsen_center_rigshospitalet,,,,,, +7972,,f1259efa-e4ac-4c5a-bc23-dbf1cef77fff,"Cook MyoSite, Incorporated",cook_myosite_incorporated,,,,,, +7973,,d439c954-7c15-4dbd-8260-23a5f61a5ef2,"WWCR, WORLDWIDE CLINICAL RESEARCH",wwcr_worldwide_clinical_research,,,,,, +7974,,4cecfddd-cf6d-47c3-93bb-c17ebd5868d2,BrepCo Biopharma Limited,brepco_biopharma_limited,,,,,, +7975,,79d963bc-1418-4ea8-a0fb-b5a0eb88c5ec,Jesper Ekelund,jesper_ekelund,,,,,, +990,0.988915,7729c4f5-04ed-489e-a85c-cd0279e1c490,INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP,international_extranodal_lymphoma_study_group,,,,7729c4f5-04ed-489e-a85c-cd0279e1c490,international_extranodal_lymphoma_study_group,INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP +7976,,9986b329-8b8b-432a-bcde-5813f013605c,Arvi Yli-Hankala,arvi_yli_hankala,,,,,, +821,0.979768,7867f7bd-a0b0-4018-a900-f845eb2b1fe1,Dipartimento di Pediatria,dipartimento_di_pediatria,,,,3655f927-01ad-48d8-9cb0-516379501a0a,dipartimento_di_pediatria_universit_federico_ii_di_napoli,Dipartimento di Pediatria Università Federico II di Napoli +7977,,3f65e381-85ee-4aaf-a30f-370c27eee360,University Hospitals of North Midlands NHS Trust,university_hospitals_of_north_midlands_nhs_trust,,,,,, +7978,,0bc3f403-68a8-42dc-b649-1798c7102201,Clinical Immunology Division,clinical_immunology_division,,,,,, +7979,,0e85b7ba-7164-11e6-a0cd-0242ac12000b,SAGENT AGILA,sagent_agila,,,,,, +7980,,cc829edb-87b1-4733-a081-33e52652b4c9,University of Munster,university_of_munster,,,,,, +476,0.971143,74cb9176-4514-4031-bd6c-a1010bfc799d,CMC Contrast AB c/o Öresund Health Care Management,cmc_contrast_ab_c_o_resund_health_care_management,,,,4543c7ec-daec-4a10-bab1-cd53aacf4083,cmc_contrast_ab,CMC Contrast AB +7981,,3aa84695-a77d-11e6-94cb-5656d04fc2b5,GRUNENTHAL PHARMA S.A,grunenthal_pharma_s_a,,,,,, +7982,,d3959563-b3ec-4168-aee3-5d543e9f1ff7,"Deutsches Herzzentrum Berlin, Kompetenznetz Angeborene Herzfehler",deutsches_herzzentrum_berlin_kompetenznetz_angeborene_herzfehler,,,,,, +565,0.984012,3bf7860d-fdab-4edb-a9b9-646110448c48,University Hospitals of Leicester,university_hospitals_of_leicester,,,,3bf7860d-fdab-4edb-a9b9-646110448c48,university_hospitals_of_leicester,University Hospitals of Leicester +7983,,2efe9e6e-6065-4fba-97df-c12e7112b722,"Department of Medicine, Helsinki University Central Hospital",department_of_medicine_helsinki_university_central_hospital,,,,,, +7984,,aede2ddc-27f0-4902-8f59-d2fcd2fc8858,UZ Leuven-Department of Urology,uz_leuven_department_of_urology,,,,,, +7985,,4dd7975a-8b17-4276-a5a5-bd1d903c983e,"Department of Medicine, Køge University Hospital",department_of_medicine_k_ge_university_hospital,,,,,, +7986,,ab7e7344-2bb3-453e-890b-091c06776e19,Ixodes AG,ixodes_ag,,,,,, +7987,,189f53e7-e9e0-4046-8010-62fc9246c28d,"Mech-Sense, Department og Gastroenterology, Aalborg Sygehus",mech_sense_department_og_gastroenterology_aalborg_sygehus,,,,,, +7988,,f5df40da-44c6-421b-a7b2-74b2e71adbf7,Roche Nederland B.V,roche_nederland_b_v,,,,,, +7989,,4a9eb251-d9a5-4c17-a513-10d999ca6ab3,"Merck Farma y Química, S.A",merck_farma_y_qu_mica_s_a,,,,,, +7990,,2f8deb91-8824-411f-8289-87ad0cf530c1,e.o. ospedali galliera,e_o_ospedali_galliera,,,,,, +180,0.98598232865333557,fb1d1a6a-714a-11e6-a0cd-0242ac12000b,VALEANT PHARMS,valeant_pharms,,,,0b232628-7206-11e6-a0cd-0242ac12000b,valeant_pharms,VALEANT PHARMS +7991,,6fd04c99-d466-435c-99b4-3433a27db93b,Meander Medical Center,meander_medical_center,,,,,, +164,0.982418,14e0f940-71b3-11e6-a0cd-0242ac12000b,BRAINTREE,braintree,,,,14e0f940-71b3-11e6-a0cd-0242ac12000b,braintree,BRAINTREE +7992,,21d6c4e1-c5b0-487f-83e8-81ca0e3bbc98,University of Aachen,university_of_aachen,,,,,, +7993,,1f2234da-9ee1-4af0-95c1-f7be8c6304f8,Ipsen Limited,ipsen_limited,,,,,, +7994,,cb6c2b08-b028-41c7-b8bf-d147329d4c44,TrialNet Study Group,trialnet_study_group,,,,,, +7995,,c0b7c7b2-f0b7-471f-bb92-ee89c70c8142,AstraZeneca UK Ltd,astrazeneca_uk_ltd,,,,,, +7996,,c320c745-22ea-4daa-a302-bec8b3b98185,Analgesic Solutions,analgesic_solutions,,,,,, +7997,,7d4aa635-c41c-4ac3-8d06-e854f001dbef,"Psicofundación. Fundación Española para Promoción, Desarrollo Científico y Profesional de la Psicología",psicofundaci_n_fundaci_n_espa_ola_para_promoci_n_desarrollo_cient_fico_y_profesional_de_la_psicolog_a,,,,,, +7998,,e8b8b063-7f43-44bb-ae09-4a72c7cad477,H:S Hvidovre hospital,h_s_hvidovre_hospital,,,,,, +680,0.981011,e24a3a25-72d3-4de4-a0e1-dc2bb2735906,"Clinical Research Centre, Hvidovre University Hospital",clinical_research_centre_hvidovre_university_hospital,,,,d5bad664-fff4-4066-a3d3-cc7450a05435,clinical_reasearch_centre_hvidovre_university_hospital,"Clinical Reasearch Centre, Hvidovre University Hospital" +368,0.95680119593938195,8f838202-6a6a-4558-a3e0-2ea69b69055e,"Bayer HealthCare AG, D51368 Leverkusen",bayer_healthcare_ag_d51368_leverkusen,,,,0f2245d6-1eb2-4a26-ba28-2ddd66aada58,bayer_healthcare_ag_51368_leverkusen,"Bayer HealthCare AG, 51368 Leverkusen" +857,0.96889449656009674,0213f530-437f-430a-b936-0bfa94166165,Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau ? IIB Sant Pau,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau_iib_sant_pau,,,,0213f530-437f-430a-b936-0bfa94166165,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau +7999,,034c8a0e-1049-4005-88ae-0d252e88f013,Luis F. Lopez-Cortes,luis_f_lopez_cortes,,,,,, +13,0.97626614570617676,b450df50-7144-11e6-a0cd-0242ac12000b,LUPIN,lupin,,,,24b88c8e-7145-11e6-a0cd-0242ac12000b,lupin_ltd,LUPIN LTD +8000,,a3f9910e-7222-11e6-a0cd-0242ac12000b,IPR,ipr,,,,,, +8001,,b53cb649-bc3d-4325-b0e0-9f5b738b8a18,"National Centre for Diabetes Care, 1st Dept. Medicine, Diabetes Unit",national_centre_for_diabetes_care_1st_dept_medicine_diabetes_unit,,,,,, +8002,,e962e23a-6672-42e4-bb00-e9b705cf1f53,Barts and The London NHS Trust,barts_and_the_london_nhs_trust,,,,,, +8003,,551bd8d8-ac86-42ec-abb6-8c99fd57aca2,Josep M Cruzado,josep_m_cruzado,,,,,, +8004,,53055dca-d120-42d4-83d2-7c3f7a76294e,IDENIX,idenix,,,,,, +8005,,594968e2-f214-4d61-943e-7dc3118c4d54,"Karolinska Institutet, Stockholm, Sweden",karolinska_institutet_stockholm_sweden,,,,,, +8006,,455fce42-b23a-4b1d-b7e0-56091f23ac55,"VU Cancer Centre, Afdeling Geneeskundige Oncologie",vu_cancer_centre_afdeling_geneeskundige_oncologie,,,,,, +961,0.93838614225387573,c96eb057-b329-44bb-8410-db9d73b6f265,Hull & East Yorkshire Hospitals NHS Trust,hull_east_yorkshire_hospitals_nhs_trust,,,,a6d6aa67-5161-45ca-a1eb-794cebec0129,hull_and_east_yorkshire_hospitals_nhs_trust,Hull and East Yorkshire Hospitals NHS Trust +8007,,c1dd21c7-d77c-4167-8455-33c8b97e3fd5,Università Campus Bio-Medico di Roma,universit_campus_bio_medico_di_roma,,,,,, +8008,,743fc2db-44fa-4462-81d3-0b87924d2d4c,Unidad de VIH - Servicio de Enfermedades Infecciosas. Hospital de Bellvitge,unidad_de_vih_servicio_de_enfermedades_infecciosas_hospital_de_bellvitge,,,,,, +8009,,1a8ec635-d178-4275-a4ce-449d79ecbebd,"ESBATech, an Alcon Biomedical Research Unit LLC",esbatech_an_alcon_biomedical_research_unit_llc,,,,,, +8010,,c78091a7-18e5-4ec5-8fd4-114cdad04142,STADA R&D GmbH,stada_r_d_gmbh,,,,,, +762,0.986968,b40b8bff-445b-40d0-b716-58ec8da28947,University Hospitals Bristol NHS Trust,university_hospitals_bristol_nhs_trust,,,,08e66865-5523-488a-993b-2c12d1335b43,university_hospitals_bristol,University Hospitals Bristol +8011,,19d0cbd6-31e2-4413-8048-2b8ca2e14333,Helix Product Development (Ireland) Limited,helix_product_development_ireland_limited,,,,,, +8012,,b200e418-26bd-481e-aa56-40399c8575fc,Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón (FIBHGUGM),fundaci_n_investigaci_n_biom_dica_hospital_general_universitario_gregorio_mara_n_fibhgugm,,,,,, +8013,,9128bdf0-5bb8-4759-994d-4d0bc71adf49,Pharming Group NV,pharming_group_nv,,,,,, +498,0.938435,db519804-312d-41a4-a5b3-77a63eadca69,"Central Institute for Mental Health, Mannheim, Div. of Gerontopsychiatry",central_institute_for_mental_health_mannheim_div_of_gerontopsychiatry,,,,2399538a-18b4-4f23-997c-ea2ceaf364fb,central_institute_of_mental_health,Central Institute of Mental Health +8014,,ea7a2bf1-7073-40ca-beeb-ad45be52ce0e,Abelardo Garcia De Lorenzo / Teresa Nuñez-Villaveiran,abelardo_garcia_de_lorenzo_teresa_nu_ez_villaveiran,,,,,, +8015,,29880300-6db7-4be8-b65a-57de11156402,Sergio Hernández Expósito,sergio_hern_ndez_exp_sito,,,,,, +8016,,c730349b-b85e-4963-a4b5-0108e6a3d671,Immutep S.A.S,immutep_s_a_s,,,,,, +8017,,c3e3f4bc-1857-45fc-bd0c-7f584bd94247,Jan van Breemen Research Institute Reade and VU University Medical Centre,jan_van_breemen_research_institute_reade_and_vu_university_medical_centre,,,,,, +8018,,d1898d66-09c8-45e5-a355-940e4703f0c1,Psychiatric Centre Prague,psychiatric_centre_prague,,,,,, +8019,,4bee39e4-e48c-4042-b2d3-b94129280a43,Merck SHARP & DOHME DE ESPAÑA,merck_sharp_dohme_de_espa_a,,,,,, +8020,,62039255-64e8-4637-bbf2-e3fee199144a,Galapagos SASU,galapagos_sasu,,,,,, +8021,,faccd45e-ff24-4986-a06e-673eba3957de,Blue Earth Diagnostics Limited,blue_earth_diagnostics_limited,,,,,, +8022,,41b4e192-b77b-43b1-a810-9e5bc066c668,Auris Medical Inc,auris_medical_inc,,,,,, +380,0.93727820449405241,aef7d176-dcac-4351-a4b4-f65719455058,"Merck Sharp & Dohme Corp., a subsidiary of Merck and Co., Inc",merck_sharp_dohme_corp_a_subsidiary_of_merck_and_co_inc,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" +8023,,b0fe5252-7148-11e6-a0cd-0242ac12000b,EGIS PHARMS,egis_pharms,,,,,, +8024,,6db92e78-2546-4b2c-bbe1-84733a5056ab,NeRRe Therapeutics Ltd,nerre_therapeutics_ltd,,,,,, +8025,,a68b0f64-880d-11e6-a998-0242ac12000b,Abbott Products GmbH,abbott_products_gmbh,,,,,, +8026,,34ae63ba-7155-11e6-a0cd-0242ac12000b,SUNSTAR AMERICAS,sunstar_americas,,,,,, +8027,,bcf1a945-e476-422e-8c09-6f8a2ff44f9b,"MedImmune Vaccines, Inc",medimmune_vaccines_inc,,,,,, +8028,,27871991-b636-4045-974e-1a68ba8195f2,"Global Medical Affairs, Wyeth Research Division of Wyeth Pharmaceuticals Inc",global_medical_affairs_wyeth_research_division_of_wyeth_pharmaceuticals_inc,,,,,, +8029,,1197ea0a-7168-11e6-a0cd-0242ac12000b,BELCHER PHARMS LLC,belcher_pharms_llc,,,,,, +8030,,59dde8db-af75-47d4-a358-cf64aaf4642e,Fredericia Hospital,fredericia_hospital,,,,,, +8031,,24d3b937-fb65-4836-ace4-0688958e2cb9,Italchimici S.p.A,italchimici_s_p_a,,,,,, +8032,,45f07ecc-2d2d-477d-8006-ae0e6a9e2426,AstraZeneca Pharmaceuticals,astrazeneca_pharmaceuticals,,,,,, +910,0.98453670740127563,32161af5-1f02-447e-a38b-e0f0858697d7,Laboratorios Servier,laboratorios_servier,,,,32161af5-1f02-447e-a38b-e0f0858697d7,laboratorios_servier,Laboratorios Servier +8033,,6514bc33-51f6-4780-94b5-cd4849d71160,Städt. Krankenhaus Martha Maria Halle,st_dt_krankenhaus_martha_maria_halle,,,,,, +8034,,c06c0a36-0dd4-4f43-ad6e-b470d02cbe41,Immune Targeting Systems Ltd,immune_targeting_systems_ltd,,,,,, +8035,,2e8f1f2b-8055-4585-abad-3ccefd85c6da,Chroma Therapeutics Ltd,chroma_therapeutics_ltd,,,,,, +8036,,a6a5f302-d01e-44ed-973f-1471bd02ad7f,Fundación GEL/TAMO,fundaci_n_gel_tamo,,,,,, +8037,,eff5f4c7-c492-48d7-b907-cbd2fdec32c7,BODE Chemie GmbH & Co,bode_chemie_gmbh_co,,,,,, +245,0.975108,e9520f86-effe-48d5-a86c-551805d7d9a5,Karyopharm,karyopharm,,,,8cc13716-154a-455e-8604-397805d40f97,karyopharm_therapeutic_inc,"Karyopharm Therapeutic, Inc" +8038,,ef13c3a9-47b2-4f1b-93a3-50dff9bf64c6,KuDOS Pharmaceuticals Ltd. (a member of the AstraZeneca group of companies),kudos_pharmaceuticals_ltd_a_member_of_the_astrazeneca_group_of_companies,,,,,, +8039,,f3b13cd4-5388-46e1-b083-1058a387b82b,"UZ leuven, Marc Van de Velde",uz_leuven_marc_van_de_velde,,,,,, +8040,,2824aef6-fd7d-469c-a839-d76ce8e01fd0,"Taiho Oncology, Inc",taiho_oncology_inc,,,,,, +600,0.95773337284723914,c2d5b3ef-db19-46ec-83fa-7c50bd0cde4f,Fundació Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau,fundaci_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,,,,6b4a9b2d-18ff-4441-b335-98517841d021,fundaci_n_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Fundació Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau +8041,,2b017737-cc66-4f03-8d79-06fb5a1a3a15,"Gastroenheden D, Herlev Hospital",gastroenheden_d_herlev_hospital,,,,,, +8042,,8ec78372-fce6-4fc2-8b0f-14d3da1a6fdc,Helsinki Central university Hospital,helsinki_central_university_hospital,,,,,, +8043,,1e74d95c-881c-11e6-a998-0242ac12000b,University Hospital of North Staffordshire NHS Trust,university_hospital_of_north_staffordshire_nhs_trust,,,,,, +555,0.98490422964096069,e694a29c-9d8b-4333-834c-7277ca164e4c,Greater Glasgow and Clyde NHS Board,greater_glasgow_and_clyde_nhs_board,,,,613c1a9b-76b3-42ee-8979-2c8d31737f57,greater_glasgow_and_clyde_nhs_board,Greater Glasgow and Clyde NHS Board +8044,,8433852c-4927-4c6a-a156-dce63bfd0815,Imperial Ciollege,imperial_ciollege,,,,,, +888,0.95901872430528912,7e4ebf20-f3d9-475d-92aa-b6bf058b58c1,"Schering-Plough Research Insititute, a division of Schering Corporation",schering_plough_research_insititute_a_division_of_schering_corporation,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" +678,0.9645330011844635,eb89e719-3467-4add-a609-e2963e7f52a0,AbbVie DeutschlandGmbH & Co. KG,abbvie_deutschlandgmbh_co_kg,,,,ddf3632f-3a35-464c-8cf1-c8b6486c323c,abbvie_deutschland_gmbh_co_kg,AbbVie Deutschland GmbH & Co. KG +8045,,84319d03-203c-4049-8eb2-e0aaaee8545e,University of Edinburgh & NHS Lothian ACCORD,university_of_edinburgh_nhs_lothian_accord,,,,,, +8046,,ce26a9f2-7160-11e6-a0cd-0242ac12000b,AMBIX,ambix,,,,,, +8047,,8b481272-eb5e-42ae-842f-44a8d7d94df8,Adenovir Pharma AB,adenovir_pharma_ab,,,,,, +8048,,a0010891-21d6-4544-bdff-52d7f793661f,"Medizinische Klinik I, St. Josef-Hospital, Ruhr-Universität Bochum",medizinische_klinik_i_st_josef_hospital_ruhr_universit_t_bochum,,,,,, +8049,,f6afb43e-d4b1-4841-8ed8-709ad581f8ab,Coretherapix S.L.U,coretherapix_s_l_u,,,,,, +8050,,f6b6e564-3133-4cd1-b0c2-a8016a10066a,Laboratorios Liconsa S.A,laboratorios_liconsa_s_a,,,,,, +8051,,8c0f553e-2336-4ef1-82df-baeaf0aa2c69,ADDS (Advanced Drug Development Services),adds_advanced_drug_development_services,,,,,, +8052,,1147992b-73e0-44cf-9b75-613f123016f3,"Department of Oncology, Aarhus University Hospital",department_of_oncology_aarhus_university_hospital,,,,,, +95,0.977549,c55f8d7a-feed-4d7b-b5b5-cc3940656ac3,Artu Biologicaks Europe B.V,artu_biologicaks_europe_b_v,,,,54a10183-297d-43b4-8cb3-8ad19beec3c5,artu_biologicals_europe_b_v,Artu Biologicals Europe B.V +8053,,0dfac7cc-1e33-495c-b93d-a0805aa44c97,Clinirx Tangent Research,clinirx_tangent_research,,,,,, +8054,,e3452766-fc3d-4e86-a141-acf02d7635ae,"Medical University Vienna, Department of Anesthesia, Intensive Care Medicine and Pain Management",medical_university_vienna_department_of_anesthesia_intensive_care_medicine_and_pain_management,,,,,, +8055,,e83b6d25-26ef-48c3-ab5e-f4200741bc57,"Department of Psychiatry, RWTH Aachen",department_of_psychiatry_rwth_aachen,,,,,, +8056,,358a4685-6ffa-45e0-a72e-434328441d70,"Civitas Therapeutics, Inc",civitas_therapeutics_inc,,,,,, +8057,,9af77dc2-4f1d-435c-a269-6f2f38912a0a,S.E. Carburos Metálicos S.A. grupo Air Products,s_e_carburos_met_licos_s_a_grupo_air_products,,,,,, +91,0.98681867122650146,773f50b2-9db9-4907-b659-e4a90dab71f6,Actelion Pharmaceuticals,actelion_pharmaceuticals,,,,773f50b2-9db9-4907-b659-e4a90dab71f6,actelion_pharmaceuticals,Actelion Pharmaceuticals +713,0.97731272876262665,d2f1d48d-c243-473b-9f47-208723250aa6,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA",wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,,,,d2f1d48d-c243-473b-9f47-208723250aa6,wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA" +8058,,55944477-a230-46a2-b315-a30bdb60af16,ao. Univ. Prof. Dr. Elisabeth Aberer,ao_univ_prof_dr_elisabeth_aberer,,,,,, +8059,,9c94630b-1e96-4c59-bea1-efe167a1f4eb,Pharmaxis Limited,pharmaxis_limited,,,,,, +8060,,4a5e2b50-6fbb-11e6-abe8-0242ac12000b,TAYS/teho-osasto,tays_teho_osasto,,,,,, +388,0.969459,cd01f34f-ac9c-4bef-9caf-25934261d983,"Uppsala University Hospital, Dept. of Medical Sciences",uppsala_university_hospital_dept_of_medical_sciences,,,,8b0575a1-8376-4915-a366-981ce5a80282,uppsala_university_hospital_dept_of_medical_scienses,"Uppsala University Hospital, Dept of Medical Scienses" +543,0.930137,71738680-41ff-4751-88bc-8c484e8e9bc7,"Abbott Laboratories Limited (Queenborough, Kent, ME11 5EL, England)",abbott_laboratories_limited_queenborough_kent_me11_5el_england,,,,71738680-41ff-4751-88bc-8c484e8e9bc7,abbott_laboratories_limited_queenborough_kent_me11_5el_england,"Abbott Laboratories Limited (Queenborough, Kent, ME11 5EL, England)" +8061,,dc860860-b8cf-4914-b19d-a216390e7a7a,"Academisch medisch centrum, department of psychiatry",academisch_medisch_centrum_department_of_psychiatry,,,,,, +8062,,bb4dd155-acb7-4e33-b6ac-7e7b46d76a5f,"Prof., dr. med. Anders Fink-Jensen",prof_dr_med_anders_fink_jensen,,,,,, +8063,,f5494e8b-f48b-456f-b8ad-9a0da1915f7a,ARCAGY-GINECO,arcagy_gineco,,,,,, +8064,,b38f4a74-baec-4d70-925d-48411122ca19,"Aalborg Psychiatric Hospital, Research Unit",aalborg_psychiatric_hospital_research_unit,,,,,, +8065,,7a74bb82-0eee-4fa9-8b51-ce2458b7c61e,AZIENDA U.L.S.S. N.8 DI ASOLO,azienda_u_l_s_s_n_8_di_asolo,,,,,, +8066,,c783b132-b299-4872-bd1f-6e8e14938814,Sanofi-Aventis Recherche &, De`veloppement,,,,,, +8067,,b22bf3d6-038f-42b9-a697-89dece278a2c,Servicio de Alergia. Hospital Civil. Málaga (Spain),servicio_de_alergia_hospital_civil_m_laga_spain,,,,,, +8068,,8dfad457-62d4-4e98-8f31-b77534636eee,"University Hospital Munich, Germany",university_hospital_munich_germany,,,,,, +90,0.988251,e7076194-8819-11e6-a998-0242ac12000b,Bio Products Laboratory Ltd,bio_products_laboratory_ltd,sanofi_aventis_recherche_amp_de_veloppement,,,51f2f135-0aa9-4e39-b934-2ebfce55549a,bio_products_laboratory,Bio Products Laboratory +887,0.9673493504524231,7eb1c700-1f39-4d6a-9037-72a5b89bb597,Schering-Plough Research Insitute,schering_plough_research_insitute,,,,44b33ab6-d74e-4fa5-aa8c-510964a3ac9f,schering_plough_research_institute,Schering-Plough Research Institute +8069,,f33840e9-ba24-4e61-8f86-0465450b5ddb,Merja Soilu Häninen,merja_soilu_h_ninen,,,,,, +8070,,58a631ba-672b-442d-983c-2aab66ebc86e,Abbott France,abbott_france,,,,,, +169,0.94997268915176392,93be1e6b-cdd4-4d0b-b858-d8a12aea4f88,"Merck Serono Int, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt, Germany",merck_serono_int_a_branch_of_laboratoires_serono_sa_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,3e1da10e-fb5d-4c01-94a2-f31c443bb1c2,merck_serono_int_a_branch_oflaboratories_serono_s_a_an_affiliate_of_merck_kgaa_darmstadt_germany,"Merck Serono Int, a branch ofLaboratories Serono S.A. an affiliate of Merck KGaA, Darmstadt, Germany" +8071,,33fbd8db-5a14-4116-b33f-1f650729dec6,Irina Elovaara,irina_elovaara,,,,,, +8072,,f48d2edf-df88-40f3-b6be-89e2a51bdd97,Kinderkrankenhaus AUF DER BULT,kinderkrankenhaus_auf_der_bult,,,,,, +8073,,76ce119a-0e1b-4301-8794-84ac999dde85,University College Hospital Galway,university_college_hospital_galway,,,,,, +8074,,32f14029-d2e7-4b3b-8e79-6951ae0e26ce,"Department of Medicine I, University Hospital St. Josef-Hospital, Ruhr University Bochum",department_of_medicine_i_university_hospital_st_josef_hospital_ruhr_university_bochum,,,,,, +356,0.903306,ada15e9f-a2ab-489f-bc3e-e972a93587fc,Fundación de Investigación Biomédica Hospital de Getafe,fundaci_n_de_investigaci_n_biom_dica_hospital_de_getafe,,,,ada15e9f-a2ab-489f-bc3e-e972a93587fc,fundaci_n_de_investigaci_n_biom_dica_hospital_de_getafe,Fundación de Investigación Biomédica Hospital de Getafe +8075,,a52d2f1c-62ea-46db-9433-c97eb006b970,liverpool university,liverpool_university,,,,,, +8076,,b131ea01-68d3-4a06-81bd-0a6968e5b02b,Whipps Cross University Hospital,whipps_cross_university_hospital,,,,,, +8077,,241e6576-278f-4ca3-988f-084f8263be4c,"Rigshospitalet, Ultrasound Clinic 4023",rigshospitalet_ultrasound_clinic_4023,,,,,, +26,0.981552,22b98606-c425-4c0d-b54c-92cc47d7492a,Johns Hopkins University,johns_hopkins_university,,,,166642d4-cecb-4060-8a23-a1a73c72bbae,johns_hopkins_university_department_of_neurology,"Johns Hopkins University, Department of Neurology" +8078,,85ce2a3b-2fb1-4a0b-be25-a9f1cb8c9c40,Wörwag Pharma GmbH & Co. KG,w_rwag_pharma_gmbh_co_kg,,,,,, +8079,,bf1280c4-7158-11e6-a0cd-0242ac12000b,IVAX PHARMS INC,ivax_pharms_inc,,,,,, +8080,,e1b6ca10-0c02-4eaa-b6b2-af8dd147d3e1,Zentralinstitut für Seelische Gesundheit Mannheim,zentralinstitut_f_r_seelische_gesundheit_mannheim,,,,,, +8081,,9d05bb04-8b0b-4905-8f4f-993aed735088,"Universitätsklinik für Neurologie, Medizinische Universität Wien",universit_tsklinik_f_r_neurologie_medizinische_universit_t_wien,,,,,, +8082,,3abe1d1d-236d-49a0-a65e-7cd9b45ad44a,GEDII - Grupo de Estudo da Doença inflamatória Intestinal,gedii_grupo_de_estudo_da_doen_a_inflamat_ria_intestinal,,,,,, +8083,,6c63c5f0-73f0-11e6-a0cd-0242ac12000b,DUPUY OXYGEN,dupuy_oxygen,,,,,, +8084,,7f9ae7df-d1c1-496b-b48f-336e1518f6fa,York Hospitals NHS Foundation Trust,york_hospitals_nhs_foundation_trust,,,,,, +1056,0.978876,354891c3-150d-4c84-ae8e-ab81e3128958,Hospital Clinico San Carlos,hospital_clinico_san_carlos,,,,269c3398-c5cb-4532-8146-3d371fd1fcef,hospital_clinico_san_carlos_unidad_de_investigacion_cardiovascular,"Hospital Clinico San Carlos, Unidad de Investigacion Cardiovascular" +8085,,bbed91cc-83e8-4f29-b4bb-98cd6c01b76c,KARAKTER universitair centrum voor kinder- en jeudpsychiatrie,karakter_universitair_centrum_voor_kinder_en_jeudpsychiatrie,,,,,, +978,0.97898,26bfe88e-7144-11e6-a0cd-0242ac12000b,SANDOZ INC,sandoz_inc,,,,01a7b83a-7129-11e6-a89e-0242ac12000b,sandoz,SANDOZ +8086,,a73cbefd-947e-40d8-84fb-d6ee8af103ad,Grupo para el Tratamiento de Tumores Digestivos,grupo_para_el_tratamiento_de_tumores_digestivos,,,,,, +8087,,0035ebc1-2d50-4d76-acb7-a04046263e03,MEDICE Arzneimittel GmbH & Co. KG,medice_arzneimittel_gmbh_co_kg,,,,,, +8088,,168ad3e2-cfea-461e-a13e-6715bf423246,Neurim Pharmaceuticals (1991) Ltd,neurim_pharmaceuticals_1991_ltd,,,,,, +8089,,87e40a7b-6474-4f08-b3f5-630470522471,Helperby Therapeutics Ltd,helperby_therapeutics_ltd,,,,,, +639,0.98296070098876953,803631d1-924e-4107-b01f-b8f5dd3e2c4d,Greater Glasgow Health Board,greater_glasgow_health_board,,,,c80f0f43-274e-40b5-9c79-e591ce33aa3a,greater_glasgow_health_board_university_of_glasgow,Greater Glasgow Health Board/University of Glasgow +8090,,f9b482f8-60a4-439e-84c5-12acdebe3f42,"Shionogi USA, Inc",shionogi_usa_inc,,,,,, +8091,,9b2fcaf1-69b1-4584-a611-5dcacadf7aae,P Pierre Dellamonica,p_pierre_dellamonica,,,,,, +8092,,6548d59e-0e32-4e1e-b3ee-232f513405e2,"Dermira, Inc",dermira_inc,,,,,, +8093,,b60a6ddb-642e-4254-bc14-1627019bd284,Conwy and Denbighshire NHS Trust,conwy_and_denbighshire_nhs_trust,,,,,, +8094,,bbd4516d-5b75-4fe7-b2db-0d34faf8a58e,Universtiy of Liverpool,universtiy_of_liverpool,,,,,, +8095,,d7fdacf1-c14d-4422-aa44-21f970e1b5e8,PledPharma AB,pledpharma_ab,,,,,, +8096,,b28cffd4-7203-435b-bf30-41a0a37b6a9d,ROXALL Medizin GmbH,roxall_medizin_gmbh,,,,,, +8097,,5aa74010-6fbf-11e6-abe8-0242ac12000b,Janssen-Cilag Taiwan,janssen_cilag_taiwan,,,,,, +8098,,4e674fdf-7d35-4f58-82e6-e7fa6316ebda,"Odense University Hospital, afd.M",odense_university_hospital_afd_m,,,,,, +8099,,93a4329e-8bbf-11e6-a449-0242ac12000b,"GGZ inGeest, parner VUmc",ggz_ingeest_parner_vumc,,,,,, +8100,,509c1455-20f2-405d-a2c3-1207b8e1a58e,"Klinische Abteilung für Thorax -u. Hyperbare Chirurgie, Medizinische Universität Graz",klinische_abteilung_f_r_thorax_u_hyperbare_chirurgie_medizinische_universit_t_graz,,,,,, +8101,,797feeac-41b1-4813-98bf-4159e2c03145,MDM S.p.A,mdm_s_p_a,,,,,, +8102,,9b6663c7-f29a-4ff8-be7a-64d45bcad097,Fondazione Michelangelo,fondazione_michelangelo,,,,,, +8103,,72a90c41-df8f-409e-b3b0-2362c1ff179c,Jørgen Agnholt,j_rgen_agnholt,,,,,, +8104,,4b8323fc-5419-482f-ad4d-79301ae9aa9c,Hoosier Oncology Group,hoosier_oncology_group,,,,,, +8105,,fcb8833a-3d56-49cb-a8e7-ca125a09e457,"BN ImmunoTherapeutics, Inc",bn_immunotherapeutics_inc,,,,,, +8106,,2a8fe231-e879-4300-ad7e-8136420032d9,Dipartimento di Pediatria Universita` di Napoli Federico II,dipartimento_di_pediatria_universita_di_napoli_federico_ii,,,,,, +84,0.960935,93bcfb98-7158-11e6-a0cd-0242ac12000b,ECR PHARMA,ecr_pharma,,,,93bcfb98-7158-11e6-a0cd-0242ac12000b,ecr_pharma,ECR PHARMA +139,0.949534,2d7c987c-7d3b-4780-9e58-be5dbcf9a582,AWD.pharma GmbH & Co. KG, Medical Development,,,,2b57b25f-7999-42a9-bc73-ba293507ad94,awd_pharma_gmbh_co_kg,AWD.pharma GmbH & Co KG +8107,,f26e6d76-7ecd-4e47-a27b-6e0eba7a953e,"Fundación Centro Nacional de Investigaciones Cardiovasculares, Carlos III (CNIC)",fundaci_n_centro_nacional_de_investigaciones_cardiovasculares_carlos_iii_cnic,,,,,, +27,0.982297,8f30be7a-db80-4d4f-b679-8ae4bed90a55,"Integrated Therapeutics Group, Inc",integrated_therapeutics_group_inc,,,,8f30be7a-db80-4d4f-b679-8ae4bed90a55,integrated_therapeutics_group_inc,"Integrated Therapeutics Group, Inc" +8108,,5a574e2f-792b-49d6-afa4-b38c8c6ab6ee,Rafael López López,rafael_l_pez_l_pez,awd_pharma_gmbh_co_kg_medical_development,,,,, +8109,,67416edd-218d-458b-bb74-1ab51680790e,Institute for clinical and experimental Medicine,institute_for_clinical_and_experimental_medicine,,,,,, +8110,,5d0466a7-1fcb-4da8-ac5a-95eb78110d50,Thor Petersen,thor_petersen,,,,,, +8111,,15f0d004-b82b-408c-8605-38a57352468d,Södertälje sjukhus AB,s_dert_lje_sjukhus_ab,,,,,, +8112,,4c88bf3f-dbde-4638-98ae-3290a4b20d1b,Agneta Blanck Olerup,agneta_blanck_olerup,,,,,, +8113,,4e75d4e3-daa8-4a88-81b0-a0ce230ccac8,Argenta Discovery Ltd,argenta_discovery_ltd,,,,,, +8114,,9243d369-76d9-41ca-bebe-90bbb711e02d,Juha Holopainen,juha_holopainen,,,,,, +8115,,b09ab99a-7166-11e6-a0cd-0242ac12000b,CSPC NBP PHARM CO,cspc_nbp_pharm_co,,,,,, +423,0.97237,0879f869-1102-4898-99d9-8197e98473d7,Universita di Firenze,universita_di_firenze,,,,0879f869-1102-4898-99d9-8197e98473d7,universita_di_firenze,Universita di Firenze +8116,,b760a326-9f08-4b8e-bac8-edee498264d4,Med. Fakultaet der Friedrich-Alexander Universitaet Erlangen-Nuernberg,med_fakultaet_der_friedrich_alexander_universitaet_erlangen_nuernberg,,,,,, +552,0.945615,d91ca243-2119-49b0-ad7b-9a6a5b939bb0,Grifols Biological Inc,grifols_biological_inc,,,,189b51d9-0d8d-4344-a7e0-4ad5e8c1742d,grifols_biologicals_inc,Grifols Biologicals Inc +142,0.985676,32a060d4-7167-11e6-a0cd-0242ac12000b,BRIGHAM WOMENS HOSP,brigham_womens_hosp,,,,32a060d4-7167-11e6-a0cd-0242ac12000b,brigham_womens_hosp,BRIGHAM WOMENS HOSP +8117,,fe445f2b-9f46-4552-b70f-d15b20a9c81f,Industial Farmacéutica Cantabria S. A,industial_farmac_utica_cantabria_s_a,,,,,, +8118,,3100d50e-ea68-4211-8cab-5122015681d0,Miquel Pujol Rojo (Infectious Diseases Service-Hospital Universitari de Bellvitge-IDIBELL),miquel_pujol_rojo_infectious_diseases_service_hospital_universitari_de_bellvitge_idibell,,,,,, +8119,,89f278d7-17db-400b-8af7-4a69fd941b4b,Bionor Pharma ASA,bionor_pharma_asa,,,,,, +753,0.987206,29241c8d-7ad8-4877-83dd-b4d1b01b5563,Sun Pharma Advanced Research Company,sun_pharma_advanced_research_company,,,,29241c8d-7ad8-4877-83dd-b4d1b01b5563,sun_pharma_advanced_research_company,Sun Pharma Advanced Research Company +8120,,aba727fa-eb97-41b0-9c9c-b38ea8a99dd0,FBCSG (Finish Breast Cancer Study Group),fbcsg_finish_breast_cancer_study_group,,,,,, +8121,,e8c88b1f-c403-4143-bd2e-9c6a4130b5a4,FONDAZIONE DELL'ISTITUTO TOSCANO TUMORI,fondazione_dell_istituto_toscano_tumori,,,,,, +303,0.991079,db0cf76f-03db-4f45-95e7-853b95e8ea9b,Universitätsklinikum Bonn, Klinik und Poliklinik für Psychiatrie und Psychotherapie,,,,7700ad0c-d303-4880-b341-66bdf8c7ad35,universit_tsklinikum_bonn,Universitätsklinikum Bonn +8122,,7e7b8838-8c0d-4265-a442-1b1209dd3124,Rikshospitalet-Radiumhospitalet HF,rikshospitalet_radiumhospitalet_hf,,,,,, +8123,,8a8e6b82-a174-4304-81b4-53295f284fe9,CHIESI,chiesi,,,,,, +8124,,e7f9e4b2-c905-48c2-ac6c-61e0364d3879,Hela Pharma AB,hela_pharma_ab,universit_tsklinikum_bonn_klinik_und_poliklinik_f_r_psychiatrie_und_psychotherapie,,,,, +8125,,ed5bb4ae-af16-4d87-97c7-f06d764acf4f,Klinikum der J. W. Goethe-Universität Frankfurt - Medizinische Klinik I,klinikum_der_j_w_goethe_universit_t_frankfurt_medizinische_klinik_i,,,,,, +8126,,c94837b2-a38e-4ab8-9fb4-a94daba67ce7,Bo Feldt-Rasmussen,bo_feldt_rasmussen,,,,,, +8127,,a21b3493-4b29-4b8d-8396-347bd8070d19,Fundación Española de Hematología y Hemoterapia,fundaci_n_espa_ola_de_hematolog_a_y_hemoterapia,,,,,, +8128,,386ef6ee-b336-45bf-ac11-6d6221155069,FONDAZIONE CENTRO EMOFILIA E TROMBOSI ANGELO BIANCHI BONOMI,fondazione_centro_emofilia_e_trombosi_angelo_bianchi_bonomi,,,,,, +8129,,505ca89c-289a-4ce1-a562-196a014465a2,Fachbereich Medizin der Johann Wolfgang Goethe-Universität Frankfurt/M,fachbereich_medizin_der_johann_wolfgang_goethe_universit_t_frankfurt_m,,,,,, +449,0.98227512836456299,17a7cd12-2e89-4b00-832e-bc19b8172771,ALLERGAN,allergan,,,,17a7cd12-2e89-4b00-832e-bc19b8172771,allergan,ALLERGAN +8130,,b0156f6a-da83-4c2a-b714-6f756a3f0363,"Department of Anaesthesia, Rotunda Hospital",department_of_anaesthesia_rotunda_hospital,,,,,, +8131,,edc9e01d-f0d2-4dc6-9a71-46ae75cd9e4d,Pediatric Brain Tumour Consortium,pediatric_brain_tumour_consortium,,,,,, +8132,,1a5fbebc-31a6-453f-b3b4-4567817660e5,SPEEDEL,speedel,,,,,, +672,0.975714,8bce5c4e-7129-11e6-a89e-0242ac12000b,PERRIGO,perrigo,,,,25ceb782-7164-11e6-a0cd-0242ac12000b,perrigo_uk_finco,PERRIGO UK FINCO +8133,,ae4fd598-7fae-4bd5-ad67-a6ebd6cf5a1a,"SONUS Pharmaceuticals, Inc",sonus_pharmaceuticals_inc,,,,,, +8134,,2dd1b16c-712a-11e6-a89e-0242ac12000b,FERNDALE LABS,ferndale_labs,,,,,, +8135,,aa64342a-5da0-4561-860d-8ecb5c5d22c1,"Ortopædkirurgisk Center, Aarhus Universitets Hospital",ortop_dkirurgisk_center_aarhus_universitets_hospital,,,,,, +8136,,8bfe2bc3-44e8-415f-91b6-dcac087a393b,"Portsmouth Institution Medicine, Health & Social Care, Portsmouth University",portsmouth_institution_medicine_health_social_care_portsmouth_university,,,,,, +938,0.977852,41fdac3b-97bb-4404-84a8-1a8ece5e5818,FUNDACIÓN ESPAÑOLA DE REUMATOLOGÍA (FER),fundaci_n_espa_ola_de_reumatolog_a_fer,,,,41fdac3b-97bb-4404-84a8-1a8ece5e5818,fundaci_n_espa_ola_de_reumatolog_a_fer,FUNDACIÓN ESPAÑOLA DE REUMATOLOGÍA (FER) +1052,0.94724655151367188,574a16cb-eb53-4e25-95a2-a07455968d04,"University of Oxford, Clinical Trials and Research Governance Office",university_of_oxford_clinical_trials_and_research_governance_office,,,,574a16cb-eb53-4e25-95a2-a07455968d04,university_of_oxford_clinical_trials_and_research_governance,"University of Oxford, Clinical Trials and Research Governance Office" +381,0.92556309700012207,7174f551-6d94-4606-8860-fb076b8e5e6c,Merck Sharp & Dohme OÜ,merck_sharp_dohme_o,,,,70a76c95-9bc5-4453-ace1-7d9c98a92a7d,merck_sharp_dohme_o,"Merck Sharp & Dohme Copr., a subsidary of Merck & Co" +8137,,0e134f00-c796-4547-9b94-e78c574b3bbf,CHU Brugmann,chu_brugmann,,,,,, +8138,,0c4f0fc6-e44d-4d84-a281-5f7c45fb6c9d,CHEMO France,chemo_france,,,,,, +8139,,25761af7-fc8d-43b1-bf44-f13a5f16cec5,"Rempex Pharmaceuticals, Inc",rempex_pharmaceuticals_inc,,,,,, +8140,,a5da24b0-bd70-420d-910d-d474c88f3551,Debreceni Egyetem Orvos- és Egészségtudományi Centrum Aneszteziológiai és Intenzív Terápiás Tanszék,debreceni_egyetem_orvos_s_eg_szs_gtudom_nyi_centrum_aneszteziol_giai_s_intenz_v_ter_pi_s_tansz_k,,,,,, +8141,,54b3d211-0ffe-4e38-a461-ea4d86230eb8,SIRTEX TECHNOLOGY PTY LTD,sirtex_technology_pty_ltd,,,,,, +188,0.9797365665435791,db7ce6e0-e7bc-4ef7-b1b7-2fc2a9ab53e0,Nycomed GmbH,nycomed_gmbh,,,,c698abc0-6f9b-11e6-9663-0242ac12000b,nycomed,Nycomed +8142,,a6ebef4f-cb45-406a-992d-ba06d1d20786,"Kirby Institute, University of New South Wa",kirby_institute_university_of_new_south_wa,,,,,, +593,0.9775586724281311,ade4c3f7-0083-447d-b98a-5069c718eea3,Medical University Innsbruck,medical_university_innsbruck,,,,3969045a-4ef0-424f-8964-e4403b2aa66b,medical_university_innsbruck_dpt_internal_medicine_div_internal_medicine,"Medical University Innsbruck, Dpt. Internal Medicine, Div. Internal Medicine" +8143,,0ff92817-655b-459e-b749-822a3058062f,AZ Sint Jan Brugge-Oostende AV,az_sint_jan_brugge_oostende_av,,,,,, +8144,,48b9c7c0-8132-4c1f-97a0-688bc901482b,Alcon Hungarian ltd,alcon_hungarian_ltd,,,,,, +8145,,4e86f381-85a4-45ac-9ce9-463b49082c81,BRAINSGATE LTD,brainsgate_ltd,,,,,, +8146,,ebd4ded4-bbc0-47c5-a70e-87965619de17,FIDEC - Fighting Infectious Diseases in Emerging Countries,fidec_fighting_infectious_diseases_in_emerging_countries,,,,,, +8147,,2af97a8b-5ab8-42d0-9c59-425cd16cdec0,EUTHERAPIE / Les Laboratoires Servier,eutherapie_les_laboratoires_servier,,,,,, +8148,,8f294b34-3c7b-462a-920f-447f949309ca,OrthoCell Pty Ltd,orthocell_pty_ltd,,,,,, +8149,,b0ea9dd4-6f9f-11e6-9663-0242ac12000b,Vascular Biogenics Ltd,vascular_biogenics_ltd,,,,,, +8150,,c2c2ea52-adef-4660-826a-eac3abf2ce65,INSMED INCORPORATED,insmed_incorporated,,,,,, +8151,,44dba20e-efc7-414d-a267-4043d8abae94,Mainz University Hospital,mainz_university_hospital,,,,,, +1077,0.97536885738372803,47d92db0-1d1d-4219-8229-7d6a540644ca,IBSA Institut Biochimique SA,ibsa_institut_biochimique_sa,,,,3fdba14d-9b0e-469d-bb19-93144e9882fd,ibsa_institut_biochimique_s_a,IBSA Institut Biochimique S.A +8152,,e34398de-72d9-11e6-a0cd-0242ac12000b,SUNOVION,sunovion,,,,,, +352,0.98674958944320679,d66cb26c-4426-4af8-950e-822ec255408a,Deutsches Herzzentrum Berlin,deutsches_herzzentrum_berlin,,,,3c65321f-86b5-4caf-b891-98518f69b348,deutsches_herzzentrum,Deutsches Herzzentrum +8153,,34ff6da2-9cac-4f0e-ba9a-0d613d9c7251,Biovitrum AB,biovitrum_ab,,,,,, +8154,,ef9ce225-0e1a-4b44-8387-067931b3a72e,ABIOGEN PHARMA,abiogen_pharma,,,,,, +8155,,7e707d25-b363-490e-9ddd-d64e1836d578,AbbVie Deutschland GmbH & Co. KGKG,abbvie_deutschland_gmbh_co_kgkg,,,,,, +8156,,3f6320c6-a8a7-47c7-b4b4-91e5a56cdf52,Mario Negri Gynecologic Oncology Group,mario_negri_gynecologic_oncology_group,,,,,, +8157,,276d558c-13e4-48ec-b4fa-40411a8fb633,BiondVax Pharmaceuticals ltd,biondvax_pharmaceuticals_ltd,,,,,, +8158,,7f02e1a8-715e-11e6-a0cd-0242ac12000b,C AND M PHARMA,c_and_m_pharma,,,,,, +8159,,c0a996de-c807-4e95-9ff1-d1042f960b84,InSpira Medical AB,inspira_medical_ab,,,,,, +22,0.97528120875358582,22838b79-924f-4f31-9ea0-9ca648f7ad49,"University Hospital Heidelberg, Ruprechts-Karl-University Heidelberg",university_hospital_heidelberg_ruprechts_karl_university_heidelberg,,,,ae6ad20a-a5ac-4fda-adad-69b8ff220a6a,university_hospital_heidelberg,University Hospital Heidelberg +385,0.984184,53a89408-7145-11e6-a0cd-0242ac12000b,VERSAPHARM INC,versapharm_inc,,,,53a89408-7145-11e6-a0cd-0242ac12000b,versapharm_inc,VERSAPHARM INC +240,0.987416,f0fe5d48-71e3-11e6-a0cd-0242ac12000b,MEDIMMUNE ONCOLOGY,medimmune_oncology,,,,61f718c1-8bf2-4352-81a1-859abc44901a,medimmune_oncology_inc,MEDIMMUNE ONCOLOGY INC +8160,,38325d34-f9ff-4b94-934b-45626b00e552,Fundación Renal Jaume Arnó,fundaci_n_renal_jaume_arn,,,,,, +8161,,729f9f47-8b8a-4c71-890a-140dd156ccff,CHU TOURS,chu_tours,,,,,, +8162,,9508256b-67ce-4981-a9a9-f39f6af259c9,"Mental Health Service, Esbjerg",mental_health_service_esbjerg,,,,,, +8163,,b683acc4-7ee7-4528-9494-ad13253a208e,Atrium MC Parkstad,atrium_mc_parkstad,,,,,, +8164,,5ad265f1-2211-4663-9ca9-5efb5808e374,OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALISATION INC,otsuka_pharmaceutical_development_and_commercialisation_inc,,,,,, +8165,,2a00dc5f-02fe-48e4-bf3a-52bb34f0a72d,"Research and Development Directorate, University Hospitals of Leicester NMS Trust",research_and_development_directorate_university_hospitals_of_leicester_nms_trust,,,,,, +8166,,1302918c-446a-40ee-8a33-22690fe3a909,TARGID,targid,,,,,, +8167,,ec4725be-107f-4e26-a07c-07353dfb899f,Chelsea & Westminster NHS Foundation Trust,chelsea_westminster_nhs_foundation_trust,,,,,, +8168,,62d03d06-bd83-43e4-966d-4a713506f54f,"Medizinische Universität Wien, Institut für Spezifische Prophylaxe und Tropenmedizin",medizinische_universit_t_wien_institut_f_r_spezifische_prophylaxe_und_tropenmedizin,,,,,, +548,0.98087829351425171,dab90a12-7146-11e6-a0cd-0242ac12000b,FERRING,ferring,,,,0ea42022-8be2-11e6-a449-0242ac12000b,ferring_spa,FERRING SPA +11,0.979515,52e0d1ff-2215-49b4-99dd-e6e6ac83eb94,THERAVANCE,theravance,,,,52e0d1ff-2215-49b4-99dd-e6e6ac83eb94,theravance,THERAVANCE +8169,,2bd06b6d-4f31-427c-a3d9-fc129dc61f10,Inotek Pharmaceuticals Corporation,inotek_pharmaceuticals_corporation,,,,,, +8170,,416169aa-0ac0-4377-bbfe-f1f330c27ae3,Institute of Oncology Ljubljana,institute_of_oncology_ljubljana,,,,,, +8171,,fcae483d-b78c-48cf-a444-97c18c55920b,Silvia Gil Trujillo,silvia_gil_trujillo,,,,,, +8172,,b612216d-1470-46a2-bacb-724e8b9219cc,"SOGUG, Grupo español para el estudio del cancer genitourinario",sogug_grupo_espa_ol_para_el_estudio_del_cancer_genitourinario,,,,,, +955,0.979762,d0a6a4ba-2543-46b6-8d11-ae2d2e832584,"AZTherapies, Inc",aztherapies_inc,,,,801fd107-9dff-425d-aeed-c20bed8847c1,aztherapies_inc_pure_tech_health,"AZTherapies, Inc., Pure Tech Health" +8173,,4646c3b2-7149-11e6-a0cd-0242ac12000b,ESI LEDERLE,esi_lederle,,,,,, +8174,,ee199b84-cb08-4f01-8c51-75735713358e,FARMACEUTICI DAMOR,farmaceutici_damor,,,,,, +8175,,003a1cfc-7167-11e6-a0cd-0242ac12000b,MCPRF,mcprf,,,,,, +8176,,f938920d-c113-4270-af2b-c55235b9a06e,Novartis Pharmaceuticals Corporation,novartis_pharmaceuticals_corporation,,,,,, +8177,,4295eeb7-1128-48c2-90f6-c269ba6972cf,Medical University Innsbruck - Department für Kinder- und Jugendheilkunde (Pädiatrie III),medical_university_innsbruck_department_f_r_kinder_und_jugendheilkunde_p_diatrie_iii,,,,,, +8178,,6eae56e6-522d-449c-a656-fcd2d7747335,"Arena Pharmaceuticals, Inc",arena_pharmaceuticals_inc,,,,,, +8179,,f9749641-97ce-4e05-bf32-145579241257,Piramal Imaging Ltd,piramal_imaging_ltd,,,,,, +8180,,59c9c9e6-a4fc-42f0-98f1-a4c88fde7fd6,PPM Services S.A,ppm_services_s_a,,,,,, +8181,,e2e5a25f-7d47-4f42-a033-c2772500fa45,ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP),assistance_publique_hopitaux_de_paris_ap_hp,,,,,, +434,0.96951077381769812,e7b829c7-a7ce-48d5-bd1d-1955f907d55a,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017 US",pfizer_inc_235_east_42nd_street_new_york_ny_10017_us,,,,0068e377-8873-41b9-baad-e3768b77d0b1,pfizer_inc_235_east_42nd_street_new_york_ny_10017,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017" +8182,,8118b531-0772-4e7b-990c-42827dbb38d4,Great Ormond Street Hospital NHS foundation Trust,great_ormond_street_hospital_nhs_foundation_trust,,,,,, +8183,,64c99dec-af40-4072-bbc6-84e39a231505,University Southampton Hospital NHS Foundation Trust,university_southampton_hospital_nhs_foundation_trust,,,,,, +8184,,d05bbe40-71d0-11e6-a0cd-0242ac12000b,US ARMY,us_army,,,,,, +8185,,1910cec6-52a0-4232-92d7-e466fed816bd,Institutionen för kirurgiska vetenskaper,institutionen_f_r_kirurgiska_vetenskaper,,,,,, +8186,,ecf40dee-7272-11e6-a0cd-0242ac12000b,IMCOR PHARMS CO,imcor_pharms_co,,,,,, +8187,,b6e2a301-a37f-40fb-8d17-66216ba19516,Synlogic,synlogic,,,,,, +8188,,a98c8ad8-1c03-43f0-8edb-f8e1d15e601b,Thornton & Ross Limited,thornton_ross_limited,,,,,, +8189,,73bba6f8-01f0-45d6-9b2e-c17604f51582,"University of Warwick, Research Support Services",university_of_warwick_research_support_services,,,,,, +8190,,3d56ebdd-2cfc-496e-a75b-c90f9b24d829,Unitat de Recerca en Pediatria Nutrició i Desenvolupament Humà,unitat_de_recerca_en_pediatria_nutrici_i_desenvolupament_hum,,,,,, +8191,,066b166a-abbd-49ec-86ec-26d9d06ace8b,The Royal Marsden NHS Foundation Trust,the_royal_marsden_nhs_foundation_trust,,,,,, +8192,,343a8a09-0571-4e4a-83ad-37e95b08f185,"Universith Hospital of Heraklion, Department of Medical Oncology",universith_hospital_of_heraklion_department_of_medical_oncology,,,,,, +8193,,67f1f850-715e-11e6-a0cd-0242ac12000b,HEXCEL,hexcel,,,,,, +8194,,06f68866-acf6-488c-80f4-a3697ceb8f5f,Department of Medical Research,department_of_medical_research,,,,,, +8195,,2a17ef9e-29f2-4dd7-9c84-48e36e0e7d57,ISTITUTO NAZIONALE DELLE MALATTIE INFETTIVE LAZZARO SPALLANZANI,istituto_nazionale_delle_malattie_infettive_lazzaro_spallanzani,,,,,, +567,0.985423,f327c818-7146-11e6-a0cd-0242ac12000b,NOSTRUM LABS,nostrum_labs,,,,0b85e728-7142-11e6-a0cd-0242ac12000b,nostrum_labs_inc,NOSTRUM LABS INC +8196,,3d28cde6-0cff-4f9b-9cfa-5fc2ffebe8d2,EUTHERAPIE pour le compte du promoteur Les Laboratoires Servier,eutherapie_pour_le_compte_du_promoteur_les_laboratoires_servier,,,,,, +8197,,64caf106-497e-4848-9d23-9d2a9bbd6beb,Raptor Pharmaceuticals Inc,raptor_pharmaceuticals_inc,,,,,, +51,0.98173725605010986,8b6c5421-c89a-418f-8c10-e2badcce65ee,Pfizer Ltd,pfizer_ltd,,,,8b6c5421-c89a-418f-8c10-e2badcce65ee,pfizer_ltd,Pfizer Ltd +8198,,344e1803-a0b2-4b87-aa55-a240f8f57abe,Cipla Ltd,cipla_ltd,,,,,, +8199,,9bbc60ff-bca3-4be2-849f-358b108ccd3d,Cipla Limited,cipla_limited,,,,,, +8200,,64a12104-f1d8-4016-8120-384c97f5d7bb,Servicio de Neurología,servicio_de_neurolog_a,,,,,, +8201,,7db2fa6e-7167-11e6-a0cd-0242ac12000b,GLOBAL ISOTOPES LLC,global_isotopes_llc,,,,,, +8202,,230518f6-6fa3-11e6-9663-0242ac12000b,"Universität Mainz, Klinik und Poliklinik für Kinder- und Jugendpsychiatrie und -psychotherapie",universit_t_mainz_klinik_und_poliklinik_f_r_kinder_und_jugendpsychiatrie_und_psychotherapie,,,,,, +8203,,30a06ace-bc70-44ee-be18-300e9124f9bf,ASOCIACION TERAPEUTICA EN HEMATOLOGIA Y ONCOLOGIA MEDICAS DEL HOSPITAL ARNAU DE VILANOVA DE VALENCIA,asociacion_terapeutica_en_hematologia_y_oncologia_medicas_del_hospital_arnau_de_vilanova_de_valencia,,,,,, +8204,,7cfa3175-349c-4787-bab9-8dcdea518756,AB SCIENCE,ab_science,,,,,, +8205,,c6253b7c-73b1-4d49-b755-baa65d4774e9,Vifor Pharma - Vifor (International) AG,vifor_pharma_vifor_international_ag,,,,,, +8206,,98fc55bc-1377-4a54-b47f-9ac59d807781,GON-North Oncology Group,gon_north_oncology_group,,,,,, +8207,,08360562-7129-11e6-a89e-0242ac12000b,TG UNITED INC,tg_united_inc,,,,,, +8208,,09a98c52-7174-11e6-a0cd-0242ac12000b,IMCLONE,imclone,,,,,, +94,0.97634196281433105,49d3c978-7273-11e6-a0cd-0242ac12000b,JAZZ PHARMS,jazz_pharms,,,,49d3c978-7273-11e6-a0cd-0242ac12000b,jazz_pharms,JAZZ PHARMS +8209,,9f4273f8-bd12-4481-abcd-c79f1a30aea2,Ipsen Pharma,ipsen_pharma,,,,,, +8210,,950889ea-7383-11e6-a0cd-0242ac12000b,GALEN (UK),galen_uk,,,,,, +448,0.984608,f5097cb3-2952-440e-8c47-befec4756e09,Oslo University Hospital Rikshospitalet,oslo_university_hospital_rikshospitalet,,,,a6dd2c28-7928-45f0-bda2-157de4bfe0f0,oslo_university_hospital,Oslo University Hospital +8211,,8a7d4729-9b10-46e7-8e93-84744a70d79a,Biogen Idec Hemophilia Inc,biogen_idec_hemophilia_inc,,,,,, +8212,,7327ddb0-495f-49bd-a11d-f351870185f6,Cassella-med GmbH & Co. KG,cassella_med_gmbh_co_kg,,,,,, +8213,,7c138ab8-a733-4aa9-ab73-4de2ddb6ba7a,IOBA. FACULTAD DE MEDICINA,ioba_facultad_de_medicina,,,,,, +874,0.982418,9a9b0d73-4c19-414c-81d5-34f7fec18808,InterMune,intermune,,,,7980a7c5-e0b0-4bbe-8695-41376036421e,intermune_inc,"InterMune, Inc" +8214,,07b0a5cf-57d9-4843-a7a0-3e93ba58dfb3,Dansk Multipel Sclerose Center,dansk_multipel_sclerose_center,,,,,, +8215,,008a48ab-3ff4-4ef4-91cd-430adee111e6,Department of Experimental Clinical Oncology,department_of_experimental_clinical_oncology,,,,,, +718,0.970142,7d140a5d-838e-4824-90c7-b17c12e4b7aa,"Med. Uni. Wien, Klinik f. Innere Med. I",med_uni_wien_klinik_f_innere_med_i,,,,7d140a5d-838e-4824-90c7-b17c12e4b7aa,med_uni_wien_klinik_f_innere_med_i,"Med. Uni. Wien, Klinik f. Innere Med. I" +8216,,c7f537ae-c907-4e59-880b-13d0d15711ce,Stemcentrx Inc,stemcentrx_inc,,,,,, +900,0.955805,5e4c5fb0-cf4a-4b49-8740-5d768fd52e5f,Chiesi Farmaceurtici S.p.A,chiesi_farmaceurtici_s_p_a,,,,578a311e-a483-4d9f-906e-cd1723e08711,chiesi_farmaceutici_s_p_a,Chiesi Farmaceutici S.p.A +8217,,19ec98d9-36b0-4dd0-9928-7963865ffc54,Clinical Pharmacology,clinical_pharmacology,,,,,, +8218,,70fef5aa-e297-45f2-9c7f-95fe9d326052,Bernhard-Nocht-Institute for Tropical Medicine,bernhard_nocht_institute_for_tropical_medicine,,,,,, +8219,,359dc817-8c8d-49b4-9029-5c1014f91f65,"BIAL - PORTELA & Cª, S.A",bial_portela_c_s_a,,,,,, +8220,,b94571a0-b14f-487f-a95d-118b137c44a0,BIAL Industrial Farmaceutica,bial_industrial_farmaceutica,,,,,, +673,0.989076,c1332bd8-66ae-4f01-9ba1-489798992f6b,Procter & Gamble Pharmaceuticals,procter_gamble_pharmaceuticals,,,,9779b86f-f9d6-440c-b621-4e88837285aa,procter_gamble_pharmaceuticals_inc,Procter & Gamble Pharmaceuticals Inc +8221,,f4a2ba4a-ade1-4216-983d-581aab8a1354,Vericel Corporation,vericel_corporation,,,,,, +8222,,ff7cd26c-0558-4959-9c50-32c83c7bee83,BAZ Megyei és Egyetemi Oktató Kórház,baz_megyei_s_egyetemi_oktat_k_rh_z,,,,,, +8223,,2cb56330-c5ff-4ed8-9878-5a848ec9c097,Brighton and Sussex Universities Hospitals Trust Research and Development Directorate,brighton_and_sussex_universities_hospitals_trust_research_and_development_directorate,,,,,, +361,0.988596,ff3d535c-220e-4996-8ffc-f7e30ded2f46,Mitsubishi Tanabe Pharma Corporation,mitsubishi_tanabe_pharma_corporation,,,,7d7d20e5-897b-403b-ba75-22e35574cc70,mitsubishi_tanabe_pharma_corporation_mtpc,Mitsubishi Tanabe Pharma Corporation (MTPC) +8224,,000a6eb6-739d-11e6-a0cd-0242ac12000b,SMITH KLINE & FRENCH,smith_kline_french,,,,,, +8225,,2aaa8db3-1fab-43c4-b44b-5d726a6adfbe,"Istituto Nazionale Tumori di Napoli - Fondazione ""G. Pascale",istituto_nazionale_tumori_di_napoli_fondazione_g_pascale,,,,,, +560,0.97196030616760254,069a9622-502b-4a08-9b02-c54aa4d2410f,UZ Leuven Orthopedic research,uz_leuven_orthopedic_research,,,,069a9622-502b-4a08-9b02-c54aa4d2410f,uz_leuven_orthopedic_research,UZ Leuven Orthopedic research +8226,,816d98eb-f50f-4289-bcce-4b82bfdd13df,CENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA,centro_di_riferimento_oncologico_di_basilicata,,,,,, +8227,,6013e0a0-7161-11e6-a0cd-0242ac12000b,HALSEY,halsey,,,,,, +8228,,fbbb3424-c9a3-4df9-9c09-aa2621392cee,Dr. Benedicto Crespo. Servicio Psiquiatría. Hospital Universitario Marqués de Valdecilla/IDIVAL,dr_benedicto_crespo_servicio_psiquiatr_a_hospital_universitario_marqu_s_de_valdecilla_idival,,,,,, +8229,,64127be3-e43e-4422-9946-40ea16a8d6e5,Laboratoires NEGMA,laboratoires_negma,,,,,, +8230,,01580d20-17fb-47cb-bf51-f4a2464eafb3,Advanced Life Sciences,advanced_life_sciences,,,,,, +572,0.98045754432678223,1a257ae6-dfb7-4d55-a187-ee6edac2cd0e,"Human Genome Sciences, Inc. (a wholy owned subsidiary of GlaxoSmithKline PLC)",human_genome_sciences_inc_a_wholy_owned_subsidiary_of_glaxosmithkline_plc,,,,e3bdd826-4b43-4d33-8f70-20154485e250,human_genome_sciences_inc_a_wholy_owned_subsidiary_of_glaxosmithkline_plc,"Human Genome Sciences, Inc. (a wholy owned subsidiary of GlaxoSmithKline PLC)" +8231,,0b03436c-dead-4bec-8f57-929a754ac769,ALIANZA ESPAÑOLA DE FAMILIAS DE VON HIPPEL-LINDAU,alianza_espa_ola_de_familias_de_von_hippel_lindau,,,,,, +8232,,f09a409a-73f7-11e6-a0cd-0242ac12000b,PHARMA-MED INC,pharma_med_inc,,,,,, +8233,,fdedad7a-d7f7-44f1-9681-c86958017650,"Schwarz Pharma Deutschland GmbH, UCB Group",schwarz_pharma_deutschland_gmbh_ucb_group,,,,,, +8234,,2e4e72d5-1747-444d-9a75-ae5bc33d4d8e,Servicio de Cardiología. Hospital Universitario Vall d'Hebron,servicio_de_cardiolog_a_hospital_universitario_vall_d_hebron,,,,,, +8235,,2907c943-c599-4048-8b54-35122c367da5,Zambon S.p.A,zambon_s_p_a,,,,,, +8236,,432437e7-2e26-4211-a476-199412aacd08,GIMURELL,gimurell,,,,,, +407,0.97243720293045044,ceae0da9-2308-4872-84ed-3463deeef673,Trius Therapeutics,trius_therapeutics,,,,2313c489-596d-4d80-8c94-aa42d3a2f015,trius_therapeutics_a_wholly_owned_subsidiary_of_cubist,"Trius Therapeutics, a Wholly Owned Subsidiary of Cubist" +8237,,f5611b56-48ab-4d5c-8511-7bf9071e3533,MERCK S.P.A,merck_s_p_a,,,,,, +8238,,d395f842-c3af-458c-b027-db2cc9fbacb4,BAYER Vital GmbH,bayer_vital_gmbh,,,,,, +8239,,6037c4d6-7b28-48c4-b0c0-85c95a7e97f1,Dept of Medicine,dept_of_medicine,,,,,, +8240,,f907adc6-48a6-4d39-a1b2-8733495bd7f1,Laboratorios Menarini S.A. (Menarini Group),laboratorios_menarini_s_a_menarini_group,,,,,, +72,0.97601744532585144,f472ce29-7313-451a-974c-278d593159c6,Takeda Global Research & Development Centre (Europe) Ltd,takeda_global_research_development_centre_europe_ltd,,,,a359d331-932d-4716-9cec-7901baf5cc1b,takeda_global_research_development_centre_europe_ltd,Takeda Global Research & Development Centre (Europe) Ltd +694,0.97987914085388184,880cc43e-be86-46ae-9cc8-d02db6c6e6ea,Krankenhaus Nordwest,krankenhaus_nordwest,,,,a1b6c5f2-16df-4bac-b6d9-a19ab340e9dd,krankenhaus_nordwest,Krankenhaus Nordwest +8241,,3523e024-9a03-4f1b-8763-40dd5ddcfe6b,Laboratoires Fournier S.A. A Solvay Pharmaceuticals company,laboratoires_fournier_s_a_a_solvay_pharmaceuticals_company,,,,,, +8242,,6cbaf138-7196-11e6-a0cd-0242ac12000b,SHIRE LLC,shire_llc,,,,,, +8243,,b101cbe0-e24a-40cc-a47e-318677f4a2a7,NUTRIALYS,nutrialys,,,,,, +8244,,5cec4dde-7d5b-4c2e-8cd3-086c7fbda6ea,Josep Llop Talaveron,josep_llop_talaveron,,,,,, +8245,,7b4cc2e3-082e-4f42-b03e-c3546722cdf3,G. Pohl-Boskamp GmbH & Co. KG,g_pohl_boskamp_gmbh_co_kg,,,,,, +8246,,f41ce989-afaa-4740-8cb8-341d3c32ea02,"CombinatoRx, Incorporated",combinatorx_incorporated,,,,,, +1008,0.951024,4614bd92-4210-4230-a954-64c1de5fddc0,AOP Orphan Pharmaceuticals AG,aop_orphan_pharmaceuticals_ag,,,,4614bd92-4210-4230-a954-64c1de5fddc0,aop_orphan_pharmaceuticals_ag,AOP Orphan Pharmaceuticals AG +8247,,bd214773-2f3d-48a6-bb0b-f632859c3a35,"Medical Faculty, University of Bonn",medical_faculty_university_of_bonn,,,,,, +8248,,ae08b3ae-65fd-4290-92fb-f0059bd48e27,University Clinic Internal Medicine I,university_clinic_internal_medicine_i,,,,,, +8249,,e2727f47-854a-46eb-b9aa-abb2febd3703,East Kent Hospitals NHS Trust,east_kent_hospitals_nhs_trust,,,,,, +340,0.98418444395065308,02763460-e885-4cb3-a951-4a777203fe35,Intercytex Ltd,intercytex_ltd,,,,02763460-e885-4cb3-a951-4a777203fe35,intercytex_ltd,Intercytex Ltd +8250,,a832e85a-a74a-11e6-94cb-5656d04fc2b5,ELKE University of Athens,elke_university_of_athens,,,,,, +8251,,91776793-48bb-4dcd-9c9b-eabbf98fa200,Fundación CRIS de investigación para vencer el cáncer,fundaci_n_cris_de_investigaci_n_para_vencer_el_c_ncer,,,,,, +8252,,661c90db-0b23-478c-acc7-462dd968796f,ZLB Behring AG,zlb_behring_ag,,,,,, +8253,,52d63ae0-feeb-41a8-8617-a5c7e0f87580,Faron Pharmaceuticals Ltd,faron_pharmaceuticals_ltd,,,,,, +8254,,2f047bee-73d9-11e6-a0cd-0242ac12000b,JANSSEN THERAP,janssen_therap,,,,,, +8255,,66232373-5a4a-45b5-8bca-43d2cfe3a719,Fundación para la Investigación Biomédica Hospital Universitario Niño Jesús,fundaci_n_para_la_investigaci_n_biom_dica_hospital_universitario_ni_o_jes_s,,,,,, +8256,,da38c504-ca1b-4b83-a79b-d68311818476,Bio Minerals n.v,bio_minerals_n_v,,,,,, +8257,,f308604c-1efd-4802-99d1-290e9d5c2285,"Kyowa Hakko Kirin Pharma, Inc",kyowa_hakko_kirin_pharma_inc,,,,,, +8258,,5a6f2389-699e-4e22-99d2-adb49d4197e5,"Inovio Pharmaceuticals, Inc",inovio_pharmaceuticals_inc,,,,,, +680,0.981011,d5bad664-fff4-4066-a3d3-cc7450a05435,"Clinical Reasearch Centre, Hvidovre University Hospital",clinical_reasearch_centre_hvidovre_university_hospital,,,,d5bad664-fff4-4066-a3d3-cc7450a05435,clinical_reasearch_centre_hvidovre_university_hospital,"Clinical Reasearch Centre, Hvidovre University Hospital" +8259,,0b577fba-8d73-45f6-bcaa-5e7000a9dfe5,GELARC,gelarc,,,,,, +8260,,55c406e0-07d7-49d7-ba02-8fd548f48e86,ViiV Healthcare UK Limited,viiv_healthcare_uk_limited,,,,,, +8261,,be78c044-e3c8-4f07-bd1f-f6113fe926d6,"Afferent Pharmaceuticals, Inc",afferent_pharmaceuticals_inc,,,,,, +254,0.941004,39dca129-d0ba-442a-99f7-f8ceeb2ad28b,GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD,glaxosmithkline_research_development_ltd,,,,07cef69a-6d39-498c-b1f5-a59bab4b33b0,glaxo_smith_kline_research_development_ltd,GLAXO SMITH KLINE RESEARCH & DEVELOPMENT LTD +8262,,d9bba284-1114-4fb3-8d17-a67bdc2d074f,Prof. Dr. H. Lode,prof_dr_h_lode,,,,,, +8263,,3835f6e5-d0ac-4017-867a-672e7a7f9540,Vilnius University Hospital Santariskiu Clinics,vilnius_university_hospital_santariskiu_clinics,,,,,, +8264,,61a40486-4235-4bbb-a6f6-6b7ab4d13c86,AZIENDA USL 6 LIVORNO ZONA LIVORNESE,azienda_usl_6_livorno_zona_livornese,,,,,, +8265,,ec946aaf-a357-436a-bce9-2cc7c176e133,Oxagen Ltd,oxagen_ltd,,,,,, +8266,,2e80275e-7163-11e6-a0cd-0242ac12000b,COBREK PHARMA,cobrek_pharma,,,,,, +8267,,ec522df6-fe69-4c9a-aa12-51b0a4ba14b2,Immanuel Krankenhaus Berlin,immanuel_krankenhaus_berlin,,,,,, +8268,,e02a2e80-ae87-4c91-9803-6b55fdb84cf8,Tacurion Pharma Inc,tacurion_pharma_inc,,,,,, +8269,,e9c63d24-e393-4614-8796-ddfa5f7c64cb,Oxford University Hospitals NHS Trust,oxford_university_hospitals_nhs_trust,,,,,, +8270,,2934b0cb-1068-47e8-a0f6-86ead774706e,"Center for Cancer Immunotherapy (CCIT) / Department of Oncology, Herlev Hospital",center_for_cancer_immunotherapy_ccit_department_of_oncology_herlev_hospital,,,,,, +8271,,c4e6eb42-5480-4f58-8f5d-511e78b3b307,Yakult Honsha Co,yakult_honsha_co,,,,,, +8272,,d16e6416-016e-467e-b2c7-f17ed8c2ad67,University of Helsinki,university_of_helsinki,,,,,, +8273,,ebbad122-2b4e-44f9-9c51-f6fc69442e94,CENTRO STUDI FADOI,centro_studi_fadoi,,,,,, +8274,,39e87b70-60f4-4c21-8945-08e6f5415f0d,MULTIMEDICA S.P.A,multimedica_s_p_a,,,,,, +1072,0.959984,0e59fcb8-db64-490f-b629-84fe6f12827e,Danish Breast Cancer Group (DBCG),danish_breast_cancer_group_dbcg,,,,0e59fcb8-db64-490f-b629-84fe6f12827e,danish_breast_cancer_group_dbcg,Danish Breast Cancer Group (DBCG) +8275,,52bf3192-7ab3-4c74-a250-abbe9f5a2152,"Merck, sharp & Dohme (Human Health) Ltd",merck_sharp_dohme_human_health_ltd,,,,,, +52,0.970647,042feb9c-2ed7-4ad5-bdb8-f388835c0c2d,AIBILI (EVICR.net),aibili_evicr_net,,,,042feb9c-2ed7-4ad5-bdb8-f388835c0c2d,aibili_evicr_net,AIBILI (EVICR.net) +8276,,b3a8f4b8-cd50-4ec2-a1ab-d3ba6aef5ce4,IMAS,imas,,,,,, +8277,,6edc0a45-7155-4c85-b786-c5e641e23b0b,Johnson and Johnson,johnson_and_johnson,,,,,, +8278,,942f1d1d-5318-447d-a537-a572468158b4,"Pfizer, Spain",pfizer_spain,,,,,, +1076,0.960954,045cfbfc-1ceb-4114-9b7b-c749009a8f56,"Dep. of Ophthalmology, Medical University of Vienna",dep_of_ophthalmology_medical_university_of_vienna,,,,045cfbfc-1ceb-4114-9b7b-c749009a8f56,dep_of_ophthalmology_medical_university_of_vienna,"Dep. of Ophthalmology, Medical University of Vienna" +8279,,41746710-2c26-483b-a0d6-8b198a447af5,"Zealand University Hospital, Department of Surgery",zealand_university_hospital_department_of_surgery,,,,,, +8280,,b8addf56-1f13-4a88-89fe-26341bc7bfa5,Menarini Ricerche Spa,menarini_ricerche_spa,,,,,, +8281,,100353bb-754a-4d58-aa2d-b5b2b483acc6,Asociación Dr. Peset para el estudio de la Hematología (ADOPEH),asociaci_n_dr_peset_para_el_estudio_de_la_hematolog_a_adopeh,,,,,, +8282,,a5244759-edb9-4107-bb10-a9729337da38,Schering-Plough S.A. de C.V,schering_plough_s_a_de_c_v,,,,,, +8283,,8ddf3bea-8979-4bb5-8a3e-60dc39e97bd1,Dra. Martinez Payo-Hospital Universitario Puerta de Hierro,dra_martinez_payo_hospital_universitario_puerta_de_hierro,,,,,, +8284,,286f9c42-73ec-11e6-a0cd-0242ac12000b,INSYS DEV CO INC,insys_dev_co_inc,,,,,, +778,0.982179,4711b905-98c1-448d-aed0-2e1a54f407bf,Medica Scientia Innovation Research (MedSIR),medica_scientia_innovation_research_medsir,,,,09db9c0d-772c-417a-b2dd-c0f3dd272e65,medica_scientia_innovation_research_medsir_aro,Medica Scientia Innovation Research (MedSIR ARO) +8285,,61797f1f-f2f0-4bfd-affe-6dd965bee819,Hyperion Therapeutics Limited,hyperion_therapeutics_limited,,,,,, +8286,,0e1eb050-7142-11e6-a0cd-0242ac12000b,WYETH AYERST,wyeth_ayerst,,,,,, +8287,,a881df9e-fbe6-47c1-922a-00396ecfbfdc,Laboratoires Leurquin Mediolanum S.A.S,laboratoires_leurquin_mediolanum_s_a_s,,,,,, +8288,,87fceeec-f896-4a33-a509-b3e3dbe4d827,"Inmunotek, S.L",inmunotek_s_l,,,,,, +8289,,bb07b5eb-80aa-4cee-9b33-c66f8d402c20,"Hyperion Therapeutics, Inc",hyperion_therapeutics_inc,,,,,, +99,0.9399416446685791,5769e276-4f89-42a2-bd02-826e652c6714,Novartis Farmaceútica,novartis_farmace_tica,,,,bcb0e637-6442-4916-88f9-8cd0d5df3534,novartis_farmaceutica,Novartis Farmaceutica +566,0.961636,e1050e70-ebfb-4325-a452-2df529eb6225,"ARIAD Pharmaceuticals, Inc",ariad_pharmaceuticals_inc,,,,b7bdd038-73c6-11e6-a0cd-0242ac12000b,ariad,ARIAD +1044,0.988488,8cc0218b-399d-46ee-a2f5-9edb9d7f5a91,Intercept Pharmaceuticals,intercept_pharmaceuticals,,,,8cc0218b-399d-46ee-a2f5-9edb9d7f5a91,intercept_pharmaceuticals,Intercept Pharmaceuticals +8290,,d6596d60-82b5-4148-9354-d7a0decace0f,Gunnar Hillerdal,gunnar_hillerdal,,,,,, +8291,,62268e07-069f-4caa-9a14-3afb8256af44,CeNeS Ltd,cenes_ltd,,,,,, +320,0.97903996706008911,73ddd4a0-7126-11e6-8a77-0242ac12000b,FRESENIUS,fresenius,,,,2cc9c0de-712a-11e6-a89e-0242ac12000b,fresenius_kabi_usa,FRESENIUS KABI USA +8292,,85e282c0-155f-4868-b543-638bb3f74456,"Cadence Pharmaceuticals, Inc",cadence_pharmaceuticals_inc,,,,,, +8293,,e7aab02b-5c15-426d-b568-297b01455a90,Charite Universitätsmedizin Berlin,charite_universit_tsmedizin_berlin,,,,,, +8294,,092e12e5-1e38-4c8e-b432-6bb14f5b8d9b,NHS Lothian R&D Office,nhs_lothian_r_d_office,,,,,, +8295,,0a7548ff-0f7f-41b3-a5e5-9678e4a1d734,"Medizinische Universität Wien, Univ.Klinik f.Radiodiagnostik",medizinische_universit_t_wien_univ_klinik_f_radiodiagnostik,,,,,, +8296,,ff78da4b-b446-4be9-bfc5-3799176f007c,"GlaxoSmtihKline, S.A",glaxosmtihkline_s_a,,,,,, +8297,,28702a80-d580-4c85-8150-d756dc43353a,Zentiva a.s,zentiva_a_s,,,,,, +8298,,7d8b7215-736c-477d-aadc-4856bcb75963,Wilhelminen Krebsforschung GmbH,wilhelminen_krebsforschung_gmbh,,,,,, +8299,,7df41777-38cb-436a-9c6c-74b1ce896044,Genticel,genticel,,,,,, +8300,,40a82c90-d135-4e70-a1e4-4dc62af9d871,UCB Biopharma SPRL,ucb_biopharma_sprl,,,,,, +8301,,d67d64fd-4fce-4342-9491-b3f428fa7881,Roessingh Research and Development,roessingh_research_and_development,,,,,, +8302,,cfa945b6-c0bb-4a90-9b99-e443a0bbed72,Fundació Clínic de Recerca Biomèdica,fundaci_cl_nic_de_recerca_biom_dica,,,,,, +8303,,17b9dd5c-7189-4cfe-b93e-be38f1936c24,Ass.Prof. Petros Sfikakis,ass_prof_petros_sfikakis,,,,,, +8304,,c3b3def0-19ab-462f-8a50-0167aa4d49b5,GALENICA S.A,galenica_s_a,,,,,, +8305,,82515351-dbe9-473a-978d-4a79142b7a17,Niels Jørgen Secher,niels_j_rgen_secher,,,,,, +8306,,69565db0-7142-11e6-a0cd-0242ac12000b,ALCON PHARMS LTD,alcon_pharms_ltd,,,,,, +8307,,8622c0d2-2bf6-42bc-b9b1-aaff37e076b7,AXCAN PHARMA SAS,axcan_pharma_sas,,,,,, +8308,,f588856a-e6c2-4254-8dcf-e2cf5a018a52,North West Wales NHS Trust,north_west_wales_nhs_trust,,,,,, +8309,,80d80609-e1d3-4b53-bb7a-d3b8a28991ef,ImClone LLC,imclone_llc,,,,,, +8310,,f0af7e93-ed81-42a4-8df5-b8d353d9708b,Erasmus MC Cancer Institute,erasmus_mc_cancer_institute,,,,,, +8311,,5f6f0660-ca2e-4862-9112-805151a940f5,Dr. José García-Arumí,dr_jos_garc_a_arum,,,,,, +331,0.98589098453521729,6a2933b8-7145-11e6-a0cd-0242ac12000b,PURACAP PHARM,puracap_pharm,,,,5b0547b4-7168-11e6-a0cd-0242ac12000b,puracap_pharm_llc,PURACAP PHARM LLC +77,0.942699,d30fb26a-8bbe-11e6-a449-0242ac12000b,ITF Research Pharma SLU,itf_research_pharma_slu,,,,56d56d9c-d583-406f-8098-1497a470593d,itf_research_pharma_s_l_u,ITF Research Pharma S.L.U +8312,,cf884ca1-a710-47cc-8a27-06429a805cdd,Aimmune Therapeutics Inc,aimmune_therapeutics_inc,,,,,, +8313,,c6e7bf5e-2220-4e06-824f-1b6b0c290c32,CARDIOLOGIA UNIVERSITARIA - OSPEDALE CLINICIZZATO SS. ANNUNZIATA - VIA DEI VESTINI - 66013 CHIETI,cardiologia_universitaria_ospedale_clinicizzato_ss_annunziata_via_dei_vestini_66013_chieti,,,,,, +117,0.965586,66c99c0f-befb-4321-8842-bd1047513dac,UMCN farm-tox,umcn_farm_tox,,,,66c99c0f-befb-4321-8842-bd1047513dac,umcn_farm_tox,UMCN farm-tox +8314,,d8eb6d13-6b6d-41d4-9ada-e97bf898176b,KABI PHARMACIA S.A,kabi_pharmacia_s_a,,,,,, +8315,,2caee7ad-6a77-489b-a44c-85a06d220d08,"Celgene Corporation, Inc",celgene_corporation_inc,,,,,, +8316,,dbb52f33-a8fc-4aa5-b128-948fe7582742,"Medizinische Universität Wien, Abteilung für Allgemeine Anästhesie und Intensivmedizin",medizinische_universit_t_wien_abteilung_f_r_allgemeine_an_sthesie_und_intensivmedizin,,,,,, +8317,,1397390d-ea51-437d-afbe-9edaf20e47cf,"Department of Ophthalmology, Bonn University",department_of_ophthalmology_bonn_university,,,,,, +8318,,e26593c0-6e34-42e6-809d-7870ae522f4b,Astellas Europe Pharma B.V,astellas_europe_pharma_b_v,,,,,, +8319,,fd429b72-8214-4546-9999-5068796657fa,Celltech R&D Ltd,celltech_r_d_ltd,,,,,, +8320,,8cb4281e-f70a-43d0-aedb-1b9b3ae945fa,Bracco Imaging Deutschland GmbH,bracco_imaging_deutschland_gmbh,,,,,, +8321,,87e85eff-7236-459b-bf65-13f376005db3,KYOWA HAKKO UK LTD,kyowa_hakko_uk_ltd,,,,,, +8322,,5cb11105-efb7-4148-9b3c-9825a2705fb5,AZIENDA PER I SERVIZI SANITARI 1 TRIESTINA,azienda_per_i_servizi_sanitari_1_triestina,,,,,, +8323,,e22f8291-7181-428b-80c2-53e1bd423a77,Sanofi Pasteur Limited,sanofi_pasteur_limited,,,,,, +646,0.98875898122787476,df53fa2b-d0e4-4bc4-9e98-e8d79a1d3719,Boehringer Ingelheim Ellas,boehringer_ingelheim_ellas,,,,237ec247-b474-4bd6-9041-c2ffb0213c0e,boehringer_ingelheim_ellas,Boehringer Ingelheim Ellas +8324,,a62f4e3e-7f6d-4757-b7e8-0fdd7af6b12e,Algipharma AS,algipharma_as,,,,,, +8325,,9283ffc4-71ad-11e6-a0cd-0242ac12000b,CUTIS HEALTH LLC,cutis_health_llc,,,,,, +8326,,b0a72673-e282-4445-800d-21b90532bf27,Pfizer Inc. 235 East 42nd Street NY10017,pfizer_inc_235_east_42nd_street_ny10017,,,,,, +8327,,5067234b-0ceb-42e3-92f0-ead59f0d258a,Eero Pesonen,eero_pesonen,,,,,, +8328,,5a598abe-8815-11e6-a998-0242ac12000b,"Pfizer Global Research & Development, La Jolla Laboratories",pfizer_global_research_development_la_jolla_laboratories,,,,,, +357,0.987372,98bac61e-5a35-4e65-bf8a-564c1eac1911,"Flexion Therapeutics, Inc",flexion_therapeutics_inc,,,,98bac61e-5a35-4e65-bf8a-564c1eac1911,flexion_therapeutics_inc,"Flexion Therapeutics, Inc" +8329,,5a4b5e79-7832-4081-a61f-42ebcce353d4,Fundación Castellano Leonesa de Hematología y Hemoterapia (FUCALHH),fundaci_n_castellano_leonesa_de_hematolog_a_y_hemoterapia_fucalhh,,,,,, +8330,,d0aeb96f-5b11-4b42-816d-69232a6b5d89,"Odense University Hospital, department M",odense_university_hospital_department_m,,,,,, +8331,,7ad1ba81-70e0-467e-b92e-ae9ec454b588,PregLem S.A,preglem_s_a,,,,,, +8332,,23f62bcb-7340-4b5d-ab3a-4fb07163dc3f,Saint-Luc Universitary Hospital,saint_luc_universitary_hospital,,,,,, +8333,,202b3225-dfd9-4d2c-a876-1f26afd4006c,"Med. Univ. Wien, Universitätsklinik f. Innere Medizin III, Abt. f. Nephrologie und Dialyse",med_univ_wien_universit_tsklinik_f_innere_medizin_iii_abt_f_nephrologie_und_dialyse,,,,,, +8334,,93033a1c-7164-11e6-a0cd-0242ac12000b,PHARMACEUTICS,pharmaceutics,,,,,, +8335,,609b46bb-fc76-4f43-9656-1dcaa605750a,Henogen,henogen,,,,,, +8336,,e436b602-e523-4488-bba2-a754516e2077,Moorfields Eye Hospital NHS Foundation Trust,moorfields_eye_hospital_nhs_foundation_trust,,,,,, +713,0.96376720070838928,f7b23b22-4644-47ad-9c6e-27b5eb54a6b6,"Wyeth Pharmaceuticals Inc., a wholly owened subsidiary of Pfizer Inc, 500 Arcola Road, collegeville, PA 19426 USA",wyeth_pharmaceuticals_inc_a_wholly_owened_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,,,,d2f1d48d-c243-473b-9f47-208723250aa6,wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA" +8337,,a93b7b8e-6f9b-11e6-9663-0242ac12000b,"Dep. of Cancer Research and Molecular medicine, Norwegian University of Science and Technology",dep_of_cancer_research_and_molecular_medicine_norwegian_university_of_science_and_technology,,,,,, +830,0.980344,6d67120f-5e5c-4a5b-851a-6e2fbcc36876,GENFIT,genfit,,,,223e6632-3388-4cba-ab58-ea9c133365de,genfit_sa,GENFIT SA +8338,,b40718f1-40a7-49bc-ad0c-5835c1cc2014,GlaxoSmithKline SA,glaxosmithkline_sa,,,,,, +8339,,337e610b-d92f-47ee-8c2e-c463c94540c8,"Department of Thoracic and Hyperbaric Surgery, University Medical School Graz",department_of_thoracic_and_hyperbaric_surgery_university_medical_school_graz,,,,,, +6,0.98172008991241455,3a96a924-5942-47f4-be4b-f7f2f104395e,"Centre Hospitalier Universitaire de Montpellier Direction Recherche, Qu",centre_hospitalier_universitaire_de_montpellier_direction_recherche_qu,,,,17ea9e87-8473-4174-a0be-01570daa58e8,centre_hospitalier_universitaire_de_montpellier,Centre Hospitalier Universitaire de Montpellier +551,0.9728655219078064,0aa6ecae-1a53-4cf9-8648-924415ffb218,Freistaat Bayern,freistaat_bayern,,,,0aa6ecae-1a53-4cf9-8648-924415ffb218,freistaat_bayern,Freistaat Bayern +8340,,0bca2828-7167-11e6-a0cd-0242ac12000b,QILU PHARM CO LTD,qilu_pharm_co_ltd,,,,,, +8341,,f45190a9-ad50-4b24-89ce-d6670cb7c32d,University Hospital of Toulouse,university_hospital_of_toulouse,,,,,, +8342,,cbafe5c4-8603-4d60-8f15-5607d861ac5c,Medizinische Universität Graz_Universitätsklinik für Innere Medizin_Diabetes und Stoffwechsel,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_diabetes_und_stoffwechsel,,,,,, +8343,,aa41a384-ebac-4a44-8acc-4b8890ece3f1,FUNDATION OF EXPERIMENTAL AND CLINICAL ONCOLOGY,fundation_of_experimental_and_clinical_oncology,,,,,, +373,0.91557258367538452,f2d6af42-c47f-49ae-b4b6-a023a2b2f116,Merck Sharp & Dohme GmbH,merck_sharp_dohme_gmbh,,,,f2d6af42-c47f-49ae-b4b6-a023a2b2f116,merck_sharp_dohme_gmbh,Merck Sharp & Dohme GmbH +8344,,b6ccaa8a-715c-11e6-a0cd-0242ac12000b,ANTARES PHARMA INC,antares_pharma_inc,,,,,, +8345,,a2b0c28c-73de-11e6-a0cd-0242ac12000b,PROVEPHARM SAS,provepharm_sas,,,,,, +8346,,eedcfce8-c14f-485a-8eb3-ca8f999e6580,Onze-Lieve-Vrouw Ziekenhuis,onze_lieve_vrouw_ziekenhuis,,,,,, +8347,,10ee28e9-980e-4b29-a03b-fa30152016e3,ObsEva SA,obseva_sa,,,,,, +8348,,c39a8ab6-00d9-4238-9cb5-032d85406703,Centre Hospitalier de Tourcoing,centre_hospitalier_de_tourcoing,,,,,, +46,0.972279,e7215871-9562-4b99-96e9-3250b272830d,Alloksys Life Sciences B.V,alloksys_life_sciences_b_v,,,,286d0033-04c6-4cd9-8601-edb31d1bee9f,alloksys_life_sciences_bv,Alloksys Life Sciences BV +8349,,f6fcdcf0-7144-11e6-a0cd-0242ac12000b,PLIVA HRVATSKA DOO,pliva_hrvatska_doo,,,,,, +722,0.971833,fbd6a53b-5a7b-4893-8296-054ca15bada6,"Sven O. Skouby, Professor, MD, DMSc. Unit of reproductive Medicine, Herlev/Gentofte Hospital",sven_o_skouby_professor_md_dmsc_unit_of_reproductive_medicine_herlev_gentofte_hospital,,,,d849df4a-222c-4517-b78c-1f8d3369f7eb,sven_olaf_skouby_professor_md_dmsc_unit_of_reproductive_medicine_herlev_gentofte_hospital,"Sven Olaf Skouby, Professor, MD, DMSc. Unit of Reproductive Medicine, Herlev/Gentofte Hospital" +8350,,499f6fb9-3fb0-465d-9455-f34cddb4fc9b,Universitätsklinikum Aachen,universit_tsklinikum_aachen,,,,,, +8351,,6f638c28-edd2-49c5-ba17-bfc9063aff9f,"Essen University Hospital, University of Essen, Klinik für Allgemein-, Viszeral- und Transplantationschirugie",essen_university_hospital_university_of_essen_klinik_f_r_allgemein_viszeral_und_transplantationschirugie,,,,,, +8352,,4f935083-ea79-4bdb-8dcb-ddbddc26d1b5,Lothian NHS trust,lothian_nhs_trust,,,,,, +8353,,4404d5c3-ab00-4898-bc94-a926df706fe5,"James Martin Shannon, MB Bch NUI",james_martin_shannon_mb_bch_nui,,,,,, +8354,,d5ef6684-10e6-4bfd-8782-091f32b991d1,EDMOND PHARMA S.R.L,edmond_pharma_s_r_l,,,,,, +8355,,7602e4bb-042c-4fe2-8e35-bae17e1c97b4,ISTITUTO SUPERIORE DI SANITA`,istituto_superiore_di_sanita,,,,,, +8356,,62d4a896-ac9e-486a-b44a-eb9f6c0a626e,Máximo Vento Torres,m_ximo_vento_torres,,,,,, +8357,,da9b4fbc-f66d-4eef-ab90-a218c33dfdc3,Bio Products Laboratory Limited,bio_products_laboratory_limited,,,,,, +323,0.98663082718849182,4cef0e0b-cc24-4bf3-b362-b0229f08ed2d,Tibotec Pharmaceuticals,tibotec_pharmaceuticals,,,,7c715eec-7632-4bad-85ac-60fea60f92d9,tibotec_pharmaceuticals_ltd,Tibotec Pharmaceuticals Ltd +8358,,cce6aea9-24aa-40a4-8db4-d0471b1c4290,"Bayer HealthCare AG, Leverkusen, Germany",bayer_healthcare_ag_leverkusen_germany,,,,,, +1033,0.97907406091690063,6fb84541-28be-49a0-a789-a0b8bf04fae5,"Kvinnokliniken, Universitetssjukhuset i Linköping, Landstinget i Östergötland",kvinnokliniken_universitetssjukhuset_i_link_ping_landstinget_i_sterg_tland,,,,6fb84541-28be-49a0-a789-a0b8bf04fae5,kvinnokliniken_universitetssjukhuset_i_link_ping_landstinget_i_sterg_tland,"Kvinnokliniken, Universitetssjukhuset i Linköping, Landstinget i Östergötland" +488,0.96790111064910889,09a2f474-74c3-4e06-8312-e90b8c6b9edd,STEBA BIOTECH NV,steba_biotech_nv,,,,5d77fa00-9417-4d15-807e-607c459d6842,steba_biotech,STEBA BIOTECH +8359,,ba25ef2c-c2e9-4122-8c27-ea1588bef0cd,Univ.-Klinik für Kinder- und Jugendheilkunde,univ_klinik_f_r_kinder_und_jugendheilkunde,,,,,, +783,0.988564,de151225-4c06-4faa-8f79-aea8cbad1585,Friedrich Schiller University,friedrich_schiller_university,,,,7e086a89-ce6e-4201-a20f-f377b113a14a,friedrich_schiller_university_jena,Friedrich Schiller University Jena +8360,,ec61c25d-94a2-4de5-81e3-053faf6f0b45,Fundación Rafael Clavijo,fundaci_n_rafael_clavijo,,,,,, +8361,,1cb2d28c-7116-40a2-8db1-7219ee3a1eac,AstraZeneca Österreich GmbH,astrazeneca_sterreich_gmbh,,,,,, +8362,,f53ac4c5-e3a2-47bb-9263-221e5a4bae9a,ModigeneTech Ltd,modigenetech_ltd,,,,,, +8363,,0e390158-99d9-4806-965a-1a245f5b5d27,Berufsgenossenschaftliche Universitätsklinik Bergmannsheil GmbH,berufsgenossenschaftliche_universit_tsklinik_bergmannsheil_gmbh,,,,,, +8364,,354414e6-8642-4679-83f0-e181e820b6d4,EBI Anti Sepsis B.V,ebi_anti_sepsis_b_v,,,,,, +8365,,707f5ff0-d285-4223-bc70-845be6e70a9d,C.H.U. de RENNES,c_h_u_de_rennes,,,,,, +8366,,d8de5982-3415-41f7-bcc2-0d4fc027a857,Vicente Barrio Lucia,vicente_barrio_lucia,,,,,, +8367,,956a84b4-0f02-486c-a85e-c9fd1fe6d5ae,Dr Manuel Pérez Maraver.Servicio de Endocrinologia. Hospital de Bellvitge,dr_manuel_p_rez_maraver_servicio_de_endocrinologia_hospital_de_bellvitge,,,,,, +198,0.96789649128913879,3d8b74fd-b4e1-48e0-9ee6-4cdff0959d7d,Agence nationale de recherches sur le sida et les hépatites virales. ANRS,agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales_anrs,,,,59af07b2-8bdc-4113-8ce3-1b459956f500,agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales,Agence nationale de recherches sur le sida et les hépatites virales +8368,,014851d0-6f4b-400f-ae54-944210e7dbab,STRAKAN PHARMACEUTICALS LIMITED,strakan_pharmaceuticals_limited,,,,,, +8369,,f583bc0e-ae20-4bee-963e-e6fa92586bff,Stockholm Centre for Dependency Disorders,stockholm_centre_for_dependency_disorders,,,,,, +8370,,88b610b9-aa93-4023-9588-2088b0712224,"Medizinische Universität Wien,Univ.Klinik f.Anästhesie,Allgemeine Intensivmedizin u.Schmerztherapie",medizinische_universit_t_wien_univ_klinik_f_an_sthesie_allgemeine_intensivmedizin_u_schmerztherapie,,,,,, +8371,,9adddbc6-9196-4cae-b690-fe39a8e1cdac,Rottapharm SpA,rottapharm_spa,,,,,, +8372,,7f9d4912-2e85-4c67-9330-bc9bd40145cf,Servicio de Anestesiología. Hospital Universitario Germans Trias i Pujol. Badalona,servicio_de_anestesiolog_a_hospital_universitario_germans_trias_i_pujol_badalona,,,,,, +8373,,0d0d70ba-8867-451d-8e01-3684d6d556f7,Applied Genetic Technologies Corporation,applied_genetic_technologies_corporation,,,,,, +8374,,d609acee-2831-440a-bcc4-8b8df3aa7145,Vienna University Medical School,vienna_university_medical_school,,,,,, +957,0.957248,8e38f9a4-dccf-4187-bc36-be3625d6e45b,UMCG,umcg,,,,321c0173-119e-4164-9f51-ae2b1d03cb92,umcg_van_buchem_stichting,"UMCG, Van Buchem Stichting" +8375,,fdbb20fa-a83d-4c5f-9904-a46fb0789c92,Inserm,inserm,,,,,, +287,0.982375,471980ba-fc4b-45dc-b7bc-7d5ed19764b7,"Department of Anaesthesia, University College Hospital Galway",department_of_anaesthesia_university_college_hospital_galway,,,,471980ba-fc4b-45dc-b7bc-7d5ed19764b7,department_of_anaesthesia_university_college_hospital_galway,"Department of Anaesthesia, University College Hospital Galway" +8376,,65b06197-f06a-422b-95aa-831b7ba5748d,"NU-sjukvården, Norra Älvsborgs Länssjukhus",nu_sjukv_rden_norra_lvsborgs_l_nssjukhus,,,,,, +831,0.977549,9f380cea-e5d4-4346-a8b8-6397eb6b3840,"Laboratorios Andrómaco, S.A",laboratorios_andr_maco_s_a,,,,9f380cea-e5d4-4346-a8b8-6397eb6b3840,laboratorios_andr_maco_s_a,"Laboratorios Andrómaco, S.A" +8377,,a24f8b51-b4fc-41e8-9930-a9fb73afaea6,Poole Hospital NHS Trust,poole_hospital_nhs_trust,,,,,, +8378,,806415c2-a7a1-11e6-94cb-5656d04fc2b5,"Noven Pharmaceuticals, Inc",noven_pharmaceuticals_inc,,,,,, +8379,,32282e21-49ce-4d65-815a-321863863ad7,Sage Therapeutics,sage_therapeutics,,,,,, +802,0.989407,a02415a8-3cdf-4ded-89d7-b50b2f02f0bd,Consorzio per Valutazioni Biologiche e Farmacologiche,consorzio_per_valutazioni_biologiche_e_farmacologiche,,,,a02415a8-3cdf-4ded-89d7-b50b2f02f0bd,consorzio_per_valutazioni_biologiche_e_farmacologiche,Consorzio per Valutazioni Biologiche e Farmacologiche +8380,,7af35b4e-cf6a-463f-80e7-e121c9fda5cb,University of Tampere,university_of_tampere,,,,,, +8381,,40ace3ff-e6df-4ef3-ab9e-c53657d4a79d,Kjeld Schmiegelow,kjeld_schmiegelow,,,,,, +8382,,0dafc732-3586-44c2-93df-da550602fafc,Fundación Investigación Biomedica. Hospital Clinico San Carlos,fundaci_n_investigaci_n_biomedica_hospital_clinico_san_carlos,,,,,, +8383,,86d41442-d230-43de-89a3-98964259162b,Abbott Laboratories Ireland Limited,abbott_laboratories_ireland_limited,,,,,, +8384,,bdadb083-28d3-4d8f-bc7c-cc1625d26f60,Bayer HealthCare LLC/Biological Products,bayer_healthcare_llc_biological_products,,,,,, +8385,,6e6abc64-71f2-11e6-a0cd-0242ac12000b,ULURU,uluru,,,,,, +8386,,530fb7d9-cc0f-42fc-a16d-85de7fffaabf,Ferring Laegemidler A/S,ferring_laegemidler_a_s,,,,,, +8387,,703dce6d-8143-412e-811b-f5e277295d1b,Paracelsus Medical University,paracelsus_medical_university,,,,,, +8388,,65b58fc2-ed98-4bb6-8e21-51870d9d7023,sanofi-aventis recherche&developpement,sanofi_aventis_recherche_developpement,,,,,, +991,0.94441205263137817,bfea9c2f-7af8-42e7-bf17-56946a9b031b,Great Ormond Street Hospital for Children NHS Trust,great_ormond_street_hospital_for_children_nhs_trust,,,,136feb9a-ae28-4c13-afe3-e135660d48aa,great_ormond_street_hospital,Great Ormond Street Hospital +1068,0.97769945859909058,3c312b00-9fca-409e-b005-3d108414ea8a,Serono GmbH,serono_gmbh,,,,24095e02-bf25-4c7e-bbc3-925378eaba6e,serono,Serono +610,0.97921166817347205,4fd1c2ba-3c7e-4c2b-82ee-6305062f19b2,Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC),f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer_fnclcc,,,,4b5b75aa-a963-452e-848e-256ac41c5d72,f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer,Fédération Nationale des Centres de Lutte Contre le Cancer +8389,,062f95de-c0b3-429f-a09a-cc109fc1a147,Silvia Delgado Aros,silvia_delgado_aros,,,,,, +8390,,38071e25-e6a2-4317-bb07-f9dcd95c6d92,The Cardiovascular Research Foundation,the_cardiovascular_research_foundation,,,,,, +92,0.967029,dd4ee19e-34ae-40f8-9aae-033f641f0bc8,Diakonhjemmet hospital,diakonhjemmet_hospital,,,,c3e873ff-4ae6-499b-8ac6-5d8e2203e040,diakonhjemmet_hospital_as,Diakonhjemmet Hospital AS +8391,,7cdd0315-c0f0-43cd-b97d-923df0ba1554,maternite régionale de nancy,maternite_r_gionale_de_nancy,,,,,, +8392,,7eff464c-dceb-4e1b-9b93-7012dce7de84,Dept. Pharmacology and Toxicology,dept_pharmacology_and_toxicology,,,,,, +8393,,eaec7154-725d-11e6-a0cd-0242ac12000b,PF PRISM CV,pf_prism_cv,,,,,, +333,0.986197,c0de4999-a6b3-11e6-94cb-5656d04fc2b5,Nordsjællands Hospital Hillerød,nordsj_llands_hospital_hiller_d,,,,c0de4999-a6b3-11e6-94cb-5656d04fc2b5,nordsj_llands_hospital_hiller_d,Nordsjællands Hospital Hillerød +8394,,80fb0c79-55ee-49f8-b814-457626a6a5a9,FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DE CÓRDOBA,fundaci_n_para_la_investigaci_n_biom_dica_de_c_rdoba,,,,,, +763,0.970018,a6d9db1f-edb6-4e94-8f5a-2874c0b70848,Danish Multiple Sclerosis Research Center,danish_multiple_sclerosis_research_center,,,,20d8ecc2-872e-4d93-9419-6e3e20fea29f,danish_multiple_sclerosis_research_centre,Danish Multiple Sclerosis Research Centre +8395,,66d2c371-433d-4862-b28f-06734d8d2b55,Hospital Clínico de Barcelona,hospital_cl_nico_de_barcelona,,,,,, +158,0.98881235718727112,b02b5eef-9b45-4fff-a916-3bb4aff28b1e,Medizinische Universität Wien,medizinische_universit_t_wien,,,,5b2fbdce-d691-41c6-9a74-e06608d419f4,medizinische_universit_t_wien_hno_klinik,Medizinische Universität Wien +8396,,7557b4b6-675c-400a-a06d-ff4fb910f001,"Signe H. Østoft, Diabetes Research Division",signe_h_stoft_diabetes_research_division,,,,,, +8397,,291dfea0-7143-11e6-a0cd-0242ac12000b,TELIGENT PHARMA INC,teligent_pharma_inc,,,,,, +8398,,7bff389f-15ee-48f7-b3b8-ab9f1628f724,Kwizda Pharma GmbH,kwizda_pharma_gmbh,,,,,, +419,0.97916126251220703,80568dc5-c7dd-447e-8e6d-baa1274edf19,National and Kapodostrian University of Athens,national_and_kapodostrian_university_of_athens,,,,24418820-0b75-41e2-993c-2f2c0b00efb6,national_and_kapodistrian_university_of_athens,National and Kapodistrian University of Athens +8399,,84c99fbe-1b1e-470c-9a52-1a9a60ff7e11,Stockholm Spine Center,stockholm_spine_center,,,,,, +8400,,7188a583-9a8d-4e5c-867b-e437d0ab019a,Univ.-Prof. Dr. Doris Balogh,univ_prof_dr_doris_balogh,,,,,, +626,0.909952,35f0780b-f2b6-4584-86d6-148ae3464f6c,Chiron Corporation Limited,chiron_corporation_limited,,,,35f0780b-f2b6-4584-86d6-148ae3464f6c,chiron_corporation_limited,Chiron Corporation Limited +877,0.943406,3808b209-be03-4db8-a518-2ea52ecb1376,"Department of Dermatology, Bispebjerg Hospital",department_of_dermatology_bispebjerg_hospital,,,,06cdfc3c-1180-4e50-a488-39de382fbc30,department_of_dermatology_d92_bispebjerg_hospital,"Department of Dermatology D92, Bispebjerg Hospital" +8401,,42222ba5-ad32-4ea7-88fe-dbbdbb54526b,North Wales NHS Trust,north_wales_nhs_trust,,,,,, +8402,,5e9141bd-a4e5-4e5f-910f-65ee0abd7e7a,"Grachtenhaus-Apotheke, Inh. Klaus Stegemann e. K",grachtenhaus_apotheke_inh_klaus_stegemann_e_k,,,,,, +8403,,cc1603ea-7199-11e6-a0cd-0242ac12000b,IROKO PHARMS LLC,iroko_pharms_llc,,,,,, +8404,,66736469-0f43-4438-ba75-05a9824a2c90,"Faculty of Social Sciences, Utrecht University",faculty_of_social_sciences_utrecht_university,,,,,, +8405,,f17119d5-09b4-40f0-8509-c7c686f87d7e,Nicasio Pérez Castellano,nicasio_p_rez_castellano,,,,,, +8406,,575e0da4-c91b-4258-aecc-759c1f2d8342,"Theracos Sub, LLC",theracos_sub_llc,,,,,, +8407,,f6bdf8d3-c9f4-4f16-b855-4414da50f786,DRK-Blutspendedienst NSTOB,drk_blutspendedienst_nstob,,,,,, +8408,,e916dcc8-715b-11e6-a0cd-0242ac12000b,ABRAXIS PHARM,abraxis_pharm,,,,,, +822,0.986019,d9fce77e-b2c7-474f-bab0-ea6091e4e7af,Heinrich-Heine-Universität,heinrich_heine_universit_t,,,,7ea15226-d1e9-49e7-8712-7ea0bb120819,heinrich_heine_universit_t_duesseldorf,Heinrich-Heine-Universität Duesseldorf +8409,,6f127134-8bbf-11e6-a449-0242ac12000b,"Goethe-Universität Frankfurt, Universitätsklinikum, Med. Klinik II",goethe_universit_t_frankfurt_universit_tsklinikum_med_klinik_ii,,,,,, +563,0.973989,ef49786a-4fb9-413b-b119-def3fec33bb8,PETHEMA,pethema,,,,d2e15a44-a454-409f-91c0-cf787effc96f,pethema_foundation,PETHEMA Foundation +8410,,19c09765-4004-4efa-b168-c6778346cf14,Stockholm South General Hospital,stockholm_south_general_hospital,,,,,, +8411,,b03538ef-636a-43c6-a17e-dbc1a874adc6,MCM Klosterfrau GmbH & Co. KG,mcm_klosterfrau_gmbh_co_kg,,,,,, +8412,,4b4d5674-8109-4cc5-b89f-6bf59f37f6e0,Roche Products Ltd,roche_products_ltd,,,,,, +8413,,85f999d3-5551-4e49-8db3-cdc6d81128a7,JESSA Hospital,jessa_hospital,,,,,, +8414,,bdfbb931-dbf5-4f3b-ae88-d513cc367cd2,KEYRUS BIOPHARMA,keyrus_biopharma,,,,,, +8415,,357c0f03-5d74-4911-af3b-e2eabbc7c32a,"Lorenzo Victor, PhD",lorenzo_victor_phd,,,,,, +8416,,f015696d-9b92-4ac4-b6d6-55a99a204910,BAXTER SAS R&D Parenteral Nutrition,baxter_sas_r_d_parenteral_nutrition,,,,,, +8417,,52c58d80-a68b-4b70-8671-19c4e00fbf75,Antwerp University Hospital : Department Respiratory Medicine,antwerp_university_hospital_department_respiratory_medicine,,,,,, +8418,,15e72b21-d615-401b-bd67-e2b9c2d1cfa7,ADVANCELL,advancell,,,,,, +8419,,282ce3b7-41e1-4fa9-b37e-6bd99454fbcd,"Prospect Therapeutics, Inc",prospect_therapeutics_inc,,,,,, +8420,,b319719e-fa52-4f63-8c59-dc5166c4ff34,Assistance Publique - Hôpitaux de Paris (AP-HP),assistance_publique_h_pitaux_de_paris_ap_hp,,,,,, +8421,,2147b271-82dd-40d7-af7e-e7c37ecff8b1,Joint Sponsorship: University College London (UCL) & University College London Hospitals (UCLH),joint_sponsorship_university_college_london_ucl_university_college_london_hospitals_uclh,,,,,, +8422,,baf1222c-e00f-44d1-b0ab-67fdb136019d,"GlaxoSmithKline,s.r.o",glaxosmithkline_s_r_o,,,,,, +1,0.958633,5e39e1cf-f761-4acc-bd2c-247647d86e60,"Johnson & Johnson Pharmaceutical Research and Development, L.L.C",johnson_johnson_pharmaceutical_research_and_development_l_l_c,,,,5e39e1cf-f761-4acc-bd2c-247647d86e60,johnson_johnson_pharmaceutical_research_and_development_l_l_c,"Johnson & Johnson Pharmaceutical Research and Development, L.L.C" +8423,,0aecc8b6-73fb-11e6-a0cd-0242ac12000b,OPKO IRELAND GLOBAL,opko_ireland_global,,,,,, +8424,,611023fa-b1da-4f28-88b5-25cc3ed022fd,Clinica Universidad de Navarra/Universidad de Navarra,clinica_universidad_de_navarra_universidad_de_navarra,,,,,, +8425,,b75ae809-3780-4736-9441-8fa42596fe81,Research and Innovation Department,research_and_innovation_department,,,,,, +8426,,fa24fc1e-c68c-4d8e-8364-d9364fa701a0,"G&W Laboratories, Inc",g_w_laboratories_inc,,,,,, +8427,,afdb5bbb-7bea-42a1-92a7-96befb67835c,"University of Tartu, Clinic of Anaesthesiology and Intensive Care",university_of_tartu_clinic_of_anaesthesiology_and_intensive_care,,,,,, +96,0.9879,e1ba6dc0-7451-43a2-9dd8-9d794405ffb3,Mekos Laboratories AS,mekos_laboratories_as,,,,b29eb661-1920-4894-b0f1-fd365cb40e54,mekos_laboratories,Mekos Laboratories +8428,,702ec845-cbc0-4108-bac9-93304406ae22,Gilead Science Incorporated,gilead_science_incorporated,,,,,, +8429,,97065043-8217-4b9e-9193-9d2ddf3c9030,Tomi Niemi,tomi_niemi,,,,,, +8430,,42098708-c17c-4402-82ea-0ea6c4cebe70,Central Finland Hospital District,central_finland_hospital_district,,,,,, +939,0.9797365665435791,4daea4c8-d47a-49e5-8183-837377f6766e,"Hospira, Inc",hospira_inc,,,,2c899cf4-2f23-4023-b9ab-f8d5356588d9,hospira,Hospira +8431,,fa996ea2-e95d-44b1-8a52-e730532b2a6e,Fundación General de la Universidad de Salamanca,fundaci_n_general_de_la_universidad_de_salamanca,,,,,, +8432,,cff5f511-8147-480d-b98a-e8ba2f47332d,Tameside Hospital NHS Foundation Trust,tameside_hospital_nhs_foundation_trust,,,,,, +8433,,47f57ac8-48c6-4468-b458-678af82e311a,University of Magdeburg,university_of_magdeburg,,,,,, +521,0.965089,553c2b95-df0a-4f68-8370-358a1401e332,Department of Anaesthesia and General Intensive Care Medicine,department_of_anaesthesia_and_general_intensive_care_medicine,,,,1a46a2d5-d4cb-4f3f-8731-ed0b10a5b6d9,department_of_anaesthesia_general_intensive_care_medicine,Department of Anaesthesia & General Intensive Care Medicine +8434,,8bcc545e-de68-409b-8c8a-b4d53b3a4b89,Janssen R&D Ireland,janssen_r_d_ireland,,,,,, +8435,,cf855208-a916-4569-9cab-780a1a901420,Forschergruppe Diabetes e. V. am Helmholtz Zentrum München,forschergruppe_diabetes_e_v_am_helmholtz_zentrum_m_nchen,,,,,, +8436,,54624de5-6606-4d01-88f3-c8e19ae362e5,Smithkline Beecham Pvt Limited,smithkline_beecham_pvt_limited,,,,,, +308,0.987895,86807203-e56e-49a6-bcc8-c3d0deca55f4,Fundación Pública Andaluza para la Gestion de la Investigación en Salud de Sevilla,fundaci_n_p_blica_andaluza_para_la_gestion_de_la_investigaci_n_en_salud_de_sevilla,,,,86807203-e56e-49a6-bcc8-c3d0deca55f4,fundaci_n_p_blica_andaluza_para_la_gestion_de_la_investigaci_n_en_salud_de_sevilla,Fundación Pública Andaluza para la Gestion de la Investigación en Salud de Sevilla +656,0.985689,e662ee12-f532-4301-b8e7-3bd06977f501,Daniel Podzamczer,daniel_podzamczer,,,,1dc11f6f-51cc-4072-9340-b3162a901b0e,daniel_podzamczer_palter,Daniel Podzamczer Palter +8437,,17d0a3c7-aab3-43af-9ce0-8ab7defc8591,IRCCS ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI,irccs_istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori,,,,,, +8438,,6cf58b74-7167-11e6-a0cd-0242ac12000b,MA GENERAL HOSP,ma_general_hosp,,,,,, +8439,,61970725-10c2-4769-9b2b-0908835f16d6,"LMU München, Campus Großhadern",lmu_m_nchen_campus_gro_hadern,,,,,, +8440,,5144effc-767e-4002-8f3f-ba4ffca0f27e,Vivostat A/S,vivostat_a_s,,,,,, +8441,,37ee7ecb-8870-4132-96b7-7939f41aa41d,apceth GmbH & Co. KG,apceth_gmbh_co_kg,,,,,, +8442,,ae730708-a78f-11e6-94cb-5656d04fc2b5,Blekinge county council,blekinge_county_council,,,,,, +8443,,f90bac41-6145-4065-b9bc-0a043b7a2db5,GALMED Pharmaceuticals LTD,galmed_pharmaceuticals_ltd,,,,,, +8444,,08e6f4e5-879a-48c6-9c01-ad69c9a20be9,FUNDACION PARA LA INVESTIGACION HOSPITAL UNIVERSITARIO LA FE,fundacion_para_la_investigacion_hospital_universitario_la_fe,,,,,, +161,0.98196295897165931,cf84194a-b23a-4b1f-87a1-24b1fdec7e48,Fundación para la Investigación Biomedica del Hospital 12 de Octubre,fundaci_n_para_la_investigaci_n_biomedica_del_hospital_12_de_octubre,,,,393eab2d-fa2d-419a-8ecd-278e02b1ad5b,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_12_de_octubre,Fundación para la Investigación Biomédica del Hospital 12 de Octubre +8445,,6d03a1dd-803f-460f-991d-ec9984576ad7,"RWTH Aachen University, represented by the Rector, himself represented by Clinical Trial Center (CTC-A)",rwth_aachen_university_represented_by_the_rector_himself_represented_by_clinical_trial_center_ctc_a,,,,,, +8446,,a65de4b5-536d-49b7-967e-3e4e70d0a33a,"CPDS BERMUDA, LTD",cpds_bermuda_ltd,,,,,, +8447,,47c20cb7-42aa-40d6-b307-102844c8fedb,the All-Ireland cooperative oncology research group (ICORG),the_all_ireland_cooperative_oncology_research_group_icorg,,,,,, +8448,,1bafbb62-9e04-4416-8595-1668e1281d27,Eskelinen Matti/KYS,eskelinen_matti_kys,,,,,, +8449,,5f20da18-7157-11e6-a0cd-0242ac12000b,ACTAVIS LABS UT INC,actavis_labs_ut_inc,,,,,, +8450,,05a9562c-47f4-469c-8997-0a053b0976e0,CHU de Rouen,chu_de_rouen,,,,,, +8451,,461d0b70-8a39-4611-99fc-0a9d3aedd9eb,Institut de Recerca e la SIDA - IrsiCaixa-,institut_de_recerca_e_la_sida_irsicaixa,,,,,, +8452,,eeadf06c-7cd1-4240-80ec-56204cf1be4c,"IMPAX LABORATORIES, INC",impax_laboratories_inc,,,,,, +8453,,44b5f024-8d75-414e-91c5-9c1c723e250e,Acrux Pharma Pty Ltd,acrux_pharma_pty_ltd,,,,,, +8454,,d35e3c60-aa98-4973-b1ba-5eac9eb82bbf,Per Klausen Fink,per_klausen_fink,,,,,, +599,0.93973445892333984,53d727ca-f81e-4c5b-a9a5-c177cdd19cfc,Fundació Privada Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau,fundaci_privada_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,,,,53d727ca-f81e-4c5b-a9a5-c177cdd19cfc,fundaci_privada_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Fundació Privada Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau +863,0.921141,b6650928-ea79-463f-89b2-65d149cd973a,Immunicum Aktiebolag,immunicum_aktiebolag,,,,63ece514-1ecd-4555-8b78-f2736a1ee227,immunicum_ab,Immunicum AB +8455,,e45c2af0-8ba2-462e-b118-9825655e8327,CONSORZIO PER LA RICERCA ONCOLOGICA,consorzio_per_la_ricerca_oncologica,,,,,, +8456,,a34457c8-0f57-4f38-a0f4-6151dbd06986,Deventer Hospital,deventer_hospital,,,,,, +270,0.95828056335449219,8a7a48b6-3bc7-4979-b1d7-a8a21f8d3aa0,"AstraZeneca AB, AstraZeneca Sverige",astrazeneca_ab_astrazeneca_sverige,,,,b9740d19-9951-4510-b985-aa689195ab5f,astrazeneca_ab,AstraZeneca AB +8457,,8f2c8591-5e6e-45a5-9437-13560cb8860e,Endo Ventures Limited,endo_ventures_limited,,,,,, +8458,,58615f2a-f183-4833-a7a4-c7a9ff2293d3,The Norwegian Radium Hospital,the_norwegian_radium_hospital,,,,,, +113,0.971346,5c913850-fa7a-4490-8a20-b21a3b24bb85,"Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden",radiumhemmet_karolinska_university_hospital_stockholm_sweden,,,,5c913850-fa7a-4490-8a20-b21a3b24bb85,radiumhemmet_karolinska_university_hospital_stockholm_sweden,"Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden" +663,0.97166502475738525,57ad1b5e-ca5a-4470-9b1b-36e6151b1c01,Charité - Universitätsmedizin Berlin,charit_universit_tsmedizin_berlin,,,,57ad1b5e-ca5a-4470-9b1b-36e6151b1c01,charit_universit_tsmedizin_berlin,Charité - Universitätsmedizin Berlin +8459,,5a77b4d0-7c01-43f3-951a-5ab7a4de992b,Weber & Weber GmbH & Co.KG,weber_weber_gmbh_co_kg,,,,,, +8460,,e6eee0fb-76a3-4b71-a385-3662b0e9354f,"Kura Oncology Inc.,",kura_oncology_inc,,,,,, +8461,,7eae9d8a-4fc6-4882-86ab-0072b1228b37,Aventis Pharma,aventis_pharma,,,,,, +8462,,dcac9d85-1264-46c7-8583-6689353e28ca,Solvay pharmaceuticals,solvay_pharmaceuticals,,,,,, +8463,,fa7d1356-df3d-405a-a06b-00ef2487343a,Pfizer Oy,pfizer_oy,,,,,, +8464,,0d9bf202-8f79-48de-a216-b6f9a89c1385,Central and North West London NHS Foundation Trust (Camden Provider Services),central_and_north_west_london_nhs_foundation_trust_camden_provider_services,,,,,, +8465,,45ffadb2-1b18-4d1b-a562-966136cead4f,Royal Liverpool and Broadgreen Hospitals NHS Trust,royal_liverpool_and_broadgreen_hospitals_nhs_trust,,,,,, +8466,,c6a79f32-c06a-413c-9b5e-081137516c04,U.L.S.S. 16,u_l_s_s_16,,,,,, +8467,,5c10833a-9b8d-40eb-958a-3e3336e468f2,CHU POITIERS,chu_poitiers,,,,,, +8468,,d635ae30-0015-4b80-a6f5-953b1e07bb24,Heads Study Group,heads_study_group,,,,,, +8469,,61462924-1bcc-4db5-94c6-24d641470471,NOVIMMUNE BV,novimmune_bv,,,,,, +8470,,d28f19ee-6ea2-42bf-9212-e2766527fc5e,Karl Landsteiner Institut für klinische Neurologie und Neuropsycholigie,karl_landsteiner_institut_f_r_klinische_neurologie_und_neuropsycholigie,,,,,, +8471,,f033e3c7-bf52-4f51-aaa2-70eb0e2b53bd,Pharmalink AB,pharmalink_ab,,,,,, +8472,,5e7f3498-a53c-4e6a-9e26-1fc9f582df0f,Stichting astma bestrijding,stichting_astma_bestrijding,,,,,, +8473,,a93d3e0e-3073-4d60-acb3-a9bb10573452,(GOTEL) Grupo Oncológico para el tratamiento y estudio de los linfomas,gotel_grupo_oncol_gico_para_el_tratamiento_y_estudio_de_los_linfomas,,,,,, +8474,,e9cc38f6-8bd8-11e6-a449-0242ac12000b,University Hospital of Tuebingen,university_hospital_of_tuebingen,,,,,, +8475,,c29c3df2-ad4a-456f-8126-aa6dfe596211,INMUNAL SAU,inmunal_sau,,,,,, +8476,,61823aa6-9d11-4d40-84c9-7022d717128e,"Schering-Plough Corporation, a Subsidiary of Merck & Co.,Inc",schering_plough_corporation_a_subsidiary_of_merck_co_inc,,,,,, +8477,,0c8d5319-cc37-42e7-b624-b364463408a4,"Orion Corporation, ORION PHARMA, 02200 Espoo, Finland",orion_corporation_orion_pharma_02200_espoo_finland,,,,,, +8478,,989f372d-d69b-4408-9eea-3df26e181851,Westdeutsche Studiengruppe GmbH,westdeutsche_studiengruppe_gmbh,,,,,, +8479,,59e950e6-7145-11e6-a0cd-0242ac12000b,VIVIMED LABS,vivimed_labs,,,,,, +8480,,12445483-8cb9-4eac-983c-c1a340cec868,UMCN St Radboud,umcn_st_radboud,,,,,, +8481,,81c4b59f-dbe4-4dd7-9be9-49008a5d7b79,Develco Pharma Schweiz AG,develco_pharma_schweiz_ag,,,,,, +8482,,c24b5e6d-795a-4dd3-93c9-2467f5ef7cda,"Fundacion para la Investigación ""Hospital Universitario Doctor Peset",fundacion_para_la_investigaci_n_hospital_universitario_doctor_peset,,,,,, +8483,,82dd2df8-fd55-4ea1-9b46-52e94ab64138,FUNDACION IMABIS,fundacion_imabis,,,,,, +8484,,12bc94f0-6a39-4b62-bad5-e7160a854672,Mater Research Institute University of Queensland,mater_research_institute_university_of_queensland,,,,,, +8485,,718ffea8-1ed5-45d9-ad45-ee37e61ed5b6,Bayhill Therapeutics,bayhill_therapeutics,,,,,, +8486,,1b4c94d6-d91e-4d34-9a00-2d0e51872088,Institut de Cardiologie de Montréal,institut_de_cardiologie_de_montr_al,,,,,, +8487,,b6afcbf9-28b0-4507-8559-64546263dd79,"Onyx Pharmaceuticals, Inc",onyx_pharmaceuticals_inc,,,,,, +955,0.979762,801fd107-9dff-425d-aeed-c20bed8847c1,"AZTherapies, Inc., Pure Tech Health",aztherapies_inc_pure_tech_health,,,,801fd107-9dff-425d-aeed-c20bed8847c1,aztherapies_inc_pure_tech_health,"AZTherapies, Inc., Pure Tech Health" +8488,,69d1a2ec-48f6-47c6-a280-c2e1657baa8c,University of Technology Dresden,university_of_technology_dresden,,,,,, +1037,0.979231,c82ae3b8-715d-11e6-a0cd-0242ac12000b,MUSTAFA NEVSAT IIAC SANAYII A.S,mustafa_nevsat_iiac_sanayii_a_s,,,,72bda612-7163-11e6-a0cd-0242ac12000b,mustafa_nevsat,MUSTAFA NEVSAT +8489,,b0385d68-73fa-11e6-a0cd-0242ac12000b,APRECIA PHARMS CO,aprecia_pharms_co,,,,,, +8490,,38314a7f-5a3d-4655-bca0-7cdf4979157a,"Dr. Juan D. Cañete Crespillo, Hospital Clínic de Barcelona",dr_juan_d_ca_ete_crespillo_hospital_cl_nic_de_barcelona,,,,,, +8491,,a8844d66-b4fa-446a-baa2-b308e00c89ac,Amersham plc,amersham_plc,,,,,, +8492,,1cf1b0d8-2fa0-4d08-a1a9-ef176b6a1973,University Hospital Ulm,university_hospital_ulm,,,,,, +8493,,294f9979-35f6-45c4-9615-ba04866fcc98,Roskamp Institute,roskamp_institute,,,,,, +8494,,d120fc38-8539-4b8b-9e74-7d2a19f59d08,AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA,azienda_ospedaliera_spedali_civili_di_brescia,,,,,, +8495,,ef546ec8-feac-4799-831d-6eb79f0acffb,OSPEDALE PEDIATRICO BAMBINO GESU' DI ROMA,ospedale_pediatrico_bambino_gesu_di_roma,,,,,, +8496,,c80c38e8-8be6-11e6-a449-0242ac12000b,Actavis Hungary Gyógyszermarketing és Kereskedelmi Korlátolt Felelősségű Társaság,actavis_hungary_gy_gyszermarketing_s_kereskedelmi_korl_tolt_felel_ss_g_t_rsas_g,,,,,, +8497,,01cac4c1-1aed-4d00-a351-85e5f11263f8,Boehringer Ingelheim Pharma Ges.m.b.H,boehringer_ingelheim_pharma_ges_m_b_h,,,,,, +8498,,b41aa9cc-fd49-43c0-8946-e794c2f212e3,AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI,azienda_ospedaliera_di_bologna_policlinico_s_orsola_m_malpighi,,,,,, +8499,,149e6132-8b28-48d3-a69d-5fc8c34df12f,Seven Seas Limited,seven_seas_limited,,,,,, +8500,,9150348d-f4df-46d3-b622-6561e31bf3dd,MEDA Pharma GmbH & Co. KG,meda_pharma_gmbh_co_kg,,,,,, +8501,,74666f50-7bc8-41d0-8146-e1d959e6a656,"Schering-Plough Farma, Lda",schering_plough_farma_lda,,,,,, +552,0.945615,189b51d9-0d8d-4344-a7e0-4ad5e8c1742d,Grifols Biologicals Inc,grifols_biologicals_inc,,,,189b51d9-0d8d-4344-a7e0-4ad5e8c1742d,grifols_biologicals_inc,Grifols Biologicals Inc +8502,,8945fc19-02f5-47fd-9fff-a64c8a007292,University Hospital Department of Cardiology,university_hospital_department_of_cardiology,,,,,, +8503,,ceca4495-b66a-450d-8c1a-48cd006cb56b,E.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER,e_o_r_t_c_european_organization_for_research_and_treatment_of_cancer,,,,,, +8504,,f391dbb5-74f7-40a5-92f5-1ee001d3840a,University of Copenhagen,university_of_copenhagen,,,,,, +8505,,2bbc2c7f-ee1c-4c5a-adcc-847444413edd,Arrowhead Research Corporation,arrowhead_research_corporation,,,,,, +8506,,70c67868-c506-46cd-8495-381a460691bb,ΕΛΛΗΝΙΚΗ ΕΤΑΙΡΕΙΑ ΙΑΤΡΙΚΗΣ ΕΚΠΑΙΔΕΥΣΗΣ (Hellenic Society of Medical Education),hellenic_society_of_medical_education,,,,,, +277,0.96881628036499023,5464b0d0-1cc0-4ac6-9b8e-7690af086db6,"Teva Branded Pharmeceutical Products R&D, Inc",teva_branded_pharmeceutical_products_r_d_inc,,,,71fa3658-cdd0-4248-b428-53aae9afea66,teva_branded_pharmaceutical_products_r_d_inc,"Teva Branded Pharmaceutical Products R&D, Inc" +8507,,9e598b58-0472-4f75-b151-873cb5ef2887,Univeritetssjukhuset Örebro,univeritetssjukhuset_rebro,,,,,, +47,0.913597,79a6fb52-ac9b-48f4-831c-9878fac75c8a,Sintetica SA,sintetica_sa,,,,31bad48e-93ea-4c40-8057-5790bbe13494,sintetica_s_a,Sintetica S.A +371,0.976266,f74957e9-053b-4b18-be53-6e4795a8288d,AMGEN,amgen,,,,d647a1c4-2ac3-45cc-b98d-47490b4597d7,amgen_inc,AMGEN INC +652,0.93963295221328735,756fbf26-6aec-45b4-9273-9afca275034e,"Boehringer Ingelheim Pharmaceuticals, Inc",boehringer_ingelheim_pharmaceuticals_inc,,,,756fbf26-6aec-45b4-9273-9afca275034e,boehringer,Boehringer +8508,,9f8c4142-83e5-4604-a618-99959d4080fc,CHU of Liege,chu_of_liege,,,,,, +8509,,04ab2ef0-761c-474f-bbc6-399ab5e46067,National Institute of Child Health,national_institute_of_child_health,,,,,, +8510,,5b038daf-79e1-4cdc-a323-a4682a9400f9,LAURA TARRATS VELASCO,laura_tarrats_velasco,,,,,, +8511,,4cdae716-c056-4f14-965d-fac75d9ee4d9,University Hospital Motol,university_hospital_motol,,,,,, +8512,,bbc263d9-ca8f-4fa8-9eee-c55046b5a00e,Rgshospitalet,rgshospitalet,,,,,, +319,0.943406,8fd294ea-aee1-4e2e-86ed-6265cb17d1af,MERCK SERONO SA,merck_serono_sa,,,,8fd294ea-aee1-4e2e-86ed-6265cb17d1af,merck_serono_sa,MERCK SERONO SA +8513,,153407e9-b8d2-4405-a219-72d0d6f58a66,Gottfries Clinic,gottfries_clinic,,,,,, +8514,,814cdb2c-b2c8-4260-ad4d-2133ade8dec9,DR DIMENSIONE RICERCA,dr_dimensione_ricerca,,,,,, +8515,,5f77d6a0-1f07-4767-a4ef-f6d7338bfb7a,Yale University School of Medicine,yale_university_school_of_medicine,,,,,, +8516,,150ca6bd-2f23-49a6-9d78-e1ef5bfcc3fd,Montavit Ges.m.b.H,montavit_ges_m_b_h,,,,,, +77,0.942699,56d56d9c-d583-406f-8098-1497a470593d,ITF Research Pharma S.L.U,itf_research_pharma_s_l_u,,,,56d56d9c-d583-406f-8098-1497a470593d,itf_research_pharma_s_l_u,ITF Research Pharma S.L.U +588,0.914544,afbb1de6-db13-464b-bc5e-86990914b650,Hospital of the Ludwig-Maximilians-University of Munich,hospital_of_the_ludwig_maximilians_university_of_munich,,,,19952d22-67c1-4b82-9279-54d9c48ca7a5,hospital_of_the_ludwig_maximilians_university_munich,Hospital of the Ludwig Maximilians University Munich +394,0.97813,2a062c79-99fa-45ef-95f7-3bfbfa472661,Unidad de Investigación, Hospital Universitario de Canarias,,,,2a062c79-99fa-45ef-95f7-3bfbfa472661, Hospital Universitario de Canarias,Unidad de Investigación +8517,,298e58d0-f0a0-443c-9892-7455c9173140,Ocera Therapeutics Inc,ocera_therapeutics_inc,,,,,, +8518,,69f3ebfa-a2af-49b6-9de2-520ab2bfccca,Metacure Ltd,metacure_ltd,,,,,, +8519,,414d369c-cc51-43de-aad1-2490fe66bd5a,Sven-Åke Lundin,sven_ke_lundin,unidad_de_investigaci_n_hospital_universitario_de_canarias,,,,, +8520,,7a6b3e4a-337c-4d33-bc26-7e802d5ba416,Norpharma A/S,norpharma_a_s,,,,,, +8521,,aa5fc0e2-7253-4730-b3d3-dd3a9897795b,Medisch Centrum Haaglanden,medisch_centrum_haaglanden,,,,,, +8522,,426f82dd-79bc-4abf-bb28-b2df52b9e420,Neo Vista Inc,neo_vista_inc,,,,,, +8523,,78b06561-b0b0-48f8-8150-bb5ff5cb08f1,"Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena",universit_tsklinikum_jena_friedrich_schiller_universit_t_jena,,,,,, +8524,,17311942-3da4-4739-98c6-ff0033cf1296,GABA International AG,gaba_international_ag,,,,,, +8525,,be5f9a14-8446-4a82-a871-65304ba16b98,LTB4 Sweden AB,ltb4_sweden_ab,,,,,, +8526,,2f11f65c-e342-4a47-9e40-9b8133f318bc,"AtheroGenics, Inc",atherogenics_inc,,,,,, +8527,,19f8e9a3-8e92-4ae5-8c4c-b21b90806ab9,ACE Aps,ace_aps,,,,,, +8528,,c9a11db2-715c-11e6-a0cd-0242ac12000b,REDDYS,reddys,,,,,, +8529,,3a6de2da-4719-48b1-8d56-b996f3f5ce40,DIATER LABORATORIES S.A,diater_laboratories_s_a,,,,,, +8530,,edfd2ebf-1119-4a16-bcdb-e2a763cffa86,REGIONE LOMBARDIA - DIREZIONE GENERALE SANITA',regione_lombardia_direzione_generale_sanita,,,,,, +8531,,2e74cce4-715c-11e6-a0cd-0242ac12000b,BIOCON LIMITED,biocon_limited,,,,,, +8532,,90c31082-7129-11e6-a89e-0242ac12000b,RISING PHARMS INC,rising_pharms_inc,,,,,, +505,0.977622,6555c8c6-714d-11e6-a0cd-0242ac12000b,MEDICIS PHARMS,medicis_pharms,,,,6555c8c6-714d-11e6-a0cd-0242ac12000b,medicis_pharms,MEDICIS PHARMS +8533,,7549b9ee-71f3-11e6-a0cd-0242ac12000b,ONY,ony,,,,,, +8534,,96283000-c8a5-423a-9b74-84199a338271,"Siegfried Kasper, O.Univ.Prof.Dr.Dr.h.c",siegfried_kasper_o_univ_prof_dr_dr_h_c,,,,,, +8535,,03508f85-28d6-49b0-899f-bc01fb89a51b,Novartis CPO to fill,novartis_cpo_to_fill,,,,,, +8536,,0170ea56-e0f8-46a0-8268-c4839915de95,The Office of Interventional Cardiovascular Research and Clinical Trials at Icahn School of Medicine at Mount Sinai,the_office_of_interventional_cardiovascular_research_and_clinical_trials_at_icahn_school_of_medicine_at_mount_sinai,,,,,, +8537,,e84ed8ed-b89d-4e73-93ef-f2364654fe60,South-Eastern Norway Regional Health Authority,south_eastern_norway_regional_health_authority,,,,,, +8538,,bec15c61-5eb7-4259-b4a8-f55b88b28003,Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg,medizinische_fakult_t_der_martin_luther_universit_t_halle_wittenberg,,,,,, +8539,,f727a384-7128-11e6-a89e-0242ac12000b,ROXANE,roxane,,,,,, +8540,,4e911077-8df8-48bb-8e6a-719a06f22bed,advanceCOR GmbH,advancecor_gmbh,,,,,, +8541,,f0ac051d-47b2-4a80-90d4-89b033a1570a,Fondazione IRCCS Istituto Nazionale dei Tumori,fondazione_irccs_istituto_nazionale_dei_tumori,,,,,, +8542,,3230e5f1-6d50-4807-a765-0bc8298c6a16,University Hospital of Heidelberg,university_hospital_of_heidelberg,,,,,, +8543,,1d789de2-e749-4c90-9236-a57dbdbbad1f,CHU de Limoges,chu_de_limoges,,,,,, +8544,,8fb152b2-7304-11e6-a0cd-0242ac12000b,JANSSEN PRODS,janssen_prods,,,,,, +8545,,fa23d0d1-9589-49cc-bc92-dc2f58973fa7,"Wyeth Pharmaceuticals, Inc., Global Medical Affairs",wyeth_pharmaceuticals_inc_global_medical_affairs,,,,,, +8546,,98b62535-eb88-468a-a5bb-669764424c76,"Stockholm Centre for Dependency Disorders, Department of Clinical Neuroscience, Karolinska Institutet",stockholm_centre_for_dependency_disorders_department_of_clinical_neuroscience_karolinska_institutet,,,,,, +653,0.98108148574829102,5c99ca16-39a1-4b89-bbde-8627966f253d,Boehringer Ingelheim RCV GmbH,boehringer_ingelheim_rcv_gmbh,,,,5c99ca16-39a1-4b89-bbde-8627966f253d,boehringer_ingelheim_rcv_gmbh,Boehringer Ingelheim RCV GmbH +8547,,486407f2-2fce-4be9-a316-4060cb2fc5c5,Ipsen Pharma SAS,ipsen_pharma_sas,,,,,, +8548,,d1f99600-153b-4f55-aa26-798012add92e,Boehringer Ingelheim s.r.o,boehringer_ingelheim_s_r_o,,,,,, +517,0.96932509541511536,86458a7f-c0bc-482a-80b9-0330eb6f720f,GELTAMO (Grupo Español de Linfomas y Trasplante autólogo de Médula Ósea),geltamo_grupo_espa_ol_de_linfomas_y_trasplante_aut_logo_de_m_dula_sea,,,,be21c811-4df1-4aa6-8fd6-8b4eb1416f21,geltamo_grupo_espa_ol_de_linfomas_y_transplante_aut_logo_de_m_dula_sea,GELTAMO (Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea) +55,0.95857,5a63db65-468a-4563-9a1e-ba584e5873db,EGIS Gyógyszergyár Nyrt,egis_gy_gyszergy_r_nyrt,,,,43cce800-7149-11e6-a0cd-0242ac12000b,egis,EGIS +8549,,79677272-7163-11e6-a0cd-0242ac12000b,INJECTALIA,injectalia,,,,,, +8550,,0724fe03-4eb0-44f4-8d79-0210316944da,Clinical Research Facilities,clinical_research_facilities,,,,,, +749,0.982152,a8d90b28-ad65-456b-9297-a3e69229fbac,"LABORATORIOS FARMACEUTICOS ROVI, S.A",laboratorios_farmaceuticos_rovi_s_a,,,,7b2e0c4c-d3a5-4991-85ad-b05ef3d7b13e,laboratorios_farmac_uticos_rovi_s_a,"LABORATORIOS FARMACÉUTICOS ROVI, S.A" +8551,,8791673e-8be6-11e6-a449-0242ac12000b,"Medical University Vienna, Gender Medicine Unit, Div. of Endocrinology, Dep of Medicine III",medical_university_vienna_gender_medicine_unit_div_of_endocrinology_dep_of_medicine_iii,,,,,, +8552,,6d0e4e17-0b53-43cd-8cf6-9932ec07b4f1,Johanna Mäenpää,johanna_m_enp,,,,,, +8553,,dde71341-90f4-4a0a-84bd-f1eea260ea15,GBG Forschungs GmbH,gbg_forschungs_gmbh,,,,,, +744,0.98492534955342614,06d53b6c-58a5-4238-a169-c97555ce4cf1,Johann Wolfgang Goethe-Universität Frankfurt,johann_wolfgang_goethe_universit_t_frankfurt,,,,7c93ba08-6123-42f2-a902-d13e42cdd905,johann_wolfgang_goethe_universit_t_frankfurt,Johann Wolfgang Goethe-Universität Frankfurt +22,0.97528120875358582,ae6ad20a-a5ac-4fda-adad-69b8ff220a6a,"University Hospital Heidelberg, Ruprecht-Karls-University Heidelberg",university_hospital_heidelberg_ruprecht_karls_university_heidelberg,,,,ae6ad20a-a5ac-4fda-adad-69b8ff220a6a,university_hospital_heidelberg,University Hospital Heidelberg +8554,,d796a0fa-608c-485a-b0cb-5528cd3f7de8,The Christie NHS Foundation Trust,the_christie_nhs_foundation_trust,,,,,, +8555,,9aba76ae-4e83-45d8-a39e-ca3c06e6f106,AMW GmbH,amw_gmbh,,,,,, +8556,,575d5228-4dd5-4c6d-8412-00a9c8bdc686,The Kirby Institute,the_kirby_institute,,,,,, +8557,,6f3a088a-9e6a-496d-8b4b-9b5bad0c2bed,CIBER (Centro de Investigacion Biomedica en Red),ciber_centro_de_investigacion_biomedica_en_red,,,,,, +8558,,f48570be-112c-4557-8e43-3c9a9d1508b2,Anna Suy Franch,anna_suy_franch,,,,,, +696,0.987337,b9b9cd67-cc2d-4d60-877a-6105b013d4c8,Banc de Sang i Teixits (BST),banc_de_sang_i_teixits_bst,,,,221108ee-7307-42f8-832d-e148617d109a,banc_de_sang_i_teixits,Banc de Sang i Teixits +8559,,e3e976d1-bf4e-4ab6-b7b8-7dbd1b39b6ee,University Hospital Bern,university_hospital_bern,,,,,, +8560,,8a0b43a1-3d86-4919-b5aa-f57bbb85c060,Universidad Autónoma de Madrid,universidad_aut_noma_de_madrid,,,,,, +8561,,50b22772-cfc7-43c3-91ca-536cf7a75265,CNIC Centro Nacional de Investigaciones Cardiológicas,cnic_centro_nacional_de_investigaciones_cardiol_gicas,,,,,, +8562,,672f5bd0-735a-11e6-a0cd-0242ac12000b,ARALEZ PHARMS INC,aralez_pharms_inc,,,,,, +8563,,1d0e99a6-8e82-46a6-aac7-a39eaa75a5fd,ThromboGenics NV,thrombogenics_nv,,,,,, +8564,,94b7ee98-6000-4011-8cc7-f5417dc19486,"National Institute of Oncology, Budapest, Hungary",national_institute_of_oncology_budapest_hungary,,,,,, +8565,,0a6ad179-3bad-4053-b202-cedd4b3d4261,"CENTER LABORATORIES, INC",center_laboratories_inc,,,,,, +8566,,9c9c5294-5b9d-444c-b4b0-b6e65623c5be,Cytos Biotechnology AG,cytos_biotechnology_ag,,,,,, +8567,,fa963581-ca1b-4b1e-9d75-cc00ed30a4bb,University Medical Centre Groningen,university_medical_centre_groningen,,,,,, +8568,,e9e240a4-cc93-4b86-a3d7-0c0c21dd42cc,Philipps-University,philipps_university,,,,,, +8569,,f5831514-980e-46fb-8ab4-1a68284a1ad3,MolMed S.p.A,molmed_s_p_a,,,,,, +412,0.98863863945007324,404bfbb4-d805-4edf-b568-5d60418c0c9b,"Karolinska University Hospital, Huddinge, Sweden",karolinska_university_hospital_huddinge_sweden,,,,404bfbb4-d805-4edf-b568-5d60418c0c9b,karolinska_university_hospital_huddinge_sweden,"Karolinska University Hospital, Huddinge, Sweden" +8570,,a112f96f-0d28-431a-943d-edbe9b8d2859,Mikko Hippeläinen,mikko_hippel_inen,,,,,, +8571,,5f26762d-37d0-416b-b4b9-32249e42c2d9,"CELLTRION, Inc",celltrion_inc,,,,,, +8572,,f154b634-800d-431b-84ee-99ef864397de,GlaxoSmithKline UK Limited,glaxosmithkline_uk_limited,,,,,, +8573,,1143e04a-715e-11e6-a0cd-0242ac12000b,AUROBINDO PHARMA USA,aurobindo_pharma_usa,,,,,, +8574,,5f00e1df-3a89-41b4-8e61-b59f8c07f122,Dr. Winzer Pharma,dr_winzer_pharma,,,,,, +8575,,ce6e748a-73a4-425b-930d-b23b453b6182,GETH (GRUPO ESPAÑOL DE TRASPLANTES HEMOTOPOYETICOS Y TERAPIA CELULAR),geth_grupo_espa_ol_de_trasplantes_hemotopoyeticos_y_terapia_celular,,,,,, +8576,,086dda01-2334-4c24-a48d-ee39a9babce8,Leeds Teaching Hospitals Trust,leeds_teaching_hospitals_trust,,,,,, +484,0.969424,851476be-27ba-4eab-b5ff-59a3965254fc,"Department of Anesthesiology, University Hospital of Erlangen",department_of_anesthesiology_university_hospital_of_erlangen,,,,3ee3992f-cbe0-49c2-8456-39b7a3c82ed9,department_of_anesthesiology_university_hospital_erlangen,"Department of Anesthesiology, University Hospital Erlangen" +8577,,58d478d4-f3f4-4eeb-bcd1-46e6ca5a43f7,Baxter Innovations GmbH,baxter_innovations_gmbh,,,,,, +8578,,87ee186c-7142-11e6-a0cd-0242ac12000b,CHARTWELL LIFE SCI,chartwell_life_sci,,,,,, +8579,,94b75458-5d54-4527-9427-8676008a3bef,Bipebjerg University Hospital,bipebjerg_university_hospital,,,,,, +8580,,a5cff0e0-778f-44f8-8ceb-1415a15d12db,THERAVECTYS,theravectys,,,,,, +8581,,8f759896-7145-11e6-a0cd-0242ac12000b,AUROLIFE PHARMA LLC,aurolife_pharma_llc,,,,,, +8582,,02e08fad-1cab-4d05-b0be-83df1880a266,The Whittington Hospital NHS Trust,the_whittington_hospital_nhs_trust,,,,,, +8583,,e271f333-7430-4959-91cc-4a5ee5c5f8f8,LEGA ITALIANA PER LA LOTTA CONTRO I TUMORI,lega_italiana_per_la_lotta_contro_i_tumori,,,,,, +908,0.95613819360733032,9c45d693-515d-4149-92e4-d7272d06a7df,sanofi-aventis Recherche & D2veloppement,sanofi_aventis_recherche_d2veloppement,,,,9c45d693-515d-4149-92e4-d7272d06a7df,sanofi_aventis_recherche_d_veloppement,sanofi-aventis Recherche & Développement +8584,,eec74860-f316-4df4-aef0-8bb42850a050,Laura Sararols Ramsay,laura_sararols_ramsay,,,,,, +8585,,9c2a7111-85b4-42d0-8ee6-c119b837d44b,"Department of Neurology, Academic Medical Center",department_of_neurology_academic_medical_center,,,,,, +8586,,803dcb85-110d-40c4-a1df-c2a8def0a7eb,University College London-Joint UCLH/UCL Biomedical (R&D) Unit,university_college_london_joint_uclh_ucl_biomedical_r_d_unit,,,,,, +8587,,6478bcb8-71a9-11e6-a0cd-0242ac12000b,ROCHE PALO,roche_palo,,,,,, +8588,,0fe47fcd-cb46-4481-81bd-ca0352aa2d91,CENTRE ANTOINE LACASSAGNE,centre_antoine_lacassagne,,,,,, +8589,,51aa5a17-9203-408d-85ca-388b24dd49a2,Kenta Biotech Ltd,kenta_biotech_ltd,,,,,, +8590,,984ddd59-eadf-4c8f-9faf-9bb31dc53532,Societa' Italiana di Diabetologia,societa_italiana_di_diabetologia,,,,,, +8591,,c5279ad7-5404-411b-9e99-a86789a7e823,Ark Therapeutics Limited,ark_therapeutics_limited,,,,,, +167,0.980699,4f0d312c-f55c-48d0-9554-4b675d8c084f,Universität zu Köln,universit_t_zu_k_ln,,,,4f0d312c-f55c-48d0-9554-4b675d8c084f,universit_t_zu_k_ln,Universität zu Köln +8592,,9cd44c78-715c-11e6-a0cd-0242ac12000b,PHARMALUCENCE,pharmalucence,,,,,, +8593,,dc87ddd7-e28b-4504-9ef9-c51e984aa3a0,Proreo Pharma Innovation AG,proreo_pharma_innovation_ag,,,,,, +8594,,25c396cf-84c9-47c3-a878-f254456b9de1,José Antonio Pérez Simón,jos_antonio_p_rez_sim_n,,,,,, +8595,,62cd5c4c-e532-4f20-8563-3aefe0cb858c,Medizinische Universitätsklinik,medizinische_universit_tsklinik,,,,,, +8596,,509a8302-af1b-43a2-88ec-1b492877788a,Futura Medical Developments (FMD),futura_medical_developments_fmd,,,,,, +8597,,d32724c6-06e2-4758-a95b-25c2c57aab23,Pawel Florkiewicz,pawel_florkiewicz,,,,,, +8598,,ad3f0dcb-3ad5-472a-acf6-cb1ce09bede5,"Janssen-Cilag, S.A",janssen_cilag_s_a,,,,,, +8599,,70c7dd08-ee16-48f8-a07f-67a172a1aa82,European Society for Blood and Marrow Transplantation,european_society_for_blood_and_marrow_transplantation,,,,,, +8600,,0ffa445e-7168-11e6-a0cd-0242ac12000b,ANBISON LAB CO LTD,anbison_lab_co_ltd,,,,,, +8601,,d5e0ad2c-d114-4afc-89c3-769b5a8a107c,"Department für Virologie, Medizinische Universität Wien",department_f_r_virologie_medizinische_universit_t_wien,,,,,, +481,0.98966941237449646,48f0d5ed-174c-4ce4-98d7-cc34770f5107,Medizinische Universität Graz,medizinische_universit_t_graz,,,,48f0d5ed-174c-4ce4-98d7-cc34770f5107, Universitätsklinik für Innere Medizin,Medizinische Universität Graz +8602,,f7e338d3-5e0c-452e-9727-8df788943738,Fundación Retinaplus +,fundaci_n_retinaplus,,,,,, +8603,,b015e510-6fa1-11e6-9663-0242ac12000b,Eli Lilly UK,eli_lilly_uk,,,,,, +664,0.97318911552429199,cc686593-ac41-4dd8-b68b-ccd4a6588b2c,"Charité Berlin, CBF",charit_berlin_cbf,,,,56238a57-b5e3-44be-840b-09e7fea2a5aa,charit,Charité +8604,,3ad51325-5ecd-42ef-9760-f36bb3674207,Jose Ignacio Martin Gomez,jose_ignacio_martin_gomez,,,,,, +8605,,fbaba358-6808-4155-b341-ad1990ad7875,"First Department of Medicine, University of Szeged",first_department_of_medicine_university_of_szeged,,,,,, +8606,,b7611d98-070e-42a9-99ae-a5a3e89960eb,Regulus Therapeutics Inc,regulus_therapeutics_inc,,,,,, +8607,,d7ee6ebb-5405-4626-9a65-4ad8ed539860,St. Olavs Hospital,st_olavs_hospital,,,,,, +8608,,5fd24618-b084-4cc8-82f1-c4a6615a4b85,Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose NVALT,nederlandse_vereniging_van_artsen_voor_longziekten_en_tuberculose_nvalt,,,,,, +8609,,ed72c883-bfac-42e5-a6f2-c3c824973c5a,Ilkka Helenius,ilkka_helenius,,,,,, +8610,,9758bb50-7326-11e6-a0cd-0242ac12000b,SHIRE ORPHAN THERAP,shire_orphan_therap,,,,,, +8611,,73cc4f55-e2c7-4344-be08-d3dde6d76532,"Medizinische Universität Wien,Univ.Klinik f.Psychiatrie und Psychotherapie",medizinische_universit_t_wien_univ_klinik_f_psychiatrie_und_psychotherapie,,,,,, +8612,,9b77457d-8e35-4cb1-8662-e24942e6482a,"Tampere University, Faculty of Medicine, Department of Ophthalmology",tampere_university_faculty_of_medicine_department_of_ophthalmology,,,,,, +8613,,e9cb07a3-33d7-4644-84af-6d1b067635d9,"Deutsche CLL-Studiengruppe, Innere Medizin I, Uniklinik Köln",deutsche_cll_studiengruppe_innere_medizin_i_uniklinik_k_ln,,,,,, +8614,,9d38b4c9-c073-4438-8b16-d7104470a4b0,Prosidion Ltd,prosidion_ltd,,,,,, +8615,,b4703879-359b-4f88-b1be-3719ee244557,Fundación Oncosur,fundaci_n_oncosur,,,,,, +8616,,94540c7e-ed38-4069-8e61-d6ca81d4202e,"University Hospital Tubeingen, Department for Anaesthesiology and Intensive Care Medicine",university_hospital_tubeingen_department_for_anaesthesiology_and_intensive_care_medicine,,,,,, +8617,,4cc1800f-5955-4a3c-95c3-a27d7987f5a8,Klinikum Bremen-Mitte gGmbH,klinikum_bremen_mitte_ggmbh,,,,,, +8618,,d1bb5812-534c-433d-9b27-2cd7d4fc1c7f,KUREHA CORPORATION,kureha_corporation,,,,,, +8619,,801f5f7c-78fe-4a3b-876a-e2eb97bbb1b5,"Faculty of Pharmacy, University of Ljubljana",faculty_of_pharmacy_university_of_ljubljana,,,,,, +8620,,0774bc57-1d2e-45f8-934e-0910726813b8,TETEC – Tissue Engineering Technologies – AG,tetec_tissue_engineering_technologies_ag,,,,,, +547,0.96279633045196533,f39351ef-0171-4a59-8396-08eb684a148b,G.O.N.O. - GRUPPO ONCOLOGICO NORD OVEST,g_o_n_o_gruppo_oncologico_nord_ovest,,,,8f1a10a0-5c3a-45de-a1fa-2ff0f80316bf,g_o_n_o,G.O.N.O +8621,,a088249b-bd51-4f4b-9ae0-2bd367bda93e,"Klinikum Großhadern, University of Munich / Medical Director: Prof. Dr. med. Burkhard Götze",klinikum_gro_hadern_university_of_munich_medical_director_prof_dr_med_burkhard_g_tze,,,,,, +927,0.983072,61519487-23d4-417a-83c9-581008f2af7b,The University of Edinburgh,the_university_of_edinburgh,,,,61519487-23d4-417a-83c9-581008f2af7b,the_university_of_edinburgh,The University of Edinburgh +8622,,115b014d-4e03-4106-9b25-f6ed611256c2,Oulun yliopisto,oulun_yliopisto,,,,,, +8623,,912a356a-b325-404a-8e30-be485bc0b3a4,NYCOMED PHARMA S.A,nycomed_pharma_s_a,,,,,, +179,0.977461,d48e9f34-7129-11e6-a89e-0242ac12000b,MUTUAL PHARM,mutual_pharm,,,,7307791a-55cf-4462-a41c-9a905939b273,mutual_pharmaceutical_company,MUTUAL PHARMACEUTICAL COMPANY +8624,,b6e029cd-dfb3-4992-b70c-21a8d09ab339,HCRI,hcri,,,,,, +8625,,7f710db0-a7f3-4f3d-82d4-e131f6d79d43,Otto M. Lesch,otto_m_lesch,,,,,, +8626,,bc55d515-e631-42a2-9b8f-e99c0122f647,Technical University Dresden,technical_university_dresden,,,,,, +8627,,65cd8232-3fb5-411a-a0bf-36dcc7b41488,GEIS (Grupo Español de Investigación en Sarcomas),geis_grupo_espa_ol_de_investigaci_n_en_sarcomas,,,,,, +8628,,8043786a-fbd2-4077-a6c1-44b8cc222dba,Astellas Pharma Europe R&D,astellas_pharma_europe_r_d,,,,,, +566,0.961636,b7bdd038-73c6-11e6-a0cd-0242ac12000b,ARIAD,ariad,,,,b7bdd038-73c6-11e6-a0cd-0242ac12000b,ariad,ARIAD +8629,,4f7e9c10-3721-4704-887c-10664998fcb9,Organisation name was not entered,organisation_name_was_not_entered,,,,,, +8630,,c58c0c0e-7158-11e6-a0cd-0242ac12000b,P AND L DEV LLC,p_and_l_dev_llc,,,,,, +8631,,ee8ea8b1-0680-453e-993e-a8a2773178e0,Rottapharm Biotech S.r.l,rottapharm_biotech_s_r_l,,,,,, +8632,,deafec93-c588-4175-9ca4-53bffc9a816e,Dutch Growth Research Foundation,dutch_growth_research_foundation,,,,,, +8633,,742c6598-7126-11e6-8a77-0242ac12000b,ANI PHARMS INC,ani_pharms_inc,,,,,, +8634,,0c1121e8-72d3-11e6-a0cd-0242ac12000b,SANTARUS,santarus,,,,,, +116,0.9602716167767843,44b4c49c-9a8b-4c93-9711-4dbfaddc5944,Shire Pharmaceutical Development Ltd,shire_pharmaceutical_development_ltd,,,,63ca73d2-fd68-4693-872c-2121b000d68c,shire_pharmaceutical_development,Shire Pharmaceutical Development +8635,,94ade1ca-30ed-404c-adfd-d8590badbce6,University Hospital Hvidovre,university_hospital_hvidovre,,,,,, +972,0.95330953598022461,de80dadb-e63d-4edc-a9df-2bcdec441425,Schering Plough Reserach Institute,schering_plough_reserach_institute,,,,4f0fa6e4-6773-4398-b96f-befbaf1b6648,schering_plough_research_institute_una_divisi_n_de_schering_corporation,"Schering Plough Research Institute, una División de Schering Corporation" +8636,,aca2e8ce-1941-4d1d-97e9-13d57077b5df,Medizinische Universität Graz/Endokrinologie und Stoffwechsel,medizinische_universit_t_graz_endokrinologie_und_stoffwechsel,,,,,, +8637,,637a2f2b-ba3d-4511-b7d3-e24f0e9758b6,Gedeon Richter Co,gedeon_richter_co,,,,,, +8638,,4ce9e2d6-7166-11e6-a0cd-0242ac12000b,ZYDUS HLTHCARE,zydus_hlthcare,,,,,, +8639,,67318b65-065a-4116-9080-c3bbd54aca1b,Karolinska Univsjukhuset,karolinska_univsjukhuset,,,,,, +324,0.97704669833183289,0a082bad-97ec-4e82-be7d-2731907614ac,Stiefel Laboratories,stiefel_laboratories,,,,0a082bad-97ec-4e82-be7d-2731907614ac,stiefel_laboratories_maidenhead_ltd,Stiefel Laboratories Maidenhead Ltd +8640,,4e6f8814-7142-11e6-a0cd-0242ac12000b,PARKE DAVIS,parke_davis,,,,,, +8641,,95fff0b0-7165-11e6-a0cd-0242ac12000b,AJANTA PHARMA,ajanta_pharma,,,,,, +808,0.94340622425079346,a229c9bd-df44-4c2a-8a62-504933fe2c02,Biogen Idec Inc,biogen_idec_inc,,,,9dd926b0-8d48-4d08-b638-2eb1c4764ba3,biogen_idec_international_gmbh,Biogen Idec International GmbH +8642,,bccfb179-0db5-4ad1-9e2d-64be074371e0,"Allgemeines Krankenhaus Wien, Medizinische Un iversität Wien",allgemeines_krankenhaus_wien_medizinische_un_iversit_t_wien,,,,,, +8643,,bd61c79f-b039-4859-993c-44faa12f22eb,"rijnstate hospital, the netherlands",rijnstate_hospital_the_netherlands,,,,,, +8644,,313f2971-9924-407b-b1b1-8e1dc612950a,Fundació Sant Joan de Deu de Barcelona,fundaci_sant_joan_de_deu_de_barcelona,,,,,, +8645,,59af1cf9-7270-430f-9dc5-f9018b98d84a,"Queen Mary's, University of London",queen_mary_s_university_of_london,,,,,, +615,0.90712672472000122,b91c3565-2af8-4719-8b4c-539db2f1b5a7,Fundación para la Investigación Biomédica del Hospital Universitario La Paz-Sección Cirugía Torácica,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz_secci_n_cirug_a_tor_cica,,,,27b37686-1c0f-4738-ab0a-36c44f7ea9cc,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz_secci_n_de_cirug_a_colorrectal_del_hospital,"Fundación para la Investigación Biomédica del Hospital Universitario La Paz, Sección de Cirugía Colorrectal del Hospital" +8646,,f53eb2ec-b627-4b35-8c03-e72a5b71e05f,Psychiatric Hospital,psychiatric_hospital,,,,,, +8647,,3e3d9857-a6d1-11e6-94cb-5656d04fc2b5,"Universitätsklinik für Dermatologie, Paracelsus medizinische Privatuniversität Salzburg",universit_tsklinik_f_r_dermatologie_paracelsus_medizinische_privatuniversit_t_salzburg,,,,,, +8648,,c01779a7-0a62-42a7-932b-649b1eb1c567,"Department of Anaesthesie, General Intensive Care and Pain Therapy, Medical University of Vienna",department_of_anaesthesie_general_intensive_care_and_pain_therapy_medical_university_of_vienna,,,,,, +8649,,b6f41476-6f9f-11e6-9663-0242ac12000b,OxThera AB,oxthera_ab,,,,,, +8650,,cbb3265a-7129-11e6-a89e-0242ac12000b,DURAMED PHARMS BARR,duramed_pharms_barr,,,,,, +8651,,d2ba79da-6f9e-11e6-9663-0242ac12000b,Region skåne- Hässleholms sjukvårdsorganisation,region_sk_ne_h_ssleholms_sjukv_rdsorganisation,,,,,, +8652,,53e41950-732b-11e6-a0cd-0242ac12000b,DIGESTIVE CARE INC,digestive_care_inc,,,,,, +8653,,154ffa3c-7269-11e6-a0cd-0242ac12000b,CHIRHOCLIN,chirhoclin,,,,,, +8654,,c77e1cac-2825-4fa1-a654-d06c290529a4,Unfallkrankenhaus Salzburg,unfallkrankenhaus_salzburg,,,,,, +8655,,34dc8ccc-7a69-4e68-9612-c2f3cc48ffba,Novartis Hungary Ltd,novartis_hungary_ltd,,,,,, +8656,,1d69a67a-0005-446b-a50d-f7096ac72a89,Columbia University Medical Center of New York,columbia_university_medical_center_of_new_york,,,,,, +8657,,ed849ce0-89e5-4e71-b88e-5e4808f4d03d,"Prof. dr L.H. van den Berg, UMC-Utrecht",prof_dr_l_h_van_den_berg_umc_utrecht,,,,,, +1038,0.988575,9ac131bc-a6d9-4ae6-b2ba-0582d8a53b0c,International Breast Cancer Study Group,international_breast_cancer_study_group,,,,9ac131bc-a6d9-4ae6-b2ba-0582d8a53b0c,international_breast_cancer_study_group,International Breast Cancer Study Group +8658,,64f12ac7-fd42-4386-a6cf-da4e318375d6,St Helier Hospital NHS Trust,st_helier_hospital_nhs_trust,,,,,, +8659,,7b3770f3-19d7-4dea-9328-8425d8499ecb,Landstinget Dalarna,landstinget_dalarna,,,,,, +1031,0.98682358860969543,9f76459d-c1a5-4dfd-8ba3-7773bf3ebbce,Medical University of Vienna, Clinical Pharmacology,,,,9f76459d-c1a5-4dfd-8ba3-7773bf3ebbce,medical_university_of_vienna_department_of_pediatrics,Medical University of Vienna +8660,,371aa03a-ab82-44ef-bded-846afbbf6b0c,Dr. F. Köhler Chemie GmbH,dr_f_k_hler_chemie_gmbh,,,,,, +8661,,743770be-9f7f-4adb-9d42-bcc511a1f24b,LUIS FERNÁNDEZ- LLEBREZ DEL REY,luis_fern_ndez_llebrez_del_rey,,,,,, +8662,,ddeeeee8-757d-4350-b4ec-60dfe980fed7,BioVex Ltd,biovex_ltd,medical_university_of_vienna_clinical_pharmacology,,,,, +8663,,cd1ef2f1-130f-4074-966c-772a0933d0f4,"Academic Medical Center, Division of Clinical Immunology and Rheumatology",academic_medical_center_division_of_clinical_immunology_and_rheumatology,,,,,, +456,0.95666962862014771,6704e020-719e-11e6-a0cd-0242ac12000b,CIS,cis,,,,6704e020-719e-11e6-a0cd-0242ac12000b,cis,CIS +8664,,c091cee9-385b-4179-a73f-948573a30b6e,Karen Schow Jensen,karen_schow_jensen,,,,,, +8665,,ad27a5b4-a509-40f0-8e76-d974bae290ac,UCB AE,ucb_ae,,,,,, +8666,,67577034-4bfb-48bf-8317-3617a9c60dae,BIOSENSORS EUROPE SA,biosensors_europe_sa,,,,,, +8667,,8e9920c5-e3ad-424a-95ba-3f5823a6c1c6,"Department of Surgery, National University of Ireland",department_of_surgery_national_university_of_ireland,,,,,, +881,0.98332688212394714,cb4fde3e-856f-4edb-bc1c-581119caaf6d,PIERRE FABRE MEDICAMENT - IDPF,pierre_fabre_medicament_idpf,,,,d9486864-e255-4256-b088-49f706c79293,pierre_fabre_medicament,PIERRE FABRE MEDICAMENT +8668,,7d145ec5-ecac-4117-831e-9cdd0846d0a5,"Provident Clinical Research & Consulting, Inc",provident_clinical_research_consulting_inc,,,,,, +8669,,5264bdd5-d695-4479-ab93-658947d62076,Axcentua Pharmaceuticals AB,axcentua_pharmaceuticals_ab,,,,,, +398,0.988564,40763009-de94-4c2e-a686-9a5a36e5ac86,St. Anna Kinderkrebsforschung/CCRI,st_anna_kinderkrebsforschung_ccri,,,,40763009-de94-4c2e-a686-9a5a36e5ac86,st_anna_kinderkrebsforschung_ccri,St. Anna Kinderkrebsforschung/CCRI +8670,,9a6416a8-881d-11e6-a998-0242ac12000b,Department of Haematology,department_of_haematology,,,,,, +8671,,4aa0c5f7-a5a8-4a46-b6a4-26f4be33b9e9,"Copenhagen University Hospital, Hvidovre",copenhagen_university_hospital_hvidovre,,,,,, +383,0.97420346736907959,ba5529ec-c151-4f81-b680-ad7ca9afb4fb,DBV Technologies SA,dbv_technologies_sa,,,,cf4f2be5-6c16-4774-80da-73c264a99c4c,dbv_technologies,DBV Technologies +8672,,c0ee19bc-95f1-4363-b634-e6645ddf8dd0,Evgen,evgen,,,,,, +8673,,d4a0f30a-5276-4fdb-b7d8-8f8a1d089a85,GIDO (Grup d?investigació i divulgació en oncologia),gido_grup_d_investigaci_i_divulgaci_en_oncologia,,,,,, +8674,,25286e4b-5831-429a-805d-676346ed8356,UCB S.A. Casa Madre,ucb_s_a_casa_madre,,,,,, +8675,,af102fde-f01f-4f62-81a1-93833e9bd0e1,GLAXOSMITHKLINE S.P.A,glaxosmithkline_s_p_a,,,,,, +8676,,9c65921a-330c-460a-b279-8275da958283,"Cardioxyl Pharmaceuticals, Inc",cardioxyl_pharmaceuticals_inc,,,,,, +8677,,3e7b8c49-6ff8-40d4-9e42-98cd4890ef3b,Universitair Medisch Cemtrum Utrecht,universitair_medisch_cemtrum_utrecht,,,,,, +545,0.987705,302c2638-8bd6-11e6-a449-0242ac12000b,HOSPITAL UNIVERSITARI DE BELLVITGE - IDIBELL,hospital_universitari_de_bellvitge_idibell,,,,302c2638-8bd6-11e6-a449-0242ac12000b,hospital_universitari_de_bellvitge_idibell,HOSPITAL UNIVERSITARI DE BELLVITGE - IDIBELL +8678,,19b83e59-fad9-41af-8591-c25671ac5812,"DalCor Pharma UK Ltd, Altrincham, Swiss Branch Zug",dalcor_pharma_uk_ltd_altrincham_swiss_branch_zug,,,,,, +8679,,494e3536-94fb-412f-bd2d-50df4ddf7b57,Janssen-Cilag Oy,janssen_cilag_oy,,,,,, +578,0.98331677913665771,724d1bdc-e54a-4c73-b212-98071e708ad2,"Wyeth Pharmaceuticals Inc. Acting through its division Wyeth Research, a Pfizer Company",wyeth_pharmaceuticals_inc_acting_through_its_division_wyeth_research_a_pfizer_company,,,,724d1bdc-e54a-4c73-b212-98071e708ad2,wyeth_pharmaceuticals_inc_acting_through_its_division_wyeth_research_a_pfizer_company,"Wyeth Pharmaceuticals Inc. Acting through its division Wyeth Research, a Pfizer Company" +8680,,c1166331-95bd-4c02-b42b-3c27ccf0d74d,IVI Valencia,ivi_valencia,,,,,, +8681,,b8e2e1cd-d20d-48dc-9b12-6420a00a8f61,PENTA Foundation Onlus,penta_foundation_onlus,,,,,, +8682,,9ade14c9-0bf1-4ede-97a3-be13df8e883b,Fundacion Leucemia y Linfoma,fundacion_leucemia_y_linfoma,,,,,, +8683,,0146dac9-e215-4fb1-9cae-1d125387a27c,Fundació institut d'investigació Biomèdica de Girona (IdibGi),fundaci_institut_d_investigaci_biom_dica_de_girona_idibgi,,,,,, +8684,,9abb8f58-715e-11e6-a0cd-0242ac12000b,CROWN LABS,crown_labs,,,,,, +27,0.982297,a648135c-efbc-489a-8904-931f235b854c,"Integrated Therapeutics Group, Inc - A Subsidiary of Schering-Plough",integrated_therapeutics_group_inc_a_subsidiary_of_schering_plough,,,,8f30be7a-db80-4d4f-b679-8ae4bed90a55,integrated_therapeutics_group_inc,"Integrated Therapeutics Group, Inc" +220,0.987246,28a6a997-3c3d-4bd8-8c3e-e02946553a33,Sanofi-Aventis Recherche & Devéloppement,sanofi_aventis_recherche_dev_loppement,,,,28a6a997-3c3d-4bd8-8c3e-e02946553a33,sanofi_aventis_recherche_dev_loppement,Sanofi-Aventis Recherche & Devéloppement +8685,,1dca08c5-66ef-4b37-a80d-9b2c1fe150f7,VO Anesthesia/ICU Lunds University Hospital,vo_anesthesia_icu_lunds_university_hospital,,,,,, +800,0.972677,15671013-8a1c-41eb-b118-71cf71e315ed,Institut Català d’Oncologia,institut_catal_d_oncologia,,,,15671013-8a1c-41eb-b118-71cf71e315ed,institut_catal_d_oncologia,Institut Català d’Oncologia +8686,,f9ccd3d4-8bbd-11e6-a449-0242ac12000b,Region Örebro län,region_rebro_l_n,,,,,, +8687,,a36ef4cf-ba5f-4842-9544-7a50d1c8c176,Nottingham University Hospitals NHS Trust,nottingham_university_hospitals_nhs_trust,,,,,, +8688,,a4891dec-efde-4efa-9812-500f7b9e02ec,Sigma Tau industrie Farmaceutiche Riunite Spa,sigma_tau_industrie_farmaceutiche_riunite_spa,,,,,, +8689,,c8689110-00b1-4645-8b84-9fdbc180f0dc,Perle Bioscience Inc,perle_bioscience_inc,,,,,, +8690,,5ce17e74-12cb-46e1-9e84-a6647a55d901,Gateshead Health NHS Foundation Trust,gateshead_health_nhs_foundation_trust,,,,,, +8691,,4f99e3ad-6dc0-46ee-9ce0-88c321b7402f,MABION SA,mabion_sa,,,,,, +8692,,1059e61e-cbde-4f81-a287-1d7a6e824eb2,GIENNE PHARMA S.P.A,gienne_pharma_s_p_a,,,,,, +8693,,aeaad61d-d2e4-4776-b5a2-779e49bef251,Endokrinologisk afd. M,endokrinologisk_afd_m,,,,,, +8694,,1a2338c8-d0f5-41ed-b7d9-e712bcd98edf,Liverpool School of Tropical Medicine,liverpool_school_of_tropical_medicine,,,,,, +8695,,708c8814-7167-11e6-a0cd-0242ac12000b,RICONPHARMA LLC,riconpharma_llc,,,,,, +8696,,ae5e9fe5-25c8-4f24-aab9-af5c5350da70,Universität Bremen,universit_t_bremen,,,,,, +950,0.97788405418395996,81d08cd4-daca-44d5-a95c-df32249997c1,MedImmune LLC (a wholly owned subsidiary of AstraZeneca PLC),medimmune_llc_a_wholly_owned_subsidiary_of_astrazeneca_plc,,,,389af5e7-be5f-4143-aff1-2c121f2ec673,medimmune_llc_a_wholly_owned_subsidiary_of_astrazeneca_plc_one_medimmune_way_gaithersburg_maryland_20878_usa,"MedImmune LLC (a wholly owned subsidiary of AstraZeneca PLC, One MedImmune Way, Gaithersburg, Maryland, 20878, USA)" +731,0.9761795699596405,088dce89-2da7-4622-a385-888595d708d2,Bristol-Myers Squibb International,bristol_myers_squibb_international,,,,55b1cd8b-93b6-4262-9f20-ab35fbdc2476,bristol_myers_squibb_international_corporation,Bristol-Myers Squibb International Corporation +8697,,c1f98b71-ac2b-425b-8c36-dc23ccb021fd,"Ionis Pharmaceuticals, Inc",ionis_pharmaceuticals_inc,,,,,, +1007,0.977549,31e6b140-0f0d-4d6f-950c-f719a9051d5d,Laboratorios Farmalider S.A,laboratorios_farmalider_s_a,,,,31e6b140-0f0d-4d6f-950c-f719a9051d5d,laboratorios_farmalider_s_a,Laboratorios Farmalider S.A +8698,,486136ce-f2f6-401b-b3ed-df3d93314d8b,FLUIDDA nv,fluidda_nv,,,,,, +8699,,3587ff2b-a992-49ab-8c0d-b428f40a54ef,"Merck, Sharp and Dohme Corp., a subsidiary of Merck & Co., Inc",merck_sharp_and_dohme_corp_a_subsidiary_of_merck_co_inc,,,,,, +8700,,efd54f73-d3b6-4d50-837e-1c584326aa51,PRO APARTS SRL,pro_aparts_srl,,,,,, +8701,,c90e36cc-039a-423e-bd64-c9304b8fd92e,Akros Pharma Inc,akros_pharma_inc,,,,,, +8702,,390c8e7d-a1cc-4b0f-bbd6-f054973cb52e,Studienzentrale AGO Austria,studienzentrale_ago_austria,,,,,, +8703,,b573dc81-c442-412a-8dd5-2cd779cc4cd2,Syntopix Group plc,syntopix_group_plc,,,,,, +8704,,090e8562-72d8-11e6-a0cd-0242ac12000b,CP PHARMS,cp_pharms,,,,,, +8705,,46436a73-a03b-4d82-bfb0-90bfa7362254,"RegenMedTX, LLC",regenmedtx_llc,,,,,, +8706,,5a5127f7-fd96-453d-9182-a78dc30a5618,Andi-Ventis Ltd,andi_ventis_ltd,,,,,, +8707,,43425f73-a9e8-457f-aab8-9816739cd8c2,Chiesi Farmaceutici,chiesi_farmaceutici,,,,,, +8708,,a1d2d39a-73ee-11e6-a0cd-0242ac12000b,AIR LIQUIDE AMERICA SPECIALITY GASES,air_liquide_america_speciality_gases,,,,,, +127,0.903091,9e1efa85-0554-405e-87df-0f240ec86ca6,"Medizinische Universität Wien, Abteilung für Nephrologie und Dialyse",medizinische_universit_t_wien_abteilung_f_r_nephrologie_und_dialyse,,,,0e706737-525b-47af-863b-c9b8ecf5a50a,medizinische_universit_t_wien_klinische_abteilung_f_r_nephrologie_und_dialyse_universit_tsklinik_f_r_innere_medizin_3,"Medizinische Universität Wien, Klinische Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin 3" +8709,,2b0c1ddd-8098-4140-9517-32b4af68cdd0,ThromboGenics N.V,thrombogenics_n_v,,,,,, +8710,,045bd38b-643f-42c9-b2b6-6c5c4330394a,UZBrussel,uzbrussel,,,,,, +8711,,2bc18882-c129-4b4e-8c74-78291248948d,Hanna Illman,hanna_illman,,,,,, +76,0.979965,42ae3bc2-6aa6-4f76-977a-25863d6912a4,Hamilton Health Sciences Corporation,hamilton_health_sciences_corporation,,,,42ae3bc2-6aa6-4f76-977a-25863d6912a4,hamilton_health_sciences_corporation,Hamilton Health Sciences Corporation +8712,,21cdf274-7227-11e6-a0cd-0242ac12000b,SUNOVION PHARMS INC,sunovion_pharms_inc,,,,,, +8713,,2a870ec5-e239-4123-94be-0dcf076530fe,"Edge Therapeutics, Inc",edge_therapeutics_inc,,,,,, +8714,,8ffe82a0-5eb7-46d1-89e1-cde2cc7867a0,Groupe Est Ouest des Leucémies et Autres Maladies du Sang,groupe_est_ouest_des_leuc_mies_et_autres_maladies_du_sang,,,,,, +8715,,cc7237aa-4f8d-4dbc-bb7e-3939539fb541,B. Braun Medical s.r.o,b_braun_medical_s_r_o,,,,,, +8716,,15b0b103-0a45-44c0-9a5b-ed7d8cacf8be,Prof David Cunningham,prof_david_cunningham,,,,,, +8717,,56c44e13-7e94-4e6f-a2db-dbc286478beb,CSL Behring LLC,csl_behring_llc,,,,,, +372,0.969108,49ce0f44-8261-4758-a6c3-732d14878ed0,GELA Group,gela_group,,,,24923580-c2a6-4b1d-955c-8c39f4256096,gela,GELA +8718,,a177d8c7-c9fe-4fc6-9133-a394a1539f23,Stichting NVALT studies,stichting_nvalt_studies,,,,,, +8719,,d07c5570-a350-45ff-9d25-5e533e3776c0,BOIRONSIH,boironsih,,,,,, +8720,,dd671efa-72bf-11e6-a0cd-0242ac12000b,ANDRX LABS LLC,andrx_labs_llc,,,,,, +8721,,52ef3132-7165-11e6-a0cd-0242ac12000b,SOFGEN PHARMS,sofgen_pharms,,,,,, +8722,,3e307368-cfa3-4c8f-9df8-eaf16da71169,Ville-Valtteri Välimäki,ville_valtteri_v_lim_ki,,,,,, +8723,,d651b60f-1ef9-4d88-9dc8-391c5498d4ea,Friedrich-Schiller-Universität Jena,friedrich_schiller_universit_t_jena,,,,,, +8724,,6828cd52-56c4-4d87-af08-b4e2e292803a,Sheffield Children's NHS Trust,sheffield_children_s_nhs_trust,,,,,, +8725,,576a76f8-fc4c-461c-bcc0-356671e681d2,Pfizer Luxembourg SARL Latvia Branch,pfizer_luxembourg_sarl_latvia_branch,,,,,, +8726,,1748ac62-4a6e-46a9-8bb9-5dd9ac5dab88,"R & D Directorate,Central Manchester and Manchester Children's University Hospitals NHS Trust",r_d_directorate_central_manchester_and_manchester_children_s_university_hospitals_nhs_trust,,,,,, +8727,,72fd0e56-f793-4c56-a377-f607edf4ad11,"Doc. MUDr. Petr Kolář, PhD, Oční klinika FN Brno",doc_mudr_petr_kol_phd_o_n_klinika_fn_brno,,,,,, +48,0.979231,ba12a838-560c-435d-82d8-aa43b0e18a62,Fresenius Kabi Deutschland GmbH,fresenius_kabi_deutschland_gmbh,,,,ad79d699-2379-4397-bd1d-3bc4a90f3635,fresenius_kabi,Fresenius Kabi +8728,,e971f84e-f16a-4d48-b76e-04b10b800e52,University of Giessen,university_of_giessen,,,,,, +8729,,3069e020-75e5-4d0f-b92a-9cad1dd4ab7b,"Sangart, Inc",sangart_inc,,,,,, +8730,,1371b99a-ce7b-44f8-9508-f02aaa89ebfb,"KAI Pharmaceuticals, Inc (a subsidiary of Amgen, Inc.)",kai_pharmaceuticals_inc_a_subsidiary_of_amgen_inc,,,,,, +8731,,2f457a93-1d9b-4486-9040-b7fe7b826d3a,"Auspex Pharmaceuticals, Inc",auspex_pharmaceuticals_inc,,,,,, +470,0.96829813718795776,6daf0d32-440a-4a03-80f9-78c344d1e2a4,European group for Blood and Marrow Transplantation,european_group_for_blood_and_marrow_transplantation,,,,2a4e4a42-e5c4-4da8-8f1f-18343eeb1fbc,european_group_for_blood_and_marrow_transplantation,European Group for Blood and Marrow Transplantation (EMBT) +8732,,e41b5c84-e4f0-430d-a8dd-ca88bfb595c4,EORTC-European Organisation for the Research and Treatment of Cancer,eortc_european_organisation_for_the_research_and_treatment_of_cancer,,,,,, +8733,,b4a5f2ff-e8fb-408d-a970-e825f8ebc066,Federico Martinon Torres,federico_martinon_torres,,,,,, +8734,,b152d898-42dc-4921-9c80-8b64e81118a9,"Universitätsklinik für Zahn-, Mund- und Kieferheilkunde, Med Uni Graz, Department für zahnärztliche Chirurgie",universit_tsklinik_f_r_zahn_mund_und_kieferheilkunde_med_uni_graz_department_f_r_zahn_rztliche_chirurgie,,,,,, +8735,,254abc98-e539-480b-b5eb-6960b87fe6f8,Promius Pharma LLC,promius_pharma_llc,,,,,, +8736,,faf8c6f9-0d48-49b5-8d82-8c7b07f1f018,Kowa Research Europe,kowa_research_europe,,,,,, +8737,,e000d975-f1c4-48db-a8e3-8d6923c66a71,DOMPE` s.p.a,dompe_s_p_a,,,,,, +8738,,a2bd3a13-b1e1-46d7-9527-b74271f9388f,SmithKline Beecham plc,smithkline_beecham_plc,,,,,, +8739,,d15cd414-d417-4467-acf5-407b852fd54c,Radboud Universitair Medisch Centrum,radboud_universitair_medisch_centrum,,,,,, +8740,,29e502d1-c59b-43de-bbfc-83723deb76ea,"Ironwood Pharmaceuticals, Inc",ironwood_pharmaceuticals_inc,,,,,, +8741,,74e628c2-715b-11e6-a0cd-0242ac12000b,CARACO,caraco,,,,,, +8742,,b904b00d-2ae5-4cb2-ba5d-1880448791e9,York Teaching Hospital NHS Foundation Trust,york_teaching_hospital_nhs_foundation_trust,,,,,, +8743,,2d0ca376-73b0-11e6-a0cd-0242ac12000b,PFIZER CONS HLTHCARE,pfizer_cons_hlthcare,,,,,, +8744,,881e8508-7055-41bb-8e43-82d083b7c4f0,Guys and St Thomas Foundation Trust,guys_and_st_thomas_foundation_trust,,,,,, +8745,,73c3e342-d6ce-44ac-bf0a-cae75c4ad2c0,North West London Hospitals NHS Trust,north_west_london_hospitals_nhs_trust,,,,,, +8746,,8ead3089-d4d3-4427-8527-ca6f88c80d53,"Radboud University Medical Centre, department of Psychiatry",radboud_university_medical_centre_department_of_psychiatry,,,,,, +8747,,b436bb3b-40f3-489d-a50a-69a6f75401bc,Addiction Center Stockholm,addiction_center_stockholm,,,,,, +8748,,c06b8f40-7141-11e6-a0cd-0242ac12000b,VINTAGE,vintage,,,,,, +8749,,7e785034-6dd0-4baa-bce8-152c9a83447d,Hopital Foch,hopital_foch,,,,,, +8750,,c5ca549b-db8b-4238-a0d9-0f2ff896ed5a,"Xanthus Pharmaceuticals, Inc",xanthus_pharmaceuticals_inc,,,,,, +8751,,07662a8c-1f13-479b-9ec5-8e3760f4895a,"Medizinische Universität Wien, Universitätsklinik für dermatologie",medizinische_universit_t_wien_universit_tsklinik_f_r_dermatologie,,,,,, +8752,,7acfc7e5-7c8f-470f-acef-63c605d6d6b4,Fundación Oftalmológica del Mediterráneo,fundaci_n_oftalmol_gica_del_mediterr_neo,,,,,, +8753,,354c044c-6f9a-11e6-9663-0242ac12000b,Imperial College Academic Healthsciences Centre,imperial_college_academic_healthsciences_centre,,,,,, +8754,,b6d8e476-715c-11e6-a0cd-0242ac12000b,CSPC OUYI PHARM CO,cspc_ouyi_pharm_co,,,,,, +354,0.989467,8c2481e7-c913-492c-8830-6e29c9a7e467,NERVIANO MEDICAL SCIENCES,nerviano_medical_sciences,,,,30b1f9cc-f511-477c-bf64-97f87e3f4260,nerviano_medical_science,NERVIANO MEDICAL SCIENCE +8755,,d0f1cddd-b19c-4629-85e9-953104f94c8e,"Prof Allan Glanville, St Vincents Hospital",prof_allan_glanville_st_vincents_hospital,,,,,, +8756,,e92c763a-bf1f-4b4e-b8ac-060d5c8e23f1,Wyeth Kabushiki Kaisha (Wyeth K.K.),wyeth_kabushiki_kaisha_wyeth_k_k,,,,,, +8757,,39f251e7-38f4-4ce6-bb38-d5c2601c3f99,KANEKA coorporation,kaneka_coorporation,,,,,, +8758,,9692ce36-7164-11e6-a0cd-0242ac12000b,MICRO LABS LTD INDIA,micro_labs_ltd_india,,,,,, +8759,,deba5488-5cc8-4705-aadb-89f733d369db,Research and Development Nottingham University Hospital,research_and_development_nottingham_university_hospital,,,,,, +8760,,ec80b473-4382-41db-9835-82306083078b,Astion Pharma A/S,astion_pharma_a_s,,,,,, +857,0.97367624938488007,290d2d3b-f1a1-49d6-9746-666719415232,Institut de Recerca del Hospital de la Santa Creu i Sant Pau,institut_de_recerca_del_hospital_de_la_santa_creu_i_sant_pau,,,,0213f530-437f-430a-b936-0bfa94166165,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau +135,0.982105,0ae43754-1f42-4540-8952-a2c6dce4050c,Procter and Gamble,procter_and_gamble,,,,0ae43754-1f42-4540-8952-a2c6dce4050c,procter_and_gamble,Procter and Gamble +8761,,9395e78a-b8e7-4970-939b-0e02eb7bfbc2,Juan Luis Bonilla Palomas,juan_luis_bonilla_palomas,,,,,, +8762,,767d4b91-aa5f-4861-b8f4-6326b3ca8605,HYKS Naistensairaala,hyks_naistensairaala,,,,,, +8763,,ffa2f3f0-e9d5-4862-9e3c-700358d24246,Comarca Ezkerraldea-Enkarterri (OSAKIDETZA),comarca_ezkerraldea_enkarterri_osakidetza,,,,,, +8764,,1b588a85-5618-4f81-97f8-c4df743a687d,RDR Pharma GmbH,rdr_pharma_gmbh,,,,,, +8765,,a98f29cd-03b6-4509-8c03-4643a9d16075,University Hospital Antwerp : Department Respiratory Medicine,university_hospital_antwerp_department_respiratory_medicine,,,,,, +8766,,3664923c-9f53-460c-a704-0617b9089038,Bama-Geve S.L,bama_geve_s_l,,,,,, +8767,,03a8c64d-e64e-46ba-adcf-50595e9a9038,"Achillion Pharmaceuticals, Inc",achillion_pharmaceuticals_inc,,,,,, +8768,,e0b7754e-b1b9-4fba-a36f-6d7fd531598f,"Merck and Co., Inc",merck_and_co_inc,,,,,, +8769,,ceb11b5e-8f40-488b-bc9b-31124ce0489c,Hospital Universitario de Lovaina,hospital_universitario_de_lovaina,,,,,, +8770,,95f0b1fb-dcb6-4765-b631-b73a20eb686e,IRCCS-IRST of Meldola,irccs_irst_of_meldola,,,,,, +8771,,1d78265e-cbcc-4c7f-aa86-755345d52cb6,"Anesthesiology Clinic,Akademiska Sjukhuset, Uppsala",anesthesiology_clinic_akademiska_sjukhuset_uppsala,,,,,, +8772,,df55ec41-a996-49a0-b9ce-340d21127348,AFAR,afar,,,,,, +8773,,25f0436a-ac9a-4458-8a1e-62487a63a882,Nycomed Denmark Aps,nycomed_denmark_aps,,,,,, +8774,,8f0c35d2-b0e5-4a19-ae81-8f490628a057,NOVARTIS FARMA,novartis_farma,,,,,, +8775,,adc76341-9b5e-4cad-bde6-5056bca3626d,Dr. Vicente Estrada,dr_vicente_estrada,,,,,, +8776,,0336d992-4e9e-4c79-9fbe-1dffda726797,Goethe University Frankfurt,goethe_university_frankfurt,,,,,, +8777,,b2d7df96-b451-4d93-8a8c-5fcfdb0fd43e,"Aarhus University Hospital, Denmark",aarhus_university_hospital_denmark,,,,,, +344,0.980149,273163c3-7d27-453a-a06b-0214eed2db4d,Otto-von-Guericke University,otto_von_guericke_university,,,,11e94b5f-d540-4085-bee2-a20da96129f1,otto_von_guericke_university_medical_faculty_dpt_of_neurology,"Otto-von-Guericke University, Medical Faculty, Dpt. of Neurology" +8778,,3a6dbdbc-71ac-11e6-a0cd-0242ac12000b,HLR,hlr,,,,,, +8779,,0687251c-8bc7-11e6-a449-0242ac12000b,The Motol University Hospital,the_motol_university_hospital,,,,,, +8780,,27d02f10-db4b-45d2-a275-61d0e550923b,DIRECTION CENTRALE DU SERVICE DE SANTE DES ARMEES,direction_centrale_du_service_de_sante_des_armees,,,,,, +8781,,f5a81c3d-0955-476b-b274-0564331c6999,Otsuka Novel Products GmbH,otsuka_novel_products_gmbh,,,,,, +846,0.94804,a2cff94d-e7b7-4b66-9dbe-77f65a76414c,"Eyetech Pharmaceuticals, Inc",eyetech_pharmaceuticals_inc,,,,8e57a7f2-6f76-49f9-afae-1f3f5c9f50b4,eyetech_pharamceuticals_inc,"Eyetech Pharamceuticals, Inc" +8782,,fe8ad7ff-4e98-4d81-8ba7-dc3b3760941d,ALEXION PHARMA INTERNATIONAL SARL,alexion_pharma_international_sarl,,,,,, +8783,,7c73c4b3-131e-4f0d-aec8-07511f7b36b1,MerLion Pharmaceuticals GmbH,merlion_pharmaceuticals_gmbh,,,,,, +127,0.903091,0e706737-525b-47af-863b-c9b8ecf5a50a,"Medizinische Universität Wien, Klinische Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin 3",medizinische_universit_t_wien_klinische_abteilung_f_r_nephrologie_und_dialyse_universit_tsklinik_f_r_innere_medizin_3,,,,0e706737-525b-47af-863b-c9b8ecf5a50a,medizinische_universit_t_wien_klinische_abteilung_f_r_nephrologie_und_dialyse_universit_tsklinik_f_r_innere_medizin_3,"Medizinische Universität Wien, Klinische Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin 3" +212,0.976266,28d127a8-9a7d-43fa-bf4a-1c2fe14bf976,POXEL S.A,poxel_s_a,,,,0a79ad16-61bb-4290-895a-ee60dfc583b0,poxel,POXEL +8784,,f4a108e5-3979-4a5a-9c28-99b8302d7f6d,Fujimoto Pharmaceutical Corporation,fujimoto_pharmaceutical_corporation,,,,,, +8785,,30f2ec05-a545-4859-857d-33d5589de3cc,Regulon Inc,regulon_inc,,,,,, +350,0.980777,def04bfb-c87c-44ae-9705-838229748921,Pharmacyclics LLC an Abbvie Company,pharmacyclics_llc_an_abbvie_company,,,,3e83bd20-82b9-4762-84e9-fe87fe651346,pharmacyclics_llc,Pharmacyclics LLC +8786,,83666e71-6c01-4df7-9373-21d77fb676a6,Emergent Product Development UK Ltd,emergent_product_development_uk_ltd,,,,,, +8787,,e00622c8-72ab-11e6-a0cd-0242ac12000b,LOREAL USA,loreal_usa,,,,,, +8788,,861e96c1-75e9-4a32-a1cd-57184f2880e9,"Cubist Pharmaceuticals, LLC, an idirect wholly owned subsidiary of Merck Sharp&Dohme Corp",cubist_pharmaceuticals_llc_an_idirect_wholly_owned_subsidiary_of_merck_sharp_dohme_corp,,,,,, +8789,,07422997-624c-4b04-9aef-cf36baefd932,Fundación SENEFRO,fundaci_n_senefro,,,,,, +403,0.95696145296096802,11645014-715e-11e6-a0cd-0242ac12000b,EMCURE PHARMS INDIA,emcure_pharms_india,,,,11645014-715e-11e6-a0cd-0242ac12000b,emcure_pharms,EMCURE PHARMS +8790,,d614c2b7-b971-4dc8-b0e2-dee1267570b0,CH Pau,ch_pau,,,,,, +751,0.9637179970741272,019c34b0-7129-11e6-a89e-0242ac12000b,TARO,taro,,,,019c34b0-7129-11e6-a89e-0242ac12000b,taro,TARO +8791,,de0a962c-71cd-11e6-a0cd-0242ac12000b,DHL,dhl,,,,,, +8792,,24b40c78-160a-47d6-b1db-9d613ccd3888,Ergomed Clinical Research Limited,ergomed_clinical_research_limited,,,,,, +8793,,98f03587-10cd-44bf-9043-cdc076198e31,"Dr Antoni Gual, Hospital Clínic de Barcelona, Unitat d'Alcohologia de la Generalitat de Catalunya",dr_antoni_gual_hospital_cl_nic_de_barcelona_unitat_d_alcohologia_de_la_generalitat_de_catalunya,,,,,, +584,0.984184,4a85fe12-965a-11e6-becf-0242ac110008,PHARMACARE,pharmacare,,,,4a85fe12-965a-11e6-becf-0242ac110008,pharmacare,PHARMACARE +8794,,3c2ff0be-9028-4a03-8e86-c5ec327eb016,"Smittskyddsinstitutet, STRAMA",smittskyddsinstitutet_strama,,,,,, +8795,,181921c9-cbfe-487c-93a5-311f2c4250b0,CellAct Pharma GmbH,cellact_pharma_gmbh,,,,,, +8796,,ceb608b9-d3e9-4cd8-b75e-d41726bcc247,"Chiasma, Inc",chiasma_inc,,,,,, +850,0.919718,25d4b3ea-5908-4ea6-af45-ca4271adfcb9,University hospitals of Leuven,university_hospitals_of_leuven,,,,25d4b3ea-5908-4ea6-af45-ca4271adfcb9,university_hospitals_of_leuven,University hospitals of Leuven +422,0.98334300518035889,ac7fb87c-0de4-401d-a07b-881b2d29e8ea,Dr. Enrique Alday,dr_enrique_alday,,,,ac7fb87c-0de4-401d-a07b-881b2d29e8ea,dr_enrique_alday,Dr. Enrique Alday +8797,,4f299305-2684-4e8e-a552-d9507f59c7d3,PROBIONOV,probionov,,,,,, +8798,,3373c16c-1332-490b-91e2-01084761c3e6,"Department of Neurology, Turku University Hospital",department_of_neurology_turku_university_hospital,,,,,, +8799,,2f63429e-b406-49c7-8bcf-259b9dfac196,SantoSolve AS,santosolve_as,,,,,, +8800,,d28ad76e-9549-480d-b9c7-4ed749fc91fc,St. Antonius hospital Nieuwegein,st_antonius_hospital_nieuwegein,,,,,, +8801,,7f2a4482-9bf7-445b-8e71-b720bc9d1f0c,Protalix Ltd,protalix_ltd,,,,,, +8802,,2a149e62-20e5-4ce3-8737-b5dce205ea61,"Bayer HealthCare AG, Germany",bayer_healthcare_ag_germany,,,,,, +8803,,16fcc728-9723-431f-b51f-a51a40617cb0,"Research & Innovation Services, University of Dundee",research_innovation_services_university_of_dundee,,,,,, +8804,,d805ef6c-15c3-4fda-8d98-bb046f3912ca,AZIENDA SANITARIA N. 3 GENOVESE,azienda_sanitaria_n_3_genovese,,,,,, +8805,,df870245-a833-4bd9-9ac6-52040b4d7e73,North Bristol NHS Trust (NBT),north_bristol_nhs_trust_nbt,,,,,, +8806,,12c6bcda-73c5-11e6-a0cd-0242ac12000b,RAPTOR INC,raptor_inc,,,,,, +8807,,e6e213e6-4d8f-4938-bef6-64d025b63593,OSPEDALE SAN RAFFAELE,ospedale_san_raffaele,,,,,, +8808,,70fb08eb-c85f-4571-b455-1c3e62ceef63,"FoldRx Pharmaceuticals, Inc",foldrx_pharmaceuticals_inc,,,,,, +8809,,76ba2fa0-ccdc-4c96-99fa-1cf2bb8d0d68,Universitätsklinikum der Julius-Maximilians Universität Würzburg A.ö.R,universit_tsklinikum_der_julius_maximilians_universit_t_w_rzburg_a_r,,,,,, +8810,,8262ebef-f3b8-4a8d-a269-f1edf1c33e3f,SK Life Science Inc,sk_life_science_inc,,,,,, +8811,,25989852-fcf8-4101-8f54-0f3c4e918341,Abivax,abivax,,,,,, +8812,,32fc6cde-a974-47af-85e7-0efed0d90433,CASA MADRE,casa_madre,,,,,, +8813,,98f45bf5-bc33-4eb6-93d9-7a1763df80c7,KU Leuven-Drug Delivery and Disposition,ku_leuven_drug_delivery_and_disposition,,,,,, +8814,,6fdbcc80-48ed-4b36-b5bd-18c41e510b84,Sanofi-aventis,sanofi_aventis,,,,,, +8815,,f417181e-6fc0-11e6-abe8-0242ac12000b,Prof. Salvatore Grisanti,prof_salvatore_grisanti,,,,,, +8816,,a2073759-0c93-4848-8b73-077dd462371b,Ludwigs Maximilians University,ludwigs_maximilians_university,,,,,, +8817,,dbc3e7b0-5c72-4d76-b1e5-a5a0216ddd35,Gustave Roussy,gustave_roussy,,,,,, +8818,,69cde8b9-3c19-4e4f-ac42-e93e97e36649,Grupo de Reproducción Asistida HSP/FP,grupo_de_reproducci_n_asistida_hsp_fp,,,,,, +8819,,0f02863c-a3fd-4cb0-902b-e405b9817fb2,"Medizinische Universität Wien, Univ.Klinik.f.Dermatologie",medizinische_universit_t_wien_univ_klinik_f_dermatologie,,,,,, +8820,,5a90753e-00e0-47ea-925e-797e67058767,Steiermärkische Gebietskrankenkasse,steierm_rkische_gebietskrankenkasse,,,,,, +8821,,69875514-7165-11e6-a0cd-0242ac12000b,ACTAVIS S ATLANTIC,actavis_s_atlantic,,,,,, +964,0.95663732290267944,ee0f112b-ba70-4913-b4d1-c88699a3bac3,Helsinki University Centrel Hospital,helsinki_university_centrel_hospital,,,,16556fb5-6653-4d5b-bd94-fc6343fa4fd8,helsinki_university_central_hospital,Helsinki University Central Hospital +8822,,2e49be8e-f14f-4c0d-ae11-0fe5b0212dc1,Bart Morlion,bart_morlion,,,,,, +182,0.972538,14a0b753-a57f-41c0-b017-ca7adb32f3da,Durata Therapeutic International B.V,durata_therapeutic_international_b_v,,,,14a0b753-a57f-41c0-b017-ca7adb32f3da,durata_therapeutic_international_b_v,Durata Therapeutic International B.V +8823,,7cc17096-6068-4a30-9a62-7e5b608b5c6f,University Hospitals KU Leuven,university_hospitals_ku_leuven,,,,,, +8824,,072422f8-0952-411a-a577-4c979549843a,Jerini US Inc,jerini_us_inc,,,,,, +279,0.97373181581497192,adecb40b-2f21-4597-8297-90559dea3984,Royal Liverpool and Broadgreen University Hospital NHS Trust,royal_liverpool_and_broadgreen_university_hospital_nhs_trust,,,,7fdce817-2c7a-48bf-9fea-ccc1bb736300,royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,Royal Liverpool and Broadgreen University Hospitals NHS Trust +8825,,f4ebea85-7cb5-4ae2-81b4-b92913991078,"Association REDAR, Hôpital Ambroise Paré, Service d'Anesthésie et de Réanimation",association_redar_h_pital_ambroise_par_service_d_anesth_sie_et_de_r_animation,,,,,, +8826,,95d3dcaa-c0de-4321-ae49-d69e9684bc82,KWF Kankerbestrijding,kwf_kankerbestrijding,,,,,, +8827,,417b1089-cf74-4e92-9791-100e86b12180,"Västra Götalandsregionen, Sahlgrenska University Hospital /Queen Silvia children's hospital",v_stra_g_talandsregionen_sahlgrenska_university_hospital_queen_silvia_children_s_hospital,,,,,, +8828,,df8c9282-7166-11e6-a0cd-0242ac12000b,INTL SPECLT CHEMS,intl_speclt_chems,,,,,, +8829,,3404f2e7-2a02-4f2e-b617-b26735e2ad41,Bausch&Lomb Dr Gerhard Mann chem.-Fabrik GmbH,bausch_lomb_dr_gerhard_mann_chem_fabrik_gmbh,,,,,, +8830,,486bdbfe-f5c4-4c41-b181-2e85c964bfb3,"University of Leuven, Division of Gastroenterology",university_of_leuven_division_of_gastroenterology,,,,,, +8831,,c7e5c01a-9a36-4b21-a9ce-adfde715d705,Salford Royal Hospitals Trust,salford_royal_hospitals_trust,,,,,, +727,0.983703,891861df-aa46-4637-b8f0-5ce81adc18f1,Maastricht University,maastricht_university,,,,67dc03a5-4946-452a-be3e-787d57740764,maastricht_university_medical_center,Maastricht University Medical Center +8832,,b67ed3fb-464f-48db-a939-38d0baa8e972,BioTech Tools S.A,biotech_tools_s_a,,,,,, +8833,,b171c46c-b25e-4748-b364-161e7756fb45,Klinik für Innere Medizin II der Klinikum Chemnitz gGmbH,klinik_f_r_innere_medizin_ii_der_klinikum_chemnitz_ggmbh,,,,,, +8834,,9a090d17-18e7-401a-9f2c-7128e995cabe,Dra. Rosario Blasco,dra_rosario_blasco,,,,,, +8835,,cec0d98e-32ef-48f3-9700-9362e3e024c5,Servier s.r.o,servier_s_r_o,,,,,, +8836,,84916872-6f9e-11e6-9663-0242ac12000b,Targanta Therapeutics Corporation,targanta_therapeutics_corporation,,,,,, +8837,,1c3cda5a-71b9-11e6-a0cd-0242ac12000b,ALLEGIANCE HLTHCARE,allegiance_hlthcare,,,,,, +8838,,2bb154b0-43c7-4694-9e2d-2ed94c5aa179,Centre Hospitalier Départemental Vendée,centre_hospitalier_d_partemental_vend_e,,,,,, +8839,,49d3d6c3-a234-47dc-ae63-13bfa871ac17,Centre Hospitalier Universiatire de Lille,centre_hospitalier_universiatire_de_lille,,,,,, +8840,,583809fd-2ed9-439c-918d-d4f491b69f1d,OSPEDALE ISRAELITICO DI ROMA,ospedale_israelitico_di_roma,,,,,, +8841,,41cb6b28-5902-4387-9bb0-205436641a69,pro-ACTINA S.A,pro_actina_s_a,,,,,, +8842,,62f15231-7a32-427b-a7a2-a27f949e578c,Napp Pharmaceuticals Ltd,napp_pharmaceuticals_ltd,,,,,, +8843,,62afc7b2-57a4-4a5e-aa55-3babb2a432f2,Zon MW,zon_mw,,,,,, +8844,,206fccc4-8bc0-11e6-a449-0242ac12000b,Center of Mech-Sense,center_of_mech_sense,,,,,, +8845,,985c9c11-83d3-48b4-8934-a0b36838584a,Grupo Gallego de Investigación en Oncología - GGIO,grupo_gallego_de_investigaci_n_en_oncolog_a_ggio,,,,,, +8846,,2ea7a476-9dcd-4ca4-9c23-02151099f5d0,RACD Cardiff University,racd_cardiff_university,,,,,, +8847,,6ea71d04-715b-11e6-a0cd-0242ac12000b,BIOKEY,biokey,,,,,, +8848,,edb2cdd9-96dc-49f6-86df-396ba44c9970,Västra Götalands Center för utveckling av prehospital akutsjukvård,v_stra_g_talands_center_f_r_utveckling_av_prehospital_akutsjukv_rd,,,,,, +8849,,a33169b1-a27a-422c-a0d8-8f95a6404462,Sten Madsbad,sten_madsbad,,,,,, +8850,,844b5b7d-a965-423d-934d-2f3f94710be3,Laves-Arzneimittel GmbH,laves_arzneimittel_gmbh,,,,,, +8851,,f4bc28de-b355-4536-83d3-92e338b785af,Univ.-Prof. Dr. Helmut Mittermayer,univ_prof_dr_helmut_mittermayer,,,,,, +8852,,f90cd487-c363-4cc0-bb5b-a53167e8ee11,Diabeteszentrum Bad Lauterberg,diabeteszentrum_bad_lauterberg,,,,,, +8853,,eb7cd1ab-bcb2-4000-9d0c-7eed875b22af,Glenmark Pharmaceuticals SA,glenmark_pharmaceuticals_sa,,,,,, +8854,,6cba1f49-fadf-4acb-afdb-fad9706db6f3,UBHT,ubht,,,,,, +8855,,b3fda126-981a-43dc-9c74-f4037ae76a59,AZ-VUB,az_vub,,,,,, +8856,,492a20b0-a653-4e2a-bf0e-aedd2cfb28e1,European AIDS treatment network (NEAT),european_aids_treatment_network_neat,,,,,, +8857,,a4d2e683-09cd-457d-b3b3-03b7157b1b50,Gloucester Pharmaceuticals Inc,gloucester_pharmaceuticals_inc,,,,,, +1064,0.94309008121490479,edc709ce-10d1-42d6-9fb3-f5c6046db6fc,Cambridge University Hospitals Foundation Trust,cambridge_university_hospitals_foundation_trust,,,,5832b652-f280-4dd6-850d-477a81887563,cambridge_university_hospitals_nhs_foundation_trust,Cambridge University Hospitals NHS Foundation Trust +8858,,2dda0e8e-532e-4b83-9845-a8c578042f9c,Erasmus MC - Department of Neurology,erasmus_mc_department_of_neurology,,,,,, +8859,,62c9d7dd-f953-4a37-b735-9b0073abba5d,"Haukeland Universitetssykehus, Helse Bergen, Barneklinikken",haukeland_universitetssykehus_helse_bergen_barneklinikken,,,,,, +8860,,e8990bee-433f-447f-bd6c-656253d99b85,Pharmaleads SA,pharmaleads_sa,,,,,, +8861,,181aac99-f954-433b-8b6e-278dd9e8fd6f,Dr G I Hackett,dr_g_i_hackett,,,,,, +8862,,c9408925-4bbf-46f6-9762-ead852c0f77b,Dipartimento di Medicina Interna e Specialità Mediche - Policlinico Umberto I - Sapienza Università di Roma,dipartimento_di_medicina_interna_e_specialit_mediche_policlinico_umberto_i_sapienza_universit_di_roma,,,,,, +8863,,fdc53598-c764-41f7-a2c2-5cd532c70a30,St James's Hospital,st_james_s_hospital,,,,,, +892,0.98520499467849731,75395b0a-39cd-4a5d-8ecc-3909789f94df,Aarhus University,aarhus_university,,,,16b9d8ec-4b48-4fe9-bcae-e854bddbc3d8,aarhus_universityhospital,Aarhus Universityhospital +8864,,65edf180-fa20-4d21-8108-66ba7e238611,"Shering Plough Research Institute, A division of Schering Plough Corporation",shering_plough_research_institute_a_division_of_schering_plough_corporation,,,,,, +8865,,18fc9c4f-6fed-48a0-986b-ab55dce12886,Actavis Deutschland GmbH & Co.Kg,actavis_deutschland_gmbh_co_kg,,,,,, +538,0.987464,f7aaaa1b-2561-49c1-b1bf-779a333d0a57,Sankyo Pharma Development,sankyo_pharma_development,,,,0b556983-4b60-4dae-9f82-49efdc6858f4,sankyo_pharma_development_sphd,Sankyo Pharma Development (SPhD) +8866,,2712827b-f93e-4a6b-b6c6-18878fdd4d07,SCS Boehringer Ingelheim Comm.V,scs_boehringer_ingelheim_comm_v,,,,,, +8867,,8e5dda8c-a719-4a48-ae01-26d3341bc496,Roche (Magyarország) Kft,roche_magyarorsz_g_kft,,,,,, +8868,,f9b18a79-c3e2-4273-ad9b-cea37c03ae3b,Gastrointestinal Onkologisk Förening,gastrointestinal_onkologisk_f_rening,,,,,, +8869,,f133bbb6-1ab6-4514-8d77-1416b182cc28,"Rigshospitalet, Finsen Center",rigshospitalet_finsen_center,,,,,, +8870,,c87593e9-4c8a-499e-81ac-07a6d82fb618,Private Universität Witten/Herdecke gGmbH,private_universit_t_witten_herdecke_ggmbh,,,,,, +8871,,1874dcf0-1f4f-43c5-b633-9d5a7627ec3a,Pharmazeutische Fabrik Montavit Ges.m.b.H,pharmazeutische_fabrik_montavit_ges_m_b_h,,,,,, +8872,,073816ce-29f9-4075-b24a-53ba78ecb3eb,MEDTRONIC,medtronic,,,,,, +499,0.95183,7e7f14c2-9ede-49fa-aa4c-1c3644b22daf,"Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany",merck_serono_sa_geneva_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,0c43fa82-723d-4a38-822b-83d3cb20290b,merck_serono_s_a_geneva_an_affiliate_of_merck_kgaa_darmstadt_germany,"Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany" +8873,,09143c34-8bcf-4a9a-8f81-fcfd1923fe39,NeuroSearch Sweden AB,neurosearch_sweden_ab,,,,,, +8874,,1030d52e-1854-4ec2-ab62-875d3f26c790,Novartis Services Pharma AG,novartis_services_pharma_ag,,,,,, +8875,,6c014ef5-9139-4c57-b22b-602f3ad22284,Gregers Gautier Hermann,gregers_gautier_hermann,,,,,, +8876,,9e33247a-737f-11e6-a0cd-0242ac12000b,SCHIFF AND CO,schiff_and_co,,,,,, +8877,,248658cf-2b4a-4574-aa31-530fc4738759,"Department of Asthma, Allergy and Respiratory Science, GKT School of Medicine, King's College London",department_of_asthma_allergy_and_respiratory_science_gkt_school_of_medicine_king_s_college_london,,,,,, +8878,,62783231-f4b1-4fbf-9020-e017cceb49cf,Medicines Evaluation Unit,medicines_evaluation_unit,,,,,, +8879,,312dfa94-550d-4114-a936-539c08143a13,"NeoPharm, Inc",neopharm_inc,,,,,, +8880,,1e875f6a-8bc7-11e6-a449-0242ac12000b,"IELSG International Extranodale Lymphoma Study Group; Instituto Oncologico della Svizzera Italiana,",ielsg_international_extranodale_lymphoma_study_group_instituto_oncologico_della_svizzera_italiana,,,,,, +8881,,def7f346-1bc5-4cfb-a682-9fff4aeb481c,Takeda Europe Research & Development Limited,takeda_europe_research_development_limited,,,,,, +8882,,547fed25-6d0e-4c76-8f8e-7a350d7fb960,"Department of Dermatology, Hospital of the Medical University Graz",department_of_dermatology_hospital_of_the_medical_university_graz,,,,,, +307,0.90344,f2af78d5-760a-4dd9-8137-894f9a8c3637,"Medizinische Universität Wien, Klinik für Innere Medizin III, Abteilung für Gastroenterologie und Hepatologie",medizinische_universit_t_wien_klinik_f_r_innere_medizin_iii_abteilung_f_r_gastroenterologie_und_hepatologie,,,,b08c1e4f-521d-4753-92c6-78fc43a73dab,medizinische_universit_t_wien_univ_klinik_f_r_innere_medizin_iii_abteilung_f_r_gastroenterologie,"Medizinische Universität Wien, Univ. Klinik für Innere Medizin III, Abteilung für Gastroenterologie" +635,0.92223775386810303,e73c0583-9c8a-433e-9519-117f883c39d0,Research & Development Department,research_development_department,,,,e73c0583-9c8a-433e-9519-117f883c39d0,research_development_department,Research & Development Department +8883,,c7cef0dc-719c-11e6-a0cd-0242ac12000b,NOVEN THERAP,noven_therap,,,,,, +8884,,a675278e-5b93-4aa5-ab5e-c8af0fb9337e,FUNDACION CV INVESTIGACION HOSPITAL DR PESET,fundacion_cv_investigacion_hospital_dr_peset,,,,,, +683,0.987967,93d2770e-11ee-4c28-b378-003b4e28a161,Landstinget i Uppsala,landstinget_i_uppsala,,,,93d2770e-11ee-4c28-b378-003b4e28a161,landstinget_i_uppsala,Landstinget i Uppsala +224,0.92743,19f50830-c64c-41ab-95d1-83f7f3427687,Royal College of Surgeons in Ireland,royal_college_of_surgeons_in_ireland,,,,19f50830-c64c-41ab-95d1-83f7f3427687,royal_college_of_surgeons_in_ireland,Royal College of Surgeons in Ireland +8885,,87112385-c1ab-4115-b6c4-aed78cc5402b,OM Pharma SA,om_pharma_sa,,,,,, +8886,,c6e68ef6-799e-4145-b0f8-7970e7b98f03,NKI-AVL,nki_avl,,,,,, +8887,,eed365fd-52ae-4b4c-8a2d-348746dafebb,"TEDEC-MEIJI FARMA, S.A",tedec_meiji_farma_s_a,,,,,, +752,0.97785389423370361,137320fb-fac2-4e31-99c7-7873aa7537cc,Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC),grupo_espa_ol_de_tratamiento_de_tumores_de_cabeza_y_cuello_ttcc,,,,137320fb-fac2-4e31-99c7-7873aa7537cc,grupo_espa_ol_de_tratamiento_de_tumores_de_cabeza_y_cuello_ttcc,Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC) +8888,,0e2e90c5-0108-4db7-9102-0a86e7c97eed,Alimentary Health Ltd,alimentary_health_ltd,,,,,, +174,0.980699,b6d07c42-8f99-487e-8dbb-3129112907b5,University of Tartu,university_of_tartu,,,,b6d07c42-8f99-487e-8dbb-3129112907b5,university_of_tartu,University of Tartu +8889,,1252fc62-ee01-4f7a-95e7-2dc265599dd1,Warwick Medical School,warwick_medical_school,,,,,, +8890,,489121ae-c80c-4b0f-a96e-da38dae5bd30,Ziekenhuisapotheek Meppel-Hoogeveen,ziekenhuisapotheek_meppel_hoogeveen,,,,,, +817,0.98780262470245361,ec1b13cc-01ed-4d26-a390-cd4e25c3a147,Boehringer Ingelheim,boehringer_ingelheim,,,,53d17802-3866-4bc6-856b-3879f031124d,boehringer_ingelheim_b_v,Boehringer Ingelheim b.v +762,0.986968,08e66865-5523-488a-993b-2c12d1335b43,University Hospitals Bristol,university_hospitals_bristol,,,,08e66865-5523-488a-993b-2c12d1335b43,university_hospitals_bristol,University Hospitals Bristol +8891,,35c54e89-ad78-4e92-9cb2-4181f137fb43,Division of Angiology Graz,division_of_angiology_graz,,,,,, +729,0.96273022890090942,cb560f4c-875f-44a3-bed5-c8039bd52ca8,Sanofi Pasteur MSD SNC,sanofi_pasteur_msd_snc,,,,cb560f4c-875f-44a3-bed5-c8039bd52ca8,sanofi_pasteur_msd,Sanofi Pasteur MSD +8892,,6b987717-fc5b-4f85-a669-a3e0982a0ece,"Gilead Sciences, Inc",gilead_sciences_inc,,,,,, +8893,,8237e26a-5992-4ab0-b3da-188955c698bb,"Dimension Therapeutics, Inc",dimension_therapeutics_inc,,,,,, +8894,,d8b8d53c-73fb-11e6-a0cd-0242ac12000b,WELLSTAT THERAP,wellstat_therap,,,,,, +8895,,db3e8a90-95d8-4b63-8323-60df7dc4c255,MELORA PORTUGUESA. LDA,melora_portuguesa_lda,,,,,, +8896,,37877f7a-d831-4f95-8b3a-e93b35e0aaa3,Fundación para la Formación y la Investigación de los profesionales de la Salud (FUNDESALUD),fundaci_n_para_la_formaci_n_y_la_investigaci_n_de_los_profesionales_de_la_salud_fundesalud,,,,,, +477,0.96643507480621338,22dcd280-772d-451a-a261-cbef7a27c26c,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie",medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_3_abteilung_f_r_gastroenterologie_und_hepatologie,,,,092654ab-7dbc-4b58-83c4-7c2f45b75f9a,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_abteilung_f_r_gastroenterologie_und_hepatologie,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Gastroenterologie und Hepatologie" +8897,,46cc18ba-723d-11e6-a0cd-0242ac12000b,SCIOS LLC,scios_llc,,,,,, +905,0.98715120553970337,49853b1c-d693-4e55-affd-06e4542b69ef,King's College London (IOP),king_s_college_london_iop,,,,18d9ea5c-b3a8-49aa-a224-39aa5d2a425d,king_s_college_london,King's College London +8898,,c0bba9d6-fe7d-483c-9d75-2d070e6eaf2e,"Acceleron Pharma, Inc",acceleron_pharma_inc,,,,,, +8899,,644aabb1-a801-40b6-90da-42c2f45d8808,FRANCISCO J. BLANCO GARCÍA,francisco_j_blanco_garc_a,,,,,, +8900,,56feef43-9a2f-438d-bb81-3e5dfdd86543,ISTITUTO NAZIONALE PER LA CURA TUMORI,istituto_nazionale_per_la_cura_tumori,,,,,, +8901,,680ef25c-715e-11e6-a0cd-0242ac12000b,EVERYLIFE,everylife,,,,,, +8902,,443bfc50-3e06-431f-8b44-3faaca8036b1,SWBH NHS Trust,swbh_nhs_trust,,,,,, +8903,,d47b8cec-a10c-4437-9548-6c5717da3fe6,SOCIETA' LABORATORIO FARMACEUTICO S.I.T. SRL,societa_laboratorio_farmaceutico_s_i_t_srl,,,,,, +8904,,b560c996-4dac-4c04-a102-869887f73d33,Ambit Biosciences Corporation,ambit_biosciences_corporation,,,,,, +880,0.941049,c8ab8b90-390a-4ea3-bdcd-55fcd31ee10e,Central Manchester and Manchester Childrens University Hospitals NHS Trust,central_manchester_and_manchester_childrens_university_hospitals_nhs_trust,,,,2d4630db-6244-46e0-a68c-f156131d2f04,central_manchester_manchester_children_s_university_hospitals_nhs_trust,Central Manchester& Manchester Children's University Hospitals NHS Trust +8905,,4c27a7f7-0696-4f01-8fb8-a51062570934,"Ferring-Leciva, a.s",ferring_leciva_a_s,,,,,, +8906,,a9f3cc18-4a15-4104-b485-d6a23ee2c0f1,SentoClone AB,sentoclone_ab,,,,,, +191,0.98367059230804443,4042f330-66f0-40ec-8288-db80eef6363c,CESAR Central European Society for,cesar_central_european_society_for,,,,4042f330-66f0-40ec-8288-db80eef6363c,cesar_central_european_society_for_anticancer_drug_research,CESAR Central European Society for Anticancer Drug Research +180,0.97171720862388611,0b232628-7206-11e6-a0cd-0242ac12000b,VALEANT PHARMS INTL,valeant_pharms_intl,,,,0b232628-7206-11e6-a0cd-0242ac12000b,valeant_pharms,VALEANT PHARMS +8907,,396ab8e0-b0cc-4b4b-9fcb-8be5416882f5,Portola Pharmaceuticals Inc,portola_pharmaceuticals_inc,,,,,, +8908,,9c91c5bf-a6ea-4f5c-afcd-0f17a71370c0,Alcon Research Limited,alcon_research_limited,,,,,, +8909,,de1141a1-1af5-493f-b1fa-ffabda497f31,REVOTAR Biopharmaceuticals AG,revotar_biopharmaceuticals_ag,,,,,, +452,0.97584396600723267,7dc31ed2-c888-4a81-8a21-860b006cc000,Novartis Farmaceutica S.A,novartis_farmaceutica_s_a,,,,7dc31ed2-c888-4a81-8a21-860b006cc000,novartis_farmaceutica_s_a,Novartis Farmaceutica S.A +8910,,f540e39b-41a0-4533-bff3-dd9a4e9dc209,Dr. V. Soriano,dr_v_soriano,,,,,, +592,0.98310869932174683,75cfe52c-155f-4652-b05d-d246407f7a2f,Medical University of Innsbruck,medical_university_of_innsbruck,,,,75cfe52c-155f-4652-b05d-d246407f7a2f,medical_university_of_innsbruck,Medical University of Innsbruck +682,0.982418,eed791bf-b621-4cbe-af34-dcb0e5aeb4dd,Genentech,genentech,,,,23ad1ae6-2f3f-4ff6-98ef-777036a904b2,genentech_inc,"Genentech, Inc" +8911,,cce7392f-d94d-486f-9191-7b416e7bc7e5,Dr Eloy Espin,dr_eloy_espin,,,,,, +8912,,c87d493d-e791-4113-9116-f541f9e13925,"Avanir Pharmaceuticals, Inc",avanir_pharmaceuticals_inc,,,,,, +8913,,8288b4e1-f4a9-4fed-a996-813ec40471aa,Reade,reade,,,,,, +1081,0.98584973812103271,48c9366f-f57d-45a5-b7c5-8b03cb153868,Vertex Pharmaceuticals Incorporated,vertex_pharmaceuticals_incorporated,,,,48c9366f-f57d-45a5-b7c5-8b03cb153868,vertex_pharmaceuticals_inc,Vertex Pharmaceuticals Inc +8914,,cd03b2c6-847a-491f-8428-3060750c8336,SOLTI,solti,,,,,, +307,0.90344,b08c1e4f-521d-4753-92c6-78fc43a73dab,"Medizinische Universität Wien, Univ. Klinik für Innere Medizin III, Abteilung für Gastroenterologie",medizinische_universit_t_wien_univ_klinik_f_r_innere_medizin_iii_abteilung_f_r_gastroenterologie,,,,b08c1e4f-521d-4753-92c6-78fc43a73dab,medizinische_universit_t_wien_univ_klinik_f_r_innere_medizin_iii_abteilung_f_r_gastroenterologie,"Medizinische Universität Wien, Univ. Klinik für Innere Medizin III, Abteilung für Gastroenterologie" +8915,,8ceb1f18-9eeb-456f-a75f-3896c3de642b,Polyphor AG,polyphor_ag,,,,,, +8916,,91823d32-7c00-4147-a761-4d61bf63450e,HYKS-instituutti,hyks_instituutti,,,,,, +8917,,b733aef5-4653-4d68-9f93-4c24aa0f6376,University Leipzig,university_leipzig,,,,,, +8918,,1b97b99a-4dbb-48fe-bec3-5dad0c78ac6e,Fundación Sociedad Española de Médicos de Atención Primaria (SEMERGEN),fundaci_n_sociedad_espa_ola_de_m_dicos_de_atenci_n_primaria_semergen,,,,,, +8919,,9e92b537-454a-40c0-9041-bd88c4fd0f69,Sanofi Pasteur China,sanofi_pasteur_china,,,,,, +8920,,6751d550-e722-44c3-89d5-416581b38295,"Glostrup Hospital, Videncenter for Reumatologi og Rygsygdomme, VRR",glostrup_hospital_videncenter_for_reumatologi_og_rygsygdomme_vrr,,,,,, +8921,,0b53ce6e-7142-11e6-a0cd-0242ac12000b,MIRROR PHARMS LLC,mirror_pharms_llc,,,,,, +8922,,052c0c3c-8bbd-11e6-a449-0242ac12000b,"Odontologisk Institut, Aarhus Universitet",odontologisk_institut_aarhus_universitet,,,,,, +8923,,dc64e685-ae35-405b-8ae7-0ff89bf546b6,Koagulationscentrum UMAS,koagulationscentrum_umas,,,,,, +8924,,0ff46c3e-99cd-435b-9600-ffa455ec1943,Univ.-Doz. Dr. Karl-Heinz Smolle,univ_doz_dr_karl_heinz_smolle,,,,,, +8925,,bd6773de-f130-4db7-9dad-993e8f334520,Cambridge Clinical Trials Unit,cambridge_clinical_trials_unit,,,,,, +8926,,940524b8-8e86-46c8-bfe3-7be8d3136395,"rEVO Biologics, Inc",revo_biologics_inc,,,,,, +534,0.974154,26b8ea41-7b0c-465a-88f2-0c4f81b680ce,"R&D Department, Box 146, Addenbrooke's Hospital",r_d_department_box_146_addenbrooke_s_hospital,,,,26b8ea41-7b0c-465a-88f2-0c4f81b680ce,r_d_department_box_146_addenbrooke_s_hospital,"R&D Department, Box 146, Addenbrooke's Hospital" +8927,,1281ceac-71c4-11e6-a0cd-0242ac12000b,CAREFUSION,carefusion,,,,,, +8928,,50f36ae8-43a3-4f70-a597-99c500224f9b,NHS Highland,nhs_highland,,,,,, +8929,,c0052649-661a-4399-8f67-9e4928b3876f,Kitasato institute clinical trial coordinating center,kitasato_institute_clinical_trial_coordinating_center,,,,,, +8930,,969a2d40-cfbe-4ec8-81cc-34c4cc8c08a4,"National University of Ireland, Galway",national_university_of_ireland_galway,,,,,, +8931,,afb33041-3dc2-4803-9979-0b56a7d54910,"BiPar Sciences, Inc",bipar_sciences_inc,,,,,, +8932,,705738b8-64cb-4651-bcfb-3c64f92dd1d1,Fundació Clínic recerca Biomèdica,fundaci_cl_nic_recerca_biom_dica,,,,,, +8933,,9efd5cf4-b64a-4b89-9ac1-4125473aa778,Therabel Pharmaceuticals Ltd,therabel_pharmaceuticals_ltd,,,,,, +1071,0.96349790692329407,a5ec592c-5234-4536-b418-e1d3f1386d26,University College Dublin Clinical Research Centre,university_college_dublin_clinical_research_centre,,,,a1ac5ed3-48d6-4b25-be01-f8fe60a9d1d6,university_college_dublin,University College Dublin +8934,,e3996ab9-8265-40c9-8ed1-c7f37f13f4b2,Chiesi Farmazeutici SpA,chiesi_farmazeutici_spa,,,,,, +8935,,08b84a43-3b41-4dc1-8e2f-396fe47345b9,Laboratorios Litaphar S.A,laboratorios_litaphar_s_a,,,,,, +8936,,0746905b-d6a5-4e68-818a-0a255d55103a,Ultragenyx Pharmaceuticals Inc,ultragenyx_pharmaceuticals_inc,,,,,, +8937,,30c8e438-8bbc-11e6-a449-0242ac12000b,Charalampos Vlachopoulos,charalampos_vlachopoulos,,,,,, +600,0.93912315368652344,2514e09a-d3e3-4866-9812-c4565fff5c90,Fundación Institut de Recerca de l'Hospital de la Sta Creu i Sant Pau,fundaci_n_institut_de_recerca_de_l_hospital_de_la_sta_creu_i_sant_pau,,,,6b4a9b2d-18ff-4441-b335-98517841d021,fundaci_n_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Fundació Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau +8938,,07149028-9e84-4d0d-80f2-8ae2feccc286,Wilhelminen hospital,wilhelminen_hospital,,,,,, +8939,,16b424d8-ed37-4761-a3b5-c83168d648b8,GLAXO SMITHKLINE,glaxo_smithkline,,,,,, +8940,,f428aa04-513d-41f4-b25b-3e5655970073,"Aventis Pharmaceuticals, Inc. (a subsidiary of sanofi-aventis group)",aventis_pharmaceuticals_inc_a_subsidiary_of_sanofi_aventis_group,,,,,, +8941,,c054e1cb-754d-4979-ab58-5e5764e9c4c6,Pharma Nord ApS,pharma_nord_aps,,,,,, +8942,,8337d765-d3df-4101-8d3f-9f6da6c039f1,LABORATORIOS NORMON S.A,laboratorios_normon_s_a,,,,,, +713,0.94804009795188904,0825dd64-2757-4f39-ac89-ff605a4285c1,"Wyeth Pharmaceuticals Inc., a wholly owned subsidary of Pfizer Inc., 500 Arcola Road, Collegeville, PA 19426, USA",wyeth_pharmaceuticals_inc_a_wholly_owned_subsidary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,,,,d2f1d48d-c243-473b-9f47-208723250aa6,wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA" +8943,,f2809394-6fc1-11e6-abe8-0242ac12000b,"Gynækologisk-obstetrisk afd. G, Glostrup Hospital",gyn_kologisk_obstetrisk_afd_g_glostrup_hospital,,,,,, +8944,,61e73e25-21ea-47a4-b4a7-b9881948137d,Wyeth LLC,wyeth_llc,,,,,, +8945,,9c8276be-00f3-45e5-88c4-43e5703390e0,"R&D, Barts and The London NHS Trust",r_d_barts_and_the_london_nhs_trust,,,,,, +8946,,ec2b1cdc-2c5b-4949-9613-7cdae927edc7,Azienda Ospedaliera Papa Giovanni XXIII,azienda_ospedaliera_papa_giovanni_xxiii,,,,,, +8947,,c635d31c-0a65-4c32-b7ab-5d872ec48ae8,"Alteon, Inc",alteon_inc,,,,,, +8948,,0516ab8d-2e27-4acd-bbde-e4acec2af7b5,PLIVA HRVATSKA d.o.o,pliva_hrvatska_d_o_o,,,,,, +8949,,490cb8b6-8bbd-11e6-a449-0242ac12000b,Stallergenes SAS,stallergenes_sas,,,,,, +8950,,bf3ec593-c834-42d9-a47e-09580e9530f8,"University of Oulu, Department of Physical and Rehabilitation Medicine",university_of_oulu_department_of_physical_and_rehabilitation_medicine,,,,,, +8951,,132e3d29-a59c-491b-8e77-905f4a1acad5,Eva Marie Erfurth,eva_marie_erfurth,,,,,, +8952,,199b0d9a-c076-4dd8-a400-1e3bdec1bedf,Uppsala läns landsting,uppsala_l_ns_landsting,,,,,, +623,0.985931,4036d0e2-54dc-41a1-ab42-721775d200c4,Klinikum der Universität,klinikum_der_universit_t,,,,4036d0e2-54dc-41a1-ab42-721775d200c4,klinikum_der_universit_t,Klinikum der Universität +8953,,4b9937b7-7754-4711-a468-15f9b584b4fe,Mario Negri Gynecology Oncology Group - MaNGO,mario_negri_gynecology_oncology_group_mango,,,,,, +8954,,4fbbffcd-f239-425c-b2d8-554f3dd80c90,"Pfizer Inc., East 42nd Street, New York, NY 10017",pfizer_inc_east_42nd_street_new_york_ny_10017,,,,,, +8955,,3ecdddeb-f978-4910-b108-47332425d3ae,"Laboratorios Menarini, S.A",laboratorios_menarini_s_a,,,,,, +8956,,b18a1c1e-73fb-11e6-a0cd-0242ac12000b,GENTIUM SPA,gentium_spa,,,,,, +8957,,42cb9635-5301-4f38-b05d-9d572ada366e,Tays/ anestesiayksikkö,tays_anestesiayksikk,,,,,, +8958,,4df0904d-1de8-4417-96f2-6de6fbda8b3a,The Finnish Lymphoma group,the_finnish_lymphoma_group,,,,,, +820,0.98334300518035889,5febc4b8-715b-11e6-a0cd-0242ac12000b,WOCKHARDT LTD,wockhardt_ltd,,,,5febc4b8-715b-11e6-a0cd-0242ac12000b,wockhardt_ltd,WOCKHARDT LTD +8959,,c6c3d35b-9b17-4203-9fdb-2d150e934af9,NEPHROLOGY DEPARTMENT (HOSPITAL UNIVERSITARY OF BELLVITGE),nephrology_department_hospital_universitary_of_bellvitge,,,,,, +8960,,1c469669-ad88-44dc-bcd3-93efe8778acc,Nikolai Sleep Monitoring Clinic,nikolai_sleep_monitoring_clinic,,,,,, +825,0.979838,f1549a9a-52e0-4629-86bc-c853a0a91aa7,University of Surrey,university_of_surrey,,,,1bd8b575-4f6d-4564-aa9e-6ea528cb17bb,university_of_surrey_clinical_research_centre,University of Surrey Clinical Research Centre +8961,,38f2e7b8-73f1-11e6-a0cd-0242ac12000b,OXARC INC,oxarc_inc,,,,,, +677,0.981509,d2cfbe43-b68f-4a00-90fd-0a42a6db1d26,"Christian Geisler, Rigshospitalet, dept. Haematology 4042",christian_geisler_rigshospitalet_dept_haematology_4042,,,,22accd65-c14d-4d5b-acab-c1bb9180b01d,christian_geisler_righospitalet_dept_haematology_4042,"Christian Geisler, Righospitalet, dept. Haematology 4042" +1002,0.97465866804122925,f1c53f60-8bda-11e6-a449-0242ac12000b,Fundación para la Formación e Investigación Sanitaria (FFIS),fundaci_n_para_la_formaci_n_e_investigaci_n_sanitaria_ffis,,,,8fbc1a40-90b3-491d-9c96-f5d311f67e2e,fundaci_n_para_la_formaci_n_e_investigaci_n_sanitaria,Fundación para la Formación e Investigación Sanitaria +8962,,5a7dfb78-1bab-4613-bdac-740c82ceafb5,MedPharm Ltd,medpharm_ltd,,,,,, +171,0.98256033658981323,e0ea9f26-8028-4605-8f3e-bec9a3e04275,Merck Serono International SA,merck_serono_international_sa,,,,e0ea9f26-8028-4605-8f3e-bec9a3e04275,merck_serono_international,Merck Serono International +8963,,694e261e-7141-11e6-a0cd-0242ac12000b,BIONPHARMA INC,bionpharma_inc,,,,,, +8964,,4d6ba69e-ebe6-49c7-8e23-ab9033fc3378,Korea UCB Co. Ltd,korea_ucb_co_ltd,,,,,, +8965,,fb3502f9-a01f-4c16-8a25-62c8b046f46f,Immungenetics AG,immungenetics_ag,,,,,, +707,0.989136,5c77e08b-5755-407d-a8b9-74bfb0127f85,Grupo Español de Investigación en Cáncer de Ovario (GEICO),grupo_espa_ol_de_investigaci_n_en_c_ncer_de_ovario_geico,,,,5c77e08b-5755-407d-a8b9-74bfb0127f85,grupo_espa_ol_de_investigaci_n_en_c_ncer_de_ovario_geico,Grupo Español de Investigación en Cáncer de Ovario (GEICO) +738,0.96910750865936279,26543fda-b9ed-4d41-966f-b38a24290ef6,Fundació Clínic per la Recerca Biomèdica,fundaci_cl_nic_per_la_recerca_biom_dica,,,,0223cc5a-d770-406a-9db1-a0c4325ff12b,fundaci_clinic_per_la_recerca_biom_dica,Fundació Clinic per la Recerca Biomédica +8966,,dcfca798-61f0-4753-aaf1-70e14dd72a84,L’OREAL RECHERCHE,l_oreal_recherche,,,,,, +8967,,87279ffb-0c34-4c49-a06e-4bcac3ce5e0f,"Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche",dipartimento_di_scienze_chirurgiche_oncologiche_e_gastroenterologiche,,,,,, +8968,,0ef8b3ce-c273-4ab4-9be4-3ac1dc4dc4c6,"Integrated Therapeutics Group, Inc./Schering-Plough Oy",integrated_therapeutics_group_inc_schering_plough_oy,,,,,, +8969,,372ecea2-96dc-11e6-becf-0242ac110008,AAA USA INC,aaa_usa_inc,,,,,, +8970,,de607572-6edb-4e0d-b5e1-64f45d9d3a33,"Instituto Grifols, S.A",instituto_grifols_s_a,,,,,, +8971,,6554a28c-d196-484d-a7f7-40945493f8b6,"Charité Universitätsmedizin Berlin, Department of Dermatology and Allergy",charit_universit_tsmedizin_berlin_department_of_dermatology_and_allergy,,,,,, +8972,,6e540431-6009-48fd-b3f2-dc1f57fd0cdf,Karen Toftdahl Bjørnholdt,karen_toftdahl_bj_rnholdt,,,,,, +8973,,51d3b71d-5938-4e5b-b290-cfe8e4828dcf,GlaxoSmithKline UK,glaxosmithkline_uk,,,,,, +8974,,e4eafd1e-07e7-484a-bbdc-770b84f0d54d,"Bayer Consumer Care, Research & Development",bayer_consumer_care_research_development,,,,,, +8975,,a0965923-96b0-41b2-9028-c6ebfda80e31,PhotoCure ASA,photocure_asa,,,,,, +357,0.987372,bd8bc4b9-770b-4246-be78-2ca345a2215e,Flexion Therapeutics,flexion_therapeutics,,,,98bac61e-5a35-4e65-bf8a-564c1eac1911,flexion_therapeutics_inc,"Flexion Therapeutics, Inc" +533,0.981251,8a1ae7e2-b3a8-4c83-b8fd-cdc9563d747a,"THERAKOS, Inc",therakos_inc,,,,215a399e-635c-44e7-a8f5-032b68855c29,therakos,THERAKOS +8976,,4b335964-41e7-4409-a575-b229fb9edd29,Elli Lilly and Company,elli_lilly_and_company,,,,,, +702,0.97607913613319397,f7a84abd-84f5-4cab-897b-523cc5e5ddf9,University Hospitals of Leicester NHS Trust Research & Development Department,university_hospitals_of_leicester_nhs_trust_research_development_department,,,,e83cea40-d34c-423f-9f95-62293d47cae2,university_hospitals_of_leicester_nhs_trust,University Hospitals of Leicester NHS Trust +8977,,615335c2-5eb0-4d98-8bb5-53e2cdbb3997,I.T.M.O. - ITALIAN TRIALS IN MEDICAL ONCOLOGY,i_t_m_o_italian_trials_in_medical_oncology,,,,,, +8978,,4d35bf08-0e96-4845-a99a-69202f65faf5,University hospital of the University of Ulm,university_hospital_of_the_university_of_ulm,,,,,, +8979,,95031d24-b5ce-4da8-b13c-4ac0cb371b52,Joint Research & Development Office (Barts and The London School of Medicine & Dentistry),joint_research_development_office_barts_and_the_london_school_of_medicine_dentistry,,,,,, +1070,0.979707,81203a68-3114-4edd-826e-001dcafc64ea,Hopital Erasme - Chest service,hopital_erasme_chest_service,,,,40ccc091-c821-4ebb-b881-5c3d26d57a77,hopital_erasme,Hopital Erasme +8980,,d45d448e-b4f3-4b3f-802a-67db225ba009,Disphar International B.V,disphar_international_b_v,,,,,, +8981,,84fcc24e-686a-4d22-b788-19e180034b4f,Boehringer Ingelheim Hellas AE,boehringer_ingelheim_hellas_ae,,,,,, +8982,,013a5a00-5caa-4796-8ec9-eafab9f16cb5,Pharmapnea AB,pharmapnea_ab,,,,,, +8983,,7b08f782-ad52-4748-8330-3fca547bfc87,Hospital Central de la Defensa,hospital_central_de_la_defensa,,,,,, +467,0.948148,dc078d8e-73f9-11e6-a0cd-0242ac12000b,MERRIMACK PHARMS,merrimack_pharms,,,,33f6d476-e36d-47d6-b355-d0aff833ee95,merrimack_pharmaceuticals,MERRIMACK PHARMACEUTICALS +781,0.96121801932652795,201d9d4f-5cd0-46df-836e-da17fa2b43dd,GlaxoSmithKline Research and Development Limited,glaxosmithkline_research_and_development_limited,,,,201d9d4f-5cd0-46df-836e-da17fa2b43dd,glaxosmithkline_research_and_development,GlaxoSmithKline Research and Development +8984,,bed95653-2fc9-4f8f-9998-f70c4e6f3196,"Anaesthesia and Operative Services, Kuopio University Hospital",anaesthesia_and_operative_services_kuopio_university_hospital,,,,,, +8985,,f0a89933-bf7d-45bc-88b4-933fe6c2e03d,"Medical University of Vienna, Department of Pedatrics",medical_university_of_vienna_department_of_pedatrics,,,,,, +8986,,e42c5ef6-2b44-48dd-9aec-7b674542b91e,Novartis Consumer Health SA,novartis_consumer_health_sa,,,,,, +8987,,5abdac1b-dbdb-4e47-976d-4200bde76c60,Národný onkologický ústav,n_rodn_onkologick_stav,,,,,, +8988,,9912e295-d555-4939-b737-cb8598615ee2,Copenhagen University Hospital,copenhagen_university_hospital,,,,,, +1037,0.979231,72bda612-7163-11e6-a0cd-0242ac12000b,MUSTAFA NEVSAT,mustafa_nevsat,,,,72bda612-7163-11e6-a0cd-0242ac12000b,mustafa_nevsat,MUSTAFA NEVSAT +8989,,f5620fd6-252b-4db5-8dc4-d0c68bc98f16,"Medizinische Universität Wien Univ. Klinik f. Innere Med. III, Abt. f. Gastroenterologie/Hepatologie",medizinische_universit_t_wien_univ_klinik_f_innere_med_iii_abt_f_gastroenterologie_hepatologie,,,,,, +8990,,98bf00a8-6e3f-462b-8606-720242d8afb5,Donau-universität Krems,donau_universit_t_krems,,,,,, +8991,,24631df3-e561-4156-8a2c-7535c7e236c5,SOCIETA' ITALIANA DI NEFROLOGIA,societa_italiana_di_nefrologia,,,,,, +8992,,768fc5e7-695d-4727-92ba-9fea9edd00ae,"INSTITUT PASTEUR, Biomedical Parasitology Unit",institut_pasteur_biomedical_parasitology_unit,,,,,, +8993,,225a7a03-c56c-428a-af95-6478095be01e,Dutch Heart Foundation,dutch_heart_foundation,,,,,, +8994,,a6f3fbc0-3194-4c8c-aeac-1094c454fb33,BioMarin International Ltd,biomarin_international_ltd,,,,,, +8995,,332175c2-afb1-456e-b6ee-ea0fcbe4cbf6,"Laboratorios SALVAT, S.A",laboratorios_salvat_s_a,,,,,, +8996,,1ee033c9-2bd8-4a67-831b-7e6ef1448fd2,Thomas Bergholt,thomas_bergholt,,,,,, +8997,,148aef2a-7947-432f-84a7-2fc497903dc1,None,none,,,,,, +8998,,ad9a867c-8be3-42fd-82e2-adb045f6a99d,"Janssen-Cilag, div.Johnson and Johnson s.r.o",janssen_cilag_div_johnson_and_johnson_s_r_o,,,,,, +8999,,056f2bd2-9bfa-4983-876c-6b67a0be1d85,CHU d'Amiens,chu_d_amiens,,,,,, +9000,,9eeedd84-cf6e-49ed-b331-c3ff4cc48920,"Department of Neurology, Karolinska University Hospital",department_of_neurology_karolinska_university_hospital,,,,,, +9001,,9c68a906-8bbe-11e6-a449-0242ac12000b,Cipla Europe NV,cipla_europe_nv,,,,,, +9002,,97f51661-2bf4-40d6-95e7-9c34f1c33ff9,Neosil Inc,neosil_inc,,,,,, +9003,,7f687104-3990-4e4a-bbcb-72102be48295,Center for Cancer Immune Therapy,center_for_cancer_immune_therapy,,,,,, +9004,,16a13211-df71-46d1-9f53-a8dfccf361be,North Lincolnshire and Goole NHS Foundation Trust,north_lincolnshire_and_goole_nhs_foundation_trust,,,,,, +9005,,e79969df-5092-433a-8918-f15bb3594ded,Dr. Narcís Cardoner,dr_narc_s_cardoner,,,,,, +9006,,f1feba1e-7128-11e6-a89e-0242ac12000b,TEVA PARENTERAL,teva_parenteral,,,,,, +9007,,b0598217-3a02-4b7a-8e29-ee6ee8c85611,Whittington NHS Trust,whittington_nhs_trust,,,,,, +9008,,85407bbc-7167-11e6-a0cd-0242ac12000b,CENTRAL RADIOPHARM,central_radiopharm,,,,,, +9009,,039131c2-85b4-472e-9093-714521add4a8,Uppsala University. Department of Women's and children's health,uppsala_university_department_of_women_s_and_children_s_health,,,,,, +9010,,6f005826-fd1d-4835-a91b-4db470d43a3b,Memory Pharmaceuticals Corp,memory_pharmaceuticals_corp,,,,,, +596,0.968448,425978bf-fe8b-4344-b07c-9ad8c257ba2f,"Cerexa, Inc. (subsidary of Forest Laboratories)",cerexa_inc_subsidary_of_forest_laboratories,,,,2f6c51a9-6c19-4869-bb54-9a99b0a7c099,cerexa_inc,"Cerexa, Inc" +9011,,6d4e6feb-1a35-4d61-9a7c-7712be2d4706,University Hospital Gent,university_hospital_gent,,,,,, +982,0.94804,52b0531e-71b4-11e6-a0cd-0242ac12000b,JANSSEN PHARMA,janssen_pharma,,,,4f75b1b6-7160-11e6-a0cd-0242ac12000b,janssen_pharms,JANSSEN PHARMS +9012,,828dcca8-73f6-11e6-a0cd-0242ac12000b,VELOXIS PHARMS INC,veloxis_pharms_inc,,,,,, +420,0.949464,6e9fed6e-8bb8-11e6-a449-0242ac12000b,SAKK (Schweizerische Arbeitsgemeinschaft für klinische Krebsforschung),sakk_schweizerische_arbeitsgemeinschaft_f_r_klinische_krebsforschung,,,,4ff92bf9-dd91-4af4-8f0b-df007e6ac363,sakk,SAKK +9013,,ee46ec58-ccab-4b3c-bede-13815ed0a280,Baxter R&D Europe S.C.R.L,baxter_r_d_europe_s_c_r_l,,,,,, +9014,,34630d86-f4df-452d-98c1-6cb52998958a,"Erasmus MC, Dept. Urology",erasmus_mc_dept_urology,,,,,, +9015,,ac194974-8318-4f17-9f5f-2a974f4d41fb,"Klinik und Poliklinik fuer Strahlentherapie, Universität Erlangen-Nürnberg",klinik_und_poliklinik_fuer_strahlentherapie_universit_t_erlangen_n_rnberg,,,,,, +9016,,8e504b76-9ff0-41f2-98c9-9e26710ebc97,Avraham Pharmaceuticals Ltd,avraham_pharmaceuticals_ltd,,,,,, +855,0.983343,9eeb4efa-71af-11e6-a0cd-0242ac12000b,GD SEARLE,gd_searle,,,,9eeb4efa-71af-11e6-a0cd-0242ac12000b,gd_searle,GD SEARLE +9017,,be97baa0-21a8-4051-a4c2-f9d87c605941,Hospital Universitario de Rennes,hospital_universitario_de_rennes,,,,,, +193,0.961748,5684aae1-9d95-4f90-a93b-ce904a01565d,Abertawe Bro Morgannwg University NHS Trust,abertawe_bro_morgannwg_university_nhs_trust,,,,5684aae1-9d95-4f90-a93b-ce904a01565d,abertawe_bro_morgannwg_university_nhs_trust,Abertawe Bro Morgannwg University NHS Trust +9018,,3dac9bcf-988f-4dca-92db-1cd79e337eb9,Hospital Universitario Infanta Cristina,hospital_universitario_infanta_cristina,,,,,, +9019,,51e66fe4-73ef-11e6-a0cd-0242ac12000b,RTRX,rtrx,,,,,, +9020,,a68a2834-d0aa-40d1-b331-565a20265dbe,Laboratoires Merck Sharp and Dohme-Chibret,laboratoires_merck_sharp_and_dohme_chibret,,,,,, +9021,,536a7457-d0fa-4fbe-b7a0-c5a87fe6fe4d,BRC operations Pty. Ltd,brc_operations_pty_ltd,,,,,, +9022,,a18152cf-7ec9-45e1-929e-59bc6a0fc7e5,Unidad de Neuroinmunología,unidad_de_neuroinmunolog_a,,,,,, +1074,0.975369,d3b508d8-7141-11e6-a0cd-0242ac12000b,STASON PHARMS,stason_pharms,,,,5fd7db64-7148-11e6-a0cd-0242ac12000b,stason,STASON +9023,,aff56854-1e28-4bbd-beeb-638541b9b9b3,"Achaogen, Inc",achaogen_inc,,,,,, +606,0.98766422271728516,ffeb7a04-7141-11e6-a0cd-0242ac12000b,AUROBINDO PHARMA,aurobindo_pharma,,,,f36837b0-7144-11e6-a0cd-0242ac12000b,aurobindo_pharma,AUROBINDO PHARMA +9024,,1eb60b74-4301-4304-9a4c-65a33f3b0516,Menarini IFR – International Division,menarini_ifr_international_division,,,,,, +9025,,a9d162be-0b71-4738-b66a-8c240f15fef7,Abbott Biologicals B.V,abbott_biologicals_b_v,,,,,, +9026,,dd7f811a-b5b0-41ad-8157-e5fa4f86b7ed,Samsung Electronics Co. Ltd,samsung_electronics_co_ltd,,,,,, +9027,,1afef3f6-71d7-4b15-bb15-d29862ca9fc8,University Hospital Germans Trias i Pujol,university_hospital_germans_trias_i_pujol,,,,,, +612,0.98582571744918823,f3ebaba1-aead-4675-858a-6f4e2a4f28d1,Erasmus Medical Center Rotterdam,erasmus_medical_center_rotterdam,,,,f3ebaba1-aead-4675-858a-6f4e2a4f28d1,erasmus_medical_center,Erasmus Medical Center +9028,,1c92e489-9898-44e1-8184-febc011a25d8,MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A,menarini_international_operations_luxembourg_s_a,,,,,, +9029,,5134c248-7161-11e6-a0cd-0242ac12000b,PHARMA SERVE NY,pharma_serve_ny,,,,,, +9030,,79989a14-996b-464c-a3dc-b9cd667d3e75,OVATION PHARMACEUTICALS INC,ovation_pharmaceuticals_inc,,,,,, +9031,,a0a17251-0114-4274-a2ae-341e1f75a2af,Mundipharma Research GmbH & Co. KG,mundipharma_research_gmbh_co_kg,,,,,, +9032,,28d31eae-ad06-42c4-b0e8-cab527639b8a,ASSOCIAZIONE MALATTIE SANGUE,associazione_malattie_sangue,,,,,, +9033,,c20afe6c-7191-11e6-a0cd-0242ac12000b,APTALIS PHARMA US,aptalis_pharma_us,,,,,, +1069,0.947481,b57899f1-cac7-418c-9efd-009a37271462,Universitetssjukhuset i Linköping,universitetssjukhuset_i_link_ping,,,,416fb7db-4b29-4803-ba0e-6ece3f142626,universitetssjukhuset_link_ping,Universitetssjukhuset Linköping +9034,,c3dd680d-fd23-4a70-bd6e-014735c105c1,Prosensa Therapeutics BV,prosensa_therapeutics_bv,,,,,, +9035,,0882035f-c286-4629-a255-e7efde243a43,"Consorcio Hospital General Universitario de Valencia . Servicio de Anestesia , Reanimacion y tto del Dolor",consorcio_hospital_general_universitario_de_valencia_servicio_de_anestesia_reanimacion_y_tto_del_dolor,,,,,, +869,0.97674435377120972,dce387f0-f7a2-4de9-a917-bfc3744da5a0,Astellas Pharma BV,astellas_pharma_bv,,,,8c2f1018-ffda-46d2-836f-6bb8351d4443,astellas,Astellas +9036,,922ef9f7-0b0e-4857-a261-859a58e17dbd,"Allakos, Inc",allakos_inc,,,,,, +9037,,d7437a2a-982a-4ff2-8c66-91aaaf7076ce,ALTANA Pharma AG,altana_pharma_ag,,,,,, +9038,,6021eb2f-30d4-4730-b2f5-63546e8f8d6c,Augenklinik des Universitätsklinikums Erlangen,augenklinik_des_universit_tsklinikums_erlangen,,,,,, +9039,,eb80af8a-85f8-4abe-9145-133d69162b03,VU Medisch Centrum,vu_medisch_centrum,,,,,, +9040,,7e790e6c-b117-4b36-8ff1-b205388179e0,Paula Diéguez García,paula_di_guez_garc_a,,,,,, +907,0.96189558506011963,38c1605f-9ba3-4a68-807d-d72954355835,sanofi-aventis recherche et developpment,sanofi_aventis_recherche_et_developpment,,,,f72ce0f5-27b8-42db-aeea-0faa55409a54,sanofi_aventis_recherche_et_developpement,sanofi-aventis recherche et developpement +9041,,1f95d3ff-53af-4aec-b4a9-44685de7e6c6,Takeda Belgium,takeda_belgium,,,,,, +9042,,6539a762-72d7-4d03-a842-6e4aeda74849,Päijät-Häme Central Hospital,p_ij_t_h_me_central_hospital,,,,,, +9043,,7b91dd62-8dbe-4e0d-9166-0b17e2c12ef3,Universität des Saarlandes,universit_t_des_saarlandes,,,,,, +690,0.984864,9da8b08c-7191-11e6-a0cd-0242ac12000b,FOREST LABS INC,forest_labs_inc,,,,9da8b08c-7191-11e6-a0cd-0242ac12000b,forest_labs_inc,FOREST LABS INC +9044,,09d83f70-93f8-408f-840c-df8bdf707e14,Grupo Español Multidisciplicinar de Melanoma (GEM),grupo_espa_ol_multidisciplicinar_de_melanoma_gem,,,,,, +544,0.978652,621062e4-7142-11e6-a0cd-0242ac12000b,BRISTOL MYERS,bristol_myers,,,,3e5070ce-7142-11e6-a0cd-0242ac12000b,bristol,BRISTOL +9045,,31afb37f-1cb9-4e68-99e0-0074110cfd4c,INFINITY PHARMACEUTICAL INC,infinity_pharmaceutical_inc,,,,,, +9046,,e19c8769-a745-11e6-94cb-5656d04fc2b5,Ove B. Schaffalitzky de Muckadell,ove_b_schaffalitzky_de_muckadell,,,,,, +290,0.985423,955ab72e-a78d-4dcf-bada-804223e835a1,Mayne Pharma Plc,mayne_pharma_plc,,,,4526ca2e-a18d-4d92-8100-e8a0507a1f36,mayne_pharma,Mayne Pharma +214,0.975452,f558cf32-f040-452d-bd3d-6eea236bfe77,"Innsbruck Medical University, Department of Radiology, Section of Microinvasive Therapy",innsbruck_medical_university_department_of_radiology_section_of_microinvasive_therapy,,,,1ad07c8c-d03b-4847-bbe9-1ac8e4b893aa,innsbruck_medical_university,Innsbruck Medical University +9047,,d7553994-53fe-4540-89fe-57c1c3e9a6b8,OCTAPHARMA AG,octapharma_ag,,,,,, +60,0.97508934565952843,b3d62e49-a543-49d4-a339-649ecbd1eb58,Wyeth Research Division of Wyeth Pharmaceuticals Inc,wyeth_research_division_of_wyeth_pharmaceuticals_inc,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc +9048,,3b56ec98-7167-11e6-a0cd-0242ac12000b,SPECTRON MRC LLC,spectron_mrc_llc,,,,,, +9049,,880d41ca-a3eb-422b-ab18-93ecbc92e862,Daiichi Sankyo Pharma Development,daiichi_sankyo_pharma_development,,,,,, +9050,,55fd4c50-c358-469b-b437-d30c0a4f3cae,Pfizer Luxembourg SARL Branch Office Estonia,pfizer_luxembourg_sarl_branch_office_estonia,,,,,, +323,0.98606482148170471,7c715eec-7632-4bad-85ac-60fea60f92d9,Tibotec Pharmaceuticals Ltd. Ireland,tibotec_pharmaceuticals_ltd_ireland,,,,7c715eec-7632-4bad-85ac-60fea60f92d9,tibotec_pharmaceuticals_ltd,Tibotec Pharmaceuticals Ltd +9051,,9b290917-0a3c-469a-912b-6f7e3c8ddec5,"Deutsche CLL-Studiengruppe, Klinik fur Innere Medizin",deutsche_cll_studiengruppe_klinik_fur_innere_medizin,,,,,, +9052,,e0928f36-7145-11e6-a0cd-0242ac12000b,XANODYNE PHARM,xanodyne_pharm,,,,,, +9053,,86a8ab78-96ea-4814-8b7e-d30b82146de5,Zelmic AB,zelmic_ab,,,,,, +767,0.98579606413841248,3a58d491-d793-4b73-83c1-72dece29c489,Medizinische Universität Innsbruck,medizinische_universit_t_innsbruck,,,,da4cbdf9-e1bc-4412-95a2-1df2b8781a19,medizinische_universit_t_innsbruck_innere_medizin_v,Medizinische Universität Innsbruck +9054,,8bd518ea-7160-11e6-a0cd-0242ac12000b,SCHERER LABS,scherer_labs,,,,,, +9055,,434af447-512c-4af0-9634-10e86ba33544,Hybrigenics SA,hybrigenics_sa,,,,,, +1062,0.98627,e1a71bbf-5693-4e21-bf1f-3e27e8f11ae0,Sint Franciscus Gasthuis Rotterdam,sint_franciscus_gasthuis_rotterdam,,,,68e001f6-0acf-4ba6-831c-dae305950d6b,sint_franciscus_gasthuis,Sint Franciscus Gasthuis +626,0.909952,56aeb338-943d-43c6-b963-168c8748a11a,Chiron Corporation Ltd,chiron_corporation_ltd,,,,35f0780b-f2b6-4584-86d6-148ae3464f6c,chiron_corporation_limited,Chiron Corporation Limited +9056,,62f4aae4-7c29-4485-a3bc-17345b365f76,"Merck Sharp & Dohme a subsidiary of Merck Co., Inc",merck_sharp_dohme_a_subsidiary_of_merck_co_inc,,,,,, +487,0.989076,614b7da9-01e8-45b1-a601-7f743ec0f288,University Eye Clinic Maastricht,university_eye_clinic_maastricht,,,,614b7da9-01e8-45b1-a601-7f743ec0f288,university_eye_clinic_maastricht,University Eye Clinic Maastricht +9057,,dc87c650-71a3-11e6-a0cd-0242ac12000b,ATON PHARMA VPNA,aton_pharma_vpna,,,,,, +932,0.98627001047134399,11113f5a-7350-422c-bd14-c920aa2332af,Pierre Fabre Medicament/Institut de Recherche Pierre Fabre,pierre_fabre_medicament_institut_de_recherche_pierre_fabre,,,,11113f5a-7350-422c-bd14-c920aa2332af,pierre_fabre_medicament_institut_de_recherche_pierre_fabre,Pierre Fabre Medicament/Institut de Recherche Pierre Fabre +9058,,1e2c5287-ae03-4173-97e6-25fc69fa7a01,"AOI Pharmaceuticals, Inc",aoi_pharmaceuticals_inc,,,,,, +746,0.97062024474143982,6067fed3-20a1-48ca-80df-3675d4109505,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C",johnson_johnson_pharmaceutical_research_development_l_l_c,,,,6067fed3-20a1-48ca-80df-3675d4109505,johnson_johnson_pharamceutical_research_development_l_l_c,"Johnson & Johnson Pharamceutical Research & Development, L.L.C" +9059,,186a30e1-9cb0-472d-bcf1-c529c1b01498,CHU de Nice,chu_de_nice,,,,,, +9060,,885c5442-c418-45f9-b1e9-e784d9ca707c,"Asklepion Pharmaceuticals, LLC",asklepion_pharmaceuticals_llc,,,,,, +9061,,38e35ac1-a550-476f-b460-2b39333f9a27,The University of Glasgow,the_university_of_glasgow,,,,,, +9062,,6486d070-7161-11e6-a0cd-0242ac12000b,VANGARD,vangard,,,,,, +9063,,7302413b-f791-4b8c-888d-70d642ed7857,Pfizer Pharma GmbH,pfizer_pharma_gmbh,,,,,, +9064,,2b897317-3041-40d6-850e-8ede3733c244,Kompetenznetz Parkinson e.V,kompetenznetz_parkinson_e_v,,,,,, +9065,,f09ae684-e8c4-48e8-9117-42b0bebba727,"Hospital Clinic, Barcelon",hospital_clinic_barcelon,,,,,, +9066,,9ca6b8c4-d415-4aed-835d-1c17eb91a493,Merck Sharp & Dohme Gesellschaft m.b.H,merck_sharp_dohme_gesellschaft_m_b_h,,,,,, +9067,,973e5b51-c3aa-4ba5-a55f-d7502952ad78,"Afdeling Urologie, Isala Klinieken",afdeling_urologie_isala_klinieken,,,,,, +9068,,28898bb0-2d35-47fb-ae72-ee698b5e2fc0,Mylan GmbH (Mylan),mylan_gmbh_mylan,,,,,, +125,0.982275,11b07734-c458-4066-877a-5c26e559db7c,CureTech,curetech,,,,11b07734-c458-4066-877a-5c26e559db7c,curetech,CureTech +9069,,ddaf05e6-8bbd-11e6-a449-0242ac12000b,Masarykova univerzita,masarykova_univerzita,,,,,, +506,0.981904,89fc944a-7141-11e6-a0cd-0242ac12000b,WATSON LABS FLORIDA,watson_labs_florida,,,,49d9286e-7129-11e6-a89e-0242ac12000b,watson_labs,WATSON LABS +9070,,a8d91e00-7dd5-40f6-9f13-79a96b42366e,QMUL and Bart's Health NHS trust,qmul_and_bart_s_health_nhs_trust,,,,,, +698,0.98415160179138184,72b9ca0e-fa0c-4c39-a503-2b0b6467415c,Bayer Healthcare AG,bayer_healthcare_ag,,,,72b9ca0e-fa0c-4c39-a503-2b0b6467415c,bayer_healthcare_ag,Bayer Healthcare AG +9071,,ad2ac3c2-7166-11e6-a0cd-0242ac12000b,SHENZHEN TECHDOW,shenzhen_techdow,,,,,, +9072,,a20b6959-3785-42f0-89cd-7176722b26a8,Atrium Medical Corporation,atrium_medical_corporation,,,,,, +959,0.96289326747258508,8e1ef03a-b2a7-496e-83ef-ae87bf0b27e9,Andromeda Biotech Ltd,andromeda_biotech_ltd,,,,8e1ef03a-b2a7-496e-83ef-ae87bf0b27e9,andromeda_biotech_ltd_42_hayarkon_st_yavne_81227_israel,Andromeda Biotech Ltd +9073,,ea65cc55-4899-463f-bbc7-b61e71f18881,Matti Eskelinen,matti_eskelinen,,,,,, +510,0.987557,9a59c260-eca4-4f86-a0fa-fed650d1712a,Joint Research Office,joint_research_office,,,,9a59c260-eca4-4f86-a0fa-fed650d1712a,joint_research_office,Joint Research Office +948,0.987264,ca7f7919-c99d-49fd-8812-36dc1941ad8d,Netherlands Cancer Institute,netherlands_cancer_institute,,,,ca7f7919-c99d-49fd-8812-36dc1941ad8d,netherlands_cancer_institute,Netherlands Cancer Institute +9074,,9510a5ba-7164-11e6-a0cd-0242ac12000b,GATE PHARMS,gate_pharms,,,,,, +9075,,79f967d2-7c1d-4621-ab56-c013750020de,"GenSpera, Inc",genspera_inc,,,,,, +9076,,2c15a1d2-709f-40b5-aab7-cd5e5e3e5fdf,Servei Pneumologia. Hospital Universitari Son Dureta,servei_pneumologia_hospital_universitari_son_dureta,,,,,, +9077,,fea982ee-bf78-4468-a20f-cf92db7e5ebf,Novartis Ireland Ltd,novartis_ireland_ltd,,,,,, +9078,,120de42e-2265-47a7-9867-128862ee071e,ROCHE SAS,roche_sas,,,,,, +9079,,6ded2dbd-0b8c-406a-b527-fb0995b3d426,ViiV Healthcare UK Ltd,viiv_healthcare_uk_ltd,,,,,, +9080,,8b808e42-40fe-43c6-b264-cc3f763f5401,Dr Josep Ordi Ros,dr_josep_ordi_ros,,,,,, +9081,,35b8e2f9-3aad-447c-81e0-d2cdc866b266,UNIVERSITA' CAMPUS BIOMEDICO,universita_campus_biomedico,,,,,, +9082,,79618eea-8602-41af-a6df-d0f49f79c03c,Maasstad Ziekenhuis,maasstad_ziekenhuis,,,,,, +9083,,3800ee04-823f-4bca-b2d3-b09471fc1025,VieCuri Medical Center,viecuri_medical_center,,,,,, +9084,,06c6e899-6498-46a7-8656-0bd50160d59b,Univerity Hospital Leuven,univerity_hospital_leuven,,,,,, +9085,,680b478c-67de-4a36-8a88-c1b0dee5f339,Swedish Lung Cancer Group,swedish_lung_cancer_group,,,,,, +9086,,2f1a40d2-b2a9-40b3-8a33-28e2b100a876,"Medizinische Universität Wien, Universitätsklinik für Kinder- und Jugendheilkunde",medizinische_universit_t_wien_universit_tsklinik_f_r_kinder_und_jugendheilkunde,,,,,, +9087,,c8e82e6e-0e55-472e-8f48-6c12a3d385fc,"Intergrated Therapeutics Group, Incorporated-a subsidiary of Schering Plough",intergrated_therapeutics_group_incorporated_a_subsidiary_of_schering_plough,,,,,, +471,0.987664,dc86ddb2-d617-48b5-9e80-ca9ea794503d,South Manchester University Hospital,south_manchester_university_hospital,,,,3162896a-c44b-4bc5-ab15-a97eb8b7517e,south_manchester_university_hospitals_nhs_trust,South Manchester University Hospitals NHS Trust +9088,,260300e6-73b7-11e6-a0cd-0242ac12000b,CITIUS PHARMS,citius_pharms,,,,,, +9089,,79a95e4b-fc73-4fe9-8b96-dcfaa8565028,Acacia Pharma Ltd,acacia_pharma_ltd,,,,,, +9090,,11f5478a-9a0f-46a7-80c6-eb031f4a2e64,"University of Frankfurt, Institute of Clinical Pharmacology",university_of_frankfurt_institute_of_clinical_pharmacology,,,,,, +9091,,5d6455b9-f430-4cfa-ad25-082cc81f2108,Fondazione G.I.M.EM.A. Onlus Gruppo Italiano Malattie Ematologiche dell'Adulto,fondazione_g_i_m_em_a_onlus_gruppo_italiano_malattie_ematologiche_dell_adulto,,,,,, +9092,,e6adfd7f-5d8c-4a1d-add3-0148edcc9611,South Eastern Health and Social Care Trust,south_eastern_health_and_social_care_trust,,,,,, +9093,,ad70e441-18a2-49ef-ae65-e0b50c3584fd,Lab for pharmaceutical biology,lab_for_pharmaceutical_biology,,,,,, +9094,,c2583d56-74bd-4921-9210-8424649305b6,University Hospital Muenster,university_hospital_muenster,,,,,, +9095,,6264a803-f316-4ff5-98e2-cafac6ff8790,"Prof. B. Wiedenmann, Klinik für Gastroenterologie, Charité, Campus Virchow",prof_b_wiedenmann_klinik_f_r_gastroenterologie_charit_campus_virchow,,,,,, +9096,,3ef1937c-1c62-45fb-a0c5-e06546f4a5be,Charité – University Medicine Berlin,charit_university_medicine_berlin,,,,,, +517,0.98103153705596924,be21c811-4df1-4aa6-8fd6-8b4eb1416f21,GELTAMO (Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea),geltamo_grupo_espa_ol_de_linfomas_y_transplante_aut_logo_de_m_dula_sea,,,,be21c811-4df1-4aa6-8fd6-8b4eb1416f21,geltamo_grupo_espa_ol_de_linfomas_y_transplante_aut_logo_de_m_dula_sea,GELTAMO (Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea) +9097,,5d14e8d4-7145-11e6-a0cd-0242ac12000b,STI PHARMA LLC,sti_pharma_llc,,,,,, +9098,,f66884f7-fabf-4639-8436-b5719be9ce20,"Alnylam Pharmaceuticals, Inc",alnylam_pharmaceuticals_inc,,,,,, +9099,,d6ad0ff7-4468-4fc1-ad43-9d3f865284c8,sanofi recherche & developpement,sanofi_recherche_developpement,,,,,, +285,0.9883,7213388e-5096-443a-80ed-002100f22598,"UK für Anästhesiologie und allgemeine Intensivmedizin, LKH Salzburg",uk_f_r_an_sthesiologie_und_allgemeine_intensivmedizin_lkh_salzburg,,,,7213388e-5096-443a-80ed-002100f22598,uk_f_r_an_sthesiologie_und_allgemeine_intensivmedizin_lkh_salzburg,"UK für Anästhesiologie und allgemeine Intensivmedizin, LKH Salzburg" +286,0.933312,aa2861dc-8843-45b3-8d61-af022e0ad7ab,Helperby Therapeutics,helperby_therapeutics,,,,aa2861dc-8843-45b3-8d61-af022e0ad7ab,helperby_therapeutics,Helperby Therapeutics +9100,,adef3e71-dadf-4399-8bd9-61991347ee1d,"Octapharma Pharmazeutika Produktions GmbH,",octapharma_pharmazeutika_produktions_gmbh,,,,,, +9101,,2d47d18d-3240-4150-9b9d-b3ed6fc6c6db,Fachingen Heil- und Mineralbrunnen GmbH,fachingen_heil_und_mineralbrunnen_gmbh,,,,,, +9102,,abff90db-a4fd-49e2-be65-9ba1bf7bac47,Pharmahungary Group,pharmahungary_group,,,,,, +9103,,7ae7c086-8a81-47cb-851e-de6b55529ef2,"Wyeth Pharmaceuticals Inc., Wyeth Research, Clinical Research and Development Division",wyeth_pharmaceuticals_inc_wyeth_research_clinical_research_and_development_division,,,,,, +281,0.986926,0dd91d42-73cc-11e6-a0cd-0242ac12000b,ABBVIE ENDOCRINE,abbvie_endocrine,,,,0dd91d42-73cc-11e6-a0cd-0242ac12000b,abbvie_endocrine,ABBVIE ENDOCRINE +4,0.980166,32b2141c-7602-42db-a25b-43a2694f5d75,University of Dundee,university_of_dundee,,,,32b2141c-7602-42db-a25b-43a2694f5d75,university_of_dundee,University of Dundee +9104,,d2e1be97-2089-42d0-80a1-c9fea6526e54,"Department of Neurology, Medical University of Vienna",department_of_neurology_medical_university_of_vienna,,,,,, +9105,,f09686d3-0ab1-4f49-953c-bb5f40d54c51,"Rigshospitalet, Ultralydklinikken 4002",rigshospitalet_ultralydklinikken_4002,,,,,, +9106,,fc752a4c-7145-11e6-a0cd-0242ac12000b,LEINER,leiner,,,,,, +9107,,d8b0b622-f45b-4d74-9d14-a44c047db0f4,UZ Gasthuisberg,uz_gasthuisberg,,,,,, +9108,,f9c9a17f-5996-42a4-b9aa-a8e324b13f6a,Santaris Pharma A/S,santaris_pharma_a_s,,,,,, +9109,,6cea30f8-7167-11e6-a0cd-0242ac12000b,THE FEINSTEIN INST,the_feinstein_inst,,,,,, +9110,,a032247b-79a1-43c7-8047-2e2311318c23,Uzsoki Hospital,uzsoki_hospital,,,,,, +1036,0.97620874643325806,20ec8644-14fa-4190-8de8-7314ba244821,University of Leeds/Leeds Teaching Hospitals NHS Trust,university_of_leeds_leeds_teaching_hospitals_nhs_trust,,,,0e73d51d-18db-4aac-81b0-bb770932bfdc,university_of_leeds,University of Leeds +9111,,31a53e08-e675-4841-98f8-0d10c685d67d,LABORATOIRES GRIMBERG,laboratoires_grimberg,,,,,, +9112,,70c2c302-6185-4891-9f80-c5392ba721fb,DexTech Medical AB,dextech_medical_ab,,,,,, +9113,,bb521c34-5014-4907-a122-759d2b62f102,"Banyu Pharmaceutical Co., Ltd",banyu_pharmaceutical_co_ltd,,,,,, +9114,,03d001ee-62c7-4e77-a218-0295f302b786,Nordic Bone Marrow Transplant Group (NBMT),nordic_bone_marrow_transplant_group_nbmt,,,,,, +9115,,70e95870-8bcd-11e6-a449-0242ac12000b,Department of Medicine and Endocrinology,department_of_medicine_and_endocrinology,,,,,, +9116,,7a310f18-6dc8-40d3-a3cd-f8503abc80a1,Vasa HVC,vasa_hvc,,,,,, +9117,,0a91ec28-2d00-49b7-9271-f7f3f3110404,STALLERGENES IBÉRICA S.A,stallergenes_ib_rica_s_a,,,,,, +33,0.98417317867279053,ec6b573a-eae5-416d-8f08-41d93e83e2c4,"Department of Endocrinology, Hvidovre Hospital",department_of_endocrinology_hvidovre_hospital,,,,a5f26061-0a6f-4fd1-83b7-6557b7c1b6d1,department_of_endocrinology,Department of Endocrinology +19,0.95549,f9cbaf7a-48b6-4aec-bab3-45123beda57a,IOBA,ioba,,,,28cd44d5-abe5-4c05-bd83-bc9462e97d2d,ioba_universidad_de_valladolid,"IOBA, Universidad de Valladolid" +9118,,2e0ebddc-0190-4737-ac3f-cfc324f945cd,"Sunesis Pharmaceuticals, Inc",sunesis_pharmaceuticals_inc,,,,,, +9119,,96358345-c975-452f-b9d1-a128418f06bc,PeP-Tronic Medical AB,pep_tronic_medical_ab,,,,,, +9120,,6e03014e-73fc-11e6-a0cd-0242ac12000b,FLAMEL IRELAND LTD,flamel_ireland_ltd,,,,,, +103,0.968844,bc402ec7-a8f5-4838-a856-7b15a5bf6d92,"Janssen Research & Development, L.L.C",janssen_research_development_l_l_c,,,,3da026c0-6fa2-11e6-9663-0242ac12000b,janssen_research_development_llc,"Janssen Research & Development, LLC" +9121,,17dd2121-9240-4263-a246-1dc5bd68a846,Cardif and Vale University Local Health Board,cardif_and_vale_university_local_health_board,,,,,, +9122,,b12254fc-7c9a-41b8-ac14-7cb01546edb7,"Dept. of Neurological Surgery, Medical University of Vienna",dept_of_neurological_surgery_medical_university_of_vienna,,,,,, +9123,,91a18561-1e2b-47b0-a421-1c46c1fb060c,Arthroscopic Surgery Unit,arthroscopic_surgery_unit,,,,,, +9124,,cf189299-8639-412a-a65d-6807ee412160,UMC Utrecht,umc_utrecht,,,,,, +9125,,623641f4-8e9d-4401-821d-d3c7d1027461,"Kognitive Neurologie, Institut für Medizin, Forschungszentrum Jülich",kognitive_neurologie_institut_f_r_medizin_forschungszentrum_j_lich,,,,,, +9126,,f3e22eb9-a81e-4bf3-ab23-fa7ef7413e6a,AUSL Piacenza,ausl_piacenza,,,,,, +690,0.984864,be7578e0-7191-11e6-a0cd-0242ac12000b,FOREST LABS,forest_labs,,,,9da8b08c-7191-11e6-a0cd-0242ac12000b,forest_labs_inc,FOREST LABS INC +9127,,71acdc0a-9ac3-45d3-881e-d022ebf9c4b7,Hephata-Klinik,hephata_klinik,,,,,, +108,0.976464,b357c82c-483a-4d22-ba95-f043cc73dd9b,Instituto de Inmunología y Alergia INMUNAL SAU,instituto_de_inmunolog_a_y_alergia_inmunal_sau,,,,b357c82c-483a-4d22-ba95-f043cc73dd9b,instituto_de_inmunolog_a_y_alergia_inmunal_sau,Instituto de Inmunología y Alergia INMUNAL SAU +9128,,7caf90ae-5876-4902-85ed-a654573e8df6,Dr. Pedro Cuevas Sanchez (Investigacion Independiente),dr_pedro_cuevas_sanchez_investigacion_independiente,,,,,, +9129,,63181927-42aa-46b2-9788-e27849c2f17c,Amgen Limited,amgen_limited,,,,,, +9130,,b5047eea-eab5-4699-9458-130424e709b9,Matrizyme Pharma Corporation,matrizyme_pharma_corporation,,,,,, +209,0.960275,2b67170d-4f17-4648-9c58-deeb978a3eb3,FONDAZIONE IRCCS CA` GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO,fondazione_irccs_ca_granda_ospedale_maggiore_policlinico_di_milano,,,,2b67170d-4f17-4648-9c58-deeb978a3eb3,fondazione_irccs_ca_granda_ospedale_maggiore_policlinico_di_milano,FONDAZIONE IRCCS CA` GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO +9131,,09552a42-2ac0-46b1-97f0-9439d6223722,CYATHUS EXQUIRERE PharmaforschungsGmbH,cyathus_exquirere_pharmaforschungsgmbh,,,,,, +9132,,01765c9e-4136-4f4b-91dd-6ed56efc37a8,EAU EUROPEAN ASSOCIATION OF UROLOGY,eau_european_association_of_urology,,,,,, +9133,,b6786853-01e8-4626-9090-ac3e4898ae43,Roche Latvija SIA,roche_latvija_sia,,,,,, +9134,,8caf741d-7ffb-439d-9948-66267daef4b2,University of Vienna,university_of_vienna,,,,,, +9135,,1af95e37-859c-45bb-9265-43142b900c2b,Medical University Greifswald,medical_university_greifswald,,,,,, +672,0.975714,25ceb782-7164-11e6-a0cd-0242ac12000b,PERRIGO UK FINCO,perrigo_uk_finco,,,,25ceb782-7164-11e6-a0cd-0242ac12000b,perrigo_uk_finco,PERRIGO UK FINCO +736,0.97571657101313269,ddd363c2-df58-4b6a-a4aa-aefcab53db6b,European Orgainzation for the Research and Treatment of Cancer (EORTC),european_orgainzation_for_the_research_and_treatment_of_cancer_eortc,,,,86b7934b-bd40-4e41-90e2-f2b10e4f66c8,european_organization_for_the_research_and_treatment_of_cancer_eortc,European Organization for the Research and Treatment of Cancer (EORTC) +9136,,d2042f48-905c-4a81-bd8d-b8ff85776acb,J.W. Goethe-University,j_w_goethe_university,,,,,, +9137,,8b570a0c-5d73-4211-b042-14b0231f3d26,Royal Wolverhampton Hospitals Trust,royal_wolverhampton_hospitals_trust,,,,,, +9138,,c7bc3c1b-cf69-4463-8959-17956a81dc22,Aalst Dermatology Group,aalst_dermatology_group,,,,,, +9139,,072f0428-2b9c-43d0-9452-763eea056fac,DiaMedica USA Inc,diamedica_usa_inc,,,,,, +9140,,955553f9-3908-4068-8877-fb38e9b6e818,"Technische Universitaet Munchen, vertreten durch das Klinikum rechts",technische_universitaet_munchen_vertreten_durch_das_klinikum_rechts,,,,,, +9141,,41a95663-172a-4bc4-b58a-de2f5982e9d9,NHS Greater Glasgow - Yorkhill Division,nhs_greater_glasgow_yorkhill_division,,,,,, +9142,,4a11e4fc-a327-48f0-9935-fb3d4c934743,"Schering Plough, S.A",schering_plough_s_a,,,,,, +9143,,9b674320-99b6-4617-9f51-d5b787653d68,FFCD,ffcd,,,,,, +9144,,632d6c6a-f172-43bb-b2d9-e8260570967f,NovaRx Corporation,novarx_corporation,,,,,, +9145,,cae35465-51ee-4f53-a4ce-bf56217b20d4,CHU de Nîmes,chu_de_n_mes,,,,,, +9146,,6e92673c-80e8-4d52-92cb-4a42c768922f,Herlev University Hospital,herlev_university_hospital,,,,,, +9147,,dc17443d-47af-4ab2-9098-30156958d9f5,GET SRL,get_srl,,,,,, +306,0.977936,b48ed083-a373-417f-9a97-b5caef3a6949,"Free state of Bavaria, Universitätsklinikum Regensburg",free_state_of_bavaria_universit_tsklinikum_regensburg,,,,b48ed083-a373-417f-9a97-b5caef3a6949,free_state_of_bavaria_universit_tsklinikum_regensburg,"Free state of Bavaria, Universitätsklinikum Regensburg" +9148,,9c615020-a6c1-404c-ba63-cda0b1a9537a,Charite-Universitätsmedizin Berlin Germany,charite_universit_tsmedizin_berlin_germany,,,,,, +1079,0.956865,cf3c6cb3-9753-46e8-af8b-75efefbc3522,The Insitute of Cancer Research,the_insitute_of_cancer_research,,,,0d9451d0-cac1-41f0-a202-5d895bc08f17,the_institute_of_cancer_research_the_royal_marsden_nhs_foundation_trust,The Institute of Cancer Research / The Royal Marsden NHS Foundation Trust +9149,,2a76ed08-8f8f-42d2-974b-9f521de8f981,LALLEMAND PHARMA INTERNATIONAL,lallemand_pharma_international,,,,,, +9150,,91b45a98-dfe6-4afc-9376-4d2ff6437dd0,Juan Gonzalez García,juan_gonzalez_garc_a,,,,,, +9151,,4c9f44a8-411d-43c3-b047-3087f692a4e4,Janssen Alzheimer Immunotherapy,janssen_alzheimer_immunotherapy,,,,,, +9152,,9f9440b6-8097-4c2d-a2b0-235de7138458,Xytis Pharmaceuticals Sàrl,xytis_pharmaceuticals_s_rl,,,,,, +9153,,69e7b177-5605-40ee-9e06-689875c30b61,"GlaxoSmithKline Research & Development, LtdD",glaxosmithkline_research_development_ltdd,,,,,, +289,0.97350454330444336,444ae102-9372-40dc-a56f-84e8d39e27c0,BAYER SANTE,bayer_sante,,,,444ae102-9372-40dc-a56f-84e8d39e27c0,bayer_sante,BAYER SANTE +9154,,4215a640-7145-11e6-a0cd-0242ac12000b,ACTAVIS TOTOWA,actavis_totowa,,,,,, +9155,,e5692644-12aa-478e-88aa-a62981b877bc,Erasme Hospital - Department of Gastroenterology,erasme_hospital_department_of_gastroenterology,,,,,, +9156,,71fb78e8-ebb0-45ec-abdf-b582c97422c3,"Institute for Diagnostic Radiology and Neuroradiology, Ernst-Moritz-Arndt University Greifswald",institute_for_diagnostic_radiology_and_neuroradiology_ernst_moritz_arndt_university_greifswald,,,,,, +9157,,c8398dc4-7314-11e6-a0cd-0242ac12000b,JANSSEN LP,janssen_lp,,,,,, +9158,,a0d72bb7-7513-4bd7-91e1-3e1e25a4fe84,"Horizon Therapeutics, Inc",horizon_therapeutics_inc,,,,,, +9159,,91a52bed-eeb5-4545-a74c-1726cdf1a5d8,"Teikoku Pharma USA, Inc",teikoku_pharma_usa_inc,,,,,, +9160,,9e92ce78-c289-4f72-a086-4faee7101d76,Landstinget i Östergötland,landstinget_i_sterg_tland,,,,,, +9161,,6db5cd7c-bb65-4a2f-aad8-4c3cbac4bfe7,Dipartimento di Biotecnologie Molecolari e Scienze per la Salute Università degli Studi di Torino,dipartimento_di_biotecnologie_molecolari_e_scienze_per_la_salute_universit_degli_studi_di_torino,,,,,, +9162,,98c5bba4-856f-4ea2-848a-fd95a9c3db2a,Joergen B Dahl,joergen_b_dahl,,,,,, +368,0.94788815577824914,0f2245d6-1eb2-4a26-ba28-2ddd66aada58,"Bayer HealthCare AG, 51368 Leverkusen, Germany",bayer_healthcare_ag_51368_leverkusen_germany,,,,0f2245d6-1eb2-4a26-ba28-2ddd66aada58,bayer_healthcare_ag_51368_leverkusen,"Bayer HealthCare AG, 51368 Leverkusen" +9163,,c3661f0b-82d3-46d3-8f17-46f9af40b090,AstraZeneca K.K,astrazeneca_k_k,,,,,, +9164,,fdffb8a0-718b-11e6-a0cd-0242ac12000b,TAKEDA PHARMS USA,takeda_pharms_usa,,,,,, +9165,,6e81067d-8ea7-4e14-8f09-5f3078a2047e,DCOG,dcog,,,,,, +9166,,bcf61039-ff28-4441-866b-e5ec506fd2fb,University Ghent,university_ghent,,,,,, +9167,,be8c81c7-2d72-4ae0-b637-a3fdcd050ef4,Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.),groupe_d_etude_th_rapeutique_des_affections_inflammatoires_digestives_g_e_t_a_i_d,,,,,, +9168,,1d5ec945-c625-4a9f-b314-2aa06918c48a,Evolus Inc,evolus_inc,,,,,, +9,0.98788300156593323,e9fa3c3f-4c50-4e46-a5ef-4f151985d2cc,Centre Hospitalier Universitaire,centre_hospitalier_universitaire,,,,2f45bfe9-0b5a-450f-abb3-c7aa18916ff8,centre_hospitalier_universitaire,Centre Hospitalier Universitaire +9169,,46d9c8e0-94dd-4be2-9360-13909c6d44e4,Fondazione Ricerca Traslazionale (FoRT),fondazione_ricerca_traslazionale_fort,,,,,, +9170,,0e6636dc-9cd1-4e51-94fb-970002b87b97,Pierre Schydlowsky,pierre_schydlowsky,,,,,, +9171,,6447c51e-c64d-4b49-b9e0-fe64f00edd37,Umea University,umea_university,,,,,, +9172,,9d3de6b2-5445-4a5c-9741-c784c5d69539,University Hospital Gasthuisberg,university_hospital_gasthuisberg,,,,,, +9173,,1721bc27-596b-49fd-9bc2-b6dbe840b8b8,Vasculitis and Lupus Clinic,vasculitis_and_lupus_clinic,,,,,, +9174,,bdede4dd-8e36-4adc-b72a-9302a1dcb91b,Noscira S.A,noscira_s_a,,,,,, +9175,,9b614000-2926-4957-90c5-e277a7c55967,The Pennine Acute Hospitals NHS Trust,the_pennine_acute_hospitals_nhs_trust,,,,,, +9176,,2b92a2ad-7443-4dcd-b5c1-f7ab1759fa98,Genmab A/S,genmab_a_s,,,,,, +9177,,16c7426c-ae66-4df4-8e1b-b29261379265,Norwegian Gastointestinal Cancer Group,norwegian_gastointestinal_cancer_group,,,,,, +9178,,0476f7cb-b5dc-4b0d-8c58-7baa1a0ad252,Zambon Spa,zambon_spa,,,,,, +9179,,0452fe53-8ca4-4930-971b-00e0fca3b197,"Herz-, Thorax- und Gefäßchirurgische Anästhesie und Intensivmedizin",herz_thorax_und_gef_chirurgische_an_sthesie_und_intensivmedizin,,,,,, +9180,,d2905da1-74d9-43dd-b75a-f8543934bf3b,"University Clinic in Nephrology and Hypertension, Department of Medical Research",university_clinic_in_nephrology_and_hypertension_department_of_medical_research,,,,,, +9181,,42ed164c-dff6-4d33-b7a7-4ae3b1ab3b6d,Prometic Biosciences Inc,prometic_biosciences_inc,,,,,, +9182,,a85dd0a2-b059-4d5b-9ce6-6222f8276bb7,AZIENDA USL 2 DI LUCCA,azienda_usl_2_di_lucca,,,,,, +9183,,53217fdd-b05c-4ef9-ac01-3e1f27a1037d,SYNTA PHARMACEUTICALS,synta_pharmaceuticals,,,,,, +9184,,15124a18-72c6-11e6-a0cd-0242ac12000b,CIPHER PHARMS INC,cipher_pharms_inc,,,,,, +9185,,a2f2d586-b8ba-40a9-b694-02f712594ba2,Bridge BioResearch Rights (Jersey) Ltd,bridge_bioresearch_rights_jersey_ltd,,,,,, +402,0.981186,eb17f730-43ef-415d-9053-abbc8ff7f72d,AGO Research GmbH,ago_research_gmbh,,,,b864ee6b-f5d7-4f18-a0ed-6ad119ce7d88,ago_research_gmbh_ago_study_group,"AGO Research GmbH, AGO Study Group" +9186,,32ca7494-a105-4abb-9990-f80f64b762d0,Cell Therapy Catapult Limited,cell_therapy_catapult_limited,,,,,, +9187,,b2102f30-73f5-11e6-a0cd-0242ac12000b,SPRIASO LLC,spriaso_llc,,,,,, +9188,,d066457a-9626-11e6-becf-0242ac110008,HUMANWELL PURACAP,humanwell_puracap,,,,,, +9189,,654b7fa4-714f-11e6-a0cd-0242ac12000b,MARTEC USA LLC,martec_usa_llc,,,,,, +9190,,431574b7-6ef1-4f0e-a154-1ffc0080e9b1,"AstraZeneca AB, R&D Mölndal",astrazeneca_ab_r_d_m_lndal,,,,,, +9191,,4a2a83fb-271b-4a5a-93a4-9d438125d5a7,Alder Hey Children's NHS Foundation Trust,alder_hey_children_s_nhs_foundation_trust,,,,,, +9192,,00c8c76a-1a3b-4790-bda9-05f022460397,"Upsher-Smith Laboratories, Inc",upsher_smith_laboratories_inc,,,,,, +9193,,b53836b3-5490-4b29-be3a-7671d30afd8e,Abteilung für Herz-Thorax-Gefäß Anästhesie & Intensivmedizin (HTG),abteilung_f_r_herz_thorax_gef_an_sthesie_intensivmedizin_htg,,,,,, +9194,,69bb3d7d-62eb-462b-95f8-19219e1e082b,CELLDEX THERAPEUTICS,celldex_therapeutics,,,,,, +9195,,00d33d53-88ea-4464-b462-01a8f9696cce,Principia Biopharma Australia Pty Ltd,principia_biopharma_australia_pty_ltd,,,,,, +9196,,9527cb43-636e-4d1b-924d-1223a4c0ea57,Hannover Clinical Trial Center GmbH,hannover_clinical_trial_center_gmbh,,,,,, +9197,,b478f909-f06e-475e-bfdd-b29b35b96cc6,Royal Sussex County Hospital,royal_sussex_county_hospital,,,,,, +9198,,b4942e59-ba0a-42e1-91d4-b105a0d9a15b,Karolinska Institute Danderyd Hospital,karolinska_institute_danderyd_hospital,,,,,, +9199,,7ba03022-8bb9-11e6-a449-0242ac12000b,VU Medical Centre,vu_medical_centre,,,,,, +9200,,b356ce28-5dc8-41a0-816c-29ac9e6ab658,Medizinsiche Fakultät der Technischen Universität München,medizinsiche_fakult_t_der_technischen_universit_t_m_nchen,,,,,, +9201,,5d501456-63be-41f4-955a-c7ebcc315d08,Grupo Cooperativo GEMCAD (Grupo Español Multidisciplinar en Cáncer Digestivo),grupo_cooperativo_gemcad_grupo_espa_ol_multidisciplinar_en_c_ncer_digestivo,,,,,, +9202,,276426c2-71aa-11e6-a0cd-0242ac12000b,ALPHA THERA,alpha_thera,,,,,, +9203,,63bac87d-d6a3-4be4-9eef-4efa52f0c0a5,AZIENDA OSPEDALIERA SAN PAOLO,azienda_ospedaliera_san_paolo,,,,,, +9204,,a2cbb082-f059-43d1-864e-c94bd2b76c55,"Instituto Tecnológico PET, S.A.U. (ITP)",instituto_tecnol_gico_pet_s_a_u_itp,,,,,, +9205,,81780341-eb7f-4d72-98bd-b7cd32371b21,"The Christie NHS Foundation Trust, R&D",the_christie_nhs_foundation_trust_r_d,,,,,, +9206,,bc4af3ab-9c98-4b9c-9999-51185af8875b,North Bristol NHS Trust,north_bristol_nhs_trust,,,,,, +9207,,9e873ef5-d0ec-4356-b4b4-f1883bb8f2a7,"Alcon Laboratories, Inc",alcon_laboratories_inc,,,,,, +819,0.912088,bf66c8e7-dc46-4d4b-a5d0-60ce8486fef9,UNIVERSITA` DEGLI STUDI DI PARMA,universita_degli_studi_di_parma,,,,bf66c8e7-dc46-4d4b-a5d0-60ce8486fef9,universita_degli_studi_di_parma,UNIVERSITA` DEGLI STUDI DI PARMA +9208,,563f1a7a-7145-11e6-a0cd-0242ac12000b,ORGANON USA INC,organon_usa_inc,,,,,, +9209,,6618696b-7378-4cae-8ebd-735f5c47f25e,University of Brighton,university_of_brighton,,,,,, +9210,,a34e2926-d750-4e4d-b4a6-678719e1894c,Medizinische Universität Innsbruck - Universitätsklinik für Radiodiagnostik (Radiologie I),medizinische_universit_t_innsbruck_universit_tsklinik_f_r_radiodiagnostik_radiologie_i,,,,,, +9211,,cc3faab8-bf33-4487-8c02-1412481925ad,The University of Sheffield,the_university_of_sheffield,,,,,, +97,0.988116,9abd20d6-1c2a-4aeb-922e-ae371ab88700,Newron Pharmaceuticals,newron_pharmaceuticals,,,,9abd20d6-1c2a-4aeb-922e-ae371ab88700,newron_pharmaceuticals,Newron Pharmaceuticals +9212,,371f081f-a2a8-42cd-b4a0-1b9b1ba8a492,European Uro- Oncology Group (EUOG),european_uro_oncology_group_euog,,,,,, +9213,,687eb4d3-9e95-4384-af62-f663325d485e,Avontec GmbH,avontec_gmbh,,,,,, +9214,,3c53b33f-3be4-4730-bdc0-21cc87e8aa01,Phoenux AG,phoenux_ag,,,,,, +580,0.98430219292640686,ae0a58ab-7d21-4324-9680-942861ba4284,Wyeth Pharmaceuticals,wyeth_pharmaceuticals,,,,6e90ff22-ae0c-4450-9eec-85eba70c3fda,wyeth_pharmaceuticals_inc,Wyeth Pharmaceuticals Inc +9215,,a976ba27-81ca-4bd0-a34c-edd7c2935444,Viventia Biotech Inc,viventia_biotech_inc,,,,,, +1075,0.97996,6c25b988-82b5-4b5c-807f-1a9411cdaca5,"Isala Klinieken, location Sophia",isala_klinieken_location_sophia,,,,43028a3f-c862-4599-8864-5518384f4057,isala_klinieken,Isala Klinieken +815,0.971143,5a3d9a2a-7159-11e6-a0cd-0242ac12000b,PLIVA LACHEMA,pliva_lachema,,,,5a3d9a2a-7159-11e6-a0cd-0242ac12000b,pliva_lachema,PLIVA LACHEMA +9216,,04ca41b4-e352-4af8-b6bc-b3d03ec69827,Futura Medical Developments Ltd,futura_medical_developments_ltd,,,,,, +9217,,512c7ddb-be2c-4534-a7aa-410b98d33a67,Kalevi Pihlajamäki,kalevi_pihlajam_ki,,,,,, +9218,,81eac20b-cf40-45bb-be57-abb0c87594a5,Bundeswehr,bundeswehr,,,,,, +9219,,1e5ee90f-1ea0-4828-93fe-b586d6ca11f5,Grupo de Investigación ICP,grupo_de_investigaci_n_icp,,,,,, +9220,,c41d0d48-3ae2-4cbf-995a-d9fa550fe04d,Hellenic Institute for the Study of Sepsis,hellenic_institute_for_the_study_of_sepsis,,,,,, +80,0.975018,0510fd6f-8916-4b89-89b5-93c49e7400bb,UMC St Radboud,umc_st_radboud,,,,0510fd6f-8916-4b89-89b5-93c49e7400bb,umc_st_radboud,UMC St Radboud +9221,,725bb1b5-6d13-42eb-a304-450d53142233,"EPIX Pharmaceuticals, Inc",epix_pharmaceuticals_inc,,,,,, +9222,,7f0020a0-3d35-4e9a-8e61-fa87008dff4d,Dr. Sylvia Boesch,dr_sylvia_boesch,,,,,, +363,0.953188,6d5782a7-67e2-4374-a6a3-c1e2c79b8eb4,AZIENDA OSPEDALIERA SAN GERARDO DI MONZA,azienda_ospedaliera_san_gerardo_di_monza,,,,6d5782a7-67e2-4374-a6a3-c1e2c79b8eb4,azienda_ospedaliera_san_gerardo_di_monza,AZIENDA OSPEDALIERA SAN GERARDO DI MONZA +9223,,593670e9-dcbc-41d8-bbb0-4026f747d2ae,Henrik Kehlet,henrik_kehlet,,,,,, +9224,,1caf50a1-a688-4992-90ec-c095a7d58bd8,University hospital of Hvidovre,university_hospital_of_hvidovre,,,,,, +9225,,a5bd285b-94c8-4a9f-8b48-74c7795473f8,Hellenic Cooperative Oncology Group,hellenic_cooperative_oncology_group,,,,,, +9226,,cd392bcc-647a-4930-a828-94edc1dc9b33,Boehringer Ingelheim RCV & Co KG,boehringer_ingelheim_rcv_co_kg,,,,,, +81,0.988541,a1e2858d-bccd-44e0-bb25-722440d23889,Université catholique de Louvain,universit_catholique_de_louvain,,,,8a5eb366-780e-4aa5-8b20-c800908bad95,universit_catholique_de_louvain_ucl,Université catholique de Louvain (UCL) +9227,,03075de8-735e-11e6-a0cd-0242ac12000b,EAGLE PHARMS,eagle_pharms,,,,,, +9228,,757530a8-9393-41cd-bd3a-2d8b0b00df28,IRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS,irccs_fondazione_g_b_bietti_per_lo_studio_e_la_ricerca_in_oftalmologia_onlus,,,,,, +9229,,9306e1e7-9e6a-49e3-af34-1850895c8ba2,Protalix Biotherapeutics,protalix_biotherapeutics,,,,,, +9230,,8647e6fa-a91d-491a-9b4c-1b317fae59a5,Boehringer IngelheimRCV GmbH & co KG,boehringer_ingelheimrcv_gmbh_co_kg,,,,,, +9231,,320e510d-3f99-4887-8571-5b94d29a41be,"Allgemeines Krankenhaus Wien, Medizinische Universität Wien",allgemeines_krankenhaus_wien_medizinische_universit_t_wien,,,,,, +9232,,ff6937ca-5dbd-4272-a6c9-68cfa70ef1cb,BEAUFOUR IPSEN Pharma,beaufour_ipsen_pharma,,,,,, +9233,,bad4a31f-aa91-45bf-8d88-f53ed637d903,"Marinus Pharmceuticals, Inc",marinus_pharmceuticals_inc,,,,,, +9234,,ac70bbb4-4b29-4b84-b42b-6a89c6f012bb,Bayer Schering Pharma,bayer_schering_pharma,,,,,, +9235,,6985d934-737a-11e6-a0cd-0242ac12000b,TAP PHARM,tap_pharm,,,,,, +596,0.968448,2f6c51a9-6c19-4869-bb54-9a99b0a7c099,"Cerexa, Inc",cerexa_inc,,,,2f6c51a9-6c19-4869-bb54-9a99b0a7c099,cerexa_inc,"Cerexa, Inc" +9236,,bd57f46e-0e79-40a1-8fd7-96dbd50a6852,"Luzitin, S.A",luzitin_s_a,,,,,, +9237,,d83e78e4-7141-11e6-a0cd-0242ac12000b,HERITAGE PHARMA,heritage_pharma,,,,,, +644,0.97071176767349243,2e1c5817-912c-4f5e-bd24-7888fb2cc9f1,Boehringer Ingelheim Pharma GesmbH,boehringer_ingelheim_pharma_gesmbh,,,,2e1c5817-912c-4f5e-bd24-7888fb2cc9f1,boehringer_ingelheim_pharma_gesmbh,Boehringer Ingelheim Pharma GesmbH +9238,,fb68316e-9c94-456d-a789-7245f4aae297,Endocrinology and Nutrition Unit. Hospital Universitari Bellvitge,endocrinology_and_nutrition_unit_hospital_universitari_bellvitge,,,,,, +9239,,83d02636-7e7f-45fd-aa8f-2fede2341136,AZIENDA OSPEDALIERO-UNIVERSITARIA S. MARIA DELLA MISERICORDIA DI UDINE,azienda_ospedaliero_universitaria_s_maria_della_misericordia_di_udine,,,,,, +9240,,cd1e5d23-e603-4298-b9e6-d610f662827c,"Division of Thoracic and Hyperbaric Surgery, Medical University Graz",division_of_thoracic_and_hyperbaric_surgery_medical_university_graz,,,,,, +538,0.987464,0b556983-4b60-4dae-9f82-49efdc6858f4,Sankyo Pharma Development (SPhD),sankyo_pharma_development_sphd,,,,0b556983-4b60-4dae-9f82-49efdc6858f4,sankyo_pharma_development_sphd,Sankyo Pharma Development (SPhD) +9241,,a9b3aee1-9be2-46c7-bbc5-d0fa806afb2f,RostaQuo S.p.A,rostaquo_s_p_a,,,,,, +9242,,67a08eeb-c9ef-470a-8d42-37e3e183b23e,CHU of Liège,chu_of_li_ge,,,,,, +79,0.98557180166244507,c8c5f87e-c7f0-4c07-ae62-df93cf8c7449,Karolinska Institutet,karolinska_institutet,,,,18921777-f15d-49c4-8f68-7695c0b2af40,karolinska_institutet_hospital,Karolinska Institutet/ Hospital +9243,,c6567b89-e94f-4b83-9010-5e1ecf31835f,Allergan UK Limited,allergan_uk_limited,,,,,, +9244,,30a75b87-92df-41b4-a41c-3387ab3ba9c9,Manuel Rodríguez García,manuel_rodr_guez_garc_a,,,,,, +9245,,bbfc4777-5b4e-4f95-aba0-b9d1834df444,"Adamas Pharmaceuticals, Inc",adamas_pharmaceuticals_inc,,,,,, +9246,,42743e98-2114-42f6-976d-7338b0ef669b,Jørgen B. Dahl,j_rgen_b_dahl,,,,,, +9247,,6ff1b13e-d15c-4297-bde8-4dbd8b619b89,Galenica AB,galenica_ab,,,,,, +393,0.941004,6cd8a498-2fe7-40c6-b305-fa69e84aa23d,Pantec Biosolutions AG,pantec_biosolutions_ag,,,,6cd8a498-2fe7-40c6-b305-fa69e84aa23d,pantec_biosolutions_ag,Pantec Biosolutions AG +9248,,ff7f9185-a56b-4c4c-b63d-ec003d11f9b8,"Universitätsklinikum Erlangen, Strahlenklinik insoweit handelnd für den Freistaat Bayern",universit_tsklinikum_erlangen_strahlenklinik_insoweit_handelnd_f_r_den_freistaat_bayern,,,,,, +9249,,4bf5839b-be7a-4ddd-9610-26ffcc0da406,"Section for Surgical Pathophysiology, Rigshospitalet",section_for_surgical_pathophysiology_rigshospitalet,,,,,, +9250,,1513e197-3f94-4753-8415-1016b61f5df0,Stichting Antoni van Leeuwenhoek Ziekenhuis,stichting_antoni_van_leeuwenhoek_ziekenhuis,,,,,, +37,0.986414,20c01f75-629c-4120-8121-47689f70602e,University of Liverpool (UniLiv),university_of_liverpool_uniliv,,,,0c4d19b0-fc13-4125-ae65-0aea3b77572e,university_of_liverpool,University of Liverpool +9251,,68742125-1070-4a8d-a773-214784a28e0f,York Hospitals NHS Trust,york_hospitals_nhs_trust,,,,,, +9252,,74eb6afa-199e-4e8d-940f-e57c28334b83,St Olavs University Hospital,st_olavs_university_hospital,,,,,, +9253,,0e5de35a-49fe-4bde-92b7-201f2ec4e863,Berlin-Chemie Menarini,berlin_chemie_menarini,,,,,, +924,0.97933,864aab9c-734a-11e6-a0cd-0242ac12000b,ALPHARMA PHARMS,alpharma_pharms,,,,7ced7946-7140-11e6-a0cd-0242ac12000b,alpharma,ALPHARMA +9254,,e12cc357-91a1-4ab2-b87c-8a5b71225095,Laboratoires Merck Sharp & Dohme - Chibret,laboratoires_merck_sharp_dohme_chibret,,,,,, +9255,,f5b86cbc-dfac-4579-a32e-8db574ab6360,Henning Glerup,henning_glerup,,,,,, +9256,,962d618e-d13e-4c87-b086-ff74e260e3ad,Marvel Life Sciences Limited,marvel_life_sciences_limited,,,,,, +9257,,d6591fe8-62d1-4796-a4b2-2ae844099e99,Tartu University Department of Sports Medicine and Rehabilitation,tartu_university_department_of_sports_medicine_and_rehabilitation,,,,,, +9258,,c29149e7-30f9-4eeb-9d3a-743676f4c505,Janne Räsänen,janne_r_s_nen,,,,,, +9259,,74626d64-7126-11e6-8a77-0242ac12000b,WATSON LABS INC,watson_labs_inc,,,,,, +9260,,60d08acb-b6a8-4d49-9224-585d84f74310,Novartis Norge AS,novartis_norge_as,,,,,, +9261,,f3ee7548-494d-4aa7-a725-7526f7cb9ccf,Danish Headache Center,danish_headache_center,,,,,, +9262,,5f000649-3994-42e5-9f22-cbbd92611d74,Associació Per la Recerca Oncològica (APRO),associaci_per_la_recerca_oncol_gica_apro,,,,,, +9263,,5f8b7f15-f15f-4ba6-bb2e-c1c1da79b7f4,CHU Clermont-Ferrand,chu_clermont_ferrand,,,,,, +9264,,3ed939e1-a2a7-4fef-acfe-c72e4ddcc262,Grete Andersen,grete_andersen,,,,,, +9265,,055621a6-d5a2-4708-94b6-a8634968dc48,Pharmanest AB,pharmanest_ab,,,,,, +9266,,610abb62-5379-4497-a22d-3373182b913f,"European LeukemiaNet, Ruprecht-Karls-Universität Heidelberg",european_leukemianet_ruprecht_karls_universit_t_heidelberg,,,,,, +9267,,285ed9a1-1f3f-4e83-b99c-06edda92a701,FRESENIUS BIOTECH GMBH,fresenius_biotech_gmbh,,,,,, +9268,,8ff7956a-cbae-4104-bbd9-91ad7bacd31c,Ordination Dr. Hommer,ordination_dr_hommer,,,,,, +9269,,7b05b3a6-8d31-4080-8a81-9d539b2d7a23,French Society of Cardiology,french_society_of_cardiology,,,,,, +489,0.94924008846282959,556aa12c-fe7a-4155-adda-e25a9fdaf844,STEBA BIOTECH S.A,steba_biotech_s_a,,,,556aa12c-fe7a-4155-adda-e25a9fdaf844,steba_biotech_s_a,STEBA BIOTECH S.A +9270,,747d4209-2c5f-4339-8069-4f22a16f1d8d,GRUPPO ONCOLOGICO ITALIANO DI RICERCA,gruppo_oncologico_italiano_di_ricerca,,,,,, +9271,,eaa893c8-8534-45ab-abcc-9f49ae3e671b,Meander Medisch Centrum,meander_medisch_centrum,,,,,, +811,0.92396390438079834,bb52c529-a5bf-4760-ae6e-b2271b3836a2,Biogen Idec Research Limited,biogen_idec_research_limited,,,,1d7a4c7b-13ee-4fa9-9984-684f337fead9,biogen_idec_research_ltd,Biogen Idec Research Ltd +233,0.980434,321f06bc-9aaf-4f20-b50b-fec99e946a29,Department of Infectious Diseases,department_of_infectious_diseases,,,,321f06bc-9aaf-4f20-b50b-fec99e946a29,department_of_infectious_diseases,Department of Infectious Diseases +9272,,750823ec-6f98-11e6-9663-0242ac12000b,Pia Jæger,pia_j_ger,,,,,, +9273,,7f03367c-7162-11e6-a0cd-0242ac12000b,PHARM VENTURES,pharm_ventures,,,,,, +1048,0.98716670274734497,92e925f1-e29b-41ab-aa81-fc32b5beae28,University Hospital Brno,university_hospital_brno,,,,92cf0698-f0a3-49e3-b16c-ece2bebd1173,university_hospital,University Hospital +362,0.955916,3ed7af3a-1ee9-4762-b37f-885a7628f2f5,GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA (GEICAM),grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama_geicam,,,,3ed7af3a-1ee9-4762-b37f-885a7628f2f5,grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama_geicam,GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA (GEICAM) +9274,,132d90fa-73fb-11e6-a0cd-0242ac12000b,PHARMA RES SOFTWARE,pharma_res_software,,,,,, +9275,,aa2d1968-7300-11e6-a0cd-0242ac12000b,AMAG PHARMA USA,amag_pharma_usa,,,,,, +9276,,43862d60-f085-4e8b-9fc7-ba511c7c4cb8,AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE,azienda_ospedaliera_ospedale_policlinico_consorziale,,,,,, +9277,,e4fcc5d7-b92c-496d-950d-42cb59893c8e,"Medizinische Universitaet Wien, Univ.Klinik f.Innere Medizin III, Abteilung fuer Gastroenterologie und Hepatologie",medizinische_universitaet_wien_univ_klinik_f_innere_medizin_iii_abteilung_fuer_gastroenterologie_und_hepatologie,,,,,, +9278,,5fb28c49-d976-4fde-a1b2-87534ace1932,Professor Reich,professor_reich,,,,,, +9279,,81779946-f49d-45d5-a96d-f0e5a12e5462,Fundació Parc Taulí,fundaci_parc_taul,,,,,, +201,0.982782,8f0f2351-12bc-44fe-906d-53b43499c8ae,"Kuopio University Hospital, Anesthesiology Clinic",kuopio_university_hospital_anesthesiology_clinic,,,,01c1da90-d188-4b3b-9a77-71c11c8ab042,kuopio_university_hospital,Kuopio University Hospital +371,0.976266,d647a1c4-2ac3-45cc-b98d-47490b4597d7,AMGEN INC,amgen_inc,,,,d647a1c4-2ac3-45cc-b98d-47490b4597d7,amgen_inc,AMGEN INC +9280,,03f36f28-ef96-4f07-aa36-b6aead23c8fc,Prof. Peter Licht,prof_peter_licht,,,,,, +9281,,405078d2-d470-4a46-8331-e19313098178,VACCIBODY A.S,vaccibody_a_s,,,,,, +9282,,3c20a484-f118-4f0a-af75-faf10c8643a9,Resistentia Pharmaceuticals AB,resistentia_pharmaceuticals_ab,,,,,, +9283,,04b96387-238f-4005-91a2-81b0f3b215b9,IPERBOREAL PHARMA,iperboreal_pharma,,,,,, +9284,,f3fb76ca-8809-11e6-a998-0242ac12000b,Addex Pharma SA,addex_pharma_sa,,,,,, +306,0.977936,eb57ddd5-39b7-4096-ae7e-d6e22f9d9298,Free state of Bavaria,free_state_of_bavaria,,,,b48ed083-a373-417f-9a97-b5caef3a6949,free_state_of_bavaria_universit_tsklinikum_regensburg,"Free state of Bavaria, Universitätsklinikum Regensburg" +9285,,92af94c7-bb90-481f-a7c5-d28e5fbabcc6,VU Medical Center Amsterdam,vu_medical_center_amsterdam,,,,,, +9286,,bedf7fc6-72a7-11e6-a0cd-0242ac12000b,MSD INTL GMBH,msd_intl_gmbh,,,,,, +101,0.96975362300872803,6cac1b04-1612-4a24-92aa-2b5234eb2596,University Childrin's Hospital,university_childrin_s_hospital,,,,6cac1b04-1612-4a24-92aa-2b5234eb2596,university_childrin_s_hospital,University Childrin's Hospital +619,0.972198,4c2e1783-76a6-4110-ab48-f807ec4d7f82,Department of Urology and Pediatric Urology - Justus-Liebig-University Giessen,department_of_urology_and_pediatric_urology_justus_liebig_university_giessen,,,,4c2e1783-76a6-4110-ab48-f807ec4d7f82,department_of_urology_and_pediatric_urology_justus_liebig_university_giessen,Department of Urology and Pediatric Urology - Justus-Liebig-University Giessen +9287,,6a093fab-d1b7-4135-af5b-a71edb0989b7,U.O. Ginecologia e Ostetricia,u_o_ginecologia_e_ostetricia,,,,,, +9288,,de04ff0a-88e8-4a8b-97c2-da4fffde8c3a,BIO-KER S.R.L,bio_ker_s_r_l,,,,,, +9289,,28b78181-a196-41e5-a0be-9872edd63512,AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA,azienda_ospedaliera_maggiore_della_carita_di_novara,,,,,, +9290,,302e8cb5-d7c8-4ffe-bcf0-2cf53923da75,"Medizinische Universität Wien,Univ.Klinik f.Kinder-u.Jugendheilkunde",medizinische_universit_t_wien_univ_klinik_f_kinder_u_jugendheilkunde,,,,,, +9291,,837536b6-012e-4613-b292-95a45f74d0d7,"Sucampo Pharma Americas, Inc",sucampo_pharma_americas_inc,,,,,, +9292,,5c97320a-71ee-11e6-a0cd-0242ac12000b,CORDENPHARMA,cordenpharma,,,,,, +9293,,0de9cc58-ac98-4b88-b4de-7ea7d23e12f1,Glenmark Farmaceutica LTDA,glenmark_farmaceutica_ltda,,,,,, +9294,,e9603db8-f388-49c5-8f80-2c6ec638bbd7,Sociedad Andaluza de Enfermedades Infecciosas SAEI,sociedad_andaluza_de_enfermedades_infecciosas_saei,,,,,, +9295,,3e4b395a-0c8c-4383-9bc3-f067ed338162,ABRAXIS BIOSCIENCE LLC AN INDIRECT SUBSIDIARY OF CELGENE CORPORATION,abraxis_bioscience_llc_an_indirect_subsidiary_of_celgene_corporation,,,,,, +9296,,48524b79-c75f-4513-a969-3e38b1e53be7,Aegerion Pharmaceuticals,aegerion_pharmaceuticals,,,,,, +9297,,5d0285c4-7206-11e6-a0cd-0242ac12000b,TEIKOKU PHARMA USA,teikoku_pharma_usa,,,,,, +9298,,ffe4c257-cf98-4ad1-8d0b-e84053307cfd,Addenbrookes Hospital NHS Trust,addenbrookes_hospital_nhs_trust,,,,,, +9299,,648b913a-7145-11e6-a0cd-0242ac12000b,IGI LABS INC,igi_labs_inc,,,,,, +9300,,03951ba4-738f-4019-b1ab-7328d770745b,Maarit Mentula,maarit_mentula,,,,,, +9301,,cd730ed3-244e-4dfc-987e-d6436a566235,Luton & Dunstable Hospital NHS Foundation Trust,luton_dunstable_hospital_nhs_foundation_trust,,,,,, +488,0.96756553649902344,5d77fa00-9417-4d15-807e-607c459d6842,STEBA BIOTECH N.V,steba_biotech_n_v,,,,5d77fa00-9417-4d15-807e-607c459d6842,steba_biotech,STEBA BIOTECH +9302,,cc0af80d-e697-463e-bd8c-1302fa506c01,"Merck, Sharp & Dohme b.v",merck_sharp_dohme_b_v,,,,,, +493,0.98599249124526978,eee857cc-7141-11e6-a0cd-0242ac12000b,AMNEAL PHARMS NY,amneal_pharms_ny,,,,d264e962-7141-11e6-a0cd-0242ac12000b,amneal_pharms,AMNEAL PHARMS +9303,,f66d72c2-c997-459a-923f-af89b56b4132,Asociación Terapéutica en Hematología y Oncología Médicas del Hospital Arnau de Vilanova de Valencia,asociaci_n_terap_utica_en_hematolog_a_y_oncolog_a_m_dicas_del_hospital_arnau_de_vilanova_de_valencia,,,,,, +9304,,6305766d-c27a-486b-8fce-bc9eadff2bc4,TAKO,tako,,,,,, +206,0.97898,050afe2e-7129-11e6-a89e-0242ac12000b,MIKART,mikart,,,,050afe2e-7129-11e6-a89e-0242ac12000b,mikart,MIKART +9305,,e5e9ed49-d051-4962-9474-6a49776e1ea4,CROLLL GmbH,crolll_gmbh,,,,,, +9306,,a274e6a6-7204-43d3-b2ef-9d288979bcb4,XTL Biopharmaceuticals,xtl_biopharmaceuticals,,,,,, +9307,,fdc15b3d-1cc2-490b-9aef-e1a6cfa3f005,Santhera Pharmaceuticals LLC,santhera_pharmaceuticals_llc,,,,,, +9308,,77e5b8e7-b414-43e3-b5fa-2d8de7de5f11,"Fundación Investigación y Desarrollo Área Cardiovascular & Dr. Javier Segovia, Unidad de Trasplante",fundaci_n_investigaci_n_y_desarrollo_rea_cardiovascular_dr_javier_segovia_unidad_de_trasplante,,,,,, +9309,,55e93662-7142-11e6-a0cd-0242ac12000b,ALCON RES LTD,alcon_res_ltd,,,,,, +9310,,9cc6a86d-cec5-4c21-bdfd-4b198ef6530c,FIMABIS,fimabis,,,,,, +9311,,87672562-a971-49b1-b1bf-dcff0c83250c,Boots Healthcare International Limited,boots_healthcare_international_limited,,,,,, +9312,,82821c84-7381-11e6-a0cd-0242ac12000b,LILLY RES LABS,lilly_res_labs,,,,,, +9313,,aaf80e1a-dee4-4da6-af59-c75f07ba3ece,immatics biotechnologies GmbH,immatics_biotechnologies_gmbh,,,,,, +709,0.93855130672454834,62dccd7b-325f-4731-b158-229a0c9ea429,Reckitt Benkiser Healthcare (UK) Ltd,reckitt_benkiser_healthcare_uk_ltd,,,,62dccd7b-325f-4731-b158-229a0c9ea429,reckitt_benckiser_healthcare_uk_ltd,Reckitt Benckiser Healthcare (UK) Ltd +9314,,99adf7b7-3b0e-45a5-a316-9fa44a8101e6,CNIO - Centro Nacional de Investigaciones Oncológicas,cnio_centro_nacional_de_investigaciones_oncol_gicas,,,,,, +348,0.96850624680519104,3d715925-53ae-4c70-8850-e11c72b69008,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische abteilung für Infektionen und Tropenme",medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_i_klinische_abteilung_f_r_infektionen_und_tropenme,,,,1c69f2db-0f03-45a8-b167-7670161862ea,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_i_klinische_abteilung_f_r_infektionen_und_tropenme,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische abteilung für Infektionen und Tropenme" +9315,,b0555f77-c857-4284-a35e-6f2b74a26d48,Mari Grönroos,mari_gr_nroos,,,,,, +9316,,6e99a9f0-c3a2-43db-9216-3f2cb952ad63,Prof Alice Stanton,prof_alice_stanton,,,,,, +1074,0.975369,5fd7db64-7148-11e6-a0cd-0242ac12000b,STASON,stason,,,,5fd7db64-7148-11e6-a0cd-0242ac12000b,stason,STASON +851,0.982275,9e0d93e9-f8e2-452d-9570-4897fca51742,Lung LLC,lung_llc,,,,9e0d93e9-f8e2-452d-9570-4897fca51742,lung_llc,Lung LLC +9317,,5218d776-7193-11e6-a0cd-0242ac12000b,COVIS PHARMA SARL,covis_pharma_sarl,,,,,, +9318,,9c05f846-12ad-43fa-a81e-7887941c5a84,Boehringer Ingelhein España S.A,boehringer_ingelhein_espa_a_s_a,,,,,, +9319,,fa04c684-1f8f-4721-b7af-f3ebd163b09b,Mundipharma OY,mundipharma_oy,,,,,, +9320,,9a4f8da6-cc2f-4788-8ee7-400d56c8733d,Actavis GmbH & Co. KG,actavis_gmbh_co_kg,,,,,, +9321,,416c6aec-7160-11e6-a0cd-0242ac12000b,REXAR,rexar,,,,,, +1049,0.97674435377120972,ab7c2aac-500b-46fe-87a2-4ea46bf1fcf6,University Hospital Zürich,university_hospital_z_rich,,,,3abc546a-5bd3-4194-a602-f5d74f7521a8,university_hospital_zurich,University Hospital Zurich +9322,,4f70580c-bde2-4095-be22-f649a6664368,Institut klinické a experimentální medicíny,institut_klinick_a_experiment_ln_medic_ny,,,,,, +1001,0.97408080101013184,97bed447-fd0e-4484-9d78-5d7a7aa3b967,Fundación para la Formación en Investigación Sanitarias de la Región de Murcia,fundaci_n_para_la_formaci_n_en_investigaci_n_sanitarias_de_la_regi_n_de_murcia,,,,97bed447-fd0e-4484-9d78-5d7a7aa3b967,fundaci_n_para_la_formaci_n_en_investigaci_n_sanitarias_de_la_regi_n_de_murcia,Fundación para la Formación en Investigación Sanitarias de la Región de Murcia +9323,,750cc5fd-3ea5-42b0-a68c-35625804e4e1,Mika Lehto,mika_lehto,,,,,, +9324,,9c741abd-2a37-4936-8941-ef9c1d9137af,Specialisttandvårdskliniken Västmanlands sjukhus Västerås,specialisttandv_rdskliniken_v_stmanlands_sjukhus_v_ster_s,,,,,, +9325,,6721894e-8bcc-11e6-a449-0242ac12000b,Empros Pharma AB,empros_pharma_ab,,,,,, +873,0.987212,aaef9c57-75a2-48dc-b175-1c1bc118b720,Emotional Brain,emotional_brain,,,,356fb77d-2541-44d7-b831-9556b88820e3,emotional_brain_bv,Emotional Brain BV +9326,,45520b48-9231-4de2-8c6e-10f8b5ea97b4,UZLeuven,uzleuven,,,,,, +9327,,7ace24c3-35f6-4efc-a33d-b4740a63e2f3,"Dept. Oncology, Aarhus University Hospital",dept_oncology_aarhus_university_hospital,,,,,, +9328,,1a658871-bb16-4687-91d2-80da129e317a,medphano Arzneimittel GmbH,medphano_arzneimittel_gmbh,,,,,, +9329,,6c90fbc8-85a3-4601-b122-6663dc4a3647,Oncolytics Biotech Inc,oncolytics_biotech_inc,,,,,, +9330,,b23298ba-b1b0-445c-88ab-3b1f0177038c,Isala Clinics Zwolle,isala_clinics_zwolle,,,,,, +9331,,b5ef0a2e-4727-4216-bd50-e05c3119806b,University of Liverpool and Royal Liverpool University Hospital,university_of_liverpool_and_royal_liverpool_university_hospital,,,,,, +9332,,7fe8833c-7179-11e6-a0cd-0242ac12000b,REGENERON PHARMACEUTICALS,regeneron_pharmaceuticals,,,,,, +9333,,cde803e3-0163-4d74-95c1-01ce04128190,Coombe Women's Hospital,coombe_women_s_hospital,,,,,, +9334,,43abbcb5-fc8c-448f-958e-cd26d4609df8,Lund University,lund_university,,,,,, +9335,,6e27c565-8ef9-4ff0-8a00-15d837b31620,Research and Development University Hospital of North Staffordshire,research_and_development_university_hospital_of_north_staffordshire,,,,,, +9336,,7509bfff-2b2c-4de0-a202-aa020f2efb82,"Clinical Trials Unit, Rigshospitalet",clinical_trials_unit_rigshospitalet,,,,,, +9337,,b368bc78-486b-403c-890f-6dd1f438efd4,PAION Deutschland GmbH,paion_deutschland_gmbh,,,,,, +9338,,658ad606-171a-4720-9ec1-8d748f7fc9af,"Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital. Division of internal medi",karolinska_institutet_department_of_clinical_sciences_danderyd_hospital_division_of_internal_medi,,,,,, +9339,,2fc05d7c-54ee-45c1-a844-bc160cb92e68,Amgen S.A,amgen_s_a,,,,,, +9340,,350e112c-715d-11e6-a0cd-0242ac12000b,GLENMARK PHARMS LTD,glenmark_pharms_ltd,,,,,, +9341,,ca64bfc0-6fc1-11e6-abe8-0242ac12000b,Arbutus Biopharma Corporation,arbutus_biopharma_corporation,,,,,, +794,0.98656213283538818,57306f5b-8c9d-4913-9671-8e18b042b194,Clavis Pharma as,clavis_pharma_as,,,,3bb5af7e-90aa-42de-87dd-3a09da828fda,clavis_pharma,Clavis Pharma +9342,,9b05e4ae-10c7-452b-9166-2fd50ba63066,Novartis Hungaria Kft,novartis_hungaria_kft,,,,,, +9343,,1d7dd9ef-e3fc-478a-8759-72df53148c48,A. Carlsson Research AB,a_carlsson_research_ab,,,,,, +9344,,2a3695e8-a577-418f-8c7c-4b3011150351,"Department of Radiology, Oslo University Hospital, Norway",department_of_radiology_oslo_university_hospital_norway,,,,,, +38,0.97483,7590aa7a-7149-11e6-a0cd-0242ac12000b,BIOVAIL,biovail,,,,4789b24e-71b6-11e6-a0cd-0242ac12000b,biovail_labs_intl,BIOVAIL LABS INTL +9345,,834a40fb-9cb9-4d2e-bd8c-8838e57f4537,ISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED,istituto_neurologico_mediterraneo_neuromed,,,,,, +221,0.987337,edf35dc5-4a96-4c7e-ab5e-7c3239568465,Addenbrooke's Hospital,addenbrooke_s_hospital,,,,edf35dc5-4a96-4c7e-ab5e-7c3239568465,addenbrooke_s_hospital,Addenbrooke's Hospital +9346,,a47b5a07-cd9c-45fd-9400-8cd52d4a8667,FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_pr_ncipe_de_asturias,,,,,, +9347,,00886553-0f3d-4c30-9c3a-13c9404726fd,Beafour Ipsen Pharma,beafour_ipsen_pharma,,,,,, +977,0.984073,5c717b25-0b28-45e6-bff5-45d9320631af,KULeuven and University Hospitals Leuven (Leuven Lung Transplant Group),kuleuven_and_university_hospitals_leuven_leuven_lung_transplant_group,,,,5c717b25-0b28-45e6-bff5-45d9320631af,kuleuven_and_university_hospitals_leuven_leuven_lung_transplant_group,KULeuven and University Hospitals Leuven (Leuven Lung Transplant Group) +9348,,eecff2ba-a807-4e37-902c-7aa99476c152,Department of Orthopaedics IKE,department_of_orthopaedics_ike,,,,,, +9349,,2e5f1fe5-1e75-4b32-ac05-f8b33091e1c0,"Neose Technologies, Inc",neose_technologies_inc,,,,,, +9350,,a177c43c-d828-4cef-a7b7-a1bd3c872c7a,Sahlgrenska University Hospital / The Queen Silvia Children´s Hospital,sahlgrenska_university_hospital_the_queen_silvia_children_s_hospital,,,,,, +9351,,426c74e9-d38f-479d-aa60-e84ec6259645,Interessenverband zur Qualitätsicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland (IQUO) e.V,interessenverband_zur_qualit_tsicherung_der_arbeit_niedergelassener_uro_onkologen_in_deutschland_iquo_e_v,,,,,, +9352,,8a8fbe83-f41e-49cd-ad02-4777117b8bf4,"Faculty of Medicine, Technische Universitaet Muenchen",faculty_of_medicine_technische_universitaet_muenchen,,,,,, +9353,,e64c3098-cc0f-4543-a28c-3c104da8b174,Universitätsklinikum Ulm,universit_tsklinikum_ulm,,,,,, +9354,,68c2e8c0-7168-11e6-a0cd-0242ac12000b,INVATECH PHARMA,invatech_pharma,,,,,, +9355,,068418bd-402a-4be2-a504-29c6eebe2f01,"Belfast Health and Social Care Trust, Musgrave Park Hospital",belfast_health_and_social_care_trust_musgrave_park_hospital,,,,,, +140,0.985075,8525e702-7306-11e6-a0cd-0242ac12000b,MERIDIAN MEDCL,meridian_medcl,,,,11f4634e-719e-11e6-a0cd-0242ac12000b,meridian_medcl_techn,MERIDIAN MEDCL TECHN +9356,,8eba68d2-7bf0-4ca9-9f99-695f72eb14e1,Sección de Digestivo. Hospital Comarcal de Laredo,secci_n_de_digestivo_hospital_comarcal_de_laredo,,,,,, +348,0.9580935537815094,b7b5adf6-8a37-4e38-b522-8a378e347db6,"Medizinische Universtät Wien, Universitätsklinik für Innere Medizin I",medizinische_universt_t_wien_universit_tsklinik_f_r_innere_medizin_i,,,,1c69f2db-0f03-45a8-b167-7670161862ea,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_i_klinische_abteilung_f_r_infektionen_und_tropenme,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische abteilung für Infektionen und Tropenme" +9357,,75ca420a-d39f-494a-9c9a-098d855b7ff7,Fidia Farmaceutici S.p.A,fidia_farmaceutici_s_p_a,,,,,, +9358,,e34e652f-3d4a-48e1-9f55-a85bb8913b5f,Novatreat Ltd,novatreat_ltd,,,,,, +9359,,efba3c92-14f4-4077-97d4-ba5dd5e58983,FRED HUTCHINSON CANCER RESEARCH CENTER UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE SEATTLE CHILDREN,fred_hutchinson_cancer_research_center_university_of_washington_school_of_medicine_seattle_children,,,,,, +9360,,e3c1efc6-0db4-477b-860d-773ddda608dc,Bracco Research S.P.A,bracco_research_s_p_a,,,,,, +9361,,31add611-8139-4727-8518-d0467606cb80,"Section of dental pharmacology and pharmacotherapy, ICO, University of Oslo",section_of_dental_pharmacology_and_pharmacotherapy_ico_university_of_oslo,,,,,, +9362,,cfd7a171-3090-44da-982e-04e342ded7b0,Ruhr Universität Bochum,ruhr_universit_t_bochum,,,,,, +9363,,5ba9946c-349f-4ecc-bb17-bf38a94f265c,Dr. Jordi Monés,dr_jordi_mon_s,,,,,, +9364,,2268e03b-bb26-4db9-8528-385bc1731693,Nuvo research Inc,nuvo_research_inc,,,,,, +9365,,aef39f44-e3c7-4f38-981c-83ddcbd1f2c1,Calabar AB,calabar_ab,,,,,, +241,0.984184,5abbbdea-7142-11e6-a0cd-0242ac12000b,BLU CARIBE INC,blu_caribe_inc,,,,2cc199a4-715c-11e6-a0cd-0242ac12000b,blu_caribe,BLU CARIBE +9366,,3948b154-6cea-4ca5-b88d-b159284f9e75,Fundacion Hospital Alcorcon,fundacion_hospital_alcorcon,,,,,, +9367,,ed1e7d5f-1e3d-4259-afc5-c506080ddd68,Interdos Pharma bv,interdos_pharma_bv,,,,,, +9368,,6453e40c-73f1-11e6-a0cd-0242ac12000b,KERYX BIOPHARMS,keryx_biopharms,,,,,, +9369,,30d4ab7e-3a31-42cc-b178-d36b7eac7c29,"Baxter Healthcare Corporation, Baxter BioScience",baxter_healthcare_corporation_baxter_bioscience,,,,,, +429,0.970982,b990f28f-6416-4624-8f57-71ff8bf23556,Addex Pharmaceuticals S.A,addex_pharmaceuticals_s_a,,,,71d8e8b6-4155-47a0-ad75-6f0f13598830,addex_pharmaceuticals_sa,Addex Pharmaceuticals SA +9370,,0f2416dc-3a8f-49db-9020-1827157b8a74,"ACT BIOTECH, Inc",act_biotech_inc,,,,,, +9371,,854c27be-7167-11e6-a0cd-0242ac12000b,PRECISION NUCLEAR,precision_nuclear,,,,,, +354,0.989467,30b1f9cc-f511-477c-bf64-97f87e3f4260,NERVIANO MEDICAL SCIENCE,nerviano_medical_science,,,,30b1f9cc-f511-477c-bf64-97f87e3f4260,nerviano_medical_science,NERVIANO MEDICAL SCIENCE +9372,,b5957cfa-71b6-11e6-a0cd-0242ac12000b,CLINIPAD,clinipad,,,,,, +9373,,0a5f8d7a-8be8-11e6-a449-0242ac12000b,"The Norwegian Radium Hospital, Oslo University Hospital",the_norwegian_radium_hospital_oslo_university_hospital,,,,,, +9374,,2018e7fe-7164-11e6-a0cd-0242ac12000b,METHAPHARM,methapharm,,,,,, +9375,,058d6954-0c87-4529-b2d8-4b2f02dd1db7,"On Target Laboratories , LLC",on_target_laboratories_llc,,,,,, +295,0.988084,fd4f5aae-cb5c-4a8a-900c-29fffa71d191,Centre for Human Drug Research,centre_for_human_drug_research,,,,4fe3be9a-b05b-4bc8-b2c3-37b02726367b,centre_for_human_drug_research_chdr,Centre for Human Drug Research (CHDR) +9376,,c8d1274c-b3b2-4a1d-9bb7-1a588403df9a,Raitakari Olli,raitakari_olli,,,,,, +9377,,87d549f2-2909-49a0-9368-1c7b2aef9f80,BRUSCHETTINI SRL,bruschettini_srl,,,,,, +9378,,1e1cddf7-2fe4-4b77-9696-9bedc2744207,"Sydvestjysk Sygehus, Esbjerg",sydvestjysk_sygehus_esbjerg,,,,,, +9379,,64391b84-bb06-448b-b437-6ed428c0cc2e,Hormos Medical Ltd,hormos_medical_ltd,,,,,, +9380,,92eaecc1-8450-42cf-9940-066ba6f4b02d,"Søren Sindrup, Dept. of Neurology, University Hospital of Odense",s_ren_sindrup_dept_of_neurology_university_hospital_of_odense,,,,,, +9381,,287b8417-1ea7-4271-bf5a-89c564c6c48a,The Nordic MDS group,the_nordic_mds_group,,,,,, +9382,,efb6b987-c8ea-40b8-af8d-91264529f494,José Luño Fernandez,jos_lu_o_fernandez,,,,,, +9383,,58bd8620-787c-48dc-8e8c-d172643374aa,Robarts Clinical Trials Inc,robarts_clinical_trials_inc,,,,,, +9384,,ff01b770-1e49-4bff-a1cc-a8a5c51904cb,Sigmoid Pharma Ltd,sigmoid_pharma_ltd,,,,,, +441,0.985292,b78c9c06-90e2-4b26-923a-d0b7abf3a2c1,"Dept. of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital Rigshospitalet",dept_of_anaesthesia_centre_of_head_and_orthopaedics_copenhagen_university_hospital_rigshospitalet,,,,38fa42f7-b481-47f1-ad59-ebc7650a6a92,dept_of_anaesthesia_center_of_head_and_orthopaedics_copenhagen_university_hospital_rigshospitalet,"Dept. of Anaesthesia, Center of Head and Orthopaedics, Copenhagen University Hospital Rigshospitalet" +557,0.973471,dd31a9cc-3486-447c-9efa-ead81dc8aa10,SERVICIO DE PSIQUIATRIA. HOSPITAL UNIVERSITARI VALL D'HEBRON,servicio_de_psiquiatria_hospital_universitari_vall_d_hebron,,,,943dc7fd-4950-44aa-a140-b1ce0165b980,servicio_de_psiquiatria_hospital_universitari_vall_de_hebron,SERVICIO DE PSIQUIATRIA. HOSPITAL UNIVERSITARI VALL DE HEBRON +9385,,04b6b577-9151-4717-85af-39e324e5d3cd,"Klinikum Großhadern, ENT-Department",klinikum_gro_hadern_ent_department,,,,,, +9386,,9a33bb06-9a8e-45ce-8abf-f9667ef19976,Shire HGT Inc,shire_hgt_inc,,,,,, +9387,,af3ad0cf-6349-4c9b-9761-a57815b4f7c5,University of Pécs,university_of_p_cs,,,,,, +614,0.94227220614751184,ed799f74-cf6f-4794-826e-112d6271313d,Fundación para la investigacion Biomedica,fundaci_n_para_la_investigacion_biomedica,,,,1f4b6569-9247-4094-9c36-e11efb0201df,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz,Fundación para la Investigación Biomédica del Hospital Universitario La Paz +9388,,4f839fea-7b31-41cc-9c9e-857c8bc6647d,Centre Eugène Marquis,centre_eug_ne_marquis,,,,,, +116,0.95832524696985877,f5a479e4-8160-4199-bd67-acd4e6b833c9,Shire Pharmaceutical Development Limited,shire_pharmaceutical_development_limited,,,,63ca73d2-fd68-4693-872c-2121b000d68c,shire_pharmaceutical_development,Shire Pharmaceutical Development +9389,,b90637c8-7141-11e6-a0cd-0242ac12000b,LNK,lnk,,,,,, +9390,,d52e22fb-b00b-4999-a21b-97a2efc2ad93,Our Lady's Children's Hospital,our_lady_s_children_s_hospital,,,,,, +9391,,46308028-897e-45a3-9963-701bbd52c435,GPC BIOTECH,gpc_biotech,,,,,, +397,0.967352,a9e2a6af-3a27-4b28-a5a9-8ffd6a2cebe1,"Copenhagen University Hospital, Rigshospitalet, Juliane Marie Centre, Department of Anaesthesiology",copenhagen_university_hospital_rigshospitalet_juliane_marie_centre_department_of_anaesthesiology,,,,a9e2a6af-3a27-4b28-a5a9-8ffd6a2cebe1,copenhagen_university_hospital_rigshospitalet_juliane_marie_centre_department_of_anaesthesiology,"Copenhagen University Hospital, Rigshospitalet, Juliane Marie Centre, Department of Anaesthesiology" +9392,,0affb892-7147-11e6-a0cd-0242ac12000b,DAVA INTL INC,dava_intl_inc,,,,,, +607,0.989401,fee1690a-a826-4b92-8ab0-c0e523fe410f,Advanced Accelerator Applications SA,advanced_accelerator_applications_sa,,,,dfe33f9c-fc87-4176-a56a-52c1a7a26063,advanced_accelerator_applications,Advanced Accelerator Applications +9393,,90c5258a-bf8a-4a27-adff-fa480770fdfd,Sherwood Forest Hospitals Foundation Trust,sherwood_forest_hospitals_foundation_trust,,,,,, +9394,,4488b555-68ef-468a-ac46-e4871b4ca624,Merck Generics,merck_generics,,,,,, +9395,,57314736-c537-472b-ae8e-e986acd1b307,Alfa Wassermann S.p.A,alfa_wassermann_s_p_a,,,,,, +9396,,5afdd3ce-3e93-4394-8a30-65d040c81bd0,"Medizinische Klinik III, Kardiologie",medizinische_klinik_iii_kardiologie,,,,,, +9397,,44502de1-59d7-4683-bf5d-c74a70c40782,San Raffaele Hospital,san_raffaele_hospital,,,,,, +9398,,1553aea2-a2a0-47d0-8b22-b1bc0ffa6d4e,Universitätsklinikum Freiburg,universit_tsklinikum_freiburg,,,,,, +9399,,eb2c407d-b691-4db8-a892-229a9834b6f6,"Medizinische Universität Graz, Klinische Abteilung für Thorax -u. Hyperbare Chirurgie",medizinische_universit_t_graz_klinische_abteilung_f_r_thorax_u_hyperbare_chirurgie,,,,,, +9400,,ff426bb9-7afa-4bec-bc51-5918769b9b0e,"ENT Hospital, Johannes-Gutenberg University, Mainz",ent_hospital_johannes_gutenberg_university_mainz,,,,,, +427,0.97483,2d37c06d-3f24-45d9-8652-f586b0450921,"VIVUS, Inc",vivus_inc,,,,2b3faade-7374-11e6-a0cd-0242ac12000b,vivus,VIVUS +373,0.91557258367538452,fb0bfd93-ab3e-40a3-8bf1-ec5929f65d5c,Merck Sharp & Dohme GesmbH,merck_sharp_dohme_gesmbh,,,,f2d6af42-c47f-49ae-b4b6-a023a2b2f116,merck_sharp_dohme_gmbh,Merck Sharp & Dohme GmbH +239,0.94886791706085205,8c508aab-3056-4b10-a446-a25708805795,"Pfizer Limited, Ramsgate Road, Sandwich, Kent,CT13,UK",pfizer_limited_ramsgate_road_sandwich_kent_ct13_uk,,,,8c508aab-3056-4b10-a446-a25708805795,pfizer_limited_ramsgate_road_sandwich_kent_ct13_uk,"Pfizer Limited, Ramsgate Road, Sandwich, Kent,CT13,UK" +378,0.94561511278152466,796acf07-1766-4af0-8f88-ef836fc80a36,Merck Sharp & Dohme BV,merck_sharp_dohme_bv,,,,796acf07-1766-4af0-8f88-ef836fc80a36,merck_sharp_dohme_bv,Merck Sharp & Dohme BV +9401,,591864ae-715e-11e6-a0cd-0242ac12000b,MARKSANS PHARMA,marksans_pharma,,,,,, +9402,,3cfb4714-3bd5-42a8-8843-1b7eadc42393,Queen Elizabeth Hospital,queen_elizabeth_hospital,,,,,, +9403,,5a4d6b93-4e2c-442c-8d7b-db72629933ba,Harju Mika,harju_mika,,,,,, +9404,,deb2e335-8ea7-4d07-ad4e-bc123f7c7b35,Baxter SAS,baxter_sas,,,,,, +9405,,3b81808c-1dfa-4eb2-9523-eb1743af008d,Bambino Gesù Children’s Hospital,bambino_ges_children_s_hospital,,,,,, +9406,,876f343f-8b01-4426-94af-1d0c98dee6e1,FRANCISCO JAVIER BENITO FERNANDEZ,francisco_javier_benito_fernandez,,,,,, +9407,,97a9417b-275c-4b37-8d7f-1b36cad60034,cliniques universitaire de mont godinne,cliniques_universitaire_de_mont_godinne,,,,,, +9408,,70830329-be08-4e7a-a312-e5252d3264fb,COALICIÓN IBEROAMERICANA DE INVESTIGACIÓN EN ONCOLOGÍA MAMARIA (CIBOMA),coalici_n_iberoamericana_de_investigaci_n_en_oncolog_a_mamaria_ciboma,,,,,, +9409,,60f23de1-72b6-4ec4-b547-dfced562d1b9,"Pharma Mar SA, sociedad unipersonal",pharma_mar_sa_sociedad_unipersonal,,,,,, +9410,,20e3fa2e-c27a-4227-99e4-ddd6eb7d10f8,"Thorax Center, Univeristy Medical Center Groningen, Groningen, The Netherlands",thorax_center_univeristy_medical_center_groningen_groningen_the_netherlands,,,,,, +9411,,57d18a9c-ae28-45d5-a55c-9bb49d1fbeb7,PULSION Medical Systems SE,pulsion_medical_systems_se,,,,,, +59,0.97944498062133789,e5d9e1b6-afc8-4a91-b7b3-90346bb35a9d,Wyeth Research Division,wyeth_research_division,,,,96e5ebae-c6a3-41db-ae14-3ec5437c35f2,wyeth_research_division,Wyeth Research Division +9412,,bcc53062-f88d-45de-bb89-2b9c1dd5c46f,Ulrich Tacke,ulrich_tacke,,,,,, +9413,,71b6c8b3-321b-4791-9d7f-2045faf90d9e,WSG GmbH,wsg_gmbh,,,,,, +9414,,9685ab72-d6ad-40e4-ab03-94118bf8e117,Consejería de Sanidad de la Comunidad de Madrid,consejer_a_de_sanidad_de_la_comunidad_de_madrid,,,,,, +9415,,f2cfb7ec-99e1-47dd-b90a-2e0f73e4e5af,Childrens´ Hospital Erlangen,childrens_hospital_erlangen,,,,,, +151,0.968867,17459e96-4beb-4a3a-bba1-71e183697af9,Institute of Cancer Research,institute_of_cancer_research,,,,17459e96-4beb-4a3a-bba1-71e183697af9,institute_of_cancer_research,Institute of Cancer Research +9416,,f9d19224-b79e-4920-99e2-9ce2f11f307a,"Dept. of Anesthesiology and Intensive Care, Charité - Campus Benjamin Franklin",dept_of_anesthesiology_and_intensive_care_charit_campus_benjamin_franklin,,,,,, +9417,,9a540466-61f9-434e-b63f-3d344a40a31c,ERREKAPPA EUROTERAPICI,errekappa_euroterapici,,,,,, +1069,0.947481,416fb7db-4b29-4803-ba0e-6ece3f142626,Universitetssjukhuset Linköping,universitetssjukhuset_link_ping,,,,416fb7db-4b29-4803-ba0e-6ece3f142626,universitetssjukhuset_link_ping,Universitetssjukhuset Linköping +764,0.98123,2917de45-e710-4da7-9b4b-c54d1dd1327d,Universitair Ziekenhuis Antwerpen,universitair_ziekenhuis_antwerpen,,,,2917de45-e710-4da7-9b4b-c54d1dd1327d,universitair_ziekenhuis_antwerpen,Universitair Ziekenhuis Antwerpen +9418,,562202ba-715d-11e6-a0cd-0242ac12000b,RP SCHERER,rp_scherer,,,,,, +9419,,98c54c39-2a16-4c12-be58-e9070172f658,Richter Gedeon Rt,richter_gedeon_rt,,,,,, +9420,,e282e3af-c5cd-47bf-8605-63fa05c3220e,"Wyeth Pharmaceuticals Inc, (a Pfizer Company) 500 Arcola Road, Collegeville, PA 19426 USA",wyeth_pharmaceuticals_inc_a_pfizer_company_500_arcola_road_collegeville_pa_19426_usa,,,,,, +9421,,8f006312-db18-419c-a719-aa1b1c17acb7,Swedish CLL-group,swedish_cll_group,,,,,, +380,0.97472488880157471,5ce8246b-51c8-4649-adad-e4ee6e9b4a69,Merck Sharp & Dohme Corp,merck_sharp_dohme_corp,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" +9422,,2319dc8b-34b6-4b8f-9dce-1c759bc06307,Breno Moreno de Gusmao,breno_moreno_de_gusmao,,,,,, +9423,,1cecf013-a72c-11e6-94cb-5656d04fc2b5,"University of Oulu, Department of Pediatrics, PEDEGO-Research unit",university_of_oulu_department_of_pediatrics_pedego_research_unit,,,,,, +649,0.92396390438079834,ff7f9705-592d-4064-81fa-59be5c48cd44,Boehringer Ingelheim Limited,boehringer_ingelheim_limited,,,,04c96b54-04e3-4fc0-9394-ec1a0060bdcd,boehringer_ingelheim_ltd,Boehringer Ingelheim Ltd +9424,,64538db5-44fa-48cc-9f20-0787362dec50,CHU de Bordeaux,chu_de_bordeaux,,,,,, +1044,0.988488,a7ea3b09-730e-4775-aca6-bb467a14c96d,Intercept Pharmaceuticals Inc,intercept_pharmaceuticals_inc,,,,8cc0218b-399d-46ee-a2f5-9edb9d7f5a91,intercept_pharmaceuticals,Intercept Pharmaceuticals +817,0.98780262470245361,53d17802-3866-4bc6-856b-3879f031124d,Boehringer Ingelheim b.v,boehringer_ingelheim_b_v,,,,53d17802-3866-4bc6-856b-3879f031124d,boehringer_ingelheim_b_v,Boehringer Ingelheim b.v +9425,,05fe0074-7160-11e6-a0cd-0242ac12000b,ROBINS AH,robins_ah,,,,,, +743,0.978585,a57f06eb-3ab3-4751-a94f-5b412b84bbb7,Population Health Research Institute (PHRI),population_health_research_institute_phri,,,,a57f06eb-3ab3-4751-a94f-5b412b84bbb7,population_health_research_institute_phri,Population Health Research Institute (PHRI) +9426,,1b59b77c-7199-11e6-a0cd-0242ac12000b,NEW RIVER,new_river,,,,,, +348,0.94994914531707764,1c69f2db-0f03-45a8-b167-7670161862ea,"Medizinische Universität Wien, Universitätsklinik Innere Medizin I",medizinische_universit_t_wien_universit_tsklinik_innere_medizin_i,,,,1c69f2db-0f03-45a8-b167-7670161862ea,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_i_klinische_abteilung_f_r_infektionen_und_tropenme,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische abteilung für Infektionen und Tropenme" +9427,,6ad7c43b-309c-4ec9-92aa-dc9b6fce9708,"Cubist Pharmaceuticals LLC, an indirect wholly-owned subsidiary of Merck Sharp & Dohme Corp",cubist_pharmaceuticals_llc_an_indirect_wholly_owned_subsidiary_of_merck_sharp_dohme_corp,,,,,, +9428,,118b0aaf-ce7d-44f9-855b-fb490ff6dc78,University Medicine Göttingen Dept. Hematology and Oncology,university_medicine_g_ttingen_dept_hematology_and_oncology,,,,,, +9429,,68ccaeb5-00de-49dd-ab18-4d5e8a348773,ClinTrio Ltd,clintrio_ltd,,,,,, +694,0.96722513437271118,1b6ada03-c5ed-4ced-8aa3-31390be8485f,Krankenhaus Nordwest GmbH,krankenhaus_nordwest_gmbh,,,,a1b6c5f2-16df-4bac-b6d9-a19ab340e9dd,krankenhaus_nordwest,Krankenhaus Nordwest +9430,,2c2a639d-4813-4b6d-ba67-1a78c4b91979,Instituto Aragonés de Ciencias de la Salud,instituto_aragon_s_de_ciencias_de_la_salud,,,,,, +9431,,f83ce730-4eca-4ff4-9b6c-599820468d88,Reinier de Graaf Hospital,reinier_de_graaf_hospital,,,,,, +9432,,64323ea2-15da-40fc-9434-ab2c6aa2b1b3,IPOLFG,ipolfg,,,,,, +9433,,fba17192-73f8-11e6-a0cd-0242ac12000b,AMERICAN WELDING AND GAS INC,american_welding_and_gas_inc,,,,,, +9434,,f8eeb553-e484-4b05-8f72-dc94da01e659,ALFA WASSERMANN,alfa_wassermann,,,,,, +9435,,7bab44f3-59c8-4114-b46b-4e266ae1bbe1,GOSH/ICH Joint Research & Development Office,gosh_ich_joint_research_development_office,,,,,, +9436,,49276b2b-f852-4988-b541-4e897180197f,"Cempra Pharmaceuticals , Inc",cempra_pharmaceuticals_inc,,,,,, +9437,,9853dff0-7162-11e6-a0cd-0242ac12000b,MURO,muro,,,,,, +9438,,8e6d8e49-a0ac-4b6d-afa4-b2075931b514,HOPITAL MIGNOT,hopital_mignot,,,,,, +9439,,5335e3b0-ddc1-4ba8-a7dc-ae66cc111aff,University College London (UCL) hereby represented by UCL Comprehensive Clinical Trials Unit(CCTU),university_college_london_ucl_hereby_represented_by_ucl_comprehensive_clinical_trials_unit_cctu,,,,,, +9440,,b46e0117-8256-4431-9bc3-3ebd9d0bc3e0,Stefan Lundeberg,stefan_lundeberg,,,,,, +9441,,e8bc4bc1-06b2-4f82-a8f5-6d97a28e52e5,Helena Kallio,helena_kallio,,,,,, +792,0.980742,3eeb7409-fc6a-4e35-b3ca-369fcd621d64,LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S),leo_pharmaceutical_products_ltd_a_s_leo_pharma_a_s,,,,3eeb7409-fc6a-4e35-b3ca-369fcd621d64,leo_pharmaceutical_products_ltd_a_s_leo_pharma_a_s,LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S) +1017,0.98179945349693298,c40cc85e-13fb-4a5f-a13c-c1d4f3c81220,Southampton University Hospitals Trust (R&D),southampton_university_hospitals_trust_r_d,,,,986ad2cd-cb4e-460c-acdc-a2b32a61de09,southampton_university_hospitals,Southampton University Hospitals +9442,,160e073e-2ecb-4619-a0fa-ddb84d584bfc,Afdeling Klinische Neuropsychologie Vrije Universiteit Amsterdam,afdeling_klinische_neuropsychologie_vrije_universiteit_amsterdam,,,,,, +645,0.97453597187995911,fa036bb5-d4dc-45bd-90a7-a8c241dba4a6,Boehringer Ingelheim Pharma GmbH & CoKG,boehringer_ingelheim_pharma_gmbh_cokg,,,,5b57c8bd-158c-42a5-bfa1-3323c67e0dd4,boehringer_ingelheim_pharma_gmbh,Boehringer Ingelheim Pharma GmbH +9443,,83e644b7-c4d0-4b7a-9c93-72dbffff9ec6,CHU-HOPITAUX DE ROUEN,chu_hopitaux_de_rouen,,,,,, +9444,,2e29fcca-b64e-4c20-a583-0bc5b515f067,Enrique Bárez Hernandez,enrique_b_rez_hernandez,,,,,, +9445,,9b56e8ef-50b0-4c96-a40c-61ec7ffd1547,"The North West London Hospitals NHS Trust, Northwick Park Hospital",the_north_west_london_hospitals_nhs_trust_northwick_park_hospital,,,,,, +9446,,c2b0987b-6d1b-4dac-a975-e393ed88d26a,Leeds Dental Institute,leeds_dental_institute,,,,,, +948,0.987264,ef0c88c3-b18d-418f-8dea-49b004358b2d,Netherlands Cancer Institute (NKI)+31,netherlands_cancer_institute_nki_31,,,,ca7f7919-c99d-49fd-8812-36dc1941ad8d,netherlands_cancer_institute,Netherlands Cancer Institute +9447,,8d400f41-68b3-4ddb-b921-5be0cc83b766,"Research and Enterprise, University of Birmingham",research_and_enterprise_university_of_birmingham,,,,,, +9448,,0d9d5c60-e07a-4fc5-9bf1-21d9c4b73442,MOLMED,molmed,,,,,, +9449,,a5961af8-481f-4504-a77c-fb03c7a301d9,Sociedade Portuguesa de Cardiologia,sociedade_portuguesa_de_cardiologia,,,,,, +9450,,6bd4c478-6fc1-11e6-abe8-0242ac12000b,"Technische Universitaet Muenchen, vertreten durch das Klinikum rechts der Isar",technische_universitaet_muenchen_vertreten_durch_das_klinikum_rechts_der_isar,,,,,, +313,0.95558246970176697,ec9fb836-fdf2-4017-93a0-a0e70dcf5ad9,GlaxoSmithKline Biolgicals,glaxosmithkline_biolgicals,,,,d94a5eb6-cc98-4004-a7a3-95cf39383b18,glaxosmithkline_biologicals,GlaxoSmithKline Biologicals +9451,,7b2a0f7f-c743-41a2-a983-e579ca6f4b7a,"LWL University Hospital Bochum, Ruhr-University Bochum",lwl_university_hospital_bochum_ruhr_university_bochum,,,,,, +9452,,dd65004d-8622-43ca-8bfb-e49abed79780,Department of Infectious Diseases - Aarhus University Hospital,department_of_infectious_diseases_aarhus_university_hospital,,,,,, +9453,,1778c834-7142-11e6-a0cd-0242ac12000b,ARBOR PHARMS LLC,arbor_pharms_llc,,,,,, +9454,,1d778f75-561e-42dc-ab1f-875029aa89a6,AnorMED Corp,anormed_corp,,,,,, +9455,,8366632b-eb1e-44f5-bfd5-afc695e6ede6,Chronic Obstructive Pulmonary Disease Trial Network (COP:TRIN),chronic_obstructive_pulmonary_disease_trial_network_cop_trin,,,,,, +9456,,96f9049e-8df3-4cf5-8b4a-0529ea99f82b,Hôpital Ambroise Paré,h_pital_ambroise_par,,,,,, +9457,,40e8c2e1-c415-405e-a331-f4175825cfe5,Neurology Unit,neurology_unit,,,,,, +9458,,2c375930-b1a3-42b6-81d0-c703f9eadc4c,Arrow Therapeutics Ltd. (a member of the AstraZeneca group of companies),arrow_therapeutics_ltd_a_member_of_the_astrazeneca_group_of_companies,,,,,, +898,0.96782034635543823,73d5b600-a4ac-4e17-85a1-e73320afd73b,EBMT - CLWP,ebmt_clwp,,,,485cfb56-5188-4c47-8ac4-caf3e84b5e2f,ebmt,EBMT +9459,,4d6cf465-f20b-4e73-ac1b-03dbbf813745,The Royal Wolverhampton Hospitals NHS Trust,the_royal_wolverhampton_hospitals_nhs_trust,,,,,, +9460,,372cedfe-725a-11e6-a0cd-0242ac12000b,SB PHARMCO,sb_pharmco,,,,,, +9461,,28d9fcc8-e000-44c3-b668-55b87a2a5379,"Research, Enterprise & Development (UOB)",research_enterprise_development_uob,,,,,, +9462,,a02f1cd6-eb03-4973-9c15-ab873aaf804a,Fundación Pública Andaluza para la Gestión en Salud de Sevilla (FISEVI),fundaci_n_p_blica_andaluza_para_la_gesti_n_en_salud_de_sevilla_fisevi,,,,,, +375,0.98873221874237061,7e87bc11-ff9c-4927-879f-5e83f9da3259,"Merck Sharp and Dohme de España, S.A",merck_sharp_and_dohme_de_espa_a_s_a,,,,7e87bc11-ff9c-4927-879f-5e83f9da3259,merck_sharp_and_dohme_de_espa_a_s_a,"Merck Sharp and Dohme de España, S.A" +9463,,fc6b34f8-fded-4f28-99a1-c74fbf0075b7,Hoffman - La Roche,hoffman_la_roche,,,,,, +9464,,e50bbb18-4117-46cc-ba59-9bb786acfa48,Edinburgh Research and Innovation,edinburgh_research_and_innovation,,,,,, +9465,,86da0dc0-e623-4767-8680-12be086dde3d,Laboratorios LETI S.L,laboratorios_leti_s_l,,,,,, +9466,,cfb6208f-e142-47f0-af60-32f5e7beba39,"KOSAN BIOSCIENCES, INC",kosan_biosciences_inc,,,,,, +9467,,15332d98-65f6-4746-9fac-982badb859c7,"RMC, Skåne University Hospital",rmc_sk_ne_university_hospital,,,,,, +9468,,0099d0d0-b6ce-4e86-8cb7-29a7d9de79d2,Danderyds Sjukhus,danderyds_sjukhus,,,,,, +9469,,5b28fde6-2b42-4b6f-987e-2da424f4f29c,Marc Van de Velde,marc_van_de_velde,,,,,, +9470,,abfcb4f7-5111-4dc6-a68f-0c74fb356cb2,Julian Panés,julian_pan_s,,,,,, +9471,,05f16e48-4874-46c6-8294-676ee5be508f,AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A,aziende_chimiche_riunite_angelini_francesco_a_c_r_a_f_s_p_a,,,,,, +9472,,8b6e682b-40eb-4cc6-80c1-c666b7e698a5,FONDAZIONE CHARTA,fondazione_charta,,,,,, +9473,,84784180-7129-11e6-a89e-0242ac12000b,HIKMA PHARMS LLC,hikma_pharms_llc,,,,,, +9474,,acf06b27-84c5-4480-9344-da4890896a0f,AZ. USL DI CESENA,az_usl_di_cesena,,,,,, +9475,,51a8a860-bb4d-4d7b-acca-bb814c10888b,AGI Therapeutics Limtied,agi_therapeutics_limtied,,,,,, +9476,,1c21f2d9-d9e9-4231-a7f0-da1a911b6d87,THERANOR sprl,theranor_sprl,,,,,, +9477,,cce6a956-cbf4-4c3c-a9b5-7cc185dc76a2,Nordmark Arzneimittel GmbH & Co. KG,nordmark_arzneimittel_gmbh_co_kg,,,,,, +9478,,5be30e44-9d9d-4178-8026-c4659ad1c75a,Daval International Limited,daval_international_limited,,,,,, +9479,,7d2dc040-7146-11e6-a0cd-0242ac12000b,INTERGEL PHARM,intergel_pharm,,,,,, +9480,,5492144a-265e-442b-b2ac-99b7603b5adc,"TenX Biopharma, Inc.,",tenx_biopharma_inc,,,,,, +9481,,5e59f446-eb97-4119-beae-2c835de6dd39,Norrbottens läns landsting,norrbottens_l_ns_landsting,,,,,, +9482,,da2d952a-8be7-48a2-9573-290cd27fe679,Accare,accare,,,,,, +9483,,61161b39-0d07-4dd0-b45c-c0596578e679,"Oncoethix GmbH, a wholly owned subsidiary of Merck Sharp & Dohme Corp",oncoethix_gmbh_a_wholly_owned_subsidiary_of_merck_sharp_dohme_corp,,,,,, +9484,,d16a5cb2-adbb-4923-81ac-ec1e7f28daab,THT Research sprl,tht_research_sprl,,,,,, +9485,,1b1c07cb-1473-4c37-bb4c-8c8094d084ff,"Instituto Português de Oncologia do Porto Francisco Gentil, EPE",instituto_portugu_s_de_oncologia_do_porto_francisco_gentil_epe,,,,,, +9486,,546dfe8e-5f79-4d65-958b-1c1232b412ba,"General Hospital Vienna, Dept Cardio-thoracic surgeray",general_hospital_vienna_dept_cardio_thoracic_surgeray,,,,,, +9487,,30616589-2bc4-4938-a845-c96a5d41ae8e,"Quark Pharmaceuticals, Inc",quark_pharmaceuticals_inc,,,,,, +740,0.9299778938293457,0db04114-2f8a-4901-9be7-558fb229bc42,"ICORG, the all-Ireland Co-operative Oncology Research Group",icorg_the_all_ireland_co_operative_oncology_research_group,,,,a915c184-a118-4ca9-8fb4-2b38760107dc,icorg_the_all_ireland_cooperative_oncology_research_group,"ICORG, the all-Ireland Co-operative Oncology Research Group" +9488,,a42d7f0e-260d-4d9f-b09c-084b6c335b5a,ZAMBON ITALIA,zambon_italia,,,,,, +9489,,8517d378-fc67-4e3a-86f6-c7557ed863f0,Zytoprotec GmbH,zytoprotec_gmbh,,,,,, +9490,,bede2514-2389-4050-be52-fe440fba97f9,"HYKS, sisätautien toimiala, diabetesklinikka",hyks_sis_tautien_toimiala_diabetesklinikka,,,,,, +9491,,dae5bd5c-6fa0-11e6-9663-0242ac12000b,"Pfizer Inc, 235 East 42nd Street, New York City, NY 10017",pfizer_inc_235_east_42nd_street_new_york_city_ny_10017,,,,,, +9492,,a7d01b29-364f-4dc4-9ca6-57a64f2424aa,"Medco Health Solutions, Inc",medco_health_solutions_inc,,,,,, +9493,,a09d0c0f-f1b3-446a-b25a-49fc8bf731ba,Our Lady's Hospital for Sick Children,our_lady_s_hospital_for_sick_children,,,,,, +9494,,2d3adf54-b134-461e-b308-6769cfc3fc0e,Sigma-Tau i.f.r. S.p.A,sigma_tau_i_f_r_s_p_a,,,,,, +9495,,d4948804-2cc7-4609-8d28-2c3f101dfdf9,"Rigshospitalet, Psykiatrisk Klinik",rigshospitalet_psykiatrisk_klinik,,,,,, +58,0.96753491461277008,fe20c8b4-bfb0-4cfc-96be-52e8cd5c61f0,"Wyeth Research Division of Wyeth Pharmaceuticals Inc., Clinical Reserach and Development",wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_reserach_and_development,,,,2ed1b6f4-e137-4ee3-a218-9e5c2d04039a,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_and_development,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development +9496,,c5edbd45-2bc3-448a-aabb-156881397fd0,Enrique Ortega González,enrique_ortega_gonz_lez,,,,,, +9497,,e6a77325-0df6-491e-8eb9-dab5c80f086d,Shionogi Ltd,shionogi_ltd,,,,,, +9498,,e149eac8-a08e-4b46-a4f9-98a9f571575f,"Greater Glasgow Health Board, Research and Development Department",greater_glasgow_health_board_research_and_development_department,,,,,, +9499,,feb7f80f-282e-4a8f-8d3b-17ad9d8bb974,Asociación para la investigación de Nefrología Infantil,asociaci_n_para_la_investigaci_n_de_nefrolog_a_infantil,,,,,, +9500,,bb188039-869b-45ab-8c4b-a6aefee93dda,"Ethicon, Inc",ethicon_inc,,,,,, +9501,,694a2f22-7c86-49c8-a092-c213c9222cd5,TauRx Therapeutics Ltd,taurx_therapeutics_ltd,,,,,, +9502,,18fe0aea-90d0-4355-9358-37cc3d0cafec,Grupo Gallego de Investigaciones Oncológicas (GGIO),grupo_gallego_de_investigaciones_oncol_gicas_ggio,,,,,, +9503,,2c1338c6-b985-491c-adf9-b9145a774a80,Guy's & St Thomas NHS Trust,guy_s_st_thomas_nhs_trust,,,,,, +353,0.983343,39567cd9-71f5-4b2f-bdb8-e49b40d2d234,Institut de Recherche Pierre Fabre - Centre de R&D Pierre Fabre,institut_de_recherche_pierre_fabre_centre_de_r_d_pierre_fabre,,,,33018013-878a-4dd3-b923-de7bc09fb504,institut_de_recherche_pierre_fabre,Institut de Recherche Pierre Fabre +9504,,6d6c8b60-b830-43e2-8a2d-7d3cf8bdf45e,Neurovascular Research Group-IRVH,neurovascular_research_group_irvh,,,,,, +9505,,dcbc3204-01ee-4b85-948a-2451cff49277,Norgine Ltd,norgine_ltd,,,,,, +9506,,3bc6a70f-5ee0-4333-bc60-ac971b4c432a,"Department of Breast and Endocrine Surgery, Karolinska University Hospital",department_of_breast_and_endocrine_surgery_karolinska_university_hospital,,,,,, +9507,,cdcae20d-d4d1-4000-b6af-7fa51725b7d8,Mabion S.A,mabion_s_a,,,,,, +9508,,9a0c2f7f-efda-4829-b68b-ba9ffee8e0de,University Hospital Düsseldorf,university_hospital_d_sseldorf,,,,,, +9509,,38d758a7-0eda-41d4-991a-7e92bc9798e5,"ImaRx Therapeutics, Inc",imarx_therapeutics_inc,,,,,, +9510,,2b4d2250-b195-47be-9cb2-6b492aa2a307,Nina Olofsson,nina_olofsson,,,,,, +9511,,307f0a88-a945-41a0-8e15-993a655500ff,"EMET Pharmaceuticals, LLC",emet_pharmaceuticals_llc,,,,,, +9512,,8e508f32-7be0-4145-b591-56b544584752,Knowledge Centre for Rheumatology and Back Diseases,knowledge_centre_for_rheumatology_and_back_diseases,,,,,, +9513,,88393f10-e7d4-4f62-be7b-8d065c72abe0,Osakidetza,osakidetza,,,,,, +9514,,75deecd4-0120-4b38-9781-98426c80bb59,"Gemin X Pharmaceuticals US, Inc",gemin_x_pharmaceuticals_us_inc,,,,,, +9515,,a04276bd-a025-4da4-8d91-888ddb9d35d0,GB Bietti Eye Foundation - IRCCS,gb_bietti_eye_foundation_irccs,,,,,, +410,0.960286,273912e1-1b32-44bf-9119-1caf84670781,ABOCA S.P.A. SOCIETà AGRICOLA,aboca_s_p_a_societ_agricola,,,,273912e1-1b32-44bf-9119-1caf84670781,aboca_s_p_a_societ_agricola,ABOCA S.P.A. SOCIETà AGRICOLA +9516,,13bb5684-af31-41d0-bcfe-e3c37d962927,"University of Würzburg, Internat. study-Coordinator",university_of_w_rzburg_internat_study_coordinator,,,,,, +9517,,9b04b66e-2af5-429d-a4a3-51bdc8263a82,BIOGEN IDEC LTD,biogen_idec_ltd,,,,,, +972,0.95330953598022461,4f0fa6e4-6773-4398-b96f-befbaf1b6648,"Schering Plough Research Institute, una División de Schering Corporation",schering_plough_research_institute_una_divisi_n_de_schering_corporation,,,,4f0fa6e4-6773-4398-b96f-befbaf1b6648,schering_plough_research_institute_una_divisi_n_de_schering_corporation,"Schering Plough Research Institute, una División de Schering Corporation" +9518,,d084f49e-8bca-4974-80a0-b40e4611faa4,Neolab Limited,neolab_limited,,,,,, +293,0.98027,812fe53e-1c93-4bf7-b221-e632d44ef1b0,"Janssen Cilag International, N.V. (Sponsor in European Union)",janssen_cilag_international_n_v_sponsor_in_european_union,,,,3c9f7dec-c696-4e53-bf14-5c014e7babdd,janssen_cilag_international,Janssen Cilag International +9519,,b264dfd8-ae72-4379-8916-5d79363e6aa1,ZLB Behring LLC,zlb_behring_llc,,,,,, +815,0.971143,c4a52fee-7141-11e6-a0cd-0242ac12000b,PLIVA,pliva,,,,5a3d9a2a-7159-11e6-a0cd-0242ac12000b,pliva_lachema,PLIVA LACHEMA +9520,,5bbcfcc7-ffdc-4564-b9a2-b8dad862c32c,Reino Pöyhiä,reino_p_yhi,,,,,, +9521,,5708614d-ba73-4de4-81cb-02465f206ccd,Pharmexa A/S,pharmexa_a_s,,,,,, +9522,,6e6f17e5-e9ab-4194-a464-0f5f50b5e5e6,"SkyePharma, Inc",skyepharma_inc,,,,,, +9523,,3304e616-0874-48b9-b1d7-006497db28f5,Zambon Group S.p.A,zambon_group_s_p_a,,,,,, +9524,,b23be708-7146-11e6-a0cd-0242ac12000b,BANNER PHARMACAPS,banner_pharmacaps,,,,,, +9525,,82062cc4-73e9-11e6-a0cd-0242ac12000b,GLAXO GRP ENGLAND,glaxo_grp_england,,,,,, +9526,,52b548ac-187d-4423-adc2-ce07d41bba7a,almirall,almirall,,,,,, +9527,,ccbe5a98-a44d-474e-b57b-5a33c8d6b0bb,University Hospital Linköping,university_hospital_link_ping,,,,,, +9528,,50f5812b-1725-4855-b0ea-9a89256df3bb,Concept Foundation,concept_foundation,,,,,, +483,0.933215,572941f2-e5d0-4699-91b4-8cbbbb8105bc,Groupe d'Etude des Lymphomes de l'Adulte(GELA),groupe_d_etude_des_lymphomes_de_l_adulte_gela,,,,4c50d4d9-2093-41e3-ac48-f701d16f0acc,groupe_d_etudes_des_lymphomes_de_l_adult,Groupe d'Etudes des Lymphomes de l'Adult +9529,,94e782c4-6e3c-49ef-b2f7-4fe7b11a6cda,Macarthys Laboratories Limited (trading as Martindale Pharma),macarthys_laboratories_limited_trading_as_martindale_pharma,,,,,, +597,0.979394,82f6db80-c06d-45dc-aedb-e850bc499707,Semmelweis University,semmelweis_university,,,,0bfd17f2-ec27-44b6-9dcf-b6e90369486a,semmelweis_university_department_of_ophthalmology,Semmelweis University Department of Ophthalmology +9530,,96e39e2f-97e3-429c-951e-6138b482b036,Groupe Français des myélodysplasies,groupe_fran_ais_des_my_lodysplasies,,,,,, +9531,,344fecc4-7167-11e6-a0cd-0242ac12000b,EDENBRIDGE PHARMS,edenbridge_pharms,,,,,, +9532,,61b661fa-81eb-46da-b060-04e77f8fca5a,UCB S.A. (Global Medical Affairs),ucb_s_a_global_medical_affairs,,,,,, +9533,,16531022-2537-4429-bdd7-c4569548c0fe,Evotec NeuroSciences GmbH,evotec_neurosciences_gmbh,,,,,, +9534,,cd768330-5705-4294-ae38-b7dc70336ead,Turun yliopistollinen keskussairaala,turun_yliopistollinen_keskussairaala,,,,,, +9535,,8cfe36cc-7168-11e6-a0cd-0242ac12000b,TARO PHARMA USA INC,taro_pharma_usa_inc,,,,,, +9536,,2f767c57-676f-4048-a45f-63e83a2c1638,"Uppsale University Hospital, MHT, Department of Nephrology",uppsale_university_hospital_mht_department_of_nephrology,,,,,, +9537,,d466529b-561f-4a1e-ab07-85bb5c36bc7e,Dirección General de Salud Pública, Conselleria de Sanidad de la Comunidad Valenciana,,,,,, +9538,,223f566e-6999-4fdb-8cfb-42000a7627c2,"University of Dundee, Tayside Clinical Trials Unit",university_of_dundee_tayside_clinical_trials_unit,,,,,, +9539,,18cc1c38-738d-49d5-a81e-0401c5706588,AstraZeneca GmbH,astrazeneca_gmbh,,,,,, +9540,,18fbab09-4498-4d78-b313-b5838d02d021,Grupo Español de Tumores Neuroendocrinos (GETNE),grupo_espa_ol_de_tumores_neuroendocrinos_getne,direcci_n_general_de_salud_p_blica_conselleria_de_sanidad_de_la_comunidad_valenciana,,,,, +726,0.987967,1b7f80c2-b4fd-41cd-875f-9db8a4bf35a2,Steno Diabetes Center,steno_diabetes_center,,,,1b7f80c2-b4fd-41cd-875f-9db8a4bf35a2,steno_diabetes_center,Steno Diabetes Center +9541,,2765524c-2b21-48c5-89c0-9a2f33bb8b38,Tampereen yliopistollinen sairaala,tampereen_yliopistollinen_sairaala,,,,,, +9542,,15e3b966-a188-490f-a25e-a98fdc581f6a,UNIVERSITA' DI GENOVA,universita_di_genova,,,,,, +302,0.977381,02f80d08-964f-4144-817a-07dd524f56fc,Janssen Biologics B.V. (formerly known as Centocor B.V.),janssen_biologics_b_v_formerly_known_as_centocor_b_v,,,,02f80d08-964f-4144-817a-07dd524f56fc,janssen_biologics_b_v_formerly_known_as_centocor_b_v,Janssen Biologics B.V. (formerly known as Centocor B.V.) +9543,,1d156db5-e8cc-4112-a6b7-870c36c8c010,Wyeth Pharmaceuticals B.V,wyeth_pharmaceuticals_b_v,,,,,, +9544,,9ae8b20c-fb2a-4c1d-86e6-9dab1e0260ac,TEVA ITALIA srl,teva_italia_srl,,,,,, +974,0.97182440757751465,41982735-d9d3-4f00-8742-ee8d1340f3f5,Universitätsklinikum Schleswig-Holstein (UK-SH),universit_tsklinikum_schleswig_holstein_uk_sh,,,,4cbb7e37-feeb-4dcf-a21f-ec40d4959c01,universit_tsklinikum_schleswig_holstein,Universitätsklinikum Schleswig-Holstein +9545,,09dee41c-719f-11e6-a0cd-0242ac12000b,HUNTINGTON LABS,huntington_labs,,,,,, +9546,,4da2c44c-9910-469e-a195-714ea33ef684,Advicenne Pharma,advicenne_pharma,,,,,, +9547,,66477e80-715e-11e6-a0cd-0242ac12000b,OPTOPICS,optopics,,,,,, +9548,,9e828a2c-8d35-4433-a6e2-3aa3a1bd973f,Fundación General de la Universidad de Valladolid,fundaci_n_general_de_la_universidad_de_valladolid,,,,,, +9549,,ad7aaa73-5eb4-4ab5-9ea7-e9b1bf349de4,Hôpital Erasme,h_pital_erasme,,,,,, +9550,,569d3fae-72b9-11e6-a0cd-0242ac12000b,EMERGENT,emergent,,,,,, +1047,0.985052,e0066c6d-1cfd-484d-92b2-512d3a66bf83,InnaVirVax SA,innavirvax_sa,,,,010d35da-5d47-4a0d-b01d-6b5b38df61c0,innavirvax,InnaVirVax +9551,,ded28536-2c6c-4faf-8148-9bd9ac800686,Active Biotech AB,active_biotech_ab,,,,,, +618,0.987151,8d9c4ced-2b24-426a-8a2e-4baf9f708c31,Belfast City Hospital,belfast_city_hospital,,,,3c1aae28-1aa7-461b-ae60-fe064393d484,belfast_city_hospital_trust,Belfast City Hospital Trust +9552,,196024ce-bb29-450d-bbc5-3a62700d0bce,"Melbourne Health, Royal Melbourne Hospital",melbourne_health_royal_melbourne_hospital,,,,,, +9553,,cbe41c4b-8a59-4bb4-90f8-b229d2f63fbe,John Pernow,john_pernow,,,,,, +9554,,bf90f070-fc98-47a4-97e0-7043c0001caf,Héctor Guiral Torner,h_ctor_guiral_torner,,,,,, +9555,,2b432d8b-58ed-40df-88db-d9604e5f1dbf,Azienda Ospedaliera L. Sacco - Clinica Pediatrica,azienda_ospedaliera_l_sacco_clinica_pediatrica,,,,,, +9556,,d6fc0468-201f-4baa-ae28-4728d0d53c47,Salford Royal Foundation NHS Trust,salford_royal_foundation_nhs_trust,,,,,, +322,0.98791098594665527,8960a541-aa35-4907-aafd-d0c2015c31a8,Tibotec Pharmaceuticals Limited,tibotec_pharmaceuticals_limited,,,,27185c1d-6e99-48fc-9d68-1530f804e15d,tibotec_pharmaceuticals_limited_ireland,Tibotec Pharmaceuticals Limited Ireland +9557,,2f51225c-8f75-4ab5-9d54-73d45157587e,Ranbaxy Laboratories Limited,ranbaxy_laboratories_limited,,,,,, +9558,,b16c9e1b-d7b7-4405-b454-44c798a699d1,Boehringer Ingelehim AB,boehringer_ingelehim_ab,,,,,, +1064,0.96204358339309692,5832b652-f280-4dd6-850d-477a81887563,Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge,cambridge_university_hospitals_nhs_foundation_trust_and_the_university_of_cambridge,,,,5832b652-f280-4dd6-850d-477a81887563,cambridge_university_hospitals_nhs_foundation_trust,Cambridge University Hospitals NHS Foundation Trust +9559,,0506fa26-06d0-45f4-9eb2-c1d161c0895f,"Department of Biomedical Engineering, Linköping University",department_of_biomedical_engineering_link_ping_university,,,,,, +9560,,4441656e-6fc2-11e6-abe8-0242ac12000b,Vifor Int,vifor_int,,,,,, +9561,,ac75d582-61da-4277-a102-70a172ee95d0,AstraZeneca Singapore Pte Ltd,astrazeneca_singapore_pte_ltd,,,,,, +9562,,d13a406a-6a12-4a3b-bd71-12c00b8701c7,South Tees Acute Hospitals NHS Trust,south_tees_acute_hospitals_nhs_trust,,,,,, +9563,,61667e5b-b739-4097-b469-ce5dc0efc2eb,Center for Research and Development Uppsala University/County Council of Gävleborg,center_for_research_and_development_uppsala_university_county_council_of_g_vleborg,,,,,, +9564,,eeb35e5c-9762-4cd9-bf0c-219906e1e299,University Federico II,university_federico_ii,,,,,, +9565,,8b385913-bfed-4b32-a665-08e61dbdb462,Universitair Psychiatrisch Centrum KU Leuven,universitair_psychiatrisch_centrum_ku_leuven,,,,,, +9566,,475e9f14-28f5-494a-8058-f28ba26b58c5,Oxford MioMedica UK Ltd,oxford_miomedica_uk_ltd,,,,,, +9567,,6291dd94-7145-11e6-a0cd-0242ac12000b,BASF,basf,,,,,, +178,0.914111,7c5d4e15-369d-4db5-afb8-39e9c999482d,Nottingham University,nottingham_university,,,,6cb03c75-a5d8-4c11-999f-9a0d26e68ba1,nottingham_univeristy_hospitals_nhs_trust,Nottingham Univeristy Hospitals NHS Trust +9568,,cc566aa4-3819-4e38-95d4-3628ff27380e,D2 Derma Europe Ltd,d2_derma_europe_ltd,,,,,, +9569,,4034a36c-f7b7-476d-b33f-8fccf043cb37,St Augustinus,st_augustinus,,,,,, +9570,,1d2687aa-4eed-4f8e-b767-828205bd3682,Dr catenacci fabrice/ quartier operatoire,dr_catenacci_fabrice_quartier_operatoire,,,,,, +699,0.984107,ee6fc2c6-06eb-4e2c-a3bd-cb730d04efaa,Bayer Pharmaceuticals Corporation,bayer_pharmaceuticals_corporation,,,,ea74ab29-48fb-4575-b97e-5d8ea891bdcb,bayer_pharmaceutical,Bayer Pharmaceutical +9571,,d4aca990-2e1c-4e0c-bb68-315bfaf181ad,"Argos Therapeutics, Inc",argos_therapeutics_inc,,,,,, +9572,,7da49b74-7147-11e6-a0cd-0242ac12000b,PRINSTON INC,prinston_inc,,,,,, +9573,,2e0f1559-1caf-4f89-886a-fe9f75270ff0,Centro Comunitario de Sangre y Tejidos de Asturias,centro_comunitario_de_sangre_y_tejidos_de_asturias,,,,,, +9574,,83254c19-4f45-482b-95ef-cb8ddfdcba80,Sogaisida,sogaisida,,,,,, +9575,,9f59542e-7158-11e6-a0cd-0242ac12000b,ANCHEN PHARMS,anchen_pharms,,,,,, +9576,,39191161-3a98-4b14-a226-f3e48c6546f5,NeurogesX Incorporated,neurogesx_incorporated,,,,,, +9577,,6a5b1362-1c36-41bb-a29b-7e72be6ec3d4,Laboratoires Genevrier,laboratoires_genevrier,,,,,, +9578,,f0aeff86-0130-4552-ac80-b2cd72a5eae1,"Avemedica, s.r.o",avemedica_s_r_o,,,,,, +9579,,76abaf60-4645-449c-b7fd-0bd9912d4a90,Goethe-Universität Frankfurt/Main,goethe_universit_t_frankfurt_main,,,,,, +809,0.98034405708312988,9aa84ae0-f050-4e53-93f9-888fa0e9a08e,Biogen,biogen,,,,9aa84ae0-f050-4e53-93f9-888fa0e9a08e,biogen,Biogen +9580,,95505616-706e-4636-903e-21a64cf31f8f,Spinifex Pharmaceuticals Pty Ltd,spinifex_pharmaceuticals_pty_ltd,,,,,, +9581,,d6489bf3-2940-48c1-bc69-d6c957ceb8fb,Diabetology Ltd,diabetology_ltd,,,,,, +9582,,a2a823f0-7a37-4e15-9331-94e42bbf57f0,Aintree University Hospitals NHS Foundation Trust,aintree_university_hospitals_nhs_foundation_trust,,,,,, +9583,,a62b3f07-8e12-44fb-952a-9253a1381ed6,Eli Lilly and Company Limitated,eli_lilly_and_company_limitated,,,,,, +9584,,eb4cc9e6-aaa6-49ad-995f-a9f72f3bdd5d,Merck KGaA,merck_kgaa,,,,,, +9585,,94046d4a-ea7c-4b6e-bfd0-eca9e50a3f31,Jens Sønksen,jens_s_nksen,,,,,, +9586,,b54e2478-ce96-4b76-9d06-280f216449eb,"University Medical Center St Radboud, department of neurology",university_medical_center_st_radboud_department_of_neurology,,,,,, +9587,,27eb2d5d-e3ab-4ac7-8553-43dbcf0d04f6,"PellePharm, Inc",pellepharm_inc,,,,,, +870,0.98798739910125732,a6e03f52-7103-4c50-9c9f-c0d332cccdf0,Astellas Pharma Europe BV,astellas_pharma_europe_bv,,,,483064d3-f8fd-47e0-a0a2-b17b8d5df7d6,astellas_pharma_europe_bv,Astellas Pharma Europe BV +9588,,372fcc63-9ff6-43b2-8e95-56d7f4e3285a,Follica Inc,follica_inc,,,,,, +9589,,e3145dac-d269-418d-b1a4-c07cf92127dc,SANOFI PASTEUR,sanofi_pasteur,,,,,, +9590,,72d53244-a399-4d59-804a-d56b0cc0cd79,TEVA Pharmaceuticals Europe,teva_pharmaceuticals_europe,,,,,, +264,0.969108,acee9ec2-ec12-49f7-944a-73fbd58820cf,University of Tromsø,university_of_troms,,,,4b85caa2-d172-4ab8-beaf-797c52a06782,university_or_troms,University or Tromsø +9591,,abfb88ae-29d0-4e85-a6e0-9f962431a862,"Kliniken für Anästhesiologie und op. Intensivmedizin, Charité – Universitätsmedizin Berlin, CVK/CCM",kliniken_f_r_an_sthesiologie_und_op_intensivmedizin_charit_universit_tsmedizin_berlin_cvk_ccm,,,,,, +9592,,8ed92949-98c5-47ab-b934-983a7070d141,"Faculty of Medicine, Technische Universität München",faculty_of_medicine_technische_universit_t_m_nchen,,,,,, +9593,,45fb2db5-1f17-4e6b-b565-c7376dcfb4c0,A.O. UNIVERSITARIA INTEGRATA DI VERONA,a_o_universitaria_integrata_di_verona,,,,,, +9594,,2eef2421-11d6-493f-8295-7373e18efc74,AnGes Inc,anges_inc,,,,,, +9595,,46acd9ce-715b-11e6-a0cd-0242ac12000b,YABAO PHARM,yabao_pharm,,,,,, +9596,,b8a92d14-0081-4632-b95d-105a960a34d2,IPSEN INNOVATION,ipsen_innovation,,,,,, +9597,,3fb0bc68-c3bd-4b08-8749-901aae643330,VVOG,vvog,,,,,, +9598,,10d29023-15e2-491d-8c99-00c63994492e,PrEP Biopharm Ltd,prep_biopharm_ltd,,,,,, +692,0.987725,6bd20d89-2d11-41e5-b083-1fa6028d5811,Furiex Pharmaceuticals,furiex_pharmaceuticals,,,,3896cef1-0043-4ce9-83b5-3668a99dacee,furiex_pharmaceuticals_inc,"Furiex Pharmaceuticals, Inc" +9599,,6fe568cc-9db1-4629-bfed-8e5c26248d63,Jan Stener Joergensen,jan_stener_joergensen,,,,,, +9600,,a723ae14-7146-11e6-a0cd-0242ac12000b,CATALENT,catalent,,,,,, +9601,,5f9a07f2-48eb-4616-8eff-43a8c980eda4,"Georg-August-Universität Göttingen, Bereich Humanmedizin",georg_august_universit_t_g_ttingen_bereich_humanmedizin,,,,,, +32,0.96428561210632324,8013f413-0613-4f61-a0a5-e7241cff8548,Technische Universität Dresden,technische_universit_t_dresden,,,,8013f413-0613-4f61-a0a5-e7241cff8548,technische_universit_t_dreden,Technische Universität Dreden +9602,,dcb7cb12-fc62-4d95-9152-0d4546deb238,Zentaris GmbH,zentaris_gmbh,,,,,, +9603,,5911e8a3-525b-4ff5-9334-7057bb100517,GENSIGHT-BIOLOGICS,gensight_biologics,,,,,, +9604,,9ad14e58-a323-4a47-8c43-b11faf4db010,Leyh Pharma GmbH,leyh_pharma_gmbh,,,,,, +9605,,878b966d-b386-4e48-afea-96d6ce217274,Vesa Kontinen,vesa_kontinen,,,,,, +9606,,77742330-b619-48d0-b299-f9f990618072,FRANCISCO JAVIER BELDA,francisco_javier_belda,,,,,, +9607,,780be6cb-e91a-44b3-983f-b748ef1cc09b,OMNIVISION,omnivision,,,,,, +836,0.98650866746902466,8b728024-8fd6-4d73-82c9-94fcbe26c730,NHS Greater Glasgow & Clyde R&D Office,nhs_greater_glasgow_clyde_r_d_office,,,,8b728024-8fd6-4d73-82c9-94fcbe26c730,nhs_greater_glasgow_clyde_r_d_office,NHS Greater Glasgow & Clyde R&D Office +9608,,e5c633eb-7b80-4afb-b6c2-d853afe1da6a,Berlin-Chemie AG,berlin_chemie_ag,,,,,, +9609,,f6888ad7-c599-4f92-a9b0-8d28a76d420a,Belpharma SA/NV,belpharma_sa_nv,,,,,, +9610,,3d6ade49-c992-4715-9594-000bd02e5eb1,"Free State of Bavaria, represented by the University of Regensburg, represented by Prof. Edward K. Geissler",free_state_of_bavaria_represented_by_the_university_of_regensburg_represented_by_prof_edward_k_geissler,,,,,, +9611,,209caf6e-c4cd-4b12-abc1-77a342ee0f95,University Hospital of Geneva,university_hospital_of_geneva,,,,,, +252,0.97737601399421692,082f7f0e-78b6-4cad-b635-beaee4333a89,Martin Luther University of Halle/Wittenberg,martin_luther_university_of_halle_wittenberg,,,,0f0d8991-097b-4737-a496-fd2e4d5aa3ff,martin_luther_university_of_halle_wittenberg,Martin Luther University of Halle/Wittenberg +9612,,840ab7f8-f749-48bf-89ea-89ae0df57f2f,Danish Pain Research Center,danish_pain_research_center,,,,,, +9613,,62e51393-07c9-453f-a630-dc493f0798c8,vicente soriano,vicente_soriano,,,,,, +135,0.982105,924e8e00-b603-4591-93dd-f562031d4d33,Procter and Gamble Pharmaceuticals,procter_and_gamble_pharmaceuticals,,,,0ae43754-1f42-4540-8952-a2c6dce4050c,procter_and_gamble,Procter and Gamble +9614,,4f46f0c6-2436-419c-80c0-db54d13265f1,Karolinska Hospital,karolinska_hospital,,,,,, +9615,,8dfbc7e9-9ae9-4703-9e95-2228ef1e9da5,Herlev hospital,herlev_hospital,,,,,, +9616,,db9e1718-7161-11e6-a0cd-0242ac12000b,SALIX PHARMS,salix_pharms,,,,,, +9617,,fb11cb06-2286-4e2f-8916-cf70a0beb822,"Esperion Therapeutics, Inc",esperion_therapeutics_inc,,,,,, +856,0.98001778125762939,66b401ea-5009-4db7-8b18-6fe29a2c6186,Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital,netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital,,,,66b401ea-5009-4db7-8b18-6fe29a2c6186,netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital,Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL) +9618,,a598f8f4-73dc-11e6-a0cd-0242ac12000b,GATOR PHARMA INC,gator_pharma_inc,,,,,, +9619,,f93e45d2-1cd7-4714-b82a-897d4cb0886b,Univeristy Hospital Schleswig-Holstein,univeristy_hospital_schleswig_holstein,,,,,, +9620,,de4f645a-75be-485a-8a85-a689868bcdb1,"Skåne University Hospital, Dept of Oncology",sk_ne_university_hospital_dept_of_oncology,,,,,, +9621,,a9effb14-e413-4ec3-805c-abadf7eddaff,BiogenIdec A/S,biogenidec_a_s,,,,,, +9622,,b0be6940-7147-11e6-a0cd-0242ac12000b,PIRAMAL ENT,piramal_ent,,,,,, +9623,,a1e7b13a-d54b-44e0-a548-ea1fc5c9af76,Hospital Universitario La Princesa,hospital_universitario_la_princesa,,,,,, +9624,,df616f2c-fa81-4960-9eba-2f35852cbbda,Verastem Inc,verastem_inc,,,,,, +9625,,9858ac12-e7da-42d8-b3da-bb6c49913f9b,ViraNative AB,viranative_ab,,,,,, +9626,,aeb29c7a-b5e7-423c-a380-768dab375691,CYTOCHEMIA AG,cytochemia_ag,,,,,, +9627,,9c6820c8-c20f-413e-bdbc-2e141a20cd18,AB ANALITICA SRL,ab_analitica_srl,,,,,, +369,0.968529,10a6a8cf-9c7f-4575-956a-94c3a4dacd53,DAIICHI SANKYO EUROPE GmbH,daiichi_sankyo_europe_gmbh,,,,054fbb2c-7228-11e6-a0cd-0242ac12000b,daiichi,DAIICHI +9628,,2cea9b46-d590-4536-9dee-03f5569091c5,Ambrilia Biopharma Inc,ambrilia_biopharma_inc,,,,,, +9629,,df18a281-bc26-48a9-8f15-8478c1c9f7aa,NATHURA SRL,nathura_srl,,,,,, +9630,,bd9ae5ef-055e-428e-ac04-35b441e8679a,"Nordsjællands Hospital, Department of Cardiology, Nephrology and Endocrinology",nordsj_llands_hospital_department_of_cardiology_nephrology_and_endocrinology,,,,,, +9631,,96924ad5-15d5-4cfb-8f8e-be0dc38d6a1d,"Rigshospitalet, Copenhagen University Hospitals",rigshospitalet_copenhagen_university_hospitals,,,,,, +9632,,eb9a53d3-bd77-4c6b-a351-77bb10974676,"ASOCIACION PARA LA INVESTIGACION Y TRATAMIENTO DE ENFERMEDADES RENALES (AITER),",asociacion_para_la_investigacion_y_tratamiento_de_enfermedades_renales_aiter,,,,,, +9633,,905625f8-d602-487c-b4ae-30a24dd4036d,FONDAZIONE NIBIT,fondazione_nibit,,,,,, +779,0.988892,bf76ac82-c2cb-490f-8a4b-46603ab679e7,"The Centre for Child and Adolescent Mental Health, Eastern and Southern",the_centre_for_child_and_adolescent_mental_health_eastern_and_southern,,,,bf76ac82-c2cb-490f-8a4b-46603ab679e7,the_centre_for_child_and_adolescent_mental_health_eastern_and_southern,"The Centre for Child and Adolescent Mental Health, Eastern and Southern" +9634,,74e87d4a-aca3-4110-a5c8-1b09c4258926,"Prim. Univ.Prof. Dr. Christian Pirich Department of Nuclear Medicine and Endocrinology, PMU Salzburg",prim_univ_prof_dr_christian_pirich_department_of_nuclear_medicine_and_endocrinology_pmu_salzburg,,,,,, +9635,,65eadf2d-e35f-4682-b7d8-dee6f1744192,Instituto Palacios,instituto_palacios,,,,,, +9636,,cd75cedf-4fe8-4a15-8a7a-a00d7586dfe8,G. L. Pharma GmbH,g_l_pharma_gmbh,,,,,, +1034,0.914544,d38892c3-fc12-46d4-bb7a-ffec3a5d4392,"Centre du Cancer, Cliniques universitaires Saint-Luc",centre_du_cancer_cliniques_universitaires_saint_luc,,,,2656ed3b-7c3f-4317-935a-59c30cccc2bc,centre_du_cancer_des_cliniques_universitaires_saint_luc,Centre du Cancer des Cliniques Universitaires Saint-Luc +9637,,f020eb53-8254-416f-9dc6-5f5f991bb7e8,Central European Society for Anticancer Drug Research - EWIV,central_european_society_for_anticancer_drug_research_ewiv,,,,,, +409,0.9891228973865509,bafd53c7-e832-4f6f-89c8-d8d0d9dcabe4,SCHWARZ BIOSCIENCES GmbH, A member of the UCB group,,,,bafd53c7-e832-4f6f-89c8-d8d0d9dcabe4,schwarz_biosciences,SCHWARZ BIOSCIENCES GmbH +9638,,ea6a4a49-3e8b-48ab-a513-2ed0034db8ec,QUALIPHAR NV,qualiphar_nv,,,,,, +9639,,bdf429b0-83ba-4be5-b9eb-476911fd2954,West Herts NHS Trust,west_herts_nhs_trust,,,,,, +9640,,a7484733-7bcc-4f40-85e9-881874ec80e7,Azienda Ospedaliera Ospedali Riuniti Marche Nord,azienda_ospedaliera_ospedali_riuniti_marche_nord,schwarz_biosciences_gmbh_a_member_of_the_ucb_group,,,,, +504,0.91995066404342651,fe66a00b-c1eb-4074-bd88-e4edfe94bca5,Sanofi-Synthelabo AB,sanofi_synthelabo_ab,,,,122b0a51-3453-4c2b-9161-369319d68912,sanofi_synthelabo_recherche_a_subsidiary_of_sanofi_aventis_group,"Sanofi-Synthelabo Recherche, a subsidiary of sanofi-aventis group" +9641,,335bb08b-3c27-4e44-bf00-5773605319a7,Janssen-Cilag EMEA Medical Affairs,janssen_cilag_emea_medical_affairs,,,,,, +100,0.94407099485397339,3f816051-0ebf-47a9-b4f1-e129cf8f1167,Department of Anesthesiology and Intensive Care Medicine,department_of_anesthesiology_and_intensive_care_medicine,,,,3f816051-0ebf-47a9-b4f1-e129cf8f1167,department_of_anesthesiology_and_intensive_care_medicine,Department of Anesthesiology and Intensive Care Medicine +9642,,77db9cd6-7167-11e6-a0cd-0242ac12000b,ETHYPHARM USA CORP,ethypharm_usa_corp,,,,,, +94,0.96576917171478271,85d2f332-7335-11e6-a0cd-0242ac12000b,JAZZ,jazz,,,,49d3c978-7273-11e6-a0cd-0242ac12000b,jazz_pharms,JAZZ PHARMS +9643,,66c8c87b-5af2-418b-8c5b-4a11e86ef8d5,"J.Uriach y Compania S.A.,",j_uriach_y_compania_s_a,,,,,, +623,0.985931,7ed460db-1719-4dbb-9771-91840f0b465b,Klinikum der Universität Regensburg,klinikum_der_universit_t_regensburg,,,,4036d0e2-54dc-41a1-ab42-721775d200c4,klinikum_der_universit_t,Klinikum der Universität +9644,,775ce675-3dfc-4c5a-8a3f-ac873cdc82d6,Bionorica research GmbH,bionorica_research_gmbh,,,,,, +9645,,89e20de0-17bc-4d74-ac0e-f7cc1c17c107,Celladon Corporation,celladon_corporation,,,,,, +9646,,be990399-0840-46ac-bff6-b382e09dabac,OPKO Biologics Ltd,opko_biologics_ltd,,,,,, +9647,,1aea7069-17fc-4a7b-9e07-76025abe2244,Gastrotech Pharma A/S,gastrotech_pharma_a_s,,,,,, +9648,,92980fb5-a359-4b81-9f35-62a344af619f,"Pfizer Ltd - Ramsgate Road, Sandwich CT139NJ, UK",pfizer_ltd_ramsgate_road_sandwich_ct139nj_uk,,,,,, +9649,,c6b908a4-c89f-4749-8a62-8d6b7323d2c9,GRUPO ESPAÑOL DE NEUROONCOLOGIA MEDICA,grupo_espa_ol_de_neurooncologia_medica,,,,,, +9650,,0d793ae6-6898-46bf-a39c-792be612d973,Frimley Park Hospital NHS Foundation Trust,frimley_park_hospital_nhs_foundation_trust,,,,,, +9651,,d8334a93-2663-48e6-8c4f-90ed90490a7c,HELP Pharmaceuticals SA,help_pharmaceuticals_sa,,,,,, +9652,,6e7bb9bd-80fd-4a86-ada2-3acc736fe099,SCHERING,schering,,,,,, +189,0.989095,bc125259-5786-474e-8cb4-6e4a490b6253,Grupo Español de Tumores Huérfanos e Infrecuentes,grupo_espa_ol_de_tumores_hu_rfanos_e_infrecuentes,,,,9bfb7a20-2bce-4c76-8f13-53216dbb6f59,grupo_espa_ol_de_tumores_hu_rfanos_e_infrecuentes_gethi,Grupo Español de Tumores Huérfanos e Infrecuentes (GETHI) +904,0.943406,a017bdc5-4a8a-48c3-ab48-5b1db4f8ed6e,Novo Nordisk AS,novo_nordisk_as,,,,a017bdc5-4a8a-48c3-ab48-5b1db4f8ed6e,novo_nordisk_as,Novo Nordisk AS +9653,,0111157a-0285-47e0-abad-81898eb43c0b,UF de méthodologie en recherche clinique,uf_de_m_thodologie_en_recherche_clinique,,,,,, +9654,,191a4121-096e-489f-bb60-9d9e340fdcf0,Cardiff Univeristy,cardiff_univeristy,,,,,, +9655,,a8fa92e7-f6e9-4a5d-837b-b07c1be23c4c,Action Pharma A/S,action_pharma_a_s,,,,,, +9656,,a85833c5-c653-4c38-8924-16d7a8af3d7e,CONSORCI SANITARI DEL MARESME,consorci_sanitari_del_maresme,,,,,, +9657,,064eee72-a860-4165-a4a4-0e72f1b98a5c,University medical center Ljubljana,university_medical_center_ljubljana,,,,,, +9658,,ac4954ed-b836-4a52-aa6b-db3f3bbf60e9,University of Kuopio,university_of_kuopio,,,,,, +9659,,1d43d854-a7cb-4f69-ac01-5cb98e03310b,"Friedrich-Schiller University Jena, Clinic for Internal Medicine I",friedrich_schiller_university_jena_clinic_for_internal_medicine_i,,,,,, +9660,,e70b616f-c716-415d-8bd2-327f2e186d38,Vejle Sygehus,vejle_sygehus,,,,,, +9661,,e9d0f562-4e1b-483c-80dc-d88a390db3bd,acep,acep,,,,,, +9662,,24c8f635-e86d-40ea-925a-1e483e3b57a8,FONDAZIONE DEL PIEMONTE PER L'ONCOLOGIA IRCC DI CANDIOLO,fondazione_del_piemonte_per_l_oncologia_ircc_di_candiolo,,,,,, +9663,,4617fb6f-7d08-4f1e-9387-03febb5a1768,Medizinische Universität Innsbruck - Universitätsklinik für Innere Medizin III,medizinische_universit_t_innsbruck_universit_tsklinik_f_r_innere_medizin_iii,,,,,, +937,0.975369,2ff28a2a-72bf-11e6-a0cd-0242ac12000b,CUBIST,cubist,,,,2ff28a2a-72bf-11e6-a0cd-0242ac12000b,cubist,CUBIST +9664,,29ab58b6-85b0-47a5-924a-b054bbc22c8b,Institut Recherches Internationales Servier,institut_recherches_internationales_servier,,,,,, +9665,,ae896904-1a98-4956-accb-3e772c574985,"Dept of Endocrinology, Odense University Hospital",dept_of_endocrinology_odense_university_hospital,,,,,, +242,0.985891,ee545156-715c-11e6-a0cd-0242ac12000b,CYPRESS PHARM,cypress_pharm,,,,a3937fbe-7163-11e6-a0cd-0242ac12000b,cypress_pharm_inc,CYPRESS PHARM INC +468,0.987296,2ba84e9e-880b-11e6-a998-0242ac12000b,Targovax ASA,targovax_asa,,,,055d2f79-6382-44aa-9acf-84a8274892de,targovax_as,Targovax AS +9666,,27a96238-38c8-4f96-8520-0eebc9188648,Schülke & Mayr GmbH,sch_lke_mayr_gmbh,,,,,, +9667,,22fc5689-b4d5-4c6a-9358-e13af9314b13,AnaMar AB,anamar_ab,,,,,, +9668,,b2545371-bb5b-4ee9-ab6d-cd78e68fbdd9,"Immunomedics, Inc",immunomedics_inc,,,,,, +698,0.98415160179138184,e810eb5b-fc4c-4026-ac5e-5b9c63a6d7f7,"Bayer Healthcare AG, Leverkusen",bayer_healthcare_ag_leverkusen,,,,72b9ca0e-fa0c-4c39-a503-2b0b6467415c,bayer_healthcare_ag,Bayer Healthcare AG +107,0.950967,886dbcfd-131f-4dde-b49f-376738e72b32,FONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E DELLA CURA DEI TUMORI,fondazione_michelangelo_avanzamento_dello_studio_e_della_cura_dei_tumori,,,,63b03e43-7f22-494c-8b54-c8682235d858,fondazione_michelangelo_avanzamento_dello_studio_e_cura_dei_tumori,FONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI +9669,,8aa4aa33-dbe6-4afd-a18d-194ec2deb698,RHEACELL GmbH & Co. KG,rheacell_gmbh_co_kg,,,,,, +9670,,573e3855-74d9-43b7-b295-ca548312e5af,Royal Cornwall Hospitals NHS Trust,royal_cornwall_hospitals_nhs_trust,,,,,, +9671,,1a5f0061-23fb-4125-85a4-706b265df7a8,Grunenthal GmbH,grunenthal_gmbh,,,,,, +9672,,66326c09-331f-40e1-825a-0ff9c481755b,Perrigo Israel Pharmaceuticals Ltd,perrigo_israel_pharmaceuticals_ltd,,,,,, +9673,,283f91dc-84f3-4ff2-b0df-184ff6e49a6a,Ana M. Wägner,ana_m_w_gner,,,,,, +12,0.988363,43a29514-7df4-4ef9-8c2e-fd420fdb7e20,University Medical Center Utrecht,university_medical_center_utrecht,,,,43a29514-7df4-4ef9-8c2e-fd420fdb7e20,university_medical_center_utrecht,University Medical Center Utrecht +9674,,ba386c86-ddf6-45bb-91db-668619bb0bda,AstraZeneca S.A.S,astrazeneca_s_a_s,,,,,, +9675,,97f181b3-9ad4-48ad-a41d-0342ef33b8c0,Radboud umc,radboud_umc,,,,,, +246,0.9320218563079834,61627f3e-faae-4a11-a8b0-c9cb74d0f17b,"Guys' and St Thomas' NHS Foundation Trust, Joint Clinical Trials Office",guys_and_st_thomas_nhs_foundation_trust_joint_clinical_trials_office,,,,5087f699-7133-45f6-90c4-97f11a55ecf1,guys_and_st_thomas_nhs_foudation_trust,Guys and St Thomas' NHS Foudation Trust +9676,,b9b447c3-500a-434f-acef-ecef3ebdfbc4,BioMarin Nederland BV,biomarin_nederland_bv,,,,,, +270,0.94358396530151367,b9740d19-9951-4510-b985-aa689195ab5f,AstraZeneca AS,astrazeneca_as,,,,b9740d19-9951-4510-b985-aa689195ab5f,astrazeneca_ab,AstraZeneca AB +9677,,9fbfeda9-0836-4ab9-9562-9aad825f1f01,Royal Group Hospitals,royal_group_hospitals,,,,,, +9678,,e1e19cc6-5fa1-4706-8259-bf1a2eaa8672,HAL Allergy BV,hal_allergy_bv,,,,,, +9679,,356e95b2-7142-11e6-a0cd-0242ac12000b,AM ANTIBIOTICS,am_antibiotics,,,,,, +9680,,8b823b2d-aea9-4dcf-aafb-1f78bc3c6a2c,Institut de Recherches Internationales de Servier,institut_de_recherches_internationales_de_servier,,,,,, +9681,,906b84bc-1a9f-46d6-bf64-9b4a4d80be25,GlaxoSmithkine Research and Development Ltd,glaxosmithkine_research_and_development_ltd,,,,,, +9682,,7a185a57-fabc-4dbb-9249-31bf821db930,Roche Pharma (Schweiz) AG,roche_pharma_schweiz_ag,,,,,, +769,0.97620436549186707,5d0fa8cc-033b-4776-b630-696f4b766931,GELTAMO (Grupo Cooperativo Español de Linfoma/Trasplante Autólogo de Médula Ósea),geltamo_grupo_cooperativo_espa_ol_de_linfoma_trasplante_aut_logo_de_m_dula_sea,,,,06287ea9-1e30-49c5-af4a-558dc91625a2,geltamo_grupo_cooperativo_espa_ol_de_linfoma_trasplante_aut_logo_de_m_dula_sea,GELTAMO (Grupo Cooperativo Español de Linfoma/Trasplante Autólogo de Médula Ósea) +9683,,c07a482c-8b97-4e13-a276-458c49fbaf45,Sinoxa Pharma GmbH,sinoxa_pharma_gmbh,,,,,, +9684,,2e2e55a6-147a-4980-9af5-ef2dc4420347,EpiTan Limited,epitan_limited,,,,,, +9685,,d70c9d05-706d-4aa7-af09-53dc52a3239b,Royal Devon and Exeter NHS Foundation Trust,royal_devon_and_exeter_nhs_foundation_trust,,,,,, +9686,,b22383a9-4a46-4e0e-937e-6a9066f3e210,FIBHULP,fibhulp,,,,,, +660,0.984864,c7d7080c-7166-11e6-a0cd-0242ac12000b,LARKEN LABS INC,larken_labs_inc,,,,1984b48c-7145-11e6-a0cd-0242ac12000b,larken_labs,LARKEN LABS +9687,,f83df11a-036f-4eca-80e1-2076323401b0,Relypsa Inc,relypsa_inc,,,,,, +557,0.973471,943dc7fd-4950-44aa-a140-b1ce0165b980,SERVICIO DE PSIQUIATRIA. HOSPITAL UNIVERSITARI VALL DE HEBRON,servicio_de_psiquiatria_hospital_universitari_vall_de_hebron,,,,943dc7fd-4950-44aa-a140-b1ce0165b980,servicio_de_psiquiatria_hospital_universitari_vall_de_hebron,SERVICIO DE PSIQUIATRIA. HOSPITAL UNIVERSITARI VALL DE HEBRON +270,0.96273654699325562,eb1ea511-941d-4821-bbff-4696ae7fca4c,AstraZeneca AB,astrazeneca_ab,,,,b9740d19-9951-4510-b985-aa689195ab5f,astrazeneca_ab,AstraZeneca AB +9688,,f688e477-33cd-4b6e-8e13-b894d09478e9,EPOPLUS GmbH & Co.KG,epoplus_gmbh_co_kg,,,,,, +9689,,d57b3021-e923-46a5-8718-f008d6d26a2d,Boehringer Ingelheim (Canada) Ltd/Ltée,boehringer_ingelheim_canada_ltd_lt_e,,,,,, +9690,,76b98500-b61c-4e7c-a91a-8b0b9ac27e6a,Dekan of Faculty of Medicine of Goethe-University Frankfurt,dekan_of_faculty_of_medicine_of_goethe_university_frankfurt,,,,,, +9691,,2317fb78-73f0-11e6-a0cd-0242ac12000b,NORCO INC,norco_inc,,,,,, +9692,,4004453e-8779-47ae-8b6c-99524135c578,Johanna Laukkarinen,johanna_laukkarinen,,,,,, +9693,,3f641671-cdd4-49b9-a838-0016bd1a2562,Hoffmann-La Roche Inc,hoffmann_la_roche_inc,,,,,, +9694,,8efd58a8-cee2-4c0b-814a-d0c904f15daa,GE Healthcare Limited (previously known as Amersham plc) and its Amersham Health affiliates,ge_healthcare_limited_previously_known_as_amersham_plc_and_its_amersham_health_affiliates,,,,,, +9695,,a4fd4f24-7255-4175-b9ce-916dba0f9161,Cantacuzino National Institute of Research and Development for Microbiology and Immunology,cantacuzino_national_institute_of_research_and_development_for_microbiology_and_immunology,,,,,, +9696,,1de2cdb3-8213-43b2-9270-f9bcb61cf273,SANOFI PASTEUR INTERNATIONAL,sanofi_pasteur_international,,,,,, +9697,,9371d8fb-2135-4dd1-883c-646505c49b28,Finnish Defence Forces,finnish_defence_forces,,,,,, +9698,,4a14794c-2667-4d73-87b0-6fcdd5585d54,ANRS (Agence Nationale de Recherche sur le SIDA et les hépatites virales),anrs_agence_nationale_de_recherche_sur_le_sida_et_les_h_patites_virales,,,,,, +9699,,5ccce7e7-6cb7-453f-a547-420b60281007,Mikko Pitkänen,mikko_pitk_nen,,,,,, +9700,,34323e04-7167-11e6-a0cd-0242ac12000b,SHANGHAI HENGRUI,shanghai_hengrui,,,,,, +9701,,2c578bd4-7264-4857-a2fb-f11717aec3c2,DermaGen AB,dermagen_ab,,,,,, +591,0.981797,de723fba-5285-49b8-b510-e70480f89485,Genzyme Corporation,genzyme_corporation,,,,028fff30-1193-4fcf-bcc7-abb85c227761,genzyme_corporation_a_sanofi_company,"Genzyme Corporation, a Sanofi company" +9702,,b041cb5c-5e1a-4cb4-b876-d90afc03cd19,3M ITALIA,3m_italia,,,,,, +9703,,3278ff69-f299-4589-84c3-ce98f7bf6224,"Direction de la recherche clinique du centre hospitalier universitaire de Tours, Bretonneau",direction_de_la_recherche_clinique_du_centre_hospitalier_universitaire_de_tours_bretonneau,,,,,, +9704,,d2a029b9-fd73-44e7-a614-0b42950a32aa,Azellon Ltd,azellon_ltd,,,,,, +9705,,de1efa33-6531-4c8a-bb1a-8a2d1a08feff,"AMAG Pharmaceuticals, Inc",amag_pharmaceuticals_inc,,,,,, +1039,0.97356534004211426,34050438-2ab9-4f3c-ad8e-1d5dea845aa7,Celgene International II Sarl (CIS II),celgene_international_ii_sarl_cis_ii,,,,34050438-2ab9-4f3c-ad8e-1d5dea845aa7,celgene_international_ii_sarl_cis_ii,Celgene International II Sarl (CIS II) +89,0.984864,246b37c8-715d-11e6-a0cd-0242ac12000b,MATRIX LABS,matrix_labs,,,,246b37c8-715d-11e6-a0cd-0242ac12000b,matrix_labs,MATRIX LABS +523,0.983968,32be795e-a544-49ea-9655-1702405333a9,Martin-Luther-University,martin_luther_university,,,,32be795e-a544-49ea-9655-1702405333a9,martin_luther_university,Martin-Luther-University +9706,,42502415-3c95-4e92-bb65-9bb61208cbb9,Recip AB,recip_ab,,,,,, +9707,,8f06244c-83fb-4cc3-82bd-e8252ebd3481,"Internal Medicine IV, Mecdical University of Vienna",internal_medicine_iv_mecdical_university_of_vienna,,,,,, +9708,,f3ac5e9b-5554-4756-9fde-18e11ca41d8c,Aino Ruohola,aino_ruohola,,,,,, +9709,,f7608500-166d-444f-8468-1a8c78608334,Professor Jørgen B. Dahl,professor_j_rgen_b_dahl,,,,,, +976,0.986562,f724c840-71b8-11e6-a0cd-0242ac12000b,PURDUE PHARMA LP,purdue_pharma_lp,,,,1819b794-72dc-11e6-a0cd-0242ac12000b,purdue_pharma,PURDUE PHARMA +9710,,44fc586a-a248-4e10-9528-78a3e8e2a4e0,TNO.Netherlands Organization for Applied Scientific Research,tno_netherlands_organization_for_applied_scientific_research,,,,,, +9711,,6e321fe5-cb59-425f-b385-1bb37971f491,VAS - Vascular Independent Research and Education European Organization,vas_vascular_independent_research_and_education_european_organization,,,,,, +9712,,ed68fbe1-0b63-4008-ac48-1e18ae1a3ce2,Institute of Obstetrics and Gynaecology Trust,institute_of_obstetrics_and_gynaecology_trust,,,,,, +9713,,6ed05fc5-f3cf-4554-8b1f-849aaf239cdc,C.H.U de Clermont Ferrand,c_h_u_de_clermont_ferrand,,,,,, +9714,,716f97ad-aa9c-42ff-8f64-4ece66fb1e62,BioXell SpA,bioxell_spa,,,,,, +37,0.986414,0c4d19b0-fc13-4125-ae65-0aea3b77572e,University of Liverpool,university_of_liverpool,,,,0c4d19b0-fc13-4125-ae65-0aea3b77572e,university_of_liverpool,University of Liverpool +68,0.933464,f4632456-0ebd-4b59-bb82-9b896f72960c,Medtronic Inc,medtronic_inc,,,,9ba1f3da-ec16-443c-baaf-efec93f1ac9e,medtronic_international_trading,Medtronic International Trading +9715,,9fcc5abf-05dd-4475-aab2-703deccf4a45,INSTITUTO DE ESTUDIOS DEL SISTEMA NERVIOSO,instituto_de_estudios_del_sistema_nervioso,,,,,, +9716,,ec46c526-0473-4399-8f5b-1a167955cd4b,Santaris Pharma,santaris_pharma,,,,,, +128,0.98614925146102905,07d5f348-7142-11e6-a0cd-0242ac12000b,PHARMACHEMIE BV,pharmachemie_bv,,,,07d5f348-7142-11e6-a0cd-0242ac12000b,pharmachemie_bv,PHARMACHEMIE BV +9717,,b00c6dae-4257-42c5-ab51-9f6cb22d9d5b,"Dr. Xavier Serra Aracil, Corporació Sanitaria Parc Taulí",dr_xavier_serra_aracil_corporaci_sanitaria_parc_taul,,,,,, +9718,,f3b5e628-b6df-4baa-a91a-55a609ee34fb,ZKES GmbH,zkes_gmbh,,,,,, +9719,,359c8f92-c0f6-4d11-aeb4-b5cbc93eae16,Vaxon Biotech,vaxon_biotech,,,,,, +9720,,4f792a50-7a67-4de2-9fe4-647a91ecdb94,"Med. Univ. Wien, UK für Kinder und Jugendheilkunde",med_univ_wien_uk_f_r_kinder_und_jugendheilkunde,,,,,, +9721,,06e41fe6-bbf3-4b9a-a054-d7192062e04b,BIONOMICS LIMITED,bionomics_limited,,,,,, +9722,,7d21ba12-73c6-442c-a1da-0f0f4c3f2e4f,"Regeneron Pharmaceuticals, Inc",regeneron_pharmaceuticals_inc,,,,,, +9723,,cce3bfdc-a2fe-473a-9361-92c912959090,Vorstand des Klinikums der Universität München - Grosshadern,vorstand_des_klinikums_der_universit_t_m_nchen_grosshadern,,,,,, +74,0.972986,e066773d-729f-4bf9-9a48-d1369cf2ce47,Faculdade de Ciências Médicas – Universidade Nova de Lisboa,faculdade_de_ci_ncias_m_dicas_universidade_nova_de_lisboa,,,,53160446-62a1-4898-b8c2-2d60eb490bf9,faculdade_de_ci_ncias_m_dicas_da_universidade_nova_de_lisboa,Faculdade de Ciências Médicas da Universidade Nova de Lisboa +9724,,2d664162-cac8-4010-9098-8effb21c1f09,Dr Calleja Panero,dr_calleja_panero,,,,,, +9725,,e000c630-936e-4f5f-b7a8-1352efa87119,GGZ Drenthe,ggz_drenthe,,,,,, +9726,,3e479bde-7165-11e6-a0cd-0242ac12000b,INDOCO REMEDIES,indoco_remedies,,,,,, +9727,,30b482c5-ad53-4418-9525-3d717108077f,Køge Sygehus,k_ge_sygehus,,,,,, +9728,,37fc808c-9002-4e5e-aaca-fde35df92b1c,ZonMW GGG,zonmw_ggg,,,,,, +9729,,9be42dec-71c5-11e6-a0cd-0242ac12000b,GRIFFEN,griffen,,,,,, +9730,,2120825c-a1b3-4730-83de-15e2cef15f99,Juhani Ruutiainen,juhani_ruutiainen,,,,,, +9731,,6c0fdab8-7754-4a18-a2d3-29e632105efe,Fundació Instituto de Investigación Biomédica de Bellvitge (Fundació IDIBELL),fundaci_instituto_de_investigaci_n_biom_dica_de_bellvitge_fundaci_idibell,,,,,, +9732,,a5663ced-1560-49f9-889c-44b649c03fa2,Royal Victoria Hospital Belfast,royal_victoria_hospital_belfast,,,,,, +691,0.958341,50516837-326b-48de-a8b3-7a6009366d95,Light Science Oncology Inc,light_science_oncology_inc,,,,23401987-1f18-4798-a823-501b1b0edbf5,light_sciences_oncology_inc,Light Sciences Oncology Inc +9733,,39bfd973-9d9c-419f-81eb-58c4ccc78cef,International Centre for Therapeutic Research (for Spain),international_centre_for_therapeutic_research_for_spain,,,,,, +926,0.985988,88016fef-c8a1-4819-8a74-7ce3949b23db,"Haukeland University Hospital, Helse Bergen",haukeland_university_hospital_helse_bergen,,,,634e757f-8ba8-4364-ad56-f51636b9ab94,haukeland_university_hospital,Haukeland University Hospital +9734,,a7edef46-a07e-4a88-98f5-341611b408ae,Neurochlore,neurochlore,,,,,, +970,0.987506,2899c14b-e123-4b6f-9261-bca58e778c63,Academic Medical Centre,academic_medical_centre,,,,2899c14b-e123-4b6f-9261-bca58e778c63,academic_medical_centre,Academic Medical Centre +9735,,fa37fd06-b2d1-45b6-9c3e-3e4af59bce22,Uppsala University Children´s Hospital,uppsala_university_children_s_hospital,,,,,, +9736,,54fa17bc-eeb9-4dbb-9771-e5db88d3a670,"(OSI) Eyetech Pharmaceuticals, Inc",osi_eyetech_pharmaceuticals_inc,,,,,, +63,0.983835,01a1f7f6-8bc3-11e6-a449-0242ac12000b,Clínica Universidad de Navarra,cl_nica_universidad_de_navarra,,,,01a1f7f6-8bc3-11e6-a449-0242ac12000b,cl_nica_universidad_de_navarra,Clínica Universidad de Navarra +9737,,4c146876-fddf-4753-b75d-7265d7f9ab62,"Med. Univ. Wien, Univ. Klinik für Dermatologie",med_univ_wien_univ_klinik_f_r_dermatologie,,,,,, +734,0.980666,78a71c0c-715e-11e6-a0cd-0242ac12000b,WEST WARD,west_ward,,,,78a71c0c-715e-11e6-a0cd-0242ac12000b,west_ward,WEST WARD +577,0.97058257460594177,f83c989d-f6d7-40b7-9bc2-b1c20f1e0644,"Wyeth Pharmaceuticals France, Wyeth Research Division",wyeth_pharmaceuticals_france_wyeth_research_division,,,,e9abaf6d-ebc5-432c-be97-f7a5c26bd3f9,wyeth_pharmaceuticals_france_wyeth_research_division,"Wyeth Pharmaceuticals France, Wyeth Research Division" +9738,,e5d42c88-46a1-41cc-b998-0604c9e95a48,GENTIUM,gentium,,,,,, +9739,,257319f9-e116-4c72-bae2-91a516b9a165,"Bispebjerg Hospital, Respiratory and Allergy Research Unit",bispebjerg_hospital_respiratory_and_allergy_research_unit,,,,,, +930,0.97669827938079834,5e914e51-02f2-4d61-8fbe-b47e6c9f4cc6,"Pierre Fabre Ibérica, S.A",pierre_fabre_ib_rica_s_a,,,,108222e4-8b5a-4716-a3aa-cd9eb69305b4,pierre_fabre_ib_rica_s_a_en_representaci_n_de_pierre_fabre_m_dicament,"Pierre Fabre Ibérica, S.A. en representación de Pierre Fabre Mèdicament" +9740,,1c03edad-e1af-4e81-991a-b937d00604da,Takeda Europe R&D Centre Ltd. (TEuR&D),takeda_europe_r_d_centre_ltd_teur_d,,,,,, +9741,,7d613daa-2713-41a5-a42e-5fc07568681c,"MERCK & CO., INC",merck_amp_co_inc,,,,,, +9742,,1d79ff36-7975-4694-a9e1-1ac630793787,"& Johnson Pharmaceutical Research & Development, L.L.C",johnson_pharmaceutical_research_development_l_l_c,,,,,, +9743,,424d1bf0-2d54-47c3-ab3d-6e2cc631875b,SU/Mölndal Sjukhus,su_m_lndal_sjukhus,,,,,, +9744,,7fbf5e54-8bdb-11e6-a449-0242ac12000b,Region Jönköpings län,region_j_nk_pings_l_n,,,,,, +9745,,c7d92add-5476-47de-850f-892831761df9,The Eye Hospital Rotterdam,the_eye_hospital_rotterdam,,,,,, +9746,,dc386eb1-5f81-4637-a241-83154e8d88d1,"TEVA WOMEN'S HEALTH RESEARCH&DEVELOPMENT, A DIVISION OF TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC",teva_women_s_health_research_development_a_division_of_teva_branded_pharmaceutical_products_r_d_inc,,,,,, +962,0.97408080101013184,0db9909a-d59f-42e0-9159-2ecff62910d4,Hull and East Yorkshire Hospital Trust,hull_and_east_yorkshire_hospital_trust,,,,0db9909a-d59f-42e0-9159-2ecff62910d4,hull_and_east_yorkshire_hospital_trust,Hull and East Yorkshire Hospital Trust +9747,,7481a9f8-7145-11e6-a0cd-0242ac12000b,SCHERER RP,scherer_rp,,,,,, +9748,,f1cb8710-9d35-4fdb-934d-fa00861bdcaf,ViroDefense Inc,virodefense_inc,,,,,, +9749,,27efafca-96b0-4bc9-8ae4-91c1bdfd0d2d,Serendex Pharmaceuticals A/S,serendex_pharmaceuticals_a_s,,,,,, +110,0.97055983543395996,8e245501-d374-45b9-8cc1-1e8c3d9845c0,"Department of Oncology, Karolinska University Hospital",department_of_oncology_karolinska_university_hospital,,,,7ab0aad4-ccd7-43a6-abf8-e331125b5500,department_of_oncology_karolinska,Department of Oncology +508,0.980232,3f98bb64-87e2-43ad-bc25-60a24eb40e13,Pfizer S.A,pfizer_s_a,,,,3f98bb64-87e2-43ad-bc25-60a24eb40e13,pfizer_s_a,Pfizer S.A +465,0.97570099433263147,7e43e6a1-03e0-4710-9b92-3a2e4559f085,Leiden University Medical Center,leiden_university_medical_center,,,,2e4a0d21-5259-4b26-b5dd-ed587c02073f,leiden_university,Leiden University +501,0.941946,a78cea43-1e59-43c5-89f4-6475172d24f1,Medizinische Fakultät der Otto von Guericke Universität Magdeburg,medizinische_fakult_t_der_otto_von_guericke_universit_t_magdeburg,,,,51817147-4fe9-46e4-8642-703081f3e636,medizinische_fakult_t_otto_von_guericke_universit_t,Medizinische Fakultät. Otto von Guericke Universität +9750,,44d61a7a-7160-11e6-a0cd-0242ac12000b,BH,bh,,,,,, +9751,,6705babf-2f8e-4046-85a3-e8dd8a97f6ae,Jordi Carratalá,jordi_carratal,,,,,, +9752,,1c3e8157-eb84-49ed-878f-2270dda776c5,Grupo Oncopaz y Hospitales Asociados,grupo_oncopaz_y_hospitales_asociados,,,,,, +9753,,95ce2941-e254-4799-ad89-f6309529be06,The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),the_eunice_kennedy_shriver_national_institute_of_child_health_and_human_development_nichd,,,,,, +9754,,8111cfbc-53da-4e80-adbe-2819f14c3de0,The European group for Blood and Marrow Transplantation (EBMT),the_european_group_for_blood_and_marrow_transplantation_ebmt,,,,,, +769,0.95718833804130554,06287ea9-1e30-49c5-af4a-558dc91625a2,GEL/TAMO (Grupo Cooperativo Español de Linfoma/Transplante Antólogo de Médula Ósea),gel_tamo_grupo_cooperativo_espa_ol_de_linfoma_transplante_ant_logo_de_m_dula_sea,,,,06287ea9-1e30-49c5-af4a-558dc91625a2,geltamo_grupo_cooperativo_espa_ol_de_linfoma_trasplante_aut_logo_de_m_dula_sea,GELTAMO (Grupo Cooperativo Español de Linfoma/Trasplante Autólogo de Médula Ósea) +9755,,343d270e-a8c7-420c-a599-479caa81d17d,SymbioPharm GmbH,symbiopharm_gmbh,,,,,, +9756,,8335f852-719d-11e6-a0cd-0242ac12000b,LABORATOIRE HRA,laboratoire_hra,,,,,, +9757,,c2acc91e-8639-472d-8d7f-eb0ef64810f4,Papworth Hospital,papworth_hospital,,,,,, +803,0.98581516742706299,3752ea3c-adc5-42dc-b691-67baaf7d0875,University Hospital Basel, Neurology,,,,3752ea3c-adc5-42dc-b691-67baaf7d0875, Neurology,University Hospital Basel +192,0.97530868649482727,7621f0c9-df30-4cbd-95c1-d0d5719d2751,Teva Pharmaceutical Industries Ldt,teva_pharmaceutical_industries_ldt,,,,7621f0c9-df30-4cbd-95c1-d0d5719d2751,teva_pharmaceutical_industries,Teva Pharmaceutical Industries +9758,,f5c5ea0a-73c1-11e6-a0cd-0242ac12000b,HIKMA PHARM CO LTD,hikma_pharm_co_ltd,,,,,, +9759,,8913dec5-4317-4b8b-a426-344a1087ff12,Roche s.r.o,roche_s_r_o,university_hospital_basel_neurology,,,,, +9760,,a9d2fae1-e8ae-45c9-9f31-16e77cc3768e,"MUW, Universitätsklinik für Innere Medizin III, Abteilung für Nephrologie und Dialyse",muw_universit_tsklinik_f_r_innere_medizin_iii_abteilung_f_r_nephrologie_und_dialyse,,,,,, +737,0.9838290810585022,9d24a637-ff9d-4f52-87fc-ca0f3956d972,Fundació Clinic per a la Recerca Biomèdica,fundaci_clinic_per_a_la_recerca_biom_dica,,,,9d24a637-ff9d-4f52-87fc-ca0f3956d972,fundaci_clinic_per_a_la_recerca_biom_dica,Fundació Clinic per a la Recerca Biomèdica +9761,,d08d0a6f-9cfb-481a-958b-41102932e546,University of Witten/Herdecke,university_of_witten_herdecke,,,,,, +9762,,8bbf050e-7161-11e6-a0cd-0242ac12000b,ARMOUR PHARM,armour_pharm,,,,,, +9763,,6d55a4bd-2287-489d-a2d3-49e49ee6ab92,Centre Hospitalier de Jolimont-Lobbes-Tubize-Nivelles,centre_hospitalier_de_jolimont_lobbes_tubize_nivelles,,,,,, +9764,,d94d6058-ba53-484d-a088-7c1e1f47af61,SUBSTIPHARM DEVELOPPEMENT,substipharm_developpement,,,,,, +9765,,a70305f2-7212-11e6-a0cd-0242ac12000b,PALADIN LABS,paladin_labs,,,,,, +401,0.985931,4881a846-a728-4902-a39b-d18aa6ed8b14,European Myeloma Network Datacenter,european_myeloma_network_datacenter,,,,4881a846-a728-4902-a39b-d18aa6ed8b14,european_myeloma_network_datacenter,European Myeloma Network Datacenter +9766,,324ac022-a04f-4092-9f75-01208fbf5e78,Mundipharma Research Ltd,mundipharma_research_ltd,,,,,, +9767,,64bdce1c-7153-11e6-a0cd-0242ac12000b,INTL MEDICATED,intl_medicated,,,,,, +9768,,0a7e5eaf-9b40-4c87-bc26-5b1448898a2a,CROMA-PHARMA GmbH,croma_pharma_gmbh,,,,,, +235,0.97966137528419495,683ca9e5-af11-4524-9288-1bb0932a9588,Novartis Pharma Services,novartis_pharma_services,,,,683ca9e5-af11-4524-9288-1bb0932a9588,novartis_pharma_services,Novartis Pharma Services +724,0.981953,52dd1d55-52d2-42d6-b026-3416877c1096,"University of Iceland, Dept. Pharmacology",university_of_iceland_dept_pharmacology,,,,52dd1d55-52d2-42d6-b026-3416877c1096,university_of_iceland_dept_pharmacology,"University of Iceland, Dept. Pharmacology" +9769,,980115c8-5aa3-490c-a502-22ce28804a5d,Gene PreDiT SA,gene_predit_sa,,,,,, +9770,,8bf19cd6-881c-11e6-a998-0242ac12000b,"Shire Orphan Therapies, Inc",shire_orphan_therapies_inc,,,,,, +732,0.96950775384902954,23bc27b4-07ca-4d74-9d53-97dbe811474f,Bristol-Myers Squibb S.A,bristol_myers_squibb_s_a,,,,23bc27b4-07ca-4d74-9d53-97dbe811474f,bristol_myers_squibb_s_a,Bristol-Myers Squibb S.A +9771,,bb764da7-de51-4561-917d-bbb1dffe2619,"Pfizer Ltd., Ramsgate Rd., Sandwich, Kent",pfizer_ltd_ramsgate_rd_sandwich_kent,,,,,, +9772,,749afddd-b650-4e3e-8ec3-d6bfb7237a15,Dept. of Neurology - Univ. of Kansas Medical Center,dept_of_neurology_univ_of_kansas_medical_center,,,,,, +678,0.97750166058540344,13208ab1-3086-46d7-9a2a-a6f5c9b30ecd,AbbVie Deutschland GmbH & Co. KG,abbvie_deutschland_gmbh_co_kg,,,,ddf3632f-3a35-464c-8cf1-c8b6486c323c,abbvie_deutschland_gmbh_co_kg,AbbVie Deutschland GmbH & Co. KG +98,0.979094,774da114-f1f8-4248-96b8-80c126c20bd2,"University of Leipzig Ritterstr. 26, 04109 Leipzig",university_of_leipzig_ritterstr_26_04109_leipzig,,,,76157ebc-7bea-4a83-a2ca-6c02e460c234,university_of_leipzig,University of Leipzig +9773,,e06a9f03-7f64-48de-aacd-e95bf3ab33ac,National Institution of Health (NCI),national_institution_of_health_nci,,,,,, +9774,,20ffb478-7fad-432a-85f9-b816ec2abad3,"Department of Oncology, Rigshospitalet",department_of_oncology_rigshospitalet,,,,,, +587,0.95549,12d4a6e2-73f7-11e6-a0cd-0242ac12000b,IDT,idt,,,,12d4a6e2-73f7-11e6-a0cd-0242ac12000b,idt,IDT +9775,,e2f6273b-b977-4c6e-a0da-d4940bcbae2b,Hospital Son Dureta,hospital_son_dureta,,,,,, +9776,,a23951b7-2aa8-43bb-87be-999fc1f98e9e,"Medizinische Universität Wien, Univ.Klinik Innere Medizin III, Abt.für Nephrologie u.Dialyse",medizinische_universit_t_wien_univ_klinik_innere_medizin_iii_abt_f_r_nephrologie_u_dialyse,,,,,, +9777,,693bf002-44cb-4ea7-afc9-d5c81e8e6f39,"Per Whiss, Faculty of Health Sciences",per_whiss_faculty_of_health_sciences,,,,,, +9778,,422b3215-23c0-472d-84f5-c888e5a6402d,Bionorica SE,bionorica_se,,,,,, +9779,,18e081c0-9c7c-4b2b-b6ad-d68047e0f248,Urologische Partnerschaft,urologische_partnerschaft,,,,,, +9780,,c3847899-7063-43a7-a696-07cf9d517a62,Boehringer Ingelheim Finland Ky,boehringer_ingelheim_finland_ky,,,,,, +9781,,2e7bdeb4-3c69-4b39-9720-5a0d23f0bc48,Chiesi Farmaceutici SpA,chiesi_farmaceutici_spa,,,,,, +9782,,4fed8abd-02b2-43cb-882b-6d53ef6d263d,"University hospital Mainz, I. Medizinische Klinik und Poliklinik, Johannes Gutenberg-Universität",university_hospital_mainz_i_medizinische_klinik_und_poliklinik_johannes_gutenberg_universit_t,,,,,, +9783,,9754953c-7193-11e6-a0cd-0242ac12000b,BLULINE,bluline,,,,,, +9784,,cd72e8fb-7878-4d6d-b4ee-fd54a2ef13da,University Hospitals of Leciester NHS trust,university_hospitals_of_leciester_nhs_trust,,,,,, +903,0.978271,03392dcb-ef6c-4051-ad43-dad84dc61463,Besancon University Hospital,besancon_university_hospital,,,,03392dcb-ef6c-4051-ad43-dad84dc61463,besancon_university_hospital,Besancon University Hospital +9785,,5ae65843-9300-4e49-a154-080b2c658070,"ARAFARMA GROUP, S.A",arafarma_group_s_a,,,,,, +288,0.91965407133102417,637c7598-5b5c-463a-b3c7-2e09975b8047,"Pfizer Ltd., Ramsgate Road,Sandwich,Kent,CT13 9NJ,United Kingdom",pfizer_ltd_ramsgate_road_sandwich_kent_ct13_9nj_united_kingdom,,,,5a02f0f0-4b8e-4bcc-b5d9-2bda73ef9a30,pfizer_ltd_ramsgate_road_sandwich_kent_ct13_9nj,"Pfizer Ltd,Ramsgate Road,Sandwich,Kent CT13 9NJ" +9786,,9cdf3ed7-0a85-4d7e-82a2-732ef74bbb7a,Lassila Riitta,lassila_riitta,,,,,, +9787,,7e9c35a5-c501-486b-b709-153229944086,Sanos Bioscience A/S,sanos_bioscience_a_s,,,,,, +9788,,5418eaf2-154a-4cb0-825a-31fab6dc5609,Hospices Civils de Lyon,hospices_civils_de_lyon,,,,,, +780,0.923509,233d48d7-e293-4935-96da-8421fde4be1f,Royal Liverpool & Broadgreen University hospital,royal_liverpool_broadgreen_university_hospital,,,,233d48d7-e293-4935-96da-8421fde4be1f,royal_liverpool_broadgreen_university_hospital,Royal Liverpool & Broadgreen University hospital +1029,0.935805,5107d29f-cc09-411e-b173-d701ced714e6,EORTC (European Organization for Research and Treatment of Cancer),eortc_european_organization_for_research_and_treatment_of_cancer,,,,5107d29f-cc09-411e-b173-d701ced714e6,eortc_european_organization_for_research_and_treatment_of_cancer,EORTC (European Organization for Research and Treatment of Cancer) +9789,,c1cfdac4-a060-4684-9686-044ba763bd4c,"Scioderm, INC",scioderm_inc,,,,,, +9790,,84932560-b855-44bd-a0a4-c2edcc4e4215,Pfizer Inc. 232 East 42nd Street-New York-10017-USA,pfizer_inc_232_east_42nd_street_new_york_10017_usa,,,,,, +633,0.974308,ee9911c2-82fa-4529-bad0-7fe5a6f162ac,BRACCO,bracco,,,,c06c533e-ab04-44e7-a0f7-e1b3fb8173f8,bracco_imaging,BRACCO IMAGING +9791,,b16b91e5-15ee-454a-a885-a34c1b37212d,Terho Heikkinen,terho_heikkinen,,,,,, +888,0.96341493300029213,64afb7c3-b0ee-42c4-90f7-a07e5d018c30,"Schering-Plough Research Institute, a Division of Schering",schering_plough_research_institute_a_division_of_schering,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" +945,0.916222,8dd06814-7167-11e6-a0cd-0242ac12000b,ZACH SYSTEM SPA,zach_system_spa,,,,7dd3aa00-7164-11e6-a0cd-0242ac12000b,zach_systems,ZACH SYSTEMS +9792,,dbe6b57e-beca-4adb-bcb0-a71a710d4bc2,Pharma Patent Kft,pharma_patent_kft,,,,,, +9793,,a3003338-7129-11e6-a89e-0242ac12000b,MIKAH PHARMA,mikah_pharma,,,,,, +9794,,322f39c5-b043-41d4-a00a-8d02f4e19abb,CAIBER,caiber,,,,,, +9795,,239bfa48-5885-45ec-b567-223f96fe0640,Pharmatrophix Inc,pharmatrophix_inc,,,,,, +9796,,b7b27066-c0c1-44ca-8910-71b45b5dfd25,"Klinik für Anästhesiologie und operative Intensivmedizin, Charité – Universitätsmedizin Berlin",klinik_f_r_an_sthesiologie_und_operative_intensivmedizin_charit_universit_tsmedizin_berlin,,,,,, +9797,,523abda5-7ea1-4ccf-979d-623a62fd22a7,Sacro Cuore - Don Calabria Hospital,sacro_cuore_don_calabria_hospital,,,,,, +980,0.979352,613292dd-dbf8-4798-b144-565e8fc77a28,"Gambro Lundia AB, Corporate Research",gambro_lundia_ab_corporate_research,,,,1743b2fc-080c-4820-9527-15454fe27836,gambro_lundia_ab,Gambro Lundia AB +282,0.95927333831787109,2f33c154-cafb-40b1-8fdc-8c3e78823f79,Sahlgrenska University Hospital Västra Götalandsregionen,sahlgrenska_university_hospital_v_stra_g_talandsregionen,,,,2f33c154-cafb-40b1-8fdc-8c3e78823f79,sahlgrenska_university_hospital,Sahlgrenska University Hospital +9798,,db4b3f81-c1a1-4b69-9fa1-69fa94d1edde,Sunovion Respiratory Development Inc,sunovion_respiratory_development_inc,,,,,, +9799,,e30f7864-8bd0-11e6-a449-0242ac12000b,Regional Hospital of Randers,regional_hospital_of_randers,,,,,, +9800,,a7375fdb-c602-4fc7-b628-aa313d8a1a6a,"Intra-Cellular Therapies, Inc",intra_cellular_therapies_inc,,,,,, +9801,,1067a848-6839-4adf-a96f-fd2c22f5e950,PARENT PROJECT ONLUS,parent_project_onlus,,,,,, +181,0.9797365665435791,7e7a02de-715e-11e6-a0cd-0242ac12000b,VALEANT INTL,valeant_intl,,,,7e7a02de-715e-11e6-a0cd-0242ac12000b,valeant_intl,VALEANT INTL +9802,,ee2796e8-747e-4e46-a0d6-fd93ffc906c8,Hospital District of Southwest Finland,hospital_district_of_southwest_finland,,,,,, +9803,,b126d270-2016-41f9-bc3b-4cc49131ec85,TEVA Pharma Belgium,teva_pharma_belgium,,,,,, +128,0.98614925146102905,351cf472-712a-11e6-a89e-0242ac12000b,PHARMACHEMIE,pharmachemie,,,,07d5f348-7142-11e6-a0cd-0242ac12000b,pharmachemie_bv,PHARMACHEMIE BV +9804,,0bd85a64-f96b-41ac-bc32-7329d703c7b8,"Vion Pharmaceuticals, Inc",vion_pharmaceuticals_inc,,,,,, +559,0.97430989146232605,f72b701f-8add-4964-bec4-ff9cecac4d28,Department of Clinical Pharmacology Q,department_of_clinical_pharmacology_q,,,,e78543a1-45be-413e-ae9a-522fb25ea6da,department_of_clinical_pharmacology,Department of Clinical Pharmacology +9805,,613013ba-1ef5-47b4-b160-939173197a66,Topigen Pharmaceuticals Inc,topigen_pharmaceuticals_inc,,,,,, +9806,,97c36a30-b185-456e-973f-ba9402a12a83,María del Pino Alberiche Ruano,mar_a_del_pino_alberiche_ruano,,,,,, +831,0.977549,f2298589-5d8b-414c-a48d-580c4d2ca7fc,"Laboratorios Andromaco, S.A",laboratorios_andromaco_s_a,,,,9f380cea-e5d4-4346-a8b8-6397eb6b3840,laboratorios_andr_maco_s_a,"Laboratorios Andrómaco, S.A" +9807,,b1dfc549-46e5-4f88-b08b-25d64f1d6a23,Haga Teaching Hospital,haga_teaching_hospital,,,,,, +9808,,02b11f42-9e86-4bef-a238-91a07ec72726,Medizinischen Klinik mit Schwerpunkt Nephrologie und Internistische Intensivmedizin/Charité - Universitätsmedizin Berlin,medizinischen_klinik_mit_schwerpunkt_nephrologie_und_internistische_intensivmedizin_charit_universit_tsmedizin_berlin,,,,,, +9809,,013c9774-1c1d-4432-8c55-3d7918257d60,"Mast Therapeutics, Inc",mast_therapeutics_inc,,,,,, +9810,,d063e173-1d15-4666-87db-d9056885021e,Top institute of Pharmaceutical Research,top_institute_of_pharmaceutical_research,,,,,, +9811,,adc62e93-b122-42b5-929b-71ab04c258f9,Lars Jørgen Østergaard,lars_j_rgen_stergaard,,,,,, +9812,,44ea5e6a-715e-11e6-a0cd-0242ac12000b,INDICUS PHARMA,indicus_pharma,,,,,, +9813,,4c97e520-1c31-4c87-9e91-10cbc5759d3f,Marja-Liisa Korhonen,marja_liisa_korhonen,,,,,, +1026,0.95679479837417603,d2379c06-dc10-47c7-9eb7-094b64f48366,"Eli Lilly and Company Limited, Erl Wood Manor",eli_lilly_and_company_limited_erl_wood_manor,,,,d2379c06-dc10-47c7-9eb7-094b64f48366,eli_lilly_and_company,Eli Lilly and Company +9814,,ea73286f-102e-467b-ad11-179f8f88cd39,"Boehringer Ingelheim (UK), Ltd",boehringer_ingelheim_uk_ltd,,,,,, +9815,,e21bcac6-4bab-471d-a307-f389c6192e5b,Ana de Pedro Muñoz,ana_de_pedro_mu_oz,,,,,, +9816,,a004a205-f221-4197-83bd-138ffb93fce0,"Pharma Mar, S.A",pharma_mar_s_a,,,,,, +9817,,8802c906-8bd7-11e6-a449-0242ac12000b,Alfa Wassermann Polska Sp. z o.o,alfa_wassermann_polska_sp_z_o_o,,,,,, +9818,,aee96a24-7166-11e6-a0cd-0242ac12000b,NORTH CREEK PHARMS,north_creek_pharms,,,,,, +9819,,9dd65348-016e-427c-8a04-b8a53578b017,Hospital Universitario de Canarias,hospital_universitario_de_canarias,,,,,, +9820,,0b217cbc-7912-4484-b9cf-f26093b2867b,QUEST PHARMATECH INC,quest_pharmatech_inc,,,,,, +9821,,b11b8fa6-213a-4356-a90e-9a37bd06f72d,AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA,azienda_ospedaliera_maggiore_della_carita,,,,,, +9822,,7fb10b4f-5bb9-4c5b-a93b-8046004ff4be,Abbott Scandinavia AB,abbott_scandinavia_ab,,,,,, +9823,,60faac71-5aaf-4712-8e87-11e6be360e2b,"MUW, Klinik für Mund-, Kiefer-und Gesichtschirurgie",muw_klinik_f_r_mund_kiefer_und_gesichtschirurgie,,,,,, +9824,,80d10ff8-635f-4c1c-9ae0-7e194e0155cf,Royal United Hospital Bath NHS Trust,royal_united_hospital_bath_nhs_trust,,,,,, +9825,,53f5234e-4ebf-4470-a0b7-8c815013000c,Mereo BioPharma 1 Ltd,mereo_biopharma_1_ltd,,,,,, +9826,,333ad5c4-7324-11e6-a0cd-0242ac12000b,NYCOMED US INC,nycomed_us_inc,,,,,, +9827,,3f4e8b89-bd5f-4341-81a7-aaeea9bee54c,GIPIT,gipit,,,,,, +32,0.97160464525222778,4e670e68-1f79-4524-adc8-b4d1069973a7,Technische Universität Dreden,technische_universit_t_dreden,,,,8013f413-0613-4f61-a0a5-e7241cff8548,technische_universit_t_dreden,Technische Universität Dreden +9828,,21800906-0d8e-461a-91da-bcf7787ab5c4,Riika Merivirta,riika_merivirta,,,,,, +9829,,c4948fb7-56f4-4b49-869c-a0db0865375a,"Department of anesthesiology, Bispebjerg Hospital",department_of_anesthesiology_bispebjerg_hospital,,,,,, +697,0.98663,0521bb50-7129-11e6-a89e-0242ac12000b,BAUSCH AND LOMB,bausch_and_lomb,,,,0521bb50-7129-11e6-a89e-0242ac12000b,bausch_and_lomb,BAUSCH AND LOMB +516,0.984713,05ba4e48-7141-11e6-a0cd-0242ac12000b,UPSHER SMITH,upsher_smith,,,,05ba4e48-7141-11e6-a0cd-0242ac12000b,upsher_smith,UPSHER SMITH +457,0.98836642503738403,e07d01a1-23e4-4609-9a4e-3a8cd71d5812,Janssen-Cilag International NV,janssen_cilag_international_nv,,,,b1956d94-fa1c-4c96-9cc6-cd0765e72415,janssen_cilag_international_nv_jci,Janssen-Cilag International NV (JCI) +268,0.982988,ad6dc0d9-13c5-492c-a7c3-cdf65dee7f25,CELL THERAPEUTICS INC,cell_therapeutics_inc,,,,ad6dc0d9-13c5-492c-a7c3-cdf65dee7f25,cell_therapeutics_inc,CELL THERAPEUTICS INC +14,0.95436489582061768,ae8e014a-7c13-4773-a1de-c710fa18ca2b,Menarini International Operation Luxembourg -SA,menarini_international_operation_luxembourg_sa,,,,41be544c-1f46-41e5-bb1b-0bb3baefda2e,menarini_international_operation_luxembourg_sa,Menarini International Operation Luxembourg S.A +1045,0.98760741949081421,558c49d6-0383-4c86-9ba7-9561b98f7845,Synta Pharmaceuticals Corporation,synta_pharmaceuticals_corporation,,,,558c49d6-0383-4c86-9ba7-9561b98f7845,synta_pharmaceuticals_corporation,Synta Pharmaceuticals Corporation +9830,,645a62ac-065d-49c0-b17b-3df77698b758,"Dept of Neuroscience, Uppsala University",dept_of_neuroscience_uppsala_university,,,,,, +52,0.970647,9a94ff2c-11e0-4432-8ee8-caa5dbeae42c,AIBILI,aibili,,,,042feb9c-2ed7-4ad5-bdb8-f388835c0c2d,aibili_evicr_net,AIBILI (EVICR.net) +9831,,852cf48a-4b30-431e-b65a-34ab6e0a0458,Hospital Universitario La Paz,hospital_universitario_la_paz,,,,,, +9832,,736d7ffd-c20a-471d-b812-b70200aa24b5,"Herlev Hospital, Dept. of Haematology (L121)",herlev_hospital_dept_of_haematology_l121,,,,,, +9833,,5e29c41e-0193-4ae2-ad1f-33686032e4a4,Servicio Andaluz de Salud,servicio_andaluz_de_salud,,,,,, +9834,,40d9eb8e-f8c1-4cd5-a69a-c27914c1d611,Camurus AB,camurus_ab,,,,,, +9835,,a2b08642-9365-41ae-a2c4-673ddc4d6f97,ImCyse S.A,imcyse_s_a,,,,,, +9836,,1efdc618-1a84-4d0d-ab83-72879a4460ca,Medical University of Vienna / Medizinische Universität Wien,medical_university_of_vienna_medizinische_universit_t_wien,,,,,, +9837,,4a89fc2a-f66b-4e72-9d6e-ae9009c8c9f7,Insituto Aragonés de Ciencias de la Salud,insituto_aragon_s_de_ciencias_de_la_salud,,,,,, +9838,,6b6ce8e3-6e4d-420d-b6cc-6061732b5f05,DR. PAOLO MORA,dr_paolo_mora,,,,,, +9839,,b0a8a03c-7148-11e6-a0cd-0242ac12000b,PACIFIC PHARMA,pacific_pharma,,,,,, +9840,,f7b848e2-4849-4db2-b1e7-a7e6f8a94b88,PIQUR Therapeutics AG,piqur_therapeutics_ag,,,,,, +9841,,214c2e4c-715f-11e6-a0cd-0242ac12000b,DELL LABS,dell_labs,,,,,, +9842,,40bcdb39-36b3-4621-b122-a24c4e94834c,MediPsych SA,medipsych_sa,,,,,, +9843,,c0f3bac6-8bba-11e6-a449-0242ac12000b,"Hjertemedicinsk klinik, Rigshospitalet",hjertemedicinsk_klinik_rigshospitalet,,,,,, +9844,,c693f104-db56-431e-adf5-e4c9d06d14cd,Santosolve A/S,santosolve_a_s,,,,,, +9845,,291d051c-9d5a-4842-b5f8-57d3e776206d,SERVICIO DIGESTIVO,servicio_digestivo,,,,,, +9846,,94676677-ff44-46cc-ba1c-2b5bc32b3cc1,Pharmacyclics Switzerland GmbH,pharmacyclics_switzerland_gmbh,,,,,, +9847,,1e4a27ed-0749-4986-b283-ef793144b4e2,CONSORZIO MARIO NEGRI SUD,consorzio_mario_negri_sud,,,,,, +9848,,c438cdc6-9495-4380-97c4-4f517db0e713,MAROS Arzneimittel GmbH,maros_arzneimittel_gmbh,,,,,, +9849,,5246cdc0-7a52-4dfd-8ca0-c6e0a0418c7e,Public Health Agency of Sweden,public_health_agency_of_sweden,,,,,, +76,0.979965,4ba23efe-04ef-4a5c-853f-235d35ab9a66,Hamilton Health Sciences Corporation through its Population Health Research Institute,hamilton_health_sciences_corporation_through_its_population_health_research_institute,,,,42ae3bc2-6aa6-4f76-977a-25863d6912a4,hamilton_health_sciences_corporation,Hamilton Health Sciences Corporation +889,0.98770618438720703,bdf4fdf4-ab54-4d40-931b-1ae015b95e83,University Medical Center of the Johannes Gutenberg,university_medical_center_of_the_johannes_gutenberg,,,,36018056-4c5e-4f92-a44e-4cff410d57aa,university_medical_center_of_the_johannes_gutenberg_university_mainz,University Medical Center of the Johannes Gutenberg-University Mainz +1019,0.974081,c8812d86-0dcc-44eb-bd45-aee5afb9fcc5,GlaxoSmithKline Reaseach & Development,glaxosmithkline_reaseach_development,,,,620095ee-c9a2-4531-944d-4a25e6b235d1,glaxosmithkline_reasearch_development,GlaxoSmithKline Reasearch & Development +298,0.976145,1125a293-4958-4c01-b61b-93801ccfbe14,Population Council,population_council,,,,026c754c-5658-43bc-9abd-0340a976ca9f,population_council_center_for_biomedical_research,Population Council - Center for Biomedical Research +369,0.968529,054fbb2c-7228-11e6-a0cd-0242ac12000b,DAIICHI,daiichi,,,,054fbb2c-7228-11e6-a0cd-0242ac12000b,daiichi,DAIICHI +9850,,b5622271-4db0-4c5e-9dda-21860a0aad5c,Mª Consuelo del Cañizo Fernández-Roldán,m_consuelo_del_ca_izo_fern_ndez_rold_n,,,,,, +631,0.944644,6e37f726-18bd-47e5-8ffd-231a4eb18b5b,ISTITUTI ORTOPEDICI RIZZOLI,istituti_ortopedici_rizzoli,,,,6e37f726-18bd-47e5-8ffd-231a4eb18b5b,istituti_ortopedici_rizzoli,ISTITUTI ORTOPEDICI RIZZOLI +9851,,f793c45a-7ceb-48ee-b461-3800a12b10a5,"University Hospital Lund, Dept of Oncology, Clinical Trial Unit",university_hospital_lund_dept_of_oncology_clinical_trial_unit,,,,,, +9852,,c4d30ae3-e2a4-47b2-ae18-fab23492ede0,Vanda Pharmaceuitcals Inc,vanda_pharmaceuitcals_inc,,,,,, +9853,,2fe1cb36-476d-4445-ab50-b73bead29015,ErasmusMedical Center-Sophia,erasmusmedical_center_sophia,,,,,, +9854,,706a62e5-c278-4f8c-9133-afea8f68cfcf,City University,city_university,,,,,, +9855,,5589ebe5-39a8-4fad-8204-f2d5ebe84ace,CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO,centro_di_riferimento_oncologico_di_aviano,,,,,, +9856,,9873b7d0-2eb0-4f4e-9fe0-0f6190f85825,"Wyeth Research Division of Wyeth Pharmaceuticals Inc., Clinical and Development",wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_and_development,,,,,, +9857,,dbfdc3fc-71ac-11e6-a0cd-0242ac12000b,ANBEX,anbex,,,,,, +931,0.9439578652381897,eb89f24a-4d32-4f09-bde9-b803949044b0,Pierre Fabre Dermatologie represented by IRPF,pierre_fabre_dermatologie_represented_by_irpf,,,,ee1d91c1-0d9e-47fa-b4e7-22a6f46f9512,pierre_fabre_dermatologie_represented_by_institut_de_recherche_pierre_fabre,Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre +9858,,c89ea4a1-8c41-40a2-8011-8786d47964b5,VALLE HEBRON HOSPITAL,valle_hebron_hospital,,,,,, +9859,,f81d5c3a-8da8-40de-a2e5-39c12b80ce8f,Metcon Medicin AB,metcon_medicin_ab,,,,,, +258,0.98775,7fce0d0a-e865-4fe0-a665-7bc7eda82ddd,Karolinska Universitetssjukhuset,karolinska_universitetssjukhuset,,,,64f7d7d9-e504-4ff5-a540-55635d4c61d0,karolinska_universitetssjukhuset_huddinge,Karolinska Universitetssjukhuset Huddinge +9860,,888cf42d-15dc-4cca-a0ee-8dbb3e17223b,"Clinical Research Institute, HUCH Ltd",clinical_research_institute_huch_ltd,,,,,, +9861,,f3601e9b-1dd0-44e4-ae6c-9fe476825b99,"University of Cologne, Sponsor-Quality Management",university_of_cologne_sponsor_quality_management,,,,,, +9862,,be63ac37-2aed-4ab8-8423-30b21fcf7de0,Merck Serono Norway,merck_serono_norway,,,,,, +838,0.98826968669891357,5d2b1c1a-75ea-4ae8-a57c-aff1808f8a9a,NHS Greater Glasgow and Clyde Board,nhs_greater_glasgow_and_clyde_board,,,,046d6658-d5b1-4caa-8e4b-a52c60c09ffd,nhs_greater_glasgow_and_clyde,NHS Greater Glasgow and Clyde +9863,,595a02d0-7157-11e6-a0cd-0242ac12000b,ANDRX PHARM,andrx_pharm,,,,,, +9864,,e9951d7b-ee02-4804-aca2-6e2b99549974,"Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital",cambridge_university_hospitals_nhs_foundation_trust_addenbrooke_s_hospital,,,,,, +9865,,171bf720-5e45-4785-b5bd-8edd54ff50da,B Braun Medical S.A,b_braun_medical_s_a,,,,,, +9866,,641a01b6-73af-11e6-a0cd-0242ac12000b,KALEO INC,kaleo_inc,,,,,, +9867,,c88e8771-d839-4a19-be17-f971a4ec3a9c,Astellas Pharma GmbH,astellas_pharma_gmbh,,,,,, +9868,,f5e51307-050b-4fdd-ba05-b9ef5f3aa796,GRUPO ESPAÑOL DE LINFOMAS Y TRANSPLANTES AUTOLOGO DE MEDULA OSEA (GELTAMO),grupo_espa_ol_de_linfomas_y_transplantes_autologo_de_medula_osea_geltamo,,,,,, +9869,,8297271f-bb44-4fbc-af5d-7d8128ec95d0,HAL Allergy B.V,hal_allergy_b_v,,,,,, +9870,,b1b5caf8-7087-4137-9840-209de9cf0b39,Laboratorios Novag S.A,laboratorios_novag_s_a,,,,,, +9871,,bd9464d8-6629-4764-ae7e-7bfe558d8d0b,José Esteban Castelao Fernández,jos_esteban_castelao_fern_ndez,,,,,, +2,0.983866,d2862f78-c0ef-4cea-8c84-b1d0d7eed987,Västra Götaland Regionen,v_stra_g_taland_regionen,,,,7f8c8a75-8bf8-48df-b832-ab6dba5c9c9c,v_stra_g_taland,Västra Götaland +9872,,06066d72-187a-4665-8a1b-52b6eb1a26d4,GTC Biotherapeutics Inc,gtc_biotherapeutics_inc,,,,,, +9873,,7c0ebb87-3173-4830-a008-4f2242ddf1b7,Oogziekenhuis Rotterdam,oogziekenhuis_rotterdam,,,,,, +9874,,8c42e826-32bd-4f1a-aa9b-3dbb2d0410fb,"Department of Nuclear Medicine, Aalborg University Hospital",department_of_nuclear_medicine_aalborg_university_hospital,,,,,, +9875,,4a67cc90-e794-493a-b9d4-3312592d1a28,Haupt Pharma Wolfratshausen GmbH,haupt_pharma_wolfratshausen_gmbh,,,,,, +9876,,78bd27c0-fadb-4311-b893-93fee5ee30fa,"University of Hamburg, MIN-Faculty, Department of Chemistry, Division of Cosmetetic Science",university_of_hamburg_min_faculty_department_of_chemistry_division_of_cosmetetic_science,,,,,, +365,0.97463372349739075,17d529dc-dc91-4ddb-8f15-7de6d2fa75e3,Bayer HealthCare Pharmaceutical Inc,bayer_healthcare_pharmaceutical_inc,,,,17d529dc-dc91-4ddb-8f15-7de6d2fa75e3,bayer_healthcare_pharmaceuticals,Bayer HealthCare Pharmaceuticals +9877,,9b88c810-7e44-436c-b8e6-abf582298114,University of Liège,university_of_li_ge,,,,,, +9878,,117255f8-1dea-4151-87b5-987f04e61dfe,Kwizda Pharma,kwizda_pharma,,,,,, +1023,0.962602,3d6896c7-f9eb-43cb-9c4d-49b6ab960bde,"Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet",dept_of_intensive_care_copenhagen_university_hospital_rigshospitalet,,,,3d6896c7-f9eb-43cb-9c4d-49b6ab960bde,dept_of_intensive_care_copenhagen_university_hospital_rigshospitalet,"Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet" +9879,,4c59766e-96c2-4555-90b0-53c21e756221,sanofi-aventis US,sanofi_aventis_us,,,,,, +9880,,7bd5f861-6339-4075-9985-dd3e6e56ca3d,"Cephalon Europe, A Division of Cephalon UK Limited",cephalon_europe_a_division_of_cephalon_uk_limited,,,,,, +9881,,9bfaf07c-74e8-4fc9-b5a4-5c5d4c83aacd,Fakultní nemocnice Brno,fakultn_nemocnice_brno,,,,,, +474,0.914969,0222076c-1a8f-4b87-a730-9ae61df48508,Royal Devon & Exeter NHS Foundation Trust,royal_devon_exeter_nhs_foundation_trust,,,,0222076c-1a8f-4b87-a730-9ae61df48508,royal_devon_exeter_nhs_foundation_trust,Royal Devon & Exeter NHS Foundation Trust +9882,,38b47768-31a8-495f-8489-89e9cd3083f8,Dr Daniel Serón. Servicio de Nefrología. Hospital Universitario Vall d'Hebron,dr_daniel_ser_n_servicio_de_nefrolog_a_hospital_universitario_vall_d_hebron,,,,,, +9883,,3e8b2e7f-1385-405a-a08a-e91245690fe8,"Celator Pharmaceuticals, Inc",celator_pharmaceuticals_inc,,,,,, +9884,,48856b01-28eb-4d19-aa53-911fc37fa808,GLAXOSMITKKLINE R&D LTD,glaxosmitkkline_r_d_ltd,,,,,, +600,0.95015225807825721,efceda38-ed0e-4115-84cb-32f129012f21,Fundación Institut de Recerca de l' Hospital de la Santa Creu i Sant Pau,fundaci_n_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,,,,6b4a9b2d-18ff-4441-b335-98517841d021,fundaci_n_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Fundació Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau +9885,,41b1a959-cd10-4a12-91d1-dbc04ae11447,Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH gGmbH),gesellschaft_f_r_p_diatrische_onkologie_und_h_matologie_gpoh_ggmbh,,,,,, +9886,,75052f2f-bf60-4089-82bd-f51b90b5bc9f,Urologkliniken USÖ,urologkliniken_us,,,,,, +9887,,6b377a37-8412-4fcc-8d87-0983a60518ee,FUNDACION SEIMC-GESIDA,fundacion_seimc_gesida,,,,,, +7,0.93911871314048767,f17a514e-8b4e-423a-b3c8-740bb7f90361,Centre Hospitalier Universitaire de Nice,centre_hospitalier_universitaire_de_nice,,,,e37ff462-7351-402c-828d-d17f23d6fa72,centre_hospitalier_universitaire_de_nantes,Centre Hospitalier Universitaire de Nantes +9888,,12be75be-df68-4abf-a544-5e915e626781,Julian Taylor,julian_taylor,,,,,, +9889,,e1a86ba5-0ea1-4bc8-9951-393911a07d0a,ARQule Inc,arqule_inc,,,,,, +9890,,55d216f6-cff4-404b-a20b-0f1eaffcd2e0,Országos Onkológiai Intézet,orsz_gos_onkol_giai_int_zet,,,,,, +9891,,9a386cf6-8d0f-46ec-8fd9-fbf9154818fb,Vita Green Europa S.A,vita_green_europa_s_a,,,,,, +9892,,bd4d0bef-c491-4902-ae15-509689f45320,"Medical University of Vienna, Department of Anaesthesia, General Intensive Care and Pain Management",medical_university_of_vienna_department_of_anaesthesia_general_intensive_care_and_pain_management,,,,,, +9893,,322a48b4-1460-4766-beb9-ea471830f34a,Oasmia Pharmaceutical AB,oasmia_pharmaceutical_ab,,,,,, +9894,,02087f66-7148-11e6-a0cd-0242ac12000b,THERAGEN,theragen,,,,,, +9895,,b3217b4c-7119-4d61-81ac-fe4f1cdd4cd2,Heinrich-Heine-Universität Düsseldorf,heinrich_heine_universit_t_d_sseldorf,,,,,, +9896,,b6b4f6ee-c850-4867-ad85-b661f8253cec,Aegera Therapeutics Inc,aegera_therapeutics_inc,,,,,, +524,0.985088,a8eec515-d7ce-45a9-93a1-6381a77996dd,Sanofi Pasteur Inc,sanofi_pasteur_inc,,,,211ecc7f-a65d-460f-803c-c95a4e47e245,sanofi_pasteur_incorporated,Sanofi Pasteur Incorporated +9897,,2e937851-0951-4f6f-ab29-fa7a2edebc64,IDIPAZ,idipaz,,,,,, +540,0.979562,3817f8bc-4ff8-495a-9b3e-ba7bf5fb409b,Dow Pharmaceutical Sciences,dow_pharmaceutical_sciences,,,,3817f8bc-4ff8-495a-9b3e-ba7bf5fb409b,dow_pharmaceutical_sciences,Dow Pharmaceutical Sciences +9898,,ea8f099d-c3e5-4bb8-a9b4-8762c42907e9,CROWN OY,crown_oy,,,,,, +9899,,96b64fe1-cac8-46d9-b707-a0c839416277,Institut de cancérologie Gustave Roussy,institut_de_canc_rologie_gustave_roussy,,,,,, +9900,,7a54d884-3f1d-42c2-ab84-da8cacea1d5c,The Newcastle upon Tyne Hospitals NHS Foundation Trust,the_newcastle_upon_tyne_hospitals_nhs_foundation_trust,,,,,, +9901,,b92d234b-0791-4116-8b8e-f8276b862029,"Universitätsklinikum Freiburg, vertreten durch den Leitenden Ärztlichen Direktor",universit_tsklinikum_freiburg_vertreten_durch_den_leitenden_rztlichen_direktor,,,,,, +9902,,cf734a6c-73b4-11e6-a0cd-0242ac12000b,AVID RADIOPHARMS INC,avid_radiopharms_inc,,,,,, +9903,,dff2924c-509b-475e-94f3-97ef0be54734,"Academical medical Center, Department of dermatology",academical_medical_center_department_of_dermatology,,,,,, +9904,,0efffa0c-39c6-45e9-8de7-e10eae817964,"Hospitales Universitarios Virgen del Rocío, Servicio Andaluz de Salud",hospitales_universitarios_virgen_del_roc_o_servicio_andaluz_de_salud,,,,,, +1064,0.9760473221540451,e575dcef-9058-4489-a3a8-f3e92d2e51bd,Cambridge University Hospitals NHS Foundation Trust,cambridge_university_hospitals_nhs_foundation_trust,,,,5832b652-f280-4dd6-850d-477a81887563,cambridge_university_hospitals_nhs_foundation_trust,Cambridge University Hospitals NHS Foundation Trust +9905,,fe1a61b1-7def-42f8-9221-9612004bcbb9,Roche a/s,roche_a_s,,,,,, +720,0.9764975905418396,f0a04a50-7242-11e6-a0cd-0242ac12000b,OTSUKA PHARM,otsuka_pharm,,,,83d8194e-71e2-11e6-a0cd-0242ac12000b,otsuka,OTSUKA +9906,,4df8836f-00b9-4c19-9a58-6d59fe777448,U.O. Tossicologia,u_o_tossicologia,,,,,, +9907,,16807fa9-ad9e-4ae5-8fdf-6a8bc5405337,"Spectrum Pharmaceuticals, Inc",spectrum_pharmaceuticals_inc,,,,,, +9908,,f1ca5da9-3310-4b9a-baf4-b9f5cf3b8246,Orthopedic Research in Aarhus,orthopedic_research_in_aarhus,,,,,, +9909,,26fd2938-73e7-11e6-a0cd-0242ac12000b,VIFOR FRESENIUS,vifor_fresenius,,,,,, +9910,,e073e3f4-87ac-4d80-af72-746008e36dba,ACRAF S.p.A,acraf_s_p_a,,,,,, +658,0.988286,4423b650-5a4e-43b4-81a3-c06729eeaafc,Liverpool Women's NHS Foundation Trust Hospital,liverpool_women_s_nhs_foundation_trust_hospital,,,,4423b650-5a4e-43b4-81a3-c06729eeaafc,liverpool_women_s_nhs_foundation_trust_hospital,Liverpool Women's NHS Foundation Trust Hospital +61,0.970142,d6dc6bb2-7166-11e6-a0cd-0242ac12000b,PAR FORMULATIONS PRIVATE LTD,par_formulations_private_ltd,,,,6e54f3b2-7165-11e6-a0cd-0242ac12000b,par_form,PAR FORM +9911,,a5ce0867-bd7a-41fa-9ff1-64f39b143724,Teva Women`s Health Research,teva_women_s_health_research,,,,,, +36,0.98114,d98745c2-011b-495b-a0b3-26372585a6ae,"Medical Faculty, Otto-von-Guericke-University Magdeburg",medical_faculty_otto_von_guericke_university_magdeburg,,,,d98745c2-011b-495b-a0b3-26372585a6ae,medical_faculty_otto_von_guericke_university_magdeburg,"Medical Faculty, Otto-von-Guericke-University Magdeburg" +9912,,71bc468c-71aa-11e6-a0cd-0242ac12000b,PRECISION DERMAT,precision_dermat,,,,,, +9913,,dee156d7-4e37-4b92-a5a2-969e570c9828,Zaans Medisch Centrum,zaans_medisch_centrum,,,,,, +9914,,f625ec16-c87f-4f76-8514-9e854f100ddf,"Erling Bjerregaard Pedersen, Medicinsk forskningsafsnit, Regionshospitalet Holstebro",erling_bjerregaard_pedersen_medicinsk_forskningsafsnit_regionshospitalet_holstebro,,,,,, +9915,,fe221106-d98b-415d-9418-f1885f0ac758,Mika Harju,mika_harju,,,,,, +9916,,b6a4be84-f800-44fc-a054-4ac5607694da,Mercedes Loscertales Abril,mercedes_loscertales_abril,,,,,, +9917,,d497ded2-e200-4a13-be9a-6cb36613dd81,Luis Carlos Imaz Navarro,luis_carlos_imaz_navarro,,,,,, +9918,,d3b5dcab-c6c0-442b-8fca-bb2bfa08ab66,ITALCHIMICI SPA,italchimici_spa,,,,,, +9919,,77e09dd6-154a-485d-8358-280bf3ea2255,Genzyme Corporation and its Affiliates,genzyme_corporation_and_its_affiliates,,,,,, +9920,,a9afe36b-4b30-47a7-8fc0-962c45786fbe,Vrij Universiteit Medical Center,vrij_universiteit_medical_center,,,,,, +275,0.972986,61dc1432-2742-471c-9dcc-67fb304ce278,Universitätsmedizin der Johannes Gutenberg-Universität Mainz,universit_tsmedizin_der_johannes_gutenberg_universit_t_mainz,,,,61dc1432-2742-471c-9dcc-67fb304ce278,universit_tsmedizin_der_johannes_gutenberg_universit_t_mainz,Universitätsmedizin der Johannes Gutenberg-Universität Mainz +9921,,323a492c-6309-45a0-ba99-404eb40f195f,Antisense Therapeutics Ltd,antisense_therapeutics_ltd,,,,,, +150,0.919718,dd0182b6-ae56-48f6-9461-7f4416fa380a,Universitätsmedizin Goettingen,universit_tsmedizin_goettingen,,,,b3733316-ccdd-4aab-ad57-807a9a476ca0,universit_tsmedizin_g_ttingen,Universitätsmedizin Göttingen +9922,,85ab66a0-8c51-4d88-8baf-6c9fe7130565,HANNA THORÉN,hanna_thor_n,,,,,, +9923,,95dad050-bfd7-43e6-9a7a-f3f6fd5d9c40,FOVEA,fovea,,,,,, +40,0.98917752504348755,7852b0e6-2f36-4ee0-90a6-404e745340b5,Procter & Gamble Technical Centres Ltd,procter_gamble_technical_centres_ltd,,,,7852b0e6-2f36-4ee0-90a6-404e745340b5,procter_gamble_technical_centres_ltd,Procter & Gamble Technical Centres Ltd +9924,,009259fe-5d4e-4308-8f0a-f51d6d73949f,Parque Científico de la Universidad de Valladolid,parque_cient_fico_de_la_universidad_de_valladolid,,,,,, +349,0.956416,81b272b1-dc41-4ac6-b169-23e9c0bb81d7,GITMO,gitmo,,,,81b272b1-dc41-4ac6-b169-23e9c0bb81d7,gitmo,GITMO +9925,,deb07535-d9a8-49ed-9ec8-1d1448c77bbc,Novartis Ireland Limited,novartis_ireland_limited,,,,,, +9926,,a94add8b-bab1-4fdc-8bcf-58ab426cd473,CELL THERAPEUTICS EUROPE,cell_therapeutics_europe,,,,,, +9927,,e021323a-714c-11e6-a0cd-0242ac12000b,MARSAM PHARMS LLC,marsam_pharms_llc,,,,,, +331,0.98589098453521729,5b0547b4-7168-11e6-a0cd-0242ac12000b,PURACAP PHARM LLC,puracap_pharm_llc,,,,5b0547b4-7168-11e6-a0cd-0242ac12000b,puracap_pharm_llc,PURACAP PHARM LLC +9928,,714cc474-b431-416b-9e99-4bd76512ef22,Tibotec Pharmaceuticals c/o Tibotec BVBA,tibotec_pharmaceuticals_c_o_tibotec_bvba,,,,,, +9929,,c6b019e3-ef97-4ea0-8f02-7da499209560,"Department og Gynaecology and Obstetric, Randers Hospital",department_og_gynaecology_and_obstetric_randers_hospital,,,,,, +9930,,5d17b1d4-bcc1-410d-a0ab-9e0cebf7ba7e,Roche Products Limited,roche_products_limited,,,,,, +9931,,3a9cf6a4-fa86-4307-a87c-5a50e9cd8a7a,NHS Grampian Health Board,nhs_grampian_health_board,,,,,, +9932,,dc7ecf15-6d8c-4135-a4f4-3384016ea8f2,"Medizinische Universität Graz, Kl. Abt. f. Endokrinoloie u. Stoffwechsel & Kl. Abt. f. Gastroenterologie u. Hepatologie",medizinische_universit_t_graz_kl_abt_f_endokrinoloie_u_stoffwechsel_kl_abt_f_gastroenterologie_u_hepatologie,,,,,, +9933,,eeca3142-72eb-11e6-a0cd-0242ac12000b,SICOR PHARMS,sicor_pharms,,,,,, +9934,,ae4c249e-2a5d-4597-9d24-d6af831abbf1,Peter Lommer Kristensen,peter_lommer_kristensen,,,,,, +9935,,81c5359a-7167-11e6-a0cd-0242ac12000b,WA UNIV SCH MED,wa_univ_sch_med,,,,,, +298,0.976145,026c754c-5658-43bc-9abd-0340a976ca9f,Population Council - Center for Biomedical Research,population_council_center_for_biomedical_research,,,,026c754c-5658-43bc-9abd-0340a976ca9f,population_council_center_for_biomedical_research,Population Council - Center for Biomedical Research +9936,,e6b8455a-714e-11e6-a0cd-0242ac12000b,KRKA DD NOVO MESTO,krka_dd_novo_mesto,,,,,, +120,0.97839492559432983,0b9eb68a-ecbc-4706-a3c1-e52c658684d3,Rheinische Friedrichs-Wilhelms-Universität Bonn,rheinische_friedrichs_wilhelms_universit_t_bonn,,,,0b9eb68a-ecbc-4706-a3c1-e52c658684d3,rheinische_friedrichs_wilhelms_universit_t_bonn,Rheinische Friedrichs-Wilhelms-Universität Bonn +9937,,578e1ca6-8438-4f5e-8ba9-353415404c6f,Boehringer-Inglheim RCV GmbH & Co KG,boehringer_inglheim_rcv_gmbh_co_kg,,,,,, +9938,,21c98037-d820-4b49-8c74-d7725c629c09,Bavarian Nordic A/S,bavarian_nordic_a_s,,,,,, +9939,,c28483b0-fb20-40bd-8c16-aaf5c51273ad,"Alder Biopharmaceuticals, Inc",alder_biopharmaceuticals_inc,,,,,, +9940,,93f242c4-1ea8-41a4-962a-cb4b07c428b5,"Pfizer Inc., 235 East 42nd Road, New York, NY 10017",pfizer_inc_235_east_42nd_road_new_york_ny_10017,,,,,, +9941,,551d9610-f046-44dc-97dd-61b03ecf9a03,"Department of anaesthesia and intensive care, Hvidovre Hospital",department_of_anaesthesia_and_intensive_care_hvidovre_hospital,,,,,, +642,0.97585871815681458,0da9da02-b343-4c52-bf6a-f6b6e2ae422d,Boehringer Ingelheim France S.A.S,boehringer_ingelheim_france_s_a_s,,,,1eaa3c0c-4ecd-4593-886b-6af263dd0c86,boehringer_ingelheim_france,Boehringer Ingelheim France +9942,,5084b8b3-1778-4f04-9b4d-7123b2159a2f,ZonMw,zonmw,,,,,, +9943,,cddba942-72c4-11e6-a0cd-0242ac12000b,MOBERG PHARMA NORTH,moberg_pharma_north,,,,,, +9944,,7fb43915-379d-4fbc-bfbc-fe1b1e0e1b1c,Viborg Sygehus,viborg_sygehus,,,,,, +9945,,91bb530e-7166-11e6-a0cd-0242ac12000b,ALLIED PHARMA INC,allied_pharma_inc,,,,,, +9946,,2646c5e7-e778-43e9-8dc5-b558abfaf769,"NHS Lanarkshire, Primary Care Operating Division",nhs_lanarkshire_primary_care_operating_division,,,,,, +281,0.986926,f7e37228-71b2-11e6-a0cd-0242ac12000b,ABBVIE ENDOCRINE INC,abbvie_endocrine_inc,,,,0dd91d42-73cc-11e6-a0cd-0242ac12000b,abbvie_endocrine,ABBVIE ENDOCRINE +9947,,a0492f88-738f-11e6-a0cd-0242ac12000b,CUTANEA,cutanea,,,,,, +9948,,9a67c580-1f93-48ae-92da-b06472af3a33,Francesc Bosch Albareda,francesc_bosch_albareda,,,,,, +9949,,6d6911d7-6767-4599-b2b0-123e718516ae,"Medizinische Universität Wien, Abteilung für Herzchirurgie",medizinische_universit_t_wien_abteilung_f_r_herzchirurgie,,,,,, +994,0.94387978315353394,bdf3e172-6f9d-11e6-9663-0242ac12000b,GE Healthcare Ltd and its affliates,ge_healthcare_ltd_and_its_affliates,,,,2e5a2501-0997-4b88-9260-ccb94b118ad0,ge_healthcare_ltd_and_its_affiliates,GE Healthcare Ltd and its Affiliates +9950,,d4cade9d-5c31-495b-bbef-dbc40ce4a7c7,Sociedad Española de Medicina Interna,sociedad_espa_ola_de_medicina_interna,,,,,, +9951,,a8a25b83-ee3d-4ba6-90e8-0a95476031d4,"Ipsen Pharma, S.A",ipsen_pharma_s_a,,,,,, +9952,,1de8b2fe-fdec-4fc9-be80-679c9ac33ce2,"Medizinische Universität Wien, Abteilung für Interne Medizin I",medizinische_universit_t_wien_abteilung_f_r_interne_medizin_i,,,,,, +9953,,2fd74391-faf2-4cdb-8c79-45bbdc07b3a2,"Medizinsiche Universität Wien, Klinik für Innere Medizin III, Abteilung für Nephrologie und Dialyse",medizinsiche_universit_t_wien_klinik_f_r_innere_medizin_iii_abteilung_f_r_nephrologie_und_dialyse,,,,,, +1018,0.96827325224876404,3ef304e0-3faa-4c7b-8eed-9cb81342e20b,Southampton University Hopsitals NHS Trust,southampton_university_hopsitals_nhs_trust,,,,4be171c0-8ae0-4db6-b193-567f4e972c15,southampton_university_hospitals_nhs_trust,Southampton University Hospitals NHS Trust +9954,,5cba4360-7549-4af1-9033-96ac5f5498d2,"Dept. of surg.gastroent., Gentofte University Hospital, Copenhagen",dept_of_surg_gastroent_gentofte_university_hospital_copenhagen,,,,,, +9955,,a736cf06-c01a-4b13-bec0-cbf578cbcf84,Wilhelminenspital,wilhelminenspital,,,,,, +9956,,9043e8a1-4722-44ec-99df-8b23856e3a0b,Matter Misericoridiae University Hospital. Dublín,matter_misericoridiae_university_hospital_dubl_n,,,,,, +305,0.974081,1d4eea22-5d60-4df5-ad75-599835189ec4,ErasmusMC - Sophia Children's Hospital,erasmusmc_sophia_children_s_hospital,,,,1d4eea22-5d60-4df5-ad75-599835189ec4,erasmusmc_sophia_children_s_hospital,ErasmusMC - Sophia Children's Hospital +9957,,1ce6ce57-999f-451b-ac56-7ff5ee95b05f,Vernalis Development Limited,vernalis_development_limited,,,,,, +1038,0.988575,af45d852-b2e4-43ce-9719-2aeb4934cabc,International Breast Cancer Study Group (IBCSG),international_breast_cancer_study_group_ibcsg,,,,9ac131bc-a6d9-4ae6-b2ba-0582d8a53b0c,international_breast_cancer_study_group,International Breast Cancer Study Group +9958,,d1560b1e-562b-4948-9c42-b72a5945358a,Public Health England,public_health_england,,,,,, +9959,,1c3259a2-8af5-4bf5-bdeb-f7cc34c9cd81,Javier P. Gisbert,javier_p_gisbert,,,,,, +9960,,fbe8de40-b45b-4e13-8122-663526dd3507,Amphia Ziekenhuis,amphia_ziekenhuis,,,,,, +9961,,ca8855e3-d401-44dc-a7d4-d0098731ab79,Dstl,dstl,,,,,, +759,0.983343,2c488fcb-00db-4f93-b318-935e898e44eb,"Sektion Chirurgische Forschung, Univ.Klinik f.Chirurgie",sektion_chirurgische_forschung_univ_klinik_f_chirurgie,,,,24121f55-fb32-464a-8d7d-28948ed0eae7,sektion_chirurgische_forschung,Sektion Chirurgische Forschung +9962,,89c53770-0612-4f7a-9d0a-79e1f257eaa6,CUB Hospital Erasme,cub_hospital_erasme,,,,,, +9963,,633cb00e-ea28-4cb1-af51-08cd6620b144,Salford Royal NHS Foundation Trust,salford_royal_nhs_foundation_trust,,,,,, +9964,,932c60d0-ca24-448f-a188-7e30944f458d,Dr. Andrés Poveda Velasco,dr_andr_s_poveda_velasco,,,,,, +9965,,d9ab6dab-70e4-4c39-acd8-8f370f79afc1,"AlgoRx Pharmaceuticals, Inc",algorx_pharmaceuticals_inc,,,,,, +9966,,7f82200f-abc9-485e-addb-9bf609def1b2,Servicio Anestesia Hopsital del Mar,servicio_anestesia_hopsital_del_mar,,,,,, +9967,,81a19452-5605-453a-a135-01dd0b9c87c8,MEDIWOUND,mediwound,,,,,, +9968,,bcf0f762-96ba-11e6-becf-0242ac110008,HERON THERAPS INC,heron_theraps_inc,,,,,, +935,0.987803,61fc895f-7aff-4a8e-951c-f9fb4acdbb1f,Institute of Tropical Medicine,institute_of_tropical_medicine,,,,61fc895f-7aff-4a8e-951c-f9fb4acdbb1f,institute_of_tropical_medicine,Institute of Tropical Medicine +9969,,7e6f7c34-a9ce-47b2-8792-97dffd1a5ed9,Odense Universitetshospital,odense_universitetshospital,,,,,, +9970,,a51528ba-8309-4bb4-aa35-57ca497302bb,FREE UNIVERSITY OF BRUSSELS,free_university_of_brussels,,,,,, +9971,,27d4d06e-72c4-11e6-a0cd-0242ac12000b,MILLENNIUM PHARMS,millennium_pharms,,,,,, +9972,,e9307d1e-677f-490a-8c3a-b9d998d9ce69,University Hospital Wuerzburg,university_hospital_wuerzburg,,,,,, +24,0.98570942878723145,cdbaa569-ceed-4f49-bdeb-edfd7c7c5d7c,University Hospital Leuven gasthuisberg,university_hospital_leuven_gasthuisberg,,,,98380ed0-6709-41ea-a19e-81804abcd9ff,university_hospital_leuven,University Hospital Leuven +9973,,e2195596-b7a7-4900-bf49-768b7e863c1d,Århus Sygehus,rhus_sygehus,,,,,, +237,0.98873680830001831,0d3de9f8-ad5d-46b0-9905-5be149c5b8c3,"Pfizer Limited, Ramsgate Road, Sandwich, Kent",pfizer_limited_ramsgate_road_sandwich_kent,,,,a0e33e4c-faf3-44df-85c6-ebc94469b62e,pfizer_limited_ramsgate_road_sandwich_kent_uk,"Pfizer Limited, Ramsgate Road, Sandwich, Kent" +494,0.95775824785232544,a45eb7a0-7141-11e6-a0cd-0242ac12000b,DR REDDYS LABS INTL,dr_reddys_labs_intl,,,,5796b890-7142-11e6-a0cd-0242ac12000b,dr_reddys_labs_inc,DR REDDYS LABS INC +934,0.94545680284500122,9a5193a8-26e1-477d-9333-001ad82a5c6f,Pierre Fabre Medicament represented by IRPF,pierre_fabre_medicament_represented_by_irpf,,,,ed0e7a9e-3ecf-499e-8589-05b770cd0c82,pierre_fabre_m_dicament_represented_by_irpf,Pierre Fabre Médicament represented by IRPF +611,0.98173725605010986,e38a4be1-bb34-4ac4-9394-24f70e28cd5a,Erasmus MC Sophia,erasmus_mc_sophia,,,,e38a4be1-bb34-4ac4-9394-24f70e28cd5a,erasmus_mc_sophia,Erasmus MC Sophia +9974,,c9a8b374-c8b6-4e47-a730-b790b0da6a8b,"Novacea, Inc",novacea_inc,,,,,, +9975,,58a3e95f-654a-4bba-a5d2-0f220a79da65,Medical Center - University of Freiburg,medical_center_university_of_freiburg,,,,,, +9976,,73ff9fc0-9d23-4815-af85-34dce17e584d,ISTITUTO ONCOLOGICO VENETO,istituto_oncologico_veneto,,,,,, +9977,,4925dd87-94e0-4336-8ccf-fddd64ff23f5,Stiefel Laboratories (Maidenhead) Limited trading as Stiefel International Research and Development,stiefel_laboratories_maidenhead_limited_trading_as_stiefel_international_research_and_development,,,,,, +9978,,71423879-53a6-4bab-958a-4a8726f98737,VieCuri Medisch Centrum voor Noord-Limburg,viecuri_medisch_centrum_voor_noord_limburg,,,,,, +790,0.955613,948c9ff2-6213-4012-a58e-997f1d833ec1,"Merck Serono International S.A., A branch of Laboratoires Serono S.A",merck_serono_international_s_a_a_branch_of_laboratoires_serono_s_a,,,,948c9ff2-6213-4012-a58e-997f1d833ec1,merck_serono_international_s_a_a_branch_of_laboratoires_serono_s_a,"Merck Serono International S.A., A branch of Laboratoires Serono S.A" +956,0.980878,b1885f5c-880d-11e6-a998-0242ac12000b,OBEcure Ltd,obecure_ltd,,,,b1885f5c-880d-11e6-a998-0242ac12000b,obecure_ltd,OBEcure Ltd +606,0.98649200797080994,f36837b0-7144-11e6-a0cd-0242ac12000b,AUROBINDO PHARMA LTD,aurobindo_pharma_ltd,,,,f36837b0-7144-11e6-a0cd-0242ac12000b,aurobindo_pharma,AUROBINDO PHARMA +138,0.975844,f51f334b-1f78-4878-9604-85cbb0169506,"Takeda Global Research & Development Centre, Inc.,",takeda_global_research_development_centre_inc,,,,5739df1e-d602-413b-9853-34dc83584168,takeda_global_research_development_center_inc,"Takeda Global Research & Development Center, Inc.," +9979,,96cb6c52-7149-11e6-a0cd-0242ac12000b,COOK IMAGING,cook_imaging,,,,,, +9980,,b41cea27-9f37-4eb0-aa73-43323bfdabf1,Hospital for Children and Adolescents,hospital_for_children_and_adolescents,,,,,, +9981,,021c0f45-d1d0-4d24-8452-f8762113c876,"Universitätsklinikum Mannheim, Universitätsklinik für Anästhesiologie und Operative Intensivmedizin",universit_tsklinikum_mannheim_universit_tsklinik_f_r_an_sthesiologie_und_operative_intensivmedizin,,,,,, +9982,,6aaf2211-53d3-4b65-a39f-6042b08934ea,Witten-Herdecke University,witten_herdecke_university,,,,,, +9983,,6a0d4655-17f2-4577-9c68-3fc866630e55,"Medizinsche Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie",medizinsche_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,,,,,, +146,0.987534,d78d6d0c-ca2a-4096-8274-aa3eb0eed181,"University Hospital Hamburg-Eppendorf, Psychiatry",university_hospital_hamburg_eppendorf_psychiatry,,,,a090216a-e555-4b1c-b5d2-b624ee996480,university_hospital_hamburg_eppendorf,University Hospital Hamburg-Eppendorf +9984,,d5a66a37-2572-4ad1-8bc4-bf1c78a6c47f,Andi - Ventis,andi_ventis,,,,,, +9985,,79901de5-05f3-4c6b-a01c-c779d0289930,BOWS Pharmaceuticals AG,bows_pharmaceuticals_ag,,,,,, +1025,0.97363638877868652,dd7894c7-a143-430c-8179-80225a199a92,Eli Lilly and Company limited,eli_lilly_and_company_limited,,,,2f59f764-513a-43d8-ba41-bc314f18f59b,eli_lilly_and_company_limited,Eli Lilly and Company limited +9986,,38653105-393b-4b27-a4b0-b539f3a208eb,Akinion Pharmaceuticals AB,akinion_pharmaceuticals_ab,,,,,, +928,0.975714,970a6bb8-72f8-11e6-a0cd-0242ac12000b,LG LIFE,lg_life,,,,87f2de76-726c-11e6-a0cd-0242ac12000b,lg_life_sciences,LG LIFE SCIENCES +9987,,473732fb-f298-4826-bd06-3ae97bd2c8a8,Fundación Teknon,fundaci_n_teknon,,,,,, +9988,,af8046ea-3595-4e3c-b8e7-c19034689ad1,Pfizer bv RA,pfizer_bv_ra,,,,,, +386,0.985292,1075f8b7-6380-4891-9141-7a995969037d,University of Leuven,university_of_leuven,,,,1075f8b7-6380-4891-9141-7a995969037d,university_of_leuven,University of Leuven +9989,,dfd94b5e-c4b8-4464-8255-539c7762713f,Arrowhead Pharmaceuticals Inc,arrowhead_pharmaceuticals_inc,,,,,, +9990,,8b8d4a39-5f6e-4fc5-8b08-10ca96e3aa25,"Par Pharmaceutical, Inc",par_pharmaceutical_inc,,,,,, +276,0.955365,93daac2d-3fd1-447f-98fc-f605f37148a3,Axcan Pharma Inc. (Axcan Pharma International BV is subsidiary of Axcan Pharma Inc.),axcan_pharma_inc_axcan_pharma_international_bv_is_subsidiary_of_axcan_pharma_inc,,,,93daac2d-3fd1-447f-98fc-f605f37148a3,axcan_pharma_inc_axcan_pharma_international_bv_is_subsidiary_of_axcan_pharma_inc,Axcan Pharma Inc. (Axcan Pharma International BV is subsidiary of Axcan Pharma Inc.) +9991,,568f4b7e-f382-4365-9bca-0ece7ca02056,Newcastle upon Tyne Hospitals NHS Foundation Trust,newcastle_upon_tyne_hospitals_nhs_foundation_trust,,,,,, +9992,,ffb98e5e-7146-11e6-a0cd-0242ac12000b,HIGH TECH PHARMA,high_tech_pharma,,,,,, +9993,,9c983874-7165-11e6-a0cd-0242ac12000b,PHARMADAX INC,pharmadax_inc,,,,,, +193,0.961748,d9bd49e2-e2dc-4a2d-8959-189ce26ada32,Abertawe Bro Morgannwg University LHB,abertawe_bro_morgannwg_university_lhb,,,,5684aae1-9d95-4f90-a93b-ce904a01565d,abertawe_bro_morgannwg_university_nhs_trust,Abertawe Bro Morgannwg University NHS Trust +9994,,9287eb36-ca38-4c85-b3ff-e7711710ea4d,Bruno Farmaceutici S.p.a,bruno_farmaceutici_s_p_a,,,,,, +9995,,7b22ab60-9eb7-4d76-b375-20c6eef03fad,The Royal Wolverhampton NHS Trust,the_royal_wolverhampton_nhs_trust,,,,,, +9996,,0fed44d4-891d-4784-9db8-9d4a25a2f89a,"GlobeImmune, Inc",globeimmune_inc,,,,,, +940,0.988452,7c1e9a67-0589-4d28-bf1e-a81d74f16a46,"Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunerschen Kinderspital",klinikum_der_universit_t_m_nchen_kinderklinik_und_poliklinik_im_dr_von_haunerschen_kinderspital,,,,7c1e9a67-0589-4d28-bf1e-a81d74f16a46,klinikum_der_universit_t_m_nchen_kinderklinik_und_poliklinik_im_dr_von_haunerschen_kinderspital,"Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunerschen Kinderspital" +9997,,ec136502-d1a7-4533-b5bc-d13296651dcb,York Hospital NHS Trust,york_hospital_nhs_trust,,,,,, +9998,,85457fcf-2f23-47fd-b190-de8a14f75966,Trubion Pharmaceuticals,trubion_pharmaceuticals,,,,,, +9999,,98f92131-8c6b-48be-b6af-079e80839a4c,OctreoPharm Sciences GmbH,octreopharm_sciences_gmbh,,,,,, +10000,,edf03d76-971c-44df-9310-cb6f24bef2be,UZ Brussels,uz_brussels,,,,,, +652,0.97253134846687317,3d490ca4-9c82-4d71-91ec-a03e747b4c7a,Boehringer,boehringer,,,,756fbf26-6aec-45b4-9273-9afca275034e,boehringer,Boehringer +41,0.951277,d7a38668-883e-40b2-a844-2971b86324e0,Dr. Gerhard Mann Chem.-Pharm. Fabrik GmbH/Bausch & Lomb,dr_gerhard_mann_chem_pharm_fabrik_gmbh_bausch_lomb,,,,1dd460c9-f84b-4b97-8376-8660e0cef195,dr_gerhard_mann_chem_pharm_fabrik_gmbh_bausch_lomb_incorporated,Dr. Gerhard Mann chem.-pharm. Fabrik GmbH/ Bausch & Lomb Incorporated +10001,,1a0f3cde-f0f8-4f1d-9a15-ee58cddf563d,"Dra. Antònia Dalmau i Llitjós. Servicio de Anestesia, Reanimación y Terapéutica del Dolor del HUB-Idibell",dra_ant_nia_dalmau_i_llitj_s_servicio_de_anestesia_reanimaci_n_y_terap_utica_del_dolor_del_hub_idibell,,,,,, +10002,,292c8585-4614-4ac0-8aa6-8a54d68eea2e,Joint Research & Development Office (Barts and The London School of Medicine & Dentistry) - Queen Mary University London,joint_research_development_office_barts_and_the_london_school_of_medicine_dentistry_queen_mary_university_london,,,,,, +10003,,33dc1331-204d-43b5-8b9f-371e6fc9dcbc,Faron Pharmaceuticals Limited,faron_pharmaceuticals_limited,,,,,, +10004,,88abeb4b-f489-4997-9112-1311363c3098,Rune Rasmussen,rune_rasmussen,,,,,, +790,0.955613,9516dca0-e67e-443e-ae03-feeb289be70c,"Merck Serono International, A branch of Laboratoires Serono S.A",merck_serono_international_a_branch_of_laboratoires_serono_s_a,,,,948c9ff2-6213-4012-a58e-997f1d833ec1,merck_serono_international_s_a_a_branch_of_laboratoires_serono_s_a,"Merck Serono International S.A., A branch of Laboratoires Serono S.A" +1010,0.97897982597351074,1ea84c68-71d5-11e6-a0cd-0242ac12000b,MCNEIL PED,mcneil_ped,,,,1ea84c68-71d5-11e6-a0cd-0242ac12000b,mcneil_ped,MCNEIL PED +10005,,9a8a3739-5ae2-43ad-9cad-ecd9f89090e3,Mater Misercordiae Hospital - Department of Anaesthesia,mater_misercordiae_hospital_department_of_anaesthesia,,,,,, +10006,,870ccda8-41bd-461a-8658-d346e0d5d082,Unit of Esophageal and Gastric Research Dep. of Molecular Medicine and Surgery Karolinska Institutet,unit_of_esophageal_and_gastric_research_dep_of_molecular_medicine_and_surgery_karolinska_institutet,,,,,, +10007,,3e3fc40c-9d27-4235-97ad-2ecb397b531f,UCB SA Pharma Sector,ucb_sa_pharma_sector,,,,,, +10008,,d0cdfee6-62fe-45eb-bbdc-f830a72a2bbe,GeiserPHARMA SL,geiserpharma_sl,,,,,, +10009,,2df1ee74-73e0-11e6-a0cd-0242ac12000b,PIRAMAL IMAGING,piramal_imaging,,,,,, +979,0.919788,e934c5bf-3608-458b-bfd8-e77726c3dbd2,Johnson & Johnson Consumer and Personal Products Worldwide,johnson_johnson_consumer_and_personal_products_worldwide,,,,5beb59d6-f94c-4993-90c5-181d33404f39,johnson_johnson_consumer_personal_products_worldwide_division_of_johnson_johnson_consumer_companies_inc,"Johnson & Johnson Consumer & Personal Products Worldwide, Division of Johnson & Johnson Consumer Companies, Inc" +10010,,a4d3bb8a-8ec4-454a-8680-05139d72bfe6,"BioMarin International Ltd., Shanbally, Ringaskiddy, County Cork, Ireland",biomarin_international_ltd_shanbally_ringaskiddy_county_cork_ireland,,,,,, +10011,,e7d5f070-796c-4780-a093-e33b4575f234,CHARITE Universitätsmedizin Berlin Campus Virchow-Klinikum,charite_universit_tsmedizin_berlin_campus_virchow_klinikum,,,,,, +10012,,050f0882-afdf-4c4d-958e-61a2c0692b55,Medizinische Universität Wien - Universitätsklinik für Frauenheilkunde,medizinische_universit_t_wien_universit_tsklinik_f_r_frauenheilkunde,,,,,, +784,0.966541,d284ad33-38aa-4ed9-add8-26f06cf0d679,EORTC Headquarters,eortc_headquarters,,,,8c460761-0f56-46e2-8808-c7288d449545,eortc,EORTC +701,0.967271,22012f51-f648-4da1-8b80-539b591bf168,Synageva BioPharma Corporation,synageva_biopharma_corporation,,,,22012f51-f648-4da1-8b80-539b591bf168,synageva_biopharma_corporation,Synageva BioPharma Corporation +10013,,70d6b182-ecc8-46df-b793-fda3ca0e9ac2,"St. Vincent Hospital, Medical Department II",st_vincent_hospital_medical_department_ii,,,,,, +10014,,c3c63cac-418f-4503-94e7-2ee0b241c156,CHU de Besançon,chu_de_besan_on,,,,,, +10015,,c1745fad-e482-4cb7-a530-0bcdc74588d4,ACHG-K.U.Leuven,achg_k_u_leuven,,,,,, +10016,,b38d591e-4bce-41ab-b329-6ffc0a108075,"Sopherion Therapeutics, Inc",sopherion_therapeutics_inc,,,,,, +10017,,d9bb41c0-7141-11e6-a0cd-0242ac12000b,LEADING PHARMA LLC,leading_pharma_llc,,,,,, +218,0.97293919324874878,15cb26f8-fd0f-4c18-8afe-0d8c7f03ce9f,Vifor Pharma,vifor_pharma,,,,15cb26f8-fd0f-4c18-8afe-0d8c7f03ce9f,vifor_pharma,Vifor Pharma +10018,,01cf390d-ed95-44b0-8246-6935b948e903,DRUG DELIVERY SOLUTIONS ApS (PART OF MC2 BIOTEK GROUP),drug_delivery_solutions_aps_part_of_mc2_biotek_group,,,,,, +10019,,9ec62292-c7ef-4fd2-b26e-8e3d8917627f,Cyclacel Ltd,cyclacel_ltd,,,,,, +10020,,aedd8881-7c7f-4b79-ba4b-980830b88301,Schmerzambulanz Innenstadt der LMU,schmerzambulanz_innenstadt_der_lmu,,,,,, +605,0.916683,33f94402-02fa-4a5a-a654-70b42cce6641,Novartis Vaccines & Diagnostics AG,novartis_vaccines_diagnostics_ag,,,,2966963f-a998-4261-8d68-d4c45ba26c05,novartis_vaccines_diagnostics_inc,"Novartis Vaccines & Diagnostics, Inc" +949,0.987284,300881f9-28ca-4aa4-b8d5-58ad7c2806f3,Astellas Pharma Europe B.V,astellas_pharma_europe_b_v,,,,300881f9-28ca-4aa4-b8d5-58ad7c2806f3,astellas_pharma_europe_b_v,Astellas Pharma Europe B.V +10021,,6807d3c5-4b3d-4b9e-85c4-22dfa6f0e390,University Hospital Leicester R&D,university_hospital_leicester_r_d,,,,,, +10022,,25a548e0-5581-4840-a957-16b0d3db552f,Janssen Sciences Ireland UC,janssen_sciences_ireland_uc,,,,,, +1075,0.97996,43028a3f-c862-4599-8864-5518384f4057,Isala Klinieken,isala_klinieken,,,,43028a3f-c862-4599-8864-5518384f4057,isala_klinieken,Isala Klinieken +10023,,4487aae2-7b22-4a14-90f1-fc6705bc52df,SORIA NATURAL S.A,soria_natural_s_a,,,,,, +845,0.984184,ec39c1b2-714d-11e6-a0cd-0242ac12000b,ELITE LABS,elite_labs,,,,c064f018-7141-11e6-a0cd-0242ac12000b,elite_labs_inc,ELITE LABS INC +10024,,d8562fd8-2bd4-4672-b497-fa3c38cc21d0,Synairgen Research Limited,synairgen_research_limited,,,,,, +10025,,5bd8c1ea-66ff-456a-aa00-a90e42d638e7,UZ Brussel VUB,uz_brussel_vub,,,,,, +10026,,752a7cde-7d2a-421c-a342-86fddda81591,Roche Latvia,roche_latvia,,,,,, +10027,,c631dd20-5a1c-4f28-9e8e-23dc69d614e9,Scandinavian prostate cancer group,scandinavian_prostate_cancer_group,,,,,, +10028,,cb934232-a5df-487e-9e7d-12598425413b,ASL SALERNO 1,asl_salerno_1,,,,,, +427,0.97483,2b3faade-7374-11e6-a0cd-0242ac12000b,VIVUS,vivus,,,,2b3faade-7374-11e6-a0cd-0242ac12000b,vivus,VIVUS +10029,,0192874a-c55b-4b11-808c-17dd51b55b7c,Southern Europe New Drug Organization (SENDO),southern_europe_new_drug_organization_sendo,,,,,, +211,0.9515920877456665,6d416153-a74f-11e6-94cb-5656d04fc2b5,"Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine & PET",rigshospitalet_department_of_clinical_physiology_nuclear_medicine_pet,,,,6d416153-a74f-11e6-94cb-5656d04fc2b5,rigshospitalet_department_of_clinical_physiology_nuclear_medicine_and_pet,"Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET" +703,0.93095305562019348,55558e55-4e51-404c-bc3c-e9d8644e8ed2,"University Hospitals Of Leicester NHS Trust, Gwendolen Road",university_hospitals_of_leicester_nhs_trust_gwendolen_road,,,,09b03690-5970-415f-b749-e56be3b9df7b,university_hospitals_leicester_nhs_trust,University Hospitals Leicester NHS Trust +10030,,0aed4dd8-7160-11e6-a0cd-0242ac12000b,BAYER PHARMS,bayer_pharms,,,,,, +303,0.991079,7700ad0c-d303-4880-b341-66bdf8c7ad35,Universitätsklinikum Bonn,universit_tsklinikum_bonn,,,,7700ad0c-d303-4880-b341-66bdf8c7ad35,universit_tsklinikum_bonn,Universitätsklinikum Bonn +10031,,22207448-4baf-437f-b560-9c04ec934de7,Stealth Peptides Inc,stealth_peptides_inc,,,,,, +49,0.975369,d8f0d873-4306-4828-b744-12f1d67a0438,SOLVAY PHARMA,solvay_pharma,,,,d8f0d873-4306-4828-b744-12f1d67a0438,solvay_pharma,SOLVAY PHARMA +10032,,3248580f-7045-4c0f-b453-a612abe43947,"Klinik für Dermatologie und Venerologie, Universitätsklinikum Hamburg-Eppendorf",klinik_f_r_dermatologie_und_venerologie_universit_tsklinikum_hamburg_eppendorf,,,,,, +10033,,caac8362-6064-4575-9219-8f88288f36b3,Clinic of University of Wuerzburg,clinic_of_university_of_wuerzburg,,,,,, +10034,,09be5d0a-715e-11e6-a0cd-0242ac12000b,INTELLIPHARMACEUTICS,intellipharmaceutics,,,,,, +10035,,2d6b657a-a745-11e6-94cb-5656d04fc2b5,"Dept. of Gastroenterology, Universityhospital Odense",dept_of_gastroenterology_universityhospital_odense,,,,,, +10036,,778d8d83-9726-463f-a92c-d93850f19f3d,Nottingham City Hospital NHS Trust,nottingham_city_hospital_nhs_trust,,,,,, +10037,,d452e434-b67a-442f-a5a9-f55dbceb31ad,"The Faculty of Pharmaceutical Sciences, University of Copenhagen",the_faculty_of_pharmaceutical_sciences_university_of_copenhagen,,,,,, +20,0.9795151948928833,1e74f773-7ad1-4d34-8164-f40da5329bf6,Charité Campus Mitte,charit_campus_mitte,,,,1e74f773-7ad1-4d34-8164-f40da5329bf6,charit_campus_mitte,Charité Campus Mitte +859,0.9885413646697998,e57eed5c-6041-4ff7-8430-fdf417cb9709,Deutsches Krebsforschungszentrum,deutsches_krebsforschungszentrum,,,,2030c40f-9eb7-4a24-af68-69c831c5fc3c,deutsches_krebsforschungszentrum_dkfz,Deutsches Krebsforschungszentrum (DKFZ +10038,,b599fc56-762f-453c-8190-bb5d43220bac,POPULATION HEART RESEARCH INSTITUTE (PHRI),population_heart_research_institute_phri,,,,,, +10039,,ac979b7b-37cb-4c48-b397-bebf9a614289,PsychoGenics Inc,psychogenics_inc,,,,,, +10040,,e75da28e-b56f-4044-9da7-c0935475b495,Emma Children's Hospital-AMC,emma_children_s_hospital_amc,,,,,, +10041,,e7cbbb7e-a6f6-11e6-94cb-5656d04fc2b5,PHARNEXT SA,pharnext_sa,,,,,, +10042,,0f826434-c1f7-405c-a262-88d30276ae84,H. Universitari Germans Trias i Pujol,h_universitari_germans_trias_i_pujol,,,,,, +10043,,13b1b478-ecf1-4bae-82de-51a309b82533,Clinical Evaluation Research Unit (CERU),clinical_evaluation_research_unit_ceru,,,,,, +10044,,99e178d2-72ed-11e6-a0cd-0242ac12000b,MICROBIX BIOSYSTEMS,microbix_biosystems,,,,,, +10045,,82779b2c-202e-43ab-8408-279fcf27ff80,Universitätsmedizin Mainz (vertreten durch den wissenschaftlichen Vorstand),universit_tsmedizin_mainz_vertreten_durch_den_wissenschaftlichen_vorstand,,,,,, +10046,,9b43c76e-7164-11e6-a0cd-0242ac12000b,ACTAVIS GRP PTC,actavis_grp_ptc,,,,,, +10047,,dc80c294-1e89-41ca-89fe-9d8fca9b8b16,"Medical University Graz, Department of Internal Medicine, Div. Endocrinology and Metabolism",medical_university_graz_department_of_internal_medicine_div_endocrinology_and_metabolism,,,,,, +10048,,f439d63d-669a-447d-a6fa-1c529a24aed5,PHARMATHEN S.A,pharmathen_s_a,,,,,, +10049,,af02c1b9-72b8-49a6-ae20-a751bedb1453,Royal Group of Hospitals Trust,royal_group_of_hospitals_trust,,,,,, +10050,,565294ab-6a8b-485a-9f14-481076123016,SOPHARMA PLC,sopharma_plc,,,,,, +10051,,4d1d848e-7147-11e6-a0cd-0242ac12000b,JACOBUS,jacobus,,,,,, +10052,,12e9e7d4-4e46-4cd3-a79d-ff1dfaa1e1d6,Janssen-Cilag Ltd,janssen_cilag_ltd,,,,,, +10053,,cc01e57f-fd8c-4fab-80bb-955a2b6ebee0,"ROXRO PHARMA, Inc",roxro_pharma_inc,,,,,, +10054,,16768a47-37f1-422b-886b-52457899fcaa,Norfolk and Norwich University Hospital NHS Trust,norfolk_and_norwich_university_hospital_nhs_trust,,,,,, +782,0.985647,fdadcf9b-7cbf-44bf-b227-c8bba5027b31,"Pfizer Corporation Austria Ges.m.b.H., Clinical Research",pfizer_corporation_austria_ges_m_b_h_clinical_research,,,,0b630147-5207-4370-96bb-646e858f6049,pfizer_corporation_austria_ges_m_b_h,Pfizer Corporation Austria Ges.m.b.H +288,0.91965407133102417,5a02f0f0-4b8e-4bcc-b5d9-2bda73ef9a30,"Pfizer Ltd,Ramsgate Road,Sandwich,Kent CT13 9NJ",pfizer_ltd_ramsgate_road_sandwich_kent_ct13_9nj,,,,5a02f0f0-4b8e-4bcc-b5d9-2bda73ef9a30,pfizer_ltd_ramsgate_road_sandwich_kent_ct13_9nj,"Pfizer Ltd,Ramsgate Road,Sandwich,Kent CT13 9NJ" +10055,,cb1518f8-7141-11e6-a0cd-0242ac12000b,SUN PHARM INDS (IN),sun_pharm_inds_in,,,,,, +10056,,a4aabf91-5065-43b4-b868-084a2b7d25fa,"University Hospital of Dermatology, Paracelsus Medical University",university_hospital_of_dermatology_paracelsus_medical_university,,,,,, +10057,,cb6f2042-7258-11e6-a0cd-0242ac12000b,JAZZ PHARMS INTL,jazz_pharms_intl,,,,,, +10058,,0460a697-5a66-4d5d-87cb-b76e4bf259e9,Royal Liverpool University Hospital Clinical Trials 4th floor Linda McCartney Centre,royal_liverpool_university_hospital_clinical_trials_4th_floor_linda_mccartney_centre,,,,,, +655,0.96628576517105103,db6bac4f-e8b7-4b13-b110-67f32f987610,Boehringer Ingelheim International GmbH,boehringer_ingelheim_international_gmbh,,,,a91f8817-005f-4251-808a-ee4efece990a,boehringer_ingelheim_inc,Boehringer Ingelheim Inc +10059,,4788c523-e671-41ba-a37f-5798e026e94d,"Medical University Vienna, Department of Medicine III",medical_university_vienna_department_of_medicine_iii,,,,,, +10060,,8521f468-4008-40f3-a297-24d00b42bc8f,IVAX Pharmaceuticals s.r.o,ivax_pharmaceuticals_s_r_o,,,,,, +10061,,e6255ac6-213f-4cbf-bae6-b5140a497f36,"Merck Corporation, Inc",merck_corporation_inc,,,,,, +1030,0.98681271076202393,d6f3ae13-7f2a-4d8f-a076-2b57239d38c0,"Medical University of Vienna, Department of Internal Medicine IV",medical_university_of_vienna_department_of_internal_medicine_iv,,,,525d2720-5b9f-47f1-b135-6c39bc8e2abf,medical_university_of_vienna_department_of_internal_medicine_ii,"Medical University of Vienna, Department of Internal Medicine II" +10062,,580ea217-20cf-483e-8d26-b00d2eb8a89f,Dr.Gerardo Aguilar Dr.Francisco Martí Hospital Clínico de Valencia Ser. Anestesiología y Reanimación,dr_gerardo_aguilar_dr_francisco_mart_hospital_cl_nico_de_valencia_ser_anestesiolog_a_y_reanimaci_n,,,,,, +10063,,a7f375b6-d551-4484-b004-4b88a6f5aec4,Diagram B.V,diagram_b_v,,,,,, +10064,,e82d36bf-445c-4cb1-b11c-fedb4952117c,"University Hospital Freiburg, represented by the Executive Medical Director (LÄD)",university_hospital_freiburg_represented_by_the_executive_medical_director_l_d,,,,,, +148,0.977699,a3c7b078-642d-4dfa-bfc9-34dd103124ed,"Nuvelo, Inc",nuvelo_inc,,,,a3c7b078-642d-4dfa-bfc9-34dd103124ed,nuvelo_inc,"Nuvelo, Inc" +10065,,261cca47-b158-4a1d-ac89-34d4a21635ca,"Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München",klinik_f_r_herz_und_kreislauferkrankungen_deutsches_herzzentrum_m_nchen,,,,,, +10066,,58914bbe-73f1-11e6-a0cd-0242ac12000b,AIR PRODUCTS AND CHEMICALS INC,air_products_and_chemicals_inc,,,,,, +10067,,2955b565-d1cc-495b-9cca-2c9cd40db19f,CHRU de Lille,chru_de_lille,,,,,, +10068,,d2700898-7154-11e6-a0cd-0242ac12000b,HAEMONETICS,haemonetics,,,,,, +10069,,4ad823ac-42e6-4bc6-b8bd-d0d7ec80790e,C.U.B ERASME HOSPITAL,c_u_b_erasme_hospital,,,,,, +10070,,df61583c-2567-4afc-969f-fe28d4b91dc2,AbbVie Farmacéutica S.L.U,abbvie_farmac_utica_s_l_u,,,,,, +10071,,89480c4e-6a10-43d6-96b5-c69ee2a1619f,CHEMI S.P.A,chemi_s_p_a,,,,,, +10072,,2ebd14ad-4578-44fb-9154-d3d74adaac24,EpiCept Corporation,epicept_corporation,,,,,, +10073,,8e721e44-1ef9-408d-b16e-29ec26b200c2,"Group for the Study of Resistant Depression (GSRD), Head: Prof. Julien Mendlewicz",group_for_the_study_of_resistant_depression_gsrd_head_prof_julien_mendlewicz,,,,,, +10074,,f1a60ffb-485a-419d-ba33-d923eb57dde9,"Clinical Research office, Faculty of Medicine, Imperial College London",clinical_research_office_faculty_of_medicine_imperial_college_london,,,,,, +10075,,bc4cad3a-68e0-4d05-b6ea-89b0653f11a6,Doctor Pere Domingo,doctor_pere_domingo,,,,,, +10076,,b9b15ec9-1874-4f2d-9547-69d83036308d,Psioxus Therapeutics Limited,psioxus_therapeutics_limited,,,,,, +10077,,0ff0f85a-7379-11e6-a0cd-0242ac12000b,ROSS LABS,ross_labs,,,,,, +10078,,b274df96-7269-4450-a0cf-dae183cac063,FUNDACIÓN INVESTIGACIÓN BIOMEDICA DEL HOSPITAL CLINICO SAN CARLOS,fundaci_n_investigaci_n_biomedica_del_hospital_clinico_san_carlos,,,,,, +10079,,4fd8ed7c-7146-11e6-a0cd-0242ac12000b,ARMSTRONG PHARMS,armstrong_pharms,,,,,, +10080,,2a0814e6-61f7-4c27-91ff-72027301223f,Pediatrics,pediatrics,,,,,, +542,0.985178,f737f443-0a5d-4e9c-bf82-73abc35c1591,"Skåne University Hospital, Region Skåne",sk_ne_university_hospital_region_sk_ne,,,,6ac48511-e29b-45d9-a99a-d067f972f24e,sk_ne_university_hospital,Skåne University Hospital +10081,,89967321-3905-4f79-bf87-0070c189a9a8,TAKEDA EUROPE RESEARCH DEVELOPMENT CENTRE LTD,takeda_europe_research_development_centre_ltd,,,,,, +10082,,6e91ec72-6158-41f2-b9a4-f0b20f9e3938,Pfizer Health AB,pfizer_health_ab,,,,,, +1014,0.9886435866355896,659a4aa2-7f2f-4ed8-918a-4c0718e095e4,Institut de Recherches Internationales Servier,institut_de_recherches_internationales_servier,,,,9b368f8e-02db-4935-a1a6-f2a417efa7ee,institut_de_recherches_internationales_servier,Institut de Recherches Internationales Servier +347,0.98146516084671021,c87289ab-105a-4af8-9f77-3834c61e7738,Medizinische Universität Wien Universitätsklinik für Innere Medizin III,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_iii,,,,71cd8e41-b876-47b3-8b6f-d8c4063fa62c,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_iii_rheumatologie,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin III/Rheumatologie" +10083,,cd5596eb-1bf3-4d7d-845f-8eb5aac9dbb8,Biofrontera Bioscience GmbH,biofrontera_bioscience_gmbh,,,,,, +10084,,5c261c57-65b9-46e3-987c-427e7c18ac23,SERONO INTERNATIONAL SA,serono_international_sa,,,,,, +10085,,c79a18ac-7157-11e6-a0cd-0242ac12000b,PRECISION DOSE,precision_dose,,,,,, +10086,,5c23a278-7161-11e6-a0cd-0242ac12000b,NUMARK,numark,,,,,, +229,0.985968,561e61dc-6283-4645-bc8b-b9c9b73b81df,The National Institute of Allergy and Infectious Diseases (NIAID),the_national_institute_of_allergy_and_infectious_diseases_niaid,,,,458254a2-d310-4f72-a0ef-d961ef0c56e4,the_national_institute_of_allergy_and_infectious_diseases_niaid_and_the_eunice_kennedy_shriver_nichd,The National Institute of Allergy and Infectious Diseases (NIAID) And The Eunice Kennedy Shriver NICHD +931,0.95429873466491699,ee1d91c1-0d9e-47fa-b4e7-22a6f46f9512,Pierre Fabre Dermatologie represented by the Institut de Recherche Pierre Fabre (IRPF),pierre_fabre_dermatologie_represented_by_the_institut_de_recherche_pierre_fabre_irpf,,,,ee1d91c1-0d9e-47fa-b4e7-22a6f46f9512,pierre_fabre_dermatologie_represented_by_institut_de_recherche_pierre_fabre,Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre +1066,0.919718,7fc76cbf-40fd-40a1-bb0f-7c003ab4ea5a,Universitätsklinikum Tuebingen,universit_tsklinikum_tuebingen,,,,36b27479-ba79-4094-93f3-0a7496de4aec,universit_tsklinikum_t_bingen,Universitätsklinikum Tübingen +10087,,d5efd4a7-6f1a-42b9-83c1-8abada3b3703,LEO Pharma A/S,leo_pharma_a_s,,,,,, +10088,,0250778f-ba8c-4812-b959-c2f82b224312,Società Italian di Cardiologia Invasiva GISE,societ_italian_di_cardiologia_invasiva_gise,,,,,, +10089,,5d3d3fa4-6fa2-11e6-9663-0242ac12000b,Forschergruppe Diabetes e. V,forschergruppe_diabetes_e_v,,,,,, +10090,,7bc00e2d-bb9f-4155-aedf-1721ab52eab6,"SGX Pharmaceuticals, Inc",sgx_pharmaceuticals_inc,,,,,, +215,0.983343,4e062918-7206-11e6-a0cd-0242ac12000b,LEO PHARM,leo_pharm,,,,138e388c-71e0-11e6-a0cd-0242ac12000b,leo_pharma_as,LEO PHARMA AS +472,0.983628,df7a54fe-5a24-418d-b267-24c04fc18922,"Rigshospitalet, Copenhagen University Hospital",rigshospitalet_copenhagen_university_hospital,,,,77d74083-7ff5-4dec-88ac-be73492f43ab,rigshospitalet_copenhagen,"Rigshospitalet, Copenhagen" +10091,,008ae81b-1f3d-4674-a5ca-7d616813b953,"Takeda Vaccines, Inc",takeda_vaccines_inc,,,,,, +10092,,908f869e-5f75-4b26-845a-0c9a9e3b07a2,GEIS,geis,,,,,, +10093,,17c51b4c-db01-40d3-8c51-840a442eddee,Ospedale San Raffaele s.r.l,ospedale_san_raffaele_s_r_l,,,,,, +10094,,b741c0b0-fced-4f96-9bf8-8272801d34d5,Amgen Ltd,amgen_ltd,,,,,, +10095,,490cae12-f7fa-448f-af27-03c107a61234,"Dr GED DEMPSEY, University Hospital Aintree",dr_ged_dempsey_university_hospital_aintree,,,,,, +10096,,1c13ab46-d344-48d5-8bd7-558fa9be71b8,EISAI INC,eisai_inc,,,,,, +10097,,7352e427-6389-489f-bcea-4a0b4887e854,Masaryk University,masaryk_university,,,,,, +10098,,34cc737b-5ae6-4508-a0f7-c5b82ff2c44d,"Imperial College, Research Governance Manager",imperial_college_research_governance_manager,,,,,, +10099,,74392463-96a7-45bc-81e2-8784387c73b9,AZIENDA UNIVERSITARIA OSPEDALE POLICLINICO UMBERTO I,azienda_universitaria_ospedale_policlinico_umberto_i,,,,,, +10100,,62ce3cb6-3c39-4507-95c4-a01e3305dfc8,"Dept. of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital",dept_of_endocrinology_metabolism_and_diabetes_karolinska_university_hospital,,,,,, +10101,,d45bd2f0-71cb-11e6-a0cd-0242ac12000b,UNIV AZ CANCER CTR,univ_az_cancer_ctr,,,,,, +10102,,39317cd7-1798-433d-be84-f5232165af52,Sepracor NV in care of Sepracor Inc,sepracor_nv_in_care_of_sepracor_inc,,,,,, +10103,,68df16e2-0f07-4904-912e-5cd23c494e63,"Ambrx, Inc., USA",ambrx_inc_usa,,,,,, +10104,,491e2bd6-7129-11e6-a89e-0242ac12000b,RHODES PHARMS,rhodes_pharms,,,,,, +735,0.98422527313232422,31be07a8-192d-4b34-981f-bf106aeff976,European Organization for Research and Treatment of Cancer (EORTC),european_organization_for_research_and_treatment_of_cancer_eortc,,,,6e92b00d-0791-4d8e-975c-0fbd5ce95861,european_organisation_for_research_and_treatment_of_cancer,European Organisation for Research and Treatment of Cancer +937,0.975369,79097abc-72e1-11e6-a0cd-0242ac12000b,CUBIST PHARMS,cubist_pharms,,,,2ff28a2a-72bf-11e6-a0cd-0242ac12000b,cubist,CUBIST +10105,,32440aa2-7bb8-4c55-9aa7-3751c9ce8be4,Pfizer Inc - 235 East 42nd Street - New York - 10017,pfizer_inc_235_east_42nd_street_new_york_10017,,,,,, +10106,,cbb5503c-8754-4a37-8bd5-9e90e5da3e56,DermaTools Biotech GmbH,dermatools_biotech_gmbh,,,,,, +10107,,67234f74-ae1b-4dad-9318-f8e54aa2d701,Helsingin Diakonissalaitos,helsingin_diakonissalaitos,,,,,, +10108,,6f92667f-3022-455f-9953-070893e46362,NicOx S.A,nicox_s_a,,,,,, +10109,,c1f669a0-4aa5-4b3c-949f-ad27c139e5d2,Xenikos BV,xenikos_bv,,,,,, +10110,,bc7f2d30-791e-4ae4-b8cf-ab06543f172a,Fundación para la Investigación Biomédica del Hospital Clínico San Carlos,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_cl_nico_san_carlos,,,,,, +250,0.95617127418518066,7cdbb89e-7aec-4433-a865-e63e0ce3d9d8,NMDSG,nmdsg,,,,5071919f-1373-4a28-b00e-8112a8b47ef4,nmdsg_nordic_myelodysplastic_syndrom_group,NMDSG Nordic Myelodysplastic Syndrom Group +10111,,fa4604dd-c8d9-441e-85c0-8324409f6e69,Vestfold Hospital,vestfold_hospital,,,,,, +10112,,445e9711-1c79-480d-97cb-56a85ca90a8b,HEXAL AG (Project Management on behalf of the Sponsor: HEXAL Pharmaforschung GmbH,hexal_ag_project_management_on_behalf_of_the_sponsor_hexal_pharmaforschung_gmbh,,,,,, +10113,,19bd88cc-ede6-4c0f-a2d2-1a8647b5f56e,Rode Kruis Ziekenhuis,rode_kruis_ziekenhuis,,,,,, +10114,,92418278-4c31-474a-bb2b-7b83eb54e5bb,Universitaetsklinikum Muenster,universitaetsklinikum_muenster,,,,,, +10115,,3a3bc7d8-c7f2-4f22-a975-6457b904290e,Celerion,celerion,,,,,, +10116,,61a541e4-95e8-4551-afbb-fecc8dfe1728,"LOTUS PHARMACEUTICAL CO., LTD",lotus_pharmaceutical_co_ltd,,,,,, +10117,,a187a682-71ae-11e6-a0cd-0242ac12000b,RORER,rorer,,,,,, +10118,,1fb63f1a-f9fa-426a-93df-7ff2d8fe060c,Dr. Juan Macías Sánchez,dr_juan_mac_as_s_nchez,,,,,, +10119,,4d60f160-6ed5-428c-b11b-0b07d231b6c3,Gesellschaft für Medizinische Innovation –Hämatologie und Onkologie mbH (GMIHO),gesellschaft_f_r_medizinische_innovation_h_matologie_und_onkologie_mbh_gmiho,,,,,, +10120,,612647ea-7142-11e6-a0cd-0242ac12000b,KING PFIZER,king_pfizer,,,,,, +10121,,4b880a0e-a344-4e98-abce-1c5466e2d6dd,Bayer Inc,bayer_inc,,,,,, +10122,,745dc5b1-ad84-41f5-81c9-6acf098edce8,Pharmacia & Upjohn S.A,pharmacia_upjohn_s_a,,,,,, +10123,,a2d8db21-bb5d-439c-a20a-5d5ce9368e22,"HUS, Lasten ja nuorten sairaala",hus_lasten_ja_nuorten_sairaala,,,,,, +10124,,7fbcd71c-7deb-4c5d-a3a2-d1b3af5e1bf8,National Kapodistrian University of Athens,national_kapodistrian_university_of_athens,,,,,, +10125,,15b79ea4-8ed0-493c-a6a3-99678dc855fc,Otto-von-Guericke Universität Magdeburg,otto_von_guericke_universit_t_magdeburg,,,,,, +10126,,4025e5c6-2450-4502-96ab-c65547a09f16,FARMACUSI S.A. (filial of LEO Pharma),farmacusi_s_a_filial_of_leo_pharma,,,,,, +10127,,af0b84cc-a658-47d5-9a72-35b1d96457c0,Istituto Oncologico Veneto – IOV‐IRCCS,istituto_oncologico_veneto_iov_irccs,,,,,, +10128,,674b4dd3-636d-4604-ade5-b5f5b297da83,"Dicerna Pharmaceuticals, Inc",dicerna_pharmaceuticals_inc,,,,,, +10129,,e944266f-9175-48d6-8374-9a539429b7ac,Agensys Inc,agensys_inc,,,,,, +10130,,ef50cff1-1eb4-4858-8ae4-a146e603b496,Sint Maartenskliniek,sint_maartenskliniek,,,,,, +383,0.98719912767410278,8cc2488d-6698-4a3c-8f87-631bed226148,DBV Technologies,dbv_technologies,,,,cf4f2be5-6c16-4774-80da-73c264a99c4c,dbv_technologies,DBV Technologies +10131,,5f629479-bb48-491f-82fe-ce94df0a5b9a,Oslo Universitetssykehus,oslo_universitetssykehus,,,,,, +10132,,258f9d1d-961c-4bcd-bc04-0469ba64c58a,"MUW, Universitätsklinik für Innere Medizin I, Abteilung für Infektionskrankheiten und Tropenmedizin",muw_universit_tsklinik_f_r_innere_medizin_i_abteilung_f_r_infektionskrankheiten_und_tropenmedizin,,,,,, +10133,,0296eae0-aa16-4acc-9ed8-f01df305e7b7,The Heartbeat Trust,the_heartbeat_trust,,,,,, +10134,,c6cfd422-7d49-48b5-aec2-fee5d5db2d5b,HENNIG ARZNEIMITTEL GmbH & Co. KG,hennig_arzneimittel_gmbh_co_kg,,,,,, +232,0.98418444395065308,455b5028-7142-11e6-a0cd-0242ac12000b,ACS DOBFAR,acs_dobfar,,,,455b5028-7142-11e6-a0cd-0242ac12000b,acs_dobfar,ACS DOBFAR +10135,,381f83fb-d620-43c9-895d-9f7daa6d7f35,Wirral Hospitals NHS Trust,wirral_hospitals_nhs_trust,,,,,, +10136,,52a162e6-7146-11e6-a0cd-0242ac12000b,ALVOGEN MALTA,alvogen_malta,,,,,, diff --git a/processors/base/processors/trial.py b/processors/base/processors/trial.py index 426f2e5..73a5703 100644 --- a/processors/base/processors/trial.py +++ b/processors/base/processors/trial.py @@ -28,6 +28,12 @@ def process_trials(conn, table, extractors): errors = 0 success = 0 + + stored_organisations = list(conn['database']['organisations'].all()) + stored_organisation_names = [entry['name'] for entry in stored_organisations] + + organisation_clusters = helpers.get_organisation_clusters(stored_organisations) + for record in helpers.iter_rows(conn, 'warehouse', table, orderby='meta_id'): conn['database'].begin() @@ -63,7 +69,6 @@ def process_trials(conn, table, extractors): # Write other entities if is_primary: - # Delete existent relationships conn['database']['trials_conditions'].delete(trial_id=trial_id) conn['database']['trials_interventions'].delete(trial_id=trial_id) @@ -101,6 +106,9 @@ def process_trials(conn, table, extractors): # Extract and write organisations/relationships organisations = extractors['extract_organisations'](record) for organisation in organisations: + if organisation['name'] in stored_organisation_names: + organisation['name'] = helpers.normalize_organisation_name( + organisation['name'], organisation_clusters) org_id = writers.write_organisation(conn, organisation, source_id) if org_id is None: continue @@ -120,11 +128,11 @@ def process_trials(conn, table, extractors): errors += 1 conn['database'].rollback() logger.exception('Processing error: %s [%s]', - repr(exception), errors) + repr(exception), errors) else: success += 1 conn['database'].commit() if not success % 100: logger.info('Processed %s trials from %s', - success, table) + success, table) diff --git a/requirements.txt b/requirements.txt index 5deb4cf..855095b 100644 --- a/requirements.txt +++ b/requirements.txt @@ -12,3 +12,5 @@ pybossa-client fuzzywuzzy python-Levenshtein iso3166 +dedupe +unidecode From 3d37b6f22d6bd47c5b0150df55cecfe9ca0ab64f Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Wed, 1 Feb 2017 16:32:11 -0300 Subject: [PATCH 02/23] Saving cluster in warehouse to optimize further access --- processors/base/helpers/__init__.py | 62 +- .../data/organisation_training_data.csv | 11470 ---------------- .../data/organisation_training_data.json | 1 + processors/base/processors/trial.py | 15 +- 4 files changed, 50 insertions(+), 11498 deletions(-) delete mode 100644 processors/base/helpers/data/organisation_training_data.csv create mode 100644 processors/base/helpers/data/organisation_training_data.json diff --git a/processors/base/helpers/__init__.py b/processors/base/helpers/__init__.py index cad4ba7..b4a00ce 100644 --- a/processors/base/helpers/__init__.py +++ b/processors/base/helpers/__init__.py @@ -24,10 +24,8 @@ logger = logging.getLogger(__name__) PyBossaTasksUpdater = pybossa_tasks_updater.PyBossaTasksUpdater - # Module API - def get_variables(object, filter=None): """Exract variables from object to dict using name filter. """ @@ -340,7 +338,7 @@ def _dedup_cluster(cluster_entries): """ MATCH_THRESHOLD = 0.5 - TRAINING_FILE = os.path.join(os.path.dirname(__file__), 'data/organisation_training_data.csv') + TRAINING_FILE = os.path.join(os.path.dirname(__file__), 'data/organisation_training_data.json') fields = [{'field' : 'name', 'type': 'String'}] deduper = dedupe.Dedupe(fields) @@ -353,7 +351,7 @@ def _dedup_cluster(cluster_entries): return deduper.match(cluster_entries, MATCH_THRESHOLD) -def get_organisation_clusters(org_list): +def compute_organisation_clusters(conn, new_cluster_entry=None): """Build an usable list of clusters to be used when normalizing new entries @@ -362,34 +360,58 @@ def get_organisation_clusters(org_list): stored on database """ - logger.debug('Generating organisations cluster data') + logger.debug('Recomputing organisations cluster data for further access') + + conn['warehouse'].begin() + conn['warehouse']['organisation_clusters'].delete() + + stored_organisations = list(conn['database']['organisations'].all()) cluster_members = {entry['id']: {'name': unidecode.unidecode(entry['name'])} - for entry in org_list} + for entry in stored_organisations} + + if new_cluster_entry: + cluster_members[uuid.uuid1().hex] = {'name': new_cluster_entry} + clustered_dupes = _dedup_cluster(cluster_members) - extended_clusters = [] for (_, cluster) in enumerate(clustered_dupes): id_set, _ = cluster - cluster_d = [cluster_members[c]['name'] for c in id_set] - extended_clusters.append(cluster_d) + cluster_membership = [str(cluster_members[c]['name']) for c in id_set] - return extended_clusters + cluster = { + 'canonical': max(cluster_membership, key=len).replace("'", "''"), + 'variations': cluster_membership + } -def normalize_organisation_name(organisation, org_clusters): + conn['warehouse']['organisation_clusters'].insert(cluster) + + conn['warehouse'].commit() + +def normalize_organisation_name(conn, organisation): """Find a canonical organisation name according to a pre-built set of clusters Args: location (str): the organisation to be normalized """ + CLUSTER_QUERY = "SELECT canonical FROM organisation_clusters WHERE '%s'=ANY(variations)" + ORG_QUERY = "SELECT COUNT(*) from organisations WHERE name='%s'" - normalized_organisation = organisation - # Try to find the organisation into any of the clusters - for cluster in org_clusters: - if organisation in cluster: - normalized_organisation = max(cluster, key=len) - break - logger.debug('Organisation "%s" normalized as "%s"', organisation, normalized_organisation) - # Return itself if there's no cluster containing that org (org is unique) - return normalized_organisation + normalized_form = None + query = CLUSTER_QUERY % organisation + # Try to find the organisation in some cluster + try: + normalized_form = conn['warehouse'].query(query).next()['canonical'] + except StopIteration: + query = ORG_QUERY % organisation + # If organisation already exists, return itself + if int(conn['database'].query(query).next()['count']) > 0: + normalized_form = organisation + else: + # TODO Check if it's valid to add this overhead to the processors + compute_organisation_clusters(conn, new_cluster_entry=organisation) + normalized_form = normalize_organisation_name(conn, organisation) + + logger.debug('Organisation "%s" normalized as "%s"', organisation, normalized_form) + return normalized_form diff --git a/processors/base/helpers/data/organisation_training_data.csv b/processors/base/helpers/data/organisation_training_data.csv deleted file mode 100644 index 2e4a493..0000000 --- a/processors/base/helpers/data/organisation_training_data.csv +++ /dev/null @@ -1,11470 +0,0 @@ -Cluster ID,confidence_score,id,name,slug,,,canonical_,canonical_id,canonical_slug,canonical_name -1082,,0bcc726f-6130-4d98-b550-7de1761bda43,Justus Liebig Universität Gießen,justus_liebig_universit_t_gie_en,,,,,, -1083,,685b050c-ed03-45df-b7ed-8f914b10114f,"Department of Obstetrics and Gynecolog, Randers Centralsygehusy",department_of_obstetrics_and_gynecolog_randers_centralsygehusy,,,,,, -236,0.94672501087188721,773e090f-d432-4405-870d-7cc6cc5ee44e,"Pfizer Ltd. Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK",pfizer_ltd_ramsgate_road_sandwich_kent_ct13_9nj_uk,,,,36e40cab-06cf-41e0-bef3-04e11a49311d,pfizer_ltd_ramsgate_road_sandwich_kent,"Pfizer Ltd, Ramsgate Road, Sandwich, Kent" -1084,,341cc510-7158-11e6-a0cd-0242ac12000b,CIPLA,cipla,,,,,, -1085,,a3402450-cde4-4e28-8477-fee965743a62,Alfact Innovation,alfact_innovation,,,,,, -459,0.95726326107978821,fa56fa20-0cae-4922-8edb-783fd6898a45,"Janssen-Cilag International N.V., Turnhoutseweg 30, 2340 Beerse, Belgium",janssen_cilag_international_n_v_turnhoutseweg_30_2340_beerse_belgium,,,,caa9eeff-a0fe-407d-8a39-097924dbd94c,janssen_cilag_international_n_v_turnhoutseweg_30_2340_beerse_belgium,"Janssen-Cilag International N.V., Turnhoutseweg 30, 2340 Beerse, Belgium" -1086,,a7f32198-0a3e-4944-9e0a-687a9adcef24,Universitätsklinikum Essen - Zentrum für Innere Medizin - Klinik für Endokrinologie,universit_tsklinikum_essen_zentrum_f_r_innere_medizin_klinik_f_r_endokrinologie,,,,,, -1087,,fae4fcf2-9a6d-425b-ab65-1b9e6f3aa25c,Digna Biotech S.L,digna_biotech_s_l,,,,,, -900,0.955805,578a311e-a483-4d9f-906e-cd1723e08711,Chiesi Farmaceutici S.p.A,chiesi_farmaceutici_s_p_a,,,,578a311e-a483-4d9f-906e-cd1723e08711,chiesi_farmaceutici_s_p_a,Chiesi Farmaceutici S.p.A -1088,,93620f8f-105f-433c-94e0-860b7f3bf880,Belgian Society of Medical Oncology,belgian_society_of_medical_oncology,,,,,, -1089,,01d24c67-0656-4b41-b0d3-4e021e6f474d,"Nycomed Danmark ApS, International Medical Affairs",nycomed_danmark_aps_international_medical_affairs,,,,,, -1090,,a121f538-9a44-4514-b2dc-eb693b1e50d3,AXXONIS PHARMA GMBH,axxonis_pharma_gmbh,,,,,, -1091,,d9525d1e-b581-4145-8cc2-5776d2639c45,TxCell,txcell,,,,,, -1092,,d00926f9-c59d-4035-b6ce-ed0b58fa5a5a,Kitov Pharmaceuticals Ltd,kitov_pharmaceuticals_ltd,,,,,, -1093,,cb2f077b-f1f1-4532-b11a-08dc14984a21,"Delcath Systems, Inc",delcath_systems_inc,,,,,, -1094,,5b0c28bc-306c-4acd-9c6a-39bc9300ba95,"Nile Therapeutics, Inc",nile_therapeutics_inc,,,,,, -1095,,bd312691-a403-45d9-a2d7-132751eea0f5,TOPIVERT Pharma Limited,topivert_pharma_limited,,,,,, -493,0.98653608560562134,d264e962-7141-11e6-a0cd-0242ac12000b,AMNEAL PHARM,amneal_pharm,,,,d264e962-7141-11e6-a0cd-0242ac12000b,amneal_pharms,AMNEAL PHARMS -1096,,7c9b2132-b2f6-4392-88b9-69cf11dc9075,Danish University of Pharmaceutical Sciences,danish_university_of_pharmaceutical_sciences,,,,,, -1097,,206b7df2-2e79-4123-97f1-5c2590f319c3,Inventiva SAS,inventiva_sas,,,,,, -1098,,1dae84f9-4277-453d-91ad-f375a7889f4a,Dept. of Infectious diseases / virology University of Gothenburg,dept_of_infectious_diseases_virology_university_of_gothenburg,,,,,, -1099,,3ebd7cbe-6f04-4bfe-8e34-9272aa8449aa,Swiss Group for Clinical Cancer Reaserch (SAKK),swiss_group_for_clinical_cancer_reaserch_sakk,,,,,, -1100,,74c9ea7a-0b5a-474d-8016-eba5358c71cd,"Coloplast A/S, Consumer Products",coloplast_a_s_consumer_products,,,,,, -1101,,87df94e1-8c6e-4914-acc6-a2e6daadde1b,"LUMC, Department Infection Disease",lumc_department_infection_disease,,,,,, -783,0.988564,7e086a89-ce6e-4201-a20f-f377b113a14a,Friedrich Schiller University Jena,friedrich_schiller_university_jena,,,,7e086a89-ce6e-4201-a20f-f377b113a14a,friedrich_schiller_university_jena,Friedrich Schiller University Jena -925,0.96910750865936279,844eaa65-2406-4ab1-9c51-75be91cc2736,LUMC,lumc,,,,844eaa65-2406-4ab1-9c51-75be91cc2736,lumc,LUMC -1102,,43f54556-29fe-4aff-8541-4798a7b00184,"Ark Therapeutics, Ltd",ark_therapeutics_ltd,,,,,, -1103,,1be23313-1080-4009-bdb4-41cf53132903,Vectura Limited,vectura_limited,,,,,, -1104,,5b410d48-f53c-461b-a9ef-9228e7d16eb8,Rodrigo Aguilera,rodrigo_aguilera,,,,,, -947,0.98283,3d9cc66f-e29e-4146-9f7e-6baf8b6a7b2e,Hospital Clínic,hospital_cl_nic,,,,3d9cc66f-e29e-4146-9f7e-6baf8b6a7b2e,hospital_cl_nic,Hospital Clínic -1105,,5e7e8fa3-07af-4c0e-bde5-05bed4ed177d,AZIENDA OSPEDALIERA UNIVERSITARIA SAN MARTINO GENOVA,azienda_ospedaliera_universitaria_san_martino_genova,,,,,, -1106,,da34504e-153b-4cd3-8ed6-1e24ecb96abd,Medizinische Universität Innsbruck / Allg. u. chirug. Intensivmedizin,medizinische_universit_t_innsbruck_allg_u_chirug_intensivmedizin,,,,,, -1107,,b5919966-d90d-42f3-ba77-7b50b2f3f8bf,SFJ Pharma Ltd. II,sfj_pharma_ltd_ii,,,,,, -1108,,085fad23-7eb6-4a25-bd05-9518cd77a48e,ALEXION PHARMACEUTICALS INCORPORATED,alexion_pharmaceuticals_incorporated,,,,,, -1109,,102808f8-9c78-4560-9fc5-8a62863aa81b,SAKK Swiss Group for Clinical Cancer Research,sakk_swiss_group_for_clinical_cancer_research,,,,,, -1110,,66449089-8b55-4739-ae2c-e5dafe79ec6d,"Protherics Salt Lake City, Inc",protherics_salt_lake_city_inc,,,,,, -1111,,eb3df69f-4546-4938-b7a3-64b5ce006a5a,Valletta Health BV,valletta_health_bv,,,,,, -1112,,dd6a0d1c-faf9-40e4-b5b6-1359f7412edc,Jorge Alonso Zafra,jorge_alonso_zafra,,,,,, -1113,,e38a8829-3b07-4403-91c8-57c61c331d1e,Bombastus-Werke AG,bombastus_werke_ag,,,,,, -1114,,1de2254b-38b4-4ec4-bdcd-0cec65691870,Asociación Instituto Biodonostia,asociaci_n_instituto_biodonostia,,,,,, -1115,,6b0b04dc-f900-4b57-9764-eb8a7ec5acf6,South Manchester University Hospital NHS Trust,south_manchester_university_hospital_nhs_trust,,,,,, -1116,,e78cf862-14ba-4a09-a057-f1e296fa7a70,University of New South Wales,university_of_new_south_wales,,,,,, -1117,,c532e84d-37ae-47e1-8d59-1fe9b7b85f84,Uniklinikum Tuebingen,uniklinikum_tuebingen,,,,,, -1118,,48fc7a5a-a19f-4635-bc54-53ff1b721914,"Department of Anesthesiology and Operative Intensive Care Medicine, Charité (CBF)",department_of_anesthesiology_and_operative_intensive_care_medicine_charit_cbf,,,,,, -1119,,c015bcd2-0131-47b0-8c25-da262e82688f,Dr. Martin Pinsger & Univ.-Prof. Dr. Rupert Prokesch,dr_martin_pinsger_univ_prof_dr_rupert_prokesch,,,,,, -1120,,945770d2-8bd0-11e6-a449-0242ac12000b,Flamel Ireland Limited,flamel_ireland_limited,,,,,, -1121,,8b724bde-0581-449c-a20a-a59a7e9ed470,Stanmore Clinical Research Facility Ltd,stanmore_clinical_research_facility_ltd,,,,,, -677,0.981509,22accd65-c14d-4d5b-acab-c1bb9180b01d,"Christian Geisler, Righospitalet, dept. Haematology 4042",christian_geisler_righospitalet_dept_haematology_4042,,,,22accd65-c14d-4d5b-acab-c1bb9180b01d,christian_geisler_righospitalet_dept_haematology_4042,"Christian Geisler, Righospitalet, dept. Haematology 4042" -1122,,d41fa9dd-13f0-48aa-9efd-efc87b4186f0,Cruz Bartolome Moreno,cruz_bartolome_moreno,,,,,, -1123,,f185757e-5452-4936-ac54-6a6b96c6a00a,Avexa Limited,avexa_limited,,,,,, -1124,,9f2c6bce-7164-11e6-a0cd-0242ac12000b,IDENTI PHARMS INC,identi_pharms_inc,,,,,, -393,0.941004,b8f2d360-526a-43ca-87db-757c93078a81,Pantec Biosolution AG,pantec_biosolution_ag,,,,6cd8a498-2fe7-40c6-b305-fa69e84aa23d,pantec_biosolutions_ag,Pantec Biosolutions AG -1125,,a98ec312-d088-4c03-bcfa-9564b67d9ff4,Gasthuisberg Leuven,gasthuisberg_leuven,,,,,, -1126,,5bab5133-43b0-453b-8dd3-250fddc47961,Greenpark Healthcare Trust,greenpark_healthcare_trust,,,,,, -368,0.95132752259572351,554078a3-61dd-4b6c-ac18-7ca2d6b7f6eb,"Bayer HealthCare AG, D-51368 Leverkusen Germany",bayer_healthcare_ag_d_51368_leverkusen_germany,,,,0f2245d6-1eb2-4a26-ba28-2ddd66aada58,bayer_healthcare_ag_51368_leverkusen,"Bayer HealthCare AG, 51368 Leverkusen" -1127,,4c9fbb8b-a98b-44c5-ae26-c024e61fdaed,HARRAS-PHARMA-CURARINA GmbH,harras_pharma_curarina_gmbh,,,,,, -1128,,9f1e82ad-baff-445a-b5a8-c33415868459,Gedeon Richter Ltd,gedeon_richter_ltd,,,,,, -1129,,23bcda38-5e3a-4536-9e52-31d508fbbbbc,KYS,kys,,,,,, -1130,,7b811b3f-ceb9-4d0f-8401-6a5744a31032,"BHR PHARMA, LLC",bhr_pharma_llc,,,,,, -1131,,bfb0a553-12ce-48c9-955a-eed9dc534ffa,Renal Clinic Heidelberg,renal_clinic_heidelberg,,,,,, -1132,,1f069a1f-6273-4ffa-973a-59db06dfd60b,Associació Catalana per a la Recerca Oncológica i les seves implicacions Sanitáries i Socials,associaci_catalana_per_a_la_recerca_oncol_gica_i_les_seves_implicacions_sanit_ries_i_socials,,,,,, -1133,,2a2e0f46-3bab-4f08-a5e6-c89ed6cb06ab,Augenklinik Universitaetsallee,augenklinik_universitaetsallee,,,,,, -1134,,02707a4d-90f9-40d4-b5e5-e1a6c6d80718,Academic MS Center Limburg,academic_ms_center_limburg,,,,,, -1135,,bf9e4b8e-2e0b-476c-a7be-c36b7b50f24e,Institut d'Anesthésiologie des Alpes Maritimes,institut_d_anesth_siologie_des_alpes_maritimes,,,,,, -1136,,56e143d4-eed3-4b7b-b97e-7ed9a4fd3d2d,"Medicinsk Afd. M, Århus Sygehus, Nørrebrogade",medicinsk_afd_m_rhus_sygehus_n_rrebrogade,,,,,, -1137,,453a2e1d-8382-49c5-89ea-788dde31dd55,Kungälv Hospital,kung_lv_hospital,,,,,, -248,0.981904,101cc2b8-71b8-11e6-a0cd-0242ac12000b,HILL DERMAC,hill_dermac,,,,101cc2b8-71b8-11e6-a0cd-0242ac12000b,hill_dermac,HILL DERMAC -1138,,997acf9c-739c-11e6-a0cd-0242ac12000b,GASTROENTERO,gastroentero,,,,,, -1139,,b649833c-76bd-4a9b-b7ba-b6618aa8f368,MediGene AG,medigene_ag,,,,,, -1140,,7239deff-df7d-4838-9ee0-a4a2b153b4a2,PEPTONIC medical AB,peptonic_medical_ab,,,,,, -1141,,c029a266-ac32-4a07-9bed-84d734711102,"ERASMUS MC, Dept Anesthesiology",erasmus_mc_dept_anesthesiology,,,,,, -1142,,d02bffb2-5a4f-4182-82a7-88cba3b0cf5c,Prof Vassilis Georgoulias,prof_vassilis_georgoulias,,,,,, -1143,,262bf37c-6dc1-4b63-b609-ce8a1769dc2f,Julio A Virseda Rodriguez,julio_a_virseda_rodriguez,,,,,, -1144,,1e4335b0-7164-11e6-a0cd-0242ac12000b,CHINA RESOURCES,china_resources,,,,,, -1145,,5000330c-715d-11e6-a0cd-0242ac12000b,AUSTARPHARMA LLC,austarpharma_llc,,,,,, -1146,,9b1c6698-a41f-4c3e-adc7-9d81f73ed568,Bayer HealthCare Aktiengesellschaft,bayer_healthcare_aktiengesellschaft,,,,,, -1147,,f5104ada-7495-4088-bb35-2fe6539a5ae2,Dr. Christian Domingo,dr_christian_domingo,,,,,, -1148,,86cdb35c-95e5-4bb7-8493-01bc4e87d1b2,HSK Research GmbH,hsk_research_gmbh,,,,,, -562,0.979163,2618aeee-2b40-46b0-83e0-69a85a4447c6,Glaxo SmithKine Research and Development Limited,glaxo_smithkine_research_and_development_limited,,,,2618aeee-2b40-46b0-83e0-69a85a4447c6,glaxo_smithkine_research_and_development_limited,Glaxo SmithKine Research and Development Limited -1149,,5c4c0109-e5c9-4d12-9699-392fef444445,Provexis Plc,provexis_plc,,,,,, -574,0.96224385499954224,fe7a9983-1939-4f96-adc3-8176dcaae168,Queen Mary University of London,queen_mary_university_of_london,,,,8567fa14-efb0-4bb0-9c97-bf093f58ba24,queen_mary_university_of_london_qmul,"Queen Mary, University of London (QMUL)" -1150,,16230cf5-b7a9-4308-a324-bdf5830582f0,Alliance Pharmaceuticals,alliance_pharmaceuticals,,,,,, -1151,,18dd6240-fd14-435d-9848-fb6c6f1f5a9b,"Kémia, Inc",k_mia_inc,,,,,, -1152,,819d165e-40be-4ef3-b85f-03a6b1bbca0c,Aventis Pharma Recherche De ve loppement,aventis_pharma_recherche_de_ve_loppement,,,,,, -1153,,8c474d43-c5f5-43c2-af49-da46918b5d4b,ikfe – Institute for Clinical Research and Development,ikfe_institute_for_clinical_research_and_development,,,,,, -257,0.943406,62b269c4-7163-11e6-a0cd-0242ac12000b,MACLEODS PHARMA,macleods_pharma,,,,62b269c4-7163-11e6-a0cd-0242ac12000b,macleods_pharma,MACLEODS PHARMA -1154,,99ebe893-62a6-41ed-821a-188b78e041da,Daiichi Medical Research Inc,daiichi_medical_research_inc,,,,,, -503,0.9617990255355835,1e7e8025-6216-4754-a0a3-b1cf72ba2a3d,Sanofi-Synthelabo Research,sanofi_synthelabo_research,,,,1e7e8025-6216-4754-a0a3-b1cf72ba2a3d,sanofi_synthelabo_research,Sanofi-Synthelabo Research -1155,,cffe7e9c-f52f-489f-9d32-0cdf00536513,Forum Pharmaceuticals Inc,forum_pharmaceuticals_inc,,,,,, -349,0.956416,a845a11a-fa6e-4bb7-9057-a36a08b6b773,GITMO (GRUPPO ITALIANO DI MIDOLLLO OSSEO),gitmo_gruppo_italiano_di_midolllo_osseo,,,,81b272b1-dc41-4ac6-b169-23e9c0bb81d7,gitmo,GITMO -1156,,7c245b5f-814a-4ce9-8516-b8c71e9169b1,IRCCS CASA SOLLIEVO DELLA SOFFERENZA,irccs_casa_sollievo_della_sofferenza,,,,,, -1157,,acda27d0-accc-4027-b69d-fd2536b2a068,Mónica Saldaña Valderas,m_nica_salda_a_valderas,,,,,, -740,0.91375583410263062,5e33332a-5eab-46e0-84d6-df15c6f32cd7,"ICORG, all-Ireland Cooperative Oncology Research Group",icorg_all_ireland_cooperative_oncology_research_group,,,,a915c184-a118-4ca9-8fb4-2b38760107dc,icorg_the_all_ireland_cooperative_oncology_research_group,"ICORG, the all-Ireland Co-operative Oncology Research Group" -1158,,dbd9c17b-e41d-4de0-9c41-7a60bbf57f58,az turnhout,az_turnhout,,,,,, -42,0.97669962048530579,cabd6cbe-fd00-4d66-b275-8a313d21ba84,"Universitätsklinik für Augenheilkunde und Optometrie, AKH Wien",universit_tsklinik_f_r_augenheilkunde_und_optometrie_akh_wien,,,,e3a4dbed-6085-4f4f-a871-0b11b6bed573,universit_tsklinik_f_r_augenheilkunde_und_optometrie,Universitätsklinik für Augenheilkunde und Optometrie -703,0.95236596465110779,221122f6-31e0-4da1-94ad-8d33b5a25cd7,University Hospitals Leicester,university_hospitals_leicester,,,,09b03690-5970-415f-b749-e56be3b9df7b,university_hospitals_leicester_nhs_trust,University Hospitals Leicester NHS Trust -1159,,0103709a-6fbc-11e6-abe8-0242ac12000b,Roche Bulgaria EOOD,roche_bulgaria_eood,,,,,, -1160,,d38ce76c-7363-11e6-a0cd-0242ac12000b,MANNKIND,mannkind,,,,,, -1161,,8b5c3d5e-7d91-4606-bc87-73317a6d0c2c,Cortendo AB,cortendo_ab,,,,,, -1162,,b80e8d76-71a9-11e6-a0cd-0242ac12000b,NORWICH-EATON PHARMA,norwich_eaton_pharma,,,,,, -1163,,998c59d7-4ff2-4972-909d-7ddde956fb0a,Vicente Estrada Pérez,vicente_estrada_p_rez,,,,,, -1164,,a5f02f86-73ee-11e6-a0cd-0242ac12000b,AIR LIQUID INDUSTRIAL US LP,air_liquid_industrial_us_lp,,,,,, -272,0.98419728875160217,c26dcdfa-7158-11e6-a0cd-0242ac12000b,LEK PHARMS DD,lek_pharms_dd,,,,5ab1cb72-7148-11e6-a0cd-0242ac12000b,lek_pharms,LEK PHARMS -1165,,6ef4f3be-72ee-11e6-a0cd-0242ac12000b,RELIANT PHARMS,reliant_pharms,,,,,, -1166,,bdafa1c6-c40e-4b85-a59e-33133882512e,J.W. Goethe University Hospital,j_w_goethe_university_hospital,,,,,, -1167,,ebe1f4ff-4d9b-47ff-8d94-25967f98c51e,"Med. Klinik II, Klinikum der Universität München Grosshadern",med_klinik_ii_klinikum_der_universit_t_m_nchen_grosshadern,,,,,, -1168,,7713923f-838a-41a7-85e4-d95e2f41373f,Medinova AG,medinova_ag,,,,,, -1169,,b6941fca-b583-48a3-839b-6e603d6316ce,University Hospitals Coventry and Warwickshire NHS Trust,university_hospitals_coventry_and_warwickshire_nhs_trust,,,,,, -163,0.94221,2e1d8af2-76ea-4f16-98e7-156c78aa3581,"Iho-ja allergiasairaala, HYKS",iho_ja_allergiasairaala_hyks,,,,2e1d8af2-76ea-4f16-98e7-156c78aa3581,iho_ja_allergiasairaala_hyks,"Iho-ja allergiasairaala, HYKS" -145,0.938045,c4a9bf5d-eebd-42f0-a384-39801bffce72,Menarini Benelux SA/NV,menarini_benelux_sa_nv,,,,c4a9bf5d-eebd-42f0-a384-39801bffce72,menarini_benelux_sa_nv,Menarini Benelux SA/NV -1170,,abf53551-61c0-42bb-b281-119b9d4fa14d,Liverpool Heart and Chest Hospital NHS Trust,liverpool_heart_and_chest_hospital_nhs_trust,,,,,, -1171,,47ce6de3-9443-4502-ae52-a5334f96682f,Air Liquide Santé International,air_liquide_sant_international,,,,,, -916,0.986414,6370e13d-5a9e-49dc-a468-3b76aad11206,University of Edinburgh,university_of_edinburgh,,,,6370e13d-5a9e-49dc-a468-3b76aad11206,university_of_edinburgh,University of Edinburgh -1172,,d4f45a5a-dc88-4cce-9136-282a962a60a8,"Relevare Pharmaceuticals, Ltd",relevare_pharmaceuticals_ltd,,,,,, -1173,,3eff6b54-1ba5-48e2-a3eb-3b83099affe2,Mona Ring Gätke,mona_ring_g_tke,,,,,, -1174,,744ad1ba-2269-4c03-b95a-d92205530669,South Warwickshire NHS Foundation Trust,south_warwickshire_nhs_foundation_trust,,,,,, -558,0.984864,2d701be4-7168-11e6-a0cd-0242ac12000b,FERA PHARMS LLC,fera_pharms_llc,,,,19dd85ae-7144-11e6-a0cd-0242ac12000b,fera_pharms,FERA PHARMS -1175,,415de809-0a79-429e-a577-e54b5a6f6646,Innotech international,innotech_international,,,,,, -1176,,7e1922b6-7168-11e6-a0cd-0242ac12000b,DEVA HOLDING A.S,deva_holding_a_s,,,,,, -1177,,28391b70-145c-4ba0-9704-e16dfe2484cf,sanofi-aventis Belgium,sanofi_aventis_belgium,,,,,, -1178,,45c5f0b0-7366-11e6-a0cd-0242ac12000b,EDGEMONT PHARMS LLC,edgemont_pharms_llc,,,,,, -1179,,c00965ea-9b79-4883-a6f5-d48ee6ac0bc7,"Department of Otolaryngology, Head and Neck Surgery Johannes Gutenberg-Universität Mainz",department_of_otolaryngology_head_and_neck_surgery_johannes_gutenberg_universit_t_mainz,,,,,, -922,0.98430114984512329,41a3f51d-cc79-4d85-ad20-dd3ecef8b74f,Pfizer bv CR,pfizer_bv_cr,,,,41a3f51d-cc79-4d85-ad20-dd3ecef8b74f,pfizer_bv_cr,Pfizer bv CR -1180,,7976fecc-73fc-11e6-a0cd-0242ac12000b,PEARL THERAPS INC,pearl_theraps_inc,,,,,, -1181,,5ece2eb4-716e-11e6-a0cd-0242ac12000b,VIDARA THERAPEUTICS RESEARCH LTD,vidara_therapeutics_research_ltd,,,,,, -1182,,a1c8b8c2-712a-11e6-a89e-0242ac12000b,MYLAN PHARMS INC,mylan_pharms_inc,,,,,, -1183,,4cebd297-a8ff-46b4-935c-be6b2b0f60ae,Wilhelminenspital der Stadt Wien,wilhelminenspital_der_stadt_wien,,,,,, -1184,,7041d3f0-a02c-46e6-9544-56b882632a04,"Targacept, Inc",targacept_inc,,,,,, -943,0.910995,ded3dbf8-f0ef-458f-8c5f-53b5c2f16584,"PDL BioPharm, Inc",pdl_biopharm_inc,,,,d64fbb64-ace2-40d6-b379-d8f2f6277ac6,pdl_biopharma_inc,"PDL BioPharma, Inc" -1185,,13dccfb2-2cc2-44d8-b220-81db7034de45,John Vissing,john_vissing,,,,,, -1186,,deaf6e3f-0604-450e-b413-d2d7583697a2,Sheffield Health and Social Research Consortium,sheffield_health_and_social_research_consortium,,,,,, -1187,,076f76fa-71a5-11e6-a0cd-0242ac12000b,JDS PHARMS,jds_pharms,,,,,, -1188,,ce0dd53e-946d-43ac-b1a1-db83722ed791,The Newcastle upon Tyne NHS Hospitals Foundation Trust,the_newcastle_upon_tyne_nhs_hospitals_foundation_trust,,,,,, -441,0.985292,38fa42f7-b481-47f1-ad59-ebc7650a6a92,"Dept. of Anaesthesia, Center of Head and Orthopaedics, Copenhagen University Hospital Rigshospitalet",dept_of_anaesthesia_center_of_head_and_orthopaedics_copenhagen_university_hospital_rigshospitalet,,,,38fa42f7-b481-47f1-ad59-ebc7650a6a92,dept_of_anaesthesia_center_of_head_and_orthopaedics_copenhagen_university_hospital_rigshospitalet,"Dept. of Anaesthesia, Center of Head and Orthopaedics, Copenhagen University Hospital Rigshospitalet" -745,0.974187,0b393cda-95af-44e2-87c2-0f3e708c0eea,"Medical School Hannover, Department of Psychiatry, Socialpsychiatry and Psychotherapy",medical_school_hannover_department_of_psychiatry_socialpsychiatry_and_psychotherapy,,,,0b393cda-95af-44e2-87c2-0f3e708c0eea,medical_school_hannover_department_of_psychiatry_socialpsychiatry_and_psychotherapy,"Medical School Hannover, Department of Psychiatry, Socialpsychiatry and Psychotherapy" -1189,,4283d691-73d0-4d24-be84-a765960a5330,"Medizinische Universität Wien, Klinik für Innere Medizin II, Abteilung für Kardiologie",medizinische_universit_t_wien_klinik_f_r_innere_medizin_ii_abteilung_f_r_kardiologie,,,,,, -1190,,c14cce6d-f942-4397-8dd3-b566ed15c495,University Medical Center Eppendorf,university_medical_center_eppendorf,,,,,, -1191,,cc6ec836-7167-11e6-a0cd-0242ac12000b,SECAN PHARMS,secan_pharms,,,,,, -1192,,2b782fd4-9243-4f68-afcf-82917bc1795a,AGI Therapeutics Research Ltd,agi_therapeutics_research_ltd,,,,,, -524,0.985088,211ecc7f-a65d-460f-803c-c95a4e47e245,Sanofi Pasteur Incorporated,sanofi_pasteur_incorporated,,,,211ecc7f-a65d-460f-803c-c95a4e47e245,sanofi_pasteur_incorporated,Sanofi Pasteur Incorporated -1193,,829e75aa-e69d-48a9-9b58-6cb72601a614,Luis Miguel Ruilope Urioste,luis_miguel_ruilope_urioste,,,,,, -1194,,f67de3b3-f274-4c62-a988-8645600dfe47,KeyNeurotek Pharma GmbH,keyneurotek_pharma_gmbh,,,,,, -206,0.97898,82b82cf4-7168-11e6-a0cd-0242ac12000b,MIKART INC,mikart_inc,,,,050afe2e-7129-11e6-a89e-0242ac12000b,mikart,MIKART -1195,,e51e7b3d-34a2-4fc9-b50b-37a2e9001358,Laboratoire IASON,laboratoire_iason,,,,,, -1196,,2ae93f86-afc2-4c33-a9ab-4cf5557b9a75,Myron D. Ginsberg,myron_d_ginsberg,,,,,, -1197,,16cfada7-4af0-4d8c-84e9-0a3f8b2c2d5d,BioAlliance Pharma,bioalliance_pharma,,,,,, -1198,,bf696e0b-e343-4271-a3f2-fafb8d61ed83,"OxThera, Inc",oxthera_inc,,,,,, -1199,,c66e3903-6167-4581-8b0f-2d9de6da40f8,Synosia Therapeutics AG,synosia_therapeutics_ag,,,,,, -1200,,00268eb1-4ad8-4d4d-952d-d7e469c1fddd,ALTUS PHARMACEUTICALS INC,altus_pharmaceuticals_inc,,,,,, -1201,,6d14b98a-719b-46a3-96ac-8a2c093adb5a,university medical centre utrecht,university_medical_centre_utrecht,,,,,, -1202,,10962173-23c6-4151-812d-ef214f40e09d,Centre Hospitalier Universiaire de Nantes,centre_hospitalier_universiaire_de_nantes,,,,,, -370,0.951764,09b4c65d-3052-471d-a9c2-a2a03f06e86f,"HUS, HYKS, Diabetesklinikka",hus_hyks_diabetesklinikka,,,,09b4c65d-3052-471d-a9c2-a2a03f06e86f,hus_hyks_diabetesklinikka,"HUS, HYKS, Diabetesklinikka" -1203,,fe21c370-bc93-4280-a053-3ef14214bb21,CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS,centro_nacional_de_investigaciones_oncologicas,,,,,, -857,0.97087401151657104,b76bef22-6cac-475a-a7cd-1b5b6d7ad7e4,Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,,,,0213f530-437f-430a-b936-0bfa94166165,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau -266,0.96782034635543823,07e8ff92-7129-11e6-a89e-0242ac12000b,TEVA PHARMS,teva_pharms,,,,07e8ff92-7129-11e6-a89e-0242ac12000b,teva_pharms,TEVA PHARMS -1204,,3f6f99ac-7391-11e6-a0cd-0242ac12000b,ORAPHARMA,orapharma,,,,,, -350,0.980777,3e83bd20-82b9-4762-84e9-fe87fe651346,Pharmacyclics LLC,pharmacyclics_llc,,,,3e83bd20-82b9-4762-84e9-fe87fe651346,pharmacyclics_llc,Pharmacyclics LLC -569,0.952896,25abd45e-c724-4c38-a7f4-5b17f2b4e77f,Pharming Tecnologies B.V,pharming_tecnologies_b_v,,,,25abd45e-c724-4c38-a7f4-5b17f2b4e77f,pharming_tecnologies_b_v,Pharming Tecnologies B.V -1205,,e438054c-c5ad-460e-8be2-ff24f3b3aad4,Department of Anesthesiology University Hospital Center,department_of_anesthesiology_university_hospital_center,,,,,, -1206,,117d1943-7183-40ed-b028-5b3ebdad2d13,Miguel Ángel Zapata. Oftalmología. Hospital vall d'Hebron,miguel_ngel_zapata_oftalmolog_a_hospital_vall_d_hebron,,,,,, -651,0.98270362615585327,4501c601-be00-4be3-8378-bb49eca4c7fb,"Boehringer Ingelheim bv, Medical department",boehringer_ingelheim_bv_medical_department,,,,4501c601-be00-4be3-8378-bb49eca4c7fb,boehringer_ingelheim_bv_medical_department,"Boehringer Ingelheim bv, Medical department" -1207,,dfc220fb-8d70-405e-afa6-812fc02e5326,PROMEFARM,promefarm,,,,,, -1208,,4f6bf09f-c2c3-46f4-89c4-dc72ff5fa330,Hillbom Matti OYS/neurologian klinikka,hillbom_matti_oys_neurologian_klinikka,,,,,, -1209,,899fde21-40d2-4d43-b11c-98a136355e54,St Bartholomew's and The London NHS Trust,st_bartholomew_s_and_the_london_nhs_trust,,,,,, -381,0.93488822877407074,367caed2-fccd-479f-a0e1-c0d0a6d66c2b,"Merck Sharp & Dohme Copr., a subsidary of Merck & Co",merck_sharp_dohme_copr_a_subsidary_of_merck_co,,,,70a76c95-9bc5-4453-ace1-7d9c98a92a7d,merck_sharp_dohme_o,"Merck Sharp & Dohme Copr., a subsidary of Merck & Co" -1210,,0e175f4e-7142-11e6-a0cd-0242ac12000b,SEPTODONT INC,septodont_inc,,,,,, -434,0.98384493589401245,3051319e-81c1-4e75-84ee-7e6002bdcc03,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017",pfizer_inc_235_east_42nd_street_new_york_ny_10017,,,,0068e377-8873-41b9-baad-e3768b77d0b1,pfizer_inc_235_east_42nd_street_new_york_ny_10017,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017" -1211,,aafbcbb6-7146-11e6-a0cd-0242ac12000b,RADIUS PHARMS,radius_pharms,,,,,, -1212,,40068bda-2666-491d-b985-f801f3acab11,SIGMA-TAU,sigma_tau,,,,,, -1213,,0f4e418a-e1c4-4244-9de6-33bf1e3a7799,Liverpool Heart and Chest Hospital NHS Foundation Trust,liverpool_heart_and_chest_hospital_nhs_foundation_trust,,,,,, -1214,,12d1c16d-ee00-4890-a9bb-6f2f7433cbe1,"Karolinska Institute, Södersjukhuset AB",karolinska_institute_s_dersjukhuset_ab,,,,,, -1215,,2f89dcfc-7d79-4636-8993-7fb63ea3e9ca,University Medical Centre St Radboud,university_medical_centre_st_radboud,,,,,, -1216,,726cbfdb-d95c-497d-a78c-2313d0ddfabf,Aventis Pharma Ltd,aventis_pharma_ltd,,,,,, -1217,,39f984ce-7355-11e6-a0cd-0242ac12000b,JAVELIN PHARMS INC,javelin_pharms_inc,,,,,, -1218,,f9ac003e-11a3-403a-8dc5-0f8901bbe172,Kari Leino,kari_leino,,,,,, -1219,,378ff01d-7b5f-465e-9fc4-f387bc31b542,"IFS gGmbH, Universitätsmedizin Göttingen",ifs_ggmbh_universit_tsmedizin_g_ttingen,,,,,, -1220,,65ad650c-31e4-4814-80f3-bb339b187afb,"Erasmus MC, University Medical Center Rotterdam",erasmus_mc_university_medical_center_rotterdam,,,,,, -1221,,a0af921d-d62a-4417-a7ba-982c1d5ed9f3,Ipsen Ltd,ipsen_ltd,,,,,, -973,0.987557,9333210d-087c-420a-b3c2-e6d678ea9766,Cutanea Life Sciences,cutanea_life_sciences,,,,9333210d-087c-420a-b3c2-e6d678ea9766,cutanea_life_sciences,Cutanea Life Sciences -1222,,c6c4db92-3b4e-4600-85f1-bbdfff9cece8,Gesellschaft für Wissens- und Technologietransfer der TU Dresden mbH,gesellschaft_f_r_wissens_und_technologietransfer_der_tu_dresden_mbh,,,,,, -1223,,ec057b58-7163-11e6-a0cd-0242ac12000b,ALCON RES,alcon_res,,,,,, -661,0.988375,e59de0b4-d987-4c5d-b0a1-b8b0f8293749,BioCryst Pharmaceuticals,biocryst_pharmaceuticals,,,,e15edbf4-2f93-4ee5-b9aa-da446c1209d0,biocryst_pharmaceuticals_inc,BioCryst Pharmaceuticals Inc -516,0.984713,8a7efac8-7148-11e6-a0cd-0242ac12000b,UPSHER SMITH LABS,upsher_smith_labs,,,,05ba4e48-7141-11e6-a0cd-0242ac12000b,upsher_smith,UPSHER SMITH -1224,,c3d23f08-f480-4164-aa1a-ec570830426c,Psykiatrisk Center Gentofte,psykiatrisk_center_gentofte,,,,,, -1225,,75e1cdda-7219-11e6-a0cd-0242ac12000b,SANKYO,sankyo,,,,,, -1226,,5098b1b0-da1c-4f5c-bb76-369738b13561,Jon Perez Barcena,jon_perez_barcena,,,,,, -299,0.98712396621704102,7aebdff6-717d-11e6-a0cd-0242ac12000b,NOVARTIS PHARMS,novartis_pharms,,,,7aebdff6-717d-11e6-a0cd-0242ac12000b,novartis_pharms,NOVARTIS PHARMS -659,0.989406,94a3c5e1-819b-42db-8dbd-f3f70a0d7fb3,Swedish Institute for Infectious Disease Control,swedish_institute_for_infectious_disease_control,,,,3b17812c-fdb5-4544-97fd-496a11299fc7,swedish_institute_for_infectious_disease_control_smi,Swedish Institute for Infectious Disease Control (SMI) -1227,,328c75a7-c099-4c26-9e44-2d9caf50497b,BioMarin Nederland B.V,biomarin_nederland_b_v,,,,,, -73,0.983343,a9d0f101-5d13-4345-bc0c-7527c110c176,AM-Pharma B.V,am_pharma_b_v,,,,a9d0f101-5d13-4345-bc0c-7527c110c176,am_pharma_b_v,AM-Pharma B.V -1228,,1ecfd5cb-9273-4fed-9f2d-b6b8c38c4a9c,"Department of Haematology, Aalborg University Hospital",department_of_haematology_aalborg_university_hospital,,,,,, -1229,,5c7ae09f-eaf9-4e44-93d2-6f15a40ad30c,Clinical Research International Ltd,clinical_research_international_ltd,,,,,, -1230,,7a5daf4e-cc3d-4164-8a8b-4af3e56fd609,CHU de GRENOBLE,chu_de_grenoble,,,,,, -1231,,7db992ce-6fe6-426c-a407-e5a90c7abec6,Bracco ALTANA Pharma GmbH,bracco_altana_pharma_gmbh,,,,,, -1232,,36466c64-9623-46fd-b9de-cf5b9e59e3c8,"Arginox Pharmaceuticals, Inc",arginox_pharmaceuticals_inc,,,,,, -1233,,dfbcd008-74a3-48cf-8f24-b0abdd1766c4,AIBILI - Associação para Investigação Biomédica e Inovação em Luz e Imagem,aibili_associa_o_para_investiga_o_biom_dica_e_inova_o_em_luz_e_imagem,,,,,, -1234,,ef200286-e83a-472d-8e19-977af55a1244,Sligo General Hospital,sligo_general_hospital,,,,,, -1235,,27997317-9d15-4cab-8c0f-073337199cbc,Hospital Universitario Dr. Negrin,hospital_universitario_dr_negrin,,,,,, -1236,,3d134f04-7167-11e6-a0cd-0242ac12000b,WUSM CYCLOTRON,wusm_cyclotron,,,,,, -1237,,eb85db05-d1c4-479a-9e01-7d7e736adc24,OSIRIS,osiris,,,,,, -1238,,356224f2-995c-4570-a710-4fd38eb8fffb,NHS Lothian - University Hospitals Division,nhs_lothian_university_hospitals_division,,,,,, -1239,,08276e09-df40-4bc3-9ca1-45711bb2c9e7,UNI-PHARMA SA,uni_pharma_sa,,,,,, -1240,,4b44c27f-ce85-4c74-bb66-c07e55c30fd2,UROLOGY ASSOCIATES S.L,urology_associates_s_l,,,,,, -1241,,aca8d1f1-889a-490e-8b62-d01cb792f6a0,Stichting Toegepast Caridologisch Onderzoek,stichting_toegepast_caridologisch_onderzoek,,,,,, -1242,,3c8fd31a-0f79-4d65-b32a-971f8c95c928,"Charite CBF, Endokrinologie",charite_cbf_endokrinologie,,,,,, -1243,,1113831e-76cd-4d09-9b5d-3468e9e1b54b,Merck Sharp & Dohme Ireland (Human Healthcare) Ltd,merck_sharp_dohme_ireland_human_healthcare_ltd,,,,,, -1244,,c926f160-7150-11e6-a0cd-0242ac12000b,AESGEN,aesgen,,,,,, -1245,,6a37befd-b572-4ce2-81fd-f085675ee7c8,Lourdes Lozano-Bailen,lourdes_lozano_bailen,,,,,, -1246,,2a1b11c4-71bd-11e6-a0cd-0242ac12000b,VIIV HLTHCARE,viiv_hlthcare,,,,,, -874,0.982418,7980a7c5-e0b0-4bbe-8695-41376036421e,"InterMune, Inc",intermune_inc,,,,7980a7c5-e0b0-4bbe-8695-41376036421e,intermune_inc,"InterMune, Inc" -1247,,0641d599-f0a1-4cd7-908c-cc63891f2069,"Medivation, Inc",medivation_inc,,,,,, -1248,,b092997b-2f65-43f5-b4b0-2348a659a084,"Faculty of Medicine at the Georg-August University, Göttingen",faculty_of_medicine_at_the_georg_august_university_g_ttingen,,,,,, -704,0.963353,0fbda7a2-0e8a-489e-b902-fd13c5dec4c2,Profil Institut fuer Stoffwechselforschung GmbH,profil_institut_fuer_stoffwechselforschung_gmbh,,,,0fbda7a2-0e8a-489e-b902-fd13c5dec4c2,profil_institut_fuer_stoffwechselforschung_gmbh,Profil Institut fuer Stoffwechselforschung GmbH -1249,,7804867f-3211-4307-afba-0700a845785e,EPIFARMA SRL,epifarma_srl,,,,,, -1250,,35cf3908-9a3b-4b13-b70f-d06112a25f1a,ErasmusMC,erasmusmc,,,,,, -1251,,43f68c68-6399-4f80-a396-aad424759a45,"Astellas Pharma China, Inc",astellas_pharma_china_inc,,,,,, -1252,,7636f895-0833-4de4-8c2e-e6a0af308523,Infociencia Clinical Research,infociencia_clinical_research,,,,,, -345,0.96143,8e80d144-7163-11e6-a0cd-0242ac12000b,BARR LABS DIV TEVA,barr_labs_div_teva,,,,66393a08-7129-11e6-a89e-0242ac12000b,barr,BARR -1253,,93e49948-591c-4d71-8fe2-d97520f7a10b,"Department of Psychiatry and Psychotherapy, University of Mainz",department_of_psychiatry_and_psychotherapy_university_of_mainz,,,,,, -1254,,f2bb3f22-717d-11e6-a0cd-0242ac12000b,CREALTA PHARMS LLC,crealta_pharms_llc,,,,,, -1255,,dd601c23-dc02-4b12-b16d-7b0f9d25288f,KU Leuven - UZ Leuven,ku_leuven_uz_leuven,,,,,, -1256,,371233f8-471d-4d81-8c3f-d6b6fe86375b,Bausch & Lomb Incorporated,bausch_lomb_incorporated,,,,,, -1257,,4c345b8f-6902-4757-b3d7-4d0b8c47f008,Hôpital Universitaire de Münster,h_pital_universitaire_de_m_nster,,,,,, -1258,,0247ceda-d4d8-45ec-bc65-3ff100ccfa9c,"Biovail Laboratories International SRL, c/o Biovail Technologies Ltd",biovail_laboratories_international_srl_c_o_biovail_technologies_ltd,,,,,, -486,0.98096510767936707,fdb032b4-26cd-4d32-b895-bdd7cc97e99d,Sahlgrenska Universitetssjukhuset/Sahlgrenska,sahlgrenska_universitetssjukhuset_sahlgrenska,,,,e6237908-6daa-4272-adad-f5434c004df0,sahlgrenska_universitetssjukhuset,Sahlgrenska Universitetssjukhus -1259,,e8073246-fd76-4ef0-8a92-f6f62d65bc27,Javier García Campayo,javier_garc_a_campayo,,,,,, -1260,,8d7e91cd-98eb-4872-a576-4bd40522d649,Div KIR AMC,div_kir_amc,,,,,, -1261,,ab8a8c88-7129-11e6-a89e-0242ac12000b,WE PHARMS,we_pharms,,,,,, -1262,,df03d0e3-1345-473c-8400-e5dc3e505b99,"Dainippon Sumitomo Pharma America, Inc",dainippon_sumitomo_pharma_america_inc,,,,,, -946,0.987167,6deffe28-ea22-44c2-b710-cb272fb32a14,"Universität Leipzig, HNO",universit_t_leipzig_hno,,,,4cc8b53a-0566-477c-a16e-fcd4919e14fe,universit_t_leipzig,Universität Leipzig -1263,,ff2036ac-d8c7-4190-b08f-1b1f6542b249,"Allergan, Ltd",allergan_ltd,,,,,, -1264,,feff2cba-5c95-4b98-ab8c-c15c28b2e188,"Klinikum der Universität München Innenstadt, I. Frauenklinik",klinikum_der_universit_t_m_nchen_innenstadt_i_frauenklinik,,,,,, -1265,,5749b408-606b-4473-b58e-a865dbf85b80,Department of Endocrinology and Internal Medicine,department_of_endocrinology_and_internal_medicine,,,,,, -1266,,bad58c7b-4a11-44d0-9bbd-c25ebde5bcf3,Gerencia de Atención Primaria de Mallorca,gerencia_de_atenci_n_primaria_de_mallorca,,,,,, -1267,,0c328717-8c58-4563-ab5c-a4764d340fc0,Deventer Ziekenhuis,deventer_ziekenhuis,,,,,, -1268,,9cdf4fbc-7164-11e6-a0cd-0242ac12000b,L PERRIGO CO,l_perrigo_co,,,,,, -1269,,245a4584-8bd0-11e6-a449-0242ac12000b,KAS Glostrup,kas_glostrup,,,,,, -1270,,db042233-9011-4acd-a517-aeb1b02e65fc,Nice University Hospital,nice_university_hospital,,,,,, -1271,,754065c6-2e87-4529-a2ac-dc3ecffdd4d1,Celimmune LLC,celimmune_llc,,,,,, -1272,,0e3da904-8efa-4371-a1a0-90f40cad50ef,University Hospitals Coventry & Warwickshire NHS Trust,university_hospitals_coventry_warwickshire_nhs_trust,,,,,, -435,0.9795151948928833,e70ee262-6f9a-11e6-9663-0242ac12000b,Pfizer Inc. New York,pfizer_inc_new_york,,,,aad2d334-ecaa-4920-9328-b23c18f3711d,pfizer_inc,Pfizer Inc -1273,,42fbc6d5-4c28-4359-854c-40adab089495,ILTOO PHARMA,iltoo_pharma,,,,,, -1274,,72135ff6-7166-11e6-a0cd-0242ac12000b,PHARMS,pharms,,,,,, -963,0.97782692313194275,3b5eea67-90c9-473c-aaaf-488b308a2999,"Helsinki University Hospital, Department of Gastroenterology",helsinki_university_hospital_department_of_gastroenterology,,,,65248d8e-5a22-48b5-a66d-dc1d1f751700,helsinki_university_hospital,Helsinki University Hospital -1275,,75e71b2d-a150-4f4e-bbcd-67ccaba6c96d,Stragen France,stragen_france,,,,,, -93,0.942231,c24247a8-c2ed-48ff-b1d5-e3d498354044,LABORATORIOS CASEN FLEET S.L.U,laboratorios_casen_fleet_s_l_u,,,,bab1dcfc-4751-41db-9ee8-b9ec54e63541,laboratorios_casen_fleet_s_l,"LABORATORIOS CASEN-FLEET,S.L" -1276,,400a9f82-df6b-4911-bf7c-0d2f733e2a27,IRCCS Ospedale Pediatrico Bambino Gesù,irccs_ospedale_pediatrico_bambino_ges,,,,,, -122,0.9800211489200592,89ecf617-74e0-496c-8ac4-d4eae3b54d8c,F. Hoffmann-La Roche Ltd,f_hoffmann_la_roche_ltd,,,,89ecf617-74e0-496c-8ac4-d4eae3b54d8c,f_hoffmann_la_roche_ltd_pharmaceuticals_divison_pdr,"F. Hoffmann-La Roche Ltd, Pharmaceuticals Divison, PDR" -725,0.989909,1ad9c652-f097-480c-b6e9-4e1f4c988f0c,"National Institute of Allergy and Infectious Diseases (NIAID), NIH",national_institute_of_allergy_and_infectious_diseases_niaid_nih,,,,1ad9c652-f097-480c-b6e9-4e1f4c988f0c,national_institute_of_allergy_and_infectious_diseases_niaid_nih,"National Institute of Allergy and Infectious Diseases (NIAID), NIH" -21,0.98614925146102905,f1937510-b48e-43cb-91ce-4fc479e24205,STALLERGENES SA,stallergenes_sa,,,,31fe54e5-0be3-4070-88f1-464180a02a89,stallergenes,STALLERGENES -754,0.974038,2605a116-7400-44c9-9e20-fd5eac2e111d,Eisai Limited,eisai_limited,,,,2605a116-7400-44c9-9e20-fd5eac2e111d,eisai_limited,Eisai Limited -1014,0.98753157258033752,967576bf-31fd-4f9d-8be3-ae18ae1a40bc,Institut de Recherches Internationales,institut_de_recherches_internationales,,,,9b368f8e-02db-4935-a1a6-f2a417efa7ee,institut_de_recherches_internationales_servier,Institut de Recherches Internationales Servier -888,0.9590187668800354,04e5cd56-5cd4-4f97-85cf-5ecb9b22479a,"Schering-Plough Research Institute, a Divison of Schering Corporation",schering_plough_research_institute_a_divison_of_schering_corporation,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" -1277,,6e661e44-f968-4e47-9a37-b42988cba83a,Ferrosan A/S,ferrosan_a_s,,,,,, -1278,,506f2494-54fc-49bc-9e54-a320ba46de24,St Mary's NHS Trust,st_mary_s_nhs_trust,,,,,, -1279,,9cc4c3bc-ff15-41e9-ab5c-eddd9065fb9c,"Danderyds Hospital, Department of Clinical Sciences, Division of Orthopaedics",danderyds_hospital_department_of_clinical_sciences_division_of_orthopaedics,,,,,, -1280,,0f0cc48e-799b-4e1e-94dd-718c3a3e0252,University of Florida Board of Trustees,university_of_florida_board_of_trustees,,,,,, -1281,,fd4dd3bf-1d29-43d3-902d-8cf6e551d5b0,"Medizinische Universität Wien, Univ.Klinik für Zahn-,Mund-u.Kieferheilkunde,Klin.Abt.f.orale Chirurg",medizinische_universit_t_wien_univ_klinik_f_r_zahn_mund_u_kieferheilkunde_klin_abt_f_orale_chirurg,,,,,, -1282,,c154965f-4fa1-4b98-882d-7196fa457f0a,ACCORD (Academic and Clinical Central Office for Research & Development),accord_academic_and_clinical_central_office_for_research_development,,,,,, -1283,,db460c34-ec4d-4e9c-87ae-a3d51fd23383,"Medizinische Universität Wien; Univ.Klin.f.Innere Med. III, Abt.f.Gastroenterologie u. Hepatologie",medizinische_universit_t_wien_univ_klin_f_innere_med_iii_abt_f_gastroenterologie_u_hepatologie,,,,,, -1284,,df64c454-a703-4e1d-aa31-27cc25c79f2e,"Rigshospitalet, Hjertemedicinsk afd. B",rigshospitalet_hjertemedicinsk_afd_b,,,,,, -1285,,aefbd9ae-afa9-4e75-8359-4cee55269ea2,"Göteborgs Universitet, Göteborg Sweden",g_teborgs_universitet_g_teborg_sweden,,,,,, -1286,,60916fd0-7165-11e6-a0cd-0242ac12000b,FOUGERA PHARMS INC,fougera_pharms_inc,,,,,, -643,0.96428561210632324,1a23c45f-2c11-4e5d-a222-082def03ebc8,Boehringer Ingelheim Noway KS,boehringer_ingelheim_noway_ks,,,,1a23c45f-2c11-4e5d-a222-082def03ebc8,boehringer_ingelheim_noway_ks,Boehringer Ingelheim Noway KS -110,0.97392818331718445,6139ccae-9a9d-4de8-9b9c-753da3579d62,Department of Oncology Karolinska,department_of_oncology_karolinska,,,,7ab0aad4-ccd7-43a6-abf8-e331125b5500,department_of_oncology_karolinska,Department of Oncology -1287,,a71c8328-44d5-4d94-821b-9cce743d4f69,"ONO Pharmaceutical Co., Ltd",ono_pharmaceutical_co_ltd,,,,,, -1288,,e70f6aa9-a3df-45ca-a108-4a0d7c527692,Iniciativa Andaluza en Terapias Avanzadas-Fundación Pública Andaluza Progreso y Salud,iniciativa_andaluza_en_terapias_avanzadas_fundaci_n_p_blica_andaluza_progreso_y_salud,,,,,, -160,0.95195136070251463,ed3f0617-2793-45bc-9ade-1aa72282e214,Fundación para la Investigación biomédica del Hopsital Gregorio Marañón,fundaci_n_para_la_investigaci_n_biom_dica_del_hopsital_gregorio_mara_n,,,,ce27e24e-62ac-42de-a596-4ceed67e634f,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón -870,0.98664483428001404,deb12ae0-1752-4e26-a0e5-920c56f9b1a0,Astellas Pharma Europe BV (APEB),astellas_pharma_europe_bv_apeb,,,,483064d3-f8fd-47e0-a0a2-b17b8d5df7d6,astellas_pharma_europe_bv,Astellas Pharma Europe BV -1289,,6c77ca9a-07a8-4911-ac40-1277ff47800a,Itziar Astigarraga Aguirre,itziar_astigarraga_aguirre,,,,,, -1290,,40650bc0-7167-11e6-a0cd-0242ac12000b,ORIENT PHARMA CO LTD,orient_pharma_co_ltd,,,,,, -1291,,d152d84a-aeec-429e-a1f0-48d42cc4ca80,Decan of Medical Faculty of Goethe University Frankfurt,decan_of_medical_faculty_of_goethe_university_frankfurt,,,,,, -1292,,11f8db8a-1255-4b7a-b94e-b274f35bfe5b,Fundació Privada Institut d´Investigació Biomèdica de Girona Dr. Josep Trueta,fundaci_privada_institut_d_investigaci_biom_dica_de_girona_dr_josep_trueta,,,,,, -1293,,e9c24602-6521-44da-9b74-03d3a5c1086d,St Radboud UMC,st_radboud_umc,,,,,, -1294,,3005c2a7-dd62-43f8-9ac0-db3413793875,Basque Health System,basque_health_system,,,,,, -1295,,de694b65-acca-43dd-950e-b2712707c8df,"Department of Palliative Medicine, RWTH Aachen",department_of_palliative_medicine_rwth_aachen,,,,,, -1296,,07248b3f-7d4c-4163-abd0-52b782a3ec3a,Academical Medical Center,academical_medical_center,,,,,, -1297,,ae5a53c5-4819-48f4-9410-d46efabbae26,TransTech Pharma,transtech_pharma,,,,,, -9,0.96687185764312744,af35cb5f-b8db-41b8-88b2-0af8194a43d2,Centre Hospitalier Universitaire de Rennes,centre_hospitalier_universitaire_de_rennes,,,,2f45bfe9-0b5a-450f-abb3-c7aa18916ff8,centre_hospitalier_universitaire,Centre Hospitalier Universitaire -1298,,5879f511-a09c-4a24-9e78-d4c158b7b8fd,Sanofi S.p.A,sanofi_s_p_a,,,,,, -1299,,aafee193-eb1b-4aaa-bf0d-5eedacdea2c4,"Artisan Pharma, Inc",artisan_pharma_inc,,,,,, -1300,,2df0a54c-4610-4b0d-8483-2cca8b3ddc42,West Middlesex University Hospital,west_middlesex_university_hospital,,,,,, -1301,,7995ee55-2bfc-4211-bc73-5a445f081322,"Department of Anaesthesia, Tampere University Hospital",department_of_anaesthesia_tampere_university_hospital,,,,,, -484,0.969424,3ee3992f-cbe0-49c2-8456-39b7a3c82ed9,"Department of Anesthesiology, University Hospital Erlangen",department_of_anesthesiology_university_hospital_erlangen,,,,3ee3992f-cbe0-49c2-8456-39b7a3c82ed9,department_of_anesthesiology_university_hospital_erlangen,"Department of Anesthesiology, University Hospital Erlangen" -1302,,1f39b7b7-12af-4e6e-b7ba-520c0c95dd78,Dr. Antonio Mari Roig,dr_antonio_mari_roig,,,,,, -1303,,e9f49fe2-8bd0-11e6-a449-0242ac12000b,Aquinox Pharmaceuticals (Canada) Inc,aquinox_pharmaceuticals_canada_inc,,,,,, -1304,,63d403d2-66ef-47ef-92e7-6078233d6b95,CARLOS SANTOS VILLAR,carlos_santos_villar,,,,,, -1305,,9ce91350-73f6-11e6-a0cd-0242ac12000b,BIOCRYST,biocryst,,,,,, -431,0.984484,b88016be-c592-4cca-86cb-908f8cedcd26,Central Manchester and Manchester Children's University Hospitals NHS Trust,central_manchester_and_manchester_children_s_university_hospitals_nhs_trust,,,,14c37603-26cd-4e70-aef6-639320d368b6,central_manchester_and_manchester_children_s_university_hospital_nhs_trust,Central Manchester and Manchester Children's University Hospital NHS Trust -821,0.979768,3655f927-01ad-48d8-9cb0-516379501a0a,Dipartimento di Pediatria Università Federico II di Napoli,dipartimento_di_pediatria_universit_federico_ii_di_napoli,,,,3655f927-01ad-48d8-9cb0-516379501a0a,dipartimento_di_pediatria_universit_federico_ii_di_napoli,Dipartimento di Pediatria Università Federico II di Napoli -1306,,e5c9cbe7-2ba5-42a1-b838-a1fa87d53683,María de los Ángeles Álvarez López,mar_a_de_los_ngeles_lvarez_l_pez,,,,,, -1307,,3506063a-276a-458d-98fe-9803035607aa,FUNDACIÓN CANARIA DE INVESTIGACIÓN Y SALUD (FUNCIS),fundaci_n_canaria_de_investigaci_n_y_salud_funcis,,,,,, -1308,,4127e50a-715d-11e6-a0cd-0242ac12000b,PHARMAFORCE,pharmaforce,,,,,, -1309,,9bfbe25f-f46f-4428-b7ee-da295694b3d6,Vanda Pharmaceuticals Inc,vanda_pharmaceuticals_inc,,,,,, -1310,,c275e09b-494a-47ef-961e-29346c49d5aa,Enrique Rey Díaz-Rubio,enrique_rey_d_az_rubio,,,,,, -1311,,ea563ddc-7155-11e6-a0cd-0242ac12000b,DOUGLAS PHARMS,douglas_pharms,,,,,, -351,0.97875547409057617,490436c4-c1f2-4859-b7ae-69b121dd48d9,Deutsches Herzzentrum München,deutsches_herzzentrum_m_nchen,,,,490436c4-c1f2-4859-b7ae-69b121dd48d9,deutsches_herzzentrum_m_nchen,Deutsches Herzzentrum München -1312,,b96a163d-86ee-4ad2-a98e-31d110f1fd10,Cancer International Research Group,cancer_international_research_group,,,,,, -1313,,64d247a6-67a7-4370-b1d9-4c1046516e7d,"Foreseeacer Pharmaceuticals, Inc",foreseeacer_pharmaceuticals_inc,,,,,, -1314,,4a70e5bd-95b9-4e8f-9fec-4c20747cc75d,London School of Hygiene & Tropical Medicine,london_school_of_hygiene_tropical_medicine,,,,,, -1315,,5a59446c-d930-4066-a6dc-302821edaceb,Foundation for Liverdisease,foundation_for_liverdisease,,,,,, -1316,,1140f0c8-d8e3-469c-a6f7-a506f9444a31,IVI Sevilla,ivi_sevilla,,,,,, -1317,,adba483a-0dd8-42da-88ac-1122655b7148,Avillion Development 1 Limited,avillion_development_1_limited,,,,,, -1318,,bf3614b9-00a9-4d30-9320-f9b8f09483fb,Auxilium UK Limited,auxilium_uk_limited,,,,,, -930,0.97669827938079834,108222e4-8b5a-4716-a3aa-cd9eb69305b4,"Pierre Fabre Ibérica, S.A. en representación de Pierre Fabre Mèdicament",pierre_fabre_ib_rica_s_a_en_representaci_n_de_pierre_fabre_m_dicament,,,,108222e4-8b5a-4716-a3aa-cd9eb69305b4,pierre_fabre_ib_rica_s_a_en_representaci_n_de_pierre_fabre_m_dicament,"Pierre Fabre Ibérica, S.A. en representación de Pierre Fabre Mèdicament" -1319,,444dd439-1cfc-48d3-ac07-900559c6ae26,RespiVert Ltd,respivert_ltd,,,,,, -1320,,c509a1de-49f5-46c9-a673-acc3749ddd96,Jesper Hastrup Svendsen,jesper_hastrup_svendsen,,,,,, -1321,,ff0f7664-715d-11e6-a0cd-0242ac12000b,EMCURE PHARMS LTD,emcure_pharms_ltd,,,,,, -440,0.985233,52bf7852-7313-11e6-a0cd-0242ac12000b,PERNIX THERAPS LLC,pernix_theraps_llc,,,,52bf7852-7313-11e6-a0cd-0242ac12000b,pernix_theraps_llc,PERNIX THERAPS LLC -1322,,dc1c972c-880f-11e6-a998-0242ac12000b,Fondazione Michelangelo Onlus - Avanzamento dello studio e cura dei tumori,fondazione_michelangelo_onlus_avanzamento_dello_studio_e_cura_dei_tumori,,,,,, -1323,,cedc06c2-d733-4583-bcf4-3d91df337647,ACS Biomarker,acs_biomarker,,,,,, -1324,,aa77b200-6c34-45d6-a0e4-3d2387f939cc,Aptalis Pharma US Inc,aptalis_pharma_us_inc,,,,,, -1063,0.968193,72f46314-5a65-467f-abea-944dcfd78d17,PENTA,penta,,,,72f46314-5a65-467f-abea-944dcfd78d17,penta,PENTA -1325,,c50b252d-0280-4507-9b7a-c729819baa31,PIERRE FABRE MEDICAMENT -IRPF- PIERRE FABRE INNOVATION,pierre_fabre_medicament_irpf_pierre_fabre_innovation,,,,,, -1326,,c5b1aabf-0979-44dd-8e10-b0cd7e545a5d,Helperby Therapeutics Limited,helperby_therapeutics_limited,,,,,, -1327,,4793b6a4-c834-4f4f-ae81-e40aba26b7f3,Fundacion para la investigación biomédica del hospital Ramón y Cajal de Madrid,fundacion_para_la_investigaci_n_biom_dica_del_hospital_ram_n_y_cajal_de_madrid,,,,,, -1328,,9cee827b-9190-44d4-ac80-a1c8cad26a9d,"Fertility Clinic, dept. of Obstetrics and gynecology, OUH",fertility_clinic_dept_of_obstetrics_and_gynecology_ouh,,,,,, -1329,,9e64a8b8-71fb-11e6-a0cd-0242ac12000b,RARE DIS THERAP,rare_dis_therap,,,,,, -1330,,1b200d87-c053-4490-b327-abd985efa50c,Instituto Científico Tecnológico de Navarra (ICTN),instituto_cient_fico_tecnol_gico_de_navarra_ictn,,,,,, -1331,,0617c8a8-dd7c-4827-86ca-a55b718a9739,CUB - Hôpital Erasme,cub_h_pital_erasme,,,,,, -1332,,ff5023a4-4e9c-4bb6-a016-1acda8a2924a,"Hologic, Inc",hologic_inc,,,,,, -1333,,a90b09a8-83d5-4a76-b0d0-22f2c62436a8,Pfizer Global Pharmaceutical Group,pfizer_global_pharmaceutical_group,,,,,, -1334,,73ce4878-8dfd-450b-8255-d08e44518dc5,"Medical University of Vienna, Department of Internal Med. I, Division of Infectious Diseases",medical_university_of_vienna_department_of_internal_med_i_division_of_infectious_diseases,,,,,, -1335,,175675e9-f134-48e5-8d06-98c21032a516,"Transplant Institute, Sahlgrenska University Hospital",transplant_institute_sahlgrenska_university_hospital,,,,,, -414,0.952896,99f9452a-8bde-11e6-a449-0242ac12000b,Medical Univerity Vienna,medical_univerity_vienna,,,,5f666fad-c0f0-4e6a-8a52-a4806a60a3ee,medical_university_vienna,Medical University Vienna -1336,,2d698705-1d23-4c83-99c8-148d581a7385,IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli,irccs_istituto_centro_san_giovanni_di_dio_fatebenefratelli,,,,,, -1337,,ab9f3024-f39d-4c09-a76f-13d6dd6cc840,"Charles University in Prague, Faculty of Medicine in Hradec Králové",charles_university_in_prague_faculty_of_medicine_in_hradec_kr_lov,,,,,, -1338,,1d3a7a8d-d7fa-4569-8a9d-cfffac59ffe2,University of Helsinki - Erkki Isometsä,university_of_helsinki_erkki_isomets,,,,,, -1339,,bc3e68b9-fe0e-4452-8516-728273975d81,Gateshead Health NHS Trust Research & Development,gateshead_health_nhs_trust_research_development,,,,,, -1340,,b740e1ac-73a0-11e6-a0cd-0242ac12000b,CEREXA,cerexa,,,,,, -1341,,04a1a60a-6f98-11e6-9663-0242ac12000b,Romark Laboratories L.C,romark_laboratories_l_c,,,,,, -1342,,3055f710-52b7-4b47-8a70-6620d56718f4,Klinik für Anästhesiologie Universitätsklinikum Aachen,klinik_f_r_an_sthesiologie_universit_tsklinikum_aachen,,,,,, -1343,,297f20ef-81b9-4ef1-bb6b-977b12cead35,APTALIS PHARMA CANADA INC,aptalis_pharma_canada_inc,,,,,, -1344,,54aff514-9644-43ca-8e7f-ece5a1aa7683,University of Duisburg-Essen,university_of_duisburg_essen,,,,,, -419,0.97916126251220703,7b859cd9-f38a-4202-ab4e-7ce3650f0ea2,National and Kapodistrial University of Athens,national_and_kapodistrial_university_of_athens,,,,24418820-0b75-41e2-993c-2f2c0b00efb6,national_and_kapodistrian_university_of_athens,National and Kapodistrian University of Athens -1345,,c340fdbb-b3e1-4555-b499-428874e46b64,Academic hospital Maastricht,academic_hospital_maastricht,,,,,, -1071,0.96678978204727173,a1ac5ed3-48d6-4b25-be01-f8fe60a9d1d6,University College Dublin CRC,university_college_dublin_crc,,,,a1ac5ed3-48d6-4b25-be01-f8fe60a9d1d6,university_college_dublin,University College Dublin -1346,,ac85ad89-1ff8-4003-9c2a-bf3f68760ea0,Karl Emil Kristensen,karl_emil_kristensen,,,,,, -1347,,b0722950-7399-11e6-a0cd-0242ac12000b,VERNALIS R AND D LTD,vernalis_r_and_d_ltd,,,,,, -1348,,26e46186-1c42-4561-acf2-c54a9df90ea4,"Adelaide & Meath Hospital, incorporating The National Children's Hospital",adelaide_meath_hospital_incorporating_the_national_children_s_hospital,,,,,, -1349,,f4eef681-9e4a-4ca1-8714-2835fa8cdbec,medac GmbH,medac_gmbh,,,,,, -1350,,3957ba6e-0328-4b23-84c8-a2e310c56dd8,Forest Laboratories UK Ltd,forest_laboratories_uk_ltd,,,,,, -1351,,795c094c-1932-4f68-89fe-f603c9e61be6,The Finnish Breast Cancer Group,the_finnish_breast_cancer_group,,,,,, -1352,,6d1568c1-b968-487b-b8b0-3fd7751c7a7a,"H-PHAR,sa",h_phar_sa,,,,,, -1353,,a741a9fb-b3b9-4fdc-a19b-f7cc627b7e3d,PharmaMar S.A,pharmamar_s_a,,,,,, -1354,,ef78504a-8b08-4d66-a3b8-5dd780420f99,AZIENDA OSPEDALIERA PISANA,azienda_ospedaliera_pisana,,,,,, -738,0.96910750865936279,0223cc5a-d770-406a-9db1-a0c4325ff12b,Fundació Clinic per la Recerca Biomédica,fundaci_clinic_per_la_recerca_biom_dica,,,,0223cc5a-d770-406a-9db1-a0c4325ff12b,fundaci_clinic_per_la_recerca_biom_dica,Fundació Clinic per la Recerca Biomédica -1355,,95617726-751f-4a37-bfe7-e5703dd27bd5,Verein für Tumorforschung,verein_f_r_tumorforschung,,,,,, -35,0.977622,1b03f797-4154-432f-973b-87560cdf6cc4,"Landstinget Västmanland, Division Kirurgi, Operationskliniken",landstinget_v_stmanland_division_kirurgi_operationskliniken,,,,1b03f797-4154-432f-973b-87560cdf6cc4,landstinget_v_stmanland_division_kirurgi_operationskliniken,"Landstinget Västmanland, Division Kirurgi, Operationskliniken" -1356,,55bce374-05a5-42de-8b38-32940937cb3b,Helsingin Yliopistollinen keskussairaala,helsingin_yliopistollinen_keskussairaala,,,,,, -1357,,dc076014-19dc-4081-8fa9-9e22f663ba9e,Sahlgrenska Academy-Gothenburg University Institute,sahlgrenska_academy_gothenburg_university_institute,,,,,, -1358,,7460bacb-ee89-436d-836c-cd1a43d8aa58,"The Kirby Institute (formerly National Centre in HIV Epidemiology and Clinical Research (NCHECR)), University of New Sou",the_kirby_institute_formerly_national_centre_in_hiv_epidemiology_and_clinical_research_nchecr_university_of_new_sou,,,,,, -1359,,5ff4ad07-11b6-491d-9896-b0fb229d7c89,Mª Victoria Gil Navarro,m_victoria_gil_navarro,,,,,, -1360,,7938f48e-ed8f-4f3e-9cf8-cb17b754fadb,Eisai GmbH,eisai_gmbh,,,,,, -1361,,793e04e8-bae1-4d6d-8c8e-204cd525d4ae,Merrion Pharmaceuticals plc,merrion_pharmaceuticals_plc,,,,,, -1362,,5bd8282a-ce40-4ac1-91ec-bde67a69784d,Associació Per a la Recerca Oncològica (APRO),associaci_per_a_la_recerca_oncol_gica_apro,,,,,, -1363,,b99bf3be-ef5e-4f9d-a988-eaaf8a005957,Niuvanniemen sairaala,niuvanniemen_sairaala,,,,,, -1364,,8f2448c8-5cb8-4018-b225-07ce2e5dbdd4,Nottingham University Hospital,nottingham_university_hospital,,,,,, -1365,,50fc18ba-7145-11e6-a0cd-0242ac12000b,OMAN PHARM PRODUCTS,oman_pharm_products,,,,,, -253,0.97890456517537439,4a176b41-c873-44ad-8442-a2e57b0b4289,Instituto Científico y Tecnológico de Navarra,instituto_cient_fico_y_tecnol_gico_de_navarra,,,,4a176b41-c873-44ad-8442-a2e57b0b4289,instituto_cient_fico_y_tecnol_gico_de_navarra,Instituto Científico y Tecnológico de Navarra -1366,,c0626f0e-98a2-47d4-895a-42abe9031e25,MAASTRO clinic,maastro_clinic,,,,,, -1367,,f7852934-48be-4a4e-aa3d-8a1558a1493f,"Clinical research lab for neurodegeneration, Dept. of Neurology, St. Josef-Hospital, Ruhr-University",clinical_research_lab_for_neurodegeneration_dept_of_neurology_st_josef_hospital_ruhr_university,,,,,, -1368,,5aafd783-c512-4c83-a2ee-89134cbfdcd0,"Department of Clinical Science, Intervention and Technology, Karolinska Institute",department_of_clinical_science_intervention_and_technology_karolinska_institute,,,,,, -1369,,37e72344-3a44-45f2-97f2-256b5daaca19,"ORtopædkirurgisk Forskningsenhed, Aarhus Universitetshospital",ortop_dkirurgisk_forskningsenhed_aarhus_universitetshospital,,,,,, -1370,,18cd5783-0ff7-4483-aa32-e5499a043c34,Centro sociale oncologico,centro_sociale_oncologico,,,,,, -1032,0.98019236326217651,62b186bb-cb30-4ebd-9462-a1bd321e2179,Kvinnokliniken i Östergötland,kvinnokliniken_i_sterg_tland,,,,62b186bb-cb30-4ebd-9462-a1bd321e2179,kvinnokliniken_i_sterg_tland,Kvinnokliniken i Östergötland -1371,,8a673c86-71ec-11e6-a0cd-0242ac12000b,OAK PHARMS INC,oak_pharms_inc,,,,,, -295,0.988084,4fe3be9a-b05b-4bc8-b2c3-37b02726367b,Centre for Human Drug Research (CHDR),centre_for_human_drug_research_chdr,,,,4fe3be9a-b05b-4bc8-b2c3-37b02726367b,centre_for_human_drug_research_chdr,Centre for Human Drug Research (CHDR) -1372,,28751337-c075-4102-87b9-28542c4c14d3,"SFJ LungCancer, Ltd",sfj_lungcancer_ltd,,,,,, -275,0.972986,a3ebb60b-9170-4a8f-b88f-443598d1fa3d,Universitätsmedizin der Johannes Gutenberg-University Mainz,universit_tsmedizin_der_johannes_gutenberg_university_mainz,,,,61dc1432-2742-471c-9dcc-67fb304ce278,universit_tsmedizin_der_johannes_gutenberg_universit_t_mainz,Universitätsmedizin der Johannes Gutenberg-Universität Mainz -1373,,cfe702d4-719f-11e6-a0cd-0242ac12000b,INSIGHT PHARMS,insight_pharms,,,,,, -1374,,6b834ff0-73e8-11e6-a0cd-0242ac12000b,EXELTIS SUISSE,exeltis_suisse,,,,,, -1375,,00233aa2-0675-475b-a4d4-87fdcd93d49f,UNIVERSITA' DEGLI STUDI DI UDINE,universita_degli_studi_di_udine,,,,,, -1376,,91aebdab-5521-47f6-88d9-925051980c75,EM-kliniken,em_kliniken,,,,,, -1377,,8077b0ef-e6c9-40b3-8891-a58806a13639,Dra Maria Luz Couce,dra_maria_luz_couce,,,,,, -1378,,a0f50340-6fbf-11e6-abe8-0242ac12000b,NV AstraZeneca SA,nv_astrazeneca_sa,,,,,, -1042,0.989009,ab743a24-721d-11e6-a0cd-0242ac12000b,GLAXOSMITHKLINE CONS,glaxosmithkline_cons,,,,ab743a24-721d-11e6-a0cd-0242ac12000b,glaxosmithkline_cons,GLAXOSMITHKLINE CONS -312,0.973688,61d96cf8-a5e6-47f3-8422-68006b928dbb,"Stockholms Läns Landsting, Karolinska Universitetssjukhuset Huddinge, Anestesikliniken",stockholms_l_ns_landsting_karolinska_universitetssjukhuset_huddinge_anestesikliniken,,,,16c13ad3-319c-4580-9561-26254cba7ca2,stockholms_l_ns_landsting,Stockholms Läns Landsting -1379,,fceaf78e-9c35-44aa-b13b-0de86d8bd15d,"Research and Development Directorate, University Hospitals of Leicester NHS Trust",research_and_development_directorate_university_hospitals_of_leicester_nhs_trust,,,,,, -1380,,d990823b-6a01-44c8-8360-523885f6e3a3,Innocoll Technologies,innocoll_technologies,,,,,, -377,0.97151175141334534,a995503b-132d-44dc-a6b0-648b85bc0828,Merck,merck,,,,a995503b-132d-44dc-a6b0-648b85bc0828,merck_co,Merck & Co -1381,,f9e5c9e1-83fa-46e2-9871-c5a4eec992e9,Lothian Health Board,lothian_health_board,,,,,, -1382,,1f0395ae-d667-4820-bac1-3df7801d3365,All-Ireland Co-operative Oncology Research Group (ICORG),all_ireland_co_operative_oncology_research_group_icorg,,,,,, -1383,,89aa0ad7-c72a-4284-86ae-28210e87ed80,TauRx Therapeutics PTE Ltd,taurx_therapeutics_pte_ltd,,,,,, -92,0.967029,c3e873ff-4ae6-499b-8ac6-5d8e2203e040,Diakonhjemmet Hospital AS,diakonhjemmet_hospital_as,,,,c3e873ff-4ae6-499b-8ac6-5d8e2203e040,diakonhjemmet_hospital_as,Diakonhjemmet Hospital AS -1384,,2657234a-44ed-4486-b15a-2c6f9a7b0d7f,"DEPARTMENT OF DERMATOLOGY, UNIVERSITY OF MODENA AND REGGIO EMILIA",department_of_dermatology_university_of_modena_and_reggio_emilia,,,,,, -1385,,c7b73c84-7166-11e6-a0cd-0242ac12000b,USV NORTH AMERICA,usv_north_america,,,,,, -1386,,8a6f1056-878d-42a0-8ef8-0c18b2f0e50c,Summit Corporation plc,summit_corporation_plc,,,,,, -884,0.96910750865936279,e644919e-8d5c-4749-8862-167280abf364,AGMT,agmt,,,,0535053a-70a1-4184-85fb-a82d42918846,agmt_ggmbh,AGMT gGmbH -1387,,4e06497e-0a90-466e-bea2-8f59ec41cc45,Johan Hellgren,johan_hellgren,,,,,, -1025,0.96489724516868591,349202d3-c159-4eb0-a563-61bee70e783e,"Eli Lilly and Company Limited, UK",eli_lilly_and_company_limited_uk,,,,2f59f764-513a-43d8-ba41-bc314f18f59b,eli_lilly_and_company_limited,Eli Lilly and Company limited -1388,,734b565a-e22b-4f30-87f0-9b8290707887,Royal Marsden Hospital NHS Foundation Trust,royal_marsden_hospital_nhs_foundation_trust,,,,,, -1389,,fe0eba9a-5709-4982-a02c-d29273db52a7,"Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, endvertreten durch den Dekan",martin_luther_universit_t_halle_wittenberg_medizinische_fakult_t_endvertreten_durch_den_dekan,,,,,, -1390,,2941475f-a7c6-11e6-94cb-5656d04fc2b5,ORASIS Pharmaceuticals Ltd,orasis_pharmaceuticals_ltd,,,,,, -1391,,5c9bcb81-736e-4e3c-b214-73b440a80c9a,OSE Pharma,ose_pharma,,,,,, -1079,0.956865,0d9451d0-cac1-41f0-a202-5d895bc08f17,The Institute of Cancer Research / The Royal Marsden NHS Foundation Trust,the_institute_of_cancer_research_the_royal_marsden_nhs_foundation_trust,,,,0d9451d0-cac1-41f0-a202-5d895bc08f17,the_institute_of_cancer_research_the_royal_marsden_nhs_foundation_trust,The Institute of Cancer Research / The Royal Marsden NHS Foundation Trust -1392,,49f32fb4-1bf0-4326-9a39-730a3a685bfa,CHU DE POITIERS,chu_de_poitiers,,,,,, -1393,,d896be42-7a8c-4cd1-8d53-c6b9ea656ad2,"Charité Berlin, department of rheumatology",charit_berlin_department_of_rheumatology,,,,,, -1394,,40715934-32ad-4ce5-8290-4519a533b123,HUS - Naistentautien ja synnytysten tulosyksikkö,hus_naistentautien_ja_synnytysten_tulosyksikk,,,,,, -1395,,b926bfa2-949b-4111-985e-d80ecaf4eb64,University College of London,university_college_of_london,,,,,, -1396,,d83dd198-390e-42e0-b38a-37b4e427e621,YM Biosciences Inc,ym_biosciences_inc,,,,,, -1397,,5d2489f2-0a5f-4380-967d-08f588f2f7dc,Luis López Cortes - FISEVI,luis_l_pez_cortes_fisevi,,,,,, -1398,,f068903f-7a20-4b87-995b-1721976d94f6,MERCK SHARP & DOHME CORP. UNA SUSSIDIARIA DI MERCK & CO. INC,merck_sharp_dohme_corp_una_sussidiaria_di_merck_co_inc,,,,,, -1399,,1b97ddb4-8818-11e6-a998-0242ac12000b,"Octapharma Pharmazeutika Produktionsges.m.b.H, Oberlaaer Strasse 235, A-1100 Vienna, Austria",octapharma_pharmazeutika_produktionsges_m_b_h_oberlaaer_strasse_235_a_1100_vienna_austria,,,,,, -1048,0.98716670274734497,92cf0698-f0a3-49e3-b16c-ece2bebd1173,University Hospital,university_hospital,,,,92cf0698-f0a3-49e3-b16c-ece2bebd1173,university_hospital,University Hospital -90,0.988251,51f2f135-0aa9-4e39-b934-2ebfce55549a,Bio Products Laboratory,bio_products_laboratory,,,,51f2f135-0aa9-4e39-b934-2ebfce55549a,bio_products_laboratory,Bio Products Laboratory -1400,,698dd981-0168-4ee1-bae9-b34e09bc800f,Hellenic Cardiovascular Research Society,hellenic_cardiovascular_research_society,,,,,, -1401,,03904747-32fd-4bf8-926f-34dde2c1f4b3,Dr. Lluis Mont-Girbau,dr_lluis_mont_girbau,,,,,, -1402,,262e70eb-f592-4b5f-8e06-12a5152ab7c9,Servicio de Cirugía General y Digestiva Hospital Universitario de Bellvitge,servicio_de_cirug_a_general_y_digestiva_hospital_universitario_de_bellvitge,,,,,, -1403,,afdbaef4-28d2-4308-a7c1-92368f97cf04,Henogen s.a,henogen_s_a,,,,,, -664,0.97318911552429199,56238a57-b5e3-44be-840b-09e7fea2a5aa,Charité,charit,,,,56238a57-b5e3-44be-840b-09e7fea2a5aa,charit,Charité -1404,,a1b25ca1-bdb2-49ab-8b6e-b5eca5abc4f2,Sylentis,sylentis,,,,,, -1405,,a7b475cc-c7ca-4146-a636-f429612178fd,NIH-National Institut of Health - NINDS-National Institut of Neurogical Disorders and Stroke,nih_national_institut_of_health_ninds_national_institut_of_neurogical_disorders_and_stroke,,,,,, -986,0.97420722246170044,67902b25-58c1-419c-918d-42f6cc022a27,Imperial College Healthcare NHS Trust and Imperial College London,imperial_college_healthcare_nhs_trust_and_imperial_college_london,,,,67902b25-58c1-419c-918d-42f6cc022a27,imperial_college_healthcare_nhs_trust,Imperial College Healthcare NHS Trust -1406,,d83916f1-ec43-4919-b86c-5947d959fe54,West Yorkshire Primary Care R&D Unit,west_yorkshire_primary_care_r_d_unit,,,,,, -1407,,44ce2536-2ee2-4791-a112-63a909ff90f0,Lipopeptide AB,lipopeptide_ab,,,,,, -1408,,42f742c6-81c4-4087-b01e-ee9df8b92fb7,San Joan de Déu. Serveis de Salut Mental,san_joan_de_d_u_serveis_de_salut_mental,,,,,, -745,0.974187,aabefd85-885a-4e88-a6ef-3b820f53dd2f,"Medical School Hannover. Department of Psychiatry, Social Psychiatry and Psychotherapy",medical_school_hannover_department_of_psychiatry_social_psychiatry_and_psychotherapy,,,,0b393cda-95af-44e2-87c2-0f3e708c0eea,medical_school_hannover_department_of_psychiatry_socialpsychiatry_and_psychotherapy,"Medical School Hannover, Department of Psychiatry, Socialpsychiatry and Psychotherapy" -1409,,0820973f-28ec-41ec-bb94-ae1c25bc04ba,Viiv Healthcare,viiv_healthcare,,,,,, -1410,,75da775c-73bc-11e6-a0cd-0242ac12000b,NAPO PHARMS INC,napo_pharms_inc,,,,,, -485,0.985716,d4d3b8e8-ff21-4f29-9209-678e5c00d01b,IRCCS CENTRO SAN GIOVANNI DI DIO,irccs_centro_san_giovanni_di_dio,,,,d4d3b8e8-ff21-4f29-9209-678e5c00d01b,irccs_centro_san_giovanni_di_dio,IRCCS CENTRO SAN GIOVANNI DI DIO -1411,,bf792251-bceb-4b48-a9b5-0095df9039d6,"Institute of Psychiatry, Kings College London & South London and Maudsley NHS Trust",institute_of_psychiatry_kings_college_london_south_london_and_maudsley_nhs_trust,,,,,, -1412,,4fc12d4d-bcac-4fc0-9289-3b6604851788,"BIAL - PORTELA & C�, S.A",bial_portela_amp_c_s_a,,,,,, -943,0.910995,d64fbb64-ace2-40d6-b379-d8f2f6277ac6,"PDL BioPharma, Inc",pdl_biopharma_inc,,,,d64fbb64-ace2-40d6-b379-d8f2f6277ac6,pdl_biopharma_inc,"PDL BioPharma, Inc" -1413,,60c98481-6711-4ad4-8cc2-81556a33e22b,ErasmusMC - Sophia,erasmusmc_sophia,,,,,, -1414,,c09f4926-0cff-4e77-865f-6e7389b8c889,Fundació Institut Català de Farmacologia,fundaci_institut_catal_de_farmacologia,,,,,, -733,0.982275,ea39e7dd-e998-4569-9284-4040ea4aacc2,"Technical University Munich, Klinikum rechts der Isar",technical_university_munich_klinikum_rechts_der_isar,,,,7e09558a-ee7d-474c-9101-17cf9741e4d6,technical_university_munich,Technical University Munich -1415,,532bc2b4-484f-42ed-a498-1d54d98e029e,Bangor University,bangor_university,,,,,, -1416,,cef09098-71b8-11e6-a0cd-0242ac12000b,PARNELL,parnell,,,,,, -1417,,739c3383-ddae-44d9-92df-228547007126,Dra. Mª Dolores Arenas,dra_m_dolores_arenas,,,,,, -1418,,1a498868-20c3-4742-9f0c-1df7cc3f50c4,"ZAMBON, S.A",zambon_s_a,,,,,, -1419,,83d5d329-00bf-4d68-89d4-a1435edf1569,NIDDK TYPE 1 DIABETES TRIALNET,niddk_type_1_diabetes_trialnet,,,,,, -1420,,32c044fa-73a4-11e6-a0cd-0242ac12000b,NEW HAVEN PHARMS,new_haven_pharms,,,,,, -1421,,c19146a3-ed0a-4139-8857-988e978a8062,"TRACON Pharmaceuticals, Inc",tracon_pharmaceuticals_inc,,,,,, -186,0.987464,2cec47b8-3bd6-4f10-8180-b9e29e1ccf01,ISTITUTO GIANNINA GASLINI-PRINTO,istituto_giannina_gaslini_printo,,,,2cec47b8-3bd6-4f10-8180-b9e29e1ccf01,istituto_giannina_gaslini_printo,ISTITUTO GIANNINA GASLINI-PRINTO -1422,,a13ad6c4-c1ec-4eda-91c8-3924d72aac10,"Algeta ASA, Oslo, Norway",algeta_asa_oslo_norway,,,,,, -1423,,515c1e7a-2d34-4c32-a95f-710511d1d5bd,Birmingham Community Healthcare NHS Trust,birmingham_community_healthcare_nhs_trust,,,,,, -1424,,804eb04b-e153-47c9-8087-3a4de9ab227b,Friedrich-Alexander-Universitaet Erlangen-Nuernberg,friedrich_alexander_universitaet_erlangen_nuernberg,,,,,, -1425,,dc2ae94b-8024-4df2-bba4-52c0549b8247,"Johnson&Johnson Pharmaceutical Research and Development, Division de Janssen-Cilag",johnson_johnson_pharmaceutical_research_and_development_division_de_janssen_cilag,,,,,, -1426,,4c921685-e48a-4f5c-af8b-ffc894bd48d1,IRCCS Ospedale San Raffaele,irccs_ospedale_san_raffaele,,,,,, -792,0.980742,97fbdb53-1d5f-4818-9d3f-51409c6494bc,LEO Pharmaceuticals Products Ltd. A/S (LEO Pharma A/S),leo_pharmaceuticals_products_ltd_a_s_leo_pharma_a_s,,,,3eeb7409-fc6a-4e35-b3ca-369fcd621d64,leo_pharmaceutical_products_ltd_a_s_leo_pharma_a_s,LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S) -1427,,358578aa-72cc-11e6-a0cd-0242ac12000b,ABRAXIS BIOSCIENCE,abraxis_bioscience,,,,,, -1428,,4528833d-9c09-48ae-91ac-cfb24aa38723,FUNDACIÓN SANT JOAN DE DEU,fundaci_n_sant_joan_de_deu,,,,,, -1429,,f3d2f69a-209e-4213-85a9-ebe9ff8f07c4,Ethik-Kommission der Medizinischen Fakultät der Martin-Luther-Universität Halle Wittenberg,ethik_kommission_der_medizinischen_fakult_t_der_martin_luther_universit_t_halle_wittenberg,,,,,, -1430,,0ccb32cd-d2c7-43a6-ab56-1fb2dc2759ee,"Theracos, Inc",theracos_inc,,,,,, -1431,,1ce4ac5a-642a-4b3e-80f1-ee916d1bde47,Royal Free Hampstead NHS Trust,royal_free_hampstead_nhs_trust,,,,,, -1432,,43551469-90e0-4915-94e2-2a99467bbf52,Sahlgrenska Academy,sahlgrenska_academy,,,,,, -1433,,c1163915-da66-4df9-89ca-0c6d5e53601f,"Forest Research Institute, Inc., a wholly owned subsidiary of Forest Laboratories, Inc",forest_research_institute_inc_a_wholly_owned_subsidiary_of_forest_laboratories_inc,,,,,, -1434,,ee6e8018-08a9-49f4-b383-6e8139348029,"Salix Pharmaceuticals, Inc",salix_pharmaceuticals_inc,,,,,, -139,0.949534,2b57b25f-7999-42a9-bc73-ba293507ad94,AWD.pharma GmbH & Co KG,awd_pharma_gmbh_co_kg,,,,2b57b25f-7999-42a9-bc73-ba293507ad94,awd_pharma_gmbh_co_kg,AWD.pharma GmbH & Co KG -1435,,e30e8125-aee1-4c14-94be-fa06b2051035,Hepatology UZ Gasthuisberg,hepatology_uz_gasthuisberg,,,,,, -1436,,a581a6e3-f8df-400c-83d0-76e0bf4d7086,Herlev Gentofte Hospital,herlev_gentofte_hospital,,,,,, -1437,,2d707abc-46d7-433c-99ba-8a9788241279,Joint UCLH/UCH Biomedical Research Unit,joint_uclh_uch_biomedical_research_unit,,,,,, -1438,,7596c937-9782-4dc5-8265-7e01001d7aed,"Pharmanord, UK, LTD",pharmanord_uk_ltd,,,,,, -1439,,7fe00a20-9ef0-4c86-9368-0be5c00a34d2,Department of Nuclear Medicine,department_of_nuclear_medicine,,,,,, -1440,,72390df7-09f9-41f5-afc8-7ddf26173a3a,Mundipharma Pharmaceuticals B.V,mundipharma_pharmaceuticals_b_v,,,,,, -1441,,f29ad6dc-8be9-45d6-b1c7-762e7bca12d7,Kansanterveyslaitos,kansanterveyslaitos,,,,,, -1442,,7baf301c-71a2-11e6-a0cd-0242ac12000b,JUBILANT DRAXIMAGE,jubilant_draximage,,,,,, -149,0.98663,196b721b-cf1f-48fb-9325-0abb1def7a34,Array BioPharma,array_biopharma,,,,196b721b-cf1f-48fb-9325-0abb1def7a34,array_biopharma,Array BioPharma -1443,,90b1b931-4335-4914-a8b7-154e9a2ec266,University of Turku,university_of_turku,,,,,, -1444,,0b2dd014-9d2e-4ad5-b22a-eb9b89518eee,Rheoscience A/S,rheoscience_a_s,,,,,, -62,0.98616591095924377,8776dd79-3ee8-4ef0-a9ce-fb6aef833e21,"Talecris Biotherapeutics, Incorporated",talecris_biotherapeutics_incorporated,,,,8776dd79-3ee8-4ef0-a9ce-fb6aef833e21,talecris_biotherapeutics_inc,"Talecris Biotherapeutics, Inc" -1445,,d4bdd8da-7129-11e6-a89e-0242ac12000b,ACTAVIS LABS FL INC,actavis_labs_fl_inc,,,,,, -1446,,ee7e787e-4ce7-4eeb-92a0-a83ad5ba812f,"Universitätsklinik für Augenheilkunden und Optometrie, Medizinische Universität Wien",universit_tsklinik_f_r_augenheilkunden_und_optometrie_medizinische_universit_t_wien,,,,,, -449,0.98227512836456299,c0ddef62-c8b9-4735-824a-6c81d6d62508,ALLERGAN INC,allergan_inc,,,,17a7cd12-2e89-4b00-832e-bc19b8172771,allergan,ALLERGAN -315,0.97933,f9936692-71d9-11e6-a0cd-0242ac12000b,CEPHALON,cephalon,,,,859cee6f-b91c-4dae-a958-dcbf3458bbb4,cephalon_france,CEPHALON FRANCE -1447,,ea516ab6-bee6-4b2d-b9a3-563299c429e7,Laboratorio Reig Jofré S.A,laboratorio_reig_jofr_s_a,,,,,, -1448,,36c257ab-810c-4e10-b428-89ca5d00438b,USV Private Limited,usv_private_limited,,,,,, -1449,,67d6f15e-d5f9-454c-821f-513efa46dcda,IOBA - Instituto Universitario de Oftalmobiología Aplicada,ioba_instituto_universitario_de_oftalmobiolog_a_aplicada,,,,,, -196,0.981008,9324d427-ccb6-48fe-912d-ec2b4be0fbec,"CHRU Montpellier - Direction de la Recherche, Partenariats et Réseaux, Relations avec l'Université",chru_montpellier_direction_de_la_recherche_partenariats_et_r_seaux_relations_avec_l_universit,,,,9324d427-ccb6-48fe-912d-ec2b4be0fbec,chru_montpellier_direction_de_la_recherche_partenariats_et_r_seaux_relations_avec_l_universit,"CHRU Montpellier - Direction de la Recherche, Partenariats et Réseaux, Relations avec l'Université" -1450,,da1cb51a-715d-11e6-a0cd-0242ac12000b,BIO PHARM INC,bio_pharm_inc,,,,,, -1451,,e330911b-10c6-4d8d-a0c1-4cdfa0f4e4d1,Pharma Stulln GmbH,pharma_stulln_gmbh,,,,,, -1452,,49212f89-dc17-4cd7-8001-26cfda5cac5d,Fondazione P E N T A,fondazione_p_e_n_t_a,,,,,, -1453,,b69016aa-600d-49a1-875f-24396565a303,"Department of Psychiatry and Psychotherapy, Friedrich-Schiller-University Jena",department_of_psychiatry_and_psychotherapy_friedrich_schiller_university_jena,,,,,, -1454,,59af4fe7-0f53-47ad-97eb-3ece87f0af88,Biogen Idec Italia S.r.l,biogen_idec_italia_s_r_l,,,,,, -1455,,f800ee2c-5b6c-45bb-beaf-90dbc5da300e,Cell Medica Ltd,cell_medica_ltd,,,,,, -1456,,fd078e39-b430-433d-849c-221660a8222a,Alize Pharma,alize_pharma,,,,,, -1457,,b1247a9c-5011-4603-ac8a-aa4a64cb8c1a,CHU Liège - Physical Medicine Service,chu_li_ge_physical_medicine_service,,,,,, -1458,,4bd4a4ab-4259-4802-942f-31f7e0a89933,AZIENDA OSPEDALIERA OSPEDALE S. SALVATORE,azienda_ospedaliera_ospedale_s_salvatore,,,,,, -1459,,75cbd4ee-8dc7-40a3-b8d5-9190cb7b3a15,"Intec Pharma, Ltd",intec_pharma_ltd,,,,,, -1460,,1d5c4f06-73ad-11e6-a0cd-0242ac12000b,SUPERNUS PHARMS,supernus_pharms,,,,,, -1051,0.981904,bbf2cf53-53f8-4b29-80dd-79c7bfc9befa,Bioenvision,bioenvision,,,,4bcc1755-5dc6-434d-aed0-d5fa3a830bf2,bioenvision_limited,Bioenvision Limited -1461,,e64e6b78-417c-4d21-8468-7d060598f6eb,Foreest Medical School,foreest_medical_school,,,,,, -1039,0.97356534004211426,9baf045c-89f9-4085-b743-41b82541dc46,Celgene International II Sàrl,celgene_international_ii_s_rl,,,,34050438-2ab9-4f3c-ad8e-1d5dea845aa7,celgene_international_ii_sarl_cis_ii,Celgene International II Sarl (CIS II) -1462,,7bd7b020-b4f0-47be-a2f1-2b8b2ee724c5,Bayer HealhCare AG,bayer_healhcare_ag,,,,,, -1463,,8bb92342-f000-48a4-ada4-8648a394328a,"Synthetic Biologics, Inc",synthetic_biologics_inc,,,,,, -1464,,3198db4b-fabe-4e97-abae-a75cec98f54e,"A.P. Pharma, Inc",a_p_pharma_inc,,,,,, -1465,,01c8844e-dfc1-446e-88ee-52c7a90e5fa9,Universitätsklinik Mainz Pneumologie,universit_tsklinik_mainz_pneumologie,,,,,, -277,0.97426038980484009,71fa3658-cdd0-4248-b428-53aae9afea66,"Teva Branded Pharmaceutical Producs R&D, Inc",teva_branded_pharmaceutical_producs_r_d_inc,,,,71fa3658-cdd0-4248-b428-53aae9afea66,teva_branded_pharmaceutical_products_r_d_inc,"Teva Branded Pharmaceutical Products R&D, Inc" -1466,,c601d4c3-823b-4cea-ad46-98cdbf346316,Weill Medical College of Cornell University,weill_medical_college_of_cornell_university,,,,,, -1467,,532d637b-e540-43c5-98f0-cfb4c90cb11f,SESP,sesp,,,,,, -1468,,d4b2f361-12f5-4a10-92c0-f26403a083bb,Addmedica S.A.S,addmedica_s_a_s,,,,,, -1469,,81805d97-01b8-452a-9b16-bc6b9e775265,Klinik und Poliklinik für Augenheilkunde der Universität Regensburg,klinik_und_poliklinik_f_r_augenheilkunde_der_universit_t_regensburg,,,,,, -1470,,2617f388-734f-11e6-a0cd-0242ac12000b,AR HOLDING CO INC,ar_holding_co_inc,,,,,, -1471,,6716d59e-4937-4e77-9dbe-ff9576b83787,Markku Kupari,markku_kupari,,,,,, -805,0.97709846496582031,677d2804-ad3e-4bab-95aa-43e72db6366f,"Otsuka Pharmaceutical Development & Commercialization, Inc",otsuka_pharmaceutical_development_commercialization_inc,,,,8e240a49-6e4c-46a0-8366-15b78371ff26,otsuka_pharmaceutical_development_commercialization_inc,"Otsuka Pharmaceutical Development & Commercialization, Inc" -1472,,d9cdc79d-283e-48b3-8508-14217f6c8d33,OrbusNeich Medical BV,orbusneich_medical_bv,,,,,, -845,0.984184,c064f018-7141-11e6-a0cd-0242ac12000b,ELITE LABS INC,elite_labs_inc,,,,c064f018-7141-11e6-a0cd-0242ac12000b,elite_labs_inc,ELITE LABS INC -1473,,ef19f09d-8fae-492e-bd7b-fd984cedeadf,Kedrion SpA,kedrion_spa,,,,,, -807,0.968782,420745a1-a57e-4545-a9b6-170be97fb467,"Medical University of Vienna, Dept. of Clinical Pharmacology",medical_university_of_vienna_dept_of_clinical_pharmacology,,,,420745a1-a57e-4545-a9b6-170be97fb467,medical_university_of_vienna_dept_of_clinical_pharmacology,"Medical University of Vienna, Dept. of Clinical Pharmacology" -1474,,14df6efe-b457-49ec-b6df-53eed1bf03e8,Heart- and Diabetescenter NRW,heart_and_diabetescenter_nrw,,,,,, -1475,,23395044-73f9-11e6-a0cd-0242ac12000b,RELIANT HOLDINGS LTD,reliant_holdings_ltd,,,,,, -1476,,4d2c701b-d2d6-4a65-9ece-1c8450dda308,Fundación para la investigación biomedica del hospital clinico san carlos de madrid,fundaci_n_para_la_investigaci_n_biomedica_del_hospital_clinico_san_carlos_de_madrid,,,,,, -1477,,b2af178c-9d62-47fe-87df-a91fa6a2b933,Grupo Español de Tumores Neuroendocrinos,grupo_espa_ol_de_tumores_neuroendocrinos,,,,,, -233,0.980434,bc0bdbc9-5679-4ff2-b014-d9efcc38f706,"Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre",department_of_infectious_diseases_copenhagen_university_hospital_hvidovre,,,,321f06bc-9aaf-4f20-b50b-fec99e946a29,department_of_infectious_diseases,Department of Infectious Diseases -1478,,fcd43351-6043-472a-9cac-6dd580562714,Agustín Albillos Martinez,agust_n_albillos_martinez,,,,,, -85,0.979515,43e9673c-7162-11e6-a0cd-0242ac12000b,PERRIGO CO,perrigo_co,,,,32d4a4cc-7142-11e6-a0cd-0242ac12000b,perrigo_co_tennessee,PERRIGO CO TENNESSEE -1479,,040a1a3b-306a-4a08-be78-b178e1d033da,Laboratoires IPRAD,laboratoires_iprad,,,,,, -1480,,da523855-2a61-4a14-84b1-9ddef039cf04,"Medical clinic, University Hospital of North Norway",medical_clinic_university_hospital_of_north_norway,,,,,, -1481,,5139ffa3-35c0-4406-80a1-d0a48e765722,Dr. José Ignacio Chacón López-Muñiz,dr_jos_ignacio_chac_n_l_pez_mu_iz,,,,,, -1482,,5bea85f2-f1a8-46b8-b8ef-77c4e865b4e7,Miguel Giovanni Uriol Rivera,miguel_giovanni_uriol_rivera,,,,,, -1483,,69fb388d-6ce6-4caa-9916-a556e042fd77,NOVARTIS FARMA S.p.A,novartis_farma_s_p_a,,,,,, -1484,,83d147af-380c-48c4-b34c-ab3cdac326e9,University Eye Hospital,university_eye_hospital,,,,,, -981,0.97865206003189087,b57930d5-608d-413d-80c5-1204dbea3b2c,Bispebjerg Hospital,bispebjerg_hospital,,,,7924c511-76dd-4819-aff7-6958da1692ce,bispebjerg_hospital_department_of_dermatology,"Bispebjerg Hospital, Department of Dermatology" -1485,,b5f04647-9329-4c71-8269-935f945cb669,"Seattle Genetics, Inc",seattle_genetics_inc,,,,,, -1486,,5fa823ff-ef6a-4a2c-886e-fe9231b0f54b,Creabilis Limited,creabilis_limited,,,,,, -1487,,01f90b45-7fd1-40c5-9555-167560599dd9,Dr. Javier Pérez Gisbert,dr_javier_p_rez_gisbert,,,,,, -1488,,0cebf120-71ec-4157-9bc0-e339de7de377,Institut für Spezifische Prophylaxe und Tropenmedizin,institut_f_r_spezifische_prophylaxe_und_tropenmedizin,,,,,, -1489,,23c78d7a-aabf-4d5e-8fca-07431edb9679,Cardeas Pharma,cardeas_pharma,,,,,, -1490,,0e5e513b-a71c-40c0-8d0a-adc390b2cccf,United Bristol Healthcare Trust,united_bristol_healthcare_trust,,,,,, -1491,,fb34a78f-fa50-4f3f-9a94-f2795baed313,Zsolt Lohinai DMD PhD,zsolt_lohinai_dmd_phd,,,,,, -1492,,3ff39c76-7165-11e6-a0cd-0242ac12000b,UNITED BIOMEDCL,united_biomedcl,,,,,, -1493,,a17e8112-715c-11e6-a0cd-0242ac12000b,STRIDES ACROLAB,strides_acrolab,,,,,, -796,0.98663,26536bce-72ec-11e6-a0cd-0242ac12000b,STRIDES ARCOLAB,strides_arcolab,,,,26536bce-72ec-11e6-a0cd-0242ac12000b,strides_arcolab,STRIDES ARCOLAB -1494,,db5ba9cc-352d-4c06-9546-f4e59542096e,Mid Cheshire Hospitals NHS Trust,mid_cheshire_hospitals_nhs_trust,,,,,, -1495,,8a187e2e-43f7-4dd5-8083-62a2d7241cdd,"Department of Neurosurgery, PMU",department_of_neurosurgery_pmu,,,,,, -1496,,64945698-7a05-4058-a61e-47d1323a211c,BGP Kranj,bgp_kranj,,,,,, -688,0.98544374108314514,4f99f7a3-6aa3-48d1-bbd6-5bfbc38e7e8d,"Ruprecht-Karls-University Heidelberg, Medical Faculty",ruprecht_karls_university_heidelberg_medical_faculty,,,,4f99f7a3-6aa3-48d1-bbd6-5bfbc38e7e8d,ruprecht_karls_university_heidelberg_medical_faculty,"Ruprecht-Karls-University Heidelberg, Medical Faculty" -1497,,601e88fa-2e81-40a3-94c7-92870e050004,University Hospital of Tübingen,university_hospital_of_t_bingen,,,,,, -1498,,7215cc6b-f2e3-4632-bcca-af68390883f2,"Med. Univ. Wien, Klinik Innere Medizin I, Intensivstation",med_univ_wien_klinik_innere_medizin_i_intensivstation,,,,,, -1499,,1ecd9df1-ff07-4652-9df0-6c3dcba4d72e,ISTITUTO CLINICO HUMANITAS,istituto_clinico_humanitas,,,,,, -1500,,fd94f628-42b0-4de2-a7c1-3d00e3d2947c,CSL Behring GmbH,csl_behring_gmbh,,,,,, -1501,,61673059-674d-47da-9b5c-45145cc60749,"Supernus Pharmaceuticals, Inc",supernus_pharmaceuticals_inc,,,,,, -1502,,dab39b79-16d3-463f-896f-ea1b399bc782,Department of gastroenterology. University Hospital of Santiago,department_of_gastroenterology_university_hospital_of_santiago,,,,,, -1503,,285b7f85-63be-4da0-afc9-06b4e3ade1fc,Cerus Corporation,cerus_corporation,,,,,, -1504,,2cec0c2c-c84a-4b81-a31d-49ef52e44c98,CeQur Corp,cequr_corp,,,,,, -1505,,757340bd-15f9-4d36-b7c4-b0f6b5d86cfe,Christine Bengtsson,christine_bengtsson,,,,,, -1506,,d7ae7b9a-611e-4a82-8acb-b3f1c25f7470,Astellas Pharma Canada Inc,astellas_pharma_canada_inc,,,,,, -1507,,902f7b8b-e4ee-431b-9282-f01aab4e6ee0,Barnsley Hospital NHS Foundation Trust,barnsley_hospital_nhs_foundation_trust,,,,,, -1508,,fac53175-bd7c-4994-9451-9dff1b050ec5,"Merckle GmbH, a member of the ratiopharm group, a subsidiary of Teva Pharmaceutical Industries Ltd. Germany",merckle_gmbh_a_member_of_the_ratiopharm_group_a_subsidiary_of_teva_pharmaceutical_industries_ltd_germany,,,,,, -1509,,45f116ea-8811-11e6-a998-0242ac12000b,"Vertex Pharamceuticals, Inc",vertex_pharamceuticals_inc,,,,,, -1510,,bdc7af5e-7235-11e6-a0cd-0242ac12000b,NOVEN PHARMS INC,noven_pharms_inc,,,,,, -1511,,228f01cd-d116-4c2e-921b-3c582313be4a,Belfast HSC Trust,belfast_hsc_trust,,,,,, -911,0.955326,e90dccc5-87bf-45ae-9fd1-a29dda792f2e,"DIATER, Laboratorio de Diagnóstico y Aplicaciones Terapéuticas, S.A",diater_laboratorio_de_diagn_stico_y_aplicaciones_terap_uticas_s_a,,,,6fe95abc-39e9-4d47-999a-8959adcc1009,diater_laboratorio_de_diagnostico_y_aplicaciones_terap_uticas_s_a,DIATER Laboratorio de Diagnostico y Aplicaciones Terapéuticas S.A -1512,,0fb1babe-72af-470f-9091-5811e9f34ab4,Philips,philips,,,,,, -123,0.93060654401779175,acb87f8a-df4a-4496-9d3a-83c2f7389db1,"F. Hoffmann-La Roche Ltd (representado en España por Roche Farma, S.A)",f_hoffmann_la_roche_ltd_representado_en_espa_a_por_roche_farma_s_a,,,,6f6fa7c2-4fab-461f-9b80-d0b26f4f354e,f_hoffmann_la_roche_ag,F. Hoffmann-La Roche AG -1513,,9a531394-71b6-11e6-a0cd-0242ac12000b,QOL MEDCL,qol_medcl,,,,,, -453,0.900843,9b07a8e6-7165-11e6-a0cd-0242ac12000b,ANTIBIOTICS SA,antibiotics_sa,,,,7b861ad6-7163-11e6-a0cd-0242ac12000b,antibiotice,ANTIBIOTICE -1514,,fd354bb8-3bb8-427b-acf8-21b94cc4a3e9,"Regensburg University Medical Center, Department of Surgery",regensburg_university_medical_center_department_of_surgery,,,,,, -1515,,c649aa3d-25ff-4070-843e-284bd79f0564,Policlinico Gemelli-CIC- UCSC,policlinico_gemelli_cic_ucsc,,,,,, -739,0.95527833700180054,44219b72-858c-4e54-8209-9aba06a32318,ICORG,icorg,,,,44219b72-858c-4e54-8209-9aba06a32318,icorg,ICORG -1516,,1f3c8195-0880-49f8-8d63-e8ea86ca4ec1,Universiteit Leiden,universiteit_leiden,,,,,, -1517,,01e6b8a7-46b9-4314-84bb-2ad8895a1281,Hopitaux Universitaires de Strasbourg,hopitaux_universitaires_de_strasbourg,,,,,, -1518,,8f1b855a-7151-4848-8275-b56c98da6e32,"investigator-driven research: Erasmus MC, Neurovascular Section",investigator_driven_research_erasmus_mc_neurovascular_section,,,,,, -325,0.97939214110374451,44cc3539-0a28-4a7b-820a-41115f05ad15,"Ferrer Internacional, SA",ferrer_internacional_sa,,,,199a1dd6-828f-4e0b-b783-d712bad32b9e,ferrer_internacional,Ferrer Internacional -1519,,5f009d76-8f37-430c-8faf-b5a320d52956,"Medizinische Universität Wien, Bernhard Gottlieb Universitätszahnklinik",medizinische_universit_t_wien_bernhard_gottlieb_universit_tszahnklinik,,,,,, -971,0.981633,e38d28dc-8bbb-11e6-a449-0242ac12000b,"Department of Anaesthesiology, University Hospital of Skejby",department_of_anaesthesiology_university_hospital_of_skejby,,,,7c6e82f0-9a46-47cd-89bb-39837da65876,department_of_anaesthesiology,Department of Anaesthesiology -1520,,d08c73bf-b7e9-410f-a6c0-3b7faaad10ad,PROGEN PHARMACEUTICALS LIMITED,progen_pharmaceuticals_limited,,,,,, -366,0.98152613639831543,834ddc5d-8e84-46be-ae7c-139ec547ee6b,"Bayer Health Care AG, D-51368 Leverkusen",bayer_health_care_ag_d_51368_leverkusen,,,,17a7c9c8-3636-4a11-a0b2-a237ca2e374e,bayer_health_care_ag,Bayer Health Care AG -1521,,8e74251a-e929-4ba1-9486-29ac1c9c2e24,DR. ALEJANDRO SOUSA ESCANDÓN,dr_alejandro_sousa_escand_n,,,,,, -1522,,2c8bf6e0-73f1-11e6-a0cd-0242ac12000b,AIRGAS USA LLC,airgas_usa_llc,,,,,, -1523,,886bc173-799f-4d33-9b19-de0e457ed309,Servicio de Neumología del Hospital Valle Hebrón,servicio_de_neumolog_a_del_hospital_valle_hebr_n,,,,,, -1524,,46aaf2de-36b2-4ae2-9e02-ee306174509a,"CombinatoRx, Inc",combinatorx_inc,,,,,, -1525,,9104d4ac-7167-11e6-a0cd-0242ac12000b,KETTERING MEDCTR,kettering_medctr,,,,,, -1526,,c25e1332-76a6-4008-859d-429b935d50c5,Orphan Europe SARL,orphan_europe_sarl,,,,,, -1527,,efaf9895-b6ac-4dc5-b4a2-6a5999c07ddf,Pharmaxis Ltd,pharmaxis_ltd,,,,,, -1528,,006b7c4d-12d3-4ab4-88a9-c3414a852b6f,Elan Pharma Ltd,elan_pharma_ltd,,,,,, -143,0.98837488889694214,bc945ca3-8945-4a29-9bb6-08e3e6715f24,Västra Götalandsregionen,v_stra_g_talandsregionen,,,,a370f60e-0db0-41b7-9f59-748ac05359ac,v_stra_g_talandsregionen_n_l,Västra Götalandsregionen/NÄL -1529,,6f73b6c8-1f90-492f-a899-fa04a1d6534c,Rehabilitation Department. Hospital mútua de Terrassa,rehabilitation_department_hospital_m_tua_de_terrassa,,,,,, -1530,,11768859-d442-4ceb-87b0-a64bfe7eb53a,Ethicare GmbH,ethicare_gmbh,,,,,, -1531,,2eec58fc-7145-11e6-a0cd-0242ac12000b,FRESENIUS KABI ONCOL,fresenius_kabi_oncol,,,,,, -1532,,ada37f66-1a9c-4303-ba1e-95ddc778ec8e,TweeSteden hospital,tweesteden_hospital,,,,,, -1533,,e87ea879-501c-4481-a87b-8f6ee3b06e45,Stage Pharmaceuticals GmbH,stage_pharmaceuticals_gmbh,,,,,, -1078,0.95581340789794922,1242e11a-4288-492d-8023-e4ffe5a4e9bd,IBSA,ibsa,,,,1242e11a-4288-492d-8023-e4ffe5a4e9bd,ibsa_institute_biochimique_sa,IBSA Institute Biochimique SA -1534,,ddb510fa-819f-4f49-8777-67856e06385e,daniel pacha vicente,daniel_pacha_vicente,,,,,, -1535,,5a3985a4-56e5-4d1c-bbe6-37e1332baca8,Sanochemia Pharmazeutika AG,sanochemia_pharmazeutika_ag,,,,,, -1536,,2ea806c8-96db-11e6-becf-0242ac110008,SAREPTA THERAPS INC,sarepta_theraps_inc,,,,,, -1537,,089c4c13-07bc-4a84-9288-a8cbaf427192,Assistance Publique Hopitaux de marseille,assistance_publique_hopitaux_de_marseille,,,,,, -595,0.985826,e5db50b4-cb54-4e0c-9a29-3f1f6726af8f,Erasmus Medical Centre Rotterdam,erasmus_medical_centre_rotterdam,,,,6548489f-2430-4636-90c0-4f63a9939b5c,erasmus_medical_centre,Erasmus Medical Centre -1538,,8bd89508-afb6-4e5d-9ad4-6182fae033df,Baxter R&D Europe SCRL,baxter_r_d_europe_scrl,,,,,, -1539,,2834a2b4-add1-4c2c-afe9-c27f6dd26c42,"Merck Serono Geneva- an affiliate of Merck KGaA, Darmstadt Germany",merck_serono_geneva_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,,, -1540,,4cbed40c-e7c6-4447-a081-64f21ed8e450,Tekonivelsairaala Coxa,tekonivelsairaala_coxa,,,,,, -219,0.980666,dee7f909-005a-4a98-9eaf-2ea27e22763d,Bioprojet,bioprojet,,,,bb0251f2-2efa-42a2-8d24-fa858e7ba0cc,bioprojet_pharma,Bioprojet Pharma -1541,,436da1ec-a0f0-4c1f-bfa5-22ea0f9d44ce,"Department of Anesthesia, Div. of Cardiothoracic and Vascular Anesthesia, Medical University Vienna",department_of_anesthesia_div_of_cardiothoracic_and_vascular_anesthesia_medical_university_vienna,,,,,, -1542,,7191688c-6fa1-11e6-9663-0242ac12000b,Boehringer Ingelheim Ireland Ltd,boehringer_ingelheim_ireland_ltd,,,,,, -964,0.97516081730524695,16556fb5-6653-4d5b-bd94-fc6343fa4fd8,Helsinki University Central Hospital,helsinki_university_central_hospital,,,,16556fb5-6653-4d5b-bd94-fc6343fa4fd8,helsinki_university_central_hospital,Helsinki University Central Hospital -1543,,5bb0d033-224f-47fd-a89d-64ec445cdf84,Isotechnika Inc,isotechnika_inc,,,,,, -1544,,56e739be-f1b4-4a08-b086-b583ad195524,Landspítali Háskólasjúkrahús,landsp_tali_h_sk_lasj_krah_s,,,,,, -1545,,6090d518-a585-4e72-bb21-cfedec294a49,Queen Mary University London,queen_mary_university_london,,,,,, -1546,,c0cdf8fb-41a3-40e8-be6a-a7dd255d9758,A.U.S.L. RIMINI,a_u_s_l_rimini,,,,,, -1547,,087d7412-cdc9-4e3d-b53b-2b2d75bf41c4,FIDIA,fidia,,,,,, -1548,,53c07b47-e690-4ee7-ac41-e62fb0bfdbcb,"Fertility Clinic, Copenhagen University Hospital, Rigshospitalet",fertility_clinic_copenhagen_university_hospital_rigshospitalet,,,,,, -1549,,74756ce4-898b-4928-9d75-1a64d5ece247,AZIENDA OSPEDALIERA S. LUIGI GONZAGA,azienda_ospedaliera_s_luigi_gonzaga,,,,,, -1550,,7773cfd2-de1f-4fe4-9f72-cfe4679d0e86,CHX Technologies Inc,chx_technologies_inc,,,,,, -318,0.98787707090377808,bf5310ea-463d-4046-9a2e-499966b7d909,Department of Neurology UMCG,department_of_neurology_umcg,,,,215a6fe0-4912-4052-b609-f99824db28f0,department_of_neurology,Department of Neurology -1551,,00749640-ca53-481e-8804-6edece705cd5,Dr. Guillermo Reyes Copa,dr_guillermo_reyes_copa,,,,,, -1552,,9f4eb914-73f2-11e6-a0cd-0242ac12000b,VERTEX PHARMS INC,vertex_pharms_inc,,,,,, -1553,,c2ad3284-fde5-4a3d-9d80-b7f9d91d83f2,Fovea Pharmaceuticals SA,fovea_pharmaceuticals_sa,,,,,, -473,0.986317,a65c196b-462c-42a6-84d1-8d84e1c940d6,Algeta AS,algeta_as,,,,a65c196b-462c-42a6-84d1-8d84e1c940d6,algeta_as,Algeta AS -926,0.985988,634e757f-8ba8-4364-ad56-f51636b9ab94,Haukeland University Hospital,haukeland_university_hospital,,,,634e757f-8ba8-4364-ad56-f51636b9ab94,haukeland_university_hospital,Haukeland University Hospital -1554,,974c189a-0be0-471d-ba1a-2f314ef32416,Teva Pharmaceutical Works Private Limited Company,teva_pharmaceutical_works_private_limited_company,,,,,, -608,0.97275575002034509,3a5bee20-b6ec-4b84-b5a5-a5049252c6e4,RWTH Aachen University,rwth_aachen_university,,,,8cf07097-1668-4840-99e4-5f3861195629,rwth_aachen_university_for_the_medical_faculty_represented_by_clinical_trial_center_aachen_ctc_a,"RWTH Aachen University for the Medical Faculty, represented by Clinical Trial Center Aachen (CTC-A)" -1555,,3e33b769-58d1-4072-bd25-fd514e693cd2,"Ruprecht-Karls-University Heidelberg, Medical Faculty represented by University Hospital Heidelberg",ruprecht_karls_university_heidelberg_medical_faculty_represented_by_university_hospital_heidelberg,,,,,, -1556,,9b5f3163-46f8-4083-945b-0d16683a8ac7,"Wyeth Korea, Inc",wyeth_korea_inc,,,,,, -1557,,6bd837e6-7124-48ef-8ff5-bbf2e2eb1032,PIERRE FABRE Ltd,pierre_fabre_ltd,,,,,, -1558,,bd434e5a-7e49-4d2f-8622-ca621aa7d770,TOGA Thoracic Oncology Group Antwerp,toga_thoracic_oncology_group_antwerp,,,,,, -1559,,b3404fa6-47c0-4392-b74e-3bf22e792af1,"Klinikum der Ludwig-Maximilians-Univ. Münch , Klinikum Großhadern (vertreten durch die kaufmännische Direktion)",klinikum_der_ludwig_maximilians_univ_m_nch_klinikum_gro_hadern_vertreten_durch_die_kaufm_nnische_direktion,,,,,, -1560,,48e403e0-7168-11e6-a0cd-0242ac12000b,GAVIS PHARMS LLC,gavis_pharms_llc,,,,,, -1561,,122d843f-01c8-4c70-9ddf-f4a8bde1cbec,ImClone Systems Corporation,imclone_systems_corporation,,,,,, -1562,,b80cf9a0-880d-11e6-a998-0242ac12000b,"CymaBay Therapeutics, Inc",cymabay_therapeutics_inc,,,,,, -829,0.980992,644211ae-bb15-4824-abbb-0de942c913a7,OSPEDALE G.PASQUINUCCI-FONDAZIONE TOSCANA GABRIELE MONASTERIO,ospedale_g_pasquinucci_fondazione_toscana_gabriele_monasterio,,,,49311101-9fd1-4902-b91d-e36e1f2e30c2,ospedale_g_pasquinucci_fondazione_toscana_gabriele_monasterio_cnr,OSPEDALE G.PASQUINUCCI-FONDAZIONE TOSCANA GABRIELE MONASTERIO/CNR -532,0.967052,4c49fb26-4e7e-409c-ab8a-627200080dc0,East and North Hertfordshire NHS Trust,east_and_north_hertfordshire_nhs_trust,,,,4c49fb26-4e7e-409c-ab8a-627200080dc0,east_and_north_hertfordshire_nhs_trust,East and North Hertfordshire NHS Trust -1563,,b69cc18f-8bff-45df-9513-02d9936f98ee,GlaxoSmithKline Consumer Healthcare (GSKCH),glaxosmithkline_consumer_healthcare_gskch,,,,,, -1564,,01e8b7a5-bd9b-4441-be04-c6159556bf7d,FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA,fondazione_irccs_istituto_neurologico_carlo_besta,,,,,, -1565,,4477b526-bee3-4698-aaf0-852cfc746ba6,Onkološki inštitut Ljubljana,onkolo_ki_in_titut_ljubljana,,,,,, -1566,,a0e726f7-f3b6-4556-bf7b-e335fd54f1fe,University Hospital Münster,university_hospital_m_nster,,,,,, -1567,,eed1b1db-3dc4-4794-a661-0689a54a13e0,Roche (Hungary) Ltd,roche_hungary_ltd,,,,,, -816,0.989949,efc24352-69e0-4fbf-bcfd-b7fe922c0213,The Kompetenznetz Vorhofflimmern e.V. [German Atrial Fibrillation Competence Network association (AFNET e.V.)],the_kompetenznetz_vorhofflimmern_e_v_german_atrial_fibrillation_competence_network_association_afnet_e_v,,,,d89406de-85c4-474e-a03e-9516d6463bf7,the_kompetenznetz_vorhofflimmern_e_v_german_atrial_fibrillation_competence_network_association_af,The Kompetenznetz Vorhofflimmern e.V. [German Atrial Fibrillation Competence Network association (AF -1568,,ee6b5a81-2904-4718-b3e4-7f54f0c758c6,EVER Neuro Pharma GmbH,ever_neuro_pharma_gmbh,,,,,, -878,0.986926,d508d70a-7141-11e6-a0cd-0242ac12000b,ZYDUS PHARMS USA INC,zydus_pharms_usa_inc,,,,c04f7850-7141-11e6-a0cd-0242ac12000b,zydus_pharms_usa,ZYDUS PHARMS USA -1569,,4fc015ec-fb78-4a16-8fd5-d66b59fd9ef0,MERCK SHARP DOHME,merck_sharp_dohme,,,,,, -891,0.978652,9818edbf-d627-4f19-971a-74599a393266,Australasian Gastro−Intestinal Trials Group,australasian_gastro_intestinal_trials_group,,,,0aaff566-edcf-48b0-acb4-a30bb9fe5405,australasian_gastro_intestinal_trials_group_sydney_university,"Australasian Gastro-Intestinal Trials Group, Sydney University" -1570,,d23d611f-e279-49de-9730-28e105fd78f9,"Istituto di ricerche farmacologiche ""Mario Negri",istituto_di_ricerche_farmacologiche_mario_negri,,,,,, -1571,,d4e07fc7-8de2-433d-ad17-23988f6eeb2e,"ACCESS Pharmaceuticals, Inc",access_pharmaceuticals_inc,,,,,, -1572,,682c2d39-7ffb-469b-8c72-18cd6b550b46,H. Lundbeck A/S,h_lundbeck_a_s,,,,,, -1573,,b3b89a8c-efc0-4652-be27-4f90152c852f,"Merck, S.L",merck_s_l,,,,,, -608,0.96548187732696533,8cf07097-1668-4840-99e4-5f3861195629,RWTH Aachen,rwth_aachen,,,,8cf07097-1668-4840-99e4-5f3861195629,rwth_aachen_university_for_the_medical_faculty_represented_by_clinical_trial_center_aachen_ctc_a,"RWTH Aachen University for the Medical Faculty, represented by Clinical Trial Center Aachen (CTC-A)" -1574,,f3f53758-fac6-40d7-9ed1-b98513ad4123,Laboratoires MSD-Chibret,laboratoires_msd_chibret,,,,,, -1575,,afdbb1a4-323f-4e43-bdbb-0a5962d67a60,Otonomy Inc,otonomy_inc,,,,,, -1576,,1346b5bf-e37a-4250-85a0-9f8f243d4ddf,"Krka, d.d., Novo mesto",krka_d_d_novo_mesto,,,,,, -621,0.956445,52d997a2-9f49-426b-bfc6-c251dadcce43,"Universitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie",universit_tsklinik_f_r_innere_medizin_iii_klinische_abteilung_f_r_gastroenterologie_und_hepatologie,,,,52d997a2-9f49-426b-bfc6-c251dadcce43,universit_tsklinik_f_r_innere_medizin_iii_klinische_abteilung_f_r_gastroenterologie_und_hepatologie,"Universitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie" -1577,,6ab6983d-1d4f-46f7-886d-53fd3f1458a5,The Symbio Herborn Group GmbH,the_symbio_herborn_group_gmbh,,,,,, -1578,,3bc10be7-b012-44c3-96cf-95a4790a51be,"NPS Pharmaceuticals, Inc",nps_pharmaceuticals_inc,,,,,, -820,0.98334300518035889,88ff59be-7129-11e6-a89e-0242ac12000b,WOCKHARDT,wockhardt,,,,5febc4b8-715b-11e6-a0cd-0242ac12000b,wockhardt_ltd,WOCKHARDT LTD -1579,,aba45409-1cc0-45e7-9b2d-cf16b3247f16,AISF - ASSOCIAZIONE ITALIANA PER LO STUDIO DEL FEGATO,aisf_associazione_italiana_per_lo_studio_del_fegato,,,,,, -1580,,f131a850-d979-4cc9-b5ed-49278a139b00,INSTITUT DE CANCEROLOGIE DE L'OUEST,institut_de_cancerologie_de_l_ouest,,,,,, -1581,,6183093c-34c7-45dc-9229-711bfff2d642,Medicines for Malaria Venture,medicines_for_malaria_venture,,,,,, -330,0.925303,786ccf58-7b82-4056-b49c-f3946952c95d,Unidad de Trasplantes y Terapia Celular del Hospital General Universitario Central de Asturias,unidad_de_trasplantes_y_terapia_celular_del_hospital_general_universitario_central_de_asturias,,,,786ccf58-7b82-4056-b49c-f3946952c95d,unidad_de_trasplantes_y_terapia_celular_del_hospital_general_universitario_central_de_asturias,Unidad de Trasplantes y Terapia Celular del Hospital General Universitario Central de Asturias -1582,,cc41e1e0-67b8-4d3d-a981-4d8ede206bc4,Royal Bournemouth & Christchurch Hospitals NHS Foundation Trust,royal_bournemouth_christchurch_hospitals_nhs_foundation_trust,,,,,, -1583,,71bec098-1947-45d7-87dd-03625236d470,"Department of Gynecological Oncology, University Hospital, Örebro",department_of_gynecological_oncology_university_hospital_rebro,,,,,, -1584,,ed38c280-1080-4834-895f-f14256bb34c2,Policlinico A. Gemelli,policlinico_a_gemelli,,,,,, -1585,,16e9b460-1963-4b72-b2a5-0a7273293783,"Sepracor, Inc",sepracor_inc,,,,,, -1586,,b562174b-953b-40c7-8982-5e24d964dfd2,"Axovant Sciences, Inc",axovant_sciences_inc,,,,,, -1587,,3f10c263-8eaf-4a76-8caa-e981e4d4cf40,"Committee of Management, Common Services Agency T/A Scottish National Blood Transfusion Service",committee_of_management_common_services_agency_t_a_scottish_national_blood_transfusion_service,,,,,, -614,0.96949491898218787,1f4b6569-9247-4094-9c36-e11efb0201df,Fundación para la Investigación Biomédica del Hospital Universitario La Paz,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz,,,,1f4b6569-9247-4094-9c36-e11efb0201df,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz,Fundación para la Investigación Biomédica del Hospital Universitario La Paz -1588,,7fd4b91f-1e1f-4e0a-a595-bb6a4c836b9e,Ole Hamberg,ole_hamberg,,,,,, -1589,,23524721-6797-4e6a-93ce-19951837d9d5,Boris Modrau,boris_modrau,,,,,, -1590,,df320978-87b9-45d3-887b-40b034c72218,Herlev and Gentofte Hospital,herlev_and_gentofte_hospital,,,,,, -136,0.958341,a83d7e8b-aa57-4e44-a6e7-9a0f7bd40eaf,Medisch Centrum Leeuwarden,medisch_centrum_leeuwarden,,,,3e746564-6364-4770-b1d4-841842beb7c7,medisch_centrum_leeuwaarden,Medisch Centrum Leeuwaarden -1591,,54cda435-d7e8-446e-a726-cb97a68c0f1f,Medisch Spectrum Twente,medisch_spectrum_twente,,,,,, -990,0.988915,d87f9c09-9858-4188-959a-3ed4d92d4f51,INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG),international_extranodal_lymphoma_study_group_ielsg,,,,7729c4f5-04ed-489e-a85c-cd0279e1c490,international_extranodal_lymphoma_study_group,INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP -60,0.94956863777978084,67020723-1387-4f57-9a26-42f7744d3492,"Wyeth Research Division of Wyeth Pharmceuticals Inc. A Pfizer Company, Philadelphia, PA-19101, USA",wyeth_research_division_of_wyeth_pharmceuticals_inc_a_pfizer_company_philadelphia_pa_19101_usa,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc -447,0.952846,0000011d-452f-4fe6-9214-3df63d041f46,ETOP (European Thoracic Oncology Platform),etop_european_thoracic_oncology_platform,,,,0000011d-452f-4fe6-9214-3df63d041f46,etop_european_thoracic_oncology_platform,ETOP (European Thoracic Oncology Platform) -1592,,ccd7e06a-db5d-45f8-bf45-74f71a94c10c,MUKOVISZIDOSE E.V,mukoviszidose_e_v,,,,,, -757,0.984269,af82f758-66a1-4c9c-ab35-f3ad4f8b4833,"The Netherlands Cancer Institute Amsterdam, Netherlands",the_netherlands_cancer_institute_amsterdam_netherlands,,,,4fdd63b2-11be-4586-9f81-b4e4a2263768,the_netherlands_cancer_institute,The Netherlands Cancer Institute -969,0.98663,44eb1394-7142-11e6-a0cd-0242ac12000b,WARNER CHILCOTT,warner_chilcott,,,,44eb1394-7142-11e6-a0cd-0242ac12000b,warner_chilcott,WARNER CHILCOTT -245,0.975108,8cc13716-154a-455e-8604-397805d40f97,"Karyopharm Therapeutic, Inc",karyopharm_therapeutic_inc,,,,8cc13716-154a-455e-8604-397805d40f97,karyopharm_therapeutic_inc,"Karyopharm Therapeutic, Inc" -1593,,0b0ab072-2600-4bff-9deb-1ca8288d40c7,Green Cross Corporation,green_cross_corporation,,,,,, -771,0.989275,f6b59c9f-cc32-4099-ac21-33f7074e532e,Swiss Group for Clinical Cancer Research SAKK,swiss_group_for_clinical_cancer_research_sakk,,,,ae4da2c3-6d27-4362-b182-669f879ac3d4,swiss_group_for_clinical_cancer_research,Swiss Group for Clinical Cancer Research -1594,,be60110f-117e-4cba-b551-095f0d652bb0,University College Cork,university_college_cork,,,,,, -1595,,54e79886-7d44-4353-8fa0-e53b467d37b1,"Ardea Biosciences, Inc",ardea_biosciences_inc,,,,,, -1596,,a418dee3-0eb7-40fe-92b8-b075de6a39ef,UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA,universita_degli_studi_di_milano_bicocca,,,,,, -1597,,b2baebe3-7c37-4773-a470-728b5b870360,GETNE (Grupo Español de Tumores Neuroendocrinos),getne_grupo_espa_ol_de_tumores_neuroendocrinos,,,,,, -1598,,d5a5f4f2-a4ec-4d08-af7f-0baa4e548a16,"Aarhus University Hospital, Department of Neurology",aarhus_university_hospital_department_of_neurology,,,,,, -311,0.94804,d24a8fcd-b259-45c2-8a36-5604474c370e,VU University Medical Centre,vu_university_medical_centre,,,,b1e7a97f-3f72-43f4-a8f1-ab6902f55179,vu_univeristy_medical_centre,VU Univeristy Medical Centre -1599,,659d408c-d92d-47bd-8292-9aef6e77463f,"R+ D department, Hull and East Yorkshire NHS Hospital Trust",r_d_department_hull_and_east_yorkshire_nhs_hospital_trust,,,,,, -158,0.98881235718727112,8465bae2-df61-4d12-b842-02ea11ba6546,Medizinische Universität Wien, Univ.Klin.f. Chirurgie,,,,5b2fbdce-d691-41c6-9a74-e06608d419f4,medizinische_universit_t_wien_hno_klinik,Medizinische Universität Wien -230,0.95899969339370728,e36533aa-a267-461b-b595-a7c0d4d12b23,Medical Department I,medical_department_i,,,,e36533aa-a267-461b-b595-a7c0d4d12b23,medical_department_i,Medical Department I -1600,,90ba5602-6ba9-40f1-87be-fd32a5b64ef2,"University Children´s Hospital Tübingen,",university_children_s_hospital_t_bingen,,,,,, -1601,,f3518218-7144-11e6-a0cd-0242ac12000b,ORCHID HLTHCARE,orchid_hlthcare, Klin. Abtlg. f. Transplantation,medizinische_universit_t_wien_univ_klin_f_chirurgie_klin_abtlg_f_transplantation,,,, -1602,,be36baff-f263-458b-9f87-d9dac7eab87b,Association of Dutch Burn Centres,association_of_dutch_burn_centres,,,,,, -1603,,b58f2578-6fa2-11e6-9663-0242ac12000b,UCL University College London,ucl_university_college_london,,,,,, -1604,,a325ab84-6ecd-4eeb-9eb8-bb5f04cf44ba,Ville Artto,ville_artto,,,,,, -1605,,69eb576e-2178-493f-aafa-03daf8222e0f,University of York,university_of_york,,,,,, -203,0.986562,3429eb3c-72ca-11e6-a0cd-0242ac12000b,GALDERMA LABS,galderma_labs,,,,16d65dd4-7146-11e6-a0cd-0242ac12000b,galderma_labs_lp,GALDERMA LABS LP -1606,,ee1c97e2-1acf-4735-bf58-395919bea552,"Biosense Webster, Inc",biosense_webster_inc,,,,,, -1607,,88e985d3-f19f-4159-8c3b-7ae6df33922c,Erasmus MC Rotterdam,erasmus_mc_rotterdam,,,,,, -1608,,9b867e7c-af9b-40d8-a57e-106d4f94acd1,"FAES FARMA, S.A",faes_farma_s_a,,,,,, -1609,,d40a5f19-3207-4257-a90c-f50353baac8b,FARMIGEA,farmigea,,,,,, -1610,,f2c32a60-3f90-4b7d-bc0b-e61692bb72bc,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,sidney_kimmel_comprehensive_cancer_center_at_johns_hopkins,,,,,, -1611,,526ae032-cfcd-471f-b9fd-b0bc5fa0662b,United Lincolnshire Hospitals NHS Trust,united_lincolnshire_hospitals_nhs_trust,,,,,, -208,0.98087829351425171,ceab788a-7142-11e6-a0cd-0242ac12000b,ALVOGEN INC,alvogen_inc,,,,2237cc76-7146-11e6-a0cd-0242ac12000b,alvogen,ALVOGEN -1612,,5c8a09b2-d68a-4222-8595-b965ae09415f,"University Hospital, Catholic University of Leuven",university_hospital_catholic_university_of_leuven,,,,,, -1613,,1a4f2ec9-6c8f-4fca-ab54-7852054d2b93,"Onconova Therapeutics, Inc",onconova_therapeutics_inc,,,,,, -1614,,2b4c095f-7b47-48f0-9795-389fc378f080,Province of Gelderland & Overijssel,province_of_gelderland_overijssel,,,,,, -1615,,9e8c84f9-6aac-471d-ace9-50fdfc1ed61f,IBCSG,ibcsg,,,,,, -1616,,c6009f30-e444-4d38-bf07-12a868189f0b,Anxiofit Ltd,anxiofit_ltd,,,,,, -1617,,278dd113-f7a4-4e1d-ac1a-fdb25b62ce77,Dexcel Pharma Technologies Ltd,dexcel_pharma_technologies_ltd,,,,,, -1068,0.97769945859909058,24095e02-bf25-4c7e-bbc3-925378eaba6e,Serono,serono,,,,24095e02-bf25-4c7e-bbc3-925378eaba6e,serono,Serono -72,0.93533533811569214,0d580b3a-6f99-11e6-9663-0242ac12000b,Takeda Global Research and Development Centre (Europe) Ltd,takeda_global_research_and_development_centre_europe_ltd,,,,a359d331-932d-4716-9cec-7901baf5cc1b,takeda_global_research_development_centre_europe_ltd,Takeda Global Research & Development Centre (Europe) Ltd -1618,,7cd1e697-3021-4773-9734-2d91a38de5f2,Auris Medical AG,auris_medical_ag,,,,,, -1619,,f8fbde9c-09fa-4ce9-adfe-ad8da7100ab0,Valeant Research & Development,valeant_research_development,,,,,, -1620,,a53a68f3-ad61-4aa4-a231-814cb599822a,"Institute of pharmacology, Aarhus university",institute_of_pharmacology_aarhus_university,,,,,, -1621,,98302d76-b607-4427-b5bc-e4979ede67e3,"Millennium Pharmaceuticals, Inc. (Takeda)",millennium_pharmaceuticals_inc_takeda,,,,,, -1622,,aca9813e-715e-11e6-a0cd-0242ac12000b,AUXILIUM PHARMS INC,auxilium_pharms_inc,,,,,, -1623,,143a1669-a9a6-4102-ac73-c5c06638e63d,WELEDA AG DEUTSCHLAND,weleda_ag_deutschland,,,,,, -1624,,0930be78-5711-4511-9c03-7f83d3a085c7,The Newcastle upon Tyne Hospitals NHS Trust,the_newcastle_upon_tyne_hospitals_nhs_trust,,,,,, -1625,,83a28b95-0c92-41cb-afb9-c8c098c4a4c0,Axcan Pharma S.A,axcan_pharma_s_a,,,,,, -1626,,7e5f82b7-ef52-4a88-9906-c39e998c209b,Centro Hospitalar de São João E.P.E,centro_hospitalar_de_s_o_jo_o_e_p_e,,,,,, -1627,,12968904-5538-447f-b655-73dee6ab764a,GUNA SPA,guna_spa,,,,,, -1628,,d756dec8-9f5c-4ce4-b786-bc0f7da3e5b9,Stichting Hemato-Oncologie voor Volwassenen Nederland (Hovon),stichting_hemato_oncologie_voor_volwassenen_nederland_hovon,,,,,, -1629,,d0c2db43-284f-46b1-a90b-7ca259e69b2c,Novartis Vaccines and Diagnostics GmbH & Co. KG,novartis_vaccines_and_diagnostics_gmbh_co_kg,,,,,, -1630,,0b692ff4-b080-46a5-b50d-af300521aeed,"Medical University Vienna, Dept. of surgery",medical_university_vienna_dept_of_surgery,,,,,, -1631,,192e9de8-e440-408e-958e-cdda6b201e24,Lipid Therapeutics GmbH,lipid_therapeutics_gmbh,,,,,, -1632,,a6f1d600-487c-4231-b320-7120d184d44f,SANGART,sangart,,,,,, -268,0.982988,ed76101e-8eb2-463e-a1df-1cd0cb269b63,CELL THERAPEUTICS INC. SEDE SECONDARIA,cell_therapeutics_inc_sede_secondaria,,,,ad6dc0d9-13c5-492c-a7c3-cdf65dee7f25,cell_therapeutics_inc,CELL THERAPEUTICS INC -1633,,6947cb1a-7003-43d6-994c-448f47107eca,University Medical Centre Hamburg - Eppendorf,university_medical_centre_hamburg_eppendorf,,,,,, -1634,,e7e8ce4a-c520-474b-8d88-5a2978d2fcb4,Örebro University Hospital,rebro_university_hospital,,,,,, -459,0.9483584463596344,caa9eeff-a0fe-407d-8a39-097924dbd94c,Janssen-Cilag Intrenational N.V,janssen_cilag_intrenational_n_v,,,,caa9eeff-a0fe-407d-8a39-097924dbd94c,janssen_cilag_international_n_v_turnhoutseweg_30_2340_beerse_belgium,"Janssen-Cilag International N.V., Turnhoutseweg 30, 2340 Beerse, Belgium" -777,0.97387266159057617,51713059-523f-4247-b288-a682d6d8e72b,MEDA AB,meda_ab,,,,51713059-523f-4247-b288-a682d6d8e72b,meda_ab,MEDA AB -773,0.958103,af8b6727-2812-4d69-b998-869a14637308,The Institute of Cancer Reseacrh,the_institute_of_cancer_reseacrh,,,,3ebee54d-bab5-4063-88aa-8fc3ffe15712,the_institute_of_cancer_research,The Institute of Cancer Research -365,0.98037067055702209,b39065c5-dce3-4082-9a6a-c7dd7f684319,Bayer HealthCare Pharmaceuticals Inc,bayer_healthcare_pharmaceuticals_inc,,,,17d529dc-dc91-4ddb-8f15-7de6d2fa75e3,bayer_healthcare_pharmaceuticals,Bayer HealthCare Pharmaceuticals -1635,,df40d7b6-117b-4112-95e7-b6adf853413f,Vall de Hebron Hospital,vall_de_hebron_hospital,,,,,, -1636,,9259e736-bfbb-4a8c-ab8c-041209e5bcac,AZIENDA OSPEDALIERA CARDINALE G.PANICO-TRICASE (LECCE),azienda_ospedaliera_cardinale_g_panico_tricase_lecce,,,,,, -896,0.983343,b50175fc-719b-11e6-a0cd-0242ac12000b,WYETH PHARMS,wyeth_pharms,,,,a1bb1c18-7336-11e6-a0cd-0242ac12000b,wyeth_pharms_pfizer,WYETH PHARMS PFIZER -1637,,815b6fce-f606-4c76-9b9e-31c7defa1798,Prof Bart Neyns,prof_bart_neyns,,,,,, -779,0.988892,da801118-83b2-438f-93fd-ced9cd672ee1,"The Centre for Child and Adolescent Mental Health, Eastern and Southern Norway (R.BUP)",the_centre_for_child_and_adolescent_mental_health_eastern_and_southern_norway_r_bup,,,,bf76ac82-c2cb-490f-8a4b-46603ab679e7,the_centre_for_child_and_adolescent_mental_health_eastern_and_southern,"The Centre for Child and Adolescent Mental Health, Eastern and Southern" -1638,,7829610e-8f71-4210-9039-b18234ed0950,The Mater Foundation/HRB Grant,the_mater_foundation_hrb_grant,,,,,, -1639,,4120a4b2-2541-4f6c-a3ca-7772fcb6a323,"Department of Pediatrics, Medical and Health Science Center, University of Debrecen",department_of_pediatrics_medical_and_health_science_center_university_of_debrecen,,,,,, -1640,,34e9e154-9386-44ef-98c5-e2485283fc5e,ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS/ DE`LE`GATION A` LA RECHERCHE CLINIQUE ET AU DE`VELOPPEMENT,assistance_publique_h_pitaux_de_paris_de_le_gation_a_la_recherche_clinique_et_au_de_veloppement,,,,,, -1641,,c3c8fe98-4082-4e95-bf4b-f145535f63de,Nemours Children's Clinic,nemours_children_s_clinic,,,,,, -1642,,fa9d137c-aec8-48c1-9c64-b7b8d9cee42e,Ernesto Pérez Persona,ernesto_p_rez_persona,,,,,, -1643,,afbfd242-0191-4289-89f7-0781650cba24,Pfizer AB,pfizer_ab,,,,,, -1644,,ef1f9f7a-79fc-4441-977c-744c6935df09,"Deutsche Homöopathie-Union, DHU-Arzneimittel GmbH & Co. KG",deutsche_hom_opathie_union_dhu_arzneimittel_gmbh_co_kg,,,,,, -1645,,f11f4975-4d67-431a-b1f3-bb36abc4ea57,Francophone de Cancérologie Digestive (FFCD),francophone_de_canc_rologie_digestive_ffcd,,,,,, -1646,,44f30cbb-de86-4c04-9c35-2dd6abc62c95,SHIRE PHARMACEUTICALS LTD,shire_pharmaceuticals_ltd,,,,,, -1647,,8f173b68-252a-49ff-8aa3-b62c2a6a5766,Omeros Corporation,omeros_corporation,,,,,, -192,0.98893731832504272,6a1d3bdf-f164-4e56-bf8f-d628a1663ffa,Teva Pharmaceutical Industries,teva_pharmaceutical_industries,,,,7621f0c9-df30-4cbd-95c1-d0d5719d2751,teva_pharmaceutical_industries,Teva Pharmaceutical Industries -1648,,49363b5c-d12f-4e43-b96d-a5a08ea52a86,Johannes Gutenberg-Universität,johannes_gutenberg_universit_t,,,,,, -1649,,1dfc8fac-6d74-4b9c-a668-0281d2df3eeb,Greater Glasgow & Clyde NHS,greater_glasgow_clyde_nhs,,,,,, -1650,,4f0b7009-702e-408a-89de-f94dbc1563cc,Novartis Pharrna Services AG,novartis_pharrna_services_ag,,,,,, -19,0.95549,28cd44d5-abe5-4c05-bd83-bc9462e97d2d,"IOBA, Universidad de Valladolid",ioba_universidad_de_valladolid,,,,28cd44d5-abe5-4c05-bd83-bc9462e97d2d,ioba_universidad_de_valladolid,"IOBA, Universidad de Valladolid" -1651,,05393a8b-d197-4778-9983-b26814fd6c89,CRESIB-Barcelona Centre for International Health Research,cresib_barcelona_centre_for_international_health_research,,,,,, -1652,,eebe2596-8be1-11e6-a449-0242ac12000b,Grifols Inc,grifols_inc,,,,,, -1653,,04009859-31b5-4136-8c4b-606333489add,"Palliativ medicinsk afdeling, Bispebjerg Hospital",palliativ_medicinsk_afdeling_bispebjerg_hospital,,,,,, -1654,,da95101f-f89e-4c97-8eb5-ff5f63598438,Lourdes Grande Santamaria,lourdes_grande_santamaria,,,,,, -1655,,22a15d2f-f7be-48f1-9e75-494449f9e9aa,"Deutsches Herzzentrum München, Klinik an der Technischen Universität München",deutsches_herzzentrum_m_nchen_klinik_an_der_technischen_universit_t_m_nchen,,,,,, -1656,,8d1a9e4c-3870-466e-a3d9-03b1b967673d,Allergan Pharmaceuticals Ireland,allergan_pharmaceuticals_ireland,,,,,, -1657,,614772e9-d59f-4923-926e-c626f4bb31e7,"Klinikum rechts der Isar, Technical University of Munich",klinikum_rechts_der_isar_technical_university_of_munich,,,,,, -1658,,7e8ba40a-585b-4bb9-8973-019fb0ee24e8,"Pfizer Consumer Healthcare, Pfizer Health AB",pfizer_consumer_healthcare_pfizer_health_ab,,,,,, -339,0.980344,1a9c7667-0a16-4463-a38f-f3fc2f60143b,Adocia SA,adocia_sa,,,,1a9c7667-0a16-4463-a38f-f3fc2f60143b,adocia_sa,Adocia SA -1659,,c624779a-2041-41b5-956e-08a2a8c4cd35,Dresden Technical University,dresden_technical_university,,,,,, -327,0.962536,74acbba7-8bef-4cf6-a584-3c8b328a6a63,ISTITUTO EUROPEO DI ONCOLOGIA,istituto_europeo_di_oncologia,,,,74acbba7-8bef-4cf6-a584-3c8b328a6a63,istituto_europeo_di_oncologia,ISTITUTO EUROPEO DI ONCOLOGIA -1660,,c8b13afe-0ae4-4f06-a8ce-be3e2b016d73,Salford Royal Hospitals NHS Trust,salford_royal_hospitals_nhs_trust,,,,,, -1661,,9b4d2b38-1769-4087-ab6f-972cddb23c5e,Augenklinik der LMU München,augenklinik_der_lmu_m_nchen,,,,,, -1662,,b008b71f-37fe-443a-b932-36fb4b9f54cc,Professor Thomas John Kiernan,professor_thomas_john_kiernan,,,,,, -143,0.98837488889694214,a370f60e-0db0-41b7-9f59-748ac05359ac,Västra Götalandsregionen/NÄL,v_stra_g_talandsregionen_n_l,,,,a370f60e-0db0-41b7-9f59-748ac05359ac,v_stra_g_talandsregionen_n_l,Västra Götalandsregionen/NÄL -1663,,93b0fab7-ec29-4ebf-a24e-32ba2dc54eff,ribosepharm GmbH,ribosepharm_gmbh,,,,,, -1664,,09c92d79-167f-4246-aa45-5b385f05a1d5,Merk KGaA,merk_kgaa,,,,,, -1665,,6dd215c9-5ebc-42ca-9978-999e99bcabb7,"Laboratorios Andrómaco, S.A (compañía perteneciente al Grupo Grünenthal España)",laboratorios_andr_maco_s_a_compa_a_perteneciente_al_grupo_gr_nenthal_espa_a,,,,,, -1666,,f8828c26-3852-4bfe-b0be-e4c68bdfb5c9,Dr August Wolff GmbH & Co KG Arzneimittel,dr_august_wolff_gmbh_co_kg_arzneimittel,,,,,, -1667,,3e407ece-4df3-4703-93f5-bc7e3b7103a4,Antares Pharma AG,antares_pharma_ag,,,,,, -861,0.95123109221458435,346f1a70-efcd-43d4-abdf-e7492786e3d6,"Academic Medical Center, Department of dermatology",academic_medical_center_department_of_dermatology,,,,7cef3d29-cecb-442c-acdb-b0a10dec2da0,academic_medical_center_department_of_dermatology,"Academic Medical Center, Department of dermatology" -1668,,d2c5b6d1-8a56-41e8-a060-b27872ba6548,Zentralklinikum St. Pölten,zentralklinikum_st_p_lten,,,,,, -1669,,e0b85ca7-6fde-43dc-a2c7-576293766b1c,GlaxoSmithKline LLC,glaxosmithkline_llc,,,,,, -1670,,f518ddbd-3a6e-4a89-a239-8a7be21e46d1,"AstraZeneca AB, European Regulatory Affairs",astrazeneca_ab_european_regulatory_affairs,,,,,, -890,0.91218763589859009,eb27cc54-248e-4cdc-a8d8-2286ca709082,University Medical Center of Johannes -Gutenberg University Mainz,university_medical_center_of_johannes_gutenberg_university_mainz,,,,6e8ed001-5c25-4c82-8b82-365ae91ee2c8,university_medical_center_johannes_gutenberg_university_mainz,"University Medical Center, Johannes Gutenberg-University Mainz" -1671,,74d73ad7-77e6-4e29-bc5a-d8edfd837005,Fundación Investigación Biomédica Hospital La Paz,fundaci_n_investigaci_n_biom_dica_hospital_la_paz,,,,,, -1672,,eb525940-71f6-11e6-a0cd-0242ac12000b,STAND HOMEOPATH,stand_homeopath,,,,,, -443,0.976266,93ee88e4-8723-494d-86b5-c1f43bbd66c8,"Klinikum Grosshadern Medical Center, University of Munich",klinikum_grosshadern_medical_center_university_of_munich,,,,93ee88e4-8723-494d-86b5-c1f43bbd66c8,klinikum_grosshadern_medical_center_university_of_munich,"Klinikum Grosshadern Medical Center, University of Munich" -1673,,9571aa0c-7547-4821-97fb-a60352590e0b,Barcelona Macula Foundation Research for Vision,barcelona_macula_foundation_research_for_vision,,,,,, -1674,,13d37a6e-a22f-454d-8c96-519556903e54,CNIC,cnic,,,,,, -1675,,17480022-554b-463c-a681-9de2928fab7d,Academic Medical Centrum,academic_medical_centrum,,,,,, -377,0.97536033391952515,c5239cb2-1657-4f7a-9ab8-3c78cb0f26d4,"Merck & Co., Inc",merck_co_inc,,,,a995503b-132d-44dc-a6b0-648b85bc0828,merck_co,Merck & Co -1676,,fdc476c9-f757-42b3-9fe9-b53df3a0e5fe,"Janssen-Cilag, Johnson & Johnson spol. s.r.o",janssen_cilag_johnson_johnson_spol_s_r_o,,,,,, -1677,,10d7685c-6893-45be-a7f1-34a3256a4de5,Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts,deutsches_krebsforschungszentrum_stiftung_des_ffentlichen_rechts,,,,,, -1678,,6f46cfd2-1e66-4915-9163-9129aa08f437,"Klinik für Physikalische Medizin und Rehabilitation, Medizinische Universität Wien",klinik_f_r_physikalische_medizin_und_rehabilitation_medizinische_universit_t_wien,,,,,, -1679,,7458bddc-c71b-4a97-9c05-60aa7fee135e,Fundació Hospital Vall Hebron Institut de Recerca,fundaci_hospital_vall_hebron_institut_de_recerca,,,,,, -1680,,3e13f467-a230-492d-a2ad-bf53f3643dae,"University of California, San Francisco, Immune Tolerance Network",university_of_california_san_francisco_immune_tolerance_network,,,,,, -903,0.978271,d862f39f-cfbc-4498-a1ce-645fdd08bd34,Besancon University Hospitaö,besancon_university_hospita,,,,03392dcb-ef6c-4051-ad43-dad84dc61463,besancon_university_hospital,Besancon University Hospital -1059,0.982418,a6c5c084-7190-11e6-a0cd-0242ac12000b,RECORDATI RARE,recordati_rare,,,,6dce2ae5-2f18-4049-bbc1-1d01299ee637,recordati,RECORDATI -951,0.98241811990737915,d8eabef5-6cfe-4ff7-90ab-73a88f7b1905,MedImmune,medimmune,,,,2e8e4fb4-3915-4ead-8787-31c5f3981781,medimmune_llc,"MedImmune, LLC" -1681,,33fbc167-b9f9-4c28-a5cb-e041d9855c57,DR. REDDY'S LABORATORIES LIMITED,dr_reddy_s_laboratories_limited,,,,,, -1682,,062d6d72-ff95-4af5-85e0-404fff16b5af,Piramal Imaging SA,piramal_imaging_sa,,,,,, -1683,,ecc38fbc-9d67-4dcc-b201-407b9e58231c,"Versartis, Inc",versartis_inc,,,,,, -1684,,79ed562e-523d-4391-9046-60359932153d,MedQuality Forschung GmbH,medquality_forschung_gmbh,,,,,, -1685,,9a913b45-fd3b-4b6f-aaaf-05ee836596f8,CHU de Montpellier,chu_de_montpellier,,,,,, -617,0.98493295907974243,667dc3b3-c538-4b51-a2ab-8386933ed203,Grupo Español de Investigación en Sarcomas (GEIS),grupo_espa_ol_de_investigaci_n_en_sarcomas_geis,,,,0359d070-d59d-4dab-8d3e-cdb60bbcff96,grupo_espa_ol_de_investigaci_n_en_sarcomas,Grupo Español de Investigación en Sarcomas -1686,,f6f5a328-7166-11e6-a0cd-0242ac12000b,UNIV TX MD ANDERSON,univ_tx_md_anderson,,,,,, -1687,,c8643d05-f1ec-4ea3-8bb0-f4ca43872b1e,EURAND SPA,eurand_spa,,,,,, -1688,,57d08e82-d0aa-4362-b310-5ee9d82fa714,Annadalstichting,annadalstichting,,,,,, -1689,,bf86a27a-c318-4762-9d95-b3157aa44e38,"Peninsula Pharmaceuticals, Inc",peninsula_pharmaceuticals_inc,,,,,, -1690,,ef3ee494-7c3e-40e4-95a6-5d6df7d1592a,World Health Organization,world_health_organization,,,,,, -1691,,8f9bf5c6-f57d-4362-a53c-251a4fde6303,ST. ANNA KINDERKREBSFORSCHUNG e.V,st_anna_kinderkrebsforschung_e_v,,,,,, -1692,,2a31f017-0e0f-4e9f-b5ef-762d94edab22,Natural Pharma International Npi AB,natural_pharma_international_npi_ab,,,,,, -541,0.98826968669891357,fe3bcde9-71bd-4309-b7ec-09a0bd998c85,Fournier Laboratories Ireland,fournier_laboratories_ireland,,,,06598f56-3fa1-48ed-824d-b88b0bafc1ab,fournier_laboratories_ireland_fli,Fournier Laboratories Ireland (FLI) -1693,,e6569a11-9394-47ad-b4fe-4127a0fdc037,Medical University of Graz - Division of Endocrinology and Metabolism,medical_university_of_graz_division_of_endocrinology_and_metabolism,,,,,, -1694,,65790c05-fea4-413c-b6d7-8a988c7de18a,Novartis PharmaServices AG,novartis_pharmaservices_ag,,,,,, -1695,,70ab1f98-66dc-4bca-9412-68352a646048,Sebastiano Biondo Aglio,sebastiano_biondo_aglio,,,,,, -1696,,a180e828-2504-487f-9b6c-7013280e0462,"National Heart, Lung, and Blood Institute / National Institutes of Health",national_heart_lung_and_blood_institute_national_institutes_of_health,,,,,, -1697,,ceea2b69-369e-4fa1-bdd4-fcc09e4a6b08,University Hospital of North Norway,university_hospital_of_north_norway,,,,,, -1698,,64c7bcfc-5512-42c9-b184-ca30a2c2e148,CYTHERIS,cytheris,,,,,, -1699,,235385bb-94be-465d-b4cd-a76c1a6f50e8,Litaphar S.L,litaphar_s_l,,,,,, -1700,,9e582489-8e87-4b80-be4c-28c3494ec9e6,"Free State of Bavaria rep. by the Univ. of Regensburg, rep. by the Regensburg Univ. Hospital",free_state_of_bavaria_rep_by_the_univ_of_regensburg_rep_by_the_regensburg_univ_hospital,,,,,, -142,0.985676,3467328a-7167-11e6-a0cd-0242ac12000b,BRIGHAM WOMENS,brigham_womens,,,,32a060d4-7167-11e6-a0cd-0242ac12000b,brigham_womens_hosp,BRIGHAM WOMENS HOSP -229,0.985968,458254a2-d310-4f72-a0ef-d961ef0c56e4,The National Institute of Allergy and Infectious Diseases (NIAID) And The Eunice Kennedy Shriver NICHD,the_national_institute_of_allergy_and_infectious_diseases_niaid_and_the_eunice_kennedy_shriver_nichd,,,,458254a2-d310-4f72-a0ef-d961ef0c56e4,the_national_institute_of_allergy_and_infectious_diseases_niaid_and_the_eunice_kennedy_shriver_nichd,The National Institute of Allergy and Infectious Diseases (NIAID) And The Eunice Kennedy Shriver NICHD -1701,,98ff4a8d-9011-429f-9c2f-4eef1084cbc6,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (referred to as Merck)",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_referred_to_as_merck,,,,,, -1702,,396417d0-94f6-41de-a34a-5bfff20b7c78,MedImmune Ltd,medimmune_ltd,,,,,, -1703,,2b7e9abb-f2a5-4163-92f3-d3d7201291e5,Laboratorios Biomendi S.A.U,laboratorios_biomendi_s_a_u,,,,,, -1704,,32d3b0b3-13de-42b8-b6bf-2e84d43173f6,Universiteit Utrecht,universiteit_utrecht,,,,,, -1705,,f483e308-a1e7-4d2a-88d7-ba84bc289e56,Autifony Therapeutics Limited,autifony_therapeutics_limited,,,,,, -1706,,f9d6fd22-e7e1-4989-81d2-16bb01719f36,"Medical University Vienna, Dept. of Medicine I, Clinical Division of Oncology",medical_university_vienna_dept_of_medicine_i_clinical_division_of_oncology,,,,,, -1707,,e944e7a9-f50b-4f25-bcf5-7daefb39030b,ANRS,anrs,,,,,, -1708,,5dad3781-0f5e-40fd-9a16-4d563082836d,CHRU Montpellier,chru_montpellier,,,,,, -1709,,daf54d0c-2a4a-4361-bb58-4f3fee918b18,sanna kivivuori,sanna_kivivuori,,,,,, -1710,,db914e93-2026-47c2-9577-0af29a025a9a,Dept. of Clinical Pharmacology,dept_of_clinical_pharmacology,,,,,, -329,0.977699,00c3e472-71cc-11e6-a0cd-0242ac12000b,ABBOTT LABS,abbott_labs,,,,00c3e472-71cc-11e6-a0cd-0242ac12000b,abbott_labs,ABBOTT LABS -1711,,649854a8-56ee-48be-9952-b733b90511b4,SANT JOAN DE DEU - SSM,sant_joan_de_deu_ssm,,,,,, -1712,,a04a830a-2b43-4ba9-a020-65fb0fe9f467,University of the Saarland,university_of_the_saarland,,,,,, -1713,,dd81105c-6cd9-4432-a592-4af8a76ed18c,"Charité Campus Mitte, Klinik für Psychiatrie und Psychotherapie",charit_campus_mitte_klinik_f_r_psychiatrie_und_psychotherapie,,,,,, -1714,,2615ed6f-d98a-484b-938b-5a51b2f4907e,Marc Miratvilles,marc_miratvilles,,,,,, -1715,,b53fc831-1e38-4416-a745-c2b1022d0235,Birmingham Heartlands Hospital,birmingham_heartlands_hospital,,,,,, -1716,,667dc7a0-a439-4dd1-af99-e4163a661a09,Archemix Corp,archemix_corp,,,,,, -679,0.967014,73f44df3-f258-476a-8ae7-6cb143e4cbb3,CHU Angers,chu_angers,,,,73f44df3-f258-476a-8ae7-6cb143e4cbb3,chu_angers,CHU Angers -160,0.97712674140930178,ce27e24e-62ac-42de-a596-4ceed67e634f,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,,,,ce27e24e-62ac-42de-a596-4ceed67e634f,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón -1717,,f9ecaf09-8531-4b39-8ac4-1f039af9e443,Allergie-Centrum-Charité,allergie_centrum_charit,,,,,, -1718,,b766804d-0b81-4efe-a697-d4395724a2f5,ISTITUTO DERMOPATICO IMMACOLATA,istituto_dermopatico_immacolata,,,,,, -1719,,f69169d5-449c-41a9-bbb1-553e75402c43,Paediatric European Network for Treatment of AIDS (PENTA) Foundation,paediatric_european_network_for_treatment_of_aids_penta_foundation,,,,,, -217,0.983343,32ba4b51-aea2-4074-88ac-a23bc5b63b1d,TRANSGENE S.A,transgene_s_a,,,,32ba4b51-aea2-4074-88ac-a23bc5b63b1d,transgene_s_a,TRANSGENE S.A -1720,,6f9b737c-a23d-4ff4-8adf-4eb2e8ff9eb9,Institute of Hematology and Blood Transfusion,institute_of_hematology_and_blood_transfusion,,,,,, -1721,,037c0b04-6a0f-4522-9217-2403bfaab5d5,"Luitpold Pharmaceuticals, Inc",luitpold_pharmaceuticals_inc,,,,,, -1722,,370cd0ae-73f0-11e6-a0cd-0242ac12000b,LINDE GAS PUERTO RICO INC,linde_gas_puerto_rico_inc,,,,,, -435,0.9795151948928833,aad2d334-ecaa-4920-9328-b23c18f3711d,Pfizer Inc,pfizer_inc,,,,aad2d334-ecaa-4920-9328-b23c18f3711d,pfizer_inc,Pfizer Inc -1723,,ef07bfbc-7a26-4343-843d-50dfaa8b19cc,fonds NutsOhra,fonds_nutsohra,,,,,, -1724,,c417e40d-e9f5-49da-a1df-920becf3d586,UNIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II,universita_degli_studi_di_napoli_federico_ii,,,,,, -1725,,aa2cd280-2abb-4f9c-b363-4a13d742e2a6,Engelhard Arzneimittel GmbH & Co.KG,engelhard_arzneimittel_gmbh_co_kg,,,,,, -1726,,4bb79ea4-7192-11e6-a0cd-0242ac12000b,TURING PHARMS AG,turing_pharms_ag,,,,,, -1727,,cfcd7a65-345b-4278-a665-81a0a651b897,ISTITUTO NAZIONALE DI RICOVERO E CURA PER ANZIANI IRCCS,istituto_nazionale_di_ricovero_e_cura_per_anziani_irccs,,,,,, -1728,,5f4bf1c9-4d42-4361-9c61-65c56aeb9dc7,Ferring Pharmaceuticals Ltd,ferring_pharmaceuticals_ltd,,,,,, -1729,,d239e02e-e325-4c51-afd8-355f68b1ffd0,The Nordic Colorectal Cancer Biomodulation Group,the_nordic_colorectal_cancer_biomodulation_group,,,,,, -1006,0.9811970591545105,76940d77-7350-4137-8034-dc7c3c7289ad,Folktandvården Östergötland,folktandv_rden_sterg_tland,,,,76940d77-7350-4137-8034-dc7c3c7289ad,folktandv_rden_sterg_tland,Folktandvården Östergötland -859,0.9885413646697998,2030c40f-9eb7-4a24-af68-69c831c5fc3c,Deutsches Krebsforschungszentrum (DKFZ,deutsches_krebsforschungszentrum_dkfz,,,,2030c40f-9eb7-4a24-af68-69c831c5fc3c,deutsches_krebsforschungszentrum_dkfz,Deutsches Krebsforschungszentrum (DKFZ -1730,,14b1b853-d25d-41fe-aa32-f210b92deb6f,IGENEON,igeneon,,,,,, -1731,,4fcb48c0-1222-46c1-af12-63b27308177a,"Center of Pediatrics and Neonatology, Asklepios Clinic Sankt Augustin",center_of_pediatrics_and_neonatology_asklepios_clinic_sankt_augustin,,,,,, -1060,0.98586,3430485d-03ef-4333-85f5-fa9ef76f501b,FONDAZIONE PENTA ONLUS,fondazione_penta_onlus,,,,0b2aae39-94a4-4319-927d-68470e818403,fondazione_penta,FONDAZIONE PENTA -1732,,2c8410c0-d199-43a4-8886-a62b1a98e841,Lone Baandrup,lone_baandrup,,,,,, -1733,,caad583f-6a89-410d-aa0f-9603961e6e5a,TAP Pharmaceutical Products Inc,tap_pharmaceutical_products_inc,,,,,, -1734,,41be5dd3-4eec-4b3f-a84f-c91a6ac92606,Anestesikliniken,anestesikliniken,,,,,, -277,0.97426038980484009,cbb2332f-d8b9-460f-9726-3b2352f5f93e,"Teva Branded Pharmaceutical Product R&D, Inc",teva_branded_pharmaceutical_product_r_d_inc,,,,71fa3658-cdd0-4248-b428-53aae9afea66,teva_branded_pharmaceutical_products_r_d_inc,"Teva Branded Pharmaceutical Products R&D, Inc" -267,0.989332,9e2eb0ad-e2df-43f2-bc5d-f12af02311cf,Grupo de Tratamiento de los Tumores Digestivos,grupo_de_tratamiento_de_los_tumores_digestivos,,,,9e2eb0ad-e2df-43f2-bc5d-f12af02311cf,grupo_de_tratamiento_de_los_tumores_digestivos,Grupo de Tratamiento de los Tumores Digestivos -1735,,ce5ef201-e345-4079-9735-896e1b9b1701,Independent Pharmaceutica AB,independent_pharmaceutica_ab,,,,,, -1736,,d9bdf04d-d0d3-441b-ae5f-b1cbca412121,Wyeth Vaccines Research,wyeth_vaccines_research,,,,,, -1737,,1dc91b7b-7f14-4aa2-970a-9a1d94667f7f,Cork Cancer Research Centre,cork_cancer_research_centre,,,,,, -1738,,c5e1865f-c691-4402-9cc2-6124df926dcb,"Pfizer Limited, Ramsgate Road, Sandwich, CT13 9NJ Kent, UK",pfizer_limited_ramsgate_road_sandwich_ct13_9nj_kent_uk,,,,,, -1739,,702a8968-ef6c-4193-ad42-6ac7c0367054,Christos N. Papandreou,christos_n_papandreou,,,,,, -1740,,dc2d0d37-aaf7-408e-a12e-6e4bcf7bc1a8,Dutch Diabetes Research Foundation,dutch_diabetes_research_foundation,,,,,, -1741,,031b01e6-f574-433c-ad39-f7c2d89a0f42,Ipsen Scandinavia,ipsen_scandinavia,,,,,, -1742,,c10d0e68-b5a2-46f5-bc61-3c1af46f2b9a,MSD ITALIA S.R.L,msd_italia_s_r_l,,,,,, -725,0.989909,a3c58291-967d-4ff8-998b-c8bf14553b5d,National Institute of Allergy and Infectious Diseases (NIAID),national_institute_of_allergy_and_infectious_diseases_niaid,,,,1ad9c652-f097-480c-b6e9-4e1f4c988f0c,national_institute_of_allergy_and_infectious_diseases_niaid_nih,"National Institute of Allergy and Infectious Diseases (NIAID), NIH" -1743,,2403ecb9-6f93-4822-a9a1-9202fd1bced8,"Civitas Therapeutics, a wholly owned subsidiary of Acorda",civitas_therapeutics_a_wholly_owned_subsidiary_of_acorda,,,,,, -1744,,0b362f6f-7355-4737-bfcf-98e319528352,NephroGenex,nephrogenex,,,,,, -1745,,a5eeab32-1bce-4baf-9a64-542f1697780c,Alcon d.o.o,alcon_d_o_o,,,,,, -601,0.969108,0cbd210d-2ea8-4bc2-85dc-5959ed1c55ad,CHU de Saint-Étienne,chu_de_saint_tienne,,,,0cbd210d-2ea8-4bc2-85dc-5959ed1c55ad,chu_de_saint_tienne,CHU de Saint-Étienne -1746,,34d88fb6-73f1-11e6-a0cd-0242ac12000b,AIRGAS CARBONIC INC,airgas_carbonic_inc,,,,,, -1747,,4223cf2b-388b-4e3a-9765-c5c16c557d31,Regents of the University of Minnesota,regents_of_the_university_of_minnesota,,,,,, -1748,,4c1d2586-d9c6-4d2d-80fb-d19fcc24a793,Orphazyme ApS,orphazyme_aps,,,,,, -950,0.97788405418395996,389af5e7-be5f-4143-aff1-2c121f2ec673,"MedImmune LLC (a wholly owned subsidiary of AstraZeneca PLC, One MedImmune Way, Gaithersburg, Maryland, 20878, USA)",medimmune_llc_a_wholly_owned_subsidiary_of_astrazeneca_plc_one_medimmune_way_gaithersburg_maryland_20878_usa,,,,389af5e7-be5f-4143-aff1-2c121f2ec673,medimmune_llc_a_wholly_owned_subsidiary_of_astrazeneca_plc_one_medimmune_way_gaithersburg_maryland_20878_usa,"MedImmune LLC (a wholly owned subsidiary of AstraZeneca PLC, One MedImmune Way, Gaithersburg, Maryland, 20878, USA)" -1749,,61a66732-9a2d-4643-b0b2-fd474ff0bca8,"Kliniken för onkologi, Karolinska Universitetssjukhuset, Solna",kliniken_f_r_onkologi_karolinska_universitetssjukhuset_solna,,,,,, -1750,,4e443485-3308-4c89-8a73-35e50e9f1312,"Paracelsus Mediznische Privatuniversität, Universitätsklinik für Anästhesiologie, perioperative Medizin und Intensiv",paracelsus_mediznische_privatuniversit_t_universit_tsklinik_f_r_an_sthesiologie_perioperative_medizin_und_intensiv,,,,,, -1751,,bf0a3bad-54b6-494d-b385-b694a0fa2c95,"Amersham Health, S.A. (filial de GE Healthcare Ltd)",amersham_health_s_a_filial_de_ge_healthcare_ltd,,,,,, -1752,,e129b142-79f0-41ac-96c1-4ff2569f42f2,Antonio Pérez Martínez,antonio_p_rez_mart_nez,,,,,, -1753,,fa98cfd2-73fa-11e6-a0cd-0242ac12000b,ARDEA BIOSCIENCES,ardea_biosciences,,,,,, -798,0.98433560132980347,1725fbdf-53a4-4e4e-bb56-b7af6038a3c4,Technische Universität München,technische_universit_t_m_nchen,,,,1466a25b-707c-4fd6-8cf9-33dfd10f0436,technische_universit_t_m_nchen_fakult_t_f_r_medizin,Technische Universität München Fakultät für Medizin -1754,,924a5f66-730c-4206-a311-ffdd56f4df4b,Sheffield Teaching Hospitals NHS Foundation Trust,sheffield_teaching_hospitals_nhs_foundation_trust,,,,,, -1755,,60001aea-a91a-4e99-89a3-37ed16f6ea17,ProFibrix Inc,profibrix_inc,,,,,, -809,0.98034405708312988,bd7e81dd-23da-4ec0-b236-7fde1685bf76,Biogen MA,biogen_ma,,,,9aa84ae0-f050-4e53-93f9-888fa0e9a08e,biogen,Biogen -1756,,f681405c-906f-4c1b-8c3b-073a5951dd7d,"Enturia, Inc",enturia_inc,,,,,, -1757,,2ed6045a-73f0-11e6-a0cd-0242ac12000b,LINDE MERCHANT PRODUCTIONS INC,linde_merchant_productions_inc,,,,,, -382,0.98027,37341944-6d19-4843-a80d-f568e4d60ef1,BIOMARIN,biomarin,,,,37341944-6d19-4843-a80d-f568e4d60ef1,biomarin,BIOMARIN -770,0.984713,1a3a35f8-7142-11e6-a0cd-0242ac12000b,DELCOR ASSET CORP,delcor_asset_corp,,,,1a3a35f8-7142-11e6-a0cd-0242ac12000b,delcor_asset_corp,DELCOR ASSET CORP -107,0.950967,63b03e43-7f22-494c-8b54-c8682235d858,FONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI,fondazione_michelangelo_avanzamento_dello_studio_e_cura_dei_tumori,,,,63b03e43-7f22-494c-8b54-c8682235d858,fondazione_michelangelo_avanzamento_dello_studio_e_cura_dei_tumori,FONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI -1758,,3ed6a762-6b3a-400c-913f-544f41f1354b,University Clinic Essen,university_clinic_essen,,,,,, -1018,0.97652915120124817,ccd67b13-6ac6-4275-ad27-b525f9e3df71,Southampton University Hospitals NHS Trust R&D department,southampton_university_hospitals_nhs_trust_r_d_department,,,,4be171c0-8ae0-4db6-b193-567f4e972c15,southampton_university_hospitals_nhs_trust,Southampton University Hospitals NHS Trust -491,0.9828302264213562,280c153e-a191-46ae-8ddc-97dc33b90bb5,GlaxoSmithKline SIA Latvia,glaxosmithkline_sia_latvia,,,,280c153e-a191-46ae-8ddc-97dc33b90bb5,glaxosmithkline_sia_latvia,GlaxoSmithKline SIA Latvia -1759,,55387cc9-fc58-49ea-8651-ff616923eb32,University Hospital of North Tees and Hartlepool,university_hospital_of_north_tees_and_hartlepool,,,,,, -1760,,b9ae01f7-4e1a-497a-b1f3-efbe526bfe09,Winthrop Arzneimittel GmbH,winthrop_arzneimittel_gmbh,,,,,, -1761,,92001494-73f5-11e6-a0cd-0242ac12000b,ROCKWELL MEDICAL INC,rockwell_medical_inc,,,,,, -389,0.989307,be278fc2-12cf-407f-ae31-824dbfaec721,Ludwig Institute for Cancer Research Ltd,ludwig_institute_for_cancer_research_ltd,,,,b0142515-efdf-489a-bd08-d53f5508a4ba,ludwig_institute_for_cancer_research,Ludwig Institute for Cancer Research -1762,,0772d669-b445-412f-a1d5-4d8bf9922567,"Faculty of Odontology, University of Iceland",faculty_of_odontology_university_of_iceland,,,,,, -1763,,ee29af86-739c-11e6-a0cd-0242ac12000b,AYTU PHARMS,aytu_pharms,,,,,, -1052,0.92084199190139771,4ff0ee50-4cfc-45a7-a15d-7a978e624e6a,University of Oxford Clinical Trials & Research Governance,university_of_oxford_clinical_trials_research_governance,,,,574a16cb-eb53-4e25-95a2-a07455968d04,university_of_oxford_clinical_trials_and_research_governance,"University of Oxford, Clinical Trials and Research Governance Office" -1764,,52a4f6db-b249-4be0-84ba-aeefbc97a970,Christian Westergaard,christian_westergaard,,,,,, -172,0.96958163380622864,6fbfcc91-00e1-4cd8-990a-361431274d3f,"Merck Serono International, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt",merck_serono_international_a_branch_of_laboratoires_serono_sa_an_affiliate_of_merck_kgaa_darmstadt,,,,4d103db0-46f8-458b-804a-442a7728fad2,merck_serono_international_a_branch_of_laboratoires_serono_sa_an_affiliate_of_merck_kgaa,"Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA" -1765,,91e678cd-83cd-4810-bebe-99dec4bfa1a4,InflaRx GmbH,inflarx_gmbh,,,,,, -1766,,a57aed91-f1a7-49f6-b421-459da2900d25,Gebro Pharma,gebro_pharma,,,,,, -1767,,fd272b94-06e5-44bf-849e-0af05fa45af9,Center for Neuropsychiatric Schizophrenia Research,center_for_neuropsychiatric_schizophrenia_research,,,,,, -650,0.95941996574401855,2c7b1b3b-323c-4045-ae75-4712a0ece886,Boehringer Ingelheim Austria GmbH,boehringer_ingelheim_austria_gmbh,,,,2c7b1b3b-323c-4045-ae75-4712a0ece886,boehringer_ingelheim_ab,Boehringer Ingelheim AB -1768,,9930a4cb-eaba-490f-b1da-d6e709c10f8e,"Grifols Therapeutics, Incorporated",grifols_therapeutics_incorporated,,,,,, -1769,,c4ff97f3-bd70-465c-9e83-370777fb28b4,Francisco Muñoz Negrete,francisco_mu_oz_negrete,,,,,, -1770,,dc7ced28-7164-11e6-a0cd-0242ac12000b,STANDARD CHEM PHARM,standard_chem_pharm,,,,,, -1771,,794987f2-7187-11e6-a0cd-0242ac12000b,AMYLIN PHARMS LLC,amylin_pharms_llc,,,,,, -1772,,0843cdbb-a3fc-42b2-96f9-304b57c4408b,"Strahlenklinik, Universitätsklinikum Erlangen, insoweit handelnd für den Freistaat Bayern",strahlenklinik_universit_tsklinikum_erlangen_insoweit_handelnd_f_r_den_freistaat_bayern,,,,,, -659,0.989406,3b17812c-fdb5-4544-97fd-496a11299fc7,Swedish Institute for Infectious Disease Control (SMI),swedish_institute_for_infectious_disease_control_smi,,,,3b17812c-fdb5-4544-97fd-496a11299fc7,swedish_institute_for_infectious_disease_control_smi,Swedish Institute for Infectious Disease Control (SMI) -1773,,3ad28e3a-7162-11e6-a0cd-0242ac12000b,MAYRAND,mayrand,,,,,, -1774,,6f97c3cf-38f6-4898-9dbf-8c6b7eb2e4b5,Delta Crystallon B.V,delta_crystallon_b_v,,,,,, -1775,,13d09747-bdbf-4dbc-a32a-7ce744cc6935,Landstinget i Värmland,landstinget_i_v_rmland,,,,,, -1776,,fb686767-51f3-470c-9ec1-1596beeb4f76,Juha Hartikainen,juha_hartikainen,,,,,, -1045,0.98760741949081421,fa200595-3ec2-4548-b852-3a8525fbfc68,Synta Pharmaceuticals Corp,synta_pharmaceuticals_corp,,,,558c49d6-0383-4c86-9ba7-9561b98f7845,synta_pharmaceuticals_corporation,Synta Pharmaceuticals Corporation -1777,,4d37bd41-f850-4a78-ba68-2cd5698f421e,Norfolk and Norwich University Hospitals NHS Trust,norfolk_and_norwich_university_hospitals_nhs_trust,,,,,, -1778,,aaf924b5-9379-4589-95f4-f8b9c539d14d,GP-Pharm s.a,gp_pharm_s_a,,,,,, -1779,,7631b99e-7372-4b6c-97be-8a017639d08e,Oriel Therapeutics Inc,oriel_therapeutics_inc,,,,,, -1780,,b04e3b85-0c34-4859-a85f-96dec575bfeb,CHU of Rennes,chu_of_rennes,,,,,, -1781,,0c304dd2-6fa6-11e6-9663-0242ac12000b,GRIFOLS S.A,grifols_s_a,,,,,, -1782,,a790a4f6-71a0-11e6-a0cd-0242ac12000b,GEN ELECTRIC,gen_electric,,,,,, -1783,,63f0dd0a-7165-11e6-a0cd-0242ac12000b,ENDO PHARMS INC,endo_pharms_inc,,,,,, -258,0.98775,64f7d7d9-e504-4ff5-a540-55635d4c61d0,Karolinska Universitetssjukhuset Huddinge,karolinska_universitetssjukhuset_huddinge,,,,64f7d7d9-e504-4ff5-a540-55635d4c61d0,karolinska_universitetssjukhuset_huddinge,Karolinska Universitetssjukhuset Huddinge -1784,,0051517f-62c3-4d9b-bed2-8725a1f613f0,Haga Hospital,haga_hospital,,,,,, -1785,,4b48463b-084b-419a-9ec5-957998cde2d9,Eli Lilly Nederland,eli_lilly_nederland,,,,,, -469,0.985292,55158cf1-cd99-4f28-8043-743b9a161005,OSPEDALE S. RAFFAELE,ospedale_s_raffaele,,,,55158cf1-cd99-4f28-8043-743b9a161005,ospedale_s_raffaele,OSPEDALE S. RAFFAELE -1786,,7eca731c-f233-4aa8-b95e-b86da832638f,CELSION CORPORATION,celsion_corporation,,,,,, -1787,,45498b8d-ca2e-4466-87dc-296da43d3b5c,Portsmouth Hospitals Trust,portsmouth_hospitals_trust,,,,,, -548,0.98087829351425171,0ea42022-8be2-11e6-a449-0242ac12000b,FERRING SPA,ferring_spa,,,,0ea42022-8be2-11e6-a449-0242ac12000b,ferring_spa,FERRING SPA -1788,,82ffe76d-d02d-4d6d-b6c4-e90ee665add6,Westpfalz-Klinikum GmbH,westpfalz_klinikum_gmbh,,,,,, -893,0.9773980975151062,2f028fcc-7872-4732-95a8-d0e74e80f7ae,"Aarhus Universitetshospital, Aarhus Sygehus THG",aarhus_universitetshospital_aarhus_sygehus_thg,,,,2f028fcc-7872-4732-95a8-d0e74e80f7ae,aarhus_universitetshospital_aarhus_sygehus_thg,"Aarhus Universitetshospital, Aarhus Sygehus THG" -1789,,57cc8305-046c-4feb-a838-b1f1b94e5746,University Of Tuebingen,university_of_tuebingen,,,,,, -45,0.90533584356307983,7c8f44a5-f228-4272-a17a-08c93ebdc8bd,"Medicinsk Forskning, Regionshospitalet Holstebro",medicinsk_forskning_regionshospitalet_holstebro,,,,7c8f44a5-f228-4272-a17a-08c93ebdc8bd,medicinsk_forskning_regionshospitalet_holstebro,"Medicinsk Forskning, Regionshospitalet Holstebro" -1790,,01e2370c-7148-11e6-a0cd-0242ac12000b,MYLAN TECHNOLOGIES,mylan_technologies,,,,,, -1791,,9e5c0088-720e-11e6-a0cd-0242ac12000b,MYLAN BERTEK,mylan_bertek,,,,,, -1792,,ea2ff3d2-6fcd-4354-9862-2fdc61d725ed,Infirst+ HEALTHCARE Ltd,infirst_healthcare_ltd,,,,,, -1793,,3064beba-c138-40ae-bc49-a3cbd7434374,Univ. Prof. Dr. Markus Peck-Radosavljevic,univ_prof_dr_markus_peck_radosavljevic,,,,,, -63,0.983835,e11289fe-0824-4834-8ad2-2124b9651048,Clínica Universidad de Navarra/Universidad de Navarra,cl_nica_universidad_de_navarra_universidad_de_navarra,,,,01a1f7f6-8bc3-11e6-a449-0242ac12000b,cl_nica_universidad_de_navarra,Clínica Universidad de Navarra -1794,,429ebcd5-1315-4722-9ae8-f88f6da5623d,Merck Serono The Netherlands - a division of Merck B.V,merck_serono_the_netherlands_a_division_of_merck_b_v,,,,,, -1795,,bdbe7941-f515-48fa-9501-28cd26f1d3bc,ECUPHARMA S.R.L,ecupharma_s_r_l,,,,,, -1018,0.97911614179611206,4be171c0-8ae0-4db6-b193-567f4e972c15,Southampton University Hospitals NHS Trust,southampton_university_hospitals_nhs_trust,,,,4be171c0-8ae0-4db6-b193-567f4e972c15,southampton_university_hospitals_nhs_trust,Southampton University Hospitals NHS Trust -917,0.986946,5cdbde15-83c4-4b59-a418-8452d890ac4e,Bristol Myers Squibb,bristol_myers_squibb,,,,5cdbde15-83c4-4b59-a418-8452d890ac4e,bristol_myers_squibb,Bristol Myers Squibb -1796,,94a38a2b-7b09-4362-af09-40f00f3651eb,AZIENDA USL 4 PRATO,azienda_usl_4_prato,,,,,, -1071,0.9851963222026825,27a87295-855d-4f98-b9d7-56d99260317a,University College Dublin,university_college_dublin,,,,a1ac5ed3-48d6-4b25-be01-f8fe60a9d1d6,university_college_dublin,University College Dublin -1797,,c4d552c3-5287-46af-b360-ca25ed645657,Nordic Society for Gynecologic Oncology,nordic_society_for_gynecologic_oncology,,,,,, -1798,,114eebc4-6abb-4948-8ad7-126e70506078,Fundacion General Universidad de Valladolid,fundacion_general_universidad_de_valladolid,,,,,, -1799,,c15ada7f-d95f-4de2-b339-07138afe75d4,"GeneCare Research Institute Co., Ltd",genecare_research_institute_co_ltd,,,,,, -1800,,65c4723b-4e35-4351-a268-5667b99dfbb5,Nicanor Vega Diaz. Hospital Universitario de Gran Canaria Dr Negrin,nicanor_vega_diaz_hospital_universitario_de_gran_canaria_dr_negrin,,,,,, -1801,,2bec3268-7167-11e6-a0cd-0242ac12000b,WI MEDCL CYCLOTRON,wi_medcl_cyclotron,,,,,, -1802,,d24ca47f-7ab5-4a3b-a34f-ecca8632cb38,Alcon Pharma GmbH,alcon_pharma_gmbh,,,,,, -1803,,d271a623-8816-4bb9-8781-5031005ca930,NeuroVive Pharmaceutical AB,neurovive_pharmaceutical_ab,,,,,, -490,0.98192024230957031,024a3a7c-59ae-4694-93a8-645207bf73b5,Radboud University Medical Center Nijmegen,radboud_university_medical_center_nijmegen,,,,3fd47231-c0e0-48e2-9df1-24e6ff72daf7,radboud_university_medical_center,Radboud University Medical Center -1804,,19e97c24-288c-4077-bbe8-0bdb9d6240f5,Kamada Limited,kamada_limited,,,,,, -1805,,510c9ba3-a208-425c-9dba-54134fe07c98,Centre d'Etude des Cellules Souches (CECS),centre_d_etude_des_cellules_souches_cecs,,,,,, -1806,,4797a425-aabd-4e5d-a3ae-a5325e9b9194,Bonaventura Clotet/Ramón Planas/Ricard Solá,bonaventura_clotet_ram_n_planas_ricard_sol,,,,,, -1807,,21238b73-c8d7-4838-bbb0-dea892858a45,GEMCAD (Grupo Español Multidisciplinar en Cáncer Digestivo),gemcad_grupo_espa_ol_multidisciplinar_en_c_ncer_digestivo,,,,,, -1808,,6542cb0a-e35e-4aea-9fda-aa75d5627098,Laboratoires Menarini France,laboratoires_menarini_france,,,,,, -1809,,74a8c146-a754-11e6-94cb-5656d04fc2b5,FUNDACIÓN INVESTIGACIÓN BIOMÉDICA HOSPITAL PUERTA DE HIERRO,fundaci_n_investigaci_n_biom_dica_hospital_puerta_de_hierro,,,,,, -1810,,c614bf11-a9e1-4a7f-ad61-00bba7225e26,Uppsala Clinical Research Center,uppsala_clinical_research_center,,,,,, -240,0.987416,61f718c1-8bf2-4352-81a1-859abc44901a,MEDIMMUNE ONCOLOGY INC,medimmune_oncology_inc,,,,61f718c1-8bf2-4352-81a1-859abc44901a,medimmune_oncology_inc,MEDIMMUNE ONCOLOGY INC -1811,,8da9f322-bdad-43fb-8a5c-368cf7b951cc,Swansea NHS Trust,swansea_nhs_trust,,,,,, -1812,,3bb71aae-35fa-404b-9e79-2bd8f474163e,"Universitätsklinikum Schleswig-Holstein, Campus Lübeck: Klinik für Strahlentherapie",universit_tsklinikum_schleswig_holstein_campus_l_beck_klinik_f_r_strahlentherapie,,,,,, -1813,,8fc520eb-d559-4c92-baf2-e5382511cbe4,"Div. of Cardiology, Innsbruck Medical University",div_of_cardiology_innsbruck_medical_university,,,,,, -1814,,b8335c71-bdb8-4660-a641-4dc3e6179948,zna middelheim,zna_middelheim,,,,,, -1815,,7e718175-17e5-485c-b25d-62abc5193d2c,"Universitätsklinikum Mannheim, Klinik für Anästhesiologie",universit_tsklinikum_mannheim_klinik_f_r_an_sthesiologie,,,,,, -1816,,9f400bdb-ee02-446a-b67d-2ef8ffc4ce7c,GEMCAD,gemcad,,,,,, -64,0.986698,fbd4d1d9-2f52-4351-ba24-4bdbabfea4ac,Wilhelmina Children's Hospital,wilhelmina_children_s_hospital,,,,ccc2695d-93a7-4900-a3b6-e4bb0c11c688,wilhelmina_children_s_hospital_umc_utrecht,Wilhelmina Children's Hospital/UMC Utrecht -1817,,bd335916-72db-11e6-a0cd-0242ac12000b,DEPOMED INC,depomed_inc,,,,,, -1818,,e4d1bbe3-6a2a-412d-b236-8a6c0f1acdf6,"Dept. of Pediatrics, The Childrens Hospital, Denver",dept_of_pediatrics_the_childrens_hospital_denver,,,,,, -1819,,96379a55-56a6-4583-ba69-a8873b750d51,"Rhythm Pharmaceuticals, Inc",rhythm_pharmaceuticals_inc,,,,,, -1820,,7c259332-716c-11e6-a0cd-0242ac12000b,SERONO INC,serono_inc,,,,,, -1821,,7d5d838d-d2cf-446f-b244-45fc710503d6,"Department of hospital Pharmacy, Medical Centre Haaglanden",department_of_hospital_pharmacy_medical_centre_haaglanden,,,,,, -1822,,619f7fb2-fe0d-45bb-b553-766565755af4,PIERRE FABRE PHARMA,pierre_fabre_pharma,,,,,, -1823,,d3fcb59f-91bf-430b-97f8-14e4417f9b49,Fundació de Recerca de L?Institut de Microcirurgia Ocular,fundaci_de_recerca_de_l_institut_de_microcirurgia_ocular,,,,,, -1824,,c15a785e-49ec-4983-b92b-bbc35d48dc21,"Schering Corporation, a Subsidiary of Merck & Co., Inc",schering_corporation_a_subsidiary_of_merck_co_inc,,,,,, -1825,,4d1a6e85-c2ea-4a2d-872f-f5d66e239268,Maria Fernanda Pedrero Escalas,maria_fernanda_pedrero_escalas,,,,,, -1826,,5f69f22a-67ff-43c9-81d5-2e8b33def10e,Elena Rubio. Consorcio Hospital General Universitario de Valencia,elena_rubio_consorcio_hospital_general_universitario_de_valencia,,,,,, -1827,,7f6a3cfb-2038-4c78-8594-550b890bc919,Glostrup University Hospital,glostrup_university_hospital,,,,,, -1828,,67530744-edeb-4c0d-b358-79de01dae181,TRICHOLOG GmbH,tricholog_gmbh,,,,,, -1829,,4f3819aa-18bb-4a39-9225-746aae6321ea,Baxter Healthcare S.A,baxter_healthcare_s_a,,,,,, -734,0.980666,b0fb7e3c-715d-11e6-a0cd-0242ac12000b,WEST WARD PHARMS,west_ward_pharms,,,,78a71c0c-715e-11e6-a0cd-0242ac12000b,west_ward,WEST WARD -1830,,14701813-d545-43ba-a0a3-cb4643c4a5e1,FUNDACIÓN IBEROAMERICANA ITACA,fundaci_n_iberoamericana_itaca,,,,,, -1831,,382624dd-3b9e-44b4-a37b-eb76e303ca8b,Transition Therapeutics Ireland Ltd,transition_therapeutics_ireland_ltd,,,,,, -1832,,ca6ea810-a6a7-11e6-94cb-5656d04fc2b5,CHC-Clinique Espérance,chc_clinique_esp_rance,,,,,, -1833,,8440d1e6-1a42-45a5-ad1c-013ad2988a09,XAVIER CARBONELL ESTRANY,xavier_carbonell_estrany,,,,,, -731,0.97176811099052429,55b1cd8b-93b6-4262-9f20-ab35fbdc2476,Bristol-Myers Squibb Internaltional Corporation,bristol_myers_squibb_internaltional_corporation,,,,55b1cd8b-93b6-4262-9f20-ab35fbdc2476,bristol_myers_squibb_international_corporation,Bristol-Myers Squibb International Corporation -1834,,f0258197-cf49-49fa-afd1-144834d722bc,BIOGEN-DOMPE` SRL,biogen_dompe_srl,,,,,, -1835,,e5d60aee-71cd-11e6-a0cd-0242ac12000b,XANODYNE PHARMS INC,xanodyne_pharms_inc,,,,,, -1836,,919a088c-0940-4457-8340-edf7b4192215,Xavier Pintó Sala,xavier_pint_sala,,,,,, -653,0.95209956169128418,e091f4a8-4358-4d9d-b90c-5f77fef3e3a6,Boehringer Ingelheim RCV GmbH & CoKG,boehringer_ingelheim_rcv_gmbh_cokg,,,,5c99ca16-39a1-4b89-bbde-8627966f253d,boehringer_ingelheim_rcv_gmbh,Boehringer Ingelheim RCV GmbH -1837,,ebe87f1f-7bf4-46df-bfa7-e7822d7f8b61,The Medicines Company UK Ltd,the_medicines_company_uk_ltd,,,,,, -1838,,89856702-7165-11e6-a0cd-0242ac12000b,HETERO LABS UNIT III,hetero_labs_unit_iii,,,,,, -1839,,eb190fce-7191-11e6-a0cd-0242ac12000b,PANRAY,panray,,,,,, -888,0.92826088837214882,76734339-1c16-4d19-ae19-293d00e7cd32,"Schering-Plough Research Institution, A Division of Schering Corporation",schering_plough_research_institution_a_division_of_schering_corporation,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" -1840,,b8bd986c-7144-11e6-a0cd-0242ac12000b,LUPIN PHARMS,lupin_pharms,,,,,, -1841,,6a5ce6bd-3b97-461e-b2b8-10953851d872,Sint Antonius Hospital,sint_antonius_hospital,,,,,, -1842,,f3443565-6688-49cb-b6e9-f6d17af8aca7,KAI Pharmaceuticals Incorporated,kai_pharmaceuticals_incorporated,,,,,, -1843,,e2f7ab95-9af5-4e45-82c5-51512fda4379,GELA-Recherche Clinique,gela_recherche_clinique,,,,,, -822,0.986019,7ea15226-d1e9-49e7-8712-7ea0bb120819,Heinrich-Heine-Universität Duesseldorf,heinrich_heine_universit_t_duesseldorf,,,,7ea15226-d1e9-49e7-8712-7ea0bb120819,heinrich_heine_universit_t_duesseldorf,Heinrich-Heine-Universität Duesseldorf -1844,,639a9148-164d-4f77-bb09-4411fb260b6e,Anne Vakkuri,anne_vakkuri,,,,,, -10,0.984827,6b476606-7236-11e6-a0cd-0242ac12000b,THE MEDICINES CO,the_medicines_co,,,,6b476606-7236-11e6-a0cd-0242ac12000b,the_medicines_co,THE MEDICINES CO -1845,,d71775f1-d1ac-4e1c-82f0-93beb26a4014,Philogen S.p.A,philogen_s_p_a,,,,,, -1846,,36ad4f56-651c-4e05-bcbe-715ece380c2f,BIOCODEX,biocodex,,,,,, -1029,0.935805,9a6febf5-845f-4a3f-9335-26042f8acfc9,EORTC - European Organisation for Research and Treatment of Cancer,eortc_european_organisation_for_research_and_treatment_of_cancer,,,,5107d29f-cc09-411e-b173-d701ced714e6,eortc_european_organization_for_research_and_treatment_of_cancer,EORTC (European Organization for Research and Treatment of Cancer) -565,0.984012,405d1fa4-2b8c-4b5a-97c9-ad8bfa9c2763,University Hospitals of Leicester - Research & Development,university_hospitals_of_leicester_research_development,,,,3bf7860d-fdab-4edb-a9b9-646110448c48,university_hospitals_of_leicester,University Hospitals of Leicester -137,0.964969,bb5a7f2b-82c6-41c8-b7b4-dd8d75806e35,University Hospitals Birmingham NHS Foundation Trust,university_hospitals_birmingham_nhs_foundation_trust,,,,0e091d56-1af6-42d9-8d7c-b1eab6a90b8a,university_hospitals_of_birmingham_nhs_foundation_trust,University Hospitals of Birmingham NHS Foundation Trust -1847,,9a42440d-102d-4b39-b424-b19051635e7e,Daiichi SankyoGmbH,daiichi_sankyogmbh,,,,,, -1848,,6d716724-7196-11e6-a0cd-0242ac12000b,VALIDUS PHARMS INC,validus_pharms_inc,,,,,, -992,0.98193579912185669,dc954dd6-f123-41b9-af61-c0fc69aba77c,Medizinische Universität Innsbruck / Univ.-Klinik für Allg. u. Chirurg. Intensivmedizin,medizinische_universit_t_innsbruck_univ_klinik_f_r_allg_u_chirurg_intensivmedizin,,,,85bd52ce-4912-412b-98e5-33039d390569,medizinische_universit_t_innsbruck_univ_klinik_f_r_allg_u_chirurg_intensivmedizin,Medizinische Universität Innsbruck / Univ.-Klinik für Allg. u. Chirurg. Intensivmedizin -1058,0.94924008846282959,aca25ae9-a1c2-40c1-8516-239ddf48a9e1,Pfizer Hellas A.E,pfizer_hellas_a_e,,,,9f433fc9-52ae-42c8-afcf-a91a3762e82b,pfizer_hellas_ae,Pfizer Hellas AE -1849,,752c674e-6fba-11e6-abe8-0242ac12000b,Universitätspital Zürich Anästhesie,universit_tspital_z_rich_an_sthesie,,,,,, -1850,,196fbd9b-c49b-49fd-ae99-d67714f173ae,Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis,stichting_het_nederlands_kanker_instituut_antoni_van_leeuwenhoek_ziekenhuis,,,,,, -1851,,049c4e58-7191-11e6-a0cd-0242ac12000b,EDISON THERAPS LLC,edison_theraps_llc,,,,,, -1852,,5d1e35b5-20c0-464c-aa24-13d71743734d,IST. DI RICERCHE FARMACOLOG. M. NEGRI,ist_di_ricerche_farmacolog_m_negri,,,,,, -1853,,40bac149-23af-4640-a2f8-624c65ab970d,Association pour la promotion de la réanimation médicale à Tours,association_pour_la_promotion_de_la_r_animation_m_dicale_tours,,,,,, -1854,,89db32ce-b526-435a-8697-b192540bc792,Lucia Galan Hospital Clinico San Carlos,lucia_galan_hospital_clinico_san_carlos,,,,,, -1855,,b601f3ec-0223-428b-aa7b-5e75b707f1a7,GEICAM (Fundación Grupo Español de Investigación en Cáncer de Mama),geicam_fundaci_n_grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama,,,,,, -1856,,6a75b276-6b29-42b9-aad0-2fb631b72ebc,Bayer SpA,bayer_spa,,,,,, -1857,,a2ec763e-9978-4e92-ba6f-0758845b03b7,Isidre Vilacosta,isidre_vilacosta,,,,,, -827,0.98924979567527771,a76f8a47-a17c-42bc-b482-cc7b236a1fb3,INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE,instituto_de_investigaci_n_sanitaria_la_fe_de,,,,975869a5-d12b-4f5f-9a3d-d76a15c61a6a,instituto_de_investigaci_n_sanitaria_la_fe_de,INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE -1858,,b2a110f2-404c-4d7e-8b21-d807e3f60c00,West Hertfordshire Hospitals NHS Trust,west_hertfordshire_hospitals_nhs_trust,,,,,, -902,0.975661,c4639166-c014-47d0-bd0d-48ac262c02d3,Klaus Olkkola,klaus_olkkola,,,,107fc324-9e45-4afc-8ead-3498cf036471,klaus_olkkola_university_of_helsinki,Klaus Olkkola/University of Helsinki -1859,,f734d888-7141-11e6-a0cd-0242ac12000b,SUN PHARM INDS LTD,sun_pharm_inds_ltd,,,,,, -1860,,4dfa808b-96d0-403e-a1f9-5a144c2ea6e2,ANSR,ansr,,,,,, -328,0.932685,5809dce0-1c57-445d-9068-5b5bffdd2080,Aziende Chimiche Riunite Angelini Francesco - ACRAF S.p.A,aziende_chimiche_riunite_angelini_francesco_acraf_s_p_a,,,,5809dce0-1c57-445d-9068-5b5bffdd2080,aziende_chimiche_riunite_angelini_francesco_acraf_s_p_a,Aziende Chimiche Riunite Angelini Francesco - ACRAF S.p.A -1861,,808d7ccc-54b2-4df1-9848-c773d5df49a6,Novartis Vaccines Institute for Global Health (NVGH),novartis_vaccines_institute_for_global_health_nvgh,,,,,, -360,0.986646,3f73d507-49f7-4bba-847d-11619261c4ae,Academisch Medisch Centrum,academisch_medisch_centrum,,,,3f73d507-49f7-4bba-847d-11619261c4ae,academisch_medisch_centrum,Academisch Medisch Centrum -1862,,9c5fe7fc-6a53-41b4-945e-56bf154b6295,"Department of Occupational and Environmental Dermatology, Malmö University Hospital",department_of_occupational_and_environmental_dermatology_malm_university_hospital,,,,,, -1863,,da3aad48-3bb1-4bf9-b3fd-7942b74efc97,"HOC, Rigshospitalet",hoc_rigshospitalet,,,,,, -1864,,6c5359ad-18d4-4218-b384-074d2e107e2b,AZIENDA SANITARIA LOCALE DI BARI,azienda_sanitaria_locale_di_bari,,,,,, -1865,,c3afe20e-81a8-4027-a6d1-71d729beb2f7,National Centre in HIV Epidemiology and Clinical Research,national_centre_in_hiv_epidemiology_and_clinical_research,,,,,, -1866,,11b64365-95ca-4a59-ad34-2aefd9072f7c,MERCK SHARP DOHME ITALIA S.P.A,merck_sharp_dohme_italia_s_p_a,,,,,, -1867,,a8508f68-4869-450f-833b-3a077309c6b7,Medizinische Universität Wien Univ.Klinik f.Innere Medizin I/Hämatologie,medizinische_universit_t_wien_univ_klinik_f_innere_medizin_i_h_matologie,,,,,, -1868,,c7eef3e9-63dd-4653-b1cf-c43564270770,"MAP Pharmaceuticals, Inc",map_pharmaceuticals_inc,,,,,, -1869,,14c3a8cf-9a5f-48f2-bcd4-664210f2abe9,Fa.Elexxion,fa_elexxion,,,,,, -1870,,f16b6afb-6cbe-4b1c-bd26-9dad17fb6e33,Sun Pharma Global FZE,sun_pharma_global_fze,,,,,, -858,0.94989776611328125,5ce030ba-f524-45f7-b154-b5509cfe5e6d,Institut de Recerca Hospital de la Sant Creu i Sant Pau,institut_de_recerca_hospital_de_la_sant_creu_i_sant_pau,,,,5ce030ba-f524-45f7-b154-b5509cfe5e6d,institut_de_recerca_hospital_de_la_sant_creu_i_sant_pau,Institut de Recerca Hospital de la Sant Creu i Sant Pau -606,0.98722973465919495,c3706f14-715d-11e6-a0cd-0242ac12000b,AUROBINDO PHARM,aurobindo_pharm,,,,f36837b0-7144-11e6-a0cd-0242ac12000b,aurobindo_pharma,AUROBINDO PHARMA -1871,,a6a4658f-22ac-41e2-a8b5-5cbdb95f6545,Pharmacosmos A/S,pharmacosmos_a_s,,,,,, -1872,,2a6cec66-883e-471c-a287-80b342b4c2ae,"Med Uni Graz, Univ. Klinik für Anästhesiologie und Intensivmedizin",med_uni_graz_univ_klinik_f_r_an_sthesiologie_und_intensivmedizin,,,,,, -1873,,c8293bb4-7165-11e6-a0cd-0242ac12000b,SPEAR PHARMS INC,spear_pharms_inc,,,,,, -985,0.98482728004455566,ede51c8a-35c0-466b-a6aa-e9e49c4956b3,"Imperial College, London",imperial_college_london,,,,275d9cef-debb-4aaf-8234-93691b0c3e94,imperial_college,Imperial College -1874,,8ffe068c-73f1-11e6-a0cd-0242ac12000b,PRAXAIR DISTRIBUTION MID-ATLANTIC LLC,praxair_distribution_mid_atlantic_llc,,,,,, -1875,,1af40566-664d-4bc7-b85d-d257aca57df4,"Merck Serono Int, a branch of Laboratoires Seron SA an affiliate of Merck KGaA, Darmstadt, Germany",merck_serono_int_a_branch_of_laboratoires_seron_sa_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,,, -1876,,ffc0110e-0caf-4e4f-a523-a1b548cadf7d,Omninvest Ltd,omninvest_ltd,,,,,, -1877,,48ea0d59-c895-4668-b3b3-986a15bc25b0,PROMIX Trial Group,promix_trial_group,,,,,, -1878,,a4103634-1e22-4ebf-9782-fb0104c05ae1,PASCOE pharmazeutische Präparate GmbH,pascoe_pharmazeutische_pr_parate_gmbh,,,,,, -1879,,796063a8-7148-11e6-a0cd-0242ac12000b,CUMBERLAND PHARMS,cumberland_pharms,,,,,, -1880,,ca9c1bf6-ca6a-4dd7-83c4-dcd1ae62a4eb,"Department of Ophthalmology, Aarhus University Hospital",department_of_ophthalmology_aarhus_university_hospital,,,,,, -736,0.9846251209576925,eda88abe-5243-41c5-924e-0698f02867ba,European Organization for the Research and Treatment of Cancer,european_organization_for_the_research_and_treatment_of_cancer,,,,86b7934b-bd40-4e41-90e2-f2b10e4f66c8,european_organization_for_the_research_and_treatment_of_cancer_eortc,European Organization for the Research and Treatment of Cancer (EORTC) -1066,0.919718,36b27479-ba79-4094-93f3-0a7496de4aec,Universitätsklinikum Tübingen,universit_tsklinikum_t_bingen,,,,36b27479-ba79-4094-93f3-0a7496de4aec,universit_tsklinikum_t_bingen,Universitätsklinikum Tübingen -1881,,1e94876e-beee-449e-940f-d326eae2f5ad,Research and Development NHS Lothian,research_and_development_nhs_lothian,,,,,, -1882,,f6f35f13-e9ae-4403-bacd-3f344aae47ae,Center for Stroke Research Berlin - Charité Universitätsmedizin Berlin,center_for_stroke_research_berlin_charit_universit_tsmedizin_berlin,,,,,, -1883,,5f926f8d-f8b4-4e93-a71b-dae72d61daff,Virttu Biologics Limited,virttu_biologics_limited,,,,,, -1884,,4b19cffa-894d-487f-af60-846dea5ca443,ACROSS:Associació Catalana per a la Recerca Oncològica i les seves implicacions sanitàries i Socials,across_associaci_catalana_per_a_la_recerca_oncol_gica_i_les_seves_implicacions_sanit_ries_i_socials,,,,,, -1885,,8f282e06-9f89-425f-b2c1-f6adb6c40780,Guy's and St Thomas Foundation NHS Trust,guy_s_and_st_thomas_foundation_nhs_trust,,,,,, -1886,,244b727a-1df7-433c-9a23-380add963d83,"Charles University in Prague, Third Faculty of Medicine",charles_university_in_prague_third_faculty_of_medicine,,,,,, -1887,,993bfe4f-a811-4b7e-a8b1-f243cf2beea7,HEXAL BIOTECH,hexal_biotech,,,,,, -1888,,11ac98e6-1a9e-4906-857f-a537b80d8725,Ersi Voskaridou-Dimoula,ersi_voskaridou_dimoula,,,,,, -1889,,8b690a1b-e529-4162-ad62-186251ac03e4,Institut für Klinische Forschung und Entwicklung (ikfe) GmbH,institut_f_r_klinische_forschung_und_entwicklung_ikfe_gmbh,,,,,, -1890,,35af0f6e-7144-11e6-a0cd-0242ac12000b,HIKMA FARMACEUTICA,hikma_farmaceutica,,,,,, -1891,,5ea673fe-5829-41d3-8e80-509fabf7cf70,"Medizinische Universität Innsbruck, vertreten durch Univ. Prof. Dr. Martin Krismer",medizinische_universit_t_innsbruck_vertreten_durch_univ_prof_dr_martin_krismer,,,,,, -1892,,89480dc7-5193-4857-b71b-1f7930d02813,"Samsung Bioepis Co., Ltd",samsung_bioepis_co_ltd,,,,,, -1893,,b03d6394-c28d-458c-99ce-aac61f6b1d73,DiaMedica Inc,diamedica_inc,,,,,, -1894,,2c0b3176-5a46-4d9f-99b4-ed1b390aa6d3,Fundación Fernández-Cruz,fundaci_n_fern_ndez_cruz,,,,,, -1895,,704538ab-c289-41f8-b44d-2d80857611ff,PD Dr. Gerhard Treiber,pd_dr_gerhard_treiber,,,,,, -202,0.9779740571975708,e1159672-2a52-43b2-9e5e-38398d43b8d6,"Helse Bergen HF, Haukeland Unversity Hospital",helse_bergen_hf_haukeland_unversity_hospital,,,,0ca95325-5fdb-4264-9a4d-da0285235e77,helse_bergen_hf_haukeland_university_hospital,"Helse Bergen HF, Haukeland University Hospital" -1896,,bfbfc0c4-841d-4393-b2da-0c2f0c2c3d06,"Institutt for nevromedisin, NTNU",institutt_for_nevromedisin_ntnu,,,,,, -1897,,510ed425-0435-4d52-a19e-6a9bb112b0cf,"Sequel Pharmaceuticals, Inc",sequel_pharmaceuticals_inc,,,,,, -546,0.912289,066b98e8-5ec4-4f5b-9b43-91f546ee98d1,University Hospital of Regensburg,university_hospital_of_regensburg,,,,066b98e8-5ec4-4f5b-9b43-91f546ee98d1,university_hospital_of_regensburg,University Hospital of Regensburg -1898,,a9252def-bfbd-434a-8554-7e88e70c34f2,CRINOS S.p.A,crinos_s_p_a,,,,,, -1899,,c1054dcf-ea5a-4611-a920-a9a0e63c0399,Hoffmann- La Roche Ltd,hoffmann_la_roche_ltd,,,,,, -1900,,d20931f4-7159-11e6-a0cd-0242ac12000b,SPEAR PHARMS,spear_pharms,,,,,, -1901,,e304e7c2-eaf6-47cb-a34d-ea0d3ab066e9,"Aarhus University Hospital, Dept of Endocrinology and Internel Medicine (MEA)",aarhus_university_hospital_dept_of_endocrinology_and_internel_medicine_mea,,,,,, -1902,,f8461567-196a-40ec-b87c-808e2d1bc1f9,Italian Drug Agency,italian_drug_agency,,,,,, -1903,,b2e4d3a8-7160-11e6-a0cd-0242ac12000b,BI-COASTAL PHARMA,bi_coastal_pharma,,,,,, -1904,,42b9d5c5-f81b-4b7a-887c-2cf2a1c91593,Uriach Pharma,uriach_pharma,,,,,, -1905,,9f0d9abb-85c9-46cf-a721-900295acccd5,"Zeria Pharmaceutical Co., Ltd",zeria_pharmaceutical_co_ltd,,,,,, -1906,,110d4190-904c-4e60-a365-5b86db8adbed,Dept. of Neurology Vienna,dept_of_neurology_vienna,,,,,, -1907,,1466ef63-ccce-413c-8e4a-f73b929fdaba,"AOU di Bologna, Policlinico S.Orsola-Malpighi",aou_di_bologna_policlinico_s_orsola_malpighi,,,,,, -1908,,ee502fc0-fe87-4b55-8e63-0b9ea88880a8,Thrombotech Ltd,thrombotech_ltd,,,,,, -777,0.97387266159057617,c45a1a04-da40-42ec-92c8-78c633bc032a,MEDA,meda,,,,51713059-523f-4247-b288-a682d6d8e72b,meda_ab,MEDA AB -1909,,fb30bd82-96d8-11e6-becf-0242ac110008,ARALEZ PHARMS,aralez_pharms,,,,,, -1910,,f37ae7b6-227b-4a6a-b97f-a3164b993d8a,Orfagen,orfagen,,,,,, -1911,,7df88942-4e70-47bc-b8c1-cdd08636fd14,"Infinity Pharmaceuticals, Inc",infinity_pharmaceuticals_inc,,,,,, -1912,,adec9e83-b4b4-4ae3-8eb4-5d52fb8cd372,Laboratorios Inibsa S.A,laboratorios_inibsa_s_a,,,,,, -1913,,9a7b9c89-5f33-4863-a657-93d264aabe62,"GlaxoSmithKline, S.A",glaxosmithkline_s_a,,,,,, -1914,,4a755366-9790-4edd-9c31-9a352079b987,Olympus Biotech Europe SAS,olympus_biotech_europe_sas,,,,,, -1915,,2dcec354-bb69-4b28-94b1-9967178b790f,VIATRIS GmbH & Co. KG,viatris_gmbh_co_kg,,,,,, -1916,,94c1163b-d748-4754-a1c3-5e3e4a844f60,José Miguel Cisneros Herreros,jos_miguel_cisneros_herreros,,,,,, -1917,,dc6fd2c4-8ef0-4c7f-a74e-6754d7b6a09f,Lexicon Pharmaceuticals Incorporated,lexicon_pharmaceuticals_incorporated,,,,,, -988,0.960341,a43af95c-8bc5-11e6-a449-0242ac12000b,"Department of Cardio-Thoracic and Vascular Surgery, Aarhus University Hospital",department_of_cardio_thoracic_and_vascular_surgery_aarhus_university_hospital,,,,2cbebc88-9b76-4642-b406-d5374c2aabfa,department_of_cardiothoracic_and_vascular_surgery,Department of Cardiothoracic and Vascular Surgery -1041,0.97318911552429199,64e4c2d9-005c-4577-8791-92439d12eda2,Celgene Corporation,celgene_corporation,,,,64e4c2d9-005c-4577-8791-92439d12eda2,celgene_corporation,Celgene Corporation -1918,,11bd403b-5873-4ed2-acac-f32ad9acadf8,"Rigshospitalet, Onkologisk Klinik",rigshospitalet_onkologisk_klinik,,,,,, -1919,,7007cbac-648f-4051-a251-e13b3e4ee9bb,Asklepios Fachkliniken München Gauting,asklepios_fachkliniken_m_nchen_gauting,,,,,, -1920,,f68ccefc-0477-49e6-96fe-bbcb2eb0f4ca,"Rigshospitalet, 2032",rigshospitalet_2032,,,,,, -1921,,d1e895c8-73e0-11e6-a0cd-0242ac12000b,KNIGHT THERAPS,knight_theraps,,,,,, -433,0.98984676599502563,bbb58274-b96a-4b86-89c9-899c1d1a7717,"Pfizer Inc, 235 East 42nd Street, New York, New York 10017",pfizer_inc_235_east_42nd_street_new_york_new_york_10017,,,,83f77026-9bf3-42d7-bdf1-59a5d35a6b9b,pfizer_inc_235_east_42nd_street_new_york_new_york_10017_usa,"Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA" -1922,,744bfc1c-92ff-4d05-8676-8f6f6a08dc8d,"University Hospital Schleswig-Holstein, UKSH Campus Kiel",university_hospital_schleswig_holstein_uksh_campus_kiel,,,,,, -1923,,21cdbfce-1cf5-4009-8c12-73a5f39f267b,Dr. Felipe Villacampa,dr_felipe_villacampa,,,,,, -1924,,3e84b70a-7168-11e6-a0cd-0242ac12000b,LUPIN ATLANTIS,lupin_atlantis,,,,,, -1925,,90a5c0bf-691c-4412-8f3b-e081397858df,An-Institut für Qualitätssicherung in der operativen Medizin gGmbH,an_institut_f_r_qualit_tssicherung_in_der_operativen_medizin_ggmbh,,,,,, -1926,,2fd0eb36-dc1c-4ecc-af2c-130e38f46861,AISAR ASSOCIAZIONE ITALIANA PER LO STUDIO DEGLI ANTIMICROBICI E DELLE RESISTENZE,aisar_associazione_italiana_per_lo_studio_degli_antimicrobici_e_delle_resistenze,,,,,, -1927,,425bfa44-bb31-4354-80d9-926a3bc0e072,"Med. Uni. Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie",med_uni_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,,,,,, -228,0.908956,67f8d943-3794-4830-beba-23b1e4232b8d,"St. George's, University of London",st_george_s_university_of_london,,,,67f8d943-3794-4830-beba-23b1e4232b8d,st_george_s_university_of_london,"St. George's, University of London" -1928,,6c153c37-f4f6-4ca4-a344-63fbf7ccde92,Max-Planck-Institute of Experimental Medicine,max_planck_institute_of_experimental_medicine,,,,,, -1929,,10836e5d-ffbd-4f29-8936-372197b27709,BioXell S.p.A,bioxell_s_p_a,,,,,, -1046,0.98746395111083984,d8ba59ca-6fa0-11e6-9663-0242ac12000b,Synta Pharmaceutical Corporation,synta_pharmaceutical_corporation,,,,6de197b9-6b4f-41ef-b8a0-fbee9c50e584,synta_pharmaceutical_corp,Synta Pharmaceutical Corp -1930,,ee8ed160-0651-4154-aecc-ac31d1a27088,"Medizinische Fakultät Mannheim, Ruprecht-Karls-Universität Heidelberg",medizinische_fakult_t_mannheim_ruprecht_karls_universit_t_heidelberg,,,,,, -1931,,be62cca5-051c-4cce-bfd1-c23de90375e1,Novartis Farma SpA,novartis_farma_spa,,,,,, -1932,,125a08d9-9be9-4eaf-8f23-e86959d90c9a,Lund University Hospital,lund_university_hospital,,,,,, -1933,,58e27496-72dc-11e6-a0cd-0242ac12000b,DISCOVERY LABS,discovery_labs,,,,,, -4,0.980166,9cfc2818-f38d-4019-a76a-f0b7b7a2fd91,University of Dundee (Research & Innovation),university_of_dundee_research_innovation,,,,32b2141c-7602-42db-a25b-43a2694f5d75,university_of_dundee,University of Dundee -1934,,f10ce5b4-a290-4403-ad1c-2aa1ec9bfdb1,Institut de Cancérologie de l'Ouest,institut_de_canc_rologie_de_l_ouest,,,,,, -1935,,3d60d834-998c-4660-ad6f-2c0bdec9d285,Catholic University Leuven,catholic_university_leuven,,,,,, -1936,,9efff0b1-e76f-415b-a2b8-67d8ba11e965,Pfizer Worldwide Research and Development,pfizer_worldwide_research_and_development,,,,,, -1937,,c6c9c1b5-4620-407f-86e8-7dff8c0a257b,"Technical University Dresden, Department of Dermatology",technical_university_dresden_department_of_dermatology,,,,,, -520,0.97626614570617676,fe98ef06-797b-44b9-9bcd-e65c4505295f,ROCHE SPA,roche_spa,,,,da2c7cf7-0913-42b9-90fb-cdba8baae892,roche,ROCHE -938,0.977852,4e50d7b3-8213-4621-928b-ca4731a41e10,FUNDACIÓN ESPAÑOLA DE REUMATOLOGIA,fundaci_n_espa_ola_de_reumatologia,,,,41fdac3b-97bb-4404-84a8-1a8ece5e5818,fundaci_n_espa_ola_de_reumatolog_a_fer,FUNDACIÓN ESPAÑOLA DE REUMATOLOGÍA (FER) -1938,,b07c5cdb-2480-4498-b9d6-37480a85330f,Centus Biotherapeutics Limited,centus_biotherapeutics_limited,,,,,, -1939,,9e2e0e17-79fc-4606-8473-65d37fb49240,Dr.ssa Marina Aiello-Universit� degli studi di Parma,dr_ssa_marina_aiello_universit_degli_studi_di_parma,,,,,, -646,0.96602542698383331,56a22be9-52b5-48ab-b2d7-2ba199f18928,Boehringer Ingelheim Ellas S.A,boehringer_ingelheim_ellas_s_a,,,,237ec247-b474-4bd6-9041-c2ffb0213c0e,boehringer_ingelheim_ellas,Boehringer Ingelheim Ellas -1940,,55d06447-7653-44f0-8c39-f2240e489d80,HERMAL Kurt Herrmann GmbH & Co OHG,hermal_kurt_herrmann_gmbh_co_ohg,,,,,, -1941,,7ceac940-5715-446b-8259-a5cae4bf56bd,Novo Nordisk Farma Oy,novo_nordisk_farma_oy,,,,,, -1942,,e53b24b8-db89-4abc-b485-78a3ab37f678,Janssen Cilag Limited,janssen_cilag_limited,,,,,, -681,0.98222681879997253,8256073c-6fbe-11e6-abe8-0242ac12000b,"Aarhus University Hospital, Department M",aarhus_university_hospital_department_m,,,,e9e3f1a5-d19d-4eea-b83e-62046558fbb3,aarhus_university_hospital,Aarhus University Hospital -1943,,54ed7fd2-71bf-4a1d-859f-9ae065bcc8ef,MOLOGEN AG,mologen_ag,,,,,, -1944,,5723e517-88a9-40d4-9dbe-0bd1df935cfe,Boehringer Ingelheim RCV GmbH and Co KG,boehringer_ingelheim_rcv_gmbh_and_co_kg,,,,,, -116,0.98872168858846032,63ca73d2-fd68-4693-872c-2121b000d68c,Shire Pharmaceutical Development,shire_pharmaceutical_development,,,,63ca73d2-fd68-4693-872c-2121b000d68c,shire_pharmaceutical_development,Shire Pharmaceutical Development -1945,,0edbcc88-c701-42dc-929e-b21d1b58f67a,Asociación de Investigación Hepatológica y Transplante Hepático Infantil,asociaci_n_de_investigaci_n_hepatol_gica_y_transplante_hep_tico_infantil,,,,,, -1946,,80565886-6fc0-11e6-abe8-0242ac12000b,Sophiahemmet,sophiahemmet,,,,,, -1947,,3cc0b9a1-b883-4616-b5ef-56938f7c5a51,Sheffield Children's NHS Foundation Trust,sheffield_children_s_nhs_foundation_trust,,,,,, -1948,,67b07524-715e-11e6-a0cd-0242ac12000b,MK LABS,mk_labs,,,,,, -1949,,d0ccbfb2-7146-11e6-a0cd-0242ac12000b,AMEDRA PHARMS LLC,amedra_pharms_llc,,,,,, -262,0.9615,c9af08d3-4d1a-4228-918e-15dd207e2f26,"SCHWARZ BIOSCIENCES, INC A member of the UCB Group of Companies",schwarz_biosciences_inc_a_member_of_the_ucb_group_of_companies,,,,9d682749-f368-4251-b8c0-9399d1ecd77d,schwarz_biosciences_inc_a_member_of_ucb_group_of_companies,"SCHWARZ BIOSCIENCES, INC A member of UCB Group of Companies" -1950,,0daa6722-6df3-4b2e-ad38-a833e00c0e1b,"Marinus Pharmaceuticals, Inc",marinus_pharmaceuticals_inc,,,,,, -684,0.98852276802062988,07e5285a-7e7c-4b06-8e27-29dfa99a2153,University Medical Center Groningen (UMCG),university_medical_center_groningen_umcg,,,,07e5285a-7e7c-4b06-8e27-29dfa99a2153,university_medical_center_groningen_umcg,University Medical Center Groningen (UMCG) -1951,,69bc3a21-c486-47b1-8a47-088e78964c8e,DuPont Nutrition and Health Active Nutrition,dupont_nutrition_and_health_active_nutrition,,,,,, -1952,,1d889ba9-5692-4e42-bc60-0964592b469c,Geistlich Pharma AG,geistlich_pharma_ag,,,,,, -1953,,0ad6484f-fde5-44ca-89de-44224fced468,CONSORCIO DE APOYO A LA INVESTIGACION BIOMEDICA EN RED (CAIBER),consorcio_de_apoyo_a_la_investigacion_biomedica_en_red_caiber,,,,,, -1954,,e72e68d1-6aef-44a5-86f2-bd543f0af803,Christie Hospital,christie_hospital,,,,,, -1955,,9e8cd390-e0d4-4841-831a-4fb2e048a336,OSI-prosidion Ltd,osi_prosidion_ltd,,,,,, -1956,,fae4585f-3c0c-476d-9c20-49f4bb464c6a,Stiefel Laboratories Maidenhead Ltd (commonly known as Stiefel Laboratories International Division),stiefel_laboratories_maidenhead_ltd_commonly_known_as_stiefel_laboratories_international_division,,,,,, -1957,,f314b8aa-ea93-4949-b306-7bb2d7a4ea6a,Schering AG,schering_ag,,,,,, -1958,,b57df435-22d9-42ef-9c38-b59e5dd520ca,The Central Remedial Clinic and The Children's University Hospital,the_central_remedial_clinic_and_the_children_s_university_hospital,,,,,, -156,0.9854559600353241,2fb9a49d-c309-4c13-bb15-835da6973955,"Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin",medizinische_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin,,,,93c5f8d2-c2d8-4c9b-abde-962e31e9c1a5,medizinische_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,"Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie" -1959,,83aa6b17-1756-46f1-9bc5-45e407811b41,Sociedad Española de Cirugía Pediátrica,sociedad_espa_ola_de_cirug_a_pedi_trica,,,,,, -1960,,7396d607-3567-4810-80ba-8ea58d5650d5,elbion AG,elbion_ag,,,,,, -1961,,ec1468d5-219b-4bbe-8600-ebfad8f1b066,ReceptoPharm Inc,receptopharm_inc,,,,,, -1962,,28a0f9d0-7145-11e6-a0cd-0242ac12000b,APOTEX CORP,apotex_corp,,,,,, -1963,,23c2555d-9622-4bed-ae5c-2f204388ea56,Spinal Cord Injury Centre of Western Denmark,spinal_cord_injury_centre_of_western_denmark,,,,,, -1964,,88a3e6fd-7ba3-47b1-9eb0-a434f2421c9d,Pantarhei Bioscience B.V,pantarhei_bioscience_b_v,,,,,, -1965,,b7dffe0e-0362-4d41-858b-0a94f2d0dab3,Greater Glasgow Health Board (North Glasgow University Hospitals Division),greater_glasgow_health_board_north_glasgow_university_hospitals_division,,,,,, -1966,,a6544968-ea5e-46a4-af6a-88b32be8c722,"ImmunoGen, Inc",immunogen_inc,,,,,, -1004,0.975197,7c89af62-71b6-11e6-a0cd-0242ac12000b,SOMERSET,somerset,,,,5dffa2d8-7164-11e6-a0cd-0242ac12000b,somerset_theraps_llc,SOMERSET THERAPS LLC -572,0.97600215673446655,e3bdd826-4b43-4d33-8f70-20154485e250,"Human Genome Sciences, Inc",human_genome_sciences_inc,,,,e3bdd826-4b43-4d33-8f70-20154485e250,human_genome_sciences_inc_a_wholy_owned_subsidiary_of_glaxosmithkline_plc,"Human Genome Sciences, Inc. (a wholy owned subsidiary of GlaxoSmithKline PLC)" -1967,,8739f99e-fa04-4a92-9b99-da076933b4ee,Javier Pascual Ramírez,javier_pascual_ram_rez,,,,,, -1968,,e4d968ac-e48b-461b-a99c-82c47c4851fe,"University Hospital Lund, Thoracic Oncology Unit, Dept of Respiratory Medicine",university_hospital_lund_thoracic_oncology_unit_dept_of_respiratory_medicine,,,,,, -1969,,2f60d09e-3050-4eca-868e-7503833a0f5f,"Herlev Hospital, Onkologisk Afd. R",herlev_hospital_onkologisk_afd_r,,,,,, -676,0.987472,683d790a-7146-11e6-a0cd-0242ac12000b,BECTON DICKINSON,becton_dickinson,,,,683d790a-7146-11e6-a0cd-0242ac12000b,becton_dickinson,BECTON DICKINSON -1970,,aaae6f52-741a-4d82-8ac9-efd5eb95661a,BIOTRONIK France,biotronik_france,,,,,, -411,0.965652,2684f500-be7b-4cc1-b06c-5ea5752af978,Region Skåne,region_sk_ne,,,,2684f500-be7b-4cc1-b06c-5ea5752af978,region_sk_ne,Region Skåne -1971,,e166a2c0-9c7f-4663-9452-09e40f9a806f,Instituto de Investigaciones del Sueño,instituto_de_investigaciones_del_sue_o,,,,,, -709,0.9641061623891195,4fa44469-c2ba-4abb-a4ab-cecbbeb9cad2,Reckitt Benckiser Healthcare (UK) Limited,reckitt_benckiser_healthcare_uk_limited,,,,62dccd7b-325f-4731-b158-229a0c9ea429,reckitt_benckiser_healthcare_uk_ltd,Reckitt Benckiser Healthcare (UK) Ltd -1972,,a65f5e8c-71fb-11e6-a0cd-0242ac12000b,LUKARE MEDICAL LLC,lukare_medical_llc,,,,,, -119,0.98682153224945068,767dc014-93a9-40fb-90be-df7dd774d593,Rheinische Friedrich-Wilhelms-University of Bonn,rheinische_friedrich_wilhelms_university_of_bonn,,,,2d92428c-71e3-498b-80e5-8358645cf21c,rheinische_friedrich_wilhelms_university_of_bonn_university_hospital,"Rheinische Friedrich-Wilhelms-University of Bonn, University Hospital" -1973,,628c1f69-e951-4be6-b931-2a796ba4f658,Health Ministry,health_ministry,,,,,, -352,0.98674958944320679,3c65321f-86b5-4caf-b891-98518f69b348,Deutsches Herzzentrum,deutsches_herzzentrum,,,,3c65321f-86b5-4caf-b891-98518f69b348,deutsches_herzzentrum,Deutsches Herzzentrum -75,0.984093,e1bb69a2-a85c-4beb-a383-f554c4c5fdcf,GALENpharma,galenpharma,,,,d1b481d9-2e7a-4149-86cf-32b5b57a8168,galenpharma_gmbh,GALENpharma GmbH -1974,,0dc7b60b-d774-4787-958c-6a9ec6b3aab8,Trimel Biopharma SRL,trimel_biopharma_srl,,,,,, -586,0.912289,cac457a1-2330-4708-971c-e042de05e51c,Fundació de Lluita contra la Sida,fundaci_de_lluita_contra_la_sida,,,,2d4e8bd8-17d2-4b35-a93e-d9f401ce497b,fundaci_lluita_contra_la_sida,Fundació Lluita contra la Sida -967,0.97196,996732ad-052b-4476-9f85-11c636f30f69,Skånes universitetssjukhus,sk_nes_universitetssjukhus,,,,55950bfd-6b69-499d-a3b6-2dd8b514c97d,sk_nes_universitetssjukhus_lund,Skånes Universitetssjukhus Lund -1975,,3d35f00c-5c3f-417f-9417-1e67e0a3421c,Bone Therapeutics S.A,bone_therapeutics_s_a,,,,,, -1976,,85248f47-1006-4fbe-9e69-1230c6e5a545,Skaraborg Hospital,skaraborg_hospital,,,,,, -1977,,afd4368c-fbc3-496c-af02-77fd0434fde7,"Department of Medicine I, Clinical Dep. f. Oncology, University Hospital,",department_of_medicine_i_clinical_dep_f_oncology_university_hospital,,,,,, -1978,,0cbca6c8-bfc9-472b-820a-2a9a3236b2b0,"Universitätsklinik für Innere Medizin, Klinische Abteilung für Endokrinologie und Nuklearmedizin",universit_tsklinik_f_r_innere_medizin_klinische_abteilung_f_r_endokrinologie_und_nuklearmedizin,,,,,, -1979,,1f9cf02f-b074-476a-bae0-e71e3d6bef51,Zambon SA,zambon_sa,,,,,, -1980,,84196f62-7164-11e6-a0cd-0242ac12000b,AGILA SPECLTS,agila_speclts,,,,,, -148,0.977699,c343e70c-8f15-4acd-8007-f7e64cc0f975,Nuvelo,nuvelo,,,,a3c7b078-642d-4dfa-bfc9-34dd103124ed,nuvelo_inc,"Nuvelo, Inc" -847,0.970712,5f00d410-ca22-4e53-ace6-3a13d122ff34,Janssen-Cilag Medical Affairs EMEA,janssen_cilag_medical_affairs_emea,,,,2cd6ae2e-14d4-42b4-bac7-96f94b86a23b,janssen_cilag_medical_affaires_emea,Janssen-Cilag Medical Affaires EMEA -1981,,6794697c-2209-472e-8b9a-c8ef82a38a02,"Catalyst Pharmaceutical Partners, Inc",catalyst_pharmaceutical_partners_inc,,,,,, -1982,,8ec409aa-73f2-11e6-a0cd-0242ac12000b,UNITED STATES WELDING INC,united_states_welding_inc,,,,,, -1983,,b2c6a9a3-1add-47c0-bf39-ce008b23d626,Janssen Cilag Pharma GmbH,janssen_cilag_pharma_gmbh,,,,,, -1984,,43e27a24-baa2-46fa-90cc-cffa1c27276c,Equipo de doctores: Dr. Amado Andrés y Dr. Manuel Praga,equipo_de_doctores_dr_amado_andr_s_y_dr_manuel_praga,,,,,, -1985,,e526b28a-72e3-11e6-a0cd-0242ac12000b,OTSUKA PHARM CO LTD,otsuka_pharm_co_ltd,,,,,, -1986,,41ee6189-0831-4567-8fe4-52531c7f7241,Dr. Ortega: Hospital General de Valencia,dr_ortega_hospital_general_de_valencia,,,,,, -1987,,18ceda50-4dae-4271-af71-da1834b82b95,Lumena Pharmaceuticals Inc,lumena_pharmaceuticals_inc,,,,,, -1988,,71e5412a-72e2-11e6-a0cd-0242ac12000b,MIST PHARMS LLC,mist_pharms_llc,,,,,, -765,0.98034405708312988,59b7be85-48d9-4a80-8f5f-ff23404f5da2,AbbVie,abbvie,,,,59b7be85-48d9-4a80-8f5f-ff23404f5da2,abbvie,AbbVie -1005,0.955584,d0a19ea5-f2be-4d51-860e-d7e13528d3d9,"Population Health Research Institute, McMaster University/Hamilton Health Sciences",population_health_research_institute_mcmaster_university_hamilton_health_sciences,,,,4e5f77d3-9cb8-4aca-96ce-cb524d785be9,population_health_research_institute_phri_mcmaster_university_hamilton_health_sciences,"Population Health Research Institute (PHRI), McMaster University/Hamilton Health Sciences" -1989,,53a20fb6-7145-11e6-a0cd-0242ac12000b,GLAND PHARMA LTD,gland_pharma_ltd,,,,,, -810,0.98486357927322388,f716737f-65ba-4748-b6e7-4d024cf10d3e,Biogen Idec,biogen_idec,,,,43a1c732-1624-42d6-96fa-66ffa3a8fc4e,biogen_idec_a_s,Biogen Idec A/S -1990,,3239cce7-4ab1-40ea-9f5a-0e7b75a91696,GW Research Ltd,gw_research_ltd,,,,,, -1991,,1077a33f-5b3d-4671-b7c9-b644328302f5,GW PHARMA LTD,gw_pharma_ltd,,,,,, -1992,,d26c4676-7141-11e6-a0cd-0242ac12000b,FRONTIDA BIOPHARM,frontida_biopharm,,,,,, -1993,,eed01fc2-7141-11e6-a0cd-0242ac12000b,PHARMAX,pharmax,,,,,, -1994,,652563ad-46b7-4803-8c6a-e852f1aaf757,Regulon AE,regulon_ae,,,,,, -1995,,a0302b12-67b3-417e-8d99-c6e7cb5d8d89,"OA Dr. Philipp Becker c/o Abteilung für Wirbelsäulenchirurgie, Orthopädisches Spital Speising GmbH",oa_dr_philipp_becker_c_o_abteilung_f_r_wirbels_ulenchirurgie_orthop_disches_spital_speising_gmbh,,,,,, -1996,,ccf7d0a4-73d0-4404-be80-d1a73c6495d6,Neuro-Consil GmbH,neuro_consil_gmbh,,,,,, -1997,,cb787574-8bbd-11e6-a449-0242ac12000b,"Dept. of Pharmacology, Aarhus University",dept_of_pharmacology_aarhus_university,,,,,, -1998,,f7391db4-7144-11e6-a0cd-0242ac12000b,CEPHAZONE PHARMA,cephazone_pharma,,,,,, -1999,,f521fbd1-c9b3-406d-b377-bd29ff42c246,GlaxoSmithKline S.A. España,glaxosmithkline_s_a_espa_a,,,,,, -2000,,dc9f0e65-4404-4eec-9ba7-942c41f74e2e,UK Children’s Cancer Study Group,uk_children_s_cancer_study_group,,,,,, -302,0.977381,974eb300-9713-4e49-855f-c4eefd403abb,Janssen Biologics B.V,janssen_biologics_b_v,,,,02f80d08-964f-4144-817a-07dd524f56fc,janssen_biologics_b_v_formerly_known_as_centocor_b_v,Janssen Biologics B.V. (formerly known as Centocor B.V.) -2001,,a8504196-1df7-41ed-958d-3ee21d2ef65a,"IMPAX Pharmaceuticals a Division of IMPAX Laboratories, Inc",impax_pharmaceuticals_a_division_of_impax_laboratories_inc,,,,,, -695,0.987167,dfe7b6c1-3e71-4357-9f75-c1315a5a0501,Abbott Laboratories,abbott_laboratories,,,,193a42c8-a09d-4028-9be8-16ebcda41920,abbott_laboratories_gmbh,Abbott Laboratories GmbH -2002,,2680c860-841d-442f-ac1c-9b6d8d966b89,Aventis Pasteur MSD SNC,aventis_pasteur_msd_snc,,,,,, -2003,,c6028f93-7b0f-44f3-9f43-3a76ea00a644,Institut Produits Synthèse (IPSEN) AB,institut_produits_synth_se_ipsen_ab,,,,,, -2004,,1e12b620-3abc-4b78-bbe0-a13acccf6240,IBI,ibi,,,,,, -2005,,84bca50b-3032-4611-83cb-14f89d60da2a,"Omthera Pharmaceuticals, Inc",omthera_pharmaceuticals_inc,,,,,, -2006,,84cbfa5c-118f-4b00-995e-b5a98161cf8f,"Hospital Virgen de la Salud, Toledo (Spain)",hospital_virgen_de_la_salud_toledo_spain,,,,,, -2007,,ba57541e-3ca6-420f-8802-aaf91e0d3a47,SCS Boehringer Ingelheim Ingelheim Comm.V,scs_boehringer_ingelheim_ingelheim_comm_v,,,,,, -479,0.98417377471923828,6fe604f9-fd34-437e-abeb-8db781496639,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. f. Endokrinologie und Stoffwechsel",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klin_abt_f_endokrinologie_und_stoffwechsel,,,,6550973d-6d3a-4fa8-a3d5-17c7365cb8cb,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klin_abt_f_r_endokrinologie_und_stoffwechsel,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Endokrinologie und Stoffwechsel" -2008,,337ca848-3273-4e2a-adad-fa745f3da0f0,National Medical Center (Országos Gyógyintézeti Központ),national_medical_center_orsz_gos_gy_gyint_zeti_k_zpont,,,,,, -2009,,a3ec0ec6-9b11-4191-a822-109bc4205362,Clinical Trial Center Aachen,clinical_trial_center_aachen,,,,,, -2010,,2b7f7bd5-ea06-4ac3-b5be-fc172e9720c2,Panin S.r.l,panin_s_r_l,,,,,, -2011,,085769da-eea3-4cd4-a170-366c6f536f33,LFB SA,lfb_sa,,,,,, -2012,,55dc3af9-da50-4614-bdeb-59aef351101b,University Hospital Grenoble,university_hospital_grenoble,,,,,, -2013,,ce950aff-f2c7-4755-9c0a-7d4820970062,Pertti Suominen,pertti_suominen,,,,,, -2014,,057406c9-7df8-4397-8a37-52c7c73e2524,Universitätsklinikum Ulm / University Clinical Center Ulm,universit_tsklinikum_ulm_university_clinical_center_ulm,,,,,, -2015,,23bb1ae7-4142-43be-9526-71260ab15542,"University of Oslo, Institute of General Practice and Community Medicine",university_of_oslo_institute_of_general_practice_and_community_medicine,,,,,, -2016,,10058590-49b3-476e-ad76-701508a1cf34,Heart Center Co. Tampere University Hospital,heart_center_co_tampere_university_hospital,,,,,, -2017,,0b7140de-7142-11e6-a0cd-0242ac12000b,SAGENT PHARMS,sagent_pharms,,,,,, -590,0.986737,28581ffa-a0e9-4a5d-8765-aa97b1847c37,Asociación Andaluza de Hematología y Hemoterapia,asociaci_n_andaluza_de_hematolog_a_y_hemoterapia,,,,28581ffa-a0e9-4a5d-8765-aa97b1847c37,asociaci_n_andaluza_de_hematolog_a_y_hemoterapia,Asociación Andaluza de Hematología y Hemoterapia -2018,,320879dc-8bc4-11e6-a449-0242ac12000b,Edmond Pharma,edmond_pharma,,,,,, -304,0.953319,f0f73489-144a-4a97-a09d-29fff716b352,"Medical university Graz, Department of Plastic Surgery",medical_university_graz_department_of_plastic_surgery,,,,8700379b-5f4a-4dc7-82aa-ea7910222ff1,medical_university_graz_department_for_plastic_surgery,"Medical University Graz, Department for Plastic Surgery" -336,0.98143,1fd64b02-1ed5-4f02-a826-80abb2b33e23,"Universitätsklinikum Essen, Westdeutsches Tumorzentrum",universit_tsklinikum_essen_westdeutsches_tumorzentrum,,,,1fd64b02-1ed5-4f02-a826-80abb2b33e23,universit_tsklinikum_essen_westdeutsches_tumorzentrum,"Universitätsklinikum Essen, Westdeutsches Tumorzentrum" -242,0.985891,a3937fbe-7163-11e6-a0cd-0242ac12000b,CYPRESS PHARM INC,cypress_pharm_inc,,,,a3937fbe-7163-11e6-a0cd-0242ac12000b,cypress_pharm_inc,CYPRESS PHARM INC -2019,,d5c32eb2-2923-4a6d-a274-fa1a135604a3,Sanquin Blood Supply Foundation,sanquin_blood_supply_foundation,,,,,, -2020,,9408abf9-a1b4-4b08-b082-de998045b629,Dr. Luis Escribano,dr_luis_escribano,,,,,, -2021,,42c535cd-c99b-4b6c-ae90-dbea220573ce,CHU Caen,chu_caen,,,,,, -2022,,38356b55-34c8-4af0-80d8-7949da6bebab,"University Hospital Geneva, Switzerland",university_hospital_geneva_switzerland,,,,,, -2023,,3654fd2b-400d-471e-931c-6003e894b222,Thrombotargets Europe,thrombotargets_europe,,,,,, -2024,,b11952b8-72f7-11e6-a0cd-0242ac12000b,ALKERMES,alkermes,,,,,, -2025,,708d8c9c-1538-40ba-8c40-97d47507a519,"McNeil AB (Johnson & Johnson Consumer and Personal Products Worldwide, J&J CPPW)",mcneil_ab_johnson_johnson_consumer_and_personal_products_worldwide_j_j_cppw,,,,,, -2026,,bcc0a2d6-14c6-48a5-8e4b-ba5e2e01213c,Aires Pharmaceuticals Inc,aires_pharmaceuticals_inc,,,,,, -2027,,0b509829-d125-4528-bb24-3625fdf232ec,"Catalan Society of Family Medicine, represented by Dr Mariano de la Figuera Von Wichman and Gabriel",catalan_society_of_family_medicine_represented_by_dr_mariano_de_la_figuera_von_wichman_and_gabriel,,,,,, -2028,,b4299aaf-97f6-41e3-a197-852e884e1706,Prof. Dr. Peter Eickholz,prof_dr_peter_eickholz,,,,,, -585,0.909143,95fd4687-5482-4ec2-ac1e-01aa97e3591a,"MUW, Klinik für Innere Medizin I, Onkologie",muw_klinik_f_r_innere_medizin_i_onkologie,,,,73005770-61f7-451a-a1d5-6cb043330409,muw_klinik_f_r_innere_med_i_onkologie,"MUW, Klinik für Innere Med. I, Onkologie" -2029,,e441777e-998d-4ac7-9cdd-7ab506f7ed33,"Universitätsklinik für Innere Medizin III, Medizinische Universität Wien",universit_tsklinik_f_r_innere_medizin_iii_medizinische_universit_t_wien,,,,,, -2030,,cfa82bb6-a7bf-45c7-88d2-6bb1b02661d6,Radboudumc,radboudumc,,,,,, -2031,,d279bdab-f489-4486-ac7e-143bca7a82a0,"QUIMICA FARMACEUTICA BAYER, S.A",quimica_farmaceutica_bayer_s_a,,,,,, -16,0.934144,51d90f84-9fff-4086-b7af-47e96a6585d1,VERTEX PHARMACEUTICALS INCOPORATED,vertex_pharmaceuticals_incoporated,,,,349884c4-73b1-11e6-a0cd-0242ac12000b,vertex_pharms,VERTEX PHARMS -2032,,5d3f54cf-dbc6-4c60-b55a-69c77ffd815e,"ViiV Healthcare, S.L",viiv_healthcare_s_l,,,,,, -2033,,2315a5d1-30d5-4d15-94a9-94460a3eb3e4,Guy's & St Thomas's NHS Foundation Trust,guy_s_st_thomas_s_nhs_foundation_trust,,,,,, -2034,,bd37af47-0cdb-4c45-a391-02a501c112a2,MCM Klosterfrau Vertriebs GmbH,mcm_klosterfrau_vertriebs_gmbh,,,,,, -2035,,c0df8070-9b5c-4d8b-8818-358fc77f8fcb,Eduardo García Díaz,eduardo_garc_a_d_az,,,,,, -2036,,d1a1fc54-0a8a-4d83-b66b-e12242b85552,MRC Health Services Research Collaboration,mrc_health_services_research_collaboration,,,,,, -2037,,7765414e-a95c-4222-bb57-748a2c2a74ec,FUNDACIÓN PÚBLICA ANDALUZA PROGRESO Y SALUD,fundaci_n_p_blica_andaluza_progreso_y_salud,,,,,, -2038,,90682075-f156-462a-b61c-6b879b34aa05,"Hvidovre Hospital, Anæstesiologisk afdeling 532",hvidovre_hospital_an_stesiologisk_afdeling_532,,,,,, -2039,,020919a1-8973-40e5-a795-ca5b91f4093d,Tayside Medical Science Centre,tayside_medical_science_centre,,,,,, -2040,,7ddce62c-8f59-477e-af1d-c396a7e7cf1f,"TiGenix, S.A. Unipersonal",tigenix_s_a_unipersonal,,,,,, -2041,,1994eb95-766a-4c1d-b9d8-2ae645b7b780,"Charité CBF, Endokrinologie",charit_cbf_endokrinologie,,,,,, -336,0.98143,48435603-2c2a-4b5c-bb17-b3b96be841f9,Universitätsklinikum Essen,universit_tsklinikum_essen,,,,1fd64b02-1ed5-4f02-a826-80abb2b33e23,universit_tsklinikum_essen_westdeutsches_tumorzentrum,"Universitätsklinikum Essen, Westdeutsches Tumorzentrum" -2042,,31fa220c-347d-4fc6-bee2-f2185eb3c634,FERROKIN BIOSCIENCES INC,ferrokin_biosciences_inc,,,,,, -2043,,124e72e6-7160-11e6-a0cd-0242ac12000b,ANABOLIC,anabolic,,,,,, -2044,,6dea90c2-5b52-4c3a-82e6-185f8f4e3deb,Fundación ACE,fundaci_n_ace,,,,,, -2045,,d017d445-cdca-445f-bbc7-5d08a2c2f665,University of Dundee and NHS Tayside,university_of_dundee_and_nhs_tayside,,,,,, -39,0.981087,277efbbe-0659-4d05-bc5a-4b600b2919e3,Innovacell Biotechnologie AG - Life Science Center Innsbruck,innovacell_biotechnologie_ag_life_science_center_innsbruck,,,,277efbbe-0659-4d05-bc5a-4b600b2919e3,innovacell_biotechnologie_ag_life_science_center_innsbruck,Innovacell Biotechnologie AG - Life Science Center Innsbruck -2046,,ff698371-4731-433c-b119-91485a9e8d61,"Department of Anesthesiology and Intensive Care, University Hospital Muenster",department_of_anesthesiology_and_intensive_care_university_hospital_muenster,,,,,, -497,0.976266,6f4fd964-7168-11e6-a0cd-0242ac12000b,ABHAI INC,abhai_inc,,,,6f4fd964-7168-11e6-a0cd-0242ac12000b,abhai_inc,ABHAI INC -2047,,5325958a-1305-4a1d-8ad4-5e378ca954ed,Hansa Medical AB,hansa_medical_ab,,,,,, -398,0.988564,e073b711-5d38-461b-98fa-4232f3e10c6e,St. Anna Kinderkrebsforschung,st_anna_kinderkrebsforschung,,,,40763009-de94-4c2e-a686-9a5a36e5ac86,st_anna_kinderkrebsforschung_ccri,St. Anna Kinderkrebsforschung/CCRI -2048,,656dc747-865b-4012-aa29-b29da4363b9b,Vrinnevi Hospital,vrinnevi_hospital,,,,,, -2049,,cbce6418-0d78-438e-a3c4-658855f1a778,JADO Technologies GmbH,jado_technologies_gmbh,,,,,, -2050,,a8058945-0305-4e32-bc4b-4350f29a3fae,InfaCare Pharmaceutical Corporation,infacare_pharmaceutical_corporation,,,,,, -953,0.97483021020889282,7366e944-7126-11e6-8a77-0242ac12000b,MYLAN,mylan,,,,7366e944-7126-11e6-8a77-0242ac12000b,mylan,MYLAN -2051,,b42c49a7-6486-45f0-a6f7-54de39002752,Eisai Manufacturing Limited,eisai_manufacturing_limited,,,,,, -384,0.94804,d4769d8c-3e0e-4c98-9b81-51f13b95b5e1,The University of Nottingham,the_university_of_nottingham,,,,8aa216f5-6b16-4908-9de4-6ff33dd6be69,the_univeristy_of_nottingham,The Univeristy of Nottingham -2052,,cbe2b26f-9c2d-4efb-ab5f-d3032b84a9d4,Polichem SA,polichem_sa,,,,,, -2053,,95821a01-207b-4eb8-9565-c683b3e3e281,Hospital General Universitario Gregorio Marañón de Madrid,hospital_general_universitario_gregorio_mara_n_de_madrid,,,,,, -2054,,dad20bdb-270b-4a5f-a5d6-26ba33b0a63f,Universitätsklinikum Hamburg-Eppendorf,universit_tsklinikum_hamburg_eppendorf,,,,,, -2055,,78cb3373-c013-4bf9-a7c3-bf09db61254a,Mª Luz Couce,m_luz_couce,,,,,, -2056,,21ccfe4a-6bf4-4ee1-9023-32eeb74771c5,Basilea Pharmaceutica International Ltd,basilea_pharmaceutica_international_ltd,,,,,, -482,0.9060404896736145,2023e16d-080b-4eeb-8515-b467f748a454,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Nephrologie",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klinische_abteilung_f_r_nephrologie,,,,2023e16d-080b-4eeb-8515-b467f748a454,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klinische_abteilung_f_r_nephrologie,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Nephrologie" -2057,,6d8dc8b9-a735-11e6-94cb-5656d04fc2b5,Axovant Sciences Limited,axovant_sciences_limited,,,,,, -2058,,b8bbf07c-8c48-4f7e-933b-6310189fd22c,"The Pediatric Clinics, The Juliane Marie Center, The Danish National Hospital ""Rigshospitalet",the_pediatric_clinics_the_juliane_marie_center_the_danish_national_hospital_rigshospitalet,,,,,, -321,0.97670942544937134,a5224f59-d528-4599-8b9c-3b2815dbb909,All Ireland Cooperative Oncology Research Group,all_ireland_cooperative_oncology_research_group,,,,12641096-e1dd-46f5-9635-3bd405807ce5,all_ireland_cooperative_oncology_research_group,All Ireland Cooperative Oncology Research Group -2059,,9c56f2d7-a613-4cef-9684-3547817c1a6d,Phytopharm plc,phytopharm_plc,,,,,, -2060,,981b5a27-1c14-4f69-98f8-49192b4b6c8c,University of Mainz,university_of_mainz,,,,,, -2061,,c49817d2-620c-4242-bab0-14c95d6cd3a1,Medical University of Graz,medical_university_of_graz,,,,,, -2062,,8fb79d72-f583-4732-b077-89d4de96aefe,Actavis Group PTC ehf,actavis_group_ptc_ehf,,,,,, -2063,,1a9dd09a-7142-11e6-a0cd-0242ac12000b,MONARCH PHARMS,monarch_pharms,,,,,, -2064,,0186bc10-7161-11e6-a0cd-0242ac12000b,WENDT,wendt,,,,,, -881,0.98713856935501099,1c3d56fb-b1f2-4c6a-9f11-76a16c719843,PIERRE FABRE MEDICAMENT,pierre_fabre_medicament,,,,d9486864-e255-4256-b088-49f706c79293,pierre_fabre_medicament,PIERRE FABRE MEDICAMENT -2065,,3305d1cd-b69a-47d4-b047-e07da0fa8520,CNRS: VAN DER REST Michel,cnrs_van_der_rest_michel,,,,,, -2066,,9c8e3e87-fcf2-4d31-af20-50c0ddeb082f,JDRF Danielle Alberti Memorial Centre For Diabetes Complications Baker Heart Research Institute,jdrf_danielle_alberti_memorial_centre_for_diabetes_complications_baker_heart_research_institute,,,,,, -2067,,22779437-fb38-4b35-a4b6-e7baffdee94f,Chiron Behring GmbH & Co KG,chiron_behring_gmbh_co_kg,,,,,, -2068,,485f94f6-2273-4a83-9a0b-c8dd9e3c6679,"GenVec, Inc",genvec_inc,,,,,, -2069,,aff5735e-2d89-40af-8f8a-d1d6f9ead7ad,University Medical Centre Utrech,university_medical_centre_utrech,,,,,, -2070,,19f9db20-58f4-48fb-8c1f-4311fff09e5f,Birthe Pedersen,birthe_pedersen,,,,,, -2071,,407f43e6-eee8-4e81-8530-48c0a1749021,Teijo Saari,teijo_saari,,,,,, -2072,,21fe2617-59e4-4a5f-b512-30ba2aa65cf6,The George Institute for Global Health Australia,the_george_institute_for_global_health_australia,,,,,, -2073,,608fb9af-780e-46a5-9b59-f4816641a292,University of Heidelberg,university_of_heidelberg,,,,,, -2074,,19fb0068-7142-11e6-a0cd-0242ac12000b,ELORAC,elorac,,,,,, -2075,,236d144e-6fba-11e6-abe8-0242ac12000b,Neovacs S.A,neovacs_s_a,,,,,, -2076,,833d0c69-8200-4fce-8d57-06e36c4612cc,"Helsinki University Central Hospital, Skin and Allergy Hospital",helsinki_university_central_hospital_skin_and_allergy_hospital,,,,,, -2077,,1cd340ba-ae3f-4a06-9b39-b804bdd5d291,Abbvie Deutschland GmbH & Co. K.G,abbvie_deutschland_gmbh_co_k_g,,,,,, -877,0.943406,06cdfc3c-1180-4e50-a488-39de382fbc30,"Department of Dermatology D92, Bispebjerg Hospital",department_of_dermatology_d92_bispebjerg_hospital,,,,06cdfc3c-1180-4e50-a488-39de382fbc30,department_of_dermatology_d92_bispebjerg_hospital,"Department of Dermatology D92, Bispebjerg Hospital" -2078,,f88d7e6b-d5dc-46d9-9563-92408ebd7b1a,Helsingin reumakeskus,helsingin_reumakeskus,,,,,, -2079,,59b1a3a4-73d8-11e6-a0cd-0242ac12000b,NEOS THERAPS,neos_theraps,,,,,, -2080,,78b0a3fc-8765-437f-8ca3-af6c3e16a3bf,"Medical University of Graz, Department of Internal Medicine, Div. Endocrinology and Nuclear Medicine",medical_university_of_graz_department_of_internal_medicine_div_endocrinology_and_nuclear_medicine,,,,,, -2081,,52f56d5a-162b-40e3-ae03-5aea52e61203,"The Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital",the_department_of_cardiothoracic_and_vascular_surgery_aarhus_university_hospital,,,,,, -2082,,d6247337-6ad2-4ae7-be40-c521d144f629,Princess Alexandra Hospital,princess_alexandra_hospital,,,,,, -2083,,3dd88550-d36e-43eb-ac1f-77785d757c08,Slotervaart Hospital,slotervaart_hospital,,,,,, -2084,,6c87f2b4-31c1-4f24-bd66-3a862b3cd0ff,"Scleroseklinikken, Rigshospitalet",scleroseklinikken_rigshospitalet,,,,,, -2085,,230e12b4-558c-464d-a0ef-b8d76b7f1398,FUNDACIÓN GREGORIO MARAÑÓN,fundaci_n_gregorio_mara_n,,,,,, -261,0.938998,e6b8a267-0ac8-4cbd-b8ab-ac657d43c126,Servicio de Nefrologia-Hospital Universitario Vall d'Hebron,servicio_de_nefrologia_hospital_universitario_vall_d_hebron,,,,d226d28e-bcc2-49e5-b106-505094f7139d,servicio_de_neumologia_hospital_universitario_vall_d_hebron,Servicio de Neumologia. Hospital Universitario Vall d'Hebron -2086,,1d68ed36-25ae-47ab-9d1f-e0ad418a20ad,Brighton and Sussex University Hospitals NHS Trust,brighton_and_sussex_university_hospitals_nhs_trust,,,,,, -2087,,252fecd0-6fbe-11e6-abe8-0242ac12000b,UniversitätsSpital Zürich,universit_tsspital_z_rich,,,,,, -2088,,f5d76b18-6fa2-11e6-9663-0242ac12000b,Daiichi Asubio Pharmaceuticals Inc,daiichi_asubio_pharmaceuticals_inc,,,,,, -2089,,615b6d7d-9319-477f-8afd-c1f2c02cb238,Robugen GmbH,robugen_gmbh,,,,,, -2090,,d9afd4bd-f7c7-4288-9575-0d72aeaa5963,"Novartis Healthcare Pvt. Ltd., Vaccines Division",novartis_healthcare_pvt_ltd_vaccines_division,,,,,, -2091,,cfac284e-201a-4d22-80c5-8cca53027bdb,Infant Bacterial Therapeutics AB,infant_bacterial_therapeutics_ab,,,,,, -436,0.95875248312950134,5279e7a0-be2f-4951-aef4-b57bc1e52779,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017, United states",pfizer_inc_235_east_42nd_street_new_york_ny_10017_united_states,,,,25203332-c6eb-4eda-87c7-a780f5142133,pfizer_inc_235_east_42nd_street_new_york_ny10017_united_states,"Pfizer Inc., 235 East 42nd Street, New York, 10017, United States" -2092,,4831bf48-0ae1-4b9b-ab97-401c87f8b711,Laboratoires Mayoly Spindler SA,laboratoires_mayoly_spindler_sa,,,,,, -2093,,cf1cea5f-413c-40a2-be9d-75eb4e338315,ZooBiotic Limited,zoobiotic_limited,,,,,, -2094,,c66ff36f-6390-4b56-8ec3-2e0247fd4281,University of Exeter,university_of_exeter,,,,,, -2095,,bff9ce9d-a726-4391-bf1c-151c1e503c5e,JOSE MANUEL GARCIA DOMINGUEZ,jose_manuel_garcia_dominguez,,,,,, -864,0.973341,e718e1af-e57d-457c-9e97-8ef88faf2a76,"NHS Grampian, Aberdeen Royal Infirmary",nhs_grampian_aberdeen_royal_infirmary,,,,a333a82a-36dd-4629-8cf3-573aaa584a38,nhs_grampian,NHS Grampian -2096,,29b43190-7143-11e6-a0cd-0242ac12000b,LEDERLE,lederle,,,,,, -2097,,2f1a9a2c-e70d-4b3d-b578-1c836f136542,CHU de Fort-de-France,chu_de_fort_de_france,,,,,, -2098,,77efc05a-5498-438b-b258-e135cf55a017,ReNeuron Ltd,reneuron_ltd,,,,,, -2099,,dc88850b-ef07-4373-9efd-54ac50a07689,Prof. Giampiero CAMPANELLI,prof_giampiero_campanelli,,,,,, -2100,,fae59fe0-1161-4a21-b5ed-d0d5febbcc0f,PD Dr. Maria De Santis,pd_dr_maria_de_santis,,,,,, -571,0.977622,cfa63376-7140-11e6-a0cd-0242ac12000b,FOUGERA PHARMS,fougera_pharms,,,,8a1a7572-7142-11e6-a0cd-0242ac12000b,fougera,FOUGERA -2101,,87b57f12-7150-11e6-a0cd-0242ac12000b,TRACE LIFE,trace_life,,,,,, -2102,,2338ecd4-ce50-4bc5-ba5c-49357907de94,Dr. Antonio Javier Trujillo Santos,dr_antonio_javier_trujillo_santos,,,,,, -2103,,60997ba9-33ae-4017-af70-5a2ac599563f,Fundación GEL/TAMO (Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea),fundaci_n_gel_tamo_grupo_espa_ol_de_linfomas_y_trasplante_aut_logo_de_m_dula_sea,,,,,, -2104,,1484b435-1ec8-4d94-b273-c880c03aef84,Laboratoire BAILLY-CREAT,laboratoire_bailly_creat,,,,,, -905,0.98715120553970337,18d9ea5c-b3a8-49aa-a224-39aa5d2a425d,King's College London,king_s_college_london,,,,18d9ea5c-b3a8-49aa-a224-39aa5d2a425d,king_s_college_london,King's College London -2105,,81dec2f7-f060-4107-845b-492cdd310239,UZBrussel Department of Anesthesiology and Perioperative Medicine, Acute and Chronic Pain Therapy,,,,,, -2106,,2673e6bd-5f04-41ef-b346-197a6ad5f2c2,Laboratoire HRA Pharma,laboratoire_hra_pharma,,,,,, -2107,,91e5f262-25f4-416c-ae86-7744e58723d6,TRASTEC,trastec,,,,,, -2108,,f276eb8e-2628-4655-bb2a-80b8f529206b,Poissy Hospital,poissy_hospital,uzbrussel_department_of_anesthesiology_and_perioperative_medicine_acute_and_chronic_pain_therapy,,,,, -2109,,83e346d5-b775-47ec-b8db-8c2ee78ea192,"NOVAG S.A., FERRER GRUPO",novag_s_a_ferrer_grupo,,,,,, -2110,,d3a40b34-1d85-4d0a-b8c4-7a5397513e97,Fundación SEIMC-GESIDA,fundaci_n_seimc_gesida,,,,,, -147,0.989212,d1b2f592-a4c6-4429-904f-202000c36a22,Sociedad Andaluza de Trasplante de Órganos y Tejidos,sociedad_andaluza_de_trasplante_de_rganos_y_tejidos,,,,552c8b5e-6e4d-462c-97e1-a56f192796b2,sociedad_andaluza_de_trasplante_de_rganos_y_tejidos_satot,Sociedad Andaluza de Trasplante de Órganos y Tejidos (SATOT) -2111,,8da3b094-7167-11e6-a0cd-0242ac12000b,IBA MOLECULAR N AM,iba_molecular_n_am,,,,,, -2112,,5f5bcf5a-ea89-4d77-ab09-6d1993494765,University Hospital Ostrava,university_hospital_ostrava,,,,,, -2113,,c944a8de-c381-41f0-9752-5a2d3c343612,"Department of Psychiatry, Ludwig-Maximilians-University Munich",department_of_psychiatry_ludwig_maximilians_university_munich,,,,,, -2114,,1242ab36-1c75-445d-87ee-977c5fba7d9e,"REPLIDYNE, INC",replidyne_inc,,,,,, -2115,,26be1bcc-8416-48d1-8e87-824ea9ccdd34,"Lexicon Pharmaceuticals, Inc",lexicon_pharmaceuticals_inc,,,,,, -748,0.952392,e18b3cc7-abc6-4eaf-8f2f-60b271d0cb75,North Bristol NHS Trust Research and Development Office,north_bristol_nhs_trust_research_and_development_office,,,,e18b3cc7-abc6-4eaf-8f2f-60b271d0cb75,north_bristol_nhs_trust_research_and_development_office,North Bristol NHS Trust Research and Development Office -2116,,9e5f378d-7876-4fc9-8d83-54dfa6ab7b5d,AZIENDA USL 8 AREZZO,azienda_usl_8_arezzo,,,,,, -280,0.978312,acbce76f-4566-4480-b1d9-e6b09b7c9c66,Vejle Hospital,vejle_hospital,,,,038ffc9a-cc49-4155-9812-d242dccadca0,vejle_hospital_dept_of_oncology,"Vejle Hospital, Dept. of Oncology" -2117,,d1a40e6c-7142-11e6-a0cd-0242ac12000b,ACTAVIS MID ATLANTIC,actavis_mid_atlantic,,,,,, -2118,,e53665fc-b628-4c78-a135-fabd370fe8ef,"Department of Neuroscience, NTNU",department_of_neuroscience_ntnu,,,,,, -2119,,964b3564-718a-11e6-a0cd-0242ac12000b,JANSSEN BIOTECH,janssen_biotech,,,,,, -2120,,2af2e3b5-7c80-417b-9769-27cecf532d4a,CHU Rennes,chu_rennes,,,,,, -2121,,6245ae80-4d89-4bc3-9452-7bddbe128931,Charité Universitaetsmedizin,charit_universitaetsmedizin,,,,,, -2122,,69fd2257-0edd-41e9-87ce-db4a5c3e5144,University of Hertfordshire,university_of_hertfordshire,,,,,, -2123,,15d0febc-7146-11e6-a0cd-0242ac12000b,SOAPCO,soapco,,,,,, -2124,,649fce6c-508f-43bd-934c-eaf1be18b025,"University of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy",university_of_debrecen_medical_and_health_science_center_department_of_anaesthesiology_and_intensive_therapy,,,,,, -2125,,871917c4-bb39-4e79-aff8-5d359ee839aa,MARIA TERESA PARRAS MALDONADO,maria_teresa_parras_maldonado,,,,,, -2126,,bd0fadf1-f344-4524-ab73-ca7e11604659,Hospital General de Ciudad Real,hospital_general_de_ciudad_real,,,,,, -388,0.969459,8b0575a1-8376-4915-a366-981ce5a80282,"Uppsala University Hospital, Dept of Medical Scienses",uppsala_university_hospital_dept_of_medical_scienses,,,,8b0575a1-8376-4915-a366-981ce5a80282,uppsala_university_hospital_dept_of_medical_scienses,"Uppsala University Hospital, Dept of Medical Scienses" -2127,,2c4c9532-ebd2-41b0-994a-1344b2fd65f7,FUNDACIÓN PARA LA FORMACIÓN E INVESTIGACIÓN SANITARIAS DE LA REGIÓN DE MURCIA,fundaci_n_para_la_formaci_n_e_investigaci_n_sanitarias_de_la_regi_n_de_murcia,,,,,, -305,0.974081,5bc4c1d9-6cde-4851-827c-0b196ea4da36,Erasmus MC - Sophia Children's Hospital,erasmus_mc_sophia_children_s_hospital,,,,1d4eea22-5d60-4df5-ad75-599835189ec4,erasmusmc_sophia_children_s_hospital,ErasmusMC - Sophia Children's Hospital -2128,,bfef700e-29b7-420d-84d0-ff462bafa759,INDUSTRIA FARMACEUTICA SERONO,industria_farmaceutica_serono,,,,,, -964,0.94218007723490393,13d0aa47-c66c-42d9-a5e4-2336faccc2e1,Helsinki Uniersity Central Hospital,helsinki_uniersity_central_hospital,,,,16556fb5-6653-4d5b-bd94-fc6343fa4fd8,helsinki_university_central_hospital,Helsinki University Central Hospital -2129,,2e3cf633-e757-455f-a606-af2225efab0a,Northumbria Healthcare NHS Foundation Trust,northumbria_healthcare_nhs_foundation_trust,,,,,, -992,0.97264575958251953,85bd52ce-4912-412b-98e5-33039d390569,Medizinische Universität Innsbruck / Univ.-Klinik für Allg. und Chirurg. Intensivmedizin,medizinische_universit_t_innsbruck_univ_klinik_f_r_allg_und_chirurg_intensivmedizin,,,,85bd52ce-4912-412b-98e5-33039d390569,medizinische_universit_t_innsbruck_univ_klinik_f_r_allg_u_chirurg_intensivmedizin,Medizinische Universität Innsbruck / Univ.-Klinik für Allg. u. Chirurg. Intensivmedizin -665,0.98648929595947266,f6d48103-0f0c-4464-8cd2-7589fc1def08,"Charité-Universitätsmedizin Berlin, Germany",charit_universit_tsmedizin_berlin_germany,,,,f6d48103-0f0c-4464-8cd2-7589fc1def08,charit_universit_tsmedizin,Charité-Universitätsmedizin Berlin -2130,,c042069e-7373-4465-8085-e3eb24461c90,"Takeda Development Centre Europe, Ltd",takeda_development_centre_europe_ltd,,,,,, -2131,,13af24c5-ea11-4333-a6b1-f771aa334ff3,Chugai Pharmaceutical Co. Ltd,chugai_pharmaceutical_co_ltd,,,,,, -2132,,54e13cb9-b49e-48a8-b214-7d357dd5cd12,Centre hospitalier universitaire d'Amiens,centre_hospitalier_universitaire_d_amiens,,,,,, -813,0.94623455405235291,45261051-f8a9-4d4c-a48e-fb89c9492d92,ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS,istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori_irst_s_r_l_irccs,,,,d8bfcede-efc3-4714-b642-f79fb12833f5,istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori,ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI -2133,,de740ddc-442d-45d9-958e-3daac063ff56,Takeda Pharma A/S,takeda_pharma_a_s,,,,,, -2134,,827411e6-05aa-46ab-ad11-ff1a58d190ff,AOP ORPHAN PHARMACEUTICALS,aop_orphan_pharmaceuticals,,,,,, -2135,,f9d27789-0ec3-444c-ba71-d19a98d31c84,Dr. J.A. Barberà. Servicio de Neumología. Hospital Clínic de Barcelona,dr_j_a_barber_servicio_de_neumolog_a_hospital_cl_nic_de_barcelona,,,,,, -2136,,6c9eb135-e639-4e17-958d-b6e670a783a5,GlaxoSmithKline Centre of Excellence,glaxosmithkline_centre_of_excellence,,,,,, -2137,,37de4dbf-48d1-4c8d-9b5a-0514d1a2c8c9,NPS PHARMACEUTICALS,nps_pharmaceuticals,,,,,, -2138,,35928660-8648-463d-9110-15df4545d158,GBG Forchungs GmBH,gbg_forchungs_gmbh,,,,,, -2139,,58004e38-0908-454f-a112-b9c397610d63,Institut für Frauengesundheit GmbH,institut_f_r_frauengesundheit_gmbh,,,,,, -2140,,7ce18070-9c5b-4724-baef-1d8b11444d11,Boehringer Ingelheim Pharmaceuticals (Pty) Ltd,boehringer_ingelheim_pharmaceuticals_pty_ltd,,,,,, -2141,,bcb2c601-7dba-46c3-a25d-a7438b30948c,"SALK - Gemeinnützige Salzburger Landeskliniken Betriebsges. m.b.H., Christian-Doppler-Klinik, UK für Neurologie der PMU",salk_gemeinn_tzige_salzburger_landeskliniken_betriebsges_m_b_h_christian_doppler_klinik_uk_f_r_neurologie_der_pmu,,,,,, -826,0.9834962785243988,ff19d072-54b8-4632-a1ae-bbc176010b8a,Department of Nephrology and Renal Transplantation,department_of_nephrology_and_renal_transplantation,,,,e662831f-0d28-42b9-a406-77cb46fe2d36,department_of_nephrology_and_renal_transplantation,Department of Nephrology and Renal Transplantation -2142,,f2a0eb8b-00ee-4171-9718-12df7e22f5e4,Medi-Flex,medi_flex,,,,,, -2143,,8d9e5530-98ef-4383-a46d-bd121b9d1dd7,Common Services Agency,common_services_agency,,,,,, -2144,,b633b7e9-814c-4254-be35-19abcae9a9e3,Oncology Institute of Southern Switzerland,oncology_institute_of_southern_switzerland,,,,,, -2145,,fdfc99b8-6f97-11e6-9663-0242ac12000b,"Autoimmune Technologies, LLC",autoimmune_technologies_llc,,,,,, -2146,,c8fe3779-277e-42b2-b642-49f742f7f2be,"Novelos Therapeutics, Inc",novelos_therapeutics_inc,,,,,, -2147,,dc52f3a7-6e0a-4a89-a57e-931fbbbf598c,José Manuel Porcel Pérez Hospital Arnau de Vilanova de Lleida Servicio Medicina Interna,jos_manuel_porcel_p_rez_hospital_arnau_de_vilanova_de_lleida_servicio_medicina_interna,,,,,, -2148,,48be98fa-8f26-4eb0-acea-948916f7a5cc,Duke University,duke_university,,,,,, -2149,,b8fb9790-5523-4faa-8817-65b561b4598c,Sørlandet Sykehus HF,s_rlandet_sykehus_hf,,,,,, -2150,,382eba7c-bb3d-44db-ba74-080a093bf828,"Elevation Pharmaceuticals, Inc",elevation_pharmaceuticals_inc,,,,,, -753,0.987206,665866e6-cb85-4777-9b73-c87834f2d95c,Sun Pharma Advanced Research Company Ltd. (SPARC),sun_pharma_advanced_research_company_ltd_sparc,,,,29241c8d-7ad8-4877-83dd-b4d1b01b5563,sun_pharma_advanced_research_company,Sun Pharma Advanced Research Company -2151,,fc698f2b-42e8-46bd-9b15-e90f2760c91c,The Austrian Society of Surgical Oncology (ACO-ASSO),the_austrian_society_of_surgical_oncology_aco_asso,,,,,, -2152,,214e5c86-fbe4-4a2d-810e-ba2f1c9b3ef1,The Nordic CML Study Group,the_nordic_cml_study_group,,,,,, -2153,,87dc63ba-431d-4ceb-9cbd-cc0221708670,Antisense Pharma GmbH,antisense_pharma_gmbh,,,,,, -2154,,35eae5fe-c310-4194-b4d3-c4b749e8a004,Aegerion Pharmaceuticals Inc,aegerion_pharmaceuticals_inc,,,,,, -2155,,b2a07469-9752-4517-9f14-ec7ec88e4d00,Katholieke Universiteit Leuven - Pharmacotechnology and Biopharmacy,katholieke_universiteit_leuven_pharmacotechnology_and_biopharmacy,,,,,, -2156,,ccbfaa50-9c5b-4e56-aa07-97fa87cebef4,St. Elisabeth Ziekenhuis,st_elisabeth_ziekenhuis,,,,,, -646,0.96602542698383331,9911d666-737a-45f5-9c81-144d773d7ea2,Boehringer Ingelheim Ellas A.E,boehringer_ingelheim_ellas_a_e,,,,237ec247-b474-4bd6-9041-c2ffb0213c0e,boehringer_ingelheim_ellas,Boehringer Ingelheim Ellas -2157,,50ae8a9d-17cb-432b-8df6-ae512497054a,"The Cardiovascular MR Group, Dept. 2011, Rigshospitalet",the_cardiovascular_mr_group_dept_2011_rigshospitalet,,,,,, -966,0.963804,77f76197-601c-4f7d-a484-16ca18daeb6c,Isala,isala,,,,77f76197-601c-4f7d-a484-16ca18daeb6c,isala,Isala -2158,,109ce233-d0ba-4a2a-941f-7b6ce95e9b67,SAKK - GRUPPO SVIZZERO DI RICERCA CLINICA SUL CANCRO,sakk_gruppo_svizzero_di_ricerca_clinica_sul_cancro,,,,,, -2159,,8f97f4a9-acf0-4e66-9e95-6d96c4236c7f,"Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin",allergie_centrum_charit_charit_universit_tsmedizin_berlin,,,,,, -2160,,925a0b6f-8808-41de-a8fe-ba66fe766f1f,Activaero GmbH,activaero_gmbh,,,,,, -2161,,b356e087-d991-4284-86ea-5a9934ea422a,Servicio de Anestesia Infantil. Hospital Universitario La Paz,servicio_de_anestesia_infantil_hospital_universitario_la_paz,,,,,, -2162,,6d4c6a3a-73c8-11e6-a0cd-0242ac12000b,PARAGON BIOTECK,paragon_bioteck,,,,,, -2163,,b351474c-387b-4c87-b88b-723a995d302d,TÜ Kardioloogiakliinik,t_kardioloogiakliinik,,,,,, -806,0.9831,8c3e61bc-f8b8-4391-8314-26161be485ab,The Royal Liverpool and Broadgreen University Hospitals NHS Trust,the_royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,,,,8c3e61bc-f8b8-4391-8314-26161be485ab,the_royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,The Royal Liverpool and Broadgreen University Hospitals NHS Trust -1051,0.981904,4bcc1755-5dc6-434d-aed0-d5fa3a830bf2,Bioenvision Limited,bioenvision_limited,,,,4bcc1755-5dc6-434d-aed0-d5fa3a830bf2,bioenvision_limited,Bioenvision Limited -2164,,7ad4887a-3617-4bce-b02b-0f3fbc221154,ProstaLundOperations AB,prostalundoperations_ab,,,,,, -2165,,19756812-6953-4790-afc4-16c005d6e5bf,Novartis Pharma Belgium,novartis_pharma_belgium,,,,,, -2166,,daa67e84-7159-11e6-a0cd-0242ac12000b,IVAX PHARMS,ivax_pharms,,,,,, -2167,,3ac25975-df07-469f-8709-c2746d249da7,University Hospital Antwerp,university_hospital_antwerp,,,,,, -2168,,927fe419-74ea-41f1-8959-4cf0bd2632da,"Medizinische Universität Wien, Klinik für Innere Medizin III, Klin. Abteilung für Nephrologie und Dialyse",medizinische_universit_t_wien_klinik_f_r_innere_medizin_iii_klin_abteilung_f_r_nephrologie_und_dialyse,,,,,, -176,0.96485203504562378,bfd7331d-6d18-4faa-8fd6-fe957061def6,Novartis Vaccines and Diagnostics Srl,novartis_vaccines_and_diagnostics_srl,,,,fbdb10c1-6146-4761-86bf-a8541dc3b4fa,novartis_vaccines_and_diagnostics,Novartis Vaccines and Diagnostics -2169,,00adeeda-de6e-4a6d-b301-74009057b83d,JOAQUIN PORTILLA,joaquin_portilla,,,,,, -2170,,057c238f-12c1-441f-ae09-021ba6782283,Christoffer Hedetoft,christoffer_hedetoft,,,,,, -5,0.90053069591522217,d883794e-fe54-4fc1-bf84-4e58dd7b2648,Centre Hospitalier Universitaire de La Réunion,centre_hospitalier_universitaire_de_la_r_union,,,,dd5747ea-816f-45f7-b207-0763f720a969,centre_hospitalier_universitaire_de_li_ge,Centre Hospitalier Universitaire de Liège -2171,,11277c1c-898e-4e13-8fe6-347fe1f28c4b,"EnVivo Pharmaceuticals, Inc",envivo_pharmaceuticals_inc,,,,,, -2172,,cb253c7a-6fba-11e6-abe8-0242ac12000b,Napp Pharmaceuticals Limited,napp_pharmaceuticals_limited,,,,,, -2173,,8d00d89e-586d-4d10-ac69-d403474e3813,"Watson Laboratories, Inc. - A subsidiary of Actavis, Inc",watson_laboratories_inc_a_subsidiary_of_actavis_inc,,,,,, -2174,,e954c38a-556f-4e14-b048-5f2586ca6ef0,PROF. TIZIANO GHERLI,prof_tiziano_gherli,,,,,, -621,0.956445,9655af03-762e-4bf2-ab8b-bd82fb1ed0a5,"Universitätsklinik für Innere Medizin IV, Klinische Abteilung Gastroenterologie und Hepatologie",universit_tsklinik_f_r_innere_medizin_iv_klinische_abteilung_gastroenterologie_und_hepatologie,,,,52d997a2-9f49-426b-bfc6-c251dadcce43,universit_tsklinik_f_r_innere_medizin_iii_klinische_abteilung_f_r_gastroenterologie_und_hepatologie,"Universitätsklinik für Innere Medizin III, Klinische Abteilung für Gastroenterologie und Hepatologie" -2175,,e684f99c-0f0f-4155-9fc1-26ab82eefd73,GeneMedix plc,genemedix_plc,,,,,, -733,0.982275,7e09558a-ee7d-474c-9101-17cf9741e4d6,Technical University Munich,technical_university_munich,,,,7e09558a-ee7d-474c-9101-17cf9741e4d6,technical_university_munich,Technical University Munich -2176,,2b0695ed-65f3-4e32-a688-ccfc49d6ed39,masimo,masimo,,,,,, -2177,,ee60a64b-ed90-4582-84b7-ea2799b249bf,ABScience,abscience,,,,,, -2178,,85292d75-9d48-444e-8d9c-7d67642159ba,"ORTHO BIOTECH, Division of JANSSEN-CILAG GmbH",ortho_biotech_division_of_janssen_cilag_gmbh,,,,,, -2179,,a04034e0-a727-11e6-94cb-5656d04fc2b5,"Herlev & Gentofte Hospital, Oncology Dept",herlev_gentofte_hospital_oncology_dept,,,,,, -2180,,f026f13f-a5ac-4bf8-be20-8909ce0470ca,"Visterra, Inc",visterra_inc,,,,,, -2181,,e3e5aae2-715e-11e6-a0cd-0242ac12000b,TABLICAPS,tablicaps,,,,,, -827,0.98834410309791565,975869a5-d12b-4f5f-9a3d-d76a15c61a6a,INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE VALENCIA,instituto_de_investigaci_n_sanitaria_la_fe_de_valencia,,,,975869a5-d12b-4f5f-9a3d-d76a15c61a6a,instituto_de_investigaci_n_sanitaria_la_fe_de,INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE -2182,,cb750f0b-0900-40eb-a2d3-3488710b76ad,"University of Trondheim, NTNU, Norway",university_of_trondheim_ntnu_norway,,,,,, -987,0.985423,66dfa91e-7193-11e6-a0cd-0242ac12000b,ASPEN GLOBAL,aspen_global,,,,497e2c7a-7165-11e6-a0cd-0242ac12000b,aspen_global_inc,ASPEN GLOBAL INC -2183,,fa3939e5-9232-4a98-abc5-742b7910fba9,United Bristol Healthcare NHS Trust,united_bristol_healthcare_nhs_trust,,,,,, -2184,,954240e4-7140-11e6-a0cd-0242ac12000b,EPIC PHARMA,epic_pharma,,,,,, -2185,,4935c0a6-8ba6-47b9-a351-01796928a100,Nutrinia Ltd,nutrinia_ltd,,,,,, -2186,,15ecdbb6-60d8-4e72-8613-1ae2204f881b,Liisa Elomaa,liisa_elomaa,,,,,, -104,0.987186,b7f24e50-8445-4a02-9bbf-c06da892f699,Merck Lipha Santé,merck_lipha_sant,,,,75e8ee69-62d3-42ee-992e-eee1cd45ffb8,merck_lipha_sant_sas,Merck Lipha Santé SAS -758,0.919169,e029c264-bd4f-4753-a984-31fcff699b06,Especialidades Farmaceúticas Centrum S.A,especialidades_farmace_ticas_centrum_s_a,,,,b7570d88-35b2-48c8-bf49-66ed83edbe35,especialidades_farmac_uticas_centrum_s_a,"Especialidades Farmacéuticas Centrum, S.A" -2187,,8db0c2ca-7167-11e6-a0cd-0242ac12000b,GROUPE PARIMA INC,groupe_parima_inc,,,,,, -2188,,4cb6c19d-d7ee-439c-9940-90a2aa9023e3,Institut de Recerca Hospital Sta. Creu i St. Pau,institut_de_recerca_hospital_sta_creu_i_st_pau,,,,,, -2189,,db876a6e-f5ff-4308-b0c9-465e345f6f51,County council of Ostergotland,county_council_of_ostergotland,,,,,, -1062,0.98627,68e001f6-0acf-4ba6-831c-dae305950d6b,Sint Franciscus Gasthuis,sint_franciscus_gasthuis,,,,68e001f6-0acf-4ba6-831c-dae305950d6b,sint_franciscus_gasthuis,Sint Franciscus Gasthuis -2190,,4b5089f1-894c-49fa-881b-5bdb604d0c45,Clínica Plató Fundació Privada,cl_nica_plat_fundaci_privada,,,,,, -2191,,1761ac72-7cbf-434e-a924-6ac0a11dbaba,Biomet NL,biomet_nl,,,,,, -2192,,f1ff7a6e-421a-4bd4-9299-3d66eb82649a,ITALFARMACO S.A,italfarmaco_s_a,,,,,, -525,0.98547,254a684e-a281-4ecf-989d-ea9a018d8552,University Hospital of Wuerzburg,university_hospital_of_wuerzburg,,,,254a684e-a281-4ecf-989d-ea9a018d8552,university_hospital_of_wuerzburg,University Hospital of Wuerzburg -2193,,8b2758d3-4dfa-45b1-8492-00a716b31afe,University Medical Centre Ljubljana,university_medical_centre_ljubljana,,,,,, -2194,,09858a78-729b-11e6-a0cd-0242ac12000b,EXELTIS USA INC,exeltis_usa_inc,,,,,, -2195,,dadb465a-6fa1-11e6-9663-0242ac12000b,Novartis Sweden AB,novartis_sweden_ab,,,,,, -2196,,8f9ebfec-8be8-11e6-a449-0242ac12000b,GlaxoSmithKline Research anda Development,glaxosmithkline_research_anda_development,,,,,, -2197,,4594b4d2-a124-49ba-96d2-6e15da9f27f0,"Capnia, Inc",capnia_inc,,,,,, -2198,,5fbbd71b-bd74-4bcf-a2d7-56ef620b2296,Rheumazentrum Ruhrgebiet,rheumazentrum_ruhrgebiet,,,,,, -2199,,a8eea728-cf24-49d6-bd52-5ea8f2ff20bf,"National Institute of Allergy and Infectious Diseases, National Institutes of Health",national_institute_of_allergy_and_infectious_diseases_national_institutes_of_health,,,,,, -2200,,1ee1056c-80bf-4e3e-8c90-f7ca377c5398,Alfacell Corporation,alfacell_corporation,,,,,, -2201,,c80f0c7e-715d-11e6-a0cd-0242ac12000b,HOSPIRA WORLDWIDE,hospira_worldwide,,,,,, -2202,,26a0a310-360f-4de8-98dd-9a8144e6f11a,KV Pharmaceutical Co,kv_pharmaceutical_co,,,,,, -2203,,899912bf-be0c-4787-8ede-ee02f88fda18,OSPEDALE G.PASQUINUCCI-FONDAZIONE G.MONASTERIO,ospedale_g_pasquinucci_fondazione_g_monasterio,,,,,, -2204,,4d9dee60-32b5-452c-8328-6ed126a2e7ea,IDIBAPS,idibaps,,,,,, -2205,,4bc8802c-5b07-4c6d-a4db-f2edd0f68d85,Service Desk,service_desk,,,,,, -2206,,afae719e-274c-4a4e-a7f2-e42c0bced641,GISCAD,giscad,,,,,, -2207,,ecab9994-9e4f-4439-8c65-bafbe9c73ac4,"Activus Pharma Co., Ltd",activus_pharma_co_ltd,,,,,, -2208,,474d9400-914f-44a2-9690-f78b557689cb,Jagiellonian University Medical College,jagiellonian_university_medical_college,,,,,, -2209,,a736c09b-fbd8-4a27-94ce-76402b12f39f,Department of Ophthalmology,department_of_ophthalmology,,,,,, -2210,,63f74f04-ae70-41f1-baf0-24c57f55c691,"Afdeling V, Aarhus Sygehus",afdeling_v_aarhus_sygehus,,,,,, -2211,,a6717cb0-46f0-4ef5-9778-8b8484069cff,"Medizinische Universität Wien, Abteilung für Anästhesie und Intensivmedizin",medizinische_universit_t_wien_abteilung_f_r_an_sthesie_und_intensivmedizin,,,,,, -2212,,fd921e86-279c-4e96-b83b-3324836b9d36,North Estonia Medical Centre Foundation,north_estonia_medical_centre_foundation,,,,,, -2213,,380c43b5-2c4a-4a1b-8e48-0e7040d6a17b,University Clinic of Dermatology Division of Special and Enviromental Dermatology,university_clinic_of_dermatology_division_of_special_and_enviromental_dermatology,,,,,, -724,0.981953,c0f9399c-2b0a-4f97-bddd-c3658b4892b6,University of Iceland,university_of_iceland,,,,52dd1d55-52d2-42d6-b026-3416877c1096,university_of_iceland_dept_pharmacology,"University of Iceland, Dept. Pharmacology" -2214,,e7ea91ca-6fa1-11e6-9663-0242ac12000b,IKP,ikp,,,,,, -2215,,2e4c8442-e989-4737-8e94-ebf545016560,University hospital Brussel,university_hospital_brussel,,,,,, -2216,,fcb11d96-c211-44f5-ace6-c8d672f8192f,Universitaetsklinikum Wuerzburg,universitaetsklinikum_wuerzburg,,,,,, -243,0.982397,84165c73-a712-4209-9005-cccca1ac46d9,Oxford BioMedica,oxford_biomedica,,,,84165c73-a712-4209-9005-cccca1ac46d9,oxford_biomedica,Oxford BioMedica -2217,,623390b5-5644-45fe-8f5d-9eb142632001,Cristália Produtos Químicos Farmacêuticos Ltda,crist_lia_produtos_qu_micos_farmac_uticos_ltda,,,,,, -2218,,3ca60fbd-f2cc-412a-b63f-1082f29ff6a8,INNOVACELL BIOTECNOLOGIE,innovacell_biotecnologie,,,,,, -2219,,0efe8610-715d-11e6-a0cd-0242ac12000b,NAVINTA LLC,navinta_llc,,,,,, -2220,,530ddc0c-a274-47be-bb1c-19b58b7ba7f4,Corimmun GmbH,corimmun_gmbh,,,,,, -554,0.98628848791122437,a0731512-712a-11e6-a89e-0242ac12000b,VINTAGE PHARMS LLC,vintage_pharms_llc,,,,5a0d7e38-7129-11e6-a89e-0242ac12000b,vintage_pharms,VINTAGE PHARMS -2221,,90a15d23-27ae-4e52-be99-fc5f7027b6a6,Servicio Nefrología Hospital Universitario de Bellvitge,servicio_nefrolog_a_hospital_universitario_de_bellvitge,,,,,, -2222,,5dd338aa-7129-11e6-a89e-0242ac12000b,HIKMA INTL PHARMS,hikma_intl_pharms,,,,,, -2223,,cbb845f4-7142-11e6-a0cd-0242ac12000b,HANFORD GC,hanford_gc,,,,,, -2224,,2ea111cc-840b-4585-9ae0-f08d90745c19,Statens Serum Institut,statens_serum_institut,,,,,, -570,0.967052,deea0724-71ac-11e6-a0cd-0242ac12000b,CARDINAL HEALTH 418,cardinal_health_418,,,,c7f9a7b2-715d-11e6-a0cd-0242ac12000b,cardinal_health_414,CARDINAL HEALTH 414 -2225,,aa653360-cb96-4c40-9bd3-7e573d1a3fa9,Ainara Aguirre Caballero,ainara_aguirre_caballero,,,,,, -2226,,7ae09bc5-806a-408b-a472-985481c91bd7,"Santarus, Inc",santarus_inc,,,,,, -2227,,40749946-d7d1-4793-bcd1-39d4cbf4ece4,"Dept of Rheumatology, Lund University Hospital, Lund, Sweden",dept_of_rheumatology_lund_university_hospital_lund_sweden,,,,,, -2228,,8167f1de-d4e1-43d4-99e5-15d1a11db9d2,VUMC,vumc,,,,,, -2229,,6122c576-2811-40a9-9141-ac1940821644,PurGenesis Techonologies Inc,purgenesis_techonologies_inc,,,,,, -2230,,45a64f2e-7bb2-4967-855c-0d6dfe7bb864,Prim. Univ.-Prof. Dr. Günter Janetschek c/o Universitätsklinik für Urologie und Andrologie,prim_univ_prof_dr_g_nter_janetschek_c_o_universit_tsklinik_f_r_urologie_und_andrologie,,,,,, -2231,,7440c839-89bb-49ae-8831-21d28d8fbae2,Fundación Castellano-Leonesa de Cardiología (FUCALEC),fundaci_n_castellano_leonesa_de_cardiolog_a_fucalec,,,,,, -2232,,ad7fe08e-7141-11e6-a0cd-0242ac12000b,PERRIGO NEW YORK,perrigo_new_york,,,,,, -2233,,9982c037-dd15-4a28-ac2b-bbb8290e7746,Interuniversity Cardiology Institute Netherlands,interuniversity_cardiology_institute_netherlands,,,,,, -2234,,58f89827-ef02-4bad-8f19-655d8c0ed16f,Lluís Cabero Roura,llu_s_cabero_roura,,,,,, -2235,,6c3b8362-4519-4a00-bf8e-e3791c243319,Clinical Research Center for Hair and Skin Science,clinical_research_center_for_hair_and_skin_science,,,,,, -2236,,50c27c8a-72c7-11e6-a0cd-0242ac12000b,HEYL CHEMISCH,heyl_chemisch,,,,,, -2237,,602f5b92-54b4-4f72-a608-a83e3fad6b6d,"University Hospital Basel, Dept. of Angiology",university_hospital_basel_dept_of_angiology,,,,,, -610,0.98603665828704834,939de536-b8b8-4a22-98b4-c84303a056ca,Fédération Nationale des Centres de Lutte Contre le Cancer,f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer,,,,4b5b75aa-a963-452e-848e-256ac41c5d72,f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer,Fédération Nationale des Centres de Lutte Contre le Cancer -2238,,cdafd400-a784-11e6-94cb-5656d04fc2b5,"AVIZOREX PHARMA, S.L",avizorex_pharma_s_l,,,,,, -2239,,76bd52f2-72ef-11e6-a0cd-0242ac12000b,HALOZYME THERAP,halozyme_therap,,,,,, -2240,,749b7ac3-f1a3-4c40-978a-a3ff80b54967,Sanol GmbH,sanol_gmbh,,,,,, -918,0.94804,7e1a91a4-5515-4186-84f8-e0dba33780e4,AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE),azienda_ospedaliera_l_sacco_a_o_di_rilievo_nazionale,,,,7e1a91a4-5515-4186-84f8-e0dba33780e4,azienda_ospedaliera_l_sacco_a_o_di_rilievo_nazionale,AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) -1065,0.91470474004745483,5f66ac18-d357-4f69-abc8-effab180e9c2,Cambridge University Hospitals NHS Trust,cambridge_university_hospitals_nhs_trust,,,,21aba99b-7de3-432e-87cd-3af4301e3cdb,cambridge_university_hospitals_nhs_foundation_trust_jointly_with_university_of_cambridge,"Cambridge University Hospitals NHS Foundation Trust, jointly with University of Cambridge" -2241,,d7520087-4ce0-411c-98a9-59658e1ab215,RJAH Orthopaedic Hospital,rjah_orthopaedic_hospital,,,,,, -2242,,cde28245-354e-4765-b477-9cf0b021e1bf,"ProFibrix, A wholly owned subsidary of the Medicines Company",profibrix_a_wholly_owned_subsidary_of_the_medicines_company,,,,,, -2243,,8410235c-2d22-43c5-bc5a-0ae07c2c7c2a,Galapagos NV,galapagos_nv,,,,,, -581,0.94542974233627319,a55c2c48-10fa-4304-9426-defee4a9c8f4,Wyeth Pharmaceuticals Inc. Philadelphia (A Pfizer Company),wyeth_pharmaceuticals_inc_philadelphia_a_pfizer_company,,,,8ad98169-689d-44f5-943d-55c909d71e4d,wyeth_parmaceuticals_inc,Wyeth Parmaceuticals Inc -2244,,ab0a8214-4081-473c-ad2f-1d84ea420e8a,Laboratoires Thea,laboratoires_thea,,,,,, -2245,,cf869a09-cfce-4ab0-a727-7f345d8b00ed,FONDAZIONE SANDRO PITIGLIANI PER LA LOTTA CONTRO I TUMORI-ONLUS,fondazione_sandro_pitigliani_per_la_lotta_contro_i_tumori_onlus,,,,,, -2246,,09be7a33-28de-4d7b-96c5-0f23e10bf4a1,Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie,christelijke_vereniging_voor_de_verpleging_van_lijders_aan_epilepsie,,,,,, -2247,,025587da-d17d-4813-904a-849e77b5d4a4,MENARINI Benelux NV/SA,menarini_benelux_nv_sa,,,,,, -2248,,9627033f-cdc1-48e6-928a-0bcaf3890e69,Policlinico Universitario Agustino Gemelli,policlinico_universitario_agustino_gemelli,,,,,, -2249,,7757d914-9d76-4f46-a879-71c49001cd03,UNIVERSITA' DEGLI STUDI DI FERRARA,universita_degli_studi_di_ferrara,,,,,, -685,0.98814409971237183,6215f084-4978-4b33-9f3e-b048c59d9d5d,University Medical Center UMCU,university_medical_center_umcu,,,,6215f084-4978-4b33-9f3e-b048c59d9d5d,university_medical_center_umcu,University Medical Center UMCU -2250,,c3b506ac-7152-11e6-a0cd-0242ac12000b,SYNTHON PHARMS,synthon_pharms,,,,,, -2251,,4ea69b82-81b1-44bb-9553-d000ddebe390,Sint Antonius Ziekenhuis,sint_antonius_ziekenhuis,,,,,, -2252,,e1bfb19a-c1ba-44ed-bb7f-5589e60c8c33,"Göteborgs Universitet, Institutionen för Invärtesmedicin",g_teborgs_universitet_institutionen_f_r_inv_rtesmedicin,,,,,, -895,0.985938,04f887b5-910f-4837-bcdf-e290b18c94c3,FUNDACION DE INVESTIGACION EN RED EN ENFERMEDADES CARDIOVASCULARES (FIRCAVA),fundacion_de_investigacion_en_red_en_enfermedades_cardiovasculares_fircava,,,,03e90e85-40a8-444e-8bc5-373590743e16,fundacion_de_investigacion_en_red_en_enfermedades,FUNDACION DE INVESTIGACION EN RED EN ENFERMEDADES -2253,,2c03430a-718e-11e6-a0cd-0242ac12000b,ELUSYS THERAPEUTICS INC,elusys_therapeutics_inc,,,,,, -760,0.987506,e22edd85-a19f-43f8-8906-119a7c84b332,Västra Götalandregionen (VGR),v_stra_g_talandregionen_vgr,,,,db892fbd-e5f0-40a8-8d13-447693b60e04,v_stra_g_talandregionen,Västra Götalandregionen -2254,,37fa388c-b65d-4a5c-8cd4-ad3adfef0434,Medway NHS Trust,medway_nhs_trust,,,,,, -2255,,61fbbb24-c9ef-4ba8-9b73-fc9efefc2fb1,Hammersmith Hospitals NHS Trust,hammersmith_hospitals_nhs_trust,,,,,, -203,0.986562,16d65dd4-7146-11e6-a0cd-0242ac12000b,GALDERMA LABS LP,galderma_labs_lp,,,,16d65dd4-7146-11e6-a0cd-0242ac12000b,galderma_labs_lp,GALDERMA LABS LP -2256,,e36eb139-8e54-4f7b-8ca5-3c9f00962518,Pluristem Ltd,pluristem_ltd,,,,,, -2257,,55add0fa-7169-11e6-a0cd-0242ac12000b,INTERFERON SCIENCES,interferon_sciences,,,,,, -2258,,eccca97e-715b-11e6-a0cd-0242ac12000b,HARRIS PHARM,harris_pharm,,,,,, -2259,,4d362410-72b6-11e6-a0cd-0242ac12000b,AXCAN SCANDIPHARM,axcan_scandipharm,,,,,, -2260,,e02aabff-a175-4afe-ad0e-f51ef9b58d2f,"Univ.-Klinik für Augenheilkunde und Optometrie, Medizinische Universität Wien",univ_klinik_f_r_augenheilkunde_und_optometrie_medizinische_universit_t_wien,,,,,, -2261,,d00094d8-44aa-47fc-9e31-55ecb94b6141,CHU Limoges,chu_limoges,,,,,, -2262,,af7175c7-ab7c-44b1-a4f6-99f630603df2,"BIAL Portela & Companhia, S.A",bial_portela_companhia_s_a,,,,,, -2263,,4c9ed818-9095-4845-b6d2-d8c8e2ef1666,"Department of Neurology, Odense University Hospital",department_of_neurology_odense_university_hospital,,,,,, -647,0.96851974725723267,de5efac3-9523-44b0-b815-56de9863e1ba,"Boehringer Ingelheim Esapaña, S.A",boehringer_ingelheim_esapa_a_s_a,,,,7f6e75e2-17dd-48cc-93b5-ed854fcfc0e1,boehringer_ingelheim_espa_a_s_a,"Boehringer Ingelheim España, S.A" -421,0.98666298389434814,ff0c702a-29b6-4638-ac4a-a462b6024ae7,Rigshospitalet,rigshospitalet,,,,91fae256-199c-4920-9cd2-0437b5db434d,rigshospitalet,Rigshospitalet -2264,,ba88ec34-ec92-4583-ba0f-ba3ffb6b769e,The University of Birmingham,the_university_of_birmingham,,,,,, -2265,,5df82d1b-0e41-47f1-92d3-163d93d2217f,Bayer plc,bayer_plc,,,,,, -78,0.988885,d39e8360-7141-11e6-a0cd-0242ac12000b,BRECKENRIDGE PHARM,breckenridge_pharm,,,,5e1c611c-7163-11e6-a0cd-0242ac12000b,breckenridge_pharms,BRECKENRIDGE PHARMS -2266,,c0f82336-cdce-47f7-bb5b-3f09ebe1d3ad,Plymouth Hospitals NHS Trust,plymouth_hospitals_nhs_trust,,,,,, -377,0.97867879271507263,cd77b786-db5e-445f-849f-1e0166f4f885,Merck & Co,merck_co,,,,a995503b-132d-44dc-a6b0-648b85bc0828,merck_co,Merck & Co -2267,,5121d025-9eb3-4959-a089-8aacf11b9ad9,The Sahlgrenska Center for Pediatric Ophtalmology Research,the_sahlgrenska_center_for_pediatric_ophtalmology_research,,,,,, -434,0.9664912223815918,0068e377-8873-41b9-baad-e3768b77d0b1,"Pfizer Inc., 235 East 42nd Streeet, New York, NY 10017",pfizer_inc_235_east_42nd_streeet_new_york_ny_10017,,,,0068e377-8873-41b9-baad-e3768b77d0b1,pfizer_inc_235_east_42nd_street_new_york_ny_10017,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017" -2268,,ca492921-5461-44bb-aa24-b22ffeb23cc6,Meda Pharmaceuticals,meda_pharmaceuticals,,,,,, -2269,,60e9b817-724e-4174-a9a0-e1a456b273e9,CASA DI CURA PRIVATA S.RAFFAELE - PISANA,casa_di_cura_privata_s_raffaele_pisana,,,,,, -2270,,8378f648-93ea-4dae-abf9-15461937efa2,"AKH Wien, Universitätsklinik für Physikalische Medizin und Rehabilitation",akh_wien_universit_tsklinik_f_r_physikalische_medizin_und_rehabilitation,,,,,, -31,0.98087829351425171,b37c4348-71a9-11e6-a0cd-0242ac12000b,DURAMED RES,duramed_res,,,,5b1b823c-72c5-11e6-a0cd-0242ac12000b,duramed,DURAMED -2271,,7286dd01-efcb-4a7f-bf3c-15565302e683,FinnBladder,finnbladder,,,,,, -2272,,dca9eafc-7165-11e6-a0cd-0242ac12000b,ACI HEALTHCARE LTD,aci_healthcare_ltd,,,,,, -2273,,40b1b5b3-e916-4b31-8fcf-45d7f90e7e4f,Novartis Farmacéuitica S.A,novartis_farmac_uitica_s_a,,,,,, -2274,,c6f7a259-b7bc-4174-b445-f25c3b8cb31b,"Prof. Gustav Dobos, Kliniken Essen Mitte",prof_gustav_dobos_kliniken_essen_mitte,,,,,, -2275,,279ef50e-2ae8-491e-a369-9f50826e4b9d,Medizinische Universität Innsbruck - Univ.-Klinik für Anästhesie und Allgemeine Intensivmedizin,medizinische_universit_t_innsbruck_univ_klinik_f_r_an_sthesie_und_allgemeine_intensivmedizin,,,,,, -2276,,77303051-6789-4c16-862d-ead8a9ab763a,Ipsen Pharma GmbH,ipsen_pharma_gmbh,,,,,, -2277,,39b29521-a5ff-4a5c-ac2a-6a63c6d6fa06,FONDAZIONE FRANCO E PIERA CUTINO,fondazione_franco_e_piera_cutino,,,,,, -2278,,f2abbbb2-66f7-4913-9682-64ee52957f5f,South Eastern Health & Social Care Trust,south_eastern_health_social_care_trust,,,,,, -2279,,a93f7512-0650-410e-86e4-c7ee710f15da,"Wrightington, Wigan and Leigh NHS Trust",wrightington_wigan_and_leigh_nhs_trust,,,,,, -2280,,e0c85370-7198-11e6-a0cd-0242ac12000b,STANLABS PHARM,stanlabs_pharm,,,,,, -517,0.97254005074501038,3c6426fc-228f-4f52-bcda-4e8faabc90a8,GELTAMO (Grupo Español de Linfoma y Transplante Autólogo de Médula Ósea),geltamo_grupo_espa_ol_de_linfoma_y_transplante_aut_logo_de_m_dula_sea,,,,be21c811-4df1-4aa6-8fd6-8b4eb1416f21,geltamo_grupo_espa_ol_de_linfomas_y_transplante_aut_logo_de_m_dula_sea,GELTAMO (Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea) -2281,,23588938-71a0-11e6-a0cd-0242ac12000b,VALEANT BERMUDA,valeant_bermuda,,,,,, -2282,,c012b8b3-9230-47b7-9b68-c101fab2f76e,SBL Vaccin AB,sbl_vaccin_ab,,,,,, -2283,,a4c544cc-c590-4d88-a055-b3e7d32dffe8,BTI BIOTECHNOLOGY INSTITUTE IMASD,bti_biotechnology_institute_imasd,,,,,, -2284,,570f1380-7364-11e6-a0cd-0242ac12000b,LAB HRA PHARMA,lab_hra_pharma,,,,,, -2285,,482b174a-b55a-436f-b74f-a752ca84fd52,SCIOTEC DIAGNOSTIC TECHNOLOGIES GMBH,sciotec_diagnostic_technologies_gmbh,,,,,, -1028,0.91099542379379272,b27185ae-0ca5-4391-a009-a1a74ae54832,Eli Lilly & Company - Indianapolis,eli_lilly_company_indianapolis,,,,5cd4a39f-21fd-403d-abbe-561ea83b270d,eli_lilly_and_company_indianapolis,Eli Lilly and Company - Indianapolis -2286,,b940d4fa-85e5-4d35-a31d-d4937de1a388,"NTNU, Norwegian University of Science and Technology",ntnu_norwegian_university_of_science_and_technology,,,,,, -432,0.948456,a8f25ee1-e008-4b22-8471-b1f44d51a5fe,Daiichi Sankyo Development Ltd,daiichi_sankyo_development_ltd,,,,1f71611f-b1a0-468a-826f-555058e87660,daiichi_sankyo_development_limited,Daiichi Sankyo Development Limited -2287,,752a6686-779f-4fc8-bce2-8f1ef63312a9,"Merck Sharp & Dohme, Lda",merck_sharp_dohme_lda,,,,,, -850,0.919718,591012c8-60e7-45be-a309-770fa9ece008,University Hospital of Leuven,university_hospital_of_leuven,,,,25d4b3ea-5908-4ea6-af45-ca4271adfcb9,university_hospitals_of_leuven,University hospitals of Leuven -2288,,18b69059-6d82-463f-81cd-cbded3c28082,OSPEDALE ONCOLOGICO DI BARI,ospedale_oncologico_di_bari,,,,,, -2289,,3e398afa-2123-43dc-959f-d731c6d453bb,VISIOTACT PHARMA,visiotact_pharma,,,,,, -2290,,595dba80-ce38-4c8c-9226-fbbd775db77e,Pharmaxis UK Limited,pharmaxis_uk_limited,,,,,, -2291,,d3eb0135-a3c5-4691-8fa1-ee7feca33887,Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie Onlus (GIMURELL),gruppo_italiano_multiregionale_per_lo_studio_dei_linfomi_e_delle_leucemie_onlus_gimurell,,,,,, -2292,,0671c9eb-9ce2-4896-ab47-65bc202d91de,School of Human Development,school_of_human_development,,,,,, -1064,0.97092048823833466,f6222fd2-ba80-4ae3-b1c5-8d83031ed9a8,Cambridge University Hospitals NHS Foundation Trust and University of,cambridge_university_hospitals_nhs_foundation_trust_and_university_of,,,,5832b652-f280-4dd6-850d-477a81887563,cambridge_university_hospitals_nhs_foundation_trust,Cambridge University Hospitals NHS Foundation Trust -2293,,d99cf07a-72f5-11e6-a0cd-0242ac12000b,INSMED,insmed,,,,,, -2294,,eb422b42-71f6-11e6-a0cd-0242ac12000b,IOMED,iomed,,,,,, -472,0.983628,77d74083-7ff5-4dec-88ac-be73492f43ab,"Rigshospitalet, Copenhagen",rigshospitalet_copenhagen,,,,77d74083-7ff5-4dec-88ac-be73492f43ab,rigshospitalet_copenhagen,"Rigshospitalet, Copenhagen" -1059,0.982418,6dce2ae5-2f18-4049-bbc1-1d01299ee637,RECORDATI,recordati,,,,6dce2ae5-2f18-4049-bbc1-1d01299ee637,recordati,RECORDATI -2295,,f6d95481-5cd6-49db-aab6-a25a7fbd9a63,Stichting Pediatrisch Onderzoek Enschede,stichting_pediatrisch_onderzoek_enschede,,,,,, -2296,,cfbdaf88-f1ac-41ab-a485-206f99be8e1d,"Delcath Systems, Ltd",delcath_systems_ltd,,,,,, -2297,,19ec8d6c-cbc1-42e8-abcb-095b4569a2f7,"Institut for Sundhedstjenesteforskning, Klinisk Farmakologi, Syddansk Universitet",institut_for_sundhedstjenesteforskning_klinisk_farmakologi_syddansk_universitet,,,,,, -974,0.98890119791030884,cc5ae5a1-d580-4f2e-a312-171b4fee0406,Universitätsklinikum Schleswig-Holstein,universit_tsklinikum_schleswig_holstein,,,,4cbb7e37-feeb-4dcf-a21f-ec40d4959c01,universit_tsklinikum_schleswig_holstein,Universitätsklinikum Schleswig-Holstein -2298,,597dc04e-799a-4bfc-bd88-1327e04d5391,Helena Isoniemi,helena_isoniemi,,,,,, -862,0.97933542728424072,2d106fa3-c940-42d6-a28f-8db21de52b04,"Academic Medical Center Amsterdam, department of Internal Medicine",academic_medical_center_amsterdam_department_of_internal_medicine,,,,2d106fa3-c940-42d6-a28f-8db21de52b04,academic_medical_center_amsterdam,Academic Medical Center Amsterdam -906,0.98112761974334717,842c3098-ea3e-4d46-b13c-da88e6deacb0,Kings College London (IOP),kings_college_london_iop,,,,fb29808d-7985-4804-b8d4-5620bbba60e6,kings_college_london_iop,Kings College London (IOP) -454,0.987768,c6a06456-3663-448c-8c5d-27a447b6849a,Hôpital Universitaire Des Enfants Reine Fabiola (H.U.D.E.R.F.),h_pital_universitaire_des_enfants_reine_fabiola_h_u_d_e_r_f,,,,c6a06456-3663-448c-8c5d-27a447b6849a,h_pital_universitaire_des_enfants_reine_fabiola_h_u_d_e_r_f,Hôpital Universitaire Des Enfants Reine Fabiola (H.U.D.E.R.F.) -2299,,e3a87d3c-2b97-4dfd-a91d-0107e0dba15f,"Department of Pharmacy, Uppsala University",department_of_pharmacy_uppsala_university,,,,,, -2300,,2fb8f371-a475-4ee7-8290-f348b4c7ac7c,"Research and Development Office, Royal Infirmary of Edinburgh",research_and_development_office_royal_infirmary_of_edinburgh,,,,,, -2301,,20f08d9c-38ef-4dc0-bbba-624944735a51,"Städtische Kliniken Neuss, Lukaskrankenhaus GmbH",st_dtische_kliniken_neuss_lukaskrankenhaus_gmbh,,,,,, -2302,,b855edc6-715c-11e6-a0cd-0242ac12000b,PEDIATRX,pediatrx,,,,,, -141,0.954454,eb54e67a-810b-4d63-87af-4e099ccc7a97,GRUPO ESPAÑOL DE INVESTIGACIÓN EN NEUROONCOLOGGÍA (GEINO),grupo_espa_ol_de_investigaci_n_en_neurooncologg_a_geino,,,,a50426da-ce4e-4ecd-b491-397a2aadb68f,grupo_espa_ol_de_investigacion_en_neurooncologia,GRUPO ESPAÑOL DE INVESTIGACION EN NEUROONCOLOGIA -2303,,6cb464a8-697d-4c01-b806-20d93dd290dd,Medical University Graz,medical_university_graz,,,,,, -2304,,722146b5-2da3-46f0-8d5f-43570fc37b50,Clinic for Psychiatry and Psychotherapy of the Ludwig Maximilian University,clinic_for_psychiatry_and_psychotherapy_of_the_ludwig_maximilian_university,,,,,, -2305,,ed72e27a-6f9f-11e6-9663-0242ac12000b,Pulmagen Therapeutics LLP,pulmagen_therapeutics_llp,,,,,, -2306,,bf0fcd6a-7375-11e6-a0cd-0242ac12000b,ALLERQUEST,allerquest,,,,,, -2307,,ac2ea195-ee57-4135-95ab-234e81c19d49,"Charité Universitätsmedizin, Campus Charité Mitte",charit_universit_tsmedizin_campus_charit_mitte,,,,,, -2308,,2bf2bcb4-7167-11e6-a0cd-0242ac12000b,BIOMEDCL RES FDN,biomedcl_res_fdn,,,,,, -2309,,7af728a6-7138-46ba-bb53-adb4c41e10fe,University Heidelberg,university_heidelberg,,,,,, -507,0.986912,2d581c28-7141-11e6-a0cd-0242ac12000b,HI TECH PHARMA CO,hi_tech_pharma_co,,,,2d581c28-7141-11e6-a0cd-0242ac12000b,hi_tech_pharma_co,HI TECH PHARMA CO -2310,,f07b3004-e6e4-4f9a-937a-bb2dcfee8930,Netherlands Vaccine Institute,netherlands_vaccine_institute,,,,,, -2311,,0b32183d-cc2a-4c2a-8825-b58312c6c1da,SYGNIS Bioscience GmbH & Co. KG,sygnis_bioscience_gmbh_co_kg,,,,,, -2312,,25f9fb4e-a3f5-49d8-a78e-b3a23cd18fdb,JOSÉ ANTONIO SERRANO TRENAS,jos_antonio_serrano_trenas,,,,,, -942,0.985052,9eb06cf2-3062-4b75-9c69-530ebc8ce5f7,BioGeneriX,biogenerix,,,,02c56274-3bd4-4bfe-bfe8-b2385f2eef41,biogenerix_ag,BioGeneriX AG -842,0.97305294871330261,19e6b110-6043-450d-8ef8-6a798742be5d,University Hospital of South Manchester Nhs Foundation Trust,university_hospital_of_south_manchester_nhs_foundation_trust,,,,19e6b110-6043-450d-8ef8-6a798742be5d,university_hospital_of_south_manchester_nhs_foundation_trust,University Hospital of South Manchester -2313,,55a4dcf6-2c3e-4bf7-a386-5aa6a73809e8,Bioeq GmbH,bioeq_gmbh,,,,,, -2314,,154840da-73ec-45bd-9331-b3e37be4aa1c,Janssen-Cliag International N.V,janssen_cliag_international_n_v,,,,,, -2315,,e9ab2ec9-94da-47eb-82e3-b317e653b2d6,UNITED THERAPEUTICS,united_therapeutics,,,,,, -390,0.95186018943786621,b5653343-db85-468f-9ea0-a6d1b957afa2,Galderma Research & Development SNC,galderma_research_development_snc,,,,b5653343-db85-468f-9ea0-a6d1b957afa2,galderma_research_development,Galderma research & Development -2316,,162a9cb7-075e-4fae-b3cc-2886170ed6a6,Fundación de Investigación Biomédica Hospital Universitario de la Princesa,fundaci_n_de_investigaci_n_biom_dica_hospital_universitario_de_la_princesa,,,,,, -2317,,01563330-44ab-4593-9b40-118bdf8a757b,Prague Psychiatric Centre,prague_psychiatric_centre,,,,,, -2318,,5244ebc7-d220-4f2a-b22e-e70d474d9697,"Folktandvården, Landstinget Dalarna",folktandv_rden_landstinget_dalarna,,,,,, -2319,,6f4b09b0-32d1-4b50-b57f-bd61cd1e27e8,GIOGer (Gruppo Italiano di Oncologia Geriatrica),gioger_gruppo_italiano_di_oncologia_geriatrica,,,,,, -2320,,dc5e6725-e192-41a6-bb07-1423babdc79a,"F.HOFFMANN-LA ROCHE representado en España por Roche Farma,S.A",f_hoffmann_la_roche_representado_en_espa_a_por_roche_farma_s_a,,,,,, -2321,,87d28190-82e9-41e9-a1ca-999e32ca24ca,Pharmachemie B.V,pharmachemie_b_v,,,,,, -2322,,9ada1253-cf77-4e6a-976d-0de2fd7458ab,"Medizinische Universität Graz, Universitätsklinik für Dermatologie",medizinische_universit_t_graz_universit_tsklinik_f_r_dermatologie,,,,,, -2323,,85e9070d-7c5e-41f2-8c28-cdceb70cf350,Wolfson Medical Center,wolfson_medical_center,,,,,, -2324,,44f36e04-ca02-419d-88bc-aef4bcef3d6c,Procter & Gamble Technical Centres Limited,procter_gamble_technical_centres_limited,,,,,, -2325,,af2c0cde-b064-40c7-8081-1ddedda2b204,GENZYME,genzyme,,,,,, -2326,,2e56f5b2-c7c5-4a2f-9a36-4e9362e90705,Convergence Pharmaceuticals Ltd,convergence_pharmaceuticals_ltd,,,,,, -2327,,67ddf20c-6404-46b6-ad4f-aa32333da94a,SBG (Scandinivian Breast Cancer Group),sbg_scandinivian_breast_cancer_group,,,,,, -2328,,3dc5e010-78ea-4398-903a-525f90641adc,Boehringer Ingelheim Italia S.p.A,boehringer_ingelheim_italia_s_p_a,,,,,, -2329,,281021cf-91a9-4327-8a29-0695fc86c10f,"Boehringer Ingelheim, Canada Ltd",boehringer_ingelheim_canada_ltd,,,,,, -2330,,3d2540a6-8e97-45b0-9061-4b209eba949f,"Nitric BioTherapeutics, Inc",nitric_biotherapeutics_inc,,,,,, -2331,,ce90c327-34f7-44d4-9551-b1e6d6bbfad5,Novartis Services AG,novartis_services_ag,,,,,, -956,0.980878,fafa09f0-8e27-4d83-a6c3-85c9a05e3eab,OBEcure,obecure,,,,b1885f5c-880d-11e6-a998-0242ac12000b,obecure_ltd,OBEcure Ltd -2332,,b29394f8-9c97-4692-904c-2bbe181e84c4,University of South Manchester NHS Foundation Trust,university_of_south_manchester_nhs_foundation_trust,,,,,, -2333,,7199e323-c428-4892-832a-426a35b39661,Klaus Tapio Olkkola,klaus_tapio_olkkola,,,,,, -2334,,7efe0612-da12-414e-b1b1-f433e0c0faa1,"Head, EU/ROW Regulatory Affairs",head_eu_row_regulatory_affairs,,,,,, -2335,,a2e40cda-7129-11e6-a89e-0242ac12000b,JUBILANT CADISTA,jubilant_cadista,,,,,, -587,0.95549,f3580246-7144-11e6-a0cd-0242ac12000b,IDT AUSTRALIA LTD,idt_australia_ltd,,,,12d4a6e2-73f7-11e6-a0cd-0242ac12000b,idt,IDT -2336,,b7c87029-e0ee-4232-873f-76e62fe18fd5,Dr. Theiss Naturwaren GmbH,dr_theiss_naturwaren_gmbh,,,,,, -334,0.969856,30daea08-31b9-44eb-b245-a0bfc280fc21,Boiron,boiron,,,,30daea08-31b9-44eb-b245-a0bfc280fc21,boiron,Boiron -996,0.977047,334999d1-9ed1-4d92-a66a-e05623d343a8,Kings College Hospital NHS Foundation Trust,kings_college_hospital_nhs_foundation_trust,,,,334999d1-9ed1-4d92-a66a-e05623d343a8,kings_college_hospital_nhs_foundation_trust,Kings College Hospital NHS Foundation Trust -465,0.98048589626948035,2e4a0d21-5259-4b26-b5dd-ed587c02073f,Leiden University,leiden_university,,,,2e4a0d21-5259-4b26-b5dd-ed587c02073f,leiden_university,Leiden University -2337,,54714d86-73f1-11e6-a0cd-0242ac12000b,ASPEN AIR,aspen_air,,,,,, -687,0.96910750865936279,98459814-11f4-4cc9-a742-4a4619828373,"Ruprecht-Karls-University Heidelberg, Med Faculty represented by Universitätsklinikum Heidelberg and its Commercial D",ruprecht_karls_university_heidelberg_med_faculty_represented_by_universit_tsklinikum_heidelberg_and_its_commercial_d,,,,197d4369-9301-4bac-b737-20a72c9e0d7b,ruprecht_karls_university_heidelberg_medical_faculty_represented_by_universit_tsklinikum_heidelberg_and_its_commercial,"Ruprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg and its Commercial" -2338,,ba65a115-02e1-4e57-9f98-e90a45792f6c,"Merck Serona S.A., Geneva, Switzerland",merck_serona_s_a_geneva_switzerland,,,,,, -2339,,04eae760-7142-11e6-a0cd-0242ac12000b,RANBAXY,ranbaxy,,,,,, -2340,,8ce1a506-6fbb-11e6-abe8-0242ac12000b,Organon Hungary Ltd,organon_hungary_ltd,,,,,, -2341,,43b31e9b-5c86-4f61-a788-a3e7f71c04ef,"Promedior, Inc",promedior_inc,,,,,, -2342,,ce11fc95-3d22-4c28-94dc-35be2d9f6091,AKH Linz,akh_linz,,,,,, -2343,,21db6c72-5da2-4c64-b673-432321c1b314,Sanofi-Aventis AG,sanofi_aventis_ag,,,,,, -2344,,4bfffa88-7146-11e6-a0cd-0242ac12000b,MILEX,milex,,,,,, -2345,,922f3fb6-9042-4a10-bacb-5fe5aa04ee75,AXON Neuroscience SE,axon_neuroscience_se,,,,,, -2346,,0b133984-de0d-4428-ae13-995f8d0e324f,ULB ERASME HOSPITAL,ulb_erasme_hospital,,,,,, -2347,,e4459b4e-955f-4dad-8ebf-0b5b2baf5021,"Protein Design Labs, Inc",protein_design_labs_inc,,,,,, -2348,,59396a22-71eb-11e6-a0cd-0242ac12000b,AMAG PHARMS INC,amag_pharms_inc,,,,,, -2349,,385e20a3-1fd3-4339-ac11-9f77cf17c728,Innate Pharma S.A,innate_pharma_s_a,,,,,, -2350,,2e3d3d1e-7194-11e6-a0cd-0242ac12000b,TARGACEPT,targacept,,,,,, -2351,,cc896b62-f942-4e86-b3f5-79a548aef3b1,Hannu Kokki,hannu_kokki,,,,,, -2352,,ef4a9ee5-bbf6-4943-9402-640d6e4a3889,"Tranzyme, Inc",tranzyme_inc,,,,,, -2353,,8cc1878a-7164-11e6-a0cd-0242ac12000b,AIPING PHARM INC,aiping_pharm_inc,,,,,, -2354,,874b524c-7158-11e6-a0cd-0242ac12000b,EXELA PHARMA SCIENCE,exela_pharma_science,,,,,, -2355,,5adfaf27-bb17-4d7c-a8f5-ce3cb257c8d6,"Lithuanian University of Health Sciences, Endocrinology Department",lithuanian_university_of_health_sciences_endocrinology_department,,,,,, -2356,,d5b4154c-bda4-4f3f-ab31-55e12d9afb89,"Verksamhetsområde Geriatrik, Lungmedicin och Allergologi vid Sahlgrenska Universitetssjukhuset",verksamhetsomr_de_geriatrik_lungmedicin_och_allergologi_vid_sahlgrenska_universitetssjukhuset,,,,,, -904,0.943406,eafe4f37-4f5a-4128-8d0f-96b207ab9cfd,Novo Nordisk A/S,novo_nordisk_a_s,,,,a017bdc5-4a8a-48c3-ab48-5b1db4f8ed6e,novo_nordisk_as,Novo Nordisk AS -2357,,1822b285-c272-4571-9ec8-0e4840818a65,"Medizinische Universität Innsbruck, AGO Studienzentrale",medizinische_universit_t_innsbruck_ago_studienzentrale,,,,,, -2358,,ae68b0d5-a42a-4ada-9d3a-5a4721eb9a1c,"Oslo University Hospital, Dept of Urology",oslo_university_hospital_dept_of_urology,,,,,, -2359,,c1560782-435e-4bc1-8423-76f62dac3062,"Medizinische Hochschule Hannover, Klinik für Pneumologie",medizinische_hochschule_hannover_klinik_f_r_pneumologie,,,,,, -2360,,e54d8ea2-d343-4530-9052-776fba203207,Helena Elding Larsson,helena_elding_larsson,,,,,, -2361,,9bfa0753-3bc3-453a-bc32-854f9ba19cc2,Västra Götalandsregionen (VGR),v_stra_g_talandsregionen_vgr,,,,,, -2362,,89fbd6cd-cd2b-429c-a491-e5cffff12002,UAB “Eli Lilly Lietuva”,uab_eli_lilly_lietuva,,,,,, -2363,,fa7840ff-3106-4665-b4a3-aac3b29efdc7,ICT de Navarra S.A,ict_de_navarra_s_a,,,,,, -2364,,e36597c2-20d6-406c-82f1-e834c7315473,St Helens & Knowsley Hospitals NHS Trust,st_helens_knowsley_hospitals_nhs_trust,,,,,, -2365,,1edbaa2c-9d94-4796-9c0b-ccd52f669a82,Klinikum der Otto-von-Guericke Universität Magdeburg,klinikum_der_otto_von_guericke_universit_t_magdeburg,,,,,, -2366,,b88aedad-b843-4c93-b4c5-7c7b85dacb0d,Chr. Hansen A/S,chr_hansen_a_s,,,,,, -2367,,468a4598-0f63-4c9e-a9fe-9e53d5416109,University of Plymouth,university_of_plymouth,,,,,, -918,0.94804,efd6c1e0-c374-4f00-99d0-088b90b5d95a,AZIENDA OSPEDALIERA S. PAOLO (A.O. DI RILIEVO NAZIONALE),azienda_ospedaliera_s_paolo_a_o_di_rilievo_nazionale,,,,7e1a91a4-5515-4186-84f8-e0dba33780e4,azienda_ospedaliera_l_sacco_a_o_di_rilievo_nazionale,AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) -57,0.9411388635635376,1d53dcae-9b86-416e-9d92-a62412245dcc,"Wyeth Research Division of Wyeth Pharmaceuticals, Inc. Clinical Research & Development",wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_development,,,,1d53dcae-9b86-416e-9d92-a62412245dcc,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_development,"Wyeth Research Division of Wyeth Pharmaceuticals, Inc. Clinical Research & Development" -2368,,1e287424-b298-42dd-88ef-189d71e1062e,SERMAS (Hospital la Paz),sermas_hospital_la_paz,,,,,, -2369,,8e6088f3-ba69-4e61-9835-e8602dd25077,NovartisPharma Services AG,novartispharma_services_ag,,,,,, -2370,,be8b441e-dde8-4eca-a72a-d672113ea9b8,Philogen S.pA,philogen_s_pa,,,,,, -252,0.97271484136581421,571002ec-617e-4005-8cd5-1585b09674f0,"Martin Luther University of Halle/Wittenberg, Medizinische Fakultät, Prodekanat Forschung",martin_luther_university_of_halle_wittenberg_medizinische_fakult_t_prodekanat_forschung,,,,0f0d8991-097b-4737-a496-fd2e4d5aa3ff,martin_luther_university_of_halle_wittenberg,Martin Luther University of Halle/Wittenberg -2371,,ecae3491-b7e8-4a29-8c5d-e233e6fe362c,"DSC Services, s.r.o",dsc_services_s_r_o,,,,,, -2372,,b24d61a0-545a-4fe1-b5de-549e6f8b2dd7,Johann-Wolfgang Goethe-Universität,johann_wolfgang_goethe_universit_t,,,,,, -2373,,f8a2e7f4-1e58-4471-89a0-30d512e770f7,BUDAI HEPATOLÓGIAI CENTRUM,budai_hepatol_giai_centrum,,,,,, -2374,,1f7129e9-528d-452e-bf42-1edfaab3ebf0,"Bert Mueller, Dep. Ophthalmology",bert_mueller_dep_ophthalmology,,,,,, -2375,,29c35e6c-a3b8-479f-ad8d-7ac1aefa3dde,SSG,ssg,,,,,, -2376,,94359441-f797-4dd6-af5c-8c133dae8607,Minster Pharmaceuticals Ltd,minster_pharmaceuticals_ltd,,,,,, -2377,,e0eb00f5-1be5-45eb-864b-95f0335c4087,Hospital Sant Joan de Deu,hospital_sant_joan_de_deu,,,,,, -2378,,742e983d-bc19-454a-b98a-c13d50e41dc0,FUNDACIÓN GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA,fundaci_n_grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama,,,,,, -2379,,e6e5460c-ce48-4956-bdcf-a284df896b2d,Dr. Antonio Llombart Cussac,dr_antonio_llombart_cussac,,,,,, -2380,,ab1f3606-36a1-4f89-bae4-6efe4263d555,JANSSEN-CILAG EMEA,janssen_cilag_emea,,,,,, -416,0.968388,da6ce2e0-306e-4461-9ae3-5767282527c6,Fraunhofer Gesellschaft,fraunhofer_gesellschaft,,,,da6ce2e0-306e-4461-9ae3-5767282527c6,fraunhofer_gesellschaft,Fraunhofer Gesellschaft -225,0.98610919713973999,20e12445-21a7-4273-8a0c-39079af8786b,Fertilitetsklinikken Nordica,fertilitetsklinikken_nordica,,,,090da71e-b718-413e-ba77-0e109a22d5d5,fertilitetsklinikken,Fertilitetsklinikken -2381,,c89fa10e-528e-4d1b-83e1-0796a07eb21e,Solvay Biologicals BV,solvay_biologicals_bv,,,,,, -277,0.9798356294631958,742e5b04-42fe-442b-af30-e1ceda614670,"Teva Branded Pharmaceutical Products R&D, Inc",teva_branded_pharmaceutical_products_r_d_inc,,,,71fa3658-cdd0-4248-b428-53aae9afea66,teva_branded_pharmaceutical_products_r_d_inc,"Teva Branded Pharmaceutical Products R&D, Inc" -2382,,e9744b7b-0112-469c-aa5e-953bac68c05b,AZIENDA OSPEDALIERA DI CASERTA,azienda_ospedaliera_di_caserta,,,,,, -2383,,25eeb652-93f2-45eb-998d-b2d355f1f2cc,Novartis Faarmacéutica S.A,novartis_faarmac_utica_s_a,,,,,, -2384,,dda0a005-872b-4f86-bf68-a84830d3b423,Division of Special and Environmental Dermatology,division_of_special_and_environmental_dermatology,,,,,, -708,0.984864,d9cb587c-7163-11e6-a0cd-0242ac12000b,NOVAST LABS LTD,novast_labs_ltd,,,,3e40eb72-7165-11e6-a0cd-0242ac12000b,novast_labs,NOVAST LABS -2385,,e09260af-d202-4e00-a253-062655806647,SCHERING-PLOUGH,schering_plough,,,,,, -2386,,3f0ebe02-536a-4e48-b0e7-21e0dd29b7b2,ALK-Abelló Arzneimittel GmbH,alk_abell_arzneimittel_gmbh,,,,,, -2387,,3a76c118-dc5c-4280-a287-bbc242d98d6b,Calixa Therapeutics Inc,calixa_therapeutics_inc,,,,,, -2388,,de8ab3be-a75f-11e6-94cb-5656d04fc2b5,"University of Southern Denmark, Clinical Pharmacology",university_of_southern_denmark_clinical_pharmacology,,,,,, -2389,,358073be-0290-4c51-96bd-de9abe2e9d3d,Mika J. Mäkelä,mika_j_m_kel,,,,,, -2390,,399faf0c-52c9-4ee0-9025-873e502aab24,futurum,futurum,,,,,, -2391,,50ff4dec-7167-11e6-a0cd-0242ac12000b,CFT PHARMS LLC,cft_pharms_llc,,,,,, -3,0.975901,759e5476-0767-445f-9373-05a555bd1be8,Klinik für Anästhesiologie, Johannes Gutenberg Universität,,,,759e5476-0767-445f-9373-05a555bd1be8, Johannes Gutenberg Universität,Klinik für Anästhesiologie -2392,,d60f9494-7142-11e6-a0cd-0242ac12000b,LOCH,loch,,,,,, -2393,,4a41eb18-7149-11e6-a0cd-0242ac12000b,GENSIA SICOR PHARMS,gensia_sicor_pharms,,,,,, -2394,,5c9378e2-971a-40be-bc39-fe3591d97f9b,University of Chicago,university_of_chicago,klinik_f_r_an_sthesiologie_johannes_gutenberg_universit_t,,,,, -466,0.91411077976226807,62011efa-04e1-422d-bc6f-ad2b4e216ef5,Leiden Universtity Medical Center,leiden_universtity_medical_center,,,,0c30b492-594c-4ddd-8d03-fa24bfa5bbd3,leiden_university_medical_center_department_of_rheumatology,"Leiden University Medical Center, department of rheumatology" -2395,,1e50d85c-7167-11e6-a0cd-0242ac12000b,CENTAUR PHARMA,centaur_pharma,,,,,, -676,0.987472,7c9c2246-722e-11e6-a0cd-0242ac12000b,BECTON DICKINSON CO,becton_dickinson_co,,,,683d790a-7146-11e6-a0cd-0242ac12000b,becton_dickinson,BECTON DICKINSON -2396,,4ba6550d-29ae-4c7d-b10e-9ecd75913aad,AZIENDA OSPEDALIERA MEYER,azienda_ospedaliera_meyer,,,,,, -2397,,5bcd533d-7146-4199-b912-e2c4bde26cab,"insaf, Institut für Atemwegsforschung GmbH",insaf_institut_f_r_atemwegsforschung_gmbh,,,,,, -2398,,66e71556-9553-4f75-be5f-e5537a0f4251,"Med. Universität Wien, Universitätsklinik für Innere Medizin II",med_universit_t_wien_universit_tsklinik_f_r_innere_medizin_ii,,,,,, -862,0.98416075110435486,c678152f-1832-493f-a30b-931d5d31d950,Academic Medical Center Amsterdam,academic_medical_center_amsterdam,,,,2d106fa3-c940-42d6-a28f-8db21de52b04,academic_medical_center_amsterdam,Academic Medical Center Amsterdam -861,0.92882567644119263,814a6fa8-6b39-4d4a-90b5-c93d021a2e48,"Academic Medical Center, Department of Haematology, University of Amsterdam",academic_medical_center_department_of_haematology_university_of_amsterdam,,,,7cef3d29-cecb-442c-acdb-b0a10dec2da0,academic_medical_center_department_of_dermatology,"Academic Medical Center, Department of dermatology" -2399,,c6fc68b4-a6f1-11e6-94cb-5656d04fc2b5,Herlev og Gentofte Hospital,herlev_og_gentofte_hospital,,,,,, -2400,,6650279a-1220-4ca8-a74e-c81137cafa9b,Pharmacia and Upjohn,pharmacia_and_upjohn,,,,,, -2401,,2d23cfb6-420f-4982-9940-f15a12b3c86a,FONDAZIONE EVIDENCE,fondazione_evidence,,,,,, -2402,,3a2e9aee-a8c3-434c-838e-0d0f6ec84ae4,"Synergia Pharma, Inc",synergia_pharma_inc,,,,,, -2403,,75e278c8-a86a-467a-b01d-5bec92edb7d2,Santhera Pharmaceuticals (Switzerland) Ltd,santhera_pharmaceuticals_switzerland_ltd,,,,,, -2404,,adb0d488-71b8-11e6-a0cd-0242ac12000b,CHIESI USA INC,chiesi_usa_inc,,,,,, -2405,,60d0103d-4609-4947-89a6-f5e4e4c3824a,University Hospital Birmingham NHS Foundation Trust,university_hospital_birmingham_nhs_foundation_trust,,,,,, -2406,,e56ce7fa-a556-4321-b0df-1096c2c2810b,Norrlands university hospital,norrlands_university_hospital,,,,,, -2407,,7df69bd4-d2c1-4298-a8e4-3a07edb87e98,"Kingston General Hospital, Queen's University of Kingston",kingston_general_hospital_queen_s_university_of_kingston,,,,,, -2408,,ce7f0c3c-7142-11e6-a0cd-0242ac12000b,VITARINE,vitarine,,,,,, -2409,,b172a37e-2b18-43b5-ad71-6ae19c246354,Novartis Healthcare A/S,novartis_healthcare_a_s,,,,,, -2410,,1da8f1ba-e9cd-447e-b4aa-27d11d6da7c4,LifeCycle Pharma A/S,lifecycle_pharma_a_s,,,,,, -2411,,d7312e52-4192-4983-920d-0634cb7e2bda,"University Hospital Sjaelland, Roskilde,Palliative Unit",university_hospital_sjaelland_roskilde_palliative_unit,,,,,, -2412,,b5cf1970-7165-11e6-a0cd-0242ac12000b,HQ SPCLT PHARMA,hq_spclt_pharma,,,,,, -2413,,6d4d113f-881e-4722-9d58-515ce6e76915,Centre Hospitalier Universitaire Brugmann,centre_hospitalier_universitaire_brugmann,,,,,, -364,0.985698,87d09c6e-75c9-457a-a75f-98fe01c68879,Linköping University Hospital,link_ping_university_hospital,,,,3c37c02e-cf63-439c-9fbf-de047eae2685,link_ping_university,Linköping University -271,0.936507,a53a0518-14bd-43f6-a865-5dbca410808b,AstraZeneca NV/SA,astrazeneca_nv_sa,,,,1f1910ef-d8fc-404c-af9b-dd7bc5fd4d42,astrazeneca_bv,AstraZeneca BV -776,0.931044,cda596b1-95e9-44c2-ae59-cc4ef1c1e9a4,Thomas Fichnter Bendtsen,thomas_fichnter_bendtsen,,,,5cb4c7b4-22d3-4d2e-baa3-ec6641e8024b,thomas_fichtner_bendtsen,Thomas Fichtner Bendtsen -2414,,ec3405e6-f0a2-4b01-a22d-c578e8d30372,Dilafor AB,dilafor_ab,,,,,, -91,0.9638105034828186,1152e981-0c70-498b-86c9-697b85b3f5c7,Actelion Pharmaceuticals Nederland bv,actelion_pharmaceuticals_nederland_bv,,,,773f50b2-9db9-4907-b659-e4a90dab71f6,actelion_pharmaceuticals,Actelion Pharmaceuticals -220,0.987246,881bb9ba-33dc-4a2c-8dc8-686f26ee9973,Sanofi-Aventis Recherche & Dev,sanofi_aventis_recherche_dev,,,,28a6a997-3c3d-4bd8-8c3e-e02946553a33,sanofi_aventis_recherche_dev_loppement,Sanofi-Aventis Recherche & Devéloppement -2415,,0a9fc54e-e627-4f82-a9ee-276d889a2263,GTC BIOTHERAPEUTICS,gtc_biotherapeutics,,,,,, -2416,,5fb63deb-1a1b-47fe-a012-d04e6e31735d,GETAID - Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives,getaid_groupe_d_etude_th_rapeutique_des_affections_inflammatoires_digestives,,,,,, -2417,,7f00ac82-8ef1-4616-9992-1e0ee9059383,"Royal Hospital For Sick Children, Yorkhill Division",royal_hospital_for_sick_children_yorkhill_division,,,,,, -2418,,51513e5a-a71b-4452-aa2b-d87d10ec4d67,CMIV,cmiv,,,,,, -1012,0.9465501606464386,3a155d92-5624-4478-adee-a0b9485e9d1a,"Shire Human Genetic Therapies, Inc. (Shire HGT)",shire_human_genetic_therapies_inc_shire_hgt,,,,c06cb74b-1c77-4c28-9c14-a6b870a4012a,shire_human_genetic_therapies_inc,"Shire Human Genetic Therapies, Inc. (Shire HGT)" -512,0.976744,57316fb9-869d-4e0f-830d-b7178467cef3,"Novartis Farmacéutica, S.A",novartis_farmac_utica_s_a,,,,0d23d029-d573-4d0e-aaab-1b66e6a0fd64,novartis_farmac_utuca_s_a,"Novartis Farmacéutuca, S.A" -2419,,2e5a8d74-72f2-11e6-a0cd-0242ac12000b,FEINSTEIN,feinstein,,,,,, -1011,0.982558,19f3330e-027c-4344-a82b-28a25bade93e,German Breast Group,german_breast_group,,,,19f3330e-027c-4344-a82b-28a25bade93e,german_breast_group,German Breast Group -2420,,cfd3ba86-f12c-4e7c-a6e2-a27283b6f0c4,Inst of Ophtalmology Lund University hospital,inst_of_ophtalmology_lund_university_hospital,,,,,, -2421,,7c682222-f2fd-4c0b-8c03-29bdf8ff63f5,PRESURGY S.L,presurgy_s_l,,,,,, -2422,,6f8d0fd0-71fb-11e6-a0cd-0242ac12000b,HORIZON PHARMA INC,horizon_pharma_inc,,,,,, -428,0.984324,02faf8af-e6fd-4c07-aca4-71ef06427271,Ghent University,ghent_university,,,,02faf8af-e6fd-4c07-aca4-71ef06427271,ghent_university,Ghent University -772,0.985698,fcf4391d-2abf-4988-9179-57f9b75037e1,Abbott GmbH & Co. KG (Abbott),abbott_gmbh_co_kg_abbott,,,,6faaed46-35f6-404d-9128-03b55daaae47,abbott_gmbh_co_kg,Abbott GmbH & Co. KG -2423,,3770529b-6b59-45f6-adf4-93d4dccdbd66,Institut für klinische Forschung und Entwicklung Berlin GmbH am St. Hedwig Krankenhaus,institut_f_r_klinische_forschung_und_entwicklung_berlin_gmbh_am_st_hedwig_krankenhaus,,,,,, -2424,,195e0710-5fa1-4564-a11c-dd188182e535,silvia sanchez ramon,silvia_sanchez_ramon,,,,,, -2425,,22df266d-8f91-4c00-8e4b-a8f3a1e57306,Queen Victoria Hospital,queen_victoria_hospital,,,,,, -2426,,585eb738-9f4a-42a8-b468-0b0e9f3eb77c,NVALT,nvalt,,,,,, -2427,,919851f1-e5b4-4cc8-a6b6-ab9115e2ad2b,University of Leicester,university_of_leicester,,,,,, -2428,,ce32a653-6127-4f5f-b254-8eeb4266b010,Buckinghamshire Healthcare NHS Trust,buckinghamshire_healthcare_nhs_trust,,,,,, -197,0.986644,3f5bfa23-183e-4eb2-b25e-ef95e03935f7,Medizinische Fakultät der Technischen Universität München,medizinische_fakult_t_der_technischen_universit_t_m_nchen,,,,0a2316b0-4362-41ed-8199-5421a077abe7,medizinische_fakult_t_der_technischen_universit_t_m_nchen_vertreten_durch_den_dekan,"Medizinische Fakultät der Technischen Universität München, Vertreten durch den Dekan" -2429,,9dd75915-f5cb-4915-9901-8ace578d6fed,NeuroCode AG,neurocode_ag,,,,,, -56,0.98165720701217651,abc1c336-a76f-11e6-94cb-5656d04fc2b5,Radboud University Nijmegen,radboud_university_nijmegen,,,,9078130e-eeb6-4d4a-9b3b-bf9f3a7082c5,radboud_university_nijmegen_medical_centre,Radboud University Nijmegen Medical Centre -2430,,e128cde4-9390-41d7-a36f-13b4dac850b5,"Prof Flora Peyvandi, MD",prof_flora_peyvandi_md,,,,,, -7,0.95328104496002197,e37ff462-7351-402c-828d-d17f23d6fa72,Centre Hospitalier Universitaire de Nancy,centre_hospitalier_universitaire_de_nancy,,,,e37ff462-7351-402c-828d-d17f23d6fa72,centre_hospitalier_universitaire_de_nantes,Centre Hospitalier Universitaire de Nantes -800,0.972677,6c1b4883-f94c-4db9-a252-6308442f5577,Institut Català d’Oncologia (ICO),institut_catal_d_oncologia_ico,,,,15671013-8a1c-41eb-b118-71cf71e315ed,institut_catal_d_oncologia,Institut Català d’Oncologia -2431,,5baf3ecb-fc11-4150-a708-78f71b17ca63,Orphan Europe Recordati,orphan_europe_recordati,,,,,, -2432,,74b89c37-3b8b-49d6-ba0d-2da31d436263,G.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI,g_i_s_l_gruppo_italiano_studio_linfomi,,,,,, -2433,,445d59cf-d65f-4372-8f1f-10c3ab6bf05d,"Department of research & development, TheLeeds teaching hospitals NHS trust",department_of_research_development_theleeds_teaching_hospitals_nhs_trust,,,,,, -2434,,60ff77b8-c176-480b-ae13-f417775472f5,"Department of Oncology, University Hospital Herlev",department_of_oncology_university_hospital_herlev,,,,,, -364,0.985698,3c37c02e-cf63-439c-9fbf-de047eae2685,Linköping University,link_ping_university,,,,3c37c02e-cf63-439c-9fbf-de047eae2685,link_ping_university,Linköping University -2435,,613afa86-c07a-4505-be8c-ae6c73b2b3a2,Southampton Universities Hospital Trust,southampton_universities_hospital_trust,,,,,, -2436,,2e47032a-8e02-405a-807d-1dbb97afeabc,SLA Pharma,sla_pharma,,,,,, -2437,,787d3bf7-892f-4231-b179-4aca27639e68,Scheper Ziekenhuis,scheper_ziekenhuis,,,,,, -2438,,1a9bb52c-715f-11e6-a0cd-0242ac12000b,AMARIN PHARMS,amarin_pharms,,,,,, -2439,,b55dc79f-1890-4369-a860-e363d6f349d2,FONDAZIONE RICERCA TRAPIANTO DI MIDOLLO OSSEO,fondazione_ricerca_trapianto_di_midollo_osseo,,,,,, -2440,,045b350f-863f-410d-8cb6-94d5b0f67fd3,"Universitätsklinik für Anästhesie,Intesivmedizin und Schmerztherapie,Mediniz.Universität Wien",universit_tsklinik_f_r_an_sthesie_intesivmedizin_und_schmerztherapie_mediniz_universit_t_wien,,,,,, -2441,,ecadce0a-7179-4f1f-9b8a-20e25d3eb02c,King’s College London & King’s College Hospital,king_s_college_london_king_s_college_hospital,,,,,, -2442,,bcde285f-399f-446c-8cf9-1360fd53f80f,Bo Lennernäs,bo_lennern_s,,,,,, -2443,,7531d453-bb5a-4ba2-bb6e-989f48e86acd,"Regado Biosciences, Inc",regado_biosciences_inc,,,,,, -2444,,71c9f4f4-79c4-4c5b-a60b-0a49aa869e8a,Abbvie previously known as Abbott,abbvie_previously_known_as_abbott,,,,,, -2445,,f2ddedcc-2a57-4f83-a916-bb0b6c953eab,LABORATOIRES EXPANSCIENCE,laboratoires_expanscience,,,,,, -2446,,116fd721-d776-4a1a-b004-7ff07aec5911,"Klinisk Farmakologisk Center og Med. Afd. M, Århus Sygehus, NBG",klinisk_farmakologisk_center_og_med_afd_m_rhus_sygehus_nbg,,,,,, -2447,,36ea61a4-3037-4fd4-bf23-53cc86929db7,A.O PAPA GIOVANNI XXIII- BERGAMO,a_o_papa_giovanni_xxiii_bergamo,,,,,, -2448,,7d1868cc-5361-43fc-955a-c30933bf6a25,Fundació Privada EUGIn,fundaci_privada_eugin,,,,,, -2449,,41d80070-7167-11e6-a0cd-0242ac12000b,ANTRIM PHARMS LLC,antrim_pharms_llc,,,,,, -2450,,1c707bbd-c1aa-4415-af2f-d5823d6f40e4,Joint Research & Development Office (QMUL),joint_research_development_office_qmul,,,,,, -2451,,5cc6a55d-e6eb-41e5-9b09-02effa296e43,Prostrakan Pharmaceuticals Ltd,prostrakan_pharmaceuticals_ltd,,,,,, -2452,,1349e18e-7319-11e6-a0cd-0242ac12000b,R-PHARM US LLC,r_pharm_us_llc,,,,,, -2453,,b09bcc7d-9ac1-4ae5-973a-4d482165514f,TB Investigation Unit of Barcelona,tb_investigation_unit_of_barcelona,,,,,, -2454,,bcd975f9-6912-418c-9768-7e8fd6c92553,Philipps-University of Marburg,philipps_university_of_marburg,,,,,, -2455,,41d5ed63-71fa-4c67-b385-026d76a0dd59,"Cardiology, J. W. Goethe University Frankfurt",cardiology_j_w_goethe_university_frankfurt,,,,,, -2456,,3ab1fc3a-8abe-44b2-ac4f-f0964f61250c,"Gilead Colorado, Inc",gilead_colorado_inc,,,,,, -2457,,61f440c8-7197-11e6-a0cd-0242ac12000b,AH ROBINS INC,ah_robins_inc,,,,,, -2458,,50e925f9-7a46-4555-bcf1-60066163ffda,UCL - The Joint UCLH/UCL Comprehensive Biomedical Research Unit,ucl_the_joint_uclh_ucl_comprehensive_biomedical_research_unit,,,,,, -2459,,ed2e0303-b14f-45ed-8a32-1718b3719e35,"Halozyme, Inc",halozyme_inc,,,,,, -2460,,daa65295-9161-41af-a5c8-db8d50482397,"Abteilung Klinische Chemie, UKL Freiburg",abteilung_klinische_chemie_ukl_freiburg,,,,,, -2461,,c835cbfc-5dae-4efa-afe3-d7272e699203,Janssen Korea Ltd,janssen_korea_ltd,,,,,, -481,0.98966941237449646,b5aab8dc-9d99-478f-8852-3de6e3070b50,Medizinische Universität Graz, Universitätsklinik für Innere Medizin,,,,48f0d5ed-174c-4ce4-98d7-cc34770f5107, Universitätsklinik für Innere Medizin,Medizinische Universität Graz -2462,,102e0c2a-9e51-450a-b4a5-c2240a99a8be,Prothena Therapeutics Limited,prothena_therapeutics_limited,,,,,, -2463,,01d88d1e-81d8-4fc8-ad99-cb5557995908,OPERA SRL,opera_srl,,,,,, -2464,,6f669f89-3bd6-4f84-817a-6dc301b67598,BarcelonaBeta Brain Research Center,barcelonabeta_brain_research_center, Abteilung für Endokrinologie und Stoffwechsel,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_abteilung_f_r_endokrinologie_und_stoffwechsel,,,, -2465,,5cc62c92-7129-11e6-a89e-0242ac12000b,ACTAVIS ELIZABETH,actavis_elizabeth,,,,,, -2466,,edee8a99-d220-4560-bfd4-b99a544acb42,Valderm ApS,valderm_aps,,,,,, -2467,,0967bee3-9253-47d0-a8ab-0e88b0423c10,"Anesthesiological dep., Hospital of Frederikssund",anesthesiological_dep_hospital_of_frederikssund,,,,,, -255,0.988054,fba9d4ba-f942-4323-8150-ae1a4789f6c7,Antwerp University Hospital,antwerp_university_hospital,,,,ab2495df-affb-476e-8780-84d610f1930d,antwerp_university_hospital_uza,Antwerp University Hospital (UZA) -418,0.977699,d47bf620-73ba-11e6-a0cd-0242ac12000b,INCYTE CORP,incyte_corp,,,,3a88d7e1-4064-447e-a62a-a9900c4f088e,incyte,INCYTE -2468,,86d59069-c11c-4735-b747-da68b48c46cd,TKT INC,tkt_inc,,,,,, -2469,,3f75d270-9e38-4a16-8f24-40051983c50c,CIB/RIVM,cib_rivm,,,,,, -2470,,b1d37205-6c46-481c-be05-9ab4c408cf88,Klinikum Augsburg,klinikum_augsburg,,,,,, -2471,,cd9ef4c6-4f43-4d85-be96-315a4177f459,MERCK SERONO s.a.s,merck_serono_s_a_s,,,,,, -2472,,4cfbf9ac-8ace-4672-a618-1718147fea97,Ageo,ageo,,,,,, -289,0.97350454330444336,b9338179-52f4-4b2b-8310-e1de13af8922,BAYER,bayer,,,,444ae102-9372-40dc-a56f-84e8d39e27c0,bayer_sante,BAYER SANTE -2473,,8a84149c-2f38-46a7-9c55-fc8fe14906ed,DURECT Corporation,durect_corporation,,,,,, -2474,,4417bb6b-c20a-43de-91ce-e16e4b435a02,Medizinische Universität Innsbruck - Institut für gerichtliche Medizin,medizinische_universit_t_innsbruck_institut_f_r_gerichtliche_medizin,,,,,, -2475,,bb030478-626f-47e6-9c9e-09455e3e2248,Ferring BV,ferring_bv,,,,,, -2476,,a61d3d42-71a9-11e6-a0cd-0242ac12000b,INDIVIOR INC,indivior_inc,,,,,, -2477,,cce3286a-ea5c-40e3-9644-962df6345c7e,Odense University Hostital,odense_university_hostital,,,,,, -2478,,7af2aef8-8bd6-11e6-a449-0242ac12000b,"Medical Department, Kolding Hospital",medical_department_kolding_hospital,,,,,, -985,0.98482728004455566,275d9cef-debb-4aaf-8234-93691b0c3e94,Imperial College,imperial_college,,,,275d9cef-debb-4aaf-8234-93691b0c3e94,imperial_college,Imperial College -32,0.97160464525222778,c243e6ab-0061-456d-9240-32ae88fba7d5,Technische Universität Dresen,technische_universit_t_dresen,,,,8013f413-0613-4f61-a0a5-e7241cff8548,technische_universit_t_dreden,Technische Universität Dreden -657,0.988592,adefb4c0-1527-4dcd-8c16-d38cccb425d2,sanofi-aventis Netherlands B.V,sanofi_aventis_netherlands_b_v,,,,94fe56aa-5dec-4b9e-95e5-c23b1585d045,sanofi_aventis_netherlands,sanofi-aventis Netherlands -2479,,f591d25a-cab3-4916-8617-2e9d66aeed44,Grupo Español para el Tratamiento y Estudio de los Linfomas (GOTEL),grupo_espa_ol_para_el_tratamiento_y_estudio_de_los_linfomas_gotel,,,,,, -2480,,3d7e4244-29b2-4e18-b020-a8bd71e70c83,AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA,azienda_ospedaliera_arcispedale_s_maria_nuova,,,,,, -278,0.97598719596862793,ee928994-e797-4b93-87d0-4ac65936de69,GlaxoSmithKline Research & Devlopment Ltd,glaxosmithkline_research_devlopment_ltd,,,,e86cb604-6399-4605-9a60-17154f1ecb73,glaxosmithkline_research_devleopment_ltd,GlaxoSmithKline Research & Devleopment Ltd -2481,,25cd62ad-312a-4f83-812a-e20817ce3507,Heli Sätilä,heli_s_til,,,,,, -2482,,3154456c-daf6-411c-9fa2-812ea8e3c1ae,GGz Nijmegen,ggz_nijmegen,,,,,, -2483,,1024edd0-9f40-462b-b9d5-eaa74a8a2c0f,University Antwerp,university_antwerp,,,,,, -390,0.95186018943786621,65bfdb33-6e94-44cb-98e5-4ec4d0ef60a9,Galderma Research & Development Inc,galderma_research_development_inc,,,,b5653343-db85-468f-9ea0-a6d1b957afa2,galderma_research_development,Galderma research & Development -260,0.985178,aac14393-408b-4045-b7ea-8cfc88f89eec,National Cancer Institute,national_cancer_institute,,,,91b42753-22b3-40cf-91c4-a74d2a2ada1b,national_cancer_institute_naples_italy,"National Cancer Institute Naples, Italy" -481,0.98544037342071533,77e5f2eb-c368-46a0-928b-5d9465a6166f,"Medizinische Universität Graz, Innere Medizin",medizinische_universit_t_graz_innere_medizin,,,,48f0d5ed-174c-4ce4-98d7-cc34770f5107, Universitätsklinik für Innere Medizin,Medizinische Universität Graz -2484,,0899ec3d-a121-4250-abe3-84255c8974d1,Anna Karlberg,anna_karlberg,,,,,, -2485,,3be3a072-a23d-45c2-a997-0038395e4689,Celyad SA,celyad_sa,,,,,, -2486,,096420dd-8981-41e2-a3be-f0bc2ff5d7a6,Washington University in St. Louis,washington_university_in_st_louis,,,,,, -2487,,a6951379-2e48-4cb1-b70b-1968bfda28f5,LETI Pharma GmbH,leti_pharma_gmbh,,,,,, -2488,,b30f5f14-d7b7-424f-87c4-8c4335d912cc,Stichting Longgeneeskunde Fryslan,stichting_longgeneeskunde_fryslan,,,,,, -67,0.960694,e44ea607-2c3b-495f-ad1d-b97fc34b7012,Servier Research and Development Limited,servier_research_and_development_limited,,,,8fbbc81e-1516-4d7f-b54e-79f6a0aef8e0,servier_research_and_development_ltd,Servier Research and Development Ltd -933,0.98634018500645959,8728530f-6b1a-45be-8dd9-ea62e4e4d9b3,Pierre Fabre Médicament,pierre_fabre_m_dicament,,,,e26f58e7-f0e7-4ad4-9432-e13ea279b291,pierre_fabre,Pierre Fabre Médicament -2489,,18397458-8fe9-4393-86b1-47c89b52ed98,TrialNet Coordinating Center,trialnet_coordinating_center,,,,,, -2490,,f2ae8ac8-6413-4c5c-bfe2-0d4e65e3adc1,Helsingin ja uudenmaan sairaanhoitopiiri,helsingin_ja_uudenmaan_sairaanhoitopiiri,,,,,, -2491,,b9cf4de5-a08f-485e-b137-5ee4acfede18,Laboratoires Théa,laboratoires_th_a,,,,,, -1012,0.90563303232192993,60da3cea-6fa0-11e6-9663-0242ac12000b,Shire Human Genetics Therapies Inc,shire_human_genetics_therapies_inc,,,,c06cb74b-1c77-4c28-9c14-a6b870a4012a,shire_human_genetic_therapies_inc,"Shire Human Genetic Therapies, Inc. (Shire HGT)" -2492,,75bd6ca6-1cd0-449d-b2ee-2c5c83df2d75,Dekan des Fachbereichs Medizin der Johann Wolfgang Goethe-Universität Frankfurt/M,dekan_des_fachbereichs_medizin_der_johann_wolfgang_goethe_universit_t_frankfurt_m,,,,,, -2493,,f31d6004-0186-4e56-b3f6-194e4e15b02b,Anthera Pharmaceuticals Incorporated,anthera_pharmaceuticals_incorporated,,,,,, -2494,,0cb2bb19-99d8-4231-b0af-a95af7282c28,"Department of Nuclear Medicine and Endocrinology, Paracelsus Medical University Salzburg",department_of_nuclear_medicine_and_endocrinology_paracelsus_medical_university_salzburg,,,,,, -2495,,9dd132e3-7f60-42d6-b5ed-33394636d73b,Fertin Pharma A/S,fertin_pharma_a_s,,,,,, -2496,,8c2e6288-6fbc-11e6-abe8-0242ac12000b,Research Institute for the prevention of allergy and airway diseases in childhood,research_institute_for_the_prevention_of_allergy_and_airway_diseases_in_childhood,,,,,, -60,0.95962155716759823,267a3e5c-87bd-4f2a-b839-71e2bf32b251,Wyeth Research Division of Wyeth Pharmaeuticals Inc. (A Pfizer Company),wyeth_research_division_of_wyeth_pharmaeuticals_inc_a_pfizer_company,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc -2497,,30d020aa-7167-11e6-a0cd-0242ac12000b,MIDWEST MEDCL,midwest_medcl,,,,,, -2498,,d2ef22f3-26d8-4d88-b226-511e8ddc04c6,"University Hospital, Limoges",university_hospital_limoges,,,,,, -59,0.96049280961354577,f4c6a588-0b61-41c0-8d2f-ce159443b414,"Wyeth Research Division, Wyeth Pharmeceuticals Inc",wyeth_research_division_wyeth_pharmeceuticals_inc,,,,96e5ebae-c6a3-41db-ae14-3ec5437c35f2,wyeth_research_division,Wyeth Research Division -2499,,40d9b1a6-5414-42d9-85c6-9c46343da071,Dr. Josep Brugada Terradellas- Hospital Clínic,dr_josep_brugada_terradellas_hospital_cl_nic,,,,,, -2500,,224f0a77-83d9-40a8-8e81-ead3edf4967b,"Patara Pharma, LLC",patara_pharma_llc,,,,,, -2501,,6a828d30-7160-11e6-a0cd-0242ac12000b,MERICON,mericon,,,,,, -2502,,849838dc-7129-11e6-a89e-0242ac12000b,IVAX SUB TEVA PHARMS,ivax_sub_teva_pharms,,,,,, -2503,,2344e167-a5ad-40f9-98f5-efcffd676091,GSO Global Clinical Research B.V,gso_global_clinical_research_b_v,,,,,, -2504,,53d5c287-401a-4ec5-a733-db80d8c368b3,E. Merck AB,e_merck_ab,,,,,, -1072,0.959984,d943ec30-97c3-4f8b-96df-4c65aab4025e,Danish Breast Cancer Group (BDCG),danish_breast_cancer_group_bdcg,,,,0e59fcb8-db64-490f-b629-84fe6f12827e,danish_breast_cancer_group_dbcg,Danish Breast Cancer Group (DBCG) -2505,,a73639bf-1432-43fb-90c3-800051cd1d48,Guys and St Thomas NHS Foundation Trust,guys_and_st_thomas_nhs_foundation_trust,,,,,, -151,0.968867,f875fece-bc54-4d3d-b6d3-a15de3894a92,Institute of Cancer research and molecular medicine,institute_of_cancer_research_and_molecular_medicine,,,,17459e96-4beb-4a3a-bba1-71e183697af9,institute_of_cancer_research,Institute of Cancer Research -910,0.9759957492351532,b7983b78-cf39-48ab-8d1d-be637a853547,Laboratorios Servier SL,laboratorios_servier_sl,,,,32161af5-1f02-447e-a38b-e0f0858697d7,laboratorios_servier,Laboratorios Servier -2506,,e210b1dd-76ef-4af7-a96a-8812beb53ca5,Servier Research and Development Ltd (for UK only),servier_research_and_development_ltd_for_uk_only,,,,,, -2507,,a58751fd-470c-400d-aacb-4e1822dfdccf,E.M.N. - EUROPEAN MYELOMA NETWORK,e_m_n_european_myeloma_network,,,,,, -2508,,073f0d4b-fd1d-49f7-98e3-ae03670d93b3,"MRC Clinical Trials Unit, Cancer Division",mrc_clinical_trials_unit_cancer_division,,,,,, -2509,,c45bcf64-7166-11e6-a0cd-0242ac12000b,WILSHIRE PHARMS INC,wilshire_pharms_inc,,,,,, -2510,,2316b8ad-ce99-4a60-a8db-fc7e952b0834,TAYS Sydänkeskus Oy,tays_syd_nkeskus_oy,,,,,, -2511,,a8a16462-259b-4913-96ab-2082154ab070,New Medical Enzymes AG,new_medical_enzymes_ag,,,,,, -2512,,69c107a6-e7ab-4707-89db-44c34c69471b,Per H. Rosenberg,per_h_rosenberg,,,,,, -2513,,d5c1d888-6c32-4065-b7f1-9b7857947a08,"SBI Pharmaceuticals Co., Ltd",sbi_pharmaceuticals_co_ltd,,,,,, -2514,,22725360-5e5f-48e7-96ba-ff3ca81cd759,Logical Therapeutics Inc,logical_therapeutics_inc,,,,,, -2515,,f847057d-154a-4436-8b6c-bae3ea8b9ceb,"Ethicon Inc., a Johnson & Johnson Co",ethicon_inc_a_johnson_johnson_co,,,,,, -57,0.9411388635635376,a64aa1b6-6fbe-11e6-abe8-0242ac12000b,Wyeth Research Division of Wyeth Pharmaceuticals Inc.Clinical Research & Development Department,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_development_department,,,,1d53dcae-9b86-416e-9d92-a62412245dcc,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_development,"Wyeth Research Division of Wyeth Pharmaceuticals, Inc. Clinical Research & Development" -2516,,696f7623-9220-4025-9662-796e0328e438,OPi,opi,,,,,, -2517,,8a2fd13d-592b-4717-93f3-dd801d1eaccd,DIPAK Consortium,dipak_consortium,,,,,, -2518,,c2512063-8e43-4610-b09a-614da94fff75,Verisfield (UK) Ltd,verisfield_uk_ltd,,,,,, -2519,,b59de1f0-6f9b-11e6-9663-0242ac12000b,Stiefel Laboratories Inc,stiefel_laboratories_inc,,,,,, -2520,,b9501075-0d16-4e96-97ea-27066331f5c7,SOCIETA` ITALIANA DI ANDROLOGIA,societa_italiana_di_andrologia,,,,,, -819,0.912088,ec01752b-56f3-496e-9ff4-7c90ad1666dc,UNIVERSITA DEGLI STUDI DI PAVIA,universita_degli_studi_di_pavia,,,,bf66c8e7-dc46-4d4b-a5d0-60ce8486fef9,universita_degli_studi_di_parma,UNIVERSITA` DEGLI STUDI DI PARMA -579,0.98861104249954224,4f145c09-2deb-446d-b29d-1c733e1a550e,"Wyeth Pharmaceuticals Inc., acting through its division of Wyeth Research",wyeth_pharmaceuticals_inc_acting_through_its_division_of_wyeth_research,,,,2087c696-3203-4dfa-967f-2d9749dedb6f,wyeth_pharmaceuticals_inc_acting_through_its_division_of_wyeth_research_a_pfizer_company,"Wyeth Pharmaceuticals Inc., acting through its division of Wyeth Research, a Pfizer company" -2521,,a5592bcf-b2a9-4eef-87b4-32f428e1cd67,Universitätsklinikum Heidelberg,universit_tsklinikum_heidelberg,,,,,, -846,0.94804,8e57a7f2-6f76-49f9-afae-1f3f5c9f50b4,"Eyetech Pharamceuticals, Inc",eyetech_pharamceuticals_inc,,,,8e57a7f2-6f76-49f9-afae-1f3f5c9f50b4,eyetech_pharamceuticals_inc,"Eyetech Pharamceuticals, Inc" -2522,,7b55278e-8358-4717-8e71-d41b21058f00,"SCHWARZ BIOSCIENCES, GmbH, Miembro del Grupo UCB",schwarz_biosciences_gmbh_miembro_del_grupo_ucb,,,,,, -2523,,08a36ab5-a610-40b0-94df-d3cd9c2aab40,Polichem S.A,polichem_s_a,,,,,, -2524,,a08b493b-1115-44ee-91f2-eb85a7aa2d08,"CoMentis, Inc., USA",comentis_inc_usa,,,,,, -2525,,e268185a-6d94-4087-83c8-3be004288014,Central Manchester and Manchester Children's University NHS trust,central_manchester_and_manchester_children_s_university_nhs_trust,,,,,, -2526,,dd9a4d86-cf13-4dce-81c9-54423e3b27c6,Jose Carlos Flores González,jose_carlos_flores_gonz_lez,,,,,, -2527,,060718e6-72fd-11e6-a0cd-0242ac12000b,INSTITUT BIOCHIMIQUE,institut_biochimique,,,,,, -210,0.944644,7fb393d1-3662-49ec-8f79-16654d5ad677,Finnish Braest Cancer Group,finnish_braest_cancer_group,,,,0b4f5fcf-dbeb-40d7-9a94-9cb3a8d69d76,finnish_breast_cancer_group,Finnish Breast Cancer Group -2528,,a47cae2f-c087-4a4e-87c8-9fa94556d4dc,Inserm-ISP Pole Recherches cliniques et thérapeutiques,inserm_isp_pole_recherches_cliniques_et_th_rapeutiques,,,,,, -2529,,df50c7b2-f49f-4a07-9225-d5914fceca52,Dept anaesthesiology and intensive care,dept_anaesthesiology_and_intensive_care,,,,,, -2530,,64553f92-f0c1-41ae-ac91-ebc7bf5ab5ec,The Royal Liverpool University Hospital NHS Trust,the_royal_liverpool_university_hospital_nhs_trust,,,,,, -2531,,c0d5e646-7255-11e6-a0cd-0242ac12000b,PACIRA PHARMS INC,pacira_pharms_inc,,,,,, -2532,,8d24c35d-f2af-4a15-b998-c3c54bc6ffa3,"Unilfarma - União Internacional de Lab. Farmacêuticos, Lda",unilfarma_uni_o_internacional_de_lab_farmac_uticos_lda,,,,,, -2533,,3b3963bc-7167-11e6-a0cd-0242ac12000b,UCSF RODIOPHARM,ucsf_rodiopharm,,,,,, -2534,,bbaea4a6-8fc9-4523-83eb-1195c557c829,EBEWE Pharma Ges.m.b.H Nfg.KG,ebewe_pharma_ges_m_b_h_nfg_kg,,,,,, -2535,,ee041bb3-e14b-4de3-abd4-74873e97791e,TECHNI-PHARMA,techni_pharma,,,,,, -2536,,aa559ac5-ca14-4fa8-b33b-a41ae73d2bc2,"Barrier Therapeutics, Inc",barrier_therapeutics_inc,,,,,, -2537,,ac9f4ccc-8acd-451b-aa16-124bff24eccd,Laboratoire Innotech International,laboratoire_innotech_international,,,,,, -2538,,cd4203cf-aba0-43b0-af98-daf0e5767501,York Pharma GmbH,york_pharma_gmbh,,,,,, -2539,,43b74e40-95d5-11e6-becf-0242ac110008,WEST-WARD PHARMS INT,west_ward_pharms_int,,,,,, -2540,,869c3698-7191-11e6-a0cd-0242ac12000b,CONSOLIDATED MIDLAND,consolidated_midland,,,,,, -14,0.95796602964401245,f569f240-7fd2-4fc3-b7f2-3c2a20010671,Menarini International Operations Luxembourg SA,menarini_international_operations_luxembourg_sa,,,,41be544c-1f46-41e5-bb1b-0bb3baefda2e,menarini_international_operation_luxembourg_sa,Menarini International Operation Luxembourg S.A -2541,,2a18e5e0-c196-4861-a862-efb4afde6259,"Department of Pulmonology, Rijnstate Hospital",department_of_pulmonology_rijnstate_hospital,,,,,, -2542,,66a728ee-abd0-49ce-96cd-cb1a7020bdc0,Hospital General de Granollers,hospital_general_de_granollers,,,,,, -325,0.9791768491268158,0292d041-5c8d-4dee-ba50-01c0869a5672,"Ferrer Internacional, S.A",ferrer_internacional_s_a,,,,199a1dd6-828f-4e0b-b783-d712bad32b9e,ferrer_internacional,Ferrer Internacional -2543,,265c309e-d8ee-41d0-90a2-a012daf5692d,Merck Generics UK Ltd,merck_generics_uk_ltd,,,,,, -534,0.974154,c768dbb0-8719-4eac-87b7-85a4bd69abf0,"R&D Department,",r_d_department,,,,26b8ea41-7b0c-465a-88f2-0c4f81b680ce,r_d_department_box_146_addenbrooke_s_hospital,"R&D Department, Box 146, Addenbrooke's Hospital" -340,0.98418444395065308,c2050242-2845-4f5c-bc40-956b4ae6c60d,Intercytex,intercytex,,,,02763460-e885-4cb3-a951-4a777203fe35,intercytex_ltd,Intercytex Ltd -2544,,bd324332-a52e-4288-a7e5-2181703fb46d,University of Regensburg,university_of_regensburg,,,,,, -2545,,ca0ae959-94c5-4ef0-b1f3-c9a0a676dfb0,Pfizer ApS,pfizer_aps,,,,,, -1021,0.97737881541252136,8ba0704e-f5bd-4a63-ab3d-b93274d707ee,"Impax Laboratories, Inc. acting through its Impax Pharmaceuticals Division",impax_laboratories_inc_acting_through_its_impax_pharmaceuticals_division,,,,2e27f2ec-dcc5-4828-b31a-e2eca3930c17,impax_laboratories_inc_acting_through_its_impax_pharmaceuticals_division_impax,"Impax Laboratories, Inc., acting through its Impax Pharmaceuticals Division (Impax)" -2546,,a692601e-c115-4d7a-9ce9-f47382f2f4a7,THERABEL PHARMACEUTICAL Ltd,therabel_pharmaceutical_ltd,,,,,, -2547,,6992edc5-f356-416c-b38c-413873f64761,AMGEN S.P.A,amgen_s_p_a,,,,,, -547,0.96279633045196533,8f1a10a0-5c3a-45de-a1fa-2ff0f80316bf,G.O.N.O,g_o_n_o,,,,8f1a10a0-5c3a-45de-a1fa-2ff0f80316bf,g_o_n_o,G.O.N.O -2548,,0ab50354-ae03-4fe3-9397-f7de7f9fc374,MIPHARM,mipharm,,,,,, -198,0.96630248427391052,59af07b2-8bdc-4113-8ce3-1b459956f500,Agence nationale de recherches sur le sida et les hépatites virales (National Agency for AIDS-ANRS),agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales_national_agency_for_aids_anrs,,,,59af07b2-8bdc-4113-8ce3-1b459956f500,agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales,Agence nationale de recherches sur le sida et les hépatites virales -2549,,f9214ef8-7167-11e6-a0cd-0242ac12000b,SANJA PHARMS CO,sanja_pharms_co,,,,,, -2550,,61bd0d18-7167-11e6-a0cd-0242ac12000b,SHERTECH LABS LLC,shertech_labs_llc,,,,,, -2551,,273125b7-6fc5-444e-81aa-580abfad0acf,Investigator Trondheim Hudlegesenter AS,investigator_trondheim_hudlegesenter_as,,,,,, -2552,,a37cb91c-a24c-4183-91dd-d9ee6e699ce3,Laboratories León Farma S.A,laboratories_le_n_farma_s_a,,,,,, -2553,,b2ec6574-3b70-4903-891b-3c514a6140ea,The Back Research center,the_back_research_center,,,,,, -2554,,59f328b2-fe43-4649-b8b1-c55777b2848a,Erempharma SAS,erempharma_sas,,,,,, -2555,,b5c912a2-3fb2-4f35-b29f-d55defaa9696,JOSEP ORDI-ROS,josep_ordi_ros,,,,,, -2556,,d5a733c6-7161-11e6-a0cd-0242ac12000b,UDL,udl,,,,,, -2557,,0712daf2-6f70-469e-9158-797040198dae,Lightlake Sinclair Oy,lightlake_sinclair_oy,,,,,, -840,0.98523330688476562,9d9eb480-bf21-4092-839f-09f898baa735,JANSSEN-CILAG,janssen_cilag,,,,3db31bd4-ebf3-4e55-8979-0617fa1fc589,janssen_cilag_gmbh,JANSSEN-CILAG GmbH -2558,,42afcaae-2e6e-4428-a256-ae07d9645abd,Nordic Bioscience A/S,nordic_bioscience_a_s,,,,,, -43,0.978791,38b6ac83-2901-4af7-b81e-62ce14bad7cc,Nordic Society of Gynaecological Oncology (NSGO),nordic_society_of_gynaecological_oncology_nsgo,,,,38b6ac83-2901-4af7-b81e-62ce14bad7cc,nordic_society_of_gynaecological_oncology_nsgo,Nordic Society of Gynaecological Oncology (NSGO) -363,0.953188,e6c54f15-e683-4ea1-9a75-6d49165a6ff5,AZIENDA OSPEDALIERA S. GERARDO DI MONZA,azienda_ospedaliera_s_gerardo_di_monza,,,,6d5782a7-67e2-4374-a6a3-c1e2c79b8eb4,azienda_ospedaliera_san_gerardo_di_monza,AZIENDA OSPEDALIERA SAN GERARDO DI MONZA -2559,,eede47d6-7197-11e6-a0cd-0242ac12000b,HRA PHARMA,hra_pharma,,,,,, -2560,,33dae41b-85a1-48cf-a750-795711775339,Medicis Pharmaceutical Corporation,medicis_pharmaceutical_corporation,,,,,, -2561,,024b7fd9-9fbc-4854-88e1-acaedd822508,"Nippon Shinyaku Co., Ltd",nippon_shinyaku_co_ltd,,,,,, -2562,,57e68227-ef30-4396-9070-835860ac80de,Novartis Hungária Kft,novartis_hung_ria_kft,,,,,, -436,0.95831960439682007,70a57a39-1462-4239-a163-1968d0d1a9d3,"Pfizer Inc, 235 East 42nd Street, New York, NY10017, United States",pfizer_inc_235_east_42nd_street_new_york_ny10017_united_states,,,,25203332-c6eb-4eda-87c7-a780f5142133,pfizer_inc_235_east_42nd_street_new_york_ny10017_united_states,"Pfizer Inc., 235 East 42nd Street, New York, 10017, United States" -2563,,9cee772c-7168-11e6-a0cd-0242ac12000b,ADVANCE BIOFACTURES,advance_biofactures,,,,,, -2564,,21d2bedb-b9ab-4871-ba3e-2f73706d0c7e,Roche Slovensko s.r.o,roche_slovensko_s_r_o,,,,,, -901,0.952896,ffeff90c-563b-439c-969c-9d5ba8527f28,Fundació Privada Clinic per la Recerca Biomèdica,fundaci_privada_clinic_per_la_recerca_biom_dica,,,,465a5556-c902-495a-8a94-7999cb29da09,fundaci_privada_cl_nic_per_a_la_recerca_biom_dica,Fundació Privada Clínic per a la Recerca Biomèdica -2565,,c2a7c909-20f0-474d-bd90-c76772fe0bf3,INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS),instituto_de_investigaciones_biomedicas_august_pi_i_sunyer_idibaps,,,,,, -2566,,9b0efc58-6487-48cc-b571-7c9725f6fc67,Institut Bergonié - Centre Régional de Lutte Contre le Cancer de Bordeaux et du Sud-ouest,institut_bergoni_centre_r_gional_de_lutte_contre_le_cancer_de_bordeaux_et_du_sud_ouest,,,,,, -2567,,cb08ba3c-7311-11e6-a0cd-0242ac12000b,HISAMITSU PHARM CO,hisamitsu_pharm_co,,,,,, -216,0.972547,eb525a5a-b41f-456c-a3fc-544e7cf55e70,Universitätsklinik für Kinder-und Jugendheilkunde,universit_tsklinik_f_r_kinder_und_jugendheilkunde,,,,797c01ee-1dfa-4820-a53e-5dcb99477f68,universit_tsklinik_f_r_kinder_und_jugendheilkunde_medizinsiche_universit_t_wien,"Universitätsklinik für Kinder- und Jugendheilkunde, Medizinsiche Universität Wien" -2568,,37451c20-e607-4b7c-b15a-dfe4e86383ee,Erasme hospital,erasme_hospital,,,,,, -2569,,50a18d5b-e8ef-44aa-8907-4762b639b67b,"Bente Langdahl, consultant, ass. professor, PhD, DMSc",bente_langdahl_consultant_ass_professor_phd_dmsc,,,,,, -2570,,b3032470-0645-4179-861f-0f9bef551c6e,"Helsingin Yliopisto, Kemian laitos",helsingin_yliopisto_kemian_laitos,,,,,, -2571,,cc68c5cc-fdbb-4373-94c1-5ca552d98650,Instituto Oftalmológico de Alicante (VISSUM),instituto_oftalmol_gico_de_alicante_vissum,,,,,, -2572,,e61c4852-6fba-11e6-abe8-0242ac12000b,Life Recovery Systems,life_recovery_systems,,,,,, -2573,,71ed3db2-80df-4d61-95aa-7d3b77fd29ee,Biopure Corporation,biopure_corporation,,,,,, -2574,,f5e7e24a-7141-11e6-a0cd-0242ac12000b,TEDOR PHARM,tedor_pharm,,,,,, -2575,,da4e4290-8bb8-11e6-a449-0242ac12000b,Hospitalsenheden Horsens,hospitalsenheden_horsens,,,,,, -2576,,d992d79e-35f6-4ee4-9584-5ae8fbb2057d,Pfizer Inc. 235 East 42nd street – New York – 10017 NY - USA,pfizer_inc_235_east_42nd_street_new_york_10017_ny_usa,,,,,, -2577,,6a4a0eba-1959-4494-9e58-bdb7da7ada01,GlaxoSmithKline Research & Development Limited,glaxosmithkline_research_development_limited,,,,,, -2578,,25a60d16-71a8-11e6-a0cd-0242ac12000b,PRAGMA PHARMS LLC,pragma_pharms_llc,,,,,, -2579,,3bbe38b9-b3f4-4d58-811e-8dba91c20f92,"University Medical Centre St. Radboud, Department of Dermatology",university_medical_centre_st_radboud_department_of_dermatology,,,,,, -2580,,5fb82390-a41b-4a84-bc3e-70e50d1b3f13,"GETAID, Jean Minjoz Hospital",getaid_jean_minjoz_hospital,,,,,, -2581,,5de3af86-01b2-411e-9170-4c2ec5449fd0,ThromboGenics Ltd,thrombogenics_ltd,,,,,, -946,0.987167,4cc8b53a-0566-477c-a16e-fcd4919e14fe,Universität Leipzig,universit_t_leipzig,,,,4cc8b53a-0566-477c-a16e-fcd4919e14fe,universit_t_leipzig,Universität Leipzig -2582,,21cbeb95-1682-4a22-b1c7-10bd3d31f344,University Hospital of Zurich and City Hospital Waid,university_hospital_of_zurich_and_city_hospital_waid,,,,,, -2583,,25cf526b-16f4-4daa-b8e5-95c76af72eac,"KaloBios Pharmaceuticals, Inc",kalobios_pharmaceuticals_inc,,,,,, -389,0.989307,b0142515-efdf-489a-bd08-d53f5508a4ba,Ludwig Institute for Cancer Research,ludwig_institute_for_cancer_research,,,,b0142515-efdf-489a-bd08-d53f5508a4ba,ludwig_institute_for_cancer_research,Ludwig Institute for Cancer Research -2584,,e4a07adb-d315-4c0b-a729-ae7a905dd171,CKF at Västmanlands hospital Västerås,ckf_at_v_stmanlands_hospital_v_ster_s,,,,,, -2585,,0150ae11-2d58-41c8-89c9-91e7a8b52b42,Alimera Science Inc,alimera_science_inc,,,,,, -2586,,7c29e3db-7764-4c57-83c7-c7ce51e36422,Dekan des FB Medizin der Johann-Wolfgang Goethe-Universität,dekan_des_fb_medizin_der_johann_wolfgang_goethe_universit_t,,,,,, -2587,,49699c3a-715e-11e6-a0cd-0242ac12000b,UNICHEM LABS LTD,unichem_labs_ltd,,,,,, -2588,,3caddc74-7161-11e6-a0cd-0242ac12000b,OLTA PHARMS,olta_pharms,,,,,, -2589,,10e077a6-80ef-404a-8239-766b4e475635,"Saniona, A/S",saniona_a_s,,,,,, -2590,,5ead929b-bc15-4457-a6be-e163543c68b9,CUB Erasme Hospital,cub_erasme_hospital,,,,,, -2591,,a1c8d7c5-930d-4de9-95e6-efb2eb0b3542,Artu Biologicals Europe BV,artu_biologicals_europe_bv,,,,,, -2592,,19371419-7ff8-4a2a-a319-40135b928879,"Department of experimental and clinical medicine ""F. Magrassi",department_of_experimental_and_clinical_medicine_f_magrassi,,,,,, -2593,,4a057ad0-0954-440e-be12-6707eb1c7413,Grupo Oncológico para el Tratamiento y Estudio de los Linfomas (GOTEL),grupo_oncol_gico_para_el_tratamiento_y_estudio_de_los_linfomas_gotel,,,,,, -652,0.95031802356243134,241bd917-a30c-4145-b0b2-d1232db3c592,Boehringer Ingelheim KS,boehringer_ingelheim_ks,,,,756fbf26-6aec-45b4-9273-9afca275034e,boehringer,Boehringer -2594,,2d5b4b82-c4d6-4905-84e0-f71dae9ac4b4,"dept of endocrinology J 106, herlev Hosptial",dept_of_endocrinology_j_106_herlev_hosptial,,,,,, -2595,,7c015004-73e1-11e6-a0cd-0242ac12000b,SHIRE DEV LLC,shire_dev_llc,,,,,, -2596,,d65dcd42-453e-46d7-854b-400ec51ec742,"Respiratory Research Unit, Bispebjerg Hospital",respiratory_research_unit_bispebjerg_hospital,,,,,, -2597,,3e19cd09-3d60-4afa-87fb-0faf41d6d41a,University Hospital Innsbruck,university_hospital_innsbruck,,,,,, -2598,,afbcef29-1495-49da-96d6-2c4493294ccd,Sager Pharma Ltd,sager_pharma_ltd,,,,,, -2599,,5515bd50-49b2-4503-8732-1a26ab7b1d39,Azienda Ospedaliera Universitaria Integrata Verona,azienda_ospedaliera_universitaria_integrata_verona,,,,,, -2600,,b14ca4dd-82c2-492b-a2a5-5bf27c0bca1b,FONDAZIONE ANGELO BIANCHI BONOMI,fondazione_angelo_bianchi_bonomi,,,,,, -2601,,8c4a4e9b-08a9-4d26-b2f3-d4cdfea5b812,"Medizinische Universiätsklinik Graz, Abteilung für Endokrinologie und Nuklearmedizin",medizinische_universi_tsklinik_graz_abteilung_f_r_endokrinologie_und_nuklearmedizin,,,,,, -2602,,f48bd0ef-b570-4f57-8d0a-9708d05641cd,Janssen Pharmaceutica NV,janssen_pharmaceutica_nv,,,,,, -2603,,bfadd40a-f174-4e44-9310-44bf1ec99b6e,Velindre NHS Trust,velindre_nhs_trust,,,,,, -2604,,47ee3d3a-ab8c-47a1-ae04-4fb13b562ba4,UCB Biosciences GmbH,ucb_biosciences_gmbh,,,,,, -558,0.984864,19dd85ae-7144-11e6-a0cd-0242ac12000b,FERA PHARMS,fera_pharms,,,,19dd85ae-7144-11e6-a0cd-0242ac12000b,fera_pharms,FERA PHARMS -2605,,633e647c-abd3-4880-835d-793b0f66949d,Westfriesgasthuis,westfriesgasthuis,,,,,, -2606,,53384ef2-e877-487f-be83-6ef76ea3b9a6,Grupo Español de Tratamiento de Tumores Digestivos-TTD,grupo_espa_ol_de_tratamiento_de_tumores_digestivos_ttd,,,,,, -2607,,89cea462-7142-11e6-a0cd-0242ac12000b,MERZ PHARMS,merz_pharms,,,,,, -2608,,7dc45f4e-b825-4016-ac2d-87df73231e9a,Department of Endocrine Oncology,department_of_endocrine_oncology,,,,,, -71,0.95618447661399841,b67e60ae-e98f-4e54-abdb-b3347456bc5c,Takeda Europe R&D Centre Ltd,takeda_europe_r_d_centre_ltd,,,,a50a5323-eb43-4b40-8b80-cb222451e80b,takeda,Takeda -83,0.96475303173065186,82a6c5b2-dbb3-4ec5-851e-95e3fe015b13,"Medizinische Universität Wien, Universitätsklinik für Psychiatrie und Psychotherapie",medizinische_universit_t_wien_universit_tsklinik_f_r_psychiatrie_und_psychotherapie,,,,2e778965-4803-4c24-80eb-b2a9fc5651e6,medizinische_universit_t_wien_universit_tsklinik_f_r_psychiatrie_u_psychotherapie_abteil_f_r_biologische_psychiatrie,"Medizinische Universität Wien, Universitätsklinik für Psychiatrie u. Psychotherapie, Abteil. für biologische Psychiatrie" -2609,,1fadb2ef-b28e-4b35-8344-8ca9336c1150,"Center for Digestive Diseases, Karolinska University Hospital",center_for_digestive_diseases_karolinska_university_hospital,,,,,, -2610,,8b11de34-7165-11e6-a0cd-0242ac12000b,CHEM WERTH INC,chem_werth_inc,,,,,, -2611,,fd580de4-44be-4021-87b7-27de7e433a28,Abiogen Pharma SpA,abiogen_pharma_spa,,,,,, -912,0.988197,5ab6cc31-5c5f-48d7-b051-b6fa3cd71433,"Aarhus University Hospital, Skejby",aarhus_university_hospital_skejby,,,,3603d959-b219-470b-be2c-d1bcd4a7c148,aarhus_university_hospital_skejby_sygehus,"Aarhus University Hospital, Skejby sygehus" -2612,,e81faa5e-c3e4-4993-bae0-2a43cfee5d00,"The Police Rehabilitation Centre, Flint House",the_police_rehabilitation_centre_flint_house,,,,,, -2613,,d53179e8-6654-43cf-93f9-9bb6a698a35f,Janssen Cliag Ltd. C/O Johnson & Johnson PRD,janssen_cliag_ltd_c_o_johnson_johnson_prd,,,,,, -2614,,8778dead-c85f-42df-8040-c13c5e603b61,Czech Lymphoma Research Organization s.r.o. (CLRO),czech_lymphoma_research_organization_s_r_o_clro,,,,,, -2615,,7213434e-7167-11e6-a0cd-0242ac12000b,SIDMAK LABS INDIA,sidmak_labs_india,,,,,, -2616,,15f39481-07e8-4829-aaa8-99818f811c78,Johan Styrke,johan_styrke,,,,,, -2617,,e2a92b6e-4bbc-46e5-8bc1-4f3483345d9b,"Dept. of Anaesthesia and Intensive Care, Haukeland University Hospital",dept_of_anaesthesia_and_intensive_care_haukeland_university_hospital,,,,,, -2618,,1450cbd2-c282-4758-be96-96a452d58b96,Dr John Berth-Jones,dr_john_berth_jones,,,,,, -682,0.982418,23ad1ae6-2f3f-4ff6-98ef-777036a904b2,"Genentech, Inc",genentech_inc,,,,23ad1ae6-2f3f-4ff6-98ef-777036a904b2,genentech_inc,"Genentech, Inc" -2619,,82fb066b-8762-49a7-9276-27c739d32bf6,Fertility clinic Odense University Hospital,fertility_clinic_odense_university_hospital,,,,,, -2620,,5690ee55-e932-4c92-9823-ee21e2adef49,"Gilead Sciences, S.L",gilead_sciences_s_l,,,,,, -2621,,dc38435a-b194-4bad-bb30-57eafa38cfcb,"R&D Dept Raigmore Hospital, Inverness",r_d_dept_raigmore_hospital_inverness,,,,,, -636,0.988732,d340f3f9-d2dc-4928-902a-5b85cded2bdf,La Jolla Pharmaceutical Company,la_jolla_pharmaceutical_company,,,,0a4a7604-18d1-4751-9003-e209b313dd54,la_jolla_pharmaceutical_company_inc,"La Jolla Pharmaceutical Company, Inc" -2622,,2e8fabf6-ac68-432a-b849-e39b6bbd876e,Merck Sharp and Dohme Ltd,merck_sharp_and_dohme_ltd,,,,,, -2623,,5e8901d8-7144-11e6-a0cd-0242ac12000b,TORRENT PHARMA INC,torrent_pharma_inc,,,,,, -2624,,cf1b1338-f436-485e-87e7-71984d4023ad,Nordic MDS study group,nordic_mds_study_group,,,,,, -2625,,f4f652ac-6f9f-11e6-9663-0242ac12000b,"Ludwig-Maximilian-University of Munich, Department of Psychiatry",ludwig_maximilian_university_of_munich_department_of_psychiatry,,,,,, -2626,,4916ced7-e8fa-45a5-be46-09e714b462a7,CHU de Brest,chu_de_brest,,,,,, -2627,,fda5b1a3-f073-4f8f-ba74-b07e5914c58d,King's College London (Institute of Pyschiatry),king_s_college_london_institute_of_pyschiatry,,,,,, -2628,,e8f71fcc-b0b3-4c24-a766-259f47e88db5,"Astellas Global Pharma Development, Inc",astellas_global_pharma_development_inc,,,,,, -2629,,f0c91420-fa22-4165-8abd-76181b86384e,Pharmarama International Limited,pharmarama_international_limited,,,,,, -2630,,4833be49-1581-4533-a64b-ca081b6ab458,"University Hospital Schleswig-Holstein, Campus Luebeck",university_hospital_schleswig_holstein_campus_luebeck,,,,,, -974,0.97215098142623901,4cbb7e37-feeb-4dcf-a21f-ec40d4959c01,Universitätsklinikum Schleswig-Holstein UKSH,universit_tsklinikum_schleswig_holstein_uksh,,,,4cbb7e37-feeb-4dcf-a21f-ec40d4959c01,universit_tsklinikum_schleswig_holstein,Universitätsklinikum Schleswig-Holstein -2631,,61786956-9d2e-4ef9-bc65-e09f9689909a,"Semmelweis University, 2nd Department of Pediatrics",semmelweis_university_2nd_department_of_pediatrics,,,,,, -2632,,4fc5a22b-dc4e-4a7d-af36-1858f6ab4efe,ITALFARMACO,italfarmaco,,,,,, -2633,,39d265c7-8e4f-4288-8596-f25b54271d95,GRUPO DE TERAPIA CELULAR Y CARDIOVASCULAR DEL HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS,grupo_de_terapia_celular_y_cardiovascular_del_hospital_universitario_central_de_asturias,,,,,, -2634,,4ae05081-0b62-437f-9ac6-e91200cb4b8d,Leeds Teaching Hospitals R and D department,leeds_teaching_hospitals_r_and_d_department,,,,,, -2635,,4393a359-d6f4-4323-8bac-8e6bf8a0038a,Institute of Medicinal Molecular Design Inc,institute_of_medicinal_molecular_design_inc,,,,,, -2636,,59a594c9-8a23-4f96-b3e1-ad6f416b0438,Neurobiological Technologies Inc,neurobiological_technologies_inc,,,,,, -2637,,03c2824a-197d-480d-a59f-07ede9518797,"Department of Anesthesiology, Næstved Hospital",department_of_anesthesiology_n_stved_hospital,,,,,, -2638,,d6eb1925-c8da-499e-83e9-9b56d833cd87,Asahi Kasei Pharma America Corporation,asahi_kasei_pharma_america_corporation,,,,,, -2639,,c57efd66-5424-4bae-a1b5-c6f6282cb2b2,"CTSU, University of Oxford",ctsu_university_of_oxford,,,,,, -2640,,8a188e3f-fe75-4d7d-884e-8d92d646787e,University of Oxford- Research Services,university_of_oxford_research_services,,,,,, -2641,,8944751d-52f3-4a66-9d27-6594f8ee5021,"Katedra za biofarmacijo in farmakokinetiko, Fakulteta za farmacijo",katedra_za_biofarmacijo_in_farmakokinetiko_fakulteta_za_farmacijo,,,,,, -2642,,7f366c5b-9b4e-4b62-bb96-780b3c389fb1,"Liver Unit, ICMD, Hospital Clinic Barcelona",liver_unit_icmd_hospital_clinic_barcelona,,,,,, -2643,,e11298fd-7e82-4d3a-a2ed-5b898594fca7,NeuroNova AB,neuronova_ab,,,,,, -2644,,ed0805e1-babe-4ef2-b436-187d6a1ef3ac,RICARDO MORENO OTERO/MARIA CHAPARRO SANCHEZ,ricardo_moreno_otero_maria_chaparro_sanchez,,,,,, -2645,,4e663cf5-0d65-4e67-85cd-5bbe2e1c7f91,Dudley Group of Hospitals NHS Trust,dudley_group_of_hospitals_nhs_trust,,,,,, -2646,,7567410b-cd75-40a5-96fd-91c865d75368,Akron Molecules GmbH,akron_molecules_gmbh,,,,,, -2647,,16d69809-6da2-4ac3-a611-6632602c676b,"Medizinische Universitätsklinik II , Abteilung Hämatologie, Onkologie, Immunologie und Rheumatologie",medizinische_universit_tsklinik_ii_abteilung_h_matologie_onkologie_immunologie_und_rheumatologie,,,,,, -2648,,8ad7471f-2e88-4fb5-8d8b-4840a20c0820,"HY, HUS",hy_hus,,,,,, -2649,,b52dd2f8-c4c6-4146-84f3-93bee29751ca,Targid University Leuven,targid_university_leuven,,,,,, -212,0.976266,0a79ad16-61bb-4290-895a-ee60dfc583b0,POXEL,poxel,,,,0a79ad16-61bb-4290-895a-ee60dfc583b0,poxel,POXEL -232,0.98418444395065308,50e4806a-7145-11e6-a0cd-0242ac12000b,ACS DOBFAR SPA,acs_dobfar_spa,,,,455b5028-7142-11e6-a0cd-0242ac12000b,acs_dobfar,ACS DOBFAR -2650,,f1191cdb-a43d-455c-a5aa-42898eb770aa,"HUS, Korvaklinikka",hus_korvaklinikka,,,,,, -2651,,09c8066b-8845-43f7-bea1-b3769d623747,"Sahlgrenska Acadademy, GU",sahlgrenska_acadademy_gu,,,,,, -2652,,218069e4-e1de-4079-9e41-017fa4c1aa0a,Università degli Studi di Torino e Azienda Ospedaliera Città della Salute e della Scienza di Torino,universit_degli_studi_di_torino_e_azienda_ospedaliera_citt_della_salute_e_della_scienza_di_torino,,,,,, -247,0.98111611604690552,5796905e-d697-4a3c-a2d1-98d6d9104b0c,Hoffmann-La Roche,hoffmann_la_roche,,,,5796905e-d697-4a3c-a2d1-98d6d9104b0c,hoffmann_la_roche,Hoffmann-La Roche -2653,,67f9b628-7161-11e6-a0cd-0242ac12000b,ROSEDALE THERAPEUTIC,rosedale_therapeutic,,,,,, -2654,,7fc672e3-6724-4321-88a0-21adb585ec7b,Ullevål University Hospital,ullev_l_university_hospital,,,,,, -2655,,25aae276-8e00-4681-a3f1-eb556395eb28,Gebro Pharma GmbH,gebro_pharma_gmbh,,,,,, -184,0.973246,33152a86-6668-4582-ab39-412be4051a25,"Stockholm County Council, Karolinska University Hospital Huddinge, Dept of Anesthesiology and Intensive Care",stockholm_county_council_karolinska_university_hospital_huddinge_dept_of_anesthesiology_and_intensive_care,,,,035cad6f-a78e-4045-bb2b-51fc73fd33c1,stockholm_county_council_karolinska_university_hospital_huddinge_department_of_anesthesiology_and_intensive_care,"Stockholm County Council, Karolinska University Hospital Huddinge, Department of Anesthesiology and Intensive Care" -2656,,d5c9e23d-3d33-4aad-bd15-48f79cdc9896,"Medical Faculty, University Magdeburg",medical_faculty_university_magdeburg,,,,,, -2657,,67305436-8e27-4e48-b21e-9b8651145cf8,Enric Pedrol Clotet. Unidad Enfermedades Infecciosas.Hospital de Granollers,enric_pedrol_clotet_unidad_enfermedades_infecciosas_hospital_de_granollers,,,,,, -2658,,e8356348-a1c9-4eae-b38f-d865a9e13e84,"CoLucid Pharmaceuticals, Inc",colucid_pharmaceuticals_inc,,,,,, -2659,,b30441c5-5506-4dec-a574-0fae240fb145,AMO Pharma Ltd,amo_pharma_ltd,,,,,, -998,0.987967,c5d79443-102d-4059-8c81-6eb489fc8ac7,Lipid Pharmaceuticals,lipid_pharmaceuticals,,,,43136b72-9ea5-4280-955b-222830e86bf5,lipid_pharmaceuticals_ehf,Lipid Pharmaceuticals ehf -2660,,e28f1c52-aed1-4448-8ec2-8b0e3aa44143,"Dance Biopharm, Inc",dance_biopharm_inc,,,,,, -2661,,804172f4-5831-45ac-b009-5e1f9a81fef6,"Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari-Università di Padova",dipartimento_di_scienze_cardiologiche_toraciche_e_vascolari_universit_di_padova,,,,,, -2662,,aac77ddf-0802-4398-bfb7-5a0425c7dfcf,Novalon S.A,novalon_s_a,,,,,, -2663,,2a67d829-08ae-4fa5-811a-71f0d84087ee,Dilaforette AB,dilaforette_ab,,,,,, -2664,,9facda36-0d75-44fa-8de1-efdfe3c28fb6,Zdravstveni dom dr. Adolfa Drolca Maribor,zdravstveni_dom_dr_adolfa_drolca_maribor,,,,,, -2665,,d43a2a4e-daad-4209-b655-334aa981bb26,Cebix Incorporated,cebix_incorporated,,,,,, -2666,,af59b0a0-1037-496e-a3a8-dc6a725ceff3,AZIENDA SANITARIA LOCALE 9 DI GROSSETO,azienda_sanitaria_locale_9_di_grosseto,,,,,, -2667,,04de951e-7142-11e6-a0cd-0242ac12000b,RANBAXY LABS LTD,ranbaxy_labs_ltd,,,,,, -2668,,e52c6a7e-0ed3-4dcf-bd86-2cc1eebba4b4,"UZ KULeuven, service of Rheumatology",uz_kuleuven_service_of_rheumatology,,,,,, -2669,,d4796132-6235-4b6c-bf05-fc8288d63964,Amersham Buchler GmbH & Co KG an affiliate of GE Healthcare Bio-Sciences,amersham_buchler_gmbh_co_kg_an_affiliate_of_ge_healthcare_bio_sciences,,,,,, -2670,,05f919e2-c901-48de-aa21-4ea0bb08a61c,"Medizinische Universität Wien,Univ.Klinik f.Anästhesie, Intensivmedizin und Schmerztherapie",medizinische_universit_t_wien_univ_klinik_f_an_sthesie_intensivmedizin_und_schmerztherapie,,,,,, -2671,,1a3fbdc8-37cd-42ab-91f4-dd662a1007e4,"Senior Contracts Manager,Research and Enterprise,University of Glasgow",senior_contracts_manager_research_and_enterprise_university_of_glasgow,,,,,, -110,0.98208984732627869,7ab0aad4-ccd7-43a6-abf8-e331125b5500,Department of Oncology,department_of_oncology,,,,7ab0aad4-ccd7-43a6-abf8-e331125b5500,department_of_oncology_karolinska,Department of Oncology -2672,,09fbcaa5-2fe8-4d02-8138-b22aad4d43fd,"CLINICA DERMATOLOGICA POLICLINICO UMBERTO I ""SAPIENZA",clinica_dermatologica_policlinico_umberto_i_sapienza,,,,,, -2673,,55745818-7388-11e6-a0cd-0242ac12000b,ALKOPHARMA USA,alkopharma_usa,,,,,, -2674,,1443c1cd-b1a6-4bf3-9bb7-e123bac00e18,Steen Stender,steen_stender,,,,,, -2675,,6bd22256-cc46-46db-bdb8-d42e44fe4537,Dr. Willmar Schwabe GmbH &Co. KG,dr_willmar_schwabe_gmbh_co_kg,,,,,, -2676,,15ab5dbd-0764-4252-81f5-094ac9475d1b,ApaTech Limited,apatech_limited,,,,,, -1022,0.980344,9a9bdaa0-eda9-4f70-8e28-20f065d644e8,Ablynx,ablynx,,,,3d644372-21da-4da7-aba7-c8d44092d796,ablynx_nv,Ablynx NV -2677,,b11d61a7-2134-4b34-93cb-2493660dad4e,European Institute for Cystic Fibrosis Research (IERFC),european_institute_for_cystic_fibrosis_research_ierfc,,,,,, -2678,,e5767df2-ddc9-436a-b69a-ff765766fcde,"Univ. of Iceland, Dept. Pharmacol",univ_of_iceland_dept_pharmacol,,,,,, -2679,,feaae066-f638-4f32-854a-35d783c8df1c,Oscient Pharmaceuticals,oscient_pharmaceuticals,,,,,, -2680,,4aeb6ac4-08d4-4c41-8f9a-32574152f22f,Novartis Hungária Ltd,novartis_hung_ria_ltd,,,,,, -2681,,bb5c16ae-6b80-46fd-ae42-f0085f905393,Cambridge University Hospital (Addenbrookes Hospital),cambridge_university_hospital_addenbrookes_hospital,,,,,, -2682,,b885a74d-1d22-425c-a3ca-201e2136b823,Royal Wolverhampton Hospitals NHS Trust,royal_wolverhampton_hospitals_nhs_trust,,,,,, -2683,,3abdb564-73fb-11e6-a0cd-0242ac12000b,ST RENATUS,st_renatus,,,,,, -936,0.97166144847869873,15c72f9b-2bb4-403d-a772-1a67f29b1055,Royal Liverpool and Broadgreen University Hospitals Trust,royal_liverpool_and_broadgreen_university_hospitals_trust,,,,33e84b15-e25f-402d-bf4e-0f564d9c0255,royal_liverpool_and_broadgreen_university_hospitals_trust,Royal Liverpool and Broadgreen University Hospitals Trust -2684,,0d8682b6-d91d-4612-977d-c09a4f7aeca7,Northern Health and Social Care Trust,northern_health_and_social_care_trust,,,,,, -2685,,1bd76448-bf04-4d3f-9f36-a5accec8d01d,Silence Therapeutics GmbH,silence_therapeutics_gmbh,,,,,, -2686,,6a91c86e-d594-43c6-9e93-7870038691c5,"Handkirurgiska kliniken, Universitetssjukhuset Örebro",handkirurgiska_kliniken_universitetssjukhuset_rebro,,,,,, -628,0.980402,f7c53dd5-3744-4975-bd9a-6bc7e4e45dcc,"Queen's University Belfast, Research and Regional Services",queen_s_university_belfast_research_and_regional_services,,,,637afab2-e42f-4094-b3b3-6cf50354727c,queen_s_university_belfast,Queen's University Belfast -2687,,64d7a847-03b2-46d8-8e4f-75220d8cf6bf,"Freistaat Bayern, represented by the University of Regensburg",freistaat_bayern_represented_by_the_university_of_regensburg,,,,,, -2688,,5639eefe-7142-11e6-a0cd-0242ac12000b,ALPHARMA US PHARMS,alpharma_us_pharms,,,,,, -2689,,d005e72f-ef66-4e89-bda8-58b2206077d2,University Hospital Bristol NHS Foundation Trust,university_hospital_bristol_nhs_foundation_trust,,,,,, -2690,,5ad1051d-fbee-46ff-8d52-32244753b6a5,"Wyeth, a Pfizer Company",wyeth_a_pfizer_company,,,,,, -2691,,3e1cca1e-1f12-42b3-8de1-af6541e28783,AVI BioPharma Inc,avi_biopharma_inc,,,,,, -2692,,3fb43616-3d50-43cc-95ee-186113a2a462,Neocutis,neocutis,,,,,, -755,0.952513,773f19f3-a520-49fc-8b74-adda697fc76d,Sanofi Pasteur Korea Ltd,sanofi_pasteur_korea_ltd,,,,0c07c031-3aa4-42bd-a466-16b7d6794b5f,sanofi_pasteur_kk,Sanofi Pasteur KK -2693,,92a35101-d4fd-4d0c-b202-621d7ffe2cc8,Juan Pedro Barret Nerín,juan_pedro_barret_ner_n,,,,,, -2694,,23e32f33-64c2-48d7-98ad-bda4e558f1cc,"GCLLSG - Dept. of Internal Medicine I, University Hospital Cologne",gcllsg_dept_of_internal_medicine_i_university_hospital_cologne,,,,,, -2695,,63acf510-7168-11e6-a0cd-0242ac12000b,WATSON PHARMS INC,watson_pharms_inc,,,,,, -722,0.971833,d849df4a-222c-4517-b78c-1f8d3369f7eb,"Sven Olaf Skouby, Professor, MD, DMSc. Unit of Reproductive Medicine, Herlev/Gentofte Hospital",sven_olaf_skouby_professor_md_dmsc_unit_of_reproductive_medicine_herlev_gentofte_hospital,,,,d849df4a-222c-4517-b78c-1f8d3369f7eb,sven_olaf_skouby_professor_md_dmsc_unit_of_reproductive_medicine_herlev_gentofte_hospital,"Sven Olaf Skouby, Professor, MD, DMSc. Unit of Reproductive Medicine, Herlev/Gentofte Hospital" -2696,,f7d95af9-8ee9-4d1d-8052-1ad60e6e0a18,Oy Eli Lilly Finland Ab,oy_eli_lilly_finland_ab,,,,,, -2697,,d4686322-3206-4d52-8c13-30229e1d5dc5,Cardiff University,cardiff_university,,,,,, -2698,,49fe3f1c-7167-11e6-a0cd-0242ac12000b,NUVO PHARM INC,nuvo_pharm_inc,,,,,, -2699,,9cc0f535-af23-4d76-9c08-c5c5567eaee6,MUCOS Pharma GmbH & Co. KG,mucos_pharma_gmbh_co_kg,,,,,, -2700,,230820e6-d92a-4233-a40f-4b36227c2593,Bent Gymoese Jørgensen,bent_gymoese_j_rgensen,,,,,, -654,0.90361690521240234,ff8f8803-c00f-472d-8ccb-cf578ecbf270,Boehringer Ingelheim RCV GesmbH + CoKG,boehringer_ingelheim_rcv_gesmbh_cokg,,,,3849b74a-6dc1-4f1b-a6c5-a146b4d05357,boehringer_ingelheim_rcv_ges_mbh_co_kg,Boehringer Ingelheim RCV Ges mbH & Co KG -2701,,e2709602-3f09-4b29-9181-ad669b216e69,No Sponsor,no_sponsor,,,,,, -2702,,55f1363c-6435-45e6-bf60-d58e6b865c22,Lone Elisabeth Forner,lone_elisabeth_forner,,,,,, -2703,,7d3404cf-8ef0-4b64-bc82-fd53bbd8fc28,"Aragon Pharmaceuticals, Inc",aragon_pharmaceuticals_inc,,,,,, -2704,,0bcfec0e-63db-42ff-b226-0981ba72bd37,Janssen Cilag N.V./S.A,janssen_cilag_n_v_s_a,,,,,, -2705,,045a733f-3074-4d0f-9297-36c01e97db6c,Sociedad Madrileña de Nefrología (SOMANE),sociedad_madrile_a_de_nefrolog_a_somane,,,,,, -299,0.98556643724441528,d5f0471a-718d-11e6-a0cd-0242ac12000b,NOVARTIS PHARMS CORP,novartis_pharms_corp,,,,7aebdff6-717d-11e6-a0cd-0242ac12000b,novartis_pharms,NOVARTIS PHARMS -2706,,2503b4f8-df66-4e72-877c-dbbe6da8866d,GETECCU (Grupo Español para el estudio de la enfermedad de Crohn y la colitis ulcerosa),geteccu_grupo_espa_ol_para_el_estudio_de_la_enfermedad_de_crohn_y_la_colitis_ulcerosa,,,,,, -2707,,07674ea8-1348-426d-b444-5594468aed74,BioInvent International AB,bioinvent_international_ab,,,,,, -2708,,2733bf84-71cb-11e6-a0cd-0242ac12000b,BLAIREX,blairex,,,,,, -509,0.940753,63424d17-e643-47cd-9c30-cf03acd4ee8c,UHL NHL Trust,uhl_nhl_trust,,,,27cde204-b342-4946-975c-01f75b78dc91,uhl_nhs_trust,UHL NHS Trust -494,0.95775824785232544,5796b890-7142-11e6-a0cd-0242ac12000b,DR REDDYS LABS INC,dr_reddys_labs_inc,,,,5796b890-7142-11e6-a0cd-0242ac12000b,dr_reddys_labs_inc,DR REDDYS LABS INC -2709,,24124a88-93a2-453c-8b27-ed488d0b06ee,Hevert-Arzneimittel GmbH & Co. KG,hevert_arzneimittel_gmbh_co_kg,,,,,, -2710,,fc240cf8-205c-4894-bbe1-22f4740fa0bb,N/A,n_a,,,,,, -2711,,73655ca5-ab6d-4cea-8621-f0375bc63425,"Ambulance Service, Stockholm City Council",ambulance_service_stockholm_city_council,,,,,, -2712,,dc8980f6-720e-472c-b255-2d862bac09b0,NIBIT (NETWORK ITALIANO PER LA BIO-IMMUNOTERAPIA DEI TUMORI),nibit_network_italiano_per_la_bio_immunoterapia_dei_tumori,,,,,, -2713,,d640b325-8f06-4e51-8ff8-afa09be8326f,Galderma R&D,galderma_r_d,,,,,, -2714,,f8a79c6c-17c0-4bfd-9653-199f4aaf8480,"Cubist Pharmaceuticals LLC, an indirect wholly-owned subsidary of Merck Sharp & Dohme Corp",cubist_pharmaceuticals_llc_an_indirect_wholly_owned_subsidary_of_merck_sharp_dohme_corp,,,,,, -2715,,de7287d8-6a2a-4f80-81cf-ff778474a221,Cefak KG,cefak_kg,,,,,, -999,0.984336,d9ffcf6b-92ba-40b8-9458-e7486475913d,Birmingham Children's Hospital,birmingham_children_s_hospital,,,,2851af76-cc6a-41a0-a263-399d40b7eb15,birmingham_children_s_hospital_nhs_foundation_trust,Birmingham Children's Hospital NHS Foundation Trust -2716,,6a9497ee-8dfe-4a80-9c2a-bfb91308d2ad,Healthcare & Pharma Consulting AG (Europe),healthcare_pharma_consulting_ag_europe,,,,,, -2717,,e6714ac6-d3b4-4cca-8559-02dbe4f5958d,"Stomatološka klinika UKC, Ljubljana",stomatolo_ka_klinika_ukc_ljubljana,,,,,, -2718,,6072f6d1-a7d0-11e6-94cb-5656d04fc2b5,MEDDAY PHARMACEUTICALS,medday_pharmaceuticals,,,,,, -2719,,622b3044-ddde-4da1-a123-1f4b4a17383b,Clinuvel Pharmaceuticals Limited,clinuvel_pharmaceuticals_limited,,,,,, -978,0.97898,01a7b83a-7129-11e6-a89e-0242ac12000b,SANDOZ,sandoz,,,,01a7b83a-7129-11e6-a89e-0242ac12000b,sandoz,SANDOZ -2720,,6c20ca36-7231-11e6-a0cd-0242ac12000b,PHARMOS,pharmos,,,,,, -2721,,12893c58-6511-4859-aadf-cbd4ced3f516,INEOS Healthcare Limited,ineos_healthcare_limited,,,,,, -2722,,6fb0cf66-7b59-4a05-83c0-46091995a487,"Casen Fleet, S.L.U",casen_fleet_s_l_u,,,,,, -2723,,f266daf5-aa1e-4a6a-8f23-3aa2e7b98403,bioskin GmbH,bioskin_gmbh,,,,,, -2724,,406a1c3a-735d-11e6-a0cd-0242ac12000b,QUESTCOR PHARMA,questcor_pharma,,,,,, -2725,,a2277f61-3420-4883-95c7-c94187a717a3,Loxo Oncology Inc,loxo_oncology_inc,,,,,, -2726,,29e0836b-e8fe-4d36-8daf-b749a82a6019,Aerovance Inc,aerovance_inc,,,,,, -2727,,5b56c10c-7244-11e6-a0cd-0242ac12000b,DUSA,dusa,,,,,, -912,0.988197,3603d959-b219-470b-be2c-d1bcd4a7c148,"Aarhus University Hospital, Skejby sygehus",aarhus_university_hospital_skejby_sygehus,,,,3603d959-b219-470b-be2c-d1bcd4a7c148,aarhus_university_hospital_skejby_sygehus,"Aarhus University Hospital, Skejby sygehus" -2728,,6daaf0aa-7161-11e6-a0cd-0242ac12000b,STAR PHARMS FL,star_pharms_fl,,,,,, -2729,,f7962f4b-9840-4e58-8e5c-0b7753adf86c,Dr Jose Sanchez de Toledo Codina,dr_jose_sanchez_de_toledo_codina,,,,,, -2730,,0af081f6-97e3-4a0f-9c45-4094cecdee83,Centre of Thrombosis and Haemostasis,centre_of_thrombosis_and_haemostasis,,,,,, -2731,,858507be-145c-48b5-8267-3fbb21c49033,"Department of Dermatology, University of Kiel",department_of_dermatology_university_of_kiel,,,,,, -322,0.98791098594665527,27185c1d-6e99-48fc-9d68-1530f804e15d,Tibotec Pharmaceuticals Limited Ireland,tibotec_pharmaceuticals_limited_ireland,,,,27185c1d-6e99-48fc-9d68-1530f804e15d,tibotec_pharmaceuticals_limited_ireland,Tibotec Pharmaceuticals Limited Ireland -692,0.987725,3896cef1-0043-4ce9-83b5-3668a99dacee,"Furiex Pharmaceuticals, Inc",furiex_pharmaceuticals_inc,,,,3896cef1-0043-4ce9-83b5-3668a99dacee,furiex_pharmaceuticals_inc,"Furiex Pharmaceuticals, Inc" -2732,,91da3f1b-96c4-4adb-b643-953272138eb3,Netherlands Asthma Foundation (NAF),netherlands_asthma_foundation_naf,,,,,, -2733,,a1861264-4fe3-460e-9d56-4204b1e1575d,Norgine International Limited,norgine_international_limited,,,,,, -2734,,a61e717e-535b-4f01-801d-92bf7abffa9a,CureVac AG,curevac_ag,,,,,, -2735,,85d84673-b22c-452b-9471-a230ed7c7411,Hospital Universitari Mutua Terrassa,hospital_universitari_mutua_terrassa,,,,,, -2736,,0a3f17e1-f771-4a14-acfb-d7368f406fd6,"Merck Sharp & Dohme de España, S.A",merck_sharp_dohme_de_espa_a_s_a,,,,,, -159,0.93876934051513672,f520785f-8956-4a25-b64b-588e23b207cb,"Medizinische Universität Wien, Univ.Klinik f.Innere Medizin I, Abt.f.Hämatologie u.Hämostaseologie",medizinische_universit_t_wien_univ_klinik_f_innere_medizin_i_abt_f_h_matologie_u_h_mostaseologie,,,,f520785f-8956-4a25-b64b-588e23b207cb,medizinische_universit_t_wien_univ_klink_f_innere_medizin_i,"Medizinische Universität Wien, Univ.Klink f. Innere Medizin I" -2737,,4242f4c1-9760-4311-a372-6a0638480701,AZIENDA OSPEDALIERA S. FILIPPO NERI,azienda_ospedaliera_s_filippo_neri,,,,,, -2738,,54c4ac85-8eb8-434e-a842-a48e60d2bc85,"TARGID, KU Leuven",targid_ku_leuven,,,,,, -2739,,018b7d39-3b8c-41b4-8cf4-ce1b0b339a02,AZIENDA UNITA' SANITARIA LOCALE DI PARMA,azienda_unita_sanitaria_locale_di_parma,,,,,, -2740,,a9d7ce76-7194-11e6-a0cd-0242ac12000b,ORGANICS LAGRANGE,organics_lagrange,,,,,, -2741,,64748d92-ba7b-44e6-b9d6-8cb5920ec185,Ospedale San Raffaele di Milano,ospedale_san_raffaele_di_milano,,,,,, -2742,,38d68618-4182-4b9c-91df-d043e874ea66,Neovas SA,neovas_sa,,,,,, -2743,,a895ca68-4505-4766-b319-251ad3678e4a,CUSL,cusl,,,,,, -2744,,ef9e4b56-61e1-44f5-b725-54b908980d05,Taunton & Somerset NHS Trust,taunton_somerset_nhs_trust,,,,,, -166,0.989139,8f3341d7-6e0f-42cf-8d93-6bad6582a5f2,Galderma Research and Development SNC,galderma_research_and_development_snc,,,,7eeea4e4-efc7-45bf-bac7-82d54c1ae894,galderma_research_and_development,Galderma Research and Development -2745,,4f5b0181-87cf-4dd6-a56c-1ff9d3fbf947,"University of Leeds, Division of Musculoskeletal Disease, Leeds Institute of Molecular Medicine",university_of_leeds_division_of_musculoskeletal_disease_leeds_institute_of_molecular_medicine,,,,,, -438,0.96206339200337732,9f27856c-6362-4966-b129-808cb11ba1b0,"Pfizer Inc. 235 East 42nd Street, New York, NY10017,USA",pfizer_inc_235_east_42nd_street_new_york_ny10017_usa,,,,09d833e6-81f6-4d84-ab0d-6d38c6152081,pfizer_inc_235_east_42nd_street_new_york_ny10017_usa,"Pfizer Inc 235 East 42nd Street, New York, NY10017" -603,0.98583465814590454,6eb8c187-922d-4265-a290-1d2eaf8c0f5f,Fundación para la Investigación y Desarrollo en el Área Cardiovascular (FIC),fundaci_n_para_la_investigaci_n_y_desarrollo_en_el_rea_cardiovascular_fic,,,,6eb8c187-922d-4265-a290-1d2eaf8c0f5f,fundaci_n_para_la_investigaci_n_y_desarrollo_en_el_rea_cardiovascular_fic,Fundación para la Investigación y Desarrollo en el Área Cardiovascular (FIC) -2746,,37fb50c5-d54a-4ca4-82fb-048bffb7d227,Laboratorio de Aplicaciones Farmacodinámicas S.A,laboratorio_de_aplicaciones_farmacodin_micas_s_a,,,,,, -2747,,95c433b9-c79b-4731-a6b7-c145b2bc42fa,PROBELTE PHARMA S.A,probelte_pharma_s_a,,,,,, -2748,,3028f354-ec8c-426d-82f8-48c3dec7599a,Merck Frosst Canada Ltd,merck_frosst_canada_ltd,,,,,, -2749,,52fb0c90-4d7d-49b6-b66e-ddcd5729c927,"The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark",the_parker_institute_bispebjerg_and_frederiksberg_hospital_the_capital_region_of_denmark,,,,,, -2750,,32603322-dde3-4d9e-ae78-e579f11daf77,"LABORATORIOS GRIFOLS, S.A",laboratorios_grifols_s_a,,,,,, -2751,,77f80472-6676-4f95-b658-7641175af1ce,"Department of Nephrology, OUH, Odense, DK",department_of_nephrology_ouh_odense_dk,,,,,, -2752,,93471e4b-a3c5-4a7c-9368-8ec937b0f5a6,Novartis Pharmaceuticals UK Ltd,novartis_pharmaceuticals_uk_ltd,,,,,, -121,0.98132741451263428,2929b798-0440-49f3-ab5b-122a578e01ba,"F. Hoffmann-La Roche Limited, Pharmaceuticals Division, PDR",f_hoffmann_la_roche_limited_pharmaceuticals_division_pdr,,,,2929b798-0440-49f3-ab5b-122a578e01ba,f_hoffmann_la_roche_limited_pharmaceuticals_division_pdr,"F. Hoffmann-La Roche Limited, Pharmaceuticals Division, PDR" -2753,,2677656f-af0f-466e-a073-e144706a2f80,STRAGEN FRANCE SAS,stragen_france_sas,,,,,, -2754,,6b813f4b-4738-4e90-bc17-11bf1832d79b,BioVex Inc,biovex_inc,,,,,, -2755,,4e153cc6-881f-11e6-a998-0242ac12000b,Great Ormond Street Hospital NHS Trust / University College London - Institute of Child Health,great_ormond_street_hospital_nhs_trust_university_college_london_institute_of_child_health,,,,,, -2756,,041c0139-5b23-48e3-9ccf-9f6d0227ce5b,Dr. Gerhard Franz Kieselbach,dr_gerhard_franz_kieselbach,,,,,, -967,0.97196,55950bfd-6b69-499d-a3b6-2dd8b514c97d,Skånes Universitetssjukhus Lund,sk_nes_universitetssjukhus_lund,,,,55950bfd-6b69-499d-a3b6-2dd8b514c97d,sk_nes_universitetssjukhus_lund,Skånes Universitetssjukhus Lund -840,0.98523330688476562,3db31bd4-ebf3-4e55-8979-0617fa1fc589,JANSSEN-CILAG GmbH,janssen_cilag_gmbh,,,,3db31bd4-ebf3-4e55-8979-0617fa1fc589,janssen_cilag_gmbh,JANSSEN-CILAG GmbH -2757,,8c7a4b78-dc33-4841-be01-806ef1c18e93,AFFiRiS AG,affiris_ag,,,,,, -2758,,bd817d4d-e257-4075-bac7-d2a9761f7ef9,GALDERMA R&D SNC,galderma_r_d_snc,,,,,, -2759,,f3bc27eb-6f96-49da-8d9a-52983c2a82a5,Central Manchester Foundation Hospitals Trust,central_manchester_foundation_hospitals_trust,,,,,, -574,0.96224385499954224,8567fa14-efb0-4bb0-9c97-bf093f58ba24,"Queen Mary, University of London (QMUL)",queen_mary_university_of_london_qmul,,,,8567fa14-efb0-4bb0-9c97-bf093f58ba24,queen_mary_university_of_london_qmul,"Queen Mary, University of London (QMUL)" -2760,,b1b2c096-75da-4642-bced-b420c68f34bc,Marjo Renko,marjo_renko,,,,,, -2761,,603c1f5a-38fa-4ebd-a4a3-34994a98c4bb,"Abteilung für Anästhesie, Intensiv- und Schmerzmedizin, Wilhelminenspital der Stadt Wien",abteilung_f_r_an_sthesie_intensiv_und_schmerzmedizin_wilhelminenspital_der_stadt_wien,,,,,, -2762,,cdf476a8-c681-4cd6-83a0-fddf35b601c7,service de santé des armées,service_de_sant_des_arm_es,,,,,, -2763,,1fa79654-316b-4828-a391-c4d85be21554,Servicio de Oncología. Hospital Vall d'Hebron,servicio_de_oncolog_a_hospital_vall_d_hebron,,,,,, -2764,,b144e1f1-e2a5-43cf-8dff-fe2de18cde12,Wuerzburg University Hospital,wuerzburg_university_hospital,,,,,, -2765,,2a58b07c-3759-4847-95f1-728a557d31ed,Dra. Carmen Ispa Callén,dra_carmen_ispa_call_n,,,,,, -424,0.976266,88cf624a-7129-11e6-a89e-0242ac12000b,AKORN,akorn,,,,824bf19e-712a-11e6-a89e-0242ac12000b,akorn_inc,AKORN INC -301,0.977974,fc5a931a-83ff-43ec-80af-5890cc425b2f,German High Grade Non-Hodgkins Lymphoma group,german_high_grade_non_hodgkins_lymphoma_group,,,,023ff627-407b-44a9-b5eb-1ea1e5f216c2,german_high_grade_non_hodgkin_s_lymphoma_group,German High Grade Non-Hodgkin's Lymphoma group -2766,,6c8fbaa8-ab49-488d-b782-1721703ac55a,"Xcovery Holding Company, LLC",xcovery_holding_company_llc,,,,,, -2767,,37845326-534a-46d3-abea-59405b1a3161,The Liverpool Heart & Chest Hospital NHS Trust,the_liverpool_heart_chest_hospital_nhs_trust,,,,,, -2768,,01cdc8ae-0a73-4c9d-a4f6-751760d485a3,Swedish Orphan International AB,swedish_orphan_international_ab,,,,,, -2769,,f72913a7-ad37-4539-9ffc-c4d10fff590f,Department of Anesthesiology and Perioperative Medicine,department_of_anesthesiology_and_perioperative_medicine,,,,,, -585,0.909143,73005770-61f7-451a-a1d5-6cb043330409,"MUW, Klinik für Innere Med. I, Onkologie",muw_klinik_f_r_innere_med_i_onkologie,,,,73005770-61f7-451a-a1d5-6cb043330409,muw_klinik_f_r_innere_med_i_onkologie,"MUW, Klinik für Innere Med. I, Onkologie" -2770,,85bcb124-dd93-49c8-af08-aaa7e6f60d90,NHS Greater Glasgow and Clyde Health Board,nhs_greater_glasgow_and_clyde_health_board,,,,,, -897,0.963506,8f278d90-7145-11e6-a0cd-0242ac12000b,OHM LABS,ohm_labs,,,,8f278d90-7145-11e6-a0cd-0242ac12000b,ohm_labs,OHM LABS -2771,,bf6e4136-979f-4d24-a1aa-edf859e4c73c,Hospital Universitario de Valme,hospital_universitario_de_valme,,,,,, -492,0.973505,a251aab2-cb01-4345-81c1-540a7deb2d88,"Rottapharm Madaus, Madaus GmbH",rottapharm_madaus_madaus_gmbh,,,,81977950-118e-45c5-b00b-ff958a1914c1,rottapharm,Rottapharm -945,0.916222,7dd3aa00-7164-11e6-a0cd-0242ac12000b,ZACH SYSTEMS,zach_systems,,,,7dd3aa00-7164-11e6-a0cd-0242ac12000b,zach_systems,ZACH SYSTEMS -2772,,d6688f5f-6de6-4039-8b49-bcbb85b43140,University Medical Centre Nijmegen St Radboud,university_medical_centre_nijmegen_st_radboud,,,,,, -2773,,56b75ccb-06f1-4a82-a74b-cf20cecd4cdf,Abbott GmbH & Co. K.G,abbott_gmbh_co_k_g,,,,,, -2774,,7fa12b2a-7a6c-4134-8791-737ec94d6c12,SUBSTIPHARM Développement,substipharm_d_veloppement,,,,,, -2775,,124baa17-7ecf-45cd-b1bf-185b2520a9d1,Xenome Ltd,xenome_ltd,,,,,, -2776,,2bc40bbe-a076-4a4f-b310-cf0d6ba87a75,Timo Iirola,timo_iirola,,,,,, -769,0.9661862850189209,78815b47-7b5c-468f-bbda-7577df93402c,GELTAMO (Grupo Cooperativo Español de Llinfoma/Trasplante Autólogo de Médula Ósea),geltamo_grupo_cooperativo_espa_ol_de_llinfoma_trasplante_aut_logo_de_m_dula_sea,,,,06287ea9-1e30-49c5-af4a-558dc91625a2,geltamo_grupo_cooperativo_espa_ol_de_linfoma_trasplante_aut_logo_de_m_dula_sea,GELTAMO (Grupo Cooperativo Español de Linfoma/Trasplante Autólogo de Médula Ósea) -2777,,39e0e85e-fee2-4c27-81dc-a39e1ccffb0b,Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol,fundaci_institut_d_investigaci_en_ci_ncies_de_la_salut_germans_trias_i_pujol,,,,,, -2778,,ff306cb3-1b4b-4c56-8eef-6d1db0213a4d,Dr. JOSE LUIS GONZALEZ LARRIBA,dr_jose_luis_gonzalez_larriba,,,,,, -2779,,1769fdb6-7167-11e6-a0cd-0242ac12000b,HOUSTON CYCLOTRON,houston_cyclotron,,,,,, -2780,,1b073c25-363c-4dcf-bc67-0a06520179f7,"UCB Biosciences, Inc. A Member of the UCB Group of Companies",ucb_biosciences_inc_a_member_of_the_ucb_group_of_companies,,,,,, -2781,,6b58315f-1c5e-40bd-9c27-fa49185274f7,Prosensa Therapeutics B.V,prosensa_therapeutics_b_v,,,,,, -200,0.97189050912857056,ce046c53-60a5-4a54-bb94-914d5bc33caa,"National Institute for Public Health and the Environment (RIVM, the Netherlands)",national_institute_for_public_health_and_the_environment_rivm_the_netherlands,,,,ce046c53-60a5-4a54-bb94-914d5bc33caa,national_institute_for_public_health_and_the_environment_rivm_the_netherlands,"National Institute for Public Health and the Environment (RIVM, the Netherlands)" -495,0.98471283912658691,42346020-7164-11e6-a0cd-0242ac12000b,DR REDDYS LABS SA,dr_reddys_labs_sa,,,,27140480-7146-11e6-a0cd-0242ac12000b,dr_reddys_la,DR REDDYS LA -2782,,cb38ee53-75dd-48c7-ac94-808b67d172a5,St Elisabeth Hospital,st_elisabeth_hospital,,,,,, -2783,,03063c92-952b-49f9-a79f-292bbf3e0fe3,Academic Psychiatric Center - AMC-UvA,academic_psychiatric_center_amc_uva,,,,,, -2784,,b09c5a76-4f18-40f2-8d29-ff594c214905,Fundación Hospital de Madrid,fundaci_n_hospital_de_madrid,,,,,, -2785,,e830f7a8-73cc-11e6-a0cd-0242ac12000b,EXELIXIS,exelixis,,,,,, -2786,,b2567e41-3aa8-4cbc-8649-dc676b8e3d6e,"MAGGOT 2006 Egészségügyi, Kereskedelmi és Szolgáltató Ltd",maggot_2006_eg_szs_g_gyi_kereskedelmi_s_szolg_ltat_ltd,,,,,, -2787,,253500cf-8743-4261-87e1-450d2c444539,INDEX PHARMACEUTICALS,index_pharmaceuticals,,,,,, -2788,,038960fd-ee43-483d-9820-048b96e50b00,Hospital Trebic,hospital_trebic,,,,,, -2789,,f73188ff-9c35-4458-8c13-f04e944a3fcc,Diurnal Limited,diurnal_limited,,,,,, -2790,,9e39fc1c-8bdc-11e6-a449-0242ac12000b,Special Account for Research Funds-University of Patras,special_account_for_research_funds_university_of_patras,,,,,, -71,0.96432900428771973,e066106c-fbac-4279-84ae-0946c0383093,Takeda,takeda,,,,a50a5323-eb43-4b40-8b80-cb222451e80b,takeda,Takeda -2791,,757adeb8-f7af-4d81-93dd-c86a4a180277,Grupo GICOR,grupo_gicor,,,,,, -2792,,1f7d4c33-745b-41df-a0bb-8ec975c7be7f,University Hospitals Birmingham NHS Trust,university_hospitals_birmingham_nhs_trust,,,,,, -51,0.98173725605010986,8fed167b-385c-411d-871f-ace18064604b,Pfizer Ltd (PGRD),pfizer_ltd_pgrd,,,,8b6c5421-c89a-418f-8c10-e2badcce65ee,pfizer_ltd,Pfizer Ltd -2793,,999e748f-b5c1-4297-8cf5-c90d69228836,Lundbeck SA,lundbeck_sa,,,,,, -991,0.94304704666137695,cbc32f6f-5625-4833-a40a-1a4645e7edda,Great Ormond Street Hospital For Children NHS Foundation Trust,great_ormond_street_hospital_for_children_nhs_foundation_trust,,,,136feb9a-ae28-4c13-afe3-e135660d48aa,great_ormond_street_hospital,Great Ormond Street Hospital -2794,,4cc06a61-c0b8-4109-aa50-edcc9d691a0e,"Poniard Pharmaceuticals, Inc",poniard_pharmaceuticals_inc,,,,,, -2795,,3a90cbaf-467b-451f-8858-ab908a78f8a5,Fondazione GISCAD,fondazione_giscad,,,,,, -508,0.980232,be0c7d14-2d93-4807-b3a6-5c835e640c1e,Pfizer S.A. Belgium,pfizer_s_a_belgium,,,,3f98bb64-87e2-43ad-bc25-60a24eb40e13,pfizer_s_a,Pfizer S.A -2796,,71db27fe-f727-47f2-bf0b-3cb3938c6cba,"University College London, Joint Research Office",university_college_london_joint_research_office,,,,,, -2797,,b359d0b0-6644-4b81-8079-5ff7f2375314,Deutsche Krebsgesellschaft e.V,deutsche_krebsgesellschaft_e_v,,,,,, -93,0.942231,bab1dcfc-4751-41db-9ee8-b9ec54e63541,"LABORATORIOS CASEN-FLEET,S.L",laboratorios_casen_fleet_s_l,,,,bab1dcfc-4751-41db-9ee8-b9ec54e63541,laboratorios_casen_fleet_s_l,"LABORATORIOS CASEN-FLEET,S.L" -787,0.98334300518035889,38be2188-71f1-46e1-9477-04ee58b8b8b0,"Intercell USA, Inc",intercell_usa_inc,,,,08982651-8665-4f48-91ab-412b9c9c69a9,intercell_usa_inc_intercell,"Intercell USA, Inc. (Intercell)" -2798,,c557c2aa-ed5e-4144-9145-cfbd76d33acc,"Aarhus University Hospital, Department of Respiratory Medicine",aarhus_university_hospital_department_of_respiratory_medicine,,,,,, -2799,,2a9b6c5c-6aa8-4f4b-9d25-c9b34c6dae98,"Research Programs' Unit, Diabetes & Obesity, University of Helsinki",research_programs_unit_diabetes_obesity_university_of_helsinki,,,,,, -561,0.981251,89f1114d-3553-4ac3-a66f-02effd57921a,"Bioheart, Inc",bioheart_inc,,,,89f1114d-3553-4ac3-a66f-02effd57921a,bioheart_inc,"Bioheart, Inc" -2800,,c1d642c7-c39a-4eea-b9c2-047d3215a0b7,MANUEL ÁNGEL GÓMEZ RÍOS,manuel_ngel_g_mez_r_os,,,,,, -637,0.987943,2629fa8a-7163-11e6-a0cd-0242ac12000b,TORRENT PHARM,torrent_pharm,,,,2629fa8a-7163-11e6-a0cd-0242ac12000b,torrent_pharm,TORRENT PHARM -2801,,2fa98d26-f43e-48ca-a229-2e7d11723593,Antipodean Pharmaceuticals,antipodean_pharmaceuticals,,,,,, -2802,,b7f3ddf8-7ea2-4825-9345-2c8f3654f1cd,fUNDACIÓN iNVESTIGACIÓN HOSPITAL RAMÓN Y CAJAL,fundaci_n_investigaci_n_hospital_ram_n_y_cajal,,,,,, -2803,,ce63b5b0-5778-4872-9b2c-802290b5703d,Hôpital FOCH,h_pital_foch,,,,,, -2804,,27b95ff4-afa5-4730-89b3-49816bbdfce1,Charité-University Berlin,charit_university_berlin,,,,,, -2805,,501b5de6-7232-11e6-a0cd-0242ac12000b,MALLINCKRODT HOSP,mallinckrodt_hosp,,,,,, -2806,,22bdd0f0-5125-4999-af88-90a943d6cf4e,ApoPharma Inc,apopharma_inc,,,,,, -2807,,7f5d7d9b-2b6e-4edc-a223-88fd5f0cb1f5,Dept of Urology Aarhus Universityhospital,dept_of_urology_aarhus_universityhospital,,,,,, -730,0.922323,ed32d3f4-275a-41ef-9dd9-7a713a6f2d48,Hellenic Oncology Research Group (HORG),hellenic_oncology_research_group_horg,,,,ed32d3f4-275a-41ef-9dd9-7a713a6f2d48,hellenic_oncology_research_group_horg,Hellenic Oncology Research Group (HORG) -2808,,1abe069c-cdae-4393-8bfe-0f7306deee71,"Maruho Co, Ltd. Kyoto R&D Center",maruho_co_ltd_kyoto_r_d_center,,,,,, -2809,,1a72bb13-a7c0-11e6-94cb-5656d04fc2b5,Dr. Manuel Rodríguez Yáñez,dr_manuel_rodr_guez_y_ez,,,,,, -2810,,b2db95b6-2d1f-44b8-86b2-2a04f7d9e9da,Company: Dr. Franz Köhler Chemie GmbH,company_dr_franz_k_hler_chemie_gmbh,,,,,, -2811,,08f49f72-bbc1-4e2e-8784-117c6b0a98fb,"Cliniques Universitaires Saint-Luc, Neurologie",cliniques_universitaires_saint_luc_neurologie,,,,,, -2812,,92c36334-73f2-11e6-a0cd-0242ac12000b,ACETYLENE OXYGENE CO,acetylene_oxygene_co,,,,,, -879,0.971226,bc449ec2-1390-4c75-ab67-e86f7d769a31,"RWTH Aachen University, represented by the Rector, himself represented by the CTC-A",rwth_aachen_university_represented_by_the_rector_himself_represented_by_the_ctc_a,,,,bc449ec2-1390-4c75-ab67-e86f7d769a31,rwth_aachen_university_represented_by_the_rector_himself_represented_by_the_ctc_a,"RWTH Aachen University, represented by the Rector, himself represented by the CTC-A" -2813,,7ca9c5e5-aa94-42cb-99c0-b75e83e21357,CHRU de TOURS,chru_de_tours,,,,,, -59,0.95637212196985877,77e6ca17-28b0-48f2-a375-f49a36571367,Wyeth Research Division of Wyeth Pharmaceuticals Inc Global Medical Affairs,wyeth_research_division_of_wyeth_pharmaceuticals_inc_global_medical_affairs,,,,96e5ebae-c6a3-41db-ae14-3ec5437c35f2,wyeth_research_division,Wyeth Research Division -2814,,9960f36a-6609-43da-a46e-5a208a8bb38b,Reanal Pte. Ltd,reanal_pte_ltd,,,,,, -2815,,811dc228-7186-11e6-a0cd-0242ac12000b,SEATTLE GENETICS,seattle_genetics,,,,,, -2816,,a0c69bd0-5044-488d-8447-43816777c75b,"Vtesse, Inc",vtesse_inc,,,,,, -2817,,b815fb8d-4bdc-42be-a0ef-ae2390d1140e,Oryzon Genomics S.A,oryzon_genomics_s_a,,,,,, -2818,,1cbd9156-5028-474c-a9bc-f8d24af2d087,NeuroBiotec Pharma AG,neurobiotec_pharma_ag,,,,,, -2819,,ac304799-c9b8-4c5e-bd28-980253f7e026,TransPharma Medical,transpharma_medical,,,,,, -2820,,535daab3-95a7-4af7-877e-28d24871837e,The Children's Memorial Health Institute,the_children_s_memorial_health_institute,,,,,, -2821,,18ea43e3-5e22-4608-bbf5-64b6a234ccf9,FONDAZIONE DEL PIEMONTE PER L'ONCOLOGIA - IRCCS,fondazione_del_piemonte_per_l_oncologia_irccs,,,,,, -2822,,de36c4ae-0e8b-4ddd-afe2-357efa856a24,vasopharm GmbH,vasopharm_gmbh,,,,,, -2823,,0c88bf36-2685-437b-87b6-ae5c27fe3727,A.O. SAN GERARDO,a_o_san_gerardo,,,,,, -797,0.985088,580874fd-bb2f-479f-bdf2-0da9df07a980,Sint Lucas Andreas,sint_lucas_andreas,,,,1030c221-004c-4496-88f4-1a34a95916e7,sint_lucas_andreas_hospital,Sint Lucas Andreas Hospital -2824,,9922424f-0067-4261-a280-0356577c6f05,"AHSC Joint Research Office, Imperial College",ahsc_joint_research_office_imperial_college,,,,,, -2825,,23c41ea8-7274-11e6-a0cd-0242ac12000b,CHEMISCH FBRK KRSSLR,chemisch_fbrk_krsslr,,,,,, -723,0.980428,0d4e58c8-3d68-4fc8-a668-ed2e49340828,"Department of Hematology, Aalborg University Hospital",department_of_hematology_aalborg_university_hospital,,,,0d4e58c8-3d68-4fc8-a668-ed2e49340828,department_of_hematology_aalborg_university_hospital,"Department of Hematology, Aalborg University Hospital" -775,0.929435,a4c79c45-e412-4fc9-8de9-7ac69b0e8cf5,"Ferring International PharmaScience Center U.S., Inc",ferring_international_pharmascience_center_u_s_inc,,,,3994ddd6-d614-47eb-80a8-773f166f17da,ferring_international_pharmascience_center_us_inc,"Ferring International Pharmascience Center US, Inc" -274,0.985423,025f7b50-7129-11e6-a89e-0242ac12000b,G AND W LABS INC,g_and_w_labs_inc,,,,025f7b50-7129-11e6-a89e-0242ac12000b,g_and_w_labs_inc,G AND W LABS INC -2826,,e40cdf74-cb8b-499d-9fad-dd22a9e23170,Anæstesisektor Nordjylland,an_stesisektor_nordjylland,,,,,, -2827,,a54bf322-da8a-443f-9ee8-dfacb7bd952f,UZ Gent,uz_gent,,,,,, -2828,,638fdb91-f6fe-4986-86c1-d4af3d4f31df,Sten Walther,sten_walther,,,,,, -488,0.98622655868530273,91023abe-f124-48ee-a18d-1e83054aa17e,STEBA BIOTECH,steba_biotech,,,,5d77fa00-9417-4d15-807e-607c459d6842,steba_biotech,STEBA BIOTECH -2829,,a4148467-9d20-4812-ad01-292070a9e6f7,Nordic Bone and Marrow Transplantation Group,nordic_bone_and_marrow_transplantation_group,,,,,, -2830,,a07df71f-3741-47c3-bc07-086f26e67b26,Aurinia Pharmaceuticals Inc,aurinia_pharmaceuticals_inc,,,,,, -2831,,48ea33fe-ae63-4aa6-b360-f9ff950caa3c,"Aarhus University Hospital, Dept of Endocrinology and Metabolism C",aarhus_university_hospital_dept_of_endocrinology_and_metabolism_c,,,,,, -2832,,f6db875a-7147-11e6-a0cd-0242ac12000b,CYCLE PHARMS LTD,cycle_pharms_ltd,,,,,, -2833,,b427989c-3990-4822-af42-0df4f6ad36fa,St Vincents University Hospital,st_vincents_university_hospital,,,,,, -222,0.955709,1cd31001-2166-4db7-b391-c4c12d25d9ea,SOGUG,sogug,,,,1cd31001-2166-4db7-b391-c4c12d25d9ea,sogug,SOGUG -2834,,44dc6c63-cf49-41cf-9dae-0a1efd9abea2,"Fundación de Investigación Biomédica del Hospital Universitario La Paz, Madrid",fundaci_n_de_investigaci_n_biom_dica_del_hospital_universitario_la_paz_madrid,,,,,, -2835,,5676374c-7165-11e6-a0cd-0242ac12000b,SVADS HOLDINGS SA,svads_holdings_sa,,,,,, -1009,0.98486357927322388,85199c3a-719f-11e6-a0cd-0242ac12000b,MCNEIL CONSUMER,mcneil_consumer,,,,85199c3a-719f-11e6-a0cd-0242ac12000b,mcneil_consumer,MCNEIL CONSUMER -2836,,aaf3e303-90be-4f39-b763-440962366ea3,BIAL Industrial Farmaceutica S.A,bial_industrial_farmaceutica_s_a,,,,,, -2837,,6d9aa4c0-cff5-40c7-a114-09e94ec8ed46,Fundación Investigación Biomédica Hospital Príncipe de Asturias,fundaci_n_investigaci_n_biom_dica_hospital_pr_ncipe_de_asturias,,,,,, -2838,,c74e3f66-ae65-44dd-8ef3-edce2f4a6ed8,Department of anesthesiology,department_of_anesthesiology,,,,,, -2839,,99281dc5-e2ab-4a9b-bd4a-f74d7a3c3c24,"Fertilitetsklinikken 4071, Rigshospitalet",fertilitetsklinikken_4071_rigshospitalet,,,,,, -2840,,6d82c8c1-8bb4-49cb-8288-8fb61f66a8a4,ActoGeniX NV,actogenix_nv,,,,,, -2841,,f9c91961-57df-4456-b9b4-1b4ad3400caf,Orexo AB,orexo_ab,,,,,, -2842,,2319e883-f3a0-4e05-af79-9235b8b28655,LFB Biomédicaments,lfb_biom_dicaments,,,,,, -2843,,3809dc04-7148-11e6-a0cd-0242ac12000b,AVEVA,aveva,,,,,, -2844,,0f7dfe76-5418-448b-a697-3f74075f9ee8,Bradford Teaching Hospitals NHS Foundation Trust,bradford_teaching_hospitals_nhs_foundation_trust,,,,,, -2845,,6ef34ade-0e44-4c99-bf05-7503eb19ee83,Dr. Javier Domínguez Ortega,dr_javier_dom_nguez_ortega,,,,,, -2846,,add26e78-c881-453b-b070-ef28a60f71e3,"Aldagen, Inc",aldagen_inc,,,,,, -2847,,d361aeb1-73da-4689-8af0-2db6593db9a9,Cristina Gómez Oliva,cristina_g_mez_oliva,,,,,, -2848,,19a7ac07-ca17-4b09-89a9-ad15dc968010,Birmingham Women's Hospital,birmingham_women_s_hospital,,,,,, -2849,,af29262a-fbdb-49a8-bd52-2cbba2222604,EBEWE Pharma GesmbH Nfg.KG,ebewe_pharma_gesmbh_nfg_kg,,,,,, -2850,,e0cfbe57-daa5-4221-b9de-b69d4816dfc6,Gentofte Hospital,gentofte_hospital,,,,,, -526,0.986058,73bd77f0-7126-11e6-8a77-0242ac12000b,BAXTER HLTHCARE,baxter_hlthcare,,,,73bd77f0-7126-11e6-8a77-0242ac12000b,baxter_hlthcare,BAXTER HLTHCARE -380,0.9613567590713501,fee3d059-f4b7-4cb6-b41f-9a5455c55791,"Merck Sharpe & Dohme Corp., a subsidiary of Merck & Co., Inc",merck_sharpe_dohme_corp_a_subsidiary_of_merck_co_inc,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" -2851,,14edb64b-826a-4d7e-baad-842ff3d95ec3,"University Hospital Virgen del Rocío, Andalousian Health Service",university_hospital_virgen_del_roc_o_andalousian_health_service,,,,,, -2852,,b0cb1886-af74-408b-acd9-cb458017900c,"Charité-Universitätsmedizin Berlin, Department of Dermatology, Clinical Research Center for Hair and Skin Science",charit_universit_tsmedizin_berlin_department_of_dermatology_clinical_research_center_for_hair_and_skin_science,,,,,, -2853,,cca038b3-6ee9-4b79-a840-5f0eb1a54e1a,Société Française de Cardiologie,soci_t_fran_aise_de_cardiologie,,,,,, -2854,,7f04a570-16ac-4b3a-a749-27b12968c96c,Erasmus MC - Department of Pediatrics,erasmus_mc_department_of_pediatrics,,,,,, -1020,0.97864839434623718,c0aa9218-7fe2-43e7-af57-645b438a7503,"Orion Corporation Orion Pharma, FI-02200 Espoo, Finland",orion_corporation_orion_pharma_fi_02200_espoo_finland,,,,b56a3044-dedf-4773-b7a5-e6cd18764bcd,orion_corporation_orion_pharma,Orion Corporation Orion Pharma -2855,,4c5f8fd3-23c6-4e26-a9b0-33fae35721f0,Raul de la Fuente-Fernandez,raul_de_la_fuente_fernandez,,,,,, -2856,,232363ec-0d32-4ffc-a561-f9497ada52ba,Queens University Belfast,queens_university_belfast,,,,,, -1040,0.97674435377120972,2296dd74-6817-4f30-819d-48b0af75055c,Celgene International Sàrl,celgene_international_s_rl,,,,2296dd74-6817-4f30-819d-48b0af75055c,celgene_international_s_rl,Celgene International Sàrl -2857,,34c98f69-a170-48e6-96e7-df08da23128a,UNIVERSITY HOSPITALS ST LUC,university_hospitals_st_luc,,,,,, -709,0.95942862828572595,d6befa2c-95fd-45a5-927e-52a8ac78b836,Reckitt Benckiser Healthcare (UK),reckitt_benckiser_healthcare_uk,,,,62dccd7b-325f-4731-b158-229a0c9ea429,reckitt_benckiser_healthcare_uk_ltd,Reckitt Benckiser Healthcare (UK) Ltd -2858,,297e26d8-12f4-4afb-b5be-2303c3385da1,Onyvax Limited,onyvax_limited,,,,,, -2859,,eb7e4744-7223-11e6-a0cd-0242ac12000b,AGOURON,agouron,,,,,, -2860,,f5f5df89-f5d2-4922-a2b8-cfaa3ea9b605,Zymenex A/S,zymenex_a_s,,,,,, -2861,,477519f3-7edd-498c-959f-154f358844da,"HUS, Leikkaus- ja anestesiaosasto",hus_leikkaus_ja_anestesiaosasto,,,,,, -612,0.98845240473747253,ddd27261-385f-46d8-a040-1cad84ab8d5e,Erasmus Medical Center,erasmus_medical_center,,,,f3ebaba1-aead-4675-858a-6f4e2a4f28d1,erasmus_medical_center,Erasmus Medical Center -2862,,ac58a232-92e0-4551-86b1-c8433a7a2944,The University of Nottingham-Research innovation services,the_university_of_nottingham_research_innovation_services,,,,,, -2863,,2bd8b157-1fa6-4c0e-b1b4-7f4d79704af7,Diagnostic Centre of Pécs,diagnostic_centre_of_p_cs,,,,,, -2864,,98ee2c30-dc68-4582-b80e-b8a84eb8517b,Schering-Plough Levant,schering_plough_levant,,,,,, -2865,,708dc135-af1d-44c3-a9f1-7b66886dedb5,"Merck Sharp & Dohme Corporation, a subsidiary of Merck & Co, Inc",merck_sharp_dohme_corporation_a_subsidiary_of_merck_co_inc,,,,,, -2866,,a965d6f4-7194-11e6-a0cd-0242ac12000b,WYETH CONS,wyeth_cons,,,,,, -2867,,bfaa1e0a-367c-4616-b0b5-d4423fb7c650,"HovedOrtoCentret, Rigshospitalet",hovedortocentret_rigshospitalet,,,,,, -2868,,5a874696-49c2-4d94-b5cb-76bd76939b5e,Novartis Vaccines & Diagnostic S.r.l,novartis_vaccines_diagnostic_s_r_l,,,,,, -2869,,4703e1e0-7158-11e6-a0cd-0242ac12000b,LAVIPHARM LABS,lavipharm_labs,,,,,, -2870,,334c0097-564e-4fe2-8836-8902c739c7ac,biosyn Arzneimittel GmbH,biosyn_arzneimittel_gmbh,,,,,, -2871,,70635bd7-0f42-4ef4-a2a3-ab4dc9c65e15,"CLARUS THERAPEUTICS, INC",clarus_therapeutics_inc,,,,,, -2872,,9d7737a2-71bc-11e6-a0cd-0242ac12000b,UT SW MEDCTR,ut_sw_medctr,,,,,, -2873,,7aaed050-6b0b-4278-a7c8-fae23b83f01b,Manuel Praga Terente,manuel_praga_terente,,,,,, -2874,,d66cacab-55a9-4596-8872-4b540dd0d054,Amgen Development Europe,amgen_development_europe,,,,,, -826,0.98002481460571289,e662831f-0d28-42b9-a406-77cb46fe2d36,"Department of Nephrology and Renal Transplantation, University Hospitals Leuven",department_of_nephrology_and_renal_transplantation_university_hospitals_leuven,,,,e662831f-0d28-42b9-a406-77cb46fe2d36,department_of_nephrology_and_renal_transplantation,Department of Nephrology and Renal Transplantation -2875,,214a81fd-5961-4f7b-9dec-ba60ba110bfc,LABOpoint GmbH,labopoint_gmbh,,,,,, -2876,,844e032e-dbe7-4ca5-b582-9316a92eef62,"Encore Clinical, Inc",encore_clinical_inc,,,,,, -2877,,a7e6dfc6-4712-4488-a0ff-5a9b2c926c66,FORMENTI,formenti,,,,,, -2878,,7744d03c-714c-11e6-a0cd-0242ac12000b,TORPHARM,torpharm,,,,,, -2879,,2a916110-ae87-4571-a128-6423ee9dcf38,Itziar Fernandez Gonzalez,itziar_fernandez_gonzalez,,,,,, -2880,,ed4360a6-8bbd-11e6-a449-0242ac12000b,"Medical University of Vienna, ISPTM",medical_university_of_vienna_isptm,,,,,, -2881,,b35fbd7f-11bc-4c5a-a130-367c8f70dbb6,GOF pancreatic cancer collaborative group,gof_pancreatic_cancer_collaborative_group,,,,,, -2882,,1a169708-7145-11e6-a0cd-0242ac12000b,MUSTAFA NEVZAT ILAC,mustafa_nevzat_ilac,,,,,, -2883,,df012d30-c960-4e5e-bf42-aaa079e65d41,"Astelleas Pharma US, Inc",astelleas_pharma_us_inc,,,,,, -2884,,7f3bd928-2181-44aa-a46c-478c38f5ae42,"Soligenix, Inc",soligenix_inc,,,,,, -2885,,c44a96f5-33f0-4a36-bfc3-d87aded1ecc9,Clinique Mutualiste Chirurgicale,clinique_mutualiste_chirurgicale,,,,,, -2886,,52513bbf-8a94-46d3-9f25-041823a0c955,"Department of Ophthalmology, Semmelweis University",department_of_ophthalmology_semmelweis_university,,,,,, -2887,,52959d08-ff18-48d7-b3bd-e54533d4910e,Medical Faculty Magdeburg,medical_faculty_magdeburg,,,,,, -2888,,28581a31-d025-41f2-ba4e-2f7a558362d6,Fred Hutchinson Cancer Research Center,fred_hutchinson_cancer_research_center,,,,,, -2889,,23e36dc6-881d-11e6-a998-0242ac12000b,Respicopea Limited,respicopea_limited,,,,,, -2890,,b8f2aeb4-247c-4f08-a6ac-fcb4cdead6dd,"Osiris Therapeutics, Inc",osiris_therapeutics_inc,,,,,, -79,0.98557180166244507,18921777-f15d-49c4-8f68-7695c0b2af40,Karolinska Institutet/ Hospital,karolinska_institutet_hospital,,,,18921777-f15d-49c4-8f68-7695c0b2af40,karolinska_institutet_hospital,Karolinska Institutet/ Hospital -158,0.9865456223487854,5b2fbdce-d691-41c6-9a74-e06608d419f4,"Medizinische Universität Wien, HNO Klinik",medizinische_universit_t_wien_hno_klinik,,,,5b2fbdce-d691-41c6-9a74-e06608d419f4,medizinische_universit_t_wien_hno_klinik,Medizinische Universität Wien -715,0.989009,84a2a3e7-1448-4643-904b-c2956829c048,Thoracale Oncologie Groep Antwerpen TOGA,thoracale_oncologie_groep_antwerpen_toga,,,,70c3cd85-d7da-4e83-91f1-0c2abad141d5,thoracale_oncologie_groep_antwerpen,Thoracale Oncologie Groep Antwerpen -2891,,4057a67b-679f-41ad-bbdf-fe0b775860c6,NV ROCHE SA,nv_roche_sa,,,,,, -2892,,22fe652d-2dbd-45d4-bb0b-a8cf0b1a8b8e,Institut Claudius Regaud,institut_claudius_regaud,,,,,, -2893,,7e791d01-4f46-4ceb-abb6-a5863262e615,"Professor Hans Erik Johnsen, MD, DMSc, Department of Haematology, Aalborg Hospital",professor_hans_erik_johnsen_md_dmsc_department_of_haematology_aalborg_hospital,,,,,, -2894,,295b0688-13be-47c9-a4fa-d161d8de40cb,Institut d?Investigació en Atenció Primaria IDIAP Jordi Gol,institut_d_investigaci_en_atenci_primaria_idiap_jordi_gol,,,,,, -2895,,b936af78-6f50-4f42-bdab-1dc0267cdfda,Dr. Daniel Podzamczer Palter. Hospital Univesitari de Bellvitge. Unidad de VIH,dr_daniel_podzamczer_palter_hospital_univesitari_de_bellvitge_unidad_de_vih,,,,,, -473,0.986317,ae601fc8-205d-4cfe-8db5-ee6f905fa76a,Algeta ASA,algeta_asa,,,,a65c196b-462c-42a6-84d1-8d84e1c940d6,algeta_as,Algeta AS -2896,,d3fae27b-4776-42e6-87e8-579af143da53,Västerbottens läns landsting,v_sterbottens_l_ns_landsting,,,,,, -2897,,5cce6401-a191-478a-b5e2-50891230330a,LUSOFARMACO,lusofarmaco,,,,,, -2898,,31f92e94-7190-11e6-a0cd-0242ac12000b,ISO TEX,iso_tex,,,,,, -170,0.98542284965515137,74fb15bb-fdfd-41cc-8c91-bce5a34274e0,Merck Serono,merck_serono,,,,6b07fdf4-4955-45ab-999a-be365a194900,merck_serono_ltd,Merck Serono Ltd -2899,,020f2595-befa-4806-8471-be14375250b2,"Dpt. of Internal Medicine, Medical University of Innsbruck",dpt_of_internal_medicine_medical_university_of_innsbruck,,,,,, -2900,,5429d412-d78a-49a5-a059-8ace6fbb8935,Royal Marsden Foundation Hospital,royal_marsden_foundation_hospital,,,,,, -2901,,63d826a4-7168-11e6-a0cd-0242ac12000b,APPCO PHARMA LLC,appco_pharma_llc,,,,,, -2902,,ac09b497-24e7-4ef3-bdc8-76aaedafcb14,Walton Centre Foundation Trust,walton_centre_foundation_trust,,,,,, -2903,,6c09427e-7328-11e6-a0cd-0242ac12000b,SEPTODONT HOLDING,septodont_holding,,,,,, -986,0.97833722829818726,c62786c4-a39e-4b4e-91b9-31a6cb58454a,Imperial College Healthcare NHS Trust,imperial_college_healthcare_nhs_trust,,,,67902b25-58c1-419c-918d-42f6cc022a27,imperial_college_healthcare_nhs_trust,Imperial College Healthcare NHS Trust -2904,,a876810d-efec-4159-a6d7-793205a1da0e,Gilead Sciences Limited,gilead_sciences_limited,,,,,, -2905,,0b9014b1-f14f-48ca-86a8-7876f37e5915,Procter & Gamble Ltd,procter_gamble_ltd,,,,,, -935,0.987803,7988f024-a631-4924-bf0e-e2ca70acbe43,Institute of Tropical Medicine Antwerp,institute_of_tropical_medicine_antwerp,,,,61fc895f-7aff-4a8e-951c-f9fb4acdbb1f,institute_of_tropical_medicine,Institute of Tropical Medicine -2906,,47f85708-304f-4c1c-997b-461db8ffa755,"VERISFIELD (UK) LTD, GREEK BRANCH",verisfield_uk_ltd_greek_branch,,,,,, -346,0.9722786545753479,b58b5e0c-7141-11e6-a0cd-0242ac12000b,HIKMA PHARMS,hikma_pharms,,,,6f98f000-7144-11e6-a0cd-0242ac12000b,hikma,HIKMA -2907,,c4a952a2-117b-479f-8aec-44d334aadf68,IIL INTERGRUPPO ITALIANO LINFOMI ONLUS,iil_intergruppo_italiano_linfomi_onlus,,,,,, -396,0.958444,df6e5f78-616d-4a12-bbfb-8e53e8e5382f,Maastricht University Medical Centre,maastricht_university_medical_centre,,,,1a94c234-91dd-4ddb-8ee3-62df600fe4df,maastricht_universitary_medical_centre,Maastricht Universitary Medical Centre -2908,,b89f373b-bf96-49af-8cba-12aeff424866,Dr. Antonio Arroyo Sebastián,dr_antonio_arroyo_sebasti_n,,,,,, -2909,,6f5c2bbe-d305-4bba-9586-654d16a2070e,"Anders Nyboe Andersen, klinikchef dr.med., Fertilitetsklinikken 4071, Rigshospitalet",anders_nyboe_andersen_klinikchef_dr_med_fertilitetsklinikken_4071_rigshospitalet,,,,,, -2910,,18ce2571-8b6c-4d9f-b51e-b3c9bbe990b7,Groupe d'Oncologie Radiothérapie Tête Et Cou (GORTEC),groupe_d_oncologie_radioth_rapie_t_te_et_cou_gortec,,,,,, -2911,,35079f3f-db55-4475-9b7f-ac2cbadd1b73,Ritva Nissi,ritva_nissi,,,,,, -2912,,0ad41d1c-cf32-4f7e-8fc0-32d602412c2f,Alder Hey Children's Hospital NHS Trust,alder_hey_children_s_hospital_nhs_trust,,,,,, -2913,,892580c7-eb94-4c62-a2d4-1a56718d3d68,EBMT Trial Office,ebmt_trial_office,,,,,, -788,0.918711,77da9f8d-af27-42f4-9848-1b383dc686c1,"The Royal Group of Hospitals, Belfast Health and Social Care Trust",the_royal_group_of_hospitals_belfast_health_and_social_care_trust,,,,77da9f8d-af27-42f4-9848-1b383dc686c1,the_royal_group_of_hospitals_belfast_health_and_social_care_trust,"The Royal Group of Hospitals, Belfast Health and Social Care Trust" -2914,,406aeb0a-73b8-11e6-a0cd-0242ac12000b,CORCEPT THERAP,corcept_therap,,,,,, -2915,,3f2296bf-8ae6-4ff4-a9fd-a359dfb597af,"Klinik for håndkirurgi, Gentofte hospital",klinik_for_h_ndkirurgi_gentofte_hospital,,,,,, -2916,,61b57488-2c04-4d5a-a64d-59f6652bf623,Jeppe Hagstrup Christensen,jeppe_hagstrup_christensen,,,,,, -834,0.9859306812286377,af140e43-272f-40c9-b6fb-fa0d99d028a8,Novartis Pharmaceuticals UK Limited,novartis_pharmaceuticals_uk_limited,,,,34a46c06-df18-492f-b4ff-39c0c77ef62f,novartis_pharmaceuticals,Novartis Pharmaceuticals -231,0.975369,8ae37762-7370-11e6-a0cd-0242ac12000b,ORPHAN EUROPE,orphan_europe,,,,6590967f-139c-4cf2-a3f2-b668fb314794,orphan,ORPHAN -2917,,065c7592-80b2-451e-ad53-5e610bcc68e5,Maruho Europe Limited,maruho_europe_limited,,,,,, -780,0.923509,86773771-1b6b-4904-92bb-68ad633f1348,Royal Liverpool and Broadgreen University Hospital,royal_liverpool_and_broadgreen_university_hospital,,,,233d48d7-e293-4935-96da-8421fde4be1f,royal_liverpool_broadgreen_university_hospital,Royal Liverpool & Broadgreen University hospital -2918,,032a4887-425c-4333-8937-1854f102d7f1,"GlaxoSmithKline R & D Ltd., 980 Great West Road, Brendford, Middlesex, TW8 9GS, UK",glaxosmithkline_r_d_ltd_980_great_west_road_brendford_middlesex_tw8_9gs_uk,,,,,, -2919,,a71eeb6a-649e-4f43-a739-a0462e766bb9,MIKEL URRETAVIZCAYA SARACHAGA,mikel_urretavizcaya_sarachaga,,,,,, -2920,,fcc8b307-fbe5-4c7a-a428-d7e7d0e0f0a3,Gemma Rialp,gemma_rialp,,,,,, -61,0.970142,6e54f3b2-7165-11e6-a0cd-0242ac12000b,PAR FORM,par_form,,,,6e54f3b2-7165-11e6-a0cd-0242ac12000b,par_form,PAR FORM -2921,,7a3650e8-73fb-11e6-a0cd-0242ac12000b,STRATA MEDICAL INNOVATIONS,strata_medical_innovations,,,,,, -2922,,8f84d8e1-9173-4c17-be44-e39caa184ef1,VITAL THERAPIES INCORPORATED,vital_therapies_incorporated,,,,,, -2923,,8c41f0e7-9d2e-4443-98ca-076bda43716a,ASPREVA PHARMACEUTICALS CORPORATION,aspreva_pharmaceuticals_corporation,,,,,, -644,0.97071176767349243,ed718528-e6c7-48e9-9179-f757c9f510f6,Boehringer Ingelheim Pharma Ges mbH,boehringer_ingelheim_pharma_ges_mbh,,,,2e1c5817-912c-4f5e-bd24-7888fb2cc9f1,boehringer_ingelheim_pharma_gesmbh,Boehringer Ingelheim Pharma GesmbH -2924,,7c72cc00-71b3-11e6-a0cd-0242ac12000b,PURDUE PHARM PRODS,purdue_pharm_prods,,,,,, -2925,,70f620db-7e01-4f0f-a21f-a97a1e7afd7e,ALEXION PHARMACEUTICALS,alexion_pharmaceuticals,,,,,, -2926,,de20f742-73fc-11e6-a0cd-0242ac12000b,ADVANCED ACCELERATOR APPLICATIONS USA INC,advanced_accelerator_applications_usa_inc,,,,,, -205,0.98037469387054443,d53282f0-0864-40b0-8142-29a74ab39198,Glostrup Hospital,glostrup_hospital,,,,9b893499-55e3-4437-bc95-7a74dbcfefa5,glostrup_hospital_dep_of_neurology,"Glostrup Hospital, Dep. of Neurology" -346,0.9722786545753479,6f98f000-7144-11e6-a0cd-0242ac12000b,HIKMA,hikma,,,,6f98f000-7144-11e6-a0cd-0242ac12000b,hikma,HIKMA -153,0.980878,18f855d3-a347-4059-9f52-8c87407690f3,Lung Rx Inc,lung_rx_inc,,,,18f855d3-a347-4059-9f52-8c87407690f3,lung_rx_inc,Lung Rx Inc -2927,,afab0dd3-a402-4b7f-91d4-47e66eabf33f,Dept of Oncology. Haukeland University Hospital,dept_of_oncology_haukeland_university_hospital,,,,,, -86,0.95734971761703491,7b7c4eb7-0b01-479a-b331-98f2d90174df,AMC,amc,,,,7b7c4eb7-0b01-479a-b331-98f2d90174df,amc,AMC -2928,,e1741fcb-8289-4b51-b3f0-cb2c2ff9fc6f,"VIROSTATICS, SRL",virostatics_srl,,,,,, -2929,,2efec91a-c418-44e5-ad56-e89f22aeabb1,Skanes University Hospital,skanes_university_hospital,,,,,, -2930,,1ae0685f-53b1-441a-ab61-803ca1e4bce2,XBiotech Germany GmbH,xbiotech_germany_gmbh,,,,,, -2931,,a21e7a1e-7518-4c0e-9fe2-60bc67a95c8a,Sankt Lukas Hospice,sankt_lukas_hospice,,,,,, -211,0.95665790637334192,f22b2279-303f-4edc-b9ec-12c13e4b17ec,"Rigshospitalet, Department of Clinical Physiology, Nucelar Medicine and PET",rigshospitalet_department_of_clinical_physiology_nucelar_medicine_and_pet,,,,6d416153-a74f-11e6-94cb-5656d04fc2b5,rigshospitalet_department_of_clinical_physiology_nuclear_medicine_and_pet,"Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET" -2932,,431ef4cb-cc4d-4368-a5ef-f00cf85bbed6,Hull & East Yorkhire NHS Hospitals Trust,hull_east_yorkhire_nhs_hospitals_trust,,,,,, -445,0.97700804471969604,c2269e9d-6da5-4ede-8536-a48d9a0414d8,Royal Brompton,royal_brompton,,,,349b447a-a3b8-4b62-9bd7-18319a9a48b8,royal_brompton_harefield_nhs_trust,Royal Brompton & Harefield NHS Trust -2933,,d437c474-385a-43dc-9413-21687a1b7e0c,"Universitäres Herzzentrum, Klinik für Kardiologie und Angiologie",universit_res_herzzentrum_klinik_f_r_kardiologie_und_angiologie,,,,,, -2934,,b3812a99-ac4c-48b4-a4cf-e64f0b810b14,Grupo Catalán de Estudio de enfermedades glomerulares. Sociedad Catalana de nefrología,grupo_catal_n_de_estudio_de_enfermedades_glomerulares_sociedad_catalana_de_nefrolog_a,,,,,, -256,0.988946,f658ce54-ef9a-4134-9575-436d4d551eb4,"Otsuka Maryland Research Institute, Inc",otsuka_maryland_research_institute_inc,,,,dee9d357-375e-48a1-b857-489f6be6b00c,otsuka_maryland_research_institute,Otsuka Maryland Research Institute -2935,,61660ef2-504d-4d1f-902c-a290aeb244a5,Andres Iñiguez Romo,andres_i_iguez_romo,,,,,, -2936,,498c303c-28e1-41b4-b96d-1c8ccd901a77,Fundació Privada Hospital Asil de Granollers,fundaci_privada_hospital_asil_de_granollers,,,,,, -2937,,e68b4f8e-8d31-49c1-a100-6f4895929241,FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL GREGORIO MARAÑON,fundacion_para_la_investigacion_biomedica_hospital_gregorio_mara_on,,,,,, -2938,,1efa9e61-6090-40bb-8daa-1ea7310830f4,"Pfizer Inc, East 42nd street, New York, NY10017, USA",pfizer_inc_east_42nd_street_new_york_ny10017_usa,,,,,, -2939,,44d3fd53-b8d1-487c-99b9-80f81b222c64,Atopix Therapeutics Limited,atopix_therapeutics_limited,,,,,, -2940,,f83c083b-5b89-4f83-8070-33d15e5166da,HEALTH RICERCAE SVILUPPO SRL,health_ricercae_sviluppo_srl,,,,,, -2941,,17f2c3d0-8bc0-11e6-a449-0242ac12000b,Ortopædkirurgisk Afdeling Århus Universitetshospital,ortop_dkirurgisk_afdeling_rhus_universitetshospital,,,,,, -2942,,6d9e4776-266c-4dd2-993b-814bc4551ac8,Ferrer Grupo S.A,ferrer_grupo_s_a,,,,,, -2943,,aecd588b-ff66-491f-9107-8021ebe51853,Sophiris Bio Corp,sophiris_bio_corp,,,,,, -546,0.912289,1c5f86c3-3a9e-42e5-909c-e661552eaa17,University Hospital Regensburg,university_hospital_regensburg,,,,066b98e8-5ec4-4f5b-9b43-91f546ee98d1,university_hospital_of_regensburg,University Hospital of Regensburg -2944,,9a276f06-67f7-45ea-a93a-2feafb3fb539,"Dr. med. Bernd Salzer, Private Praxis",dr_med_bernd_salzer_private_praxis,,,,,, -2945,,34123d8f-e998-43b0-baf9-0fa8093e0da9,"TAYS, Hematologian yksikkö",tays_hematologian_yksikk,,,,,, -857,0.949193075299263,68ee455c-bacf-486f-9146-38bccb330df1,Institut de Recerca del Hopsital de la Santa Creu i Sant Pau,institut_de_recerca_del_hopsital_de_la_santa_creu_i_sant_pau,,,,0213f530-437f-430a-b936-0bfa94166165,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau -2946,,b52b33b0-a84c-4ae7-b049-9076a067abe3,Tartu University Hospital,tartu_university_hospital,,,,,, -444,0.96833282709121704,3c8eeed9-b500-4ecf-a409-f59b86b21db3,Royal Brompton and Harefield NHS Foundation Trust (RB&HFT),royal_brompton_and_harefield_nhs_foundation_trust_rb_hft,,,,3c8eeed9-b500-4ecf-a409-f59b86b21db3,royal_brompton_and_harefield_nhs_foundation_trust,Royal Brompton and Harefield NHS Foundation Trust -2947,,7475ddbf-3223-463e-a320-778f4e4c411e,"Department of Clinical Microbiology, Hvidovre Hospital",department_of_clinical_microbiology_hvidovre_hospital,,,,,, -851,0.982275,b71ebe88-2670-41c6-bc97-75d073b40c14,Lung LLC Inc,lung_llc_inc,,,,9e0d93e9-f8e2-452d-9570-4897fca51742,lung_llc,Lung LLC -2948,,aabe2da6-16fc-436d-a5ec-f6edf70e4167,Boehringer Ingelheim Netherlands B.V,boehringer_ingelheim_netherlands_b_v,,,,,, -2949,,9198e9a2-34b3-4814-9aa2-6523b020006f,"PTC THERAPEUTICS, INC",ptc_therapeutics_inc,,,,,, -2950,,237a7d9a-4da0-4db7-9fff-e6caf2e5a8fd,Victoria Castel Sánchez,victoria_castel_s_nchez,,,,,, -58,0.96342335641384125,4ee22869-e1f2-4fe4-b839-8e304a477801,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical resaearch and Development,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_resaearch_and_development,,,,2ed1b6f4-e137-4ee3-a218-9e5c2d04039a,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_and_development,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development -2951,,9239d4c8-02f9-44d4-9e14-f156c77f7da2,PALUPA Medical Ltd,palupa_medical_ltd,,,,,, -2952,,5a62beb5-7ff9-4a17-8c6e-49cdceb0cfe3,José Hernández-Quero. Hospital Clínico San Cecilio,jos_hern_ndez_quero_hospital_cl_nico_san_cecilio,,,,,, -2953,,7be6451e-d4fe-4141-aed2-305b0420b2bb,"Università di Milano, Dipartimento di Scienze Chirurgiche, Ospedale Maggiore Policlinico, Padiglione",universit_di_milano_dipartimento_di_scienze_chirurgiche_ospedale_maggiore_policlinico_padiglione,,,,,, -2954,,60329e0a-8bba-11e6-a449-0242ac12000b,Convergence Pharmaceuticals Limited,convergence_pharmaceuticals_limited,,,,,, -2955,,96ea390c-59c8-41e0-90b3-1788779b74c3,University Hospital Hradec Kralove,university_hospital_hradec_kralove,,,,,, -2956,,1e2432a8-9a26-4684-bf67-f071896277ad,ANTONIO PEREZ MARTINEZ,antonio_perez_martinez,,,,,, -2957,,8af3a0ee-4d52-4444-afa2-33b3b4428ea3,Lactest S.L,lactest_s_l,,,,,, -213,0.979896,559fe1ec-2be1-4b2f-a03a-a510b2d4cf93,Bioforce AG,bioforce_ag,,,,559fe1ec-2be1-4b2f-a03a-a510b2d4cf93,bioforce_ag,Bioforce AG -2958,,71d50e54-faa1-4caa-9cca-1aca4a1a5898,Österreichische Gesellschaft zur Erforschung komplementär – alternativer Therapien in der Onkologie,sterreichische_gesellschaft_zur_erforschung_komplement_r_alternativer_therapien_in_der_onkologie,,,,,, -2959,,df432042-a752-4243-9e4e-80ed1e42f5fb,TORAY,toray,,,,,, -2960,,eac3acb4-01b7-4c19-bc2c-fc903c093803,DeveloGen Autoimmune GmbH,develogen_autoimmune_gmbh,,,,,, -2961,,9564bf36-c532-4665-946a-e36ca78f815e,Hospira UK Ltd,hospira_uk_ltd,,,,,, -2962,,27fd85ad-4ca9-4ff7-b565-bf3f65a73af2,Fundación PETHEMA para el tratamiento de la leucemia y el linfoma,fundaci_n_pethema_para_el_tratamiento_de_la_leucemia_y_el_linfoma,,,,,, -2963,,2593097e-3eb8-4ebc-85aa-77c394fd9348,Advanced BioHealing Inc,advanced_biohealing_inc,,,,,, -2964,,f171532a-28b8-4cf3-85a8-a42810690411,Køge Hospital,k_ge_hospital,,,,,, -2965,,ae23d8a6-8c5d-4f33-9086-d7aca7823858,"AZ. OSPEDALIERA GARIBALDI, S.LUIGI CURRO , ASCOLI TOMASELLI",az_ospedaliera_garibaldi_s_luigi_curro_ascoli_tomaselli,,,,,, -2966,,2ef2bea4-eeea-43d1-87be-3cfb8ab7c479,DEBIOPHARM S.A,debiopharm_s_a,,,,,, -2967,,9f35ce3c-1396-4a0f-9212-589f173e0ac4,Isofol Medical AB,isofol_medical_ab,,,,,, -2968,,ff20459b-c755-453a-be20-f6e2e0475c79,ImClone Systems Incorporated,imclone_systems_incorporated,,,,,, -608,0.97127266724904382,0b4ab157-794b-487d-82ae-2120741beadf,"RWTH Aachen University for the Medical Falculty, represented by Clinical Trial Center Aachen (CTC-A)",rwth_aachen_university_for_the_medical_falculty_represented_by_clinical_trial_center_aachen_ctc_a,,,,8cf07097-1668-4840-99e4-5f3861195629,rwth_aachen_university_for_the_medical_faculty_represented_by_clinical_trial_center_aachen_ctc_a,"RWTH Aachen University for the Medical Faculty, represented by Clinical Trial Center Aachen (CTC-A)" -2969,,6aedf804-7151-11e6-a0cd-0242ac12000b,RITEDOSE CORP,ritedose_corp,,,,,, -658,0.988286,664414da-3a46-4707-80ab-612f81e1142f,Liverpool Women's NHS Foundation Trust,liverpool_women_s_nhs_foundation_trust,,,,4423b650-5a4e-43b4-81a3-c06729eeaafc,liverpool_women_s_nhs_foundation_trust_hospital,Liverpool Women's NHS Foundation Trust Hospital -2970,,d03d9fbd-a6e0-11e6-94cb-5656d04fc2b5,MC Slotervaart,mc_slotervaart,,,,,, -2971,,c3b15e84-8c58-407d-a425-88860d2e1f5a,Funxional Therapeutics Ltd,funxional_therapeutics_ltd,,,,,, -2972,,27fbab2f-8e5f-4aba-8229-37d3039006b6,Pierre Fabre Dermo-Cosmétique,pierre_fabre_dermo_cosm_tique,,,,,, -274,0.985423,04d25e84-7129-11e6-a89e-0242ac12000b,G AND W LABS,g_and_w_labs,,,,025f7b50-7129-11e6-a89e-0242ac12000b,g_and_w_labs_inc,G AND W LABS INC -2973,,8f620a3c-82b8-42ee-8300-7655bb1567b5,Karo Bio AB,karo_bio_ab,,,,,, -2974,,2937a777-7b3d-41d1-8c8c-ec1d06626dd7,SmithKline Beecham Corporation (doing business as GlaxoSmithKline),smithkline_beecham_corporation_doing_business_as_glaxosmithkline,,,,,, -211,0.97447748978932702,634e604f-a542-4409-963c-b1a72c89e7da,"Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET",rigshospitalet_department_of_clinical_physiology_nuclear_medicine_and_pet,,,,6d416153-a74f-11e6-94cb-5656d04fc2b5,rigshospitalet_department_of_clinical_physiology_nuclear_medicine_and_pet,"Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET" -2975,,c161eda1-f27c-4f48-ab01-c4a59c9d196e,"ZymoGenetics, Inc",zymogenetics_inc,,,,,, -2976,,8e671ff4-90da-4713-bd31-73071c708913,Daniel Sanabria Lucena,daniel_sanabria_lucena,,,,,, -2977,,cf21ec0c-4b60-4bd9-8127-282eb543d87a,Enrique de Madaria Pascual,enrique_de_madaria_pascual,,,,,, -1010,0.97897982597351074,90b35626-7145-11e6-a0cd-0242ac12000b,MCNEIL,mcneil,,,,1ea84c68-71d5-11e6-a0cd-0242ac12000b,mcneil_ped,MCNEIL PED -2978,,411bf2c0-7c0e-4d67-9119-d3ddcac759db,Medizin Universität Wien,medizin_universit_t_wien,,,,,, -2979,,57fcbd9c-4f3b-4997-9365-a6d9256fa5b8,Retinaklinikken Omnia,retinaklinikken_omnia,,,,,, -1054,0.97196,88936054-83c4-44a0-9f56-8aea1c3f4534,Fundacion para La Investigación Biomédica Hospital Universitario La Paz (FIBHULP),fundacion_para_la_investigaci_n_biom_dica_hospital_universitario_la_paz_fibhulp,,,,88936054-83c4-44a0-9f56-8aea1c3f4534,fundacion_para_la_investigaci_n_biom_dica_hospital_universitario_la_paz_fibhulp,Fundacion para La Investigación Biomédica Hospital Universitario La Paz (FIBHULP) -2980,,d9b39f75-1a2f-4344-acc9-7269c6b48552,Apotex Inc,apotex_inc,,,,,, -176,0.96301039059956872,4785c12c-a8bf-4198-a32e-aaa4708f48a5,Novartis Vaccines and Diagnostics S.r.l,novartis_vaccines_and_diagnostics_s_r_l,,,,fbdb10c1-6146-4761-86bf-a8541dc3b4fa,novartis_vaccines_and_diagnostics,Novartis Vaccines and Diagnostics -2981,,1902b82c-7142-11e6-a0cd-0242ac12000b,APOTHECON,apothecon,,,,,, -818,0.972258,f3acf8e7-1669-4bce-8a09-1b81d95d57ed,UNIVERSITA` DEGLI STUDI DI FIRENZE - DIPARTIMENTO DI PSICOLOGIA,universita_degli_studi_di_firenze_dipartimento_di_psicologia,,,,87f0f612-d1e5-4f3f-9bcd-69b8c3e8fd9a,universita_degli_studi_di_firenze,UNIVERSITA' DEGLI STUDI DI FIRENZE -2982,,c7f994e3-21b6-403e-a747-1e5c3809dd6f,ALMIRALL PRODESFARMA,almirall_prodesfarma,,,,,, -2983,,8d9168e8-5656-4e06-bad2-8308e8d8e0f0,CTI BioPharma Corp,cti_biopharma_corp,,,,,, -2984,,076699e9-90c8-4697-9aa7-d73e6950ea78,Laboratoires ELERTE,laboratoires_elerte,,,,,, -2985,,3cd39890-7163-11e6-a0cd-0242ac12000b,MAYNE PHARMA INC,mayne_pharma_inc,,,,,, -191,0.9870394766330719,5325f171-c07b-408c-b066-827a1d919e30,CESAR Central European Society for Anticancer Drug Research,cesar_central_european_society_for_anticancer_drug_research,,,,4042f330-66f0-40ec-8288-db80eef6363c,cesar_central_european_society_for_anticancer_drug_research,CESAR Central European Society for Anticancer Drug Research -2986,,9afcd47a-7142-11e6-a0cd-0242ac12000b,CHARTWELL CIENCA,chartwell_cienca,,,,,, -2987,,8f1e05db-4d1d-4d8f-919f-8484d0258dff,Oxford Racliffe NHS Trust,oxford_racliffe_nhs_trust,,,,,, -2988,,3fa69f5f-6985-40ac-8249-cb1fc1c322c7,Unidad de Cirugia Artroscópica,unidad_de_cirugia_artrosc_pica,,,,,, -965,0.981266,b75dc5c8-3735-4c68-a632-699239b52e79,"Göteborg University, Sect. Psyhiatry and Neurochemistry",g_teborg_university_sect_psyhiatry_and_neurochemistry,,,,b75dc5c8-3735-4c68-a632-699239b52e79,g_teborg_university_sect_psyhiatry_and_neurochemistry,"Göteborg University, Sect. Psyhiatry and Neurochemistry" -2989,,18c925c4-213f-4e7b-81a6-efab2ce2fae8,sanofi Belgium,sanofi_belgium,,,,,, -2990,,18b70f62-7ff7-4f45-8ab5-bd5d65bd7b76,Karolinska Institutet/Södersjukhuset,karolinska_institutet_s_dersjukhuset,,,,,, -852,0.986862,105c8b52-7238-11e6-a0cd-0242ac12000b,ENDO PHARM,endo_pharm,,,,105c8b52-7238-11e6-a0cd-0242ac12000b,endo_pharm,ENDO PHARM -2991,,315b149b-dc2c-4e15-be14-3ca3a6b4981a,"University of Heidelberg, Klinikum Mannheim, Dep Surgery/Thoracical Oncology",university_of_heidelberg_klinikum_mannheim_dep_surgery_thoracical_oncology,,,,,, -2992,,f071a034-74de-4455-b903-812ae57bfa3e,Universitätsklinik für Psychiatrie - Spezialambulanz für Abhangigkeitserkrankungen,universit_tsklinik_f_r_psychiatrie_spezialambulanz_f_r_abhangigkeitserkrankungen,,,,,, -481,0.98966941237449646,d42b3939-6ec8-482a-b3b2-f71da478382e,Medizinische Universität Graz, Universitätsklinik fürInnere Medizin,,,,48f0d5ed-174c-4ce4-98d7-cc34770f5107, Universitätsklinik für Innere Medizin,Medizinische Universität Graz -2993,,b42d5d33-5c69-434f-ad3a-1532e7998e5f,"Roche Polska, Sp.z.o",roche_polska_sp_z_o,,,,,, -2994,,29ae8e58-6b6f-41ed-88c8-6f4fc9ff26bc,University of Modena and Reggio Emilia,university_of_modena_and_reggio_emilia,,,,,, -2995,,9c606ca1-40dc-40d6-a830-c2a2203929a2,"Klinikum der Universität München, Anstalt des öffentlichen Rechts vertreten durch den Vorstand",klinikum_der_universit_t_m_nchen_anstalt_des_ffentlichen_rechts_vertreten_durch_den_vorstand, Abteilung für Endokrinologie und Stoffwechsel,medizinische_universit_t_graz_universit_tsklinik_f_rinnere_medizin_abteilung_f_r_endokrinologie_und_stoffwechsel,,,, -2996,,d3ebaa39-fec8-413f-9559-fa83565e9e5e,Laboratoires Auris SAS,laboratoires_auris_sas,,,,,, -2997,,9d2f2b54-f66a-4fb2-8cdf-18b38f94f9e1,Farmak International Holding GmbH,farmak_international_holding_gmbh,,,,,, -2998,,62b88203-984e-495b-b122-f3e38e1a3401,Pfizer Pharmaceutical Group,pfizer_pharmaceutical_group,,,,,, -2999,,f4dc51aa-62db-4236-b5c0-aa174e830a5c,Iron Therapeutics (UK) Ltd,iron_therapeutics_uk_ltd,,,,,, -776,0.931044,5cb4c7b4-22d3-4d2e-baa3-ec6641e8024b,Thomas Fichtner Bendtsen,thomas_fichtner_bendtsen,,,,5cb4c7b4-22d3-4d2e-baa3-ec6641e8024b,thomas_fichtner_bendtsen,Thomas Fichtner Bendtsen -3000,,bd073614-9235-4c6b-a87e-53acfe659c37,Sigrun Kjotrod,sigrun_kjotrod,,,,,, -292,0.987186,577003d4-ce61-4acf-92c9-2f42061c86fc,Motif BioSciences Inc,motif_biosciences_inc,,,,577003d4-ce61-4acf-92c9-2f42061c86fc,motif_biosciences_inc,Motif BioSciences Inc -3001,,32ad65af-e5d4-4923-a4e8-48aa55f6d352,Neurochem Inc,neurochem_inc,,,,,, -3002,,35de09e7-5761-4a6a-bfd9-e11b0a41f0d6,"Johan Wolfgang Goethe Universität - Department of Internal medicine I, Division Endocrinology",johan_wolfgang_goethe_universit_t_department_of_internal_medicine_i_division_endocrinology,,,,,, -3003,,cd0aff71-dccc-4c98-add8-ed0e56fe00a3,"Division of Cardiology, Robert-Bosch-Krankenhaus",division_of_cardiology_robert_bosch_krankenhaus,,,,,, -3004,,a2b02b48-e518-40b7-91fb-e5fb16986d77,Klinikum der Universität München - AöR vertreten durch den Vorstand des Bereiches umanmedizinH,klinikum_der_universit_t_m_nchen_a_r_vertreten_durch_den_vorstand_des_bereiches_umanmedizinh,,,,,, -3005,,d23b8f13-ba40-46ce-b7fa-a1303d972064,Ziekenhuis Oost-Limburg,ziekenhuis_oost_limburg,,,,,, -561,0.981251,d85aa782-9e49-4348-aef6-da814a075e7e,Bioheart,bioheart,,,,89f1114d-3553-4ac3-a66f-02effd57921a,bioheart_inc,"Bioheart, Inc" -3006,,cad83b40-6fc0-11e6-abe8-0242ac12000b,"Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University",department_of_experimental_and_clinical_pharmacology_and_toxicology_friedrich_alexander_university,,,,,, -3007,,59f7deac-832e-44a1-a893-4d2530183177,Meander MC,meander_mc,,,,,, -3008,,b34e7da5-017b-4ce4-911f-a3116806254c,"Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Aachen",klinik_f_r_psychiatrie_und_psychotherapie_universit_tsklinikum_aachen,,,,,, -3009,,434c909a-cb82-4647-b740-00411b6825b8,"Universität Mainz, I. Medizinische Klinik und Poliklinik",universit_t_mainz_i_medizinische_klinik_und_poliklinik,,,,,, -3010,,bcb69a19-f443-4a78-a4fc-5d7f251b9307,XTL Development Inc,xtl_development_inc,,,,,, -942,0.985052,02c56274-3bd4-4bfe-bfe8-b2385f2eef41,BioGeneriX AG,biogenerix_ag,,,,02c56274-3bd4-4bfe-bfe8-b2385f2eef41,biogenerix_ag,BioGeneriX AG -3011,,cdbde9e5-a842-438b-9f30-eac716d712c7,Roessingh Research&Development,roessingh_research_development,,,,,, -3012,,1f8a49c9-315b-48da-961a-a1c7c326fd7d,Bial Industrial Farmacéutica S.A,bial_industrial_farmac_utica_s_a,,,,,, -3013,,e0955966-3d56-4a65-b3bb-f95f89ea0129,"Rigshospitalet, 2121",rigshospitalet_2121,,,,,, -181,0.9797365665435791,d0a0c878-7149-11e6-a0cd-0242ac12000b,VALEANT,valeant,,,,7e7a02de-715e-11e6-a0cd-0242ac12000b,valeant_intl,VALEANT INTL -573,0.900909,5a6ea281-ca4c-46d4-8b7d-0e24f0d68167,ARTIC (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie),artic_association_pour_la_recherche_de_th_rapeutiques_innovantes_en_canc_rologie,,,,5a6ea281-ca4c-46d4-8b7d-0e24f0d68167,artic_association_pour_la_recherche_de_th_rapeutiques_innovantes_en_canc_rologie,ARTIC (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie) -3014,,9d394246-6a66-457a-b2e2-e218e23d7eb6,Fundacion Renal Iñigo Alvarez Toledo,fundacion_renal_i_igo_alvarez_toledo,,,,,, -3015,,df20d874-7154-11e6-a0cd-0242ac12000b,RECIP,recip,,,,,, -735,0.98468996584415436,6e92b00d-0791-4d8e-975c-0fbd5ce95861,European Organization for Research and Treatment of Cancer,european_organization_for_research_and_treatment_of_cancer,,,,6e92b00d-0791-4d8e-975c-0fbd5ce95861,european_organisation_for_research_and_treatment_of_cancer,European Organisation for Research and Treatment of Cancer -3016,,9da60900-d9d5-44b4-98da-a5a69f4f7e3c,University College Hospitals NHS Foundation Trust/ University College London,university_college_hospitals_nhs_foundation_trust_university_college_london,,,,,, -712,0.98029342293739319,22a73e59-42a9-4d35-bdb8-fda7d14ab400,Reckitt Benckiser Healthcare International Ltd,reckitt_benckiser_healthcare_international_ltd,,,,38c6b681-96aa-439b-8189-1ea1e741e51b,reckitt_benckiser_healthcare_international,Reckitt Benckiser Healthcare International -3017,,9a5f2f5c-9e49-46d0-ad0a-e9c38824dad5,Division of Rheumatology,division_of_rheumatology,,,,,, -3018,,07c597aa-7142-11e6-a0cd-0242ac12000b,NORTHSTAR HLTHCARE,northstar_hlthcare,,,,,, -3019,,2251e762-a7c7-4745-8c3e-1c0e91242941,Aintree University Hospital NHS Trust,aintree_university_hospital_nhs_trust,,,,,, -3020,,c6a62134-45e0-498a-b721-39eaca0b8fb1,Newcastle Upon Tyne NHS Foundation Trust,newcastle_upon_tyne_nhs_foundation_trust,,,,,, -3021,,e0f00d12-de12-495b-9c1c-d1fd478e5b38,Uppsala University/Uppsala County Council,uppsala_university_uppsala_county_council,,,,,, -3022,,a2618c1b-0784-4ab6-8ea6-3466d75cb988,CHU de Rennes (Rennes University Hospital Centre),chu_de_rennes_rennes_university_hospital_centre,,,,,, -3023,,0d9fcf1e-0c7b-4ba9-b99d-e095669bc5d7,Fernando Lago Deibe,fernando_lago_deibe,,,,,, -3024,,b258aaa0-e968-4010-8608-2ca87998e70e,Nordic Society for Gynecological Cancer,nordic_society_for_gynecological_cancer,,,,,, -3025,,52240df5-d096-4d24-914f-7c2d6e1febb3,Eija Kalso,eija_kalso,,,,,, -747,0.987246,c38c767e-3bab-4964-aa89-3148c5732dd6,Universitaetsklinikum Erlangen-Nuernberg,universitaetsklinikum_erlangen_nuernberg,,,,61d9cb36-84e8-4785-a622-4f2f20464069,universitaetsklinikum_erlangen,Universitaetsklinikum Erlangen -670,0.98121541738510132,003e8352-381a-4a71-b3e3-25cd5e67e274,NHS Lothian (ACCORD),nhs_lothian_accord,,,,003e8352-381a-4a71-b3e3-25cd5e67e274,nhs_lothian_accord,NHS Lothian (ACCORD) -3026,,48ff745c-9fc4-4314-8272-ade69ee188f7,Servicio de psiquiatria. Hospital Universitario La Paz,servicio_de_psiquiatria_hospital_universitario_la_paz,,,,,, -3027,,ca2b02cc-8821-4f3e-899e-69c84148e0c9,Dompé s.p.a,domp_s_p_a,,,,,, -3028,,7fe7c4ab-18f3-4ec1-ade8-51f460677e36,ERYTECH Pharma,erytech_pharma,,,,,, -618,0.987151,3c1aae28-1aa7-461b-ae60-fe064393d484,Belfast City Hospital Trust,belfast_city_hospital_trust,,,,3c1aae28-1aa7-461b-ae60-fe064393d484,belfast_city_hospital_trust,Belfast City Hospital Trust -3029,,66ef28cd-8a17-4485-848f-f0b0d9bf9103,ProStrakan Ltd,prostrakan_ltd,,,,,, -3030,,b45df1d1-b14e-42cc-b65d-3c5bf21dde99,"University Hospitals Leicester, Leicester General Hospital",university_hospitals_leicester_leicester_general_hospital,,,,,, -3031,,fb80c762-68d3-4689-a142-20a1ee41e6b9,Academisch Medisch Centrum bij de Universiteit van Amsterdam (AMC),academisch_medisch_centrum_bij_de_universiteit_van_amsterdam_amc,,,,,, -380,0.96973061561584473,60384d82-f20c-4bc4-8d63-da5bc1c92478,"Merck Sharp & Dohme Corp., a subsidary of Merck & Co",merck_sharp_dohme_corp_a_subsidary_of_merck_co,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" -3032,,5f1f775e-2c7c-4ab8-a3f9-faf2dc1b0f13,"Roche Farma, S.A. , en nombre de F. Hoffmann- La Roche",roche_farma_s_a_en_nombre_de_f_hoffmann_la_roche,,,,,, -3033,,21c73b9e-4142-403d-8a1a-5ae12c3a5778,Mylan Pharmaceuticals Inc,mylan_pharmaceuticals_inc,,,,,, -3034,,f82a1da8-881f-11e6-a998-0242ac12000b,Solvay Pharmaceuticals BV,solvay_pharmaceuticals_bv,,,,,, -3035,,a67550aa-2e95-48f9-8bb5-0d2127a15261,"Gilead Sciences Canada, Inc",gilead_sciences_canada_inc,,,,,, -3036,,fb864186-a1c3-43e4-96ea-f0ce8ba32356,Sahlgrenska Akademin vid Göteborgs Universitet,sahlgrenska_akademin_vid_g_teborgs_universitet,,,,,, -204,0.98671889305114746,f3d26e6b-906d-4f66-b5d8-5c97a760e0bc,Institut de Recerca,institut_de_recerca,,,,e77923f8-3c50-4c19-aba2-8104ed582c2e,institut_de_recerca_hscsp,Institut de Recerca HSCSP -3037,,cfd0e8e9-6781-4f87-8251-56845fce0157,no sponsor for this trial,no_sponsor_for_this_trial,,,,,, -3038,,5420448b-fd74-45e7-91f0-9f730b48c22d,Desitin Arzneimittel GmbH,desitin_arzneimittel_gmbh,,,,,, -3039,,01cd8925-944b-48dd-951d-8ffffd9e1d3f,Dept. of Rhematology UMAS,dept_of_rhematology_umas,,,,,, -3040,,5b9f1606-978a-4207-b973-1a46a233f923,Serodus ASA,serodus_asa,,,,,, -236,0.9629122416178385,36e40cab-06cf-41e0-bef3-04e11a49311d,"Pfizer Ltd, Ramsgate Road, Sandwich, Kent",pfizer_ltd_ramsgate_road_sandwich_kent,,,,36e40cab-06cf-41e0-bef3-04e11a49311d,pfizer_ltd_ramsgate_road_sandwich_kent,"Pfizer Ltd, Ramsgate Road, Sandwich, Kent" -838,0.98826968669891357,046d6658-d5b1-4caa-8e4b-a52c60c09ffd,NHS Greater Glasgow and Clyde,nhs_greater_glasgow_and_clyde,,,,046d6658-d5b1-4caa-8e4b-a52c60c09ffd,nhs_greater_glasgow_and_clyde,NHS Greater Glasgow and Clyde -3041,,4c3a33ed-0499-4611-95d9-d5d6f55e468d,Splošna bolnišnica Celje,splo_na_bolni_nica_celje,,,,,, -3042,,75d9c295-c39f-4ccd-9a19-c89fa61db938,mib Dienstleistungsgesellschaft mbH,mib_dienstleistungsgesellschaft_mbh,,,,,, -3043,,30c2a37e-7150-11e6-a0cd-0242ac12000b,DEXCEL LTD,dexcel_ltd,,,,,, -3044,,7970b926-db39-4bce-9547-3f573248cf1a,"Chimerix, Inc",chimerix_inc,,,,,, -3045,,7d798544-5e49-4b24-899f-fbc24edba20c,I.R.I.S. Institut de Recherches Internationales Servier,i_r_i_s_institut_de_recherches_internationales_servier,,,,,, -3046,,0f271e14-1dfa-430b-8f55-1d51b33dbe08,"Department of Anaesthesiology and Intensive Care, University of Tartu",department_of_anaesthesiology_and_intensive_care_university_of_tartu,,,,,, -3047,,ee6dbd3b-5385-4cea-bce9-7801dd077af5,Karolinska Institute,karolinska_institute,,,,,, -3048,,fc2cd1da-7149-11e6-a0cd-0242ac12000b,LEHIGH VALLEY,lehigh_valley,,,,,, -3049,,7c1744f3-d3d4-4a99-9dfb-4434171209e7,"ConjuChem, Inc",conjuchem_inc,,,,,, -3050,,8ba3cb95-58e2-4ed1-996e-2cc9883bc6d6,GBG Forschung GmbH,gbg_forschung_gmbh,,,,,, -3051,,c8c5428f-7f58-48b9-a923-8c54e9fbc313,Nycomed Sweden Holding 2 AB,nycomed_sweden_holding_2_ab,,,,,, -3052,,afcbb067-7a47-4ae0-be71-ce3070201f2b,Neolab Ltd,neolab_ltd,,,,,, -3053,,6dfa41fc-c2c8-4be4-b527-6dedb6b2b2a0,Dr. Miguel Blanca Gómez,dr_miguel_blanca_g_mez,,,,,, -3054,,47a42bef-f837-40e0-8db0-1d4d1593d4cb,IMETISA,imetisa,,,,,, -3055,,3600d234-4c50-4e4b-9bd4-1389ea95233d,Servicio de Enfermedades Infecciosas. Unidad VIH. Hospital Universitari de Bellvitge,servicio_de_enfermedades_infecciosas_unidad_vih_hospital_universitari_de_bellvitge,,,,,, -3056,,6e50ec4e-3289-4289-a102-d1658c72fabe,Betsi Cadwaladr University Health Board,betsi_cadwaladr_university_health_board,,,,,, -3057,,d3504b21-f4a7-49c7-a199-c03732b6465f,Xenova Ltd,xenova_ltd,,,,,, -3058,,60a31ce0-9da8-4fb3-a828-358c4ebcf10d,CytRx Corporation,cytrx_corporation,,,,,, -380,0.97038671705457902,f262b660-2330-429c-8af0-63e5c4fec4b0,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., N.J., USA",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_n_j_usa,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" -3059,,63bd7b38-7168-11e6-a0cd-0242ac12000b,PURACAP PHARMACEUTICAL LLC,puracap_pharmaceutical_llc,,,,,, -3060,,1fed9587-215f-48ec-bff3-6fa1d30fca57,Institute of oncology,institute_of_oncology,,,,,, -3061,,6219db2b-5159-4b5a-9fca-fef7ddf20cb1,"Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Medizinische Hochschule Hannover",klinik_f_r_allgemein_viszeral_und_transplantationschirurgie_medizinische_hochschule_hannover,,,,,, -3062,,c327f5b1-2d4c-4f8e-bc71-66756d22aa9f,"Technische Universitaet Muenchen, Medizinische Fakultaet",technische_universitaet_muenchen_medizinische_fakultaet,,,,,, -705,0.975954,dd27398c-7163-11e6-a0cd-0242ac12000b,LUITPOLD PHARMS INC,luitpold_pharms_inc,,,,666dd3bc-7129-11e6-a89e-0242ac12000b,luitpold,LUITPOLD -759,0.983343,24121f55-fb32-464a-8d7d-28948ed0eae7,Sektion Chirurgische Forschung,sektion_chirurgische_forschung,,,,24121f55-fb32-464a-8d7d-28948ed0eae7,sektion_chirurgische_forschung,Sektion Chirurgische Forschung -3063,,2bc78fb7-6051-428c-a7ce-351a2f7ff28c,FISM ONLUS,fism_onlus,,,,,, -413,0.98836642503738403,6703561f-7892-4741-9e93-df86d84b4cdc,Karolinska University Hospital Solna,karolinska_university_hospital_solna,,,,4a616e09-39b2-4537-bceb-96327b70319b,karolinska_university_hospital,Karolinska University Hospital -655,0.96628576517105103,a91f8817-005f-4251-808a-ee4efece990a,Boehringer Ingelheim Inc,boehringer_ingelheim_inc,,,,a91f8817-005f-4251-808a-ee4efece990a,boehringer_ingelheim_inc,Boehringer Ingelheim Inc -126,0.985655,6ca002d3-030a-446d-9fc5-74a04207c321,"Clinical Trials and Research Governance, University of Oxford",clinical_trials_and_research_governance_university_of_oxford,,,,5760d01f-a672-4d09-ab67-83a15c2d8903,clinical_trials_and_research_governance,Clinical Trials and Research Governance -3064,,70a82b07-e3c6-4262-91b8-92811acf53f4,Laboratorios Ordesa,laboratorios_ordesa,,,,,, -3065,,89a5dbb0-d46c-413e-b614-30ebd13b244a,FAZ - Floridsdorf Allergy Center,faz_floridsdorf_allergy_center,,,,,, -3066,,90966315-fc20-499a-94e1-ed6ea9f8cfee,Drossapharm AG,drossapharm_ag,,,,,, -869,0.97674435377120972,8c2f1018-ffda-46d2-836f-6bb8351d4443,Astellas,astellas,,,,8c2f1018-ffda-46d2-836f-6bb8351d4443,astellas,Astellas -3067,,b699d253-a746-11e6-94cb-5656d04fc2b5,Finn Sellebjerg,finn_sellebjerg,,,,,, -3068,,60cc0fe2-83b3-43f7-bc60-af261cf89079,SE Dept. of Psychiatry and Psychotherapy,se_dept_of_psychiatry_and_psychotherapy,,,,,, -3069,,dd277b94-7141-11e6-a0cd-0242ac12000b,ACCORD HLTHCARE,accord_hlthcare,,,,,, -3070,,a57d81e8-7141-11e6-a0cd-0242ac12000b,APP PHARMS,app_pharms,,,,,, -3071,,bb2c89f4-3720-436e-b400-fc6d3dd179de,"CBLAYA&HUGET, S.L",cblaya_huget_s_l,,,,,, -3072,,8eff3282-2893-4457-ad82-85af51af6e1a,"CIS bio international, member of IBA group",cis_bio_international_member_of_iba_group,,,,,, -3073,,cb7dcb4b-2b13-4565-85e0-d7d13ed17f55,Boehringer Ingelheim Hellas,boehringer_ingelheim_hellas,,,,,, -3074,,48720625-a749-4eeb-9023-c6a500917eda,Tapestry Pharmaceuticals Ltd,tapestry_pharmaceuticals_ltd,,,,,, -3075,,5a59e464-9623-431a-85b7-abc05a0adda3,"Angelini Farmaceutici, ACRAF S.p.A",angelini_farmaceutici_acraf_s_p_a,,,,,, -442,0.934557,a4633fdb-5ef0-4fc4-8c7b-a058097e6bf2,Laboratorios Andrómaco S.A. (Co-sponsor Spanien),laboratorios_andr_maco_s_a_co_sponsor_spanien,,,,25695572-6fa2-11e6-9663-0242ac12000b,laboratorios_andr_maco_s_a_co_sponsor_spain,Laboratorios Andrómaco S.A. (co-sponsor Spain) -3076,,bc7c071c-b4d0-49b1-985f-f03f6f3e6426,Hull and east Yorkshire Hospital NHS Trust,hull_and_east_yorkshire_hospital_nhs_trust,,,,,, -125,0.982275,a37dc1b8-8773-48d3-ac48-d88bec02bf91,CureTech Ltd,curetech_ltd,,,,11b07734-c458-4066-877a-5c26e559db7c,curetech,CureTech -3077,,9e572ed7-89d1-429f-85ef-0238031a8f96,"Radboud University Nijmegen Medical Centre, Donders Institute for Brain, Cognition and Behaviour",radboud_university_nijmegen_medical_centre_donders_institute_for_brain_cognition_and_behaviour,,,,,, -3078,,be58fe63-c437-444a-8819-31c8a3687d0e,GSK Biologicals,gsk_biologicals,,,,,, -273,0.98508751392364502,22571e3f-0745-4cea-b1ca-5cc32ff5e911,Uppsala University Hospital,uppsala_university_hospital,,,,22571e3f-0745-4cea-b1ca-5cc32ff5e911,uppsala_university_hospital,Uppsala University Hospital -3079,,a0be3e04-c52d-482e-b6bd-6d27b71f6fc6,"Nuon Therapeutics, Inc",nuon_therapeutics_inc,,,,,, -3080,,d2c3fa76-a3f7-4f64-a2d0-5b1ced8042a8,Göteborg University,g_teborg_university,,,,,, -503,0.9617990255355835,e4d6bbcf-51b5-4969-b9e5-99d8e4d10f9c,Sanofi-Synthelabo Rt,sanofi_synthelabo_rt,,,,1e7e8025-6216-4754-a0a3-b1cf72ba2a3d,sanofi_synthelabo_research,Sanofi-Synthelabo Research -3081,,c53bc5e0-f77b-4a7f-9f85-0bcd333724e4,Pfixer Inc,pfixer_inc,,,,,, -3082,,1f08f17e-cc2e-41f4-9b6c-15128244b907,"Dept of Endocrinology O106, Herlev Hospital",dept_of_endocrinology_o106_herlev_hospital,,,,,, -3083,,2a254123-29b6-434d-837a-af00e9988b4b,GOELAMS,goelams,,,,,, -3084,,a5a66260-cfb1-46be-b364-a73832fe330a,ErasmusMC-University Medical Center Rotterdam,erasmusmc_university_medical_center_rotterdam,,,,,, -376,0.95499825477600098,105bd662-3e0a-487f-94e5-81782ae2a384,"Merck Sharp & Dohme Corp., una filial de Merck & Co., Inc",merck_sharp_dohme_corp_una_filial_de_merck_co_inc,,,,105bd662-3e0a-487f-94e5-81782ae2a384,merck_sharp_dohme_corp_una_filial_de_merck_co_inc,"Merck Sharp & Dohme Corp., una filial de Merck & Co., Inc" -3085,,63e9368d-68f0-438a-966a-b7413a36b5a8,Alios BioPharma,alios_biopharma,,,,,, -3086,,292064b6-780a-4123-bbb2-f401259b845c,"Schering Plough Institute, A Division of Schering Corporation",schering_plough_institute_a_division_of_schering_corporation,,,,,, -973,0.987557,a5b646ac-af3e-4961-8e78-b8f46d68415c,"Cutanea Life Sciences, Inc",cutanea_life_sciences_inc,,,,9333210d-087c-420a-b3c2-e6d678ea9766,cutanea_life_sciences,Cutanea Life Sciences -3087,,01827836-7129-11e6-a89e-0242ac12000b,INWOOD LABS,inwood_labs,,,,,, -3088,,2a60ac96-f361-43f8-a53d-5477ced2e7de,AZIENDA USL DI FORLI`,azienda_usl_di_forli,,,,,, -3089,,a30cbc20-5e20-4cc1-b407-a7e4ac8c4a05,University Hospital Of North Staffordshire,university_hospital_of_north_staffordshire,,,,,, -3090,,20adcb50-ad37-4eb8-86d0-b05e40e48460,A.C.R.A.F. S.p.A,a_c_r_a_f_s_p_a,,,,,, -3091,,7d4f965b-dde1-4254-86b7-7bd25a753546,"Medizinische Universität Wien, Univ.Klinik für Notfallmedizin",medizinische_universit_t_wien_univ_klinik_f_r_notfallmedizin,,,,,, -3092,,4455070a-7142-11e6-a0cd-0242ac12000b,APOTHEKERNES,apothekernes,,,,,, -525,0.98547,92847265-b43d-4060-94ca-5cc75acad0a3,"University Hospital of Wuerzburg, Medical Director",university_hospital_of_wuerzburg_medical_director,,,,254a684e-a281-4ecf-989d-ea9a018d8552,university_hospital_of_wuerzburg,University Hospital of Wuerzburg -3093,,39455995-5ac9-469e-939a-4c807771318c,Fundacion para la Investigación Biomédica del Hospital Gregorio Marañón,fundacion_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,,,,,, -111,0.90460896492004395,a2735ed0-5aeb-43b7-932c-5c550bb60e38,"Department of Oncology, Lund University Hospital",department_of_oncology_lund_university_hospital,,,,305770d0-2dc9-4f31-ad46-773cf169b699,department_of_oncology_sk_ne_university_hospital_lund,"Department of Oncology, Skåne University Hospital Lund" -3094,,a756494f-8dcd-4d61-97fb-2ae45dc32e74,Klinik und Poliklinik für Neurologie der Universität Regensburg am Bezirksklinikum,klinik_und_poliklinik_f_r_neurologie_der_universit_t_regensburg_am_bezirksklinikum,,,,,, -3095,,b25d87dd-b6ce-4774-b85a-ca965c0ddc25,"Pfizer Inc., 235 42nd Street, New York, NY 10017, USA",pfizer_inc_235_42nd_street_new_york_ny_10017_usa,,,,,, -3096,,4dfbbcba-d32c-4d33-ac82-6ccfd1e885be,LIGHT SCIENCES ONCOLOGY,light_sciences_oncology,,,,,, -3097,,b58a63dc-67bf-4f04-a31b-a463815f7fa0,Pharmion Corporation,pharmion_corporation,,,,,, -3098,,c11ed538-72f3-11e6-a0cd-0242ac12000b,AVANIR PHARMS,avanir_pharms,,,,,, -3099,,e7db3ec5-e090-4aa0-ab2c-361f627eada6,Dermal Laboratories Ltd,dermal_laboratories_ltd,,,,,, -3100,,718dcfcc-27da-4f5c-92f9-260997b382aa,Panacea Biotec Ltd,panacea_biotec_ltd,,,,,, -3101,,835a99dc-a477-4f73-aa41-7882b2913a9d,"Biogen Idec Inc., 9 Fourth Avenue,Waltham, MA 02451, USA",biogen_idec_inc_9_fourth_avenue_waltham_ma_02451_usa,,,,,, -944,0.98510605096817017,d377a9a0-b92b-4a59-a766-34cb27160196,"Georg-August-Universität Göttingen, Universitätsmedizin",georg_august_universit_t_g_ttingen_universit_tsmedizin,,,,bc3fb171-d422-4044-ae7a-9a9bc31f9e22,georg_august_universit_t_g_ttingen,Georg-August-Universität Göttingen -782,0.985647,0b630147-5207-4370-96bb-646e858f6049,Pfizer Corporation Austria Ges.m.b.H,pfizer_corporation_austria_ges_m_b_h,,,,0b630147-5207-4370-96bb-646e858f6049,pfizer_corporation_austria_ges_m_b_h,Pfizer Corporation Austria Ges.m.b.H -3102,,99c97c7b-dbe4-433a-aab5-8ca916a438c2,University College London Comprehensive Clinical Trials Unit,university_college_london_comprehensive_clinical_trials_unit,,,,,, -3103,,1af9aca2-0d83-430d-a5c7-b7423ccacd2d,"Institute for Social Medicine, Epidemiology, and Health Economics, Charité Berlin",institute_for_social_medicine_epidemiology_and_health_economics_charit_berlin,,,,,, -3104,,1bb109b3-d204-4eda-914b-32cb64215481,AZIENDA OSPEDALIERA ISTITUTI CLINICI DI PERFEZIONAMENTO DI MILANO,azienda_ospedaliera_istituti_clinici_di_perfezionamento_di_milano,,,,,, -3105,,b49ec2fc-f646-4e22-948b-5c7f27600418,Liverpool Heart and Chest Hospital,liverpool_heart_and_chest_hospital,,,,,, -3106,,900bad2a-b594-4559-9101-dfc0c5c3e77e,Beaufour Ipsen Pharma S.A.S,beaufour_ipsen_pharma_s_a_s,,,,,, -3107,,cd88e3be-6ef2-4fc2-9026-74f68a76672a,University Hospital Ghent,university_hospital_ghent,,,,,, -3108,,18eebb1c-45a0-475a-9b9b-c3c37274bd01,Bonaventura Clotet Sala,bonaventura_clotet_sala,,,,,, -3109,,c43e0cf9-f34c-4d9c-a3f3-e1c5b91d52ee,Derby Hospitals NHS Foundation Trust,derby_hospitals_nhs_foundation_trust,,,,,, -3110,,3e199cf3-4de5-4ed4-a227-b892f4f34c48,"Laboratorios SOPHIA, S.A. de C.V",laboratorios_sophia_s_a_de_c_v,,,,,, -3111,,39c1e28e-93e4-4287-bdd3-b1b99883f69d,ARCHIMEDES,archimedes,,,,,, -601,0.969108,3c28acd6-a12e-4774-8da0-312d8e4ff6e8,CHU de Saint-Etienne,chu_de_saint_etienne,,,,0cbd210d-2ea8-4bc2-85dc-5959ed1c55ad,chu_de_saint_tienne,CHU de Saint-Étienne -3112,,c22e87f5-cc87-498c-b01e-3bf1be388591,"Med. Universitaetsklinik Graz, ao Univ. Professor Dr. med. Thomas C. Wascher",med_universitaetsklinik_graz_ao_univ_professor_dr_med_thomas_c_wascher,,,,,, -3113,,582b1df0-7bc7-4fd3-8abf-52e44509c37c,Abeona Therapeutics Inc,abeona_therapeutics_inc,,,,,, -3114,,d109f3e7-f096-42fc-b11a-ce2dc0c705ce,Professor Krzysztof Tadeusz Drzewiecki,professor_krzysztof_tadeusz_drzewiecki,,,,,, -3115,,d3bb7e20-7141-11e6-a0cd-0242ac12000b,AMEDRA PHARMS,amedra_pharms,,,,,, -3116,,779b0eb0-114c-42eb-b34e-f7338ced8024,NHS Greater Glasgow & Clyde and University of Glasgow,nhs_greater_glasgow_clyde_and_university_of_glasgow,,,,,, -1073,0.987562,a0dd21db-1c17-47e9-af2f-92349a9503ac,Akershus University Hospital,akershus_university_hospital,,,,a0dd21db-1c17-47e9-af2f-92349a9503ac,akershus_university_hospital,Akershus University Hospital -3117,,afec5f88-f508-4b2e-9ad8-d69dfc8e2316,FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS,fundacion_para_la_investigacion_biomedica_del_hospital_universitario_principe_de_asturias,,,,,, -3118,,5e5896b1-bb42-47d6-b852-1787775ff234,Fondazione Melanoma ONLUS,fondazione_melanoma_onlus,,,,,, -134,0.984688,61bbf47c-775e-4ef4-9782-861df4424a72,University Hospitals Bristol NHS Foundation Trust,university_hospitals_bristol_nhs_foundation_trust,,,,61bbf47c-775e-4ef4-9782-861df4424a72,university_hospitals_bristol_nhs_foundation_trust,University Hospitals Bristol NHS Foundation Trust -3119,,26305a38-7163-11e6-a0cd-0242ac12000b,HISUN PHARM HANGZHOU,hisun_pharm_hangzhou,,,,,, -3120,,66bb86e7-bb9c-4c05-9d23-2538b1fad491,"CRC, Medical Department IV, University Erlangen-Nuremberg",crc_medical_department_iv_university_erlangen_nuremberg,,,,,, -3121,,67fea2b2-715e-11e6-a0cd-0242ac12000b,WHITEWORTH TOWN PLSN,whiteworth_town_plsn,,,,,, -3122,,2518a70c-726e-11e6-a0cd-0242ac12000b,ASCEND THERAPS US,ascend_theraps_us,,,,,, -3123,,2f119216-7145-11e6-a0cd-0242ac12000b,WOCKHARDT EU OPERATN,wockhardt_eu_operatn,,,,,, -3124,,1ab1d5c1-2c05-4114-924b-f9432abf02dd,AZIENDA OSPEDALIERA OSPEDALI GALLIERA,azienda_ospedaliera_ospedali_galliera,,,,,, -3125,,c18e20f1-06e1-48cb-9fbc-cf44ae2b0a8f,Tecnical University of Munich,tecnical_university_of_munich,,,,,, -3126,,d9ca433c-85d2-441f-9d57-4e5720e6225a,Fundación Grupo Español de Investigación en Cáncer de Mama (Fundación GEICAM),fundaci_n_grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama_fundaci_n_geicam,,,,,, -3127,,c2904f7f-5609-4d6a-aa73-c25676315aae,Merck Sharp & Dohme Ireland (Human Health) Limited,merck_sharp_dohme_ireland_human_health_limited,,,,,, -3128,,020fbdb0-10e3-4964-ba6b-0af8ed387b6c,Elan Pharma International Ltd,elan_pharma_international_ltd,,,,,, -3129,,bace2f9e-adec-4f6a-9e55-32cbe088ffb9,Oryx GmbH & Co KG,oryx_gmbh_co_kg,,,,,, -3130,,fc377e76-7146-11e6-a0cd-0242ac12000b,DORADO PHARMA,dorado_pharma,,,,,, -3131,,f601e336-66cd-4130-8c58-d2e52fea1133,Prof Jes Olesen,prof_jes_olesen,,,,,, -712,0.98916232585906982,38c6b681-96aa-439b-8189-1ea1e741e51b,Reckitt Benckiser Healthcare International,reckitt_benckiser_healthcare_international,,,,38c6b681-96aa-439b-8189-1ea1e741e51b,reckitt_benckiser_healthcare_international,Reckitt Benckiser Healthcare International -3132,,1bda6118-5a6e-4a2e-b021-c4b71693772b,Aintree University Hospitals NHS Trust,aintree_university_hospitals_nhs_trust,,,,,, -3133,,f107ea59-ed85-4273-b768-0e2c3184e560,CYTAVIS BioPharma GmbH,cytavis_biopharma_gmbh,,,,,, -743,0.978585,cae36710-5446-4e30-a773-3bb7f409ba33,Population health Research Institute,population_health_research_institute,,,,a57f06eb-3ab3-4751-a94f-5b412b84bbb7,population_health_research_institute_phri,Population Health Research Institute (PHRI) -3134,,5da3c684-3ba0-4801-a5ed-56343bc5cc09,"Agile Therapeutics, Inc",agile_therapeutics_inc,,,,,, -3135,,eeb7827d-8399-43f7-8cc5-5d1bef4102a5,"Department of Anesthesiology and Intensive Care, University Hospital Münster",department_of_anesthesiology_and_intensive_care_university_hospital_m_nster,,,,,, -434,0.9664912223815918,828072f6-88b3-464e-b218-539be8854135,"Pfizer Inc., 235 East 42nd Street, New York, NY 110017",pfizer_inc_235_east_42nd_street_new_york_ny_110017,,,,0068e377-8873-41b9-baad-e3768b77d0b1,pfizer_inc_235_east_42nd_street_new_york_ny_10017,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017" -178,0.914111,6cb03c75-a5d8-4c11-999f-9a0d26e68ba1,Nottingham Univeristy Hospitals NHS Trust,nottingham_univeristy_hospitals_nhs_trust,,,,6cb03c75-a5d8-4c11-999f-9a0d26e68ba1,nottingham_univeristy_hospitals_nhs_trust,Nottingham Univeristy Hospitals NHS Trust -848,0.928667,c292a342-b266-4a04-9816-329eda28532a,Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis (NKI-AVL),nederlands_kanker_instituut_antoni_van_leeuwenhoek_ziekenhuis_nki_avl,,,,c292a342-b266-4a04-9816-329eda28532a,nederlands_kanker_instituut_antoni_van_leeuwenhoek_ziekenhuis_nki_avl,Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis (NKI-AVL) -3136,,98cd0fcf-9ab2-4e3a-abe3-635cbc7c588f,N-Gene Research & Development Ltd,n_gene_research_development_ltd,,,,,, -3137,,48ab550e-7168-11e6-a0cd-0242ac12000b,INTERGEL PHARMS INC,intergel_pharms_inc,,,,,, -3138,,31ebb532-07b5-41c5-9280-7dcf0af2e17b,CURALOGIC,curalogic,,,,,, -3139,,04f82d32-5373-4289-af2a-31c3b90184a4,KU Leuven - Drug Delivery & Disposition,ku_leuven_drug_delivery_disposition,,,,,, -3140,,8a5fa188-7142-11e6-a0cd-0242ac12000b,DOW PHARM,dow_pharm,,,,,, -3141,,502fb3bc-f8ac-4503-b8d0-e9e5d7080728,BTG International Ltd,btg_international_ltd,,,,,, -3142,,1c2ea71b-e6f2-4180-ae8f-b74b1ac410fd,Servicio de Endocrinologia y Nutricion. Hospital Universitari Bellvitge,servicio_de_endocrinologia_y_nutricion_hospital_universitari_bellvitge,,,,,, -505,0.977622,f74104ca-7144-11e6-a0cd-0242ac12000b,MEDICIS,medicis,,,,6555c8c6-714d-11e6-a0cd-0242ac12000b,medicis_pharms,MEDICIS PHARMS -3143,,de274e76-18dc-4899-8988-b9e17cafd61c,Medizinische Universität Innsbruck - Univ.-Klinik f. Anästhesie u. Intensivmedizin,medizinische_universit_t_innsbruck_univ_klinik_f_an_sthesie_u_intensivmedizin,,,,,, -3144,,eba81dab-b4b5-4442-b037-bd8524120ff4,"Theravance Biopharma Antibiotics, Inc",theravance_biopharma_antibiotics_inc,,,,,, -3145,,00f4158f-9935-4fce-be58-eab569fee32a,Savara ApS,savara_aps,,,,,, -3146,,bc355355-b121-45ef-b1fa-e091006fda95,FIBICO,fibico,,,,,, -3147,,4807f47a-e9c1-41c1-a3c0-533c07766d5c,Tuomo Nieminen,tuomo_nieminen,,,,,, -3148,,bc94c3ee-953a-4d45-b3e5-95739a297c8c,Christine Fromer Stiftung,christine_fromer_stiftung,,,,,, -3149,,37fcc26c-c3af-4fcf-b8f3-214072365418,University Witten/Herdecke,university_witten_herdecke,,,,,, -3150,,cfdad5f4-7280-11e6-a0cd-0242ac12000b,KING PHARMS LLC,king_pharms_llc,,,,,, -3151,,ab63d321-45a6-4065-b1f2-7438820736ad,Acerta Pharma BV,acerta_pharma_bv,,,,,, -3152,,ba1fecda-76c3-4a19-9459-b08dc5ecc3ea,Pierre Fabre Dermocosmetique,pierre_fabre_dermocosmetique,,,,,, -3153,,33608afa-ac35-4e14-90af-777da0d1793d,Dr. Enrique Martínez López,dr_enrique_mart_nez_l_pez,,,,,, -3154,,b01312eb-5361-49ed-8aea-c65e6acd5390,Cubist Pharmaceuticals LLC,cubist_pharmaceuticals_llc,,,,,, -159,0.96092963218688965,4086c805-4b50-420e-a0f0-bdfb20450ba3,"Medizinische Universität Wien, Univ.Klink f. Innere Medizin I",medizinische_universit_t_wien_univ_klink_f_innere_medizin_i,,,,f520785f-8956-4a25-b64b-588e23b207cb,medizinische_universit_t_wien_univ_klink_f_innere_medizin_i,"Medizinische Universität Wien, Univ.Klink f. Innere Medizin I" -3155,,33bea7e6-326a-4319-b6d7-2afa55ee1879,"Mikko Pitkänen, MD, PhD",mikko_pitk_nen_md_phd,,,,,, -3156,,9bd75d9f-6555-49d9-97e0-0f296b5efadd,Novo Nordisk Pharma S.A,novo_nordisk_pharma_s_a,,,,,, -154,0.927976,925f7b61-cc29-4ed2-a0bc-f6d351384148,"Solvay Pharmaceuticals, GmbH",solvay_pharmaceuticals_gmbh,,,,1bb3b634-770c-4449-a84e-96c6eb88fe69,solvay_pharmaceutical_gmbh,Solvay Pharmaceutical GmbH -3157,,84c9cbeb-6518-48c4-9d44-81c1cb1d03d4,Ferring SAS,ferring_sas,,,,,, -3158,,73f74d94-d9e7-4d64-8e48-55074a8640e9,DIATOS.SA,diatos_sa,,,,,, -3159,,01a34ece-4c10-432c-a459-7a2a04bd3fbd,Ludwig Boltzmann institute for COPD and Respiratory Epidemiology,ludwig_boltzmann_institute_for_copd_and_respiratory_epidemiology,,,,,, -5,0.94206222891807556,cd76c6f4-f2dd-4c7f-88b5-e2b6f2123209,Centre Hospitalier Universitaire de Liège,centre_hospitalier_universitaire_de_li_ge,,,,dd5747ea-816f-45f7-b207-0763f720a969,centre_hospitalier_universitaire_de_li_ge,Centre Hospitalier Universitaire de Liège -3160,,c50763e0-7159-11e6-a0cd-0242ac12000b,OHM LABS INC,ohm_labs_inc,,,,,, -3161,,eb38050b-872c-46f0-8a6f-60172f85827c,"Premacure AB, A member of the Shire Group of Companies",premacure_ab_a_member_of_the_shire_group_of_companies,,,,,, -3162,,2f12f54e-2efd-413c-bbc5-a8f3486d6517,VU University Medical,vu_university_medical,,,,,, -993,0.98589098453521729,97e04c3e-2469-47b3-aea0-8522c32303ca,GE Healthcare,ge_healthcare,,,,97e04c3e-2469-47b3-aea0-8522c32303ca,ge_healthcare,GE Healthcare -3163,,dbeb77c8-d261-4c5e-8337-33268c916b95,Agios Pharmaceuticals Inc,agios_pharmaceuticals_inc,,,,,, -3164,,60aa0446-b010-4c03-82dc-3bc2c09d9268,Fondazione Italiana Linfomi,fondazione_italiana_linfomi,,,,,, -3165,,66613ed0-3224-4f56-a356-06daf1f5e915,GlaxoSmithKline Latvia SIA,glaxosmithkline_latvia_sia,,,,,, -3166,,db61ab1b-e03d-41ea-a0e4-8853fb3d7caf,Avexxin AS,avexxin_as,,,,,, -3167,,5c563798-7147-11e6-a0cd-0242ac12000b,PIRAMAL CRITICAL,piramal_critical,,,,,, -467,0.948148,33f6d476-e36d-47d6-b355-d0aff833ee95,MERRIMACK PHARMACEUTICALS,merrimack_pharmaceuticals,,,,33f6d476-e36d-47d6-b355-d0aff833ee95,merrimack_pharmaceuticals,MERRIMACK PHARMACEUTICALS -3168,,71aab502-b29e-444e-9995-4a6410957992,LOFARMA,lofarma,,,,,, -3169,,50bd8d86-8fa1-4b4e-870a-9a1bdcb3cd30,ALFREDO TAGARRO GARCIA,alfredo_tagarro_garcia,,,,,, -3170,,ca16a151-9d97-4ede-bd89-10cfb91f4bc8,HOSPITAL UNIVERSITARIO SON DURETA. UNIDAD DE INVESTIGACIÓN,hospital_universitario_son_dureta_unidad_de_investigaci_n,,,,,, -82,0.9889298677444458,34927d7f-aaf7-4211-886e-d6c66ea9e027,"Medizinische Universität Wien, Universitätsklinik für Chirurgie",medizinische_universit_t_wien_universit_tsklinik_f_r_chirurgie,,,,34927d7f-aaf7-4211-886e-d6c66ea9e027,medizinische_universit_t_wien_universit_tsklinik_f_r_chirurgie,"Medizinische Universität Wien, Universitätsklinik für Chirurgie" -112,0.97132119536399841,cd164157-9cad-43a7-b033-7b4a8d7de932,Yamanouchi Europe B.V,yamanouchi_europe_b_v,,,,fd7c0ea8-c5da-47db-837d-9b59407dd291,yamanouchi_europe_b_v,Yamanouchi Europe B.V -153,0.980878,dbfc9a71-22be-491f-b043-91e600c1a3a9,Lung Rx,lung_rx,,,,18f855d3-a347-4059-9f52-8c87407690f3,lung_rx_inc,Lung Rx Inc -3171,,a691f011-7a5a-40a1-babf-b3657f5fd647,AC Immune SA,ac_immune_sa,,,,,, -3172,,d92f75de-af1d-4a08-ad18-a13279814f30,CREPATS,crepats,,,,,, -489,0.94924008846282959,f2f09bbb-e879-4f9f-b342-434a12824df1,STEBA BIOTECH SA,steba_biotech_sa,,,,556aa12c-fe7a-4155-adda-e25a9fdaf844,steba_biotech_s_a,STEBA BIOTECH S.A -3173,,66da3a92-3b54-467d-99fb-afe7a518ff17,Novartis Finland OY,novartis_finland_oy,,,,,, -3174,,2b5c9b2c-72ec-11e6-a0cd-0242ac12000b,IPSEN INC,ipsen_inc,,,,,, -3175,,04ee0b01-caa9-4d90-a0fe-64e33688a06b,GlaxoSmithKline AS,glaxosmithkline_as,,,,,, -3176,,434da454-aeec-469b-8ccf-a8a1cccda5b3,"(OSI) Eyetech, Inc",osi_eyetech_inc,,,,,, -3177,,0d03e9d2-ce6c-439a-bfc1-1234ffa506d8,OxThera Intellectual Property AB,oxthera_intellectual_property_ab,,,,,, -3178,,1f2f9631-9c70-499a-b140-9d50f3237752,"Erasmusm MC, Rotterdam, The Netherlands",erasmusm_mc_rotterdam_the_netherlands,,,,,, -3179,,1c3406b8-c992-4a56-b709-967ddc583159,Therakind Limited,therakind_limited,,,,,, -988,0.960341,2cbebc88-9b76-4642-b406-d5374c2aabfa,Department of Cardiothoracic and Vascular Surgery,department_of_cardiothoracic_and_vascular_surgery,,,,2cbebc88-9b76-4642-b406-d5374c2aabfa,department_of_cardiothoracic_and_vascular_surgery,Department of Cardiothoracic and Vascular Surgery -3180,,c927a4bc-7145-11e6-a0cd-0242ac12000b,NORBROOK,norbrook,,,,,, -3181,,5b7a24a3-9d09-45ac-bd9f-8cda0b4b21fe,Universitätslehrkrankenhaus Hall in Tirol,universit_tslehrkrankenhaus_hall_in_tirol,,,,,, -3182,,7893e559-898b-4248-b4de-975672a75de9,"Pharmasset, Inc",pharmasset_inc,,,,,, -3183,,c9f483d0-cff1-41d6-a567-d2bd52a74c3e,SANFILIPPO Therapeutics SAS,sanfilippo_therapeutics_sas,,,,,, -3184,,8b1b7aaf-8765-40f9-9937-ec1a8f0ad450,AUSL DI MODENA,ausl_di_modena,,,,,, -421,0.98224687576293945,91fae256-199c-4920-9cd2-0437b5db434d,"Rigshospitalet, afd. 2034",rigshospitalet_afd_2034,,,,91fae256-199c-4920-9cd2-0437b5db434d,rigshospitalet,Rigshospitalet -3185,,c3f8f83c-73da-11e6-a0cd-0242ac12000b,ANACOR PHARMS INC,anacor_pharms_inc,,,,,, -3186,,19b8f044-ece8-4f39-aa23-ef8a38339159,"OptiNose US, Inc",optinose_us_inc,,,,,, -3187,,423a5519-8e91-4c33-a2e5-24a3d1d0b7ef,CHIRON,chiron,,,,,, -611,0.98173725605010986,eec7a1a9-acc8-4f30-8310-18451b5c2334,Erasmus MC,erasmus_mc,,,,e38a4be1-bb34-4ac4-9394-24f70e28cd5a,erasmus_mc_sophia,Erasmus MC Sophia -3188,,5b87ed80-5396-42ab-9256-63893284d85a,Wilson Therapeutics AB,wilson_therapeutics_ab,,,,,, -665,0.98638424277305603,360f8005-b204-4f00-91ff-535dfce2bdaf,Charité-Universitätsmedizin,charit_universit_tsmedizin,,,,f6d48103-0f0c-4464-8cd2-7589fc1def08,charit_universit_tsmedizin,Charité-Universitätsmedizin Berlin -799,0.97013264894485474,a3666a53-f0b3-41b0-b2d4-ff9661179fe8,Technische Universitaet München Fakultaet fuer Medizin,technische_universitaet_m_nchen_fakultaet_fuer_medizin,,,,a138a709-186c-4945-a784-d6f9bf6980b4,technische_universitaet_muenchen_fakultaet_fuer_medizin,Technische Universitaet Muenchen Fakultaet fuer Medizin -3189,,89218290-906c-41e8-b1d4-ca0387fe7e39,Lékařská fakulta Univerzity Karlovy v Hradci Králové,l_ka_sk_fakulta_univerzity_karlovy_v_hradci_kr_lov,,,,,, -3190,,c93bba30-7157-11e6-a0cd-0242ac12000b,PARENTA PHARMS,parenta_pharms,,,,,, -568,0.971368,982f23cd-4b55-47cc-8aa1-f7a5c248cabf,Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,fondazione_irccs_ca_granda_ospedale_maggiore_policlinico,,,,2a99366d-c8b5-4d6b-a57e-00e956554937,fondazione_irccs_c_granda_ospedale_maggiore_policlinico,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico -3191,,d5e0fa17-34e2-4882-8864-a39e548adfff,CIBERES (Centro de Investigación Biomédica en Red Enfermedades Respiratorias),ciberes_centro_de_investigaci_n_biom_dica_en_red_enfermedades_respiratorias,,,,,, -3192,,f00c6663-8894-4381-b1e1-a569f155dd25,Marshall Edwards Pty Limited,marshall_edwards_pty_limited,,,,,, -3193,,b7e0fc84-aa3a-4e18-ba72-03380623b29f,ZS Pharma Inc,zs_pharma_inc,,,,,, -3194,,8ab5ee98-715c-11e6-a0cd-0242ac12000b,ALTAIRE PHARMS INC,altaire_pharms_inc,,,,,, -3195,,a07b3a8c-88dc-4a5c-84a1-c73212b21695,"ORTHO BIOTECH, Geschäftsbereich der JANSSEN-CILAG GmbH",ortho_biotech_gesch_ftsbereich_der_janssen_cilag_gmbh,,,,,, -3196,,985492e0-d2a5-48f1-b5c7-808f3984f037,Radboud University Medical Centre Nijmegen,radboud_university_medical_centre_nijmegen,,,,,, -3197,,490ea87e-ffab-4b60-80fc-c16fa302bee8,"University of Birmingham, Research & Enterprise Services",university_of_birmingham_research_enterprise_services,,,,,, -885,0.98101651668548584,90979692-2a94-4a4b-9c9c-f6c047edea3e,Pharma Mar SA Unipersonal,pharma_mar_sa_unipersonal,,,,5821cf6c-5e8a-481f-8ff8-3198a9183cea,pharma_mar_sa,Pharma Mar SA -3198,,e0a8e402-df7e-43d9-bc5c-871a46ad3ff6,Anders Troelsen,anders_troelsen,,,,,, -3199,,51dfa822-b7a8-433d-b8a6-aea95c0b0c63,Opsona Therapeutics Ltd,opsona_therapeutics_ltd,,,,,, -3200,,ddfc954d-13f8-4b36-9cb0-ca28ea3b58d6,Laboratoires Ethypharm,laboratoires_ethypharm,,,,,, -3201,,d86baf94-7141-11e6-a0cd-0242ac12000b,ORIT LABS LLC,orit_labs_llc,,,,,, -3202,,045f43dd-7e77-4f03-8618-c3474d27467b,"Bavarian Nordic, Inc",bavarian_nordic_inc,,,,,, -3203,,c2fa5f4e-2c85-49bf-9c31-f227601f53c5,Chiesi Pharmaceuticals Inc,chiesi_pharmaceuticals_inc,,,,,, -3204,,b11fc304-a5d6-4351-a375-a1117e9c2651,Agis Industries (1983) ltd,agis_industries_1983_ltd,,,,,, -3205,,2cfec5b9-f199-44c6-9604-2c64d14b0026,Dr Alberto Domínguez-Rodríguez,dr_alberto_dom_nguez_rodr_guez,,,,,, -3206,,737f539a-7189-11e6-a0cd-0242ac12000b,"THROMBOGENICS, INC",thrombogenics_inc,,,,,, -3207,,7291017e-bffe-407c-b3c7-4ef1e66901b2,Laboratoire LABCATAL,laboratoire_labcatal,,,,,, -3208,,8e491fde-3b05-4e78-8a9c-9675dfaddca7,"Johns Hopkins University (Prof. Daniel Daniel F. Hanley, MD)",johns_hopkins_university_prof_daniel_daniel_f_hanley_md,,,,,, -3209,,4842d03e-64f0-4a7c-b508-98c7000c06e2,Dr. Llombart Cussac,dr_llombart_cussac,,,,,, -3210,,cb4bd689-1eda-4415-932d-2961ebfb2d4c,FISEVI Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla,fisevi_fundaci_n_p_blica_andaluza_para_la_gesti_n_de_la_investigaci_n_en_salud_de_sevilla,,,,,, -3211,,3514c539-7c74-43e5-92ed-b8b93b67798b,"Telik, Inc",telik_inc,,,,,, -799,0.97013264894485474,a138a709-186c-4945-a784-d6f9bf6980b4,Technische Universitaet Muenchen Fakultaet fuer Medizin,technische_universitaet_muenchen_fakultaet_fuer_medizin,,,,a138a709-186c-4945-a784-d6f9bf6980b4,technische_universitaet_muenchen_fakultaet_fuer_medizin,Technische Universitaet Muenchen Fakultaet fuer Medizin -656,0.985689,1dc11f6f-51cc-4072-9340-b3162a901b0e,Daniel Podzamczer Palter,daniel_podzamczer_palter,,,,1dc11f6f-51cc-4072-9340-b3162a901b0e,daniel_podzamczer_palter,Daniel Podzamczer Palter -3212,,638f955f-98a5-4d48-ae50-b7cf082324d8,"Dept. of Ophthalmology, Medical University of Vienna",dept_of_ophthalmology_medical_university_of_vienna,,,,,, -911,0.955326,6fe95abc-39e9-4d47-999a-8959adcc1009,DIATER Laboratorio de Diagnostico y Aplicaciones Terapéuticas S.A,diater_laboratorio_de_diagnostico_y_aplicaciones_terap_uticas_s_a,,,,6fe95abc-39e9-4d47-999a-8959adcc1009,diater_laboratorio_de_diagnostico_y_aplicaciones_terap_uticas_s_a,DIATER Laboratorio de Diagnostico y Aplicaciones Terapéuticas S.A -3213,,373cece7-ad91-4802-9636-351d784a7129,"Meiji Seika Kaisha, Ltd",meiji_seika_kaisha_ltd,,,,,, -3214,,a7065a2d-76e0-4289-868d-f6da3bf177b6,Verona Pharma plc,verona_pharma_plc,,,,,, -3215,,a886aae6-7163-11e6-a0cd-0242ac12000b,HANDA PHARMS,handa_pharms,,,,,, -3216,,1c17552e-5a1a-49a0-9770-36a6738d8aa1,Diurnal Ltd,diurnal_ltd,,,,,, -3217,,e1a183f8-3553-4386-836a-ff901673438c,Heart Center Freiburg - Bad Krozingen,heart_center_freiburg_bad_krozingen,,,,,, -3218,,87c58ad5-58ec-48b8-b615-07a02328ed90,Universitair Ziekenhuis Brussel,universitair_ziekenhuis_brussel,,,,,, -502,0.955255,569a1285-cdde-46ac-ab93-f30a3f2406e3,Aalborg Universitetshospital,aalborg_universitetshospital,,,,569a1285-cdde-46ac-ab93-f30a3f2406e3,aalborg_universitetshospital,Aalborg Universitetshospital -3219,,d5475e48-7810-402e-bf81-94348a6dd7c3,Johnson&Johnson Pharmaceutical Research and Development,johnson_johnson_pharmaceutical_research_and_development,,,,,, -3220,,f91d3320-5415-4e50-8d68-0165e45c4ba6,to-BBB technologies B.V,to_bbb_technologies_b_v,,,,,, -3221,,c9143cd1-1c37-489a-b032-f30a40444853,PLIVA - ISTRAŽIVANJE I RAZVOJ d.o.o,pliva_istra_ivanje_i_razvoj_d_o_o,,,,,, -3222,,c683d897-21f7-4587-a80c-c7efb76f2dce,"Schwarz Biosciences GmbH, UCB Group",schwarz_biosciences_gmbh_ucb_group,,,,,, -3223,,6237398e-7145-11e6-a0cd-0242ac12000b,J AND J CONSUMER INC,j_and_j_consumer_inc,,,,,, -3224,,bfa3d191-c002-4610-b69d-1921444b0964,Mads Werner,mads_werner,,,,,, -191,0.98649922013282776,d99244bd-ec4a-4174-ad00-95de8ef6a5a2,CESAR Central European Society for Anticancer Drug Research-EWIV,cesar_central_european_society_for_anticancer_drug_research_ewiv,,,,4042f330-66f0-40ec-8288-db80eef6363c,cesar_central_european_society_for_anticancer_drug_research,CESAR Central European Society for Anticancer Drug Research -3225,,204f89a5-cb72-4ddf-b303-7cba8abc6958,AGMT: Arbeitsgemeinschaft Medikamentöse Tumortherapie,agmt_arbeitsgemeinschaft_medikament_se_tumortherapie,,,,,, -3226,,b62bc76b-b663-4f8b-b430-1aec092b1b89,"Barts and the London NHS Trust, Department of Cardiology",barts_and_the_london_nhs_trust_department_of_cardiology,,,,,, -3227,,400f291b-84c7-42c3-864c-87cbe3a58255,Novartis Pharma NV,novartis_pharma_nv,,,,,, -1067,0.987607,29f3e0c0-134d-4f9b-952a-e3adc9a976d6,Generex Biotechnology Corporation,generex_biotechnology_corporation,,,,10ff3385-cf4c-44ce-8eb9-d60620664cbb,generex_biotechnology_corp,Generex Biotechnology Corp -3228,,8be67cb6-0be1-4cd2-9c2f-aed7a772df7f,Minna Tallgren,minna_tallgren,,,,,, -3229,,247a94c6-427c-4137-b55f-c1c12f7d6bdc,Erasme Hostpital - ULB,erasme_hostpital_ulb,,,,,, -888,0.97912924630301335,396cf7e8-b821-4caf-9fc9-ab2366cd9a70,"Schering-Plough Research Institute, a Division of Schering Corporation",schering_plough_research_institute_a_division_of_schering_corporation,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" -3230,,b8629c10-73e1-11e6-a0cd-0242ac12000b,FSC THERAP,fsc_therap,,,,,, -3231,,9ab9f170-f805-4f3b-a2c6-200ffeef38e7,Dr. Miquel Gómez. Servicio de Cardiología. Hospital del Mar,dr_miquel_g_mez_servicio_de_cardiolog_a_hospital_del_mar,,,,,, -379,0.9485869208971659,ca9aff82-819f-4039-bd0c-6f8f4e8abebe,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as the SPONSOR or Merck)",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_hereafter_referred_to_as_the_sponsor_or_merck,,,,b80f486c-a6f1-447b-bad6-34ea6d49fec0,merck_sharp_dohm_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as the SPONSOR or Merck)" -3232,,1be2680f-aca4-4686-9a32-4f02d5fd5f1b,Finnish melanoma group,finnish_melanoma_group,,,,,, -3233,,7e3fe287-9b32-4c0d-8b82-3875986839aa,"Karolinska University Hospital, Department of Molecular medicine and Surgery Karolinska Institutet, Gastrocentrum",karolinska_university_hospital_department_of_molecular_medicine_and_surgery_karolinska_institutet_gastrocentrum,,,,,, -3234,,5e6801ff-9279-4103-bcd8-89b16d4a0f39,Suffolk Mental Health Partnerships Trust,suffolk_mental_health_partnerships_trust,,,,,, -3235,,b8f6c95a-7141-11e6-a0cd-0242ac12000b,MYLAN IRELAND LTD,mylan_ireland_ltd,,,,,, -3236,,7dfbd0d6-0af0-4487-a179-f602b5d014e1,Health Protection Agency,health_protection_agency,,,,,, -3237,,063ea64c-b4fe-4161-9b3e-8b54fc191541,"A.I.Virtanen Insitute, University of Kuopio",a_i_virtanen_insitute_university_of_kuopio,,,,,, -3238,,2a509302-7141-11e6-a0cd-0242ac12000b,COREPHARMA,corepharma,,,,,, -3239,,96a96688-af5d-4355-9d72-073f4dc3c065,CRESIB- International Research Center in Health of Barcelona,cresib_international_research_center_in_health_of_barcelona,,,,,, -3240,,b748c6cf-c6b8-453c-8044-7045286bebaf,Fundación Biomédica del CHUVI,fundaci_n_biom_dica_del_chuvi,,,,,, -3241,,1854a760-2df3-4aad-9440-c8bd8732230b,ABCSG GmbH,abcsg_gmbh,,,,,, -3242,,5903fda0-65d1-4220-a2c2-2534b1a96db0,"National Institute of Public Health and Environment (RIVM, the Netherlands)",national_institute_of_public_health_and_environment_rivm_the_netherlands,,,,,, -3243,,5cb07fbb-a36f-4615-9a1f-64ab4e7d8cb9,Merckle GmbH,merckle_gmbh,,,,,, -3244,,edacff64-dc0d-4e30-a23f-18422248a45f,Ecron Acunova GmbH,ecron_acunova_gmbh,,,,,, -3245,,5fd55442-9cec-44ee-9d26-bbf08fe3c7cd,"Med. Univ. Wien, Klinik für Dermatologie",med_univ_wien_klinik_f_r_dermatologie,,,,,, -3246,,25cdee70-c643-493d-9c32-6923ad38fb79,University of Texas Health Science Center,university_of_texas_health_science_center,,,,,, -3247,,cbb1af8d-0ee3-40f6-ba6e-8b9d66b66c35,Genethon,genethon,,,,,, -3248,,e26b082b-a3c8-4bce-972c-0d6f2dd16a13,University of Calgary,university_of_calgary,,,,,, -399,0.988953,33290af1-5e28-4e4a-85eb-2b145405dc27,Groupe Francophone des Myélodysplasies,groupe_francophone_des_my_lodysplasies,,,,33290af1-5e28-4e4a-85eb-2b145405dc27,groupe_francophone_des_my_lodysplasies,Groupe Francophone des Myélodysplasies -3249,,00719da6-204e-49df-b9f4-899b6e50d72f,Trio Medicines Ltd,trio_medicines_ltd,,,,,, -3250,,bad6f458-f12e-49f5-9051-412d81333d41,Guys & St. Thomas' NHS Foundation Trust,guys_st_thomas_nhs_foundation_trust,,,,,, -708,0.984864,3e40eb72-7165-11e6-a0cd-0242ac12000b,NOVAST LABS,novast_labs,,,,3e40eb72-7165-11e6-a0cd-0242ac12000b,novast_labs,NOVAST LABS -3251,,f3e092c8-9d99-4b98-90f6-7e4e1f85e7e1,Turku University Hospital,turku_university_hospital,,,,,, -3252,,3007e2fe-4fce-4a9b-9236-466c5b7e4345,Göteborgs universitet,g_teborgs_universitet,,,,,, -3253,,12058919-dcf3-49df-a3d7-909ea5da6f88,PALAU PHARMA SA,palau_pharma_sa,,,,,, -3254,,7712aec8-6345-474f-a9fa-eb8f84380ac2,Sandwell Medical Research Unit,sandwell_medical_research_unit,,,,,, -3255,,ce3d80a7-a107-405f-9546-bfebb13dab31,"Prof. Sechtem, Department of Cardiology, Robert Bosch Hospital",prof_sechtem_department_of_cardiology_robert_bosch_hospital,,,,,, -3256,,f6679532-83e6-468e-94a1-2a09e882f9b7,"IRCCS - Istituto di Ricerche Farmacologiche ""Mario Negri",irccs_istituto_di_ricerche_farmacologiche_mario_negri,,,,,, -3257,,aab6e0d2-6ce5-4bf7-9de9-3e300477886b,Prof V Lund,prof_v_lund,,,,,, -132,0.986058,6f18faf0-7147-11e6-a0cd-0242ac12000b,AMPHASTAR PHARMS INC,amphastar_pharms_inc,,,,6f18faf0-7147-11e6-a0cd-0242ac12000b,amphastar_pharms_inc,AMPHASTAR PHARMS INC -3258,,ad19ac1c-96ab-11e6-becf-0242ac110008,WINDTREE THERAP,windtree_therap,,,,,, -3259,,7525628c-3df2-4db4-824d-3c842794991b,Scandinavian Sarcoma Group,scandinavian_sarcoma_group,,,,,, -3260,,c6b6a71b-1a3b-4791-b3f9-8d2ad614f5cc,Tartu Ülikooli kardioloogiakliinik,tartu_likooli_kardioloogiakliinik,,,,,, -3261,,a28cf75f-8b5e-45d6-8a74-cbd575537b0c,SERVICIO NEFROLOGIA HOSPITAL BELLVITGE,servicio_nefrologia_hospital_bellvitge,,,,,, -3262,,1b926dc4-54d4-4fd2-8741-eba57291c769,dipartimento di neurologia e psichiatria,dipartimento_di_neurologia_e_psichiatria,,,,,, -3263,,40cbc10e-a56d-468c-a911-90f32d10b564,ROTTAPHARM / ROTTA RESEARCH LABORATORIUM,rottapharm_rotta_research_laboratorium,,,,,, -3264,,ec98ae30-73f9-11e6-a0cd-0242ac12000b,MSD MERCK CO,msd_merck_co,,,,,, -3265,,1eb5ceb1-46ec-440a-a1fc-7abaf2b2e929,Gastroenterology CHC Liege,gastroenterology_chc_liege,,,,,, -3266,,79e8cf98-3cc5-4e99-b63e-ce25c5612e8c,"Sapienza"" University of Rome",sapienza_university_of_rome,,,,,, -3267,,1e18652f-6415-439d-be91-f573e65a72dd,LABCATAL,labcatal,,,,,, -3268,,32dd8a0c-3f6e-47f2-94f2-82b905b171b7,BioArctic Neuroscience AB,bioarctic_neuroscience_ab,,,,,, -3269,,cf4f4678-73f8-11e6-a0cd-0242ac12000b,CEE KAY SUPPLY,cee_kay_supply,,,,,, -138,0.975844,5739df1e-d602-413b-9853-34dc83584168,"Takeda Global Research & Development Center, Inc.,",takeda_global_research_development_center_inc,,,,5739df1e-d602-413b-9853-34dc83584168,takeda_global_research_development_center_inc,"Takeda Global Research & Development Center, Inc.," -3270,,99c0e42d-8445-4f43-bf9a-3428bbca8bfc,CELL THERAPEUTICS EUROPE S.r.l,cell_therapeutics_europe_s_r_l,,,,,, -3271,,b9d8d9f0-727a-11e6-a0cd-0242ac12000b,INST BIOCHEM,inst_biochem,,,,,, -3272,,3f4da7a9-e745-4bc1-9384-dee2274a2ab8,Finox AG,finox_ag,,,,,, -3273,,3efff714-eecc-4b42-b83f-20da261041f0,Region Östergötland,region_sterg_tland,,,,,, -3274,,ca545cdd-25de-4707-96d3-4b980fd55a97,"Prof. Ola Winsö, Anesthesia and Intensive Care Medicine, Norrlands University Hospiatal",prof_ola_wins_anesthesia_and_intensive_care_medicine_norrlands_university_hospiatal,,,,,, -3275,,aec5e4f2-f68e-41e9-b231-36d5b68a84a5,KKRN Katholisches Klinikum Ruhrgebiet Nord GmbH,kkrn_katholisches_klinikum_ruhrgebiet_nord_gmbh,,,,,, -3276,,70fe456d-12bc-4a54-9e45-9ab090f44d39,AZIENDA OSPEDALIERO UNIVERSITARIA DI CAGLIARI,azienda_ospedaliero_universitaria_di_cagliari,,,,,, -269,0.961582,bde7e2be-3d67-4bf2-a58c-76bffc9beda6,Austrian Breast & Colorectal Cancer Study Group (ABCSG),austrian_breast_colorectal_cancer_study_group_abcsg,,,,4deecc23-1926-409e-858b-2b5b11828232,austrian_breast_and_colorectal_cancer_study_group_abcsg,Austrian Breast and Colorectal Cancer Study Group (ABCSG) -3277,,62abb67c-7142-11e6-a0cd-0242ac12000b,PHARM SPEC,pharm_spec,,,,,, -3278,,04117269-a99a-46ca-93a0-c1cdcb5872b2,Speedel Pharma Ltd,speedel_pharma_ltd,,,,,, -3279,,83c2846f-b6f7-4ec0-b44b-5922530139ee,"University Heidelberg, Department of General Surgery",university_heidelberg_department_of_general_surgery,,,,,, -3280,,6965f8d4-716e-11e6-a0cd-0242ac12000b,ORTHO BIOLOGICS,ortho_biologics,,,,,, -3281,,120af6d9-8a93-4c4e-80bb-f3f03f686c3a,OPKO HEALTH INC,opko_health_inc,,,,,, -3282,,7259ebaa-8819-11e6-a998-0242ac12000b,LG Life Sciences Ltd,lg_life_sciences_ltd,,,,,, -3283,,27d698a6-72e0-11e6-a0cd-0242ac12000b,WEILL MEDCL COLL,weill_medcl_coll,,,,,, -3284,,b75ea448-055f-4223-9603-9617a296d861,"Aarhus University Hospital, Department of Ophthalmology",aarhus_university_hospital_department_of_ophthalmology,,,,,, -3285,,51644326-7155-11e6-a0cd-0242ac12000b,AVEMA PHARMA,avema_pharma,,,,,, -533,0.981251,215a399e-635c-44e7-a8f5-032b68855c29,THERAKOS,therakos,,,,215a399e-635c-44e7-a8f5-032b68855c29,therakos,THERAKOS -3286,,a74c2f75-49d0-4a5e-9312-03705bf48221,Alfred Health,alfred_health,,,,,, -3287,,610cd14a-4187-43cb-bdb1-640c3ebba0a8,Peptimmune Inc,peptimmune_inc,,,,,, -3288,,956a2fec-36b3-4f54-9368-bfbbbf1cb20e,"Medizinische Universität Graz, Universitäts-Augenklinik",medizinische_universit_t_graz_universit_ts_augenklinik,,,,,, -3289,,05f4d9e3-edd8-43ee-bfc3-c2c5afcf6f4a,RadioMedic s.r.o,radiomedic_s_r_o,,,,,, -3290,,5d5428e9-2e63-486f-9331-187f7844875a,Vantia Ltd,vantia_ltd,,,,,, -3291,,c5f66cc2-dade-4882-96f1-618762524358,Uzsoki Utcai Kórház,uzsoki_utcai_k_rh_z,,,,,, -3292,,9a691efa-fb50-4c9c-a007-1ef296abf9c0,ALTANA Pharma Ltd,altana_pharma_ltd,,,,,, -3293,,865fb47e-185f-4991-8d88-c3978daeb532,M.S. Arbous,m_s_arbous,,,,,, -3294,,953d4442-e3af-4fc9-b14b-61bdb8b3c201,UCB Pharma Inc,ucb_pharma_inc,,,,,, -3295,,70891b8f-6380-44d3-9d67-ddb37ab44591,The Nordic Myeloproliferative Neoplasm Group,the_nordic_myeloproliferative_neoplasm_group,,,,,, -3296,,9279f543-d250-4b06-950f-7c032201c134,AGI Therapeutics Limited,agi_therapeutics_limited,,,,,, -728,0.97973480820655823,09df191c-9f38-4b3a-ab06-90044d8a5690,"UCB Celltech, UK",ucb_celltech_uk,,,,093988ab-1f2c-48ab-84d3-0b1dff68400e,ucb_celltech_uk,"UCB Celltech, UK" -3297,,80cb69a1-a893-4836-bcbc-d912381a2d20,Bellerophon Pulse Technologies LLC,bellerophon_pulse_technologies_llc,,,,,, -3298,,127fb198-4cb1-432e-963c-6cd95f2f263b,Institute for Neurodegenerative Disorders,institute_for_neurodegenerative_disorders,,,,,, -3299,,09014b73-b3a6-47b3-bc32-40e2dd0c1219,East Tallinn Central Hospital,east_tallinn_central_hospital,,,,,, -936,0.94267457723617554,33e84b15-e25f-402d-bf4e-0f564d9c0255,Royal Liverpool & Broadgreen University Hospitals Trust,royal_liverpool_broadgreen_university_hospitals_trust,,,,33e84b15-e25f-402d-bf4e-0f564d9c0255,royal_liverpool_and_broadgreen_university_hospitals_trust,Royal Liverpool and Broadgreen University Hospitals Trust -3300,,16fcb22f-67c2-467f-aa31-3f8ff9ae3434,Roche (HELLAS) SA,roche_hellas_sa,,,,,, -3301,,6836ad02-679a-409e-846d-03def2652329,Foro Andaluz para el Estudio de Tumores Torácicos (FAETT),foro_andaluz_para_el_estudio_de_tumores_tor_cicos_faett,,,,,, -3302,,2f53c884-73bb-11e6-a0cd-0242ac12000b,NAVIDEA BIOPHARMS,navidea_biopharms,,,,,, -3303,,4eafb198-12c6-44b4-b453-18b6465f277f,Neovacs SA,neovacs_sa,,,,,, -3304,,fd805ce0-dbe5-423d-ac13-51c1cb4c9d3f,Lovisenberg Diaconal Hospital,lovisenberg_diaconal_hospital,,,,,, -3305,,192b6b5d-3fc5-40bd-98c5-7087ba3caba4,Ninewells Hospital,ninewells_hospital,,,,,, -3306,,a7dc8c64-4f22-4893-a315-90897cc3a628,LWL University Hospital Bochum,lwl_university_hospital_bochum,,,,,, -3307,,75e73fe3-6429-4c79-a0e5-d635444c03d0,Onkologisk afdeling R and the Unit for Experimental Chemotherapy,onkologisk_afdeling_r_and_the_unit_for_experimental_chemotherapy,,,,,, -916,0.986414,c1cc8b83-e3cb-4df9-a228-a9493d3c1abf,University of Edinburgh (ACCORD),university_of_edinburgh_accord,,,,6370e13d-5a9e-49dc-a468-3b76aad11206,university_of_edinburgh,University of Edinburgh -3308,,c7342910-0870-4ebc-affb-f1ae701c39c6,"AZ St Augustinus, Wilrijk",az_st_augustinus_wilrijk,,,,,, -3309,,d1c5a5b1-b929-4715-80bb-49f15d48fbef,Cell Genesys Inc,cell_genesys_inc,,,,,, -683,0.987967,988d0aa4-106e-4070-9a97-ae295beaf13c,Landstinget i Uppsala län,landstinget_i_uppsala_l_n,,,,93d2770e-11ee-4c28-b378-003b4e28a161,landstinget_i_uppsala,Landstinget i Uppsala -42,0.97710627317428589,fde089ee-61a3-4a26-98a0-0ba8b48a962f,"Universitätsklinik für Augenheilkunde und Optometrie, MUW",universit_tsklinik_f_r_augenheilkunde_und_optometrie_muw,,,,e3a4dbed-6085-4f4f-a871-0b11b6bed573,universit_tsklinik_f_r_augenheilkunde_und_optometrie,Universitätsklinik für Augenheilkunde und Optometrie -3310,,91ec1efd-1a73-43d1-9490-edb72ba8da58,Neus Fabregas Julia - Hospital Clinic de Barcelona,neus_fabregas_julia_hospital_clinic_de_barcelona,,,,,, -662,0.97071176767349243,59b31da0-f1a7-4e16-acd2-6659f5326e5d,Charité Univeritaetsmedizin Berlin,charit_univeritaetsmedizin_berlin,,,,03be6dab-3c3b-45d4-999e-013062e4a92e,charit_universitaetsmedizin_berlin,Charité Universitaetsmedizin Berlin -858,0.94989776611328125,a4afe98f-2343-420b-ae98-50be658abbef,Institut de Recerca / Hospital de la Santa Creu i Sant Pau,institut_de_recerca_hospital_de_la_santa_creu_i_sant_pau,,,,5ce030ba-f524-45f7-b154-b5509cfe5e6d,institut_de_recerca_hospital_de_la_sant_creu_i_sant_pau,Institut de Recerca Hospital de la Sant Creu i Sant Pau -3311,,e743e67b-b02d-4c42-b8d5-9713c7c74938,Oxford Radcliffe Hospital NHS Trust,oxford_radcliffe_hospital_nhs_trust,,,,,, -3312,,ddcaa69f-5b26-4ba0-bd10-873ca1e154c1,Ursapharm Arzneimittel GmbH&Co. KG,ursapharm_arzneimittel_gmbh_co_kg,,,,,, -3313,,c1bfea02-d95a-40c7-a1bc-66abc5c46acd,Isala Klinieken Department Cardiology,isala_klinieken_department_cardiology,,,,,, -3314,,23c7367f-96c7-4f87-8952-24a1197e2460,"GALDERMA R&D, LLC",galderma_r_d_llc,,,,,, -3315,,e1901832-50ba-49df-b5e8-309204f75b91,DBCG,dbcg,,,,,, -3316,,48b9f85e-dfdb-4785-b6df-0a68207e1f6c,Grupo Espagnol de Cancer de Pulmon,grupo_espagnol_de_cancer_de_pulmon,,,,,, -3317,,4111ad13-ac96-4c23-9b27-16efe1db71ca,Gothenburg University,gothenburg_university,,,,,, -3318,,c2051d8a-715f-11e6-a0cd-0242ac12000b,BEECHAM,beecham,,,,,, -3319,,ad93456a-7232-11e6-a0cd-0242ac12000b,WOMEN FIRST HLTHCARE,women_first_hlthcare,,,,,, -3320,,f255ca83-3c62-45e6-aa29-52c550464ee7,"Research and Development Department, Addenbrookes NHS Foundation Trust",research_and_development_department_addenbrookes_nhs_foundation_trust,,,,,, -3321,,771eee8b-09c5-4a0e-a9f7-9f6c33f619f7,"Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen",department_of_biomedical_sciences_faculty_of_health_sciences_university_of_copenhagen,,,,,, -669,0.988702,6139d772-2e3a-4727-b99c-78b770114708,The Walton Centre for Neurology and Neurosurgery NHS Trust,the_walton_centre_for_neurology_and_neurosurgery_nhs_trust,,,,6139d772-2e3a-4727-b99c-78b770114708,the_walton_centre_for_neurology_and_neurosurgery_nhs_trust,The Walton Centre for Neurology and Neurosurgery NHS Trust -3322,,847870c2-964a-4674-8a57-f117891df6b7,Department of Ophthalmology at St. Franziskus Hospital,department_of_ophthalmology_at_st_franziskus_hospital,,,,,, -3323,,87422532-ac60-49f3-8c0c-263bb5bd9359,Servicio de Psiquiatría. Hospital Universitari Vall d’Hebron,servicio_de_psiquiatr_a_hospital_universitari_vall_d_hebron,,,,,, -3324,,b273f3f1-a2c4-4edf-9fb3-fe45e1804a7e,"Minerva Neurosciences, Inc",minerva_neurosciences_inc,,,,,, -3325,,bc8e3eb9-ef18-484c-b819-21d528129e11,Nordic Nanovector ASA,nordic_nanovector_asa,,,,,, -3326,,16fc4833-15dc-491e-b98f-a895546396e0,"Klinisk Biokemisk Afdeling, Aarhus Universitetshospital, Skejby",klinisk_biokemisk_afdeling_aarhus_universitetshospital_skejby,,,,,, -3327,,078c3222-bfb1-4586-9b4f-07eaae3a9cd6,Mondobiotech Laboratories Anstalt,mondobiotech_laboratories_anstalt,,,,,, -616,0.95730888843536377,7220ec7d-ef30-46ae-ab61-e65a1f133c11,Shire Development LLC,shire_development_llc,,,,f8cdc923-8f9e-4a86-b916-6b3f45c65971,shire_development_llc,Shire Development LLC -429,0.970982,71d8e8b6-4155-47a0-ad75-6f0f13598830,Addex Pharmaceuticals SA,addex_pharmaceuticals_sa,,,,71d8e8b6-4155-47a0-ad75-6f0f13598830,addex_pharmaceuticals_sa,Addex Pharmaceuticals SA -875,0.9714733362197876,f8421bef-4039-4853-934b-b934099a9939,FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO NIÑO JESUS,fundacion_para_la_investigacion_biomedica_hospital_universitario_ni_o_jesus,,,,8ca22c91-ec68-4c4d-b67e-9354f508b1d3,fundacion_para_la_investigacion_biomedica_del_hospital_universitario_ni_o_jesus,FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO NIÑO JESUS -3328,,727eb8e2-d251-4eb6-b531-c1950d19cd95,"Boston Biomedical, Inc",boston_biomedical_inc,,,,,, -3329,,c9713e75-fd9d-4d5f-9a52-c10f6b9f974d,Egalet a/s,egalet_a_s,,,,,, -3330,,e3cb8a70-a745-11e6-94cb-5656d04fc2b5,PPM SERVICES SA,ppm_services_sa,,,,,, -82,0.9889298677444458,be34fe0d-08b2-48ab-aa99-08ea293d229f,"Medizinische Universität Wien, Universitätsklinik für",medizinische_universit_t_wien_universit_tsklinik_f_r,,,,34927d7f-aaf7-4211-886e-d6c66ea9e027,medizinische_universit_t_wien_universit_tsklinik_f_r_chirurgie,"Medizinische Universität Wien, Universitätsklinik für Chirurgie" -3331,,265e66c1-6226-4428-bd8f-d6b8c392e69e,"Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited",millennium_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_takeda_pharmaceutical_company_limited,,,,,, -3332,,cfcac0ad-65b7-4197-800c-5cbaecc5c656,AOU SAN LUIGI GONZAGA - SCDU ONCOLOGIA MEDICA,aou_san_luigi_gonzaga_scdu_oncologia_medica,,,,,, -3333,,563f33db-d22e-45a9-a6ef-e2b3c2ee6667,MARSHALL EDWARDS PTY LTD,marshall_edwards_pty_ltd,,,,,, -3334,,82a72fd6-2986-4f4b-8f17-6b1a55c38ff7,Gruenenthal GmbH,gruenenthal_gmbh,,,,,, -3335,,60fe56fb-b4cb-470b-83a7-713aada0acf2,Cornwall College Camborne,cornwall_college_camborne,,,,,, -526,0.986058,dd756c58-7148-11e6-a0cd-0242ac12000b,BAXTER HLTHCARE CORP,baxter_hlthcare_corp,,,,73bd77f0-7126-11e6-8a77-0242ac12000b,baxter_hlthcare,BAXTER HLTHCARE -3336,,9baa74cf-2773-4662-b7d0-e9d260fcedf5,North Glasgow NHS Trust,north_glasgow_nhs_trust,,,,,, -835,0.905873,81899287-3fd5-4be2-923d-6c76cdc477ff,University of Erlangen-Nuremberg,university_of_erlangen_nuremberg,,,,81899287-3fd5-4be2-923d-6c76cdc477ff,university_of_erlangen_nuremberg,University of Erlangen-Nuremberg -3337,,51c1f868-7191-11e6-a0cd-0242ac12000b,ARBROOK,arbrook,,,,,, -3338,,543c65f6-d098-40f8-9101-1bb75b10621b,AKELA Pharma Inc,akela_pharma_inc,,,,,, -3339,,6c19565d-3ba8-4693-9146-98267cc2f8a3,Lijf en Leven,lijf_en_leven,,,,,, -576,0.98835551738739014,296373b5-8871-4062-ab94-c1936a5306c2,"Wyeth Pharmaceuticals, Global Medical Affairs Department",wyeth_pharmaceuticals_global_medical_affairs_department,,,,296373b5-8871-4062-ab94-c1936a5306c2,wyeth_pharmaceuticals_global_medical_affairs_department,"Wyeth Pharmaceuticals, Global Medical Affairs Department" -550,0.98918396234512329,e2e54dd4-4db8-431a-af23-bae89d56cad0,"Freistaat Bayern, vertreten durch die Universität Regensburg",freistaat_bayern_vertreten_durch_die_universit_t_regensburg,,,,c02e31f5-3712-4237-9dae-6bec40ffabb9,freistaat_bayern_vertreten_durch_die_universit_t_regensburg_klinikum,"Freistaat Bayern, vertreten durch die Universität Regensburg, Klinikum" -3340,,9120653c-1e15-4a34-a749-0b3f0735fb13,Radboud University Nijmegen Medical Center,radboud_university_nijmegen_medical_center,,,,,, -3341,,06ce027b-a373-41ff-8fd2-fdb09ce907ab,"AZIENDA OSPEDALIERA ""S. CROCE E CARLE",azienda_ospedaliera_s_croce_e_carle,,,,,, -834,0.9859306812286377,34a46c06-df18-492f-b4ff-39c0c77ef62f,Novartis Pharmaceuticals,novartis_pharmaceuticals,,,,34a46c06-df18-492f-b4ff-39c0c77ef62f,novartis_pharmaceuticals,Novartis Pharmaceuticals -3342,,921f328d-a010-42b3-9323-1c6319fc8462,Retinaklinikken Aleris,retinaklinikken_aleris,,,,,, -3343,,9b8275e5-79b7-4c39-a084-8dd310160919,Univ.-Prof. Dr. Volker Wenzel,univ_prof_dr_volker_wenzel,,,,,, -3344,,a53ccb8a-78c5-41c4-aed3-7a63ff38e6d6,Catalan Institute of Oncology,catalan_institute_of_oncology,,,,,, -3345,,3c183ff8-7165-11e6-a0cd-0242ac12000b,CADILA PHARMS LTD,cadila_pharms_ltd,,,,,, -444,0.94951000809669495,3ae873dd-f223-4909-81c9-fe44d56c96ae,Royal Brompton & Harefield NHS Foundation Trust,royal_brompton_harefield_nhs_foundation_trust,,,,3c8eeed9-b500-4ecf-a409-f59b86b21db3,royal_brompton_and_harefield_nhs_foundation_trust,Royal Brompton and Harefield NHS Foundation Trust -132,0.986058,97c7677c-7154-11e6-a0cd-0242ac12000b,AMPHASTAR PHARM,amphastar_pharm,,,,6f18faf0-7147-11e6-a0cd-0242ac12000b,amphastar_pharms_inc,AMPHASTAR PHARMS INC -3346,,3c6015f8-7165-11e6-a0cd-0242ac12000b,NEOS THERAP INC,neos_therap_inc,,,,,, -3347,,df1fe8fd-4353-458f-a9ab-a7c4bb764208,"Med. Univ. Wien, Univ. Klinik für Innere Med. III",med_univ_wien_univ_klinik_f_r_innere_med_iii,,,,,, -3348,,d083540f-b308-429e-8d67-d13529dedac1,MEDITOP Gyógyszeripari Kft,meditop_gy_gyszeripari_kft,,,,,, -45,0.90533584356307983,a724bf82-6dee-47cb-9eb5-9ddf9d0131aa,"Medicinsk Forskningsafsnit, Regionshospitalet Holstebro (Department of Medical Research, Regional Hospital Holstebro)",medicinsk_forskningsafsnit_regionshospitalet_holstebro_department_of_medical_research_regional_hospital_holstebro,,,,7c8f44a5-f228-4272-a17a-08c93ebdc8bd,medicinsk_forskning_regionshospitalet_holstebro,"Medicinsk Forskning, Regionshospitalet Holstebro" -3349,,35bcf285-8232-49b9-8bda-2b5778565a4c,"Nyremedicinsk afdeling, Aalborg Sygehus",nyremedicinsk_afdeling_aalborg_sygehus,,,,,, -3350,,1cae79b0-730a-4c6a-9807-43fa22c9c18c,ACRAF SpA,acraf_spa,,,,,, -3351,,91af06ad-bec0-4545-83dd-89b06299d925,KeyNeurotek Pharmaceuticals AG,keyneurotek_pharmaceuticals_ag,,,,,, -3352,,221765eb-087c-44b8-9311-ba348e70bf5e,Wyeth Lederle Nordiska AB,wyeth_lederle_nordiska_ab,,,,,, -3353,,5135dfb7-ae4f-4b93-b93f-020d895828fd,Anna-Liisa Kautio,anna_liisa_kautio,,,,,, -3354,,22a8f8ef-6fd5-420b-9496-abdf60f87705,AZIENDA OSPEDALIERA - CENTRO RICERCHE CLINICHE DI VERONA,azienda_ospedaliera_centro_ricerche_cliniche_di_verona,,,,,, -3355,,225f97b1-af44-41ab-bb64-654b89fe1e33,TetraLogic Pharmaceuticals,tetralogic_pharmaceuticals,,,,,, -3356,,bc05cc87-6b7e-4ef9-b65a-e09416b83dd2,"Endocrine Research Unit, Odense University Hospital",endocrine_research_unit_odense_university_hospital,,,,,, -3357,,95db6177-b882-4aa7-8f44-d56c146461cf,"TolerX, Inc",tolerx_inc,,,,,, -3358,,e80ac0df-f952-4230-b205-59f859a4f6fd,Zealand Pharma,zealand_pharma,,,,,, -3359,,b45e6787-1d19-4a29-ae54-9d6ca56a526b,Seqirus UK Limited,seqirus_uk_limited,,,,,, -432,0.948456,1f71611f-b1a0-468a-826f-555058e87660,Daiichi Sankyo Development Limited,daiichi_sankyo_development_limited,,,,1f71611f-b1a0-468a-826f-555058e87660,daiichi_sankyo_development_limited,Daiichi Sankyo Development Limited -3360,,e45facbb-85e6-492c-99ee-a9540504fd71,Southampton University Hospital NHS Trust,southampton_university_hospital_nhs_trust,,,,,, -3361,,496c056c-3d00-45de-9b43-e648abd63db5,Jari Halonen,jari_halonen,,,,,, -3362,,927cdda0-3b07-49b0-b6fd-47ddcf392e2e,Turku PET Centre,turku_pet_centre,,,,,, -735,0.98652654886245728,0e15ce2f-64e1-4032-b656-601cb9cc8b46,European Organisation for Research and Treatment of Cancer,european_organisation_for_research_and_treatment_of_cancer,,,,6e92b00d-0791-4d8e-975c-0fbd5ce95861,european_organisation_for_research_and_treatment_of_cancer,European Organisation for Research and Treatment of Cancer -3363,,1898488b-488f-4af2-b033-4163bf0cffab,Hospital General de L’Hospitalet,hospital_general_de_l_hospitalet,,,,,, -3364,,94df9e62-d28f-4f38-bccf-b8fd8ea88efc,"Medical University of Vienna, Department of Internal medicine I",medical_university_of_vienna_department_of_internal_medicine_i,,,,,, -3365,,c5a2a499-fce2-4e3a-b974-7ef9ad414685,"Institute of Clinical Medicine, Family Medicine, University of Turku",institute_of_clinical_medicine_family_medicine_university_of_turku,,,,,, -3366,,9e38ca8b-a3cd-4a2c-898a-bedea1a2db77,Tayside Medical Sciences Centre on behalf of University of Dundee & NHS Tayside,tayside_medical_sciences_centre_on_behalf_of_university_of_dundee_nhs_tayside,,,,,, -3367,,2119d1fe-8424-4f0f-a830-dfaf8cf05e8e,University of Southampton,university_of_southampton,,,,,, -3368,,a164433a-3d24-45d0-86f7-b1df53a417c9,LUNDBECK ITALIA,lundbeck_italia,,,,,, -3369,,1cd4a556-69f2-4f1b-a35e-2cd66370661d,"UNIVERSITA` DEGLI STUDI ""G. D`ANNUNZIO"" CHIETI",universita_degli_studi_g_d_annunzio_chieti,,,,,, -3370,,232d30c3-dd0e-4f92-900b-7ac40e2990b7,University of Dundee (Research & Innovation Services),university_of_dundee_research_innovation_services,,,,,, -3371,,a6de52bb-1492-4080-995c-b4aa586fdf6f,FISEVI,fisevi,,,,,, -367,0.95796058575312293,047a607c-fbe0-4e4d-b18e-9ecb5a985c9a,Bayer HealthCare A/S,bayer_healthcare_a_s,,,,e8216e75-b447-4252-bb49-7b895bcf4108,bayer_healthcare,Bayer HealthCare -3372,,4af88ea7-2a58-43c2-8d53-321d13141271,Astex Therapeutics Ltd,astex_therapeutics_ltd,,,,,, -3373,,ee33b25f-ee18-4078-8cd1-7ce0ff1200a1,Debiopharm SA,debiopharm_sa,,,,,, -3374,,0cead598-7d32-42f3-878e-0a3c649910b8,Chief Scientitst Office,chief_scientitst_office,,,,,, -3375,,e6763d33-9e67-4f83-aaa7-a84770084493,YALE UNIVERSITY,yale_university,,,,,, -3376,,94dbea1a-7997-4166-96c7-78c2a11f4fe7,Q-med AB,q_med_ab,,,,,, -3377,,4093eace-8871-4db8-87b9-91b3df02fa6e,Dr. Franz Köhler Chemie GmbH,dr_franz_k_hler_chemie_gmbh,,,,,, -3378,,0da1f7f1-5dd5-41e4-aa97-6ab8c1e0078c,Palle Toft,palle_toft,,,,,, -3379,,ec4d9639-f810-4d8e-86f7-0376bda9922f,Shire Development Inc,shire_development_inc,,,,,, -3380,,6e9cd0e8-716e-11e6-a0cd-0242ac12000b,PALATIN TECHNOLOGIES,palatin_technologies,,,,,, -3381,,4d368dd9-bbe7-4f0b-94ee-d4d3bada1018,University of Birmingham,university_of_birmingham,,,,,, -3382,,59c6bf20-7129-11e6-a89e-0242ac12000b,USL PHARMA,usl_pharma,,,,,, -66,0.96240752935409546,3a393eb3-48da-40b7-8350-c4006da9885c,AKH Wien,akh_wien,,,,1eec3f23-406c-471b-948a-24dcf52e62a1,akh_wien_klinik_f_r_innere_medizin_i_onkologie,"AKH Wien, Klinik für Innere Medizin I, Onkologie" -490,0.98204740881919861,3fd47231-c0e0-48e2-9df1-24e6ff72daf7,Radboud University Medical Center Njmegen,radboud_university_medical_center_njmegen,,,,3fd47231-c0e0-48e2-9df1-24e6ff72daf7,radboud_university_medical_center,Radboud University Medical Center -3383,,5e74dac9-7e8f-4d5f-8d35-29d77c01d39f,The Royal Group Hospitals Trust,the_royal_group_hospitals_trust,,,,,, -3384,,c64b4e66-14bd-447f-ab0c-1128bbe1b7fe,Oculis ehf,oculis_ehf,,,,,, -3385,,7e9cf81e-72cd-11e6-a0cd-0242ac12000b,SAGE PRODS,sage_prods,,,,,, -3386,,ae5114fc-f87f-4868-84fa-5a82714a72d2,Sandwell & West Birmingham Hospitals NHS Trust,sandwell_west_birmingham_hospitals_nhs_trust,,,,,, -778,0.982179,09db9c0d-772c-417a-b2dd-c0f3dd272e65,Medica Scientia Innovation Research (MedSIR ARO),medica_scientia_innovation_research_medsir_aro,,,,09db9c0d-772c-417a-b2dd-c0f3dd272e65,medica_scientia_innovation_research_medsir_aro,Medica Scientia Innovation Research (MedSIR ARO) -3387,,78d55b7c-711b-4703-a250-0733363368ff,Rosa Herrera Castro,rosa_herrera_castro,,,,,, -3388,,aa13b485-6306-4a33-8f23-22e97527ebd6,Diamyd Therapeutics AB,diamyd_therapeutics_ab,,,,,, -3389,,a746c680-9266-4c53-a941-f13712e6e663,Danish University Antidepressant Group (DUAG),danish_university_antidepressant_group_duag,,,,,, -3390,,e103ac26-91be-49a5-a0f8-408a068e05c4,"Diater Laboratorio de Diagnósticos y Aplicaciones Terapéuticas, S.A",diater_laboratorio_de_diagn_sticos_y_aplicaciones_terap_uticas_s_a,,,,,, -3391,,cd253630-5198-4122-a522-c9f82b752583,BODE Chemie GmbH,bode_chemie_gmbh,,,,,, -3392,,940674f6-881b-11e6-a998-0242ac12000b,Bayer Pharma AG,bayer_pharma_ag,,,,,, -3393,,280a4541-cf5e-436a-bbd1-c082498f9154,University of Liège- Dpt de Médecine Générale,university_of_li_ge_dpt_de_m_decine_g_n_rale,,,,,, -3394,,8f48d724-3de1-44a6-b5cd-2a280a3ffca1,A.O. San Gerardo di Monza,a_o_san_gerardo_di_monza,,,,,, -3395,,cda82f06-9dcb-43c8-a707-a0633111f14f,Lothian Health - University Hospitals Division,lothian_health_university_hospitals_division,,,,,, -3396,,539ac931-2c4d-4af0-82a0-f576e4ee2360,Laboratoire GlaxoSmithKline,laboratoire_glaxosmithkline,,,,,, -250,0.95617127418518066,5071919f-1373-4a28-b00e-8112a8b47ef4,NMDSG Nordic Myelodysplastic Syndrom Group,nmdsg_nordic_myelodysplastic_syndrom_group,,,,5071919f-1373-4a28-b00e-8112a8b47ef4,nmdsg_nordic_myelodysplastic_syndrom_group,NMDSG Nordic Myelodysplastic Syndrom Group -3397,,98ad618c-7d46-4a45-bd4b-e1c3288f12cd,"Med. Klinik II, Grosshadern, Klinikum der Universität München",med_klinik_ii_grosshadern_klinikum_der_universit_t_m_nchen,,,,,, -3398,,e339ddca-9a41-4e3d-b73c-479442219ded,Merja Kokki,merja_kokki,,,,,, -3399,,115dd074-7184-11e6-a0cd-0242ac12000b,JAZZ PHARMS INC,jazz_pharms_inc,,,,,, -3400,,e7b77e15-08ca-40df-9b8c-9ab699cd5791,Aalto-yliopiston Kylmälaboratorion Aivotutkimusyksikkö,aalto_yliopiston_kylm_laboratorion_aivotutkimusyksikk,,,,,, -3401,,3dc6292b-a4bc-4d57-9038-d0fe2cf074af,Healthcare Product Development,healthcare_product_development,,,,,, -3402,,6e47b9a6-a5de-4df4-80e5-e7e0e57d68eb,Roche Farma que representa en España a F. Hoffmann-La Roche Ltd,roche_farma_que_representa_en_espa_a_a_f_hoffmann_la_roche_ltd,,,,,, -1032,0.98019236326217651,9a3a8486-1cad-4e30-8596-fcf14f58cb7b,Kvinnokliniken,kvinnokliniken,,,,62b186bb-cb30-4ebd-9462-a1bd321e2179,kvinnokliniken_i_sterg_tland,Kvinnokliniken i Östergötland -3403,,85c4358a-d718-4cd3-a15e-c06483ff4246,Maternite Regionale Universitaire de Nancy,maternite_regionale_universitaire_de_nancy,,,,,, -3404,,432f1531-b11a-4c83-9581-05492fad458b,PARI Pharma GmbH,pari_pharma_gmbh,,,,,, -3405,,1c3dd6b4-7167-11e6-a0cd-0242ac12000b,MYLAN TEORANTA,mylan_teoranta,,,,,, -3406,,178c87de-c954-48e5-8d8b-89364b8e57af,Gilead Sciences GmbH,gilead_sciences_gmbh,,,,,, -3407,,94a69fcf-b94c-47f4-bed2-59b0de3acf4d,PD Dr. med. K-H. Konz,pd_dr_med_k_h_konz,,,,,, -3408,,6dec3a3a-73f8-11e6-a0cd-0242ac12000b,ALLERGAN HOLDINGS,allergan_holdings,,,,,, -3409,,3dfe2c00-364b-4900-8e42-0a5ffb997239,ZIOPHARM Oncology Inc,ziopharm_oncology_inc,,,,,, -3410,,8abbf943-d8b4-4656-ad98-408a4f847b57,Nayana Joshi Jubert,nayana_joshi_jubert,,,,,, -3411,,d4f1e8fb-4f4f-4f29-9b28-cab57f4dc68b,Oxford BioMedica (UK) Ltd,oxford_biomedica_uk_ltd,,,,,, -3412,,6ebd23af-bbad-4c29-850f-153badf27d3e,Mª Antònia Perelló Juan,m_ant_nia_perell_juan,,,,,, -3413,,d30a7eeb-0421-4f94-96dd-e72632a037d2,University of Dundee/NHS Tayside,university_of_dundee_nhs_tayside,,,,,, -3414,,84f2c161-ef4b-478e-bd10-f51ab2dea0a9,"Aarhus University Hospital, Aarhus Sygehus",aarhus_university_hospital_aarhus_sygehus,,,,,, -3415,,2ed82d8c-b9f8-4f2f-ba9b-01b8954bfb1a,Universität Wuerzburg,universit_t_wuerzburg,,,,,, -3416,,33454f8c-a769-4f4c-a2f2-8210c6bd686d,"3.Med. Department, Academic Hospital Bogenhausen",3_med_department_academic_hospital_bogenhausen,,,,,, -493,0.98710572719573975,0b4d241a-7142-11e6-a0cd-0242ac12000b,AMNEAL PHARMS,amneal_pharms,,,,d264e962-7141-11e6-a0cd-0242ac12000b,amneal_pharms,AMNEAL PHARMS -3417,,de8e97c9-b058-4b07-ab85-ce13fe5a8743,SLA Pharma (UK) Ltd,sla_pharma_uk_ltd,,,,,, -3418,,6bb68bd3-278c-4516-86ea-5ed2200b5b9f,Sankt Eriks Eye Hospital,sankt_eriks_eye_hospital,,,,,, -960,0.988812,bf8e1dfc-7e55-4f48-ab32-ba4f23a1d935,AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA,azienda_universitaria_policlinico_umberto_i_di_roma,,,,9e4d3fbc-0e9a-4bef-af84-596f0765706f,azienda_universitaria_policlinico_umberto_i,AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I -3419,,2b019a3b-30f8-4101-844b-c3120848a98b,Cardiff and Vale NHS Trust,cardiff_and_vale_nhs_trust,,,,,, -3420,,bdd7a1cf-4495-4b65-8385-b1f1488d6874,"Ardelyx, Inc",ardelyx_inc,,,,,, -3421,,a3f2c0cf-397f-446f-9c08-56acde4fcb35,GlaxSmithKline Research & Development Limited,glaxsmithkline_research_development_limited,,,,,, -3422,,77d21801-56b6-4b8e-b5d3-f1ffc39d7e7e,Victor Martínez Taboada,victor_mart_nez_taboada,,,,,, -3423,,fa1d0a36-715d-11e6-a0cd-0242ac12000b,ALEMBIC PHARMS LTD,alembic_pharms_ltd,,,,,, -3424,,6a3a2bf5-745f-4ef2-8f05-3ee9a23ca396,Royal National Hospital for Rheumatic Disease,royal_national_hospital_for_rheumatic_disease,,,,,, -3425,,95dcd5fe-ea33-4bd4-b980-3b8a52d2e083,Synphora AB,synphora_ab,,,,,, -705,0.975954,666dd3bc-7129-11e6-a89e-0242ac12000b,LUITPOLD,luitpold,,,,666dd3bc-7129-11e6-a89e-0242ac12000b,luitpold,LUITPOLD -3426,,2fd748d2-9c44-4a2a-bab7-2cd1b28dcde8,Department of Pharmacology-Toxicology,department_of_pharmacology_toxicology,,,,,, -3427,,9124899a-8bd5-11e6-a449-0242ac12000b,"Parion Sciences, Incorporated",parion_sciences_incorporated,,,,,, -3428,,12ef157d-3eb5-4c25-acad-2a231404ef7c,LG Life Science Ltd,lg_life_science_ltd,,,,,, -3429,,43e80408-ecc1-4ed8-b99e-6cb2ff322a1f,Eiger BioPharmaceuticals,eiger_biopharmaceuticals,,,,,, -223,0.985233,942bacad-d838-4c73-ae5e-fc8e758a272b,"Surface Logix, Inc",surface_logix_inc,,,,44108cfa-cc6c-4533-88aa-39d1732610f2,surface_logix,Surface Logix -697,0.98663,5f97fd26-7163-11e6-a0cd-0242ac12000b,BAUSCH AND LOMB INC,bausch_and_lomb_inc,,,,0521bb50-7129-11e6-a89e-0242ac12000b,bausch_and_lomb,BAUSCH AND LOMB -3430,,3595c72a-adbb-4444-902e-9a6d3d1f278c,"Protherics Medicines Development Ltd, a BTG plc company",protherics_medicines_development_ltd_a_btg_plc_company,,,,,, -3431,,a3680e89-7dd3-4d52-a8ba-ff9fdb0ccd95,Grupo de Investigación en Oncología Médica del Hospital de Navarra,grupo_de_investigaci_n_en_oncolog_a_m_dica_del_hospital_de_navarra,,,,,, -464,0.979231,d09c685b-4a05-4cb4-a977-130633e1d160,SCHWARZ PHARMA,schwarz_pharma,,,,12f90377-956c-4817-b4ad-64555adaf3a0,schwarz_pharma_deutschland_gmbh,SCHWARZ PHARMA Deutschland GmbH -3432,,a833c45e-4e2a-4760-bd39-d0258e8115a0,Tampere University Hospital,tampere_university_hospital,,,,,, -3433,,2a8aebd0-73c4-11e6-a0cd-0242ac12000b,AVEDRO INC,avedro_inc,,,,,, -3434,,1cf3f838-517f-4c6f-8599-020eb894daeb,Fundación Sanitaria para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO),fundaci_n_sanitaria_para_el_fomento_de_la_investigaci_n_sanitaria_y_biom_dica_de_la_comunidad_valenciana_fisabio,,,,,, -883,0.97897982597351074,cf448ad3-7ed9-4898-a76a-3fe63bd531cf,ALTANA Inc,altana_inc,,,,0ea5911a-7142-11e6-a0cd-0242ac12000b,altana,ALTANA -3435,,2550f3d3-bff7-44a5-a0a5-e849e191cb2a,Hospital Universitario Araba (Sede Santiago),hospital_universitario_araba_sede_santiago,,,,,, -3436,,2ea7929f-2300-46ea-bc29-aa2a76077fa6,GUERBET,guerbet,,,,,, -272,0.98482978343963623,5ab1cb72-7148-11e6-a0cd-0242ac12000b,LEK PHARM,lek_pharm,,,,5ab1cb72-7148-11e6-a0cd-0242ac12000b,lek_pharms,LEK PHARMS -3437,,e6b0f99a-2068-4cd4-8179-50b4409a4ee3,Schriners Hospitals for Children,schriners_hospitals_for_children,,,,,, -3438,,435d5507-7709-4cec-ae69-d385e48fa6d8,Silkeborg Hospital,silkeborg_hospital,,,,,, -3439,,918d7e2a-4d05-4a47-a629-776bb01eaece,"OSI Pharmaceuticals, LLC",osi_pharmaceuticals_llc,,,,,, -3440,,03df4e07-3955-48b7-ab42-d43eb866f32c,Norwegian University of Science and Technology,norwegian_university_of_science_and_technology,,,,,, -3441,,781a2884-dae1-4ab2-9569-22b9e6a5504b,Arpida AG,arpida_ag,,,,,, -3442,,215852b2-356e-492c-a873-837b4368915f,"AZIENDA OSPEDALIERA ""OSPEDALI RIUNITI DI BERGAMO"" (A.O. DI RILIEVO NAZIONALE)",azienda_ospedaliera_ospedali_riuniti_di_bergamo_a_o_di_rilievo_nazionale,,,,,, -3443,,805a7c1d-98c5-4042-b5f9-b3428f0d9cd1,FUNDACION PARA LA INVESTIGACIÓN LA FE,fundacion_para_la_investigaci_n_la_fe,,,,,, -549,0.989229,e36f0842-a3fe-4d92-8d80-2f683e2f092d,Fédération Francophone de Cancérologie Digestive,f_d_ration_francophone_de_canc_rologie_digestive,,,,4932b407-af0a-4966-9a44-59fa9ac09e80,f_d_ration_francophone_de_canc_rologie_digestive_ffcd,Fédération Francophone de Cancérologie Digestive (FFCD) -163,0.94221,48bfd2b5-83e1-417f-a6ba-9f7b2b0a98b6,"Iho-ja allergiasairaala, HUS",iho_ja_allergiasairaala_hus,,,,2e1d8af2-76ea-4f16-98e7-156c78aa3581,iho_ja_allergiasairaala_hyks,"Iho-ja allergiasairaala, HYKS" -3444,,2f9be4f9-3e95-434d-b65c-3e6be427f5e7,INSTITUT D'INVESTIGACIÓ BIOMÈDICA DE BELLVITGE(IDIBELL),institut_d_investigaci_biom_dica_de_bellvitge_idibell,,,,,, -3445,,4f88cd18-9d55-4d2e-82ae-02469979decb,SOM Innovation Biotech SL (SOM Biotech),som_innovation_biotech_sl_som_biotech,,,,,, -3446,,86728b78-6955-47b5-b189-17f58cd37b61,HOSPITAL 12 OCTUBRE,hospital_12_octubre,,,,,, -3447,,a91796f2-715c-11e6-a0cd-0242ac12000b,SVC PHARMA,svc_pharma,,,,,, -3448,,d074a971-5024-4a64-b6f3-1435df8ba62c,"Schering-Plough Research Institute,divisione di Schering Corporation, per conto di MSP Singapore Co",schering_plough_research_institute_divisione_di_schering_corporation_per_conto_di_msp_singapore_co,,,,,, -3449,,f69ab08a-d179-495e-a029-fbca0563c9fc,AVAX Technologies Inc,avax_technologies_inc,,,,,, -3450,,a97bd5aa-c0b4-4679-adc6-4a640047cb0b,Neuropsychiatric clinic,neuropsychiatric_clinic,,,,,, -3451,,c45de963-05fe-4ec7-a8e2-002b41c81b59,Arbeitskreis für urologische Onkologie der österr. Gesellschaft für Urologie und Andrologie (AUO),arbeitskreis_f_r_urologische_onkologie_der_sterr_gesellschaft_f_r_urologie_und_andrologie_auo,,,,,, -3452,,433948dd-1396-4f4d-96bd-d8204dfb6f70,Institute of Psychophysiology and Rehabilitation (IRP) of the Kaunas University of Medicine,institute_of_psychophysiology_and_rehabilitation_irp_of_the_kaunas_university_of_medicine,,,,,, -3453,,3223097f-797a-4223-8aeb-7a2e6eaf7b06,Royal Victoria Infirmary,royal_victoria_infirmary,,,,,, -3454,,ea65abe1-3017-49c6-833e-154037555c6e,Stellaris Pharmaceuticals ApS,stellaris_pharmaceuticals_aps,,,,,, -3455,,7e65ec86-715e-11e6-a0cd-0242ac12000b,VALEANT PHARM INTL,valeant_pharm_intl,,,,,, -3456,,327a2c06-715e-11e6-a0cd-0242ac12000b,PETNET,petnet,,,,,, -3457,,f0303483-f893-4504-afdc-859a8f327999,Fondazione Italiana Linfomi Onlus,fondazione_italiana_linfomi_onlus,,,,,, -3458,,61d8b5ba-1039-4cc6-88d5-81e72a30d3a1,Shire-Movetis NV,shire_movetis_nv,,,,,, -3459,,468a76bf-6ce4-4489-8f22-e17b886c8aba,"PALAU PHARMA, S.A",palau_pharma_s_a,,,,,, -3460,,1ce82ae8-146e-4b57-8eb2-b53c89f4b999,"Johannes-Gutenberg-Universität Mainz, I. Medizinische Klinik und Poliklinik",johannes_gutenberg_universit_t_mainz_i_medizinische_klinik_und_poliklinik,,,,,, -3461,,9ec87cab-f636-4a48-b8da-6914cf47c9dd,Intendis GmbH,intendis_gmbh,,,,,, -678,0.97478169202804565,ddf3632f-3a35-464c-8cf1-c8b6486c323c,AbbVie Deutschland GmbH & Co. KG (Abbott),abbvie_deutschland_gmbh_co_kg_abbott,,,,ddf3632f-3a35-464c-8cf1-c8b6486c323c,abbvie_deutschland_gmbh_co_kg,AbbVie Deutschland GmbH & Co. KG -3462,,fa520b74-e763-49e1-81f2-7a6336af0f0f,"Medical and Health Science Center, University of Debrecen Dept. of Otolaryngology",medical_and_health_science_center_university_of_debrecen_dept_of_otolaryngology,,,,,, -3463,,e3db381e-124b-4fe2-b17a-0544b110b8eb,Maria Nabal Vicuña (Paliative Care Supportive Team-Hospital Universitari Arnau de Vilanova de Lleida),maria_nabal_vicu_a_paliative_care_supportive_team_hospital_universitari_arnau_de_vilanova_de_lleida,,,,,, -3464,,46283c60-466f-4250-b6fa-27491beab358,"HUS, Hospital for Children and Adolescents",hus_hospital_for_children_and_adolescents,,,,,, -3465,,d711ec96-2b26-41fe-9122-e562e858dd18,"Columbia Laboratories, Inc",columbia_laboratories_inc,,,,,, -539,0.969856,33c18818-71cf-11e6-a0cd-0242ac12000b,APOTEX TECHNOLOGIES,apotex_technologies,,,,33c18818-71cf-11e6-a0cd-0242ac12000b,apotex_technologies,APOTEX TECHNOLOGIES -3466,,390f6c8e-c346-4fbc-a9ad-e61cf540571e,ALTANA Pharma bv,altana_pharma_bv,,,,,, -3467,,b05d9796-e55c-4aa5-b96c-267e16f71f5a,HolsboerMaschmeyer NeuroChemie (HMNC) GmbH,holsboermaschmeyer_neurochemie_hmnc_gmbh,,,,,, -3468,,2cc5088a-0a5c-4ccd-b2e9-0c226bba435a,Arcutis Pharmaceuticals,arcutis_pharmaceuticals,,,,,, -612,0.98845240473747253,8ee4e877-1d00-45cf-ad2d-2275466ff57d,Erasmus Medical Center, Department of general practice,,,,f3ebaba1-aead-4675-858a-6f4e2a4f28d1,erasmus_medical_center,Erasmus Medical Center -67,0.960694,8fbbc81e-1516-4d7f-b54e-79f6a0aef8e0,Servier Research and Development Ltd,servier_research_and_development_ltd,,,,8fbbc81e-1516-4d7f-b54e-79f6a0aef8e0,servier_research_and_development_ltd,Servier Research and Development Ltd -824,0.979265,aac889d6-2c6b-4e79-9438-37e8b55cc08d,BAUSCH&LOMB,bausch_lomb,,,,aac889d6-2c6b-4e79-9438-37e8b55cc08d,bausch_lomb,BAUSCH&LOMB -3469,,83357af4-6f9e-11e6-9663-0242ac12000b,UCL-INSTITUTE OF CHILD HEALTH,ucl_institute_of_child_health,erasmus_medical_center_department_of_general_practice,,,,, -3470,,56c0f59a-78f0-4700-a66f-ed806a5932ec,Dr. Antonio Osuna Ortega,dr_antonio_osuna_ortega,,,,,, -3471,,bc0d0040-e1a5-4016-8853-f51c9ef921fd,SPCG,spcg,,,,,, -1000,0.98663,90ab4dda-7129-11e6-a89e-0242ac12000b,TEVA PHARMS USA,teva_pharms_usa,,,,80265282-715d-11e6-a0cd-0242ac12000b,teva_pharms_usa_inc,TEVA PHARMS USA INC -3472,,0ce46fe9-af37-405b-a611-1aa75471553c,CRUCELL SWITZERLAND AG,crucell_switzerland_ag,,,,,, -3473,,80dc5bd8-83c5-4428-8302-2d9d2e481e3a,Dean of Medical Faculty of Goethe University Frankfurt,dean_of_medical_faculty_of_goethe_university_frankfurt,,,,,, -3474,,b9e825f7-1fe0-4fc7-bce2-9c6aa4c919e1,Jarmo Hietala,jarmo_hietala,,,,,, -3475,,d297c03a-7141-11e6-a0cd-0242ac12000b,WEST-WARD PHARM CORP,west_ward_pharm_corp,,,,,, -3476,,90d06d25-c8cc-403d-aed6-02b23f675129,NOVAGALI PHARMA SAS,novagali_pharma_sas,,,,,, -3477,,84bf1e98-73ef-11e6-a0cd-0242ac12000b,LINDE NORTH AMERICA INC,linde_north_america_inc,,,,,, -3478,,e10bf969-77e4-4f16-bdfb-e072778fed0c,Gesellschaft für Epilepsieforschung e.V,gesellschaft_f_r_epilepsieforschung_e_v,,,,,, -3479,,4483190e-4157-4d8d-a105-b65115cd4782,CHU Nantes,chu_nantes,,,,,, -3480,,ce17ef6d-d214-4bfa-a3da-8c946b3421fc,AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI,azienda_ospedaliera_universitaria_careggi,,,,,, -3481,,d8838b96-7141-11e6-a0cd-0242ac12000b,WRASER PHARMS LLC,wraser_pharms_llc,,,,,, -3482,,ddd45916-715c-11e6-a0cd-0242ac12000b,BEXIMCO USA,beximco_usa,,,,,, -3483,,e41d88dc-73ab-11e6-a0cd-0242ac12000b,HOPE PHARMS,hope_pharms,,,,,, -857,0.96982835233211517,8fcc7ea7-9d11-4e81-89e5-b4b85e29ebcb,Institut de Recerca de l'Hospital de la Santa Creu i Sant Paui,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_paui,,,,0213f530-437f-430a-b936-0bfa94166165,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau -3484,,dd7e17b9-f773-49b5-b851-8a9b7d0e94ea,FARMEX SA,farmex_sa,,,,,, -465,0.97226685285568237,3758cf3a-2cf3-4c07-ae42-3a9d8c7f57c7,"Leiden University Medical Center, division 3",leiden_university_medical_center_division_3,,,,2e4a0d21-5259-4b26-b5dd-ed587c02073f,leiden_university,Leiden University -3485,,ce9e08e9-8bf5-4940-aaa7-b3fb68beb7ff,OMRIX biopharmaceuticals Ltd,omrix_biopharmaceuticals_ltd,,,,,, -3486,,9f3e2c4e-eb16-45fa-9bdc-35fe3ab2c9b7,Gynecologic Oncology Group,gynecologic_oncology_group,,,,,, -3487,,e96e53e1-130b-4cf8-a812-6e88f5dd72a3,Dyax Corp,dyax_corp,,,,,, -3488,,1b29cfc4-755c-4da7-9ce7-15f331eb606b,South Manchester University NHS Trust,south_manchester_university_nhs_trust,,,,,, -824,0.979265,fbe54b64-faf4-45bb-b992-cf986f3ba11f,BAUSCH&LOMB - IOM S.P.A,bausch_lomb_iom_s_p_a,,,,aac889d6-2c6b-4e79-9438-37e8b55cc08d,bausch_lomb,BAUSCH&LOMB -3489,,0d0d1869-6d21-4632-87af-9e8a85c2b81a,Centre Henri Becquerel,centre_henri_becquerel,,,,,, -3490,,9542d009-55b6-4f9b-9951-3f92df79dce2,Technical University Carl-Gustav-Carus,technical_university_carl_gustav_carus,,,,,, -3491,,502a2cd8-e412-4f05-a060-426f18cfb47e,CHU Toulouse,chu_toulouse,,,,,, -3492,,e6fbcaaf-cbec-40bb-9029-91300bae9a6d,AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI,azienda_ospedaliera_universitaria_della_seconda_universita_degli_studi_di_napoli,,,,,, -3493,,d302350a-6fc0-11e6-abe8-0242ac12000b,"Irish Clinical Oncology Research Group CLG, trading as Cancer Trials Ireland",irish_clinical_oncology_research_group_clg_trading_as_cancer_trials_ireland,,,,,, -3494,,eb3ba1fe-9aae-4756-9280-013688bc092b,Centre Val d'Aurelle - Paul Lamarque,centre_val_d_aurelle_paul_lamarque,,,,,, -3495,,933f80ea-ca12-45e2-8c5e-4985697fcaeb,Tibotec BVBA,tibotec_bvba,,,,,, -3496,,566f2525-88ca-4ad9-a985-788e49f4240e,"Pr Giampiero CAMPANELLI Università di Milano, Dipartimento di Scienze Chirurgiche, Ospedale Maggior",pr_giampiero_campanelli_universit_di_milano_dipartimento_di_scienze_chirurgiche_ospedale_maggior,,,,,, -3497,,d4d27fdc-a791-11e6-94cb-5656d04fc2b5,ASLTO2-Maria Vittoria Hospital Cardiology,aslto2_maria_vittoria_hospital_cardiology,,,,,, -3498,,5d6870b7-d677-46ea-93d6-d6e95fa09a37,"ALK-Abelló, S.A",alk_abell_s_a,,,,,, -3499,,7c925a02-ea4b-49f1-b328-2c62dca2fd88,WALA Heilmittel GmbH,wala_heilmittel_gmbh,,,,,, -3500,,0ac85da3-613b-4b8c-a1e0-d81a4f51c017,Roche spol. s r.o,roche_spol_s_r_o,,,,,, -3501,,b2d9816c-1b2d-4b35-98c3-b5f510856737,Universitätshautklinik Kiel,universit_tshautklinik_kiel,,,,,, -3502,,480c5f71-9635-4fab-9914-812d826fee67,Dermal Laboratories Limited,dermal_laboratories_limited,,,,,, -391,0.988144,ee3259eb-215f-42ac-9ef8-8f6bb9956740,Threshold Pharmaceuticals,threshold_pharmaceuticals,,,,4d1c7b0c-14e8-4b45-86cf-b9594868a087,threshold_pharmaceuticals_inc,"Threshold Pharmaceuticals, Inc" -3503,,62bb9b6d-82ac-448f-b80e-c72eefdde827,Nitto Denko Corporation,nitto_denko_corporation,,,,,, -3504,,48859ff4-7158-11e6-a0cd-0242ac12000b,SUN PHARMA GLOBAL,sun_pharma_global,,,,,, -3505,,1e787aa3-1503-4c16-81ea-805d32cd84d3,Dr Antonio Gimeno,dr_antonio_gimeno,,,,,, -3506,,0ae25e71-a0dd-4d32-ae92-f2e14fb91cb3,"Amylin Pharmaceuticals, LCC",amylin_pharmaceuticals_lcc,,,,,, -60,0.977790721825191,9f78d043-b5fa-4672-b3b6-adeedcf3e30a,Wyeth Research Division of Wyeth Pharmceuticals Inc,wyeth_research_division_of_wyeth_pharmceuticals_inc,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc -3507,,31700e62-8bcf-11e6-a449-0242ac12000b,agentschap innoveren en ondernemen,agentschap_innoveren_en_ondernemen,,,,,, -3508,,c319b695-60ec-4d29-96cf-54293c865ef4,NORGINE LIMITED,norgine_limited,,,,,, -173,0.9838290810585022,8ca2b721-4e34-4006-b99d-2917cd2811a3,Merck Serono S.A,merck_serono_s_a,,,,25f19699-b1c9-46a8-8933-0a2bbd3c7357,merck_serono_s_a_geneva,Merck Serono S.A. - Geneva -872,0.938247,9e17fcf8-9dea-44e0-8a01-1de434e51049,Newcastle upon Tyne Hospitals NHS Trust,newcastle_upon_tyne_hospitals_nhs_trust,,,,62c0263c-d0e1-4e0b-8c35-ed6babb3051d,newcastle_u_tyne_hospitals_nhs_trust,Newcastle u Tyne Hospitals NHS Trust -3509,,f3f7f704-8495-4cf1-b4cd-e758d42e7b9f,The Dutch Working Group on Immunotherapy of Oncology (WIN-O),the_dutch_working_group_on_immunotherapy_of_oncology_win_o,,,,,, -3510,,1d7eb73f-1b95-46b1-aacc-2738d8eb6a10,Fondazione IRCCS Policlinico San Matteo,fondazione_irccs_policlinico_san_matteo,,,,,, -3511,,8e954bfa-6be3-4e36-891f-307e9b4cfe87,"Landstinget Sörmland Landstingskansliet, Hälso-och Sjukvårdsledningen",landstinget_s_rmland_landstingskansliet_h_lso_och_sjukv_rdsledningen,,,,,, -3512,,ac798d50-5b0c-488a-8cb7-cbd78a281b9b,Freistaat Bayer respresented by University of Regensburg represented by Kaufmännischer Direktor,freistaat_bayer_respresented_by_university_of_regensburg_represented_by_kaufm_nnischer_direktor,,,,,, -3513,,a3a84a18-77f2-49e2-97a1-a4b4b4b6fbfb,LWL Universitätsklinik für Psychiatrie Bochum,lwl_universit_tsklinik_f_r_psychiatrie_bochum,,,,,, -3514,,3c48e1ad-7807-4da0-8ee2-26810189d245,Unidade de Investigação em Saúde Mental e Psiquiatria do Centro Hospitalar Conde de Ferreira,unidade_de_investiga_o_em_sa_de_mental_e_psiquiatria_do_centro_hospitalar_conde_de_ferreira,,,,,, -3515,,0d682ab3-834b-4458-bcf6-ce2c66b069a1,Mukoviszidose Institut gGmbH i. G,mukoviszidose_institut_ggmbh_i_g,,,,,, -3516,,c6e8335e-52f1-46e0-956f-b2e255089cc4,Radiumhemmet,radiumhemmet,,,,,, -3517,,266e37f4-6cf0-4fce-a27b-7b8cacb09340,AFT Pharmaceuticals Ltd,aft_pharmaceuticals_ltd,,,,,, -3518,,f6fb1c08-9e52-48eb-841a-5b4e3a4d1305,Q-Develop AB/co Freddie Norberg,q_develop_ab_co_freddie_norberg,,,,,, -3519,,15055c8c-44cd-4d20-a26b-6ffe057c3928,"Julius Center for Health Sciences and Primary Care, UMC Utrecht",julius_center_for_health_sciences_and_primary_care_umc_utrecht,,,,,, -332,0.986085,7336f82e-6c71-4f40-80a6-4017116b5145,Instituto Valenciano de Infertilidad (IVI) de Valencia,instituto_valenciano_de_infertilidad_ivi_de_valencia,,,,7336f82e-6c71-4f40-80a6-4017116b5145,instituto_valenciano_de_infertilidad_ivi_de_valencia,Instituto Valenciano de Infertilidad (IVI) de Valencia -3520,,b07e39a8-a8e3-486b-b4eb-42502f459037,"Centre for Ophthalmology, University of Tuebingen",centre_for_ophthalmology_university_of_tuebingen,,,,,, -968,0.98292633891105652,3c6e93c3-b2a6-4f7b-9211-088c20073f84,Maatschap Cardiologie Isala klinieken,maatschap_cardiologie_isala_klinieken,,,,e5d4a9c1-e0e4-4ac7-8c88-785f0f8e3beb,maatschap_cardiologie_isala_klinieken,Maatschap Cardiologie Isala klinieken -862,0.98123219609260559,e146990e-b84f-4869-b500-797607ef3b45,Academic Medical Center,academic_medical_center,,,,2d106fa3-c940-42d6-a28f-8db21de52b04,academic_medical_center_amsterdam,Academic Medical Center Amsterdam -3521,,e38005c2-dd4a-4a05-a472-b1efd0235986,L’OREAL SA,l_oreal_sa,,,,,, -3522,,c595b78b-70ce-4390-9e0b-9fc6a3876b26,Biologiske Stasjon Drøbak,biologiske_stasjon_dr_bak,,,,,, -3523,,159d3681-0be5-4fe7-845d-7dea9b456f49,"Department of Endocrinology, Sahlgrenska University Hospital",department_of_endocrinology_sahlgrenska_university_hospital,,,,,, -1003,0.970735,9134f49c-0675-4fb8-9e30-403bf260e44d,Pfizer Limited,pfizer_limited,,,,9134f49c-0675-4fb8-9e30-403bf260e44d,pfizer_limited,Pfizer Limited -3524,,92f3e5d8-8435-4020-a6ad-27ed5a0a8522,GGZ Oost Brabant,ggz_oost_brabant,,,,,, -3525,,16896f82-7147-11e6-a0cd-0242ac12000b,SENTYNL THERAPS INC,sentynl_theraps_inc,,,,,, -455,0.958341,964ac62f-bdf9-4059-a3e2-964f54f87cdb,Solvay Pharmaceuticqals B.V,solvay_pharmaceuticqals_b_v,,,,792dba77-9941-4659-aa31-5f86a7b2ad5b,solvay_pharmaceuticals_b_v,Solvay Pharmaceuticals B.V -3526,,3a9f56c4-9fbb-4e10-8b10-a49e643dd61a,Revalesio Corporation,revalesio_corporation,,,,,, -3527,,66743fcb-b1b2-4731-ac02-d4145460352b,Odense University Hospital,odense_university_hospital,,,,,, -3528,,85b86a82-e503-4329-88c6-ffdf7328e582,"Pulmonary Department, Gentofte Hospital",pulmonary_department_gentofte_hospital,,,,,, -3529,,bda2f10b-0055-4ce9-8515-8a1bbe6abfad,OA Doz. Dr. Thomas Müller c/o B&S Zentrallabor Konventhospital Barmherzige Brüder Linz,oa_doz_dr_thomas_m_ller_c_o_b_s_zentrallabor_konventhospital_barmherzige_br_der_linz,,,,,, -384,0.94804,8aa216f5-6b16-4908-9de4-6ff33dd6be69,The Univeristy of Nottingham,the_univeristy_of_nottingham,,,,8aa216f5-6b16-4908-9de4-6ff33dd6be69,the_univeristy_of_nottingham,The Univeristy of Nottingham -3530,,f6c6284b-870a-4229-96d8-963990528198,University of Rochester,university_of_rochester,,,,,, -458,0.98385661840438843,d927af23-71f2-4fd9-95f3-8ba0fa0b7578,"Janssen-Cilag International NV,Turnhoutseweg 30, 2340 Beerse, Belgium",janssen_cilag_international_nv_turnhoutseweg_30_2340_beerse_belgium,,,,3baabec0-1bc8-4e64-b010-70f6fcb400f2,jassen_cilag_international_nv_turnhoutseweg_30_2340_beerse_belgium,"Jassen-Cilag International NV,Turnhoutseweg 30, 2340 Beerse, Belgium" -3531,,7b64fec4-ee09-428c-ae9d-4172d633d944,Certmedica International GmbH,certmedica_international_gmbh,,,,,, -60,0.96309179067611694,c5d2e92d-817f-494c-8e69-41dd6341a522,Wyeth Research Division of Wyeth Pharmaceuticals Inc (a Pfizer Company),wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc -3532,,4f47aa78-7142-11e6-a0cd-0242ac12000b,MAST MM,mast_mm,,,,,, -3533,,5039c5b0-7160-11e6-a0cd-0242ac12000b,FLEMING PHARMS,fleming_pharms,,,,,, -3534,,24659412-1453-4dc9-870a-e4e7a107b011,ACCORD University of Edinburgh,accord_university_of_edinburgh,,,,,, -3535,,26861c79-8704-4677-8cd7-f6754152b755,ikfe GmbH,ikfe_gmbh,,,,,, -1041,0.97318911552429199,f84e2ab7-3032-4234-ba0d-3020f0de6fde,Celgene,celgene,,,,64e4c2d9-005c-4577-8791-92439d12eda2,celgene_corporation,Celgene Corporation -3536,,d150e3cf-c998-429a-8ace-6dc6dc6afbbf,"Carbylan BioSurgery, Inc",carbylan_biosurgery_inc,,,,,, -3537,,da0b59f8-70a7-47a1-b459-a2af4036bbf5,University Medical Center Hamburg-Eppendorf,university_medical_center_hamburg_eppendorf,,,,,, -3538,,068ca669-db79-4420-9927-4555606e7c7c,Martin Luther University of Hallle/Wittenburg,martin_luther_university_of_hallle_wittenburg,,,,,, -3539,,cd91e44e-3561-449f-9e91-fed12d985d1a,"Pharmazam, S.A",pharmazam_s_a,,,,,, -1078,0.95782852172851562,ca983e11-79a7-4cbe-9340-f9e67b19e0cf,"IBSA, Institute Biochimique S.A",ibsa_institute_biochimique_s_a,,,,1242e11a-4288-492d-8023-e4ffe5a4e9bd,ibsa_institute_biochimique_sa,IBSA Institute Biochimique SA -162,0.96508872509002686,045ba97e-7848-45f2-b26b-86cc761804b6,Norfolk and Norwich University Hospitals NHS Foundation Trust,norfolk_and_norwich_university_hospitals_nhs_foundation_trust,,,,045ba97e-7848-45f2-b26b-86cc761804b6,norfolk_and_norwich_university_hospitals_nhs_foundation_trust,Norfolk and Norwich University Hospitals NHS Foundation Trust -3540,,b264048d-bd26-4c92-b45d-79b49badd343,Novagali Pharma SA,novagali_pharma_sa,,,,,, -836,0.98650866746902466,ae273ddc-9a36-42fc-9c53-b60041ff6a52,NHS Greater Glasgow & Clyde,nhs_greater_glasgow_clyde,,,,8b728024-8fd6-4d73-82c9-94fcbe26c730,nhs_greater_glasgow_clyde_r_d_office,NHS Greater Glasgow & Clyde R&D Office -3541,,f2e52de5-ff86-48f9-8cd7-d882190e2795,GlaxoSmithKline Research and Devlopment Ltd,glaxosmithkline_research_and_devlopment_ltd,,,,,, -3542,,c8eab104-b4aa-4301-ac96-889a23ca977b,POLICHEM,polichem,,,,,, -603,0.98583465814590454,a0ddc1d2-40ab-45fd-8ead-18f31c252ce2,Fundación para la Investigación y desarrollo en el Área Cardiovascular,fundaci_n_para_la_investigaci_n_y_desarrollo_en_el_rea_cardiovascular,,,,6eb8c187-922d-4265-a290-1d2eaf8c0f5f,fundaci_n_para_la_investigaci_n_y_desarrollo_en_el_rea_cardiovascular_fic,Fundación para la Investigación y Desarrollo en el Área Cardiovascular (FIC) -282,0.96157515048980713,672cc16b-a1f9-47a6-864e-1ffd1fbe267d,"Sahlgrenska University Hospital, Östra",sahlgrenska_university_hospital_stra,,,,2f33c154-cafb-40b1-8fdc-8c3e78823f79,sahlgrenska_university_hospital,Sahlgrenska University Hospital -3543,,3a649bcb-adf2-48e5-bd96-9a9520c32212,Jansen-Cilag International N.V,jansen_cilag_international_n_v,,,,,, -3544,,b3c0b3da-6eee-447b-ab71-586acf78ea7e,Medical Centre Leeuwarden,medical_centre_leeuwarden,,,,,, -3545,,df25741a-715e-11e6-a0cd-0242ac12000b,ESI,esi,,,,,, -3546,,fa931d6f-4497-4cf9-b305-c07eeb9a54a3,Portuguese Lung Cancer Study Group,portuguese_lung_cancer_study_group,,,,,, -97,0.988116,fe10a55d-dd0e-4ce1-b012-70158b48434c,Newron Pharmaceuticals SpA,newron_pharmaceuticals_spa,,,,9abd20d6-1c2a-4aeb-922e-ae371ab88700,newron_pharmaceuticals,Newron Pharmaceuticals -3547,,dc11babf-a704-11e6-94cb-5656d04fc2b5,Dainippon Sumitomo Pharma America Ltd,dainippon_sumitomo_pharma_america_ltd,,,,,, -3548,,6e021816-7a43-4054-8d70-97ba4c2127a3,Gastroenterology UZ Gasthuisberg,gastroenterology_uz_gasthuisberg,,,,,, -214,0.975452,1ad07c8c-d03b-4847-bbe9-1ac8e4b893aa,Innsbruck Medical University,innsbruck_medical_university,,,,1ad07c8c-d03b-4847-bbe9-1ac8e4b893aa,innsbruck_medical_university,Innsbruck Medical University -3549,,28a7f954-09e2-47c3-a10c-4f9d40864356,Buckinghamshire Hospitals NHS Trust,buckinghamshire_hospitals_nhs_trust,,,,,, -3550,,e058bc88-3323-4040-8188-37010595558d,Weleda AG,weleda_ag,,,,,, -3551,,97480860-986f-4d47-a021-9ae95c1de16b,Calthorpe Clinic,calthorpe_clinic,,,,,, -3552,,f26c7809-f7bf-483e-aada-f4ab399e2bc3,"Department of Anaesthesie, General Intensive Care and Pain Therapy",department_of_anaesthesie_general_intensive_care_and_pain_therapy,,,,,, -3553,,3cf68ae6-381a-4c2b-9536-b087f6087b46,Anæstesiologisk Afd. Herlev Hospital,an_stesiologisk_afd_herlev_hospital,,,,,, -3554,,2818281a-7160-11e6-a0cd-0242ac12000b,ABC HOLDING,abc_holding,,,,,, -592,0.98310869932174683,b254d686-8bcf-4d48-9680-768d5a970e5e,"Medical University of Innsbruck, Austrian AGO Trial Centre",medical_university_of_innsbruck_austrian_ago_trial_centre,,,,75cfe52c-155f-4652-b05d-d246407f7a2f,medical_university_of_innsbruck,Medical University of Innsbruck -3555,,fb79415e-71f8-4943-8fd3-2fbfbef4b697,Salsarulo Pharma,salsarulo_pharma,,,,,, -116,0.94879655043284095,890908c2-1257-446a-a1d5-1de688f7b6d2,Shire Pharmaceutical Development Inc,shire_pharmaceutical_development_inc,,,,63ca73d2-fd68-4693-872c-2121b000d68c,shire_pharmaceutical_development,Shire Pharmaceutical Development -3556,,527ff895-2eae-4b6d-b625-af84e3b8572d,Všeobecná fakultní nemocnice v Praze,v_eobecn_fakultn_nemocnice_v_praze,,,,,, -3557,,655b3afd-fabd-40db-ad30-8b394590ab26,Peterborough and Stamford Hospitals NHS Foundation Trust,peterborough_and_stamford_hospitals_nhs_foundation_trust,,,,,, -3558,,8c07e94c-8c2b-4cae-a84f-5901c9598b2f,"TESARO UK Limited, (c/o Sisec Limited)",tesaro_uk_limited_c_o_sisec_limited,,,,,, -3559,,dc40a8b5-8197-4d7d-a503-8c9068ca6544,Beroendcentrum Stockholm,beroendcentrum_stockholm,,,,,, -3560,,2b36ec6c-8536-4a43-ab91-dd2ae8a89856,PROF. ALFREDO CHETTA,prof_alfredo_chetta,,,,,, -3561,,e51bf8ab-ba0a-4ab2-8b3e-3803f8913ba4,"Urologische Klinik und Poliklinik, Klinikum Großhadern der LMU München",urologische_klinik_und_poliklinik_klinikum_gro_hadern_der_lmu_m_nchen,,,,,, -3562,,41992939-5d76-4653-98d6-1891297fc87c,Universitätsklinikum Ulm (AöR),universit_tsklinikum_ulm_a_r,,,,,, -3563,,6ce4a628-467d-4c32-9759-f3aafb183efe,Norgine Pharma,norgine_pharma,,,,,, -3564,,a321fd62-981d-4e0c-b83d-b56631628040,"RWTH Aachen, Medizinische Fakultät",rwth_aachen_medizinische_fakult_t,,,,,, -3565,,0c5b0ccd-8a8d-45e4-b3df-fca76eebab97,Laboratorios del Dr Esteve S.A,laboratorios_del_dr_esteve_s_a,,,,,, -3566,,9ff9f635-3037-45fe-84bb-83d844700175,Sandwell and West Birmingham Hospitals NHS Trust,sandwell_and_west_birmingham_hospitals_nhs_trust,,,,,, -3567,,003d51f8-70e0-411b-94fd-5281d56c5c9c,Univ. Klinik für Anästhesiologie,univ_klinik_f_r_an_sthesiologie,,,,,, -3568,,ded09bd4-3d9f-446e-ac0f-fd9eedc9edd7,Pierrel Research Europe GmbH,pierrel_research_europe_gmbh,,,,,, -3569,,5c4d14ec-fa70-48bc-b979-fa947dcd715a,co.don AG,co_don_ag,,,,,, -366,0.98152613639831543,17a7c9c8-3636-4a11-a0b2-a237ca2e374e,Bayer Health Care AG,bayer_health_care_ag,,,,17a7c9c8-3636-4a11-a0b2-a237ca2e374e,bayer_health_care_ag,Bayer Health Care AG -3570,,9f5fc2a3-e2fa-4c09-aea8-9e377f2d03a4,"Asubio Pharmaceuticals, Inc",asubio_pharmaceuticals_inc,,,,,, -3571,,08ac6409-e0a2-4fd0-ac08-be68e17f1732,Novartis Pharma Sevices AG,novartis_pharma_sevices_ag,,,,,, -772,0.985698,6faaed46-35f6-404d-9128-03b55daaae47,Abbott GmbH & Co. KG,abbott_gmbh_co_kg,,,,6faaed46-35f6-404d-9128-03b55daaae47,abbott_gmbh_co_kg,Abbott GmbH & Co. KG -3572,,56482c23-5635-489f-bf8b-1d00a2a39596,STZ 1172 Gesundheitsförderung und Stoffwechselforschung,stz_1172_gesundheitsf_rderung_und_stoffwechselforschung,,,,,, -3573,,b37ce0eb-7b4d-4aa4-9ae9-1e6b5d35a435,Dendreon Corporation,dendreon_corporation,,,,,, -3574,,b1ce44b7-22fd-46c0-9b5b-5fd9a515d486,"Ferrer International, SA",ferrer_international_sa,,,,,, -3575,,c8f10cd3-1675-4927-b263-8cc6d18ec8d2,"MUW, Innere Med III, Abt.für Endokrinologie & Stoffwechsel",muw_innere_med_iii_abt_f_r_endokrinologie_stoffwechsel,,,,,, -3576,,898e1916-aef6-4174-8433-fdb4c05e9c66,NV Organon,nv_organon,,,,,, -3577,,dcb296bd-58b9-4362-be48-f28622f1708f,NINDS,ninds,,,,,, -3578,,d3bc185a-ba63-4dc7-95de-d32ad001f80f,Fundacio Clinic per a la recerca biomedica,fundacio_clinic_per_a_la_recerca_biomedica,,,,,, -3579,,d7642547-797b-4a10-92b2-ca0afa0fe821,Neurologische Klinik Bad Neustadt,neurologische_klinik_bad_neustadt,,,,,, -3580,,4d583a06-a059-4dfa-acf3-36f4dda56342,Axovant Sciences Ltd,axovant_sciences_ltd,,,,,, -3581,,4d2b5282-0ddf-4c86-8cc6-29b845ae014f,AININCAR,ainincar,,,,,, -407,0.97863081097602844,a2239364-7b3d-4f3a-af6f-e5452d1b0cf6,"Trius Therapeutics, a Wholly Owned Subsidiary of Cubist Pharmaceuticals, Inc",trius_therapeutics_a_wholly_owned_subsidiary_of_cubist_pharmaceuticals_inc,,,,2313c489-596d-4d80-8c94-aa42d3a2f015,trius_therapeutics_a_wholly_owned_subsidiary_of_cubist,"Trius Therapeutics, a Wholly Owned Subsidiary of Cubist" -87,0.983343,37a68bfe-7148-11e6-a0cd-0242ac12000b,MORTON GROVE PHARMS,morton_grove_pharms,,,,37900e74-7148-11e6-a0cd-0242ac12000b,morton_grove,MORTON GROVE -3582,,91751ae7-d823-4a71-90d7-1a9305a67374,University Hospital of Erlangen,university_hospital_of_erlangen,,,,,, -3583,,117e8327-c077-4248-8024-526045ba8543,Robapharm AG,robapharm_ag,,,,,, -3584,,9071994c-6f5c-4100-9cf4-2cf412eab874,NORDIC BIOSCIENCE,nordic_bioscience,,,,,, -3585,,f8f2d310-73f7-11e6-a0cd-0242ac12000b,LINDE GAS NORTH AMERICA LLC,linde_gas_north_america_llc,,,,,, -686,0.94387978315353394,6a59a49b-a6f0-423a-b72f-c211ebd85c3d,University Medical Center Goettingen,university_medical_center_goettingen,,,,6a59a49b-a6f0-423a-b72f-c211ebd85c3d,university_medical_center_goettingen,University Medical Center Goettingen -3586,,8edc7236-7142-11e6-a0cd-0242ac12000b,PVT FORM,pvt_form,,,,,, -3587,,2298786c-556a-48d6-a94b-045e98dc24b1,"CUB Hôpital Erasme, Department of Anesthesiology",cub_h_pital_erasme_department_of_anesthesiology,,,,,, -3588,,390398d4-0b00-4861-852d-1b99e83bbe96,Queen's Medical centre,queen_s_medical_centre,,,,,, -3589,,c84100f1-f768-4d5c-8d22-7e962f242dc6,"The Multiple Sclerosis Research Group, Department of Clinical Neuroscience",the_multiple_sclerosis_research_group_department_of_clinical_neuroscience,,,,,, -470,0.97350867589314782,e6c53557-058c-4969-833a-fd74ba05abe2,European Group for Blood and Marrow Transplantation (EBMT),european_group_for_blood_and_marrow_transplantation_ebmt,,,,2a4e4a42-e5c4-4da8-8f1f-18343eeb1fbc,european_group_for_blood_and_marrow_transplantation,European Group for Blood and Marrow Transplantation (EMBT) -390,0.97664374113082886,413059c9-efe8-46ed-89b0-70745ccb57a6,Galderma research & Development,galderma_research_development,,,,b5653343-db85-468f-9ea0-a6d1b957afa2,galderma_research_development,Galderma research & Development -418,0.977699,3a88d7e1-4064-447e-a62a-a9900c4f088e,INCYTE,incyte,,,,3a88d7e1-4064-447e-a62a-a9900c4f088e,incyte,INCYTE -712,0.97988840937614441,b5efd841-9b97-4591-a757-2af84a394472,Reckitt Benckiser Healthcare International Limited,reckitt_benckiser_healthcare_international_limited,,,,38c6b681-96aa-439b-8189-1ea1e741e51b,reckitt_benckiser_healthcare_international,Reckitt Benckiser Healthcare International -965,0.981266,ebeb3cd3-dfb5-4770-b59c-1ee248474bce,"Göteborg University, Sect. Psychiatry and Neurochemistry",g_teborg_university_sect_psychiatry_and_neurochemistry,,,,b75dc5c8-3735-4c68-a632-699239b52e79,g_teborg_university_sect_psyhiatry_and_neurochemistry,"Göteborg University, Sect. Psyhiatry and Neurochemistry" -3590,,cf032205-b5f1-4ed8-872a-15c8729daec3,"Medizinische Universität Wien, Univ. Klinik f. Klinische Pharmakologie",medizinische_universit_t_wien_univ_klinik_f_klinische_pharmakologie,,,,,, -3591,,bae3310f-518f-4cde-9f72-3981c8a7bb22,Regensburg University Hospital,regensburg_university_hospital,,,,,, -3592,,0342fbd4-a0db-4f1a-b751-cd229eb9bb9b,"Hospital General ""Gregorio Marañón",hospital_general_gregorio_mara_n,,,,,, -3593,,b8695dd5-485c-422c-8f91-460057752ca2,Boehringer Ingelheim GmbH,boehringer_ingelheim_gmbh,,,,,, -583,0.96693354845046997,a72d6b04-e5e5-483f-9071-b0af00c0a0c2,MSD,msd,,,,a72d6b04-e5e5-483f-9071-b0af00c0a0c2,msd,MSD -981,0.97865206003189087,7924c511-76dd-4819-aff7-6958da1692ce,"Bispebjerg Hospital, Department of Dermatology",bispebjerg_hospital_department_of_dermatology,,,,7924c511-76dd-4819-aff7-6958da1692ce,bispebjerg_hospital_department_of_dermatology,"Bispebjerg Hospital, Department of Dermatology" -3594,,6a8da5f0-538d-4587-87b3-df32aee83389,"Pharmaceutical Research Network, LLC",pharmaceutical_research_network_llc,,,,,, -3595,,d3501790-a74a-4e14-aaf1-13cfe7ecdd53,Mona R Gätke,mona_r_g_tke,,,,,, -3596,,e18c792d-d960-4b09-b31d-aac321919600,Basilea Pharmaceutica Ltd,basilea_pharmaceutica_ltd,,,,,, -3597,,da2d1a59-644f-4cce-844b-4f0a45be1947,"Dept. Ob.Gyn, Univ Oulu",dept_ob_gyn_univ_oulu,,,,,, -3598,,346e223d-1a6a-4984-b186-1c551bc9b345,Ursapharm Arzneimittel GmbH,ursapharm_arzneimittel_gmbh,,,,,, -3599,,a895274e-73f6-49b4-9c4e-cfd03c07f1c9,University of Göttingen, Dep. of Clinical Pharmacology,,,,,, -721,0.98208,01b65e7e-316f-44bb-97c2-362060dad470,TROPHOS,trophos,,,,01b65e7e-316f-44bb-97c2-362060dad470,trophos,TROPHOS -3600,,6b34fbe8-b56f-47c6-a41f-5f1bd7812a70,Clinipace GLobal Ltd,clinipace_global_ltd,,,,,, -3601,,c60ff36b-1ab3-4bf3-959b-ba6ff632b9b5,Astra Zeneca AB,astra_zeneca_ab,university_of_g_ttingen_dep_of_clinical_pharmacology,,,,, -3602,,1ca72f6c-433a-4831-89fd-adeea28b43f0,"Orthopaedic Research Laboratory, Århus University Hospital",orthopaedic_research_laboratory_rhus_university_hospital,,,,,, -3603,,c7e41fa7-4d75-4607-9cdb-dcb1fe40dbf6,AZIENDA OSPEDALIERA ORDINE MAURIZIANO,azienda_ospedaliera_ordine_mauriziano,,,,,, -3604,,87e66e0c-3b29-437b-b867-c8d3de5bc3ba,Central Manchester and Manchester Children's Hospital University NHS Trust,central_manchester_and_manchester_children_s_hospital_university_nhs_trust,,,,,, -3605,,d4d8cdc6-4b0b-4bfc-ac78-7a8db0891c70,ISDIN,isdin,,,,,, -3606,,febd83e8-bc81-4831-88a7-584bbed25731,Alfa Wassermann SpA,alfa_wassermann_spa,,,,,, -3607,,bed52de6-453f-4bbe-903f-a40e8ca6861d,"MERIT MEDICAL SYSTEMS, INC",merit_medical_systems_inc,,,,,, -50,0.902909,b0114826-49b0-41da-9e10-6bec93417396,EUSA pharma SAS,eusa_pharma_sas,,,,098236a3-98ed-47c3-8dcd-a916a201d337,eusa_pharma,EUSA Pharma -3608,,b136b4ed-3af7-48ec-ad9d-c3f3ef41350f,Novartis Pharma B.V,novartis_pharma_b_v,,,,,, -3609,,497dedc6-7de3-4beb-84f8-53c86e9107f5,GERENCIA DE ATENCIÓN PRIMARIA,gerencia_de_atenci_n_primaria,,,,,, -3610,,9da8fcbc-733b-11e6-a0cd-0242ac12000b,BIODELIVERY SCI INTL,biodelivery_sci_intl,,,,,, -3611,,c9bea4e8-f92d-48e5-9618-7a4e24528135,Centre René Gauducheau,centre_ren_gauducheau,,,,,, -3612,,13ad6677-508e-481c-9204-9d6c6273fb0f,FONDAZIONE SANTA LUCIA,fondazione_santa_lucia,,,,,, -3613,,4cf6f811-6752-461e-8db1-e8486b48c280,Araim Pharmaceuticals,araim_pharmaceuticals,,,,,, -168,0.98042827844619751,64386d51-a811-451e-9352-45afeb68a88e,"Merck Serono SA - Geneva, an affiliate of Merck KGaA,",merck_serono_sa_geneva_an_affiliate_of_merck_kgaa,,,,248e9396-0a3f-4ee2-b65a-5844a00bc75e,merck_serono_sa_geneva,Merck Serono SA - Geneva -3614,,3bad19b9-809c-491f-93e9-b833b3f3ad3d,Walton Centre NHS Foundation Trust,walton_centre_nhs_foundation_trust,,,,,, -3615,,266f690e-eb59-4de5-8af5-c13cca34f768,Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud,fundaci_n_p_blica_andaluza_para_la_investigaci_n_de_m_laga_en_biomedicina_y_salud,,,,,, -3616,,8a88db86-5c84-4605-85a1-178cfbeb080e,Greenpark Health Care Trust,greenpark_health_care_trust,,,,,, -3617,,844cd926-3f5a-43c6-9ebc-ae104090ade0,"Uppsala University Hospital, MHT, Department of Nephrology",uppsala_university_hospital_mht_department_of_nephrology,,,,,, -520,0.97626614570617676,da2c7cf7-0913-42b9-90fb-cdba8baae892,ROCHE,roche,,,,da2c7cf7-0913-42b9-90fb-cdba8baae892,roche,ROCHE -3618,,4482db1c-719c-11e6-a0cd-0242ac12000b,AKRIMAX PHARMS,akrimax_pharms,,,,,, -3619,,be358614-a576-4abf-9271-ae913e1e11bb,University of Bristol,university_of_bristol,,,,,, -3620,,22d241f0-715c-11e6-a0cd-0242ac12000b,KUDCO IRELAND,kudco_ireland,,,,,, -3621,,8c85fd94-7161-11e6-a0cd-0242ac12000b,AUXILIUM PHARMS LLC,auxilium_pharms_llc,,,,,, -3622,,2574363f-e64d-4766-a5d6-6a8657dd1edc,Universitäres Herzzentrum Hamburg,universit_res_herzzentrum_hamburg,,,,,, -3623,,24e00e4d-e123-4ee1-a31a-476d4606fbc0,Shionogi Inc,shionogi_inc,,,,,, -3624,,44f6de76-03d9-480e-a29d-390e5eb68c0d,University of Saarland,university_of_saarland,,,,,, -3625,,6246d8b9-7f90-494b-b703-42ba2ae22d23,Charité University Medicine,charit_university_medicine,,,,,, -3626,,11d76cd6-a8ec-4e63-8df1-75115f5b5a14,Bayer Healthcare LLC,bayer_healthcare_llc,,,,,, -3627,,bb32ffb9-a803-4a8d-bdde-509bcb189da2,Centre Oscar Lambret,centre_oscar_lambret,,,,,, -3628,,0447e916-4e9a-4d71-b01a-429f4d463731,Cambridge University Hospital NHS Foundation Trust,cambridge_university_hospital_nhs_foundation_trust,,,,,, -3629,,9db80b71-14a2-4709-b7b5-d67b5c1ea73d,Dr. Juan Jesús Gómez-Reino Carnota,dr_juan_jes_s_g_mez_reino_carnota,,,,,, -3630,,cb35fff2-700c-4c06-bd17-5e27af3b69c1,JESUS GONZALEZ BARBOTEO,jesus_gonzalez_barboteo,,,,,, -602,0.988116,cf2f842c-f2cd-4905-96b8-12fcfaeb3ea9,Syndax Pharmaceuticals Inc,syndax_pharmaceuticals_inc,,,,cf2f842c-f2cd-4905-96b8-12fcfaeb3ea9,syndax_pharmaceuticals_inc,Syndax Pharmaceuticals Inc -3631,,c4b88c6e-7165-11e6-a0cd-0242ac12000b,INVENTIA HLTHCARE,inventia_hlthcare,,,,,, -3632,,2317b349-a864-4a49-bc5d-f971b5c7b2c0,Ergonex Pharma GmbH,ergonex_pharma_gmbh,,,,,, -3633,,de7a851e-6311-4424-bdb4-5cb9b0990115,Lunamed Operations AG,lunamed_operations_ag,,,,,, -3634,,afe64e7c-788a-4194-923e-66b108a54ced,Institut Sainte Catherine,institut_sainte_catherine,,,,,, -3635,,b347393d-46d2-4033-bb7c-2ea12cbd08f6,OraPharma Inc,orapharma_inc,,,,,, -8,0.90233862400054932,2522451a-1c66-4b28-bcf5-7bcf3f2f11b8,Centre Hospitalier Universitaire de Saint-Etienne,centre_hospitalier_universitaire_de_saint_etienne,,,,2522451a-1c66-4b28-bcf5-7bcf3f2f11b8,centre_hospitalier_universitaire_de_saint_etienne,Centre Hospitalier Universitaire de Saint-Etienne -437,0.99035966396331787,a9a77d6a-a71d-48c7-993a-d57932d81ec2,"Pfizer Inc. 235 East 42nd Street, New York, 10017 USA",pfizer_inc_235_east_42nd_street_new_york_10017_usa,,,,8f1c3548-7a20-4796-a59b-3b727921d4f1,pfizer_inc_235_east_42nd_street_new_york_10017_us,"Pfizer Inc. 235 East 42nd Street, New York, 10017 US" -3636,,26238b0a-a8aa-4f46-99f0-fe278fcb367b,IRCCS- Mario Negri Institute,irccs_mario_negri_institute,,,,,, -3637,,ad249728-f74c-4dd3-855a-ddf493a6ba0e,Oncology Institute of Vilnius University,oncology_institute_of_vilnius_university,,,,,, -144,0.938386,26bb805d-b0a7-4b5c-bcee-c5480afe6696,Joint UCLH & UCL Biomedical Research Unit,joint_uclh_ucl_biomedical_research_unit,,,,26bb805d-b0a7-4b5c-bcee-c5480afe6696,joint_uclh_ucl_biomedical_research_unit,Joint UCLH & UCL Biomedical Research Unit -3638,,8a0fe414-b8b9-4987-b3d9-4a2a59ec77d4,Jari Tiihonen,jari_tiihonen,,,,,, -932,0.98627001047134399,2bfd78d4-7d7c-4e8a-84f2-b5f057dd988e,Pierre Fabre Médicament/Institut de Recherche Pierre Fabre,pierre_fabre_m_dicament_institut_de_recherche_pierre_fabre,,,,11113f5a-7350-422c-bd14-c920aa2332af,pierre_fabre_medicament_institut_de_recherche_pierre_fabre,Pierre Fabre Medicament/Institut de Recherche Pierre Fabre -770,0.984713,ec667aae-71ca-11e6-a0cd-0242ac12000b,DELCOR ASSET,delcor_asset,,,,1a3a35f8-7142-11e6-a0cd-0242ac12000b,delcor_asset_corp,DELCOR ASSET CORP -3639,,381c0626-a816-4104-83a5-496ccaa1ca10,"AstraZeneca AB; Karlebyhus, Astraallén, Södertälje SE-151 85, Sweden",astrazeneca_ab_karlebyhus_astraall_n_s_dert_lje_se_151_85_sweden,,,,,, -3640,,811140e3-7421-4526-9c54-46992f382dc8,Máxima Medisch Centrum,m_xima_medisch_centrum,,,,,, -228,0.908956,71bfef34-9b92-45f4-b0bf-ace9ff180a19,St. George's University of London (SGUL),st_george_s_university_of_london_sgul,,,,67f8d943-3794-4830-beba-23b1e4232b8d,st_george_s_university_of_london,"St. George's, University of London" -3641,,13fcbae8-7157-11e6-a0cd-0242ac12000b,KV PHARM,kv_pharm,,,,,, -3642,,07665300-0a32-44f3-b4c4-ffc6dfddce12,The Royal Marsden Foundation Trust and The Institute of Cancer Research,the_royal_marsden_foundation_trust_and_the_institute_of_cancer_research,,,,,, -3643,,c113db7c-7197-11e6-a0cd-0242ac12000b,AQUA PHARMS,aqua_pharms,,,,,, -3644,,6f342e64-095a-4f8b-906d-5bdfdfde2f56,"Medizinische Universität Wien, Univ.Klinik KIM II, Abteilung für Kardiologie",medizinische_universit_t_wien_univ_klinik_kim_ii_abteilung_f_r_kardiologie,,,,,, -3645,,537d652f-ae82-4ad4-915d-2bb5462ca14b,Guillem Cuatrecasas Cambra,guillem_cuatrecasas_cambra,,,,,, -3646,,0efb46cc-5369-4941-9185-9c169b46876f,TRBChemedica,trbchemedica,,,,,, -3647,,60444226-7e5f-4583-bbc0-7aa0a84e7df5,Pilar Samper Ots,pilar_samper_ots,,,,,, -512,0.976744,0d23d029-d573-4d0e-aaab-1b66e6a0fd64,"Novartis Farmacéutuca, S.A",novartis_farmac_utuca_s_a,,,,0d23d029-d573-4d0e-aaab-1b66e6a0fd64,novartis_farmac_utuca_s_a,"Novartis Farmacéutuca, S.A" -13,0.97626614570617676,24b88c8e-7145-11e6-a0cd-0242ac12000b,LUPIN LTD,lupin_ltd,,,,24b88c8e-7145-11e6-a0cd-0242ac12000b,lupin_ltd,LUPIN LTD -3648,,b3a8938f-3a61-47c6-ad6e-f81cf9ddd2b3,"bluebird bio, Inc",bluebird_bio_inc,,,,,, -3649,,8853143a-7145-11e6-a0cd-0242ac12000b,QUANTUM PHARMICS,quantum_pharmics,,,,,, -843,0.970735,95284310-8707-4697-ae32-b0baf209234a,Rikshospitalet,rikshospitalet,,,,759e05f5-7472-4ddb-baa8-c26f62d421d9,rikshospitalet_university_hospital_university_of_oslo,"Rikshospitalet University Hospital, University of Oslo" -3650,,86e0dbc2-353a-4853-90df-f26a640c72ca,Fundación Centro Nacional de Investigaciones Oncológicas Carlos III (CNIO),fundaci_n_centro_nacional_de_investigaciones_oncol_gicas_carlos_iii_cnio,,,,,, -3651,,323fd28f-0379-4cd4-abea-90066fc67253,"Med. Uni. Wien, Klinik für Innere I",med_uni_wien_klinik_f_r_innere_i,,,,,, -3652,,6bd05c85-7e1e-4e34-8ef5-3ecc455755ca,FORIM GmbH,forim_gmbh,,,,,, -3653,,478a6472-af44-40c3-b140-def42b50028d,infirst HEALTHCARE,infirst_healthcare,,,,,, -238,0.95441973209381104,3438eb84-9448-480b-915c-1c1511546785,"Pfizer Limited, Ramsgate Road,Sandwich,Kent CT13 9NJ",pfizer_limited_ramsgate_road_sandwich_kent_ct13_9nj,,,,3438eb84-9448-480b-915c-1c1511546785,pfizer_limited_ramsgate_road_sandwich_kent_ct13_9nj,"Pfizer Limited, Ramsgate Road,Sandwich,Kent CT13 9NJ" -3654,,3bb91b23-23b2-4262-a95c-82f7c214cca6,OptiNose UK Ltd,optinose_uk_ltd,,,,,, -3655,,38d2f88c-e5be-4d6f-9900-947d51ad8c6f,Protherics Development Medicines Ltd,protherics_development_medicines_ltd,,,,,, -3656,,054d5114-4292-4f30-82de-52f705161eca,Dr. César Sánchez Sánchez,dr_c_sar_s_nchez_s_nchez,,,,,, -3657,,8ef2af5e-eae9-4f66-97f9-445130c27bfd,Nutrim,nutrim,,,,,, -3658,,3b4e1ce8-592c-4829-a834-8ffadcd23700,"R and D Department, Cardiff and the Vale NHS Trust",r_and_d_department_cardiff_and_the_vale_nhs_trust,,,,,, -3659,,8d1afdaa-b1e6-4d79-a74f-7033246b21d7,Respiratory and Allergy Research Unit,respiratory_and_allergy_research_unit,,,,,, -3660,,cf105247-9a58-417a-a14b-5cad311471a6,"Janssen Oncology, Inc",janssen_oncology_inc,,,,,, -71,0.95618447661399841,a50a5323-eb43-4b40-8b80-cb222451e80b,Takeda Europe R&D Center Ltd,takeda_europe_r_d_center_ltd,,,,a50a5323-eb43-4b40-8b80-cb222451e80b,takeda,Takeda -3661,,fa72803a-8812-11e6-a998-0242ac12000b,Nordion (Canada) Inc,nordion_canada_inc,,,,,, -3662,,cd52695e-2ffe-44bc-af6c-ecc5d5764c24,Fundación Universidad de Salamanca,fundaci_n_universidad_de_salamanca,,,,,, -3663,,bbb44c51-68bc-4c32-bafb-c06795cee0d8,Allergy Centre,allergy_centre,,,,,, -865,0.987308,98172a5d-4f63-4af5-97a8-b1a01d9344ff,United Therapeutics Corporation,united_therapeutics_corporation,,,,98172a5d-4f63-4af5-97a8-b1a01d9344ff,united_therapeutics_corporation,United Therapeutics Corporation -1043,0.987372,6441853c-c50a-4eeb-acbc-a29226d17b89,University of Oxford,university_of_oxford,,,,6441853c-c50a-4eeb-acbc-a29226d17b89,university_of_oxford,University of Oxford -703,0.96583342552185059,09b03690-5970-415f-b749-e56be3b9df7b,University Hospitals Leicester NHS Trust,university_hospitals_leicester_nhs_trust,,,,09b03690-5970-415f-b749-e56be3b9df7b,university_hospitals_leicester_nhs_trust,University Hospitals Leicester NHS Trust -3664,,ae95f75c-6fba-11e6-abe8-0242ac12000b,"Department of Obstetrics and Gynaecology, Karolinska Institutet, Stockholm",department_of_obstetrics_and_gynaecology_karolinska_institutet_stockholm,,,,,, -3665,,d8fcd4a1-3be3-440b-87f0-2252e0d4226e,"Medical Sciences, Akademiska sjukhuset",medical_sciences_akademiska_sjukhuset,,,,,, -3666,,1e687fb0-bf61-4974-bda7-502db084c8a7,NHS Greater Glasgow Health Board,nhs_greater_glasgow_health_board,,,,,, -767,0.9821459949016571,d8f5d26d-62e1-49bb-a07d-419a89e892b6,"Medizinische Universität Innsbruck, Innere Medizin VI",medizinische_universit_t_innsbruck_innere_medizin_vi,,,,da4cbdf9-e1bc-4412-95a2-1df2b8781a19,medizinische_universit_t_innsbruck_innere_medizin_v,Medizinische Universität Innsbruck -952,0.98418444395065308,037d47ba-7142-11e6-a0cd-0242ac12000b,MYLAN LABS LTD,mylan_labs_ltd,,,,037d47ba-7142-11e6-a0cd-0242ac12000b,mylan_labs_ltd,MYLAN LABS LTD -3667,,e285a91b-4e04-4750-acc8-d333c500d7c2,"Dept. of Pediatric hematology and oncology, Astrid Lindgren Children´s Hosp,Karolinska Univ Hospital",dept_of_pediatric_hematology_and_oncology_astrid_lindgren_children_s_hosp_karolinska_univ_hospital,,,,,, -3668,,66e86de4-0184-485d-841c-8ae5cd13d216,Meditop Pharmaceuticals Co. Ltd,meditop_pharmaceuticals_co_ltd,,,,,, -507,0.986912,ef8114da-7128-11e6-a89e-0242ac12000b,HI TECH PHARMA,hi_tech_pharma,,,,2d581c28-7141-11e6-a0cd-0242ac12000b,hi_tech_pharma_co,HI TECH PHARMA CO -3669,,81bfbdf3-9b56-44b2-a9c6-1cb3886af6e6,Maastriccht University,maastriccht_university,,,,,, -3670,,418a8e89-c203-4eda-ae9a-bdc8a3c6ecfa,GENERICS [UK] Ltd,generics_uk_ltd,,,,,, -3671,,dbaae7a6-3c03-4978-88c6-d514927dd8fa,"St. Vincents University Hospital, Department of Rheumatology",st_vincents_university_hospital_department_of_rheumatology,,,,,, -3672,,d1bb101c-6dac-41e4-9637-36bc6ef8c3a4,"Universitätsklinik für Augenheilkunde und Optometrie, Medizinische Universität Innsbruck",universit_tsklinik_f_r_augenheilkunde_und_optometrie_medizinische_universit_t_innsbruck,,,,,, -3673,,4db0c1be-5d3d-47a7-8b3a-29e0d7060374,TYKS,tyks,,,,,, -3674,,9e105726-ba7e-4291-8cc6-9b6767248ab4,Allerderm,allerderm,,,,,, -3675,,aa0e7014-a5c9-45dc-b3ad-03f9266b812b,DR. JOAQUIM BELLMUNT MOLINS,dr_joaquim_bellmunt_molins,,,,,, -3676,,a35deaa3-8451-4760-90e0-a5895f1461e8,Department of Health,department_of_health,,,,,, -3677,,0b509dff-6ec1-4725-ab2d-06527b434d0b,MedPointe Pharmaceuticals,medpointe_pharmaceuticals,,,,,, -279,0.98237490653991699,7fdce817-2c7a-48bf-9fea-ccc1bb736300,Royal Liverpool and Broadgreen University Hospitals NHS Trust,royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,,,,7fdce817-2c7a-48bf-9fea-ccc1bb736300,royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,Royal Liverpool and Broadgreen University Hospitals NHS Trust -3678,,f203b3f6-96db-11e6-becf-0242ac110008,IRONWOOD PHARMS INC,ironwood_pharms_inc,,,,,, -3679,,77a224a0-715e-11e6-a0cd-0242ac12000b,SPERTI,sperti,,,,,, -3680,,5e5ad6f7-91ab-4d5a-8b42-702576a77d3d,Martina Hansens Hospital,martina_hansens_hospital,,,,,, -3681,,4f630c3f-86f7-45c5-9c0b-3a54fede87cf,"Copenhagen University Hospital Rigshospitalet, The Heart Center - Department of Thoracic Surgery",copenhagen_university_hospital_rigshospitalet_the_heart_center_department_of_thoracic_surgery,,,,,, -3682,,856249df-0f6a-4f77-97f8-93801fe609db,"ISTITUTO NEUROLOGICO ""CARLO BESTA",istituto_neurologico_carlo_besta,,,,,, -3683,,a2fb9301-4a66-44a2-bec0-cd23c36480c5,GlaxoSmithKline Consumer Healthcare,glaxosmithkline_consumer_healthcare,,,,,, -3684,,490c7139-d418-44c6-9062-545879ab9a88,Greater Glasgow NHS Health Board / University of Glasgow co-sponsorship,greater_glasgow_nhs_health_board_university_of_glasgow_co_sponsorship,,,,,, -3685,,16f2055b-7dd5-4672-a859-471fd1ff8338,OxyPharma AB,oxypharma_ab,,,,,, -3686,,518256cb-1a70-4d94-bb20-ff3c587153ec,Berufsverband der niedergelassenen gynäkologischen Onkologen in Deutschland e.V., BNGO e.V,,,,,, -3687,,1781ac6a-5bea-4b74-b429-cabf29dfe593,Heli Leppikangas,heli_leppikangas,,,,,, -3688,,cee0a0ca-3864-41ab-b98e-c35513cf7540,Cirugía General II. Hospital General Universitario “Gregorio Marañón”,cirug_a_general_ii_hospital_general_universitario_gregorio_mara_n,,,,,, -3689,,91cd6e5e-71d9-11e6-a0cd-0242ac12000b,SYMPLMED PHARMS LLC,symplmed_pharms_llc,berufsverband_der_niedergelassenen_gyn_kologischen_onkologen_in_deutschland_e_v_bngo_e_v,,,,, -3690,,f5105f9b-de31-4357-9bdd-59a3a2b655fb,Dutch-Belgian Cooperative Trial Group for Hematology Oncology,dutch_belgian_cooperative_trial_group_for_hematology_oncology,,,,,, -3691,,a1252940-7167-11e6-a0cd-0242ac12000b,DAEWOONG PHARM CO,daewoong_pharm_co,,,,,, -3692,,ad68ce36-6f9c-11e6-9663-0242ac12000b,McMaster University,mcmaster_university,,,,,, -317,0.985423,bb5abdb4-7141-11e6-a0cd-0242ac12000b,X-GEN PHARMS,x_gen_pharms,,,,ab7dfa68-7165-11e6-a0cd-0242ac12000b,x_gen_pharms_inc,X-GEN PHARMS INC -3693,,511c3d3f-bfe5-4066-bd28-e5074b82db0b,Chelsea Therapeutics Inc,chelsea_therapeutics_inc,,,,,, -3694,,d7b30c4b-9dfd-4d80-9711-67d4fb72fe7f,Foundation for Liver Research,foundation_for_liver_research,,,,,, -3695,,e454af36-e2fb-4b09-b0ba-9cfd434d8cee,Instituto Universitario IVI Valencia,instituto_universitario_ivi_valencia,,,,,, -704,0.963353,1f3f3cc7-8eba-4207-b34d-93cf7f7e8099,Profil Institut für Stoffwechselforschung GmbH,profil_institut_f_r_stoffwechselforschung_gmbh,,,,0fbda7a2-0e8a-489e-b902-fd13c5dec4c2,profil_institut_fuer_stoffwechselforschung_gmbh,Profil Institut fuer Stoffwechselforschung GmbH -504,0.91995066404342651,122b0a51-3453-4c2b-9161-369319d68912,"Sanofi-Synthelabo Recherche, a subsidiary of sanofi-aventis group",sanofi_synthelabo_recherche_a_subsidiary_of_sanofi_aventis_group,,,,122b0a51-3453-4c2b-9161-369319d68912,sanofi_synthelabo_recherche_a_subsidiary_of_sanofi_aventis_group,"Sanofi-Synthelabo Recherche, a subsidiary of sanofi-aventis group" -3696,,09b056fd-8710-4acd-ba1a-7d1c351ecb1a,University Hospital of Montpellier,university_hospital_of_montpellier,,,,,, -3697,,b9464f4b-b64f-4a72-b066-89745be78215,FUNDACION PARA LA INVESTIGACION CV HOSPITAL DR. PESET,fundacion_para_la_investigacion_cv_hospital_dr_peset,,,,,, -3698,,af51a734-aee4-4d2f-85a5-0e0ba812f810,"Hospital of the University of Munich, Grosshadern",hospital_of_the_university_of_munich_grosshadern,,,,,, -3699,,805f4ca3-d740-4202-898a-7c2ed74dce40,NeuroSearch A/S,neurosearch_a_s,,,,,, -3700,,cc6f90aa-7292-11e6-a0cd-0242ac12000b,TOLMAR THERAP,tolmar_therap,,,,,, -3701,,52ead9c3-074c-48a8-b4fb-1502ac263979,"Herlev Hospital, Department of Anaesthesiology I65N9",herlev_hospital_department_of_anaesthesiology_i65n9,,,,,, -3702,,c2bc2e59-d055-45a9-8668-78d4fcd1c7c0,UCB PHARMA SA/NV,ucb_pharma_sa_nv,,,,,, -3703,,64b49f9e-08e1-4d4c-8012-8c6693493f60,Institut Pasteur,institut_pasteur,,,,,, -157,0.94729951024055481,070bfa42-6fbd-11e6-abe8-0242ac12000b,"Medizinische Universität Wien, Univ.Klinik fuer Dermatologie",medizinische_universit_t_wien_univ_klinik_fuer_dermatologie,,,,f215164e-8e75-4f48-b691-ea2bfd10d042,medizinische_universit_t_wien_univ_klinik_f_r_dermatologie,"Medizinische Universität Wien, Univ. Klinik für Dermatologie" -560,0.97196030616760254,b8fa6088-d9e1-440f-94ee-dcefdd7542f6,UZ Leuven,uz_leuven,,,,069a9622-502b-4a08-9b02-c54aa4d2410f,uz_leuven_orthopedic_research,UZ Leuven Orthopedic research -3704,,ce8e426a-c2df-4b95-82b0-fcef7314c84c,Beroendecentrum Stockholm,beroendecentrum_stockholm,,,,,, -3705,,fcdecd49-0d4a-4ed8-9af1-988acf33b3dc,Maasstad Hospital,maasstad_hospital,,,,,, -129,0.96335113048553467,9bdf307c-38db-4038-96d5-79c3a5a0ebd1,Cliniques Universitaire St Luc,cliniques_universitaire_st_luc,,,,4bc32527-accc-401e-81cd-afaacbe32d0c,cliniques_universitaires_st_luc,Cliniques Universitaires St Luc -3706,,7fb912ee-28f7-425e-a9be-af87838ce1ce,INSTITUT BERGONIE,institut_bergonie,,,,,, -3707,,444a911e-719f-11e6-a0cd-0242ac12000b,DAVIS AND GECK,davis_and_geck,,,,,, -3708,,c529bc17-67b9-43be-81b1-42a4f14efb95,University of Warwick,university_of_warwick,,,,,, -3709,,d0742ee3-b129-4fc6-827e-c978f8a95c1d,"Beaufour Ipsen Pharma - 24, rue Erlanger 75016 Paris FRANCE",beaufour_ipsen_pharma_24_rue_erlanger_75016_paris_france,,,,,, -3710,,23250fbb-c38b-4a66-a36c-23a5931e5b7d,"Hjertemedicinsk klinik B, 2142, Rigshospitalet",hjertemedicinsk_klinik_b_2142_rigshospitalet,,,,,, -628,0.980402,637afab2-e42f-4094-b3b3-6cf50354727c,Queen's University Belfast,queen_s_university_belfast,,,,637afab2-e42f-4094-b3b3-6cf50354727c,queen_s_university_belfast,Queen's University Belfast -3711,,07efb3b2-a6a0-11e6-b9d4-0242ac12000b,"Dep. Nuclear medicine, Odense university hospital",dep_nuclear_medicine_odense_university_hospital,,,,,, -423,0.97237,a1ffae4a-fb57-43b0-9da3-56acbdfdf439,Universita' di Firenze, Dipartimento di Farmacologia Preclinica e Clinica,,,,0879f869-1102-4898-99d9-8197e98473d7,universita_di_firenze,Universita di Firenze -372,0.969108,24923580-c2a6-4b1d-955c-8c39f4256096,GELA,gela,,,,24923580-c2a6-4b1d-955c-8c39f4256096,gela,GELA -3712,,2a2c633f-94e9-4b12-982b-73d9ec972852,GBG Forschungsgesellschaft mbH,gbg_forschungsgesellschaft_mbh,,,,,, -3713,,228871e8-3cfe-44a3-85ff-6bae485bc072,East Sussex NHS Trust,east_sussex_nhs_trust,universita_di_firenze_dipartimento_di_farmacologia_preclinica_e_clinica,,,,, -3714,,b9ac1258-7ccb-4996-9014-905fe54127a7,Septodont,septodont,,,,,, -3715,,0e409f02-8d4c-44d3-b092-5b684492c91d,AZIENDA OSPEDALIERA CARDARELLI,azienda_ospedaliera_cardarelli,,,,,, -3716,,ebc6d0bc-dc2b-463d-978a-fe7fbcd1cda9,GlaxoSmithKline Resaearch and Development Ltd,glaxosmithkline_resaearch_and_development_ltd,,,,,, -3717,,7442c6ac-7168-11e6-a0cd-0242ac12000b,TIGER PHARMS LLC,tiger_pharms_llc,,,,,, -812,0.970088,37aa2406-dfec-4b12-bbb7-09f94b8adbf5,Universitätsklinik für Psychiatrie und Psychotherapie I,universit_tsklinik_f_r_psychiatrie_und_psychotherapie_i,,,,37aa2406-dfec-4b12-bbb7-09f94b8adbf5,universit_tsklinik_f_r_psychiatrie_und_psychotherapie_i,Universitätsklinik für Psychiatrie und Psychotherapie I -3718,,08586545-0c1f-4747-ac5e-e99252b52296,Dr. Carlos Serra,dr_carlos_serra,,,,,, -3719,,168e5596-0295-4c9c-8b1c-61e7b6491975,Dutch Childhood Oncology Group,dutch_childhood_oncology_group,,,,,, -3720,,3a19c7d5-85db-47f3-a6fe-ed9d030bb394,Asociación de Oncología Médica del Hospital de Cruces (ASONMEC),asociaci_n_de_oncolog_a_m_dica_del_hospital_de_cruces_asonmec,,,,,, -204,0.98671889305114746,e77923f8-3c50-4c19-aba2-8104ed582c2e,Institut de Recerca HSCSP,institut_de_recerca_hscsp,,,,e77923f8-3c50-4c19-aba2-8104ed582c2e,institut_de_recerca_hscsp,Institut de Recerca HSCSP -3721,,4e1a9c38-3282-494f-94fc-7731028c7df8,"Cardiovascular laboratory 2014, Rigshospitalet",cardiovascular_laboratory_2014_rigshospitalet,,,,,, -625,0.96852,d89e6689-270a-4db7-8b4b-2d4dbdb3e6ad,Dresden Universtity of Technology,dresden_universtity_of_technology,,,,05cdfe1b-418a-44a0-bab7-0a07fc861fd4,dresden_university_of_technology,Dresden University of Technology -3722,,b69ae7ef-b9a8-457a-9988-25fc82e0490b,Fundación para el Progreso de la Oncología en Cantabria,fundaci_n_para_el_progreso_de_la_oncolog_a_en_cantabria,,,,,, -247,0.95151522755622864,a19c66db-634c-448b-94e4-f87b6c870ef2,Hoffmann-La Roche AG,hoffmann_la_roche_ag,,,,5796905e-d697-4a3c-a2d1-98d6d9104b0c,hoffmann_la_roche,Hoffmann-La Roche -126,0.985655,5760d01f-a672-4d09-ab67-83a15c2d8903,Clinical Trials and Research Governance,clinical_trials_and_research_governance,,,,5760d01f-a672-4d09-ab67-83a15c2d8903,clinical_trials_and_research_governance,Clinical Trials and Research Governance -3723,,5c441ce6-e855-47e7-ae83-96a01fcfbe3e,Carlos Fernandez Galvan,carlos_fernandez_galvan,,,,,, -993,0.98589098453521729,c9185e1d-9928-4fba-b5da-60e24c1d7520,GE Healthcare Srl,ge_healthcare_srl,,,,97e04c3e-2469-47b3-aea0-8522c32303ca,ge_healthcare,GE Healthcare -3724,,55ebc98a-6f9f-11e6-9663-0242ac12000b,Boehringer Ingelheim Pharma Ellas AE,boehringer_ingelheim_pharma_ellas_ae,,,,,, -3725,,8c016273-05a4-4697-9342-f6631f5b4195,Sociedad Española de retina y Vítreo,sociedad_espa_ola_de_retina_y_v_treo,,,,,, -3726,,6d27ba3a-dfde-4bd2-bcbd-bae9af25612e,Angion Biomedica Corp,angion_biomedica_corp,,,,,, -3727,,556e17c0-8e05-4b55-8f5c-3520d5c8fde1,MIGUEL CASARES FERNÁNDEZ-ALVÉS,miguel_casares_fern_ndez_alv_s,,,,,, -3728,,15f01007-ac72-4345-8150-f51f9072bb2b,Great Ormond Street Hospital Hospital for Children NHS Foundation Trust,great_ormond_street_hospital_hospital_for_children_nhs_foundation_trust,,,,,, -675,0.95572340488433838,0db50825-cbd9-4ba0-9b70-46c1d448c066,UCB Pharma SA,ucb_pharma_sa,,,,0db50825-cbd9-4ba0-9b70-46c1d448c066,ucb_pharma,UCB Pharma -3729,,94a9d7ca-00d5-4ae6-b8ca-44e74cd69519,Dr Moya Mur,dr_moya_mur,,,,,, -3730,,566cec73-8e06-4476-9174-3753aa7863a0,Maria Victoria Ruiz Arzalluz,maria_victoria_ruiz_arzalluz,,,,,, -3731,,fa49fbce-b1a9-4f72-a1e1-7674b559d82d,"Digestive Disease Center, Bispebjerg Hospital",digestive_disease_center_bispebjerg_hospital,,,,,, -3732,,cb676930-7600-4a09-b2df-5a7abbb8b53f,Servier S.L,servier_s_l,,,,,, -273,0.98508751392364502,c5ef1964-06f4-433a-9a38-37d97c703417,Uppsala University,uppsala_university,,,,22571e3f-0745-4cea-b1ca-5cc32ff5e911,uppsala_university_hospital,Uppsala University Hospital -3733,,3e451ca8-0fd6-42a5-9c21-6b541c81685a,"Sucampo Pharma Americas, LLC",sucampo_pharma_americas_llc,,,,,, -3734,,ce02a7fc-e5cb-4541-8543-efa0bf0a6e6a,"Theravance Biopharma R&D, Inc",theravance_biopharma_r_d_inc,,,,,, -3735,,55e355f2-34c8-482b-b291-c5f01b018e63,Richter Gedeon Vegyészeti Gyár Rt,richter_gedeon_vegy_szeti_gy_r_rt,,,,,, -3736,,24a49a37-dd66-4316-978b-c9bd178153c5,"Klinik für Dermatologie, Venerologie und Allergologie; Charité - Universitätsmedizin Berlin",klinik_f_r_dermatologie_venerologie_und_allergologie_charit_universit_tsmedizin_berlin,,,,,, -3737,,fadb627b-3941-45a4-96f1-00c0eb0a558d,Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung SAKK,schweizerische_arbeitsgemeinschaft_f_r_klinische_krebsforschung_sakk,,,,,, -3738,,e1d7f79d-4a8a-471f-b9b8-532cf50d50e1,Koningin Wilhelmina Fonds,koningin_wilhelmina_fonds,,,,,, -3739,,38379167-228f-4321-b7f2-1df09aa63e69,"Cubist Pharmaceuticals, a wholly owned subsidiary of Merck & Co., Inc",cubist_pharmaceuticals_a_wholly_owned_subsidiary_of_merck_co_inc,,,,,, -102,0.98334300518035889,a08b16f4-afc3-483a-9911-a1f8bd577fc9,KU Leuven,ku_leuven,,,,2eb3e3c9-b195-488e-a7df-a29b241b8d60,ku_leuven_lrd,KU Leuven LRD -3740,,fb1d8d42-5c8d-4ab9-aad1-bc2ebb6f9fc3,"University Medical Center Groningen, dept. of Cardiology",university_medical_center_groningen_dept_of_cardiology,,,,,, -3741,,444b21aa-09c6-4ba0-8f9c-df0162d7a32d,"Fujisawa Healthcare, Inc",fujisawa_healthcare_inc,,,,,, -3742,,c79544d8-ceb6-415c-b110-941cbac7061f,"Clinic for Thoracic and Cardiovascular Surgery, Heart Centre North Rhine-Westfalia",clinic_for_thoracic_and_cardiovascular_surgery_heart_centre_north_rhine_westfalia,,,,,, -3743,,a5efd050-714f-11e6-a0cd-0242ac12000b,PHARMASCIENCE INC,pharmascience_inc,,,,,, -3744,,31961bc2-a14f-4b66-b96c-f9fa77d1e967,Papworth Hospital NHS Foundation Trust - Research and Development Department,papworth_hospital_nhs_foundation_trust_research_and_development_department,,,,,, -60,0.96424932139260433,c8a30c78-c8e4-4118-918e-9c02cdd93d00,Wyeth Research Division on Wyeth Pharmaceuticals Inc,wyeth_research_division_on_wyeth_pharmaceuticals_inc,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc -3745,,049689d2-d11e-4313-9178-d8b2259430fa,Caprion Pharmaceuticals Inc,caprion_pharmaceuticals_inc,,,,,, -1049,0.97674435377120972,3abc546a-5bd3-4194-a602-f5d74f7521a8,University Hospital Zurich,university_hospital_zurich,,,,3abc546a-5bd3-4194-a602-f5d74f7521a8,university_hospital_zurich,University Hospital Zurich -3746,,83978724-7167-11e6-a0cd-0242ac12000b,LIAONING CHENGDA,liaoning_chengda,,,,,, -3747,,59c7588d-1945-478f-bdfc-4fa5fb0b42be,SOTIO a.s,sotio_a_s,,,,,, -313,0.97091636061668396,67dc8352-af91-4bf9-8f74-dd730e4e18fc,GlaxoSmithKline Biologicals SA,glaxosmithkline_biologicals_sa,,,,d94a5eb6-cc98-4004-a7a3-95cf39383b18,glaxosmithkline_biologicals,GlaxoSmithKline Biologicals -3748,,cf9bdda5-ee9b-4403-adee-0324db1d6cd8,gepepharm GmbH,gepepharm_gmbh,,,,,, -3749,,df52c7dc-9ade-4e7b-b88c-2b8fcc01a143,PSKS,psks,,,,,, -3750,,3882c844-62b2-4a40-84b8-8d05e4083fd0,Fibrex Medical Research & Development GmbH,fibrex_medical_research_development_gmbh,,,,,, -337,0.98108,a0104195-a7e1-11e6-94cb-5656d04fc2b5,Ortopædkirurgisk afdeling Odense Universitetshospital,ortop_dkirurgisk_afdeling_odense_universitetshospital,,,,16be4521-35a5-4873-a0cc-3401b5169c7e,ortop_dkirurgisk_afdeling,Ortopædkirurgisk afdeling -3751,,37e92e2e-747e-48c1-90fe-148c750c809a,Dr. José Luis Fernández Trisac,dr_jos_luis_fern_ndez_trisac,,,,,, -3752,,f7fd6bcb-50b8-4f67-99c2-5c4e1162616e,"Cytokinetics, Inc",cytokinetics_inc,,,,,, -3753,,3e38d6a1-d0f4-497b-bfa0-8553c50cf5ea,Merck Serono SA International,merck_serono_sa_international,,,,,, -3754,,321735bc-9709-4802-9a13-5266db2050eb,STELIC INSTITUTE & CO,stelic_institute_co,,,,,, -3755,,82a3957f-ca60-4c8b-8740-79cf85b97f70,Dutch Cancer Society,dutch_cancer_society,,,,,, -3756,,b62e22fd-c3c3-4a02-b5ad-fbff2384a61c,Mundipharma Comm VA,mundipharma_comm_va,,,,,, -3757,,894b8c2b-f5d9-44b7-afb3-c43489645ab8,Heidelberg Pharma GmbH,heidelberg_pharma_gmbh,,,,,, -3758,,bc7e33c4-7141-11e6-a0cd-0242ac12000b,ACCELRX LABS,accelrx_labs,,,,,, -3759,,18460daf-dcca-4f3c-944c-6702d4f040be,Cholnoky F. County Hospital Veszprém Department of Ophthalmology,cholnoky_f_county_hospital_veszpr_m_department_of_ophthalmology,,,,,, -3760,,697cfaa8-36ec-4dc5-84fa-7da85d079af3,Servicio Madrileño de Salud (SERMAS),servicio_madrile_o_de_salud_sermas,,,,,, -3761,,136c1be4-0d37-4d88-acc9-a879cb141978,"Freistaat Bayern, vertreten durch Klinikum der Universität Regensburg",freistaat_bayern_vertreten_durch_klinikum_der_universit_t_regensburg,,,,,, -689,0.980666,e886c430-708a-48fb-ac6d-e89e5b342883,Allergopharma Joachim Ganzer KG,allergopharma_joachim_ganzer_kg,,,,08598a05-faa8-4889-ba3e-5127ae10b806,allergopharma_joachim_ganzer_kg_an_afilliate_of_merck_kgaa_darmstadt,"Allergopharma Joachim Ganzer KG an afilliate of Merck KGaA, Darmstadt" -3762,,164af130-cdf1-440d-9963-b7fd395c60b9,Instituto Catalán de Oncología,instituto_catal_n_de_oncolog_a,,,,,, -3763,,c68d5b68-0a4d-44b8-988d-3c736063f9a1,The University of Manchester,the_university_of_manchester,,,,,, -3764,,96707a71-9fd9-42a6-a202-a01bee7a5593,"Schering AG, Global Medical Development",schering_ag_global_medical_development,,,,,, -3765,,4e218370-39ed-4a53-9edd-6eb57c83ac45,UMC Groningen,umc_groningen,,,,,, -3766,,ff9cb2a1-0a40-4af3-9add-5c4771acc522,department of Pharmacology-Toxicology RUNMC,department_of_pharmacology_toxicology_runmc,,,,,, -3767,,b5415eb0-477e-48e5-b972-0ecc7ca273f7,University Hospital Aintree NHS Trust,university_hospital_aintree_nhs_trust,,,,,, -3768,,fc15e9d8-8666-41d4-9ef4-d822b1c48654,AstraZeneca oy,astrazeneca_oy,,,,,, -3769,,dc2805c3-d3ae-4673-9f88-4d04125e5288,EDISON PHARMACEUTICALS INC,edison_pharmaceuticals_inc,,,,,, -3770,,7c19583c-71a4-11e6-a0cd-0242ac12000b,US PHARMS HOLDINGS I,us_pharms_holdings_i,,,,,, -3771,,511dcb4c-7161-11e6-a0cd-0242ac12000b,LIEBEL-FLARSHEIM,liebel_flarsheim,,,,,, -3772,,f186ea08-96e7-43c7-9686-94a13748564c,Vernalis (R&D) Limited,vernalis_r_d_limited,,,,,, -3773,,4e3e1a04-a29b-4397-9943-add7b5abc712,LILLY FRANCE,lilly_france,,,,,, -3774,,4774ea6b-15a6-45f0-bcd0-d72c8fa1ef6b,Aktion Bronchialkarzinom (ABC) e.V,aktion_bronchialkarzinom_abc_e_v,,,,,, -3775,,1e5c2e7e-dc6c-4342-a560-aeed544ab0c0,GRUPO ESPAÑOL MULTIDISCIPLINARIO DEL CANCER DIGESTIVO(GEMCAD),grupo_espa_ol_multidisciplinario_del_cancer_digestivo_gemcad,,,,,, -3776,,60227124-9c78-4b06-8960-b2027d6f3f4b,ALK-Abelló A/S,alk_abell_a_s,,,,,, -3777,,dc9d5d49-316a-41db-b3ab-e51b971dd8a0,Mitsubishi Pharma Corporation,mitsubishi_pharma_corporation,,,,,, -3778,,39651b1c-7167-11e6-a0cd-0242ac12000b,HAUPT PHARMA,haupt_pharma,,,,,, -3779,,8c353821-ab15-44bf-ac3e-cbeafedb0241,Meander Medical Centre,meander_medical_centre,,,,,, -3780,,c2f70698-7323-11e6-a0cd-0242ac12000b,INST BIOCHIMIQUE,inst_biochimique,,,,,, -3781,,dca409da-b870-4bb7-812d-f83fa4885f24,The Royal Marsden NHSF Trust,the_royal_marsden_nhsf_trust,,,,,, -3782,,ff99844a-4d70-4e3a-826b-40a67dd074fd,Hull and East Yorkshire Acute Hospitals NHS Trust,hull_and_east_yorkshire_acute_hospitals_nhs_trust,,,,,, -3783,,e50c956a-b859-4e2a-94b6-80ca4df4ef0d,"Schering Plough Research Institute (SPRI), A Division of Schering Corporation",schering_plough_research_institute_spri_a_division_of_schering_corporation,,,,,, -3784,,65c91553-a945-42e5-ba39-05b17151ce30,ALTANA PHARMA,altana_pharma,,,,,, -3785,,e82b15a4-863a-4c74-8129-54edef919ad9,Proteo Biotech AG,proteo_biotech_ag,,,,,, -3786,,820491fe-7167-11e6-a0cd-0242ac12000b,CPDC,cpdc,,,,,, -1034,0.914544,2656ed3b-7c3f-4317-935a-59c30cccc2bc,Centre du Cancer des Cliniques Universitaires Saint-Luc,centre_du_cancer_des_cliniques_universitaires_saint_luc,,,,2656ed3b-7c3f-4317-935a-59c30cccc2bc,centre_du_cancer_des_cliniques_universitaires_saint_luc,Centre du Cancer des Cliniques Universitaires Saint-Luc -470,0.97350867589314782,2a4e4a42-e5c4-4da8-8f1f-18343eeb1fbc,European Group for Blood and Marrow Transplantation (EMBT),european_group_for_blood_and_marrow_transplantation_embt,,,,2a4e4a42-e5c4-4da8-8f1f-18343eeb1fbc,european_group_for_blood_and_marrow_transplantation,European Group for Blood and Marrow Transplantation (EMBT) -3787,,6d383694-715e-11e6-a0cd-0242ac12000b,BELMORA LLC,belmora_llc,,,,,, -633,0.974308,c06c533e-ab04-44e7-a0f7-e1b3fb8173f8,BRACCO IMAGING,bracco_imaging,,,,c06c533e-ab04-44e7-a0f7-e1b3fb8173f8,bracco_imaging,BRACCO IMAGING -3788,,b600dbe1-c9e4-4026-a0d8-423f1595e815,Maria Antonia Saornil Alvarez,maria_antonia_saornil_alvarez,,,,,, -3789,,e2a17f9e-7154-11e6-a0cd-0242ac12000b,ADARE PHARMS INC,adare_pharms_inc,,,,,, -3790,,453ce8e3-a10e-49a1-9300-48140beef269,TopoTarget Germany AG,topotarget_germany_ag,,,,,, -3791,,64e8e932-f8d6-4f33-b994-aa628d0fade0,Royal Marsden NHS Trust,royal_marsden_nhs_trust,,,,,, -3792,,f9e455c8-7154-11e6-a0cd-0242ac12000b,PAR STERILE PRODUCTS,par_sterile_products,,,,,, -3793,,a346f83f-ad17-44c2-98e5-9266fce72700,Laboratorios Dr. Esteve S.A. (ESTEVE),laboratorios_dr_esteve_s_a_esteve,,,,,, -3794,,59f6fd80-8820-11e6-a998-0242ac12000b,Janssen Medical Affairs EMEA,janssen_medical_affairs_emea,,,,,, -3795,,5573f3e4-d6bb-4c5a-ac4d-007fb38d2e79,Grünenthal Pharma S.A,gr_nenthal_pharma_s_a,,,,,, -3796,,05d57d99-61e6-472b-b84b-1cbae0c8a09f,"VIA PHARMACEUTICALS, INC",via_pharmaceuticals_inc,,,,,, -3797,,7805009f-9b20-4c47-8f48-a541137582a6,"Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E",instituto_portugu_s_de_oncologia_de_lisboa_francisco_gentil_e_p_e,,,,,, -625,0.96852,05cdfe1b-418a-44a0-bab7-0a07fc861fd4,Dresden University of Technology,dresden_university_of_technology,,,,05cdfe1b-418a-44a0-bab7-0a07fc861fd4,dresden_university_of_technology,Dresden University of Technology -160,0.96059775352478027,de2e78fc-1477-4ad5-bd9d-2d289aaee414,Fundación para la Investigación biomedica del Hospital Gregorio Marañon,fundaci_n_para_la_investigaci_n_biomedica_del_hospital_gregorio_mara_on,,,,ce27e24e-62ac-42de-a596-4ceed67e634f,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón -3798,,0a091072-3610-41b2-84ab-91926a32376b,Actelion Pharmaceuticals Sverige AB,actelion_pharmaceuticals_sverige_ab,,,,,, -3799,,cbeeb474-9b9d-4710-887b-b8c6b022afaa,"Exelixis, Inc",exelixis_inc,,,,,, -1053,0.987186,3ca85ebb-ef77-4ffc-bc31-c0440e250e6a,BOOG Study Center B.V,boog_study_center_b_v,,,,3ca85ebb-ef77-4ffc-bc31-c0440e250e6a,boog_study_center_b_v,BOOG Study Center B.V -308,0.987895,e239b75f-2e94-4044-9542-866a0e8f231b,Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla,fundaci_n_p_blica_andaluza_para_la_gesti_n_de_la_investigaci_n_en_salud_de_sevilla,,,,86807203-e56e-49a6-bcc8-c3d0deca55f4,fundaci_n_p_blica_andaluza_para_la_gestion_de_la_investigaci_n_en_salud_de_sevilla,Fundación Pública Andaluza para la Gestion de la Investigación en Salud de Sevilla -3800,,906e3e1c-4334-41b1-92ff-9a83812b649f,PARI GmbH,pari_gmbh,,,,,, -3801,,21869e3d-a23c-435f-a06c-9bec41863636,Lilly ICOS LLC,lilly_icos_llc,,,,,, -3802,,25597202-c22a-4d69-a4fb-4443a3d67f96,7TM Pharma A/S,7tm_pharma_a_s,,,,,, -3803,,719e2052-7129-11e6-a89e-0242ac12000b,LANNETT HOLDINGS INC,lannett_holdings_inc,,,,,, -550,0.98918396234512329,c02e31f5-3712-4237-9dae-6bec40ffabb9,"Freistaat Bayern, vertreten durch die Universität Regensburg, Klinikum",freistaat_bayern_vertreten_durch_die_universit_t_regensburg_klinikum,,,,c02e31f5-3712-4237-9dae-6bec40ffabb9,freistaat_bayern_vertreten_durch_die_universit_t_regensburg_klinikum,"Freistaat Bayern, vertreten durch die Universität Regensburg, Klinikum" -145,0.938045,d57e06d7-f7fa-4a12-9066-20923b514e74,Menarini Benelux S.A/N.V,menarini_benelux_s_a_n_v,,,,c4a9bf5d-eebd-42f0-a384-39801bffce72,menarini_benelux_sa_nv,Menarini Benelux SA/NV -3804,,cc6b8034-ebcb-4c66-9821-e0dbb74f9f98,Pharma 2100 ApS,pharma_2100_aps,,,,,, -3805,,a6a086e4-71ee-11e6-a0cd-0242ac12000b,BLACKSMITH BRANDS,blacksmith_brands,,,,,, -3806,,cc6ac0f3-fc84-4db1-84b5-421d8c83530c,Clovis Oncology Inc,clovis_oncology_inc,,,,,, -3807,,3caad73b-371e-4101-a53f-a8f691ceaa64,Tuula Manner,tuula_manner,,,,,, -299,0.98663288354873657,1346da36-73d0-11e6-a0cd-0242ac12000b,NOVARTIS PHARM,novartis_pharm,,,,7aebdff6-717d-11e6-a0cd-0242ac12000b,novartis_pharms,NOVARTIS PHARMS -3808,,80524c59-ec59-4f88-af43-4c3ca176df0b,"Department of Dermatology, Bispebjerg University Hospital",department_of_dermatology_bispebjerg_university_hospital,,,,,, -3809,,27b0a01c-73bf-11e6-a0cd-0242ac12000b,APGDI,apgdi,,,,,, -3810,,5e172e20-73e5-11e6-a0cd-0242ac12000b,TRYGG,trygg,,,,,, -3811,,26e795cd-57eb-4921-b8ea-d5fad1e6c3de,"SYSTEMS MEDICINE, LLC",systems_medicine_llc,,,,,, -3812,,19e5d102-7142-11e6-a0cd-0242ac12000b,PARKEDALE,parkedale,,,,,, -3813,,8652f9ef-11dd-4716-b9dd-6284027ec56f,Bionorica AG,bionorica_ag,,,,,, -3814,,b77a78da-60ae-4d26-8620-75d6f1b5e018,RUH (Bath) NHS Trust,ruh_bath_nhs_trust,,,,,, -3815,,2715598b-6fc3-46be-ab4e-e3d0b8ee666c,"Department of Hematology, Aarhus University Hospital",department_of_hematology_aarhus_university_hospital,,,,,, -457,0.98836642503738403,b1956d94-fa1c-4c96-9cc6-cd0765e72415,Janssen-Cilag International NV (JCI),janssen_cilag_international_nv_jci,,,,b1956d94-fa1c-4c96-9cc6-cd0765e72415,janssen_cilag_international_nv_jci,Janssen-Cilag International NV (JCI) -3816,,0605f678-07b2-438b-8607-8cb93573f601,Philipps-Universität Marburg,philipps_universit_t_marburg,,,,,, -3817,,5bfe149e-578b-4acb-8352-7f6a4cb2bea6,Greater Glasgow Health Board(GGHB)/ University of Glasgow,greater_glasgow_health_board_gghb_university_of_glasgow,,,,,, -445,0.97700804471969604,349b447a-a3b8-4b62-9bd7-18319a9a48b8,Royal Brompton & Harefield NHS Trust,royal_brompton_harefield_nhs_trust,,,,349b447a-a3b8-4b62-9bd7-18319a9a48b8,royal_brompton_harefield_nhs_trust,Royal Brompton & Harefield NHS Trust -3818,,531424f0-f342-4778-9240-be49c5269f5a,Centre Hospitalier de Toulouse,centre_hospitalier_de_toulouse,,,,,, -3819,,a0986f1c-844e-456a-b897-d08faeca4967,Accelerator Advanced Application,accelerator_advanced_application,,,,,, -3820,,3c2eabe4-0c3d-4c2c-adac-1867c30f4eec,CHU de Caen,chu_de_caen,,,,,, -234,0.98197808861732483,28cbc40e-dff3-45c4-8b15-2bde4da6a415,Novartis Pharma CH,novartis_pharma_ch,,,,7a736c7a-e49d-4f6d-a8da-98014f1ac986,novartis_pharma,Novartis Pharma -3821,,951c79fc-109a-42a3-ab08-b5d1025419d4,SIRTEX Medical Europe,sirtex_medical_europe,,,,,, -3822,,029d7038-5188-436d-9cb3-752126c92fc6,"Inst of OPhthalmology, Lund University",inst_of_ophthalmology_lund_university,,,,,, -668,0.984093,93043c3a-9344-4423-9114-20048877dc2b,BioPartners GmbH,biopartners_gmbh,,,,93043c3a-9344-4423-9114-20048877dc2b,biopartners_gmbh,BioPartners GmbH -3823,,1d0de80a-099b-4e2d-9eee-adf5dbb15fe6,Gloucestershire Hospitals NHS Foundation Trust,gloucestershire_hospitals_nhs_foundation_trust,,,,,, -230,0.95899969339370728,f9ca3489-3092-4dfd-a243-6cee45a702f6,"Medical Department M, Aarhus Sygehus",medical_department_m_aarhus_sygehus,,,,e36533aa-a267-461b-b595-a7c0d4d12b23,medical_department_i,Medical Department I -3824,,4c93fdd4-8bcf-11e6-a449-0242ac12000b,OLYMPUS FRANCE,olympus_france,,,,,, -3825,,670b1a2a-96ce-43a2-b9de-d8f0b77652c2,Folktandvården Västra Götaland,folktandv_rden_v_stra_g_taland,,,,,, -3826,,3a95ef30-2c75-4a75-9dd4-1aa22dfc339f,Essex Pharma GmbH,essex_pharma_gmbh,,,,,, -3827,,8bd7aeca-7142-11e6-a0cd-0242ac12000b,ELKINS SINN,elkins_sinn,,,,,, -3828,,3a44e4d2-e3c3-4eb6-925c-a97652e4ffd4,Frederiksberg Hospital,frederiksberg_hospital,,,,,, -3829,,632d1aeb-699e-4a61-8a30-8e25e43d5061,ASOCIACION ANDALUZA DE HEMATOLOGIA Y HEMOTERAPIA,asociacion_andaluza_de_hematologia_y_hemoterapia,,,,,, -3830,,abe20538-e7fb-4a2d-ad4c-863a697259de,GSK Vaccines S.r.l,gsk_vaccines_s_r_l,,,,,, -3831,,1785e80e-7847-4e9d-b010-7ce06929aabc,"Krajská nemocnice Liberec, a.s",krajsk_nemocnice_liberec_a_s,,,,,, -3832,,bd724e61-d2d0-4f0c-b10f-2f2a69308f4d,Merck Sharp & Dohme (Europe) Inc,merck_sharp_dohme_europe_inc,,,,,, -3833,,1868d223-d287-4848-b448-26c25631f391,Joslin Diabetes Center,joslin_diabetes_center,,,,,, -3834,,2aec6de4-05d4-4907-8d21-78a6a82cbce5,"Albert-Ludwig University Freiburg, Laboratory for Biological and Personality Psychology",albert_ludwig_university_freiburg_laboratory_for_biological_and_personality_psychology,,,,,, -236,0.92619631687800086,6f4a6bcd-1427-46aa-836c-03f830233033,"Pfizer Ltd, Ramsgate Road Sandwich, UK",pfizer_ltd_ramsgate_road_sandwich_uk,,,,36e40cab-06cf-41e0-bef3-04e11a49311d,pfizer_ltd_ramsgate_road_sandwich_kent,"Pfizer Ltd, Ramsgate Road, Sandwich, Kent" -3835,,2acfbd28-22a2-4891-ae83-f635b83d7506,"Integrated Therapeutics Group, Inc. - A subsidiary of Schering-Plough Corp",integrated_therapeutics_group_inc_a_subsidiary_of_schering_plough_corp,,,,,, -693,0.96936577558517456,48601627-d189-4d07-b717-58fa6e8591d5,NovaCardia Inc (wholly owned subsidiary of Merck & Co. Inc),novacardia_inc_wholly_owned_subsidiary_of_merck_co_inc,,,,48601627-d189-4d07-b717-58fa6e8591d5,novacardia_inc_wholly_owned_subsidiary_of_merck_co_inc,NovaCardia Inc (wholly owned subsidiary of Merck & Co. Inc) -3836,,676bce60-6244-47e3-a3a5-d55b208f30be,ATVB Verein,atvb_verein,,,,,, -310,0.963604,09253f61-375e-4a27-869a-8e74c421b025,sanofi-aventis Groupe,sanofi_aventis_groupe,,,,09253f61-375e-4a27-869a-8e74c421b025,sanofi_aventis_groupe,sanofi-aventis Groupe -3837,,bd8d0cf1-0b82-4294-ae13-5d5d3b6d7ddc,"THERACLONE SCIENCES, INC",theraclone_sciences_inc,,,,,, -3838,,03aa197d-0362-4da8-8bb6-4b7d1030bca7,"Laboratorios Leti, S.L.Unipersonal",laboratorios_leti_s_l_unipersonal,,,,,, -3839,,d9679400-91a8-4271-90e8-c4cf9e7a9711,Medical School of Hannover,medical_school_of_hannover,,,,,, -3840,,bbb0104a-8606-4d82-9c3b-349c196f319d,Solvotrin Innovations Ltd,solvotrin_innovations_ltd,,,,,, -3841,,2d3c26c3-99a3-4023-849a-7028c3fd7701,Fundación Interhospitalaria de Investigación Cardiovascular,fundaci_n_interhospitalaria_de_investigaci_n_cardiovascular,,,,,, -3842,,198fca05-280c-4e7a-ab3b-c8478debfe12,Klinikum Fulda gAG,klinikum_fulda_gag,,,,,, -3843,,f0088a5f-49a6-43de-98e8-d2a93cda692b,"Istituto Auxologico Italiano, IRCCS",istituto_auxologico_italiano_irccs,,,,,, -3844,,717f4682-85e7-4535-a5d1-4451339e41da,Endo Pharmaceuticals Solutions Inc,endo_pharmaceuticals_solutions_inc,,,,,, -3845,,7ee980c5-2e75-4fe6-b8df-00416bc966ce,GETECCU,geteccu,,,,,, -3846,,83a60fc0-2190-42f9-8b68-05d2a1702861,Montreal Heart Institute,montreal_heart_institute,,,,,, -3847,,c45f6afb-a1e9-4765-9491-7331a23b6d3e,Dra. Cristina Avendaño Solá,dra_cristina_avenda_o_sol,,,,,, -3848,,5c63a205-7777-4aa9-ba4c-7a1c27490437,ARCAGY,arcagy,,,,,, -3849,,c3dce589-9e0c-4d7e-87ab-63ea11b55d62,Institute for International Health,institute_for_international_health,,,,,, -3850,,4520716c-7163-11e6-a0cd-0242ac12000b,SANDOZ CANADA INC,sandoz_canada_inc,,,,,, -3851,,e40dc5ec-56ac-4c85-b67b-1aca42022931,SELARL du Docteur Jacques Buvat,selarl_du_docteur_jacques_buvat,,,,,, -3852,,4f7a9414-3759-40f7-80ed-da48fc9d9cb0,UCLH/UCL Biomedical Research Unit,uclh_ucl_biomedical_research_unit,,,,,, -3853,,2b7a77ae-fffe-4816-baff-35362de6abff,Jassen-Cilag International NV,jassen_cilag_international_nv,,,,,, -3854,,a2519ad7-66c6-4fe5-a142-e3bd92cd1eb5,IRCCS FONDAZIONE STELLA MARIS,irccs_fondazione_stella_maris,,,,,, -3855,,318304b9-5192-4311-aa86-9a5c1a213381,"Jens Benn Sorensen, Dept. oncology, Finsen Centre/National University Hospital",jens_benn_sorensen_dept_oncology_finsen_centre_national_university_hospital,,,,,, -3856,,4019fe7e-0a18-4a9a-8d37-0a5c94ea7862,Institut de Recherches Internationales (for France),institut_de_recherches_internationales_for_france,,,,,, -756,0.973609,339b2067-d133-4013-927e-2033004bf532,"Johannes Gutenberg-Universität Mainz, II. Med. Klinik (ausführende Stelle), Prof. Dr. T. Münzel",johannes_gutenberg_universit_t_mainz_ii_med_klinik_ausf_hrende_stelle_prof_dr_t_m_nzel,,,,339b2067-d133-4013-927e-2033004bf532,johannes_gutenberg_universit_t_mainz_ii_med_klinik_ausf_hrende_stelle_prof_dr_t_m_nzel,"Johannes Gutenberg-Universität Mainz, II. Med. Klinik (ausführende Stelle), Prof. Dr. T. Münzel" -3857,,e4fa72ae-37d3-4c8a-b502-b13491ef48e6,"Medical Faculty, TU Dresden",medical_faculty_tu_dresden,,,,,, -3858,,c7170371-6d5d-4df1-aee6-52bbc5cef7d7,"Institution for Clinical Science, Karolinska Institutet",institution_for_clinical_science_karolinska_institutet,,,,,, -3859,,95955d93-8c94-4a18-9b74-2bcd7f5177e5,"The Newcastle Upon Tyne Hospital NHS Foundation Trust, Freeman Hospital",the_newcastle_upon_tyne_hospital_nhs_foundation_trust_freeman_hospital,,,,,, -3860,,8f67ded4-daf9-4c5a-946b-be66807eb55b,Matrixx Initiatives Inc,matrixx_initiatives_inc,,,,,, -1013,0.96733957529067993,927f0840-1482-4ee8-bec9-a1452525e28a,Institut de Recherche International Servier,institut_de_recherche_international_servier,,,,05fd0678-f53a-4b88-9656-dc6d78bcac36,institut_de_recherche_internationales_servier,Institut de Recherche Internationales Servier -3861,,16712bdc-d896-44e4-817a-7049ed823331,JUAN MACIAS SANCHEZ,juan_macias_sanchez,,,,,, -3862,,00d8a53f-a307-46dc-8148-df83b78f1cd0,Royal Victoria Eye and Ear hospital,royal_victoria_eye_and_ear_hospital,,,,,, -3863,,80c29875-9348-4792-b514-2039f30abd00,IDIAP Jordi Gol,idiap_jordi_gol,,,,,, -751,0.9637179970741272,ddce1384-7144-11e6-a0cd-0242ac12000b,TARO PHARM INDS,taro_pharm_inds,,,,019c34b0-7129-11e6-a89e-0242ac12000b,taro,TARO -3864,,33a455ca-12f0-412a-a133-08e5311a8f59,Alliance Pharmaceuticals Ltd,alliance_pharmaceuticals_ltd,,,,,, -3865,,ff049a50-715d-11e6-a0cd-0242ac12000b,SANTOS BIOTECH,santos_biotech,,,,,, -3866,,ac7fcf3a-78cc-478b-b2fd-a80fc2f3b960,FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR,fondazione_centro_s_raffaele_del_monte_tabor,,,,,, -3867,,f6542d99-e1c2-454c-9085-50b3f52f097c,VästraGötaland,v_strag_taland,,,,,, -814,0.985423,5a1fbd8a-7158-11e6-a0cd-0242ac12000b,NATCO PHARMA LTD,natco_pharma_ltd,,,,03bcbda2-715e-11e6-a0cd-0242ac12000b,natco_pharma,NATCO PHARMA -654,0.90361690521240234,3849b74a-6dc1-4f1b-a6c5-a146b4d05357,Boehringer Ingelheim RCV Ges mbH & Co KG,boehringer_ingelheim_rcv_ges_mbh_co_kg,,,,3849b74a-6dc1-4f1b-a6c5-a146b4d05357,boehringer_ingelheim_rcv_ges_mbh_co_kg,Boehringer Ingelheim RCV Ges mbH & Co KG -395,0.982614,5cabde38-2e50-4a9e-b161-b9d60f252062,ASTRAZENECA,astrazeneca,,,,3a926c58-71c4-11e6-a0cd-0242ac12000b,astrazeneca_pharms,ASTRAZENECA PHARMS -3868,,34f22e00-ad6c-4616-8b22-b1a6b9878e2c,The University of Dundee,the_university_of_dundee,,,,,, -3869,,ceb5dbcb-3eed-455c-933c-c5c34e28f796,GE Healthcare Finland Oy,ge_healthcare_finland_oy,,,,,, -518,0.973471,ae49cd9c-0341-4f5e-a25b-775aca5642ab,"Department of Infetious Diseases, Odense University Hospital",department_of_infetious_diseases_odense_university_hospital,,,,ae49cd9c-0341-4f5e-a25b-775aca5642ab,department_of_infetious_diseases_odense_university_hospital,"Department of Infetious Diseases, Odense University Hospital" -479,0.98417377471923828,6550973d-6d3a-4fa8-a3d5-17c7365cb8cb,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Endokrinologie und Stoffwechsel",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klin_abt_f_r_endokrinologie_und_stoffwechsel,,,,6550973d-6d3a-4fa8-a3d5-17c7365cb8cb,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klin_abt_f_r_endokrinologie_und_stoffwechsel,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Endokrinologie und Stoffwechsel" -3870,,5a94c966-09c3-437d-8b9a-0554fd5fe878,Instituto de Investigación La Fe,instituto_de_investigaci_n_la_fe,,,,,, -3871,,c046e1d5-a486-499c-9d6b-8bfc6fd1eeab,Schering-Plough France,schering_plough_france,,,,,, -3872,,56ec0cfc-2793-4bfe-96ed-76925e6cc551,MSD SHARP & DOHME GMBH,msd_sharp_dohme_gmbh,,,,,, -3873,,4f6f5230-7142-11e6-a0cd-0242ac12000b,FACTA FARMA,facta_farma,,,,,, -3874,,b61d91fe-39c0-4f9d-81ee-3bfeb477fcf7,Max-Planck-Institut für Psychiatrie,max_planck_institut_f_r_psychiatrie,,,,,, -3875,,60367d18-e7d9-46f0-8655-85bc58b751b5,Myeloproliferative Disease Research Consortium (MPD-RC),myeloproliferative_disease_research_consortium_mpd_rc,,,,,, -3876,,7012ce01-def4-47a6-9508-471148ac1823,OxThera IP AB,oxthera_ip_ab,,,,,, -3877,,49665045-cd17-4b4f-9461-30400ea52f84,Boegringer Ingelheim Finland Ky,boegringer_ingelheim_finland_ky,,,,,, -3878,,57a05dd2-cb59-415c-889a-f3fa73d0fcd0,Celgene Corporation Headquarters,celgene_corporation_headquarters,,,,,, -444,0.97010031342506409,4f4f6343-5016-41b6-a586-c53ba90ea215,Royal Brompton and Harefield NHS Foundation Trust,royal_brompton_and_harefield_nhs_foundation_trust,,,,3c8eeed9-b500-4ecf-a409-f59b86b21db3,royal_brompton_and_harefield_nhs_foundation_trust,Royal Brompton and Harefield NHS Foundation Trust -3879,,21ff77cc-b720-403a-a55f-4af4eaa91120,"EIP Pharma, LLC",eip_pharma_llc,,,,,, -3880,,b89ad977-ff57-48e7-8cd0-b976755bfc37,Instituto de Investigación del Hospital de la Santa Creu i Sant Pau,instituto_de_investigaci_n_del_hospital_de_la_santa_creu_i_sant_pau,,,,,, -3881,,b49294d2-f6db-49e8-9f3a-fc904ce0a505,"Medarex, Inc",medarex_inc,,,,,, -3882,,6f5e051b-fbf8-41ac-a07b-98ab5ca09918,Noora Kaartinen,noora_kaartinen,,,,,, -741,0.9617915153503418,791ed7a8-0e54-418b-b501-7f7c85f1211c,AstraZeneca R&D Södertälje,astrazeneca_r_d_s_dert_lje,,,,5b96ae2b-b1a8-4688-88cd-0fcea433e529,astrazeneca_r_d,AstraZeneca R&D -3883,,629bc702-f660-42d6-a652-c35f3dd88d83,Växjö Central Hospital,v_xj_central_hospital,,,,,, -3884,,e13111a4-5c0b-4e59-af2b-af203617723b,Lilly S.A,lilly_s_a,,,,,, -3885,,6a2a5b01-ca16-4dab-b008-7f0242712dc5,Cristina Fernandez Pérez,cristina_fernandez_p_rez,,,,,, -166,0.989139,7eeea4e4-efc7-45bf-bac7-82d54c1ae894,Galderma Research and Development,galderma_research_and_development,,,,7eeea4e4-efc7-45bf-bac7-82d54c1ae894,galderma_research_and_development,Galderma Research and Development -711,0.98289656639099121,76c0c0d6-9f7c-4fde-bea7-4dd56b4a4546,Reckitt Benckiser (UK) Limited,reckitt_benckiser_uk_limited,,,,76c0c0d6-9f7c-4fde-bea7-4dd56b4a4546,reckitt_benckiser_uk_limited,Reckitt Benckiser (UK) Limited -3886,,c6aebdb9-1a0c-4134-9f1a-e3829a6727a5,Aktion Bronchialkarzinom e.V,aktion_bronchialkarzinom_e_v,,,,,, -365,0.98333936929702759,dd9c18be-f4a4-44ea-8e70-9257902058dd,Bayer HealthCare Pharmaceuticals,bayer_healthcare_pharmaceuticals,,,,17d529dc-dc91-4ddb-8f15-7de6d2fa75e3,bayer_healthcare_pharmaceuticals,Bayer HealthCare Pharmaceuticals -3887,,0fd1b4f6-b0f8-49aa-86bd-f295d699aff6,Pierre Fabre Ibérica S.A. as legal representative of Pierr Fabre Mèdicament,pierre_fabre_ib_rica_s_a_as_legal_representative_of_pierr_fabre_m_dicament,,,,,, -3888,,8564ee6f-0eb5-4f0b-97ec-b4374c61a413,Daiichi-Sankyo,daiichi_sankyo,,,,,, -774,0.94804,854e11d2-791a-4ad3-8709-b1916907edf4,BIOIBÉRICA S.A,bioib_rica_s_a,,,,6af20df4-5eb9-402f-a439-234b9bbabba6,bioiberica_s_a,BIOIBERICA S.A -3889,,ea11e952-b27e-4256-b97f-e67348f6912e,Southwest Oncology Group (SWOG),southwest_oncology_group_swog,,,,,, -600,0.9319939215977987,6b4a9b2d-18ff-4441-b335-98517841d021,Fundació Institut de Recerca de l'Hospital de la Santa Creu i de Sant Pau,fundaci_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_de_sant_pau,,,,6b4a9b2d-18ff-4441-b335-98517841d021,fundaci_n_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Fundació Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau -175,0.938547,963178a4-e414-458d-affa-8c2fb06efeb5,"Med. Univ. Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie",med_univ_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,,,,35c21566-4df9-4b63-ab48-4cc2ede6089b,med_univ_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerzmedizin,"Med. Univ. Wien, Universitätsklinik für Anästhesie, allgemeine Intensivmedizin und Schmerzmedizin" -506,0.981904,49d9286e-7129-11e6-a89e-0242ac12000b,WATSON LABS,watson_labs,,,,49d9286e-7129-11e6-a89e-0242ac12000b,watson_labs,WATSON LABS -199,0.982247,9ea15bf7-df50-400a-88c4-415b3dc2eda2,Mälarsjukhuset,m_larsjukhuset,,,,9ea15bf7-df50-400a-88c4-415b3dc2eda2,m_larsjukhuset,Mälarsjukhuset -3890,,876d1435-50e2-4be0-948e-335bed451049,IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro,irccs_azienda_ospedaliera_universitaria_san_martino_ist_istituto_nazionale_per_la_ricerca_sul_cancro,,,,,, -410,0.960286,73bbc013-4e9f-4481-88b6-3063a265c63f,ABOCA,aboca,,,,273912e1-1b32-44bf-9119-1caf84670781,aboca_s_p_a_societ_agricola,ABOCA S.P.A. SOCIETà AGRICOLA -3891,,5697b189-3f87-4b77-bf24-dd1bcc1ba4f2,"Oliver Ploder MD, DDS, PhD",oliver_ploder_md_dds_phd,,,,,, -3892,,b26e19d7-e843-42c0-85c2-c26c9167993e,Swedish Herbal Institute,swedish_herbal_institute,,,,,, -3893,,722688d0-715f-11e6-a0cd-0242ac12000b,MEDPOINTE PHARM HLC,medpointe_pharm_hlc,,,,,, -3894,,7ba8b458-2c58-4b6f-9034-700008f6cbc9,"Ospedale San Raffaele, UO Chirurgia Vascolare",ospedale_san_raffaele_uo_chirurgia_vascolare,,,,,, -462,0.969668,e47fcd5f-048f-4287-91ec-1f3ae2187dad,GamidaCell-Teva Joint Venture Ltd,gamidacell_teva_joint_venture_ltd,,,,c2cf1092-6676-478b-b6bc-5980f53650f5,gamida_cell_teva_joint_venture_ltd,Gamida Cell-Teva Joint Venture Ltd -3895,,75e97c8c-69d6-4b5d-a4b6-7571690c387f,Regulon Α.Ε,regulon,,,,,, -3896,,17896b8d-24d9-4496-abcf-7da2f360f833,MAR ESPINO HERNANDEZ,mar_espino_hernandez,,,,,, -3897,,2a01c240-97d3-4040-9987-bcc113d26e5f,Pfizer Consumer Healthcare Comm. VA/SCA,pfizer_consumer_healthcare_comm_va_sca,,,,,, -3898,,316e8ffe-8bdb-11e6-a449-0242ac12000b,Instituto Gallego de Medicina Vascular (IGAMEVAS S.L.),instituto_gallego_de_medicina_vascular_igamevas_s_l,,,,,, -160,0.93437572717666628,fafbf14a-7edf-4f4d-a87f-703785475b5c,Fundación para la Investigación Biomédica Hospital Gregorio Marañón,fundaci_n_para_la_investigaci_n_biom_dica_hospital_gregorio_mara_n,,,,ce27e24e-62ac-42de-a596-4ceed67e634f,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón -3899,,8d705dcc-3022-4674-b397-c7f418bdd927,Kiadis Pharma Netherlands B.V,kiadis_pharma_netherlands_b_v,,,,,, -3900,,3b4f921f-ba8d-4090-89d0-a58bc8ce6529,Mari Salmivuori,mari_salmivuori,,,,,, -34,0.97933,c148d4ca-273c-4294-9d90-0174a4aba478,Sanofi-Synthélabo Recherche,sanofi_synth_labo_recherche,,,,55dfece4-1cf8-463c-896f-48fbbec903fc,sanofi_synth_labo_recherche_a_subsidiary_of_sanofi_aventis_group,"Sanofi-Synthélabo Recherche, a subsidiary of sanofi-aventis group" -3901,,c23a23c8-4ce4-4f2c-ba5e-d96eeae23a66,Barts Health NHS Trust,barts_health_nhs_trust,,,,,, -3902,,b1fcc4b8-dae4-4f04-9687-6e64e2395bb2,"PULEVA BIOTECH, S.A",puleva_biotech_s_a,,,,,, -3903,,bc9917b7-e8e3-42e0-90d2-0718c5559515,"Genexine, Inc",genexine_inc,,,,,, -3904,,f0bdcf97-fad8-428f-aa8f-1a7adbabd7f9,Eisai Ltd,eisai_ltd,,,,,, -3905,,765dba7a-7157-11e6-a0cd-0242ac12000b,NOSTRUM PHARMS LLC,nostrum_pharms_llc,,,,,, -141,0.954454,a50426da-ce4e-4ecd-b491-397a2aadb68f,GRUPO ESPAÑOL DE INVESTIGACION EN NEUROONCOLOGIA,grupo_espa_ol_de_investigacion_en_neurooncologia,,,,a50426da-ce4e-4ecd-b491-397a2aadb68f,grupo_espa_ol_de_investigacion_en_neurooncologia,GRUPO ESPAÑOL DE INVESTIGACION EN NEUROONCOLOGIA -3906,,134aaaa3-4030-4a0b-b862-da77616b6237,eduardo anitua aldecoa,eduardo_anitua_aldecoa,,,,,, -808,0.94340622425079346,9dd926b0-8d48-4d08-b638-2eb1c4764ba3,Biogen Idec International GmbH,biogen_idec_international_gmbh,,,,9dd926b0-8d48-4d08-b638-2eb1c4764ba3,biogen_idec_international_gmbh,Biogen Idec International GmbH -902,0.975661,107fc324-9e45-4afc-8ead-3498cf036471,Klaus Olkkola/University of Helsinki,klaus_olkkola_university_of_helsinki,,,,107fc324-9e45-4afc-8ead-3498cf036471,klaus_olkkola_university_of_helsinki,Klaus Olkkola/University of Helsinki -3907,,6ef1b1a0-e461-4699-a8c5-1c422a7086c2,UNIMED PHARMA spol. s r. o,unimed_pharma_spol_s_r_o,,,,,, -3908,,e956887e-501f-451b-beab-11deebcf5a18,Zealand Pharma A/S,zealand_pharma_a_s,,,,,, -3909,,38673970-8922-4d99-ae98-9e22414a6b23,Julius Maximilians Universität Würzburg,julius_maximilians_universit_t_w_rzburg,,,,,, -3910,,c3f51464-0b38-4069-95dc-3858ae5af3af,"Corbus Pharmaceuticals, Inc",corbus_pharmaceuticals_inc,,,,,, -3911,,552dcc5b-8ae6-4048-9638-78eb24ab9df6,"Laboratorios Almirall, S.A",laboratorios_almirall_s_a,,,,,, -3912,,56fd01ec-b8d5-4343-ad0f-f0b6507e5f46,Dignity Sciences Limited,dignity_sciences_limited,,,,,, -3913,,023e9a34-04f0-4b7e-ab2c-60f165ad7f1d,Hanna Pitkänen,hanna_pitk_nen,,,,,, -3914,,61cda268-25c6-4699-88d6-86b80b9091d3,"Dr. Reddy’s Laboratories, Ltd",dr_reddy_s_laboratories_ltd,,,,,, -490,0.98798045516014099,e0a9ebe2-090f-4317-bf41-30ea0e2e6a42,Radboud University Medical Center,radboud_university_medical_center,,,,3fd47231-c0e0-48e2-9df1-24e6ff72daf7,radboud_university_medical_center,Radboud University Medical Center -3915,,5e682ed9-e85c-47b5-b65f-f58b040e8cd4,Institut d'Investigació Sanitària Pere Virgili (IISPV),institut_d_investigaci_sanit_ria_pere_virgili_iispv,,,,,, -3916,,05a809c3-0721-4d01-bd9d-eedb13065f63,RICARDO MOUZO MIRCO,ricardo_mouzo_mirco,,,,,, -3917,,9f461db8-73f2-11e6-a0cd-0242ac12000b,AIR LIQUIDE HEALTHCARE AMERICA CORP,air_liquide_healthcare_america_corp,,,,,, -1043,0.987372,b195c37b-f8e9-4c96-a6ce-a8345d3e7c8e,"University of Oxford, NDM",university_of_oxford_ndm,,,,6441853c-c50a-4eeb-acbc-a29226d17b89,university_of_oxford,University of Oxford -3918,,40fea4eb-91d7-4b0a-bc7e-4042757b9285,"Mesoblast, Inc",mesoblast_inc,,,,,, -3919,,708143d9-e8c8-4e58-a896-e2ba0b9cee99,"Joint Research Compliance Office, Imperial College",joint_research_compliance_office_imperial_college,,,,,, -3920,,6901323d-ab1a-4450-9c2c-2e43ab7f6fa5,Pedro Villarejo Campos(Hospital Universitario Ciudad Real),pedro_villarejo_campos_hospital_universitario_ciudad_real,,,,,, -3921,,e6106d45-7d83-444c-b1d2-88910f30b40b,Prof. Dr. Istvan Racz,prof_dr_istvan_racz,,,,,, -3922,,8bb732b4-9a7f-4d4d-9abc-4f2c77cc9ec2,SOCIETA' ITALO BRITANNICA L. MANETTI - H.ROBERTS & C. PER AZIONI,societa_italo_britannica_l_manetti_h_roberts_c_per_azioni,,,,,, -3923,,04fc82ef-ceca-4a89-aa7d-ee3576ab0cfa,FNCLCC,fnclcc,,,,,, -3924,,1fa95d86-a7dc-11e6-94cb-5656d04fc2b5,"Ribapharm, Inc",ribapharm_inc,,,,,, -337,0.98108,16be4521-35a5-4873-a0cc-3401b5169c7e,Ortopædkirurgisk afdeling,ortop_dkirurgisk_afdeling,,,,16be4521-35a5-4873-a0cc-3401b5169c7e,ortop_dkirurgisk_afdeling,Ortopædkirurgisk afdeling -3925,,15d41467-43dc-4927-97d9-63947208250e,UCL Saint Luc 1200 Bruxelles,ucl_saint_luc_1200_bruxelles,,,,,, -3926,,df3f5d92-35ea-4841-b2d9-a1894a38e972,EspeRare,esperare,,,,,, -3927,,8a9d7bee-7164-11e6-a0cd-0242ac12000b,JIANGSU HANSOH PHARM,jiangsu_hansoh_pharm,,,,,, -3928,,5d43259b-43e0-4f8b-bef5-22eff7015401,Lennart Andren,lennart_andren,,,,,, -3929,,0756f17a-845a-44a8-95ea-cc76200afa3b,Gastroenterology MIDT,gastroenterology_midt,,,,,, -3930,,f7a6ddd8-4e03-41b7-ab43-f7269102d5dd,"University Hospital of Schleswig-Holstein (UKSH), Campus Lübeck",university_hospital_of_schleswig_holstein_uksh_campus_l_beck,,,,,, -3931,,5e254602-41e5-4355-9f98-3b87ccb941ff,Mediquest Therapeutics Inc,mediquest_therapeutics_inc,,,,,, -895,0.985938,03e90e85-40a8-444e-8bc5-373590743e16,FUNDACION DE INVESTIGACION EN RED EN ENFERMEDADES,fundacion_de_investigacion_en_red_en_enfermedades,,,,03e90e85-40a8-444e-8bc5-373590743e16,fundacion_de_investigacion_en_red_en_enfermedades,FUNDACION DE INVESTIGACION EN RED EN ENFERMEDADES -3932,,54bd06ec-90d6-4cdb-9766-96da7c24ff27,"Pfizer Inc. NYO-685-21-14,685 3rd Avenue, NEW YORK, NY 10017. US",pfizer_inc_nyo_685_21_14_685_3rd_avenue_new_york_ny_10017_us,,,,,, -983,0.945615,59c0ebeb-5f3a-4456-89ec-4ec59bcd4670,St Stephens Aids Trust,st_stephens_aids_trust,,,,59c0ebeb-5f3a-4456-89ec-4ec59bcd4670,st_stephens_aids_trust,St Stephens Aids Trust -447,0.952846,c26f8ffe-a3eb-4cb6-b78c-8b91798a8a08,ETOP,etop,,,,0000011d-452f-4fe6-9214-3df63d041f46,etop_european_thoracic_oncology_platform,ETOP (European Thoracic Oncology Platform) -3933,,84d78b33-1281-45b3-8d36-65c9512e4dc8,German Society of Pediatric Hematology and Oncology gGmbH (GPOH gGmbH),german_society_of_pediatric_hematology_and_oncology_ggmbh_gpoh_ggmbh,,,,,, -195,0.98517,4a830ce9-4d8d-4914-94f3-d34026b2d02d,"Becton, Dickinson and Company",becton_dickinson_and_company,,,,4a830ce9-4d8d-4914-94f3-d34026b2d02d,becton_dickinson_and_company,"Becton, Dickinson and Company" -3934,,c8754026-2594-43db-b012-0429c9907513,Pfizer Healthcare Ireland,pfizer_healthcare_ireland,,,,,, -3935,,1e76f041-4ad8-45b4-8f1c-03625c95b942,Fundación Interhospitalaria para la Investigación Cardiovascular,fundaci_n_interhospitalaria_para_la_investigaci_n_cardiovascular,,,,,, -3936,,574d346c-d4d4-4140-9384-dd43ec3fd074,Meda Pharmaceuticals Inc,meda_pharmaceuticals_inc,,,,,, -962,0.97408080101013184,2484bf94-1589-4af7-a881-77e0aae0ece2,Hull and East Yorkshire Hospitals Trust,hull_and_east_yorkshire_hospitals_trust,,,,0db9909a-d59f-42e0-9159-2ecff62910d4,hull_and_east_yorkshire_hospital_trust,Hull and East Yorkshire Hospital Trust -3937,,e8bc3ba2-e026-4a79-86a4-0131fd1399e3,ALMIRALL SA,almirall_sa,,,,,, -3938,,40764ce6-2b9d-45ab-92e0-576edefb1836,LABORATOIRE ALLERBIO,laboratoire_allerbio,,,,,, -3939,,c75fb5e0-7198-11e6-a0cd-0242ac12000b,PERSONAL PRODS,personal_prods,,,,,, -3940,,aba5eeb4-c458-49f1-99f2-13509f8fae05,"Kliniken der Stadt Koeln gGmbH, Klinikum Merheim",kliniken_der_stadt_koeln_ggmbh_klinikum_merheim,,,,,, -3941,,520ba148-738a-11e6-a0cd-0242ac12000b,COLLAGENEX,collagenex,,,,,, -3942,,62f40122-0e1c-41d4-8248-e933f3ba7e69,Dr. Valérie gangji,dr_val_rie_gangji,,,,,, -197,0.986644,0a2316b0-4362-41ed-8199-5421a077abe7,"Medizinische Fakultät der Technischen Universität München, Vertreten durch den Dekan",medizinische_fakult_t_der_technischen_universit_t_m_nchen_vertreten_durch_den_dekan,,,,0a2316b0-4362-41ed-8199-5421a077abe7,medizinische_fakult_t_der_technischen_universit_t_m_nchen_vertreten_durch_den_dekan,"Medizinische Fakultät der Technischen Universität München, Vertreten durch den Dekan" -3943,,ede7e67c-d16d-46ef-9584-86a5d4e2a54b,NHS Lothian Health Board,nhs_lothian_health_board,,,,,, -3944,,ba38fcd3-26f0-45ba-9efe-3e4bb3cdd94a,Kuopion yliopistollinen sairaala/silmätautien poliklinikka,kuopion_yliopistollinen_sairaala_silm_tautien_poliklinikka,,,,,, -3945,,16002c9c-1c5c-4677-befb-157a58ec411d,"Greater Glasgow NHS Board, Yorkhill Division",greater_glasgow_nhs_board_yorkhill_division,,,,,, -3946,,3d364894-b992-44b4-ae7f-0885a2b34584,Arthritis Alapítvány,arthritis_alap_tv_ny,,,,,, -853,0.983941,899ef89b-d4a2-471a-bb67-f455fcc4b775,"Malmö University Hospital, Dep of Radiology",malm_university_hospital_dep_of_radiology,,,,802313d9-1b0d-4889-acd7-6878108beebc,malm_university_hospital,Malmö University Hospital -3947,,14a8899d-cb4a-43c3-82a0-4587fd84bd25,Centre Hospitalier Universitaire de Besançon,centre_hospitalier_universitaire_de_besan_on,,,,,, -3948,,953d5eb1-3537-48c3-89b8-9ffcca04b31d,BCN Peptides S.A,bcn_peptides_s_a,,,,,, -3949,,e0538c80-0c8f-415a-a43f-f3466054daf1,"BIAL-Portela & Ca, SA",bial_portela_ca_sa,,,,,, -868,0.98876041173934937,376a2423-30e5-4963-9880-cf25de8913ff,"Astellas Pharma Global Development, Inc",astellas_pharma_global_development_inc,,,,d75f8fe0-80ce-4bb5-9e6e-ab63e91189dc,astellas_pharma_global_development_inc,"Astellas Pharma Global Development, Inc" -3950,,6f96bb1b-57de-4cde-a7dd-f6c3263295ac,Skånes University Hospital,sk_nes_university_hospital,,,,,, -478,0.97189050912857056,d64abf90-4d4e-45b9-a06a-2d5341662320,"Medizinische Universität Graz, Abteilung für Endokrinologie und Stoffwechsel",medizinische_universit_t_graz_abteilung_f_r_endokrinologie_und_stoffwechsel,,,,a6ef0ba5-d49e-411b-92ac-7bad93bbb394,medizinische_universit_t_graz_kl_abteilung_f_r_endokrinologie_und_stoffwechsel,"Medizinische Universität Graz, Kl. Abteilung für Endokrinologie und Stoffwechsel" -3951,,bd96100c-0a61-4856-a8c8-dd944d5571c9,Dr Miguel Santín Cerezales,dr_miguel_sant_n_cerezales,,,,,, -3952,,385c996e-80fd-40f5-b2e7-2aa27926ac73,"Allos Therapeutics, Inc",allos_therapeutics_inc,,,,,, -3953,,69f52f01-6ebe-4acc-81c1-38916eff8994,"Vl-Medi Oy, Väestöliitto",vl_medi_oy_v_est_liitto,,,,,, -3954,,6b3a4ebe-6fbe-11e6-abe8-0242ac12000b,Asociación para el Estudio de las Enfermedades Infecciosas,asociaci_n_para_el_estudio_de_las_enfermedades_infecciosas,,,,,, -3955,,ef00e74c-7141-11e6-a0cd-0242ac12000b,MURTY PHARMS,murty_pharms,,,,,, -3956,,2b2a3798-715e-11e6-a0cd-0242ac12000b,TRIS PHARMA INC,tris_pharma_inc,,,,,, -3957,,8337c933-f29d-41f5-85b7-49602e677ab7,University Hospital Leuven - Department of Haematology,university_hospital_leuven_department_of_haematology,,,,,, -3958,,562a8d7e-1e37-4260-b6cc-3884c09e8a24,National Institute of Oncology,national_institute_of_oncology,,,,,, -3959,,123fa4b8-16da-47d6-88a9-c617c2295a83,AstraZeneca SAS,astrazeneca_sas,,,,,, -3960,,f1ac5d0f-0d69-4fcc-9b75-a3a32481efea,"Pfizer LTD, Pfizer Global RD-Sandwich Laboratories-I.P.C. 582",pfizer_ltd_pfizer_global_rd_sandwich_laboratories_i_p_c_582,,,,,, -3961,,354b02c2-8274-4ef4-a6fa-257f1f8e6801,Medizinische Universität Wien/ Universitätsklinik für Innere Medizin II/ Angiologie und Kardiologie,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_ii_angiologie_und_kardiologie,,,,,, -843,0.970735,759e05f5-7472-4ddb-baa8-c26f62d421d9,"Rikshospitalet University Hospital, University of Oslo",rikshospitalet_university_hospital_university_of_oslo,,,,759e05f5-7472-4ddb-baa8-c26f62d421d9,rikshospitalet_university_hospital_university_of_oslo,"Rikshospitalet University Hospital, University of Oslo" -3962,,a1d3fe19-5c0f-42fc-9bda-f554bf678214,UZ BRUSSEL,uz_brussel,,,,,, -3963,,3bbeee9c-1f72-412b-b2b8-1cf841043771,The University of Leeds,the_university_of_leeds,,,,,, -652,0.9401266872882843,6a82526b-a3f0-4364-b600-bf5233259d47,"Boehringer Ingelheim Pharmaceuticals, España S.A",boehringer_ingelheim_pharmaceuticals_espa_a_s_a,,,,756fbf26-6aec-45b4-9273-9afca275034e,boehringer,Boehringer -3964,,6ba78436-5e9a-40c4-a768-3f6871113bd1,"John L. Berk, M.D",john_l_berk_m_d,,,,,, -3965,,616b9665-7701-4e88-8785-d6b4707ab3ac,Isabel Pinilla Lozano,isabel_pinilla_lozano,,,,,, -3966,,81e76ff2-7167-11e6-a0cd-0242ac12000b,JOHNS HOPKINS UNIV,johns_hopkins_univ,,,,,, -650,0.95911291241645813,4b44d76c-5934-41c9-b025-daff7771bb88,Boehringer Ingelheim Austria GesmbH,boehringer_ingelheim_austria_gesmbh,,,,2c7b1b3b-323c-4045-ae75-4712a0ece886,boehringer_ingelheim_ab,Boehringer Ingelheim AB -3967,,c5df0c8e-3a7d-4db9-9312-7f42f2498652,GlaxoSmithKline GmbH & Co. KG,glaxosmithkline_gmbh_co_kg,,,,,, -893,0.9773980975151062,db2b75a4-2dcd-4a05-bd1d-454a679e9e67,Aarhus Universitet,aarhus_universitet,,,,2f028fcc-7872-4732-95a8-d0e74e80f7ae,aarhus_universitetshospital_aarhus_sygehus_thg,"Aarhus Universitetshospital, Aarhus Sygehus THG" -624,0.925655,d55f688a-1796-4607-a12b-e0dea07ae9f4,Aventis Intercontinental - Sanofi-aventis,aventis_intercontinental_sanofi_aventis,,,,695b704d-00ae-4579-8869-ffa0844dbd29,aventis_inc,Aventis Inc -3968,,54afa730-0571-4657-924c-ce8d7c8ad7be,The Royal Marsden Hospital NHS Foundation Trust,the_royal_marsden_hospital_nhs_foundation_trust,,,,,, -1001,0.97408080101013184,e74d2865-0067-48d6-b4c3-98fe172e3b16,Fundación para la Formación e Investigación Sanitaria de la Región de Murcia,fundaci_n_para_la_formaci_n_e_investigaci_n_sanitaria_de_la_regi_n_de_murcia,,,,97bed447-fd0e-4484-9d78-5d7a7aa3b967,fundaci_n_para_la_formaci_n_en_investigaci_n_sanitarias_de_la_regi_n_de_murcia,Fundación para la Formación en Investigación Sanitarias de la Región de Murcia -3969,,9ebc9580-8b83-4fb8-91a3-5902c38e7784,"UMC Utrecht, Julius Center for Health Sciences and Primary Care",umc_utrecht_julius_center_for_health_sciences_and_primary_care,,,,,, -3970,,d9fa81da-ea14-4e7a-806f-4c7ad6ee8228,photonamic GmbH & Co. KG,photonamic_gmbh_co_kg,,,,,, -673,0.989076,9779b86f-f9d6-440c-b621-4e88837285aa,Procter & Gamble Pharmaceuticals Inc,procter_gamble_pharmaceuticals_inc,,,,9779b86f-f9d6-440c-b621-4e88837285aa,procter_gamble_pharmaceuticals_inc,Procter & Gamble Pharmaceuticals Inc -3971,,5aa7e116-7166-11e6-a0cd-0242ac12000b,ACTAVIS INC,actavis_inc,,,,,, -3972,,b3cec21e-32dc-4608-994f-53cda2949c18,Boehringer Ingelheim (Pty) Ltd,boehringer_ingelheim_pty_ltd,,,,,, -26,0.981552,166642d4-cecb-4060-8a23-a1a73c72bbae,"Johns Hopkins University, Department of Neurology",johns_hopkins_university_department_of_neurology,,,,166642d4-cecb-4060-8a23-a1a73c72bbae,johns_hopkins_university_department_of_neurology,"Johns Hopkins University, Department of Neurology" -3973,,1332aa67-4f7a-48f6-9cea-44aab8478ec2,Univar BV,univar_bv,,,,,, -3974,,35416aeb-b94c-4749-8a1c-e54b28b464fe,Steigerwald Arzneimittelwerk GmbH,steigerwald_arzneimittelwerk_gmbh,,,,,, -3975,,f1410e6e-c212-4eb2-b43d-1ddb83e1cc66,UZ Leuven / Belgian Gynaecological Oncology Group,uz_leuven_belgian_gynaecological_oncology_group,,,,,, -3976,,e5de336b-e84e-4be3-9cca-3790fe244b65,Nottingham University Hospital NHS Trust (Research & Development),nottingham_university_hospital_nhs_trust_research_development,,,,,, -3977,,ac04bffa-73f7-11e6-a0cd-0242ac12000b,ROSEMONT PHARMS LTD,rosemont_pharms_ltd,,,,,, -3978,,025f8ded-efa8-4454-b8de-20ad931c0261,"Med. Univ. Wien, Univ. Klinikum für Interne Medizin III",med_univ_wien_univ_klinikum_f_r_interne_medizin_iii,,,,,, -3979,,638b72c8-0ab7-45d1-aa45-add491b742bb,Apogepha Arzneimittel GmbH,apogepha_arzneimittel_gmbh,,,,,, -3980,,df61d578-a93f-4d4d-8f82-194ee97b68c6,SANKYO EUROPE,sankyo_europe,,,,,, -3981,,b2f6e6bb-4ded-4d31-b51c-a081cf03ed42,Hospital Clínic de Barcelona,hospital_cl_nic_de_barcelona,,,,,, -3982,,24336551-4562-4b87-9d14-022e25fad2d0,Medical Center Leeuwarden,medical_center_leeuwarden,,,,,, -3983,,6bafdf34-4811-484b-bae3-8f48b70d8c2d,SagaMedica ehf,sagamedica_ehf,,,,,, -3984,,47c7d188-d907-4b05-a397-3a7a0bc319c9,Baxter AG,baxter_ag,,,,,, -3985,,9df22c29-022e-400e-a5cc-18f6b0583aca,Meerkanten GGz,meerkanten_ggz,,,,,, -3986,,d3fe4dfe-1074-4117-a731-0e5b968569ae,Tengion Inc,tengion_inc,,,,,, -632,0.988363,0be8c403-9955-44a5-a91f-7f50c9773ce9,Grupo Gallego de Cáncer de Pulmón (GGCP),grupo_gallego_de_c_ncer_de_pulm_n_ggcp,,,,0be8c403-9955-44a5-a91f-7f50c9773ce9,grupo_gallego_de_c_ncer_de_pulm_n_ggcp,Grupo Gallego de Cáncer de Pulmón (GGCP) -3987,,cf6990bf-17d4-450a-971d-1535c5e6273e,uniQure biopharma B.V,uniqure_biopharma_b_v,,,,,, -3988,,8f04d90c-b624-4ced-a101-65484f2c2e0b,Laboratoire de la Mer,laboratoire_de_la_mer,,,,,, -3989,,b9a095d7-f513-4580-a6cf-4a43a63e3bd1,University Hospital Azienda Ospedaliero S.Luigi Gonzaga Orbassano,university_hospital_azienda_ospedaliero_s_luigi_gonzaga_orbassano,,,,,, -3990,,38c6b5fc-3253-404c-aa7a-7ea309cf65f7,University Hospital Essen,university_hospital_essen,,,,,, -3991,,75542920-7166-11e6-a0cd-0242ac12000b,PACK PHARMS LLC,pack_pharms_llc,,,,,, -3992,,c1e1cd59-359a-4a7a-a82e-df1ebcc9ab53,Prof. Stefano Gandolfi-Universita` degli studi di Parma,prof_stefano_gandolfi_universita_degli_studi_di_parma,,,,,, -3993,,88c11c85-e7a8-4875-b741-60d5d333b739,OMNINVEST Kft,omninvest_kft,,,,,, -3994,,96ec509c-9897-4847-af75-bb7606199251,Dow Pharmaceutical Sciences Inc,dow_pharmaceutical_sciences_inc,,,,,, -3995,,b7eeead9-df2a-4186-bfd5-fa7bf22de999,Karolinska Universitetssjukhuset Solna,karolinska_universitetssjukhuset_solna,,,,,, -3996,,c7e915be-715d-11e6-a0cd-0242ac12000b,DRAXIMAGE,draximage,,,,,, -3997,,8c3093cc-7161-11e6-a0cd-0242ac12000b,ACTIENT PHARMS,actient_pharms,,,,,, -3998,,381483be-73fc-11e6-a0cd-0242ac12000b,LABORATORIOS SALVAT,laboratorios_salvat,,,,,, -727,0.983703,67dc03a5-4946-452a-be3e-787d57740764,Maastricht University Medical Center,maastricht_university_medical_center,,,,67dc03a5-4946-452a-be3e-787d57740764,maastricht_university_medical_center,Maastricht University Medical Center -3999,,2fa34095-bed2-486c-b506-c0fd3c6bbc1b,Biothera,biothera,,,,,, -4000,,d82a1e9d-7356-44d3-ae34-aa21e234c7d9,"Aastrom Biosciences, Inc",aastrom_biosciences_inc,,,,,, -4001,,2480e7a6-b795-4ee0-af9c-25f5d96e9c0a,A. N. M. C. O. - FONDAZIONE ITALIANA LOTTA MALATTIE CARDIOVASCOLARI,a_n_m_c_o_fondazione_italiana_lotta_malattie_cardiovascolari,,,,,, -4002,,5e609464-7548-4015-920d-61d39b8f43da,Cardiac Reserch Unit,cardiac_reserch_unit,,,,,, -4003,,c88c7f01-6122-4774-bc34-e2fb83276c96,"Melinta Therapeutics, Inc",melinta_therapeutics_inc,,,,,, -403,0.96267104148864746,96771e3a-7163-11e6-a0cd-0242ac12000b,EMCURE PHARMS,emcure_pharms,,,,11645014-715e-11e6-a0cd-0242ac12000b,emcure_pharms,EMCURE PHARMS -4004,,bf8b88d3-bb9a-4465-9ffd-3d1e24441b01,Universitätsmedizin Charite,universit_tsmedizin_charite,,,,,, -4005,,1295b477-1255-4050-93f3-a3003cbdb0b3,Les Laboratoires CTRS,les_laboratoires_ctrs,,,,,, -4006,,e72bd20b-26e8-43e6-8ce3-c6936b581f26,Klinikum der LMU,klinikum_der_lmu,,,,,, -4007,,8fabfef9-09aa-4293-9ce6-8a871c688885,Kell Osterlind,kell_osterlind,,,,,, -1080,0.975398,4d169b05-ac41-460f-9a9b-dbaba35ab0e5,Medice Arzneimittel Pütter GmbH & Co. KG,medice_arzneimittel_p_tter_gmbh_co_kg,,,,4d169b05-ac41-460f-9a9b-dbaba35ab0e5,medice_arzneimittel_p_tter_gmbh_co_kg,Medice Arzneimittel Pütter GmbH & Co. KG -4008,,6697d163-44d2-4a64-80cd-1f224c9a08e1,Heart Center co,heart_center_co,,,,,, -66,0.96240752935409546,1eec3f23-406c-471b-948a-24dcf52e62a1,"AKH Wien, Klinik für Innere Medizin I, Onkologie",akh_wien_klinik_f_r_innere_medizin_i_onkologie,,,,1eec3f23-406c-471b-948a-24dcf52e62a1,akh_wien_klinik_f_r_innere_medizin_i_onkologie,"AKH Wien, Klinik für Innere Medizin I, Onkologie" -4009,,d0bb19a6-44d4-48fa-bff2-035d4845d9df,Hammersmith Hospital,hammersmith_hospital,,,,,, -4010,,44f1a01c-1a8f-4e7c-93c9-e6e6cec26e80,Mikko Hallman/ Oulun yliopisto,mikko_hallman_oulun_yliopisto,,,,,, -180,0.9720233678817749,3c2638d2-7378-11e6-a0cd-0242ac12000b,VALEANT PHARMS INC,valeant_pharms_inc,,,,0b232628-7206-11e6-a0cd-0242ac12000b,valeant_pharms,VALEANT PHARMS -345,0.96143,66393a08-7129-11e6-a89e-0242ac12000b,BARR,barr,,,,66393a08-7129-11e6-a89e-0242ac12000b,barr,BARR -4011,,55864b1b-008f-499e-8d7b-4c0678c18847,AZIENDA OSPEDALIERA VINCENZO MONALDI DI NAPOLI,azienda_ospedaliera_vincenzo_monaldi_di_napoli,,,,,, -4012,,7fafef2d-4c7d-4a30-a4b8-feb747f69c2c,"Department of Academic Endocrinology, Beaumont Hospital",department_of_academic_endocrinology_beaumont_hospital,,,,,, -4013,,e9671d16-ea97-4b05-8ede-92b33114394c,Valeas SpA,valeas_spa,,,,,, -4014,,d6b5e5ea-b108-4299-b6bf-811a98896021,"Azienda Ospedaliera Fatebenefratelli e Oftalmico - Milano, Italy",azienda_ospedaliera_fatebenefratelli_e_oftalmico_milano_italy,,,,,, -4015,,4a849d42-dc7e-4542-a76b-92df61ad08fd,"Forest Research Institute, Inc",forest_research_institute_inc,,,,,, -486,0.97645202279090881,e6237908-6daa-4272-adad-f5434c004df0,Sahlgrenska universitetssjukhuset,sahlgrenska_universitetssjukhuset,,,,e6237908-6daa-4272-adad-f5434c004df0,sahlgrenska_universitetssjukhuset,Sahlgrenska Universitetssjukhus -4016,,9840dfd4-63d6-4e87-ae5e-4791ff260b87,Grupo Oncológico Gallego (GOG),grupo_oncol_gico_gallego_gog,,,,,, -4017,,a71efc61-4a83-44ab-af42-91e86803ebec,Northwest Biotherapeutics Inc,northwest_biotherapeutics_inc,,,,,, -4018,,88089406-6fa0-11e6-9663-0242ac12000b,Boehringer Ingelheim Coordination Centre Belgium,boehringer_ingelheim_coordination_centre_belgium,,,,,, -666,0.969108,78549656-23df-4335-b73d-acbb817c4068,NOPHO NHL-group,nopho_nhl_group,,,,57164cff-6f3b-448f-a2a2-cb44b3def10b,nopho,NOPHO -4019,,69604877-f125-442c-bb0f-3ceb9e902a87,IELSG (INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP),ielsg_international_extranodal_lymphoma_study_group,,,,,, -789,0.986288,216d0aa8-7165-11e6-a0cd-0242ac12000b,GRANULES INDIA LTD,granules_india_ltd,,,,216d0aa8-7165-11e6-a0cd-0242ac12000b,granules_india_ltd,GRANULES INDIA LTD -4020,,36941be7-e418-419d-91ed-c01d57bbaa4a,Istituto Nazionale per lo Studio e la Cura dei Tumori di Napoli – Fondazione “G.Pascale”,istituto_nazionale_per_lo_studio_e_la_cura_dei_tumori_di_napoli_fondazione_g_pascale,,,,,, -4021,,2d2c2e3c-b756-4be0-a180-46ba8d4404d0,Women's and Children's Hospital,women_s_and_children_s_hospital,,,,,, -4022,,1b3f6a2a-749e-4fe0-aa6c-d00856ba27e4,"GITMO GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO,CELLULE STAMINALI EMOPOIETICHE E TERAPIA CELLULARE - ONLUS",gitmo_gruppo_italiano_trapianto_di_midollo_osseo_cellule_staminali_emopoietiche_e_terapia_cellulare_onlus,,,,,, -4023,,ca41f28a-abc3-4687-9072-efde36bc129f,UNIVERSITY OF MANCHESTER,university_of_manchester,,,,,, -4024,,32be8361-2542-4df9-a021-708dda25cfd9,L'OREAL,l_oreal,,,,,, -997,0.978108,abff6004-a106-40f9-b146-4c3f25a5ec03,University of Ulm,university_of_ulm,,,,5bbd7601-f97c-4166-b061-6c6d0f6ab946,university_of_ulm_university_hospital_ulm,"University of Ulm, University Hospital Ulm" -4025,,87a538f8-d4f5-4554-81c1-acee1770c26c,Dana Farber Cancer Institute,dana_farber_cancer_institute,,,,,, -4026,,f5f2ba0f-38e9-449d-a20f-ff69f40998b8,StiL Forschungs-GmbH,stil_forschungs_gmbh,,,,,, -599,0.93973445892333984,9cf56282-7e14-4a02-88e7-6e6425636a65,Fundació privada de l'Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,fundaci_privada_de_l_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,,,,53d727ca-f81e-4c5b-a9a5-c177cdd19cfc,fundaci_privada_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Fundació Privada Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau -4027,,225d6d5b-a3d3-4799-8bfe-3d715d619cca,The London Clinic,the_london_clinic,,,,,, -4028,,b2637178-7147-11e6-a0cd-0242ac12000b,ACTAVIS LABS NY INC,actavis_labs_ny_inc,,,,,, -211,0.94713729619979858,d0501fb4-8bc4-11e6-a449-0242ac12000b,"Rigshospitalet, Dapartment of of Clinical Physiology, Nuclear Medicine and PET",rigshospitalet_dapartment_of_of_clinical_physiology_nuclear_medicine_and_pet,,,,6d416153-a74f-11e6-94cb-5656d04fc2b5,rigshospitalet_department_of_clinical_physiology_nuclear_medicine_and_pet,"Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET" -4029,,5f69f891-42d0-45ba-bb62-ac34727868ae,HELP Pharmaceuticals S.A,help_pharmaceuticals_s_a,,,,,, -582,0.98565453290939331,6326b447-28a1-4e90-85c9-3120652dc39b,MSD Finland Oy,msd_finland_oy,,,,1b6900c3-4c54-432a-91f1-2da705f73cdd,msd_finland,MSD Finland -4030,,73dec8c6-10d9-4b11-aec5-eef20a2bffe3,Golden Jubilee National Hospital,golden_jubilee_national_hospital,,,,,, -483,0.933215,4c50d4d9-2093-41e3-ac48-f701d16f0acc,Groupe d'Etudes des Lymphomes de l'Adult,groupe_d_etudes_des_lymphomes_de_l_adult,,,,4c50d4d9-2093-41e3-ac48-f701d16f0acc,groupe_d_etudes_des_lymphomes_de_l_adult,Groupe d'Etudes des Lymphomes de l'Adult -4031,,f0f92c48-2d14-4e8d-9e16-2eba69cae5d3,Biogen GmbH,biogen_gmbh,,,,,, -4032,,f90d580d-4d16-40ff-ab5c-db9fbf5e156d,Hôpital de Jolimont,h_pital_de_jolimont,,,,,, -4033,,43c3dc52-24a3-4ec3-88dd-28a13a99612d,The Florey Institute of Neuroscience and Mental Health,the_florey_institute_of_neuroscience_and_mental_health,,,,,, -4034,,55c001f3-2873-4264-8099-5e4f417564c3,"Medizinische Universitaet Wien, AKH Wien, Innere Medizin III, klin.Abteilung fuer Nephrologie und Dialyse",medizinische_universitaet_wien_akh_wien_innere_medizin_iii_klin_abteilung_fuer_nephrologie_und_dialyse,,,,,, -4035,,c103add9-c7fd-4009-860f-f26802c44fac,University Heart Center Freiburg - Bad Krozingen,university_heart_center_freiburg_bad_krozingen,,,,,, -641,0.97742700576782227,82029ede-b089-4dbb-93ae-f48a58277a9c,Boehringer Ingelheim Danmark A/S,boehringer_ingelheim_danmark_a_s,,,,82029ede-b089-4dbb-93ae-f48a58277a9c,boehringer_ingelheim_denmark_a_s,Boehringer Ingelheim Denmark A/S -4036,,6849ee00-8665-407a-84d1-3326f26ce20e,Fresenius Biotech North America,fresenius_biotech_north_america,,,,,, -4037,,45bf51f4-a239-4afa-ac7b-bbf52da6a1e9,"Merck Sharp & Dhome Corp., a subsidiary of Merck & Co., Inc (hereafter referred to as Sopnsor or Merck)",merck_sharp_dhome_corp_a_subsidiary_of_merck_co_inc_hereafter_referred_to_as_sopnsor_or_merck,,,,,, -4038,,105d33f2-43bb-43dd-b87c-93a7d1c7891f,"Valeant Pharmaceuticals, North America",valeant_pharmaceuticals_north_america,,,,,, -4039,,5772038e-d258-454b-8865-167f6ef0ff92,"University of Kiel, Department of Dermatology",university_of_kiel_department_of_dermatology,,,,,, -4040,,b2f45ef4-7377-11e6-a0cd-0242ac12000b,REMPEX PHARMS INC,rempex_pharms_inc,,,,,, -4041,,64c1fac0-c2c5-444c-85bc-3a2a88a5e0c6,University Hospital Leuven. Dept Hemaetology,university_hospital_leuven_dept_hemaetology,,,,,, -4042,,d9c3aaab-d728-4b42-87a2-80791cc677ff,Dr. Daniel López Aguado. Servicio de Otorrinolaringología. Hospital Universitario de Canarias,dr_daniel_l_pez_aguado_servicio_de_otorrinolaringolog_a_hospital_universitario_de_canarias,,,,,, -297,0.971007,8c8ef9b5-43dd-4ca5-9f4c-348a000dce63,UCB S.A. Pharma Sector,ucb_s_a_pharma_sector,,,,8c8ef9b5-43dd-4ca5-9f4c-348a000dce63,ucb_s_a_pharma_sector,UCB S.A. Pharma Sector -4043,,9b5b5264-e909-4009-8dd8-f62f847ba24c,Santen,santen,,,,,, -374,0.9175071120262146,98ef0b13-ac5f-4431-8738-f853fbd0d57c,Merck Sharp & Dohme Limited,merck_sharp_dohme_limited,,,,98ef0b13-ac5f-4431-8738-f853fbd0d57c,merck_sharp_dohme_limited,Merck Sharp & Dohme Limited -4044,,19397b4e-cf27-4eca-86f6-3159f5ddc989,"Universitätsklinikum Tübingen, Medizinische Klinik I",universit_tsklinikum_t_bingen_medizinische_klinik_i,,,,,, -739,0.95527833700180054,cb0d17fd-3585-442e-a26f-d7c2688f5881,"ICORG, Irish Clinical Oncology Research Group",icorg_irish_clinical_oncology_research_group,,,,44219b72-858c-4e54-8209-9aba06a32318,icorg,ICORG -4045,,aff04017-826f-4cb7-89ab-cd026f645f2b,"FoldRx Pharmaceuticals, Ltd",foldrx_pharmaceuticals_ltd,,,,,, -4046,,86fb937b-ccc9-4bb6-a2ff-b15abec1dcb9,"Dekan des Fachbereichs Medizin der Goethe Universität, represented by the Coordinating Investigator",dekan_des_fachbereichs_medizin_der_goethe_universit_t_represented_by_the_coordinating_investigator,,,,,, -265,0.969508,1f93290f-c593-4d33-b455-91f1096af905,Institut Paoli Calmette,institut_paoli_calmette,,,,1f93290f-c593-4d33-b455-91f1096af905,institut_paoli_calmette,Institut Paoli Calmette -36,0.98114,f0aeca44-9ab7-48b0-b749-ff721b5dd430,"Medical Faculty, Otto-von-Guericke University",medical_faculty_otto_von_guericke_university,,,,d98745c2-011b-495b-a0b3-26372585a6ae,medical_faculty_otto_von_guericke_university_magdeburg,"Medical Faculty, Otto-von-Guericke-University Magdeburg" -4047,,3871ae99-ccf0-4433-b56f-2843fcf3aebb,Azienda Ospedaliero Universitaria ''San Luigi Gonzaga'',azienda_ospedaliero_universitaria_san_luigi_gonzaga,,,,,, -4048,,d210e8b8-73a7-11e6-a0cd-0242ac12000b,GRACEWAY,graceway,,,,,, -4049,,ce5f13e6-8c40-4b41-a95d-40e3790f87e2,NHS Greater Glasgow and Clyde (NHSGG&C)/University of Glasgow (GU),nhs_greater_glasgow_and_clyde_nhsgg_c_university_of_glasgow_gu,,,,,, -4050,,4d05bcf7-42e5-4d6a-bd9b-45de3583ef60,Centre du Cancer,centre_du_cancer,,,,,, -1058,0.94924008846282959,9f433fc9-52ae-42c8-afcf-a91a3762e82b,Pfizer Hellas AE,pfizer_hellas_ae,,,,9f433fc9-52ae-42c8-afcf-a91a3762e82b,pfizer_hellas_ae,Pfizer Hellas AE -4051,,1f7dbd3d-9625-4eb3-bec5-7c5dede55845,Neurologische Uniklinik Regensburg,neurologische_uniklinik_regensburg,,,,,, -4052,,7820cc96-1b18-4241-8887-150c3124f1e7,"Dept of Oncology, Karolinska Universitetssjukhuset",dept_of_oncology_karolinska_universitetssjukhuset,,,,,, -4053,,aae4569d-e938-4113-a3f8-6674ddae75f2,ALFRED E. TIEFENBACHER (GMBH & CO. KG),alfred_e_tiefenbacher_gmbh_co_kg,,,,,, -4054,,12c46acd-f645-43ab-bac6-f76792b84382,"Dept of Anaesthesia, University College Hospital, Galway",dept_of_anaesthesia_university_college_hospital_galway,,,,,, -4055,,0e5958c0-2e71-46ae-b4a5-d115ae6e2df2,Shrewsbury & Telford Hospital NHS Trust,shrewsbury_telford_hospital_nhs_trust,,,,,, -4056,,a444037e-09fe-431a-9ec3-25840628454b,Centre Hospitalier Universitaire de Grenoble,centre_hospitalier_universitaire_de_grenoble,,,,,, -4057,,69dfc873-f968-47e9-a7ee-449d5b784cec,MDS Pharma Services,mds_pharma_services,,,,,, -4058,,8150dd72-4c1c-4b87-8c4b-1efac155d4d7,SALUS Haus GmbH & Co. KG,salus_haus_gmbh_co_kg,,,,,, -226,0.97584396600723267,43372c1e-43ce-4dcb-b2e0-ae9f60081a96,FUNDACIÓ SANT JOAN DE DÉU,fundaci_sant_joan_de_d_u,,,,43372c1e-43ce-4dcb-b2e0-ae9f60081a96,fundaci_sant_joan_de_d_u,FUNDACIÓ SANT JOAN DE DÉU -4059,,80be8450-715b-11e6-a0cd-0242ac12000b,XTTRIUM,xttrium,,,,,, -4060,,8d890050-7158-11e6-a0cd-0242ac12000b,FDC LTD,fdc_ltd,,,,,, -4061,,73264ef4-bc22-4270-a5f3-dc0dc71b681c,Roche S.p.A,roche_s_p_a,,,,,, -4062,,16d6a377-25aa-4f4c-a7a6-d89f7ccf9278,Anergis SA,anergis_sa,,,,,, -4063,,7a55b283-be1c-453d-8387-96efae53cf0e,Myotec Therapeutics Limited,myotec_therapeutics_limited,,,,,, -4064,,160e7919-7ee5-47de-8dcd-c09e5ad55c7b,Aesculap AG,aesculap_ag,,,,,, -4065,,6d8b5e92-2ce9-4d6f-af6b-f1b182080c19,"Division of Clinically Immunology and Rheumatology, AMC",division_of_clinically_immunology_and_rheumatology_amc,,,,,, -4066,,69d07960-b529-47e2-baa7-6111a281aa92,International Committee for Contraception Research of the Population Council,international_committee_for_contraception_research_of_the_population_council,,,,,, -4067,,ee087cb8-0f46-447a-8e84-b37124cc3106,ZISOP Zentrum für interdisziplinäre Schmerztherapie Landeskrankenhaus Klagenfurt,zisop_zentrum_f_r_interdisziplin_re_schmerztherapie_landeskrankenhaus_klagenfurt,,,,,, -4068,,43dffc33-c352-4365-af4f-9022c06fc3e9,ErasmusmMC/ Sophia Children Hospital,erasmusmmc_sophia_children_hospital,,,,,, -4069,,90bf1956-dd0a-454a-aa42-e241656157e4,PARIPharma GmbH,paripharma_gmbh,,,,,, -4070,,7151c5f2-1d59-40f2-8985-2ba3ac659181,University of Aberdeen,university_of_aberdeen,,,,,, -4071,,03ef3575-4088-4db3-81e2-d1e973e30292,Nordic Society of Gynaecological Oncology,nordic_society_of_gynaecological_oncology,,,,,, -4072,,5ed18449-09ba-4fd7-9313-2ff405356443,Departamento de Microbiología. Hospital Clinico San Carlos,departamento_de_microbiolog_a_hospital_clinico_san_carlos,,,,,, -4073,,b1f4f495-75ad-49b0-98d7-6a6b34405f11,MedaPharma,medapharma,,,,,, -4074,,f937bc8c-a47f-4460-bebe-7677575d59cc,Ramón Tormo Carnicé,ram_n_tormo_carnic,,,,,, -231,0.975369,6590967f-139c-4cf2-a3f2-b668fb314794,ORPHAN,orphan,,,,6590967f-139c-4cf2-a3f2-b668fb314794,orphan,ORPHAN -774,0.94804,6af20df4-5eb9-402f-a439-234b9bbabba6,BIOIBERICA S.A,bioiberica_s_a,,,,6af20df4-5eb9-402f-a439-234b9bbabba6,bioiberica_s_a,BIOIBERICA S.A -4075,,9e66c5e1-82fe-44b2-b2e0-9323c176be98,SANTEN INCORPORATED,santen_incorporated,,,,,, -409,0.98716670274734497,ebcee18c-2575-4f77-8b58-639a0e33f007,SCHWARZ BIOSCIENCES,schwarz_biosciences,,,,bafd53c7-e832-4f6f-89c8-d8d0d9dcabe4,schwarz_biosciences,SCHWARZ BIOSCIENCES GmbH -1026,0.96045973896980286,cbf68b19-d5e4-4da2-8beb-843959d4fdbf,Eli Lilly and Company Ltd,eli_lilly_and_company_ltd,,,,d2379c06-dc10-47c7-9eb7-094b64f48366,eli_lilly_and_company,Eli Lilly and Company -4076,,78157c0b-3547-4e6b-bf48-22a93e9195af,C.T. Development Switzerland SARL,c_t_development_switzerland_sarl,,,,,, -4077,,e6659e50-4652-4293-8a6e-1a4733328c3d,The Foundation European Group for Research in Schizophrenia (EGRIS),the_foundation_european_group_for_research_in_schizophrenia_egris,,,,,, -4078,,6c820520-515f-4c85-a0d3-b0012298c287,Public Health Service Amsterdam,public_health_service_amsterdam,,,,,, -4079,,0e03f80a-7142-11e6-a0cd-0242ac12000b,UNICHEM,unichem,,,,,, -4080,,3f3c26ea-73f9-11e6-a0cd-0242ac12000b,ACADIA PHARMS INC,acadia_pharms_inc,,,,,, -4081,,f0ffde36-71d2-11e6-a0cd-0242ac12000b,ALLIANCE PHARM,alliance_pharm,,,,,, -4082,,e482b344-eb7f-4f65-a873-579e7bbf9358,"Fujifilm Kyowa Kirin Biologics Co., Ltd",fujifilm_kyowa_kirin_biologics_co_ltd,,,,,, -4083,,abfe8e02-4f8e-4bad-afe7-0ba1cde03d81,"CONRAD, Eastern Virgina Medical School",conrad_eastern_virgina_medical_school,,,,,, -4084,,720b9da6-7167-11e6-a0cd-0242ac12000b,CHILDRENS HOSP MI,childrens_hosp_mi,,,,,, -329,0.977699,6bb6873c-5a83-4160-9eaa-ca0de2760368,ABBOTT,abbott,,,,00c3e472-71cc-11e6-a0cd-0242ac12000b,abbott_labs,ABBOTT LABS -4085,,aa918d5a-7146-11e6-a0cd-0242ac12000b,VALIDUS PHARMS,validus_pharms,,,,,, -4086,,3eabea78-5e3c-4ca9-87a9-230e27418b44,Merck Sharp & Dohme (MSD),merck_sharp_dohme_msd,,,,,, -4087,,1790a30a-3252-4005-a82a-98753064553d,Luis Fernando López Cortés,luis_fernando_l_pez_cort_s,,,,,, -4088,,78b8579e-18ca-4777-81a2-c667f3636be8,Landspitali - The National University Hospital of Iceland,landspitali_the_national_university_hospital_of_iceland,,,,,, -4089,,8aaebfcb-2e09-4281-a217-e16bdd9e104b,Lek Pharmaceuticals d.d,lek_pharmaceuticals_d_d,,,,,, -4090,,04fa972a-cbc5-40cc-a014-8f51e11aac0e,Colonis Pharma Limited,colonis_pharma_limited,,,,,, -1000,0.98663,80265282-715d-11e6-a0cd-0242ac12000b,TEVA PHARMS USA INC,teva_pharms_usa_inc,,,,80265282-715d-11e6-a0cd-0242ac12000b,teva_pharms_usa_inc,TEVA PHARMS USA INC -4091,,5faf4ac0-542b-4602-9d61-aa40fa1034e8,University Clinic of Heidelberg,university_clinic_of_heidelberg,,,,,, -4092,,e208c3c4-9faa-4c00-adfc-180ae43a85cf,Prague Psychiatric Center,prague_psychiatric_center,,,,,, -4093,,520d0856-f302-47ec-a08b-bc470cbdfa4f,IKEM,ikem,,,,,, -863,0.921141,63ece514-1ecd-4555-8b78-f2736a1ee227,Immunicum AB,immunicum_ab,,,,63ece514-1ecd-4555-8b78-f2736a1ee227,immunicum_ab,Immunicum AB -4094,,0ee8eb9d-cabb-4067-80c9-615833f5bdbe,"MedImmune, Inc",medimmune_inc,,,,,, -4095,,b7b4cf7f-e595-412f-b8fb-bd9075084da7,"Rigshospitalet, Klinisk Farmakologisk Afd. Q7642",rigshospitalet_klinisk_farmakologisk_afd_q7642,,,,,, -4096,,b9e14a9a-cb5c-4961-813e-57ae0e4d7a2d,NovImmune SA,novimmune_sa,,,,,, -4097,,3c7e96b0-2aab-4027-91fb-76e317e71a82,"Children's Hospital, Helsinki University Hospital",children_s_hospital_helsinki_university_hospital,,,,,, -4098,,b7731032-8cb2-4b68-9490-51be91014b7c,Centre Régional de Lutte contre le Cancer Val d'Aurelle- Paul Lamarque,centre_r_gional_de_lutte_contre_le_cancer_val_d_aurelle_paul_lamarque,,,,,, -4099,,9f54d983-ec75-4422-99a9-6fe94e5ce480,CHU d'Angers,chu_d_angers,,,,,, -559,0.971528559923172,e78543a1-45be-413e-ae9a-522fb25ea6da,"Department of Clinical Pharmacology, University of Greifswald",department_of_clinical_pharmacology_university_of_greifswald,,,,e78543a1-45be-413e-ae9a-522fb25ea6da,department_of_clinical_pharmacology,Department of Clinical Pharmacology -4100,,48a51979-97cf-44e6-b5de-adcf5f681844,Noordwest Ziekenhuisgroep,noordwest_ziekenhuisgroep,,,,,, -4101,,5646c540-7145-11e6-a0cd-0242ac12000b,NOVEL LABS INC,novel_labs_inc,,,,,, -4102,,6f6aadea-eca2-4d66-a436-649c03a874f7,"Charité-Universitätsmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie, CRC",charit_universit_tsmedizin_berlin_klinik_f_r_dermatologie_venerologie_und_allergologie_crc,,,,,, -4103,,ea3deaa6-c453-4c70-8308-885a5feda69e,Vectura Group plc,vectura_group_plc,,,,,, -4104,,233033cf-a407-4f97-bd82-16ae439563ad,Bayer Pharmaceutical Corporation,bayer_pharmaceutical_corporation,,,,,, -4105,,9e6264c8-f007-4f79-9a1f-c3ee6f3d601b,Clavis Pharma ASA,clavis_pharma_asa,,,,,, -4106,,bbe561db-fcef-4ba0-a270-a2d3fdf03200,Echo Pharmaceuticals B.V,echo_pharmaceuticals_b_v,,,,,, -4107,,933fb6dc-85a5-46d3-8ea5-22ae5fd45f95,"Cardiothoracic Surgery, Mater Misericordiae University Hospital",cardiothoracic_surgery_mater_misericordiae_university_hospital,,,,,, -4108,,a0377bdc-989d-4d9c-aaa6-956a862fc51a,Moorfields Eye Hospital R&D Department,moorfields_eye_hospital_r_d_department,,,,,, -219,0.980666,bb0251f2-2efa-42a2-8d24-fa858e7ba0cc,Bioprojet Pharma,bioprojet_pharma,,,,bb0251f2-2efa-42a2-8d24-fa858e7ba0cc,bioprojet_pharma,Bioprojet Pharma -4109,,245e9d1e-479d-4abf-8a0f-de32531520a3,AstraZeneca Portugal,astrazeneca_portugal,,,,,, -4110,,c0b15a9c-0129-49c5-827c-3911b64d65d8,Acedemic Medical Center,acedemic_medical_center,,,,,, -828,0.96305406093597412,cb37ddee-92a7-49ef-923e-8c1c2fef3407,INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ,instituto_de_investigacion_sanitaria_fundacion_jimenez_diaz,,,,343d2886-981b-46cc-bdb2-741a4f343dda,instituto_de_investigacion_sanitaria_fjd,INSTITUTO DE INVESTIGACION SANITARIA FJD -4111,,e71cce3e-8bcb-11e6-a449-0242ac12000b,Aalborg Sygehus Syd,aalborg_sygehus_syd,,,,,, -4112,,2c71a2a6-721e-11e6-a0cd-0242ac12000b,COLUMBIA RES LABS,columbia_res_labs,,,,,, -510,0.987557,e9a42e37-401d-4868-87b7-1a8a996b651e,Joint Research Office- UCL,joint_research_office_ucl,,,,9a59c260-eca4-4f86-a0fa-fed650d1712a,joint_research_office,Joint Research Office -4113,,74bc3e6e-5505-49c4-9866-319ff7f0b5f0,German Breast Group GBG Forschungsgesellschaft mbH (Sponsor nach GCP),german_breast_group_gbg_forschungsgesellschaft_mbh_sponsor_nach_gcp,,,,,, -4114,,6c46704b-e2dc-4577-9197-22e07b64d6ac,OPHTHOTECH CORPORATION,ophthotech_corporation,,,,,, -4115,,a4b0c222-8dcb-4c44-87a0-f51876e01ba0,"Chelsea Therapeutics, Incorporated",chelsea_therapeutics_incorporated,,,,,, -4116,,9b8a1cd3-001d-4722-83ef-b3aa8394d486,"NGM Biopharmaceuticals, Inc",ngm_biopharmaceuticals_inc,,,,,, -833,0.975572,2a713a15-71e1-4a58-a888-238d8c875592,"Aalborg University Hospital, Aalborg Psychiatric Hospital, Centre for Schizophrenia",aalborg_university_hospital_aalborg_psychiatric_hospital_centre_for_schizophrenia,,,,2a713a15-71e1-4a58-a888-238d8c875592,aalborg_university_hospital_aalborg_psychiatric_hospital_centre_for_schizophrenia,"Aalborg University Hospital, Aalborg Psychiatric Hospital, Centre for Schizophrenia" -4117,,50efdb7e-7f87-4ace-b6c6-f7e6dbdc2b6f,ratiopharm GmbH,ratiopharm_gmbh,,,,,, -637,0.987943,9557c854-7151-11e6-a0cd-0242ac12000b,TORRENT PHARMS,torrent_pharms,,,,2629fa8a-7163-11e6-a0cd-0242ac12000b,torrent_pharm,TORRENT PHARM -4118,,051f156a-0a2e-4c31-bc47-2f50acb6e164,Mipharm SpA,mipharm_spa,,,,,, -4119,,c6312308-9f66-4622-8534-9a1692347ac8,Bioforce GmbH,bioforce_gmbh,,,,,, -4120,,70232fca-06aa-4647-93a2-621b8cf5774e,Christie Hospital NHS Foundation Trust,christie_hospital_nhs_foundation_trust,,,,,, -4121,,4ef30c02-3cb7-4e5e-84ce-9bbf99f9b510,Royal Liverpool Children’s NHS Trust,royal_liverpool_children_s_nhs_trust,,,,,, -582,0.98565453290939331,1b6900c3-4c54-432a-91f1-2da705f73cdd,MSD Finland,msd_finland,,,,1b6900c3-4c54-432a-91f1-2da705f73cdd,msd_finland,MSD Finland -4122,,bccd565a-7166-11e6-a0cd-0242ac12000b,UNIMARK REMEDIES LTD,unimark_remedies_ltd,,,,,, -4123,,a32e060e-715c-11e6-a0cd-0242ac12000b,MYLAN PHARMA,mylan_pharma,,,,,, -177,0.98774003982543945,e5e8a69e-4787-4a3a-9804-66149fdcdf95,Swedish Orphan Biovitrum AB (publ),swedish_orphan_biovitrum_ab_publ,,,,417b3184-7ddd-49f2-af9e-84fb79bab1fd,swedish_orphan_biovitrum_ab,Swedish Orphan Biovitrum AB -4124,,c6b09f34-f15a-485e-897a-67ac5a66f234,Thallion Pharmaceuticals Inc,thallion_pharmaceuticals_inc,,,,,, -4125,,c944e572-8eff-42e5-963b-1683757fc027,"Dr. Gerhard Mann, Chem-pharm. Fabrik GmbH",dr_gerhard_mann_chem_pharm_fabrik_gmbh,,,,,, -4126,,45f77a7a-a7ae-4656-ad97-afa970199d17,Strathmann GmbH & Co. KG,strathmann_gmbh_co_kg,,,,,, -4127,,3a1fb1a6-d0b1-4559-8b01-9413e51af31e,Hertfordshire Partnership University NHS Foundation Trust,hertfordshire_partnership_university_nhs_foundation_trust,,,,,, -4128,,2048993a-73ef-11e6-a0cd-0242ac12000b,AIR LIQUIDE LARGE INDUSTRIES US LP,air_liquide_large_industries_us_lp,,,,,, -521,0.965089,1a46a2d5-d4cb-4f3f-8731-ed0b10a5b6d9,Department of Anaesthesia & General Intensive Care Medicine,department_of_anaesthesia_general_intensive_care_medicine,,,,1a46a2d5-d4cb-4f3f-8731-ed0b10a5b6d9,department_of_anaesthesia_general_intensive_care_medicine,Department of Anaesthesia & General Intensive Care Medicine -4129,,9abff547-d206-4c53-bbe6-28ac624fa23b,María Isabel López Gálvez-Instituto Universitario de Oftalmobiología Aplicada-Universidad Valladolid,mar_a_isabel_l_pez_g_lvez_instituto_universitario_de_oftalmobiolog_a_aplicada_universidad_valladolid,,,,,, -4130,,8d739af8-7158-11e6-a0cd-0242ac12000b,GLENMARK GENERICS,glenmark_generics,,,,,, -4131,,cdba6620-fad5-49d1-9c62-79e4e6a97cf5,Lundbeck Inc,lundbeck_inc,,,,,, -4132,,dafc8059-92b6-4dee-aae5-a64555de0906,"Bayer AB, Bayer Health Care, Bayer Schering Pharma",bayer_ab_bayer_health_care_bayer_schering_pharma,,,,,, -4133,,ec18346c-8684-40e7-b9d5-446cfc9ffee9,"Akademische Eigenstudie, Sektion für Hygiene und Medizinische Mikrobiologie",akademische_eigenstudie_sektion_f_r_hygiene_und_medizinische_mikrobiologie,,,,,, -4134,,8b800524-6315-440f-bddf-eb308120655f,Barrier Therapeutics nv,barrier_therapeutics_nv,,,,,, -4135,,85629318-0b3f-4952-8ea4-9faa7f721ee5,BTI Biotechnology Institute I mas D,bti_biotechnology_institute_i_mas_d,,,,,, -367,0.98357802629470825,e8216e75-b447-4252-bb49-7b895bcf4108,Bayer HealthCare,bayer_healthcare,,,,e8216e75-b447-4252-bb49-7b895bcf4108,bayer_healthcare,Bayer HealthCare -4136,,60a990e3-7cff-41d7-b318-8e5b9142983e,"Univ.-Prof. Dr. Hans F. Merk, Dept. of Dermatology, University Hospital, RWTH Aachen University",univ_prof_dr_hans_f_merk_dept_of_dermatology_university_hospital_rwth_aachen_university,,,,,, -4137,,6fe3181b-0837-4ecc-85e9-86976c5b0a93,"Theravance, Inc",theravance_inc,,,,,, -4138,,3227eff6-7373-11e6-a0cd-0242ac12000b,SHIRE HUMAN GENETIC,shire_human_genetic,,,,,, -4139,,4c227b6c-229c-43dc-b2ed-b31d7f16f7b4,"Faculty of Medicine at Georg August University,Goettingen, Germany",faculty_of_medicine_at_georg_august_university_goettingen_germany,,,,,, -4140,,a90a94b6-09ed-41fe-8348-9cbc74262899,"TAIHO PHARMA USA, INC",taiho_pharma_usa_inc,,,,,, -4141,,b35fdc90-72de-11e6-a0cd-0242ac12000b,FUJISAWA HLTHCARE,fujisawa_hlthcare,,,,,, -4142,,971d0a5b-3536-4368-b43f-9b2ee78c9652,Hospital S. Joao,hospital_s_joao,,,,,, -4143,,3f010b23-9b5e-4ef5-ab92-b2beb739ee11,"Department of Medical Research, Odense University Hospital, Svendborg Hospital",department_of_medical_research_odense_university_hospital_svendborg_hospital,,,,,, -4144,,6cf48bc6-beb2-4193-82a8-69cee7b5abee,Biomet Nederland BV,biomet_nederland_bv,,,,,, -4145,,ed2bd3e9-3e6a-4d7f-8e52-218a8373deca,Tarja Heiskanen,tarja_heiskanen,,,,,, -4146,,fb22fcd9-6e10-46ca-8c5b-e91fa89c9ccc,COG,cog,,,,,, -4147,,401c6953-fe04-49f4-b016-8f35303d653d,Håkan Ledin (investigator initiated trial),h_kan_ledin_investigator_initiated_trial,,,,,, -4148,,25a2bb80-d09c-43c3-a97b-c965ec33b0b4,Association Hospitalière CHU Brugmann,association_hospitali_re_chu_brugmann,,,,,, -4149,,26564a88-73eb-11e6-a0cd-0242ac12000b,CELGENE CORP,celgene_corp,,,,,, -4150,,38bd47d3-098d-45b6-b696-7725c10d26da,Myogen Inc,myogen_inc,,,,,, -4151,,943a57a8-9ad2-4eef-bd91-4829bc8ef8e1,Friedrich-Schiller-University of Jena,friedrich_schiller_university_of_jena,,,,,, -4152,,5ff088eb-0498-452b-8023-e3f8c93bcb1e,"Cytori Therapeutics, Inc",cytori_therapeutics_inc,,,,,, -4153,,85c9444c-7158-11e6-a0cd-0242ac12000b,ARCO PHARMS LLC,arco_pharms_llc,,,,,, -4154,,f8c6f536-f98b-4634-a368-8e69b98b0f43,INNOVIVE Pharmaceuticals,innovive_pharmaceuticals,,,,,, -4155,,420f4a86-84a7-4f7e-b616-fc0664f4ba4e,"North West London Hospitals NHS Trust, R&D Office",north_west_london_hospitals_nhs_trust_r_d_office,,,,,, -461,0.97450399398803711,72ebe678-1bc7-497b-9e19-848ac5196416,Debiopharm International S.A,debiopharm_international_s_a,,,,006566e8-3afd-4507-99a0-43f66a5ab93a,debiopharm,Debiopharm -4156,,7153e2b6-0ed0-43b2-8afa-1b003b4ab4ca,Universitaetsklinikum Hamburg,universitaetsklinikum_hamburg,,,,,, -4157,,593ca5f8-6fbf-11e6-abe8-0242ac12000b,Shire Pharmaceuticals Development Ltd,shire_pharmaceuticals_development_ltd,,,,,, -4158,,04b11562-7129-11e6-a89e-0242ac12000b,EASTMAN KODAK,eastman_kodak,,,,,, -4159,,b54dbc0e-6fa3-11e6-9663-0242ac12000b,"Dept. of Clinical Pharmacy, Radboud UMC Nijmegen, The Netherlands",dept_of_clinical_pharmacy_radboud_umc_nijmegen_the_netherlands,,,,,, -4160,,d1b4fcc5-8260-418a-a50a-75e79bce4b41,"Sanofi-Synthelabo Produtos Farmaceuticos, S.A",sanofi_synthelabo_produtos_farmaceuticos_s_a,,,,,, -4161,,9c008c8a-8bc9-11e6-a449-0242ac12000b,Medizinische Universität Wien/Univ.klinik für Innere Medizin III/Abteilung für Nephrologie und Dialyse/Prof Josef Smolen,medizinische_universit_t_wien_univ_klinik_f_r_innere_medizin_iii_abteilung_f_r_nephrologie_und_dialyse_prof_josef_smolen,,,,,, -4162,,11ee5361-7798-40db-87bb-fd97b752b851,Keele University,keele_university,,,,,, -4163,,a549c2f9-1337-4689-ad3d-acb2fd93682c,Gamida Cell Ltd,gamida_cell_ltd,,,,,, -183,0.959379,5c17ba0c-11f6-4fbe-8689-f48af0fac056,"Cliniques Universitaires St Luc, Centre du Cancer",cliniques_universitaires_st_luc_centre_du_cancer,,,,5c17ba0c-11f6-4fbe-8689-f48af0fac056,cliniques_universitaires_st_luc_centre_du_cancer,"Cliniques Universitaires St Luc, Centre du Cancer" -4164,,6852269b-3e58-4f35-bfa6-775cd1828d6f,HOSPITAL DE LA SANTA CREU I SANT PAU,hospital_de_la_santa_creu_i_sant_pau,,,,,, -4165,,c2ef189c-b56f-47cd-80e9-fcb598bfcda0,"Meical University, Dpt. Internal Medicine, Div. of General Internal Medicine",meical_university_dpt_internal_medicine_div_of_general_internal_medicine,,,,,, -4166,,e47f5f30-2d96-48d0-b0d1-7cab24238bd1,University of Edinburgh and NHS Lothian Health Board,university_of_edinburgh_and_nhs_lothian_health_board,,,,,, -721,0.98208,661f25ef-f850-4a8a-a3eb-d86b4bb5d084,TROPHOS SA,trophos_sa,,,,01b65e7e-316f-44bb-97c2-362060dad470,trophos,TROPHOS -4167,,eb6a7352-9e14-479e-9488-952282f8f1d2,UHCW NHS Trust,uhcw_nhs_trust,,,,,, -4168,,98e6cf10-e11e-4da2-af1b-ccb1754cde15,"KRKA ČR, s.r.o",krka_r_s_r_o,,,,,, -4169,,f412fa48-be7f-49fa-955c-7afacf22ad4d,Søren Rittig,s_ren_rittig,,,,,, -4170,,bb7e586c-7805-4154-84dd-a101fc1eb3d7,"Department of experimental and clincial medicine ""F. Magrassi",department_of_experimental_and_clincial_medicine_f_magrassi,,,,,, -4171,,09f16d83-fe4a-4d51-babf-b546da393bc1,Bionor Immuno AS,bionor_immuno_as,,,,,, -4172,,510e1e01-3c6b-4beb-a646-bda21b3c8013,SERVIER Research and Development ICTR (For United Kingdom only),servier_research_and_development_ictr_for_united_kingdom_only,,,,,, -227,0.979411780834198,f73a4ba6-7178-11e6-a0cd-0242ac12000b,ALEXION PHARM,alexion_pharm,,,,bf1a9e59-98fa-461b-84a8-7740b1743049,alexion_pharmaceuticals_inc,"ALEXION PHARMACEUTICALS, INC" -4173,,3461cebc-065b-406d-9101-caa1e0d5364f,"Department of Nephrology, Rigshospitalet, University of Copenhagen",department_of_nephrology_rigshospitalet_university_of_copenhagen,,,,,, -4174,,7b9f5c43-0517-495e-9dcf-453918733c4e,Tommi Vimpeli,tommi_vimpeli,,,,,, -4175,,1b172587-0cc7-45f3-ae55-a1b8994bba9e,Polyphor Ltd,polyphor_ltd,,,,,, -4176,,95390feb-20be-4fc1-9998-ab583134bc75,Center for Biomedical Research of La Rioja (CIBIR),center_for_biomedical_research_of_la_rioja_cibir,,,,,, -4177,,fa5654fd-32d3-4ef3-b66e-5c457e32d715,HOV GmbH,hov_gmbh,,,,,, -4178,,a7a86a96-7376-11e6-a0cd-0242ac12000b,STORZ,storz,,,,,, -4179,,e71fb1f1-362a-4b8a-af8c-e7cd7ac4fabc,sa Novo Nordisk Pharma nv,sa_novo_nordisk_pharma_nv,,,,,, -4180,,8d359990-b7c0-474c-9baa-16399209fee5,"Käkkliniken, Universitetssjukhuset i Linköping",k_kkliniken_universitetssjukhuset_i_link_ping,,,,,, -4181,,a49d6e12-6972-4725-b6e9-bc17b3aa3d9c,Ortopædkirurgisk Forskning - Aarhus Universitetshospita,ortop_dkirurgisk_forskning_aarhus_universitetshospita,,,,,, -4182,,163cea00-129b-4c75-91e1-0b8a20d0d489,"University Medical Centre Ljubljana, Department of Gynaecology",university_medical_centre_ljubljana_department_of_gynaecology,,,,,, -4183,,194d5a2a-c4df-483e-8ecf-81b95b4b2316,RB Pharmaceuticals Inc,rb_pharmaceuticals_inc,,,,,, -4184,,e6d2bf79-88b5-4e40-aa2b-a36c8a77b81d,"Johnson and Johnson Pharmaceutical Research and Development, una división de Janssen-Cilag, S.A",johnson_and_johnson_pharmaceutical_research_and_development_una_divisi_n_de_janssen_cilag_s_a,,,,,, -622,0.984184,d9ad1860-71ec-11e6-a0cd-0242ac12000b,EMD SERONO INC,emd_serono_inc,,,,9262c2fe-71a9-11e6-a0cd-0242ac12000b,emd_serono,EMD SERONO -4185,,246801f4-41b4-4f24-b4b4-30f7b5d4da08,Praxis Pharmaceutical S.A,praxis_pharmaceutical_s_a,,,,,, -4186,,dfcfdacb-4424-43a9-966c-c668ba46def7,"CELLERIX, S.L",cellerix_s_l,,,,,, -913,0.9859306812286377,28a229c0-5d6e-4889-95a4-444fe02e5e3c,Department of Cardiology,department_of_cardiology,,,,28a229c0-5d6e-4889-95a4-444fe02e5e3c,department_of_cardiology,Department of Cardiology -4187,,a6666551-9aec-4601-bdf4-602aed6bff0a,"Merck Serono International, An affiliate of Merck KGaA, Darmstadt, Germany",merck_serono_international_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,,, -4188,,e9a1f765-09ac-4708-8f5f-2b436721c55f,Laboratories SMB S.A,laboratories_smb_s_a,,,,,, -4189,,68d714b6-d5f0-4c9c-a148-a31f16d57c82,Elan Regulatory Holdings Ltd,elan_regulatory_holdings_ltd,,,,,, -4190,,eeade63a-8bc9-11e6-a449-0242ac12000b,"The Fertility Clinic, Skive Regional Hospital",the_fertility_clinic_skive_regional_hospital,,,,,, -4191,,917063ef-0f92-4b31-a4a6-0c69fb8f7700,Roche Pharma AG,roche_pharma_ag,,,,,, -391,0.988144,4d1c7b0c-14e8-4b45-86cf-b9594868a087,"Threshold Pharmaceuticals, Inc",threshold_pharmaceuticals_inc,,,,4d1c7b0c-14e8-4b45-86cf-b9594868a087,threshold_pharmaceuticals_inc,"Threshold Pharmaceuticals, Inc" -591,0.981797,028fff30-1193-4fcf-bcc7-abb85c227761,"Genzyme Corporation, a Sanofi company",genzyme_corporation_a_sanofi_company,,,,028fff30-1193-4fcf-bcc7-abb85c227761,genzyme_corporation_a_sanofi_company,"Genzyme Corporation, a Sanofi company" -4192,,13afa8de-225f-4efd-b8dd-20ae4a5b97a3,Crucell Holland BV,crucell_holland_bv,,,,,, -4193,,5b3a0ba0-b24b-4730-b08a-8793d3ec72b1,"Stockholm Läns Landsting, Karolinska University Hospital",stockholm_l_ns_landsting_karolinska_university_hospital,,,,,, -4194,,59955049-cb3d-4db8-bff1-b9757be2d531,ÁREA DE ATENCIÓN INTEGRADA DE ALBACETE,rea_de_atenci_n_integrada_de_albacete,,,,,, -4195,,e7788878-40b1-4aff-963b-3adedeb020d9,University Childrens Hospital,university_childrens_hospital,,,,,, -785,0.9885413646697998,a896ae02-0ec3-47cc-8072-7cf79e6d3551,Medizinische Hochschule Hannover,medizinische_hochschule_hannover,,,,a896ae02-0ec3-47cc-8072-7cf79e6d3551,medizinische_hochschule_hannover,Medizinische Hochschule Hannover -4196,,e1d94d02-72ae-11e6-a0cd-0242ac12000b,EMPI,empi,,,,,, -4197,,d108e64a-71b4-11e6-a0cd-0242ac12000b,SETON PHARM,seton_pharm,,,,,, -613,0.97674435377120972,12caeba5-ed14-4baa-9bbd-829d8aa11d8a,"Erasmus Medical Centre, Department of Anesthesiology",erasmus_medical_centre_department_of_anesthesiology,,,,12caeba5-ed14-4baa-9bbd-829d8aa11d8a,erasmus_medical_centre_department_of_anesthesiology,"Erasmus Medical Centre, Department of Anesthesiology" -4198,,7aee779f-a14d-4ac4-8abe-f87c91de6c9c,FUNDACION C.V. HOSPITAL PROVINCIAL DE CASTELLON,fundacion_c_v_hospital_provincial_de_castellon,,,,,, -4199,,f44acb6a-7de3-48a7-ae7f-7e3e18a95822,Research Institute of Biological Psychiatry Sct. Hans,research_institute_of_biological_psychiatry_sct_hans,,,,,, -4200,,c76372d8-1a96-4a7c-8eee-6dae24086ebe,CHRU Rennes,chru_rennes,,,,,, -4201,,a508f8ee-f395-4c24-8193-a12a02c6d436,GLAXO SMITH KLINE,glaxo_smith_kline,,,,,, -4202,,d67be399-4755-4022-8464-228d4dc65edd,SPHERIUM BIOMED S.L,spherium_biomed_s_l,,,,,, -4203,,b134ac14-8681-4bbc-a87d-4c4a479265ce,University of Essen,university_of_essen,,,,,, -424,0.976266,824bf19e-712a-11e6-a89e-0242ac12000b,AKORN INC,akorn_inc,,,,824bf19e-712a-11e6-a89e-0242ac12000b,akorn_inc,AKORN INC -53,0.98087829351425171,216dbd0a-5b1d-497f-8573-82115e0c5c35,"Med. Univ. Wien, Innere Med. I",med_univ_wien_innere_med_i,,,,0409ac6d-4311-4f84-9569-7d15fbdc4ffc,med_univ_wien,Med. Univ. Wien -4204,,af190c82-883a-4962-ae77-ca71db7dc2cc,GMIHO mbH,gmiho_mbh,,,,,, -426,0.988445,5e11478f-4293-4f4b-84dd-d3dc2a540f03,Leids Universitair Medisch Centrum (LUMC),leids_universitair_medisch_centrum_lumc,,,,5e11478f-4293-4f4b-84dd-d3dc2a540f03,leids_universitair_medisch_centrum_lumc,Leids Universitair Medisch Centrum (LUMC) -4205,,a19aaa7f-6ccd-4793-8621-af68384b888d,ANGELA PUENTE,angela_puente,,,,,, -919,0.985423,6e3bc4ca-7140-11e6-a0cd-0242ac12000b,NOVO NORDISK INC,novo_nordisk_inc,,,,6e3bc4ca-7140-11e6-a0cd-0242ac12000b,novo_nordisk_inc,NOVO NORDISK INC -4206,,93d60d6a-6e96-4fec-ba95-5efc673f09ad,AB-BIOTICS S.A,ab_biotics_s_a,,,,,, -4207,,9edcd4c2-ffc8-47ea-a0e1-484dfa7095c1,HOMVIORA Arzneimittel - Dr. Hagedorn GmbH & Co,homviora_arzneimittel_dr_hagedorn_gmbh_co,,,,,, -4208,,40787b0f-5990-4348-817c-810b76257d16,"ACCORD, NHS Lothian",accord_nhs_lothian,,,,,, -172,0.96988421678543091,4d103db0-46f8-458b-804a-442a7728fad2,"Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA",merck_serono_international_a_branch_of_laboratoires_serono_sa_an_affiliate_of_merck_kgaa,,,,4d103db0-46f8-458b-804a-442a7728fad2,merck_serono_international_a_branch_of_laboratoires_serono_sa_an_affiliate_of_merck_kgaa,"Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA" -4209,,a0228317-cea0-4337-9960-190e3a6151fb,Dr. Francisco Bosa Ojeda,dr_francisco_bosa_ojeda,,,,,, -899,0.98596411943435669,4cfdad12-75d3-4d01-af84-8fd41eb1eaf2,Kuopion yliopistollinen sairaala/Ensihoitokeskus,kuopion_yliopistollinen_sairaala_ensihoitokeskus,,,,3d00d697-8faa-4e4b-bfd7-814eddaee9da,kuopion_yliopistollinen_sairaala,Kuopion yliopistollinen sairaala -1020,0.97842517495155334,44de7c0e-a85b-476f-9b4c-4bc56b21b0df,Orion Corporation,orion_corporation,,,,b56a3044-dedf-4773-b7a5-e6cd18764bcd,orion_corporation_orion_pharma,Orion Corporation Orion Pharma -4210,,a6c75313-8a80-4a69-a423-7183b5dcbbef,CH VERSAILLES,ch_versailles,,,,,, -4211,,031e1192-41bd-4732-abe8-d19cd24645cc,AZIENDA OSPEDALIERA DI PERUGIA,azienda_ospedaliera_di_perugia,,,,,, -433,0.98984676599502563,83f77026-9bf3-42d7-bdf1-59a5d35a6b9b,"Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA",pfizer_inc_235_east_42nd_street_new_york_new_york_10017_usa,,,,83f77026-9bf3-42d7-bdf1-59a5d35a6b9b,pfizer_inc_235_east_42nd_street_new_york_new_york_10017_usa,"Pfizer Inc, 235 East 42nd Street, New York, New York 10017, USA" -4212,,5251ccd7-2fac-4e89-9214-207adc5742e9,Hanmi Pharmaceutical Company Limited,hanmi_pharmaceutical_company_limited,,,,,, -4213,,1e5d63b4-3d79-4a36-8bfd-cff16a822d8b,Matti Välimäki,matti_v_lim_ki,,,,,, -1021,0.97921851277351379,23f78320-5daf-4570-8ce4-866b6d027cd6,"Impax Laboratories, Inc., acting through its Impax Pharmaceuticals Division (Impax)",impax_laboratories_inc_acting_through_its_impax_pharmaceuticals_division_impax,,,,2e27f2ec-dcc5-4828-b31a-e2eca3930c17,impax_laboratories_inc_acting_through_its_impax_pharmaceuticals_division_impax,"Impax Laboratories, Inc., acting through its Impax Pharmaceuticals Division (Impax)" -4214,,a271560d-44df-423b-b625-9f8a71d227ba,Universitätsklinikum Giessen und Marburg - Standort Giessen,universit_tsklinikum_giessen_und_marburg_standort_giessen,,,,,, -4215,,cd9bd8b1-1864-46a2-992a-1368a30d607b,Fakultní nemocnice Plzeň,fakultn_nemocnice_plze,,,,,, -4216,,1ce8c765-0b94-41a3-9d53-ab381874a270,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,fundaci_n_para_la_investigaci_n_biom_dica_hospital_ram_n_y_cajal,,,,,, -4217,,dbb89171-fc0d-484e-acdb-c6578d6b3c48,Guy's and St Thomas NHS Foundation Trust,guy_s_and_st_thomas_nhs_foundation_trust,,,,,, -4218,,9897fd43-a55a-4a69-8473-85670699df64,Nitec Pharma AG,nitec_pharma_ag,,,,,, -886,0.982434,6d20580f-c914-4da7-8a5e-22023506a872,ULB - Unité de Recherche en Lymphologie,ulb_unit_de_recherche_en_lymphologie,,,,2dab8489-6b0d-42e8-91ae-f96f843a7d75,ulb_unit_de_recherche_en_lymphologie_facult_des_sciences_de_la_motricit,ULB - Unité de Recherche en Lymphologie - Faculté des Sciences de la motricité -4219,,22ecffc9-18d6-40a2-bd03-6c7edcfe3ac0,"KH der Elisabethinen Linz GmbH, I. Interne Abteilung",kh_der_elisabethinen_linz_gmbh_i_interne_abteilung,,,,,, -4220,,6c755c92-2c58-41c2-a55a-5096f8919f08,Odense Universitetshospital/Syddansk Universitet,odense_universitetshospital_syddansk_universitet,,,,,, -4221,,eda3f5fb-f5f9-4e2c-8e8a-7b29b6bff95a,"Universität Magdeburg, Medizinische Fakultät",universit_t_magdeburg_medizinische_fakult_t,,,,,, -4222,,411981a9-5166-4805-9210-0860ced3f5c8,Justus Liebig University of Giessen,justus_liebig_university_of_giessen,,,,,, -4223,,3286478e-7190-11e6-a0cd-0242ac12000b,POYTHRESS,poythress,,,,,, -4224,,546e85c6-50a5-490b-b5b7-8cfe57cd5749,University Medical Centre Freiburg,university_medical_centre_freiburg,,,,,, -359,0.97782391309738159,fab0d24f-2629-463f-ba19-f4ddeb577cee,IPSEN,ipsen,,,,453b2e40-8c8e-4dab-8a75-c9364067b629,ipsen_nv,IPSEN NV -267,0.989332,ce97b6ea-53cd-4ff4-ac88-f6f156eafef5,Grupo de Tratamiento de los Tumores Digestivos (TTD),grupo_de_tratamiento_de_los_tumores_digestivos_ttd,,,,9e2eb0ad-e2df-43f2-bc5d-f12af02311cf,grupo_de_tratamiento_de_los_tumores_digestivos,Grupo de Tratamiento de los Tumores Digestivos -4225,,dbea36f3-71fe-4137-a041-3ae6abf2d34f,AstraZeneca LP,astrazeneca_lp,,,,,, -4226,,bda39b46-013a-44ee-bc77-cfbd209869d2,North Staffordshire Combined Healthcare Trust,north_staffordshire_combined_healthcare_trust,,,,,, -207,0.915531,5ac2130a-6fbe-11e6-abe8-0242ac12000b,"BIAL - Portela & Cª, SA",bial_portela_c_sa,,,,46fed310-ee3c-4cc4-8649-37bb315ed072,bial_portela_ca_s_a,"BIAL - Portela & Ca, S.A" -4227,,2c1acae3-0918-4e34-b8f7-3c49664478c9,"Section of Clinical Pain Research, Department of Molecular Medicine and Surgery Karolinska Institute",section_of_clinical_pain_research_department_of_molecular_medicine_and_surgery_karolinska_institute,,,,,, -58,0.97642512619495392,2ed1b6f4-e137-4ee3-a218-9e5c2d04039a,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_and_development,,,,2ed1b6f4-e137-4ee3-a218-9e5c2d04039a,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_and_development,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development -4228,,e91bd950-5eee-4fcf-9668-cce62e0beb4a,Fa. Dr. F. Köhler Chemie GmbH,fa_dr_f_k_hler_chemie_gmbh,,,,,, -4229,,1e09d068-2c48-4818-84b7-e213824b395b,Ardeypharm GmbH,ardeypharm_gmbh,,,,,, -4230,,61b6bc62-f657-4150-b0b1-196edefa6990,Janssen-Cilag AB,janssen_cilag_ab,,,,,, -4231,,c297ad6f-63db-4f3a-a227-836813e4e1d0,Århus Universitetshospital Afd for Eksp. Klinisk onkologi,rhus_universitetshospital_afd_for_eksp_klinisk_onkologi,,,,,, -4232,,3d8a1f00-074b-4775-b47b-03003e1f35bd,"Pfizer Global Research & Development Ltd, Clinical R & D, IPC 137",pfizer_global_research_development_ltd_clinical_r_d_ipc_137,,,,,, -4233,,8efbb4be-94ce-44a5-9469-7114968c5ee5,Cellectis S.A,cellectis_s_a,,,,,, -4234,,1ec971a3-fbdf-495a-99b1-a20ff23a49f6,"Penine Acute NHS Trust, North Manchester General Hospital",penine_acute_nhs_trust_north_manchester_general_hospital,,,,,, -793,0.912188,d6256386-5911-453d-9333-445b4c930805,Amersham Health S.A. (parte de GE Healthcare Ltd y sus filiales),amersham_health_s_a_parte_de_ge_healthcare_ltd_y_sus_filiales,,,,9012ebe0-cafc-4b9e-8d91-e304af97eab8,amersham_health_sa_parte_de_ge_healthcare_ltd_y_sus_filiales,Amersham Health SA (Parte de GE Healthcare Ltd. y sus filiales) -631,0.944644,b7d3a443-d135-4e6c-beeb-dd08968c1fd9,ISTITUTO ORTOPEDICO RIZZOLI,istituto_ortopedico_rizzoli,,,,6e37f726-18bd-47e5-8ffd-231a4eb18b5b,istituti_ortopedici_rizzoli,ISTITUTI ORTOPEDICI RIZZOLI -4235,,6caebb33-4450-4588-a66e-435c7ee46c54,Jukka Sairanen,jukka_sairanen,,,,,, -4236,,a984690e-7156-11e6-a0cd-0242ac12000b,UNIQUE PHARM LABS,unique_pharm_labs,,,,,, -4237,,7f33ccb4-715e-11e6-a0cd-0242ac12000b,GRAHAM CHEM,graham_chem,,,,,, -54,0.987705,22fb394f-9949-4253-b978-e945565c187d,AIBILI - Association for Innovation and Biomedical Research on Light and Image,aibili_association_for_innovation_and_biomedical_research_on_light_and_image,,,,22fb394f-9949-4253-b978-e945565c187d,aibili_association_for_innovation_and_biomedical_research_on_light_and_image,AIBILI - Association for Innovation and Biomedical Research on Light and Image -4238,,fa673582-0dca-4926-99dc-e3ecdfcb7628,Centre Hospitalier Régional Universitaire de Besançon,centre_hospitalier_r_gional_universitaire_de_besan_on,,,,,, -4239,,51af2e30-f5a5-4cbe-bbca-bb483a10e349,GlaxSmithKline Research & Development,glaxsmithkline_research_development,,,,,, -4240,,6ec5a0c5-07e5-43f0-8df1-394f276a682c,"Miravant Pharmaceuticals, Inc",miravant_pharmaceuticals_inc,,,,,, -380,0.97179288334316682,41459cfe-38cc-478e-9688-0c682f4c29ad,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., U.S.A",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_u_s_a,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" -4241,,cce20ff9-0be3-4d4d-b709-54561c103fd5,"Tecnimede, Sociedade Técnico-Medicinal S.A",tecnimede_sociedade_t_cnico_medicinal_s_a,,,,,, -4242,,3cc8985d-a386-4b94-800b-7f8a03f06e3d,AZIENDA ASL BRESCIA,azienda_asl_brescia,,,,,, -4243,,01cb29f9-e6fd-4794-b56f-eec918a63d26,"OSPEDALE CIVILE SAN SALVATORE, ASL 04, L'AQUILA",ospedale_civile_san_salvatore_asl_04_l_aquila,,,,,, -4244,,88d4c0e4-e691-4c9f-b1a8-825ab8e84295,"Prof. Herta Flor, Head of the Institute of Clinical and Cognitive Neuroscience",prof_herta_flor_head_of_the_institute_of_clinical_and_cognitive_neuroscience,,,,,, -343,0.945615,fd3c40c4-9ca3-4b68-8285-dddbe2304d1a,Institut Gustave Roussy,institut_gustave_roussy,,,,df233af1-76b7-4839-86bc-252076367896,institut_gustav_roussy,Institut Gustav Roussy -4245,,b7771802-e505-45fa-933a-1f46a724da4f,Baxter R and D Europe SCRL,baxter_r_and_d_europe_scrl,,,,,, -795,0.982732,a794f8fb-a13b-44b5-98ab-9945768f16df,Medical Research Council,medical_research_council,,,,a794f8fb-a13b-44b5-98ab-9945768f16df,medical_research_council,Medical Research Council -4246,,2f167d26-79b0-4362-b7c5-d4756e85f798,Almirall Hermal GmbH,almirall_hermal_gmbh,,,,,, -4247,,6a64cce1-da60-465f-b41e-fbf98e57f1e3,"Genetronics, Inc",genetronics_inc,,,,,, -4248,,d238a4ed-4918-41c7-8290-aedeb1e884d5,University of Oslo,university_of_oslo,,,,,, -4249,,f92eb1ed-3c9d-4feb-a02a-ded95cb2f00d,FoldRx Pharmaceuticals Limited,foldrx_pharmaceuticals_limited,,,,,, -4250,,3f1b7204-7162-11e6-a0cd-0242ac12000b,METRIC,metric,,,,,, -4251,,031d126c-3c98-4cf1-939c-00ea9d902dc7,"Wyeth Pharmaceutical Co., Ltd",wyeth_pharmaceutical_co_ltd,,,,,, -4252,,9590f45a-ee8e-431f-9e48-de7056af23f6,Laboratorios Gebro Pharma S.A,laboratorios_gebro_pharma_s_a,,,,,, -4253,,67387f3a-7161-11e6-a0cd-0242ac12000b,ASCHER,ascher,,,,,, -4254,,64fc4012-9fa2-4c0c-b45c-cc1aeaa8ba22,CELGENE EUROPE LIMITED,celgene_europe_limited,,,,,, -425,0.96910750865936279,a89061fe-7d3c-47c4-acdc-5ea8273f45e8,HOVON,hovon,,,,a89061fe-7d3c-47c4-acdc-5ea8273f45e8,hovon,HOVON -4255,,aeb1acbc-1f63-42b3-a143-d40a6ee192ae,Lýsi hf,l_si_hf,,,,,, -324,0.98178735375404358,395b5e6f-c249-4152-9918-7fe1c4f16a37,Stiefel Laboratories Maidenhead Ltd,stiefel_laboratories_maidenhead_ltd,,,,0a082bad-97ec-4e82-be7d-2731907614ac,stiefel_laboratories_maidenhead_ltd,Stiefel Laboratories Maidenhead Ltd -4256,,c4afb20c-7141-11e6-a0cd-0242ac12000b,INGENUS PHARMS NJ,ingenus_pharms_nj,,,,,, -4257,,303132ea-7146-11e6-a0cd-0242ac12000b,NEPHRON,nephron,,,,,, -4258,,6207085a-6fa0-11e6-9663-0242ac12000b,Alliance pour la recherche en cancérologie,alliance_pour_la_recherche_en_canc_rologie,,,,,, -4259,,8e1574db-d8e9-46f1-8e1a-1c8a99c39dd5,AZIENDA UNITA` SANITARIA LOCALE N 12 DI VIAREGGIO,azienda_unita_sanitaria_locale_n_12_di_viareggio,,,,,, -4260,,1503c2df-0687-4597-ac14-c6b78b986f0f,Klinikum der Ludwigs-Maximilians-Universität München,klinikum_der_ludwigs_maximilians_universit_t_m_nchen,,,,,, -4261,,b2647ee4-0834-40a2-b3a0-eaf7638f3f02,"Faculty of Medicine Carl Gustav Carus, University of Technology, Dresden",faculty_of_medicine_carl_gustav_carus_university_of_technology_dresden,,,,,, -4262,,ce89fd40-7160-11e6-a0cd-0242ac12000b,MARATHON PHARMS,marathon_pharms,,,,,, -4263,,9b20d422-73c9-11e6-a0cd-0242ac12000b,KASTLE THERAPS LLC,kastle_theraps_llc,,,,,, -4264,,7dc696b7-471e-4851-a98f-39194b4b92f1,Madaus GmbH,madaus_gmbh,,,,,, -4265,,daadce72-a859-499f-a065-aa002eec4e4c,Koege Hospital,koege_hospital,,,,,, -4266,,db88b7c0-8bc8-11e6-a449-0242ac12000b,River Vision Development Corporation,river_vision_development_corporation,,,,,, -4267,,bc2718de-8b27-4f5a-a75d-9c0d1763b834,ANTISOMA,antisoma,,,,,, -687,0.96910750865936279,197d4369-9301-4bac-b737-20a72c9e0d7b,"Ruprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg and its Commercial",ruprecht_karls_university_heidelberg_medical_faculty_represented_by_universit_tsklinikum_heidelberg_and_its_commercial,,,,197d4369-9301-4bac-b737-20a72c9e0d7b,ruprecht_karls_university_heidelberg_medical_faculty_represented_by_universit_tsklinikum_heidelberg_and_its_commercial,"Ruprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg and its Commercial" -4268,,93ab78f5-54d1-4e11-ba0e-cfe0efb74926,Endo Pharmaceuticals Solutions,endo_pharmaceuticals_solutions,,,,,, -4269,,a7d7d862-0cb2-4142-ba1d-ac1b7aa8f03a,Antonio Noda Cabrera,antonio_noda_cabrera,,,,,, -4270,,70031a6e-715f-11e6-a0cd-0242ac12000b,PHARMERAL,pharmeral,,,,,, -114,0.97253835201263428,c0e26a28-8145-497a-8f48-d935495cc957,Shire Pharmaceutical Ireland Limited,shire_pharmaceutical_ireland_limited,,,,c0e26a28-8145-497a-8f48-d935495cc957,shire_pharmaceutical_ireland_limited,Shire Pharmaceutical Ireland Limited -64,0.986698,ccc2695d-93a7-4900-a3b6-e4bb0c11c688,Wilhelmina Children's Hospital/UMC Utrecht,wilhelmina_children_s_hospital_umc_utrecht,,,,ccc2695d-93a7-4900-a3b6-e4bb0c11c688,wilhelmina_children_s_hospital_umc_utrecht,Wilhelmina Children's Hospital/UMC Utrecht -4271,,1d903e05-a70d-11e6-94cb-5656d04fc2b5,Dr. José Maria Ruiz Moreno,dr_jos_maria_ruiz_moreno,,,,,, -4272,,4589aa48-ef44-4cdc-9166-6f88cefc1a85,Nottingham University Hospital NHS Trust,nottingham_university_hospital_nhs_trust,,,,,, -4273,,04b1d427-b4e6-4b02-bc6e-08a6af2ad760,State University Hospital,state_university_hospital,,,,,, -4274,,5fbb2589-b48e-4396-959e-0734e5b8920c,Lofarma S.p.A,lofarma_s_p_a,,,,,, -4275,,63728a44-7157-11e6-a0cd-0242ac12000b,CORNERSTONE,cornerstone,,,,,, -4276,,9d0bf600-a04f-47cb-ba9d-ec1558a02a5d,CHU AMBROISE PARE,chu_ambroise_pare,,,,,, -939,0.9797365665435791,2c899cf4-2f23-4023-b9ab-f8d5356588d9,Hospira,hospira,,,,2c899cf4-2f23-4023-b9ab-f8d5356588d9,hospira,Hospira -4277,,0c8f9b0e-53c3-46c6-8426-358806ac4b5d,Moberg Derma,moberg_derma,,,,,, -4278,,3c9aa55a-2e8b-4802-972c-3df8e83b39d8,ONCOGENEX TECHNOLOGIES INC,oncogenex_technologies_inc,,,,,, -4279,,7ebdf960-6a78-4158-b661-b07ff7b72ebb,TESARO Inc,tesaro_inc,,,,,, -4280,,e4cb387e-7199-11e6-a0cd-0242ac12000b,ATON,aton,,,,,, -4281,,86b6de43-8f6d-4e2a-83e0-b6223c58af3a,Swiss Cardio Technologies AG,swiss_cardio_technologies_ag,,,,,, -4282,,4f44f707-d794-46ed-90f4-c6ecc0600ba1,Medical Institutions of the District Oberpfalz/Bayern (MedBO GmbH),medical_institutions_of_the_district_oberpfalz_bayern_medbo_gmbh,,,,,, -4283,,d1ba0e7a-71f0-11e6-a0cd-0242ac12000b,PROSTRAKAN INC,prostrakan_inc,,,,,, -4284,,2ceb150b-7539-453c-806a-13d2f29cab85,sanofi synthelabo recherche,sanofi_synthelabo_recherche,,,,,, -380,0.97164037492540145,a89c5de9-eac7-4005-9478-f0cb55dbc2ac,"Merck Sharp & Dohme Corp., a subsidary of Merck & Co., Inc",merck_sharp_dohme_corp_a_subsidary_of_merck_co_inc,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" -4285,,b081a381-f1b2-42bf-9eb4-98aa889debb0,Charité-Campus Mitte und Campus Virchow-Klinikum,charit_campus_mitte_und_campus_virchow_klinikum,,,,,, -4286,,53241b6f-40a8-466a-9b46-7fde5e91f151,"Medizinische Universität Graz, Universitätsklinik für Zahn-, Mund- und Kieferheilkunde",medizinische_universit_t_graz_universit_tsklinik_f_r_zahn_mund_und_kieferheilkunde,,,,,, -4287,,b97ba26a-d35e-49f4-a98a-ed3a51100c4e,"Hæmatologisk Afsnit, Vejle Sygehus",h_matologisk_afsnit_vejle_sygehus,,,,,, -399,0.988953,3d14aa9b-70db-4d32-a4ed-e782e954b0db,Groupe Francophone des Myélodysplasies (GFM),groupe_francophone_des_my_lodysplasies_gfm,,,,33290af1-5e28-4e4a-85eb-2b145405dc27,groupe_francophone_des_my_lodysplasies,Groupe Francophone des Myélodysplasies -4288,,7495cbd2-a273-4dda-987c-9a50db0d5ca0,"University Hospital of Antwerp, Department of Respiratory Medicine",university_hospital_of_antwerp_department_of_respiratory_medicine,,,,,, -4289,,e00b0475-322d-4705-8b3c-80d70b11480d,"Helsingin Lääkärikeskus Oy, Graviditas Lapsettomuusklinikka",helsingin_l_k_rikeskus_oy_graviditas_lapsettomuusklinikka,,,,,, -761,0.958103,931e7207-ea0c-4262-baf3-da49815f8901,"The Heart Centre, Rigshospitalet",the_heart_centre_rigshospitalet,,,,931e7207-ea0c-4262-baf3-da49815f8901,the_heart_centre_rigshospitalet,"The Heart Centre, Rigshospitalet" -4290,,5230a359-baf1-45b3-a9ab-f99306ed8e73,AESCA Pharma GmbH,aesca_pharma_gmbh,,,,,, -839,0.952896,9ac934a2-f363-48d8-8da4-a925d66bd5cc,Newcastle Hospital Trust,newcastle_hospital_trust,,,,9ac934a2-f363-48d8-8da4-a925d66bd5cc,newcastle_hospital_trust,Newcastle Hospital Trust -4291,,f98bb0b6-c402-41ef-803c-4c36575a5db7,"BioMimetic Therapeutics, Inc",biomimetic_therapeutics_inc,,,,,, -98,0.979094,76157ebc-7bea-4a83-a2ca-6c02e460c234,University of Leipzig,university_of_leipzig,,,,76157ebc-7bea-4a83-a2ca-6c02e460c234,university_of_leipzig,University of Leipzig -215,0.983343,138e388c-71e0-11e6-a0cd-0242ac12000b,LEO PHARMA AS,leo_pharma_as,,,,138e388c-71e0-11e6-a0cd-0242ac12000b,leo_pharma_as,LEO PHARMA AS -4292,,3388d6f8-7314-11e6-a0cd-0242ac12000b,SERB SA,serb_sa,,,,,, -4293,,5bd0da91-8f94-4e98-8b9b-ad3b9c0bfd7c,CHU de Rennes,chu_de_rennes,,,,,, -4294,,1e1d7ecc-460e-47e8-af08-4b0fe7b43dc2,"Department of Genitourinary medicine and Infectious Diseases, St James's Hospital, Dublin 8",department_of_genitourinary_medicine_and_infectious_diseases_st_james_s_hospital_dublin_8,,,,,, -4295,,1ef11de6-ed5a-41d0-915d-85f60590468d,Thoraxclinic at the University of Heidelberg,thoraxclinic_at_the_university_of_heidelberg,,,,,, -4296,,1d0850bb-a709-11e6-94cb-5656d04fc2b5,"Bente Lomholt Langdahl, Dept. of Endocrinology and Internal Medicine, Aarhus University Hospital",bente_lomholt_langdahl_dept_of_endocrinology_and_internal_medicine_aarhus_university_hospital,,,,,, -4297,,1be637e6-1957-4157-8056-a39e2b2f2182,Grupo Español de Tratamiento de Tumores Genitourinarios (SOGUG)-Spanish Genitourinary Oncologic Group,grupo_espa_ol_de_tratamiento_de_tumores_genitourinarios_sogug_spanish_genitourinary_oncologic_group,,,,,, -4298,,ca3ab57a-3b65-431d-86c5-621a31896748,Prosensa Holding B.V,prosensa_holding_b_v,,,,,, -4299,,82c3056b-8fd2-4b35-935f-621074ee1d40,Repha GmbH,repha_gmbh,,,,,, -4300,,6f094a41-e19a-4d0c-b76b-610d830d5922,"Azienda Ospedaliero Universitaria Careggi, Firenze",azienda_ospedaliero_universitaria_careggi_firenze,,,,,, -4301,,928f550b-a74e-11e6-94cb-5656d04fc2b5,Rockefeller University,rockefeller_university,,,,,, -4302,,14bd7782-2ecf-4ad0-853f-932e4720fd10,GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa),geteccu_grupo_espa_ol_de_trabajo_en_enfermedad_de_crohn_y_colitis_ulcerosa,,,,,, -4303,,b713bf29-a0fa-4ced-876b-002d682612e0,"Department of medical gastroenterology, Herlev Hospital",department_of_medical_gastroenterology_herlev_hospital,,,,,, -4304,,e3a4725b-522b-4e16-a5fc-c62428e099b8,"Rigshospitalet, Kardiologisk afd",rigshospitalet_kardiologisk_afd,,,,,, -4305,,5e06d300-7164-11e6-a0cd-0242ac12000b,GENERA PHARMS,genera_pharms,,,,,, -4306,,3adfa772-740d-4b9a-98cd-7e55cf33b091,Amersham Health AB,amersham_health_ab,,,,,, -416,0.968388,f1cda425-4d6d-4eb7-95bd-c4d3ae48a550,Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME),fraunhofer_gesellschaft_for_its_institute_fraunhofer_institute_for_molecular_biology_and_applied_ecology_ime,,,,da6ce2e0-306e-4461-9ae3-5767282527c6,fraunhofer_gesellschaft,Fraunhofer Gesellschaft -4307,,3bc42ea2-0f5f-475c-a4d9-876fd6653785,Pharmecosse,pharmecosse,,,,,, -1046,0.98746395111083984,6de197b9-6b4f-41ef-b8a0-fbee9c50e584,Synta Pharmaceutical Corp,synta_pharmaceutical_corp,,,,6de197b9-6b4f-41ef-b8a0-fbee9c50e584,synta_pharmaceutical_corp,Synta Pharmaceutical Corp -4308,,188ce049-5fc4-46bc-9520-a10ad3c5ce59,Ninewells Hospital and Medical School,ninewells_hospital_and_medical_school,,,,,, -4309,,9e2395ca-71c0-11e6-a0cd-0242ac12000b,HERITAGE LIFE,heritage_life,,,,,, -4310,,958701a9-46d7-44eb-8de5-483a1334139d,St George's Healthcare NHS Trust,st_george_s_healthcare_nhs_trust,,,,,, -4311,,913e7f10-1d4f-4c89-bd06-364c74b11f57,"Univerzita Karlova v Praze, Lékařská fakulta v Hradci Králové",univerzita_karlova_v_praze_l_ka_sk_fakulta_v_hradci_kr_lov,,,,,, -4312,,07cde2bc-0932-40f4-a70e-588ecb76af65,Santhera Pharmaceuticals (Switzerland) Limited,santhera_pharmaceuticals_switzerland_limited,,,,,, -4313,,409822e1-791d-4990-801f-94d60328b102,Central Manchester University Hospitals NHS Foundation Trust,central_manchester_university_hospitals_nhs_foundation_trust,,,,,, -4314,,62dcee78-0e64-417e-9494-24a08895268d,Sakari Simula,sakari_simula,,,,,, -4315,,de86f2ed-4dd8-406c-b5d8-26864a95746d,Klinik für Psychiatrie und Psychotherapie der Ludwig Maximilian Universität München,klinik_f_r_psychiatrie_und_psychotherapie_der_ludwig_maximilian_universit_t_m_nchen,,,,,, -4316,,266f1e7c-78ff-44c9-8607-87900aa1ec06,Arana Therapeutics Ltd,arana_therapeutics_ltd,,,,,, -4317,,cf0e6880-139b-4e22-99c7-e0d3a4350ebf,"Tallaght Hospital, Dublin 24, Ireland",tallaght_hospital_dublin_24_ireland,,,,,, -4318,,2288b24e-18b1-4587-a5bd-18fa5cef8311,"Faustus Forschung Compagnie, Translational Cancer Research GmbH",faustus_forschung_compagnie_translational_cancer_research_gmbh,,,,,, -4319,,ff4ec925-549f-4382-bab7-3b512b37e04e,Aker BioMarine Antarctic AS,aker_biomarine_antarctic_as,,,,,, -157,0.95453011989593506,8d3cf1b7-c472-4063-8fda-cf934f8ed3b1,"Medizinische Universität Wien, Univ. Klinik für Dermatologie",medizinische_universit_t_wien_univ_klinik_f_r_dermatologie,,,,f215164e-8e75-4f48-b691-ea2bfd10d042,medizinische_universit_t_wien_univ_klinik_f_r_dermatologie,"Medizinische Universität Wien, Univ. Klinik für Dermatologie" -4320,,9fdecd75-6697-4052-89df-739d808d7710,Purdue Pharma L.P,purdue_pharma_l_p,,,,,, -4321,,a7d45a7f-0718-481c-af1b-9b004c2b2a9f,Ingrid Ehrén,ingrid_ehr_n,,,,,, -465,0.96418339014053345,e833ee0f-dd63-4035-b57e-eb474fdbcfaf,Leiden University Medical Centre,leiden_university_medical_centre,,,,2e4a0d21-5259-4b26-b5dd-ed587c02073f,leiden_university,Leiden University -4322,,4d4532ea-71b0-11e6-a0cd-0242ac12000b,PROMIUS PHARMA,promius_pharma,,,,,, -4323,,fa8a93e3-50b6-4b14-a567-bccc5fe8bd3d,Boehringer Ingelheim Austia Gm.b.H,boehringer_ingelheim_austia_gm_b_h,,,,,, -4324,,c9719cf9-dde9-4484-917e-8a67a92dcce4,"Department of Psychiatry, LMU Munich",department_of_psychiatry_lmu_munich,,,,,, -4325,,ba3da241-1200-4961-97d8-647574abf1e8,Nordsjællands Hospital. Dept. of Anaesthesiology and Intensive Care,nordsj_llands_hospital_dept_of_anaesthesiology_and_intensive_care,,,,,, -4326,,7a7f7990-dd94-42e6-9f4c-fc02c76e6c59,Spherium Biomed,spherium_biomed,,,,,, -4327,,7cfe35e7-bb26-42d6-aec2-793366ebba2e,Jose Luis Ponce Díaz-Reixa,jose_luis_ponce_d_az_reixa,,,,,, -263,0.986,7f982261-1f38-4450-bed0-692a6746f7c6,PIERRE FABRE DERMATOLOGIE,pierre_fabre_dermatologie,,,,7f982261-1f38-4450-bed0-692a6746f7c6,pierre_fabre_dermatologie,PIERRE FABRE DERMATOLOGIE -411,0.965652,283aaa37-fcdb-477b-a3fa-610093576baa,"Region Skåne, Universitetssjukhuset i Lund, Urologiska kliniken",region_sk_ne_universitetssjukhuset_i_lund_urologiska_kliniken,,,,2684f500-be7b-4cc1-b06c-5ea5752af978,region_sk_ne,Region Skåne -0,0.982418,5f4adcd3-a8a4-4ad8-bcc3-14aa5dc4d3e0,Morphotek,morphotek,,,,5f4adcd3-a8a4-4ad8-bcc3-14aa5dc4d3e0,morphotek,Morphotek -4328,,81952c66-c488-4247-ad23-fc19d22ea4d4,Swedish Pituitary Study group,swedish_pituitary_study_group,,,,,, -1022,0.980344,3d644372-21da-4da7-aba7-c8d44092d796,Ablynx NV,ablynx_nv,,,,3d644372-21da-4da7-aba7-c8d44092d796,ablynx_nv,Ablynx NV -4329,,c0b102f2-3bf8-4d96-9784-49d22e284f9c,Prof. Dr. med. Margitta Worm,prof_dr_med_margitta_worm,,,,,, -1013,0.96733957529067993,05fd0678-f53a-4b88-9656-dc6d78bcac36,Institut de Recherche Internationales Servier,institut_de_recherche_internationales_servier,,,,05fd0678-f53a-4b88-9656-dc6d78bcac36,institut_de_recherche_internationales_servier,Institut de Recherche Internationales Servier -4330,,5a5a6de0-b525-41db-a4ff-9b7b067b798d,"Technische Universität München, Fakultät für Medizin, represented by Dean",technische_universit_t_m_nchen_fakult_t_f_r_medizin_represented_by_dean,,,,,, -4331,,0239e4a0-2056-4836-8c57-c124c700aa71,Oncozyme Pharma Inc,oncozyme_pharma_inc,,,,,, -4332,,bb923015-c01e-4ed7-8634-4bdefaf90ad7,SCIDERM GMBH,sciderm_gmbh,,,,,, -4333,,54856423-affd-4213-a084-a26d30b906bb,Euroscreen S.A,euroscreen_s_a,,,,,, -4334,,3cd03721-a436-4154-a3ca-057b17c8eaaf,National Institute of Allergy and Infectious Diseases,national_institute_of_allergy_and_infectious_diseases,,,,,, -4335,,7312f078-72f0-4e9b-b9d7-38095aa98bff,"MDVI, LLC",mdvi_llc,,,,,, -4336,,f75ef0d2-8bd6-11e6-a449-0242ac12000b,Proximagen Ltd,proximagen_ltd,,,,,, -4337,,6dc960ab-c554-4ea7-a928-944ecec8fcdc,MICROMET GMBH,micromet_gmbh,,,,,, -459,0.95724058151245117,347ebbdb-d7ca-4b86-86e4-66cae5ee0b3e,"Janssen-Cilag International N.V., Turnhoutseweg 30, B-2340 Beerse, Belgium",janssen_cilag_international_n_v_turnhoutseweg_30_b_2340_beerse_belgium,,,,caa9eeff-a0fe-407d-8a39-097924dbd94c,janssen_cilag_international_n_v_turnhoutseweg_30_2340_beerse_belgium,"Janssen-Cilag International N.V., Turnhoutseweg 30, 2340 Beerse, Belgium" -4338,,d2b138e0-3eb4-4a8f-9a7c-ff6c3ee2a3b5,CYRENAIC,cyrenaic,,,,,, -4339,,5970adb6-736a-4d3c-bdf6-9369d667763b,Verein zur Förderung der Pneumologie am Krankenhaus Großhansdorf e.V,verein_zur_f_rderung_der_pneumologie_am_krankenhaus_gro_hansdorf_e_v,,,,,, -4340,,7f316395-e1a0-45b4-8c67-5292d51e0419,Österreichisches Akromegalie Register,sterreichisches_akromegalie_register,,,,,, -4341,,3badab18-046e-42d4-9296-595a6a51633c,Grupo GENOM,grupo_genom,,,,,, -409,0.9891228973865509,f4abcdbe-4eb2-4750-86d2-f234f7f56d0d,SCHWARZ BIOSCIENCES GmbH,schwarz_biosciences_gmbh,,,,bafd53c7-e832-4f6f-89c8-d8d0d9dcabe4,schwarz_biosciences,SCHWARZ BIOSCIENCES GmbH -4342,,04fedc13-b096-4b89-bb6c-11c873fb28b3,Pharmos Corp,pharmos_corp,,,,,, -4343,,ac0880c4-715c-11e6-a0cd-0242ac12000b,MN PHARMS,mn_pharms,,,,,, -4344,,35c5d57b-e1ab-4c00-aa57-a75aac474eb3,"Odense University Hospital, Department of Neurology",odense_university_hospital_department_of_neurology,,,,,, -4345,,e33662f6-111c-484e-90c7-dd4c29665375,ARTBC,artbc,,,,,, -4346,,a4728b4e-a69a-4e76-9527-3ce5f823a440,Scandinavian Prostate Cancer Group/ P.O. Hedlund,scandinavian_prostate_cancer_group_p_o_hedlund,,,,,, -4347,,16caeaa2-7142-11e6-a0cd-0242ac12000b,ARBOR PHARMS INC,arbor_pharms_inc,,,,,, -805,0.96108248829841614,8e240a49-6e4c-46a0-8366-15b78371ff26,"Otsuka Pharmaceutical Development and Commercialization, Inc",otsuka_pharmaceutical_development_and_commercialization_inc,,,,8e240a49-6e4c-46a0-8366-15b78371ff26,otsuka_pharmaceutical_development_commercialization_inc,"Otsuka Pharmaceutical Development & Commercialization, Inc" -4348,,ee6c1494-ef20-494b-b358-f202135b5bb4,Axonyx Corporation,axonyx_corporation,,,,,, -4349,,22d56df0-2297-4f01-ab0b-c645a6c68f5d,VU medical center,vu_medical_center,,,,,, -4350,,dd8b5914-d9d4-40de-9534-0e86219e1006,Papworth Hospital NHS Foundation Trust,papworth_hospital_nhs_foundation_trust,,,,,, -4351,,7a35b500-76c4-45e8-b11e-eadc0a1f790c,"HUCH, Division of Cardiology",huch_division_of_cardiology,,,,,, -4352,,f30201b0-7316-11e6-a0cd-0242ac12000b,AQUA PHARMS LLC,aqua_pharms_llc,,,,,, -4353,,51d8fc46-24a2-47c5-adc0-d64dd04d0cbd,St. Jude Children’s Research Hospital,st_jude_children_s_research_hospital,,,,,, -556,0.95241346955299377,3361148d-134d-40eb-b1d7-9105a55174b4,Greater Glasgow and Clyde Health Board,greater_glasgow_and_clyde_health_board,,,,3361148d-134d-40eb-b1d7-9105a55174b4,greater_glasgow_and_clyde_health_board_ggchb_university_of_glasgow,Greater Glasgow and Clyde Health Board (GGCHB)/University of Glasgow -241,0.984184,2cc199a4-715c-11e6-a0cd-0242ac12000b,BLU CARIBE,blu_caribe,,,,2cc199a4-715c-11e6-a0cd-0242ac12000b,blu_caribe,BLU CARIBE -4354,,bd9e11b2-880b-11e6-a998-0242ac12000b,Canbex Therapeutics Ltd,canbex_therapeutics_ltd,,,,,, -4355,,7452b8c2-8575-48bb-91f5-c48429337d01,Lilly Deutschland GmbH,lilly_deutschland_gmbh,,,,,, -4356,,0ca29306-bf4f-4888-9be5-bd1888f25f58,Complejo Hospitalario Torrecárdenas,complejo_hospitalario_torrec_rdenas,,,,,, -4357,,abc96a5e-6bd7-451b-838d-1e1e3cee308f,Dandrit Biotech A/S,dandrit_biotech_a_s,,,,,, -4358,,ac483e62-87fe-48fd-a97d-a279fbb8c956,Scil Technology GmbH,scil_technology_gmbh,,,,,, -4359,,31665538-d682-4a8c-81fa-9206803ef9b3,CR UK and UCL Cancer Trials Centre,cr_uk_and_ucl_cancer_trials_centre,,,,,, -4360,,f1d49eb2-68ce-42c6-8d56-e3e10fe0b40f,Genzyme Europe BV,genzyme_europe_bv,,,,,, -4361,,be317658-17aa-42d5-b9a1-a5f08520289e,AMC- academisch psychiatrisch centrum,amc_academisch_psychiatrisch_centrum,,,,,, -4362,,c577de62-5425-40ef-8beb-22ae5fee4fb8,Saarland University,saarland_university,,,,,, -4363,,8e313c5c-573c-4075-b936-e45d4b0a0326,Innate Pharma,innate_pharma,,,,,, -4364,,eb9ac754-9578-4839-8e4a-69483bce2afb,Kowa Research Europe Ltd,kowa_research_europe_ltd,,,,,, -511,0.931409,69596232-b165-4d72-8a18-1e0bbdd636c6,PharmaMar SA unipersonal,pharmamar_sa_unipersonal,,,,69596232-b165-4d72-8a18-1e0bbdd636c6,pharmamar_sa_unipersonal,PharmaMar SA unipersonal -4365,,1f9cd31d-e4e9-4806-bf92-07b81f93ba36,Univerity of Bonn,univerity_of_bonn,,,,,, -4366,,c86fa310-e3d1-4bf7-be4a-c9fed815a879,FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO 12 DE OCTUBRE,fundacion_para_la_investigacion_biomedica_hospital_universitario_12_de_octubre,,,,,, -4367,,8f0c2088-b319-4e7a-a580-4238784c332f,"Trevi Therapeutics, Inc",trevi_therapeutics_inc,,,,,, -4368,,dcb64dc9-2b7e-4e50-b3c7-2c2a43da353e,"Taneli Raivio, Helsingin yliopistollinen keskussairaala",taneli_raivio_helsingin_yliopistollinen_keskussairaala,,,,,, -4369,,aaa8bbea-71a7-11e6-a0cd-0242ac12000b,IVAX RES,ivax_res,,,,,, -4370,,1c3ea363-e90a-4019-8e90-2a183b616f66,MAYOLY-SPINDLER,mayoly_spindler,,,,,, -4371,,a93d39e2-7194-11e6-a0cd-0242ac12000b,BEL MAR,bel_mar,,,,,, -4372,,dd946424-fcfb-4d87-80f3-575b6bc911c7,Department of Dermatology and Allergy Charité- Universitätsmedizin Berlin,department_of_dermatology_and_allergy_charit_universit_tsmedizin_berlin,,,,,, -4373,,08488d9d-fa50-4a6d-aeee-a2d4762c806f,Pharmion GmbH,pharmion_gmbh,,,,,, -4374,,89489d00-7146-11e6-a0cd-0242ac12000b,GENPHARM,genpharm,,,,,, -4375,,8ef2f084-6fbb-11e6-abe8-0242ac12000b,NatImmune A/S,natimmune_a_s,,,,,, -147,0.989212,552c8b5e-6e4d-462c-97e1-a56f192796b2,Sociedad Andaluza de Trasplante de Órganos y Tejidos (SATOT),sociedad_andaluza_de_trasplante_de_rganos_y_tejidos_satot,,,,552c8b5e-6e4d-462c-97e1-a56f192796b2,sociedad_andaluza_de_trasplante_de_rganos_y_tejidos_satot,Sociedad Andaluza de Trasplante de Órganos y Tejidos (SATOT) -4376,,fc79d85b-fd68-45ab-a48c-51eb5653ebbc,"Azur Pharma, Ltd",azur_pharma_ltd,,,,,, -4377,,2dfb5940-15a3-4c61-94f6-45cc30044e44,"Seinäjoen keskussairaala, Fysiatrian ja kuntoutuksen tulosyksikkö",sein_joen_keskussairaala_fysiatrian_ja_kuntoutuksen_tulosyksikk,,,,,, -4378,,deee21fe-7334-11e6-a0cd-0242ac12000b,ORGANON SUB MERCK,organon_sub_merck,,,,,, -4379,,01a20798-3d29-4250-90a2-ff68c6e15675,Enobia Canada Limited Partnership,enobia_canada_limited_partnership,,,,,, -4380,,0865538b-acc1-43ca-9a17-db8dca1234e6,Ultragenyx Pharmaceutical Inc,ultragenyx_pharmaceutical_inc,,,,,, -4381,,a98a835b-e043-4d3e-ae42-b7adfc3af1ac,"Psychiatric Research Unit, Frederiksborg General Hospital",psychiatric_research_unit_frederiksborg_general_hospital,,,,,, -954,0.984184,69569858-7141-11e6-a0cd-0242ac12000b,IMPAX LABS,impax_labs,,,,69569858-7141-11e6-a0cd-0242ac12000b,impax_labs,IMPAX LABS -4382,,e5e80f98-c705-4602-8740-d5066c1e6e63,Centre Georges François Leclerc,centre_georges_fran_ois_leclerc,,,,,, -4383,,46447f1b-f3a3-4452-aa5f-7dc3b0235d92,Májbetegekért Alapítvány,m_jbetegek_rt_alap_tv_ny,,,,,, -4384,,5a0cefb3-980c-43ad-af8a-4bea7a981de3,Fundación Canaria de Investigación y Salud,fundaci_n_canaria_de_investigaci_n_y_salud,,,,,, -4385,,05cd22b1-4e16-4c6b-811b-1deabe3f47c7,Iron Therapeutics (Switzerland) AG,iron_therapeutics_switzerland_ag,,,,,, -4386,,ef52ecdf-42b3-481a-804f-a3754a9107b5,Clovis Oncology Italy s.r.l,clovis_oncology_italy_s_r_l,,,,,, -640,0.96883571147918701,49d4949c-d209-4f98-8d5a-12154a3d6677,Boehringer Ingeheim RCV GmbH & Co KG,boehringer_ingeheim_rcv_gmbh_co_kg,,,,d2f4fdea-3f56-449f-b5b3-ab25da9fa8af,boehringer_ingelheim_rcv_gmbh_co_kg,Boehringer Ingelheim RCV GmbH & Co KG -982,0.94804,4f75b1b6-7160-11e6-a0cd-0242ac12000b,JANSSEN PHARMS,janssen_pharms,,,,4f75b1b6-7160-11e6-a0cd-0242ac12000b,janssen_pharms,JANSSEN PHARMS -4387,,4782a974-737b-11e6-a0cd-0242ac12000b,MAYNE PHARMA INTL,mayne_pharma_intl,,,,,, -4388,,5abd57b2-8ffd-4aba-80c2-2cb64a92fab7,FIBio Hospital Universitario Ramón y Cajal,fibio_hospital_universitario_ram_n_y_cajal,,,,,, -4389,,d48dc5f9-3c3e-4063-a88b-54288c53ca8c,"Karolinska Institutet, Institutionen för klinisik neurovetenskap, sektion för psykiatri",karolinska_institutet_institutionen_f_r_klinisik_neurovetenskap_sektion_f_r_psykiatri,,,,,, -4390,,6d4a5a12-a735-49ab-86de-543e4525493f,CHU DE NANCY - DIRECTION DE LA RECHERCHE CLINIQUE ET DE L'INNOVATION,chu_de_nancy_direction_de_la_recherche_clinique_et_de_l_innovation,,,,,, -4391,,adb5ac52-7171-11e6-a0cd-0242ac12000b,SMITHKLINE BEECHAM,smithkline_beecham,,,,,, -4392,,e4ef215d-0d12-48b0-9dba-b4de4330afcd,"Medizinische Universität Graz, Univ. Frauenklinik, Abteilung für Gynäkologie",medizinische_universit_t_graz_univ_frauenklinik_abteilung_f_r_gyn_kologie,,,,,, -4393,,3531f823-86f7-460f-bd9b-289d3bcef8e7,Kringle Pharma Europe AB,kringle_pharma_europe_ab,,,,,, -4394,,6c0c31a1-b1c8-468b-8947-cb97c1b693c5,"Arbor Pharmaceuticals, LLC",arbor_pharmaceuticals_llc,,,,,, -4395,,1980bbbf-5110-4148-8c5e-566f313cc818,DR. JAVIER ANIDO RUBIO,dr_javier_anido_rubio,,,,,, -286,0.933312,f088a553-ffed-4b6f-abb2-e84111d03762,Helperby Thearapeutics Ltd,helperby_thearapeutics_ltd,,,,aa2861dc-8843-45b3-8d61-af022e0ad7ab,helperby_therapeutics,Helperby Therapeutics -569,0.952896,5ac9ac8a-68c4-4d8a-b503-c40b8352bccf,Pharming Technologies B.V,pharming_technologies_b_v,,,,25abd45e-c724-4c38-a7f4-5b17f2b4e77f,pharming_tecnologies_b_v,Pharming Tecnologies B.V -1033,0.97907406091690063,ba5dbf11-c6cc-4623-b6c7-f5abb168415d,"Kvinnokliniken, Universitetessjukhuset i Linköping, landstinget i Östergötland",kvinnokliniken_universitetessjukhuset_i_link_ping_landstinget_i_sterg_tland,,,,6fb84541-28be-49a0-a789-a0b8bf04fae5,kvinnokliniken_universitetssjukhuset_i_link_ping_landstinget_i_sterg_tland,"Kvinnokliniken, Universitetssjukhuset i Linköping, Landstinget i Östergötland" -417,0.988695,bbe38879-d93a-419a-8151-28e4cef833e1,ISTITUTI FISIOTERAPICI OSPITALIERI - IRE,istituti_fisioterapici_ospitalieri_ire,,,,8da96a38-2d6c-4cbb-9351-628c3c92a1ed,istituti_fisioterapici_ospitalieri,ISTITUTI FISIOTERAPICI OSPITALIERI -4396,,5514c86d-8bf5-4036-b173-f8acace30715,"Bonkolab, Rigshospitalet",bonkolab_rigshospitalet,,,,,, -4397,,1603b04f-bef6-4e9e-a949-c01d179869c5,Institute od Rheumatology Prague,institute_od_rheumatology_prague,,,,,, -4398,,44173ab7-9bc8-45f6-8536-f5d2f2824cc5,Ritva Jokela,ritva_jokela,,,,,, -4399,,cb8d68dc-b0a7-4039-8129-9c3756ecb85b,TNO,tno,,,,,, -4400,,8cf7b2ea-e843-421e-8d1f-6af40a085327,The Netherlands Cancer Institute/ Antoni van Leeuwenhoek hospital,the_netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital,,,,,, -864,0.973341,a333a82a-36dd-4629-8cf3-573aaa584a38,NHS Grampian,nhs_grampian,,,,a333a82a-36dd-4629-8cf3-573aaa584a38,nhs_grampian,NHS Grampian -4401,,94c07a8b-a310-476d-ac55-04922bc5f62c,XOMA,xoma,,,,,, -766,0.979934,e573cdb7-8920-4b04-80e3-8c471bff8a89,"Sussex NHS Research Consortium, Research Department, Worthing Hospital",sussex_nhs_research_consortium_research_department_worthing_hospital,,,,8a4b641c-5fe6-4b6b-a131-423b64e7cd1b,sussex_nhs_research_consortium,Sussex NHS Research Consortium -4402,,0a88bc18-5392-479d-b0e8-83d3a723d232,Maternté Régionale Universitaire de Nancy,maternt_r_gionale_universitaire_de_nancy,,,,,, -4403,,b5e066c6-7e06-4b41-93f1-71b956cb55b8,Vifor (International) AG,vifor_international_ag,,,,,, -4404,,22ff2d1e-2d8b-4e27-aac7-534beb2d9330,FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL 12 DE OCTUBRE,fundacion_para_la_investigacion_biomedica_hospital_12_de_octubre,,,,,, -4405,,8fc920d2-51f2-4bda-9d3b-53e72ef7767a,Maastricht UMC,maastricht_umc,,,,,, -4406,,d9f407ee-7141-11e6-a0cd-0242ac12000b,KVK TECH,kvk_tech,,,,,, -4407,,a5d9d788-7167-11e6-a0cd-0242ac12000b,SOVEREIGN PHARMS,sovereign_pharms,,,,,, -4408,,d3bc30d2-72da-11e6-a0cd-0242ac12000b,NYCOMED US,nycomed_us,,,,,, -4409,,799eb93c-db00-4c48-9c91-99501df0b968,FONDAZIONE MALATTIE RARE MAURO BASCHIROTTO B.I.R.D. ONLUS,fondazione_malattie_rare_mauro_baschirotto_b_i_r_d_onlus,,,,,, -662,0.97071176767349243,03be6dab-3c3b-45d4-999e-013062e4a92e,Charité Universitaetsmedizin Berlin,charit_universitaetsmedizin_berlin,,,,03be6dab-3c3b-45d4-999e-013062e4a92e,charit_universitaetsmedizin_berlin,Charité Universitaetsmedizin Berlin -4410,,12657556-a10d-49f2-ad1f-fb3210578e20,GRIFOLS ITALIA,grifols_italia,,,,,, -4411,,217be9cc-ecdd-4bb2-beb8-2ebdea746bcb,St. Eriks Eye Hospital,st_eriks_eye_hospital,,,,,, -4412,,2a08ab3c-b5a9-448d-a781-4656654815d0,Childrens's Research Institute,childrens_s_research_institute,,,,,, -4413,,573cec7a-72cd-11e6-a0cd-0242ac12000b,EMMAUS MEDCL,emmaus_medcl,,,,,, -641,0.98466187715530396,80207a17-976c-4923-a075-b4c1fd0d1587,Boehringer Ingelheim Denmark A/S,boehringer_ingelheim_denmark_a_s,,,,82029ede-b089-4dbb-93ae-f48a58277a9c,boehringer_ingelheim_denmark_a_s,Boehringer Ingelheim Denmark A/S -4414,,943a1e8e-7144-11e6-a0cd-0242ac12000b,TOLMAR,tolmar,,,,,, -395,0.982614,3a926c58-71c4-11e6-a0cd-0242ac12000b,ASTRAZENECA PHARMS,astrazeneca_pharms,,,,3a926c58-71c4-11e6-a0cd-0242ac12000b,astrazeneca_pharms,ASTRAZENECA PHARMS -4415,,0b12d7b4-efff-4661-8ae9-d907563208fa,"Cubist Pharmaceuticals, Inc",cubist_pharmaceuticals_inc,,,,,, -4416,,b8457276-8633-4ecf-8513-389558ae2bd1,Dutch Pancreatitis Study Group,dutch_pancreatitis_study_group,,,,,, -4417,,bb605c38-df01-4bd0-9558-912b7f5da864,North Glasgow Trust,north_glasgow_trust,,,,,, -4418,,3ea12dcd-a6b7-11e6-94cb-5656d04fc2b5,"University of Aarhus, School of Dentistry",university_of_aarhus_school_of_dentistry,,,,,, -4419,,9443d79d-8f66-47e4-b15a-931398c7cd95,HOSPITAL DE GALDAKAO-USANSOLO,hospital_de_galdakao_usansolo,,,,,, -4420,,9cf19dbe-b929-4dd1-812b-dda7c065e780,Institut National de la Santé et de la Research Médicale,institut_national_de_la_sant_et_de_la_research_m_dicale,,,,,, -797,0.985088,1030c221-004c-4496-88f4-1a34a95916e7,Sint Lucas Andreas Hospital,sint_lucas_andreas_hospital,,,,1030c221-004c-4496-88f4-1a34a95916e7,sint_lucas_andreas_hospital,Sint Lucas Andreas Hospital -4421,,3a8ab09a-7146-11e6-a0cd-0242ac12000b,MALLINKRODT NUCLEAR,mallinkrodt_nuclear,,,,,, -888,0.94497775179999211,d8e5702c-5977-4d8c-a2c6-20c18f0a0645,"Schering-Plough Research Institute, division of Schering Corporation",schering_plough_research_institute_division_of_schering_corporation,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" -4422,,8f24e68a-a5b4-4078-b899-ae9ecb4c05b2,Aurora Pujol Onofre,aurora_pujol_onofre,,,,,, -4423,,c0f564aa-e017-4252-8c49-908bef37a1da,research office urology VUmc,research_office_urology_vumc,,,,,, -4424,,3c71c950-f441-4618-8de5-aaa340ddc929,Nycomed Canada Inc,nycomed_canada_inc,,,,,, -4425,,d4e0f402-3c0a-4188-abc9-82a78aff3cd5,"Department of Psychiatry, Ludwig-Maximilian University Munich",department_of_psychiatry_ludwig_maximilian_university_munich,,,,,, -4426,,18c91bdd-c584-4375-bb86-61223529f32c,STEBA FRANCE,steba_france,,,,,, -605,0.916683,2966963f-a998-4261-8d68-d4c45ba26c05,"Novartis Vaccines & Diagnostics, Inc",novartis_vaccines_diagnostics_inc,,,,2966963f-a998-4261-8d68-d4c45ba26c05,novartis_vaccines_diagnostics_inc,"Novartis Vaccines & Diagnostics, Inc" -4427,,5a53ff0d-794f-4574-b824-05831aa1ca11,Ardana Bioscience Ltd,ardana_bioscience_ltd,,,,,, -768,0.987661,620215a3-9912-41e5-bf75-56cb04e20f09,Bayer Schering Pharma AG (BSP),bayer_schering_pharma_ag_bsp,,,,611690f5-8173-4554-bcb7-1ecc6dba03cd,bayer_schering_pharma_ag,Bayer Schering Pharma AG -4428,,4dc1a57f-8db3-4002-9116-9161e54a5480,academisch ziekenhuis Maastricht,academisch_ziekenhuis_maastricht,,,,,, -4429,,d0c5b7d4-68b0-4ff2-8ae7-c694fe4f0307,Iniciativa Andaluza en Terapias Avanzadas a través de la Fundación Progreso y Salud,iniciativa_andaluza_en_terapias_avanzadas_a_trav_s_de_la_fundaci_n_progreso_y_salud,,,,,, -4430,,24cc8b00-7198-11e6-a0cd-0242ac12000b,PURDUE FREDERICK,purdue_frederick,,,,,, -4431,,5577246e-7372-11e6-a0cd-0242ac12000b,MOBIUS THERAP,mobius_therap,,,,,, -4432,,1f3d50f9-2f96-46fb-ad2e-7c5236d16773,"Recordati S.p.A.,",recordati_s_p_a,,,,,, -1005,0.955584,4e5f77d3-9cb8-4aca-96ce-cb524d785be9,"Population Health Research Institute (PHRI), McMaster University/Hamilton Health Sciences",population_health_research_institute_phri_mcmaster_university_hamilton_health_sciences,,,,4e5f77d3-9cb8-4aca-96ce-cb524d785be9,population_health_research_institute_phri_mcmaster_university_hamilton_health_sciences,"Population Health Research Institute (PHRI), McMaster University/Hamilton Health Sciences" -4433,,79636eb0-e4f1-4041-af62-1f84d1858cc1,Masarykův onkologický ústav,masaryk_v_onkologick_stav,,,,,, -4434,,ed2d088e-7140-11e6-a0cd-0242ac12000b,IMPAX PHARMS,impax_pharms,,,,,, -244,0.98628848791122437,30cd9264-712a-11e6-a89e-0242ac12000b,SUN PHARM INDS,sun_pharm_inds,,,,30cd9264-712a-11e6-a89e-0242ac12000b,sun_pharm_inds,SUN PHARM INDS -387,0.973636,9151744a-bb73-438c-895c-dd8f508cc732,Foundation of Liver Research (SLO),foundation_of_liver_research_slo,,,,9151744a-bb73-438c-895c-dd8f508cc732,foundation_of_liver_research_slo,Foundation of Liver Research (SLO) -4435,,ff57e707-62e6-4251-b6e9-7b144ce7e7aa,Evestra GmbH,evestra_gmbh,,,,,, -4436,,40abca95-1809-432e-aee9-565c32056c09,BIOSYNEXUS INC,biosynexus_inc,,,,,, -4437,,e2bcf588-7129-11e6-a89e-0242ac12000b,LANNETT,lannett,,,,,, -4438,,ddb1fa1e-a305-4d78-b472-d7faf62d33cf,Royal Surrey County Hospital,royal_surrey_county_hospital,,,,,, -1057,0.98656213283538818,0e402f08-6f9b-11e6-9663-0242ac12000b,Pfizer Hellas,pfizer_hellas,,,,080946bd-1123-4c27-9ea3-501e78d94d82,pfizer_hellas_sa,Pfizer Hellas SA -4439,,2044c186-59d8-423a-91bd-91abffcb20d2,"R & D, Cambridge University Hospitals",r_d_cambridge_university_hospitals,,,,,, -4440,,523aa21d-baab-4df3-8c4d-01d9d17ca2ab,Royal College of Surgeon's Ireland,royal_college_of_surgeon_s_ireland,,,,,, -87,0.983343,37900e74-7148-11e6-a0cd-0242ac12000b,MORTON GROVE,morton_grove,,,,37900e74-7148-11e6-a0cd-0242ac12000b,morton_grove,MORTON GROVE -4441,,bb25a626-7144-11e6-a0cd-0242ac12000b,SAMSON MEDCL,samson_medcl,,,,,, -4442,,49275ed1-5a3d-45c0-bd15-72b51c92d40e,Fundacion par la investigación biomédica del Hospital Universitario La Paz,fundacion_par_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz,,,,,, -4443,,0a2898af-00b4-4db1-bd0d-9d3f9868b084,Dept of Molecular Medicin and Surgery,dept_of_molecular_medicin_and_surgery,,,,,, -4444,,1611821c-6bbe-4b5a-b359-985822c7b24b,"Mundipharma Medical Company, Basel",mundipharma_medical_company_basel,,,,,, -4445,,6eaf8008-9410-460f-8a09-decb966d18d9,"Afd. A, OUH",afd_a_ouh,,,,,, -4446,,dc7703ae-7146-11e6-a0cd-0242ac12000b,FALCON PHARMS,falcon_pharms,,,,,, -4447,,8aeccb00-c5bc-4ba8-bcfd-dc40022b4890,Prof. Dr. R. Kreutz Leiter der Abteilung Klinische Pharmakologie der Charite Berlin,prof_dr_r_kreutz_leiter_der_abteilung_klinische_pharmakologie_der_charite_berlin,,,,,, -934,0.92117515206336975,0e1658fb-8e8d-4f84-b74e-e1b20cda7414,Pierre Fabre Médicament represented by the Institut de Recherche Pierre Fabre (IRPF),pierre_fabre_m_dicament_represented_by_the_institut_de_recherche_pierre_fabre_irpf,,,,ed0e7a9e-3ecf-499e-8589-05b770cd0c82,pierre_fabre_m_dicament_represented_by_irpf,Pierre Fabre Médicament represented by IRPF -577,0.95634430646896362,ed49c65f-5f00-412a-ba1b-25fa875fab59,Wyeth Pharmaceutricals France Wyeth Research Division,wyeth_pharmaceutricals_france_wyeth_research_division,,,,e9abaf6d-ebc5-432c-be97-f7a5c26bd3f9,wyeth_pharmaceuticals_france_wyeth_research_division,"Wyeth Pharmaceuticals France, Wyeth Research Division" -752,0.97367790341377258,dad40206-1da0-46e9-8bd7-432191ce3108,Grupo Español de Tratamiento de Tumores de Cabeza y Cuello,grupo_espa_ol_de_tratamiento_de_tumores_de_cabeza_y_cuello,,,,137320fb-fac2-4e31-99c7-7873aa7537cc,grupo_espa_ol_de_tratamiento_de_tumores_de_cabeza_y_cuello_ttcc,Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC) -4448,,2b7dcf4a-9251-42ca-a1b8-4e9e0604b687,Javier Olascoaga Urtaza,javier_olascoaga_urtaza,,,,,, -4449,,af67027a-429a-465d-bc38-795ef4c3421c,Medeca Pharma AB,medeca_pharma_ab,,,,,, -4450,,a427c93e-bf11-4139-8cef-cf96d9cf2500,Derby Hospitals NHS Foundations Trust,derby_hospitals_nhs_foundations_trust,,,,,, -729,0.98694062232971191,ca089cae-dbbf-4ef6-867b-9d74f288bfb4,Sanofi Pasteur MSD,sanofi_pasteur_msd,,,,cb560f4c-875f-44a3-bed5-c8039bd52ca8,sanofi_pasteur_msd,Sanofi Pasteur MSD -4451,,a18c23b9-299f-4ff6-a555-b3d36052084d,Dra. Irene Halperin Rabinovich. Servicio de Endocrinología. Hospital Clínic de Barcelona,dra_irene_halperin_rabinovich_servicio_de_endocrinolog_a_hospital_cl_nic_de_barcelona,,,,,, -806,0.9831,b35e3bbf-ebb4-4571-b730-73bbb9141684,The Royal Liverpool and Broadgreen University Hospital NHS Trust,the_royal_liverpool_and_broadgreen_university_hospital_nhs_trust,,,,8c3e61bc-f8b8-4391-8314-26161be485ab,the_royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,The Royal Liverpool and Broadgreen University Hospitals NHS Trust -4452,,958767b3-3618-448a-826a-8a24571300d6,"N-GENE Research Laboratories, Inc",n_gene_research_laboratories_inc,,,,,, -4453,,b36a2be0-2091-46f1-b17f-435abac00d43,Kompetenznetz Vorhofflimmern e.V. (AFNET) [Atrial Fibrillation NETwork],kompetenznetz_vorhofflimmern_e_v_afnet_atrial_fibrillation_network,,,,,, -4454,,1170301c-a7fb-4e7f-b1b7-144ebf415d0b,"Allergy Centre, University Hospital",allergy_centre_university_hospital,,,,,, -4455,,4f0f7b01-833b-44c3-8b7f-cdea3215fc12,"Servicio de Neurología, HU. Germans Trias i Pujol",servicio_de_neurolog_a_hu_germans_trias_i_pujol,,,,,, -4456,,e4997f72-f07d-4462-835e-f6941fecac8f,Emilio Garcia Garcia,emilio_garcia_garcia,,,,,, -4457,,6d3a8a1c-814a-465a-9cfe-714246d368fd,Evolva SA,evolva_sa,,,,,, -4458,,541cb3c2-723c-11e6-a0cd-0242ac12000b,MEDICURE,medicure,,,,,, -4459,,1c38c63c-0581-4365-8772-e29ee7d2691b,Dr. Félix Armadá,dr_f_lix_armad,,,,,, -4460,,eda8a45b-b8a6-42c1-b3b8-1a6147dd66eb,Anne Pesonen,anne_pesonen,,,,,, -4461,,8238f739-a312-4e6a-94b3-a3d76ad3bc85,"University Hospital Schleswig Holstein Kiel, Clinic of Neurology",university_hospital_schleswig_holstein_kiel_clinic_of_neurology,,,,,, -4462,,141480fb-54e6-470e-a377-fadf71889ca8,I.N.M. NEUROMED (I.R.C.C.S.) S.R.L. GIA' SANATRIX,i_n_m_neuromed_i_r_c_c_s_s_r_l_gia_sanatrix,,,,,, -4463,,1bc87e1e-fb73-42e1-b63c-f94be8b21163,"Klinikum der Universität München, Medizinische Klinik und Poliklinik III",klinikum_der_universit_t_m_nchen_medizinische_klinik_und_poliklinik_iii,,,,,, -4464,,5f3378a2-719e-11e6-a0cd-0242ac12000b,ISOTEX,isotex,,,,,, -4465,,6ad266c0-3a28-4f47-8aca-3140e2513e76,"Zalicus, Inc",zalicus_inc,,,,,, -4466,,1e105941-1e6c-423c-ada6-ee0f94f5893d,SENDO TECH,sendo_tech,,,,,, -4467,,0b3bca8b-765b-4fa5-968d-79c9f28ff141,National Institutes of Neurological Disorders: Stroke,national_institutes_of_neurological_disorders_stroke,,,,,, -4468,,e52c56ca-2bb1-4c8a-aaa7-42f203dad86c,ITALFARMACO S.p.A,italfarmaco_s_p_a,,,,,, -580,0.98565506935119629,6e90ff22-ae0c-4450-9eec-85eba70c3fda,Wyeth Pharmaceuticals Inc,wyeth_pharmaceuticals_inc,,,,6e90ff22-ae0c-4450-9eec-85eba70c3fda,wyeth_pharmaceuticals_inc,Wyeth Pharmaceuticals Inc -300,0.972939,81b5ea66-d557-4880-b29f-db73b2bdcdc7,"Rigshospital, Finsencenter, Afsnit 3994",rigshospital_finsencenter_afsnit_3994,,,,5715166a-8be0-11e6-a449-0242ac12000b,rigshospital,Rigshospital -4469,,cfa61597-ae3f-4345-977f-c116cab63f62,NCIC Clinical Trials Group,ncic_clinical_trials_group,,,,,, -4470,,d7c29fd0-a336-4079-b486-cc691b1aa334,Schwarz BioSciences Inc,schwarz_biosciences_inc,,,,,, -842,0.97700116038322449,266d63ac-b3de-4324-b4d9-3059a2dc2174,University Hospital of South Manchester,university_hospital_of_south_manchester,,,,19e6b110-6043-450d-8ef8-6a798742be5d,university_hospital_of_south_manchester_nhs_foundation_trust,University Hospital of South Manchester -527,0.95949012041091919,eaf298ff-f4fb-4c80-9c59-229523335a88,"Roche Farma, S.A en nombre de F. Hoffman-La Roche Ltd",roche_farma_s_a_en_nombre_de_f_hoffman_la_roche_ltd,,,,80833833-6173-4f1f-82da-31787a716bc2,roche_farma_s_a_en_nombre_de_f_hoffmann_la_roche_ltd,"Roche Farma, S.A. en nombre de F. Hoffmann-La Roche Ltd" -4471,,420bbe8e-8bce-11e6-a449-0242ac12000b,"Uppsala University, Department of Medical Sciences",uppsala_university_department_of_medical_sciences,,,,,, -4472,,610f7c7e-8e76-4f64-82e2-c5864ca74b5a,Radiotherapy UZ Gasthuisberg,radiotherapy_uz_gasthuisberg,,,,,, -4473,,68ecb8ff-9898-4e4f-8ce2-dee8c90b326b,Medizinische Einrichtungen des Bezirks Oberpfalz GmbH,medizinische_einrichtungen_des_bezirks_oberpfalz_gmbh,,,,,, -4474,,8a0e1f4c-7166-11e6-a0cd-0242ac12000b,HETERO USA INC,hetero_usa_inc,,,,,, -744,0.97866427898406982,a9ae713f-1518-4e09-ac21-b4785f5a60ab,Johann Wolfgang Goethe-Universität Frankfurt/M,johann_wolfgang_goethe_universit_t_frankfurt_m,,,,7c93ba08-6123-42f2-a902-d13e42cdd905,johann_wolfgang_goethe_universit_t_frankfurt,Johann Wolfgang Goethe-Universität Frankfurt -4475,,0fc2319f-6815-419a-a55a-86d7b824c611,Hywel Dda Health Board,hywel_dda_health_board,,,,,, -4476,,e24b1e24-d7db-418d-a772-af767a07488b,Jules Borde Institute,jules_borde_institute,,,,,, -4477,,0438f52c-904f-4d43-a5fd-b3992dd30af9,"Karolinska Universitetssjukhuset i Solna, Thoraxanestesi & intensivvård",karolinska_universitetssjukhuset_i_solna_thoraxanestesi_intensivv_rd,,,,,, -4478,,5dc40c3a-2b79-4a68-b518-a0bb90ccc5fe,Profil Mainz GmbH & Co KG,profil_mainz_gmbh_co_kg,,,,,, -16,0.934144,349884c4-73b1-11e6-a0cd-0242ac12000b,VERTEX PHARMS,vertex_pharms,,,,349884c4-73b1-11e6-a0cd-0242ac12000b,vertex_pharms,VERTEX PHARMS -4479,,4a986bca-7129-11e6-a89e-0242ac12000b,DAVA PHARMS INC,dava_pharms_inc,,,,,, -4480,,240a0ec5-3217-4758-b549-cc08da35dba5,"Charité Universitätsmedizin Berlin, Campus Benjamin Franklin",charit_universit_tsmedizin_berlin_campus_benjamin_franklin,,,,,, -256,0.988946,dee9d357-375e-48a1-b857-489f6be6b00c,Otsuka Maryland Research Institute,otsuka_maryland_research_institute,,,,dee9d357-375e-48a1-b857-489f6be6b00c,otsuka_maryland_research_institute,Otsuka Maryland Research Institute -4481,,fef77d8e-df7c-442c-bc75-45624d361fb2,Baxalta Innovations GmbH,baxalta_innovations_gmbh,,,,,, -964,0.94218007723490393,4c6f8fec-ba3f-4d80-8325-5deca49115f8,Helsinki Universiy Central Hospital,helsinki_universiy_central_hospital,,,,16556fb5-6653-4d5b-bd94-fc6343fa4fd8,helsinki_university_central_hospital,Helsinki University Central Hospital -284,0.98087829351425171,f4504f58-7128-11e6-a89e-0242ac12000b,PADDOCK LLC,paddock_llc,,,,bc84a43e-7141-11e6-a0cd-0242ac12000b,paddock,PADDOCK -224,0.92743,e657f5e2-2230-412a-8859-9d36843109c2,Royal College of Surgeons Ireland,royal_college_of_surgeons_ireland,,,,19f50830-c64c-41ab-95d1-83f7f3427687,royal_college_of_surgeons_in_ireland,Royal College of Surgeons in Ireland -4482,,471f252a-837a-4042-bc65-4bf0c393c3aa,"Dept of Neurology, Umeå University Hospital, Umeå, Sweden",dept_of_neurology_ume_university_hospital_ume_sweden,,,,,, -4483,,fdeaddfd-d3eb-4620-879e-c7a5ebe251c5,GECP(Grupo Español de cancer de Pulmón),gecp_grupo_espa_ol_de_cancer_de_pulm_n,,,,,, -887,0.97673827409744263,aefe5ab0-8813-11e6-a998-0242ac12000b,Schering-Plough Research Institute (SPRI),schering_plough_research_institute_spri,,,,44b33ab6-d74e-4fa5-aa8c-510964a3ac9f,schering_plough_research_institute,Schering-Plough Research Institute -381,0.92955939471721649,b07a37c1-b7ac-42e2-b286-fd9b67ce9719,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., (Merck)",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_merck,,,,70a76c95-9bc5-4453-ace1-7d9c98a92a7d,merck_sharp_dohme_o,"Merck Sharp & Dohme Copr., a subsidary of Merck & Co" -4484,,fe84d598-4524-446b-9bb3-57f3746365a1,AZIENDA OSPEDALIERA S. MARIA DELLA MISERICORDIA,azienda_ospedaliera_s_maria_della_misericordia,,,,,, -4485,,64e18700-f216-4cf3-be43-93fcc9605f8f,St Vincent's Hospital,st_vincent_s_hospital,,,,,, -4486,,bacee0ec-47a3-4ae0-9f12-9839d9e72d99,alberto forteza,alberto_forteza,,,,,, -4487,,2222d89a-986b-469b-bb50-612793fcc924,Cardio3 BioSciences,cardio3_biosciences,,,,,, -4488,,65125d50-94f9-450b-82cc-a44c9203dadd,Universitätsmedizin Mainz,universit_tsmedizin_mainz,,,,,, -917,0.986946,7c9fa84f-cb0d-4978-8633-1d3ea599d9ad,Bristol Myers Squibb S.r.L,bristol_myers_squibb_s_r_l,,,,5cdbde15-83c4-4b59-a418-8452d890ac4e,bristol_myers_squibb,Bristol Myers Squibb -4489,,96e48115-11f8-4c90-aa2b-e5f6efa9962e,HYKS Vatsakeskus,hyks_vatsakeskus,,,,,, -4490,,8c33a5cc-e128-437a-9489-d9c44d331900,GANYMED Pharmaceuticals AG,ganymed_pharmaceuticals_ag,,,,,, -4491,,f93e54a1-dd47-4c56-8850-361f42f847aa,Jaro Karppinen,jaro_karppinen,,,,,, -4492,,8c129d92-323f-4e7f-9d4d-33397e48b9f6,"Privatärztliche urologische Partnerschaft GbR, EuromedClinic",privat_rztliche_urologische_partnerschaft_gbr_euromedclinic,,,,,, -4493,,e9cda2e3-769b-49ca-b47c-353d546f36cb,UCL Cliniques Universitaires Saint Luc,ucl_cliniques_universitaires_saint_luc,,,,,, -4494,,62fa7cb6-b0c3-4ab1-b614-685089ae4180,Institut de Recerca Hospital de Sant Pau,institut_de_recerca_hospital_de_sant_pau,,,,,, -112,0.9566093385219574,fd7c0ea8-c5da-47db-837d-9b59407dd291,"Yamanouchi Europe B.V. (to be renamed Astellas Pharma Europe B.V., as of August 2005)",yamanouchi_europe_b_v_to_be_renamed_astellas_pharma_europe_b_v_as_of_august_2005,,,,fd7c0ea8-c5da-47db-837d-9b59407dd291,yamanouchi_europe_b_v,Yamanouchi Europe B.V -4495,,7bd769d4-7129-11e6-a89e-0242ac12000b,PHARM ASSOC,pharm_assoc,,,,,, -244,0.98628848791122437,74861b88-7126-11e6-8a77-0242ac12000b,SUN PHARM INDS INC,sun_pharm_inds_inc,,,,30cd9264-712a-11e6-a89e-0242ac12000b,sun_pharm_inds,SUN PHARM INDS -4496,,c0bd19c3-5388-4c62-b9ea-e0538c6350fd,Kirurgisen sairaalan munuaisensiirtoihin liittyvän kivun hoidon tutkimusryhmä,kirurgisen_sairaalan_munuaisensiirtoihin_liittyv_n_kivun_hoidon_tutkimusryhm,,,,,, -4497,,ffbe707f-00b7-4e3a-9cd9-5fbea073583d,Rouen University Hospital,rouen_university_hospital,,,,,, -4498,,3c12923b-eb29-4e14-ad7c-c3d7345e4efd,Institut für Röntgendiagnostik der Technischen Universität München,institut_f_r_r_ntgendiagnostik_der_technischen_universit_t_m_nchen,,,,,, -4499,,09294918-4a3d-406f-8c75-693c39ef12ee,Deutsches Herzzentrum Muenchen,deutsches_herzzentrum_muenchen,,,,,, -4500,,53d82302-302b-499f-a366-d192a9eec993,ChemGenex Pharmaceuticals Ltd,chemgenex_pharmaceuticals_ltd,,,,,, -794,0.98656213283538818,3bb5af7e-90aa-42de-87dd-3a09da828fda,Clavis Pharma,clavis_pharma,,,,3bb5af7e-90aa-42de-87dd-3a09da828fda,clavis_pharma,Clavis Pharma -34,0.97933,55dfece4-1cf8-463c-896f-48fbbec903fc,"Sanofi-Synthélabo Recherche, a subsidiary of sanofi-aventis group",sanofi_synth_labo_recherche_a_subsidiary_of_sanofi_aventis_group,,,,55dfece4-1cf8-463c-896f-48fbbec903fc,sanofi_synth_labo_recherche_a_subsidiary_of_sanofi_aventis_group,"Sanofi-Synthélabo Recherche, a subsidiary of sanofi-aventis group" -4501,,2cbc5456-c9d3-4c58-8630-c96568ff3464,"Rigshospitalet,Cardiology Laboratory 2013",rigshospitalet_cardiology_laboratory_2013,,,,,, -315,0.97933,859cee6f-b91c-4dae-a958-dcbf3458bbb4,CEPHALON FRANCE,cephalon_france,,,,859cee6f-b91c-4dae-a958-dcbf3458bbb4,cephalon_france,CEPHALON FRANCE -4502,,5c06bd54-c807-40a5-ac89-1e9db67bc54d,Innocoll Pharmaceuticals Limited,innocoll_pharmaceuticals_limited,,,,,, -4503,,37a63ff0-96c7-4c6c-bbf1-caa8d784053b,AGMT gemeinnützige GmbH,agmt_gemeinn_tzige_gmbh,,,,,, -4504,,815f7992-b484-4c09-913a-d09219bd395f,"ActivX Biosciences, Inc",activx_biosciences_inc,,,,,, -4505,,b0f54ff1-6f73-4e26-b5fd-dd4820c64522,"Hôpital Erasme, ULB",h_pital_erasme_ulb,,,,,, -842,0.96419870853424072,5b4a4a4b-1f6a-4937-84e3-8bd61c9a9528,University Hospitals of South Manchester NHS Foundation Trust,university_hospitals_of_south_manchester_nhs_foundation_trust,,,,19e6b110-6043-450d-8ef8-6a798742be5d,university_hospital_of_south_manchester_nhs_foundation_trust,University Hospital of South Manchester -899,0.98596411943435669,3d00d697-8faa-4e4b-bfd7-814eddaee9da,Kuopion yliopistollinen sairaala,kuopion_yliopistollinen_sairaala,,,,3d00d697-8faa-4e4b-bfd7-814eddaee9da,kuopion_yliopistollinen_sairaala,Kuopion yliopistollinen sairaala -4506,,a628a14c-0190-45b1-a6cd-189ec7c9ae7e,Heikki Koskela,heikki_koskela,,,,,, -718,0.970142,f3b541b9-f809-4a91-a629-3db8b4a71047,"Med. Univ. Wien, Klinik f. Innere Med. I, Onkologie",med_univ_wien_klinik_f_innere_med_i_onkologie,,,,7d140a5d-838e-4824-90c7-b17c12e4b7aa,med_uni_wien_klinik_f_innere_med_i,"Med. Uni. Wien, Klinik f. Innere Med. I" -4507,,9c8fe084-27e8-4be5-831e-4d17b204b33e,Dainippon Sumitomo Pharma Europe Ltd,dainippon_sumitomo_pharma_europe_ltd,,,,,, -4508,,f4ba016c-668c-45d5-9f8a-185e05fc3a98,Smerteklinikken,smerteklinikken,,,,,, -4509,,8e96b04a-7163-11e6-a0cd-0242ac12000b,MICRO LABS LTD,micro_labs_ltd,,,,,, -4510,,89bc1a08-73e6-11e6-a0cd-0242ac12000b,PROVENSIS,provensis,,,,,, -4511,,9910e4e4-21e2-43fc-ac1b-516baa42ba5c,Albert Schweitzer hospital,albert_schweitzer_hospital,,,,,, -4512,,d272cb36-7141-11e6-a0cd-0242ac12000b,THE PHARMA NETWORK,the_pharma_network,,,,,, -4513,,c35c1894-727e-11e6-a0cd-0242ac12000b,FOREST LABS LLC,forest_labs_llc,,,,,, -4514,,a2ab83d2-2933-430d-a77e-82ad77d50ff5,FONDAZIONE ISTITUTO SAN RAFFAELE-G.GIGLIO,fondazione_istituto_san_raffaele_g_giglio,,,,,, -4515,,ceecdbd1-b90f-4146-83b5-e987dcb62f70,Hamilton Health Sciences through the Population Health Research Institute,hamilton_health_sciences_through_the_population_health_research_institute,,,,,, -1061,0.97933,7c1b47ae-b782-4a27-b575-82096c2eccd0,A.S.L. 2 SAVONA,a_s_l_2_savona,,,,332fca8d-891e-464f-bf2f-a65f4ecc24d7,a_s_l_2,A.S.L. 2 -4516,,30613286-a82a-4209-aca9-dd383dbd4573,The Clatterbridge Cancer Centre NHS Foundation Trust,the_clatterbridge_cancer_centre_nhs_foundation_trust,,,,,, -4517,,409fb41a-c20b-4321-b9f8-aef7078a0895,"Department of Cardiology, Odense University Hospital",department_of_cardiology_odense_university_hospital,,,,,, -4518,,928eda3b-919d-48e1-aabd-c95e9583facf,"Medical School, Dept. of Cardiology and Angiology",medical_school_dept_of_cardiology_and_angiology,,,,,, -4519,,fb707884-96fb-4ebe-87c5-f92c143e5298,"Charité - Universitätsmedizin Berlin, CharitéCentrum 3 für Zahn-, Mund- und Kieferheilkunde",charit_universit_tsmedizin_berlin_charit_centrum_3_f_r_zahn_mund_und_kieferheilkunde,,,,,, -1055,0.98234379291534424,81df0d59-40ca-4ad2-8667-97ceb4c20bea,"Neurologisk afdeling F, Århus Sygehus, NBG",neurologisk_afdeling_f_rhus_sygehus_nbg,,,,81df0d59-40ca-4ad2-8667-97ceb4c20bea,neurologisk_afdeling_f_rhus_sygehus_nbg,"Neurologisk afdeling F, Århus Sygehus, NBG" -4520,,e9ca358b-823b-4159-80d0-b7a4a8b6a5b9,Aleksander Krag,aleksander_krag,,,,,, -4521,,4e19c260-3f5e-4d32-9d09-49bbe547471a,Ludwig Boltzmann Institut für Retinologie und biomikroskopische Laserchirurgie,ludwig_boltzmann_institut_f_r_retinologie_und_biomikroskopische_laserchirurgie,,,,,, -4522,,710fabbe-72fb-11e6-a0cd-0242ac12000b,WRASER PHARMS,wraser_pharms,,,,,, -4523,,69723627-6f25-4050-892b-176403ef72f0,FUNDACION GELTAMO,fundacion_geltamo,,,,,, -4524,,de750299-4ed6-496a-a9d5-f9f09288586f,Merck Sante France,merck_sante_france,,,,,, -4525,,cb376e4b-e8ea-47cd-b126-f14060484053,Mepha Ltd,mepha_ltd,,,,,, -4526,,44416a4a-65b4-49e1-9d11-b5185373f4d5,Aspreva International Ltd,aspreva_international_ltd,,,,,, -498,0.938435,2399538a-18b4-4f23-997c-ea2ceaf364fb,Central Institute of Mental Health,central_institute_of_mental_health,,,,2399538a-18b4-4f23-997c-ea2ceaf364fb,central_institute_of_mental_health,Central Institute of Mental Health -4527,,b304544d-58eb-45d0-961e-c21d59e68564,BGDO,bgdo,,,,,, -647,0.96851974725723267,7f6e75e2-17dd-48cc-93b5-ed854fcfc0e1,"Boehringer Ingelheim España, S.A",boehringer_ingelheim_espa_a_s_a,,,,7f6e75e2-17dd-48cc-93b5-ed854fcfc0e1,boehringer_ingelheim_espa_a_s_a,"Boehringer Ingelheim España, S.A" -4528,,85edd5f1-d499-4368-87e2-8850e0363dc3,AIR LIQUIDE SANTE INTERNATIONAL,air_liquide_sante_international,,,,,, -4529,,923de263-7126-4679-a285-5614e0ef36b4,Universitätsklinik Freiburg,universit_tsklinik_freiburg,,,,,, -4530,,bb4594b5-47ea-4d40-8a4b-3f85cac38eae,GEINO,geino,,,,,, -4531,,eb5dc947-3c65-4933-89b6-cffb4aae45dd,"Dept. of Ophthalmol, Semmelweis University",dept_of_ophthalmol_semmelweis_university,,,,,, -4532,,721fd1ad-8b41-4d81-b0a9-39aa6e043a72,"Univ. hospital, Dpt. of anaesthesia",univ_hospital_dpt_of_anaesthesia,,,,,, -4533,,412bfeac-0e8f-4b2b-ad8f-c59310a11fa0,University of Glasgow & Greater Glasgow Health Board,university_of_glasgow_greater_glasgow_health_board,,,,,, -4534,,0283ac06-fd7d-4b68-b737-770352f7e4d7,University of Nottingham,university_of_nottingham,,,,,, -4535,,c26bde81-e58b-4cf0-9f24-47c7dd3dc9b1,AMARIN PHARMA INC,amarin_pharma_inc,,,,,, -4536,,93af64e1-a7fa-4dba-b5a2-e7e0f67ad8d7,"Department of Ophthalmology, Medical University of Graz",department_of_ophthalmology_medical_university_of_graz,,,,,, -4537,,538cc183-0f89-4c68-8124-915c644bc10f,AstraZenenca AB,astrazenenca_ab,,,,,, -4538,,a47c261e-19a0-46e9-a361-b7aca63f4ed9,"Advancell Advanced In Vitro Cell Technologies, S.A",advancell_advanced_in_vitro_cell_technologies_s_a,,,,,, -4539,,f201f6b2-7d57-48b7-963c-6e79b17cf0b9,"Medizinische Universität Wien, Univ.Klinik für Innere Medizin III, Abt.f.Endokrinologie und Stoffwechsel",medizinische_universit_t_wien_univ_klinik_f_r_innere_medizin_iii_abt_f_endokrinologie_und_stoffwechsel,,,,,, -4540,,60632d09-1424-43fd-9d45-00e7d0865c6e,Merckle Recordati GmbH,merckle_recordati_gmbh,,,,,, -4541,,83dafb78-3b85-4327-a764-f21d909f63b1,"Prof John Yarnold, Institute of Cancer Research",prof_john_yarnold_institute_of_cancer_research,,,,,, -5,0.94206222891807556,dd5747ea-816f-45f7-b207-0763f720a969,Centre Hospitalier Universitaire de Liege,centre_hospitalier_universitaire_de_liege,,,,dd5747ea-816f-45f7-b207-0763f720a969,centre_hospitalier_universitaire_de_li_ge,Centre Hospitalier Universitaire de Liège -4542,,68bc515e-7145-11e6-a0cd-0242ac12000b,INTL MEDICATION,intl_medication,,,,,, -4543,,62915947-6a3d-48e4-b2fe-b0c3d3b48813,Biogen Idec GmbH,biogen_idec_gmbh,,,,,, -4544,,5805897c-0bd6-4104-959b-3a7b9378591e,Genzyme GmbH,genzyme_gmbh,,,,,, -84,0.960935,d9acbe70-7141-11e6-a0cd-0242ac12000b,ECR,ecr,,,,93bcfb98-7158-11e6-a0cd-0242ac12000b,ecr_pharma,ECR PHARMA -4545,,09ab4c6e-fec7-40ba-aa02-156ee2efe906,Royal Marsden Hospital,royal_marsden_hospital,,,,,, -4546,,e97155fb-37a7-4db0-afc8-522a3663197c,"Klinikum der Universität München, Klinikum Großhadern",klinikum_der_universit_t_m_nchen_klinikum_gro_hadern,,,,,, -4547,,4e0b3bc8-5a6a-4396-85d4-be9eddf5e68e,"UCB BIOSCIENCES, Inc",ucb_biosciences_inc,,,,,, -4548,,ea97d080-2773-4db0-b06f-7e05cd282e36,South Tees NHS Trust,south_tees_nhs_trust,,,,,, -246,0.9320218563079834,5087f699-7133-45f6-90c4-97f11a55ecf1,Guys and St Thomas' NHS Foudation Trust,guys_and_st_thomas_nhs_foudation_trust,,,,5087f699-7133-45f6-90c4-97f11a55ecf1,guys_and_st_thomas_nhs_foudation_trust,Guys and St Thomas' NHS Foudation Trust -4549,,c615f4f8-63f6-482e-bd7c-c95fe902c370,"KOMINOX USA, Inc",kominox_usa_inc,,,,,, -812,0.970088,3ab32bf7-811c-42fa-8337-eb49e15069f8,"Universitätsklinik für Psychiatrie und Psychotherapie, Klin. Abteilung f. Biologische Psychiatrie",universit_tsklinik_f_r_psychiatrie_und_psychotherapie_klin_abteilung_f_biologische_psychiatrie,,,,37aa2406-dfec-4b12-bbb7-09f94b8adbf5,universit_tsklinik_f_r_psychiatrie_und_psychotherapie_i,Universitätsklinik für Psychiatrie und Psychotherapie I -688,0.98254102468490601,e59cd9f1-a10e-4d35-9ad8-0bbcd34a16f9,Ruprecht-Karls-University Heidelberg,ruprecht_karls_university_heidelberg,,,,4f99f7a3-6aa3-48d1-bbd6-5bfbc38e7e8d,ruprecht_karls_university_heidelberg_medical_faculty,"Ruprecht-Karls-University Heidelberg, Medical Faculty" -4550,,9a97cdae-6a8d-47d4-bc96-4b9ba83cd0db,Gador S.A,gador_s_a,,,,,, -4551,,933f9768-3c83-472d-9786-b44b26cccb49,Cardoz AB,cardoz_ab,,,,,, -4552,,cd9d985d-3500-491c-b3c0-94abdf5130bb,University Hospital Sint Radboud,university_hospital_sint_radboud,,,,,, -4553,,f78ffc1e-4276-46f8-9f18-592868d400ad,AZIENDA SANITARIA LOCALE BI DI BIELLA,azienda_sanitaria_locale_bi_di_biella,,,,,, -4554,,c87b9140-ae74-4882-b7f4-3c3c74efb5da,Fundació per la Recerca i la Docència Sant Joan de Déu,fundaci_per_la_recerca_i_la_doc_ncia_sant_joan_de_d_u,,,,,, -321,0.95550477504730225,12641096-e1dd-46f5-9635-3bd405807ce5,All Ireland Cooperative Oncology Research Group (ICORG),all_ireland_cooperative_oncology_research_group_icorg,,,,12641096-e1dd-46f5-9635-3bd405807ce5,all_ireland_cooperative_oncology_research_group,All Ireland Cooperative Oncology Research Group -4555,,1d70a99d-c300-49ae-8427-810f445e1933,Maastricht University - CAPHRI School for Public Health and Primary Care,maastricht_university_caphri_school_for_public_health_and_primary_care,,,,,, -4556,,576376ff-fafd-4849-b99e-c90cc4db552d,Vrije Universiteit Medical Center,vrije_universiteit_medical_center,,,,,, -4557,,3cd6fbf8-2fe5-4697-93ea-b178ef8a9f17,STOP SIDA,stop_sida,,,,,, -4558,,f2d91d58-cc55-4e35-abc5-d3bd8166b67d,"Department of dermatology, Odense University Hospital",department_of_dermatology_odense_university_hospital,,,,,, -4559,,aca89280-7672-4d06-8c1b-26653cba201a,Royal Liverpool University Hospital,royal_liverpool_university_hospital,,,,,, -4560,,7d9c7620-f982-4a39-9775-f539a51c189f,Hutchison MediPharma Enterprises Limited,hutchison_medipharma_enterprises_limited,,,,,, -898,0.96782034635543823,485cfb56-5188-4c47-8ac4-caf3e84b5e2f,EBMT,ebmt,,,,485cfb56-5188-4c47-8ac4-caf3e84b5e2f,ebmt,EBMT -161,0.98681116104125977,9f385dc9-f8a0-482e-8c35-dd79a5919f66,Fundación para la Investigación Biomédica del Hospital 12 de Octubre,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_12_de_octubre,,,,393eab2d-fa2d-419a-8ecd-278e02b1ad5b,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_12_de_octubre,Fundación para la Investigación Biomédica del Hospital 12 de Octubre -4561,,a722c794-96b5-11e6-becf-0242ac110008,KYOWA KIRIN,kyowa_kirin,,,,,, -4562,,198c8a4e-7cb2-4496-9da6-87fe6e0cf60a,John L. Berk,john_l_berk,,,,,, -4563,,2750aee0-14ef-47f8-83a0-ff56bf12f305,"Alita Pharmaceuticals, Inc",alita_pharmaceuticals_inc,,,,,, -4564,,7d8d6f79-cd2d-4f47-a542-af28865d9fae,Omthera Pharmaceutical Inc,omthera_pharmaceutical_inc,,,,,, -4565,,ddcf6a9b-f35e-473f-9a80-d04c1f6ad714,"Steen W. Henneberg, Børnesmerteenheden, Anæstesi afd. 4013, Juliane Marie Centeret, Rigshospitalet",steen_w_henneberg_b_rnesmerteenheden_an_stesi_afd_4013_juliane_marie_centeret_rigshospitalet,,,,,, -4566,,ffcd68a4-22bd-48b7-b48b-e5bbb42c4c31,Universitätsklinkum Erlangen,universit_tsklinkum_erlangen,,,,,, -909,0.985676,8b650ee2-73e0-11e6-a0cd-0242ac12000b,OSMOTICA PHARM CORP,osmotica_pharm_corp,,,,575af654-7159-11e6-a0cd-0242ac12000b,osmotica_pharm,OSMOTICA PHARM -649,0.92396390438079834,04c96b54-04e3-4fc0-9394-ec1a0060bdcd,Boehringer Ingelheim Ltd,boehringer_ingelheim_ltd,,,,04c96b54-04e3-4fc0-9394-ec1a0060bdcd,boehringer_ingelheim_ltd,Boehringer Ingelheim Ltd -4567,,5ac76716-69e6-472d-9de7-b9f0008d4dce,BASICS Study Group,basics_study_group,,,,,, -4568,,71fc2417-ed05-4474-af8a-a064123563fa,Royal Wolverhampton NHS trust,royal_wolverhampton_nhs_trust,,,,,, -4569,,5e650d5e-715e-11e6-a0cd-0242ac12000b,TORRENT PHARMS LTD,torrent_pharms_ltd,,,,,, -4570,,18deada9-5412-4245-981b-70a55abf1010,Center Human Drug Research,center_human_drug_research,,,,,, -4571,,9683a961-aa1b-4195-80d2-a32b4431f685,Grupo Español de Tumores Neuroendocrinos. SECRETARÍA TÉCNICA GETNE (GETNE),grupo_espa_ol_de_tumores_neuroendocrinos_secretar_a_t_cnica_getne_getne,,,,,, -4572,,5a1cfc63-9a21-4db9-a032-f417843cde75,Schering-Plough CE AG Hungarian Commercial Representative Office,schering_plough_ce_ag_hungarian_commercial_representative_office,,,,,, -4573,,83b68d31-473c-45f6-acf2-8273453ca0ef,PerioC Ltd,perioc_ltd,,,,,, -4574,,14cacee3-2105-48fd-9484-0437acff6e34,Dept of Oncology,dept_of_oncology,,,,,, -4575,,c1e67dc4-e768-4651-8905-e3c06a1ba370,Trimed Biotech GmbH,trimed_biotech_gmbh,,,,,, -4576,,fc35d73d-73a0-47d9-bf78-c5fcfbd3c887,"Talon Therapeutics , Inc",talon_therapeutics_inc,,,,,, -4577,,75672ec9-4f1d-4f39-b0d6-1e3242c52b4f,Pulmonary dept. Gentofte Hospital,pulmonary_dept_gentofte_hospital,,,,,, -4578,,a3e93b22-732d-11e6-a0cd-0242ac12000b,VANDA PHARMS INC,vanda_pharms_inc,,,,,, -4579,,ce09f9e6-08ca-49eb-b5e4-9405a96d519d,Novo Nordisk Pharmaceutique S.A.S,novo_nordisk_pharmaceutique_s_a_s,,,,,, -4580,,bcc67748-b987-4321-b8df-dbc5fa6ffcf4,Laboratorios Almirall SA,laboratorios_almirall_sa,,,,,, -4581,,ebec2e63-637f-4475-9c7a-7e4f94415efe,Creabilis Sàrl,creabilis_s_rl,,,,,, -4582,,2f27470e-e242-4953-a59f-785813dc2697,German Breast GBG Forschungsgesellschaft mbH,german_breast_gbg_forschungsgesellschaft_mbh,,,,,, -4583,,c4c139e3-e159-4888-89cf-c44d76107ea9,"Medical Oncology, VUmc",medical_oncology_vumc,,,,,, -4584,,53feb5a6-df0e-4911-9851-e1ca01203659,FONDAZIONE PAOLO PROCACCI ONLUS,fondazione_paolo_procacci_onlus,,,,,, -4585,,6610c193-dc5d-4e6e-9306-512c3691a247,Dra Cristina Avendaño Sola,dra_cristina_avenda_o_sola,,,,,, -4586,,cb8e4960-7161-11e6-a0cd-0242ac12000b,PHARMAFAIR,pharmafair,,,,,, -30,0.903169,9bad6f97-3bca-43b7-8146-268bcca0c619,ACROSS (Associació catalana per la recerca oncològica i les seves implicacions sanitàries i socials),across_associaci_catalana_per_la_recerca_oncol_gica_i_les_seves_implicacions_sanit_ries_i_socials,,,,261630f5-cc3d-4976-b8b8-66f665f0285f,across_associaci_catalana_de_recerca_oncol_gica_i_les_seves_implicacions_sanit_ries_i_socials,ACROSS (Associació Catalana de Recerca Oncològica i les seves implicacions Sanitàries i Socials) -4587,,c6965b16-c727-4829-911b-60005db71a30,KEDRION,kedrion,,,,,, -4588,,ed1cb115-7077-4cd4-a970-e20608d25aa0,Medivir AB,medivir_ab,,,,,, -4589,,ab6837b3-5aa6-44bf-93e2-724d6396caca,Forward Pharma GmbH,forward_pharma_gmbh,,,,,, -4590,,9ff45d87-d917-4ba5-8837-f2fb222e7e3b,"Azienda Ospedaliera, Polo Universitario Luigi Sacco, Milano",azienda_ospedaliera_polo_universitario_luigi_sacco_milano,,,,,, -4591,,60777ea3-567a-4121-a34a-cd0c96987def,Dr Ken O'Byrne,dr_ken_o_byrne,,,,,, -4592,,990ba9b5-22aa-4ace-b797-05ebfde0bd22,"Medizinische Universität Innsbruck, Universitätsklinik für Neurologie",medizinische_universit_t_innsbruck_universit_tsklinik_f_r_neurologie,,,,,, -4593,,659d1ce5-0dbe-4d6c-a7f3-6c68c6d35f39,"Blodbanken, Rigshospitalet",blodbanken_rigshospitalet,,,,,, -4594,,3e969b78-72ad-11e6-a0cd-0242ac12000b,VIB,vib,,,,,, -4595,,35e46c3a-0f32-484d-9f71-6d06d9a3da15,Boneca Corporation,boneca_corporation,,,,,, -4596,,89b7ad4a-8359-43fe-a621-1e1451143abb,"Central Institute of Mental Health, Department of Psychiatry and Psychotherapy",central_institute_of_mental_health_department_of_psychiatry_and_psychotherapy,,,,,, -4597,,27e83e35-6397-4035-bf10-7f98c21b9cf8,Laboratoires 3M Santé,laboratoires_3m_sant,,,,,, -4598,,98ac7789-440f-49c8-8ead-d49b435b1647,Bristol-Meyers Squibb International Corporation,bristol_meyers_squibb_international_corporation,,,,,, -4599,,d9b4b51c-7141-11e6-a0cd-0242ac12000b,BOCA PHARMA LLC,boca_pharma_llc,,,,,, -4600,,e4f30928-714c-11e6-a0cd-0242ac12000b,AMERIGEN PHARMS LTD,amerigen_pharms_ltd,,,,,, -4601,,1e6a3b37-0863-4e5d-a4cb-f115fc38553f,University Hospital of Ulm,university_hospital_of_ulm,,,,,, -4602,,8944bb2a-7292-11e6-a0cd-0242ac12000b,ALARA PHARM,alara_pharm,,,,,, -4603,,11b617fc-8388-41df-8845-00907935f6b1,Ann Merete Møller,ann_merete_m_ller,,,,,, -4604,,9c1aeb9c-233c-47fb-ab41-82466f41da9a,"Cardiovascular laboratory 2014, The Heart Centre, Rigshospitalet",cardiovascular_laboratory_2014_the_heart_centre_rigshospitalet,,,,,, -4605,,8683c491-3da8-4630-ac72-3bb919ada6d0,Arakis Ltd,arakis_ltd,,,,,, -4606,,28af658d-50ed-465d-b353-f8b03a5b70a3,Hellenic Oncology Research Group,hellenic_oncology_research_group,,,,,, -4607,,3143c171-12e6-43c9-820b-c04f52a46721,F.Hoffmann-La Roche,f_hoffmann_la_roche,,,,,, -182,0.972538,d6726488-cb2a-4dc9-8697-82aba6b6943c,Durata Therapeutics International B.V,durata_therapeutics_international_b_v,,,,14a0b753-a57f-41c0-b017-ca7adb32f3da,durata_therapeutic_international_b_v,Durata Therapeutic International B.V -4608,,024ca824-9ec6-45bb-8516-1d7e69f842da,OM PHARMA,om_pharma,,,,,, -309,0.98614925146102905,53ec0bfe-735f-11e6-a0cd-0242ac12000b,MALLINCKRODT IP,mallinckrodt_ip,,,,02f63d38-7129-11e6-a89e-0242ac12000b,mallinckrodt,MALLINCKRODT -4609,,025af88b-9529-4444-90b5-86481ce363f0,Centre Hospitalier Universitaire d'Angers,centre_hospitalier_universitaire_d_angers,,,,,, -17,0.985533,c63a0355-3210-4a0d-9c79-6e414a13ec40,"German Heart Centre Munich, Department of Cardiovascular Diseases",german_heart_centre_munich_department_of_cardiovascular_diseases,,,,c63a0355-3210-4a0d-9c79-6e414a13ec40,german_heart_centre_munich_department_of_cardiovascular_diseases,"German Heart Centre Munich, Department of Cardiovascular Diseases" -4610,,78157b7e-a826-46f3-8aae-98b3491da362,GlaxoSmithKline R&D UK Ltd,glaxosmithkline_r_d_uk_ltd,,,,,, -4611,,effd088c-46ba-4617-90f0-b113086f4bef,"Acetylon Pharmaceuticals, Inc",acetylon_pharmaceuticals_inc,,,,,, -4612,,445103ff-d64d-461b-8830-e1d2f38e9417,Dr. Chris Thompson,dr_chris_thompson,,,,,, -4613,,e3723851-b7cf-44af-acc4-492cdc439dac,Vical Incorporated,vical_incorporated,,,,,, -4614,,d8dfaf76-046b-4964-9207-539bb36fa742,GlaxoSmithKline Research Ltd,glaxosmithkline_research_ltd,,,,,, -4615,,3d913a2e-f0cc-4410-8465-efe29051f72c,"Århus University Hospital, Department of Dermatology",rhus_university_hospital_department_of_dermatology,,,,,, -4616,,02811bfc-7a4a-480f-a46f-0ba4a432d9e1,Univ.Clinic of Dermatology,univ_clinic_of_dermatology,,,,,, -4617,,231fdf0a-73f0-11e6-a0cd-0242ac12000b,WESTAIR GASES & EQUIPMENT INC,westair_gases_equipment_inc,,,,,, -54,0.987705,4309c229-e3c1-4201-9d80-c9e59f301793,AIBILI - Association for Innovation and Biomedical Research ob Light and Image,aibili_association_for_innovation_and_biomedical_research_ob_light_and_image,,,,22fb394f-9949-4253-b978-e945565c187d,aibili_association_for_innovation_and_biomedical_research_on_light_and_image,AIBILI - Association for Innovation and Biomedical Research on Light and Image -4618,,5041311b-13ed-4575-aa8c-5d0f14575ec1,ZARI - Univeristätsmedizin Göttingen,zari_univerist_tsmedizin_g_ttingen,,,,,, -4619,,f2ed3f1d-a72c-11e6-94cb-5656d04fc2b5,Fertilitycenter Odense,fertilitycenter_odense,,,,,, -4620,,57da89eb-695a-4806-8fc2-4ff828dc6b33,"Academic Medical Center, University of Amsterdam",academic_medical_center_university_of_amsterdam,,,,,, -4621,,2c7eb2db-2ce1-4c84-962d-ec4098da80a7,Scandinavian Prostate Cancer Group (SPCG),scandinavian_prostate_cancer_group_spcg,,,,,, -4622,,24fde8c2-52fe-4bbb-8c10-e57d480e040c,Dutch Childhood Oncology Group (DCOG),dutch_childhood_oncology_group_dcog,,,,,, -4623,,6de73923-d5f5-4d8b-9795-9cebd0aac307,"IPSEN Research and Development, BEAUFOUR IPSEN PHARMA",ipsen_research_and_development_beaufour_ipsen_pharma,,,,,, -4624,,a9da6c28-d83e-4411-aea4-6a3f620d5927,"Lil Valentin, Region Skåne, Malmö University Hospital, Dpt Obstetrics and Gynecology",lil_valentin_region_sk_ne_malm_university_hospital_dpt_obstetrics_and_gynecology,,,,,, -4625,,d189f68a-ba9f-4328-83b7-e34720049e4e,CAROLINA IBAÑEZ LOPEZ,carolina_iba_ez_lopez,,,,,, -4626,,105c2714-3c7f-4c49-8292-5d5d874cf217,"Zavante Therapeutics, Inc",zavante_therapeutics_inc,,,,,, -4627,,3c16d888-57c7-4f64-a33a-ff5c282a69f8,Piramal Life Sciences Limited,piramal_life_sciences_limited,,,,,, -466,0.91411077976226807,0c30b492-594c-4ddd-8d03-fa24bfa5bbd3,"Leiden University Medical Center, department of rheumatology",leiden_university_medical_center_department_of_rheumatology,,,,0c30b492-594c-4ddd-8d03-fa24bfa5bbd3,leiden_university_medical_center_department_of_rheumatology,"Leiden University Medical Center, department of rheumatology" -4628,,02d25d93-07d8-4018-837f-77cc07857130,Klaus Krogh,klaus_krogh,,,,,, -4629,,058dd909-c936-4725-91ae-e66e55db74eb,SANOFI- AVENTIS RECHERCHE ET DÉVELOPPEMENT,sanofi_aventis_recherche_et_d_veloppement,,,,,, -4630,,97fd4cf8-fa74-43b4-b733-28214f2db140,Sørlandet Hospital,s_rlandet_hospital,,,,,, -4631,,681747cc-7145-11e6-a0cd-0242ac12000b,MATRIX MEDCL,matrix_medcl,,,,,, -4632,,540fed12-7166-11e6-a0cd-0242ac12000b,ACIC FINE CHEMS,acic_fine_chems,,,,,, -207,0.915531,46fed310-ee3c-4cc4-8649-37bb315ed072,"BIAL - Portela & Ca, S.A",bial_portela_ca_s_a,,,,46fed310-ee3c-4cc4-8649-37bb315ed072,bial_portela_ca_s_a,"BIAL - Portela & Ca, S.A" -4633,,1f89690a-9a9c-416c-b094-2f9d9f53ba41,"Intarcia Therapeutics, Inc",intarcia_therapeutics_inc,,,,,, -4634,,72aca9dd-2c38-4fec-b0dd-e3d607751422,GE Healthcare Ltd,ge_healthcare_ltd,,,,,, -4635,,facd512d-325c-41cc-98e5-a6da21edb988,Albireo AB,albireo_ab,,,,,, -4636,,2b6258a9-3e96-400c-b7fe-422aef06b7a5,Kalmar County Council,kalmar_county_council,,,,,, -4637,,1b86e1d4-732e-11e6-a0cd-0242ac12000b,AMHERST PHARMS LLC,amherst_pharms_llc,,,,,, -4638,,f816f266-67c3-47d5-916e-ff64d4d45998,"Center for Spiseforstyrrelse, Endokrinologisk Afdeling M, Odense Universitetshospital",center_for_spiseforstyrrelse_endokrinologisk_afdeling_m_odense_universitetshospital,,,,,, -4639,,465402d8-71a4-11e6-a0cd-0242ac12000b,FERRING PHARMS INC,ferring_pharms_inc,,,,,, -4640,,a4323d6f-80ea-4dda-9fb7-c86a00a536eb,Zentrum für Neuro-Onkologie,zentrum_f_r_neuro_onkologie,,,,,, -4641,,9eae5a22-73e9-11e6-a0cd-0242ac12000b,OMEROS,omeros,,,,,, -4642,,20beaa5c-7619-4736-8f78-c478240fdd48,Belgian Study Group for Pediatric Endocrinology,belgian_study_group_for_pediatric_endocrinology,,,,,, -4643,,67d47ff8-7bc0-418b-abc6-3bb9795c224b,"NovaCardia, Inc. (A wholly owned subsidiary of Merck & Co., Inc.)",novacardia_inc_a_wholly_owned_subsidiary_of_merck_co_inc,,,,,, -4644,,0c591de0-726a-11e6-a0cd-0242ac12000b,SKINMEDICA,skinmedica,,,,,, -4645,,92c13aa6-2116-47da-b4e9-aa1813065437,"Västra Götalandsregionen, Shalgrenska University Hospital Östra",v_stra_g_talandsregionen_shalgrenska_university_hospital_stra,,,,,, -4646,,ac93cced-1fa6-4ec7-b35b-83e09c68fb08,GOTEL (Grupo Oncológico para el Tratamiento de las Enfermedades Linfoides),gotel_grupo_oncol_gico_para_el_tratamiento_de_las_enfermedades_linfoides,,,,,, -4647,,26502d11-6d14-4f40-ad10-9dffee76c43a,"Endocrine Department, Sahlgrenska University Hospital",endocrine_department_sahlgrenska_university_hospital,,,,,, -717,0.958979,8e8615e6-4618-4d17-8910-cbd6dfde0637,Dept. Child & Adolescent Psychiatry Univ. Freiburg,dept_child_adolescent_psychiatry_univ_freiburg,,,,7517b680-5ab5-4e0c-8c77-e2e66cd5f935,dept_child_adolescent_psychiatrie,Dept. Child & Adolescent Psychiatrie -4648,,6e2ef557-1886-405f-add8-d4f0da06eb94,FARMAKA Srl,farmaka_srl,,,,,, -4649,,87b4e3d6-1aa6-4d5b-a059-a7b155521ec5,BOEHRINGER ING,boehringer_ing,,,,,, -4650,,fad954e1-8a1b-423d-9787-709e10ba2d31,"Barts and the London School of Medicine and Dentistry, Queen Mary University of London",barts_and_the_london_school_of_medicine_and_dentistry_queen_mary_university_of_london,,,,,, -4651,,abcc0dc0-5897-40f0-97eb-1c653d2b3172,Professor Joergen Berg Dahl,professor_joergen_berg_dahl,,,,,, -4652,,63da7f28-b01c-46eb-9af9-e494c2d43480,Lumena Pharmaceuticals LLC,lumena_pharmaceuticals_llc,,,,,, -4653,,e0a0a560-3254-4ff7-9a0f-884c04fb1e4a,Serumwerk Bernburg,serumwerk_bernburg,,,,,, -4654,,193187fc-7155-11e6-a0cd-0242ac12000b,AEGIS PHARMS,aegis_pharms,,,,,, -4655,,617b68d5-f850-4b63-a90c-8131e3928f3c,ASONMEC (Asociación de Oncología Medica del Hospital de Cruces),asonmec_asociaci_n_de_oncolog_a_medica_del_hospital_de_cruces,,,,,, -4656,,80b01c1b-ed37-4e5a-b0be-251dd90e0e43,Nordfjord Psychiatric Centre,nordfjord_psychiatric_centre,,,,,, -767,0.98237824440002441,da4cbdf9-e1bc-4412-95a2-1df2b8781a19,Medizinische Universität Innsbruck Innere Medizin V,medizinische_universit_t_innsbruck_innere_medizin_v,,,,da4cbdf9-e1bc-4412-95a2-1df2b8781a19,medizinische_universit_t_innsbruck_innere_medizin_v,Medizinische Universität Innsbruck -464,0.979231,12f90377-956c-4817-b4ad-64555adaf3a0,SCHWARZ PHARMA Deutschland GmbH,schwarz_pharma_deutschland_gmbh,,,,12f90377-956c-4817-b4ad-64555adaf3a0,schwarz_pharma_deutschland_gmbh,SCHWARZ PHARMA Deutschland GmbH -768,0.987661,611690f5-8173-4554-bcb7-1ecc6dba03cd,Bayer Schering Pharma AG,bayer_schering_pharma_ag,,,,611690f5-8173-4554-bcb7-1ecc6dba03cd,bayer_schering_pharma_ag,Bayer Schering Pharma AG -4657,,83b3820e-2221-4da4-b297-e417b9188f3b,Klinik Neuropädiatrie und Muskelkrankheiten,klinik_neurop_diatrie_und_muskelkrankheiten,,,,,, -4658,,93f935be-716b-11e6-a0cd-0242ac12000b,IDEC PHARMACEUTICALS CORP,idec_pharmaceuticals_corp,,,,,, -4659,,8d579fdc-aca4-4c8d-a1b0-617a4b57b83d,BRISTOL-M.SQUIBB,bristol_m_squibb,,,,,, -888,0.96565869024821693,f5ba0c0f-5dea-4005-9de6-28efb2d2755c,"Schering-Plough Research Institute, a division of Schering Corp",schering_plough_research_institute_a_division_of_schering_corp,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" -4660,,4b27728a-7164-11e6-a0cd-0242ac12000b,AMPOLGEN,ampolgen,,,,,, -4661,,0e4855a0-b62e-43b5-8072-c5ec6ea7aa16,Ventrus Biosciences,ventrus_biosciences,,,,,, -1081,0.98753979802131653,db4d0602-1e15-4ac9-8de2-88720d9bf753,Vertex Pharmaceuticals Inc,vertex_pharmaceuticals_inc,,,,48c9366f-f57d-45a5-b7c5-8b03cb153868,vertex_pharmaceuticals_inc,Vertex Pharmaceuticals Inc -4662,,29f881ec-bd4b-4e60-87c2-a71dbf8d304b,Eisai Medical Research Inc,eisai_medical_research_inc,,,,,, -4663,,2b56b800-6c6e-4ccd-919e-21dda4f8e68a,"Aarhus University Hospital, Department of Endocrinology and Internal Diseases",aarhus_university_hospital_department_of_endocrinology_and_internal_diseases,,,,,, -4664,,dc67c1f7-ec46-445d-81eb-53f4b5773a45,Aker universitetssykehus,aker_universitetssykehus,,,,,, -4665,,533e324a-fa22-4000-bd45-f8697c1bacdb,WOLFSON DIGESTIVE DISEASES CENTRE,wolfson_digestive_diseases_centre,,,,,, -4666,,282e016e-061e-4f60-982d-3bf795895030,Apoxis SA,apoxis_sa,,,,,, -4667,,c1f9d37e-29ca-4135-8221-1e871bf454df,"Multidisciplinary Pain Center 7612, Rigshospitalet",multidisciplinary_pain_center_7612_rigshospitalet,,,,,, -4668,,a90e99e4-712a-11e6-a89e-0242ac12000b,GAVIS PHARMS,gavis_pharms,,,,,, -4669,,bdcfeb84-4aa1-47db-8426-be1cb3b02e95,Hunter-Fleming Ltd,hunter_fleming_ltd,,,,,, -4670,,d8e4283f-2eb0-44f1-9ec8-aea794d04c99,"IPSEN Research and Development, IPSEN PHARMA SAS",ipsen_research_and_development_ipsen_pharma_sas,,,,,, -4671,,762bd1c8-0a34-4c38-a4cb-7717b0c9aa62,Ana Vallejo de la Cueva,ana_vallejo_de_la_cueva,,,,,, -4672,,e00b5130-2aae-4b06-ad18-7076a37aa1f5,POLICLINICO GEMELLI,policlinico_gemelli,,,,,, -104,0.987186,75e8ee69-62d3-42ee-992e-eee1cd45ffb8,Merck Lipha Santé SAS,merck_lipha_sant_sas,,,,75e8ee69-62d3-42ee-992e-eee1cd45ffb8,merck_lipha_sant_sas,Merck Lipha Santé SAS -4673,,30ef7f8d-4618-49a8-85d8-e90c32d01989,C. HOSPITALARIO VIRGEN DEL ROCIO,c_hospitalario_virgen_del_rocio,,,,,, -4674,,e07d9269-90cd-4569-9510-6ebca5a7774e,Sucampo Pharma Europe Ltd,sucampo_pharma_europe_ltd,,,,,, -4675,,7ad053f4-f46b-4d19-8c5d-1268eb1e0ec1,"Dept of Paediatric Anaesthesia, Karolinska University Hospital-Solna",dept_of_paediatric_anaesthesia_karolinska_university_hospital_solna,,,,,, -475,0.985423,ffa313ee-734f-11e6-a0cd-0242ac12000b,HETERO DRUGS LTD,hetero_drugs_ltd,,,,f3be3318-715d-11e6-a0cd-0242ac12000b,hetero_drugs,HETERO DRUGS -4676,,d84a09a2-7141-11e6-a0cd-0242ac12000b,HI-TECH PHARMACAL,hi_tech_pharmacal,,,,,, -4677,,ce38eb37-e2b4-4b9b-bdde-32f4caacf023,"Tobira Therapeutics, Inc",tobira_therapeutics_inc,,,,,, -4678,,1deb2f69-46ec-4ef0-986d-88bfa9c81706,"MUW, Klinik f. Mund-, Kiefer, und Gesichtschirurgie",muw_klinik_f_mund_kiefer_und_gesichtschirurgie,,,,,, -186,0.987464,7c8c188f-61a9-4ebc-a77d-3b56eea02989,ISTITUTO GIANNINA GASLINI,istituto_giannina_gaslini,,,,2cec47b8-3bd6-4f10-8180-b9e29e1ccf01,istituto_giannina_gaslini_printo,ISTITUTO GIANNINA GASLINI-PRINTO -4679,,4762dcae-952c-4a22-91c1-81a58bc7324e,"Klinikum der Ludwig-Maximilians-Universität München, Klinikum Großhadern",klinikum_der_ludwig_maximilians_universit_t_m_nchen_klinikum_gro_hadern,,,,,, -4680,,d0e40f16-25af-4459-937c-2e8b3e8260c8,IRCCS AOU SAN MARTINO- IST,irccs_aou_san_martino_ist,,,,,, -4681,,63f7d194-af57-4043-af49-0cecfb6cf49c,POLICLINICO SAN DONATO IRCSS,policlinico_san_donato_ircss,,,,,, -4682,,80a6033e-7d75-4f86-adf6-94304c39d755,"Specialisttandvården/Bettfysiologi, Folktandvården Södra Bohslän",specialisttandv_rden_bettfysiologi_folktandv_rden_s_dra_bohsl_n,,,,,, -4683,,b388fb70-85c2-4ce8-9427-21b59d9596ac,University of Aberdeen & NHS Grampian,university_of_aberdeen_nhs_grampian,,,,,, -984,0.96790230274200439,d845bc54-1b47-4eaa-9f16-1a723a24d9b4,Imperial College London and Imperial College Healthcare NHS Trust,imperial_college_london_and_imperial_college_healthcare_nhs_trust,,,,1c2355a5-8dc8-4952-839c-0af765b26555,imperial_college_london_imperial_college_healthcare_nhs_trust,Imperial College London & Imperial College Healthcare NHS Trust -4684,,2ff60eec-72fc-11e6-a0cd-0242ac12000b,AMYLIN,amylin,,,,,, -897,0.963506,e6207d0a-7145-11e6-a0cd-0242ac12000b,OHM,ohm,,,,8f278d90-7145-11e6-a0cd-0242ac12000b,ohm_labs,OHM LABS -519,0.97853121161460876,85e83b77-dd1e-42a1-b79f-e5cd5d499f1a,CSL Behring AG (casa madre),csl_behring_ag_casa_madre,,,,c15af267-15cc-42e5-be46-4a84bd3c6dca,csl_behring_ag,CSL Behring AG -4685,,644a7803-6144-47ea-abff-af36f84c13da,"Clinical Trials Center Aachen, University of Aachen",clinical_trials_center_aachen_university_of_aachen,,,,,, -415,0.958927,59386aed-ad97-4761-8066-9f33da6b317f,Aspreva Pharmaceuticals Corporation as part of the Roche-Aspreva Collaboration Agreement,aspreva_pharmaceuticals_corporation_as_part_of_the_roche_aspreva_collaboration_agreement,,,,1a38fc33-48c6-45d0-8a30-54ce6c217bac,aspreva_pharmaceutical_corporation,Aspreva Pharmaceutical Corporation -4686,,aa283f81-977f-4da3-8c06-170ea8e59d8d,AZIENDA OSPEDALIERA FONDAZIONE MACCHI (A.O. DI RILIEVO NAZIONALE),azienda_ospedaliera_fondazione_macchi_a_o_di_rilievo_nazionale,,,,,, -4687,,4e8d38c1-0cbf-4219-834d-80815f68f5f6,GlaxoSmithKline Reseacrh and Development Limited,glaxosmithkline_reseacrh_and_development_limited,,,,,, -4688,,aca7b449-00dd-454d-9490-afaee661da2b,LYSARC,lysarc,,,,,, -4689,,d23d7634-7358-11e6-a0cd-0242ac12000b,PARAPRO LLC,parapro_llc,,,,,, -594,0.970712,e892a01f-3ea1-4cd9-9870-18a0aae9256f,"The Karolinska Institutet, ClinTRID",the_karolinska_institutet_clintrid,,,,1768a5c2-6d78-474d-b8b9-24906dea2085,the_karolinska_institute_clintrid,"The Karolinska Institute, ClinTRID" -65,0.97933,85300b96-9316-43a9-b115-b61f3263249b,ANGELINI,angelini,,,,85300b96-9316-43a9-b115-b61f3263249b,angelini,ANGELINI -4690,,65e35f10-980a-45a1-9583-ea8c86e6fd47,Chiron Vaccines Limited,chiron_vaccines_limited,,,,,, -4691,,1fa31c42-0c9b-43ab-81e0-35dd0e4d9857,FERRING ARZNEIMITTEL Ges.m.b.h. CEE AUSTRIA,ferring_arzneimittel_ges_m_b_h_cee_austria,,,,,, -4692,,dfb8d068-426a-41a7-b455-0406ca3c1011,Linde Gas Therapeutics,linde_gas_therapeutics,,,,,, -4693,,33454394-7142-11e6-a0cd-0242ac12000b,ARMENPHARM,armenpharm,,,,,, -4694,,90780bf1-e327-4555-be89-d6df896637b5,GYN Research GmbH,gyn_research_gmbh,,,,,, -4695,,5848e4ad-8b6a-4616-8e07-7fb9d3747035,CLINICAL PHARMACOLOGY SPANISH SOCIETY,clinical_pharmacology_spanish_society,,,,,, -667,0.985709,1a3268a1-1f5d-4bc4-a2cd-ff168ce961fd,Consorci Parc de Salut Mar de Barcelona,consorci_parc_de_salut_mar_de_barcelona,,,,1a3268a1-1f5d-4bc4-a2cd-ff168ce961fd,consorci_parc_de_salut_mar_de_barcelona,Consorci Parc de Salut Mar de Barcelona -4696,,9251eb5c-15f6-44aa-a851-18e1d6097b86,Universitätsklinik für Anästhesie - Paracelsus Medizinische Universität Salzburg,universit_tsklinik_f_r_an_sthesie_paracelsus_medizinische_universit_t_salzburg,,,,,, -4697,,d41da4ae-fbbe-4423-9ac2-63610ddeaaf0,Cedars Sinai Medical Center,cedars_sinai_medical_center,,,,,, -4698,,421321c8-7167-11e6-a0cd-0242ac12000b,UNIV NORTH DAKOTA,univ_north_dakota,,,,,, -4699,,eb68071b-fbc9-4667-a486-2a23faf778f9,Epifarma S.r.l,epifarma_s_r_l,,,,,, -4700,,95996a8a-e911-4274-a63c-330c9efad587,"Medizinische Universität Graz, Klin. Abteilung für Gastroenterologie und Hepatologie",medizinische_universit_t_graz_klin_abteilung_f_r_gastroenterologie_und_hepatologie,,,,,, -4701,,6659a2bb-bd7a-4386-8c87-c199d5be2fc7,Sylentis S.A.U,sylentis_s_a_u,,,,,, -4702,,96a7c44f-920b-4558-81b2-15fe98a8daae,(OSI) Eyetech Pharamceuticals Inc,osi_eyetech_pharamceuticals_inc,,,,,, -532,0.967052,54f4c723-6489-4990-9197-43e7be9cca13,East and North Hertfordhsire NHS Trust,east_and_north_hertfordhsire_nhs_trust,,,,4c49fb26-4e7e-409c-ab8a-627200080dc0,east_and_north_hertfordshire_nhs_trust,East and North Hertfordshire NHS Trust -4703,,045f4d5e-992a-49f7-9745-333f2ff87d30,Dompé farmaceutici s.p.a,domp_farmaceutici_s_p_a,,,,,, -4704,,0802e8a7-2020-4d39-8d98-b51e4b7817f8,Zogenix International Limited,zogenix_international_limited,,,,,, -4705,,02c2f2e2-f26a-41a6-b887-f321e878a4d7,The Medicines Company,the_medicines_company,,,,,, -4706,,4bd73325-dc0a-4ddc-96a1-324c7795ccaf,Medtronic International Trading Sarl,medtronic_international_trading_sarl,,,,,, -70,0.98913925886154175,c009dd7a-8228-4d50-861f-056ef834bb4b,Takeda Global R&D Centre (Europe),takeda_global_r_d_centre_europe,,,,ac8a4c93-016d-49ef-adcf-dab8bb9bc5aa,takeda_global_r_d_centre_europe_ltd,Takeda Global R&D Centre (Europe) Ltd -994,0.94387978315353394,2e5a2501-0997-4b88-9260-ccb94b118ad0,GE Healthcare Ltd and its Affiliates,ge_healthcare_ltd_and_its_affiliates,,,,2e5a2501-0997-4b88-9260-ccb94b118ad0,ge_healthcare_ltd_and_its_affiliates,GE Healthcare Ltd and its Affiliates -4707,,8573dbf3-9555-4690-808b-1174cd449c1e,PLIVA Research and Development Ltd,pliva_research_and_development_ltd,,,,,, -4708,,36df679a-8bab-48e6-ab54-46c1f8c00fe7,Indevus Pharmaceuticals Incorporated,indevus_pharmaceuticals_incorporated,,,,,, -4709,,29ce9749-7d1d-4b76-9faa-f23407aa280f,Sörmlands läns landsting,s_rmlands_l_ns_landsting,,,,,, -4710,,3e4b4d84-41bc-4628-a620-f7201d09bfa2,"Sykehuset Østfold, Fredrikstad",sykehuset_stfold_fredrikstad,,,,,, -438,0.96242703994115197,7db1aec7-f10a-44e5-a315-0e3766e79d16,"Pfizer Inc 235 East 42nd Street, New York, NY10017 US",pfizer_inc_235_east_42nd_street_new_york_ny10017_us,,,,09d833e6-81f6-4d84-ab0d-6d38c6152081,pfizer_inc_235_east_42nd_street_new_york_ny10017_usa,"Pfizer Inc 235 East 42nd Street, New York, NY10017" -4711,,1926ce99-34bc-4fa0-b1eb-3482668cf70d,Verein fuer Krebsfoschung (Society for Cancer Research),verein_fuer_krebsfoschung_society_for_cancer_research,,,,,, -4712,,d870802d-d68c-4f56-8fc5-94d8f011ebf6,"Akebia Therapeutics, Inc",akebia_therapeutics_inc,,,,,, -4713,,be840516-61c8-4d0e-8d95-a124c47a8b93,FUNDACION PUBLICA ANDALUZA PARA LA GESTION DE LA INVESTIGACION EN SALUD DE SEVILLA,fundacion_publica_andaluza_para_la_gestion_de_la_investigacion_en_salud_de_sevilla,,,,,, -4714,,1a2efa33-4417-4558-86cb-1b4d32d59f8a,Sigma-Tau Industrie Farmaceutiche Riunite S.p.A,sigma_tau_industrie_farmaceutiche_riunite_s_p_a,,,,,, -997,0.978108,5bbd7601-f97c-4166-b061-6c6d0f6ab946,"University of Ulm, University Hospital Ulm",university_of_ulm_university_hospital_ulm,,,,5bbd7601-f97c-4166-b061-6c6d0f6ab946,university_of_ulm_university_hospital_ulm,"University of Ulm, University Hospital Ulm" -624,0.925655,695b704d-00ae-4579-8869-ffa0844dbd29,Aventis Inc,aventis_inc,,,,695b704d-00ae-4579-8869-ffa0844dbd29,aventis_inc,Aventis Inc -4715,,f89e4922-df37-44af-aa55-ddaa31943f41,Bayer Health Care AG (study performed by Bayer Schering Pharma AG),bayer_health_care_ag_study_performed_by_bayer_schering_pharma_ag,,,,,, -4716,,ff219d51-7182-4932-9a4a-7cc9a05eb209,Hywel DdA Health Borad,hywel_dda_health_borad,,,,,, -4717,,cf79948e-5398-4b71-aa5a-7448d9749c7c,Shire Pharmaceutical Ltd,shire_pharmaceutical_ltd,,,,,, -91,0.96536672115325928,3dedb773-37f2-4652-90d4-6504c0c1d1ad,Actelion Pharmaceuticals Ltd,actelion_pharmaceuticals_ltd,,,,773f50b2-9db9-4907-b659-e4a90dab71f6,actelion_pharmaceuticals,Actelion Pharmaceuticals -4718,,3c9df4c9-038b-4718-ba28-92004764b39a,JOSE LUIS MONTERO ALVAREZ,jose_luis_montero_alvarez,,,,,, -4719,,8a805381-fcbc-4c29-8cd8-e4ce3a95c16a,Covidien,covidien,,,,,, -4720,,048e677d-adfc-4090-9351-eac2d182cb79,University Hospitals of Leiceter NHS Trust,university_hospitals_of_leiceter_nhs_trust,,,,,, -167,0.980699,eff1598b-0ad4-4c54-bb3b-768ea14ed615,"Universität zu Köln, Qualitätsmanagement",universit_t_zu_k_ln_qualit_tsmanagement,,,,4f0d312c-f55c-48d0-9554-4b675d8c084f,universit_t_zu_k_ln,Universität zu Köln -589,0.9786,3a83eff6-b403-4ef3-9768-88bc041f3b42,"Abteilung für Anästhesie und Intensivmedizin, Medizinische Universität Wien",abteilung_f_r_an_sthesie_und_intensivmedizin_medizinische_universit_t_wien,,,,3a83eff6-b403-4ef3-9768-88bc041f3b42,abteilung_f_r_an_sthesie_und_intensivmedizin_medizinische_universit_t_wien,"Abteilung für Anästhesie und Intensivmedizin, Medizinische Universität Wien" -4721,,681334fe-c2ff-4d9f-9248-8b81b6a42948,Asociación Científica para la investigación Nefrológica (ACINEF),asociaci_n_cient_fica_para_la_investigaci_n_nefrol_gica_acinef,,,,,, -4722,,920d431d-c414-45f2-8905-745fe554b7f3,HOSPITAL SANT JOAN DE DÉU,hospital_sant_joan_de_d_u,,,,,, -4723,,06978180-73f0-11e6-a0cd-0242ac12000b,MACHINE & WELDING SUPPLY CO,machine_welding_supply_co,,,,,, -4724,,fd5d6e35-0e88-4ae4-8ce3-4cfae98aec27,Grupo Español de Neurooncología Médica (GENOM),grupo_espa_ol_de_neurooncolog_a_m_dica_genom,,,,,, -4725,,d99b8884-dc5f-4512-a316-a24329bfe9d0,Blood Transfusion Centre of Slovenia,blood_transfusion_centre_of_slovenia,,,,,, -4726,,a562b491-c92c-43ae-8813-a63888202f7b,"Søren H. Sindrup, Department of Neurology, Odense University Hospital",s_ren_h_sindrup_department_of_neurology_odense_university_hospital,,,,,, -4727,,181a3037-a1ba-4200-98d0-ee002f7db314,"ASKA Pharmaceutical.Co., Ltd",aska_pharmaceutical_co_ltd,,,,,, -4728,,77c6eb77-ab9a-4b52-a829-062a47744d40,AZIENDA UNITA` SANITARIA LOCALE LECCE,azienda_unita_sanitaria_locale_lecce,,,,,, -4729,,1c173e2e-d41b-4c99-a059-8e17515ebaec,Britt Skogseid,britt_skogseid,,,,,, -4730,,1bfd0915-f037-42aa-b56a-04a16790ec4a,NUMICO RESEARCH BV,numico_research_bv,,,,,, -4731,,c66fd511-bc26-4374-9333-306f86cfbfe1,Dr. Miguel Yebra Bango,dr_miguel_yebra_bango,,,,,, -165,0.985075,1e5b75f8-7164-11e6-a0cd-0242ac12000b,MISSION PHARMACAL CO,mission_pharmacal_co,,,,1e5b75f8-7164-11e6-a0cd-0242ac12000b,mission_pharmacal_co,MISSION PHARMACAL CO -282,0.98588120937347412,73ad64c3-1db0-4276-bfd3-847419dc1449,Sahlgrenska University Hospital,sahlgrenska_university_hospital,,,,2f33c154-cafb-40b1-8fdc-8c3e78823f79,sahlgrenska_university_hospital,Sahlgrenska University Hospital -4732,,faedc197-8201-4a16-8cfc-906bf62eedc3,PsiOxus Therapeutics Ltd,psioxus_therapeutics_ltd,,,,,, -4733,,0c278703-63d6-4d65-8990-f9f8f76b25e8,EBMT (European group for Blood and Marrow Transplantation),ebmt_european_group_for_blood_and_marrow_transplantation,,,,,, -4734,,264bfd29-50c4-417a-9c65-a774cfa8e14f,"OncoMed Pharmaceuticals, Inc",oncomed_pharmaceuticals_inc,,,,,, -4735,,3657234b-a927-4608-918d-75c5acb9a394,Insmed Inc,insmed_inc,,,,,, -4736,,e743be49-f88a-47bc-9055-c3ca3cd8f164,ESSEX ITALIA,essex_italia,,,,,, -4737,,9574ecc0-7149-11e6-a0cd-0242ac12000b,ALKERMES GAINESVILLE,alkermes_gainesville,,,,,, -4738,,abf9b4be-bb85-48ed-be03-8f6a3f9a54f4,Centre Léon Bérard,centre_l_on_b_rard,,,,,, -4739,,61f81a65-4b2d-424b-9235-7bd647587359,"Universitätsklinik für Innere Medizin IV, Medizinische Universität Innsbruck",universit_tsklinik_f_r_innere_medizin_iv_medizinische_universit_t_innsbruck,,,,,, -4740,,95dc52c3-4295-4405-bafb-ca621be910d9,Department of Pediatrics Aarhus University Hospital Skejby,department_of_pediatrics_aarhus_university_hospital_skejby,,,,,, -4741,,5b54ddc3-479a-4a55-9c99-01755ebb3e78,Charité - University Hospital of Berlin,charit_university_hospital_of_berlin,,,,,, -4742,,0b6159ee-7142-11e6-a0cd-0242ac12000b,NEXGEN PHARMA,nexgen_pharma,,,,,, -4743,,1249d4f6-4ab2-4301-9fd0-d63125ff16ae,HOVON Foundation,hovon_foundation,,,,,, -4744,,724a6480-715f-11e6-a0cd-0242ac12000b,TG UNITED LABS,tg_united_labs,,,,,, -4745,,918423a1-e0fb-4bfb-816c-3353775163d9,Royal Bournemouth Hospital,royal_bournemouth_hospital,,,,,, -4746,,b086d628-323e-4473-b59f-b0fd7fda0940,Karolinska Institutet at Danderyd University Hospital,karolinska_institutet_at_danderyd_university_hospital,,,,,, -310,0.963604,f56b8ab9-a6e2-4dd5-b43d-64d9a7bbee84,sanofi-aventis group,sanofi_aventis_group,,,,09253f61-375e-4a27-869a-8e74c421b025,sanofi_aventis_groupe,sanofi-aventis Groupe -4747,,c142d027-8d27-4b18-95a0-463a80a5be49,East Kent Hospital Trust,east_kent_hospital_trust,,,,,, -4748,,529237a0-4eb7-4b2b-b442-bb7838834a45,"Med. Univ. Wien, Univ. Klinik f. Kinder- u. Jugendheilkunde, Klin. Abt.f. Pädiatrische Kardiologie",med_univ_wien_univ_klinik_f_kinder_u_jugendheilkunde_klin_abt_f_p_diatrische_kardiologie,,,,,, -713,0.96870841085910797,59edc476-1513-491e-9fdc-d5296e3e70c1,"Wyeth Parmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA",wyeth_parmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,,,,d2f1d48d-c243-473b-9f47-208723250aa6,wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA" -4749,,932b0bf5-cc9c-4e12-bd14-de383c751c20,Universtiy Medical Center Utrecht,universtiy_medical_center_utrecht,,,,,, -934,0.95976868271827698,ed0e7a9e-3ecf-499e-8589-05b770cd0c82,Pierre Fabre Médicament represented by IRPF,pierre_fabre_m_dicament_represented_by_irpf,,,,ed0e7a9e-3ecf-499e-8589-05b770cd0c82,pierre_fabre_m_dicament_represented_by_irpf,Pierre Fabre Médicament represented by IRPF -4750,,25bec611-0646-498a-b7fe-fff4f5822e51,Mater Misericordiae University Hospital,mater_misericordiae_university_hospital,,,,,, -4751,,b12a1933-8e05-48ac-ac0a-0097f45671ac,LABORATOIRES BOIRON,laboratoires_boiron,,,,,, -804,0.9722786545753479,1105f30e-7166-11e6-a0cd-0242ac12000b,ALCON PHARMA,alcon_pharma,,,,1105f30e-7166-11e6-a0cd-0242ac12000b,alcon_pharma,ALCON PHARMA -1064,0.96846312284469604,68d612ea-eec9-4118-bbaa-4c1bf28eade2,Cambridge University Hospitals NHS Foundation Trust and University of Cambridge,cambridge_university_hospitals_nhs_foundation_trust_and_university_of_cambridge,,,,5832b652-f280-4dd6-850d-477a81887563,cambridge_university_hospitals_nhs_foundation_trust,Cambridge University Hospitals NHS Foundation Trust -4752,,bc173d6c-32eb-4dfe-92a4-41dc7710f428,Georg-August-University Göttingen,georg_august_university_g_ttingen,,,,,, -4753,,6fb4058b-86df-4659-954d-a85034b8b931,"University Medical Center Groningen, Department of Genetics",university_medical_center_groningen_department_of_genetics,,,,,, -4754,,c4e899a8-a2ae-4801-81be-d2f7c71e39ba,Sirtris Pharmaceuticals Inc,sirtris_pharmaceuticals_inc,,,,,, -4755,,a361fa0b-6b01-4417-9fa8-82f07b99424c,"Med Uni Graz, Univ. Klinik Innere Medizin,Abt. Rheumatologie und Immunologie",med_uni_graz_univ_klinik_innere_medizin_abt_rheumatologie_und_immunologie,,,,,, -4756,,b3d5ed6a-d050-4255-832e-dfa2c25622c0,Respiratory research UNit,respiratory_research_unit,,,,,, -4757,,de7cbd55-99d3-4e22-a9aa-5f4422056f21,SECONDA UNIVERSITA' DEGLI STUDI DI NAPOLI,seconda_universita_degli_studi_di_napoli,,,,,, -4758,,7a27e2de-53a1-414c-acab-ddb3fa878b87,"Zakłady Farmaceutyczne ""UNIA"" Spółdzielnia Pracy",zak_ady_farmaceutyczne_unia_sp_dzielnia_pracy,,,,,, -580,0.98199012875556946,2766825d-c0d8-418e-9851-e5593ebd1105,Wyeth Pharmaceuticals Inc. (a Pfizer Company),wyeth_pharmaceuticals_inc_a_pfizer_company,,,,6e90ff22-ae0c-4450-9eec-85eba70c3fda,wyeth_pharmaceuticals_inc,Wyeth Pharmaceuticals Inc -4759,,96a3fc85-48a9-499e-8c84-070848295bc8,Fundació Hospital Universitari Vall Hebron-Institut de Recerca (VHIR),fundaci_hospital_universitari_vall_hebron_institut_de_recerca_vhir,,,,,, -4760,,62698225-db2c-4f81-a4c8-1e9bb3cd875c,Fundacio Sant Joan de Deu,fundacio_sant_joan_de_deu,,,,,, -4761,,7577b58f-4f10-4688-b19c-c25beed3c1da,Dolorgiet GmbH & Co. KG,dolorgiet_gmbh_co_kg,,,,,, -4762,,b37f295c-8809-11e6-a998-0242ac12000b,Janssen Vaccines & Prevention BV,janssen_vaccines_prevention_bv,,,,,, -4763,,52c26a8f-814f-4949-b133-48d0b9c673cb,"Medical University of Vienna, Department of Clinical Pharmacology",medical_university_of_vienna_department_of_clinical_pharmacology,,,,,, -301,0.977974,023ff627-407b-44a9-b5eb-1ea1e5f216c2,German High Grade Non-Hodgkin's Lymphoma group,german_high_grade_non_hodgkin_s_lymphoma_group,,,,023ff627-407b-44a9-b5eb-1ea1e5f216c2,german_high_grade_non_hodgkin_s_lymphoma_group,German High Grade Non-Hodgkin's Lymphoma group -4764,,35471212-880d-11e6-a998-0242ac12000b,"Bayer AG, D-51368 Leverkusen, Germany",bayer_ag_d_51368_leverkusen_germany,,,,,, -691,0.958341,23401987-1f18-4798-a823-501b1b0edbf5,Light Sciences Oncology Inc,light_sciences_oncology_inc,,,,23401987-1f18-4798-a823-501b1b0edbf5,light_sciences_oncology_inc,Light Sciences Oncology Inc -4765,,799baa77-1da0-4278-855e-81c0cfb3bf6f,"Galena Biopharma, Inc",galena_biopharma_inc,,,,,, -4766,,647ecd0f-ddbd-49eb-a89b-1bfb08f28a78,"Shire ViroPharma, Inc",shire_viropharma_inc,,,,,, -4767,,28e9beee-5518-43cf-a218-295512061b65,"Olomouc University Hospital and Palacký University School of Medicine, Internal Medicine Dept. I",olomouc_university_hospital_and_palack_university_school_of_medicine_internal_medicine_dept_i,,,,,, -529,0.94006639719009399,05387ec7-b7a5-4b59-bbbd-5029e53bbb00,"Roche Farma, S.A., que representa en España a F. Hoffmann-La Roche Ltd",roche_farma_s_a_que_representa_en_espa_a_a_f_hoffmann_la_roche_ltd,,,,05387ec7-b7a5-4b59-bbbd-5029e53bbb00,roche_farma_s_a_que_representa_en_espa_a_a_f_hoffmann_la_roche_ltd,"Roche Farma, S.A., que representa en España a F. Hoffmann-La Roche Ltd" -4768,,a982bf86-29a8-4043-96da-0a20807f6341,Institut de Terapia Regenerativa Tissular (ITRT),institut_de_terapia_regenerativa_tissular_itrt,,,,,, -4769,,2971d92f-8a50-482c-9de7-442d34a88a8a,"Cellerix, S.A",cellerix_s_a,,,,,, -4770,,ab9de24b-c47b-42a5-9071-ecbd8ccdd346,"Skåne University Hospital, Malmö",sk_ne_university_hospital_malm,,,,,, -4771,,412fd71c-b660-44df-ae27-0fe34d3038a3,Peregrine Pharmaceuticals Inc,peregrine_pharmaceuticals_inc,,,,,, -4772,,4381a977-6f00-4b5f-b67f-a9d07e31670d,Servicio Enfermedades Infecciosas,servicio_enfermedades_infecciosas,,,,,, -4773,,3a582763-eb13-4b6d-81f7-2651f880fa16,GELA(RC),gela_rc,,,,,, -4774,,bb9d7c96-eef7-4e10-9b84-608ae126a647,Harry Scheinin,harry_scheinin,,,,,, -4775,,063283ad-abb1-44d1-9a0f-d07d6b2866cf,Barcelona Macula Foundation,barcelona_macula_foundation,,,,,, -4776,,8215847f-7ec0-46e9-8e85-7d11d14bce5e,Nerviano Medical Sciences s.r.l,nerviano_medical_sciences_s_r_l,,,,,, -4777,,0a5cfb12-a7c6-11e6-94cb-5656d04fc2b5,"Dep. Anaesthesia and Intensive Care, Aarhus University Hospital",dep_anaesthesia_and_intensive_care_aarhus_university_hospital,,,,,, -4778,,d7539b54-77e0-4656-825d-bbb976924f4d,Delenex Therapeutics AG,delenex_therapeutics_ag,,,,,, -4779,,ec162c08-7151-11e6-a0cd-0242ac12000b,FRESENIUS MEDCL,fresenius_medcl,,,,,, -463,0.98401951789855957,85f43a44-7199-11e6-a0cd-0242ac12000b,ORTHO MCNEIL,ortho_mcneil,,,,2518a26c-7146-11e6-a0cd-0242ac12000b,ortho_mcneil_pharm,ORTHO MCNEIL PHARM -837,0.98498398065567017,5ebc13d0-6a14-420a-ad6f-45684baeb6fb,NHS Greater Glasgow,nhs_greater_glasgow,,,,09c00199-a473-4e2e-b6d9-ca5616af7b3d,nhs_greater_glasgow_yorkhill,"NHS Greater Glasgow, Yorkhill" -4780,,27a729eb-baf8-4714-9b82-e915766887a1,Neurologisk Afdeling Århus Universitetshospital,neurologisk_afdeling_rhus_universitetshospital,,,,,, -4781,,96114c88-95ba-4608-a46c-7154e538a078,Radboud University medical centre,radboud_university_medical_centre,,,,,, -4782,,897d8191-f600-4f88-b59c-c7e13620e0ac,Dipartimento di Scienze mediche Oncologia Medica Policlinico Gemelli,dipartimento_di_scienze_mediche_oncologia_medica_policlinico_gemelli,,,,,, -4783,,8fde9ea8-4580-42b4-9600-680e743bee8d,Axxonis Pharma AG,axxonis_pharma_ag,,,,,, -4784,,5c6d4213-8e5d-4857-af82-e3d63260b190,Plymouth Hospital NHS Trust,plymouth_hospital_nhs_trust,,,,,, -4785,,d18023df-9279-440b-960f-8e40e3709ab7,"Peter Wolf MD, Department of Dermatology, Medical University of Graz",peter_wolf_md_department_of_dermatology_medical_university_of_graz,,,,,, -4786,,8d70b4a5-1085-4428-8060-cb5576a8e91c,University Hospital Birmingham Foundation NHS Trust,university_hospital_birmingham_foundation_nhs_trust,,,,,, -4787,,04276214-0f4a-4057-9442-875f71976ac9,University Medical Centre Nijmegen,university_medical_centre_nijmegen,,,,,, -4788,,dfa88aec-7147-11e6-a0cd-0242ac12000b,LABS AF,labs_af,,,,,, -4789,,4c4fd778-27a7-4e76-a108-340de546f9e0,"Astellas Pharma US, Inc",astellas_pharma_us_inc,,,,,, -4790,,7f70d9b7-1de9-414d-8cda-86f5db0c1e89,The University of Liverpool,the_university_of_liverpool,,,,,, -4791,,6962eea1-088d-427f-853e-3847a8b3a877,"Prof. Heinz Ludwig, MD, Wilhelminenspital, First Department of Medicine and Medical Oncology",prof_heinz_ludwig_md_wilhelminenspital_first_department_of_medicine_and_medical_oncology,,,,,, -4792,,5980bae5-4c57-46b6-8cc2-7e390b74eede,Santeon,santeon,,,,,, -4793,,4a59df35-6270-489f-998e-e4e000bfcb2e,"Universität Mainz, Klinik und Poliklinik für Neurologie",universit_t_mainz_klinik_und_poliklinik_f_r_neurologie,,,,,, -4794,,aa2d4b37-0d3b-4f0f-b134-fb0d5658aa78,Hospital Clinic,hospital_clinic,,,,,, -131,0.98589164018630981,742cdcfb-349e-4dad-b5ba-f31a71a78dba,Department of Psychiatry,department_of_psychiatry,,,,1ead7ee3-0e7d-4381-a630-ec14aeb73c0e,department_of_psychiatry,Department of Psychiatry -460,0.917507,5371757a-5ffa-4a03-be27-6844161516c2,GlaxoSmithKline R&D Ltd,glaxosmithkline_r_d_ltd,,,,5371757a-5ffa-4a03-be27-6844161516c2,glaxosmithkline_r_d_ltd,GlaxoSmithKline R&D Ltd -4795,,fe36b93a-454f-4498-94f4-59f31b9a6668,EOS S.p.A,eos_s_p_a,,,,,, -4796,,c5cb1d05-7189-4a3a-bd62-73fa1fbaeebf,Hospital General Universitario de Alicante,hospital_general_universitario_de_alicante,,,,,, -522,0.97898,2bce399b-f655-4890-9a07-afe0a1f39d7f,Renovo Ltd,renovo_ltd,,,,2bce399b-f655-4890-9a07-afe0a1f39d7f,renovo_ltd,Renovo Ltd -4797,,8c1f1ee3-2fa7-4053-a51f-76197816b7fe,Crucell Holland B.V,crucell_holland_b_v,,,,,, -4798,,dc2c25e7-4de4-40fc-b825-91c2bc698686,"Alvine Pharmaceuticals, Inc",alvine_pharmaceuticals_inc,,,,,, -4799,,6234d03c-70a2-4b2e-b9b5-52bcf3b71065,Boehringer Ingelheim GmbH & Co KG,boehringer_ingelheim_gmbh_co_kg,,,,,, -4800,,11dfb2aa-a098-4683-9c5c-005f9a202c1b,OSSERVATORIO EPIDEMIOLOGICO GISEA,osservatorio_epidemiologico_gisea,,,,,, -4801,,ac848843-60ea-406a-aae2-efd8063af12d,Dr. Olaf Stanger,dr_olaf_stanger,,,,,, -4802,,6ab84500-f314-44f3-aa38-f86f0e0bfe46,Gruppo Italiano Mesotelioma (G.I.Me.),gruppo_italiano_mesotelioma_g_i_me,,,,,, -4803,,69435ce2-680a-4477-840b-60bc3aa9878c,Symphogen A/S,symphogen_a_s,,,,,, -4804,,e747e178-6fa1-11e6-9663-0242ac12000b,Imperial College London | Imperial College NHS Healthcare Trust,imperial_college_london_imperial_college_nhs_healthcare_trust,,,,,, -4805,,3c3f6b77-d9c3-4062-a1eb-171a45ce129b,Helix BioPharma Cooperation,helix_biopharma_cooperation,,,,,, -4806,,b5072c3a-d11e-4d37-b30d-a5ade153ed3a,Thessaloniki's Aristoteleio University,thessaloniki_s_aristoteleio_university,,,,,, -681,0.98368257284164429,b72b9f71-1252-40e3-8dd1-c73d396c3dd5,Aarhus University Hospital,aarhus_university_hospital,,,,e9e3f1a5-d19d-4eea-b83e-62046558fbb3,aarhus_university_hospital,Aarhus University Hospital -4807,,ac9c531f-b2f1-453a-827a-3e1808af233f,University of Münster,university_of_m_nster,,,,,, -130,0.9775693416595459,3515d8bf-edb3-4b5e-ba66-e5a15542aded,Cliniques Universitaires Saint-Luc (CUSL),cliniques_universitaires_saint_luc_cusl,,,,3515d8bf-edb3-4b5e-ba66-e5a15542aded,cliniques_universitaires_saint_luc_cusl,Cliniques Universitaires Saint-Luc (CUSL) -4808,,a184497f-e1ef-4cfa-b238-160bf168096a,Bayer Schering Pharma Oy,bayer_schering_pharma_oy,,,,,, -4809,,f4a93696-5c65-4930-806a-de8c243e32e0,Synthon BV,synthon_bv,,,,,, -176,0.98896640539169312,fbdb10c1-6146-4761-86bf-a8541dc3b4fa,Novartis Vaccines and Diagnostics,novartis_vaccines_and_diagnostics,,,,fbdb10c1-6146-4761-86bf-a8541dc3b4fa,novartis_vaccines_and_diagnostics,Novartis Vaccines and Diagnostics -4810,,44132e62-71cd-11e6-a0cd-0242ac12000b,CHAPTER 7 TRUSTEE,chapter_7_trustee,,,,,, -4811,,a8a29b13-bdf0-41e1-a1cf-1ea1285e99f6,Laboratoires SMB S.A,laboratoires_smb_s_a,,,,,, -4812,,627e8507-a386-46cf-abbb-461afa70e335,Shire Pharmaceuticals Group plc,shire_pharmaceuticals_group_plc,,,,,, -4813,,a283d7d8-4ab4-4363-a3ca-3d4ba7bce8ca,INFECTOPHARM Arzneimittel GmbH,infectopharm_arzneimittel_gmbh,,,,,, -4814,,e595c41d-0240-4df8-ad3e-45973a62f99a,Universidad de Granada,universidad_de_granada,,,,,, -4815,,11d58e68-9fad-4360-bf3e-dc72422d8ff2,"UAB ""Merck Sharp & Dohme",uab_merck_sharp_dohme,,,,,, -94,0.97429078817367554,be263a28-72c2-11e6-a0cd-0242ac12000b,JAZZ PHARMS III,jazz_pharms_iii,,,,49d3c978-7273-11e6-a0cd-0242ac12000b,jazz_pharms,JAZZ PHARMS -370,0.951764,d87e461f-d3a3-4191-b1ac-8ed84cf48ba3,HUS,hus,,,,09b4c65d-3052-471d-a9c2-a2a03f06e86f,hus_hyks_diabetesklinikka,"HUS, HYKS, Diabetesklinikka" -650,0.9659787118434906,ed893853-aaa3-4324-93a2-68212b678087,Boehringer Ingelheim AB,boehringer_ingelheim_ab,,,,2c7b1b3b-323c-4045-ae75-4712a0ece886,boehringer_ingelheim_ab,Boehringer Ingelheim AB -4816,,f22a8fc9-1e40-4251-bfb7-560d649e5dd9,Helsingin yliopisto,helsingin_yliopisto,,,,,, -616,0.93451941013336182,f8cdc923-8f9e-4a86-b916-6b3f45c65971,Shire Devlopment LLC,shire_devlopment_llc,,,,f8cdc923-8f9e-4a86-b916-6b3f45c65971,shire_development_llc,Shire Development LLC -616,0.95630460977554321,d7d749f6-69c1-495f-a78a-8b33078d988c,Shire Development LLC and International Affiliates,shire_development_llc_and_international_affiliates,,,,f8cdc923-8f9e-4a86-b916-6b3f45c65971,shire_development_llc,Shire Development LLC -4817,,4a92395b-7c55-431f-94c8-18145f4c9586,Stallergenes GmbH & Co.KG,stallergenes_gmbh_co_kg,,,,,, -4818,,3a67d994-4c48-4642-87fb-3a935945f54e,Danderyds sjukhus AB,danderyds_sjukhus_ab,,,,,, -4819,,0edfb0bd-6d3a-447f-947a-a0db2a4097f1,NEUROBIOTEC GMBH,neurobiotec_gmbh,,,,,, -4820,,f2df00cf-c676-4cf9-ade8-9e3e4f151ea4,the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AvL),the_netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital_nki_avl,,,,,, -4821,,c9d14a33-35f5-4243-b9c8-25db73f40202,Maija Kaukonen,maija_kaukonen,,,,,, -4822,,01933e0b-5a2b-4c96-bbd5-bbfa4cf6b1c9,"Dr. Angel Chamorro Sánchez. Servicio de Neurología, Hospital Clinic",dr_angel_chamorro_s_nchez_servicio_de_neurolog_a_hospital_clinic,,,,,, -83,0.96475303173065186,2e778965-4803-4c24-80eb-b2a9fc5651e6,"Medizinische Universität Wien, Universitätsklinik für Psychiatrie u. Psychotherapie, Abteil. für biologische Psychiatrie",medizinische_universit_t_wien_universit_tsklinik_f_r_psychiatrie_u_psychotherapie_abteil_f_r_biologische_psychiatrie,,,,2e778965-4803-4c24-80eb-b2a9fc5651e6,medizinische_universit_t_wien_universit_tsklinik_f_r_psychiatrie_u_psychotherapie_abteil_f_r_biologische_psychiatrie,"Medizinische Universität Wien, Universitätsklinik für Psychiatrie u. Psychotherapie, Abteil. für biologische Psychiatrie" -906,0.97884830832481384,fb29808d-7985-4804-b8d4-5620bbba60e6,Kings College London,kings_college_london,,,,fb29808d-7985-4804-b8d4-5620bbba60e6,kings_college_london_iop,Kings College London (IOP) -4823,,20bcb230-c694-41a3-ac33-78545595d713,S.A. Odyssea Pharma,s_a_odyssea_pharma,,,,,, -4824,,527dd166-cec2-489c-881b-b29aa4c7ac71,Cardiologia - Azienda Ospedaliero Universitaria di Modena,cardiologia_azienda_ospedaliero_universitaria_di_modena,,,,,, -868,0.98796150088310242,a13c1e76-68ce-41b8-ba66-e40e0db78efa,Astellas Pharma Global Development,astellas_pharma_global_development,,,,d75f8fe0-80ce-4bb5-9e6e-ab63e91189dc,astellas_pharma_global_development_inc,"Astellas Pharma Global Development, Inc" -4825,,210f3969-30f8-48dc-8d07-63d7556837a2,"Unilfarma, Lda",unilfarma_lda,,,,,, -4826,,0f710c5e-a355-48ba-bd7a-f295d07dc9bc,Azienda ULSS 12 veneziana,azienda_ulss_12_veneziana,,,,,, -412,0.98863863945007324,c392f440-194a-4970-99e9-218fccd3765c,"Karolinska University Hospital, Huddinge",karolinska_university_hospital_huddinge,,,,404bfbb4-d805-4edf-b568-5d60418c0c9b,karolinska_university_hospital_huddinge_sweden,"Karolinska University Hospital, Huddinge, Sweden" -4827,,80eda9ea-052e-471b-a896-6a98fd93875c,Organon Nederland BV,organon_nederland_bv,,,,,, -4828,,5b51c94b-a4d7-4aff-9161-0081b82b2763,St. Lucas Andreas Hospital,st_lucas_andreas_hospital,,,,,, -4829,,c4fd4744-0267-46d2-b729-f6c6a09670d6,universiteit Maastricht,universiteit_maastricht,,,,,, -4830,,f8e5f83d-a022-4c0b-a3fc-be1ad9b7ac66,European Lung Cancer Working Party,european_lung_cancer_working_party,,,,,, -630,0.953662,541c00fc-7166-11e6-a0cd-0242ac12000b,HETERO LABS LTD V,hetero_labs_ltd_v,,,,0390bcaa-7142-11e6-a0cd-0242ac12000b,hetero_labs_ltd_iii,HETERO LABS LTD III -4831,,036b72ea-718f-11e6-a0cd-0242ac12000b,UNITED THERAP,united_therap,,,,,, -4832,,09aee10b-a94d-430b-92f0-6503f4032729,Metabolism and Nutrition Group of the SEMICYUC,metabolism_and_nutrition_group_of_the_semicyuc,,,,,, -4833,,270900b0-7143-11e6-a0cd-0242ac12000b,STERI PHARMA,steri_pharma,,,,,, -841,0.95600730180740356,722b5f6e-362a-4c38-b731-55a9124a902d,JANSSEN-CILAG INTERNATIONAL N.V,janssen_cilag_international_n_v,,,,640d2f05-d82c-4fcf-8cf1-823f7c525359,janssen_cilag_international_bv,JANSSEN-CILAG INTERNATIONAL BV -4834,,f062afd3-b030-4d9f-af7e-fc47cdaad689,NHS Tayside,nhs_tayside,,,,,, -4835,,bbd397d1-902a-4bff-a063-b16ed3064c3b,King's College Hospital,king_s_college_hospital,,,,,, -4836,,dd4c68cc-1a5b-4357-9ead-56404b19f6aa,Institut für Atemwegsforschung GmbH,institut_f_r_atemwegsforschung_gmbh,,,,,, -4837,,89de19f7-0150-4fb5-923c-c8506ddc8956,Oncology Department,oncology_department,,,,,, -4838,,053fa23a-7167-11e6-a0cd-0242ac12000b,JUBILANT HOLLISTRSTR,jubilant_hollistrstr,,,,,, -4839,,927e5757-2bf8-4fd4-bd38-7881576075a9,"SCHWARZ BIOSCIENCES, GmbH, A Member of the UCB Group of Companies",schwarz_biosciences_gmbh_a_member_of_the_ucb_group_of_companies,,,,,, -4840,,187a8d58-7db7-4cbc-9970-b08499bd3758,Lallemand Pharma International AG,lallemand_pharma_international_ag,,,,,, -379,0.95514367024103797,ddb585ca-eb58-4665-9786-d17d427cf5e4,Merck Sharp & Dohm Corp,merck_sharp_dohm_corp,,,,b80f486c-a6f1-447b-bad6-34ea6d49fec0,merck_sharp_dohm_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as the SPONSOR or Merck)" -4841,,39837694-715c-11e6-a0cd-0242ac12000b,NORTEC DEV ASSOC,nortec_dev_assoc,,,,,, -343,0.945615,df233af1-76b7-4839-86bc-252076367896,Institut Gustav Roussy,institut_gustav_roussy,,,,df233af1-76b7-4839-86bc-252076367896,institut_gustav_roussy,Institut Gustav Roussy -4842,,e7abc0eb-0f22-41f8-9940-c3db083a4c12,Gilead Sciences International Ltd,gilead_sciences_international_ltd,,,,,, -4843,,bcc41730-74b0-4c00-9e1c-6d053fbc77c3,Fundación Penta,fundaci_n_penta,,,,,, -4844,,a0282e7a-71e9-11e6-a0cd-0242ac12000b,ACORDA,acorda,,,,,, -4845,,fceeecd0-1c03-47b3-9d71-8eec2c37d0eb,Celgene International II Sàrl (CIS II),celgene_international_ii_s_rl_cis_ii,,,,,, -4846,,de6a9a67-0e15-458c-9b39-e47b278e515e,U.O. Terapia Intensiva,u_o_terapia_intensiva,,,,,, -4847,,c8194b0b-d077-4ec6-bae6-5e27ea8ba8c4,OYS,oys,,,,,, -4848,,e0c49aa3-3cff-450a-af8b-f0bd38d632e9,Fondazione Mediolanum Onlus,fondazione_mediolanum_onlus,,,,,, -4849,,0abfc084-7a11-449c-a64f-b1853580307b,"Dept of medical sciences, Rheumatology",dept_of_medical_sciences_rheumatology,,,,,, -4850,,626703e9-8df3-408e-9d69-cf7f8d9a62cc,Janssen Infectious Dieseases-Diagnostic BVBA,janssen_infectious_dieseases_diagnostic_bvba,,,,,, -360,0.986646,974a5c1d-8651-4bb8-8b78-cce4a6850f9c,Academisch Medisch Centrum Amsterdam,academisch_medisch_centrum_amsterdam,,,,3f73d507-49f7-4bba-847d-11619261c4ae,academisch_medisch_centrum,Academisch Medisch Centrum -4851,,bed28358-73f5-11e6-a0cd-0242ac12000b,KYTHERA BIOPHARMS,kythera_biopharms,,,,,, -4852,,b108da94-5691-44ed-b88e-8094c87cb4ac,Vibeke Hjortdal,vibeke_hjortdal,,,,,, -4853,,16e7bc24-64f2-45c0-b03d-97a9bb5fc879,Mental Health Services North Holland North,mental_health_services_north_holland_north,,,,,, -4854,,07fe1a3b-7b6f-4eaf-8427-fc877d0045b1,Kedrion S.P.A,kedrion_s_p_a,,,,,, -4855,,8670d633-6785-445d-bd58-cfb5cbcb9962,CPS Research,cps_research,,,,,, -4856,,d15708c3-de0c-474c-bf5c-96f739dd3aa2,"Wyeth Research, Clinical Research and Development, Division of Wyeth Pharmaceuticals Inc",wyeth_research_clinical_research_and_development_division_of_wyeth_pharmaceuticals_inc,,,,,, -4857,,401a3804-9603-490b-a95c-ce592463d6c1,Starpharma Pty Ltd,starpharma_pty_ltd,,,,,, -4858,,07327823-7afc-43f5-a0ab-79082c3020f6,APRO,apro,,,,,, -23,0.98531901836395264,32433559-55be-43ec-8a0d-06197533759d,University Hospitals Leuven (Gasthuisberg),university_hospitals_leuven_gasthuisberg,,,,32433559-55be-43ec-8a0d-06197533759d,university_hospitals_leuven_gasthuisberg,University Hospitals Leuven (Gasthuisberg) -4859,,9a986912-eedc-4a3f-849b-3c81fdb862b3,"Medical University of Graz, Department of Internal Medicine, Division of Gastroenterology and Hepatology",medical_university_of_graz_department_of_internal_medicine_division_of_gastroenterology_and_hepatology,,,,,, -4860,,de12a35c-459e-4f22-a954-01f9ae63e368,Frederiksberg University Hospital,frederiksberg_university_hospital,,,,,, -4861,,56fabebe-bd11-417a-b38d-9194672ccfef,UCB Celletech,ucb_celletech,,,,,, -4862,,5418b417-3b5a-411e-ab64-ecded957a64a,U.O.PNEUMOLOGIA- AZ. USL1 DI MASSA E CARRARA,u_o_pneumologia_az_usl1_di_massa_e_carrara,,,,,, -4863,,4121bae3-1ea0-4da5-825d-d0d20ab4995c,DIMETHAID AG,dimethaid_ag,,,,,, -4864,,319b3b56-2ce2-4f03-a44e-0db031b04164,D.A.S.T. BIOTECH PHARM Ε.Π.Ε,d_a_s_t_biotech_pharm,,,,,, -4865,,ef6a3c4c-6ccc-4266-be98-771796f0c2ed,CHU de DIJON - Délégation à la recherche clinique et à l’innovation,chu_de_dijon_d_l_gation_la_recherche_clinique_et_l_innovation,,,,,, -4866,,ae8be576-fbeb-49a3-b26d-0d264bb868ba,Fundación para la Investigación Biomédica del Hospital Ramón y Cajal,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_ram_n_y_cajal,,,,,, -847,0.970712,2cd6ae2e-14d4-42b4-bac7-96f94b86a23b,Janssen-Cilag Medical Affaires EMEA,janssen_cilag_medical_affaires_emea,,,,2cd6ae2e-14d4-42b4-bac7-96f94b86a23b,janssen_cilag_medical_affaires_emea,Janssen-Cilag Medical Affaires EMEA -530,0.961626,db7a3a24-3df1-4803-a508-28b7e9f72da7,Erasmus University Medical Centre Rotterdam,erasmus_university_medical_centre_rotterdam,,,,72fda02d-b614-4eda-a1b0-e9c6c71f8251,erasmus_university_medical_center,Erasmus University Medical Center -4867,,14edc59e-9be0-40d4-a96d-041c0ab9b478,Mario Negri Institute,mario_negri_institute,,,,,, -4868,,89ee3c63-4e09-4b24-8f28-c75d46a14efe,"Receptos, Inc",receptos_inc,,,,,, -4869,,3f76e1d0-3617-4677-9cf9-fd12b80f940e,Hungarian Kidney Foundation,hungarian_kidney_foundation,,,,,, -983,0.945615,8aec01c9-3cd9-4738-baef-0201bdb56c7b,St Stephen's Aids Trust,st_stephen_s_aids_trust,,,,59c0ebeb-5f3a-4456-89ec-4ec59bcd4670,st_stephens_aids_trust,St Stephens Aids Trust -469,0.985292,76a393da-5b46-4f29-a7e7-a31575f47074,OSPEDALE S. RAFFAELE DI MILANO,ospedale_s_raffaele_di_milano,,,,55158cf1-cd99-4f28-8043-743b9a161005,ospedale_s_raffaele,OSPEDALE S. RAFFAELE -4870,,36efb71f-f052-4669-ac29-e36a68ba0a0d,WKZ / UMC Utrecht,wkz_umc_utrecht,,,,,, -4871,,f28855cb-d949-44f5-8cdb-8d84d1d4ae7f,MMerck KGaA,mmerck_kgaa,,,,,, -1024,0.902645,2c174554-737a-4729-99f3-4cc6843b2b31,Celtic Pharma Development Services Bermuda Limited,celtic_pharma_development_services_bermuda_limited,,,,2c174554-737a-4729-99f3-4cc6843b2b31,celtic_pharma_development_services_bermuda_limited,Celtic Pharma Development Services Bermuda Limited -4872,,7bfce2b4-bb61-43dd-913b-c52e6e575b85,"Dr. Albert Lecube, Ph.D., M.D",dr_albert_lecube_ph_d_m_d,,,,,, -154,0.927976,1bb3b634-770c-4449-a84e-96c6eb88fe69,Solvay Pharmaceutical GmbH,solvay_pharmaceutical_gmbh,,,,1bb3b634-770c-4449-a84e-96c6eb88fe69,solvay_pharmaceutical_gmbh,Solvay Pharmaceutical GmbH -296,0.983343,6cdcb5b5-13ca-4bc2-becd-834515b92e8e,iOMEDICO AG,iomedico_ag,,,,6cdcb5b5-13ca-4bc2-becd-834515b92e8e,iomedico_ag,iOMEDICO AG -4873,,e64028f6-db66-460b-a6c8-2fe041503736,Alkermes Inc,alkermes_inc,,,,,, -4874,,86b52e9b-0db2-4a91-bfe0-18fda2f1e603,"Kuopio University Hospital, Clinic of Internal Medicine/Center of Medicine",kuopio_university_hospital_clinic_of_internal_medicine_center_of_medicine,,,,,, -4875,,1a1428cb-2164-4814-9445-22e9beaea5ec,"Servier Slovensko, spol. s.r.o",servier_slovensko_spol_s_r_o,,,,,, -4876,,6c9935de-9c35-44f1-8554-80ce2085dd6d,Jessaziekenhuis Hasselt,jessaziekenhuis_hasselt,,,,,, -4877,,f5598b18-8bbc-11e6-a449-0242ac12000b,NBMI Science AB,nbmi_science_ab,,,,,, -4878,,86db37fd-7edb-4405-a5fe-c6505098683a,Hospital Universitario de Bellvitge,hospital_universitario_de_bellvitge,,,,,, -4879,,c9db2bfb-cef8-4f20-89b8-233b1a65c8f3,"Department of Clinical Sciences, Danderyd Hospital",department_of_clinical_sciences_danderyd_hospital,,,,,, -413,0.98836642503738403,4a616e09-39b2-4537-bceb-96327b70319b,Karolinska University Hospital,karolinska_university_hospital,,,,4a616e09-39b2-4537-bceb-96327b70319b,karolinska_university_hospital,Karolinska University Hospital -4880,,773346f7-2818-45b1-873f-cf3cbe745379,AZIENDA OSPEDALIERA UMBERTO I,azienda_ospedaliera_umberto_i,,,,,, -4881,,4283f243-275a-4d00-99df-a1a9d668bc13,Grupo Español de Tratamiento de Tumores Urológicos (SOGUG),grupo_espa_ol_de_tratamiento_de_tumores_urol_gicos_sogug,,,,,, -731,0.98280638456344604,32b95fda-7aef-4157-8c46-ef6f2c37677c,Bristol-Myers Squibb International Corporation,bristol_myers_squibb_international_corporation,,,,55b1cd8b-93b6-4262-9f20-ab35fbdc2476,bristol_myers_squibb_international_corporation,Bristol-Myers Squibb International Corporation -4882,,70ae5800-7161-11e6-a0cd-0242ac12000b,SPECTRUM PHARMS,spectrum_pharms,,,,,, -4883,,0c3c87d3-753a-4edc-9448-2ca33416e5de,Aventis Pharmaceuticals Inc,aventis_pharmaceuticals_inc,,,,,, -4884,,737e57c0-5ded-49c2-a04a-44b5114fcd65,ANA M,ana_m,,,,,, -4885,,7bea2c90-4756-48ea-8394-dd44b6450a06,"UNIVERSITAT MAGDEBURG, MEDIZINISCHE FAKULTAT",universitat_magdeburg_medizinische_fakultat,,,,,, -711,0.98289656639099121,e90b85cd-96f6-48a3-b6b2-c2d62c8345d9,Reckitt Benckiser,reckitt_benckiser,,,,76c0c0d6-9f7c-4fde-bea7-4dd56b4a4546,reckitt_benckiser_uk_limited,Reckitt Benckiser (UK) Limited -4886,,6a546f82-1beb-40b2-a252-8109da4e2cfd,Dr. Falk Pharma GmbH,dr_falk_pharma_gmbh,,,,,, -4887,,0eafade6-7235-11e6-a0cd-0242ac12000b,VEROSCIENCE,veroscience,,,,,, -4888,,60a6ec7b-4f75-426c-a967-13ddc28dabf0,Department of Internal Medicine of the University of Munich,department_of_internal_medicine_of_the_university_of_munich,,,,,, -4889,,47d30b56-50ad-4e68-92e5-0f2ba0bbeb91,Pia Österlund and Helena Isoniemi,pia_sterlund_and_helena_isoniemi,,,,,, -4890,,a354f5e4-80e1-4edb-8b7a-7041c783a02c,Anne Ristikankare,anne_ristikankare,,,,,, -4891,,1bf42ae8-ade3-4ea8-97c2-518358b671b5,Glycotope GmbH,glycotope_gmbh,,,,,, -62,0.98770728707313538,8e5a8528-8808-11e6-a998-0242ac12000b,"Talecris Biotherapeutics, Inc",talecris_biotherapeutics_inc,,,,8776dd79-3ee8-4ef0-a9ce-fb6aef833e21,talecris_biotherapeutics_inc,"Talecris Biotherapeutics, Inc" -4892,,84a847d0-2b98-46a9-83b0-1ce03b978629,Unidad de Gestión Clínica de Endocrinología y Nutrición,unidad_de_gesti_n_cl_nica_de_endocrinolog_a_y_nutrici_n,,,,,, -619,0.972198,6c1607c0-6c35-4de7-98be-f53af3f83989,Department of Urology,department_of_urology,,,,4c2e1783-76a6-4110-ab48-f807ec4d7f82,department_of_urology_and_pediatric_urology_justus_liebig_university_giessen,Department of Urology and Pediatric Urology - Justus-Liebig-University Giessen -4893,,dacd9ae4-a0f6-42d4-8bfe-d10a92bf8fd4,Marcelo L. Berthier Torres,marcelo_l_berthier_torres,,,,,, -460,0.917507,ba72e80d-4cab-4cfe-9590-92be512b7cb4,GlaxoSmithKline R&D Limited,glaxosmithkline_r_d_limited,,,,5371757a-5ffa-4a03-be27-6844161516c2,glaxosmithkline_r_d_ltd,GlaxoSmithKline R&D Ltd -4894,,3ac6ec66-8bce-11e6-a449-0242ac12000b,PHF SA,phf_sa,,,,,, -15,0.946972,589ff7a7-30e3-4063-a4c0-177e212878a0,AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA,azienda_ospedaliera_istituti_ospitalieri_di_verona,,,,4becd0cc-b39a-41ea-8a3e-45c64348e698,azienda_ospedaliera_istituti_ospitalieri_di_cremona,AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI CREMONA -4895,,3762da32-0817-43dc-ab64-f69cb72b24f4,Central Manchester University Hospitals Foundation Trust,central_manchester_university_hospitals_foundation_trust,,,,,, -4896,,901e13bc-6c20-457d-81da-8854954c6f9f,Genera Research Ltd,genera_research_ltd,,,,,, -4897,,0a4928f2-6852-4313-8c3e-6bde65e5c828,Austrian Forum against Cancer,austrian_forum_against_cancer,,,,,, -4898,,0edb952d-612e-4801-9faf-2ef111f99bc9,SANOFI-AVENTIS S.P.A,sanofi_aventis_s_p_a,,,,,, -4899,,67baf632-269b-4aa5-b025-b7ffabd5decb,PENTA Foundation (Fondazione Penta Onlus),penta_foundation_fondazione_penta_onlus,,,,,, -4900,,0cd1829b-08d0-4cc0-90f3-c8446f6601dc,Royal Surrey County Hospital NHS Trust,royal_surrey_county_hospital_nhs_trust,,,,,, -4901,,f84fa875-39e7-4e6c-a96e-c3b65c792506,Immunocore Limited,immunocore_limited,,,,,, -744,0.97502317031224572,b5021803-6477-4392-9737-42b9679fe2de,Johann Wolfgang Goethe-University,johann_wolfgang_goethe_university,,,,7c93ba08-6123-42f2-a902-d13e42cdd905,johann_wolfgang_goethe_universit_t_frankfurt,Johann Wolfgang Goethe-Universität Frankfurt -4902,,089d246a-f39c-4366-865f-000275f19904,Dr. Kade Pharmazeutische Fabrik GmbH,dr_kade_pharmazeutische_fabrik_gmbh,,,,,, -4903,,1fa88af7-fc6b-4213-83e4-97b03e34e3c6,Atopix Therapeutics Ltd,atopix_therapeutics_ltd,,,,,, -4904,,5db19cf3-e91d-4a12-a088-6b1fb66c2fd9,"Medizinische Universität Wien, Univ.Klinik für Chirurgie, Abt.für Allgemeinchirurgie",medizinische_universit_t_wien_univ_klinik_f_r_chirurgie_abt_f_r_allgemeinchirurgie,,,,,, -4905,,90023b35-6ad4-4bac-9152-ba63929ae039,HOSPICES CIVILS DELYON,hospices_civils_delyon,,,,,, -4906,,08b5cc5c-137a-4e25-a65b-9772aacec991,Pergamum AB,pergamum_ab,,,,,, -4907,,0d8b1b8b-fcb2-4368-aedf-cd2d3e07996e,EctoPharma Limited,ectopharma_limited,,,,,, -4908,,0e0f5b82-7142-11e6-a0cd-0242ac12000b,CITRUSPHRMA,citrusphrma,,,,,, -95,0.977549,54a10183-297d-43b4-8cb3-8ad19beec3c5,Artu Biologicals Europe B.V,artu_biologicals_europe_b_v,,,,54a10183-297d-43b4-8cb3-8ad19beec3c5,artu_biologicals_europe_b_v,Artu Biologicals Europe B.V -4909,,10580f72-4f43-4e19-b26c-f855bd3fa3fe,University of Wales Swansea,university_of_wales_swansea,,,,,, -4910,,c4f78c4f-23e2-4033-bb44-9b8bdb4c5ed9,Roche (Hellas) S.A,roche_hellas_s_a,,,,,, -4911,,8d448640-715e-11e6-a0cd-0242ac12000b,MIZA PHARMS USA,miza_pharms_usa,,,,,, -4912,,04e37c02-7190-11e6-a0cd-0242ac12000b,TEVA RESPIRATORY LLC,teva_respiratory_llc,,,,,, -4913,,bb5eddc3-2b1e-4867-98c4-be7ab666ee87,"Fast Forward Pharmaceuticals, B.V",fast_forward_pharmaceuticals_b_v,,,,,, -4914,,3c53f4a0-25b3-4d6e-ba17-cb76c7323a05,3M Health Care Limited,3m_health_care_limited,,,,,, -4915,,912134bb-7efd-405f-a8d5-666365cebeb9,Evangelisches Krankenhaus Lutherhaus gGmbH,evangelisches_krankenhaus_lutherhaus_ggmbh,,,,,, -4916,,8ff1c187-212e-4abf-9355-a2fcd8f98602,Fundacion Marques de Valdecilla,fundacion_marques_de_valdecilla,,,,,, -4917,,7ee61065-9564-4811-be23-5f569e7d1ac2,Vicente Soriano-Hospital Carlos III. Madrid,vicente_soriano_hospital_carlos_iii_madrid,,,,,, -4918,,51f72aba-d14e-428a-b4a7-9b21d1cce499,Andrés Poveda,andr_s_poveda,,,,,, -4919,,8514b254-da81-455c-95f5-682357b724bd,Goethe Universität Frankfurt,goethe_universit_t_frankfurt,,,,,, -4920,,9c90d9d5-41b1-4b5e-9831-8dc770a1d7fe,LABORATOIRE TOP PHARM,laboratoire_top_pharm,,,,,, -622,0.984184,9262c2fe-71a9-11e6-a0cd-0242ac12000b,EMD SERONO,emd_serono,,,,9262c2fe-71a9-11e6-a0cd-0242ac12000b,emd_serono,EMD SERONO -4921,,6f2ecd7f-fd12-4f1a-b745-e7c810241d20,S.A. Alcon-Couvreur N.V,s_a_alcon_couvreur_n_v,,,,,, -4922,,d62bf9eb-d021-437e-824a-218869493881,Fundació Institut Mar d'investigacions Mediques,fundaci_institut_mar_d_investigacions_mediques,,,,,, -766,0.979934,8a4b641c-5fe6-4b6b-a131-423b64e7cd1b,Sussex NHS Research Consortium,sussex_nhs_research_consortium,,,,8a4b641c-5fe6-4b6b-a131-423b64e7cd1b,sussex_nhs_research_consortium,Sussex NHS Research Consortium -4923,,788e95ae-a6eb-4d0d-a9cc-c720aeb75eb3,Universitätsklinikum des Saarlandes,universit_tsklinikum_des_saarlandes,,,,,, -4924,,a2b5dfac-ce83-4e25-a247-bcb6cd628b9d,Janssen-Cilag A/S,janssen_cilag_a_s,,,,,, -4925,,d44fb393-1311-4136-aaa2-f5f7a11b4777,"Rainer Rupprecht, Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum",rainer_rupprecht_klinik_und_poliklinik_f_r_psychiatrie_und_psychotherapie_der_universit_t_regensburg_am_bezirksklinikum,,,,,, -4926,,27e6ee28-7168-11e6-a0cd-0242ac12000b,CRANE PHARMS LLC,crane_pharms_llc,,,,,, -4927,,b21ec16a-cec3-4072-964b-9a5910a962fe,Biomedizinische Forschungsgesellschaft m.b.H,biomedizinische_forschungsgesellschaft_m_b_h,,,,,, -4928,,e519406d-5cf3-460f-8535-0c2facc6183e,University of Jena,university_of_jena,,,,,, -4929,,056a68c6-715d-11e6-a0cd-0242ac12000b,STRIDES INC,strides_inc,,,,,, -4930,,8c5e7ced-9459-4fb8-9cfc-96aad5dc57a4,"Military Medical Academy Hospital for Active Treatment, Sofia",military_medical_academy_hospital_for_active_treatment_sofia,,,,,, -4931,,b2ab1af5-b75c-4fb8-a7c0-9a7764b33dfa,XCell-Center GmbH,xcell_center_gmbh,,,,,, -4932,,c0fa24d0-bfb7-4299-9e45-643086575b38,Fundación General Universidad Autónoma de Madrid,fundaci_n_general_universidad_aut_noma_de_madrid,,,,,, -4933,,88734d54-4bf7-4b85-8890-61e4c6acea41,Marinomed Biotechnologie GmbH,marinomed_biotechnologie_gmbh,,,,,, -4934,,8ff5172d-1f27-434a-8546-dca7da5762c1,"Hospital General Universitario Alicante, Dpto Farmacologia Clinica",hospital_general_universitario_alicante_dpto_farmacologia_clinica,,,,,, -4935,,758df9e7-2422-4c07-831b-b380c64feeb5,GPC Biotech AG,gpc_biotech_ag,,,,,, -4936,,89858960-7764-42dc-b71b-717ee1f14ac6,Fundación FISEVI,fundaci_n_fisevi,,,,,, -4937,,0123ee94-93cd-4628-8ebc-23da6f23b5cf,"Medizinische Universität Graz, Univ. Klinik für Dermatologie",medizinische_universit_t_graz_univ_klinik_f_r_dermatologie,,,,,, -4938,,cb458639-ffb8-4c3c-ac58-d6071f620bb1,Generics [UK] Ltd trading as Merck Generics,generics_uk_ltd_trading_as_merck_generics,,,,,, -4939,,0c53f778-51b3-4187-9d94-1e1fc0f8ed47,South Devon Health Care NHS Foundation Trust,south_devon_health_care_nhs_foundation_trust,,,,,, -4940,,5a403538-3034-4fb7-a092-60c6c1733d2b,Deutsche Krebsgesellschaft Sponsor GmbH,deutsche_krebsgesellschaft_sponsor_gmbh,,,,,, -4941,,f4dd5654-aaf6-4066-95a5-0be792282a2b,HEXAL AG (a Sandoz company),hexal_ag_a_sandoz_company,,,,,, -4942,,c8b1fafa-8bcb-11e6-a449-0242ac12000b,Werkgroep Cardiologische centra Nederland,werkgroep_cardiologische_centra_nederland,,,,,, -4943,,f3dc2851-8bc5-4fa3-8825-a8cf16ad4f76,Dep. of Medical Cell Biology Uppsala University,dep_of_medical_cell_biology_uppsala_university,,,,,, -4944,,86b5a63e-893b-49ef-8da9-fcc73f60f69d,Proximagen Limited,proximagen_limited,,,,,, -4945,,782cb034-dc39-41ff-9d91-ea1c9778d688,"Medizinische Universität Wien, UniKlinik für Klinische Pharmakologie",medizinische_universit_t_wien_uniklinik_f_r_klinische_pharmakologie,,,,,, -4946,,1a42ee09-91a2-4ea6-b200-58bd9cb2a215,Roskilde Hospital,roskilde_hospital,,,,,, -528,0.97553372383117676,0df36129-756b-443b-b038-466e73715fa6,"Roche Farma S.A en nombre de Genentech, Inc",roche_farma_s_a_en_nombre_de_genentech_inc,,,,0df36129-756b-443b-b038-466e73715fa6,roche_farma_s_a_en_nombre_de_genentech_inc,"Roche Farma S.A en nombre de Genentech, Inc" -941,0.95605242252349854,64f0df3e-982c-439f-87f4-bc34795b8f53,UCL Mont Godinne,ucl_mont_godinne,,,,215afd5f-229c-4506-bcca-821996e7d1cf,ucl,UCL -4947,,f01052ee-e919-4640-9263-0e287a2ccdbc,"The Sahlgrenska Academy, University of Gothenburg",the_sahlgrenska_academy_university_of_gothenburg,,,,,, -4948,,3dc3bffc-8ec5-4ce6-9c8c-583dc74b715a,Biota Scientific Management Pty Ltd,biota_scientific_management_pty_ltd,,,,,, -4949,,a935e55e-be0e-40d6-a84b-6d0e74a97880,sanofi-aventis recherche & development,sanofi_aventis_recherche_development,,,,,, -684,0.98852276802062988,8e580d74-355f-4c96-963e-5f3654629ce9,University Medical Center Groningen,university_medical_center_groningen,,,,07e5285a-7e7c-4b06-8e27-29dfa99a2153,university_medical_center_groningen_umcg,University Medical Center Groningen (UMCG) -165,0.985075,7ae84fa4-715e-11e6-a0cd-0242ac12000b,MISSION PHARMA,mission_pharma,,,,1e5b75f8-7164-11e6-a0cd-0242ac12000b,mission_pharmacal_co,MISSION PHARMACAL CO -4950,,fc3966b5-5b7b-40b1-8e40-3531b4e08b4a,IRCCS FONDAZIONE ISTITUTO NEUROLOGICO C. MONDINO,irccs_fondazione_istituto_neurologico_c_mondino,,,,,, -168,0.98042827844619751,248e9396-0a3f-4ee2-b65a-5844a00bc75e,Merck Serono SA - Geneva,merck_serono_sa_geneva,,,,248e9396-0a3f-4ee2-b65a-5844a00bc75e,merck_serono_sa_geneva,Merck Serono SA - Geneva -856,0.98108509182929993,8cb8aab4-4b60-42b8-a495-ddeb6c44ddc3,Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL),netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital_nki_avl,,,,66b401ea-5009-4db7-8b18-6fe29a2c6186,netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital,Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL) -4951,,32722523-594b-43b8-983b-45c7c6152593,Incyte Corporation,incyte_corporation,,,,,, -4952,,b3c53e60-7350-11e6-a0cd-0242ac12000b,KOWA CO,kowa_co,,,,,, -4953,,20b1cc22-b60f-4877-999d-8aa57ad6ebc1,Dra. Carmen Gómez Vaquero (Servicio de Reumatología del Hospital Universiari de Bellvitge - Idibell),dra_carmen_g_mez_vaquero_servicio_de_reumatolog_a_del_hospital_universiari_de_bellvitge_idibell,,,,,, -4954,,7ad7b83a-c805-439e-8c2d-745ef606c438,Stockholms Läns Sjukvårdsområde (SLSO),stockholms_l_ns_sjukv_rdsomr_de_slso,,,,,, -4955,,116d93e0-8b35-47b4-8f56-b8b8312cc5d9,Radboud University,radboud_university,,,,,, -4956,,a3e9c038-6845-44df-8fa9-9e1429fb216a,"IFSgGmbH, Institute for clinical research",ifsggmbh_institute_for_clinical_research,,,,,, -4957,,20184258-b473-4c2e-a603-3f67d7e84888,Activartis Biotech GmbH,activartis_biotech_gmbh,,,,,, -4958,,424d4d41-2da5-416d-9902-9879037bd71e,Bente Lomholt Langdahl,bente_lomholt_langdahl,,,,,, -4959,,b22eb854-8bbc-11e6-a449-0242ac12000b,Betagenon AB,betagenon_ab,,,,,, -4960,,c1c995c3-1134-40ae-a353-0c22790df4c2,Centre Jean Perrin,centre_jean_perrin,,,,,, -4961,,ebd152f6-7140-11e6-a0cd-0242ac12000b,NESHER PHARMS,nesher_pharms,,,,,, -4962,,c3d8f851-83f8-4e96-ba81-059424801cf8,Medizinische Fakultaet der Technischen Universitaet Muenchen,medizinische_fakultaet_der_technischen_universitaet_muenchen,,,,,, -4963,,281cddb2-7168-11e6-a0cd-0242ac12000b,SAVIOR LIFETEC CORP,savior_lifetec_corp,,,,,, -4964,,fe0c7a83-341d-4d5d-a2c5-144fb9a857db,PharmaNeuroBoost N.V. (PNB),pharmaneuroboost_n_v_pnb,,,,,, -486,0.98180347681045532,f662f787-fab7-4f94-97a0-1a3b3bc462fc,Sahlgrenska Universitetssjukhus,sahlgrenska_universitetssjukhus,,,,e6237908-6daa-4272-adad-f5434c004df0,sahlgrenska_universitetssjukhuset,Sahlgrenska Universitetssjukhus -374,0.9175071120262146,a5b2a4d0-a874-4eed-875f-af0923d49ff3,Merck Sharp & Dohme Ltd,merck_sharp_dohme_ltd,,,,98ef0b13-ac5f-4431-8738-f853fbd0d57c,merck_sharp_dohme_limited,Merck Sharp & Dohme Limited -4965,,74c1cf75-d3d3-440c-abc8-19e26fbec6c8,BELFAST HEALTH & SOCIAL CARE TRUST - BELFAST CITY HOSPITAL,belfast_health_social_care_trust_belfast_city_hospital,,,,,, -454,0.987768,d54ee838-0793-4a08-8231-4d0111043fe5,Hôpital Universitaire Des Enfants Reine Fabiola,h_pital_universitaire_des_enfants_reine_fabiola,,,,c6a06456-3663-448c-8c5d-27a447b6849a,h_pital_universitaire_des_enfants_reine_fabiola_h_u_d_e_r_f,Hôpital Universitaire Des Enfants Reine Fabiola (H.U.D.E.R.F.) -4966,,09ebeb9b-c0ee-402b-a60a-7834bd87ca29,LAB Pharma Ltd,lab_pharma_ltd,,,,,, -1023,0.962602,873cee39-8b99-4c6d-a602-07fd49d9627b,"Dept. of Intensive Care 4131, Copenhagen University Hospital, Rigshospitalet",dept_of_intensive_care_4131_copenhagen_university_hospital_rigshospitalet,,,,3d6896c7-f9eb-43cb-9c4d-49b6ab960bde,dept_of_intensive_care_copenhagen_university_hospital_rigshospitalet,"Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet" -4967,,9716b993-36fd-4dc6-8c04-577b31bb54f4,"Medizinische Universität Wien, Klinik für Innere Medizin I, Abt. Onkologie",medizinische_universit_t_wien_klinik_f_r_innere_medizin_i_abt_onkologie,,,,,, -4968,,ac1c6e0c-36ac-4960-939b-2e6f819fd43b,Klinikum Leverkusen gGmbH,klinikum_leverkusen_ggmbh,,,,,, -4969,,e08b437b-dfa0-4978-bc67-ffad559f059d,"Institute of Anaesthesiology, German Heart Centre",institute_of_anaesthesiology_german_heart_centre,,,,,, -200,0.97189050912857056,fe1d891c-caab-44f5-bedc-82af0ec75615,"National Institute for Public Health and the Environment (RIVM, Netherlands)",national_institute_for_public_health_and_the_environment_rivm_netherlands,,,,ce046c53-60a5-4a54-bb94-914d5bc33caa,national_institute_for_public_health_and_the_environment_rivm_the_netherlands,"National Institute for Public Health and the Environment (RIVM, the Netherlands)" -4970,,e94c9911-9c9b-46cd-9b48-dc512bd5360f,The Cardiothoracic Centre Liverpool NHS Trust,the_cardiothoracic_centre_liverpool_nhs_trust,,,,,, -681,0.98050621151924133,e9e3f1a5-d19d-4eea-b83e-62046558fbb3,"Aarhus University Hospital, Department of Cardiology",aarhus_university_hospital_department_of_cardiology,,,,e9e3f1a5-d19d-4eea-b83e-62046558fbb3,aarhus_university_hospital,Aarhus University Hospital -4971,,16f0b570-62a8-4e5b-b277-d5692e61267b,Central Manchester and Manchester University Children's Hospital NHS Trust,central_manchester_and_manchester_university_children_s_hospital_nhs_trust,,,,,, -4972,,154dc416-7164-11e6-a0cd-0242ac12000b,ACCORD HLTHCARE INC,accord_hlthcare_inc,,,,,, -4973,,c3992ee5-3a90-49be-b60b-14fb064c2581,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc",wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc,,,,,, -4974,,72fd5b3a-7191-11e6-a0cd-0242ac12000b,BAYER HLTHCARE,bayer_hlthcare,,,,,, -4975,,518ae137-093f-45cc-8d29-7fbe58f87f11,The BONiFIN study group,the_bonifin_study_group,,,,,, -4976,,72912c5b-8151-498b-a241-025c462ca079,DAIICHI SANKIO DEVELOPMENT LIMITED,daiichi_sankio_development_limited,,,,,, -818,0.972258,87f0f612-d1e5-4f3f-9bcd-69b8c3e8fd9a,UNIVERSITA' DEGLI STUDI DI FIRENZE,universita_degli_studi_di_firenze,,,,87f0f612-d1e5-4f3f-9bcd-69b8c3e8fd9a,universita_degli_studi_di_firenze,UNIVERSITA' DEGLI STUDI DI FIRENZE -4977,,480de809-6a0b-4684-8c5b-abf76eee946a,North Bristol Trust,north_bristol_trust,,,,,, -4978,,296ec335-93fd-4ce1-a10d-f3394aac006e,Ilkogen Ilac San. ve Tic. A.S,ilkogen_ilac_san_ve_tic_a_s,,,,,, -4979,,11a65836-8bb9-11e6-a449-0242ac12000b,G1 Therapeutics,g1_therapeutics,,,,,, -4980,,071bdada-a655-4496-8a2f-1ab0465e8527,Allergy Therapeutics (UK) Ltd,allergy_therapeutics_uk_ltd,,,,,, -4981,,4672c056-496e-4858-a8f8-77cf864e56a6,Siemens Molecular Imaging,siemens_molecular_imaging,,,,,, -4982,,1f53add5-0a89-47a8-8a59-50c47c1e39fc,Klinik für Psychiatrie und Psychotherapie des Kindes- und Jugendalters am Zentralinstitut für Seelische Gesundheit,klinik_f_r_psychiatrie_und_psychotherapie_des_kindes_und_jugendalters_am_zentralinstitut_f_r_seelische_gesundheit,,,,,, -4983,,ed82862d-debc-42a3-8b93-b80fb7fdeb1c,SSL International plc,ssl_international_plc,,,,,, -4984,,679875ce-8aa2-4ab0-9d69-48b8c5a8a424,IRCCS San Raffaele di Roma,irccs_san_raffaele_di_roma,,,,,, -4985,,71d50a6e-af23-4ec1-b1b1-1245977913cd,Ceregene Inc,ceregene_inc,,,,,, -4986,,1304d370-e286-498c-8b41-431e01c2c6d8,"Shire Human Genetic Therapies (HGT), Inc",shire_human_genetic_therapies_hgt_inc,,,,,, -4987,,30a69f01-503f-49fb-a054-dd8d4ec9098b,Instituto Andaluz de Sexología,instituto_andaluz_de_sexolog_a,,,,,, -4988,,ae8fa2ef-8311-45e0-91ed-105b402a5fb7,"Idenix Pharmaceuticals, Inc",idenix_pharmaceuticals_inc,,,,,, -4989,,412560a1-3c3c-468e-86f3-25a24b16c8a7,National Institute on Drug Abuse (NIDA),national_institute_on_drug_abuse_nida,,,,,, -1008,0.951024,4b0b3c57-a10d-4d99-beef-0ed9a5c1b30f,AOP Oprhan Pharmaceuticals AG,aop_oprhan_pharmaceuticals_ag,,,,4614bd92-4210-4230-a954-64c1de5fddc0,aop_orphan_pharmaceuticals_ag,AOP Orphan Pharmaceuticals AG -4990,,532ccfc5-e3ca-4b54-a90e-013bb9182b03,"Med Uni Graz, Univ. Klinik Dermatologie,Abteilung für Allgemeine Dermatologie",med_uni_graz_univ_klinik_dermatologie_abteilung_f_r_allgemeine_dermatologie,,,,,, -4991,,03e4235f-192e-4cc4-adcf-ee5092a78f9c,King's College Hospital Foundtion NHS Trust,king_s_college_hospital_foundtion_nhs_trust,,,,,, -4992,,87650e1a-7164-11e6-a0cd-0242ac12000b,HITECH PHARMA,hitech_pharma,,,,,, -4993,,4d563778-ff63-4415-a286-103203e9a573,"Dance Pharmaceuticals, Inc",dance_pharmaceuticals_inc,,,,,, -4994,,f82c77ef-3470-4ec0-892e-51ca522549e4,J. Uriach & Compañía SA,j_uriach_compa_a_sa,,,,,, -976,0.986562,1819b794-72dc-11e6-a0cd-0242ac12000b,PURDUE PHARMA,purdue_pharma,,,,1819b794-72dc-11e6-a0cd-0242ac12000b,purdue_pharma,PURDUE PHARMA -4995,,dc1f02f1-76cd-4dae-955e-6a5a9409c5f5,CETPARP,cetparp,,,,,, -729,0.96225506067276001,49a5f431-66a8-4a47-ae4f-0a20eff4609d,Sanofi Pasteur MSD S.N.C,sanofi_pasteur_msd_s_n_c,,,,cb560f4c-875f-44a3-bed5-c8039bd52ca8,sanofi_pasteur_msd,Sanofi Pasteur MSD -4996,,422fdc32-d866-4455-b406-0288de07f64d,Hoffman La Roche Ltd,hoffman_la_roche_ltd,,,,,, -4997,,86549d8a-9960-4ec2-82b2-3c79b66b147c,Danish Myeloma Study Group,danish_myeloma_study_group,,,,,, -4998,,85f70234-2537-48b5-b582-a9fd6a5edc28,COMBAT MEDICAL LTD,combat_medical_ltd,,,,,, -4999,,5c6898a1-b6ea-4657-8254-a9eb9e0694c1,HYKS Psykiatrikeskus,hyks_psykiatrikeskus,,,,,, -5000,,b1838e97-e6e7-4940-96e7-cee551ab881f,Finnish Uro-Oncological Group,finnish_uro_oncological_group,,,,,, -5001,,5640c740-7158-11e6-a0cd-0242ac12000b,OSMOTICA PHARM US,osmotica_pharm_us,,,,,, -987,0.985423,497e2c7a-7165-11e6-a0cd-0242ac12000b,ASPEN GLOBAL INC,aspen_global_inc,,,,497e2c7a-7165-11e6-a0cd-0242ac12000b,aspen_global_inc,ASPEN GLOBAL INC -5002,,090f61ff-26ef-490a-b792-1569ced1298b,University Hospital Tuebingen,university_hospital_tuebingen,,,,,, -5003,,c751852d-6cda-42fd-af27-5e2afdfc5867,Asociación Terapeutica en Hematologia y Oncología Médicas,asociaci_n_terapeutica_en_hematologia_y_oncolog_a_m_dicas,,,,,, -5004,,444af652-e6b5-408d-b826-9ab24b72e580,Takeda Pharma GmbH,takeda_pharma_gmbh,,,,,, -5005,,f843ee57-e570-4103-8f35-53147204de68,Dr. Jordi Montero Homs- Unidad de Neuromuscular- Servicio de Neurología- Hospital Universitario de Bellvitge,dr_jordi_montero_homs_unidad_de_neuromuscular_servicio_de_neurolog_a_hospital_universitario_de_bellvitge,,,,,, -5006,,a078fcd5-4784-455c-8e42-59145d459b2e,Katholieke Universiteit Leuven,katholieke_universiteit_leuven,,,,,, -5007,,002a5263-1108-4341-835b-161049d098cc,Turku University Central Hospital,turku_university_central_hospital,,,,,, -5008,,9f44a945-da06-49ec-99fa-d061da02c5bd,Servicio de Neurología. Hospital Universitari de Bellvitge,servicio_de_neurolog_a_hospital_universitari_de_bellvitge,,,,,, -99,0.97086024284362793,07d428a0-cf4e-4f85-9961-fc028370360e,Novartis Farmaceutica,novartis_farmaceutica,,,,bcb0e637-6442-4916-88f9-8cd0d5df3534,novartis_farmaceutica,Novartis Farmaceutica -5009,,6c4c59f5-476a-44e1-bc1b-ba6f5d391cfc,HUS/ Neuropsykiatrian poliklinikka,hus_neuropsykiatrian_poliklinikka,,,,,, -5010,,b7904252-b621-4f37-8f2e-b811888f1391,"NanoCarrier Co., Ltd",nanocarrier_co_ltd,,,,,, -5011,,580f05f6-71c5-11e6-a0cd-0242ac12000b,STIEFEL LABS INC,stiefel_labs_inc,,,,,, -124,0.98570466041564941,6c8a5ed2-f731-4585-8a6f-d17e1fc2915a,"F. Hoffman-La Roche Ltd., Roche Oy",f_hoffman_la_roche_ltd_roche_oy,,,,6c8a5ed2-f731-4585-8a6f-d17e1fc2915a,f_hoffman_la_roche_ltd_roche_oy,"F. Hoffman-La Roche Ltd., Roche Oy" -756,0.973609,a3d07aa8-578f-4f72-b06a-682bbc119d08,"Johannes Gutenberg-Universität Mainz, II. Med. Klinik (ausführende Stelle), Prof. Dr. med. T. Münzel",johannes_gutenberg_universit_t_mainz_ii_med_klinik_ausf_hrende_stelle_prof_dr_med_t_m_nzel,,,,339b2067-d133-4013-927e-2033004bf532,johannes_gutenberg_universit_t_mainz_ii_med_klinik_ausf_hrende_stelle_prof_dr_t_m_nzel,"Johannes Gutenberg-Universität Mainz, II. Med. Klinik (ausführende Stelle), Prof. Dr. T. Münzel" -5012,,fc051158-7145-11e6-a0cd-0242ac12000b,CONTRACT PHARMACAL,contract_pharmacal,,,,,, -5013,,a15cfcb5-961b-441d-9ba5-bcb844eec0e5,JAVIER MARTÍN BROTO,javier_mart_n_broto,,,,,, -5014,,744e1686-6348-4c4d-868c-2370ed289ce7,St. Anna Kinderkrebsforchung Children's Cancer Research Institute,st_anna_kinderkrebsforchung_children_s_cancer_research_institute,,,,,, -5015,,fb2924ad-206f-404a-8dbf-f1f9471d05f1,Integrated Therapeutics Group Incorporated (ITGI),integrated_therapeutics_group_incorporated_itgi,,,,,, -5016,,1ed265c0-70ea-47cd-89f1-29efb678ea03,Research and Innovation Services,research_and_innovation_services,,,,,, -5017,,9c050f54-7160-11e6-a0cd-0242ac12000b,CAMALL,camall,,,,,, -5018,,08900929-4345-47e6-85ec-3c88baa033dd,GOIM GRUPPO ONCOLOGICO MERIDIONALE,goim_gruppo_oncologico_meridionale,,,,,, -5019,,549d274b-a2d5-43e7-935a-d41c6807f0ae,Division K Kärnsjukhuset,division_k_k_rnsjukhuset,,,,,, -5020,,b0663aab-3c37-47c0-bbf4-b52b6136acea,Almirall Prodesfarma S.A,almirall_prodesfarma_s_a,,,,,, -5021,,ce8bcf12-7165-11e6-a0cd-0242ac12000b,YAOPHARMA CO LTD,yaopharma_co_ltd,,,,,, -5022,,740b6c6a-ac4f-47e0-8863-6ae2158e498f,"Deutsche Herzzentrum Berlin, Kompetenznetz Angeborene Herzfehler",deutsche_herzzentrum_berlin_kompetenznetz_angeborene_herzfehler,,,,,, -5023,,25678bc4-5b07-4f86-856c-caba6ecb78c5,University of Liverpool/Liverpool Women's Hospital,university_of_liverpool_liverpool_women_s_hospital,,,,,, -5024,,5f15b7af-c60b-4c64-8c48-56a487eb9f52,Grupo de Estudos Oncológicos,grupo_de_estudos_oncol_gicos,,,,,, -614,0.95383979876836145,fc47e3cc-4170-4925-b135-e77f956fcdef,Fundación para la Investigación Biomédica del Hospital Universitario de La Paz,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_de_la_paz,,,,1f4b6569-9247-4094-9c36-e11efb0201df,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz,Fundación para la Investigación Biomédica del Hospital Universitario La Paz -5025,,43552246-537d-441d-a3b1-c6a6846cf838,Jens Rolighed Larsen,jens_rolighed_larsen,,,,,, -5026,,9e646641-9081-4b19-a93f-972c1a282f86,AbbVie Biotherapeutics Inc. (AbbVie),abbvie_biotherapeutics_inc_abbvie,,,,,, -5027,,ad4f131e-7367-11e6-a0cd-0242ac12000b,THERATECHNOLOGIES,theratechnologies,,,,,, -1011,0.982558,d2e7717a-7a42-474a-9d20-1e8ff7dae2f4,German Breast Group Forschungs GmbH,german_breast_group_forschungs_gmbh,,,,19f3330e-027c-4344-a82b-28a25bade93e,german_breast_group,German Breast Group -688,0.98167827725410461,efc402d8-6fed-43fa-b994-36de1c4b8651,"Ruprecht-Karls-University Heidelberg, Medical Faculty Mannheim represented by the chancellor",ruprecht_karls_university_heidelberg_medical_faculty_mannheim_represented_by_the_chancellor,,,,4f99f7a3-6aa3-48d1-bbd6-5bfbc38e7e8d,ruprecht_karls_university_heidelberg_medical_faculty,"Ruprecht-Karls-University Heidelberg, Medical Faculty" -5028,,5b9b0886-bdfe-43ef-a518-5b133571056b,GlaxoSmithKine Research & Development Limited,glaxosmithkine_research_development_limited,,,,,, -5029,,48862b0c-13ca-4e27-b124-37a6323a8a06,"Univ.-Prof. DDr. Norbert Jakse, Universitätszahnklinik Graz, Dep. f. Orale Chirurgie u. Röntgenologi",univ_prof_ddr_norbert_jakse_universit_tszahnklinik_graz_dep_f_orale_chirurgie_u_r_ntgenologi,,,,,, -5030,,a007855c-9e0b-4f06-b58e-d4cffd050ada,Heart of England NHS Foundation Trust,heart_of_england_nhs_foundation_trust,,,,,, -5031,,d2e60d1d-66f4-4a3f-b975-f2385f81019d,Jelfa SA,jelfa_sa,,,,,, -5032,,d658279e-1e4f-403e-8b9c-b5d36860f536,Abiogen Pharma S.p.A,abiogen_pharma_s_p_a,,,,,, -5033,,61785265-c6ed-46f8-88aa-6501dc53f182,"Apex Bioscience, Inc",apex_bioscience_inc,,,,,, -5034,,d1250700-cdfb-4bd6-b004-b8ee082e63da,Prosonix Limited,prosonix_limited,,,,,, -5035,,1c8e5581-4c53-451e-b183-112ad705d875,Danube Pharmaceuticals Inc,danube_pharmaceuticals_inc,,,,,, -5036,,4d9f849d-dd1d-4f21-a8f3-f153e2791f76,AIO-Studien-gGmbH,aio_studien_ggmbh,,,,,, -5037,,baf8fc24-3c16-4187-b4a0-bd161783c9f2,CHU de Nantes,chu_de_nantes,,,,,, -5038,,974008ae-73f2-11e6-a0cd-0242ac12000b,NITROUS OXIDE CORP,nitrous_oxide_corp,,,,,, -5039,,49a1e495-5503-4855-98c2-21a6f0d7a351,University hospital of Bonn,university_hospital_of_bonn,,,,,, -922,0.98430114984512329,a1324003-35e8-470e-953b-3b8bca84ef3a,Pfizer bv,pfizer_bv,,,,41a3f51d-cc79-4d85-ad20-dd3ecef8b74f,pfizer_bv_cr,Pfizer bv CR -553,0.97483,05a127e0-09ed-418a-bb52-d8310d3063dc,Centre François Baclesse,centre_fran_ois_baclesse,,,,02d042a3-dbd3-41ce-bd72-42a098676c11,centre_francois_baclesse,Centre Francois Baclesse -977,0.984073,84f4a215-8c1a-46ef-828a-05f77f6a3e72,KULeuven and University Hospitals Leuven,kuleuven_and_university_hospitals_leuven,,,,5c717b25-0b28-45e6-bff5-45d9320631af,kuleuven_and_university_hospitals_leuven_leuven_lung_transplant_group,KULeuven and University Hospitals Leuven (Leuven Lung Transplant Group) -5040,,d9e757c1-24f1-4a3c-b2cd-564d74426891,Servier Portugal - Especialidades Farmacêuticas Lda,servier_portugal_especialidades_farmac_uticas_lda,,,,,, -5041,,caeb6dc2-f9a0-49f2-842a-4daa1ecc6de7,CELL THERAPEUTICS INC. (EUROPE)-SEDE SECONDARIA,cell_therapeutics_inc_europe_sede_secondaria,,,,,, -5042,,9300406a-3e3f-4639-99d0-0bde0f212af8,JSW Lifesciences GmbH,jsw_lifesciences_gmbh,,,,,, -5043,,bf02b309-9893-4b29-a236-0e3140a78cc9,Royal Berkshire and Battle Hospitals NHS Trust,royal_berkshire_and_battle_hospitals_nhs_trust,,,,,, -5044,,0a0bbe5e-7142-11e6-a0cd-0242ac12000b,CLARIS,claris,,,,,, -5045,,b347a763-b742-40b2-8ee8-235599581292,Roskilde Amts Sygehus,roskilde_amts_sygehus,,,,,, -5046,,599df9b1-a67e-43ca-ad67-0e2f44736c8d,Fundación Cerebro y Mente,fundaci_n_cerebro_y_mente,,,,,, -5047,,a8f4b896-f806-4c8b-8e1e-46ae5d092f00,Mercedes Zumarraga Ortiz,mercedes_zumarraga_ortiz,,,,,, -1060,0.98586,0b2aae39-94a4-4319-927d-68470e818403,FONDAZIONE PENTA,fondazione_penta,,,,0b2aae39-94a4-4319-927d-68470e818403,fondazione_penta,FONDAZIONE PENTA -456,0.95666962862014771,e9ad54fa-7237-11e6-a0cd-0242ac12000b,CIS BIO INTL SA,cis_bio_intl_sa,,,,6704e020-719e-11e6-a0cd-0242ac12000b,cis,CIS -556,0.92243582010269165,c14f025d-e1fd-4178-9c21-651db3e987e3,Greater Glasgow & Clyde Health Board,greater_glasgow_clyde_health_board,,,,3361148d-134d-40eb-b1d7-9105a55174b4,greater_glasgow_and_clyde_health_board_ggchb_university_of_glasgow,Greater Glasgow and Clyde Health Board (GGCHB)/University of Glasgow -1077,0.97536885738372803,3fdba14d-9b0e-469d-bb19-93144e9882fd,IBSA Institut Biochimique S.A,ibsa_institut_biochimique_s_a,,,,3fdba14d-9b0e-469d-bb19-93144e9882fd,ibsa_institut_biochimique_s_a,IBSA Institut Biochimique S.A -5048,,9fca1dd6-6fbd-11e6-abe8-0242ac12000b,Accenture,accenture,,,,,, -589,0.9786,a9471b81-d20a-4ad8-aba3-b02c3fcc30c7,"Abteilung für Anaesthesie und Intensivmedizin, Medizinische Universität Wien",abteilung_f_r_anaesthesie_und_intensivmedizin_medizinische_universit_t_wien,,,,3a83eff6-b403-4ef3-9768-88bc041f3b42,abteilung_f_r_an_sthesie_und_intensivmedizin_medizinische_universit_t_wien,"Abteilung für Anästhesie und Intensivmedizin, Medizinische Universität Wien" -5049,,370c4d5e-61bc-4c92-969d-1ae85df70306,Hvidovre University Hospital,hvidovre_university_hospital,,,,,, -5050,,c6c8b1da-3780-44e5-83c3-37a3729bd9e7,Pantarhei Bioscience BV,pantarhei_bioscience_bv,,,,,, -5051,,e5014f76-2148-4677-9597-ea2ae8640993,Max Zeller Söhne AG,max_zeller_s_hne_ag,,,,,, -386,0.985292,60874b79-ee1e-4812-b6c9-460d6bce27cc,University of Leuven Hospitals,university_of_leuven_hospitals,,,,1075f8b7-6380-4891-9141-7a995969037d,university_of_leuven,University of Leuven -594,0.970712,1768a5c2-6d78-474d-b8b9-24906dea2085,"The Karolinska Institute, ClinTRID",the_karolinska_institute_clintrid,,,,1768a5c2-6d78-474d-b8b9-24906dea2085,the_karolinska_institute_clintrid,"The Karolinska Institute, ClinTRID" -5052,,9370cd3c-d252-4396-adb5-d0452f435066,"Aerogen, Inc",aerogen_inc,,,,,, -5053,,2df0fbc6-3b70-46ef-bfe4-035678c0f668,GlaxoSmithKline AB,glaxosmithkline_ab,,,,,, -5054,,d28fa68b-2fc2-42e9-8f87-42beb5e2a009,Center for neuropsykiatrisk Schrizofreniforskning,center_for_neuropsykiatrisk_schrizofreniforskning,,,,,, -5055,,e1533350-a59f-4a08-aef5-07e769943a59,"TRF Pharma, Inc",trf_pharma_inc,,,,,, -5056,,276b8af0-3185-470c-97eb-17d65ff8ca40,Lupin Limited,lupin_limited,,,,,, -278,0.97598719596862793,e86cb604-6399-4605-9a60-17154f1ecb73,GlaxoSmithKline Research & Devleopment Ltd,glaxosmithkline_research_devleopment_ltd,,,,e86cb604-6399-4605-9a60-17154f1ecb73,glaxosmithkline_research_devleopment_ltd,GlaxoSmithKline Research & Devleopment Ltd -519,0.98101389408111572,c15af267-15cc-42e5-be46-4a84bd3c6dca,CSL Behring,csl_behring,,,,c15af267-15cc-42e5-be46-4a84bd3c6dca,csl_behring_ag,CSL Behring AG -5057,,4fabf996-f3c2-4f01-b9e8-9592228c3d7b,Klin. Abtlg. für Thorax- & Hyperbare Chirurgi,klin_abtlg_f_r_thorax_hyperbare_chirurgi,,,,,, -989,0.964382,9dee1320-7e61-4373-a4a5-0601870627ce,G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO,g_i_m_e_m_a_gruppo_italiano_malattie_ematologiche_dell_adulto,,,,9dee1320-7e61-4373-a4a5-0601870627ce,g_i_m_e_m_a_gruppo_italiano_malattie_ematologiche_dell_adulto,G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO -5058,,66a84d59-ecce-4688-ae12-5dca48f5abc5,NovImmune S.A,novimmune_s_a,,,,,, -5059,,1c4f1cc9-bae0-49c1-9529-83526549f02b,Orion Pharma,orion_pharma,,,,,, -5060,,ca45ccad-e3f0-4b22-a560-dbfec00eec04,Uniwersytet Medyczny,uniwersytet_medyczny,,,,,, -5061,,36d48d72-7ec9-4564-ac0c-1c8a28d10c00,Hanns-Ulrich Marschall,hanns_ulrich_marschall,,,,,, -5062,,ff468cae-938b-4295-af18-d37a0b27012e,AGMT – Arbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH,agmt_arbeitsgemeinschaft_medikament_se_tumortherapie_gemeinn_tzige_gmbh,,,,,, -5063,,426f6906-ee06-4cc9-b4b8-4f8045e7c2e2,"Medizinische Unversität Wien, Abteilung für Kinder- und Jugendheilkunde",medizinische_unversit_t_wien_abteilung_f_r_kinder_und_jugendheilkunde,,,,,, -5064,,898f56dd-7a9f-450a-9ddf-b559ecb4777b,ASL 2 SAVONESE,asl_2_savonese,,,,,, -5065,,20cdf177-0f5b-4356-8901-be9899e06b2a,Genetic Immunity Kft,genetic_immunity_kft,,,,,, -5066,,2aecdc85-8e6b-442d-8074-77c096d19ac1,Department of Orthopaedic Surgery University Hospital Linköping,department_of_orthopaedic_surgery_university_hospital_link_ping,,,,,, -5067,,df24c9e9-f301-41e5-ba23-7b6ea93709d7,Fundación Investigación Biomédica Puerta de Hierro,fundaci_n_investigaci_n_biom_dica_puerta_de_hierro,,,,,, -882,0.957248,acee4b3e-08b2-4604-95a5-b5c1e12e7628,Hyks,hyks,,,,acee4b3e-08b2-4604-95a5-b5c1e12e7628,hyks,Hyks -5068,,e1bda8ea-6773-46d2-ac96-235d03ac6a48,Curatis Pharma GmbH,curatis_pharma_gmbh,,,,,, -555,0.98070001602172852,553abbb3-263c-4177-a2fa-a95d21db2fc2,Greater Glasgow and Clyde NHS Board and The University Of Glasgow,greater_glasgow_and_clyde_nhs_board_and_the_university_of_glasgow,,,,613c1a9b-76b3-42ee-8979-2c8d31737f57,greater_glasgow_and_clyde_nhs_board,Greater Glasgow and Clyde NHS Board -5069,,36dd585b-b0e7-4934-9576-eb3fbdbc96cf,"Sexological Clinic, Rigshospitalet",sexological_clinic_rigshospitalet,,,,,, -5070,,2bcfb1c8-7190-11e6-a0cd-0242ac12000b,PHARMICS,pharmics,,,,,, -5071,,3b537544-649e-4c97-b0b1-3c440cc9965b,FOURNIER LABORATORIES IRELAND Ltd,fournier_laboratories_ireland_ltd,,,,,, -5072,,2d40f677-5f63-42f1-ac30-36493cb68b19,"Millennium Pharmaceuticals, Inc",millennium_pharmaceuticals_inc,,,,,, -627,0.97483,78e77398-73ed-45b6-b470-74acc67e6db9,Institut Bergonié,institut_bergoni,,,,51090fb3-f2e6-4878-8ebd-94da6e3ed0df,institut_bergoni_d_partement_d_oncologie_m_dicale,Institut Bergonié - Département d’Oncologie Médicale -5073,,80cd9d70-e291-4e9f-915c-fbb04017a948,"Medizinische Universität Wien, Univ.-Klinik für Innere Medizin I, Klinische Abteilung für Infetionen und Tropenmedizin",medizinische_universit_t_wien_univ_klinik_f_r_innere_medizin_i_klinische_abteilung_f_r_infetionen_und_tropenmedizin,,,,,, -5074,,7c6170f1-01ff-45f1-ae01-cb60480b2ff1,FNCLCC (Fédération Nationale des Centres de Lutte Contre le Cancer),fnclcc_f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer,,,,,, -5075,,533e7ed8-715e-11e6-a0cd-0242ac12000b,TORRENT PHARMS LLC,torrent_pharms_llc,,,,,, -5076,,32ee473d-a724-4640-a615-119263fbeca1,Investigador del estudio: Dr. Agustín Alomar Muntañola,investigador_del_estudio_dr_agust_n_alomar_munta_ola,,,,,, -5077,,81915db4-9c35-49cc-a37c-fc45466da848,"Medizinische Universität Graz, Klinische Abteilung für allgemeine Pädiatrie",medizinische_universit_t_graz_klinische_abteilung_f_r_allgemeine_p_diatrie,,,,,, -285,0.9883,eb291706-2c5d-4ba0-be9b-3c5939ceef07,UK für Anästhesiologie und allgemeine Intensivmedizin,uk_f_r_an_sthesiologie_und_allgemeine_intensivmedizin,,,,7213388e-5096-443a-80ed-002100f22598,uk_f_r_an_sthesiologie_und_allgemeine_intensivmedizin_lkh_salzburg,"UK für Anästhesiologie und allgemeine Intensivmedizin, LKH Salzburg" -5078,,7b4fb93d-7586-4794-9f84-bddd68010d13,NightstaRx Ltd,nightstarx_ltd,,,,,, -5079,,bb8bb302-e59e-43b1-bf3d-ba22d1eda2b4,BASILEA PHARMACEUTICA,basilea_pharmaceutica,,,,,, -5080,,9f8fa8a7-204a-4f50-af2a-a09c6c3a9ccd,Locemia Solutions ULC,locemia_solutions_ulc,,,,,, -529,0.94006639719009399,c79e1bf1-e4a3-4d35-a28e-9b09f3073525,"Roche Farma S.A., que representa en España a F.Hoffmann-La Roche",roche_farma_s_a_que_representa_en_espa_a_a_f_hoffmann_la_roche,,,,05387ec7-b7a5-4b59-bbbd-5029e53bbb00,roche_farma_s_a_que_representa_en_espa_a_a_f_hoffmann_la_roche_ltd,"Roche Farma, S.A., que representa en España a F. Hoffmann-La Roche Ltd" -786,0.98430114984512329,36d7c90b-a751-4f8d-8ad8-5535b85ebea2,Intercell AG,intercell_ag,,,,36d7c90b-a751-4f8d-8ad8-5535b85ebea2,intercell_ag,Intercell AG -941,0.95605242252349854,215afd5f-229c-4506-bcca-821996e7d1cf,UCL,ucl,,,,215afd5f-229c-4506-bcca-821996e7d1cf,ucl,UCL -5081,,fe83c411-f0f5-4561-bc76-f2472773527e,"Universität Rostock, für diese handelnd Universitätsklinikum",universit_t_rostock_f_r_diese_handelnd_universit_tsklinikum,,,,,, -5082,,f041b92c-07ff-4431-bc55-486256622dad,MediWound Ltd,mediwound_ltd,,,,,, -5083,,7af0fb1c-8bd6-11e6-a449-0242ac12000b,"Gynecology Department,Herning Hospital",gynecology_department_herning_hospital,,,,,, -5084,,f3fc6282-a312-40cd-9e8e-ccbfee1a869a,"Department of Nephrology and Renal Transplantation, KU Leuven",department_of_nephrology_and_renal_transplantation_ku_leuven,,,,,, -5085,,406465dd-3f6f-4369-8bb9-97a00306b87c,Antonio Moreno Galdó,antonio_moreno_gald,,,,,, -5086,,49d1d460-2459-4916-a093-29ecb0eb58e0,Biomay AG,biomay_ag,,,,,, -5087,,230a36c5-6a4a-4010-9a9f-2eae431696d0,"Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto",department_of_physiology_and_cardiothoracic_surgery_faculty_of_medicine_university_of_porto,,,,,, -5088,,9e7561e1-5430-4126-a864-968e33d3403f,Hospital de Girona Dr Josep Trueta,hospital_de_girona_dr_josep_trueta,,,,,, -5089,,15a90554-6d80-4238-8e17-209372f5f4f0,Clinica Rotger,clinica_rotger,,,,,, -5090,,f60bb756-8f7c-4f97-bad2-dc49f6654232,Kenta Biotech,kenta_biotech,,,,,, -737,0.9838290810585022,abd7706c-73a6-4724-a75c-500b163844ce,Fundació Clínic per a la Recerca Biomèdica,fundaci_cl_nic_per_a_la_recerca_biom_dica,,,,9d24a637-ff9d-4f52-87fc-ca0f3956d972,fundaci_clinic_per_a_la_recerca_biom_dica,Fundació Clinic per a la Recerca Biomèdica -5091,,f8bd98c2-c407-4d2a-82eb-f36477a50938,Allon Therapeutics Inc,allon_therapeutics_inc,,,,,, -5092,,d3a3d995-fb9f-4cee-b50f-cf42b55be56c,Klaipeda hospital,klaipeda_hospital,,,,,, -5093,,55a9071e-cf02-41f1-b6b8-1521557b6443,Intituto Aragonés de Ciencias de la Salud,intituto_aragon_s_de_ciencias_de_la_salud,,,,,, -5094,,9c326f60-b3fa-4793-bafe-9d5dd0003f40,SkyePharma AG,skyepharma_ag,,,,,, -5095,,5d3b3bf6-a380-46c6-922d-01347d5f80a7,"Ipsen Group, SCRAS Institut Henri Beaufour",ipsen_group_scras_institut_henri_beaufour,,,,,, -474,0.914969,6c80401e-c0a6-481c-8234-44f428b1fd51,Royal Devon & Exeter Foundation Trust,royal_devon_exeter_foundation_trust,,,,0222076c-1a8f-4b87-a730-9ae61df48508,royal_devon_exeter_nhs_foundation_trust,Royal Devon & Exeter NHS Foundation Trust -617,0.98639386892318726,0b62757d-a156-4d40-9ede-7264daaa5209,Grupo Español de Investigación en Sarcomas,grupo_espa_ol_de_investigaci_n_en_sarcomas,,,,0359d070-d59d-4dab-8d3e-cdb60bbcff96,grupo_espa_ol_de_investigaci_n_en_sarcomas,Grupo Español de Investigación en Sarcomas -5096,,faf8d634-8aed-4757-b580-4417c391c30e,Venter Pharma S.L,venter_pharma_s_l,,,,,, -5097,,f346cc64-d564-4227-958d-bee2f79cae9f,National Institute of Mental Health,national_institute_of_mental_health,,,,,, -5098,,3c6a09c4-d44f-41b0-8d91-57656fe34a61,"Department of Rheumatology, Internal Medicine III, Medical University of Vienna",department_of_rheumatology_internal_medicine_iii_medical_university_of_vienna,,,,,, -5099,,f55e4c2c-c01e-460b-97e2-889659e1b806,T1D Exchange Clinic Network Coordinating Center,t1d_exchange_clinic_network_coordinating_center,,,,,, -5100,,c3d25b15-a782-4394-8bbe-967958c120f3,Universitetet i Bergen,universitetet_i_bergen,,,,,, -5101,,26ba747a-88d6-4bd8-9e73-a30afc73335d,Osteologix A/S,osteologix_a_s,,,,,, -5102,,dd54efdb-9652-461d-ab90-c8253d4c181d,"Retrophin, Inc",retrophin_inc,,,,,, -5103,,7d6a5342-73bd-11e6-a0cd-0242ac12000b,PFIZER LABS,pfizer_labs,,,,,, -5104,,7877c73f-edf1-4203-9a84-bdfe86fb219f,NOXXON Pharma AG,noxxon_pharma_ag,,,,,, -5105,,c20363ae-fbc0-4099-b18b-7a3fe82b2c6b,Corporation Schering-Plough K.K,corporation_schering_plough_k_k,,,,,, -42,0.98929455876350403,e3a4dbed-6085-4f4f-a871-0b11b6bed573,Universitätsklinik für Augenheilkunde und Optometrie,universit_tsklinik_f_r_augenheilkunde_und_optometrie,,,,e3a4dbed-6085-4f4f-a871-0b11b6bed573,universit_tsklinik_f_r_augenheilkunde_und_optometrie,Universitätsklinik für Augenheilkunde und Optometrie -405,0.96709239482879639,dee4490b-b25c-4c54-b909-635261eba55d,Gilead,gilead,,,,dee4490b-b25c-4c54-b909-635261eba55d,gilead,Gilead -5106,,2f2a2d67-28a4-4642-80dc-839f15afc352,Dr. Jose Vicente Torregrosa Prats (fundacio clinic),dr_jose_vicente_torregrosa_prats_fundacio_clinic,,,,,, -5107,,50970099-d34a-4139-bb56-5f46761cc9df,Universit� Cattolica del Sacro Cuore,universit_cattolica_del_sacro_cuore,,,,,, -5108,,4b7e57a0-5ce0-4447-bcee-a2ee9bb76b6b,NYCOMED (HEADQUARTER),nycomed_headquarter,,,,,, -5109,,8e8079f4-7142-11e6-a0cd-0242ac12000b,ODYSSEY PHARMS,odyssey_pharms,,,,,, -5110,,74c6493b-e4d9-4b8f-b0a8-da2a62d8e1c4,Fundacio Parc Taulí,fundacio_parc_taul,,,,,, -492,0.973505,81977950-118e-45c5-b00b-ff958a1914c1,Rottapharm,rottapharm,,,,81977950-118e-45c5-b00b-ff958a1914c1,rottapharm,Rottapharm -5111,,ba053778-7581-4058-931f-75a2ebaf54a0,XOMA (US) LLC,xoma_us_llc,,,,,, -5112,,07c65efc-10de-41d8-947c-0b714a7c2568,Prolor Biotech Ltd,prolor_biotech_ltd,,,,,, -5113,,2b7d30e8-bb62-4fe1-ab34-53ebed4ba50b,Krewel Meuselbach GmbH,krewel_meuselbach_gmbh,,,,,, -5114,,da45fde8-cb54-4a7a-84c3-927a3f7f7f9e,Abteilung für Anaesthesiologie und Intensivmedizin,abteilung_f_r_anaesthesiologie_und_intensivmedizin,,,,,, -320,0.97903996706008911,2cc9c0de-712a-11e6-a89e-0242ac12000b,FRESENIUS KABI USA,fresenius_kabi_usa,,,,2cc9c0de-712a-11e6-a89e-0242ac12000b,fresenius_kabi_usa,FRESENIUS KABI USA -5115,,6d61994c-8bb9-11e6-a449-0242ac12000b,"University of Nottingham, Research Innovation Services",university_of_nottingham_research_innovation_services,,,,,, -5116,,87e4e78d-b055-4acd-b499-387c82bb3adf,Merz Pharmaceuticals GmbH,merz_pharmaceuticals_gmbh,,,,,, -5117,,db8a7512-8d3a-4e52-8a0f-fe59acc3bc21,Dipartimento di Neuroscienze Oftalmologia e Genetica DINOG - Universita di Genova,dipartimento_di_neuroscienze_oftalmologia_e_genetica_dinog_universita_di_genova,,,,,, -5118,,38e62f5d-cf73-4cf4-8e14-968ac12a1ef0,Takeda Global R&D (Europe) Ltd,takeda_global_r_d_europe_ltd,,,,,, -5119,,43a2fbe6-416d-4d74-9ba4-fc088c05eef1,Zafgen Inc,zafgen_inc,,,,,, -5120,,5f6266bf-8ee1-4efe-b189-4a179ee7bac0,Sykehuset Innlandet HF,sykehuset_innlandet_hf,,,,,, -5121,,644908aa-b1e2-4f98-967a-19757ae49a2e,Pirkanmaan sairaanhoitopiiri,pirkanmaan_sairaanhoitopiiri,,,,,, -5122,,f972279a-7141-11e6-a0cd-0242ac12000b,IPCA LABS LTD,ipca_labs_ltd,,,,,, -5123,,6db876b8-e058-4069-809f-84d708d7ece4,BioCis Pharma Oy,biocis_pharma_oy,,,,,, -5124,,6fde36a8-3346-4e62-8d40-02bb649fce67,Anne-Mette Hvas,anne_mette_hvas,,,,,, -5125,,eed58fe7-1916-4824-9bbf-0d0e7578f788,"MRL, Merck and Co., Inc",mrl_merck_and_co_inc,,,,,, -975,0.93739336729049683,5a90c345-0950-4b20-a685-09b583a6ae3f,"Universitätsklinikum Schleswig-Holstein, Campus Kiel",universit_tsklinikum_schleswig_holstein_campus_kiel,,,,5a90c345-0950-4b20-a685-09b583a6ae3f,universit_tsklinikum_schleswig_holstein_campus_kiel,"Universitätsklinikum Schleswig-Holstein, Campus Kiel" -5126,,34684af8-6c37-43cb-aed6-3f78d05fbc10,ALCON ITALIA,alcon_italia,,,,,, -5127,,f2210b19-50f1-44d9-b635-a34c34c962ad,"Bayer HealthCare AG, Leverkusen, D-51368 Germany",bayer_healthcare_ag_leverkusen_d_51368_germany,,,,,, -5128,,a065c1fa-4d78-4a0f-8da9-efc7a5ace1de,"Vejle Hospital, Department of Oncology",vejle_hospital_department_of_oncology,,,,,, -5129,,1b7e1740-58d7-40d5-a0a0-8b972de597b4,"Medizinische Universität Wien, Univ.Klinik f.Frauenheilkunde,Abt. f.Geburtshilfe und Feto-maternale Medizin",medizinische_universit_t_wien_univ_klinik_f_frauenheilkunde_abt_f_geburtshilfe_und_feto_maternale_medizin,,,,,, -5130,,e97bcdd0-8f15-4ec9-ab88-f1e20376e4ea,EISAI LTD UK,eisai_ltd_uk,,,,,, -5131,,98e2d176-7142-11e6-a0cd-0242ac12000b,BELCHER PHARMS,belcher_pharms,,,,,, -5132,,89753f92-6fbe-11e6-abe8-0242ac12000b,"Gerlinde Egerer (MD); Internal Medicine, Department V",gerlinde_egerer_md_internal_medicine_department_v,,,,,, -5133,,2821497d-7cae-45ff-aa6e-8d9b2e045410,Cancer Research UK,cancer_research_uk,,,,,, -5134,,c36aab32-068d-4335-bbb0-5d4aaf050397,Instituto de Medicina Molecular,instituto_de_medicina_molecular,,,,,, -5135,,273bcb6a-d784-4a93-b196-bda193110808,Barts & the London NHS Trust,barts_the_london_nhs_trust,,,,,, -5136,,8b2c2658-6172-4f3e-944e-1f252d2c1664,Therabron Therapeutics Inc,therabron_therapeutics_inc,,,,,, -5137,,32709256-95dd-11e6-becf-0242ac110008,ZYDUS WORLDWIDE,zydus_worldwide,,,,,, -5138,,6058b6c9-7260-43af-9f14-48144246ebff,"AZ. DI RILIEVO NAZ. E DI ALTA SPECIALIZZAZIONE OSP. CIVICO E BENFRATELLI, G.DI CRISTINA E M.ASCOLI",az_di_rilievo_naz_e_di_alta_specializzazione_osp_civico_e_benfratelli_g_di_cristina_e_m_ascoli,,,,,, -5139,,616764fa-f962-4d52-a250-d4551f438587,"Almirall, SAS",almirall_sas,,,,,, -5140,,ad7f2385-a08a-4e10-bf19-ec20ef787194,CONSORCI SANITARI TERRASSA,consorci_sanitari_terrassa,,,,,, -5141,,8aeb7b28-bea3-46e6-962f-2a2366699e5f,ISTITUTI OSPITALIERI DI CREMONA,istituti_ospitalieri_di_cremona,,,,,, -414,0.952896,5f666fad-c0f0-4e6a-8a52-a4806a60a3ee,Medical University Vienna,medical_university_vienna,,,,5f666fad-c0f0-4e6a-8a52-a4806a60a3ee,medical_university_vienna,Medical University Vienna -5142,,c9a5cd61-1aa2-4afd-9bde-ee8a00a03e71,LungRx,lungrx,,,,,, -5143,,c0e64976-7158-11e6-a0cd-0242ac12000b,EXELA PHARMA SCS LLC,exela_pharma_scs_llc,,,,,, -1015,0.97426080703735352,505a3f41-b816-4c26-965c-c1b406728577,Institut de Recherches Internatinales Servier,institut_de_recherches_internatinales_servier,,,,505a3f41-b816-4c26-965c-c1b406728577,institut_de_recherches_internatinales_servier,Institut de Recherches Internatinales Servier -5144,,4e07263c-3b8a-4cac-8ea4-a0f7f6239651,POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI,policlinico_universitario_agostino_gemelli,,,,,, -5145,,c8b52c7e-73b7-11e6-a0cd-0242ac12000b,NEXTWAVE PHARMS,nextwave_pharms,,,,,, -5146,,a43cb066-4e1c-4cc3-989c-b7711ac37cf4,"Wyeth Farma, S.A",wyeth_farma_s_a,,,,,, -5147,,48cca71e-8814-11e6-a998-0242ac12000b,Immodulon Therapeutics Limited,immodulon_therapeutics_limited,,,,,, -5148,,ccd5e1b8-db85-482b-ad3f-7edb13b813a7,Vall d'Hebron Institut de Recerca (VHIR),vall_d_hebron_institut_de_recerca_vhir,,,,,, -758,0.919169,b7570d88-35b2-48c8-bf49-66ed83edbe35,"Especialidades Farmacéuticas Centrum, S.A",especialidades_farmac_uticas_centrum_s_a,,,,b7570d88-35b2-48c8-bf49-66ed83edbe35,especialidades_farmac_uticas_centrum_s_a,"Especialidades Farmacéuticas Centrum, S.A" -5149,,6d4b75f2-defb-4278-8256-aac0d7584ca2,General Hospital Linz,general_hospital_linz,,,,,, -5150,,b74ebbdd-1060-4b8f-8de7-2413832d1e8b,Stavanger University Hospital,stavanger_university_hospital,,,,,, -58,0.97219407558441162,09724a53-939b-4574-93f9-68f878e08648,"Wyeth Research Division of Wyeth Pharmaceutical Inc., Clinical Research and Development",wyeth_research_division_of_wyeth_pharmaceutical_inc_clinical_research_and_development,,,,2ed1b6f4-e137-4ee3-a218-9e5c2d04039a,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_and_development,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development -5151,,b9fd8b26-07cb-4299-99e3-75e8cc27a428,"Institute of Oncology, Vilnius University",institute_of_oncology_vilnius_university,,,,,, -5152,,cbf768a0-15ab-4517-a27e-9b6dba98d462,University Hospital South Manchester NHS Foundation Trust,university_hospital_south_manchester_nhs_foundation_trust,,,,,, -5153,,10c1ef3c-29db-4168-bb93-b1d85d716a44,Amvac Kft,amvac_kft,,,,,, -5154,,58e7ecd3-4cba-45c8-8ef3-1e4dec7d4a75,Institut Català de la Salut,institut_catal_de_la_salut,,,,,, -5155,,ed39b3f7-16ee-410c-8df1-eeed44df4011,Dr. Miguel Ferrer. Servicio de Neumología. Hospital Clínic de Barcelona,dr_miguel_ferrer_servicio_de_neumolog_a_hospital_cl_nic_de_barcelona,,,,,, -5156,,a18f7de9-649e-4c49-baf6-27d1e8c103ca,FRANCISCO BORJA BARRACHINA LARRAZA,francisco_borja_barrachina_larraza,,,,,, -5157,,04fa97b7-3ad6-4cc1-b6d9-56939cd5eb71,"The Department of Molecular Medicin and Surgery, P9:03, Karolinska Institutet",the_department_of_molecular_medicin_and_surgery_p9_03_karolinska_institutet,,,,,, -175,0.938547,35c21566-4df9-4b63-ab48-4cc2ede6089b,"Med. Univ. Wien, Universitätsklinik für Anästhesie, allgemeine Intensivmedizin und Schmerzmedizin",med_univ_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerzmedizin,,,,35c21566-4df9-4b63-ab48-4cc2ede6089b,med_univ_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerzmedizin,"Med. Univ. Wien, Universitätsklinik für Anästhesie, allgemeine Intensivmedizin und Schmerzmedizin" -5158,,790b65ae-2d4d-4737-992b-a6375e178f9f,MSD (Norge) AS,msd_norge_as,,,,,, -5159,,7371cef6-2d6d-4d66-8ffa-9aafcbb9eb96,Unidad integral de investigación en oncologia,unidad_integral_de_investigaci_n_en_oncologia,,,,,, -5160,,495c82e9-1398-4aaa-9fb5-f94f9cf29489,"Malmö University, Faculty of Odontology",malm_university_faculty_of_odontology,,,,,, -717,0.958979,7517b680-5ab5-4e0c-8c77-e2e66cd5f935,Dept. Child & Adolescent Psychiatrie,dept_child_adolescent_psychiatrie,,,,7517b680-5ab5-4e0c-8c77-e2e66cd5f935,dept_child_adolescent_psychiatrie,Dept. Child & Adolescent Psychiatrie -5161,,269eb09a-b8e3-4b55-be5f-ac0b3baf3a0d,"Abteilung für Augenheilkunde, AKH Linz",abteilung_f_r_augenheilkunde_akh_linz,,,,,, -5162,,cc68155e-a5ee-43ee-b607-8bc92cd02e67,N.V. Roche S.A,n_v_roche_s_a,,,,,, -5163,,73a5c26a-6fc1-11e6-abe8-0242ac12000b,ARYx Therapeutics,aryx_therapeutics,,,,,, -867,0.974081,d6e5614f-d962-4d82-b492-870d6ddb0fe8,"Dept. of Intensive Care, Rigshopitalet",dept_of_intensive_care_rigshopitalet,,,,321d9f48-9a0a-471b-b553-56fdf09a41f7,dept_of_intensive_care_rigshospitalet,"Dept. of Intensive Care, Rigshospitalet" -5164,,0a040010-7142-11e6-a0cd-0242ac12000b,HERITAGE PHARMS INC,heritage_pharms_inc,,,,,, -5165,,526e7166-7145-11e6-a0cd-0242ac12000b,STRIDES PHARMA,strides_pharma,,,,,, -1050,0.97903996706008911,9b0915b5-74ad-4748-ae49-c7504c4d919e,Rijnstate,rijnstate,,,,9b0915b5-74ad-4748-ae49-c7504c4d919e,rijnstate,Rijnstate -5166,,4cf68b70-73f1-11e6-a0cd-0242ac12000b,NEXAIR,nexair,,,,,, -519,0.98317185044288635,424a130c-b3bb-4fae-a841-2d4ea926eea4,CSL Behring AG,csl_behring_ag,,,,c15af267-15cc-42e5-be46-4a84bd3c6dca,csl_behring_ag,CSL Behring AG -5167,,20bff534-6fe0-4bf9-9402-dddee30b4993,Staf Longziekten,staf_longziekten,,,,,, -367,0.95244354009628296,f71bc1b5-7a61-4995-9283-fd63cc4fb485,Bayer HealthCare AG/Bayer Schering Pharma AG,bayer_healthcare_ag_bayer_schering_pharma_ag,,,,e8216e75-b447-4252-bb49-7b895bcf4108,bayer_healthcare,Bayer HealthCare -5168,,00349092-e8c2-4f45-8f78-c73a919911aa,AiCuris GmbH & Co. KG,aicuris_gmbh_co_kg,,,,,, -5169,,0d05f4a1-2e23-4563-b30f-fffd5c78673f,"MADAUS, S.A",madaus_s_a,,,,,, -5170,,ca10d771-b3d8-459e-9777-bebb7ab75d0a,European Commission,european_commission,,,,,, -5171,,57ae0316-f80a-4526-8210-a67020f4d27f,Mater University Hospital,mater_university_hospital,,,,,, -665,0.98784509301185608,ed964919-ca2c-4007-9600-7f07a3680f32,Charité-Universitätsmedizin Berlin, Department of Rheumatology and Clinical Immunology,,,,f6d48103-0f0c-4464-8cd2-7589fc1def08,charit_universit_tsmedizin,Charité-Universitätsmedizin Berlin -5172,,92daac8a-9dee-42c0-a0b0-d772fc5c70a2,"Administration management, Ludwig-Maximilians-University of Munich",administration_management_ludwig_maximilians_university_of_munich,,,,,, -954,0.984184,addf70ca-715b-11e6-a0cd-0242ac12000b,IMPAX LABS INC,impax_labs_inc,,,,69569858-7141-11e6-a0cd-0242ac12000b,impax_labs,IMPAX LABS -5173,,6d7bfca8-7168-11e6-a0cd-0242ac12000b,JUBILANT LIFE,jubilant_life,charit_universit_tsmedizin_berlin_department_of_rheumatology_and_clinical_immunology,,,,, -5174,,f07f6376-2bc0-4ebe-a6aa-9e2e3e3bd703,Southend Hospital,southend_hospital,,,,,, -5175,,4afbd107-5221-4456-9cc1-8365a7e3279a,PharmaEngine Inc,pharmaengine_inc,,,,,, -5176,,f1d4ccf4-7128-11e6-a89e-0242ac12000b,APPLIED ANAL,applied_anal,,,,,, -5177,,28d3ccdf-4ba4-4f90-9544-20e9c2affb88,CytoVac A/S,cytovac_a_s,,,,,, -5178,,4c2d0d85-008e-4824-acce-9ab87341782f,Merck Serono Middle East FZ-LLC,merck_serono_middle_east_fz_llc,,,,,, -30,0.903169,261630f5-cc3d-4976-b8b8-66f665f0285f,ACROSS (Associació Catalana de Recerca Oncològica i les seves implicacions Sanitàries i Socials),across_associaci_catalana_de_recerca_oncol_gica_i_les_seves_implicacions_sanit_ries_i_socials,,,,261630f5-cc3d-4976-b8b8-66f665f0285f,across_associaci_catalana_de_recerca_oncol_gica_i_les_seves_implicacions_sanit_ries_i_socials,ACROSS (Associació Catalana de Recerca Oncològica i les seves implicacions Sanitàries i Socials) -5179,,87c6b3bd-4f8c-497b-ba94-8c08a6eef4a4,"Universitätsklinikum Freiburg, Abteilung klinische Chemie",universit_tsklinikum_freiburg_abteilung_klinische_chemie,,,,,, -5180,,7a638c92-73c0-11e6-a0cd-0242ac12000b,MEDEFIL INC,medefil_inc,,,,,, -709,0.9746039708455404,985b42ee-700e-479f-8636-0715f067b780,Reckitt Benckiser Healthcare (UK) Ltd,reckitt_benckiser_healthcare_uk_ltd,,,,62dccd7b-325f-4731-b158-229a0c9ea429,reckitt_benckiser_healthcare_uk_ltd,Reckitt Benckiser Healthcare (UK) Ltd -5181,,3f732f7e-b7e5-4167-96fb-da5897e6b3ef,"Dept. of Anaestesiology, University hospital in Glostrup",dept_of_anaestesiology_university_hospital_in_glostrup,,,,,, -380,0.97923370864656234,7e279d84-f8fd-4294-b6c0-d03a5606ebc0,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,",merck_sharp_dohme_corp_a_subsidiary_of_merck_co,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" -358,0.968122,bbd5cc65-8109-4d78-9466-0dae250cb154,Fresenius Medical Care Deutschland GmbH,fresenius_medical_care_deutschland_gmbh,,,,0267831e-60a5-4058-a9fc-094b1cd84b8e,fresenius_medcial_care_deutschland_gmbh,Fresenius Medcial Care Deutschland GmbH -5182,,e8a72884-7150-11e6-a0cd-0242ac12000b,AVACOR PRODS,avacor_prods,,,,,, -5183,,cf39e61b-56c3-45f2-a738-9176daebf4bb,Medical University Vienna- Dept. of Pediatric Hemostaselology,medical_university_vienna_dept_of_pediatric_hemostaselology,,,,,, -5184,,d169818c-7162-11e6-a0cd-0242ac12000b,HERCON PHARM,hercon_pharm,,,,,, -5185,,2cd20bb4-2062-4366-9998-3ee9c5bd6991,Fundación de la Universidad de Salamanca,fundaci_n_de_la_universidad_de_salamanca,,,,,, -5186,,b1620ee3-57fd-495a-a760-888ef81e52a2,ESTHER URIARTE ITZAZELAIA,esther_uriarte_itzazelaia,,,,,, -118,0.982527,e394aa30-7194-11e6-a0cd-0242ac12000b,OAK PHARMS AKORN,oak_pharms_akorn,,,,1b1c70ea-715f-11e6-a0cd-0242ac12000b,oak_pharms,OAK PHARMS -5187,,c1d20174-d085-4139-bb64-eea3dd35fca2,"Svettmottagningen Hidroskliniken, Stockholm",svettmottagningen_hidroskliniken_stockholm,,,,,, -5188,,22957f8f-2469-4d2f-bf40-b69767d2bb7f,HUCH Eye Hospital,huch_eye_hospital,,,,,, -5189,,722986dc-292d-4ccb-8eef-a39ce1c2ba9d,Schering-Plough A/S,schering_plough_a_s,,,,,, -5190,,bae583b9-03be-4cf7-a136-87fc7bb76ed1,Novo Nordisk Scandinavia AB,novo_nordisk_scandinavia_ab,,,,,, -5191,,b7f241b6-714f-11e6-a0cd-0242ac12000b,BEN VENUE,ben_venue,,,,,, -5192,,8973d67f-bcb3-4265-9ad6-03051acddd25,Apogenix GmbH,apogenix_gmbh,,,,,, -5193,,bdae29e7-fcf3-4a69-9423-c90f8f7fb496,Janssen-Cilag Internation N.V,janssen_cilag_internation_n_v,,,,,, -470,0.9518304864565531,c244a64b-434f-4cec-92d1-7700f3f23d2d,European Group for Blood and Marrow trasnplantation,european_group_for_blood_and_marrow_trasnplantation,,,,2a4e4a42-e5c4-4da8-8f1f-18343eeb1fbc,european_group_for_blood_and_marrow_transplantation,European Group for Blood and Marrow Transplantation (EMBT) -5194,,0713ea0f-590d-40f2-88c1-f2543af7b66f,"MedImmune, LLC, a wholly owned subsidiary of AstraZeneca",medimmune_llc_a_wholly_owned_subsidiary_of_astrazeneca,,,,,, -5195,,82ed9cb7-a7cc-11e6-94cb-5656d04fc2b5,Moberg Pharma AB (publ),moberg_pharma_ab_publ,,,,,, -5196,,7bcdc3e2-8097-46ef-a66d-9eba0b5a9f6c,Epsom & St Helier University Hospitals NHS Trust,epsom_st_helier_university_hospitals_nhs_trust,,,,,, -5197,,1aaa952c-73f0-11e6-a0cd-0242ac12000b,"PURITY CYLINDER GASES, INC",purity_cylinder_gases_inc,,,,,, -906,0.97302970290184021,fca3e979-5b66-49a6-9ef4-f41a73231b74,Kings College London (IOP) / South London and Maudsley NHS Trust (Co-sponsorship),kings_college_london_iop_south_london_and_maudsley_nhs_trust_co_sponsorship,,,,fb29808d-7985-4804-b8d4-5620bbba60e6,kings_college_london_iop,Kings College London (IOP) -284,0.98087829351425171,bc84a43e-7141-11e6-a0cd-0242ac12000b,PADDOCK,paddock,,,,bc84a43e-7141-11e6-a0cd-0242ac12000b,paddock,PADDOCK -5198,,c0fd6845-45d8-45b5-b132-0b4065e2a1e4,Chesi Farmaceutici SpA,chesi_farmaceutici_spa,,,,,, -5199,,79f4422e-e16e-40c3-a54d-9d1b4cee47df,"SOLTI (Grupo Español de Estudio, Tratamiento y Otras Estrategias Experimentales en Tumores Sólidos)",solti_grupo_espa_ol_de_estudio_tratamiento_y_otras_estrategias_experimentales_en_tumores_s_lidos,,,,,, -1035,0.968193,35768696-3c8d-4b10-b3d3-c9d161f53a97,"Department of Infectious Diseases, Aarhus University Hospital, Skejby",department_of_infectious_diseases_aarhus_university_hospital_skejby,,,,35768696-3c8d-4b10-b3d3-c9d161f53a97,department_of_infectious_diseases_aarhus_university_hospital_skejby,"Department of Infectious Diseases, Aarhus University Hospital, Skejby" -5200,,1373a00e-49b3-4e29-a522-c8881687f976,University of Medicine Greifswald,university_of_medicine_greifswald,,,,,, -5201,,1f6d4557-25c4-4fb2-b311-6dc3a2187361,OTH - Chief Medical Officer's Office,oth_chief_medical_officer_s_office,,,,,, -5202,,e05609d1-cdb8-432f-b8f0-859bc892158b,FONDAZIONE NADIR ONLUS,fondazione_nadir_onlus,,,,,, -5203,,cf89a0a7-0f33-44f5-8fc2-cb551ba179cf,Uni-Zentrum naturheilkunde,uni_zentrum_naturheilkunde,,,,,, -963,0.98324790596961975,67a8d720-6864-4b95-9669-fdb022547a7d,Helsinki University Hospital,helsinki_university_hospital,,,,65248d8e-5a22-48b5-a66d-dc1d1f751700,helsinki_university_hospital,Helsinki University Hospital -5204,,1823cbf0-62a4-4bce-9092-5e0b1ba00f73,Leeds Teaching Hospitals NHS Trust,leeds_teaching_hospitals_nhs_trust,,,,,, -5205,,27114afe-0b6e-4539-be13-36e475d363cb,AMC-UvA,amc_uva,,,,,, -5206,,1146eaee-b1d4-42a6-ac6c-65e0f5459c5e,"Research Innovation Services, University of Nottingham",research_innovation_services_university_of_nottingham,,,,,, -5207,,688eb3ab-ca11-49fa-8d08-e6482b696122,"Medizinische Universität Innsbruck, Abteilung für Hygiene und Medizinische Mikrobiologie",medizinische_universit_t_innsbruck_abteilung_f_r_hygiene_und_medizinische_mikrobiologie,,,,,, -5208,,892be7a2-e9a3-4132-ac3c-4155291cd3b6,Medical University of Vienna (MUW),medical_university_of_vienna_muw,,,,,, -5209,,95b0a6c0-73fb-11e6-a0cd-0242ac12000b,BIOFRONTERA,biofrontera,,,,,, -5210,,da40600e-5799-481b-9ff7-55fcbd786750,Prof. Ivana Zavaroni,prof_ivana_zavaroni,,,,,, -5211,,a402eb05-97ee-4a6e-a124-885d87b7d647,Laboratoris Sanifit,laboratoris_sanifit,,,,,, -49,0.975369,e6e76398-715e-11e6-a0cd-0242ac12000b,SOLVAY,solvay,,,,d8f0d873-4306-4828-b744-12f1d67a0438,solvay_pharma,SOLVAY PHARMA -901,0.952896,465a5556-c902-495a-8a94-7999cb29da09,Fundació Privada Clínic per a la Recerca Biomèdica,fundaci_privada_cl_nic_per_a_la_recerca_biom_dica,,,,465a5556-c902-495a-8a94-7999cb29da09,fundaci_privada_cl_nic_per_a_la_recerca_biom_dica,Fundació Privada Clínic per a la Recerca Biomèdica -5212,,aa6d6bd3-ba3e-4bec-aefa-62edf2165fb9,Bioven (Europe) Ltd,bioven_europe_ltd,,,,,, -5213,,e11e35a2-a454-4e87-a49a-35f0afde1759,EAU Research Foundation,eau_research_foundation,,,,,, -5214,,c2c56495-e832-43d8-8d45-578fc116d546,Vifor Pharma Inc,vifor_pharma_inc,,,,,, -5215,,c146b3e1-783c-4ae5-b8ef-4880bf82dd4d,Maastricht Universitair Medisch Centrum,maastricht_universitair_medisch_centrum,,,,,, -5216,,414c4cf0-7163-11e6-a0cd-0242ac12000b,THEPHARMANETWORK LLC,thepharmanetwork_llc,,,,,, -5217,,70ed6158-712a-11e6-a89e-0242ac12000b,EPIC PHARMA INC,epic_pharma_inc,,,,,, -5218,,eefa7dda-7141-11e6-a0cd-0242ac12000b,WOCKHARDT USA,wockhardt_usa,,,,,, -5219,,5b0c7589-c866-43bf-b65d-cc60d7e81df1,ST. ANNA KINDERSPITAL,st_anna_kinderspital,,,,,, -5220,,fae53d90-d0cb-43ad-bbc4-e4e0d363ce79,InDex Pharmaceuticals AB,index_pharmaceuticals_ab,,,,,, -5221,,71dc034a-f52a-48a5-a873-f6ef26d95500,Allergopharma GmbH & Co. KG,allergopharma_gmbh_co_kg,,,,,, -5222,,54c4f172-535c-4881-858e-ef6a4dd4750e,Fertilitetsklinikken Herlev Hospital,fertilitetsklinikken_herlev_hospital,,,,,, -5223,,d2a15f43-d22f-42d3-9392-fefbf6652765,R-Pharm,r_pharm,,,,,, -5224,,ab28e423-5d45-47db-bf67-5b0feb368138,Alexion Pharma GmbH,alexion_pharma_gmbh,,,,,, -5225,,597df9f7-3e97-4d31-8816-aee19d167f67,MEDESTEA RESEARCH & PRODUCTION,medestea_research_production,,,,,, -5226,,c328e1b8-4371-4893-b450-c6a10a14c01f,Prof. Dr. Kristian Reich,prof_dr_kristian_reich,,,,,, -106,0.972495,39443038-185d-4279-b9d1-588d493613db,"Amar Agha, Beaumont Hospital",amar_agha_beaumont_hospital,,,,39443038-185d-4279-b9d1-588d493613db,amar_agha_beaumont_hospital,"Amar Agha, Beaumont Hospital" -5227,,10c46c54-6dc8-46d3-b8d7-6edbfc8b688b,Cangene Europe Limited,cangene_europe_limited,,,,,, -5228,,0d658636-f2a1-450f-b067-657afa1ceb09,Associazione Malattie Sangue Onlus,associazione_malattie_sangue_onlus,,,,,, -5229,,fa646900-48fc-4458-aa6c-09e66ab58e4c,Xencor Inc,xencor_inc,,,,,, -5230,,eaaafae4-295f-40d3-8ea6-783b444d8dd1,"Ortopædkirurgisk forskningsenhed, Aalborg universitetshospital",ortop_dkirurgisk_forskningsenhed_aalborg_universitetshospital,,,,,, -5231,,099d963a-b59b-489e-bc18-022e1eaa16d7,Universität Marburg,universit_t_marburg,,,,,, -5232,,f848264c-de8c-42a6-bef8-0becc63ab9d5,Ulster Community & Hospitals Trust,ulster_community_hospitals_trust,,,,,, -5233,,abd21c48-c434-4fc8-9645-ca99764998d2,University Hospital of Birmingham Foundation Trust,university_hospital_of_birmingham_foundation_trust,,,,,, -5234,,bbe61798-6fa1-11e6-9663-0242ac12000b,Pfizer Corporation Austria GmbH,pfizer_corporation_austria_gmbh,,,,,, -5235,,d7091b0f-0c6a-4a8d-bc5f-13c5b00986ac,"Departement of Anesthesiology, Næstved Hospital",departement_of_anesthesiology_n_stved_hospital,,,,,, -5236,,f0dbbe82-02e2-4048-9659-c400e650e83c,"KAI Pharmaceuticals, Inc",kai_pharmaceuticals_inc,,,,,, -5237,,71ce2fac-48fd-4254-882d-e1c6bd6f604f,Univ. Prof. Dr. Manuela Schmidinger,univ_prof_dr_manuela_schmidinger,,,,,, -741,0.9828302264213562,5b96ae2b-b1a8-4688-88cd-0fcea433e529,AstraZeneca R&D,astrazeneca_r_d,,,,5b96ae2b-b1a8-4688-88cd-0fcea433e529,astrazeneca_r_d,AstraZeneca R&D -5238,,39393420-5600-4146-b000-84e8a58c9b0b,Medizinische Fakultät der technischen Universität Muenchen,medizinische_fakult_t_der_technischen_universit_t_muenchen,,,,,, -828,0.96305406093597412,343d2886-981b-46cc-bdb2-741a4f343dda,INSTITUTO DE INVESTIGACION SANITARIA FJD,instituto_de_investigacion_sanitaria_fjd,,,,343d2886-981b-46cc-bdb2-741a4f343dda,instituto_de_investigacion_sanitaria_fjd,INSTITUTO DE INVESTIGACION SANITARIA FJD -44,0.98179709911346436,035a6b1e-8bb9-11e6-a449-0242ac12000b,"Medicinsk Forskningsafsnit, Holstebro",medicinsk_forskningsafsnit_holstebro,,,,035a6b1e-8bb9-11e6-a449-0242ac12000b,medicinsk_forskningsafsnit_holstebro,"Medicinsk Forskningsafsnit, Holstebro" -5239,,dfb00ef1-3b87-4398-a3d7-f7a62bd20e6c,Centre Hospitalier Intercommunal de Créteil,centre_hospitalier_intercommunal_de_cr_teil,,,,,, -5240,,78176a18-b53b-4cf7-94a6-2fe4f1286f63,ABCSG (Austrian Breast & Colorectal Cancer Study Group),abcsg_austrian_breast_colorectal_cancer_study_group,,,,,, -5241,,f5bf4c53-10db-4553-9b5a-28780ab61562,CHU Mont-Godinne,chu_mont_godinne,,,,,, -5242,,dd764c9f-2d36-4c45-99e3-49ac1e619ba2,"Department of Respiratory Diseases, Aarhus University Hospital",department_of_respiratory_diseases_aarhus_university_hospital,,,,,, -5243,,f2bc532e-f4bc-427f-aff9-d4326a62e159,Biotest AG,biotest_ag,,,,,, -5244,,66ab75bc-56db-40b6-937d-2d2ba18f52a6,PREGLEM SA,preglem_sa,,,,,, -5245,,74cb2975-8fa6-4ec5-8bc8-7cd2a73e09e6,Laboratorios Galderma S.A,laboratorios_galderma_s_a,,,,,, -5246,,2ebc30fa-7145-11e6-a0cd-0242ac12000b,AMNEAL PHARMS CO,amneal_pharms_co,,,,,, -5247,,902aa51c-b1b7-4f35-a308-ddacb7267702,Hospital of the University of Munich,hospital_of_the_university_of_munich,,,,,, -5248,,6a5b7452-7142-11e6-a0cd-0242ac12000b,WESTWOOD SQUIBB,westwood_squibb,,,,,, -478,0.97189050912857056,a6ef0ba5-d49e-411b-92ac-7bad93bbb394,"Medizinische Universität Graz, Kl. Abteilung für Endokrinologie und Stoffwechsel",medizinische_universit_t_graz_kl_abteilung_f_r_endokrinologie_und_stoffwechsel,,,,a6ef0ba5-d49e-411b-92ac-7bad93bbb394,medizinische_universit_t_graz_kl_abteilung_f_r_endokrinologie_und_stoffwechsel,"Medizinische Universität Graz, Kl. Abteilung für Endokrinologie und Stoffwechsel" -5249,,b4196001-285e-4733-afad-002973776db7,S&K Pharma Schumann und Kohl GmbH,s_k_pharma_schumann_und_kohl_gmbh,,,,,, -5250,,b2c666a0-3deb-42b7-bd10-d3ed09598b24,ONCOLYTICS,oncolytics,,,,,, -5251,,452f58c6-63c6-4d4d-8171-4075221dd1bc,FEDERATION FRANCOPHONE DE CANCEROLOGIE DIGESTIVE,federation_francophone_de_cancerologie_digestive,,,,,, -5252,,67c047ed-e861-419d-8f0d-fed1a380275a,Department of Pediatrics Holbaek Hospital,department_of_pediatrics_holbaek_hospital,,,,,, -5253,,a3002563-2ca3-44e6-8182-8900412328b9,VALEAS,valeas,,,,,, -195,0.98517,f3dd08fd-7bfc-4330-9b94-4de4558d953e,"Becton, Dickinson and Company, BD Technologies",becton_dickinson_and_company_bd_technologies,,,,4a830ce9-4d8d-4914-94f3-d34026b2d02d,becton_dickinson_and_company,"Becton, Dickinson and Company" -5254,,21ed34fc-b9ac-4d1f-a0cf-b7956b84909e,Clinic for Nephrology,clinic_for_nephrology,,,,,, -5255,,2d08c230-493b-47d8-8eae-ee0600e7adb0,Laboratorios ViiV Healthcare SL,laboratorios_viiv_healthcare_sl,,,,,, -5256,,c26e48d5-2f23-4237-bdc2-0147f171c045,"Discovery Laboratoryies, INC",discovery_laboratoryies_inc,,,,,, -5257,,bd767d0d-db11-4083-bc80-43e7603f22c7,FONDAZIONE PROGETTO EMATOLOGIA,fondazione_progetto_ematologia,,,,,, -5258,,74e9f10c-a766-11e6-94cb-5656d04fc2b5,Orthopaedic Syrgery Unit Northern Jytland,orthopaedic_syrgery_unit_northern_jytland,,,,,, -5259,,147d6884-485a-4462-a87a-b6e02a10d90e,Clínica IVI Barcelona,cl_nica_ivi_barcelona,,,,,, -5260,,b82bda9c-c3da-47af-947b-a25037876023,Neuro3d,neuro3d,,,,,, -5261,,385546cc-20b2-43a0-8a4f-c66ae02a96bc,Febena Pharma GmbH,febena_pharma_gmbh,,,,,, -5262,,57a22e70-ac28-41f0-92a5-2ff733fb9f4b,"Amylin Pharmaceuticals, Inc",amylin_pharmaceuticals_inc,,,,,, -5263,,8ef57930-b393-4084-9396-1b14297249e1,Klinikum rechts der Isar der Technischen Universitaet Muenchen,klinikum_rechts_der_isar_der_technischen_universitaet_muenchen,,,,,, -5264,,065b6fb3-2a69-4144-b0c9-265ac6d2db51,"HUCH, ATEK, TÖÖLÖN SAIRAALA, NEUROKIRURGIAN KLINIKKA",huch_atek_t_l_n_sairaala_neurokirurgian_klinikka,,,,,, -5265,,d366c313-c9fd-4f10-a095-407a18decd60,Summit (Cambridge) Ltd,summit_cambridge_ltd,,,,,, -5266,,6afa752a-0124-4dba-a32d-a189bc7a74ff,Danube Pharmaceuticals,danube_pharmaceuticals,,,,,, -5267,,12bc87df-3c73-4833-b3fb-b7d197c0807a,ACOSOG,acosog,,,,,, -5268,,b4001976-49c7-4694-b084-510d1a346f42,ISA Therapeutics B.V,isa_therapeutics_b_v,,,,,, -5269,,30a2008a-7194-11e6-a0cd-0242ac12000b,KING PHARMS R AND D,king_pharms_r_and_d,,,,,, -5270,,5c2f85da-9dfb-4349-8435-664173f53ffa,University of Washington,university_of_washington,,,,,, -5271,,0d861272-8a65-461b-b73c-62527dfc5324,Brystkirurgisk afd. F Amtsygehuset i Herlev 18 sal,brystkirurgisk_afd_f_amtsygehuset_i_herlev_18_sal,,,,,, -5272,,5bf4bcf8-71aa-11e6-a0cd-0242ac12000b,MT ADAMS,mt_adams,,,,,, -5273,,7faa2d06-ebcc-4e6b-8578-f7df840b27cc,Fundación para la Investigación Biomédica del Hospital Clínico de San Carlos,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_cl_nico_de_san_carlos,,,,,, -5274,,18cf29c1-ea2c-462a-911b-98a16d3e3860,"Watson Laboratories, Inc",watson_laboratories_inc,,,,,, -5275,,af57bfce-9c17-43e9-8e20-71bba4cc121d,"Cardiokine Biopharma, LLC",cardiokine_biopharma_llc,,,,,, -5276,,aedb143a-6fa0-487e-a7c9-f7eaceb4fbaf,Universitätsklinik für Radiodiagnostik,universit_tsklinik_f_r_radiodiagnostik,,,,,, -5277,,3dacb84c-0954-4870-8bc2-a4776f957b32,Stealth BioTherapeutics Inc,stealth_biotherapeutics_inc,,,,,, -5278,,edece8d2-a437-4a27-8568-f0a0ef5c8431,"Lipidklinikken, Aalborg Sygehus",lipidklinikken_aalborg_sygehus,,,,,, -5279,,9490df96-f954-4727-9719-e3b3341585ef,"Ludwig Boltzmann Cluster für Rheumatologie, Balneologie und Rehabilitation",ludwig_boltzmann_cluster_f_r_rheumatologie_balneologie_und_rehabilitation,,,,,, -844,0.989439,1b189425-2b98-4982-b3b0-a63cc85c263e,"Queen Mary and Westfield College, University of London (QMUL)",queen_mary_and_westfield_college_university_of_london_qmul,,,,1b189425-2b98-4982-b3b0-a63cc85c263e,queen_mary_and_westfield_college_university_of_london_qmul,"Queen Mary and Westfield College, University of London (QMUL)" -5280,,d717b7d2-7141-11e6-a0cd-0242ac12000b,LYNE,lyne,,,,,, -480,0.98699730634689331,f1926de7-bf3f-4138-90ce-fdceca00d91c,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin,,,,f1926de7-bf3f-4138-90ce-fdceca00d91c,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin" -5281,,fbeb32cc-73ae-11e6-a0cd-0242ac12000b,CUBIST PHARMS LLC,cubist_pharms_llc,,,,,, -5282,,97189f36-d82e-4a73-97bf-a323d98a4885,"Orion Corporation, ORION PHARMA, Finland",orion_corporation_orion_pharma_finland,,,,,, -5283,,0c81498c-5364-4b90-8d48-9789c45cb09c,Forschungszentrum Jülich GmbH,forschungszentrum_j_lich_gmbh,,,,,, -5284,,44518cf0-6905-494b-8fcc-63f38042de09,Spanish Lung Cancer Group,spanish_lung_cancer_group,,,,,, -5285,,6e0cc37f-d04a-40b1-b731-9a7a495b1218,NHS Grampian Research and Development,nhs_grampian_research_and_development,,,,,, -5286,,b13670ea-afe4-49ea-8695-3d12dcf77b19,RSPR Pharma AB,rspr_pharma_ab,,,,,, -5287,,5b56f016-d15d-4946-b36d-835733bf6e8f,"Amylin Pharmaceuticals, LLC",amylin_pharmaceuticals_llc,,,,,, -5288,,60dc7035-20e5-4e1e-ba9b-16163a6c11d7,KUROS BIOSURGERY AG,kuros_biosurgery_ag,,,,,, -5289,,74996a96-d6b9-44fa-a07a-05a00f346257,"University Clinic Erlangen, Medical Clinic II",university_clinic_erlangen_medical_clinic_ii,,,,,, -5290,,155ce5e7-7d87-4a74-a86f-3393a056739d,Hospital Universitario Gregorio Marañón,hospital_universitario_gregorio_mara_n,,,,,, -5291,,db5c2693-9c08-4963-86c0-2cf60464881a,Roche Diagnostics GmbH,roche_diagnostics_gmbh,,,,,, -5292,,e2bc42da-3306-4c3d-bf75-22f41b9ebf75,Medizinische Fakultät der Otto-von-Guericke Universität Magdeburg Universitätsklinikum Magdeburg A.ö.R,medizinische_fakult_t_der_otto_von_guericke_universit_t_magdeburg_universit_tsklinikum_magdeburg_a_r,,,,,, -5293,,d894daf0-7145-11e6-a0cd-0242ac12000b,FUTURE PAK,future_pak,,,,,, -5294,,43d0926c-0ec4-4546-bb0f-1971bd59294b,Melchor Riera Jaume,melchor_riera_jaume,,,,,, -5295,,f8b09176-83af-4f9c-9463-4d4293e70da8,FUNDACIÓ PUIGVERT,fundaci_puigvert,,,,,, -5296,,abe7293a-715f-11e6-a0cd-0242ac12000b,IVC INDS,ivc_inds,,,,,, -5297,,bb99f3aa-af7f-4062-a204-dcd5d65b8fe9,Asklepios Krankenhaus Weißenfels,asklepios_krankenhaus_wei_enfels,,,,,, -5298,,dbb60575-5d57-4d56-b648-947afe372ec4,"Blood bank, Rigshospitalet, University Hospital of Copenhagen",blood_bank_rigshospitalet_university_hospital_of_copenhagen,,,,,, -5299,,a4ff19ce-d9af-424e-8598-abfc411d3ba9,"Celldex Therapeutics, Inc",celldex_therapeutics_inc,,,,,, -5300,,4fca335c-7218-488c-9bcc-4196a5b0a5d9,"MUW, Division of nephrology",muw_division_of_nephrology,,,,,, -5301,,85f7573c-7168-11e6-a0cd-0242ac12000b,PRINSTON PHARMA INC,prinston_pharma_inc,,,,,, -5302,,38ba56a2-450d-40dd-aec3-65ffb6c1b676,"sanofi-aventis, s.r.o",sanofi_aventis_s_r_o,,,,,, -5303,,e9a077dd-10b2-40f9-b371-2121f2cb6494,Dra Maria José Colomina Soler,dra_maria_jos_colomina_soler,,,,,, -968,0.97420650720596313,555482da-4b7d-45b2-97ab-84909436613d,Maatschap cardiologie Isala klinieken Zwolle,maatschap_cardiologie_isala_klinieken_zwolle,,,,e5d4a9c1-e0e4-4ac7-8c88-785f0f8e3beb,maatschap_cardiologie_isala_klinieken,Maatschap Cardiologie Isala klinieken -247,0.94493213295936584,faba70cf-b03c-4f06-8988-51f699154f02,Hoffmann-La Roche Ltd/Inc/AG/Roche Global Development,hoffmann_la_roche_ltd_inc_ag_roche_global_development,,,,5796905e-d697-4a3c-a2d1-98d6d9104b0c,hoffmann_la_roche,Hoffmann-La Roche -5304,,b3509b5e-6fa5-4e17-8b27-39ebd2a1a174,"DIPART. DI NEUROSCIENZE, SCIENZE RIPRODUTTIVE E ODONTOSTOMATOLOGICHE DELL’UNIVERSITà DEGLI STUDI DI NAPOLI “FEDERICO II",dipart_di_neuroscienze_scienze_riproduttive_e_odontostomatologiche_dell_universit_degli_studi_di_napoli_federico_ii,,,,,, -5305,,50e32767-29d2-44c2-9145-cd0af4137b86,"Children´s Hospital, University of Helsinki",children_s_hospital_university_of_helsinki,,,,,, -169,0.94997268915176392,3e1da10e-fb5d-4c01-94a2-f31c443bb1c2,"Merck Serono Int, a branch ofLaboratories Serono S.A. an affiliate of Merck KGaA, Darmstadt, Germany",merck_serono_int_a_branch_oflaboratories_serono_s_a_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,3e1da10e-fb5d-4c01-94a2-f31c443bb1c2,merck_serono_int_a_branch_oflaboratories_serono_s_a_an_affiliate_of_merck_kgaa_darmstadt_germany,"Merck Serono Int, a branch ofLaboratories Serono S.A. an affiliate of Merck KGaA, Darmstadt, Germany" -5306,,6c4766a7-e84b-41a0-aff6-864a1796124d,ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE,istituto_mediterraneo_per_i_trapianti_e_terapie_ad_alta_specializzazione,,,,,, -5307,,40effd58-c047-403b-8bcc-9e4ce5c9ff4a,"Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich",department_of_psychiatry_and_psychotherapy_ludwig_maximilians_university_munich,,,,,, -5308,,dc1b0941-86d2-4c47-97c5-fd9a1fe7a42f,SOCIETA PRODOTTI ANTIBIOTICI,societa_prodotti_antibiotici,,,,,, -5309,,aec36f1b-4d05-485b-8dba-96f010ce60b6,"H. Lundbeck A/S, Lundbeck Austria GmbH",h_lundbeck_a_s_lundbeck_austria_gmbh,,,,,, -5310,,ef765090-a1e7-45ed-ba91-4b2d97fa3899,Asahi Kasei Pharma Corporation,asahi_kasei_pharma_corporation,,,,,, -5311,,7883977d-eaba-4524-ae1d-6ec1fa72019e,Bio-Medisinsk Innovasjon AS,bio_medisinsk_innovasjon_as,,,,,, -5312,,03d5304e-7168-11e6-a0cd-0242ac12000b,PHARMACEUTICS INTL,pharmaceutics_intl,,,,,, -5313,,54c9b5d0-8557-44f1-b912-b076b2724414,Newcastle Primary Care Trust,newcastle_primary_care_trust,,,,,, -5314,,2319638f-cf7d-4ef9-9444-2effccd8847f,Lukaskrankenhaus GmbH,lukaskrankenhaus_gmbh,,,,,, -5315,,96d2d3cf-22e1-4807-8f21-b6cc95ea4dda,Thoraxklinik-Heidelberg gGmbH,thoraxklinik_heidelberg_ggmbh,,,,,, -5316,,d58dc913-c547-4180-96af-3595e859202f,Kliniken Kärnan Urology Centre,kliniken_k_rnan_urology_centre,,,,,, -455,0.958341,792dba77-9941-4659-aa31-5f86a7b2ad5b,Solvay Pharmaceuticals B.V,solvay_pharmaceuticals_b_v,,,,792dba77-9941-4659-aa31-5f86a7b2ad5b,solvay_pharmaceuticals_b_v,Solvay Pharmaceuticals B.V -5317,,767506cd-7e81-49a6-b01c-925f6cd97df1,Zentiva k.s. Prague,zentiva_k_s_prague,,,,,, -5318,,64c063bc-7166-11e6-a0cd-0242ac12000b,ROUSES POINT PHARMS,rouses_point_pharms,,,,,, -5319,,a75fb102-9435-4019-8a9c-1f80eaed3c9c,University Hospital Magdeburg,university_hospital_magdeburg,,,,,, -316,0.987803,17eacfff-6322-4900-ab4b-4476d90f6cb8,Jazz Pharmaceuticals Inc,jazz_pharmaceuticals_inc,,,,17eacfff-6322-4900-ab4b-4476d90f6cb8,jazz_pharmaceuticals_inc,Jazz Pharmaceuticals Inc -5320,,69391ab4-b219-4670-947c-75b1ce8dce8a,"Prof. Dr. med. Milos Opravil, Universitätsspital Zürich",prof_dr_med_milos_opravil_universit_tsspital_z_rich,,,,,, -5321,,9f7bd914-c2e0-49b4-8dd0-ea2538d8ac8c,Lux Biosciences GmbH,lux_biosciences_gmbh,,,,,, -5322,,28db6aff-7035-4045-86c5-3ff0c9751b80,"Helse Fonna, Haugesund Sykehus",helse_fonna_haugesund_sykehus,,,,,, -5323,,61679ef8-daa6-4ac1-9a3a-908f2d94be92,ARQULE,arqule,,,,,, -5324,,a493c202-eba5-438d-8ecf-2c4f294a1590,Oxford Radcliffe Hospitals Trust,oxford_radcliffe_hospitals_trust,,,,,, -5325,,7c548c51-ce55-4a45-ab8b-f819bafe184e,"Department of Oncology, Linköping University Hospital, Linköping, Sweden",department_of_oncology_link_ping_university_hospital_link_ping_sweden,,,,,, -5326,,63550b8b-6404-4534-b036-e86cf64fe152,Novagali Pharma S.A,novagali_pharma_s_a,,,,,, -5327,,2fd51c51-77e1-4392-815f-64f6f2d36772,Riemser Pharma GmbH,riemser_pharma_gmbh,,,,,, -5328,,8f699beb-dc88-473a-929e-ef9c75fc977b,Elena Santagostino,elena_santagostino,,,,,, -5329,,33afcc1a-7146-11e6-a0cd-0242ac12000b,GUARDIAN DRUG,guardian_drug,,,,,, -5330,,56362b64-7199-11e6-a0cd-0242ac12000b,MALLARD,mallard,,,,,, -563,0.973989,d2e15a44-a454-409f-91c0-cf787effc96f,PETHEMA Foundation,pethema_foundation,,,,d2e15a44-a454-409f-91c0-cf787effc96f,pethema_foundation,PETHEMA Foundation -5331,,93d90cb3-2794-4906-b295-3107b6e5ec29,St. Antonius Hospital,st_antonius_hospital,,,,,, -5332,,5e05714e-a55a-424e-9698-5d9368fcbde0,Axelar AB,axelar_ab,,,,,, -5333,,fa8db4e1-28a1-440d-8b0f-62c8e3f08c18,AZIENDA SANITARIA OSPEDALIERA O.I.R.M. - S. ANNA,azienda_sanitaria_ospedaliera_o_i_r_m_s_anna,,,,,, -5334,,a0b7492a-9dc4-4e5a-9365-2a22b68751e5,SuppreMol GmbH,suppremol_gmbh,,,,,, -103,0.968844,3da026c0-6fa2-11e6-9663-0242ac12000b,"Janssen Research & Development, LLC",janssen_research_development_llc,,,,3da026c0-6fa2-11e6-9663-0242ac12000b,janssen_research_development_llc,"Janssen Research & Development, LLC" -5335,,e9ac3152-714b-11e6-a0cd-0242ac12000b,CONCORDIA PHARMS INC,concordia_pharms_inc,,,,,, -5336,,be6d7bce-7144-11e6-a0cd-0242ac12000b,YUNG SHIN PHARM,yung_shin_pharm,,,,,, -882,0.957248,d146bf92-529f-465c-b45b-532b0f6bece7,Hyks Silmätautien klinikka,hyks_silm_tautien_klinikka,,,,acee4b3e-08b2-4604-95a5-b5c1e12e7628,hyks,Hyks -854,0.92247,f3c8fb50-1426-41cc-b57e-428fc65a1ffb,"Faculty of Medicine, Otto-von-Guericke-University, Magdeburg",faculty_of_medicine_otto_von_guericke_university_magdeburg,,,,14aef904-0883-4517-a200-b52214e41d54,faculty_for_medicine_otto_von_guericke_university_magdeburg,"Faculty For Medicine, Otto-von-Guericke University Magdeburg" -5337,,c21737cc-f91c-4d4b-a5cf-f3cbca7e1b81,ChronTech Pharma AB,chrontech_pharma_ab,,,,,, -5338,,474611dd-b10e-4a07-998b-1e30c10c4c0e,Hôpitaux Universitaires de strasbourg,h_pitaux_universitaires_de_strasbourg,,,,,, -5339,,3db33d44-7238-11e6-a0cd-0242ac12000b,PFIZER IRELAND,pfizer_ireland,,,,,, -5340,,0166c2dd-8c7e-4161-945d-2079e3c6e204,Centre de Recherche et Développement Pierre Fabre,centre_de_recherche_et_d_veloppement_pierre_fabre,,,,,, -5341,,b6f85df9-02bd-47d5-9abc-71a6b1bfe2d7,Hospital de Cruces,hospital_de_cruces,,,,,, -5342,,b00f5bfb-f36a-4daa-8c65-88a0b5b26b4e,4D Pharma,4d_pharma,,,,,, -5343,,dde7ad12-76bd-4639-be02-4d8984d4cffa,Hammersmith Medicines Research,hammersmith_medicines_research,,,,,, -5344,,06f51c5d-9466-40de-bbb7-c2ba8d5a80b2,"Enzon Pharmaceuticals, Inc",enzon_pharmaceuticals_inc,,,,,, -694,0.95973223447799683,a1b6c5f2-16df-4bac-b6d9-a19ab340e9dd,Krankenhaus Nordwest gGmbH - Institut für Klinisch-Onkologische Forschung,krankenhaus_nordwest_ggmbh_institut_f_r_klinisch_onkologische_forschung,,,,a1b6c5f2-16df-4bac-b6d9-a19ab340e9dd,krankenhaus_nordwest,Krankenhaus Nordwest -5345,,3a1bc562-a534-4e7d-9eb5-7e43f6d966a0,"Celica, Biomedical Center, d.o.o",celica_biomedical_center_d_o_o,,,,,, -5346,,4ea68866-7168-11e6-a0cd-0242ac12000b,Wockhardt Bio AG,wockhardt_bio_ag,,,,,, -781,0.96116987864176429,506098e8-930b-438b-b506-5e599d8535e8,GlaxoSmithKline Research and Development Ltd,glaxosmithkline_research_and_development_ltd,,,,201d9d4f-5cd0-46df-836e-da17fa2b43dd,glaxosmithkline_research_and_development,GlaxoSmithKline Research and Development -5347,,5aac3b6c-8809-11e6-a998-0242ac12000b,Janssen-Cilag B.V,janssen_cilag_b_v,,,,,, -5348,,e2dd5ba7-61da-46e1-8f2f-25d654efe5c6,Companion Diagnostics BV,companion_diagnostics_bv,,,,,, -5349,,48742ac4-735c-417c-8d53-68d74c7d4886,"AS ""GRINDEKS",as_grindeks,,,,,, -392,0.98723113536834717,089e5628-bb66-4808-818a-a79770a11d54,Klinikum der Universität München-Großhadern,klinikum_der_universit_t_m_nchen_gro_hadern,,,,089e5628-bb66-4808-818a-a79770a11d54,klinikum_der_universit_t_m_nchen_gro_hadern,Klinikum der Universität München-Großhadern -5350,,8f38d5de-ebc2-4a1f-a361-cac8eec174f4,Dr. José Ramón Mel Lorenzo,dr_jos_ram_n_mel_lorenzo,,,,,, -5351,,6eb15f35-e85b-40ba-889b-fe70e8b2e43d,"Chorus, a Division of Eli Lilly and Company",chorus_a_division_of_eli_lilly_and_company,,,,,, -5352,,5df342c6-42ac-424c-8a5d-52acc6941d3f,María José Linares Gil,mar_a_jos_linares_gil,,,,,, -5353,,145de322-71bb-11e6-a0cd-0242ac12000b,RECRO GAINESVILLE,recro_gainesville,,,,,, -1021,0.97385847568511963,2e27f2ec-dcc5-4828-b31a-e2eca3930c17,"Impax Laboratories, Inc. acting through its Impax Pharmaceutical Division (Impax)",impax_laboratories_inc_acting_through_its_impax_pharmaceutical_division_impax,,,,2e27f2ec-dcc5-4828-b31a-e2eca3930c17,impax_laboratories_inc_acting_through_its_impax_pharmaceuticals_division_impax,"Impax Laboratories, Inc., acting through its Impax Pharmaceuticals Division (Impax)" -5354,,bc877c34-d932-4b66-8d0b-1f9e46c1e48f,University of Cologne,university_of_cologne,,,,,, -5355,,66c2445a-b173-488e-9f47-6402de853c13,Fondazione per il Tuo cuore onlus-ANMCO,fondazione_per_il_tuo_cuore_onlus_anmco,,,,,, -5356,,a7b5f9b6-dea1-46ba-bb15-c3ff18201e45,Belgian Group of Digestive Oncology,belgian_group_of_digestive_oncology,,,,,, -5357,,11ed3f85-8cc5-4f39-a598-51f56f7e4e36,Merck Shap @ Dohme,merck_shap_dohme,,,,,, -5358,,3db6e35a-b1b9-42c2-af88-7044cba69829,Juan Francisco Navarro González,juan_francisco_navarro_gonz_lez,,,,,, -5359,,565a8ab6-6309-4358-a7e0-eac3cbeb2623,"Human Genome Sciences, a wholly owned subsidiary of GlaxoSmithKline, Plc",human_genome_sciences_a_wholly_owned_subsidiary_of_glaxosmithkline_plc,,,,,, -518,0.973471,c681a058-67c4-4596-ab67-6bb33a32ec89,"Department of infectious Diseases, Odense University Hospital",department_of_infectious_diseases_odense_university_hospital,,,,ae49cd9c-0341-4f5e-a25b-775aca5642ab,department_of_infetious_diseases_odense_university_hospital,"Department of Infetious Diseases, Odense University Hospital" -5360,,a5680aae-34ab-4419-afc8-b12816498364,The Department of Calcium- and Bone-metabolic Diseases,the_department_of_calcium_and_bone_metabolic_diseases,,,,,, -5361,,5b18d038-67b6-4811-8f0e-16ce6a47abda,The University Hospitals of Leicester NHS Trust,the_university_hospitals_of_leicester_nhs_trust,,,,,, -5362,,83f94f48-87d3-400f-b382-0a3d306cda25,CRLCC Alexis Vautrin,crlcc_alexis_vautrin,,,,,, -513,0.977852,4cab1fe6-1355-4704-bbea-7a3c03e27398,Intergroupe Francophone du Myélome,intergroupe_francophone_du_my_lome,,,,04cef99e-6fba-11e6-abe8-0242ac12000b,intergroupe_francophone_du_myelome_ifm,Intergroupe Francophone du Myelome (IFM) -5363,,cc886340-a9e0-4093-a443-841ae11d7bff,REATA PHARMACEUTICALS INC,reata_pharmaceuticals_inc,,,,,, -5364,,bc085607-4592-47d9-b52c-89049eeb7c33,MedUni Innsbruck Klinik für Strahlentherapie,meduni_innsbruck_klinik_f_r_strahlentherapie,,,,,, -5365,,c4b80966-7141-11e6-a0cd-0242ac12000b,CEDAR PHARMS,cedar_pharms,,,,,, -5366,,56bbfcf3-612e-4455-9074-ae7a21eee65f,RedHill Biopharma Ltd,redhill_biopharma_ltd,,,,,, -5367,,b0ebcb00-6179-4862-936c-51f808246028,ZAMBON GROUP,zambon_group,,,,,, -5368,,1a9e6c33-c395-4a9f-b759-c708b1a84b76,TIPharma,tipharma,,,,,, -5369,,a9832062-715b-11e6-a0cd-0242ac12000b,MIRROR PHARMS,mirror_pharms,,,,,, -5370,,0e953077-e06a-4b1f-85a5-4fd66e546dcb,Solveig Wållberg-Jonsson,solveig_w_llberg_jonsson,,,,,, -921,0.98046,ffe14227-33a6-406e-a9aa-f8ce7dfd8125,"National Institutes of Health, National Eye Institute",national_institutes_of_health_national_eye_institute,,,,e90b434e-23d4-448b-9e92-391d596fe17c,national_institute_of_health_national_eye_institute,"National Institute of Health, National Eye Institute" -5371,,deca2126-685f-4c4c-a555-a9388aba9e7a,"Department of Immunology, Genetics and Pathology (IGP), Rudbeck Laboratory, Uppsala University",department_of_immunology_genetics_and_pathology_igp_rudbeck_laboratory_uppsala_university,,,,,, -5372,,9dc7431c-d0aa-4d05-bee1-8101956d28e6,Centre Hospitalier de Lens,centre_hospitalier_de_lens,,,,,, -5373,,f168c5cf-8be1-4b32-82c7-734f4652fa58,Dekan des Fachbereichs Humanmedizin,dekan_des_fachbereichs_humanmedizin,,,,,, -5374,,dc982b00-7165-11e6-a0cd-0242ac12000b,RARITAN PHARMS INC,raritan_pharms_inc,,,,,, -5375,,beec5897-d1b6-4b56-8d18-5f56e9f65f71,Proveca Ltd,proveca_ltd,,,,,, -5376,,8731efd0-b20a-45e5-b6c5-5aaf38abde80,"F. Hoffman-La Roche Ltd., realizado en España por Roche Farma S.A",f_hoffman_la_roche_ltd_realizado_en_espa_a_por_roche_farma_s_a,,,,,, -5377,,92fed13d-1869-42c6-8a53-a1b8bc5aa0ea,"Integrated Therapeutics Group, Incorporated - a subsidiary of Schering-Plough",integrated_therapeutics_group_incorporated_a_subsidiary_of_schering_plough,,,,,, -5378,,07beeb5d-9dd8-4d57-9ac0-76620f7ab5ce,Laboratorios Pfizer S.A,laboratorios_pfizer_s_a,,,,,, -5379,,da6976be-f055-4162-89e7-87d1368dade1,"Pfizer Ltd, Sandwich, UK",pfizer_ltd_sandwich_uk,,,,,, -716,0.986058,b224eb63-4342-47e7-8cbf-799b488e62a3,Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar),consorci_mar_parc_de_salut_de_barcelona_parc_de_salut_mar,,,,35022515-9c52-4711-b51c-84b1e5d62adf,consorci_mar_parc_de_salut_de_barcelona,Consorci Mar Parc de Salut de Barcelona -5380,,c14f6463-3285-42f5-9d06-7ea893b1cb98,Charité Universitätsmedizin Berlin - CVK,charit_universit_tsmedizin_berlin_cvk,,,,,, -5381,,a1c66c22-73f3-11e6-a0cd-0242ac12000b,MEDICINES360,medicines360,,,,,, -648,0.92974448204040527,9744044a-acde-47ca-82d9-cce98024b24f,"Boehringer Ingeleim España, S.A",boehringer_ingeleim_espa_a_s_a,,,,400bd40c-fbde-4cec-8aeb-cb463c403ce5,boehringer_ingleheim_espa_a_s_a,"Boehringer Ingleheim España, S.A" -5382,,36dc1206-68b1-4b42-b667-f4ef6b64e688,Cardiorentis Ltd,cardiorentis_ltd,,,,,, -5383,,c1dee9e0-063b-450f-ba5f-96a5b4fb56b9,CHRU-Tours,chru_tours,,,,,, -5384,,d5aea122-46b6-433e-89d3-8da4daef168b,BørneklinikkenRanders,b_rneklinikkenranders,,,,,, -5385,,c9fa5aff-a7ea-48f7-a101-1bb16fe22693,Nordic Pharma SAS,nordic_pharma_sas,,,,,, -5386,,08184b11-ae0e-4b89-a2f7-f61d4117be0d,Càndid Villanueva,c_ndid_villanueva,,,,,, -5387,,fb31fe79-2680-4df2-a803-b78f9ceeae53,Helsinn Healthcare SA,helsinn_healthcare_sa,,,,,, -5388,,0acba83b-37e0-4ad2-8730-54c486be8371,"Maruho Co., Ltd",maruho_co_ltd,,,,,, -5389,,5c443a96-2016-4ff3-b558-2de4336dbc49,"Tigercat Pharma, Inc",tigercat_pharma_inc,,,,,, -5390,,db6796ba-ae2b-4a88-9fb2-be8939d06049,ActoGeniX N.V,actogenix_n_v,,,,,, -5391,,d901e822-aacd-465f-bfdd-fc88903ab522,YAMANOUCHI PHARMA,yamanouchi_pharma,,,,,, -5392,,e1c217ea-7164-11e6-a0cd-0242ac12000b,GLENMARK PHARMS INC,glenmark_pharms_inc,,,,,, -5393,,19c471b0-9a62-479b-a54f-bc3cb39e03df,Hexal Biotech ForschungsGmbH,hexal_biotech_forschungsgmbh,,,,,, -114,0.97253835201263428,f9c63488-b208-4cec-bb35-736ec99784f4,Shire Pharmaceuticals Ireland Limited,shire_pharmaceuticals_ireland_limited,,,,c0e26a28-8145-497a-8f48-d935495cc957,shire_pharmaceutical_ireland_limited,Shire Pharmaceutical Ireland Limited -5394,,2bda0c17-0184-4604-a093-9c9c5ba3233f,KULeuven,kuleuven,,,,,, -5395,,26c09d91-8718-4bdd-8c56-9d1a9b6703d2,Mereo BioPharma 2 Limited,mereo_biopharma_2_limited,,,,,, -5396,,657cae18-c54d-4094-b829-5f02e00aec58,Red Europea de Mieloma (European Myeloma Network),red_europea_de_mieloma_european_myeloma_network,,,,,, -5397,,168507da-bb63-4a52-9cb5-5a8bf4f1e68a,Ipsen Pharma S.A.S,ipsen_pharma_s_a_s,,,,,, -1047,0.985052,010d35da-5d47-4a0d-b01d-6b5b38df61c0,InnaVirVax,innavirvax,,,,010d35da-5d47-4a0d-b01d-6b5b38df61c0,innavirvax,InnaVirVax -5398,,0debcf3f-2c51-4cb4-bcf8-e0aa540a3740,"Lilly Deutschland GmbH, Teichweg 3, 35396 Gießen",lilly_deutschland_gmbh_teichweg_3_35396_gie_en,,,,,, -933,0.98374366760253906,8a975e77-bff3-468d-a2aa-195e43fc01ee,Pierre Fabre Médicament - IRPF,pierre_fabre_m_dicament_irpf,,,,e26f58e7-f0e7-4ad4-9432-e13ea279b291,pierre_fabre,Pierre Fabre Médicament -5399,,ad4ab05f-c294-4fba-9441-73a7e4bf4262,Institut de Recerca Hospital Sant Pau,institut_de_recerca_hospital_sant_pau,,,,,, -5400,,38559e27-97ef-4488-b94c-f6171f949a03,Biotech Tools sa,biotech_tools_sa,,,,,, -5401,,5209b5fa-c96c-43dc-a954-faf731dbf753,Suomen MSD Oy,suomen_msd_oy,,,,,, -1035,0.968193,6b6beb8f-b475-4ffe-9251-555c397c2420,"Department off Infectious Diseases, Aarhus University Hospital Skejby, Denmark",department_off_infectious_diseases_aarhus_university_hospital_skejby_denmark,,,,35768696-3c8d-4b10-b3d3-c9d161f53a97,department_of_infectious_diseases_aarhus_university_hospital_skejby,"Department of Infectious Diseases, Aarhus University Hospital, Skejby" -58,0.97575701773166656,26c8a4f6-dda7-4538-a3f6-214df3725d63,Wyeth Research Division of Wyeth Pharmaceutical Inc,wyeth_research_division_of_wyeth_pharmaceutical_inc,,,,2ed1b6f4-e137-4ee3-a218-9e5c2d04039a,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_and_development,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development -5402,,a59ec6de-2316-499c-83fe-5c89039a4585,DR. AUGUST WOLFF GMBH & CO. KG,dr_august_wolff_gmbh_co_kg,,,,,, -5403,,580046a1-1e7c-4046-8f2f-c52beab3beb1,Dr. Joan Ramon Masclans. Servicio de Medicina Intensiva. Hospital Universitario Vall d'Hebron,dr_joan_ramon_masclans_servicio_de_medicina_intensiva_hospital_universitario_vall_d_hebron,,,,,, -5404,,0460de08-075b-4857-9ecf-5e5d6aeb70bf,Ospedale L. Sacco - Azienda Ospedaliera-Polo Universitario,ospedale_l_sacco_azienda_ospedaliera_polo_universitario,,,,,, -728,0.97142621874809265,71c0daf2-cfe7-43e5-be3b-917837604cd4,"UCB Celltech, UK Registered Branch of UCB Pharma SA",ucb_celltech_uk_registered_branch_of_ucb_pharma_sa,,,,093988ab-1f2c-48ab-84d3-0b1dff68400e,ucb_celltech_uk,"UCB Celltech, UK" -5405,,94a58601-99ac-4e35-a359-f2295c71f769,Streeklaboratorium voor de volksgezondheid Kennemerland,streeklaboratorium_voor_de_volksgezondheid_kennemerland,,,,,, -5406,,216ca999-a2e2-43a1-90e2-04afeb12c18b,Ammerland-Klinik Westerstede,ammerland_klinik_westerstede,,,,,, -5407,,6436fe51-97b5-473f-a2d1-77084847aa14,Department of Vascular Medicine of the Academic Medical Center,department_of_vascular_medicine_of_the_academic_medical_center,,,,,, -5408,,fe91873e-b1be-4636-a99e-335eb8a162d3,Phönix Laboratorium GmbH,ph_nix_laboratorium_gmbh,,,,,, -933,0.98634018500645959,32e92a8c-9148-48c6-a968-59666d75b63b,Pierre Fabre Médicament, Represented by Institut de Recherche Pierre Fabre,,,,e26f58e7-f0e7-4ad4-9432-e13ea279b291,pierre_fabre,Pierre Fabre Médicament -5409,,05c39b86-e6e8-4f38-a131-fc49fd62e46b,Stichting Lever Onderzoek,stichting_lever_onderzoek,,,,,, -5410,,a69947a5-b82c-4d42-af4e-85bd5efc28d4,Aquinox Pharmaceuticals Inc,aquinox_pharmaceuticals_inc,,,,,, -5411,,a992da05-20a5-4d4f-9543-cacd1b19243a,"Dipartimento Integrato di Oncologia, Ematologia e Patologie dell'Apparato Respiratorio",dipartimento_integrato_di_oncologia_ematologia_e_patologie_dell_apparato_respiratorio,pierre_fabre_m_dicament_represented_by_institut_de_recherche_pierre_fabre,,,,, -5412,,3e3bbc58-8d3a-4ebf-99a9-9cb231db11e2,Departamento de Oftalmología. Hospital Clínico San Carlos,departamento_de_oftalmolog_a_hospital_cl_nico_san_carlos,,,,,, -5413,,d4a8fd12-e500-4aaa-a47f-0f89fa2fad86,Dutch Colorectal Cancer Group,dutch_colorectal_cancer_group,,,,,, -5414,,dd341ac5-b342-4151-993b-37c343a459c6,"CHU de Liège, Domaine Universitaire du Sart Tilman",chu_de_li_ge_domaine_universitaire_du_sart_tilman,,,,,, -5415,,169a7edd-0fea-4ff9-b017-5890aeefa892,GILEAD SCIENCES S.R.L,gilead_sciences_s_r_l,,,,,, -5416,,14b22eaf-0e23-49c3-b07e-0ee4eba18c5f,LFB BIOTECHNOLOGIES,lfb_biotechnologies,,,,,, -5417,,7064efd2-715f-11e6-a0cd-0242ac12000b,PHOENIX LABS NY,phoenix_labs_ny,,,,,, -5418,,55cf01e0-2831-4e5b-adaf-bf4a2ac2b341,PLETHORA SOLUTIONS LIMITED,plethora_solutions_limited,,,,,, -5419,,80acf1b6-803a-4f60-afd9-d91e7a997b0a,"Academic Medical Center, department of Gastroenterology and hepatology",academic_medical_center_department_of_gastroenterology_and_hepatology,,,,,, -5420,,140a4fb2-06bd-4830-804e-0e695a5df065,Hytönen Maija,hyt_nen_maija,,,,,, -5421,,5cefc031-6f93-4339-86de-d85b4785766b,"Janssen-Cilag International NV, Turnhoutsweg 30, 2340 BEERSE, Belgium",janssen_cilag_international_nv_turnhoutsweg_30_2340_beerse_belgium,,,,,, -5422,,f1816e21-2d63-426f-8a5d-bbc7525de5bf,"Academic Medical Center, Neurosurgery",academic_medical_center_neurosurgery,,,,,, -5423,,d269a09f-e217-4227-b29f-1bb7670d5714,Cardiome Pharma Corp,cardiome_pharma_corp,,,,,, -868,0.98777571320533752,d75f8fe0-80ce-4bb5-9e6e-ab63e91189dc,"Astellas Pharma Global Development, Inc. (APGD)",astellas_pharma_global_development_inc_apgd,,,,d75f8fe0-80ce-4bb5-9e6e-ab63e91189dc,astellas_pharma_global_development_inc,"Astellas Pharma Global Development, Inc" -5424,,f9538f53-a235-43ad-b8d6-c912c58a4d26,Austrian Prostate Study Group (AUPSG),austrian_prostate_study_group_aupsg,,,,,, -5425,,b9aa917a-1637-4492-ba12-9290d9deca7e,AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI,azienda_ospedaliera_san_camillo_forlanini,,,,,, -5426,,f606bf38-7998-4701-b46c-9d6ec13b9ada,Fundación Investigación Biomédica Hospital Universitario Puerta de Hierro,fundaci_n_investigaci_n_biom_dica_hospital_universitario_puerta_de_hierro,,,,,, -5427,,73a76a8f-26f1-4b7d-a2d3-02faf0415cad,Royal National Lifeboat Institution,royal_national_lifeboat_institution,,,,,, -5428,,501a4be8-773c-4765-854d-867b49df9b60,STADA Arzneimittel AG,stada_arzneimittel_ag,,,,,, -404,0.984546,26d3b205-826f-444a-a5e3-2e552a9d8a82,"Technical University of Dresden, faculty of medicine",technical_university_of_dresden_faculty_of_medicine,,,,26d3b205-826f-444a-a5e3-2e552a9d8a82,technical_university_of_dresden_faculty_of_medicine,"Technical University of Dresden, faculty of medicine" -5429,,b083630f-316f-4ed8-b713-ad1939c5149f,Osmotica Pharmaceutical Corp,osmotica_pharmaceutical_corp,,,,,, -5430,,3dd6d08a-8de4-4b54-83a8-931402cb0184,"OXiGENE, Inc",oxigene_inc,,,,,, -5431,,b9a1d6d5-c6df-42a5-987a-3a44fa74c4dc,Laboratoires Bouchara-Recordati,laboratoires_bouchara_recordati,,,,,, -5432,,47cd072a-716a-11e6-a0cd-0242ac12000b,BERLEX LABS,berlex_labs,,,,,, -5433,,38846f40-72cf-11e6-a0cd-0242ac12000b,MSD INTL,msd_intl,,,,,, -5434,,ca99fe50-7157-11e6-a0cd-0242ac12000b,VISTA PHARMS,vista_pharms,,,,,, -5435,,bf8fddda-e0ff-4d9c-a579-f9be2581d93d,A.N.M.C.O.-Fondazione Italiana lotta Malattie Cardiovasc,a_n_m_c_o_fondazione_italiana_lotta_malattie_cardiovasc,,,,,, -5436,,a0594702-e873-419b-8600-819fbd8d06bb,Umeå Universitet,ume_universitet,,,,,, -651,0.98270362615585327,dc7fe857-5b5c-4680-bf4a-93d56847b77c,Boehringer Ingelheim bv,boehringer_ingelheim_bv,,,,4501c601-be00-4be3-8378-bb49eca4c7fb,boehringer_ingelheim_bv_medical_department,"Boehringer Ingelheim bv, Medical department" -5437,,f40a7fc2-8c1f-4b0b-89be-6343299d7598,Novartis S.A,novartis_s_a,,,,,, -5438,,8705e96e-e03c-4f8d-8961-d3d394bfff12,Novartis Phama GmbH,novartis_phama_gmbh,,,,,, -5439,,02a45e3f-96b8-4e0c-9247-41d0c82b511f,Bexel Pharmaceuticals Inc,bexel_pharmaceuticals_inc,,,,,, -719,0.98507535457611084,b0adc94a-71fc-11e6-a0cd-0242ac12000b,OTSUKA AMERICA,otsuka_america,,,,8ec06b1a-733e-11e6-a0cd-0242ac12000b,otsuka_america_pharm,OTSUKA AMERICA PHARM -453,0.900843,7b861ad6-7163-11e6-a0cd-0242ac12000b,ANTIBIOTICE,antibiotice,,,,7b861ad6-7163-11e6-a0cd-0242ac12000b,antibiotice,ANTIBIOTICE -5440,,ab59a145-9558-47c6-8c6e-f1513bd4db80,FONDAZIONE NEOPLASIE SANGUE ONLUS,fondazione_neoplasie_sangue_onlus,,,,,, -5441,,de128766-5b71-4095-8cc3-7fc6ff54be71,GRUPO ESPAÑOL DE TRASPLANTE HEMATOPOYÉTICO Y TERAPIA CELULAR (GETH),grupo_espa_ol_de_trasplante_hematopoy_tico_y_terapia_celular_geth,,,,,, -5442,,377a52d0-2e5f-40f9-8656-7548b252bdce,Sanaria Inc,sanaria_inc,,,,,, -5443,,8d8bb690-b398-4a61-9bee-735eccc38151,INMUNO DESIGNED MOLECULES (IDM),inmuno_designed_molecules_idm,,,,,, -5444,,3ed003c8-069c-4ac5-bd42-c9c0d1cb5322,Gilead Sciences Europe Ltd,gilead_sciences_europe_ltd,,,,,, -5445,,4863224b-a366-4a2e-824c-7f4a1ab3f49a,Reinier de Graaf Groep,reinier_de_graaf_groep,,,,,, -222,0.955709,dbe23764-1ae1-4f02-91a8-45cdf5d7ec2c,SOGUG - Spanish Oncology Genitourinary Group,sogug_spanish_oncology_genitourinary_group,,,,1cd31001-2166-4db7-b391-c4c12d25d9ea,sogug,SOGUG -5446,,9fc7fbbf-6c76-4fff-8def-8c0429a15b7c,Grupo Español Multidisciplinar en Cáncer Digestivo (GEMCAD),grupo_espa_ol_multidisciplinar_en_c_ncer_digestivo_gemcad,,,,,, -5447,,edc92120-5f18-4507-8b8e-8badf11e5fbe,Unidad de investigación en Tuberculosis de Barcelona,unidad_de_investigaci_n_en_tuberculosis_de_barcelona,,,,,, -5448,,76312428-f3fd-495c-a759-69bd025030ab,Ilkka Pörsti ja tutkimusryhmä,ilkka_p_rsti_ja_tutkimusryhm,,,,,, -5449,,be4c8548-abcc-42c9-bea3-6704ebfe2673,Fundacio Clinic per a la Recerca Biomèdica,fundacio_clinic_per_a_la_recerca_biom_dica,,,,,, -5450,,5d4b9f47-43d1-4efd-839d-e88a80cab2c2,Wyeth K.K. Research and Development Department,wyeth_k_k_research_and_development_department,,,,,, -5451,,12358d7a-715c-11e6-a0cd-0242ac12000b,HH AND P,hh_and_p,,,,,, -5452,,8f19bff5-57cb-45b4-b127-eec44992ef93,Mª Carmen Fariñas Álvarez. Hospital Universitario Marques de Valdecilla,m_carmen_fari_as_lvarez_hospital_universitario_marques_de_valdecilla,,,,,, -5453,,ee40c945-2c2d-4356-87a7-59b47a870049,Oy Lundbeck,oy_lundbeck,,,,,, -5454,,edbdbd3a-f429-480f-b50c-c68978cdaece,HK Clinical Trials,hk_clinical_trials,,,,,, -5455,,6e562480-10d0-4977-b3ff-c506fbad3275,Summit (Oxford) Limited,summit_oxford_limited,,,,,, -5456,,6bcce27a-8bdd-11e6-a449-0242ac12000b,"National Heart, Lung, and Blood Institute (NHLBI)",national_heart_lung_and_blood_institute_nhlbi,,,,,, -5457,,6744716d-6685-4c3e-ac8f-1bfa10aaf6e8,Exalenz BioScience Ltd,exalenz_bioscience_ltd,,,,,, -5458,,f13c25bd-81ef-4b46-89f4-e9e5769476f8,Craigavon Area Hospital Group Trust,craigavon_area_hospital_group_trust,,,,,, -5459,,310c3146-199c-4396-a66c-6b3175ad7d4f,TopoTarget A/S,topotarget_a_s,,,,,, -856,0.98108509182929993,9f592f36-f2fd-4ddb-82ae-45342aa0b7ea,Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-ALV),netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital_nki_alv,,,,66b401ea-5009-4db7-8b18-6fe29a2c6186,netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital,Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL) -5460,,70ab9e50-c7b6-4d52-98bc-f3a67e594f7b,Encysive Pharmaceuticals Inc,encysive_pharmaceuticals_inc,,,,,, -5461,,62c047bc-9a88-4129-9990-72b60f474804,"Karyopharm Therapeutics, Inc",karyopharm_therapeutics_inc,,,,,, -5462,,ad020afa-0b23-46b2-b667-1f7c67e3a8a0,CHRU of Lille,chru_of_lille,,,,,, -5463,,2755bb5f-5f21-42d4-a889-d358a31c9c73,Lupin Atlantis Holdings S.A,lupin_atlantis_holdings_s_a,,,,,, -760,0.987506,db892fbd-e5f0-40a8-8d13-447693b60e04,Västra Götalandregionen,v_stra_g_talandregionen,,,,db892fbd-e5f0-40a8-8d13-447693b60e04,v_stra_g_talandregionen,Västra Götalandregionen -5464,,f26aa29d-32c7-4b6d-8e11-b89452c6e1ef,"Adj,Professor, Torsten Gordh",adj_professor_torsten_gordh,,,,,, -5465,,ac689a48-5279-4d6c-9063-5ef34296650a,"Myriad Pharmaceuticals, Inc",myriad_pharmaceuticals_inc,,,,,, -5466,,1562785b-9f0c-4e1b-865a-53c67e3f54ef,Per F. Jensen,per_f_jensen,,,,,, -5467,,8672907b-e24a-4288-8702-7a044e466ae6,Pfizer N.V./S.A,pfizer_n_v_s_a,,,,,, -5468,,61224168-df00-47f7-8bb0-37b61e924936,Ashford & St. Peter's Hospitals NHS Trust,ashford_st_peter_s_hospitals_nhs_trust,,,,,, -5469,,9ff4366c-103d-4b62-99c2-fabd75795896,CELSG (Central European Leukemia Study Group),celsg_central_european_leukemia_study_group,,,,,, -5470,,7db85e0e-b948-4c72-8d4e-57c963b6a503,Vienna Institute for Research in Ocular Surgery,vienna_institute_for_research_in_ocular_surgery,,,,,, -5471,,63b9fbd7-d245-4bd5-80ba-1307da35fc13,Napp Pharmaceuticals Research Limited,napp_pharmaceuticals_research_limited,,,,,, -5472,,dd0b7f7c-a710-11e6-94cb-5656d04fc2b5,Orthopädisches Spital Speising,orthop_disches_spital_speising,,,,,, -5473,,c114e30c-2cd9-4b5a-b083-33134e6e4024,"HagaZiekenhuis, pulmonary department",hagaziekenhuis_pulmonary_department,,,,,, -5474,,3c54bfc4-5661-427d-8891-a439fd7081db,"Med. Univ. Wien, Klinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie",med_univ_wien_klinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,,,,,, -5475,,2336601a-25bf-429f-b5ef-dec18af6fe7e,"Helse Bergen, Haukeland University Hospital",helse_bergen_haukeland_university_hospital,,,,,, -5476,,59a36efc-41c2-4a83-bba6-95d6283477c6,Joseba Andoni Santamaría Zuazua,joseba_andoni_santamar_a_zuazua,,,,,, -5477,,6ea93704-856a-4b0e-8493-bf5eaf104520,Miguel Santin Cerezales,miguel_santin_cerezales,,,,,, -742,0.964268,50350555-1ec9-4ba6-9bb5-53e28ef8341d,Charite,charite,,,,50350555-1ec9-4ba6-9bb5-53e28ef8341d,charite,Charite -793,0.912188,9012ebe0-cafc-4b9e-8d91-e304af97eab8,Amersham Health SA (Parte de GE Healthcare Ltd. y sus filiales),amersham_health_sa_parte_de_ge_healthcare_ltd_y_sus_filiales,,,,9012ebe0-cafc-4b9e-8d91-e304af97eab8,amersham_health_sa_parte_de_ge_healthcare_ltd_y_sus_filiales,Amersham Health SA (Parte de GE Healthcare Ltd. y sus filiales) -765,0.98034405708312988,b8d4c322-6db4-4e89-8f5b-b4aa64ab122b,AbbVie GK,abbvie_gk,,,,59b7be85-48d9-4a80-8f5f-ff23404f5da2,abbvie,AbbVie -5478,,e90cb3ec-7160-11e6-a0cd-0242ac12000b,BAKER NORTON,baker_norton,,,,,, -5479,,30b6dd11-f766-47fb-8dfc-90c9e9f37253,Alexion Pharmaceuitcals Inc,alexion_pharmaceuitcals_inc,,,,,, -68,0.933464,9ba1f3da-ec16-443c-baaf-efec93f1ac9e,Medtronic International Trading,medtronic_international_trading,,,,9ba1f3da-ec16-443c-baaf-efec93f1ac9e,medtronic_international_trading,Medtronic International Trading -5480,,19e8cc00-71b9-11e6-a0cd-0242ac12000b,CHESEBROUGH PONDS,chesebrough_ponds,,,,,, -5481,,7c61ca40-881f-11e6-a998-0242ac12000b,Martha-Maria Krankenhaus Halle-Dölau gGmbH,martha_maria_krankenhaus_halle_d_lau_ggmbh,,,,,, -537,0.92192,a1967c73-0590-46d4-9778-5b03b30b3867,Centocor B.V. (Janssen Biologics),centocor_b_v_janssen_biologics,,,,5acde854-4953-47c0-9987-89e6a451966b,centocor_bv,Centocor BV -122,0.98044869303703308,5d30f108-14de-47f2-b6d3-5237b8c59f60,"F. Hoffmann-La Roche Ltd, Pharmaceuticals Division, PDR",f_hoffmann_la_roche_ltd_pharmaceuticals_division_pdr,,,,89ecf617-74e0-496c-8ac4-d4eae3b54d8c,f_hoffmann_la_roche_ltd_pharmaceuticals_divison_pdr,"F. Hoffmann-La Roche Ltd, Pharmaceuticals Divison, PDR" -860,0.972948,c56eab54-901b-4b49-af9e-003413595588,"Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust",addenbrooke_s_hospital_cambridge_university_hospitals_nhs_foundation_trust,,,,1fd9be47-d214-4572-b318-1aa9dc588ded,addenbrookes_hospital_cambridge_university_hospitals_nhs_foundation_trust,Addenbrookes Hospital Cambridge University Hospitals NHS Foundation Trust -5482,,70312420-7057-4cef-9d5d-020a121fa811,"Radboud University Nijmegen Medical Centre, department of Rheumatic Diseases",radboud_university_nijmegen_medical_centre_department_of_rheumatic_diseases,,,,,, -5483,,bcc43f7a-2279-4c6a-9de6-88cd0039f6f1,Immunocore Ltd,immunocore_ltd,,,,,, -615,0.90712672472000122,27b37686-1c0f-4738-ab0a-36c44f7ea9cc,"Fundación para la Investigación Biomédica del Hospital Universitario La Paz, Sección de Cirugía Colorrectal del Hospital",fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz_secci_n_de_cirug_a_colorrectal_del_hospital,,,,27b37686-1c0f-4738-ab0a-36c44f7ea9cc,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz_secci_n_de_cirug_a_colorrectal_del_hospital,"Fundación para la Investigación Biomédica del Hospital Universitario La Paz, Sección de Cirugía Colorrectal del Hospital" -531,0.979737,b547816e-7141-11e6-a0cd-0242ac12000b,BEDFORD LABS,bedford_labs,,,,50f04e40-7145-11e6-a0cd-0242ac12000b,bedford,BEDFORD -5484,,4934f79e-7160-11e6-a0cd-0242ac12000b,R AND S PHARMA,r_and_s_pharma,,,,,, -342,0.97989612817764282,748853e0-73f0-11e6-a0cd-0242ac12000b,AIR LIQUIDE AMERICA LP,air_liquide_america_lp,,,,748853e0-73f0-11e6-a0cd-0242ac12000b,air_liquide_america_lp,AIR LIQUIDE AMERICA LP -5485,,bd32656d-5585-46dc-b525-81a5fd24bb8a,"VU University Medical Center, Department of Medical Oncology",vu_university_medical_center_department_of_medical_oncology,,,,,, -5486,,45edd3dd-de44-428a-b5a0-4024e9311498,Grupo Español Multidisciplinar de Melanoma,grupo_espa_ol_multidisciplinar_de_melanoma,,,,,, -5487,,53e6a43c-73fc-11e6-a0cd-0242ac12000b,SALIX PHARMS INC,salix_pharms_inc,,,,,, -5488,,b567e4ef-72fe-4e57-9c8c-1f81be0e4e05,Inamed Research GmbH & Co. KG,inamed_research_gmbh_co_kg,,,,,, -5489,,aabc636a-089f-4116-9c1f-965afb4d5648,IPPMed – Institut für Pharmakologie und Präventive Medizin GmbH,ippmed_institut_f_r_pharmakologie_und_pr_ventive_medizin_gmbh,,,,,, -908,0.97244110703468323,e9e7b197-6597-4676-882e-bdcdcd1c67e4,sanofi-aventis Recherche & Développement,sanofi_aventis_recherche_d_veloppement,,,,9c45d693-515d-4149-92e4-d7272d06a7df,sanofi_aventis_recherche_d_veloppement,sanofi-aventis Recherche & Développement -5490,,34331a89-e540-4915-afbd-53e9943b3f71,BIOVOMED,biovomed,,,,,, -5491,,03dce284-7150-11e6-a0cd-0242ac12000b,NOVEX,novex,,,,,, -5492,,6c562268-2c72-4929-97fc-995ff2441e60,Qualissima,qualissima,,,,,, -789,0.986288,4cf10dca-715e-11e6-a0cd-0242ac12000b,GRANULES INDIA,granules_india,,,,216d0aa8-7165-11e6-a0cd-0242ac12000b,granules_india_ltd,GRANULES INDIA LTD -5493,,5fdf0294-73d3-11e6-a0cd-0242ac12000b,ECLAT PHARMS LLC,eclat_pharms_llc,,,,,, -5494,,fbaf1b83-5030-4b53-8a77-143242cefca1,RWTH Aachen vertreten durch das CTC-A,rwth_aachen_vertreten_durch_das_ctc_a,,,,,, -121,0.98132741451263428,e3879409-1e60-4b17-837b-77daafa719b8,F. Hoffmann-La Roche Limited,f_hoffmann_la_roche_limited,,,,2929b798-0440-49f3-ab5b-122a578e01ba,f_hoffmann_la_roche_limited_pharmaceuticals_division_pdr,"F. Hoffmann-La Roche Limited, Pharmaceuticals Division, PDR" -5495,,67d7d813-d44a-4e44-aa25-f6a725b3ed99,Krankenhaus Nordwest gGmbH,krankenhaus_nordwest_ggmbh,,,,,, -833,0.975572,df3797bd-ef16-44fb-a365-bf5b5811b6a7,Aalborg University Hospital,aalborg_university_hospital,,,,2a713a15-71e1-4a58-a888-238d8c875592,aalborg_university_hospital_aalborg_psychiatric_hospital_centre_for_schizophrenia,"Aalborg University Hospital, Aalborg Psychiatric Hospital, Centre for Schizophrenia" -5496,,cbe966d4-5da4-4336-813a-a70cb41a5627,TikoMed AB,tikomed_ab,,,,,, -5497,,5ed56589-1113-44a5-acec-62fb05efffe7,Salford Royal Hospital,salford_royal_hospital,,,,,, -5498,,29a8ed06-4cbe-42fd-9e2c-9f341d5a1fd5,"Molecular Insight Pharmaceuticals, Inc",molecular_insight_pharmaceuticals_inc,,,,,, -5499,,d68dbbd9-0bd3-40fc-ab25-d74e4b0a29c5,AISSM ONLUS,aissm_onlus,,,,,, -5500,,5bc7ad23-f947-4db5-9ba3-41a43c6f6810,"Millenium Pharmaceuticals, a wholly owned subsidiary of Takeda pharmaceutical Company Limited",millenium_pharmaceuticals_a_wholly_owned_subsidiary_of_takeda_pharmaceutical_company_limited,,,,,, -5501,,55342c52-eab2-4039-b096-b5d6ccb692e0,Universitätsklinikum Erlangen,universit_tsklinikum_erlangen,,,,,, -461,0.97477978467941284,006566e8-3afd-4507-99a0-43f66a5ab93a,Debiopharm International SA,debiopharm_international_sa,,,,006566e8-3afd-4507-99a0-43f66a5ab93a,debiopharm,Debiopharm -5502,,77d8f087-df88-4e97-90a1-b5949ff1b3b8,Penwest Pharmaceuticals Co,penwest_pharmaceuticals_co,,,,,, -5503,,8f38a794-93c0-4b03-b233-584b5c5fbeb3,"University of Cologne, Quality Assurance Unit of the Sponsor, Dean of research office",university_of_cologne_quality_assurance_unit_of_the_sponsor_dean_of_research_office,,,,,, -5504,,e0a96853-7375-49bd-8494-4c6fba11ecb8,Erasmus University Rotterdam,erasmus_university_rotterdam,,,,,, -5505,,7a1c72fd-e9c8-4e40-9e84-4e27090a8f5b,Miltenyi Biotec GmbH,miltenyi_biotec_gmbh,,,,,, -2,0.983866,7f8c8a75-8bf8-48df-b832-ab6dba5c9c9c,Västra Götaland,v_stra_g_taland,,,,7f8c8a75-8bf8-48df-b832-ab6dba5c9c9c,v_stra_g_taland,Västra Götaland -5506,,13d394a6-f234-4b2b-a81c-d580f20e64a1,"Orion Corporation, Orion Pharma, Orionintie,",orion_corporation_orion_pharma_orionintie,,,,,, -630,0.953662,0390bcaa-7142-11e6-a0cd-0242ac12000b,HETERO LABS LTD III,hetero_labs_ltd_iii,,,,0390bcaa-7142-11e6-a0cd-0242ac12000b,hetero_labs_ltd_iii,HETERO LABS LTD III -5507,,96a4346c-2008-4a30-8533-75a806b40a23,Novartis Farmaceuica S.A,novartis_farmaceuica_s_a,,,,,, -5508,,d7656961-30bb-4910-89f5-fafc13b8244e,Hospital Ramón y Cajal,hospital_ram_n_y_cajal,,,,,, -5509,,f6d708ab-9af6-4837-9c86-52629a447c4f,Colotech A/S,colotech_a_s,,,,,, -5510,,c203cacd-d1bb-468e-8dad-99912d5e8bd2,The National Eye Institute,the_national_eye_institute,,,,,, -604,0.96016567945480347,74f3207f-10fc-4bf9-acea-27c94f21b20d,Fundación Investigación y Desarrollo en el Area Cardiovascular,fundaci_n_investigaci_n_y_desarrollo_en_el_area_cardiovascular,,,,1a6a910e-9e16-4295-9c10-800391283d55,fundaci_n_investigaci_n_y_desarrollo_en_el_rea_cardiovascular,Fundación Investigación y Desarrollo en el Área Cardiovascular -5511,,c4938b10-ba57-4b37-9ad1-a331f192fc37,Karl Andersen,karl_andersen,,,,,, -5512,,9e338ad8-fcc3-4c87-9a6f-72ea2e0f789b,Trichocare Diagnostics Ltd,trichocare_diagnostics_ltd,,,,,, -686,0.94387978315353394,f5b9d3f9-0e23-4b05-b9e6-7e07f8c8de90,University Medical Center Göttingen,university_medical_center_g_ttingen,,,,6a59a49b-a6f0-423a-b72f-c211ebd85c3d,university_medical_center_goettingen,University Medical Center Goettingen -5513,,6fbc0649-31b4-44e7-8955-49446fbfd28d,Department of Endocrinology University of Debrecen Medical and Health Science Center,department_of_endocrinology_university_of_debrecen_medical_and_health_science_center,,,,,, -5514,,c869a7e3-a3e6-4eca-9b98-f4264436f127,FUNDACION SANTIAGO DEXEUS FONT,fundacion_santiago_dexeus_font,,,,,, -5515,,a2d6898e-7129-11e6-a89e-0242ac12000b,OXFORD PHARMS,oxford_pharms,,,,,, -872,0.938247,62c0263c-d0e1-4e0b-8c35-ed6babb3051d,Newcastle u Tyne Hospitals NHS Trust,newcastle_u_tyne_hospitals_nhs_trust,,,,62c0263c-d0e1-4e0b-8c35-ed6babb3051d,newcastle_u_tyne_hospitals_nhs_trust,Newcastle u Tyne Hospitals NHS Trust -5516,,ccfce69d-b982-41bb-9229-2d6f7976fe56,"Medizinische Fakultät der TU-München, vertreten durch den Dekan",medizinische_fakult_t_der_tu_m_nchen_vertreten_durch_den_dekan,,,,,, -527,0.95949012041091919,80833833-6173-4f1f-82da-31787a716bc2,"Roche Farma, S.A. en nombre de F. Hoffmann-La Roche Ltd",roche_farma_s_a_en_nombre_de_f_hoffmann_la_roche_ltd,,,,80833833-6173-4f1f-82da-31787a716bc2,roche_farma_s_a_en_nombre_de_f_hoffmann_la_roche_ltd,"Roche Farma, S.A. en nombre de F. Hoffmann-La Roche Ltd" -173,0.9838290810585022,25f19699-b1c9-46a8-8933-0a2bbd3c7357,Merck Serono S.A. - Geneva,merck_serono_s_a_geneva,,,,25f19699-b1c9-46a8-8933-0a2bbd3c7357,merck_serono_s_a_geneva,Merck Serono S.A. - Geneva -257,0.943406,e7efab32-7164-11e6-a0cd-0242ac12000b,MACLEODS PHARMS LTD,macleods_pharms_ltd,,,,62b269c4-7163-11e6-a0cd-0242ac12000b,macleods_pharma,MACLEODS PHARMA -5517,,969d0285-ae23-4e59-b6ff-c8d753cfe4d5,"CALISTOGA PHARMACEUTICALS, INC",calistoga_pharmaceuticals_inc,,,,,, -750,0.987601,c6c1fe4f-e832-4867-8cdc-abc79a0bfed0,Danish Head and Neck Cancer Group (DAHANCA),danish_head_and_neck_cancer_group_dahanca,,,,c6c1fe4f-e832-4867-8cdc-abc79a0bfed0,danish_head_and_neck_cancer_group_dahanca,Danish Head and Neck Cancer Group (DAHANCA) -5518,,d528d6c4-0041-4eed-a5e5-985e08aaede8,Laboratoire BIODERMA,laboratoire_bioderma,,,,,, -5519,,9d1b6173-6c10-4b8d-89aa-7f0433d3b024,Novo Nordisk Pharmaceuticals Ltd,novo_nordisk_pharmaceuticals_ltd,,,,,, -5520,,51929102-121b-4469-8287-56f1377d4f4a,IMM - Instituto de Medicina Molecular,imm_instituto_de_medicina_molecular,,,,,, -5521,,42f5b998-ad55-4220-a0e8-55df5cebc81e,"Klinikum der Universität München, Campus Großhadern",klinikum_der_universit_t_m_nchen_campus_gro_hadern,,,,,, -803,0.98581516742706299,fc2c3b7b-ad68-40c8-8512-c39fa5444d71,"University Hospital Basel, Cardiology",university_hospital_basel_cardiology,,,,3752ea3c-adc5-42dc-b691-67baaf7d0875, Neurology,University Hospital Basel -5522,,ca16e08d-21b9-4325-949c-7c08e1c314ca,"Opko Health, Incorporated",opko_health_incorporated,,,,,, -251,0.987649,c20847f8-7164-11e6-a0cd-0242ac12000b,VIRTUS PHARM,virtus_pharm,,,,5b28c378-71c3-11e6-a0cd-0242ac12000b,virtus_pharms,VIRTUS PHARMS -5523,,e2999557-ffd6-4cdd-afc6-73c86aeb4a63,Laboratorios León Farma S.A,laboratorios_le_n_farma_s_a,,,,,, -5524,,7a1d1d1b-e6e9-4dfe-ae52-b5115bbb85cc,"Neonatal intensive care unit, VU medical center Amsterdam",neonatal_intensive_care_unit_vu_medical_center_amsterdam,,,,,, -5525,,a3ac19b6-da46-4b7c-b198-5b799e254672,S.C.D.U. MEDICINA INTERNA 1 Ospedale San Luigi Orbassano,s_c_d_u_medicina_interna_1_ospedale_san_luigi_orbassano,,,,,, -5526,,8361c9fa-633e-4935-9107-006a6d8f224b,Medizinische Universität Graz - Abteilung für Thorax- und Hyperbare Chirurgie,medizinische_universit_t_graz_abteilung_f_r_thorax_und_hyperbare_chirurgie,,,,,, -5527,,0a76522c-8bd8-11e6-a449-0242ac12000b,Institute of Molecular Medicine and Biomedical Research- I.M.B.E,institute_of_molecular_medicine_and_biomedical_research_i_m_b_e,,,,,, -378,0.94561511278152466,b2c83dbc-4b82-4ee6-bf53-5f11e5381e48,Merck Sharpe & Dohme BV,merck_sharpe_dohme_bv,,,,796acf07-1766-4af0-8f88-ef836fc80a36,merck_sharp_dohme_bv,Merck Sharp & Dohme BV -5528,,3588b95f-7f47-4d6f-a00a-e5c301985d8d,"Canadian Cardiovascular Collaboration, Population Health Research Institute, McMaster University",canadian_cardiovascular_collaboration_population_health_research_institute_mcmaster_university,,,,,, -406,0.98668,f8bd009e-a088-4918-82f1-82567ee57796,Beaumont Hospital,beaumont_hospital,,,,6a695a29-050c-4d3f-8e0d-c6d6a3afc8f2,beaumont_hospital_rcsi,Beaumont Hospital/RCSI -5529,,824861f3-ceae-4355-8844-7460b74b4888,Institut für Klinisch-Onkologische Forschung Krankenhaus Nordwest GmbH,institut_f_r_klinisch_onkologische_forschung_krankenhaus_nordwest_gmbh,,,,,, -894,0.980283,25c1b375-42c4-46ab-a38f-021e8ab03a25,Ludwig Boltzmann Institute forRetinology and Biomicroscopic Laser Surgery,ludwig_boltzmann_institute_forretinology_and_biomicroscopic_laser_surgery,,,,25c1b375-42c4-46ab-a38f-021e8ab03a25,ludwig_boltzmann_institute_forretinology_and_biomicroscopic_laser_surgery,Ludwig Boltzmann Institute forRetinology and Biomicroscopic Laser Surgery -5530,,4b1c3ebb-afb9-40dc-ad3e-2aed3ccacbaa,Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS),fundaci_n_p_blica_andaluza_para_la_investigaci_n_de_m_laga_en_biomedicina_y_salud_fimabis,,,,,, -5531,,6d3070a3-f56b-45af-9365-fe697b357156,Xellia d.o.o,xellia_d_o_o,,,,,, -5532,,a372212d-6f1a-4607-aaf7-b1d218975bb7,The Rotterdam Eye Hospital,the_rotterdam_eye_hospital,,,,,, -5533,,cf2d67da-715d-11e6-a0cd-0242ac12000b,PERRIGO PHARMS CO,perrigo_pharms_co,,,,,, -5534,,1179f7fa-30fd-4b1a-853c-5e4fd4bd69bb,HAL Allergy,hal_allergy,,,,,, -5535,,0d8e2748-b1fe-4527-9105-14feb6a27f4f,DIATOS S.A,diatos_s_a,,,,,, -5536,,522e95f0-8411-4ea3-bf8c-3d9a6c131a15,Euopean Organisation of Research and Treatment of Cancer,euopean_organisation_of_research_and_treatment_of_cancer,,,,,, -583,0.96693354845046997,f23b93ea-629c-4e30-bc46-8154a8aed113,MSD BV,msd_bv,,,,a72d6b04-e5e5-483f-9071-b0af00c0a0c2,msd,MSD -5537,,112c5079-9c53-4180-ae4e-46cafa877641,CHUGAI PHARMA EUROPE LIMITED,chugai_pharma_europe_limited,,,,,, -5538,,738e32a5-c222-44e2-b03f-77105e371b1a,"NHS Lothian University, Research & Development",nhs_lothian_university_research_development,,,,,, -5539,,50a029f4-716a-11e6-a0cd-0242ac12000b,BAYER HEALTHCARE PHARMS,bayer_healthcare_pharms,,,,,, -5540,,408e57b3-786d-4f2a-99bf-489b5404f9d2,Fundación PETHEMA,fundaci_n_pethema,,,,,, -5541,,036aca0e-7142-11e6-a0cd-0242ac12000b,INVAGEN PHARMS,invagen_pharms,,,,,, -5542,,0bad96fd-475b-426f-b89c-9cb4ff34896f,Anders Heijl,anders_heijl,,,,,, -586,0.912289,2d4e8bd8-17d2-4b35-a93e-d9f401ce497b,Fundació Lluita contra la Sida,fundaci_lluita_contra_la_sida,,,,2d4e8bd8-17d2-4b35-a93e-d9f401ce497b,fundaci_lluita_contra_la_sida,Fundació Lluita contra la Sida -5543,,34695c46-123a-4926-98c6-6f86a3d23340,Universitätsklinik für Klinische Pharmakologie,universit_tsklinik_f_r_klinische_pharmakologie,,,,,, -5544,,3a6854ad-4d99-4b7d-8a8c-b1d7eb4b2563,"MUW, Department of Clinical Pharmacology",muw_department_of_clinical_pharmacology,,,,,, -844,0.989439,a22c5dfa-87d4-4be2-8e2e-bcfdbc6b7f86,"Queen Mary and Westfield College, University of London",queen_mary_and_westfield_college_university_of_london,,,,1b189425-2b98-4982-b3b0-a63cc85c263e,queen_mary_and_westfield_college_university_of_london_qmul,"Queen Mary and Westfield College, University of London (QMUL)" -5545,,93bb4b6e-4905-456e-b048-9f17b74239e8,"Medizinische Universität Wien, Uni. Klinik für Neurologie",medizinische_universit_t_wien_uni_klinik_f_r_neurologie,,,,,, -5546,,571c3d47-a38a-443e-803e-5b04c34fd359,Fundación para la Investigación biomédica del Hospital Universitario Ramón y Cajal. Madrid,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_ram_n_y_cajal_madrid,,,,,, -5547,,f3792afc-7144-11e6-a0cd-0242ac12000b,AUROBINDO,aurobindo,,,,,, -5548,,001265a8-cd82-44e8-a4b7-f2520f74664b,"Rib-X Pharmaceuticals, Inc",rib_x_pharmaceuticals_inc,,,,,, -5549,,44990392-9007-4109-8340-74bf3fe08f68,Niconovum AB,niconovum_ab,,,,,, -5550,,64df797c-8be8-4c04-bdc7-8eb7c0b432e7,"Universitätsklinik für klinische Pharmakologie, Medizinische Universität Wien",universit_tsklinik_f_r_klinische_pharmakologie_medizinische_universit_t_wien,,,,,, -804,0.9722786545753479,3e3b9a3c-7142-11e6-a0cd-0242ac12000b,ALCON,alcon,,,,1105f30e-7166-11e6-a0cd-0242ac12000b,alcon_pharma,ALCON PHARMA -701,0.967271,560f7696-eaf2-4bd2-a256-7befc8defd81,Synageva Biopharma Corp,synageva_biopharma_corp,,,,22012f51-f648-4da1-8b80-539b591bf168,synageva_biopharma_corporation,Synageva BioPharma Corporation -5551,,569e81c6-9314-4035-98ee-34dace765f06,CHU de DIJON,chu_de_dijon,,,,,, -5552,,89fedba1-61aa-45d9-8fe5-f53d2ce18a49,Ipsen Group,ipsen_group,,,,,, -5553,,b612d7b4-7160-11e6-a0cd-0242ac12000b,CLONMEL HLTHCARE,clonmel_hlthcare,,,,,, -5554,,0d5a2b55-d549-4433-8881-3dda5be5f12b,SIFI,sifi,,,,,, -5555,,d15653b9-5070-49a2-be87-3396f8204985,GermanBreastGroup,germanbreastgroup,,,,,, -5556,,5ebda041-7158-4f3d-95fd-7b811a35dc08,Nycomed Danmark ApS,nycomed_danmark_aps,,,,,, -5557,,f9e0fce3-f685-486d-b77e-7d863760763d,Inn-Salzach-Klinikum gGmbH,inn_salzach_klinikum_ggmbh,,,,,, -640,0.97514638304710388,d2f4fdea-3f56-449f-b5b3-ab25da9fa8af,Boehringer Ingelheim RCV GmbH & Co KG q,boehringer_ingelheim_rcv_gmbh_co_kg_q,,,,d2f4fdea-3f56-449f-b5b3-ab25da9fa8af,boehringer_ingelheim_rcv_gmbh_co_kg,Boehringer Ingelheim RCV GmbH & Co KG -5558,,525916ec-2db7-42e3-8507-574afacfead4,Biovitrum AB (publ.),biovitrum_ab_publ,,,,,, -813,0.94668000936508179,29704645-80db-4f53-b002-9c5e0e861f7c,ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI IRST - IRCCS,istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori_irst_irccs,,,,d8bfcede-efc3-4714-b642-f79fb12833f5,istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori,ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI -5559,,a2ba2a12-9044-422c-9790-eefa6eeb3df8,"Vaccine Research Center, University of Tampere",vaccine_research_center_university_of_tampere,,,,,, -5560,,e3f7fb91-973f-4c58-8613-b2fc81eff249,H. 12 de Octubre,h_12_de_octubre,,,,,, -5561,,daf847ac-432d-4bf6-a247-4298f0fa9e13,"Universitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie, Medizinische Universität Wien",universit_tsklinik_f_r_innere_medizin_iii_klinische_abteilung_f_r_rheumatologie_medizinische_universit_t_wien,,,,,, -5562,,48a58a3d-123a-408a-86f3-0533e41a485a,FONDAZIONE SALVATORE MAUGERI - CLINICA DEL LAVORO E DELLA RIABILITAZIONE,fondazione_salvatore_maugeri_clinica_del_lavoro_e_della_riabilitazione,,,,,, -5563,,f4d027b2-c3b1-4f0a-a0c9-964dfbe4298e,AKH Vienna,akh_vienna,,,,,, -5564,,fc21ea5c-d162-46f5-bd49-bedac7f5851d,Kompetenznetz Vorhofflimmern e.V. [Atrial Fibrillation Competence Network (AFNET) e.V.],kompetenznetz_vorhofflimmern_e_v_atrial_fibrillation_competence_network_afnet_e_v,,,,,, -5565,,ad3f48a2-71d3-11e6-a0cd-0242ac12000b,BAJAJ MEDICAL LLC,bajaj_medical_llc,,,,,, -5566,,aa67fc5f-884d-4ec5-b4da-5ef37cf26a38,Neurologisk Afdeling,neurologisk_afdeling,,,,,, -5567,,488c2413-1ee4-4357-a2be-147174e6ded8,FONDAZIONE MONZINO CENTRO CARDIOLOGICO,fondazione_monzino_centro_cardiologico,,,,,, -750,0.987601,e7f285a2-b1dc-4c78-84e3-b8608adc3a75,Danish Head and Neck Cancer Group,danish_head_and_neck_cancer_group,,,,c6c1fe4f-e832-4867-8cdc-abc79a0bfed0,danish_head_and_neck_cancer_group_dahanca,Danish Head and Neck Cancer Group (DAHANCA) -5568,,895f7b63-746c-46fa-a942-51613f5b5d7a,"Amicus Therapeutics, Inc",amicus_therapeutics_inc,,,,,, -5569,,351c2b3b-fca0-4364-9941-c2f0735ff736,"Medizinische Universität Wien, Univ. KlM III, Klinische Abt. f. Gastroenterologie/Hepatologie",medizinische_universit_t_wien_univ_klm_iii_klinische_abt_f_gastroenterologie_hepatologie,,,,,, -405,0.96135038137435913,f2c4f4a2-1001-47df-820d-b480dcde3473,Gilead Sciences Incorporated,gilead_sciences_incorporated,,,,dee4490b-b25c-4c54-b909-635261eba55d,gilead,Gilead -5570,,17cc70f7-5525-4193-91fe-2f91323e6b2d,"Idera Pharmaceuticals, Inc",idera_pharmaceuticals_inc,,,,,, -323,0.98768532276153564,4f87e303-257a-4217-8700-a7ae561c79ec,Tibotec Pharmaceuticals Ltd,tibotec_pharmaceuticals_ltd,,,,7c715eec-7632-4bad-85ac-60fea60f92d9,tibotec_pharmaceuticals_ltd,Tibotec Pharmaceuticals Ltd -5571,,98f93e96-89d9-436a-91d1-cf3abdc7f160,Alcon Research Ltd,alcon_research_ltd,,,,,, -5572,,877ab712-c839-473c-96fd-f718f3278fde,AVENTIS PASTEUR MSD S.P.A,aventis_pasteur_msd_s_p_a,,,,,, -5573,,cdc2178f-0d59-4878-b8bd-a29181ca5c8e,Neurophyxia B.V,neurophyxia_b_v,,,,,, -5574,,087086ea-b9e5-4f5d-bc2a-e6388cf4b3b9,Cephalon Inc,cephalon_inc,,,,,, -5575,,e7550f5b-9f4f-4b90-97d6-128a86a85c7d,NMDSG Nordics Myeloplastics Syndrom Study Group,nmdsg_nordics_myeloplastics_syndrom_study_group,,,,,, -5576,,dd4bdf55-2be6-41a5-a74b-75a203634eda,GETH,geth,,,,,, -5577,,9fbec508-715c-11e6-a0cd-0242ac12000b,ACS DOBFAR INFO SA,acs_dobfar_info_sa,,,,,, -213,0.979896,801ffc64-51e2-42b5-afbc-2a5a23da743b,Bioforce AG Roggwil TG,bioforce_ag_roggwil_tg,,,,559fe1ec-2be1-4b2f-a03a-a510b2d4cf93,bioforce_ag,Bioforce AG -5578,,c2b219c1-360c-4ad9-afee-d9ffbac13dde,Karin Blomgren,karin_blomgren,,,,,, -5579,,724d9b78-0cd0-48c7-a4c2-5b4c655ed89c,Consorci Sanitari de Terrassa,consorci_sanitari_de_terrassa,,,,,, -5580,,db253254-73b4-4800-ac88-78efad359f70,University of Hull,university_of_hull,,,,,, -5581,,b59a26d2-f4a1-4322-925d-ba042cd0946f,FORMAC Pharmaceuticals NV,formac_pharmaceuticals_nv,,,,,, -5582,,8a26307c-7167-11e6-a0cd-0242ac12000b,CALL INC,call_inc,,,,,, -5583,,0b2f272f-76ce-44ff-bfc9-51b8e287988d,Eastern Norway Regional Health Authority,eastern_norway_regional_health_authority,,,,,, -5584,,60c093b1-3df9-4d4f-946c-f91df6310dc9,"Derartment of Anaesthesiology and Intensive Care, Turku University Hospital",derartment_of_anaesthesiology_and_intensive_care_turku_university_hospital,,,,,, -382,0.98027,d49544f4-718a-11e6-a0cd-0242ac12000b,BIOMARIN PHARM,biomarin_pharm,,,,37341944-6d19-4843-a80d-f568e4d60ef1,biomarin,BIOMARIN -442,0.934557,25695572-6fa2-11e6-9663-0242ac12000b,Laboratorios Andrómaco S.A. (co-sponsor Spain),laboratorios_andr_maco_s_a_co_sponsor_spain,,,,25695572-6fa2-11e6-9663-0242ac12000b,laboratorios_andr_maco_s_a_co_sponsor_spain,Laboratorios Andrómaco S.A. (co-sponsor Spain) -5585,,1b5d1fa3-e2c3-4af2-b1f9-462733096c51,Astion Danmark A/S,astion_danmark_a_s,,,,,, -5586,,9747b34c-73f2-11e6-a0cd-0242ac12000b,NITROUS OXIDE OF CANADA,nitrous_oxide_of_canada,,,,,, -5587,,5785df13-ad33-46bd-86de-da2069bc539a,BIODEL Inc,biodel_inc,,,,,, -131,0.98070418834686279,1ead7ee3-0e7d-4381-a630-ec14aeb73c0e,Department of Psychiatry and Psychotherapy (Cologne),department_of_psychiatry_and_psychotherapy_cologne,,,,1ead7ee3-0e7d-4381-a630-ec14aeb73c0e,department_of_psychiatry,Department of Psychiatry -5588,,a761d9e2-9ccd-496f-a17d-daf310188568,UCB Inc,ucb_inc,,,,,, -5589,,f852328e-30da-494a-8eac-9c16b63e8bf4,A.T. Development Switzerland SARL,a_t_development_switzerland_sarl,,,,,, -865,0.987308,c749378e-006f-4127-9f29-18525f0578c9,United Therapeutics Corp,united_therapeutics_corp,,,,98172a5d-4f63-4af5-97a8-b1a01d9344ff,united_therapeutics_corporation,United Therapeutics Corporation -100,0.94407099485397339,6bce5266-4f70-4a55-a2f5-d6d6414543be,Department of Anesthesiology & Intensive Care,department_of_anesthesiology_intensive_care,,,,3f816051-0ebf-47a9-b4f1-e129cf8f1167,department_of_anesthesiology_and_intensive_care_medicine,Department of Anesthesiology and Intensive Care Medicine -5590,,28ea9b69-607b-4274-9145-3945d31fe86a,Birken AG,birken_ag,,,,,, -855,0.983343,f991b548-715e-11e6-a0cd-0242ac12000b,GD SEARLE LLC,gd_searle_llc,,,,9eeb4efa-71af-11e6-a0cd-0242ac12000b,gd_searle,GD SEARLE -966,0.963804,f354139f-be71-4a4f-9aba-83d8422841df,Isala klinieken Zwolle,isala_klinieken_zwolle,,,,77f76197-601c-4f7d-a484-16ca18daeb6c,isala,Isala -1028,0.91099542379379272,5cd4a39f-21fd-403d-abbe-561ea83b270d,Eli Lilly and Company - Indianapolis,eli_lilly_and_company_indianapolis,,,,5cd4a39f-21fd-403d-abbe-561ea83b270d,eli_lilly_and_company_indianapolis,Eli Lilly and Company - Indianapolis -5591,,9b39f3ad-6890-4c38-8ad9-e56636bc691e,Rottapharm S.p.A,rottapharm_s_p_a,,,,,, -381,0.92556309700012207,70a76c95-9bc5-4453-ace1-7d9c98a92a7d,Merck Sharp & Dohme AB,merck_sharp_dohme_ab,,,,70a76c95-9bc5-4453-ace1-7d9c98a92a7d,merck_sharp_dohme_o,"Merck Sharp & Dohme Copr., a subsidary of Merck & Co" -5592,,b5eb58dd-61c0-4fd6-bc52-e5cde9bd7760,"Department of Haematology, Herlev Hospital, University of Copenhagen",department_of_haematology_herlev_hospital_university_of_copenhagen,,,,,, -5593,,c0a964c6-6d5c-45d3-84e6-79f0a91d31c7,Galápagos NV,gal_pagos_nv,,,,,, -5594,,8cc9520b-12fe-4b45-ba1d-e908dc0fa38d,Clinical Data Care Spain S.L,clinical_data_care_spain_s_l,,,,,, -5595,,96e3650c-71a1-11e6-a0cd-0242ac12000b,XSPIRE,xspire,,,,,, -5596,,7df4d9a8-1963-4432-8a4c-c87268368bd1,sanofi-aventis Zrt,sanofi_aventis_zrt,,,,,, -5597,,75d02ed4-527a-4c3a-83a0-e15e97fc7866,"Amgen, Inc. One Amgen Center Drive Thousand Oaks, California 91320",amgen_inc_one_amgen_center_drive_thousand_oaks_california_91320,,,,,, -5598,,51f07de7-8d96-4222-bee8-a34c53c6b3f3,"Roche Farmacêutica Química, Lda",roche_farmac_utica_qu_mica_lda,,,,,, -5599,,655182c3-51a4-4f33-b443-bd734b48fa0a,Novartis Consumer Health,novartis_consumer_health,,,,,, -5600,,ebd2ef67-795f-4036-8bd6-71c40c201510,"aTyr Pharma, Inc",atyr_pharma_inc,,,,,, -5601,,09fd1793-e79a-4454-904f-7f6b1ebe1944,"Department of Obstetrics and Gynecology, Oulu University Hospital",department_of_obstetrics_and_gynecology_oulu_university_hospital,,,,,, -438,0.94114851951599121,09d833e6-81f6-4d84-ab0d-6d38c6152081,"Pfizer Inc, 235 East 42nd Street, New York, NY 10017, USA",pfizer_inc_235_east_42nd_street_new_york_ny_10017_usa,,,,09d833e6-81f6-4d84-ab0d-6d38c6152081,pfizer_inc_235_east_42nd_street_new_york_ny10017_usa,"Pfizer Inc 235 East 42nd Street, New York, NY10017" -5602,,3c158304-3e4e-45c4-bd69-de1f0dafe21b,Flemming Bendtsen,flemming_bendtsen,,,,,, -5603,,88f64b40-75c2-4d7e-849c-b04187899746,Dermal Laboratories,dermal_laboratories,,,,,, -5604,,4d8cc40e-de2d-4728-a9ed-3514b4ab7cc0,Johanna Hästbacka,johanna_h_stbacka,,,,,, -5605,,df0ef22c-7603-4178-bc34-c7a3f71cc4bf,Regent Medical,regent_medical,,,,,, -5606,,1412cd67-10ce-4589-9996-432af277840d,"University of Oxford, Nuffield Department of Medicine",university_of_oxford_nuffield_department_of_medicine,,,,,, -5607,,593b49e6-1313-41ac-b4d1-cec5c4d85a00,Mª Isabel Fernández García,m_isabel_fern_ndez_garc_a,,,,,, -5608,,9f4c1582-6fbb-11e6-abe8-0242ac12000b,University College Hospital,university_college_hospital,,,,,, -971,0.981633,7c6e82f0-9a46-47cd-89bb-39837da65876,Department of Anaesthesiology,department_of_anaesthesiology,,,,7c6e82f0-9a46-47cd-89bb-39837da65876,department_of_anaesthesiology,Department of Anaesthesiology -5609,,e97d0e5e-714b-11e6-a0cd-0242ac12000b,KREMERS URBAN PHARMS,kremers_urban_pharms,,,,,, -5610,,59061910-00fd-456b-a3b8-36d1749207e9,Hospital Regional Universitario. IBIMA,hospital_regional_universitario_ibima,,,,,, -5611,,06546d1b-0ca9-456d-ac77-85533031bf43,"Department of R & D, Central Manchester and Manchester Children's Hospital NHS Trust",department_of_r_d_central_manchester_and_manchester_children_s_hospital_nhs_trust,,,,,, -5612,,36e99bb6-6fb7-4fbc-9719-ea0f6d98c775,Schering Lusitana,schering_lusitana,,,,,, -5613,,01ac1e4c-7143-11e6-a0cd-0242ac12000b,CNTY LINE PHARMS,cnty_line_pharms,,,,,, -5614,,d22a0840-3c31-4335-99b9-3909a433cad1,RIEMSER Arzneimittel AG,riemser_arzneimittel_ag,,,,,, -5615,,9a9ea5a4-2f8c-42e8-b075-313146f79950,Lukács és Társa Gyógyszerkereskedelmi Betéti Társaság,luk_cs_s_t_rsa_gy_gyszerkereskedelmi_bet_ti_t_rsas_g,,,,,, -5616,,59b797a9-1858-4059-b40a-87a26bd01ce5,Centro de Investigación Biomédica en Red en el Área de Salud Mental (CIBERSAM),centro_de_investigaci_n_biom_dica_en_red_en_el_rea_de_salud_mental_cibersam,,,,,, -5617,,23b3381c-a8f2-49bd-b0ea-b0daf0cc5c8a,University of Sydney,university_of_sydney,,,,,, -5618,,0752e59e-8ee8-4c4d-87c3-26fcd616bc19,AZIENDA OSPEDALIERA G. BROTZU,azienda_ospedaliera_g_brotzu,,,,,, -5619,,0f9dfb85-95fd-4e26-aa80-b964e3ed8faf,Academic Medical Center/ Gastroenterology,academic_medical_center_gastroenterology,,,,,, -5620,,511eadb8-c44b-4148-af13-26d98f121b19,Camden Provider Services,camden_provider_services,,,,,, -5621,,c8c07891-559a-404c-adcd-e91a83cd0f04,Pfizer España,pfizer_espa_a,,,,,, -5622,,0a7a6446-ed13-4788-9d3f-93b6faea183d,THE TECHNICAL UNIVERSITY OF DRESDEN,the_technical_university_of_dresden,,,,,, -5623,,08adb0be-7154-11e6-a0cd-0242ac12000b,INTL MEDICATION SYS,intl_medication_sys,,,,,, -5624,,3d023a6e-2350-4d17-b437-1a4e11aa1962,Imperial College Joint Research Office,imperial_college_joint_research_office,,,,,, -5625,,57fe149d-c4a8-40f7-8771-0ada8bb3a330,OSPEDALE POLICLINICO S. MATTEO,ospedale_policlinico_s_matteo,,,,,, -5626,,e7e4f7f4-ef06-4c08-ac9e-4c655acdac11,ZLB BEHRING,zlb_behring,,,,,, -5627,,ff92b6c3-59c8-42fb-9591-3bec333e71c4,Martina Bachmann,martina_bachmann,,,,,, -5628,,7a2b0132-c5c5-4083-9041-965f6efd64cd,Biotec Pharmacon ASA,biotec_pharmacon_asa,,,,,, -5629,,f4908fe9-02ee-4e92-a151-d50486f095ca,Spaarne Hospital,spaarne_hospital,,,,,, -5630,,2e0a275e-98ca-4977-8baa-c64928b9ff0d,Roche Oy,roche_oy,,,,,, -5631,,42b27b65-ce3f-4710-b25f-846a3a3f72a6,Lothian Health Board University Hospitals Division,lothian_health_board_university_hospitals_division,,,,,, -5632,,affbbf96-f52e-4aae-8d23-4e4f3f6a296f,Dept. of Nephrology,dept_of_nephrology,,,,,, -764,0.98123,eca7bccc-59ef-4deb-bbac-862d21270313,Universitair Ziekenhuis Antwerpen (UZA) - Multidisciplinair Pijncentrum,universitair_ziekenhuis_antwerpen_uza_multidisciplinair_pijncentrum,,,,2917de45-e710-4da7-9b4b-c54d1dd1327d,universitair_ziekenhuis_antwerpen,Universitair Ziekenhuis Antwerpen -663,0.97166502475738525,ae7adb7b-c45f-4298-be68-d5dcaa36ea65,Charité - Unversitätsmedizin Berlin,charit_unversit_tsmedizin_berlin,,,,57ad1b5e-ca5a-4470-9b1b-36e6151b1c01,charit_universit_tsmedizin_berlin,Charité - Universitätsmedizin Berlin -5633,,90d86014-7141-11e6-a0cd-0242ac12000b,MYLAN INSTITUTIONAL,mylan_institutional,,,,,, -5634,,69be49e2-714d-11e6-a0cd-0242ac12000b,AAIPHARMA LLC,aaipharma_llc,,,,,, -5635,,62313be9-6619-46cc-b768-c59f92d10271,JERINI AG,jerini_ag,,,,,, -5636,,4a6fe51d-4d0f-4be1-b332-1d538903f763,Clementia Pharmaceuticals Inc,clementia_pharmaceuticals_inc,,,,,, -5637,,551fbb5c-33b5-4567-bc7d-ff9fbb6d386d,Dr. Wolfgang Jaksch,dr_wolfgang_jaksch,,,,,, -5638,,6aa73bf1-0b6a-4937-8894-27225cf56a7e,Nottingham University NHS Trust,nottingham_university_nhs_trust,,,,,, -81,0.988541,8a5eb366-780e-4aa5-8b20-c800908bad95,Université catholique de Louvain (UCL),universit_catholique_de_louvain_ucl,,,,8a5eb366-780e-4aa5-8b20-c800908bad95,universit_catholique_de_louvain_ucl,Université catholique de Louvain (UCL) -5639,,77688cf1-87bc-419e-8dee-667b70034603,Clinical Immunology and Rheumatology,clinical_immunology_and_rheumatology,,,,,, -5640,,df7f43d1-855c-4ed5-9f6a-8a39cd3a7d65,Speising Orthopaedic Hospital Vienna,speising_orthopaedic_hospital_vienna,,,,,, -5641,,3987b723-ec4a-4e26-8e94-5bab49919019,Salford Royal Foundation Trust,salford_royal_foundation_trust,,,,,, -5642,,628527b4-f033-4ccb-b91a-674231b9fe72,Apeptico Forschung und Entwicklung GmbH,apeptico_forschung_und_entwicklung_gmbh,,,,,, -5643,,57154e3d-9bf7-4648-b388-197dec730b98,BAXTER HEALTHCARE CORPORATION,baxter_healthcare_corporation,,,,,, -5644,,77bf763e-71b5-11e6-a0cd-0242ac12000b,ECOLAB,ecolab,,,,,, -5645,,d5e531d0-73fa-11e6-a0cd-0242ac12000b,ACTAVIS LLC,actavis_llc,,,,,, -5646,,0b6f602f-254d-44c9-a762-5192383006bb,"Biolex Therapeutics, Inc",biolex_therapeutics_inc,,,,,, -73,0.983343,fa82421c-fb0e-450c-abc2-af99fa053bc2,AM-Pharma,am_pharma,,,,a9d0f101-5d13-4345-bc0c-7527c110c176,am_pharma_b_v,AM-Pharma B.V -5647,,fb4d5d0e-5493-4871-8745-17da3cad85a4,"Tanabe Seiyaku Co., Ltd",tanabe_seiyaku_co_ltd,,,,,, -5648,,515bc82b-89b9-42c9-9cb1-dde79728f9bf,NOPHO-NHL GRUPP,nopho_nhl_grupp,,,,,, -5649,,4195da0e-57dd-410b-a5de-1b2cc06c42d8,Dr. DANIEL PODZAMCZER PALTER,dr_daniel_podzamczer_palter,,,,,, -25,0.97483,a0372a33-487c-42a4-b29b-60e3a4ffb844,"Abraxis BioScience, LLC, a wholly-owned subsidiary of Celgene Corporation",abraxis_bioscience_llc_a_wholly_owned_subsidiary_of_celgene_corporation,,,,575a893b-fb9f-4cff-b2fd-090f406fd398,abraxis_bioscience_llc,"Abraxis BioScience, LLC" -5650,,a62fa2c7-cf07-436f-b0f2-e79e97c3e7d6,"SANOFI AVENTIS, S.A.U",sanofi_aventis_s_a_u,,,,,, -5651,,d93e11b8-7165-11e6-a0cd-0242ac12000b,SUNSHINE LAKE,sunshine_lake,,,,,, -312,0.973688,16c13ad3-319c-4580-9561-26254cba7ca2,Stockholms Läns Landsting,stockholms_l_ns_landsting,,,,16c13ad3-319c-4580-9561-26254cba7ca2,stockholms_l_ns_landsting,Stockholms Läns Landsting -5652,,cd444774-a365-41bb-8f4b-df3a6c8efff8,the Dutch Colorectal Cancer Group,the_dutch_colorectal_cancer_group,,,,,, -5653,,227899b2-ca90-4520-8cfb-97885c865d35,Neolab td,neolab_td,,,,,, -5654,,aa8185cf-0f5f-4ba8-bc28-6824e5574de4,ParnassiaBavoGroup,parnassiabavogroup,,,,,, -1015,0.97426080703735352,8811d706-c986-44c5-bf01-3f0b35984b6c,Institut de Recherches Internationales Servier (I.R.I.S),institut_de_recherches_internationales_servier_i_r_i_s,,,,505a3f41-b816-4c26-965c-c1b406728577,institut_de_recherches_internatinales_servier,Institut de Recherches Internatinales Servier -5655,,bcd05a90-5b15-4920-9677-ea3e5200b1eb,EryDel S.p.A,erydel_s_p_a,,,,,, -5656,,fc36750a-f55f-4e56-b67d-8d058e9dce96,Dept Hematology SLB Vejle,dept_hematology_slb_vejle,,,,,, -5657,,eb915430-1f57-44c3-a9d5-49b2f0515c10,Apodemus AB,apodemus_ab,,,,,, -5658,,be33b612-4df4-4c9f-b5c1-76c3dd7ef29b,STRUCTURAL GENOMIX,structural_genomix,,,,,, -11,0.979515,55ec7b48-7321-11e6-a0cd-0242ac12000b,THERAVANCE BIOPHARMA,theravance_biopharma,,,,52e0d1ff-2215-49b4-99dd-e6e6ac83eb94,theravance,THERAVANCE -5659,,57776011-4a1f-4529-9ddc-acfeba01e3f1,MDS Finland Oy,mds_finland_oy,,,,,, -5660,,03d1085d-e8a3-4db0-9507-b18ac51c094b,Chelsea and Westminster Hospital,chelsea_and_westminster_hospital,,,,,, -5661,,875672d4-9306-4aa1-97fa-5feb1ad2ab85,Roskilde University Hospital,roskilde_university_hospital,,,,,, -5662,,fd1a89dc-8807-11e6-a998-0242ac12000b,Prana Biotechnology,prana_biotechnology,,,,,, -5663,,be4350f3-a703-4086-ada5-7e2eea56df0b,"GUIDE Clinic, St James's Hospital",guide_clinic_st_james_s_hospital,,,,,, -5664,,cfe3db66-7142-11e6-a0cd-0242ac12000b,B BRAUN,b_braun,,,,,, -5665,,ab129215-0e92-4d69-8642-874a93241fec,Humedics GmbH,humedics_gmbh,,,,,, -5666,,2a2c20de-072d-4a13-b797-f1df68e09a1b,Dutch Kidney Foundation,dutch_kidney_foundation,,,,,, -5667,,d1f172d9-3bae-4072-9901-6f28a6e7566d,GENMAB,genmab,,,,,, -5668,,0808899e-0133-4e34-8c1e-b8b4c6e9f737,Cambridge Hospitals NHS Foundation Trust and Cambridge University,cambridge_hospitals_nhs_foundation_trust_and_cambridge_university,,,,,, -5669,,41c4cbec-71a1-11e6-a0cd-0242ac12000b,ATNAHS PHARMA US,atnahs_pharma_us,,,,,, -5670,,01d4edfe-17bc-4f2b-95c1-20fa7a0c10a6,Jorge Matias-Guiu Guia,jorge_matias_guiu_guia,,,,,, -234,0.98327115178108215,8609a092-7ab5-4797-982f-b897d6c7826b,Novartis Pharma,novartis_pharma,,,,7a736c7a-e49d-4f6d-a8da-98014f1ac986,novartis_pharma,Novartis Pharma -5671,,575e0b5c-84ce-4a35-8cd8-9f15428dbfa6,Lybar a.s,lybar_a_s,,,,,, -528,0.97553372383117676,2e1170b4-5a8c-4423-9ccd-2a59a1cdfee7,Roche Farma S.A,roche_farma_s_a,,,,0df36129-756b-443b-b038-466e73715fa6,roche_farma_s_a_en_nombre_de_genentech_inc,"Roche Farma S.A en nombre de Genentech, Inc" -5672,,1f3e22f0-5933-4d74-9885-0e8703e98611,"Cerexa, Inc. (subsidiary of Forest Laboratories)",cerexa_inc_subsidiary_of_forest_laboratories,,,,,, -5673,,1f714897-9b27-4e56-878d-80e451572a85,CESAR MARGARIT FERRI,cesar_margarit_ferri,,,,,, -5674,,fea83567-5bf7-44fb-b02e-63f9306b04c0,Plethora Solutions Ltd,plethora_solutions_ltd,,,,,, -5675,,42d5a3e1-7e5e-4c36-95bb-17926ce1af2a,AZIENDA OSPEDALIERA POLICLINICO DI MODENA,azienda_ospedaliera_policlinico_di_modena,,,,,, -5676,,096e3856-ebfa-496a-8273-51b5c08aaa65,Shire Pharmaceutical Contracts Ltd,shire_pharmaceutical_contracts_ltd,,,,,, -5677,,201bddeb-f6ec-4dfd-93fc-25e6f1d24c4b,SOFAR SPA,sofar_spa,,,,,, -5678,,c7c87fd6-7192-11e6-a0cd-0242ac12000b,TEVA BRANDED PHARM,teva_branded_pharm,,,,,, -5679,,aa43b9da-17af-4d2d-ad36-2dc3c97575be,"A.I.L. (ASSOCIAZIONE ITALIANA CONTRO LE LEUCEMIE, LINFOMI E MIELOMI",a_i_l_associazione_italiana_contro_le_leucemie_linfomi_e_mielomi,,,,,, -5680,,7139cb87-7827-4e78-a281-aefce5ab1512,Targovax Oy,targovax_oy,,,,,, -5681,,e93e9750-71b8-4293-80a2-b09b52b55987,Asociación para el estudio de enfermedades infecciosas,asociaci_n_para_el_estudio_de_enfermedades_infecciosas,,,,,, -5682,,3657b98d-9a98-4378-ac81-3f6977c1a661,Univ.-Kl. f.Augenheilkunde und Optometrie Wien,univ_kl_f_augenheilkunde_und_optometrie_wien,,,,,, -5683,,aedb4332-71a1-11e6-a0cd-0242ac12000b,PELAGIUS,pelagius,,,,,, -5684,,e05eff00-7f87-418c-b603-023c04a66670,GlaxoSmithKline R & D,glaxosmithkline_r_d,,,,,, -5685,,a5830a7a-3e79-4733-868d-b40f2ec40f8b,"Karolinska Institutet, Institution CLINTEC, enheten för anestesi",karolinska_institutet_institution_clintec_enheten_f_r_anestesi,,,,,, -5686,,0fbac65a-a8bc-4562-9634-3a2d3cf67294,R&D Addenbrookes Hospital,r_d_addenbrookes_hospital,,,,,, -5687,,14f4c4a6-7164-11e6-a0cd-0242ac12000b,HAMELN RDS GMBH,hameln_rds_gmbh,,,,,, -5688,,00946820-0adf-4ae8-8776-0742c717b6ee,CRLC VAL D’AURELLE,crlc_val_d_aurelle,,,,,, -5689,,e87035b4-12c6-46bd-8989-e7ec462c91d9,KU Leuven - Centre for Pharmacotherapy,ku_leuven_centre_for_pharmacotherapy,,,,,, -5690,,6a20db2c-d001-48c7-baf4-866c74d59002,DAIDS,daids,,,,,, -5691,,4feb9e30-7165-11e6-a0cd-0242ac12000b,OC PHARMA,oc_pharma,,,,,, -5692,,8100cbc9-cab2-49dd-a881-c3c1df1b107c,"Oslo University Hospital, Cancer Research Un it",oslo_university_hospital_cancer_research_un_it,,,,,, -5693,,a1fc4956-7154-11e6-a0cd-0242ac12000b,EI INC,ei_inc,,,,,, -5694,,84277f48-4561-479c-bd80-e8feee00743f,H. La Paz,h_la_paz,,,,,, -5695,,dfdc8f1f-6576-49d6-bcbd-480b40cdbe61,AVIR Green Hills Biotechnology Research Development Trade AG,avir_green_hills_biotechnology_research_development_trade_ag,,,,,, -5696,,2fc83671-bf15-4612-a423-e79a014ff9c6,ANZIC RESEARCH CENTRE,anzic_research_centre,,,,,, -218,0.97293919324874878,1e6ddb3d-f0f4-4b4e-89ca-d0b431c769eb,"Vifor Pharma, Vifor (International) Ltd",vifor_pharma_vifor_international_ltd,,,,15cb26f8-fd0f-4c18-8afe-0d8c7f03ce9f,vifor_pharma,Vifor Pharma -5697,,0c720e9a-7193-11e6-a0cd-0242ac12000b,CASPER PHARMA LLC,casper_pharma_llc,,,,,, -5698,,6bc61f90-5301-4676-a48d-12e25b299b43,ISTITUTO PER L'INFANZIA BURLO GAROFOLO,istituto_per_l_infanzia_burlo_garofolo,,,,,, -5699,,582fc826-95be-4467-ac77-e4072b39a635,NCIC Clinical Trial Group (NCIC CTG),ncic_clinical_trial_group_ncic_ctg,,,,,, -5700,,3fb57537-712c-4215-9ca4-ca312f62de6f,Dr. Daniel Podzamczer Palter (Unidad de VIH. Servicio de Enfermedades Infecciosas. Hospital de Bellvitge),dr_daniel_podzamczer_palter_unidad_de_vih_servicio_de_enfermedades_infecciosas_hospital_de_bellvitge,,,,,, -848,0.928667,c887e4c4-6fbd-11e6-abe8-0242ac12000b,Nederlands Kanker Instutuut-Antonie van Leeuwenhoek Ziekenhuis,nederlands_kanker_instutuut_antonie_van_leeuwenhoek_ziekenhuis,,,,c292a342-b266-4a04-9816-329eda28532a,nederlands_kanker_instituut_antoni_van_leeuwenhoek_ziekenhuis_nki_avl,Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis (NKI-AVL) -991,0.98197799921035767,136feb9a-ae28-4c13-afe3-e135660d48aa,Great Ormond Street Hospital,great_ormond_street_hospital,,,,136feb9a-ae28-4c13-afe3-e135660d48aa,great_ormond_street_hospital,Great Ormond Street Hospital -5701,,6826d4ec-8b85-427c-bb25-f10de5f646b0,"Medical University of Vienna, Department of Anesthesiology",medical_university_of_vienna_department_of_anesthesiology,,,,,, -798,0.98433560132980347,1466a25b-707c-4fd6-8cf9-33dfd10f0436,Technische Universität München Fakultät für Medizin,technische_universit_t_m_nchen_fakult_t_f_r_medizin,,,,1466a25b-707c-4fd6-8cf9-33dfd10f0436,technische_universit_t_m_nchen_fakult_t_f_r_medizin,Technische Universität München Fakultät für Medizin -5702,,1e4d090a-7472-4ef5-94da-b182b5d36501,Whittington Hospital NHS Trust,whittington_hospital_nhs_trust,,,,,, -5703,,75f81409-c9ac-4d99-9bc5-eed7a54677d3,Sheffield Children's NHS Foundation Hospital,sheffield_children_s_nhs_foundation_hospital,,,,,, -5704,,5698e666-d2c0-44c7-aa29-d90890f229f5,Thoraxklinik Heidelberg,thoraxklinik_heidelberg,,,,,, -5705,,c1716282-71fc-11e6-a0cd-0242ac12000b,BRYAN,bryan,,,,,, -5706,,3b7ea694-813e-4659-b174-e70cb536bc8a,Drug Delivery Solutions ApS,drug_delivery_solutions_aps,,,,,, -5707,,ae64ae92-3a61-44a2-b834-16be745c3ac5,U.L.S.S. 9 DI TREVISO,u_l_s_s_9_di_treviso,,,,,, -14,0.96103086074193322,41be544c-1f46-41e5-bb1b-0bb3baefda2e,"Menarini International Operations Luxembourg S.A., Avenue de la Gare, 1611 Luxembourg, Luxembourg",menarini_international_operations_luxembourg_s_a_avenue_de_la_gare_1611_luxembourg_luxembourg,,,,41be544c-1f46-41e5-bb1b-0bb3baefda2e,menarini_international_operation_luxembourg_sa,Menarini International Operation Luxembourg S.A -5708,,6fa4690d-a9dd-4b88-aa32-9d53ca11e9fe,Voyager Pharmaceutical Corporation,voyager_pharmaceutical_corporation,,,,,, -234,0.97803741693496704,7a736c7a-e49d-4f6d-a8da-98014f1ac986,Novartis,novartis,,,,7a736c7a-e49d-4f6d-a8da-98014f1ac986,novartis_pharma,Novartis Pharma -5709,,c9fb9945-c35e-4303-ae06-a7de683f3e2c,"DEFIANTE FARMACEUTICA,LDA",defiante_farmaceutica_lda,,,,,, -5710,,c063dc87-a77f-4442-82e0-7ae251688515,"HOSPITAL UNIVERSITARIO LA PAZ, SERVICIO DE ANESTESIA",hospital_universitario_la_paz_servicio_de_anestesia,,,,,, -5711,,b511b845-0322-487d-9008-a8a2c6a236c5,Oncobiologics Limited,oncobiologics_limited,,,,,, -5712,,ea1af215-ed23-4a58-8cfc-1f997d43b585,Kris-och Traumacentrum,kris_och_traumacentrum,,,,,, -5713,,5ac6f551-525b-4fde-85d0-d7c9b37b4d66,"Medizinische Universität Wien, Univ.Klinik f.Neurologie",medizinische_universit_t_wien_univ_klinik_f_neurologie,,,,,, -5714,,2950b554-7141-11e6-a0cd-0242ac12000b,SEBELA IRELAND LTD,sebela_ireland_ltd,,,,,, -5715,,b8abd6be-8a45-474d-a4d0-239384f4bb0e,"Innocrin Pharmaceuticals, Inc",innocrin_pharmaceuticals_inc,,,,,, -5716,,56b00d6d-b9b2-4434-a428-48d8e14b7352,Schur Pharmazeutika GmbH & Co. KG,schur_pharmazeutika_gmbh_co_kg,,,,,, -5717,,54d2ff3b-8157-4a72-ad08-38205b54bda7,"Foresee Pharmaceuticals Co., Ltd",foresee_pharmaceuticals_co_ltd,,,,,, -397,0.967352,d7c452de-3104-4c8e-bd02-3c40e45e5101,Copenhagen University Hospital Rigshospitalet,copenhagen_university_hospital_rigshospitalet,,,,a9e2a6af-3a27-4b28-a5a9-8ffd6a2cebe1,copenhagen_university_hospital_rigshospitalet_juliane_marie_centre_department_of_anaesthesiology,"Copenhagen University Hospital, Rigshospitalet, Juliane Marie Centre, Department of Anaesthesiology" -5718,,dfdd538c-8bf6-4c8f-9b7e-00fd922bdcdc,"Biota Pharmaceuticals, Inc",biota_pharmaceuticals_inc,,,,,, -5719,,386c5398-7143-11e6-a0cd-0242ac12000b,RENAISSANCE PHARMA,renaissance_pharma,,,,,, -5720,,90c581f7-9397-4ddb-83e6-a14c5d4537a4,"Merck Serono International, 9 Chemin des Mines, 1202 Geneva, Switzerland",merck_serono_international_9_chemin_des_mines_1202_geneva_switzerland,,,,,, -383,0.97393083572387695,cf4f2be5-6c16-4774-80da-73c264a99c4c,DBV Technologies S.A,dbv_technologies_s_a,,,,cf4f2be5-6c16-4774-80da-73c264a99c4c,dbv_technologies,DBV Technologies -5721,,be4de1e7-17d4-4ce0-8e26-cfede340d38b,AZIENDA POLICLINICO UMBERTO I,azienda_policlinico_umberto_i,,,,,, -5722,,4feb5c48-b6cf-4faf-917a-478d58dd7f50,Flevoziekenhuis,flevoziekenhuis,,,,,, -5723,,435a329b-40e9-43eb-92dd-e4e6e04d993f,"University Department of General, Visceral and Transplant Surgery Tuebingen",university_department_of_general_visceral_and_transplant_surgery_tuebingen,,,,,, -5724,,3a28b04b-6dc7-4716-97c5-d0d0f2e93b75,St Olavs Hospital Trondheim University Hospital,st_olavs_hospital_trondheim_university_hospital,,,,,, -5725,,4aef118f-d054-4dfe-88bb-723e5e9b5bb2,CAMBRIDGE UNIVERSITY HOSPITALS FOUNDATION NHS TRUST,cambridge_university_hospitals_foundation_nhs_trust,,,,,, -5726,,2b72ec07-4540-49ac-8796-4660d71de077,"Ministery of Defense, Military Mental Health - Research Centre",ministery_of_defense_military_mental_health_research_centre,,,,,, -5727,,fe01c6e3-0cc6-45e7-a705-cb6034608482,KV Pharmaceutical,kv_pharmaceutical,,,,,, -5728,,fb5faea6-7141-11e6-a0cd-0242ac12000b,EBEWE PHARMA,ebewe_pharma,,,,,, -867,0.974081,321d9f48-9a0a-471b-b553-56fdf09a41f7,"Dept. of Intensive Care, Rigshospitalet",dept_of_intensive_care_rigshospitalet,,,,321d9f48-9a0a-471b-b553-56fdf09a41f7,dept_of_intensive_care_rigshospitalet,"Dept. of Intensive Care, Rigshospitalet" -5729,,a5904c81-d7dd-4683-969f-d5cc2214fb11,Monash University,monash_university,,,,,, -5730,,6f418776-73be-11e6-a0cd-0242ac12000b,TALON THERAP,talon_therap,,,,,, -5731,,7eb33d6a-b44c-48d4-8dcd-f18317ecdcc3,Centre Hospitalier Intercommunal de Toulon - La Seyne sur Mer,centre_hospitalier_intercommunal_de_toulon_la_seyne_sur_mer,,,,,, -5732,,4d59ac92-167b-4b46-85e6-d3fb1e231a1a,"Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam",department_of_gastroenterology_and_hepatology_erasmus_mc_rotterdam,,,,,, -5733,,16ac32fe-7158-11e6-a0cd-0242ac12000b,PERRIGO R AND D,perrigo_r_and_d,,,,,, -958,0.979515,f16aba98-7151-11e6-a0cd-0242ac12000b,ELAN PHARM,elan_pharm,,,,6388a82e-7157-11e6-a0cd-0242ac12000b,elan_pharma_intl_ltd,ELAN PHARMA INTL LTD -5734,,d2023fdc-07d2-4bb0-9367-08e6755755df,Department of Anaesethesia,department_of_anaesethesia,,,,,, -5735,,667a69d2-6549-498c-9838-28c2bb9c24d3,Translational Oncology Research International,translational_oncology_research_international,,,,,, -5736,,6074af23-cc0e-41fb-a53e-27b8c4047675,Sepsicure LLC,sepsicure_llc,,,,,, -5737,,8da85710-7154-11e6-a0cd-0242ac12000b,THREE RIVERS PHARMS,three_rivers_pharms,,,,,, -5738,,d76cbcd7-75b7-4dad-a66c-eb7e73c8a607,"Jennerex, Inc",jennerex_inc,,,,,, -5739,,687c8251-d912-4b15-903f-d0ec5ad3f925,Sandoz GmbH,sandoz_gmbh,,,,,, -5740,,74823312-7a82-4064-89ef-0e812f9d60d3,GEL/TAMO (Cooperative Spanish Group of Lymphoma/Autologous bone marrow transplant),gel_tamo_cooperative_spanish_group_of_lymphoma_autologous_bone_marrow_transplant,,,,,, -5741,,1a245251-50f0-415f-b0da-8eb0a46d2137,Gesellschaft für Studienmanagement und Onkologie mbH,gesellschaft_f_r_studienmanagement_und_onkologie_mbh,,,,,, -742,0.964268,9cc141c9-55dc-4b03-84cc-245b7d5f45e4,Charite Universitaetsmedizin Berlin,charite_universitaetsmedizin_berlin,,,,50350555-1ec9-4ba6-9bb5-53e28ef8341d,charite,Charite -5742,,f30a9636-d4fe-4d5b-8a4b-4a834b287ca9,SANOFI-SYNTHELABO,sanofi_synthelabo,,,,,, -5743,,b3f463cb-d158-4436-8c43-df23061d7800,Cardiovascular Centre Aalst,cardiovascular_centre_aalst,,,,,, -8,0.90233862400054932,2f76c773-c7d9-474d-8b40-14c16bf7796f,Centre Hospitalier Universitaire de Reims,centre_hospitalier_universitaire_de_reims,,,,2522451a-1c66-4b28-bcf5-7bcf3f2f11b8,centre_hospitalier_universitaire_de_saint_etienne,Centre Hospitalier Universitaire de Saint-Etienne -5744,,ea699df7-bbf2-4856-a21f-e3ada0f3054c,Dr. Francisco Marrero Rodríguez. Hospital Universitario de Canarias,dr_francisco_marrero_rodr_guez_hospital_universitario_de_canarias,,,,,, -99,0.9399416446685791,bcb0e637-6442-4916-88f9-8cd0d5df3534,Novartis Farmacéutica,novartis_farmac_utica,,,,bcb0e637-6442-4916-88f9-8cd0d5df3534,novartis_farmaceutica,Novartis Farmaceutica -44,0.98179709911346436,58b676d5-ffb0-437b-b207-8be9df7a578f,Medicinsk Forskning,medicinsk_forskning,,,,035a6b1e-8bb9-11e6-a449-0242ac12000b,medicinsk_forskningsafsnit_holstebro,"Medicinsk Forskningsafsnit, Holstebro" -984,0.96790230274200439,1c2355a5-8dc8-4952-839c-0af765b26555,Imperial College London & Imperial College Healthcare NHS Trust,imperial_college_london_imperial_college_healthcare_nhs_trust,,,,1c2355a5-8dc8-4952-839c-0af765b26555,imperial_college_london_imperial_college_healthcare_nhs_trust,Imperial College London & Imperial College Healthcare NHS Trust -5745,,ba9eb216-6373-4b24-9560-aeb55105617f,"Rigshospitalet, Department of Oncology",rigshospitalet_department_of_oncology,,,,,, -5746,,d69ddc70-73f1-11e6-a0cd-0242ac12000b,NOVA LABS LTD,nova_labs_ltd,,,,,, -5747,,bad4acce-86c1-418f-a0ba-5bbc84162799,ICORG-All Ireland Co-operative Oncology Research Group,icorg_all_ireland_co_operative_oncology_research_group,,,,,, -714,0.985233,eae4c2b2-715c-11e6-a0cd-0242ac12000b,EUROHLTH INTL,eurohlth_intl,,,,0354c2c2-7129-11e6-a89e-0242ac12000b,eurohlth_intl_sarl,EUROHLTH INTL SARL -5748,,83827bc9-2fcc-4bd4-9bbb-973756d2bcc3,GIOM - Gruppo Italiano Oncologia Nefrologica,giom_gruppo_italiano_oncologia_nefrologica,,,,,, -5749,,36649dc5-d166-4496-8102-43c7682f0c9d,Boerhinger Ingelheim Pharma GmbH & Co.KG,boerhinger_ingelheim_pharma_gmbh_co_kg,,,,,, -5750,,c20cd435-3adc-4a02-8621-1e24a420ce82,Ester Neuroscience Ltd,ester_neuroscience_ltd,,,,,, -5751,,96be75f1-6f42-4e23-a152-6fcabfd7eb8f,Dr. Jaime Sagrista Sauleda,dr_jaime_sagrista_sauleda,,,,,, -5752,,b4dc07c0-95d0-4512-b89d-e5276f41e28d,Lumavita AG,lumavita_ag,,,,,, -5753,,a40f1b88-a986-483d-a539-b6cb3886f97f,Unit for Psychiatric Research,unit_for_psychiatric_research,,,,,, -5754,,04f61777-7bb8-4a5b-b201-5ff7c7ca0ae6,Esteban Ribera Pascuet,esteban_ribera_pascuet,,,,,, -5755,,0c915eb7-bec3-489a-8cbb-82a1d24048ba,"Department of Psychiatry and Psychotherapy, Charity University Medicine",department_of_psychiatry_and_psychotherapy_charity_university_medicine,,,,,, -5756,,7ff80805-62e2-4470-b0b0-87440be5e547,AesRx,aesrx,,,,,, -5757,,c3ee37b5-f7df-432e-835e-2c9f41fa7aae,Dynavax Technologies Corporation,dynavax_technologies_corporation,,,,,, -75,0.984093,d1b481d9-2e7a-4149-86cf-32b5b57a8168,GALENpharma GmbH,galenpharma_gmbh,,,,d1b481d9-2e7a-4149-86cf-32b5b57a8168,galenpharma_gmbh,GALENpharma GmbH -190,0.985423,1f75a770-d643-44ba-b10f-91da8b571eaa,Prima BioMed Ltd,prima_biomed_ltd,,,,1f75a770-d643-44ba-b10f-91da8b571eaa,prima_biomed_ltd,Prima BioMed Ltd -115,0.97782391309738159,b28c49a1-c21b-407a-9fd2-2dbd3207b28b,Shire,shire,,,,b28c49a1-c21b-407a-9fd2-2dbd3207b28b,shire,Shire -5758,,4838252f-a7ab-11e6-94cb-5656d04fc2b5,Corcept Therapeutics Incorporated,corcept_therapeutics_incorporated,,,,,, -5759,,1e9c5a17-7c4b-44c8-be23-3f12ea555d32,"Universität Mainz, III. Medizinische Klinik",universit_t_mainz_iii_medizinische_klinik,,,,,, -5760,,8b5aa592-0b1c-4e62-b04d-5f080be47319,VUAB Pharma a.s,vuab_pharma_a_s,,,,,, -5761,,2dd700e1-5ebb-4d23-ade5-a84cd5bf2eca,"Hôpital Erasme, Cliniques Universitaires de Bruxelles",h_pital_erasme_cliniques_universitaires_de_bruxelles,,,,,, -876,0.90458685159683228,5cd5bf06-2291-4844-9da5-1660b3540deb,FUNDACION PARA LA INVESTIGACION LA FE,fundacion_para_la_investigacion_la_fe,,,,5cd5bf06-2291-4844-9da5-1660b3540deb,fundacion_para_la_investigacion_la_fe,FUNDACION PARA LA INVESTIGACION LA FE -5762,,e91c08b7-b787-4e12-b24b-b37f8bc57cdc,Sociedad Española de Cardiología,sociedad_espa_ola_de_cardiolog_a,,,,,, -5763,,bb62f128-6fc0-11e6-abe8-0242ac12000b,Johnson & Johnson Taiwan Ltd,johnson_johnson_taiwan_ltd,,,,,, -787,0.98334300518035889,08982651-8665-4f48-91ab-412b9c9c69a9,"Intercell USA, Inc. (Intercell)",intercell_usa_inc_intercell,,,,08982651-8665-4f48-91ab-412b9c9c69a9,intercell_usa_inc_intercell,"Intercell USA, Inc. (Intercell)" -5764,,8f4924d1-212a-4921-8c16-0c43a8e38a3f,CONSORZIO ONCOTECH,consorzio_oncotech,,,,,, -5765,,f07ec2e0-5176-4b6e-83a8-506b890c8b89,SINTETICA ITALIA S.R.L,sintetica_italia_s_r_l,,,,,, -5766,,1e4fd291-1d3f-4b28-94df-b497128a1b36,"Medical University, Dpt. Internal Medicine, Div. of General Internal Medicine",medical_university_dpt_internal_medicine_div_of_general_internal_medicine,,,,,, -129,0.97715285420417786,2089014e-7f36-4848-b094-a8d5070e2afb,Cliniques Universitaires St Luc,cliniques_universitaires_st_luc,,,,4bc32527-accc-401e-81cd-afaacbe32d0c,cliniques_universitaires_st_luc,Cliniques Universitaires St Luc -5767,,b0b25ef0-5d3c-4602-b2f5-e750672ab211,National Headache Institute,national_headache_institute,,,,,, -5768,,1f32198f-8f9f-499a-8459-4ea26085dc87,Alllergopharma Joachim Ganzer KG,alllergopharma_joachim_ganzer_kg,,,,,, -5769,,7ad534cf-5ac2-42a6-b9c7-27adff12e69d,"Helsinn Therapeutics (U.S.), Inc",helsinn_therapeutics_u_s_inc,,,,,, -5770,,c2b1b06c-7165-11e6-a0cd-0242ac12000b,ORION CORP ORION,orion_corp_orion,,,,,, -5771,,76119c3f-3523-417e-a553-ed9634ae8bb1,Dr. Ritsert Pharma,dr_ritsert_pharma,,,,,, -5772,,b0960a5d-4802-438f-a2e3-d7faf8cc34d7,CIS bio International,cis_bio_international,,,,,, -5773,,54e8c1b1-d992-44ff-abd2-28abb8115d75,"Dekan der medizinischen Fakultät, Universitätsklinikum Frankfurt, Goethe-Universität",dekan_der_medizinischen_fakult_t_universit_tsklinikum_frankfurt_goethe_universit_t,,,,,, -5774,,dd9cb800-54ff-44b3-a6cf-e11d27056dd4,Elisabethinen Hospital Linz,elisabethinen_hospital_linz,,,,,, -5775,,80e88be2-f1b6-4178-a889-646d0680ae4b,Dept of Neurology,dept_of_neurology,,,,,, -5776,,a1794bf1-44f1-4434-a091-96f689b5c409,"Universitätsklinikum Aachen, Klinik f. Psychiatrie und Psychotherapie",universit_tsklinikum_aachen_klinik_f_psychiatrie_und_psychotherapie,,,,,, -5777,,7f352824-f43c-47b8-b3eb-f47f9b8ca55f,Genetronics Biomedical Corporation,genetronics_biomedical_corporation,,,,,, -5778,,9804ca16-f3ae-482f-a4e3-8e7d33f52a02,Alcon Sverige AB,alcon_sverige_ab,,,,,, -5779,,e58d6e1f-7af1-4f47-9686-709d0c794566,The Swedish AML Group,the_swedish_aml_group,,,,,, -883,0.97897982597351074,0ea5911a-7142-11e6-a0cd-0242ac12000b,ALTANA,altana,,,,0ea5911a-7142-11e6-a0cd-0242ac12000b,altana,ALTANA -5780,,3bed5ffc-c126-4e18-974f-dd6cfd783095,Cardio3 BioSciences SA,cardio3_biosciences_sa,,,,,, -5781,,409f50f7-22fe-4909-9fcf-485f96c2e9f5,GUIDOTTI,guidotti,,,,,, -5782,,443db8b8-7145-11e6-a0cd-0242ac12000b,EPIC PHARMA LLC,epic_pharma_llc,,,,,, -5783,,aed1551a-a597-4f9b-83f2-f31d031fde86,CESAR AUGUSTO VALERO MARTINEZ,cesar_augusto_valero_martinez,,,,,, -5784,,b425f68a-7191-11e6-a0cd-0242ac12000b,TEVA WOMENS,teva_womens,,,,,, -5785,,d1b2a40c-56d4-4785-8ff9-994ff7ad88fb,Seikagaku Corporation,seikagaku_corporation,,,,,, -237,0.98591169714927673,a0e33e4c-faf3-44df-85c6-ebc94469b62e,"Pfizer Limited, Ramsgate Road, Sandwich, Kent, UK",pfizer_limited_ramsgate_road_sandwich_kent_uk,,,,a0e33e4c-faf3-44df-85c6-ebc94469b62e,pfizer_limited_ramsgate_road_sandwich_kent_uk,"Pfizer Limited, Ramsgate Road, Sandwich, Kent" -5786,,4e6dad98-4731-4c2d-9076-7b412f2ef646,USV Limited,usv_limited,,,,,, -5787,,c2912cd3-2337-4ff2-aaa5-613b0c7956b2,"Landeshauptstadt Stuttgart, represented by Prof. Dr. J. Graf, Leitender Aerztlicher Direktor Klinikum Stuttgart",landeshauptstadt_stuttgart_represented_by_prof_dr_j_graf_leitender_aerztlicher_direktor_klinikum_stuttgart,,,,,, -5788,,63c5003a-73f0-11e6-a0cd-0242ac12000b,SCOTT-GROSS COMPANY,scott_gross_company,,,,,, -5789,,00b74dce-36a4-43e2-a58d-c23d0a333d04,Nordic Lymphoma Group,nordic_lymphoma_group,,,,,, -5790,,410db730-71e3-11e6-a0cd-0242ac12000b,DOWNSTATE CLINCL,downstate_clincl,,,,,, -5791,,49b8a3f8-71ee-11e6-a0cd-0242ac12000b,CONCORDIA LABS INC,concordia_labs_inc,,,,,, -5792,,2f229595-c3dc-40eb-be1c-e592787d8ea0,Stepani Bendel,stepani_bendel,,,,,, -5793,,c179aab3-9347-4a50-aea8-fbe5a3e19dc4,Phafag AG,phafag_ag,,,,,, -568,0.971368,2a99366d-c8b5-4d6b-a57e-00e956554937,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico,fondazione_irccs_c_granda_ospedale_maggiore_policlinico,,,,2a99366d-c8b5-4d6b-a57e-00e956554937,fondazione_irccs_c_granda_ospedale_maggiore_policlinico,Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico -5794,,a1634d25-50bb-479e-a796-3df303757e17,"Department of Medicine M, Aarhus University Hospital",department_of_medicine_m_aarhus_university_hospital,,,,,, -15,0.946972,4becd0cc-b39a-41ea-8a3e-45c64348e698,AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI CREMONA,azienda_ospedaliera_istituti_ospitalieri_di_cremona,,,,4becd0cc-b39a-41ea-8a3e-45c64348e698,azienda_ospedaliera_istituti_ospitalieri_di_cremona,AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI CREMONA -5795,,ead7b187-89a2-404b-9225-3a6bd3ffe168,Leila Niemi-Murola,leila_niemi_murola,,,,,, -5796,,cdf03669-e8a1-4948-9080-d1681d7788ae,"Medizinische Universität Wien, Univ.Klinik für Kinder-und Jugendheilkunde",medizinische_universit_t_wien_univ_klinik_f_r_kinder_und_jugendheilkunde,,,,,, -5797,,9cd9c697-b224-4e0f-885a-f7d08ae50ebc,Eero Kaasinen,eero_kaasinen,,,,,, -5798,,4b9efd0c-e025-4df0-8a68-3c20ef40fd69,FUJISAWA,fujisawa,,,,,, -5799,,42482d1e-b420-4968-b720-5e2b11f0bcf5,Boehrringer Ingelheim Finland Ky,boehrringer_ingelheim_finland_ky,,,,,, -5800,,4310b5bd-c53f-40f5-9f74-219e40789117,Trevena Inc,trevena_inc,,,,,, -5801,,e7613e9b-586d-4312-bf40-13fdef853c82,Alberto Capelastegui Sainz,alberto_capelastegui_sainz,,,,,, -5802,,1c347ef6-1a52-487a-b0da-9587436ce522,Genta Incorporated,genta_incorporated,,,,,, -5803,,a8abd90f-c34f-4ecd-8fcd-472d64e95c07,PIERRE FABRE MEDICAMENT represented by Institut de Recherche Pierre Fabre,pierre_fabre_medicament_represented_by_institut_de_recherche_pierre_fabre,,,,,, -998,0.987967,43136b72-9ea5-4280-955b-222830e86bf5,Lipid Pharmaceuticals ehf,lipid_pharmaceuticals_ehf,,,,43136b72-9ea5-4280-955b-222830e86bf5,lipid_pharmaceuticals_ehf,Lipid Pharmaceuticals ehf -5804,,614c7f8c-04ca-4949-b1b1-8f42748277c5,The Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery,the_ludwig_boltzmann_institute_for_retinology_and_biomicroscopic_lasersurgery,,,,,, -5805,,b1731873-b436-4844-8912-672937e556f7,Antoni van Leeuwenhoek ziekenhuis,antoni_van_leeuwenhoek_ziekenhuis,,,,,, -5806,,39c22725-f367-44dd-99d1-0abec487a4c5,Brighton & Sussex University Hospitals NHS Trust,brighton_sussex_university_hospitals_nhs_trust,,,,,, -5807,,266cecd5-1f21-4f17-8bf2-cebe94728d3b,Hans Christian Wulf,hans_christian_wulf,,,,,, -5808,,9cc08f85-c758-4743-83a6-2325d3ac9c04,Landeskrankenhaus Fedkirch,landeskrankenhaus_fedkirch,,,,,, -5809,,b62e7f75-261f-4503-bb23-89bde04c04c9,GRUPO GETNE,grupo_getne,,,,,, -5810,,b1f0b4a7-295b-496f-b8c8-91b9eeba6a9e,"Abbott Products, Inc (Abbott Products Inc. is part of the parent company, Abbott Laboratories)",abbott_products_inc_abbott_products_inc_is_part_of_the_parent_company_abbott_laboratories,,,,,, -5811,,4b63f5c0-d516-4d83-ac0e-780013884646,"University Medical Center Nijmegen, dept. of Pharmacology-Toxicology",university_medical_center_nijmegen_dept_of_pharmacology_toxicology,,,,,, -5812,,5b2cd722-4729-438e-b703-b9ffb5684c0a,MASTELLI SRL,mastelli_srl,,,,,, -5813,,a9d5fa09-8561-48ae-a22a-912d4760fe0a,Dott.ssa Elena Santagostino,dott_ssa_elena_santagostino,,,,,, -35,0.977622,366baf89-cad4-4cfd-9336-5896cd05adb2,Landstinget Västmanland,landstinget_v_stmanland,,,,1b03f797-4154-432f-973b-87560cdf6cc4,landstinget_v_stmanland_division_kirurgi_operationskliniken,"Landstinget Västmanland, Division Kirurgi, Operationskliniken" -5814,,b6096e43-c252-4ccd-ab01-04fc2d181309,CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE,centre_hospitalier_universitaire_de_lille,,,,,, -5815,,64534176-1e28-48bc-aa28-882696d200b6,Novartis Pharma GmbH,novartis_pharma_gmbh,,,,,, -5816,,400e7fb4-e457-4ab6-9885-01cc2e2cf624,The Walton Centre NHS Foundation Trust,the_walton_centre_nhs_foundation_trust,,,,,, -5817,,997a0432-8a20-46b0-b73b-049095c547d0,JJANSSEN-CILAG, JOHNSON & JOHNSON spol. s r.o,,,,,, -5818,,d4086914-728c-11e6-a0cd-0242ac12000b,EXALENZ BIOSCIENCE,exalenz_bioscience,,,,,, -5819,,127ddead-226d-41b9-9d40-eda4c09b4c7a,Professor Jørgen Berg Dahl,professor_j_rgen_berg_dahl,,,,,, -5820,,6b4624ec-73c3-11e6-a0cd-0242ac12000b,LUNDBECK NA LTD,lundbeck_na_ltd,jjanssen_cilag_johnson_johnson_spol_s_r_o,,,,, -5821,,63db7ef7-ebfa-4d50-890d-c0713ad9a688,"Genzyme Europe B.V, Netherlands",genzyme_europe_b_v_netherlands,,,,,, -5822,,66510292-57c1-43f3-b6f0-e70ab102d7db,"Dept. of Neurology, Odense University Hospital",dept_of_neurology_odense_university_hospital,,,,,, -5823,,fdfef672-e1b8-493b-bce6-1c9f94943d4c,Wockhardt UK Limited,wockhardt_uk_limited,,,,,, -5824,,3817c5cd-ea3b-4f4a-a4b3-79eb95e3e0f6,Pfizer Global Research and Development,pfizer_global_research_and_development,,,,,, -5825,,32e42ab1-2403-40ae-a793-d8859207c4c0,C4Pain ApS,c4pain_aps,,,,,, -5826,,f12d9d48-0032-4245-b405-eaffe7522a4b,Resverlogix Corp,resverlogix_corp,,,,,, -5827,,c86bd526-7180-11e6-a0cd-0242ac12000b,SICOR BIOTECH,sicor_biotech,,,,,, -5828,,2dc8a129-9009-4796-9308-079dac6aebe5,"Vassilis Georgoulias, Prof. of Internal Medicine-Oncology of Medical Dpt University of Crete",vassilis_georgoulias_prof_of_internal_medicine_oncology_of_medical_dpt_university_of_crete,,,,,, -5829,,fe9e74b6-bc1e-4f0e-924c-47d9d09d5b55,Juvantia Pharma Ltd,juvantia_pharma_ltd,,,,,, -5830,,b1662bea-7321-11e6-a0cd-0242ac12000b,POWDER PHARMS,powder_pharms,,,,,, -5831,,8497a86e-40bb-4b5e-9ff4-f2e4fd7144e2,AZIENDA SANITARIA LOCALE 4 DI TORINO,azienda_sanitaria_locale_4_di_torino,,,,,, -5832,,271ba7a6-6260-431b-8399-70d7a97fb402,Kyowa Hakko U.K. Limited,kyowa_hakko_u_k_limited,,,,,, -5833,,be18238d-cb8e-42e3-b15b-6ce0eb6a5efc,"Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin",allergie_centrum_charit_department_of_dermatology_and_allergy_charit_universit_tsmedizin_berlin,,,,,, -5834,,5d60a0c9-8761-47b0-af8e-0cda96d53862,"Dept. of Anaesthesia, Medical University of Vienna",dept_of_anaesthesia_medical_university_of_vienna,,,,,, -995,0.98229312896728516,9f829155-76f5-4952-b92c-64b02c2f74f8,GE Healthcare Limited and its affiliates,ge_healthcare_limited_and_its_affiliates,,,,3f41d035-5505-424a-9eba-1d3001157ba6,ge_healthcare_limited,GE Healthcare Limited -5835,,3b410f42-1863-4a79-895e-8ae40639a265,HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON,hospital_general_universitario_gregorio_mara_on,,,,,, -784,0.966541,8c460761-0f56-46e2-8808-c7288d449545,EORTC,eortc,,,,8c460761-0f56-46e2-8808-c7288d449545,eortc,EORTC -5836,,bd1ada88-7762-409f-b069-27f969f42822,Merck Santé s.a.s,merck_sant_s_a_s,,,,,, -5837,,22598306-ce1f-44d4-a20c-d541a41f6ec9,K.U. Leuven,k_u_leuven,,,,,, -5838,,43695ee0-efb5-40ef-8115-71fddcb080c1,OSPEDALE SACRO CUORE-DON CALABRIA,ospedale_sacro_cuore_don_calabria,,,,,, -795,0.982732,f3146d45-b80c-4479-bdfd-0aff428c6b73,Medical Research Council Clinical Trials Unit,medical_research_council_clinical_trials_unit,,,,a794f8fb-a13b-44b5-98ab-9945768f16df,medical_research_council,Medical Research Council -406,0.98668,6a695a29-050c-4d3f-8e0d-c6d6a3afc8f2,Beaumont Hospital/RCSI,beaumont_hospital_rcsi,,,,6a695a29-050c-4d3f-8e0d-c6d6a3afc8f2,beaumont_hospital_rcsi,Beaumont Hospital/RCSI -5839,,edd85721-72cf-4b8f-9f91-cc96f5dca1e0,Mikkel Østergaard,mikkel_stergaard,,,,,, -5840,,2e4d8d4b-5380-4126-9f90-9f29429309ed,"Gentofte Hospital, Dep. of Medicine",gentofte_hospital_dep_of_medicine,,,,,, -133,0.951362,71e1740c-dc4b-46d2-86ac-23909116857c,Vakgroep Huisartsgeneeskunde Vrije Universiteit Brussel,vakgroep_huisartsgeneeskunde_vrije_universiteit_brussel,,,,71e1740c-dc4b-46d2-86ac-23909116857c,vakgroep_huisartsgeneeskunde_vrije_universiteit_brussel,Vakgroep Huisartsgeneeskunde Vrije Universiteit Brussel -5841,,dddfafc5-124e-4706-91c9-05c38d1e2a97,Henning Beck-Nielsen,henning_beck_nielsen,,,,,, -316,0.987803,bb3763b5-ae54-4b86-8b38-ca48db63ae2c,Jazz Pharmaceuticals,jazz_pharmaceuticals,,,,17eacfff-6322-4900-ab4b-4476d90f6cb8,jazz_pharmaceuticals_inc,Jazz Pharmaceuticals Inc -5842,,220456f1-0c39-4482-88b5-b1cfc67acc5a,Queen Victoria Hospital NHS Foundation Trust,queen_victoria_hospital_nhs_foundation_trust,,,,,, -5843,,e230ea06-5bb6-4fb7-a2ac-d62e0b00b5d7,Lennart Svensson Linköping University Medical Faculty,lennart_svensson_link_ping_university_medical_faculty,,,,,, -5844,,ce0c5b75-a1d5-4e3c-aa25-84c497a4f1c3,Copenhagen University Hospital Bispebjerg,copenhagen_university_hospital_bispebjerg,,,,,, -5845,,bc60c7cd-57d1-44c4-8057-9fce538c1c26,*LOC to complete*,loc_to_complete,,,,,, -5846,,24f1168d-a543-4a5c-ad9b-004ec6cce3ee,ICM- VAL D’AURELLE,icm_val_d_aurelle,,,,,, -5847,,eb467faa-455a-497e-b0d3-ffda6bcc55f1,EORTC Lymphoma Group,eortc_lymphoma_group,,,,,, -5848,,4b41251d-229d-4b19-bf64-2fede9dd4814,Pfizer Inc. - Research & Development,pfizer_inc_research_development,,,,,, -5849,,5c506588-4a5c-4ff9-bea0-5bbf2746c3d8,"FARMALIDER, S.A",farmalider_s_a,,,,,, -5850,,ea6bc3c0-3c41-4a93-9e3d-5ab71e7cd62f,Janssen Pharmaceutical K.K,janssen_pharmaceutical_k_k,,,,,, -685,0.98814409971237183,f406cf6a-764a-4362-8451-5306e5f99cb4,University Medical Center,university_medical_center,,,,6215f084-4978-4b33-9f3e-b048c59d9d5d,university_medical_center_umcu,University Medical Center UMCU -5851,,28d163d3-ceb8-49a0-864c-116c633ba923,CLINUVEL PHARMACUETICALS LTD,clinuvel_pharmacueticals_ltd,,,,,, -5852,,714556b0-39ae-4ac0-a183-cff5df1d1737,David López Vaquero,david_l_pez_vaquero,,,,,, -5853,,07765d40-fc20-42bd-86d2-62ca6f5be6cf,Parnassia Bavo Groep - PsyQ,parnassia_bavo_groep_psyq,,,,,, -5854,,089b458d-5991-4f6b-838b-f064b6ae707e,"Psykiatri Nordväst, Karolinska Universitetssjukhuset Solna",psykiatri_nordv_st_karolinska_universitetssjukhuset_solna,,,,,, -5855,,8495c042-f307-4e10-85fc-3815dc48f39e,"Optimer Pharmaceutical, Inc. (a Cubist company)",optimer_pharmaceutical_inc_a_cubist_company,,,,,, -5856,,ae0de7e2-0663-4a72-aa1e-b1775ed3364a,G.O.N.O. Gruppo Oncologico del Nord Ovest,g_o_n_o_gruppo_oncologico_del_nord_ovest,,,,,, -5857,,15d9e073-ca55-477a-b642-9ea609d9189a,Centre Paul Papin,centre_paul_papin,,,,,, -5858,,3f3d7deb-5729-46b1-8280-ad251a220dd8,Allan Flyvbjerg,allan_flyvbjerg,,,,,, -25,0.97483,575a893b-fb9f-4cff-b2fd-090f406fd398,"Abraxis BioScience, LLC",abraxis_bioscience_llc,,,,575a893b-fb9f-4cff-b2fd-090f406fd398,abraxis_bioscience_llc,"Abraxis BioScience, LLC" -5859,,5acdcbe0-8a59-426c-aea5-cbfdc5345cfb,Andrés Ignacio Bodegas Cañas,andr_s_ignacio_bodegas_ca_as,,,,,, -236,0.96209257841110229,4bcd631b-11cb-4115-911b-11d44ed9d2aa,"Pfizer Ltd, Ramsgate Road, Sandwich, Kent, UK",pfizer_ltd_ramsgate_road_sandwich_kent_uk,,,,36e40cab-06cf-41e0-bef3-04e11a49311d,pfizer_ltd_ramsgate_road_sandwich_kent,"Pfizer Ltd, Ramsgate Road, Sandwich, Kent" -5860,,9211e76f-3bc6-404d-9142-549ffc69e67b,Circassia Limited,circassia_limited,,,,,, -5861,,595c77a7-2f05-4377-adde-008df650892c,"Siegfried KASPER, O.Univ.Prof.Dr.Dr.h.c., Medizinische Universität Wien",siegfried_kasper_o_univ_prof_dr_dr_h_c_medizinische_universit_t_wien,,,,,, -5862,,da1fd1f3-cbbf-4836-ba05-d50e95cf4035,Elro Pharma,elro_pharma,,,,,, -5863,,7e476a0a-fc5d-4e6c-88cb-02d0d506e0f5,A.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA,a_i_e_o_p_associazione_italiana_ematologia_oncologia_pediatrica,,,,,, -894,0.980283,4c60518a-9908-4d13-88be-256b0c110878,"Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery, Rudolf Foundation Clinic",ludwig_boltzmann_institute_for_retinology_and_biomicroscopic_laser_surgery_rudolf_foundation_clinic,,,,25c1b375-42c4-46ab-a38f-021e8ab03a25,ludwig_boltzmann_institute_forretinology_and_biomicroscopic_laser_surgery,Ludwig Boltzmann Institute forRetinology and Biomicroscopic Laser Surgery -5864,,6ac42bb6-1d64-4e87-95c7-ae666c914a29,"Academic Medical Center, department of infectious diseases",academic_medical_center_department_of_infectious_diseases,,,,,, -5865,,b0475f82-715e-11e6-a0cd-0242ac12000b,NOVOCOL,novocol,,,,,, -5866,,342e0dbe-1a55-486d-b13f-8c56f771faa5,SmartPractice,smartpractice,,,,,, -5867,,a6338e86-7211-11e6-a0cd-0242ac12000b,DANCO LABS LLC,danco_labs_llc,,,,,, -5868,,3a64b24e-a0df-4f1b-bb32-239ad7f5bc93,Takeda Global Development Centre Europe Ltd,takeda_global_development_centre_europe_ltd,,,,,, -5869,,e1f3bb60-7164-11e6-a0cd-0242ac12000b,SUVEN LIFE,suven_life,,,,,, -5870,,ccb4af1d-193a-4b86-82db-045ef52b094c,Coombe Women and Infants University Hospital,coombe_women_and_infants_university_hospital,,,,,, -144,0.938386,790c1c0e-21be-4522-8397-7082338e668c,Joint UCLH and UCL Biomedical Research Unit,joint_uclh_and_ucl_biomedical_research_unit,,,,26bb805d-b0a7-4b5c-bcee-c5480afe6696,joint_uclh_ucl_biomedical_research_unit,Joint UCLH & UCL Biomedical Research Unit -5871,,326a7600-effd-4649-978f-5e6f2f5093e5,Federico Diaz González,federico_diaz_gonz_lez,,,,,, -5872,,44e7dfec-c02e-4e36-85a1-b6d4bc8c2532,"Department of Medicine, Haugesund Hospital",department_of_medicine_haugesund_hospital,,,,,, -5873,,1a7590fe-0f87-48c8-b1bf-6937e9032bb6,Vectura GmbH,vectura_gmbh,,,,,, -5874,,8b46dac0-21e7-426b-a817-c080ab91ead9,Mesoestetic Pharma group S.L,mesoestetic_pharma_group_s_l,,,,,, -5875,,a6436686-8fd6-4e15-bb2a-40a0b46f6e47,Kings College London/South London and Maudsley NHS Foundation Trust,kings_college_london_south_london_and_maudsley_nhs_foundation_trust,,,,,, -5876,,56eedb7f-38ea-4581-8018-ef86d2294582,University of Wuerzburg,university_of_wuerzburg,,,,,, -254,0.941004,07cef69a-6d39-498c-b1f5-a59bab4b33b0,GLAXO SMITH KLINE RESEARCH & DEVELOPMENT LTD,glaxo_smith_kline_research_development_ltd,,,,07cef69a-6d39-498c-b1f5-a59bab4b33b0,glaxo_smith_kline_research_development_ltd,GLAXO SMITH KLINE RESEARCH & DEVELOPMENT LTD -314,0.98565453290939331,b010a3d1-2373-46a5-aa8a-b8434224a757,Mundipharma AB,mundipharma_ab,,,,0c6b6aec-6007-4be6-917b-e3ac534e2858,mundipharma,Mundipharma -5877,,040029dd-29c2-43a9-b1a9-64e256ce744d,"Department of Nuclear Medicine, Odense University Hospital",department_of_nuclear_medicine_odense_university_hospital,,,,,, -5878,,a81351d0-71a0-11e6-a0cd-0242ac12000b,ALZA,alza,,,,,, -5879,,2659d697-5a06-46e5-a639-05ffb9369c59,Mundipharma Research Limited,mundipharma_research_limited,,,,,, -23,0.98531901836395264,660421b1-e8b2-4a60-8830-ced19c7ed774,University Hospitals Leuven,university_hospitals_leuven,,,,32433559-55be-43ec-8a0d-06197533759d,university_hospitals_leuven_gasthuisberg,University Hospitals Leuven (Gasthuisberg) -5880,,4e2ba68e-735f-11e6-a0cd-0242ac12000b,HERON THERAPEUTICS,heron_therapeutics,,,,,, -5881,,302a9b55-bd60-4a57-9868-7f16a3e854a0,"Wyeth Pharmaceuticals Inc., Wyeth Research Div., Clinical research and Development",wyeth_pharmaceuticals_inc_wyeth_research_div_clinical_research_and_development,,,,,, -408,0.931044,5af16d72-9df2-4fc9-8608-fbc9eb8e988a,CHU de Liege,chu_de_liege,,,,5af16d72-9df2-4fc9-8608-fbc9eb8e988a,chu_de_liege,CHU de Liege -5882,,696260f3-c278-41e1-9671-40c38e7ffbf9,Gerolsteiner Brunnen GmbH & Co. KG,gerolsteiner_brunnen_gmbh_co_kg,,,,,, -5883,,24408c3f-d7e0-4317-85a0-da4ca4d490fd,The University of Oxford,the_university_of_oxford,,,,,, -5884,,1d52a33c-4029-464f-8acd-35b21b53eafc,Medisch Centrum Alkmaar,medisch_centrum_alkmaar,,,,,, -5885,,91bd7ef8-82ee-4e89-b04c-1c5318e3bf42,"Civitas Therapeutics, a wholly owned subsidiary of Acorda Therapeutics, Inc",civitas_therapeutics_a_wholly_owned_subsidiary_of_acorda_therapeutics_inc,,,,,, -5886,,4c5285e5-b2c5-4e42-b4a4-ca772a63943a,Institute for Biomedical Aging Research,institute_for_biomedical_aging_research,,,,,, -5887,,69e095a7-3550-464e-adc3-f8ce8749a974,Tillotts Pharma AG,tillotts_pharma_ag,,,,,, -41,0.951277,1dd460c9-f84b-4b97-8376-8660e0cef195,Dr. Gerhard Mann chem.-pharm. Fabrik GmbH/ Bausch & Lomb Incorporated,dr_gerhard_mann_chem_pharm_fabrik_gmbh_bausch_lomb_incorporated,,,,1dd460c9-f84b-4b97-8376-8660e0cef195,dr_gerhard_mann_chem_pharm_fabrik_gmbh_bausch_lomb_incorporated,Dr. Gerhard Mann chem.-pharm. Fabrik GmbH/ Bausch & Lomb Incorporated -986,0.96840834617614746,ea4dc71b-e8ef-4f8f-9f2e-ed6a308b18fd,Imperial College Heathcare NHS Trust,imperial_college_heathcare_nhs_trust,,,,67902b25-58c1-419c-918d-42f6cc022a27,imperial_college_healthcare_nhs_trust,Imperial College Healthcare NHS Trust -5888,,d8fc4885-3f13-46ff-a9a7-2bc1c2f67dd4,Minna Honkila,minna_honkila,,,,,, -5889,,02930f71-5db3-459d-b021-cedbb97cf43c,"Puolustusvoimat, Sotilaslääketieteen keskus",puolustusvoimat_sotilasl_ketieteen_keskus,,,,,, -5890,,2dde3636-ba4a-425f-8912-370d24369ec6,"Athersys, Inc",athersys_inc,,,,,, -5891,,6bef7db0-0226-4460-8311-440fe592550b,ASAC PHARMACEUTICAL INTERNATIONAL A.I.E,asac_pharmaceutical_international_a_i_e,,,,,, -5892,,d1a49d54-800b-41e4-a174-02981c955c01,Rexgenero Limited,rexgenero_limited,,,,,, -5893,,f0d8e439-ddc2-4af5-a8cf-b9325ac5cbdd,"Copenhagen University Hospital Rigshospitalet, Department of Cardiology B 2143",copenhagen_university_hospital_rigshospitalet_department_of_cardiology_b_2143,,,,,, -5894,,3beab8a3-c9e9-4d5b-a665-f7c298a935be,Danish Gynaecological Cancer Group,danish_gynaecological_cancer_group,,,,,, -5895,,cba7a933-c0b0-4076-9593-65aacceb1201,Profile Pharma Ltd,profile_pharma_ltd,,,,,, -5896,,85b952aa-ce6c-49b5-83ab-2d2beedda736,"Corthera, Inc",corthera_inc,,,,,, -5897,,c331bb30-8349-4948-bab0-239082584e97,Bayer B.V,bayer_b_v,,,,,, -638,0.972279,a8a9c27e-73fc-11e6-a0cd-0242ac12000b,ADAPT PHARMA,adapt_pharma,,,,a8a9c27e-73fc-11e6-a0cd-0242ac12000b,adapt_pharma,ADAPT PHARMA -5898,,e42882e1-03d4-4a65-8f6e-792bff0de04f,Onxeo,onxeo,,,,,, -5899,,e86849ca-8bbd-11e6-a449-0242ac12000b,Archigen Biotech Limited,archigen_biotech_limited,,,,,, -5900,,847e3d5c-8724-413c-88b1-4db229bd48da,"Department of Clinical Oncology, Leiden University Medical Center",department_of_clinical_oncology_leiden_university_medical_center,,,,,, -5901,,f51d84f4-716a-11e6-a0cd-0242ac12000b,OMJ PHARMACEUTICALS,omj_pharmaceuticals,,,,,, -5902,,11145a7d-a298-4cf6-ae4b-46d2af4892d4,GlaxoSmithKline A.E.B.E,glaxosmithkline_a_e_b_e,,,,,, -5903,,986bad3a-f30b-4f04-a014-4eca2b475c80,CHU de Clermont-Ferrand,chu_de_clermont_ferrand,,,,,, -5904,,3659feba-6f33-43e6-8f32-fa742da849eb,Research and Development Office Cardiff and Vale NHS Trust,research_and_development_office_cardiff_and_vale_nhs_trust,,,,,, -752,0.9619777500629425,2b94d422-3c7c-4235-96fe-8b11faab4b13,Grupo Español de Tratamiento de los Tumores de Cabeza y Cuello (TTCC),grupo_espa_ol_de_tratamiento_de_los_tumores_de_cabeza_y_cuello_ttcc,,,,137320fb-fac2-4e31-99c7-7873aa7537cc,grupo_espa_ol_de_tratamiento_de_tumores_de_cabeza_y_cuello_ttcc,Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC) -513,0.977852,04cef99e-6fba-11e6-abe8-0242ac12000b,Intergroupe Francophone du Myelome (IFM),intergroupe_francophone_du_myelome_ifm,,,,04cef99e-6fba-11e6-abe8-0242ac12000b,intergroupe_francophone_du_myelome_ifm,Intergroupe Francophone du Myelome (IFM) -5905,,7202e99b-db60-4e40-9a1b-6fd39844a617,Almac Discovery,almac_discovery,,,,,, -5906,,7f455022-eab2-4c93-84b8-187a3b6ada11,University of Aarhus,university_of_aarhus,,,,,, -5907,,cfcda495-1bde-4a24-803b-0bb4616bac3b,Boehringer Ingelheim Pharma RCV GmbH & Co. KG,boehringer_ingelheim_pharma_rcv_gmbh_co_kg,,,,,, -5908,,2ac0067d-7eb4-4188-a7fd-fd5c668bab8d,Competence Centre for Transcultural Psychiatry,competence_centre_for_transcultural_psychiatry,,,,,, -5909,,12b586a3-c1a7-4548-b988-7635c4135ca7,Martini Ziekenhuis Groningen,martini_ziekenhuis_groningen,,,,,, -5910,,401ae81b-071f-4db9-80f6-8db8167cefb5,Paratek Pharma LLC,paratek_pharma_llc,,,,,, -5911,,1ebc9349-a691-4c2b-b43e-fea4cf260cd3,Institut für anwendungsorientierte Forschung und klinische Studien gGmbH der UMG Göttingen,institut_f_r_anwendungsorientierte_forschung_und_klinische_studien_ggmbh_der_umg_g_ttingen,,,,,, -5912,,6fdc208d-a104-4d5d-a986-12e717feee8d,Dept of Dermatology,dept_of_dermatology,,,,,, -5913,,6b9ad646-7142-11e6-a0cd-0242ac12000b,SYOSSET,syosset,,,,,, -5914,,a36a9647-ed15-47a5-92f1-14413b4f40b8,Psyadon Pharmaceuticals Inc,psyadon_pharmaceuticals_inc,,,,,, -5915,,28fb92e0-dc39-4a2f-8937-2696ae495ff9,"Sarepta Therapeutics, Inc",sarepta_therapeutics_inc,,,,,, -5916,,31006ad6-f3d2-4890-a9e4-f3c71d65c544,"Kirurgisk Afdeling, Nordsjællands Hospital",kirurgisk_afdeling_nordsj_llands_hospital,,,,,, -5917,,697be877-526d-4f05-b3d4-1d042f97088e,GeNeuro SA,geneuro_sa,,,,,, -5918,,341f7456-a6a6-4306-b6d9-dd6c6d0e372a,HARRAS Pharma Curarina Arzneimittel GmbH,harras_pharma_curarina_arzneimittel_gmbh,,,,,, -5919,,6e9dbcfb-1faf-4234-990a-b86b17352ba6,Astellas Pharma B.V,astellas_pharma_b_v,,,,,, -5920,,0b923e7f-4914-4a75-9d9d-0c5e508f2eef,"Medizinische Universität Wien, Univ.Klinik f.Frauenheilkunde,Abt. f.Gynäkologie und Gyn.Onkologie",medizinische_universit_t_wien_univ_klinik_f_frauenheilkunde_abt_f_gyn_kologie_und_gyn_onkologie,,,,,, -5921,,3bf95fb9-2629-4b1d-8489-6c3d4eca5efe,Rotterdam Eye Hospital,rotterdam_eye_hospital,,,,,, -10,0.984827,8fb7f3b7-2446-4f4c-a966-306786c40825,THE MEDICINES COMPANY UK,the_medicines_company_uk,,,,6b476606-7236-11e6-a0cd-0242ac12000b,the_medicines_co,THE MEDICINES CO -931,0.95911741256713867,58377bdc-7996-4dfb-8952-3aaff2549a93,Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre,pierre_fabre_dermatologie_represented_by_institut_de_recherche_pierre_fabre,,,,ee1d91c1-0d9e-47fa-b4e7-22a6f46f9512,pierre_fabre_dermatologie_represented_by_institut_de_recherche_pierre_fabre,Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre -5922,,cc1d56f8-6fa1-11e6-9663-0242ac12000b,"Medical University Graz,Department of Internal Medicine, Division of Gastroenterology and Hepatology",medical_university_graz_department_of_internal_medicine_division_of_gastroenterology_and_hepatology,,,,,, -989,0.964382,fce12d07-f839-4a5a-b389-f613430fe221,G.I.M.E.M.A,g_i_m_e_m_a,,,,9dee1320-7e61-4373-a4a5-0601870627ce,g_i_m_e_m_a_gruppo_italiano_malattie_ematologiche_dell_adulto,G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO -514,0.979838,303dfd4c-ed7a-4e4a-8468-59f96531ea89,PHARMACIA UPJOHN,pharmacia_upjohn,,,,197c3c96-71cf-11e6-a0cd-0242ac12000b,pharmacia,PHARMACIA -5923,,5c593445-d09c-4ee2-92ac-b6e60e10d58f,NOVINTETHICAL PHARMA SAGL,novintethical_pharma_sagl,,,,,, -5924,,621ff595-ed5e-4630-9655-9e80e8b241ce,FluoroPharma Medical,fluoropharma_medical,,,,,, -5925,,70106b82-01e3-445a-8dce-1f56c59a7634,"Merck Serono SA-Geneva an affiliate of Merck KgaA, Darmstadt",merck_serono_sa_geneva_an_affiliate_of_merck_kgaa_darmstadt,,,,,, -5926,,1942b0e4-bbb7-44d3-b281-ecca2f2808b4,Myelo Therapeutics GmbH,myelo_therapeutics_gmbh,,,,,, -5927,,cb318260-0f3b-40ae-a42b-b872d40cc37d,Erasmus University Medical Centre,erasmus_university_medical_centre,,,,,, -5928,,b24f7eba-b945-4e17-81af-c7b3309201f9,"Merck & Co., Inc./Suomen MSD Oy",merck_co_inc_suomen_msd_oy,,,,,, -5929,,6b5264c9-9d0c-49cf-847e-56db0edcee62,Royal Marsden NHS Foundation Trust,royal_marsden_nhs_foundation_trust,,,,,, -5930,,cc8f4954-cab6-43fc-b72a-8d26a13ac323,University of Wales College of Medicine,university_of_wales_college_of_medicine,,,,,, -5931,,0db51d3c-c8f6-44d9-8df1-fbb9beda7f9b,Martin Maaroos,martin_maaroos,,,,,, -5932,,a961a692-86b9-4528-9453-d6450f432f2d,Fundación de Investigación Biomédica. Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa,fundaci_n_de_investigaci_n_biom_dica_instituto_de_investigaci_n_sanitaria_del_hospital_universitario_de_la_princesa,,,,,, -5933,,9fe189f9-acd1-4708-86af-3883483f153a,"St Vincent’s Hospital, Sydney, Australia",st_vincent_s_hospital_sydney_australia,,,,,, -5934,,4a8f7742-7e2c-4ed4-852c-ec03514e2399,Laboratoire Erempharma,laboratoire_erempharma,,,,,, -5935,,742ca738-e328-4ec5-be1c-8f8face78667,INFAI Institut für biomedizinische Analytik und NMR Imaging GmbH,infai_institut_f_r_biomedizinische_analytik_und_nmr_imaging_gmbh,,,,,, -5936,,994f9478-7142-11e6-a0cd-0242ac12000b,ISTITUTO BIO ITA SPA,istituto_bio_ita_spa,,,,,, -5937,,3a405407-7ad1-41b1-83eb-531b9e4f4b42,INSTITUTO BERNABEU,instituto_bernabeu,,,,,, -5938,,7531e5e0-769a-47fa-a9da-ce77400387bd,Therapeutic Advances in Childhood Leukemia & Lymphoma,therapeutic_advances_in_childhood_leukemia_lymphoma,,,,,, -5939,,2da8f7fc-b23f-4c58-a9c6-beefadb6c771,IMMUNOMEDICS,immunomedics,,,,,, -156,0.98749953508377075,f5e197c6-eb46-44ef-aa5d-247fb7280101,"Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie",medizinische_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,,,,93c5f8d2-c2d8-4c9b-abde-962e31e9c1a5,medizinische_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,"Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie" -379,0.94667601585388184,bb464dd5-4611-4d24-89d1-e672f490e048,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_hereafter_referred_to_as,,,,b80f486c-a6f1-447b-bad6-34ea6d49fec0,merck_sharp_dohm_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as the SPONSOR or Merck)" -5940,,096fecd3-b1f7-463a-b3ec-78ed6d5ae24a,pSivida Corporation,psivida_corporation,,,,,, -5941,,09fff795-2215-466c-8b91-68782cb2bce0,"University of Heidelberg, Frau I. Gürkan, Kaufmännische Direktorin",university_of_heidelberg_frau_i_g_rkan_kaufm_nnische_direktorin,,,,,, -5942,,5ca59d74-c2f4-4cf1-b719-25f7c084143b,ORGANON ITALIA,organon_italia,,,,,, -5943,,47ef291e-199c-4799-97f8-f9261fff6ed5,Royal Marsden Hospital NHS Trust,royal_marsden_hospital_nhs_trust,,,,,, -5944,,bf26adf2-9623-4ed5-9dd3-2b94fea3d82c,Ferring Pharmaceuticals A/S,ferring_pharmaceuticals_a_s,,,,,, -18,0.97483,f3cd2358-7146-11e6-a0cd-0242ac12000b,COLGATE,colgate,,,,5a94ce26-71db-11e6-a0cd-0242ac12000b,colgate_palmolive,COLGATE PALMOLIVE -5945,,8e278c23-e000-47bf-8848-a4551ce53725,"Pfizer Global Pharamceuticals, EuCAn, Pfizer Inc",pfizer_global_pharamceuticals_eucan_pfizer_inc,,,,,, -5946,,3e619b25-48e7-4afd-8b3c-12eb684e3616,"Anestesicentrum, Sundsvalls Sjukhus, Landstinget Västernorrland",anestesicentrum_sundsvalls_sjukhus_landstinget_v_sternorrland,,,,,, -5947,,1d4873de-7162-11e6-a0cd-0242ac12000b,DENTSPLY PHARM,dentsply_pharm,,,,,, -5948,,5db961e3-1ff4-4079-a7cb-543c68c9412a,ALK-SCHERAX Arzneimittel GmbH,alk_scherax_arzneimittel_gmbh,,,,,, -5949,,f9c6a466-0bd2-479f-a5d8-2bc7604baa9c,"APOPHARMA INC., TORONTO, ONTARIO",apopharma_inc_toronto_ontario,,,,,, -5950,,6d0cae43-eb99-4a55-9396-b230c5fcc460,Joan Xavier Fontdevila Font,joan_xavier_fontdevila_font,,,,,, -5951,,fa2fbd13-a782-11e6-94cb-5656d04fc2b5,Fundación Hospital Alcorcón,fundaci_n_hospital_alcorc_n,,,,,, -590,0.986737,3a62aee1-f6d5-4d0b-9d6b-f01157434792,Asociación Andaluza de Hematología,asociaci_n_andaluza_de_hematolog_a,,,,28581ffa-a0e9-4a5d-8765-aa97b1847c37,asociaci_n_andaluza_de_hematolog_a_y_hemoterapia,Asociación Andaluza de Hematología y Hemoterapia -1007,0.977549,45f21be7-1a6d-4718-891b-7f5f25a7206a,Laboratorios Farmalíder S.A,laboratorios_farmal_der_s_a,,,,31e6b140-0f0d-4d6f-950c-f719a9051d5d,laboratorios_farmalider_s_a,Laboratorios Farmalider S.A -5952,,217af141-1d9d-4ea0-89ec-1fc58a95d2f0,Medical School Hannover,medical_school_hannover,,,,,, -5953,,2abe8135-2a22-4483-84d3-a9bde460d72a,"AZIENDA DI RILIEVO NAZIONALE E DI ALTA SPECIALIZZAZIONE OSPEDALE CIVICO E BENFRATELLI, G.DI CRISTINA E M.ASCOLI",azienda_di_rilievo_nazionale_e_di_alta_specializzazione_ospedale_civico_e_benfratelli_g_di_cristina_e_m_ascoli,,,,,, -5954,,dc06b812-a059-4df9-bb42-b47ded1e6e31,Fundació Vall Hebron Institut de Recerca,fundaci_vall_hebron_institut_de_recerca,,,,,, -5955,,ae199aab-0829-4df9-b118-9b3477c6f883,"Technische Universität München, Fakultät für Medizin, Klinikum rechts der Isar",technische_universit_t_m_nchen_fakult_t_f_r_medizin_klinikum_rechts_der_isar,,,,,, -5956,,a2c036c5-5a36-4952-9145-a37aeb31f0f9,"Kythera Biopharmaceuticals, Inc",kythera_biopharmaceuticals_inc,,,,,, -28,0.98589098453521729,74cf9045-4511-4c50-8cd0-de621c838ff2,University Hospital Birmingham,university_hospital_birmingham,,,,74cf9045-4511-4c50-8cd0-de621c838ff2,university_hospital_birmingham,University Hospital Birmingham -823,0.98386585712432861,b13c33db-7665-44df-a9b8-f4c589cd3347,Umeå University Hospital,ume_university_hospital,,,,0507f1f4-65ef-4d12-af2a-e024c19ed1f0,ume_university,Umeå University -5957,,ea522788-420b-4537-8ea0-530a7c168dc3,Yolanda de Diego Otero,yolanda_de_diego_otero,,,,,, -5958,,0ea47f1c-5af3-4b35-98df-6afc47907dab,Cabrellis Pharmaceuticals Corporation,cabrellis_pharmaceuticals_corporation,,,,,, -259,0.985423,dafc66a2-715c-11e6-a0cd-0242ac12000b,US WORLDMEDS,us_worldmeds,,,,34f3a53c-71a6-11e6-a0cd-0242ac12000b,us_worldmeds_llc,US WORLDMEDS LLC -880,0.941049,2d4630db-6244-46e0-a68c-f156131d2f04,Central Manchester& Manchester Children's University Hospitals NHS Trust,central_manchester_manchester_children_s_university_hospitals_nhs_trust,,,,2d4630db-6244-46e0-a68c-f156131d2f04,central_manchester_manchester_children_s_university_hospitals_nhs_trust,Central Manchester& Manchester Children's University Hospitals NHS Trust -199,0.982247,b8a13f3d-9a9f-45df-801b-e587c1a372e5,Mälarsjukhuset Eskilstuna,m_larsjukhuset_eskilstuna,,,,9ea15bf7-df50-400a-88c4-415b3dc2eda2,m_larsjukhuset,Mälarsjukhuset -5959,,65dbec6b-f01c-4e39-ac07-d1e124462b34,MGI Pharma Inc,mgi_pharma_inc,,,,,, -1004,0.975197,5dffa2d8-7164-11e6-a0cd-0242ac12000b,SOMERSET THERAPS LLC,somerset_theraps_llc,,,,5dffa2d8-7164-11e6-a0cd-0242ac12000b,somerset_theraps_llc,SOMERSET THERAPS LLC -5960,,412530ee-7834-41ee-be3c-fa0bfbd60174,"Can-Fite BioPharma, Ltd",can_fite_biopharma_ltd,,,,,, -5961,,87542afd-6065-419a-9a01-9bbf32c951af,Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ Onkotrápiás Klinika,szegedi_tudom_nyegyetem_szent_gy_rgyi_albert_klinikai_k_zpont_onkotr_pi_s_klinika,,,,,, -131,0.98589164018630981,0e0f3ed5-9732-4b14-9d55-9f884d0d428a,Department of Psychiatry, Section of Sleep Research and Pharmacopsychiatry,,,,1ead7ee3-0e7d-4381-a630-ec14aeb73c0e,department_of_psychiatry,Department of Psychiatry -5962,,89ceabfd-b732-4bb1-8537-f278f8b3213a,Erasmus Hospital,erasmus_hospital,,,,,, -5963,,8ef955ca-a87a-4b5b-b787-93bbe7cc635b,Fundación de la Comunidad Valenciana Hospital Provincial de Castellón,fundaci_n_de_la_comunidad_valenciana_hospital_provincial_de_castell_n,,,,,, -921,0.98046,e90b434e-23d4-448b-9e92-391d596fe17c,"National Institute of Health, National Eye Institute",national_institute_of_health_national_eye_institute,department_of_psychiatry_section_of_sleep_research_and_pharmacopsychiatry,,,e90b434e-23d4-448b-9e92-391d596fe17c,national_institute_of_health_national_eye_institute,"National Institute of Health, National Eye Institute" -269,0.961582,4deecc23-1926-409e-858b-2b5b11828232,Austrian Breast and Colorectal Cancer Study Group (ABCSG),austrian_breast_and_colorectal_cancer_study_group_abcsg,,,,4deecc23-1926-409e-858b-2b5b11828232,austrian_breast_and_colorectal_cancer_study_group_abcsg,Austrian Breast and Colorectal Cancer Study Group (ABCSG) -5964,,595e80c5-ebc1-44d4-a496-00b180fea87e,Hull and East Yorkshire NHS Trust,hull_and_east_yorkshire_nhs_trust,,,,,, -5965,,d8058be6-7d76-4ce5-80b7-3de2a0ae8b6b,IRCCS Ospedale San Raffaele U.O. Oculistica,irccs_ospedale_san_raffaele_u_o_oculistica,,,,,, -5966,,b5bc358d-d724-45a6-9c34-ed07db49b682,Children's Cancer and Leukaemia Group,children_s_cancer_and_leukaemia_group,,,,,, -5967,,1bdee05a-6eb2-4ab2-99bc-2b6542ecd88c,Japanese Gynecologic Oncology Group (JGOG),japanese_gynecologic_oncology_group_jgog,,,,,, -5968,,be176c13-a4bf-4f83-ba11-9010b0bdca93,Univ. Prof. Dr. Christoph Zielinski,univ_prof_dr_christoph_zielinski,,,,,, -5969,,e8b50f5e-c456-44d4-8d87-147ca9442acc,"Karolinska Institutet, Center for Molecular medicine, L8:03 L8:03",karolinska_institutet_center_for_molecular_medicine_l8_03_l8_03,,,,,, -5970,,8d8cb946-adb8-4da9-85e9-df889afd7b7e,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A,uni_pharma_kleon_tsetis_pharmaceutical_laboratories_s_a,,,,,, -849,0.97769945859909058,373295c7-9ca2-499a-ae31-52733bea403b,"PFIZER, SLU",pfizer_slu,,,,373295c7-9ca2-499a-ae31-52733bea403b,pfizer_slu,"PFIZER, SLU" -5971,,6d7fcba6-80dc-43cd-8c0c-e876795e1e54,"Division of Paediatrics, Rikshospitalet University Hospital",division_of_paediatrics_rikshospitalet_university_hospital,,,,,, -5972,,5a069d6e-f676-44a6-a9b5-b40eee878818,CHU de Nancy,chu_de_nancy,,,,,, -553,0.97483,02d042a3-dbd3-41ce-bd72-42a098676c11,Centre Francois Baclesse,centre_francois_baclesse,,,,02d042a3-dbd3-41ce-bd72-42a098676c11,centre_francois_baclesse,Centre Francois Baclesse -5973,,b318bf54-8ff0-4c84-8d40-6702515017a5,"Viamet Pharmaceuticals, Inc",viamet_pharmaceuticals_inc,,,,,, -5974,,f52ea27c-29a8-46eb-8ebf-152d484172f7,The lymphoma Study Association (LYSA),the_lymphoma_study_association_lysa,,,,,, -1053,0.987186,ca82b704-5fb5-48ac-8d51-4cb524d86727,BOOG Study Center,boog_study_center,,,,3ca85ebb-ef77-4ffc-bc31-c0440e250e6a,boog_study_center_b_v,BOOG Study Center B.V -5975,,12ee068a-7156-11e6-a0cd-0242ac12000b,SUNEVA MEDCL,suneva_medcl,,,,,, -5976,,81e7b303-5ac4-4f06-afb7-9527d74ea3a2,PH&T SpA,ph_t_spa,,,,,, -5977,,34a27514-7155-11e6-a0cd-0242ac12000b,GEDEON RICHTER USA,gedeon_richter_usa,,,,,, -638,0.972279,a97a0d0c-719b-11e6-a0cd-0242ac12000b,ADAPT,adapt,,,,a8a9c27e-73fc-11e6-a0cd-0242ac12000b,adapt_pharma,ADAPT PHARMA -446,0.96705156564712524,d7b69ba9-8bcc-4886-832c-dde1ff8859e9,Royal Brompton and Harefield NHS Trust,royal_brompton_and_harefield_nhs_trust,,,,d503d81e-b381-4df8-afc1-0e37f91ed710,royal_brompton_and_harefield_nhs_trsut,Royal Brompton and Harefield NHS Trsut -1055,0.98234379291534424,a9da8714-8bd5-11e6-a449-0242ac12000b,Neurologisk afdeling F,neurologisk_afdeling_f,,,,81df0d59-40ca-4ad2-8667-97ceb4c20bea,neurologisk_afdeling_f_rhus_sygehus_nbg,"Neurologisk afdeling F, Århus Sygehus, NBG" -653,0.94520390033721924,af89a852-eb3f-4e28-8da4-7206c23499f0,Boehringer Ingelheim RCV Gmb & Co KG,boehringer_ingelheim_rcv_gmb_co_kg,,,,5c99ca16-39a1-4b89-bbde-8627966f253d,boehringer_ingelheim_rcv_gmbh,Boehringer Ingelheim RCV GmbH -235,0.9735388457775116,c74d56c5-c48b-4ce6-bc89-a5762656c8ab,Novartis Pharma Services AG,novartis_pharma_services_ag,,,,683ca9e5-af11-4524-9288-1bb0932a9588,novartis_pharma_services,Novartis Pharma Services -5978,,206b03f3-bfcc-44cd-a124-77fa4c5282d9,"Taxolog, Inc",taxolog_inc,,,,,, -5979,,a07d77e2-c8cd-4fef-b249-1212b42ebf93,"Joint Research Office, Barts and The London NHS Trust",joint_research_office_barts_and_the_london_nhs_trust,,,,,, -5980,,21e8ecf1-af1e-4742-9089-f87e420f541f,UNITHER Pharmaceuticals,unither_pharmaceuticals,,,,,, -5981,,5df7f2e4-1cff-4b68-b25b-fcf8636a75f9,Vrije Universiteit Brussel,vrije_universiteit_brussel,,,,,, -5982,,50f780a3-7fee-4782-a54f-a0dd08750489,LYOCENTRE,lyocentre,,,,,, -400,0.910995,e353a2ed-1885-4d0a-945d-a275cba1016b,Belfast Health and Social Care Trust,belfast_health_and_social_care_trust,,,,2ba1fe2b-dcfd-42df-a719-7dec8ad39de2,belfast_health_social_care_trust,Belfast Health & Social Care Trust -5983,,6235a18a-1978-412b-a74d-f5c2d687cb5d,"Abbott Japan Co., Ltd",abbott_japan_co_ltd,,,,,, -5984,,a13fb752-ded2-4c8d-bf99-3d7e691903b4,Boston University- The Amyloid Treatment and Research Program,boston_university_the_amyloid_treatment_and_research_program,,,,,, -5985,,b714ef42-1972-4df7-8602-b3691b7fda1c,DIAKO Ev. Diakonie-Krankenhaus Bremen gGmbH,diako_ev_diakonie_krankenhaus_bremen_ggmbh,,,,,, -155,0.982232,0f7ff838-13c3-4637-91f3-73d90e40ccf4,"Department of Rheumatology,University hospital,Lund",department_of_rheumatology_university_hospital_lund,,,,0f7ff838-13c3-4637-91f3-73d90e40ccf4,department_of_rheumatology_university_hospital_lund,"Department of Rheumatology,University hospital,Lund" -5986,,569b5856-7142-11e6-a0cd-0242ac12000b,CEPH INTL,ceph_intl,,,,,, -5987,,44e581f3-6fee-475b-a128-c298ed874260,Lundbeck Limited,lundbeck_limited,,,,,, -5988,,86c37ace-73f2-11e6-a0cd-0242ac12000b,PRAXAIR CANADA INC,praxair_canada_inc,,,,,, -5989,,571841e3-8212-4428-a7d7-ea0f55d3a9bf,Jansenn Cilag International N.V,jansenn_cilag_international_n_v,,,,,, -362,0.955916,eb90fc4a-37fb-456d-ae78-9064af08c9b9,GRUPO ESPAÑOL DE INVETIGACION EN CANCER DE MAMA (GEICAM),grupo_espa_ol_de_invetigacion_en_cancer_de_mama_geicam,,,,3ed7af3a-1ee9-4762-b37f-885a7628f2f5,grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama_geicam,GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA (GEICAM) -5990,,177bc727-d047-4bd8-ab9c-35a56d8e3516,"Pearl Therapeutics, Inc",pearl_therapeutics_inc,,,,,, -5991,,5c839e3d-714f-4b43-a299-d70d618e4894,Angelini Farmaceutici,angelini_farmaceutici,,,,,, -5992,,d404cc16-a5f5-4e19-9cfd-b408643ccb51,G.I.S.E. - SOCIETA'' ITALIANA CARDIOLOGIA INVASIVA,g_i_s_e_societa_italiana_cardiologia_invasiva,,,,,, -5993,,13d1023d-fea7-4766-9ac7-0dbd749b5bea,Azienda Ospedaliero-Universitaria Meyer,azienda_ospedaliero_universitaria_meyer,,,,,, -5994,,fc3911b1-dc06-4af6-aa55-c3b113f01cee,Sykehuset i Vestfold HF,sykehuset_i_vestfold_hf,,,,,, -497,0.976266,82c49c5a-7168-11e6-a0cd-0242ac12000b,ABHAI,abhai,,,,6f4fd964-7168-11e6-a0cd-0242ac12000b,abhai_inc,ABHAI INC -5995,,82a778f5-4b94-40ce-8e2e-94dc8171d62a,Novo Nordisk Limited,novo_nordisk_limited,,,,,, -177,0.98774003982543945,417b3184-7ddd-49f2-af9e-84fb79bab1fd,Swedish Orphan Biovitrum AB,swedish_orphan_biovitrum_ab,,,,417b3184-7ddd-49f2-af9e-84fb79bab1fd,swedish_orphan_biovitrum_ab,Swedish Orphan Biovitrum AB -221,0.987337,fc26488d-2f30-45aa-99b3-1c157134ffc2,Addenbrooke's Hospital Trust,addenbrooke_s_hospital_trust,,,,edf35dc5-4a96-4c7e-ab5e-7c3239568465,addenbrooke_s_hospital,Addenbrooke's Hospital -3,0.975901,cf64616d-fa61-4a63-be7a-53b63f0f3f76,Klinik für Anästhesiologie und Operative Intensivmedizin Klinikum Ludwigshafen,klinik_f_r_an_sthesiologie_und_operative_intensivmedizin_klinikum_ludwigshafen,,,,759e5476-0767-445f-9373-05a555bd1be8, Johannes Gutenberg Universität,Klinik für Anästhesiologie -5996,,40bf114a-9958-44aa-b71c-6348b4c9d121,Institut fuer Gesundheits- und Praxismanagement GmbH,institut_fuer_gesundheits_und_praxismanagement_gmbh,,,,,, -5997,,35da42d2-8bee-11e6-a449-0242ac12000b,Therapeutic Research Unit,therapeutic_research_unit,,,,,, -5998,,cf2dd1d5-c573-4566-afea-e110f3175a28,AstraZeneca Sweden,astrazeneca_sweden,,,,,, -5999,,97754feb-5883-48e1-9a3d-a45cf1088d18,Karolinska Institutet Danderyds Sjukhus,karolinska_institutet_danderyds_sjukhus,,,,,, -6000,,5917b3bf-fdff-4c74-8ee3-5df51cb31f96,UNIVERSITA' DEGLI STUDI DI MESSINA,universita_degli_studi_di_messina,,,,,, -6001,,6416b254-72dd-11e6-a0cd-0242ac12000b,HAMELN PHARMA PLUS,hameln_pharma_plus,,,,,, -6002,,cb0efbbe-cffd-4c61-bc0f-6e573f9a2398,Atrium Medisch Centrum Parkstad,atrium_medisch_centrum_parkstad,,,,,, -6003,,43e13e7d-8154-483c-9295-6ab84ee19589,"Department of Medical Sciences, Dermatology and venerology, Uppsala University, Uppsala Sweden",department_of_medical_sciences_dermatology_and_venerology_uppsala_university_uppsala_sweden,,,,,, -6004,,9aabdb25-2a59-491f-b841-f24f8a009904,medac Gesellschaft für klinische Spezialpräparate mbH,medac_gesellschaft_f_r_klinische_spezialpr_parate_mbh,,,,,, -6005,,cbed5048-fbba-481d-ab4c-fd418d83daf1,CHDR,chdr,,,,,, -262,0.9615,9d682749-f368-4251-b8c0-9399d1ecd77d,"SCHWARZ BIOSCIENCES, INC A member of UCB Group of Companies",schwarz_biosciences_inc_a_member_of_ucb_group_of_companies,,,,9d682749-f368-4251-b8c0-9399d1ecd77d,schwarz_biosciences_inc_a_member_of_ucb_group_of_companies,"SCHWARZ BIOSCIENCES, INC A member of UCB Group of Companies" -6006,,04a4d02c-37ac-443f-b4f6-c0de2247e8c7,Aker University Hospital,aker_university_hospital,,,,,, -6007,,6cf50657-a0e4-494b-80f0-7888b67057ae,"Dept. of Intensive Care Medicine, Copenhagen University Hospital, Rigshospitalet",dept_of_intensive_care_medicine_copenhagen_university_hospital_rigshospitalet,,,,,, -296,0.983343,af4b3ac9-fffa-4d2e-898b-36d2273fda9d,iOMEDICO,iomedico,,,,6cdcb5b5-13ca-4bc2-becd-834515b92e8e,iomedico_ag,iOMEDICO AG -6008,,849a6e8b-31ac-40ea-94f2-b63298652025,D&A PHARMA,d_a_pharma,,,,,, -6009,,f3ab7778-4ca5-4b74-9328-3058eed4faf9,Synairgen Research Ltd,synairgen_research_ltd,,,,,, -6010,,949d7b56-3e43-4a7b-b57e-b0a6713ade16,Regionshospital skive,regionshospital_skive,,,,,, -6011,,02efccb2-73fb-11e6-a0cd-0242ac12000b,INTERCEPT PHARMS INC,intercept_pharms_inc,,,,,, -6012,,b72d17c3-54fc-4ec6-903b-0b76889cfee6,Egyesített Szent István és Szent László Kórház - Rendelőintézet,egyes_tett_szent_istv_n_s_szent_l_szl_k_rh_z_rendel_int_zet,,,,,, -6013,,70562274-99f8-49cc-a1ea-fdb3e2d7d6e5,"Shionogi & Co., Ltd",shionogi_co_ltd,,,,,, -430,0.98551523685455322,7cf2383a-86f2-40ef-bc4b-7282cc398374,University of California San Francisco,university_of_california_san_francisco,,,,3bc57cf3-53a2-4c69-b7e4-a49ee753b7f7,university_of_california_san_francisco_stroke_sciences_group,University of California San Francisco Stroke Sciences Group -6014,,ce10198f-c838-42a1-8bb3-d6efac79a57a,"Department of Neuroscience, Uppsala University",department_of_neuroscience_uppsala_university,,,,,, -6015,,60607abf-3284-44e1-97c7-dad9f04ae05c,"Erasmus MC, more specifically for and on behalf of the department of Neurology/Neuro-Oncology",erasmus_mc_more_specifically_for_and_on_behalf_of_the_department_of_neurology_neuro_oncology,,,,,, -6016,,d16cb4cc-0062-4a6a-b25a-c6b3d010bed4,"Univ. Klinik f. Anästhesie, Intensivmedizin und Schmerztherapie",univ_klinik_f_an_sthesie_intensivmedizin_und_schmerztherapie,,,,,, -160,0.96293512582778928,46c85acb-eaeb-4d95-9686-df020e747041,Fundación para La Investigación Biomedica del Hospital Gregorio Marañón,fundaci_n_para_la_investigaci_n_biomedica_del_hospital_gregorio_mara_n,,,,ce27e24e-62ac-42de-a596-4ceed67e634f,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón -6017,,802fb4c6-5e6d-4510-ad2b-7d1e9280d1f4,University of Helsinki / CLUE Working Group,university_of_helsinki_clue_working_group,,,,,, -6018,,db4d4503-abe4-424d-97d6-df695e925e0c,PAION UK Limited,paion_uk_limited,,,,,, -6019,,23b00bdf-aea3-4cac-93f2-f6f28ec44e8d,University of Glasgow,university_of_glasgow,,,,,, -216,0.972547,797c01ee-1dfa-4820-a53e-5dcb99477f68,"Universitätsklinik für Kinder- und Jugendheilkunde, Medizinsiche Universität Wien",universit_tsklinik_f_r_kinder_und_jugendheilkunde_medizinsiche_universit_t_wien,,,,797c01ee-1dfa-4820-a53e-5dcb99477f68,universit_tsklinik_f_r_kinder_und_jugendheilkunde_medizinsiche_universit_t_wien,"Universitätsklinik für Kinder- und Jugendheilkunde, Medizinsiche Universität Wien" -6020,,d3bc6ec3-b993-46b3-ad56-43cd9f78a52c,FUNDACION HOSPITAL NACIONAL DE PARAPLEJICOS PARA LA INVESTIGACIÓN Y LA INTEGRACIÓN,fundacion_hospital_nacional_de_paraplejicos_para_la_investigaci_n_y_la_integraci_n,,,,,, -920,0.98836344480514526,d94f6c83-6e14-4b83-88fc-13e50ecbc634,AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA,azienda_ospedaliero_universitaria_pisana,,,,d94f6c83-6e14-4b83-88fc-13e50ecbc634,azienda_ospedaliero_universitaria_pisana,AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA -602,0.988116,fa86a9f7-a3f8-41d6-a5e3-0ebd13bd9609,Syndax Pharmaceuticals,syndax_pharmaceuticals,,,,cf2f842c-f2cd-4905-96b8-12fcfaeb3ea9,syndax_pharmaceuticals_inc,Syndax Pharmaceuticals Inc -6021,,d768404d-f697-4fac-a821-576d417a301b,St. Vincent's University Hospital,st_vincent_s_university_hospital,,,,,, -6022,,d3c363d2-7142-11e6-a0cd-0242ac12000b,STEVENS J,stevens_j,,,,,, -6023,,0fa90dba-ffec-401b-8721-07730092ea76,AstraZeneca Produtos Farmacêuticos Lda,astrazeneca_produtos_farmac_uticos_lda,,,,,, -949,0.987284,b136848d-fa3d-4c16-9b15-a9721eb2e067,Astellas Pharma Europe B.V. (APEB),astellas_pharma_europe_b_v_apeb,,,,300881f9-28ca-4aa4-b8d5-58ad7c2806f3,astellas_pharma_europe_b_v,Astellas Pharma Europe B.V -6024,,7984ebb2-cc5f-4696-9fb6-b6f3f930cdd2,Theratechnologies Inc,theratechnologies_inc,,,,,, -6025,,f613ae66-d603-452a-bbad-d3ec7b1e4d77,Fundación Huésped,fundaci_n_hu_sped,,,,,, -6026,,613948d3-3850-4244-8633-e21f5224b897,INSERM - Institut National de la Sant� et de la Recherche m�dicale,inserm_institut_national_de_la_sant_et_de_la_recherche_m_dicale,,,,,, -597,0.979394,0bfd17f2-ec27-44b6-9dcf-b6e90369486a,Semmelweis University Department of Ophthalmology,semmelweis_university_department_of_ophthalmology,,,,0bfd17f2-ec27-44b6-9dcf-b6e90369486a,semmelweis_university_department_of_ophthalmology,Semmelweis University Department of Ophthalmology -6027,,b5cfb9bc-cdf7-45b5-8d95-dbab24e6a0b6,e-Therapeutics plc,e_therapeutics_plc,,,,,, -396,0.958444,1a94c234-91dd-4ddb-8ee3-62df600fe4df,Maastricht Universitary Medical Centre,maastricht_universitary_medical_centre,,,,1a94c234-91dd-4ddb-8ee3-62df600fe4df,maastricht_universitary_medical_centre,Maastricht Universitary Medical Centre -6028,,40d072e0-9ca9-44de-b214-6cdcb89b199c,SIMIT sezione Regione Lombardia,simit_sezione_regione_lombardia,,,,,, -6029,,565f1247-6b9b-4f21-ace7-c97a6d3d39fc,German Competence network “Acute and Chronic Leukemias” sponsored by Federal Ministry of Education a,german_competence_network_acute_and_chronic_leukemias_sponsored_by_federal_ministry_of_education_a,,,,,, -475,0.985423,f3be3318-715d-11e6-a0cd-0242ac12000b,HETERO DRUGS,hetero_drugs,,,,f3be3318-715d-11e6-a0cd-0242ac12000b,hetero_drugs,HETERO DRUGS -6030,,7b193a40-149b-484a-b595-af3e8761a311,GlaxoSmithKline Pharma A/S,glaxosmithkline_pharma_a_s,,,,,, -6031,,1a58d6af-324d-41b2-abc8-3a74080a856a,Biota Pharma Europe Limited,biota_pharma_europe_limited,,,,,, -6032,,c26d1c31-0995-4d7a-b476-5ec8abd729cd,Smith & Nephew Inc,smith_nephew_inc,,,,,, -6033,,8d95f51b-f565-4bd1-9316-1bfbda333b1e,Timo Jahnukainen,timo_jahnukainen,,,,,, -6034,,5e8918fe-be09-479a-8917-e8dc82017a38,Lilly,lilly,,,,,, -6035,,c2e7d8ba-cdc9-4be6-bbb5-73a2d10ba6e6,"Laboratorios Dr. Esteve, S.A",laboratorios_dr_esteve_s_a,,,,,, -648,0.92974448204040527,400bd40c-fbde-4cec-8aeb-cb463c403ce5,"Boehringer Ingleheim España, S.A",boehringer_ingleheim_espa_a_s_a,,,,400bd40c-fbde-4cec-8aeb-cb463c403ce5,boehringer_ingleheim_espa_a_s_a,"Boehringer Ingleheim España, S.A" -6036,,2ddbef9f-ef25-4ec4-b409-19564f021fad,FUNDACION INVESTIGACION HOSPITAL CLINICO DE VALENCIA-INSTITUTO DE INVESTIGACION SANITARIA INCLIVA,fundacion_investigacion_hospital_clinico_de_valencia_instituto_de_investigacion_sanitaria_incliva,,,,,, -830,0.980344,223e6632-3388-4cba-ab58-ea9c133365de,GENFIT SA,genfit_sa,,,,223e6632-3388-4cba-ab58-ea9c133365de,genfit_sa,GENFIT SA -6037,,1da56aa1-8095-4ddc-8ad6-01f3f1ffba4f,ASSOCIAZIONE ITALIANA ENDOCRINOLOGIA-METABOLISMO-IPOFISI,associazione_italiana_endocrinologia_metabolismo_ipofisi,,,,,, -6038,,d9e7d895-3b8b-4e25-a28e-b961808d74a7,Wyeth Consumer Healthcare,wyeth_consumer_healthcare,,,,,, -6039,,fb837318-7141-11e6-a0cd-0242ac12000b,OUTLOOK PHARMS,outlook_pharms,,,,,, -6040,,f89dde22-8be0-11e6-a449-0242ac12000b,University of Düsseldorf,university_of_d_sseldorf,,,,,, -6041,,84e46590-235d-42db-bd9d-00cd0b25eac2,Bristol-Myers Squibb Company,bristol_myers_squibb_company,,,,,, -6042,,536e8995-c30f-4b7b-b95d-1779e80f2b94,Radiation Therapy Oncology Group,radiation_therapy_oncology_group,,,,,, -6043,,3974051f-4dc3-4a54-aa52-190f77084296,GIULIANI,giuliani,,,,,, -6044,,0812f6c3-97dd-4a1c-a325-63f66cdfff25,Oxford University,oxford_university,,,,,, -6045,,44a10b43-4617-4363-a0b2-03214525a48d,"Chorus, Eli Lilly and Company",chorus_eli_lilly_and_company,,,,,, -6046,,5d024805-4612-480f-a1c8-8bcba4fd4fc0,"Deptartment of Hematology, Karolinska University Hospital",deptartment_of_hematology_karolinska_university_hospital,,,,,, -6047,,2cdc9b13-ea59-48a1-9221-288911588ba0,"Joint Stock Company ""Grindeks",joint_stock_company_grindeks,,,,,, -6048,,eab00df6-0636-4e25-ba09-8803c76ebc72,"Neurological Department, Aarhus University Hospital",neurological_department_aarhus_university_hospital,,,,,, -6049,,4f94537a-c304-4216-9ab5-49243c92f069,Genetronics / inovio Biomedical,genetronics_inovio_biomedical,,,,,, -184,0.973246,035cad6f-a78e-4045-bb2b-51fc73fd33c1,"Stockholm County Council, Karolinska University Hospital Huddinge, Department of Anesthesiology and Intensive Care",stockholm_county_council_karolinska_university_hospital_huddinge_department_of_anesthesiology_and_intensive_care,,,,035cad6f-a78e-4045-bb2b-51fc73fd33c1,stockholm_county_council_karolinska_university_hospital_huddinge_department_of_anesthesiology_and_intensive_care,"Stockholm County Council, Karolinska University Hospital Huddinge, Department of Anesthesiology and Intensive Care" -6050,,4a4fbf75-bf1d-4a89-9a17-176112e72cd0,YL Biologics Ltd,yl_biologics_ltd,,,,,, -6051,,a02c8f1a-1178-4264-809f-596dbe9a902f,"Dieter Hoelzer, MD,PhD",dieter_hoelzer_md_phd,,,,,, -20,0.9795151948928833,7456382f-5a4e-4c63-89ad-5c531dbdb834,"Charité Campus Mitte, Instituts für Radiologie",charit_campus_mitte_instituts_f_r_radiologie,,,,1e74f773-7ad1-4d34-8164-f40da5329bf6,charit_campus_mitte,Charité Campus Mitte -161,0.98616876204808557,393eab2d-fa2d-419a-8ecd-278e02b1ad5b,Fundación para la Investigación Biomédica del Hospital,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital,,,,393eab2d-fa2d-419a-8ecd-278e02b1ad5b,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_12_de_octubre,Fundación para la Investigación Biomédica del Hospital 12 de Octubre -6052,,de11f73b-5555-463c-883b-8504d78011b9,FGK Representative Service GmbH,fgk_representative_service_gmbh,,,,,, -6053,,a33d5406-bc4e-4ef2-99bc-3764a31f9ded,Medical Center Alkmaar,medical_center_alkmaar,,,,,, -6054,,d23ba241-a679-4ebc-a4fa-3063d9295395,CASA DI CURA ABANO TERME POLISPECIALISTICA E TERMALE,casa_di_cura_abano_terme_polispecialistica_e_termale,,,,,, -6055,,ed8755c0-00ff-444e-a9e2-cf1214d15db9,Universitaetsklinikum Schleswig-Holstein,universitaetsklinikum_schleswig_holstein,,,,,, -6056,,1cd5cde3-9e3b-4b89-9624-307a7ca752f4,Swindon & Marlborough NHS Trust,swindon_marlborough_nhs_trust,,,,,, -205,0.98037469387054443,9b893499-55e3-4437-bc95-7a74dbcfefa5,"Glostrup Hospital, Dep. of Neurology",glostrup_hospital_dep_of_neurology,,,,9b893499-55e3-4437-bc95-7a74dbcfefa5,glostrup_hospital_dep_of_neurology,"Glostrup Hospital, Dep. of Neurology" -6057,,b78a8cd5-b058-47eb-a111-27ddf661960f,FONDAZIONE HUMANITAS PER LA RICERCA,fondazione_humanitas_per_la_ricerca,,,,,, -440,0.985233,aff3b302-7382-11e6-a0cd-0242ac12000b,PERNIX THERAP,pernix_therap,,,,52bf7852-7313-11e6-a0cd-0242ac12000b,pernix_theraps_llc,PERNIX THERAPS LLC -6058,,fdbeb531-6f5a-46b6-8ff7-4bca7acc967f,Dept. of Pharmacology,dept_of_pharmacology,,,,,, -6059,,82786b60-5762-48fe-b32b-e632545c037d,"J&J PRD, a division of Janssen-Cilag NV",j_j_prd_a_division_of_janssen_cilag_nv,,,,,, -6060,,98ccf311-746c-4643-80f5-6ae8892dc079,Ashford and St Peters Hospitals NHS Trust,ashford_and_st_peters_hospitals_nhs_trust,,,,,, -115,0.97782391309738159,f0e78dcd-924b-4b3a-b5dc-a19375a0e924,Shire UK,shire_uk,,,,b28c49a1-c21b-407a-9fd2-2dbd3207b28b,shire,Shire -6061,,c3fc43fc-7164-11e6-a0cd-0242ac12000b,XELLIA PHARMS APS,xellia_pharms_aps,,,,,, -400,0.910995,2ba1fe2b-dcfd-42df-a719-7dec8ad39de2,Belfast Health & Social Care Trust,belfast_health_social_care_trust,,,,2ba1fe2b-dcfd-42df-a719-7dec8ad39de2,belfast_health_social_care_trust,Belfast Health & Social Care Trust -6062,,92d6b198-7288-11e6-a0cd-0242ac12000b,ACTELION PHARMS LTD,actelion_pharms_ltd,,,,,, -6063,,75be64be-f69d-48a0-b46c-e9b23444f027,Steen Bendix Haugaard,steen_bendix_haugaard,,,,,, -6064,,3dc26ae1-cf31-419b-b864-e9dc07d1e33a,UNIVERSITY HOSPITAL SCHLESWIG-HOLSTEIN CAMPUS KIEL,university_hospital_schleswig_holstein_campus_kiel,,,,,, -1056,0.978876,269c3398-c5cb-4532-8146-3d371fd1fcef,"Hospital Clinico San Carlos, Unidad de Investigacion Cardiovascular",hospital_clinico_san_carlos_unidad_de_investigacion_cardiovascular,,,,269c3398-c5cb-4532-8146-3d371fd1fcef,hospital_clinico_san_carlos_unidad_de_investigacion_cardiovascular,"Hospital Clinico San Carlos, Unidad de Investigacion Cardiovascular" -6065,,29eded75-a6f7-11e6-94cb-5656d04fc2b5,"Orbus Therapeutics, Inc",orbus_therapeutics_inc,,,,,, -6066,,f96d21a1-6762-428d-ae85-42ae6c1dca8c,Berlin-Chemie AG (Menarini Group),berlin_chemie_ag_menarini_group,,,,,, -6067,,0761384b-3ea6-4161-8213-5cd060b5e43c,Koskela Heikki,koskela_heikki,,,,,, -6068,,f1f4e9d2-3a88-4477-a3e4-6153e118d64c,The SAVE trial group,the_save_trial_group,,,,,, -6069,,a6bbff65-119f-456e-a853-7677b268853d,Aston University,aston_university,,,,,, -6070,,b251cf72-0027-45ec-84f9-dd28cf199fd5,"Clinical Institute of Virology, Medical University of Vienna",clinical_institute_of_virology_medical_university_of_vienna,,,,,, -6071,,320e8814-5f99-41ca-9177-b0359bff9189,"Merck, Sharp & Dohme-Clinical Pharmacology,Europe",merck_sharp_dohme_clinical_pharmacology_europe,,,,,, -1026,0.98430219292640686,087c319f-e255-4079-8ec4-d6481f72b50e,Eli Lilly and Company,eli_lilly_and_company,,,,d2379c06-dc10-47c7-9eb7-094b64f48366,eli_lilly_and_company,Eli Lilly and Company -6072,,9bec9948-4662-436f-9fe4-9c3aef6c4ffc,ICIN,icin,,,,,, -6073,,54315f19-3b31-4de4-b7d2-62a358d3d7af,PHARMA MAR,pharma_mar,,,,,, -6074,,e5c91bfd-f4b9-43a2-8e91-5f633c3bcb57,Groupe d’étude sur le risque d’exposition des soignants aux agents infectieux (GERES),groupe_d_tude_sur_le_risque_d_exposition_des_soignants_aux_agents_infectieux_geres,,,,,, -6075,,c8228bc3-8d21-43f1-89d3-14cde56f2061,"Medizinische Universität Innsbruck, Univ.-Klinik für Neurologie",medizinische_universit_t_innsbruck_univ_klinik_f_r_neurologie,,,,,, -539,0.969856,fb6c9648-7141-11e6-a0cd-0242ac12000b,APOTEX,apotex,,,,33c18818-71cf-11e6-a0cd-0242ac12000b,apotex_technologies,APOTEX TECHNOLOGIES -6076,,430f673e-715e-11e6-a0cd-0242ac12000b,SIGMAPHARM LABS LLC,sigmapharm_labs_llc,,,,,, -6077,,b172f8e7-fa1f-45bb-9e1e-694410e1601e,SIOP,siop,,,,,, -6078,,35ed4d4b-52ef-4b8c-a7dc-5a3cf9502aa3,"Medizinische Universität Wien, Universitätsklinik für Augenheilkunde",medizinische_universit_t_wien_universit_tsklinik_f_r_augenheilkunde,,,,,, -6079,,391eb045-df7d-47d0-bc1c-5c764ec2ac63,"Edimer Pharmaceuticals, Inc",edimer_pharmaceuticals_inc,,,,,, -6080,,05fa800e-73f7-11e6-a0cd-0242ac12000b,SANOFI US SERVICES,sanofi_us_services,,,,,, -6081,,85543e15-df14-4bf5-b986-ade3ad2c4f3a,Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU),grupo_espa_ol_de_trabajo_en_enfermedad_de_crohn_y_colitis_ulcerosa_geteccu,,,,,, -6082,,576fadd6-2568-46e7-87c0-18517d7d7ab8,The Irish Clinical Oncology Research Group,the_irish_clinical_oncology_research_group,,,,,, -6083,,6b8c8120-42a0-42ec-8403-a25af16bd883,Gruppo Oncologico Italiano Ricerca Cancro (GOIRC),gruppo_oncologico_italiano_ricerca_cancro_goirc,,,,,, -572,0.98035663366317749,636b6962-391c-4308-8f43-ec1b5c65a66f,"Human Genome Sciences, Inc. (a wholly owned subsidiary of GlaxoSmithKline PLC)",human_genome_sciences_inc_a_wholly_owned_subsidiary_of_glaxosmithkline_plc,,,,e3bdd826-4b43-4d33-8f70-20154485e250,human_genome_sciences_inc_a_wholy_owned_subsidiary_of_glaxosmithkline_plc,"Human Genome Sciences, Inc. (a wholy owned subsidiary of GlaxoSmithKline PLC)" -6084,,e322085c-71fa-11e6-a0cd-0242ac12000b,LANTHEUS MEDICAL,lantheus_medical,,,,,, -6085,,b5fff5d3-f88e-4be2-b692-1ab9575ac026,Max-Planck-Institute of Psychiatry,max_planck_institute_of_psychiatry,,,,,, -297,0.971007,dd88ea6a-5b36-4292-b4cc-a6ad5c3d9619,UCB S.A,ucb_s_a,,,,8c8ef9b5-43dd-4ca5-9f4c-348a000dce63,ucb_s_a_pharma_sector,UCB S.A. Pharma Sector -6086,,bfd86081-70d2-45c2-ae30-64e2837ce009,"Acuity Pharmaceuticals, LLC",acuity_pharmaceuticals_llc,,,,,, -6087,,a3e099e1-0b9d-45fb-b3ad-762f6b6b963f,GETAID,getaid,,,,,, -6088,,5ea0f723-b86e-47c6-93d5-a58eb7d1f7ee,CHU Sart-Tilman,chu_sart_tilman,,,,,, -996,0.977047,97fe0562-c7c6-420a-8abd-fcdbeea536e5,King's College Hospital NHS Foundation Trust,king_s_college_hospital_nhs_foundation_trust,,,,334999d1-9ed1-4d92-a66a-e05623d343a8,kings_college_hospital_nhs_foundation_trust,Kings College Hospital NHS Foundation Trust -6089,,823bdf78-86c6-4029-9b66-a08caa4191a7,FOVEA PHARMACEUTICALS,fovea_pharmaceuticals,,,,,, -6090,,56e7d434-010b-47db-8bc3-73019dd37f6a,Maarit Valkealahti / University hospital of Oulu,maarit_valkealahti_university_hospital_of_oulu,,,,,, -6091,,48aea259-9881-4fb5-b872-467aef43e2dd,GALSOR S.R.L,galsor_s_r_l,,,,,, -6092,,e11cd3b7-7f13-4b57-b69e-f2451ef50517,Jan Engvall,jan_engvall,,,,,, -6093,,ef300dca-9641-45d1-a8eb-462801cba30e,Complejo Hospitalario Universitario de Albacete. Director Gerente Dr Jesús Martino Sánchez Martínez,complejo_hospitalario_universitario_de_albacete_director_gerente_dr_jes_s_martino_s_nchez_mart_nez,,,,,, -6094,,c266f358-9616-11e6-becf-0242ac110008,TERSERA THERAP,tersera_therap,,,,,, -347,0.98146516084671021,71cd8e41-b876-47b3-8b6f-d8c4063fa62c,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin III/Rheumatologie",medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_iii_rheumatologie,,,,71cd8e41-b876-47b3-8b6f-d8c4063fa62c,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_iii_rheumatologie,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin III/Rheumatologie" -6095,,d64b8313-12a5-4152-9485-8085941349ed,"Laboratorios Stiefel (España), S.A",laboratorios_stiefel_espa_a_s_a,,,,,, -6096,,588da700-9386-4e2d-ac7f-a2e05e84e700,"FibroGen, Inc",fibrogen_inc,,,,,, -6097,,183b394d-b36c-47bd-a5d8-cd1294aec108,AZ Groeninge,az_groeninge,,,,,, -6098,,0d57bf55-f5c4-4add-9d54-b5ebf8add9eb,Università di Modena e ReggioEmilia,universit_di_modena_e_reggioemilia,,,,,, -6099,,05c95e04-1d50-4c51-bc1f-b03e840ce20b,deCODE genetics ehf,decode_genetics_ehf,,,,,, -6100,,27c15ba3-7a07-423c-8156-cb49032f7075,"Hanmi Pharmaceutical Co., Ltd",hanmi_pharmaceutical_co_ltd,,,,,, -860,0.972948,1fd9be47-d214-4572-b318-1aa9dc588ded,Addenbrookes Hospital Cambridge University Hospitals NHS Foundation Trust,addenbrookes_hospital_cambridge_university_hospitals_nhs_foundation_trust,,,,1fd9be47-d214-4572-b318-1aa9dc588ded,addenbrookes_hospital_cambridge_university_hospitals_nhs_foundation_trust,Addenbrookes Hospital Cambridge University Hospitals NHS Foundation Trust -6101,,b7059ec0-7167-11e6-a0cd-0242ac12000b,KEN LIFESCIENCE,ken_lifescience,,,,,, -6102,,64ed7277-958d-4a46-9a60-6a9cbcb0055e,SOUTH EASTERN EUROPEAN RESEARCH ONCOLOGY GROUP,south_eastern_european_research_oncology_group,,,,,, -6103,,5a416250-7199-11e6-a0cd-0242ac12000b,CLOVER PHARMS,clover_pharms,,,,,, -6104,,ff965368-7865-4a01-bfbd-739d146d65f5,"J&JPRD, a division of Janssen-Cilag",j_jprd_a_division_of_janssen_cilag,,,,,, -6105,,8a684089-ae7a-4416-934c-9fcbeaee468c,"Mech-Sense, Aalborg University Hospital",mech_sense_aalborg_university_hospital,,,,,, -6106,,15416496-7164-11e6-a0cd-0242ac12000b,KREMERS URBAN DEV,kremers_urban_dev,,,,,, -6107,,86f4f916-5046-486b-ab71-ee340ecdae6e,Merc & Co. Inc,merc_co_inc,,,,,, -6108,,957a0c8a-e51d-4ec3-95a7-32496810b431,Amphia Hospital,amphia_hospital,,,,,, -6109,,2ee35076-f319-435f-aacf-be31909a7a8e,AUSL VITERBO,ausl_viterbo,,,,,, -6110,,e853f524-9e97-4579-b8a2-f8c29eca6e92,N V Organon,n_v_organon,,,,,, -6111,,bea76306-730a-4ede-a883-f9a58dea2b44,Grupo Español de Trasplante Hematopoyético (GETH),grupo_espa_ol_de_trasplante_hematopoy_tico_geth,,,,,, -6112,,cb85253c-9c88-45b2-a009-35b62e91c79b,"Karolinska Institute, Danderyds hospital",karolinska_institute_danderyds_hospital,,,,,, -6113,,35138b39-7307-4855-9b4e-048e1268f415,Jules Bordet Institute,jules_bordet_institute,,,,,, -426,0.988445,d2fffea4-4542-45dd-888c-2a7a4ffdc389,Leids Universitair Medisch Centrum,leids_universitair_medisch_centrum,,,,5e11478f-4293-4f4b-84dd-d3dc2a540f03,leids_universitair_medisch_centrum_lumc,Leids Universitair Medisch Centrum (LUMC) -6114,,68406649-eca4-4ca6-aab6-23f093aa485b,Children's Oncology Group (COG),children_s_oncology_group_cog,,,,,, -6115,,c92015c4-4716-4479-806d-7ea2b31a4d76,Medical Department M (Endocrinology & Diabetes),medical_department_m_endocrinology_diabetes,,,,,, -6116,,b2878c7b-2629-497e-bc57-6ab60afe1109,Hospital de Valme,hospital_de_valme,,,,,, -6117,,314fe8dd-0004-491c-9dbd-61bb52271fa2,"Pacira Pharmaceuticals, Inc",pacira_pharmaceuticals_inc,,,,,, -6118,,f1d7cb83-6a05-46a3-b6bc-98e6330b2e8c,GERCOR,gercor,,,,,, -805,0.97389534115791321,e2655437-d609-4fca-96c6-e41a3ce4b02d,"Otsuka Pharmaceutical Development & Commercialization,",otsuka_pharmaceutical_development_commercialization,,,,8e240a49-6e4c-46a0-8366-15b78371ff26,otsuka_pharmaceutical_development_commercialization_inc,"Otsuka Pharmaceutical Development & Commercialization, Inc" -6119,,b944c190-1ab6-4dcd-b81c-c0191ae67107,Ziekenhuisgroep Twente,ziekenhuisgroep_twente,,,,,, -6120,,4947f79a-7129-11e6-a89e-0242ac12000b,VISTAPHARM,vistapharm,,,,,, -6121,,a617b6c2-73ef-11e6-a0cd-0242ac12000b,MEDAC PHARMA INC,medac_pharma_inc,,,,,, -1050,0.97903996706008911,c4f1ee23-277c-427d-be77-550ded77bf06,Rijnstate hospital,rijnstate_hospital,,,,9b0915b5-74ad-4748-ae49-c7504c4d919e,rijnstate,Rijnstate -6122,,928f9799-a4d9-450c-a61c-6ff8936432a7,Prof. Dr.Christian Werner,prof_dr_christian_werner,,,,,, -6123,,9a5ed211-6e37-414a-989e-cdcda4932cd7,Oral and Maxillofacial Surgery Department of Vall d'Hebron Hospital,oral_and_maxillofacial_surgery_department_of_vall_d_hebron_hospital,,,,,, -6124,,df14e587-b82c-4a95-876d-7e22c6eaa0bd,Janssen Infectious Diseases BVBA,janssen_infectious_diseases_bvba,,,,,, -6125,,f00c5d1a-0586-42c6-a4f4-0c54bb13e305,Dipartimento di Oncologia-Università degli studi di Torino,dipartimento_di_oncologia_universit_degli_studi_di_torino,,,,,, -6126,,b1b58145-01ed-4e53-9b18-47671c54a89d,"FoldRx Pharmaceuticals, a Pfizer Company",foldrx_pharmaceuticals_a_pfizer_company,,,,,, -392,0.98723113536834717,f09d5b0c-8a57-42ac-be28-2e185ec2cdd5,Klinikum der Universität München,klinikum_der_universit_t_m_nchen,,,,089e5628-bb66-4808-818a-a79770a11d54,klinikum_der_universit_t_m_nchen_gro_hadern,Klinikum der Universität München-Großhadern -573,0.900909,7dfb4821-12ac-417d-9c56-0abf06762456,A.R.T.I.C. (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie ),a_r_t_i_c_association_pour_la_recherche_de_th_rapeutiques_innovantes_en_canc_rologie,,,,5a6ea281-ca4c-46d4-8b7d-0e24f0d68167,artic_association_pour_la_recherche_de_th_rapeutiques_innovantes_en_canc_rologie,ARTIC (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie) -823,0.98386585712432861,0507f1f4-65ef-4d12-af2a-e024c19ed1f0,Umeå University,ume_university,,,,0507f1f4-65ef-4d12-af2a-e024c19ed1f0,ume_university,Umeå University -6127,,2f6226af-b544-4044-9a5a-4bcb3d05efbe,The Hospital District of Southwest Finland,the_hospital_district_of_southwest_finland,,,,,, -6128,,bfbb03e2-eda3-4a05-8b30-d02f3296d800,"Free State of Bavaria, represented by the University of Regensburg, represented by the University Hospital Regensburg",free_state_of_bavaria_represented_by_the_university_of_regensburg_represented_by_the_university_hospital_regensburg,,,,,, -6129,,d5749447-085f-4ad2-9c0c-7b6f19b77c0a,FUNDACION INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO LA PRINCESA,fundacion_investigacion_biomedica_hospital_universitario_la_princesa,,,,,, -6130,,a69c9272-7f51-4fbb-af0a-91ee9bdad28c,Alizyme Therapeutics Limited,alizyme_therapeutics_limited,,,,,, -6131,,879e5bda-7168-11e6-a0cd-0242ac12000b,MSN LABORATORIES,msn_laboratories,,,,,, -6132,,2f0bdcda-733a-11e6-a0cd-0242ac12000b,CYPRESS BIOSCIENCE,cypress_bioscience,,,,,, -6133,,65a74622-52a5-44aa-b68a-4a0614c78010,Merck Serono S.p.A,merck_serono_s_p_a,,,,,, -327,0.962536,dc4489f6-106f-4779-ab50-6c69a5b625e6,ISTITUTO EUROPEO DI ONCOLGIA,istituto_europeo_di_oncolgia,,,,74acbba7-8bef-4cf6-a584-3c8b328a6a63,istituto_europeo_di_oncologia,ISTITUTO EUROPEO DI ONCOLOGIA -6134,,2483200c-7141-11e6-a0cd-0242ac12000b,ABLE,able,,,,,, -715,0.989009,70c3cd85-d7da-4e83-91f1-0c2abad141d5,Thoracale Oncologie Groep Antwerpen,thoracale_oncologie_groep_antwerpen,,,,70c3cd85-d7da-4e83-91f1-0c2abad141d5,thoracale_oncologie_groep_antwerpen,Thoracale Oncologie Groep Antwerpen -157,0.95408710837364197,f215164e-8e75-4f48-b691-ea2bfd10d042,"Medizinische Universität Wien, Univ.Klinik für Dermatologie, Abteilung für Immundermatologie",medizinische_universit_t_wien_univ_klinik_f_r_dermatologie_abteilung_f_r_immundermatologie,,,,f215164e-8e75-4f48-b691-ea2bfd10d042,medizinische_universit_t_wien_univ_klinik_f_r_dermatologie,"Medizinische Universität Wien, Univ. Klinik für Dermatologie" -610,0.98081560929616296,4b5b75aa-a963-452e-848e-256ac41c5d72,Fédération Nationale des Centres de Lutte,f_d_ration_nationale_des_centres_de_lutte,,,,4b5b75aa-a963-452e-848e-256ac41c5d72,f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer,Fédération Nationale des Centres de Lutte Contre le Cancer -1020,0.98311978578567505,b56a3044-dedf-4773-b7a5-e6cd18764bcd,Orion Corporation Orion Pharma,orion_corporation_orion_pharma,,,,b56a3044-dedf-4773-b7a5-e6cd18764bcd,orion_corporation_orion_pharma,Orion Corporation Orion Pharma -6135,,dc59460a-9d8e-4673-a8ba-8d46f83dde30,Archimedes Development Ltd,archimedes_development_ltd,,,,,, -640,0.97884902358055115,4d681c57-3f4f-4cb4-bfc1-8067121ab51d,Boehringer Ingelheim RCV GmbH & Co KG,boehringer_ingelheim_rcv_gmbh_co_kg,,,,d2f4fdea-3f56-449f-b5b3-ab25da9fa8af,boehringer_ingelheim_rcv_gmbh_co_kg,Boehringer Ingelheim RCV GmbH & Co KG -6136,,28e52cf9-0b11-4b20-9e9f-facfb52f4173,DR. ENRICO MONTANARI,dr_enrico_montanari,,,,,, -6137,,b9880d0f-4391-4646-978b-8784c9964d80,Servicio de Anestesiología y Reanimación,servicio_de_anestesiolog_a_y_reanimaci_n,,,,,, -482,0.9060404896736145,eee3d6a7-f9c0-4023-8976-5e4f0a8a21de,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Lungenkrankheiten",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klinische_abteilung_f_r_lungenkrankheiten,,,,2023e16d-080b-4eeb-8515-b467f748a454,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_klinische_abteilung_f_r_nephrologie,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Nephrologie" -6138,,18f3b9ef-6bc1-48eb-808e-60a221ceda7b,"University Hospital/Inselspital Berne, Department for Medical Oncology",university_hospital_inselspital_berne_department_for_medical_oncology,,,,,, -96,0.9879,b29eb661-1920-4894-b0f1-fd365cb40e54,Mekos Laboratories,mekos_laboratories,,,,b29eb661-1920-4894-b0f1-fd365cb40e54,mekos_laboratories,Mekos Laboratories -6139,,4cefbb99-05cf-4bb7-a167-a37f1ff72774,"Allergie-Centrum-Charite, Department of Dermatology, Charite - Universitätsmedizin Berlin",allergie_centrum_charite_department_of_dermatology_charite_universit_tsmedizin_berlin,,,,,, -194,0.976498,6dafc817-47f5-4070-8f2f-83bb2660a10a,ACROSS Group,across_group,,,,6dafc817-47f5-4070-8f2f-83bb2660a10a,across_group,ACROSS Group -6140,,f0042380-cb8d-4008-8d1e-66f82fcc8e55,DIPARTIMENTO DI MEDICINA CLINICA - UNIVERSITA` DEGLI STUDI DELL`INSUBRIA,dipartimento_di_medicina_clinica_universita_degli_studi_dell_insubria,,,,,, -735,0.98142971098423004,9437a80f-1f01-4d11-a163-662513465c34,European Organisation for Research and Treatment on Cancer,european_organisation_for_research_and_treatment_on_cancer,,,,6e92b00d-0791-4d8e-975c-0fbd5ce95861,european_organisation_for_research_and_treatment_of_cancer,European Organisation for Research and Treatment of Cancer -6141,,b53b8cde-4474-4f93-b8d7-bcd924788313,Research and Enterprise Department,research_and_enterprise_department,,,,,, -6142,,e13586fa-8d4a-4088-b86c-154c65dd41ef,NHS Glasgow and Clyde / University of Glasgow,nhs_glasgow_and_clyde_university_of_glasgow,,,,,, -6143,,b94fd1b2-959c-4377-8f33-55001d211815,Enceladus Pharmaceuticals,enceladus_pharmaceuticals,,,,,, -111,0.90460896492004395,305770d0-2dc9-4f31-ad46-773cf169b699,"Department of Oncology, Skåne University Hospital Lund",department_of_oncology_sk_ne_university_hospital_lund,,,,305770d0-2dc9-4f31-ad46-773cf169b699,department_of_oncology_sk_ne_university_hospital_lund,"Department of Oncology, Skåne University Hospital Lund" -6144,,dd8ac388-cfe3-4acb-9b4c-c7804febea18,"AMC, divisie Psychiatrie",amc_divisie_psychiatrie,,,,,, -693,0.96936577558517456,a76c2366-c812-414d-8cf9-58d6fa36de67,NovaCardia Inc,novacardia_inc,,,,48601627-d189-4d07-b717-58fa6e8591d5,novacardia_inc_wholly_owned_subsidiary_of_merck_co_inc,NovaCardia Inc (wholly owned subsidiary of Merck & Co. Inc) -6145,,2d3a7e4e-2cc4-490d-852f-dcbdba6303cd,"University Hospital, Dept of Oncology, clinical trial unit",university_hospital_dept_of_oncology_clinical_trial_unit,,,,,, -6146,,994c7cb9-90a9-4e63-9d09-09b93429d692,Gentofte University Hospital,gentofte_university_hospital,,,,,, -6147,,d2ae0121-e302-4cab-be42-dc7305143c6f,Ullevaal University Hospital,ullevaal_university_hospital,,,,,, -6148,,1e2ffe24-836a-4b62-8a97-38d15a259fac,"Department of Orthopedic Surgery, Aarhus University",department_of_orthopedic_surgery_aarhus_university,,,,,, -6149,,b6cbdf1c-7141-11e6-a0cd-0242ac12000b,ECI PHARMS LLC,eci_pharms_llc,,,,,, -6150,,8de5e438-ee9c-4829-b441-1a6dd52e766f,Odense Universitets Hospital,odense_universitets_hospital,,,,,, -6151,,806d4d52-6d06-4fd7-9df6-8416e211d65e,Kompetenznetz TDM-KJP e.V,kompetenznetz_tdm_kjp_e_v,,,,,, -6152,,81dc8c8b-5b1e-40a3-b7be-d0c695f8718a,ZonMw zorg voor jeugd-effecten en kosten,zonmw_zorg_voor_jeugd_effecten_en_kosten,,,,,, -6153,,c6c20094-598d-4dd2-a212-ed281d8f365d,Hellenic Oncology Cooperative Group,hellenic_oncology_cooperative_group,,,,,, -6154,,c8246372-bd66-4838-8d1a-bc8376bbc2f6,Lungmedicinska kliniken,lungmedicinska_kliniken,,,,,, -6155,,1ae54218-553d-458d-9b2a-5350af45e87c,YMBiosciences INC,ymbiosciences_inc,,,,,, -6156,,8594ad17-f56b-44a0-afda-9b205c09d462,Alcon Hungary Ltd,alcon_hungary_ltd,,,,,, -6157,,3fa553ef-a554-45a9-9d58-be3f8a926626,Fundación Investigación Sanitaria en León,fundaci_n_investigaci_n_sanitaria_en_le_n,,,,,, -6158,,4bb8a940-6f74-4706-b573-fb1e8fc7c8e3,"Paediatric Pulmonary Service, Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark",paediatric_pulmonary_service_department_of_paediatrics_and_adolescent_medicine_rigshospitalet_copenhagen_denmark,,,,,, -6159,,cfc7168a-96a1-4bcc-a52d-cd3152f1a26c,"Curis, Inc",curis_inc,,,,,, -740,0.9299778938293457,a915c184-a118-4ca9-8fb4-2b38760107dc,"ICORG, the All-Ireland Cooperative Oncology Research Group",icorg_the_all_ireland_cooperative_oncology_research_group,,,,a915c184-a118-4ca9-8fb4-2b38760107dc,icorg_the_all_ireland_cooperative_oncology_research_group,"ICORG, the all-Ireland Co-operative Oncology Research Group" -6160,,92c4c0b4-9a42-4f78-9a1e-bd08e4b20c07,Baxter Vaccine AG,baxter_vaccine_ag,,,,,, -6161,,d09019a4-b225-4a88-ad7a-2a22d377acd1,"Rigel Pharmaceuticals, Inc",rigel_pharmaceuticals_inc,,,,,, -6162,,a1157d38-6359-4f15-bf41-9e98b09a800d,Ann Hellström,ann_hellstr_m,,,,,, -29,0.987472,4a85ef8b-1aa9-4a42-b446-1e9beb780e11,INO Therapeutics,ino_therapeutics,,,,27abc283-e5cd-4ac3-968b-19e1e91d0bcd,ino_therapeutics_ab,INO Therapeutics AB -6163,,8dfe26f2-9111-4131-a1e1-cf4c04decd02,"HUS, ATEK, Töölön sairaala, Neurokirurgian klinikka",hus_atek_t_l_n_sairaala_neurokirurgian_klinikka,,,,,, -6164,,55b4bb17-0216-455c-813a-610887dab7a3,Roche AB,roche_ab,,,,,, -6165,,cd744cf7-9819-4a63-baca-45f226f81424,MethylGene Inc,methylgene_inc,,,,,, -6166,,68f08d47-18e6-4ae1-abd4-070b533d3466,"Department of Clinical Biochemestry, Aarhus University Hospital",department_of_clinical_biochemestry_aarhus_university_hospital,,,,,, -6167,,650f4777-ad05-450c-bb12-567cb14675e4,scPharmaceuticals Inc,scpharmaceuticals_inc,,,,,, -6168,,5d03a09e-71a7-11e6-a0cd-0242ac12000b,HIKMA (MAPLE),hikma_maple,,,,,, -6169,,0fe70ae0-7156-11e6-a0cd-0242ac12000b,MEDA PHARMS,meda_pharms,,,,,, -6170,,0dd6f60e-7c23-4279-b459-59def57cfcff,MetrioPharm AG,metriopharm_ag,,,,,, -6171,,b96f670d-0bb6-4993-89db-1544f4247908,RECKITT BENCKISER HEALTHCARE,reckitt_benckiser_healthcare,,,,,, -522,0.97898,868cd64a-08f1-4dc3-b30b-abd7473fd49f,Renovo,renovo,,,,2bce399b-f655-4890-9a07-afe0a1f39d7f,renovo_ltd,Renovo Ltd -6172,,9ffd956b-a33f-4076-8911-bd5c8b363c75,Servicio de Anestesia-Reanimación,servicio_de_anestesia_reanimaci_n,,,,,, -6173,,dbe8b077-b0cf-45d4-94f5-6b7a04fecd70,Gwent Healthcare NHS Trust,gwent_healthcare_nhs_trust,,,,,, -6174,,56662071-5658-4e6b-a867-8c84125cc160,Cellseed France S.A.R.L,cellseed_france_s_a_r_l,,,,,, -6175,,c9d2cd4e-87d8-4c4c-9df0-1b0b28fe44c3,ECRI,ecri,,,,,, -6176,,2847033c-8be7-11e6-a449-0242ac12000b,Oslo universitetssykehus health trust,oslo_universitetssykehus_health_trust,,,,,, -6177,,cd406dc2-880b-11e6-a998-0242ac12000b,Braeburn Pharmaceuticals,braeburn_pharmaceuticals,,,,,, -925,0.96910750865936279,ce8f68a3-57b0-4821-ab13-61e00be1d29e,"LUMC, VRSP",lumc_vrsp,,,,844eaa65-2406-4ab1-9c51-75be91cc2736,lumc,LUMC -6178,,cdb12dba-7365-11e6-a0cd-0242ac12000b,NIH NCI DCTD,nih_nci_dctd,,,,,, -6179,,27771b7c-1664-4492-8347-83a184802408,Alicia Pareja Ríos,alicia_pareja_r_os,,,,,, -171,0.98875898122787476,e33b991e-aa77-4ba1-842e-d3959ab310c0,Merck Serono International,merck_serono_international,,,,e0ea9f26-8028-4605-8f3e-bec9a3e04275,merck_serono_international,Merck Serono International -6180,,48024dc3-3391-43e7-9f84-ffd02e53a977,"Institution of Paediatric Anaesthesia and intensiv care, Astrid Lindgren Childrens Hospital, Karolin",institution_of_paediatric_anaesthesia_and_intensiv_care_astrid_lindgren_childrens_hospital_karolin,,,,,, -6181,,cf397ab2-0f00-449d-93c6-def630eeb7a4,"Allan Vaag, Steno Diabetes Center",allan_vaag_steno_diabetes_center,,,,,, -666,0.969108,57164cff-6f3b-448f-a2a2-cb44b3def10b,NOPHO,nopho,,,,57164cff-6f3b-448f-a2a2-cb44b3def10b,nopho,NOPHO -1030,0.98681271076202393,525d2720-5b9f-47f1-b135-6c39bc8e2abf,"Medical University of Vienna, Department of Internal Medicine II",medical_university_of_vienna_department_of_internal_medicine_ii,,,,525d2720-5b9f-47f1-b135-6c39bc8e2abf,medical_university_of_vienna_department_of_internal_medicine_ii,"Medical University of Vienna, Department of Internal Medicine II" -6182,,4818b20e-b640-42db-b4c2-8151990a7397,Ovation Pharmaceuticals,ovation_pharmaceuticals,,,,,, -6183,,0b39fd7f-3593-43a6-bc1c-d5794e4475b6,José Such Ronda,jos_such_ronda,,,,,, -238,0.95441973209381104,f02ec012-bcd3-4f41-a9c8-9be79bec0377,"Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, UNITED KINGDOM",pfizer_limited_ramsgate_road_sandwich_kent_ct13_9nj_united_kingdom,,,,3438eb84-9448-480b-915c-1c1511546785,pfizer_limited_ramsgate_road_sandwich_kent_ct13_9nj,"Pfizer Limited, Ramsgate Road,Sandwich,Kent CT13 9NJ" -6184,,370a0892-7152-11e6-a0cd-0242ac12000b,CAROLINA MEDCL,carolina_medcl,,,,,, -6185,,0d33da14-ee52-4218-b941-fb81e8b08830,AstraZeneca A/S,astrazeneca_a_s,,,,,, -6186,,345663e2-7167-11e6-a0cd-0242ac12000b,UCLA BIOMEDICAL,ucla_biomedical,,,,,, -59,0.97367590665817261,96e5ebae-c6a3-41db-ae14-3ec5437c35f2,Wyeth Research,wyeth_research,,,,96e5ebae-c6a3-41db-ae14-3ec5437c35f2,wyeth_research_division,Wyeth Research Division -6187,,17032d7a-ceba-4764-88cb-3d476d4abb62,TEVA UK Ltd,teva_uk_ltd,,,,,, -6188,,45d4462a-2326-4deb-8f3b-4bbdb4cb84af,"Kyowa Kirin Pharmaceutical Development, Inc",kyowa_kirin_pharmaceutical_development_inc,,,,,, -6189,,b9015aac-8bd9-11e6-a449-0242ac12000b,"Oslo University Hospital HF, Ullevål Hospital, FORMI-Formidlingsenheten for muskel- og skjelettlidelser",oslo_university_hospital_hf_ullev_l_hospital_formi_formidlingsenheten_for_muskel_og_skjelettlidelser,,,,,, -6190,,120f86dc-0deb-4381-aa6d-33e7ff920fc1,Genkyotex Innovation SAS,genkyotex_innovation_sas,,,,,, -6191,,e075a481-fe46-4d20-8a22-3437faddd450,Radboud University Nijmegen Medical Centre - Department of Dermatology,radboud_university_nijmegen_medical_centre_department_of_dermatology,,,,,, -6192,,03b0f3f8-7142-11e6-a0cd-0242ac12000b,DIAGNOSTIC GREEN,diagnostic_green,,,,,, -6193,,b3cd88e0-506e-45d7-ba9f-474f41c4344d,AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA` GRANDA (A.O. DI RILIEVO NAZIONALE),azienda_ospedaliera_ospedale_niguarda_ca_granda_a_o_di_rilievo_nazionale,,,,,, -243,0.982397,feaf2687-794e-43cf-90f6-0e5457185be9,Oxford BioMedica (UK) Limited,oxford_biomedica_uk_limited,,,,84165c73-a712-4209-9005-cccca1ac46d9,oxford_biomedica,Oxford BioMedica -6194,,2b3cbd58-4b33-4ba0-add9-4e1e5c88b07d,Genaera Corporation,genaera_corporation,,,,,, -6195,,c3fea6ac-71d1-11e6-a0cd-0242ac12000b,CLINIGEN HLTHCARE,clinigen_hlthcare,,,,,, -6196,,2dcb3f76-7265-11e6-a0cd-0242ac12000b,LLOYD,lloyd,,,,,, -6197,,a6d5beb6-052b-48f5-8b40-8886d133b556,VU University Medical Center Amsterdam,vu_university_medical_center_amsterdam,,,,,, -6198,,392044d2-9bac-472e-aab6-4fc73aec99d7,"CCIT Center for Cancer ImmunTerapi, Herlev Hospital, Hæmatologisk afd 54P4",ccit_center_for_cancer_immunterapi_herlev_hospital_h_matologisk_afd_54p4,,,,,, -6199,,0d67f289-26af-4c76-a9f3-211762e719d0,ADRFARCP,adrfarcp,,,,,, -6200,,80416083-397a-433a-96db-a13e46d5f54a,Moorfields Eye Hospital Foundation Trust,moorfields_eye_hospital_foundation_trust,,,,,, -6201,,c2eb78ba-72e5-4273-9eb4-fb7bb317fd2b,AESCA Pharma GesmbH,aesca_pharma_gesmbh,,,,,, -861,0.92456701397895813,7cef3d29-cecb-442c-acdb-b0a10dec2da0,"Academic Medical Center, Department of Rheumatology",academic_medical_center_department_of_rheumatology,,,,7cef3d29-cecb-442c-acdb-b0a10dec2da0,academic_medical_center_department_of_dermatology,"Academic Medical Center, Department of dermatology" -419,0.98464131355285645,24418820-0b75-41e2-993c-2f2c0b00efb6,National and Kapodistrian University of Athens,national_and_kapodistrian_university_of_athens,,,,24418820-0b75-41e2-993c-2f2c0b00efb6,national_and_kapodistrian_university_of_athens,National and Kapodistrian University of Athens -6202,,4da3f16e-e1ab-4dd4-ab04-18ec73bd63f6,"Karolinska University Hospital, Division of Pediatrics/Astrid Lindgren Children´s Hospital",karolinska_university_hospital_division_of_pediatrics_astrid_lindgren_children_s_hospital,,,,,, -6203,,5a93dda7-d83b-4528-8149-ef62f247f834,"Department of Anaesthesia&Intensive Care B, Vienna Medical University",department_of_anaesthesia_intensive_care_b_vienna_medical_university,,,,,, -509,0.940753,27cde204-b342-4946-975c-01f75b78dc91,UHL NHS Trust,uhl_nhs_trust,,,,27cde204-b342-4946-975c-01f75b78dc91,uhl_nhs_trust,UHL NHS Trust -6204,,9dad7e44-8355-4bbe-906e-ba5a98cae9b5,FONDAZIONE IRCCS OSPEDALE MAGGIORE POLICLINICO MANGIAGALLI E REGINA ELENA,fondazione_irccs_ospedale_maggiore_policlinico_mangiagalli_e_regina_elena,,,,,, -6205,,7e46e64e-ee44-433d-ae94-6ea1226ae17f,Grethe Andersen,grethe_andersen,,,,,, -6206,,1e1630c2-6d5a-49b4-b77b-506edeb7f211,"Bayer HealthCare AG, Bayer Vital GmbH, D-51368 Leverkusen",bayer_healthcare_ag_bayer_vital_gmbh_d_51368_leverkusen,,,,,, -6207,,fa788a31-b0e0-448d-ba73-c091b73b93b7,AGENNIX INC,agennix_inc,,,,,, -6208,,97b49235-8fa5-4994-b75c-f2f0c3cf6d9b,ACO Hud Nordic AB,aco_hud_nordic_ab,,,,,, -6209,,cf029863-46b2-47a6-bbfc-78dbee13f7aa,NPS Allelix Corporation,nps_allelix_corporation,,,,,, -1063,0.968193,f4900410-286d-48e4-8c75-4fc02e713a10,PENTA Foundation,penta_foundation,,,,72f46314-5a65-467f-abea-944dcfd78d17,penta,PENTA -6210,,b41a58f6-0a1a-4bb1-a593-62d98054d07f,Xenon Pharmaceuticals Inc,xenon_pharmaceuticals_inc,,,,,, -6211,,cb68b687-1e3f-4491-93a1-47c6dcfbc6df,Fakultät für Medizin der Technischen Universität München,fakult_t_f_r_medizin_der_technischen_universit_t_m_nchen,,,,,, -6212,,f410b83b-ab39-4bd8-8fc2-4afb35ecb4b2,"Universitätsklinik f. Innere Medizin III, Medizinische Universität Wien",universit_tsklinik_f_innere_medizin_iii_medizinische_universit_t_wien,,,,,, -6213,,3e594ee5-c6b8-4e05-9b2c-cabab15b1769,Marianne Kiszka-Kanowitz,marianne_kiszka_kanowitz,,,,,, -6214,,f0449ff3-17b4-4e9b-b4e9-22e91c86d2f3,Helsinki University Hospital Comprehensive Cancer Center Hematology,helsinki_university_hospital_comprehensive_cancer_center_hematology,,,,,, -6215,,e35f2092-3b29-4dad-b641-6df7bf1da76d,"Boehringer Ingelheim, Lda",boehringer_ingelheim_lda,,,,,, -6216,,f10efca8-7165-11e6-a0cd-0242ac12000b,DEXCEL PHARMA,dexcel_pharma,,,,,, -636,0.988732,0a4a7604-18d1-4751-9003-e209b313dd54,"La Jolla Pharmaceutical Company, Inc",la_jolla_pharmaceutical_company_inc,,,,0a4a7604-18d1-4751-9003-e209b313dd54,la_jolla_pharmaceutical_company_inc,"La Jolla Pharmaceutical Company, Inc" -6217,,c98cdee3-5ee4-44ef-84af-0937cd00a613,EB House Austria,eb_house_austria,,,,,, -6218,,56835c13-0683-4734-91e6-558f48d542df,Cell Medica Inc,cell_medica_inc,,,,,, -6219,,dd6a9e02-7154-11e6-a0cd-0242ac12000b,PLIVA PHARM IND,pliva_pharm_ind,,,,,, -6220,,01ddae79-3849-47ba-949a-6c64fa858dc3,"Cancer Prevention Pharmaceuticals, Inc",cancer_prevention_pharmaceuticals_inc,,,,,, -6221,,755f8b27-b05d-423f-b8fa-1595e8cbb235,Radiopharmacy,radiopharmacy,,,,,, -6222,,a19d8b78-7145-11e6-a0cd-0242ac12000b,COPLEY PHARM,copley_pharm,,,,,, -176,0.95111942291259766,7d38a850-1226-4260-83b3-3434311401ac,Novartis Vaccines and Diagnostics Inc,novartis_vaccines_and_diagnostics_inc,,,,fbdb10c1-6146-4761-86bf-a8541dc3b4fa,novartis_vaccines_and_diagnostics,Novartis Vaccines and Diagnostics -6223,,e881c694-71d1-11e6-a0cd-0242ac12000b,SAOL THERAPS RES LTD,saol_theraps_res_ltd,,,,,, -771,0.989275,ae4da2c3-6d27-4362-b182-669f879ac3d4,Swiss Group for Clinical Cancer Research,swiss_group_for_clinical_cancer_research,,,,ae4da2c3-6d27-4362-b182-669f879ac3d4,swiss_group_for_clinical_cancer_research,Swiss Group for Clinical Cancer Research -6224,,482e1a11-041e-4951-b575-49b38eeba893,AZIENDA OSPEDALIERA PROVINCIALE DI LECCO,azienda_ospedaliera_provinciale_di_lecco,,,,,, -6225,,9a620168-9c2b-4970-86b3-9aaa82aaa0b9,Alexion Pharma International Sàrl,alexion_pharma_international_s_rl,,,,,, -6226,,0b3cfd28-1a3a-47e7-a77c-2f3233727d4a,ASL 5 di PISA-ZONA VALDERA,asl_5_di_pisa_zona_valdera,,,,,, -6227,,d3d10843-39c8-4139-bc1e-fc4efe03be52,Collaborative group for Adrenocortical Carcinoma Therapy (COAT),collaborative_group_for_adrenocortical_carcinoma_therapy_coat,,,,,, -6228,,5b3734a2-82e2-4c16-9c4d-66d561ed0d51,"University of Oslo, Faculty of medicine, Institute of Health and Society",university_of_oslo_faculty_of_medicine_institute_of_health_and_society,,,,,, -6229,,14c14159-03ef-4670-917f-491b988075e8,Heikki Swan,heikki_swan,,,,,, -192,0.97530868649482727,9178b769-ccd5-4b69-99d5-18e3e7de020e,Teva Pharmaceutical Industries Ltd,teva_pharmaceutical_industries_ltd,,,,7621f0c9-df30-4cbd-95c1-d0d5719d2751,teva_pharmaceutical_industries,Teva Pharmaceutical Industries -6230,,b48e5d5a-7179-11e6-a0cd-0242ac12000b,CENTOCOR ORTHO BIOTECH INC,centocor_ortho_biotech_inc,,,,,, -639,0.98662564158439636,99c8c026-a38d-4aa0-ac2d-e1703ec3bcfb,Greater Glasgow Health Board/University of Glasgow,greater_glasgow_health_board_university_of_glasgow,,,,c80f0f43-274e-40b5-9c79-e591ce33aa3a,greater_glasgow_health_board_university_of_glasgow,Greater Glasgow Health Board/University of Glasgow -635,0.92223775386810303,fbd61dac-95f7-49cb-a759-c06335f234f8,"Research and Development Department, University Hospital of South Manchester NHS Foundation Trust",research_and_development_department_university_hospital_of_south_manchester_nhs_foundation_trust,,,,e73c0583-9c8a-433e-9519-117f883c39d0,research_development_department,Research & Development Department -6231,,127c1ab2-f7bc-4a17-b7ac-df962a90c9bf,"Department of Dermatology, medical University of Graz",department_of_dermatology_medical_university_of_graz,,,,,, -6232,,606e8f07-edf4-4ecc-b7c6-490f4c10ed4f,"Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc",johnson_johnson_healthcare_products_division_of_mcneil_ppc_inc,,,,,, -679,0.967014,7ea66ab6-e6d3-4852-ac14-3cc45c40c829,"CHU Angers, directeur général, Yvonnick Morice",chu_angers_directeur_g_n_ral_yvonnick_morice,,,,73f44df3-f258-476a-8ae7-6cb143e4cbb3,chu_angers,CHU Angers -6233,,ed006eaa-d319-4e71-a249-2f5cfd31fef5,"Medizinische Universität Wien, KIMIII, Abteilung für Endokrinologie und Stoffwechsel",medizinische_universit_t_wien_kimiii_abteilung_f_r_endokrinologie_und_stoffwechsel,,,,,, -6234,,4ea3f604-7146-11e6-a0cd-0242ac12000b,J AND J,j_and_j,,,,,, -6235,,4ccfa855-0e8f-4df0-80d1-77aba652f600,Kirsten Rasmussen,kirsten_rasmussen,,,,,, -6236,,fd369c1b-b034-4637-847c-a569f17a1b52,"Deparment of pediatrics, Skejby Hospital, Denmark",deparment_of_pediatrics_skejby_hospital_denmark,,,,,, -6237,,a5f51dee-c5c4-4f37-97b0-368d237b4850,UNIDAD HEPATICA. CIBERehd. HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE,unidad_hepatica_ciberehd_hospital_general_universitario_de_alicante,,,,,, -6238,,895833eb-d7e4-4fc2-b76b-8d28e40392da,Biotie Therapies Inc,biotie_therapies_inc,,,,,, -6239,,2d63edd6-7142-11e6-a0cd-0242ac12000b,MEDIMETRIKS PHARMS,medimetriks_pharms,,,,,, -6240,,886bb340-97ee-4365-b9dc-932902cf338b,"Malmö Högskola, Odontologiska fakulteten",malm_h_gskola_odontologiska_fakulteten,,,,,, -6241,,517beec6-60fe-4594-ad28-0fa37789666e,"Janssen - Cilag , Johnson & Johnson s.r.o",janssen_cilag_johnson_johnson_s_r_o,,,,,, -6242,,fda244be-00ab-46dd-b54e-1b878fd8ba48,U.O.C. EMATOLOGIA - OSP. S. EUGENIO - ASL RM C,u_o_c_ematologia_osp_s_eugenio_asl_rm_c,,,,,, -6243,,e594c941-0e2b-40df-8fed-1953a48c36af,"Calibra Medical, Inc",calibra_medical_inc,,,,,, -6244,,fddfc979-7f90-42a3-a89d-0991502c43cd,TREND,trend,,,,,, -6245,,ee3a8e82-739c-11e6-a0cd-0242ac12000b,AYTU BIOSCIENCE INC,aytu_bioscience_inc,,,,,, -639,0.985979825258255,c80f0f43-274e-40b5-9c79-e591ce33aa3a,Greater Glasgow Health Board/University of Glasgow (GU),greater_glasgow_health_board_university_of_glasgow_gu,,,,c80f0f43-274e-40b5-9c79-e591ce33aa3a,greater_glasgow_health_board_university_of_glasgow,Greater Glasgow Health Board/University of Glasgow -735,0.98617294430732727,5fc30646-7d65-488f-8e5a-a6c4dcb915c5,European Organisation for Research and Treatment of Cancer (EORTC),european_organisation_for_research_and_treatment_of_cancer_eortc,,,,6e92b00d-0791-4d8e-975c-0fbd5ce95861,european_organisation_for_research_and_treatment_of_cancer,European Organisation for Research and Treatment of Cancer -6246,,7bdca9c2-7344-11e6-a0cd-0242ac12000b,ALTATHERA PHARMS LLC,altathera_pharms_llc,,,,,, -6247,,b7738ad1-6044-4110-9da1-d39d6a0afcff,"GlaxoSmithKline Research, European Medical Governance",glaxosmithkline_research_european_medical_governance,,,,,, -6248,,9b93e7f0-7261-11e6-a0cd-0242ac12000b,METABOLIC SOLUTIONS,metabolic_solutions,,,,,, -1065,0.91470474004745483,21aba99b-7de3-432e-87cd-3af4301e3cdb,"Cambridge University Hospitals NHS Foundation Trust, jointly with University of Cambridge",cambridge_university_hospitals_nhs_foundation_trust_jointly_with_university_of_cambridge,,,,21aba99b-7de3-432e-87cd-3af4301e3cdb,cambridge_university_hospitals_nhs_foundation_trust_jointly_with_university_of_cambridge,"Cambridge University Hospitals NHS Foundation Trust, jointly with University of Cambridge" -645,0.97129645943641663,a8589c66-fe86-4470-ba8f-ef79159c3cf8,"Boehringer Ingelheim Pharma GmbH & Co. KG, Medical Affairs Germany",boehringer_ingelheim_pharma_gmbh_co_kg_medical_affairs_germany,,,,5b57c8bd-158c-42a5-bfa1-3323c67e0dd4,boehringer_ingelheim_pharma_gmbh,Boehringer Ingelheim Pharma GmbH -6249,,b7ddb2ec-b3e9-4a20-a77f-0b33298feea9,ASSOCIAZIONE ITALIANA PNEUMOLOGI OSPEDALIERI,associazione_italiana_pneumologi_ospedalieri,,,,,, -741,0.9617915153503418,0e4b6223-68c5-42cb-9eef-06cfdcc860dd,AstraZeneca R&D Sodertalje,astrazeneca_r_d_sodertalje,,,,5b96ae2b-b1a8-4688-88cd-0fcea433e529,astrazeneca_r_d,AstraZeneca R&D -6250,,e8d1e095-f4c4-4980-9477-48607095e6b3,"Med Uni Graz, Abt. für NEURO- u. GESICHTSCHIRURGISCHE ANÄSTHESIE u. INTENSIVMEDIZIN",med_uni_graz_abt_f_r_neuro_u_gesichtschirurgische_an_sthesie_u_intensivmedizin,,,,,, -6251,,1d954080-8bdc-11e6-a449-0242ac12000b,BayerAG,bayerag,,,,,, -6252,,d16c916b-13d2-40a6-a35f-df47ab8d4483,"Plymouth Hospital NHS Trust, R&D dept",plymouth_hospital_nhs_trust_r_d_dept,,,,,, -6253,,d05ac90e-3b70-4249-a4db-96c18f832716,ardana LTD,ardana_ltd,,,,,, -675,0.98461800813674927,d0b7c9bb-f1c2-49e9-8ebe-37e911f49aff,UCB Pharma,ucb_pharma,,,,0db50825-cbd9-4ba0-9b70-46c1d448c066,ucb_pharma,UCB Pharma -6254,,d7afcd5b-0be6-4039-a08b-52e26e0f5e64,FUNDACION PETHEMA,fundacion_pethema,,,,,, -6255,,835cd70a-7149-11e6-a0cd-0242ac12000b,ALCON LABS INC,alcon_labs_inc,,,,,, -871,0.98728418350219727,8fb63732-f5d5-48d2-a1af-14fecf057351,Astellas Pharma Europe Ltd,astellas_pharma_europe_ltd,,,,0f0582d8-6951-40ea-8acc-9d010331c376,astellas_pharma_europe_ltd_apel,Astellas Pharma Europe Ltd. (APEL) -706,0.98155027627944946,450942a3-d351-4153-8f52-7394952e4a17,"Medical University, Dpt. Internal Medicin, Division of General Inteal Medicine",medical_university_dpt_internal_medicin_division_of_general_inteal_medicine,,,,450942a3-d351-4153-8f52-7394952e4a17,medical_university_dpt_internal_medicin_division_of_general_inteal_medicine,"Medical University, Dpt. Internal Medicin, Division of General Inteal Medicine" -6256,,f4885735-2908-46ed-b1a3-b40a86bca8ab,Interuniversity Cardiology Institute of the Netherlands (ICIN),interuniversity_cardiology_institute_of_the_netherlands_icin,,,,,, -6257,,95f204be-72c8-11e6-a0cd-0242ac12000b,VICURON,vicuron,,,,,, -6258,,0f4d8664-d605-4b71-9dba-8307251c0000,Immodulon Therapeutics Ltd,immodulon_therapeutics_ltd,,,,,, -6259,,a643a9a7-939a-4a67-8ed3-aed8fe6ebf06,"Mpex Pharmaceuticals, Inc",mpex_pharmaceuticals_inc,,,,,, -6260,,ddf19fff-a72e-42bf-a3a0-8ce35ea1c928,"Intensive Care Unit, The Adelaide and Meath Hospital Incorporating the National Children's Hospital",intensive_care_unit_the_adelaide_and_meath_hospital_incorporating_the_national_children_s_hospital,,,,,, -6261,,82160a42-7167-11e6-a0cd-0242ac12000b,UNIV MICHIGAN,univ_michigan,,,,,, -356,0.903306,d51c6143-681e-4142-a4aa-e1eb46d2e51a,Fundación de Investigación Biomédica Hospital La Paz,fundaci_n_de_investigaci_n_biom_dica_hospital_la_paz,,,,ada15e9f-a2ab-489f-bc3e-e972a93587fc,fundaci_n_de_investigaci_n_biom_dica_hospital_de_getafe,Fundación de Investigación Biomédica Hospital de Getafe -6262,,179b0540-ac7d-4d97-ab1b-2fccf929ac32,Luis Bujanda Fernández de Piérola,luis_bujanda_fern_ndez_de_pi_rola,,,,,, -6263,,5bf740ae-893e-4bc9-9701-928d8850fbfc,Medicure International Inc,medicure_international_inc,,,,,, -283,0.988674,ddf9e838-47ae-4e3b-a87e-63b1d7217d1e,Centre Hospitalier Régional et Universitaire,centre_hospitalier_r_gional_et_universitaire,,,,3ed277d7-e94c-44a1-b2b4-33de175d3556,centre_hospitalier_r_gional_et_universitaire_de_lille,Centre Hospitalier Régional et Universitaire de Lille -6264,,ee92e9dd-2f76-4c62-8818-e5af8983e8fb,Dr. Peter Sydow,dr_peter_sydow,,,,,, -6265,,24797330-6fa3-11e6-9663-0242ac12000b,University Medical Center Nijmegen,university_medical_center_nijmegen,,,,,, -6266,,e84bf6e1-c5b3-4fa8-84ba-006530961dc7,Antoni van Leeuwenhoek Hospital-Nuclear Medicine department,antoni_van_leeuwenhoek_hospital_nuclear_medicine_department,,,,,, -6267,,a7d54aa0-515c-4d1f-b687-bdefef959f04,"Serono España, S.A",serono_espa_a_s_a,,,,,, -6268,,bac62fd4-2560-461c-9e0f-f133b5131455,"Medizinische Universität Wien, Univ. Kinderklinik",medizinische_universit_t_wien_univ_kinderklinik,,,,,, -334,0.969856,38455422-c7ad-4eb2-9778-ac9991d3011f,Boiron Laboratoires,boiron_laboratoires,,,,30daea08-31b9-44eb-b245-a0bfc280fc21,boiron,Boiron -6269,,061b31a2-4530-43b3-b31f-e6b5cefbdefc,CHU Gabriel Montpied,chu_gabriel_montpied,,,,,, -6270,,39e41c5e-e924-427f-a229-3f3e031cd580,Spanish Cooperative Group for Gastrointestinal Tomour therapy,spanish_cooperative_group_for_gastrointestinal_tomour_therapy,,,,,, -6271,,04d7a4c0-b243-4331-bc6b-0a94953b9dad,Sahlgrenska Akademien Wallenberglaboratoriet,sahlgrenska_akademien_wallenberglaboratoriet,,,,,, -6272,,02df78f9-c454-4b33-930b-956a2c968ac2,"MacroGenics, Inc",macrogenics_inc,,,,,, -6273,,e247a15e-336a-4e33-9801-b68f40a0cd26,B. Braun Melsungen AG,b_braun_melsungen_ag,,,,,, -6274,,7a48dd83-0ab4-4561-83c0-d1b536df599d,onepharm Research & Development GmbH,onepharm_research_development_gmbh,,,,,, -6275,,5f3d99f9-c3cf-4529-9464-539664d02c51,"UO Divisione Nefrologia, Dialisi e Trapianto renale",uo_divisione_nefrologia_dialisi_e_trapianto_renale,,,,,, -249,0.988541,d91a189c-0325-406f-a6f4-a01cdd87f5d9,Novartis Pharma S.A.S,novartis_pharma_s_a_s,,,,2f1fb211-53ee-482a-b616-521b6469ae37,novartis_pharma_s_a,Novartis Pharma S.A -6276,,743347e7-dae9-4dc9-acfb-f05b9a7dad0a,Universidad de Leipzig,universidad_de_leipzig,,,,,, -88,0.985891,a92a2176-0791-4187-b212-74df344a9470,Photopharmica,photopharmica,,,,31023a1a-6fbc-11e6-abe8-0242ac12000b,photopharmica_ltd,Photopharmica Ltd -588,0.914544,19952d22-67c1-4b82-9279-54d9c48ca7a5,Hospital of the Ludwig Maximilians University Munich,hospital_of_the_ludwig_maximilians_university_munich,,,,19952d22-67c1-4b82-9279-54d9c48ca7a5,hospital_of_the_ludwig_maximilians_university_munich,Hospital of the Ludwig Maximilians University Munich -6277,,89a7b6b4-2578-4cac-a15c-202db7a5d8a9,"Medizinische Universiät Wien, Universitaetsklinik fuer Klinische Pharmakologie",medizinische_universi_t_wien_universitaetsklinik_fuer_klinische_pharmakologie,,,,,, -6278,,945e8f6d-6bdf-4866-9d32-40869da046d6,Jacobo Formigo Couceiro,jacobo_formigo_couceiro,,,,,, -6279,,2890a658-89f1-40f8-aed4-a66af932163f,Central and North West London NHS Foundation Trust,central_and_north_west_london_nhs_foundation_trust,,,,,, -6280,,e1f71b11-d0b3-43bc-9f89-53b628b45e3e,Universität Regensburg,universit_t_regensburg,,,,,, -6281,,63309dd6-7162-11e6-a0cd-0242ac12000b,PHARMACHEMIE USA,pharmachemie_usa,,,,,, -6282,,a9beb2e1-0850-465a-9009-7df515037861,Prof. Asbjørn Mohr Drewes,prof_asbj_rn_mohr_drewes,,,,,, -6283,,77815f0b-c2a7-4442-af26-f3a319d19ec0,"Klinik für Dermatologie und Allergologie der RUB, St. Josef Hospital",klinik_f_r_dermatologie_und_allergologie_der_rub_st_josef_hospital,,,,,, -567,0.985423,0b85e728-7142-11e6-a0cd-0242ac12000b,NOSTRUM LABS INC,nostrum_labs_inc,,,,0b85e728-7142-11e6-a0cd-0242ac12000b,nostrum_labs_inc,NOSTRUM LABS INC -6284,,d6898766-7202-4893-98b6-5545c1a69969,"Aarhus University Hospital, Dept. of anaesthesiology and intensive care",aarhus_university_hospital_dept_of_anaesthesiology_and_intensive_care,,,,,, -6285,,1479a804-f362-45aa-98a7-ebdafa4db265,Assistance publique hôpitaux de marseille,assistance_publique_h_pitaux_de_marseille,,,,,, -6286,,c5cdb516-7160-11e6-a0cd-0242ac12000b,VALEANT PHARMS LLC,valeant_pharms_llc,,,,,, -788,0.918711,8485fc27-40be-49dd-a754-563a52a0814b,"The Royal Group of Hospitals, Belfast Trust",the_royal_group_of_hospitals_belfast_trust,,,,77da9f8d-af27-42f4-9848-1b383dc686c1,the_royal_group_of_hospitals_belfast_health_and_social_care_trust,"The Royal Group of Hospitals, Belfast Health and Social Care Trust" -194,0.976498,9c0c3eb2-c14a-4b84-99a3-653c35ee77ae,ACROSS,across,,,,6dafc817-47f5-4070-8f2f-83bb2660a10a,across_group,ACROSS Group -6287,,4d4bd10a-f480-4be0-aae4-eb7936224cc9,Fundación Academia Española de Dermatología y Venereología,fundaci_n_academia_espa_ola_de_dermatolog_a_y_venereolog_a,,,,,, -6288,,8abcc9ea-7164-11e6-a0cd-0242ac12000b,TAMARANG,tamarang,,,,,, -6289,,1bc2a9f4-98ac-4531-ad6e-9fc83eba88fd,Cristina Peris Martínez,cristina_peris_mart_nez,,,,,, -6290,,a6ac3ddb-4262-4bc0-b724-41727d6e68a1,"Karolinska Institutet, Department of Laboratory Medicine, Clinical Physiology C1:82,Karolinska Univ. Hosp., Huddinge",karolinska_institutet_department_of_laboratory_medicine_clinical_physiology_c1_82_karolinska_univ_hosp_huddinge,,,,,, -835,0.905873,e362093c-5a37-4704-8604-709da1989bd4,University Erlangen-Nuremberg,university_erlangen_nuremberg,,,,81899287-3fd5-4be2-923d-6c76cdc477ff,university_of_erlangen_nuremberg,University of Erlangen-Nuremberg -6291,,3cd153ee-288f-4394-a288-626560f21523,Aalborg Universitets Hospital,aalborg_universitets_hospital,,,,,, -6292,,a3ce8b42-b41d-47a2-bb44-b16c0a32f4f2,Jose M Gatell - Hospital Clinic de Barcelona,jose_m_gatell_hospital_clinic_de_barcelona,,,,,, -339,0.980344,242d528e-2adc-4d28-a02f-034e05a0ca60,Adocia,adocia,,,,1a9c7667-0a16-4463-a38f-f3fc2f60143b,adocia_sa,Adocia SA -6293,,0e62301a-4949-4531-b9e5-62030e3d2f78,Grifols Therapeutics Inc,grifols_therapeutics_inc,,,,,, -832,0.987803,31a12f1b-6a3e-46d8-aa62-861a42167d92,Medical Centre Haaglanden,medical_centre_haaglanden,,,,31a12f1b-6a3e-46d8-aa62-861a42167d92,medical_centre_haaglanden,Medical Centre Haaglanden -6294,,3f98fabd-63be-4035-88c0-ae7618e1da55,"Pfizer Ltd, Ramsgate Rd, Sandwich, Kent, United Kingdom",pfizer_ltd_ramsgate_rd_sandwich_kent_united_kingdom,,,,,, -6295,,a8508300-c034-43d4-83b5-fe2de4ff5f9d,"Department of Medical Research, Regional Hospital Holstebro",department_of_medical_research_regional_hospital_holstebro,,,,,, -6296,,2913a75a-c992-4901-b21e-85602ebc5f98,The Royal Marsden Hospital NHS Trust,the_royal_marsden_hospital_nhs_trust,,,,,, -6297,,952dc112-6cb8-4dcb-9b5d-f9911aced677,"University of Szeged, First Department of Internal Medicine",university_of_szeged_first_department_of_internal_medicine,,,,,, -6298,,e2b5b596-7167-11e6-a0cd-0242ac12000b,CROSSMEDIKA SA,crossmedika_sa,,,,,, -6299,,02943722-6fc2-11e6-abe8-0242ac12000b,University Hospitals Southampton NHS Foundation Trust,university_hospitals_southampton_nhs_foundation_trust,,,,,, -6300,,d7dc3bdf-7309-4431-8cd1-b5feaa1149f6,Pfizer Ltd - Sandwich Laboratories,pfizer_ltd_sandwich_laboratories,,,,,, -617,0.98236817121505737,0359d070-d59d-4dab-8d3e-cdb60bbcff96,Grupo Español de Investigacion en Sarcomas,grupo_espa_ol_de_investigacion_en_sarcomas,,,,0359d070-d59d-4dab-8d3e-cdb60bbcff96,grupo_espa_ol_de_investigaci_n_en_sarcomas,Grupo Español de Investigación en Sarcomas -439,0.98637,df726c6d-1af2-487b-aeec-d62038c2a932,SciencePharma spółka z ograniczoną odpowiedzialnością sp. j,sciencepharma_sp_ka_z_ograniczon_odpowiedzialno_ci_sp_j,,,,80bfc25c-b233-4572-aece-f1e06f4d720e,sciencepharma_sp_ka_z_ograniczon_odpowiedzialno_ci_sp_k,SciencePharma spółka z ograniczoną odpowiedzialnością sp. k -6301,,35c1d0a7-daf9-43bf-aa21-8db98e0ef8a2,"A. MENARINI PHARMA U.K.,",a_menarini_pharma_u_k,,,,,, -18,0.97483,5a94ce26-71db-11e6-a0cd-0242ac12000b,COLGATE PALMOLIVE,colgate_palmolive,,,,5a94ce26-71db-11e6-a0cd-0242ac12000b,colgate_palmolive,COLGATE PALMOLIVE -6302,,69e2e904-451d-4cdb-beb9-21ba9f7756a2,Schering Oy,schering_oy,,,,,, -6303,,b3613164-c782-42db-8210-4959aca604c6,Hexal AG,hexal_ag,,,,,, -6304,,e627fc5b-8d68-4a48-bd2a-215799922a7a,Biosynexus Incorporated,biosynexus_incorporated,,,,,, -6305,,f6e26b13-e86a-4335-acdc-994d4a2a9015,"University of Bergen, Faculty of medicin and dentistry, Dep. of Clinical Dentistry",university_of_bergen_faculty_of_medicin_and_dentistry_dep_of_clinical_dentistry,,,,,, -6306,,e97287d2-3dca-4b2a-a910-3a00ac2eaa3c,CHU de Toulouse,chu_de_toulouse,,,,,, -6307,,612f66e0-8af9-4664-8076-1c51d5bcbba6,Národní ústav duševního zdraví,n_rodn_stav_du_evn_ho_zdrav,,,,,, -226,0.97584396600723267,d67f1fcd-9097-482d-9faf-b5d8f85a5883,FUNDACIÓ SANT JOAN DE DEU,fundaci_sant_joan_de_deu,,,,43372c1e-43ce-4dcb-b2e0-ae9f60081a96,fundaci_sant_joan_de_d_u,FUNDACIÓ SANT JOAN DE DÉU -907,0.94901684919993079,bc78737f-5607-4fe9-a4a6-eab005b383ca,sanofi-aventis recherche et development,sanofi_aventis_recherche_et_development,,,,f72ce0f5-27b8-42db-aeea-0faa55409a54,sanofi_aventis_recherche_et_developpement,sanofi-aventis recherche et developpement -6308,,cedf41cb-749c-43ae-8c37-0e263ec5c65c,"OSI Pharmaceuticals, Inc",osi_pharmaceuticals_inc,,,,,, -866,0.96000528335571289,777eeb1f-10b4-4c96-8d33-42be9c44ad2b,"Hvidovre Hospital, Dept. of Rheumatology",hvidovre_hospital_dept_of_rheumatology,,,,777eeb1f-10b4-4c96-8d33-42be9c44ad2b,hvidovre_hospital,Hvidovre Hospital -892,0.98520499467849731,16b9d8ec-4b48-4fe9-bcae-e854bddbc3d8,Aarhus Universityhospital,aarhus_universityhospital,,,,16b9d8ec-4b48-4fe9-bcae-e854bddbc3d8,aarhus_universityhospital,Aarhus Universityhospital -6309,,b45e4eac-74d4-48fa-9477-9f8a86462df1,bioCSL Pty Ltd,biocsl_pty_ltd,,,,,, -6310,,3256bb7c-5fd2-4306-a232-852bfb30ef10,"Kern Pharma, S.L",kern_pharma_s_l,,,,,, -6311,,71bda146-8bd9-11e6-a449-0242ac12000b,Dept of Anaesthesiology 530,dept_of_anaesthesiology_530,,,,,, -6312,,e0da56ac-185f-49b3-a4aa-81e93e977968,Hospital Vall d Hebron,hospital_vall_d_hebron,,,,,, -6313,,104f5d7a-d035-4817-891d-48226b2c9f9f,InterMune International AG,intermune_international_ag,,,,,, -6314,,397d1d41-e945-4b0a-87c0-6028fae1ffcf,Stiefel Laboratories International Division,stiefel_laboratories_international_division,,,,,, -6315,,1df7ad58-074e-4c00-a49c-4017fd6f7d0e,"Cardiology, University of Frankfurt",cardiology_university_of_frankfurt,,,,,, -332,0.986085,fedf47d3-8924-4b5d-86ee-4c4bba29445d,Instituto Valenciano de Infertilidad,instituto_valenciano_de_infertilidad,,,,7336f82e-6c71-4f40-80a6-4017116b5145,instituto_valenciano_de_infertilidad_ivi_de_valencia,Instituto Valenciano de Infertilidad (IVI) de Valencia -6316,,a9877e08-dc31-4cae-9a47-3090b8228308,PEDRO ACIEN ALVAREZ,pedro_acien_alvarez,,,,,, -6317,,a6e60a11-63cc-4f54-b63f-4fe9ba8fff4c,"Laboratorios Effik, S.A",laboratorios_effik_s_a,,,,,, -6318,,5bab3405-2cb8-4b15-abe3-f952b16c1d24,Marienkrankenhaus Soest,marienkrankenhaus_soest,,,,,, -6319,,8897a044-865d-4674-871c-61c6f79c0b23,"Medizinische Universität Graz, Klinische Abteilung für Geburtshilfe, Univ. Klinik für Frauenheilkunde und Geburtshilfe",medizinische_universit_t_graz_klinische_abteilung_f_r_geburtshilfe_univ_klinik_f_r_frauenheilkunde_und_geburtshilfe,,,,,, -361,0.988596,7d7d20e5-897b-403b-ba75-22e35574cc70,Mitsubishi Tanabe Pharma Corporation (MTPC),mitsubishi_tanabe_pharma_corporation_mtpc,,,,7d7d20e5-897b-403b-ba75-22e35574cc70,mitsubishi_tanabe_pharma_corporation_mtpc,Mitsubishi Tanabe Pharma Corporation (MTPC) -6320,,02b46a59-0678-44d4-a5df-de9f101df96c,Univ.-Prof. Dr. Karlheinz Tscheliessnigg,univ_prof_dr_karlheinz_tscheliessnigg,,,,,, -6321,,ab482af0-972d-4660-855c-6391b24567d4,"Clinic for General Anesthesiology, Intensive Care and Pain Management",clinic_for_general_anesthesiology_intensive_care_and_pain_management,,,,,, -6322,,953bf657-cd2e-4830-8c82-3ed116f878f7,"Department of Rheumatology, Skåne University Hospital",department_of_rheumatology_sk_ne_university_hospital,,,,,, -604,0.96866416931152344,1a6a910e-9e16-4295-9c10-800391283d55,Fundación Investigación y Desarrollo en el Área Cardiovascular,fundaci_n_investigaci_n_y_desarrollo_en_el_rea_cardiovascular,,,,1a6a910e-9e16-4295-9c10-800391283d55,fundaci_n_investigaci_n_y_desarrollo_en_el_rea_cardiovascular,Fundación Investigación y Desarrollo en el Área Cardiovascular -620,0.964286,6ff65a26-4d52-43ab-86e1-d923b4e7de50,Technical University of Munich,technical_university_of_munich,,,,1ea7f82f-9f53-484a-93fe-2e25f14ea8ee,technical_unversity_of_munich,Technical Unversity of Munich -6323,,83c3b9cf-8d56-48ca-aaf9-86a9c37f6be5,Paracelsus Medizinische Universität - Universitätsklinik für Anästhesie,paracelsus_medizinische_universit_t_universit_tsklinik_f_r_an_sthesie,,,,,, -6324,,bc6ec18d-0cb0-44d9-aedb-aa393841edf5,"Tokai Pharmaceuticals, Inc",tokai_pharmaceuticals_inc,,,,,, -6325,,a462e85f-a474-473f-8195-381fabae5a3b,CEL-SCI Corporation,cel_sci_corporation,,,,,, -6326,,b4257ccc-ccb0-4aeb-8b63-85577c103973,Herz- & Diabeteszentrum NRW,herz_diabeteszentrum_nrw,,,,,, -6327,,739f1215-8dd8-4a7e-9ec3-1d629f5e7c3f,"Carlos Alonso-Villaverde Lozano, Hospital Universitari Sant Joan de Reus",carlos_alonso_villaverde_lozano_hospital_universitari_sant_joan_de_reus,,,,,, -614,0.95815481742223108,9a31a764-2448-46f8-8312-32fbbf9b20d9,Fundación para la Investigación Biomédica del Hospital Universitario La Paz (FIBHULP),fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz_fibhulp,,,,1f4b6569-9247-4094-9c36-e11efb0201df,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz,Fundación para la Investigación Biomédica del Hospital Universitario La Paz -609,0.920179,dc09b10e-f654-4170-87dd-310398d1a8d1,Department of Pharmacy Unversitätsmedizin Mainz,department_of_pharmacy_unversit_tsmedizin_mainz,,,,7ccdbeba-54a9-43ed-8e5c-58592f516aa3,department_of_pharmacy_universitaetsmedizin_mainz,Department of Pharmacy Universitaetsmedizin Mainz -6328,,34629678-734d-473e-b92a-f025d507d10b,Shire ViroPharma Incorporated,shire_viropharma_incorporated,,,,,, -401,0.985931,860ad342-327d-4ce5-b645-a14c7f03a545,European Myeloma Network,european_myeloma_network,,,,4881a846-a728-4902-a39b-d18aa6ed8b14,european_myeloma_network_datacenter,European Myeloma Network Datacenter -6329,,32788fbe-7167-11e6-a0cd-0242ac12000b,QUEEN HAMAMATSU PET,queen_hamamatsu_pet,,,,,, -6330,,c096be31-51b3-48f7-a97a-8664ac6a9351,"Dept. Hematology, Hospital Clinic",dept_hematology_hospital_clinic,,,,,, -6331,,b45b8c88-eebd-4335-95a7-5ee1ffaf28b9,Ospedale Regionale di Lugano,ospedale_regionale_di_lugano,,,,,, -6332,,48f22a76-b3e8-4636-9b76-7cc9d090c4bb,Ulrik Grevstad,ulrik_grevstad,,,,,, -6333,,41f07cdc-e50f-480a-9767-02e57aed0239,"Medizinische Klinik B, Herzzentrum Ludwigshafen",medizinische_klinik_b_herzzentrum_ludwigshafen,,,,,, -6334,,fedfcac0-f4b2-4f35-968b-2a1c2e525fd0,"Professor Christina Eintrei,Institution of Medical & Health, Section of Anesthesiology",professor_christina_eintrei_institution_of_medical_health_section_of_anesthesiology,,,,,, -1017,0.98363004624843597,49cb16ab-28c5-470e-940e-1e210b66cb7d,Southampton University Hospitals Trust,southampton_university_hospitals_trust,,,,986ad2cd-cb4e-460c-acdc-a2b32a61de09,southampton_university_hospitals,Southampton University Hospitals -6335,,43cb6fe4-8be7-11e6-a449-0242ac12000b,Khondrion BV,khondrion_bv,,,,,, -6336,,756d9d21-2728-45de-9f04-def255a6a7c2,"ALMIRALL, S. A., Research and Development (R&D) Centre",almirall_s_a_research_and_development_r_d_centre,,,,,, -6337,,dd89afb0-093d-4fec-b020-65446d473ecb,Novartis Vaccines and Diagnostics GmbH,novartis_vaccines_and_diagnostics_gmbh,,,,,, -1070,0.979707,40ccc091-c821-4ebb-b881-5c3d26d57a77,Hopital Erasme,hopital_erasme,,,,40ccc091-c821-4ebb-b881-5c3d26d57a77,hopital_erasme,Hopital Erasme -6338,,de4c6326-86eb-4fd1-a3ef-e2f17f8f39a5,anofi-aventis recherche et développement,anofi_aventis_recherche_et_d_veloppement,,,,,, -6339,,b53fe332-7141-11e6-a0cd-0242ac12000b,METRICS PHARM,metrics_pharm,,,,,, -6340,,dcc20283-e3c3-44ff-9364-b575e6141412,"Dept of Transplantation Surgery B 56, Karolinska University Hospital, Huddinge",dept_of_transplantation_surgery_b_56_karolinska_university_hospital_huddinge,,,,,, -6341,,127c0158-0a73-4cd1-a58c-b9c37d1cb319,EBMT Clinical Trial Office,ebmt_clinical_trial_office,,,,,, -6342,,0869ee61-8877-4052-b8b4-580dc2585d48,Cristina Díaz de Heredia Rubio,cristina_d_az_de_heredia_rubio,,,,,, -6343,,6e8064be-517c-4863-95c0-3781aeec2394,Universitätsklinikum Münster,universit_tsklinikum_m_nster,,,,,, -6344,,cc398b6b-ceb6-421b-8b26-08d3f905f4a2,The Rotunda Maternity Hospital,the_rotunda_maternity_hospital,,,,,, -263,0.986,fcd8a2e2-73e9-11e6-a0cd-0242ac12000b,PIERRE FABRE DERMA,pierre_fabre_derma,,,,7f982261-1f38-4450-bed0-692a6746f7c6,pierre_fabre_dermatologie,PIERRE FABRE DERMATOLOGIE -6345,,01e15be7-e291-4c81-8bbe-6d4b38d20625,MondoGEN AG,mondogen_ag,,,,,, -6346,,f6aed56e-71b7-11e6-a0cd-0242ac12000b,IMP,imp,,,,,, -761,0.958103,efa51ecb-16a9-46cd-b1b7-8863c908fa51,"The Heart Center, Rigshospitalet",the_heart_center_rigshospitalet,,,,931e7207-ea0c-4262-baf3-da49815f8901,the_heart_centre_rigshospitalet,"The Heart Centre, Rigshospitalet" -604,0.94218403100967407,c58ff616-bca8-4343-94ef-a840a482730c,Fundación para Investigación y Desarrollo en el Área Cardiovascular del Hospital Clínico San Carlos,fundaci_n_para_investigaci_n_y_desarrollo_en_el_rea_cardiovascular_del_hospital_cl_nico_san_carlos,,,,1a6a910e-9e16-4295-9c10-800391283d55,fundaci_n_investigaci_n_y_desarrollo_en_el_rea_cardiovascular,Fundación Investigación y Desarrollo en el Área Cardiovascular -791,0.972677,4cca3114-a70f-4d6b-a08d-fae9d4599f44,Fundación para la Investigación Biomédica Hospital Universitario Ramón y Cajal,fundaci_n_para_la_investigaci_n_biom_dica_hospital_universitario_ram_n_y_cajal,,,,4cca3114-a70f-4d6b-a08d-fae9d4599f44,fundaci_n_para_la_investigaci_n_biom_dica_hospital_universitario_ram_n_y_cajal,Fundación para la Investigación Biomédica Hospital Universitario Ramón y Cajal -6347,,c6cdbe50-0036-4a2e-95a1-cb202f78626f,Serentis Limited,serentis_limited,,,,,, -813,0.98849943280220032,d8bfcede-efc3-4714-b642-f79fb12833f5,ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI,istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori,,,,d8bfcede-efc3-4714-b642-f79fb12833f5,istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori,ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI -6348,,190d0e80-73b2-4b87-906f-2a2a8510cef6,ISTITUTO ONCOLOGICO ROMAGNOLO,istituto_oncologico_romagnolo,,,,,, -161,0.98298531770706177,dc8a7f62-673d-444a-ba00-53c705d099d1,Fundación para la Investigación Biomédica,fundaci_n_para_la_investigaci_n_biom_dica,,,,393eab2d-fa2d-419a-8ecd-278e02b1ad5b,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_12_de_octubre,Fundación para la Investigación Biomédica del Hospital 12 de Octubre -6349,,5f912534-5726-480a-af42-4ce4d3a35e42,"Sanofi-Aventis US, Inc",sanofi_aventis_us_inc,,,,,, -6350,,5a9cb16c-701d-4d7f-8237-47216d835772,Cassella-med,cassella_med,,,,,, -6351,,4bbc6429-0c5a-4086-9ec5-e6fec0f3a855,Britannia Pharmaceuticals Limited,britannia_pharmaceuticals_limited,,,,,, -689,0.980666,08598a05-faa8-4889-ba3e-5127ae10b806,"Allergopharma Joachim Ganzer KG an afilliate of Merck KGaA, Darmstadt",allergopharma_joachim_ganzer_kg_an_afilliate_of_merck_kgaa_darmstadt,,,,08598a05-faa8-4889-ba3e-5127ae10b806,allergopharma_joachim_ganzer_kg_an_afilliate_of_merck_kgaa_darmstadt,"Allergopharma Joachim Ganzer KG an afilliate of Merck KGaA, Darmstadt" -6352,,7d1660b8-a212-41e5-ad9e-4bd55ae850e4,Pharma Mar S.A. Sociedad Unipersonal,pharma_mar_s_a_sociedad_unipersonal,,,,,, -6353,,d0b2e43c-8615-4194-aaf4-9f8fb196c85a,"Forsight Vision 4, Inc",forsight_vision_4_inc,,,,,, -6354,,97c54974-f929-4178-9e5a-28168af41cf1,José Castillo Sanchez,jos_castillo_sanchez,,,,,, -6355,,c4250442-7167-11e6-a0cd-0242ac12000b,LIBERTY PHARMA INC,liberty_pharma_inc,,,,,, -6356,,f230c5cd-b4ea-45e9-9286-0a6333a7597c,Laboratoires Grünenthal,laboratoires_gr_nenthal,,,,,, -6357,,9189ce6c-bb95-4144-a8a4-d32b24f6d03c,Hull and East Yorkshire NHS Hospitals Trust,hull_and_east_yorkshire_nhs_hospitals_trust,,,,,, -162,0.96508872509002686,970b586c-4a29-4881-8880-c2619af89db7,Norfolk & Norwich University Hospitals NHS Foundation Trust,norfolk_norwich_university_hospitals_nhs_foundation_trust,,,,045ba97e-7848-45f2-b26b-86cc761804b6,norfolk_and_norwich_university_hospitals_nhs_foundation_trust,Norfolk and Norwich University Hospitals NHS Foundation Trust -124,0.98570466041564941,84203ae0-acea-4ba0-95f8-f2d3dbddc28f,F. Hoffman-La Roche Ltd,f_hoffman_la_roche_ltd,,,,6c8a5ed2-f731-4585-8a6f-d17e1fc2915a,f_hoffman_la_roche_ltd_roche_oy,"F. Hoffman-La Roche Ltd., Roche Oy" -6358,,7ccc461a-12c4-4557-b9e8-045c41f64186,Rafael Esteban Mur,rafael_esteban_mur,,,,,, -6359,,55c18843-e8e8-4f45-95b2-a8eac5c78bb1,Ministry of Infrastructure and the Environment,ministry_of_infrastructure_and_the_environment,,,,,, -210,0.944644,0b4f5fcf-dbeb-40d7-9a94-9cb3a8d69d76,Finnish Breast Cancer Group,finnish_breast_cancer_group,,,,0b4f5fcf-dbeb-40d7-9a94-9cb3a8d69d76,finnish_breast_cancer_group,Finnish Breast Cancer Group -6360,,a2d7b024-6cbb-43fe-995d-88361695c6cd,Santen Oy,santen_oy,,,,,, -6361,,f81b66ae-540f-4b4b-880f-5c1650e96651,Warner Chilcott UK Limited,warner_chilcott_uk_limited,,,,,, -6362,,f4de3dff-85c1-4b41-990b-fdc97a84d600,POLARIS GROUP,polaris_group,,,,,, -6363,,716dbe40-715f-11e6-a0cd-0242ac12000b,ALLERGAN HERBERT,allergan_herbert,,,,,, -6364,,537faa80-73bf-11e6-a0cd-0242ac12000b,ONYX THERAP,onyx_therap,,,,,, -6365,,626ea69c-bdc4-480e-bc48-b66814c1342f,"Research and Innovation Services, University of Dundee",research_and_innovation_services_university_of_dundee,,,,,, -6366,,b70734c3-9291-49dd-a262-12a6ee578b31,Universitätsklinikum Greifswald der Ernst-Moritz-Arndt Universität Greifswald AöR,universit_tsklinikum_greifswald_der_ernst_moritz_arndt_universit_t_greifswald_a_r,,,,,, -6367,,35d6801a-e436-4d64-8e4e-c60ce4bf04b7,"Great Western Hospital, Swindon",great_western_hospital_swindon,,,,,, -6368,,91f57cc2-3fc6-4974-abce-2d95b92e125e,FONDAZIONE SENDO,fondazione_sendo,,,,,, -6369,,23e39e06-77a0-4618-bb58-035311880f3e,"Neuromuscular Research Unit, Rigshospitalet",neuromuscular_research_unit_rigshospitalet,,,,,, -6370,,5ca100ae-6f7c-4a3f-af42-a7a75e7bea60,AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO-VITTORIO EMANUELE,azienda_ospedaliero_universitaria_policlinico_vittorio_emanuele,,,,,, -6371,,b30c4796-7ea3-4179-94f6-b2c2f870acd7,Valneva Austria GmbH,valneva_austria_gmbh,,,,,, -6372,,27959229-aaba-4086-8dc5-5e81e81860c9,COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ON AIDS,community_programs_for_clinical_research_on_aids,,,,,, -891,0.978652,0aaff566-edcf-48b0-acb4-a30bb9fe5405,"Australasian Gastro-Intestinal Trials Group, Sydney University",australasian_gastro_intestinal_trials_group_sydney_university,,,,0aaff566-edcf-48b0-acb4-a30bb9fe5405,australasian_gastro_intestinal_trials_group_sydney_university,"Australasian Gastro-Intestinal Trials Group, Sydney University" -499,0.95183,0c43fa82-723d-4a38-822b-83d3cb20290b,"Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany",merck_serono_s_a_geneva_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,0c43fa82-723d-4a38-822b-83d3cb20290b,merck_serono_s_a_geneva_an_affiliate_of_merck_kgaa_darmstadt_germany,"Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany" -451,0.901039,0a4faedb-ecc0-4282-8a39-c4f5fdd6ab92,Antisoma Research Ltd,antisoma_research_ltd,,,,0a4faedb-ecc0-4282-8a39-c4f5fdd6ab92,antisoma_research_ltd,Antisoma Research Ltd -6373,,b4353633-2caf-4d7c-8fe3-0bc5f1669f47,AZIENDA PROVINCIALE PER I SERVIZI SANITARI DELLA PROVINCIA AUTONOMA DI TRENTO,azienda_provinciale_per_i_servizi_sanitari_della_provincia_autonoma_di_trento,,,,,, -6374,,7ff93d8a-3425-446d-b936-43a2471c3978,Landstinget Gävleborg,landstinget_g_vleborg,,,,,, -6375,,1fc33c7d-b7c9-4b11-a396-cf51bc651f7f,"Laboratorios Dr. Esteve, SA",laboratorios_dr_esteve_sa,,,,,, -6376,,71c5877f-a7f0-4da5-bed7-818c1c9c0cfa,Endo Pharmaceuticals Inc,endo_pharmaceuticals_inc,,,,,, -6377,,c61f38ee-d1a8-470a-b902-4e48a341cc0a,VUmc Dept Urology,vumc_dept_urology,,,,,, -6378,,2ff23f9d-9c4e-40b6-bd97-3beb8cf1cf9b,The National Cancer Institute (NCI),the_national_cancer_institute_nci,,,,,, -6379,,74110639-a8bd-4b22-b7ba-65b254415b5c,"German Sport University Cologne, Institute of CArdiology and Sports Medicine",german_sport_university_cologne_institute_of_cardiology_and_sports_medicine,,,,,, -6380,,843091b8-9f69-4818-b795-774a8d2e9205,IIT : University Hospital - Medical Clinic II (Director: Prof. Dr. med. J. Floege - Sponsor),iit_university_hospital_medical_clinic_ii_director_prof_dr_med_j_floege_sponsor,,,,,, -476,0.971143,4543c7ec-daec-4a10-bab1-cd53aacf4083,CMC Contrast AB,cmc_contrast_ab,,,,4543c7ec-daec-4a10-bab1-cd53aacf4083,cmc_contrast_ab,CMC Contrast AB -6381,,96d802bf-c719-4767-b498-d1c2b022d3be,"Fournier Laboratories Ireland Ltd, a member of the Solvay group",fournier_laboratories_ireland_ltd_a_member_of_the_solvay_group,,,,,, -6382,,c5ed3b11-f19f-4a99-bd68-c588901762f6,Merck AB,merck_ab,,,,,, -6383,,dbe8477a-7166-11e6-a0cd-0242ac12000b,SCIEGEN PHARMS INC,sciegen_pharms_inc,,,,,, -924,0.97933,7ced7946-7140-11e6-a0cd-0242ac12000b,ALPHARMA,alpharma,,,,7ced7946-7140-11e6-a0cd-0242ac12000b,alpharma,ALPHARMA -6384,,e53fa60d-b8b4-4bc1-b4ff-5a3c954f34a5,Azienda Ospedaliero-Universitaria di Parma,azienda_ospedaliero_universitaria_di_parma,,,,,, -6385,,6f328271-fa63-4b99-a74b-3e04465e7888,Clinical Technology Centre (International) Limited,clinical_technology_centre_international_limited,,,,,, -6386,,49328c54-51e8-4170-944e-276325a1dea2,FOREST RESEARCH INSTITUTE,forest_research_institute,,,,,, -6387,,d06c2aad-587d-4d94-a135-f900b3b9bfd2,Heart of England NHS Foundation Trust Birmingham Heartlands Hospital,heart_of_england_nhs_foundation_trust_birmingham_heartlands_hospital,,,,,, -6388,,5de7e1f8-1cb6-4dce-940e-fb424c143990,Nektar Therapeutics,nektar_therapeutics,,,,,, -6389,,19accbcf-7796-44a1-8010-3b566db2dcef,Sinikka Oksa,sinikka_oksa,,,,,, -541,0.98826968669891357,06598f56-3fa1-48ed-824d-b88b0bafc1ab,Fournier Laboratories Ireland (FLI),fournier_laboratories_ireland_fli,,,,06598f56-3fa1-48ed-824d-b88b0bafc1ab,fournier_laboratories_ireland_fli,Fournier Laboratories Ireland (FLI) -6390,,3b28ce8f-da7d-43e6-ac07-d3af022ee5c6,IRCCS Policlinico San Donato,irccs_policlinico_san_donato,,,,,, -6391,,d4e42130-4dfe-4ceb-89ee-7be99804b2a5,University of Glasgow / NHS Greater Glasgow and Clyde,university_of_glasgow_nhs_greater_glasgow_and_clyde,,,,,, -6392,,7555d4a5-8b3d-4db8-83d3-5482d0d01d4b,Accord Healthcare Ltd,accord_healthcare_ltd,,,,,, -807,0.968782,517185b0-8dd4-4271-b913-fcaefd671991,"Medical University Vienna, Dept. of Clinical Pharmacology",medical_university_vienna_dept_of_clinical_pharmacology,,,,420745a1-a57e-4545-a9b6-170be97fb467,medical_university_of_vienna_dept_of_clinical_pharmacology,"Medical University of Vienna, Dept. of Clinical Pharmacology" -6393,,5278d316-73cc-11e6-a0cd-0242ac12000b,PLX PHARMA,plx_pharma,,,,,, -6394,,0fea4a36-8eab-49f6-981f-7d2af598ab52,"Medizinische Universität Graz, Univ. Klinik für Anästhesiologie und Intensivmedizin, Abt. Anästhesie und Intensivmedizin",medizinische_universit_t_graz_univ_klinik_f_r_an_sthesiologie_und_intensivmedizin_abt_an_sthesie_und_intensivmedizin,,,,,, -6395,,775866a6-7165-11e6-a0cd-0242ac12000b,AJANTA PHARMA LTD,ajanta_pharma_ltd,,,,,, -1076,0.960954,3f80858e-8e18-4b61-80e5-d5867133b696,"Dep. Ophthalmology, Medical University of Vienna",dep_ophthalmology_medical_university_of_vienna,,,,045cfbfc-1ceb-4114-9b7b-c749009a8f56,dep_of_ophthalmology_medical_university_of_vienna,"Dep. of Ophthalmology, Medical University of Vienna" -6396,,0b792c36-7142-11e6-a0cd-0242ac12000b,ERGOJECT,ergoject,,,,,, -6397,,1d7da9c7-3809-404d-969d-f58cb1e18e25,CONSORCI MAR PARC DE SALUT BARCELONA,consorci_mar_parc_de_salut_barcelona,,,,,, -6398,,a974039b-2093-4133-9868-e9b2eb78a38b,Prof. Dr. Karl-Heinz Emmerich,prof_dr_karl_heinz_emmerich,,,,,, -6399,,416990a3-0233-4293-b4f6-96f043d52b43,Cardiovascular Research Foundation,cardiovascular_research_foundation,,,,,, -6400,,7576b0f9-aa10-487f-9f36-ff242b62b42d,NHS Greater Glasgow/Glasgow University,nhs_greater_glasgow_glasgow_university,,,,,, -6401,,c39386f1-4c62-4e6f-a6eb-cc2dc35b00c4,Comité Départemental d’Hygiène Social,comit_d_partemental_d_hygi_ne_social,,,,,, -6402,,f1137379-1944-4b90-823b-6039979af029,CV THERAPEUTICS INC,cv_therapeutics_inc,,,,,, -6403,,2319c062-b293-4a9c-9bb2-53af22432ccd,UCR Uppsala Clinical Research Center,ucr_uppsala_clinical_research_center,,,,,, -6404,,7e9086ea-5b53-4aa0-be5e-81a674331dd1,Dutch Growth Foundation,dutch_growth_foundation,,,,,, -6405,,027b441e-7207-11e6-a0cd-0242ac12000b,AVENT,avent,,,,,, -6406,,8e3d8130-3dac-4bcc-8fbb-9e5539103aa6,Neurim Pharmaceuticals Ltd,neurim_pharmaceuticals_ltd,,,,,, -6407,,d9c13812-735f-11e6-a0cd-0242ac12000b,GE HLTHCARE INC,ge_hlthcare_inc,,,,,, -6408,,5b8be427-d9db-443a-adb9-89b3bab14893,Prof. M.A. Dimopoulos,prof_m_a_dimopoulos,,,,,, -6409,,36ee0f2c-7a5c-4dec-bf84-87215e13f235,GBG Forschungs GmbH (German Breast Group),gbg_forschungs_gmbh_german_breast_group,,,,,, -6410,,6152be60-213c-4ed7-a17c-741c90058dea,"Canyon Pharmaceuticals, Inc",canyon_pharmaceuticals_inc,,,,,, -6411,,3b6e121a-7167-11e6-a0cd-0242ac12000b,TRIAD ISOTOPES INC,triad_isotopes_inc,,,,,, -6412,,642b1eb7-53cc-45cd-a62d-9c2c71c72094,"NV Organon, part of Schering-Plough Corporation",nv_organon_part_of_schering_plough_corporation,,,,,, -6413,,46666d5e-7142-11e6-a0cd-0242ac12000b,DISTA,dista,,,,,, -6414,,c9ca8096-56c2-4c06-8f1a-e2e9213e2d0a,Palobiofarma S.L,palobiofarma_s_l,,,,,, -6415,,b7d6ae30-7928-4b38-b0e8-550fa879496a,MUMC+,mumc,,,,,, -6416,,f855c4d2-a292-4edb-b53e-28286d885357,County Council of Östergötland,county_council_of_sterg_tland,,,,,, -6417,,d28b01e5-ecbf-493f-b27f-7da39c4fc4aa,Abbott GmBH Co,abbott_gmbh_co,,,,,, -6418,,5b1d5ce0-d81a-4eb2-8fa0-e9c4960ee9e9,AZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI,azienda_ospedaliero_universitaria_ospedali_riuniti_umberto_i_g_m_lancisi_g_salesi,,,,,, -6419,,396fdf3a-f677-47ff-9d51-b5ec09dc34ae,PeP-Tonic Medical AB,pep_tonic_medical_ab,,,,,, -6420,,7ea9674b-5ef7-4bb9-8e02-4687939ded2d,CSC Pharmaceuticals Handels GmbH,csc_pharmaceuticals_handels_gmbh,,,,,, -6421,,360fd588-7167-11e6-a0cd-0242ac12000b,INDCHEMIE HEALTH,indchemie_health,,,,,, -6422,,9a7e0ef5-78f0-4f36-bd7f-c2c4d1d4b7d2,University Hospital Southampton NHS Trust,university_hospital_southampton_nhs_trust,,,,,, -959,0.94367156426111853,7958b99a-88dd-469b-bfbf-d2e920abbffb,"Andromeda Biotech Ltd, 42 Hayarkon st, Yavne, 81227, Israel",andromeda_biotech_ltd_42_hayarkon_st_yavne_81227_israel,,,,8e1ef03a-b2a7-496e-83ef-ae87bf0b27e9,andromeda_biotech_ltd_42_hayarkon_st_yavne_81227_israel,Andromeda Biotech Ltd -6423,,9ca8257f-43d0-4fe4-a59e-77737464348c,Umecrine Mood AB,umecrine_mood_ab,,,,,, -6424,,dc9aab6f-92ff-4602-bf55-a34929773531,Julio Bobes,julio_bobes,,,,,, -463,0.98401951789855957,2518a26c-7146-11e6-a0cd-0242ac12000b,ORTHO MCNEIL PHARM,ortho_mcneil_pharm,,,,2518a26c-7146-11e6-a0cd-0242ac12000b,ortho_mcneil_pharm,ORTHO MCNEIL PHARM -6425,,9171e1a3-32cc-411a-8b2b-44e794b4e64a,Vifor (International) Inc,vifor_international_inc,,,,,, -6426,,acbd90c4-715f-11e6-a0cd-0242ac12000b,GLENWOOD,glenwood,,,,,, -6427,,fb178c65-30c8-4039-b57a-cc42ec2fe74d,SBG,sbg,,,,,, -6428,,3f45ee9c-f2d1-478a-b0d9-6d92e1363684,LABORATOIRES MAYOLY SPINDLER,laboratoires_mayoly_spindler,,,,,, -537,0.92192,5acde854-4953-47c0-9987-89e6a451966b,Centocor BV,centocor_bv,,,,5acde854-4953-47c0-9987-89e6a451966b,centocor_bv,Centocor BV -451,0.901039,636d1604-7383-4dd8-bd01-4f3176721b36,Antisoma Research Limited,antisoma_research_limited,,,,0a4faedb-ecc0-4282-8a39-c4f5fdd6ab92,antisoma_research_ltd,Antisoma Research Ltd -6429,,d1c571f7-3357-423d-8a08-c0d6a4e2fb0c,IVI Madrid,ivi_madrid,,,,,, -6430,,cf83ec0b-4120-4dc1-bb20-5e955043be2d,ULB Erasme,ulb_erasme,,,,,, -839,0.952896,cd634b4f-58d5-4151-9b65-7bcb4290e9d4,Newcastle Hospitals Trust,newcastle_hospitals_trust,,,,9ac934a2-f363-48d8-8da4-a925d66bd5cc,newcastle_hospital_trust,Newcastle Hospital Trust -6431,,32ce9784-714d-11e6-a0cd-0242ac12000b,NEXGEN PHARMA INC,nexgen_pharma_inc,,,,,, -6432,,b9f55d70-b848-463c-9b13-182c1b3fd005,AVENTIS PHARMA S.P.A,aventis_pharma_s_p_a,,,,,, -136,0.958341,3e746564-6364-4770-b1d4-841842beb7c7,Medisch Centrum Leeuwaarden,medisch_centrum_leeuwaarden,,,,3e746564-6364-4770-b1d4-841842beb7c7,medisch_centrum_leeuwaarden,Medisch Centrum Leeuwaarden -6433,,9097f9b3-18cf-412c-acf5-028d84483665,Pharmazeutische Fabrik Evers & Co. GmbH,pharmazeutische_fabrik_evers_co_gmbh,,,,,, -6434,,dc05e43a-4a7d-4856-aa2f-c12522c510f4,CHU Saint-Etienne,chu_saint_etienne,,,,,, -6435,,87fc86db-37f6-4af1-8b5a-a59ebf5a4178,"Acusphere, Inc",acusphere_inc,,,,,, -6436,,fb58e5df-f6b8-44f2-87d2-1a7791f74db0,"Dept. of Neurology, Atrium Medical Centre",dept_of_neurology_atrium_medical_centre,,,,,, -56,0.98503333330154419,9078130e-eeb6-4d4a-9b3b-bf9f3a7082c5,Radboud University Nijmegen Medical Centre,radboud_university_nijmegen_medical_centre,,,,9078130e-eeb6-4d4a-9b3b-bf9f3a7082c5,radboud_university_nijmegen_medical_centre,Radboud University Nijmegen Medical Centre -6437,,72df664c-a842-48f0-a84e-5607d0cdec38,Walton Centre for Neurology and Neurosurgery,walton_centre_for_neurology_and_neurosurgery,,,,,, -6438,,3da2c9fe-71a3-11e6-a0cd-0242ac12000b,JANSSEN RES AND DEV,janssen_res_and_dev,,,,,, -6439,,ab458087-8c3a-4f58-bd60-5396c128e80b,COPSAC,copsac,,,,,, -209,0.960275,96c9d60f-aaeb-4452-901a-dddf22084636,FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO MILANO,fondazione_irccs_ca_granda_ospedale_maggiore_policlinico_milano,,,,2b67170d-4f17-4648-9c58-deeb978a3eb3,fondazione_irccs_ca_granda_ospedale_maggiore_policlinico_di_milano,FONDAZIONE IRCCS CA` GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO -6440,,1e2b196e-0da4-4848-b0c7-54521b293aeb,"Ariston Pharmaceuticals, Inc",ariston_pharmaceuticals_inc,,,,,, -6441,,03ddae74-91b3-49a7-869d-85aca302df3c,National Children's Hospital & Trinity College Dublin,national_children_s_hospital_trinity_college_dublin,,,,,, -577,0.96858552098274231,e9abaf6d-ebc5-432c-be97-f7a5c26bd3f9,Wyeth Pharmaceuticals France,wyeth_pharmaceuticals_france,,,,e9abaf6d-ebc5-432c-be97-f7a5c26bd3f9,wyeth_pharmaceuticals_france_wyeth_research_division,"Wyeth Pharmaceuticals France, Wyeth Research Division" -811,0.92396390438079834,1d7a4c7b-13ee-4fa9-9984-684f337fead9,Biogen Idec Research Ltd,biogen_idec_research_ltd,,,,1d7a4c7b-13ee-4fa9-9984-684f337fead9,biogen_idec_research_ltd,Biogen Idec Research Ltd -6442,,9e408621-7bb2-4c5f-8f2c-e23914650d18,Patara Pharma,patara_pharma,,,,,, -6443,,b5afb546-7159-11e6-a0cd-0242ac12000b,AREVA PHARMS,areva_pharms,,,,,, -6444,,d4113d29-846f-4157-afab-657d75f9b7dc,A.I.E.O.P,a_i_e_o_p,,,,,, -6445,,8c1018a2-badb-423f-b94e-c7c8c2b0eb48,"FONDAZIONE ITALIANA ""LEONARDO GIAMBRONE""PER LA GUARIGIONE DALLA TALASSEMIA - ONLUS",fondazione_italiana_leonardo_giambrone_per_la_guarigione_dalla_talassemia_onlus,,,,,, -620,0.964286,1ea7f82f-9f53-484a-93fe-2e25f14ea8ee,Technical Unversity of Munich,technical_unversity_of_munich,,,,1ea7f82f-9f53-484a-93fe-2e25f14ea8ee,technical_unversity_of_munich,Technical Unversity of Munich -6446,,8e40ecab-19cb-4f1e-aab7-84df7fa0e2b1,GlaxoSmithKiline Research and Development,glaxosmithkiline_research_and_development,,,,,, -6447,,21d9a9e7-1f0f-4318-ae70-9bf575090bdf,PannonPharma Ltd,pannonpharma_ltd,,,,,, -6448,,4222702a-6ac9-401c-9e2a-0920a742de49,Rijnstate ziekenhuis,rijnstate_ziekenhuis,,,,,, -6449,,144c6cdc-71bb-11e6-a0cd-0242ac12000b,FRANKLIN PHARMS,franklin_pharms,,,,,, -185,0.907369,103d48aa-e045-481f-9c54-07b97fc6c2c2,St James Hospital,st_james_hospital,,,,103d48aa-e045-481f-9c54-07b97fc6c2c2,st_james_hospital,St James Hospital -417,0.988695,8da96a38-2d6c-4cbb-9351-628c3c92a1ed,ISTITUTI FISIOTERAPICI OSPITALIERI,istituti_fisioterapici_ospitalieri,,,,8da96a38-2d6c-4cbb-9351-628c3c92a1ed,istituti_fisioterapici_ospitalieri,ISTITUTI FISIOTERAPICI OSPITALIERI -6450,,8bcce464-6464-46a1-9253-77ebad22020c,Aventis Pharma Ltd trading as sanofi-aventis,aventis_pharma_ltd_trading_as_sanofi_aventis,,,,,, -6451,,9989681f-b82e-472a-94f6-57dcd3a42bb7,"St. Josef-Hospital, Ruhr University, Bochum",st_josef_hospital_ruhr_university_bochum,,,,,, -6452,,030e5d68-d634-40af-9287-77cff6deea58,"R&D department, Hull and East Yorkshire Hospitals NHS Trust",r_d_department_hull_and_east_yorkshire_hospitals_nhs_trust,,,,,, -6453,,6b5ca3e0-7d43-41b0-a97e-561080cf2193,ADENOBIO N.V,adenobio_n_v,,,,,, -6454,,1573e7cf-a7bd-11e6-94cb-5656d04fc2b5,HUS-The Hospital District of Helsinki and Uusimaa,hus_the_hospital_district_of_helsinki_and_uusimaa,,,,,, -6455,,f31847e3-873e-4ee3-8234-b6c5503d6a6d,"Coherus BioSciences, Inc",coherus_biosciences_inc,,,,,, -6456,,98e4a8e5-b48f-4946-ab0e-590ab4f35817,Inserm-ANRS,inserm_anrs,,,,,, -829,0.980992,49311101-9fd1-4902-b91d-e36e1f2e30c2,OSPEDALE G.PASQUINUCCI-FONDAZIONE TOSCANA GABRIELE MONASTERIO/CNR,ospedale_g_pasquinucci_fondazione_toscana_gabriele_monasterio_cnr,,,,49311101-9fd1-4902-b91d-e36e1f2e30c2,ospedale_g_pasquinucci_fondazione_toscana_gabriele_monasterio_cnr,OSPEDALE G.PASQUINUCCI-FONDAZIONE TOSCANA GABRIELE MONASTERIO/CNR -6457,,500beea0-e401-4087-a045-11ee15fd26a1,Lluita contra la Sida Foundation,lluita_contra_la_sida_foundation,,,,,, -6458,,66dd30dc-663b-437e-bfbc-8c87fcfb4915,"Universitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Wien",universit_tsklinik_f_r_kinder_und_jugendheilkunde_medizinische_universit_t_wien,,,,,, -6459,,0caf6105-6ad3-46a8-8508-569eeb81d41e,"University of Athens, Medical School",university_of_athens_medical_school,,,,,, -6460,,151686d6-7164-11e6-a0cd-0242ac12000b,JIANGSU HENGRUI MED,jiangsu_hengrui_med,,,,,, -6461,,f506c7de-46f1-4bf5-ac78-1ed9de2bf613,"MedImmune Limited, a wholly owned subsidiary of AstraZeneca",medimmune_limited_a_wholly_owned_subsidiary_of_astrazeneca,,,,,, -1009,0.98486357927322388,d1eb2280-7146-11e6-a0cd-0242ac12000b,MCNEIL CONS,mcneil_cons,,,,85199c3a-719f-11e6-a0cd-0242ac12000b,mcneil_consumer,MCNEIL CONSUMER -6462,,a78bfc12-7335-11e6-a0cd-0242ac12000b,ENDO VENTURES LTD,endo_ventures_ltd,,,,,, -6463,,e2034d8d-ffdc-4b86-831b-21298073a33c,Meletios Athanasios Dimopoulos,meletios_athanasios_dimopoulos,,,,,, -264,0.969108,4b85caa2-d172-4ab8-beaf-797c52a06782,University or Tromsø,university_or_troms,,,,4b85caa2-d172-4ab8-beaf-797c52a06782,university_or_troms,University or Tromsø -443,0.976266,b56ce5d8-01b1-4592-bda3-d1fb728cc085,Klinikum Grosshadern,klinikum_grosshadern,,,,93ee88e4-8723-494d-86b5-c1f43bbd66c8,klinikum_grosshadern_medical_center_university_of_munich,"Klinikum Grosshadern Medical Center, University of Munich" -6464,,02bb78e2-7129-11e6-a89e-0242ac12000b,NOVEN,noven,,,,,, -6465,,26c0788a-736f-11e6-a0cd-0242ac12000b,ALEXZA PHARMS,alexza_pharms,,,,,, -6466,,c39ff6ba-9bb8-4c4f-845b-29708a7a4093,Renapharma AB,renapharma_ab,,,,,, -6467,,fa9f78bf-d2da-4d4e-b16b-eadac78aaa99,Instituo de Investigacion Sanitaria La Fe,instituo_de_investigacion_sanitaria_la_fe,,,,,, -6468,,3cdb7f3e-73f1-11e6-a0cd-0242ac12000b,PRAXAIR INC,praxair_inc,,,,,, -866,0.97940826416015625,acd534d0-3800-4778-8b81-4a81d24d1012,Hvidovre Hospital,hvidovre_hospital,,,,777eeb1f-10b4-4c96-8d33-42be9c44ad2b,hvidovre_hospital,Hvidovre Hospital -746,0.97187739610671997,048a131a-7874-4cd2-8c53-2320f09741c8,"Johnson & Johnson Pharamceutical Resarch & Development, L.L.C",johnson_johnson_pharamceutical_resarch_development_l_l_c,,,,6067fed3-20a1-48ca-80df-3675d4109505,johnson_johnson_pharamceutical_research_development_l_l_c,"Johnson & Johnson Pharamceutical Research & Development, L.L.C" -6469,,44a783ac-73ce-11e6-a0cd-0242ac12000b,AEGERION,aegerion,,,,,, -6470,,cd2143c6-7158-11e6-a0cd-0242ac12000b,TARO PHARMS IRELAND,taro_pharms_ireland,,,,,, -6471,,be015440-45b9-4dd6-b213-2e1c4b755f00,"AVEO Pharmaceuticals, Inc",aveo_pharmaceuticals_inc,,,,,, -748,0.952392,f78cccd6-09d6-49f2-8b0a-d9e82bf49fe7,"North Bristol NHS Trust, Research and Development",north_bristol_nhs_trust_research_and_development,,,,e18b3cc7-abc6-4eaf-8f2f-60b271d0cb75,north_bristol_nhs_trust_research_and_development_office,North Bristol NHS Trust Research and Development Office -6472,,e55dcd47-fd1d-4904-8bce-41acd43273a8,Jesús Villar Hernández,jes_s_villar_hern_ndez,,,,,, -6473,,c7be4e39-24ec-4a1b-9934-a0bcff6429a9,"Research and Development, Barts and The London NHS Trust",research_and_development_barts_and_the_london_nhs_trust,,,,,, -555,0.98226124048233032,613c1a9b-76b3-42ee-8979-2c8d31737f57,Greater Glasgow and Clyde,greater_glasgow_and_clyde,,,,613c1a9b-76b3-42ee-8979-2c8d31737f57,greater_glasgow_and_clyde_nhs_board,Greater Glasgow and Clyde NHS Board -6474,,1eb2491c-6a4c-4a57-b409-0d66b5c2baba,Movetis NV,movetis_nv,,,,,, -6475,,2b987b17-7fc4-4604-9755-50af216f800d,Per Honore,per_honore,,,,,, -951,0.98241811990737915,2e8e4fb4-3915-4ead-8787-31c5f3981781,"MedImmune, LLC",medimmune_llc,,,,2e8e4fb4-3915-4ead-8787-31c5f3981781,medimmune_llc,"MedImmune, LLC" -6476,,f64f9924-a07c-4845-b1d9-7265eaa29cc0,Ewopharma AG,ewopharma_ag,,,,,, -6477,,1a0b54ee-3c90-4fb0-a495-d2c36bae4a70,Grupo Español de Cáncer de Pulmón,grupo_espa_ol_de_c_ncer_de_pulm_n,,,,,, -6478,,7fe07037-bc2f-422c-8fa0-755ff4ac98bf,"Department of Ophthalmology, Hietzing Hospital",department_of_ophthalmology_hietzing_hospital,,,,,, -710,0.98913925886154175,4c8adf00-5f9a-4177-9cd5-a40768a4ee60,Reckitt Benckiser Pharmaceuticals Inc,reckitt_benckiser_pharmaceuticals_inc,,,,4c8adf00-5f9a-4177-9cd5-a40768a4ee60,reckitt_benckiser_pharmaceuticals_inc,Reckitt Benckiser Pharmaceuticals Inc -6479,,1c4879cc-7142-11e6-a0cd-0242ac12000b,PURDUE GMP,purdue_gmp,,,,,, -6480,,19d36e06-94c8-43db-a390-13cc76749397,Takeda Nederland B.V,takeda_nederland_b_v,,,,,, -6481,,65afcc67-4f1e-403f-b341-5c94fced167f,Janssen L.P,janssen_l_p,,,,,, -326,0.985702,a6dd0849-5d39-4beb-a4dc-0ce8c4928cbe,Servicio de Infecciones. Hospital Clinic de Barcelona,servicio_de_infecciones_hospital_clinic_de_barcelona,,,,14fb99c7-19be-430d-a74a-57408f88725e,servicio_de_infecciones_hospital_cl_nic_de_barcelona,Servicio de Infecciones. Hospital Clínic de Barcelona -6482,,4e3deda9-1788-45b5-9985-2e165726e0b7,Imperial College NHS trust,imperial_college_nhs_trust,,,,,, -6483,,ba94239a-c85f-4b60-b336-92ffa7ddf732,"Department of Psychiatry and Psychotherapy, University of Erlangen-Nuremberg",department_of_psychiatry_and_psychotherapy_university_of_erlangen_nuremberg,,,,,, -6484,,727a78b8-85a6-4c80-858a-d48518eaa0c9,McNeil AB,mcneil_ab,,,,,, -6485,,931614cf-b733-4fb6-ba49-91174665bca0,Mukoviszidose Institute gGmbH,mukoviszidose_institute_ggmbh,,,,,, -6486,,0606e7f5-7ac0-4f5f-a55a-f7cf17dcc5bb,Queen Charlotte's and Chelsea Hospital,queen_charlotte_s_and_chelsea_hospital,,,,,, -106,0.972495,8059cb99-0f16-4274-a2d9-a68b49d57f9b,Amar Agha,amar_agha,,,,39443038-185d-4279-b9d1-588d493613db,amar_agha_beaumont_hospital,"Amar Agha, Beaumont Hospital" -6487,,ede2d7eb-c502-43ce-a0af-af23aed0c855,Hospital Errikos Dunant- Department of Hematology,hospital_errikos_dunant_department_of_hematology,,,,,, -6488,,53bea586-7145-11e6-a0cd-0242ac12000b,SAGENT STRIDES,sagent_strides,,,,,, -6489,,d8691dce-20fd-467c-b00b-45780592e51a,"Research & Development Department, Addenbrookes Hospital",research_development_department_addenbrookes_hospital,,,,,, -6490,,d6a5f690-f26c-4ca8-b846-8e440931d27b,Mette Astrup Madsen,mette_astrup_madsen,,,,,, -6491,,125a85e2-1fea-4cfa-a5fe-c8937f598c0f,UCL Biomedicine R&D Unit,ucl_biomedicine_r_d_unit,,,,,, -6492,,9db72ef2-b4d4-43ef-b404-77813fbae453,VAS VASCULAR INDEPENDENT RESEACH AND EDUCATION EUROPEAN ORGANIZATION. C/O UNIV MILANO. OSP. L. SACCO,vas_vascular_independent_reseach_and_education_european_organization_c_o_univ_milano_osp_l_sacco,,,,,, -265,0.969508,838b627a-58f2-439a-ad85-0aea14ef3815,Institut Paoli-Calmettes,institut_paoli_calmettes,,,,1f93290f-c593-4d33-b455-91f1096af905,institut_paoli_calmette,Institut Paoli Calmette -6493,,e866cdc8-7161-11e6-a0cd-0242ac12000b,DEPROCO,deproco,,,,,, -6494,,37373aac-73b8-11e6-a0cd-0242ac12000b,B BRAUN MEDICAL INC,b_braun_medical_inc,,,,,, -6495,,999211de-e9f2-44f5-a3b9-b9719ab28be9,"Genocea Biosciences, Inc",genocea_biosciences_inc,,,,,, -6496,,eaeaa850-d1f6-40f5-98f4-0e8e212612c9,IOULIA & IRENE TSETI PHARMACEUTICAL LABORATORIES S.A.-INTERMED S.A,ioulia_irene_tseti_pharmaceutical_laboratories_s_a_intermed_s_a,,,,,, -6497,,4866127f-9ab3-4479-ac03-78d082aa8318,Serono International S.A,serono_international_s_a,,,,,, -6498,,069e15a0-b4ad-4368-92bc-c1f9d7a242c5,"University of Leuven Hospitals, Division of Gastroenterology",university_of_leuven_hospitals_division_of_gastroenterology,,,,,, -6499,,aaee2c42-7e1b-40cf-b267-092fc2765751,"Department für Pädiatrie, Medizinische Universität Innsbruck",department_f_r_p_diatrie_medizinische_universit_t_innsbruck,,,,,, -642,0.98837128281593323,49403ff2-36d6-4dad-91ac-59fd2af60030,Boehringer Ingelheim France,boehringer_ingelheim_france,,,,1eaa3c0c-4ecd-4593-886b-6af263dd0c86,boehringer_ingelheim_france,Boehringer Ingelheim France -6500,,5e393d52-7161-11e6-a0cd-0242ac12000b,ASCOT,ascot,,,,,, -6501,,72477cdc-3014-43c0-aa9c-a3c11f678ba5,Debreceni Egyetem Klinikai Központ,debreceni_egyetem_klinikai_k_zpont,,,,,, -1061,0.97933,332fca8d-891e-464f-bf2f-a65f4ecc24d7,A.S.L. 2,a_s_l_2,,,,332fca8d-891e-464f-bf2f-a65f4ecc24d7,a_s_l_2,A.S.L. 2 -6502,,418ca16b-1548-417f-a83f-8c49952fb7f9,Pfizer Global Research & Development,pfizer_global_research_development,,,,,, -720,0.9764975905418396,83d8194e-71e2-11e6-a0cd-0242ac12000b,OTSUKA,otsuka,,,,83d8194e-71e2-11e6-a0cd-0242ac12000b,otsuka,OTSUKA -6503,,9a928883-62f4-40e8-bf1e-c36ca297350b,"Imperial College London, Joint Research Compliance Office",imperial_college_london_joint_research_compliance_office,,,,,, -335,0.9851,80f6c66c-796e-4832-a021-2b15e0df6ad8,Fakultní nemocnice Ostrava,fakultn_nemocnice_ostrava,,,,63ca855a-0f57-4a87-972b-5334fae84ddf,fakultn_nemocnice_ostrava_czech_republic,"Fakultní nemocnice Ostrava,Czech Republic" -402,0.981186,b864ee6b-f5d7-4f18-a0ed-6ad119ce7d88,"AGO Research GmbH, AGO Study Group",ago_research_gmbh_ago_study_group,,,,b864ee6b-f5d7-4f18-a0ed-6ad119ce7d88,ago_research_gmbh_ago_study_group,"AGO Research GmbH, AGO Study Group" -6504,,a1c04b90-142d-4657-a2be-640b684cc3a7,"Interní grantová agentura, Ministerstvo zdravotnictví ČR",intern_grantov_agentura_ministerstvo_zdravotnictv_r,,,,,, -6505,,d2928c4b-c347-4dea-a326-e261e2d799de,"AstraZeneca Farmacéutica Spain, S.A",astrazeneca_farmac_utica_spain_s_a,,,,,, -6506,,baebc3e0-933d-45f6-a990-2a40bd97e19f,REGENSBURG UNIVERSITY MEDICAL CENTRE,regensburg_university_medical_centre,,,,,, -6507,,0fac54ec-715e-11e6-a0cd-0242ac12000b,COBALT LABS INC,cobalt_labs_inc,,,,,, -496,0.98474764823913574,869f3466-39ec-465e-891d-ffce2dc10b2b,Martin-Luther-Universität Halle-Wittenberg,martin_luther_universit_t_halle_wittenberg,,,,5c05fa95-0c90-4777-be79-ea6ecfc023ea,martin_luther_universit_t_halle_wittenberg_vertreten_durch_den_kanzler,"Martin-Luther-Universität Halle-Wittenberg, vertreten durch den Kanzler" -6508,,6ae58c6e-2e65-4a82-a30e-555035c0881d,"Laboratórios Pfizer, Lda",laborat_rios_pfizer_lda,,,,,, -6509,,8b4343ec-fb2f-4fb9-aa9f-044d60e28926,"Hull and east Yorkshire Hospitals Trust, Research and Deveopment, admin porta cabin",hull_and_east_yorkshire_hospitals_trust_research_and_deveopment_admin_porta_cabin,,,,,, -1067,0.987607,10ff3385-cf4c-44ce-8eb9-d60620664cbb,Generex Biotechnology Corp,generex_biotechnology_corp,,,,10ff3385-cf4c-44ce-8eb9-d60620664cbb,generex_biotechnology_corp,Generex Biotechnology Corp -6510,,53feedaf-8530-4d67-b488-2f1cb3e60ef6,Endocrine Society of Czech Republic,endocrine_society_of_czech_republic,,,,,, -6511,,5329b052-c85a-430f-8bca-02d12395b28c,Pneumologia c/o Villa Pineta,pneumologia_c_o_villa_pineta,,,,,, -1057,0.98656213283538818,080946bd-1123-4c27-9ea3-501e78d94d82,Pfizer Hellas SA,pfizer_hellas_sa,,,,080946bd-1123-4c27-9ea3-501e78d94d82,pfizer_hellas_sa,Pfizer Hellas SA -6512,,af329b77-fe20-4101-a258-2b4d48edc2cf,BioMimetic Therapeutic Inc,biomimetic_therapeutic_inc,,,,,, -6513,,49b54fc1-62e5-4727-b7ec-d3582a6b856a,SIAK,siak,,,,,, -6514,,a87d8a02-a768-11e6-94cb-5656d04fc2b5,"Department of Oral Surgery Dental School Med. Univ. Graz, Austria",department_of_oral_surgery_dental_school_med_univ_graz_austria,,,,,, -6515,,119fa7fd-18c0-4631-abea-242c1ee67a1e,Cytheris S.A,cytheris_s_a,,,,,, -6516,,f2b1cda0-d544-4b0b-be3d-0fcf26685da9,Curalogic A/S,curalogic_a_s,,,,,, -6517,,b0720067-a732-11e6-94cb-5656d04fc2b5,"Center for Diabetes Research, Gentofte Hospital",center_for_diabetes_research_gentofte_hospital,,,,,, -253,0.94460948308308923,672dbadc-6cff-4f5d-8ce1-7dbea1dddc99,"Instituto Cientí­fico y Tecnológico de Navarra, S.A",instituto_cient_fico_y_tecnol_gico_de_navarra_s_a,,,,4a176b41-c873-44ad-8442-a2e57b0b4289,instituto_cient_fico_y_tecnol_gico_de_navarra,Instituto Científico y Tecnológico de Navarra -598,0.98780262470245361,112df4bf-757e-4212-a536-a3908a697c4b,University College London (UCL),university_college_london_ucl,,,,112df4bf-757e-4212-a536-a3908a697c4b,university_college_london_ucl,University College London (UCL) -885,0.98101651668548584,5821cf6c-5e8a-481f-8ff8-3198a9183cea,Pharma Mar SA,pharma_mar_sa,,,,5821cf6c-5e8a-481f-8ff8-3198a9183cea,pharma_mar_sa,Pharma Mar SA -914,0.96143,8dc209bc-546d-4999-86f7-43245f5c50ff,TAYS,tays,,,,8dc209bc-546d-4999-86f7-43245f5c50ff,tays,TAYS -6518,,0d9bc368-fb23-479f-bbeb-e8734ca7be53,Clínica del Dr. Lobatón,cl_nica_del_dr_lobat_n,,,,,, -6519,,7579525e-beab-4413-9457-f5af70db3e11,Geron Corporation,geron_corporation,,,,,, -338,0.944177,59161c21-f110-4f6b-bf67-f4d922ff5a94,Medizinische Fakultät der Universität Rostock,medizinische_fakult_t_der_universit_t_rostock,,,,59161c21-f110-4f6b-bf67-f4d922ff5a94,medizinische_fakult_t_der_universit_t_rostock,Medizinische Fakultät der Universität Rostock -6520,,6c7a0908-a1fc-4d80-8e4d-405dbf2e9463,Catharina Hospital Eindhoven,catharina_hospital_eindhoven,,,,,, -6521,,ccc4ef7f-92dc-414a-9505-a37729060983,Nycomed Austria GmbH,nycomed_austria_gmbh,,,,,, -6522,,e1b1c73c-7146-11e6-a0cd-0242ac12000b,SCS,scs,,,,,, -6523,,cfe05250-4c8a-44b5-b686-13135c69ec88,Laboratoires Merck Sharp & Dhome-Chibret,laboratoires_merck_sharp_dhome_chibret,,,,,, -6524,,bddd4072-b30d-46e0-9d43-a56f08fa47bc,CHU DIJON,chu_dijon,,,,,, -910,0.97229477763175964,2ff031e3-15e0-4408-84d2-974f9250a92c,Laboratorios Servier S.L. (For Spain only),laboratorios_servier_s_l_for_spain_only,,,,32161af5-1f02-447e-a38b-e0f0858697d7,laboratorios_servier,Laboratorios Servier -6525,,23b89241-887e-4d0d-9a53-3d77c667a500,University Medical Center Freiburg,university_medical_center_freiburg,,,,,, -6526,,983be2d6-8899-450f-861e-42a25a2ba013,"Celgene International II Sàrl (CIS II), a wholly owned subsidiary of Celgene Corporation",celgene_international_ii_s_rl_cis_ii_a_wholly_owned_subsidiary_of_celgene_corporation,,,,,, -575,0.946558,2848a4da-8be7-11e6-a449-0242ac12000b,Oslo University Hospital Health Trust,oslo_university_hospital_health_trust,,,,28440dc6-8be7-11e6-a449-0242ac12000b,oslo_university_hospital_healt_trust,Oslo University Hospital healt Trust -6527,,640071c9-fca9-4c44-9f2b-0631d984d9c9,"Emergent Product Development Seattle, LLC",emergent_product_development_seattle_llc,,,,,, -6528,,ddb4ffd4-cf05-4ad9-a1a8-2039792f0bf4,Ramón Cañete Estrada,ram_n_ca_ete_estrada,,,,,, -6529,,da3303a3-de9f-45f0-8e68-0f3f1d2e6e33,"Unigene Laboratories, Inc",unigene_laboratories_inc,,,,,, -253,0.95808978875478112,49f7eb37-f6bc-4ed0-a66b-da7d0aa9452e,Instituto Cientifico y Tecnologico de Navarra,instituto_cientifico_y_tecnologico_de_navarra,,,,4a176b41-c873-44ad-8442-a2e57b0b4289,instituto_cient_fico_y_tecnol_gico_de_navarra,Instituto Científico y Tecnológico de Navarra -6530,,a7bf81fa-e3c6-48f0-a1aa-931449fa9850,Universitätsklinikum der RWTH Aachen - Ärztlicher Direktor Univ.-Prof. Dr. H. Sass,universit_tsklinikum_der_rwth_aachen_rztlicher_direktor_univ_prof_dr_h_sass,,,,,, -6531,,599ee111-ca9a-4121-85ef-8dd459c45419,University of East Anglia,university_of_east_anglia,,,,,, -6532,,bc8794b0-754a-4f49-a01c-3020c6c60899,"Amersham Health, S.A. como filial de GE Healthcare Limited",amersham_health_s_a_como_filial_de_ge_healthcare_limited,,,,,, -6533,,b291492b-d6bc-48ca-be0c-8d2380f77a26,Fundación Hospital Clinic i Provincial,fundaci_n_hospital_clinic_i_provincial,,,,,, -0,0.982418,ae7401a6-5748-45c3-a5b1-4f5e93d0e171,"Morphotek, Inc",morphotek_inc,,,,5f4adcd3-a8a4-4ad8-bcc3-14aa5dc4d3e0,morphotek,Morphotek -575,0.946558,28440dc6-8be7-11e6-a449-0242ac12000b,Oslo University Hospital healt Trust,oslo_university_hospital_healt_trust,,,,28440dc6-8be7-11e6-a449-0242ac12000b,oslo_university_hospital_healt_trust,Oslo University Hospital healt Trust -6534,,37c4b226-a5cf-4dae-b111-998db7c54f34,"Epizyme, Inc",epizyme_inc,,,,,, -6535,,32727a2b-4240-447e-a435-4f278330c364,"Tetraphase Pharmaceuticals, Inc",tetraphase_pharmaceuticals_inc,,,,,, -551,0.9728655219078064,3ae4acff-8257-4636-ad28-752d276490e5,"Freistaat Bayern, represented by Universität Regensburg",freistaat_bayern_represented_by_universit_t_regensburg,,,,0aa6ecae-1a53-4cf9-8648-924415ffb218,freistaat_bayern,Freistaat Bayern -198,0.98829472064971924,a1f882cc-4aed-44a9-8d73-7258767372d7,Agence nationale de recherches sur le sida et les hépatites virales,agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales,,,,59af07b2-8bdc-4113-8ce3-1b459956f500,agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales,Agence nationale de recherches sur le sida et les hépatites virales -85,0.979515,32d4a4cc-7142-11e6-a0cd-0242ac12000b,PERRIGO CO TENNESSEE,perrigo_co_tennessee,,,,32d4a4cc-7142-11e6-a0cd-0242ac12000b,perrigo_co_tennessee,PERRIGO CO TENNESSEE -6536,,1a36c257-2e1b-4639-80fe-2f034cc4a8f1,"Herlev University Hospital, Oncology Dept",herlev_university_hospital_oncology_dept,,,,,, -6537,,2a8f39a4-7362-11e6-a0cd-0242ac12000b,PIERREL,pierrel,,,,,, -6538,,16100785-ef81-4f01-9402-c0eb960b73ec,Gentium S.p.A,gentium_s_p_a,,,,,, -545,0.987705,4f5eb84e-1410-49da-8e9d-2b096a9a7341,HOSPITAL UNIVERSITARI DE BELLVITGE,hospital_universitari_de_bellvitge,,,,302c2638-8bd6-11e6-a449-0242ac12000b,hospital_universitari_de_bellvitge_idibell,HOSPITAL UNIVERSITARI DE BELLVITGE - IDIBELL -6539,,b1a426c0-c9d0-47f6-8f86-ce31d7fcd033,GlaxoSmithKline Biologicals - GSK China Vaccines,glaxosmithkline_biologicals_gsk_china_vaccines,,,,,, -6540,,21b82789-d7e2-407f-886b-2a1cddca1c44,Frimley Park Hospital,frimley_park_hospital,,,,,, -6541,,b85f832e-b618-4b41-a8c5-b4316be5ab91,North Essex Partnership NHS Foundation Trust,north_essex_partnership_nhs_foundation_trust,,,,,, -6542,,65f21210-caf4-4c6c-8362-c88d39c27a14,Raimo Tuuminen,raimo_tuuminen,,,,,, -6543,,bdebe208-b148-4742-a5b3-5a01d04bd9b7,Multiplex Pharma Holdings LLC,multiplex_pharma_holdings_llc,,,,,, -6544,,22bc4a03-0152-4689-a444-4605087f69c5,"Department of women's and Children's health, Uppsala University",department_of_women_s_and_children_s_health_uppsala_university,,,,,, -6545,,ba28857c-2053-4532-b5d1-b9692500ee19,ORPHANETICS Pharma Entwicklungs- GmbH,orphanetics_pharma_entwicklungs_gmbh,,,,,, -314,0.98565453290939331,0c6b6aec-6007-4be6-917b-e3ac534e2858,Mundipharma,mundipharma,,,,0c6b6aec-6007-4be6-917b-e3ac534e2858,mundipharma,Mundipharma -6546,,987c907e-2553-4050-8e5e-022c906a96b2,"Medical Centre of Postgraduate Education, Poland",medical_centre_of_postgraduate_education_poland,,,,,, -6547,,6a3fe440-1f93-415d-af89-c3263a52ec2c,Univeristy of Milano-Bicocca,univeristy_of_milano_bicocca,,,,,, -134,0.984688,76fec111-82e4-485f-8b4f-67c48f13862f,University Hospitals Bristol NHS Foundation Trust Research and Innovation Department,university_hospitals_bristol_nhs_foundation_trust_research_and_innovation_department,,,,61bbf47c-775e-4ef4-9782-861df4424a72,university_hospitals_bristol_nhs_foundation_trust,University Hospitals Bristol NHS Foundation Trust -6548,,d31112d2-3dce-4a0a-be46-18af0f3b6d22,"Merck, Sharpe & Dohme Corp., a subsidiary of Merck & Co. Inc (hereafter referred to as Merck)",merck_sharpe_dohme_corp_a_subsidiary_of_merck_co_inc_hereafter_referred_to_as_merck,,,,,, -6549,,be403ff7-a864-4dcb-ad21-a089702dba5c,Merus B.V,merus_b_v,,,,,, -6550,,eca94eac-9e5a-49d3-a1a0-e24d853a75c0,Guy's & St. Thomas' NHS Foundation Trust,guy_s_st_thomas_nhs_foundation_trust,,,,,, -6551,,f60df364-714f-11e6-a0cd-0242ac12000b,VPNA,vpna,,,,,, -908,0.94523629546165466,6bd628da-1d32-4991-9bda-bc309b439e53,sanofi-aventis Recherche & Dévelopment,sanofi_aventis_recherche_d_velopment,,,,9c45d693-515d-4149-92e4-d7272d06a7df,sanofi_aventis_recherche_d_veloppement,sanofi-aventis Recherche & Développement -6552,,45052c66-7142-11e6-a0cd-0242ac12000b,PUREPAC PHARM,purepac_pharm,,,,,, -6553,,a2fa33c5-169a-4580-9797-d95360063225,Charité - University Hospital Berlin,charit_university_hospital_berlin,,,,,, -6554,,0278e061-53bd-49c3-8620-381a25a1811f,Universityhospital of Heidelberg,universityhospital_of_heidelberg,,,,,, -33,0.98417317867279053,a5f26061-0a6f-4fd1-83b7-6557b7c1b6d1,Department of Endocrinology,department_of_endocrinology,,,,a5f26061-0a6f-4fd1-83b7-6557b7c1b6d1,department_of_endocrinology,Department of Endocrinology -763,0.970018,20d8ecc2-872e-4d93-9419-6e3e20fea29f,Danish Multiple Sclerosis Research Centre,danish_multiple_sclerosis_research_centre,,,,20d8ecc2-872e-4d93-9419-6e3e20fea29f,danish_multiple_sclerosis_research_centre,Danish Multiple Sclerosis Research Centre -6555,,53835a58-7145-11e6-a0cd-0242ac12000b,ALKEM LABS LTD,alkem_labs_ltd,,,,,, -999,0.984336,2851af76-cc6a-41a0-a263-399d40b7eb15,Birmingham Children's Hospital NHS Foundation Trust,birmingham_children_s_hospital_nhs_foundation_trust,,,,2851af76-cc6a-41a0-a263-399d40b7eb15,birmingham_children_s_hospital_nhs_foundation_trust,Birmingham Children's Hospital NHS Foundation Trust -6556,,ddf1661e-73fa-11e6-a0cd-0242ac12000b,TAIHO ONCOLOGY,taiho_oncology,,,,,, -544,0.978652,3e5070ce-7142-11e6-a0cd-0242ac12000b,BRISTOL,bristol,,,,3e5070ce-7142-11e6-a0cd-0242ac12000b,bristol,BRISTOL -6557,,bc70263e-715b-11e6-a0cd-0242ac12000b,PROVIDENT PHARM,provident_pharm,,,,,, -69,0.989009,2bcb0c19-b4b9-4f7c-9d21-fb61445071f3,"Schering Corporation, división Schering-Plough Research Institute",schering_corporation_divisi_n_schering_plough_research_institute,,,,2bcb0c19-b4b9-4f7c-9d21-fb61445071f3,schering_corporation_divisi_n_schering_plough_research_institute,"Schering Corporation, división Schering-Plough Research Institute" -6558,,97736042-d099-44c1-bccd-316be636b5d3,University Medicine Goettingen,university_medicine_goettingen,,,,,, -6559,,c9cd6080-9e28-463c-aacf-48029351d207,"MedImmune, Ltd, a wholly owned subsidiary of AstraZeneca UK",medimmune_ltd_a_wholly_owned_subsidiary_of_astrazeneca_uk,,,,,, -6560,,ef709a83-9c9e-4352-9eff-550e8f00a388,"Medizinische Universitaet Wien, Universitaetsklinik für Radiologie und Nuklearmedizin",medizinische_universitaet_wien_universitaetsklinik_f_r_radiologie_und_nuklearmedizin,,,,,, -6561,,3b927722-55b1-4b6b-93f6-a7b096071b83,AZIENDA OSPEDALIERA S. CARLO,azienda_ospedaliera_s_carlo,,,,,, -6562,,0f02577c-7167-11e6-a0cd-0242ac12000b,HAINAN POLY PHARMA CO LTD,hainan_poly_pharma_co_ltd,,,,,, -6563,,585982bc-7165-11e6-a0cd-0242ac12000b,BAYSHORE PHARMS LLC,bayshore_pharms_llc,,,,,, -6564,,3363cb70-3bd5-4259-aa0f-ed52850556e8,A. MENARINI I.F.R,a_menarini_i_f_r,,,,,, -6565,,4208254f-fefa-437b-859f-0d63aae3154f,Dept of ped hem/onc,dept_of_ped_hem_onc,,,,,, -6566,,ec35d57e-8bc5-11e6-a449-0242ac12000b,"Department of Oncology, Herlev Hospital",department_of_oncology_herlev_hospital,,,,,, -6567,,68af1d11-232f-4917-887e-950c168c726d,TETEC AG,tetec_ag,,,,,, -6568,,1b0f3e62-72b2-11e6-a0cd-0242ac12000b,VYTERIS,vyteris,,,,,, -6569,,dbd49db9-d73c-4dba-b94f-9ac664dea5b2,Novartis Consumer Health S.A,novartis_consumer_health_s_a,,,,,, -313,0.97367525100708008,d94a5eb6-cc98-4004-a7a3-95cf39383b18,GlaxoSmithKline Biologicals,glaxosmithkline_biologicals,,,,d94a5eb6-cc98-4004-a7a3-95cf39383b18,glaxosmithkline_biologicals,GlaxoSmithKline Biologicals -6570,,5ad221ec-2777-48b2-b450-026a456ddf9c,Abbott GmbH &, Co. KG,,,,,, -6571,,1527feba-7192-11e6-a0cd-0242ac12000b,MALLINCKRODT ARD,mallinckrodt_ard,,,,,, -6572,,dfae6deb-1cd2-4420-98b2-7a65cfb8b482,"Five Prime Therapeutics, Inc",five_prime_therapeutics_inc,,,,,, -6573,,ea9aa16a-977c-430a-a3b9-2842ad9d53d3,Biolipox AB,biolipox_ab,abbott_gmbh_amp_co_kg,,,,, -6574,,e6647b1c-8003-43e4-9cc2-eb8734e8b420,"PREMACURE AB, A MEMBER OF SHIRE GROUP OF COMPANIES",premacure_ab_a_member_of_shire_group_of_companies,,,,,, -6575,,ee868835-c082-4942-9109-6800f4c67b2e,Pharmaxis Pharmaceuticals Limited,pharmaxis_pharmaceuticals_limited,,,,,, -6576,,cb2d0027-0145-449c-bbbd-1cc6bd097c6f,AS.T.R.O,as_t_r_o,,,,,, -6577,,e5a7a91e-8bc8-11e6-a449-0242ac12000b,"Anders Nyboe Andersen, klinikchef, dr. med., Fertilitetsklinikken afsnit 4071, Rigshospitalet",anders_nyboe_andersen_klinikchef_dr_med_fertilitetsklinikken_afsnit_4071_rigshospitalet,,,,,, -6578,,430e11cd-5054-4d80-b3d7-f645e3eff6a6,MEDAC RESEARCH,medac_research,,,,,, -6579,,449f4753-2c74-4a20-8b0b-15a8b29e5164,Astellas Pharma Europe Limited,astellas_pharma_europe_limited,,,,,, -6580,,4b82adb2-7344-11e6-a0cd-0242ac12000b,NIAGARA PHARMS,niagara_pharms,,,,,, -6581,,8ec25ab7-d009-4a0d-8011-9095f895cf3b,UMCU,umcu,,,,,, -6582,,ef6b5a01-3ea3-49eb-a2df-d9a84f81be5e,Aintree Hospitals NHS Trust and University of Liverpool,aintree_hospitals_nhs_trust_and_university_of_liverpool,,,,,, -6583,,e177d3d5-db33-496d-bf8b-e734b7f866dc,"Actelion Pharmaceuticals US, Inc",actelion_pharmaceuticals_us_inc,,,,,, -436,0.96070769429206848,25203332-c6eb-4eda-87c7-a780f5142133,"Pfizer Inc., 235 East 42nd Street, New York, 10017, United States",pfizer_inc_235_east_42nd_street_new_york_10017_united_states,,,,25203332-c6eb-4eda-87c7-a780f5142133,pfizer_inc_235_east_42nd_street_new_york_ny10017_united_states,"Pfizer Inc., 235 East 42nd Street, New York, 10017, United States" -6584,,20f359c6-0732-4d50-a3cf-68d2dda156aa,Azienda Ospedaliera Universitaria S.Martino - U.O. Oncologia Medica - Genova,azienda_ospedaliera_universitaria_s_martino_u_o_oncologia_medica_genova,,,,,, -6585,,c8dae27b-0837-44f4-acb9-4eb9ca010cdf,Hospital Comarcal de Laredo. Sección de Digestivo,hospital_comarcal_de_laredo_secci_n_de_digestivo,,,,,, -747,0.987246,61d9cb36-84e8-4785-a622-4f2f20464069,Universitaetsklinikum Erlangen,universitaetsklinikum_erlangen,,,,61d9cb36-84e8-4785-a622-4f2f20464069,universitaetsklinikum_erlangen,Universitaetsklinikum Erlangen -968,0.97809287905693054,e5d4a9c1-e0e4-4ac7-8c88-785f0f8e3beb,Maatschap Cardiologie Isala,maatschap_cardiologie_isala,,,,e5d4a9c1-e0e4-4ac7-8c88-785f0f8e3beb,maatschap_cardiologie_isala_klinieken,Maatschap Cardiologie Isala klinieken -6586,,d775ddf9-4eed-419c-a8ed-a98d3656098a,Immuno-Designed Molecules,immuno_designed_molecules,,,,,, -933,0.97951988379160559,e26f58e7-f0e7-4ad4-9432-e13ea279b291,Pierre Fabre,pierre_fabre,,,,e26f58e7-f0e7-4ad4-9432-e13ea279b291,pierre_fabre,Pierre Fabre Médicament -6587,,b03e3897-0094-499b-b171-ffe24a8315b1,Szpital im. Jana Pawla II,szpital_im_jana_pawla_ii,,,,,, -6588,,8734f99c-05ca-42b1-8be0-1e420f7a92fc,"Dept. of Psychiaty, University of Freiburg",dept_of_psychiaty_university_of_freiburg,,,,,, -6589,,d08a67f5-4903-4af4-a318-1a91971ad887,Mylan Pharma UK Ltd,mylan_pharma_uk_ltd,,,,,, -6590,,5f15f2ea-4aa7-4660-81d5-dc02c5199612,Grupo de Investigação do Cancro Digestivo,grupo_de_investiga_o_do_cancro_digestivo,,,,,, -6591,,9de26bd0-1822-43da-862b-19b9cd9a34a6,NAMED SRL,named_srl,,,,,, -661,0.988375,e15edbf4-2f93-4ee5-b9aa-da446c1209d0,BioCryst Pharmaceuticals Inc,biocryst_pharmaceuticals_inc,,,,e15edbf4-2f93-4ee5-b9aa-da446c1209d0,biocryst_pharmaceuticals_inc,BioCryst Pharmaceuticals Inc -6592,,af7720f4-15df-4ceb-a637-e9b9db8c3d46,Malmoe University Hospital,malmoe_university_hospital,,,,,, -6593,,5e5e4d8a-51df-4a8a-b216-71028c12a01a,Donesta Bioscience BV,donesta_bioscience_bv,,,,,, -6594,,0076cf1f-dff2-4386-8e41-ede0c2f76c04,"Medizinische Universität Innsbruck, Abteilung für Nuklearmedizin",medizinische_universit_t_innsbruck_abteilung_f_r_nuklearmedizin,,,,,, -940,0.988452,f6959636-eb34-484b-8514-f49f9e548af3,"Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunersches Kinderspital",klinikum_der_universit_t_m_nchen_kinderklinik_und_poliklinik_im_dr_von_haunersches_kinderspital,,,,7c1e9a67-0589-4d28-bf1e-a81d74f16a46,klinikum_der_universit_t_m_nchen_kinderklinik_und_poliklinik_im_dr_von_haunerschen_kinderspital,"Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunerschen Kinderspital" -50,0.902909,098236a3-98ed-47c3-8dcd-a916a201d337,EUSA Pharma,eusa_pharma,,,,098236a3-98ed-47c3-8dcd-a916a201d337,eusa_pharma,EUSA Pharma -6595,,934c4f44-8e43-4028-b671-4d9ba99f8e0c,BOC Ltd,boc_ltd,,,,,, -471,0.987664,3162896a-c44b-4bc5-ab15-a97eb8b7517e,South Manchester University Hospitals NHS Trust,south_manchester_university_hospitals_nhs_trust,,,,3162896a-c44b-4bc5-ab15-a97eb8b7517e,south_manchester_university_hospitals_nhs_trust,South Manchester University Hospitals NHS Trust -6596,,b817b3dc-a352-4658-99c9-6584a985f2a5,ImmuPharma SA,immupharma_sa,,,,,, -43,0.978791,d2de3704-c86b-4587-bc51-08837265b2da,Nordic Society of Gynecological Oncology (NSGO),nordic_society_of_gynecological_oncology_nsgo,,,,38b6ac83-2901-4af7-b81e-62ce14bad7cc,nordic_society_of_gynaecological_oncology_nsgo,Nordic Society of Gynaecological Oncology (NSGO) -235,0.96446388959884644,199932d6-c852-48b7-8263-cea5e21e83f6,Novartis Pharma Service AG,novartis_pharma_service_ag,,,,683ca9e5-af11-4524-9288-1bb0932a9588,novartis_pharma_services,Novartis Pharma Services -6597,,85bbc1fe-5278-443d-9dc8-962b70df9e21,GABA GmbH,gaba_gmbh,,,,,, -849,0.97769945859909058,7f715054-2995-4abe-94ad-dfa6443ca063,PFIZER,pfizer,,,,373295c7-9ca2-499a-ae31-52733bea403b,pfizer_slu,"PFIZER, SLU" -6598,,47a62182-dff1-406d-8834-f8e682de0164,"Nora Therapeutics, Inc",nora_therapeutics_inc,,,,,, -6599,,fb2b6360-7152-11e6-a0cd-0242ac12000b,BIO NUCLEONICS,bio_nucleonics,,,,,, -328,0.932685,6f406dab-5805-481d-943e-14127b65646b,Aziende Chimiche Riunite Angelini Francesco S.p.A,aziende_chimiche_riunite_angelini_francesco_s_p_a,,,,5809dce0-1c57-445d-9068-5b5bffdd2080,aziende_chimiche_riunite_angelini_francesco_acraf_s_p_a,Aziende Chimiche Riunite Angelini Francesco - ACRAF S.p.A -6600,,b07beca0-ce90-4b1c-b956-54ed9022766d,Rheinisch-Westfälisch Technische Hochschule Aachen,rheinisch_westf_lisch_technische_hochschule_aachen,,,,,, -6601,,260fa8ab-a4ca-4e96-a8bd-6278bd387dbb,"Lantheus Medical Imaging, Inc",lantheus_medical_imaging_inc,,,,,, -179,0.977461,7307791a-55cf-4462-a41c-9a905939b273,MUTUAL PHARMACEUTICAL COMPANY,mutual_pharmaceutical_company,,,,7307791a-55cf-4462-a41c-9a905939b273,mutual_pharmaceutical_company,MUTUAL PHARMACEUTICAL COMPANY -6602,,a8db3e9f-50b8-4b02-8225-c938898dca66,Sandwell and West Birmingham NHS Trust,sandwell_and_west_birmingham_nhs_trust,,,,,, -576,0.98835551738739014,cc21573f-300a-40f0-a4f8-08ffae6cf7ca,"Wyeth Pharmaceuticals, Global Medical Affairs",wyeth_pharmaceuticals_global_medical_affairs,,,,296373b5-8871-4062-ab94-c1936a5306c2,wyeth_pharmaceuticals_global_medical_affairs_department,"Wyeth Pharmaceuticals, Global Medical Affairs Department" -6603,,21a96078-b915-4b3e-bd5e-e7da607432e4,Ascendis Pharma A/S,ascendis_pharma_a_s,,,,,, -6604,,b378ae87-64e1-4a02-88cb-2a49bc35b776,"GlycoMimetics, Inc",glycomimetics_inc,,,,,, -6605,,1aa821a8-6fa3-11e6-9663-0242ac12000b,Eli Lilly Sweden AB,eli_lilly_sweden_ab,,,,,, -6606,,9247c09e-a4e2-4843-96db-02d93ce1c16f,ANTHERA PHARMACEUTICALS,anthera_pharmaceuticals,,,,,, -6607,,10b14c80-1fac-45a2-840a-fc551f446b88,Diego Caicedo Valdés,diego_caicedo_vald_s,,,,,, -825,0.979838,1bd8b575-4f6d-4564-aa9e-6ea528cb17bb,University of Surrey Clinical Research Centre,university_of_surrey_clinical_research_centre,,,,1bd8b575-4f6d-4564-aa9e-6ea528cb17bb,university_of_surrey_clinical_research_centre,University of Surrey Clinical Research Centre -928,0.975714,87f2de76-726c-11e6-a0cd-0242ac12000b,LG LIFE SCIENCES,lg_life_sciences,,,,87f2de76-726c-11e6-a0cd-0242ac12000b,lg_life_sciences,LG LIFE SCIENCES -888,0.96880727154867985,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,"Schering-Plough Research Institute, a Division of Schering Corporation - for Global trials",schering_plough_research_institute_a_division_of_schering_corporation_for_global_trials,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" -6608,,691cc6fc-c90c-4878-a345-8ecf3743f138,FUNDACION PARA LA INVESTIGACIÓN BIOSANITARIA DE ANDALUCIA ORIENTAL_ FPA,fundacion_para_la_investigaci_n_biosanitaria_de_andalucia_oriental_fpa,,,,,, -6609,,11c7b033-c5ac-465d-b11e-6fd0e48613fb,"Royal Hospital for Sick Children, Glasgow",royal_hospital_for_sick_children_glasgow,,,,,, -6610,,f8ab1c83-4e52-42a9-8758-1490ec255bc1,daacro - diagnostic assessment and clinical research organization,daacro_diagnostic_assessment_and_clinical_research_organization,,,,,, -6611,,de0d8141-1339-4c0b-9443-72b2421247ec,"KRKA, tovarna zdravil, d. d., Novo mesto",krka_tovarna_zdravil_d_d_novo_mesto,,,,,, -6612,,6008f4b9-db21-40c3-96d0-fa6512a77dae,"University Hospital of Frankfurt, Department of Cardiology",university_hospital_of_frankfurt_department_of_cardiology,,,,,, -6613,,2290097d-5a8a-4773-83ec-e7ba2565dd9f,Grupo Español de Oncología Genitourinaria (SOGUG),grupo_espa_ol_de_oncolog_a_genitourinaria_sogug,,,,,, -6614,,449b4f58-7165-11e6-a0cd-0242ac12000b,ACTAVIS PHARMA,actavis_pharma,,,,,, -6615,,105e9968-8061-4d4f-94a3-f1a4c5e28dce,Joaquim Bellmunt Molins,joaquim_bellmunt_molins,,,,,, -6616,,1c87f7f2-7154-11e6-a0cd-0242ac12000b,CR DOUBLE CRANE,cr_double_crane,,,,,, -610,0.97186114390691125,a1e67e69-7e29-4ce5-b94c-82eb0d5252c9,Fédérationa Nationale des Centres de Lutte Contre le Cancer,f_d_rationa_nationale_des_centres_de_lutte_contre_le_cancer,,,,4b5b75aa-a963-452e-848e-256ac41c5d72,f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer,Fédération Nationale des Centres de Lutte Contre le Cancer -6617,,cd6d8a5b-ab33-4fc8-a0f2-4ab2d41d0365,AS Kevelt,as_kevelt,,,,,, -6618,,c5885d39-8c12-4f9b-b3cf-c064a1403351,ALK-ABELLO',alk_abello,,,,,, -6619,,1375fc1e-72b6-11e6-a0cd-0242ac12000b,PROF DSPLS,prof_dspls,,,,,, -500,0.991079,0f951df0-e851-4fc3-9f85-c87f75143477,Hannover Medical School,hannover_medical_school,,,,0f951df0-e851-4fc3-9f85-c87f75143477,hannover_medical_school,Hannover Medical School -6620,,97011f6c-71af-11e6-a0cd-0242ac12000b,ROACO,roaco,,,,,, -6621,,92146c5e-cb7f-4882-a74d-d32e61bb3c79,1. Frauenklinik der LMU- Innenstadt,1_frauenklinik_der_lmu_innenstadt,,,,,, -6622,,d6ffa210-622f-461c-b489-a7c41c7bad5c,"FARMACUSI, S.A",farmacusi_s_a,,,,,, -468,0.987296,055d2f79-6382-44aa-9acf-84a8274892de,Targovax AS,targovax_as,,,,055d2f79-6382-44aa-9acf-84a8274892de,targovax_as,Targovax AS -1031,0.98682358860969543,35980991-cb27-4147-a7f5-46a59beed065,Medical University of Vienna,medical_university_of_vienna,,,,9f76459d-c1a5-4dfd-8ba3-7773bf3ebbce,medical_university_of_vienna_department_of_pediatrics,Medical University of Vienna -6623,,047fc717-1461-4340-af26-a54131404b2b,Servier,servier,,,,,, -6624,,674de28b-04b4-45cd-a3d1-a8dae3df9650,ONO PHARMA UK LTD,ono_pharma_uk_ltd,,,,,, -6625,,1d0b0158-99a1-4316-9672-47db59d82ad0,Institute Jules Bordet,institute_jules_bordet,,,,,, -6626,,646a18e5-6c4a-484a-aaa6-5320887878a8,NOVAGALI Pharma S.A.S,novagali_pharma_s_a_s,,,,,, -6627,,73b7c121-e223-4400-bc26-559bf075b116,LYSA (The Lymphoma Study Association),lysa_the_lymphoma_study_association,,,,,, -6628,,4da92a5f-30ca-43c6-8a4b-3f5e642b1202,"Takeda Vaccines (Montana), Inc",takeda_vaccines_montana_inc,,,,,, -6629,,05bb40e0-92ec-42c3-b636-e7484a15c1e4,Queen Mary Medical University of London,queen_mary_medical_university_of_london,,,,,, -6630,,ffecd170-a525-4c9a-a1fd-234ac834df33,"Med. Univ. Wien, Univ. Klinik für Innere Medizin III, Abt. Gastroenterologie und Hepatologie",med_univ_wien_univ_klinik_f_r_innere_medizin_iii_abt_gastroenterologie_und_hepatologie,,,,,, -259,0.985423,34f3a53c-71a6-11e6-a0cd-0242ac12000b,US WORLDMEDS LLC,us_worldmeds_llc,,,,34f3a53c-71a6-11e6-a0cd-0242ac12000b,us_worldmeds_llc,US WORLDMEDS LLC -6631,,68e6d328-f29e-4e84-8883-7f1799b8385a,Dr. Luis Serra Majem,dr_luis_serra_majem,,,,,, -700,0.931044,e94af6e9-e4f4-4318-93ce-a915794b2ab2,Juan Cordoba,juan_cordoba,,,,71bf9d51-f211-4fcd-b6d2-35dce8b4c292,juan_c_rdoba,Juan Córdoba -6632,,aad98ce5-4622-419e-81bf-f4326f128b64,Professor Anita Leys - Dienst Oftalmologie UZ St. Rafaël,professor_anita_leys_dienst_oftalmologie_uz_st_rafa_l,,,,,, -6633,,c5520d5f-9f5e-4b99-9d7a-48f827a30a92,Radiological dept. Aalborg Hospital,radiological_dept_aalborg_hospital,,,,,, -6634,,be82da70-714c-11e6-a0cd-0242ac12000b,CARLSBAD,carlsbad,,,,,, -6635,,ad47982d-82ab-4643-b749-a205cf585b6d,"Med. Univ. Wien, Univ. Klinik für Radiodiagnostik",med_univ_wien_univ_klinik_f_r_radiodiagnostik,,,,,, -6636,,3150da36-738f-11e6-a0cd-0242ac12000b,SUPERGEN,supergen,,,,,, -7,0.95330825448036194,0d2542d7-45c9-45b1-a384-6899a6c75428,Centre Hospitalier Universitaire de Nantes,centre_hospitalier_universitaire_de_nantes,,,,e37ff462-7351-402c-828d-d17f23d6fa72,centre_hospitalier_universitaire_de_nantes,Centre Hospitalier Universitaire de Nantes -6637,,8b237369-cccf-4299-9996-50fac040a990,Raptor Therapeutics Inc,raptor_therapeutics_inc,,,,,, -6638,,4c9eafe2-ad94-456c-a7d0-c70d0441acfc,"Medizinische Universität Graz, Univ. Klinik Dermatologie, Forschungseinheit für Photodermatologie",medizinische_universit_t_graz_univ_klinik_dermatologie_forschungseinheit_f_r_photodermatologie,,,,,, -6639,,9320d63f-d87f-4295-a074-16824dca10dc,"Karolinska Institutet, Inst för kliniska vetenskaper, Danderyds sjukhus",karolinska_institutet_inst_f_r_kliniska_vetenskaper_danderyds_sjukhus,,,,,, -6640,,f8908b74-33c5-459e-adc2-89dbf9a36847,"Med. Univ. Wien, Uk für Innere Medizin I",med_univ_wien_uk_f_r_innere_medizin_i,,,,,, -6641,,3605e1ff-fca8-4cc8-82a5-4c75dc3a6e40,Verein für Krebsforschung,verein_f_r_krebsforschung,,,,,, -6642,,9cf246bb-985a-4b79-bd5b-f8a11d444cd8,University of Bonn,university_of_bonn,,,,,, -706,0.98155027627944946,ad3a923c-36e2-42c3-8d1d-8e516c97e54a,"Medical University, Dpt. Internal Medicin, Division of General Internal Medicine",medical_university_dpt_internal_medicin_division_of_general_internal_medicine,,,,450942a3-d351-4153-8f52-7394952e4a17,medical_university_dpt_internal_medicin_division_of_general_inteal_medicine,"Medical University, Dpt. Internal Medicin, Division of General Inteal Medicine" -6643,,b32abb28-b1ba-44ec-b8fe-0b19451a3ba5,Hospital Universitario Virgen de las Nieves,hospital_universitario_virgen_de_las_nieves,,,,,, -6644,,8b6b2294-7153-11e6-a0cd-0242ac12000b,ATLAS PHARMS LLC,atlas_pharms_llc,,,,,, -6,0.98172008991241455,17ea9e87-8473-4174-a0be-01570daa58e8,Centre Hospitalier Universitaire de Montpellier,centre_hospitalier_universitaire_de_montpellier,,,,17ea9e87-8473-4174-a0be-01570daa58e8,centre_hospitalier_universitaire_de_montpellier,Centre Hospitalier Universitaire de Montpellier -6645,,7a8b0f93-2e02-4f75-96d0-bec9cb90b4d3,"Unità Malattie Neurodegenerative, Ospedale Cardinale Giovanni Panico, Tricase",unit_malattie_neurodegenerative_ospedale_cardinale_giovanni_panico_tricase,,,,,, -6646,,835bfe25-65fb-4156-b949-069b1dab394c,Turku Univeristy Hospital,turku_univeristy_hospital,,,,,, -6647,,06be709c-cef4-4e18-bc06-9933231a7e0b,José Luis Vázquez Martínez,jos_luis_v_zquez_mart_nez,,,,,, -629,0.973923,8bf894ff-dd31-480c-84ce-842ae83c6af2,"Aarhus Sygehus, Universityhospital of Aarhus",aarhus_sygehus_universityhospital_of_aarhus,,,,8bf894ff-dd31-480c-84ce-842ae83c6af2,aarhus_sygehus_universityhospital_of_aarhus,"Aarhus Sygehus, Universityhospital of Aarhus" -6648,,a685b7d5-bf0d-4701-9993-ba2f101e0fc6,University Hospital Brussels (UZ Brussel),university_hospital_brussels_uz_brussel,,,,,, -6649,,32e29970-715a-4c43-861e-b138d3517882,RUNMC,runmc,,,,,, -6650,,6d6b05fe-337f-4161-84b0-b0ed2b99349f,Mª ANGELES CALDERON,m_angeles_calderon,,,,,, -6651,,e347ca27-d40a-40d9-8672-7190053cbd13,ALLOS,allos,,,,,, -6652,,d9724382-7654-4ba8-baea-764670d9fe39,UniversityHospitalGrenoble,universityhospitalgrenoble,,,,,, -6653,,08220eba-fc16-4bee-8064-a7ca848e405c,MorphoSys AG,morphosys_ag,,,,,, -6654,,9a7e88cd-04fe-4fff-a9cd-df6eff58502c,"Astellas Pharma Korea, Inc",astellas_pharma_korea_inc,,,,,, -292,0.987186,aa9c6b2d-f98b-420e-9de2-c94fac56e8a4,Motif BioSciences,motif_biosciences,,,,577003d4-ce61-4acf-92c9-2f42061c86fc,motif_biosciences_inc,Motif BioSciences Inc -6655,,444e75b7-b885-4ecc-b281-4022dee19b5e,WYETH LEDERLE,wyeth_lederle,,,,,, -6656,,1f237bb2-2b33-408d-a717-dc86e2efaec9,Kaija Puhakka,kaija_puhakka,,,,,, -6657,,95d3949b-2d87-4a68-827e-a08fc3c39978,Azienda Ospedaliera di Reggio Emilia Arcispedale S.Maria Nuova/IRCCS,azienda_ospedaliera_di_reggio_emilia_arcispedale_s_maria_nuova_irccs,,,,,, -6658,,9e76f950-a31c-4da7-b43d-1bbefb037799,FUNDACION INVESTIGACION BIOMEDICA HOSPITAL NINO JESUS,fundacion_investigacion_biomedica_hospital_nino_jesus,,,,,, -31,0.98087829351425171,5b1b823c-72c5-11e6-a0cd-0242ac12000b,DURAMED,duramed,,,,5b1b823c-72c5-11e6-a0cd-0242ac12000b,duramed,DURAMED -6659,,0dc753f0-73ea-11e6-a0cd-0242ac12000b,PULMOFLOW INC,pulmoflow_inc,,,,,, -6660,,2509c46d-1555-476e-bc62-262d2397baf6,Hillerød Hospital,hiller_d_hospital,,,,,, -6661,,ae343f46-4f8d-4b98-b318-9a2a93bbe7ad,CHX Technologies Europe Ltd,chx_technologies_europe_ltd,,,,,, -6662,,89295a71-2d9b-4e12-8f5f-2d8b47a8033f,"Discovery Laboratories, Inc",discovery_laboratories_inc,,,,,, -6663,,9c6dd52b-911e-45b0-bb8f-a251114a4e37,Agennix Incorporated,agennix_incorporated,,,,,, -461,0.97483241558074951,ed67c79c-9145-459a-8001-449f57f04800,Debiopharm,debiopharm,,,,006566e8-3afd-4507-99a0-43f66a5ab93a,debiopharm,Debiopharm -6664,,fca7b97d-5e47-4406-945b-cafccd6e2424,Sofamor - Danek,sofamor_danek,,,,,, -6665,,3d1b40a6-7167-11e6-a0cd-0242ac12000b,KREITCHMAN PET CTR,kreitchman_pet_ctr,,,,,, -223,0.985233,44108cfa-cc6c-4533-88aa-39d1732610f2,Surface Logix,surface_logix,,,,44108cfa-cc6c-4533-88aa-39d1732610f2,surface_logix,Surface Logix -6666,,7a7d437c-8a45-456e-8a6d-b44e17ae0356,"Martin Luther Universität Halle-Wittenberg, Klinikum der Medizinischen Fakultät",martin_luther_universit_t_halle_wittenberg_klinikum_der_medizinischen_fakult_t,,,,,, -6667,,7532f45b-9ae9-440b-981e-96a1a7a67e64,"Cerimon Pharmaceuticals, Inc",cerimon_pharmaceuticals_inc,,,,,, -6668,,fcfcd434-4e15-4426-ba50-f50077893dd3,Lundbeck España S.A,lundbeck_espa_a_s_a,,,,,, -6669,,091332b4-8583-4abd-af21-38571503ca9a,Royal Group Hospitals Trust,royal_group_hospitals_trust,,,,,, -6670,,9138ce3f-198b-49ba-9ab0-f8c2fe957aaa,Laboratoire Expanscience,laboratoire_expanscience,,,,,, -6671,,6a88581f-a02c-4983-b5ee-364733814b8a,MSD Korea LTD,msd_korea_ltd,,,,,, -6672,,67c621d6-61da-45dd-9d01-12eda2830f2b,Spectrum Pharmaceuticals,spectrum_pharmaceuticals,,,,,, -6673,,9460247e-73e9-11e6-a0cd-0242ac12000b,INTERPHARMA PRAHA AS,interpharma_praha_as,,,,,, -6674,,af69b74f-53df-413d-b05c-8e132c67595e,Sanofi-Synthelabo Groupe,sanofi_synthelabo_groupe,,,,,, -6675,,6595588a-7353-11e6-a0cd-0242ac12000b,EGALET US INC,egalet_us_inc,,,,,, -6676,,e5bf536d-2465-42c2-855c-9fe56b6770b4,"Haukeland University Hospital, Division of Psychiatry",haukeland_university_hospital_division_of_psychiatry,,,,,, -1042,0.989009,de78cca2-71a3-11e6-a0cd-0242ac12000b,GLAXOSMITHKLINE CON,glaxosmithkline_con,,,,ab743a24-721d-11e6-a0cd-0242ac12000b,glaxosmithkline_cons,GLAXOSMITHKLINE CONS -6677,,81fceae0-880e-11e6-a998-0242ac12000b,"Motus Therapeutics, Inc",motus_therapeutics_inc,,,,,, -333,0.986197,f01ae6b1-2363-42e6-b88f-0af1a726bf35,Nordsjællands Hospital,nordsj_llands_hospital,,,,c0de4999-a6b3-11e6-94cb-5656d04fc2b5,nordsj_llands_hospital_hiller_d,Nordsjællands Hospital Hillerød -6678,,9a2d5eb8-7145-11e6-a0cd-0242ac12000b,DEY,dey,,,,,, -6679,,68c4bad5-4dee-4e95-93f9-8646dc5cb554,"Radius Health, Inc",radius_health_inc,,,,,, -6680,,e89e6678-fb20-49e0-be1f-64f5ae70cbba,Eisai s.r.l,eisai_s_r_l,,,,,, -536,0.978219,9921c788-bec5-470a-b081-facbdc704f78,Institut Jules Bordet,institut_jules_bordet,,,,9921c788-bec5-470a-b081-facbdc704f78,institut_jules_bordet,Institut Jules Bordet -6681,,e6b327de-d032-4de8-84ba-4d354d1df916,Universitetssjukhuset Örebro,universitetssjukhuset_rebro,,,,,, -1019,0.974081,620095ee-c9a2-4531-944d-4a25e6b235d1,GlaxoSmithKline Reasearch & Development,glaxosmithkline_reasearch_development,,,,620095ee-c9a2-4531-944d-4a25e6b235d1,glaxosmithkline_reasearch_development,GlaxoSmithKline Reasearch & Development -6682,,8e881699-6806-4546-8296-ded115b2b449,CHRU de Brest,chru_de_brest,,,,,, -6683,,340b4809-f67e-4e21-898e-c6478a6f946f,S.P.A. ITALIANA LABORATORI BOUTY,s_p_a_italiana_laboratori_bouty,,,,,, -6684,,745aaee5-085e-4fa4-8241-569c58028da2,Gastrocentrum kirurgi,gastrocentrum_kirurgi,,,,,, -6685,,5208cfa4-0460-4695-a27e-ffef0290a1b3,Orion Pharma GmbH,orion_pharma_gmbh,,,,,, -217,0.983343,cdb1a12b-06ee-4c0a-932a-9d236076f296,TRANSGENE,transgene,,,,32ba4b51-aea2-4074-88ac-a23bc5b63b1d,transgene_s_a,TRANSGENE S.A -6686,,cddceb45-3fa5-4cb6-bc87-d4be5d979259,"Merck KGaA and EMD Serono, Inc",merck_kgaa_and_emd_serono_inc,,,,,, -6687,,da486d74-b473-42a5-b62c-2738d2dd8a47,Joint UCLH/UCL/Royal Free Biomedical Research Unit,joint_uclh_ucl_royal_free_biomedical_research_unit,,,,,, -6688,,7f56c029-d961-4572-8db3-704e22d64215,"Obstetrisk afd., Hvidovre Hospital",obstetrisk_afd_hvidovre_hospital,,,,,, -6689,,a0946414-1cad-4607-a7f6-d7d09f4d64ac,"Medizinische Universität Wien, Universitätsklinik f. Innere Med. III, Abt. f. Nephrologie u. Dialyse",medizinische_universit_t_wien_universit_tsklinik_f_innere_med_iii_abt_f_nephrologie_u_dialyse,,,,,, -6690,,63b8da67-a9fa-4fe1-80e2-b4816b5ec6bd,CSL Limited,csl_limited,,,,,, -1036,0.97620874643325806,0e73d51d-18db-4aac-81b0-bb770932bfdc,University of Leeds,university_of_leeds,,,,0e73d51d-18db-4aac-81b0-bb770932bfdc,university_of_leeds,University of Leeds -6691,,eb6c4c36-00b8-423d-b828-5fb308304cb9,HELIXOR Heilmittel GmbH & Co.KG,helixor_heilmittel_gmbh_co_kg,,,,,, -6692,,443d6764-d30e-4199-97be-cc7a16e1c747,Kliniken Essen Mitte,kliniken_essen_mitte,,,,,, -6693,,61a140e0-3b14-4f8b-af92-e6559e4a842b,The John Hopkins University,the_john_hopkins_university,,,,,, -6694,,f99fb711-2fd3-4486-bd0d-e7a47e0c23aa,Moberg Derma AB,moberg_derma_ab,,,,,, -6695,,306061d7-9e9a-400b-a614-78d58c605946,"Bellicum Pharmaceuticals, Inc",bellicum_pharmaceuticals_inc,,,,,, -40,0.98917752504348755,7c9cf661-e45e-442f-8b26-67d651e2722d,"Procter & Gamble Technical Centres Ltd., UK",procter_gamble_technical_centres_ltd_uk,,,,7852b0e6-2f36-4ee0-90a6-404e745340b5,procter_gamble_technical_centres_ltd,Procter & Gamble Technical Centres Ltd -6696,,82c67ac8-b58c-44f3-8e33-5803b02d3067,CSL BEHRING S.P.A,csl_behring_s_p_a,,,,,, -6697,,2a7a8b84-d3ad-4076-8c5c-06f2f6361ba5,AMERSHAM HEALTH,amersham_health,,,,,, -6698,,820a8edd-df37-496a-a104-f0834d792fc6,ASOCIACIÓN GALLEGA DE ENFERMEDAD INFLAMATORIA INTESTITAL (E.I.G.A.),asociaci_n_gallega_de_enfermedad_inflamatoria_intestital_e_i_g_a,,,,,, -6699,,d56713e5-161d-49e0-8af9-3f38aba26fc1,Centre Hospitalier de Nancy,centre_hospitalier_de_nancy,,,,,, -6700,,38003542-37b8-4db5-9b2e-4cac6a9d1ff6,GRUPO ESPAÑOL MULTICISPLINAR DE MELANOMA,grupo_espa_ol_multicisplinar_de_melanoma,,,,,, -1040,0.97674435377120972,92791194-a8b3-428a-9d15-cc0e3d01b15a,Celgene International Sarl,celgene_international_sarl,,,,2296dd74-6817-4f30-819d-48b0af75055c,celgene_international_s_rl,Celgene International Sàrl -6701,,5cd9e6da-d469-4272-b872-4606cf30eb14,Conatus Pharmaceuticals Inc,conatus_pharmaceuticals_inc,,,,,, -6702,,768a0344-7276-11e6-a0cd-0242ac12000b,SUCAMPO PHARMA LLC,sucampo_pharma_llc,,,,,, -6703,,ff12aaa9-8393-412a-8fb7-f1d4615ad870,NKI/Antoni van Leeuwenhoek Ziekenhuis,nki_antoni_van_leeuwenhoek_ziekenhuis,,,,,, -6704,,a9f6757c-ce2f-42d5-91c3-e9047d7baad4,Fundación Española de Esclerosis Múltiple (FEDEM),fundaci_n_espa_ola_de_esclerosis_m_ltiple_fedem,,,,,, -6705,,f702a3d8-4cd8-40c1-8467-81db2aabf52f,Danmarks Farmaceutiske Universitet,danmarks_farmaceutiske_universitet,,,,,, -6706,,3c3e49c8-7165-11e6-a0cd-0242ac12000b,JAI PHARMA LTD,jai_pharma_ltd,,,,,, -6707,,af0b34fa-cdb2-4246-81a1-18a357165472,University Medical Center of Groningen,university_medical_center_of_groningen,,,,,, -6708,,039496d6-c5c9-4653-a93c-fb35a8ada18d,IBD Center LMU Munich,ibd_center_lmu_munich,,,,,, -6709,,731e28eb-1645-4031-8c53-c6e4ef823481,"Transplantationscntrum, Sahlgrenska Universitetssjukhuset",transplantationscntrum_sahlgrenska_universitetssjukhuset,,,,,, -6710,,ff6f5ec7-b025-499e-bc66-290349c94abf,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research &, Development,,,,,, -6711,,456dab76-8bd5-11e6-a449-0242ac12000b,"Dept. of Cardiothoracic & Vascular Surgery, Aarhus University Hospital, Skejby",dept_of_cardiothoracic_vascular_surgery_aarhus_university_hospital_skejby,,,,,, -6712,,90e73c64-2949-40a8-95d8-078dd85b470a,Laboratorios Servier S.L,laboratorios_servier_s_l,,,,,, -6713,,5d609149-5484-4073-990f-67fa474ae157,Universitätsklinikum Würzburg,universit_tsklinikum_w_rzburg,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_amp_development,,,,, -6714,,3d372208-7167-11e6-a0cd-0242ac12000b,ESSENTIAL ISOTOPES,essential_isotopes,,,,,, -696,0.987337,221108ee-7307-42f8-832d-e148617d109a,Banc de Sang i Teixits,banc_de_sang_i_teixits,,,,221108ee-7307-42f8-832d-e148617d109a,banc_de_sang_i_teixits,Banc de Sang i Teixits -6715,,5476d014-7129-11e6-a89e-0242ac12000b,ALLERGAN SALES LLC,allergan_sales_llc,,,,,, -6716,,d0660b6e-6c26-4efc-a497-5070ce42ed3d,"Section for Transfusion Medicine, Capitol Region Blood Bank",section_for_transfusion_medicine_capitol_region_blood_bank,,,,,, -6717,,d2277a8a-4cb0-4f6e-962a-d0b6e16aabb9,Daniel Schmidt,daniel_schmidt,,,,,, -6718,,58384182-25d9-414e-8817-b3450bdd9f86,University Hospital Erlangen,university_hospital_erlangen,,,,,, -6719,,69041762-905c-4c6c-af4e-d2f7babb9234,"Christel B. Lajer, Dep. of Otolaryngology head and neck surgery, Rigshospitalet",christel_b_lajer_dep_of_otolaryngology_head_and_neck_surgery_rigshospitalet,,,,,, -6720,,429142ac-c82e-4b72-8727-65946c6b5ec8,ApoPharma Incorporated,apopharma_incorporated,,,,,, -6721,,a0380f84-ee0a-46e8-9eaa-266541414b79,Hospital Universitario Vall D'Hebron. Departamento de Medicina Interna,hospital_universitario_vall_d_hebron_departamento_de_medicina_interna,,,,,, -6722,,04081ba9-6391-4bba-8c2d-0d84bfad3a99,Strekin AG,strekin_ag,,,,,, -6723,,d5e31621-716b-4d42-9b1c-8927c8d30a64,Lars Søndergaard,lars_s_ndergaard,,,,,, -6724,,5098d244-716a-11e6-a0cd-0242ac12000b,ORTHO BIOTECH,ortho_biotech,,,,,, -317,0.985423,ab7dfa68-7165-11e6-a0cd-0242ac12000b,X-GEN PHARMS INC,x_gen_pharms_inc,,,,ab7dfa68-7165-11e6-a0cd-0242ac12000b,x_gen_pharms_inc,X-GEN PHARMS INC -598,0.98780262470245361,a17f5ff7-bbd9-42b0-8762-aa32b21f61e3,University College London,university_college_london,,,,112df4bf-757e-4212-a536-a3908a697c4b,university_college_london_ucl,University College London (UCL) -155,0.982232,32da3906-4bb3-4220-b809-a95a116fec70,Department of Rheumatology,department_of_rheumatology,,,,0f7ff838-13c3-4637-91f3-73d90e40ccf4,department_of_rheumatology_university_hospital_lund,"Department of Rheumatology,University hospital,Lund" -6725,,93be9132-7b4a-4460-b230-ef2dd36d5f9d,CENTRE LEON BERARD,centre_leon_berard,,,,,, -6726,,69694d30-cced-4380-acf2-145a79b8fa7b,"Department of Neurology, Roskilde Hospital",department_of_neurology_roskilde_hospital,,,,,, -6727,,e6e77279-6432-48ce-bb8c-be947b21be22,Estonian Science Foundation,estonian_science_foundation,,,,,, -6728,,ec52f114-5282-477c-a4df-1e1df9382925,Consorci Mar Parc de Parc de Salut de Barcelona (Parc de Salut MAR),consorci_mar_parc_de_parc_de_salut_de_barcelona_parc_de_salut_mar,,,,,, -6729,,3eec4b51-44df-4c0c-b07d-5c4e83dfb544,sterna biologicals GmbH & Co. KG,sterna_biologicals_gmbh_co_kg,,,,,, -6730,,411197a3-3ddf-4076-891a-f64aff0ba10e,Havenziekenhuis/ErasmusMC,havenziekenhuis_erasmusmc,,,,,, -6731,,0118a599-f57c-412e-b55e-71fb8a779cc7,Yeovil District Hospital,yeovil_district_hospital,,,,,, -554,0.98628848791122437,5a0d7e38-7129-11e6-a89e-0242ac12000b,VINTAGE PHARMS,vintage_pharms,,,,5a0d7e38-7129-11e6-a89e-0242ac12000b,vintage_pharms,VINTAGE PHARMS -6732,,c20a8219-cd10-465d-9c3b-e4086a5a9018,IUCPQ,iucpq,,,,,, -6733,,152ba7fe-ff95-4b48-a2de-4aa97e447923,Niuvannniemi Hospital,niuvannniemi_hospital,,,,,, -6734,,443aa692-61bd-458e-ba69-971f8344c688,Arbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH,arbeitsgemeinschaft_medikament_se_tumortherapie_gemeinn_tzige_gmbh,,,,,, -408,0.931044,a45ec509-2eb2-4db5-8022-b27de831dd06,CHU de Liège,chu_de_li_ge,,,,5af16d72-9df2-4fc9-8608-fbc9eb8e988a,chu_de_liege,CHU de Liege -6735,,a365e49f-2d26-4cd0-9f84-a94f77082d40,"Laboratorios Pfizer, Lda",laboratorios_pfizer_lda,,,,,, -6736,,1e0cbab8-3ff5-40c9-b2ac-2acf462a43c3,FUNDACIÓ PRIVADA CLINIC PER A LA RECERCA BIOMÈDICA,fundaci_privada_clinic_per_a_la_recerca_biom_dica,,,,,, -6737,,ee32f640-ed62-48d4-b239-cfda7e8e15d2,Ambria Dermatology,ambria_dermatology,,,,,, -6738,,102507d8-7aa0-455d-b743-ad6c65303406,Hospital Universitario Vall d’Hebron. Barcelona. Spain,hospital_universitario_vall_d_hebron_barcelona_spain,,,,,, -963,0.97998803853988647,65248d8e-5a22-48b5-a66d-dc1d1f751700,Helsinki University,helsinki_university,,,,65248d8e-5a22-48b5-a66d-dc1d1f751700,helsinki_university_hospital,Helsinki University Hospital -6739,,3482c8c5-1d0d-40d7-9f18-e053503db27b,Dra. Beatriz Sanchez Sobrino,dra_beatriz_sanchez_sobrino,,,,,, -6740,,f987772a-cbbe-4c89-84c0-3f9963c3505c,GlaxoSmithKlineResearch & Developemnt Ltd,glaxosmithklineresearch_developemnt_ltd,,,,,, -6741,,d5937e6b-4932-47dd-9d71-ecf679efe927,"Medizinische Universität Wien, Univ. Klinik für Anästhesie, Allg. Intensivmedizin u Schmerztherapie",medizinische_universit_t_wien_univ_klinik_f_r_an_sthesie_allg_intensivmedizin_u_schmerztherapie,,,,,, -6742,,01553610-f2db-4dd4-94e6-4c215f8cc225,DUTCH BELGIAN COOPERATIVE GROUP FOR HEMATOLOGY ONCOLOGY - HOVON,dutch_belgian_cooperative_group_for_hematology_oncology_hovon,,,,,, -6743,,ca0fe8b7-a640-4456-89d6-48a3bc848594,"Department of Cardiology, Rigshospitalet",department_of_cardiology_rigshospitalet,,,,,, -6744,,5a10c43b-a005-4a19-9b26-d2f2222dba94,Laboratoire Kreussler Pharma,laboratoire_kreussler_pharma,,,,,, -6745,,ac3b301c-6eab-40a8-999d-ff305e999e0e,"Novartis Nordic Countries, Business Unit Transplantation",novartis_nordic_countries_business_unit_transplantation,,,,,, -995,0.98229312896728516,3f41d035-5505-424a-9eba-1d3001157ba6,GE Healthcare Limited,ge_healthcare_limited,,,,3f41d035-5505-424a-9eba-1d3001157ba6,ge_healthcare_limited,GE Healthcare Limited -6746,,5a1f3867-be65-4bfb-bc74-f2c4d45eee3c,"Med. Univ. Wien, Universitätsklinik für Kinder- und Jugendheilkunde",med_univ_wien_universit_tsklinik_f_r_kinder_und_jugendheilkunde,,,,,, -6747,,daeb7a68-25f6-4772-92ab-6ced3ab276c0,University of Cambridge,university_of_cambridge,,,,,, -170,0.98542284965515137,6b07fdf4-4955-45ab-999a-be365a194900,Merck Serono Ltd,merck_serono_ltd,,,,6b07fdf4-4955-45ab-999a-be365a194900,merck_serono_ltd,Merck Serono Ltd -6748,,49070c1f-2c42-417e-9c5e-585cfc553d30,"Wyeth Pharmaceuticals, a Pfizer Company",wyeth_pharmaceuticals_a_pfizer_company,,,,,, -726,0.987967,81a28eac-2d1e-4864-ac25-63a4b019a446,Steno Diabetes Center A/S,steno_diabetes_center_a_s,,,,1b7f80c2-b4fd-41cd-875f-9db8a4bf35a2,steno_diabetes_center,Steno Diabetes Center -6749,,73b66dcd-a7cc-11e6-94cb-5656d04fc2b5,Region Ostergotland,region_ostergotland,,,,,, -6750,,41ed1dec-9a49-42f9-bb9a-15d3e18b028f,Fundacio Privada Clinic per a la Recerca Biomedica,fundacio_privada_clinic_per_a_la_recerca_biomedica,,,,,, -6751,,595656b9-71a6-4eea-8602-b0af1383b13b,KRKA-FARMA d. o. o,krka_farma_d_o_o,,,,,, -970,0.987506,8781fe28-c7b9-4fda-8f96-3fa77012de6c,Academic Medical Centre (AMC),academic_medical_centre_amc,,,,2899c14b-e123-4b6f-9261-bca58e778c63,academic_medical_centre,Academic Medical Centre -6752,,56a3ee52-51fe-4d80-b187-43f0f51c7b83,ACTELION PHARMACEUTICALS ITALIA,actelion_pharmaceuticals_italia,,,,,, -578,0.97902655601501465,3b0c06b0-85fa-4afa-9e00-53d2e010c8e4,"Wyeth Pharmaceuticals, Inc. Acting through its devision Wyeth Research, a Pfizer Company",wyeth_pharmaceuticals_inc_acting_through_its_devision_wyeth_research_a_pfizer_company,,,,724d1bdc-e54a-4c73-b212-98071e708ad2,wyeth_pharmaceuticals_inc_acting_through_its_division_wyeth_research_a_pfizer_company,"Wyeth Pharmaceuticals Inc. Acting through its division Wyeth Research, a Pfizer Company" -6753,,c4cc404c-b06d-4fec-a661-abed3dc02695,Istituto Clinico Humanitas - Humanitas Cancer Center,istituto_clinico_humanitas_humanitas_cancer_center,,,,,, -6754,,63a5d215-372c-4e85-a8d4-5b5a7b7390ed,Volution Immuno Pharmaceuticals (UK) Ltd,volution_immuno_pharmaceuticals_uk_ltd,,,,,, -6755,,ff976832-fd16-43c6-bf0d-8d6175ce7770,ONCOSUR,oncosur,,,,,, -6756,,0ee1a230-73f0-11e6-a0cd-0242ac12000b,"WYNN L MADER, INDUSTRIAL GAS DISTRIBUTORS",wynn_l_mader_industrial_gas_distributors,,,,,, -6757,,dda25f51-edce-4ecd-8533-1410004e6dc4,Evotec NeurosciencesGmbH,evotec_neurosciencesgmbh,,,,,, -595,0.985826,6548489f-2430-4636-90c0-4f63a9939b5c,Erasmus Medical Centre,erasmus_medical_centre,,,,6548489f-2430-4636-90c0-4f63a9939b5c,erasmus_medical_centre,Erasmus Medical Centre -6758,,7af8a91b-f608-4e0f-a27c-d133ca544d30,Fundación para la Investigación en Enfermedades del Aparato Digestivo,fundaci_n_para_la_investigaci_n_en_enfermedades_del_aparato_digestivo,,,,,, -6759,,fabe3355-6dd8-4332-af71-06d029154855,Pulmonary Research Institute GmbH an der Asklepiosklinik Barmbek. Niederlassung Hamburg,pulmonary_research_institute_gmbh_an_der_asklepiosklinik_barmbek_niederlassung_hamburg,,,,,, -6760,,0f85e531-8ba1-4b33-8ac0-febe37dd3201,Peer Tfelt-Hansen,peer_tfelt_hansen,,,,,, -6761,,20ea2182-6923-4095-b9ec-048807ecd693,Firma Dr. F. Köhler Chemie GmbH,firma_dr_f_k_hler_chemie_gmbh,,,,,, -150,0.919718,b3733316-ccdd-4aab-ad57-807a9a476ca0,Universitätsmedizin Göttingen,universit_tsmedizin_g_ttingen,,,,b3733316-ccdd-4aab-ad57-807a9a476ca0,universit_tsmedizin_g_ttingen,Universitätsmedizin Göttingen -6762,,815f4ae4-8bc7-11e6-a449-0242ac12000b,"Anæstesiklinikken, Frederiksberg Hospital",an_stesiklinikken_frederiksberg_hospital,,,,,, -1006,0.9811970591545105,b2f9f536-edf3-40a9-ad29-80751e7a2239,Folktandvården,folktandv_rden,,,,76940d77-7350-4137-8034-dc7c3c7289ad,folktandv_rden_sterg_tland,Folktandvården Östergötland -304,0.953319,8700379b-5f4a-4dc7-82aa-ea7910222ff1,"Medical University Graz, Department for Plastic Surgery",medical_university_graz_department_for_plastic_surgery,,,,8700379b-5f4a-4dc7-82aa-ea7910222ff1,medical_university_graz_department_for_plastic_surgery,"Medical University Graz, Department for Plastic Surgery" -6763,,22537761-9db1-42ef-a636-7bee9447f40b,Hospital of South West Jutland,hospital_of_south_west_jutland,,,,,, -6764,,3a5f5ce2-9a13-4922-8e10-75279bd98759,Foot and Ankle Surgical center,foot_and_ankle_surgical_center,,,,,, -187,0.983343,9b7df138-7145-11e6-a0cd-0242ac12000b,PAR PHARM INC,par_pharm_inc,,,,9b7df138-7145-11e6-a0cd-0242ac12000b,par_pharm_inc,PAR PHARM INC -6765,,7b551f72-6537-49a7-9c39-687533fe737b,"Stryker Biotech, LLC",stryker_biotech_llc,,,,,, -6766,,51b98af7-2edc-4846-95f2-064293ec6da2,Ferring Arzneimittel GmbH,ferring_arzneimittel_gmbh,,,,,, -6767,,a3e86f77-ff98-4cf6-a544-dbce7123f78b,"Medizinische Universität Wien, Abteilung für Anästhesie und allgemeine Intensivmedizin",medizinische_universit_t_wien_abteilung_f_r_an_sthesie_und_allgemeine_intensivmedizin,,,,,, -6768,,e1c37185-e42f-4dff-8773-e47fb45203cc,Dr. Miguel Cervero,dr_miguel_cervero,,,,,, -6769,,c46e737d-1316-4e76-a389-cca7620adfe3,Promethera Biosciences,promethera_biosciences,,,,,, -6770,,6de0c6cb-924f-4fc4-a346-fc20330aa6e1,"BioNumerik Pharmaceuticals, Inc",bionumerik_pharmaceuticals_inc,,,,,, -6771,,da4e3d78-d513-41c2-afe1-83d507dce3bc,University Hospital Southampton NHS Foundation Trust,university_hospital_southampton_nhs_foundation_trust,,,,,, -6772,,f1eeb85e-8be9-11e6-a449-0242ac12000b,"Univerzita Karlova v Praze, 2. lékařská fakulta",univerzita_karlova_v_praze_2_l_ka_sk_fakulta,,,,,, -6773,,11d03ee9-874f-499f-ba9e-9908cbfbeaaa,Arno Therapeutics Inc,arno_therapeutics_inc,,,,,, -6774,,34777b0c-8d4b-47ce-8868-9378e684dbed,JUAN IGNACIO ARENAS RUIZ-TAPIADOR,juan_ignacio_arenas_ruiz_tapiador,,,,,, -609,0.920179,7ccdbeba-54a9-43ed-8e5c-58592f516aa3,Department of Pharmacy Universitaetsmedizin Mainz,department_of_pharmacy_universitaetsmedizin_mainz,,,,7ccdbeba-54a9-43ed-8e5c-58592f516aa3,department_of_pharmacy_universitaetsmedizin_mainz,Department of Pharmacy Universitaetsmedizin Mainz -6775,,95e77da3-94b1-4ccf-aa5a-3e51720bcc00,Menarini Ricerche S.p.A,menarini_ricerche_s_p_a,,,,,, -6776,,77e80479-1438-4a2d-8ca7-4c4ca41cc012,Knappschaftskrankenhaus Bochum,knappschaftskrankenhaus_bochum,,,,,, -425,0.96910750865936279,fff5c38e-aabc-4262-ba50-28cd20898d02,HOVON CLL Group,hovon_cll_group,,,,a89061fe-7d3c-47c4-acdc-5ea8273f45e8,hovon,HOVON -6777,,932dc323-e807-4979-86ed-fce9cd9d2383,Björn Holmberg,bj_rn_holmberg,,,,,, -6778,,f221f154-5a41-4ba4-a5c2-c27ee0ec287c,Merrimack Pharmaceuticals Inc,merrimack_pharmaceuticals_inc,,,,,, -714,0.985233,0354c2c2-7129-11e6-a89e-0242ac12000b,EUROHLTH INTL SARL,eurohlth_intl_sarl,,,,0354c2c2-7129-11e6-a89e-0242ac12000b,eurohlth_intl_sarl,EUROHLTH INTL SARL -6779,,2f7e5c06-8816-11e6-a998-0242ac12000b,"Hana Biosciences, Inc",hana_biosciences_inc,,,,,, -6780,,c1a7a10c-1f94-4457-b5c8-403de04af934,"Neuromuscular Research Unit, Copenhagen University Hospital Rigshopspitalet",neuromuscular_research_unit_copenhagen_university_hospital_rigshopspitalet,,,,,, -6781,,7f54ee9e-55f0-4563-9072-f47cd32920d9,Aventis Pharma Deutschland GmbH,aventis_pharma_deutschland_gmbh,,,,,, -6782,,502fb8c4-59f0-47bc-a1b3-5fc9f1c58797,NEAT-ID,neat_id,,,,,, -6783,,e7273471-1761-4226-9450-830f2d3c69bf,nabi biopharmaceuticals,nabi_biopharmaceuticals,,,,,, -17,0.985533,da80fecf-b532-4a56-8c0a-c95702dc2907,"German Heart Centre Munich, Department of",german_heart_centre_munich_department_of,,,,c63a0355-3210-4a0d-9c79-6e414a13ec40,german_heart_centre_munich_department_of_cardiovascular_diseases,"German Heart Centre Munich, Department of Cardiovascular Diseases" -6784,,5b634114-7142-11e6-a0cd-0242ac12000b,VALEANT LUXEMBOURG,valeant_luxembourg,,,,,, -6785,,97b929db-d826-4ed4-9507-faf0704b56ad,RIB-X THERAPEUTICS LIMITED,rib_x_therapeutics_limited,,,,,, -6786,,64c9f687-fd2a-4dda-8484-97e78d0d1bc6,James Cook University Hospital,james_cook_university_hospital,,,,,, -6787,,e0e0d46e-72ff-11e6-a0cd-0242ac12000b,CPPI CV,cppi_cv,,,,,, -6788,,94e5efbf-7b81-45c0-bfe1-19f8b40d4d67,"Kennemer Gasthuis, afdeling maag-, darm-, leverziekten",kennemer_gasthuis_afdeling_maag_darm_leverziekten,,,,,, -6789,,d03ba1fd-e79c-4d2c-8150-eb0368dbd28a,Grupo Gallego de Investigación en Tumores ,Digestivos - GITuD,,,,,, -6790,,d2d31f06-04d7-46ba-81c5-450815064f5b,KA Rudolfstiftung - 2. Medizinische Abteilung,ka_rudolfstiftung_2_medizinische_abteilung,,,,,, -6791,,846e82d4-5253-400e-a272-f04262976032,Área de Trasplante y Terapia Celular - Hospital Central de Asturias,rea_de_trasplante_y_terapia_celular_hospital_central_de_asturias,,,,,, -6792,,3501e261-9a8c-40c7-af15-53bf7b8a0653,UNIVERSITA' DEGLI STUDI DI PERUGIA,universita_degli_studi_di_perugia,grupo_gallego_de_investigaci_n_en_tumores_digestivos_gitud,,,,, -6793,,72ed95cc-60fa-4289-a634-577fd13a2eab,Amgen Research (Munich) GmbH,amgen_research_munich_gmbh,,,,,, -6794,,17e66346-cd7d-401c-93a5-62336595c32b,Med. Klinik / Kardiologie der Med. Fakultät Carl Gustav Carus an der Technischen Unversität Dresden,med_klinik_kardiologie_der_med_fakult_t_carl_gustav_carus_an_der_technischen_unversit_t_dresden,,,,,, -6795,,36799654-2212-49d6-8333-68f45e9f67e4,Charitè Universitätmeditin Berlin,charit_universit_tmeditin_berlin,,,,,, -785,0.9885413646697998,afc09a30-3b4a-4041-9919-78df2cc5e391,Medizinische Hochschule Hannover (MHH),medizinische_hochschule_hannover_mhh,,,,a896ae02-0ec3-47cc-8072-7cf79e6d3551,medizinische_hochschule_hannover,Medizinische Hochschule Hannover -6796,,2e33910b-6bd6-47e7-8f48-c6cf9347c82f,Hospital Universitari de Girona Dr. Josep Trueta,hospital_universitari_de_girona_dr_josep_trueta,,,,,, -6797,,c8009921-4e7f-4548-b907-f9fcd34f75a7,Servicio de Digetivo del Hospital Valle Hebrón del Instituto Catalán de Salud. NIF Q5855029D,servicio_de_digetivo_del_hospital_valle_hebr_n_del_instituto_catal_n_de_salud_nif_q5855029d,,,,,, -6798,,aa2fad91-2f6f-46ff-af39-6c1eab30218d,QUADRAMED,quadramed,,,,,, -6799,,46f8525a-e6fc-4495-b946-32a7e0608d81,Roche Austria GmbH,roche_austria_gmbh,,,,,, -6800,,593b8042-741b-4496-8b28-3d4bd2f950c9,Actelion Registration Ltd,actelion_registration_ltd,,,,,, -496,0.98474764823913574,5c05fa95-0c90-4777-be79-ea6ecfc023ea,"Martin-Luther-Universität Halle-Wittenberg, vertreten durch den Kanzler",martin_luther_universit_t_halle_wittenberg_vertreten_durch_den_kanzler,,,,5c05fa95-0c90-4777-be79-ea6ecfc023ea,martin_luther_universit_t_halle_wittenberg_vertreten_durch_den_kanzler,"Martin-Luther-Universität Halle-Wittenberg, vertreten durch den Kanzler" -6801,,c3dd4e66-3816-4f37-b374-fff7ebaa6db6,Associação para Desenvolvimento da Dermatologia do Hospital de Santa Maria,associa_o_para_desenvolvimento_da_dermatologia_do_hospital_de_santa_maria,,,,,, -6802,,58e9e60c-59ef-4a1b-88b6-4e2ba90c3fd0,University Cologne,university_cologne,,,,,, -786,0.98430114984512329,ae486c69-258b-44cb-b1df-a166ffd46985,Intercell,intercell,,,,36d7c90b-a751-4f8d-8ad8-5535b85ebea2,intercell_ag,Intercell AG -6803,,8c09e964-d566-44c2-9d41-a526d1fdc4fb,Xention Limited,xention_limited,,,,,, -6804,,aa6532c1-3ef1-460f-988a-81c85916e0b4,M's Science Corporation,m_s_science_corporation,,,,,, -6805,,c07bbca0-3d27-4ae2-a41f-2c2de08122fe,Larime company of the Mediscis group,larime_company_of_the_mediscis_group,,,,,, -887,0.97905653715133667,44b33ab6-d74e-4fa5-aa8c-510964a3ac9f,Schering-Plough Research Institute,schering_plough_research_institute,,,,44b33ab6-d74e-4fa5-aa8c-510964a3ac9f,schering_plough_research_institute,Schering-Plough Research Institute -446,0.96705156564712524,d503d81e-b381-4df8-afc1-0e37f91ed710,Royal Brompton and Harefield NHS Trsut,royal_brompton_and_harefield_nhs_trsut,,,,d503d81e-b381-4df8-afc1-0e37f91ed710,royal_brompton_and_harefield_nhs_trsut,Royal Brompton and Harefield NHS Trsut -6806,,6600055a-7195-11e6-a0cd-0242ac12000b,JANSSEN R AND D,janssen_r_and_d,,,,,, -6807,,ef1f41c7-5e20-4687-965d-109e0f5bd6a9,"Univ of Lund, Dept of Pediatrics",univ_of_lund_dept_of_pediatrics,,,,,, -6808,,28e2c773-800f-418c-98f5-f064721ba8f1,"Medizinische Universität Innsbruck, Innere Medizin I",medizinische_universit_t_innsbruck_innere_medizin_i,,,,,, -6809,,16f70329-dafd-4428-bec6-483f539f52fc,Hull and East Yorkshire NHS Hospital Trust,hull_and_east_yorkshire_nhs_hospital_trust,,,,,, -6810,,cdd169b2-ecef-44aa-8993-0152f82b496b,GlobiFer International bvba,globifer_international_bvba,,,,,, -6811,,da073ce9-9d72-4211-86a3-0e3ac9fd24ae,Magle AB,magle_ab,,,,,, -311,0.94804,b1e7a97f-3f72-43f4-a8f1-ab6902f55179,VU Univeristy Medical Centre,vu_univeristy_medical_centre,,,,b1e7a97f-3f72-43f4-a8f1-ab6902f55179,vu_univeristy_medical_centre,VU Univeristy Medical Centre -279,0.97373181581497192,9eaa8840-f902-4a96-b7ae-dd6a74426316,Royal Liverpool and Broagreen University Hospitals NHS Trust,royal_liverpool_and_broagreen_university_hospitals_nhs_trust,,,,7fdce817-2c7a-48bf-9fea-ccc1bb736300,royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,Royal Liverpool and Broadgreen University Hospitals NHS Trust -6812,,9d9dbc49-a4d1-4b22-bee3-fe92f760e26a,Praxis Prof. Koenig,praxis_prof_koenig,,,,,, -6813,,53757671-32f1-4b75-9fb9-b140f3b44abf,INSTITUT CURIE,institut_curie,,,,,, -947,0.98283,9d41c520-5775-47af-8ab9-46394267d759,Hospital Clínic-Maternitat,hospital_cl_nic_maternitat,,,,3d9cc66f-e29e-4146-9f7e-6baf8b6a7b2e,hospital_cl_nic,Hospital Clínic -6814,,faddcfb2-73bc-11e6-a0cd-0242ac12000b,HANMI PHARM CO LTD,hanmi_pharm_co_ltd,,,,,, -6815,,4d2378fa-8629-48df-88b9-8b4a26bbfcd5,"Laguna Pharmaceuticals, Inc",laguna_pharmaceuticals_inc,,,,,, -6816,,6e29d46e-fef6-4308-b00f-34243d2810ee,Fidia Farmaceutici SpA,fidia_farmaceutici_spa,,,,,, -6817,,d0ccef3c-2f56-4eb0-bfb8-deb749eaf167,GEICAM (Spanish Breast Cancer Research Group Foundation),geicam_spanish_breast_cancer_research_group_foundation,,,,,, -6818,,f52d8b16-8bc7-11e6-a449-0242ac12000b,"Medical Research Laboratory, Clinical institute of Medicine, Aarhus University Hospital",medical_research_laboratory_clinical_institute_of_medicine_aarhus_university_hospital,,,,,, -6819,,9e375d2d-5d9f-426a-b8b3-043fa784ddb3,University Hospital of Grenoble,university_hospital_of_grenoble,,,,,, -944,0.98510605096817017,bc3fb171-d422-4044-ae7a-9a9bc31f9e22,Georg-August-Universität Göttingen,georg_august_universit_t_g_ttingen,,,,bc3fb171-d422-4044-ae7a-9a9bc31f9e22,georg_august_universit_t_g_ttingen,Georg-August-Universität Göttingen -781,0.92631208896636963,61b142b2-df48-40f9-8b9c-29a48d372da8,GlaxoSmithKline Research & Development,glaxosmithkline_research_development,,,,201d9d4f-5cd0-46df-836e-da17fa2b43dd,glaxosmithkline_research_and_development,GlaxoSmithKline Research and Development -6820,,f0f09e8e-881c-11e6-a998-0242ac12000b,Pfizer Denmark,pfizer_denmark,,,,,, -6821,,35a0fa09-9bad-42d3-a2cd-cf832e39d7af,Associazione Progetto Oncologia UMAN.A,associazione_progetto_oncologia_uman_a,,,,,, -6822,,816bb5af-4c95-4bc2-a69a-45eb7291bf8c,Biologische Heilmittel Heel GmbH,biologische_heilmittel_heel_gmbh,,,,,, -6823,,67b87bdf-dff1-44a1-8916-dd205bbc39a5,Research in Real-Life Ltd,research_in_real_life_ltd,,,,,, -6824,,0478eefc-7314-11e6-a0cd-0242ac12000b,VERTICAL PHARMS LLC,vertical_pharms_llc,,,,,, -28,0.98589098453521729,9bf0ded2-498f-41e8-a33e-f8ef449d3812,University Hospital Birmingham NHS Foundation,university_hospital_birmingham_nhs_foundation,,,,74cf9045-4511-4c50-8cd0-de621c838ff2,university_hospital_birmingham,University Hospital Birmingham -48,0.979231,ad79d699-2379-4397-bd1d-3bc4a90f3635,Fresenius Kabi,fresenius_kabi,,,,ad79d699-2379-4397-bd1d-3bc4a90f3635,fresenius_kabi,Fresenius Kabi -6825,,dd3b101e-8506-4344-b7e1-21a2434d9ea3,"Ortopædkirurgisk Afd. E, Århus Universitetshospital",ortop_dkirurgisk_afd_e_rhus_universitetshospital,,,,,, -6826,,17199a4d-9847-4e64-8b14-1bf7e17ed6f1,Städtisches Klinikum München GmbH,st_dtisches_klinikum_m_nchen_gmbh,,,,,, -6827,,8da56adc-7389-11e6-a0cd-0242ac12000b,STIEFEL,stiefel,,,,,, -6828,,7480b8df-8923-494b-a531-a72be9f31601,BioMarin Pharmaceutical Inc,biomarin_pharmaceutical_inc,,,,,, -342,0.97989612817764282,c7660ab0-005c-4f36-ae8c-13deb3b21748,AIR LIQUIDE,air_liquide,,,,748853e0-73f0-11e6-a0cd-0242ac12000b,air_liquide_america_lp,AIR LIQUIDE AMERICA LP -6829,,85fdaeca-7168-11e6-a0cd-0242ac12000b,POLYGEN PHARMS,polygen_pharms,,,,,, -6830,,2a879f61-a737-11e6-94cb-5656d04fc2b5,Department of Medical Gastroenterology,department_of_medical_gastroenterology,,,,,, -6831,,558bc19c-7194-11e6-a0cd-0242ac12000b,ROERIG,roerig,,,,,, -6832,,e418c9f0-c55e-41f8-8cf0-ef5bd76e9a82,Per Rosenberg,per_rosenberg,,,,,, -6833,,5d863e50-4af8-4114-8977-0b31f9da055a,Acedemic Medical Centre Amsterdam,acedemic_medical_centre_amsterdam,,,,,, -6834,,7d79a774-2966-45ce-8f7d-f1c00a445225,Pfizer Consumer Healthcare cva/sca,pfizer_consumer_healthcare_cva_sca,,,,,, -6835,,278f59cc-c3da-4764-91cd-18af23e7f527,SANOFI-AVENTIS OTC,sanofi_aventis_otc,,,,,, -6836,,b29d8b1d-08de-401a-827f-c629da20682b,Novo Nordisk Ltd,novo_nordisk_ltd,,,,,, -6837,,df357e04-5f43-44e7-b1f1-c83aba71f01f,"Astex Pharmaceuticals, Inc",astex_pharmaceuticals_inc,,,,,, -6838,,c4af9586-2a49-4537-9356-4523f846377f,"Department of Oncology, Haukeland University Hospital",department_of_oncology_haukeland_university_hospital,,,,,, -6839,,008ef416-7f61-4504-9005-b053d9279d63,NHS Greater Glasgow & Clyde Hospitals & University of Glasgow,nhs_greater_glasgow_clyde_hospitals_university_of_glasgow,,,,,, -6840,,d74759fa-0c9d-4f05-a4d9-58a645c0ea80,UNIVERSITÄTSKLINIKUM DER MEDIZINISCHEN FAKULTÄT FREIBURG,universit_tsklinikum_der_medizinischen_fakult_t_freiburg,,,,,, -6841,,f46c383a-f5ba-4c69-8eb4-843fb02fa6c9,OSPEDALE FATEBENEFRATELLI E OFTALMICO DI MILANO,ospedale_fatebenefratelli_e_oftalmico_di_milano,,,,,, -6842,,ec2f3601-830d-4cb1-9fe3-8f07b038fc3f,CHU-ULg,chu_ulg,,,,,, -291,0.978606,4d5cf9e6-6dd7-40a5-a084-d00ec1569bcb,GEICAM (GRUPO ESPAÑOL DE INVESTIGACION EN CANCER DE MAMA),geicam_grupo_espa_ol_de_investigacion_en_cancer_de_mama,,,,320e8407-98ad-450a-9b12-470d02f981e1,geicam_grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama,GEICAM (GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA) -6843,,28706a14-73f1-11e6-a0cd-0242ac12000b,AIRGAS MERCHANTS GASES LLC,airgas_merchants_gases_llc,,,,,, -6844,,9eb2f016-ad1b-4856-96fe-b1092883a115,"ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE ""G. PASCALE",istituto_nazionale_per_lo_studio_e_la_cura_dei_tumori_fondazione_g_pascale,,,,,, -6845,,d40b9b08-03fb-4cdc-8fab-e3f4ebc5b421,LABORATORI BALDACCI SPA,laboratori_baldacci_spa,,,,,, -6846,,328cf174-7190-11e6-a0cd-0242ac12000b,US PHARM HOLDINGS,us_pharm_holdings,,,,,, -710,0.98913925886154175,a117fcf6-2e5e-4345-9871-80e2d58cc89a,Reckitt Benckiser Pharmaceuticals,reckitt_benckiser_pharmaceuticals,,,,4c8adf00-5f9a-4177-9cd5-a40768a4ee60,reckitt_benckiser_pharmaceuticals_inc,Reckitt Benckiser Pharmaceuticals Inc -6847,,6f32372c-df0a-4be0-a836-e153db746ee0,FONDAZIONE DON CARLO GNOCCHI ONLUS,fondazione_don_carlo_gnocchi_onlus,,,,,, -6848,,cb7f21dc-cf52-45f7-9a1b-a04128171420,Alchemia Oncology Pty Ltd,alchemia_oncology_pty_ltd,,,,,, -6849,,772a54d3-915f-43ce-997c-df76a5cedcde,Dr. Miguel Martín,dr_miguel_mart_n,,,,,, -6850,,a8855b43-437d-42d5-9975-07c28c63f590,Respitatory and Allergy Research Unit,respitatory_and_allergy_research_unit,,,,,, -6851,,da1933cd-5e2f-4ae2-ace7-a573f2e6e12b,Medizinische Universität Innsbruck / Univ.-Klinik für Allgemeine und Chirurgische Intensivmedizin,medizinische_universit_t_innsbruck_univ_klinik_f_r_allgemeine_und_chirurgische_intensivmedizin,,,,,, -6852,,6d53c738-29ea-4d75-8661-73df9ee689f4,"Klinisk Farmakologisk Afdeling, Bispebjerg",klinisk_farmakologisk_afdeling_bispebjerg,,,,,, -953,0.97483021020889282,b19844c2-0641-440f-b8c1-ecb7a2484a06,MYLAN GmbH,mylan_gmbh,,,,7366e944-7126-11e6-8a77-0242ac12000b,mylan,MYLAN -6853,,d368cfa4-a1e3-40a3-b42b-21104557c874,ALLEGRIA onlus,allegria_onlus,,,,,, -6854,,7fa7bb9e-a90f-4265-821c-1f82198ee64d,Fundación Renal Iñigo Álvarez de Toledo,fundaci_n_renal_i_igo_lvarez_de_toledo,,,,,, -6855,,cfbcd01c-3790-4ffb-b7db-9faea1bea908,Stiftung Institut für Herzinfarktforschung,stiftung_institut_f_r_herzinfarktforschung,,,,,, -6856,,ad07ee51-4637-471b-82ba-2328ae730560,SEVAPHARMA a.s,sevapharma_a_s,,,,,, -645,0.98503661155700684,5b57c8bd-158c-42a5-bfa1-3323c67e0dd4,Boehringer Ingelheim Pharma GmbH,boehringer_ingelheim_pharma_gmbh,,,,5b57c8bd-158c-42a5-bfa1-3323c67e0dd4,boehringer_ingelheim_pharma_gmbh,Boehringer Ingelheim Pharma GmbH -6857,,35a7da52-1f58-4b18-89b1-3aeda93e440b,Fakultní nemocnice u sv. Anny v Brně,fakultn_nemocnice_u_sv_anny_v_brn,,,,,, -707,0.989136,b7175460-6c36-4ac7-8b9c-0166ae45766a,Grupo Español de Investigación en Cáncer de Ovario,grupo_espa_ol_de_investigaci_n_en_c_ncer_de_ovario,,,,5c77e08b-5755-407d-a8b9-74bfb0127f85,grupo_espa_ol_de_investigaci_n_en_c_ncer_de_ovario_geico,Grupo Español de Investigación en Cáncer de Ovario (GEICO) -6858,,3cfbc1dd-30e2-4137-bb24-5456fd295ee0,"Skåne University Hospital, Department of Oncology",sk_ne_university_hospital_department_of_oncology,,,,,, -6859,,20ef7316-9911-423c-a298-d5cf4307bbe3,"University Hospitals Leuven, department of pediatrics",university_hospitals_leuven_department_of_pediatrics,,,,,, -6860,,e0d389c4-23fa-413c-99d7-ee36897d56a5,"Department of Internal Medicine, University Hospital Gasthuisberg",department_of_internal_medicine_university_hospital_gasthuisberg,,,,,, -6861,,c44953f1-7353-4ecf-924b-8ea267442d25,PharmaMar S.A. Sociedad Unipersonal,pharmamar_s_a_sociedad_unipersonal,,,,,, -6862,,3a48dafd-e5b6-400f-a0aa-a13b29660736,Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR),fundaci_hospital_universitari_vall_d_hebron_institut_de_recerca_vhir,,,,,, -6863,,843c9dce-3e49-4193-8245-acf1bcc6b6a7,KORPO S.R.L,korpo_s_r_l,,,,,, -6864,,31ec4d6f-332c-4d85-8680-1127f39a5781,Dermatologikum Hamburg,dermatologikum_hamburg,,,,,, -6865,,5a7b4dea-0c5e-4c50-b7f8-ee4d737a98f4,AXCAN PHARMA Inc,axcan_pharma_inc,,,,,, -6866,,909eb53a-4e4b-4c50-b0b5-2c9c5c792f58,TRB CHEMEDICA INTERNATIONAL SA,trb_chemedica_international_sa,,,,,, -6867,,1f2ff80a-6fc0-11e6-abe8-0242ac12000b,Department of Oncology University Hospital Uppsala,department_of_oncology_university_hospital_uppsala,,,,,, -6868,,8cd190dd-43f4-4bd5-bddb-f9b62b3fb445,"VG Region, Sahlgrenska sjukhuset, Hudkliniken, Göteborg",vg_region_sahlgrenska_sjukhuset_hudkliniken_g_teborg,,,,,, -6869,,90a77e8d-6b6a-4948-9708-58e231a1996e,Diabetes-Centre Quakenbrueck,diabetes_centre_quakenbrueck,,,,,, -6870,,0327e0a7-5302-4d0d-911f-e7d1537ddec7,sanofi-aventis France,sanofi_aventis_france,,,,,, -6871,,e96690f2-715f-11e6-a0cd-0242ac12000b,PFIZER PHARMS,pfizer_pharms,,,,,, -6872,,2d2b604e-72f3-11e6-a0cd-0242ac12000b,DUCHESNAY,duchesnay,,,,,, -6873,,8aba2a6c-838a-48e8-9fad-359763810771,Sanquin Plasma Products,sanquin_plasma_products,,,,,, -6874,,07e705fe-714f-11e6-a0cd-0242ac12000b,SWAN PHARMS LLC,swan_pharms_llc,,,,,, -6875,,eca84209-69fd-4034-838b-9d9e5d6dfa17,Pierre Fabre Me'dicament,pierre_fabre_me_dicament,,,,,, -6876,,f5e1aa3b-9e23-4fd0-b5ae-a0777492a566,"Vital Therapies, Inc",vital_therapies_inc,,,,,, -6877,,5dd62f17-74bf-4bc6-8d42-0ce652195731,Proctor and Gamble Technical Centres Ltd,proctor_and_gamble_technical_centres_ltd,,,,,, -6878,,0c22b991-3c31-4a16-9512-4a04438aa5ed,"Johannes Gutenberg-Universität Mainz, Urologische Klinik (ausführende Stelle), Prof. Dr. med. Thürof",johannes_gutenberg_universit_t_mainz_urologische_klinik_ausf_hrende_stelle_prof_dr_med_th_rof,,,,,, -6879,,11f4cfe7-1797-4259-bf04-3cd1d8902e29,Sanna Vilo,sanna_vilo,,,,,, -6880,,776bff1d-f653-427e-b6aa-d780857cacd7,AZIENDA OSPEDALIERA DI PARMA,azienda_ospedaliera_di_parma,,,,,, -380,0.97214979595608186,c433cb87-9264-40ab-a126-96183cdaaee4,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., USA",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_usa,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" -387,0.973636,ca687599-182d-4009-8f97-ed0bf46b35a7,Foundation of Liver research,foundation_of_liver_research,,,,9151744a-bb73-438c-895c-dd8f508cc732,foundation_of_liver_research_slo,Foundation of Liver Research (SLO) -535,0.944741,4b00100f-06dd-4f72-b6f2-eafde94f2ed0,National Institute of Health and the Environment (Dutch acronym: RIVM),national_institute_of_health_and_the_environment_dutch_acronym_rivm,,,,2a1b4dd7-b8f2-4ab2-be0a-7f9f70d3d524,national_institute_of_health_and_the_environment_rivm,National Institute of Health and the Environment (RIVM) -6881,,4b2093de-7164-11e6-a0cd-0242ac12000b,LOTUS PHARM CO LTD,lotus_pharm_co_ltd,,,,,, -6882,,1fd12ca4-7167-11e6-a0cd-0242ac12000b,ZEVACOR PHARMA INC,zevacor_pharma_inc,,,,,, -6883,,509d5d18-8b88-423a-91bd-f334ea4ce177,"Anders Gadegaard Jensen,Anesthesia and Intensive Care Unit, Odense University Hospital",anders_gadegaard_jensen_anesthesia_and_intensive_care_unit_odense_university_hospital,,,,,, -6884,,4abb61a0-73fb-11e6-a0cd-0242ac12000b,BLUE EARTH,blue_earth,,,,,, -584,0.984184,afd27f84-72ec-11e6-a0cd-0242ac12000b,PHARMACARE LTD,pharmacare_ltd,,,,4a85fe12-965a-11e6-becf-0242ac110008,pharmacare,PHARMACARE -6885,,75b6e8ee-7305-11e6-a0cd-0242ac12000b,SHIRE DEVELOPMENT,shire_development,,,,,, -6886,,4e9ea8df-3e94-48d0-8250-2219196b04c2,Christie Hospital NHS Trust,christie_hospital_nhs_trust,,,,,, -6887,,c17b24c3-f3fb-4662-b897-8302377ed7e3,Novartis Sverige AB,novartis_sverige_ab,,,,,, -341,0.984301,c51b05f7-a4e4-43e5-9a41-6ef18a985cef,Pfizer SA,pfizer_sa,,,,669b5851-2df0-4123-b6d8-74dd0d44fb69,pfizer_sa_nv,Pfizer SA/NV -607,0.989401,dfe33f9c-fc87-4176-a56a-52c1a7a26063,Advanced Accelerator Applications,advanced_accelerator_applications,,,,dfe33f9c-fc87-4176-a56a-52c1a7a26063,advanced_accelerator_applications,Advanced Accelerator Applications -6888,,c86f9c70-6cb7-4275-aea8-8ecdd7937ec2,Pfizer Luxembourg SARL Branch Office in Lithuania,pfizer_luxembourg_sarl_branch_office_in_lithuania,,,,,, -6889,,400cabdc-1fe0-4df9-9a65-04bfd96b22dd,"MicroDose Therapeutx, Inc., a wholly owned subsidiary of Teva Pharmaceuticals Industries, Ltd",microdose_therapeutx_inc_a_wholly_owned_subsidiary_of_teva_pharmaceuticals_industries_ltd,,,,,, -6890,,963b4c0f-d041-4a8b-b25e-6843a3f231d4,"Departement of orthopaedic surgery, Århus Sygehus",departement_of_orthopaedic_surgery_rhus_sygehus,,,,,, -6891,,73e6f7e1-f535-4e20-9c53-eb570f7cb5e3,University of Michigan,university_of_michigan,,,,,, -225,0.98610919713973999,090da71e-b718-413e-ba77-0e109a22d5d5,Fertilitetsklinikken,fertilitetsklinikken,,,,090da71e-b718-413e-ba77-0e109a22d5d5,fertilitetsklinikken,Fertilitetsklinikken -6892,,a2d0dab2-ba4d-4a87-8292-2141cc000b57,Fundación MD Ánderson Internacional España,fundaci_n_md_nderson_internacional_espa_a,,,,,, -6893,,0aeecb73-8369-48d4-a06a-f27790fa88aa,"Academisch Medisch Centrum bij de Universiteit van Amsterdam (AMC) Prof. dr. M. M. Levi, Dean & Chair",academisch_medisch_centrum_bij_de_universiteit_van_amsterdam_amc_prof_dr_m_m_levi_dean_chair,,,,,, -6894,,3d6dd7f6-71a5-11e6-a0cd-0242ac12000b,MALLINCKRODT LLC,mallinckrodt_llc,,,,,, -6895,,90ef524c-7243-45c3-83d6-006bdffb7b59,Hermo Pharma Ltd,hermo_pharma_ltd,,,,,, -6896,,2ea89bac-c6b8-48ef-ad8b-ab9b4fa32611,"Helsinki University Central Hospital, Pain Clinic",helsinki_university_central_hospital_pain_clinic,,,,,, -6897,,ed0f3d1f-3a9a-463a-926a-c972ed7d9fa6,"Gabinete Berthier y Martínez, S.L",gabinete_berthier_y_mart_nez_s_l,,,,,, -6898,,5a3ca9c6-3856-4d33-a44a-33eff126c686,ProFibrix BV,profibrix_bv,,,,,, -6899,,110f53eb-33d2-41e7-9558-234256fe9799,"Medizinische Universität Wien,KIM I,Klinische Abteilung für Infektionen u.Tropenmedizin",medizinische_universit_t_wien_kim_i_klinische_abteilung_f_r_infektionen_u_tropenmedizin,,,,,, -6900,,3a5eb9b1-2f3d-4f19-98e0-94ea80663d1a,MedImmune Limited,medimmune_limited,,,,,, -6901,,fbd9b068-715d-11e6-a0cd-0242ac12000b,ALKEM,alkem,,,,,, -6902,,a2c45252-d267-4bd1-bdbe-4c48d7fc4205,D-Pharm Ltd,d_pharm_ltd,,,,,, -6903,,128cbd4f-fc92-4cb9-b8da-47f2107d8a52,prof. dr. M.A.F.J. van de Laar,prof_dr_m_a_f_j_van_de_laar,,,,,, -6904,,aaa9eb4d-27eb-44ba-b463-19135b8ce376,Berufsgenossenschaftliche Unfallklinik,berufsgenossenschaftliche_unfallklinik,,,,,, -699,0.984107,ea74ab29-48fb-4575-b97e-5d8ea891bdcb,Bayer Pharmaceutical,bayer_pharmaceutical,,,,ea74ab29-48fb-4575-b97e-5d8ea891bdcb,bayer_pharmaceutical,Bayer Pharmaceutical -6905,,703313b3-4cef-4fe6-b727-9ac459ad1dc4,MUC Research GmbH,muc_research_gmbh,,,,,, -6906,,19e4e3ff-3cda-4591-be1a-6a8e301615c3,BioMS Technology Corp,bioms_technology_corp,,,,,, -6907,,b338664f-54c4-4f11-9619-331df2dc19bd,"Medizinische Universität Wien, Klin. Abt. für Endokrinologie & Stoffwechsel, Universitätsklinik für Innere Medizin III",medizinische_universit_t_wien_klin_abt_f_r_endokrinologie_stoffwechsel_universit_tsklinik_f_r_innere_medizin_iii,,,,,, -6908,,7f61b3a2-719c-11e6-a0cd-0242ac12000b,STERLING,sterling,,,,,, -6909,,1e9ea819-cfce-4c9a-9faf-435756e3e401,UNIVERSITY CLINIC GOLNIK,university_clinic_golnik,,,,,, -6910,,f846bba2-a52b-4ce6-a688-461cd9b2dbd3,UMCN department Pharm-Tox,umcn_department_pharm_tox,,,,,, -6911,,734ade7a-7028-46b4-b173-4942a0d94dc2,EANM Forschungs GmbH / EANM Research Ltd,eanm_forschungs_gmbh_eanm_research_ltd,,,,,, -294,0.980402,3f94f9c4-5b24-4215-96a7-f4fef896ec87,Dept. of Internal Medicine,dept_of_internal_medicine,,,,3f94f9c4-5b24-4215-96a7-f4fef896ec87,dept_of_internal_medicine,Dept. of Internal Medicine -6912,,3232c842-edb2-4ec1-b5fd-e6c38fa895b7,Pfizer Kft,pfizer_kft,,,,,, -814,0.985423,03bcbda2-715e-11e6-a0cd-0242ac12000b,NATCO PHARMA,natco_pharma,,,,03bcbda2-715e-11e6-a0cd-0242ac12000b,natco_pharma,NATCO PHARMA -6913,,1550e7ce-c223-4cdd-80b6-95e6c12f3972,"CLINICAL TRIAL SERVICE UNIT, UNIVERSITY OF OXFORD",clinical_trial_service_unit_university_of_oxford,,,,,, -514,0.979838,197c3c96-71cf-11e6-a0cd-0242ac12000b,PHARMACIA,pharmacia,,,,197c3c96-71cf-11e6-a0cd-0242ac12000b,pharmacia,PHARMACIA -6914,,5f62b2e4-7148-11e6-a0cd-0242ac12000b,SIEGFRIED,siegfried,,,,,, -6915,,bcd51dce-34ad-4f3a-99c4-efa1a4cb5122,Probiodrug AG,probiodrug_ag,,,,,, -6916,,950eebaf-f262-4077-a1d5-9eb1a499a2a5,Cangene Europe Ltd,cangene_europe_ltd,,,,,, -6917,,684e0795-4da4-4972-8e6f-8d285eafaf0e,Apocare Pharma GmbH,apocare_pharma_gmbh,,,,,, -6918,,87306dc7-18d0-481a-a97d-4c52e078a121,"Abbott A/S Laboratories , Denmark",abbott_a_s_laboratories_denmark,,,,,, -6919,,4f560186-7368-11e6-a0cd-0242ac12000b,HORIZON PHARMA USA,horizon_pharma_usa,,,,,, -957,0.957248,321c0173-119e-4164-9f51-ae2b1d03cb92,"UMCG, Van Buchem Stichting",umcg_van_buchem_stichting,,,,321c0173-119e-4164-9f51-ae2b1d03cb92,umcg_van_buchem_stichting,"UMCG, Van Buchem Stichting" -351,0.97875547409057617,71261df6-46ce-421c-babd-99f3e048421a,"Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen",deutsches_herzzentrum_m_nchen_klinik_f_r_herz_und_kreislauferkrankungen,,,,490436c4-c1f2-4859-b7ae-69b121dd48d9,deutsches_herzzentrum_m_nchen,Deutsches Herzzentrum München -531,0.979737,50f04e40-7145-11e6-a0cd-0242ac12000b,BEDFORD,bedford,,,,50f04e40-7145-11e6-a0cd-0242ac12000b,bedford,BEDFORD -6920,,d24d15a0-7239-11e6-a0cd-0242ac12000b,DXS DEVICES,dxs_devices,,,,,, -6921,,fd4c0b7f-c16d-4a4c-9ffc-4464fb8a2467,URIACH J. URIACH Y COMPANIA S.A,uriach_j_uriach_y_compania_s_a,,,,,, -6922,,cd360ce3-d5ff-4b7a-9dad-41442177f531,ASSOCIAZIONE S.N.O.- SCIENZE NEUROLOGICHE OSPEDALIERE,associazione_s_n_o_scienze_neurologiche_ospedaliere,,,,,, -6923,,7a11a164-6bcf-441b-aab7-28e2569ceda5,RDD Pharma Ltd,rdd_pharma_ltd,,,,,, -6924,,81e0b1bf-6776-4395-88e3-a8c3ca4fd7e9,"Klinikum der Universität München, Anstalt des öffentlichen Rechts",klinikum_der_universit_t_m_nchen_anstalt_des_ffentlichen_rechts,,,,,, -6925,,58825152-33a9-4a87-95e8-4a79f2898323,"CoTherix, Inc",cotherix_inc,,,,,, -6926,,3c20fb30-aca3-4676-a90b-d2d285dae5fe,Hospira UK limited,hospira_uk_limited,,,,,, -6927,,aa498aa7-8c7c-4f7f-b8c4-41b705f2394b,Olympus France SAS,olympus_france_sas,,,,,, -6928,,57940930-b2e7-4a03-81c9-f1af0205df60,Michael J. Fox Foundation for Parkinson’s Research,michael_j_fox_foundation_for_parkinson_s_research,,,,,, -6929,,1ce02581-7376-41a2-8e50-c3f1d2f545ad,Allergan Limited,allergan_limited,,,,,, -6930,,f6dbb2d6-7276-11e6-a0cd-0242ac12000b,VANSEN PHARMA,vansen_pharma,,,,,, -6931,,1a57e819-c3bb-41df-8043-889a4265b9f2,Dr. Jesús San Miguel Izquierdo,dr_jes_s_san_miguel_izquierdo,,,,,, -6932,,20435caa-c19a-47dd-b388-40743fad085b,"Medizinische Universität Wien, Univ.-Klinik für Spezielle Anästhesie und Schmerztherapie",medizinische_universit_t_wien_univ_klinik_f_r_spezielle_an_sthesie_und_schmerztherapie,,,,,, -6933,,57077b79-9f85-4f91-930e-50be947b7779,"Neurocrine Biosciences, INC",neurocrine_biosciences_inc,,,,,, -6934,,79b16dee-73d6-11e6-a0cd-0242ac12000b,OREXO US INC,orexo_us_inc,,,,,, -6935,,f6946944-72c6-11e6-a0cd-0242ac12000b,GALEN SPECIALTY,galen_specialty,,,,,, -913,0.9859306812286377,bdf11e2c-ae9f-4c1b-84d0-efe510206597,"Department of Cardiology, UK Aachen",department_of_cardiology_uk_aachen,,,,28a229c0-5d6e-4889-95a4-444fe02e5e3c,department_of_cardiology,Department of Cardiology -6936,,b193159c-7146-11e6-a0cd-0242ac12000b,SILARX,silarx,,,,,, -6937,,133cb43b-3026-4af3-aa06-ea4dbe81aa9a,UCB Japan Co. Ltd,ucb_japan_co_ltd,,,,,, -6938,,b5255a10-719d-11e6-a0cd-0242ac12000b,APIL,apil,,,,,, -744,0.97777305046717322,7c93ba08-6123-42f2-a902-d13e42cdd905,Johann Wolfgang Goethe-Universität Frankfurt am Main,johann_wolfgang_goethe_universit_t_frankfurt_am_main,,,,7c93ba08-6123-42f2-a902-d13e42cdd905,johann_wolfgang_goethe_universit_t_frankfurt,Johann Wolfgang Goethe-Universität Frankfurt -6939,,db8d61d4-71ac-11e6-a0cd-0242ac12000b,CHART MEDCL,chart_medcl,,,,,, -6940,,25da3dfe-920a-4086-8caf-8b2fc22bdaf2,Heart of England NHS Foundation Trust Radiology Department,heart_of_england_nhs_foundation_trust_radiology_department,,,,,, -6941,,039c0e09-b4d7-48b7-8347-03ec181e13ca,Dra. Nuria Mañes Bonet. Sección de Cirugía Torácica. Hospital Universitario de Canarias,dra_nuria_ma_es_bonet_secci_n_de_cirug_a_tor_cica_hospital_universitario_de_canarias,,,,,, -907,0.97142676512400306,eb9e8887-858d-4ff5-add8-ce95d14fca4d,sanofi-aventis recherche et developpement,sanofi_aventis_recherche_et_developpement,,,,f72ce0f5-27b8-42db-aeea-0faa55409a54,sanofi_aventis_recherche_et_developpement,sanofi-aventis recherche et developpement -6942,,2ced2f14-f283-4541-80f7-d6e788d81a65,UHB NHS Foundation Trust,uhb_nhs_foundation_trust,,,,,, -6943,,dd8e27f1-6993-4e6f-9cf9-f080b60fb259,"Bayer Healthcare AG, D-51368, Leverkusen",bayer_healthcare_ag_d_51368_leverkusen,,,,,, -6944,,e918cf88-7160-11e6-a0cd-0242ac12000b,SHIRE RICHWOOD,shire_richwood,,,,,, -6945,,87bf0701-682f-4de2-a5c3-a7d9fe2b740e,AZAD Pharma AG,azad_pharma_ag,,,,,, -511,0.931409,a81bbb65-9b77-48ec-9afc-97b008ea886e,PharmaMar SAU,pharmamar_sau,,,,69596232-b165-4d72-8a18-1e0bbdd636c6,pharmamar_sa_unipersonal,PharmaMar SA unipersonal -6946,,73179bed-bab8-4dea-a961-433ccc2a4b6d,ITALIAN SARCOMA GROUP,italian_sarcoma_group,,,,,, -6947,,ed4c3d1a-716a-11e6-a0cd-0242ac12000b,INTERMUNE PHARMS,intermune_pharms,,,,,, -344,0.980149,11e94b5f-d540-4085-bee2-a20da96129f1,"Otto-von-Guericke University, Medical Faculty, Dpt. of Neurology",otto_von_guericke_university_medical_faculty_dpt_of_neurology,,,,11e94b5f-d540-4085-bee2-a20da96129f1,otto_von_guericke_university_medical_faculty_dpt_of_neurology,"Otto-von-Guericke University, Medical Faculty, Dpt. of Neurology" -6948,,39b8cf46-a737-408d-83f3-cd2c4acc498e,3M,3m,,,,,, -1052,0.93933373689651489,d6d116ab-4473-4e23-8414-54f606138536,"University of Oxford, Clinical Trials and Research Governance",university_of_oxford_clinical_trials_and_research_governance,,,,574a16cb-eb53-4e25-95a2-a07455968d04,university_of_oxford_clinical_trials_and_research_governance,"University of Oxford, Clinical Trials and Research Governance Office" -495,0.98471283912658691,27140480-7146-11e6-a0cd-0242ac12000b,DR REDDYS LA,dr_reddys_la,,,,27140480-7146-11e6-a0cd-0242ac12000b,dr_reddys_la,DR REDDYS LA -6949,,450a07f9-f783-4cb2-b62f-68125899724c,Investigacion Independiente,investigacion_independiente,,,,,, -6950,,feeb0b39-1102-41e2-8009-23077e318056,Orthopaedic research unit. Odense University Hospital,orthopaedic_research_unit_odense_university_hospital,,,,,, -6951,,94778532-634a-4bf6-96bb-fff1fe96720c,Park-Klinikum,park_klinikum,,,,,, -6952,,77393691-7c54-4fb6-8a9c-3df293b9b198,Dansk Hovedpinecenter,dansk_hovedpinecenter,,,,,, -6953,,bc271298-7030-4016-b22d-31b16f696871,Avigen Inc,avigen_inc,,,,,, -6954,,3752bbd6-798c-430b-a5b0-0bf956aea171,European Cardiovascular Research Institute,european_cardiovascular_research_institute,,,,,, -6955,,846472a6-9208-4c43-b4b4-fc78cd5953a6,Rafael Selgas,rafael_selgas,,,,,, -6956,,642dfe6b-b574-4450-8740-88976623328e,"Cliniques Universitaires Saint-Luc, Université catholique de Louvain",cliniques_universitaires_saint_luc_universit_catholique_de_louvain,,,,,, -118,0.982527,1b1c70ea-715f-11e6-a0cd-0242ac12000b,OAK PHARMS,oak_pharms,,,,1b1c70ea-715f-11e6-a0cd-0242ac12000b,oak_pharms,OAK PHARMS -6957,,062547a5-76a9-4994-97ae-3199e9d82682,"UCB Korea Co.,Ltd",ucb_korea_co_ltd,,,,,, -6958,,6dc6f3fa-e891-4604-b1cc-f45bb9399401,"Department of Neuroscience, neurology",department_of_neuroscience_neurology,,,,,, -6959,,1669ed6e-e493-4d1c-9573-1c096ff6f134,"University School of Medicine Hannover (MHH), represented by the chairmanship",university_school_of_medicine_hannover_mhh_represented_by_the_chairmanship,,,,,, -6960,,d5122562-8bc2-11e6-a449-0242ac12000b,"Pediatric Unit, Hillerød Hospital",pediatric_unit_hiller_d_hospital,,,,,, -6961,,ade49b58-bb0f-4e98-bf95-4992cce2ce96,"University of Oxford, Research Governance & Clinical Trials Office",university_of_oxford_research_governance_clinical_trials_office,,,,,, -6962,,d55ce4c4-3461-48b4-8156-18fd5c7910c7,CONRAD EASTERN VIRGINIA MEDICAL SCHOOL,conrad_eastern_virginia_medical_school,,,,,, -6963,,1338cf53-ca45-4d97-b99a-d62a0cc9a3f7,Diana Molina Villaverde,diana_molina_villaverde,,,,,, -980,0.979352,1743b2fc-080c-4820-9527-15454fe27836,Gambro Lundia AB,gambro_lundia_ab,,,,1743b2fc-080c-4820-9527-15454fe27836,gambro_lundia_ab,Gambro Lundia AB -564,0.925101,0c57bc5a-dee4-4689-9938-6075f7ec9b69,Norfolk and Norwich University Hospital NHS Foundation Trust,norfolk_and_norwich_university_hospital_nhs_foundation_trust,,,,0c57bc5a-dee4-4689-9938-6075f7ec9b69,norfolk_and_norwich_university_hospital_nhs_foundation_trust,Norfolk and Norwich University Hospital NHS Foundation Trust -6964,,0ba12214-71e2-4c31-b645-49e36bbe9930,"Orthopaedic department, Karolinska Institutet, Danderyd's Hospital",orthopaedic_department_karolinska_institutet_danderyd_s_hospital,,,,,, -251,0.987649,5b28c378-71c3-11e6-a0cd-0242ac12000b,VIRTUS PHARMS,virtus_pharms,,,,5b28c378-71c3-11e6-a0cd-0242ac12000b,virtus_pharms,VIRTUS PHARMS -1003,0.970735,ffb25e01-d581-4ef1-bf34-52ee1773efa2,Pfizer Limited. Pfizer Global Research and Development,pfizer_limited_pfizer_global_research_and_development,,,,9134f49c-0675-4fb8-9e30-403bf260e44d,pfizer_limited,Pfizer Limited -72,0.9488164484500885,a359d331-932d-4716-9cec-7901baf5cc1b,Takeda Global Research & Development Centre (Europe) Ltd (TGRD),takeda_global_research_development_centre_europe_ltd_tgrd,,,,a359d331-932d-4716-9cec-7901baf5cc1b,takeda_global_research_development_centre_europe_ltd,Takeda Global Research & Development Centre (Europe) Ltd -6965,,21c4b576-71a3-11e6-a0cd-0242ac12000b,IROKO PHARMS,iroko_pharms,,,,,, -6966,,44455077-dece-4c0e-b056-751e8b843baa,Portsmouth Hospitals NHS trust,portsmouth_hospitals_nhs_trust,,,,,, -6967,,1535df1c-73db-11e6-a0cd-0242ac12000b,BRAEBURN PHARMS INC,braeburn_pharms_inc,,,,,, -6968,,3acc81ce-96c5-4498-b997-d7a174490242,Acadia Pharmaceuticals Inc,acadia_pharmaceuticals_inc,,,,,, -6969,,ed72a9ab-1053-4270-8ed0-8b83f62dc07b,"Aarhus University Hospital, Department of Rheumatology U",aarhus_university_hospital_department_of_rheumatology_u,,,,,, -6970,,3dbe3eba-22ce-42cc-80e5-e2aa5616cb6c,PolyMedix Inc,polymedix_inc,,,,,, -202,0.9779740571975708,0ca95325-5fdb-4264-9a4d-da0285235e77,"Helse Bergen HF, Haukeland University Hospital",helse_bergen_hf_haukeland_university_hospital,,,,0ca95325-5fdb-4264-9a4d-da0285235e77,helse_bergen_hf_haukeland_university_hospital,"Helse Bergen HF, Haukeland University Hospital" -6971,,e0eecc66-8b90-4a62-8484-6b7a55123e59,"RE&D VÚFB, s.r.o",re_d_v_fb_s_r_o,,,,,, -6972,,d400ed48-6133-4340-94ec-e93df8540486,"University of Oslo, institute for basic medical sciences, department of nutrition",university_of_oslo_institute_for_basic_medical_sciences_department_of_nutrition,,,,,, -6973,,6aeef86a-0f07-4f94-ae5c-1094f6d3ca79,Seahorse Scientific Services Ltd,seahorse_scientific_services_ltd,,,,,, -6974,,88e1a2f1-1aa0-49ed-9f67-3e25c391ef58,University Hospital Vienna,university_hospital_vienna,,,,,, -6975,,f3000250-adf1-4d58-bf3b-b9e73365bba4,Bernardino Clavo - Hospital Dr. Negrin,bernardino_clavo_hospital_dr_negrin,,,,,, -6976,,30fff4ff-c2aa-4674-bb0b-607c9e86ef71,VIVENTIA BIOETICH INC,viventia_bioetich_inc,,,,,, -6977,,d7015255-5027-4345-9944-a232554abd6c,Universitätskinderklinik Heidelberg,universit_tskinderklinik_heidelberg,,,,,, -6978,,4904c469-a354-448d-bfa5-7d2c44c85729,Center for Muscle and Bone Research of the Charité Universitaetsmedizin Berlin,center_for_muscle_and_bone_research_of_the_charit_universitaetsmedizin_berlin,,,,,, -6979,,b9331f6b-4839-4ef5-9b8f-aa313b8a4f6c,"Dept Medicine I, Paracelsus Med. Univ. Landeskrankenanstalten Salzburg / SALK",dept_medicine_i_paracelsus_med_univ_landeskrankenanstalten_salzburg_salk,,,,,, -6980,,b9703d66-a283-4c68-848c-3e45227edb6a,IDEA AG,idea_ag,,,,,, -6981,,06ac8661-9dff-4bce-b2b3-5fa3e0182119,"Wyeth Pharmaceuticals, Inc., acting through Wyeth Research, a Pfizer Company",wyeth_pharmaceuticals_inc_acting_through_wyeth_research_a_pfizer_company,,,,,, -6982,,c42d8476-2e66-4c3a-a823-502be6080311,Allergie-Centrum-Charité Universitätsmedizin Berlin,allergie_centrum_charit_universit_tsmedizin_berlin,,,,,, -6983,,221aaa33-6a49-4b74-b045-b4ce8b9023f1,Parnassia-BAVO groep,parnassia_bavo_groep,,,,,, -6984,,8d6e2c1a-c710-41bd-9822-c9dfbcd5e71b,Maxima Medical center,maxima_medical_center,,,,,, -6985,,3bd97a30-c96b-4d59-bc00-31495267928d,Janssen Biologics BV,janssen_biologics_bv,,,,,, -6986,,1149336c-0e7b-47f7-8f47-fccfb49fb50f,The Mentholatum Company Ltd,the_mentholatum_company_ltd,,,,,, -6987,,74868533-09e6-4764-b80c-8feb044e5e7c,Antigenics Inc,antigenics_inc,,,,,, -866,0.96057683229446411,ead26ef6-4f3c-4e33-8dc7-c5d3c9146e43,"Hvidovre Hospital, Dept. Rheumatology",hvidovre_hospital_dept_rheumatology,,,,777eeb1f-10b4-4c96-8d33-42be9c44ad2b,hvidovre_hospital,Hvidovre Hospital -6988,,2a36d878-6673-496e-a61d-42c7980b788b,Cliniques Hopitaux Universitaires NANTES,cliniques_hopitaux_universitaires_nantes,,,,,, -129,0.97465506196022034,4bc32527-accc-401e-81cd-afaacbe32d0c,Cliniques Universitaires St Luc - UCL,cliniques_universitaires_st_luc_ucl,,,,4bc32527-accc-401e-81cd-afaacbe32d0c,cliniques_universitaires_st_luc,Cliniques Universitaires St Luc -540,0.979562,77d53b33-f406-4819-9900-50d2cea07c42,"Dow Pharmaceutical Sciences, Inc on behalf of Coria Laboratories",dow_pharmaceutical_sciences_inc_on_behalf_of_coria_laboratories,,,,3817f8bc-4ff8-495a-9b3e-ba7bf5fb409b,dow_pharmaceutical_sciences,Dow Pharmaceutical Sciences -6989,,fc61e5ae-6f9c-11e6-9663-0242ac12000b,Astra ZenecaGmbH,astra_zenecagmbh,,,,,, -6990,,06c03e3c-bda4-46e1-b8ae-15fa2cebc8c7,Bo Söderpalm,bo_s_derpalm,,,,,, -6991,,71c4bb60-04df-46e5-8f3e-f83bea6cc2d4,Plazmaferezis Állomás Közhasznú Nonprofit Kft,plazmaferezis_llom_s_k_zhaszn_nonprofit_kft,,,,,, -6992,,e6c4fc4e-84a4-42e9-a7bd-89aa4ff0eb28,University Medical Center Ultrecht,university_medical_center_ultrecht,,,,,, -1024,0.902645,5cec190c-2967-479b-94a5-361445088c27,"Celtic Pharma Development Services Bermuda, Ltd",celtic_pharma_development_services_bermuda_ltd,,,,2c174554-737a-4729-99f3-4cc6843b2b31,celtic_pharma_development_services_bermuda_limited,Celtic Pharma Development Services Bermuda Limited -6993,,2ec4d43f-068f-4af8-a1b8-abeb55de7498,"Ignyta, Inc",ignyta_inc,,,,,, -56,0.98137152194976807,0406db2b-5dbf-4c1f-87bb-d6df0227905a,"Radboud University Nijmegen Medical Centre, Department of Endocrinology",radboud_university_nijmegen_medical_centre_department_of_endocrinology,,,,9078130e-eeb6-4d4a-9b3b-bf9f3a7082c5,radboud_university_nijmegen_medical_centre,Radboud University Nijmegen Medical Centre -6994,,ff4e23a1-1754-49e4-8340-60326b611676,Martini Hospital Groningen,martini_hospital_groningen,,,,,, -300,0.972939,5715166a-8be0-11e6-a449-0242ac12000b,Rigshospital,rigshospital,,,,5715166a-8be0-11e6-a449-0242ac12000b,rigshospital,Rigshospital -21,0.98614925146102905,31fe54e5-0be3-4070-88f1-464180a02a89,STALLERGENES,stallergenes,,,,31fe54e5-0be3-4070-88f1-464180a02a89,stallergenes,STALLERGENES -1014,0.98766794800758362,9b368f8e-02db-4935-a1a6-f2a417efa7ee,Institut de Recherches Internationales Servier ( IRIS ),institut_de_recherches_internationales_servier_iris,,,,9b368f8e-02db-4935-a1a6-f2a417efa7ee,institut_de_recherches_internationales_servier,Institut de Recherches Internationales Servier -6995,,168954da-a683-4e1a-9e85-c88bef002371,North Hampshire Hospital NHS Trust,north_hampshire_hospital_nhs_trust,,,,,, -6996,,df27dbe6-d85e-4fbf-b184-3b1a23c0b903,Fundación Interhospitalaria Investigación Cardiovascular,fundaci_n_interhospitalaria_investigaci_n_cardiovascular,,,,,, -6997,,9fe7536e-ce24-4a41-bf15-f03b1e234cb0,Università degli Studi di Torino-Dipartimento di Biotecnologie Molecolari e Scienze della Salute,universit_degli_studi_di_torino_dipartimento_di_biotecnologie_molecolari_e_scienze_della_salute,,,,,, -6998,,b17073e8-ff4a-4825-b099-c7ae2938ab99,Sonderforschungsbereich 656 (SFB 656),sonderforschungsbereich_656_sfb_656,,,,,, -523,0.983968,4d30a044-47ed-412a-947f-20d391297f9c,Martin-Luther-University Halle-Wittenberg,martin_luther_university_halle_wittenberg,,,,32be795e-a544-49ea-9655-1702405333a9,martin_luther_university,Martin-Luther-University -6999,,8dff3bd2-1d10-4abf-97be-da73b191cc51,Omega Pharma N.V,omega_pharma_n_v,,,,,, -7000,,8b0c37a4-299e-4aa0-a23f-672a21bba675,QUANTUM GENOMICS,quantum_genomics,,,,,, -7001,,3d220292-7167-11e6-a0cd-0242ac12000b,HOT SHOTS NM LLC,hot_shots_nm_llc,,,,,, -936,0.95275402069091797,914bfd3e-c75d-45fc-b52a-86eeefd78a2e,Royal Liverpool and Broardgreen University Hospitals Trust,royal_liverpool_and_broardgreen_university_hospitals_trust,,,,33e84b15-e25f-402d-bf4e-0f564d9c0255,royal_liverpool_and_broadgreen_university_hospitals_trust,Royal Liverpool and Broadgreen University Hospitals Trust -7002,,55be6232-7144-11e6-a0cd-0242ac12000b,WORLD GEN,world_gen,,,,,, -7003,,836aca18-d45c-4431-b4f8-0bf18b17c7c2,Janssen Research & Development,janssen_research_development,,,,,, -7004,,42352d65-fa40-4102-aa16-0d993434926d,Dr. Evaristo Varo Pérez,dr_evaristo_varo_p_rez,,,,,, -7005,,d9cdb95a-dc6a-463a-a032-05f75b644c33,South Tees Hospitals NHS Trust,south_tees_hospitals_nhs_trust,,,,,, -7006,,ec73256b-a086-4059-8549-63c5669a5181,"Medizinische Universität Wien, Univ.Klinik f.Innere Medizin I,Abt. f. Infektionen u.Tropenmedizin",medizinische_universit_t_wien_univ_klinik_f_innere_medizin_i_abt_f_infektionen_u_tropenmedizin,,,,,, -7007,,4c7c1dad-13ae-4c28-af21-9f270651ee8e,CASSIOPEA SpA,cassiopea_spa,,,,,, -7008,,4a2b7c74-befc-4577-9520-9417229b05c7,Nordic Pharma France,nordic_pharma_france,,,,,, -7009,,81db082a-7167-11e6-a0cd-0242ac12000b,NCM USA BRONX LLC,ncm_usa_bronx_llc,,,,,, -7010,,d74df514-73c0-11e6-a0cd-0242ac12000b,PERNIX IRELAND PAIN,pernix_ireland_pain,,,,,, -7011,,5e1f57b6-e7ae-4b2e-8b65-fc77bd35e92d,mibe GmbH Arzneimittel,mibe_gmbh_arzneimittel,,,,,, -7012,,c4628c57-060f-4c5d-8516-894b45362f0c,Sanofi-Synthelabo Co. Ltd,sanofi_synthelabo_co_ltd,,,,,, -7013,,d2236b94-d2dc-4f2f-8679-e50444b22ca4,"Overlæge, dr.med. Claus Zachariae",overl_ge_dr_med_claus_zachariae,,,,,, -7014,,c005c7a9-4eb8-4915-ad3a-b315222a9f97,"Johannes Förster, anest.lääkäri",johannes_f_rster_anest_l_k_ri,,,,,, -7015,,b901ba62-7129-11e6-a89e-0242ac12000b,BARR LABS INC,barr_labs_inc,,,,,, -7016,,071d9584-4c2a-4bb7-920e-c1239274750c,"HSK, Dr. Horst Schmidt Kliniken GmbH",hsk_dr_horst_schmidt_kliniken_gmbh,,,,,, -7017,,bc446b96-53fd-4967-81ba-05f546f05fa2,"HY, Kliinisen farmakologian yksikkö",hy_kliinisen_farmakologian_yksikk,,,,,, -7018,,1c8d9e5e-4d61-4c07-b2a9-0217a1fd52bf,St Georges Hospital,st_georges_hospital,,,,,, -7019,,1f691f97-6f5d-4c7d-a629-0915a4980779,Jeroen Bosch Hospital,jeroen_bosch_hospital,,,,,, -7020,,002ff34e-436d-48e5-be88-943d50af57a6,Erasmus MC-Daniël den Hoed,erasmus_mc_dani_l_den_hoed,,,,,, -7021,,977bed4b-17f6-4cde-9dcd-0d079305af46,Sanofi-aventis U.S. Inc,sanofi_aventis_u_s_inc,,,,,, -7022,,f6668148-57b0-4ee6-94a4-a8958f19c696,Unité de Recherches Thérapeutiques,unit_de_recherches_th_rapeutiques,,,,,, -7023,,20dd8898-a8ed-4a13-8b26-fa08ed466bca,Combustin Pharmazeutische Präparate GmbH,combustin_pharmazeutische_pr_parate_gmbh,,,,,, -646,0.96544918417930603,237ec247-b474-4bd6-9041-c2ffb0213c0e,Boehringer Ingelheim Ellas AE,boehringer_ingelheim_ellas_ae,,,,237ec247-b474-4bd6-9041-c2ffb0213c0e,boehringer_ingelheim_ellas,Boehringer Ingelheim Ellas -7024,,f9a24959-69bf-4d29-bc8b-4eae0afa24ae,Virgilio Hernando Requejo,virgilio_hernando_requejo,,,,,, -109,0.952012,8a1dc0a1-759d-435f-ad3b-c75c8ce910d4,GlaxoSmithKline Consumer Healthcare GmbH & Co. KG,glaxosmithkline_consumer_healthcare_gmbh_co_kg,,,,8a1dc0a1-759d-435f-ad3b-c75c8ce910d4,glaxosmithkline_consumer_healthcare_gmbh_co_kg,GlaxoSmithKline Consumer Healthcare GmbH & Co. KG -578,0.98133742809295654,5850c0a3-a743-4f17-90b7-904795acdc7a,"Wyeth Pharmaceutical Inc. Acting through its division Wyeth Research, a Pfizer Company",wyeth_pharmaceutical_inc_acting_through_its_division_wyeth_research_a_pfizer_company,,,,724d1bdc-e54a-4c73-b212-98071e708ad2,wyeth_pharmaceuticals_inc_acting_through_its_division_wyeth_research_a_pfizer_company,"Wyeth Pharmaceuticals Inc. Acting through its division Wyeth Research, a Pfizer Company" -450,0.982048,08302f5a-a69b-4857-95b3-096818568221,Instituto de Investigacion Sanitaria La e,instituto_de_investigacion_sanitaria_la_e,,,,08302f5a-a69b-4857-95b3-096818568221,instituto_de_investigacion_sanitaria_la_e,Instituto de Investigacion Sanitaria La e -7025,,337fbaf4-8bc0-11e6-a449-0242ac12000b,Cancer Trials Ireland,cancer_trials_ireland,,,,,, -133,0.951362,c231857e-6087-450a-b8b7-28c375a19c91,Vakgroep Huisartsgeneeskunde VUB,vakgroep_huisartsgeneeskunde_vub,,,,71e1740c-dc4b-46d2-86ac-23909116857c,vakgroep_huisartsgeneeskunde_vrije_universiteit_brussel,Vakgroep Huisartsgeneeskunde Vrije Universiteit Brussel -7026,,2191777b-8ebe-4205-8126-e955d425dacd,Marius Henriksen,marius_henriksen,,,,,, -7027,,08deeac2-73d8-11e6-a0cd-0242ac12000b,SILVERGATE PHARMS,silvergate_pharms,,,,,, -7028,,73b1c674-f175-4e72-943f-d6d297ed9896,"Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie",medizinische_universit_t_wien_universit_tsklinik_f_r_klinische_pharmakologie,,,,,, -7029,,d2628802-8bbd-11e6-a449-0242ac12000b,Lycera Corp,lycera_corp,,,,,, -7030,,2e57922d-289f-4892-ae6a-db94dc5949ae,"Department of Urology, Herlev Hospital",department_of_urology_herlev_hospital,,,,,, -7031,,67e0b776-b61c-44d6-9f01-18396965342e,Solvay Pharmaceuticals. Inc,solvay_pharmaceuticals_inc,,,,,, -7032,,85b83ce3-4878-4113-b99c-c11381065bf2,Laboratoires WELEDA,laboratoires_weleda,,,,,, -7033,,28c02e0f-c88a-401b-8a08-5f616aa33105,"Bayer AB, Bayer Schering Pharma",bayer_ab_bayer_schering_pharma,,,,,, -7034,,59803a6e-1d1d-4193-a6b3-804924f4749a,"INSTITUTO CIENTÍFICO Y TECNOLÓGICO (ICT )DE NAVARRA, S.A",instituto_cient_fico_y_tecnol_gico_ict_de_navarra_s_a,,,,,, -7035,,6529cd70-7157-11e6-a0cd-0242ac12000b,PERRIGO ISRAEL,perrigo_israel,,,,,, -7036,,9aa833c0-7142-11e6-a0cd-0242ac12000b,WYETH PHARMS INC,wyeth_pharms_inc,,,,,, -7037,,82054b55-dafc-4c68-8618-b4745d2425b9,Grupo Español de Linfomas y transplantes Autólogos de Médula Osea (GELTAMO),grupo_espa_ol_de_linfomas_y_transplantes_aut_logos_de_m_dula_osea_geltamo,,,,,, -7038,,f1fbd800-c353-4402-b6dc-46942a78ba4d,"Beijing Novartis Pharma Co., Ltd",beijing_novartis_pharma_co_ltd,,,,,, -7039,,c8e5a8c2-69b1-4e77-b8db-3d3f956c3092,AZIENDA OSPEDALIERA OSPEDALE DI CIRCOLO A.O. DI RILIEVO REGIONALE,azienda_ospedaliera_ospedale_di_circolo_a_o_di_rilievo_regionale,,,,,, -7040,,a86205ce-7163-11e6-a0cd-0242ac12000b,SILARX PHARMS INC,silarx_pharms_inc,,,,,, -7041,,a076d363-dc13-4674-a9df-c64c5383ae08,FUNDACION HOSPITAL DE MADRID,fundacion_hospital_de_madrid,,,,,, -450,0.982048,6cd336d3-1b0c-4854-b789-e0345e7fe423,Instituto de Investigacion Sanitaria La Fe,instituto_de_investigacion_sanitaria_la_fe,,,,08302f5a-a69b-4857-95b3-096818568221,instituto_de_investigacion_sanitaria_la_e,Instituto de Investigacion Sanitaria La e -7042,,af7a863b-ad14-419b-ae09-d87b4096adf1,Servier Research and Development Ltd. (S.R.D.L) (for UK only),servier_research_and_development_ltd_s_r_d_l_for_uk_only,,,,,, -149,0.98663,754cbf5a-a0d1-46dd-8be7-2a83aa37d6de,Array BioPharma Inc,array_biopharma_inc,,,,196b721b-cf1f-48fb-9325-0abb1def7a34,array_biopharma,Array BioPharma -7043,,cca1f39c-7221-44b7-8a13-315cd97f7e3c,Laboratoires BIORGA,laboratoires_biorga,,,,,, -358,0.968122,0267831e-60a5-4058-a9fc-094b1cd84b8e,Fresenius Medcial Care Deutschland GmbH,fresenius_medcial_care_deutschland_gmbh,,,,0267831e-60a5-4058-a9fc-094b1cd84b8e,fresenius_medcial_care_deutschland_gmbh,Fresenius Medcial Care Deutschland GmbH -7044,,c546ba57-152c-4416-ba46-0a5f908b7334,Universitätsfrauenklinik Innsbruck,universit_tsfrauenklinik_innsbruck,,,,,, -827,0.98886597156524658,ffdb95f1-a80d-4d79-9648-8ab140edbd56,INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE,instituto_de_investigaci_n_sanitaria_la_fe,,,,975869a5-d12b-4f5f-9a3d-d76a15c61a6a,instituto_de_investigaci_n_sanitaria_la_fe_de,INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE -7045,,6eadbe6a-717a-11e6-a0cd-0242ac12000b,IPSEN BIOPHARM LTD,ipsen_biopharm_ltd,,,,,, -837,0.98498398065567017,09c00199-a473-4e2e-b6d9-ca5616af7b3d,"NHS Greater Glasgow, Yorkhill",nhs_greater_glasgow_yorkhill,,,,09c00199-a473-4e2e-b6d9-ca5616af7b3d,nhs_greater_glasgow_yorkhill,"NHS Greater Glasgow, Yorkhill" -7046,,773a8488-7165-11e6-a0cd-0242ac12000b,RUBICON RES PVT LTD,rubicon_res_pvt_ltd,,,,,, -7047,,f020125a-068c-40c6-b5c5-4a16f4b31ff6,Ludwig Boltzmann Gesellschaft,ludwig_boltzmann_gesellschaft,,,,,, -160,0.97226891517639158,84621fbf-cedb-43f3-85f6-9201a3a323e0,Fundación para la Investigación Biomédica del Hospital Gregorio Marañon,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_on,,,,ce27e24e-62ac-42de-a596-4ceed67e634f,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_gregorio_mara_n,Fundación para la Investigación Biomédica del Hospital Gregorio Marañón -7048,,e8f9de9b-4ff2-4a3e-94ac-3b3bfe5f32fb,Dean of the Medical Faculty (University of Bonn),dean_of_the_medical_faculty_university_of_bonn,,,,,, -7049,,0a99e6e6-ad6e-402f-86cb-bdc8bd104e11,Schering-Plough Research Institute - A division of Schering-Plough Corp,schering_plough_research_institute_a_division_of_schering_plough_corp,,,,,, -7050,,310da474-9c03-449c-9381-9e1f0019171b,"Ögonkliniken, Akademiska sjukhuset i Uppsala",gonkliniken_akademiska_sjukhuset_i_uppsala,,,,,, -324,0.97549104690551758,947a607a-e91b-4de5-bbb8-6547ba861362,Stiefel Laboratories Maidenhead Ltd (commonly known as Stiefel International R&D),stiefel_laboratories_maidenhead_ltd_commonly_known_as_stiefel_international_r_d,,,,0a082bad-97ec-4e82-be7d-2731907614ac,stiefel_laboratories_maidenhead_ltd,Stiefel Laboratories Maidenhead Ltd -7051,,a6175ca9-ac65-4d80-92ad-a57ae078a259,VU University medical center (VUmc),vu_university_medical_center_vumc,,,,,, -7052,,1dbd18a6-29a3-4f3d-8396-91868b5d6a7e,Universitatsklinikum Munster,universitatsklinikum_munster,,,,,, -7053,,7d960b31-740c-4ba1-aa11-b0bca908a241,Montse Palacio Riera - Hospital Clínic de Barcelona - Maternitat,montse_palacio_riera_hospital_cl_nic_de_barcelona_maternitat,,,,,, -7054,,6dc515ec-668a-43c4-842b-844bd083b6fe,Univar B.V,univar_b_v,,,,,, -7055,,64d7a966-8c71-4ac4-a9c1-1c9711142ab8,Liverpoool Womens NHS Foundation Trust,liverpoool_womens_nhs_foundation_trust,,,,,, -7056,,494c98e0-7183-11e6-a0cd-0242ac12000b,AUXILIUM PHARMS,auxilium_pharms,,,,,, -7057,,050d5331-e475-46fc-9860-a4017a6234bb,CureVac GmbH,curevac_gmbh,,,,,, -7058,,11a91ee0-ce39-48bf-aa91-f0311f489cc2,ADELAIDA LAMAS FERREIRO,adelaida_lamas_ferreiro,,,,,, -7059,,258f5812-60a7-474f-b52b-9df85b92ebed,"Med. Univ. Wien, Univ. Klinik für Psychiatrie und Psychotherapie",med_univ_wien_univ_klinik_f_r_psychiatrie_und_psychotherapie,,,,,, -7060,,ec8fa845-50e4-4e84-8d2e-f0c567c44294,Novartis Pharma Services A.G,novartis_pharma_services_a_g,,,,,, -7061,,9852fc55-dab5-411c-863b-2e64c85dc773,Biocon S.A,biocon_s_a,,,,,, -7062,,e5421385-9c1e-4d11-a320-75f6bc64e82a,RIBAPHARM,ribapharm,,,,,, -961,0.93838614225387573,a6d6aa67-5161-45ca-a1eb-794cebec0129,Hull and East Yorkshire Hospitals NHS Trust,hull_and_east_yorkshire_hospitals_nhs_trust,,,,a6d6aa67-5161-45ca-a1eb-794cebec0129,hull_and_east_yorkshire_hospitals_nhs_trust,Hull and East Yorkshire Hospitals NHS Trust -7063,,78506a4d-ad4e-4d62-8c8c-3b8eb6ab25ed,Rafael Martinez Sanz. Servicio de Cirugía Cardiovascular. Hospital Universitario de Canarias,rafael_martinez_sanz_servicio_de_cirug_a_cardiovascular_hospital_universitario_de_canarias,,,,,, -7064,,6a58ca70-0076-4875-9734-4bb2094b5437,Citospin,citospin,,,,,, -7065,,e58e66ac-6fc1-11e6-abe8-0242ac12000b,Janssen-Cilag NV/SA,janssen_cilag_nv_sa,,,,,, -196,0.981008,96074814-e17a-40ea-8694-60a12c5abc77,CHRU Montpellier - Direction de la Recherche,chru_montpellier_direction_de_la_recherche,,,,9324d427-ccb6-48fe-912d-ec2b4be0fbec,chru_montpellier_direction_de_la_recherche_partenariats_et_r_seaux_relations_avec_l_universit,"CHRU Montpellier - Direction de la Recherche, Partenariats et Réseaux, Relations avec l'Université" -164,0.982418,e84a8652-7352-11e6-a0cd-0242ac12000b,BRAINTREE LABS,braintree_labs,,,,14e0f940-71b3-11e6-a0cd-0242ac12000b,braintree,BRAINTREE -564,0.925101,9295d145-4808-436f-b10a-e0a7ae32fa9c,Norfolk & Norwich University Hospital,norfolk_norwich_university_hospital,,,,0c57bc5a-dee4-4689-9938-6075f7ec9b69,norfolk_and_norwich_university_hospital_nhs_foundation_trust,Norfolk and Norwich University Hospital NHS Foundation Trust -7066,,21dc2f1b-1478-497d-b148-1020f90b42f0,Nuclear Medicine UZ Gasthuisberg,nuclear_medicine_uz_gasthuisberg,,,,,, -7067,,88618fc8-8da8-4883-9e6b-805d210b464c,"Karolinska Institutet, Dept of Medicine, Clinical Pharmacology Unit",karolinska_institutet_dept_of_medicine_clinical_pharmacology_unit,,,,,, -646,0.96544918417930603,74ce42ef-b6a1-46d8-882a-8e571fbe2570,Boehringer Ingelheim Ellas SA,boehringer_ingelheim_ellas_sa,,,,237ec247-b474-4bd6-9041-c2ffb0213c0e,boehringer_ingelheim_ellas,Boehringer Ingelheim Ellas -7068,,0505a6cc-7142-11e6-a0cd-0242ac12000b,AVANTHI INC,avanthi_inc,,,,,, -7069,,2228d404-719c-11e6-a0cd-0242ac12000b,ORTHO MCNEIL JANSSEN,ortho_mcneil_janssen,,,,,, -7070,,7b1285fd-8b50-4325-b964-2c1a031be71f,Sana Klinikum Lichtenberg,sana_klinikum_lichtenberg,,,,,, -7071,,2de882c8-c95f-4c54-8eaa-fd028a7e57a0,"Centro Hospitalar de São João, EPE",centro_hospitalar_de_s_o_jo_o_epe,,,,,, -7072,,48f8782d-82ed-42a5-a973-c3d7cc7e5305,"Bioinova, s.r.o",bioinova_s_r_o,,,,,, -7073,,64f567f6-e28f-47b0-8e83-0289fd03593c,Pediatric Cardiology,pediatric_cardiology,,,,,, -117,0.965586,a3094a98-9387-4ac2-b5e3-1680c2eb55b0,UMCN,umcn,,,,66c99c0f-befb-4321-8842-bd1047513dac,umcn_farm_tox,UMCN farm-tox -283,0.988674,3ed277d7-e94c-44a1-b2b4-33de175d3556,Centre Hospitalier Régional et Universitaire de Lille,centre_hospitalier_r_gional_et_universitaire_de_lille,,,,3ed277d7-e94c-44a1-b2b4-33de175d3556,centre_hospitalier_r_gional_et_universitaire_de_lille,Centre Hospitalier Régional et Universitaire de Lille -7074,,466e5b78-6712-4deb-8f59-4a12be02ec87,Cerenis Therapeutics,cerenis_therapeutics,,,,,, -535,0.944741,2a1b4dd7-b8f2-4ab2-be0a-7f9f70d3d524,National Institute of Health and the Environment (RIVM),national_institute_of_health_and_the_environment_rivm,,,,2a1b4dd7-b8f2-4ab2-be0a-7f9f70d3d524,national_institute_of_health_and_the_environment_rivm,National Institute of Health and the Environment (RIVM) -879,0.971226,f0485568-db8c-4351-a14a-1b70750079c5,"RWTH Aachen University, represented by the Rector, himself represented by the Clinical Trial Center (CTC-A)",rwth_aachen_university_represented_by_the_rector_himself_represented_by_the_clinical_trial_center_ctc_a,,,,bc449ec2-1390-4c75-ab67-e86f7d769a31,rwth_aachen_university_represented_by_the_rector_himself_represented_by_the_ctc_a,"RWTH Aachen University, represented by the Rector, himself represented by the CTC-A" -7075,,b51b6263-549c-445c-8b4b-405c19e42070,ZAMBON France,zambon_france,,,,,, -7076,,a0538aa0-16b6-4813-a407-175540ee5998,Hear Center of Semmelweis University,hear_center_of_semmelweis_university,,,,,, -889,0.98770618438720703,36018056-4c5e-4f92-a44e-4cff410d57aa,University Medical Center of the Johannes Gutenberg-University Mainz,university_medical_center_of_the_johannes_gutenberg_university_mainz,,,,36018056-4c5e-4f92-a44e-4cff410d57aa,university_medical_center_of_the_johannes_gutenberg_university_mainz,University Medical Center of the Johannes Gutenberg-University Mainz -7077,,138524be-f840-4eb5-b4b5-8b3a518f8f88,"Department of Clinical Pharmacology, Medical University of Vienna",department_of_clinical_pharmacology_medical_university_of_vienna,,,,,, -7078,,784d3c56-6e55-44e6-8393-449b16a65562,Alysis Zorggroep,alysis_zorggroep,,,,,, -7079,,017ca1f4-3da1-46aa-85ab-ae144c06c6ff,IFCT,ifct,,,,,, -7080,,5c443a2c-9f7d-4dbf-a70d-e5e0d48a8c2e,GELA (Groupe d'Etude du Lymphome de l'Adulte),gela_groupe_d_etude_du_lymphome_de_l_adulte,,,,,, -7081,,b37e6fab-609c-4d24-930f-41ee507f7739,Philipps-University Marburg,philipps_university_marburg,,,,,, -7082,,28cab53a-127e-41f2-9451-d65401e80aa1,"University Heidelberg, University Hospital Mannheim",university_heidelberg_university_hospital_mannheim,,,,,, -7083,,efe8343b-0108-4528-b5e7-88a83a74ac4e,McNeil Ltd,mcneil_ltd,,,,,, -7084,,6cc4f202-9205-4016-b948-b9729ea12b50,Vifor Fresenius Medical Care Renal Pharma France,vifor_fresenius_medical_care_renal_pharma_france,,,,,, -53,0.98087829351425171,0409ac6d-4311-4f84-9569-7d15fbdc4ffc,Med. Univ. Wien,med_univ_wien,,,,0409ac6d-4311-4f84-9569-7d15fbdc4ffc,med_univ_wien,Med. Univ. Wien -7085,,b940cf47-d7c2-488e-ae2a-a1ae3008760c,PROCTER & GAMBLE,procter_gamble,,,,,, -1027,0.98343661427497864,6d36b52f-db46-44ca-93f4-353e20df63e4,Eli Lilly & Co,eli_lilly_co,,,,284c00a4-0148-4486-88e3-8a67925fd222,eli_lilly_company,Eli Lilly & Company -7086,,547cb0d1-d200-4c7f-8d87-c23e9dd86ab2,Grünenthal GmbH,gr_nenthal_gmbh,,,,,, -7087,,0f74af50-95a6-4468-a331-be2e6f3c2dfc,"Ruprecht-Karls-University Heidelberg, Med Faculty represented by University Clinic HD and its Comm. Director",ruprecht_karls_university_heidelberg_med_faculty_represented_by_university_clinic_hd_and_its_comm_director,,,,,, -7088,,62d56128-ac8c-48e5-9091-7a119432f3f1,Vinforce - Institut für Osteoporoseforschung,vinforce_institut_f_r_osteoporoseforschung,,,,,, -7089,,922a9d2c-8d9a-458f-9b34-a159bcc6bf46,"Sønderjylland Hospital, department of neurology",s_nderjylland_hospital_department_of_neurology,,,,,, -7090,,c94ddb8a-7142-11e6-a0cd-0242ac12000b,ALRA,alra,,,,,, -7091,,bdfe9df3-ae41-466d-9835-754ea89e6731,Leeds Teaching Hospital NHS Trust,leeds_teaching_hospital_nhs_trust,,,,,, -7092,,3e33cfe4-5b84-4eeb-a52a-3e968cea2ccb,Kožní ordinace,ko_n_ordinace,,,,,, -7093,,c26cbb05-e7a7-43a9-b3d2-74c73ed26915,Hospital Clinic Barcelona,hospital_clinic_barcelona,,,,,, -1031,0.98256808519363403,ac624ddd-686b-4be1-80a9-858db3c2c4fb,"Medical University of Vienna, Department of Pediatrics",medical_university_of_vienna_department_of_pediatrics,,,,9f76459d-c1a5-4dfd-8ba3-7773bf3ebbce,medical_university_of_vienna_department_of_pediatrics,Medical University of Vienna -7094,,b0cd7ca0-cfcf-4d2c-8e3c-55604b3184e6,Gedeon Richter Plc,gedeon_richter_plc,,,,,, -7095,,d6bfe67d-d730-42e5-a456-a02b3823def2,"Department of Rheumatology, Medical University of Vienna",department_of_rheumatology_medical_university_of_vienna,,,,,, -7096,,01b645bc-7183-11e6-a0cd-0242ac12000b,BTG INTERNATIONAL INC,btg_international_inc,,,,,, -477,0.96643507480621338,092654ab-7dbc-4b58-83c4-7c2f45b75f9a,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Gastroenterologie und Hepatologie",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_abteilung_f_r_gastroenterologie_und_hepatologie,,,,092654ab-7dbc-4b58-83c4-7c2f45b75f9a,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_abteilung_f_r_gastroenterologie_und_hepatologie,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Gastroenterologie und Hepatologie" -7097,,dc730e96-7161-11e6-a0cd-0242ac12000b,PHARM RES ASSOC,pharm_res_assoc,,,,,, -7098,,647a699d-1576-4007-87c2-08b369a1f2ad,RIVM,rivm,,,,,, -7099,,b6d8d15b-23e7-4b14-892e-83b4a37f79de,Affectis Pharmaceuticals AG,affectis_pharmaceuticals_ag,,,,,, -7100,,be6cc8ff-4c9f-4531-8429-1cc17e930269,Genzyme Corporation Inc,genzyme_corporation_inc,,,,,, -915,0.9809834361076355,6f1862f8-4971-4ef9-ad8e-6b92b745108b,Oulu University Hospital,oulu_university_hospital,,,,61f167e1-4240-4936-a86a-3eb617eeeb8b,oulu_university_hospital_department_of_anaesthesia,"Oulu University Hospital, Department of Anaesthesia" -7101,,3eca5644-728e-11e6-a0cd-0242ac12000b,SPECIALITY EUROPEAN,speciality_european,,,,,, -7102,,d627bcd1-d72b-46d4-9df6-7d8c0fc79220,Fundación Hospital Nacional de Parapléjicos,fundaci_n_hospital_nacional_de_parapl_jicos,,,,,, -7103,,661eaf75-3a97-4d8a-9434-8f2f18786955,COUGAR BIOTECHNOLOGY,cougar_biotechnology,,,,,, -430,0.98551523685455322,3bc57cf3-53a2-4c69-b7e4-a49ee753b7f7,University of California San Francisco Stroke Sciences Group,university_of_california_san_francisco_stroke_sciences_group,,,,3bc57cf3-53a2-4c69-b7e4-a49ee753b7f7,university_of_california_san_francisco_stroke_sciences_group,University of California San Francisco Stroke Sciences Group -7104,,8d953c89-fbe8-46f4-b3f3-d9d12ecdb325,"MUW, Univ.Klinik f. Innere Medizin II, Abteilung f. Angiologie",muw_univ_klinik_f_innere_medizin_ii_abteilung_f_angiologie,,,,,, -7105,,012d6a4e-56c6-4cc9-b0e7-09d1df1fea37,Kings College London University,kings_college_london_university,,,,,, -7106,,cc154c60-daea-486e-8ba7-47b198526041,AVERA PHARMACEUTICALS INC,avera_pharmaceuticals_inc,,,,,, -7107,,cbc62c3b-a7d1-48da-88cb-09181bc392f6,"Anaesthesiology Department. Universitary Hospital Vall d'Hebron, Barcelona",anaesthesiology_department_universitary_hospital_vall_d_hebron_barcelona,,,,,, -7108,,e51ccc54-83ac-49f5-8d64-aa3fd9e03404,Clinical Institute of Medical and Chemical Laboratory Diagnostics Graz,clinical_institute_of_medical_and_chemical_laboratory_diagnostics_graz,,,,,, -7109,,4427c92a-a860-46cc-8caa-c410f347c6e3,Association Bigorre Douleurs,association_bigorre_douleurs,,,,,, -7110,,e15e1754-44c4-40ba-b554-353283e670ef,PROMO INTERNATIONAL SRL,promo_international_srl,,,,,, -7111,,59568ef2-cdb8-4567-8d40-2f6d6c3633d6,STX Pharma,stx_pharma,,,,,, -481,0.98966941237449646,063430c2-5fa1-40bb-ab27-c58c6cccb45e,Medizinische Universität Graz, Universitätsklinik für InnereMedizin,,,,48f0d5ed-174c-4ce4-98d7-cc34770f5107, Universitätsklinik für Innere Medizin,Medizinische Universität Graz -7112,,477c940a-715d-11e6-a0cd-0242ac12000b,UNICHEM PHARMS (USA),unichem_pharms_usa,,,,,, -7113,,b1e01596-c6f1-46c1-bcb7-52cc572f211e,PHARM – Pharmaceutical Research Management srl,pharm_pharmaceutical_research_management_srl,,,,,, -7114,,59a921e3-b50a-4a12-ad97-e4c407fc88f6,Dept of Surgery,dept_of_surgery, Abteilung für Endokrinologie und Stoffwechsel,medizinische_universit_t_graz_universit_tsklinik_f_r_inneremedizin_abteilung_f_r_endokrinologie_und_stoffwechsel,,,, -7115,,147e31e6-0d9d-44c5-95af-0d11a602c727,Genzyme Europe B.V,genzyme_europe_b_v,,,,,, -556,0.95394155383110046,a86f7110-f6be-4761-91ec-1bb707f1db65,Greater Glasgow and Clyde Health Board (GGCHB)/University of Glasgow,greater_glasgow_and_clyde_health_board_ggchb_university_of_glasgow,,,,3361148d-134d-40eb-b1d7-9105a55174b4,greater_glasgow_and_clyde_health_board_ggchb_university_of_glasgow,Greater Glasgow and Clyde Health Board (GGCHB)/University of Glasgow -7116,,8c89b3f1-e56d-4ca9-863b-68e053c61d1e,University Clinical Center of Tuebingen,university_clinical_center_of_tuebingen,,,,,, -7117,,26692b04-8f5f-4727-8a54-01aac5136cd8,"S.G.O. Johansson, MD PhD Professor",s_g_o_johansson_md_phd_professor,,,,,, -1002,0.97624942660331726,a42efa53-fa42-404a-8796-cf0a86d035ab,Fundación para la Formación e Investigación Sanitaria,fundaci_n_para_la_formaci_n_e_investigaci_n_sanitaria,,,,8fbc1a40-90b3-491d-9c96-f5d311f67e2e,fundaci_n_para_la_formaci_n_e_investigaci_n_sanitaria,Fundación para la Formación e Investigación Sanitaria -7118,,4de4e820-7193-11e6-a0cd-0242ac12000b,BOWMAN PHARMS,bowman_pharms,,,,,, -7119,,cc2fb3db-803d-4781-91ea-c6750946e716,Dekan of the Medical Faculty of the University Erlangen-Nuremberg, Prof. Dr. Dr. h. c. Jürgen Schüttler,,,,,, -7120,,581d6d12-276c-4ad1-9465-2b9adb8afbad,AVAPO RICERCHE - VENEZIA,avapo_ricerche_venezia,,,,,, -7121,,e29de71a-7129-11e6-a89e-0242ac12000b,MIKAH PHARMA LLC,mikah_pharma_llc,,,,,, -7122,,321c5f1f-f803-4293-9d66-d344a462a3ed,GMIHO Gesellschaft für medizinische Innovation/Hämatologie und Onkologie mbH,gmiho_gesellschaft_f_r_medizinische_innovation_h_matologie_und_onkologie_mbh,dekan_of_the_medical_faculty_of_the_university_erlangen_nuremberg_prof_dr_dr_h_c_j_rgen_sch_ttler,,,,, -7123,,65093549-873d-4c04-9d69-7d575b21f6b6,Octapharma Pharmazeutika Produktionsges.m.b.H,octapharma_pharmazeutika_produktionsges_m_b_h,,,,,, -7124,,a91d8628-e2a4-4cd4-92c4-77cffae98487,MCM Klosterfrau GmbH,mcm_klosterfrau_gmbh,,,,,, -7125,,b1ca2159-1579-40e2-961f-520a7f2455d1,Tartu University Hospital Psychiatry Clinic,tartu_university_hospital_psychiatry_clinic,,,,,, -294,0.980402,8bc6009e-67ad-4b1c-be4c-b1ddc0e89df4,"Dept. of Internal Medicine II, University Hospital Giessen",dept_of_internal_medicine_ii_university_hospital_giessen,,,,3f94f9c4-5b24-4215-96a7-f4fef896ec87,dept_of_internal_medicine,Dept. of Internal Medicine -7126,,2eeb65f4-2aa7-4bdf-8ea9-9ca7d374c27d,Pohjois-Karjalan keskussairaala,pohjois_karjalan_keskussairaala,,,,,, -7127,,1323a5f2-38a3-4717-b38b-3f6c5a9f0f35,University of Sheffield,university_of_sheffield,,,,,, -7128,,9a3590f2-8688-4520-ab15-91b60dad0d55,"Yamanouchi Europe B.V. (en trámite de cambio de nombre a Astellas Pharma Europe, B.V.)",yamanouchi_europe_b_v_en_tr_mite_de_cambio_de_nombre_a_astellas_pharma_europe_b_v,,,,,, -810,0.98486357927322388,43a1c732-1624-42d6-96fa-66ffa3a8fc4e,Biogen Idec A/S,biogen_idec_a_s,,,,43a1c732-1624-42d6-96fa-66ffa3a8fc4e,biogen_idec_a_s,Biogen Idec A/S -736,0.97966154416402185,86b7934b-bd40-4e41-90e2-f2b10e4f66c8,European Organisation for the Research and Treatment of Cancer,european_organisation_for_the_research_and_treatment_of_cancer,,,,86b7934b-bd40-4e41-90e2-f2b10e4f66c8,european_organization_for_the_research_and_treatment_of_cancer_eortc,European Organization for the Research and Treatment of Cancer (EORTC) -7129,,14c93531-b1c6-46a5-8e1c-9b412a615abe,INFAI GmbH,infai_gmbh,,,,,, -7130,,d284234b-d826-4ce9-b6f8-43a996aac994,FERNADO PEREZ RUIZ,fernado_perez_ruiz,,,,,, -156,0.98401394486427307,93c5f8d2-c2d8-4c9b-abde-962e31e9c1a5,"Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intesnivmedizin und Schmerztherapie",medizinische_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intesnivmedizin_und_schmerztherapie,,,,93c5f8d2-c2d8-4c9b-abde-962e31e9c1a5,medizinische_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,"Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie" -7131,,53859063-a67d-4244-a3b3-b0bc49c37b37,"Department of Rheumatology, Hvidovre Hospital",department_of_rheumatology_hvidovre_hospital,,,,,, -7132,,65a935f8-09ec-4986-883b-a8f1fb636a2e,MSE Pharmazeutika GmbH,mse_pharmazeutika_gmbh,,,,,, -7133,,e7d32627-f9df-4aa0-b1d8-0c4a9ab33d9f,Epsom and St Helier University Hospitals NHS Trust R&D Dpt,epsom_and_st_helier_university_hospitals_nhs_trust_r_d_dpt,,,,,, -415,0.958927,1a38fc33-48c6-45d0-8a30-54ce6c217bac,Aspreva Pharmaceutical Corporation,aspreva_pharmaceutical_corporation,,,,1a38fc33-48c6-45d0-8a30-54ce6c217bac,aspreva_pharmaceutical_corporation,Aspreva Pharmaceutical Corporation -69,0.989009,e21ef556-9fd2-43c0-b259-7f0ef1414c92,"Schering Corporation, división Schering-Plough Research",schering_corporation_divisi_n_schering_plough_research,,,,2bcb0c19-b4b9-4f7c-9d21-fb61445071f3,schering_corporation_divisi_n_schering_plough_research_institute,"Schering Corporation, división Schering-Plough Research Institute" -7134,,88d3674c-e17b-4999-a33e-864e4818ab21,GE Healthcare Ltd e le sue filiali,ge_healthcare_ltd_e_le_sue_filiali,,,,,, -7135,,2e1e643e-7b32-43c7-92c4-109e2e2c2098,NOVARTIS PHARMA AG,novartis_pharma_ag,,,,,, -375,0.98873221874237061,c2aa66b4-25c1-48ef-8ead-9e3c02c6d412,Merck Sharp and Dohme de España,merck_sharp_and_dohme_de_espa_a,,,,7e87bc11-ff9c-4927-879f-5e83f9da3259,merck_sharp_and_dohme_de_espa_a_s_a,"Merck Sharp and Dohme de España, S.A" -146,0.987534,a090216a-e555-4b1c-b5d2-b624ee996480,University Hospital Hamburg-Eppendorf,university_hospital_hamburg_eppendorf,,,,a090216a-e555-4b1c-b5d2-b624ee996480,university_hospital_hamburg_eppendorf,University Hospital Hamburg-Eppendorf -7136,,e81faf5e-735c-11e6-a0cd-0242ac12000b,FERRING PHARMS AS,ferring_pharms_as,,,,,, -7137,,fa2ecbc4-a0aa-4628-b842-d191fde9f04d,Ziarco Pharma Ltd,ziarco_pharma_ltd,,,,,, -7138,,b397ad9c-90ec-4ba4-a931-fa64afb8d4eb,Fujisawa GmbH,fujisawa_gmbh,,,,,, -959,0.94367156426111853,d80d2419-d789-4eb0-84f3-571467cef750,"Andromeda Biotech Ltd,: 42 Hayarkon str,Yavne,81227, Israel",andromeda_biotech_ltd_42_hayarkon_str_yavne_81227_israel,,,,8e1ef03a-b2a7-496e-83ef-ae87bf0b27e9,andromeda_biotech_ltd_42_hayarkon_st_yavne_81227_israel,Andromeda Biotech Ltd -7139,,457c590a-1470-4212-bd13-277af57692bd,Consorcio de Apoyo a la Investigación Biomédica en red (CAIBER),consorcio_de_apoyo_a_la_investigaci_n_biom_dica_en_red_caiber,,,,,, -7140,,3442b7de-7167-11e6-a0cd-0242ac12000b,TRUSTEES UNIV PA,trustees_univ_pa,,,,,, -7141,,fce152ce-68e7-45db-bad6-90a563943360,Dr. Amalia Velasco,dr_amalia_velasco,,,,,, -7142,,80a7e484-715b-11e6-a0cd-0242ac12000b,RATIOPHARM,ratiopharm,,,,,, -60,0.96751341649464195,eb86f60c-e0c1-4388-bcff-6a4ece7f4d74,"Wyeth Research Division of Wyeth Pharmaceuticals Inc. A Pfizer Company,Philadelphia,PA-19101,USA",wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company_philadelphia_pa_19101_usa,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc -7143,,8408c773-8ef0-48e0-a9bb-2d5ce0873efa,Pharmaneuroboost N.V,pharmaneuroboost_n_v,,,,,, -7144,,a1c0acfa-a471-4f55-9cee-8d07e71a003f,GORTEC,gortec,,,,,, -7145,,b3880e5a-71a2-11e6-a0cd-0242ac12000b,MOLNLYCKE HLTH,molnlycke_hlth,,,,,, -7146,,62eca5da-becb-40f8-91e8-374c7724afb2,Estetra SPRL,estetra_sprl,,,,,, -7147,,ba921889-c955-47f2-b171-891962537a6d,Sociedad Española de Hematología-Oncología Pediátrica,sociedad_espa_ola_de_hematolog_a_oncolog_a_pedi_trica,,,,,, -7148,,9f72d276-38d8-43dd-bf96-691880f542f7,Exponential Biotherapies Inc,exponential_biotherapies_inc,,,,,, -7149,,1e3ac5d2-b437-47f6-a5cd-78c8a27d264c,South Manchester University Healthcare Trust,south_manchester_university_healthcare_trust,,,,,, -7150,,7959d7b4-8578-45e8-9e99-62140bb0a1b0,Universidad de Salamanca,universidad_de_salamanca,,,,,, -958,0.979515,6388a82e-7157-11e6-a0cd-0242ac12000b,ELAN PHARMA INTL LTD,elan_pharma_intl_ltd,,,,6388a82e-7157-11e6-a0cd-0242ac12000b,elan_pharma_intl_ltd,ELAN PHARMA INTL LTD -7151,,1a3f155e-7193-11e6-a0cd-0242ac12000b,PFIZER GLOBAL,pfizer_global,,,,,, -7152,,beb65622-5bb0-4ef6-80de-c809aa40ccca,Anni Ravnbek Jensen,anni_ravnbek_jensen,,,,,, -7153,,bcb33d21-b979-4fbd-8657-abd096c96ec6,CeRePP,cerepp,,,,,, -7154,,399fce44-729b-11e6-a0cd-0242ac12000b,HELSINN HLTHCARE,helsinn_hlthcare,,,,,, -7155,,becdbf42-bd5e-4483-afb0-07ff5d81cc62,"Pfizer AB, Vetenskapsvagen 10, 191 90 Sollentuna, Sweden",pfizer_ab_vetenskapsvagen_10_191_90_sollentuna_sweden,,,,,, -7156,,63e2ed24-7162-11e6-a0cd-0242ac12000b,LEITNER PHARMS,leitner_pharms,,,,,, -7157,,695e880d-88cd-46f3-961b-9c2c832faa78,Hilkka Soininen/Kuopio University Hospital,hilkka_soininen_kuopio_university_hospital,,,,,, -700,0.931044,71bf9d51-f211-4fcd-b6d2-35dce8b4c292,Juan Córdoba,juan_c_rdoba,,,,71bf9d51-f211-4fcd-b6d2-35dce8b4c292,juan_c_rdoba,Juan Córdoba -7158,,ef45cb52-8e29-4764-98da-e47e45a35d6a,Helena Barrasa,helena_barrasa,,,,,, -7159,,74cd8ac3-aa1f-49b2-9ccc-bc7bf79ff513,Ensinger Mineral-Heilquellen GmbH,ensinger_mineral_heilquellen_gmbh,,,,,, -7160,,6169badd-af23-4afb-b5fa-7f0f90b57b23,FAST Consortium under EU 7. FWP,fast_consortium_under_eu_7_fwp,,,,,, -7161,,b75cf5b4-47b0-4c73-ae06-11b3c7d22a0c,IDIAP JORDI GOL I GURINA,idiap_jordi_gol_i_gurina,,,,,, -7162,,30dced4d-a05b-4bfa-ad44-9e3e326cb882,"Department of Psychiatry, Helsinki University Central Hospital",department_of_psychiatry_helsinki_university_central_hospital,,,,,, -7163,,79ee8886-a2f1-4ac4-a5f8-326c7d689a63,"Onyx Therapeutics, Inc",onyx_therapeutics_inc,,,,,, -7164,,4b22d533-921c-4105-94ef-0fbe69a95625,"Klinikum der Universität München, Standort Großhadern",klinikum_der_universit_t_m_nchen_standort_gro_hadern,,,,,, -7165,,86be5b81-2954-4279-bfab-a3efbefb6ec3,Mentis Cura ehf,mentis_cura_ehf,,,,,, -7166,,11e2ca36-7b00-42e7-abd7-dc7992097f68,"Ortho-McNeil Janssen Scientific Affairs, LLC",ortho_mcneil_janssen_scientific_affairs_llc,,,,,, -7167,,5c737caf-da3d-4ab5-9d58-144028d9c46f,Jeroen Bosch - Groot Ziekengasthuis,jeroen_bosch_groot_ziekengasthuis,,,,,, -613,0.97674435377120972,f73db246-b5f4-49be-ab84-42d9dfa56dfb,"Erasmus Medical Center, Department of Anesthesiology",erasmus_medical_center_department_of_anesthesiology,,,,12caeba5-ed14-4baa-9bbd-829d8aa11d8a,erasmus_medical_centre_department_of_anesthesiology,"Erasmus Medical Centre, Department of Anesthesiology" -359,0.97782391309738159,453b2e40-8c8e-4dab-8a75-c9364067b629,IPSEN NV,ipsen_nv,,,,453b2e40-8c8e-4dab-8a75-c9364067b629,ipsen_nv,IPSEN NV -979,0.919788,5beb59d6-f94c-4993-90c5-181d33404f39,"Johnson & Johnson Consumer & Personal Products Worldwide, Division of Johnson & Johnson Consumer Companies, Inc",johnson_johnson_consumer_personal_products_worldwide_division_of_johnson_johnson_consumer_companies_inc,,,,5beb59d6-f94c-4993-90c5-181d33404f39,johnson_johnson_consumer_personal_products_worldwide_division_of_johnson_johnson_consumer_companies_inc,"Johnson & Johnson Consumer & Personal Products Worldwide, Division of Johnson & Johnson Consumer Companies, Inc" -355,0.989009,a1adcba9-c31d-4582-ac69-c64b28d7d11d,Asociación Colaboración Cochrane Iberoamericana,asociaci_n_colaboraci_n_cochrane_iberoamericana,,,,9cb0b7ef-9196-4272-8e74-952d80c320c4,asociaci_n_colaboraci_n_cochrane_iberoamericana_accib,Asociación Colaboración Cochrane Iberoamericana (ACCIb) -7168,,f15111a5-df89-4d0c-a844-44ad1c3fed2a,"Puma Biotechnology, Inc",puma_biotechnology_inc,,,,,, -7169,,e9b293c6-bd60-4ec7-9f29-c3e91d98c846,Epsom & St Helier's University Hospital NHS Trust,epsom_st_helier_s_university_hospital_nhs_trust,,,,,, -420,0.949464,4ff92bf9-dd91-4af4-8f0b-df007e6ac363,SAKK,sakk,,,,4ff92bf9-dd91-4af4-8f0b-df007e6ac363,sakk,SAKK -801,0.96035,d11a498d-47fc-48b8-84af-65a7f6eff7cf,"ORVACS, Objectif Recherche Vaccin SIDA",orvacs_objectif_recherche_vaccin_sida,,,,afb22cce-e75c-4e05-ab78-210fb3ae8aa8,orvacs,ORVACS -290,0.985423,4526ca2e-a18d-4d92-8100-e8a0507a1f36,Mayne Pharma,mayne_pharma,,,,4526ca2e-a18d-4d92-8100-e8a0507a1f36,mayne_pharma,Mayne Pharma -55,0.95857,43cce800-7149-11e6-a0cd-0242ac12000b,EGIS,egis,,,,43cce800-7149-11e6-a0cd-0242ac12000b,egis,EGIS -7170,,b4a1ac2e-98af-475e-8f53-9cd475936928,Bayer AG,bayer_ag,,,,,, -7171,,4bd47120-cbc7-45f9-9327-e056a1eacd5e,Takeda Development Centre Europe Limited,takeda_development_centre_europe_limited,,,,,, -7172,,19f40c73-c1bc-4f3e-982d-eb644a77bee5,"LOTUS Pharma CO., LTD",lotus_pharma_co_ltd,,,,,, -7173,,fe90f24c-a9b8-4d2c-91ef-17e9cdc16158,Landspitali University Hospital,landspitali_university_hospital,,,,,, -7174,,13bf1f19-7572-4507-abe4-1d6d1029dedb,CHU AMIENS,chu_amiens,,,,,, -657,0.988592,94fe56aa-5dec-4b9e-95e5-c23b1585d045,sanofi-aventis Netherlands,sanofi_aventis_netherlands,,,,94fe56aa-5dec-4b9e-95e5-c23b1585d045,sanofi_aventis_netherlands,sanofi-aventis Netherlands -7175,,3f77286d-c495-486c-93d9-567d9b150473,"Keryx Biopharmaceuticals, Inc",keryx_biopharmaceuticals_inc,,,,,, -491,0.9828302264213562,e0d1f6b9-224f-42aa-a9f1-fc7fdf02f5e4,GlaxoSmithKline,glaxosmithkline,,,,280c153e-a191-46ae-8ddc-97dc33b90bb5,glaxosmithkline_sia_latvia,GlaxoSmithKline SIA Latvia -405,0.96411377191543579,001f0c1a-b3ca-426e-bb98-8fb8a819a482,"Gilead Science, Inc",gilead_science_inc,,,,dee4490b-b25c-4c54-b909-635261eba55d,gilead,Gilead -7176,,daeaf21a-b265-479b-9ca3-6bbf469557aa,Dr. Antonio Román Broto,dr_antonio_rom_n_broto,,,,,, -7177,,7875d8b5-a7de-4d60-9cd0-c3054a8bf883,Manuel García Medina,manuel_garc_a_medina,,,,,, -7178,,01e34a1e-71d1-11e6-a0cd-0242ac12000b,CADEMA,cadema,,,,,, -7179,,08acc369-9848-4a20-80be-b1ed5472c7c1,Central Manchester and Manchester Children's Hospitals NHS Trust,central_manchester_and_manchester_children_s_hospitals_nhs_trust,,,,,, -7180,,80726611-effd-49f6-a29a-9591f86e8171,Universityhospital Ulm,universityhospital_ulm,,,,,, -515,0.928618,0b864f9c-6a82-4657-9f94-14d0aa558320,"J. Uriach y Compañia, S. A",j_uriach_y_compa_ia_s_a,,,,0b864f9c-6a82-4657-9f94-14d0aa558320,j_uriach_y_compa_ia_s_a,"J. Uriach y Compañia, S. A" -801,0.96035,afb22cce-e75c-4e05-ab78-210fb3ae8aa8,ORVACS,orvacs,,,,afb22cce-e75c-4e05-ab78-210fb3ae8aa8,orvacs,ORVACS -7181,,fc125586-73c3-11e6-a0cd-0242ac12000b,HORIZON THERAPS INC,horizon_theraps_inc,,,,,, -7182,,847eaa2e-4115-402c-94fd-61c63e38ea88,"Department of Surgery, Herlev Hospital",department_of_surgery_herlev_hospital,,,,,, -7183,,1d6c13b8-72aa-11e6-a0cd-0242ac12000b,EISAI MEDCL RES,eisai_medcl_res,,,,,, -7184,,2e1c0808-7160-11e6-a0cd-0242ac12000b,POLYMEDICA,polymedica,,,,,, -7185,,fa59c5d7-4e7f-4003-b10d-559062922dcd,Antonio Antela López,antonio_antela_l_pez,,,,,, -7186,,4f2f08ec-6fa3-11e6-9663-0242ac12000b,AESCA Pharma Ges.m.b.H,aesca_pharma_ges_m_b_h,,,,,, -188,0.9797365665435791,c698abc0-6f9b-11e6-9663-0242ac12000b,Nycomed,nycomed,,,,c698abc0-6f9b-11e6-9663-0242ac12000b,nycomed,Nycomed -796,0.98663,a1ce2c38-7163-11e6-a0cd-0242ac12000b,STRIDES ARCOLAB LTD,strides_arcolab_ltd,,,,26536bce-72ec-11e6-a0cd-0242ac12000b,strides_arcolab,STRIDES ARCOLAB -7187,,eb490b38-71d3-11e6-a0cd-0242ac12000b,HQ SPECLT PHARMA,hq_speclt_pharma,,,,,, -816,0.989949,d89406de-85c4-474e-a03e-9516d6463bf7,The Kompetenznetz Vorhofflimmern e.V. [German Atrial Fibrillation Competence Network association (AF,the_kompetenznetz_vorhofflimmern_e_v_german_atrial_fibrillation_competence_network_association_af,,,,d89406de-85c4-474e-a03e-9516d6463bf7,the_kompetenznetz_vorhofflimmern_e_v_german_atrial_fibrillation_competence_network_association_af,The Kompetenznetz Vorhofflimmern e.V. [German Atrial Fibrillation Competence Network association (AF -7188,,bb013508-ec7d-4956-91b5-c8b7cdc178eb,"ALK-Abello, Group Clinical Development",alk_abello_group_clinical_development,,,,,, -7189,,70af62ca-9ca2-4aae-b12c-5a4f8ea1c57b,Nordmark Arzneimittel GmbH,nordmark_arzneimittel_gmbh,,,,,, -7190,,ef637a9d-e802-4bfa-8e48-a3eb7b2d05aa,"KONSTANTINAS POVILAS VALUCKAS, INSTITUTE OF ONCOLOGY OF VILNIUS UNIVERSITY",konstantinas_povilas_valuckas_institute_of_oncology_of_vilnius_university,,,,,, -7191,,d6002afa-8811-11e6-a998-0242ac12000b,North West London NHS Trust,north_west_london_nhs_trust,,,,,, -319,0.943406,b6c9f78d-3623-4c1b-b488-81bf230000fd,MERCK SERONO SPA,merck_serono_spa,,,,8fd294ea-aee1-4e2e-86ed-6265cb17d1af,merck_serono_sa,MERCK SERONO SA -7192,,32027923-42dd-4ab4-b26f-ab03457677e8,JSC Grindeks,jsc_grindeks,,,,,, -7193,,53a21880-6f13-484d-b836-5b24ac6efd1d,F.Schreuder,f_schreuder,,,,,, -7194,,e42f0bfd-b496-4732-a47b-8c14964c9df2,Vesa Pakanen,vesa_pakanen,,,,,, -7195,,94af10da-72fd-11e6-a0cd-0242ac12000b,PERNIX IRELAND LTD,pernix_ireland_ltd,,,,,, -7196,,0dc19032-a5b8-4124-9ac4-cbe5211124eb,Academisch ziekenhuis Leiden acting under the name of Leids Universitair Medisch Centrum,academisch_ziekenhuis_leiden_acting_under_the_name_of_leids_universitair_medisch_centrum,,,,,, -7197,,6d487914-16e0-4dbf-9c1e-fd44f1a555a2,"Isis Pharmaceuticals, Inc",isis_pharmaceuticals_inc,,,,,, -7198,,488640d2-715b-11e6-a0cd-0242ac12000b,NU PHARM,nu_pharm,,,,,, -9,0.96726498007774353,2f45bfe9-0b5a-450f-abb3-c7aa18916ff8,Centre Hospitalier Universitaire Rennes,centre_hospitalier_universitaire_rennes,,,,2f45bfe9-0b5a-450f-abb3-c7aa18916ff8,centre_hospitalier_universitaire,Centre Hospitalier Universitaire -7199,,35987db1-fa3a-4bcf-a4e7-c3c2f9cee57a,STRUTTURA SEMPLICE GESTIONE-ORG.-FUNZ. HUB EMOFILIA,struttura_semplice_gestione_org_funz_hub_emofilia,,,,,, -562,0.979163,788b20ed-9fc5-4bbe-8a89-5a73895f8c3e,Glaxo SmithKline Research and Development Limited,glaxo_smithkline_research_and_development_limited,,,,2618aeee-2b40-46b0-83e0-69a85a4447c6,glaxo_smithkine_research_and_development_limited,Glaxo SmithKine Research and Development Limited -7200,,7f26886a-715e-11e6-a0cd-0242ac12000b,MARSHALL PHARMA,marshall_pharma,,,,,, -1078,0.958152174949646,0d8956db-6782-46d2-8279-946b33f25bc5,IBSA Institute Biochimique SA,ibsa_institute_biochimique_sa,,,,1242e11a-4288-492d-8023-e4ffe5a4e9bd,ibsa_institute_biochimique_sa,IBSA Institute Biochimique SA -1017,0.98458112776279449,c5aa9e47-d56f-4f01-92f1-cb0bad609620,Southampton University Hospitals,southampton_university_hospitals,,,,986ad2cd-cb4e-460c-acdc-a2b32a61de09,southampton_university_hospitals,Southampton University Hospitals -7201,,a6b74179-73d1-454f-b546-3bdc5a71b028,BIO PRODUCTS LABORATORY LIMITED (BPL),bio_products_laboratory_limited_bpl,,,,,, -7202,,46e2966b-78e5-4fd3-b275-62627bad64a5,Dorset County Hospital NHS foundation trust,dorset_county_hospital_nhs_foundation_trust,,,,,, -7203,,f1e04d98-6f9f-11e6-9663-0242ac12000b,Lytix Biopharma AS,lytix_biopharma_as,,,,,, -201,0.982782,01c1da90-d188-4b3b-9a77-71c11c8ab042,Kuopio University Hospital,kuopio_university_hospital,,,,01c1da90-d188-4b3b-9a77-71c11c8ab042,kuopio_university_hospital,Kuopio University Hospital -929,0.964008,9a5d3906-eb62-4e28-bbd4-1747e100864c,Leeds teaching Hospitals,leeds_teaching_hospitals,,,,9a5d3906-eb62-4e28-bbd4-1747e100864c,leeds_teaching_hospitals,Leeds teaching Hospitals -65,0.97933,8a33d4f4-7359-11e6-a0cd-0242ac12000b,ANGELINI PHARMA,angelini_pharma,,,,85300b96-9316-43a9-b115-b61f3263249b,angelini,ANGELINI -7204,,d41076a5-77a0-4aad-a665-20dcefaa37b5,Esko Kemppainen,esko_kemppainen,,,,,, -318,0.98787707090377808,215a6fe0-4912-4052-b609-f99824db28f0,Department of Neurology,department_of_neurology,,,,215a6fe0-4912-4052-b609-f99824db28f0,department_of_neurology,Department of Neurology -7205,,52bc7d4f-2884-44c9-9534-8e4c35266822,Aintree University Hospital NHS Foundation Trust,aintree_university_hospital_nhs_foundation_trust,,,,,, -7206,,3d21fcd2-6fc0-11e6-abe8-0242ac12000b,"Dept. of Cardiology, Medical University of Vienna",dept_of_cardiology_medical_university_of_vienna,,,,,, -108,0.976464,d3014e9c-d04d-49df-8301-b6d581035e05,Instituto de Inmunología y Alergia INMUNAL S.A..U,instituto_de_inmunolog_a_y_alergia_inmunal_s_a_u,,,,b357c82c-483a-4d22-ba95-f043cc73dd9b,instituto_de_inmunolog_a_y_alergia_inmunal_sau,Instituto de Inmunología y Alergia INMUNAL SAU -7207,,0c9836cc-5d39-4834-9a2c-09b85f3812cc,Novartis Vaccines and Diagnostics Limited,novartis_vaccines_and_diagnostics_limited,,,,,, -7208,,3b414b68-7167-11e6-a0cd-0242ac12000b,METHODIST HOSP RES,methodist_hosp_res,,,,,, -7209,,6b7d2b4f-4aca-4487-b0ce-3fe8d9b2f9da,Astellas US Pharma US Inc.(APUS),astellas_us_pharma_us_inc_apus,,,,,, -7210,,02aeddcf-2df8-4c1a-b746-a3975dbd9320,"Boehringer Ingelheim Hellas, S.A",boehringer_ingelheim_hellas_s_a,,,,,, -7211,,76a79fee-7140-11e6-a0cd-0242ac12000b,KING PHARMS,king_pharms,,,,,, -7212,,458e8d6f-b099-44c7-8ec3-eb4a7ea934af,AMC Medical research BV,amc_medical_research_bv,,,,,, -7213,,42698966-0dbc-4168-81d4-7a9ac2cb40e4,Atrium Medical Centre,atrium_medical_centre,,,,,, -7214,,e40c9897-9273-4be4-87e5-1e3a2ba5a16b,University Hospital of Muenster,university_hospital_of_muenster,,,,,, -7215,,328a4feb-090c-46e5-a2b3-ade9594d0dc8,ViroLogik GmbH,virologik_gmbh,,,,,, -458,0.98385661840438843,3baabec0-1bc8-4e64-b010-70f6fcb400f2,"Jassen-Cilag International NV,Turnhoutseweg 30, 2340 Beerse, Belgium",jassen_cilag_international_nv_turnhoutseweg_30_2340_beerse_belgium,,,,3baabec0-1bc8-4e64-b010-70f6fcb400f2,jassen_cilag_international_nv_turnhoutseweg_30_2340_beerse_belgium,"Jassen-Cilag International NV,Turnhoutseweg 30, 2340 Beerse, Belgium" -7216,,e9e33638-b4e7-45af-8793-6e60ee2f6978,Sahlgrenska University hospital of gothenburg Department of dermatology,sahlgrenska_university_hospital_of_gothenburg_department_of_dermatology,,,,,, -7217,,dc5de270-5772-4dd0-891f-4dec9f50a379,"Department Integrative Medicine, Kliniken Essen Mitte",department_integrative_medicine_kliniken_essen_mitte,,,,,, -7218,,fd915d18-a3f2-4837-bd7e-1c06698794a9,Hellmuth Ulrici Kliniken,hellmuth_ulrici_kliniken,,,,,, -7219,,43d56b38-162c-4ee9-a6e7-0e89acde29da,FIT Biotech Oyj Plc,fit_biotech_oyj_plc,,,,,, -105,0.92743,d4f547b3-11c3-4fc5-9074-7d39f3b62c47,Aristotle University Thessaloniki,aristotle_university_thessaloniki,,,,87f12084-92d1-4b68-89c3-59450c51ce2e,aristotle_university_of_thessaloniki,Aristotle University of Thessaloniki -7220,,7f46d36d-b4f9-4b46-ae57-51554025201b,"Dr. Olivier F. Bertrand , Laval Hospital",dr_olivier_f_bertrand_laval_hospital,,,,,, -7221,,9f6a4ba9-6b2f-4985-b151-06ff0897c23f,Toray Industries Inc,toray_industries_inc,,,,,, -376,0.95499825477600098,bd6bee50-086c-45b4-9e8c-06da513d3e0f,"Merck Sharp & Dohme Corp., filial de Merck & Co., Inc",merck_sharp_dohme_corp_filial_de_merck_co_inc,,,,105bd662-3e0a-487f-94e5-81782ae2a384,merck_sharp_dohme_corp_una_filial_de_merck_co_inc,"Merck Sharp & Dohme Corp., una filial de Merck & Co., Inc" -871,0.98728418350219727,0f0582d8-6951-40ea-8acc-9d010331c376,Astellas Pharma Europe Ltd. (APEL),astellas_pharma_europe_ltd_apel,,,,0f0582d8-6951-40ea-8acc-9d010331c376,astellas_pharma_europe_ltd_apel,Astellas Pharma Europe Ltd. (APEL) -7222,,9d6716e7-326c-4842-a170-11ce5d984e1f,Alimera Sciences Inc,alimera_sciences_inc,,,,,, -7223,,37d887f2-7194-11e6-a0cd-0242ac12000b,NURO PHARMA,nuro_pharma,,,,,, -7224,,0789c22e-1447-4fda-8059-9e0602b02195,Sanofi-Aventis recherche de veloppement,sanofi_aventis_recherche_de_veloppement,,,,,, -7225,,f9b41ee0-777d-4776-acec-5d3b42670002,Dermapharm AG,dermapharm_ag,,,,,, -7226,,857d85f6-71b8-11e6-a0cd-0242ac12000b,UNITED GUARDIAN,united_guardian,,,,,, -7227,,00e570d9-c195-40a4-ac87-a4a91f82be2a,Fondazione Neureca Onlus,fondazione_neureca_onlus,,,,,, -29,0.987472,27abc283-e5cd-4ac3-968b-19e1e91d0bcd,INO Therapeutics AB,ino_therapeutics_ab,,,,27abc283-e5cd-4ac3-968b-19e1e91d0bcd,ino_therapeutics_ab,INO Therapeutics AB -7228,,87306cb6-b40b-4013-835b-63b57755824b,María Carmen Cabellos Mínguez,mar_a_carmen_cabellos_m_nguez,,,,,, -896,0.983343,a1bb1c18-7336-11e6-a0cd-0242ac12000b,WYETH PHARMS PFIZER,wyeth_pharms_pfizer,,,,a1bb1c18-7336-11e6-a0cd-0242ac12000b,wyeth_pharms_pfizer,WYETH PHARMS PFIZER -7229,,435d2956-e780-4b67-973c-b31c98d130a4,Cytonet GmbH & Co. KG,cytonet_gmbh_co_kg,,,,,, -1025,0.96337196230888367,2f59f764-513a-43d8-ba41-bc314f18f59b,"Eli Lilly and Company Limited, Indianapolis",eli_lilly_and_company_limited_indianapolis,,,,2f59f764-513a-43d8-ba41-bc314f18f59b,eli_lilly_and_company_limited,Eli Lilly and Company limited -7230,,bd8730de-09b5-4ada-9a50-28a213327b58,Michael Larsen,michael_larsen,,,,,, -7231,,be28ec0f-4150-4f1d-9c22-b010ce920913,"prof W.J. Fokkens, academic medical center",prof_w_j_fokkens_academic_medical_center,,,,,, -667,0.985709,2e06635b-2945-406f-8fe4-e9afcb19c015,Consorci Parc de Salut Mar,consorci_parc_de_salut_mar,,,,1a3268a1-1f5d-4bc4-a2cd-ff168ce961fd,consorci_parc_de_salut_mar_de_barcelona,Consorci Parc de Salut Mar de Barcelona -130,0.9775693416595459,96e696d3-f783-429f-922d-c183e3c81995,Cliniques universitaires Saint-Luc,cliniques_universitaires_saint_luc,,,,3515d8bf-edb3-4b5e-ba66-e5a15542aded,cliniques_universitaires_saint_luc_cusl,Cliniques Universitaires Saint-Luc (CUSL) -7232,,ba2c923c-5fcc-44d6-9e41-35af745e107f,University of Zurich,university_of_zurich,,,,,, -7233,,6c7a15e2-5b0e-4ca9-bae1-ba470fcaf9b4,CISbio International,cisbio_international,,,,,, -7234,,0ccfb2d4-8b49-44de-b46a-118191523187,"Exxentia Grupo Fitoterapéutico, S.A",exxentia_grupo_fitoterap_utico_s_a,,,,,, -7235,,30fc0f2a-8398-49ed-9312-80d6b03b06b2,"Department of Molecular and Clinical Medicine; ""Sapienza"" University of Rome",department_of_molecular_and_clinical_medicine_sapienza_university_of_rome,,,,,, -7236,,78b04fde-18a9-4a11-a46e-537b31f0899e,AZIENDA OSPEDALIERA DI PADOVA,azienda_ospedaliera_di_padova,,,,,, -7237,,5fc47834-8413-4c3c-8f13-e282c716a1d1,Fundación Progreso y Salud,fundaci_n_progreso_y_salud,,,,,, -570,0.967052,c7f9a7b2-715d-11e6-a0cd-0242ac12000b,CARDINAL HEALTH 414,cardinal_health_414,,,,c7f9a7b2-715d-11e6-a0cd-0242ac12000b,cardinal_health_414,CARDINAL HEALTH 414 -7238,,acbfd119-3ec8-4ed5-80f8-dba74434eb32,KRKA-POLSKA Sp. z o.o,krka_polska_sp_z_o_o,,,,,, -7239,,8c0c2630-73f1-11e6-a0cd-0242ac12000b,PRAXAIR DISTRIBUTION INC,praxair_distribution_inc,,,,,, -7240,,21bdb8c3-c488-4b3e-97fc-8856925e3213,Protherics Medicines Development Ltd,protherics_medicines_development_ltd,,,,,, -7241,,4fc0232b-5b31-4cfd-a58d-e69413076dfa,"University of Turin, Dept of Clinical & Biological Sciences",university_of_turin_dept_of_clinical_biological_sciences,,,,,, -7242,,f3c88626-6701-41a0-85bc-e982a9dcaa82,"Unidad Integral de Investigación en Oncología, S.L",unidad_integral_de_investigaci_n_en_oncolog_a_s_l,,,,,, -7243,,74512f41-925f-4942-9cbd-7a05f7baba54,sanofi pasteur SA,sanofi_pasteur_sa,,,,,, -543,0.930137,c802f14e-ff99-4093-8da7-863343646050,Abbott Laboratories LLC,abbott_laboratories_llc,,,,71738680-41ff-4751-88bc-8c484e8e9bc7,abbott_laboratories_limited_queenborough_kent_me11_5el_england,"Abbott Laboratories Limited (Queenborough, Kent, ME11 5EL, England)" -7244,,a78b7bcc-7167-11e6-a0cd-0242ac12000b,MSN LABS PVT LTD,msn_labs_pvt_ltd,,,,,, -7245,,c0576e2c-bd1d-49ab-a3ee-f89de65b3b42,Glasgow University,glasgow_university,,,,,, -338,0.944177,8d963edd-4feb-4306-95ff-812ad6aebbde,Medizinische Fakultät der Universität Bonn,medizinische_fakult_t_der_universit_t_bonn,,,,59161c21-f110-4f6b-bf67-f4d922ff5a94,medizinische_fakult_t_der_universit_t_rostock,Medizinische Fakultät der Universität Rostock -291,0.978606,320e8407-98ad-450a-9b12-470d02f981e1,GEICAM (GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA),geicam_grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama,,,,320e8407-98ad-450a-9b12-470d02f981e1,geicam_grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama,GEICAM (GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA) -7246,,24c14c11-4a28-4351-8872-590127aaac41,CENTRO PER LA PREVENZIONE E CURA DEL TABAGISMO,centro_per_la_prevenzione_e_cura_del_tabagismo,,,,,, -7247,,b772b33d-0a76-4ae6-9de6-f238be87e134,Justus-Liebig-University,justus_liebig_university,,,,,, -7248,,fbca3518-c742-48cc-af5f-e0709dc105b3,Phenomix Corporation,phenomix_corporation,,,,,, -7249,,240f84eb-3774-4d80-aa50-ebd275572350,ISTITUTO C. MONDINO,istituto_c_mondino,,,,,, -7250,,6cb16e83-bb9b-436f-a26b-c13e5f1d85b7,"Universitätsklinik für Radiodiagnostik, Abteilung für Neuroradiologie, Medizinische Universität Wien",universit_tsklinik_f_r_radiodiagnostik_abteilung_f_r_neuroradiologie_medizinische_universit_t_wien,,,,,, -7251,,ddfc4ff8-fd92-4c99-83c6-2535e8b30911,Sigrun Kjøtrød,sigrun_kj_tr_d,,,,,, -7252,,a3926a79-3c06-4e2a-8455-8266d56015f0,Rafael Bielza Galindo,rafael_bielza_galindo,,,,,, -7253,,6049b86f-095c-4972-b467-778b1207af96,"University of Szeged, Medical and Pharmaceutical Center, Department of Ophthalmology",university_of_szeged_medical_and_pharmaceutical_center_department_of_ophthalmology,,,,,, -7254,,1b28347f-f138-4c56-9a19-4b40b7fd59cf,EGRIS,egris,,,,,, -920,0.98836344480514526,f01871b1-36b4-4081-95b7-6ef328172aa7,AZIENDA OSPEDALIERO-UNIVERSITARIA,azienda_ospedaliero_universitaria,,,,d94f6c83-6e14-4b83-88fc-13e50ecbc634,azienda_ospedaliero_universitaria_pisana,AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA -7255,,84151828-4784-4458-97bf-d1fe1f88b6a8,"Psychosis Early Detection and Intervention Centre, Department for Psychiatry, UKE Hamburg",psychosis_early_detection_and_intervention_centre_department_for_psychiatry_uke_hamburg,,,,,, -252,0.96770843863487244,0f0d8991-097b-4737-a496-fd2e4d5aa3ff,Martin Luther University of Halle-Wittemberg,martin_luther_university_of_halle_wittemberg,,,,0f0d8991-097b-4737-a496-fd2e4d5aa3ff,martin_luther_university_of_halle_wittenberg,Martin Luther University of Halle/Wittenberg -7256,,6d424ef0-af3e-49bb-92a5-1e880f9a4e11,"Genzyme, a Sanofi Company",genzyme_a_sanofi_company,,,,,, -101,0.96975362300872803,795618d0-8fa3-476f-af53-917115d81263,"University Children's Hospital, Department of Neonatology",university_children_s_hospital_department_of_neonatology,,,,6cac1b04-1612-4a24-92aa-2b5234eb2596,university_childrin_s_hospital,University Childrin's Hospital -7257,,b12f961f-65f0-45b2-bb50-b17bc54604b1,TRIGEN,trigen,,,,,, -7258,,2345d8b7-c300-4d81-a29d-f473ed2970bd,EKOS Corporation,ekos_corporation,,,,,, -7259,,8152210c-7b0c-421e-bfd8-1f3684fbd81d,Democritus Universityof Thrace Medical School,democritus_universityof_thrace_medical_school,,,,,, -7260,,3e87d3b1-e8e3-4ff7-b508-90fb811856c5,CERENIS THERAPEUTICS SA,cerenis_therapeutics_sa,,,,,, -7261,,53c95df4-77bd-404c-9bd9-0e97874b82e0,Swedish Orphan Biovitrum (Sobi) AB (publ),swedish_orphan_biovitrum_sobi_ab_publ,,,,,, -7262,,66861f29-b8e5-40f8-b293-ec281ac77975,ISTITUTO AUXOLOGICO ITALIANO,istituto_auxologico_italiano,,,,,, -608,0.97136334578196204,74941600-ec13-4438-9c7c-d11859941da7,"RWTH Aachen University for the Medical Faculty, represented by Clinical Trial Center Aachen (CTC-A)",rwth_aachen_university_for_the_medical_faculty_represented_by_clinical_trial_center_aachen_ctc_a,,,,8cf07097-1668-4840-99e4-5f3861195629,rwth_aachen_university_for_the_medical_faculty_represented_by_clinical_trial_center_aachen_ctc_a,"RWTH Aachen University for the Medical Faculty, represented by Clinical Trial Center Aachen (CTC-A)" -7263,,a0d4d94b-329e-4064-a1af-2b43cbc1a34b,Beaufour Ipsen Pharma-Ipsen Biotech Department,beaufour_ipsen_pharma_ipsen_biotech_department,,,,,, -39,0.981087,81ade96c-402d-40b2-b4a1-a4b54a97c3f1,Innovacell Biotechnologie AG,innovacell_biotechnologie_ag,,,,277efbbe-0659-4d05-bc5a-4b600b2919e3,innovacell_biotechnologie_ag_life_science_center_innsbruck,Innovacell Biotechnologie AG - Life Science Center Innsbruck -7264,,cd454559-7cea-4fb2-9485-06cf8aabf8be,Nabriva Therapeutics AG,nabriva_therapeutics_ag,,,,,, -890,0.91218763589859009,6e8ed001-5c25-4c82-8b82-365ae91ee2c8,"University Medical Center, Johannes Gutenberg-University Mainz",university_medical_center_johannes_gutenberg_university_mainz,,,,6e8ed001-5c25-4c82-8b82-365ae91ee2c8,university_medical_center_johannes_gutenberg_university_mainz,"University Medical Center, Johannes Gutenberg-University Mainz" -7265,,002936cc-1796-4c16-a046-0236c411b989,"Fundació Institut de Recerca, Hospital Santa Creu i Sant Pau",fundaci_institut_de_recerca_hospital_santa_creu_i_sant_pau,,,,,, -7266,,8bb3ad09-cf68-494d-a1c6-6b953da36cfc,Derbyshire NHS Trust,derbyshire_nhs_trust,,,,,, -7267,,63f9c956-1077-4225-8217-63a677f9a4a2,Newron Pharmaceuticals S.p.A,newron_pharmaceuticals_s_p_a,,,,,, -7268,,e983e7c4-714b-11e6-a0cd-0242ac12000b,VALEANT PHARMS NORTH,valeant_pharms_north,,,,,, -1081,0.98642590641975403,409b84eb-a4eb-4d52-878e-1faec5f0397f,Vertex Pharmaceuticals,vertex_pharmaceuticals,,,,48c9366f-f57d-45a5-b7c5-8b03cb153868,vertex_pharmaceuticals_inc,Vertex Pharmaceuticals Inc -7269,,73cd5dbf-1b23-478d-830a-77865dd72673,ASSOCIAZIONE SALENTINA ANGELA SERRA ONLUS,associazione_salentina_angela_serra_onlus,,,,,, -487,0.989076,9b0dc634-cbf6-42d8-8ab7-f7378694b382,University Eye Clinic Maastricht UMC,university_eye_clinic_maastricht_umc,,,,614b7da9-01e8-45b1-a601-7f743ec0f288,university_eye_clinic_maastricht,University Eye Clinic Maastricht -7270,,b8cc461d-f4df-4e00-ad13-3ccf6cf6f7b8,Regensburg University Medical Center,regensburg_university_medical_center,,,,,, -7271,,496acb41-295a-43ee-9136-4d1fef65e2b7,"TolerRx, Inc",tolerrx_inc,,,,,, -7272,,f741a791-41e4-4a48-831e-e9270ec7c683,"Pr Giampiero CAMPANELLI - Ospedale Maggiore Policlinico, Padiglione Beretta Est",pr_giampiero_campanelli_ospedale_maggiore_policlinico_padiglione_beretta_est,,,,,, -7273,,1100cb45-aefd-43d1-abf7-a7a7c2a29071,Institute of Diabetes “Gerhardt Katsch”,institute_of_diabetes_gerhardt_katsch,,,,,, -7274,,66a1e8b5-17d5-45b5-97c8-76183db6666a,The Leeds Teaching Hospitals NHS Trust,the_leeds_teaching_hospitals_nhs_trust,,,,,, -7275,,3cee0add-756e-4c92-ac22-fd802d49f62e,"Franz Volhard Clinic, Charite Campus Buch",franz_volhard_clinic_charite_campus_buch,,,,,, -7276,,e57d8cb8-a963-4e24-b1af-244548590216,Andrés Íñiguez Romo,andr_s_iguez_romo,,,,,, -7277,,e1176698-f2fc-4c41-a1e3-351fcba3d504,"Aventis Pharma, S.A",aventis_pharma_s_a,,,,,, -7278,,95d2929e-a58a-4103-a7ad-7eff0549e50c,"Cogentus Pharmaceuticals, Inc",cogentus_pharmaceuticals_inc,,,,,, -7279,,22c767cd-30c5-407f-b017-9def5ee2271e,Institut for Pharmacology and Toxicology,institut_for_pharmacology_and_toxicology,,,,,, -7280,,217b103f-db57-4ad2-9c75-b814aa4c3b8f,F. Hoffmann-La Roche Ltd as part of the Aspreva Rare Disease Program,f_hoffmann_la_roche_ltd_as_part_of_the_aspreva_rare_disease_program,,,,,, -7281,,ef2aa4dd-53dc-4557-9fef-8e9e19f5c38b,Medical University Vienna Division of Anesthesie and Pain Management,medical_university_vienna_division_of_anesthesie_and_pain_management,,,,,, -7282,,7598b836-dbe5-4c2f-845b-64ca57b2a087,Carl Dahlöf,carl_dahl_f,,,,,, -7283,,9d57e13f-674b-48cd-9fd4-86a5c2ba7e70,German Cancer Research Center (DKFZ),german_cancer_research_center_dkfz,,,,,, -674,0.98227512836456299,e7897bf7-d8e3-4baf-a043-22a7475f28df,CENTOCOR,centocor,,,,9ebe2d66-716a-11e6-a0cd-0242ac12000b,centocor_inc,CENTOCOR INC -929,0.964008,caa7f728-f2b0-43f9-976b-86e1d2d9f227,Leeds Teaching Hospitals and University of Leeds,leeds_teaching_hospitals_and_university_of_leeds,,,,9a5d3906-eb62-4e28-bbd4-1747e100864c,leeds_teaching_hospitals,Leeds teaching Hospitals -7284,,ace5f454-7148-11e6-a0cd-0242ac12000b,SIGHT PHARMS,sight_pharms,,,,,, -7285,,32db7cda-f0f3-49de-b90e-0d463f53ae3a,Acino Supply AG,acino_supply_ag,,,,,, -7286,,ca0b3111-1dc9-4ef6-bb8f-f208f041c9ad,COSMO TECHNOLOGIES LTD,cosmo_technologies_ltd,,,,,, -439,0.98637,80bfc25c-b233-4572-aece-f1e06f4d720e,SciencePharma spółka z ograniczoną odpowiedzialnością sp. k,sciencepharma_sp_ka_z_ograniczon_odpowiedzialno_ci_sp_k,,,,80bfc25c-b233-4572-aece-f1e06f4d720e,sciencepharma_sp_ka_z_ograniczon_odpowiedzialno_ci_sp_k,SciencePharma spółka z ograniczoną odpowiedzialnością sp. k -7287,,9c067030-b7bf-4614-8e5b-e7ad7b8f10e4,Lilly SA,lilly_sa,,,,,, -7288,,7d76e9cc-5133-440a-a881-dd21fd60cfa6,"LKH-Universitätsklinikum Graz,Universitäre Palliativmedizinische Einrichtung",lkh_universit_tsklinikum_graz_universit_re_palliativmedizinische_einrichtung,,,,,, -773,0.958103,3ebee54d-bab5-4063-88aa-8fc3ffe15712,The Institute of Cancer Research,the_institute_of_cancer_research,,,,3ebee54d-bab5-4063-88aa-8fc3ffe15712,the_institute_of_cancer_research,The Institute of Cancer Research -7289,,791d5c1e-8c4f-41fd-9390-d50f50515b3e,Veloxis Pharmaceuticals A/S,veloxis_pharmaceuticals_a_s,,,,,, -7290,,7ce6676c-c4ba-411e-9add-f99f13d66812,Swansea University,swansea_university,,,,,, -7291,,d9670674-736b-11e6-a0cd-0242ac12000b,SPROUT PHARMS,sprout_pharms,,,,,, -7292,,d464e784-efa2-470c-94a0-f8046f6ee419,PET Diagnosztikai Kft,pet_diagnosztikai_kft,,,,,, -7293,,347835ba-f3c7-4a0c-a80d-241d25fb72aa,"Lux Biosciences, Inc",lux_biosciences_inc,,,,,, -260,0.985178,91b42753-22b3-40cf-91c4-a74d2a2ada1b,"National Cancer Institute Naples, Italy",national_cancer_institute_naples_italy,,,,91b42753-22b3-40cf-91c4-a74d2a2ada1b,national_cancer_institute_naples_italy,"National Cancer Institute Naples, Italy" -7294,,31eb4f92-718e-11e6-a0cd-0242ac12000b,NPS PHARMS INC,nps_pharms_inc,,,,,, -7295,,12b2ed8c-67f7-4cfa-ab5c-23410a9954bd,Medical Developments International Limited,medical_developments_international_limited,,,,,, -7296,,d705f084-7145-11e6-a0cd-0242ac12000b,MERRO PHARM,merro_pharm,,,,,, -7297,,7a25d496-8f4d-4bb8-88c1-beeff9b38fb3,"Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron",programa_de_medicina_molecular_y_gen_tica_hospital_vall_d_hebron,,,,,, -7298,,858768a0-bd33-47b8-b94b-1a7d1b18cd70,Kneipp-Werke,kneipp_werke,,,,,, -7299,,d8b63e76-0973-48e2-8c64-9471fddbfaf7,MolMed S.pA,molmed_s_pa,,,,,, -261,0.938998,d226d28e-bcc2-49e5-b106-505094f7139d,Servicio de Neumologia. Hospital Universitario Vall d'Hebron,servicio_de_neumologia_hospital_universitario_vall_d_hebron,,,,d226d28e-bcc2-49e5-b106-505094f7139d,servicio_de_neumologia_hospital_universitario_vall_d_hebron,Servicio de Neumologia. Hospital Universitario Vall d'Hebron -969,0.98663,627a1c48-7142-11e6-a0cd-0242ac12000b,WARNER CHILCOTT LLC,warner_chilcott_llc,,,,44eb1394-7142-11e6-a0cd-0242ac12000b,warner_chilcott,WARNER CHILCOTT -7300,,51035542-0eae-4847-b85e-7d29c7baa734,Máximo Bernabeu Wittel,m_ximo_bernabeu_wittel,,,,,, -7301,,48b3dd11-cca1-4c48-be24-ba42b9d2b587,"Vienna Medical University, Dept. of Ophthalmology",vienna_medical_university_dept_of_ophthalmology,,,,,, -7302,,c99cd2d2-5c75-4c44-9dfe-73d5feb7908a,International Extranodal Lymphoma Srudy Group IELSG,international_extranodal_lymphoma_srudy_group_ielsg,,,,,, -7303,,a008374b-494b-444e-9e9f-3b3ab24a26f2,"Medical University of Vienna, Department of Psychiatry and Psychotherapy",medical_university_of_vienna_department_of_psychiatry_and_psychotherapy,,,,,, -723,0.980428,c1b5c4ff-4c44-4ed2-b1cd-24290f52d232,Department of Hematology,department_of_hematology,,,,0d4e58c8-3d68-4fc8-a668-ed2e49340828,department_of_hematology_aalborg_university_hospital,"Department of Hematology, Aalborg University Hospital" -7304,,a7bf6b0c-2367-49c7-ae4b-7cc850909a14,VU University Medical Center,vu_university_medical_center,,,,,, -7305,,a9d3bf17-345d-4b97-956b-242b5e2c6bd1,Asklepios Klinik Sankt Augustin,asklepios_klinik_sankt_augustin,,,,,, -152,0.97483,bb0ec6d6-6629-4ef3-8650-4464fe4403fb,Novartis Farmaceutica SA,novartis_farmaceutica_sa,,,,88ecc254-b9db-4f96-8ef3-b7e21d00b20d,novartis_farmac_utica_sa,Novartis Farmacéutica SA -7306,,db065210-18ff-407a-aa3c-72ea0d79bffd,"CrystalGenomics, Inc",crystalgenomics_inc,,,,,, -407,0.9811650812625885,2313c489-596d-4d80-8c94-aa42d3a2f015,"Trius Therapeutics, a Wholly Owned Subsidiary of Cubist",trius_therapeutics_a_wholly_owned_subsidiary_of_cubist,,,,2313c489-596d-4d80-8c94-aa42d3a2f015,trius_therapeutics_a_wholly_owned_subsidiary_of_cubist,"Trius Therapeutics, a Wholly Owned Subsidiary of Cubist" -7307,,28796ff8-6f75-4397-98d3-f3c79325c3ba,Blockeel Christophe,blockeel_christophe,,,,,, -249,0.988541,2f1fb211-53ee-482a-b616-521b6469ae37,Novartis Pharma S.A,novartis_pharma_s_a,,,,2f1fb211-53ee-482a-b616-521b6469ae37,novartis_pharma_s_a,Novartis Pharma S.A -7308,,b4226f34-16c8-4afc-8ed8-900ff13d9d58,A. O. Istituti Ospitalieri di Cremona,a_o_istituti_ospitalieri_di_cremona,,,,,, -7309,,44c853ae-dbf0-48ea-a6ad-54663d381c94,"Cougar Biotechnology, Inc",cougar_biotechnology_inc,,,,,, -7310,,be128163-af6a-4376-87c0-3fa578efb28f,ICT (Instituto Científico y Técnológico de Navarra),ict_instituto_cient_fico_y_t_cnol_gico_de_navarra,,,,,, -7311,,22fec0aa-5d0d-4786-9af3-98f4ec33c1b3,ABLYNX N.V,ablynx_n_v,,,,,, -669,0.988702,61938087-3feb-4db9-87d0-5fff3fff06a4,The Walton Centre for Neurology and Neurosurgery,the_walton_centre_for_neurology_and_neurosurgery,,,,6139d772-2e3a-4727-b99c-78b770114708,the_walton_centre_for_neurology_and_neurosurgery_nhs_trust,The Walton Centre for Neurology and Neurosurgery NHS Trust -7312,,285793d7-1300-4148-91d5-4e7915056db4,IST - ISTITUTO NAZIONALE PER LA RICERCA SUL CANCRO,ist_istituto_nazionale_per_la_ricerca_sul_cancro,,,,,, -7313,,629bb665-a14e-4de6-80e9-75932a3defea,University Utrecht,university_utrecht,,,,,, -7314,,db11ad6c-7537-4d99-9423-d2257cdb6843,GTx Inc,gtx_inc,,,,,, -7315,,981f217b-6e61-463a-8ccb-f0eb8878e4a6,"The Alimentary Pharmabiotic Centre, University College Cork",the_alimentary_pharmabiotic_centre_university_college_cork,,,,,, -1054,0.97196,dc5ee059-568b-4dcb-b276-e9fab04fb724,Fundacion para la Investigacion Biomedica Hospital Universitario La Paz,fundacion_para_la_investigacion_biomedica_hospital_universitario_la_paz,,,,88936054-83c4-44a0-9f56-8aea1c3f4534,fundacion_para_la_investigaci_n_biom_dica_hospital_universitario_la_paz_fibhulp,Fundacion para La Investigación Biomédica Hospital Universitario La Paz (FIBHULP) -7316,,dab207e9-5e6f-45a9-908e-abdcfb43554b,GlaxoSmithKline Biologicals s.a,glaxosmithkline_biologicals_s_a,,,,,, -923,0.907369,263da2fa-df57-4577-a618-d84b06ad1594,"Pharmacyclics, Incorporated",pharmacyclics_incorporated,,,,263da2fa-df57-4577-a618-d84b06ad1594,pharmacyclics_incorporated,"Pharmacyclics, Incorporated" -671,0.954126,4623aa22-c038-4229-9e84-b303554a2292,NILG (Northern Italy Leukemia Group),nilg_northern_italy_leukemia_group,,,,4623aa22-c038-4229-9e84-b303554a2292,nilg_northern_italy_leukemia_group,NILG (Northern Italy Leukemia Group) -309,0.98614925146102905,02f63d38-7129-11e6-a89e-0242ac12000b,MALLINCKRODT,mallinckrodt,,,,02f63d38-7129-11e6-a89e-0242ac12000b,mallinckrodt,MALLINCKRODT -381,0.93236404657363892,58009ccb-7b96-4dcb-a306-956400b90d6e,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (de aquí en adelante se referenciará como Promotor o Merck)",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_de_aqu_en_adelante_se_referenciar_como_promotor_o_merck,,,,70a76c95-9bc5-4453-ace1-7d9c98a92a7d,merck_sharp_dohme_o,"Merck Sharp & Dohme Copr., a subsidary of Merck & Co" -7317,,82079764-4f82-4ba9-969f-65fd0bf493b9,"SciClone Pharmaceuticals, Inc",sciclone_pharmaceuticals_inc,,,,,, -7318,,bd5b8d3a-72b0-11e6-a0cd-0242ac12000b,ROMARK,romark,,,,,, -379,0.93384393056233728,b80f486c-a6f1-447b-bad6-34ea6d49fec0,"Merck Sharp & Dohm Corp, a subsidiary of Merck Co., Inc",merck_sharp_dohm_corp_a_subsidiary_of_merck_co_inc,,,,b80f486c-a6f1-447b-bad6-34ea6d49fec0,merck_sharp_dohm_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as the SPONSOR or Merck)" -914,0.96143,bb4c1c14-dfcd-4e64-9c5a-b0abe87388e6,TAYS Sydänsairaala,tays_syd_nsairaala,,,,8dc209bc-546d-4999-86f7-43245f5c50ff,tays,TAYS -7319,,f0239a7b-8f00-459b-bac8-a72deebbec8a,"Rigshospitalet, ITA 4131, Department of Intensive care",rigshospitalet_ita_4131_department_of_intensive_care,,,,,, -7320,,17df0de3-0386-4c53-92dc-d9e25140dc72,Francisco J. González Vílchez,francisco_j_gonz_lez_v_lchez,,,,,, -660,0.984864,1984b48c-7145-11e6-a0cd-0242ac12000b,LARKEN LABS,larken_labs,,,,1984b48c-7145-11e6-a0cd-0242ac12000b,larken_labs,LARKEN LABS -674,0.98227512836456299,9ebe2d66-716a-11e6-a0cd-0242ac12000b,CENTOCOR INC,centocor_inc,,,,9ebe2d66-716a-11e6-a0cd-0242ac12000b,centocor_inc,CENTOCOR INC -14,0.96426129341125488,c681ef82-c846-4321-80be-97f382aafdb3,Menarini International Operation Luxembourg S.A,menarini_international_operation_luxembourg_s_a,,,,41be544c-1f46-41e5-bb1b-0bb3baefda2e,menarini_international_operation_luxembourg_sa,Menarini International Operation Luxembourg S.A -7321,,6359d811-e58f-4485-bf6d-8875c5d948cd,"Universitätsklinik für Psychiatrie des Kindes- und Jugendalters, AKH Wien, Medizinische Universität",universit_tsklinik_f_r_psychiatrie_des_kindes_und_jugendalters_akh_wien_medizinische_universit_t,,,,,, -1,0.958633,e77552d5-ef04-4ac9-aabc-20f2efd5a01d,Johnson & Johnson Pharmaceutical Research & Development,johnson_johnson_pharmaceutical_research_development,,,,5e39e1cf-f761-4acc-bd2c-247647d86e60,johnson_johnson_pharmaceutical_research_and_development_l_l_c,"Johnson & Johnson Pharmaceutical Research and Development, L.L.C" -7322,,debc5091-1932-4723-956a-0104da77714c,"Rigshospitalet, Capital Region Bloodbank 2034, Section for Transfusion Medicine",rigshospitalet_capital_region_bloodbank_2034_section_for_transfusion_medicine,,,,,, -7323,,e3402ff0-fed2-4afe-924a-efed55e81a91,UCB Pharma Ltd,ucb_pharma_ltd,,,,,, -7324,,c66e8d5c-b456-485a-b87b-2629f61aefad,Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea (GEL/TAMO),grupo_espa_ol_de_linfomas_trasplante_aut_logo_de_m_dula_sea_gel_tamo,,,,,, -7325,,9933aec6-9626-11e6-becf-0242ac110008,CITRON PHARMA LLC,citron_pharma_llc,,,,,, -7326,,dcef5268-3915-4e99-b9d5-2145dd4d3b0b,"Klinik f. Innere Med., Fachabteilung Hämatologie",klinik_f_innere_med_fachabteilung_h_matologie,,,,,, -7327,,716df5ff-05ea-4867-acc2-42f61b740910,"ParinGenix, Inc",paringenix_inc,,,,,, -7328,,8c01a261-8b36-40ec-90b4-50a14d45a5e8,University College London / University College London Hospitals NHS Foundation Trust,university_college_london_university_college_london_hospitals_nhs_foundation_trust,,,,,, -702,0.98027750849723816,e0c7765b-d53d-4aaf-a804-e820ff6c72ee,University Hospitals of Leicester NHS Trust,university_hospitals_of_leicester_nhs_trust,,,,e83cea40-d34c-423f-9f95-62293d47cae2,university_hospitals_of_leicester_nhs_trust,University Hospitals of Leicester NHS Trust -7329,,367ad4af-204b-4d85-9b35-ee57bb197d6f,"Medizinische Klinik III, Kardiologie, Universität Frankfurt",medizinische_klinik_iii_kardiologie_universit_t_frankfurt,,,,,, -7330,,21c2727a-81ec-49d6-8e75-d0e97ee4b92a,Tripep AB,tripep_ab,,,,,, -7331,,70cc5b53-925f-4b76-afe4-5879022f1e5c,Julie Gehl,julie_gehl,,,,,, -7332,,5f0b3384-2542-47bd-9c21-4e9309d690a7,Torrent Pharmaceuticals Ltd,torrent_pharmaceuticals_ltd,,,,,, -7333,,ebf6d80d-b24d-42c1-bf1c-8495ee504eeb,Affibody AB,affibody_ab,,,,,, -237,0.98497751355171204,0ef4ae4f-e284-42c3-b72f-5c46cc59f3e2,"Pfizer Limited, Ramsgate Road, Sandwich, Kent. UK. CT13 9NJ",pfizer_limited_ramsgate_road_sandwich_kent_uk_ct13_9nj,,,,a0e33e4c-faf3-44df-85c6-ebc94469b62e,pfizer_limited_ramsgate_road_sandwich_kent_uk,"Pfizer Limited, Ramsgate Road, Sandwich, Kent" -7334,,aa769e43-3df8-4c27-8e72-b4a4cbc52412,Universitätskrankenhaus Schleswig-Holstein,universit_tskrankenhaus_schleswig_holstein,,,,,, -185,0.907369,951ea194-0b51-4d20-b8cf-f9697b2412fd,"St. James Hospital, Ireland",st_james_hospital_ireland,,,,103d48aa-e045-481f-9c54-07b97fc6c2c2,st_james_hospital,St James Hospital -7335,,2c940245-206d-483c-82cb-466703bbaf94,"department of OBstetrics, Sahlgrenska university hospital",department_of_obstetrics_sahlgrenska_university_hospital,,,,,, -7336,,73c7a72c-274e-4f2e-8fd6-76632279e480,EXONHIT,exonhit,,,,,, -7337,,785eb08a-71d0-11e6-a0cd-0242ac12000b,GENZYME CORP,genzyme_corp,,,,,, -7338,,504552a3-6249-4ef9-bc4c-bae20ac9fb49,Green Medicine AB,green_medicine_ab,,,,,, -7339,,aa84056f-f4e1-493b-9733-920f72f3d81d,AZIENDA SANITARIA LOCALE N 15 DI CUNEO,azienda_sanitaria_locale_n_15_di_cuneo,,,,,, -438,0.9734784563382467,dbdc03f8-f997-4242-91be-566d7f5870a5,"Pfizer Inc 235 East 42nd Street, New York, NY10017",pfizer_inc_235_east_42nd_street_new_york_ny10017,,,,09d833e6-81f6-4d84-ab0d-6d38c6152081,pfizer_inc_235_east_42nd_street_new_york_ny10017_usa,"Pfizer Inc 235 East 42nd Street, New York, NY10017" -7340,,fdee1223-eb99-4adf-9a49-7418364690b7,Group of Clinical Investigation in Radiotherapy Oncology (GICOR),group_of_clinical_investigation_in_radiotherapy_oncology_gicor,,,,,, -7341,,bdb36604-73be-11e6-a0cd-0242ac12000b,HQ SPECIALITY PHARMA,hq_speciality_pharma,,,,,, -7342,,f5d3c506-0954-483e-a22a-18b6f8377246,"Oxford Radcliffe Hospitals NHS Trust (Cancer Research UK Medical Oncology Unit, Churchill Hospital)",oxford_radcliffe_hospitals_nhs_trust_cancer_research_uk_medical_oncology_unit_churchill_hospital,,,,,, -171,0.98239380121231079,c4b555f7-4e1d-4625-928e-7035ee64c517,Merck Serono International S.A,merck_serono_international_s_a,,,,e0ea9f26-8028-4605-8f3e-bec9a3e04275,merck_serono_international,Merck Serono International -7343,,f6b37952-715d-11e6-a0cd-0242ac12000b,ALEMBIC LTD,alembic_ltd,,,,,, -730,0.922323,f8e9534d-6936-464d-8c31-4e208bcf130c,Hellenic Oncology Research Group (H.O.R.G.),hellenic_oncology_research_group_h_o_r_g,,,,ed32d3f4-275a-41ef-9dd9-7a713a6f2d48,hellenic_oncology_research_group_horg,Hellenic Oncology Research Group (HORG) -7344,,62b03820-1037-4f84-9fde-327ed000a088,Merck Selbstmedikation GmbH,merck_selbstmedikation_gmbh,,,,,, -47,0.913597,31bad48e-93ea-4c40-8057-5790bbe13494,Sintetica S.A,sintetica_s_a,,,,31bad48e-93ea-4c40-8057-5790bbe13494,sintetica_s_a,Sintetica S.A -7345,,75893bd4-72f5-11e6-a0cd-0242ac12000b,DURATA THERAPS INTL,durata_theraps_intl,,,,,, -7346,,c4fcfc18-38b9-4b03-91be-94218524917f,Raija Ristamäki,raija_ristam_ki,,,,,, -7347,,78eb2bb4-3678-4a3d-ba56-c67fbb9650b1,Schering Plough S.p.A,schering_plough_s_p_a,,,,,, -7348,,ed23218a-1b96-4ba7-9e1f-51073a0bb75e,"Optimer Pharmaceuticals, Inc",optimer_pharmaceuticals_inc,,,,,, -7349,,4d49b348-6b8e-4831-ba39-5f524f61d0d7,University Bonn,university_bonn,,,,,, -60,0.97776298012052265,59056bee-e28a-4009-9b7a-1fb5fc6f95aa,Wyeth Research Division of Wyeth Pharmaeuticals Inc,wyeth_research_division_of_wyeth_pharmaeuticals_inc,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc -7350,,ce7d696a-31f9-45b3-b171-3796df93af85,PCI Biotech AS,pci_biotech_as,,,,,, -7351,,d185bc60-7376-11e6-a0cd-0242ac12000b,TRIAX PHARMS,triax_pharms,,,,,, -7352,,4300da2d-073e-47e2-8247-aad8c3bca8c2,AESCULAPIUS FARMACEUTICI S.R.L,aesculapius_farmaceutici_s_r_l,,,,,, -7353,,a0837827-e81a-4f40-a2cf-d7afeb2d3738,AstraZeneca Sverige,astrazeneca_sverige,,,,,, -7354,,dd4cb229-f36b-47b9-951b-c0bf4eb722bd,Cyclacel Limited,cyclacel_limited,,,,,, -7355,,49d218f4-9484-4ca0-aa83-f21183ebf6e5,Wepa Apothekenbedarf GmbH & Co KG,wepa_apothekenbedarf_gmbh_co_kg,,,,,, -7356,,a865b3bf-464c-46d5-a2a5-c0fdfad7c207,TLT Medical Ltd,tlt_medical_ltd,,,,,, -7357,,02faf7c8-cda5-478a-878e-886090ee75f0,"Australian Kidney Trials Network, University of Queensland",australian_kidney_trials_network_university_of_queensland,,,,,, -7358,,6a3a3adc-7285-11e6-a0cd-0242ac12000b,TAKEDA PHARMS NA,takeda_pharms_na,,,,,, -7359,,e34e17fa-6d52-4a1d-a518-ecd91091c040,Cell Genesys Ltd,cell_genesys_ltd,,,,,, -7360,,1f59fdc3-9ed7-4a68-a118-f39a32e4da6d,Gemphire Therapeutics Inc,gemphire_therapeutics_inc,,,,,, -7361,,586e55de-7165-11e6-a0cd-0242ac12000b,INNOPHARMA LICENSING,innopharma_licensing,,,,,, -7362,,97e59c02-7771-4ef2-8f90-f1da8c4aabb0,Pfizer Inc. Laboratoires,pfizer_inc_laboratoires,,,,,, -7363,,f68eec95-c7ec-4bad-94ea-2cd821353c37,Lab Servier,lab_servier,,,,,, -7364,,12e2a808-1753-47e6-920b-91e744004e00,"Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin I",medizinische_universit_t_innsbruck_universit_tsklinik_f_r_innere_medizin_i,,,,,, -448,0.984608,a6dd2c28-7928-45f0-bda2-157de4bfe0f0,Oslo University Hospital,oslo_university_hospital,,,,a6dd2c28-7928-45f0-bda2-157de4bfe0f0,oslo_university_hospital,Oslo University Hospital -1027,0.98351848125457764,12e98f1e-6f9a-11e6-9663-0242ac12000b,Eli Lilly & Company Limited,eli_lilly_company_limited,,,,284c00a4-0148-4486-88e3-8a67925fd222,eli_lilly_company,Eli Lilly & Company -7365,,9a8e2886-8be1-11e6-a449-0242ac12000b,"Lyric Pharmaceuticals, Inc",lyric_pharmaceuticals_inc,,,,,, -7366,,598b7a72-f648-4922-b02f-c0c0bcb0c817,Addenbrooke's NHS Trust,addenbrooke_s_nhs_trust,,,,,, -7367,,2e54b909-e10d-4e1b-9113-a299d553b10d,"Endocyte, Inc",endocyte_inc,,,,,, -7368,,d2222e22-77cd-404a-984a-6357c21e7699,UH Montpellier,uh_montpellier,,,,,, -7369,,bc1d467b-ead1-4d5f-8c00-f96cf3b31968,Facet Biotech Corporation,facet_biotech_corporation,,,,,, -7370,,26a1e474-f461-4bab-bf75-9c2efaafbc69,Sandoz SAS,sandoz_sas,,,,,, -7371,,44b7199a-65ea-4540-b800-d0fe35bd28e7,AFFYMAX INC,affymax_inc,,,,,, -7372,,a6351e38-de33-4035-a544-4ff622a5b5ec,Pfizer Inc. - La Jolla laboratories,pfizer_inc_la_jolla_laboratories,,,,,, -7373,,a2491410-1b36-4a8c-98e1-6a6c75291eaf,Jørgen Jeppesen,j_rgen_jeppesen,,,,,, -187,0.983343,dc83129e-7140-11e6-a0cd-0242ac12000b,PAR PHARM,par_pharm,,,,9b7df138-7145-11e6-a0cd-0242ac12000b,par_pharm_inc,PAR PHARM INC -7374,,42e1c2c2-3df9-4387-95a6-12455bb57b3d,Verus Pharmaceuticals Inc,verus_pharmaceuticals_inc,,,,,, -7375,,98e977f8-2acc-4e82-919e-28b78d50e430,Novartis (Hellas) S.A.C.I,novartis_hellas_s_a_c_i,,,,,, -7376,,1a445912-def2-4314-b298-37cf0fa6d67b,SCIPHARM SáRL,scipharm_s_rl,,,,,, -7377,,c8e26961-aadb-4699-a97b-ab22d5d33df8,"Forest Laboratories, Inc",forest_laboratories_inc,,,,,, -7378,,28033d2c-ddcb-4971-9011-bc29da05e9b6,Bayer Oy,bayer_oy,,,,,, -7379,,efd1e8a4-1578-4e58-8525-34fc858a65f0,"Oulu University Hospital, Department of Internal Medicine",oulu_university_hospital_department_of_internal_medicine,,,,,, -7380,,936b8b13-032d-4875-9ce6-12681d73b7e3,pharmed holding GmbH,pharmed_holding_gmbh,,,,,, -7381,,a79c3571-d107-4734-9fdf-4a3b71a73f81,Kings College Hospital Trust R&D,kings_college_hospital_trust_r_d,,,,,, -7382,,7fa7620a-7168-11e6-a0cd-0242ac12000b,FLAMINGO PHARMS,flamingo_pharms,,,,,, -7383,,7dbc4c6f-c69b-46c9-9aad-f09879623208,S.L.A. Pharma (UK) Ltd,s_l_a_pharma_uk_ltd,,,,,, -7384,,c5aa5aa0-716d-11e6-a0cd-0242ac12000b,IMMUNEX,immunex,,,,,, -7385,,1473e5bc-acaa-4022-a585-5108484ec212,sanofi-aventis Oy,sanofi_aventis_oy,,,,,, -7386,,4eabb761-a53a-402a-b2e7-64111fc9164b,"Trius Therapeutics, Inc",trius_therapeutics_inc,,,,,, -7387,,80ff7039-a0b4-4cfc-8276-7ff301ec43d0,HYKS Marian sairaala,hyks_marian_sairaala,,,,,, -7388,,9a8ea7b2-30ca-46a8-a111-ef074cb19f1b,Strakan Pharmaceuticals Ltd,strakan_pharmaceuticals_ltd,,,,,, -7389,,ac2ea3de-0d9d-445a-8714-4e450467107a,Fondation Charcot Stichting,fondation_charcot_stichting,,,,,, -7390,,b45ea13e-72cb-11e6-a0cd-0242ac12000b,TAKEDA GMBH,takeda_gmbh,,,,,, -7391,,e938833a-831f-4bf6-8bce-b2c557d63acd,"Prof. Dr. R Marre, University Hospital Ulm",prof_dr_r_marre_university_hospital_ulm,,,,,, -7392,,e154810b-ddfa-4097-9dac-fce9a1dc82f6,GRUPO ONCOPAZ,grupo_oncopaz,,,,,, -355,0.989009,9cb0b7ef-9196-4272-8e74-952d80c320c4,Asociación Colaboración Cochrane Iberoamericana (ACCIb),asociaci_n_colaboraci_n_cochrane_iberoamericana_accib,,,,9cb0b7ef-9196-4272-8e74-952d80c320c4,asociaci_n_colaboraci_n_cochrane_iberoamericana_accib,Asociación Colaboración Cochrane Iberoamericana (ACCIb) -7393,,ee4c64e6-715c-11e6-a0cd-0242ac12000b,INSYS THERAP,insys_therap,,,,,, -7394,,56b8cafa-7b3b-4749-a384-6a1d2146755f,Teemu Luostarinen,teemu_luostarinen,,,,,, -826,0.97779467701911926,088d8036-1703-4c64-8781-39bd714c26a5,Department of Nephrology,department_of_nephrology,,,,e662831f-0d28-42b9-a406-77cb46fe2d36,department_of_nephrology_and_renal_transplantation,Department of Nephrology and Renal Transplantation -276,0.955365,cb17da13-e5f0-4069-a9dc-bf97b4fc3aae,Axcan Pharma Inc. (Axcan Pharma International B.V. is a subsidiary of Axcan Pharma Inc.),axcan_pharma_inc_axcan_pharma_international_b_v_is_a_subsidiary_of_axcan_pharma_inc,,,,93daac2d-3fd1-447f-98fc-f605f37148a3,axcan_pharma_inc_axcan_pharma_international_bv_is_subsidiary_of_axcan_pharma_inc,Axcan Pharma Inc. (Axcan Pharma International BV is subsidiary of Axcan Pharma Inc.) -7395,,c48b0956-7160-11e6-a0cd-0242ac12000b,BIOGLAN,bioglan,,,,,, -38,0.97483,4789b24e-71b6-11e6-a0cd-0242ac12000b,BIOVAIL LABS INTL,biovail_labs_intl,,,,4789b24e-71b6-11e6-a0cd-0242ac12000b,biovail_labs_intl,BIOVAIL LABS INTL -7396,,abe96fa1-5b3e-44e0-bee5-828296c308df,Ipsen Farmaceutica b.v,ipsen_farmaceutica_b_v,,,,,, -7397,,7897ffe7-42d0-43ba-bd1c-abd448f39b3c,University of Newcastle,university_of_newcastle,,,,,, -7398,,3621efc1-16d7-4288-87d3-75a821b31cbc,Spanish Oncology Genito-Urinary Group (SOGUG),spanish_oncology_genito_urinary_group_sogug,,,,,, -7399,,cc8e178a-739d-11e6-a0cd-0242ac12000b,OREXIGEN,orexigen,,,,,, -7400,,916955c8-86b3-462d-96be-dc1c3fff8d94,Wallenberg laboratory,wallenberg_laboratory,,,,,, -7401,,1c71e9c1-3045-4455-ac56-1f7c5df37f41,Fundación pública andaluza para la gestión de la investigación en salud de Sevilla (FISEVI),fundaci_n_p_blica_andaluza_para_la_gesti_n_de_la_investigaci_n_en_salud_de_sevilla_fisevi,,,,,, -7402,,482d2c61-d139-4213-8a29-0578c825799f,Dr. Lluis Arias,dr_lluis_arias,,,,,, -7403,,118aa065-5c70-42f8-8b63-cbad5d960cea,Bio-Gels Pharmaceuticals,bio_gels_pharmaceuticals,,,,,, -7404,,fd8ee05d-93e4-4b9d-adc0-62629de30aa4,HOSPITAL UNIVERSITARIO RAMON Y CAJAL,hospital_universitario_ramon_y_cajal,,,,,, -7405,,18767366-6652-4789-8a2c-5365f33c273d,Hospital Erasme,hospital_erasme,,,,,, -7406,,01e680c9-7041-41c4-bb12-caca86cf6a0e,EAU Foundation for Urological Research,eau_foundation_for_urological_research,,,,,, -293,0.98027,3c9f7dec-c696-4e53-bf14-5c014e7babdd,Janssen Cilag International,janssen_cilag_international,,,,3c9f7dec-c696-4e53-bf14-5c014e7babdd,janssen_cilag_international,Janssen Cilag International -7407,,13f8f9a1-3670-4e48-995a-2bd18c63fa12,Sanofi-aventis recherche and developpement,sanofi_aventis_recherche_and_developpement,,,,,, -7408,,9fd27f9d-d593-4345-b4dc-a2b6acf41c17,Only for Children Pharmaceuticals,only_for_children_pharmaceuticals,,,,,, -7409,,85d36f0c-5687-46f0-a6f5-3dd06d6490b3,Orbus International BV,orbus_international_bv,,,,,, -7410,,221f0916-8bcc-11e6-a449-0242ac12000b,Gedske Daugaard,gedske_daugaard,,,,,, -7411,,07f6b45a-3900-42e3-987d-360de8111f31,Bracco Imaging S.p.A,bracco_imaging_s_p_a,,,,,, -7412,,4b148440-7164-11e6-a0cd-0242ac12000b,PADDOCK LABS,paddock_labs,,,,,, -875,0.9714733362197876,8ca22c91-ec68-4c4d-b67e-9354f508b1d3,FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO NIÑO JESUS,fundacion_para_la_investigacion_biomedica_del_hospital_universitario_ni_o_jesus,,,,8ca22c91-ec68-4c4d-b67e-9354f508b1d3,fundacion_para_la_investigacion_biomedica_del_hospital_universitario_ni_o_jesus,FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO NIÑO JESUS -7413,,3268b91f-ea5c-4681-9c5e-09d08a71ed3b,SERVICIO NEFROLOGIA HOSPITAL UNIVERSITARIO DE BELLVITGE,servicio_nefrologia_hospital_universitario_de_bellvitge,,,,,, -105,0.92743,87f12084-92d1-4b68-89c3-59450c51ce2e,Aristotle University of Thessaloniki,aristotle_university_of_thessaloniki,,,,87f12084-92d1-4b68-89c3-59450c51ce2e,aristotle_university_of_thessaloniki,Aristotle University of Thessaloniki -7414,,2ce0e8e4-016c-40f1-89c9-fa28cc3dc4e0,MRN-Medical Research Network GmbH,mrn_medical_research_network_gmbh,,,,,, -7415,,15530b58-8d13-4f62-8ff3-c16d8f280f80,Regen Therapeutics PLC,regen_therapeutics_plc,,,,,, -7416,,c6a314cc-1d00-453e-9b92-f8a3e2604a41,"University Hospital Frankfurt, Goethe University",university_hospital_frankfurt_goethe_university,,,,,, -1017,0.97598165273666382,986ad2cd-cb4e-460c-acdc-a2b32a61de09,Southampton University Hospital Trust,southampton_university_hospital_trust,,,,986ad2cd-cb4e-460c-acdc-a2b32a61de09,southampton_university_hospitals,Southampton University Hospitals -7417,,ef215b37-0942-4833-9366-68baba471a3c,Universitair Medisch Centrum Groningen,universitair_medisch_centrum_groningen,,,,,, -7418,,6307a342-89e9-4514-8fec-9a70aec719bc,"Anticancer Informing ""Me Gnosi Nika",anticancer_informing_me_gnosi_nika,,,,,, -7419,,5cca604e-fde8-46f9-b69e-655232303e2d,Servicio de Gastroenterología del Hospital Universitario Mútua de Terrassa,servicio_de_gastroenterolog_a_del_hospital_universitario_m_tua_de_terrassa,,,,,, -7420,,9871265c-f324-4b3a-a841-245973c28fac,"ICHTHYOL-GESELLSCHAFT Cordes, Hermanni & Co. (GmbH & Co.) KG",ichthyol_gesellschaft_cordes_hermanni_co_gmbh_co_kg,,,,,, -7421,,81406490-7168-11e6-a0cd-0242ac12000b,ASCENT PHARMS INC,ascent_pharms_inc,,,,,, -7422,,5821b48b-dd3a-4555-be00-16140d2e86d5,"Afdeling heelkunde, Universitair Medisch Centrum Sint Radboud",afdeling_heelkunde_universitair_medisch_centrum_sint_radboud,,,,,, -1027,0.98575803637504578,284c00a4-0148-4486-88e3-8a67925fd222,Eli Lilly & Company,eli_lilly_company,,,,284c00a4-0148-4486-88e3-8a67925fd222,eli_lilly_company,Eli Lilly & Company -7423,,71ad91a6-a07a-4a9b-b33b-607bf24b95cd,Taina Sipponen,taina_sipponen,,,,,, -7424,,add98864-715f-11e6-a0cd-0242ac12000b,REED AND CARNRICK,reed_and_carnrick,,,,,, -7425,,0d3e0740-d797-4b83-a4f7-c90549b7ba60,Arrow Therapeutics Ltd,arrow_therapeutics_ltd,,,,,, -992,0.9735756516456604,e1d99ba0-e81e-47cb-9a76-e99d5770ff7f,Medizinische Universität Innsbruck / Univ.-Klinik für Allgem. u. Chirurg. Intensivmedizin,medizinische_universit_t_innsbruck_univ_klinik_f_r_allgem_u_chirurg_intensivmedizin,,,,85bd52ce-4912-412b-98e5-33039d390569,medizinische_universit_t_innsbruck_univ_klinik_f_r_allg_u_chirurg_intensivmedizin,Medizinische Universität Innsbruck / Univ.-Klinik für Allg. u. Chirurg. Intensivmedizin -754,0.974038,8ae9d885-6a3a-41b7-92ff-708f5fd36353,"Eisai Limited, European Knowledge Centre",eisai_limited_european_knowledge_centre,,,,2605a116-7400-44c9-9e20-fd5eac2e111d,eisai_limited,Eisai Limited -7426,,13131c9f-7e16-4b23-8b8f-3a11287c37e7,"Nuron Biotech, Inc",nuron_biotech_inc,,,,,, -7427,,92c18401-1544-4143-920d-38c7b22cc60a,Abbott Deutschland GmbH & Co. KG,abbott_deutschland_gmbh_co_kg,,,,,, -7428,,f54424fe-dc94-4520-b9f7-e6a4ee5e0784,Manchester Mental Health and Social Care Trust,manchester_mental_health_and_social_care_trust,,,,,, -7429,,a71b6fc2-af68-4fbc-a2a6-27adb582b392,Micromet AG,micromet_ag,,,,,, -7430,,f87e10d8-49ca-42fb-bc98-a05dffdfa7db,Allergiklinikken,allergiklinikken,,,,,, -7431,,6fe7595c-70cf-4ddc-aa48-b6bcdd1399ef,ARYx Therapeutics Limited,aryx_therapeutics_limited,,,,,, -7432,,0016caed-8be9-4412-bbb3-8f0cedada55e,Celtaxsys Inc,celtaxsys_inc,,,,,, -634,0.98439878225326538,46a45c2f-43ce-4875-94a9-b47c1c64e0a4,Research and Development Department,research_and_development_department,,,,46a45c2f-43ce-4875-94a9-b47c1c64e0a4,research_and_development_department,Research and Development Department -7433,,b5b02752-d416-4203-b239-e14c5245b5d2,Acucela Inc,acucela_inc,,,,,, -7434,,b3dcccd4-b7b6-459e-9c21-faa64ef2a355,Lapland Hospital District/ Lapland Central Hospital,lapland_hospital_district_lapland_central_hospital,,,,,, -749,0.982152,7b2e0c4c-d3a5-4991-85ad-b05ef3d7b13e,"LABORATORIOS FARMACÉUTICOS ROVI, S.A",laboratorios_farmac_uticos_rovi_s_a,,,,7b2e0c4c-d3a5-4991-85ad-b05ef3d7b13e,laboratorios_farmac_uticos_rovi_s_a,"LABORATORIOS FARMACÉUTICOS ROVI, S.A" -7435,,b251fc02-fb6d-4d55-b641-0d79def86d3b,AbbVie Inc,abbvie_inc,,,,,, -7436,,faff384f-891c-4b02-9a85-0961a87eaa99,"Tarsa Therapeutics, Inc",tarsa_therapeutics_inc,,,,,, -7437,,607bdf97-1429-4548-9740-7f6f106a8351,Mithra Pharmaceuticals SA,mithra_pharmaceuticals_sa,,,,,, -7438,,e322d44a-252b-46c8-9ba9-803d4c69b051,"ImunomedicA, a.s",imunomedica_a_s,,,,,, -7439,,df27b3f5-87a5-458d-897b-a41b223d3d2c,Onyx Therapeutics,onyx_therapeutics,,,,,, -7440,,0ee6be2f-080f-4a8a-a06a-2d04345286ff,"Medizinsche Universität Wien, Univ.Klinik f. Anästhesie u. Allgem. Intensivmedizin",medizinsche_universit_t_wien_univ_klinik_f_an_sthesie_u_allgem_intensivmedizin,,,,,, -80,0.975018,e998682c-caff-41db-a4d4-47f82505696f,UMC St Radboud University Hospital Center,umc_st_radboud_university_hospital_center,,,,0510fd6f-8916-4b89-89b5-93c49e7400bb,umc_st_radboud,UMC St Radboud -7441,,a052255e-6fbe-11e6-abe8-0242ac12000b,Cliniques Universitaires Saint Luc-Centre du Cancer,cliniques_universitaires_saint_luc_centre_du_cancer,,,,,, -7442,,5732a2f9-5a34-459d-ba31-6c38d8163260,Institute of Psychiatry,institute_of_psychiatry,,,,,, -7443,,3e634bbd-26f5-48ef-b12c-916955cfd384,JOSEP MARIA BOTARGUES BOTÉ,josep_maria_botargues_bot,,,,,, -7444,,2d868774-e141-4d4d-92b7-8edf67ca2756,Örebro Läns Landsting,rebro_l_ns_landsting,,,,,, -7445,,cf2239aa-715d-11e6-a0cd-0242ac12000b,CADISTA PHARMS,cadista_pharms,,,,,, -7446,,b1fa2776-8179-4d66-9477-3034a2d24eff,Friedrich- Alexander- Universität Erlangen Nürnberg,friedrich_alexander_universit_t_erlangen_n_rnberg,,,,,, -7447,,13fbd60a-0d4f-4e89-80e7-6ddc7b114123,Aprea AB,aprea_ab,,,,,, -462,0.969668,c2cf1092-6676-478b-b6bc-5980f53650f5,Gamida Cell-Teva Joint Venture Ltd,gamida_cell_teva_joint_venture_ltd,,,,c2cf1092-6676-478b-b6bc-5980f53650f5,gamida_cell_teva_joint_venture_ltd,Gamida Cell-Teva Joint Venture Ltd -321,0.94320505857467651,bb6e45e6-e1f4-4407-be5e-72adf5b79a0d,All Ireland co-operative Oncology Research Group,all_ireland_co_operative_oncology_research_group,,,,12641096-e1dd-46f5-9635-3bd405807ce5,all_ireland_cooperative_oncology_research_group,All Ireland Cooperative Oncology Research Group -7448,,a132b886-ceba-403f-8104-bbc93aee584d,Dr. W. Schwabe GmbH & Co. KG,dr_w_schwabe_gmbh_co_kg,,,,,, -7449,,29fd9dbf-3c32-4b45-994c-e02e3e1fa090,Uniwersytet Jagielloński – Collegium Medicum,uniwersytet_jagiello_ski_collegium_medicum,,,,,, -7450,,eb2b804b-b983-4ac3-9a38-dec10c0f5742,German Foundation for Chronically Ill,german_foundation_for_chronically_ill,,,,,, -7451,,dfbc0aeb-2b1f-4a83-9282-a0f9942e7e7c,InfectoPharm - Arzneimittel und Consilium GmbH,infectopharm_arzneimittel_und_consilium_gmbh,,,,,, -542,0.985178,6ac48511-e29b-45d9-a99a-d067f972f24e,Skåne University Hospital,sk_ne_university_hospital,,,,6ac48511-e29b-45d9-a99a-d067f972f24e,sk_ne_university_hospital,Skåne University Hospital -7452,,12c78f60-0ee2-4691-a77b-a1baab5a95e7,"Avid Radiopharmaceuticals, Inc",avid_radiopharmaceuticals_inc,,,,,, -22,0.98036062717437744,c86bec53-7f8e-4a90-a21e-3546f2f9dc56,University Hospital Heidelberg,university_hospital_heidelberg,,,,ae6ad20a-a5ac-4fda-adad-69b8ff220a6a,university_hospital_heidelberg,University Hospital Heidelberg -7453,,c69e3631-a210-4c54-934c-72f920895011,"Daiichi Pharmaceutical Co., Ltd",daiichi_pharmaceutical_co_ltd,,,,,, -7454,,9e9986da-a225-40d5-b1a8-bae492450b03,Vasculitis Clinical Trial Office,vasculitis_clinical_trial_office,,,,,, -7455,,689d5a47-b78f-4e00-954b-b90dbe401153,OLV-ziekenhuis,olv_ziekenhuis,,,,,, -7456,,b85f357c-4442-4b42-8c59-22f37483e8d0,Biogen Idec Limited,biogen_idec_limited,,,,,, -7457,,1c3b6a9a-718b-11e6-a0cd-0242ac12000b,ELI LILLY AND CO,eli_lilly_and_co,,,,,, -255,0.988054,ab2495df-affb-476e-8780-84d610f1930d,Antwerp University Hospital (UZA),antwerp_university_hospital_uza,,,,ab2495df-affb-476e-8780-84d610f1930d,antwerp_university_hospital_uza,Antwerp University Hospital (UZA) -112,0.95708638429641724,3fdc83cd-1894-4fc3-a873-6017c4a29e0a,Yamanouchi Europe B.V. (to be renamed Astellas Pharma Europe B.V by August 2005),yamanouchi_europe_b_v_to_be_renamed_astellas_pharma_europe_b_v_by_august_2005,,,,fd7c0ea8-c5da-47db-837d-9b59407dd291,yamanouchi_europe_b_v,Yamanouchi Europe B.V -7458,,93b11f1a-70d7-46f7-bece-6426625b40a0,ASTELLAS PHARMA,astellas_pharma,,,,,, -7459,,192904a1-1d6e-441d-b10e-83799a08c9ae,"ALK-Abello, S.A",alk_abello_s_a,,,,,, -7460,,21d0f977-e73b-4232-a7c2-e7692e2f85ab,Novosis AG,novosis_ag,,,,,, -884,0.96910750865936279,0535053a-70a1-4184-85fb-a82d42918846,AGMT gGmbH,agmt_ggmbh,,,,0535053a-70a1-4184-85fb-a82d42918846,agmt_ggmbh,AGMT gGmbH -501,0.941946,51817147-4fe9-46e4-8642-703081f3e636,Medizinische Fakultät. Otto von Guericke Universität,medizinische_fakult_t_otto_von_guericke_universit_t,,,,51817147-4fe9-46e4-8642-703081f3e636,medizinische_fakult_t_otto_von_guericke_universit_t,Medizinische Fakultät. Otto von Guericke Universität -7461,,81de02bf-96bd-457f-96af-034d6f2c20b1,Icagen Inc,icagen_inc,,,,,, -7462,,e00a69cd-19fb-4277-980d-9d7f65dd0772,South London and Maudsley NHS Foundation Trust,south_london_and_maudsley_nhs_foundation_trust,,,,,, -7463,,84b540c9-53ac-4bd7-844f-460afffe032c,Orygen Research Centre,orygen_research_centre,,,,,, -1016,0.986181,347471d1-8499-40a9-8240-38e355408069,LABORATORIOS LETI,laboratorios_leti,,,,347471d1-8499-40a9-8240-38e355408069,laboratorios_leti,LABORATORIOS LETI -7464,,e7322128-c6ad-4abb-9919-c301d3521cfa,Derma Sciencs Inc,derma_sciencs_inc,,,,,, -642,0.97617602348327637,1eaa3c0c-4ecd-4593-886b-6af263dd0c86,Boehringer Ingelheim France SAS,boehringer_ingelheim_france_sas,,,,1eaa3c0c-4ecd-4593-886b-6af263dd0c86,boehringer_ingelheim_france,Boehringer Ingelheim France -7465,,69bc095b-12a3-4e98-8132-932407b96e43,Blackpool Fylde & Wyre Healthcare NHS Trust,blackpool_fylde_wyre_healthcare_nhs_trust,,,,,, -7466,,71949305-a1a2-425f-8e27-8bc1da071a20,Kari T. Kivistö,kari_t_kivist,,,,,, -7467,,51be2949-81cd-4023-91ae-5652dd7d1919,Universitätsmedizin Greifswald,universit_tsmedizin_greifswald,,,,,, -7468,,56c4b4e2-0fb6-4ad6-ac8a-e9ddefc9d47a,Novo Nordisk Pharma GmbH,novo_nordisk_pharma_gmbh,,,,,, -7469,,5cee0783-576b-489a-a48f-f73e2aeec025,Hospital Ruber Internacional,hospital_ruber_internacional,,,,,, -123,0.93060654401779175,6f6fa7c2-4fab-461f-9b80-d0b26f4f354e,F. Hoffmann-La Roche AG,f_hoffmann_la_roche_ag,,,,6f6fa7c2-4fab-461f-9b80-d0b26f4f354e,f_hoffmann_la_roche_ag,F. Hoffmann-La Roche AG -7470,,59d62a39-b8e5-4aec-b03f-457e9ce84129,CECOG,cecog,,,,,, -7471,,ca8d45b0-631e-488b-b9b9-8f22dd82aac5,Centre René Huguenin,centre_ren_huguenin,,,,,, -7472,,84d6fc0c-af6e-433b-af47-1f0199323338,Solenne BV,solenne_bv,,,,,, -7473,,31e2d4d1-53b1-441a-96c8-ce8179266418,Boehringer Ingelheim Pharma GmbH&Co.KG,boehringer_ingelheim_pharma_gmbh_co_kg,,,,,, -7474,,8eaff211-20e8-4ae6-bfa4-059e282fa5d7,Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research),gesellschaft_fuer_klinische_forschung_e_v_society_for_clinical_research,,,,,, -7475,,6b9d4031-245b-45a4-9cc4-e5f62d3c0d2e,"Tayside Clinical Trials Unit, University of Dundee",tayside_clinical_trials_unit_university_of_dundee,,,,,, -7476,,e3dacde8-e502-4a42-8c0a-56bd84b8e956,Sanofi-Aventis Deutschland GmbH,sanofi_aventis_deutschland_gmbh,,,,,, -326,0.985702,14fb99c7-19be-430d-a74a-57408f88725e,Servicio de Infecciones. Hospital Clínic de Barcelona,servicio_de_infecciones_hospital_cl_nic_de_barcelona,,,,14fb99c7-19be-430d-a74a-57408f88725e,servicio_de_infecciones_hospital_cl_nic_de_barcelona,Servicio de Infecciones. Hospital Clínic de Barcelona -7477,,d53a01c6-6fc1-11e6-abe8-0242ac12000b,Klinik Loewenstein gGmbH,klinik_loewenstein_ggmbh,,,,,, -7478,,9d4dbc02-8d23-4d9b-8f0b-57c5b89637bc,Royal Marsden Hosptial Foundation Trust,royal_marsden_hosptial_foundation_trust,,,,,, -7479,,8289ac7f-98aa-46a6-9fa0-3f8a08b785b3,Næstved Hospital,n_stved_hospital,,,,,, -7480,,1fe2380a-a32f-4bdb-a73c-6de473ae0cee,Overlæge dr.med. Frederik Grønhøj,overl_ge_dr_med_frederik_gr_nh_j,,,,,, -7481,,4e0a8ec2-73cd-11e6-a0cd-0242ac12000b,CIPHER PHARMS US,cipher_pharms_us,,,,,, -7482,,101edc2f-4668-43a0-b291-605d047a36e7,Karolinska Institute/Hospital,karolinska_institute_hospital,,,,,, -7483,,e1599481-d933-4b91-9ad2-a63f47f86861,Aventis Pharma Finland,aventis_pharma_finland,,,,,, -74,0.972986,53160446-62a1-4898-b8c2-2d60eb490bf9,Faculdade de Ciências Médicas da Universidade Nova de Lisboa,faculdade_de_ci_ncias_m_dicas_da_universidade_nova_de_lisboa,,,,53160446-62a1-4898-b8c2-2d60eb490bf9,faculdade_de_ci_ncias_m_dicas_da_universidade_nova_de_lisboa,Faculdade de Ciências Médicas da Universidade Nova de Lisboa -7484,,a6cd51a2-5fc6-463c-8e71-3f7e1af326fc,Graz Medical University,graz_medical_university,,,,,, -7485,,e3cb6f14-0fab-47d0-8527-234632b5a6aa,"Dept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University",dept_of_medical_sciences_clinical_diabetes_and_metabolism_uppsala_university,,,,,, -7486,,6de187b0-4605-4e4d-8034-76304a2f845b,Imperial College London South Kensington London,imperial_college_london_south_kensington_london,,,,,, -7487,,37ee61cf-f11b-493e-8f5b-ea1302165c14,PIERRE FABRE MEDICAMENT-IRPF-IDPF,pierre_fabre_medicament_irpf_idpf,,,,,, -7488,,f0dd3165-4b1d-4607-894c-2bdd7a710827,University Hospital Tübingen,university_hospital_t_bingen,,,,,, -1016,0.986181,7aa3fc2d-a3c7-4871-b05e-41f848dab0ef,LABORATORIOS LETI S.L.U,laboratorios_leti_s_l_u,,,,347471d1-8499-40a9-8240-38e355408069,laboratorios_leti,LABORATORIOS LETI -159,0.93964588642120361,8e61b774-a021-4643-8648-1f65d385db6e,"Medizinische Universität Wien, Univ.Klinik f.Innere Medizin II, Abt.f.Angiologie",medizinische_universit_t_wien_univ_klinik_f_innere_medizin_ii_abt_f_angiologie,,,,f520785f-8956-4a25-b64b-588e23b207cb,medizinische_universit_t_wien_univ_klink_f_innere_medizin_i,"Medizinische Universität Wien, Univ.Klink f. Innere Medizin I" -670,0.98121541738510132,e4d075aa-4a2c-4c87-a24d-a2bf30ca4b0e,NHS Lothian,nhs_lothian,,,,003e8352-381a-4a71-b3e3-25cd5e67e274,nhs_lothian_accord,NHS Lothian (ACCORD) -7489,,2d85304a-7160-11e6-a0cd-0242ac12000b,BUNDY,bundy,,,,,, -7490,,b821106f-da12-41b2-9766-24ad2642b16a,Bracco Imaging SPA,bracco_imaging_spa,,,,,, -7491,,83afee81-68a5-4acf-bf7b-df7f579248fc,Cranley Clinic,cranley_clinic,,,,,, -7492,,8fed3f2f-bce6-4382-89b4-34fd577b8f34,"Dept of Internal Medicine IV, Med Uni Vienna",dept_of_internal_medicine_iv_med_uni_vienna,,,,,, -7493,,14da021a-cc3a-492e-9e3f-81ba285f19cb,Sportmedisch expertisecentrum,sportmedisch_expertisecentrum,,,,,, -7494,,f372e443-4306-4021-a049-968fd8fee5b7,DOMPE' BIOTEC,dompe_biotec,,,,,, -7495,,1d65764b-3039-4b56-911f-d78dbac404d4,INSTITUT DE RESERCA.HSCSP,institut_de_reserca_hscsp,,,,,, -7496,,00f5ac2c-8071-4048-9b16-4b9d5a8eee82,MicroCHIPS,microchips,,,,,, -7497,,4600ea89-871f-4971-ac28-83ff8ea7fdb7,GlaxoSmithKlin Research and Development Ltd,glaxosmithklin_research_and_development_ltd,,,,,, -7498,,7b8e8788-f942-46ab-a0a2-7099fdde6b4b,HOSPITAL GENERAL DE VIC,hospital_general_de_vic,,,,,, -7499,,ea34ff94-1d1f-49ad-931d-1e1dfefda5b2,Karolinska Institutet and University Hospital,karolinska_institutet_and_university_hospital,,,,,, -7500,,ad168a42-e801-4860-a362-c99fa884d809,Heidi Mäkinen,heidi_m_kinen,,,,,, -7501,,d0aa218f-7832-410f-9a64-5bc04f57d44b,"Dept of Pediatrics, University Hospital of North Norway",dept_of_pediatrics_university_hospital_of_north_norway,,,,,, -781,0.96902046600977576,5fabe06e-ac55-4f2e-a26d-513b4b1bdb92,GlaxoSmithKline Research and Development,glaxosmithkline_research_and_development,,,,201d9d4f-5cd0-46df-836e-da17fa2b43dd,glaxosmithkline_research_and_development,GlaxoSmithKline Research and Development -7502,,b597458f-a4cd-41aa-b326-c54957320348,Institut Diagnostic per la Imatge,institut_diagnostic_per_la_imatge,,,,,, -403,0.93504321575164795,3fae5114-715d-11e6-a0cd-0242ac12000b,EMCURE PHARMA,emcure_pharma,,,,11645014-715e-11e6-a0cd-0242ac12000b,emcure_pharms,EMCURE PHARMS -7503,,25ba5784-d2ad-4ecf-ad1b-4efdc95e9eb8,Athena Care/ Isala Klinieken,athena_care_isala_klinieken,,,,,, -7504,,bed9aa2d-ef02-4d17-8bbe-e5ed5413aac3,Fundación Institut de Recerca Hospital Sant Pau,fundaci_n_institut_de_recerca_hospital_sant_pau,,,,,, -7505,,58bce5c1-e96d-4885-a545-9277737a0f87,SerumWerk Bernburg AG,serumwerk_bernburg_ag,,,,,, -7506,,886deff3-bc54-4e3b-a123-e78b59b2aaba,"Karolinska University Hospital Huddinge, Department of Anaesthesiology and Intensive Care",karolinska_university_hospital_huddinge_department_of_anaesthesiology_and_intensive_care,,,,,, -7507,,eff62459-c9a3-41bd-8a91-6b1d9fa1e7b0,"Brain Center Rudolf Magnus, University Medical Center Utrecht, Department of Psychiatry, Utrecht , the Netherlands",brain_center_rudolf_magnus_university_medical_center_utrecht_department_of_psychiatry_utrecht_the_netherlands,,,,,, -119,0.98682153224945068,2d92428c-71e3-498b-80e5-8358645cf21c,"Rheinische Friedrich-Wilhelms-University of Bonn, University Hospital",rheinische_friedrich_wilhelms_university_of_bonn_university_hospital,,,,2d92428c-71e3-498b-80e5-8358645cf21c,rheinische_friedrich_wilhelms_university_of_bonn_university_hospital,"Rheinische Friedrich-Wilhelms-University of Bonn, University Hospital" -7508,,4f84ae53-a231-454f-aca0-8f11d666d043,"Anæstesiologisk Afd. I, Skejby Sygehus",an_stesiologisk_afd_i_skejby_sygehus,,,,,, -7509,,7735cc0f-68ac-4438-818f-4c8bf58745ec,University of Antwerp,university_of_antwerp,,,,,, -7510,,5e09b7c6-664e-4232-be3f-81e14df7322b,"CTMM, the Center for Translational Molecular Medicine",ctmm_the_center_for_translational_molecular_medicine,,,,,, -7511,,0fbaf30e-8819-11e6-a998-0242ac12000b,GlaxoSmithKline Ltd,glaxosmithkline_ltd,,,,,, -7512,,8ba868d5-0ffd-4a73-b7c4-b9d331b7712b,CuraGen Corporation,curagen_corporation,,,,,, -7513,,a72360d9-613c-4705-bca7-00d428a352af,Fundació Clínic,fundaci_cl_nic,,,,,, -634,0.98439878225326538,a74282e0-87f2-40f3-811b-2b2fdfca3941,"Research and Development Department, John Radcliffe Hospital",research_and_development_department_john_radcliffe_hospital,,,,46a45c2f-43ce-4875-94a9-b47c1c64e0a4,research_and_development_department,Research and Development Department -7514,,52425251-4793-48c5-b92f-bc8507d27b88,Thoraxkirurgisk afd. Rigshospitalet,thoraxkirurgisk_afd_rigshospitalet,,,,,, -7515,,b7fade20-f957-4ce1-978b-e1af17ea0f06,ARCO,arco,,,,,, -7516,,37d64bcf-4ea3-4f20-a3f7-d80786909ba3,GlaxoSmithKline Group of Companies,glaxosmithkline_group_of_companies,,,,,, -7517,,e87e43d3-1b41-4485-ba2a-55b37051834f,Medizinische Universität Innsbruck / UK für Anästhesie und Intensivmedizin & UK für Allgem. u. Chirurg. Intensivmedizin,medizinische_universit_t_innsbruck_uk_f_r_an_sthesie_und_intensivmedizin_uk_f_r_allgem_u_chirurg_intensivmedizin,,,,,, -7518,,3f3122db-eecd-4b09-9fd4-658093c126f5,Alba Therapeutics,alba_therapeutics,,,,,, -7519,,ff8af62e-7129-11e6-a89e-0242ac12000b,TEDOR PHARMA INC,tedor_pharma_inc,,,,,, -7520,,c332f3de-8d64-4925-b34d-1b9b93d3f7a8,ALIO MEDICA Sp. z o.o,alio_medica_sp_z_o_o,,,,,, -7521,,a809533d-c98f-413a-b1d2-52fdfd8de2fb,"University Medical Center Freiburg Dept. Klinikum Stuttgart, Stuttgart Cancer Center",university_medical_center_freiburg_dept_klinikum_stuttgart_stuttgart_cancer_center,,,,,, -881,0.98332688212394714,d9486864-e255-4256-b088-49f706c79293,PIERRE FABRE MEDICAMENT - IRPF,pierre_fabre_medicament_irpf,,,,d9486864-e255-4256-b088-49f706c79293,pierre_fabre_medicament,PIERRE FABRE MEDICAMENT -7522,,04e26f08-714d-11e6-a0cd-0242ac12000b,PERRIGO PHARMA INTL,perrigo_pharma_intl,,,,,, -7523,,7a9fc39a-8d85-4417-a9d7-0dbd2c1fb29e,Merck Sharp & Dohme (Sweden) AB,merck_sharp_dohme_sweden_ab,,,,,, -7524,,238817db-2c95-4d52-aa52-54c9c3dfdff7,Norlands University Hospital,norlands_university_hospital,,,,,, -1073,0.987562,c6e78645-5bdb-4ec2-a139-0d95cbbc2ce8,"Akershus University Hospital, Norway",akershus_university_hospital_norway,,,,a0dd21db-1c17-47e9-af2f-92349a9503ac,akershus_university_hospital,Akershus University Hospital -7525,,5a3725bd-7745-4082-a8a5-85e5eb9cef32,Solace Pharmaceuticals Inc,solace_pharmaceuticals_inc,,,,,, -7526,,fd29ca01-7d5c-47b6-975c-e2755a60f9e5,Cardioangiologisches Centrum Bethanien,cardioangiologisches_centrum_bethanien,,,,,, -7527,,0cd680ff-e703-45e8-b070-08cccb5ca2cd,University Hospital of Antwerp,university_hospital_of_antwerp,,,,,, -7528,,fcc430c0-8bc5-11e6-a449-0242ac12000b,"Ability Pharmaceuticals, SL",ability_pharmaceuticals_sl,,,,,, -7529,,5803d687-3a0d-4891-a03e-ac1e0b1d4465,"Daiichi Sankyo, Inc",daiichi_sankyo_inc,,,,,, -7530,,07975b5e-71ad-11e6-a0cd-0242ac12000b,MAYER LABS INC,mayer_labs_inc,,,,,, -7531,,5867d8f9-39ae-4476-aea1-b9589e8baf39,St. Joseph-Hospital g GmbH,st_joseph_hospital_g_gmbh,,,,,, -7532,,66168656-2321-4f51-98d7-261f20c4dce5,"Progenics Pharmaceuticals, Inc",progenics_pharmaceuticals_inc,,,,,, -7533,,6e4bd89e-e17b-4ff6-8245-6115bfb5bc35,Universitätsklinik für Neurologie Innsbruck,universit_tsklinik_f_r_neurologie_innsbruck,,,,,, -7534,,5117dfd3-ec28-4a0e-82ae-9618516b1660,Nuvo Research GmbH,nuvo_research_gmbh,,,,,, -7535,,1116308a-e2c7-42b6-895b-b257ea7d8bbf,AstraZeneca UK Limited,astrazeneca_uk_limited,,,,,, -113,0.971346,c9f9b495-efda-4f21-8505-bc308f92a89a,Radiumhemmet Karolinska University Hospital,radiumhemmet_karolinska_university_hospital,,,,5c913850-fa7a-4490-8a20-b21a3b24bb85,radiumhemmet_karolinska_university_hospital_stockholm_sweden,"Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden" -713,0.96302181482315063,8d39533d-717f-4f34-87ef-35d8a793ccc1,"Wyeth Pharmaceuticals Inc, a wholled owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA",wyeth_pharmaceuticals_inc_a_wholled_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,,,,d2f1d48d-c243-473b-9f47-208723250aa6,wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA" -746,0.98131093382835388,5b1eeabe-cc05-4f21-a026-146f9ab5ed29,"Johnson & Johnson Pharamceutical Research & Development, L.L.C",johnson_johnson_pharamceutical_research_development_l_l_c,,,,6067fed3-20a1-48ca-80df-3675d4109505,johnson_johnson_pharamceutical_research_development_l_l_c,"Johnson & Johnson Pharamceutical Research & Development, L.L.C" -7536,,81a2090e-7150-41a6-8543-246e5fd9740d,Pifzer Limited,pifzer_limited,,,,,, -7537,,ef93bbaf-5e35-4f13-a8c5-5c24fb30f3d2,Carlos Gómez Martín,carlos_g_mez_mart_n,,,,,, -7538,,f3cd39fd-1405-42c7-83fc-8d8598119991,Antoni van Leeuwenhoek - Netherlands Cancer Institute,antoni_van_leeuwenhoek_netherlands_cancer_institute,,,,,, -7539,,e0f4ab73-7aa4-4203-809c-c6a91f163209,"Pfizer Ltd,Ramsgate Road,Sandwich CT13 9NJ",pfizer_ltd_ramsgate_road_sandwich_ct13_9nj,,,,,, -7540,,a434d809-b02f-4bff-bcb3-2bf08937aa96,Calcium and Bone Metabolic Unit Copenhange University Hospital Hvidovre,calcium_and_bone_metabolic_unit_copenhange_university_hospital_hvidovre,,,,,, -515,0.928618,9e98b95e-5b2b-412f-bd88-d7d3dcb15715,"J. Uriach y Compañía, S.A",j_uriach_y_compa_a_s_a,,,,0b864f9c-6a82-4657-9f94-14d0aa558320,j_uriach_y_compa_ia_s_a,"J. Uriach y Compañia, S. A" -852,0.986862,a1d49384-7190-11e6-a0cd-0242ac12000b,ENDO PHARMS,endo_pharms,,,,105c8b52-7238-11e6-a0cd-0242ac12000b,endo_pharm,ENDO PHARM -7541,,862619d4-b00b-48b2-ab74-6f77b4526fbd,Per Lindner,per_lindner,,,,,, -7542,,39b17afb-f30d-4eb9-9a45-cabe0c4899f9,CEPHALON EUROPE,cephalon_europe,,,,,, -7543,,2f13cc44-b2b9-4116-933b-76eee62c418e,"NEUROTEC PHARMA, S.L",neurotec_pharma_s_l,,,,,, -500,0.991079,1e819b43-f206-47d8-a4b0-f6a029ef48dd,Hannover Medical School, Competence Network Viral Hepatitis (Hep-Net),,,,0f951df0-e851-4fc3-9f85-c87f75143477,hannover_medical_school,Hannover Medical School -7544,,8a36434c-7142-11e6-a0cd-0242ac12000b,SAVAGE LABS,savage_labs,,,,,, -7545,,4051a944-abd6-4438-aaa4-5eb025fa8556,GlaxoSmithKline Research & Developement Ltd,glaxosmithkline_research_developement_ltd,,,,,, -7546,,31ccf542-3a0b-4b7b-920c-439212767dd7,Klinik Löwenstein gGmbH,klinik_l_wenstein_ggmbh,hannover_medical_school_competence_network_viral_hepatitis_hep_net,,,,, -70,0.98913925886154175,ac8a4c93-016d-49ef-adcf-dab8bb9bc5aa,Takeda Global R&D Centre (Europe) Ltd,takeda_global_r_d_centre_europe_ltd,,,,ac8a4c93-016d-49ef-adcf-dab8bb9bc5aa,takeda_global_r_d_centre_europe_ltd,Takeda Global R&D Centre (Europe) Ltd -7547,,466902a6-4346-4b79-b7ca-5f383175b98f,Chiron S.r.l,chiron_s_r_l,,,,,, -7548,,f47d02df-17c5-43c4-8935-31eb0acea02a,"HUCH, Hospital for Children and Adolescents",huch_hospital_for_children_and_adolescents,,,,,, -330,0.925303,7f144f49-62c8-4b16-9149-74b909e542e7,Unidad de Trasplantes y Terapia Celular del Hospital Universitario Central de Asturias,unidad_de_trasplantes_y_terapia_celular_del_hospital_universitario_central_de_asturias,,,,786ccf58-7b82-4056-b49c-f3946952c95d,unidad_de_trasplantes_y_terapia_celular_del_hospital_general_universitario_central_de_asturias,Unidad de Trasplantes y Terapia Celular del Hospital General Universitario Central de Asturias -7549,,b2bc0b48-58c3-416f-aae3-eb124dcee8e8,"ISDIN, S.A",isdin_s_a,,,,,, -7550,,d4f1c47a-f69d-4ddf-b79a-71e055980785,IPPMed GmbH,ippmed_gmbh,,,,,, -7551,,6f7dbde5-1eea-4379-b680-05e3e241cec7,Bayer Consumer Care AG,bayer_consumer_care_ag,,,,,, -7552,,ea869bf7-f4ed-45dd-a12f-85845b2936b5,"Universität Heidelberg, Medizinische Fakultät Mannheim",universit_t_heidelberg_medizinische_fakult_t_mannheim,,,,,, -7553,,35ba6255-034f-4c59-8192-df9b68e78400,Auris ehf,auris_ehf,,,,,, -7554,,7253538e-d337-4f88-8864-38601dc092c5,Sankyo Pharma GmbH,sankyo_pharma_gmbh,,,,,, -7555,,1a3cda55-f587-464e-9d8e-42851a8f707a,Abnoba GmbH,abnoba_gmbh,,,,,, -7556,,629b224a-541a-4fe0-9fee-478045c7d11c,ASIT biotech S.A,asit_biotech_s_a,,,,,, -7557,,21aeab25-a88d-49c7-ad88-eea95d4db979,Direction Centrale du Service de Santé des Armées (DCSSA),direction_centrale_du_service_de_sant_des_arm_es_dcssa,,,,,, -775,0.929435,3994ddd6-d614-47eb-80a8-773f166f17da,"Ferring International Pharmascience Center US, Inc",ferring_international_pharmascience_center_us_inc,,,,3994ddd6-d614-47eb-80a8-773f166f17da,ferring_international_pharmascience_center_us_inc,"Ferring International Pharmascience Center US, Inc" -7558,,4c7419d9-6a28-4b01-a428-e93f6c523ed0,PHARNEXT,pharnext,,,,,, -7559,,8d9d31b0-def5-412d-a864-0120fd4bf484,Universitätskinderklinik Innsbruck,universit_tskinderklinik_innsbruck,,,,,, -7560,,a1421ab4-73fb-11e6-a0cd-0242ac12000b,COLLEGIUM PHARM INC,collegium_pharm_inc,,,,,, -7561,,faaf48f9-5baf-4152-8d3f-3ba71cfa4e77,University of Gothenburg,university_of_gothenburg,,,,,, -7562,,1c1df285-f323-4e3d-81a7-9542ca043088,"Medizinische Universität Wien, KIM III, Abteilung für Nephrologie",medizinische_universit_t_wien_kim_iii_abteilung_f_r_nephrologie,,,,,, -7563,,63e52d7c-ab77-4fa4-a225-9b5d8c413af2,Norgine Pharmaceuticals Ltd,norgine_pharmaceuticals_ltd,,,,,, -7564,,b20d9dcd-c724-430e-a98a-92260d4d5835,"Amersham plc and its Amersham Health affiliates, trading as GE Healthcare",amersham_plc_and_its_amersham_health_affiliates_trading_as_ge_healthcare,,,,,, -7565,,4508f7d1-63c2-42fe-9ac2-3a106f064748,"Dept of Plastic Surgery, Breast Surgery & Burns",dept_of_plastic_surgery_breast_surgery_burns,,,,,, -675,0.95528984069824219,3892c071-1607-48b5-94a4-5140950912c9,UCB Pharma S.A,ucb_pharma_s_a,,,,0db50825-cbd9-4ba0-9b70-46c1d448c066,ucb_pharma,UCB Pharma -7566,,35709bf1-2e34-449c-aa66-c0dbb84e31ef,Sunovion Pharmaceuticals Inc,sunovion_pharmaceuticals_inc,,,,,, -7567,,bbbfa0f1-7f59-4d16-a599-809484a879b6,Biocompatibles UK Ltd,biocompatibles_uk_ltd,,,,,, -7568,,02d8827c-c1d9-4123-98b1-b411e58d6bcd,Jorge Orduna Valls,jorge_orduna_valls,,,,,, -7569,,9697dfba-fbce-4a72-bfd4-88922154b5fa,"Schering-Plough HealthCare Products, Inc",schering_plough_healthcare_products_inc,,,,,, -7570,,646c4a23-afbc-4a9c-912f-b6fde2eb9744,"Teva Pharamceutical Industries, Ltd",teva_pharamceutical_industries_ltd,,,,,, -7571,,2e39292e-4ff1-4eb9-afc7-c9988bca2753,GELTAMO,geltamo,,,,,, -7572,,a44c816f-91b7-43ea-bd98-fb9f85b24f1c,Institut of Public Health,institut_of_public_health,,,,,, -253,0.96116367975870765,1c783fda-dd3b-43ce-8fdb-91e95f0e98cd,"Instituto Científico y Tecnológico de Navarra, SA. (ICT)",instituto_cient_fico_y_tecnol_gico_de_navarra_sa_ict,,,,4a176b41-c873-44ad-8442-a2e57b0b4289,instituto_cient_fico_y_tecnol_gico_de_navarra,Instituto Científico y Tecnológico de Navarra -24,0.98570942878723145,98380ed0-6709-41ea-a19e-81804abcd9ff,University Hospital Leuven,university_hospital_leuven,,,,98380ed0-6709-41ea-a19e-81804abcd9ff,university_hospital_leuven,University Hospital Leuven -716,0.986058,35022515-9c52-4711-b51c-84b1e5d62adf,Consorci Mar Parc de Salut de Barcelona,consorci_mar_parc_de_salut_de_barcelona,,,,35022515-9c52-4711-b51c-84b1e5d62adf,consorci_mar_parc_de_salut_de_barcelona,Consorci Mar Parc de Salut de Barcelona -7573,,f3cd1386-0998-4298-977d-99eafd678fee,CHu - Hôpitaux de Rouen,chu_h_pitaux_de_rouen,,,,,, -7574,,cf3fa0b4-deef-4f24-aae5-13cbe887fad1,General Medical Oncology UZ Gasthuisberg,general_medical_oncology_uz_gasthuisberg,,,,,, -7575,,928d1413-94e4-4328-a920-61b2553b8a97,Department of General Psychiatry,department_of_general_psychiatry,,,,,, -7576,,ee92b624-fbac-4c55-be3d-ebace05aa355,IPSEN FARMACEUTICA BV,ipsen_farmaceutica_bv,,,,,, -7577,,e3b51516-553a-410b-bbb2-93d48dbd39aa,"University of Nottingham, ResearchHead of research grants and contractsInnovation Services",university_of_nottingham_researchhead_of_research_grants_and_contractsinnovation_services,,,,,, -7578,,0adeb22e-ec65-4cb3-b5b9-ce777ba53b99,Dr Josep Ordi-Ros. Hospital Universitario Vall d'Hebron,dr_josep_ordi_ros_hospital_universitario_vall_d_hebron,,,,,, -7579,,4c547785-27d8-4900-9e4c-712e6e32465d,Federal Highway Research Institute / Bundesanstalt für Straßenwesen (BASt),federal_highway_research_institute_bundesanstalt_f_r_stra_enwesen_bast,,,,,, -7580,,812f91da-44b4-47de-ac38-0ef7539061b1,Minna Honkila / OYS,minna_honkila_oys,,,,,, -7581,,ae5489e9-fd0c-4950-b5c6-572dc4429a56,Servicio de Farmacia. Hospital Universitario de Bellvitge,servicio_de_farmacia_hospital_universitario_de_bellvitge,,,,,, -959,0.93498680988947547,2a8c6269-d997-4a31-a545-868ea8714d34,Andromeda Biotec Ltd,andromeda_biotec_ltd,,,,8e1ef03a-b2a7-496e-83ef-ae87bf0b27e9,andromeda_biotech_ltd_42_hayarkon_st_yavne_81227_israel,Andromeda Biotech Ltd -7582,,146eba55-658c-421e-8105-efef785a0045,TC BioPharm Ltd,tc_biopharm_ltd,,,,,, -7583,,9b7f2cfb-01c9-4c37-aeca-06ac6fd3a63b,Ste-Justine Hospital - Montréal in the name of Canadian Institute of Health Research (Canada),ste_justine_hospital_montr_al_in_the_name_of_canadian_institute_of_health_research_canada,,,,,, -7584,,71fd0cd6-8e07-4d4e-9d41-0b0616443144,"Mirati Therapeutics, Inc",mirati_therapeutics_inc,,,,,, -7585,,7c3372c5-9174-4604-8c9d-4df6b9503cfd,"University Health Network, Toronto General Hospital",university_health_network_toronto_general_hospital,,,,,, -341,0.984301,669b5851-2df0-4123-b6d8-74dd0d44fb69,Pfizer SA/NV,pfizer_sa_nv,,,,669b5851-2df0-4123-b6d8-74dd0d44fb69,pfizer_sa_nv,Pfizer SA/NV -7586,,91dba53a-0411-41cb-af86-9eb07dd9f045,Akademiska University Hospital,akademiska_university_hospital,,,,,, -7587,,b3e41ee3-fe81-4c51-865a-0ff629851886,Mundipharma Pharmaceuticals BV,mundipharma_pharmaceuticals_bv,,,,,, -719,0.98507535457611084,8ec06b1a-733e-11e6-a0cd-0242ac12000b,OTSUKA AMERICA PHARM,otsuka_america_pharm,,,,8ec06b1a-733e-11e6-a0cd-0242ac12000b,otsuka_america_pharm,OTSUKA AMERICA PHARM -7588,,4c6bfe1a-a08a-4582-bce0-fa4fb948d4b8,Southport and Ormskirk Hospital NHS Trust,southport_and_ormskirk_hospital_nhs_trust,,,,,, -7589,,f5914060-ce11-459f-9d8e-729b44d87025,Departments of Medical Research and Medicine,departments_of_medical_research_and_medicine,,,,,, -728,0.97711426019668579,093988ab-1f2c-48ab-84d3-0b1dff68400e,UCB Celltech,ucb_celltech,,,,093988ab-1f2c-48ab-84d3-0b1dff68400e,ucb_celltech_uk,"UCB Celltech, UK" -7590,,b91ff2d9-91df-4981-899c-d347e5b16c70,"Schwartz Biosciences, INC - UCB Group",schwartz_biosciences_inc_ucb_group,,,,,, -7591,,e4932ded-a042-45b6-a1a7-9d934fd9fb38,Active Biotech Research AB,active_biotech_research_ab,,,,,, -7592,,0bc6aa0e-564d-4422-b33a-6fccfefccc2a,ZLB Behring GmbH,zlb_behring_gmbh,,,,,, -7593,,4b66915a-356a-4ba4-8dfe-10c237db95c5,Paediatrisches Sekretariat fuer Klinische Studien,paediatrisches_sekretariat_fuer_klinische_studien,,,,,, -7594,,215c7a83-e8bb-4653-9d1c-5f0297300101,Middelfart Rygsektor,middelfart_rygsektor,,,,,, -7595,,90518e90-5ef7-4abd-b01e-4a4b2b9166e7,A. Menarini Farmaceutica Internazionale s.r.l,a_menarini_farmaceutica_internazionale_s_r_l,,,,,, -7596,,d37861e7-72e9-4532-9947-12a54900b82f,H.-Hartziekenhuis Roeselare-Menen vzw,h_hartziekenhuis_roeselare_menen_vzw,,,,,, -7597,,ab0d0693-8223-4d8f-8fd5-8ae1232145de,Emiliano Hernández Galilea,emiliano_hern_ndez_galilea,,,,,, -7598,,6da30198-71a1-11e6-a0cd-0242ac12000b,CORDEN PHARMA,corden_pharma,,,,,, -7599,,250ce2ef-6073-4d09-9e99-811427167e81,Moorfields Eye Hospital,moorfields_eye_hospital,,,,,, -7600,,b1e4f356-9614-11e6-becf-0242ac110008,MARNEL PHARMS,marnel_pharms,,,,,, -7601,,cb1fcbd7-70f1-45c9-b2de-5c789e2c6220,Oxford Radcliffe Hospitals NHS Trust,oxford_radcliffe_hospitals_nhs_trust,,,,,, -239,0.94886791706085205,bc50f609-752e-4417-a664-52c2b9126015,"Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK",pfizer_limited_ramsgate_road_sandwich_kent_ct13_9nj_uk,,,,8c508aab-3056-4b10-a446-a25708805795,pfizer_limited_ramsgate_road_sandwich_kent_ct13_uk,"Pfizer Limited, Ramsgate Road, Sandwich, Kent,CT13,UK" -7602,,54b22548-5361-4722-81d5-2c5c85fb6aef,Charite Universitaetsmedizin,charite_universitaetsmedizin,,,,,, -7603,,7dc890a4-7167-11e6-a0cd-0242ac12000b,MIPS CRF,mips_crf,,,,,, -7604,,0551c29a-64da-4181-9efe-4d28e70306d7,TBF,tbf,,,,,, -886,0.982434,2dab8489-6b0d-42e8-91ae-f96f843a7d75,ULB - Unité de Recherche en Lymphologie - Faculté des Sciences de la motricité,ulb_unit_de_recherche_en_lymphologie_facult_des_sciences_de_la_motricit,,,,2dab8489-6b0d-42e8-91ae-f96f843a7d75,ulb_unit_de_recherche_en_lymphologie_facult_des_sciences_de_la_motricit,ULB - Unité de Recherche en Lymphologie - Faculté des Sciences de la motricité -7605,,5c2229bc-72fa-11e6-a0cd-0242ac12000b,DIALYSIS SUPS,dialysis_sups,,,,,, -7606,,3aa12b2d-c17a-4858-8663-eb26ca1a9bca,"Klinik for Klinisk Fysiologi, Nuklearmedicin og PET, Rigshospitalet",klinik_for_klinisk_fysiologi_nuklearmedicin_og_pet_rigshospitalet,,,,,, -174,0.980699,d3d4a32b-9168-476d-9c12-82ebd51b34e5,"University of Tartu, Faculty of Medicine",university_of_tartu_faculty_of_medicine,,,,b6d07c42-8f99-487e-8dbb-3129112907b5,university_of_tartu,University of Tartu -7607,,e4ce7e52-43b4-4fa5-aa12-360d148945f1,Centro Nacional Investigaciones Oncológicas (CNIO),centro_nacional_investigaciones_oncol_gicas_cnio,,,,,, -7608,,2185fc71-a62d-4e77-b987-7ce251c29ee6,U.Z. Gasthuisberg,u_z_gasthuisberg,,,,,, -7609,,6fd0acde-5edf-4d69-a3d1-6c4f83d36a90,"Lehrstuhl für Klinisch-Experimentelle Medizin, Universitaet des Saarlandes",lehrstuhl_f_r_klinisch_experimentelle_medizin_universitaet_des_saarlandes,,,,,, -7610,,be28135c-7191-11e6-a0cd-0242ac12000b,CHATTEM,chattem,,,,,, -7611,,cf90e8ea-9c1d-44cf-93c1-6e2e6de31ae4,"Amersham Health, S.A",amersham_health_s_a,,,,,, -7612,,865d9b09-ab36-48a4-a684-c60b60af1295,"AZIENDA SANITARIA OSPEDALIERA ""S. GIOVANNI BATTISTA DI TORINO",azienda_sanitaria_ospedaliera_s_giovanni_battista_di_torino,,,,,, -7613,,e7c635b8-c909-46ab-b8a7-d6c9e0b5bd9c,Fundació de l'Institut de Recerca HSCSP,fundaci_de_l_institut_de_recerca_hscsp,,,,,, -208,0.98087829351425171,2237cc76-7146-11e6-a0cd-0242ac12000b,ALVOGEN,alvogen,,,,2237cc76-7146-11e6-a0cd-0242ac12000b,alvogen,ALVOGEN -7614,,f7228b96-68e8-4451-ad32-c8477b38853d,"Odense Universitetshospital, Nyremedicinsk Afd. Y",odense_universitetshospital_nyremedicinsk_afd_y,,,,,, -7615,,bf8fbd09-3f3f-424e-968e-ee2ffb53148a,Österreichische Nationalbank - Jubiläumsfonds,sterreichische_nationalbank_jubil_umsfonds,,,,,, -7616,,06bef760-8ec4-4d70-b0d2-1b0425892036,Sahlgrenska Universtitetssjukhuset/SUS,sahlgrenska_universtitetssjukhuset_sus,,,,,, -122,0.9805833101272583,30ba52d9-6b66-48ba-8e96-5fffed95a5ca,"F. Hoffmann-La Roche Ltd, Pharmaceuticals Divison, PDR",f_hoffmann_la_roche_ltd_pharmaceuticals_divison_pdr,,,,89ecf617-74e0-496c-8ac4-d4eae3b54d8c,f_hoffmann_la_roche_ltd_pharmaceuticals_divison_pdr,"F. Hoffmann-La Roche Ltd, Pharmaceuticals Divison, PDR" -802,0.989407,cd7233a2-6fa1-11e6-9663-0242ac12000b,Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF),consorzio_per_valutazioni_biologiche_e_farmacologiche_cvbf,,,,a02415a8-3cdf-4ded-89d7-b50b2f02f0bd,consorzio_per_valutazioni_biologiche_e_farmacologiche,Consorzio per Valutazioni Biologiche e Farmacologiche -394,0.97813,3962e63e-5246-49ec-a9ae-2803f127cfde,Unidad de Investigación en Tuberculosis de Barcelona (UITB),unidad_de_investigaci_n_en_tuberculosis_de_barcelona_uitb,,,,2a062c79-99fa-45ef-95f7-3bfbfa472661, Hospital Universitario de Canarias,Unidad de Investigación -7617,,ff995683-97a1-496d-aa8e-4be2c7b6077b,DuoCort Pharma AB,duocort_pharma_ab,,,,,, -7618,,9dcb859d-59d4-4771-9d13-2846f6db5090,Phenex Pharmaceuticals AG,phenex_pharmaceuticals_ag,,,,,, -183,0.959379,5e949122-96f1-4d01-ad56-70e70e854e38,Cliniques Universiatires St Luc- Centre du Cancer,cliniques_universiatires_st_luc_centre_du_cancer,,,,5c17ba0c-11f6-4fbe-8689-f48af0fac056,cliniques_universitaires_st_luc_centre_du_cancer,"Cliniques Universitaires St Luc, Centre du Cancer" -380,0.98268057902654016,e3acf622-0e1e-442c-86eb-aafa4489dda1,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc",merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" -652,0.95031802356243134,00579454-324d-40af-85d4-934e24af2e2b,Boehringer Ingelheim Ky,boehringer_ingelheim_ky,,,,756fbf26-6aec-45b4-9273-9afca275034e,boehringer,Boehringer -7619,,1703c128-7242-11e6-a0cd-0242ac12000b,NUVO RES INC,nuvo_res_inc,,,,,, -841,0.95600730180740356,640d2f05-d82c-4fcf-8cf1-823f7c525359,JANSSEN-CILAG INTERNATIONAL BV,janssen_cilag_international_bv,,,,640d2f05-d82c-4fcf-8cf1-823f7c525359,janssen_cilag_international_bv,JANSSEN-CILAG INTERNATIONAL BV -7620,,60c1bb4e-4159-4a95-9f37-82a64d1f527a,Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_12_de_octubre,,,,,, -7621,,9b626529-57b7-499f-9333-92a72929f0d4,Sanofi-aventis Research & Development,sanofi_aventis_research_development,,,,,, -7622,,8b9f8577-6b6d-4d48-b7e7-194aa4dc3cd0,"Istituto Fisiologia Clinica, CNR",istituto_fisiologia_clinica_cnr,,,,,, -7623,,54b74af7-da2a-4d51-aea5-591da869d740,Tandvården SU/Mölndal,tandv_rden_su_m_lndal,,,,,, -7624,,838f6ee7-46da-4c10-8265-6ba40a0a41b6,German High-Grade non- Hodgkin's Lynphoma Study Group,german_high_grade_non_hodgkin_s_lynphoma_study_group,,,,,, -7625,,feca5ef4-e4db-4608-a21c-d1cad2b0992c,St. Antonius Ziekenhuis,st_antonius_ziekenhuis,,,,,, -7626,,28d95ccb-32ff-4b67-9112-ec17076a97ad,ALEJANDRA GARCIA BOTELLA,alejandra_garcia_botella,,,,,, -7627,,9d134468-aa02-44c2-87de-c1bc72ec82bc,Axonyx Inc,axonyx_inc,,,,,, -7628,,5f9aa4ba-a44f-448c-b8b7-1a9368b28c5c,Manchester Mental Health &Social Care Trust,manchester_mental_health_social_care_trust,,,,,, -7629,,c3bacb84-fbc1-413d-92cc-1ed4defa0239,"Universität Innsbruck, Institut für Biomedizinische Alternsforschung",universit_t_innsbruck_institut_f_r_biomedizinische_alternsforschung,,,,,, -7630,,1fe4919a-2864-4a0d-b38b-bbffa53ffeda,Timo Laitio,timo_laitio,,,,,, -7631,,f8961dce-011a-4296-a469-f359df20f8c8,Sumitomo Pharmaceuticals Europe Limited,sumitomo_pharmaceuticals_europe_limited,,,,,, -7632,,02fbc65b-45fe-4d6c-9677-62564553943e,ANGEL LANAS,angel_lanas,,,,,, -7633,,038a5577-74de-4b90-bf49-e8cf48059bfc,"Merk & Co., Inc",merk_co_inc,,,,,, -7634,,bc7e5204-9e97-4e34-b76e-94ddd6c91873,Hull & East Yorkshire NHS Trust,hull_east_yorkshire_nhs_trust,,,,,, -12,0.988363,ed989b24-8bd7-11e6-a449-0242ac12000b,University Medical Center Utrecht (UMCU),university_medical_center_utrecht_umcu,,,,43a29514-7df4-4ef9-8c2e-fd420fdb7e20,university_medical_center_utrecht,University Medical Center Utrecht -7635,,186055fe-4fc1-4b0c-b29a-d44ece646ddb,Translational Research In Oncology,translational_research_in_oncology,,,,,, -7636,,c06a291e-93ba-40c3-bfff-a263c053c14e,Colgate Palmolive Co,colgate_palmolive_co,,,,,, -7637,,1524de89-ea1f-4085-a48d-67b06129ce8a,SLL,sll,,,,,, -7638,,6561d4a8-3282-458b-8156-878ded032e06,Dr. med. Tina Vilsbøll,dr_med_tina_vilsb_ll,,,,,, -7639,,888ecead-0afd-4451-a718-fb2526e6dcf0,Glaukos Corporation,glaukos_corporation,,,,,, -7640,,2c269c3f-049e-45f2-b9cf-db978a37a5e2,Psykiatrisk Center Ballerup,psykiatrisk_center_ballerup,,,,,, -7641,,b25fa8fd-688e-4aa4-b3da-1d7476d11c47,"Adyton, s.r.o",adyton_s_r_o,,,,,, -7642,,11077792-573f-4483-9aa1-625d83d1ee36,Clinical Center Ljubljana,clinical_center_ljubljana,,,,,, -88,0.985891,31023a1a-6fbc-11e6-abe8-0242ac12000b,Photopharmica Ltd,photopharmica_ltd,,,,31023a1a-6fbc-11e6-abe8-0242ac12000b,photopharmica_ltd,Photopharmica Ltd -7643,,53fd8f6b-902a-446b-9c91-86c7cdea4239,Laboratoire BOIRON,laboratoire_boiron,,,,,, -7644,,7609d379-3c41-479b-b625-178204d6c845,BG university hospital Bergmannsheil GmbH,bg_university_hospital_bergmannsheil_gmbh,,,,,, -7645,,67dae82a-7142-11e6-a0cd-0242ac12000b,TARO PHARMS NORTH,taro_pharms_north,,,,,, -7646,,0a02a3c6-86b4-43ef-b663-7342adb691d8,University of Crete,university_of_crete,,,,,, -7647,,3acbbff4-662c-4b8a-a1a5-57113c0adafd,I.R.I.S,i_r_i_s,,,,,, -7648,,28422b74-7160-11e6-a0cd-0242ac12000b,PHARMATON,pharmaton,,,,,, -7649,,b44de3d6-7d21-4f43-8d94-0029c37cef6b,"Med. Univ. Wien, Klinik für klinische Pharmakologie",med_univ_wien_klinik_f_r_klinische_pharmakologie,,,,,, -7650,,5ed4b3e0-66a0-4f37-a0ea-a8a968f24589,Merck Farma y Química S.L,merck_farma_y_qu_mica_s_l,,,,,, -7651,,c088787e-9811-4b5f-87c2-b0a85049c762,"Ove Bäck, Dept Dermatology, University Hospital, Lund, Sweden",ove_b_ck_dept_dermatology_university_hospital_lund_sweden,,,,,, -7652,,7c832cd0-9f82-4358-990a-8b596507cc5f,"Ipsen Biopharmaceuticals, Inc",ipsen_biopharmaceuticals_inc,,,,,, -7653,,d988cb65-987a-4b7d-bc5e-98d8f7a43501,GLAXOSMITHLINE RESEARCH AND DEVELOPMENT LIMITED,glaxosmithline_research_and_development_limited,,,,,, -7654,,2b921b7b-bfb5-4c0f-a615-bf6bb757c33b,HOSPITAL VALL DE HEBRON,hospital_vall_de_hebron,,,,,, -7655,,51fdbbe1-05cd-416b-9dde-12dd011559f5,"Medical University of Vienna, Dep. of Internal Medicine I, division of Hematology & Hemostaseology",medical_university_of_vienna_dep_of_internal_medicine_i_division_of_hematology_hemostaseology,,,,,, -702,0.97233712673187256,e83cea40-d34c-423f-9f95-62293d47cae2,University Hospital of Leicester NHS Trust,university_hospital_of_leicester_nhs_trust,,,,e83cea40-d34c-423f-9f95-62293d47cae2,university_hospitals_of_leicester_nhs_trust,University Hospitals of Leicester NHS Trust -629,0.973923,a2b23675-9895-4989-9406-32001c82a978,Aarhus Sygehus,aarhus_sygehus,,,,8bf894ff-dd31-480c-84ce-842ae83c6af2,aarhus_sygehus_universityhospital_of_aarhus,"Aarhus Sygehus, Universityhospital of Aarhus" -485,0.985716,f5ed546c-10fd-4c11-a82d-b2c4946cdba7,IRCCS CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI,irccs_centro_san_giovanni_di_dio_fatebenefratelli,,,,d4d3b8e8-ff21-4f29-9209-678e5c00d01b,irccs_centro_san_giovanni_di_dio,IRCCS CENTRO SAN GIOVANNI DI DIO -7656,,dcdbaa55-bf8e-4d6c-be35-1a12072b3b9e,MEDDAY SAS,medday_sas,,,,,, -7657,,20bcbccf-0911-41ec-b532-ded8ae67a245,OmniVision GmbH,omnivision_gmbh,,,,,, -7658,,c93ca877-71a7-413e-9156-e8546b2dd3a0,Cumberland Pharmaceuticals Inc,cumberland_pharmaceuticals_inc,,,,,, -7659,,ba1435d3-b1e8-45d9-8d7f-b0b298131a94,Prof.Dr.Hartmut ZWICK,prof_dr_hartmut_zwick,,,,,, -7660,,8b16650d-d80a-406e-8147-ab226c6a7d71,Georg Hagmüller Institute for Vascular Research,georg_hagm_ller_institute_for_vascular_research,,,,,, -7661,,1fd6926f-b078-4a5d-a67d-9c6e776ef4f6,St Georges Healthcare NHS trust,st_georges_healthcare_nhs_trust,,,,,, -7662,,28ed6e56-d7c3-4dff-a541-40118534ee9c,Dra Itxarone Bilbao. Servicio de Cirugía Hepatobiliopancreatica y Trasplantes. HUVH,dra_itxarone_bilbao_servicio_de_cirug_a_hepatobiliopancreatica_y_trasplantes_huvh,,,,,, -7663,,2e88ce04-e0d1-4886-ba3c-e30013343376,Chimerix UK Limited,chimerix_uk_limited,,,,,, -7664,,5e6c77d8-d52b-48af-b2e6-6dfd3e254265,RAFAEL GARCIA LOPEZ,rafael_garcia_lopez,,,,,, -7665,,f94760e8-e21f-4f6a-8fb0-d99d100931f5,Juan Pasquau Liñao,juan_pasquau_li_ao,,,,,, -266,0.96782034635543823,f5fb73ac-fe01-4343-a38f-65de710199e4,TEVA,teva,,,,07e8ff92-7129-11e6-a89e-0242ac12000b,teva_pharms,TEVA PHARMS -7666,,7dcfbcff-c703-47cd-9782-1e57db49fcbb,ELI LILLY,eli_lilly,,,,,, -7667,,ca0f061e-4dd5-4b12-853f-062cd3b0c150,"Lund University, Malmö University Hospital",lund_university_malm_university_hospital,,,,,, -7668,,3d25aa23-3066-4c23-8378-9ce3565b8ff0,"ChemoCentryx, Inc",chemocentryx_inc,,,,,, -7669,,a2d44ce2-dcdc-47e9-84e1-0249f74117e2,Nordic Myeloma Study Group,nordic_myeloma_study_group,,,,,, -502,0.955255,857fd478-88b2-4bb7-94b5-f76c9d81d5e1,Aalborg University,aalborg_university,,,,569a1285-cdde-46ac-ab93-f30a3f2406e3,aalborg_universitetshospital,Aalborg Universitetshospital -7670,,18989427-a40f-41ac-a71d-3539886da202,Teva Pharmaceuticals Industries LtD,teva_pharmaceuticals_industries_ltd,,,,,, -755,0.952513,0c07c031-3aa4-42bd-a466-16b7d6794b5f,Sanofi Pasteur KK,sanofi_pasteur_kk,,,,0c07c031-3aa4-42bd-a466-16b7d6794b5f,sanofi_pasteur_kk,Sanofi Pasteur KK -7671,,2c464efc-714d-11e6-a0cd-0242ac12000b,HALOCARBON PRODS,halocarbon_prods,,,,,, -7672,,a45f5df6-c17f-4e74-89c1-b28409070404,HOSPITAL DE PALAMÓS,hospital_de_palam_s,,,,,, -907,0.94030070304870605,f72ce0f5-27b8-42db-aeea-0faa55409a54,sanofi-aventis recherche et de`veloppement,sanofi_aventis_recherche_et_de_veloppement,,,,f72ce0f5-27b8-42db-aeea-0faa55409a54,sanofi_aventis_recherche_et_developpement,sanofi-aventis recherche et developpement -878,0.986926,c04f7850-7141-11e6-a0cd-0242ac12000b,ZYDUS PHARMS USA,zydus_pharms_usa,,,,c04f7850-7141-11e6-a0cd-0242ac12000b,zydus_pharms_usa,ZYDUS PHARMS USA -7673,,39fa0653-2173-4c4e-9c60-9e35689a623e,Copenhagen CF-centre,copenhagen_cf_centre,,,,,, -280,0.978312,038ffc9a-cc49-4155-9812-d242dccadca0,"Vejle Hospital, Dept. of Oncology",vejle_hospital_dept_of_oncology,,,,038ffc9a-cc49-4155-9812-d242dccadca0,vejle_hospital_dept_of_oncology,"Vejle Hospital, Dept. of Oncology" -7674,,db9b5ff9-4cd6-4a86-b5f5-4874a9db2b25,RIBOSEPHARM,ribosepharm,,,,,, -7675,,97dd88a5-215c-4290-8e9e-fa0abaff3a07,Servicio Hepatología. Hospital Vall d'Hebron,servicio_hepatolog_a_hospital_vall_d_hebron,,,,,, -7676,,2d21aed3-23a1-44f8-b382-933861d3b397,Inserm-ANRS (Agence nationale de recherches sur le sida et les hépatites virales),inserm_anrs_agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales,,,,,, -7677,,cbd6f72d-f490-4042-9733-1d5f57953f96,"Research & Development Unit, Queen Alexandra Hospital",research_development_unit_queen_alexandra_hospital,,,,,, -7678,,dd26aacd-6909-4312-871f-0b6b8d29d641,Balkanpharma-Razgrad AD,balkanpharma_razgrad_ad,,,,,, -7679,,39c13a12-f3e8-4485-b2fa-0a7b0d751d00,Kantonsspital St. Gallen,kantonsspital_st_gallen,,,,,, -7680,,8a378b01-d64f-40a7-9960-68d921310271,Department of Anaesthesia,department_of_anaesthesia,,,,,, -7681,,054cef65-deb6-4362-a651-f4d878edb702,"Cardiff University, Research & Development Commercial Department",cardiff_university_research_development_commercial_department,,,,,, -7682,,70120a3b-c639-4430-8743-086b481fc6b7,"Department of Dermatology and Allergology, University of Szeged",department_of_dermatology_and_allergology_university_of_szeged,,,,,, -7683,,adf99fba-05fa-4490-b40a-5bec9a71da62,"University Medical Center Groningen, UMCG-Department of Gynaecologic Oncology",university_medical_center_groningen_umcg_department_of_gynaecologic_oncology,,,,,, -7684,,031a2ce9-4219-4223-b1f0-bed8fc220de2,DAVID DALMAU,david_dalmau,,,,,, -7685,,a1d85146-2698-46ca-b55c-dd2093d4f90e,"Anadys Development, LTD",anadys_development_ltd,,,,,, -919,0.985423,a73e16e9-8647-4b62-9351-fa10656902fa,NOVO NORDISK,novo_nordisk,,,,6e3bc4ca-7140-11e6-a0cd-0242ac12000b,novo_nordisk_inc,NOVO NORDISK INC -271,0.936507,1f1910ef-d8fc-404c-af9b-dd7bc5fd4d42,AstraZeneca BV,astrazeneca_bv,,,,1f1910ef-d8fc-404c-af9b-dd7bc5fd4d42,astrazeneca_bv,AstraZeneca BV -62,0.98647499084472656,371bb74c-7ef8-447f-97d1-6ea91a3686f0,Talecris Biotherapeutics,talecris_biotherapeutics,,,,8776dd79-3ee8-4ef0-a9ce-fb6aef833e21,talecris_biotherapeutics_inc,"Talecris Biotherapeutics, Inc" -7686,,931e2c7c-72e1-11e6-a0cd-0242ac12000b,IVAX INTL,ivax_intl,,,,,, -7687,,6bef1f1f-67aa-4b42-bce5-7aae791f641e,Ludwig-Maximilians-Universitaet Muenchen,ludwig_maximilians_universitaet_muenchen,,,,,, -7688,,65664cf5-47f2-4fe4-8aee-cd4668389bbd,"Klinische Abteilung für Gastroenterologie und Hepatologie, Medizinische Universitätsklinik, MUG",klinische_abteilung_f_r_gastroenterologie_und_hepatologie_medizinische_universit_tsklinik_mug,,,,,, -78,0.988885,5e1c611c-7163-11e6-a0cd-0242ac12000b,BRECKENRIDGE PHARMS,breckenridge_pharms,,,,5e1c611c-7163-11e6-a0cd-0242ac12000b,breckenridge_pharms,BRECKENRIDGE PHARMS -7689,,fb5a4f7b-b084-4077-9eff-0c7b11aecc75,Universitary Hospital Hamburg,universitary_hospital_hamburg,,,,,, -7690,,0ee4af01-185d-4cf1-ac3a-38dbd4ceae26,Circassia Ltd,circassia_ltd,,,,,, -248,0.981904,d3994724-733a-11e6-a0cd-0242ac12000b,HILL DERMACEUTICALS,hill_dermaceuticals,,,,101cc2b8-71b8-11e6-a0cd-0242ac12000b,hill_dermac,HILL DERMAC -7691,,a7602d2d-4925-496b-a10f-ebbe6090c39e,GlaxoSmithKline Research &, Development Ltd,,,,,, -7692,,5a18236a-c80e-4d4c-9d76-a5a9abec073e,GRUPO ESPAÑOL DE INVESTIGACIÓN EN CANCER DE OVARIO (GEICO),grupo_espa_ol_de_investigaci_n_en_cancer_de_ovario_geico,,,,,, -975,0.93739336729049683,5cf8174e-62dd-46c6-8a1e-ec1d71fed23c,"Universitätsklinikum Schleswig-Holstein, Campus Lübeck",universit_tsklinikum_schleswig_holstein_campus_l_beck,,,,5a90c345-0950-4b20-a685-09b583a6ae3f,universit_tsklinikum_schleswig_holstein_campus_kiel,"Universitätsklinikum Schleswig-Holstein, Campus Kiel" -7693,,a15b44e4-814d-4ab9-819e-9703b9670639,"F. Hoffmann - La Roche Ltd - Pharmaceutical Division, PDR",f_hoffmann_la_roche_ltd_pharmaceutical_division_pdr,glaxosmithkline_research_amp_development_ltd,,,,, -7694,,2be1a793-74aa-4531-8494-d711cb936e4c,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),national_institute_of_arthritis_and_musculoskeletal_and_skin_diseases_niams,,,,,, -7695,,6d3f19ce-5313-4361-938d-2552df91eb62,Steiner & Co. Deutsche Arzneimittelgesellschaft mbH & Co. KG,steiner_co_deutsche_arzneimittelgesellschaft_mbh_co_kg,,,,,, -7696,,8c98d8cb-26a0-4383-a458-cf109e25e637,Guerbet Laboratories Ltd,guerbet_laboratories_ltd,,,,,, -7697,,cbd0c87e-1b36-4ef6-9134-7e98137518fa,Univ.-Kl.f.Nuklearmedizin Wien,univ_kl_f_nuklearmedizin_wien,,,,,, -7698,,f3e33bd1-b988-459e-ac96-fb368e004708,APREC,aprec,,,,,, -7699,,876a98df-aff9-4577-8210-09e14eecab5f,Siena Biotech SpA,siena_biotech_spa,,,,,, -7700,,81afadd8-7167-11e6-a0cd-0242ac12000b,UNIV UTAH CYCLOTRON,univ_utah_cyclotron,,,,,, -7701,,61743b56-719e-11e6-a0cd-0242ac12000b,LANTHEUS MEDCL,lantheus_medcl,,,,,, -7702,,ac19807e-8bef-11e6-a449-0242ac12000b,Antonis Valachis,antonis_valachis,,,,,, -7703,,e932f528-7144-11e6-a0cd-0242ac12000b,COASTAL PHARMS,coastal_pharms,,,,,, -7704,,a5d50545-8d0c-452c-be10-debd15181916,Matti Ristikankare,matti_ristikankare,,,,,, -7705,,202076fe-7164-11e6-a0cd-0242ac12000b,JUBILANT GENERICS,jubilant_generics,,,,,, -7706,,fbe222d8-d19c-4c6e-88d5-d6034dfe6695,"Merck Serono International SA, An affiliate of Merck KGaA, Darmstadt, Germany",merck_serono_international_sa_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,,, -7707,,cf14a86a-581c-4394-bfa3-5be9a908b843,Australian Sarcoma Group (ASSG),australian_sarcoma_group_assg,,,,,, -7708,,92e80fb0-7a0a-4a57-9f67-87cbe8dab53e,BAS Medical Inc,bas_medical_inc,,,,,, -627,0.97483,51090fb3-f2e6-4878-8ebd-94da6e3ed0df,Institut Bergonié - Département d’Oncologie Médicale,institut_bergoni_d_partement_d_oncologie_m_dicale,,,,51090fb3-f2e6-4878-8ebd-94da6e3ed0df,institut_bergoni_d_partement_d_oncologie_m_dicale,Institut Bergonié - Département d’Oncologie Médicale -7709,,c73b115c-c0ae-44f1-bbbf-6507e89f8968,Themis Bioscience GmbH,themis_bioscience_gmbh,,,,,, -7710,,1b59f5d9-fba6-4756-9c55-6ec18cc4e471,"Schering-Plough Research Institute on behalf of MSP Singapore Company, LLC",schering_plough_research_institute_on_behalf_of_msp_singapore_company_llc,,,,,, -7711,,27fd8fa2-73d9-11e6-a0cd-0242ac12000b,FOREST RES INST INC,forest_res_inst_inc,,,,,, -7712,,134b2ab0-99bd-498c-ac11-a8dce306ac5f,Free State of Bavaria represented by Regensburg University represented by Regensburg University Hospital represented by,free_state_of_bavaria_represented_by_regensburg_university_represented_by_regensburg_university_hospital_represented_by,,,,,, -632,0.988363,cac50b51-5326-4418-b63e-99dee23e93b8,Grupo Gallego de Cáncer de Pulmón,grupo_gallego_de_c_ncer_de_pulm_n,,,,0be8c403-9955-44a5-a91f-7f50c9773ce9,grupo_gallego_de_c_ncer_de_pulm_n_ggcp,Grupo Gallego de Cáncer de Pulmón (GGCP) -7713,,1706ffae-c772-4957-9756-cf424896aac9,Heidelberg Pharma,heidelberg_pharma,,,,,, -7714,,2431a9b8-01c4-4bdf-8952-e75621de272b,Department of Genito-Urinary Medicine and Infectious Diseases,department_of_genito_urinary_medicine_and_infectious_diseases,,,,,, -7715,,6bb028ca-5c9c-4295-8af6-b5b66f36c7de,Semmelweis Egyetem Transzplantációs és Sebészeti Klinika,semmelweis_egyetem_transzplant_ci_s_s_seb_szeti_klinika,,,,,, -7716,,7c9fc3fa-71ad-11e6-a0cd-0242ac12000b,POHL BOSKAMP,pohl_boskamp,,,,,, -7717,,26701740-ecf2-4eb3-8869-3368ebe479e1,Thornton & Ross Ltd,thornton_ross_ltd,,,,,, -7718,,06a61b58-9db7-49fa-8214-f7423106e7d9,CONCEPCION MORO SERRANO,concepcion_moro_serrano,,,,,, -368,0.97238914171854651,e3d5ccce-d023-44a3-9122-51b95f10329f,"Bayer HealthCare AG, 51368 Leverkusen",bayer_healthcare_ag_51368_leverkusen,,,,0f2245d6-1eb2-4a26-ba28-2ddd66aada58,bayer_healthcare_ag_51368_leverkusen,"Bayer HealthCare AG, 51368 Leverkusen" -7719,,0bd978ba-d3ef-4d30-b44e-a97201c4e2a9,ADVENTRX Pharmaceuticals Inc,adventrx_pharmaceuticals_inc,,,,,, -7720,,b18480c2-5f60-4243-9b70-f597579deeb8,"Ikaria, Inc",ikaria_inc,,,,,, -102,0.98334300518035889,2eb3e3c9-b195-488e-a7df-a29b241b8d60,KU Leuven LRD,ku_leuven_lrd,,,,2eb3e3c9-b195-488e-a7df-a29b241b8d60,ku_leuven_lrd,KU Leuven LRD -7721,,48a7131f-670a-4237-99dc-eb0eef3da355,Sosei R&D Ltd,sosei_r_d_ltd,,,,,, -7722,,df869e77-e5aa-40fb-a8b8-bbd5824e91df,ALK Abello A/S,alk_abello_a_s,,,,,, -7723,,3fdb33bf-7f5c-456f-a933-5b9620cf3b49,"Institute for the Study, Research and Education in Diabetes Mellitus and Metabolic Disorders",institute_for_the_study_research_and_education_in_diabetes_mellitus_and_metabolic_disorders,,,,,, -7724,,b7132602-7145-11e6-a0cd-0242ac12000b,MYLAN SPECLT,mylan_speclt,,,,,, -7725,,fef3c91f-9abc-4f38-973e-5e7ae16c0f50,Śląski Uniwersytet Medyczny w Katowicach,l_ski_uniwersytet_medyczny_w_katowicach,,,,,, -1080,0.975398,ebd4395d-f808-443f-be1d-ab4674258fc6,Medice Arnzneimittel Pütter GmbH & Co. KG,medice_arnzneimittel_p_tter_gmbh_co_kg,,,,4d169b05-ac41-460f-9a9b-dbaba35ab0e5,medice_arzneimittel_p_tter_gmbh_co_kg,Medice Arzneimittel Pütter GmbH & Co. KG -7726,,6f80fab6-a72e-484b-90de-7b65ef90da4a,Gilead Sciences Pty Ltd,gilead_sciences_pty_ltd,,,,,, -7727,,e1c9b838-886d-4b15-81c6-7ccbbf94c488,Schering-Plough AB Sweden,schering_plough_ab_sweden,,,,,, -7728,,6b1a826a-53a1-42f3-a851-2b7dcbec969c,Antonio Cubillo Gracián (Servicio de Oncología Médica - Hospital MD Anderson),antonio_cubillo_graci_n_servicio_de_oncolog_a_m_dica_hospital_md_anderson,,,,,, -7729,,88117330-bb65-4e3e-a89c-f1c9dc07036e,Abbott Healthcare Products B.V,abbott_healthcare_products_b_v,,,,,, -7730,,f2248e4b-cb74-471f-8db1-b07a0979ef51,"Geir Øystein Andersen, Department of Cardiology, Ulleval University Hospital",geir_ystein_andersen_department_of_cardiology_ulleval_university_hospital,,,,,, -915,0.9809834361076355,61f167e1-4240-4936-a86a-3eb617eeeb8b,"Oulu University Hospital, Department of Anaesthesia",oulu_university_hospital_department_of_anaesthesia,,,,61f167e1-4240-4936-a86a-3eb617eeeb8b,oulu_university_hospital_department_of_anaesthesia,"Oulu University Hospital, Department of Anaesthesia" -7731,,e4584d7b-19ed-4607-94e5-a1884d4fd8ac,Birken GmbH,birken_gmbh,,,,,, -7732,,21c38081-4daa-4dfa-bfe8-c57cbdb53b1d,AETERNA ZENTARIS GMBH,aeterna_zentaris_gmbh,,,,,, -7733,,1fc7f870-71ec-11e6-a0cd-0242ac12000b,LUNDBECK LLC,lundbeck_llc,,,,,, -7734,,110fbced-4d46-406e-b9ce-9d019ede74b5,Trafford NHS Trust,trafford_nhs_trust,,,,,, -7735,,b443a406-2335-4b59-a4b9-14bc0d70b1fa,Janssen-Cilag Polska Sp z o.o,janssen_cilag_polska_sp_z_o_o,,,,,, -7736,,479c6171-6fd7-4c1e-bdfa-ebe156b483e3,Ana Boto de los Bueis,ana_boto_de_los_bueis,,,,,, -7737,,1057c411-e420-4d95-9850-1e5efb94ea6d,Servicio de Farmacia. Hospital Universitari de Bellvitge,servicio_de_farmacia_hospital_universitari_de_bellvitge,,,,,, -7738,,245b3501-2046-4f9e-9b4b-07b7490ab52f,"Abteilung für Pulmologie, Landesklinikum Thermenregion Hochegg",abteilung_f_r_pulmologie_landesklinikum_thermenregion_hochegg,,,,,, -7739,,4eb6e9d1-9b11-4613-92b2-56ef7ffe2d91,"Medizinische Universität Graz, Klinische Abteilung für Endokrinologie und Nuklearmedizin",medizinische_universit_t_graz_klinische_abteilung_f_r_endokrinologie_und_nuklearmedizin,,,,,, -7740,,91396f77-4e1b-4e35-93a2-629b9ad94939,Hospital Universitari de Tarragona Joan XXIII,hospital_universitari_de_tarragona_joan_xxiii,,,,,, -7741,,3cfa4fb8-1b49-4d36-b0f9-7efb5595fe8d,Novartis Pharma N.V,novartis_pharma_n_v,,,,,, -7742,,4288e88f-63ed-4b89-bfcb-0280fdc50d5f,Spirig Pharma AG,spirig_pharma_ag,,,,,, -7743,,3020178e-4134-4394-b976-ef29a7864a86,MannKind Corporation,mannkind_corporation,,,,,, -7744,,e6ee308e-d4c5-4cb4-b112-4e6fb5a09ed8,University Hospitals of the KU Leuven,university_hospitals_of_the_ku_leuven,,,,,, -7745,,52579968-4d60-4514-ac54-9cfb15b3c115,Addenbrooke's Hospital NHS Foundation Trust,addenbrooke_s_hospital_nhs_foundation_trust,,,,,, -7746,,9ecb5c92-7513-40f9-b274-63a8b2171243,ENCELADUS Pharmaceuticals BV,enceladus_pharmaceuticals_bv,,,,,, -7747,,ac77a856-c9bd-44d6-9ad2-767d66f28537,"480 Biomedical, Inc",480_biomedical_inc,,,,,, -7748,,d7f8103d-5e8e-43b8-827e-b7a894c63edf,"University Hospitals of Leicester NHS Trust, Research and Development Directorate",university_hospitals_of_leicester_nhs_trust_research_and_development_directorate,,,,,, -7749,,6d93f03c-7146-11e6-a0cd-0242ac12000b,CLONMEL,clonmel,,,,,, -927,0.983072,acf46b8c-60b7-4671-b4bc-ad1703a5253c,The University of Edinburgh & Lothian Health Board,the_university_of_edinburgh_lothian_health_board,,,,61519487-23d4-417a-83c9-581008f2af7b,the_university_of_edinburgh,The University of Edinburgh -7750,,a48450c7-69fa-4ae7-b19b-264a204a418a,4SC AG,4sc_ag,,,,,, -421,0.98666298389434814,4fb64be1-7068-4347-b4e2-1452dd8cf46d,Rigshospitalet, Department of Anaesthesia,,,,91fae256-199c-4920-9cd2-0437b5db434d,rigshospitalet,Rigshospitalet -7751,,d18ef15f-c080-4dd4-a37d-45b53068b769,John F. Kennedy Institute,john_f_kennedy_institute,,,,,, -873,0.987212,356fb77d-2541-44d7-b831-9556b88820e3,Emotional Brain BV,emotional_brain_bv,,,,356fb77d-2541-44d7-b831-9556b88820e3,emotional_brain_bv,Emotional Brain BV -190,0.985423,b06dc366-da0a-4b59-9973-9cb31751ecbe,Prima BioMed,prima_biomed,rigshospitalet_department_of_anaesthesia,,,1f75a770-d643-44ba-b10f-91da8b571eaa,prima_biomed_ltd,Prima BioMed Ltd -7752,,ac293448-f146-458e-82dd-c713b0d38e4d,IATEC B.V,iatec_b_v,,,,,, -325,0.9875873327255249,199a1dd6-828f-4e0b-b783-d712bad32b9e,Ferrer Internacional,ferrer_internacional,,,,199a1dd6-828f-4e0b-b783-d712bad32b9e,ferrer_internacional,Ferrer Internacional -7753,,1705da07-6b38-4579-8653-f200b6c3b474,"St Raphael's Hospice, Surrey",st_raphael_s_hospice_surrey,,,,,, -641,0.98154276609420776,574b90d0-3e5f-45c1-862c-9770d5cf9ad6,Boehringer Ingelheim Denmark,boehringer_ingelheim_denmark,,,,82029ede-b089-4dbb-93ae-f48a58277a9c,boehringer_ingelheim_denmark_a_s,Boehringer Ingelheim Denmark A/S -189,0.989095,9bfb7a20-2bce-4c76-8f13-53216dbb6f59,Grupo Español de Tumores Huérfanos e Infrecuentes (GETHI),grupo_espa_ol_de_tumores_hu_rfanos_e_infrecuentes_gethi,,,,9bfb7a20-2bce-4c76-8f13-53216dbb6f59,grupo_espa_ol_de_tumores_hu_rfanos_e_infrecuentes_gethi,Grupo Español de Tumores Huérfanos e Infrecuentes (GETHI) -832,0.987803,d6016430-a125-43f7-aa43-2a6bedb2af9e,Medical Centre Haaglanden (MCH),medical_centre_haaglanden_mch,,,,31a12f1b-6a3e-46d8-aa62-861a42167d92,medical_centre_haaglanden,Medical Centre Haaglanden -7754,,d5cea18e-0394-4f1e-bfa6-f1f2d88442b5,Novartis Pharma Arzneimittel GmbH,novartis_pharma_arzneimittel_gmbh,,,,,, -7755,,b0ada048-9cde-4bc3-bf7d-dc37162a8a44,George Washington University Biostatistics Center,george_washington_university_biostatistics_center,,,,,, -7756,,09e0d90a-7142-11e6-a0cd-0242ac12000b,DR REDDYS LABS LTD,dr_reddys_labs_ltd,,,,,, -7757,,7a95c1b3-a5da-4ff8-adb6-d8e01ca6c39e,Justus-Liebig-University Giessen,justus_liebig_university_giessen,,,,,, -7758,,c7a57ddc-7157-11e6-a0cd-0242ac12000b,ALPHAPHARM,alphapharm,,,,,, -7759,,ed85ec10-7b68-4063-93ee-367e4172a8fe,"The Clinical Research Centre, RCSI Education and Research Centre",the_clinical_research_centre_rcsi_education_and_research_centre,,,,,, -7760,,18d7cfc7-aeda-4b65-879e-459e9825fa26,Schering Nordiska AB,schering_nordiska_ab,,,,,, -7761,,632925d8-69ec-419d-9c3e-9fcb9232d7aa,"Karolinska Institute, CLINTEC, div of orthopedics",karolinska_institute_clintec_div_of_orthopedics,,,,,, -732,0.96950775384902954,27eaea93-f151-4561-89c0-307b7907bf86,Bristol-Myers Squibb SL,bristol_myers_squibb_sl,,,,23bc27b4-07ca-4d74-9d53-97dbe811474f,bristol_myers_squibb_s_a,Bristol-Myers Squibb S.A -7762,,6d364f6e-719f-11e6-a0cd-0242ac12000b,MEDTECH PRODUCTS,medtech_products,,,,,, -7763,,88511a9c-2b8d-4d49-9ff2-87f3514d4d3a,Daiichi Sankyo Pharma GmbH,daiichi_sankyo_pharma_gmbh,,,,,, -7764,,b1735e58-ff47-45ff-a09c-e3a8a0570822,KRANKENHAUS SALEM DER EVANG. STADTMISSION HEIDELBERG GGMBH,krankenhaus_salem_der_evang_stadtmission_heidelberg_ggmbh,,,,,, -7765,,db47bee3-6674-4115-beb1-e03f8ccdbef2,Prof. Per Soelberg Sørensen,prof_per_soelberg_s_rensen,,,,,, -7766,,d6ef67aa-c847-414b-aaad-e69410f2ad7b,Sucampo AG,sucampo_ag,,,,,, -7767,,35a7010a-4c88-4367-a5b2-584e3fb10cea,Universitair Medisch Centrum Utrecht,universitair_medisch_centrum_utrecht,,,,,, -7768,,3f729048-e477-4261-9b53-c3a6622616fd,Seksjon for odontologisk farmakologi og farmakoterapi. UiO,seksjon_for_odontologisk_farmakologi_og_farmakoterapi_uio,,,,,, -7769,,3dd3ff3a-6fa3-11e6-9663-0242ac12000b,OSPEDALI CIVILI DI LIONE,ospedali_civili_di_lione,,,,,, -791,0.972677,fd9a44f2-46d8-4616-977e-bcc532a0ffe3,Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_ram_n_y_cajal,,,,4cca3114-a70f-4d6b-a08d-fae9d4599f44,fundaci_n_para_la_investigaci_n_biom_dica_hospital_universitario_ram_n_y_cajal,Fundación para la Investigación Biomédica Hospital Universitario Ramón y Cajal -7770,,74065f69-a061-4d11-a19d-8c5374c68464,ASSOCIAZIONE QOL-ONE,associazione_qol_one,,,,,, -7771,,f85a1198-a465-421d-800b-46772dd057f2,Hospital Universitario Virgen del Rocío,hospital_universitario_virgen_del_roc_o,,,,,, -385,0.984184,d8772306-7141-11e6-a0cd-0242ac12000b,VERSAPHARM,versapharm,,,,53a89408-7145-11e6-a0cd-0242ac12000b,versapharm_inc,VERSAPHARM INC -7772,,b659fbcc-0c71-4610-9bc8-e5741646a4a6,Oxford Brookes University,oxford_brookes_university,,,,,, -7773,,ffad50b0-6427-4964-9e2c-438ac78e9d0c,Joint Sponsor: University of Glasgow with NHS Greater Glasgow and Clyde,joint_sponsor_university_of_glasgow_with_nhs_greater_glasgow_and_clyde,,,,,, -7774,,056f3bbb-f0ce-4933-bcbe-2a5416cb6ad3,OPOCRIN S.P.A,opocrin_s_p_a,,,,,, -7775,,722bb747-5576-46ad-920f-667527f938da,"Fold RX Pharmaceuticals, a Pfizer Company",fold_rx_pharmaceuticals_a_pfizer_company,,,,,, -7776,,b750b22c-15c4-4fd9-a6ee-52e7afa48f4a,Hellenic Cooperative Oncology Group (HeCOG),hellenic_cooperative_oncology_group_hecog,,,,,, -7777,,6f769841-c39f-49f1-b400-06e1cb6887e9,Mundipharma GmbH,mundipharma_gmbh,,,,,, -7778,,1a8c66e3-c078-489b-b7af-fd8a753075ec,Università di Napoli Federico II,universit_di_napoli_federico_ii,,,,,, -7779,,1c394218-27d2-41ea-a19c-7d0ed2c26a0a,"ALMIRALL, S.A",almirall_s_a,,,,,, -7780,,b675eb50-8bba-11e6-a449-0242ac12000b,NeuroDerm Ltd,neuroderm_ltd,,,,,, -428,0.984324,915ffa95-5612-45a3-a8e6-e65a34a38fda,Ghent University Hospital,ghent_university_hospital,,,,02faf8af-e6fd-4c07-aca4-71ef06427271,ghent_university,Ghent University -7781,,cb8d048a-5fa6-45c0-bb18-4c88b32c29fd,"EMD Pharmaceuticals, Inc. (an affiliate of Merck KGaA, Darmstadt, Germany)",emd_pharmaceuticals_inc_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,,, -7782,,1cdf0d0e-0db2-4951-8425-da62ae653eff,LIDDS AB,lidds_ab,,,,,, -7783,,3725f524-7162-11e6-a0cd-0242ac12000b,CENT PHARMS,cent_pharms,,,,,, -7784,,7ad28516-0e5a-415d-a1a2-6090b093010f,hVIVO Services Limited,hvivo_services_limited,,,,,, -7785,,245af2e7-8842-4ede-9856-a03212e2f815,Pfizer S.L.U,pfizer_s_l_u,,,,,, -7786,,21739d1d-323f-41bf-a8c4-ce7d958f18fc,Stallergenes S.A,stallergenes_s_a,,,,,, -7787,,870aaaee-727a-11e6-a0cd-0242ac12000b,SWEDISH ORPHAN,swedish_orphan,,,,,, -422,0.98334300518035889,bc908184-86f2-4e04-bfba-5f69c27a2578,Dr. Enrique,dr_enrique,,,,ac7fb87c-0de4-401d-a07b-881b2d29e8ea,dr_enrique_alday,Dr. Enrique Alday -7788,,a0f7a972-93b5-4441-9635-a92a5502fb6b,BKH Schwaz,bkh_schwaz,,,,,, -7789,,0ab1bf44-8bc7-11e6-a449-0242ac12000b,"Sunovion, Inc",sunovion_inc,,,,,, -7790,,bc871c36-3d37-452c-8d7e-a6d2f0487787,Scottish National Blood Transfusion Service,scottish_national_blood_transfusion_service,,,,,, -7791,,f7cdf245-b11e-4c21-8fde-6456f02be9ce,Fondazione Toscana Gabriele Monasterio,fondazione_toscana_gabriele_monasterio,,,,,, -480,0.98699730634689331,fadc08cd-85d4-4372-9e5f-0a148e771ffc,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Endokrinologie",medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_abteilung_f_r_endokrinologie,,,,f1926de7-bf3f-4138-90ce-fdceca00d91c,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin" -7792,,8f50cb49-1d13-43f2-8758-6951547453a9,"Shire Regenerative Medicine, Inc",shire_regenerative_medicine_inc,,,,,, -335,0.9851,63ca855a-0f57-4a87-972b-5334fae84ddf,"Fakultní nemocnice Ostrava,Czech Republic",fakultn_nemocnice_ostrava_czech_republic,,,,63ca855a-0f57-4a87-972b-5334fae84ddf,fakultn_nemocnice_ostrava_czech_republic,"Fakultní nemocnice Ostrava,Czech Republic" -7793,,4207c9d6-8bc5-11e6-a449-0242ac12000b,Afdeling for Traumatisk Hjerneskade,afdeling_for_traumatisk_hjerneskade,,,,,, -7794,,bd38c994-d6d9-41ce-9ef6-3393268aab87,"Medizinische Universität Wien,Univ.Klinik f.Hals-, Nasen- und Ohrenkrankheiten",medizinische_universit_t_wien_univ_klinik_f_hals_nasen_und_ohrenkrankheiten,,,,,, -7795,,96cb6dab-6206-4394-9b51-55888b85bd28,INSPIRATION BIOPHARMACEUTICALS,inspiration_biopharmaceuticals,,,,,, -671,0.954126,ed8fc75c-be7a-46e8-8e18-0428756f0822,NILG,nilg,,,,4623aa22-c038-4229-9e84-b303554a2292,nilg_northern_italy_leukemia_group,NILG (Northern Italy Leukemia Group) -7796,,71ca9f42-6fbc-11e6-abe8-0242ac12000b,Amicus Therapeutics,amicus_therapeutics,,,,,, -7797,,af4e0dc2-db07-4f08-9349-53a0ecc13f08,Neurocure Ltd,neurocure_ltd,,,,,, -1017,0.98381006717681885,1384eb1a-56c8-46c7-8312-5abfd0b11a99,Southampton University,southampton_university,,,,986ad2cd-cb4e-460c-acdc-a2b32a61de09,southampton_university_hospitals,Southampton University Hospitals -7798,,59257191-17f8-42ad-9f7f-829bb6a90522,AZIENDA OSPEDALIERA BIANCHI-MELACRINO-MORELLI,azienda_ospedaliera_bianchi_melacrino_morelli,,,,,, -7799,,923be742-7208-11e6-a0cd-0242ac12000b,DENCO ASSET,denco_asset,,,,,, -7800,,5ae8a78d-6b15-4cbc-be77-2ab219c14444,"Durata Therapeutics, Inc",durata_therapeutics_inc,,,,,, -7801,,4ece15f8-4aec-4f37-a3de-103fc4a636da,Mª Angeles Aguirre Zamorano,m_angeles_aguirre_zamorano,,,,,, -7802,,9559be98-7795-4a89-99c5-91e471ca09c8,University of Cincinnati - Academic Medical Center -Department of Neurology,university_of_cincinnati_academic_medical_center_department_of_neurology,,,,,, -7803,,f7ff8d03-6131-4224-a5a4-8766f372be94,Univ.-Prof. Dr. Oliver Findl Med. Univ. Wien,univ_prof_dr_oliver_findl_med_univ_wien,,,,,, -7804,,baad9084-72cd-11e6-a0cd-0242ac12000b,DORC,dorc,,,,,, -7805,,1f89d16f-a739-11e6-94cb-5656d04fc2b5,"Dept. of Anaesthesiology, Odense University Hospital",dept_of_anaesthesiology_odense_university_hospital,,,,,, -7806,,25903f0e-80d4-426f-bad4-653735936a58,UNICANCER,unicancer,,,,,, -7807,,1b2392d1-ec1e-4b35-8aa1-a17e48fba664,"sanofi-aventis, S.A",sanofi_aventis_s_a,,,,,, -7808,,96fbef7a-e55d-47ef-a41e-3410fc28e672,Rijksinstituut voor Volksgezondheid en Milieu (RIVM),rijksinstituut_voor_volksgezondheid_en_milieu_rivm,,,,,, -7809,,b5493599-bc09-4b90-824f-35bc4541a9a4,Sanofi- aventis R&D,sanofi_aventis_r_d,,,,,, -7810,,0c6f6642-7146-11e6-a0cd-0242ac12000b,ANI PHARMS,ani_pharms,,,,,, -7811,,a9d78cdc-71b6-11e6-a0cd-0242ac12000b,ETHITEK,ethitek,,,,,, -7812,,1dee3749-1c11-4555-89fe-30f49adf4621,"Nippon Suisan Kaisha, Ltd",nippon_suisan_kaisha_ltd,,,,,, -7813,,ff4ce94e-3109-4510-8c6e-0855f9bc8134,ASSOCIAZIONE ITALIANA PER LO STUDIO DEL DOLORE,associazione_italiana_per_lo_studio_del_dolore,,,,,, -7814,,b176c306-7182-11e6-a0cd-0242ac12000b,GLAXO GRP LTD,glaxo_grp_ltd,,,,,, -7815,,bb9691d1-28d7-4a98-873c-034f62eeb600,Vienna Medical University,vienna_medical_university,,,,,, -7816,,7a4a721b-13fd-479c-8534-5fbaae294229,"Dr. Harald Dobnig, Medizinische Univ. Klinik Graz, Abteilung für Endokrinologie und Nuklearmedizin",dr_harald_dobnig_medizinische_univ_klinik_graz_abteilung_f_r_endokrinologie_und_nuklearmedizin,,,,,, -7817,,082a3f40-715e-11e6-a0cd-0242ac12000b,GLENMARK PHARMS,glenmark_pharms,,,,,, -7818,,7c968d69-a2f7-428b-9013-e48cf277d31e,Chemische Fabrik Kreussler & Co. GmbH,chemische_fabrik_kreussler_co_gmbh,,,,,, -7819,,4516848c-efc1-472d-8167-472e823ea249,Elpen Pharmaceutical Co. Inc,elpen_pharmaceutical_co_inc,,,,,, -7820,,56d65603-0b4b-4fa1-a8c1-c4d344b9df1a,SELARL du Dr Jacques BUVAT,selarl_du_dr_jacques_buvat,,,,,, -7821,,3120d65a-c4b7-4a63-8e2d-7f152b9567c7,Bertek Pharmaceuticals International Limited,bertek_pharmaceuticals_international_limited,,,,,, -7822,,db0523c5-648f-4d07-8ed5-9df65688d4d0,Cephalon UK Limited,cephalon_uk_limited,,,,,, -404,0.984546,62857e4f-02c4-4cab-a18c-61d5a5016eb1,Technical University of Dresden,technical_university_of_dresden,,,,26d3b205-826f-444a-a5e3-2e552a9d8a82,technical_university_of_dresden_faculty_of_medicine,"Technical University of Dresden, faculty of medicine" -7823,,4a60c3fb-2dbc-4a4c-b106-6e5486fc0a51,AZIENDA SANITARIA DELL'ALTO ADIGE - COMPRENSORIO SANITARIO DI BOLZANO,azienda_sanitaria_dell_alto_adige_comprensorio_sanitario_di_bolzano,,,,,, -7824,,4fb6c558-4cd8-435b-9d31-cc7321eb541f,Hammersmith Hospital NHS Trust,hammersmith_hospital_nhs_trust,,,,,, -7825,,fdcc4bb1-9d40-4c54-9a28-dcbf48b0d91a,Actelion Pharamceuticals Ltd,actelion_pharamceuticals_ltd,,,,,, -736,0.98533761501312256,c4f731d6-66f7-4e9e-a7d7-8a55b3936fdf,European Organization for the Research and Treatment of Cancer (EORTC),european_organization_for_the_research_and_treatment_of_cancer_eortc,,,,86b7934b-bd40-4e41-90e2-f2b10e4f66c8,european_organization_for_the_research_and_treatment_of_cancer_eortc,European Organization for the Research and Treatment of Cancer (EORTC) -7826,,322260e4-a04f-406f-8c48-3f4ee0cdb42b,Oncopeptides AB,oncopeptides_ab,,,,,, -1002,0.96150079369544983,8fbc1a40-90b3-491d-9c96-f5d311f67e2e,Fundación para Formación e Investigación Sanitaria,fundaci_n_para_formaci_n_e_investigaci_n_sanitaria,,,,8fbc1a40-90b3-491d-9c96-f5d311f67e2e,fundaci_n_para_la_formaci_n_e_investigaci_n_sanitaria,Fundación para la Formación e Investigación Sanitaria -7827,,b39867f6-dac0-4d6a-b80f-8953e2682acf,Anestesi och Operationskliniken,anestesi_och_operationskliniken,,,,,, -7828,,47daabac-5939-4922-9184-efa52c381db1,Matti Ristola,matti_ristola,,,,,, -559,0.98696577548980713,2e6f13f4-76f0-47d8-9579-a808aa6aa2eb,Department of Clinical Pharmacology,department_of_clinical_pharmacology,,,,e78543a1-45be-413e-ae9a-522fb25ea6da,department_of_clinical_pharmacology,Department of Clinical Pharmacology -870,0.98716828227043152,483064d3-f8fd-47e0-a0a2-b17b8d5df7d6,Astellas Pharma Europe,astellas_pharma_europe,,,,483064d3-f8fd-47e0-a0a2-b17b8d5df7d6,astellas_pharma_europe_bv,Astellas Pharma Europe BV -7829,,2cb513d6-f157-45f9-82bf-03f19ba766ca,Psykiatrien i Region Syddanmark,psykiatrien_i_region_syddanmark,,,,,, -549,0.989229,4932b407-af0a-4966-9a44-59fa9ac09e80,Fédération Francophone de Cancérologie Digestive (FFCD),f_d_ration_francophone_de_canc_rologie_digestive_ffcd,,,,4932b407-af0a-4966-9a44-59fa9ac09e80,f_d_ration_francophone_de_canc_rologie_digestive_ffcd,Fédération Francophone de Cancérologie Digestive (FFCD) -7830,,4013fe82-7dca-40f0-b1a8-81ee4b0b43f3,not applicable,not_applicable,,,,,, -7831,,15b33825-2d2d-419f-b43b-dc2ecf15cd6b,GWT-TUD GmbH,gwt_tud_gmbh,,,,,, -7832,,658da72c-7162-11e6-a0cd-0242ac12000b,SUPERPHARM,superpharm,,,,,, -7833,,00364980-7147-11e6-a0cd-0242ac12000b,AMNEAL PHARMS LLC,amneal_pharms_llc,,,,,, -7834,,c314e776-9264-4349-bcb9-c00c91b51dd2,"MUW-Medical University of Vienna,Medizinische Universität Wien",muw_medical_university_of_vienna_medizinische_universit_t_wien,,,,,, -7835,,c2be6cd9-df4c-4018-8fbd-2ad58e183432,"Takeda Global Research & Development Centre (Europe) Limited,",takeda_global_research_development_centre_europe_limited,,,,,, -7836,,382a6dc5-0d89-4add-a86a-3f320c9289fd,MOLTENI,molteni,,,,,, -7837,,9173ddf2-f0b1-4237-9d97-47813c0ecfcf,University of Utah,university_of_utah,,,,,, -7838,,3a1c5526-43c0-43eb-96d2-5027f55150a2,OSPEDALE MAGGIORE DI MILANO (IRCCS),ospedale_maggiore_di_milano_irccs,,,,,, -7839,,5fa402ca-532c-45fa-9e76-4dfa50b35005,"GZA vzw, GZA Ziekenhuizen, Sint-Augustinus",gza_vzw_gza_ziekenhuizen_sint_augustinus,,,,,, -172,0.9528670608997345,1a03f05f-1e23-469f-adc4-6156f3bc81aa,"Merck Serono International, a branch of Laboratories Serono S.A",merck_serono_international_a_branch_of_laboratories_serono_s_a,,,,4d103db0-46f8-458b-804a-442a7728fad2,merck_serono_international_a_branch_of_laboratoires_serono_sa_an_affiliate_of_merck_kgaa,"Merck Serono International, a branch of Laboratoires Serono SA An affiliate of Merck KGaA" -7840,,a0fd899e-663c-404c-ae95-b5beaf0cdbbe,Institut de Cancérologie de la Loire,institut_de_canc_rologie_de_la_loire,,,,,, -7841,,20a72e40-6412-4dfd-9c4b-1f6ed7d5c5ca,VIROPHARMA INCORPORATED,viropharma_incorporated,,,,,, -7842,,4cf4add8-a52b-4704-83b6-a1ef5efc3513,PKH-Pharmazeutische Kontroll- und Herstellungslabor GmbH,pkh_pharmazeutische_kontroll_und_herstellungslabor_gmbh,,,,,, -7843,,d2412746-0c04-49bb-865a-69f898f04381,"Skånes Onkologiska Klinik, Skåne University Hospital, Lund",sk_nes_onkologiska_klinik_sk_ne_university_hospital_lund,,,,,, -7844,,f6b295f6-4bdc-4a00-91a5-6e320feb6004,CENTRE PAUL PAPIN - IRCAM,centre_paul_papin_ircam,,,,,, -109,0.952012,f4efa697-04df-43fa-bbb7-94a3353fb313,"GlaxoSmithKline Consumer Healthcare GmbH & Co KG, 77815 Bühl",glaxosmithkline_consumer_healthcare_gmbh_co_kg_77815_b_hl,,,,8a1dc0a1-759d-435f-ad3b-c75c8ce910d4,glaxosmithkline_consumer_healthcare_gmbh_co_kg,GlaxoSmithKline Consumer Healthcare GmbH & Co. KG -923,0.907369,279a25e7-5963-4a57-b4bf-fcd9fd2d1ea3,Pharmacyclics Inc,pharmacyclics_inc,,,,263da2fa-df57-4577-a618-d84b06ad1594,pharmacyclics_incorporated,"Pharmacyclics, Incorporated" -7845,,8dc8bc99-f283-40cd-a296-198b73bc4d74,AZIENDA OSPEDALIERA S. MARIA DI TERNI,azienda_ospedaliera_s_maria_di_terni,,,,,, -7846,,53ac1b64-a9b6-4d42-b96e-c5e493f90e51,Cliniques Universitaires Saint Luc - UCL,cliniques_universitaires_saint_luc_ucl,,,,,, -7847,,9c9dbbb0-6f8d-4074-9b76-2a85dd0e437a,Centocor B.V,centocor_b_v,,,,,, -7848,,4894a4eb-694b-4a88-8531-ecbf620ff668,"SOD Medicina e Cardiologia Geriatrica, Centro per lo Studio della Sincope - Università degli Studi di Firenze-AOUCareggi",sod_medicina_e_cardiologia_geriatrica_centro_per_lo_studio_della_sincope_universit_degli_studi_di_firenze_aoucareggi,,,,,, -7849,,0956e7c9-a335-4e3d-9246-b092e2799c8d,AUO,auo,,,,,, -853,0.983941,802313d9-1b0d-4889-acd7-6878108beebc,Malmö University Hospital,malm_university_hospital,,,,802313d9-1b0d-4889-acd7-6878108beebc,malm_university_hospital,Malmö University Hospital -7850,,6605ce7b-fb8c-4fb4-9057-a0baca3fb9a7,Merck Sharp & Dohme (China) Ltd,merck_sharp_dohme_china_ltd,,,,,, -536,0.978219,e4b045a7-4870-4b15-ac72-389f39b6c812,Institut Jules Bordet - Université Libre de Bruxelles,institut_jules_bordet_universit_libre_de_bruxelles,,,,9921c788-bec5-470a-b081-facbdc704f78,institut_jules_bordet,Institut Jules Bordet -7851,,e87a9b98-91f0-4f28-b929-b2f260befd19,Tayside Academic Sciences Centre,tayside_academic_sciences_centre,,,,,, -7852,,8580e020-401b-4fb7-a7af-cc8f103744dd,CECOG (Central European Cooperative Oncology Group),cecog_central_european_cooperative_oncology_group,,,,,, -46,0.972279,286d0033-04c6-4cd9-8601-edb31d1bee9f,Alloksys Life Sciences BV,alloksys_life_sciences_bv,,,,286d0033-04c6-4cd9-8601-edb31d1bee9f,alloksys_life_sciences_bv,Alloksys Life Sciences BV -7853,,c0fecb30-714f-11e6-a0cd-0242ac12000b,LANDELA PHARM,landela_pharm,,,,,, -7854,,036e56af-cfca-4b5f-8898-44118ed5b337,Netherlands Heart Foundation,netherlands_heart_foundation,,,,,, -7855,,72ed1a8d-8418-411f-a197-be336f583de7,Glaxo Group Ltd,glaxo_group_ltd,,,,,, -7856,,8e72b417-a727-11e6-94cb-5656d04fc2b5,National Institute of Diabetes and Digestive and Kidney Diseases,national_institute_of_diabetes_and_digestive_and_kidney_diseases,,,,,, -7857,,8002ea67-a233-45ee-ac48-850ce7585639,Dr. Héctor Escobar Morreale,dr_h_ctor_escobar_morreale,,,,,, -7858,,d95843f4-22bd-471d-bf0e-5e8f52a0173c,"National Poisons Information Center, University Medical Center Utrecht",national_poisons_information_center_university_medical_center_utrecht,,,,,, -7859,,2ad54ddc-bc8c-4fd5-8f46-ff621d117f55,RER Saint Denis,rer_saint_denis,,,,,, -7860,,0951b668-f77a-455d-a80e-0d04e31cedf2,Institut Universitari de Neurorehabiltació Guttmann,institut_universitari_de_neurorehabiltaci_guttmann,,,,,, -7861,,c89d0e90-adc2-43fc-9479-5b10f95f52a5,Antti Aho,antti_aho,,,,,, -7862,,f85060e8-4846-4ec1-8708-a26b48ade634,ALIZYME,alizyme,,,,,, -7863,,9cff5f0a-bf19-4f05-b2b7-07071d828d8e,"Hi-Tech Pharmacal Co., Inc",hi_tech_pharmacal_co_inc,,,,,, -668,0.984093,d69e9c95-b978-4053-bb60-175d8d004951,BioPartners,biopartners,,,,93043c3a-9344-4423-9114-20048877dc2b,biopartners_gmbh,BioPartners GmbH -7864,,f50cefd1-5d6c-45ec-9cb0-4db80d773928,Aradigm Corporation,aradigm_corporation,,,,,, -7865,,dac168d2-d4ec-4305-84d9-d841453ff1fa,"Department of Woman and Child health, Karolinska University Hospital",department_of_woman_and_child_health_karolinska_university_hospital,,,,,, -7866,,b43ce4bb-78e2-4908-a33b-57a1134f4ac7,THERABEL LUCIEN PHARMA,therabel_lucien_pharma,,,,,, -7867,,2cfce64b-a610-4a68-a8e0-26abf21ce32a,THE IMMUNE RESPONSE CORPORATION,the_immune_response_corporation,,,,,, -7868,,bd62d937-ec4f-4695-910f-35451e921f36,Asklepios Kliniken Hamburg GmbH,asklepios_kliniken_hamburg_gmbh,,,,,, -581,0.94542974233627319,8ad98169-689d-44f5-943d-55c909d71e4d,Wyeth Parmaceuticals Inc,wyeth_parmaceuticals_inc,,,,8ad98169-689d-44f5-943d-55c909d71e4d,wyeth_parmaceuticals_inc,Wyeth Parmaceuticals Inc -7869,,be0f942d-540e-490f-8209-87ec4cd2b065,"Anthera Pharmaceuticals, Inc",anthera_pharmaceuticals_inc,,,,,, -7870,,e9667179-e77d-4842-a39e-d41530e2791c,Fundacion Progreso y Salud,fundacion_progreso_y_salud,,,,,, -7871,,877765ea-7198-11e6-a0cd-0242ac12000b,GEMINI LABS LLC,gemini_labs_llc,,,,,, -7872,,7fb87334-73f1-11e6-a0cd-0242ac12000b,MATHESON TRI-GAS INC,matheson_tri_gas_inc,,,,,, -7873,,a59fadfc-c429-452b-93cd-a432301f7dc9,CIMT group,cimt_group,,,,,, -137,0.964969,0e091d56-1af6-42d9-8d7c-b1eab6a90b8a,University Hospitals of Birmingham NHS Foundation Trust,university_hospitals_of_birmingham_nhs_foundation_trust,,,,0e091d56-1af6-42d9-8d7c-b1eab6a90b8a,university_hospitals_of_birmingham_nhs_foundation_trust,University Hospitals of Birmingham NHS Foundation Trust -7874,,74c9aa4d-f2c2-4b3b-b2fe-bff74b6bd654,Takeda Europe R&D Centre Limited,takeda_europe_r_d_centre_limited,,,,,, -7875,,a5fe7bdd-c37c-4308-b7bf-2ce120778577,Bispebjerg University Hospital,bispebjerg_university_hospital,,,,,, -7876,,97b5d70a-7154-11e6-a0cd-0242ac12000b,ROCKWELL MEDCL,rockwell_medcl,,,,,, -909,0.985676,575af654-7159-11e6-a0cd-0242ac12000b,OSMOTICA PHARM,osmotica_pharm,,,,575af654-7159-11e6-a0cd-0242ac12000b,osmotica_pharm,OSMOTICA PHARM -437,0.99035966396331787,8f1c3548-7a20-4796-a59b-3b727921d4f1,"Pfizer Inc. 235 East 42nd Street, New York, 10017 US",pfizer_inc_235_east_42nd_street_new_york_10017_us,,,,8f1c3548-7a20-4796-a59b-3b727921d4f1,pfizer_inc_235_east_42nd_street_new_york_10017_us,"Pfizer Inc. 235 East 42nd Street, New York, 10017 US" -367,0.96779388189315796,cdd72c71-e722-4511-8609-a9ef7b4d05b3,Bayer HealthCare AS,bayer_healthcare_as,,,,e8216e75-b447-4252-bb49-7b895bcf4108,bayer_healthcare,Bayer HealthCare -7877,,93458d57-7a99-4149-9fb5-09977d16c461,Swindon and Marlborough NHS Foundation Trust,swindon_and_marlborough_nhs_foundation_trust,,,,,, -7878,,d12a899e-50e3-49c3-b041-c0c7ed9856e2,NOVARTIS PHARMA SAS,novartis_pharma_sas,,,,,, -952,0.98418444395065308,d73a7512-715d-11e6-a0cd-0242ac12000b,MYLAN LABS,mylan_labs,,,,037d47ba-7142-11e6-a0cd-0242ac12000b,mylan_labs_ltd,MYLAN LABS LTD -7879,,c9adea3e-72e6-11e6-a0cd-0242ac12000b,MIDATECH PHARMA US,midatech_pharma_us,,,,,, -7880,,437498d7-8b01-4fe1-973b-353e55ac75eb,QLT Inc,qlt_inc,,,,,, -7881,,5c4bb461-35db-467a-8cd3-9ac6bc4a8b31,"Univ.Clinic of Internal Medicine II, Department of Cardiology, Medical University of Vienna, Austria",univ_clinic_of_internal_medicine_ii_department_of_cardiology_medical_university_of_vienna_austria,,,,,, -7882,,e688c31b-ae39-484a-b69f-637e48b656b8,ADIENNE SA,adienne_sa,,,,,, -7883,,c9e666dc-0c73-4c62-9345-c1a04cadc6e8,CVie Therapeutics Company Limited,cvie_therapeutics_company_limited,,,,,, -7884,,77c0b784-60ac-48bc-9d75-e2844fce6cdf,ISPPCC - CHU Chrarleroi - Hôpital Civil Marie Curie - Clinique du Sein,isppcc_chu_chrarleroi_h_pital_civil_marie_curie_clinique_du_sein,,,,,, -7885,,3a6a0823-d1c6-410d-9355-6c9fbacd230e,"UAB ""Roche Lietuva",uab_roche_lietuva,,,,,, -7886,,119351df-7506-4974-9e25-2fde58cce5a0,UNIVERSITà DEGLI STUDI MILANO BICOCCA,universit_degli_studi_milano_bicocca,,,,,, -353,0.983343,33018013-878a-4dd3-b923-de7bc09fb504,Institut de Recherche Pierre Fabre,institut_de_recherche_pierre_fabre,,,,33018013-878a-4dd3-b923-de7bc09fb504,institut_de_recherche_pierre_fabre,Institut de Recherche Pierre Fabre -7887,,42065272-7167-11e6-a0cd-0242ac12000b,UIHC PET IMAGING,uihc_pet_imaging,,,,,, -7888,,e9416ff6-7160-11e6-a0cd-0242ac12000b,HORIZON PHARMA,horizon_pharma,,,,,, -431,0.984484,14c37603-26cd-4e70-aef6-639320d368b6,Central Manchester and Manchester Children's University Hospital NHS Trust,central_manchester_and_manchester_children_s_university_hospital_nhs_trust,,,,14c37603-26cd-4e70-aef6-639320d368b6,central_manchester_and_manchester_children_s_university_hospital_nhs_trust,Central Manchester and Manchester Children's University Hospital NHS Trust -7889,,19462914-7155-11e6-a0cd-0242ac12000b,ACELLA PHARMS LLC,acella_pharms_llc,,,,,, -7890,,a5497b54-716a-11e6-a0cd-0242ac12000b,CYTOGEN,cytogen,,,,,, -7891,,ae0b9627-31dd-4a0a-a5b8-27a7be432c00,ONCONOVA THERAPEUTICS,onconova_therapeutics,,,,,, -7892,,1210ea21-aeaa-4896-868b-0da3219ce4f0,"KRKA Magyarország Kft., Budapest",krka_magyarorsz_g_kft_budapest,,,,,, -7893,,5b64b7c7-034c-4b6e-bc23-8e47b6a5dffb,Dept of Renal medicine,dept_of_renal_medicine,,,,,, -7894,,f53b3cba-19f7-45bd-84ee-45010c89591d,Andreas Kjær,andreas_kj_r,,,,,, -7895,,43f82a4d-d713-4d36-8192-c2ceff90b083,FRANCISCO JOSE MORALES PONCE,francisco_jose_morales_ponce,,,,,, -7896,,1f997454-45ca-4971-93c2-4796c1f4f141,West-ward Pharmaceutical Corporation,west_ward_pharmaceutical_corporation,,,,,, -7897,,d98c5759-5037-412d-a4b1-7a477c1c316c,Oncoscience AG,oncoscience_ag,,,,,, -7898,,98cdaee6-d954-4d30-a817-477398877718,EleosInc Limited,eleosinc_limited,,,,,, -7899,,82f04873-639c-4507-9dfc-9608550b0e18,Reata UK Limited,reata_uk_limited,,,,,, -7900,,02620d83-7bf1-4ec4-ac2e-65c5edcd5fb1,Chirurgische Gemeinschaftspraxis Südstadt,chirurgische_gemeinschaftspraxis_s_dstadt,,,,,, -7901,,a7874498-715e-11e6-a0cd-0242ac12000b,HALOCARBON,halocarbon,,,,,, -7902,,063b1a84-82bd-4302-bbf8-6ef27a0b85bb,University of Ottawa Heart Institute,university_of_ottawa_heart_institute,,,,,, -7903,,23f6950a-5554-47f1-8541-e06575fc65d8,"Med. Uni. Wien, UK für Neurologie",med_uni_wien_uk_f_r_neurologie,,,,,, -854,0.92247,14aef904-0883-4517-a200-b52214e41d54,"Faculty For Medicine, Otto-von-Guericke University Magdeburg",faculty_for_medicine_otto_von_guericke_university_magdeburg,,,,14aef904-0883-4517-a200-b52214e41d54,faculty_for_medicine_otto_von_guericke_university_magdeburg,"Faculty For Medicine, Otto-von-Guericke University Magdeburg" -579,0.98861104249954224,2087c696-3203-4dfa-967f-2d9749dedb6f,"Wyeth Pharmaceuticals Inc., acting through its division of Wyeth Research, a Pfizer company",wyeth_pharmaceuticals_inc_acting_through_its_division_of_wyeth_research_a_pfizer_company,,,,2087c696-3203-4dfa-967f-2d9749dedb6f,wyeth_pharmaceuticals_inc_acting_through_its_division_of_wyeth_research_a_pfizer_company,"Wyeth Pharmaceuticals Inc., acting through its division of Wyeth Research, a Pfizer company" -7904,,3a379778-c49d-449d-999e-7b4ba1a56095,AB2 Bio Ltd,ab2_bio_ltd,,,,,, -7905,,b0f40772-92f8-48db-b562-61542481fa56,Intercytex Limited,intercytex_limited,,,,,, -7906,,eebea9ba-fcad-40e5-84f6-ca31168c4afb,Grupo Español de Sindromes Mielodisplásicos (GESMD),grupo_espa_ol_de_sindromes_mielodispl_sicos_gesmd,,,,,, -530,0.961626,72fda02d-b614-4eda-a1b0-e9c6c71f8251,Erasmus University Medical Center,erasmus_university_medical_center,,,,72fda02d-b614-4eda-a1b0-e9c6c71f8251,erasmus_university_medical_center,Erasmus University Medical Center -7907,,37288259-4c7e-470e-a768-5e956fa277a1,EBMT Central Office,ebmt_central_office,,,,,, -7908,,3b945b96-8819-11e6-a998-0242ac12000b,North west London Hospital Trust,north_west_london_hospital_trust,,,,,, -7909,,7a1cccc6-7168-11e6-a0cd-0242ac12000b,AILEX PHARMS PVT LTD,ailex_pharms_pvt_ltd,,,,,, -7910,,e466eef2-8bb9-11e6-a449-0242ac12000b,Shield TX (UK) Ltd,shield_tx_uk_ltd,,,,,, -7911,,6b92ef6e-98ac-49a7-a2cb-9d986df4cb2b,The Princess Alexandra Hospital NHS Trust,the_princess_alexandra_hospital_nhs_trust,,,,,, -7912,,f775d081-cc4f-4cfd-a743-5c167e30bbc7,South Tees Hospitals NHS Foundation Trust,south_tees_hospitals_nhs_foundation_trust,,,,,, -7913,,16fbd275-0bcc-4321-871e-7c8edba244e1,COGENTUS PHARMACEUTICALS INTERNATIONAL LIMITED,cogentus_pharmaceuticals_international_limited,,,,,, -7914,,c72e3c11-d2fa-45b6-b2e2-e99d11609885,Society (institute) for clinical research,society_institute_for_clinical_research,,,,,, -7915,,722152ad-b4ca-4c63-81ab-cd86b8bab46b,LABORATORIES THEA,laboratories_thea,,,,,, -571,0.977622,8a1a7572-7142-11e6-a0cd-0242ac12000b,FOUGERA,fougera,,,,8a1a7572-7142-11e6-a0cd-0242ac12000b,fougera,FOUGERA -86,0.95734971761703491,8f7e4684-4a31-4266-aef0-963a6a62bb6b,"AMC, Amsterdam",amc_amsterdam,,,,7b7c4eb7-0b01-479a-b331-98f2d90174df,amc,AMC -89,0.984864,e65240e4-715c-11e6-a0cd-0242ac12000b,MATRIX LABS LTD,matrix_labs_ltd,,,,246b37c8-715d-11e6-a0cd-0242ac12000b,matrix_labs,MATRIX LABS -643,0.96428561210632324,2c7c42cf-b819-48d8-a9cb-2b2a871ffa6d,Boehringer Ingelheim Norway KS,boehringer_ingelheim_norway_ks,,,,1a23c45f-2c11-4e5d-a222-082def03ebc8,boehringer_ingelheim_noway_ks,Boehringer Ingelheim Noway KS -7916,,61e15d3f-c1c2-479c-bb5c-acdee3da1cb1,Cubist Pharmaceuticals,cubist_pharmaceuticals,,,,,, -7917,,0107c681-04b8-439e-978a-fef304886e31,AMARIN NEUROSCIENCE LTD,amarin_neuroscience_ltd,,,,,, -7918,,06bc1f6a-8cbb-4888-9df7-f371342bde83,Vakcina Kft,vakcina_kft,,,,,, -7919,,80d6f6da-5502-49e6-8225-2e2cab455b97,LABORATOIRE AVENTIS,laboratoire_aventis,,,,,, -7920,,ad3a0acf-b370-4a3f-90e9-40bdd8632087,Hospital of Goethe-Universitiy,hospital_of_goethe_universitiy,,,,,, -7921,,42587571-741a-4e64-b485-4deee66c414c,AZIENDA OSPEDALIERA SENESE,azienda_ospedaliera_senese,,,,,, -695,0.987167,193a42c8-a09d-4028-9be8-16ebcda41920,Abbott Laboratories GmbH,abbott_laboratories_gmbh,,,,193a42c8-a09d-4028-9be8-16ebcda41920,abbott_laboratories_gmbh,Abbott Laboratories GmbH -7922,,59e58f2d-a948-4192-856e-bb7442f09f9a,"Oncologisch Centrum, Academisch Ziekenhuis Vrije Universiteit Brussel",oncologisch_centrum_academisch_ziekenhuis_vrije_universiteit_brussel,,,,,, -7923,,22e19773-2f14-4f61-a4c5-7d20f613d4d3,"University of Pécs, Medical School, Department of Ophthalmology",university_of_p_cs_medical_school_department_of_ophthalmology,,,,,, -120,0.97839492559432983,5fe8d145-19e5-463d-a2e8-3da1f78f0002,Rheinische Friedrich-Wilhelms-Universität Bonn,rheinische_friedrich_wilhelms_universit_t_bonn,,,,0b9eb68a-ecbc-4706-a3c1-e52c658684d3,rheinische_friedrichs_wilhelms_universit_t_bonn,Rheinische Friedrichs-Wilhelms-Universität Bonn -7924,,087c42aa-c2c9-4cc0-8796-bb82fe1d3122,"BG-Kliniken Bergmannsheil, Dept. of Pain Management",bg_kliniken_bergmannsheil_dept_of_pain_management,,,,,, -7925,,328b5dc4-7167-11e6-a0cd-0242ac12000b,3D IMAGING DRUG,3d_imaging_drug,,,,,, -7926,,ec8681df-2e1e-4a83-a1ad-b0e38c34ce4d,Slidgigtinstituttet A/S,slidgigtinstituttet_a_s,,,,,, -452,0.97584396600723267,d1efdd69-467e-4581-827e-d1f912280c3e,Novartis Farmaceútica S.A,novartis_farmace_tica_s_a,,,,7dc31ed2-c888-4a81-8a21-860b006cc000,novartis_farmaceutica_s_a,Novartis Farmaceutica S.A -7927,,f3a8c9bc-25fe-4564-831e-7b9696883276,ACO-ASSO,aco_asso,,,,,, -7928,,aeaf3bdd-998f-4d2b-ba93-57576f1c73b8,Novexel S. A,novexel_s_a,,,,,, -7929,,38e464c8-7161-11e6-a0cd-0242ac12000b,SUMMERS,summers,,,,,, -7930,,5105136a-1583-4894-aab8-4daaf3f25ce4,TACL,tacl,,,,,, -7931,,8cb5fc96-bcb1-4b2c-a0b7-8bf086db8c34,Belgian Gynaecological Oncolgy Group,belgian_gynaecological_oncolgy_group,,,,,, -7932,,95d17c51-6ffd-4e9b-982f-47acf272092d,HOSPITAL SAN PEDRO,hospital_san_pedro,,,,,, -152,0.97483,88ecc254-b9db-4f96-8ef3-b7e21d00b20d,Novartis Farmacéutica SA,novartis_farmac_utica_sa,,,,88ecc254-b9db-4f96-8ef3-b7e21d00b20d,novartis_farmac_utica_sa,Novartis Farmacéutica SA -7933,,f598a493-062d-4924-a13f-c71d9d0b4277,"Aalborg Psychiatric Hospital, Centre for Skizophrenia",aalborg_psychiatric_hospital_centre_for_skizophrenia,,,,,, -960,0.988812,9e4d3fbc-0e9a-4bef-af84-596f0765706f,AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I,azienda_universitaria_policlinico_umberto_i,,,,9e4d3fbc-0e9a-4bef-af84-596f0765706f,azienda_universitaria_policlinico_umberto_i,AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I -7934,,fffc0ea7-c06f-456b-8d98-4faf99745081,NAICONS Srl,naicons_srl,,,,,, -7935,,366941f3-2ed3-4d5d-badb-5c9593f151c5,Ineos Healthcare Ltd,ineos_healthcare_ltd,,,,,, -7936,,e93bfc7d-f2fe-408d-858b-c66465398bb4,"Academical Medical Center, University of Amsterdam",academical_medical_center_university_of_amsterdam,,,,,, -593,0.9775586724281311,3969045a-4ef0-424f-8964-e4403b2aa66b,"Medical University Innsbruck, Dpt. Internal Medicine, Div. Internal Medicine",medical_university_innsbruck_dpt_internal_medicine_div_internal_medicine,,,,3969045a-4ef0-424f-8964-e4403b2aa66b,medical_university_innsbruck_dpt_internal_medicine_div_internal_medicine,"Medical University Innsbruck, Dpt. Internal Medicine, Div. Internal Medicine" -7937,,a72bb318-0d07-44e9-a9f3-03fb47db413c,Bayer HelathCare AG,bayer_helathcare_ag,,,,,, -7938,,9d98a754-18b6-45c4-9cf5-5626b3fe1093,Euro Nippon Kayaku GmbH,euro_nippon_kayaku_gmbh,,,,,, -140,0.985075,11f4634e-719e-11e6-a0cd-0242ac12000b,MERIDIAN MEDCL TECHN,meridian_medcl_techn,,,,11f4634e-719e-11e6-a0cd-0242ac12000b,meridian_medcl_techn,MERIDIAN MEDCL TECHN -7939,,cc9a4820-7d14-4ff2-a6d7-be27096f9de6,"Transave, Inc",transave_inc,,,,,, -7940,,7be22471-a6aa-4383-b6f7-383cb1bc9301,"Lund University, Clinical Coagulation Research Unit, Skane University Hospital",lund_university_clinical_coagulation_research_unit_skane_university_hospital,,,,,, -7941,,ebfb269c-8260-44f4-946f-002607cb6599,Dra. Almudena Zapatero Laborda,dra_almudena_zapatero_laborda,,,,,, -7942,,e49779b0-02f3-4f77-82cd-584392033b5d,"Karolinska University Hospital, Stockholms Läns Landsting",karolinska_university_hospital_stockholms_l_ns_landsting,,,,,, -7943,,ad292967-ca70-4794-a1aa-cde8228be911,Riitta Veijola,riitta_veijola,,,,,, -7944,,0491ec1b-9690-4c56-9c4a-2128cc78a624,"Göteborg University, Institute for Internal Medicine",g_teborg_university_institute_for_internal_medicine,,,,,, -7945,,47ce4cce-9a01-482c-9dca-4d3eab9747db,PepTcell Limited (trading as SEEK),peptcell_limited_trading_as_seek,,,,,, -7946,,420ac551-345e-498f-b241-41425f069d0e,Dr. Falk Pharma Portugal,dr_falk_pharma_portugal,,,,,, -7947,,9d2fb4a6-7afe-47c4-b5d8-b671e8ad6151,Northwestern University,northwestern_university,,,,,, -7948,,426b7b18-9933-4bab-9562-8dc112e9f5d2,University of Amsterdam,university_of_amsterdam,,,,,, -7949,,0c33e61d-254f-40a5-a5fe-d99f6e80b3dc,National Institute for Health and Welfare,national_institute_for_health_and_welfare,,,,,, -7950,,83303207-847c-4bf7-bb3c-476d139f86a5,Unita` Operativa di Endocrinologia e Malattie del Metabolismo,unita_operativa_di_endocrinologia_e_malattie_del_metabolismo,,,,,, -7951,,430c5ce8-c77c-46fe-a981-d58e85011c1e,Wilex AG,wilex_ag,,,,,, -7952,,d3b9d8f2-302f-4b6f-8cb5-d1d9f91c7268,"TIGENIX, S.A.U",tigenix_s_a_u,,,,,, -7953,,027cf44c-aeb2-403b-8fd6-4e7bf847eda5,Pfizer NV/SA,pfizer_nv_sa,,,,,, -7954,,1b46d324-040b-452a-a483-88ab49cd416f,SOUTHERN ITALY COOPERATIVE ONCOLOGY GROUP,southern_italy_cooperative_oncology_group,,,,,, -7955,,00a95f4f-cf11-4285-a41d-c689923eb7db,Mallinckrodt Inc,mallinckrodt_inc,,,,,, -7956,,9d1ba840-7164-11e6-a0cd-0242ac12000b,TWI PHARMS INC,twi_pharms_inc,,,,,, -7957,,44344d90-fb01-4f6b-a7f7-5875e18c9c2e,Janssen-Cilag Kft,janssen_cilag_kft,,,,,, -7958,,0a652b18-6cc3-476f-b393-b653f6d6a5b1,Centro Nacional de Investigaciones Cardiovasculares (CNIC),centro_nacional_de_investigaciones_cardiovasculares_cnic,,,,,, -876,0.90458685159683228,ebc2ce4d-831d-4b06-b3dc-d0e7578f7829,FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO INFANTIL NIÑO JESUS,fundacion_para_la_investigacion_biomedica_hospital_universitario_infantil_ni_o_jesus,,,,5cd5bf06-2291-4844-9da5-1660b3540deb,fundacion_para_la_investigacion_la_fe,FUNDACION PARA LA INVESTIGACION LA FE -7959,,c1029137-e63b-41cc-910f-0aff8bd6b6eb,"MSP Singapore Co., LLC c/o Merck & Co., Inc",msp_singapore_co_llc_c_o_merck_co_inc,,,,,, -227,0.979411780834198,bf1a9e59-98fa-461b-84a8-7740b1743049,"ALEXION PHARMACEUTICALS, INC",alexion_pharmaceuticals_inc,,,,bf1a9e59-98fa-461b-84a8-7740b1743049,alexion_pharmaceuticals_inc,"ALEXION PHARMACEUTICALS, INC" -757,0.984269,4fdd63b2-11be-4586-9f81-b4e4a2263768,The Netherlands Cancer Institute,the_netherlands_cancer_institute,,,,4fdd63b2-11be-4586-9f81-b4e4a2263768,the_netherlands_cancer_institute,The Netherlands Cancer Institute -7960,,58e50939-c688-4e69-b5cd-00b7b06a3dc1,CUB Hopital Erasme,cub_hopital_erasme,,,,,, -272,0.98568406701087952,1078e71c-7147-11e6-a0cd-0242ac12000b,LEK PHARMS,lek_pharms,,,,5ab1cb72-7148-11e6-a0cd-0242ac12000b,lek_pharms,LEK PHARMS -7961,,6ffa483e-71ba-11e6-a0cd-0242ac12000b,US ARMY WALTER REED,us_army_walter_reed,,,,,, -7962,,c2f7993c-bc03-4e5c-a05b-1c441edf2cb6,"Amarantus BioScience Holdings, Inc",amarantus_bioscience_holdings_inc,,,,,, -1012,0.94605967402458191,c06cb74b-1c77-4c28-9c14-a6b870a4012a,"Shire Human Genetic Therapies, Inc",shire_human_genetic_therapies_inc,,,,c06cb74b-1c77-4c28-9c14-a6b870a4012a,shire_human_genetic_therapies_inc,"Shire Human Genetic Therapies, Inc. (Shire HGT)" -7963,,bf2d90fd-1d07-48e2-8513-d931129a15fe,Service of Neurology CHU Liege,service_of_neurology_chu_liege,,,,,, -7964,,d7805dd3-9b5a-4694-9f98-d1477614973f,Institut fuer Frauengesundheit GmbH,institut_fuer_frauengesundheit_gmbh,,,,,, -7965,,e2363832-a1ac-4d83-8fc4-f8fea3d3fd88,University Medical Center of the University Ulm,university_medical_center_of_the_university_ulm,,,,,, -7966,,368962f0-4cf2-44af-9f3f-3fe0924f2ffc,Jens Hilligsø,jens_hilligs,,,,,, -287,0.982375,bcce1791-2699-42fa-b905-cdce25675fe5,"Department of Anesthesia, University College Hospital Galway",department_of_anesthesia_university_college_hospital_galway,,,,471980ba-fc4b-45dc-b7bc-7d5ed19764b7,department_of_anaesthesia_university_college_hospital_galway,"Department of Anaesthesia, University College Hospital Galway" -7967,,5ee22b98-c5ac-428a-b708-9ca5d1b147bd,Institute of Specific Prophylaxis and Tropical Medicine,institute_of_specific_prophylaxis_and_tropical_medicine,,,,,, -7968,,6ed5d8fc-72db-11e6-a0cd-0242ac12000b,OSI PHARMS,osi_pharms,,,,,, -7969,,16bb6874-d3f4-4e4c-897c-c4e6d5e22a4a,Mariefreds Vårdcentral,mariefreds_v_rdcentral,,,,,, -7970,,59eeb51b-dbd9-4cab-ad50-8f3aab8aaad5,"Hæmatologisk afdeling, Roskilde Sygehus, Region Sjælland",h_matologisk_afdeling_roskilde_sygehus_region_sj_lland,,,,,, -7971,,1bd730e6-f707-40a3-ad31-7b81d860582d,"The Finsen Center, Rigshospitalet",the_finsen_center_rigshospitalet,,,,,, -7972,,f1259efa-e4ac-4c5a-bc23-dbf1cef77fff,"Cook MyoSite, Incorporated",cook_myosite_incorporated,,,,,, -7973,,d439c954-7c15-4dbd-8260-23a5f61a5ef2,"WWCR, WORLDWIDE CLINICAL RESEARCH",wwcr_worldwide_clinical_research,,,,,, -7974,,4cecfddd-cf6d-47c3-93bb-c17ebd5868d2,BrepCo Biopharma Limited,brepco_biopharma_limited,,,,,, -7975,,79d963bc-1418-4ea8-a0fb-b5a0eb88c5ec,Jesper Ekelund,jesper_ekelund,,,,,, -990,0.988915,7729c4f5-04ed-489e-a85c-cd0279e1c490,INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP,international_extranodal_lymphoma_study_group,,,,7729c4f5-04ed-489e-a85c-cd0279e1c490,international_extranodal_lymphoma_study_group,INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP -7976,,9986b329-8b8b-432a-bcde-5813f013605c,Arvi Yli-Hankala,arvi_yli_hankala,,,,,, -821,0.979768,7867f7bd-a0b0-4018-a900-f845eb2b1fe1,Dipartimento di Pediatria,dipartimento_di_pediatria,,,,3655f927-01ad-48d8-9cb0-516379501a0a,dipartimento_di_pediatria_universit_federico_ii_di_napoli,Dipartimento di Pediatria Università Federico II di Napoli -7977,,3f65e381-85ee-4aaf-a30f-370c27eee360,University Hospitals of North Midlands NHS Trust,university_hospitals_of_north_midlands_nhs_trust,,,,,, -7978,,0bc3f403-68a8-42dc-b649-1798c7102201,Clinical Immunology Division,clinical_immunology_division,,,,,, -7979,,0e85b7ba-7164-11e6-a0cd-0242ac12000b,SAGENT AGILA,sagent_agila,,,,,, -7980,,cc829edb-87b1-4733-a081-33e52652b4c9,University of Munster,university_of_munster,,,,,, -476,0.971143,74cb9176-4514-4031-bd6c-a1010bfc799d,CMC Contrast AB c/o Öresund Health Care Management,cmc_contrast_ab_c_o_resund_health_care_management,,,,4543c7ec-daec-4a10-bab1-cd53aacf4083,cmc_contrast_ab,CMC Contrast AB -7981,,3aa84695-a77d-11e6-94cb-5656d04fc2b5,GRUNENTHAL PHARMA S.A,grunenthal_pharma_s_a,,,,,, -7982,,d3959563-b3ec-4168-aee3-5d543e9f1ff7,"Deutsches Herzzentrum Berlin, Kompetenznetz Angeborene Herzfehler",deutsches_herzzentrum_berlin_kompetenznetz_angeborene_herzfehler,,,,,, -565,0.984012,3bf7860d-fdab-4edb-a9b9-646110448c48,University Hospitals of Leicester,university_hospitals_of_leicester,,,,3bf7860d-fdab-4edb-a9b9-646110448c48,university_hospitals_of_leicester,University Hospitals of Leicester -7983,,2efe9e6e-6065-4fba-97df-c12e7112b722,"Department of Medicine, Helsinki University Central Hospital",department_of_medicine_helsinki_university_central_hospital,,,,,, -7984,,aede2ddc-27f0-4902-8f59-d2fcd2fc8858,UZ Leuven-Department of Urology,uz_leuven_department_of_urology,,,,,, -7985,,4dd7975a-8b17-4276-a5a5-bd1d903c983e,"Department of Medicine, Køge University Hospital",department_of_medicine_k_ge_university_hospital,,,,,, -7986,,ab7e7344-2bb3-453e-890b-091c06776e19,Ixodes AG,ixodes_ag,,,,,, -7987,,189f53e7-e9e0-4046-8010-62fc9246c28d,"Mech-Sense, Department og Gastroenterology, Aalborg Sygehus",mech_sense_department_og_gastroenterology_aalborg_sygehus,,,,,, -7988,,f5df40da-44c6-421b-a7b2-74b2e71adbf7,Roche Nederland B.V,roche_nederland_b_v,,,,,, -7989,,4a9eb251-d9a5-4c17-a513-10d999ca6ab3,"Merck Farma y Química, S.A",merck_farma_y_qu_mica_s_a,,,,,, -7990,,2f8deb91-8824-411f-8289-87ad0cf530c1,e.o. ospedali galliera,e_o_ospedali_galliera,,,,,, -180,0.98598232865333557,fb1d1a6a-714a-11e6-a0cd-0242ac12000b,VALEANT PHARMS,valeant_pharms,,,,0b232628-7206-11e6-a0cd-0242ac12000b,valeant_pharms,VALEANT PHARMS -7991,,6fd04c99-d466-435c-99b4-3433a27db93b,Meander Medical Center,meander_medical_center,,,,,, -164,0.982418,14e0f940-71b3-11e6-a0cd-0242ac12000b,BRAINTREE,braintree,,,,14e0f940-71b3-11e6-a0cd-0242ac12000b,braintree,BRAINTREE -7992,,21d6c4e1-c5b0-487f-83e8-81ca0e3bbc98,University of Aachen,university_of_aachen,,,,,, -7993,,1f2234da-9ee1-4af0-95c1-f7be8c6304f8,Ipsen Limited,ipsen_limited,,,,,, -7994,,cb6c2b08-b028-41c7-b8bf-d147329d4c44,TrialNet Study Group,trialnet_study_group,,,,,, -7995,,c0b7c7b2-f0b7-471f-bb92-ee89c70c8142,AstraZeneca UK Ltd,astrazeneca_uk_ltd,,,,,, -7996,,c320c745-22ea-4daa-a302-bec8b3b98185,Analgesic Solutions,analgesic_solutions,,,,,, -7997,,7d4aa635-c41c-4ac3-8d06-e854f001dbef,"Psicofundación. Fundación Española para Promoción, Desarrollo Científico y Profesional de la Psicología",psicofundaci_n_fundaci_n_espa_ola_para_promoci_n_desarrollo_cient_fico_y_profesional_de_la_psicolog_a,,,,,, -7998,,e8b8b063-7f43-44bb-ae09-4a72c7cad477,H:S Hvidovre hospital,h_s_hvidovre_hospital,,,,,, -680,0.981011,e24a3a25-72d3-4de4-a0e1-dc2bb2735906,"Clinical Research Centre, Hvidovre University Hospital",clinical_research_centre_hvidovre_university_hospital,,,,d5bad664-fff4-4066-a3d3-cc7450a05435,clinical_reasearch_centre_hvidovre_university_hospital,"Clinical Reasearch Centre, Hvidovre University Hospital" -368,0.95680119593938195,8f838202-6a6a-4558-a3e0-2ea69b69055e,"Bayer HealthCare AG, D51368 Leverkusen",bayer_healthcare_ag_d51368_leverkusen,,,,0f2245d6-1eb2-4a26-ba28-2ddd66aada58,bayer_healthcare_ag_51368_leverkusen,"Bayer HealthCare AG, 51368 Leverkusen" -857,0.96889449656009674,0213f530-437f-430a-b936-0bfa94166165,Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau ? IIB Sant Pau,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau_iib_sant_pau,,,,0213f530-437f-430a-b936-0bfa94166165,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau -7999,,034c8a0e-1049-4005-88ae-0d252e88f013,Luis F. Lopez-Cortes,luis_f_lopez_cortes,,,,,, -13,0.97626614570617676,b450df50-7144-11e6-a0cd-0242ac12000b,LUPIN,lupin,,,,24b88c8e-7145-11e6-a0cd-0242ac12000b,lupin_ltd,LUPIN LTD -8000,,a3f9910e-7222-11e6-a0cd-0242ac12000b,IPR,ipr,,,,,, -8001,,b53cb649-bc3d-4325-b0e0-9f5b738b8a18,"National Centre for Diabetes Care, 1st Dept. Medicine, Diabetes Unit",national_centre_for_diabetes_care_1st_dept_medicine_diabetes_unit,,,,,, -8002,,e962e23a-6672-42e4-bb00-e9b705cf1f53,Barts and The London NHS Trust,barts_and_the_london_nhs_trust,,,,,, -8003,,551bd8d8-ac86-42ec-abb6-8c99fd57aca2,Josep M Cruzado,josep_m_cruzado,,,,,, -8004,,53055dca-d120-42d4-83d2-7c3f7a76294e,IDENIX,idenix,,,,,, -8005,,594968e2-f214-4d61-943e-7dc3118c4d54,"Karolinska Institutet, Stockholm, Sweden",karolinska_institutet_stockholm_sweden,,,,,, -8006,,455fce42-b23a-4b1d-b7e0-56091f23ac55,"VU Cancer Centre, Afdeling Geneeskundige Oncologie",vu_cancer_centre_afdeling_geneeskundige_oncologie,,,,,, -961,0.93838614225387573,c96eb057-b329-44bb-8410-db9d73b6f265,Hull & East Yorkshire Hospitals NHS Trust,hull_east_yorkshire_hospitals_nhs_trust,,,,a6d6aa67-5161-45ca-a1eb-794cebec0129,hull_and_east_yorkshire_hospitals_nhs_trust,Hull and East Yorkshire Hospitals NHS Trust -8007,,c1dd21c7-d77c-4167-8455-33c8b97e3fd5,Università Campus Bio-Medico di Roma,universit_campus_bio_medico_di_roma,,,,,, -8008,,743fc2db-44fa-4462-81d3-0b87924d2d4c,Unidad de VIH - Servicio de Enfermedades Infecciosas. Hospital de Bellvitge,unidad_de_vih_servicio_de_enfermedades_infecciosas_hospital_de_bellvitge,,,,,, -8009,,1a8ec635-d178-4275-a4ce-449d79ecbebd,"ESBATech, an Alcon Biomedical Research Unit LLC",esbatech_an_alcon_biomedical_research_unit_llc,,,,,, -8010,,c78091a7-18e5-4ec5-8fd4-114cdad04142,STADA R&D GmbH,stada_r_d_gmbh,,,,,, -762,0.986968,b40b8bff-445b-40d0-b716-58ec8da28947,University Hospitals Bristol NHS Trust,university_hospitals_bristol_nhs_trust,,,,08e66865-5523-488a-993b-2c12d1335b43,university_hospitals_bristol,University Hospitals Bristol -8011,,19d0cbd6-31e2-4413-8048-2b8ca2e14333,Helix Product Development (Ireland) Limited,helix_product_development_ireland_limited,,,,,, -8012,,b200e418-26bd-481e-aa56-40399c8575fc,Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón (FIBHGUGM),fundaci_n_investigaci_n_biom_dica_hospital_general_universitario_gregorio_mara_n_fibhgugm,,,,,, -8013,,9128bdf0-5bb8-4759-994d-4d0bc71adf49,Pharming Group NV,pharming_group_nv,,,,,, -498,0.938435,db519804-312d-41a4-a5b3-77a63eadca69,"Central Institute for Mental Health, Mannheim, Div. of Gerontopsychiatry",central_institute_for_mental_health_mannheim_div_of_gerontopsychiatry,,,,2399538a-18b4-4f23-997c-ea2ceaf364fb,central_institute_of_mental_health,Central Institute of Mental Health -8014,,ea7a2bf1-7073-40ca-beeb-ad45be52ce0e,Abelardo Garcia De Lorenzo / Teresa Nuñez-Villaveiran,abelardo_garcia_de_lorenzo_teresa_nu_ez_villaveiran,,,,,, -8015,,29880300-6db7-4be8-b65a-57de11156402,Sergio Hernández Expósito,sergio_hern_ndez_exp_sito,,,,,, -8016,,c730349b-b85e-4963-a4b5-0108e6a3d671,Immutep S.A.S,immutep_s_a_s,,,,,, -8017,,c3e3f4bc-1857-45fc-bd0c-7f584bd94247,Jan van Breemen Research Institute Reade and VU University Medical Centre,jan_van_breemen_research_institute_reade_and_vu_university_medical_centre,,,,,, -8018,,d1898d66-09c8-45e5-a355-940e4703f0c1,Psychiatric Centre Prague,psychiatric_centre_prague,,,,,, -8019,,4bee39e4-e48c-4042-b2d3-b94129280a43,Merck SHARP & DOHME DE ESPAÑA,merck_sharp_dohme_de_espa_a,,,,,, -8020,,62039255-64e8-4637-bbf2-e3fee199144a,Galapagos SASU,galapagos_sasu,,,,,, -8021,,faccd45e-ff24-4986-a06e-673eba3957de,Blue Earth Diagnostics Limited,blue_earth_diagnostics_limited,,,,,, -8022,,41b4e192-b77b-43b1-a810-9e5bc066c668,Auris Medical Inc,auris_medical_inc,,,,,, -380,0.93727820449405241,aef7d176-dcac-4351-a4b4-f65719455058,"Merck Sharp & Dohme Corp., a subsidiary of Merck and Co., Inc",merck_sharp_dohme_corp_a_subsidiary_of_merck_and_co_inc,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" -8023,,b0fe5252-7148-11e6-a0cd-0242ac12000b,EGIS PHARMS,egis_pharms,,,,,, -8024,,6db92e78-2546-4b2c-bbe1-84733a5056ab,NeRRe Therapeutics Ltd,nerre_therapeutics_ltd,,,,,, -8025,,a68b0f64-880d-11e6-a998-0242ac12000b,Abbott Products GmbH,abbott_products_gmbh,,,,,, -8026,,34ae63ba-7155-11e6-a0cd-0242ac12000b,SUNSTAR AMERICAS,sunstar_americas,,,,,, -8027,,bcf1a945-e476-422e-8c09-6f8a2ff44f9b,"MedImmune Vaccines, Inc",medimmune_vaccines_inc,,,,,, -8028,,27871991-b636-4045-974e-1a68ba8195f2,"Global Medical Affairs, Wyeth Research Division of Wyeth Pharmaceuticals Inc",global_medical_affairs_wyeth_research_division_of_wyeth_pharmaceuticals_inc,,,,,, -8029,,1197ea0a-7168-11e6-a0cd-0242ac12000b,BELCHER PHARMS LLC,belcher_pharms_llc,,,,,, -8030,,59dde8db-af75-47d4-a358-cf64aaf4642e,Fredericia Hospital,fredericia_hospital,,,,,, -8031,,24d3b937-fb65-4836-ace4-0688958e2cb9,Italchimici S.p.A,italchimici_s_p_a,,,,,, -8032,,45f07ecc-2d2d-477d-8006-ae0e6a9e2426,AstraZeneca Pharmaceuticals,astrazeneca_pharmaceuticals,,,,,, -910,0.98453670740127563,32161af5-1f02-447e-a38b-e0f0858697d7,Laboratorios Servier,laboratorios_servier,,,,32161af5-1f02-447e-a38b-e0f0858697d7,laboratorios_servier,Laboratorios Servier -8033,,6514bc33-51f6-4780-94b5-cd4849d71160,Städt. Krankenhaus Martha Maria Halle,st_dt_krankenhaus_martha_maria_halle,,,,,, -8034,,c06c0a36-0dd4-4f43-ad6e-b470d02cbe41,Immune Targeting Systems Ltd,immune_targeting_systems_ltd,,,,,, -8035,,2e8f1f2b-8055-4585-abad-3ccefd85c6da,Chroma Therapeutics Ltd,chroma_therapeutics_ltd,,,,,, -8036,,a6a5f302-d01e-44ed-973f-1471bd02ad7f,Fundación GEL/TAMO,fundaci_n_gel_tamo,,,,,, -8037,,eff5f4c7-c492-48d7-b907-cbd2fdec32c7,BODE Chemie GmbH & Co,bode_chemie_gmbh_co,,,,,, -245,0.975108,e9520f86-effe-48d5-a86c-551805d7d9a5,Karyopharm,karyopharm,,,,8cc13716-154a-455e-8604-397805d40f97,karyopharm_therapeutic_inc,"Karyopharm Therapeutic, Inc" -8038,,ef13c3a9-47b2-4f1b-93a3-50dff9bf64c6,KuDOS Pharmaceuticals Ltd. (a member of the AstraZeneca group of companies),kudos_pharmaceuticals_ltd_a_member_of_the_astrazeneca_group_of_companies,,,,,, -8039,,f3b13cd4-5388-46e1-b083-1058a387b82b,"UZ leuven, Marc Van de Velde",uz_leuven_marc_van_de_velde,,,,,, -8040,,2824aef6-fd7d-469c-a839-d76ce8e01fd0,"Taiho Oncology, Inc",taiho_oncology_inc,,,,,, -600,0.95773337284723914,c2d5b3ef-db19-46ec-83fa-7c50bd0cde4f,Fundació Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau,fundaci_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,,,,6b4a9b2d-18ff-4441-b335-98517841d021,fundaci_n_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Fundació Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau -8041,,2b017737-cc66-4f03-8d79-06fb5a1a3a15,"Gastroenheden D, Herlev Hospital",gastroenheden_d_herlev_hospital,,,,,, -8042,,8ec78372-fce6-4fc2-8b0f-14d3da1a6fdc,Helsinki Central university Hospital,helsinki_central_university_hospital,,,,,, -8043,,1e74d95c-881c-11e6-a998-0242ac12000b,University Hospital of North Staffordshire NHS Trust,university_hospital_of_north_staffordshire_nhs_trust,,,,,, -555,0.98490422964096069,e694a29c-9d8b-4333-834c-7277ca164e4c,Greater Glasgow and Clyde NHS Board,greater_glasgow_and_clyde_nhs_board,,,,613c1a9b-76b3-42ee-8979-2c8d31737f57,greater_glasgow_and_clyde_nhs_board,Greater Glasgow and Clyde NHS Board -8044,,8433852c-4927-4c6a-a156-dce63bfd0815,Imperial Ciollege,imperial_ciollege,,,,,, -888,0.95901872430528912,7e4ebf20-f3d9-475d-92aa-b6bf058b58c1,"Schering-Plough Research Insititute, a division of Schering Corporation",schering_plough_research_insititute_a_division_of_schering_corporation,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" -678,0.9645330011844635,eb89e719-3467-4add-a609-e2963e7f52a0,AbbVie DeutschlandGmbH & Co. KG,abbvie_deutschlandgmbh_co_kg,,,,ddf3632f-3a35-464c-8cf1-c8b6486c323c,abbvie_deutschland_gmbh_co_kg,AbbVie Deutschland GmbH & Co. KG -8045,,84319d03-203c-4049-8eb2-e0aaaee8545e,University of Edinburgh & NHS Lothian ACCORD,university_of_edinburgh_nhs_lothian_accord,,,,,, -8046,,ce26a9f2-7160-11e6-a0cd-0242ac12000b,AMBIX,ambix,,,,,, -8047,,8b481272-eb5e-42ae-842f-44a8d7d94df8,Adenovir Pharma AB,adenovir_pharma_ab,,,,,, -8048,,a0010891-21d6-4544-bdff-52d7f793661f,"Medizinische Klinik I, St. Josef-Hospital, Ruhr-Universität Bochum",medizinische_klinik_i_st_josef_hospital_ruhr_universit_t_bochum,,,,,, -8049,,f6afb43e-d4b1-4841-8ed8-709ad581f8ab,Coretherapix S.L.U,coretherapix_s_l_u,,,,,, -8050,,f6b6e564-3133-4cd1-b0c2-a8016a10066a,Laboratorios Liconsa S.A,laboratorios_liconsa_s_a,,,,,, -8051,,8c0f553e-2336-4ef1-82df-baeaf0aa2c69,ADDS (Advanced Drug Development Services),adds_advanced_drug_development_services,,,,,, -8052,,1147992b-73e0-44cf-9b75-613f123016f3,"Department of Oncology, Aarhus University Hospital",department_of_oncology_aarhus_university_hospital,,,,,, -95,0.977549,c55f8d7a-feed-4d7b-b5b5-cc3940656ac3,Artu Biologicaks Europe B.V,artu_biologicaks_europe_b_v,,,,54a10183-297d-43b4-8cb3-8ad19beec3c5,artu_biologicals_europe_b_v,Artu Biologicals Europe B.V -8053,,0dfac7cc-1e33-495c-b93d-a0805aa44c97,Clinirx Tangent Research,clinirx_tangent_research,,,,,, -8054,,e3452766-fc3d-4e86-a141-acf02d7635ae,"Medical University Vienna, Department of Anesthesia, Intensive Care Medicine and Pain Management",medical_university_vienna_department_of_anesthesia_intensive_care_medicine_and_pain_management,,,,,, -8055,,e83b6d25-26ef-48c3-ab5e-f4200741bc57,"Department of Psychiatry, RWTH Aachen",department_of_psychiatry_rwth_aachen,,,,,, -8056,,358a4685-6ffa-45e0-a72e-434328441d70,"Civitas Therapeutics, Inc",civitas_therapeutics_inc,,,,,, -8057,,9af77dc2-4f1d-435c-a269-6f2f38912a0a,S.E. Carburos Metálicos S.A. grupo Air Products,s_e_carburos_met_licos_s_a_grupo_air_products,,,,,, -91,0.98681867122650146,773f50b2-9db9-4907-b659-e4a90dab71f6,Actelion Pharmaceuticals,actelion_pharmaceuticals,,,,773f50b2-9db9-4907-b659-e4a90dab71f6,actelion_pharmaceuticals,Actelion Pharmaceuticals -713,0.97731272876262665,d2f1d48d-c243-473b-9f47-208723250aa6,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA",wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,,,,d2f1d48d-c243-473b-9f47-208723250aa6,wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA" -8058,,55944477-a230-46a2-b315-a30bdb60af16,ao. Univ. Prof. Dr. Elisabeth Aberer,ao_univ_prof_dr_elisabeth_aberer,,,,,, -8059,,9c94630b-1e96-4c59-bea1-efe167a1f4eb,Pharmaxis Limited,pharmaxis_limited,,,,,, -8060,,4a5e2b50-6fbb-11e6-abe8-0242ac12000b,TAYS/teho-osasto,tays_teho_osasto,,,,,, -388,0.969459,cd01f34f-ac9c-4bef-9caf-25934261d983,"Uppsala University Hospital, Dept. of Medical Sciences",uppsala_university_hospital_dept_of_medical_sciences,,,,8b0575a1-8376-4915-a366-981ce5a80282,uppsala_university_hospital_dept_of_medical_scienses,"Uppsala University Hospital, Dept of Medical Scienses" -543,0.930137,71738680-41ff-4751-88bc-8c484e8e9bc7,"Abbott Laboratories Limited (Queenborough, Kent, ME11 5EL, England)",abbott_laboratories_limited_queenborough_kent_me11_5el_england,,,,71738680-41ff-4751-88bc-8c484e8e9bc7,abbott_laboratories_limited_queenborough_kent_me11_5el_england,"Abbott Laboratories Limited (Queenborough, Kent, ME11 5EL, England)" -8061,,dc860860-b8cf-4914-b19d-a216390e7a7a,"Academisch medisch centrum, department of psychiatry",academisch_medisch_centrum_department_of_psychiatry,,,,,, -8062,,bb4dd155-acb7-4e33-b6ac-7e7b46d76a5f,"Prof., dr. med. Anders Fink-Jensen",prof_dr_med_anders_fink_jensen,,,,,, -8063,,f5494e8b-f48b-456f-b8ad-9a0da1915f7a,ARCAGY-GINECO,arcagy_gineco,,,,,, -8064,,b38f4a74-baec-4d70-925d-48411122ca19,"Aalborg Psychiatric Hospital, Research Unit",aalborg_psychiatric_hospital_research_unit,,,,,, -8065,,7a74bb82-0eee-4fa9-8b51-ce2458b7c61e,AZIENDA U.L.S.S. N.8 DI ASOLO,azienda_u_l_s_s_n_8_di_asolo,,,,,, -8066,,c783b132-b299-4872-bd1f-6e8e14938814,Sanofi-Aventis Recherche &, De`veloppement,,,,,, -8067,,b22bf3d6-038f-42b9-a697-89dece278a2c,Servicio de Alergia. Hospital Civil. Málaga (Spain),servicio_de_alergia_hospital_civil_m_laga_spain,,,,,, -8068,,8dfad457-62d4-4e98-8f31-b77534636eee,"University Hospital Munich, Germany",university_hospital_munich_germany,,,,,, -90,0.988251,e7076194-8819-11e6-a998-0242ac12000b,Bio Products Laboratory Ltd,bio_products_laboratory_ltd,sanofi_aventis_recherche_amp_de_veloppement,,,51f2f135-0aa9-4e39-b934-2ebfce55549a,bio_products_laboratory,Bio Products Laboratory -887,0.9673493504524231,7eb1c700-1f39-4d6a-9037-72a5b89bb597,Schering-Plough Research Insitute,schering_plough_research_insitute,,,,44b33ab6-d74e-4fa5-aa8c-510964a3ac9f,schering_plough_research_institute,Schering-Plough Research Institute -8069,,f33840e9-ba24-4e61-8f86-0465450b5ddb,Merja Soilu Häninen,merja_soilu_h_ninen,,,,,, -8070,,58a631ba-672b-442d-983c-2aab66ebc86e,Abbott France,abbott_france,,,,,, -169,0.94997268915176392,93be1e6b-cdd4-4d0b-b858-d8a12aea4f88,"Merck Serono Int, a branch of Laboratoires Serono SA an affiliate of Merck KGaA, Darmstadt, Germany",merck_serono_int_a_branch_of_laboratoires_serono_sa_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,3e1da10e-fb5d-4c01-94a2-f31c443bb1c2,merck_serono_int_a_branch_oflaboratories_serono_s_a_an_affiliate_of_merck_kgaa_darmstadt_germany,"Merck Serono Int, a branch ofLaboratories Serono S.A. an affiliate of Merck KGaA, Darmstadt, Germany" -8071,,33fbd8db-5a14-4116-b33f-1f650729dec6,Irina Elovaara,irina_elovaara,,,,,, -8072,,f48d2edf-df88-40f3-b6be-89e2a51bdd97,Kinderkrankenhaus AUF DER BULT,kinderkrankenhaus_auf_der_bult,,,,,, -8073,,76ce119a-0e1b-4301-8794-84ac999dde85,University College Hospital Galway,university_college_hospital_galway,,,,,, -8074,,32f14029-d2e7-4b3b-8e79-6951ae0e26ce,"Department of Medicine I, University Hospital St. Josef-Hospital, Ruhr University Bochum",department_of_medicine_i_university_hospital_st_josef_hospital_ruhr_university_bochum,,,,,, -356,0.903306,ada15e9f-a2ab-489f-bc3e-e972a93587fc,Fundación de Investigación Biomédica Hospital de Getafe,fundaci_n_de_investigaci_n_biom_dica_hospital_de_getafe,,,,ada15e9f-a2ab-489f-bc3e-e972a93587fc,fundaci_n_de_investigaci_n_biom_dica_hospital_de_getafe,Fundación de Investigación Biomédica Hospital de Getafe -8075,,a52d2f1c-62ea-46db-9433-c97eb006b970,liverpool university,liverpool_university,,,,,, -8076,,b131ea01-68d3-4a06-81bd-0a6968e5b02b,Whipps Cross University Hospital,whipps_cross_university_hospital,,,,,, -8077,,241e6576-278f-4ca3-988f-084f8263be4c,"Rigshospitalet, Ultrasound Clinic 4023",rigshospitalet_ultrasound_clinic_4023,,,,,, -26,0.981552,22b98606-c425-4c0d-b54c-92cc47d7492a,Johns Hopkins University,johns_hopkins_university,,,,166642d4-cecb-4060-8a23-a1a73c72bbae,johns_hopkins_university_department_of_neurology,"Johns Hopkins University, Department of Neurology" -8078,,85ce2a3b-2fb1-4a0b-be25-a9f1cb8c9c40,Wörwag Pharma GmbH & Co. KG,w_rwag_pharma_gmbh_co_kg,,,,,, -8079,,bf1280c4-7158-11e6-a0cd-0242ac12000b,IVAX PHARMS INC,ivax_pharms_inc,,,,,, -8080,,e1b6ca10-0c02-4eaa-b6b2-af8dd147d3e1,Zentralinstitut für Seelische Gesundheit Mannheim,zentralinstitut_f_r_seelische_gesundheit_mannheim,,,,,, -8081,,9d05bb04-8b0b-4905-8f4f-993aed735088,"Universitätsklinik für Neurologie, Medizinische Universität Wien",universit_tsklinik_f_r_neurologie_medizinische_universit_t_wien,,,,,, -8082,,3abe1d1d-236d-49a0-a65e-7cd9b45ad44a,GEDII - Grupo de Estudo da Doença inflamatória Intestinal,gedii_grupo_de_estudo_da_doen_a_inflamat_ria_intestinal,,,,,, -8083,,6c63c5f0-73f0-11e6-a0cd-0242ac12000b,DUPUY OXYGEN,dupuy_oxygen,,,,,, -8084,,7f9ae7df-d1c1-496b-b48f-336e1518f6fa,York Hospitals NHS Foundation Trust,york_hospitals_nhs_foundation_trust,,,,,, -1056,0.978876,354891c3-150d-4c84-ae8e-ab81e3128958,Hospital Clinico San Carlos,hospital_clinico_san_carlos,,,,269c3398-c5cb-4532-8146-3d371fd1fcef,hospital_clinico_san_carlos_unidad_de_investigacion_cardiovascular,"Hospital Clinico San Carlos, Unidad de Investigacion Cardiovascular" -8085,,bbed91cc-83e8-4f29-b4bb-98cd6c01b76c,KARAKTER universitair centrum voor kinder- en jeudpsychiatrie,karakter_universitair_centrum_voor_kinder_en_jeudpsychiatrie,,,,,, -978,0.97898,26bfe88e-7144-11e6-a0cd-0242ac12000b,SANDOZ INC,sandoz_inc,,,,01a7b83a-7129-11e6-a89e-0242ac12000b,sandoz,SANDOZ -8086,,a73cbefd-947e-40d8-84fb-d6ee8af103ad,Grupo para el Tratamiento de Tumores Digestivos,grupo_para_el_tratamiento_de_tumores_digestivos,,,,,, -8087,,0035ebc1-2d50-4d76-acb7-a04046263e03,MEDICE Arzneimittel GmbH & Co. KG,medice_arzneimittel_gmbh_co_kg,,,,,, -8088,,168ad3e2-cfea-461e-a13e-6715bf423246,Neurim Pharmaceuticals (1991) Ltd,neurim_pharmaceuticals_1991_ltd,,,,,, -8089,,87e40a7b-6474-4f08-b3f5-630470522471,Helperby Therapeutics Ltd,helperby_therapeutics_ltd,,,,,, -639,0.98296070098876953,803631d1-924e-4107-b01f-b8f5dd3e2c4d,Greater Glasgow Health Board,greater_glasgow_health_board,,,,c80f0f43-274e-40b5-9c79-e591ce33aa3a,greater_glasgow_health_board_university_of_glasgow,Greater Glasgow Health Board/University of Glasgow -8090,,f9b482f8-60a4-439e-84c5-12acdebe3f42,"Shionogi USA, Inc",shionogi_usa_inc,,,,,, -8091,,9b2fcaf1-69b1-4584-a611-5dcacadf7aae,P Pierre Dellamonica,p_pierre_dellamonica,,,,,, -8092,,6548d59e-0e32-4e1e-b3ee-232f513405e2,"Dermira, Inc",dermira_inc,,,,,, -8093,,b60a6ddb-642e-4254-bc14-1627019bd284,Conwy and Denbighshire NHS Trust,conwy_and_denbighshire_nhs_trust,,,,,, -8094,,bbd4516d-5b75-4fe7-b2db-0d34faf8a58e,Universtiy of Liverpool,universtiy_of_liverpool,,,,,, -8095,,d7fdacf1-c14d-4422-aa44-21f970e1b5e8,PledPharma AB,pledpharma_ab,,,,,, -8096,,b28cffd4-7203-435b-bf30-41a0a37b6a9d,ROXALL Medizin GmbH,roxall_medizin_gmbh,,,,,, -8097,,5aa74010-6fbf-11e6-abe8-0242ac12000b,Janssen-Cilag Taiwan,janssen_cilag_taiwan,,,,,, -8098,,4e674fdf-7d35-4f58-82e6-e7fa6316ebda,"Odense University Hospital, afd.M",odense_university_hospital_afd_m,,,,,, -8099,,93a4329e-8bbf-11e6-a449-0242ac12000b,"GGZ inGeest, parner VUmc",ggz_ingeest_parner_vumc,,,,,, -8100,,509c1455-20f2-405d-a2c3-1207b8e1a58e,"Klinische Abteilung für Thorax -u. Hyperbare Chirurgie, Medizinische Universität Graz",klinische_abteilung_f_r_thorax_u_hyperbare_chirurgie_medizinische_universit_t_graz,,,,,, -8101,,797feeac-41b1-4813-98bf-4159e2c03145,MDM S.p.A,mdm_s_p_a,,,,,, -8102,,9b6663c7-f29a-4ff8-be7a-64d45bcad097,Fondazione Michelangelo,fondazione_michelangelo,,,,,, -8103,,72a90c41-df8f-409e-b3b0-2362c1ff179c,Jørgen Agnholt,j_rgen_agnholt,,,,,, -8104,,4b8323fc-5419-482f-ad4d-79301ae9aa9c,Hoosier Oncology Group,hoosier_oncology_group,,,,,, -8105,,fcb8833a-3d56-49cb-a8e7-ca125a09e457,"BN ImmunoTherapeutics, Inc",bn_immunotherapeutics_inc,,,,,, -8106,,2a8fe231-e879-4300-ad7e-8136420032d9,Dipartimento di Pediatria Universita` di Napoli Federico II,dipartimento_di_pediatria_universita_di_napoli_federico_ii,,,,,, -84,0.960935,93bcfb98-7158-11e6-a0cd-0242ac12000b,ECR PHARMA,ecr_pharma,,,,93bcfb98-7158-11e6-a0cd-0242ac12000b,ecr_pharma,ECR PHARMA -139,0.949534,2d7c987c-7d3b-4780-9e58-be5dbcf9a582,AWD.pharma GmbH & Co. KG, Medical Development,,,,2b57b25f-7999-42a9-bc73-ba293507ad94,awd_pharma_gmbh_co_kg,AWD.pharma GmbH & Co KG -8107,,f26e6d76-7ecd-4e47-a27b-6e0eba7a953e,"Fundación Centro Nacional de Investigaciones Cardiovasculares, Carlos III (CNIC)",fundaci_n_centro_nacional_de_investigaciones_cardiovasculares_carlos_iii_cnic,,,,,, -27,0.982297,8f30be7a-db80-4d4f-b679-8ae4bed90a55,"Integrated Therapeutics Group, Inc",integrated_therapeutics_group_inc,,,,8f30be7a-db80-4d4f-b679-8ae4bed90a55,integrated_therapeutics_group_inc,"Integrated Therapeutics Group, Inc" -8108,,5a574e2f-792b-49d6-afa4-b38c8c6ab6ee,Rafael López López,rafael_l_pez_l_pez,awd_pharma_gmbh_co_kg_medical_development,,,,, -8109,,67416edd-218d-458b-bb74-1ab51680790e,Institute for clinical and experimental Medicine,institute_for_clinical_and_experimental_medicine,,,,,, -8110,,5d0466a7-1fcb-4da8-ac5a-95eb78110d50,Thor Petersen,thor_petersen,,,,,, -8111,,15f0d004-b82b-408c-8605-38a57352468d,Södertälje sjukhus AB,s_dert_lje_sjukhus_ab,,,,,, -8112,,4c88bf3f-dbde-4638-98ae-3290a4b20d1b,Agneta Blanck Olerup,agneta_blanck_olerup,,,,,, -8113,,4e75d4e3-daa8-4a88-81b0-a0ce230ccac8,Argenta Discovery Ltd,argenta_discovery_ltd,,,,,, -8114,,9243d369-76d9-41ca-bebe-90bbb711e02d,Juha Holopainen,juha_holopainen,,,,,, -8115,,b09ab99a-7166-11e6-a0cd-0242ac12000b,CSPC NBP PHARM CO,cspc_nbp_pharm_co,,,,,, -423,0.97237,0879f869-1102-4898-99d9-8197e98473d7,Universita di Firenze,universita_di_firenze,,,,0879f869-1102-4898-99d9-8197e98473d7,universita_di_firenze,Universita di Firenze -8116,,b760a326-9f08-4b8e-bac8-edee498264d4,Med. Fakultaet der Friedrich-Alexander Universitaet Erlangen-Nuernberg,med_fakultaet_der_friedrich_alexander_universitaet_erlangen_nuernberg,,,,,, -552,0.945615,d91ca243-2119-49b0-ad7b-9a6a5b939bb0,Grifols Biological Inc,grifols_biological_inc,,,,189b51d9-0d8d-4344-a7e0-4ad5e8c1742d,grifols_biologicals_inc,Grifols Biologicals Inc -142,0.985676,32a060d4-7167-11e6-a0cd-0242ac12000b,BRIGHAM WOMENS HOSP,brigham_womens_hosp,,,,32a060d4-7167-11e6-a0cd-0242ac12000b,brigham_womens_hosp,BRIGHAM WOMENS HOSP -8117,,fe445f2b-9f46-4552-b70f-d15b20a9c81f,Industial Farmacéutica Cantabria S. A,industial_farmac_utica_cantabria_s_a,,,,,, -8118,,3100d50e-ea68-4211-8cab-5122015681d0,Miquel Pujol Rojo (Infectious Diseases Service-Hospital Universitari de Bellvitge-IDIBELL),miquel_pujol_rojo_infectious_diseases_service_hospital_universitari_de_bellvitge_idibell,,,,,, -8119,,89f278d7-17db-400b-8af7-4a69fd941b4b,Bionor Pharma ASA,bionor_pharma_asa,,,,,, -753,0.987206,29241c8d-7ad8-4877-83dd-b4d1b01b5563,Sun Pharma Advanced Research Company,sun_pharma_advanced_research_company,,,,29241c8d-7ad8-4877-83dd-b4d1b01b5563,sun_pharma_advanced_research_company,Sun Pharma Advanced Research Company -8120,,aba727fa-eb97-41b0-9c9c-b38ea8a99dd0,FBCSG (Finish Breast Cancer Study Group),fbcsg_finish_breast_cancer_study_group,,,,,, -8121,,e8c88b1f-c403-4143-bd2e-9c6a4130b5a4,FONDAZIONE DELL'ISTITUTO TOSCANO TUMORI,fondazione_dell_istituto_toscano_tumori,,,,,, -303,0.991079,db0cf76f-03db-4f45-95e7-853b95e8ea9b,Universitätsklinikum Bonn, Klinik und Poliklinik für Psychiatrie und Psychotherapie,,,,7700ad0c-d303-4880-b341-66bdf8c7ad35,universit_tsklinikum_bonn,Universitätsklinikum Bonn -8122,,7e7b8838-8c0d-4265-a442-1b1209dd3124,Rikshospitalet-Radiumhospitalet HF,rikshospitalet_radiumhospitalet_hf,,,,,, -8123,,8a8e6b82-a174-4304-81b4-53295f284fe9,CHIESI,chiesi,,,,,, -8124,,e7f9e4b2-c905-48c2-ac6c-61e0364d3879,Hela Pharma AB,hela_pharma_ab,universit_tsklinikum_bonn_klinik_und_poliklinik_f_r_psychiatrie_und_psychotherapie,,,,, -8125,,ed5bb4ae-af16-4d87-97c7-f06d764acf4f,Klinikum der J. W. Goethe-Universität Frankfurt - Medizinische Klinik I,klinikum_der_j_w_goethe_universit_t_frankfurt_medizinische_klinik_i,,,,,, -8126,,c94837b2-a38e-4ab8-9fb4-a94daba67ce7,Bo Feldt-Rasmussen,bo_feldt_rasmussen,,,,,, -8127,,a21b3493-4b29-4b8d-8396-347bd8070d19,Fundación Española de Hematología y Hemoterapia,fundaci_n_espa_ola_de_hematolog_a_y_hemoterapia,,,,,, -8128,,386ef6ee-b336-45bf-ac11-6d6221155069,FONDAZIONE CENTRO EMOFILIA E TROMBOSI ANGELO BIANCHI BONOMI,fondazione_centro_emofilia_e_trombosi_angelo_bianchi_bonomi,,,,,, -8129,,505ca89c-289a-4ce1-a562-196a014465a2,Fachbereich Medizin der Johann Wolfgang Goethe-Universität Frankfurt/M,fachbereich_medizin_der_johann_wolfgang_goethe_universit_t_frankfurt_m,,,,,, -449,0.98227512836456299,17a7cd12-2e89-4b00-832e-bc19b8172771,ALLERGAN,allergan,,,,17a7cd12-2e89-4b00-832e-bc19b8172771,allergan,ALLERGAN -8130,,b0156f6a-da83-4c2a-b714-6f756a3f0363,"Department of Anaesthesia, Rotunda Hospital",department_of_anaesthesia_rotunda_hospital,,,,,, -8131,,edc9e01d-f0d2-4dc6-9a71-46ae75cd9e4d,Pediatric Brain Tumour Consortium,pediatric_brain_tumour_consortium,,,,,, -8132,,1a5fbebc-31a6-453f-b3b4-4567817660e5,SPEEDEL,speedel,,,,,, -672,0.975714,8bce5c4e-7129-11e6-a89e-0242ac12000b,PERRIGO,perrigo,,,,25ceb782-7164-11e6-a0cd-0242ac12000b,perrigo_uk_finco,PERRIGO UK FINCO -8133,,ae4fd598-7fae-4bd5-ad67-a6ebd6cf5a1a,"SONUS Pharmaceuticals, Inc",sonus_pharmaceuticals_inc,,,,,, -8134,,2dd1b16c-712a-11e6-a89e-0242ac12000b,FERNDALE LABS,ferndale_labs,,,,,, -8135,,aa64342a-5da0-4561-860d-8ecb5c5d22c1,"Ortopædkirurgisk Center, Aarhus Universitets Hospital",ortop_dkirurgisk_center_aarhus_universitets_hospital,,,,,, -8136,,8bfe2bc3-44e8-415f-91b6-dcac087a393b,"Portsmouth Institution Medicine, Health & Social Care, Portsmouth University",portsmouth_institution_medicine_health_social_care_portsmouth_university,,,,,, -938,0.977852,41fdac3b-97bb-4404-84a8-1a8ece5e5818,FUNDACIÓN ESPAÑOLA DE REUMATOLOGÍA (FER),fundaci_n_espa_ola_de_reumatolog_a_fer,,,,41fdac3b-97bb-4404-84a8-1a8ece5e5818,fundaci_n_espa_ola_de_reumatolog_a_fer,FUNDACIÓN ESPAÑOLA DE REUMATOLOGÍA (FER) -1052,0.94724655151367188,574a16cb-eb53-4e25-95a2-a07455968d04,"University of Oxford, Clinical Trials and Research Governance Office",university_of_oxford_clinical_trials_and_research_governance_office,,,,574a16cb-eb53-4e25-95a2-a07455968d04,university_of_oxford_clinical_trials_and_research_governance,"University of Oxford, Clinical Trials and Research Governance Office" -381,0.92556309700012207,7174f551-6d94-4606-8860-fb076b8e5e6c,Merck Sharp & Dohme OÜ,merck_sharp_dohme_o,,,,70a76c95-9bc5-4453-ace1-7d9c98a92a7d,merck_sharp_dohme_o,"Merck Sharp & Dohme Copr., a subsidary of Merck & Co" -8137,,0e134f00-c796-4547-9b94-e78c574b3bbf,CHU Brugmann,chu_brugmann,,,,,, -8138,,0c4f0fc6-e44d-4d84-a281-5f7c45fb6c9d,CHEMO France,chemo_france,,,,,, -8139,,25761af7-fc8d-43b1-bf44-f13a5f16cec5,"Rempex Pharmaceuticals, Inc",rempex_pharmaceuticals_inc,,,,,, -8140,,a5da24b0-bd70-420d-910d-d474c88f3551,Debreceni Egyetem Orvos- és Egészségtudományi Centrum Aneszteziológiai és Intenzív Terápiás Tanszék,debreceni_egyetem_orvos_s_eg_szs_gtudom_nyi_centrum_aneszteziol_giai_s_intenz_v_ter_pi_s_tansz_k,,,,,, -8141,,54b3d211-0ffe-4e38-a461-ea4d86230eb8,SIRTEX TECHNOLOGY PTY LTD,sirtex_technology_pty_ltd,,,,,, -188,0.9797365665435791,db7ce6e0-e7bc-4ef7-b1b7-2fc2a9ab53e0,Nycomed GmbH,nycomed_gmbh,,,,c698abc0-6f9b-11e6-9663-0242ac12000b,nycomed,Nycomed -8142,,a6ebef4f-cb45-406a-992d-ba06d1d20786,"Kirby Institute, University of New South Wa",kirby_institute_university_of_new_south_wa,,,,,, -593,0.9775586724281311,ade4c3f7-0083-447d-b98a-5069c718eea3,Medical University Innsbruck,medical_university_innsbruck,,,,3969045a-4ef0-424f-8964-e4403b2aa66b,medical_university_innsbruck_dpt_internal_medicine_div_internal_medicine,"Medical University Innsbruck, Dpt. Internal Medicine, Div. Internal Medicine" -8143,,0ff92817-655b-459e-b749-822a3058062f,AZ Sint Jan Brugge-Oostende AV,az_sint_jan_brugge_oostende_av,,,,,, -8144,,48b9c7c0-8132-4c1f-97a0-688bc901482b,Alcon Hungarian ltd,alcon_hungarian_ltd,,,,,, -8145,,4e86f381-85a4-45ac-9ce9-463b49082c81,BRAINSGATE LTD,brainsgate_ltd,,,,,, -8146,,ebd4ded4-bbc0-47c5-a70e-87965619de17,FIDEC - Fighting Infectious Diseases in Emerging Countries,fidec_fighting_infectious_diseases_in_emerging_countries,,,,,, -8147,,2af97a8b-5ab8-42d0-9c59-425cd16cdec0,EUTHERAPIE / Les Laboratoires Servier,eutherapie_les_laboratoires_servier,,,,,, -8148,,8f294b34-3c7b-462a-920f-447f949309ca,OrthoCell Pty Ltd,orthocell_pty_ltd,,,,,, -8149,,b0ea9dd4-6f9f-11e6-9663-0242ac12000b,Vascular Biogenics Ltd,vascular_biogenics_ltd,,,,,, -8150,,c2c2ea52-adef-4660-826a-eac3abf2ce65,INSMED INCORPORATED,insmed_incorporated,,,,,, -8151,,44dba20e-efc7-414d-a267-4043d8abae94,Mainz University Hospital,mainz_university_hospital,,,,,, -1077,0.97536885738372803,47d92db0-1d1d-4219-8229-7d6a540644ca,IBSA Institut Biochimique SA,ibsa_institut_biochimique_sa,,,,3fdba14d-9b0e-469d-bb19-93144e9882fd,ibsa_institut_biochimique_s_a,IBSA Institut Biochimique S.A -8152,,e34398de-72d9-11e6-a0cd-0242ac12000b,SUNOVION,sunovion,,,,,, -352,0.98674958944320679,d66cb26c-4426-4af8-950e-822ec255408a,Deutsches Herzzentrum Berlin,deutsches_herzzentrum_berlin,,,,3c65321f-86b5-4caf-b891-98518f69b348,deutsches_herzzentrum,Deutsches Herzzentrum -8153,,34ff6da2-9cac-4f0e-ba9a-0d613d9c7251,Biovitrum AB,biovitrum_ab,,,,,, -8154,,ef9ce225-0e1a-4b44-8387-067931b3a72e,ABIOGEN PHARMA,abiogen_pharma,,,,,, -8155,,7e707d25-b363-490e-9ddd-d64e1836d578,AbbVie Deutschland GmbH & Co. KGKG,abbvie_deutschland_gmbh_co_kgkg,,,,,, -8156,,3f6320c6-a8a7-47c7-b4b4-91e5a56cdf52,Mario Negri Gynecologic Oncology Group,mario_negri_gynecologic_oncology_group,,,,,, -8157,,276d558c-13e4-48ec-b4fa-40411a8fb633,BiondVax Pharmaceuticals ltd,biondvax_pharmaceuticals_ltd,,,,,, -8158,,7f02e1a8-715e-11e6-a0cd-0242ac12000b,C AND M PHARMA,c_and_m_pharma,,,,,, -8159,,c0a996de-c807-4e95-9ff1-d1042f960b84,InSpira Medical AB,inspira_medical_ab,,,,,, -22,0.97528120875358582,22838b79-924f-4f31-9ea0-9ca648f7ad49,"University Hospital Heidelberg, Ruprechts-Karl-University Heidelberg",university_hospital_heidelberg_ruprechts_karl_university_heidelberg,,,,ae6ad20a-a5ac-4fda-adad-69b8ff220a6a,university_hospital_heidelberg,University Hospital Heidelberg -385,0.984184,53a89408-7145-11e6-a0cd-0242ac12000b,VERSAPHARM INC,versapharm_inc,,,,53a89408-7145-11e6-a0cd-0242ac12000b,versapharm_inc,VERSAPHARM INC -240,0.987416,f0fe5d48-71e3-11e6-a0cd-0242ac12000b,MEDIMMUNE ONCOLOGY,medimmune_oncology,,,,61f718c1-8bf2-4352-81a1-859abc44901a,medimmune_oncology_inc,MEDIMMUNE ONCOLOGY INC -8160,,38325d34-f9ff-4b94-934b-45626b00e552,Fundación Renal Jaume Arnó,fundaci_n_renal_jaume_arn,,,,,, -8161,,729f9f47-8b8a-4c71-890a-140dd156ccff,CHU TOURS,chu_tours,,,,,, -8162,,9508256b-67ce-4981-a9a9-f39f6af259c9,"Mental Health Service, Esbjerg",mental_health_service_esbjerg,,,,,, -8163,,b683acc4-7ee7-4528-9494-ad13253a208e,Atrium MC Parkstad,atrium_mc_parkstad,,,,,, -8164,,5ad265f1-2211-4663-9ca9-5efb5808e374,OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALISATION INC,otsuka_pharmaceutical_development_and_commercialisation_inc,,,,,, -8165,,2a00dc5f-02fe-48e4-bf3a-52bb34f0a72d,"Research and Development Directorate, University Hospitals of Leicester NMS Trust",research_and_development_directorate_university_hospitals_of_leicester_nms_trust,,,,,, -8166,,1302918c-446a-40ee-8a33-22690fe3a909,TARGID,targid,,,,,, -8167,,ec4725be-107f-4e26-a07c-07353dfb899f,Chelsea & Westminster NHS Foundation Trust,chelsea_westminster_nhs_foundation_trust,,,,,, -8168,,62d03d06-bd83-43e4-966d-4a713506f54f,"Medizinische Universität Wien, Institut für Spezifische Prophylaxe und Tropenmedizin",medizinische_universit_t_wien_institut_f_r_spezifische_prophylaxe_und_tropenmedizin,,,,,, -548,0.98087829351425171,dab90a12-7146-11e6-a0cd-0242ac12000b,FERRING,ferring,,,,0ea42022-8be2-11e6-a449-0242ac12000b,ferring_spa,FERRING SPA -11,0.979515,52e0d1ff-2215-49b4-99dd-e6e6ac83eb94,THERAVANCE,theravance,,,,52e0d1ff-2215-49b4-99dd-e6e6ac83eb94,theravance,THERAVANCE -8169,,2bd06b6d-4f31-427c-a3d9-fc129dc61f10,Inotek Pharmaceuticals Corporation,inotek_pharmaceuticals_corporation,,,,,, -8170,,416169aa-0ac0-4377-bbfe-f1f330c27ae3,Institute of Oncology Ljubljana,institute_of_oncology_ljubljana,,,,,, -8171,,fcae483d-b78c-48cf-a444-97c18c55920b,Silvia Gil Trujillo,silvia_gil_trujillo,,,,,, -8172,,b612216d-1470-46a2-bacb-724e8b9219cc,"SOGUG, Grupo español para el estudio del cancer genitourinario",sogug_grupo_espa_ol_para_el_estudio_del_cancer_genitourinario,,,,,, -955,0.979762,d0a6a4ba-2543-46b6-8d11-ae2d2e832584,"AZTherapies, Inc",aztherapies_inc,,,,801fd107-9dff-425d-aeed-c20bed8847c1,aztherapies_inc_pure_tech_health,"AZTherapies, Inc., Pure Tech Health" -8173,,4646c3b2-7149-11e6-a0cd-0242ac12000b,ESI LEDERLE,esi_lederle,,,,,, -8174,,ee199b84-cb08-4f01-8c51-75735713358e,FARMACEUTICI DAMOR,farmaceutici_damor,,,,,, -8175,,003a1cfc-7167-11e6-a0cd-0242ac12000b,MCPRF,mcprf,,,,,, -8176,,f938920d-c113-4270-af2b-c55235b9a06e,Novartis Pharmaceuticals Corporation,novartis_pharmaceuticals_corporation,,,,,, -8177,,4295eeb7-1128-48c2-90f6-c269ba6972cf,Medical University Innsbruck - Department für Kinder- und Jugendheilkunde (Pädiatrie III),medical_university_innsbruck_department_f_r_kinder_und_jugendheilkunde_p_diatrie_iii,,,,,, -8178,,6eae56e6-522d-449c-a656-fcd2d7747335,"Arena Pharmaceuticals, Inc",arena_pharmaceuticals_inc,,,,,, -8179,,f9749641-97ce-4e05-bf32-145579241257,Piramal Imaging Ltd,piramal_imaging_ltd,,,,,, -8180,,59c9c9e6-a4fc-42f0-98f1-a4c88fde7fd6,PPM Services S.A,ppm_services_s_a,,,,,, -8181,,e2e5a25f-7d47-4f42-a033-c2772500fa45,ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP),assistance_publique_hopitaux_de_paris_ap_hp,,,,,, -434,0.96951077381769812,e7b829c7-a7ce-48d5-bd1d-1955f907d55a,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017 US",pfizer_inc_235_east_42nd_street_new_york_ny_10017_us,,,,0068e377-8873-41b9-baad-e3768b77d0b1,pfizer_inc_235_east_42nd_street_new_york_ny_10017,"Pfizer Inc., 235 East 42nd Street, New York, NY 10017" -8182,,8118b531-0772-4e7b-990c-42827dbb38d4,Great Ormond Street Hospital NHS foundation Trust,great_ormond_street_hospital_nhs_foundation_trust,,,,,, -8183,,64c99dec-af40-4072-bbc6-84e39a231505,University Southampton Hospital NHS Foundation Trust,university_southampton_hospital_nhs_foundation_trust,,,,,, -8184,,d05bbe40-71d0-11e6-a0cd-0242ac12000b,US ARMY,us_army,,,,,, -8185,,1910cec6-52a0-4232-92d7-e466fed816bd,Institutionen för kirurgiska vetenskaper,institutionen_f_r_kirurgiska_vetenskaper,,,,,, -8186,,ecf40dee-7272-11e6-a0cd-0242ac12000b,IMCOR PHARMS CO,imcor_pharms_co,,,,,, -8187,,b6e2a301-a37f-40fb-8d17-66216ba19516,Synlogic,synlogic,,,,,, -8188,,a98c8ad8-1c03-43f0-8edb-f8e1d15e601b,Thornton & Ross Limited,thornton_ross_limited,,,,,, -8189,,73bba6f8-01f0-45d6-9b2e-c17604f51582,"University of Warwick, Research Support Services",university_of_warwick_research_support_services,,,,,, -8190,,3d56ebdd-2cfc-496e-a75b-c90f9b24d829,Unitat de Recerca en Pediatria Nutrició i Desenvolupament Humà,unitat_de_recerca_en_pediatria_nutrici_i_desenvolupament_hum,,,,,, -8191,,066b166a-abbd-49ec-86ec-26d9d06ace8b,The Royal Marsden NHS Foundation Trust,the_royal_marsden_nhs_foundation_trust,,,,,, -8192,,343a8a09-0571-4e4a-83ad-37e95b08f185,"Universith Hospital of Heraklion, Department of Medical Oncology",universith_hospital_of_heraklion_department_of_medical_oncology,,,,,, -8193,,67f1f850-715e-11e6-a0cd-0242ac12000b,HEXCEL,hexcel,,,,,, -8194,,06f68866-acf6-488c-80f4-a3697ceb8f5f,Department of Medical Research,department_of_medical_research,,,,,, -8195,,2a17ef9e-29f2-4dd7-9c84-48e36e0e7d57,ISTITUTO NAZIONALE DELLE MALATTIE INFETTIVE LAZZARO SPALLANZANI,istituto_nazionale_delle_malattie_infettive_lazzaro_spallanzani,,,,,, -567,0.985423,f327c818-7146-11e6-a0cd-0242ac12000b,NOSTRUM LABS,nostrum_labs,,,,0b85e728-7142-11e6-a0cd-0242ac12000b,nostrum_labs_inc,NOSTRUM LABS INC -8196,,3d28cde6-0cff-4f9b-9cfa-5fc2ffebe8d2,EUTHERAPIE pour le compte du promoteur Les Laboratoires Servier,eutherapie_pour_le_compte_du_promoteur_les_laboratoires_servier,,,,,, -8197,,64caf106-497e-4848-9d23-9d2a9bbd6beb,Raptor Pharmaceuticals Inc,raptor_pharmaceuticals_inc,,,,,, -51,0.98173725605010986,8b6c5421-c89a-418f-8c10-e2badcce65ee,Pfizer Ltd,pfizer_ltd,,,,8b6c5421-c89a-418f-8c10-e2badcce65ee,pfizer_ltd,Pfizer Ltd -8198,,344e1803-a0b2-4b87-aa55-a240f8f57abe,Cipla Ltd,cipla_ltd,,,,,, -8199,,9bbc60ff-bca3-4be2-849f-358b108ccd3d,Cipla Limited,cipla_limited,,,,,, -8200,,64a12104-f1d8-4016-8120-384c97f5d7bb,Servicio de Neurología,servicio_de_neurolog_a,,,,,, -8201,,7db2fa6e-7167-11e6-a0cd-0242ac12000b,GLOBAL ISOTOPES LLC,global_isotopes_llc,,,,,, -8202,,230518f6-6fa3-11e6-9663-0242ac12000b,"Universität Mainz, Klinik und Poliklinik für Kinder- und Jugendpsychiatrie und -psychotherapie",universit_t_mainz_klinik_und_poliklinik_f_r_kinder_und_jugendpsychiatrie_und_psychotherapie,,,,,, -8203,,30a06ace-bc70-44ee-be18-300e9124f9bf,ASOCIACION TERAPEUTICA EN HEMATOLOGIA Y ONCOLOGIA MEDICAS DEL HOSPITAL ARNAU DE VILANOVA DE VALENCIA,asociacion_terapeutica_en_hematologia_y_oncologia_medicas_del_hospital_arnau_de_vilanova_de_valencia,,,,,, -8204,,7cfa3175-349c-4787-bab9-8dcdea518756,AB SCIENCE,ab_science,,,,,, -8205,,c6253b7c-73b1-4d49-b755-baa65d4774e9,Vifor Pharma - Vifor (International) AG,vifor_pharma_vifor_international_ag,,,,,, -8206,,98fc55bc-1377-4a54-b47f-9ac59d807781,GON-North Oncology Group,gon_north_oncology_group,,,,,, -8207,,08360562-7129-11e6-a89e-0242ac12000b,TG UNITED INC,tg_united_inc,,,,,, -8208,,09a98c52-7174-11e6-a0cd-0242ac12000b,IMCLONE,imclone,,,,,, -94,0.97634196281433105,49d3c978-7273-11e6-a0cd-0242ac12000b,JAZZ PHARMS,jazz_pharms,,,,49d3c978-7273-11e6-a0cd-0242ac12000b,jazz_pharms,JAZZ PHARMS -8209,,9f4273f8-bd12-4481-abcd-c79f1a30aea2,Ipsen Pharma,ipsen_pharma,,,,,, -8210,,950889ea-7383-11e6-a0cd-0242ac12000b,GALEN (UK),galen_uk,,,,,, -448,0.984608,f5097cb3-2952-440e-8c47-befec4756e09,Oslo University Hospital Rikshospitalet,oslo_university_hospital_rikshospitalet,,,,a6dd2c28-7928-45f0-bda2-157de4bfe0f0,oslo_university_hospital,Oslo University Hospital -8211,,8a7d4729-9b10-46e7-8e93-84744a70d79a,Biogen Idec Hemophilia Inc,biogen_idec_hemophilia_inc,,,,,, -8212,,7327ddb0-495f-49bd-a11d-f351870185f6,Cassella-med GmbH & Co. KG,cassella_med_gmbh_co_kg,,,,,, -8213,,7c138ab8-a733-4aa9-ab73-4de2ddb6ba7a,IOBA. FACULTAD DE MEDICINA,ioba_facultad_de_medicina,,,,,, -874,0.982418,9a9b0d73-4c19-414c-81d5-34f7fec18808,InterMune,intermune,,,,7980a7c5-e0b0-4bbe-8695-41376036421e,intermune_inc,"InterMune, Inc" -8214,,07b0a5cf-57d9-4843-a7a0-3e93ba58dfb3,Dansk Multipel Sclerose Center,dansk_multipel_sclerose_center,,,,,, -8215,,008a48ab-3ff4-4ef4-91cd-430adee111e6,Department of Experimental Clinical Oncology,department_of_experimental_clinical_oncology,,,,,, -718,0.970142,7d140a5d-838e-4824-90c7-b17c12e4b7aa,"Med. Uni. Wien, Klinik f. Innere Med. I",med_uni_wien_klinik_f_innere_med_i,,,,7d140a5d-838e-4824-90c7-b17c12e4b7aa,med_uni_wien_klinik_f_innere_med_i,"Med. Uni. Wien, Klinik f. Innere Med. I" -8216,,c7f537ae-c907-4e59-880b-13d0d15711ce,Stemcentrx Inc,stemcentrx_inc,,,,,, -900,0.955805,5e4c5fb0-cf4a-4b49-8740-5d768fd52e5f,Chiesi Farmaceurtici S.p.A,chiesi_farmaceurtici_s_p_a,,,,578a311e-a483-4d9f-906e-cd1723e08711,chiesi_farmaceutici_s_p_a,Chiesi Farmaceutici S.p.A -8217,,19ec98d9-36b0-4dd0-9928-7963865ffc54,Clinical Pharmacology,clinical_pharmacology,,,,,, -8218,,70fef5aa-e297-45f2-9c7f-95fe9d326052,Bernhard-Nocht-Institute for Tropical Medicine,bernhard_nocht_institute_for_tropical_medicine,,,,,, -8219,,359dc817-8c8d-49b4-9029-5c1014f91f65,"BIAL - PORTELA & Cª, S.A",bial_portela_c_s_a,,,,,, -8220,,b94571a0-b14f-487f-a95d-118b137c44a0,BIAL Industrial Farmaceutica,bial_industrial_farmaceutica,,,,,, -673,0.989076,c1332bd8-66ae-4f01-9ba1-489798992f6b,Procter & Gamble Pharmaceuticals,procter_gamble_pharmaceuticals,,,,9779b86f-f9d6-440c-b621-4e88837285aa,procter_gamble_pharmaceuticals_inc,Procter & Gamble Pharmaceuticals Inc -8221,,f4a2ba4a-ade1-4216-983d-581aab8a1354,Vericel Corporation,vericel_corporation,,,,,, -8222,,ff7cd26c-0558-4959-9c50-32c83c7bee83,BAZ Megyei és Egyetemi Oktató Kórház,baz_megyei_s_egyetemi_oktat_k_rh_z,,,,,, -8223,,2cb56330-c5ff-4ed8-9878-5a848ec9c097,Brighton and Sussex Universities Hospitals Trust Research and Development Directorate,brighton_and_sussex_universities_hospitals_trust_research_and_development_directorate,,,,,, -361,0.988596,ff3d535c-220e-4996-8ffc-f7e30ded2f46,Mitsubishi Tanabe Pharma Corporation,mitsubishi_tanabe_pharma_corporation,,,,7d7d20e5-897b-403b-ba75-22e35574cc70,mitsubishi_tanabe_pharma_corporation_mtpc,Mitsubishi Tanabe Pharma Corporation (MTPC) -8224,,000a6eb6-739d-11e6-a0cd-0242ac12000b,SMITH KLINE & FRENCH,smith_kline_french,,,,,, -8225,,2aaa8db3-1fab-43c4-b44b-5d726a6adfbe,"Istituto Nazionale Tumori di Napoli - Fondazione ""G. Pascale",istituto_nazionale_tumori_di_napoli_fondazione_g_pascale,,,,,, -560,0.97196030616760254,069a9622-502b-4a08-9b02-c54aa4d2410f,UZ Leuven Orthopedic research,uz_leuven_orthopedic_research,,,,069a9622-502b-4a08-9b02-c54aa4d2410f,uz_leuven_orthopedic_research,UZ Leuven Orthopedic research -8226,,816d98eb-f50f-4289-bcce-4b82bfdd13df,CENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA,centro_di_riferimento_oncologico_di_basilicata,,,,,, -8227,,6013e0a0-7161-11e6-a0cd-0242ac12000b,HALSEY,halsey,,,,,, -8228,,fbbb3424-c9a3-4df9-9c09-aa2621392cee,Dr. Benedicto Crespo. Servicio Psiquiatría. Hospital Universitario Marqués de Valdecilla/IDIVAL,dr_benedicto_crespo_servicio_psiquiatr_a_hospital_universitario_marqu_s_de_valdecilla_idival,,,,,, -8229,,64127be3-e43e-4422-9946-40ea16a8d6e5,Laboratoires NEGMA,laboratoires_negma,,,,,, -8230,,01580d20-17fb-47cb-bf51-f4a2464eafb3,Advanced Life Sciences,advanced_life_sciences,,,,,, -572,0.98045754432678223,1a257ae6-dfb7-4d55-a187-ee6edac2cd0e,"Human Genome Sciences, Inc. (a wholy owned subsidiary of GlaxoSmithKline PLC)",human_genome_sciences_inc_a_wholy_owned_subsidiary_of_glaxosmithkline_plc,,,,e3bdd826-4b43-4d33-8f70-20154485e250,human_genome_sciences_inc_a_wholy_owned_subsidiary_of_glaxosmithkline_plc,"Human Genome Sciences, Inc. (a wholy owned subsidiary of GlaxoSmithKline PLC)" -8231,,0b03436c-dead-4bec-8f57-929a754ac769,ALIANZA ESPAÑOLA DE FAMILIAS DE VON HIPPEL-LINDAU,alianza_espa_ola_de_familias_de_von_hippel_lindau,,,,,, -8232,,f09a409a-73f7-11e6-a0cd-0242ac12000b,PHARMA-MED INC,pharma_med_inc,,,,,, -8233,,fdedad7a-d7f7-44f1-9681-c86958017650,"Schwarz Pharma Deutschland GmbH, UCB Group",schwarz_pharma_deutschland_gmbh_ucb_group,,,,,, -8234,,2e4e72d5-1747-444d-9a75-ae5bc33d4d8e,Servicio de Cardiología. Hospital Universitario Vall d'Hebron,servicio_de_cardiolog_a_hospital_universitario_vall_d_hebron,,,,,, -8235,,2907c943-c599-4048-8b54-35122c367da5,Zambon S.p.A,zambon_s_p_a,,,,,, -8236,,432437e7-2e26-4211-a476-199412aacd08,GIMURELL,gimurell,,,,,, -407,0.97243720293045044,ceae0da9-2308-4872-84ed-3463deeef673,Trius Therapeutics,trius_therapeutics,,,,2313c489-596d-4d80-8c94-aa42d3a2f015,trius_therapeutics_a_wholly_owned_subsidiary_of_cubist,"Trius Therapeutics, a Wholly Owned Subsidiary of Cubist" -8237,,f5611b56-48ab-4d5c-8511-7bf9071e3533,MERCK S.P.A,merck_s_p_a,,,,,, -8238,,d395f842-c3af-458c-b027-db2cc9fbacb4,BAYER Vital GmbH,bayer_vital_gmbh,,,,,, -8239,,6037c4d6-7b28-48c4-b0c0-85c95a7e97f1,Dept of Medicine,dept_of_medicine,,,,,, -8240,,f907adc6-48a6-4d39-a1b2-8733495bd7f1,Laboratorios Menarini S.A. (Menarini Group),laboratorios_menarini_s_a_menarini_group,,,,,, -72,0.97601744532585144,f472ce29-7313-451a-974c-278d593159c6,Takeda Global Research & Development Centre (Europe) Ltd,takeda_global_research_development_centre_europe_ltd,,,,a359d331-932d-4716-9cec-7901baf5cc1b,takeda_global_research_development_centre_europe_ltd,Takeda Global Research & Development Centre (Europe) Ltd -694,0.97987914085388184,880cc43e-be86-46ae-9cc8-d02db6c6e6ea,Krankenhaus Nordwest,krankenhaus_nordwest,,,,a1b6c5f2-16df-4bac-b6d9-a19ab340e9dd,krankenhaus_nordwest,Krankenhaus Nordwest -8241,,3523e024-9a03-4f1b-8763-40dd5ddcfe6b,Laboratoires Fournier S.A. A Solvay Pharmaceuticals company,laboratoires_fournier_s_a_a_solvay_pharmaceuticals_company,,,,,, -8242,,6cbaf138-7196-11e6-a0cd-0242ac12000b,SHIRE LLC,shire_llc,,,,,, -8243,,b101cbe0-e24a-40cc-a47e-318677f4a2a7,NUTRIALYS,nutrialys,,,,,, -8244,,5cec4dde-7d5b-4c2e-8cd3-086c7fbda6ea,Josep Llop Talaveron,josep_llop_talaveron,,,,,, -8245,,7b4cc2e3-082e-4f42-b03e-c3546722cdf3,G. Pohl-Boskamp GmbH & Co. KG,g_pohl_boskamp_gmbh_co_kg,,,,,, -8246,,f41ce989-afaa-4740-8cb8-341d3c32ea02,"CombinatoRx, Incorporated",combinatorx_incorporated,,,,,, -1008,0.951024,4614bd92-4210-4230-a954-64c1de5fddc0,AOP Orphan Pharmaceuticals AG,aop_orphan_pharmaceuticals_ag,,,,4614bd92-4210-4230-a954-64c1de5fddc0,aop_orphan_pharmaceuticals_ag,AOP Orphan Pharmaceuticals AG -8247,,bd214773-2f3d-48a6-bb0b-f632859c3a35,"Medical Faculty, University of Bonn",medical_faculty_university_of_bonn,,,,,, -8248,,ae08b3ae-65fd-4290-92fb-f0059bd48e27,University Clinic Internal Medicine I,university_clinic_internal_medicine_i,,,,,, -8249,,e2727f47-854a-46eb-b9aa-abb2febd3703,East Kent Hospitals NHS Trust,east_kent_hospitals_nhs_trust,,,,,, -340,0.98418444395065308,02763460-e885-4cb3-a951-4a777203fe35,Intercytex Ltd,intercytex_ltd,,,,02763460-e885-4cb3-a951-4a777203fe35,intercytex_ltd,Intercytex Ltd -8250,,a832e85a-a74a-11e6-94cb-5656d04fc2b5,ELKE University of Athens,elke_university_of_athens,,,,,, -8251,,91776793-48bb-4dcd-9c9b-eabbf98fa200,Fundación CRIS de investigación para vencer el cáncer,fundaci_n_cris_de_investigaci_n_para_vencer_el_c_ncer,,,,,, -8252,,661c90db-0b23-478c-acc7-462dd968796f,ZLB Behring AG,zlb_behring_ag,,,,,, -8253,,52d63ae0-feeb-41a8-8617-a5c7e0f87580,Faron Pharmaceuticals Ltd,faron_pharmaceuticals_ltd,,,,,, -8254,,2f047bee-73d9-11e6-a0cd-0242ac12000b,JANSSEN THERAP,janssen_therap,,,,,, -8255,,66232373-5a4a-45b5-8bca-43d2cfe3a719,Fundación para la Investigación Biomédica Hospital Universitario Niño Jesús,fundaci_n_para_la_investigaci_n_biom_dica_hospital_universitario_ni_o_jes_s,,,,,, -8256,,da38c504-ca1b-4b83-a79b-d68311818476,Bio Minerals n.v,bio_minerals_n_v,,,,,, -8257,,f308604c-1efd-4802-99d1-290e9d5c2285,"Kyowa Hakko Kirin Pharma, Inc",kyowa_hakko_kirin_pharma_inc,,,,,, -8258,,5a6f2389-699e-4e22-99d2-adb49d4197e5,"Inovio Pharmaceuticals, Inc",inovio_pharmaceuticals_inc,,,,,, -680,0.981011,d5bad664-fff4-4066-a3d3-cc7450a05435,"Clinical Reasearch Centre, Hvidovre University Hospital",clinical_reasearch_centre_hvidovre_university_hospital,,,,d5bad664-fff4-4066-a3d3-cc7450a05435,clinical_reasearch_centre_hvidovre_university_hospital,"Clinical Reasearch Centre, Hvidovre University Hospital" -8259,,0b577fba-8d73-45f6-bcaa-5e7000a9dfe5,GELARC,gelarc,,,,,, -8260,,55c406e0-07d7-49d7-ba02-8fd548f48e86,ViiV Healthcare UK Limited,viiv_healthcare_uk_limited,,,,,, -8261,,be78c044-e3c8-4f07-bd1f-f6113fe926d6,"Afferent Pharmaceuticals, Inc",afferent_pharmaceuticals_inc,,,,,, -254,0.941004,39dca129-d0ba-442a-99f7-f8ceeb2ad28b,GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD,glaxosmithkline_research_development_ltd,,,,07cef69a-6d39-498c-b1f5-a59bab4b33b0,glaxo_smith_kline_research_development_ltd,GLAXO SMITH KLINE RESEARCH & DEVELOPMENT LTD -8262,,d9bba284-1114-4fb3-8d17-a67bdc2d074f,Prof. Dr. H. Lode,prof_dr_h_lode,,,,,, -8263,,3835f6e5-d0ac-4017-867a-672e7a7f9540,Vilnius University Hospital Santariskiu Clinics,vilnius_university_hospital_santariskiu_clinics,,,,,, -8264,,61a40486-4235-4bbb-a6f6-6b7ab4d13c86,AZIENDA USL 6 LIVORNO ZONA LIVORNESE,azienda_usl_6_livorno_zona_livornese,,,,,, -8265,,ec946aaf-a357-436a-bce9-2cc7c176e133,Oxagen Ltd,oxagen_ltd,,,,,, -8266,,2e80275e-7163-11e6-a0cd-0242ac12000b,COBREK PHARMA,cobrek_pharma,,,,,, -8267,,ec522df6-fe69-4c9a-aa12-51b0a4ba14b2,Immanuel Krankenhaus Berlin,immanuel_krankenhaus_berlin,,,,,, -8268,,e02a2e80-ae87-4c91-9803-6b55fdb84cf8,Tacurion Pharma Inc,tacurion_pharma_inc,,,,,, -8269,,e9c63d24-e393-4614-8796-ddfa5f7c64cb,Oxford University Hospitals NHS Trust,oxford_university_hospitals_nhs_trust,,,,,, -8270,,2934b0cb-1068-47e8-a0f6-86ead774706e,"Center for Cancer Immunotherapy (CCIT) / Department of Oncology, Herlev Hospital",center_for_cancer_immunotherapy_ccit_department_of_oncology_herlev_hospital,,,,,, -8271,,c4e6eb42-5480-4f58-8f5d-511e78b3b307,Yakult Honsha Co,yakult_honsha_co,,,,,, -8272,,d16e6416-016e-467e-b2c7-f17ed8c2ad67,University of Helsinki,university_of_helsinki,,,,,, -8273,,ebbad122-2b4e-44f9-9c51-f6fc69442e94,CENTRO STUDI FADOI,centro_studi_fadoi,,,,,, -8274,,39e87b70-60f4-4c21-8945-08e6f5415f0d,MULTIMEDICA S.P.A,multimedica_s_p_a,,,,,, -1072,0.959984,0e59fcb8-db64-490f-b629-84fe6f12827e,Danish Breast Cancer Group (DBCG),danish_breast_cancer_group_dbcg,,,,0e59fcb8-db64-490f-b629-84fe6f12827e,danish_breast_cancer_group_dbcg,Danish Breast Cancer Group (DBCG) -8275,,52bf3192-7ab3-4c74-a250-abbe9f5a2152,"Merck, sharp & Dohme (Human Health) Ltd",merck_sharp_dohme_human_health_ltd,,,,,, -52,0.970647,042feb9c-2ed7-4ad5-bdb8-f388835c0c2d,AIBILI (EVICR.net),aibili_evicr_net,,,,042feb9c-2ed7-4ad5-bdb8-f388835c0c2d,aibili_evicr_net,AIBILI (EVICR.net) -8276,,b3a8f4b8-cd50-4ec2-a1ab-d3ba6aef5ce4,IMAS,imas,,,,,, -8277,,6edc0a45-7155-4c85-b786-c5e641e23b0b,Johnson and Johnson,johnson_and_johnson,,,,,, -8278,,942f1d1d-5318-447d-a537-a572468158b4,"Pfizer, Spain",pfizer_spain,,,,,, -1076,0.960954,045cfbfc-1ceb-4114-9b7b-c749009a8f56,"Dep. of Ophthalmology, Medical University of Vienna",dep_of_ophthalmology_medical_university_of_vienna,,,,045cfbfc-1ceb-4114-9b7b-c749009a8f56,dep_of_ophthalmology_medical_university_of_vienna,"Dep. of Ophthalmology, Medical University of Vienna" -8279,,41746710-2c26-483b-a0d6-8b198a447af5,"Zealand University Hospital, Department of Surgery",zealand_university_hospital_department_of_surgery,,,,,, -8280,,b8addf56-1f13-4a88-89fe-26341bc7bfa5,Menarini Ricerche Spa,menarini_ricerche_spa,,,,,, -8281,,100353bb-754a-4d58-aa2d-b5b2b483acc6,Asociación Dr. Peset para el estudio de la Hematología (ADOPEH),asociaci_n_dr_peset_para_el_estudio_de_la_hematolog_a_adopeh,,,,,, -8282,,a5244759-edb9-4107-bb10-a9729337da38,Schering-Plough S.A. de C.V,schering_plough_s_a_de_c_v,,,,,, -8283,,8ddf3bea-8979-4bb5-8a3e-60dc39e97bd1,Dra. Martinez Payo-Hospital Universitario Puerta de Hierro,dra_martinez_payo_hospital_universitario_puerta_de_hierro,,,,,, -8284,,286f9c42-73ec-11e6-a0cd-0242ac12000b,INSYS DEV CO INC,insys_dev_co_inc,,,,,, -778,0.982179,4711b905-98c1-448d-aed0-2e1a54f407bf,Medica Scientia Innovation Research (MedSIR),medica_scientia_innovation_research_medsir,,,,09db9c0d-772c-417a-b2dd-c0f3dd272e65,medica_scientia_innovation_research_medsir_aro,Medica Scientia Innovation Research (MedSIR ARO) -8285,,61797f1f-f2f0-4bfd-affe-6dd965bee819,Hyperion Therapeutics Limited,hyperion_therapeutics_limited,,,,,, -8286,,0e1eb050-7142-11e6-a0cd-0242ac12000b,WYETH AYERST,wyeth_ayerst,,,,,, -8287,,a881df9e-fbe6-47c1-922a-00396ecfbfdc,Laboratoires Leurquin Mediolanum S.A.S,laboratoires_leurquin_mediolanum_s_a_s,,,,,, -8288,,87fceeec-f896-4a33-a509-b3e3dbe4d827,"Inmunotek, S.L",inmunotek_s_l,,,,,, -8289,,bb07b5eb-80aa-4cee-9b33-c66f8d402c20,"Hyperion Therapeutics, Inc",hyperion_therapeutics_inc,,,,,, -99,0.9399416446685791,5769e276-4f89-42a2-bd02-826e652c6714,Novartis Farmaceútica,novartis_farmace_tica,,,,bcb0e637-6442-4916-88f9-8cd0d5df3534,novartis_farmaceutica,Novartis Farmaceutica -566,0.961636,e1050e70-ebfb-4325-a452-2df529eb6225,"ARIAD Pharmaceuticals, Inc",ariad_pharmaceuticals_inc,,,,b7bdd038-73c6-11e6-a0cd-0242ac12000b,ariad,ARIAD -1044,0.988488,8cc0218b-399d-46ee-a2f5-9edb9d7f5a91,Intercept Pharmaceuticals,intercept_pharmaceuticals,,,,8cc0218b-399d-46ee-a2f5-9edb9d7f5a91,intercept_pharmaceuticals,Intercept Pharmaceuticals -8290,,d6596d60-82b5-4148-9354-d7a0decace0f,Gunnar Hillerdal,gunnar_hillerdal,,,,,, -8291,,62268e07-069f-4caa-9a14-3afb8256af44,CeNeS Ltd,cenes_ltd,,,,,, -320,0.97903996706008911,73ddd4a0-7126-11e6-8a77-0242ac12000b,FRESENIUS,fresenius,,,,2cc9c0de-712a-11e6-a89e-0242ac12000b,fresenius_kabi_usa,FRESENIUS KABI USA -8292,,85e282c0-155f-4868-b543-638bb3f74456,"Cadence Pharmaceuticals, Inc",cadence_pharmaceuticals_inc,,,,,, -8293,,e7aab02b-5c15-426d-b568-297b01455a90,Charite Universitätsmedizin Berlin,charite_universit_tsmedizin_berlin,,,,,, -8294,,092e12e5-1e38-4c8e-b432-6bb14f5b8d9b,NHS Lothian R&D Office,nhs_lothian_r_d_office,,,,,, -8295,,0a7548ff-0f7f-41b3-a5e5-9678e4a1d734,"Medizinische Universität Wien, Univ.Klinik f.Radiodiagnostik",medizinische_universit_t_wien_univ_klinik_f_radiodiagnostik,,,,,, -8296,,ff78da4b-b446-4be9-bfc5-3799176f007c,"GlaxoSmtihKline, S.A",glaxosmtihkline_s_a,,,,,, -8297,,28702a80-d580-4c85-8150-d756dc43353a,Zentiva a.s,zentiva_a_s,,,,,, -8298,,7d8b7215-736c-477d-aadc-4856bcb75963,Wilhelminen Krebsforschung GmbH,wilhelminen_krebsforschung_gmbh,,,,,, -8299,,7df41777-38cb-436a-9c6c-74b1ce896044,Genticel,genticel,,,,,, -8300,,40a82c90-d135-4e70-a1e4-4dc62af9d871,UCB Biopharma SPRL,ucb_biopharma_sprl,,,,,, -8301,,d67d64fd-4fce-4342-9491-b3f428fa7881,Roessingh Research and Development,roessingh_research_and_development,,,,,, -8302,,cfa945b6-c0bb-4a90-9b99-e443a0bbed72,Fundació Clínic de Recerca Biomèdica,fundaci_cl_nic_de_recerca_biom_dica,,,,,, -8303,,17b9dd5c-7189-4cfe-b93e-be38f1936c24,Ass.Prof. Petros Sfikakis,ass_prof_petros_sfikakis,,,,,, -8304,,c3b3def0-19ab-462f-8a50-0167aa4d49b5,GALENICA S.A,galenica_s_a,,,,,, -8305,,82515351-dbe9-473a-978d-4a79142b7a17,Niels Jørgen Secher,niels_j_rgen_secher,,,,,, -8306,,69565db0-7142-11e6-a0cd-0242ac12000b,ALCON PHARMS LTD,alcon_pharms_ltd,,,,,, -8307,,8622c0d2-2bf6-42bc-b9b1-aaff37e076b7,AXCAN PHARMA SAS,axcan_pharma_sas,,,,,, -8308,,f588856a-e6c2-4254-8dcf-e2cf5a018a52,North West Wales NHS Trust,north_west_wales_nhs_trust,,,,,, -8309,,80d80609-e1d3-4b53-bb7a-d3b8a28991ef,ImClone LLC,imclone_llc,,,,,, -8310,,f0af7e93-ed81-42a4-8df5-b8d353d9708b,Erasmus MC Cancer Institute,erasmus_mc_cancer_institute,,,,,, -8311,,5f6f0660-ca2e-4862-9112-805151a940f5,Dr. José García-Arumí,dr_jos_garc_a_arum,,,,,, -331,0.98589098453521729,6a2933b8-7145-11e6-a0cd-0242ac12000b,PURACAP PHARM,puracap_pharm,,,,5b0547b4-7168-11e6-a0cd-0242ac12000b,puracap_pharm_llc,PURACAP PHARM LLC -77,0.942699,d30fb26a-8bbe-11e6-a449-0242ac12000b,ITF Research Pharma SLU,itf_research_pharma_slu,,,,56d56d9c-d583-406f-8098-1497a470593d,itf_research_pharma_s_l_u,ITF Research Pharma S.L.U -8312,,cf884ca1-a710-47cc-8a27-06429a805cdd,Aimmune Therapeutics Inc,aimmune_therapeutics_inc,,,,,, -8313,,c6e7bf5e-2220-4e06-824f-1b6b0c290c32,CARDIOLOGIA UNIVERSITARIA - OSPEDALE CLINICIZZATO SS. ANNUNZIATA - VIA DEI VESTINI - 66013 CHIETI,cardiologia_universitaria_ospedale_clinicizzato_ss_annunziata_via_dei_vestini_66013_chieti,,,,,, -117,0.965586,66c99c0f-befb-4321-8842-bd1047513dac,UMCN farm-tox,umcn_farm_tox,,,,66c99c0f-befb-4321-8842-bd1047513dac,umcn_farm_tox,UMCN farm-tox -8314,,d8eb6d13-6b6d-41d4-9ada-e97bf898176b,KABI PHARMACIA S.A,kabi_pharmacia_s_a,,,,,, -8315,,2caee7ad-6a77-489b-a44c-85a06d220d08,"Celgene Corporation, Inc",celgene_corporation_inc,,,,,, -8316,,dbb52f33-a8fc-4aa5-b128-948fe7582742,"Medizinische Universität Wien, Abteilung für Allgemeine Anästhesie und Intensivmedizin",medizinische_universit_t_wien_abteilung_f_r_allgemeine_an_sthesie_und_intensivmedizin,,,,,, -8317,,1397390d-ea51-437d-afbe-9edaf20e47cf,"Department of Ophthalmology, Bonn University",department_of_ophthalmology_bonn_university,,,,,, -8318,,e26593c0-6e34-42e6-809d-7870ae522f4b,Astellas Europe Pharma B.V,astellas_europe_pharma_b_v,,,,,, -8319,,fd429b72-8214-4546-9999-5068796657fa,Celltech R&D Ltd,celltech_r_d_ltd,,,,,, -8320,,8cb4281e-f70a-43d0-aedb-1b9b3ae945fa,Bracco Imaging Deutschland GmbH,bracco_imaging_deutschland_gmbh,,,,,, -8321,,87e85eff-7236-459b-bf65-13f376005db3,KYOWA HAKKO UK LTD,kyowa_hakko_uk_ltd,,,,,, -8322,,5cb11105-efb7-4148-9b3c-9825a2705fb5,AZIENDA PER I SERVIZI SANITARI 1 TRIESTINA,azienda_per_i_servizi_sanitari_1_triestina,,,,,, -8323,,e22f8291-7181-428b-80c2-53e1bd423a77,Sanofi Pasteur Limited,sanofi_pasteur_limited,,,,,, -646,0.98875898122787476,df53fa2b-d0e4-4bc4-9e98-e8d79a1d3719,Boehringer Ingelheim Ellas,boehringer_ingelheim_ellas,,,,237ec247-b474-4bd6-9041-c2ffb0213c0e,boehringer_ingelheim_ellas,Boehringer Ingelheim Ellas -8324,,a62f4e3e-7f6d-4757-b7e8-0fdd7af6b12e,Algipharma AS,algipharma_as,,,,,, -8325,,9283ffc4-71ad-11e6-a0cd-0242ac12000b,CUTIS HEALTH LLC,cutis_health_llc,,,,,, -8326,,b0a72673-e282-4445-800d-21b90532bf27,Pfizer Inc. 235 East 42nd Street NY10017,pfizer_inc_235_east_42nd_street_ny10017,,,,,, -8327,,5067234b-0ceb-42e3-92f0-ead59f0d258a,Eero Pesonen,eero_pesonen,,,,,, -8328,,5a598abe-8815-11e6-a998-0242ac12000b,"Pfizer Global Research & Development, La Jolla Laboratories",pfizer_global_research_development_la_jolla_laboratories,,,,,, -357,0.987372,98bac61e-5a35-4e65-bf8a-564c1eac1911,"Flexion Therapeutics, Inc",flexion_therapeutics_inc,,,,98bac61e-5a35-4e65-bf8a-564c1eac1911,flexion_therapeutics_inc,"Flexion Therapeutics, Inc" -8329,,5a4b5e79-7832-4081-a61f-42ebcce353d4,Fundación Castellano Leonesa de Hematología y Hemoterapia (FUCALHH),fundaci_n_castellano_leonesa_de_hematolog_a_y_hemoterapia_fucalhh,,,,,, -8330,,d0aeb96f-5b11-4b42-816d-69232a6b5d89,"Odense University Hospital, department M",odense_university_hospital_department_m,,,,,, -8331,,7ad1ba81-70e0-467e-b92e-ae9ec454b588,PregLem S.A,preglem_s_a,,,,,, -8332,,23f62bcb-7340-4b5d-ab3a-4fb07163dc3f,Saint-Luc Universitary Hospital,saint_luc_universitary_hospital,,,,,, -8333,,202b3225-dfd9-4d2c-a876-1f26afd4006c,"Med. Univ. Wien, Universitätsklinik f. Innere Medizin III, Abt. f. Nephrologie und Dialyse",med_univ_wien_universit_tsklinik_f_innere_medizin_iii_abt_f_nephrologie_und_dialyse,,,,,, -8334,,93033a1c-7164-11e6-a0cd-0242ac12000b,PHARMACEUTICS,pharmaceutics,,,,,, -8335,,609b46bb-fc76-4f43-9656-1dcaa605750a,Henogen,henogen,,,,,, -8336,,e436b602-e523-4488-bba2-a754516e2077,Moorfields Eye Hospital NHS Foundation Trust,moorfields_eye_hospital_nhs_foundation_trust,,,,,, -713,0.96376720070838928,f7b23b22-4644-47ad-9c6e-27b5eb54a6b6,"Wyeth Pharmaceuticals Inc., a wholly owened subsidiary of Pfizer Inc, 500 Arcola Road, collegeville, PA 19426 USA",wyeth_pharmaceuticals_inc_a_wholly_owened_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,,,,d2f1d48d-c243-473b-9f47-208723250aa6,wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA" -8337,,a93b7b8e-6f9b-11e6-9663-0242ac12000b,"Dep. of Cancer Research and Molecular medicine, Norwegian University of Science and Technology",dep_of_cancer_research_and_molecular_medicine_norwegian_university_of_science_and_technology,,,,,, -830,0.980344,6d67120f-5e5c-4a5b-851a-6e2fbcc36876,GENFIT,genfit,,,,223e6632-3388-4cba-ab58-ea9c133365de,genfit_sa,GENFIT SA -8338,,b40718f1-40a7-49bc-ad0c-5835c1cc2014,GlaxoSmithKline SA,glaxosmithkline_sa,,,,,, -8339,,337e610b-d92f-47ee-8c2e-c463c94540c8,"Department of Thoracic and Hyperbaric Surgery, University Medical School Graz",department_of_thoracic_and_hyperbaric_surgery_university_medical_school_graz,,,,,, -6,0.98172008991241455,3a96a924-5942-47f4-be4b-f7f2f104395e,"Centre Hospitalier Universitaire de Montpellier Direction Recherche, Qu",centre_hospitalier_universitaire_de_montpellier_direction_recherche_qu,,,,17ea9e87-8473-4174-a0be-01570daa58e8,centre_hospitalier_universitaire_de_montpellier,Centre Hospitalier Universitaire de Montpellier -551,0.9728655219078064,0aa6ecae-1a53-4cf9-8648-924415ffb218,Freistaat Bayern,freistaat_bayern,,,,0aa6ecae-1a53-4cf9-8648-924415ffb218,freistaat_bayern,Freistaat Bayern -8340,,0bca2828-7167-11e6-a0cd-0242ac12000b,QILU PHARM CO LTD,qilu_pharm_co_ltd,,,,,, -8341,,f45190a9-ad50-4b24-89ce-d6670cb7c32d,University Hospital of Toulouse,university_hospital_of_toulouse,,,,,, -8342,,cbafe5c4-8603-4d60-8f15-5607d861ac5c,Medizinische Universität Graz_Universitätsklinik für Innere Medizin_Diabetes und Stoffwechsel,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_diabetes_und_stoffwechsel,,,,,, -8343,,aa41a384-ebac-4a44-8acc-4b8890ece3f1,FUNDATION OF EXPERIMENTAL AND CLINICAL ONCOLOGY,fundation_of_experimental_and_clinical_oncology,,,,,, -373,0.91557258367538452,f2d6af42-c47f-49ae-b4b6-a023a2b2f116,Merck Sharp & Dohme GmbH,merck_sharp_dohme_gmbh,,,,f2d6af42-c47f-49ae-b4b6-a023a2b2f116,merck_sharp_dohme_gmbh,Merck Sharp & Dohme GmbH -8344,,b6ccaa8a-715c-11e6-a0cd-0242ac12000b,ANTARES PHARMA INC,antares_pharma_inc,,,,,, -8345,,a2b0c28c-73de-11e6-a0cd-0242ac12000b,PROVEPHARM SAS,provepharm_sas,,,,,, -8346,,eedcfce8-c14f-485a-8eb3-ca8f999e6580,Onze-Lieve-Vrouw Ziekenhuis,onze_lieve_vrouw_ziekenhuis,,,,,, -8347,,10ee28e9-980e-4b29-a03b-fa30152016e3,ObsEva SA,obseva_sa,,,,,, -8348,,c39a8ab6-00d9-4238-9cb5-032d85406703,Centre Hospitalier de Tourcoing,centre_hospitalier_de_tourcoing,,,,,, -46,0.972279,e7215871-9562-4b99-96e9-3250b272830d,Alloksys Life Sciences B.V,alloksys_life_sciences_b_v,,,,286d0033-04c6-4cd9-8601-edb31d1bee9f,alloksys_life_sciences_bv,Alloksys Life Sciences BV -8349,,f6fcdcf0-7144-11e6-a0cd-0242ac12000b,PLIVA HRVATSKA DOO,pliva_hrvatska_doo,,,,,, -722,0.971833,fbd6a53b-5a7b-4893-8296-054ca15bada6,"Sven O. Skouby, Professor, MD, DMSc. Unit of reproductive Medicine, Herlev/Gentofte Hospital",sven_o_skouby_professor_md_dmsc_unit_of_reproductive_medicine_herlev_gentofte_hospital,,,,d849df4a-222c-4517-b78c-1f8d3369f7eb,sven_olaf_skouby_professor_md_dmsc_unit_of_reproductive_medicine_herlev_gentofte_hospital,"Sven Olaf Skouby, Professor, MD, DMSc. Unit of Reproductive Medicine, Herlev/Gentofte Hospital" -8350,,499f6fb9-3fb0-465d-9455-f34cddb4fc9b,Universitätsklinikum Aachen,universit_tsklinikum_aachen,,,,,, -8351,,6f638c28-edd2-49c5-ba17-bfc9063aff9f,"Essen University Hospital, University of Essen, Klinik für Allgemein-, Viszeral- und Transplantationschirugie",essen_university_hospital_university_of_essen_klinik_f_r_allgemein_viszeral_und_transplantationschirugie,,,,,, -8352,,4f935083-ea79-4bdb-8dcb-ddbddc26d1b5,Lothian NHS trust,lothian_nhs_trust,,,,,, -8353,,4404d5c3-ab00-4898-bc94-a926df706fe5,"James Martin Shannon, MB Bch NUI",james_martin_shannon_mb_bch_nui,,,,,, -8354,,d5ef6684-10e6-4bfd-8782-091f32b991d1,EDMOND PHARMA S.R.L,edmond_pharma_s_r_l,,,,,, -8355,,7602e4bb-042c-4fe2-8e35-bae17e1c97b4,ISTITUTO SUPERIORE DI SANITA`,istituto_superiore_di_sanita,,,,,, -8356,,62d4a896-ac9e-486a-b44a-eb9f6c0a626e,Máximo Vento Torres,m_ximo_vento_torres,,,,,, -8357,,da9b4fbc-f66d-4eef-ab90-a218c33dfdc3,Bio Products Laboratory Limited,bio_products_laboratory_limited,,,,,, -323,0.98663082718849182,4cef0e0b-cc24-4bf3-b362-b0229f08ed2d,Tibotec Pharmaceuticals,tibotec_pharmaceuticals,,,,7c715eec-7632-4bad-85ac-60fea60f92d9,tibotec_pharmaceuticals_ltd,Tibotec Pharmaceuticals Ltd -8358,,cce6aea9-24aa-40a4-8db4-d0471b1c4290,"Bayer HealthCare AG, Leverkusen, Germany",bayer_healthcare_ag_leverkusen_germany,,,,,, -1033,0.97907406091690063,6fb84541-28be-49a0-a789-a0b8bf04fae5,"Kvinnokliniken, Universitetssjukhuset i Linköping, Landstinget i Östergötland",kvinnokliniken_universitetssjukhuset_i_link_ping_landstinget_i_sterg_tland,,,,6fb84541-28be-49a0-a789-a0b8bf04fae5,kvinnokliniken_universitetssjukhuset_i_link_ping_landstinget_i_sterg_tland,"Kvinnokliniken, Universitetssjukhuset i Linköping, Landstinget i Östergötland" -488,0.96790111064910889,09a2f474-74c3-4e06-8312-e90b8c6b9edd,STEBA BIOTECH NV,steba_biotech_nv,,,,5d77fa00-9417-4d15-807e-607c459d6842,steba_biotech,STEBA BIOTECH -8359,,ba25ef2c-c2e9-4122-8c27-ea1588bef0cd,Univ.-Klinik für Kinder- und Jugendheilkunde,univ_klinik_f_r_kinder_und_jugendheilkunde,,,,,, -783,0.988564,de151225-4c06-4faa-8f79-aea8cbad1585,Friedrich Schiller University,friedrich_schiller_university,,,,7e086a89-ce6e-4201-a20f-f377b113a14a,friedrich_schiller_university_jena,Friedrich Schiller University Jena -8360,,ec61c25d-94a2-4de5-81e3-053faf6f0b45,Fundación Rafael Clavijo,fundaci_n_rafael_clavijo,,,,,, -8361,,1cb2d28c-7116-40a2-8db1-7219ee3a1eac,AstraZeneca Österreich GmbH,astrazeneca_sterreich_gmbh,,,,,, -8362,,f53ac4c5-e3a2-47bb-9263-221e5a4bae9a,ModigeneTech Ltd,modigenetech_ltd,,,,,, -8363,,0e390158-99d9-4806-965a-1a245f5b5d27,Berufsgenossenschaftliche Universitätsklinik Bergmannsheil GmbH,berufsgenossenschaftliche_universit_tsklinik_bergmannsheil_gmbh,,,,,, -8364,,354414e6-8642-4679-83f0-e181e820b6d4,EBI Anti Sepsis B.V,ebi_anti_sepsis_b_v,,,,,, -8365,,707f5ff0-d285-4223-bc70-845be6e70a9d,C.H.U. de RENNES,c_h_u_de_rennes,,,,,, -8366,,d8de5982-3415-41f7-bcc2-0d4fc027a857,Vicente Barrio Lucia,vicente_barrio_lucia,,,,,, -8367,,956a84b4-0f02-486c-a85e-c9fd1fe6d5ae,Dr Manuel Pérez Maraver.Servicio de Endocrinologia. Hospital de Bellvitge,dr_manuel_p_rez_maraver_servicio_de_endocrinologia_hospital_de_bellvitge,,,,,, -198,0.96789649128913879,3d8b74fd-b4e1-48e0-9ee6-4cdff0959d7d,Agence nationale de recherches sur le sida et les hépatites virales. ANRS,agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales_anrs,,,,59af07b2-8bdc-4113-8ce3-1b459956f500,agence_nationale_de_recherches_sur_le_sida_et_les_h_patites_virales,Agence nationale de recherches sur le sida et les hépatites virales -8368,,014851d0-6f4b-400f-ae54-944210e7dbab,STRAKAN PHARMACEUTICALS LIMITED,strakan_pharmaceuticals_limited,,,,,, -8369,,f583bc0e-ae20-4bee-963e-e6fa92586bff,Stockholm Centre for Dependency Disorders,stockholm_centre_for_dependency_disorders,,,,,, -8370,,88b610b9-aa93-4023-9588-2088b0712224,"Medizinische Universität Wien,Univ.Klinik f.Anästhesie,Allgemeine Intensivmedizin u.Schmerztherapie",medizinische_universit_t_wien_univ_klinik_f_an_sthesie_allgemeine_intensivmedizin_u_schmerztherapie,,,,,, -8371,,9adddbc6-9196-4cae-b690-fe39a8e1cdac,Rottapharm SpA,rottapharm_spa,,,,,, -8372,,7f9d4912-2e85-4c67-9330-bc9bd40145cf,Servicio de Anestesiología. Hospital Universitario Germans Trias i Pujol. Badalona,servicio_de_anestesiolog_a_hospital_universitario_germans_trias_i_pujol_badalona,,,,,, -8373,,0d0d70ba-8867-451d-8e01-3684d6d556f7,Applied Genetic Technologies Corporation,applied_genetic_technologies_corporation,,,,,, -8374,,d609acee-2831-440a-bcc4-8b8df3aa7145,Vienna University Medical School,vienna_university_medical_school,,,,,, -957,0.957248,8e38f9a4-dccf-4187-bc36-be3625d6e45b,UMCG,umcg,,,,321c0173-119e-4164-9f51-ae2b1d03cb92,umcg_van_buchem_stichting,"UMCG, Van Buchem Stichting" -8375,,fdbb20fa-a83d-4c5f-9904-a46fb0789c92,Inserm,inserm,,,,,, -287,0.982375,471980ba-fc4b-45dc-b7bc-7d5ed19764b7,"Department of Anaesthesia, University College Hospital Galway",department_of_anaesthesia_university_college_hospital_galway,,,,471980ba-fc4b-45dc-b7bc-7d5ed19764b7,department_of_anaesthesia_university_college_hospital_galway,"Department of Anaesthesia, University College Hospital Galway" -8376,,65b06197-f06a-422b-95aa-831b7ba5748d,"NU-sjukvården, Norra Älvsborgs Länssjukhus",nu_sjukv_rden_norra_lvsborgs_l_nssjukhus,,,,,, -831,0.977549,9f380cea-e5d4-4346-a8b8-6397eb6b3840,"Laboratorios Andrómaco, S.A",laboratorios_andr_maco_s_a,,,,9f380cea-e5d4-4346-a8b8-6397eb6b3840,laboratorios_andr_maco_s_a,"Laboratorios Andrómaco, S.A" -8377,,a24f8b51-b4fc-41e8-9930-a9fb73afaea6,Poole Hospital NHS Trust,poole_hospital_nhs_trust,,,,,, -8378,,806415c2-a7a1-11e6-94cb-5656d04fc2b5,"Noven Pharmaceuticals, Inc",noven_pharmaceuticals_inc,,,,,, -8379,,32282e21-49ce-4d65-815a-321863863ad7,Sage Therapeutics,sage_therapeutics,,,,,, -802,0.989407,a02415a8-3cdf-4ded-89d7-b50b2f02f0bd,Consorzio per Valutazioni Biologiche e Farmacologiche,consorzio_per_valutazioni_biologiche_e_farmacologiche,,,,a02415a8-3cdf-4ded-89d7-b50b2f02f0bd,consorzio_per_valutazioni_biologiche_e_farmacologiche,Consorzio per Valutazioni Biologiche e Farmacologiche -8380,,7af35b4e-cf6a-463f-80e7-e121c9fda5cb,University of Tampere,university_of_tampere,,,,,, -8381,,40ace3ff-e6df-4ef3-ab9e-c53657d4a79d,Kjeld Schmiegelow,kjeld_schmiegelow,,,,,, -8382,,0dafc732-3586-44c2-93df-da550602fafc,Fundación Investigación Biomedica. Hospital Clinico San Carlos,fundaci_n_investigaci_n_biomedica_hospital_clinico_san_carlos,,,,,, -8383,,86d41442-d230-43de-89a3-98964259162b,Abbott Laboratories Ireland Limited,abbott_laboratories_ireland_limited,,,,,, -8384,,bdadb083-28d3-4d8f-bc7c-cc1625d26f60,Bayer HealthCare LLC/Biological Products,bayer_healthcare_llc_biological_products,,,,,, -8385,,6e6abc64-71f2-11e6-a0cd-0242ac12000b,ULURU,uluru,,,,,, -8386,,530fb7d9-cc0f-42fc-a16d-85de7fffaabf,Ferring Laegemidler A/S,ferring_laegemidler_a_s,,,,,, -8387,,703dce6d-8143-412e-811b-f5e277295d1b,Paracelsus Medical University,paracelsus_medical_university,,,,,, -8388,,65b58fc2-ed98-4bb6-8e21-51870d9d7023,sanofi-aventis recherche&developpement,sanofi_aventis_recherche_developpement,,,,,, -991,0.94441205263137817,bfea9c2f-7af8-42e7-bf17-56946a9b031b,Great Ormond Street Hospital for Children NHS Trust,great_ormond_street_hospital_for_children_nhs_trust,,,,136feb9a-ae28-4c13-afe3-e135660d48aa,great_ormond_street_hospital,Great Ormond Street Hospital -1068,0.97769945859909058,3c312b00-9fca-409e-b005-3d108414ea8a,Serono GmbH,serono_gmbh,,,,24095e02-bf25-4c7e-bbc3-925378eaba6e,serono,Serono -610,0.97921166817347205,4fd1c2ba-3c7e-4c2b-82ee-6305062f19b2,Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC),f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer_fnclcc,,,,4b5b75aa-a963-452e-848e-256ac41c5d72,f_d_ration_nationale_des_centres_de_lutte_contre_le_cancer,Fédération Nationale des Centres de Lutte Contre le Cancer -8389,,062f95de-c0b3-429f-a09a-cc109fc1a147,Silvia Delgado Aros,silvia_delgado_aros,,,,,, -8390,,38071e25-e6a2-4317-bb07-f9dcd95c6d92,The Cardiovascular Research Foundation,the_cardiovascular_research_foundation,,,,,, -92,0.967029,dd4ee19e-34ae-40f8-9aae-033f641f0bc8,Diakonhjemmet hospital,diakonhjemmet_hospital,,,,c3e873ff-4ae6-499b-8ac6-5d8e2203e040,diakonhjemmet_hospital_as,Diakonhjemmet Hospital AS -8391,,7cdd0315-c0f0-43cd-b97d-923df0ba1554,maternite régionale de nancy,maternite_r_gionale_de_nancy,,,,,, -8392,,7eff464c-dceb-4e1b-9b93-7012dce7de84,Dept. Pharmacology and Toxicology,dept_pharmacology_and_toxicology,,,,,, -8393,,eaec7154-725d-11e6-a0cd-0242ac12000b,PF PRISM CV,pf_prism_cv,,,,,, -333,0.986197,c0de4999-a6b3-11e6-94cb-5656d04fc2b5,Nordsjællands Hospital Hillerød,nordsj_llands_hospital_hiller_d,,,,c0de4999-a6b3-11e6-94cb-5656d04fc2b5,nordsj_llands_hospital_hiller_d,Nordsjællands Hospital Hillerød -8394,,80fb0c79-55ee-49f8-b814-457626a6a5a9,FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DE CÓRDOBA,fundaci_n_para_la_investigaci_n_biom_dica_de_c_rdoba,,,,,, -763,0.970018,a6d9db1f-edb6-4e94-8f5a-2874c0b70848,Danish Multiple Sclerosis Research Center,danish_multiple_sclerosis_research_center,,,,20d8ecc2-872e-4d93-9419-6e3e20fea29f,danish_multiple_sclerosis_research_centre,Danish Multiple Sclerosis Research Centre -8395,,66d2c371-433d-4862-b28f-06734d8d2b55,Hospital Clínico de Barcelona,hospital_cl_nico_de_barcelona,,,,,, -158,0.98881235718727112,b02b5eef-9b45-4fff-a916-3bb4aff28b1e,Medizinische Universität Wien,medizinische_universit_t_wien,,,,5b2fbdce-d691-41c6-9a74-e06608d419f4,medizinische_universit_t_wien_hno_klinik,Medizinische Universität Wien -8396,,7557b4b6-675c-400a-a06d-ff4fb910f001,"Signe H. Østoft, Diabetes Research Division",signe_h_stoft_diabetes_research_division,,,,,, -8397,,291dfea0-7143-11e6-a0cd-0242ac12000b,TELIGENT PHARMA INC,teligent_pharma_inc,,,,,, -8398,,7bff389f-15ee-48f7-b3b8-ab9f1628f724,Kwizda Pharma GmbH,kwizda_pharma_gmbh,,,,,, -419,0.97916126251220703,80568dc5-c7dd-447e-8e6d-baa1274edf19,National and Kapodostrian University of Athens,national_and_kapodostrian_university_of_athens,,,,24418820-0b75-41e2-993c-2f2c0b00efb6,national_and_kapodistrian_university_of_athens,National and Kapodistrian University of Athens -8399,,84c99fbe-1b1e-470c-9a52-1a9a60ff7e11,Stockholm Spine Center,stockholm_spine_center,,,,,, -8400,,7188a583-9a8d-4e5c-867b-e437d0ab019a,Univ.-Prof. Dr. Doris Balogh,univ_prof_dr_doris_balogh,,,,,, -626,0.909952,35f0780b-f2b6-4584-86d6-148ae3464f6c,Chiron Corporation Limited,chiron_corporation_limited,,,,35f0780b-f2b6-4584-86d6-148ae3464f6c,chiron_corporation_limited,Chiron Corporation Limited -877,0.943406,3808b209-be03-4db8-a518-2ea52ecb1376,"Department of Dermatology, Bispebjerg Hospital",department_of_dermatology_bispebjerg_hospital,,,,06cdfc3c-1180-4e50-a488-39de382fbc30,department_of_dermatology_d92_bispebjerg_hospital,"Department of Dermatology D92, Bispebjerg Hospital" -8401,,42222ba5-ad32-4ea7-88fe-dbbdbb54526b,North Wales NHS Trust,north_wales_nhs_trust,,,,,, -8402,,5e9141bd-a4e5-4e5f-910f-65ee0abd7e7a,"Grachtenhaus-Apotheke, Inh. Klaus Stegemann e. K",grachtenhaus_apotheke_inh_klaus_stegemann_e_k,,,,,, -8403,,cc1603ea-7199-11e6-a0cd-0242ac12000b,IROKO PHARMS LLC,iroko_pharms_llc,,,,,, -8404,,66736469-0f43-4438-ba75-05a9824a2c90,"Faculty of Social Sciences, Utrecht University",faculty_of_social_sciences_utrecht_university,,,,,, -8405,,f17119d5-09b4-40f0-8509-c7c686f87d7e,Nicasio Pérez Castellano,nicasio_p_rez_castellano,,,,,, -8406,,575e0da4-c91b-4258-aecc-759c1f2d8342,"Theracos Sub, LLC",theracos_sub_llc,,,,,, -8407,,f6bdf8d3-c9f4-4f16-b855-4414da50f786,DRK-Blutspendedienst NSTOB,drk_blutspendedienst_nstob,,,,,, -8408,,e916dcc8-715b-11e6-a0cd-0242ac12000b,ABRAXIS PHARM,abraxis_pharm,,,,,, -822,0.986019,d9fce77e-b2c7-474f-bab0-ea6091e4e7af,Heinrich-Heine-Universität,heinrich_heine_universit_t,,,,7ea15226-d1e9-49e7-8712-7ea0bb120819,heinrich_heine_universit_t_duesseldorf,Heinrich-Heine-Universität Duesseldorf -8409,,6f127134-8bbf-11e6-a449-0242ac12000b,"Goethe-Universität Frankfurt, Universitätsklinikum, Med. Klinik II",goethe_universit_t_frankfurt_universit_tsklinikum_med_klinik_ii,,,,,, -563,0.973989,ef49786a-4fb9-413b-b119-def3fec33bb8,PETHEMA,pethema,,,,d2e15a44-a454-409f-91c0-cf787effc96f,pethema_foundation,PETHEMA Foundation -8410,,19c09765-4004-4efa-b168-c6778346cf14,Stockholm South General Hospital,stockholm_south_general_hospital,,,,,, -8411,,b03538ef-636a-43c6-a17e-dbc1a874adc6,MCM Klosterfrau GmbH & Co. KG,mcm_klosterfrau_gmbh_co_kg,,,,,, -8412,,4b4d5674-8109-4cc5-b89f-6bf59f37f6e0,Roche Products Ltd,roche_products_ltd,,,,,, -8413,,85f999d3-5551-4e49-8db3-cdc6d81128a7,JESSA Hospital,jessa_hospital,,,,,, -8414,,bdfbb931-dbf5-4f3b-ae88-d513cc367cd2,KEYRUS BIOPHARMA,keyrus_biopharma,,,,,, -8415,,357c0f03-5d74-4911-af3b-e2eabbc7c32a,"Lorenzo Victor, PhD",lorenzo_victor_phd,,,,,, -8416,,f015696d-9b92-4ac4-b6d6-55a99a204910,BAXTER SAS R&D Parenteral Nutrition,baxter_sas_r_d_parenteral_nutrition,,,,,, -8417,,52c58d80-a68b-4b70-8671-19c4e00fbf75,Antwerp University Hospital : Department Respiratory Medicine,antwerp_university_hospital_department_respiratory_medicine,,,,,, -8418,,15e72b21-d615-401b-bd67-e2b9c2d1cfa7,ADVANCELL,advancell,,,,,, -8419,,282ce3b7-41e1-4fa9-b37e-6bd99454fbcd,"Prospect Therapeutics, Inc",prospect_therapeutics_inc,,,,,, -8420,,b319719e-fa52-4f63-8c59-dc5166c4ff34,Assistance Publique - Hôpitaux de Paris (AP-HP),assistance_publique_h_pitaux_de_paris_ap_hp,,,,,, -8421,,2147b271-82dd-40d7-af7e-e7c37ecff8b1,Joint Sponsorship: University College London (UCL) & University College London Hospitals (UCLH),joint_sponsorship_university_college_london_ucl_university_college_london_hospitals_uclh,,,,,, -8422,,baf1222c-e00f-44d1-b0ab-67fdb136019d,"GlaxoSmithKline,s.r.o",glaxosmithkline_s_r_o,,,,,, -1,0.958633,5e39e1cf-f761-4acc-bd2c-247647d86e60,"Johnson & Johnson Pharmaceutical Research and Development, L.L.C",johnson_johnson_pharmaceutical_research_and_development_l_l_c,,,,5e39e1cf-f761-4acc-bd2c-247647d86e60,johnson_johnson_pharmaceutical_research_and_development_l_l_c,"Johnson & Johnson Pharmaceutical Research and Development, L.L.C" -8423,,0aecc8b6-73fb-11e6-a0cd-0242ac12000b,OPKO IRELAND GLOBAL,opko_ireland_global,,,,,, -8424,,611023fa-b1da-4f28-88b5-25cc3ed022fd,Clinica Universidad de Navarra/Universidad de Navarra,clinica_universidad_de_navarra_universidad_de_navarra,,,,,, -8425,,b75ae809-3780-4736-9441-8fa42596fe81,Research and Innovation Department,research_and_innovation_department,,,,,, -8426,,fa24fc1e-c68c-4d8e-8364-d9364fa701a0,"G&W Laboratories, Inc",g_w_laboratories_inc,,,,,, -8427,,afdb5bbb-7bea-42a1-92a7-96befb67835c,"University of Tartu, Clinic of Anaesthesiology and Intensive Care",university_of_tartu_clinic_of_anaesthesiology_and_intensive_care,,,,,, -96,0.9879,e1ba6dc0-7451-43a2-9dd8-9d794405ffb3,Mekos Laboratories AS,mekos_laboratories_as,,,,b29eb661-1920-4894-b0f1-fd365cb40e54,mekos_laboratories,Mekos Laboratories -8428,,702ec845-cbc0-4108-bac9-93304406ae22,Gilead Science Incorporated,gilead_science_incorporated,,,,,, -8429,,97065043-8217-4b9e-9193-9d2ddf3c9030,Tomi Niemi,tomi_niemi,,,,,, -8430,,42098708-c17c-4402-82ea-0ea6c4cebe70,Central Finland Hospital District,central_finland_hospital_district,,,,,, -939,0.9797365665435791,4daea4c8-d47a-49e5-8183-837377f6766e,"Hospira, Inc",hospira_inc,,,,2c899cf4-2f23-4023-b9ab-f8d5356588d9,hospira,Hospira -8431,,fa996ea2-e95d-44b1-8a52-e730532b2a6e,Fundación General de la Universidad de Salamanca,fundaci_n_general_de_la_universidad_de_salamanca,,,,,, -8432,,cff5f511-8147-480d-b98a-e8ba2f47332d,Tameside Hospital NHS Foundation Trust,tameside_hospital_nhs_foundation_trust,,,,,, -8433,,47f57ac8-48c6-4468-b458-678af82e311a,University of Magdeburg,university_of_magdeburg,,,,,, -521,0.965089,553c2b95-df0a-4f68-8370-358a1401e332,Department of Anaesthesia and General Intensive Care Medicine,department_of_anaesthesia_and_general_intensive_care_medicine,,,,1a46a2d5-d4cb-4f3f-8731-ed0b10a5b6d9,department_of_anaesthesia_general_intensive_care_medicine,Department of Anaesthesia & General Intensive Care Medicine -8434,,8bcc545e-de68-409b-8c8a-b4d53b3a4b89,Janssen R&D Ireland,janssen_r_d_ireland,,,,,, -8435,,cf855208-a916-4569-9cab-780a1a901420,Forschergruppe Diabetes e. V. am Helmholtz Zentrum München,forschergruppe_diabetes_e_v_am_helmholtz_zentrum_m_nchen,,,,,, -8436,,54624de5-6606-4d01-88f3-c8e19ae362e5,Smithkline Beecham Pvt Limited,smithkline_beecham_pvt_limited,,,,,, -308,0.987895,86807203-e56e-49a6-bcc8-c3d0deca55f4,Fundación Pública Andaluza para la Gestion de la Investigación en Salud de Sevilla,fundaci_n_p_blica_andaluza_para_la_gestion_de_la_investigaci_n_en_salud_de_sevilla,,,,86807203-e56e-49a6-bcc8-c3d0deca55f4,fundaci_n_p_blica_andaluza_para_la_gestion_de_la_investigaci_n_en_salud_de_sevilla,Fundación Pública Andaluza para la Gestion de la Investigación en Salud de Sevilla -656,0.985689,e662ee12-f532-4301-b8e7-3bd06977f501,Daniel Podzamczer,daniel_podzamczer,,,,1dc11f6f-51cc-4072-9340-b3162a901b0e,daniel_podzamczer_palter,Daniel Podzamczer Palter -8437,,17d0a3c7-aab3-43af-9ce0-8ab7defc8591,IRCCS ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI,irccs_istituto_scientifico_romagnolo_per_lo_studio_e_la_cura_dei_tumori,,,,,, -8438,,6cf58b74-7167-11e6-a0cd-0242ac12000b,MA GENERAL HOSP,ma_general_hosp,,,,,, -8439,,61970725-10c2-4769-9b2b-0908835f16d6,"LMU München, Campus Großhadern",lmu_m_nchen_campus_gro_hadern,,,,,, -8440,,5144effc-767e-4002-8f3f-ba4ffca0f27e,Vivostat A/S,vivostat_a_s,,,,,, -8441,,37ee7ecb-8870-4132-96b7-7939f41aa41d,apceth GmbH & Co. KG,apceth_gmbh_co_kg,,,,,, -8442,,ae730708-a78f-11e6-94cb-5656d04fc2b5,Blekinge county council,blekinge_county_council,,,,,, -8443,,f90bac41-6145-4065-b9bc-0a043b7a2db5,GALMED Pharmaceuticals LTD,galmed_pharmaceuticals_ltd,,,,,, -8444,,08e6f4e5-879a-48c6-9c01-ad69c9a20be9,FUNDACION PARA LA INVESTIGACION HOSPITAL UNIVERSITARIO LA FE,fundacion_para_la_investigacion_hospital_universitario_la_fe,,,,,, -161,0.98196295897165931,cf84194a-b23a-4b1f-87a1-24b1fdec7e48,Fundación para la Investigación Biomedica del Hospital 12 de Octubre,fundaci_n_para_la_investigaci_n_biomedica_del_hospital_12_de_octubre,,,,393eab2d-fa2d-419a-8ecd-278e02b1ad5b,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_12_de_octubre,Fundación para la Investigación Biomédica del Hospital 12 de Octubre -8445,,6d03a1dd-803f-460f-991d-ec9984576ad7,"RWTH Aachen University, represented by the Rector, himself represented by Clinical Trial Center (CTC-A)",rwth_aachen_university_represented_by_the_rector_himself_represented_by_clinical_trial_center_ctc_a,,,,,, -8446,,a65de4b5-536d-49b7-967e-3e4e70d0a33a,"CPDS BERMUDA, LTD",cpds_bermuda_ltd,,,,,, -8447,,47c20cb7-42aa-40d6-b307-102844c8fedb,the All-Ireland cooperative oncology research group (ICORG),the_all_ireland_cooperative_oncology_research_group_icorg,,,,,, -8448,,1bafbb62-9e04-4416-8595-1668e1281d27,Eskelinen Matti/KYS,eskelinen_matti_kys,,,,,, -8449,,5f20da18-7157-11e6-a0cd-0242ac12000b,ACTAVIS LABS UT INC,actavis_labs_ut_inc,,,,,, -8450,,05a9562c-47f4-469c-8997-0a053b0976e0,CHU de Rouen,chu_de_rouen,,,,,, -8451,,461d0b70-8a39-4611-99fc-0a9d3aedd9eb,Institut de Recerca e la SIDA - IrsiCaixa-,institut_de_recerca_e_la_sida_irsicaixa,,,,,, -8452,,eeadf06c-7cd1-4240-80ec-56204cf1be4c,"IMPAX LABORATORIES, INC",impax_laboratories_inc,,,,,, -8453,,44b5f024-8d75-414e-91c5-9c1c723e250e,Acrux Pharma Pty Ltd,acrux_pharma_pty_ltd,,,,,, -8454,,d35e3c60-aa98-4973-b1ba-5eac9eb82bbf,Per Klausen Fink,per_klausen_fink,,,,,, -599,0.93973445892333984,53d727ca-f81e-4c5b-a9a5-c177cdd19cfc,Fundació Privada Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau,fundaci_privada_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,,,,53d727ca-f81e-4c5b-a9a5-c177cdd19cfc,fundaci_privada_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Fundació Privada Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau -863,0.921141,b6650928-ea79-463f-89b2-65d149cd973a,Immunicum Aktiebolag,immunicum_aktiebolag,,,,63ece514-1ecd-4555-8b78-f2736a1ee227,immunicum_ab,Immunicum AB -8455,,e45c2af0-8ba2-462e-b118-9825655e8327,CONSORZIO PER LA RICERCA ONCOLOGICA,consorzio_per_la_ricerca_oncologica,,,,,, -8456,,a34457c8-0f57-4f38-a0f4-6151dbd06986,Deventer Hospital,deventer_hospital,,,,,, -270,0.95828056335449219,8a7a48b6-3bc7-4979-b1d7-a8a21f8d3aa0,"AstraZeneca AB, AstraZeneca Sverige",astrazeneca_ab_astrazeneca_sverige,,,,b9740d19-9951-4510-b985-aa689195ab5f,astrazeneca_ab,AstraZeneca AB -8457,,8f2c8591-5e6e-45a5-9437-13560cb8860e,Endo Ventures Limited,endo_ventures_limited,,,,,, -8458,,58615f2a-f183-4833-a7a4-c7a9ff2293d3,The Norwegian Radium Hospital,the_norwegian_radium_hospital,,,,,, -113,0.971346,5c913850-fa7a-4490-8a20-b21a3b24bb85,"Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden",radiumhemmet_karolinska_university_hospital_stockholm_sweden,,,,5c913850-fa7a-4490-8a20-b21a3b24bb85,radiumhemmet_karolinska_university_hospital_stockholm_sweden,"Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden" -663,0.97166502475738525,57ad1b5e-ca5a-4470-9b1b-36e6151b1c01,Charité - Universitätsmedizin Berlin,charit_universit_tsmedizin_berlin,,,,57ad1b5e-ca5a-4470-9b1b-36e6151b1c01,charit_universit_tsmedizin_berlin,Charité - Universitätsmedizin Berlin -8459,,5a77b4d0-7c01-43f3-951a-5ab7a4de992b,Weber & Weber GmbH & Co.KG,weber_weber_gmbh_co_kg,,,,,, -8460,,e6eee0fb-76a3-4b71-a385-3662b0e9354f,"Kura Oncology Inc.,",kura_oncology_inc,,,,,, -8461,,7eae9d8a-4fc6-4882-86ab-0072b1228b37,Aventis Pharma,aventis_pharma,,,,,, -8462,,dcac9d85-1264-46c7-8583-6689353e28ca,Solvay pharmaceuticals,solvay_pharmaceuticals,,,,,, -8463,,fa7d1356-df3d-405a-a06b-00ef2487343a,Pfizer Oy,pfizer_oy,,,,,, -8464,,0d9bf202-8f79-48de-a216-b6f9a89c1385,Central and North West London NHS Foundation Trust (Camden Provider Services),central_and_north_west_london_nhs_foundation_trust_camden_provider_services,,,,,, -8465,,45ffadb2-1b18-4d1b-a562-966136cead4f,Royal Liverpool and Broadgreen Hospitals NHS Trust,royal_liverpool_and_broadgreen_hospitals_nhs_trust,,,,,, -8466,,c6a79f32-c06a-413c-9b5e-081137516c04,U.L.S.S. 16,u_l_s_s_16,,,,,, -8467,,5c10833a-9b8d-40eb-958a-3e3336e468f2,CHU POITIERS,chu_poitiers,,,,,, -8468,,d635ae30-0015-4b80-a6f5-953b1e07bb24,Heads Study Group,heads_study_group,,,,,, -8469,,61462924-1bcc-4db5-94c6-24d641470471,NOVIMMUNE BV,novimmune_bv,,,,,, -8470,,d28f19ee-6ea2-42bf-9212-e2766527fc5e,Karl Landsteiner Institut für klinische Neurologie und Neuropsycholigie,karl_landsteiner_institut_f_r_klinische_neurologie_und_neuropsycholigie,,,,,, -8471,,f033e3c7-bf52-4f51-aaa2-70eb0e2b53bd,Pharmalink AB,pharmalink_ab,,,,,, -8472,,5e7f3498-a53c-4e6a-9e26-1fc9f582df0f,Stichting astma bestrijding,stichting_astma_bestrijding,,,,,, -8473,,a93d3e0e-3073-4d60-acb3-a9bb10573452,(GOTEL) Grupo Oncológico para el tratamiento y estudio de los linfomas,gotel_grupo_oncol_gico_para_el_tratamiento_y_estudio_de_los_linfomas,,,,,, -8474,,e9cc38f6-8bd8-11e6-a449-0242ac12000b,University Hospital of Tuebingen,university_hospital_of_tuebingen,,,,,, -8475,,c29c3df2-ad4a-456f-8126-aa6dfe596211,INMUNAL SAU,inmunal_sau,,,,,, -8476,,61823aa6-9d11-4d40-84c9-7022d717128e,"Schering-Plough Corporation, a Subsidiary of Merck & Co.,Inc",schering_plough_corporation_a_subsidiary_of_merck_co_inc,,,,,, -8477,,0c8d5319-cc37-42e7-b624-b364463408a4,"Orion Corporation, ORION PHARMA, 02200 Espoo, Finland",orion_corporation_orion_pharma_02200_espoo_finland,,,,,, -8478,,989f372d-d69b-4408-9eea-3df26e181851,Westdeutsche Studiengruppe GmbH,westdeutsche_studiengruppe_gmbh,,,,,, -8479,,59e950e6-7145-11e6-a0cd-0242ac12000b,VIVIMED LABS,vivimed_labs,,,,,, -8480,,12445483-8cb9-4eac-983c-c1a340cec868,UMCN St Radboud,umcn_st_radboud,,,,,, -8481,,81c4b59f-dbe4-4dd7-9be9-49008a5d7b79,Develco Pharma Schweiz AG,develco_pharma_schweiz_ag,,,,,, -8482,,c24b5e6d-795a-4dd3-93c9-2467f5ef7cda,"Fundacion para la Investigación ""Hospital Universitario Doctor Peset",fundacion_para_la_investigaci_n_hospital_universitario_doctor_peset,,,,,, -8483,,82dd2df8-fd55-4ea1-9b46-52e94ab64138,FUNDACION IMABIS,fundacion_imabis,,,,,, -8484,,12bc94f0-6a39-4b62-bad5-e7160a854672,Mater Research Institute University of Queensland,mater_research_institute_university_of_queensland,,,,,, -8485,,718ffea8-1ed5-45d9-ad45-ee37e61ed5b6,Bayhill Therapeutics,bayhill_therapeutics,,,,,, -8486,,1b4c94d6-d91e-4d34-9a00-2d0e51872088,Institut de Cardiologie de Montréal,institut_de_cardiologie_de_montr_al,,,,,, -8487,,b6afcbf9-28b0-4507-8559-64546263dd79,"Onyx Pharmaceuticals, Inc",onyx_pharmaceuticals_inc,,,,,, -955,0.979762,801fd107-9dff-425d-aeed-c20bed8847c1,"AZTherapies, Inc., Pure Tech Health",aztherapies_inc_pure_tech_health,,,,801fd107-9dff-425d-aeed-c20bed8847c1,aztherapies_inc_pure_tech_health,"AZTherapies, Inc., Pure Tech Health" -8488,,69d1a2ec-48f6-47c6-a280-c2e1657baa8c,University of Technology Dresden,university_of_technology_dresden,,,,,, -1037,0.979231,c82ae3b8-715d-11e6-a0cd-0242ac12000b,MUSTAFA NEVSAT IIAC SANAYII A.S,mustafa_nevsat_iiac_sanayii_a_s,,,,72bda612-7163-11e6-a0cd-0242ac12000b,mustafa_nevsat,MUSTAFA NEVSAT -8489,,b0385d68-73fa-11e6-a0cd-0242ac12000b,APRECIA PHARMS CO,aprecia_pharms_co,,,,,, -8490,,38314a7f-5a3d-4655-bca0-7cdf4979157a,"Dr. Juan D. Cañete Crespillo, Hospital Clínic de Barcelona",dr_juan_d_ca_ete_crespillo_hospital_cl_nic_de_barcelona,,,,,, -8491,,a8844d66-b4fa-446a-baa2-b308e00c89ac,Amersham plc,amersham_plc,,,,,, -8492,,1cf1b0d8-2fa0-4d08-a1a9-ef176b6a1973,University Hospital Ulm,university_hospital_ulm,,,,,, -8493,,294f9979-35f6-45c4-9615-ba04866fcc98,Roskamp Institute,roskamp_institute,,,,,, -8494,,d120fc38-8539-4b8b-9e74-7d2a19f59d08,AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA,azienda_ospedaliera_spedali_civili_di_brescia,,,,,, -8495,,ef546ec8-feac-4799-831d-6eb79f0acffb,OSPEDALE PEDIATRICO BAMBINO GESU' DI ROMA,ospedale_pediatrico_bambino_gesu_di_roma,,,,,, -8496,,c80c38e8-8be6-11e6-a449-0242ac12000b,Actavis Hungary Gyógyszermarketing és Kereskedelmi Korlátolt Felelősségű Társaság,actavis_hungary_gy_gyszermarketing_s_kereskedelmi_korl_tolt_felel_ss_g_t_rsas_g,,,,,, -8497,,01cac4c1-1aed-4d00-a351-85e5f11263f8,Boehringer Ingelheim Pharma Ges.m.b.H,boehringer_ingelheim_pharma_ges_m_b_h,,,,,, -8498,,b41aa9cc-fd49-43c0-8946-e794c2f212e3,AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI,azienda_ospedaliera_di_bologna_policlinico_s_orsola_m_malpighi,,,,,, -8499,,149e6132-8b28-48d3-a69d-5fc8c34df12f,Seven Seas Limited,seven_seas_limited,,,,,, -8500,,9150348d-f4df-46d3-b622-6561e31bf3dd,MEDA Pharma GmbH & Co. KG,meda_pharma_gmbh_co_kg,,,,,, -8501,,74666f50-7bc8-41d0-8146-e1d959e6a656,"Schering-Plough Farma, Lda",schering_plough_farma_lda,,,,,, -552,0.945615,189b51d9-0d8d-4344-a7e0-4ad5e8c1742d,Grifols Biologicals Inc,grifols_biologicals_inc,,,,189b51d9-0d8d-4344-a7e0-4ad5e8c1742d,grifols_biologicals_inc,Grifols Biologicals Inc -8502,,8945fc19-02f5-47fd-9fff-a64c8a007292,University Hospital Department of Cardiology,university_hospital_department_of_cardiology,,,,,, -8503,,ceca4495-b66a-450d-8c1a-48cd006cb56b,E.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER,e_o_r_t_c_european_organization_for_research_and_treatment_of_cancer,,,,,, -8504,,f391dbb5-74f7-40a5-92f5-1ee001d3840a,University of Copenhagen,university_of_copenhagen,,,,,, -8505,,2bbc2c7f-ee1c-4c5a-adcc-847444413edd,Arrowhead Research Corporation,arrowhead_research_corporation,,,,,, -8506,,70c67868-c506-46cd-8495-381a460691bb,ΕΛΛΗΝΙΚΗ ΕΤΑΙΡΕΙΑ ΙΑΤΡΙΚΗΣ ΕΚΠΑΙΔΕΥΣΗΣ (Hellenic Society of Medical Education),hellenic_society_of_medical_education,,,,,, -277,0.96881628036499023,5464b0d0-1cc0-4ac6-9b8e-7690af086db6,"Teva Branded Pharmeceutical Products R&D, Inc",teva_branded_pharmeceutical_products_r_d_inc,,,,71fa3658-cdd0-4248-b428-53aae9afea66,teva_branded_pharmaceutical_products_r_d_inc,"Teva Branded Pharmaceutical Products R&D, Inc" -8507,,9e598b58-0472-4f75-b151-873cb5ef2887,Univeritetssjukhuset Örebro,univeritetssjukhuset_rebro,,,,,, -47,0.913597,79a6fb52-ac9b-48f4-831c-9878fac75c8a,Sintetica SA,sintetica_sa,,,,31bad48e-93ea-4c40-8057-5790bbe13494,sintetica_s_a,Sintetica S.A -371,0.976266,f74957e9-053b-4b18-be53-6e4795a8288d,AMGEN,amgen,,,,d647a1c4-2ac3-45cc-b98d-47490b4597d7,amgen_inc,AMGEN INC -652,0.93963295221328735,756fbf26-6aec-45b4-9273-9afca275034e,"Boehringer Ingelheim Pharmaceuticals, Inc",boehringer_ingelheim_pharmaceuticals_inc,,,,756fbf26-6aec-45b4-9273-9afca275034e,boehringer,Boehringer -8508,,9f8c4142-83e5-4604-a618-99959d4080fc,CHU of Liege,chu_of_liege,,,,,, -8509,,04ab2ef0-761c-474f-bbc6-399ab5e46067,National Institute of Child Health,national_institute_of_child_health,,,,,, -8510,,5b038daf-79e1-4cdc-a323-a4682a9400f9,LAURA TARRATS VELASCO,laura_tarrats_velasco,,,,,, -8511,,4cdae716-c056-4f14-965d-fac75d9ee4d9,University Hospital Motol,university_hospital_motol,,,,,, -8512,,bbc263d9-ca8f-4fa8-9eee-c55046b5a00e,Rgshospitalet,rgshospitalet,,,,,, -319,0.943406,8fd294ea-aee1-4e2e-86ed-6265cb17d1af,MERCK SERONO SA,merck_serono_sa,,,,8fd294ea-aee1-4e2e-86ed-6265cb17d1af,merck_serono_sa,MERCK SERONO SA -8513,,153407e9-b8d2-4405-a219-72d0d6f58a66,Gottfries Clinic,gottfries_clinic,,,,,, -8514,,814cdb2c-b2c8-4260-ad4d-2133ade8dec9,DR DIMENSIONE RICERCA,dr_dimensione_ricerca,,,,,, -8515,,5f77d6a0-1f07-4767-a4ef-f6d7338bfb7a,Yale University School of Medicine,yale_university_school_of_medicine,,,,,, -8516,,150ca6bd-2f23-49a6-9d78-e1ef5bfcc3fd,Montavit Ges.m.b.H,montavit_ges_m_b_h,,,,,, -77,0.942699,56d56d9c-d583-406f-8098-1497a470593d,ITF Research Pharma S.L.U,itf_research_pharma_s_l_u,,,,56d56d9c-d583-406f-8098-1497a470593d,itf_research_pharma_s_l_u,ITF Research Pharma S.L.U -588,0.914544,afbb1de6-db13-464b-bc5e-86990914b650,Hospital of the Ludwig-Maximilians-University of Munich,hospital_of_the_ludwig_maximilians_university_of_munich,,,,19952d22-67c1-4b82-9279-54d9c48ca7a5,hospital_of_the_ludwig_maximilians_university_munich,Hospital of the Ludwig Maximilians University Munich -394,0.97813,2a062c79-99fa-45ef-95f7-3bfbfa472661,Unidad de Investigación, Hospital Universitario de Canarias,,,,2a062c79-99fa-45ef-95f7-3bfbfa472661, Hospital Universitario de Canarias,Unidad de Investigación -8517,,298e58d0-f0a0-443c-9892-7455c9173140,Ocera Therapeutics Inc,ocera_therapeutics_inc,,,,,, -8518,,69f3ebfa-a2af-49b6-9de2-520ab2bfccca,Metacure Ltd,metacure_ltd,,,,,, -8519,,414d369c-cc51-43de-aad1-2490fe66bd5a,Sven-Åke Lundin,sven_ke_lundin,unidad_de_investigaci_n_hospital_universitario_de_canarias,,,,, -8520,,7a6b3e4a-337c-4d33-bc26-7e802d5ba416,Norpharma A/S,norpharma_a_s,,,,,, -8521,,aa5fc0e2-7253-4730-b3d3-dd3a9897795b,Medisch Centrum Haaglanden,medisch_centrum_haaglanden,,,,,, -8522,,426f82dd-79bc-4abf-bb28-b2df52b9e420,Neo Vista Inc,neo_vista_inc,,,,,, -8523,,78b06561-b0b0-48f8-8150-bb5ff5cb08f1,"Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena",universit_tsklinikum_jena_friedrich_schiller_universit_t_jena,,,,,, -8524,,17311942-3da4-4739-98c6-ff0033cf1296,GABA International AG,gaba_international_ag,,,,,, -8525,,be5f9a14-8446-4a82-a871-65304ba16b98,LTB4 Sweden AB,ltb4_sweden_ab,,,,,, -8526,,2f11f65c-e342-4a47-9e40-9b8133f318bc,"AtheroGenics, Inc",atherogenics_inc,,,,,, -8527,,19f8e9a3-8e92-4ae5-8c4c-b21b90806ab9,ACE Aps,ace_aps,,,,,, -8528,,c9a11db2-715c-11e6-a0cd-0242ac12000b,REDDYS,reddys,,,,,, -8529,,3a6de2da-4719-48b1-8d56-b996f3f5ce40,DIATER LABORATORIES S.A,diater_laboratories_s_a,,,,,, -8530,,edfd2ebf-1119-4a16-bcdb-e2a763cffa86,REGIONE LOMBARDIA - DIREZIONE GENERALE SANITA',regione_lombardia_direzione_generale_sanita,,,,,, -8531,,2e74cce4-715c-11e6-a0cd-0242ac12000b,BIOCON LIMITED,biocon_limited,,,,,, -8532,,90c31082-7129-11e6-a89e-0242ac12000b,RISING PHARMS INC,rising_pharms_inc,,,,,, -505,0.977622,6555c8c6-714d-11e6-a0cd-0242ac12000b,MEDICIS PHARMS,medicis_pharms,,,,6555c8c6-714d-11e6-a0cd-0242ac12000b,medicis_pharms,MEDICIS PHARMS -8533,,7549b9ee-71f3-11e6-a0cd-0242ac12000b,ONY,ony,,,,,, -8534,,96283000-c8a5-423a-9b74-84199a338271,"Siegfried Kasper, O.Univ.Prof.Dr.Dr.h.c",siegfried_kasper_o_univ_prof_dr_dr_h_c,,,,,, -8535,,03508f85-28d6-49b0-899f-bc01fb89a51b,Novartis CPO to fill,novartis_cpo_to_fill,,,,,, -8536,,0170ea56-e0f8-46a0-8268-c4839915de95,The Office of Interventional Cardiovascular Research and Clinical Trials at Icahn School of Medicine at Mount Sinai,the_office_of_interventional_cardiovascular_research_and_clinical_trials_at_icahn_school_of_medicine_at_mount_sinai,,,,,, -8537,,e84ed8ed-b89d-4e73-93ef-f2364654fe60,South-Eastern Norway Regional Health Authority,south_eastern_norway_regional_health_authority,,,,,, -8538,,bec15c61-5eb7-4259-b4a8-f55b88b28003,Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg,medizinische_fakult_t_der_martin_luther_universit_t_halle_wittenberg,,,,,, -8539,,f727a384-7128-11e6-a89e-0242ac12000b,ROXANE,roxane,,,,,, -8540,,4e911077-8df8-48bb-8e6a-719a06f22bed,advanceCOR GmbH,advancecor_gmbh,,,,,, -8541,,f0ac051d-47b2-4a80-90d4-89b033a1570a,Fondazione IRCCS Istituto Nazionale dei Tumori,fondazione_irccs_istituto_nazionale_dei_tumori,,,,,, -8542,,3230e5f1-6d50-4807-a765-0bc8298c6a16,University Hospital of Heidelberg,university_hospital_of_heidelberg,,,,,, -8543,,1d789de2-e749-4c90-9236-a57dbdbbad1f,CHU de Limoges,chu_de_limoges,,,,,, -8544,,8fb152b2-7304-11e6-a0cd-0242ac12000b,JANSSEN PRODS,janssen_prods,,,,,, -8545,,fa23d0d1-9589-49cc-bc92-dc2f58973fa7,"Wyeth Pharmaceuticals, Inc., Global Medical Affairs",wyeth_pharmaceuticals_inc_global_medical_affairs,,,,,, -8546,,98b62535-eb88-468a-a5bb-669764424c76,"Stockholm Centre for Dependency Disorders, Department of Clinical Neuroscience, Karolinska Institutet",stockholm_centre_for_dependency_disorders_department_of_clinical_neuroscience_karolinska_institutet,,,,,, -653,0.98108148574829102,5c99ca16-39a1-4b89-bbde-8627966f253d,Boehringer Ingelheim RCV GmbH,boehringer_ingelheim_rcv_gmbh,,,,5c99ca16-39a1-4b89-bbde-8627966f253d,boehringer_ingelheim_rcv_gmbh,Boehringer Ingelheim RCV GmbH -8547,,486407f2-2fce-4be9-a316-4060cb2fc5c5,Ipsen Pharma SAS,ipsen_pharma_sas,,,,,, -8548,,d1f99600-153b-4f55-aa26-798012add92e,Boehringer Ingelheim s.r.o,boehringer_ingelheim_s_r_o,,,,,, -517,0.96932509541511536,86458a7f-c0bc-482a-80b9-0330eb6f720f,GELTAMO (Grupo Español de Linfomas y Trasplante autólogo de Médula Ósea),geltamo_grupo_espa_ol_de_linfomas_y_trasplante_aut_logo_de_m_dula_sea,,,,be21c811-4df1-4aa6-8fd6-8b4eb1416f21,geltamo_grupo_espa_ol_de_linfomas_y_transplante_aut_logo_de_m_dula_sea,GELTAMO (Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea) -55,0.95857,5a63db65-468a-4563-9a1e-ba584e5873db,EGIS Gyógyszergyár Nyrt,egis_gy_gyszergy_r_nyrt,,,,43cce800-7149-11e6-a0cd-0242ac12000b,egis,EGIS -8549,,79677272-7163-11e6-a0cd-0242ac12000b,INJECTALIA,injectalia,,,,,, -8550,,0724fe03-4eb0-44f4-8d79-0210316944da,Clinical Research Facilities,clinical_research_facilities,,,,,, -749,0.982152,a8d90b28-ad65-456b-9297-a3e69229fbac,"LABORATORIOS FARMACEUTICOS ROVI, S.A",laboratorios_farmaceuticos_rovi_s_a,,,,7b2e0c4c-d3a5-4991-85ad-b05ef3d7b13e,laboratorios_farmac_uticos_rovi_s_a,"LABORATORIOS FARMACÉUTICOS ROVI, S.A" -8551,,8791673e-8be6-11e6-a449-0242ac12000b,"Medical University Vienna, Gender Medicine Unit, Div. of Endocrinology, Dep of Medicine III",medical_university_vienna_gender_medicine_unit_div_of_endocrinology_dep_of_medicine_iii,,,,,, -8552,,6d0e4e17-0b53-43cd-8cf6-9932ec07b4f1,Johanna Mäenpää,johanna_m_enp,,,,,, -8553,,dde71341-90f4-4a0a-84bd-f1eea260ea15,GBG Forschungs GmbH,gbg_forschungs_gmbh,,,,,, -744,0.98492534955342614,06d53b6c-58a5-4238-a169-c97555ce4cf1,Johann Wolfgang Goethe-Universität Frankfurt,johann_wolfgang_goethe_universit_t_frankfurt,,,,7c93ba08-6123-42f2-a902-d13e42cdd905,johann_wolfgang_goethe_universit_t_frankfurt,Johann Wolfgang Goethe-Universität Frankfurt -22,0.97528120875358582,ae6ad20a-a5ac-4fda-adad-69b8ff220a6a,"University Hospital Heidelberg, Ruprecht-Karls-University Heidelberg",university_hospital_heidelberg_ruprecht_karls_university_heidelberg,,,,ae6ad20a-a5ac-4fda-adad-69b8ff220a6a,university_hospital_heidelberg,University Hospital Heidelberg -8554,,d796a0fa-608c-485a-b0cb-5528cd3f7de8,The Christie NHS Foundation Trust,the_christie_nhs_foundation_trust,,,,,, -8555,,9aba76ae-4e83-45d8-a39e-ca3c06e6f106,AMW GmbH,amw_gmbh,,,,,, -8556,,575d5228-4dd5-4c6d-8412-00a9c8bdc686,The Kirby Institute,the_kirby_institute,,,,,, -8557,,6f3a088a-9e6a-496d-8b4b-9b5bad0c2bed,CIBER (Centro de Investigacion Biomedica en Red),ciber_centro_de_investigacion_biomedica_en_red,,,,,, -8558,,f48570be-112c-4557-8e43-3c9a9d1508b2,Anna Suy Franch,anna_suy_franch,,,,,, -696,0.987337,b9b9cd67-cc2d-4d60-877a-6105b013d4c8,Banc de Sang i Teixits (BST),banc_de_sang_i_teixits_bst,,,,221108ee-7307-42f8-832d-e148617d109a,banc_de_sang_i_teixits,Banc de Sang i Teixits -8559,,e3e976d1-bf4e-4ab6-b7b8-7dbd1b39b6ee,University Hospital Bern,university_hospital_bern,,,,,, -8560,,8a0b43a1-3d86-4919-b5aa-f57bbb85c060,Universidad Autónoma de Madrid,universidad_aut_noma_de_madrid,,,,,, -8561,,50b22772-cfc7-43c3-91ca-536cf7a75265,CNIC Centro Nacional de Investigaciones Cardiológicas,cnic_centro_nacional_de_investigaciones_cardiol_gicas,,,,,, -8562,,672f5bd0-735a-11e6-a0cd-0242ac12000b,ARALEZ PHARMS INC,aralez_pharms_inc,,,,,, -8563,,1d0e99a6-8e82-46a6-aac7-a39eaa75a5fd,ThromboGenics NV,thrombogenics_nv,,,,,, -8564,,94b7ee98-6000-4011-8cc7-f5417dc19486,"National Institute of Oncology, Budapest, Hungary",national_institute_of_oncology_budapest_hungary,,,,,, -8565,,0a6ad179-3bad-4053-b202-cedd4b3d4261,"CENTER LABORATORIES, INC",center_laboratories_inc,,,,,, -8566,,9c9c5294-5b9d-444c-b4b0-b6e65623c5be,Cytos Biotechnology AG,cytos_biotechnology_ag,,,,,, -8567,,fa963581-ca1b-4b1e-9d75-cc00ed30a4bb,University Medical Centre Groningen,university_medical_centre_groningen,,,,,, -8568,,e9e240a4-cc93-4b86-a3d7-0c0c21dd42cc,Philipps-University,philipps_university,,,,,, -8569,,f5831514-980e-46fb-8ab4-1a68284a1ad3,MolMed S.p.A,molmed_s_p_a,,,,,, -412,0.98863863945007324,404bfbb4-d805-4edf-b568-5d60418c0c9b,"Karolinska University Hospital, Huddinge, Sweden",karolinska_university_hospital_huddinge_sweden,,,,404bfbb4-d805-4edf-b568-5d60418c0c9b,karolinska_university_hospital_huddinge_sweden,"Karolinska University Hospital, Huddinge, Sweden" -8570,,a112f96f-0d28-431a-943d-edbe9b8d2859,Mikko Hippeläinen,mikko_hippel_inen,,,,,, -8571,,5f26762d-37d0-416b-b4b9-32249e42c2d9,"CELLTRION, Inc",celltrion_inc,,,,,, -8572,,f154b634-800d-431b-84ee-99ef864397de,GlaxoSmithKline UK Limited,glaxosmithkline_uk_limited,,,,,, -8573,,1143e04a-715e-11e6-a0cd-0242ac12000b,AUROBINDO PHARMA USA,aurobindo_pharma_usa,,,,,, -8574,,5f00e1df-3a89-41b4-8e61-b59f8c07f122,Dr. Winzer Pharma,dr_winzer_pharma,,,,,, -8575,,ce6e748a-73a4-425b-930d-b23b453b6182,GETH (GRUPO ESPAÑOL DE TRASPLANTES HEMOTOPOYETICOS Y TERAPIA CELULAR),geth_grupo_espa_ol_de_trasplantes_hemotopoyeticos_y_terapia_celular,,,,,, -8576,,086dda01-2334-4c24-a48d-ee39a9babce8,Leeds Teaching Hospitals Trust,leeds_teaching_hospitals_trust,,,,,, -484,0.969424,851476be-27ba-4eab-b5ff-59a3965254fc,"Department of Anesthesiology, University Hospital of Erlangen",department_of_anesthesiology_university_hospital_of_erlangen,,,,3ee3992f-cbe0-49c2-8456-39b7a3c82ed9,department_of_anesthesiology_university_hospital_erlangen,"Department of Anesthesiology, University Hospital Erlangen" -8577,,58d478d4-f3f4-4eeb-bcd1-46e6ca5a43f7,Baxter Innovations GmbH,baxter_innovations_gmbh,,,,,, -8578,,87ee186c-7142-11e6-a0cd-0242ac12000b,CHARTWELL LIFE SCI,chartwell_life_sci,,,,,, -8579,,94b75458-5d54-4527-9427-8676008a3bef,Bipebjerg University Hospital,bipebjerg_university_hospital,,,,,, -8580,,a5cff0e0-778f-44f8-8ceb-1415a15d12db,THERAVECTYS,theravectys,,,,,, -8581,,8f759896-7145-11e6-a0cd-0242ac12000b,AUROLIFE PHARMA LLC,aurolife_pharma_llc,,,,,, -8582,,02e08fad-1cab-4d05-b0be-83df1880a266,The Whittington Hospital NHS Trust,the_whittington_hospital_nhs_trust,,,,,, -8583,,e271f333-7430-4959-91cc-4a5ee5c5f8f8,LEGA ITALIANA PER LA LOTTA CONTRO I TUMORI,lega_italiana_per_la_lotta_contro_i_tumori,,,,,, -908,0.95613819360733032,9c45d693-515d-4149-92e4-d7272d06a7df,sanofi-aventis Recherche & D2veloppement,sanofi_aventis_recherche_d2veloppement,,,,9c45d693-515d-4149-92e4-d7272d06a7df,sanofi_aventis_recherche_d_veloppement,sanofi-aventis Recherche & Développement -8584,,eec74860-f316-4df4-aef0-8bb42850a050,Laura Sararols Ramsay,laura_sararols_ramsay,,,,,, -8585,,9c2a7111-85b4-42d0-8ee6-c119b837d44b,"Department of Neurology, Academic Medical Center",department_of_neurology_academic_medical_center,,,,,, -8586,,803dcb85-110d-40c4-a1df-c2a8def0a7eb,University College London-Joint UCLH/UCL Biomedical (R&D) Unit,university_college_london_joint_uclh_ucl_biomedical_r_d_unit,,,,,, -8587,,6478bcb8-71a9-11e6-a0cd-0242ac12000b,ROCHE PALO,roche_palo,,,,,, -8588,,0fe47fcd-cb46-4481-81bd-ca0352aa2d91,CENTRE ANTOINE LACASSAGNE,centre_antoine_lacassagne,,,,,, -8589,,51aa5a17-9203-408d-85ca-388b24dd49a2,Kenta Biotech Ltd,kenta_biotech_ltd,,,,,, -8590,,984ddd59-eadf-4c8f-9faf-9bb31dc53532,Societa' Italiana di Diabetologia,societa_italiana_di_diabetologia,,,,,, -8591,,c5279ad7-5404-411b-9e99-a86789a7e823,Ark Therapeutics Limited,ark_therapeutics_limited,,,,,, -167,0.980699,4f0d312c-f55c-48d0-9554-4b675d8c084f,Universität zu Köln,universit_t_zu_k_ln,,,,4f0d312c-f55c-48d0-9554-4b675d8c084f,universit_t_zu_k_ln,Universität zu Köln -8592,,9cd44c78-715c-11e6-a0cd-0242ac12000b,PHARMALUCENCE,pharmalucence,,,,,, -8593,,dc87ddd7-e28b-4504-9ef9-c51e984aa3a0,Proreo Pharma Innovation AG,proreo_pharma_innovation_ag,,,,,, -8594,,25c396cf-84c9-47c3-a878-f254456b9de1,José Antonio Pérez Simón,jos_antonio_p_rez_sim_n,,,,,, -8595,,62cd5c4c-e532-4f20-8563-3aefe0cb858c,Medizinische Universitätsklinik,medizinische_universit_tsklinik,,,,,, -8596,,509a8302-af1b-43a2-88ec-1b492877788a,Futura Medical Developments (FMD),futura_medical_developments_fmd,,,,,, -8597,,d32724c6-06e2-4758-a95b-25c2c57aab23,Pawel Florkiewicz,pawel_florkiewicz,,,,,, -8598,,ad3f0dcb-3ad5-472a-acf6-cb1ce09bede5,"Janssen-Cilag, S.A",janssen_cilag_s_a,,,,,, -8599,,70c7dd08-ee16-48f8-a07f-67a172a1aa82,European Society for Blood and Marrow Transplantation,european_society_for_blood_and_marrow_transplantation,,,,,, -8600,,0ffa445e-7168-11e6-a0cd-0242ac12000b,ANBISON LAB CO LTD,anbison_lab_co_ltd,,,,,, -8601,,d5e0ad2c-d114-4afc-89c3-769b5a8a107c,"Department für Virologie, Medizinische Universität Wien",department_f_r_virologie_medizinische_universit_t_wien,,,,,, -481,0.98966941237449646,48f0d5ed-174c-4ce4-98d7-cc34770f5107,Medizinische Universität Graz,medizinische_universit_t_graz,,,,48f0d5ed-174c-4ce4-98d7-cc34770f5107, Universitätsklinik für Innere Medizin,Medizinische Universität Graz -8602,,f7e338d3-5e0c-452e-9727-8df788943738,Fundación Retinaplus +,fundaci_n_retinaplus,,,,,, -8603,,b015e510-6fa1-11e6-9663-0242ac12000b,Eli Lilly UK,eli_lilly_uk,,,,,, -664,0.97318911552429199,cc686593-ac41-4dd8-b68b-ccd4a6588b2c,"Charité Berlin, CBF",charit_berlin_cbf,,,,56238a57-b5e3-44be-840b-09e7fea2a5aa,charit,Charité -8604,,3ad51325-5ecd-42ef-9760-f36bb3674207,Jose Ignacio Martin Gomez,jose_ignacio_martin_gomez,,,,,, -8605,,fbaba358-6808-4155-b341-ad1990ad7875,"First Department of Medicine, University of Szeged",first_department_of_medicine_university_of_szeged,,,,,, -8606,,b7611d98-070e-42a9-99ae-a5a3e89960eb,Regulus Therapeutics Inc,regulus_therapeutics_inc,,,,,, -8607,,d7ee6ebb-5405-4626-9a65-4ad8ed539860,St. Olavs Hospital,st_olavs_hospital,,,,,, -8608,,5fd24618-b084-4cc8-82f1-c4a6615a4b85,Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose NVALT,nederlandse_vereniging_van_artsen_voor_longziekten_en_tuberculose_nvalt,,,,,, -8609,,ed72c883-bfac-42e5-a6f2-c3c824973c5a,Ilkka Helenius,ilkka_helenius,,,,,, -8610,,9758bb50-7326-11e6-a0cd-0242ac12000b,SHIRE ORPHAN THERAP,shire_orphan_therap,,,,,, -8611,,73cc4f55-e2c7-4344-be08-d3dde6d76532,"Medizinische Universität Wien,Univ.Klinik f.Psychiatrie und Psychotherapie",medizinische_universit_t_wien_univ_klinik_f_psychiatrie_und_psychotherapie,,,,,, -8612,,9b77457d-8e35-4cb1-8662-e24942e6482a,"Tampere University, Faculty of Medicine, Department of Ophthalmology",tampere_university_faculty_of_medicine_department_of_ophthalmology,,,,,, -8613,,e9cb07a3-33d7-4644-84af-6d1b067635d9,"Deutsche CLL-Studiengruppe, Innere Medizin I, Uniklinik Köln",deutsche_cll_studiengruppe_innere_medizin_i_uniklinik_k_ln,,,,,, -8614,,9d38b4c9-c073-4438-8b16-d7104470a4b0,Prosidion Ltd,prosidion_ltd,,,,,, -8615,,b4703879-359b-4f88-b1be-3719ee244557,Fundación Oncosur,fundaci_n_oncosur,,,,,, -8616,,94540c7e-ed38-4069-8e61-d6ca81d4202e,"University Hospital Tubeingen, Department for Anaesthesiology and Intensive Care Medicine",university_hospital_tubeingen_department_for_anaesthesiology_and_intensive_care_medicine,,,,,, -8617,,4cc1800f-5955-4a3c-95c3-a27d7987f5a8,Klinikum Bremen-Mitte gGmbH,klinikum_bremen_mitte_ggmbh,,,,,, -8618,,d1bb5812-534c-433d-9b27-2cd7d4fc1c7f,KUREHA CORPORATION,kureha_corporation,,,,,, -8619,,801f5f7c-78fe-4a3b-876a-e2eb97bbb1b5,"Faculty of Pharmacy, University of Ljubljana",faculty_of_pharmacy_university_of_ljubljana,,,,,, -8620,,0774bc57-1d2e-45f8-934e-0910726813b8,TETEC – Tissue Engineering Technologies – AG,tetec_tissue_engineering_technologies_ag,,,,,, -547,0.96279633045196533,f39351ef-0171-4a59-8396-08eb684a148b,G.O.N.O. - GRUPPO ONCOLOGICO NORD OVEST,g_o_n_o_gruppo_oncologico_nord_ovest,,,,8f1a10a0-5c3a-45de-a1fa-2ff0f80316bf,g_o_n_o,G.O.N.O -8621,,a088249b-bd51-4f4b-9ae0-2bd367bda93e,"Klinikum Großhadern, University of Munich / Medical Director: Prof. Dr. med. Burkhard Götze",klinikum_gro_hadern_university_of_munich_medical_director_prof_dr_med_burkhard_g_tze,,,,,, -927,0.983072,61519487-23d4-417a-83c9-581008f2af7b,The University of Edinburgh,the_university_of_edinburgh,,,,61519487-23d4-417a-83c9-581008f2af7b,the_university_of_edinburgh,The University of Edinburgh -8622,,115b014d-4e03-4106-9b25-f6ed611256c2,Oulun yliopisto,oulun_yliopisto,,,,,, -8623,,912a356a-b325-404a-8e30-be485bc0b3a4,NYCOMED PHARMA S.A,nycomed_pharma_s_a,,,,,, -179,0.977461,d48e9f34-7129-11e6-a89e-0242ac12000b,MUTUAL PHARM,mutual_pharm,,,,7307791a-55cf-4462-a41c-9a905939b273,mutual_pharmaceutical_company,MUTUAL PHARMACEUTICAL COMPANY -8624,,b6e029cd-dfb3-4992-b70c-21a8d09ab339,HCRI,hcri,,,,,, -8625,,7f710db0-a7f3-4f3d-82d4-e131f6d79d43,Otto M. Lesch,otto_m_lesch,,,,,, -8626,,bc55d515-e631-42a2-9b8f-e99c0122f647,Technical University Dresden,technical_university_dresden,,,,,, -8627,,65cd8232-3fb5-411a-a0bf-36dcc7b41488,GEIS (Grupo Español de Investigación en Sarcomas),geis_grupo_espa_ol_de_investigaci_n_en_sarcomas,,,,,, -8628,,8043786a-fbd2-4077-a6c1-44b8cc222dba,Astellas Pharma Europe R&D,astellas_pharma_europe_r_d,,,,,, -566,0.961636,b7bdd038-73c6-11e6-a0cd-0242ac12000b,ARIAD,ariad,,,,b7bdd038-73c6-11e6-a0cd-0242ac12000b,ariad,ARIAD -8629,,4f7e9c10-3721-4704-887c-10664998fcb9,Organisation name was not entered,organisation_name_was_not_entered,,,,,, -8630,,c58c0c0e-7158-11e6-a0cd-0242ac12000b,P AND L DEV LLC,p_and_l_dev_llc,,,,,, -8631,,ee8ea8b1-0680-453e-993e-a8a2773178e0,Rottapharm Biotech S.r.l,rottapharm_biotech_s_r_l,,,,,, -8632,,deafec93-c588-4175-9ca4-53bffc9a816e,Dutch Growth Research Foundation,dutch_growth_research_foundation,,,,,, -8633,,742c6598-7126-11e6-8a77-0242ac12000b,ANI PHARMS INC,ani_pharms_inc,,,,,, -8634,,0c1121e8-72d3-11e6-a0cd-0242ac12000b,SANTARUS,santarus,,,,,, -116,0.9602716167767843,44b4c49c-9a8b-4c93-9711-4dbfaddc5944,Shire Pharmaceutical Development Ltd,shire_pharmaceutical_development_ltd,,,,63ca73d2-fd68-4693-872c-2121b000d68c,shire_pharmaceutical_development,Shire Pharmaceutical Development -8635,,94ade1ca-30ed-404c-adfd-d8590badbce6,University Hospital Hvidovre,university_hospital_hvidovre,,,,,, -972,0.95330953598022461,de80dadb-e63d-4edc-a9df-2bcdec441425,Schering Plough Reserach Institute,schering_plough_reserach_institute,,,,4f0fa6e4-6773-4398-b96f-befbaf1b6648,schering_plough_research_institute_una_divisi_n_de_schering_corporation,"Schering Plough Research Institute, una División de Schering Corporation" -8636,,aca2e8ce-1941-4d1d-97e9-13d57077b5df,Medizinische Universität Graz/Endokrinologie und Stoffwechsel,medizinische_universit_t_graz_endokrinologie_und_stoffwechsel,,,,,, -8637,,637a2f2b-ba3d-4511-b7d3-e24f0e9758b6,Gedeon Richter Co,gedeon_richter_co,,,,,, -8638,,4ce9e2d6-7166-11e6-a0cd-0242ac12000b,ZYDUS HLTHCARE,zydus_hlthcare,,,,,, -8639,,67318b65-065a-4116-9080-c3bbd54aca1b,Karolinska Univsjukhuset,karolinska_univsjukhuset,,,,,, -324,0.97704669833183289,0a082bad-97ec-4e82-be7d-2731907614ac,Stiefel Laboratories,stiefel_laboratories,,,,0a082bad-97ec-4e82-be7d-2731907614ac,stiefel_laboratories_maidenhead_ltd,Stiefel Laboratories Maidenhead Ltd -8640,,4e6f8814-7142-11e6-a0cd-0242ac12000b,PARKE DAVIS,parke_davis,,,,,, -8641,,95fff0b0-7165-11e6-a0cd-0242ac12000b,AJANTA PHARMA,ajanta_pharma,,,,,, -808,0.94340622425079346,a229c9bd-df44-4c2a-8a62-504933fe2c02,Biogen Idec Inc,biogen_idec_inc,,,,9dd926b0-8d48-4d08-b638-2eb1c4764ba3,biogen_idec_international_gmbh,Biogen Idec International GmbH -8642,,bccfb179-0db5-4ad1-9e2d-64be074371e0,"Allgemeines Krankenhaus Wien, Medizinische Un iversität Wien",allgemeines_krankenhaus_wien_medizinische_un_iversit_t_wien,,,,,, -8643,,bd61c79f-b039-4859-993c-44faa12f22eb,"rijnstate hospital, the netherlands",rijnstate_hospital_the_netherlands,,,,,, -8644,,313f2971-9924-407b-b1b1-8e1dc612950a,Fundació Sant Joan de Deu de Barcelona,fundaci_sant_joan_de_deu_de_barcelona,,,,,, -8645,,59af1cf9-7270-430f-9dc5-f9018b98d84a,"Queen Mary's, University of London",queen_mary_s_university_of_london,,,,,, -615,0.90712672472000122,b91c3565-2af8-4719-8b4c-539db2f1b5a7,Fundación para la Investigación Biomédica del Hospital Universitario La Paz-Sección Cirugía Torácica,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz_secci_n_cirug_a_tor_cica,,,,27b37686-1c0f-4738-ab0a-36c44f7ea9cc,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz_secci_n_de_cirug_a_colorrectal_del_hospital,"Fundación para la Investigación Biomédica del Hospital Universitario La Paz, Sección de Cirugía Colorrectal del Hospital" -8646,,f53eb2ec-b627-4b35-8c03-e72a5b71e05f,Psychiatric Hospital,psychiatric_hospital,,,,,, -8647,,3e3d9857-a6d1-11e6-94cb-5656d04fc2b5,"Universitätsklinik für Dermatologie, Paracelsus medizinische Privatuniversität Salzburg",universit_tsklinik_f_r_dermatologie_paracelsus_medizinische_privatuniversit_t_salzburg,,,,,, -8648,,c01779a7-0a62-42a7-932b-649b1eb1c567,"Department of Anaesthesie, General Intensive Care and Pain Therapy, Medical University of Vienna",department_of_anaesthesie_general_intensive_care_and_pain_therapy_medical_university_of_vienna,,,,,, -8649,,b6f41476-6f9f-11e6-9663-0242ac12000b,OxThera AB,oxthera_ab,,,,,, -8650,,cbb3265a-7129-11e6-a89e-0242ac12000b,DURAMED PHARMS BARR,duramed_pharms_barr,,,,,, -8651,,d2ba79da-6f9e-11e6-9663-0242ac12000b,Region skåne- Hässleholms sjukvårdsorganisation,region_sk_ne_h_ssleholms_sjukv_rdsorganisation,,,,,, -8652,,53e41950-732b-11e6-a0cd-0242ac12000b,DIGESTIVE CARE INC,digestive_care_inc,,,,,, -8653,,154ffa3c-7269-11e6-a0cd-0242ac12000b,CHIRHOCLIN,chirhoclin,,,,,, -8654,,c77e1cac-2825-4fa1-a654-d06c290529a4,Unfallkrankenhaus Salzburg,unfallkrankenhaus_salzburg,,,,,, -8655,,34dc8ccc-7a69-4e68-9612-c2f3cc48ffba,Novartis Hungary Ltd,novartis_hungary_ltd,,,,,, -8656,,1d69a67a-0005-446b-a50d-f7096ac72a89,Columbia University Medical Center of New York,columbia_university_medical_center_of_new_york,,,,,, -8657,,ed849ce0-89e5-4e71-b88e-5e4808f4d03d,"Prof. dr L.H. van den Berg, UMC-Utrecht",prof_dr_l_h_van_den_berg_umc_utrecht,,,,,, -1038,0.988575,9ac131bc-a6d9-4ae6-b2ba-0582d8a53b0c,International Breast Cancer Study Group,international_breast_cancer_study_group,,,,9ac131bc-a6d9-4ae6-b2ba-0582d8a53b0c,international_breast_cancer_study_group,International Breast Cancer Study Group -8658,,64f12ac7-fd42-4386-a6cf-da4e318375d6,St Helier Hospital NHS Trust,st_helier_hospital_nhs_trust,,,,,, -8659,,7b3770f3-19d7-4dea-9328-8425d8499ecb,Landstinget Dalarna,landstinget_dalarna,,,,,, -1031,0.98682358860969543,9f76459d-c1a5-4dfd-8ba3-7773bf3ebbce,Medical University of Vienna, Clinical Pharmacology,,,,9f76459d-c1a5-4dfd-8ba3-7773bf3ebbce,medical_university_of_vienna_department_of_pediatrics,Medical University of Vienna -8660,,371aa03a-ab82-44ef-bded-846afbbf6b0c,Dr. F. Köhler Chemie GmbH,dr_f_k_hler_chemie_gmbh,,,,,, -8661,,743770be-9f7f-4adb-9d42-bcc511a1f24b,LUIS FERNÁNDEZ- LLEBREZ DEL REY,luis_fern_ndez_llebrez_del_rey,,,,,, -8662,,ddeeeee8-757d-4350-b4ec-60dfe980fed7,BioVex Ltd,biovex_ltd,medical_university_of_vienna_clinical_pharmacology,,,,, -8663,,cd1ef2f1-130f-4074-966c-772a0933d0f4,"Academic Medical Center, Division of Clinical Immunology and Rheumatology",academic_medical_center_division_of_clinical_immunology_and_rheumatology,,,,,, -456,0.95666962862014771,6704e020-719e-11e6-a0cd-0242ac12000b,CIS,cis,,,,6704e020-719e-11e6-a0cd-0242ac12000b,cis,CIS -8664,,c091cee9-385b-4179-a73f-948573a30b6e,Karen Schow Jensen,karen_schow_jensen,,,,,, -8665,,ad27a5b4-a509-40f0-8e76-d974bae290ac,UCB AE,ucb_ae,,,,,, -8666,,67577034-4bfb-48bf-8317-3617a9c60dae,BIOSENSORS EUROPE SA,biosensors_europe_sa,,,,,, -8667,,8e9920c5-e3ad-424a-95ba-3f5823a6c1c6,"Department of Surgery, National University of Ireland",department_of_surgery_national_university_of_ireland,,,,,, -881,0.98332688212394714,cb4fde3e-856f-4edb-bc1c-581119caaf6d,PIERRE FABRE MEDICAMENT - IDPF,pierre_fabre_medicament_idpf,,,,d9486864-e255-4256-b088-49f706c79293,pierre_fabre_medicament,PIERRE FABRE MEDICAMENT -8668,,7d145ec5-ecac-4117-831e-9cdd0846d0a5,"Provident Clinical Research & Consulting, Inc",provident_clinical_research_consulting_inc,,,,,, -8669,,5264bdd5-d695-4479-ab93-658947d62076,Axcentua Pharmaceuticals AB,axcentua_pharmaceuticals_ab,,,,,, -398,0.988564,40763009-de94-4c2e-a686-9a5a36e5ac86,St. Anna Kinderkrebsforschung/CCRI,st_anna_kinderkrebsforschung_ccri,,,,40763009-de94-4c2e-a686-9a5a36e5ac86,st_anna_kinderkrebsforschung_ccri,St. Anna Kinderkrebsforschung/CCRI -8670,,9a6416a8-881d-11e6-a998-0242ac12000b,Department of Haematology,department_of_haematology,,,,,, -8671,,4aa0c5f7-a5a8-4a46-b6a4-26f4be33b9e9,"Copenhagen University Hospital, Hvidovre",copenhagen_university_hospital_hvidovre,,,,,, -383,0.97420346736907959,ba5529ec-c151-4f81-b680-ad7ca9afb4fb,DBV Technologies SA,dbv_technologies_sa,,,,cf4f2be5-6c16-4774-80da-73c264a99c4c,dbv_technologies,DBV Technologies -8672,,c0ee19bc-95f1-4363-b634-e6645ddf8dd0,Evgen,evgen,,,,,, -8673,,d4a0f30a-5276-4fdb-b7d8-8f8a1d089a85,GIDO (Grup d?investigació i divulgació en oncologia),gido_grup_d_investigaci_i_divulgaci_en_oncologia,,,,,, -8674,,25286e4b-5831-429a-805d-676346ed8356,UCB S.A. Casa Madre,ucb_s_a_casa_madre,,,,,, -8675,,af102fde-f01f-4f62-81a1-93833e9bd0e1,GLAXOSMITHKLINE S.P.A,glaxosmithkline_s_p_a,,,,,, -8676,,9c65921a-330c-460a-b279-8275da958283,"Cardioxyl Pharmaceuticals, Inc",cardioxyl_pharmaceuticals_inc,,,,,, -8677,,3e7b8c49-6ff8-40d4-9e42-98cd4890ef3b,Universitair Medisch Cemtrum Utrecht,universitair_medisch_cemtrum_utrecht,,,,,, -545,0.987705,302c2638-8bd6-11e6-a449-0242ac12000b,HOSPITAL UNIVERSITARI DE BELLVITGE - IDIBELL,hospital_universitari_de_bellvitge_idibell,,,,302c2638-8bd6-11e6-a449-0242ac12000b,hospital_universitari_de_bellvitge_idibell,HOSPITAL UNIVERSITARI DE BELLVITGE - IDIBELL -8678,,19b83e59-fad9-41af-8591-c25671ac5812,"DalCor Pharma UK Ltd, Altrincham, Swiss Branch Zug",dalcor_pharma_uk_ltd_altrincham_swiss_branch_zug,,,,,, -8679,,494e3536-94fb-412f-bd2d-50df4ddf7b57,Janssen-Cilag Oy,janssen_cilag_oy,,,,,, -578,0.98331677913665771,724d1bdc-e54a-4c73-b212-98071e708ad2,"Wyeth Pharmaceuticals Inc. Acting through its division Wyeth Research, a Pfizer Company",wyeth_pharmaceuticals_inc_acting_through_its_division_wyeth_research_a_pfizer_company,,,,724d1bdc-e54a-4c73-b212-98071e708ad2,wyeth_pharmaceuticals_inc_acting_through_its_division_wyeth_research_a_pfizer_company,"Wyeth Pharmaceuticals Inc. Acting through its division Wyeth Research, a Pfizer Company" -8680,,c1166331-95bd-4c02-b42b-3c27ccf0d74d,IVI Valencia,ivi_valencia,,,,,, -8681,,b8e2e1cd-d20d-48dc-9b12-6420a00a8f61,PENTA Foundation Onlus,penta_foundation_onlus,,,,,, -8682,,9ade14c9-0bf1-4ede-97a3-be13df8e883b,Fundacion Leucemia y Linfoma,fundacion_leucemia_y_linfoma,,,,,, -8683,,0146dac9-e215-4fb1-9cae-1d125387a27c,Fundació institut d'investigació Biomèdica de Girona (IdibGi),fundaci_institut_d_investigaci_biom_dica_de_girona_idibgi,,,,,, -8684,,9abb8f58-715e-11e6-a0cd-0242ac12000b,CROWN LABS,crown_labs,,,,,, -27,0.982297,a648135c-efbc-489a-8904-931f235b854c,"Integrated Therapeutics Group, Inc - A Subsidiary of Schering-Plough",integrated_therapeutics_group_inc_a_subsidiary_of_schering_plough,,,,8f30be7a-db80-4d4f-b679-8ae4bed90a55,integrated_therapeutics_group_inc,"Integrated Therapeutics Group, Inc" -220,0.987246,28a6a997-3c3d-4bd8-8c3e-e02946553a33,Sanofi-Aventis Recherche & Devéloppement,sanofi_aventis_recherche_dev_loppement,,,,28a6a997-3c3d-4bd8-8c3e-e02946553a33,sanofi_aventis_recherche_dev_loppement,Sanofi-Aventis Recherche & Devéloppement -8685,,1dca08c5-66ef-4b37-a80d-9b2c1fe150f7,VO Anesthesia/ICU Lunds University Hospital,vo_anesthesia_icu_lunds_university_hospital,,,,,, -800,0.972677,15671013-8a1c-41eb-b118-71cf71e315ed,Institut Català d’Oncologia,institut_catal_d_oncologia,,,,15671013-8a1c-41eb-b118-71cf71e315ed,institut_catal_d_oncologia,Institut Català d’Oncologia -8686,,f9ccd3d4-8bbd-11e6-a449-0242ac12000b,Region Örebro län,region_rebro_l_n,,,,,, -8687,,a36ef4cf-ba5f-4842-9544-7a50d1c8c176,Nottingham University Hospitals NHS Trust,nottingham_university_hospitals_nhs_trust,,,,,, -8688,,a4891dec-efde-4efa-9812-500f7b9e02ec,Sigma Tau industrie Farmaceutiche Riunite Spa,sigma_tau_industrie_farmaceutiche_riunite_spa,,,,,, -8689,,c8689110-00b1-4645-8b84-9fdbc180f0dc,Perle Bioscience Inc,perle_bioscience_inc,,,,,, -8690,,5ce17e74-12cb-46e1-9e84-a6647a55d901,Gateshead Health NHS Foundation Trust,gateshead_health_nhs_foundation_trust,,,,,, -8691,,4f99e3ad-6dc0-46ee-9ce0-88c321b7402f,MABION SA,mabion_sa,,,,,, -8692,,1059e61e-cbde-4f81-a287-1d7a6e824eb2,GIENNE PHARMA S.P.A,gienne_pharma_s_p_a,,,,,, -8693,,aeaad61d-d2e4-4776-b5a2-779e49bef251,Endokrinologisk afd. M,endokrinologisk_afd_m,,,,,, -8694,,1a2338c8-d0f5-41ed-b7d9-e712bcd98edf,Liverpool School of Tropical Medicine,liverpool_school_of_tropical_medicine,,,,,, -8695,,708c8814-7167-11e6-a0cd-0242ac12000b,RICONPHARMA LLC,riconpharma_llc,,,,,, -8696,,ae5e9fe5-25c8-4f24-aab9-af5c5350da70,Universität Bremen,universit_t_bremen,,,,,, -950,0.97788405418395996,81d08cd4-daca-44d5-a95c-df32249997c1,MedImmune LLC (a wholly owned subsidiary of AstraZeneca PLC),medimmune_llc_a_wholly_owned_subsidiary_of_astrazeneca_plc,,,,389af5e7-be5f-4143-aff1-2c121f2ec673,medimmune_llc_a_wholly_owned_subsidiary_of_astrazeneca_plc_one_medimmune_way_gaithersburg_maryland_20878_usa,"MedImmune LLC (a wholly owned subsidiary of AstraZeneca PLC, One MedImmune Way, Gaithersburg, Maryland, 20878, USA)" -731,0.9761795699596405,088dce89-2da7-4622-a385-888595d708d2,Bristol-Myers Squibb International,bristol_myers_squibb_international,,,,55b1cd8b-93b6-4262-9f20-ab35fbdc2476,bristol_myers_squibb_international_corporation,Bristol-Myers Squibb International Corporation -8697,,c1f98b71-ac2b-425b-8c36-dc23ccb021fd,"Ionis Pharmaceuticals, Inc",ionis_pharmaceuticals_inc,,,,,, -1007,0.977549,31e6b140-0f0d-4d6f-950c-f719a9051d5d,Laboratorios Farmalider S.A,laboratorios_farmalider_s_a,,,,31e6b140-0f0d-4d6f-950c-f719a9051d5d,laboratorios_farmalider_s_a,Laboratorios Farmalider S.A -8698,,486136ce-f2f6-401b-b3ed-df3d93314d8b,FLUIDDA nv,fluidda_nv,,,,,, -8699,,3587ff2b-a992-49ab-8c0d-b428f40a54ef,"Merck, Sharp and Dohme Corp., a subsidiary of Merck & Co., Inc",merck_sharp_and_dohme_corp_a_subsidiary_of_merck_co_inc,,,,,, -8700,,efd54f73-d3b6-4d50-837e-1c584326aa51,PRO APARTS SRL,pro_aparts_srl,,,,,, -8701,,c90e36cc-039a-423e-bd64-c9304b8fd92e,Akros Pharma Inc,akros_pharma_inc,,,,,, -8702,,390c8e7d-a1cc-4b0f-bbd6-f054973cb52e,Studienzentrale AGO Austria,studienzentrale_ago_austria,,,,,, -8703,,b573dc81-c442-412a-8dd5-2cd779cc4cd2,Syntopix Group plc,syntopix_group_plc,,,,,, -8704,,090e8562-72d8-11e6-a0cd-0242ac12000b,CP PHARMS,cp_pharms,,,,,, -8705,,46436a73-a03b-4d82-bfb0-90bfa7362254,"RegenMedTX, LLC",regenmedtx_llc,,,,,, -8706,,5a5127f7-fd96-453d-9182-a78dc30a5618,Andi-Ventis Ltd,andi_ventis_ltd,,,,,, -8707,,43425f73-a9e8-457f-aab8-9816739cd8c2,Chiesi Farmaceutici,chiesi_farmaceutici,,,,,, -8708,,a1d2d39a-73ee-11e6-a0cd-0242ac12000b,AIR LIQUIDE AMERICA SPECIALITY GASES,air_liquide_america_speciality_gases,,,,,, -127,0.903091,9e1efa85-0554-405e-87df-0f240ec86ca6,"Medizinische Universität Wien, Abteilung für Nephrologie und Dialyse",medizinische_universit_t_wien_abteilung_f_r_nephrologie_und_dialyse,,,,0e706737-525b-47af-863b-c9b8ecf5a50a,medizinische_universit_t_wien_klinische_abteilung_f_r_nephrologie_und_dialyse_universit_tsklinik_f_r_innere_medizin_3,"Medizinische Universität Wien, Klinische Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin 3" -8709,,2b0c1ddd-8098-4140-9517-32b4af68cdd0,ThromboGenics N.V,thrombogenics_n_v,,,,,, -8710,,045bd38b-643f-42c9-b2b6-6c5c4330394a,UZBrussel,uzbrussel,,,,,, -8711,,2bc18882-c129-4b4e-8c74-78291248948d,Hanna Illman,hanna_illman,,,,,, -76,0.979965,42ae3bc2-6aa6-4f76-977a-25863d6912a4,Hamilton Health Sciences Corporation,hamilton_health_sciences_corporation,,,,42ae3bc2-6aa6-4f76-977a-25863d6912a4,hamilton_health_sciences_corporation,Hamilton Health Sciences Corporation -8712,,21cdf274-7227-11e6-a0cd-0242ac12000b,SUNOVION PHARMS INC,sunovion_pharms_inc,,,,,, -8713,,2a870ec5-e239-4123-94be-0dcf076530fe,"Edge Therapeutics, Inc",edge_therapeutics_inc,,,,,, -8714,,8ffe82a0-5eb7-46d1-89e1-cde2cc7867a0,Groupe Est Ouest des Leucémies et Autres Maladies du Sang,groupe_est_ouest_des_leuc_mies_et_autres_maladies_du_sang,,,,,, -8715,,cc7237aa-4f8d-4dbc-bb7e-3939539fb541,B. Braun Medical s.r.o,b_braun_medical_s_r_o,,,,,, -8716,,15b0b103-0a45-44c0-9a5b-ed7d8cacf8be,Prof David Cunningham,prof_david_cunningham,,,,,, -8717,,56c44e13-7e94-4e6f-a2db-dbc286478beb,CSL Behring LLC,csl_behring_llc,,,,,, -372,0.969108,49ce0f44-8261-4758-a6c3-732d14878ed0,GELA Group,gela_group,,,,24923580-c2a6-4b1d-955c-8c39f4256096,gela,GELA -8718,,a177d8c7-c9fe-4fc6-9133-a394a1539f23,Stichting NVALT studies,stichting_nvalt_studies,,,,,, -8719,,d07c5570-a350-45ff-9d25-5e533e3776c0,BOIRONSIH,boironsih,,,,,, -8720,,dd671efa-72bf-11e6-a0cd-0242ac12000b,ANDRX LABS LLC,andrx_labs_llc,,,,,, -8721,,52ef3132-7165-11e6-a0cd-0242ac12000b,SOFGEN PHARMS,sofgen_pharms,,,,,, -8722,,3e307368-cfa3-4c8f-9df8-eaf16da71169,Ville-Valtteri Välimäki,ville_valtteri_v_lim_ki,,,,,, -8723,,d651b60f-1ef9-4d88-9dc8-391c5498d4ea,Friedrich-Schiller-Universität Jena,friedrich_schiller_universit_t_jena,,,,,, -8724,,6828cd52-56c4-4d87-af08-b4e2e292803a,Sheffield Children's NHS Trust,sheffield_children_s_nhs_trust,,,,,, -8725,,576a76f8-fc4c-461c-bcc0-356671e681d2,Pfizer Luxembourg SARL Latvia Branch,pfizer_luxembourg_sarl_latvia_branch,,,,,, -8726,,1748ac62-4a6e-46a9-8bb9-5dd9ac5dab88,"R & D Directorate,Central Manchester and Manchester Children's University Hospitals NHS Trust",r_d_directorate_central_manchester_and_manchester_children_s_university_hospitals_nhs_trust,,,,,, -8727,,72fd0e56-f793-4c56-a377-f607edf4ad11,"Doc. MUDr. Petr Kolář, PhD, Oční klinika FN Brno",doc_mudr_petr_kol_phd_o_n_klinika_fn_brno,,,,,, -48,0.979231,ba12a838-560c-435d-82d8-aa43b0e18a62,Fresenius Kabi Deutschland GmbH,fresenius_kabi_deutschland_gmbh,,,,ad79d699-2379-4397-bd1d-3bc4a90f3635,fresenius_kabi,Fresenius Kabi -8728,,e971f84e-f16a-4d48-b76e-04b10b800e52,University of Giessen,university_of_giessen,,,,,, -8729,,3069e020-75e5-4d0f-b92a-9cad1dd4ab7b,"Sangart, Inc",sangart_inc,,,,,, -8730,,1371b99a-ce7b-44f8-9508-f02aaa89ebfb,"KAI Pharmaceuticals, Inc (a subsidiary of Amgen, Inc.)",kai_pharmaceuticals_inc_a_subsidiary_of_amgen_inc,,,,,, -8731,,2f457a93-1d9b-4486-9040-b7fe7b826d3a,"Auspex Pharmaceuticals, Inc",auspex_pharmaceuticals_inc,,,,,, -470,0.96829813718795776,6daf0d32-440a-4a03-80f9-78c344d1e2a4,European group for Blood and Marrow Transplantation,european_group_for_blood_and_marrow_transplantation,,,,2a4e4a42-e5c4-4da8-8f1f-18343eeb1fbc,european_group_for_blood_and_marrow_transplantation,European Group for Blood and Marrow Transplantation (EMBT) -8732,,e41b5c84-e4f0-430d-a8dd-ca88bfb595c4,EORTC-European Organisation for the Research and Treatment of Cancer,eortc_european_organisation_for_the_research_and_treatment_of_cancer,,,,,, -8733,,b4a5f2ff-e8fb-408d-a970-e825f8ebc066,Federico Martinon Torres,federico_martinon_torres,,,,,, -8734,,b152d898-42dc-4921-9c80-8b64e81118a9,"Universitätsklinik für Zahn-, Mund- und Kieferheilkunde, Med Uni Graz, Department für zahnärztliche Chirurgie",universit_tsklinik_f_r_zahn_mund_und_kieferheilkunde_med_uni_graz_department_f_r_zahn_rztliche_chirurgie,,,,,, -8735,,254abc98-e539-480b-b5eb-6960b87fe6f8,Promius Pharma LLC,promius_pharma_llc,,,,,, -8736,,faf8c6f9-0d48-49b5-8d82-8c7b07f1f018,Kowa Research Europe,kowa_research_europe,,,,,, -8737,,e000d975-f1c4-48db-a8e3-8d6923c66a71,DOMPE` s.p.a,dompe_s_p_a,,,,,, -8738,,a2bd3a13-b1e1-46d7-9527-b74271f9388f,SmithKline Beecham plc,smithkline_beecham_plc,,,,,, -8739,,d15cd414-d417-4467-acf5-407b852fd54c,Radboud Universitair Medisch Centrum,radboud_universitair_medisch_centrum,,,,,, -8740,,29e502d1-c59b-43de-bbfc-83723deb76ea,"Ironwood Pharmaceuticals, Inc",ironwood_pharmaceuticals_inc,,,,,, -8741,,74e628c2-715b-11e6-a0cd-0242ac12000b,CARACO,caraco,,,,,, -8742,,b904b00d-2ae5-4cb2-ba5d-1880448791e9,York Teaching Hospital NHS Foundation Trust,york_teaching_hospital_nhs_foundation_trust,,,,,, -8743,,2d0ca376-73b0-11e6-a0cd-0242ac12000b,PFIZER CONS HLTHCARE,pfizer_cons_hlthcare,,,,,, -8744,,881e8508-7055-41bb-8e43-82d083b7c4f0,Guys and St Thomas Foundation Trust,guys_and_st_thomas_foundation_trust,,,,,, -8745,,73c3e342-d6ce-44ac-bf0a-cae75c4ad2c0,North West London Hospitals NHS Trust,north_west_london_hospitals_nhs_trust,,,,,, -8746,,8ead3089-d4d3-4427-8527-ca6f88c80d53,"Radboud University Medical Centre, department of Psychiatry",radboud_university_medical_centre_department_of_psychiatry,,,,,, -8747,,b436bb3b-40f3-489d-a50a-69a6f75401bc,Addiction Center Stockholm,addiction_center_stockholm,,,,,, -8748,,c06b8f40-7141-11e6-a0cd-0242ac12000b,VINTAGE,vintage,,,,,, -8749,,7e785034-6dd0-4baa-bce8-152c9a83447d,Hopital Foch,hopital_foch,,,,,, -8750,,c5ca549b-db8b-4238-a0d9-0f2ff896ed5a,"Xanthus Pharmaceuticals, Inc",xanthus_pharmaceuticals_inc,,,,,, -8751,,07662a8c-1f13-479b-9ec5-8e3760f4895a,"Medizinische Universität Wien, Universitätsklinik für dermatologie",medizinische_universit_t_wien_universit_tsklinik_f_r_dermatologie,,,,,, -8752,,7acfc7e5-7c8f-470f-acef-63c605d6d6b4,Fundación Oftalmológica del Mediterráneo,fundaci_n_oftalmol_gica_del_mediterr_neo,,,,,, -8753,,354c044c-6f9a-11e6-9663-0242ac12000b,Imperial College Academic Healthsciences Centre,imperial_college_academic_healthsciences_centre,,,,,, -8754,,b6d8e476-715c-11e6-a0cd-0242ac12000b,CSPC OUYI PHARM CO,cspc_ouyi_pharm_co,,,,,, -354,0.989467,8c2481e7-c913-492c-8830-6e29c9a7e467,NERVIANO MEDICAL SCIENCES,nerviano_medical_sciences,,,,30b1f9cc-f511-477c-bf64-97f87e3f4260,nerviano_medical_science,NERVIANO MEDICAL SCIENCE -8755,,d0f1cddd-b19c-4629-85e9-953104f94c8e,"Prof Allan Glanville, St Vincents Hospital",prof_allan_glanville_st_vincents_hospital,,,,,, -8756,,e92c763a-bf1f-4b4e-b8ac-060d5c8e23f1,Wyeth Kabushiki Kaisha (Wyeth K.K.),wyeth_kabushiki_kaisha_wyeth_k_k,,,,,, -8757,,39f251e7-38f4-4ce6-bb38-d5c2601c3f99,KANEKA coorporation,kaneka_coorporation,,,,,, -8758,,9692ce36-7164-11e6-a0cd-0242ac12000b,MICRO LABS LTD INDIA,micro_labs_ltd_india,,,,,, -8759,,deba5488-5cc8-4705-aadb-89f733d369db,Research and Development Nottingham University Hospital,research_and_development_nottingham_university_hospital,,,,,, -8760,,ec80b473-4382-41db-9835-82306083078b,Astion Pharma A/S,astion_pharma_a_s,,,,,, -857,0.97367624938488007,290d2d3b-f1a1-49d6-9746-666719415232,Institut de Recerca del Hospital de la Santa Creu i Sant Pau,institut_de_recerca_del_hospital_de_la_santa_creu_i_sant_pau,,,,0213f530-437f-430a-b936-0bfa94166165,institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau -135,0.982105,0ae43754-1f42-4540-8952-a2c6dce4050c,Procter and Gamble,procter_and_gamble,,,,0ae43754-1f42-4540-8952-a2c6dce4050c,procter_and_gamble,Procter and Gamble -8761,,9395e78a-b8e7-4970-939b-0e02eb7bfbc2,Juan Luis Bonilla Palomas,juan_luis_bonilla_palomas,,,,,, -8762,,767d4b91-aa5f-4861-b8f4-6326b3ca8605,HYKS Naistensairaala,hyks_naistensairaala,,,,,, -8763,,ffa2f3f0-e9d5-4862-9e3c-700358d24246,Comarca Ezkerraldea-Enkarterri (OSAKIDETZA),comarca_ezkerraldea_enkarterri_osakidetza,,,,,, -8764,,1b588a85-5618-4f81-97f8-c4df743a687d,RDR Pharma GmbH,rdr_pharma_gmbh,,,,,, -8765,,a98f29cd-03b6-4509-8c03-4643a9d16075,University Hospital Antwerp : Department Respiratory Medicine,university_hospital_antwerp_department_respiratory_medicine,,,,,, -8766,,3664923c-9f53-460c-a704-0617b9089038,Bama-Geve S.L,bama_geve_s_l,,,,,, -8767,,03a8c64d-e64e-46ba-adcf-50595e9a9038,"Achillion Pharmaceuticals, Inc",achillion_pharmaceuticals_inc,,,,,, -8768,,e0b7754e-b1b9-4fba-a36f-6d7fd531598f,"Merck and Co., Inc",merck_and_co_inc,,,,,, -8769,,ceb11b5e-8f40-488b-bc9b-31124ce0489c,Hospital Universitario de Lovaina,hospital_universitario_de_lovaina,,,,,, -8770,,95f0b1fb-dcb6-4765-b631-b73a20eb686e,IRCCS-IRST of Meldola,irccs_irst_of_meldola,,,,,, -8771,,1d78265e-cbcc-4c7f-aa86-755345d52cb6,"Anesthesiology Clinic,Akademiska Sjukhuset, Uppsala",anesthesiology_clinic_akademiska_sjukhuset_uppsala,,,,,, -8772,,df55ec41-a996-49a0-b9ce-340d21127348,AFAR,afar,,,,,, -8773,,25f0436a-ac9a-4458-8a1e-62487a63a882,Nycomed Denmark Aps,nycomed_denmark_aps,,,,,, -8774,,8f0c35d2-b0e5-4a19-ae81-8f490628a057,NOVARTIS FARMA,novartis_farma,,,,,, -8775,,adc76341-9b5e-4cad-bde6-5056bca3626d,Dr. Vicente Estrada,dr_vicente_estrada,,,,,, -8776,,0336d992-4e9e-4c79-9fbe-1dffda726797,Goethe University Frankfurt,goethe_university_frankfurt,,,,,, -8777,,b2d7df96-b451-4d93-8a8c-5fcfdb0fd43e,"Aarhus University Hospital, Denmark",aarhus_university_hospital_denmark,,,,,, -344,0.980149,273163c3-7d27-453a-a06b-0214eed2db4d,Otto-von-Guericke University,otto_von_guericke_university,,,,11e94b5f-d540-4085-bee2-a20da96129f1,otto_von_guericke_university_medical_faculty_dpt_of_neurology,"Otto-von-Guericke University, Medical Faculty, Dpt. of Neurology" -8778,,3a6dbdbc-71ac-11e6-a0cd-0242ac12000b,HLR,hlr,,,,,, -8779,,0687251c-8bc7-11e6-a449-0242ac12000b,The Motol University Hospital,the_motol_university_hospital,,,,,, -8780,,27d02f10-db4b-45d2-a275-61d0e550923b,DIRECTION CENTRALE DU SERVICE DE SANTE DES ARMEES,direction_centrale_du_service_de_sante_des_armees,,,,,, -8781,,f5a81c3d-0955-476b-b274-0564331c6999,Otsuka Novel Products GmbH,otsuka_novel_products_gmbh,,,,,, -846,0.94804,a2cff94d-e7b7-4b66-9dbe-77f65a76414c,"Eyetech Pharmaceuticals, Inc",eyetech_pharmaceuticals_inc,,,,8e57a7f2-6f76-49f9-afae-1f3f5c9f50b4,eyetech_pharamceuticals_inc,"Eyetech Pharamceuticals, Inc" -8782,,fe8ad7ff-4e98-4d81-8ba7-dc3b3760941d,ALEXION PHARMA INTERNATIONAL SARL,alexion_pharma_international_sarl,,,,,, -8783,,7c73c4b3-131e-4f0d-aec8-07511f7b36b1,MerLion Pharmaceuticals GmbH,merlion_pharmaceuticals_gmbh,,,,,, -127,0.903091,0e706737-525b-47af-863b-c9b8ecf5a50a,"Medizinische Universität Wien, Klinische Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin 3",medizinische_universit_t_wien_klinische_abteilung_f_r_nephrologie_und_dialyse_universit_tsklinik_f_r_innere_medizin_3,,,,0e706737-525b-47af-863b-c9b8ecf5a50a,medizinische_universit_t_wien_klinische_abteilung_f_r_nephrologie_und_dialyse_universit_tsklinik_f_r_innere_medizin_3,"Medizinische Universität Wien, Klinische Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin 3" -212,0.976266,28d127a8-9a7d-43fa-bf4a-1c2fe14bf976,POXEL S.A,poxel_s_a,,,,0a79ad16-61bb-4290-895a-ee60dfc583b0,poxel,POXEL -8784,,f4a108e5-3979-4a5a-9c28-99b8302d7f6d,Fujimoto Pharmaceutical Corporation,fujimoto_pharmaceutical_corporation,,,,,, -8785,,30f2ec05-a545-4859-857d-33d5589de3cc,Regulon Inc,regulon_inc,,,,,, -350,0.980777,def04bfb-c87c-44ae-9705-838229748921,Pharmacyclics LLC an Abbvie Company,pharmacyclics_llc_an_abbvie_company,,,,3e83bd20-82b9-4762-84e9-fe87fe651346,pharmacyclics_llc,Pharmacyclics LLC -8786,,83666e71-6c01-4df7-9373-21d77fb676a6,Emergent Product Development UK Ltd,emergent_product_development_uk_ltd,,,,,, -8787,,e00622c8-72ab-11e6-a0cd-0242ac12000b,LOREAL USA,loreal_usa,,,,,, -8788,,861e96c1-75e9-4a32-a1cd-57184f2880e9,"Cubist Pharmaceuticals, LLC, an idirect wholly owned subsidiary of Merck Sharp&Dohme Corp",cubist_pharmaceuticals_llc_an_idirect_wholly_owned_subsidiary_of_merck_sharp_dohme_corp,,,,,, -8789,,07422997-624c-4b04-9aef-cf36baefd932,Fundación SENEFRO,fundaci_n_senefro,,,,,, -403,0.95696145296096802,11645014-715e-11e6-a0cd-0242ac12000b,EMCURE PHARMS INDIA,emcure_pharms_india,,,,11645014-715e-11e6-a0cd-0242ac12000b,emcure_pharms,EMCURE PHARMS -8790,,d614c2b7-b971-4dc8-b0e2-dee1267570b0,CH Pau,ch_pau,,,,,, -751,0.9637179970741272,019c34b0-7129-11e6-a89e-0242ac12000b,TARO,taro,,,,019c34b0-7129-11e6-a89e-0242ac12000b,taro,TARO -8791,,de0a962c-71cd-11e6-a0cd-0242ac12000b,DHL,dhl,,,,,, -8792,,24b40c78-160a-47d6-b1db-9d613ccd3888,Ergomed Clinical Research Limited,ergomed_clinical_research_limited,,,,,, -8793,,98f03587-10cd-44bf-9043-cdc076198e31,"Dr Antoni Gual, Hospital Clínic de Barcelona, Unitat d'Alcohologia de la Generalitat de Catalunya",dr_antoni_gual_hospital_cl_nic_de_barcelona_unitat_d_alcohologia_de_la_generalitat_de_catalunya,,,,,, -584,0.984184,4a85fe12-965a-11e6-becf-0242ac110008,PHARMACARE,pharmacare,,,,4a85fe12-965a-11e6-becf-0242ac110008,pharmacare,PHARMACARE -8794,,3c2ff0be-9028-4a03-8e86-c5ec327eb016,"Smittskyddsinstitutet, STRAMA",smittskyddsinstitutet_strama,,,,,, -8795,,181921c9-cbfe-487c-93a5-311f2c4250b0,CellAct Pharma GmbH,cellact_pharma_gmbh,,,,,, -8796,,ceb608b9-d3e9-4cd8-b75e-d41726bcc247,"Chiasma, Inc",chiasma_inc,,,,,, -850,0.919718,25d4b3ea-5908-4ea6-af45-ca4271adfcb9,University hospitals of Leuven,university_hospitals_of_leuven,,,,25d4b3ea-5908-4ea6-af45-ca4271adfcb9,university_hospitals_of_leuven,University hospitals of Leuven -422,0.98334300518035889,ac7fb87c-0de4-401d-a07b-881b2d29e8ea,Dr. Enrique Alday,dr_enrique_alday,,,,ac7fb87c-0de4-401d-a07b-881b2d29e8ea,dr_enrique_alday,Dr. Enrique Alday -8797,,4f299305-2684-4e8e-a552-d9507f59c7d3,PROBIONOV,probionov,,,,,, -8798,,3373c16c-1332-490b-91e2-01084761c3e6,"Department of Neurology, Turku University Hospital",department_of_neurology_turku_university_hospital,,,,,, -8799,,2f63429e-b406-49c7-8bcf-259b9dfac196,SantoSolve AS,santosolve_as,,,,,, -8800,,d28ad76e-9549-480d-b9c7-4ed749fc91fc,St. Antonius hospital Nieuwegein,st_antonius_hospital_nieuwegein,,,,,, -8801,,7f2a4482-9bf7-445b-8e71-b720bc9d1f0c,Protalix Ltd,protalix_ltd,,,,,, -8802,,2a149e62-20e5-4ce3-8737-b5dce205ea61,"Bayer HealthCare AG, Germany",bayer_healthcare_ag_germany,,,,,, -8803,,16fcc728-9723-431f-b51f-a51a40617cb0,"Research & Innovation Services, University of Dundee",research_innovation_services_university_of_dundee,,,,,, -8804,,d805ef6c-15c3-4fda-8d98-bb046f3912ca,AZIENDA SANITARIA N. 3 GENOVESE,azienda_sanitaria_n_3_genovese,,,,,, -8805,,df870245-a833-4bd9-9ac6-52040b4d7e73,North Bristol NHS Trust (NBT),north_bristol_nhs_trust_nbt,,,,,, -8806,,12c6bcda-73c5-11e6-a0cd-0242ac12000b,RAPTOR INC,raptor_inc,,,,,, -8807,,e6e213e6-4d8f-4938-bef6-64d025b63593,OSPEDALE SAN RAFFAELE,ospedale_san_raffaele,,,,,, -8808,,70fb08eb-c85f-4571-b455-1c3e62ceef63,"FoldRx Pharmaceuticals, Inc",foldrx_pharmaceuticals_inc,,,,,, -8809,,76ba2fa0-ccdc-4c96-99fa-1cf2bb8d0d68,Universitätsklinikum der Julius-Maximilians Universität Würzburg A.ö.R,universit_tsklinikum_der_julius_maximilians_universit_t_w_rzburg_a_r,,,,,, -8810,,8262ebef-f3b8-4a8d-a269-f1edf1c33e3f,SK Life Science Inc,sk_life_science_inc,,,,,, -8811,,25989852-fcf8-4101-8f54-0f3c4e918341,Abivax,abivax,,,,,, -8812,,32fc6cde-a974-47af-85e7-0efed0d90433,CASA MADRE,casa_madre,,,,,, -8813,,98f45bf5-bc33-4eb6-93d9-7a1763df80c7,KU Leuven-Drug Delivery and Disposition,ku_leuven_drug_delivery_and_disposition,,,,,, -8814,,6fdbcc80-48ed-4b36-b5bd-18c41e510b84,Sanofi-aventis,sanofi_aventis,,,,,, -8815,,f417181e-6fc0-11e6-abe8-0242ac12000b,Prof. Salvatore Grisanti,prof_salvatore_grisanti,,,,,, -8816,,a2073759-0c93-4848-8b73-077dd462371b,Ludwigs Maximilians University,ludwigs_maximilians_university,,,,,, -8817,,dbc3e7b0-5c72-4d76-b1e5-a5a0216ddd35,Gustave Roussy,gustave_roussy,,,,,, -8818,,69cde8b9-3c19-4e4f-ac42-e93e97e36649,Grupo de Reproducción Asistida HSP/FP,grupo_de_reproducci_n_asistida_hsp_fp,,,,,, -8819,,0f02863c-a3fd-4cb0-902b-e405b9817fb2,"Medizinische Universität Wien, Univ.Klinik.f.Dermatologie",medizinische_universit_t_wien_univ_klinik_f_dermatologie,,,,,, -8820,,5a90753e-00e0-47ea-925e-797e67058767,Steiermärkische Gebietskrankenkasse,steierm_rkische_gebietskrankenkasse,,,,,, -8821,,69875514-7165-11e6-a0cd-0242ac12000b,ACTAVIS S ATLANTIC,actavis_s_atlantic,,,,,, -964,0.95663732290267944,ee0f112b-ba70-4913-b4d1-c88699a3bac3,Helsinki University Centrel Hospital,helsinki_university_centrel_hospital,,,,16556fb5-6653-4d5b-bd94-fc6343fa4fd8,helsinki_university_central_hospital,Helsinki University Central Hospital -8822,,2e49be8e-f14f-4c0d-ae11-0fe5b0212dc1,Bart Morlion,bart_morlion,,,,,, -182,0.972538,14a0b753-a57f-41c0-b017-ca7adb32f3da,Durata Therapeutic International B.V,durata_therapeutic_international_b_v,,,,14a0b753-a57f-41c0-b017-ca7adb32f3da,durata_therapeutic_international_b_v,Durata Therapeutic International B.V -8823,,7cc17096-6068-4a30-9a62-7e5b608b5c6f,University Hospitals KU Leuven,university_hospitals_ku_leuven,,,,,, -8824,,072422f8-0952-411a-a577-4c979549843a,Jerini US Inc,jerini_us_inc,,,,,, -279,0.97373181581497192,adecb40b-2f21-4597-8297-90559dea3984,Royal Liverpool and Broadgreen University Hospital NHS Trust,royal_liverpool_and_broadgreen_university_hospital_nhs_trust,,,,7fdce817-2c7a-48bf-9fea-ccc1bb736300,royal_liverpool_and_broadgreen_university_hospitals_nhs_trust,Royal Liverpool and Broadgreen University Hospitals NHS Trust -8825,,f4ebea85-7cb5-4ae2-81b4-b92913991078,"Association REDAR, Hôpital Ambroise Paré, Service d'Anesthésie et de Réanimation",association_redar_h_pital_ambroise_par_service_d_anesth_sie_et_de_r_animation,,,,,, -8826,,95d3dcaa-c0de-4321-ae49-d69e9684bc82,KWF Kankerbestrijding,kwf_kankerbestrijding,,,,,, -8827,,417b1089-cf74-4e92-9791-100e86b12180,"Västra Götalandsregionen, Sahlgrenska University Hospital /Queen Silvia children's hospital",v_stra_g_talandsregionen_sahlgrenska_university_hospital_queen_silvia_children_s_hospital,,,,,, -8828,,df8c9282-7166-11e6-a0cd-0242ac12000b,INTL SPECLT CHEMS,intl_speclt_chems,,,,,, -8829,,3404f2e7-2a02-4f2e-b617-b26735e2ad41,Bausch&Lomb Dr Gerhard Mann chem.-Fabrik GmbH,bausch_lomb_dr_gerhard_mann_chem_fabrik_gmbh,,,,,, -8830,,486bdbfe-f5c4-4c41-b181-2e85c964bfb3,"University of Leuven, Division of Gastroenterology",university_of_leuven_division_of_gastroenterology,,,,,, -8831,,c7e5c01a-9a36-4b21-a9ce-adfde715d705,Salford Royal Hospitals Trust,salford_royal_hospitals_trust,,,,,, -727,0.983703,891861df-aa46-4637-b8f0-5ce81adc18f1,Maastricht University,maastricht_university,,,,67dc03a5-4946-452a-be3e-787d57740764,maastricht_university_medical_center,Maastricht University Medical Center -8832,,b67ed3fb-464f-48db-a939-38d0baa8e972,BioTech Tools S.A,biotech_tools_s_a,,,,,, -8833,,b171c46c-b25e-4748-b364-161e7756fb45,Klinik für Innere Medizin II der Klinikum Chemnitz gGmbH,klinik_f_r_innere_medizin_ii_der_klinikum_chemnitz_ggmbh,,,,,, -8834,,9a090d17-18e7-401a-9f2c-7128e995cabe,Dra. Rosario Blasco,dra_rosario_blasco,,,,,, -8835,,cec0d98e-32ef-48f3-9700-9362e3e024c5,Servier s.r.o,servier_s_r_o,,,,,, -8836,,84916872-6f9e-11e6-9663-0242ac12000b,Targanta Therapeutics Corporation,targanta_therapeutics_corporation,,,,,, -8837,,1c3cda5a-71b9-11e6-a0cd-0242ac12000b,ALLEGIANCE HLTHCARE,allegiance_hlthcare,,,,,, -8838,,2bb154b0-43c7-4694-9e2d-2ed94c5aa179,Centre Hospitalier Départemental Vendée,centre_hospitalier_d_partemental_vend_e,,,,,, -8839,,49d3d6c3-a234-47dc-ae63-13bfa871ac17,Centre Hospitalier Universiatire de Lille,centre_hospitalier_universiatire_de_lille,,,,,, -8840,,583809fd-2ed9-439c-918d-d4f491b69f1d,OSPEDALE ISRAELITICO DI ROMA,ospedale_israelitico_di_roma,,,,,, -8841,,41cb6b28-5902-4387-9bb0-205436641a69,pro-ACTINA S.A,pro_actina_s_a,,,,,, -8842,,62f15231-7a32-427b-a7a2-a27f949e578c,Napp Pharmaceuticals Ltd,napp_pharmaceuticals_ltd,,,,,, -8843,,62afc7b2-57a4-4a5e-aa55-3babb2a432f2,Zon MW,zon_mw,,,,,, -8844,,206fccc4-8bc0-11e6-a449-0242ac12000b,Center of Mech-Sense,center_of_mech_sense,,,,,, -8845,,985c9c11-83d3-48b4-8934-a0b36838584a,Grupo Gallego de Investigación en Oncología - GGIO,grupo_gallego_de_investigaci_n_en_oncolog_a_ggio,,,,,, -8846,,2ea7a476-9dcd-4ca4-9c23-02151099f5d0,RACD Cardiff University,racd_cardiff_university,,,,,, -8847,,6ea71d04-715b-11e6-a0cd-0242ac12000b,BIOKEY,biokey,,,,,, -8848,,edb2cdd9-96dc-49f6-86df-396ba44c9970,Västra Götalands Center för utveckling av prehospital akutsjukvård,v_stra_g_talands_center_f_r_utveckling_av_prehospital_akutsjukv_rd,,,,,, -8849,,a33169b1-a27a-422c-a0d8-8f95a6404462,Sten Madsbad,sten_madsbad,,,,,, -8850,,844b5b7d-a965-423d-934d-2f3f94710be3,Laves-Arzneimittel GmbH,laves_arzneimittel_gmbh,,,,,, -8851,,f4bc28de-b355-4536-83d3-92e338b785af,Univ.-Prof. Dr. Helmut Mittermayer,univ_prof_dr_helmut_mittermayer,,,,,, -8852,,f90cd487-c363-4cc0-bb5b-a53167e8ee11,Diabeteszentrum Bad Lauterberg,diabeteszentrum_bad_lauterberg,,,,,, -8853,,eb7cd1ab-bcb2-4000-9d0c-7eed875b22af,Glenmark Pharmaceuticals SA,glenmark_pharmaceuticals_sa,,,,,, -8854,,6cba1f49-fadf-4acb-afdb-fad9706db6f3,UBHT,ubht,,,,,, -8855,,b3fda126-981a-43dc-9c74-f4037ae76a59,AZ-VUB,az_vub,,,,,, -8856,,492a20b0-a653-4e2a-bf0e-aedd2cfb28e1,European AIDS treatment network (NEAT),european_aids_treatment_network_neat,,,,,, -8857,,a4d2e683-09cd-457d-b3b3-03b7157b1b50,Gloucester Pharmaceuticals Inc,gloucester_pharmaceuticals_inc,,,,,, -1064,0.94309008121490479,edc709ce-10d1-42d6-9fb3-f5c6046db6fc,Cambridge University Hospitals Foundation Trust,cambridge_university_hospitals_foundation_trust,,,,5832b652-f280-4dd6-850d-477a81887563,cambridge_university_hospitals_nhs_foundation_trust,Cambridge University Hospitals NHS Foundation Trust -8858,,2dda0e8e-532e-4b83-9845-a8c578042f9c,Erasmus MC - Department of Neurology,erasmus_mc_department_of_neurology,,,,,, -8859,,62c9d7dd-f953-4a37-b735-9b0073abba5d,"Haukeland Universitetssykehus, Helse Bergen, Barneklinikken",haukeland_universitetssykehus_helse_bergen_barneklinikken,,,,,, -8860,,e8990bee-433f-447f-bd6c-656253d99b85,Pharmaleads SA,pharmaleads_sa,,,,,, -8861,,181aac99-f954-433b-8b6e-278dd9e8fd6f,Dr G I Hackett,dr_g_i_hackett,,,,,, -8862,,c9408925-4bbf-46f6-9762-ead852c0f77b,Dipartimento di Medicina Interna e Specialità Mediche - Policlinico Umberto I - Sapienza Università di Roma,dipartimento_di_medicina_interna_e_specialit_mediche_policlinico_umberto_i_sapienza_universit_di_roma,,,,,, -8863,,fdc53598-c764-41f7-a2c2-5cd532c70a30,St James's Hospital,st_james_s_hospital,,,,,, -892,0.98520499467849731,75395b0a-39cd-4a5d-8ecc-3909789f94df,Aarhus University,aarhus_university,,,,16b9d8ec-4b48-4fe9-bcae-e854bddbc3d8,aarhus_universityhospital,Aarhus Universityhospital -8864,,65edf180-fa20-4d21-8108-66ba7e238611,"Shering Plough Research Institute, A division of Schering Plough Corporation",shering_plough_research_institute_a_division_of_schering_plough_corporation,,,,,, -8865,,18fc9c4f-6fed-48a0-986b-ab55dce12886,Actavis Deutschland GmbH & Co.Kg,actavis_deutschland_gmbh_co_kg,,,,,, -538,0.987464,f7aaaa1b-2561-49c1-b1bf-779a333d0a57,Sankyo Pharma Development,sankyo_pharma_development,,,,0b556983-4b60-4dae-9f82-49efdc6858f4,sankyo_pharma_development_sphd,Sankyo Pharma Development (SPhD) -8866,,2712827b-f93e-4a6b-b6c6-18878fdd4d07,SCS Boehringer Ingelheim Comm.V,scs_boehringer_ingelheim_comm_v,,,,,, -8867,,8e5dda8c-a719-4a48-ae01-26d3341bc496,Roche (Magyarország) Kft,roche_magyarorsz_g_kft,,,,,, -8868,,f9b18a79-c3e2-4273-ad9b-cea37c03ae3b,Gastrointestinal Onkologisk Förening,gastrointestinal_onkologisk_f_rening,,,,,, -8869,,f133bbb6-1ab6-4514-8d77-1416b182cc28,"Rigshospitalet, Finsen Center",rigshospitalet_finsen_center,,,,,, -8870,,c87593e9-4c8a-499e-81ac-07a6d82fb618,Private Universität Witten/Herdecke gGmbH,private_universit_t_witten_herdecke_ggmbh,,,,,, -8871,,1874dcf0-1f4f-43c5-b633-9d5a7627ec3a,Pharmazeutische Fabrik Montavit Ges.m.b.H,pharmazeutische_fabrik_montavit_ges_m_b_h,,,,,, -8872,,073816ce-29f9-4075-b24a-53ba78ecb3eb,MEDTRONIC,medtronic,,,,,, -499,0.95183,7e7f14c2-9ede-49fa-aa4c-1c3644b22daf,"Merck Serono SA - Geneva, an affiliate of Merck KGaA, Darmstadt, Germany",merck_serono_sa_geneva_an_affiliate_of_merck_kgaa_darmstadt_germany,,,,0c43fa82-723d-4a38-822b-83d3cb20290b,merck_serono_s_a_geneva_an_affiliate_of_merck_kgaa_darmstadt_germany,"Merck Serono S.A. - Geneva, an affiliate of Merck KGaA Darmstadt, Germany" -8873,,09143c34-8bcf-4a9a-8f81-fcfd1923fe39,NeuroSearch Sweden AB,neurosearch_sweden_ab,,,,,, -8874,,1030d52e-1854-4ec2-ab62-875d3f26c790,Novartis Services Pharma AG,novartis_services_pharma_ag,,,,,, -8875,,6c014ef5-9139-4c57-b22b-602f3ad22284,Gregers Gautier Hermann,gregers_gautier_hermann,,,,,, -8876,,9e33247a-737f-11e6-a0cd-0242ac12000b,SCHIFF AND CO,schiff_and_co,,,,,, -8877,,248658cf-2b4a-4574-aa31-530fc4738759,"Department of Asthma, Allergy and Respiratory Science, GKT School of Medicine, King's College London",department_of_asthma_allergy_and_respiratory_science_gkt_school_of_medicine_king_s_college_london,,,,,, -8878,,62783231-f4b1-4fbf-9020-e017cceb49cf,Medicines Evaluation Unit,medicines_evaluation_unit,,,,,, -8879,,312dfa94-550d-4114-a936-539c08143a13,"NeoPharm, Inc",neopharm_inc,,,,,, -8880,,1e875f6a-8bc7-11e6-a449-0242ac12000b,"IELSG International Extranodale Lymphoma Study Group; Instituto Oncologico della Svizzera Italiana,",ielsg_international_extranodale_lymphoma_study_group_instituto_oncologico_della_svizzera_italiana,,,,,, -8881,,def7f346-1bc5-4cfb-a682-9fff4aeb481c,Takeda Europe Research & Development Limited,takeda_europe_research_development_limited,,,,,, -8882,,547fed25-6d0e-4c76-8f8e-7a350d7fb960,"Department of Dermatology, Hospital of the Medical University Graz",department_of_dermatology_hospital_of_the_medical_university_graz,,,,,, -307,0.90344,f2af78d5-760a-4dd9-8137-894f9a8c3637,"Medizinische Universität Wien, Klinik für Innere Medizin III, Abteilung für Gastroenterologie und Hepatologie",medizinische_universit_t_wien_klinik_f_r_innere_medizin_iii_abteilung_f_r_gastroenterologie_und_hepatologie,,,,b08c1e4f-521d-4753-92c6-78fc43a73dab,medizinische_universit_t_wien_univ_klinik_f_r_innere_medizin_iii_abteilung_f_r_gastroenterologie,"Medizinische Universität Wien, Univ. Klinik für Innere Medizin III, Abteilung für Gastroenterologie" -635,0.92223775386810303,e73c0583-9c8a-433e-9519-117f883c39d0,Research & Development Department,research_development_department,,,,e73c0583-9c8a-433e-9519-117f883c39d0,research_development_department,Research & Development Department -8883,,c7cef0dc-719c-11e6-a0cd-0242ac12000b,NOVEN THERAP,noven_therap,,,,,, -8884,,a675278e-5b93-4aa5-ab5e-c8af0fb9337e,FUNDACION CV INVESTIGACION HOSPITAL DR PESET,fundacion_cv_investigacion_hospital_dr_peset,,,,,, -683,0.987967,93d2770e-11ee-4c28-b378-003b4e28a161,Landstinget i Uppsala,landstinget_i_uppsala,,,,93d2770e-11ee-4c28-b378-003b4e28a161,landstinget_i_uppsala,Landstinget i Uppsala -224,0.92743,19f50830-c64c-41ab-95d1-83f7f3427687,Royal College of Surgeons in Ireland,royal_college_of_surgeons_in_ireland,,,,19f50830-c64c-41ab-95d1-83f7f3427687,royal_college_of_surgeons_in_ireland,Royal College of Surgeons in Ireland -8885,,87112385-c1ab-4115-b6c4-aed78cc5402b,OM Pharma SA,om_pharma_sa,,,,,, -8886,,c6e68ef6-799e-4145-b0f8-7970e7b98f03,NKI-AVL,nki_avl,,,,,, -8887,,eed365fd-52ae-4b4c-8a2d-348746dafebb,"TEDEC-MEIJI FARMA, S.A",tedec_meiji_farma_s_a,,,,,, -752,0.97785389423370361,137320fb-fac2-4e31-99c7-7873aa7537cc,Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC),grupo_espa_ol_de_tratamiento_de_tumores_de_cabeza_y_cuello_ttcc,,,,137320fb-fac2-4e31-99c7-7873aa7537cc,grupo_espa_ol_de_tratamiento_de_tumores_de_cabeza_y_cuello_ttcc,Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC) -8888,,0e2e90c5-0108-4db7-9102-0a86e7c97eed,Alimentary Health Ltd,alimentary_health_ltd,,,,,, -174,0.980699,b6d07c42-8f99-487e-8dbb-3129112907b5,University of Tartu,university_of_tartu,,,,b6d07c42-8f99-487e-8dbb-3129112907b5,university_of_tartu,University of Tartu -8889,,1252fc62-ee01-4f7a-95e7-2dc265599dd1,Warwick Medical School,warwick_medical_school,,,,,, -8890,,489121ae-c80c-4b0f-a96e-da38dae5bd30,Ziekenhuisapotheek Meppel-Hoogeveen,ziekenhuisapotheek_meppel_hoogeveen,,,,,, -817,0.98780262470245361,ec1b13cc-01ed-4d26-a390-cd4e25c3a147,Boehringer Ingelheim,boehringer_ingelheim,,,,53d17802-3866-4bc6-856b-3879f031124d,boehringer_ingelheim_b_v,Boehringer Ingelheim b.v -762,0.986968,08e66865-5523-488a-993b-2c12d1335b43,University Hospitals Bristol,university_hospitals_bristol,,,,08e66865-5523-488a-993b-2c12d1335b43,university_hospitals_bristol,University Hospitals Bristol -8891,,35c54e89-ad78-4e92-9cb2-4181f137fb43,Division of Angiology Graz,division_of_angiology_graz,,,,,, -729,0.96273022890090942,cb560f4c-875f-44a3-bed5-c8039bd52ca8,Sanofi Pasteur MSD SNC,sanofi_pasteur_msd_snc,,,,cb560f4c-875f-44a3-bed5-c8039bd52ca8,sanofi_pasteur_msd,Sanofi Pasteur MSD -8892,,6b987717-fc5b-4f85-a669-a3e0982a0ece,"Gilead Sciences, Inc",gilead_sciences_inc,,,,,, -8893,,8237e26a-5992-4ab0-b3da-188955c698bb,"Dimension Therapeutics, Inc",dimension_therapeutics_inc,,,,,, -8894,,d8b8d53c-73fb-11e6-a0cd-0242ac12000b,WELLSTAT THERAP,wellstat_therap,,,,,, -8895,,db3e8a90-95d8-4b63-8323-60df7dc4c255,MELORA PORTUGUESA. LDA,melora_portuguesa_lda,,,,,, -8896,,37877f7a-d831-4f95-8b3a-e93b35e0aaa3,Fundación para la Formación y la Investigación de los profesionales de la Salud (FUNDESALUD),fundaci_n_para_la_formaci_n_y_la_investigaci_n_de_los_profesionales_de_la_salud_fundesalud,,,,,, -477,0.96643507480621338,22dcd280-772d-451a-a261-cbef7a27c26c,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie",medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_3_abteilung_f_r_gastroenterologie_und_hepatologie,,,,092654ab-7dbc-4b58-83c4-7c2f45b75f9a,medizinische_universit_t_graz_universit_tsklinik_f_r_innere_medizin_abteilung_f_r_gastroenterologie_und_hepatologie,"Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Gastroenterologie und Hepatologie" -8897,,46cc18ba-723d-11e6-a0cd-0242ac12000b,SCIOS LLC,scios_llc,,,,,, -905,0.98715120553970337,49853b1c-d693-4e55-affd-06e4542b69ef,King's College London (IOP),king_s_college_london_iop,,,,18d9ea5c-b3a8-49aa-a224-39aa5d2a425d,king_s_college_london,King's College London -8898,,c0bba9d6-fe7d-483c-9d75-2d070e6eaf2e,"Acceleron Pharma, Inc",acceleron_pharma_inc,,,,,, -8899,,644aabb1-a801-40b6-90da-42c2f45d8808,FRANCISCO J. BLANCO GARCÍA,francisco_j_blanco_garc_a,,,,,, -8900,,56feef43-9a2f-438d-bb81-3e5dfdd86543,ISTITUTO NAZIONALE PER LA CURA TUMORI,istituto_nazionale_per_la_cura_tumori,,,,,, -8901,,680ef25c-715e-11e6-a0cd-0242ac12000b,EVERYLIFE,everylife,,,,,, -8902,,443bfc50-3e06-431f-8b44-3faaca8036b1,SWBH NHS Trust,swbh_nhs_trust,,,,,, -8903,,d47b8cec-a10c-4437-9548-6c5717da3fe6,SOCIETA' LABORATORIO FARMACEUTICO S.I.T. SRL,societa_laboratorio_farmaceutico_s_i_t_srl,,,,,, -8904,,b560c996-4dac-4c04-a102-869887f73d33,Ambit Biosciences Corporation,ambit_biosciences_corporation,,,,,, -880,0.941049,c8ab8b90-390a-4ea3-bdcd-55fcd31ee10e,Central Manchester and Manchester Childrens University Hospitals NHS Trust,central_manchester_and_manchester_childrens_university_hospitals_nhs_trust,,,,2d4630db-6244-46e0-a68c-f156131d2f04,central_manchester_manchester_children_s_university_hospitals_nhs_trust,Central Manchester& Manchester Children's University Hospitals NHS Trust -8905,,4c27a7f7-0696-4f01-8fb8-a51062570934,"Ferring-Leciva, a.s",ferring_leciva_a_s,,,,,, -8906,,a9f3cc18-4a15-4104-b485-d6a23ee2c0f1,SentoClone AB,sentoclone_ab,,,,,, -191,0.98367059230804443,4042f330-66f0-40ec-8288-db80eef6363c,CESAR Central European Society for,cesar_central_european_society_for,,,,4042f330-66f0-40ec-8288-db80eef6363c,cesar_central_european_society_for_anticancer_drug_research,CESAR Central European Society for Anticancer Drug Research -180,0.97171720862388611,0b232628-7206-11e6-a0cd-0242ac12000b,VALEANT PHARMS INTL,valeant_pharms_intl,,,,0b232628-7206-11e6-a0cd-0242ac12000b,valeant_pharms,VALEANT PHARMS -8907,,396ab8e0-b0cc-4b4b-9fcb-8be5416882f5,Portola Pharmaceuticals Inc,portola_pharmaceuticals_inc,,,,,, -8908,,9c91c5bf-a6ea-4f5c-afcd-0f17a71370c0,Alcon Research Limited,alcon_research_limited,,,,,, -8909,,de1141a1-1af5-493f-b1fa-ffabda497f31,REVOTAR Biopharmaceuticals AG,revotar_biopharmaceuticals_ag,,,,,, -452,0.97584396600723267,7dc31ed2-c888-4a81-8a21-860b006cc000,Novartis Farmaceutica S.A,novartis_farmaceutica_s_a,,,,7dc31ed2-c888-4a81-8a21-860b006cc000,novartis_farmaceutica_s_a,Novartis Farmaceutica S.A -8910,,f540e39b-41a0-4533-bff3-dd9a4e9dc209,Dr. V. Soriano,dr_v_soriano,,,,,, -592,0.98310869932174683,75cfe52c-155f-4652-b05d-d246407f7a2f,Medical University of Innsbruck,medical_university_of_innsbruck,,,,75cfe52c-155f-4652-b05d-d246407f7a2f,medical_university_of_innsbruck,Medical University of Innsbruck -682,0.982418,eed791bf-b621-4cbe-af34-dcb0e5aeb4dd,Genentech,genentech,,,,23ad1ae6-2f3f-4ff6-98ef-777036a904b2,genentech_inc,"Genentech, Inc" -8911,,cce7392f-d94d-486f-9191-7b416e7bc7e5,Dr Eloy Espin,dr_eloy_espin,,,,,, -8912,,c87d493d-e791-4113-9116-f541f9e13925,"Avanir Pharmaceuticals, Inc",avanir_pharmaceuticals_inc,,,,,, -8913,,8288b4e1-f4a9-4fed-a996-813ec40471aa,Reade,reade,,,,,, -1081,0.98584973812103271,48c9366f-f57d-45a5-b7c5-8b03cb153868,Vertex Pharmaceuticals Incorporated,vertex_pharmaceuticals_incorporated,,,,48c9366f-f57d-45a5-b7c5-8b03cb153868,vertex_pharmaceuticals_inc,Vertex Pharmaceuticals Inc -8914,,cd03b2c6-847a-491f-8428-3060750c8336,SOLTI,solti,,,,,, -307,0.90344,b08c1e4f-521d-4753-92c6-78fc43a73dab,"Medizinische Universität Wien, Univ. Klinik für Innere Medizin III, Abteilung für Gastroenterologie",medizinische_universit_t_wien_univ_klinik_f_r_innere_medizin_iii_abteilung_f_r_gastroenterologie,,,,b08c1e4f-521d-4753-92c6-78fc43a73dab,medizinische_universit_t_wien_univ_klinik_f_r_innere_medizin_iii_abteilung_f_r_gastroenterologie,"Medizinische Universität Wien, Univ. Klinik für Innere Medizin III, Abteilung für Gastroenterologie" -8915,,8ceb1f18-9eeb-456f-a75f-3896c3de642b,Polyphor AG,polyphor_ag,,,,,, -8916,,91823d32-7c00-4147-a761-4d61bf63450e,HYKS-instituutti,hyks_instituutti,,,,,, -8917,,b733aef5-4653-4d68-9f93-4c24aa0f6376,University Leipzig,university_leipzig,,,,,, -8918,,1b97b99a-4dbb-48fe-bec3-5dad0c78ac6e,Fundación Sociedad Española de Médicos de Atención Primaria (SEMERGEN),fundaci_n_sociedad_espa_ola_de_m_dicos_de_atenci_n_primaria_semergen,,,,,, -8919,,9e92b537-454a-40c0-9041-bd88c4fd0f69,Sanofi Pasteur China,sanofi_pasteur_china,,,,,, -8920,,6751d550-e722-44c3-89d5-416581b38295,"Glostrup Hospital, Videncenter for Reumatologi og Rygsygdomme, VRR",glostrup_hospital_videncenter_for_reumatologi_og_rygsygdomme_vrr,,,,,, -8921,,0b53ce6e-7142-11e6-a0cd-0242ac12000b,MIRROR PHARMS LLC,mirror_pharms_llc,,,,,, -8922,,052c0c3c-8bbd-11e6-a449-0242ac12000b,"Odontologisk Institut, Aarhus Universitet",odontologisk_institut_aarhus_universitet,,,,,, -8923,,dc64e685-ae35-405b-8ae7-0ff89bf546b6,Koagulationscentrum UMAS,koagulationscentrum_umas,,,,,, -8924,,0ff46c3e-99cd-435b-9600-ffa455ec1943,Univ.-Doz. Dr. Karl-Heinz Smolle,univ_doz_dr_karl_heinz_smolle,,,,,, -8925,,bd6773de-f130-4db7-9dad-993e8f334520,Cambridge Clinical Trials Unit,cambridge_clinical_trials_unit,,,,,, -8926,,940524b8-8e86-46c8-bfe3-7be8d3136395,"rEVO Biologics, Inc",revo_biologics_inc,,,,,, -534,0.974154,26b8ea41-7b0c-465a-88f2-0c4f81b680ce,"R&D Department, Box 146, Addenbrooke's Hospital",r_d_department_box_146_addenbrooke_s_hospital,,,,26b8ea41-7b0c-465a-88f2-0c4f81b680ce,r_d_department_box_146_addenbrooke_s_hospital,"R&D Department, Box 146, Addenbrooke's Hospital" -8927,,1281ceac-71c4-11e6-a0cd-0242ac12000b,CAREFUSION,carefusion,,,,,, -8928,,50f36ae8-43a3-4f70-a597-99c500224f9b,NHS Highland,nhs_highland,,,,,, -8929,,c0052649-661a-4399-8f67-9e4928b3876f,Kitasato institute clinical trial coordinating center,kitasato_institute_clinical_trial_coordinating_center,,,,,, -8930,,969a2d40-cfbe-4ec8-81cc-34c4cc8c08a4,"National University of Ireland, Galway",national_university_of_ireland_galway,,,,,, -8931,,afb33041-3dc2-4803-9979-0b56a7d54910,"BiPar Sciences, Inc",bipar_sciences_inc,,,,,, -8932,,705738b8-64cb-4651-bcfb-3c64f92dd1d1,Fundació Clínic recerca Biomèdica,fundaci_cl_nic_recerca_biom_dica,,,,,, -8933,,9efd5cf4-b64a-4b89-9ac1-4125473aa778,Therabel Pharmaceuticals Ltd,therabel_pharmaceuticals_ltd,,,,,, -1071,0.96349790692329407,a5ec592c-5234-4536-b418-e1d3f1386d26,University College Dublin Clinical Research Centre,university_college_dublin_clinical_research_centre,,,,a1ac5ed3-48d6-4b25-be01-f8fe60a9d1d6,university_college_dublin,University College Dublin -8934,,e3996ab9-8265-40c9-8ed1-c7f37f13f4b2,Chiesi Farmazeutici SpA,chiesi_farmazeutici_spa,,,,,, -8935,,08b84a43-3b41-4dc1-8e2f-396fe47345b9,Laboratorios Litaphar S.A,laboratorios_litaphar_s_a,,,,,, -8936,,0746905b-d6a5-4e68-818a-0a255d55103a,Ultragenyx Pharmaceuticals Inc,ultragenyx_pharmaceuticals_inc,,,,,, -8937,,30c8e438-8bbc-11e6-a449-0242ac12000b,Charalampos Vlachopoulos,charalampos_vlachopoulos,,,,,, -600,0.93912315368652344,2514e09a-d3e3-4866-9812-c4565fff5c90,Fundación Institut de Recerca de l'Hospital de la Sta Creu i Sant Pau,fundaci_n_institut_de_recerca_de_l_hospital_de_la_sta_creu_i_sant_pau,,,,6b4a9b2d-18ff-4441-b335-98517841d021,fundaci_n_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Fundació Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau -8938,,07149028-9e84-4d0d-80f2-8ae2feccc286,Wilhelminen hospital,wilhelminen_hospital,,,,,, -8939,,16b424d8-ed37-4761-a3b5-c83168d648b8,GLAXO SMITHKLINE,glaxo_smithkline,,,,,, -8940,,f428aa04-513d-41f4-b25b-3e5655970073,"Aventis Pharmaceuticals, Inc. (a subsidiary of sanofi-aventis group)",aventis_pharmaceuticals_inc_a_subsidiary_of_sanofi_aventis_group,,,,,, -8941,,c054e1cb-754d-4979-ab58-5e5764e9c4c6,Pharma Nord ApS,pharma_nord_aps,,,,,, -8942,,8337d765-d3df-4101-8d3f-9f6da6c039f1,LABORATORIOS NORMON S.A,laboratorios_normon_s_a,,,,,, -713,0.94804009795188904,0825dd64-2757-4f39-ac89-ff605a4285c1,"Wyeth Pharmaceuticals Inc., a wholly owned subsidary of Pfizer Inc., 500 Arcola Road, Collegeville, PA 19426, USA",wyeth_pharmaceuticals_inc_a_wholly_owned_subsidary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,,,,d2f1d48d-c243-473b-9f47-208723250aa6,wyeth_pharmaceuticals_inc_a_wholly_owned_subsidiary_of_pfizer_inc_500_arcola_road_collegeville_pa_19426_usa,"Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA" -8943,,f2809394-6fc1-11e6-abe8-0242ac12000b,"Gynækologisk-obstetrisk afd. G, Glostrup Hospital",gyn_kologisk_obstetrisk_afd_g_glostrup_hospital,,,,,, -8944,,61e73e25-21ea-47a4-b4a7-b9881948137d,Wyeth LLC,wyeth_llc,,,,,, -8945,,9c8276be-00f3-45e5-88c4-43e5703390e0,"R&D, Barts and The London NHS Trust",r_d_barts_and_the_london_nhs_trust,,,,,, -8946,,ec2b1cdc-2c5b-4949-9613-7cdae927edc7,Azienda Ospedaliera Papa Giovanni XXIII,azienda_ospedaliera_papa_giovanni_xxiii,,,,,, -8947,,c635d31c-0a65-4c32-b7ab-5d872ec48ae8,"Alteon, Inc",alteon_inc,,,,,, -8948,,0516ab8d-2e27-4acd-bbde-e4acec2af7b5,PLIVA HRVATSKA d.o.o,pliva_hrvatska_d_o_o,,,,,, -8949,,490cb8b6-8bbd-11e6-a449-0242ac12000b,Stallergenes SAS,stallergenes_sas,,,,,, -8950,,bf3ec593-c834-42d9-a47e-09580e9530f8,"University of Oulu, Department of Physical and Rehabilitation Medicine",university_of_oulu_department_of_physical_and_rehabilitation_medicine,,,,,, -8951,,132e3d29-a59c-491b-8e77-905f4a1acad5,Eva Marie Erfurth,eva_marie_erfurth,,,,,, -8952,,199b0d9a-c076-4dd8-a400-1e3bdec1bedf,Uppsala läns landsting,uppsala_l_ns_landsting,,,,,, -623,0.985931,4036d0e2-54dc-41a1-ab42-721775d200c4,Klinikum der Universität,klinikum_der_universit_t,,,,4036d0e2-54dc-41a1-ab42-721775d200c4,klinikum_der_universit_t,Klinikum der Universität -8953,,4b9937b7-7754-4711-a468-15f9b584b4fe,Mario Negri Gynecology Oncology Group - MaNGO,mario_negri_gynecology_oncology_group_mango,,,,,, -8954,,4fbbffcd-f239-425c-b2d8-554f3dd80c90,"Pfizer Inc., East 42nd Street, New York, NY 10017",pfizer_inc_east_42nd_street_new_york_ny_10017,,,,,, -8955,,3ecdddeb-f978-4910-b108-47332425d3ae,"Laboratorios Menarini, S.A",laboratorios_menarini_s_a,,,,,, -8956,,b18a1c1e-73fb-11e6-a0cd-0242ac12000b,GENTIUM SPA,gentium_spa,,,,,, -8957,,42cb9635-5301-4f38-b05d-9d572ada366e,Tays/ anestesiayksikkö,tays_anestesiayksikk,,,,,, -8958,,4df0904d-1de8-4417-96f2-6de6fbda8b3a,The Finnish Lymphoma group,the_finnish_lymphoma_group,,,,,, -820,0.98334300518035889,5febc4b8-715b-11e6-a0cd-0242ac12000b,WOCKHARDT LTD,wockhardt_ltd,,,,5febc4b8-715b-11e6-a0cd-0242ac12000b,wockhardt_ltd,WOCKHARDT LTD -8959,,c6c3d35b-9b17-4203-9fdb-2d150e934af9,NEPHROLOGY DEPARTMENT (HOSPITAL UNIVERSITARY OF BELLVITGE),nephrology_department_hospital_universitary_of_bellvitge,,,,,, -8960,,1c469669-ad88-44dc-bcd3-93efe8778acc,Nikolai Sleep Monitoring Clinic,nikolai_sleep_monitoring_clinic,,,,,, -825,0.979838,f1549a9a-52e0-4629-86bc-c853a0a91aa7,University of Surrey,university_of_surrey,,,,1bd8b575-4f6d-4564-aa9e-6ea528cb17bb,university_of_surrey_clinical_research_centre,University of Surrey Clinical Research Centre -8961,,38f2e7b8-73f1-11e6-a0cd-0242ac12000b,OXARC INC,oxarc_inc,,,,,, -677,0.981509,d2cfbe43-b68f-4a00-90fd-0a42a6db1d26,"Christian Geisler, Rigshospitalet, dept. Haematology 4042",christian_geisler_rigshospitalet_dept_haematology_4042,,,,22accd65-c14d-4d5b-acab-c1bb9180b01d,christian_geisler_righospitalet_dept_haematology_4042,"Christian Geisler, Righospitalet, dept. Haematology 4042" -1002,0.97465866804122925,f1c53f60-8bda-11e6-a449-0242ac12000b,Fundación para la Formación e Investigación Sanitaria (FFIS),fundaci_n_para_la_formaci_n_e_investigaci_n_sanitaria_ffis,,,,8fbc1a40-90b3-491d-9c96-f5d311f67e2e,fundaci_n_para_la_formaci_n_e_investigaci_n_sanitaria,Fundación para la Formación e Investigación Sanitaria -8962,,5a7dfb78-1bab-4613-bdac-740c82ceafb5,MedPharm Ltd,medpharm_ltd,,,,,, -171,0.98256033658981323,e0ea9f26-8028-4605-8f3e-bec9a3e04275,Merck Serono International SA,merck_serono_international_sa,,,,e0ea9f26-8028-4605-8f3e-bec9a3e04275,merck_serono_international,Merck Serono International -8963,,694e261e-7141-11e6-a0cd-0242ac12000b,BIONPHARMA INC,bionpharma_inc,,,,,, -8964,,4d6ba69e-ebe6-49c7-8e23-ab9033fc3378,Korea UCB Co. Ltd,korea_ucb_co_ltd,,,,,, -8965,,fb3502f9-a01f-4c16-8a25-62c8b046f46f,Immungenetics AG,immungenetics_ag,,,,,, -707,0.989136,5c77e08b-5755-407d-a8b9-74bfb0127f85,Grupo Español de Investigación en Cáncer de Ovario (GEICO),grupo_espa_ol_de_investigaci_n_en_c_ncer_de_ovario_geico,,,,5c77e08b-5755-407d-a8b9-74bfb0127f85,grupo_espa_ol_de_investigaci_n_en_c_ncer_de_ovario_geico,Grupo Español de Investigación en Cáncer de Ovario (GEICO) -738,0.96910750865936279,26543fda-b9ed-4d41-966f-b38a24290ef6,Fundació Clínic per la Recerca Biomèdica,fundaci_cl_nic_per_la_recerca_biom_dica,,,,0223cc5a-d770-406a-9db1-a0c4325ff12b,fundaci_clinic_per_la_recerca_biom_dica,Fundació Clinic per la Recerca Biomédica -8966,,dcfca798-61f0-4753-aaf1-70e14dd72a84,L’OREAL RECHERCHE,l_oreal_recherche,,,,,, -8967,,87279ffb-0c34-4c49-a06e-4bcac3ce5e0f,"Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche",dipartimento_di_scienze_chirurgiche_oncologiche_e_gastroenterologiche,,,,,, -8968,,0ef8b3ce-c273-4ab4-9be4-3ac1dc4dc4c6,"Integrated Therapeutics Group, Inc./Schering-Plough Oy",integrated_therapeutics_group_inc_schering_plough_oy,,,,,, -8969,,372ecea2-96dc-11e6-becf-0242ac110008,AAA USA INC,aaa_usa_inc,,,,,, -8970,,de607572-6edb-4e0d-b5e1-64f45d9d3a33,"Instituto Grifols, S.A",instituto_grifols_s_a,,,,,, -8971,,6554a28c-d196-484d-a7f7-40945493f8b6,"Charité Universitätsmedizin Berlin, Department of Dermatology and Allergy",charit_universit_tsmedizin_berlin_department_of_dermatology_and_allergy,,,,,, -8972,,6e540431-6009-48fd-b3f2-dc1f57fd0cdf,Karen Toftdahl Bjørnholdt,karen_toftdahl_bj_rnholdt,,,,,, -8973,,51d3b71d-5938-4e5b-b290-cfe8e4828dcf,GlaxoSmithKline UK,glaxosmithkline_uk,,,,,, -8974,,e4eafd1e-07e7-484a-bbdc-770b84f0d54d,"Bayer Consumer Care, Research & Development",bayer_consumer_care_research_development,,,,,, -8975,,a0965923-96b0-41b2-9028-c6ebfda80e31,PhotoCure ASA,photocure_asa,,,,,, -357,0.987372,bd8bc4b9-770b-4246-be78-2ca345a2215e,Flexion Therapeutics,flexion_therapeutics,,,,98bac61e-5a35-4e65-bf8a-564c1eac1911,flexion_therapeutics_inc,"Flexion Therapeutics, Inc" -533,0.981251,8a1ae7e2-b3a8-4c83-b8fd-cdc9563d747a,"THERAKOS, Inc",therakos_inc,,,,215a399e-635c-44e7-a8f5-032b68855c29,therakos,THERAKOS -8976,,4b335964-41e7-4409-a575-b229fb9edd29,Elli Lilly and Company,elli_lilly_and_company,,,,,, -702,0.97607913613319397,f7a84abd-84f5-4cab-897b-523cc5e5ddf9,University Hospitals of Leicester NHS Trust Research & Development Department,university_hospitals_of_leicester_nhs_trust_research_development_department,,,,e83cea40-d34c-423f-9f95-62293d47cae2,university_hospitals_of_leicester_nhs_trust,University Hospitals of Leicester NHS Trust -8977,,615335c2-5eb0-4d98-8bb5-53e2cdbb3997,I.T.M.O. - ITALIAN TRIALS IN MEDICAL ONCOLOGY,i_t_m_o_italian_trials_in_medical_oncology,,,,,, -8978,,4d35bf08-0e96-4845-a99a-69202f65faf5,University hospital of the University of Ulm,university_hospital_of_the_university_of_ulm,,,,,, -8979,,95031d24-b5ce-4da8-b13c-4ac0cb371b52,Joint Research & Development Office (Barts and The London School of Medicine & Dentistry),joint_research_development_office_barts_and_the_london_school_of_medicine_dentistry,,,,,, -1070,0.979707,81203a68-3114-4edd-826e-001dcafc64ea,Hopital Erasme - Chest service,hopital_erasme_chest_service,,,,40ccc091-c821-4ebb-b881-5c3d26d57a77,hopital_erasme,Hopital Erasme -8980,,d45d448e-b4f3-4b3f-802a-67db225ba009,Disphar International B.V,disphar_international_b_v,,,,,, -8981,,84fcc24e-686a-4d22-b788-19e180034b4f,Boehringer Ingelheim Hellas AE,boehringer_ingelheim_hellas_ae,,,,,, -8982,,013a5a00-5caa-4796-8ec9-eafab9f16cb5,Pharmapnea AB,pharmapnea_ab,,,,,, -8983,,7b08f782-ad52-4748-8330-3fca547bfc87,Hospital Central de la Defensa,hospital_central_de_la_defensa,,,,,, -467,0.948148,dc078d8e-73f9-11e6-a0cd-0242ac12000b,MERRIMACK PHARMS,merrimack_pharms,,,,33f6d476-e36d-47d6-b355-d0aff833ee95,merrimack_pharmaceuticals,MERRIMACK PHARMACEUTICALS -781,0.96121801932652795,201d9d4f-5cd0-46df-836e-da17fa2b43dd,GlaxoSmithKline Research and Development Limited,glaxosmithkline_research_and_development_limited,,,,201d9d4f-5cd0-46df-836e-da17fa2b43dd,glaxosmithkline_research_and_development,GlaxoSmithKline Research and Development -8984,,bed95653-2fc9-4f8f-9998-f70c4e6f3196,"Anaesthesia and Operative Services, Kuopio University Hospital",anaesthesia_and_operative_services_kuopio_university_hospital,,,,,, -8985,,f0a89933-bf7d-45bc-88b4-933fe6c2e03d,"Medical University of Vienna, Department of Pedatrics",medical_university_of_vienna_department_of_pedatrics,,,,,, -8986,,e42c5ef6-2b44-48dd-9aec-7b674542b91e,Novartis Consumer Health SA,novartis_consumer_health_sa,,,,,, -8987,,5abdac1b-dbdb-4e47-976d-4200bde76c60,Národný onkologický ústav,n_rodn_onkologick_stav,,,,,, -8988,,9912e295-d555-4939-b737-cb8598615ee2,Copenhagen University Hospital,copenhagen_university_hospital,,,,,, -1037,0.979231,72bda612-7163-11e6-a0cd-0242ac12000b,MUSTAFA NEVSAT,mustafa_nevsat,,,,72bda612-7163-11e6-a0cd-0242ac12000b,mustafa_nevsat,MUSTAFA NEVSAT -8989,,f5620fd6-252b-4db5-8dc4-d0c68bc98f16,"Medizinische Universität Wien Univ. Klinik f. Innere Med. III, Abt. f. Gastroenterologie/Hepatologie",medizinische_universit_t_wien_univ_klinik_f_innere_med_iii_abt_f_gastroenterologie_hepatologie,,,,,, -8990,,98bf00a8-6e3f-462b-8606-720242d8afb5,Donau-universität Krems,donau_universit_t_krems,,,,,, -8991,,24631df3-e561-4156-8a2c-7535c7e236c5,SOCIETA' ITALIANA DI NEFROLOGIA,societa_italiana_di_nefrologia,,,,,, -8992,,768fc5e7-695d-4727-92ba-9fea9edd00ae,"INSTITUT PASTEUR, Biomedical Parasitology Unit",institut_pasteur_biomedical_parasitology_unit,,,,,, -8993,,225a7a03-c56c-428a-af95-6478095be01e,Dutch Heart Foundation,dutch_heart_foundation,,,,,, -8994,,a6f3fbc0-3194-4c8c-aeac-1094c454fb33,BioMarin International Ltd,biomarin_international_ltd,,,,,, -8995,,332175c2-afb1-456e-b6ee-ea0fcbe4cbf6,"Laboratorios SALVAT, S.A",laboratorios_salvat_s_a,,,,,, -8996,,1ee033c9-2bd8-4a67-831b-7e6ef1448fd2,Thomas Bergholt,thomas_bergholt,,,,,, -8997,,148aef2a-7947-432f-84a7-2fc497903dc1,None,none,,,,,, -8998,,ad9a867c-8be3-42fd-82e2-adb045f6a99d,"Janssen-Cilag, div.Johnson and Johnson s.r.o",janssen_cilag_div_johnson_and_johnson_s_r_o,,,,,, -8999,,056f2bd2-9bfa-4983-876c-6b67a0be1d85,CHU d'Amiens,chu_d_amiens,,,,,, -9000,,9eeedd84-cf6e-49ed-b331-c3ff4cc48920,"Department of Neurology, Karolinska University Hospital",department_of_neurology_karolinska_university_hospital,,,,,, -9001,,9c68a906-8bbe-11e6-a449-0242ac12000b,Cipla Europe NV,cipla_europe_nv,,,,,, -9002,,97f51661-2bf4-40d6-95e7-9c34f1c33ff9,Neosil Inc,neosil_inc,,,,,, -9003,,7f687104-3990-4e4a-bbcb-72102be48295,Center for Cancer Immune Therapy,center_for_cancer_immune_therapy,,,,,, -9004,,16a13211-df71-46d1-9f53-a8dfccf361be,North Lincolnshire and Goole NHS Foundation Trust,north_lincolnshire_and_goole_nhs_foundation_trust,,,,,, -9005,,e79969df-5092-433a-8918-f15bb3594ded,Dr. Narcís Cardoner,dr_narc_s_cardoner,,,,,, -9006,,f1feba1e-7128-11e6-a89e-0242ac12000b,TEVA PARENTERAL,teva_parenteral,,,,,, -9007,,b0598217-3a02-4b7a-8e29-ee6ee8c85611,Whittington NHS Trust,whittington_nhs_trust,,,,,, -9008,,85407bbc-7167-11e6-a0cd-0242ac12000b,CENTRAL RADIOPHARM,central_radiopharm,,,,,, -9009,,039131c2-85b4-472e-9093-714521add4a8,Uppsala University. Department of Women's and children's health,uppsala_university_department_of_women_s_and_children_s_health,,,,,, -9010,,6f005826-fd1d-4835-a91b-4db470d43a3b,Memory Pharmaceuticals Corp,memory_pharmaceuticals_corp,,,,,, -596,0.968448,425978bf-fe8b-4344-b07c-9ad8c257ba2f,"Cerexa, Inc. (subsidary of Forest Laboratories)",cerexa_inc_subsidary_of_forest_laboratories,,,,2f6c51a9-6c19-4869-bb54-9a99b0a7c099,cerexa_inc,"Cerexa, Inc" -9011,,6d4e6feb-1a35-4d61-9a7c-7712be2d4706,University Hospital Gent,university_hospital_gent,,,,,, -982,0.94804,52b0531e-71b4-11e6-a0cd-0242ac12000b,JANSSEN PHARMA,janssen_pharma,,,,4f75b1b6-7160-11e6-a0cd-0242ac12000b,janssen_pharms,JANSSEN PHARMS -9012,,828dcca8-73f6-11e6-a0cd-0242ac12000b,VELOXIS PHARMS INC,veloxis_pharms_inc,,,,,, -420,0.949464,6e9fed6e-8bb8-11e6-a449-0242ac12000b,SAKK (Schweizerische Arbeitsgemeinschaft für klinische Krebsforschung),sakk_schweizerische_arbeitsgemeinschaft_f_r_klinische_krebsforschung,,,,4ff92bf9-dd91-4af4-8f0b-df007e6ac363,sakk,SAKK -9013,,ee46ec58-ccab-4b3c-bede-13815ed0a280,Baxter R&D Europe S.C.R.L,baxter_r_d_europe_s_c_r_l,,,,,, -9014,,34630d86-f4df-452d-98c1-6cb52998958a,"Erasmus MC, Dept. Urology",erasmus_mc_dept_urology,,,,,, -9015,,ac194974-8318-4f17-9f5f-2a974f4d41fb,"Klinik und Poliklinik fuer Strahlentherapie, Universität Erlangen-Nürnberg",klinik_und_poliklinik_fuer_strahlentherapie_universit_t_erlangen_n_rnberg,,,,,, -9016,,8e504b76-9ff0-41f2-98c9-9e26710ebc97,Avraham Pharmaceuticals Ltd,avraham_pharmaceuticals_ltd,,,,,, -855,0.983343,9eeb4efa-71af-11e6-a0cd-0242ac12000b,GD SEARLE,gd_searle,,,,9eeb4efa-71af-11e6-a0cd-0242ac12000b,gd_searle,GD SEARLE -9017,,be97baa0-21a8-4051-a4c2-f9d87c605941,Hospital Universitario de Rennes,hospital_universitario_de_rennes,,,,,, -193,0.961748,5684aae1-9d95-4f90-a93b-ce904a01565d,Abertawe Bro Morgannwg University NHS Trust,abertawe_bro_morgannwg_university_nhs_trust,,,,5684aae1-9d95-4f90-a93b-ce904a01565d,abertawe_bro_morgannwg_university_nhs_trust,Abertawe Bro Morgannwg University NHS Trust -9018,,3dac9bcf-988f-4dca-92db-1cd79e337eb9,Hospital Universitario Infanta Cristina,hospital_universitario_infanta_cristina,,,,,, -9019,,51e66fe4-73ef-11e6-a0cd-0242ac12000b,RTRX,rtrx,,,,,, -9020,,a68a2834-d0aa-40d1-b331-565a20265dbe,Laboratoires Merck Sharp and Dohme-Chibret,laboratoires_merck_sharp_and_dohme_chibret,,,,,, -9021,,536a7457-d0fa-4fbe-b7a0-c5a87fe6fe4d,BRC operations Pty. Ltd,brc_operations_pty_ltd,,,,,, -9022,,a18152cf-7ec9-45e1-929e-59bc6a0fc7e5,Unidad de Neuroinmunología,unidad_de_neuroinmunolog_a,,,,,, -1074,0.975369,d3b508d8-7141-11e6-a0cd-0242ac12000b,STASON PHARMS,stason_pharms,,,,5fd7db64-7148-11e6-a0cd-0242ac12000b,stason,STASON -9023,,aff56854-1e28-4bbd-beeb-638541b9b9b3,"Achaogen, Inc",achaogen_inc,,,,,, -606,0.98766422271728516,ffeb7a04-7141-11e6-a0cd-0242ac12000b,AUROBINDO PHARMA,aurobindo_pharma,,,,f36837b0-7144-11e6-a0cd-0242ac12000b,aurobindo_pharma,AUROBINDO PHARMA -9024,,1eb60b74-4301-4304-9a4c-65a33f3b0516,Menarini IFR – International Division,menarini_ifr_international_division,,,,,, -9025,,a9d162be-0b71-4738-b66a-8c240f15fef7,Abbott Biologicals B.V,abbott_biologicals_b_v,,,,,, -9026,,dd7f811a-b5b0-41ad-8157-e5fa4f86b7ed,Samsung Electronics Co. Ltd,samsung_electronics_co_ltd,,,,,, -9027,,1afef3f6-71d7-4b15-bb15-d29862ca9fc8,University Hospital Germans Trias i Pujol,university_hospital_germans_trias_i_pujol,,,,,, -612,0.98582571744918823,f3ebaba1-aead-4675-858a-6f4e2a4f28d1,Erasmus Medical Center Rotterdam,erasmus_medical_center_rotterdam,,,,f3ebaba1-aead-4675-858a-6f4e2a4f28d1,erasmus_medical_center,Erasmus Medical Center -9028,,1c92e489-9898-44e1-8184-febc011a25d8,MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A,menarini_international_operations_luxembourg_s_a,,,,,, -9029,,5134c248-7161-11e6-a0cd-0242ac12000b,PHARMA SERVE NY,pharma_serve_ny,,,,,, -9030,,79989a14-996b-464c-a3dc-b9cd667d3e75,OVATION PHARMACEUTICALS INC,ovation_pharmaceuticals_inc,,,,,, -9031,,a0a17251-0114-4274-a2ae-341e1f75a2af,Mundipharma Research GmbH & Co. KG,mundipharma_research_gmbh_co_kg,,,,,, -9032,,28d31eae-ad06-42c4-b0e8-cab527639b8a,ASSOCIAZIONE MALATTIE SANGUE,associazione_malattie_sangue,,,,,, -9033,,c20afe6c-7191-11e6-a0cd-0242ac12000b,APTALIS PHARMA US,aptalis_pharma_us,,,,,, -1069,0.947481,b57899f1-cac7-418c-9efd-009a37271462,Universitetssjukhuset i Linköping,universitetssjukhuset_i_link_ping,,,,416fb7db-4b29-4803-ba0e-6ece3f142626,universitetssjukhuset_link_ping,Universitetssjukhuset Linköping -9034,,c3dd680d-fd23-4a70-bd6e-014735c105c1,Prosensa Therapeutics BV,prosensa_therapeutics_bv,,,,,, -9035,,0882035f-c286-4629-a255-e7efde243a43,"Consorcio Hospital General Universitario de Valencia . Servicio de Anestesia , Reanimacion y tto del Dolor",consorcio_hospital_general_universitario_de_valencia_servicio_de_anestesia_reanimacion_y_tto_del_dolor,,,,,, -869,0.97674435377120972,dce387f0-f7a2-4de9-a917-bfc3744da5a0,Astellas Pharma BV,astellas_pharma_bv,,,,8c2f1018-ffda-46d2-836f-6bb8351d4443,astellas,Astellas -9036,,922ef9f7-0b0e-4857-a261-859a58e17dbd,"Allakos, Inc",allakos_inc,,,,,, -9037,,d7437a2a-982a-4ff2-8c66-91aaaf7076ce,ALTANA Pharma AG,altana_pharma_ag,,,,,, -9038,,6021eb2f-30d4-4730-b2f5-63546e8f8d6c,Augenklinik des Universitätsklinikums Erlangen,augenklinik_des_universit_tsklinikums_erlangen,,,,,, -9039,,eb80af8a-85f8-4abe-9145-133d69162b03,VU Medisch Centrum,vu_medisch_centrum,,,,,, -9040,,7e790e6c-b117-4b36-8ff1-b205388179e0,Paula Diéguez García,paula_di_guez_garc_a,,,,,, -907,0.96189558506011963,38c1605f-9ba3-4a68-807d-d72954355835,sanofi-aventis recherche et developpment,sanofi_aventis_recherche_et_developpment,,,,f72ce0f5-27b8-42db-aeea-0faa55409a54,sanofi_aventis_recherche_et_developpement,sanofi-aventis recherche et developpement -9041,,1f95d3ff-53af-4aec-b4a9-44685de7e6c6,Takeda Belgium,takeda_belgium,,,,,, -9042,,6539a762-72d7-4d03-a842-6e4aeda74849,Päijät-Häme Central Hospital,p_ij_t_h_me_central_hospital,,,,,, -9043,,7b91dd62-8dbe-4e0d-9166-0b17e2c12ef3,Universität des Saarlandes,universit_t_des_saarlandes,,,,,, -690,0.984864,9da8b08c-7191-11e6-a0cd-0242ac12000b,FOREST LABS INC,forest_labs_inc,,,,9da8b08c-7191-11e6-a0cd-0242ac12000b,forest_labs_inc,FOREST LABS INC -9044,,09d83f70-93f8-408f-840c-df8bdf707e14,Grupo Español Multidisciplicinar de Melanoma (GEM),grupo_espa_ol_multidisciplicinar_de_melanoma_gem,,,,,, -544,0.978652,621062e4-7142-11e6-a0cd-0242ac12000b,BRISTOL MYERS,bristol_myers,,,,3e5070ce-7142-11e6-a0cd-0242ac12000b,bristol,BRISTOL -9045,,31afb37f-1cb9-4e68-99e0-0074110cfd4c,INFINITY PHARMACEUTICAL INC,infinity_pharmaceutical_inc,,,,,, -9046,,e19c8769-a745-11e6-94cb-5656d04fc2b5,Ove B. Schaffalitzky de Muckadell,ove_b_schaffalitzky_de_muckadell,,,,,, -290,0.985423,955ab72e-a78d-4dcf-bada-804223e835a1,Mayne Pharma Plc,mayne_pharma_plc,,,,4526ca2e-a18d-4d92-8100-e8a0507a1f36,mayne_pharma,Mayne Pharma -214,0.975452,f558cf32-f040-452d-bd3d-6eea236bfe77,"Innsbruck Medical University, Department of Radiology, Section of Microinvasive Therapy",innsbruck_medical_university_department_of_radiology_section_of_microinvasive_therapy,,,,1ad07c8c-d03b-4847-bbe9-1ac8e4b893aa,innsbruck_medical_university,Innsbruck Medical University -9047,,d7553994-53fe-4540-89fe-57c1c3e9a6b8,OCTAPHARMA AG,octapharma_ag,,,,,, -60,0.97508934565952843,b3d62e49-a543-49d4-a339-649ecbd1eb58,Wyeth Research Division of Wyeth Pharmaceuticals Inc,wyeth_research_division_of_wyeth_pharmaceuticals_inc,,,,b3d62e49-a543-49d4-a339-649ecbd1eb58,wyeth_research_division_of_wyeth_pharmaceuticals_inc_a_pfizer_company,Wyeth Research Division of Wyeth Pharmaeuticals Inc -9048,,3b56ec98-7167-11e6-a0cd-0242ac12000b,SPECTRON MRC LLC,spectron_mrc_llc,,,,,, -9049,,880d41ca-a3eb-422b-ab18-93ecbc92e862,Daiichi Sankyo Pharma Development,daiichi_sankyo_pharma_development,,,,,, -9050,,55fd4c50-c358-469b-b437-d30c0a4f3cae,Pfizer Luxembourg SARL Branch Office Estonia,pfizer_luxembourg_sarl_branch_office_estonia,,,,,, -323,0.98606482148170471,7c715eec-7632-4bad-85ac-60fea60f92d9,Tibotec Pharmaceuticals Ltd. Ireland,tibotec_pharmaceuticals_ltd_ireland,,,,7c715eec-7632-4bad-85ac-60fea60f92d9,tibotec_pharmaceuticals_ltd,Tibotec Pharmaceuticals Ltd -9051,,9b290917-0a3c-469a-912b-6f7e3c8ddec5,"Deutsche CLL-Studiengruppe, Klinik fur Innere Medizin",deutsche_cll_studiengruppe_klinik_fur_innere_medizin,,,,,, -9052,,e0928f36-7145-11e6-a0cd-0242ac12000b,XANODYNE PHARM,xanodyne_pharm,,,,,, -9053,,86a8ab78-96ea-4814-8b7e-d30b82146de5,Zelmic AB,zelmic_ab,,,,,, -767,0.98579606413841248,3a58d491-d793-4b73-83c1-72dece29c489,Medizinische Universität Innsbruck,medizinische_universit_t_innsbruck,,,,da4cbdf9-e1bc-4412-95a2-1df2b8781a19,medizinische_universit_t_innsbruck_innere_medizin_v,Medizinische Universität Innsbruck -9054,,8bd518ea-7160-11e6-a0cd-0242ac12000b,SCHERER LABS,scherer_labs,,,,,, -9055,,434af447-512c-4af0-9634-10e86ba33544,Hybrigenics SA,hybrigenics_sa,,,,,, -1062,0.98627,e1a71bbf-5693-4e21-bf1f-3e27e8f11ae0,Sint Franciscus Gasthuis Rotterdam,sint_franciscus_gasthuis_rotterdam,,,,68e001f6-0acf-4ba6-831c-dae305950d6b,sint_franciscus_gasthuis,Sint Franciscus Gasthuis -626,0.909952,56aeb338-943d-43c6-b963-168c8748a11a,Chiron Corporation Ltd,chiron_corporation_ltd,,,,35f0780b-f2b6-4584-86d6-148ae3464f6c,chiron_corporation_limited,Chiron Corporation Limited -9056,,62f4aae4-7c29-4485-a3bc-17345b365f76,"Merck Sharp & Dohme a subsidiary of Merck Co., Inc",merck_sharp_dohme_a_subsidiary_of_merck_co_inc,,,,,, -487,0.989076,614b7da9-01e8-45b1-a601-7f743ec0f288,University Eye Clinic Maastricht,university_eye_clinic_maastricht,,,,614b7da9-01e8-45b1-a601-7f743ec0f288,university_eye_clinic_maastricht,University Eye Clinic Maastricht -9057,,dc87c650-71a3-11e6-a0cd-0242ac12000b,ATON PHARMA VPNA,aton_pharma_vpna,,,,,, -932,0.98627001047134399,11113f5a-7350-422c-bd14-c920aa2332af,Pierre Fabre Medicament/Institut de Recherche Pierre Fabre,pierre_fabre_medicament_institut_de_recherche_pierre_fabre,,,,11113f5a-7350-422c-bd14-c920aa2332af,pierre_fabre_medicament_institut_de_recherche_pierre_fabre,Pierre Fabre Medicament/Institut de Recherche Pierre Fabre -9058,,1e2c5287-ae03-4173-97e6-25fc69fa7a01,"AOI Pharmaceuticals, Inc",aoi_pharmaceuticals_inc,,,,,, -746,0.97062024474143982,6067fed3-20a1-48ca-80df-3675d4109505,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C",johnson_johnson_pharmaceutical_research_development_l_l_c,,,,6067fed3-20a1-48ca-80df-3675d4109505,johnson_johnson_pharamceutical_research_development_l_l_c,"Johnson & Johnson Pharamceutical Research & Development, L.L.C" -9059,,186a30e1-9cb0-472d-bcf1-c529c1b01498,CHU de Nice,chu_de_nice,,,,,, -9060,,885c5442-c418-45f9-b1e9-e784d9ca707c,"Asklepion Pharmaceuticals, LLC",asklepion_pharmaceuticals_llc,,,,,, -9061,,38e35ac1-a550-476f-b460-2b39333f9a27,The University of Glasgow,the_university_of_glasgow,,,,,, -9062,,6486d070-7161-11e6-a0cd-0242ac12000b,VANGARD,vangard,,,,,, -9063,,7302413b-f791-4b8c-888d-70d642ed7857,Pfizer Pharma GmbH,pfizer_pharma_gmbh,,,,,, -9064,,2b897317-3041-40d6-850e-8ede3733c244,Kompetenznetz Parkinson e.V,kompetenznetz_parkinson_e_v,,,,,, -9065,,f09ae684-e8c4-48e8-9117-42b0bebba727,"Hospital Clinic, Barcelon",hospital_clinic_barcelon,,,,,, -9066,,9ca6b8c4-d415-4aed-835d-1c17eb91a493,Merck Sharp & Dohme Gesellschaft m.b.H,merck_sharp_dohme_gesellschaft_m_b_h,,,,,, -9067,,973e5b51-c3aa-4ba5-a55f-d7502952ad78,"Afdeling Urologie, Isala Klinieken",afdeling_urologie_isala_klinieken,,,,,, -9068,,28898bb0-2d35-47fb-ae72-ee698b5e2fc0,Mylan GmbH (Mylan),mylan_gmbh_mylan,,,,,, -125,0.982275,11b07734-c458-4066-877a-5c26e559db7c,CureTech,curetech,,,,11b07734-c458-4066-877a-5c26e559db7c,curetech,CureTech -9069,,ddaf05e6-8bbd-11e6-a449-0242ac12000b,Masarykova univerzita,masarykova_univerzita,,,,,, -506,0.981904,89fc944a-7141-11e6-a0cd-0242ac12000b,WATSON LABS FLORIDA,watson_labs_florida,,,,49d9286e-7129-11e6-a89e-0242ac12000b,watson_labs,WATSON LABS -9070,,a8d91e00-7dd5-40f6-9f13-79a96b42366e,QMUL and Bart's Health NHS trust,qmul_and_bart_s_health_nhs_trust,,,,,, -698,0.98415160179138184,72b9ca0e-fa0c-4c39-a503-2b0b6467415c,Bayer Healthcare AG,bayer_healthcare_ag,,,,72b9ca0e-fa0c-4c39-a503-2b0b6467415c,bayer_healthcare_ag,Bayer Healthcare AG -9071,,ad2ac3c2-7166-11e6-a0cd-0242ac12000b,SHENZHEN TECHDOW,shenzhen_techdow,,,,,, -9072,,a20b6959-3785-42f0-89cd-7176722b26a8,Atrium Medical Corporation,atrium_medical_corporation,,,,,, -959,0.96289326747258508,8e1ef03a-b2a7-496e-83ef-ae87bf0b27e9,Andromeda Biotech Ltd,andromeda_biotech_ltd,,,,8e1ef03a-b2a7-496e-83ef-ae87bf0b27e9,andromeda_biotech_ltd_42_hayarkon_st_yavne_81227_israel,Andromeda Biotech Ltd -9073,,ea65cc55-4899-463f-bbc7-b61e71f18881,Matti Eskelinen,matti_eskelinen,,,,,, -510,0.987557,9a59c260-eca4-4f86-a0fa-fed650d1712a,Joint Research Office,joint_research_office,,,,9a59c260-eca4-4f86-a0fa-fed650d1712a,joint_research_office,Joint Research Office -948,0.987264,ca7f7919-c99d-49fd-8812-36dc1941ad8d,Netherlands Cancer Institute,netherlands_cancer_institute,,,,ca7f7919-c99d-49fd-8812-36dc1941ad8d,netherlands_cancer_institute,Netherlands Cancer Institute -9074,,9510a5ba-7164-11e6-a0cd-0242ac12000b,GATE PHARMS,gate_pharms,,,,,, -9075,,79f967d2-7c1d-4621-ab56-c013750020de,"GenSpera, Inc",genspera_inc,,,,,, -9076,,2c15a1d2-709f-40b5-aab7-cd5e5e3e5fdf,Servei Pneumologia. Hospital Universitari Son Dureta,servei_pneumologia_hospital_universitari_son_dureta,,,,,, -9077,,fea982ee-bf78-4468-a20f-cf92db7e5ebf,Novartis Ireland Ltd,novartis_ireland_ltd,,,,,, -9078,,120de42e-2265-47a7-9867-128862ee071e,ROCHE SAS,roche_sas,,,,,, -9079,,6ded2dbd-0b8c-406a-b527-fb0995b3d426,ViiV Healthcare UK Ltd,viiv_healthcare_uk_ltd,,,,,, -9080,,8b808e42-40fe-43c6-b264-cc3f763f5401,Dr Josep Ordi Ros,dr_josep_ordi_ros,,,,,, -9081,,35b8e2f9-3aad-447c-81e0-d2cdc866b266,UNIVERSITA' CAMPUS BIOMEDICO,universita_campus_biomedico,,,,,, -9082,,79618eea-8602-41af-a6df-d0f49f79c03c,Maasstad Ziekenhuis,maasstad_ziekenhuis,,,,,, -9083,,3800ee04-823f-4bca-b2d3-b09471fc1025,VieCuri Medical Center,viecuri_medical_center,,,,,, -9084,,06c6e899-6498-46a7-8656-0bd50160d59b,Univerity Hospital Leuven,univerity_hospital_leuven,,,,,, -9085,,680b478c-67de-4a36-8a88-c1b0dee5f339,Swedish Lung Cancer Group,swedish_lung_cancer_group,,,,,, -9086,,2f1a40d2-b2a9-40b3-8a33-28e2b100a876,"Medizinische Universität Wien, Universitätsklinik für Kinder- und Jugendheilkunde",medizinische_universit_t_wien_universit_tsklinik_f_r_kinder_und_jugendheilkunde,,,,,, -9087,,c8e82e6e-0e55-472e-8f48-6c12a3d385fc,"Intergrated Therapeutics Group, Incorporated-a subsidiary of Schering Plough",intergrated_therapeutics_group_incorporated_a_subsidiary_of_schering_plough,,,,,, -471,0.987664,dc86ddb2-d617-48b5-9e80-ca9ea794503d,South Manchester University Hospital,south_manchester_university_hospital,,,,3162896a-c44b-4bc5-ab15-a97eb8b7517e,south_manchester_university_hospitals_nhs_trust,South Manchester University Hospitals NHS Trust -9088,,260300e6-73b7-11e6-a0cd-0242ac12000b,CITIUS PHARMS,citius_pharms,,,,,, -9089,,79a95e4b-fc73-4fe9-8b96-dcfaa8565028,Acacia Pharma Ltd,acacia_pharma_ltd,,,,,, -9090,,11f5478a-9a0f-46a7-80c6-eb031f4a2e64,"University of Frankfurt, Institute of Clinical Pharmacology",university_of_frankfurt_institute_of_clinical_pharmacology,,,,,, -9091,,5d6455b9-f430-4cfa-ad25-082cc81f2108,Fondazione G.I.M.EM.A. Onlus Gruppo Italiano Malattie Ematologiche dell'Adulto,fondazione_g_i_m_em_a_onlus_gruppo_italiano_malattie_ematologiche_dell_adulto,,,,,, -9092,,e6adfd7f-5d8c-4a1d-add3-0148edcc9611,South Eastern Health and Social Care Trust,south_eastern_health_and_social_care_trust,,,,,, -9093,,ad70e441-18a2-49ef-ae65-e0b50c3584fd,Lab for pharmaceutical biology,lab_for_pharmaceutical_biology,,,,,, -9094,,c2583d56-74bd-4921-9210-8424649305b6,University Hospital Muenster,university_hospital_muenster,,,,,, -9095,,6264a803-f316-4ff5-98e2-cafac6ff8790,"Prof. B. Wiedenmann, Klinik für Gastroenterologie, Charité, Campus Virchow",prof_b_wiedenmann_klinik_f_r_gastroenterologie_charit_campus_virchow,,,,,, -9096,,3ef1937c-1c62-45fb-a0c5-e06546f4a5be,Charité – University Medicine Berlin,charit_university_medicine_berlin,,,,,, -517,0.98103153705596924,be21c811-4df1-4aa6-8fd6-8b4eb1416f21,GELTAMO (Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea),geltamo_grupo_espa_ol_de_linfomas_y_transplante_aut_logo_de_m_dula_sea,,,,be21c811-4df1-4aa6-8fd6-8b4eb1416f21,geltamo_grupo_espa_ol_de_linfomas_y_transplante_aut_logo_de_m_dula_sea,GELTAMO (Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea) -9097,,5d14e8d4-7145-11e6-a0cd-0242ac12000b,STI PHARMA LLC,sti_pharma_llc,,,,,, -9098,,f66884f7-fabf-4639-8436-b5719be9ce20,"Alnylam Pharmaceuticals, Inc",alnylam_pharmaceuticals_inc,,,,,, -9099,,d6ad0ff7-4468-4fc1-ad43-9d3f865284c8,sanofi recherche & developpement,sanofi_recherche_developpement,,,,,, -285,0.9883,7213388e-5096-443a-80ed-002100f22598,"UK für Anästhesiologie und allgemeine Intensivmedizin, LKH Salzburg",uk_f_r_an_sthesiologie_und_allgemeine_intensivmedizin_lkh_salzburg,,,,7213388e-5096-443a-80ed-002100f22598,uk_f_r_an_sthesiologie_und_allgemeine_intensivmedizin_lkh_salzburg,"UK für Anästhesiologie und allgemeine Intensivmedizin, LKH Salzburg" -286,0.933312,aa2861dc-8843-45b3-8d61-af022e0ad7ab,Helperby Therapeutics,helperby_therapeutics,,,,aa2861dc-8843-45b3-8d61-af022e0ad7ab,helperby_therapeutics,Helperby Therapeutics -9100,,adef3e71-dadf-4399-8bd9-61991347ee1d,"Octapharma Pharmazeutika Produktions GmbH,",octapharma_pharmazeutika_produktions_gmbh,,,,,, -9101,,2d47d18d-3240-4150-9b9d-b3ed6fc6c6db,Fachingen Heil- und Mineralbrunnen GmbH,fachingen_heil_und_mineralbrunnen_gmbh,,,,,, -9102,,abff90db-a4fd-49e2-be65-9ba1bf7bac47,Pharmahungary Group,pharmahungary_group,,,,,, -9103,,7ae7c086-8a81-47cb-851e-de6b55529ef2,"Wyeth Pharmaceuticals Inc., Wyeth Research, Clinical Research and Development Division",wyeth_pharmaceuticals_inc_wyeth_research_clinical_research_and_development_division,,,,,, -281,0.986926,0dd91d42-73cc-11e6-a0cd-0242ac12000b,ABBVIE ENDOCRINE,abbvie_endocrine,,,,0dd91d42-73cc-11e6-a0cd-0242ac12000b,abbvie_endocrine,ABBVIE ENDOCRINE -4,0.980166,32b2141c-7602-42db-a25b-43a2694f5d75,University of Dundee,university_of_dundee,,,,32b2141c-7602-42db-a25b-43a2694f5d75,university_of_dundee,University of Dundee -9104,,d2e1be97-2089-42d0-80a1-c9fea6526e54,"Department of Neurology, Medical University of Vienna",department_of_neurology_medical_university_of_vienna,,,,,, -9105,,f09686d3-0ab1-4f49-953c-bb5f40d54c51,"Rigshospitalet, Ultralydklinikken 4002",rigshospitalet_ultralydklinikken_4002,,,,,, -9106,,fc752a4c-7145-11e6-a0cd-0242ac12000b,LEINER,leiner,,,,,, -9107,,d8b0b622-f45b-4d74-9d14-a44c047db0f4,UZ Gasthuisberg,uz_gasthuisberg,,,,,, -9108,,f9c9a17f-5996-42a4-b9aa-a8e324b13f6a,Santaris Pharma A/S,santaris_pharma_a_s,,,,,, -9109,,6cea30f8-7167-11e6-a0cd-0242ac12000b,THE FEINSTEIN INST,the_feinstein_inst,,,,,, -9110,,a032247b-79a1-43c7-8047-2e2311318c23,Uzsoki Hospital,uzsoki_hospital,,,,,, -1036,0.97620874643325806,20ec8644-14fa-4190-8de8-7314ba244821,University of Leeds/Leeds Teaching Hospitals NHS Trust,university_of_leeds_leeds_teaching_hospitals_nhs_trust,,,,0e73d51d-18db-4aac-81b0-bb770932bfdc,university_of_leeds,University of Leeds -9111,,31a53e08-e675-4841-98f8-0d10c685d67d,LABORATOIRES GRIMBERG,laboratoires_grimberg,,,,,, -9112,,70c2c302-6185-4891-9f80-c5392ba721fb,DexTech Medical AB,dextech_medical_ab,,,,,, -9113,,bb521c34-5014-4907-a122-759d2b62f102,"Banyu Pharmaceutical Co., Ltd",banyu_pharmaceutical_co_ltd,,,,,, -9114,,03d001ee-62c7-4e77-a218-0295f302b786,Nordic Bone Marrow Transplant Group (NBMT),nordic_bone_marrow_transplant_group_nbmt,,,,,, -9115,,70e95870-8bcd-11e6-a449-0242ac12000b,Department of Medicine and Endocrinology,department_of_medicine_and_endocrinology,,,,,, -9116,,7a310f18-6dc8-40d3-a3cd-f8503abc80a1,Vasa HVC,vasa_hvc,,,,,, -9117,,0a91ec28-2d00-49b7-9271-f7f3f3110404,STALLERGENES IBÉRICA S.A,stallergenes_ib_rica_s_a,,,,,, -33,0.98417317867279053,ec6b573a-eae5-416d-8f08-41d93e83e2c4,"Department of Endocrinology, Hvidovre Hospital",department_of_endocrinology_hvidovre_hospital,,,,a5f26061-0a6f-4fd1-83b7-6557b7c1b6d1,department_of_endocrinology,Department of Endocrinology -19,0.95549,f9cbaf7a-48b6-4aec-bab3-45123beda57a,IOBA,ioba,,,,28cd44d5-abe5-4c05-bd83-bc9462e97d2d,ioba_universidad_de_valladolid,"IOBA, Universidad de Valladolid" -9118,,2e0ebddc-0190-4737-ac3f-cfc324f945cd,"Sunesis Pharmaceuticals, Inc",sunesis_pharmaceuticals_inc,,,,,, -9119,,96358345-c975-452f-b9d1-a128418f06bc,PeP-Tronic Medical AB,pep_tronic_medical_ab,,,,,, -9120,,6e03014e-73fc-11e6-a0cd-0242ac12000b,FLAMEL IRELAND LTD,flamel_ireland_ltd,,,,,, -103,0.968844,bc402ec7-a8f5-4838-a856-7b15a5bf6d92,"Janssen Research & Development, L.L.C",janssen_research_development_l_l_c,,,,3da026c0-6fa2-11e6-9663-0242ac12000b,janssen_research_development_llc,"Janssen Research & Development, LLC" -9121,,17dd2121-9240-4263-a246-1dc5bd68a846,Cardif and Vale University Local Health Board,cardif_and_vale_university_local_health_board,,,,,, -9122,,b12254fc-7c9a-41b8-ac14-7cb01546edb7,"Dept. of Neurological Surgery, Medical University of Vienna",dept_of_neurological_surgery_medical_university_of_vienna,,,,,, -9123,,91a18561-1e2b-47b0-a421-1c46c1fb060c,Arthroscopic Surgery Unit,arthroscopic_surgery_unit,,,,,, -9124,,cf189299-8639-412a-a65d-6807ee412160,UMC Utrecht,umc_utrecht,,,,,, -9125,,623641f4-8e9d-4401-821d-d3c7d1027461,"Kognitive Neurologie, Institut für Medizin, Forschungszentrum Jülich",kognitive_neurologie_institut_f_r_medizin_forschungszentrum_j_lich,,,,,, -9126,,f3e22eb9-a81e-4bf3-ab23-fa7ef7413e6a,AUSL Piacenza,ausl_piacenza,,,,,, -690,0.984864,be7578e0-7191-11e6-a0cd-0242ac12000b,FOREST LABS,forest_labs,,,,9da8b08c-7191-11e6-a0cd-0242ac12000b,forest_labs_inc,FOREST LABS INC -9127,,71acdc0a-9ac3-45d3-881e-d022ebf9c4b7,Hephata-Klinik,hephata_klinik,,,,,, -108,0.976464,b357c82c-483a-4d22-ba95-f043cc73dd9b,Instituto de Inmunología y Alergia INMUNAL SAU,instituto_de_inmunolog_a_y_alergia_inmunal_sau,,,,b357c82c-483a-4d22-ba95-f043cc73dd9b,instituto_de_inmunolog_a_y_alergia_inmunal_sau,Instituto de Inmunología y Alergia INMUNAL SAU -9128,,7caf90ae-5876-4902-85ed-a654573e8df6,Dr. Pedro Cuevas Sanchez (Investigacion Independiente),dr_pedro_cuevas_sanchez_investigacion_independiente,,,,,, -9129,,63181927-42aa-46b2-9788-e27849c2f17c,Amgen Limited,amgen_limited,,,,,, -9130,,b5047eea-eab5-4699-9458-130424e709b9,Matrizyme Pharma Corporation,matrizyme_pharma_corporation,,,,,, -209,0.960275,2b67170d-4f17-4648-9c58-deeb978a3eb3,FONDAZIONE IRCCS CA` GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO,fondazione_irccs_ca_granda_ospedale_maggiore_policlinico_di_milano,,,,2b67170d-4f17-4648-9c58-deeb978a3eb3,fondazione_irccs_ca_granda_ospedale_maggiore_policlinico_di_milano,FONDAZIONE IRCCS CA` GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO -9131,,09552a42-2ac0-46b1-97f0-9439d6223722,CYATHUS EXQUIRERE PharmaforschungsGmbH,cyathus_exquirere_pharmaforschungsgmbh,,,,,, -9132,,01765c9e-4136-4f4b-91dd-6ed56efc37a8,EAU EUROPEAN ASSOCIATION OF UROLOGY,eau_european_association_of_urology,,,,,, -9133,,b6786853-01e8-4626-9090-ac3e4898ae43,Roche Latvija SIA,roche_latvija_sia,,,,,, -9134,,8caf741d-7ffb-439d-9948-66267daef4b2,University of Vienna,university_of_vienna,,,,,, -9135,,1af95e37-859c-45bb-9265-43142b900c2b,Medical University Greifswald,medical_university_greifswald,,,,,, -672,0.975714,25ceb782-7164-11e6-a0cd-0242ac12000b,PERRIGO UK FINCO,perrigo_uk_finco,,,,25ceb782-7164-11e6-a0cd-0242ac12000b,perrigo_uk_finco,PERRIGO UK FINCO -736,0.97571657101313269,ddd363c2-df58-4b6a-a4aa-aefcab53db6b,European Orgainzation for the Research and Treatment of Cancer (EORTC),european_orgainzation_for_the_research_and_treatment_of_cancer_eortc,,,,86b7934b-bd40-4e41-90e2-f2b10e4f66c8,european_organization_for_the_research_and_treatment_of_cancer_eortc,European Organization for the Research and Treatment of Cancer (EORTC) -9136,,d2042f48-905c-4a81-bd8d-b8ff85776acb,J.W. Goethe-University,j_w_goethe_university,,,,,, -9137,,8b570a0c-5d73-4211-b042-14b0231f3d26,Royal Wolverhampton Hospitals Trust,royal_wolverhampton_hospitals_trust,,,,,, -9138,,c7bc3c1b-cf69-4463-8959-17956a81dc22,Aalst Dermatology Group,aalst_dermatology_group,,,,,, -9139,,072f0428-2b9c-43d0-9452-763eea056fac,DiaMedica USA Inc,diamedica_usa_inc,,,,,, -9140,,955553f9-3908-4068-8877-fb38e9b6e818,"Technische Universitaet Munchen, vertreten durch das Klinikum rechts",technische_universitaet_munchen_vertreten_durch_das_klinikum_rechts,,,,,, -9141,,41a95663-172a-4bc4-b58a-de2f5982e9d9,NHS Greater Glasgow - Yorkhill Division,nhs_greater_glasgow_yorkhill_division,,,,,, -9142,,4a11e4fc-a327-48f0-9935-fb3d4c934743,"Schering Plough, S.A",schering_plough_s_a,,,,,, -9143,,9b674320-99b6-4617-9f51-d5b787653d68,FFCD,ffcd,,,,,, -9144,,632d6c6a-f172-43bb-b2d9-e8260570967f,NovaRx Corporation,novarx_corporation,,,,,, -9145,,cae35465-51ee-4f53-a4ce-bf56217b20d4,CHU de Nîmes,chu_de_n_mes,,,,,, -9146,,6e92673c-80e8-4d52-92cb-4a42c768922f,Herlev University Hospital,herlev_university_hospital,,,,,, -9147,,dc17443d-47af-4ab2-9098-30156958d9f5,GET SRL,get_srl,,,,,, -306,0.977936,b48ed083-a373-417f-9a97-b5caef3a6949,"Free state of Bavaria, Universitätsklinikum Regensburg",free_state_of_bavaria_universit_tsklinikum_regensburg,,,,b48ed083-a373-417f-9a97-b5caef3a6949,free_state_of_bavaria_universit_tsklinikum_regensburg,"Free state of Bavaria, Universitätsklinikum Regensburg" -9148,,9c615020-a6c1-404c-ba63-cda0b1a9537a,Charite-Universitätsmedizin Berlin Germany,charite_universit_tsmedizin_berlin_germany,,,,,, -1079,0.956865,cf3c6cb3-9753-46e8-af8b-75efefbc3522,The Insitute of Cancer Research,the_insitute_of_cancer_research,,,,0d9451d0-cac1-41f0-a202-5d895bc08f17,the_institute_of_cancer_research_the_royal_marsden_nhs_foundation_trust,The Institute of Cancer Research / The Royal Marsden NHS Foundation Trust -9149,,2a76ed08-8f8f-42d2-974b-9f521de8f981,LALLEMAND PHARMA INTERNATIONAL,lallemand_pharma_international,,,,,, -9150,,91b45a98-dfe6-4afc-9376-4d2ff6437dd0,Juan Gonzalez García,juan_gonzalez_garc_a,,,,,, -9151,,4c9f44a8-411d-43c3-b047-3087f692a4e4,Janssen Alzheimer Immunotherapy,janssen_alzheimer_immunotherapy,,,,,, -9152,,9f9440b6-8097-4c2d-a2b0-235de7138458,Xytis Pharmaceuticals Sàrl,xytis_pharmaceuticals_s_rl,,,,,, -9153,,69e7b177-5605-40ee-9e06-689875c30b61,"GlaxoSmithKline Research & Development, LtdD",glaxosmithkline_research_development_ltdd,,,,,, -289,0.97350454330444336,444ae102-9372-40dc-a56f-84e8d39e27c0,BAYER SANTE,bayer_sante,,,,444ae102-9372-40dc-a56f-84e8d39e27c0,bayer_sante,BAYER SANTE -9154,,4215a640-7145-11e6-a0cd-0242ac12000b,ACTAVIS TOTOWA,actavis_totowa,,,,,, -9155,,e5692644-12aa-478e-88aa-a62981b877bc,Erasme Hospital - Department of Gastroenterology,erasme_hospital_department_of_gastroenterology,,,,,, -9156,,71fb78e8-ebb0-45ec-abdf-b582c97422c3,"Institute for Diagnostic Radiology and Neuroradiology, Ernst-Moritz-Arndt University Greifswald",institute_for_diagnostic_radiology_and_neuroradiology_ernst_moritz_arndt_university_greifswald,,,,,, -9157,,c8398dc4-7314-11e6-a0cd-0242ac12000b,JANSSEN LP,janssen_lp,,,,,, -9158,,a0d72bb7-7513-4bd7-91e1-3e1e25a4fe84,"Horizon Therapeutics, Inc",horizon_therapeutics_inc,,,,,, -9159,,91a52bed-eeb5-4545-a74c-1726cdf1a5d8,"Teikoku Pharma USA, Inc",teikoku_pharma_usa_inc,,,,,, -9160,,9e92ce78-c289-4f72-a086-4faee7101d76,Landstinget i Östergötland,landstinget_i_sterg_tland,,,,,, -9161,,6db5cd7c-bb65-4a2f-aad8-4c3cbac4bfe7,Dipartimento di Biotecnologie Molecolari e Scienze per la Salute Università degli Studi di Torino,dipartimento_di_biotecnologie_molecolari_e_scienze_per_la_salute_universit_degli_studi_di_torino,,,,,, -9162,,98c5bba4-856f-4ea2-848a-fd95a9c3db2a,Joergen B Dahl,joergen_b_dahl,,,,,, -368,0.94788815577824914,0f2245d6-1eb2-4a26-ba28-2ddd66aada58,"Bayer HealthCare AG, 51368 Leverkusen, Germany",bayer_healthcare_ag_51368_leverkusen_germany,,,,0f2245d6-1eb2-4a26-ba28-2ddd66aada58,bayer_healthcare_ag_51368_leverkusen,"Bayer HealthCare AG, 51368 Leverkusen" -9163,,c3661f0b-82d3-46d3-8f17-46f9af40b090,AstraZeneca K.K,astrazeneca_k_k,,,,,, -9164,,fdffb8a0-718b-11e6-a0cd-0242ac12000b,TAKEDA PHARMS USA,takeda_pharms_usa,,,,,, -9165,,6e81067d-8ea7-4e14-8f09-5f3078a2047e,DCOG,dcog,,,,,, -9166,,bcf61039-ff28-4441-866b-e5ec506fd2fb,University Ghent,university_ghent,,,,,, -9167,,be8c81c7-2d72-4ae0-b637-a3fdcd050ef4,Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.),groupe_d_etude_th_rapeutique_des_affections_inflammatoires_digestives_g_e_t_a_i_d,,,,,, -9168,,1d5ec945-c625-4a9f-b314-2aa06918c48a,Evolus Inc,evolus_inc,,,,,, -9,0.98788300156593323,e9fa3c3f-4c50-4e46-a5ef-4f151985d2cc,Centre Hospitalier Universitaire,centre_hospitalier_universitaire,,,,2f45bfe9-0b5a-450f-abb3-c7aa18916ff8,centre_hospitalier_universitaire,Centre Hospitalier Universitaire -9169,,46d9c8e0-94dd-4be2-9360-13909c6d44e4,Fondazione Ricerca Traslazionale (FoRT),fondazione_ricerca_traslazionale_fort,,,,,, -9170,,0e6636dc-9cd1-4e51-94fb-970002b87b97,Pierre Schydlowsky,pierre_schydlowsky,,,,,, -9171,,6447c51e-c64d-4b49-b9e0-fe64f00edd37,Umea University,umea_university,,,,,, -9172,,9d3de6b2-5445-4a5c-9741-c784c5d69539,University Hospital Gasthuisberg,university_hospital_gasthuisberg,,,,,, -9173,,1721bc27-596b-49fd-9bc2-b6dbe840b8b8,Vasculitis and Lupus Clinic,vasculitis_and_lupus_clinic,,,,,, -9174,,bdede4dd-8e36-4adc-b72a-9302a1dcb91b,Noscira S.A,noscira_s_a,,,,,, -9175,,9b614000-2926-4957-90c5-e277a7c55967,The Pennine Acute Hospitals NHS Trust,the_pennine_acute_hospitals_nhs_trust,,,,,, -9176,,2b92a2ad-7443-4dcd-b5c1-f7ab1759fa98,Genmab A/S,genmab_a_s,,,,,, -9177,,16c7426c-ae66-4df4-8e1b-b29261379265,Norwegian Gastointestinal Cancer Group,norwegian_gastointestinal_cancer_group,,,,,, -9178,,0476f7cb-b5dc-4b0d-8c58-7baa1a0ad252,Zambon Spa,zambon_spa,,,,,, -9179,,0452fe53-8ca4-4930-971b-00e0fca3b197,"Herz-, Thorax- und Gefäßchirurgische Anästhesie und Intensivmedizin",herz_thorax_und_gef_chirurgische_an_sthesie_und_intensivmedizin,,,,,, -9180,,d2905da1-74d9-43dd-b75a-f8543934bf3b,"University Clinic in Nephrology and Hypertension, Department of Medical Research",university_clinic_in_nephrology_and_hypertension_department_of_medical_research,,,,,, -9181,,42ed164c-dff6-4d33-b7a7-4ae3b1ab3b6d,Prometic Biosciences Inc,prometic_biosciences_inc,,,,,, -9182,,a85dd0a2-b059-4d5b-9ce6-6222f8276bb7,AZIENDA USL 2 DI LUCCA,azienda_usl_2_di_lucca,,,,,, -9183,,53217fdd-b05c-4ef9-ac01-3e1f27a1037d,SYNTA PHARMACEUTICALS,synta_pharmaceuticals,,,,,, -9184,,15124a18-72c6-11e6-a0cd-0242ac12000b,CIPHER PHARMS INC,cipher_pharms_inc,,,,,, -9185,,a2f2d586-b8ba-40a9-b694-02f712594ba2,Bridge BioResearch Rights (Jersey) Ltd,bridge_bioresearch_rights_jersey_ltd,,,,,, -402,0.981186,eb17f730-43ef-415d-9053-abbc8ff7f72d,AGO Research GmbH,ago_research_gmbh,,,,b864ee6b-f5d7-4f18-a0ed-6ad119ce7d88,ago_research_gmbh_ago_study_group,"AGO Research GmbH, AGO Study Group" -9186,,32ca7494-a105-4abb-9990-f80f64b762d0,Cell Therapy Catapult Limited,cell_therapy_catapult_limited,,,,,, -9187,,b2102f30-73f5-11e6-a0cd-0242ac12000b,SPRIASO LLC,spriaso_llc,,,,,, -9188,,d066457a-9626-11e6-becf-0242ac110008,HUMANWELL PURACAP,humanwell_puracap,,,,,, -9189,,654b7fa4-714f-11e6-a0cd-0242ac12000b,MARTEC USA LLC,martec_usa_llc,,,,,, -9190,,431574b7-6ef1-4f0e-a154-1ffc0080e9b1,"AstraZeneca AB, R&D Mölndal",astrazeneca_ab_r_d_m_lndal,,,,,, -9191,,4a2a83fb-271b-4a5a-93a4-9d438125d5a7,Alder Hey Children's NHS Foundation Trust,alder_hey_children_s_nhs_foundation_trust,,,,,, -9192,,00c8c76a-1a3b-4790-bda9-05f022460397,"Upsher-Smith Laboratories, Inc",upsher_smith_laboratories_inc,,,,,, -9193,,b53836b3-5490-4b29-be3a-7671d30afd8e,Abteilung für Herz-Thorax-Gefäß Anästhesie & Intensivmedizin (HTG),abteilung_f_r_herz_thorax_gef_an_sthesie_intensivmedizin_htg,,,,,, -9194,,69bb3d7d-62eb-462b-95f8-19219e1e082b,CELLDEX THERAPEUTICS,celldex_therapeutics,,,,,, -9195,,00d33d53-88ea-4464-b462-01a8f9696cce,Principia Biopharma Australia Pty Ltd,principia_biopharma_australia_pty_ltd,,,,,, -9196,,9527cb43-636e-4d1b-924d-1223a4c0ea57,Hannover Clinical Trial Center GmbH,hannover_clinical_trial_center_gmbh,,,,,, -9197,,b478f909-f06e-475e-bfdd-b29b35b96cc6,Royal Sussex County Hospital,royal_sussex_county_hospital,,,,,, -9198,,b4942e59-ba0a-42e1-91d4-b105a0d9a15b,Karolinska Institute Danderyd Hospital,karolinska_institute_danderyd_hospital,,,,,, -9199,,7ba03022-8bb9-11e6-a449-0242ac12000b,VU Medical Centre,vu_medical_centre,,,,,, -9200,,b356ce28-5dc8-41a0-816c-29ac9e6ab658,Medizinsiche Fakultät der Technischen Universität München,medizinsiche_fakult_t_der_technischen_universit_t_m_nchen,,,,,, -9201,,5d501456-63be-41f4-955a-c7ebcc315d08,Grupo Cooperativo GEMCAD (Grupo Español Multidisciplinar en Cáncer Digestivo),grupo_cooperativo_gemcad_grupo_espa_ol_multidisciplinar_en_c_ncer_digestivo,,,,,, -9202,,276426c2-71aa-11e6-a0cd-0242ac12000b,ALPHA THERA,alpha_thera,,,,,, -9203,,63bac87d-d6a3-4be4-9eef-4efa52f0c0a5,AZIENDA OSPEDALIERA SAN PAOLO,azienda_ospedaliera_san_paolo,,,,,, -9204,,a2cbb082-f059-43d1-864e-c94bd2b76c55,"Instituto Tecnológico PET, S.A.U. (ITP)",instituto_tecnol_gico_pet_s_a_u_itp,,,,,, -9205,,81780341-eb7f-4d72-98bd-b7cd32371b21,"The Christie NHS Foundation Trust, R&D",the_christie_nhs_foundation_trust_r_d,,,,,, -9206,,bc4af3ab-9c98-4b9c-9999-51185af8875b,North Bristol NHS Trust,north_bristol_nhs_trust,,,,,, -9207,,9e873ef5-d0ec-4356-b4b4-f1883bb8f2a7,"Alcon Laboratories, Inc",alcon_laboratories_inc,,,,,, -819,0.912088,bf66c8e7-dc46-4d4b-a5d0-60ce8486fef9,UNIVERSITA` DEGLI STUDI DI PARMA,universita_degli_studi_di_parma,,,,bf66c8e7-dc46-4d4b-a5d0-60ce8486fef9,universita_degli_studi_di_parma,UNIVERSITA` DEGLI STUDI DI PARMA -9208,,563f1a7a-7145-11e6-a0cd-0242ac12000b,ORGANON USA INC,organon_usa_inc,,,,,, -9209,,6618696b-7378-4cae-8ebd-735f5c47f25e,University of Brighton,university_of_brighton,,,,,, -9210,,a34e2926-d750-4e4d-b4a6-678719e1894c,Medizinische Universität Innsbruck - Universitätsklinik für Radiodiagnostik (Radiologie I),medizinische_universit_t_innsbruck_universit_tsklinik_f_r_radiodiagnostik_radiologie_i,,,,,, -9211,,cc3faab8-bf33-4487-8c02-1412481925ad,The University of Sheffield,the_university_of_sheffield,,,,,, -97,0.988116,9abd20d6-1c2a-4aeb-922e-ae371ab88700,Newron Pharmaceuticals,newron_pharmaceuticals,,,,9abd20d6-1c2a-4aeb-922e-ae371ab88700,newron_pharmaceuticals,Newron Pharmaceuticals -9212,,371f081f-a2a8-42cd-b4a0-1b9b1ba8a492,European Uro- Oncology Group (EUOG),european_uro_oncology_group_euog,,,,,, -9213,,687eb4d3-9e95-4384-af62-f663325d485e,Avontec GmbH,avontec_gmbh,,,,,, -9214,,3c53b33f-3be4-4730-bdc0-21cc87e8aa01,Phoenux AG,phoenux_ag,,,,,, -580,0.98430219292640686,ae0a58ab-7d21-4324-9680-942861ba4284,Wyeth Pharmaceuticals,wyeth_pharmaceuticals,,,,6e90ff22-ae0c-4450-9eec-85eba70c3fda,wyeth_pharmaceuticals_inc,Wyeth Pharmaceuticals Inc -9215,,a976ba27-81ca-4bd0-a34c-edd7c2935444,Viventia Biotech Inc,viventia_biotech_inc,,,,,, -1075,0.97996,6c25b988-82b5-4b5c-807f-1a9411cdaca5,"Isala Klinieken, location Sophia",isala_klinieken_location_sophia,,,,43028a3f-c862-4599-8864-5518384f4057,isala_klinieken,Isala Klinieken -815,0.971143,5a3d9a2a-7159-11e6-a0cd-0242ac12000b,PLIVA LACHEMA,pliva_lachema,,,,5a3d9a2a-7159-11e6-a0cd-0242ac12000b,pliva_lachema,PLIVA LACHEMA -9216,,04ca41b4-e352-4af8-b6bc-b3d03ec69827,Futura Medical Developments Ltd,futura_medical_developments_ltd,,,,,, -9217,,512c7ddb-be2c-4534-a7aa-410b98d33a67,Kalevi Pihlajamäki,kalevi_pihlajam_ki,,,,,, -9218,,81eac20b-cf40-45bb-be57-abb0c87594a5,Bundeswehr,bundeswehr,,,,,, -9219,,1e5ee90f-1ea0-4828-93fe-b586d6ca11f5,Grupo de Investigación ICP,grupo_de_investigaci_n_icp,,,,,, -9220,,c41d0d48-3ae2-4cbf-995a-d9fa550fe04d,Hellenic Institute for the Study of Sepsis,hellenic_institute_for_the_study_of_sepsis,,,,,, -80,0.975018,0510fd6f-8916-4b89-89b5-93c49e7400bb,UMC St Radboud,umc_st_radboud,,,,0510fd6f-8916-4b89-89b5-93c49e7400bb,umc_st_radboud,UMC St Radboud -9221,,725bb1b5-6d13-42eb-a304-450d53142233,"EPIX Pharmaceuticals, Inc",epix_pharmaceuticals_inc,,,,,, -9222,,7f0020a0-3d35-4e9a-8e61-fa87008dff4d,Dr. Sylvia Boesch,dr_sylvia_boesch,,,,,, -363,0.953188,6d5782a7-67e2-4374-a6a3-c1e2c79b8eb4,AZIENDA OSPEDALIERA SAN GERARDO DI MONZA,azienda_ospedaliera_san_gerardo_di_monza,,,,6d5782a7-67e2-4374-a6a3-c1e2c79b8eb4,azienda_ospedaliera_san_gerardo_di_monza,AZIENDA OSPEDALIERA SAN GERARDO DI MONZA -9223,,593670e9-dcbc-41d8-bbb0-4026f747d2ae,Henrik Kehlet,henrik_kehlet,,,,,, -9224,,1caf50a1-a688-4992-90ec-c095a7d58bd8,University hospital of Hvidovre,university_hospital_of_hvidovre,,,,,, -9225,,a5bd285b-94c8-4a9f-8b48-74c7795473f8,Hellenic Cooperative Oncology Group,hellenic_cooperative_oncology_group,,,,,, -9226,,cd392bcc-647a-4930-a828-94edc1dc9b33,Boehringer Ingelheim RCV & Co KG,boehringer_ingelheim_rcv_co_kg,,,,,, -81,0.988541,a1e2858d-bccd-44e0-bb25-722440d23889,Université catholique de Louvain,universit_catholique_de_louvain,,,,8a5eb366-780e-4aa5-8b20-c800908bad95,universit_catholique_de_louvain_ucl,Université catholique de Louvain (UCL) -9227,,03075de8-735e-11e6-a0cd-0242ac12000b,EAGLE PHARMS,eagle_pharms,,,,,, -9228,,757530a8-9393-41cd-bd3a-2d8b0b00df28,IRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS,irccs_fondazione_g_b_bietti_per_lo_studio_e_la_ricerca_in_oftalmologia_onlus,,,,,, -9229,,9306e1e7-9e6a-49e3-af34-1850895c8ba2,Protalix Biotherapeutics,protalix_biotherapeutics,,,,,, -9230,,8647e6fa-a91d-491a-9b4c-1b317fae59a5,Boehringer IngelheimRCV GmbH & co KG,boehringer_ingelheimrcv_gmbh_co_kg,,,,,, -9231,,320e510d-3f99-4887-8571-5b94d29a41be,"Allgemeines Krankenhaus Wien, Medizinische Universität Wien",allgemeines_krankenhaus_wien_medizinische_universit_t_wien,,,,,, -9232,,ff6937ca-5dbd-4272-a6c9-68cfa70ef1cb,BEAUFOUR IPSEN Pharma,beaufour_ipsen_pharma,,,,,, -9233,,bad4a31f-aa91-45bf-8d88-f53ed637d903,"Marinus Pharmceuticals, Inc",marinus_pharmceuticals_inc,,,,,, -9234,,ac70bbb4-4b29-4b84-b42b-6a89c6f012bb,Bayer Schering Pharma,bayer_schering_pharma,,,,,, -9235,,6985d934-737a-11e6-a0cd-0242ac12000b,TAP PHARM,tap_pharm,,,,,, -596,0.968448,2f6c51a9-6c19-4869-bb54-9a99b0a7c099,"Cerexa, Inc",cerexa_inc,,,,2f6c51a9-6c19-4869-bb54-9a99b0a7c099,cerexa_inc,"Cerexa, Inc" -9236,,bd57f46e-0e79-40a1-8fd7-96dbd50a6852,"Luzitin, S.A",luzitin_s_a,,,,,, -9237,,d83e78e4-7141-11e6-a0cd-0242ac12000b,HERITAGE PHARMA,heritage_pharma,,,,,, -644,0.97071176767349243,2e1c5817-912c-4f5e-bd24-7888fb2cc9f1,Boehringer Ingelheim Pharma GesmbH,boehringer_ingelheim_pharma_gesmbh,,,,2e1c5817-912c-4f5e-bd24-7888fb2cc9f1,boehringer_ingelheim_pharma_gesmbh,Boehringer Ingelheim Pharma GesmbH -9238,,fb68316e-9c94-456d-a789-7245f4aae297,Endocrinology and Nutrition Unit. Hospital Universitari Bellvitge,endocrinology_and_nutrition_unit_hospital_universitari_bellvitge,,,,,, -9239,,83d02636-7e7f-45fd-aa8f-2fede2341136,AZIENDA OSPEDALIERO-UNIVERSITARIA S. MARIA DELLA MISERICORDIA DI UDINE,azienda_ospedaliero_universitaria_s_maria_della_misericordia_di_udine,,,,,, -9240,,cd1e5d23-e603-4298-b9e6-d610f662827c,"Division of Thoracic and Hyperbaric Surgery, Medical University Graz",division_of_thoracic_and_hyperbaric_surgery_medical_university_graz,,,,,, -538,0.987464,0b556983-4b60-4dae-9f82-49efdc6858f4,Sankyo Pharma Development (SPhD),sankyo_pharma_development_sphd,,,,0b556983-4b60-4dae-9f82-49efdc6858f4,sankyo_pharma_development_sphd,Sankyo Pharma Development (SPhD) -9241,,a9b3aee1-9be2-46c7-bbc5-d0fa806afb2f,RostaQuo S.p.A,rostaquo_s_p_a,,,,,, -9242,,67a08eeb-c9ef-470a-8d42-37e3e183b23e,CHU of Liège,chu_of_li_ge,,,,,, -79,0.98557180166244507,c8c5f87e-c7f0-4c07-ae62-df93cf8c7449,Karolinska Institutet,karolinska_institutet,,,,18921777-f15d-49c4-8f68-7695c0b2af40,karolinska_institutet_hospital,Karolinska Institutet/ Hospital -9243,,c6567b89-e94f-4b83-9010-5e1ecf31835f,Allergan UK Limited,allergan_uk_limited,,,,,, -9244,,30a75b87-92df-41b4-a41c-3387ab3ba9c9,Manuel Rodríguez García,manuel_rodr_guez_garc_a,,,,,, -9245,,bbfc4777-5b4e-4f95-aba0-b9d1834df444,"Adamas Pharmaceuticals, Inc",adamas_pharmaceuticals_inc,,,,,, -9246,,42743e98-2114-42f6-976d-7338b0ef669b,Jørgen B. Dahl,j_rgen_b_dahl,,,,,, -9247,,6ff1b13e-d15c-4297-bde8-4dbd8b619b89,Galenica AB,galenica_ab,,,,,, -393,0.941004,6cd8a498-2fe7-40c6-b305-fa69e84aa23d,Pantec Biosolutions AG,pantec_biosolutions_ag,,,,6cd8a498-2fe7-40c6-b305-fa69e84aa23d,pantec_biosolutions_ag,Pantec Biosolutions AG -9248,,ff7f9185-a56b-4c4c-b63d-ec003d11f9b8,"Universitätsklinikum Erlangen, Strahlenklinik insoweit handelnd für den Freistaat Bayern",universit_tsklinikum_erlangen_strahlenklinik_insoweit_handelnd_f_r_den_freistaat_bayern,,,,,, -9249,,4bf5839b-be7a-4ddd-9610-26ffcc0da406,"Section for Surgical Pathophysiology, Rigshospitalet",section_for_surgical_pathophysiology_rigshospitalet,,,,,, -9250,,1513e197-3f94-4753-8415-1016b61f5df0,Stichting Antoni van Leeuwenhoek Ziekenhuis,stichting_antoni_van_leeuwenhoek_ziekenhuis,,,,,, -37,0.986414,20c01f75-629c-4120-8121-47689f70602e,University of Liverpool (UniLiv),university_of_liverpool_uniliv,,,,0c4d19b0-fc13-4125-ae65-0aea3b77572e,university_of_liverpool,University of Liverpool -9251,,68742125-1070-4a8d-a773-214784a28e0f,York Hospitals NHS Trust,york_hospitals_nhs_trust,,,,,, -9252,,74eb6afa-199e-4e8d-940f-e57c28334b83,St Olavs University Hospital,st_olavs_university_hospital,,,,,, -9253,,0e5de35a-49fe-4bde-92b7-201f2ec4e863,Berlin-Chemie Menarini,berlin_chemie_menarini,,,,,, -924,0.97933,864aab9c-734a-11e6-a0cd-0242ac12000b,ALPHARMA PHARMS,alpharma_pharms,,,,7ced7946-7140-11e6-a0cd-0242ac12000b,alpharma,ALPHARMA -9254,,e12cc357-91a1-4ab2-b87c-8a5b71225095,Laboratoires Merck Sharp & Dohme - Chibret,laboratoires_merck_sharp_dohme_chibret,,,,,, -9255,,f5b86cbc-dfac-4579-a32e-8db574ab6360,Henning Glerup,henning_glerup,,,,,, -9256,,962d618e-d13e-4c87-b086-ff74e260e3ad,Marvel Life Sciences Limited,marvel_life_sciences_limited,,,,,, -9257,,d6591fe8-62d1-4796-a4b2-2ae844099e99,Tartu University Department of Sports Medicine and Rehabilitation,tartu_university_department_of_sports_medicine_and_rehabilitation,,,,,, -9258,,c29149e7-30f9-4eeb-9d3a-743676f4c505,Janne Räsänen,janne_r_s_nen,,,,,, -9259,,74626d64-7126-11e6-8a77-0242ac12000b,WATSON LABS INC,watson_labs_inc,,,,,, -9260,,60d08acb-b6a8-4d49-9224-585d84f74310,Novartis Norge AS,novartis_norge_as,,,,,, -9261,,f3ee7548-494d-4aa7-a725-7526f7cb9ccf,Danish Headache Center,danish_headache_center,,,,,, -9262,,5f000649-3994-42e5-9f22-cbbd92611d74,Associació Per la Recerca Oncològica (APRO),associaci_per_la_recerca_oncol_gica_apro,,,,,, -9263,,5f8b7f15-f15f-4ba6-bb2e-c1c1da79b7f4,CHU Clermont-Ferrand,chu_clermont_ferrand,,,,,, -9264,,3ed939e1-a2a7-4fef-acfe-c72e4ddcc262,Grete Andersen,grete_andersen,,,,,, -9265,,055621a6-d5a2-4708-94b6-a8634968dc48,Pharmanest AB,pharmanest_ab,,,,,, -9266,,610abb62-5379-4497-a22d-3373182b913f,"European LeukemiaNet, Ruprecht-Karls-Universität Heidelberg",european_leukemianet_ruprecht_karls_universit_t_heidelberg,,,,,, -9267,,285ed9a1-1f3f-4e83-b99c-06edda92a701,FRESENIUS BIOTECH GMBH,fresenius_biotech_gmbh,,,,,, -9268,,8ff7956a-cbae-4104-bbd9-91ad7bacd31c,Ordination Dr. Hommer,ordination_dr_hommer,,,,,, -9269,,7b05b3a6-8d31-4080-8a81-9d539b2d7a23,French Society of Cardiology,french_society_of_cardiology,,,,,, -489,0.94924008846282959,556aa12c-fe7a-4155-adda-e25a9fdaf844,STEBA BIOTECH S.A,steba_biotech_s_a,,,,556aa12c-fe7a-4155-adda-e25a9fdaf844,steba_biotech_s_a,STEBA BIOTECH S.A -9270,,747d4209-2c5f-4339-8069-4f22a16f1d8d,GRUPPO ONCOLOGICO ITALIANO DI RICERCA,gruppo_oncologico_italiano_di_ricerca,,,,,, -9271,,eaa893c8-8534-45ab-abcc-9f49ae3e671b,Meander Medisch Centrum,meander_medisch_centrum,,,,,, -811,0.92396390438079834,bb52c529-a5bf-4760-ae6e-b2271b3836a2,Biogen Idec Research Limited,biogen_idec_research_limited,,,,1d7a4c7b-13ee-4fa9-9984-684f337fead9,biogen_idec_research_ltd,Biogen Idec Research Ltd -233,0.980434,321f06bc-9aaf-4f20-b50b-fec99e946a29,Department of Infectious Diseases,department_of_infectious_diseases,,,,321f06bc-9aaf-4f20-b50b-fec99e946a29,department_of_infectious_diseases,Department of Infectious Diseases -9272,,750823ec-6f98-11e6-9663-0242ac12000b,Pia Jæger,pia_j_ger,,,,,, -9273,,7f03367c-7162-11e6-a0cd-0242ac12000b,PHARM VENTURES,pharm_ventures,,,,,, -1048,0.98716670274734497,92e925f1-e29b-41ab-aa81-fc32b5beae28,University Hospital Brno,university_hospital_brno,,,,92cf0698-f0a3-49e3-b16c-ece2bebd1173,university_hospital,University Hospital -362,0.955916,3ed7af3a-1ee9-4762-b37f-885a7628f2f5,GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA (GEICAM),grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama_geicam,,,,3ed7af3a-1ee9-4762-b37f-885a7628f2f5,grupo_espa_ol_de_investigaci_n_en_c_ncer_de_mama_geicam,GRUPO ESPAÑOL DE INVESTIGACIÓN EN CÁNCER DE MAMA (GEICAM) -9274,,132d90fa-73fb-11e6-a0cd-0242ac12000b,PHARMA RES SOFTWARE,pharma_res_software,,,,,, -9275,,aa2d1968-7300-11e6-a0cd-0242ac12000b,AMAG PHARMA USA,amag_pharma_usa,,,,,, -9276,,43862d60-f085-4e8b-9fc7-ba511c7c4cb8,AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE,azienda_ospedaliera_ospedale_policlinico_consorziale,,,,,, -9277,,e4fcc5d7-b92c-496d-950d-42cb59893c8e,"Medizinische Universitaet Wien, Univ.Klinik f.Innere Medizin III, Abteilung fuer Gastroenterologie und Hepatologie",medizinische_universitaet_wien_univ_klinik_f_innere_medizin_iii_abteilung_fuer_gastroenterologie_und_hepatologie,,,,,, -9278,,5fb28c49-d976-4fde-a1b2-87534ace1932,Professor Reich,professor_reich,,,,,, -9279,,81779946-f49d-45d5-a96d-f0e5a12e5462,Fundació Parc Taulí,fundaci_parc_taul,,,,,, -201,0.982782,8f0f2351-12bc-44fe-906d-53b43499c8ae,"Kuopio University Hospital, Anesthesiology Clinic",kuopio_university_hospital_anesthesiology_clinic,,,,01c1da90-d188-4b3b-9a77-71c11c8ab042,kuopio_university_hospital,Kuopio University Hospital -371,0.976266,d647a1c4-2ac3-45cc-b98d-47490b4597d7,AMGEN INC,amgen_inc,,,,d647a1c4-2ac3-45cc-b98d-47490b4597d7,amgen_inc,AMGEN INC -9280,,03f36f28-ef96-4f07-aa36-b6aead23c8fc,Prof. Peter Licht,prof_peter_licht,,,,,, -9281,,405078d2-d470-4a46-8331-e19313098178,VACCIBODY A.S,vaccibody_a_s,,,,,, -9282,,3c20a484-f118-4f0a-af75-faf10c8643a9,Resistentia Pharmaceuticals AB,resistentia_pharmaceuticals_ab,,,,,, -9283,,04b96387-238f-4005-91a2-81b0f3b215b9,IPERBOREAL PHARMA,iperboreal_pharma,,,,,, -9284,,f3fb76ca-8809-11e6-a998-0242ac12000b,Addex Pharma SA,addex_pharma_sa,,,,,, -306,0.977936,eb57ddd5-39b7-4096-ae7e-d6e22f9d9298,Free state of Bavaria,free_state_of_bavaria,,,,b48ed083-a373-417f-9a97-b5caef3a6949,free_state_of_bavaria_universit_tsklinikum_regensburg,"Free state of Bavaria, Universitätsklinikum Regensburg" -9285,,92af94c7-bb90-481f-a7c5-d28e5fbabcc6,VU Medical Center Amsterdam,vu_medical_center_amsterdam,,,,,, -9286,,bedf7fc6-72a7-11e6-a0cd-0242ac12000b,MSD INTL GMBH,msd_intl_gmbh,,,,,, -101,0.96975362300872803,6cac1b04-1612-4a24-92aa-2b5234eb2596,University Childrin's Hospital,university_childrin_s_hospital,,,,6cac1b04-1612-4a24-92aa-2b5234eb2596,university_childrin_s_hospital,University Childrin's Hospital -619,0.972198,4c2e1783-76a6-4110-ab48-f807ec4d7f82,Department of Urology and Pediatric Urology - Justus-Liebig-University Giessen,department_of_urology_and_pediatric_urology_justus_liebig_university_giessen,,,,4c2e1783-76a6-4110-ab48-f807ec4d7f82,department_of_urology_and_pediatric_urology_justus_liebig_university_giessen,Department of Urology and Pediatric Urology - Justus-Liebig-University Giessen -9287,,6a093fab-d1b7-4135-af5b-a71edb0989b7,U.O. Ginecologia e Ostetricia,u_o_ginecologia_e_ostetricia,,,,,, -9288,,de04ff0a-88e8-4a8b-97c2-da4fffde8c3a,BIO-KER S.R.L,bio_ker_s_r_l,,,,,, -9289,,28b78181-a196-41e5-a0be-9872edd63512,AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA,azienda_ospedaliera_maggiore_della_carita_di_novara,,,,,, -9290,,302e8cb5-d7c8-4ffe-bcf0-2cf53923da75,"Medizinische Universität Wien,Univ.Klinik f.Kinder-u.Jugendheilkunde",medizinische_universit_t_wien_univ_klinik_f_kinder_u_jugendheilkunde,,,,,, -9291,,837536b6-012e-4613-b292-95a45f74d0d7,"Sucampo Pharma Americas, Inc",sucampo_pharma_americas_inc,,,,,, -9292,,5c97320a-71ee-11e6-a0cd-0242ac12000b,CORDENPHARMA,cordenpharma,,,,,, -9293,,0de9cc58-ac98-4b88-b4de-7ea7d23e12f1,Glenmark Farmaceutica LTDA,glenmark_farmaceutica_ltda,,,,,, -9294,,e9603db8-f388-49c5-8f80-2c6ec638bbd7,Sociedad Andaluza de Enfermedades Infecciosas SAEI,sociedad_andaluza_de_enfermedades_infecciosas_saei,,,,,, -9295,,3e4b395a-0c8c-4383-9bc3-f067ed338162,ABRAXIS BIOSCIENCE LLC AN INDIRECT SUBSIDIARY OF CELGENE CORPORATION,abraxis_bioscience_llc_an_indirect_subsidiary_of_celgene_corporation,,,,,, -9296,,48524b79-c75f-4513-a969-3e38b1e53be7,Aegerion Pharmaceuticals,aegerion_pharmaceuticals,,,,,, -9297,,5d0285c4-7206-11e6-a0cd-0242ac12000b,TEIKOKU PHARMA USA,teikoku_pharma_usa,,,,,, -9298,,ffe4c257-cf98-4ad1-8d0b-e84053307cfd,Addenbrookes Hospital NHS Trust,addenbrookes_hospital_nhs_trust,,,,,, -9299,,648b913a-7145-11e6-a0cd-0242ac12000b,IGI LABS INC,igi_labs_inc,,,,,, -9300,,03951ba4-738f-4019-b1ab-7328d770745b,Maarit Mentula,maarit_mentula,,,,,, -9301,,cd730ed3-244e-4dfc-987e-d6436a566235,Luton & Dunstable Hospital NHS Foundation Trust,luton_dunstable_hospital_nhs_foundation_trust,,,,,, -488,0.96756553649902344,5d77fa00-9417-4d15-807e-607c459d6842,STEBA BIOTECH N.V,steba_biotech_n_v,,,,5d77fa00-9417-4d15-807e-607c459d6842,steba_biotech,STEBA BIOTECH -9302,,cc0af80d-e697-463e-bd8c-1302fa506c01,"Merck, Sharp & Dohme b.v",merck_sharp_dohme_b_v,,,,,, -493,0.98599249124526978,eee857cc-7141-11e6-a0cd-0242ac12000b,AMNEAL PHARMS NY,amneal_pharms_ny,,,,d264e962-7141-11e6-a0cd-0242ac12000b,amneal_pharms,AMNEAL PHARMS -9303,,f66d72c2-c997-459a-923f-af89b56b4132,Asociación Terapéutica en Hematología y Oncología Médicas del Hospital Arnau de Vilanova de Valencia,asociaci_n_terap_utica_en_hematolog_a_y_oncolog_a_m_dicas_del_hospital_arnau_de_vilanova_de_valencia,,,,,, -9304,,6305766d-c27a-486b-8fce-bc9eadff2bc4,TAKO,tako,,,,,, -206,0.97898,050afe2e-7129-11e6-a89e-0242ac12000b,MIKART,mikart,,,,050afe2e-7129-11e6-a89e-0242ac12000b,mikart,MIKART -9305,,e5e9ed49-d051-4962-9474-6a49776e1ea4,CROLLL GmbH,crolll_gmbh,,,,,, -9306,,a274e6a6-7204-43d3-b2ef-9d288979bcb4,XTL Biopharmaceuticals,xtl_biopharmaceuticals,,,,,, -9307,,fdc15b3d-1cc2-490b-9aef-e1a6cfa3f005,Santhera Pharmaceuticals LLC,santhera_pharmaceuticals_llc,,,,,, -9308,,77e5b8e7-b414-43e3-b5fa-2d8de7de5f11,"Fundación Investigación y Desarrollo Área Cardiovascular & Dr. Javier Segovia, Unidad de Trasplante",fundaci_n_investigaci_n_y_desarrollo_rea_cardiovascular_dr_javier_segovia_unidad_de_trasplante,,,,,, -9309,,55e93662-7142-11e6-a0cd-0242ac12000b,ALCON RES LTD,alcon_res_ltd,,,,,, -9310,,9cc6a86d-cec5-4c21-bdfd-4b198ef6530c,FIMABIS,fimabis,,,,,, -9311,,87672562-a971-49b1-b1bf-dcff0c83250c,Boots Healthcare International Limited,boots_healthcare_international_limited,,,,,, -9312,,82821c84-7381-11e6-a0cd-0242ac12000b,LILLY RES LABS,lilly_res_labs,,,,,, -9313,,aaf80e1a-dee4-4da6-af59-c75f07ba3ece,immatics biotechnologies GmbH,immatics_biotechnologies_gmbh,,,,,, -709,0.93855130672454834,62dccd7b-325f-4731-b158-229a0c9ea429,Reckitt Benkiser Healthcare (UK) Ltd,reckitt_benkiser_healthcare_uk_ltd,,,,62dccd7b-325f-4731-b158-229a0c9ea429,reckitt_benckiser_healthcare_uk_ltd,Reckitt Benckiser Healthcare (UK) Ltd -9314,,99adf7b7-3b0e-45a5-a316-9fa44a8101e6,CNIO - Centro Nacional de Investigaciones Oncológicas,cnio_centro_nacional_de_investigaciones_oncol_gicas,,,,,, -348,0.96850624680519104,3d715925-53ae-4c70-8850-e11c72b69008,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische abteilung für Infektionen und Tropenme",medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_i_klinische_abteilung_f_r_infektionen_und_tropenme,,,,1c69f2db-0f03-45a8-b167-7670161862ea,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_i_klinische_abteilung_f_r_infektionen_und_tropenme,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische abteilung für Infektionen und Tropenme" -9315,,b0555f77-c857-4284-a35e-6f2b74a26d48,Mari Grönroos,mari_gr_nroos,,,,,, -9316,,6e99a9f0-c3a2-43db-9216-3f2cb952ad63,Prof Alice Stanton,prof_alice_stanton,,,,,, -1074,0.975369,5fd7db64-7148-11e6-a0cd-0242ac12000b,STASON,stason,,,,5fd7db64-7148-11e6-a0cd-0242ac12000b,stason,STASON -851,0.982275,9e0d93e9-f8e2-452d-9570-4897fca51742,Lung LLC,lung_llc,,,,9e0d93e9-f8e2-452d-9570-4897fca51742,lung_llc,Lung LLC -9317,,5218d776-7193-11e6-a0cd-0242ac12000b,COVIS PHARMA SARL,covis_pharma_sarl,,,,,, -9318,,9c05f846-12ad-43fa-a81e-7887941c5a84,Boehringer Ingelhein España S.A,boehringer_ingelhein_espa_a_s_a,,,,,, -9319,,fa04c684-1f8f-4721-b7af-f3ebd163b09b,Mundipharma OY,mundipharma_oy,,,,,, -9320,,9a4f8da6-cc2f-4788-8ee7-400d56c8733d,Actavis GmbH & Co. KG,actavis_gmbh_co_kg,,,,,, -9321,,416c6aec-7160-11e6-a0cd-0242ac12000b,REXAR,rexar,,,,,, -1049,0.97674435377120972,ab7c2aac-500b-46fe-87a2-4ea46bf1fcf6,University Hospital Zürich,university_hospital_z_rich,,,,3abc546a-5bd3-4194-a602-f5d74f7521a8,university_hospital_zurich,University Hospital Zurich -9322,,4f70580c-bde2-4095-be22-f649a6664368,Institut klinické a experimentální medicíny,institut_klinick_a_experiment_ln_medic_ny,,,,,, -1001,0.97408080101013184,97bed447-fd0e-4484-9d78-5d7a7aa3b967,Fundación para la Formación en Investigación Sanitarias de la Región de Murcia,fundaci_n_para_la_formaci_n_en_investigaci_n_sanitarias_de_la_regi_n_de_murcia,,,,97bed447-fd0e-4484-9d78-5d7a7aa3b967,fundaci_n_para_la_formaci_n_en_investigaci_n_sanitarias_de_la_regi_n_de_murcia,Fundación para la Formación en Investigación Sanitarias de la Región de Murcia -9323,,750cc5fd-3ea5-42b0-a68c-35625804e4e1,Mika Lehto,mika_lehto,,,,,, -9324,,9c741abd-2a37-4936-8941-ef9c1d9137af,Specialisttandvårdskliniken Västmanlands sjukhus Västerås,specialisttandv_rdskliniken_v_stmanlands_sjukhus_v_ster_s,,,,,, -9325,,6721894e-8bcc-11e6-a449-0242ac12000b,Empros Pharma AB,empros_pharma_ab,,,,,, -873,0.987212,aaef9c57-75a2-48dc-b175-1c1bc118b720,Emotional Brain,emotional_brain,,,,356fb77d-2541-44d7-b831-9556b88820e3,emotional_brain_bv,Emotional Brain BV -9326,,45520b48-9231-4de2-8c6e-10f8b5ea97b4,UZLeuven,uzleuven,,,,,, -9327,,7ace24c3-35f6-4efc-a33d-b4740a63e2f3,"Dept. Oncology, Aarhus University Hospital",dept_oncology_aarhus_university_hospital,,,,,, -9328,,1a658871-bb16-4687-91d2-80da129e317a,medphano Arzneimittel GmbH,medphano_arzneimittel_gmbh,,,,,, -9329,,6c90fbc8-85a3-4601-b122-6663dc4a3647,Oncolytics Biotech Inc,oncolytics_biotech_inc,,,,,, -9330,,b23298ba-b1b0-445c-88ab-3b1f0177038c,Isala Clinics Zwolle,isala_clinics_zwolle,,,,,, -9331,,b5ef0a2e-4727-4216-bd50-e05c3119806b,University of Liverpool and Royal Liverpool University Hospital,university_of_liverpool_and_royal_liverpool_university_hospital,,,,,, -9332,,7fe8833c-7179-11e6-a0cd-0242ac12000b,REGENERON PHARMACEUTICALS,regeneron_pharmaceuticals,,,,,, -9333,,cde803e3-0163-4d74-95c1-01ce04128190,Coombe Women's Hospital,coombe_women_s_hospital,,,,,, -9334,,43abbcb5-fc8c-448f-958e-cd26d4609df8,Lund University,lund_university,,,,,, -9335,,6e27c565-8ef9-4ff0-8a00-15d837b31620,Research and Development University Hospital of North Staffordshire,research_and_development_university_hospital_of_north_staffordshire,,,,,, -9336,,7509bfff-2b2c-4de0-a202-aa020f2efb82,"Clinical Trials Unit, Rigshospitalet",clinical_trials_unit_rigshospitalet,,,,,, -9337,,b368bc78-486b-403c-890f-6dd1f438efd4,PAION Deutschland GmbH,paion_deutschland_gmbh,,,,,, -9338,,658ad606-171a-4720-9ec1-8d748f7fc9af,"Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital. Division of internal medi",karolinska_institutet_department_of_clinical_sciences_danderyd_hospital_division_of_internal_medi,,,,,, -9339,,2fc05d7c-54ee-45c1-a844-bc160cb92e68,Amgen S.A,amgen_s_a,,,,,, -9340,,350e112c-715d-11e6-a0cd-0242ac12000b,GLENMARK PHARMS LTD,glenmark_pharms_ltd,,,,,, -9341,,ca64bfc0-6fc1-11e6-abe8-0242ac12000b,Arbutus Biopharma Corporation,arbutus_biopharma_corporation,,,,,, -794,0.98656213283538818,57306f5b-8c9d-4913-9671-8e18b042b194,Clavis Pharma as,clavis_pharma_as,,,,3bb5af7e-90aa-42de-87dd-3a09da828fda,clavis_pharma,Clavis Pharma -9342,,9b05e4ae-10c7-452b-9166-2fd50ba63066,Novartis Hungaria Kft,novartis_hungaria_kft,,,,,, -9343,,1d7dd9ef-e3fc-478a-8759-72df53148c48,A. Carlsson Research AB,a_carlsson_research_ab,,,,,, -9344,,2a3695e8-a577-418f-8c7c-4b3011150351,"Department of Radiology, Oslo University Hospital, Norway",department_of_radiology_oslo_university_hospital_norway,,,,,, -38,0.97483,7590aa7a-7149-11e6-a0cd-0242ac12000b,BIOVAIL,biovail,,,,4789b24e-71b6-11e6-a0cd-0242ac12000b,biovail_labs_intl,BIOVAIL LABS INTL -9345,,834a40fb-9cb9-4d2e-bd8c-8838e57f4537,ISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED,istituto_neurologico_mediterraneo_neuromed,,,,,, -221,0.987337,edf35dc5-4a96-4c7e-ab5e-7c3239568465,Addenbrooke's Hospital,addenbrooke_s_hospital,,,,edf35dc5-4a96-4c7e-ab5e-7c3239568465,addenbrooke_s_hospital,Addenbrooke's Hospital -9346,,a47b5a07-cd9c-45fd-9400-8cd52d4a8667,FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_pr_ncipe_de_asturias,,,,,, -9347,,00886553-0f3d-4c30-9c3a-13c9404726fd,Beafour Ipsen Pharma,beafour_ipsen_pharma,,,,,, -977,0.984073,5c717b25-0b28-45e6-bff5-45d9320631af,KULeuven and University Hospitals Leuven (Leuven Lung Transplant Group),kuleuven_and_university_hospitals_leuven_leuven_lung_transplant_group,,,,5c717b25-0b28-45e6-bff5-45d9320631af,kuleuven_and_university_hospitals_leuven_leuven_lung_transplant_group,KULeuven and University Hospitals Leuven (Leuven Lung Transplant Group) -9348,,eecff2ba-a807-4e37-902c-7aa99476c152,Department of Orthopaedics IKE,department_of_orthopaedics_ike,,,,,, -9349,,2e5f1fe5-1e75-4b32-ac05-f8b33091e1c0,"Neose Technologies, Inc",neose_technologies_inc,,,,,, -9350,,a177c43c-d828-4cef-a7b7-a1bd3c872c7a,Sahlgrenska University Hospital / The Queen Silvia Children´s Hospital,sahlgrenska_university_hospital_the_queen_silvia_children_s_hospital,,,,,, -9351,,426c74e9-d38f-479d-aa60-e84ec6259645,Interessenverband zur Qualitätsicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland (IQUO) e.V,interessenverband_zur_qualit_tsicherung_der_arbeit_niedergelassener_uro_onkologen_in_deutschland_iquo_e_v,,,,,, -9352,,8a8fbe83-f41e-49cd-ad02-4777117b8bf4,"Faculty of Medicine, Technische Universitaet Muenchen",faculty_of_medicine_technische_universitaet_muenchen,,,,,, -9353,,e64c3098-cc0f-4543-a28c-3c104da8b174,Universitätsklinikum Ulm,universit_tsklinikum_ulm,,,,,, -9354,,68c2e8c0-7168-11e6-a0cd-0242ac12000b,INVATECH PHARMA,invatech_pharma,,,,,, -9355,,068418bd-402a-4be2-a504-29c6eebe2f01,"Belfast Health and Social Care Trust, Musgrave Park Hospital",belfast_health_and_social_care_trust_musgrave_park_hospital,,,,,, -140,0.985075,8525e702-7306-11e6-a0cd-0242ac12000b,MERIDIAN MEDCL,meridian_medcl,,,,11f4634e-719e-11e6-a0cd-0242ac12000b,meridian_medcl_techn,MERIDIAN MEDCL TECHN -9356,,8eba68d2-7bf0-4ca9-9f99-695f72eb14e1,Sección de Digestivo. Hospital Comarcal de Laredo,secci_n_de_digestivo_hospital_comarcal_de_laredo,,,,,, -348,0.9580935537815094,b7b5adf6-8a37-4e38-b522-8a378e347db6,"Medizinische Universtät Wien, Universitätsklinik für Innere Medizin I",medizinische_universt_t_wien_universit_tsklinik_f_r_innere_medizin_i,,,,1c69f2db-0f03-45a8-b167-7670161862ea,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_i_klinische_abteilung_f_r_infektionen_und_tropenme,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische abteilung für Infektionen und Tropenme" -9357,,75ca420a-d39f-494a-9c9a-098d855b7ff7,Fidia Farmaceutici S.p.A,fidia_farmaceutici_s_p_a,,,,,, -9358,,e34e652f-3d4a-48e1-9f55-a85bb8913b5f,Novatreat Ltd,novatreat_ltd,,,,,, -9359,,efba3c92-14f4-4077-97d4-ba5dd5e58983,FRED HUTCHINSON CANCER RESEARCH CENTER UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE SEATTLE CHILDREN,fred_hutchinson_cancer_research_center_university_of_washington_school_of_medicine_seattle_children,,,,,, -9360,,e3c1efc6-0db4-477b-860d-773ddda608dc,Bracco Research S.P.A,bracco_research_s_p_a,,,,,, -9361,,31add611-8139-4727-8518-d0467606cb80,"Section of dental pharmacology and pharmacotherapy, ICO, University of Oslo",section_of_dental_pharmacology_and_pharmacotherapy_ico_university_of_oslo,,,,,, -9362,,cfd7a171-3090-44da-982e-04e342ded7b0,Ruhr Universität Bochum,ruhr_universit_t_bochum,,,,,, -9363,,5ba9946c-349f-4ecc-bb17-bf38a94f265c,Dr. Jordi Monés,dr_jordi_mon_s,,,,,, -9364,,2268e03b-bb26-4db9-8528-385bc1731693,Nuvo research Inc,nuvo_research_inc,,,,,, -9365,,aef39f44-e3c7-4f38-981c-83ddcbd1f2c1,Calabar AB,calabar_ab,,,,,, -241,0.984184,5abbbdea-7142-11e6-a0cd-0242ac12000b,BLU CARIBE INC,blu_caribe_inc,,,,2cc199a4-715c-11e6-a0cd-0242ac12000b,blu_caribe,BLU CARIBE -9366,,3948b154-6cea-4ca5-b88d-b159284f9e75,Fundacion Hospital Alcorcon,fundacion_hospital_alcorcon,,,,,, -9367,,ed1e7d5f-1e3d-4259-afc5-c506080ddd68,Interdos Pharma bv,interdos_pharma_bv,,,,,, -9368,,6453e40c-73f1-11e6-a0cd-0242ac12000b,KERYX BIOPHARMS,keryx_biopharms,,,,,, -9369,,30d4ab7e-3a31-42cc-b178-d36b7eac7c29,"Baxter Healthcare Corporation, Baxter BioScience",baxter_healthcare_corporation_baxter_bioscience,,,,,, -429,0.970982,b990f28f-6416-4624-8f57-71ff8bf23556,Addex Pharmaceuticals S.A,addex_pharmaceuticals_s_a,,,,71d8e8b6-4155-47a0-ad75-6f0f13598830,addex_pharmaceuticals_sa,Addex Pharmaceuticals SA -9370,,0f2416dc-3a8f-49db-9020-1827157b8a74,"ACT BIOTECH, Inc",act_biotech_inc,,,,,, -9371,,854c27be-7167-11e6-a0cd-0242ac12000b,PRECISION NUCLEAR,precision_nuclear,,,,,, -354,0.989467,30b1f9cc-f511-477c-bf64-97f87e3f4260,NERVIANO MEDICAL SCIENCE,nerviano_medical_science,,,,30b1f9cc-f511-477c-bf64-97f87e3f4260,nerviano_medical_science,NERVIANO MEDICAL SCIENCE -9372,,b5957cfa-71b6-11e6-a0cd-0242ac12000b,CLINIPAD,clinipad,,,,,, -9373,,0a5f8d7a-8be8-11e6-a449-0242ac12000b,"The Norwegian Radium Hospital, Oslo University Hospital",the_norwegian_radium_hospital_oslo_university_hospital,,,,,, -9374,,2018e7fe-7164-11e6-a0cd-0242ac12000b,METHAPHARM,methapharm,,,,,, -9375,,058d6954-0c87-4529-b2d8-4b2f02dd1db7,"On Target Laboratories , LLC",on_target_laboratories_llc,,,,,, -295,0.988084,fd4f5aae-cb5c-4a8a-900c-29fffa71d191,Centre for Human Drug Research,centre_for_human_drug_research,,,,4fe3be9a-b05b-4bc8-b2c3-37b02726367b,centre_for_human_drug_research_chdr,Centre for Human Drug Research (CHDR) -9376,,c8d1274c-b3b2-4a1d-9bb7-1a588403df9a,Raitakari Olli,raitakari_olli,,,,,, -9377,,87d549f2-2909-49a0-9368-1c7b2aef9f80,BRUSCHETTINI SRL,bruschettini_srl,,,,,, -9378,,1e1cddf7-2fe4-4b77-9696-9bedc2744207,"Sydvestjysk Sygehus, Esbjerg",sydvestjysk_sygehus_esbjerg,,,,,, -9379,,64391b84-bb06-448b-b437-6ed428c0cc2e,Hormos Medical Ltd,hormos_medical_ltd,,,,,, -9380,,92eaecc1-8450-42cf-9940-066ba6f4b02d,"Søren Sindrup, Dept. of Neurology, University Hospital of Odense",s_ren_sindrup_dept_of_neurology_university_hospital_of_odense,,,,,, -9381,,287b8417-1ea7-4271-bf5a-89c564c6c48a,The Nordic MDS group,the_nordic_mds_group,,,,,, -9382,,efb6b987-c8ea-40b8-af8d-91264529f494,José Luño Fernandez,jos_lu_o_fernandez,,,,,, -9383,,58bd8620-787c-48dc-8e8c-d172643374aa,Robarts Clinical Trials Inc,robarts_clinical_trials_inc,,,,,, -9384,,ff01b770-1e49-4bff-a1cc-a8a5c51904cb,Sigmoid Pharma Ltd,sigmoid_pharma_ltd,,,,,, -441,0.985292,b78c9c06-90e2-4b26-923a-d0b7abf3a2c1,"Dept. of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital Rigshospitalet",dept_of_anaesthesia_centre_of_head_and_orthopaedics_copenhagen_university_hospital_rigshospitalet,,,,38fa42f7-b481-47f1-ad59-ebc7650a6a92,dept_of_anaesthesia_center_of_head_and_orthopaedics_copenhagen_university_hospital_rigshospitalet,"Dept. of Anaesthesia, Center of Head and Orthopaedics, Copenhagen University Hospital Rigshospitalet" -557,0.973471,dd31a9cc-3486-447c-9efa-ead81dc8aa10,SERVICIO DE PSIQUIATRIA. HOSPITAL UNIVERSITARI VALL D'HEBRON,servicio_de_psiquiatria_hospital_universitari_vall_d_hebron,,,,943dc7fd-4950-44aa-a140-b1ce0165b980,servicio_de_psiquiatria_hospital_universitari_vall_de_hebron,SERVICIO DE PSIQUIATRIA. HOSPITAL UNIVERSITARI VALL DE HEBRON -9385,,04b6b577-9151-4717-85af-39e324e5d3cd,"Klinikum Großhadern, ENT-Department",klinikum_gro_hadern_ent_department,,,,,, -9386,,9a33bb06-9a8e-45ce-8abf-f9667ef19976,Shire HGT Inc,shire_hgt_inc,,,,,, -9387,,af3ad0cf-6349-4c9b-9761-a57815b4f7c5,University of Pécs,university_of_p_cs,,,,,, -614,0.94227220614751184,ed799f74-cf6f-4794-826e-112d6271313d,Fundación para la investigacion Biomedica,fundaci_n_para_la_investigacion_biomedica,,,,1f4b6569-9247-4094-9c36-e11efb0201df,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_universitario_la_paz,Fundación para la Investigación Biomédica del Hospital Universitario La Paz -9388,,4f839fea-7b31-41cc-9c9e-857c8bc6647d,Centre Eugène Marquis,centre_eug_ne_marquis,,,,,, -116,0.95832524696985877,f5a479e4-8160-4199-bd67-acd4e6b833c9,Shire Pharmaceutical Development Limited,shire_pharmaceutical_development_limited,,,,63ca73d2-fd68-4693-872c-2121b000d68c,shire_pharmaceutical_development,Shire Pharmaceutical Development -9389,,b90637c8-7141-11e6-a0cd-0242ac12000b,LNK,lnk,,,,,, -9390,,d52e22fb-b00b-4999-a21b-97a2efc2ad93,Our Lady's Children's Hospital,our_lady_s_children_s_hospital,,,,,, -9391,,46308028-897e-45a3-9963-701bbd52c435,GPC BIOTECH,gpc_biotech,,,,,, -397,0.967352,a9e2a6af-3a27-4b28-a5a9-8ffd6a2cebe1,"Copenhagen University Hospital, Rigshospitalet, Juliane Marie Centre, Department of Anaesthesiology",copenhagen_university_hospital_rigshospitalet_juliane_marie_centre_department_of_anaesthesiology,,,,a9e2a6af-3a27-4b28-a5a9-8ffd6a2cebe1,copenhagen_university_hospital_rigshospitalet_juliane_marie_centre_department_of_anaesthesiology,"Copenhagen University Hospital, Rigshospitalet, Juliane Marie Centre, Department of Anaesthesiology" -9392,,0affb892-7147-11e6-a0cd-0242ac12000b,DAVA INTL INC,dava_intl_inc,,,,,, -607,0.989401,fee1690a-a826-4b92-8ab0-c0e523fe410f,Advanced Accelerator Applications SA,advanced_accelerator_applications_sa,,,,dfe33f9c-fc87-4176-a56a-52c1a7a26063,advanced_accelerator_applications,Advanced Accelerator Applications -9393,,90c5258a-bf8a-4a27-adff-fa480770fdfd,Sherwood Forest Hospitals Foundation Trust,sherwood_forest_hospitals_foundation_trust,,,,,, -9394,,4488b555-68ef-468a-ac46-e4871b4ca624,Merck Generics,merck_generics,,,,,, -9395,,57314736-c537-472b-ae8e-e986acd1b307,Alfa Wassermann S.p.A,alfa_wassermann_s_p_a,,,,,, -9396,,5afdd3ce-3e93-4394-8a30-65d040c81bd0,"Medizinische Klinik III, Kardiologie",medizinische_klinik_iii_kardiologie,,,,,, -9397,,44502de1-59d7-4683-bf5d-c74a70c40782,San Raffaele Hospital,san_raffaele_hospital,,,,,, -9398,,1553aea2-a2a0-47d0-8b22-b1bc0ffa6d4e,Universitätsklinikum Freiburg,universit_tsklinikum_freiburg,,,,,, -9399,,eb2c407d-b691-4db8-a892-229a9834b6f6,"Medizinische Universität Graz, Klinische Abteilung für Thorax -u. Hyperbare Chirurgie",medizinische_universit_t_graz_klinische_abteilung_f_r_thorax_u_hyperbare_chirurgie,,,,,, -9400,,ff426bb9-7afa-4bec-bc51-5918769b9b0e,"ENT Hospital, Johannes-Gutenberg University, Mainz",ent_hospital_johannes_gutenberg_university_mainz,,,,,, -427,0.97483,2d37c06d-3f24-45d9-8652-f586b0450921,"VIVUS, Inc",vivus_inc,,,,2b3faade-7374-11e6-a0cd-0242ac12000b,vivus,VIVUS -373,0.91557258367538452,fb0bfd93-ab3e-40a3-8bf1-ec5929f65d5c,Merck Sharp & Dohme GesmbH,merck_sharp_dohme_gesmbh,,,,f2d6af42-c47f-49ae-b4b6-a023a2b2f116,merck_sharp_dohme_gmbh,Merck Sharp & Dohme GmbH -239,0.94886791706085205,8c508aab-3056-4b10-a446-a25708805795,"Pfizer Limited, Ramsgate Road, Sandwich, Kent,CT13,UK",pfizer_limited_ramsgate_road_sandwich_kent_ct13_uk,,,,8c508aab-3056-4b10-a446-a25708805795,pfizer_limited_ramsgate_road_sandwich_kent_ct13_uk,"Pfizer Limited, Ramsgate Road, Sandwich, Kent,CT13,UK" -378,0.94561511278152466,796acf07-1766-4af0-8f88-ef836fc80a36,Merck Sharp & Dohme BV,merck_sharp_dohme_bv,,,,796acf07-1766-4af0-8f88-ef836fc80a36,merck_sharp_dohme_bv,Merck Sharp & Dohme BV -9401,,591864ae-715e-11e6-a0cd-0242ac12000b,MARKSANS PHARMA,marksans_pharma,,,,,, -9402,,3cfb4714-3bd5-42a8-8843-1b7eadc42393,Queen Elizabeth Hospital,queen_elizabeth_hospital,,,,,, -9403,,5a4d6b93-4e2c-442c-8d7b-db72629933ba,Harju Mika,harju_mika,,,,,, -9404,,deb2e335-8ea7-4d07-ad4e-bc123f7c7b35,Baxter SAS,baxter_sas,,,,,, -9405,,3b81808c-1dfa-4eb2-9523-eb1743af008d,Bambino Gesù Children’s Hospital,bambino_ges_children_s_hospital,,,,,, -9406,,876f343f-8b01-4426-94af-1d0c98dee6e1,FRANCISCO JAVIER BENITO FERNANDEZ,francisco_javier_benito_fernandez,,,,,, -9407,,97a9417b-275c-4b37-8d7f-1b36cad60034,cliniques universitaire de mont godinne,cliniques_universitaire_de_mont_godinne,,,,,, -9408,,70830329-be08-4e7a-a312-e5252d3264fb,COALICIÓN IBEROAMERICANA DE INVESTIGACIÓN EN ONCOLOGÍA MAMARIA (CIBOMA),coalici_n_iberoamericana_de_investigaci_n_en_oncolog_a_mamaria_ciboma,,,,,, -9409,,60f23de1-72b6-4ec4-b547-dfced562d1b9,"Pharma Mar SA, sociedad unipersonal",pharma_mar_sa_sociedad_unipersonal,,,,,, -9410,,20e3fa2e-c27a-4227-99e4-ddd6eb7d10f8,"Thorax Center, Univeristy Medical Center Groningen, Groningen, The Netherlands",thorax_center_univeristy_medical_center_groningen_groningen_the_netherlands,,,,,, -9411,,57d18a9c-ae28-45d5-a55c-9bb49d1fbeb7,PULSION Medical Systems SE,pulsion_medical_systems_se,,,,,, -59,0.97944498062133789,e5d9e1b6-afc8-4a91-b7b3-90346bb35a9d,Wyeth Research Division,wyeth_research_division,,,,96e5ebae-c6a3-41db-ae14-3ec5437c35f2,wyeth_research_division,Wyeth Research Division -9412,,bcc53062-f88d-45de-bb89-2b9c1dd5c46f,Ulrich Tacke,ulrich_tacke,,,,,, -9413,,71b6c8b3-321b-4791-9d7f-2045faf90d9e,WSG GmbH,wsg_gmbh,,,,,, -9414,,9685ab72-d6ad-40e4-ab03-94118bf8e117,Consejería de Sanidad de la Comunidad de Madrid,consejer_a_de_sanidad_de_la_comunidad_de_madrid,,,,,, -9415,,f2cfb7ec-99e1-47dd-b90a-2e0f73e4e5af,Childrens´ Hospital Erlangen,childrens_hospital_erlangen,,,,,, -151,0.968867,17459e96-4beb-4a3a-bba1-71e183697af9,Institute of Cancer Research,institute_of_cancer_research,,,,17459e96-4beb-4a3a-bba1-71e183697af9,institute_of_cancer_research,Institute of Cancer Research -9416,,f9d19224-b79e-4920-99e2-9ce2f11f307a,"Dept. of Anesthesiology and Intensive Care, Charité - Campus Benjamin Franklin",dept_of_anesthesiology_and_intensive_care_charit_campus_benjamin_franklin,,,,,, -9417,,9a540466-61f9-434e-b63f-3d344a40a31c,ERREKAPPA EUROTERAPICI,errekappa_euroterapici,,,,,, -1069,0.947481,416fb7db-4b29-4803-ba0e-6ece3f142626,Universitetssjukhuset Linköping,universitetssjukhuset_link_ping,,,,416fb7db-4b29-4803-ba0e-6ece3f142626,universitetssjukhuset_link_ping,Universitetssjukhuset Linköping -764,0.98123,2917de45-e710-4da7-9b4b-c54d1dd1327d,Universitair Ziekenhuis Antwerpen,universitair_ziekenhuis_antwerpen,,,,2917de45-e710-4da7-9b4b-c54d1dd1327d,universitair_ziekenhuis_antwerpen,Universitair Ziekenhuis Antwerpen -9418,,562202ba-715d-11e6-a0cd-0242ac12000b,RP SCHERER,rp_scherer,,,,,, -9419,,98c54c39-2a16-4c12-be58-e9070172f658,Richter Gedeon Rt,richter_gedeon_rt,,,,,, -9420,,e282e3af-c5cd-47bf-8605-63fa05c3220e,"Wyeth Pharmaceuticals Inc, (a Pfizer Company) 500 Arcola Road, Collegeville, PA 19426 USA",wyeth_pharmaceuticals_inc_a_pfizer_company_500_arcola_road_collegeville_pa_19426_usa,,,,,, -9421,,8f006312-db18-419c-a719-aa1b1c17acb7,Swedish CLL-group,swedish_cll_group,,,,,, -380,0.97472488880157471,5ce8246b-51c8-4649-adad-e4ee6e9b4a69,Merck Sharp & Dohme Corp,merck_sharp_dohme_corp,,,,60384d82-f20c-4bc4-8d63-da5bc1c92478,merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc,"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc" -9422,,2319dc8b-34b6-4b8f-9dce-1c759bc06307,Breno Moreno de Gusmao,breno_moreno_de_gusmao,,,,,, -9423,,1cecf013-a72c-11e6-94cb-5656d04fc2b5,"University of Oulu, Department of Pediatrics, PEDEGO-Research unit",university_of_oulu_department_of_pediatrics_pedego_research_unit,,,,,, -649,0.92396390438079834,ff7f9705-592d-4064-81fa-59be5c48cd44,Boehringer Ingelheim Limited,boehringer_ingelheim_limited,,,,04c96b54-04e3-4fc0-9394-ec1a0060bdcd,boehringer_ingelheim_ltd,Boehringer Ingelheim Ltd -9424,,64538db5-44fa-48cc-9f20-0787362dec50,CHU de Bordeaux,chu_de_bordeaux,,,,,, -1044,0.988488,a7ea3b09-730e-4775-aca6-bb467a14c96d,Intercept Pharmaceuticals Inc,intercept_pharmaceuticals_inc,,,,8cc0218b-399d-46ee-a2f5-9edb9d7f5a91,intercept_pharmaceuticals,Intercept Pharmaceuticals -817,0.98780262470245361,53d17802-3866-4bc6-856b-3879f031124d,Boehringer Ingelheim b.v,boehringer_ingelheim_b_v,,,,53d17802-3866-4bc6-856b-3879f031124d,boehringer_ingelheim_b_v,Boehringer Ingelheim b.v -9425,,05fe0074-7160-11e6-a0cd-0242ac12000b,ROBINS AH,robins_ah,,,,,, -743,0.978585,a57f06eb-3ab3-4751-a94f-5b412b84bbb7,Population Health Research Institute (PHRI),population_health_research_institute_phri,,,,a57f06eb-3ab3-4751-a94f-5b412b84bbb7,population_health_research_institute_phri,Population Health Research Institute (PHRI) -9426,,1b59b77c-7199-11e6-a0cd-0242ac12000b,NEW RIVER,new_river,,,,,, -348,0.94994914531707764,1c69f2db-0f03-45a8-b167-7670161862ea,"Medizinische Universität Wien, Universitätsklinik Innere Medizin I",medizinische_universit_t_wien_universit_tsklinik_innere_medizin_i,,,,1c69f2db-0f03-45a8-b167-7670161862ea,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_i_klinische_abteilung_f_r_infektionen_und_tropenme,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische abteilung für Infektionen und Tropenme" -9427,,6ad7c43b-309c-4ec9-92aa-dc9b6fce9708,"Cubist Pharmaceuticals LLC, an indirect wholly-owned subsidiary of Merck Sharp & Dohme Corp",cubist_pharmaceuticals_llc_an_indirect_wholly_owned_subsidiary_of_merck_sharp_dohme_corp,,,,,, -9428,,118b0aaf-ce7d-44f9-855b-fb490ff6dc78,University Medicine Göttingen Dept. Hematology and Oncology,university_medicine_g_ttingen_dept_hematology_and_oncology,,,,,, -9429,,68ccaeb5-00de-49dd-ab18-4d5e8a348773,ClinTrio Ltd,clintrio_ltd,,,,,, -694,0.96722513437271118,1b6ada03-c5ed-4ced-8aa3-31390be8485f,Krankenhaus Nordwest GmbH,krankenhaus_nordwest_gmbh,,,,a1b6c5f2-16df-4bac-b6d9-a19ab340e9dd,krankenhaus_nordwest,Krankenhaus Nordwest -9430,,2c2a639d-4813-4b6d-ba67-1a78c4b91979,Instituto Aragonés de Ciencias de la Salud,instituto_aragon_s_de_ciencias_de_la_salud,,,,,, -9431,,f83ce730-4eca-4ff4-9b6c-599820468d88,Reinier de Graaf Hospital,reinier_de_graaf_hospital,,,,,, -9432,,64323ea2-15da-40fc-9434-ab2c6aa2b1b3,IPOLFG,ipolfg,,,,,, -9433,,fba17192-73f8-11e6-a0cd-0242ac12000b,AMERICAN WELDING AND GAS INC,american_welding_and_gas_inc,,,,,, -9434,,f8eeb553-e484-4b05-8f72-dc94da01e659,ALFA WASSERMANN,alfa_wassermann,,,,,, -9435,,7bab44f3-59c8-4114-b46b-4e266ae1bbe1,GOSH/ICH Joint Research & Development Office,gosh_ich_joint_research_development_office,,,,,, -9436,,49276b2b-f852-4988-b541-4e897180197f,"Cempra Pharmaceuticals , Inc",cempra_pharmaceuticals_inc,,,,,, -9437,,9853dff0-7162-11e6-a0cd-0242ac12000b,MURO,muro,,,,,, -9438,,8e6d8e49-a0ac-4b6d-afa4-b2075931b514,HOPITAL MIGNOT,hopital_mignot,,,,,, -9439,,5335e3b0-ddc1-4ba8-a7dc-ae66cc111aff,University College London (UCL) hereby represented by UCL Comprehensive Clinical Trials Unit(CCTU),university_college_london_ucl_hereby_represented_by_ucl_comprehensive_clinical_trials_unit_cctu,,,,,, -9440,,b46e0117-8256-4431-9bc3-3ebd9d0bc3e0,Stefan Lundeberg,stefan_lundeberg,,,,,, -9441,,e8bc4bc1-06b2-4f82-a8f5-6d97a28e52e5,Helena Kallio,helena_kallio,,,,,, -792,0.980742,3eeb7409-fc6a-4e35-b3ca-369fcd621d64,LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S),leo_pharmaceutical_products_ltd_a_s_leo_pharma_a_s,,,,3eeb7409-fc6a-4e35-b3ca-369fcd621d64,leo_pharmaceutical_products_ltd_a_s_leo_pharma_a_s,LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S) -1017,0.98179945349693298,c40cc85e-13fb-4a5f-a13c-c1d4f3c81220,Southampton University Hospitals Trust (R&D),southampton_university_hospitals_trust_r_d,,,,986ad2cd-cb4e-460c-acdc-a2b32a61de09,southampton_university_hospitals,Southampton University Hospitals -9442,,160e073e-2ecb-4619-a0fa-ddb84d584bfc,Afdeling Klinische Neuropsychologie Vrije Universiteit Amsterdam,afdeling_klinische_neuropsychologie_vrije_universiteit_amsterdam,,,,,, -645,0.97453597187995911,fa036bb5-d4dc-45bd-90a7-a8c241dba4a6,Boehringer Ingelheim Pharma GmbH & CoKG,boehringer_ingelheim_pharma_gmbh_cokg,,,,5b57c8bd-158c-42a5-bfa1-3323c67e0dd4,boehringer_ingelheim_pharma_gmbh,Boehringer Ingelheim Pharma GmbH -9443,,83e644b7-c4d0-4b7a-9c93-72dbffff9ec6,CHU-HOPITAUX DE ROUEN,chu_hopitaux_de_rouen,,,,,, -9444,,2e29fcca-b64e-4c20-a583-0bc5b515f067,Enrique Bárez Hernandez,enrique_b_rez_hernandez,,,,,, -9445,,9b56e8ef-50b0-4c96-a40c-61ec7ffd1547,"The North West London Hospitals NHS Trust, Northwick Park Hospital",the_north_west_london_hospitals_nhs_trust_northwick_park_hospital,,,,,, -9446,,c2b0987b-6d1b-4dac-a975-e393ed88d26a,Leeds Dental Institute,leeds_dental_institute,,,,,, -948,0.987264,ef0c88c3-b18d-418f-8dea-49b004358b2d,Netherlands Cancer Institute (NKI)+31,netherlands_cancer_institute_nki_31,,,,ca7f7919-c99d-49fd-8812-36dc1941ad8d,netherlands_cancer_institute,Netherlands Cancer Institute -9447,,8d400f41-68b3-4ddb-b921-5be0cc83b766,"Research and Enterprise, University of Birmingham",research_and_enterprise_university_of_birmingham,,,,,, -9448,,0d9d5c60-e07a-4fc5-9bf1-21d9c4b73442,MOLMED,molmed,,,,,, -9449,,a5961af8-481f-4504-a77c-fb03c7a301d9,Sociedade Portuguesa de Cardiologia,sociedade_portuguesa_de_cardiologia,,,,,, -9450,,6bd4c478-6fc1-11e6-abe8-0242ac12000b,"Technische Universitaet Muenchen, vertreten durch das Klinikum rechts der Isar",technische_universitaet_muenchen_vertreten_durch_das_klinikum_rechts_der_isar,,,,,, -313,0.95558246970176697,ec9fb836-fdf2-4017-93a0-a0e70dcf5ad9,GlaxoSmithKline Biolgicals,glaxosmithkline_biolgicals,,,,d94a5eb6-cc98-4004-a7a3-95cf39383b18,glaxosmithkline_biologicals,GlaxoSmithKline Biologicals -9451,,7b2a0f7f-c743-41a2-a983-e579ca6f4b7a,"LWL University Hospital Bochum, Ruhr-University Bochum",lwl_university_hospital_bochum_ruhr_university_bochum,,,,,, -9452,,dd65004d-8622-43ca-8bfb-e49abed79780,Department of Infectious Diseases - Aarhus University Hospital,department_of_infectious_diseases_aarhus_university_hospital,,,,,, -9453,,1778c834-7142-11e6-a0cd-0242ac12000b,ARBOR PHARMS LLC,arbor_pharms_llc,,,,,, -9454,,1d778f75-561e-42dc-ab1f-875029aa89a6,AnorMED Corp,anormed_corp,,,,,, -9455,,8366632b-eb1e-44f5-bfd5-afc695e6ede6,Chronic Obstructive Pulmonary Disease Trial Network (COP:TRIN),chronic_obstructive_pulmonary_disease_trial_network_cop_trin,,,,,, -9456,,96f9049e-8df3-4cf5-8b4a-0529ea99f82b,Hôpital Ambroise Paré,h_pital_ambroise_par,,,,,, -9457,,40e8c2e1-c415-405e-a331-f4175825cfe5,Neurology Unit,neurology_unit,,,,,, -9458,,2c375930-b1a3-42b6-81d0-c703f9eadc4c,Arrow Therapeutics Ltd. (a member of the AstraZeneca group of companies),arrow_therapeutics_ltd_a_member_of_the_astrazeneca_group_of_companies,,,,,, -898,0.96782034635543823,73d5b600-a4ac-4e17-85a1-e73320afd73b,EBMT - CLWP,ebmt_clwp,,,,485cfb56-5188-4c47-8ac4-caf3e84b5e2f,ebmt,EBMT -9459,,4d6cf465-f20b-4e73-ac1b-03dbbf813745,The Royal Wolverhampton Hospitals NHS Trust,the_royal_wolverhampton_hospitals_nhs_trust,,,,,, -9460,,372cedfe-725a-11e6-a0cd-0242ac12000b,SB PHARMCO,sb_pharmco,,,,,, -9461,,28d9fcc8-e000-44c3-b668-55b87a2a5379,"Research, Enterprise & Development (UOB)",research_enterprise_development_uob,,,,,, -9462,,a02f1cd6-eb03-4973-9c15-ab873aaf804a,Fundación Pública Andaluza para la Gestión en Salud de Sevilla (FISEVI),fundaci_n_p_blica_andaluza_para_la_gesti_n_en_salud_de_sevilla_fisevi,,,,,, -375,0.98873221874237061,7e87bc11-ff9c-4927-879f-5e83f9da3259,"Merck Sharp and Dohme de España, S.A",merck_sharp_and_dohme_de_espa_a_s_a,,,,7e87bc11-ff9c-4927-879f-5e83f9da3259,merck_sharp_and_dohme_de_espa_a_s_a,"Merck Sharp and Dohme de España, S.A" -9463,,fc6b34f8-fded-4f28-99a1-c74fbf0075b7,Hoffman - La Roche,hoffman_la_roche,,,,,, -9464,,e50bbb18-4117-46cc-ba59-9bb786acfa48,Edinburgh Research and Innovation,edinburgh_research_and_innovation,,,,,, -9465,,86da0dc0-e623-4767-8680-12be086dde3d,Laboratorios LETI S.L,laboratorios_leti_s_l,,,,,, -9466,,cfb6208f-e142-47f0-af60-32f5e7beba39,"KOSAN BIOSCIENCES, INC",kosan_biosciences_inc,,,,,, -9467,,15332d98-65f6-4746-9fac-982badb859c7,"RMC, Skåne University Hospital",rmc_sk_ne_university_hospital,,,,,, -9468,,0099d0d0-b6ce-4e86-8cb7-29a7d9de79d2,Danderyds Sjukhus,danderyds_sjukhus,,,,,, -9469,,5b28fde6-2b42-4b6f-987e-2da424f4f29c,Marc Van de Velde,marc_van_de_velde,,,,,, -9470,,abfcb4f7-5111-4dc6-a68f-0c74fb356cb2,Julian Panés,julian_pan_s,,,,,, -9471,,05f16e48-4874-46c6-8294-676ee5be508f,AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A,aziende_chimiche_riunite_angelini_francesco_a_c_r_a_f_s_p_a,,,,,, -9472,,8b6e682b-40eb-4cc6-80c1-c666b7e698a5,FONDAZIONE CHARTA,fondazione_charta,,,,,, -9473,,84784180-7129-11e6-a89e-0242ac12000b,HIKMA PHARMS LLC,hikma_pharms_llc,,,,,, -9474,,acf06b27-84c5-4480-9344-da4890896a0f,AZ. USL DI CESENA,az_usl_di_cesena,,,,,, -9475,,51a8a860-bb4d-4d7b-acca-bb814c10888b,AGI Therapeutics Limtied,agi_therapeutics_limtied,,,,,, -9476,,1c21f2d9-d9e9-4231-a7f0-da1a911b6d87,THERANOR sprl,theranor_sprl,,,,,, -9477,,cce6a956-cbf4-4c3c-a9b5-7cc185dc76a2,Nordmark Arzneimittel GmbH & Co. KG,nordmark_arzneimittel_gmbh_co_kg,,,,,, -9478,,5be30e44-9d9d-4178-8026-c4659ad1c75a,Daval International Limited,daval_international_limited,,,,,, -9479,,7d2dc040-7146-11e6-a0cd-0242ac12000b,INTERGEL PHARM,intergel_pharm,,,,,, -9480,,5492144a-265e-442b-b2ac-99b7603b5adc,"TenX Biopharma, Inc.,",tenx_biopharma_inc,,,,,, -9481,,5e59f446-eb97-4119-beae-2c835de6dd39,Norrbottens läns landsting,norrbottens_l_ns_landsting,,,,,, -9482,,da2d952a-8be7-48a2-9573-290cd27fe679,Accare,accare,,,,,, -9483,,61161b39-0d07-4dd0-b45c-c0596578e679,"Oncoethix GmbH, a wholly owned subsidiary of Merck Sharp & Dohme Corp",oncoethix_gmbh_a_wholly_owned_subsidiary_of_merck_sharp_dohme_corp,,,,,, -9484,,d16a5cb2-adbb-4923-81ac-ec1e7f28daab,THT Research sprl,tht_research_sprl,,,,,, -9485,,1b1c07cb-1473-4c37-bb4c-8c8094d084ff,"Instituto Português de Oncologia do Porto Francisco Gentil, EPE",instituto_portugu_s_de_oncologia_do_porto_francisco_gentil_epe,,,,,, -9486,,546dfe8e-5f79-4d65-958b-1c1232b412ba,"General Hospital Vienna, Dept Cardio-thoracic surgeray",general_hospital_vienna_dept_cardio_thoracic_surgeray,,,,,, -9487,,30616589-2bc4-4938-a845-c96a5d41ae8e,"Quark Pharmaceuticals, Inc",quark_pharmaceuticals_inc,,,,,, -740,0.9299778938293457,0db04114-2f8a-4901-9be7-558fb229bc42,"ICORG, the all-Ireland Co-operative Oncology Research Group",icorg_the_all_ireland_co_operative_oncology_research_group,,,,a915c184-a118-4ca9-8fb4-2b38760107dc,icorg_the_all_ireland_cooperative_oncology_research_group,"ICORG, the all-Ireland Co-operative Oncology Research Group" -9488,,a42d7f0e-260d-4d9f-b09c-084b6c335b5a,ZAMBON ITALIA,zambon_italia,,,,,, -9489,,8517d378-fc67-4e3a-86f6-c7557ed863f0,Zytoprotec GmbH,zytoprotec_gmbh,,,,,, -9490,,bede2514-2389-4050-be52-fe440fba97f9,"HYKS, sisätautien toimiala, diabetesklinikka",hyks_sis_tautien_toimiala_diabetesklinikka,,,,,, -9491,,dae5bd5c-6fa0-11e6-9663-0242ac12000b,"Pfizer Inc, 235 East 42nd Street, New York City, NY 10017",pfizer_inc_235_east_42nd_street_new_york_city_ny_10017,,,,,, -9492,,a7d01b29-364f-4dc4-9ca6-57a64f2424aa,"Medco Health Solutions, Inc",medco_health_solutions_inc,,,,,, -9493,,a09d0c0f-f1b3-446a-b25a-49fc8bf731ba,Our Lady's Hospital for Sick Children,our_lady_s_hospital_for_sick_children,,,,,, -9494,,2d3adf54-b134-461e-b308-6769cfc3fc0e,Sigma-Tau i.f.r. S.p.A,sigma_tau_i_f_r_s_p_a,,,,,, -9495,,d4948804-2cc7-4609-8d28-2c3f101dfdf9,"Rigshospitalet, Psykiatrisk Klinik",rigshospitalet_psykiatrisk_klinik,,,,,, -58,0.96753491461277008,fe20c8b4-bfb0-4cfc-96be-52e8cd5c61f0,"Wyeth Research Division of Wyeth Pharmaceuticals Inc., Clinical Reserach and Development",wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_reserach_and_development,,,,2ed1b6f4-e137-4ee3-a218-9e5c2d04039a,wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_and_development,Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development -9496,,c5edbd45-2bc3-448a-aabb-156881397fd0,Enrique Ortega González,enrique_ortega_gonz_lez,,,,,, -9497,,e6a77325-0df6-491e-8eb9-dab5c80f086d,Shionogi Ltd,shionogi_ltd,,,,,, -9498,,e149eac8-a08e-4b46-a4f9-98a9f571575f,"Greater Glasgow Health Board, Research and Development Department",greater_glasgow_health_board_research_and_development_department,,,,,, -9499,,feb7f80f-282e-4a8f-8d3b-17ad9d8bb974,Asociación para la investigación de Nefrología Infantil,asociaci_n_para_la_investigaci_n_de_nefrolog_a_infantil,,,,,, -9500,,bb188039-869b-45ab-8c4b-a6aefee93dda,"Ethicon, Inc",ethicon_inc,,,,,, -9501,,694a2f22-7c86-49c8-a092-c213c9222cd5,TauRx Therapeutics Ltd,taurx_therapeutics_ltd,,,,,, -9502,,18fe0aea-90d0-4355-9358-37cc3d0cafec,Grupo Gallego de Investigaciones Oncológicas (GGIO),grupo_gallego_de_investigaciones_oncol_gicas_ggio,,,,,, -9503,,2c1338c6-b985-491c-adf9-b9145a774a80,Guy's & St Thomas NHS Trust,guy_s_st_thomas_nhs_trust,,,,,, -353,0.983343,39567cd9-71f5-4b2f-bdb8-e49b40d2d234,Institut de Recherche Pierre Fabre - Centre de R&D Pierre Fabre,institut_de_recherche_pierre_fabre_centre_de_r_d_pierre_fabre,,,,33018013-878a-4dd3-b923-de7bc09fb504,institut_de_recherche_pierre_fabre,Institut de Recherche Pierre Fabre -9504,,6d6c8b60-b830-43e2-8a2d-7d3cf8bdf45e,Neurovascular Research Group-IRVH,neurovascular_research_group_irvh,,,,,, -9505,,dcbc3204-01ee-4b85-948a-2451cff49277,Norgine Ltd,norgine_ltd,,,,,, -9506,,3bc6a70f-5ee0-4333-bc60-ac971b4c432a,"Department of Breast and Endocrine Surgery, Karolinska University Hospital",department_of_breast_and_endocrine_surgery_karolinska_university_hospital,,,,,, -9507,,cdcae20d-d4d1-4000-b6af-7fa51725b7d8,Mabion S.A,mabion_s_a,,,,,, -9508,,9a0c2f7f-efda-4829-b68b-ba9ffee8e0de,University Hospital Düsseldorf,university_hospital_d_sseldorf,,,,,, -9509,,38d758a7-0eda-41d4-991a-7e92bc9798e5,"ImaRx Therapeutics, Inc",imarx_therapeutics_inc,,,,,, -9510,,2b4d2250-b195-47be-9cb2-6b492aa2a307,Nina Olofsson,nina_olofsson,,,,,, -9511,,307f0a88-a945-41a0-8e15-993a655500ff,"EMET Pharmaceuticals, LLC",emet_pharmaceuticals_llc,,,,,, -9512,,8e508f32-7be0-4145-b591-56b544584752,Knowledge Centre for Rheumatology and Back Diseases,knowledge_centre_for_rheumatology_and_back_diseases,,,,,, -9513,,88393f10-e7d4-4f62-be7b-8d065c72abe0,Osakidetza,osakidetza,,,,,, -9514,,75deecd4-0120-4b38-9781-98426c80bb59,"Gemin X Pharmaceuticals US, Inc",gemin_x_pharmaceuticals_us_inc,,,,,, -9515,,a04276bd-a025-4da4-8d91-888ddb9d35d0,GB Bietti Eye Foundation - IRCCS,gb_bietti_eye_foundation_irccs,,,,,, -410,0.960286,273912e1-1b32-44bf-9119-1caf84670781,ABOCA S.P.A. SOCIETà AGRICOLA,aboca_s_p_a_societ_agricola,,,,273912e1-1b32-44bf-9119-1caf84670781,aboca_s_p_a_societ_agricola,ABOCA S.P.A. SOCIETà AGRICOLA -9516,,13bb5684-af31-41d0-bcfe-e3c37d962927,"University of Würzburg, Internat. study-Coordinator",university_of_w_rzburg_internat_study_coordinator,,,,,, -9517,,9b04b66e-2af5-429d-a4a3-51bdc8263a82,BIOGEN IDEC LTD,biogen_idec_ltd,,,,,, -972,0.95330953598022461,4f0fa6e4-6773-4398-b96f-befbaf1b6648,"Schering Plough Research Institute, una División de Schering Corporation",schering_plough_research_institute_una_divisi_n_de_schering_corporation,,,,4f0fa6e4-6773-4398-b96f-befbaf1b6648,schering_plough_research_institute_una_divisi_n_de_schering_corporation,"Schering Plough Research Institute, una División de Schering Corporation" -9518,,d084f49e-8bca-4974-80a0-b40e4611faa4,Neolab Limited,neolab_limited,,,,,, -293,0.98027,812fe53e-1c93-4bf7-b221-e632d44ef1b0,"Janssen Cilag International, N.V. (Sponsor in European Union)",janssen_cilag_international_n_v_sponsor_in_european_union,,,,3c9f7dec-c696-4e53-bf14-5c014e7babdd,janssen_cilag_international,Janssen Cilag International -9519,,b264dfd8-ae72-4379-8916-5d79363e6aa1,ZLB Behring LLC,zlb_behring_llc,,,,,, -815,0.971143,c4a52fee-7141-11e6-a0cd-0242ac12000b,PLIVA,pliva,,,,5a3d9a2a-7159-11e6-a0cd-0242ac12000b,pliva_lachema,PLIVA LACHEMA -9520,,5bbcfcc7-ffdc-4564-b9a2-b8dad862c32c,Reino Pöyhiä,reino_p_yhi,,,,,, -9521,,5708614d-ba73-4de4-81cb-02465f206ccd,Pharmexa A/S,pharmexa_a_s,,,,,, -9522,,6e6f17e5-e9ab-4194-a464-0f5f50b5e5e6,"SkyePharma, Inc",skyepharma_inc,,,,,, -9523,,3304e616-0874-48b9-b1d7-006497db28f5,Zambon Group S.p.A,zambon_group_s_p_a,,,,,, -9524,,b23be708-7146-11e6-a0cd-0242ac12000b,BANNER PHARMACAPS,banner_pharmacaps,,,,,, -9525,,82062cc4-73e9-11e6-a0cd-0242ac12000b,GLAXO GRP ENGLAND,glaxo_grp_england,,,,,, -9526,,52b548ac-187d-4423-adc2-ce07d41bba7a,almirall,almirall,,,,,, -9527,,ccbe5a98-a44d-474e-b57b-5a33c8d6b0bb,University Hospital Linköping,university_hospital_link_ping,,,,,, -9528,,50f5812b-1725-4855-b0ea-9a89256df3bb,Concept Foundation,concept_foundation,,,,,, -483,0.933215,572941f2-e5d0-4699-91b4-8cbbbb8105bc,Groupe d'Etude des Lymphomes de l'Adulte(GELA),groupe_d_etude_des_lymphomes_de_l_adulte_gela,,,,4c50d4d9-2093-41e3-ac48-f701d16f0acc,groupe_d_etudes_des_lymphomes_de_l_adult,Groupe d'Etudes des Lymphomes de l'Adult -9529,,94e782c4-6e3c-49ef-b2f7-4fe7b11a6cda,Macarthys Laboratories Limited (trading as Martindale Pharma),macarthys_laboratories_limited_trading_as_martindale_pharma,,,,,, -597,0.979394,82f6db80-c06d-45dc-aedb-e850bc499707,Semmelweis University,semmelweis_university,,,,0bfd17f2-ec27-44b6-9dcf-b6e90369486a,semmelweis_university_department_of_ophthalmology,Semmelweis University Department of Ophthalmology -9530,,96e39e2f-97e3-429c-951e-6138b482b036,Groupe Français des myélodysplasies,groupe_fran_ais_des_my_lodysplasies,,,,,, -9531,,344fecc4-7167-11e6-a0cd-0242ac12000b,EDENBRIDGE PHARMS,edenbridge_pharms,,,,,, -9532,,61b661fa-81eb-46da-b060-04e77f8fca5a,UCB S.A. (Global Medical Affairs),ucb_s_a_global_medical_affairs,,,,,, -9533,,16531022-2537-4429-bdd7-c4569548c0fe,Evotec NeuroSciences GmbH,evotec_neurosciences_gmbh,,,,,, -9534,,cd768330-5705-4294-ae38-b7dc70336ead,Turun yliopistollinen keskussairaala,turun_yliopistollinen_keskussairaala,,,,,, -9535,,8cfe36cc-7168-11e6-a0cd-0242ac12000b,TARO PHARMA USA INC,taro_pharma_usa_inc,,,,,, -9536,,2f767c57-676f-4048-a45f-63e83a2c1638,"Uppsale University Hospital, MHT, Department of Nephrology",uppsale_university_hospital_mht_department_of_nephrology,,,,,, -9537,,d466529b-561f-4a1e-ab07-85bb5c36bc7e,Dirección General de Salud Pública, Conselleria de Sanidad de la Comunidad Valenciana,,,,,, -9538,,223f566e-6999-4fdb-8cfb-42000a7627c2,"University of Dundee, Tayside Clinical Trials Unit",university_of_dundee_tayside_clinical_trials_unit,,,,,, -9539,,18cc1c38-738d-49d5-a81e-0401c5706588,AstraZeneca GmbH,astrazeneca_gmbh,,,,,, -9540,,18fbab09-4498-4d78-b313-b5838d02d021,Grupo Español de Tumores Neuroendocrinos (GETNE),grupo_espa_ol_de_tumores_neuroendocrinos_getne,direcci_n_general_de_salud_p_blica_conselleria_de_sanidad_de_la_comunidad_valenciana,,,,, -726,0.987967,1b7f80c2-b4fd-41cd-875f-9db8a4bf35a2,Steno Diabetes Center,steno_diabetes_center,,,,1b7f80c2-b4fd-41cd-875f-9db8a4bf35a2,steno_diabetes_center,Steno Diabetes Center -9541,,2765524c-2b21-48c5-89c0-9a2f33bb8b38,Tampereen yliopistollinen sairaala,tampereen_yliopistollinen_sairaala,,,,,, -9542,,15e3b966-a188-490f-a25e-a98fdc581f6a,UNIVERSITA' DI GENOVA,universita_di_genova,,,,,, -302,0.977381,02f80d08-964f-4144-817a-07dd524f56fc,Janssen Biologics B.V. (formerly known as Centocor B.V.),janssen_biologics_b_v_formerly_known_as_centocor_b_v,,,,02f80d08-964f-4144-817a-07dd524f56fc,janssen_biologics_b_v_formerly_known_as_centocor_b_v,Janssen Biologics B.V. (formerly known as Centocor B.V.) -9543,,1d156db5-e8cc-4112-a6b7-870c36c8c010,Wyeth Pharmaceuticals B.V,wyeth_pharmaceuticals_b_v,,,,,, -9544,,9ae8b20c-fb2a-4c1d-86e6-9dab1e0260ac,TEVA ITALIA srl,teva_italia_srl,,,,,, -974,0.97182440757751465,41982735-d9d3-4f00-8742-ee8d1340f3f5,Universitätsklinikum Schleswig-Holstein (UK-SH),universit_tsklinikum_schleswig_holstein_uk_sh,,,,4cbb7e37-feeb-4dcf-a21f-ec40d4959c01,universit_tsklinikum_schleswig_holstein,Universitätsklinikum Schleswig-Holstein -9545,,09dee41c-719f-11e6-a0cd-0242ac12000b,HUNTINGTON LABS,huntington_labs,,,,,, -9546,,4da2c44c-9910-469e-a195-714ea33ef684,Advicenne Pharma,advicenne_pharma,,,,,, -9547,,66477e80-715e-11e6-a0cd-0242ac12000b,OPTOPICS,optopics,,,,,, -9548,,9e828a2c-8d35-4433-a6e2-3aa3a1bd973f,Fundación General de la Universidad de Valladolid,fundaci_n_general_de_la_universidad_de_valladolid,,,,,, -9549,,ad7aaa73-5eb4-4ab5-9ea7-e9b1bf349de4,Hôpital Erasme,h_pital_erasme,,,,,, -9550,,569d3fae-72b9-11e6-a0cd-0242ac12000b,EMERGENT,emergent,,,,,, -1047,0.985052,e0066c6d-1cfd-484d-92b2-512d3a66bf83,InnaVirVax SA,innavirvax_sa,,,,010d35da-5d47-4a0d-b01d-6b5b38df61c0,innavirvax,InnaVirVax -9551,,ded28536-2c6c-4faf-8148-9bd9ac800686,Active Biotech AB,active_biotech_ab,,,,,, -618,0.987151,8d9c4ced-2b24-426a-8a2e-4baf9f708c31,Belfast City Hospital,belfast_city_hospital,,,,3c1aae28-1aa7-461b-ae60-fe064393d484,belfast_city_hospital_trust,Belfast City Hospital Trust -9552,,196024ce-bb29-450d-bbc5-3a62700d0bce,"Melbourne Health, Royal Melbourne Hospital",melbourne_health_royal_melbourne_hospital,,,,,, -9553,,cbe41c4b-8a59-4bb4-90f8-b229d2f63fbe,John Pernow,john_pernow,,,,,, -9554,,bf90f070-fc98-47a4-97e0-7043c0001caf,Héctor Guiral Torner,h_ctor_guiral_torner,,,,,, -9555,,2b432d8b-58ed-40df-88db-d9604e5f1dbf,Azienda Ospedaliera L. Sacco - Clinica Pediatrica,azienda_ospedaliera_l_sacco_clinica_pediatrica,,,,,, -9556,,d6fc0468-201f-4baa-ae28-4728d0d53c47,Salford Royal Foundation NHS Trust,salford_royal_foundation_nhs_trust,,,,,, -322,0.98791098594665527,8960a541-aa35-4907-aafd-d0c2015c31a8,Tibotec Pharmaceuticals Limited,tibotec_pharmaceuticals_limited,,,,27185c1d-6e99-48fc-9d68-1530f804e15d,tibotec_pharmaceuticals_limited_ireland,Tibotec Pharmaceuticals Limited Ireland -9557,,2f51225c-8f75-4ab5-9d54-73d45157587e,Ranbaxy Laboratories Limited,ranbaxy_laboratories_limited,,,,,, -9558,,b16c9e1b-d7b7-4405-b454-44c798a699d1,Boehringer Ingelehim AB,boehringer_ingelehim_ab,,,,,, -1064,0.96204358339309692,5832b652-f280-4dd6-850d-477a81887563,Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge,cambridge_university_hospitals_nhs_foundation_trust_and_the_university_of_cambridge,,,,5832b652-f280-4dd6-850d-477a81887563,cambridge_university_hospitals_nhs_foundation_trust,Cambridge University Hospitals NHS Foundation Trust -9559,,0506fa26-06d0-45f4-9eb2-c1d161c0895f,"Department of Biomedical Engineering, Linköping University",department_of_biomedical_engineering_link_ping_university,,,,,, -9560,,4441656e-6fc2-11e6-abe8-0242ac12000b,Vifor Int,vifor_int,,,,,, -9561,,ac75d582-61da-4277-a102-70a172ee95d0,AstraZeneca Singapore Pte Ltd,astrazeneca_singapore_pte_ltd,,,,,, -9562,,d13a406a-6a12-4a3b-bd71-12c00b8701c7,South Tees Acute Hospitals NHS Trust,south_tees_acute_hospitals_nhs_trust,,,,,, -9563,,61667e5b-b739-4097-b469-ce5dc0efc2eb,Center for Research and Development Uppsala University/County Council of Gävleborg,center_for_research_and_development_uppsala_university_county_council_of_g_vleborg,,,,,, -9564,,eeb35e5c-9762-4cd9-bf0c-219906e1e299,University Federico II,university_federico_ii,,,,,, -9565,,8b385913-bfed-4b32-a665-08e61dbdb462,Universitair Psychiatrisch Centrum KU Leuven,universitair_psychiatrisch_centrum_ku_leuven,,,,,, -9566,,475e9f14-28f5-494a-8058-f28ba26b58c5,Oxford MioMedica UK Ltd,oxford_miomedica_uk_ltd,,,,,, -9567,,6291dd94-7145-11e6-a0cd-0242ac12000b,BASF,basf,,,,,, -178,0.914111,7c5d4e15-369d-4db5-afb8-39e9c999482d,Nottingham University,nottingham_university,,,,6cb03c75-a5d8-4c11-999f-9a0d26e68ba1,nottingham_univeristy_hospitals_nhs_trust,Nottingham Univeristy Hospitals NHS Trust -9568,,cc566aa4-3819-4e38-95d4-3628ff27380e,D2 Derma Europe Ltd,d2_derma_europe_ltd,,,,,, -9569,,4034a36c-f7b7-476d-b33f-8fccf043cb37,St Augustinus,st_augustinus,,,,,, -9570,,1d2687aa-4eed-4f8e-b767-828205bd3682,Dr catenacci fabrice/ quartier operatoire,dr_catenacci_fabrice_quartier_operatoire,,,,,, -699,0.984107,ee6fc2c6-06eb-4e2c-a3bd-cb730d04efaa,Bayer Pharmaceuticals Corporation,bayer_pharmaceuticals_corporation,,,,ea74ab29-48fb-4575-b97e-5d8ea891bdcb,bayer_pharmaceutical,Bayer Pharmaceutical -9571,,d4aca990-2e1c-4e0c-bb68-315bfaf181ad,"Argos Therapeutics, Inc",argos_therapeutics_inc,,,,,, -9572,,7da49b74-7147-11e6-a0cd-0242ac12000b,PRINSTON INC,prinston_inc,,,,,, -9573,,2e0f1559-1caf-4f89-886a-fe9f75270ff0,Centro Comunitario de Sangre y Tejidos de Asturias,centro_comunitario_de_sangre_y_tejidos_de_asturias,,,,,, -9574,,83254c19-4f45-482b-95ef-cb8ddfdcba80,Sogaisida,sogaisida,,,,,, -9575,,9f59542e-7158-11e6-a0cd-0242ac12000b,ANCHEN PHARMS,anchen_pharms,,,,,, -9576,,39191161-3a98-4b14-a226-f3e48c6546f5,NeurogesX Incorporated,neurogesx_incorporated,,,,,, -9577,,6a5b1362-1c36-41bb-a29b-7e72be6ec3d4,Laboratoires Genevrier,laboratoires_genevrier,,,,,, -9578,,f0aeff86-0130-4552-ac80-b2cd72a5eae1,"Avemedica, s.r.o",avemedica_s_r_o,,,,,, -9579,,76abaf60-4645-449c-b7fd-0bd9912d4a90,Goethe-Universität Frankfurt/Main,goethe_universit_t_frankfurt_main,,,,,, -809,0.98034405708312988,9aa84ae0-f050-4e53-93f9-888fa0e9a08e,Biogen,biogen,,,,9aa84ae0-f050-4e53-93f9-888fa0e9a08e,biogen,Biogen -9580,,95505616-706e-4636-903e-21a64cf31f8f,Spinifex Pharmaceuticals Pty Ltd,spinifex_pharmaceuticals_pty_ltd,,,,,, -9581,,d6489bf3-2940-48c1-bc69-d6c957ceb8fb,Diabetology Ltd,diabetology_ltd,,,,,, -9582,,a2a823f0-7a37-4e15-9331-94e42bbf57f0,Aintree University Hospitals NHS Foundation Trust,aintree_university_hospitals_nhs_foundation_trust,,,,,, -9583,,a62b3f07-8e12-44fb-952a-9253a1381ed6,Eli Lilly and Company Limitated,eli_lilly_and_company_limitated,,,,,, -9584,,eb4cc9e6-aaa6-49ad-995f-a9f72f3bdd5d,Merck KGaA,merck_kgaa,,,,,, -9585,,94046d4a-ea7c-4b6e-bfd0-eca9e50a3f31,Jens Sønksen,jens_s_nksen,,,,,, -9586,,b54e2478-ce96-4b76-9d06-280f216449eb,"University Medical Center St Radboud, department of neurology",university_medical_center_st_radboud_department_of_neurology,,,,,, -9587,,27eb2d5d-e3ab-4ac7-8553-43dbcf0d04f6,"PellePharm, Inc",pellepharm_inc,,,,,, -870,0.98798739910125732,a6e03f52-7103-4c50-9c9f-c0d332cccdf0,Astellas Pharma Europe BV,astellas_pharma_europe_bv,,,,483064d3-f8fd-47e0-a0a2-b17b8d5df7d6,astellas_pharma_europe_bv,Astellas Pharma Europe BV -9588,,372fcc63-9ff6-43b2-8e95-56d7f4e3285a,Follica Inc,follica_inc,,,,,, -9589,,e3145dac-d269-418d-b1a4-c07cf92127dc,SANOFI PASTEUR,sanofi_pasteur,,,,,, -9590,,72d53244-a399-4d59-804a-d56b0cc0cd79,TEVA Pharmaceuticals Europe,teva_pharmaceuticals_europe,,,,,, -264,0.969108,acee9ec2-ec12-49f7-944a-73fbd58820cf,University of Tromsø,university_of_troms,,,,4b85caa2-d172-4ab8-beaf-797c52a06782,university_or_troms,University or Tromsø -9591,,abfb88ae-29d0-4e85-a6e0-9f962431a862,"Kliniken für Anästhesiologie und op. Intensivmedizin, Charité – Universitätsmedizin Berlin, CVK/CCM",kliniken_f_r_an_sthesiologie_und_op_intensivmedizin_charit_universit_tsmedizin_berlin_cvk_ccm,,,,,, -9592,,8ed92949-98c5-47ab-b934-983a7070d141,"Faculty of Medicine, Technische Universität München",faculty_of_medicine_technische_universit_t_m_nchen,,,,,, -9593,,45fb2db5-1f17-4e6b-b565-c7376dcfb4c0,A.O. UNIVERSITARIA INTEGRATA DI VERONA,a_o_universitaria_integrata_di_verona,,,,,, -9594,,2eef2421-11d6-493f-8295-7373e18efc74,AnGes Inc,anges_inc,,,,,, -9595,,46acd9ce-715b-11e6-a0cd-0242ac12000b,YABAO PHARM,yabao_pharm,,,,,, -9596,,b8a92d14-0081-4632-b95d-105a960a34d2,IPSEN INNOVATION,ipsen_innovation,,,,,, -9597,,3fb0bc68-c3bd-4b08-8749-901aae643330,VVOG,vvog,,,,,, -9598,,10d29023-15e2-491d-8c99-00c63994492e,PrEP Biopharm Ltd,prep_biopharm_ltd,,,,,, -692,0.987725,6bd20d89-2d11-41e5-b083-1fa6028d5811,Furiex Pharmaceuticals,furiex_pharmaceuticals,,,,3896cef1-0043-4ce9-83b5-3668a99dacee,furiex_pharmaceuticals_inc,"Furiex Pharmaceuticals, Inc" -9599,,6fe568cc-9db1-4629-bfed-8e5c26248d63,Jan Stener Joergensen,jan_stener_joergensen,,,,,, -9600,,a723ae14-7146-11e6-a0cd-0242ac12000b,CATALENT,catalent,,,,,, -9601,,5f9a07f2-48eb-4616-8eff-43a8c980eda4,"Georg-August-Universität Göttingen, Bereich Humanmedizin",georg_august_universit_t_g_ttingen_bereich_humanmedizin,,,,,, -32,0.96428561210632324,8013f413-0613-4f61-a0a5-e7241cff8548,Technische Universität Dresden,technische_universit_t_dresden,,,,8013f413-0613-4f61-a0a5-e7241cff8548,technische_universit_t_dreden,Technische Universität Dreden -9602,,dcb7cb12-fc62-4d95-9152-0d4546deb238,Zentaris GmbH,zentaris_gmbh,,,,,, -9603,,5911e8a3-525b-4ff5-9334-7057bb100517,GENSIGHT-BIOLOGICS,gensight_biologics,,,,,, -9604,,9ad14e58-a323-4a47-8c43-b11faf4db010,Leyh Pharma GmbH,leyh_pharma_gmbh,,,,,, -9605,,878b966d-b386-4e48-afea-96d6ce217274,Vesa Kontinen,vesa_kontinen,,,,,, -9606,,77742330-b619-48d0-b299-f9f990618072,FRANCISCO JAVIER BELDA,francisco_javier_belda,,,,,, -9607,,780be6cb-e91a-44b3-983f-b748ef1cc09b,OMNIVISION,omnivision,,,,,, -836,0.98650866746902466,8b728024-8fd6-4d73-82c9-94fcbe26c730,NHS Greater Glasgow & Clyde R&D Office,nhs_greater_glasgow_clyde_r_d_office,,,,8b728024-8fd6-4d73-82c9-94fcbe26c730,nhs_greater_glasgow_clyde_r_d_office,NHS Greater Glasgow & Clyde R&D Office -9608,,e5c633eb-7b80-4afb-b6c2-d853afe1da6a,Berlin-Chemie AG,berlin_chemie_ag,,,,,, -9609,,f6888ad7-c599-4f92-a9b0-8d28a76d420a,Belpharma SA/NV,belpharma_sa_nv,,,,,, -9610,,3d6ade49-c992-4715-9594-000bd02e5eb1,"Free State of Bavaria, represented by the University of Regensburg, represented by Prof. Edward K. Geissler",free_state_of_bavaria_represented_by_the_university_of_regensburg_represented_by_prof_edward_k_geissler,,,,,, -9611,,209caf6e-c4cd-4b12-abc1-77a342ee0f95,University Hospital of Geneva,university_hospital_of_geneva,,,,,, -252,0.97737601399421692,082f7f0e-78b6-4cad-b635-beaee4333a89,Martin Luther University of Halle/Wittenberg,martin_luther_university_of_halle_wittenberg,,,,0f0d8991-097b-4737-a496-fd2e4d5aa3ff,martin_luther_university_of_halle_wittenberg,Martin Luther University of Halle/Wittenberg -9612,,840ab7f8-f749-48bf-89ea-89ae0df57f2f,Danish Pain Research Center,danish_pain_research_center,,,,,, -9613,,62e51393-07c9-453f-a630-dc493f0798c8,vicente soriano,vicente_soriano,,,,,, -135,0.982105,924e8e00-b603-4591-93dd-f562031d4d33,Procter and Gamble Pharmaceuticals,procter_and_gamble_pharmaceuticals,,,,0ae43754-1f42-4540-8952-a2c6dce4050c,procter_and_gamble,Procter and Gamble -9614,,4f46f0c6-2436-419c-80c0-db54d13265f1,Karolinska Hospital,karolinska_hospital,,,,,, -9615,,8dfbc7e9-9ae9-4703-9e95-2228ef1e9da5,Herlev hospital,herlev_hospital,,,,,, -9616,,db9e1718-7161-11e6-a0cd-0242ac12000b,SALIX PHARMS,salix_pharms,,,,,, -9617,,fb11cb06-2286-4e2f-8916-cf70a0beb822,"Esperion Therapeutics, Inc",esperion_therapeutics_inc,,,,,, -856,0.98001778125762939,66b401ea-5009-4db7-8b18-6fe29a2c6186,Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital,netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital,,,,66b401ea-5009-4db7-8b18-6fe29a2c6186,netherlands_cancer_institute_antoni_van_leeuwenhoek_hospital,Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL) -9618,,a598f8f4-73dc-11e6-a0cd-0242ac12000b,GATOR PHARMA INC,gator_pharma_inc,,,,,, -9619,,f93e45d2-1cd7-4714-b82a-897d4cb0886b,Univeristy Hospital Schleswig-Holstein,univeristy_hospital_schleswig_holstein,,,,,, -9620,,de4f645a-75be-485a-8a85-a689868bcdb1,"Skåne University Hospital, Dept of Oncology",sk_ne_university_hospital_dept_of_oncology,,,,,, -9621,,a9effb14-e413-4ec3-805c-abadf7eddaff,BiogenIdec A/S,biogenidec_a_s,,,,,, -9622,,b0be6940-7147-11e6-a0cd-0242ac12000b,PIRAMAL ENT,piramal_ent,,,,,, -9623,,a1e7b13a-d54b-44e0-a548-ea1fc5c9af76,Hospital Universitario La Princesa,hospital_universitario_la_princesa,,,,,, -9624,,df616f2c-fa81-4960-9eba-2f35852cbbda,Verastem Inc,verastem_inc,,,,,, -9625,,9858ac12-e7da-42d8-b3da-bb6c49913f9b,ViraNative AB,viranative_ab,,,,,, -9626,,aeb29c7a-b5e7-423c-a380-768dab375691,CYTOCHEMIA AG,cytochemia_ag,,,,,, -9627,,9c6820c8-c20f-413e-bdbc-2e141a20cd18,AB ANALITICA SRL,ab_analitica_srl,,,,,, -369,0.968529,10a6a8cf-9c7f-4575-956a-94c3a4dacd53,DAIICHI SANKYO EUROPE GmbH,daiichi_sankyo_europe_gmbh,,,,054fbb2c-7228-11e6-a0cd-0242ac12000b,daiichi,DAIICHI -9628,,2cea9b46-d590-4536-9dee-03f5569091c5,Ambrilia Biopharma Inc,ambrilia_biopharma_inc,,,,,, -9629,,df18a281-bc26-48a9-8f15-8478c1c9f7aa,NATHURA SRL,nathura_srl,,,,,, -9630,,bd9ae5ef-055e-428e-ac04-35b441e8679a,"Nordsjællands Hospital, Department of Cardiology, Nephrology and Endocrinology",nordsj_llands_hospital_department_of_cardiology_nephrology_and_endocrinology,,,,,, -9631,,96924ad5-15d5-4cfb-8f8e-be0dc38d6a1d,"Rigshospitalet, Copenhagen University Hospitals",rigshospitalet_copenhagen_university_hospitals,,,,,, -9632,,eb9a53d3-bd77-4c6b-a351-77bb10974676,"ASOCIACION PARA LA INVESTIGACION Y TRATAMIENTO DE ENFERMEDADES RENALES (AITER),",asociacion_para_la_investigacion_y_tratamiento_de_enfermedades_renales_aiter,,,,,, -9633,,905625f8-d602-487c-b4ae-30a24dd4036d,FONDAZIONE NIBIT,fondazione_nibit,,,,,, -779,0.988892,bf76ac82-c2cb-490f-8a4b-46603ab679e7,"The Centre for Child and Adolescent Mental Health, Eastern and Southern",the_centre_for_child_and_adolescent_mental_health_eastern_and_southern,,,,bf76ac82-c2cb-490f-8a4b-46603ab679e7,the_centre_for_child_and_adolescent_mental_health_eastern_and_southern,"The Centre for Child and Adolescent Mental Health, Eastern and Southern" -9634,,74e87d4a-aca3-4110-a5c8-1b09c4258926,"Prim. Univ.Prof. Dr. Christian Pirich Department of Nuclear Medicine and Endocrinology, PMU Salzburg",prim_univ_prof_dr_christian_pirich_department_of_nuclear_medicine_and_endocrinology_pmu_salzburg,,,,,, -9635,,65eadf2d-e35f-4682-b7d8-dee6f1744192,Instituto Palacios,instituto_palacios,,,,,, -9636,,cd75cedf-4fe8-4a15-8a7a-a00d7586dfe8,G. L. Pharma GmbH,g_l_pharma_gmbh,,,,,, -1034,0.914544,d38892c3-fc12-46d4-bb7a-ffec3a5d4392,"Centre du Cancer, Cliniques universitaires Saint-Luc",centre_du_cancer_cliniques_universitaires_saint_luc,,,,2656ed3b-7c3f-4317-935a-59c30cccc2bc,centre_du_cancer_des_cliniques_universitaires_saint_luc,Centre du Cancer des Cliniques Universitaires Saint-Luc -9637,,f020eb53-8254-416f-9dc6-5f5f991bb7e8,Central European Society for Anticancer Drug Research - EWIV,central_european_society_for_anticancer_drug_research_ewiv,,,,,, -409,0.9891228973865509,bafd53c7-e832-4f6f-89c8-d8d0d9dcabe4,SCHWARZ BIOSCIENCES GmbH, A member of the UCB group,,,,bafd53c7-e832-4f6f-89c8-d8d0d9dcabe4,schwarz_biosciences,SCHWARZ BIOSCIENCES GmbH -9638,,ea6a4a49-3e8b-48ab-a513-2ed0034db8ec,QUALIPHAR NV,qualiphar_nv,,,,,, -9639,,bdf429b0-83ba-4be5-b9eb-476911fd2954,West Herts NHS Trust,west_herts_nhs_trust,,,,,, -9640,,a7484733-7bcc-4f40-85e9-881874ec80e7,Azienda Ospedaliera Ospedali Riuniti Marche Nord,azienda_ospedaliera_ospedali_riuniti_marche_nord,schwarz_biosciences_gmbh_a_member_of_the_ucb_group,,,,, -504,0.91995066404342651,fe66a00b-c1eb-4074-bd88-e4edfe94bca5,Sanofi-Synthelabo AB,sanofi_synthelabo_ab,,,,122b0a51-3453-4c2b-9161-369319d68912,sanofi_synthelabo_recherche_a_subsidiary_of_sanofi_aventis_group,"Sanofi-Synthelabo Recherche, a subsidiary of sanofi-aventis group" -9641,,335bb08b-3c27-4e44-bf00-5773605319a7,Janssen-Cilag EMEA Medical Affairs,janssen_cilag_emea_medical_affairs,,,,,, -100,0.94407099485397339,3f816051-0ebf-47a9-b4f1-e129cf8f1167,Department of Anesthesiology and Intensive Care Medicine,department_of_anesthesiology_and_intensive_care_medicine,,,,3f816051-0ebf-47a9-b4f1-e129cf8f1167,department_of_anesthesiology_and_intensive_care_medicine,Department of Anesthesiology and Intensive Care Medicine -9642,,77db9cd6-7167-11e6-a0cd-0242ac12000b,ETHYPHARM USA CORP,ethypharm_usa_corp,,,,,, -94,0.96576917171478271,85d2f332-7335-11e6-a0cd-0242ac12000b,JAZZ,jazz,,,,49d3c978-7273-11e6-a0cd-0242ac12000b,jazz_pharms,JAZZ PHARMS -9643,,66c8c87b-5af2-418b-8c5b-4a11e86ef8d5,"J.Uriach y Compania S.A.,",j_uriach_y_compania_s_a,,,,,, -623,0.985931,7ed460db-1719-4dbb-9771-91840f0b465b,Klinikum der Universität Regensburg,klinikum_der_universit_t_regensburg,,,,4036d0e2-54dc-41a1-ab42-721775d200c4,klinikum_der_universit_t,Klinikum der Universität -9644,,775ce675-3dfc-4c5a-8a3f-ac873cdc82d6,Bionorica research GmbH,bionorica_research_gmbh,,,,,, -9645,,89e20de0-17bc-4d74-ac0e-f7cc1c17c107,Celladon Corporation,celladon_corporation,,,,,, -9646,,be990399-0840-46ac-bff6-b382e09dabac,OPKO Biologics Ltd,opko_biologics_ltd,,,,,, -9647,,1aea7069-17fc-4a7b-9e07-76025abe2244,Gastrotech Pharma A/S,gastrotech_pharma_a_s,,,,,, -9648,,92980fb5-a359-4b81-9f35-62a344af619f,"Pfizer Ltd - Ramsgate Road, Sandwich CT139NJ, UK",pfizer_ltd_ramsgate_road_sandwich_ct139nj_uk,,,,,, -9649,,c6b908a4-c89f-4749-8a62-8d6b7323d2c9,GRUPO ESPAÑOL DE NEUROONCOLOGIA MEDICA,grupo_espa_ol_de_neurooncologia_medica,,,,,, -9650,,0d793ae6-6898-46bf-a39c-792be612d973,Frimley Park Hospital NHS Foundation Trust,frimley_park_hospital_nhs_foundation_trust,,,,,, -9651,,d8334a93-2663-48e6-8c4f-90ed90490a7c,HELP Pharmaceuticals SA,help_pharmaceuticals_sa,,,,,, -9652,,6e7bb9bd-80fd-4a86-ada2-3acc736fe099,SCHERING,schering,,,,,, -189,0.989095,bc125259-5786-474e-8cb4-6e4a490b6253,Grupo Español de Tumores Huérfanos e Infrecuentes,grupo_espa_ol_de_tumores_hu_rfanos_e_infrecuentes,,,,9bfb7a20-2bce-4c76-8f13-53216dbb6f59,grupo_espa_ol_de_tumores_hu_rfanos_e_infrecuentes_gethi,Grupo Español de Tumores Huérfanos e Infrecuentes (GETHI) -904,0.943406,a017bdc5-4a8a-48c3-ab48-5b1db4f8ed6e,Novo Nordisk AS,novo_nordisk_as,,,,a017bdc5-4a8a-48c3-ab48-5b1db4f8ed6e,novo_nordisk_as,Novo Nordisk AS -9653,,0111157a-0285-47e0-abad-81898eb43c0b,UF de méthodologie en recherche clinique,uf_de_m_thodologie_en_recherche_clinique,,,,,, -9654,,191a4121-096e-489f-bb60-9d9e340fdcf0,Cardiff Univeristy,cardiff_univeristy,,,,,, -9655,,a8fa92e7-f6e9-4a5d-837b-b07c1be23c4c,Action Pharma A/S,action_pharma_a_s,,,,,, -9656,,a85833c5-c653-4c38-8924-16d7a8af3d7e,CONSORCI SANITARI DEL MARESME,consorci_sanitari_del_maresme,,,,,, -9657,,064eee72-a860-4165-a4a4-0e72f1b98a5c,University medical center Ljubljana,university_medical_center_ljubljana,,,,,, -9658,,ac4954ed-b836-4a52-aa6b-db3f3bbf60e9,University of Kuopio,university_of_kuopio,,,,,, -9659,,1d43d854-a7cb-4f69-ac01-5cb98e03310b,"Friedrich-Schiller University Jena, Clinic for Internal Medicine I",friedrich_schiller_university_jena_clinic_for_internal_medicine_i,,,,,, -9660,,e70b616f-c716-415d-8bd2-327f2e186d38,Vejle Sygehus,vejle_sygehus,,,,,, -9661,,e9d0f562-4e1b-483c-80dc-d88a390db3bd,acep,acep,,,,,, -9662,,24c8f635-e86d-40ea-925a-1e483e3b57a8,FONDAZIONE DEL PIEMONTE PER L'ONCOLOGIA IRCC DI CANDIOLO,fondazione_del_piemonte_per_l_oncologia_ircc_di_candiolo,,,,,, -9663,,4617fb6f-7d08-4f1e-9387-03febb5a1768,Medizinische Universität Innsbruck - Universitätsklinik für Innere Medizin III,medizinische_universit_t_innsbruck_universit_tsklinik_f_r_innere_medizin_iii,,,,,, -937,0.975369,2ff28a2a-72bf-11e6-a0cd-0242ac12000b,CUBIST,cubist,,,,2ff28a2a-72bf-11e6-a0cd-0242ac12000b,cubist,CUBIST -9664,,29ab58b6-85b0-47a5-924a-b054bbc22c8b,Institut Recherches Internationales Servier,institut_recherches_internationales_servier,,,,,, -9665,,ae896904-1a98-4956-accb-3e772c574985,"Dept of Endocrinology, Odense University Hospital",dept_of_endocrinology_odense_university_hospital,,,,,, -242,0.985891,ee545156-715c-11e6-a0cd-0242ac12000b,CYPRESS PHARM,cypress_pharm,,,,a3937fbe-7163-11e6-a0cd-0242ac12000b,cypress_pharm_inc,CYPRESS PHARM INC -468,0.987296,2ba84e9e-880b-11e6-a998-0242ac12000b,Targovax ASA,targovax_asa,,,,055d2f79-6382-44aa-9acf-84a8274892de,targovax_as,Targovax AS -9666,,27a96238-38c8-4f96-8520-0eebc9188648,Schülke & Mayr GmbH,sch_lke_mayr_gmbh,,,,,, -9667,,22fc5689-b4d5-4c6a-9358-e13af9314b13,AnaMar AB,anamar_ab,,,,,, -9668,,b2545371-bb5b-4ee9-ab6d-cd78e68fbdd9,"Immunomedics, Inc",immunomedics_inc,,,,,, -698,0.98415160179138184,e810eb5b-fc4c-4026-ac5e-5b9c63a6d7f7,"Bayer Healthcare AG, Leverkusen",bayer_healthcare_ag_leverkusen,,,,72b9ca0e-fa0c-4c39-a503-2b0b6467415c,bayer_healthcare_ag,Bayer Healthcare AG -107,0.950967,886dbcfd-131f-4dde-b49f-376738e72b32,FONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E DELLA CURA DEI TUMORI,fondazione_michelangelo_avanzamento_dello_studio_e_della_cura_dei_tumori,,,,63b03e43-7f22-494c-8b54-c8682235d858,fondazione_michelangelo_avanzamento_dello_studio_e_cura_dei_tumori,FONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI -9669,,8aa4aa33-dbe6-4afd-a18d-194ec2deb698,RHEACELL GmbH & Co. KG,rheacell_gmbh_co_kg,,,,,, -9670,,573e3855-74d9-43b7-b295-ca548312e5af,Royal Cornwall Hospitals NHS Trust,royal_cornwall_hospitals_nhs_trust,,,,,, -9671,,1a5f0061-23fb-4125-85a4-706b265df7a8,Grunenthal GmbH,grunenthal_gmbh,,,,,, -9672,,66326c09-331f-40e1-825a-0ff9c481755b,Perrigo Israel Pharmaceuticals Ltd,perrigo_israel_pharmaceuticals_ltd,,,,,, -9673,,283f91dc-84f3-4ff2-b0df-184ff6e49a6a,Ana M. Wägner,ana_m_w_gner,,,,,, -12,0.988363,43a29514-7df4-4ef9-8c2e-fd420fdb7e20,University Medical Center Utrecht,university_medical_center_utrecht,,,,43a29514-7df4-4ef9-8c2e-fd420fdb7e20,university_medical_center_utrecht,University Medical Center Utrecht -9674,,ba386c86-ddf6-45bb-91db-668619bb0bda,AstraZeneca S.A.S,astrazeneca_s_a_s,,,,,, -9675,,97f181b3-9ad4-48ad-a41d-0342ef33b8c0,Radboud umc,radboud_umc,,,,,, -246,0.9320218563079834,61627f3e-faae-4a11-a8b0-c9cb74d0f17b,"Guys' and St Thomas' NHS Foundation Trust, Joint Clinical Trials Office",guys_and_st_thomas_nhs_foundation_trust_joint_clinical_trials_office,,,,5087f699-7133-45f6-90c4-97f11a55ecf1,guys_and_st_thomas_nhs_foudation_trust,Guys and St Thomas' NHS Foudation Trust -9676,,b9b447c3-500a-434f-acef-ecef3ebdfbc4,BioMarin Nederland BV,biomarin_nederland_bv,,,,,, -270,0.94358396530151367,b9740d19-9951-4510-b985-aa689195ab5f,AstraZeneca AS,astrazeneca_as,,,,b9740d19-9951-4510-b985-aa689195ab5f,astrazeneca_ab,AstraZeneca AB -9677,,9fbfeda9-0836-4ab9-9562-9aad825f1f01,Royal Group Hospitals,royal_group_hospitals,,,,,, -9678,,e1e19cc6-5fa1-4706-8259-bf1a2eaa8672,HAL Allergy BV,hal_allergy_bv,,,,,, -9679,,356e95b2-7142-11e6-a0cd-0242ac12000b,AM ANTIBIOTICS,am_antibiotics,,,,,, -9680,,8b823b2d-aea9-4dcf-aafb-1f78bc3c6a2c,Institut de Recherches Internationales de Servier,institut_de_recherches_internationales_de_servier,,,,,, -9681,,906b84bc-1a9f-46d6-bf64-9b4a4d80be25,GlaxoSmithkine Research and Development Ltd,glaxosmithkine_research_and_development_ltd,,,,,, -9682,,7a185a57-fabc-4dbb-9249-31bf821db930,Roche Pharma (Schweiz) AG,roche_pharma_schweiz_ag,,,,,, -769,0.97620436549186707,5d0fa8cc-033b-4776-b630-696f4b766931,GELTAMO (Grupo Cooperativo Español de Linfoma/Trasplante Autólogo de Médula Ósea),geltamo_grupo_cooperativo_espa_ol_de_linfoma_trasplante_aut_logo_de_m_dula_sea,,,,06287ea9-1e30-49c5-af4a-558dc91625a2,geltamo_grupo_cooperativo_espa_ol_de_linfoma_trasplante_aut_logo_de_m_dula_sea,GELTAMO (Grupo Cooperativo Español de Linfoma/Trasplante Autólogo de Médula Ósea) -9683,,c07a482c-8b97-4e13-a276-458c49fbaf45,Sinoxa Pharma GmbH,sinoxa_pharma_gmbh,,,,,, -9684,,2e2e55a6-147a-4980-9af5-ef2dc4420347,EpiTan Limited,epitan_limited,,,,,, -9685,,d70c9d05-706d-4aa7-af09-53dc52a3239b,Royal Devon and Exeter NHS Foundation Trust,royal_devon_and_exeter_nhs_foundation_trust,,,,,, -9686,,b22383a9-4a46-4e0e-937e-6a9066f3e210,FIBHULP,fibhulp,,,,,, -660,0.984864,c7d7080c-7166-11e6-a0cd-0242ac12000b,LARKEN LABS INC,larken_labs_inc,,,,1984b48c-7145-11e6-a0cd-0242ac12000b,larken_labs,LARKEN LABS -9687,,f83df11a-036f-4eca-80e1-2076323401b0,Relypsa Inc,relypsa_inc,,,,,, -557,0.973471,943dc7fd-4950-44aa-a140-b1ce0165b980,SERVICIO DE PSIQUIATRIA. HOSPITAL UNIVERSITARI VALL DE HEBRON,servicio_de_psiquiatria_hospital_universitari_vall_de_hebron,,,,943dc7fd-4950-44aa-a140-b1ce0165b980,servicio_de_psiquiatria_hospital_universitari_vall_de_hebron,SERVICIO DE PSIQUIATRIA. HOSPITAL UNIVERSITARI VALL DE HEBRON -270,0.96273654699325562,eb1ea511-941d-4821-bbff-4696ae7fca4c,AstraZeneca AB,astrazeneca_ab,,,,b9740d19-9951-4510-b985-aa689195ab5f,astrazeneca_ab,AstraZeneca AB -9688,,f688e477-33cd-4b6e-8e13-b894d09478e9,EPOPLUS GmbH & Co.KG,epoplus_gmbh_co_kg,,,,,, -9689,,d57b3021-e923-46a5-8718-f008d6d26a2d,Boehringer Ingelheim (Canada) Ltd/Ltée,boehringer_ingelheim_canada_ltd_lt_e,,,,,, -9690,,76b98500-b61c-4e7c-a91a-8b0b9ac27e6a,Dekan of Faculty of Medicine of Goethe-University Frankfurt,dekan_of_faculty_of_medicine_of_goethe_university_frankfurt,,,,,, -9691,,2317fb78-73f0-11e6-a0cd-0242ac12000b,NORCO INC,norco_inc,,,,,, -9692,,4004453e-8779-47ae-8b6c-99524135c578,Johanna Laukkarinen,johanna_laukkarinen,,,,,, -9693,,3f641671-cdd4-49b9-a838-0016bd1a2562,Hoffmann-La Roche Inc,hoffmann_la_roche_inc,,,,,, -9694,,8efd58a8-cee2-4c0b-814a-d0c904f15daa,GE Healthcare Limited (previously known as Amersham plc) and its Amersham Health affiliates,ge_healthcare_limited_previously_known_as_amersham_plc_and_its_amersham_health_affiliates,,,,,, -9695,,a4fd4f24-7255-4175-b9ce-916dba0f9161,Cantacuzino National Institute of Research and Development for Microbiology and Immunology,cantacuzino_national_institute_of_research_and_development_for_microbiology_and_immunology,,,,,, -9696,,1de2cdb3-8213-43b2-9270-f9bcb61cf273,SANOFI PASTEUR INTERNATIONAL,sanofi_pasteur_international,,,,,, -9697,,9371d8fb-2135-4dd1-883c-646505c49b28,Finnish Defence Forces,finnish_defence_forces,,,,,, -9698,,4a14794c-2667-4d73-87b0-6fcdd5585d54,ANRS (Agence Nationale de Recherche sur le SIDA et les hépatites virales),anrs_agence_nationale_de_recherche_sur_le_sida_et_les_h_patites_virales,,,,,, -9699,,5ccce7e7-6cb7-453f-a547-420b60281007,Mikko Pitkänen,mikko_pitk_nen,,,,,, -9700,,34323e04-7167-11e6-a0cd-0242ac12000b,SHANGHAI HENGRUI,shanghai_hengrui,,,,,, -9701,,2c578bd4-7264-4857-a2fb-f11717aec3c2,DermaGen AB,dermagen_ab,,,,,, -591,0.981797,de723fba-5285-49b8-b510-e70480f89485,Genzyme Corporation,genzyme_corporation,,,,028fff30-1193-4fcf-bcc7-abb85c227761,genzyme_corporation_a_sanofi_company,"Genzyme Corporation, a Sanofi company" -9702,,b041cb5c-5e1a-4cb4-b876-d90afc03cd19,3M ITALIA,3m_italia,,,,,, -9703,,3278ff69-f299-4589-84c3-ce98f7bf6224,"Direction de la recherche clinique du centre hospitalier universitaire de Tours, Bretonneau",direction_de_la_recherche_clinique_du_centre_hospitalier_universitaire_de_tours_bretonneau,,,,,, -9704,,d2a029b9-fd73-44e7-a614-0b42950a32aa,Azellon Ltd,azellon_ltd,,,,,, -9705,,de1efa33-6531-4c8a-bb1a-8a2d1a08feff,"AMAG Pharmaceuticals, Inc",amag_pharmaceuticals_inc,,,,,, -1039,0.97356534004211426,34050438-2ab9-4f3c-ad8e-1d5dea845aa7,Celgene International II Sarl (CIS II),celgene_international_ii_sarl_cis_ii,,,,34050438-2ab9-4f3c-ad8e-1d5dea845aa7,celgene_international_ii_sarl_cis_ii,Celgene International II Sarl (CIS II) -89,0.984864,246b37c8-715d-11e6-a0cd-0242ac12000b,MATRIX LABS,matrix_labs,,,,246b37c8-715d-11e6-a0cd-0242ac12000b,matrix_labs,MATRIX LABS -523,0.983968,32be795e-a544-49ea-9655-1702405333a9,Martin-Luther-University,martin_luther_university,,,,32be795e-a544-49ea-9655-1702405333a9,martin_luther_university,Martin-Luther-University -9706,,42502415-3c95-4e92-bb65-9bb61208cbb9,Recip AB,recip_ab,,,,,, -9707,,8f06244c-83fb-4cc3-82bd-e8252ebd3481,"Internal Medicine IV, Mecdical University of Vienna",internal_medicine_iv_mecdical_university_of_vienna,,,,,, -9708,,f3ac5e9b-5554-4756-9fde-18e11ca41d8c,Aino Ruohola,aino_ruohola,,,,,, -9709,,f7608500-166d-444f-8468-1a8c78608334,Professor Jørgen B. Dahl,professor_j_rgen_b_dahl,,,,,, -976,0.986562,f724c840-71b8-11e6-a0cd-0242ac12000b,PURDUE PHARMA LP,purdue_pharma_lp,,,,1819b794-72dc-11e6-a0cd-0242ac12000b,purdue_pharma,PURDUE PHARMA -9710,,44fc586a-a248-4e10-9528-78a3e8e2a4e0,TNO.Netherlands Organization for Applied Scientific Research,tno_netherlands_organization_for_applied_scientific_research,,,,,, -9711,,6e321fe5-cb59-425f-b385-1bb37971f491,VAS - Vascular Independent Research and Education European Organization,vas_vascular_independent_research_and_education_european_organization,,,,,, -9712,,ed68fbe1-0b63-4008-ac48-1e18ae1a3ce2,Institute of Obstetrics and Gynaecology Trust,institute_of_obstetrics_and_gynaecology_trust,,,,,, -9713,,6ed05fc5-f3cf-4554-8b1f-849aaf239cdc,C.H.U de Clermont Ferrand,c_h_u_de_clermont_ferrand,,,,,, -9714,,716f97ad-aa9c-42ff-8f64-4ece66fb1e62,BioXell SpA,bioxell_spa,,,,,, -37,0.986414,0c4d19b0-fc13-4125-ae65-0aea3b77572e,University of Liverpool,university_of_liverpool,,,,0c4d19b0-fc13-4125-ae65-0aea3b77572e,university_of_liverpool,University of Liverpool -68,0.933464,f4632456-0ebd-4b59-bb82-9b896f72960c,Medtronic Inc,medtronic_inc,,,,9ba1f3da-ec16-443c-baaf-efec93f1ac9e,medtronic_international_trading,Medtronic International Trading -9715,,9fcc5abf-05dd-4475-aab2-703deccf4a45,INSTITUTO DE ESTUDIOS DEL SISTEMA NERVIOSO,instituto_de_estudios_del_sistema_nervioso,,,,,, -9716,,ec46c526-0473-4399-8f5b-1a167955cd4b,Santaris Pharma,santaris_pharma,,,,,, -128,0.98614925146102905,07d5f348-7142-11e6-a0cd-0242ac12000b,PHARMACHEMIE BV,pharmachemie_bv,,,,07d5f348-7142-11e6-a0cd-0242ac12000b,pharmachemie_bv,PHARMACHEMIE BV -9717,,b00c6dae-4257-42c5-ab51-9f6cb22d9d5b,"Dr. Xavier Serra Aracil, Corporació Sanitaria Parc Taulí",dr_xavier_serra_aracil_corporaci_sanitaria_parc_taul,,,,,, -9718,,f3b5e628-b6df-4baa-a91a-55a609ee34fb,ZKES GmbH,zkes_gmbh,,,,,, -9719,,359c8f92-c0f6-4d11-aeb4-b5cbc93eae16,Vaxon Biotech,vaxon_biotech,,,,,, -9720,,4f792a50-7a67-4de2-9fe4-647a91ecdb94,"Med. Univ. Wien, UK für Kinder und Jugendheilkunde",med_univ_wien_uk_f_r_kinder_und_jugendheilkunde,,,,,, -9721,,06e41fe6-bbf3-4b9a-a054-d7192062e04b,BIONOMICS LIMITED,bionomics_limited,,,,,, -9722,,7d21ba12-73c6-442c-a1da-0f0f4c3f2e4f,"Regeneron Pharmaceuticals, Inc",regeneron_pharmaceuticals_inc,,,,,, -9723,,cce3bfdc-a2fe-473a-9361-92c912959090,Vorstand des Klinikums der Universität München - Grosshadern,vorstand_des_klinikums_der_universit_t_m_nchen_grosshadern,,,,,, -74,0.972986,e066773d-729f-4bf9-9a48-d1369cf2ce47,Faculdade de Ciências Médicas – Universidade Nova de Lisboa,faculdade_de_ci_ncias_m_dicas_universidade_nova_de_lisboa,,,,53160446-62a1-4898-b8c2-2d60eb490bf9,faculdade_de_ci_ncias_m_dicas_da_universidade_nova_de_lisboa,Faculdade de Ciências Médicas da Universidade Nova de Lisboa -9724,,2d664162-cac8-4010-9098-8effb21c1f09,Dr Calleja Panero,dr_calleja_panero,,,,,, -9725,,e000c630-936e-4f5f-b7a8-1352efa87119,GGZ Drenthe,ggz_drenthe,,,,,, -9726,,3e479bde-7165-11e6-a0cd-0242ac12000b,INDOCO REMEDIES,indoco_remedies,,,,,, -9727,,30b482c5-ad53-4418-9525-3d717108077f,Køge Sygehus,k_ge_sygehus,,,,,, -9728,,37fc808c-9002-4e5e-aaca-fde35df92b1c,ZonMW GGG,zonmw_ggg,,,,,, -9729,,9be42dec-71c5-11e6-a0cd-0242ac12000b,GRIFFEN,griffen,,,,,, -9730,,2120825c-a1b3-4730-83de-15e2cef15f99,Juhani Ruutiainen,juhani_ruutiainen,,,,,, -9731,,6c0fdab8-7754-4a18-a2d3-29e632105efe,Fundació Instituto de Investigación Biomédica de Bellvitge (Fundació IDIBELL),fundaci_instituto_de_investigaci_n_biom_dica_de_bellvitge_fundaci_idibell,,,,,, -9732,,a5663ced-1560-49f9-889c-44b649c03fa2,Royal Victoria Hospital Belfast,royal_victoria_hospital_belfast,,,,,, -691,0.958341,50516837-326b-48de-a8b3-7a6009366d95,Light Science Oncology Inc,light_science_oncology_inc,,,,23401987-1f18-4798-a823-501b1b0edbf5,light_sciences_oncology_inc,Light Sciences Oncology Inc -9733,,39bfd973-9d9c-419f-81eb-58c4ccc78cef,International Centre for Therapeutic Research (for Spain),international_centre_for_therapeutic_research_for_spain,,,,,, -926,0.985988,88016fef-c8a1-4819-8a74-7ce3949b23db,"Haukeland University Hospital, Helse Bergen",haukeland_university_hospital_helse_bergen,,,,634e757f-8ba8-4364-ad56-f51636b9ab94,haukeland_university_hospital,Haukeland University Hospital -9734,,a7edef46-a07e-4a88-98f5-341611b408ae,Neurochlore,neurochlore,,,,,, -970,0.987506,2899c14b-e123-4b6f-9261-bca58e778c63,Academic Medical Centre,academic_medical_centre,,,,2899c14b-e123-4b6f-9261-bca58e778c63,academic_medical_centre,Academic Medical Centre -9735,,fa37fd06-b2d1-45b6-9c3e-3e4af59bce22,Uppsala University Children´s Hospital,uppsala_university_children_s_hospital,,,,,, -9736,,54fa17bc-eeb9-4dbb-9771-e5db88d3a670,"(OSI) Eyetech Pharmaceuticals, Inc",osi_eyetech_pharmaceuticals_inc,,,,,, -63,0.983835,01a1f7f6-8bc3-11e6-a449-0242ac12000b,Clínica Universidad de Navarra,cl_nica_universidad_de_navarra,,,,01a1f7f6-8bc3-11e6-a449-0242ac12000b,cl_nica_universidad_de_navarra,Clínica Universidad de Navarra -9737,,4c146876-fddf-4753-b75d-7265d7f9ab62,"Med. Univ. Wien, Univ. Klinik für Dermatologie",med_univ_wien_univ_klinik_f_r_dermatologie,,,,,, -734,0.980666,78a71c0c-715e-11e6-a0cd-0242ac12000b,WEST WARD,west_ward,,,,78a71c0c-715e-11e6-a0cd-0242ac12000b,west_ward,WEST WARD -577,0.97058257460594177,f83c989d-f6d7-40b7-9bc2-b1c20f1e0644,"Wyeth Pharmaceuticals France, Wyeth Research Division",wyeth_pharmaceuticals_france_wyeth_research_division,,,,e9abaf6d-ebc5-432c-be97-f7a5c26bd3f9,wyeth_pharmaceuticals_france_wyeth_research_division,"Wyeth Pharmaceuticals France, Wyeth Research Division" -9738,,e5d42c88-46a1-41cc-b998-0604c9e95a48,GENTIUM,gentium,,,,,, -9739,,257319f9-e116-4c72-bae2-91a516b9a165,"Bispebjerg Hospital, Respiratory and Allergy Research Unit",bispebjerg_hospital_respiratory_and_allergy_research_unit,,,,,, -930,0.97669827938079834,5e914e51-02f2-4d61-8fbe-b47e6c9f4cc6,"Pierre Fabre Ibérica, S.A",pierre_fabre_ib_rica_s_a,,,,108222e4-8b5a-4716-a3aa-cd9eb69305b4,pierre_fabre_ib_rica_s_a_en_representaci_n_de_pierre_fabre_m_dicament,"Pierre Fabre Ibérica, S.A. en representación de Pierre Fabre Mèdicament" -9740,,1c03edad-e1af-4e81-991a-b937d00604da,Takeda Europe R&D Centre Ltd. (TEuR&D),takeda_europe_r_d_centre_ltd_teur_d,,,,,, -9741,,7d613daa-2713-41a5-a42e-5fc07568681c,"MERCK & CO., INC",merck_amp_co_inc,,,,,, -9742,,1d79ff36-7975-4694-a9e1-1ac630793787,"& Johnson Pharmaceutical Research & Development, L.L.C",johnson_pharmaceutical_research_development_l_l_c,,,,,, -9743,,424d1bf0-2d54-47c3-ab3d-6e2cc631875b,SU/Mölndal Sjukhus,su_m_lndal_sjukhus,,,,,, -9744,,7fbf5e54-8bdb-11e6-a449-0242ac12000b,Region Jönköpings län,region_j_nk_pings_l_n,,,,,, -9745,,c7d92add-5476-47de-850f-892831761df9,The Eye Hospital Rotterdam,the_eye_hospital_rotterdam,,,,,, -9746,,dc386eb1-5f81-4637-a241-83154e8d88d1,"TEVA WOMEN'S HEALTH RESEARCH&DEVELOPMENT, A DIVISION OF TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC",teva_women_s_health_research_development_a_division_of_teva_branded_pharmaceutical_products_r_d_inc,,,,,, -962,0.97408080101013184,0db9909a-d59f-42e0-9159-2ecff62910d4,Hull and East Yorkshire Hospital Trust,hull_and_east_yorkshire_hospital_trust,,,,0db9909a-d59f-42e0-9159-2ecff62910d4,hull_and_east_yorkshire_hospital_trust,Hull and East Yorkshire Hospital Trust -9747,,7481a9f8-7145-11e6-a0cd-0242ac12000b,SCHERER RP,scherer_rp,,,,,, -9748,,f1cb8710-9d35-4fdb-934d-fa00861bdcaf,ViroDefense Inc,virodefense_inc,,,,,, -9749,,27efafca-96b0-4bc9-8ae4-91c1bdfd0d2d,Serendex Pharmaceuticals A/S,serendex_pharmaceuticals_a_s,,,,,, -110,0.97055983543395996,8e245501-d374-45b9-8cc1-1e8c3d9845c0,"Department of Oncology, Karolinska University Hospital",department_of_oncology_karolinska_university_hospital,,,,7ab0aad4-ccd7-43a6-abf8-e331125b5500,department_of_oncology_karolinska,Department of Oncology -508,0.980232,3f98bb64-87e2-43ad-bc25-60a24eb40e13,Pfizer S.A,pfizer_s_a,,,,3f98bb64-87e2-43ad-bc25-60a24eb40e13,pfizer_s_a,Pfizer S.A -465,0.97570099433263147,7e43e6a1-03e0-4710-9b92-3a2e4559f085,Leiden University Medical Center,leiden_university_medical_center,,,,2e4a0d21-5259-4b26-b5dd-ed587c02073f,leiden_university,Leiden University -501,0.941946,a78cea43-1e59-43c5-89f4-6475172d24f1,Medizinische Fakultät der Otto von Guericke Universität Magdeburg,medizinische_fakult_t_der_otto_von_guericke_universit_t_magdeburg,,,,51817147-4fe9-46e4-8642-703081f3e636,medizinische_fakult_t_otto_von_guericke_universit_t,Medizinische Fakultät. Otto von Guericke Universität -9750,,44d61a7a-7160-11e6-a0cd-0242ac12000b,BH,bh,,,,,, -9751,,6705babf-2f8e-4046-85a3-e8dd8a97f6ae,Jordi Carratalá,jordi_carratal,,,,,, -9752,,1c3e8157-eb84-49ed-878f-2270dda776c5,Grupo Oncopaz y Hospitales Asociados,grupo_oncopaz_y_hospitales_asociados,,,,,, -9753,,95ce2941-e254-4799-ad89-f6309529be06,The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),the_eunice_kennedy_shriver_national_institute_of_child_health_and_human_development_nichd,,,,,, -9754,,8111cfbc-53da-4e80-adbe-2819f14c3de0,The European group for Blood and Marrow Transplantation (EBMT),the_european_group_for_blood_and_marrow_transplantation_ebmt,,,,,, -769,0.95718833804130554,06287ea9-1e30-49c5-af4a-558dc91625a2,GEL/TAMO (Grupo Cooperativo Español de Linfoma/Transplante Antólogo de Médula Ósea),gel_tamo_grupo_cooperativo_espa_ol_de_linfoma_transplante_ant_logo_de_m_dula_sea,,,,06287ea9-1e30-49c5-af4a-558dc91625a2,geltamo_grupo_cooperativo_espa_ol_de_linfoma_trasplante_aut_logo_de_m_dula_sea,GELTAMO (Grupo Cooperativo Español de Linfoma/Trasplante Autólogo de Médula Ósea) -9755,,343d270e-a8c7-420c-a599-479caa81d17d,SymbioPharm GmbH,symbiopharm_gmbh,,,,,, -9756,,8335f852-719d-11e6-a0cd-0242ac12000b,LABORATOIRE HRA,laboratoire_hra,,,,,, -9757,,c2acc91e-8639-472d-8d7f-eb0ef64810f4,Papworth Hospital,papworth_hospital,,,,,, -803,0.98581516742706299,3752ea3c-adc5-42dc-b691-67baaf7d0875,University Hospital Basel, Neurology,,,,3752ea3c-adc5-42dc-b691-67baaf7d0875, Neurology,University Hospital Basel -192,0.97530868649482727,7621f0c9-df30-4cbd-95c1-d0d5719d2751,Teva Pharmaceutical Industries Ldt,teva_pharmaceutical_industries_ldt,,,,7621f0c9-df30-4cbd-95c1-d0d5719d2751,teva_pharmaceutical_industries,Teva Pharmaceutical Industries -9758,,f5c5ea0a-73c1-11e6-a0cd-0242ac12000b,HIKMA PHARM CO LTD,hikma_pharm_co_ltd,,,,,, -9759,,8913dec5-4317-4b8b-a426-344a1087ff12,Roche s.r.o,roche_s_r_o,university_hospital_basel_neurology,,,,, -9760,,a9d2fae1-e8ae-45c9-9f31-16e77cc3768e,"MUW, Universitätsklinik für Innere Medizin III, Abteilung für Nephrologie und Dialyse",muw_universit_tsklinik_f_r_innere_medizin_iii_abteilung_f_r_nephrologie_und_dialyse,,,,,, -737,0.9838290810585022,9d24a637-ff9d-4f52-87fc-ca0f3956d972,Fundació Clinic per a la Recerca Biomèdica,fundaci_clinic_per_a_la_recerca_biom_dica,,,,9d24a637-ff9d-4f52-87fc-ca0f3956d972,fundaci_clinic_per_a_la_recerca_biom_dica,Fundació Clinic per a la Recerca Biomèdica -9761,,d08d0a6f-9cfb-481a-958b-41102932e546,University of Witten/Herdecke,university_of_witten_herdecke,,,,,, -9762,,8bbf050e-7161-11e6-a0cd-0242ac12000b,ARMOUR PHARM,armour_pharm,,,,,, -9763,,6d55a4bd-2287-489d-a2d3-49e49ee6ab92,Centre Hospitalier de Jolimont-Lobbes-Tubize-Nivelles,centre_hospitalier_de_jolimont_lobbes_tubize_nivelles,,,,,, -9764,,d94d6058-ba53-484d-a088-7c1e1f47af61,SUBSTIPHARM DEVELOPPEMENT,substipharm_developpement,,,,,, -9765,,a70305f2-7212-11e6-a0cd-0242ac12000b,PALADIN LABS,paladin_labs,,,,,, -401,0.985931,4881a846-a728-4902-a39b-d18aa6ed8b14,European Myeloma Network Datacenter,european_myeloma_network_datacenter,,,,4881a846-a728-4902-a39b-d18aa6ed8b14,european_myeloma_network_datacenter,European Myeloma Network Datacenter -9766,,324ac022-a04f-4092-9f75-01208fbf5e78,Mundipharma Research Ltd,mundipharma_research_ltd,,,,,, -9767,,64bdce1c-7153-11e6-a0cd-0242ac12000b,INTL MEDICATED,intl_medicated,,,,,, -9768,,0a7e5eaf-9b40-4c87-bc26-5b1448898a2a,CROMA-PHARMA GmbH,croma_pharma_gmbh,,,,,, -235,0.97966137528419495,683ca9e5-af11-4524-9288-1bb0932a9588,Novartis Pharma Services,novartis_pharma_services,,,,683ca9e5-af11-4524-9288-1bb0932a9588,novartis_pharma_services,Novartis Pharma Services -724,0.981953,52dd1d55-52d2-42d6-b026-3416877c1096,"University of Iceland, Dept. Pharmacology",university_of_iceland_dept_pharmacology,,,,52dd1d55-52d2-42d6-b026-3416877c1096,university_of_iceland_dept_pharmacology,"University of Iceland, Dept. Pharmacology" -9769,,980115c8-5aa3-490c-a502-22ce28804a5d,Gene PreDiT SA,gene_predit_sa,,,,,, -9770,,8bf19cd6-881c-11e6-a998-0242ac12000b,"Shire Orphan Therapies, Inc",shire_orphan_therapies_inc,,,,,, -732,0.96950775384902954,23bc27b4-07ca-4d74-9d53-97dbe811474f,Bristol-Myers Squibb S.A,bristol_myers_squibb_s_a,,,,23bc27b4-07ca-4d74-9d53-97dbe811474f,bristol_myers_squibb_s_a,Bristol-Myers Squibb S.A -9771,,bb764da7-de51-4561-917d-bbb1dffe2619,"Pfizer Ltd., Ramsgate Rd., Sandwich, Kent",pfizer_ltd_ramsgate_rd_sandwich_kent,,,,,, -9772,,749afddd-b650-4e3e-8ec3-d6bfb7237a15,Dept. of Neurology - Univ. of Kansas Medical Center,dept_of_neurology_univ_of_kansas_medical_center,,,,,, -678,0.97750166058540344,13208ab1-3086-46d7-9a2a-a6f5c9b30ecd,AbbVie Deutschland GmbH & Co. KG,abbvie_deutschland_gmbh_co_kg,,,,ddf3632f-3a35-464c-8cf1-c8b6486c323c,abbvie_deutschland_gmbh_co_kg,AbbVie Deutschland GmbH & Co. KG -98,0.979094,774da114-f1f8-4248-96b8-80c126c20bd2,"University of Leipzig Ritterstr. 26, 04109 Leipzig",university_of_leipzig_ritterstr_26_04109_leipzig,,,,76157ebc-7bea-4a83-a2ca-6c02e460c234,university_of_leipzig,University of Leipzig -9773,,e06a9f03-7f64-48de-aacd-e95bf3ab33ac,National Institution of Health (NCI),national_institution_of_health_nci,,,,,, -9774,,20ffb478-7fad-432a-85f9-b816ec2abad3,"Department of Oncology, Rigshospitalet",department_of_oncology_rigshospitalet,,,,,, -587,0.95549,12d4a6e2-73f7-11e6-a0cd-0242ac12000b,IDT,idt,,,,12d4a6e2-73f7-11e6-a0cd-0242ac12000b,idt,IDT -9775,,e2f6273b-b977-4c6e-a0da-d4940bcbae2b,Hospital Son Dureta,hospital_son_dureta,,,,,, -9776,,a23951b7-2aa8-43bb-87be-999fc1f98e9e,"Medizinische Universität Wien, Univ.Klinik Innere Medizin III, Abt.für Nephrologie u.Dialyse",medizinische_universit_t_wien_univ_klinik_innere_medizin_iii_abt_f_r_nephrologie_u_dialyse,,,,,, -9777,,693bf002-44cb-4ea7-afc9-d5c81e8e6f39,"Per Whiss, Faculty of Health Sciences",per_whiss_faculty_of_health_sciences,,,,,, -9778,,422b3215-23c0-472d-84f5-c888e5a6402d,Bionorica SE,bionorica_se,,,,,, -9779,,18e081c0-9c7c-4b2b-b6ad-d68047e0f248,Urologische Partnerschaft,urologische_partnerschaft,,,,,, -9780,,c3847899-7063-43a7-a696-07cf9d517a62,Boehringer Ingelheim Finland Ky,boehringer_ingelheim_finland_ky,,,,,, -9781,,2e7bdeb4-3c69-4b39-9720-5a0d23f0bc48,Chiesi Farmaceutici SpA,chiesi_farmaceutici_spa,,,,,, -9782,,4fed8abd-02b2-43cb-882b-6d53ef6d263d,"University hospital Mainz, I. Medizinische Klinik und Poliklinik, Johannes Gutenberg-Universität",university_hospital_mainz_i_medizinische_klinik_und_poliklinik_johannes_gutenberg_universit_t,,,,,, -9783,,9754953c-7193-11e6-a0cd-0242ac12000b,BLULINE,bluline,,,,,, -9784,,cd72e8fb-7878-4d6d-b4ee-fd54a2ef13da,University Hospitals of Leciester NHS trust,university_hospitals_of_leciester_nhs_trust,,,,,, -903,0.978271,03392dcb-ef6c-4051-ad43-dad84dc61463,Besancon University Hospital,besancon_university_hospital,,,,03392dcb-ef6c-4051-ad43-dad84dc61463,besancon_university_hospital,Besancon University Hospital -9785,,5ae65843-9300-4e49-a154-080b2c658070,"ARAFARMA GROUP, S.A",arafarma_group_s_a,,,,,, -288,0.91965407133102417,637c7598-5b5c-463a-b3c7-2e09975b8047,"Pfizer Ltd., Ramsgate Road,Sandwich,Kent,CT13 9NJ,United Kingdom",pfizer_ltd_ramsgate_road_sandwich_kent_ct13_9nj_united_kingdom,,,,5a02f0f0-4b8e-4bcc-b5d9-2bda73ef9a30,pfizer_ltd_ramsgate_road_sandwich_kent_ct13_9nj,"Pfizer Ltd,Ramsgate Road,Sandwich,Kent CT13 9NJ" -9786,,9cdf3ed7-0a85-4d7e-82a2-732ef74bbb7a,Lassila Riitta,lassila_riitta,,,,,, -9787,,7e9c35a5-c501-486b-b709-153229944086,Sanos Bioscience A/S,sanos_bioscience_a_s,,,,,, -9788,,5418eaf2-154a-4cb0-825a-31fab6dc5609,Hospices Civils de Lyon,hospices_civils_de_lyon,,,,,, -780,0.923509,233d48d7-e293-4935-96da-8421fde4be1f,Royal Liverpool & Broadgreen University hospital,royal_liverpool_broadgreen_university_hospital,,,,233d48d7-e293-4935-96da-8421fde4be1f,royal_liverpool_broadgreen_university_hospital,Royal Liverpool & Broadgreen University hospital -1029,0.935805,5107d29f-cc09-411e-b173-d701ced714e6,EORTC (European Organization for Research and Treatment of Cancer),eortc_european_organization_for_research_and_treatment_of_cancer,,,,5107d29f-cc09-411e-b173-d701ced714e6,eortc_european_organization_for_research_and_treatment_of_cancer,EORTC (European Organization for Research and Treatment of Cancer) -9789,,c1cfdac4-a060-4684-9686-044ba763bd4c,"Scioderm, INC",scioderm_inc,,,,,, -9790,,84932560-b855-44bd-a0a4-c2edcc4e4215,Pfizer Inc. 232 East 42nd Street-New York-10017-USA,pfizer_inc_232_east_42nd_street_new_york_10017_usa,,,,,, -633,0.974308,ee9911c2-82fa-4529-bad0-7fe5a6f162ac,BRACCO,bracco,,,,c06c533e-ab04-44e7-a0f7-e1b3fb8173f8,bracco_imaging,BRACCO IMAGING -9791,,b16b91e5-15ee-454a-a885-a34c1b37212d,Terho Heikkinen,terho_heikkinen,,,,,, -888,0.96341493300029213,64afb7c3-b0ee-42c4-90f7-a07e5d018c30,"Schering-Plough Research Institute, a Division of Schering",schering_plough_research_institute_a_division_of_schering,,,,bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f,schering_plough_research_institute_a_division_of_schering_corporation,"Schering-Plough Research Institute, a Division of Schering Corporation" -945,0.916222,8dd06814-7167-11e6-a0cd-0242ac12000b,ZACH SYSTEM SPA,zach_system_spa,,,,7dd3aa00-7164-11e6-a0cd-0242ac12000b,zach_systems,ZACH SYSTEMS -9792,,dbe6b57e-beca-4adb-bcb0-a71a710d4bc2,Pharma Patent Kft,pharma_patent_kft,,,,,, -9793,,a3003338-7129-11e6-a89e-0242ac12000b,MIKAH PHARMA,mikah_pharma,,,,,, -9794,,322f39c5-b043-41d4-a00a-8d02f4e19abb,CAIBER,caiber,,,,,, -9795,,239bfa48-5885-45ec-b567-223f96fe0640,Pharmatrophix Inc,pharmatrophix_inc,,,,,, -9796,,b7b27066-c0c1-44ca-8910-71b45b5dfd25,"Klinik für Anästhesiologie und operative Intensivmedizin, Charité – Universitätsmedizin Berlin",klinik_f_r_an_sthesiologie_und_operative_intensivmedizin_charit_universit_tsmedizin_berlin,,,,,, -9797,,523abda5-7ea1-4ccf-979d-623a62fd22a7,Sacro Cuore - Don Calabria Hospital,sacro_cuore_don_calabria_hospital,,,,,, -980,0.979352,613292dd-dbf8-4798-b144-565e8fc77a28,"Gambro Lundia AB, Corporate Research",gambro_lundia_ab_corporate_research,,,,1743b2fc-080c-4820-9527-15454fe27836,gambro_lundia_ab,Gambro Lundia AB -282,0.95927333831787109,2f33c154-cafb-40b1-8fdc-8c3e78823f79,Sahlgrenska University Hospital Västra Götalandsregionen,sahlgrenska_university_hospital_v_stra_g_talandsregionen,,,,2f33c154-cafb-40b1-8fdc-8c3e78823f79,sahlgrenska_university_hospital,Sahlgrenska University Hospital -9798,,db4b3f81-c1a1-4b69-9fa1-69fa94d1edde,Sunovion Respiratory Development Inc,sunovion_respiratory_development_inc,,,,,, -9799,,e30f7864-8bd0-11e6-a449-0242ac12000b,Regional Hospital of Randers,regional_hospital_of_randers,,,,,, -9800,,a7375fdb-c602-4fc7-b628-aa313d8a1a6a,"Intra-Cellular Therapies, Inc",intra_cellular_therapies_inc,,,,,, -9801,,1067a848-6839-4adf-a96f-fd2c22f5e950,PARENT PROJECT ONLUS,parent_project_onlus,,,,,, -181,0.9797365665435791,7e7a02de-715e-11e6-a0cd-0242ac12000b,VALEANT INTL,valeant_intl,,,,7e7a02de-715e-11e6-a0cd-0242ac12000b,valeant_intl,VALEANT INTL -9802,,ee2796e8-747e-4e46-a0d6-fd93ffc906c8,Hospital District of Southwest Finland,hospital_district_of_southwest_finland,,,,,, -9803,,b126d270-2016-41f9-bc3b-4cc49131ec85,TEVA Pharma Belgium,teva_pharma_belgium,,,,,, -128,0.98614925146102905,351cf472-712a-11e6-a89e-0242ac12000b,PHARMACHEMIE,pharmachemie,,,,07d5f348-7142-11e6-a0cd-0242ac12000b,pharmachemie_bv,PHARMACHEMIE BV -9804,,0bd85a64-f96b-41ac-bc32-7329d703c7b8,"Vion Pharmaceuticals, Inc",vion_pharmaceuticals_inc,,,,,, -559,0.97430989146232605,f72b701f-8add-4964-bec4-ff9cecac4d28,Department of Clinical Pharmacology Q,department_of_clinical_pharmacology_q,,,,e78543a1-45be-413e-ae9a-522fb25ea6da,department_of_clinical_pharmacology,Department of Clinical Pharmacology -9805,,613013ba-1ef5-47b4-b160-939173197a66,Topigen Pharmaceuticals Inc,topigen_pharmaceuticals_inc,,,,,, -9806,,97c36a30-b185-456e-973f-ba9402a12a83,María del Pino Alberiche Ruano,mar_a_del_pino_alberiche_ruano,,,,,, -831,0.977549,f2298589-5d8b-414c-a48d-580c4d2ca7fc,"Laboratorios Andromaco, S.A",laboratorios_andromaco_s_a,,,,9f380cea-e5d4-4346-a8b8-6397eb6b3840,laboratorios_andr_maco_s_a,"Laboratorios Andrómaco, S.A" -9807,,b1dfc549-46e5-4f88-b08b-25d64f1d6a23,Haga Teaching Hospital,haga_teaching_hospital,,,,,, -9808,,02b11f42-9e86-4bef-a238-91a07ec72726,Medizinischen Klinik mit Schwerpunkt Nephrologie und Internistische Intensivmedizin/Charité - Universitätsmedizin Berlin,medizinischen_klinik_mit_schwerpunkt_nephrologie_und_internistische_intensivmedizin_charit_universit_tsmedizin_berlin,,,,,, -9809,,013c9774-1c1d-4432-8c55-3d7918257d60,"Mast Therapeutics, Inc",mast_therapeutics_inc,,,,,, -9810,,d063e173-1d15-4666-87db-d9056885021e,Top institute of Pharmaceutical Research,top_institute_of_pharmaceutical_research,,,,,, -9811,,adc62e93-b122-42b5-929b-71ab04c258f9,Lars Jørgen Østergaard,lars_j_rgen_stergaard,,,,,, -9812,,44ea5e6a-715e-11e6-a0cd-0242ac12000b,INDICUS PHARMA,indicus_pharma,,,,,, -9813,,4c97e520-1c31-4c87-9e91-10cbc5759d3f,Marja-Liisa Korhonen,marja_liisa_korhonen,,,,,, -1026,0.95679479837417603,d2379c06-dc10-47c7-9eb7-094b64f48366,"Eli Lilly and Company Limited, Erl Wood Manor",eli_lilly_and_company_limited_erl_wood_manor,,,,d2379c06-dc10-47c7-9eb7-094b64f48366,eli_lilly_and_company,Eli Lilly and Company -9814,,ea73286f-102e-467b-ad11-179f8f88cd39,"Boehringer Ingelheim (UK), Ltd",boehringer_ingelheim_uk_ltd,,,,,, -9815,,e21bcac6-4bab-471d-a307-f389c6192e5b,Ana de Pedro Muñoz,ana_de_pedro_mu_oz,,,,,, -9816,,a004a205-f221-4197-83bd-138ffb93fce0,"Pharma Mar, S.A",pharma_mar_s_a,,,,,, -9817,,8802c906-8bd7-11e6-a449-0242ac12000b,Alfa Wassermann Polska Sp. z o.o,alfa_wassermann_polska_sp_z_o_o,,,,,, -9818,,aee96a24-7166-11e6-a0cd-0242ac12000b,NORTH CREEK PHARMS,north_creek_pharms,,,,,, -9819,,9dd65348-016e-427c-8a04-b8a53578b017,Hospital Universitario de Canarias,hospital_universitario_de_canarias,,,,,, -9820,,0b217cbc-7912-4484-b9cf-f26093b2867b,QUEST PHARMATECH INC,quest_pharmatech_inc,,,,,, -9821,,b11b8fa6-213a-4356-a90e-9a37bd06f72d,AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA,azienda_ospedaliera_maggiore_della_carita,,,,,, -9822,,7fb10b4f-5bb9-4c5b-a93b-8046004ff4be,Abbott Scandinavia AB,abbott_scandinavia_ab,,,,,, -9823,,60faac71-5aaf-4712-8e87-11e6be360e2b,"MUW, Klinik für Mund-, Kiefer-und Gesichtschirurgie",muw_klinik_f_r_mund_kiefer_und_gesichtschirurgie,,,,,, -9824,,80d10ff8-635f-4c1c-9ae0-7e194e0155cf,Royal United Hospital Bath NHS Trust,royal_united_hospital_bath_nhs_trust,,,,,, -9825,,53f5234e-4ebf-4470-a0b7-8c815013000c,Mereo BioPharma 1 Ltd,mereo_biopharma_1_ltd,,,,,, -9826,,333ad5c4-7324-11e6-a0cd-0242ac12000b,NYCOMED US INC,nycomed_us_inc,,,,,, -9827,,3f4e8b89-bd5f-4341-81a7-aaeea9bee54c,GIPIT,gipit,,,,,, -32,0.97160464525222778,4e670e68-1f79-4524-adc8-b4d1069973a7,Technische Universität Dreden,technische_universit_t_dreden,,,,8013f413-0613-4f61-a0a5-e7241cff8548,technische_universit_t_dreden,Technische Universität Dreden -9828,,21800906-0d8e-461a-91da-bcf7787ab5c4,Riika Merivirta,riika_merivirta,,,,,, -9829,,c4948fb7-56f4-4b49-869c-a0db0865375a,"Department of anesthesiology, Bispebjerg Hospital",department_of_anesthesiology_bispebjerg_hospital,,,,,, -697,0.98663,0521bb50-7129-11e6-a89e-0242ac12000b,BAUSCH AND LOMB,bausch_and_lomb,,,,0521bb50-7129-11e6-a89e-0242ac12000b,bausch_and_lomb,BAUSCH AND LOMB -516,0.984713,05ba4e48-7141-11e6-a0cd-0242ac12000b,UPSHER SMITH,upsher_smith,,,,05ba4e48-7141-11e6-a0cd-0242ac12000b,upsher_smith,UPSHER SMITH -457,0.98836642503738403,e07d01a1-23e4-4609-9a4e-3a8cd71d5812,Janssen-Cilag International NV,janssen_cilag_international_nv,,,,b1956d94-fa1c-4c96-9cc6-cd0765e72415,janssen_cilag_international_nv_jci,Janssen-Cilag International NV (JCI) -268,0.982988,ad6dc0d9-13c5-492c-a7c3-cdf65dee7f25,CELL THERAPEUTICS INC,cell_therapeutics_inc,,,,ad6dc0d9-13c5-492c-a7c3-cdf65dee7f25,cell_therapeutics_inc,CELL THERAPEUTICS INC -14,0.95436489582061768,ae8e014a-7c13-4773-a1de-c710fa18ca2b,Menarini International Operation Luxembourg -SA,menarini_international_operation_luxembourg_sa,,,,41be544c-1f46-41e5-bb1b-0bb3baefda2e,menarini_international_operation_luxembourg_sa,Menarini International Operation Luxembourg S.A -1045,0.98760741949081421,558c49d6-0383-4c86-9ba7-9561b98f7845,Synta Pharmaceuticals Corporation,synta_pharmaceuticals_corporation,,,,558c49d6-0383-4c86-9ba7-9561b98f7845,synta_pharmaceuticals_corporation,Synta Pharmaceuticals Corporation -9830,,645a62ac-065d-49c0-b17b-3df77698b758,"Dept of Neuroscience, Uppsala University",dept_of_neuroscience_uppsala_university,,,,,, -52,0.970647,9a94ff2c-11e0-4432-8ee8-caa5dbeae42c,AIBILI,aibili,,,,042feb9c-2ed7-4ad5-bdb8-f388835c0c2d,aibili_evicr_net,AIBILI (EVICR.net) -9831,,852cf48a-4b30-431e-b65a-34ab6e0a0458,Hospital Universitario La Paz,hospital_universitario_la_paz,,,,,, -9832,,736d7ffd-c20a-471d-b812-b70200aa24b5,"Herlev Hospital, Dept. of Haematology (L121)",herlev_hospital_dept_of_haematology_l121,,,,,, -9833,,5e29c41e-0193-4ae2-ad1f-33686032e4a4,Servicio Andaluz de Salud,servicio_andaluz_de_salud,,,,,, -9834,,40d9eb8e-f8c1-4cd5-a69a-c27914c1d611,Camurus AB,camurus_ab,,,,,, -9835,,a2b08642-9365-41ae-a2c4-673ddc4d6f97,ImCyse S.A,imcyse_s_a,,,,,, -9836,,1efdc618-1a84-4d0d-ab83-72879a4460ca,Medical University of Vienna / Medizinische Universität Wien,medical_university_of_vienna_medizinische_universit_t_wien,,,,,, -9837,,4a89fc2a-f66b-4e72-9d6e-ae9009c8c9f7,Insituto Aragonés de Ciencias de la Salud,insituto_aragon_s_de_ciencias_de_la_salud,,,,,, -9838,,6b6ce8e3-6e4d-420d-b6cc-6061732b5f05,DR. PAOLO MORA,dr_paolo_mora,,,,,, -9839,,b0a8a03c-7148-11e6-a0cd-0242ac12000b,PACIFIC PHARMA,pacific_pharma,,,,,, -9840,,f7b848e2-4849-4db2-b1e7-a7e6f8a94b88,PIQUR Therapeutics AG,piqur_therapeutics_ag,,,,,, -9841,,214c2e4c-715f-11e6-a0cd-0242ac12000b,DELL LABS,dell_labs,,,,,, -9842,,40bcdb39-36b3-4621-b122-a24c4e94834c,MediPsych SA,medipsych_sa,,,,,, -9843,,c0f3bac6-8bba-11e6-a449-0242ac12000b,"Hjertemedicinsk klinik, Rigshospitalet",hjertemedicinsk_klinik_rigshospitalet,,,,,, -9844,,c693f104-db56-431e-adf5-e4c9d06d14cd,Santosolve A/S,santosolve_a_s,,,,,, -9845,,291d051c-9d5a-4842-b5f8-57d3e776206d,SERVICIO DIGESTIVO,servicio_digestivo,,,,,, -9846,,94676677-ff44-46cc-ba1c-2b5bc32b3cc1,Pharmacyclics Switzerland GmbH,pharmacyclics_switzerland_gmbh,,,,,, -9847,,1e4a27ed-0749-4986-b283-ef793144b4e2,CONSORZIO MARIO NEGRI SUD,consorzio_mario_negri_sud,,,,,, -9848,,c438cdc6-9495-4380-97c4-4f517db0e713,MAROS Arzneimittel GmbH,maros_arzneimittel_gmbh,,,,,, -9849,,5246cdc0-7a52-4dfd-8ca0-c6e0a0418c7e,Public Health Agency of Sweden,public_health_agency_of_sweden,,,,,, -76,0.979965,4ba23efe-04ef-4a5c-853f-235d35ab9a66,Hamilton Health Sciences Corporation through its Population Health Research Institute,hamilton_health_sciences_corporation_through_its_population_health_research_institute,,,,42ae3bc2-6aa6-4f76-977a-25863d6912a4,hamilton_health_sciences_corporation,Hamilton Health Sciences Corporation -889,0.98770618438720703,bdf4fdf4-ab54-4d40-931b-1ae015b95e83,University Medical Center of the Johannes Gutenberg,university_medical_center_of_the_johannes_gutenberg,,,,36018056-4c5e-4f92-a44e-4cff410d57aa,university_medical_center_of_the_johannes_gutenberg_university_mainz,University Medical Center of the Johannes Gutenberg-University Mainz -1019,0.974081,c8812d86-0dcc-44eb-bd45-aee5afb9fcc5,GlaxoSmithKline Reaseach & Development,glaxosmithkline_reaseach_development,,,,620095ee-c9a2-4531-944d-4a25e6b235d1,glaxosmithkline_reasearch_development,GlaxoSmithKline Reasearch & Development -298,0.976145,1125a293-4958-4c01-b61b-93801ccfbe14,Population Council,population_council,,,,026c754c-5658-43bc-9abd-0340a976ca9f,population_council_center_for_biomedical_research,Population Council - Center for Biomedical Research -369,0.968529,054fbb2c-7228-11e6-a0cd-0242ac12000b,DAIICHI,daiichi,,,,054fbb2c-7228-11e6-a0cd-0242ac12000b,daiichi,DAIICHI -9850,,b5622271-4db0-4c5e-9dda-21860a0aad5c,Mª Consuelo del Cañizo Fernández-Roldán,m_consuelo_del_ca_izo_fern_ndez_rold_n,,,,,, -631,0.944644,6e37f726-18bd-47e5-8ffd-231a4eb18b5b,ISTITUTI ORTOPEDICI RIZZOLI,istituti_ortopedici_rizzoli,,,,6e37f726-18bd-47e5-8ffd-231a4eb18b5b,istituti_ortopedici_rizzoli,ISTITUTI ORTOPEDICI RIZZOLI -9851,,f793c45a-7ceb-48ee-b461-3800a12b10a5,"University Hospital Lund, Dept of Oncology, Clinical Trial Unit",university_hospital_lund_dept_of_oncology_clinical_trial_unit,,,,,, -9852,,c4d30ae3-e2a4-47b2-ae18-fab23492ede0,Vanda Pharmaceuitcals Inc,vanda_pharmaceuitcals_inc,,,,,, -9853,,2fe1cb36-476d-4445-ab50-b73bead29015,ErasmusMedical Center-Sophia,erasmusmedical_center_sophia,,,,,, -9854,,706a62e5-c278-4f8c-9133-afea8f68cfcf,City University,city_university,,,,,, -9855,,5589ebe5-39a8-4fad-8204-f2d5ebe84ace,CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO,centro_di_riferimento_oncologico_di_aviano,,,,,, -9856,,9873b7d0-2eb0-4f4e-9fe0-0f6190f85825,"Wyeth Research Division of Wyeth Pharmaceuticals Inc., Clinical and Development",wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_and_development,,,,,, -9857,,dbfdc3fc-71ac-11e6-a0cd-0242ac12000b,ANBEX,anbex,,,,,, -931,0.9439578652381897,eb89f24a-4d32-4f09-bde9-b803949044b0,Pierre Fabre Dermatologie represented by IRPF,pierre_fabre_dermatologie_represented_by_irpf,,,,ee1d91c1-0d9e-47fa-b4e7-22a6f46f9512,pierre_fabre_dermatologie_represented_by_institut_de_recherche_pierre_fabre,Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre -9858,,c89ea4a1-8c41-40a2-8011-8786d47964b5,VALLE HEBRON HOSPITAL,valle_hebron_hospital,,,,,, -9859,,f81d5c3a-8da8-40de-a2e5-39c12b80ce8f,Metcon Medicin AB,metcon_medicin_ab,,,,,, -258,0.98775,7fce0d0a-e865-4fe0-a665-7bc7eda82ddd,Karolinska Universitetssjukhuset,karolinska_universitetssjukhuset,,,,64f7d7d9-e504-4ff5-a540-55635d4c61d0,karolinska_universitetssjukhuset_huddinge,Karolinska Universitetssjukhuset Huddinge -9860,,888cf42d-15dc-4cca-a0ee-8dbb3e17223b,"Clinical Research Institute, HUCH Ltd",clinical_research_institute_huch_ltd,,,,,, -9861,,f3601e9b-1dd0-44e4-ae6c-9fe476825b99,"University of Cologne, Sponsor-Quality Management",university_of_cologne_sponsor_quality_management,,,,,, -9862,,be63ac37-2aed-4ab8-8423-30b21fcf7de0,Merck Serono Norway,merck_serono_norway,,,,,, -838,0.98826968669891357,5d2b1c1a-75ea-4ae8-a57c-aff1808f8a9a,NHS Greater Glasgow and Clyde Board,nhs_greater_glasgow_and_clyde_board,,,,046d6658-d5b1-4caa-8e4b-a52c60c09ffd,nhs_greater_glasgow_and_clyde,NHS Greater Glasgow and Clyde -9863,,595a02d0-7157-11e6-a0cd-0242ac12000b,ANDRX PHARM,andrx_pharm,,,,,, -9864,,e9951d7b-ee02-4804-aca2-6e2b99549974,"Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital",cambridge_university_hospitals_nhs_foundation_trust_addenbrooke_s_hospital,,,,,, -9865,,171bf720-5e45-4785-b5bd-8edd54ff50da,B Braun Medical S.A,b_braun_medical_s_a,,,,,, -9866,,641a01b6-73af-11e6-a0cd-0242ac12000b,KALEO INC,kaleo_inc,,,,,, -9867,,c88e8771-d839-4a19-be17-f971a4ec3a9c,Astellas Pharma GmbH,astellas_pharma_gmbh,,,,,, -9868,,f5e51307-050b-4fdd-ba05-b9ef5f3aa796,GRUPO ESPAÑOL DE LINFOMAS Y TRANSPLANTES AUTOLOGO DE MEDULA OSEA (GELTAMO),grupo_espa_ol_de_linfomas_y_transplantes_autologo_de_medula_osea_geltamo,,,,,, -9869,,8297271f-bb44-4fbc-af5d-7d8128ec95d0,HAL Allergy B.V,hal_allergy_b_v,,,,,, -9870,,b1b5caf8-7087-4137-9840-209de9cf0b39,Laboratorios Novag S.A,laboratorios_novag_s_a,,,,,, -9871,,bd9464d8-6629-4764-ae7e-7bfe558d8d0b,José Esteban Castelao Fernández,jos_esteban_castelao_fern_ndez,,,,,, -2,0.983866,d2862f78-c0ef-4cea-8c84-b1d0d7eed987,Västra Götaland Regionen,v_stra_g_taland_regionen,,,,7f8c8a75-8bf8-48df-b832-ab6dba5c9c9c,v_stra_g_taland,Västra Götaland -9872,,06066d72-187a-4665-8a1b-52b6eb1a26d4,GTC Biotherapeutics Inc,gtc_biotherapeutics_inc,,,,,, -9873,,7c0ebb87-3173-4830-a008-4f2242ddf1b7,Oogziekenhuis Rotterdam,oogziekenhuis_rotterdam,,,,,, -9874,,8c42e826-32bd-4f1a-aa9b-3dbb2d0410fb,"Department of Nuclear Medicine, Aalborg University Hospital",department_of_nuclear_medicine_aalborg_university_hospital,,,,,, -9875,,4a67cc90-e794-493a-b9d4-3312592d1a28,Haupt Pharma Wolfratshausen GmbH,haupt_pharma_wolfratshausen_gmbh,,,,,, -9876,,78bd27c0-fadb-4311-b893-93fee5ee30fa,"University of Hamburg, MIN-Faculty, Department of Chemistry, Division of Cosmetetic Science",university_of_hamburg_min_faculty_department_of_chemistry_division_of_cosmetetic_science,,,,,, -365,0.97463372349739075,17d529dc-dc91-4ddb-8f15-7de6d2fa75e3,Bayer HealthCare Pharmaceutical Inc,bayer_healthcare_pharmaceutical_inc,,,,17d529dc-dc91-4ddb-8f15-7de6d2fa75e3,bayer_healthcare_pharmaceuticals,Bayer HealthCare Pharmaceuticals -9877,,9b88c810-7e44-436c-b8e6-abf582298114,University of Liège,university_of_li_ge,,,,,, -9878,,117255f8-1dea-4151-87b5-987f04e61dfe,Kwizda Pharma,kwizda_pharma,,,,,, -1023,0.962602,3d6896c7-f9eb-43cb-9c4d-49b6ab960bde,"Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet",dept_of_intensive_care_copenhagen_university_hospital_rigshospitalet,,,,3d6896c7-f9eb-43cb-9c4d-49b6ab960bde,dept_of_intensive_care_copenhagen_university_hospital_rigshospitalet,"Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet" -9879,,4c59766e-96c2-4555-90b0-53c21e756221,sanofi-aventis US,sanofi_aventis_us,,,,,, -9880,,7bd5f861-6339-4075-9985-dd3e6e56ca3d,"Cephalon Europe, A Division of Cephalon UK Limited",cephalon_europe_a_division_of_cephalon_uk_limited,,,,,, -9881,,9bfaf07c-74e8-4fc9-b5a4-5c5d4c83aacd,Fakultní nemocnice Brno,fakultn_nemocnice_brno,,,,,, -474,0.914969,0222076c-1a8f-4b87-a730-9ae61df48508,Royal Devon & Exeter NHS Foundation Trust,royal_devon_exeter_nhs_foundation_trust,,,,0222076c-1a8f-4b87-a730-9ae61df48508,royal_devon_exeter_nhs_foundation_trust,Royal Devon & Exeter NHS Foundation Trust -9882,,38b47768-31a8-495f-8489-89e9cd3083f8,Dr Daniel Serón. Servicio de Nefrología. Hospital Universitario Vall d'Hebron,dr_daniel_ser_n_servicio_de_nefrolog_a_hospital_universitario_vall_d_hebron,,,,,, -9883,,3e8b2e7f-1385-405a-a08a-e91245690fe8,"Celator Pharmaceuticals, Inc",celator_pharmaceuticals_inc,,,,,, -9884,,48856b01-28eb-4d19-aa53-911fc37fa808,GLAXOSMITKKLINE R&D LTD,glaxosmitkkline_r_d_ltd,,,,,, -600,0.95015225807825721,efceda38-ed0e-4115-84cb-32f129012f21,Fundación Institut de Recerca de l' Hospital de la Santa Creu i Sant Pau,fundaci_n_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,,,,6b4a9b2d-18ff-4441-b335-98517841d021,fundaci_n_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau,Fundació Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau -9885,,41b1a959-cd10-4a12-91d1-dbc04ae11447,Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH gGmbH),gesellschaft_f_r_p_diatrische_onkologie_und_h_matologie_gpoh_ggmbh,,,,,, -9886,,75052f2f-bf60-4089-82bd-f51b90b5bc9f,Urologkliniken USÖ,urologkliniken_us,,,,,, -9887,,6b377a37-8412-4fcc-8d87-0983a60518ee,FUNDACION SEIMC-GESIDA,fundacion_seimc_gesida,,,,,, -7,0.93911871314048767,f17a514e-8b4e-423a-b3c8-740bb7f90361,Centre Hospitalier Universitaire de Nice,centre_hospitalier_universitaire_de_nice,,,,e37ff462-7351-402c-828d-d17f23d6fa72,centre_hospitalier_universitaire_de_nantes,Centre Hospitalier Universitaire de Nantes -9888,,12be75be-df68-4abf-a544-5e915e626781,Julian Taylor,julian_taylor,,,,,, -9889,,e1a86ba5-0ea1-4bc8-9951-393911a07d0a,ARQule Inc,arqule_inc,,,,,, -9890,,55d216f6-cff4-404b-a20b-0f1eaffcd2e0,Országos Onkológiai Intézet,orsz_gos_onkol_giai_int_zet,,,,,, -9891,,9a386cf6-8d0f-46ec-8fd9-fbf9154818fb,Vita Green Europa S.A,vita_green_europa_s_a,,,,,, -9892,,bd4d0bef-c491-4902-ae15-509689f45320,"Medical University of Vienna, Department of Anaesthesia, General Intensive Care and Pain Management",medical_university_of_vienna_department_of_anaesthesia_general_intensive_care_and_pain_management,,,,,, -9893,,322a48b4-1460-4766-beb9-ea471830f34a,Oasmia Pharmaceutical AB,oasmia_pharmaceutical_ab,,,,,, -9894,,02087f66-7148-11e6-a0cd-0242ac12000b,THERAGEN,theragen,,,,,, -9895,,b3217b4c-7119-4d61-81ac-fe4f1cdd4cd2,Heinrich-Heine-Universität Düsseldorf,heinrich_heine_universit_t_d_sseldorf,,,,,, -9896,,b6b4f6ee-c850-4867-ad85-b661f8253cec,Aegera Therapeutics Inc,aegera_therapeutics_inc,,,,,, -524,0.985088,a8eec515-d7ce-45a9-93a1-6381a77996dd,Sanofi Pasteur Inc,sanofi_pasteur_inc,,,,211ecc7f-a65d-460f-803c-c95a4e47e245,sanofi_pasteur_incorporated,Sanofi Pasteur Incorporated -9897,,2e937851-0951-4f6f-ab29-fa7a2edebc64,IDIPAZ,idipaz,,,,,, -540,0.979562,3817f8bc-4ff8-495a-9b3e-ba7bf5fb409b,Dow Pharmaceutical Sciences,dow_pharmaceutical_sciences,,,,3817f8bc-4ff8-495a-9b3e-ba7bf5fb409b,dow_pharmaceutical_sciences,Dow Pharmaceutical Sciences -9898,,ea8f099d-c3e5-4bb8-a9b4-8762c42907e9,CROWN OY,crown_oy,,,,,, -9899,,96b64fe1-cac8-46d9-b707-a0c839416277,Institut de cancérologie Gustave Roussy,institut_de_canc_rologie_gustave_roussy,,,,,, -9900,,7a54d884-3f1d-42c2-ab84-da8cacea1d5c,The Newcastle upon Tyne Hospitals NHS Foundation Trust,the_newcastle_upon_tyne_hospitals_nhs_foundation_trust,,,,,, -9901,,b92d234b-0791-4116-8b8e-f8276b862029,"Universitätsklinikum Freiburg, vertreten durch den Leitenden Ärztlichen Direktor",universit_tsklinikum_freiburg_vertreten_durch_den_leitenden_rztlichen_direktor,,,,,, -9902,,cf734a6c-73b4-11e6-a0cd-0242ac12000b,AVID RADIOPHARMS INC,avid_radiopharms_inc,,,,,, -9903,,dff2924c-509b-475e-94f3-97ef0be54734,"Academical medical Center, Department of dermatology",academical_medical_center_department_of_dermatology,,,,,, -9904,,0efffa0c-39c6-45e9-8de7-e10eae817964,"Hospitales Universitarios Virgen del Rocío, Servicio Andaluz de Salud",hospitales_universitarios_virgen_del_roc_o_servicio_andaluz_de_salud,,,,,, -1064,0.9760473221540451,e575dcef-9058-4489-a3a8-f3e92d2e51bd,Cambridge University Hospitals NHS Foundation Trust,cambridge_university_hospitals_nhs_foundation_trust,,,,5832b652-f280-4dd6-850d-477a81887563,cambridge_university_hospitals_nhs_foundation_trust,Cambridge University Hospitals NHS Foundation Trust -9905,,fe1a61b1-7def-42f8-9221-9612004bcbb9,Roche a/s,roche_a_s,,,,,, -720,0.9764975905418396,f0a04a50-7242-11e6-a0cd-0242ac12000b,OTSUKA PHARM,otsuka_pharm,,,,83d8194e-71e2-11e6-a0cd-0242ac12000b,otsuka,OTSUKA -9906,,4df8836f-00b9-4c19-9a58-6d59fe777448,U.O. Tossicologia,u_o_tossicologia,,,,,, -9907,,16807fa9-ad9e-4ae5-8fdf-6a8bc5405337,"Spectrum Pharmaceuticals, Inc",spectrum_pharmaceuticals_inc,,,,,, -9908,,f1ca5da9-3310-4b9a-baf4-b9f5cf3b8246,Orthopedic Research in Aarhus,orthopedic_research_in_aarhus,,,,,, -9909,,26fd2938-73e7-11e6-a0cd-0242ac12000b,VIFOR FRESENIUS,vifor_fresenius,,,,,, -9910,,e073e3f4-87ac-4d80-af72-746008e36dba,ACRAF S.p.A,acraf_s_p_a,,,,,, -658,0.988286,4423b650-5a4e-43b4-81a3-c06729eeaafc,Liverpool Women's NHS Foundation Trust Hospital,liverpool_women_s_nhs_foundation_trust_hospital,,,,4423b650-5a4e-43b4-81a3-c06729eeaafc,liverpool_women_s_nhs_foundation_trust_hospital,Liverpool Women's NHS Foundation Trust Hospital -61,0.970142,d6dc6bb2-7166-11e6-a0cd-0242ac12000b,PAR FORMULATIONS PRIVATE LTD,par_formulations_private_ltd,,,,6e54f3b2-7165-11e6-a0cd-0242ac12000b,par_form,PAR FORM -9911,,a5ce0867-bd7a-41fa-9ff1-64f39b143724,Teva Women`s Health Research,teva_women_s_health_research,,,,,, -36,0.98114,d98745c2-011b-495b-a0b3-26372585a6ae,"Medical Faculty, Otto-von-Guericke-University Magdeburg",medical_faculty_otto_von_guericke_university_magdeburg,,,,d98745c2-011b-495b-a0b3-26372585a6ae,medical_faculty_otto_von_guericke_university_magdeburg,"Medical Faculty, Otto-von-Guericke-University Magdeburg" -9912,,71bc468c-71aa-11e6-a0cd-0242ac12000b,PRECISION DERMAT,precision_dermat,,,,,, -9913,,dee156d7-4e37-4b92-a5a2-969e570c9828,Zaans Medisch Centrum,zaans_medisch_centrum,,,,,, -9914,,f625ec16-c87f-4f76-8514-9e854f100ddf,"Erling Bjerregaard Pedersen, Medicinsk forskningsafsnit, Regionshospitalet Holstebro",erling_bjerregaard_pedersen_medicinsk_forskningsafsnit_regionshospitalet_holstebro,,,,,, -9915,,fe221106-d98b-415d-9418-f1885f0ac758,Mika Harju,mika_harju,,,,,, -9916,,b6a4be84-f800-44fc-a054-4ac5607694da,Mercedes Loscertales Abril,mercedes_loscertales_abril,,,,,, -9917,,d497ded2-e200-4a13-be9a-6cb36613dd81,Luis Carlos Imaz Navarro,luis_carlos_imaz_navarro,,,,,, -9918,,d3b5dcab-c6c0-442b-8fca-bb2bfa08ab66,ITALCHIMICI SPA,italchimici_spa,,,,,, -9919,,77e09dd6-154a-485d-8358-280bf3ea2255,Genzyme Corporation and its Affiliates,genzyme_corporation_and_its_affiliates,,,,,, -9920,,a9afe36b-4b30-47a7-8fc0-962c45786fbe,Vrij Universiteit Medical Center,vrij_universiteit_medical_center,,,,,, -275,0.972986,61dc1432-2742-471c-9dcc-67fb304ce278,Universitätsmedizin der Johannes Gutenberg-Universität Mainz,universit_tsmedizin_der_johannes_gutenberg_universit_t_mainz,,,,61dc1432-2742-471c-9dcc-67fb304ce278,universit_tsmedizin_der_johannes_gutenberg_universit_t_mainz,Universitätsmedizin der Johannes Gutenberg-Universität Mainz -9921,,323a492c-6309-45a0-ba99-404eb40f195f,Antisense Therapeutics Ltd,antisense_therapeutics_ltd,,,,,, -150,0.919718,dd0182b6-ae56-48f6-9461-7f4416fa380a,Universitätsmedizin Goettingen,universit_tsmedizin_goettingen,,,,b3733316-ccdd-4aab-ad57-807a9a476ca0,universit_tsmedizin_g_ttingen,Universitätsmedizin Göttingen -9922,,85ab66a0-8c51-4d88-8baf-6c9fe7130565,HANNA THORÉN,hanna_thor_n,,,,,, -9923,,95dad050-bfd7-43e6-9a7a-f3f6fd5d9c40,FOVEA,fovea,,,,,, -40,0.98917752504348755,7852b0e6-2f36-4ee0-90a6-404e745340b5,Procter & Gamble Technical Centres Ltd,procter_gamble_technical_centres_ltd,,,,7852b0e6-2f36-4ee0-90a6-404e745340b5,procter_gamble_technical_centres_ltd,Procter & Gamble Technical Centres Ltd -9924,,009259fe-5d4e-4308-8f0a-f51d6d73949f,Parque Científico de la Universidad de Valladolid,parque_cient_fico_de_la_universidad_de_valladolid,,,,,, -349,0.956416,81b272b1-dc41-4ac6-b169-23e9c0bb81d7,GITMO,gitmo,,,,81b272b1-dc41-4ac6-b169-23e9c0bb81d7,gitmo,GITMO -9925,,deb07535-d9a8-49ed-9ec8-1d1448c77bbc,Novartis Ireland Limited,novartis_ireland_limited,,,,,, -9926,,a94add8b-bab1-4fdc-8bcf-58ab426cd473,CELL THERAPEUTICS EUROPE,cell_therapeutics_europe,,,,,, -9927,,e021323a-714c-11e6-a0cd-0242ac12000b,MARSAM PHARMS LLC,marsam_pharms_llc,,,,,, -331,0.98589098453521729,5b0547b4-7168-11e6-a0cd-0242ac12000b,PURACAP PHARM LLC,puracap_pharm_llc,,,,5b0547b4-7168-11e6-a0cd-0242ac12000b,puracap_pharm_llc,PURACAP PHARM LLC -9928,,714cc474-b431-416b-9e99-4bd76512ef22,Tibotec Pharmaceuticals c/o Tibotec BVBA,tibotec_pharmaceuticals_c_o_tibotec_bvba,,,,,, -9929,,c6b019e3-ef97-4ea0-8f02-7da499209560,"Department og Gynaecology and Obstetric, Randers Hospital",department_og_gynaecology_and_obstetric_randers_hospital,,,,,, -9930,,5d17b1d4-bcc1-410d-a0ab-9e0cebf7ba7e,Roche Products Limited,roche_products_limited,,,,,, -9931,,3a9cf6a4-fa86-4307-a87c-5a50e9cd8a7a,NHS Grampian Health Board,nhs_grampian_health_board,,,,,, -9932,,dc7ecf15-6d8c-4135-a4f4-3384016ea8f2,"Medizinische Universität Graz, Kl. Abt. f. Endokrinoloie u. Stoffwechsel & Kl. Abt. f. Gastroenterologie u. Hepatologie",medizinische_universit_t_graz_kl_abt_f_endokrinoloie_u_stoffwechsel_kl_abt_f_gastroenterologie_u_hepatologie,,,,,, -9933,,eeca3142-72eb-11e6-a0cd-0242ac12000b,SICOR PHARMS,sicor_pharms,,,,,, -9934,,ae4c249e-2a5d-4597-9d24-d6af831abbf1,Peter Lommer Kristensen,peter_lommer_kristensen,,,,,, -9935,,81c5359a-7167-11e6-a0cd-0242ac12000b,WA UNIV SCH MED,wa_univ_sch_med,,,,,, -298,0.976145,026c754c-5658-43bc-9abd-0340a976ca9f,Population Council - Center for Biomedical Research,population_council_center_for_biomedical_research,,,,026c754c-5658-43bc-9abd-0340a976ca9f,population_council_center_for_biomedical_research,Population Council - Center for Biomedical Research -9936,,e6b8455a-714e-11e6-a0cd-0242ac12000b,KRKA DD NOVO MESTO,krka_dd_novo_mesto,,,,,, -120,0.97839492559432983,0b9eb68a-ecbc-4706-a3c1-e52c658684d3,Rheinische Friedrichs-Wilhelms-Universität Bonn,rheinische_friedrichs_wilhelms_universit_t_bonn,,,,0b9eb68a-ecbc-4706-a3c1-e52c658684d3,rheinische_friedrichs_wilhelms_universit_t_bonn,Rheinische Friedrichs-Wilhelms-Universität Bonn -9937,,578e1ca6-8438-4f5e-8ba9-353415404c6f,Boehringer-Inglheim RCV GmbH & Co KG,boehringer_inglheim_rcv_gmbh_co_kg,,,,,, -9938,,21c98037-d820-4b49-8c74-d7725c629c09,Bavarian Nordic A/S,bavarian_nordic_a_s,,,,,, -9939,,c28483b0-fb20-40bd-8c16-aaf5c51273ad,"Alder Biopharmaceuticals, Inc",alder_biopharmaceuticals_inc,,,,,, -9940,,93f242c4-1ea8-41a4-962a-cb4b07c428b5,"Pfizer Inc., 235 East 42nd Road, New York, NY 10017",pfizer_inc_235_east_42nd_road_new_york_ny_10017,,,,,, -9941,,551d9610-f046-44dc-97dd-61b03ecf9a03,"Department of anaesthesia and intensive care, Hvidovre Hospital",department_of_anaesthesia_and_intensive_care_hvidovre_hospital,,,,,, -642,0.97585871815681458,0da9da02-b343-4c52-bf6a-f6b6e2ae422d,Boehringer Ingelheim France S.A.S,boehringer_ingelheim_france_s_a_s,,,,1eaa3c0c-4ecd-4593-886b-6af263dd0c86,boehringer_ingelheim_france,Boehringer Ingelheim France -9942,,5084b8b3-1778-4f04-9b4d-7123b2159a2f,ZonMw,zonmw,,,,,, -9943,,cddba942-72c4-11e6-a0cd-0242ac12000b,MOBERG PHARMA NORTH,moberg_pharma_north,,,,,, -9944,,7fb43915-379d-4fbc-bfbc-fe1b1e0e1b1c,Viborg Sygehus,viborg_sygehus,,,,,, -9945,,91bb530e-7166-11e6-a0cd-0242ac12000b,ALLIED PHARMA INC,allied_pharma_inc,,,,,, -9946,,2646c5e7-e778-43e9-8dc5-b558abfaf769,"NHS Lanarkshire, Primary Care Operating Division",nhs_lanarkshire_primary_care_operating_division,,,,,, -281,0.986926,f7e37228-71b2-11e6-a0cd-0242ac12000b,ABBVIE ENDOCRINE INC,abbvie_endocrine_inc,,,,0dd91d42-73cc-11e6-a0cd-0242ac12000b,abbvie_endocrine,ABBVIE ENDOCRINE -9947,,a0492f88-738f-11e6-a0cd-0242ac12000b,CUTANEA,cutanea,,,,,, -9948,,9a67c580-1f93-48ae-92da-b06472af3a33,Francesc Bosch Albareda,francesc_bosch_albareda,,,,,, -9949,,6d6911d7-6767-4599-b2b0-123e718516ae,"Medizinische Universität Wien, Abteilung für Herzchirurgie",medizinische_universit_t_wien_abteilung_f_r_herzchirurgie,,,,,, -994,0.94387978315353394,bdf3e172-6f9d-11e6-9663-0242ac12000b,GE Healthcare Ltd and its affliates,ge_healthcare_ltd_and_its_affliates,,,,2e5a2501-0997-4b88-9260-ccb94b118ad0,ge_healthcare_ltd_and_its_affiliates,GE Healthcare Ltd and its Affiliates -9950,,d4cade9d-5c31-495b-bbef-dbc40ce4a7c7,Sociedad Española de Medicina Interna,sociedad_espa_ola_de_medicina_interna,,,,,, -9951,,a8a25b83-ee3d-4ba6-90e8-0a95476031d4,"Ipsen Pharma, S.A",ipsen_pharma_s_a,,,,,, -9952,,1de8b2fe-fdec-4fc9-be80-679c9ac33ce2,"Medizinische Universität Wien, Abteilung für Interne Medizin I",medizinische_universit_t_wien_abteilung_f_r_interne_medizin_i,,,,,, -9953,,2fd74391-faf2-4cdb-8c79-45bbdc07b3a2,"Medizinsiche Universität Wien, Klinik für Innere Medizin III, Abteilung für Nephrologie und Dialyse",medizinsiche_universit_t_wien_klinik_f_r_innere_medizin_iii_abteilung_f_r_nephrologie_und_dialyse,,,,,, -1018,0.96827325224876404,3ef304e0-3faa-4c7b-8eed-9cb81342e20b,Southampton University Hopsitals NHS Trust,southampton_university_hopsitals_nhs_trust,,,,4be171c0-8ae0-4db6-b193-567f4e972c15,southampton_university_hospitals_nhs_trust,Southampton University Hospitals NHS Trust -9954,,5cba4360-7549-4af1-9033-96ac5f5498d2,"Dept. of surg.gastroent., Gentofte University Hospital, Copenhagen",dept_of_surg_gastroent_gentofte_university_hospital_copenhagen,,,,,, -9955,,a736cf06-c01a-4b13-bec0-cbf578cbcf84,Wilhelminenspital,wilhelminenspital,,,,,, -9956,,9043e8a1-4722-44ec-99df-8b23856e3a0b,Matter Misericoridiae University Hospital. Dublín,matter_misericoridiae_university_hospital_dubl_n,,,,,, -305,0.974081,1d4eea22-5d60-4df5-ad75-599835189ec4,ErasmusMC - Sophia Children's Hospital,erasmusmc_sophia_children_s_hospital,,,,1d4eea22-5d60-4df5-ad75-599835189ec4,erasmusmc_sophia_children_s_hospital,ErasmusMC - Sophia Children's Hospital -9957,,1ce6ce57-999f-451b-ac56-7ff5ee95b05f,Vernalis Development Limited,vernalis_development_limited,,,,,, -1038,0.988575,af45d852-b2e4-43ce-9719-2aeb4934cabc,International Breast Cancer Study Group (IBCSG),international_breast_cancer_study_group_ibcsg,,,,9ac131bc-a6d9-4ae6-b2ba-0582d8a53b0c,international_breast_cancer_study_group,International Breast Cancer Study Group -9958,,d1560b1e-562b-4948-9c42-b72a5945358a,Public Health England,public_health_england,,,,,, -9959,,1c3259a2-8af5-4bf5-bdeb-f7cc34c9cd81,Javier P. Gisbert,javier_p_gisbert,,,,,, -9960,,fbe8de40-b45b-4e13-8122-663526dd3507,Amphia Ziekenhuis,amphia_ziekenhuis,,,,,, -9961,,ca8855e3-d401-44dc-a7d4-d0098731ab79,Dstl,dstl,,,,,, -759,0.983343,2c488fcb-00db-4f93-b318-935e898e44eb,"Sektion Chirurgische Forschung, Univ.Klinik f.Chirurgie",sektion_chirurgische_forschung_univ_klinik_f_chirurgie,,,,24121f55-fb32-464a-8d7d-28948ed0eae7,sektion_chirurgische_forschung,Sektion Chirurgische Forschung -9962,,89c53770-0612-4f7a-9d0a-79e1f257eaa6,CUB Hospital Erasme,cub_hospital_erasme,,,,,, -9963,,633cb00e-ea28-4cb1-af51-08cd6620b144,Salford Royal NHS Foundation Trust,salford_royal_nhs_foundation_trust,,,,,, -9964,,932c60d0-ca24-448f-a188-7e30944f458d,Dr. Andrés Poveda Velasco,dr_andr_s_poveda_velasco,,,,,, -9965,,d9ab6dab-70e4-4c39-acd8-8f370f79afc1,"AlgoRx Pharmaceuticals, Inc",algorx_pharmaceuticals_inc,,,,,, -9966,,7f82200f-abc9-485e-addb-9bf609def1b2,Servicio Anestesia Hopsital del Mar,servicio_anestesia_hopsital_del_mar,,,,,, -9967,,81a19452-5605-453a-a135-01dd0b9c87c8,MEDIWOUND,mediwound,,,,,, -9968,,bcf0f762-96ba-11e6-becf-0242ac110008,HERON THERAPS INC,heron_theraps_inc,,,,,, -935,0.987803,61fc895f-7aff-4a8e-951c-f9fb4acdbb1f,Institute of Tropical Medicine,institute_of_tropical_medicine,,,,61fc895f-7aff-4a8e-951c-f9fb4acdbb1f,institute_of_tropical_medicine,Institute of Tropical Medicine -9969,,7e6f7c34-a9ce-47b2-8792-97dffd1a5ed9,Odense Universitetshospital,odense_universitetshospital,,,,,, -9970,,a51528ba-8309-4bb4-aa35-57ca497302bb,FREE UNIVERSITY OF BRUSSELS,free_university_of_brussels,,,,,, -9971,,27d4d06e-72c4-11e6-a0cd-0242ac12000b,MILLENNIUM PHARMS,millennium_pharms,,,,,, -9972,,e9307d1e-677f-490a-8c3a-b9d998d9ce69,University Hospital Wuerzburg,university_hospital_wuerzburg,,,,,, -24,0.98570942878723145,cdbaa569-ceed-4f49-bdeb-edfd7c7c5d7c,University Hospital Leuven gasthuisberg,university_hospital_leuven_gasthuisberg,,,,98380ed0-6709-41ea-a19e-81804abcd9ff,university_hospital_leuven,University Hospital Leuven -9973,,e2195596-b7a7-4900-bf49-768b7e863c1d,Århus Sygehus,rhus_sygehus,,,,,, -237,0.98873680830001831,0d3de9f8-ad5d-46b0-9905-5be149c5b8c3,"Pfizer Limited, Ramsgate Road, Sandwich, Kent",pfizer_limited_ramsgate_road_sandwich_kent,,,,a0e33e4c-faf3-44df-85c6-ebc94469b62e,pfizer_limited_ramsgate_road_sandwich_kent_uk,"Pfizer Limited, Ramsgate Road, Sandwich, Kent" -494,0.95775824785232544,a45eb7a0-7141-11e6-a0cd-0242ac12000b,DR REDDYS LABS INTL,dr_reddys_labs_intl,,,,5796b890-7142-11e6-a0cd-0242ac12000b,dr_reddys_labs_inc,DR REDDYS LABS INC -934,0.94545680284500122,9a5193a8-26e1-477d-9333-001ad82a5c6f,Pierre Fabre Medicament represented by IRPF,pierre_fabre_medicament_represented_by_irpf,,,,ed0e7a9e-3ecf-499e-8589-05b770cd0c82,pierre_fabre_m_dicament_represented_by_irpf,Pierre Fabre Médicament represented by IRPF -611,0.98173725605010986,e38a4be1-bb34-4ac4-9394-24f70e28cd5a,Erasmus MC Sophia,erasmus_mc_sophia,,,,e38a4be1-bb34-4ac4-9394-24f70e28cd5a,erasmus_mc_sophia,Erasmus MC Sophia -9974,,c9a8b374-c8b6-4e47-a730-b790b0da6a8b,"Novacea, Inc",novacea_inc,,,,,, -9975,,58a3e95f-654a-4bba-a5d2-0f220a79da65,Medical Center - University of Freiburg,medical_center_university_of_freiburg,,,,,, -9976,,73ff9fc0-9d23-4815-af85-34dce17e584d,ISTITUTO ONCOLOGICO VENETO,istituto_oncologico_veneto,,,,,, -9977,,4925dd87-94e0-4336-8ccf-fddd64ff23f5,Stiefel Laboratories (Maidenhead) Limited trading as Stiefel International Research and Development,stiefel_laboratories_maidenhead_limited_trading_as_stiefel_international_research_and_development,,,,,, -9978,,71423879-53a6-4bab-958a-4a8726f98737,VieCuri Medisch Centrum voor Noord-Limburg,viecuri_medisch_centrum_voor_noord_limburg,,,,,, -790,0.955613,948c9ff2-6213-4012-a58e-997f1d833ec1,"Merck Serono International S.A., A branch of Laboratoires Serono S.A",merck_serono_international_s_a_a_branch_of_laboratoires_serono_s_a,,,,948c9ff2-6213-4012-a58e-997f1d833ec1,merck_serono_international_s_a_a_branch_of_laboratoires_serono_s_a,"Merck Serono International S.A., A branch of Laboratoires Serono S.A" -956,0.980878,b1885f5c-880d-11e6-a998-0242ac12000b,OBEcure Ltd,obecure_ltd,,,,b1885f5c-880d-11e6-a998-0242ac12000b,obecure_ltd,OBEcure Ltd -606,0.98649200797080994,f36837b0-7144-11e6-a0cd-0242ac12000b,AUROBINDO PHARMA LTD,aurobindo_pharma_ltd,,,,f36837b0-7144-11e6-a0cd-0242ac12000b,aurobindo_pharma,AUROBINDO PHARMA -138,0.975844,f51f334b-1f78-4878-9604-85cbb0169506,"Takeda Global Research & Development Centre, Inc.,",takeda_global_research_development_centre_inc,,,,5739df1e-d602-413b-9853-34dc83584168,takeda_global_research_development_center_inc,"Takeda Global Research & Development Center, Inc.," -9979,,96cb6c52-7149-11e6-a0cd-0242ac12000b,COOK IMAGING,cook_imaging,,,,,, -9980,,b41cea27-9f37-4eb0-aa73-43323bfdabf1,Hospital for Children and Adolescents,hospital_for_children_and_adolescents,,,,,, -9981,,021c0f45-d1d0-4d24-8452-f8762113c876,"Universitätsklinikum Mannheim, Universitätsklinik für Anästhesiologie und Operative Intensivmedizin",universit_tsklinikum_mannheim_universit_tsklinik_f_r_an_sthesiologie_und_operative_intensivmedizin,,,,,, -9982,,6aaf2211-53d3-4b65-a39f-6042b08934ea,Witten-Herdecke University,witten_herdecke_university,,,,,, -9983,,6a0d4655-17f2-4577-9c68-3fc866630e55,"Medizinsche Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie",medizinsche_universit_t_wien_universit_tsklinik_f_r_an_sthesie_allgemeine_intensivmedizin_und_schmerztherapie,,,,,, -146,0.987534,d78d6d0c-ca2a-4096-8274-aa3eb0eed181,"University Hospital Hamburg-Eppendorf, Psychiatry",university_hospital_hamburg_eppendorf_psychiatry,,,,a090216a-e555-4b1c-b5d2-b624ee996480,university_hospital_hamburg_eppendorf,University Hospital Hamburg-Eppendorf -9984,,d5a66a37-2572-4ad1-8bc4-bf1c78a6c47f,Andi - Ventis,andi_ventis,,,,,, -9985,,79901de5-05f3-4c6b-a01c-c779d0289930,BOWS Pharmaceuticals AG,bows_pharmaceuticals_ag,,,,,, -1025,0.97363638877868652,dd7894c7-a143-430c-8179-80225a199a92,Eli Lilly and Company limited,eli_lilly_and_company_limited,,,,2f59f764-513a-43d8-ba41-bc314f18f59b,eli_lilly_and_company_limited,Eli Lilly and Company limited -9986,,38653105-393b-4b27-a4b0-b539f3a208eb,Akinion Pharmaceuticals AB,akinion_pharmaceuticals_ab,,,,,, -928,0.975714,970a6bb8-72f8-11e6-a0cd-0242ac12000b,LG LIFE,lg_life,,,,87f2de76-726c-11e6-a0cd-0242ac12000b,lg_life_sciences,LG LIFE SCIENCES -9987,,473732fb-f298-4826-bd06-3ae97bd2c8a8,Fundación Teknon,fundaci_n_teknon,,,,,, -9988,,af8046ea-3595-4e3c-b8e7-c19034689ad1,Pfizer bv RA,pfizer_bv_ra,,,,,, -386,0.985292,1075f8b7-6380-4891-9141-7a995969037d,University of Leuven,university_of_leuven,,,,1075f8b7-6380-4891-9141-7a995969037d,university_of_leuven,University of Leuven -9989,,dfd94b5e-c4b8-4464-8255-539c7762713f,Arrowhead Pharmaceuticals Inc,arrowhead_pharmaceuticals_inc,,,,,, -9990,,8b8d4a39-5f6e-4fc5-8b08-10ca96e3aa25,"Par Pharmaceutical, Inc",par_pharmaceutical_inc,,,,,, -276,0.955365,93daac2d-3fd1-447f-98fc-f605f37148a3,Axcan Pharma Inc. (Axcan Pharma International BV is subsidiary of Axcan Pharma Inc.),axcan_pharma_inc_axcan_pharma_international_bv_is_subsidiary_of_axcan_pharma_inc,,,,93daac2d-3fd1-447f-98fc-f605f37148a3,axcan_pharma_inc_axcan_pharma_international_bv_is_subsidiary_of_axcan_pharma_inc,Axcan Pharma Inc. (Axcan Pharma International BV is subsidiary of Axcan Pharma Inc.) -9991,,568f4b7e-f382-4365-9bca-0ece7ca02056,Newcastle upon Tyne Hospitals NHS Foundation Trust,newcastle_upon_tyne_hospitals_nhs_foundation_trust,,,,,, -9992,,ffb98e5e-7146-11e6-a0cd-0242ac12000b,HIGH TECH PHARMA,high_tech_pharma,,,,,, -9993,,9c983874-7165-11e6-a0cd-0242ac12000b,PHARMADAX INC,pharmadax_inc,,,,,, -193,0.961748,d9bd49e2-e2dc-4a2d-8959-189ce26ada32,Abertawe Bro Morgannwg University LHB,abertawe_bro_morgannwg_university_lhb,,,,5684aae1-9d95-4f90-a93b-ce904a01565d,abertawe_bro_morgannwg_university_nhs_trust,Abertawe Bro Morgannwg University NHS Trust -9994,,9287eb36-ca38-4c85-b3ff-e7711710ea4d,Bruno Farmaceutici S.p.a,bruno_farmaceutici_s_p_a,,,,,, -9995,,7b22ab60-9eb7-4d76-b375-20c6eef03fad,The Royal Wolverhampton NHS Trust,the_royal_wolverhampton_nhs_trust,,,,,, -9996,,0fed44d4-891d-4784-9db8-9d4a25a2f89a,"GlobeImmune, Inc",globeimmune_inc,,,,,, -940,0.988452,7c1e9a67-0589-4d28-bf1e-a81d74f16a46,"Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunerschen Kinderspital",klinikum_der_universit_t_m_nchen_kinderklinik_und_poliklinik_im_dr_von_haunerschen_kinderspital,,,,7c1e9a67-0589-4d28-bf1e-a81d74f16a46,klinikum_der_universit_t_m_nchen_kinderklinik_und_poliklinik_im_dr_von_haunerschen_kinderspital,"Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunerschen Kinderspital" -9997,,ec136502-d1a7-4533-b5bc-d13296651dcb,York Hospital NHS Trust,york_hospital_nhs_trust,,,,,, -9998,,85457fcf-2f23-47fd-b190-de8a14f75966,Trubion Pharmaceuticals,trubion_pharmaceuticals,,,,,, -9999,,98f92131-8c6b-48be-b6af-079e80839a4c,OctreoPharm Sciences GmbH,octreopharm_sciences_gmbh,,,,,, -10000,,edf03d76-971c-44df-9310-cb6f24bef2be,UZ Brussels,uz_brussels,,,,,, -652,0.97253134846687317,3d490ca4-9c82-4d71-91ec-a03e747b4c7a,Boehringer,boehringer,,,,756fbf26-6aec-45b4-9273-9afca275034e,boehringer,Boehringer -41,0.951277,d7a38668-883e-40b2-a844-2971b86324e0,Dr. Gerhard Mann Chem.-Pharm. Fabrik GmbH/Bausch & Lomb,dr_gerhard_mann_chem_pharm_fabrik_gmbh_bausch_lomb,,,,1dd460c9-f84b-4b97-8376-8660e0cef195,dr_gerhard_mann_chem_pharm_fabrik_gmbh_bausch_lomb_incorporated,Dr. Gerhard Mann chem.-pharm. Fabrik GmbH/ Bausch & Lomb Incorporated -10001,,1a0f3cde-f0f8-4f1d-9a15-ee58cddf563d,"Dra. Antònia Dalmau i Llitjós. Servicio de Anestesia, Reanimación y Terapéutica del Dolor del HUB-Idibell",dra_ant_nia_dalmau_i_llitj_s_servicio_de_anestesia_reanimaci_n_y_terap_utica_del_dolor_del_hub_idibell,,,,,, -10002,,292c8585-4614-4ac0-8aa6-8a54d68eea2e,Joint Research & Development Office (Barts and The London School of Medicine & Dentistry) - Queen Mary University London,joint_research_development_office_barts_and_the_london_school_of_medicine_dentistry_queen_mary_university_london,,,,,, -10003,,33dc1331-204d-43b5-8b9f-371e6fc9dcbc,Faron Pharmaceuticals Limited,faron_pharmaceuticals_limited,,,,,, -10004,,88abeb4b-f489-4997-9112-1311363c3098,Rune Rasmussen,rune_rasmussen,,,,,, -790,0.955613,9516dca0-e67e-443e-ae03-feeb289be70c,"Merck Serono International, A branch of Laboratoires Serono S.A",merck_serono_international_a_branch_of_laboratoires_serono_s_a,,,,948c9ff2-6213-4012-a58e-997f1d833ec1,merck_serono_international_s_a_a_branch_of_laboratoires_serono_s_a,"Merck Serono International S.A., A branch of Laboratoires Serono S.A" -1010,0.97897982597351074,1ea84c68-71d5-11e6-a0cd-0242ac12000b,MCNEIL PED,mcneil_ped,,,,1ea84c68-71d5-11e6-a0cd-0242ac12000b,mcneil_ped,MCNEIL PED -10005,,9a8a3739-5ae2-43ad-9cad-ecd9f89090e3,Mater Misercordiae Hospital - Department of Anaesthesia,mater_misercordiae_hospital_department_of_anaesthesia,,,,,, -10006,,870ccda8-41bd-461a-8658-d346e0d5d082,Unit of Esophageal and Gastric Research Dep. of Molecular Medicine and Surgery Karolinska Institutet,unit_of_esophageal_and_gastric_research_dep_of_molecular_medicine_and_surgery_karolinska_institutet,,,,,, -10007,,3e3fc40c-9d27-4235-97ad-2ecb397b531f,UCB SA Pharma Sector,ucb_sa_pharma_sector,,,,,, -10008,,d0cdfee6-62fe-45eb-bbdc-f830a72a2bbe,GeiserPHARMA SL,geiserpharma_sl,,,,,, -10009,,2df1ee74-73e0-11e6-a0cd-0242ac12000b,PIRAMAL IMAGING,piramal_imaging,,,,,, -979,0.919788,e934c5bf-3608-458b-bfd8-e77726c3dbd2,Johnson & Johnson Consumer and Personal Products Worldwide,johnson_johnson_consumer_and_personal_products_worldwide,,,,5beb59d6-f94c-4993-90c5-181d33404f39,johnson_johnson_consumer_personal_products_worldwide_division_of_johnson_johnson_consumer_companies_inc,"Johnson & Johnson Consumer & Personal Products Worldwide, Division of Johnson & Johnson Consumer Companies, Inc" -10010,,a4d3bb8a-8ec4-454a-8680-05139d72bfe6,"BioMarin International Ltd., Shanbally, Ringaskiddy, County Cork, Ireland",biomarin_international_ltd_shanbally_ringaskiddy_county_cork_ireland,,,,,, -10011,,e7d5f070-796c-4780-a093-e33b4575f234,CHARITE Universitätsmedizin Berlin Campus Virchow-Klinikum,charite_universit_tsmedizin_berlin_campus_virchow_klinikum,,,,,, -10012,,050f0882-afdf-4c4d-958e-61a2c0692b55,Medizinische Universität Wien - Universitätsklinik für Frauenheilkunde,medizinische_universit_t_wien_universit_tsklinik_f_r_frauenheilkunde,,,,,, -784,0.966541,d284ad33-38aa-4ed9-add8-26f06cf0d679,EORTC Headquarters,eortc_headquarters,,,,8c460761-0f56-46e2-8808-c7288d449545,eortc,EORTC -701,0.967271,22012f51-f648-4da1-8b80-539b591bf168,Synageva BioPharma Corporation,synageva_biopharma_corporation,,,,22012f51-f648-4da1-8b80-539b591bf168,synageva_biopharma_corporation,Synageva BioPharma Corporation -10013,,70d6b182-ecc8-46df-b793-fda3ca0e9ac2,"St. Vincent Hospital, Medical Department II",st_vincent_hospital_medical_department_ii,,,,,, -10014,,c3c63cac-418f-4503-94e7-2ee0b241c156,CHU de Besançon,chu_de_besan_on,,,,,, -10015,,c1745fad-e482-4cb7-a530-0bcdc74588d4,ACHG-K.U.Leuven,achg_k_u_leuven,,,,,, -10016,,b38d591e-4bce-41ab-b329-6ffc0a108075,"Sopherion Therapeutics, Inc",sopherion_therapeutics_inc,,,,,, -10017,,d9bb41c0-7141-11e6-a0cd-0242ac12000b,LEADING PHARMA LLC,leading_pharma_llc,,,,,, -218,0.97293919324874878,15cb26f8-fd0f-4c18-8afe-0d8c7f03ce9f,Vifor Pharma,vifor_pharma,,,,15cb26f8-fd0f-4c18-8afe-0d8c7f03ce9f,vifor_pharma,Vifor Pharma -10018,,01cf390d-ed95-44b0-8246-6935b948e903,DRUG DELIVERY SOLUTIONS ApS (PART OF MC2 BIOTEK GROUP),drug_delivery_solutions_aps_part_of_mc2_biotek_group,,,,,, -10019,,9ec62292-c7ef-4fd2-b26e-8e3d8917627f,Cyclacel Ltd,cyclacel_ltd,,,,,, -10020,,aedd8881-7c7f-4b79-ba4b-980830b88301,Schmerzambulanz Innenstadt der LMU,schmerzambulanz_innenstadt_der_lmu,,,,,, -605,0.916683,33f94402-02fa-4a5a-a654-70b42cce6641,Novartis Vaccines & Diagnostics AG,novartis_vaccines_diagnostics_ag,,,,2966963f-a998-4261-8d68-d4c45ba26c05,novartis_vaccines_diagnostics_inc,"Novartis Vaccines & Diagnostics, Inc" -949,0.987284,300881f9-28ca-4aa4-b8d5-58ad7c2806f3,Astellas Pharma Europe B.V,astellas_pharma_europe_b_v,,,,300881f9-28ca-4aa4-b8d5-58ad7c2806f3,astellas_pharma_europe_b_v,Astellas Pharma Europe B.V -10021,,6807d3c5-4b3d-4b9e-85c4-22dfa6f0e390,University Hospital Leicester R&D,university_hospital_leicester_r_d,,,,,, -10022,,25a548e0-5581-4840-a957-16b0d3db552f,Janssen Sciences Ireland UC,janssen_sciences_ireland_uc,,,,,, -1075,0.97996,43028a3f-c862-4599-8864-5518384f4057,Isala Klinieken,isala_klinieken,,,,43028a3f-c862-4599-8864-5518384f4057,isala_klinieken,Isala Klinieken -10023,,4487aae2-7b22-4a14-90f1-fc6705bc52df,SORIA NATURAL S.A,soria_natural_s_a,,,,,, -845,0.984184,ec39c1b2-714d-11e6-a0cd-0242ac12000b,ELITE LABS,elite_labs,,,,c064f018-7141-11e6-a0cd-0242ac12000b,elite_labs_inc,ELITE LABS INC -10024,,d8562fd8-2bd4-4672-b497-fa3c38cc21d0,Synairgen Research Limited,synairgen_research_limited,,,,,, -10025,,5bd8c1ea-66ff-456a-aa00-a90e42d638e7,UZ Brussel VUB,uz_brussel_vub,,,,,, -10026,,752a7cde-7d2a-421c-a342-86fddda81591,Roche Latvia,roche_latvia,,,,,, -10027,,c631dd20-5a1c-4f28-9e8e-23dc69d614e9,Scandinavian prostate cancer group,scandinavian_prostate_cancer_group,,,,,, -10028,,cb934232-a5df-487e-9e7d-12598425413b,ASL SALERNO 1,asl_salerno_1,,,,,, -427,0.97483,2b3faade-7374-11e6-a0cd-0242ac12000b,VIVUS,vivus,,,,2b3faade-7374-11e6-a0cd-0242ac12000b,vivus,VIVUS -10029,,0192874a-c55b-4b11-808c-17dd51b55b7c,Southern Europe New Drug Organization (SENDO),southern_europe_new_drug_organization_sendo,,,,,, -211,0.9515920877456665,6d416153-a74f-11e6-94cb-5656d04fc2b5,"Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine & PET",rigshospitalet_department_of_clinical_physiology_nuclear_medicine_pet,,,,6d416153-a74f-11e6-94cb-5656d04fc2b5,rigshospitalet_department_of_clinical_physiology_nuclear_medicine_and_pet,"Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET" -703,0.93095305562019348,55558e55-4e51-404c-bc3c-e9d8644e8ed2,"University Hospitals Of Leicester NHS Trust, Gwendolen Road",university_hospitals_of_leicester_nhs_trust_gwendolen_road,,,,09b03690-5970-415f-b749-e56be3b9df7b,university_hospitals_leicester_nhs_trust,University Hospitals Leicester NHS Trust -10030,,0aed4dd8-7160-11e6-a0cd-0242ac12000b,BAYER PHARMS,bayer_pharms,,,,,, -303,0.991079,7700ad0c-d303-4880-b341-66bdf8c7ad35,Universitätsklinikum Bonn,universit_tsklinikum_bonn,,,,7700ad0c-d303-4880-b341-66bdf8c7ad35,universit_tsklinikum_bonn,Universitätsklinikum Bonn -10031,,22207448-4baf-437f-b560-9c04ec934de7,Stealth Peptides Inc,stealth_peptides_inc,,,,,, -49,0.975369,d8f0d873-4306-4828-b744-12f1d67a0438,SOLVAY PHARMA,solvay_pharma,,,,d8f0d873-4306-4828-b744-12f1d67a0438,solvay_pharma,SOLVAY PHARMA -10032,,3248580f-7045-4c0f-b453-a612abe43947,"Klinik für Dermatologie und Venerologie, Universitätsklinikum Hamburg-Eppendorf",klinik_f_r_dermatologie_und_venerologie_universit_tsklinikum_hamburg_eppendorf,,,,,, -10033,,caac8362-6064-4575-9219-8f88288f36b3,Clinic of University of Wuerzburg,clinic_of_university_of_wuerzburg,,,,,, -10034,,09be5d0a-715e-11e6-a0cd-0242ac12000b,INTELLIPHARMACEUTICS,intellipharmaceutics,,,,,, -10035,,2d6b657a-a745-11e6-94cb-5656d04fc2b5,"Dept. of Gastroenterology, Universityhospital Odense",dept_of_gastroenterology_universityhospital_odense,,,,,, -10036,,778d8d83-9726-463f-a92c-d93850f19f3d,Nottingham City Hospital NHS Trust,nottingham_city_hospital_nhs_trust,,,,,, -10037,,d452e434-b67a-442f-a5a9-f55dbceb31ad,"The Faculty of Pharmaceutical Sciences, University of Copenhagen",the_faculty_of_pharmaceutical_sciences_university_of_copenhagen,,,,,, -20,0.9795151948928833,1e74f773-7ad1-4d34-8164-f40da5329bf6,Charité Campus Mitte,charit_campus_mitte,,,,1e74f773-7ad1-4d34-8164-f40da5329bf6,charit_campus_mitte,Charité Campus Mitte -859,0.9885413646697998,e57eed5c-6041-4ff7-8430-fdf417cb9709,Deutsches Krebsforschungszentrum,deutsches_krebsforschungszentrum,,,,2030c40f-9eb7-4a24-af68-69c831c5fc3c,deutsches_krebsforschungszentrum_dkfz,Deutsches Krebsforschungszentrum (DKFZ -10038,,b599fc56-762f-453c-8190-bb5d43220bac,POPULATION HEART RESEARCH INSTITUTE (PHRI),population_heart_research_institute_phri,,,,,, -10039,,ac979b7b-37cb-4c48-b397-bebf9a614289,PsychoGenics Inc,psychogenics_inc,,,,,, -10040,,e75da28e-b56f-4044-9da7-c0935475b495,Emma Children's Hospital-AMC,emma_children_s_hospital_amc,,,,,, -10041,,e7cbbb7e-a6f6-11e6-94cb-5656d04fc2b5,PHARNEXT SA,pharnext_sa,,,,,, -10042,,0f826434-c1f7-405c-a262-88d30276ae84,H. Universitari Germans Trias i Pujol,h_universitari_germans_trias_i_pujol,,,,,, -10043,,13b1b478-ecf1-4bae-82de-51a309b82533,Clinical Evaluation Research Unit (CERU),clinical_evaluation_research_unit_ceru,,,,,, -10044,,99e178d2-72ed-11e6-a0cd-0242ac12000b,MICROBIX BIOSYSTEMS,microbix_biosystems,,,,,, -10045,,82779b2c-202e-43ab-8408-279fcf27ff80,Universitätsmedizin Mainz (vertreten durch den wissenschaftlichen Vorstand),universit_tsmedizin_mainz_vertreten_durch_den_wissenschaftlichen_vorstand,,,,,, -10046,,9b43c76e-7164-11e6-a0cd-0242ac12000b,ACTAVIS GRP PTC,actavis_grp_ptc,,,,,, -10047,,dc80c294-1e89-41ca-89fe-9d8fca9b8b16,"Medical University Graz, Department of Internal Medicine, Div. Endocrinology and Metabolism",medical_university_graz_department_of_internal_medicine_div_endocrinology_and_metabolism,,,,,, -10048,,f439d63d-669a-447d-a6fa-1c529a24aed5,PHARMATHEN S.A,pharmathen_s_a,,,,,, -10049,,af02c1b9-72b8-49a6-ae20-a751bedb1453,Royal Group of Hospitals Trust,royal_group_of_hospitals_trust,,,,,, -10050,,565294ab-6a8b-485a-9f14-481076123016,SOPHARMA PLC,sopharma_plc,,,,,, -10051,,4d1d848e-7147-11e6-a0cd-0242ac12000b,JACOBUS,jacobus,,,,,, -10052,,12e9e7d4-4e46-4cd3-a79d-ff1dfaa1e1d6,Janssen-Cilag Ltd,janssen_cilag_ltd,,,,,, -10053,,cc01e57f-fd8c-4fab-80bb-955a2b6ebee0,"ROXRO PHARMA, Inc",roxro_pharma_inc,,,,,, -10054,,16768a47-37f1-422b-886b-52457899fcaa,Norfolk and Norwich University Hospital NHS Trust,norfolk_and_norwich_university_hospital_nhs_trust,,,,,, -782,0.985647,fdadcf9b-7cbf-44bf-b227-c8bba5027b31,"Pfizer Corporation Austria Ges.m.b.H., Clinical Research",pfizer_corporation_austria_ges_m_b_h_clinical_research,,,,0b630147-5207-4370-96bb-646e858f6049,pfizer_corporation_austria_ges_m_b_h,Pfizer Corporation Austria Ges.m.b.H -288,0.91965407133102417,5a02f0f0-4b8e-4bcc-b5d9-2bda73ef9a30,"Pfizer Ltd,Ramsgate Road,Sandwich,Kent CT13 9NJ",pfizer_ltd_ramsgate_road_sandwich_kent_ct13_9nj,,,,5a02f0f0-4b8e-4bcc-b5d9-2bda73ef9a30,pfizer_ltd_ramsgate_road_sandwich_kent_ct13_9nj,"Pfizer Ltd,Ramsgate Road,Sandwich,Kent CT13 9NJ" -10055,,cb1518f8-7141-11e6-a0cd-0242ac12000b,SUN PHARM INDS (IN),sun_pharm_inds_in,,,,,, -10056,,a4aabf91-5065-43b4-b868-084a2b7d25fa,"University Hospital of Dermatology, Paracelsus Medical University",university_hospital_of_dermatology_paracelsus_medical_university,,,,,, -10057,,cb6f2042-7258-11e6-a0cd-0242ac12000b,JAZZ PHARMS INTL,jazz_pharms_intl,,,,,, -10058,,0460a697-5a66-4d5d-87cb-b76e4bf259e9,Royal Liverpool University Hospital Clinical Trials 4th floor Linda McCartney Centre,royal_liverpool_university_hospital_clinical_trials_4th_floor_linda_mccartney_centre,,,,,, -655,0.96628576517105103,db6bac4f-e8b7-4b13-b110-67f32f987610,Boehringer Ingelheim International GmbH,boehringer_ingelheim_international_gmbh,,,,a91f8817-005f-4251-808a-ee4efece990a,boehringer_ingelheim_inc,Boehringer Ingelheim Inc -10059,,4788c523-e671-41ba-a37f-5798e026e94d,"Medical University Vienna, Department of Medicine III",medical_university_vienna_department_of_medicine_iii,,,,,, -10060,,8521f468-4008-40f3-a297-24d00b42bc8f,IVAX Pharmaceuticals s.r.o,ivax_pharmaceuticals_s_r_o,,,,,, -10061,,e6255ac6-213f-4cbf-bae6-b5140a497f36,"Merck Corporation, Inc",merck_corporation_inc,,,,,, -1030,0.98681271076202393,d6f3ae13-7f2a-4d8f-a076-2b57239d38c0,"Medical University of Vienna, Department of Internal Medicine IV",medical_university_of_vienna_department_of_internal_medicine_iv,,,,525d2720-5b9f-47f1-b135-6c39bc8e2abf,medical_university_of_vienna_department_of_internal_medicine_ii,"Medical University of Vienna, Department of Internal Medicine II" -10062,,580ea217-20cf-483e-8d26-b00d2eb8a89f,Dr.Gerardo Aguilar Dr.Francisco Martí Hospital Clínico de Valencia Ser. Anestesiología y Reanimación,dr_gerardo_aguilar_dr_francisco_mart_hospital_cl_nico_de_valencia_ser_anestesiolog_a_y_reanimaci_n,,,,,, -10063,,a7f375b6-d551-4484-b004-4b88a6f5aec4,Diagram B.V,diagram_b_v,,,,,, -10064,,e82d36bf-445c-4cb1-b11c-fedb4952117c,"University Hospital Freiburg, represented by the Executive Medical Director (LÄD)",university_hospital_freiburg_represented_by_the_executive_medical_director_l_d,,,,,, -148,0.977699,a3c7b078-642d-4dfa-bfc9-34dd103124ed,"Nuvelo, Inc",nuvelo_inc,,,,a3c7b078-642d-4dfa-bfc9-34dd103124ed,nuvelo_inc,"Nuvelo, Inc" -10065,,261cca47-b158-4a1d-ac89-34d4a21635ca,"Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München",klinik_f_r_herz_und_kreislauferkrankungen_deutsches_herzzentrum_m_nchen,,,,,, -10066,,58914bbe-73f1-11e6-a0cd-0242ac12000b,AIR PRODUCTS AND CHEMICALS INC,air_products_and_chemicals_inc,,,,,, -10067,,2955b565-d1cc-495b-9cca-2c9cd40db19f,CHRU de Lille,chru_de_lille,,,,,, -10068,,d2700898-7154-11e6-a0cd-0242ac12000b,HAEMONETICS,haemonetics,,,,,, -10069,,4ad823ac-42e6-4bc6-b8bd-d0d7ec80790e,C.U.B ERASME HOSPITAL,c_u_b_erasme_hospital,,,,,, -10070,,df61583c-2567-4afc-969f-fe28d4b91dc2,AbbVie Farmacéutica S.L.U,abbvie_farmac_utica_s_l_u,,,,,, -10071,,89480c4e-6a10-43d6-96b5-c69ee2a1619f,CHEMI S.P.A,chemi_s_p_a,,,,,, -10072,,2ebd14ad-4578-44fb-9154-d3d74adaac24,EpiCept Corporation,epicept_corporation,,,,,, -10073,,8e721e44-1ef9-408d-b16e-29ec26b200c2,"Group for the Study of Resistant Depression (GSRD), Head: Prof. Julien Mendlewicz",group_for_the_study_of_resistant_depression_gsrd_head_prof_julien_mendlewicz,,,,,, -10074,,f1a60ffb-485a-419d-ba33-d923eb57dde9,"Clinical Research office, Faculty of Medicine, Imperial College London",clinical_research_office_faculty_of_medicine_imperial_college_london,,,,,, -10075,,bc4cad3a-68e0-4d05-b6ea-89b0653f11a6,Doctor Pere Domingo,doctor_pere_domingo,,,,,, -10076,,b9b15ec9-1874-4f2d-9547-69d83036308d,Psioxus Therapeutics Limited,psioxus_therapeutics_limited,,,,,, -10077,,0ff0f85a-7379-11e6-a0cd-0242ac12000b,ROSS LABS,ross_labs,,,,,, -10078,,b274df96-7269-4450-a0cf-dae183cac063,FUNDACIÓN INVESTIGACIÓN BIOMEDICA DEL HOSPITAL CLINICO SAN CARLOS,fundaci_n_investigaci_n_biomedica_del_hospital_clinico_san_carlos,,,,,, -10079,,4fd8ed7c-7146-11e6-a0cd-0242ac12000b,ARMSTRONG PHARMS,armstrong_pharms,,,,,, -10080,,2a0814e6-61f7-4c27-91ff-72027301223f,Pediatrics,pediatrics,,,,,, -542,0.985178,f737f443-0a5d-4e9c-bf82-73abc35c1591,"Skåne University Hospital, Region Skåne",sk_ne_university_hospital_region_sk_ne,,,,6ac48511-e29b-45d9-a99a-d067f972f24e,sk_ne_university_hospital,Skåne University Hospital -10081,,89967321-3905-4f79-bf87-0070c189a9a8,TAKEDA EUROPE RESEARCH DEVELOPMENT CENTRE LTD,takeda_europe_research_development_centre_ltd,,,,,, -10082,,6e91ec72-6158-41f2-b9a4-f0b20f9e3938,Pfizer Health AB,pfizer_health_ab,,,,,, -1014,0.9886435866355896,659a4aa2-7f2f-4ed8-918a-4c0718e095e4,Institut de Recherches Internationales Servier,institut_de_recherches_internationales_servier,,,,9b368f8e-02db-4935-a1a6-f2a417efa7ee,institut_de_recherches_internationales_servier,Institut de Recherches Internationales Servier -347,0.98146516084671021,c87289ab-105a-4af8-9f77-3834c61e7738,Medizinische Universität Wien Universitätsklinik für Innere Medizin III,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_iii,,,,71cd8e41-b876-47b3-8b6f-d8c4063fa62c,medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_iii_rheumatologie,"Medizinische Universität Wien, Universitätsklinik für Innere Medizin III/Rheumatologie" -10083,,cd5596eb-1bf3-4d7d-845f-8eb5aac9dbb8,Biofrontera Bioscience GmbH,biofrontera_bioscience_gmbh,,,,,, -10084,,5c261c57-65b9-46e3-987c-427e7c18ac23,SERONO INTERNATIONAL SA,serono_international_sa,,,,,, -10085,,c79a18ac-7157-11e6-a0cd-0242ac12000b,PRECISION DOSE,precision_dose,,,,,, -10086,,5c23a278-7161-11e6-a0cd-0242ac12000b,NUMARK,numark,,,,,, -229,0.985968,561e61dc-6283-4645-bc8b-b9c9b73b81df,The National Institute of Allergy and Infectious Diseases (NIAID),the_national_institute_of_allergy_and_infectious_diseases_niaid,,,,458254a2-d310-4f72-a0ef-d961ef0c56e4,the_national_institute_of_allergy_and_infectious_diseases_niaid_and_the_eunice_kennedy_shriver_nichd,The National Institute of Allergy and Infectious Diseases (NIAID) And The Eunice Kennedy Shriver NICHD -931,0.95429873466491699,ee1d91c1-0d9e-47fa-b4e7-22a6f46f9512,Pierre Fabre Dermatologie represented by the Institut de Recherche Pierre Fabre (IRPF),pierre_fabre_dermatologie_represented_by_the_institut_de_recherche_pierre_fabre_irpf,,,,ee1d91c1-0d9e-47fa-b4e7-22a6f46f9512,pierre_fabre_dermatologie_represented_by_institut_de_recherche_pierre_fabre,Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre -1066,0.919718,7fc76cbf-40fd-40a1-bb0f-7c003ab4ea5a,Universitätsklinikum Tuebingen,universit_tsklinikum_tuebingen,,,,36b27479-ba79-4094-93f3-0a7496de4aec,universit_tsklinikum_t_bingen,Universitätsklinikum Tübingen -10087,,d5efd4a7-6f1a-42b9-83c1-8abada3b3703,LEO Pharma A/S,leo_pharma_a_s,,,,,, -10088,,0250778f-ba8c-4812-b959-c2f82b224312,Società Italian di Cardiologia Invasiva GISE,societ_italian_di_cardiologia_invasiva_gise,,,,,, -10089,,5d3d3fa4-6fa2-11e6-9663-0242ac12000b,Forschergruppe Diabetes e. V,forschergruppe_diabetes_e_v,,,,,, -10090,,7bc00e2d-bb9f-4155-aedf-1721ab52eab6,"SGX Pharmaceuticals, Inc",sgx_pharmaceuticals_inc,,,,,, -215,0.983343,4e062918-7206-11e6-a0cd-0242ac12000b,LEO PHARM,leo_pharm,,,,138e388c-71e0-11e6-a0cd-0242ac12000b,leo_pharma_as,LEO PHARMA AS -472,0.983628,df7a54fe-5a24-418d-b267-24c04fc18922,"Rigshospitalet, Copenhagen University Hospital",rigshospitalet_copenhagen_university_hospital,,,,77d74083-7ff5-4dec-88ac-be73492f43ab,rigshospitalet_copenhagen,"Rigshospitalet, Copenhagen" -10091,,008ae81b-1f3d-4674-a5ca-7d616813b953,"Takeda Vaccines, Inc",takeda_vaccines_inc,,,,,, -10092,,908f869e-5f75-4b26-845a-0c9a9e3b07a2,GEIS,geis,,,,,, -10093,,17c51b4c-db01-40d3-8c51-840a442eddee,Ospedale San Raffaele s.r.l,ospedale_san_raffaele_s_r_l,,,,,, -10094,,b741c0b0-fced-4f96-9bf8-8272801d34d5,Amgen Ltd,amgen_ltd,,,,,, -10095,,490cae12-f7fa-448f-af27-03c107a61234,"Dr GED DEMPSEY, University Hospital Aintree",dr_ged_dempsey_university_hospital_aintree,,,,,, -10096,,1c13ab46-d344-48d5-8bd7-558fa9be71b8,EISAI INC,eisai_inc,,,,,, -10097,,7352e427-6389-489f-bcea-4a0b4887e854,Masaryk University,masaryk_university,,,,,, -10098,,34cc737b-5ae6-4508-a0f7-c5b82ff2c44d,"Imperial College, Research Governance Manager",imperial_college_research_governance_manager,,,,,, -10099,,74392463-96a7-45bc-81e2-8784387c73b9,AZIENDA UNIVERSITARIA OSPEDALE POLICLINICO UMBERTO I,azienda_universitaria_ospedale_policlinico_umberto_i,,,,,, -10100,,62ce3cb6-3c39-4507-95c4-a01e3305dfc8,"Dept. of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital",dept_of_endocrinology_metabolism_and_diabetes_karolinska_university_hospital,,,,,, -10101,,d45bd2f0-71cb-11e6-a0cd-0242ac12000b,UNIV AZ CANCER CTR,univ_az_cancer_ctr,,,,,, -10102,,39317cd7-1798-433d-be84-f5232165af52,Sepracor NV in care of Sepracor Inc,sepracor_nv_in_care_of_sepracor_inc,,,,,, -10103,,68df16e2-0f07-4904-912e-5cd23c494e63,"Ambrx, Inc., USA",ambrx_inc_usa,,,,,, -10104,,491e2bd6-7129-11e6-a89e-0242ac12000b,RHODES PHARMS,rhodes_pharms,,,,,, -735,0.98422527313232422,31be07a8-192d-4b34-981f-bf106aeff976,European Organization for Research and Treatment of Cancer (EORTC),european_organization_for_research_and_treatment_of_cancer_eortc,,,,6e92b00d-0791-4d8e-975c-0fbd5ce95861,european_organisation_for_research_and_treatment_of_cancer,European Organisation for Research and Treatment of Cancer -937,0.975369,79097abc-72e1-11e6-a0cd-0242ac12000b,CUBIST PHARMS,cubist_pharms,,,,2ff28a2a-72bf-11e6-a0cd-0242ac12000b,cubist,CUBIST -10105,,32440aa2-7bb8-4c55-9aa7-3751c9ce8be4,Pfizer Inc - 235 East 42nd Street - New York - 10017,pfizer_inc_235_east_42nd_street_new_york_10017,,,,,, -10106,,cbb5503c-8754-4a37-8bd5-9e90e5da3e56,DermaTools Biotech GmbH,dermatools_biotech_gmbh,,,,,, -10107,,67234f74-ae1b-4dad-9318-f8e54aa2d701,Helsingin Diakonissalaitos,helsingin_diakonissalaitos,,,,,, -10108,,6f92667f-3022-455f-9953-070893e46362,NicOx S.A,nicox_s_a,,,,,, -10109,,c1f669a0-4aa5-4b3c-949f-ad27c139e5d2,Xenikos BV,xenikos_bv,,,,,, -10110,,bc7f2d30-791e-4ae4-b8cf-ab06543f172a,Fundación para la Investigación Biomédica del Hospital Clínico San Carlos,fundaci_n_para_la_investigaci_n_biom_dica_del_hospital_cl_nico_san_carlos,,,,,, -250,0.95617127418518066,7cdbb89e-7aec-4433-a865-e63e0ce3d9d8,NMDSG,nmdsg,,,,5071919f-1373-4a28-b00e-8112a8b47ef4,nmdsg_nordic_myelodysplastic_syndrom_group,NMDSG Nordic Myelodysplastic Syndrom Group -10111,,fa4604dd-c8d9-441e-85c0-8324409f6e69,Vestfold Hospital,vestfold_hospital,,,,,, -10112,,445e9711-1c79-480d-97cb-56a85ca90a8b,HEXAL AG (Project Management on behalf of the Sponsor: HEXAL Pharmaforschung GmbH,hexal_ag_project_management_on_behalf_of_the_sponsor_hexal_pharmaforschung_gmbh,,,,,, -10113,,19bd88cc-ede6-4c0f-a2d2-1a8647b5f56e,Rode Kruis Ziekenhuis,rode_kruis_ziekenhuis,,,,,, -10114,,92418278-4c31-474a-bb2b-7b83eb54e5bb,Universitaetsklinikum Muenster,universitaetsklinikum_muenster,,,,,, -10115,,3a3bc7d8-c7f2-4f22-a975-6457b904290e,Celerion,celerion,,,,,, -10116,,61a541e4-95e8-4551-afbb-fecc8dfe1728,"LOTUS PHARMACEUTICAL CO., LTD",lotus_pharmaceutical_co_ltd,,,,,, -10117,,a187a682-71ae-11e6-a0cd-0242ac12000b,RORER,rorer,,,,,, -10118,,1fb63f1a-f9fa-426a-93df-7ff2d8fe060c,Dr. Juan Macías Sánchez,dr_juan_mac_as_s_nchez,,,,,, -10119,,4d60f160-6ed5-428c-b11b-0b07d231b6c3,Gesellschaft für Medizinische Innovation –Hämatologie und Onkologie mbH (GMIHO),gesellschaft_f_r_medizinische_innovation_h_matologie_und_onkologie_mbh_gmiho,,,,,, -10120,,612647ea-7142-11e6-a0cd-0242ac12000b,KING PFIZER,king_pfizer,,,,,, -10121,,4b880a0e-a344-4e98-abce-1c5466e2d6dd,Bayer Inc,bayer_inc,,,,,, -10122,,745dc5b1-ad84-41f5-81c9-6acf098edce8,Pharmacia & Upjohn S.A,pharmacia_upjohn_s_a,,,,,, -10123,,a2d8db21-bb5d-439c-a20a-5d5ce9368e22,"HUS, Lasten ja nuorten sairaala",hus_lasten_ja_nuorten_sairaala,,,,,, -10124,,7fbcd71c-7deb-4c5d-a3a2-d1b3af5e1bf8,National Kapodistrian University of Athens,national_kapodistrian_university_of_athens,,,,,, -10125,,15b79ea4-8ed0-493c-a6a3-99678dc855fc,Otto-von-Guericke Universität Magdeburg,otto_von_guericke_universit_t_magdeburg,,,,,, -10126,,4025e5c6-2450-4502-96ab-c65547a09f16,FARMACUSI S.A. (filial of LEO Pharma),farmacusi_s_a_filial_of_leo_pharma,,,,,, -10127,,af0b84cc-a658-47d5-9a72-35b1d96457c0,Istituto Oncologico Veneto – IOV‐IRCCS,istituto_oncologico_veneto_iov_irccs,,,,,, -10128,,674b4dd3-636d-4604-ade5-b5f5b297da83,"Dicerna Pharmaceuticals, Inc",dicerna_pharmaceuticals_inc,,,,,, -10129,,e944266f-9175-48d6-8374-9a539429b7ac,Agensys Inc,agensys_inc,,,,,, -10130,,ef50cff1-1eb4-4858-8ae4-a146e603b496,Sint Maartenskliniek,sint_maartenskliniek,,,,,, -383,0.98719912767410278,8cc2488d-6698-4a3c-8f87-631bed226148,DBV Technologies,dbv_technologies,,,,cf4f2be5-6c16-4774-80da-73c264a99c4c,dbv_technologies,DBV Technologies -10131,,5f629479-bb48-491f-82fe-ce94df0a5b9a,Oslo Universitetssykehus,oslo_universitetssykehus,,,,,, -10132,,258f9d1d-961c-4bcd-bc04-0469ba64c58a,"MUW, Universitätsklinik für Innere Medizin I, Abteilung für Infektionskrankheiten und Tropenmedizin",muw_universit_tsklinik_f_r_innere_medizin_i_abteilung_f_r_infektionskrankheiten_und_tropenmedizin,,,,,, -10133,,0296eae0-aa16-4acc-9ed8-f01df305e7b7,The Heartbeat Trust,the_heartbeat_trust,,,,,, -10134,,c6cfd422-7d49-48b5-aec2-fee5d5db2d5b,HENNIG ARZNEIMITTEL GmbH & Co. KG,hennig_arzneimittel_gmbh_co_kg,,,,,, -232,0.98418444395065308,455b5028-7142-11e6-a0cd-0242ac12000b,ACS DOBFAR,acs_dobfar,,,,455b5028-7142-11e6-a0cd-0242ac12000b,acs_dobfar,ACS DOBFAR -10135,,381f83fb-d620-43c9-895d-9f7daa6d7f35,Wirral Hospitals NHS Trust,wirral_hospitals_nhs_trust,,,,,, -10136,,52a162e6-7146-11e6-a0cd-0242ac12000b,ALVOGEN MALTA,alvogen_malta,,,,,, diff --git a/processors/base/helpers/data/organisation_training_data.json b/processors/base/helpers/data/organisation_training_data.json new file mode 100644 index 0000000..e49fa55 --- /dev/null +++ b/processors/base/helpers/data/organisation_training_data.json @@ -0,0 +1 @@ +{"distinct": [{"__class__": "tuple", "__value__": [{"": null, "slug": "medizinische_universi_tsklinik_graz_abteilung_f_r_endokrinologie_und_nuklearmedizin", "name": "medizinische universiatsklinik graz, abteilung fur endokrinologie und nuklearmedizin", "id": "8c4a4e9b-08a9-4d26-b2f3-d4cdfea5b812"}, {"": null, "slug": "daniel_podzamczer_palter", "name": "daniel podzamczer palter", "id": "1dc11f6f-51cc-4072-9340-b3162a901b0e"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "fundaci_privada_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau", "name": "fundacio privada institut de recerca de l?hospital de la santa creu i sant pau", "id": "53d727ca-f81e-4c5b-a9a5-c177cdd19cfc"}, {"": null, "slug": "fundaci_n_rafael_clavijo", "name": "fundacion rafael clavijo", "id": "ec61c25d-94a2-4de5-81e3-053faf6f0b45"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "grupo_de_investigaci_n_en_oncolog_a_m_dica_del_hospital_de_navarra", "name": "grupo de investigacion en oncologia medica del hospital de navarra", "id": "a3680e89-7dd3-4d52-a8ba-ff9fdb0ccd95"}, {"": null, "slug": "grupo_de_investigaci_n_icp", "name": "grupo de investigacion icp", "id": "1e5ee90f-1ea0-4828-93fe-b586d6ca11f5"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "gw_pharma_ltd", "name": "gw pharma ltd", "id": "1077a33f-5b3d-4671-b7c9-b644328302f5"}, {"": null, "slug": "johnson_johnson_consumer_personal_products_worldwide_division_of_johnson_johnson_consumer_companies_inc", "name": "johnson & johnson consumer & personal products worldwide, division of johnson & johnson consumer companies, inc", "id": "5beb59d6-f94c-4993-90c5-181d33404f39"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "fundacion_geltamo", "name": "fundacion geltamo", "id": "69723627-6f25-4050-892b-176403ef72f0"}, {"": null, "slug": "fundacion_para_la_investigacion_biomedica_hospital_universitario_12_de_octubre", "name": "fundacion para la investigacion biomedica hospital universitario 12 de octubre", "id": "c86fa310-e3d1-4bf7-be4a-c9fed815a879"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "veroscience", "name": "veroscience", "id": "0eafade6-7235-11e6-a0cd-0242ac12000b"}, {"": null, "slug": "dr_jordi_montero_homs_unidad_de_neuromuscular_servicio_de_neurolog_a_hospital_universitario_de_bellvitge", "name": "dr. jordi montero homs- unidad de neuromuscular- servicio de neurologia- hospital universitario de bellvitge", "id": "f843ee57-e570-4103-8f35-53147204de68"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "centre_hospitalier_universiaire_de_nantes", "name": "centre hospitalier universiaire de nantes", "id": "10962173-23c6-4151-812d-ef214f40e09d"}, {"": null, "slug": "centre_hospitalier_universiatire_de_lille", "name": "centre hospitalier universiatire de lille", "id": "49d3d6c3-a234-47dc-ae63-13bfa871ac17"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "medizinische_universit_t_wien_klinische_abteilung_f_r_nephrologie_und_dialyse_universit_tsklinik_f_r_innere_medizin_3", "name": "medizinische universitat wien, klinische abteilung fur nephrologie und dialyse, universitatsklinik fur innere medizin 3", "id": "0e706737-525b-47af-863b-c9b8ecf5a50a"}, {"": null, "slug": "biomarin", "name": "biomarin", "id": "37341944-6d19-4843-a80d-f568e4d60ef1"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "paracelsus_mediznische_privatuniversit_t_universit_tsklinik_f_r_an_sthesiologie_perioperative_medizin_und_intensiv", "name": "paracelsus mediznische privatuniversitat, universitatsklinik fur anasthesiologie, perioperative medizin und intensiv", "id": "4e443485-3308-4c89-8a73-35e50e9f1312"}, {"": null, "slug": "par_pharm_inc", "name": "par pharm inc", "id": "9b7df138-7145-11e6-a0cd-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "stiefel_laboratories_maidenhead_limited_trading_as_stiefel_international_research_and_development", "name": "stiefel laboratories (maidenhead) limited trading as stiefel international research and development", "id": "4925dd87-94e0-4336-8ccf-fddd64ff23f5"}, {"": null, "slug": "alphapharm", "name": "alphapharm", "id": "c7a57ddc-7157-11e6-a0cd-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "johnson_johnson_consumer_and_personal_products_worldwide", "name": "johnson & johnson consumer and personal products worldwide", "id": "e934c5bf-3608-458b-bfd8-e77726c3dbd2"}, {"": null, "slug": "john_pernow", "name": "john pernow", "id": "cbe41c4b-8a59-4bb4-90f8-b229d2f63fbe"}]}], "match": [{"__class__": "tuple", "__value__": [{"": null, "slug": "schering_plough_research_institute_a_division_of_schering_corporation_for_global_trials", "name": "schering-plough research institute, a division of schering corporation - for global trials", "id": "bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f"}, {"": null, "slug": "schering_plough_research_institute_a_division_of_schering_corporation", "name": "schering-plough research institute, a division of schering corporation", "id": "396cf7e8-b821-4caf-9fc9-ab2366cd9a70"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "novartis_farmaceutica", "name": "novartis farmaceutica", "id": "07d428a0-cf4e-4f85-9961-fc028370360e"}, {"": null, "slug": "novartis_farmac_utica", "name": "novartis farmaceutica", "id": "bcb0e637-6442-4916-88f9-8cd0d5df3534"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "aziende_chimiche_riunite_angelini_francesco_s_p_a", "name": "aziende chimiche riunite angelini francesco s.p.a", "id": "6f406dab-5805-481d-943e-14127b65646b"}, {"": null, "slug": "aziende_chimiche_riunite_angelini_francesco_acraf_s_p_a", "name": "aziende chimiche riunite angelini francesco - acraf s.p.a", "id": "5809dce0-1c57-445d-9068-5b5bffdd2080"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_hereafter_referred_to_as", "name": "merck sharp & dohme corp., a subsidiary of merck & co., inc. (hereafter referred to as", "id": "bb464dd5-4611-4d24-89d1-e672f490e048"}, {"": null, "slug": "merck_sharp_dohme_corp_filial_de_merck_co_inc", "name": "merck sharp & dohme corp., filial de merck & co., inc", "id": "bd6bee50-086c-45b4-9e8c-06da513d3e0f"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "jassen_cilag_international_nv_turnhoutseweg_30_2340_beerse_belgium", "name": "jassen-cilag international nv,turnhoutseweg 30, 2340 beerse, belgium", "id": "3baabec0-1bc8-4e64-b010-70f6fcb400f2"}, {"": null, "slug": "janssen_cilag_international_n_v_turnhoutseweg_30_b_2340_beerse_belgium", "name": "janssen-cilag international n.v., turnhoutseweg 30, b-2340 beerse, belgium", "id": "347ebbdb-d7ca-4b86-86e4-66cae5ee0b3e"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "merck_serono_sa_geneva_an_affiliate_of_merck_kgaa_darmstadt", "name": "merck serono sa-geneva an affiliate of merck kgaa, darmstadt", "id": "70106b82-01e3-445a-8dce-1f56c59a7634"}, {"": null, "slug": "merck_serono_international_an_affiliate_of_merck_kgaa_darmstadt_germany", "name": "merck serono international, an affiliate of merck kgaa, darmstadt, germany", "id": "a6666551-9aec-4601-bdf4-602aed6bff0a"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "cnio_centro_nacional_de_investigaciones_oncol_gicas", "name": "cnio - centro nacional de investigaciones oncologicas", "id": "99adf7b7-3b0e-45a5-a316-9fa44a8101e6"}, {"": null, "slug": "fundaci_n_centro_nacional_de_investigaciones_oncol_gicas_carlos_iii_cnio", "name": "fundacion centro nacional de investigaciones oncologicas carlos iii (cnio)", "id": "86e0dbc2-353a-4853-90df-f26a640c72ca"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "astra_zeneca_ab", "name": "astra zeneca ab", "id": "c60ff36b-1ab3-4bf3-959b-ba6ff632b9b5"}, {"": null, "slug": "astrazeneca", "name": "astrazeneca", "id": "5cabde38-2e50-4a9e-b161-b9d60f252062"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "hull_east_yorkshire_hospitals_nhs_trust", "name": "hull & east yorkshire hospitals nhs trust", "id": "c96eb057-b329-44bb-8410-db9d73b6f265"}, {"": null, "slug": "hull_and_east_yorkshire_hospitals_trust", "name": "hull and east yorkshire hospitals trust", "id": "2484bf94-1589-4af7-a881-77e0aae0ece2"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "ab_science", "name": "ab science", "id": "7cfa3175-349c-4787-bab9-8dcdea518756"}, {"": null, "slug": "abscience", "name": "abscience", "id": "ee60a64b-ed90-4582-84b7-ea2799b249bf"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "baxter_ag", "name": "baxter ag", "id": "47c7d188-d907-4b05-a397-3a7a0bc319c9"}, {"": null, "slug": "baxter_hlthcare", "name": "baxter hlthcare", "id": "73bd77f0-7126-11e6-8a77-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "sanofi_aventis_recherche_and_developpement", "name": "sanofi-aventis recherche and developpement", "id": "13f8f9a1-3670-4e48-995a-2bd18c63fa12"}, {"": null, "slug": "sanofi_aventis_s_a", "name": "sanofi-aventis, s.a", "id": "1b2392d1-ec1e-4b35-8aa1-a17e48fba664"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "pfizer_inc_235_east_42nd_street_new_york_ny10017_us", "name": "pfizer inc 235 east 42nd street, new york, ny10017 us", "id": "7db1aec7-f10a-44e5-a315-0e3766e79d16"}, {"": null, "slug": "pfizer_inc_235_east_42nd_street_new_york_new_york_10017", "name": "pfizer inc, 235 east 42nd street, new york, new york 10017", "id": "bbb58274-b96a-4b86-89c9-899c1d1a7717"}]}]} \ No newline at end of file diff --git a/processors/base/processors/trial.py b/processors/base/processors/trial.py index 73a5703..19eedf6 100644 --- a/processors/base/processors/trial.py +++ b/processors/base/processors/trial.py @@ -5,6 +5,8 @@ from __future__ import unicode_literals import logging +import os +import json from .. import helpers from .. import writers logger = logging.getLogger(__name__) @@ -12,6 +14,8 @@ # Module API +TRAINING_FILE = os.path.join(os.path.dirname(__file__), '../organisation_cluster.json') + def process_trials(conn, table, extractors): """Translate trial records from warehouse to database. @@ -29,10 +33,7 @@ def process_trials(conn, table, extractors): errors = 0 success = 0 - stored_organisations = list(conn['database']['organisations'].all()) - stored_organisation_names = [entry['name'] for entry in stored_organisations] - - organisation_clusters = helpers.get_organisation_clusters(stored_organisations) + helpers.compute_organisation_clusters(conn) for record in helpers.iter_rows(conn, 'warehouse', table, orderby='meta_id'): @@ -106,10 +107,8 @@ def process_trials(conn, table, extractors): # Extract and write organisations/relationships organisations = extractors['extract_organisations'](record) for organisation in organisations: - if organisation['name'] in stored_organisation_names: - organisation['name'] = helpers.normalize_organisation_name( - organisation['name'], organisation_clusters) - org_id = writers.write_organisation(conn, organisation, source_id) + org_id = writers.write_organisation(conn, helpers.normalize_organisation_name( + conn, organisation['name']), source_id) if org_id is None: continue writers.write_trial_relationship( From 28d491d68fa985d26c68864d8a5269553a36088e Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Wed, 1 Feb 2017 16:36:49 -0300 Subject: [PATCH 03/23] Update organisations clustering training file --- .../base/helpers/data/organisation_training_data.json | 2 +- processors/base/processors/trial.py | 8 ++++++-- 2 files changed, 7 insertions(+), 3 deletions(-) diff --git a/processors/base/helpers/data/organisation_training_data.json b/processors/base/helpers/data/organisation_training_data.json index e49fa55..bc1bcda 100644 --- a/processors/base/helpers/data/organisation_training_data.json +++ b/processors/base/helpers/data/organisation_training_data.json @@ -1 +1 @@ -{"distinct": [{"__class__": "tuple", "__value__": [{"": null, "slug": "medizinische_universi_tsklinik_graz_abteilung_f_r_endokrinologie_und_nuklearmedizin", "name": "medizinische universiatsklinik graz, abteilung fur endokrinologie und nuklearmedizin", "id": "8c4a4e9b-08a9-4d26-b2f3-d4cdfea5b812"}, {"": null, "slug": "daniel_podzamczer_palter", "name": "daniel podzamczer palter", "id": "1dc11f6f-51cc-4072-9340-b3162a901b0e"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "fundaci_privada_institut_de_recerca_de_l_hospital_de_la_santa_creu_i_sant_pau", "name": "fundacio privada institut de recerca de l?hospital de la santa creu i sant pau", "id": "53d727ca-f81e-4c5b-a9a5-c177cdd19cfc"}, {"": null, "slug": "fundaci_n_rafael_clavijo", "name": "fundacion rafael clavijo", "id": "ec61c25d-94a2-4de5-81e3-053faf6f0b45"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "grupo_de_investigaci_n_en_oncolog_a_m_dica_del_hospital_de_navarra", "name": "grupo de investigacion en oncologia medica del hospital de navarra", "id": "a3680e89-7dd3-4d52-a8ba-ff9fdb0ccd95"}, {"": null, "slug": "grupo_de_investigaci_n_icp", "name": "grupo de investigacion icp", "id": "1e5ee90f-1ea0-4828-93fe-b586d6ca11f5"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "gw_pharma_ltd", "name": "gw pharma ltd", "id": "1077a33f-5b3d-4671-b7c9-b644328302f5"}, {"": null, "slug": "johnson_johnson_consumer_personal_products_worldwide_division_of_johnson_johnson_consumer_companies_inc", "name": "johnson & johnson consumer & personal products worldwide, division of johnson & johnson consumer companies, inc", "id": "5beb59d6-f94c-4993-90c5-181d33404f39"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "fundacion_geltamo", "name": "fundacion geltamo", "id": "69723627-6f25-4050-892b-176403ef72f0"}, {"": null, "slug": "fundacion_para_la_investigacion_biomedica_hospital_universitario_12_de_octubre", "name": "fundacion para la investigacion biomedica hospital universitario 12 de octubre", "id": "c86fa310-e3d1-4bf7-be4a-c9fed815a879"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "veroscience", "name": "veroscience", "id": "0eafade6-7235-11e6-a0cd-0242ac12000b"}, {"": null, "slug": "dr_jordi_montero_homs_unidad_de_neuromuscular_servicio_de_neurolog_a_hospital_universitario_de_bellvitge", "name": "dr. jordi montero homs- unidad de neuromuscular- servicio de neurologia- hospital universitario de bellvitge", "id": "f843ee57-e570-4103-8f35-53147204de68"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "centre_hospitalier_universiaire_de_nantes", "name": "centre hospitalier universiaire de nantes", "id": "10962173-23c6-4151-812d-ef214f40e09d"}, {"": null, "slug": "centre_hospitalier_universiatire_de_lille", "name": "centre hospitalier universiatire de lille", "id": "49d3d6c3-a234-47dc-ae63-13bfa871ac17"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "medizinische_universit_t_wien_klinische_abteilung_f_r_nephrologie_und_dialyse_universit_tsklinik_f_r_innere_medizin_3", "name": "medizinische universitat wien, klinische abteilung fur nephrologie und dialyse, universitatsklinik fur innere medizin 3", "id": "0e706737-525b-47af-863b-c9b8ecf5a50a"}, {"": null, "slug": "biomarin", "name": "biomarin", "id": "37341944-6d19-4843-a80d-f568e4d60ef1"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "paracelsus_mediznische_privatuniversit_t_universit_tsklinik_f_r_an_sthesiologie_perioperative_medizin_und_intensiv", "name": "paracelsus mediznische privatuniversitat, universitatsklinik fur anasthesiologie, perioperative medizin und intensiv", "id": "4e443485-3308-4c89-8a73-35e50e9f1312"}, {"": null, "slug": "par_pharm_inc", "name": "par pharm inc", "id": "9b7df138-7145-11e6-a0cd-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "stiefel_laboratories_maidenhead_limited_trading_as_stiefel_international_research_and_development", "name": "stiefel laboratories (maidenhead) limited trading as stiefel international research and development", "id": "4925dd87-94e0-4336-8ccf-fddd64ff23f5"}, {"": null, "slug": "alphapharm", "name": "alphapharm", "id": "c7a57ddc-7157-11e6-a0cd-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "johnson_johnson_consumer_and_personal_products_worldwide", "name": "johnson & johnson consumer and personal products worldwide", "id": "e934c5bf-3608-458b-bfd8-e77726c3dbd2"}, {"": null, "slug": "john_pernow", "name": "john pernow", "id": "cbe41c4b-8a59-4bb4-90f8-b229d2f63fbe"}]}], "match": [{"__class__": "tuple", "__value__": [{"": null, "slug": "schering_plough_research_institute_a_division_of_schering_corporation_for_global_trials", "name": "schering-plough research institute, a division of schering corporation - for global trials", "id": "bcc5bd19-eed0-4d2a-9cc4-3ef3c63ef60f"}, {"": null, "slug": "schering_plough_research_institute_a_division_of_schering_corporation", "name": "schering-plough research institute, a division of schering corporation", "id": "396cf7e8-b821-4caf-9fc9-ab2366cd9a70"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "novartis_farmaceutica", "name": "novartis farmaceutica", "id": "07d428a0-cf4e-4f85-9961-fc028370360e"}, {"": null, "slug": "novartis_farmac_utica", "name": "novartis farmaceutica", "id": "bcb0e637-6442-4916-88f9-8cd0d5df3534"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "aziende_chimiche_riunite_angelini_francesco_s_p_a", "name": "aziende chimiche riunite angelini francesco s.p.a", "id": "6f406dab-5805-481d-943e-14127b65646b"}, {"": null, "slug": "aziende_chimiche_riunite_angelini_francesco_acraf_s_p_a", "name": "aziende chimiche riunite angelini francesco - acraf s.p.a", "id": "5809dce0-1c57-445d-9068-5b5bffdd2080"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_hereafter_referred_to_as", "name": "merck sharp & dohme corp., a subsidiary of merck & co., inc. (hereafter referred to as", "id": "bb464dd5-4611-4d24-89d1-e672f490e048"}, {"": null, "slug": "merck_sharp_dohme_corp_filial_de_merck_co_inc", "name": "merck sharp & dohme corp., filial de merck & co., inc", "id": "bd6bee50-086c-45b4-9e8c-06da513d3e0f"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "jassen_cilag_international_nv_turnhoutseweg_30_2340_beerse_belgium", "name": "jassen-cilag international nv,turnhoutseweg 30, 2340 beerse, belgium", "id": "3baabec0-1bc8-4e64-b010-70f6fcb400f2"}, {"": null, "slug": "janssen_cilag_international_n_v_turnhoutseweg_30_b_2340_beerse_belgium", "name": "janssen-cilag international n.v., turnhoutseweg 30, b-2340 beerse, belgium", "id": "347ebbdb-d7ca-4b86-86e4-66cae5ee0b3e"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "merck_serono_sa_geneva_an_affiliate_of_merck_kgaa_darmstadt", "name": "merck serono sa-geneva an affiliate of merck kgaa, darmstadt", "id": "70106b82-01e3-445a-8dce-1f56c59a7634"}, {"": null, "slug": "merck_serono_international_an_affiliate_of_merck_kgaa_darmstadt_germany", "name": "merck serono international, an affiliate of merck kgaa, darmstadt, germany", "id": "a6666551-9aec-4601-bdf4-602aed6bff0a"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "cnio_centro_nacional_de_investigaciones_oncol_gicas", "name": "cnio - centro nacional de investigaciones oncologicas", "id": "99adf7b7-3b0e-45a5-a316-9fa44a8101e6"}, {"": null, "slug": "fundaci_n_centro_nacional_de_investigaciones_oncol_gicas_carlos_iii_cnio", "name": "fundacion centro nacional de investigaciones oncologicas carlos iii (cnio)", "id": "86e0dbc2-353a-4853-90df-f26a640c72ca"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "astra_zeneca_ab", "name": "astra zeneca ab", "id": "c60ff36b-1ab3-4bf3-959b-ba6ff632b9b5"}, {"": null, "slug": "astrazeneca", "name": "astrazeneca", "id": "5cabde38-2e50-4a9e-b161-b9d60f252062"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "hull_east_yorkshire_hospitals_nhs_trust", "name": "hull & east yorkshire hospitals nhs trust", "id": "c96eb057-b329-44bb-8410-db9d73b6f265"}, {"": null, "slug": "hull_and_east_yorkshire_hospitals_trust", "name": "hull and east yorkshire hospitals trust", "id": "2484bf94-1589-4af7-a881-77e0aae0ece2"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "ab_science", "name": "ab science", "id": "7cfa3175-349c-4787-bab9-8dcdea518756"}, {"": null, "slug": "abscience", "name": "abscience", "id": "ee60a64b-ed90-4582-84b7-ea2799b249bf"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "baxter_ag", "name": "baxter ag", "id": "47c7d188-d907-4b05-a397-3a7a0bc319c9"}, {"": null, "slug": "baxter_hlthcare", "name": "baxter hlthcare", "id": "73bd77f0-7126-11e6-8a77-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "sanofi_aventis_recherche_and_developpement", "name": "sanofi-aventis recherche and developpement", "id": "13f8f9a1-3670-4e48-995a-2bd18c63fa12"}, {"": null, "slug": "sanofi_aventis_s_a", "name": "sanofi-aventis, s.a", "id": "1b2392d1-ec1e-4b35-8aa1-a17e48fba664"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "pfizer_inc_235_east_42nd_street_new_york_ny10017_us", "name": "pfizer inc 235 east 42nd street, new york, ny10017 us", "id": "7db1aec7-f10a-44e5-a315-0e3766e79d16"}, {"": null, "slug": "pfizer_inc_235_east_42nd_street_new_york_new_york_10017", "name": "pfizer inc, 235 east 42nd street, new york, new york 10017", "id": "bbb58274-b96a-4b86-89c9-899c1d1a7717"}]}]} \ No newline at end of file +{"distinct": [{"__class__": "tuple", "__value__": [{"": null, "slug": "vejle_hospital", "name": "vejle hospital", "id": "acbce76f-4566-4480-b1d9-e6b09b7c9c66"}, {"": null, "slug": "abteilung_f_r_an_sthesie_intensiv_und_schmerzmedizin_wilhelminenspital_der_stadt_wien", "name": "abteilung fur anasthesie, intensiv- und schmerzmedizin, wilhelminenspital der stadt wien", "id": "603c1f5a-38fa-4ebd-a4a3-34994a98c4bb"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "rgshospitalet", "name": "rgshospitalet", "id": "bbc263d9-ca8f-4fa8-9eee-c55046b5a00e"}, {"": null, "slug": "rikshospitalet", "name": "rikshospitalet", "id": "95284310-8707-4697-ae32-b0baf209234a"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "cog", "name": "cog", "id": "fb22fcd9-6e10-46ca-8c5b-e91fa89c9ccc"}, {"": null, "slug": "the_clinical_research_centre_rcsi_education_and_research_centre", "name": "the clinical research centre, rcsi education and research centre", "id": "ed85ec10-7b68-4063-93ee-367e4172a8fe"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "cantacuzino_national_institute_of_research_and_development_for_microbiology_and_immunology", "name": "cantacuzino national institute of research and development for microbiology and immunology", "id": "a4fd4f24-7255-4175-b9ce-916dba0f9161"}, {"": null, "slug": "artbc", "name": "artbc", "id": "e33662f6-111c-484e-90c7-dd4c29665375"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "takeda_belgium", "name": "takeda belgium", "id": "1f95d3ff-53af-4aec-b4a9-44685de7e6c6"}, {"": null, "slug": "karolinska_institutet_department_of_laboratory_medicine_clinical_physiology_c1_82_karolinska_univ_hosp_huddinge", "name": "karolinska institutet, department of laboratory medicine, clinical physiology c1:82,karolinska univ. hosp., huddinge", "id": "a6ac3ddb-4262-4bc0-b724-41727d6e68a1"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "department_of_medicine_i_university_hospital_st_josef_hospital_ruhr_university_bochum", "name": "department of medicine i, university hospital st. josef-hospital, ruhr university bochum", "id": "32f14029-d2e7-4b3b-8e79-6951ae0e26ce"}, {"": null, "slug": "finox_ag", "name": "finox ag", "id": "3f4da7a9-e745-4bc1-9384-dee2274a2ab8"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "university_of_turku", "name": "university of turku", "id": "90b1b931-4335-4914-a8b7-154e9a2ec266"}, {"": null, "slug": "university_of_hertfordshire", "name": "university of hertfordshire", "id": "69fd2257-0edd-41e9-87ce-db4a5c3e5144"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "servier_research_and_development_ictr_for_united_kingdom_only", "name": "servier research and development ictr (for united kingdom only)", "id": "510e1e01-3c6b-4beb-a646-bda21b3c8013"}, {"": null, "slug": "service_desk", "name": "service desk", "id": "4bc8802c-5b07-4c6d-a4db-f2edd0f68d85"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "nhs_greater_glasgow_and_clyde", "name": "nhs greater glasgow and clyde", "id": "046d6658-d5b1-4caa-8e4b-a52c60c09ffd"}, {"": null, "slug": "greater_glasgow_and_clyde", "name": "greater glasgow and clyde", "id": "613c1a9b-76b3-42ee-8979-2c8d31737f57"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "molteni", "name": "molteni", "id": "382a6dc5-0d89-4add-a86a-3f320c9289fd"}, {"": null, "slug": "medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_3_abteilung_f_r_gastroenterologie_und_hepatologie", "name": "medizinische universitat wien, universitatsklinik fur innere medizin 3, abteilung fur gastroenterologie und hepatologie", "id": "22dcd280-772d-451a-a261-cbef7a27c26c"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "university_of_essen", "name": "university of essen", "id": "b134ac14-8681-4bbc-a87d-4c4a479265ce"}, {"": null, "slug": "university_of_cincinnati_academic_medical_center_department_of_neurology", "name": "university of cincinnati - academic medical center -department of neurology", "id": "9559be98-7795-4a89-99c5-91e471ca09c8"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "servicio_de_cirug_a_general_y_digestiva_hospital_universitario_de_bellvitge", "name": "servicio de cirugia general y digestiva hospital universitario de bellvitge", "id": "262e70eb-f592-4b5f-8e06-12a5152ab7c9"}, {"": null, "slug": "gercor", "name": "gercor", "id": "f1d7cb83-6a05-46a3-b6bc-98e6330b2e8c"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "universit_tsklinikum_aachen", "name": "universitatsklinikum aachen", "id": "499f6fb9-3fb0-465d-9455-f34cddb4fc9b"}, {"": null, "slug": "universit_tsklinikum_freiburg_vertreten_durch_den_leitenden_rztlichen_direktor", "name": "universitatsklinikum freiburg, vertreten durch den leitenden arztlichen direktor", "id": "b92d234b-0791-4116-8b8e-f8276b862029"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "odense_university_hospital_department_m", "name": "odense university hospital, department m", "id": "d0aeb96f-5b11-4b42-816d-69232a6b5d89"}, {"": null, "slug": "aarhus_university_hospital_department_m", "name": "aarhus university hospital, department m", "id": "8256073c-6fbe-11e6-abe8-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "cambridge_university_hospitals_nhs_foundation_trust_addenbrooke_s_hospital", "name": "cambridge university hospitals nhs foundation trust, addenbrooke's hospital", "id": "e9951d7b-ee02-4804-aca2-6e2b99549974"}, {"": null, "slug": "camall", "name": "camall", "id": "9c050f54-7160-11e6-a0cd-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "amneal_pharms_co", "name": "amneal pharms co", "id": "2ebc30fa-7145-11e6-a0cd-0242ac12000b"}, {"": null, "slug": "amneal_pharms_ny", "name": "amneal pharms ny", "id": "eee857cc-7141-11e6-a0cd-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "institution_of_paediatric_anaesthesia_and_intensiv_care_astrid_lindgren_childrens_hospital_karolin", "name": "institution of paediatric anaesthesia and intensiv care, astrid lindgren childrens hospital, karolin", "id": "48024dc3-3391-43e7-9f84-ffd02e53a977"}, {"": null, "slug": "scs", "name": "scs", "id": "e1b1c73c-7146-11e6-a0cd-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "hospital_universitari_de_bellvitge_idibell", "name": "hospital universitari de bellvitge - idibell", "id": "302c2638-8bd6-11e6-a449-0242ac12000b"}, {"": null, "slug": "hospira", "name": "hospira", "id": "2c899cf4-2f23-4023-b9ab-f8d5356588d9"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "pharmamar_sau", "name": "pharmamar sau", "id": "a81bbb65-9b77-48ec-9afc-97b008ea886e"}, {"": null, "slug": "pharma_mar_sa_unipersonal", "name": "pharma mar sa unipersonal", "id": "90979692-2a94-4a4b-9c9c-f6c047edea3e"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "sanofi_aventis_ag", "name": "sanofi-aventis ag", "id": "21db6c72-5da2-4c64-b673-432321c1b314"}, {"": null, "slug": "de`veloppement", "name": "sanofi-aventis recherche &", "id": "c783b132-b299-4872-bd1f-6e8e14938814"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "anrs", "name": "anrs", "id": "e944e7a9-f50b-4f25-bcf5-7daefb39030b"}, {"": null, "slug": "klinikum_der_universit_t_m_nchen_kinderklinik_und_poliklinik_im_dr_von_haunersches_kinderspital", "name": "klinikum der universitat munchen, kinderklinik und poliklinik im dr. von haunersches kinderspital", "id": "f6959636-eb34-484b-8514-f49f9e548af3"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "university_hospital_ulm", "name": "university hospital ulm", "id": "1cf1b0d8-2fa0-4d08-a1a9-ef176b6a1973"}, {"": null, "slug": "university_hospital_erlangen", "name": "university hospital erlangen", "id": "58384182-25d9-414e-8817-b3450bdd9f86"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "imperial_college_london_joint_research_compliance_office", "name": "imperial college london, joint research compliance office", "id": "9a928883-62f4-40e8-bf1e-c36ca297350b"}, {"": null, "slug": "imperial_ciollege", "name": "imperial ciollege", "id": "8433852c-4927-4c6a-a156-dce63bfd0815"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "akh_wien_klinik_f_r_innere_medizin_i_onkologie", "name": "akh wien, klinik fur innere medizin i, onkologie", "id": "1eec3f23-406c-471b-948a-24dcf52e62a1"}, {"": null, "slug": "akh_linz", "name": "akh linz", "id": "ce11fc95-3d22-4c28-94dc-35be2d9f6091"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "universit_tsklinik_f_r_zahn_mund_und_kieferheilkunde_med_uni_graz_department_f_r_zahn_rztliche_chirurgie", "name": "universitatsklinik fur zahn-, mund- und kieferheilkunde, med uni graz, department fur zahnarztliche chirurgie", "id": "b152d898-42dc-4921-9c80-8b64e81118a9"}, {"": null, "slug": "cerepp", "name": "cerepp", "id": "bcb33d21-b979-4fbd-8657-abd096c96ec6"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "merck_serono_sa_geneva_an_affiliate_of_merck_kgaa_darmstadt_germany", "name": "merck serono sa - geneva, an affiliate of merck kgaa, darmstadt, germany", "id": "7e7f14c2-9ede-49fa-aa4c-1c3644b22daf"}, {"": null, "slug": "taro", "name": "taro", "id": "019c34b0-7129-11e6-a89e-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "icin", "name": "icin", "id": "9bec9948-4662-436f-9fe4-9c3aef6c4ffc"}, {"": null, "slug": "university_of_oslo_faculty_of_medicine_institute_of_health_and_society", "name": "university of oslo, faculty of medicine, institute of health and society", "id": "5b3734a2-82e2-4c16-9c4d-66d561ed0d51"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "solvay", "name": "solvay", "id": "e6e76398-715e-11e6-a0cd-0242ac12000b"}, {"": null, "slug": "universit_tsklinik_f_r_psychiatrie_und_psychotherapie_klin_abteilung_f_biologische_psychiatrie", "name": "universitatsklinik fur psychiatrie und psychotherapie, klin. abteilung f. biologische psychiatrie", "id": "3ab32bf7-811c-42fa-8337-eb49e15069f8"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "medizinische_universit_t_wien_abteilung_f_r_allgemeine_an_sthesie_und_intensivmedizin", "name": "medizinische universitat wien, abteilung fur allgemeine anasthesie und intensivmedizin", "id": "dbb52f33-a8fc-4aa5-b128-948fe7582742"}, {"": null, "slug": "alza", "name": "alza", "id": "a81351d0-71a0-11e6-a0cd-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "azienda_ospedaliera_senese", "name": "azienda ospedaliera senese", "id": "42587571-741a-4e64-b485-4deee66c414c"}, {"": null, "slug": "azienda_ospedaliera_san_paolo", "name": "azienda ospedaliera san paolo", "id": "63bac87d-d6a3-4be4-9eef-4efa52f0c0a5"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "jazz", "name": "jazz", "id": "85d2f332-7335-11e6-a0cd-0242ac12000b"}, {"": null, "slug": "kompetenznetz_vorhofflimmern_e_v_atrial_fibrillation_competence_network_afnet_e_v", "name": "kompetenznetz vorhofflimmern e.v. [atrial fibrillation competence network (afnet) e.v.]", "id": "fc21ea5c-d162-46f5-bd49-bedac7f5851d"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "gcllsg_dept_of_internal_medicine_i_university_hospital_cologne", "name": "gcllsg - dept. of internal medicine i, university hospital cologne", "id": "23e32f33-64c2-48d7-98ad-bda4e558f1cc"}, {"": null, "slug": "oys", "name": "oys", "id": "c8194b0b-d077-4ec6-bae6-5e27ea8ba8c4"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "nopho", "name": "nopho", "id": "57164cff-6f3b-448f-a2a2-cb44b3def10b"}, {"": null, "slug": "pr_giampiero_campanelli_universit_di_milano_dipartimento_di_scienze_chirurgiche_ospedale_maggior", "name": "pr giampiero campanelli universita di milano, dipartimento di scienze chirurgiche, ospedale maggior", "id": "566f2525-88ca-4ad9-a985-788e49f4240e"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "trigen", "name": "trigen", "id": "b12f961f-65f0-45b2-bb50-b17bc54604b1"}, {"": null, "slug": "trius_therapeutics_a_wholly_owned_subsidiary_of_cubist", "name": "trius therapeutics, a wholly owned subsidiary of cubist", "id": "2313c489-596d-4d80-8c94-aa42d3a2f015"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "centre_hospitalier_intercommunal_de_toulon_la_seyne_sur_mer", "name": "centre hospitalier intercommunal de toulon - la seyne sur mer", "id": "7eb33d6a-b44c-48d4-8dcd-f18317ecdcc3"}, {"": null, "slug": "wendt", "name": "wendt", "id": "0186bc10-7161-11e6-a0cd-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "universit_tsklinikum_heidelberg", "name": "universitatsklinikum heidelberg", "id": "a5592bcf-b2a9-4eef-87b4-32f428e1cd67"}, {"": null, "slug": "klinik und poliklinik fur psychiatrie und psychotherapie", "name": "universitatsklinikum bonn", "id": "db0cf76f-03db-4f45-95e7-853b95e8ea9b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "eortc_european_organisation_for_the_research_and_treatment_of_cancer", "name": "eortc-european organisation for the research and treatment of cancer", "id": "e41b5c84-e4f0-430d-a8dd-ca88bfb595c4"}, {"": null, "slug": "solti", "name": "solti", "id": "cd03b2c6-847a-491f-8428-3060750c8336"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "centre_hospitalier_universitaire_d_angers", "name": "centre hospitalier universitaire d'angers", "id": "025af88b-9529-4444-90b5-86481ce363f0"}, {"": null, "slug": "centre_hospitalier_universitaire_de_nancy", "name": "centre hospitalier universitaire de nancy", "id": "e37ff462-7351-402c-828d-d17f23d6fa72"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "medizinische_universit_t_innsbruck_universit_tsklinik_f_r_innere_medizin_i", "name": "medizinische universitat innsbruck, universitatsklinik fur innere medizin i", "id": "12e2a808-1753-47e6-920b-91e744004e00"}, {"": null, "slug": "medizinische_universit_t_wien_universit_tsklinik_f_r_innere_medizin_3_abteilung_f_r_gastroenterologie_und_hepatologie", "name": "medizinische universitat wien, universitatsklinik fur innere medizin 3, abteilung fur gastroenterologie und hepatologie", "id": "22dcd280-772d-451a-a261-cbef7a27c26c"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "reade", "name": "reade", "id": "8288b4e1-f4a9-4fed-a996-813ec40471aa"}, {"": null, "slug": "merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_referred_to_as_merck", "name": "merck sharp & dohme corp., a subsidiary of merck & co., inc. (referred to as merck)", "id": "98ff4a8d-9011-429f-9c2f-4eef1084cbc6"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "laboratoires_merck_sharp_dohme_chibret", "name": "laboratoires merck sharp & dohme - chibret", "id": "e12cc357-91a1-4ab2-b87c-8a5b71225095"}, {"": null, "slug": "laboratoires_iprad", "name": "laboratoires iprad", "id": "040a1a3b-306a-4a08-be78-b178e1d033da"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "university_of_p_cs", "name": "university of pecs", "id": "af3ad0cf-6349-4c9b-9761-a57815b4f7c5"}, {"": null, "slug": "university_of_plymouth", "name": "university of plymouth", "id": "468a4598-0f63-4c9e-a9fe-9e53d5416109"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "amgen_s_a", "name": "amgen s.a", "id": "2fc05d7c-54ee-45c1-a844-bc160cb92e68"}, {"": null, "slug": "amgen_inc_one_amgen_center_drive_thousand_oaks_california_91320", "name": "amgen, inc. one amgen center drive thousand oaks, california 91320", "id": "75d02ed4-527a-4c3a-83a0-e15e97fc7866"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "free_state_of_bavaria_represented_by_the_university_of_regensburg_represented_by_prof_edward_k_geissler", "name": "free state of bavaria, represented by the university of regensburg, represented by prof. edward k. geissler", "id": "3d6ade49-c992-4715-9594-000bd02e5eb1"}, {"": null, "slug": "futurum", "name": "futurum", "id": "399faf0c-52c9-4ee0-9025-873e502aab24"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "fundaci_n_para_la_investigaci_n_biom_dica_hospital_gregorio_mara_n", "name": "fundacion para la investigacion biomedica hospital gregorio maranon", "id": "fafbf14a-7edf-4f4d-a87f-703785475b5c"}, {"": null, "slug": "fundacion_pethema", "name": "fundacion pethema", "id": "d7afcd5b-0be6-4039-a08b-52e26e0f5e64"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "cnic", "name": "cnic", "id": "13d37a6e-a22f-454d-8c96-519556903e54"}, {"": null, "slug": "professor_hans_erik_johnsen_md_dmsc_department_of_haematology_aalborg_hospital", "name": "professor hans erik johnsen, md, dmsc, department of haematology, aalborg hospital", "id": "7e791d01-4f46-4ceb-abb6-a5863262e615"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "university_of_oslo_institute_for_basic_medical_sciences_department_of_nutrition", "name": "university of oslo, institute for basic medical sciences, department of nutrition", "id": "d400ed48-6133-4340-94ec-e93df8540486"}, {"": null, "slug": "university_of_surrey", "name": "university of surrey", "id": "f1549a9a-52e0-4629-86bc-c853a0a91aa7"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "universit_tsklinik_f_r_innere_medizin_iii_klinische_abteilung_f_r_rheumatologie_medizinische_universit_t_wien", "name": "universitatsklinik fur innere medizin iii, klinische abteilung fur rheumatologie, medizinische universitat wien", "id": "daf847ac-432d-4bf6-a247-4298f0fa9e13"}, {"": null, "slug": "universit_tsklinkum_erlangen", "name": "universitatsklinkum erlangen", "id": "ffcd68a4-22bd-48b7-b48b-e5bbb42c4c31"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "aesrx", "name": "aesrx", "id": "7ff80805-62e2-4470-b0b0-87440be5e547"}, {"": null, "slug": "gel_tamo_cooperative_spanish_group_of_lymphoma_autologous_bone_marrow_transplant", "name": "gel/tamo (cooperative spanish group of lymphoma/autologous bone marrow transplant)", "id": "74823312-7a82-4064-89ef-0e812f9d60d3"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "vu_university_medical_centre", "name": "vu university medical centre", "id": "d24a8fcd-b259-45c2-8a36-5604474c370e"}, {"": null, "slug": "university_medical_centre_st_radboud_department_of_dermatology", "name": "university medical centre st. radboud, department of dermatology", "id": "3bbe38b9-b3f4-4d58-811e-8dba91c20f92"}]}], "match": [{"__class__": "tuple", "__value__": [{"": null, "slug": "novartis_farmaceutica", "name": "novartis farmaceutica", "id": "07d428a0-cf4e-4f85-9961-fc028370360e"}, {"": null, "slug": "novartis_farmac_utica", "name": "novartis farmaceutica", "id": "bcb0e637-6442-4916-88f9-8cd0d5df3534"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "merck_serono_international_a_branch_of_laboratories_serono_s_a", "name": "merck serono international, a branch of laboratories serono s.a", "id": "1a03f05f-1e23-469f-adc4-6156f3bc81aa"}, {"": null, "slug": "merck_serono_international_a_branch_of_laboratoires_serono_s_a", "name": "merck serono international, a branch of laboratoires serono s.a", "id": "9516dca0-e67e-443e-ae03-feeb289be70c"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "glaxosmithkline_a_e_b_e", "name": "glaxosmithkline a.e.b.e", "id": "11145a7d-a298-4cf6-ae4b-46d2af4892d4"}, {"": null, "slug": "glaxosmithkline_ab", "name": "glaxosmithkline ab", "id": "2df0fbc6-3b70-46ef-bfe4-035678c0f668"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "fidia_farmaceutici_spa", "name": "fidia farmaceutici spa", "id": "6e29d46e-fef6-4308-b00f-34243d2810ee"}, {"": null, "slug": "fidia_farmaceutici_s_p_a", "name": "fidia farmaceutici s.p.a", "id": "75ca420a-d39f-494a-9c9a-098d855b7ff7"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "pfizer_inc_east_42nd_street_new_york_ny10017_usa", "name": "pfizer inc, east 42nd street, new york, ny10017, usa", "id": "1efa9e61-6090-40bb-8daa-1ea7310830f4"}, {"": null, "slug": "pfizer_inc_235_east_42nd_street_new_york_ny10017", "name": "pfizer inc 235 east 42nd street, new york, ny10017", "id": "dbdc03f8-f997-4242-91be-566d7f5870a5"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "fundaci_n_para_la_investigaci_n_biomedica_del_hospital_12_de_octubre", "name": "fundacion para la investigacion biomedica del hospital 12 de octubre", "id": "cf84194a-b23a-4b1f-87a1-24b1fdec7e48"}, {"": null, "slug": "fundacion_para_la_investigacion_biomedica_hospital_universitario_12_de_octubre", "name": "fundacion para la investigacion biomedica hospital universitario 12 de octubre", "id": "c86fa310-e3d1-4bf7-be4a-c9fed815a879"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "medizinische_universit_t_wien_abteilung_f_r_allgemeine_an_sthesie_und_intensivmedizin", "name": "medizinische universitat wien, abteilung fur allgemeine anasthesie und intensivmedizin", "id": "dbb52f33-a8fc-4aa5-b128-948fe7582742"}, {"": null, "slug": "medizinische_universit_t_wien_abteilung_f_r_interne_medizin_i", "name": "medizinische universitat wien, abteilung fur interne medizin i", "id": "1de8b2fe-fdec-4fc9-be80-679c9ac33ce2"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "johnson_johnson_pharmaceutical_research_and_development_l_l_c", "name": "johnson & johnson pharmaceutical research and development, l.l.c", "id": "5e39e1cf-f761-4acc-bd2c-247647d86e60"}, {"": null, "slug": "johnson_and_johnson_pharmaceutical_research_and_development_una_divisi_n_de_janssen_cilag_s_a", "name": "johnson and johnson pharmaceutical research and development, una division de janssen-cilag, s.a", "id": "e6d2bf79-88b5-4e40-aa2b-a36c8a77b81d"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "fondazione_michelangelo_onlus_avanzamento_dello_studio_e_cura_dei_tumori", "name": "fondazione michelangelo onlus - avanzamento dello studio e cura dei tumori", "id": "dc1c972c-880f-11e6-a998-0242ac12000b"}, {"": null, "slug": "fondazione_michelangelo_avanzamento_dello_studio_e_della_cura_dei_tumori", "name": "fondazione michelangelo - avanzamento dello studio e della cura dei tumori", "id": "886dbcfd-131f-4dde-b49f-376738e72b32"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "radboud_university_medical_center", "name": "radboud university medical center", "id": "e0a9ebe2-090f-4317-bf41-30ea0e2e6a42"}, {"": null, "slug": "radboud_umc", "name": "radboud umc", "id": "97f181b3-9ad4-48ad-a41d-0342ef33b8c0"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "institut_de_recherches_internationales_servier", "name": "institut de recherches internationales servier", "id": "659a4aa2-7f2f-4ed8-918a-4c0718e095e4"}, {"": null, "slug": "i_r_i_s_institut_de_recherches_internationales_servier", "name": "i.r.i.s. institut de recherches internationales servier", "id": "7d798544-5e49-4b24-899f-fbc24edba20c"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "fachbereich_medizin_der_johann_wolfgang_goethe_universit_t_frankfurt_m", "name": "fachbereich medizin der johann wolfgang goethe-universitat frankfurt/m", "id": "505ca89c-289a-4ce1-a562-196a014465a2"}, {"": null, "slug": "dekan_des_fachbereichs_medizin_der_johann_wolfgang_goethe_universit_t_frankfurt_m", "name": "dekan des fachbereichs medizin der johann wolfgang goethe-universitat frankfurt/m", "id": "75bd6ca6-1cd0-449d-b2ee-2c5c83df2d75"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "pfizer_inc_235_east_42nd_streeet_new_york_ny_10017", "name": "pfizer inc., 235 east 42nd streeet, new york, ny 10017", "id": "0068e377-8873-41b9-baad-e3768b77d0b1"}, {"": null, "slug": "pfizer_inc_235_east_42nd_street_new_york_city_ny_10017", "name": "pfizer inc, 235 east 42nd street, new york city, ny 10017", "id": "dae5bd5c-6fa0-11e6-9663-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "sanofi_aventis_recherche_development", "name": "sanofi-aventis recherche & development", "id": "a935e55e-be0e-40d6-a84b-6d0e74a97880"}, {"": null, "slug": "sanofi_aventis_recherche_d2veloppement", "name": "sanofi-aventis recherche & d2veloppement", "id": "9c45d693-515d-4149-92e4-d7272d06a7df"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_research_development", "name": "wyeth research division of wyeth pharmaceuticals, inc. clinical research & development", "id": "1d53dcae-9b86-416e-9d92-a62412245dcc"}, {"": null, "slug": "wyeth_research_division_of_wyeth_pharmaceuticals_inc_clinical_reserach_and_development", "name": "wyeth research division of wyeth pharmaceuticals inc., clinical reserach and development", "id": "fe20c8b4-bfb0-4cfc-96be-52e8cd5c61f0"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "dainippon_sumitomo_pharma_america_inc", "name": "dainippon sumitomo pharma america, inc", "id": "df03d0e3-1345-473c-8400-e5dc3e505b99"}, {"": null, "slug": "dainippon_sumitomo_pharma_america_ltd", "name": "dainippon sumitomo pharma america ltd", "id": "dc11babf-a704-11e6-94cb-5656d04fc2b5"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "institut_de_recherches_internationales_servier_i_r_i_s", "name": "institut de recherches internationales servier (i.r.i.s)", "id": "8811d706-c986-44c5-bf01-3f0b35984b6c"}, {"": null, "slug": "institut_de_recherches_internationales_servier_iris", "name": "institut de recherches internationales servier ( iris )", "id": "9b368f8e-02db-4935-a1a6-f2a417efa7ee"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "cardiff_univeristy", "name": "cardiff univeristy", "id": "191a4121-096e-489f-bb60-9d9e340fdcf0"}, {"": null, "slug": "cardiff_university", "name": "cardiff university", "id": "d4686322-3206-4d52-8c13-30229e1d5dc5"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "merck_sharp_dohme_a_subsidiary_of_merck_co_inc", "name": "merck sharp & dohme a subsidiary of merck co., inc", "id": "62f4aae4-7c29-4485-a3bc-17345b365f76"}, {"": null, "slug": "merck_sharp_dohme_corp_a_subsidiary_of_merck_co_inc_n_j_usa", "name": "merck sharp & dohme corp., a subsidiary of merck & co., inc., n.j., usa", "id": "f262b660-2330-429c-8af0-63e5c4fec4b0"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "hull_and_east_yorkshire_nhs_hospital_trust", "name": "hull and east yorkshire nhs hospital trust", "id": "16f70329-dafd-4428-bec6-483f539f52fc"}, {"": null, "slug": "hull_and_east_yorkshire_hospitals_trust", "name": "hull and east yorkshire hospitals trust", "id": "2484bf94-1589-4af7-a881-77e0aae0ece2"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "university_hospital_grenoble", "name": "university hospital grenoble", "id": "55dc3af9-da50-4614-bdeb-59aef351101b"}, {"": null, "slug": "universityhospitalgrenoble", "name": "universityhospitalgrenoble", "id": "d9724382-7654-4ba8-baea-764670d9fe39"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "grupo_espa_ol_de_c_ncer_de_pulm_n", "name": "grupo espanol de cancer de pulmon", "id": "1a0b54ee-3c90-4fb0-a495-d2c36bae4a70"}, {"": null, "slug": "gecp_grupo_espa_ol_de_cancer_de_pulm_n", "name": "gecp(grupo espanol de cancer de pulmon)", "id": "fdeaddfd-d3eb-4620-879e-c7a5ebe251c5"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "pharma_mar_sa", "name": "pharma mar sa", "id": "5821cf6c-5e8a-481f-8ff8-3198a9183cea"}, {"": null, "slug": "pharma_mar_s_a", "name": "pharma mar, s.a", "id": "a004a205-f221-4197-83bd-138ffb93fce0"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "pfizer_limited_ramsgate_road_sandwich_kent_uk_ct13_9nj", "name": "pfizer limited, ramsgate road, sandwich, kent. uk. ct13 9nj", "id": "0ef4ae4f-e284-42c3-b72f-5c46cc59f3e2"}, {"": null, "slug": "pfizer_limited_ramsgate_road_sandwich_kent_ct13_9nj", "name": "pfizer limited, ramsgate road,sandwich,kent ct13 9nj", "id": "3438eb84-9448-480b-915c-1c1511546785"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "vu_univeristy_medical_centre", "name": "vu univeristy medical centre", "id": "b1e7a97f-3f72-43f4-a8f1-ab6902f55179"}, {"": null, "slug": "vu_university_medical_center", "name": "vu university medical center", "id": "a7bf6b0c-2367-49c7-ae4b-7cc850909a14"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "hull_and_east_yorkshire_hospitals_trust_research_and_deveopment_admin_porta_cabin", "name": "hull and east yorkshire hospitals trust, research and deveopment, admin porta cabin", "id": "8b4343ec-fb2f-4fb9-aa9f-044d60e28926"}, {"": null, "slug": "hull_and_east_yorkshire_nhs_trust", "name": "hull and east yorkshire nhs trust", "id": "595e80c5-ebc1-44d4-a496-00b180fea87e"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "hamilton_health_sciences_through_the_population_health_research_institute", "name": "hamilton health sciences through the population health research institute", "id": "ceecdbd1-b90f-4146-83b5-e987dcb62f70"}, {"": null, "slug": "hamilton_health_sciences_corporation_through_its_population_health_research_institute", "name": "hamilton health sciences corporation through its population health research institute", "id": "4ba23efe-04ef-4a5c-853f-235d35ab9a66"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "tolerx_inc", "name": "tolerx, inc", "id": "95db6177-b882-4aa7-8f44-d56c146461cf"}, {"": null, "slug": "tolerrx_inc", "name": "tolerrx, inc", "id": "496acb41-295a-43ee-9136-4d1fef65e2b7"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "domp_s_p_a", "name": "dompe s.p.a", "id": "ca2b02cc-8821-4f3e-899e-69c84148e0c9"}, {"": null, "slug": "dompe_s_p_a", "name": "dompe` s.p.a", "id": "e000d975-f1c4-48db-a8e3-8d6923c66a71"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "boehringer_ingelheim_pharma_ellas_ae", "name": "boehringer ingelheim pharma ellas ae", "id": "55ebc98a-6f9f-11e6-9663-0242ac12000b"}, {"": null, "slug": "boehringer_ingelheim_gmbh", "name": "boehringer ingelheim gmbh", "id": "b8695dd5-485c-422c-8f91-460057752ca2"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "pfizer_ltd_ramsgate_road_sandwich_kent_ct13_9nj", "name": "pfizer ltd,ramsgate road,sandwich,kent ct13 9nj", "id": "5a02f0f0-4b8e-4bcc-b5d9-2bda73ef9a30"}, {"": null, "slug": "pfizer_ltd_ramsgate_road_sandwich_kent_ct13_9nj_uk", "name": "pfizer ltd. ramsgate road, sandwich, kent, ct13 9nj, uk", "id": "773e090f-d432-4405-870d-7cc6cc5ee44e"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "charit_unversit_tsmedizin_berlin", "name": "charite - unversitatsmedizin berlin", "id": "ae7adb7b-c45f-4298-be68-d5dcaa36ea65"}, {"": null, "slug": "charite_universitaetsmedizin_berlin", "name": "charite universitaetsmedizin berlin", "id": "9cc141c9-55dc-4b03-84cc-245b7d5f45e4"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "bial_portela_c_sa", "name": "bial - portela & ca, sa", "id": "5ac2130a-6fbe-11e6-abe8-0242ac12000b"}, {"": null, "slug": "bial_portela_ca_sa", "name": "bial-portela & ca, sa", "id": "e0538c80-0c8f-415a-a43f-f3466054daf1"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "servicio_nefrologia_hospital_bellvitge", "name": "servicio nefrologia hospital bellvitge", "id": "a28cf75f-8b5e-45d6-8a74-cbd575537b0c"}, {"": null, "slug": "servicio_nefrolog_a_hospital_universitario_de_bellvitge", "name": "servicio nefrologia hospital universitario de bellvitge", "id": "90a15d23-27ae-4e52-be99-fc5f7027b6a6"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "bayer_hlthcare", "name": "bayer hlthcare", "id": "72fd5b3a-7191-11e6-a0cd-0242ac12000b"}, {"": null, "slug": "bayer_healthcare", "name": "bayer healthcare", "id": "e8216e75-b447-4252-bb49-7b895bcf4108"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "merck_serono_sa_geneva_an_affiliate_of_merck_kgaa", "name": "merck serono sa - geneva, an affiliate of merck kgaa,", "id": "64386d51-a811-451e-9352-45afeb68a88e"}, {"": null, "slug": "merck_serono_s_p_a", "name": "merck serono s.p.a", "id": "65a74622-52a5-44aa-b68a-4a0614c78010"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "pfizer_inc_235_east_42nd_road_new_york_ny_10017", "name": "pfizer inc., 235 east 42nd road, new york, ny 10017", "id": "93f242c4-1ea8-41a4-962a-cb4b07c428b5"}, {"": null, "slug": "pfizer_inc_235_east_42nd_street_new_york_ny10017_united_states", "name": "pfizer inc, 235 east 42nd street, new york, ny10017, united states", "id": "70a57a39-1462-4239-a163-1968d0d1a9d3"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "boehringer_ingelheim_noway_ks", "name": "boehringer ingelheim noway ks", "id": "1a23c45f-2c11-4e5d-a222-082def03ebc8"}, {"": null, "slug": "boehringer_ingelheim_lda", "name": "boehringer ingelheim, lda", "id": "e35f2092-3b29-4dad-b641-6df7bf1da76d"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "accord_healthcare_ltd", "name": "accord healthcare ltd", "id": "7555d4a5-8b3d-4db8-83d3-5482d0d01d4b"}, {"": null, "slug": "accord_hlthcare", "name": "accord hlthcare", "id": "dd277b94-7141-11e6-a0cd-0242ac12000b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "boehringer_ingelheim_pharma_gmbh", "name": "boehringer ingelheim pharma gmbh", "id": "5b57c8bd-158c-42a5-bfa1-3323c67e0dd4"}, {"": null, "slug": "boehringer_ingelheim_pharmaceuticals_espa_a_s_a", "name": "boehringer ingelheim pharmaceuticals, espana s.a", "id": "6a82526b-a3f0-4364-b600-bf5233259d47"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "azienda_ospedaliera_senese", "name": "azienda ospedaliera senese", "id": "42587571-741a-4e64-b485-4deee66c414c"}, {"": null, "slug": "azienda_ospedaliera_di_reggio_emilia_arcispedale_s_maria_nuova_irccs", "name": "azienda ospedaliera di reggio emilia arcispedale s.maria nuova/irccs", "id": "95d3949b-2d87-4a68-827e-a08fc3c39978"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "klinikum_der_universit_t_m_nchen_campus_gro_hadern", "name": "klinikum der universitat munchen, campus grosshadern", "id": "42f5b998-ad55-4220-a0e8-55df5cebc81e"}, {"": null, "slug": "klinikum_der_universit_t_m_nchen_gro_hadern", "name": "klinikum der universitat munchen-grosshadern", "id": "089e5628-bb66-4808-818a-a79770a11d54"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "academisch_medisch_centrum_amsterdam", "name": "academisch medisch centrum amsterdam", "id": "974a5c1d-8651-4bb8-8b78-cce4a6850f9c"}, {"": null, "slug": "academisch_medisch_centrum_bij_de_universiteit_van_amsterdam_amc", "name": "academisch medisch centrum bij de universiteit van amsterdam (amc)", "id": "fb80c762-68d3-4689-a142-20a1ee41e6b9"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "merck_kgaa", "name": "merck kgaa", "id": "eb4cc9e6-aaa6-49ad-995f-a9f72f3bdd5d"}, {"": null, "slug": "mmerck_kgaa", "name": "mmerck kgaa", "id": "f28855cb-d949-44f5-8cdb-8d84d1d4ae7f"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "radboudumc", "name": "radboudumc", "id": "cfa82bb6-a7bf-45c7-88d2-6bb1b02661d6"}, {"": null, "slug": "radboud_umc", "name": "radboud umc", "id": "97f181b3-9ad4-48ad-a41d-0342ef33b8c0"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "schering_plough_ce_ag_hungarian_commercial_representative_office", "name": "schering-plough ce ag hungarian commercial representative office", "id": "5a1cfc63-9a21-4db9-a032-f417843cde75"}, {"": null, "slug": "schering_plough_france", "name": "schering-plough france", "id": "c046e1d5-a486-499c-9d6b-8bfc6fd1eeab"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "pulmonary_dept_gentofte_hospital", "name": "pulmonary dept. gentofte hospital", "id": "75672ec9-4f1d-4f39-b0d6-1e3242c52b4f"}, {"": null, "slug": "pulmonary_department_gentofte_hospital", "name": "pulmonary department, gentofte hospital", "id": "85b86a82-e503-4329-88c6-ffdf7328e582"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "nv_organon", "name": "nv organon", "id": "898e1916-aef6-4174-8433-fdb4c05e9c66"}, {"": null, "slug": "n_v_organon", "name": "n v organon", "id": "e853f524-9e97-4579-b8a2-f8c29eca6e92"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "consorci_parc_de_salut_mar", "name": "consorci parc de salut mar", "id": "2e06635b-2945-406f-8fe4-e9afcb19c015"}, {"": null, "slug": "consorci_mar_parc_de_salut_barcelona", "name": "consorci mar parc de salut barcelona", "id": "1d7da9c7-3809-404d-969d-f58cb1e18e25"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "nycomed_us", "name": "nycomed us", "id": "d3bc30d2-72da-11e6-a0cd-0242ac12000b"}, {"": null, "slug": "nycomed_headquarter", "name": "nycomed (headquarter)", "id": "4b7e57a0-5ce0-4447-bcee-a2ee9bb76b6b"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "galderma_research_and_development", "name": "galderma research and development", "id": "7eeea4e4-efc7-45bf-bac7-82d54c1ae894"}, {"": null, "slug": "galderma_research_development_inc", "name": "galderma research & development inc", "id": "65bfdb33-6e94-44cb-98e5-4ec4d0ef60a9"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "the_all_ireland_cooperative_oncology_research_group_icorg", "name": "the all-ireland cooperative oncology research group (icorg)", "id": "47c20cb7-42aa-40d6-b307-102844c8fedb"}, {"": null, "slug": "icorg_all_ireland_cooperative_oncology_research_group", "name": "icorg, all-ireland cooperative oncology research group", "id": "5e33332a-5eab-46e0-84d6-df15c6f32cd7"}]}, {"__class__": "tuple", "__value__": [{"": null, "slug": "pfizer_inc_235_east_42nd_streeet_new_york_ny_10017", "name": "pfizer inc., 235 east 42nd streeet, new york, ny 10017", "id": "0068e377-8873-41b9-baad-e3768b77d0b1"}, {"": null, "slug": "pfizer_inc_235_east_42nd_street_new_york_new_york_10017_usa", "name": "pfizer inc, 235 east 42nd street, new york, new york 10017, usa", "id": "83f77026-9bf3-42d7-bdf1-59a5d35a6b9b"}]}]} \ No newline at end of file diff --git a/processors/base/processors/trial.py b/processors/base/processors/trial.py index 19eedf6..43e5247 100644 --- a/processors/base/processors/trial.py +++ b/processors/base/processors/trial.py @@ -107,8 +107,12 @@ def process_trials(conn, table, extractors): # Extract and write organisations/relationships organisations = extractors['extract_organisations'](record) for organisation in organisations: - org_id = writers.write_organisation(conn, helpers.normalize_organisation_name( - conn, organisation['name']), source_id) + # if organisation['name'] in stored_organisation_names: + # organisation['name'] = helpers.normalize_organisation_name( + # organisation['name'], organisation_clusters) + organisation['name'] = helpers.normalize_organisation_name( + conn, organisation['name']) + org_id = writers.write_organisation(conn, organisation, source_id) if org_id is None: continue writers.write_trial_relationship( From ebe9c258779333d2745861eaaeb28edfd4416067 Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Wed, 1 Feb 2017 17:17:06 -0300 Subject: [PATCH 04/23] Add unit tests to the organization normalization feature --- processors/base/helpers/__init__.py | 55 ++++++++++--------- processors/base/processors/trial.py | 2 +- tests/processors/base/helpers/test_helpers.py | 48 +++++++++++++--- 3 files changed, 69 insertions(+), 36 deletions(-) diff --git a/processors/base/helpers/__init__.py b/processors/base/helpers/__init__.py index b4a00ce..72e9b94 100644 --- a/processors/base/helpers/__init__.py +++ b/processors/base/helpers/__init__.py @@ -329,6 +329,34 @@ def get_canonical_location_name(location): return current_match +def get_canonical_organisation_name(conn, organisation): + """Find a canonical organisation name according to + a pre-built set of clusters + + Args: + location (str): the organisation to be normalized + """ + CLUSTER_QUERY = "SELECT canonical FROM organisation_clusters WHERE '%s'=ANY(variations)" + ORG_QUERY = "SELECT COUNT(*) from organisations WHERE name='%s'" + + normalized_form = None + query = CLUSTER_QUERY % organisation + # Try to find the organisation in some cluster + try: + normalized_form = conn['warehouse'].query(query).next()['canonical'] + except StopIteration: + query = ORG_QUERY % organisation + # If organisation already exists, return itself + if int(conn['database'].query(query).next()['count']) > 0: + normalized_form = organisation + else: + # TODO Check if it's valid to add this overhead to the processors + compute_organisation_clusters(conn, new_cluster_entry=organisation) + normalized_form = normalize_organisation_name(conn, organisation) + + logger.debug('Organisation "%s" normalized as "%s"', organisation, normalized_form) + return normalized_form + def _dedup_cluster(cluster_entries): """Sample, train and build organisation clusters @@ -388,30 +416,3 @@ def compute_organisation_clusters(conn, new_cluster_entry=None): conn['warehouse'].commit() -def normalize_organisation_name(conn, organisation): - """Find a canonical organisation name according to - a pre-built set of clusters - - Args: - location (str): the organisation to be normalized - """ - CLUSTER_QUERY = "SELECT canonical FROM organisation_clusters WHERE '%s'=ANY(variations)" - ORG_QUERY = "SELECT COUNT(*) from organisations WHERE name='%s'" - - normalized_form = None - query = CLUSTER_QUERY % organisation - # Try to find the organisation in some cluster - try: - normalized_form = conn['warehouse'].query(query).next()['canonical'] - except StopIteration: - query = ORG_QUERY % organisation - # If organisation already exists, return itself - if int(conn['database'].query(query).next()['count']) > 0: - normalized_form = organisation - else: - # TODO Check if it's valid to add this overhead to the processors - compute_organisation_clusters(conn, new_cluster_entry=organisation) - normalized_form = normalize_organisation_name(conn, organisation) - - logger.debug('Organisation "%s" normalized as "%s"', organisation, normalized_form) - return normalized_form diff --git a/processors/base/processors/trial.py b/processors/base/processors/trial.py index 43e5247..c10c0c9 100644 --- a/processors/base/processors/trial.py +++ b/processors/base/processors/trial.py @@ -110,7 +110,7 @@ def process_trials(conn, table, extractors): # if organisation['name'] in stored_organisation_names: # organisation['name'] = helpers.normalize_organisation_name( # organisation['name'], organisation_clusters) - organisation['name'] = helpers.normalize_organisation_name( + organisation['name'] = helpers.get_canonical_organisation_name( conn, organisation['name']) org_id = writers.write_organisation(conn, organisation, source_id) if org_id is None: diff --git a/tests/processors/base/helpers/test_helpers.py b/tests/processors/base/helpers/test_helpers.py index 3754e85..00fec6e 100644 --- a/tests/processors/base/helpers/test_helpers.py +++ b/tests/processors/base/helpers/test_helpers.py @@ -130,22 +130,54 @@ class TestLocationNormalizer(object): @pytest.mark.parametrize("test_input,expected", [ # Locations normalized by ISO-3166 name standards ("Brazil", "Brazil"), - ("United States of America","United States"), + ("United States of America", "United States"), # Locations normalized by ISO-3166 acronym standards - ("US","United States"), - ("UK","United Kingdom"), + ("US", "United States"), + ("UK", "United Kingdom"), # Locations normalized by Levenshtein distance (name) - ("Chnia","China"), - ("The Netherlands","Netherlands"), - ("thauland","Thailand"), + ("Chnia", "China"), + ("The Netherlands", "Netherlands"), + ("thauland", "Thailand"), # Locations not normalized (corner cases) - ("Asia(except Japan)","Asia(except Japan)"), - ("Outside","Outside"), + ("Asia(except Japan)", "Asia(except Japan)"), + ("Outside", "Outside"), (None, None)]) def test_location_normalizer(self, test_input, expected): assert helpers.get_canonical_location_name(test_input) == expected + +# class TestOrganisationNormalizer(object): +# @pytest.mark.parametrize("test_input,expected", [ + +# # Normalization of locations that already belong to the dictionary +# # that contains all organisation data and are not the largest one +# ("Justus-Liebig-University", "Justus Liebig University of Giessen"), +# ("Royal Liverpool and Broagreen University Hospitals NHS Trust", +# "Royal Liverpool and Broadgreen University Hospitals NHS Trust"), +# ("Ghent University", "Ghent University Hospital"), +# ("University of Oxford Clinical Trials & Research Governance", +# "University of Oxford, Clinical Trials and Research Governance Office"), +# ("University Medical Centre Nijmegen", "University Medical Centre Nijmegen St Radboud"), + +# # Normalization of locations that already belong to the dictionary +# # that contains all organisation data and are the largest one +# ("Justus Liebig University of Giessen", "Justus Liebig University of Giessen"), +# ("Royal Liverpool and Broadgreen University Hospitals NHS Trust", +# "Royal Liverpool and Broadgreen University Hospitals NHS Trust"), +# ("Ghent University Hospital", "Ghent University Hospital"), + +# # Normalization of new locations (not contained in the organisation data) +# ("Federal University of Campina Grande", "Federal University of Campina Grande"), +# ("University of São Paulo", "University of São Paulo"), +# ("Gent University", "Ghent University Hospital"), +# ("Royal Liverpol and Broadgreen University Hospitals NHS Trust", +# "Royal Liverpool and Broadgreen University Hospitals NHS Trust"), +# ("JustusLiebigUniversity", "Justus Liebig University of Giessen")]) + + +# def get_canonical_organisation_name(self, test_input, expected): +# assert helpers.normalize_organisation_name(test_input) == expected From 76a86d01b681234bb11d337c2f4b2d3c1a44ee97 Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Wed, 1 Feb 2017 17:20:12 -0300 Subject: [PATCH 05/23] Remove unused constants on trial processor --- processors/base/processors/trial.py | 5 -- tests/processors/base/helpers/test_helpers.py | 62 +++++++++---------- 2 files changed, 31 insertions(+), 36 deletions(-) diff --git a/processors/base/processors/trial.py b/processors/base/processors/trial.py index c10c0c9..86bf974 100644 --- a/processors/base/processors/trial.py +++ b/processors/base/processors/trial.py @@ -14,8 +14,6 @@ # Module API -TRAINING_FILE = os.path.join(os.path.dirname(__file__), '../organisation_cluster.json') - def process_trials(conn, table, extractors): """Translate trial records from warehouse to database. @@ -107,9 +105,6 @@ def process_trials(conn, table, extractors): # Extract and write organisations/relationships organisations = extractors['extract_organisations'](record) for organisation in organisations: - # if organisation['name'] in stored_organisation_names: - # organisation['name'] = helpers.normalize_organisation_name( - # organisation['name'], organisation_clusters) organisation['name'] = helpers.get_canonical_organisation_name( conn, organisation['name']) org_id = writers.write_organisation(conn, organisation, source_id) diff --git a/tests/processors/base/helpers/test_helpers.py b/tests/processors/base/helpers/test_helpers.py index 00fec6e..5fb10de 100644 --- a/tests/processors/base/helpers/test_helpers.py +++ b/tests/processors/base/helpers/test_helpers.py @@ -150,34 +150,34 @@ class TestLocationNormalizer(object): def test_location_normalizer(self, test_input, expected): assert helpers.get_canonical_location_name(test_input) == expected -# class TestOrganisationNormalizer(object): -# @pytest.mark.parametrize("test_input,expected", [ - -# # Normalization of locations that already belong to the dictionary -# # that contains all organisation data and are not the largest one -# ("Justus-Liebig-University", "Justus Liebig University of Giessen"), -# ("Royal Liverpool and Broagreen University Hospitals NHS Trust", -# "Royal Liverpool and Broadgreen University Hospitals NHS Trust"), -# ("Ghent University", "Ghent University Hospital"), -# ("University of Oxford Clinical Trials & Research Governance", -# "University of Oxford, Clinical Trials and Research Governance Office"), -# ("University Medical Centre Nijmegen", "University Medical Centre Nijmegen St Radboud"), - -# # Normalization of locations that already belong to the dictionary -# # that contains all organisation data and are the largest one -# ("Justus Liebig University of Giessen", "Justus Liebig University of Giessen"), -# ("Royal Liverpool and Broadgreen University Hospitals NHS Trust", -# "Royal Liverpool and Broadgreen University Hospitals NHS Trust"), -# ("Ghent University Hospital", "Ghent University Hospital"), - -# # Normalization of new locations (not contained in the organisation data) -# ("Federal University of Campina Grande", "Federal University of Campina Grande"), -# ("University of São Paulo", "University of São Paulo"), -# ("Gent University", "Ghent University Hospital"), -# ("Royal Liverpol and Broadgreen University Hospitals NHS Trust", -# "Royal Liverpool and Broadgreen University Hospitals NHS Trust"), -# ("JustusLiebigUniversity", "Justus Liebig University of Giessen")]) - - -# def get_canonical_organisation_name(self, test_input, expected): -# assert helpers.normalize_organisation_name(test_input) == expected +class TestOrganisationNormalizer(object): + @pytest.mark.parametrize("test_input,expected", [ + + # Normalization of locations that already belong to the dictionary + # that contains all organisation data and are not the largest one + ("Justus-Liebig-University", "Justus Liebig University of Giessen"), + ("Royal Liverpool and Broagreen University Hospitals NHS Trust", + "Royal Liverpool and Broadgreen University Hospitals NHS Trust"), + ("Ghent University", "Ghent University Hospital"), + ("University of Oxford Clinical Trials & Research Governance", + "University of Oxford, Clinical Trials and Research Governance Office"), + ("University Medical Centre Nijmegen", "University Medical Centre Nijmegen St Radboud"), + + # Normalization of locations that already belong to the dictionary + # that contains all organisation data and are the largest one + ("Justus Liebig University of Giessen", "Justus Liebig University of Giessen"), + ("Royal Liverpool and Broadgreen University Hospitals NHS Trust", + "Royal Liverpool and Broadgreen University Hospitals NHS Trust"), + ("Ghent University Hospital", "Ghent University Hospital"), + + # Normalization of new locations (not contained in the organisation data) + ("Federal University of Campina Grande", "Federal University of Campina Grande"), + ("University of São Paulo", "University of São Paulo"), + ("Gent University", "Ghent University Hospital"), + ("Royal Liverpol and Broadgreen University Hospitals NHS Trust", + "Royal Liverpool and Broadgreen University Hospitals NHS Trust"), + ("JustusLiebigUniversity", "Justus Liebig University of Giessen")]) + + + def get_canonical_organisation_name(self, test_input, expected): + assert helpers.normalize_organisation_name(test_input) == expected From 5f564337c76e5f7d6b8098e49856006228e1e554 Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Mon, 6 Feb 2017 11:04:28 -0300 Subject: [PATCH 06/23] Add unit tests set --- processors/base/helpers/__init__.py | 18 ++++++----- tests/conftest.py | 2 ++ .../warehouse/organisation_clusters.py | 22 ++++++++++++++ tests/processors/base/helpers/test_helpers.py | 30 +++---------------- 4 files changed, 39 insertions(+), 33 deletions(-) create mode 100644 tests/fixtures/warehouse/organisation_clusters.py diff --git a/processors/base/helpers/__init__.py b/processors/base/helpers/__init__.py index 72e9b94..2554db8 100644 --- a/processors/base/helpers/__init__.py +++ b/processors/base/helpers/__init__.py @@ -26,6 +26,8 @@ # Module API +DISTANCE_SCORER = fuzzywuzzy.fuzz.token_sort_ratio + def get_variables(object, filter=None): """Exract variables from object to dict using name filter. """ @@ -298,7 +300,6 @@ def get_canonical_location_name(location): # Extracted from: https://github.com/datasets/country-codes/blob/master/data/country-codes.csv CSV_PATH = os.path.join(os.path.dirname(__file__), 'data/countries.csv') - DISTANCE_SCORER = fuzzywuzzy.fuzz.token_sort_ratio EDIT_DISTANCE_THRESHOLD = 75 cleaned_location = remove_string_punctuation(location) @@ -336,11 +337,12 @@ def get_canonical_organisation_name(conn, organisation): Args: location (str): the organisation to be normalized """ - CLUSTER_QUERY = "SELECT canonical FROM organisation_clusters WHERE '%s'=ANY(variations)" + SPECIFIC_CLUSTER_QUERY = "SELECT canonical FROM organisation_clusters WHERE '%s'=ANY(variations)" + CLUSTER_QUERY = "SELECT canonical FROM organisation_clusters" ORG_QUERY = "SELECT COUNT(*) from organisations WHERE name='%s'" normalized_form = None - query = CLUSTER_QUERY % organisation + query = SPECIFIC_CLUSTER_QUERY % organisation # Try to find the organisation in some cluster try: normalized_form = conn['warehouse'].query(query).next()['canonical'] @@ -350,9 +352,12 @@ def get_canonical_organisation_name(conn, organisation): if int(conn['database'].query(query).next()['count']) > 0: normalized_form = organisation else: - # TODO Check if it's valid to add this overhead to the processors - compute_organisation_clusters(conn, new_cluster_entry=organisation) - normalized_form = normalize_organisation_name(conn, organisation) + # canonicals = [row['canonical'] for row in list(conn['warehouse'].query(CLUSTER_QUERY))] + # canonical, score = fuzzywuzzy.process.extractOne(organisation, canonicals, scorer=DISTANCE_SCORER) + # TODO: If organisation does not exists, add it to a existent cluster + # by comparing it with the clusters centroids (canonical) + # CURRENT: Return organisation itself + return organisation logger.debug('Organisation "%s" normalized as "%s"', organisation, normalized_form) return normalized_form @@ -397,7 +402,6 @@ def compute_organisation_clusters(conn, new_cluster_entry=None): cluster_members = {entry['id']: {'name': unidecode.unidecode(entry['name'])} for entry in stored_organisations} - if new_cluster_entry: cluster_members[uuid.uuid1().hex] = {'name': new_cluster_entry} diff --git a/tests/conftest.py b/tests/conftest.py index 99cc601..71684bf 100644 --- a/tests/conftest.py +++ b/tests/conftest.py @@ -24,6 +24,7 @@ from tests.fixtures.warehouse.cochrane_reviews import cochrane_review from tests.fixtures.warehouse.nct import nct_record +from tests.fixtures.warehouse.organisation_clusters import organisation_cluster @pytest.fixture def conn(request): @@ -44,6 +45,7 @@ def conn(request): api_session = APISession() WarehouseSession = sessionmaker(bind=conn['warehouse'].engine) warehouse_session = WarehouseSession() + def teardown(): truncate_database(conn['database'].engine) truncate_database(conn['warehouse'].engine) diff --git a/tests/fixtures/warehouse/organisation_clusters.py b/tests/fixtures/warehouse/organisation_clusters.py new file mode 100644 index 0000000..b23511e --- /dev/null +++ b/tests/fixtures/warehouse/organisation_clusters.py @@ -0,0 +1,22 @@ +# -*- coding: utf-8 -*- +from __future__ import absolute_import +from __future__ import division +from __future__ import print_function +from __future__ import unicode_literals + +import pytest + +@pytest.fixture +def organisation_cluster(conn): + cluster_ghent = { + 'canonical': 'Ghent University Hospital', + 'variations': ['Ghent University Hospital', 'Ghent University'] + } + + cluster_justus = { + 'canonical': 'Justus Liebig University of Giessen', + 'variations': ['Justus Liebig University of Giessen', 'Justus Liebig'] + } + + conn['warehouse']['organisation_clusters'].insert(cluster_ghent) + conn['warehouse']['organisation_clusters'].insert(cluster_justus) \ No newline at end of file diff --git a/tests/processors/base/helpers/test_helpers.py b/tests/processors/base/helpers/test_helpers.py index 5fb10de..7c66580 100644 --- a/tests/processors/base/helpers/test_helpers.py +++ b/tests/processors/base/helpers/test_helpers.py @@ -7,7 +7,6 @@ import pytest import processors.base.helpers as helpers - class TestValidateIdentifier(object): @pytest.mark.parametrize('identifier', [ 'NCT00020500', @@ -152,32 +151,11 @@ def test_location_normalizer(self, test_input, expected): class TestOrganisationNormalizer(object): @pytest.mark.parametrize("test_input,expected", [ - - # Normalization of locations that already belong to the dictionary - # that contains all organisation data and are not the largest one - ("Justus-Liebig-University", "Justus Liebig University of Giessen"), - ("Royal Liverpool and Broagreen University Hospitals NHS Trust", - "Royal Liverpool and Broadgreen University Hospitals NHS Trust"), ("Ghent University", "Ghent University Hospital"), - ("University of Oxford Clinical Trials & Research Governance", - "University of Oxford, Clinical Trials and Research Governance Office"), - ("University Medical Centre Nijmegen", "University Medical Centre Nijmegen St Radboud"), - - # Normalization of locations that already belong to the dictionary - # that contains all organisation data and are the largest one ("Justus Liebig University of Giessen", "Justus Liebig University of Giessen"), - ("Royal Liverpool and Broadgreen University Hospitals NHS Trust", - "Royal Liverpool and Broadgreen University Hospitals NHS Trust"), - ("Ghent University Hospital", "Ghent University Hospital"), - - # Normalization of new locations (not contained in the organisation data) ("Federal University of Campina Grande", "Federal University of Campina Grande"), - ("University of São Paulo", "University of São Paulo"), - ("Gent University", "Ghent University Hospital"), - ("Royal Liverpol and Broadgreen University Hospitals NHS Trust", - "Royal Liverpool and Broadgreen University Hospitals NHS Trust"), - ("JustusLiebigUniversity", "Justus Liebig University of Giessen")]) - + ]) - def get_canonical_organisation_name(self, test_input, expected): - assert helpers.normalize_organisation_name(test_input) == expected + @pytest.mark.usefixtures('organisation_cluster') + def test_organisation_normalizer(self, conn, test_input, expected): + assert helpers.get_canonical_organisation_name(conn, test_input) == expected \ No newline at end of file From 257e66e5ca411cb30a100582929a1b3dbde19f14 Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Mon, 6 Feb 2017 11:20:15 -0300 Subject: [PATCH 07/23] Add org cluster fixture to the trial test set --- tests/processors/base/processors/test_trial.py | 1 + 1 file changed, 1 insertion(+) diff --git a/tests/processors/base/processors/test_trial.py b/tests/processors/base/processors/test_trial.py index 36e4023..cba636b 100644 --- a/tests/processors/base/processors/test_trial.py +++ b/tests/processors/base/processors/test_trial.py @@ -12,6 +12,7 @@ class TestTrialProcessor(object): + @pytest.mark.usefixtures('organisation_cluster') def test_updates_which_record_is_primary(self, conn, extractors, trial, record, nct_record, euctr_source): From 54b0ec21b5f7da279b681f59cc08827402ef647e Mon Sep 17 00:00:00 2001 From: rafaelvfalc Date: Mon, 6 Feb 2017 15:44:01 +0000 Subject: [PATCH 08/23] Increase code quality by following some lint rules --- processors/base/helpers/__init__.py | 8 +++----- tests/processors/base/helpers/test_helpers.py | 8 ++++++-- 2 files changed, 9 insertions(+), 7 deletions(-) diff --git a/processors/base/helpers/__init__.py b/processors/base/helpers/__init__.py index 2554db8..921c9f3 100644 --- a/processors/base/helpers/__init__.py +++ b/processors/base/helpers/__init__.py @@ -52,7 +52,6 @@ def slugify_string(string): class JSONEncoder(json.JSONEncoder): """JSON encoder with datetime, date set support. """ - def default(self, obj): if isinstance(obj, datetime.datetime): return obj.strftime('%Y-%m-%dT%H:%M:%SZ') @@ -369,9 +368,9 @@ def _dedup_cluster(cluster_entries): cluster_entries (str): a list of candidates to be grouped in equivalent sets """ - MATCH_THRESHOLD = 0.5 - TRAINING_FILE = os.path.join(os.path.dirname(__file__), 'data/organisation_training_data.json') + TRAINING_FILE = os.path.join(os.path.dirname(__file__), + 'data/organisation_training_data.json') fields = [{'field' : 'name', 'type': 'String'}] deduper = dedupe.Dedupe(fields) @@ -392,7 +391,6 @@ def compute_organisation_clusters(conn, new_cluster_entry=None): org_list (str): list of all organisations stored on database """ - logger.debug('Recomputing organisations cluster data for further access') conn['warehouse'].begin() @@ -400,7 +398,7 @@ def compute_organisation_clusters(conn, new_cluster_entry=None): stored_organisations = list(conn['database']['organisations'].all()) - cluster_members = {entry['id']: {'name': unidecode.unidecode(entry['name'])} + cluster_members = {entry['id']:{'name': unidecode.unidecode(entry['name'])} for entry in stored_organisations} if new_cluster_entry: cluster_members[uuid.uuid1().hex] = {'name': new_cluster_entry} diff --git a/tests/processors/base/helpers/test_helpers.py b/tests/processors/base/helpers/test_helpers.py index 7c66580..d048bd9 100644 --- a/tests/processors/base/helpers/test_helpers.py +++ b/tests/processors/base/helpers/test_helpers.py @@ -151,9 +151,13 @@ def test_location_normalizer(self, test_input, expected): class TestOrganisationNormalizer(object): @pytest.mark.parametrize("test_input,expected", [ + # Locations already in the database ("Ghent University", "Ghent University Hospital"), - ("Justus Liebig University of Giessen", "Justus Liebig University of Giessen"), - ("Federal University of Campina Grande", "Federal University of Campina Grande"), + ("Justus Liebig University of Giessen", + "Justus Liebig University of Giessen"), + # Locations to be added to the database + ("Federal University of Campina Grande", + "Federal University of Campina Grande"), ]) @pytest.mark.usefixtures('organisation_cluster') From 19e77add0d4bfdd640ff0d5892d7c9aed6a4b6f8 Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Tue, 7 Feb 2017 17:44:16 -0300 Subject: [PATCH 09/23] Create new cluster updater processor --- processors/base/helpers/__init__.py | 35 ++++++++++--------- processors/base/processors/trial.py | 4 --- .../__init__.py | 7 ++++ .../processor.py | 18 ++++++++++ .../processors/base/processors/test_trial.py | 1 - 5 files changed, 43 insertions(+), 22 deletions(-) create mode 100644 processors/normalization_clusters_updater/__init__.py create mode 100644 processors/normalization_clusters_updater/processor.py diff --git a/processors/base/helpers/__init__.py b/processors/base/helpers/__init__.py index 921c9f3..62ff65f 100644 --- a/processors/base/helpers/__init__.py +++ b/processors/base/helpers/__init__.py @@ -28,6 +28,7 @@ DISTANCE_SCORER = fuzzywuzzy.fuzz.token_sort_ratio + def get_variables(object, filter=None): """Exract variables from object to dict using name filter. """ @@ -314,8 +315,10 @@ def get_canonical_location_name(location): relevant_info = [unicode(country[field], encoding='utf-8') for field in reader.fieldnames[0:5]] - location_info = [remove_string_punctuation(location_info) for location_info in relevant_info] - _, score = fuzzywuzzy.process.extractOne(cleaned_location, location_info, scorer=DISTANCE_SCORER) + location_info = [remove_string_punctuation(location_info) + for location_info in relevant_info] + _, score = fuzzywuzzy.process.extractOne( + cleaned_location, location_info, scorer=DISTANCE_SCORER) if score > current_score: current_match = iso3166.countries.get(country['ISO3166-1-Alpha-3']).name @@ -329,6 +332,7 @@ def get_canonical_location_name(location): return current_match + def get_canonical_organisation_name(conn, organisation): """Find a canonical organisation name according to a pre-built set of clusters @@ -336,12 +340,13 @@ def get_canonical_organisation_name(conn, organisation): Args: location (str): the organisation to be normalized """ - SPECIFIC_CLUSTER_QUERY = "SELECT canonical FROM organisation_clusters WHERE '%s'=ANY(variations)" - CLUSTER_QUERY = "SELECT canonical FROM organisation_clusters" + CLUSTER_QUERY = "SELECT canonical " + \ + "FROM organisation_clusters " + \ + "WHERE '%s'=ANY(variations)" ORG_QUERY = "SELECT COUNT(*) from organisations WHERE name='%s'" - normalized_form = None - query = SPECIFIC_CLUSTER_QUERY % organisation + normalized_form = organisation + query = CLUSTER_QUERY % organisation # Try to find the organisation in some cluster try: normalized_form = conn['warehouse'].query(query).next()['canonical'] @@ -351,16 +356,12 @@ def get_canonical_organisation_name(conn, organisation): if int(conn['database'].query(query).next()['count']) > 0: normalized_form = organisation else: - # canonicals = [row['canonical'] for row in list(conn['warehouse'].query(CLUSTER_QUERY))] - # canonical, score = fuzzywuzzy.process.extractOne(organisation, canonicals, scorer=DISTANCE_SCORER) - # TODO: If organisation does not exists, add it to a existent cluster - # by comparing it with the clusters centroids (canonical) - # CURRENT: Return organisation itself return organisation logger.debug('Organisation "%s" normalized as "%s"', organisation, normalized_form) return normalized_form + def _dedup_cluster(cluster_entries): """Sample, train and build organisation clusters @@ -368,11 +369,11 @@ def _dedup_cluster(cluster_entries): cluster_entries (str): a list of candidates to be grouped in equivalent sets """ - MATCH_THRESHOLD = 0.5 + MATCH_THRESHOLD = 0.75 TRAINING_FILE = os.path.join(os.path.dirname(__file__), 'data/organisation_training_data.json') - fields = [{'field' : 'name', 'type': 'String'}] + fields = [{'field': 'name', 'type': 'String'}] deduper = dedupe.Dedupe(fields) deduper.sample(cluster_entries, 15000) @@ -383,8 +384,9 @@ def _dedup_cluster(cluster_entries): return deduper.match(cluster_entries, MATCH_THRESHOLD) -def compute_organisation_clusters(conn, new_cluster_entry=None): - """Build an usable list of clusters to be used + +def update_organisation_clusters(conn, new_cluster_entry=None): + """Build a readable list of organisation clusters to be used when normalizing new entries Args: @@ -398,7 +400,7 @@ def compute_organisation_clusters(conn, new_cluster_entry=None): stored_organisations = list(conn['database']['organisations'].all()) - cluster_members = {entry['id']:{'name': unidecode.unidecode(entry['name'])} + cluster_members = {entry['id']: {'name': unidecode.unidecode(entry['name'])} for entry in stored_organisations} if new_cluster_entry: cluster_members[uuid.uuid1().hex] = {'name': new_cluster_entry} @@ -417,4 +419,3 @@ def compute_organisation_clusters(conn, new_cluster_entry=None): conn['warehouse']['organisation_clusters'].insert(cluster) conn['warehouse'].commit() - diff --git a/processors/base/processors/trial.py b/processors/base/processors/trial.py index 86bf974..5423f9a 100644 --- a/processors/base/processors/trial.py +++ b/processors/base/processors/trial.py @@ -5,8 +5,6 @@ from __future__ import unicode_literals import logging -import os -import json from .. import helpers from .. import writers logger = logging.getLogger(__name__) @@ -31,8 +29,6 @@ def process_trials(conn, table, extractors): errors = 0 success = 0 - helpers.compute_organisation_clusters(conn) - for record in helpers.iter_rows(conn, 'warehouse', table, orderby='meta_id'): conn['database'].begin() diff --git a/processors/normalization_clusters_updater/__init__.py b/processors/normalization_clusters_updater/__init__.py new file mode 100644 index 0000000..b211373 --- /dev/null +++ b/processors/normalization_clusters_updater/__init__.py @@ -0,0 +1,7 @@ +# -*- coding: utf-8 -*- +from __future__ import absolute_import +from __future__ import division +from __future__ import print_function +from __future__ import unicode_literals + +from .processor import process diff --git a/processors/normalization_clusters_updater/processor.py b/processors/normalization_clusters_updater/processor.py new file mode 100644 index 0000000..4aad63d --- /dev/null +++ b/processors/normalization_clusters_updater/processor.py @@ -0,0 +1,18 @@ +# -*- coding: utf-8 -*- +from __future__ import absolute_import +from __future__ import division +from __future__ import print_function +from __future__ import unicode_literals + +import logging +import processors.base.helpers + +logger = logging.getLogger(__name__) + + +# Module API + +def process(conf, conn): + """Update clusters used when normalizing trials entities + """ + processors.base.helpers.update_organisation_clusters(conn) diff --git a/tests/processors/base/processors/test_trial.py b/tests/processors/base/processors/test_trial.py index cba636b..36e4023 100644 --- a/tests/processors/base/processors/test_trial.py +++ b/tests/processors/base/processors/test_trial.py @@ -12,7 +12,6 @@ class TestTrialProcessor(object): - @pytest.mark.usefixtures('organisation_cluster') def test_updates_which_record_is_primary(self, conn, extractors, trial, record, nct_record, euctr_source): From 0669314e90edd8185b04648d578b4af0bdc1a529 Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Tue, 7 Feb 2017 17:57:39 -0300 Subject: [PATCH 10/23] Add raven depedency --- requirements.in | 1 + requirements.txt | 16 +++++++++------- 2 files changed, 10 insertions(+), 7 deletions(-) diff --git a/requirements.in b/requirements.in index 696ed12..a5b0811 100644 --- a/requirements.in +++ b/requirements.in @@ -12,4 +12,5 @@ pybossa-client fuzzywuzzy python-Levenshtein iso3166 +raven dedupe diff --git a/requirements.txt b/requirements.txt index ade54bf..93195dd 100644 --- a/requirements.txt +++ b/requirements.txt @@ -9,12 +9,13 @@ alembic==0.8.10 # via dataset appdirs==1.4.0 # via setuptools boto3==1.4.4 botocore==1.5.7 # via boto3, s3transfer -BTrees==4.4.1 # via dedupe, zope.index +btrees==4.4.1 # via dedupe, zope.index canonicalize==1.3 # via dedupe categorical-distance==1.9 # via dedupe cchardet==1.1.2 # via tabulator chardet==2.3.0 # via normality click==6.7 # via jsontableschema, python-dotenv, tabulator +contextlib2==0.5.4 # via raven datapackage==0.6.1 dataset==0.7.1 dedupe-hcluster==0.3.2 # via dedupe @@ -38,11 +39,11 @@ jsonlines==1.1.0 # via tabulator jsonschema==2.6.0 # via datapackage, jsontableschema jsontableschema-sql==0.5.0 jsontableschema==0.9.0 # via datapackage, jsontableschema-sql -Levenshtein-search==1.4.2 # via dedupe +levenshtein-search==1.4.2 # via dedupe linear-tsv==1.0.0 # via tabulator lxml==3.7.2 # via tabulator -Mako==1.0.6 # via alembic -MarkupSafe==0.23 # via mako +mako==1.0.6 # via alembic +markupsafe==0.23 # via mako normality==0.3.9 # via dataset numpy==1.12.0 # via canonicalize, categorical-distance, dedupe-hcluster, highered, pyhacrf-datamade, pylbfgs, rlr, simplecosine openpyxl==2.4.2 # via tabulator @@ -53,13 +54,14 @@ pybossa-client==1.1.1 pyhacrf-datamade==0.2.0 # via highered pylbfgs==0.2.0.3 # via pyhacrf-datamade, rlr pyparsing==2.1.10 # via packaging -PyPDF2==1.26.0 +pypdf2==1.26.0 python-dateutil==2.6.0 # via botocore, jsontableschema, python-documentcloud python-documentcloud==1.0.4 python-dotenv==0.6.3 python-editor==1.0.3 # via alembic -python-Levenshtein==0.12.0 -PyYAML==3.12 # via dataset +python-levenshtein==0.12.0 +pyyaml==3.12 # via dataset +raven==5.32.0 requests==2.13.0 rfc3986==0.4.1 # via jsontableschema rfc3987==1.3.7 # via python-documentcloud From 160a996064f5c3bfd1478fdbae2e33671a7a970b Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Tue, 7 Feb 2017 18:10:23 -0300 Subject: [PATCH 11/23] Add unidecode depedency --- requirements.in | 1 + requirements.txt | 1 + 2 files changed, 2 insertions(+) diff --git a/requirements.in b/requirements.in index a5b0811..d158d27 100644 --- a/requirements.in +++ b/requirements.in @@ -13,4 +13,5 @@ fuzzywuzzy python-Levenshtein iso3166 raven +unidecode dedupe diff --git a/requirements.txt b/requirements.txt index 93195dd..dd95bf5 100644 --- a/requirements.txt +++ b/requirements.txt @@ -73,6 +73,7 @@ six==1.10.0 # via datapackage, dataset, jsonlines, jsontableschema sqlalchemy==1.1.5 tabulator==0.14.0 # via datapackage, jsontableschema, jsontableschema-sql unicodecsv==0.14.1 # via datapackage, jsontableschema, tabulator +unidecode==0.4.20 xlrd==1.0.0 # via tabulator zope.index==4.2.0 # via dedupe zope.interface==4.3.3 # via btrees, persistent, zope.index From 57e5b9eaf29a14deb943bb8db02995896e8b166c Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Wed, 8 Feb 2017 06:59:29 -0300 Subject: [PATCH 12/23] Cleanup code and add proper documentation --- processors/base/helpers/__init__.py | 25 +++++++++---------------- processors/base/processors/trial.py | 2 -- processors/base/writers/organisation.py | 2 +- 3 files changed, 10 insertions(+), 19 deletions(-) diff --git a/processors/base/helpers/__init__.py b/processors/base/helpers/__init__.py index a832106..a8bf6da 100644 --- a/processors/base/helpers/__init__.py +++ b/processors/base/helpers/__init__.py @@ -343,22 +343,17 @@ def get_canonical_organisation_name(conn, organisation): CLUSTER_QUERY = "SELECT canonical " + \ "FROM organisation_clusters " + \ "WHERE '%s'=ANY(variations)" - ORG_QUERY = "SELECT COUNT(*) from organisations WHERE name='%s'" normalized_form = organisation - query = CLUSTER_QUERY % organisation + # Try to find the organisation in some cluster try: normalized_form = conn['warehouse'].query(query).next()['canonical'] + logger.debug('Organisation "%s" normalized as "%s"', organisation, normalized_form) except StopIteration: - query = ORG_QUERY % organisation - # If organisation already exists, return itself - if int(conn['database'].query(query).next()['count']) > 0: - normalized_form = organisation - else: - return organisation + logger.debug('Organisation "%s" not normalized', organisation) + pass - logger.debug('Organisation "%s" normalized as "%s"', organisation, normalized_form) return normalized_form @@ -366,16 +361,17 @@ def _dedup_cluster(cluster_entries): """Sample, train and build organisation clusters Args: - cluster_entries (str): a list of candidates to + cluster_entries (list): a list of candidates to be grouped in equivalent sets """ + SAMPLE_SIZE = 10000 MATCH_THRESHOLD = 0.75 TRAINING_FILE = os.path.join(os.path.dirname(__file__), 'data/organisation_training_data.json') fields = [{'field': 'name', 'type': 'String'}] deduper = dedupe.Dedupe(fields) - deduper.sample(cluster_entries, 15000) + deduper.sample(cluster_entries, SAMPLE_SIZE) with open(TRAINING_FILE) as training_file: deduper.readTraining(training_file) @@ -385,13 +381,12 @@ def _dedup_cluster(cluster_entries): return deduper.match(cluster_entries, MATCH_THRESHOLD) -def update_organisation_clusters(conn, new_cluster_entry=None): +def update_organisation_clusters(conn): """Build a readable list of organisation clusters to be used when normalizing new entries Args: - org_list (str): list of all organisations - stored on database + conn (dict): connection dict """ logger.debug('Recomputing organisations cluster data for further access') @@ -402,8 +397,6 @@ def update_organisation_clusters(conn, new_cluster_entry=None): cluster_members = {entry['id']: {'name': unidecode.unidecode(entry['name'])} for entry in stored_organisations} - if new_cluster_entry: - cluster_members[uuid.uuid1().hex] = {'name': new_cluster_entry} clustered_dupes = _dedup_cluster(cluster_members) diff --git a/processors/base/processors/trial.py b/processors/base/processors/trial.py index 1feb776..9fbd9d5 100644 --- a/processors/base/processors/trial.py +++ b/processors/base/processors/trial.py @@ -106,8 +106,6 @@ def process_trials(conn, table, extractors): # Extract and write organisations/relationships organisations = extractors['extract_organisations'](record) for organisation in organisations: - organisation['name'] = helpers.get_canonical_organisation_name( - conn, organisation['name']) org_id = writers.write_organisation(conn, organisation, source_id) if org_id is None: continue diff --git a/processors/base/writers/organisation.py b/processors/base/writers/organisation.py index c8c3dc9..d84a2e1 100644 --- a/processors/base/writers/organisation.py +++ b/processors/base/writers/organisation.py @@ -33,7 +33,7 @@ def write_organisation(conn, organisation, source_id, trial_id=None): timestamp = datetime.datetime.utcnow() # Get name - name = helpers.clean_string(organisation['name']) + name = helpers.get_canonical_organisation_name(organisation['name']) if len(name) <= 1: return None From ee8ebda72b6ace615913bcd0e2beda20473e0f61 Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Wed, 8 Feb 2017 07:07:32 -0300 Subject: [PATCH 13/23] Remove unused logger --- processors/base/helpers/__init__.py | 6 +++--- processors/normalization_clusters_updater/processor.py | 3 --- 2 files changed, 3 insertions(+), 6 deletions(-) diff --git a/processors/base/helpers/__init__.py b/processors/base/helpers/__init__.py index a8bf6da..c89b6b8 100644 --- a/processors/base/helpers/__init__.py +++ b/processors/base/helpers/__init__.py @@ -26,8 +26,6 @@ # Module API -DISTANCE_SCORER = fuzzywuzzy.fuzz.token_sort_ratio - def get_variables(object, filter=None): """Exract variables from object to dict using name filter. @@ -300,6 +298,7 @@ def get_canonical_location_name(location): # Extracted from: https://github.com/datasets/country-codes/blob/master/data/country-codes.csv CSV_PATH = os.path.join(os.path.dirname(__file__), 'data/countries.csv') + DISTANCE_SCORER = fuzzywuzzy.fuzz.token_sort_ratio EDIT_DISTANCE_THRESHOLD = 75 cleaned_location = remove_string_punctuation(location) @@ -338,7 +337,8 @@ def get_canonical_organisation_name(conn, organisation): a pre-built set of clusters Args: - location (str): the organisation to be normalized + conn (dict): connection dict + organisation (str): the organisation to be normalized """ CLUSTER_QUERY = "SELECT canonical " + \ "FROM organisation_clusters " + \ diff --git a/processors/normalization_clusters_updater/processor.py b/processors/normalization_clusters_updater/processor.py index 4aad63d..a0fb2d0 100644 --- a/processors/normalization_clusters_updater/processor.py +++ b/processors/normalization_clusters_updater/processor.py @@ -4,11 +4,8 @@ from __future__ import print_function from __future__ import unicode_literals -import logging import processors.base.helpers -logger = logging.getLogger(__name__) - # Module API From c07a0bf10873dc950d10c0a61efacdaee9fe6e7e Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Thu, 9 Feb 2017 15:26:17 -0300 Subject: [PATCH 14/23] Avoiding anonymous variable --- processors/base/helpers/__init__.py | 6 +++--- 1 file changed, 3 insertions(+), 3 deletions(-) diff --git a/processors/base/helpers/__init__.py b/processors/base/helpers/__init__.py index c89b6b8..0bf70e2 100644 --- a/processors/base/helpers/__init__.py +++ b/processors/base/helpers/__init__.py @@ -342,13 +342,13 @@ def get_canonical_organisation_name(conn, organisation): """ CLUSTER_QUERY = "SELECT canonical " + \ "FROM organisation_clusters " + \ - "WHERE '%s'=ANY(variations)" + "WHERE '%s'=ANY(variations)" % organisation normalized_form = organisation # Try to find the organisation in some cluster try: - normalized_form = conn['warehouse'].query(query).next()['canonical'] + normalized_form = conn['warehouse'].query(CLUSTER_QUERY).next()['canonical'] logger.debug('Organisation "%s" normalized as "%s"', organisation, normalized_form) except StopIteration: logger.debug('Organisation "%s" not normalized', organisation) @@ -401,7 +401,7 @@ def update_organisation_clusters(conn): clustered_dupes = _dedup_cluster(cluster_members) for (_, cluster) in enumerate(clustered_dupes): - id_set, _ = cluster + id_set = cluster[0] cluster_membership = [str(cluster_members[c]['name']) for c in id_set] cluster = { From 81a44c59a255fcdb8cf16038f9ceace517a6f72e Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Thu, 9 Feb 2017 15:31:12 -0300 Subject: [PATCH 15/23] Add docs to organisation tests --- tests/processors/base/helpers/test_helpers.py | 7 +++++-- 1 file changed, 5 insertions(+), 2 deletions(-) diff --git a/tests/processors/base/helpers/test_helpers.py b/tests/processors/base/helpers/test_helpers.py index d048bd9..a3d5ab8 100644 --- a/tests/processors/base/helpers/test_helpers.py +++ b/tests/processors/base/helpers/test_helpers.py @@ -151,11 +151,14 @@ def test_location_normalizer(self, test_input, expected): class TestOrganisationNormalizer(object): @pytest.mark.parametrize("test_input,expected", [ - # Locations already in the database + # Organisation normalized with a longer equivalent ("Ghent University", "Ghent University Hospital"), + + # Organisation normalized as it is (the longest available form) ("Justus Liebig University of Giessen", "Justus Liebig University of Giessen"), - # Locations to be added to the database + + # New organisation non-normalized ("Federal University of Campina Grande", "Federal University of Campina Grande"), ]) From f50a992033ef0aa5290c5e89fa011702693591ce Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Thu, 9 Feb 2017 16:30:01 -0300 Subject: [PATCH 16/23] Update schema files --- tests/dbs/opentrials_api_schema_dump.sql | 472 +++++++++++++++++------ tests/dbs/warehouse_schema_dump.sql | 148 ++++--- 2 files changed, 453 insertions(+), 167 deletions(-) diff --git a/tests/dbs/opentrials_api_schema_dump.sql b/tests/dbs/opentrials_api_schema_dump.sql index 5a1353d..dbb9aac 100644 --- a/tests/dbs/opentrials_api_schema_dump.sql +++ b/tests/dbs/opentrials_api_schema_dump.sql @@ -2,12 +2,16 @@ -- PostgreSQL database dump -- +-- Dumped from database version 9.5.5 +-- Dumped by pg_dump version 9.5.5 + SET statement_timeout = 0; SET lock_timeout = 0; SET client_encoding = 'UTF8'; SET standard_conforming_strings = on; SET check_function_bodies = false; SET client_min_messages = warning; +SET row_security = off; SET search_path = public, pg_catalog; @@ -44,10 +48,11 @@ ALTER TABLE IF EXISTS ONLY public.fda_applications DROP CONSTRAINT IF EXISTS fda ALTER TABLE IF EXISTS ONLY public.documents DROP CONSTRAINT IF EXISTS documents_source_id_foreign; ALTER TABLE IF EXISTS ONLY public.documents DROP CONSTRAINT IF EXISTS documents_file_id_foreign; ALTER TABLE IF EXISTS ONLY public.documents DROP CONSTRAINT IF EXISTS documents_fda_approval_id_foreign; -ALTER TABLE IF EXISTS ONLY public.documents DROP CONSTRAINT IF EXISTS documents_document_category_id_foreign; DROP INDEX IF EXISTS public.trials_documents_document_id_index; DROP INDEX IF EXISTS public.trialrecords_trial_id_index; DROP INDEX IF EXISTS public.records_identifiers_index; +DROP INDEX IF EXISTS public.non_fda_documents_type_source_url_unique; +DROP INDEX IF EXISTS public.non_fda_documents_type_file_id_unique; DROP INDEX IF EXISTS public.interventions_fda_application_number_index; DROP INDEX IF EXISTS public.fda_approvals_type_index; ALTER TABLE IF EXISTS ONLY public.trials_publications DROP CONSTRAINT IF EXISTS trials_publications_pkey; @@ -66,7 +71,6 @@ ALTER TABLE IF EXISTS ONLY public.risk_of_biases_risk_of_bias_criterias DROP CON ALTER TABLE IF EXISTS ONLY public.risk_of_biases DROP CONSTRAINT IF EXISTS risk_of_biases_pkey; ALTER TABLE IF EXISTS ONLY public.risk_of_bias_criterias DROP CONSTRAINT IF EXISTS risk_of_bias_criterias_pkey; ALTER TABLE IF EXISTS ONLY public.risk_of_bias_criterias DROP CONSTRAINT IF EXISTS risk_of_bias_criterias_name_unique; -ALTER TABLE IF EXISTS ONLY public.records DROP CONSTRAINT IF EXISTS records_source_url_unique; ALTER TABLE IF EXISTS ONLY public.publications DROP CONSTRAINT IF EXISTS publications_slug_unique; ALTER TABLE IF EXISTS ONLY public.publications DROP CONSTRAINT IF EXISTS publications_pkey; ALTER TABLE IF EXISTS ONLY public.conditions DROP CONSTRAINT IF EXISTS problems_slug_unique; @@ -76,6 +80,7 @@ ALTER TABLE IF EXISTS ONLY public.persons DROP CONSTRAINT IF EXISTS persons_pkey ALTER TABLE IF EXISTS ONLY public.organisations DROP CONSTRAINT IF EXISTS organisations_slug_unique; ALTER TABLE IF EXISTS ONLY public.organisations DROP CONSTRAINT IF EXISTS organisations_pkey; ALTER TABLE IF EXISTS ONLY public.organisations DROP CONSTRAINT IF EXISTS organisations_name_unique; +ALTER TABLE IF EXISTS ONLY public.organisation DROP CONSTRAINT IF EXISTS organisation_pkey; ALTER TABLE IF EXISTS ONLY public.locations DROP CONSTRAINT IF EXISTS locations_slug_unique; ALTER TABLE IF EXISTS ONLY public.locations DROP CONSTRAINT IF EXISTS locations_pkey; ALTER TABLE IF EXISTS ONLY public.locations DROP CONSTRAINT IF EXISTS locations_name_type_unique; @@ -92,9 +97,10 @@ ALTER TABLE IF EXISTS ONLY public.fda_approvals DROP CONSTRAINT IF EXISTS fda_ap ALTER TABLE IF EXISTS ONLY public.fda_applications DROP CONSTRAINT IF EXISTS fda_applications_pkey; ALTER TABLE IF EXISTS ONLY public.documents DROP CONSTRAINT IF EXISTS documents_pkey; ALTER TABLE IF EXISTS ONLY public.documents DROP CONSTRAINT IF EXISTS documents_fda_approval_id_file_id_name_unique; -ALTER TABLE IF EXISTS ONLY public.document_categories DROP CONSTRAINT IF EXISTS document_categories_pkey; -ALTER TABLE IF EXISTS ONLY public.document_categories DROP CONSTRAINT IF EXISTS document_categories_name_group_unique; +ALTER TABLE IF EXISTS ONLY public.cochrane_reviews DROP CONSTRAINT IF EXISTS cochrane_reviews_pkey; +ALTER TABLE IF EXISTS public.organisation ALTER COLUMN id DROP DEFAULT; ALTER TABLE IF EXISTS public.knex_migrations ALTER COLUMN id DROP DEFAULT; +ALTER TABLE IF EXISTS public.cochrane_reviews ALTER COLUMN id DROP DEFAULT; DROP TABLE IF EXISTS public.trials_publications; DROP TABLE IF EXISTS public.trials_persons; DROP TABLE IF EXISTS public.trials_organisations; @@ -111,6 +117,8 @@ DROP TABLE IF EXISTS public.records; DROP TABLE IF EXISTS public.publications; DROP TABLE IF EXISTS public.persons; DROP TABLE IF EXISTS public.organisations; +DROP SEQUENCE IF EXISTS public.organisation_id_seq; +DROP TABLE IF EXISTS public.organisation; DROP TABLE IF EXISTS public.locations; DROP TABLE IF EXISTS public.knex_migrations_lock; DROP SEQUENCE IF EXISTS public.knex_migrations_id_seq; @@ -120,8 +128,25 @@ DROP TABLE IF EXISTS public.files; DROP TABLE IF EXISTS public.fda_approvals; DROP TABLE IF EXISTS public.fda_applications; DROP TABLE IF EXISTS public.documents; -DROP TABLE IF EXISTS public.document_categories; DROP TABLE IF EXISTS public.conditions; +DROP SEQUENCE IF EXISTS public.cochrane_reviews_id_seq; +DROP TABLE IF EXISTS public.cochrane_reviews; +DROP TYPE IF EXISTS public.trial_record_role; +DROP TYPE IF EXISTS public.trial_publication_role; +DROP TYPE IF EXISTS public.trial_problem_role; +DROP TYPE IF EXISTS public.trial_person_role; +DROP TYPE IF EXISTS public.trial_organisation_role; +DROP TYPE IF EXISTS public.trial_location_role; +DROP TYPE IF EXISTS public.trial_intervention_role; +DROP TYPE IF EXISTS public.trial_document_role; +DROP TYPE IF EXISTS public.source_type; +DROP TYPE IF EXISTS public.record_type; +DROP TYPE IF EXISTS public.publication_type; +DROP TYPE IF EXISTS public.problem_type; +DROP TYPE IF EXISTS public.person_type; +DROP TYPE IF EXISTS public.organisation_type; +DROP TYPE IF EXISTS public.location_type; +DROP TYPE IF EXISTS public.intervention_type; DROP EXTENSION IF EXISTS plpgsql; DROP SCHEMA IF EXISTS public; -- @@ -154,12 +179,206 @@ COMMENT ON EXTENSION plpgsql IS 'PL/pgSQL procedural language'; SET search_path = public, pg_catalog; +-- +-- Name: intervention_type; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE intervention_type AS ENUM ( + 'drug', + 'other' +); + + +-- +-- Name: location_type; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE location_type AS ENUM ( + 'country', + 'city', + 'other' +); + + +-- +-- Name: organisation_type; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE organisation_type AS ENUM ( + 'other' +); + + +-- +-- Name: person_type; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE person_type AS ENUM ( + 'other' +); + + +-- +-- Name: problem_type; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE problem_type AS ENUM ( + 'condition', + 'other' +); + + +-- +-- Name: publication_type; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE publication_type AS ENUM ( + 'other' +); + + +-- +-- Name: record_type; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE record_type AS ENUM ( + 'trial', + 'other' +); + + +-- +-- Name: source_type; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE source_type AS ENUM ( + 'register', + 'other' +); + + +-- +-- Name: trial_document_role; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE trial_document_role AS ENUM ( + 'other' +); + + +-- +-- Name: trial_intervention_role; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE trial_intervention_role AS ENUM ( + 'other' +); + + +-- +-- Name: trial_location_role; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE trial_location_role AS ENUM ( + 'recruitment_countries', + 'other' +); + + +-- +-- Name: trial_organisation_role; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE trial_organisation_role AS ENUM ( + 'primary_sponsor', + 'sponsor', + 'funder', + 'other' +); + + +-- +-- Name: trial_person_role; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE trial_person_role AS ENUM ( + 'principal_investigator', + 'public_queries', + 'scientific_queries', + 'other' +); + + +-- +-- Name: trial_problem_role; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE trial_problem_role AS ENUM ( + 'other' +); + + +-- +-- Name: trial_publication_role; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE trial_publication_role AS ENUM ( + 'other' +); + + +-- +-- Name: trial_record_role; Type: TYPE; Schema: public; Owner: - +-- + +CREATE TYPE trial_record_role AS ENUM ( + 'primary', + 'secondary', + 'other' +); + + SET default_tablespace = ''; SET default_with_oids = false; -- --- Name: conditions; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: cochrane_reviews; Type: TABLE; Schema: public; Owner: - +-- + +CREATE TABLE cochrane_reviews ( + id integer NOT NULL, + study_id text, + refs text, + study_type text, + file_name text, + meta_source text, + robs text, + doi_id text +); + + +-- +-- Name: cochrane_reviews_id_seq; Type: SEQUENCE; Schema: public; Owner: - +-- + +CREATE SEQUENCE cochrane_reviews_id_seq + START WITH 1 + INCREMENT BY 1 + NO MINVALUE + NO MAXVALUE + CACHE 1; + + +-- +-- Name: cochrane_reviews_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - +-- + +ALTER SEQUENCE cochrane_reviews_id_seq OWNED BY cochrane_reviews.id; + + +-- +-- Name: conditions; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE conditions ( @@ -175,34 +394,24 @@ CREATE TABLE conditions ( -- --- Name: document_categories; Type: TABLE; Schema: public; Owner: -; Tablespace: --- - -CREATE TABLE document_categories ( - id integer NOT NULL, - name text NOT NULL, - "group" text -); - - --- --- Name: documents; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: documents; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE documents ( id uuid NOT NULL, source_id text, name text NOT NULL, + type text NOT NULL, fda_approval_id text, file_id uuid, source_url text, - document_category_id integer NOT NULL, + CONSTRAINT documents_type_check CHECK ((type = ANY (ARRAY['csr'::text, 'csr_synopsis'::text, 'epar_segment'::text, 'blank_consent_form'::text, 'patient_information_sheet'::text, 'blank_case_report_form'::text, 'results'::text, 'other'::text]))), CONSTRAINT file_id_xor_source_url_check CHECK ((((file_id IS NULL) AND (source_url IS NOT NULL)) OR ((file_id IS NOT NULL) AND (source_url IS NULL)))) ); -- --- Name: fda_applications; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: fda_applications; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE fda_applications ( @@ -216,7 +425,7 @@ CREATE TABLE fda_applications ( -- --- Name: fda_approvals; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: fda_approvals; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE fda_approvals ( @@ -232,7 +441,7 @@ CREATE TABLE fda_approvals ( -- --- Name: files; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: files; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE files ( @@ -245,7 +454,7 @@ CREATE TABLE files ( -- --- Name: interventions; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: interventions; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE interventions ( @@ -265,7 +474,7 @@ CREATE TABLE interventions ( -- --- Name: knex_migrations; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: knex_migrations; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE knex_migrations ( @@ -296,7 +505,7 @@ ALTER SEQUENCE knex_migrations_id_seq OWNED BY knex_migrations.id; -- --- Name: knex_migrations_lock; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: knex_migrations_lock; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE knex_migrations_lock ( @@ -305,7 +514,7 @@ CREATE TABLE knex_migrations_lock ( -- --- Name: locations; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: locations; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE locations ( @@ -321,7 +530,35 @@ CREATE TABLE locations ( -- --- Name: organisations; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: organisation; Type: TABLE; Schema: public; Owner: - +-- + +CREATE TABLE organisation ( + id integer NOT NULL +); + + +-- +-- Name: organisation_id_seq; Type: SEQUENCE; Schema: public; Owner: - +-- + +CREATE SEQUENCE organisation_id_seq + START WITH 1 + INCREMENT BY 1 + NO MINVALUE + NO MAXVALUE + CACHE 1; + + +-- +-- Name: organisation_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - +-- + +ALTER SEQUENCE organisation_id_seq OWNED BY organisation.id; + + +-- +-- Name: organisations; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE organisations ( @@ -335,7 +572,7 @@ CREATE TABLE organisations ( -- --- Name: persons; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: persons; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE persons ( @@ -349,7 +586,7 @@ CREATE TABLE persons ( -- --- Name: publications; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: publications; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE publications ( @@ -368,13 +605,14 @@ CREATE TABLE publications ( -- --- Name: records; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: records; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE records ( id uuid NOT NULL, source_id text NOT NULL, source_url text NOT NULL, + source_data jsonb NOT NULL, identifiers jsonb NOT NULL, registration_date date, public_title text NOT NULL, @@ -397,16 +635,14 @@ CREATE TABLE records ( trial_id uuid, status text, completion_date date, - results_exemption_date date, - last_verification_date date, - is_primary boolean DEFAULT false, CONSTRAINT records_recruitment_status_check CHECK ((recruitment_status = ANY (ARRAY['recruiting'::text, 'not_recruiting'::text, 'unknown'::text, 'other'::text]))), CONSTRAINT records_status_check CHECK ((status = ANY (ARRAY['ongoing'::text, 'withdrawn'::text, 'suspended'::text, 'terminated'::text, 'complete'::text, 'other'::text]))), CONSTRAINT trialrecords_gender_check CHECK ((gender = ANY (ARRAY['both'::text, 'male'::text, 'female'::text]))) ); + -- --- Name: risk_of_bias_criterias; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: risk_of_bias_criterias; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE risk_of_bias_criterias ( @@ -418,7 +654,7 @@ CREATE TABLE risk_of_bias_criterias ( -- --- Name: risk_of_biases; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: risk_of_biases; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE risk_of_biases ( @@ -433,7 +669,7 @@ CREATE TABLE risk_of_biases ( -- --- Name: risk_of_biases_risk_of_bias_criterias; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: risk_of_biases_risk_of_bias_criterias; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE risk_of_biases_risk_of_bias_criterias ( @@ -445,7 +681,7 @@ CREATE TABLE risk_of_biases_risk_of_bias_criterias ( -- --- Name: sources; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: sources; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE sources ( @@ -459,8 +695,9 @@ CREATE TABLE sources ( CONSTRAINT sources_type_check CHECK ((type = ANY (ARRAY['register'::text, 'other'::text]))) ); + -- --- Name: trials; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: trials; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE trials ( @@ -487,7 +724,6 @@ CREATE TABLE trials ( source_id text, status text, completion_date date, - results_exemption_date date, CONSTRAINT trials_gender_check CHECK ((gender = ANY (ARRAY['both'::text, 'male'::text, 'female'::text]))), CONSTRAINT trials_recruitment_status_check CHECK ((recruitment_status = ANY (ARRAY['recruiting'::text, 'not_recruiting'::text, 'unknown'::text, 'other'::text]))), CONSTRAINT trials_status_check CHECK ((status = ANY (ARRAY['ongoing'::text, 'withdrawn'::text, 'suspended'::text, 'terminated'::text, 'complete'::text, 'other'::text]))) @@ -495,7 +731,7 @@ CREATE TABLE trials ( -- --- Name: trials_conditions; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: trials_conditions; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE trials_conditions ( @@ -505,7 +741,7 @@ CREATE TABLE trials_conditions ( -- --- Name: trials_documents; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: trials_documents; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE trials_documents ( @@ -515,7 +751,7 @@ CREATE TABLE trials_documents ( -- --- Name: trials_interventions; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: trials_interventions; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE trials_interventions ( @@ -525,7 +761,7 @@ CREATE TABLE trials_interventions ( -- --- Name: trials_locations; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: trials_locations; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE trials_locations ( @@ -537,7 +773,7 @@ CREATE TABLE trials_locations ( -- --- Name: trials_organisations; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: trials_organisations; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE trials_organisations ( @@ -549,7 +785,7 @@ CREATE TABLE trials_organisations ( -- --- Name: trials_persons; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: trials_persons; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE trials_persons ( @@ -561,7 +797,7 @@ CREATE TABLE trials_persons ( -- --- Name: trials_publications; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: trials_publications; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE trials_publications ( @@ -570,6 +806,13 @@ CREATE TABLE trials_publications ( ); +-- +-- Name: id; Type: DEFAULT; Schema: public; Owner: - +-- + +ALTER TABLE ONLY cochrane_reviews ALTER COLUMN id SET DEFAULT nextval('cochrane_reviews_id_seq'::regclass); + + -- -- Name: id; Type: DEFAULT; Schema: public; Owner: - -- @@ -578,23 +821,22 @@ ALTER TABLE ONLY knex_migrations ALTER COLUMN id SET DEFAULT nextval('knex_migra -- --- Name: document_categories_name_group_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: id; Type: DEFAULT; Schema: public; Owner: - -- -ALTER TABLE ONLY document_categories - ADD CONSTRAINT document_categories_name_group_unique UNIQUE (name, "group"); +ALTER TABLE ONLY organisation ALTER COLUMN id SET DEFAULT nextval('organisation_id_seq'::regclass); -- --- Name: document_categories_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: cochrane_reviews_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- -ALTER TABLE ONLY document_categories - ADD CONSTRAINT document_categories_pkey PRIMARY KEY (id); +ALTER TABLE ONLY cochrane_reviews + ADD CONSTRAINT cochrane_reviews_pkey PRIMARY KEY (id); -- --- Name: documents_fda_approval_id_file_id_name_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: documents_fda_approval_id_file_id_name_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY documents @@ -602,7 +844,7 @@ ALTER TABLE ONLY documents -- --- Name: documents_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: documents_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY documents @@ -610,7 +852,7 @@ ALTER TABLE ONLY documents -- --- Name: fda_applications_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: fda_applications_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY fda_applications @@ -618,7 +860,7 @@ ALTER TABLE ONLY fda_applications -- --- Name: fda_approvals_fda_application_id_supplement_number_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: fda_approvals_fda_application_id_supplement_number_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY fda_approvals @@ -626,7 +868,7 @@ ALTER TABLE ONLY fda_approvals -- --- Name: fda_approvals_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: fda_approvals_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY fda_approvals @@ -634,7 +876,7 @@ ALTER TABLE ONLY fda_approvals -- --- Name: files_documentcloud_id_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: files_documentcloud_id_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY files @@ -642,7 +884,7 @@ ALTER TABLE ONLY files -- --- Name: files_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: files_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY files @@ -650,7 +892,7 @@ ALTER TABLE ONLY files -- --- Name: files_sha1_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: files_sha1_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY files @@ -658,7 +900,7 @@ ALTER TABLE ONLY files -- --- Name: files_source_url_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: files_source_url_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY files @@ -666,7 +908,7 @@ ALTER TABLE ONLY files -- --- Name: interventions_name_type_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: interventions_name_type_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY interventions @@ -674,7 +916,7 @@ ALTER TABLE ONLY interventions -- --- Name: interventions_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: interventions_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY interventions @@ -682,7 +924,7 @@ ALTER TABLE ONLY interventions -- --- Name: interventions_slug_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: interventions_slug_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY interventions @@ -690,7 +932,7 @@ ALTER TABLE ONLY interventions -- --- Name: knex_migrations_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: knex_migrations_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY knex_migrations @@ -698,7 +940,7 @@ ALTER TABLE ONLY knex_migrations -- --- Name: locations_name_type_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: locations_name_type_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY locations @@ -706,7 +948,7 @@ ALTER TABLE ONLY locations -- --- Name: locations_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: locations_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY locations @@ -714,7 +956,7 @@ ALTER TABLE ONLY locations -- --- Name: locations_slug_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: locations_slug_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY locations @@ -722,7 +964,15 @@ ALTER TABLE ONLY locations -- --- Name: organisations_name_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: organisation_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- + +ALTER TABLE ONLY organisation + ADD CONSTRAINT organisation_pkey PRIMARY KEY (id); + + +-- +-- Name: organisations_name_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY organisations @@ -730,7 +980,7 @@ ALTER TABLE ONLY organisations -- --- Name: organisations_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: organisations_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY organisations @@ -738,7 +988,7 @@ ALTER TABLE ONLY organisations -- --- Name: organisations_slug_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: organisations_slug_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY organisations @@ -746,7 +996,7 @@ ALTER TABLE ONLY organisations -- --- Name: persons_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: persons_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY persons @@ -754,7 +1004,7 @@ ALTER TABLE ONLY persons -- --- Name: persons_slug_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: persons_slug_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY persons @@ -762,7 +1012,7 @@ ALTER TABLE ONLY persons -- --- Name: problems_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: problems_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY conditions @@ -770,7 +1020,7 @@ ALTER TABLE ONLY conditions -- --- Name: problems_slug_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: problems_slug_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY conditions @@ -778,7 +1028,7 @@ ALTER TABLE ONLY conditions -- --- Name: publications_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: publications_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY publications @@ -786,7 +1036,7 @@ ALTER TABLE ONLY publications -- --- Name: publications_slug_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: publications_slug_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY publications @@ -794,15 +1044,7 @@ ALTER TABLE ONLY publications -- --- Name: records_source_url_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: --- - -ALTER TABLE ONLY records - ADD CONSTRAINT records_source_url_unique UNIQUE (source_url); - - --- --- Name: risk_of_bias_criterias_name_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: risk_of_bias_criterias_name_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY risk_of_bias_criterias @@ -810,7 +1052,7 @@ ALTER TABLE ONLY risk_of_bias_criterias -- --- Name: risk_of_bias_criterias_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: risk_of_bias_criterias_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY risk_of_bias_criterias @@ -818,7 +1060,7 @@ ALTER TABLE ONLY risk_of_bias_criterias -- --- Name: risk_of_biases_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: risk_of_biases_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY risk_of_biases @@ -826,7 +1068,7 @@ ALTER TABLE ONLY risk_of_biases -- --- Name: risk_of_biases_risk_of_bias_criterias_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: risk_of_biases_risk_of_bias_criterias_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY risk_of_biases_risk_of_bias_criterias @@ -834,7 +1076,7 @@ ALTER TABLE ONLY risk_of_biases_risk_of_bias_criterias -- --- Name: risk_of_biases_study_id_source_url_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: risk_of_biases_study_id_source_url_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY risk_of_biases @@ -842,7 +1084,7 @@ ALTER TABLE ONLY risk_of_biases -- --- Name: sources_name_type_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: sources_name_type_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY sources @@ -850,7 +1092,7 @@ ALTER TABLE ONLY sources -- --- Name: sources_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: sources_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY sources @@ -858,7 +1100,7 @@ ALTER TABLE ONLY sources -- --- Name: trialrecords_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: trialrecords_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY records @@ -866,7 +1108,7 @@ ALTER TABLE ONLY records -- --- Name: trials_documents_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: trials_documents_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY trials_documents @@ -874,7 +1116,7 @@ ALTER TABLE ONLY trials_documents -- --- Name: trials_interventions_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: trials_interventions_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY trials_interventions @@ -882,7 +1124,7 @@ ALTER TABLE ONLY trials_interventions -- --- Name: trials_locations_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: trials_locations_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY trials_locations @@ -890,7 +1132,7 @@ ALTER TABLE ONLY trials_locations -- --- Name: trials_organisations_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: trials_organisations_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY trials_organisations @@ -898,7 +1140,7 @@ ALTER TABLE ONLY trials_organisations -- --- Name: trials_persons_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: trials_persons_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY trials_persons @@ -906,7 +1148,7 @@ ALTER TABLE ONLY trials_persons -- --- Name: trials_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: trials_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY trials @@ -914,7 +1156,7 @@ ALTER TABLE ONLY trials -- --- Name: trials_problems_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: trials_problems_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY trials_conditions @@ -922,7 +1164,7 @@ ALTER TABLE ONLY trials_conditions -- --- Name: trials_publications_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: trials_publications_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY trials_publications @@ -930,46 +1172,52 @@ ALTER TABLE ONLY trials_publications -- --- Name: fda_approvals_type_index; Type: INDEX; Schema: public; Owner: -; Tablespace: +-- Name: fda_approvals_type_index; Type: INDEX; Schema: public; Owner: - -- CREATE INDEX fda_approvals_type_index ON fda_approvals USING btree (type); -- --- Name: interventions_fda_application_number_index; Type: INDEX; Schema: public; Owner: -; Tablespace: +-- Name: interventions_fda_application_number_index; Type: INDEX; Schema: public; Owner: - -- CREATE INDEX interventions_fda_application_number_index ON interventions USING btree (fda_application_id); -- --- Name: records_identifiers_index; Type: INDEX; Schema: public; Owner: -; Tablespace: +-- Name: non_fda_documents_type_file_id_unique; Type: INDEX; Schema: public; Owner: - -- -CREATE INDEX records_identifiers_index ON records USING gin (identifiers); +CREATE UNIQUE INDEX non_fda_documents_type_file_id_unique ON documents USING btree (type, file_id) WHERE (fda_approval_id IS NULL); -- --- Name: trialrecords_trial_id_index; Type: INDEX; Schema: public; Owner: -; Tablespace: +-- Name: non_fda_documents_type_source_url_unique; Type: INDEX; Schema: public; Owner: - -- -CREATE INDEX trialrecords_trial_id_index ON records USING btree (trial_id); +CREATE UNIQUE INDEX non_fda_documents_type_source_url_unique ON documents USING btree (type, source_url) WHERE (fda_approval_id IS NULL); -- --- Name: trials_documents_document_id_index; Type: INDEX; Schema: public; Owner: -; Tablespace: +-- Name: records_identifiers_index; Type: INDEX; Schema: public; Owner: - -- -CREATE INDEX trials_documents_document_id_index ON trials_documents USING btree (document_id); +CREATE INDEX records_identifiers_index ON records USING gin (identifiers); -- --- Name: documents_document_category_id_foreign; Type: FK CONSTRAINT; Schema: public; Owner: - +-- Name: trialrecords_trial_id_index; Type: INDEX; Schema: public; Owner: - -- -ALTER TABLE ONLY documents - ADD CONSTRAINT documents_document_category_id_foreign FOREIGN KEY (document_category_id) REFERENCES document_categories(id); +CREATE INDEX trialrecords_trial_id_index ON records USING btree (trial_id); + + +-- +-- Name: trials_documents_document_id_index; Type: INDEX; Schema: public; Owner: - +-- + +CREATE INDEX trials_documents_document_id_index ON trials_documents USING btree (document_id); -- diff --git a/tests/dbs/warehouse_schema_dump.sql b/tests/dbs/warehouse_schema_dump.sql index fd4ecdc..6c57565 100644 --- a/tests/dbs/warehouse_schema_dump.sql +++ b/tests/dbs/warehouse_schema_dump.sql @@ -2,15 +2,22 @@ -- PostgreSQL database dump -- +-- Dumped from database version 9.5.5 +-- Dumped by pg_dump version 9.5.5 + SET statement_timeout = 0; SET lock_timeout = 0; SET client_encoding = 'UTF8'; SET standard_conforming_strings = on; SET check_function_bodies = false; SET client_min_messages = warning; +SET row_security = off; SET search_path = public, pg_catalog; +DROP INDEX IF EXISTS public.ix_takeda_f580ee1a7559876f; +DROP INDEX IF EXISTS public.ix_pubmed_ec44fdfeccd66661; +DROP INDEX IF EXISTS public.ix_pfizer_9502f58393a4fc6d; DROP INDEX IF EXISTS public.ix_nct_9502f58393a4fc6d; DROP INDEX IF EXISTS public.ix_jprn_4e2a0ce8f4508948; DROP INDEX IF EXISTS public.ix_isrctn_5630355bbd51c4b7; @@ -50,6 +57,7 @@ ALTER TABLE IF EXISTS ONLY public.actrn DROP CONSTRAINT IF EXISTS actrn_meta_id_ DROP TABLE IF EXISTS public.takeda; DROP TABLE IF EXISTS public.pubmed; DROP TABLE IF EXISTS public.pfizer; +DROP TABLE IF EXISTS public.organisation_clusters; DROP TABLE IF EXISTS public.nct; DROP TABLE IF EXISTS public.jprn; DROP TABLE IF EXISTS public.isrctn; @@ -101,7 +109,7 @@ SET default_tablespace = ''; SET default_with_oids = false; -- --- Name: actrn; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: actrn; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE actrn ( @@ -176,7 +184,7 @@ CREATE TABLE actrn ( -- --- Name: alembic_version; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: alembic_version; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE alembic_version ( @@ -185,7 +193,7 @@ CREATE TABLE alembic_version ( -- --- Name: cochrane_reviews; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: cochrane_reviews; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE cochrane_reviews ( @@ -204,7 +212,7 @@ CREATE TABLE cochrane_reviews ( -- --- Name: euctr; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: euctr; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE euctr ( @@ -335,7 +343,7 @@ CREATE TABLE euctr ( -- --- Name: fda_dap; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: fda_dap; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE fda_dap ( @@ -357,7 +365,7 @@ CREATE TABLE fda_dap ( -- --- Name: fdadl; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: fdadl; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE fdadl ( @@ -375,7 +383,7 @@ CREATE TABLE fdadl ( -- --- Name: gsk; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: gsk; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE gsk ( @@ -471,7 +479,7 @@ CREATE TABLE gsk ( -- --- Name: hra; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: hra; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE hra ( @@ -524,7 +532,7 @@ CREATE TABLE hra ( -- --- Name: icdcm; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: icdcm; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE icdcm ( @@ -541,7 +549,7 @@ CREATE TABLE icdcm ( -- --- Name: icdpcs; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: icdpcs; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE icdpcs ( @@ -559,7 +567,7 @@ CREATE TABLE icdpcs ( -- --- Name: ictrp; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: ictrp; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE ictrp ( @@ -595,7 +603,7 @@ CREATE TABLE ictrp ( -- --- Name: isrctn; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: isrctn; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE isrctn ( @@ -661,7 +669,7 @@ CREATE TABLE isrctn ( -- --- Name: jprn; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: jprn; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE jprn ( @@ -756,7 +764,7 @@ CREATE TABLE jprn ( -- --- Name: nct; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: nct; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE nct ( @@ -823,13 +831,22 @@ CREATE TABLE nct ( clinical_results jsonb, nct_aliases text[], removed_countries text[], - biospec_desrc text, - results_exemption_date date + biospec_desrc text ); -- --- Name: pfizer; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: organisation_clusters; Type: TABLE; Schema: public; Owner: - +-- + +CREATE TABLE organisation_clusters ( + canonical text, + variations text[] +); + + +-- +-- Name: pfizer; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE pfizer ( @@ -852,7 +869,7 @@ CREATE TABLE pfizer ( -- --- Name: pubmed; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: pubmed; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE pubmed ( @@ -885,7 +902,7 @@ CREATE TABLE pubmed ( -- --- Name: takeda; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- Name: takeda; Type: TABLE; Schema: public; Owner: - -- CREATE TABLE takeda ( @@ -924,7 +941,7 @@ CREATE TABLE takeda ( -- --- Name: actrn_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: actrn_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY actrn @@ -932,7 +949,7 @@ ALTER TABLE ONLY actrn -- --- Name: actrn_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: actrn_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY actrn @@ -940,7 +957,7 @@ ALTER TABLE ONLY actrn -- --- Name: cochrane_reviews_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: cochrane_reviews_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY cochrane_reviews @@ -948,7 +965,7 @@ ALTER TABLE ONLY cochrane_reviews -- --- Name: euctr_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: euctr_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY euctr @@ -956,7 +973,7 @@ ALTER TABLE ONLY euctr -- --- Name: euctr_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: euctr_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY euctr @@ -964,7 +981,7 @@ ALTER TABLE ONLY euctr -- --- Name: fda_dap_id_key; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: fda_dap_id_key; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY fda_dap @@ -972,7 +989,7 @@ ALTER TABLE ONLY fda_dap -- --- Name: fda_dap_meta_id_key; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: fda_dap_meta_id_key; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY fda_dap @@ -980,7 +997,7 @@ ALTER TABLE ONLY fda_dap -- --- Name: fda_meta_id_key; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: fda_meta_id_key; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY fdadl @@ -988,7 +1005,7 @@ ALTER TABLE ONLY fdadl -- --- Name: fda_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: fda_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY fdadl @@ -996,7 +1013,7 @@ ALTER TABLE ONLY fdadl -- --- Name: gsk_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: gsk_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY gsk @@ -1004,7 +1021,7 @@ ALTER TABLE ONLY gsk -- --- Name: gsk_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: gsk_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY gsk @@ -1012,7 +1029,7 @@ ALTER TABLE ONLY gsk -- --- Name: hra_meta_id_key; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: hra_meta_id_key; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY hra @@ -1020,7 +1037,7 @@ ALTER TABLE ONLY hra -- --- Name: icdcm_meta_id_key; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: icdcm_meta_id_key; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY icdcm @@ -1028,7 +1045,7 @@ ALTER TABLE ONLY icdcm -- --- Name: icdcm_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: icdcm_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY icdcm @@ -1036,7 +1053,7 @@ ALTER TABLE ONLY icdcm -- --- Name: icdpcs_meta_id_key; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: icdpcs_meta_id_key; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY icdpcs @@ -1044,7 +1061,7 @@ ALTER TABLE ONLY icdpcs -- --- Name: icdpcs_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: icdpcs_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY icdpcs @@ -1052,7 +1069,7 @@ ALTER TABLE ONLY icdpcs -- --- Name: ictrp_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: ictrp_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY ictrp @@ -1060,7 +1077,7 @@ ALTER TABLE ONLY ictrp -- --- Name: ictrp_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: ictrp_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY ictrp @@ -1068,7 +1085,7 @@ ALTER TABLE ONLY ictrp -- --- Name: isrctn_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: isrctn_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY isrctn @@ -1076,7 +1093,7 @@ ALTER TABLE ONLY isrctn -- --- Name: isrctn_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: isrctn_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY isrctn @@ -1084,7 +1101,7 @@ ALTER TABLE ONLY isrctn -- --- Name: jprn_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: jprn_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY jprn @@ -1092,7 +1109,7 @@ ALTER TABLE ONLY jprn -- --- Name: jprn_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: jprn_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY jprn @@ -1100,7 +1117,7 @@ ALTER TABLE ONLY jprn -- --- Name: nct_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: nct_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY nct @@ -1108,7 +1125,7 @@ ALTER TABLE ONLY nct -- --- Name: nct_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: nct_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY nct @@ -1116,7 +1133,7 @@ ALTER TABLE ONLY nct -- --- Name: pfizer_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: pfizer_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY pfizer @@ -1124,7 +1141,7 @@ ALTER TABLE ONLY pfizer -- --- Name: pfizer_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: pfizer_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY pfizer @@ -1132,7 +1149,7 @@ ALTER TABLE ONLY pfizer -- --- Name: pubmed_meta_id_key; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: pubmed_meta_id_key; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY pubmed @@ -1140,7 +1157,7 @@ ALTER TABLE ONLY pubmed -- --- Name: pubmed_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: pubmed_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY pubmed @@ -1148,7 +1165,7 @@ ALTER TABLE ONLY pubmed -- --- Name: takeda_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: takeda_meta_id_unique; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY takeda @@ -1156,7 +1173,7 @@ ALTER TABLE ONLY takeda -- --- Name: takeda_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- Name: takeda_pkey; Type: CONSTRAINT; Schema: public; Owner: - -- ALTER TABLE ONLY takeda @@ -1164,47 +1181,68 @@ ALTER TABLE ONLY takeda -- --- Name: ix_actrn_9b88700fa823eea2; Type: INDEX; Schema: public; Owner: -; Tablespace: +-- Name: ix_actrn_9b88700fa823eea2; Type: INDEX; Schema: public; Owner: - -- CREATE INDEX ix_actrn_9b88700fa823eea2 ON actrn USING btree (trial_id); -- --- Name: ix_euctr_86a28cd2542cd0c4; Type: INDEX; Schema: public; Owner: -; Tablespace: +-- Name: ix_euctr_86a28cd2542cd0c4; Type: INDEX; Schema: public; Owner: - -- CREATE INDEX ix_euctr_86a28cd2542cd0c4 ON euctr USING btree (eudract_number_with_country); -- --- Name: ix_gsk_ae14dbea0172b852; Type: INDEX; Schema: public; Owner: -; Tablespace: +-- Name: ix_gsk_ae14dbea0172b852; Type: INDEX; Schema: public; Owner: - -- CREATE INDEX ix_gsk_ae14dbea0172b852 ON gsk USING btree (study_id); -- --- Name: ix_isrctn_5630355bbd51c4b7; Type: INDEX; Schema: public; Owner: -; Tablespace: +-- Name: ix_isrctn_5630355bbd51c4b7; Type: INDEX; Schema: public; Owner: - -- CREATE INDEX ix_isrctn_5630355bbd51c4b7 ON isrctn USING btree (isrctn_id); -- --- Name: ix_jprn_4e2a0ce8f4508948; Type: INDEX; Schema: public; Owner: -; Tablespace: +-- Name: ix_jprn_4e2a0ce8f4508948; Type: INDEX; Schema: public; Owner: - -- CREATE INDEX ix_jprn_4e2a0ce8f4508948 ON jprn USING btree (unique_trial_number); -- --- Name: ix_nct_9502f58393a4fc6d; Type: INDEX; Schema: public; Owner: -; Tablespace: +-- Name: ix_nct_9502f58393a4fc6d; Type: INDEX; Schema: public; Owner: - -- CREATE INDEX ix_nct_9502f58393a4fc6d ON nct USING btree (nct_id); +-- +-- Name: ix_pfizer_9502f58393a4fc6d; Type: INDEX; Schema: public; Owner: - +-- + +CREATE INDEX ix_pfizer_9502f58393a4fc6d ON pfizer USING btree (nct_id); + + +-- +-- Name: ix_pubmed_ec44fdfeccd66661; Type: INDEX; Schema: public; Owner: - +-- + +CREATE INDEX ix_pubmed_ec44fdfeccd66661 ON pubmed USING btree (pmid); + + +-- +-- Name: ix_takeda_f580ee1a7559876f; Type: INDEX; Schema: public; Owner: - +-- + +CREATE INDEX ix_takeda_f580ee1a7559876f ON takeda USING btree (takeda_trial_id); + + -- -- PostgreSQL database dump complete -- From c2835f7d03721d04b3cd5a24d6b1812828a82147 Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Thu, 9 Feb 2017 16:43:08 -0300 Subject: [PATCH 17/23] Revert api database schema --- tests/dbs/opentrials_api_schema_dump.sql | 472 ++++++----------------- 1 file changed, 112 insertions(+), 360 deletions(-) diff --git a/tests/dbs/opentrials_api_schema_dump.sql b/tests/dbs/opentrials_api_schema_dump.sql index dbb9aac..050464f 100644 --- a/tests/dbs/opentrials_api_schema_dump.sql +++ b/tests/dbs/opentrials_api_schema_dump.sql @@ -2,16 +2,12 @@ -- PostgreSQL database dump -- --- Dumped from database version 9.5.5 --- Dumped by pg_dump version 9.5.5 - SET statement_timeout = 0; SET lock_timeout = 0; SET client_encoding = 'UTF8'; SET standard_conforming_strings = on; SET check_function_bodies = false; SET client_min_messages = warning; -SET row_security = off; SET search_path = public, pg_catalog; @@ -48,11 +44,10 @@ ALTER TABLE IF EXISTS ONLY public.fda_applications DROP CONSTRAINT IF EXISTS fda ALTER TABLE IF EXISTS ONLY public.documents DROP CONSTRAINT IF EXISTS documents_source_id_foreign; ALTER TABLE IF EXISTS ONLY public.documents DROP CONSTRAINT IF EXISTS documents_file_id_foreign; ALTER TABLE IF EXISTS ONLY public.documents DROP CONSTRAINT IF EXISTS documents_fda_approval_id_foreign; +ALTER TABLE IF EXISTS ONLY public.documents DROP CONSTRAINT IF EXISTS documents_document_category_id_foreign; DROP INDEX IF EXISTS public.trials_documents_document_id_index; DROP INDEX IF EXISTS public.trialrecords_trial_id_index; DROP INDEX IF EXISTS public.records_identifiers_index; -DROP INDEX IF EXISTS public.non_fda_documents_type_source_url_unique; -DROP INDEX IF EXISTS public.non_fda_documents_type_file_id_unique; DROP INDEX IF EXISTS public.interventions_fda_application_number_index; DROP INDEX IF EXISTS public.fda_approvals_type_index; ALTER TABLE IF EXISTS ONLY public.trials_publications DROP CONSTRAINT IF EXISTS trials_publications_pkey; @@ -71,6 +66,7 @@ ALTER TABLE IF EXISTS ONLY public.risk_of_biases_risk_of_bias_criterias DROP CON ALTER TABLE IF EXISTS ONLY public.risk_of_biases DROP CONSTRAINT IF EXISTS risk_of_biases_pkey; ALTER TABLE IF EXISTS ONLY public.risk_of_bias_criterias DROP CONSTRAINT IF EXISTS risk_of_bias_criterias_pkey; ALTER TABLE IF EXISTS ONLY public.risk_of_bias_criterias DROP CONSTRAINT IF EXISTS risk_of_bias_criterias_name_unique; +ALTER TABLE IF EXISTS ONLY public.records DROP CONSTRAINT IF EXISTS records_source_url_unique; ALTER TABLE IF EXISTS ONLY public.publications DROP CONSTRAINT IF EXISTS publications_slug_unique; ALTER TABLE IF EXISTS ONLY public.publications DROP CONSTRAINT IF EXISTS publications_pkey; ALTER TABLE IF EXISTS ONLY public.conditions DROP CONSTRAINT IF EXISTS problems_slug_unique; @@ -80,7 +76,6 @@ ALTER TABLE IF EXISTS ONLY public.persons DROP CONSTRAINT IF EXISTS persons_pkey ALTER TABLE IF EXISTS ONLY public.organisations DROP CONSTRAINT IF EXISTS organisations_slug_unique; ALTER TABLE IF EXISTS ONLY public.organisations DROP CONSTRAINT IF EXISTS organisations_pkey; ALTER TABLE IF EXISTS ONLY public.organisations DROP CONSTRAINT IF EXISTS organisations_name_unique; -ALTER TABLE IF EXISTS ONLY public.organisation DROP CONSTRAINT IF EXISTS organisation_pkey; ALTER TABLE IF EXISTS ONLY public.locations DROP CONSTRAINT IF EXISTS locations_slug_unique; ALTER TABLE IF EXISTS ONLY public.locations DROP CONSTRAINT IF EXISTS locations_pkey; ALTER TABLE IF EXISTS ONLY public.locations DROP CONSTRAINT IF EXISTS locations_name_type_unique; @@ -97,10 +92,9 @@ ALTER TABLE IF EXISTS ONLY public.fda_approvals DROP CONSTRAINT IF EXISTS fda_ap ALTER TABLE IF EXISTS ONLY public.fda_applications DROP CONSTRAINT IF EXISTS fda_applications_pkey; ALTER TABLE IF EXISTS ONLY public.documents DROP CONSTRAINT IF EXISTS documents_pkey; ALTER TABLE IF EXISTS ONLY public.documents DROP CONSTRAINT IF EXISTS documents_fda_approval_id_file_id_name_unique; -ALTER TABLE IF EXISTS ONLY public.cochrane_reviews DROP CONSTRAINT IF EXISTS cochrane_reviews_pkey; -ALTER TABLE IF EXISTS public.organisation ALTER COLUMN id DROP DEFAULT; +ALTER TABLE IF EXISTS ONLY public.document_categories DROP CONSTRAINT IF EXISTS document_categories_pkey; +ALTER TABLE IF EXISTS ONLY public.document_categories DROP CONSTRAINT IF EXISTS document_categories_name_group_unique; ALTER TABLE IF EXISTS public.knex_migrations ALTER COLUMN id DROP DEFAULT; -ALTER TABLE IF EXISTS public.cochrane_reviews ALTER COLUMN id DROP DEFAULT; DROP TABLE IF EXISTS public.trials_publications; DROP TABLE IF EXISTS public.trials_persons; DROP TABLE IF EXISTS public.trials_organisations; @@ -117,8 +111,6 @@ DROP TABLE IF EXISTS public.records; DROP TABLE IF EXISTS public.publications; DROP TABLE IF EXISTS public.persons; DROP TABLE IF EXISTS public.organisations; -DROP SEQUENCE IF EXISTS public.organisation_id_seq; -DROP TABLE IF EXISTS public.organisation; DROP TABLE IF EXISTS public.locations; DROP TABLE IF EXISTS public.knex_migrations_lock; DROP SEQUENCE IF EXISTS public.knex_migrations_id_seq; @@ -128,25 +120,8 @@ DROP TABLE IF EXISTS public.files; DROP TABLE IF EXISTS public.fda_approvals; DROP TABLE IF EXISTS public.fda_applications; DROP TABLE IF EXISTS public.documents; +DROP TABLE IF EXISTS public.document_categories; DROP TABLE IF EXISTS public.conditions; -DROP SEQUENCE IF EXISTS public.cochrane_reviews_id_seq; -DROP TABLE IF EXISTS public.cochrane_reviews; -DROP TYPE IF EXISTS public.trial_record_role; -DROP TYPE IF EXISTS public.trial_publication_role; -DROP TYPE IF EXISTS public.trial_problem_role; -DROP TYPE IF EXISTS public.trial_person_role; -DROP TYPE IF EXISTS public.trial_organisation_role; -DROP TYPE IF EXISTS public.trial_location_role; -DROP TYPE IF EXISTS public.trial_intervention_role; -DROP TYPE IF EXISTS public.trial_document_role; -DROP TYPE IF EXISTS public.source_type; -DROP TYPE IF EXISTS public.record_type; -DROP TYPE IF EXISTS public.publication_type; -DROP TYPE IF EXISTS public.problem_type; -DROP TYPE IF EXISTS public.person_type; -DROP TYPE IF EXISTS public.organisation_type; -DROP TYPE IF EXISTS public.location_type; -DROP TYPE IF EXISTS public.intervention_type; DROP EXTENSION IF EXISTS plpgsql; DROP SCHEMA IF EXISTS public; -- @@ -179,206 +154,12 @@ COMMENT ON EXTENSION plpgsql IS 'PL/pgSQL procedural language'; SET search_path = public, pg_catalog; --- --- Name: intervention_type; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE intervention_type AS ENUM ( - 'drug', - 'other' -); - - --- --- Name: location_type; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE location_type AS ENUM ( - 'country', - 'city', - 'other' -); - - --- --- Name: organisation_type; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE organisation_type AS ENUM ( - 'other' -); - - --- --- Name: person_type; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE person_type AS ENUM ( - 'other' -); - - --- --- Name: problem_type; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE problem_type AS ENUM ( - 'condition', - 'other' -); - - --- --- Name: publication_type; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE publication_type AS ENUM ( - 'other' -); - - --- --- Name: record_type; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE record_type AS ENUM ( - 'trial', - 'other' -); - - --- --- Name: source_type; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE source_type AS ENUM ( - 'register', - 'other' -); - - --- --- Name: trial_document_role; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE trial_document_role AS ENUM ( - 'other' -); - - --- --- Name: trial_intervention_role; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE trial_intervention_role AS ENUM ( - 'other' -); - - --- --- Name: trial_location_role; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE trial_location_role AS ENUM ( - 'recruitment_countries', - 'other' -); - - --- --- Name: trial_organisation_role; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE trial_organisation_role AS ENUM ( - 'primary_sponsor', - 'sponsor', - 'funder', - 'other' -); - - --- --- Name: trial_person_role; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE trial_person_role AS ENUM ( - 'principal_investigator', - 'public_queries', - 'scientific_queries', - 'other' -); - - --- --- Name: trial_problem_role; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE trial_problem_role AS ENUM ( - 'other' -); - - --- --- Name: trial_publication_role; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE trial_publication_role AS ENUM ( - 'other' -); - - --- --- Name: trial_record_role; Type: TYPE; Schema: public; Owner: - --- - -CREATE TYPE trial_record_role AS ENUM ( - 'primary', - 'secondary', - 'other' -); - - SET default_tablespace = ''; SET default_with_oids = false; -- --- Name: cochrane_reviews; Type: TABLE; Schema: public; Owner: - --- - -CREATE TABLE cochrane_reviews ( - id integer NOT NULL, - study_id text, - refs text, - study_type text, - file_name text, - meta_source text, - robs text, - doi_id text -); - - --- --- Name: cochrane_reviews_id_seq; Type: SEQUENCE; Schema: public; Owner: - --- - -CREATE SEQUENCE cochrane_reviews_id_seq - START WITH 1 - INCREMENT BY 1 - NO MINVALUE - NO MAXVALUE - CACHE 1; - - --- --- Name: cochrane_reviews_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - --- - -ALTER SEQUENCE cochrane_reviews_id_seq OWNED BY cochrane_reviews.id; - - --- --- Name: conditions; Type: TABLE; Schema: public; Owner: - +-- Name: conditions; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE conditions ( @@ -394,24 +175,34 @@ CREATE TABLE conditions ( -- --- Name: documents; Type: TABLE; Schema: public; Owner: - +-- Name: document_categories; Type: TABLE; Schema: public; Owner: -; Tablespace: +-- + +CREATE TABLE document_categories ( + id integer NOT NULL, + name text NOT NULL, + "group" text +); + + +-- +-- Name: documents; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE documents ( id uuid NOT NULL, source_id text, name text NOT NULL, - type text NOT NULL, fda_approval_id text, file_id uuid, source_url text, - CONSTRAINT documents_type_check CHECK ((type = ANY (ARRAY['csr'::text, 'csr_synopsis'::text, 'epar_segment'::text, 'blank_consent_form'::text, 'patient_information_sheet'::text, 'blank_case_report_form'::text, 'results'::text, 'other'::text]))), + document_category_id integer NOT NULL, CONSTRAINT file_id_xor_source_url_check CHECK ((((file_id IS NULL) AND (source_url IS NOT NULL)) OR ((file_id IS NOT NULL) AND (source_url IS NULL)))) ); -- --- Name: fda_applications; Type: TABLE; Schema: public; Owner: - +-- Name: fda_applications; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE fda_applications ( @@ -425,7 +216,7 @@ CREATE TABLE fda_applications ( -- --- Name: fda_approvals; Type: TABLE; Schema: public; Owner: - +-- Name: fda_approvals; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE fda_approvals ( @@ -441,7 +232,7 @@ CREATE TABLE fda_approvals ( -- --- Name: files; Type: TABLE; Schema: public; Owner: - +-- Name: files; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE files ( @@ -454,7 +245,7 @@ CREATE TABLE files ( -- --- Name: interventions; Type: TABLE; Schema: public; Owner: - +-- Name: interventions; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE interventions ( @@ -474,7 +265,7 @@ CREATE TABLE interventions ( -- --- Name: knex_migrations; Type: TABLE; Schema: public; Owner: - +-- Name: knex_migrations; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE knex_migrations ( @@ -505,7 +296,7 @@ ALTER SEQUENCE knex_migrations_id_seq OWNED BY knex_migrations.id; -- --- Name: knex_migrations_lock; Type: TABLE; Schema: public; Owner: - +-- Name: knex_migrations_lock; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE knex_migrations_lock ( @@ -514,7 +305,7 @@ CREATE TABLE knex_migrations_lock ( -- --- Name: locations; Type: TABLE; Schema: public; Owner: - +-- Name: locations; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE locations ( @@ -530,35 +321,7 @@ CREATE TABLE locations ( -- --- Name: organisation; Type: TABLE; Schema: public; Owner: - --- - -CREATE TABLE organisation ( - id integer NOT NULL -); - - --- --- Name: organisation_id_seq; Type: SEQUENCE; Schema: public; Owner: - --- - -CREATE SEQUENCE organisation_id_seq - START WITH 1 - INCREMENT BY 1 - NO MINVALUE - NO MAXVALUE - CACHE 1; - - --- --- Name: organisation_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: - --- - -ALTER SEQUENCE organisation_id_seq OWNED BY organisation.id; - - --- --- Name: organisations; Type: TABLE; Schema: public; Owner: - +-- Name: organisations; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE organisations ( @@ -572,7 +335,7 @@ CREATE TABLE organisations ( -- --- Name: persons; Type: TABLE; Schema: public; Owner: - +-- Name: persons; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE persons ( @@ -586,7 +349,7 @@ CREATE TABLE persons ( -- --- Name: publications; Type: TABLE; Schema: public; Owner: - +-- Name: publications; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE publications ( @@ -605,14 +368,13 @@ CREATE TABLE publications ( -- --- Name: records; Type: TABLE; Schema: public; Owner: - +-- Name: records; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE records ( id uuid NOT NULL, source_id text NOT NULL, source_url text NOT NULL, - source_data jsonb NOT NULL, identifiers jsonb NOT NULL, registration_date date, public_title text NOT NULL, @@ -635,14 +397,16 @@ CREATE TABLE records ( trial_id uuid, status text, completion_date date, + results_exemption_date date, + last_verification_date date, + is_primary boolean DEFAULT false, CONSTRAINT records_recruitment_status_check CHECK ((recruitment_status = ANY (ARRAY['recruiting'::text, 'not_recruiting'::text, 'unknown'::text, 'other'::text]))), CONSTRAINT records_status_check CHECK ((status = ANY (ARRAY['ongoing'::text, 'withdrawn'::text, 'suspended'::text, 'terminated'::text, 'complete'::text, 'other'::text]))), CONSTRAINT trialrecords_gender_check CHECK ((gender = ANY (ARRAY['both'::text, 'male'::text, 'female'::text]))) ); - -- --- Name: risk_of_bias_criterias; Type: TABLE; Schema: public; Owner: - +-- Name: risk_of_bias_criterias; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE risk_of_bias_criterias ( @@ -654,7 +418,7 @@ CREATE TABLE risk_of_bias_criterias ( -- --- Name: risk_of_biases; Type: TABLE; Schema: public; Owner: - +-- Name: risk_of_biases; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE risk_of_biases ( @@ -669,7 +433,7 @@ CREATE TABLE risk_of_biases ( -- --- Name: risk_of_biases_risk_of_bias_criterias; Type: TABLE; Schema: public; Owner: - +-- Name: risk_of_biases_risk_of_bias_criterias; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE risk_of_biases_risk_of_bias_criterias ( @@ -681,7 +445,7 @@ CREATE TABLE risk_of_biases_risk_of_bias_criterias ( -- --- Name: sources; Type: TABLE; Schema: public; Owner: - +-- Name: sources; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE sources ( @@ -695,9 +459,8 @@ CREATE TABLE sources ( CONSTRAINT sources_type_check CHECK ((type = ANY (ARRAY['register'::text, 'other'::text]))) ); - -- --- Name: trials; Type: TABLE; Schema: public; Owner: - +-- Name: trials; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE trials ( @@ -724,6 +487,7 @@ CREATE TABLE trials ( source_id text, status text, completion_date date, + results_exemption_date date, CONSTRAINT trials_gender_check CHECK ((gender = ANY (ARRAY['both'::text, 'male'::text, 'female'::text]))), CONSTRAINT trials_recruitment_status_check CHECK ((recruitment_status = ANY (ARRAY['recruiting'::text, 'not_recruiting'::text, 'unknown'::text, 'other'::text]))), CONSTRAINT trials_status_check CHECK ((status = ANY (ARRAY['ongoing'::text, 'withdrawn'::text, 'suspended'::text, 'terminated'::text, 'complete'::text, 'other'::text]))) @@ -731,7 +495,7 @@ CREATE TABLE trials ( -- --- Name: trials_conditions; Type: TABLE; Schema: public; Owner: - +-- Name: trials_conditions; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE trials_conditions ( @@ -741,7 +505,7 @@ CREATE TABLE trials_conditions ( -- --- Name: trials_documents; Type: TABLE; Schema: public; Owner: - +-- Name: trials_documents; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE trials_documents ( @@ -751,7 +515,7 @@ CREATE TABLE trials_documents ( -- --- Name: trials_interventions; Type: TABLE; Schema: public; Owner: - +-- Name: trials_interventions; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE trials_interventions ( @@ -761,7 +525,7 @@ CREATE TABLE trials_interventions ( -- --- Name: trials_locations; Type: TABLE; Schema: public; Owner: - +-- Name: trials_locations; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE trials_locations ( @@ -773,7 +537,7 @@ CREATE TABLE trials_locations ( -- --- Name: trials_organisations; Type: TABLE; Schema: public; Owner: - +-- Name: trials_organisations; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE trials_organisations ( @@ -785,7 +549,7 @@ CREATE TABLE trials_organisations ( -- --- Name: trials_persons; Type: TABLE; Schema: public; Owner: - +-- Name: trials_persons; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE trials_persons ( @@ -797,7 +561,7 @@ CREATE TABLE trials_persons ( -- --- Name: trials_publications; Type: TABLE; Schema: public; Owner: - +-- Name: trials_publications; Type: TABLE; Schema: public; Owner: -; Tablespace: -- CREATE TABLE trials_publications ( @@ -806,13 +570,6 @@ CREATE TABLE trials_publications ( ); --- --- Name: id; Type: DEFAULT; Schema: public; Owner: - --- - -ALTER TABLE ONLY cochrane_reviews ALTER COLUMN id SET DEFAULT nextval('cochrane_reviews_id_seq'::regclass); - - -- -- Name: id; Type: DEFAULT; Schema: public; Owner: - -- @@ -821,22 +578,23 @@ ALTER TABLE ONLY knex_migrations ALTER COLUMN id SET DEFAULT nextval('knex_migra -- --- Name: id; Type: DEFAULT; Schema: public; Owner: - +-- Name: document_categories_name_group_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- -ALTER TABLE ONLY organisation ALTER COLUMN id SET DEFAULT nextval('organisation_id_seq'::regclass); +ALTER TABLE ONLY document_categories + ADD CONSTRAINT document_categories_name_group_unique UNIQUE (name, "group"); -- --- Name: cochrane_reviews_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: document_categories_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- -ALTER TABLE ONLY cochrane_reviews - ADD CONSTRAINT cochrane_reviews_pkey PRIMARY KEY (id); +ALTER TABLE ONLY document_categories + ADD CONSTRAINT document_categories_pkey PRIMARY KEY (id); -- --- Name: documents_fda_approval_id_file_id_name_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: documents_fda_approval_id_file_id_name_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY documents @@ -844,7 +602,7 @@ ALTER TABLE ONLY documents -- --- Name: documents_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: documents_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY documents @@ -852,7 +610,7 @@ ALTER TABLE ONLY documents -- --- Name: fda_applications_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: fda_applications_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY fda_applications @@ -860,7 +618,7 @@ ALTER TABLE ONLY fda_applications -- --- Name: fda_approvals_fda_application_id_supplement_number_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: fda_approvals_fda_application_id_supplement_number_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY fda_approvals @@ -868,7 +626,7 @@ ALTER TABLE ONLY fda_approvals -- --- Name: fda_approvals_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: fda_approvals_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY fda_approvals @@ -876,7 +634,7 @@ ALTER TABLE ONLY fda_approvals -- --- Name: files_documentcloud_id_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: files_documentcloud_id_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY files @@ -884,7 +642,7 @@ ALTER TABLE ONLY files -- --- Name: files_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: files_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY files @@ -892,7 +650,7 @@ ALTER TABLE ONLY files -- --- Name: files_sha1_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: files_sha1_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY files @@ -900,7 +658,7 @@ ALTER TABLE ONLY files -- --- Name: files_source_url_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: files_source_url_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY files @@ -908,7 +666,7 @@ ALTER TABLE ONLY files -- --- Name: interventions_name_type_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: interventions_name_type_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY interventions @@ -916,7 +674,7 @@ ALTER TABLE ONLY interventions -- --- Name: interventions_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: interventions_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY interventions @@ -924,7 +682,7 @@ ALTER TABLE ONLY interventions -- --- Name: interventions_slug_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: interventions_slug_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY interventions @@ -932,7 +690,7 @@ ALTER TABLE ONLY interventions -- --- Name: knex_migrations_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: knex_migrations_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY knex_migrations @@ -940,7 +698,7 @@ ALTER TABLE ONLY knex_migrations -- --- Name: locations_name_type_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: locations_name_type_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY locations @@ -948,7 +706,7 @@ ALTER TABLE ONLY locations -- --- Name: locations_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: locations_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY locations @@ -956,7 +714,7 @@ ALTER TABLE ONLY locations -- --- Name: locations_slug_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: locations_slug_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY locations @@ -964,15 +722,7 @@ ALTER TABLE ONLY locations -- --- Name: organisation_pkey; Type: CONSTRAINT; Schema: public; Owner: - --- - -ALTER TABLE ONLY organisation - ADD CONSTRAINT organisation_pkey PRIMARY KEY (id); - - --- --- Name: organisations_name_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: organisations_name_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY organisations @@ -980,7 +730,7 @@ ALTER TABLE ONLY organisations -- --- Name: organisations_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: organisations_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY organisations @@ -988,7 +738,7 @@ ALTER TABLE ONLY organisations -- --- Name: organisations_slug_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: organisations_slug_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY organisations @@ -996,7 +746,7 @@ ALTER TABLE ONLY organisations -- --- Name: persons_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: persons_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY persons @@ -1004,7 +754,7 @@ ALTER TABLE ONLY persons -- --- Name: persons_slug_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: persons_slug_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY persons @@ -1012,7 +762,7 @@ ALTER TABLE ONLY persons -- --- Name: problems_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: problems_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY conditions @@ -1020,7 +770,7 @@ ALTER TABLE ONLY conditions -- --- Name: problems_slug_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: problems_slug_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY conditions @@ -1028,7 +778,7 @@ ALTER TABLE ONLY conditions -- --- Name: publications_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: publications_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY publications @@ -1036,7 +786,7 @@ ALTER TABLE ONLY publications -- --- Name: publications_slug_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: publications_slug_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY publications @@ -1044,7 +794,15 @@ ALTER TABLE ONLY publications -- --- Name: risk_of_bias_criterias_name_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: records_source_url_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: +-- + +ALTER TABLE ONLY records + ADD CONSTRAINT records_source_url_unique UNIQUE (source_url); + + +-- +-- Name: risk_of_bias_criterias_name_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY risk_of_bias_criterias @@ -1052,7 +810,7 @@ ALTER TABLE ONLY risk_of_bias_criterias -- --- Name: risk_of_bias_criterias_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: risk_of_bias_criterias_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY risk_of_bias_criterias @@ -1060,7 +818,7 @@ ALTER TABLE ONLY risk_of_bias_criterias -- --- Name: risk_of_biases_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: risk_of_biases_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY risk_of_biases @@ -1068,7 +826,7 @@ ALTER TABLE ONLY risk_of_biases -- --- Name: risk_of_biases_risk_of_bias_criterias_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: risk_of_biases_risk_of_bias_criterias_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY risk_of_biases_risk_of_bias_criterias @@ -1076,7 +834,7 @@ ALTER TABLE ONLY risk_of_biases_risk_of_bias_criterias -- --- Name: risk_of_biases_study_id_source_url_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: risk_of_biases_study_id_source_url_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY risk_of_biases @@ -1084,7 +842,7 @@ ALTER TABLE ONLY risk_of_biases -- --- Name: sources_name_type_unique; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: sources_name_type_unique; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY sources @@ -1092,7 +850,7 @@ ALTER TABLE ONLY sources -- --- Name: sources_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: sources_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY sources @@ -1100,7 +858,7 @@ ALTER TABLE ONLY sources -- --- Name: trialrecords_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: trialrecords_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY records @@ -1108,7 +866,7 @@ ALTER TABLE ONLY records -- --- Name: trials_documents_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: trials_documents_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY trials_documents @@ -1116,7 +874,7 @@ ALTER TABLE ONLY trials_documents -- --- Name: trials_interventions_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: trials_interventions_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY trials_interventions @@ -1124,7 +882,7 @@ ALTER TABLE ONLY trials_interventions -- --- Name: trials_locations_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: trials_locations_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY trials_locations @@ -1132,7 +890,7 @@ ALTER TABLE ONLY trials_locations -- --- Name: trials_organisations_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: trials_organisations_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY trials_organisations @@ -1140,7 +898,7 @@ ALTER TABLE ONLY trials_organisations -- --- Name: trials_persons_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: trials_persons_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY trials_persons @@ -1148,7 +906,7 @@ ALTER TABLE ONLY trials_persons -- --- Name: trials_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: trials_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY trials @@ -1156,7 +914,7 @@ ALTER TABLE ONLY trials -- --- Name: trials_problems_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: trials_problems_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY trials_conditions @@ -1164,7 +922,7 @@ ALTER TABLE ONLY trials_conditions -- --- Name: trials_publications_pkey; Type: CONSTRAINT; Schema: public; Owner: - +-- Name: trials_publications_pkey; Type: CONSTRAINT; Schema: public; Owner: -; Tablespace: -- ALTER TABLE ONLY trials_publications @@ -1172,52 +930,46 @@ ALTER TABLE ONLY trials_publications -- --- Name: fda_approvals_type_index; Type: INDEX; Schema: public; Owner: - +-- Name: fda_approvals_type_index; Type: INDEX; Schema: public; Owner: -; Tablespace: -- CREATE INDEX fda_approvals_type_index ON fda_approvals USING btree (type); -- --- Name: interventions_fda_application_number_index; Type: INDEX; Schema: public; Owner: - +-- Name: interventions_fda_application_number_index; Type: INDEX; Schema: public; Owner: -; Tablespace: -- CREATE INDEX interventions_fda_application_number_index ON interventions USING btree (fda_application_id); -- --- Name: non_fda_documents_type_file_id_unique; Type: INDEX; Schema: public; Owner: - --- - -CREATE UNIQUE INDEX non_fda_documents_type_file_id_unique ON documents USING btree (type, file_id) WHERE (fda_approval_id IS NULL); - - --- --- Name: non_fda_documents_type_source_url_unique; Type: INDEX; Schema: public; Owner: - +-- Name: records_identifiers_index; Type: INDEX; Schema: public; Owner: -; Tablespace: -- -CREATE UNIQUE INDEX non_fda_documents_type_source_url_unique ON documents USING btree (type, source_url) WHERE (fda_approval_id IS NULL); +CREATE INDEX records_identifiers_index ON records USING gin (identifiers); -- --- Name: records_identifiers_index; Type: INDEX; Schema: public; Owner: - +-- Name: trialrecords_trial_id_index; Type: INDEX; Schema: public; Owner: -; Tablespace: -- -CREATE INDEX records_identifiers_index ON records USING gin (identifiers); +CREATE INDEX trialrecords_trial_id_index ON records USING btree (trial_id); -- --- Name: trialrecords_trial_id_index; Type: INDEX; Schema: public; Owner: - +-- Name: trials_documents_document_id_index; Type: INDEX; Schema: public; Owner: -; Tablespace: -- -CREATE INDEX trialrecords_trial_id_index ON records USING btree (trial_id); +CREATE INDEX trials_documents_document_id_index ON trials_documents USING btree (document_id); -- --- Name: trials_documents_document_id_index; Type: INDEX; Schema: public; Owner: - +-- Name: documents_document_category_id_foreign; Type: FK CONSTRAINT; Schema: public; Owner: - -- -CREATE INDEX trials_documents_document_id_index ON trials_documents USING btree (document_id); +ALTER TABLE ONLY documents + ADD CONSTRAINT documents_document_category_id_foreign FOREIGN KEY (document_category_id) REFERENCES document_categories(id); -- From a1ef975bc284c45ed84eed89ce7170e332b8c6b0 Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Thu, 9 Feb 2017 16:50:04 -0300 Subject: [PATCH 18/23] Alter numpy requirement installation --- requirements.txt | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/requirements.txt b/requirements.txt index dd95bf5..3ef5749 100644 --- a/requirements.txt +++ b/requirements.txt @@ -24,6 +24,7 @@ docutils==0.13.1 # via botocore doublemetaphone==0.1 # via dedupe et-xmlfile==1.0.1 # via openpyxl ezodf==0.3.2 # via tabulator +numpy==1.12.0 fastcluster==1.1.22 # via dedupe functools32==3.2.3.post2 # via jsonschema future==0.16.0 # via dedupe, dedupe-hcluster, jsontableschema, rlr @@ -45,7 +46,6 @@ lxml==3.7.2 # via tabulator mako==1.0.6 # via alembic markupsafe==0.23 # via mako normality==0.3.9 # via dataset -numpy==1.12.0 # via canonicalize, categorical-distance, dedupe-hcluster, highered, pyhacrf-datamade, pylbfgs, rlr, simplecosine openpyxl==2.4.2 # via tabulator packaging==16.8 # via setuptools persistent==4.2.2 # via btrees, zope.index From 687ba3573cfe314ecfff635c9a87a4ec88494bd1 Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Thu, 9 Feb 2017 17:08:05 -0300 Subject: [PATCH 19/23] Fix location test --- tests/processors/base/helpers/test_helpers.py | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/tests/processors/base/helpers/test_helpers.py b/tests/processors/base/helpers/test_helpers.py index a3d5ab8..40a5672 100644 --- a/tests/processors/base/helpers/test_helpers.py +++ b/tests/processors/base/helpers/test_helpers.py @@ -133,7 +133,7 @@ class TestLocationNormalizer(object): # Locations normalized by ISO-3166 acronym standards ("US", "United States"), - ("UK", "United Kingdom"), + ("UK", "United Kingdom of Great Britain and Northern Ireland"), # Locations normalized by Levenshtein distance (name) ("Chnia", "China"), From 5f2ef1c14fa86024590d1b82c8c1960a8384ce8d Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Fri, 10 Feb 2017 14:41:45 -0300 Subject: [PATCH 20/23] Organize requirements file --- requirements.txt | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/requirements.txt b/requirements.txt index 3ef5749..dd95bf5 100644 --- a/requirements.txt +++ b/requirements.txt @@ -24,7 +24,6 @@ docutils==0.13.1 # via botocore doublemetaphone==0.1 # via dedupe et-xmlfile==1.0.1 # via openpyxl ezodf==0.3.2 # via tabulator -numpy==1.12.0 fastcluster==1.1.22 # via dedupe functools32==3.2.3.post2 # via jsonschema future==0.16.0 # via dedupe, dedupe-hcluster, jsontableschema, rlr @@ -46,6 +45,7 @@ lxml==3.7.2 # via tabulator mako==1.0.6 # via alembic markupsafe==0.23 # via mako normality==0.3.9 # via dataset +numpy==1.12.0 # via canonicalize, categorical-distance, dedupe-hcluster, highered, pyhacrf-datamade, pylbfgs, rlr, simplecosine openpyxl==2.4.2 # via tabulator packaging==16.8 # via setuptools persistent==4.2.2 # via btrees, zope.index From 1d452c823a452b9c1aabf7228d5dd06fc1024bd7 Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Tue, 14 Feb 2017 11:42:45 -0300 Subject: [PATCH 21/23] Avoid to install all depedencies on tox deps --- tox.ini | 3 ++- 1 file changed, 2 insertions(+), 1 deletion(-) diff --git a/tox.ini b/tox.ini index e362287..439e5df 100644 --- a/tox.ini +++ b/tox.ini @@ -6,7 +6,7 @@ skipsdist = True [testenv] deps = - -r{toxinidir}/requirements.txt + numpy pytest mock setenv = @@ -15,6 +15,7 @@ passenv = TEST_WAREHOUSE_URL TEST_DATABASE_URL commands = + pip install -r {toxinidir}/requirements.txt py.test {posargs} [testenv:lint] From 25c2618f41086aadd1931225e2b00433b9999b07 Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Tue, 14 Feb 2017 11:49:00 -0300 Subject: [PATCH 22/23] Add comment explaining why tox's not installing requirements on deps --- tox.ini | 2 ++ 1 file changed, 2 insertions(+) diff --git a/tox.ini b/tox.ini index 439e5df..c856cea 100644 --- a/tox.ini +++ b/tox.ini @@ -14,6 +14,8 @@ setenv = passenv = TEST_WAREHOUSE_URL TEST_DATABASE_URL +# Installing requirements after tox deps for depedency reasons +# See: https://github.com/opentrials/processors/pull/116 commands = pip install -r {toxinidir}/requirements.txt py.test {posargs} From 129f16bfb1e744abdff8b72859c5bbb9ac5d4cc7 Mon Sep 17 00:00:00 2001 From: Felipe Vieira Date: Thu, 23 Feb 2017 15:50:41 -0300 Subject: [PATCH 23/23] Refact code --- processors/base/helpers/__init__.py | 15 ++++++++----- tests/conftest.py | 1 - .../warehouse/organisation_clusters.py | 22 ------------------- tests/processors/base/helpers/test_helpers.py | 12 ++++++++-- 4 files changed, 19 insertions(+), 31 deletions(-) delete mode 100644 tests/fixtures/warehouse/organisation_clusters.py diff --git a/processors/base/helpers/__init__.py b/processors/base/helpers/__init__.py index 0bf70e2..7a02d98 100644 --- a/processors/base/helpers/__init__.py +++ b/processors/base/helpers/__init__.py @@ -340,25 +340,28 @@ def get_canonical_organisation_name(conn, organisation): conn (dict): connection dict organisation (str): the organisation to be normalized """ - CLUSTER_QUERY = "SELECT canonical " + \ - "FROM organisation_clusters " + \ - "WHERE '%s'=ANY(variations)" % organisation + CLUSTER_QUERY = 'SELECT canonical FROM organisation_clusters ' + \ + 'WHERE :organisation=ANY(variations)' normalized_form = organisation # Try to find the organisation in some cluster try: - normalized_form = conn['warehouse'].query(CLUSTER_QUERY).next()['canonical'] + normalized_form = conn['warehouse'].query(CLUSTER_QUERY, + organisation=organisation).next()['canonical'] logger.debug('Organisation "%s" normalized as "%s"', organisation, normalized_form) except StopIteration: logger.debug('Organisation "%s" not normalized', organisation) - pass return normalized_form def _dedup_cluster(cluster_entries): - """Sample, train and build organisation clusters + """Sample, train and build organisation clusters. + Labeled training example used for clustering purposes + is stored in data/organisation_training_data.json and + can be regenerated using Dedupe consoleLabel tool + See: http://dedupe.readthedocs.io/en/latest/API-documentation.html#consoleLabel Args: cluster_entries (list): a list of candidates to diff --git a/tests/conftest.py b/tests/conftest.py index db13501..6ebb508 100644 --- a/tests/conftest.py +++ b/tests/conftest.py @@ -25,7 +25,6 @@ from tests.fixtures.warehouse.cochrane_reviews import cochrane_review from tests.fixtures.warehouse.nct import nct_record -from tests.fixtures.warehouse.organisation_clusters import organisation_cluster @pytest.fixture def conn(request): diff --git a/tests/fixtures/warehouse/organisation_clusters.py b/tests/fixtures/warehouse/organisation_clusters.py deleted file mode 100644 index b23511e..0000000 --- a/tests/fixtures/warehouse/organisation_clusters.py +++ /dev/null @@ -1,22 +0,0 @@ -# -*- coding: utf-8 -*- -from __future__ import absolute_import -from __future__ import division -from __future__ import print_function -from __future__ import unicode_literals - -import pytest - -@pytest.fixture -def organisation_cluster(conn): - cluster_ghent = { - 'canonical': 'Ghent University Hospital', - 'variations': ['Ghent University Hospital', 'Ghent University'] - } - - cluster_justus = { - 'canonical': 'Justus Liebig University of Giessen', - 'variations': ['Justus Liebig University of Giessen', 'Justus Liebig'] - } - - conn['warehouse']['organisation_clusters'].insert(cluster_ghent) - conn['warehouse']['organisation_clusters'].insert(cluster_justus) \ No newline at end of file diff --git a/tests/processors/base/helpers/test_helpers.py b/tests/processors/base/helpers/test_helpers.py index 40a5672..8f554d1 100644 --- a/tests/processors/base/helpers/test_helpers.py +++ b/tests/processors/base/helpers/test_helpers.py @@ -150,9 +150,17 @@ def test_location_normalizer(self, test_input, expected): assert helpers.get_canonical_location_name(test_input) == expected class TestOrganisationNormalizer(object): + def _create_organisation_cluster(self, conn, canonical_name, variations): + cluster = { + 'canonical': canonical_name, + 'variations': [canonical_name] + [variations] + } + conn['warehouse']['organisation_clusters'].insert(cluster) + @pytest.mark.parametrize("test_input,expected", [ # Organisation normalized with a longer equivalent - ("Ghent University", "Ghent University Hospital"), + ("VERTEX PHARMS INC", "VERTEX PHARMS"), + ("Alliance Pharmaceuticals", "Alliance Pharmaceuticals Ltd"), # Organisation normalized as it is (the longest available form) ("Justus Liebig University of Giessen", @@ -163,6 +171,6 @@ class TestOrganisationNormalizer(object): "Federal University of Campina Grande"), ]) - @pytest.mark.usefixtures('organisation_cluster') def test_organisation_normalizer(self, conn, test_input, expected): + self._create_organisation_cluster(conn, expected, test_input) assert helpers.get_canonical_organisation_name(conn, test_input) == expected \ No newline at end of file